Apple CD-ROM Explorer/Apple CD-ROM Explorer.bin/Aries Medline/MESHDB.ARID

Text File | 1987-06-09 | 5MB | 1 lines

 SH*abnormalities (Subheading) LA; ; ; ; ; ; ; ; ; ; ; MSUsed with organs for congenital defects producing changes in the morphology of the organ. OLsearch policy: Online Manual; use: main heading/AB or AB (SH) or SUBS APPLY AB ANsubhead only; congenital & structural only: does not include abnormal function ( = /physiopathology or disease heading); includes ╥deformity╙, ╥malformation╙, ╥anomalous╙, ╥teratology╙; includes agenesis, aplasia, atresia, ectopy, hypoplasia, etc.; includes more or less than the normal number of organs (as one ureter, six fingers); see MeSH scope note in Introduction; indexing policy: Manual 19.4.1; DF: /abnorm or /AB LT LQ  SH*administration & dosage (Subheading) LA MSUsed with drugs for dosage forms, routes of administration, frequency and duration of administration, quantity of medication, and the effects of these factors. OLsearch policy: Online Manual; use: main heading/AD or AD (SH) or SUBS APPLY AD ANsubhead only; for routes of administration, timing, amounts of doses; not for ╥dosage╙ in Romance languages ( = /analysis) ; see MeSH scope note in Introduction; indexing policy: Manual 19.4.2; DF: /admin or /AD LT LQ  SH*adverse effects (Subheading) LA; ; ; ; ; MSUsed with drugs, chemicals, or biological agents in accepted dosage, - or with physical agents or manufactured products in normal usage, - when intended for diagnostic, therapeutic, prophylactic or anesthetic purposes. Used also for adverse effects or complications of diagnostic, therapeutic, prophylactic, anesthetic, surgical, or other procedures. OLsearch policy: Online Manual; use: main heading/AE or AE (SH) or SUBS APPLY AE ANsubhead only; includes ╥injurious effects╙, ╥undesirable effects ╙, ╥side effects╙ in normal use; for complications following various procedures; see also /poisoning & /toxicity ; see MeSH scope note in Introduction; indexing policy: Manual 19.4.3; DF: /adv eff or /AE LT LQ  SH*analogs & derivatives (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with drugs and chemicals for substances that share the same parent molecule or have similar electronic structure but differ by the addition or substitution of other atoms or molecules. Used when the specific chemical heading is not available, and no appropriate group heading exists. OLsearch policy: Online Manual; use: main heading/AA or AA (SH) or SUBS APPLY AA ANsubhead only; includes ╥related compounds╙, ╥simulants╙; do not use with elements, isotopes, plural chemicals or enzymes; see MeSH scope note in Introduction; indexing policy: Manual 19.4.4; DF: /analogs or /AA LT LQ  SH*analysis (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed for the identification or quantitative determination of a substance or its constituents and metabolites; includes the chemical analysis of tissues, tumors, body fluids, organisms, plants, air, water, or other environmental carrier. Applies to both methodology and results. For analysis of substances in blood, cerebrospinal fluid, and urine the specific subheading designating the fluid is used. OLsearch policy: Online Manual; use: main heading/AN or AN (SH) or SUBS APPLY AN ANsubhead only; includes ╥assay╙, ╥determination╙, ╥chemical analysis╙; for qualitative or quantitative analysis of substances; for chemical composition of organs & organisms, as ╥chemical composition of the liver╙ = LIVER /analysis; for analysis of chemical substances in the blood use /blood; in the cerebrospinal fluid, use /cerebrospinal fluid; in the urine, use /urine; see MeSH scope note in Introduction; indexing policy: Manual 19.4.5; DF: /anal or /AN LT LQ  SH*anatomy & histology (Subheading) LA; ; ; ; MSUsed with organs, regions, and tissues for normal descriptive anatomy and histology; used for normal anatomy and structure of animals and plants. OLsearch policy: Online Manual; use: main heading/AH or AH (SH) or SUBS APPLY AH ANsubhead only; includes ╥morphology╙; normal structure only; for disordered structural change use /pathology; see also /cytology & /ultrastructure; see also /blood supply & /innervation; see also /abnormalities; see MeSH scope note in Introduction; indexing policy: Manual 19.4.6; DF: /anat or /AH LT LQ  SH*antagonists & inhibitors (Subheading) LA MSUsed with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism. OLsearch policy: Online Manual; use: main heading/AI or AI (SH) or SUBS APPLY AI ANsubhead only; for exogenous & endogenous substances; see MeSH scope note in Introduction; indexing policy: Manual 19.4.7; DF: /antag or /AI LT LQ  SH*biosynthesis (Subheading) LA MSUsed for the formation of chemical substances in organisms, in living cells, or by subcellular fractions. OLsearch policy: Online Manual; use: main heading/BI or BI (SH) or SUBS APPLY BI ANsubhead only; includes ╥formation╙ & ╥production╙ of substances by living tissue or organisms; see MeSH scope note in Introduction; indexing policy: Manual 19.4.8; DF /biosyn or /BI LT LQ  SH*blood (Subheading) LA; ; ; ; ; ; ; ; ; MSUsed for the presence or analysis of substances in the blood; also for examination of, or changes in, the blood in disease states. Excludes serodiagnosis, for which the subheading ╥diagnosis╙ is used, and serology, for which ╥immunology╙ is used. OLsearch policy: Online Manual; use: main heading/BL or BL (SH) or SUBS APPLY BL ANsubhead only; for ╥in blood╙ or ╥blood in╙ animals or diseases; includes the presence of cells, coagulating elements, endogenous & exogenous chemical substances; not for ╥serology╙ ( = /immunology), nor for ╥serodiagnosis╙ ( = /diagnosis), nor for the presence of microbes or parasites in the blood in disease ( = /microbiology or /parasitology); see MeSH scope note in Introduction; indexing policy: Manual 19.4.9; DF: /blood or /BL LT LQ  SH*blood supply (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed for arterial, capillary, and venous systems of an organ or region whenever the specific heading for the vessel does not exist; includes blood flow through the organ. OLsearch policy: Online Manual; use: main heading/BS or BS (SH) or SUBS APPLY BS ANsubhead only; includes arteries, veins, capillaries & microvasculature; covers vascular anatomy, circulation & pressure; see MeSH scope note in Introduction; indexing policy: Manual 19.4.10; DF: /blood supply or /BS LT LQ  SH*cerebrospinal fluid (Subheading) LA; ; ; ; ; ; ; ; ; MSUsed for the presence or analysis of substances in the cerebrospinal fluid; also for examination of or changes in cerebrospinal fluid in disease states. OLsearch policy: Online Manual; use: main heading/CF or CF (SH) or SUBS APPLY CF ANsubhead only; for ╥in cerebrospinal fluid╙ or ╥cerebrospinal fluid in╙ animals or diseases; includes the presence of cells & endogenous & exogenous chemical substances; not for the presence of microbes or parasites in the cerebrospinal fluid in disease ( = /microbiology or /parasitology); see MeSH scope note in Introduction; indexing policy: Manual 19.4.11; DF: /csf or /CF LT LQ  SH*chemical synthesis (Subheading) LA MSUsed for the chemical preparation of molecules in vitro. For the formation of chemical substances in organisms, living cells, or subcellular fractions, ╥biosynthesis╙ is used. OLsearch policy: Online Manual; use: main heading/CS or CS (SH) or SUBS APPLY CS ANsubhead only; for chemical preparation or production of substances in vitro only, in laboratories or industry; not for formation of substances in living tissue ( = /biosynthesis); see MeSH scope note in Introduction; indexing policy: Manual 19.4.12; DF: /chem syn or /CS LT LQ  SH*chemically induced (Subheading) LA; MSUsed for diseases, syndromes, congenital abnormalities, or symptoms caused by chemical compounds in man or animals. OLsearch policy: Online Manual; use: main heading/CI or CI (SH) or SUBS APPLY CI ANsubhead only; for diseases induced by exogenous substances only; see MeSH scope note in Introduction; indexing policy: Manual 19.4.13; DF: /chem ind or /CI LT LQ  SH*classification (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed for taxonomic or other systematic or hierarchical classification systems. OLsearch policy: Online Manual; use: main heading/CL or CL (SH) or SUBS APPLY CL ANsubhead only; includes ╥taxonomy╙, ╥systematics╙, ╥hierarchies╙; indexing policy: Manual 19.4.14; DF: /class or /CL LT LQ  SH*complications (Subheading) LA; MSUsed with diseases to indicate conditions that co-exist or follow, i.e. co-existing diseases, complications, or sequelae. OLsearch policy: Online Manual; use: main heading/CO or CO (SH) or SUBS APPLY CO ANsubhead only; includes ╥sequelae╙; also for ╥co-existent╙ or ╥associated╙ diseases; see MeSH scope note in Introduction; indexing policy: Manual 19.4.15; DF: /compl or /CO LT LQ  SH*congenital (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with disease headings to indicate those conditions existing at, and usually before birth; excludes morphologic abnormalities and birth injuries, for which ╥abnormalities╙ and ╥injuries╙ are used. OLsearch policy: Online Manual; use: main heading/CN or CN (SH) or SUBS APPLY CN ANsubhead only; diseases existing at or before birth; not for structural abnormalities ( = /abnormalities) nor for birth injuries ( = /injuries); indexing policy: Manual 19.4.16; DF: /congen or /CN LT LQ  SH*cytology (Subheading) LA; ; ; ; ; MSUsed for normal cellular morphology of unicellular and multicellular organisms. OLsearch policy: Online Manual; use: main heading/CY or CY (SH) or SUBS APPLY CY ANsubhead only; normal structure only; for non-normal, use /pathology; includes cellular & intracellular structure, morphology, multiplication, cell cycle, differentiation, etc.; see also /ultrastructure; see MeSH scope note in Introduction; indexing policy: Manual 19.4.17; DF: /cytol or /CY LT LQ  SH*deficiency (Subheading) LA MSUsed with endogenous and exogenous substances which are absent or in diminished amount relative to the normal requirement of an organism or a biologic system. OLsearch policy: Online Manual; use: main heading/DF or DF (SH) or SUBS APPLY DF ANsubhead only; for deficient or inadequate intake or biosynthesis; also for deficient secretion of endogenous substances; see MeSH scope note in Introduction; indexing policy: Manual 19.4.18; /DF: /defic or DF LT LQ  SH*diagnosis (Subheading) LA; MSUsed with diseases for all aspects of diagnosis, including examination, differential diagnosis and prognosis; excludes mass screening for which ╥prevention & control╙ is used. The subheading ╥radiography╙ is used for radiographic diagnosis. OLsearch policy: Online Manual; use: main heading/DI or DI (SH) or SUBS APPLY DI ANsubhead only; includes ╥examination╙, ╥symptoms╙, ╥differential diagnosis╙; not for X-ray diagnosis ( = /radiography), nor for radioisotope scanning ( = /radionuclide imaging), nor for mass screening ( = prevention & control); indexing policy: Manual 19.4.19; DF: /diag or /DI LT LQ  SH*diagnostic use (Subheading) LA; MSUsed with chemical compounds, drugs, and physical agents when used for studies of clinical function of an organ, or for the diagnosis of human or animal diseases. OLsearch policy: Online Manual; use: main heading/DU or DU (SH) or SUBS APPLY DU ANsubhead only; for substances & physical agents used in diagnosis of disease or study of organ function; see MeSH scope note in Introduction; indexing policy: Manual 19.4.20; DF: /diag use or /DU LT LQ  SH*diet therapy (Subheading) LA; MSUsed with disease headings for dietary and nutritional management of the disease. Does not include vitamin or mineral supplements, for which ╥drug therapy╙ may be used. OLsearch policy: Online Manual; use: main heading/DH or DH (SH) or SUBS APPLY DH ANsubhead only; for dietary & nutritional management of a disease by a physician; not for self diets; not for vitamin or mineral supplements prescribed by a physician ( = /drug therapy); indexing policy: Manual 19.4.2l; DF: /diet ther or /DH LT LQ  SH*drug effects (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with organs, regions, tissues, or organisms and physiological and psychological processes for the effects of drugs and chemicals. OLsearch policy: Online Manual; use: main heading/DE or DE (SH) or SUBS APPLY DE ANsubhead only; for effect of exogenously administered drugs & chemicals; includes their mechanism of action; see MeSH scope note in Introduction; indexing policy: Manual 19.4.22; DF: /drug eff or /DE LT LQ  SH*drug therapy (Subheading) LA; MSUsed with disease headings for the treatment of the disease by the administration of drugs, chemicals, and antibiotics. For diet therapy and radiotherapy, use specific subheadings. Excludes immunotherapy and treatment with biologicals for which ╥therapy╙ is used. OLsearch policy: Online Manual; use: main heading/DT or DT (SH) or SUBS APPLY DT ANsubhead only; includes treatment or prevention by drugs & chemicals; includes therapy with antibiotics; not for immunotherapy ( = /therapy) nor for tissue therapy or therapy with biological products ( = /therapy); see MeSH scope note in Introduction; indexing policy: Manual 19.4.23; DF: /drug ther or /DT LT LQ  SH*economics (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; MSUsed for the economic aspects of any subject, as well as for all aspects of financial management. Includes the raising or providing of funds. OLsearch policy: Online Manual; use: main heading/EC or EC (SH) or SUBS APPLY EC ANsubhead only; includes ╥finances╙, ╥financing╙, ╥funding╙, ╥costs╙, ╥fees╙, ╥salaries╙, ╥financial management╙, etc.; see MeSH scope note in Introduction; indexing policy: Manual 19.4.69; DF: /econ or /EC LT LQ  SH*education (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; MSUsed for education and training programs in various fields and disciplines, and for training groups of persons. OLsearch policy: Online Manual; use: main heading/ED or ED (SH) or SUBS APPLY ED ANsubhead only; includes ╥training╙, ╥teaching╙, ╥curriculum╙; for the teacher teaching, the student learning & the courses taught; see MeSH scope note in Introduction; indexing policy: Manual 19.4.24; DF: /educ or /ED LT LQ  SH*embryology (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with organs, regions, and animal headings for embryologic and fetal development; also used with diseases for embryologic factors contributing to postnatal disorders. OLsearch policy: Online Manual; use: main heading/EM or EM (SH) or SUBS APPLY EM ANsubhead only; includes ╥embryonic╙, ╥embryonal╙, ╥embryological aspects╙; for embryonic & fetal development; see MeSH scope note in Introduction; indexing policy: Manual 19.4.25; DF: /embryol or /EM LT LQ  SH*enzymology (Subheading) LA; ; ; ; ; ; ; MSUsed with organisms, except vertebrates, and with organs and tissues, also used, with diseases, for enzymes during the course of the disease. Excludes diagnostic enzyme tests, for which ╥diagnosis╙ is used. OLsearch policy: Online Manual; use: main heading/EN or EN (SH) or SUBS APPLY EN ANsubhead only; for enzymatic metabolism, kinetics, analysis & inhibition; not for enzyme tests ( = /diagnosis); see MeSH scope note in Introduction; indexing policy: Manual 19.4.26; DF: /enzymol or /EN LT LQ  SH*ethnology (Subheading) LA; ; ; ; ; ; ; ; MSUsed with diseases for ethnic or racial aspects, and with geographic headings to indicate the place of origin of a group of people. OLsearch policy: Online Manual; use: main heading/EH or EH (SH) or SUBS APPLY EH ANsubhead only; with disease & selected terms for ╥the place of origin of a group of people╙; with geog terms for the place of origin of people living outside their native land, as New York City Cubans ( = CUBA/ethnology); indexing policy: Manual 19.4.27; DF: /ethnol or /EH LT LQ  SH*etiology (Subheading) LA; MSUsed with diseases for causative agents including microorganisms; includes environmental and social factors and personal habits as contributing factors; includes pathogenesis. OLsearch policy: Online Manual; use: main heading/ET or ET (SH) or SUBS APPLY ET ANsubhead only; includes ╥pathogenesis╙ & ╥causes╙; see MeSH scope note in Introduction; indexing policy: Manual 19.4.28; DF: /etiol or /ET LT LQ  SH*familial & genetic (Subheading) LA; MSUsed for studies of genetic basis of disease; studies of diseases occurring in family groups due to environmental factors including infection, and common family dietary habits; includes hereditary disease. OLsearch policy: Online Manual; use: main heading/FG or FG (SH) or SUBS APPLY FG ANsubhead only; includes ╥hereditary╙; with diseases only; see also /genetics; see MeSH scope note in Introduction; indexing policy: Manual 19.4.29; DF: /familial or /FG LT LQ  SH*genetics (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed for studies of the mechanisms of heredity in organisms, or genetic aspects of endogenous chemicals. OLsearch policy: Online Manual; use: main heading/GE or GE (SH) or SUBS APPLY GE ANsubhead only; includes ╥heredity╙; with organisms for genetic discussions; with endogenous chemicals only for their genetic aspects; for genetic aspects of disease use /familial & genetic; indexing policy: Manual 19.4.70; DF: /genet or /GE LT LQ  SH*growth & development (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with microorganisms, plants, and the postnatal period of animals for growth and development; includes postnatal growth or development of organs or anatomical parts. OLsearch policy: Online Manual; use: main heading/GD or GD (SH) or SUBS APPLY GD ANsubhead only; for micro-organisms & plants; with animals, for postnatal development only: for prenatal development, see /embryology; see MeSH scope note in Introduction; indexing policy: Manual 19.4.30; DF: /growth or /GD LT LQ  SH*history (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed for the historical aspects of any subject; includes brief historical notes. Excludes case histories. OLsearch policy: Online Manual; use: main heading/HI or HI (SH) or SUBS APPLY HI ANsubhead only; for historical articles or historical notes in articles; not for ╥case histories╙ ( = check tag CASE REPORT); see MeSH scope note in Introduction; indexing policy: Manual 19.4.31; DF: /hist or /HI LT LQ  SH*immunology (Subheading) LA; ; ; ; ; ; ; ; ; ; MSUsed for immunologic studies of tissues, organs, microorganisms, fungi, viruses, and animals; includes immunologic aspects of diseases but not immunologic procedures used for diagnostic, preventive, or therapeutic purposes, for which ╥diagnosis╙, ╥prevention & control╙, or ╥therapy╙ are used. Also used for chemicals as antigens or haptens. OLsearch policy: Online Manual; use: main heading/IM or IM (SH) or SUBS APPLY IM ANsubhead only; for ╥immunological aspects╙ or ╥serological aspects╙; for substances as antigens or haptens; for antibodies to substances, organs or organisms; not for immunotherapy ( = /therapy), nor for immunologic prevention, as with vaccines ( = /prevention & control), nor for serodiagnosis ( = /diagnosis); see MeSH scope note in Introduction; indexing policy: Manual 19.4.32; DF: /immunol or /IM LT LQ  SH*in adolescence (Subheading) LA; ; ; MSUsed for occurrence during adolescence, 13 to 18 years of age. OLsearch policy: CATLINE, AVLINE only; Online Manual; use: main heading/AO or SUBS APPLY AO ANsubhead only; for catalogers only; covers ages 13 to 18 years; indexers use check tag ADOLESCENCE (see Manual 18.5) LT LQ  SH*in adulthood (Subheading) LA; ; ; MSUsed for occurrence during adulthood, 19 to 44 years of age. OLsearch policy: CATLINE, AVLINE only; Online Manual; use: main heading/AU or SUBS APPLY AU ANsubhead only; for catalogers only; covers ages 19 to 44 years; indexers use check tag ADULT (see Manual 18.5) LT LQ  SH*in infancy & childhood (Subheading) LA; ; ; MSUsed for occurrence during infancy and childhood, birth to 12 years of age. OLsearch policy: CATLINE, AVLINE only; Online Manual; use: main heading/IC or SUBS APPLY IC ANsubhead only; for catalogers only; covers ages 0 to 12 years; indexers use check tags INFANT; INFANT, NEWBORN; CHILD; CHILD, PRESCHOOL (see Manual 18.5) LT LQ  SH*in middle age (Subheading) LA; ; ; MSUsed for occurrence during middle age, 45 to 64 years of age. OLsearch policy: CATLINE, AVLINE only; Online Manual; use: main heading/MY or SUBS APPLY MY ANsubhead only; for catalogers only; covers ages 45 to 64 years; indexers use check tag MIDDLE AGE (see Manual 18.5) LT LQ  SH*in old age (Subheading) LA; ; ; MSUsed for occurrence during old age, 65 years of age and older. OLsearch policy: CATLINE, AVLINE only; Online Manual; use: main heading/OA or SUBS APPLY OA ANsubhead only; for catalogers only; covers ages 65 years & older; indexers use check tag AGED (see Manual 18.5) LT LQ  SH*in pregnancy (Subheading) LA; ; ; MSUsed for occurrence during pregnancy. OLsearch policy: CATLINE, AVLINE only; Online Manual; use: main heading/PR or SUBS APPLY PR ANsubhead only; for catalogers only; indexers use check tag PREGNANCY (see Manual 18.4) LT LQ  SH*injuries (Subheading) LA; ; ; ; ; ; ; ; ; ; ; MSUsed with anatomic headings for wounds and injuries. Excludes cell damage, for which ╥pathology╙ is used. OLsearch policy: Online Manual; use: main heading/IN or IN (SH) or SUBS APPLY IN ANsubhead only; by physical trauma only; includes ╥wounds╙, ╥trauma╙; for ╥lesion╙ in Romance languages; not for cell damage ( = /pathology); indexing policy: Manual 19.4.33; DF: /inj or /IN LT LQ  SH*innervation (Subheading) LA; ; ; ; ; ; ; ; ; ; ; MSUsed with organs, regions, or tissues for their nerve supply. OLsearch policy: Online Manual; use: main heading/IR or IR (SH) or SUBS APPLY IR ANsubhead only; includes ╥nerve supply╙; see MeSH scope note in Introduction; indexing policy: Manual 19.4.34; DF: /innerv or /IR LT LQ  SH*instrumentation (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with diagnostic or therapeutic procedures, analytic technics, and specialties or disciplines, for the development or modification of apparatus, instruments, or equipment. OLsearch policy: Online Manual; use: main heading/IS or IS (SH) or SUBS APPLY IS ANsubhead only; includes ╥apparatus╙, ╥appliances╙, ╥instruments╙,╥equipment╙, ╥supplies╙, ╥devices╙; not for technics ( = /methods); see MeSH scope note in Introduction; indexing policy: Manual 19.4.35; DF: /instrum or /IS LT LQ  SH*isolation & purification (Subheading) LA; ; ; ; MSUsed with bacteria, viruses, fungi, protozoa, and helminths for the obtaining of pure strains or for the demonstration of the presence of or identification of organisms by DNA analyses, immunologic, or other methods; includes culture technics. Also with biological substances and chemicals for the isolation and purification of the constituents. OLsearch policy: Online Manual; use: main heading/IP or IP (SH) or SUBS APPLY IP ANsubhead only; with micro-organisms & helminths includes obtaining pure strains, demonstrating presence & culture technics but consider also /growth & development; with chemicals & biological substances includes isolation of constituents; indexing policy: Manual 19.4.36; DF: /isol or /IP LT LQ  SH*legislation & jurisprudence (Subheading) LA; ; ; ; ; MSUsed for laws, statutes, ordinances, or government regulations, as well as for legal controversy and court decisions. OLsearch policy: Online Manual; use: main heading/LJ or LJ (SH) or SUBS APPLY LJ ANsubhead only; includes ╥legal╙, ╥laws╙, ╥government regulations╙,╥statutes╙, ╥ordinances╙, ╥medicolegal╙, ╥judicial╙, ╥juridical╙, ╥suits╙, ╥avoidance of suits╙, ╥litigation╙, ╥court decisions╙; indexing policy: Manual 19.4.71; DF: /legis or /LJ LT LQ  SH*manpower (Subheading) LA; ; ; ; ; ; ; ; ; ; MSUsed with disciplines and programs for the demand, supply, distribution, recruitment, and use of personnel. OLsearch policy: Online Manual; use: main heading/MA or MA (SH) or SUBS APPLY MA ANsubhead only; for availability of personnel only; see MeSH scope note in Introduction; indexing policy: Manual 19.4.37; DF: /man or /MA LT LQ  SH*metabolism (Subheading) LA; ; ; ; ; ; ; ; ; ; MSUsed with organs, cells and subcellular fractions, organisms, and diseases for metabolism; with drugs and chemicals for absorption, distribution, and excretion. For biosynthesis, enzymology, and secretion use the specific subheadings. OLsearch policy: Online Manual; use: main heading/ME or ME (SH) or SUBS APPLY ME ANsubhead only; includes ╥absorption╙, ╥anabolism╙, ╥binding╙, ╥catabolism╙, ╥conversion╙, ╥degradation╙, ╥distribution╙, ╥incorporation╙, ╥mobilization╙, ╥pharmacokinetics╙, ╥release╙, ╥splitting╙, ╥storage╙, ╥transport╙, ╥turnover╙, ╥uptake╙, ╥utilization╙; for excretion into the blood use /blood, into the cerebrospinal fluid use /cerebrospinal fluid, into the urine use /urine; for biosynthesis or synthesis use /biosynthesis; for secretion use /secretion; for any metabolic aspect of enzymes use /enzymology; indexing policy: Manual 19.4.38; DF: /metab or /ME LT LQ  SH*methods (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with technics, procedures, and programs for methods. OLsearch policy: Online Manual; use: main heading/MT or MT (SH) or SUBS APPLY MT ANsubhead only; includes ╥technic╙, ╥methodology╙, ╥procedures╙; see also /instrumentation; indexing policy: Manual 19.4.39; DF: /methods or /MT LT LQ  SH*microbiology (Subheading) LA; ; ; ; ; ; MSUsed with organs, animals and higher plants and with diseases for microbiologic studies. For parasites, ╥parasitology╙ is used. OLsearch policy: Online Manual; use: main heading/MI or MI (SH) or SUBS APPLY MI ANsubhead only; for bacteria, rickettsia, viruses, fungi & nonparasitic protozoa; for parasitic protozoa use /parasitology; for ability of organisms to cause disease use /pathogenicity; see MeSH scope note in Introduction; indexing policy: Manual 19.4.40; DF: /microbiol or /MI LT LQ  SH*mortality (Subheading) LA; ; ; MSUsed with diseases for mortality statistics, and with procedures for deaths resulting from the procedure. OLsearch policy: Online Manual; use: main heading/MO or MO (SH) or SUBS APPLY MO ANsubhead only; includes ╥survival╙; see MeSH scope note in Introduction; indexing policy: Manual 19.4.41; DF: /mortal or /MO LT LQ  SH*nursing (Subheading) LA; ; MSUsed with diseases for nursing care and technics in their management; includes the nursing role in diagnostic, therapeutic, and preventive procedures. OLsearch policy: Online Manual; use: main heading/NU or NU (SH) or SUBS APPLY NU ANsubhead only; includes ╥nursing care╙ by professional nurse or physician-prescribed home programs; see MeSH scope note in Introduction; indexing policy: Manual 19.4.42; DF: /nurs or /NU LT LQ  SH*occurrence (Subheading) LA; ; ; MSUsed with diseases for incidence and prevalence; includes endemic and epidemic outbreaks; includes surveys and estimates of morbidity in geographic areas and in subdivisions of populations. Excludes mortality, for which ╥mortality╙ is used. OLsearch policy: Online Manual; use: main heading/OC or OC (SH) or SUBS APPLY OC ANsubhead only; includes ╥epidemiology╙, ╥statistics╙, ╥incidence╙, ╥outbreaks╙, ╥frequency╙, ╥prevalence╙, ╥morbidity╙; not for ╥mortality╙ ( = /mortality); see MeSH scope note in Introduction; indexing policy: Manual 19.4.43; DF: /occur or /OC LT LQ  SH*organization & administration (Subheading) LA; ; ; ; MSUsed for administrative structure and management. OLsearch policy: Online Manual; use: main heading/OG or OG (SH) or SUBS APPLY OG ANsubhead only; includes organizational structure & management; indexing policy: Manual 19.4.72; DF: /organ or /OG LT LQ  SH*parasitology (Subheading) LA; ; ; ; ; ; MSUsed with animals, higher plants, organs and diseases for parasitic factors; do not use if the parasitic involvement is implicit in the diagnosis. OLsearch policy: Online Manual; use: main heading/PS or PS (SH) or SUBS APPLY PS ANsubhead only; for parasitic protozoa & higher parasites; for non-parasitic protozoa use /microbiology; see MeSH scope note in Introduction; indexing policy: Manual 19.4.44; DF: /parasitol or /PS LT LQ  SH*pathogenicity (Subheading) LA; ; ; MSUsed with microorganisms, viruses, and parasites for studies of their ability to cause disease in man or animals. OLsearch policy: Online Manual; use: main heading/PY or PY (SH) or SUBS APPLY PY ANsubhead only; for the potential ability of micro-organisms or parasites to cause disease in man or animal under specified conditions: not for specific infections; includes virulence; see MeSH scope note in Introduction; indexing policy: Manual 19.4.45; DF: /pathogen or /PY LT LQ  SH*pathology (Subheading) LA; ; ; MSUsed for organ, tissue, or cell structure in disease states. OLsearch policy: Online Manual; use: main heading/PA or PA (SH) or SUBS APPLY PA ANsubhead only; for description of tissue or cell structure in disease: not for normal tissue ( = /anatomy & histology) nor for normal cells ( = /cytology); not a synonym for ╥disease╙; includes biopsy; for subcellular pathology use /ultrastruct; indexing policy: Manual 19.4.46; DF: /pathol or /PA LT LQ  SH*pharmacodynamics (Subheading) LA MSUsed with drugs and exogenously administered chemical substances for their actions on tissues and organisms; includes effects upon metabolism, acceleration or inhibition of biological processes, and the mechanisms of action. OLsearch policy: Online Manual; use: main heading/PD or PD (SH) or SUBS APPLY PD ANsubhead only; includes ╥pharmacology╙, ╥mechanism of action╙, ╥mode of action╙; not for pharmacokinetics ( = /metabolism); see also /adverse effects, /poisoning & /toxicity; see MeSH scope note in Introduction; indexing policy: Manual 19.4.47; DF: /pharm or /PD LT LQ  SH*physiology (Subheading) LA; ; ; ; ; ; ; ; ; ; MSUsed with organs, tissues, and cells of unicellular and multicellular organisms for normal function; used also with biochemical substances, endogenously produced, for their physiologic role. OLsearch policy: Online Manual; use: main heading/PH or PH (SH) or SUBS APPLY PH ANsubhead only; normal ╥function╙ only: for function in disease use /physiopathology; with endogenous chemicals only, for their physiologic role; see MeSH scope note in Introduction; indexing policy: Manual 19.4.48; DF: /physiol or /PH LT LQ  SH*physiopathology (Subheading) LA; ; MSUsed with organs and diseases for disordered function in disease states. OLsearch policy: Online Manual; use: main heading/PP or PP (SH) or SUBS APPLY PP ANsubhead only; for function of organs in disease states only; not a synonym for ╥disease╙; indexing policy: Manual 19.4.49; DF: /physiopathology or /PP LT LQ  SH*poisoning (Subheading) LA; MSUsed with drugs, chemicals, and industrial materials for human or animal poisoning, acute or chronic, whether the poisoning is accidental, occupational, suicidal, by medication error, or by environmental exposure. OLsearch policy: Online Manual; use: main heading/PO or PO (SH) or SUBS APPLY PO ANsubhead only; for clinical & veterinary only; for human & animal experiments use /toxicity; see also /adverse effects & /toxicity; see MeSH scope note in Introduction; indexing policy: Manual 19.4.50; DF: /pois or /PO LT LQ  SH*prevention & control (Subheading) LA; ; ; ; MSUsed with disease headings for increasing human or animal resistance against disease, (e.g. immunization); for control of transmission agents; for prevention and control of environmental hazards; for prevention and control of social factors leading to disease; includes preventive measures in individual cases. OLsearch policy: Online Manual; use: main heading/PC or PC (SH) or SUBS APPLY PC ANsubhead only; includes ╥preventive therapy╙; includes vaccination; for prevention on epidemiologic or personal level; see MeSH scope note in Introduction; indexing policy: Manual 19.4.51; DF: /prev or /PC LT LQ  SH*psychology (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with non-psychiatric disease, technics, and named groups for psychologic, psychiatric, psychosomatic, psychosocial, behavioral, and emotional aspects, and with psychiatric disease for psychologic aspects. OLsearch policy: Online Manual; use: main heading/PX or PX (SH) or SUBS APPLY PX ANsubhead only; includes ╥psychiatric╙, ╥psychosomatic╙, ╥psychogenic╙, ╥emotional╙, ╥affective╙, ╥behavioral╙; see MeSH scope note in Introduction; indexing policy: Manual 19.4.73; DF: /psychol or /PX LT LQ  SH*radiation effects (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed for effects of ionizing and nonionizing radiation upon living organisms, organs and tissues, and their constituents, and upon physiologic processes; includes effect of irradiation on drugs and chemicals. OLsearch policy: Online Manual; use: main heading/RE or RE (SH) or SUBS APPLY RE ANsubhead only; includes ionizing & non-ionizing radiation; not for therapeutic effect of radiations ( = /radiotherapy); see MeSH scope note in Introduction; indexing policy: Manual 19.4.52; DF: /rad eff or /RE LT LQ  SH*radiography (Subheading) LA; MSUsed with organs, regions, and diseases for x-ray examinations. Does not include radionuclide imaging for which ╥radionuclide imaging╙ is used. OLsearch policy: Online Manual; use: main heading/RA or RA (SH) or SUBS APPLY RA ANsubhead only; includes ╥x-ray diagnosis╙, ╥roentgenography╙; not for radioisotope scanning ( = /radionuclide imaging); indexing policy: Manual 19.4.53; DF: /radiogr or /RA LT LQ  SH*radionuclide imaging (Subheading) LA; MSUsed for radionuclide imaging of any anatomical structure, or for the diagnosis of disease. OLsearch policy: Online Manual; use: main heading/RI or RI (SH) or SUBS APPLY RI ANsubhead only; includes ╥radioisotope scanning╙; see MeSH scope note in Introduction; indexing policy: Manual 19.4.74; DF: /radionuclide or /RI LT LQ  SH*radiotherapy (Subheading) LA MSUsed with disease headings for the therapeutic use of ionizing and nonionizing radiation; includes use of radioisotope therapy. OLsearch policy: Online Manual; use: main heading/RT or RT (SH) or SUBS APPLY RT ANsubhead only; includes x-ray, radioisotope, other ionizing radiation & non-ionizing radiation; indexing policy: Manual 19.4.54; DF: /radiother or /RT LT LQ  SH*rehabilitation (Subheading) LA; ; MSUsed with diseases and surgical procedures for restoration of function of the individual. OLsearch policy: Online Manual; use: main heading/RH or RH (SH) or SUBS APPLY RH ANsubhead only; for restoration of patient to pre-disease or pre-therapy state; for ╥re-education╙ in French; indexing policy: Manual 19.4.55; DF: /rehabil or /RH LT LQ  SH*secondary (Subheading) LA MSUsed to indicate the secondary location to which the neoplastic process has metastasized. OLsearch policy: Online Manual; use: main heading/SC or SC (SH) or SUBS APPLY SC ANsubhead only; for cancer only; includes ╥metastatic cancer╙ but not ╥cancer metastasizing to╙ ( = /pathology + NEOPLASM METASTASIS); see MeSH scope note in Introduction; indexing policy: Manual 19.4.76; DF: /second or /SC LT LQ  SH*secretion (Subheading) LA; ; MSUsed for the discharge across the cell membrane, into the intracellular space or ducts, of endogenous substances resulting from the activity of intact cells of glands, tissues, or organs. OLsearch policy: Online Manual; use: main heading/SE or SE (SH) or SUBS APPLY SE ANsubhead only; for the act or function of secreting: not for ╥secretions╙; see MeSH scope note in Introduction; indexing policy: Manual 19.4.56; DF: /secret or /SE LT LQ  SH*standards (Subheading) LA; ; ; ; ; ; ; ; ; ; MSUsed with facilities, personnel, and program headings for the development, testing, and application of standards of adequacy or acceptable performance, used with chemicals and drugs for standards of identification, quality, and potency; includes health or safety standards in industries and occupations. OLsearch policy: Online Manual; use: main heading/ST or ST (SH) or SUBS APPLY ST ANsubhead only; for standards in testing & performance of programs & procedures; with drugs for standards in assay technics, quality & potency; see MeSH scope note in Introduction; indexing policy: Manual 19.4.57; DF: /stand or /ST LT LQ  SH*supply & distribution (Subheading) LA; ; ; ; ; ; ; ; ; MSUsed for the quantitative availability and distribution of material, equipment, health services, and facilities. Excludes food supply and water supply in industries and occupations. OLsearch policy: Online Manual; use: main heading/SD or SD (SH) or SUBS APPLY SD ANsubhead only; includes ╥availability╙; for personnel, services & facilities; for drugs; not for food ( = FOOD SUPPLY) nor for water ( = WATER SUPPLY); see MeSH scope note in Introduction; indexing policy: Manual 19.4.58; DF: /supply or /SD LT LQ  SH*surgery (Subheading) LA; ; ; MSUsed for operative procedures on organs, regions, or tissues in the treatment of diseases; includes tissue section by lasers. Excludes transplantation, for which ╥transplantation╙ is used. OLsearch policy: Online Manual; use: main heading/SU or SU (SH) or SUBS APPLY SU ANsubhead only; includes ╥operation╙, ╥surgical therapy╙; for tissue section or coagulation by laser; not for transplantation ( = /transplantation); indexing policy: Manual 19.4.59; DF: /surg or /SU LT LQ  SH*therapeutic use (Subheading) LA; MSUsed with drugs, biological preparations, and physical agents for their use in the prophylaxis and treatment of disease; includes veterinary use. OLsearch policy: Online Manual; use: main heading/TU or TU (SH) or SUBS APPLY TU ANsubhead only; for treatment or preventive use of drugs or physical agents in clinical or experimental human or animal disease; indexing policy: Manual 19.4.60; DF: /ther use or /TU LT LQ  SH*therapy (Subheading) LA; MSUsed with diseases for therapies except drug therapy, diet therapy, radiotherapy, and surgery, for which subheadings exist; also to be used for articles dealing with multiple therapies. OLsearch policy: Online Manual; use: main heading/TH or TH (SH) or SUBS APPLY TH ANsubhead only; for general or unspecified therapy & multiple therapies; for immunotherapy, tissue therapy & therapy with biological products; not for drug therapy ( =/drug therapy), nor for diet therapy ( = /diet therapy), nor for surgical therapy ( = /surgery), nor for radiotherapy ( = /radiotherapy), nor for rehabilitative therapy ( = /rehabilitation); indexing policy: Manual 19.4.61; DF: /ther or /TH LT LQ  SH*toxicity (Subheading) LA; MSUsed with drugs and chemicals for experimental human and animal studies of their ill effects; includes studies to determine the margin of safety or the reactions accompanying administration at various dose levels; used also for experimental studies of exposure to environmental agents. OLsearch policy: Online Manual; use: main heading/TO or TO (SH) or SUBS APPLY TO ANsubhead only; for experimental human & animal studies; includes margin of safety & experimental exposure to environmental agents; see also /adverse effects & /poisoning; see MeSH scope note in Introduction; indexing policy: Manual 19.4.62; DF: /tox or /TO LT LQ  SH*transmission (Subheading) LA MSUsed with diseases for studies of the modes of transmission. OLsearch policy: Online Manual; use: main heading/TM or TM (SH) or SUBS APPLY TM ANsubhead only; for transmission & mechanism of transmission of disease from man to man, from man to animal, from animal to man or animal to animal; indexing policy: Manual 19.4.63; DF: /transm or /TM LT LQ  SH*transplantation (Subheading) LA MSUsed with organs, tissues, or cells for transplantation from one site to another within the same subject, or from one subject to another of the same species or different species. OLsearch policy: Online Manual; use: main heading/TR or TR (SH) or SUBS APPLY TR ANsubhead only; includes ╥grafts╙ & ╥grafting╙ from one site to another in the same subject, from one to another of same species, from one to another of a different species; indexing policy: Manual 19.4.64; DF: /transpl or /TR LT LQ  SH*trends (Subheading) LA; ; ; ; ; ; ; MSUsed for the manner in which a subject changes, qualitatively or quantitatively, with time, whether past, present, or future. Excludes discussions of the course of disease in particular patients. OLsearch policy: Online Manual; use: main heading/TD or TD (SH) or SUBS APPLY TD ANsubhead only; includes ╥forecasting╙ & ╥futurology╙; for a continuum from past to present, present to future; see MeSH scope note in Introduction; indexing policy: Manual 19.4.75; DF: /trends or /TD LT LQ  SH*ultrastructure (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed with tissues and cells (including neoplasms) and microorganisms for microanatomic structures, generally below the size visible by light microscopy. OLsearch policy: Online Manual; use: main heading/UL or UL (SH) or SUBS APPLY UL ANsubhead only; for normal or pathological subcellular structure; see MeSH scope note in Introduction; indexing policy: Manual 19.4.65; DF: /ultrastruct or /UL LT LQ  SH*urine (Subheading) LA; ; ; ; ; ; ; ; ; MSUsed for the presence or analysis of substances in the urine; also for the examination of, or changes in, the urine in diseases. OLsearch policy: Online Manual; use: main heading/UR or UR (SH) or SUBS APPLY UR ANsubhead only; for ╥in urine╙ or ╥urine in╙ animals or diseases; includes the presence of cells & endogenous & exogenous chemical substances; not for the presence of microbes or parasites in the urine in disease ( = /microbiology or /parasitology); see MeSH scope note in Introduction; indexing policy: Manual 19.4.66; DF: /urine or /UR LT LQ  SH*utilization (Subheading) LA; ; ; ; ; ; ; ; MSUsed with equipment, facilities, programs, services, and health personnel for discussions, usually with data, of how much they are used. Includes discussions of overuse and underuse. OLsearch policy: Online Manual; use: main heading/UT or UT (SH) or SUBS APPLY UT ANsubhead only; not for ╥use╙ of procedures in treating or diagnosing patients; only for how much equipment, facilities, services & personnel are used, underused, overused or abused; indexing policy: Manual 19.4.67; DF: /util or /UT LT LQ  SH*veterinary (Subheading) LA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; MSUsed for naturally occurring diseases in animals, or for diagnostic, preventive, or therapeutic procedures used in veterinary medicine. OLsearch policy: Online Manual; use: main heading/VE or VE (SH) or SUBS APPLY VE ANsubhead only; for pets & domestic, wild & zoo animals in veterinary medicine; for laboratory animals only if of concern to the veterinarian, not as experimental animals; see MeSH scope note in Introduction; indexing policy: Manual 19.4.68; DF: /vet or /VE LT LQ  MSAn ionophorous antibiotic from Streptomyces chartreusensis. It binds and transports cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. PM84; was see under ANTIBIOTICS 1975-83 HN84(75); was see under ANTIBIOTICS 1975-83 MHÑA-23187 ANdo not use /defic /physiol RN52665-69-7 PIAntibiotics (73-74); Carboxylic Acids (73-74) MND8.373.936.500.25; D20.85.10 LH  HN(72) MHÑAbate ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN3383-96-8 PIInsecticides (66-71) MND2.719.27; D5.723.491.657.31 DMÑInsecticides, Organothiophosphate LH LM  MSPlaces where animals are slaughtered and dressed for market. MHÑAbattoirs ANonly /econ /hist /stand MNJ1.576.598.256 XSSLAUGHTERHOUSES LH LS  MSShortened forms of written words or phrases used for brevity. MHÑAbbreviations ANincludes acronyms; IM; no qualif CATALOG: /form /lang MNL1.143.506.598.400.556.131 LH  MHÑAbdomen ANregion & abdominal organs (tend to prefer specific organs); not for rectus abdominis & other abdom muscles (index under ABDOMINAL WALL); /inj = ABDOMINAL INJURIES; abdominal pain = ABDOMEN (IM) + PAIN (IM); abrupt dis requiring emerg surg = ABDOMEN, ACUTE MNA1.47 LH  MSClinical syndrome characterized by abdominal pain of great severity associated with other symptoms and signs, usually those of acute peritonitis, which might well be the result of a ruptured abdominal viscus or a similar abdominal catastrophe requiring urgent surgical operation. MHÑAbdomen, Acute ANabrupt abdom dis requiring emerg surg MNC23.304.61 LH  MHÑAbdominal Injuries ANgeneral term for inj of organs in the abdom cavity; prefer specific organs /inj MNC21.866.17 LH  MHÑAbdominal Neoplasms ANgeneral term for neopl of organs in the abdom cavity; prefer specific organ/neopl terms; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl if given (IM) MNC4.588.33 LH  MHÑAbdominal Wall ANrectus abdominis & other abdom muscles go here; hernia = HERNIA, VENTRAL MNA2.633.61; A2.633.740.61 LH  OLuse ABDUCENS NERVE to search ABDUCENT NERVE back thru 1966 PM77; was ABDUCENT NERVE 1963-76 HN77; was ABDUCENT NERVE 1963-76 MHÑAbducens Nerve AN6th cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.44 LH  MSA defective murine leukemia virus capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with Friend, Moloney or Rauscher virus. HN(80) MHÑAbelson Leukemia Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) PIMouse Leukemia Viruses (66-79) MNB4.909.574.807.674.632.41; B4.909.777.731.674.632.41; B4.909.777.779.674.632.41 DMÑMouse Leukemia Viruses LH LM  PM66 HN66(64) MHÑAbetalipoproteinemia ANdo not confuse with HYPOBETALIPOPROTEINEMIA MNC10.228.140.163.47; C15.378.147.68; C18.452.648.556.485.131 XSBASSEN-KORNZWEIG SYNDROME LH LS  MSCongenital malformations of organs or parts; includes the field of teratology. Use for general material; for abnormalities of a specific part use the subheading ╥Abnormalities╙ after the name of the part. MHÑAbnormalities ANGEN only: prefer /abnorm: Manual 19.5+; /chem ind = ABNORMALITIES, DRUG-INDUCED; do not use /compl /congen; policy: Manual 23.26+; TN 109: relation to /congen & INFANT, NEWBORN, DISEASES MNC16.131 XSBirth Defects; Congenital Defects; DEFORMITIES FXÑFetal Diseases LH LS; ; LX  MSCongenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother or to which she is inadvertently exposed during the manufacture of such substances. Excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.  PM64 HN64 MHÑAbnormalities, Drug-Induced ANIM; do not use /chem ind /compl /congen; coord IM with specific chem /ad-poi-tox (IM) + specific organ /abnorm or specific abnorm /chem ind (IM); Manual 23.26.2 MNC16.131.42; C21.613.276.131 FXÑMaternal-Fetal Exchange; ÑTeratogens LH LX;  PM68 HN68 MHÑAbnormalities, Multiple ANIM; do not use /compl /congen; coord IM with specific abnorm (IM); Manual 23.26.3 PIAbnormalities (66-67) MNC16.131.77 XUÑOrofaciodigital Syndromes; ÑRubinstein-Taybi Syndrome; ÑWaardenburg's Syndrome LH LU; ;  MSCongenital changes in the morphology of organs produced by exposure to ionizing and non-ionizing radiation. PM79 HN79 MHÑAbnormalities, Radiation-Induced ANIM; do not use /compl /congen; coord IM with specific abnorm (IM) PIAbnormalities (66-78); Radiation Injuries (66-78) MNC16.131.80; C21.866.733.31; G3.850.810.300.360.31 LH  MSThe major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present; A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. OLuse ABO BLOOD-GROUP SYSTEM to search ABO FACTORS back thru 1966 PM76; was ABO FACTORS 1963-75 HN76; was ABO FACTORS 1963-75 MHÑABO Blood-Group System ANonly /genet /immunol; TN 230 MND24.611.216.705.230.31; G4.610.241.31; G9.188.229.31 XSABO Factors LH LS  PM68 HN68 MHÑAbomasum ANabomasal cancer = ABOMASUM + NEOPLASMS (not STOMACH NEOPLASMS); abomasal ulcer = ABOMASUM + ULCER (not STOMACH ULCER) PIStomach (66-67) MNA13.869.106 LH  MSChemical substances that interrupt pregnancy after implantation. PM75 HN75 MHÑAbortifacient Agents ANdo not use /analogs /biosyn /defic /physiol; do not use /ther use for use of abortifacients as abortifacients PIAbortion, Induced (70-74) MND7.131 XUÑAbortifacient Agents, Non-Steroidal; ÑAbortifacient Agents, Steroidal LH LU;  MSNon-steroidal chemical compounds with abortifacient activity. HN(75) MHÑAbortifacient Agents, Non-Steroidal ANdo not use /analogs /biosyn /defic /physiol PIAbortion, Induced (70-74); specific chemical (71-74) MND7.131.100 DMÑAbortifacient Agents LH LM  MSSteroidal compounds with abortifacient activity. HN(75) MHÑAbortifacient Agents, Steroidal ANdo not use /analogs /biosyn /defic /physiol PIAbortion, Induced (70-74); specific chemical (70-74) MND7.131.200 DMÑAbortifacient Agents LH LM  MSExpulsion of the products of conception before the 20th completed week of gestation without deliberate interference. MHÑAbortion AN/chem ind permitted but do not confuse with ABORTION, INDUCED (E4); /chem ind: consider also ABORTIFACIENT AGENTS; /ther permitted; do not use /prev; /vet = ABORTION, VETERINARY; ╥chronic abortion╙ = ABORTION, HABITUAL; don't forget also check tags HUMAN & FEMALE & PREGNANCY MNC13.703.39 XSMISCARRIAGE LH LS  MSIndividuals requesting induced abortions. PM76; was see under ABORTION 1975 HN76(75); was see under ABORTION 1975 MHÑAbortion Applicants ANonly /psychol; don't forget also check tags HUMAN & FEMALE & PREGNANCY PIAbortion, Induced (70-74); Abortion, Therapeutic (66-74) MNM1.50 XSAbortion Seekers LH LS  MSIllegal termination of pregnancy. MHÑAbortion, Criminal ANno qualif; don't forget also check tags HUMAN & FEMALE & PREGNANCY; for abortifacients in crim abort see note on ABORTION, INDUCED MNI1.198.240.89 XSAbortion, Illegal LH LS  MSAbortion performed because of possible fetal defects. HN(75) MHÑAbortion, Eugenic ANdo not use /util except by MeSH definition; don't forget also check tags HUMAN or ANIMAL & FEMALE & PREGNANCY MNE4.819.774.173.90 XSEugenic Abortion DMÑAbortion, Induced LH LS LM  MSThree or more consecutive spontaneous abortions. MHÑAbortion, Habitual AN/prev /ther /vet permitted; don't forget also check tags FEMALE & PREGNANCY MNC13.703.39.89 LH  MSAbortion in which not all the products of conception have been expelled. PM75 HN75 MHÑAbortion, Incomplete ANrestrict to spontaneous, not induced abortions; do not use /prev; don't forget also check tags FEMALE & PREGNANCY PIAbortion (66-74) MNC13.703.39.93 LH  OLuse ABORTION, INDUCED to search EMBRYOTOMY back thru 1966; search ABORTION, CRIMINAL & ABORTION, LEGAL & ABORTION, THERAPEUTIC 1966-70 PM71; was see under ABORTION, CRIMINAL & ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85 HN71; was see under ABORTION, CRIMINAL & ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85 MHÑAbortion, Induced AN/vet permitted; do not use /util except by MeSH definition; for ABORTION, CRIMINAL, Cat D term with no qualif unless text specifically discusses adverse eff ( = /adv eff); don't forget also check tags FEMALE & PREGNANCY CATALOG: /geog /form PIAbortion, Criminal (66-70); Abortion, Legal (66-70); Abortion, Therapeutic (66-70) MNE4.819.774.173 XSEmbryotomy XUÑAbortion, Eugenic LH LS LU  PM64 HN64 MHÑAbortion, Legal AN/adv eff permitted; do not use /util (except by MeSH definition) /vet; don't forget also HUMAN & FEMALE & PREGNANCY CATALOG: /geog /form MNE4.819.774.173.173 XSAbortion on Demand FXÑPopulation Control LH LS LX  MSThe retention in the uterus of a dead fetus two months or more after its death. MHÑAbortion, Missed AN/prev /ther /vet permitted; don't forget also check tags FEMALE & PREGNANCY MNC13.703.39.173 LH  MSInfected abortion in which there is dissemination of microorganisms and their products into the maternal systemic circulation. MHÑAbortion, Septic AN/prev /ther permitted; /vet permitted only if discussed as ╥septic╙ abortion: do not use automatically for animal abortion in brucellosis, vibriosis, trichomoniasis, etc. in animals; don't forget also check tags FEMALE & PREGNANCY MNC1.539.674.173; C13.703.39.256; C13.703.700.173 LH  MHÑAbortion, Therapeutic AN/vet permitted; do not use /util except by MeSH definition; don't forget also check tags FEMALE & PREGNANCY MNE4.819.774.173.340 LH  MSCondition of vaginal bleeding with or without pain in early pregnancy which may presage an abortion. MHÑAbortion, Threatened AN/prev /ther /vet permitted; don't forget check tags FEMALE & PREGNANCY MNC13.703.39.339 LH  MSPremature expulsion of the fetus in animals. MHÑAbortion, Veterinary ANIM + specific type of abortion with /vet (NIM); don't forget also check tags ANIMAL & FEMALE & PREGNANCY MNC13.703.39.422; C22.21 LH  MSA process in psychotherapy in which the patient is ╥desensitized╙ to emotionally painful, often forgotten (repressed) memories by recalling and reacting to them in the ╥safety╙ of the treatment setting. PM68 HN68 MHÑAbreaction ANno qualif MNF4.754.919.107 XUÑCatharsis LH LU  MSAgglutinin. Toxalbumin from seeds of jequirity, Abrus precatorius L. Very active poison. Two peptide chains are held together by disulfide bonds. HN(75) MHÑAbrin ANdo not use /defic /physiol; /analogs NIM only RN1393-62-0 PIDisulfides (73-74); Plant Proteins (71-75) MND12.776.765.60; D24.185.526.545.60; D24.310.545.60; D24.611.125.44.545.60 DMÑPlant Proteins LH LM  MSPremature separation of the normally implanted placenta. MHÑAbruptio Placentae MNC13.703.420.78; C13.703.590.132 LH  MHÑAbscess ANIM; coord IM with site (organ/dis term) (IM) + precoord organism/infect term (IM); if unspecified bacterial abscess do not coord with BACTERIAL INFECTIONS (since most abscesses are bact) but coord with specific bact infect term if given (as ABSCESS + STAPH INFECTIONS); amebic abscess = AMEBIASIS but note that LIVER ABSCESS, AMEBIC is available MNC1.539.26; C23.739.487.90 LH  MHÑAbscess, Peritonsillar MNC1.539.26.69; C8.730.817.257; C9.775.107 LH  MSPlant growth substances isolated from fruit. HN(75) MHÑAbscissins ANdo not use /analogs /defic /physiol PICyclohexanecarboxylic Acids (74) MND2.241.223.268.30; D11.303.760.30 XSAbscissic Acid I; Abscissic Acid II DMÑCyclohexanecarboxylic Acids LH LS; LM  MSChronic absence from work or other duty. HNwas in Cat F & J 1967-82, was in Cat F & I 1963-66 MHÑAbsenteeism ANIM; no qualif MNF2.784.692.107 LH  MHÑAbsorption ANalmost never IM; no qualif; coord NIM with substance /metab (IM) or organ /metab (IM) when absorptive process, degree or rate in article; TN 1: relation to metab & importance in pharmacol MNH1.181.529.23 LH  MSShortening or summarizing of documents; assigning of descriptors for referencing documents. MHÑAbstracting and Indexing ANIM; only /econ /hist /methods /stand /trends; med abstracting & indexing: do not coord with MEDICINE; DF: ABSTRACTING MNL1.300.100 XSIndexing LH LS  PM70 HN70 MHÑAbutments, Dental ANno qualif PIDental Cavity Preparation (66-69); Denture, Partial (66-69) MNE6.780.377.45 LH  MSAny leguminous woody vine or tree of the genus Acacia, also called locust or wattle; the gums and tanning agents obtained from Acacia are called GUM ARABIC. HN(86)63 MHÑAcacia ANdo not use /isol /pathogen; acacia pharmaceut agents are probably GUM ARABIC (Cat D) MNB6.15; B6.915.63 XSLocust Tree; Wattle Tree DMÑTrees LH LS; LM  MSMedical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc. OLsearch HOSPITALS, UNIVERSITY 1979 PM80; was see HOSPITALS, UNIVERSITY 1979 HN80; was see HOSPITALS, UNIVERSITY 1979 MHÑAcademic Medical Centers ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util; specify geog CATALOG: /geog /form PIHospitals, Teaching (68-74); Hospitals, University (75-79) MNN2.278.20 XSMedical Centers, Academic; Medical Centers, University; University Medical Centers LH LS; ;  MSOrganizations representing specialized fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., National Academy of Sciences, Brookings Institution, etc. PM70 HN70(65) MHÑAcademies and Institutes ANnot for educ acad & institutes ( = SCHOOLS or its indentions); only /class /hist /organ /stand; Acad of Med: do not index also under MEDICINE; NY Acad of Med: when geog coord needed use NEW YORK CITY; DF: ACADEMIES CATALOG: /geog /form MNN3.540.52 XSInstitutes; Research Institutes LH LS;  MSA phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine. OLsearch HELMINTHS 1966-73 PM74; was see under HELMINTHS 1963-73 HN74; was see under HELMINTHS 1963-73 MHÑAcanthocephala ANdo not use /blood-csf-urine; infection: coord NIM with HELMINTHIASIS (IM) MNB1.500.132 XSThorny-Headed Worms XUÑMoniliformis LH LS LU  MSErythrocytes with protoplasmic projections giving the cell a thorny appearance. HN(75) MHÑAcanthocytes ANA 11 qualif & /class MNA11.118.413.330.100; A15.145.229.413.330.100 DMÑErythrocytes, Abnormal LH LM  MSSeparation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer; seen in diseases such as pemphigus vulgaris and keratosis follicularis. HN(69) MHÑAcantholysis PISkin/PA (66-68); specific skin disease/PA (66-68) MNC17.816.70; C23.739.35 DMÑSkin Diseases LH LM  MSA circumscribed melanosis consisting of a brown pigmented velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. Occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder. MHÑAcanthosis Nigricans MNC17.621.530.100 LH  MSA large, cosmopolitan order of arachnids comprising the mites and ticks, including parasites of plants, animals, and man, as well as several important disease vectors. PM75 HN75 MHÑAcari ANGEN, comprising the MITES and TICKS; /microbiol /parasitol permitted; acaricides: index under INSECTICIDES even though Acari are not insects PIArachnida (66-74) MNB1.131.166.132 LH  MHÑAcceleration ANIM; only /adv eff MNH1.671.538.107 FXÑAviation XUÑDeceleration LH LX LU  MHÑAccessory Nerve AN11th cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.83 XSSPINAL ACCESSORY NERVE LH LS  MHÑAccident Prevention ANno qualif MNG3.850.110.60 FXÑPROTECTIVE DEVICES XUÑSafety LH LX LU  MSTendency toward involvement in accidents. Implies certain personality characteristics which predispose to accidents. PM75 HN75 MHÑAccident Proneness ANno qualif PIAccidents (66-74) MNF1.145.15 LH  MSFalls due to slipping or tripping which result in injury. HN(87) MHÑAccidental Falls ANonly /econ /prev PIAccidents (66-86) MNG3.850.110.85 XSFalls, Accidental DMÑAccidents LH LS LM  MHÑAccidents ANonly /econ; /prev = ACCIDENT PREVENTION CATALOG: /geog /form MNG3.850.110 FXÑEnvironmental Health XUÑAccidental Falls LH LX LU  MHÑAccidents, Aviation ANonly /econ /prev CATALOG: /geog /form MNG3.850.110.185 FXÑAerospace Medicine LH LX  PM70 HN70(69) MHÑAccidents, Home ANonly /econ /prev CATALOG: /geog /form PIAccidents (66-68) MNG3.850.110.205 XSHOME ACCIDENTS LH LS  OLuse ACCIDENTS, OCCUPATIONAL to search ACCIDENTS, INDUSTRIAL back thru 1966 PM79; was ACCIDENTS, INDUSTRIAL 1963-78 HN79; was in Cat G & J 1979-82, was ACCIDENTS, INDUSTRIAL in Cat G & J 1967-78 & Cat G & I 1963-66 MHÑAccidents, Occupational ANonly /econ /prev CATALOG: /geog /form MNG3.850.110.250 XSAccidents, Industrial LH LS  MHÑAccidents, Traffic ANimplies automobile accid so do not coord with AUTOMOBILES unless the auto is especially discussed; only /econ /prev CATALOG: /geog /form MNG3.850.110.320 FXÑAutomobile Driving LH LX  MHÑAcclimatization ANincludes to climate, altitude, weather but not to gravity ( = ADAPTATION, PHYSIOLOGICAL); only /drug eff /rad eff MNG7.62.133 FXÑClimate LH LX  MHÑAccommodation, Ocular ANonly /drug eff /rad eff MNG11.697.79 LH  MSSystem of recording financial transactions. MHÑAccounting ANonly /legis /methods /stand /trends MNN3.219.463.30 XUÑAccounts Payable and Receivable; ÑDepreciation; ÑFinancial Audit; ÑPatient Credit and Collection LH LU; ; ;  MSShort-term debt obligations and assets in the regular course of operational transactions. HN(78) MHÑAccounts Payable and Receivable ANno qualif; DF: ACCOUNTS PAYABLE PIAccounting (66-77) MNN3.219.463.30.80 DMÑAccounting LH LM  MSCertification as complying with a standard set by non-governmental organizations, applied for by institutions, programs and facilities on a voluntary basis. PM66 HN66(64) MHÑAccreditation ANby the profession; do not confuse with LICENSURE (by the state); only /legis /stand /trends MNN3.706.110.70 XUÑJoint Commission on Accreditation of Hospitals LH LU  MSProcess of cultural change in which one group or members of a group assimilates various cultural patterns from another. OLuse ACCULTURATION to search ASSIMILATION back thru 1968 HNASSIMILATION was see under ACCULTURATION 1968-82 MHÑAcculturation ANno qualif MNI1.76.201.450.50; I1.880.143.79 XSAssimilation LH LS  MS1-(2-Acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride. A cardioselective beta adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action. Synonyms; M&B 17803; Sectral. PM75 HN75 MHÑAcebutolol ANdo not use /biosyn /defic /physiol RN37517-30-9 PIAnilides (74); Ethanolamines (74); Phenyl Ethers (74); Propylamines (74) MND2.33.329.624.25; D2.92.63.624.25; D16.848.215.25 LH  MS3-Quinuclidinol acetate ester. Cholinomimetic used to reduce intraocular pressure in glaucoma. Synonym: Glaucostat HN(75) MHÑAceclidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN827-61-2 PIQuinuclidines (71-75) MND3.605.687.30; D16.698.30 DMÑQuinuclidines LH LM  MS4',4'''-Sulfonylbis(acetanilide). Acetylated sulfone that is slowly metabolized to give long-term, low blood levels of dapsone; it has antimicrobial and antimalarial action, but is mainly used as a depot antileprotic agents. Synonyms: Camilan; Hansolar; Rodilone; Sulfadiamin. HN(76) MHÑAcedapsone ANdo not use /biosyn /defic /physiol RN77-46-3 PIAcetanilides (72-74); Acetamides (75); Dapsone/AA (75); Sulfones (72-74) MND2.886.590.263.50; D20.661.370.26 XSAcetyldiphenazonum; DADDS; Diacetyldapsone DMÑDapsone LH LS; ; LM  PM73 HN73(72) MHÑAcenaphthenes ANdo not use /analogs /biosyn /defic /physiol PINaphthalenes (66-71) MND4.615.50 LH  MHÑAcenocoumarol ANdo not use /biosyn /defic /physiol RN152-72-7 MND3.438.150.446.520.79; D19.461.119.196.475.22 XSAcenocoumarin; Nicoumalone LH LS;  MHÑAcepromazine ANdo not use /biosyn /defic /physiol RN61-00-7 MND3.494.741.29; D15.236.872.331.628.31 XSAcetazine; Acetopromazine; Acetylpromazine LH LS; ;  MSA genus of green algae found in the Mediterranean and other warm seas. HN(72) MHÑAcetabularia ANdo not use /anat /embryol /microbiol /parasitol PIAlgae, Green (70-71) MNB5.104.234.133 DMÑAlgae, Green LH LM  MHÑAcetabulum ANpoint of union of the 3 pelvic bones; do not confuse with HIP or HIP JOINT or PELVIC BONES; fract = ACETABULUM /inj (IM) + FRACTURES (IM) MNA2.835.232.611.108 LH  MS4'Fluoro-4-(4-acetamidomethyl-4-phenylpiperidine)butyrophenone. Alpha adrenergic blocking agent. Synonym: R 3248. HN(76) MHÑAcetabutone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN807-31-8 PIButyrophenones (72-75); Piperidines (72-75) MND2.522.352.40; D16.848.115.45 XSAceperone DMÑButyrophenones LH LS LM  MHÑAcetaldehyde ANdo not use /biosyn /defic /physiol RN75-07-0 MND2.47.64 LH  PM74 HN74(72) MHÑAcetals ANdo not use /analogs /biosyn /defic /physiol PIEthers (66-71) MND2.355.71 LH  PM73 HN73(71) MHÑAcetamides ANdo not use /analogs /biosyn /defic /physiol PIAcetic Acids (66-70); Amides (66-70) MND2.65.64; D2.241.81.38.108 XUÑAllylisopropylacetamide; ÑThioacetamide LH LU;  MSN-(4-Hydroxyphenyl)acetanilid. Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell and kidney damage. Synonyms: Acamol; Anapap; Panets; Paramol; Tempra; Tylenol; Valadol. PM65 HN65 MHÑAcetaminophen ANdo not use /biosyn /defic /physiol RN103-90-2 MND2.65.199.92.40; D14.73.20 XSAcetamidophenol; HYDROXYACETANILIDE; PARACETAMOL LH LS; ;  MSN-Phenylacetamide. Precursor of many drugs, dyes and other compounds in chemical synthesis; formerly used as analgesic and antipyretic, but often causes lethal methemoglobinemia. Synonyms: acetylaniline; acetylaminobenzene; antifebrin. OLuse ACETANILIDES to search ACETANILIDE & ACETANILID back thru 1966 PM79; was ACETANILIDE 1968-78, was ACETANILID 1963-67 HN79; was ACETANILIDE 1968-78, was ACETANILID 1963-67 MHÑAcetanilides ANdo not use /analogs /biosyn /defic /physiol MND2.65.199.92 XUÑDiamfenetide; ÑEtidocaine; ÑTrimecaine LH LU; ;  MSATP:acetate phosphotransferase. An enzyme found predominantly in microorganisms. Catalyzes reversibly the phosphorylation of acetate in the presence of a divalent cation and ATP with the formation of acetylphosphate and ADP. Important in the glycolysis process. Synonym: acetokinase. EC 2.7.2.1. HN(79) MHÑAcetate Kinase ANdo not use /analogs RNEC 2.7.2.1 PIAcetates (66-78); Acetic Acids (68-78); Phosphotransferases (66-73); Phosphotransferases, ATP (74-78) MND8.586.913.696.729.20 DMÑPhosphotransferases, ATP LH LM  MHÑAcetates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.38.209 LH  MHÑAcetazolamide ANdo not use /biosyn /defic /physiol RN59-66-5 MND8.373.220.109; D19.770.224.266.109 LH  OLsearch ACETIC ACIDS 1968-74 HN(75) MHÑAcetic Acid Esters ANdo not use /analogs MND2.241.81.38.250; D10.516.251.400.92.259 DMÑAcetic Acids LH LM  PM68 HN68 MHÑAcetic Acids ANdo not use /analogs; note ACETIC ACID ESTERS as XU: acetic acid salts = ACETATES PIAcetates (66-67) MND2.241.81.38; D2.241.81.465.92; D10.516.251.400.92 XUÑAcetic Acid Esters; ÑAcetic Anhydrides; ÑAminooxyacetic Acid; ÑDichloroacetate; ÑNitrilotriacetic Acid; ÑPeracetic Acid LH LU; ; ; ; ;  MSAnhydrides of acetic acid. Used extensively as acetylation, oxidation and dehydrating agents and in the modification of proteins and enzymes. HN(79) MHÑAcetic Anhydrides ANdo not use /analogs /defic PIAcetates (66-67); Acetic Acids (68-78); Anhydrides (66-78) MND2.113.75; D2.241.81.38.270 DMÑAcetic Acids LH LM  MHÑAcetoacetates ANdo not use /analogs MND2.241.607.80; D2.522.585.175 LH  MHÑAcetobacter ANin vinegar & souring fruits MNB3.400.71 LH  PM66 HN66(64) MHÑAcetohexamide ANdo not use /biosyn /defic /physiol RN968-81-0 MND2.886.590.795.71; D2.948.828.71; D9.482.59 LH  MS3-Hydroxy-2-butanone. A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide. HN(75) MHÑAcetoin ANdo not use /defic /physiol; /analogs NIM only RN513-86-0 PIAlcohols, Butyl (72-74); Butanones (70-74) MND2.33.210.40; D2.33.555.233.40; D2.522.296.100; D10.516.289.233.40 XSAcetylmethylcarbinol DMÑButanones LH LS LM  MSAcetoin:NAD+ oxidoreductase. Catalyzes the conversion of acetoin to diacetyl in the presence of NAD. HN(75) MHÑAcetoin Dehydrogenase ANdo not use /analogs RNEC 1.1.1.5 PIAlcohol Oxidoreductases (72-74); Butanones (72-74) MND8.586.682.47.50 XSDiacetyl Reductase DMÑAlcohol Oxidoreductases LH LS LM  MSAcetolactate pyruvate-lyase(carboxylating). A flavo-protein which catalyzes the formation of acetolactate from 2 moles of pyruvate in the biosynthesis of valine and the formation of acetohydroxybutyrate from pyruvate and alpha-ketobutyrate in the biosynthesis of isoleucine. HN(75) MHÑAcetolactate Synthase ANdo not use /analogs RNEC 4.1.3.18 PIKetoacid-Lyases (72-74); Pyruvates (72-74) MND8.586.520.567.100 XSAcetohydroxy Acid Synthase; Acetohydroxy Acid Synthetase; Acetolactate Synthetase DMÑKetoacid-Lyases LH LS; ; LM  MHÑAcetone ANdo not use /biosyn /defic /physiol; acetonemia & acetonuria go under KETONE BODIES RN67-64-1 MND2.522.64; D2.522.585.342 LH  MSCompounds in which a methyl group is attached to the cyano moiety. PM75 HN75 MHÑAcetonitriles ANdo not use /analogs /biosyn /defic /physiol PINitriles (69-74) MND2.626.80 XSCyanomethanes; Ethane Nitriles; Methyl Cyanides XUÑAminoacetonitrile LH LS; ; LU  MHÑAcetophenones ANdo not use /analogs /biosyn /defic /physiol MND2.522.120 LH  MSN,O-Diacetyl-N-fluoren-2-yl-hydroxylamine. A fluorene derivative with carcinogenic action. HN(75); was see under FLUORENES 1975-79 MHÑAcetoxyacetylaminofluorene AND25-26 qualif RN6098-44-8 PIAcetamides (73-74); Acetates (66-67); Acetic Acids (68-72); Amides (66-72); Fluorenes (66-74) MND2.65.64.150.100; D2.241.81.38.108.80.70; D4.615.389.50.60; D26.191.372.16.14 XSAcetoxyacetamidofluorene; Acetoxyfluorenylacetamide DMÑ2-Acetylaminofluorene LH LS; LM  MHÑAcetrizoic Acid AND25-26 qualif RN85-36-9 MND26.298.45 LH  MSAcetyl-CoA:acetyl-CoA C-acetyltransferase. Catalyzes the reversible formation of acetoacetyl-CoA from two molecules of acetyl-CoA. HN(75) MHÑAcetyl CoA Acetyltransferase ANdo not use /analogs; do not confuse with ACETYL COA ACYLTRANSFERASE RNEC 2.3.1.9 PIAcetyltransferases (73-74); Acetyl Coenzyme A (73-74); Acetoacetates (74) MND8.586.913.50.134.60 XSAcetoacetyl CoA Thiolase; Acetyl Coenzyme A Acetyltransferase DMÑAcetyltransferases LH LS; LM  MSAcyl-CoA:acetyl-CoA C-acyltransferase catalyzes the final step of fatty acid oxidation in which acetyl-CoA is released and the CoA ester of a fatty acid two carbons shorter is formed. HN(75) MHÑAcetyl CoA Acyltransferase ANdo not use /analogs; do not confuse with ACETYL COA ACETYLTRANSFERASE RNEC 2.3.1.16 PIAcyltransferases (73-74); Acetyl Coenzyme A (73-74) MND8.586.913.50.80 XS3-Ketoacyl CoA Thiolase; 3-Ketothiolase; Acetyl Coenzyme A Acyltransferase; beta-Ketothiolase DMÑAcyltransferases LH LS; ; ; LM  HN(73) MHÑAcetyl CoA Carboxylase ANdo not use /analogs RNEC 6.4.1.2 MND8.586.464.65 XSAcetyl Coenzyme A Carboxylase DMÑLigases LH LS LM  MSAcetyl-CoA hydrolase. Catalyzes reversibly the hydrolysis of acetyl-CoA to yield CoA and acetate. The enzyme is involved in the oxidation of fatty acids. EC 3.1.2.1. HN(78) MHÑAcetyl CoA Hydrolase ANdo not use /analogs RNEC 3.1.2.1 PIThiolester Hydrolases (73-77) MND8.586.277.352.897.75 XSAcetyl CoA Acylase; Acetyl CoA Deacylase; Acetyl Coenzyme A Hydrolase DMÑThiolester Hydrolases LH LS; ; LM  MSS-Acetate coenzyme A. Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent. PM78; was see under COENZYME A 1975-77 HN78(73); was see under COENZYME A 1975-77 MHÑAcetyl Coenzyme A ANdo not confuse with ACYL COENZYME A RN72-89-9 PICoenzyme A (66-72) MND8.176.211.300.75; D13.695.667.138.382.259; D13.695.827.68.382.259 XSAcetyl CoA LH LS  MSAcetate:CoA ligase (AMP-forming). Catalyzes the formation of CoA derivatives from ATP, acetate and CoA to form AMP, pyrophosphate and acetyl CoA. Acts also on propionates and acrylates. HN(76) MHÑAcetyl Coenzyme A Synthetase ANdo not use /analogs RNEC 6.2.1.1 PIAcetyl Coenzyme A (74-75); Coenzyme A Synthetases (74-75) MND8.586.464.271.50 XSAcetate Thiokinase; Acetyl Activating Enzyme; Acetyl CoA Synthetase DMÑCoenzyme A Synthetases LH LS; ; LM  HN(73) MHÑAcetylation ANalmost never IM; no qualif; enzymatic acetylation: coord NIM with ACETYLTRANSFERASES (IM) + substrate (NIM) or specific acetyltransferase (IM) PIChemistry, Organic (66-72) MNH1.181.404.95.52 DMÑChemistry, Organic LH LM  MS2-(Acetyloxy)-3-carboxy-N,N,N-trimethyl-1-propanaminium. An acetic acid ester of carnitine which facilitates movement of acetyl CoA into the matrices of mammalian mitochondria during the oxidation of fatty acids. HN(78) MHÑAcetylcarnitine AN/biosyn /physiol permitted RN14992-62-2 PICarnitine (66-77) MND11.786.708.168.90 XSAcetyl Carnitine DMÑCarnitine LH LS LM  MHÑAcetylcholine AN/biosyn /physiol permitted RN51-84-3 MND16.538.72; D16.698.72 LH  MHÑAcetylcholinesterase AN/biosyn /physiol permitted; do not use /analogs; /antag = CHOLINESTERASE INHIBITORS; reactivation or reactivators: coord NIM (with no qualif) with CHOLINESTERASE REACTIVATORS (IM) RNEC 3.1.1.7 MND8.586.277.352.100.170.176 LH  PM66 HN66(64) MHÑAcetylcysteine AND25-26 qualif RN616-91-1 MND12.125.166.230.259; D23.338.454.134 XSMERCAPTURIC ACID LH LS  MS3-beta,14-beta-Dihydroxy-5-beta-card-20(22)-enolide-3-monoacetyl tridigitoxosides. Cardioactive derivatives of lanatoside A or of digitoxin; used for fast digitalization in congestive heart failure. Synonyms: Acylanid; Acedigal; Acigoxin; Lanacetyl; Digicetyl; Nidacil. OLto search ACETYLDIGITOXIN use ACETYLDIGITOXINS back thru 1975 & DIGITOXIN 1966-74 HN(80); was ACETYLDIGITOXIN see under DIGITOXIN 1966-79 MHÑAcetyldigitoxins ANdo not confuse with ACETYLDIGOXINS; do not use /analogs /defic /physiol MND4.808.155.160.278.259; D9.203.408.180.261.336.259; D18.222.175.324.261.259 XSDesglucolanatosides A DMÑDigitoxin LH LS LM  MSAlpha or beta acetyl derivatives of digoxin or lanatoside C from Digitalis lanata; better absorbed and longer acting than digoxin; used in congestive heart failure. Synonyms: Acygoxine; desglucolanatoside C; Dioxanin; Lanatilin; Novodigal; Sandolanid. HN(79) MHÑAcetyldigoxins ANdo not confuse with ACETYLDIGITOXINS; do not use /analogs /biosyn /defic /physiol; alpha isomer & beta isomer go here PIDigoxin (66-78) MND4.808.155.160.349.50; D9.203.408.180.261.436.50; D18.222.175.324.386.42 XSDesglucolanatosides C DMÑDigoxin LH LS LM  MHÑAcetylene ANdo not use /biosyn /defic /physiol RN74-86-2 MND2.455.326.397.259 LH  MHÑAcetylesterase ANdo not use /analogs RNEC 3.1.1.6 MND8.586.277.352.100.50 XSACETYLASE LH LS  MS2-Acetamido-2-deoxygalactopyranose. The N-acetyl derivative of galactosamine. HN(75) MHÑAcetylgalactosamine ANdo not use /defic /physiol RN31022-50-1 PIGalactosamine (73-74) MND9.203.67.342.356.50 DMÑGalactosamine LH LM  MS2-Acetamido-2-deoxyglucopyranose. The N-acetyl derivative of glucosamine. HN(75) MHÑAcetylglucosamine ANdo not use /defic /physiol RN7512-17-6 PIGlucosamine (73-74) MND9.203.67.342.531.50 DMÑGlucosamine LH LM  MS2-Acetamido-2-deoxy-beta-D-glucoside acetamidodeoxygluco-hydrolase. Catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as mucolipidosis and various inflammatory disorders of muscle and connective tissue. HN(75) MHÑAcetylglucosaminidase ANdo not use /analogs RNEC 3.2.1.30 PIAcetamides (73-74); Glucosaminidase (72-74) MND8.586.277.450.483.531.80 XSN-Acetyl-beta-D-glucosaminidase DMÑGlucosaminidase LH LS LM  MSN-Acetylmuramyl-L-alanyl-D-isoglutamine. Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity. Synonyms: N-acetylmuramylpeptide(s); N-acetylmuramyl dipeptide(s). PM83; was see under GLYCOPEPTIDES 1979-82 HN83(79); was see under GLYCOPEPTIDES 1979-82 MHÑAcetylmuramyl-Alanyl-Isoglutamine AN/biosyn permitted; do not use /defic /physiol; DF: AMAIG RN53678-77-6 PIGlycopeptides (71-78); Peptides (66-70); Polysaccharides (66-70) MND9.203.67.550.50; D9.203.811.522.50; D12.644.233.50; D24.611.59.41 XSMur-NAc-L-Ala-D-isoGln; Muramyl Dipeptide LH LS;  MS4-(Acetylamino)- N-(2-(diethylamino)ethyl)benzamide. Major metabolite of procainamide; its anti-arrhythmic action may cause cardiac toxicity in kidney failure. HN(80) MHÑAcetylprocainamide ANdo not use /biosyn /defic /physiol RN32795-44-1 PIProcainamide (66-74) /AA (75-79) MND2.241.223.106.61.75.40; D18.97.622.24 DMÑProcainamide LH LM  MSCatalyzes the transfer of a methyl group from S-adenosylmethionine to N-acetylserotonin to form N-acetyl-5-methoxytryptamine (melatonin). HN(75) MHÑAcetylserotonin Methyltransferase ANdo not use /analogs; DF: HIOMT RNEC 2.1.1.4 PIMethyltransferases (74); Serotonin (74) MND8.586.913.517.40 XSHydroxyindole O-Methyltransferase DMÑMethyltransferases LH LS LM  MS2-(Acetylthio)-N,N,N-trimethyl-ethanaminium. A cholinergic agent used to determine cholinesterase activity. HN(75) MHÑAcetylthiocholine ANdo not use /biosyn /defic /physiol RN4468-05-7 PIAcetylcholine (72-74); Sulfhydryl Compounds (73-74) MND2.92.102.232.800.30; D2.675.276.232.800.30; D16.698.82 DMÑCholine LH LM  PM73 HN73 MHÑAcetyltransferases ANdo not use /analogs RNEC 2.3.1. PIAcyltransferases (66-72) MND8.586.913.50.134 XUÑAcetyl CoA Acetyltransferase; ÑArylamine Acetyltransferases; ÑCarnitine Acetyltransferase; ÑPhosphate Acetyltransferase LH LU; ; ;  MSSuccess in bringing an effort to the desired end; the degree or level of success attained in some specified area (esp. scholastic) or in general. PM65 HN65(64) MHÑAchievement ANno qualif MNF1.658.59; F2.784.629.54 LH  MHÑAchilles Tendon ANrupture = ACHILLES TENDON /inj (IM) + RUPTURE (NIM) MNA2.633.837.176 FXÑHeel LH LX  OLuse ACHLORHYDRIA to search ACHYLIA GASTRICA back thru 1966 HNACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78 MHÑAchlorhydria ANabsence of gastric HCl MNC6.405.748.45; C18.452.42 XSAchylia Gastrica FXÑGastric Acid LH LS LX  MSA genus of Gram-negative organisms including saprophytic and parasitic or pathogenic species. PM76 HN76 MHÑAcholeplasma ANdo not use /blood-csf-urine PIMycoplasma (66-75) MNB3.600.580.100.150 LH  MSAn organism originally isolated from sewage, manure, humus, and soil, but recently found as a parasite in mammals and birds. OLuse ACHOLEPLASMA LAIDLAWII to search MYCOPLASMA LAIDLAWII back thru 1972 PM76; was MYCOPLASMA LAIDLAWII 1972-75 HN76; was MYCOPLASMA LAIDLAWII 1972-75 MHÑAcholeplasma laidlawii ANin sewage, dung, soil & animals PIMycoplasma (66-71) MNB3.600.580.100.150.500 XSMycoplasma laidlawii LH LS  MSGran-negative organisms including apparently free-living saprophytes as well as mammalian and avian parasites, and possibly pathogens. PM76 HN76 MHÑAcholeplasmataceae PIBacteria (66-74); Mycoplasmataceae (75) MNB3.600.580.100 LH  MHÑAchondroplasia MNC5.116.99.708.17; C5.116.99.343.110 LH  MSA family of bacteria found in fresh-water and marine environments. PM75 HN75 MHÑAchromatiaceae ANin fresh & sea water PIBacteria (66-74) MNB3.350.260 LH  MHÑAchromatium ANin water & marine mud MNB3.350.260.260 LH  MSA family of Gram-negative bacteria generally found in soil, fresh water or salt water--includes some plant pathogens. HN(76)75 MHÑAchromobacteriaceae ANin soil & water PIBacteria (66-74) MNB3.400.85 DMÑGram-Negative Aerobic Bacteria LH LM  MSPretreatment of tooth surfaces with etching agents, usually phosphoric acid, to increase the adhesion of various resin systems. HN(77) MHÑAcid Etching, Dental ANdo not use /man /mortal /nurs /supply /util (except by MeSH definition) PIBonding, Dental (71-76); Dental Enamel (66-76); Phosphoric Acids (68-76) MNE6.95.100 XSEtching, Dental DMÑBonding, Dental LH LS LM  OLuse ACID PHOSPHATASE to search BLOOD ACID PHOSPHATASE 1966-67 PM/blood was BLOOD ACID PHOSPHATASE 1963-67 HN/blood was BLOOD ACID PHOSPHATASE 1963-67 MHÑAcid Phosphatase ANdo not use /analogs; /defic permitted: TN 222 RNEC 3.1.3.2 MND8.586.277.352.630.654.81 LH  MHÑAcid-Base Equilibrium ANonly /drug eff /rad eff; consider also ACID-BASE IMBALANCE MNG6.184.29; G7.621.110; G9.188.51; H1.181.529.428.176 XSAnion Gap FXÑACIDOSIS; ÑALKALOSIS LH LS LX;  MSDisturbances in the body's acid-base equilibrium. PM76 HN76; was NON MESH before 1976 MHÑAcid-Base Imbalance PIAcid-Base Equilibrium (66-75); specific acid-base imbalance heading MNC18.452.76 LH  MHÑAcidosis ANGEN & unspecified; note specifics below MNC18.452.76.176 FXÑAcid-Base Equilibrium XUÑKetosis LH LX LU  MHÑAcidosis, Diabetic MNC18.452.76.176.110; C18.452.297.55; C19.246.55 XUÑKetosis, Diabetic LH LU  MSAcidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as diabetes mellitus, leukemia, or liver failure. PM87 HN87 MHÑAcidosis, Lactic PIAcidosis (66-86); Lactates (66-86) MNC18.452.76.176.180 XSLactic Acidosis LH LS  MSA rare sometimes familial disorder of the renal tubule characterized by the inability to excrete urine of normal acidity. This leads to a hyperchloremic acidosis which is often associated with one or more secondary complications such as hypercalcinuria with nephrolithiasis and nephrocalcinosis, rickets, or osteomalacia and severe potassium depletion. PM65 HN65 MHÑAcidosis, Renal Tubular MNC12.777.419.815.93; C18.452.76.176.210; C18.452.648.851.93 LH  PM67 HN67 MHÑAcidosis, Respiratory PIAcidosis (66) MNC8.618.846.93; C18.452.76.176.310 XSRESPIRATORY ACIDOSIS LH LS  MHÑAcids ANGEN; do not use for specific acids, acid-fast bacteria, acid reactions, etc.; avoid; do not use /analogs /biosyn /defic /physiol MND1.29 LH  OL╥acyclic acids╙ is indexed as CARBOXYLIC ACIDS MH*Acids, Acyclic (Non Mesh) MND2.241.81 LH  MH*Acids, Aldehydic (Non Mesh) MND2.241.152 LH  OLdo not confuse with CARBOXYLIC ACIDS MH*Acids, Carbocyclic (Non Mesh) MND2.241.223 LH  MH*Acids, Heterocyclic (Non Mesh) MND3.66 LH  MH*Acids, Noncarboxylic (Non Mesh) MND1.29.260 LH  MSA sodium fluoride solution, paste or powder, which has been acidulated to pH 3 to 4 and buffered with a phosphate. Used in the prevention of dental caries. HN(77); was see under FLUORIDES 1977-83 MHÑAcidulated Phosphate Fluoride ANdo not use /analogs /biosyn /defic /physiol RN39456-59-2 PIFluorides (66-76); Fluorides, Topical (66-76); Phosphates (66-76) MND1.396.514.348.800.100; D1.696.620.603.100; D25.223.432.866.35 XSPhosphate Fluoride, Acidulated DMÑSodium Fluoride LH LS LM  MSA genus of Gram-negative bacteria of the family Neisseriaceae, found in soil and water and of uncertain pathogenicity. OLsearch ALCALIGENES 1974; use ACINETOBACTER to search MIMAE back thru 1966 PM76; was see under ACHROMOBACTER 1974-75; MIMAE was heading 1963-75 HN76(75); was see under ACHROMOBACTER 1974-75; MIMAE was heading 1963-75 MHÑAcinetobacter ANinfection = ACINETOBACTER INFECTIONS PIAlcaligenes (74) MNB3.400.699.261 XSColloides; Herella; Mimae LH LS; ;  MSInfections with bacteria of the genus Acinetobacter. OLuse ACINETOBACTER INFECTIONS to search MIMAE INFECTIONS back thru 1968 PM77; was MIMAE INFECTIONS 1968-76 HN77; was MIMAE INFECTIONS 1968-76 MHÑAcinetobacter Infections PIAcinetobacter (66-67) MNC1.252.22 XSMimae Infections LH LS  MHÑAcne MNC17.271.177; C17.805.711.111 LH  OLsearch FOLLICULITIS 1966-74 HN(75) MHÑAcne Keloid MNC17.805.305.383.261 DMÑFolliculitis LH LM  MSCitrate (isocitrate) hydro-lyase. Catalyzes the reversible hydration of cis-aconitate to yield citrate or isocitrate. One of the citric acid cycle enzymes. EC 4.2.1.3. PM78; was see under HYDRO-LYASES 1975-77 HN78(73); was see under HYDRO-LYASES 1975-77 MHÑAconitate Hydratase ANdo not use /analogs RNEC 4.2.1.3 PIHydro-Lyases (66-72) MND8.586.520.497.66 XSAconitase; Citrate Hydro-Lyase; Isocitrate Hydro-Lyase LH LS; ;  MHÑAconite ANdo not confuse with ACONITINE; do not use /defic /physiol RN8063-12-5 MND3.132.26 XUÑAconitine LH LU  HN(73) MHÑAconitic Acid ANdo not use /defic /physiol; /analogs NIM only RN499-12-7 MND2.241.81.901.177 DMÑTricarboxylic Acids LH LM  MS16-Ethyl-l alpha,6 alpha,19 beta-trimethoxy-4-(methoxymethyl)-aconitane-3 alpha,8,10 alpha,11,18 alpha-pentol, 8-acetate 10-benzoate. A poisonous alkaloid from the root of Aconitum napellus L. Used to induce arrhythmia in experimental animals. HN(75) MHÑAconitine ANdo not confuse with ACONITE; do not use /defic /physiol RN302-27-2 PIAconite (72-74) MND3.132.26.30 XSAcetylbenzoylaconine DMÑAconite LH LS LM  MSObjective tests of middle ear function based on the difficulty (impedance) or ease (admittance) of sound flow through the middle ear. Includes static impedance and dynamic impedance (i.e., tympanometry and impedance tests in conjunction with intra-aural muscle reflex elicitation). Use also for various components of impedance and admittance (e.g., compliance, conductance, reactance, resistance, susceptance). PM78 HN78 MHÑAcoustic Impedance Tests ANdo not use /util except by MeSH definition PIAudiometry (66-77); Ear, Middle (66-77); Tympanic Membrane (66-77) MNE1.276.299.375.100 XSAudiometry, Impedance; Electroacoustic Impedance Tests; Impedance Tests, Acoustic; Tympanometry FXÑEar, Middle LH LS; ; ; LX  MHÑAcoustic Nerve AN8th cranial nerve; neopl: coord ACOUSTIC NERVE DISEASES (IM) with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) but note that NEUROMA, ACOUSTIC is also available; do not use /innerv MNA8.796.214.125 XSAuditory Nerve LH LS  MSDiseases of the eighth cranial nerve. These include vestibular neuronitis, cochlear neuritis and acoustic neuroma. PM80; was see under PERIPHERAL NERVE DISEASES 1979 HN80(79); was see under PERIPHERAL NERVE DISEASES 1979 MHÑAcoustic Nerve Diseases ANIM GEN or unspecified; NIM coord with COCHLEAR NERVE (IM) for cochlear nerve dis or with VESTIBULAR NERVE (IM) for vestibular nerve dis PIAcoustic Nerve (66-78); Cochlear Nerve (66-78); Peripheral Nerve Diseases (66-78); Vestibular Nerve (66-78) MNC9.218.807.23; C10.772.204.25 LH  PM73 HN73(72) MHÑAcoustic Stimulation AN= auditory stimulation; only /adv eff /instrum /methods; EVOKED POTENTIALS, AUDITORY is also available PISound (66-71) MNE5.723.136 XSStimulation, Acoustic FXÑHearing; ÑNoise; ÑSound LH LS LX; ;  MHÑAcoustics ANonly /instrum; PSYCHOACOUSTICS & SPEECH ACOUSTICS are also available MNH1.671.31 LH  MSAn acquired defect of cellular immunity, probably caused by an infectious agent, probably a virus. The defect manifests itself in an increased susceptibility to Kaposi's sarcoma and to a variety of pathogens including Pneumocystis carinii, Cytomegaloviruses, herpes simplex virus, Candida, Cryptococcus, and Toxoplasma. PM83 HN83 MHÑAcquired Immunodeficiency Syndrome ANcaused by HTLV-III; ╥immunocompromised host╙ goes here or IMMUNOLOGIC DEFICIENCY SYNDROMES or IMMUNE TOLERANCE: check text; OPPORTUNISTIC INFECTIONS is available if particularly discussed: see note there PIImmunologic Deficiency Syndromes (79-82) MNC1.539.780.20; C2.782.815.483.23; C20.673.483.23 XSAIDS; HTLV-III Infection; HTLV-III-LAV Infection; Immunodeficiency Syndrome, Acquired; Immunologic Deficiency Syndrome, Acquired LH LS; ; ; ;  MSA deuteromycetous fungal genus of the class Hyphomycetes. Cephalosporin antibiotics are derived from this genus. OLuse ACREMONIUM to search CEPHALOSPORIUM back thru 1966 PM86; was CEPHALOSPORIUM 1963-85 HN86; was CEPHALOSPORIUM 1963-85 MHÑAcremonium ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.25 XSCephalosporium LH LS  MS3,6-Bis-(dimethylamino)acridine. Cationic cytochemical stain specific for cell nuclei, especially DNA; used as supravital stain, also for fluorescence cytochemistry; may cause mutations in microorganisms. Synonyms: Basic Orange 3RN; C.I. Basic Orange 14; Euchrysin; C.I. 46005; Rhoduline Orange. PM79 HN79 MHÑAcridine Orange AND25-26 qualif RN65-61-2 PIAcridines (66-78); Dimethylamines (74) MND3.494.46.250.150; D26.408.24; D26.408.348.24 XSTetramethyl Acridine Diamine LH LS  MHÑAcridines AND25-26 qualif; acridinamines & acridinylamines = AMINOACRIDINES MND3.494.46 XUÑEthacridine; ÑProflavine LH LU;  MS3,6-Diamino-10-methylacridinium chloride mixed with 3,6-diaminoacridine. Fluorescent dye used as local antiseptic; also as biological stain; intercalates into nucleic acids thereby inhibiting bacterial and viral replication. Synonyms: Bioacridine; Flaviform; Gonacrine; Trypaflavine. OLsearch ACRIDINES 1966-74 HN(75); was see under ACRIDINES 1963-81 MHÑAcriflavine AND25-26 qualif; /analogs NIM only RN8048-52-0 MND3.494.46.250.177; D26.408.348.42 XSEuflavin; Flavacridium; Xanthacridinum DMÑAminoacridines LH LS; ; LM  MHÑAcrocephalosyndactylia ANdo not use /congen MNC5.116.99.370.885.15; C5.116.99.370.894.232.15; C16.131.621.906.136 XSApert Syndrome LH LS  MHÑAcrodermatitis MNC16.131.831.66; C17.827.66 LH  MHÑAcrodynia MNC10.772.56 XSERYTHREDEMA POLYNEUROPATHY; FEER'S DISEASE; PINK DISEASE; SWIFT'S DISEASE LH LS; ; ;  OLsearch ALDEHYDES 1966-72 HN(73) MHÑAcrolein ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-02-8 MND2.47.122 DMÑAldehydes LH LM  MSA disorder due to excessive secretion of pituitary growth hormone, characterized by progressive enlargement of the head and face, hands and feet, and thorax. MHÑAcromegaly MNC5.116.132.82; C19.700.355.178 FXÑAdenoma, Eosinophilic LH LX  OLsearch SHOULDER JOINT 1966-74 PM79; was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64 HN79(75); was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64 MHÑAcromioclavicular Joint ANdislocation: coord (IM) with DISLOCATIONS (IM); any Cat A qualif PIShoulder Joint (66-74) MNA2.835.583.32 LH  OLsearch SCAPULA 1966-74 HN(75) MHÑAcromion ANfracture = ACROMION /inj (IM) + FRACTURES (IM), not SHOULDER FRACTURES MNA2.835.232.87.783.261 DMÑScapula LH LM  MS3,12-Dihydro-6-methoxy-3,3,12-trimethyl-7H-pyrano(2,3-c)acridin-7-one. An alkalid antineoplastic agent isolated from Acronychia baueri. Disrupts the function of intracellular membranes. HN(75) MHÑAcronine ANdo not use /defic /physiol; /analogs NIM only; /biosyn permitted if by plant RN7008-42-6 PIAlkaloids (71-74); Acridines (71-74) MND3.132.35; D3.494.46.220; D22.204.179.15 XSAcronycine DMÑAlkaloids LH LS LM  MSA trypsin-like enzyme of spermatozoa which is not inhibited by alpha 1 antitrypsin. HN(75) MHÑAcrosin ANdo not use /analogs RNEC 3.4.21.10 PIPeptide Peptidohydrolases (73-74) MND8.586.277.656.732.30 XSAcrosomal proteinase DMÑPeptide Peptidohydrolases LH LS LM  MSCap-like structure covering the nucleus and anterior part of the sperm head. HN(75) MHÑAcrosome ANA 11 qualif except /cytol; /growth permitted MNA5.360.490.890.820.100; A11.497.760.400.100 DMÑSpermatozoa LH LM  PM73 HN73(71) MHÑAcrylamides ANdo not use /analogs /biosyn /defic /physiol PIAcrylates (66-70) MND2.65.122; D2.241.81.69.94 LH  PM66 HN66 MHÑAcrylates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.69 XUÑMethacrylates LH LU  MHÑAcrylic Resins AND25-26 qualif MND25.720.716.822.111 FXÑDental Materials; ÑDental Restoration, Permanent; ÑDental Restoration, Temporary; ÑTooth, Artificial LH LX; ; ;  MSA highly poisonous compound used widely in the manufacture of plastics, adhesives and synthetic rubber. Also used as fumigant. Synonyms: Fumigrain; Ventox. HN(77) MHÑAcrylonitrile ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-13-1 PIAcrylates (68-76); Nitriles (68-76); Vinyl Compounds (73-76) MND2.626.95 XSVinyl Cyanide DMÑNitriles LH LS LM  MSSymptom complex due to ACTH production by non-pituitary neoplasms. HN(80) MHÑACTH Syndrome, Ectopic ANcaused by ╥ACTH production by non-pituitary neoplasms╙; do not use /anal /blood supply /second /secret /ultrastruct; coord IM with precoord organ/neopl term with /secret (IM) + histol type of neopl /secret (IM) PIAdrenocorticotropic Hormone (66-79) MNC4.730.713.317; C19.576.317 XSEctopic ACTH Syndrome DMÑNeoplastic Endocrine-Like Syndromes LH LS LM  MSAn extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics; exact composition unknown. Proposed as a radiation-protective agent. Synonym: S 1021. HN(75) MHÑActihaemyl ANdo not use /analogs /defic /physiol RN37239-28-4 PIBlood (73-74); Tisue Extracts (73-74) MND24.185.893.50 XSSolcoseryl DMÑTissue Extracts LH LS LM  MSExpressing unconscious emotional conflicts or feelings, often of hostility or love, through overt behavior. PM68 HN68 MHÑActing Out ANno qualif PIPsychoanalytic Therapy (66-67) MNF1.393.47; F3.407.47; F4.754.919.211 FXÑPsychodrama LH LX  MSA protein factor which regulates the length of R-actin. It is chemically similar, but immunochemically distinguishable from actin. PM85; was see under MUSCLE PROTEINS 1976-84 HN85(76); was see under MUSCLE PROTEINS 1976-84 MHÑActinin AN/biosyn /physiol permitted RN11003-00-2 PIMuscle Proteins (70-75) MND12.776.210.500.95; D12.776.220.525.90 XSAlpha Actinin LH LS  MHÑActinium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-34-8 MND1.287.33; D1.552.517.42 LH  MSA disease characterized by suppurative and granulomatous lesions in the respiratory tract, upper alimentary tract, skin, kidneys, joints and other tissues. Actinobacillus lignieresii infects cattle and sheep; A equuli infects horses and pigs. PM68 HN68 MHÑActinobacillosis ANa vet dis entity: do not confuse with ACTINOBACILLUS INFECTIONS; do not use /vet but check tag ANIMAL PICattle Diseases (66-67) MNC1.252.30.178; C22.39 LH  MHÑActinobacillus ANdo not use /blood-csf-urine; infection = ACTINOBACILLUS INFECTIONS or ACTINOBACILLOSIS: see notes there MNB3.475.82 LH  MSInfections with bacteria of the genus Actinobacillus, general or unspecified. PM72 HN72 MHÑActinobacillus Infections ANdo not confuse with ACTINOBACILLOSIS, a vet dis entity PIActinobacillosis (68-71); Actinobacillus (66-71) MNC1.252.30 LH  MHÑActinomyces ANa genus of the family ACTINOMYCETACEAE of the order ACTINOMYCETALES; infection = ACTINOMYCOSIS; A. canis = NOCARDIA; A. candidus = STREPTOMYCES; A. rhodnii = STREPTOMYCES; do not use /blood-csf-urine MNB3.100.67.137.178 LH  MSA family of bacteria including numerous parasitic and pathogenic forms. PM75 HN75 MHÑActinomycetaceae ANa family of the order ACTINOMYCETALES; do not use /blood-csf-urine PIActinomycetales (66-74) MNB3.100.67.137 LH  MSAn order of Gram-positive, primarily aerobic bacteria that tend to form branching filaments. OLuse ACTINOMYCETALES to search ACTINOMYCETES back thru 1966 PM67; was ACTINOMYCETES 1963-66 HN67; was ACTINOMYCETES 1963-66 MHÑActinomycetales ANan order of which ACTINOMYCETACEAE is a family; do not use /blood-csf-urine; infection: see note below MNB3.100.67 LH  MSInfections with bacteria of the order Actinomycetales. OLuse ACTINOMYCETALES INFECTIONS to search ACTINOMYCETE INFECTIONS back thru 1972 PM77; was ACTINOMYCETE INFECTIONS 1972-76 HN77; was ACTINOMYCETE INFECTIONS 1972-76 MHÑActinomycetales Infections ANinfection by organism of the order of ACTINOMYCETALES; do not confuse with ACTINOMYCOSIS, infection by genus ACTINOMYCES PIActinomyces (66-71); Actinomycetales (66-71) MNC1.252.40 XSActinomycete Infections LH LS  MH*Actinomycetes and Related Organisms (Non Mesh) MNB3.100 LH  MHÑActinomycin ANdo not use /defic /physiol RN1402-38-6 MND20.85.75.41; D22.204.106.38 LH  MHÑActinomycosis AN= infection by genus ACTINOMYCES: do not confuse with ACTINOMYCETALES INFECTIONS, infection by order ACTINOMYCETALES MNC1.252.40.137 LH  MHÑActinomycosis, Cervicofacial MNC1.252.40.137.262; C17.838.208.83 LH  PM73 HN73(65) MHÑActinospectacin ANdo not use /defic /physiol RN1695-77-8 MND20.85.25; D22.204.106.64 XSActinospectocin; SPECTINOMYCIN LH LS;  OLuse ACTINS to search ACTIN back thru 1971 (as Prov 1971-72) PM82; was ACTIN 1973-81 HN82; was ACTIN 1971-81 (Prov 1971-72) MHÑActins AN/biosyn /physiol permitted; alpha-actin, beta-actin, gamma-actin, F-actin, G-actin, etc. go here; do not use /analogs PIMuscle Proteins (66-70) MND12.776.210.500.82; D12.776.220.525.75 XSF-Actin; G-Actin LH LS;  MSThe electric response of a nerve or muscle to its stimulation. PM68 HN68(67) MHÑAction Potentials ANNIM; only /drug eff /rad eff; spike potentials go here PIElectrophysiology (66) MNG7.453.697.100; G11.561.450.100 LH  PM67 HN67(63) MHÑActivation Analysis ANNIM; only /instrum /methods MNE5.196.39; H1.181.278.41 XUÑNeutron Activation Analysis LH LU  MSLoose-fitting removable orthodontic appliances which redirect the pressures of the facial and masticatory muscles onto the teeth and their supporting structures to produce improvements in tooth arrangements and occlusal relations. HN(75) MHÑActivator Appliances ANdo not use /instrum /methods /util (except by MeSH definition) MNE6.658.453.578.100 XSAndresen Appliance; Bionator; Functional Orthodontic Appliances; Orthodontic Appliances, Activator DMÑOrthodontic Appliances, Removable LH LS; ; ; LM  MSThe performance of the basic activities of self care in rehabilitation; dressing, ambulation, eating, etc. OLuse ACTIVITIES OF DAILY LIVING to search SELF CARE 1979-80 PM68; SELF CARE (REHABILITATION) was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80 HN68; SELF CARE (REHABILITATION) was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80 MHÑActivities of Daily Living ANIM; no qualif PIRehabilitation (66-67) MNE2.831.67; I3.50; N2.421.784.110 XSADL; Chronic Limitation of Activity; Independent Living; Limitation of Activity, Chronic; Self Care (Rehabilitation) LH LS; ; ; ;  MSBouts of physical irritability or movement alternating with periods of quiescence; includes biochemical activity and hormonal activity which may be cellular; these cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system. OLsearch CIRCADIAN RHYTHM 1968-74 HN(75) MHÑActivity Cycles ANless than 24 hours; only /drug eff /rad eff MNG7.450.730.190.25 XSUltradian Cycles DMÑCircadian Rhythm LH LS LM  OLsearch MUSCLE PROTEINS 1966-70 PM73; was see under MUSCLE PROTEINS 1963-72 HN73(71); was see under MUSCLE PROTEINS 1963-72 MHÑActomyosin AN/biosyn /physiol permitted RN9013-26-7 PIMuscle Proteins (66-70) MND12.776.210.500.154 LH  MSThe application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability or death. May include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs. PM79 HN79 MHÑActuarial Analysis ANonly /hist /instrum /methods /stand /util (if by MeSH definition) MNH1.548.832.67 XSLife Table Methods LH LS  MHÑAcupuncture ANdo not use /util except by MeSH definition MNE2.30 LH  MSDisease having a short and relatively severe course. PM68 HN68 MHÑAcute Disease ANIM GEN only; only /class /econ /mortal /nurs /occur /psychol /rehabil /ther; usually NIM; no qualif when NIM; Manual 23.23+ MNC23.280.50; N1.407.306.137 LH  MSProteins which are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins can serve as inhibitors or mediators of the inflammatory processes. Certain acute phase proteins have been used to diagnose and follow the course of diseases or as tumor markers. PM87 HN87 MHÑAcute Phase Proteins AN/biosyn /physiol permitted PIBlood Proteins (66-86); C-Reactive Protein (66-86); Glycoproteins (66-86) MND12.776.124.50 XSAcute Phase Reactants; Proteins, Acute Phase; Reactants, Acute Phase LH LS; ;  MSAn early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma; the reaction is mediated by endogenous pyrogens, the hypothalamus, adrenal hormones, and other factors. HN(87) MHÑAcute Phase Reaction ANnote category: in presence of a dis, use /etiol, not /compl PIAcute Disease (68-86); Inflammation (66-86) MNC23.739.487.99 XSAcute Phase State; Reaction, Acute Phase; Response, Acute Phase DMÑInflammation LH LS; ; LM  MHÑAcute Yellow Atrophy MNC6.552.45 LH  MS9-[(2-Hydroxyethoxy)methyl] guanine. Functional analog of the nucleoside guanosine; acts as antimetabolite, especially in viruses; proposed as antiviral agent, especially in herpes infections. PM83 HN83 MHÑAcyclovir ANdo not use /biosyn /defic /physiol RN59277-89-3 PIGuanine (66-82) MND3.438.759.758.399.454.250; D20.388.9; D26.87.9 XSAcycloguanosine LH LS  MSConsists of a polypeptide chain and 4'-phosphopantetheine linked to a serine residue by a phosphodiester bond. Acyl groups are bound as thiol esters to the pantothenyl group. Acyl carrier protein is involved in every step of fatty acid synthesis by the cytoplasmic system. PM78 HN78 MHÑAcyl Carrier Protein AN/biosyn /physiol permitted PICarrier Proteins (71-77) MND12.776.157.50 LH  MSS-Acyl coenzyme A. Fatty acid coenzyme A derivatives are involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation. PM78 HN78 MHÑAcyl Coenzyme A ANdo not use /analogs; do not confuse with ACETYL COENZYME A PICoenzyme A (66-77) MND8.176.211.300; D13.695.667.138.382.300; D13.695.827.68.382.300 XSAcyl CoA; Fatty Acyl CoA; Long Chain Acyl CoA XUÑMalonyl Coenzyme A; ÑPalmitoyl Coenzyme A LH LS; ; LU;  PM74 HN74(71) MHÑAcylation ANalmost never IM; no qualif; enzymatic acylation: coord NIM with ACYLTRANSFERASES (IM) + substrate (NIM) or specific acyltransferase (IM); ACETYLATION & ACETYLTRANSFERASES are also available PIChemistry, Organic (66-70) MNH1.181.404.95 LH  MSCTP:N-acylneuraminate cytidylyltransferase. Forms CMP-acylneuraminic acids, which donate the N-acylneuraminic acid residues to the terminal sugar residue of a ganglioside or glycoprotein. HN(75) MHÑAcylneuraminate Cytidylyltransferase ANdo not use /analogs; DF: ACYLNEURAMINATE CMP TRANSFERASE RNEC 2.7.7.43 PICytosine Nucleotides (73-74); Neuraminic Acids (73-74); Nucleotidyltransferases (73-74) MND8.586.913.696.445.35 XSCMP Sialate Pyrophosphorylase; CMP Sialate Synthase; CMP-N-Acetylneuraminic Acid Synthetase DMÑNucleotidyltransferases LH LS; ; LM  PM64 HN64 MHÑAcyltransferases ANdo not use /analogs RNEC 2.3. MND8.586.913.50 XUÑ3-Oxoacyl (Acyl Carrier Protein) Synthase; ÑAcetyl CoA Acyltransferase; ÑCarnitine Acyltransferases; ÑCarnitine Palmitoyltransferase; ÑGamma-Glutamylcyclotransferase; ÑGlycerolphosphate Acyltransferase; ÑLysolecithin Acyltransferase; ÑPeptidyl Transferases LH LU; ; ; ; ; ; ;  MSTricyclo[3.3.1/3,7]decane. A tricyclo bridged hydrocarbon. PM80; was see under BRIDGED COMPOUNDS 1975-79 HN80(75); was see under BRIDGED COMPOUNDS 1975-79 MHÑAdamantane ANdo not use /biosyn /defic /physiol RN281-23-2 PIBridged Compounds (66-74); Cycloparaffins (66-74) MND2.219.75; D2.455.426.392.368.75; D4.615.236.75 XSDiamantane XUÑRimantadine LH LS LU  MSTransient asystole or ventricular fibrillation in the presence of atrioventricular block. PM65; was see under HEART BLOCK 1963-64 HN65(63); was see under HEART BLOCK 1963-64 MHÑAdams-Stokes Syndrome MNC14.280.67.558.137 XSStokes-Adams Attacks LH LS  MHÑAdaptation, Biological ANonly /drug eff /rad eff; much of biol adapt will be ADAPTATION, PHYSIOLOGICAL as more specific; mimicry goes here MNG4.185.57 LH  MHÑAdaptation, Ocular ANonly /drug eff /rad eff MNG11.697.154 LH  MHÑAdaptation, Physiological ANonly /drug eff /rad eff MNG7.62 XUÑEstivation LH LU  MSFavorable changes experienced by an individual, either as regards himself or his relationship with his environment, which lead to adjustment - also a rearrangement in mental attitude. MHÑAdaptation, Psychological ANhuman & animal; only /drug eff /physiol /rad eff MNF1.58 XSCoping Behavior FXÑSOCIAL ADJUSTMENT LH LS LX  MHÑAddison's Disease MNC19.53.264.263; C20.111.163 LH  MHÑAdenine AN/biosyn /physiol permitted; adenine deoxyriboside, adenine deoxyribonucleoside = DEOXYADENOSINE; adenine riboside, adenine ribonucleoside = ADENOSINE RN73-24-5 MND3.438.759.138 XUÑ2-Aminopurine LH LU  MSCatalyzes the exchange between endogenous and exogenous adenine nucleotides in mitochondria. HN(76) MHÑAdenine Nucleotide Translocase ANdo not use /analogs RNEC 2.7.7.- PIAdenine Nucleotides (72-75); Nucleotidyltransferases (72-75) MND8.586.913.696.445.60 XSADP,ATP Carrier; ADP,ATP Translocator Protein DMÑNucleotidyltransferases LH LS; LM  MHÑAdenine Nucleotides AN/biosyn /physiol permitted; do not use /analogs MND13.695.667.138; D13.695.827.68 XSAdenosine Phosphates XUÑPhosphoadenosine Phosphosulfate LH LS LU  MSAMP:pyrophosphate phosphoribosyltransferase. Catalyzes the formation of AMP from adenine and phosphoribosylpyrophosphate. Can act as a salvage enzyme for recycling of adenine into nucleic acids. HN(75) MHÑAdenine Phosphoribosyltransferase ANdo not use /analogs RNEC 2.4.2.7 PIAdenine (72-74); Pentosephosphates (72-74); Pentosyltransferases (72-74); Pyrophosphoric Acids (72-74) MND8.586.913.647.50 XSAMP Pyrophosphorylase; Transphosphoribosidase DMÑPentosyltransferases LH LS; LM  MSDefective viruses comprising a genus of the Parvoviridae, whose members are able to multiply only upon concurrent infection of cells with ╥helper╙ Adenoviridae. OLsearch SATELLITE VIRUSES 1975-78 PM79; was indexed under ASSOCIATED VIRUSES 1975-78 HN79; was see SATELLITE VIRUSES 1975-78 MHÑAdeno-Associated Viruses ANdo not use /blood-csf-urine /cytol PIAdenoviridae (66); Satellite Viruses (67-78); Viruses (66) MNB4.265.658.96; B4.909.204.671.96 LH  MHÑAdenocarcinoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.36 LH  MHÑAdenocarcinoma, Papillary AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.36.263 LH  MHÑAdenofibroma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.33 LH  MHÑAdenoidectomy ANdo not use /util except by MeSH definition MNE4.847.68 LH  MHÑAdenoids AN/surg: probably ADENOIDECTOMY; pharyngeal tonsil goes here MNA15.382.520.604.84 FXÑLymphoid Tissue LH LX  MSA benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma; usually found in the salivary glands, especially the parotid. MHÑAdenolymphoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.53 XSCystadenoma Lymphomatosum, Papillary; Warthin Tumor LH LS;  MHÑAdenoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); malignant adenoma = ADENOCARCINOMA; ╥prostatic adenoma╙ = PROSTATIC HYPERTROPHY; polypoid adenoma = POLYPS; congen cystic adenomatoid malform of lung = LUNG /abnorm & not also here MNC4.557.576.60 LH  MHÑAdenoma, Basophilic AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.60.96 LH  MHÑAdenoma, Chromophobe AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.60.179 LH  MHÑAdenoma, Eosinophilic AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.60.262 FXÑACROMEGALY; ÑGIGANTISM LH LX;  MHÑAdenoma, Virilizing AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.60.345 LH  OLsearch NUCLEOSIDES 1966-71 PM72; was see under NUCLEOSIDES 1963-71 HN72; was see under NUCLEOSIDES 1963-71 MHÑAdenosine AN/biosyn /physiol permitted RN58-61-7 PINucleosides (66-71) MND13.570.583.138; D13.570.800.96 XUÑIsopentenyladenosine; ÑPhenylisopropyladenosine LH LU;  MSAdenosine, cyclic 3',5'-(hydrogen Phosphate). An adenine nucleotide containing one phosphate group which is esterified to both the 3' and 5' positions of the sugar moiety. OLuse ADENOSINE CYCLIC MONOPHOSPHATE to search ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE back thru 1968 (as Prov 1968-71) PM80; ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE was heading 1972-79 HN80; ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE was heading 1968-79 (Prov 1968-71) MHÑAdenosine Cyclic Monophosphate AN/biosyn /physiol permitted; cAMP receptor protein, cyclic AMP receptor protein: index under RECEPTORS, CYCLIC AMP; DF: CYCL AMP RN60-92-4 PIAdenine Nucleotides (66-68) MND13.695.462.180; D13.695.667.138.69; D13.695.827.68.69 XSAdenosine Cyclic 2',3'-Monophosphate; Adenosine Cyclic 3',5'-Monophosphate; Cyclic AMP LH LS; ;  MSCatalyzes the hydrolysis of adenosine to inosine with the elimination of ammonia. Since there are wide tissue and species variations in the enzyme, it has been used as a tool in the study of human and animal genetics and in medical diagnosis. HN(75) MHÑAdenosine Deaminase ANdo not use /analogs RNEC 3.5.4.4 PIAminohydrolases (72-74); Adenosine (72-74) MND8.586.277.151.486.75 XSAdenosine Aminohydrolase DMÑNucleoside Deaminases LH LS LM  MSAn adenine nucleotide containing two phosphate groups esterified to the sugar moiety usually at the 5' position. Synonyms: ARPP: adenosine 5'-pyrophosphate. PM73 HN73(71) MHÑAdenosine Diphosphate AN/biosyn /physiol permitted RN58-64-0 PIAdenine Nucleotides (66-70) MND13.695.667.138.124; D13.695.827.68.124 XSADENOSINE PYROPHOSPHATE; ADP LH LS;  MSServes as the glycosyl donor for formation of bacterial glycogen, amylose in green algae and amylopectin in higher plants. HN(75) MHÑAdenosine Diphosphate Glucose AN/analogs NIM only RN2140-58-1 PIAdenosine (73-74); Glucose (73-74); Nucleoside Diphosphate Sugars (73-74) MND9.203.408.620.569.70.75; D13.695.667.138.124.70.75; D13.695.827.68.124.70.75; D13.695.827.708.70.75 XSADP Glucose; ADPG; Adenosine Diphosphoglucose; Adenosine Pyrophosphateglucose DMÑNucleoside Diphosphate Sugars LH LS; ; ; LM  MSAdenosine 5'-(trihydrogen diphosphate),5'-5-ester with D-ribose. An ester formed between the aldehydic carbon of ribose and the terminal phosphate of adenosine diphosphate. Serves as a ribose carrier. PM87; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86 HN87(80); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86 MHÑAdenosine Diphosphate Ribose ANdo not use /analogs RN20762-30-5 PIAdenine Nucleotides (66-70); Adenosine Diphosphate Sugars (75-79); Nucleoside Diphosphate Sugars (71-74); Ribose (66-74) /AA (75-79) MND9.203.408.620.569.70.125; D13.695.667.138.124.70.125; D13.695.827.68.124.70.125; D13.695.827.708.70.125 XSADP Ribose; Adenosine Diphosphoribose LH LS;  MSEsters formed between the aldehydic carbon of sugars and the terminal phosphate of adenosine diphosphate. HN(75) MHÑAdenosine Diphosphate Sugars ANdo not use /analogs PIAdenosine (73-74); Nucleoside Diphosphate Sugars (73-74) MND9.203.408.620.569.70; D13.695.667.138.124.70; D13.695.827.68.124.70; D13.695.827.708.70 XSADP Sugars DMÑNucleoside Diphosphate Sugars LH LS LM  MSATP:adenosine 5'-phosphotransferase. Catalyzes the formation of ADP plus AMP from adenosine plus ATP. Can serve as a salvage mechanism for returning adenosine to nucleic acids. HN(75) MHÑAdenosine Kinase ANdo not use /analogs RNEC 2.7.1.20 PIAdenosine (74); Phosphotransferases, ATP (74) MND8.586.913.696.729.30 DMÑPhosphotransferases, ATP LH LM  MSAdenosine(dihydrogen phosphate). Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. OLto search ADENYLIC ACIDS use ADENOSINE MONOPHOSPHATE back thru 1973, ADENOSINE MONOPHOSPHATE & ADENINE NUCLEOTIDES 1971-72 & ADENINE NUCLEOTIDES 1966-70 PM73; ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72 HN73(71); ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72 MHÑAdenosine Monophosphate AN/biosyn /physiol permitted RN61-19-8 PIAdenine Nucleotides (66-70) MND13.695.667.138.180; D13.695.827.68.180 XSADENYLIC ACID; AMP XUÑAdenosine Phosphosulfate LH LS; LU  MS5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS. HN(79) MHÑAdenosine Phosphosulfate ANdo not use /biosyn /defic /physiol RN485-84-7 PIAdenine Nucleotides (66-70); Adenosine Monophosphate (71-78); Sulfuric Acids (66-75) MND13.695.667.138.180.80; D13.695.827.68.180.80 XSAdenylyl Sulfate DMÑAdenosine Monophosphate LH LS LM  MHÑAdenosine Triphosphatase ANdo not use /analogs RNEC 3.6.1.3 MND8.586.277.352.630.114 XSATPase; Actomyosin ATPase; Myosin ATPase XUÑDynein LH LS; ; LU  MSAn enzyme found in the sarcoplasmic reticulum vesicle membrane. During the relaxation of skeletal muscles and muscle rich in mitochondria, this enzyme catalyzes the active transport of calcium into the sarcoplasmic reticulum vesicles from the sarcoplasm. A subgroup of EC 3.6.1.3. PM79 HN79 MHÑAdenosine Triphosphatase, Calcium ANdo not use /analogs; DF: CA ATPASE RNEC 3.6.1.- PIAdenosine Triphosphatase (66-78); Calcium (66-78) MND8.586.277.352.630.114.50 XSATPase, Calcium; Calcium ATPase LH LS;  MSAn enzyme found in the membrane of a variety of tissues. It is magnesium-dependent for its activities. May act as a proton pump. Subgroup of EC 3.6.1.3. PM86 HN86 MHÑAdenosine Triphosphatase, Magnesium ANdo not use /analogs; DF: MG ATPASE RNEC 3.6.1.- PIAdenosine Triphosphatase (66-85) MND8.586.277.352.630.114.60 XSATPase, Magnesium; Magnesium ATPase LH LS;  MSAn active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. A subgroup of EC 3.6.1.3. PM79 HN79 MHÑAdenosine Triphosphatase, Sodium, Potassium ANdo not use /analogs; DF: NA K ATPASE RNEC 3.6.1.- PIAdenosine Triphosphatase (66-78); Potassium (66-78); Sodium (66-78) MND8.586.277.352.630.114.100 XSATPase, Sodium, Potassium; Sodium, Potassium ATPase LH LS;  MSAdenosine 5'-(tetrahydrogen triphosphate). An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. MHÑAdenosine Triphosphate AN/biosyn /physiol permitted RN56-65-5 MND13.695.667.138.236; D13.695.827.68.236 XSADENYLPYROPHOSPHATE; ATP XUÑAdenylyl Imidodiphosphate; ÑEthenoadenosine Triphosphate LH LS; LU;  OLuse ADENOVIRIDAE to search ADENOVIRUSES & ADENOVIRUS back thru 1966 PM81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74 HN81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74 MHÑAdenoviridae ANadeno- refers to early isol from adenoids; do not use /blood-csf-urine /cytol MNB4.909.204.97 XUÑAdenoviruses, Avian; ÑAdenoviruses, Simian LH LU;  MHÑAdenovirus Infections ANfor general or unspecified infect; note ADENOVIRUS INFECTIONS, HUMAN below MNC2.256.76 XUÑAdenovirus Infections, Human LH LU  MSRespiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses. OLto search PHARYNGO-CONJUNCTIVAL FEVER use ADENOVIRUS INFECTIONS, HUMAN back thru 1975 & ADENOVIRUS INFECTIONS 1966-74 HN(77); PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76 MHÑAdenovirus Infections, Human MNC2.256.76.45 XSPharyngo-Conjunctival Fever DMÑAdenovirus Infections LH LS LM  MSAdenoviridae pathogenic for birds. OLuse ADENOVIRUSES, AVIAN to search CELO VIRUS back thru 1975 HN(77); was see under ADENOVIRUSES 1975-80; CELO VIRUS (Chicken Embryo Lethal Organ virus) was see under ADENOVIRUSES 1975-76 MHÑAdenoviruses, Avian ANdo not use /blood-csf-urine /cytol PIAdenoviruses (66-74) MNB4.909.204.97.145 XSCelo Virus DMÑAdenoviridae LH LS LM  MSSerotypes of Adenoviridae pathogenic for man. OLto search APC VIRUS use ADENOVIRUSES, HUMAN back thru 1975 & ADENOVIRIDAE 1966-74; use ADENOVIRUSES, HUMAN to search ACUTE RESPIRATORY DISEASE VIRUS back thru 1975 PM77; APC VIRUS (Adenoidal-Pharyngeal-Conjunctival virus) was see under ADENOVIRUSES 1975-76, was see under ADENOVIRUS 1963-74; ACUTE RESPIRATORY DISEASE VIRUS (ARD virus) was see under ADENOVIRUSES 1975-76 HN77; APC VIRUS (Adenoidal-Pharyngeal-Conjunctival virus) was see under ADENOVIRUSES 1975-76, was see under ADENOVIRUS 1963-74; ACUTE RESPIRATORY DISEASE VIRUS (ARD virus) was see under ADENOVIRUSES 1975-76 MHÑAdenoviruses, Human ANdo not use /blood-csf-urine /cytol PIAdenoviridae (66-74) MNB4.909.204.97.170 XSAPC Viruses; Acute Respiratory Disease Viruses; BP Viruses LH LS; ;  MSA group of Adenoviridae associated with respiratory and enteric infections in primates. HN(75); was see under ADENOVIRUSES 1975-80 MHÑAdenoviruses, Simian ANdo not use /blood-csf-urine /cytol MNB4.909.204.97.200 XSSimian Adenoviruses DMÑAdenoviridae LH LS LM  PM72 HN72(68) MHÑAdenyl Cyclase ANdo not use /analogs; regulation: consider also CALMODULIN RNEC 4.6.1.1 PIAdenine Nucleotides (66-67); Enzymes (66-67) MND8.586.520.59 XSAdenylate Cyclase LH LS  MSCatalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. HN(75) MHÑAdenylate Kinase ANdo not use /analogs RNEC 2.7.4.3 PIAdenosine Monophosphate (74); Phosphotransferases, ATP (74) MND8.586.913.696.729.510.40 XSMyokinase DMÑPhosphotransferases, ATP LH LS LM  MSAdenylosuccinate AMP-lyase. In the course of purine ribonucleotide biosynthesis, this enzyme catalyzes the conversion of 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole to 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosucinic acid to AMP. EC 4.3.2.2. HN(79) MHÑAdenylosuccinate Lyase ANdo not use /analogs RNEC 4.3.2.2 PIAdenosine Monophosphate (71-78); Lyases (66-78); Succinates (66-78) MND8.586.520.70 XSAdenylosuccinase DMÑLyases LH LS LM  MSIMP:L-aspartate ligase (GDP-forming). During purine ribonucleotide biosynthesis, this enzyme catalyzes the synthesis of adenylosuccinate from GTP, IMP and aspartate with the formation of orthophosphate and GDP. EC 6.3.4.4. HN(79) MHÑAdenylosuccinate Synthetase ANdo not use /analogs RNEC 6.3.4.4 PIAspartic Acid (66-78); Inosine Monophosphate (75-78); Inosine Nucleotides (71-78); Ligases (66-78) MND8.586.464.75 DMÑLigases LH LM  MS5'-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation. HN(76) MHÑAdenylyl Imidodiphosphate AN/biosyn /physiol permitted; DF: APPNHP RN25612-73-1 PIAdenosine Diphosphate (73-74); Adenosine Triphosphate/AA (75); Imides (73-75); Phosphoric Acids (73-74) MND13.695.667.138.236.50; D13.695.827.68.236.50 XSAdenyl Imidodiphosphate; gamma-Imino-ATP DMÑAdenosine Triphosphate LH LS; LM  MHÑAdhesions ANIM GEN only; coord NIM with organ/dis precoord (IM) MNC23.37 LH  PM74 HN74(69) MHÑAdhesiveness ANalmost never IM; no qualif PISurface Properties (66-68) MNH1.181.529.875.139 FXÑPlatelet Adhesiveness LH LX  MSSubstances that cause the adherence of two surfaces; include glues (properly collagen-derived adhesives), mucilages, sticky pastes, gums, resins or latex. PM78 HN78 MHÑAdhesives AND25-26 qualif; coord IM with DENTAL PROSTHESIS RETENTION (IM) for denture adhesives; spray adhesives: coord IM with AEROSOLS (NIM) if pertinent; available also are TISSUE ADHESIVES, BONE CEMENTS & DENTAL CEMENTS MND26.16; J1.637.16 XSGlues LH LS  MHÑAdie's Syndrome MNC10.597.704.180; C11.716.180; C23.888.592.717.180 LH  MHÑAdiphenine ANdo not use /biosyn /defic /physiol RN64-95-9 MND2.241.223.601.238.100; D16.653.52 LH  OLuse ADIPIC ACIDS to search ADIPIC ACID back thru 1966 PM75; was ADIPIC ACID 1963-74 HN75; was ADIPIC ACID 1963-74 MHÑAdipic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.337.52 LH  MHÑAdipose Tissue ANdo not use /abnorm /growth /inj /innerv; suction lipolysis, liposuction, etc. as in obesity is indexed under ADIPOSE TISSUE /surg (IM) + SUCTION (NIM) MNA10.165.114 XSFATTY TISSUE FXÑBROWN FAT XUÑFat Body LH LS LX LU  MHÑAdiposis Dolorosa MNC17.849.77 XSDERCUM'S DISEASE LH LS  MSMaladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor. OLuse ADJUSTMENT DISORDERS to search DEPRESSION, REACTIVE back thru 1966 (as Prov 1966-68) PM81; was DEPRESSION, REACTIVE 1969-80 HN81; was DEPRESSION, REACTIVE 1966-80 (Prov 1966-68) MHÑAdjustment Disorders ANdo not use /drug eff /physiol /rad eff MNF3.709.80 XSAnniversary Reaction; Depression, Reactive; Reactive Disorders; Transient Situational Disturbance LH LS; ; ;  MSSubstances that enhance, stimulate, activate or potentiate the immune response; they may be microbial products, specific chemicals or other; used mainly in the immunotherapy of neoplasms. PM65 HN65 MHÑAdjuvants, Immunologic ANdo not use /analogs /immunol MND24.611.59 XSImmunoactivators; Immunoadjuvants; Immunologic Adjuvants; Immunomodulators; Immunopotentiators; Immunostimulants LH LS; ; ; ; ;  MSAgents that aid or increase the action of the principle drug; agents that affect the absorption, mechanism of action, metabolism or excretion of the primary drug in such a way as to enhance its effects. OLsearch PHARMACEUTIC AIDS 1969-74 PM75; was see under PHARMACEUTIC AIDS 1969-74 HN75; was see under PHARMACEUTIC AIDS 1969-74 MHÑAdjuvants, Pharmaceutic AND25-26 qualif PIPharmaceutic Aids (68-74) MND26.698.64 LH  MSThe application of suitable drug dosage forms to the skin for either local or systemic effects. PM87 HN87 MHÑAdministration, Cutaneous ANNIM; no qualif PIAdministration, Topical (66-86) MNE5.300.120.60 XSCutaneous Administration, Drug; Cutaneous Drug Administration; Dermal Drug Administration; Drug Administration, Dermal; Percutaneous Administration; Skin Administration, Drug; Skin Drug Administration; Transcutaneous Administration; Transdermal Administration FXÑSkin Absorption LH LS; ; ; ; ; ; ; ; LX  MSThe administration of drugs by the respiratory route; insufflation into the respiratory tract goes here also. PM87 HN87 MHÑAdministration, Inhalation ANNIM; no qualif PIAerosols (66-86); Lung (66-86); Respiration (66-86); Respiratory Therapy (78-86) MNE5.300.50 XSDrug Administration, Inhalation; Drug Administration, Respiratory; Drug Aerosol Therapy; Inhalation Drug Administration; Inhalation of Drugs; Respiratory Drug Administration FXÑAdministration, Intranasal; ÑAerosols; ÑAnesthesia, Inhalation; ÑRespiratory Therapy LH LS; ; ; ; ; LX; ; ;  PM73 HN73 MHÑAdministration, Intranasal ANNIM; no qualif PIspecific drug/AD (66-72) MNE5.300.80; E5.300.120.80 XSDRUG ADMINISTRATION, INTRANASAL FXÑAdministration, Inhalation; ÑNebulizers and Vaporizers LH LS LX;  MSThe insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor; the dosage forms may include medicated pessaries, irrigation fluids, and suppositories. HN(87) MHÑAdministration, Intravaginal ANNIM; no qualif PIAdministration, Topical (74-86); Vagina (66-86); Vaginal Creams, Foams and Jellies (75-86) MNE5.300.120.500 XSAdministration, Vaginal; Drug Administration, Vaginal; Instillation, Vaginal; Intravaginal Administration; Vaginal Drug Administration FXÑVaginal Creams, Foams and Jellies DMÑAdministration, Topical LH LS; ; ; ; LX LM  MSThe instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. PM87 HN87 MHÑAdministration, Intravesical ANNIM; no qualif PIAdministration, Topical (74-86); Bladder (66-86) MNE5.300.120.505 XSDrug Administration, Bladder; Drug Therapy, Intravesical; Instillation, Bladder; Intravesical Chemotherapy; Intravesical Drug Administration LH LS; ; ; ;  MSThe giving of drugs, chemicals, or other substances by mouth. PM73 HN73(70) MHÑAdministration, Oral ANNIM but only if discussed: do not index here routinely for every orally administered drug; no qualif PIspecific drug/AD (66-69) MNE5.300.100 XSDRUG ADMINISTRATION, ORAL LH LS  MSThe insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose. PM87 HN87 MHÑAdministration, Rectal ANNIM; no qualif PIIntestinal Absorption (66-86); Rectum (66-86); Suppositories (66-86) MNE5.300.110; E5.300.120.610 XSAnal Drug Administration; Drug Administration, Rectal; Instillation, Rectal; Rectal Drug Administration FXÑAnesthesia, Rectal; ÑSuppositories LH LS; ; ; LX;  PM74 HN74 MHÑAdministration, Topical ANNIM; no qualif; consider also OINTMENTS, LINIMENTS & POWDERS; ADMINISTRATION, CUTANEOUS is also available MNE5.300.120 XSDRUG ADMINISTRATION, TOPICAL FXÑSkin Absorption XUÑAdministration, Intravaginal LH LS LX LU  MSIndividuals responsible for the development of policy and supervision of the execution of plans and functional operations. PM68 HN68 MHÑAdministrative Personnel ANdo not use /man /methods PIOrganization and Administration (66-67) MNM1.526.70; N2.350.45 XSAdministrators XUÑNurse Administrators LH LS LU  MSHospital department responsible for the flow of patients and the processing of admissions, discharges, transfers, and also most procedures to be carried out in the event of a patient's death. HN(Aug 77) MHÑAdmitting Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: ADMIT DEP MNN2.278.354.422.40; N4.452.442.422.40 XSHospital Admissions Office; Hospital Admitting Department DMÑHospital Departments LH LS; LM  MHÑAdnexa Uteri ANinflammation = ADNEXITIS MNA5.360.319.114 XUÑBroad Ligament; ÑRound Ligament LH LU;  PM66 HN66 MHÑAdnexal Diseases ANinflamm dis = ADNEXITIS MNC13.371.56 LH  MHÑAdnexitis ANfemale only: note category; ╥male adnexitis╙: index under GENITAL DISEASES, MALE MNC13.371.56.114 XSPELVIC INFLAMMATORY DISEASE LH LS  MHÑAdolescence ANage 13-18 yr; IM as physiol, psychol & sociol entity, but no qualif; check tag ADOLESCENCE for NIM; Manual 18.5.12, 34.10, 34.13; /psychol = ADOLESCENT PSYCHOLOGY MNM1.471.80 XSYOUTH LH LS  MSAny observable response or action of an adolescent. PM81 HN81 MHÑAdolescent Behavior ANonly /drug eff; check also tag ADOLESCENCE PIAdolescent Psychology (67-80) MNF1.145.22 XSBehavior, Adolescent LH LS  MSA branch of medicine pertaining to the diagnosis and treatment of diseases occurring during the period beginning with puberty until the cessation of somatic growth. PM80 HN80 MHÑAdolescent Medicine ANSPEC; SPEC qualif; when permitted for ╥adolescent dis╙: Manual 28.9; relation to ADOLESCENCE: Manual 34.13 PIAdolescence (66-79) MNG2.403.28 LH  MSThe medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in individuals 13-18 years. PM67 HN67 MHÑAdolescent Psychiatry ANSPEC: SPEC qualif; not for mental disorders in adolescents ( = MENTAL DISORDERS (IM) + ADOLESCENCE (NIM) ): Manual 27.9 PIChild Psychiatry (66); Psychiatry (66); Psychoanalysis (66) MNF4.96.544.65; G2.403.642.80 LH  MSField of psychology concerned with normal and abnormal behavior of adolescents -- includes mental processes as well as observable responses. PM67 HN67 MHÑAdolescent Psychology ANSPEC but also the way a normal adolescent thinks & acts; when SPEC, SPEC qualif; Manual 27.12 MNF4.96.628.65 LH  MSAdolescent hospitalized for short term care. PM83 HN83 MHÑAdolescent, Hospitalized ANnot for dis in adolescent in hosp for diag or ther: use only for hospitalized adolescents as a psychol, sociol or social entity; only /educ /psychol; check also tag ADOLESCENCE PIAdolescence (66-82; Hospitalization (66-82) MNM1.471.80.280; M1.643.50 LH  MSAdolescent placed in institutions on a long term basis. PM83 HN83 MHÑAdolescent, Institutionalized ANonly /educ /psychol; check also tag ADOLESCENCE PIAdolescence (66-82; Institutionalization (79-82); Residential Facilities (68-82) MNM1.471.80.305 LH  MSVoluntary acceptance of a child of other parents to be as one's own child, usually with legal confirmation. MHÑAdoption ANno qualif MNI1.880.225.140 LH  MS6 beta-Iodomethyl-19-norcholest-5(10)-en-3 beta-ol. A sterol usually substituted with radioactive iodine. It is an adrenal cortex scanning agent with demonstrated high adrenal concentration and superior adrenal imaging. Synonyms: NCL-6. HN(79) MHÑAdosterol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN55623-03-5 PICholestenes (73-78); Iodine Radioisotopes (66-78); Sterols (66-78) MND4.808.247.808.50 XS6-Iodomethylnorcholesterol; NP-59 DMÑSterols LH LS; LM  MSThe outer layer of the adrenal gland; it secretes mineralocorticoids, androgens and glucocorticoids. OLsearch ADRENAL GLANDS 1966-74 PM78,63-67; was see under ADRENAL GLANDS 1968-77 HN78(75)63-67; was see under ADRENAL GLANDS 1968-77 MHÑAdrenal Cortex ANPITUITARY-ADRENAL SYSTEM is available PIAdrenal Glands (66-74) MNA6.407.71.140 LH  OLsearch ADRENAL GLAND DISEASES 1966-74 PM79,63-67; was see under ADRENAL GLAND DISEASES 1975-78 HN79(75)63-67; was see under ADRENAL GLAND DISEASES 1975-78 MHÑAdrenal Cortex Diseases PIAdrenal Gland Diseases (66-74) MNC19.53.98 LH  OLsearch PITUITARY-ADRENAL FUNCTION TESTS 1966-74 HN(75)63-67 MHÑAdrenal Cortex Function Tests ANonly /instrum /methods /vet MNE1.197.86 DMÑPituitary-Adrenal Function Tests LH LM  MHÑAdrenal Cortex Hormones ANGEN only; avoid: prefer specifics; do not use /analogs; /defic: consider also ADRENAL GLAND HYPOFUNCTION MND6.472.40 XSCORTICOIDS; Corticosteroids LH LS;  OLsearch ADRENAL GLAND NEOPLASMS 1966-74 PM79,63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78 HN79(75)63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78 MHÑAdrenal Cortex Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIAdrenal Gland Neoplasms (66-74) MNC4.588.322.78.265; C19.53.347.265 LH  MHÑAdrenal Gland Diseases ANas IM to mean adrenal dis GEN or unspecified; as NIM to be coord for dis of adrenal medulla; for adrenal hyperplasia see note at ADRENAL GLANDS MNC19.53 LH  OLuse ADRENAL GLAND HYPERFUNCTION to search ADRENAL CORTEX HYPERFUNCTION back thru 1966 PM68; ADRENAL CORTEX HYPERFUNCTION was heading 1963-67 HN68; ADRENAL CORTEX HYPERFUNCTION was heading 1963-67 MHÑAdrenal Gland Hyperfunction ANdo not use /congen ( = ADRENAL HYPERPLASIA, CONGENITAL); non-congen adrenal hyperplasia: index under ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM) MNC19.53.181 XSHYPERCORTICISM LH LS  OLuse ADRENAL GLAND HYPOFUNCTION to search ADRENAL CORTEX HYPOFUNCTION back thru 1966 PM68; ADRENAL CORTEX HYPOFUNCTION was heading 1963-67 HN68; ADRENAL CORTEX HYPOFUNCTION was heading 1963-67 MHÑAdrenal Gland Hypofunction MNC19.53.264 LH  MHÑAdrenal Gland Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.322.78; C19.53.347 LH  MSPaired glands situated in the retroperitoneal tissues at the superior pole of each kidney. MHÑAdrenal Glands AN/surg = probably ADRENALECTOMY; hypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM; hyperplasia = ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM); congenital adrenal hyperplasia (CAH) = ADRENAL HYPERPLASIA, CONGENITAL MNA6.407.71 XUÑInterrenal Gland LH LU  MSA group of inherited disorders of adrenal steroidogenesis the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form and a 3-beta-hydroxysteroid deficiency form. OLuse ADRENAL HYPERPLASIA, CONGENITAL to search ADRENOGENITAL SYNDROME back thru 1966 PM80; was ADRENOGENITAL SYNDROME 1963-79 HN80; was ADRENOGENITAL SYNDROME 1963-79 MHÑAdrenal Hyperplasia, Congenital ANdo not use /congen MNC19.53.440; C19.391.90 XSAdrenogenital Syndrome FXÑPuberty, Precocious; ÑVirilism; ÑVirilism LH LS LX; ;  MSThe inner part of the adrenal gland; it synthesizes, stores and releases catecholamines. MHÑAdrenal Medulla ANdis = ADRENAL MEDULLA (IM) + ADRENAL GLAND DISEASES (NIM); medulla enucleation: for physiol studies, ADRENAL MEDULLA /physiol, for surg ther, ADRENAL MEDULLA /surg MNA6.224.115; A6.407.71.265 LH  MSA rare, usually benign, ovarian tumor thought to be derived from embryonic rest cells of the adrenals. This tumor causes varying degrees of masculinization. OLuse ADRENAL REST TUMOR to search ADRENAL CORTICAL REST TUMOR back thru 1966 PM82; was ADRENAL CORTICAL REST TUMOR 1963-81 HN82; was ADRENAL CORTICAL REST TUMOR 1963-81 MHÑAdrenal Rest Tumor AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.85 XSAdrenal Cortical Rest Tumor LH LS  MHÑAdrenalectomy ANexcision of entire adrenal; enucleation: see note above under ADRENAL MEDULLA MNE4.779.115 LH  PM73 HN73(69) MHÑAdrenergic Alpha Receptor Agonists ANdo not confuse with adren alpha recept antagonists ( = ADREN ALPHA RECEPT BLOCK); do not use /analogs /biosyn /defic /physiol; DF: ADREN ALPHA RECEPT AG PISympathomimetics (66-68) MND16.893.116.182 XSALPHA ADRENERGIC RECEPTOR AGONISTS LH LS  PM73 HN73(69) MHÑAdrenergic Alpha Receptor Blockaders AN= adren alpha recept antagonists: do not confuse with ADRENERGIC ALPHA RECEPTOR AGONISTS; do not use /analogs /biosyn /defic /physiol; DF: ADREN ALPHA RECEPT BLOCK PISympatholytics (66-68) MND16.848.115 XSALPHA ADRENERGIC RECEPTOR BLOCKADERS LH LS  PM73 HN73(69) MHÑAdrenergic Beta Receptor Agonists ANdo not confuse with adren beta recept antagonists ( = ADREN BETA RECEPT BLOCK); do not use /analogs /biosyn /defic /physiol; DF: ADREN BETA RECEPT AG PISympathomimetics (66-68) MND16.893.116.348 XSBETA ADRENERGIC RECEPTOR AGONISTS LH LS  PM73 HN73(69) MHÑAdrenergic Beta Receptor Blockaders AN= adren beta recept antagonists: do not confuse with ADRENERGIC BETA RECEPTOR AGONISTS; do not use /analogs /biosyn /defic /physiol; DF: ADREN BETA RECEPT BLOCK PISympatholytics (66-68) MND16.848.215 XSBETA ADRENERGIC RECEPTOR BLOCKADERS LH LS  MSNerve fibers liberating catecholamines at a synapse after an impulse. PM77 HN77 MHÑAdrenergic Fibers ANdo not use /innerv PISympathetic Nervous System (66-76) MNA8.99.893.52; A8.663.542.75 XSSympathetic Fibers LH LS  PM73 HN73(71) MHÑAdrenergic Neurohumor Depleters ANdo not use /analogs /biosyn /defic /physiol PISympatholytics (66-70) MND16.848.415 FXÑTransmitter Uptake Inhibitors, Neuronal LH LX  MSSympathomimetic amines; substances acting on postganglionic adrenergic nerve endings and structures innervated by them; these agents may stimulate either alpha or beta receptors or both; the actions are peripheral excitation of some and inhibition of other smooth muscle, cardiac stimulation, changes in glucose and fatty acid metabolism and excitation of the higher reaches of the central nervous system. PM75 HN75 MHÑAdrenergic Receptor Agonists ANdo not use /analogs /biosyn /defic /physiol PISympathomimetics (66-74) MND16.893.116 LH  PMCARBAZOCHROME was see under INDOLES 1976; CARBAZOCHROME SALICYLATE (now see CARBAZOCHROME, an XU below) was see under ADRENOCHROME 1975-79, was see under HEMOSTATICS 1963-74 MHÑAdrenochrome AN/physiol permitted RN54-06-8 MND3.438.473.25; D11.557.61; D15.236.372.61 XUÑCarbazochrome LH LU  OLuse ADRENOCORTICOTROPIC HORMONE to search CORTICOTROPIN back thru 1966 PM87; was CORTICOTROPIN 1963-86; /adverse effects /poisoning /toxicity were CORTICOTROPIN TOXICOLOGY 1963-65; /therapeutic use was CORTICOTROPIN, THERAPEUTIC 1965 HN87; was CORTICOTROPIN 1963-86; /ad-poi-tox was CORTICOTROPIN TOXICOLOGY 1963-65; /therapeutic use was CORTICOTROPIN, THERAPEUTIC 1965 MHÑAdrenocorticotropic Hormone AN/biosyn /physiol permitted RN9002-60-2 MND6.472.734.525.183; D12.644.20; D12.776.641.650.20 XSACTH; Corticotropin XUÑCosyntropin LH LS; LU  MSAn iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin and cytochrome P-450. PM75 HN75 MHÑAdrenodoxin ANdo not use /analogs /defic RN12687-22-8 PIFerredoxins (66-74); Carrier Proteins (74); Metalloproteins (74) MND12.776.157.435.50; D12.776.556.580.50 LH  MSA sphingolipidosis which combines the features of leukodystrophy and Addison's disease; formerly considered part of Schilder's disease (ENCEPHALITIS PERIAXIALIS). HN(83) MHÑAdrenoleukodystrophy PIAdrenal Gland Hypofunction (68-82); Cerebral Sclerosis, Diffuse (66-82); Demyelinating Diseases (66-82) MNC10.228.337.144.30; C18.452.648.556.641.803.100; C19.53.264.270 DMÑCerebral Sclerosis, Diffuse LH LM  MHÑAdsorption ANalmost never IM; no qualif MNH1.181.529.47 LH  PM66 HN66 MHÑAdult ANage 19-44 yr; almost never IM; IM only as social, sociol, polit, etc. entity; NIM as check tag; no qualif when NIM, only /psychol when IM but this is as unlikely as ADULT as IM; Manual 18.5+, 34.10 MNM1.471.116 LH  MHÑAdvertising ANonly /econ /hist /legis /methods /stand /trends /util (if by MeSH definition) MNL1.143.50 LH  MHÑAedes AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 MNB1.131.617.289.610.116 LH  MSA photoprotein isolated from the bioluminescent jellyfish Aequorea. It emits visible light by an intramolecular reaction when a trace amount of calcium ion is added. The light-emitting moiety in the bioluminescence reaction is believed to be 2-amino-3-benzyl-5-(p-hydroxyphenyl)pyrazine (AF-350). HN(75); was see under PROTEINS 1975-78 MHÑAequorin AN/analogs NIM only RN50934-79-7 PICoelenterata (72-74); Proteins (72-74) MND12.776.532.20 DMÑLuminescent Proteins LH LM  HN(71) MHÑAerobiosis ANalmost never IM; only /drug eff /rad eff PIappropriate heading/GD (66-70); appropriate heading/ME (66-70) MNG6.535.51 DMÑMetabolism LH LM  MHÑAeromonas ANin fish; infection: coord NIM with BACTERIAL INFECTIONS (IM) MNB3.475.900.141 LH  MSSpasmodic swallowing of air. MHÑAerophagy ANdo not use /drug eff /physiol /rad eff MNC23.888.821.61; F3.126.36 XSAir Swallowing LH LS  HN(73); was in Cat D & J 1973-82 MHÑAerosol Propellants AND25-26 qualif with discretion PIAerosols (66-72); specific chemical MND26.394.225.220.54.266 DMÑAerosols LH LM  MSColloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellent agents. HNwas in Cat D & J 1973-82, was in Cat D only 1963-72 MHÑAerosols ANGEN; NIM with specific drug IM; no qualif when NIM; IM when general only & only /adv eff /anal (with caution) /stand /supply MND26.394.225.220.54 FXÑAdministration, Inhalation; ÑNebulizers and Vaporizers; ÑRespiratory Therapy XUÑAerosol Propellants LH LX; ; LU  MSA specialty which is concerned with the health and medical problems of man in aviation (aviation medicine) and space (space medicine). OLsearch SPACE FLIGHT 1975-79; use AEROSPACE MEDICINE to search AVIATION MEDICINE back thru 1966; use AEROSPACE MEDICINE + DENTISTRY to search AVIATION DENTISTRY 1966-79 PM80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79 HN80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79 MHÑAerospace Medicine ANSPEC; SPEC qualif except /methods; med, physiol or psychol aspects of aviation go here: Manual 28.10; SPACE MEDICINE as a specialty goes here but med, physiol or psychol aspects of space flight go under SPACE FLIGHT CATALOG: /geog /form PISpace Flight (75-79) MNG2.403.790.548.80 XSAviation Medicine; Space Medicine FXÑAccidents, Aviation; ÑAltitude; ÑDecompression Sickness; ÑProtective Devices; ÑSpace Flight LH LS; LX; ; ; ;  MHÑAET AND25-26 qualif RN56-10-0 MND26.763.141 XSAMINOETHYLISOTHIURONIUM BROMIDE HYDROBROMIDE LH LS  MSThe feeling-tone accompaniment of an idea or mental representation; the most direct psychic derivatives of the instincts, psychic representatives of the various bodily changes by means of which instincts manifest themselves. PM65; was see under EMOTIONS 1963-64 HN65(64); was see under EMOTIONS 1963-64 MHÑAffect ANonly /drug eff /physiol /rad eff MNF1.470.47 LH  MSLong-standing illnesses characterized by either sustained or intermittent disturbance in mood with no psychotic features, such as delusions, hallucinations, etc. OLsearch AFFECTIVE DISTURBANCES under AFFECTIVE SYMPTOMS 1969-80 PM81; CYCLOTHYMIC DISORDER was CYCLOTHYMIC PERSONALITY DISORDERS 1968-80; AFFECTIVE DISTURBANCES was heading 1969-80 HN81; AFFECTIVE DISTURBANCES was heading 1969-80 MHÑAffective Disorders ANhuman only; do not use /drug eff /physiol /rad eff; do not confuse with AFFECTIVE SYMPTOMS: read MeSH definitions & follow text MNF3.709.438.100 XSMood Disorders, Non-Psychotic XUÑCyclothymic Disorder LH LS LU  MSDisorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc. OLuse AFFECTIVE DISORDERS, PSYCHOTIC to search DEPRESSION, REACTIVE, PSYCHOTIC back thru 1977; search AFFECTIVE DISTURBANCES under AFFECTIVE SYMPTOMS 1969-80 PM81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80 HN81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80 MHÑAffective Disorders, Psychotic ANdo not use /drug eff /physiol /rad eff MNF3.709.680.80 XSDepression, Reactive, Psychotic; Mood Disorders, Psychotic; Psychoses, Affective LH LS; ;  MSMood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus. OLuse AFFECTIVE SYMPTOMS to search AFFECTIVE DISTURBANCES 1969-80 PM81; was AFFECTIVE DISTURBANCES 1969-80 HN81; was AFFECTIVE DISTURBANCES 1969-80 MHÑAffective Symptoms ANhuman only; do not use /drug eff /physiol /rad eff; do not confuse with AFFECTIVE DISORDERS: read MeSH definitions & follow text PIAffect (66-68); Anxiety (66-68); Emotions (66-68) MNF3.126.56 XSAlexithymia; Emotional Disturbances FXÑEmotions LH LS; LX  MSA complication of gastrojejunostomy, caused by acute or chronic obstruction of the afferent loop due to hernia, intussusception, kinking, volvulus, etc.; characterized by pain and vomiting of bile-stained fluid. Includes acute afferent loop obstruction, bilious vomiting. OLsearch DUMPING SYNDROME 1966-68 PM70; was see under DUMPING SYNDROME 1963-69 HN70(69); was see under DUMPING SYNDROME 1963-69 MHÑAfferent Loop Syndrome PIDumping Syndrome (66-68) MNC6.405.469.531.99; C23.814.66 LH  MSNerve structures through which impulses are conducted from a peripheral part toward a nerve center. PM76 HN76; was NON MESH before 1976 MHÑAfferent Pathways ANdo not use /innerv; coord NIM with origin (IM) + termination (IM) PINeural Transmission (68-75); Neurons, Afferent (69-75); Receptors, Sensory (66-75); specific sensory receptor; specific central nervous system heading MNA8.612.220 LH  MSAnalogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. PM75 HN75 MHÑAffinity Labels ANonly /chem syn /metab /pharm PIBinding Sites (68-74); Indicators and Reagents (68-74) MND26.550.20 XSAffinity Labeling Reagents LH LS  MHÑAfghanistan MNZ1.252.245.42; Z1.630.70 LH  MHÑAfibrinogenemia MNC15.378.463.134.72 XSFIBRINOGEN DEFICIENCY LH LS  OLuse AFLATOXINS to search AFLATOXIN back thru 1966 PM75; was AFLATOXIN 1967-74 HN75; was AFLATOXIN 1965-74 (Prov 1965-66) MHÑAflatoxins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS MND24.185.926.587.142; D26.191.23 FXÑAspergillus Flavus LH LX  MHÑAfrica MNZ1.58 LH  MHÑAfrica, Central MNZ1.58.100 LH  MHÑAfrica, Eastern MNZ1.58.183 LH  MHÑAfrica, Northern MNZ1.58.266 LH  MHÑAfrica, Southern ANdo not confuse with SOUTH AFRICA ( = The Republic of South Africa) MNZ1.58.349 LH  MHÑAfrica, Western MNZ1.58.432 LH  MSAn insect-borne reovirus infection of horses, mules and donkeys in Africa and the Middle East; characterized by pulmonary edema, cardiac involvement, and edema of the head and neck. PM70 HN70 MHÑAfrican Horsesickness ANdo not use /vet; don't forget also HORSES (NIM) & check tag ANIMAL PIHorse Diseases (66-69); Reovirus Infections (68-79) MNC2.782.791.142; C2.81.30; C22.488.88 LH  MSAn RNA Virus which causes disease in horses, mules, and donkeys. HN(75); was see under REOVIRUSES 1975-80 MHÑAfrican Horsesickness Virus ANdo not use /blood-csf-urine /cytol MNB4.909.777.714.150 DMÑReoviridae LH LM  MSA usually fatal iridovirus infection of pigs, characterized by fever, cough, diarrhea, hemorrhagic lymph nodes and edema of the gall bladder. Syn: wart-hog disease, Montgomery's disease. PM70 HN70 MHÑAfrican Swine Fever ANdo not use /vet; don't forget also SWINE (NIM) & check tag ANIMAL; do not confuse with swine fever ( = HOG CHOLERA) PISwine Diseases (66-69); Virus Diseases (66-69) MNC2.256.142; C2.81.40; C22.905.72 LH  MSA virus causing a fatal disease among domestic pigs in Africa; the disease is less virulent in Europe. HN(75); was see under IRIDOVIRUSES 1975-80, was see under DNA VIRUSES 1975-77 MHÑAfrican Swine Fever Virus ANdo not use /blood-csf-urine /cytol PIDNA Viruses (66-74) MNB4.909.204.490.120 XSWart-hog Disease Virus DMÑIridoviridae LH LS LM  MSThe care and treatment of a convalescent patient; especially that of a patient after surgery. Synonym: After Treatment. PM68 HN68 MHÑAfter Care ANmed, nurs, psychiat care after discharge from a hosp or other health facil; differentiate from REHABILITATION which is for getting a person back to his pre-illness work or other activity; only /econ /legis /methods /organ /psychol /stand /trends PIProgressive Patient Care (66-67) MNE2.472.58; N2.421.589.79 FXÑHALFWAY HOUSES; ÑPatient Care Planning LH LX;  MSContinuation of visual impression after cessation of stimuli causing the original image. MHÑAfterimage ANonly /drug eff /physiol /rad eff; differentiate from FIGURAL AFTEREFFECT which is displacement of (usually) geometric pattern in shape & space; while both are in the field of perception, AFTERIMAGE is likely to be in ophthalmol jrnls, FIGURAL AFTEREFFECT, in psychol jrnls MNF2.463.593.932.73; G11.697.911.860.80 LH  MSAn immunologic deficiency state characterized by an extremely low level of generally all classes of gamma globulin in the blood. Called also hypogammaglobulinemia. MHÑAgammaglobulinemia ANTN 225: relation to HYPO- & DYSGAMMAGLOBULINEMIA MNC15.378.147.142; C15.604.515.32; C20.673.88 XSHypogammaglobulinemia LH LS  MHÑAgar AND25-26 qualif RN9002-18-0 MND9.203.698.360.41; D19.316.396.50; D26.342.267 LH  MSAn extensive order of basidiomycetous fungi that includes the gilled mushrooms and a number of related forms. OLto search AGARICACEAE use AGARICALES back thru 1975 & BASIDIOMYCETES back thru 1966 PM75; AGARICACEAE & COPRINUS were headings 1975-85, was see MUSHROOMS 1963-74; AMANITA was see under AGARICACEAE 1975-85 HN75; AGARICACEAE was heading 1975-85, was see MUSHROOMS 1963-74 MHÑAgaricales ANdo not use /embryol /microbiol /parasitol PIBasidiomycetes (66-74) MNB5.354.179.100 XSAgaricaceae XUÑAgaricus; ÑAmanita; ÑCoprinus; ÑCortinarius LH LS LU; ; ;  MSA basidiomycetous fungal genus of the family Agaricaceae, order Agaricales which includes the field mushroom (A.campestris) and the commercial mushroom (A.bisporus). HN(86) MHÑAgaricus ANdo not use /embryol /microbiol /parasitol PIAgaricales (66-85); Basidiomycetes (66-85) MNB5.354.179.100.105 DMÑAgaricales LH LM  OLuse AGE DETERMINATION BY SKELETON to search SKELETAL AGE MEASUREMENT back thru 1966 PM67; was SKELETAL AGE MEASUREMENT 1965-66 HN67; was SKELETAL AGE MEASUREMENT 1965-66 MHÑAge Determination by Skeleton ANonly /vet MNE1.818.43 XSBONE AGE MEASUREMENT; SKELETAL AGE MEASUREMENT LH LS;  PM67 HN67(64) MHÑAge Determination by Teeth ANonly /vet MNE1.262.556.184; E1.818.727.184; E6.342.764.142 LH  MSUse when age is discussed as a factor in relation to some specific subject or problem. PM68 HN68 MHÑAge Factors ANNIM; no qualif; human & animal; mainly statist in concept: differentiate from AGING, a physiol concept; policy: Manual 35.7 PIAging (66-67) MNG7.168.142; N1.224.67 LH  PM66; was see under GERIATRICS 1963-65 HN66; was see under GERIATRICS 1963-65 MHÑAged ANage 65-79 if IM, age 65 & over as check tag: see below AGED, 80 AND OVER; IM as physiol, psychol or sociol entity; NIM as check tag; only /psychol; Manual 18.5+, 34.14; differentiate from AGING, a physiol process & AGE FACTORS, a statist concept CATALOG: form qualif = GERIATRICS /form MNM1.471.116.100 FXÑGeriatrics; ÑHOMES FOR THE AGED; ÑHealth Insurance for Aged and Disabled, Title 18; ÑHealth Services for the Aged; ÑLongevity; ÑPensions; ÑRetirement LH LX; ; ; ; ; ;  MSPersons 80 years of age and older. PM87 HN87 MHÑAged, 80 and over ANage 80 yr & over; IM as physiol, psychol or sociol entity; NIM as for AGED check tag; whether IM or NIM check tag AGED; Manual 18.5+, 34.14 CATALOG: form qualif = GERIATRICS /form PIAged (66-86) MNM1.471.116.100.80 XSCentenarian; Nonagenarian; Octogenarian; Oldest Old FXÑLongevity LH LS; ; ; LX  OLsearch TASTE DISORDERS 1974 HN(75) MHÑAgeusia MNC10.597.751.861.184; C23.888.592.763.861.184 DMÑTaste Disorders LH LM  MHÑAgglutination ANNIM, no qualif; when IM, only /drug eff /rad eff MNG4.610.143.100 LH  PM66 HN66 MHÑAgglutination Tests ANNIM; only /instrum /methods /vet MNE1.223.495.826.67 LH  MSSubstances, usually of biological origin, that cause cells or other organic particles to aggregate and stick to each other; those antibodies which cause aggregation or agglutination of a particulate or insoluble antigen. PM73 HN73 MHÑAgglutinins ANonly /admin /anal /csf /class /immunol /isol /urine; cold agglutinin disease = COLD AGGLUTININ DISEASE see ANEMIA, HEMOLYTIC, AUTOIMMUNE PIAntibodies (66-72) MND24.611.125.44 LH  MSA goal-directed self assertion with an associated implication of attack, of hostile, destructive intent. MHÑAggression ANhuman & animal; only /drug eff /physiol /psychol /rad eff; ╥agression╙ in French is translated ╥stress╙ & indexed under a STRESS heading; ╥agressologie╙ = STRESS MNF1.145.40.28; F3.126.842.89 XUÑAgonistic Behavior LH LU  MHÑAging ANhuman & animal; IM; aging process anywhere between birth & old age; qualif permitted: /blood-csf-urine /drug eff /ethnol /genet /immunol /metab /pathol /physiol /psychol /rad eff; differentiate from AGE FACTORS, a statist concept; as physiol concept: Manual 28.35; relation to AGED: Manual 34.14; ╥aging╙ of lower organisms, cultures, drugs, etc. is probably TIME FACTORS: Manual 35.7.4; ╥premature aging╙ = probably PROGERIA MNG7.168 XSSENESCENCE LH LS  MS4-(Aminobutyl)guanidine. Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle. HN(75) MHÑAgmatine ANdo not use /defic /physiol; /analogs NIM only RN306-60-5 PIButylamines (73-74); Guanidines (68-74) MND2.78.370.60 DMÑGuanidines LH LM  MSLoss of the ability to recognize the significance of perceptions via one or more of the special senses (i.e. sight, taste, hearing, smell and tactile). In psychiatry agnosia also refers to the loss or disuse of knowledge of objects, when the knowledge appears to have been altered by emotional circumstances. MHÑAgnosia ANdo not use /congen /drug eff /physiol /rad eff MNC10.597.44; C23.888.592.43; F3.126.185.794.118 LH  MSAny behavior associated with conflict between two individuals. OLsearch AGGRESSION 1968-74 HN(75) MHÑAgonistic Behavior ANanimal; only /drug eff /physiol /rad eff MNF1.145.40.28.20 DMÑAggression LH LM  MSObsessive, persistent, intense fear of open places. OLsearch PHOBIC DISORDERS 1968-74 HN(75); was see under PHOBIAS 1968-80 MHÑAgoraphobia ANdo not use /drug eff /physiol /rad eff MNF3.709.438.180.508.80 DMÑPhobic Disorders LH LM  MHÑAgranulocytosis ANfeline = FELINE INFECTIOUS ENTERITIS MNC15.378.553.546.184 XSGRANULOCYTOPENIA XUÑNeutropenia LH LS LU  MSLoss of the ability to express thoughts in writing. MHÑAgraphia ANdo not use /congen /drug eff /physiol /rad eff MNC10.597.257.543.74.59; C23.888.592.257.543.74.59; F3.126.219.543.74.59 FXÑHandwriting LH LX  MHÑAgricultural Workers' Diseases ANdo not use /congen /compl MNC21.447.80 FXÑRural Health LH LX  MSThe science of soil cultivation, crop production, and livestock raising. MHÑAgriculture ANIM; only /econ /hist /instrum /methods /stand MNJ1.40 LH  MHÑAgrobacterium ANin soil, plants, marine mud MNB3.400.861.143 LH  MSFinancial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the Social Security Act, Title IV, in the U.S. OLsearch PUBLIC ASSISTANCE 1968-74 PM78; was see under PUBLIC ASSISTANCE 1968-77 HN78(75); was see under PUBLIC ASSISTANCE 1968-77 MHÑAid to Families with Dependent Children ANtreed under SOCIAL SECURITY; only /hist /legis /organ /trends; specify geog; DF: AFDC MNN3.219.521.346.506.849.95 LH  MSA prodromal phase or possibly milder form of infection associated with the HTLV-III or lymphadenopathy-associated viruses. PM87 HN87 MHÑAIDS-Related Complex PIAcquired Immunodeficiency Syndrome (83-86) MNC2.782.815.483.23.80; C20.673.483.23.80 XSLymphadenopathy Syndrome LH LS  MHÑAinhum MNC5.116.264.143; C23.304.351.81 XSDACTYLOLYSIS SPONTANEA LH LS  MHÑAir ANonly /anal; do not confuse with ATMOSPHERE or OXYGEN; air embolism = EMBOLISM, AIR MNG3.230.300.100.150 LH  MHÑAir Conditioning ANonly /adv eff /econ /instrum /methods /stand /trends MNG3.230.150.50 LH  PM70 HN70(65) MHÑAir Ionization ANno qualif MNG3.230.300.100.150.100; H1.181.529.65 LH  MHÑAir Microbiology ANIM; no qualif; coord IM with specific microbe (IM) MNG1.273.540.81; G3.850.425.110 LH  PM74; WIND was see under WEATHER 1969-73 HN74(72) MHÑAir Movements ANno qualif; note WIND here but for typhoons & hurricanes consider NATURAL DISASTERS PIAir (66-71); Weather (66-71) MNG3.230.300.100.150.185 XUÑWind LH LU  MSSubstances which pollute the air. Use for air pollutants in general or for which there is no specific heading. PM75 HN75 MHÑAir Pollutants ANonly /ad-poi-tox /anal /isol PIAir Pollution (66-74) MND5.284.101 XUÑAir Pollutants, Radioactive LH LU  MSAir pollutants which affect environmental conditions. Use when the effect of pollutant(s) on the environment is discussed. PM84; was see under AIR POLLUTANTS 1975-83 HN84(75); was see under AIR POLLUTANTS 1975-83 MHÑAir Pollutants, Environmental ANonly /ad-poi-tox /anal /isol MND5.284.101.143 XSEnvironmental Air Pollutants LH LS  MSAir pollutants found in the work area; usually produced by the specific nature of the occupation. PM84; was see under AIR POLLUTANTS 1975-83 HN84(75); was see under AIR POLLUTANTS 1975-83 MHÑAir Pollutants, Occupational ANonly /ad-poi-tox /anal /isol MND5.284.101.268 XSOccupational Air Pollutants LH LS  MSPollutants, present in air, which exhibit radioactivity. HN(75) MHÑAir Pollutants, Radioactive ANonly /ad-poi-tox /anal /isol MND5.284.101.393; D5.284.638.101 XSRadioactive Air Pollutants DMÑAir Pollutants LH LS LM  MHÑAir Pollution ANonly /adv eff /anal /econ /prev; includes pollen in the air (coord with POLLEN) CATALOG: /geog /form MNG3.850.460.100 LH  MHÑAir Pollution, Radioactive ANonly /adv eff /anal /econ /prev CATALOG: /geog /form MNG3.850.810.80; G3.850.460.100.110 LH  MSThe force per unit area that the air exerts on any surface in contact with it. Primarily used for articles pertaining to air pressure within a closed environment. OLsearch ATMOSPHERIC PRESSURE 1966-74 HN(75) MHÑAir Pressure ANno qualif MNG3.230.300.100.185.100 DMÑAtmospheric Pressure LH LM  MSThin-walled sacs or spaces which function as a part of the respiratory system in birds, fishes, insects, and mammals. OLuse AIR SACS to search AIR BLADDER back thru 1966 PM68; AIR BLADDER was heading 1968-80 HN68; AIR BLADDER was heading 1968-80 MHÑAir Sacs ANin birds, fish, insects & mammals; sacculitis: coord IM with RESPIRATORY TRACT DISEASES or RESPIRATORY TRACT INFECTIONS probably with /vet (NIM) PIBirds (66-67); Bronchi (66-67) MNA13.48 XSAir Bladder; Swimbladder FXÑLung LH LS; LX  OLuse AIRCRAFT to search EJECTION SEATS back thru 1966 PMEJECTION SEATS was heading 1963-82 HNEJECTION SEATS was heading 1963-82 MHÑAircraft ANonly /econ /hist /instrum /stand MNJ1.95.70; J1.937.70; N2.421.297.879.50 XSEjection Seats; Helicopters LH LS;  PM72 HN72(71) MHÑAirway Obstruction ANacute: chronic airway obstruct, chronic airflow obstruct & COAD (chronic obstruct airway dis) go under LUNG DISEASES, OBSTRUCTIVE (see note there) PIRespiratory Tract Diseases (66-70) MNC8.618.846.185 XSChoking LH LS  PM70 HN70 MHÑAirway Resistance ANonly /drug eff /rad eff PIRespiration (66-70); Respiratory System/PH (66-70) MNE1.302.796.57; G9.772.521.69 LH  MS(17R)-Ajmalan-17,21-alpha-diol. An alkaloid from Rauwolfia serpentina and related species; used in cardiac arrhythmias; may cause liver damage; its chloroacetyl salt is less toxic. Synonyms: Cardiorhythmine; Gilurytmal; rauwolfine; Tachmalin; Viaductor. PM73 HN73(71) MHÑAjmaline ANdo not use /biosyn /defic /physiol RN4360-12-7 PIRauwolfia (66-70) MND3.132.973.641.119; D3.549.937.641.144; D16.848.415.804.28; D18.97.69 XSLorajmine XUÑPrajmaline LH LS LU  PM71 HN71 MHÑAkinetic Mutism PIMutism (66-70) MNC10.228.140.42 XSMUTISM, AKINETIC LH LS  MSA virus isolated from spontaneous leukemia of AKR Strain mice. HN(75) MHÑAKR Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM) MNB4.909.574.807.674.632.100; B4.909.777.731.674.632.100; B4.909.777.779.674.632.100 DMÑMouse Leukemia Viruses LH LM  MHÑAlabama MNZ1.107.567.875.27 LH  MSL-Prolyl-2-methylalanyl-L-alanyl-2-methylalanyl-L-alanyl-L-glutaminyl-2-methylalanyl-L-valyl-2-methyl-alanylglycyl-L-leucyl-2-methylalanyl-L-prolyl-L-valyl-2-methylalanyl-2-methylalanyl-L-alpha-glutamyl-L-glutamine cyclic peptide. Cyclic nonadecapeptide antibiotic. HN(75) MHÑAlamethicin ANdo not use /defic /physiol; /analogs NIM only RN27061-78-5 PIAntibiotics (71-75); Peptides, Cyclic (73-74) MND12.644.641.42; D20.85.38 DMÑAntibiotics LH LM  MHÑAlanine ANBETA-ALANINE is also available RN6898-94-8 MND12.125.42 XUÑ3-Aminopropionic Acid LH LU  HNGLUTAMIC-PYRUVIC TRANSAMINASE was see under ALANINE 1963 MHÑAlanine Aminotransferase AN/blood = SGPT /blood (not just SGPT); do not use /analogs RNEC 2.6.1.2 MND8.586.913.140.119 XSGLUTAMIC-PYRUVIC TRANSAMINASE; SGPT LH LS;  MSA pyridoxal-phosphate protein which reversibly catalyzes the conversion of L-alanine to D-alanine. HN(76) MHÑAlanine Racemase ANdo not use /analogs RNEC 5.1.1.1 PIAlanine (74-75); Amino Acid Isomerases (70-75) MND8.586.399.124.60 DMÑAmino Acid Isomerases LH LM  MSL-Alanine:tRNA-Ala ligase (AMP-forming). Activates alanine with its specific transfer RNA. HN(75) MHÑAlanyl T RNA Synthetase ANdo not use /analogs RNEC 6.1.1.7 PIAmino Acyl T RNA Synthetases (73-74); Alanine (73-74) MND8.586.464.136.40 DMÑAmino Acyl T RNA Synthetases LH LM  MHÑAlaska MNZ1.107.567.875.36 LH  MSA mild form of smallpox, caused by a virus slightly less virulent for the chick embryo than the virus causing variola major, and distinguished from the latter disease by its much lower fatality rate. OLsearch SMALLPOX 1966-74 HN(75) MHÑAlastrim MNC2.256.743.826.269 XSVariola Minor DMÑSmallpox LH LS LM  MHÑAlbania ANin translations use spelling: People's Republic, not Peoples' nor Peoples MNZ1.542.248.64 LH  MHÑAlberta MNZ1.107.567.176.64 LH  MHÑAlbinism MNC11.38; C17.621.102; C17.827.130; C18.452.648.66.102 FXÑCHEDIAK-HIGASHI SYNDROME LH LX  MHÑAlbumins AN/blood = SERUM ALBUMIN; /urine = ALBUMINURIA; do not use /analogs; PREALBUMIN is available MND12.776.34 LH  MHÑAlbuminuria MNC12.777.584.269 FXÑUrine LH LX  PM74 HN74 MHÑAlbuterol ANdo not use /biosyn /defic /physiol RN18559-94-9 MND2.33.329.291.57; D2.92.63.291.57; D2.92.471.683.61; D16.116.38; D16.893.116.348.38 XSSALBUTAMOL LH LS  OLuse ALCALIGENES to search ACHROMOBACTER back thru 1966 PM76; was ACHROMOBACTER 1963-75 HN76; was ACHROMOBACTER 1963-75 MHÑAlcaligenes MNB3.400.100 XSAchromobacter LH LS  MHÑAlchemy ANno qualif MNK1.419.75 FXÑChemistry LH LX  MSA copper-containing dye used as a gelling agent for lubricants, for staining of bacteria and for the dyeing of histiocytes and fibroblasts in vivo. Synonyms: C.I. 74240; C.I. Ingrain Blue 1. HN(75) MHÑAlcian Blue AND25-26 qualif; /analogs NIM only RN12040-44-7 PIIndoles (73-74); Onium Compounds (74) MND3.438.473.50; D26.408.50 DMÑIndoles LH LM  MS(4-(Allyloxy)-3-chlorophenyl)acetic acid. An anti-inflammatory agent used in the treatment of rheumatoid arthritis. Acts also as an analgesic and an antipyretic. HN(75) MHÑAlclofenac ANdo not use /biosyn /defic /physiol; /analogs NIM only RN22131-79-9 PIAllyl Compounds (72-74); Phenyl Ethers (74); Phenylacetates (71-75) MND2.241.223.601.75; D14.73.278.115; D26.74.75.115 DMÑPhenylacetates LH LM  MSA mental disorder with brain damage characterized by amnesia, compensatory confabulation, disturbance of attention, and peripheral neuritis. Usually associated with alcoholism and dietary deficiencies. OLuse ALCOHOL AMNESTIC DISORDER to search KORSAKOFF'S SYNDROME back thru 1966 PM81; was KORSAKOFF'S SYNDROME 1963-80 HN81; was KORSAKOFF'S SYNDROME 1963-80 MHÑAlcohol Amnestic Disorder ANdo not use /congen /drug eff /physiol /rad eff MNC21.613.53.270.630.587; F3.709.680.610.80; F3.709.680.610.580.510.60 XSKorsakoff Psychosis; Korsakoff Syndrome LH LS;  MSAlcohol:NAD+ oxidoreductase. This enzyme catalyzes reversibly the final step of alcoholic fermentation by reducing an aldehyde to an alcohol. In the case of ethanol, acetaldehyde is reduced to ethanol in the presence of NADH and hydrogen. The enzyme is a zinc protein which acts on primary and secondary alcohols or hemi-acetals. EC 1.1.1.1 PM87 HN87 MHÑAlcohol Dehydrogenase ANdo not use /analogs RNEC 1.1.1.1 PIAlcohol Oxidoreductases (66-86) MND8.586.682.47.70 LH  MHÑAlcohol Deterrents AND25-26 qualif; consider also ALCOHOLISM /drug ther MND26.32 LH  MSBehaviors associated with the ingesting of alcoholic beverages; includes social drinking. PM69 HN69 MHÑAlcohol Drinking ANfor ╥alcohol consumption╙; only /drug eff /ethnol /physiol /psychol /rad eff; chronic alcohol consumption = ALCOHOLISM; TEMPERANCE is available PIAlcoholic Beverages (66-68) MNF1.145.317.269 XSDRINKING, ALCOHOL LH LS  PM64 HN64 MHÑAlcohol Oxidoreductases ANdo not use /analogs RNEC 1.1. MND8.586.682.47 XSALCOHOL DEHYDROGENASES XUÑAcetoin Dehydrogenase; ÑHomoserine Dehydrogenase LH LS LU;  MSAn acute organic mental disorder due to recent cessation or reduction in alcohol consumption with the essential characteristic being delirium. Autonomic hyperactivity - that is, tachycardia, sweating, and elevated blood pressure - is also present. Formerly called delirium tremens. OLto search DELIRIUM TREMENS use ALCOHOL WITHDRAWAL DELIRIUM back thru 1975 & PSYCHOSES, ALCOHOLIC 1966-74 HN(81); was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80 MHÑAlcohol Withdrawal Delirium ANdo not use /chem ind /drug eff /physiol /rad eff; do not confuse with ╥alcohol withdrawal syndrome╥ ( = SUBSTANCE WITHDRAWAL SYNDROME (IM) + ALCOHOL, ETHYL /adv eff (IM)) MNC21.613.53.270.630.290; F3.709.680.610.580.510.80 XSDelirium Tremens DMÑPsychoses, Alcoholic LH LS LM  MHÑAlcohol, Ethyl ANfor ╥alcohol╙ unspecified; /antag = ALCOHOL DETERRENTS; /pois = ALCOHOLIC INTOXICATION; do not use /biosyn /defic /physiol; consider also ALCOHOLIC BEVERAGES; hypophysectomy by alcohol injection = HYPOPHYSECTOMY, CHEMICAL & do not index under ALCOHOL, ETHYL unless particularly discussed RN64-17-5 MND2.33.57 XSEthanol FXÑAlcoholic Beverages XUÑEthamoxytriphetol; ÑPhenethyl Alcohol; ÑTrifluoroethanol LH LS LX LU; ;  MHÑAlcohol, Methyl ANfor wood alcohol; /pois permitted; do not use /biosyn /defic /physiol RN67-56-1 MND2.33.95 XSMETHANOL LH LS  MHÑAlcohol, Propyl ANdo not use /biosyn /defic /physiol RN71-23-8 MND2.33.134; D2.33.555.91; D10.516.289.91 XSIsopropanol; Isopropyl Alcohol; PROPANOL LH LS; ;  MHÑAlcoholic Beverages ANGEN; BEER & WINE are available; only /ad-poi-tox /anal /class /hist /rad eff /stand /supply; chronic consumption of alcoholic bev = ALCOHOLISM MNJ1.125.91 FXÑAlcohol, Ethyl LH LX  MHÑAlcoholic Intoxication ANhuman & animal; acute alcohol intox: do not coord with ACUTE DISEASE; chronic alcohol intox = ALCOHOLISM MNC21.613.53; F3.709.508.490.80 XSIntoxication, Alcoholic LH LS  MSAn organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence. PM74 HN74 MHÑAlcoholics Anonymous ANonly /hist /organ CATALOG: use NAF Entry MNN3.540.782.270 FXÑAlcoholism LH LX  MSThe overuse of alcohol to the extent of habituation, dependence, or addiction. Alcoholism is medically significant when it impairs or threatens physical or mental health, or when it hampers personal relationships and individual effectiveness. MHÑAlcoholism ANhuman & animal; do not coord with CHRONIC DISEASE: alcoholism is presumed to be chronic; differentiate from ALCOHOLIC INTOXICATION, being drunk, not chronic; do not use /congen ( = FETAL ALCOHOL SYNDROME) /drug eff /physiol /rad eff; /drug ther: consider also ALCOHOL DETERRENTS; consider also LIVER DISEASES, ALCOHOLIC & its specifics FATTY LIVER, ALCOHOLIC; HEPATITIS, ALCOHOLIC & LIVER CIRRHOSIS, ALCOHOLIC; CARDIOMYOPATHY, ALCOHOLIC & FETAL ALCOHOL SYNDROME; PSYCHOSES, ALCOHOLIC & SKID ROW ALCOHOLICS are also available; index other compl of alcoholism under ALCOHOLISM /compl (IM) + disease /etiol not /chem ind (IM); alcoholic ulcero-mutilating acropathy = ALCOHOLISM (IM) + PERIPHERAL NERVE DISEASES (IM) MNC21.613.53.270; F3.709.597.780.660.80 XSAlcohol Abuse FXÑAlcoholics Anonymous; ÑFetal Alcohol Syndrome; ÑSkid Row Alcoholics; ÑSocial Problems LH LS LX; ; ;  MHÑAlcohols ANdo not use for ╥alcohol╙ ( = ALCOHOL, ETHYL); do not use /analogs /biosyn /defic /physiol; diols = GLYCOLS; hypophysectomy by alcohol (ethanol) injection = HYPOPHYSECTOMY, CHEMICAL & do not index under ALCOHOL, ETHYL unless particularly discussed MND2.33 LH  PM74 HN74(72) MHÑAlcohols, Amyl ANdo not use /analogs /biosyn /defic /physiol; = pentyl alcohols PIAlcohols (66-71) MND2.33.172; D2.33.555.162; D10.516.289.162 XSPENTANOLS LH LS  PM74 HN74(72) MHÑAlcohols, Butyl ANdo not use /analogs /biosyn /defic /physiol PIAlcohols (66-71) MND2.33.210; D2.33.555.233; D10.516.289.233 XSButanols LH LS  PM74 HN74(72) MHÑAlcohols, Hexyl ANdo not use /analogs /biosyn /defic /physiol MND2.33.248; D2.33.555.304; D10.516.289.304 XSHEXANOLS LH LS  PM74 HN74(72) MHÑAlcohols, Octyl ANdo not use /analogs /biosyn /defic /physiol MND2.33.286; D2.33.555.375; D10.516.289.375 XSOCTANOLS LH LS  MSN,N'-Diallylnortoxiferinium dichloride. Non-depolarizing skeletal muscle relaxant similar to tubocurarine; used as anesthesia adjuvant. Synonym: Alloferin. HN(75) MHÑAlcuronium ANdo not use /biosyn /defic /physiol RN23214-96-2 PIAllyl Compounds (72-74); Toxiferine (72-74) MND2.92.102.844.50; D2.675.276.844.50; D3.132.267.712.50; D17.563.367.217.712.50 XSAllnortoxiferine; Alloferin; Diallylnortoxiferine DMÑToxiferine LH LS; ; LM  MSAldehyde:NAD+ oxidoreductase. Oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. EC 1.2.1.3; before 1978 was classified as EC 1.1.1.70. PM85 HN85 MHÑAldehyde Dehydrogenase ANdo not use /analogs RNEC 1.2.1.3 PIAlcohol Oxidoreductases (74-79); Aldehyde Oxidoreductases (80-84) MND8.586.682.75.100 XSD-Glucuronolactone Dehydrogenase LH LS  PM73 HN73 MHÑAldehyde Oxidoreductases ANdo not use /analogs RNEC 1.2. PIOxidoreductases (66-72) MND8.586.682.75 XUÑFormate Dehydrogenases LH LU  MHÑAldehyde-Lyases ANdo not use /analogs RNEC 4.1.2. MND8.586.520.110 XUÑPhospho-2-Keto-3-Deoxy-Heptonate Aldolase LH LU  MHÑAldehydes ANdo not use /analogs /biosyn /defic /physiol MND2.47 XUÑAcrolein; ÑGlutaraldehyde; ÑGlyoxal; ÑHydroxypentenal; ÑPhenylglyoxal; ÑPyruvaldehyde; Ño-Phthalaldehyde LH LU; ; ; ; ; ;  HN(72) MHÑAldicarb ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN116-06-3 PICarbamates (66-71); Insecticides (66-71) MND2.241.81.251.46; D5.723.491.408.103 DMÑInsecticides, Carbamate LH LM  MSAlditol:NADP(+)1-oxidoreductase. Catalyzes reversibly the oxidation of an aldose to an alditol. Possesses broad specificity for many aldoses. HN(76); was see under ALCOHOL OXIDOREDUCTASES 1976-77 MHÑAldose Reductase ANdo not use /analogs RNEC 1.1.1.21 PIAlcohol Oxidoreductases (72-75); Sugar Alcohols (72-75) MND8.586.682.47.150.700.75 DMÑSugar Alcohol Dehydrogenases LH LM  MHÑAldosterone AN/biosyn /physiol permitted; /antag = ALDOSTERONE ANTAGONISTS; /physiol: consider also RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM see RENIN-ANGIOTENSIN SYSTEM & do not index under ALDOSTERONE unless particularly discussed RN52-39-1 MND4.808.745.745.654.62; D6.472.40.668.478.561.187 LH  MSCompounds which inhibit or antagonize the biosynthesis or actions of aldosterone. OLsearch ALDOSTERONE /AI 1968-77 & ALDOSTERONE 1966-67 PM78,63-67 HN78,63-67 MHÑAldosterone Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: ALDOSTERONE ANTAG PIAldosterone (66-77) MND6.347.50 LH  PM73 HN73(71) MHÑAldrin ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN309-00-2 PIHydrocarbons, Halogenated (66-70); Insecticides (66-70) MND2.455.526.439.42; D5.723.491.491.53 LH  MSA slow progressive disease of mink, characterized by poor reproduction, weight loss, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible. An unclassified virus can precipitate the disease, possibly by stimulating somatic mutation to which the animal mounts an autoimmune response. PM71 HN71 MHÑAleutian Mink Disease ANdo not use /vet; don't forget also MINK (NIM) & check tag ANIMAL PICarnivora (66-67); Mink (68-70); Virus Diseases (66-70) MNC2.839.91; C20.673.774.257.270; C22.62 FXÑCHEDIAK-HIGASHI SYNDROME LH LX  MSA parvovirus that causes a disease in mink, mainly those homozygous for the recessive Aleutian gene which determines a desirable coat color. HN(75); was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85 MHÑAleutian Mink Disease Virus ANdo not use /blood-csf-urine /cytol MNB4.909.204.671.115 DMÑParvoviridae LH LM  MHÑAlfalfa ANdo not use /isol /pathogen; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.570.42; J1.341.52.146 XSLUCERNE; Medicago LH LS;  MHÑAlgae ANGEN; do not use /anat /embryol /microbiol /parasitol MNB5.104 XUÑAlgae, Brown LH LU  MH*Algae and Fungi (Non Mesh) MNB5 LH  MSPhototrophic procaryote organisms that use water as an electron donor and hence produce oxygen in the presence of light. Common genera are Anabaena, Tolypothrix, and Plectonema. Together with the Bacteria they make up the kingdom Procaryotae. PM70 HN70 MHÑAlgae, Blue-Green ANcommon genera: Anabaena, Tolypothrix, Plectonema; do not use /anat /embryol /microbiol /parasitol PIAlgae (66-69) MNB5.104.92 XSCYANOPHYCEAE; CYANOPHYTA; Cyanobacteria LH LS; ;  MSPredominantly marine algae of the division Phaeophyta, having chromatophores containing carotenoid pigments. Genera include Ascophyllum, Fucus, Eisenia, Petalonia, Ectocarpus. HN(71) MHÑAlgae, Brown ANcommon genera: Ascophyllum, Fucus, Eisenia, Petalonia, Ectocarpus; do not use /anat /embryol /microbiol /parasitol PIAlgae (66-70) MNB5.104.163 DMÑAlgae LH LM  MSAlgae of the division Chlorophyta, in which the green pigment of chlorophyll is not masked by other pigments. Classes include: Charophyceae, Bryopsidophyceae, Conjugatophyceae, Oedogoniophyceae, Chlorophyceae, Prasinophyceae; common genera are Acetabularia, Chlamydomonas, Chlorella, Nitella, rPrototheca, Scenedesmus, Spiragyra, Volvox. PM70 HN70 MHÑAlgae, Green ANcommon genera: ACETABULARIA, CHLAMYDOMONAS, CHLORELLA, Nitella, Prototheca, Scenedesmus, Spirogyra, Volvox; do not use /anat /embryol /microbiol /parasitol PIAlgae (66-69) MNB5.104.234 XSCHLOROPHYTA XUÑAcetabularia LH LS LU  MSAlgae of the division Rhodophyta, in which the pigment is predominantly red; common genera are Gelidium, Gracilaria, and Polysiphonia. PM74 HN74(71) MHÑAlgae, Red ANcommon genera: Gelidium, Gracilaria, Polysiphonia; do not use /anat /embryol /microbiol /parasitol PIAlgae (66-70) MNB5.104.305 LH  MHÑAlgeria MNZ1.58.266.104 LH  PM74 HN74 MHÑAlgestone Acetophenide ANdo not use /biosyn /defic /physiol RN24356-94-3 MND4.808.745.745.654.829.50; D6.597.799.47 XSAlphasone Acetophenide; Dihydroxyprogesterone Acetophenide XUÑAlphasone LH LS; LU  MHÑAlginates AND25-26 qualif MND9.203.698.68; D25.339.334.187 LH  MSA procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. PM87 HN87 MHÑAlgorithms ANIM; no qualif MNH1.548.35; H1.770.35; L1.700.568.110.50 LH  PM74 HN74 MHÑAlkadienes ANdo not use /analogs /biosyn /defic /physiol MND2.455.326.271.665.146 XSDIOLEFINS LH LS  MSNon-motile anaerogenic enteric organisms that ferment lactose late or not at all; formerly classified with the Shigella, but biochemically and antigenically resembling atypical strains of Escherichia. OLsearch SHIGELLA 1974 & ENTEROBACTERIACEAE 1966-73 HN(75); was see under SHIGELLA 1974, was see under ENTEROBACTERIACEAE 1968-73, was heading 1963-67 (Prov) MHÑAlkalescens-Dispar Group ANdo not use /blood-csf-urine MNB3.475.300.325.100 DMÑEscherichia LH LM  MHÑAlkalies ANsingular form is ╥alkali╙; do not use /analogs /biosyn /defic /physiol; /adv eff: consider also MILK-ALKALI SYNDROME MND1.455.121 LH  OLuse ALKALINE PHOSPHATASE to search BLOOD ALKALINE PHOSPHATASE 1966-67 PM/blood was BLOOD ALKALINE PHOSPHATASE 1963-67 HN/blood was BLOOD ALKALINE PHOSPHATASE 1963-67 MHÑAlkaline Phosphatase ANdo not use /analogs; /defic: consider also HYPOPHOSPHATASIA RNEC 3.1.3.1 MND8.586.277.352.630.654.163 LH  MHÑAlkaloids ANGEN; alkaloids from specific plants go here (IM) + name of plant or PLANTS, MEDICINAL, etc.; do not use /analogs /defic /physiol MND3.132 FXÑPlants, Medicinal XUÑAcronine; ÑDihydro-beta-Erythroidine; ÑEllipticines; ÑHarmaline; ÑHarmine; ÑHarringtonines; ÑIbogaine; ÑRyanodine; ÑTomatine LH LX LU; ; ; ; ; ; ; ;  MHÑAlkalosis MNC18.452.76.354 FXÑAcid-Base Equilibrium LH LX  PM74 HN74(71) MHÑAlkalosis, Respiratory PIAlkalosis (66-70); Hyperventilation (66-70) MNC8.618.501.271; C18.452.76.354.271 XSRESPIRATORY ALKALOSIS LH LS  PM66 HN66 MHÑAlkanes ANdo not use /analogs /biosyn /defic /physiol; cycloalkanes = CYCLOPARAFFINS MND2.455.326.146 XUÑNitroparaffins LH LU  MHÑAlkaptonuria ANdo not use /congen MNC18.452.648.66.187; C23.205.87 FXÑUrine LH LX  PM66 HN66 MHÑAlkenes ANdo not use /analogs /biosyn /defic /physiol; cycloalkenes = CYCLOPARAFFINS MND2.455.326.271 XSOLEFINS LH LS  PM73 HN73 MHÑAlkyl Sulfonates ANdo not use /analogs /biosyn /defic /physiol PIAlkylating Agents (66-72); Sulfonic Acids (66-72) MND2.241.866.540.121; D2.455.326.146.92; D2.886.610.121 XUÑIsethionic Acid LH LU  MSHighly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Most are very toxic, with carcinogenic, mutagenic, teratogenic and immunosuppressant actions; many are used as antineoplastic agents and formerly as poison gases. PM66 HN66(64) MHÑAlkylating Agents ANdo not use /analogs /biosyn /defic /physiol MND26.550.25 FXÑAntineoplastic Agents; ÑCarcinogens; ÑNitrogen Mustard Compounds LH LX; ;  PM66 HN66 MHÑAlkylation ANalmost never IM; no qualif; enzymatic alkylation: coord NIM with TRANSFERASES (IM) + substrate (NIM); METHYLATION & METHYLTRANSFERASES are also available MNH1.181.404.146 LH  MSOrganic mercury compounds in which the mercury is attached to an alkyl group. OLuse ALKYLMERCURY COMPOUNDS to search ALKYL MERCURY COMPOUNDS back thru 1977 PM80; was ALKYL MERCURY COMPOUNDS 1977-79 HN80; was ALKYL MERCURY COMPOUNDS 1977-79 MHÑAlkylmercury Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ALKYLMERCURY CPDS PIMercury (66-76); Organometallic Compounds (68-76) MND2.691.750.100; D5.723.288.50 XSAlkyl Mercury Compounds; Alkylmercurials LH LS;  PM66 HN66 MHÑAlkynes ANdo not use /analogs /biosyn /defic /physiol MND2.455.326.397 LH  PM72 HN72(64) MHÑAllantoin RN97-59-6 MND3.383.374.411.105 LH  MSAn embryonic diverticulum of the hindgut of reptiles, birds, and mammals; in man its blood vessels give rise to those of the umbilical cord. OLsearch FETAL MEMBRANES 1966-74 HN(75) MHÑAllantois ANmammalian, avian or reptilian; do not use /abnorm /embryol /growth /inj MNA16.254.403.147 DMÑFetal Membranes LH LM  MSMutually exclusive forms of the same gene, occupying the same locus on homologous chromosomes, and governing the same biochemical and developmental process. Syn: allelomorphs. PM68 HN68 MHÑAlleles ANno qualif; = allelomorphs PIGenes (66-67) MNG5.275.77 LH  PM68 HN68 MHÑAllelism Test ANno qualif PIGenetics (66-67) MNE5.393.281.188 LH  PM65 HN65 MHÑAllergens ANonly /admin /anal /class /diag use /immunol /isol /pharm /rad eff /stand /tox MND24.611.216.63 FXÑBITES AND STINGS; ÑDUST; ÑFEATHERS; ÑFUNGI LH LX; ; ;  MSA medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder. OLuse ALLERGY AND IMMUNOLOGY to search IMMUNOLOGY back thru 1966; search RADIATION IMMUNOLOGY under RADIATION EFFECTS 1966 PM80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66 HN80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66 MHÑAllergy and Immunology ANSPEC: SPEC qualif; do not confuse with ALLERGY see HYPERSENSITIVITY above (Cat C); consider also /immunol: Manual 19.5+; /methods = IMMUNOLOGIC TECHNICS; immunohematology is indexed under BLOOD GROUPS; immunologic processes = IMMUNITY or specific; DF: ALLERGY IMMUNOL CATALOG: use with form qualif instead of IMMUNITY /form or IMMUNOLOGIC DISEASES /form or HYPERSENSITIVITY /form MNG2.403.776.30 XSAllergy (Specialty); Immunology LH LS;  PM74 HN74(72) MHÑAllethrin ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN584-79-2 PICycloparaffins (66-71); Pyrethrum (66-71) MND2.455.849.700.272; D5.723.491.324.550.272 LH  MSIndividuals, who receive formal or on-the-job-training, to assist the highly trained professional personnel, e.g., pharmacists' assistants, physicians' aides. PM71 HN71 MHÑAllied Health Personnel ANonly /class /econ /educ /hist /legis /psychol /stand /supply /trends /util PIHealth Manpower (68-70); Health Occupations (66-70) MNM1.526.485.67; N2.350.84 XSParamedical Personnel; Paramedics XUÑEmergency Medical Technicians LH LS; LU  MSLarge, long-tailed reptiles of the order Loricata including caimans. HN(75) MHÑAlligators and Crocodiles ANincludes caymans (caimans); IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; DF: ALLIGATORS MNB2.833.100 XSCrocodiles DMÑReptiles LH LS LM  MSA genus of liliaceous herbs containing Allium cepa or onion, Allium sativum or garlic, Allium porrum or leeks, Allium ascalonicum or shallots, and others; many produce pungent, often bacteriostatic and physiologically active compounds and are used as food, condiment, and medicament, the latter in folk medicine. PM86 HN86 MHÑAllium ANdo not use /isol /pathogen; includes ONIONS, leeks & shallots but ALLIUM SATIVUM see GARLIC is available PIGarlic (66-85); Plants (66-85); Vegetables (66-85) MNB6.510.26 XSOnions LH LS  MS5,5-Diallylbarbituric acid. A hypnotic and sedative of intermediate duration. Synonyms: Dial; Malilum; Diadol. HN(76) MHÑAllobarbital ANdo not use /biosyn /defic /physiol; /analogs NIM only RN52-43-7 PIAllyl Compounds (74-75); Barbiturates (70-75) MND3.383.742.698.253.50; D14.591.220.50 XSAllobarbitone; Diallylbarbital; Diallylbarbituric Acid; Diallylmal DMÑBarbiturates LH LS; ; ; LM  MSCatalyzes the hydrolysis of allophanic acid to two molecules of ammonia plus two molecules of ╥active carbon dioxide╙. HN(75) MHÑAllophanate Hydrolase ANdo not use /analogs RNEC 3.5.1.- PIAmidohydrolases (74); Carboxylic Acids (74); Urea (74) MND8.586.277.87.60 DMÑAmidohydrolases LH LM  PM68 HN68(67) MHÑAllopurinol ANdo not use /biosyn /defic /physiol RN315-30-0 PIEnzymes (66); Xanthine Oxidase (66) MND8.373.57; D14.73.278.398.28; D22.204.144.55; D26.74.75.574.28; D26.87.12 LH  PM78; was see under BIOCHEMISTRY 1975-77 HN78(71); was see under BIOCHEMISTRY 1975-77 MHÑAllosteric Regulation ANalmost never IM; only /drug eff /rad eff PIBinding Sites (68-70); Chemistry (66-70); Enzyme Activation (69-70); Enzyme Induction (66-70); Kinetics (66-70) MNG6.184.60 LH  OLsearch BINDING SITES 1968-74 HN(75) MHÑAllosteric Site ANonly /drug eff /rad eff MNG6.184.154.147 DMÑBinding Sites LH LM  MHÑAlloxan ANdo not use /biosyn /defic /physiol; ALLOXAN DIABETES indexed as DIABETES MELLITUS, EXPERIMENTAL (IM) + ALLOXAN (NIM) only if chem is particularly discussed RN50-71-5 MND3.383.742.698.122 LH  PM65; STEEL was see under METALS 1963-67 HN65 MHÑAlloys AND25-26 qualif MND1.552.33; D25.58 XUÑSteel LH LU  PM73 HN73(71) MHÑAllyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ALLYL CPDS PIAlkenes (66-70) MND2.455.326.271.122 LH  MSPossesses an unusual and selective cytotoxicity for vascular smooth muscle cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation. HN(76) MHÑAllylamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-11-9 PIAllyl Compounds (74-75); Amines (74-75) MND2.92.50; D2.455.326.271.122.100 XS3-Aminopropylene DMÑAmines LH LS LM  MS17-Allylestr-4-en-17 beta-ol. A synthetic steroid with progestational activity. HN(75) MHÑAllylestrenol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN432-60-0 PIAllyl Compounds (73-74); Estranes (70-74); Hydroxysteroids (73-74) MND4.808.365.415.50; D6.597.799.65 DMÑEstrenes LH LM  MS2-Amino-4-pentenoic acid. A glutamate decarboxylase and GABA inhibitor; has convulsant activity. HN(80) MHÑAllylglycine ANdo not use /biosyn /defic /physiol RN1069-48-3 PIAllyl Compounds (71-75); Analeptics (66-74); Convulsants (74-79); Glycine (66-74) /AA (75-79) MND2.455.326.271.122.260; D12.125.481.100; D15.128.224.52 DMÑGlycine LH LM  HN(73) MHÑAllylisopropylacetamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN299-78-5 MND2.65.64.189; D2.241.81.38.108.189; D2.455.326.271.122.272 DMÑAcetamides LH LM  MHÑAlmanacs ANonly /hist MNL1.178.682.192.836.72 LH  MSVarious species of aloe (Liliaceae) containing anthraquinone glycosides (aloin-emodin, aloe-emodin) that cause gastrointestinal irritation, purgation and kidney damage; used formerly as laxatives and for dermatitis. HN(78)63; was in Cat B & D 1963-77 MHÑAloe ANplant source of drugs with various uses; do not use /isol /pathogen MNB6.560.50 DMÑPlants, Medicinal LH LM  MHÑAlopecia MNC17.805.305.122 XSBALDNESS XUÑAlopecia Mucinosa; ÑHypotrichosis LH LS LU;  MHÑAlopecia Areata MNC17.805.305.122.147 LH  HN(65) MHÑAlopecia Mucinosa MNC17.805.305.122.272 DMÑAlopecia LH LM  MSA genus of the family Cebidae composed of five species. They are A. villosa (mantled howler), A. seniculus (red howler, A. belzebul (red-handed howler), A. fusca (brown howler), and A. caraya (black howler). They inhabit forests in Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches. OLuse ALOUATTA to search HOWLER MONKEYS back thru 1975 HN(81); was HOWLER MONKEYS see under MONKEYS 1975-80 MHÑAlouatta ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.370.80 XSMonkey, Howler DMÑCebidae LH LS LM  MSThe first alpha globulins to appear in mammalian sera during development of the embryo and the dominant serum protein in early embryonic life. They reappear in the adult serum during certain pathologic states, primarily with hepatocellular carcinoma. PM77; was see under FETAL GLOBULINS 1975-76 HN77(75); was see under FETAL GLOBULINS 1975-76 MHÑAlpha Fetoproteins ANdo not use /analogs /blood; /biosyn /physiol permitted PIFetal Proteins (70-74) MND12.776.320.50 XSAFP; Fetuins LH LS;  OLuse ALPHA GLOBULINS to search ALPHA GLOBULIN back thru 1966 PM75; was ALPHA GLOBULIN 1965-74 HN75; was ALPHA GLOBULIN 1964-74 (Prov 1964) MHÑAlpha Globulins ANdo not use /analogs /blood MND12.776.124.790.106; D12.776.377.715.85 XUÑProgesterone-Binding Globulin LH LU  MSGlycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. Includes alpha 1-macroglobulins and alpha 2-macroglobulins. Exhibit trypsin-, chymotrypsin-, thrombin- and plasmin-binding activity and function as hormonal transporters. PM76 HN76 MHÑAlpha Macroglobulins ANdo not use /analogs /blood PIAlpha Globulins (74-75); Macroglobulins (73-75) MND12.776.124.50.80; D12.776.124.790.106.100; D12.776.124.790.720.100; D12.776.377.715.85.100; D12.776.377.715.647.100 XSAlpha 2-Acute Phase Globulins; Alpha 2-Glucoproteins; Alpha Macrofetoproteins; Slow Alpha 2-Macroglobulins LH LS; ; ;  MSPositively charged particles composed of two protons and two neutrons, i.e., helium nuclei, emitted during disintegration of very heavy isotopes; a beam of alpha particles or an alpha ray has very strong ionizing power, but weak penetrability. PM66 HN66 MHÑAlpha Particles ANionizing; no qualif; radiation policy: see Manual index under RADIATION & entries following MNH1.671.579.55; H1.671.768.513.55 XSAlpha Rays LH LS  PM74 HN74(72) MHÑAlpha Rhythm ANno qualif PIElectroencephalography (66-71) MNE1.236.257.401.148; E1.399.277.148 XSElectroencephalography, Alpha Rhythm LH LS  MSGlycoprotein found in alpha(1)-globulin region in human serum. It inhibits chymotrypsin-like proteinases in vivo and cytotoxic killer cell activity in vitro. The protein also has a role as an acute phase protein and is active in the control of immunologic and inflammatory processes and as a tumor marker. PM87 HN87 MHÑAlpha 1-Antichymotrypsin AN/biosyn /physiol permitted PIChymotrypsin/antagonists & inhibitors (68-86); Glycoproteins (66-86); Protease Inhibitors (79-86) MND8.373.745.50; D12.776.124.50.50; D12.776.124.790.106.50; D12.776.377.715.85.50 LH  PM74 HN74 MHÑAlpha 1-Antitrypsin ANdo not use /analogs /antag /blood; /defic: Pi phenotype goes here + PHENOTYPE MND8.373.745.896.189; D12.776.124.50.70; D12.776.124.790.106.85; D12.776.377.715.85.85 XSTrypsin Inhibitor, Alpha 1-Antitrypsin LH LS  MS1,4-alpha-D-Glucan glucanohydrolase. Catalyzes the endohydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen and related polysaccharides and oligosaccharides containing 3 or more 1,4-alpha-linked D-glucose units. EC 3.2.1.1. PM84; was see under AMYLASES 1978-83 HN84(78); was see under AMYLASES 1978-83 MHÑAlpha-Amylase ANdo not use / analogs RNEC 3.2.1.1 PIAmylases (66-77) MND8.586.277.450.66.50 XSTaka-Amylase A LH LS  MS3-Chloro-1,2-propanediol. A chlorinated propanediol compound. Has shown anti-fertility activity in males. HN(75) MHÑalpha-Chlorohydrin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN96-24-2 PIChlorine (72-74); Propanediols (69-74) MND2.33.440.250; D2.33.618.706.320; D7.360.443.200 XSalpha-Chlorhydrin DMÑChlorohydrins LH LS LM  MS2-(Difluoromethyl)ornithine. This compound is an inhibitor of ornithine decarboxylase, the rate limiting enzyme of the polyamine biosynthetic pathway. Due to the inhibition of polyamine synthesis, the compound precludes cancer formation in many organ systems, inhibits cancer growth, and reduces tumor size. It also has synergistic action with other antineoplastic agents. Furthermore it has been found effective as a trypanocidal agent. PM87 HN87 MHÑAlpha-Difluoromethylornithine ANdo not use /biosyn /defic /physiol; DF:DFMO RN70052-12-9 PIOrnithine (66-74); Ornithine/analogs & derivatives (75-86) MND8.373.65; D12.125.95.765.65; D21.370.884.45; D22.204.45 XSDifluoromethylornithine LH LS  MSalpha-D-Galactoside galactohydrolases. This group of enzymes catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans and galactolipids. EC 3.2.1.22. OLto search MELIBIASES use ALPHA-GALACTOSIDASES back thru 1979, ALPHA-GALACTOSIDASES & GALACTOSIDASES 1978 & GALACTOSIDASES 1966-77 HN(78); MELIBIASE was see GALACTOSIDASE 1963-78 MHÑAlpha-Galactosidases ANdo not use /analogs; do not confuse MELIBIASES with MELIBIOSE RNEC 3.2.1.22 PIGalactosidases (66-78) MND8.586.277.450.410.50 XSMelibiases DMÑGalactosidases LH LS LM  MSalpha-D-Glucoside glucohydrolases. Catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. EC 3.2.1.20. PM87; was see under GLUCOSIDASES 1978-86 HN87(78); was see under GLUCOSIDASES 1978-86 MHÑAlpha-Glucosidases ANdo not use / analogs RNEC 3.2.1.20 PIGlucosidases (66-77) MND8.586.277.450.420.50 XSMaltases LH LS  PM65 HN65(64) MHÑAlphaprodine ANdo not use /biosyn /defic /physiol RN77-20-3 MND3.383.621.40; D14.73.153.491.189; D14.757.471.23 XSProdine LH LS  OLsearch ALPHASONE & ALGESTONE ACETOPHENIDE 1975-76 & ALGESTONE ACETOPHENIDE 1966-74 (as Prov 1966-73) HN(75); was see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974, was heading 1964-73 (Prov) MHÑAlphasone ANdo not use /biosyn /defic /physiol RN595-77-7 MND4.808.745.745.654.829.70; D6.597.799.47.273 XSAlgestone; Dihydroxyprogesterone DMÑAlgestone Acetophenide LH LS; LM  MSA genus of Togaviridae, also known as Group A arboviruses, serologically related to each other but not to other Togaviridae. The viruses are transmitted by mosquitoes. The type species is the Sindbis virus. OLsearch ARBOVIRUSES 1978-80 PM81; was see ARBOVIRUSES 1978-80; ENCEPHALITIS VIRUS, EASTERN EQUINE was see under ENCEPHALITIS VIRUSES 1975-80; ROSS RIVER VIRUS was see under ARBOVIRUSES 1975-80 HN81; was see ARBOVIRUSES 1978-80 MHÑAlphaviruses ANone of the Togaviridae; do not use /blood-csf-urine /cytol; infection: coord NIM with TOGAVIRUS INFECTIONS (IM) PIArboviruses (66-80) MNB4.909.777.923.54 XSArboviruses, Group A XUÑEncephalitis Virus, Eastern Equine; ÑRoss River Virus LH LS LU;  MS8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a) (1,4) benzodiazepine. A triazolobenzodiazepine compound which is used in the treatment of anxiety states and depressive disorders. Withdrawal symptoms after abrupt discontinuation of the drug constitute its most prominent adverse effect. PM87 HN87 MHÑAlprazolam ANdo not use /biosyn /defic /physiol RN28981-97-7 PIAzepines (66-67); Benzazepines (68-73); Benzodiazepines (75-86) MND3.438.79.80.30; D15.236.122.30; D15.236.872.659.191.30 LH  PM73 HN73(72) MHÑAlprenolol ANdo not use /biosyn /defic /physiol RN13655-52-2 PIAmino Alcohols (66-71); Sympatholytics (66-71) MND2.33.329.624.58; D2.92.63.624.58; D16.848.215.106 XUÑDihydroalprenolol LH LU  MS11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid. Potent vasodilator agent which will increase peripheral blood flow. Inhibits platelet aggregation and has many other biological effects such as bronchodilation, mediation of inflammation, etc. PM86 HN86 MHÑAlprostadil AN/biosyn /physiol permitted (note X ref) RN745-65-3 PIProstaglandins (66-74); Prostaglandins E (75-85) MND2.241.81.436.687.150.50; D10.516.251.355.708.250.50; D24.185.798.575.250.30 XSPGE1; Prostaglandin E1 LH LS;  MSA deuteromycetous fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. HN(75); was see under MONILIALES 1975-85 MHÑAlternaria ANdo not use /anat /embryol /microbiol /parasitol; infection = MYCOSES (IM) + ALTERNARIA (NIM) MNB5.354.381.546.75 DMÑHyphomycetes LH LM  MSNon-orthodox therapeutic systems which usually have no satisfactory scientific explanation for their effectiveness. PM86 HN86 MHÑAlternative Medicine AN╥non-orthodox therapeutic systems which usually have no satisfactory explanation for their effectiveness╙: do not editorialize: use the term used by the author; do not confuse with ╥alternative health care delivery system╙ (index under general DELIVERY OF HEALTH CARE or specific health service or facility); no qualif MNE2.40 XSMedicine, Alternative LH LS  MS3 alpha-Hydroxy-5 alpha-pregnane-11,20-dione and 21-acetoxy-3 alpha-hydroxy-5 alpha-pregnane-11,20-dione. A steroidal induction anesthetic. It acts rapidly and is of short duration. PM80; was see under PREGNANEDIONES 1975-79 HN80(75); was see under PREGNANEDIONES 1975-79 MHÑAlthesin ANdo not use /biosyn /defic /physiol RN8067-82-1 PIDrug Combinations (74); Hydroxysteroids (74); Pregnanediones (74) MND4.808.745.558.50; D14.166.35 XSAlphadione LH LS  MHÑAltitude ANno qualif; consider also ATMOSPHERIC PRESSURE; /adv eff = probably ALTITUDE SICKNESS MNG3.230.58 FXÑAerospace Medicine; ÑMountaineering LH LX;  MSA morbid condition of anoxia caused by the reduced pressure of oxygen at high altitudes. OLsearch ANOXIA 1966-74 HN(75) MHÑAltitude Sickness MNC23.888.852.79.189 DMÑAnoxia LH LM  MSConsideration and concern for other people which can be a motivating influence; as opposed to self-love or egoism. PM78 HN78 MHÑAltruism ANno qualif PISocial Behavior (69-77) MNF1.145.813.90; F1.829.233.70; F1.829.759.90; K1.752.256.70 LH  MSAluminum metal sulfate compounds used medically as an astringent and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leucorrhea, conjunctivitis, pharngitis, metritis and minor wounds. HN(75) MHÑAlum Compounds AND25-26 qualif; do not use /analogs; DF: ALUM CPDS PIAluminum (73-74); Sulfates (73-74) MND1.552.45.150; D1.877.814.539.70; D26.368.233.70 XSAluminum Ammonium Sulfate; Aluminum Potassium Sulfate DMÑAluminum LH LS; LM  MHÑAluminum ANAl-27; do not use /analogs /biosyn /defic /physiol; Al-23-26, 28-30 = ALUMINUM (IM) + RADIOISOTOPES (IM) RN7429-90-5 MND1.268.29; D1.552.45 XUÑAlum Compounds; ÑAluminum Oxide LH LU;  MSHydrated aluminum. Has many applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc. OLto search ALUMINUM HYDROXIDE GEL use ALUMINUM HYDROXIDE back thru 1972 (as Prov 1972) & ANTACIDS 1966-71 PM78; ALUMINUM HYDROXIDE GEL was heading 1973-77; ALUMINUM GELS was see under ANTACIDS 1963-72 HN78; ALUMINUM HYDROXIDE GEL was heading 1972-77 (Prov 1972); ALUMINUM GELS was see under ANTACIDS 1963-72 MHÑAluminum Hydroxide ANdo not use /analogs /biosyn /defic /physiol RN21645-51-2 PIAluminum (66-77); Antacids (66-71); Hydroxides (66-77) MND1.455.150; D1.552.45.165; D19.316.203.59.26 XSAluminum Hydroxide Gel; Hydrated Alumina LH LS;  MSAn oxide of aluminum. HN(78) MHÑAluminum Oxide ANdo not use /analogs /biosyn /defic /physiol RN1344-28-1 PIAluminum (66-77); Oxides (66-77) MND1.552.45.178; D1.655.498.75 XSAlumina DMÑAluminum LH LS LM  MHÑAluminum Silicates ANdo not use /analogs /biosyn /defic /physiol MND1.552.45.189; D1.836.189 LH  PM65 HN65 MHÑAlveolar Process ANpart of jaw surrounding & supporting the teeth; for /surg, prefer ALVEOLECTOMY or ALVEOLOPLASTY; alveolar ridge goes here; alveolar osteitis or periostitis = DRY SOCKET; alveolitis sicca dolorosa = DRY SOCKET; inferior alveolar nerve: index under MANDIBULAR NERVE, superior alveolar nerve: index under MAXILLARY NERVE MNA2.835.232.781.324.502.125; A14.254.646.94; A14.521.125 FXÑDENTAL ARCH LH LX  MSPreprosthetic surgery involving rib, cartilage, or iliac crest bone grafts, usually autologous, or synthetic implants for rebuilding the alveolar ridge. HN(80) MHÑAlveolar Ridge Augmentation ANdo not use /util except by MeSH definition PIAlveoloplasty (66-79); Mandible/SU (66-79); Mandibular Diseases/SU (66-79) MNE4.833.800.100; E6.892.800.100 XSMandibular Ridge Augmentation; Maxillary Ridge Augmentation DMÑSurgery, Oral, Preprosthetic LH LS; LM  PM65 HN65 MHÑAlveolectomy ANexcision of part of the ALVEOLAR PROCESS (see note above); do not confuse with ALVEOLOPLASTY; do not use /util except by MeSH definition MNE4.833.800.140; E6.892.800.140 LH  MSConditions in which inhalation of organic dusts results in hypersensitivity reactions at the alveolar level, associated with the production of precipitins. PM77 HN77 MHÑAlveolitis, Extrinsic Allergic PIRespiratory Hypersensitivity (66-76) MNC8.674.55; C20.543.480.680.75 XSAllergic Alveolitis, Extrinsic; Hypersensitivity Pneumonitis XUÑBird Fancier's Lung LH LS; LU  PM65 HN65 MHÑAlveoloplasty ANrefers to ALVEOLAR PROCESS (see note there); do not confuse with ALVEOLECTOMY; do not use /util except by MeSH definition MNE4.833.800.180; E6.892.800.180 FXÑDENTURE, COMPLETE, IMMEDIATE LH LX  MSA degenerative organic mental disease characterized by progressive brain deterioration and dementia; frequently occurring late in life, after 65. OLsearch DEMENTIA, PRESENILE 1966-74 PM84; was see under DEMENTIA, PRESENILE 1967-83, was see under PSYCHOSES, PRESENILE 1963-66 HN84(75); was see under DEMENTIA, PRESENILE 1967-83, was see under PSYCHOSES, PRESENILE 1963-66 MHÑAlzheimer's Disease ANdo not use /drug eff /physiol /rad eff MNC10.228.140.79.60; C10.228.140.382.190; F3.709.680.610.392.300.60; F3.709.680.610.392.360.60 LH  MSA genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous. HN(75); was see under AGARICACEAE 1975-85 MHÑAmanita ANdo not use /embryol /microbiol /parasitol; poisonous; coord NIM for MUSHROOM POISONING (IM) by Amanita MNB5.354.179.100.110 DMÑAgaricales LH LM  MSA group of very potent toxins from Amanita species which cause lethal liver and kidney damage and inhibit some RNA synthesis. PM75 HN75 MHÑAmanitins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS PIMycotoxins (74); Oligopeptides (74); Peptides, Cyclic (74) MND12.644.456.50; D12.644.641.50; D24.185.926.587.175 LH  PM68 HN68(65) MHÑAmantadine ANdo not use /biosyn /defic /physiol RN768-94-5 MND2.219.75.80; D2.455.426.392.368.75.80; D4.615.236.75.80; D14.307.106; D20.388.123 XUÑMemantine LH LU  MS1-(4-Sulfo-1-naphthylazo)-2-naphthol-3,6-disulfonic acid trisodium salt. A sulfonic acid naphthylazo dye used as a coloring agent for foodstuffs and medicines and as a dye and chemical indicator. HN(75) MHÑAmaranth AND25-26 qualif; /analogs NIM only; a coloring agent; index Amaranth, the plant, under HERBS RN915-67-3 PIAzo Compounds (69-75); Naphthalenesulfonates (74) MND2.172.25; D2.241.866.540.244.639.200; D2.886.610.244.639.200; D4.615.638.555.200; D26.408.54 XSC.I. 16185; C.I. Acid Red 27; FD&C Red No. 2; Red Dye No. 2 DMÑAzo Compounds LH LS; ; ; LM  PM65 HN65 MHÑAmbenonium Chloride ANdo not use /biosyn /defic /physiol RN115-79-7 MND2.92.102.46; D2.675.276.46; D8.373.275.79; D16.698.410.46 XSAmbestigminum LH LS  MHÑAmblyopia MNC10.597.751.941.73; C11.966.73; C23.888.592.763.941.73 LH  MSN-(trans-4-Hydroxycyclohexyl)-(2-amino-3,5-dibromobenzyl)-amine. A metabolite of bromhexine that stimulates mucociliary action and clears the air passages in the respiratory tract. HN(77) MHÑAmbroxol ANdo not use /biosyn /defic /physiol RN18683-91-5 PIAniline Compounds (74); Bromhexine/AA (75-76); Cyclohexylamines (74) MND2.92.146.271.100; D2.92.384.175.100; D23.338.454.321.45 XSBromhexine Metabolite VIII; NA 872 DMÑBromhexine LH LS; LM  MSA vehicle equipped for transporting patients in need of emergency care. MHÑAmbulances ANonly /hist /stand /supply MNN2.421.297.879.100 XSEmergency Mobile Units; Mobile Emergency Units LH LS;  MSCare provided patients who are not confined to bed. PM68 HN68(66) MHÑAmbulatory Care ANonly /econ /legis /methods /organ /psychol /stand /trends /util (if by MeSH definition) MNE2.472.106; N2.421.589.148 FXÑOutpatient Clinics, Hospital LH LX  MSThose facilities which administer health services to individuals who do not require hospitalization or institutionalization. OLuse AMBULATORY CARE FACILITIES to search AMBULATORY CARE FACILITIES, NON-HOSPITAL back thru 1980 & HEALTH CENTERS 1979 PM83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82, was HEALTH CENTERS 1979 HN83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82, was HEALTH CENTERS 1979 MHÑAmbulatory Care Facilities ANdo not use /educ /methods CATALOG: /geog /form PIHealth Facilities (68-78) MNN2.278.35 XSClinics, Free-Standing; Health Centers, Ambulatory; Outpatient Clinics LH LS; ;  MSComputerized systems which are developed to support the delivery and management of health care in ambulatory settings. HN(87) MHÑAmbulatory Care Information Systems MNL1.700.508.300.50 DMÑInformation Systems LH LM  MSSurgery performed on an outpatient basis. May be hospital-based or performed in an office or surgicenter. PM80 HN80 MHÑAmbulatory Surgery ANoutpatient surg performed in MD's office, surgicenter or hosp; only /econ /methods /psychol /stand /trends /util (if by MeSH definition) PIAmbulatory Care (66-79); Outpatient Clinics, Hospital (66-79) MNE4.30 XSOffice Surgery; Outpatient Surgery; Surgery, Office; Surgery, Outpatient FXÑSurgicenters LH LS; ; ; LX  MSA genus of the Ambystomatidae family. The best known species of this genus are the axolotl forms AMBYSTOMA MEXICANUM and Ambystoma tigrinum. They may retain gills and remain aquatic without developing all of the adult characteristics. However, under proper changes in the environment they metamorphose. PM72 HN72 MHÑAmbystoma ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIUrodela (66-71) MNB2.90.608.80.68 XSAXOLOTL; Amblystoma XUÑAmbystoma mexicanum LH LS; LU  MSAn axolotl form found in Mexican mountain lakes and accounts for about 30 percent of the urodeles used in research. HN(81) MHÑAmbystoma mexicanum ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAmbystoma (72-80) MNB2.90.608.80.68.525 XSAxolotl, Mexican DMÑAmbystoma LH LS LM  MSA family of the class Urodela which includes 4 living genera, about 33 species, and occurs only in North America. Adults are usually terrestrial, but the larval forms are aquatic. PM81 HN81 MHÑAmbystomatidae ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.90.608.80 XSSalamander, Mole LH LS  MS6-beta-[((Hexahydro-1H-azepin-1-yl)methylene)amino]-penicillanic acid. Amidinopenicillanic acid derivative with broad spectrum antibacterial action; poorly absorbed if given orally; used in urinary infections and typhus. OLuse AMDINOCILLIN to search MECILLINAM back thru 1978 PM85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84; AMDINOCILLIN PIVOXIL was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84 HN85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84 MHÑAmdinocillin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN32887-01-7 PIAntibiotics (66-72); Penicillanic Acids (73-77); Thiazoles (66-72) MND20.85.99.739.49 XSFL 1060; Mecillinam XUÑAmdinocillin Pivoxil LH LS; LU  MSHydroxymethyl (2S,5R,6R)-6-[((hexahydro-1H-azepin-1-yl) -methylene)-amino]penicillanic acid, pivalate ester. Pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken to amdinocillin in the intestinal mucosa; active against gram negative organisms; used as amdinocillin. OLuse AMDINOCILLIN PIVOXIL to search PIVMECILLINAM back thru 1978 HN(85); was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84 MHÑAmdinocillin Pivoxil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN32886-97-8 PIAntibiotics (66-72); Penicillanic Acids (73-77); Thiazoles (66-77) MND20.85.99.739.49.50 XSFL 1039; Pivmecillinam DMÑAmdinocillin LH LS; LM  MHÑAmebiasis AN/drug ther: consider also AMEBICIDES MNC3.752.55 XSAMOEBIASIS; Ameboma; Iodamoebiasis XUÑDientamoebiasis; ÑEntamoebiasis LH LS; ; LU;  MHÑAmebicides ANdo not use /analogs /biosyn /defic /physiol; consider also AMOEBA /drug eff & AMEBIASIS /drug ther MND21.370.107 LH  PM65; was ADAMANTINOMA 1963-64 HN65; was ADAMANTINOMA 1963-64 MHÑAmeloblastoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.789.149; C5.500.499.690.100 XSADAMANTINOMA LH LS  PM65 HN65 MHÑAmeloblasts ANA 11 qualif & /class MNA11.436.107 FXÑDental Enamel LH LX  PM65 HN65 MHÑAmelogenesis ANonly /drug eff /rad eff MNG7.553.767.190 FXÑDental Enamel LH LX  PM65 HN65 MHÑAmelogenesis Imperfecta ANdo not use /congen MNC16.131.314.904.65 LH  MSAbsence of menstruation. MHÑAmenorrhea ANHYPOMENORRHEA & OLIGOMENORRHEA are also available; ╥postpartum amenorrhea╙ is indexed under AMENORRHEA (IM) + PUERPERIUM (IM) & not LACTATION unless lactation is particularly discussed MNC13.371.491.124 LH  HN75 MHÑAmerica ANtoo general; avoid; prefer specific continents or countries MNZ1.107 LH  MSA voluntary organization concerned with the prevention and treatment of cancer through education and research. OLsearch VOLUNTARY HEALTH AGENCIES 1967-74 HN(75) MHÑAmerican Cancer Society ANonly /hist /organ; add UNITED STATES or specific state (NIM) CATALOG: use NAF entry PINeoplasms (66-74); specific neoplasm; Societies, Medical (66-74); Societies, Scientific (66-74); Voluntary Health Agencies (66-74) MNN3.540.630.780.80 DMÑVoluntary Health Agencies LH LM  MSProfessional society representing the field of dentistry. PM66 HN66 MHÑAmerican Dental Association ANonly /hist /organ; add UNITED STATES (NIM); DF: ADA CATALOG: use NAF entry MNN3.540.828.506.274 LH  MSA voluntary organization concerned with the prevention and treatment of heart and vascular diseases. OLsearch VOLUNTARY HEALTH AGENCIES 1967-74 HN(75) MHÑAmerican Heart Association ANonly /hist /organ; add UNITED STATES or specific state (NIM) CATALOG: use NAF entry PICardiovascular Diseases (66-74); Heart Diseases (66-74); Societies, Medical (66-74); Voluntary Health Agencies (66-74) MNN3.540.630.780.110 DMÑVoluntary Health Agencies LH LM  MSA society whose membership is composed of hospitals. PM78 HN78 MHÑAmerican Hospital Association ANonly /hist /organ; add UNITED STATES (NIM); DF: AHA CATALOG: use NAF entry MNN3.540.828.540.80 LH  MSProfessional society representing the field of medicine. PM66 HN66 MHÑAmerican Medical Association ANonly /hist /organ; add UNITED STATES (NIM); DF: AMA CATALOG: use NAF entry MNN3.540.828.589.274 LH  MSProfessional society representing the field of nursing. PM67 HN67(65) MHÑAmerican Nurses' Association ANonly /hist /organ; add UNITED STATES (NIM); DF: ANA CATALOG: use NAF entry MNN3.540.828.672.274 LH  MHÑAmericium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-35-9 MND1.287.67; D1.552.517.86 LH  MHÑAmides ANdo not use /analogs /biosyn /defic /physiol MND2.65 XUÑThioamides LH LU  MHÑAmidines ANdo not use /analogs /biosyn /defic /physiol MND2.78 XUÑBenzamidines; ÑChlorphenamidine; ÑDiminazene; ÑPentamidine LH LU; ; ;  PM74 HN74(73) MHÑAmidinotransferases ANdo not use /analogs RNEC 2.1.4. MND8.586.913.100 XSTransamidinases LH LS  MS4-Amino-5-hydroxy-3-[(4-nitrophenyl)azo]-6-(phenylazo)-2,7-naphthalenedisulfonic acid. A dye used to stain proteins in electrophoretic technics; its disodium salt is also used interchangeably. Synonyms: Aniline Blue Black; Agalma Black 10B; Naphthalene Black 12B; Pontacyl Blue Black SX; C.I. 20470; Amido Black 10B. HN(76) MHÑAmido Black AND25-26 qualif; /analogs NIM only RN1064-48-8 PIAzo Compounds (69-75); Naphthalenesulfonates (74-75); Nitrobenzenes (74-75) MND2.172.29; D2.241.866.540.244.639.220; D2.886.610.244.639.220; D4.615.638.555.220; D26.408.58 XSAcid Black 1; C.I. Acid Black 1; Naphthol Blue Black DMÑAzo Compounds LH LS; ; LM  MHÑAmidohydrolases ANdo not use /analogs RNEC 3.5. MND8.586.277.87 XSAMIDASES XUÑAllophanate Hydrolase; ÑAspartylglucosylaminase; ÑDihydro-Orotase; ÑFormamidase; ÑHistone Deacetylase; ÑN-Acetylmuramoyl-L-Alanine Amidase; ÑNicotinamidase; ÑPenicillin Amidase; ÑPyroglutamate Hydrolase LH LS LU; ; ; ; ; ; ; ;  MS5-Phosphoribosylamine:pyrophosphate phosphoribosyltransferase (glutamate-amidating). An enzyme involved in the early steps of purine nucleotide biosynthesis which catalyzes the formation of 5-phosphoribosylamine from glutamine and phosphoribosylpyrophosphate. Synonym: Ribosylamine-5-phosphate:pyrophosphate phosphoribosyltransferase. HN(75) MHÑAmidophosphoribosyltransferase ANdo not use /analogs RNEC 2.4.2.14 PIGlutamine (74); Pentosephosphates (74); Pentosyltransferases (74); Pyrophosphoric Acids (74) MND8.586.913.647.80 XSGlutamine Phosphoribosyl Pyrophosphate Amidotransferase; Phosphoribosyl Pyrophosphate Amidotransferase DMÑPentosyltransferases LH LS; LM  MSA broad spectrum antibiotic derived from kanamycin. Reno- and ototoxic like the other aminoglycoside antibiotics. PM87; was see under KANAMYCIN 1975-86 HN87(75); was see under KANAMYCIN 1975-86 MHÑAmikacin ANdo not use /biosyn /defic /physiol RN37517-28-5 PIAminobutyric Acids (73-74); Kanamycin (73-74) MND9.203.408.51.476.60; D20.85.45 XSBB-K8 LH LS  PM86; was see under PYRAZINES 1975-85 HN86(72); was see under PYRAZINES 1975-85, was Prov 1972-74 MHÑAmiloride ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2609-46-3 PIDiuretics (66-71); Pyrazines (66-71) MND3.383.679.149; D19.770.224.87 LH  MS9-Acridinamine. Highly fluorescent anti-infective dye; used clinically as topical antiseptic and experimentally as mutagen, due to its interaction with DNA; also used as intracellular pH indicator. Synonyms: Acramidine; Acriflex; Acrisan; Cimlac; Flavacrin; Monacrin. HN(80) MHÑAminacrine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN90-45-9 PIAcridines (66-79) MND3.494.46.250.200; D20.187.60; D26.408.348.60 XS9-Aminoacridine; Acridinamine DMÑAminoacridines LH LS; LM  PM74 HN74(71) MHÑAmination ANalmost never IM; no qualif; enzymatic amination: coord NIM with AMINOTRANSFERASES (IM) + substrate (NIM) or specific aminotransferase (IM); DEAMINATION is also available PIChemistry, Organic (66-70) MNH1.181.404.190 LH  MSEnzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed. PM75 HN75 MHÑAmine Oxidoreductases ANdo not use /analogs RNEC 1.5. PIOxidoreductases (66-74) MND8.586.682.107 XUÑProline Oxidase; ÑPyridoxaminephosphate Oxidase; ÑPyrroline Carboxylate Reductases; ÑSaccharopine Dehydrogenases LH LU; ; ;  MHÑAmines ANdo not use /analogs /biosyn /defic /physiol MND2.92 XUÑAllylamine; ÑMannich Bases LH LU;  MSThe first step of protein synthesis, whereby an amino acid reacts with adenosine triphosphate in the presence of aminoacyl RNA synthetase to produce an amino acid adenylate, which provides the energy necessary for the attachment of the amino acid to a specific transfer RNA molecule. PM73 HN73(71) MHÑAmino Acid Activation ANIM; coord with specific amino acid (IM); only /drug eff /rad eff PIPeptides/BI (66-70) MNG5.331.914.124; G6.535.770.124 FXÑAMINO ACYL T RNA SYNTHETASES LH LX  MSInhibitors of serine proteinases and sulfhydryl group containing enzymes. Act as alkylating agents and are known to interfere in the translation process. PM77; TOSYLLYSINE CHLOROMETHYL KETONE was see under LYSINE 1975-76; TOSYLPHENYLALANYL CHLOROMETHYL KETONE was see under PHENYLALANINE 1975-76 HN77 MHÑAmino Acid Chloromethyl Ketones ANdo not use /analogs; DF: AACK PIPeptides (66-76); specific amino acid MND8.373.745.75; D12.125.65 XSPeptide Chloromethyl Ketones XUÑTosyllysine Chloromethyl Ketone; ÑTosylphenylalanyl Chloromethyl Ketone LH LS LU;  PM74 HN74(72) MHÑAmino Acid Isomerases ANdo not use /analogs RNEC 5.1.1. PIIsomerases (66-71); specific amino acid MND8.586.399.124 XUÑAlanine Racemase LH LU  PM65; PROTEIN METABOLISM DISORDERS was heading 1963-64 HN65; PROTEIN METABOLISM DISORDERS was heading 1963-64 MHÑAmino Acid Metabolism, Inborn Errors ANdo not use /congen; coord IM with specific amino acid /metab (IM); DF: AA METAB INBORN ERR MNC18.452.648.66 LH  PM74 HN74 MHÑAmino Acid Naphthylamidases ANdo not use /analogs RNEC 3.4.11. MND8.586.277.656.81.150 XSARYLAMIDASES; NAPHTHYLAMIDASES LH LS;  OLuse AMINO ACID OXIDOREDUCTASES to search AMINOACID OXIDOREDUCTASES back thru 1966 PM74; was AMINOACID OXIDOREDUCTASES 1964-73 HN74; was AMINOACID OXIDOREDUCTASES 1964-73 MHÑAmino Acid Oxidoreductases ANdo not use /analogs RNEC 1.4. MND8.586.682.135 XUÑLysyl Oxidase LH LU  MSThe sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule; it is of fundamental importance in determining protein structure. PM66 HN66 MHÑAmino Acid Sequence ANIM for general only; NIM when specific chemical is IM; only /drug eff /rad eff MNG6.184.82 LH  PM/metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64 HN/metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64 MHÑAmino Acids ANdo not use /analogs; /urine permitted but consider also AMINOACIDURIA, RENAL MND12.125 XUÑCycloleucine; ÑDesmosine; ÑIsodesmosine; ÑOxamic Acid LH LU; ; ;  MSAmino acids which have a branched carbon chain. PM79 HN79 MHÑAmino Acids, Branched-Chain ANdo not use /analogs PIAmino Acids (66-78) MND12.125.70 LH  MH*Amino Acids, Cyclic (Non Mesh) MND12.125.72 LH  PM74; DIAMINOPIMELIC ACID was see under PIMELIC ACIDS 1975-79 HN74 MHÑAmino Acids, Diamino ANdo not use /analogs MND12.125.95 XSAmino Acids, Dibasic; DIAMINO AMINO ACIDS XUÑDiaminopimelic Acid LH LS; LU  PM74 HN74 MHÑAmino Acids, Dicarboxylic ANdo not use /analogs MND12.125.119 XSDICARBOXYLIC AMINO ACIDS XUÑ2-Aminoadipic Acid LH LS LU  PM74 HN74 MHÑAmino Acids, Essential ANdo not use /analogs MND12.125.142 XSESSENTIAL AMINO ACIDS LH LS  MH*Amino Acids, Peptides and Proteins (Non Mesh) MND12 LH  PM74 HN74 MHÑAmino Acids, Sulfur ANdo not use /analogs MND12.125.166 XSSULFUR AMINO ACIDS XUÑCysteic Acid; ÑMercaptopropionylglycine LH LS LU;  MSIntermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase. They are key compounds in the genetic translation process. PM78 HN78 MHÑAmino Acyl T RNA AN/drug eff /ultrastruct permitted; do not use /analogs PIAmino Acids (66-77); specific amino acid; RNA, Transfer (66-77) MND12.125.180; D13.444.735.757.200 LH  OLto search AMINO ACID ACTIVATING ENZYMES use AMINO ACYL T RNA SYNTHETASES back thru 1973 & LIGASES 1966-72 PM72; AMINO ACID ACTIVATING ENZYMES was see under LIGASES 1963-72 HN72; AMINO ACID ACTIVATING ENZYMES was see under LIGASES 1963-72 MHÑAmino Acyl T RNA Synthetases ANnote spacing; do not use /analogs RNEC 6.1.1. PILigases (66-71) MND8.586.464.136 XSAMINO ACID ACTIVATING ENZYMES FXÑAmino Acid Activation XUÑAlanyl T RNA Synthetase; ÑArginyl T RNA Synthetase; ÑAspartyl T RNA Synthetase; ÑGlutamyl T RNA Synthetase; ÑGlycyl T RNA Synthetase; ÑHistidyl T RNA Synthetase; ÑIsoleucyl T RNA Synthetase; ÑLeucyl T RNA Synthetase; ÑLysyl T RNA Synthetase; ÑMethionyl T RNA Synthetase; ÑPhenylalanyl T RNA Synthetase; ÑSeryl T RNA Synthetase; ÑThreonyl T RNA Synthetase; ÑTryptophanyl T RNA Synthetase; ÑTyrosyl T RNA Synthetase; ÑValyl T RNA Synthetase LH LS LX LU; ; ; ; ; ; ; ; ; ; ; ; ; ; ;  MHÑAmino Alcohols ANdo not use /analogs /biosyn /defic /physiol MND2.33.329; D2.92.63 XUÑHeptaminol; ÑIsoetharine LH LU;  MHÑAmino Sugars ANdo not use /analogs /defic /physiol MND9.203.67 LH  MSCyanomethylamine. HN(75) MHÑAminoacetonitrile ANdo not use /biosyn /defic /physiol; /analogs NIM only RN540-61-4 PIMethylamines (72-74); Nitriles (68-74) MND2.626.80.85 XSCyanomethylamine; Glycinonitrile DMÑAcetonitriles LH LS; LM  MSImpairment of renal tubular transport of amino acids. PM65; was AMINOACIDURIA 1963-64 HN65; was AMINOACIDURIA 1963-64 MHÑAminoaciduria, Renal ANdo not use /congen; coord IM with specific amino acid /urine (IM) MNC12.777.419.815.191; C18.452.648.66.210; C18.452.648.851.191 FXÑUrine LH LX  MSAcridines which are substituted in any position by one or more amino groups or substituted amino groups. PM80; ACRIFLAVINE was see under ACRIDINES 1963-81; NITRACRINE was see under ACRIDINES 1975-80; TACRINE was see under ACRIDINES 1975-83 HN80 MHÑAminoacridines ANdo not use /analogs /biosyn /defic /physiol PIAcridines (66-79) MND3.494.46.250 XUÑAcriflavine; ÑAminacrine; ÑNitracrine; ÑTacrine LH LU; ; ;  OLuse AMINOBENZOIC ACIDS to search AMINOBENZOIC ACID back thru 1966 PM75; was AMINOBENZOIC ACID 1965-74; PARA-AMINOBENZOIC ACID was heading 1963-64 HN75; was AMINOBENZOIC ACID 1965-74 MHÑAminobenzoic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.106.61; D11.786.708.54 XUÑEthopabate; Ñp-Aminobenzoic Acid LH LU;  MSBiphenyl compounds substituted in any position by one or more amino groups. Permitted are any substituents except fused rings. PM75 HN75 MHÑAminobiphenyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: AMINOBIPHENYL CPDS PIBiphenyl Compounds (72-74) MND2.455.426.559.389.185.60 XSBiphenylamines FXÑCarcinogens LH LS LX  MS4-Aminobutyrate:2-oxoglutarate aminotransferase. Enzyme which converts brain gamma-aminobutyric acid into succinate semialdehyde, which can be converted to succinic acid and enter the citric acid cycle. Also acts on beta-alanine. PM84; was see under AMINOTRANSFERASES 1975-83 HN84(75); was see under AMINOTRANSFERASES 1975-83 MHÑAminobutyrate Aminotransferase ANdo not use /analogs RNEC 2.6.1.19 PIAminobutyric Acid (74); Aminotransferases (74) MND8.586.913.140.160 XSGABA Transaminase; beta-Alanine Ketoglutarate Aminotransferase LH LS;  MSAliphatic four carbon acids substituted in any position(s) with amino group(s); found in most living things; the best known is GABA. OLuse AMINOBUTYRIC ACIDS to search AMINOBUTYRIC ACID back thru 1966 PM75; was AMINOBUTYRIC ACID 1963-74 HN75; was AMINOBUTYRIC ACID 1963-74 MHÑAminobutyric Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.161.125; D12.125.190; D16.538.85 LH  OLuse AMINOCAPROIC ACIDS to search AMINOCAPROIC ACID back thru 1966 PM75; was AMINOCAPROIC ACID 1964-74 HN75; was AMINOCAPROIC ACID 1963-74 (Prov 1963) MHÑAminocaproic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.193.150; D12.125.213 XUÑ6-Aminocaproic Acid; ÑNorleucine LH LU;  MS(2-Aminoethyl)-phosphonic acid. An organophosphorus compound isolated from human and animal tissues. HN(75) MHÑAminoethylphosphonic Acid ANdo not use /defic /physiol; /analogs NIM only RN2041-14-7 PIEthylamines (73-74); Organophosphorus Compounds (73-74); Phosphonic Acids (73-74) MND2.705.50 XS2-Aminoethylphosphonic Acid; Ciliatine DMÑOrganophosphorus Compounds LH LS; LM  PM73 HN73(66) MHÑAminoglutethimide ANdo not use /biosyn /defic /physiol RN125-84-8 MND3.383.621.808.425.100; D14.261.28 LH  PM74 HN74 MHÑAminoglycosides ANdo not use /analogs; aminoglycoside antibiotics: index under ANTIBIOTICS (IM) + AMINOGLYCOSIDES (NIM), using the same qualif for both MND9.203.408.51 LH  OLuse AMINOHIPPURIC ACIDS to search AMINOHIPPURIC ACID back thru 1966 PM77; was AMINOHIPPURIC ACID 1965-76; PARA-AMINOHIPPURIC ACID was heading 1963-64 HN77; was AMINOHIPPURIC ACID 1965-76 MHÑAminohippuric Acids ANdo not use /analogs /biosyn /defic /physiol MND2.65.277.431.192; D2.241.223.106.162.431.151; D2.241.607.360.192 XUÑp-Aminohippuric Acid LH LU  MHÑAminohydrolases ANdo not use /analogs RNEC 3.5.4. MND8.586.277.151 XUÑGTP Cyclohydrolase; ÑGuanine Deaminase LH LU;  MS5-Amino-1H-imidazole-4-carboxamide. An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases. Synonyms: Ba 2756; AIC; AICA. HN(78) MHÑAminoimidazole Carboxamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN360-97-4 PIImidazoles (66-77) MND3.383.374.30 DMÑImidazoles LH LM  OLuse AMINOISOBUTYRIC ACIDS to search AMINOISOBUTYRIC ACID back thru 1966 PM83; was AMINOISOBUTYRIC ACID 1963-82 HN83; was AMINOISOBUTYRIC ACID 1963-82 MHÑAminoisobutyric Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.161.226; D12.125.70.75; D12.125.190.192 LH  OLsearch LEVULINIC ACIDS 1973-74 HN(75); was see under LEVULINIC ACID 1973-74 MHÑAminolevulinic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN106-60-5 MND2.241.607.547.276 DMÑLevulinic Acids LH LM  MS5-Aminolevulinate hydro-lyase(adding 5-aminolevulinate and cyclizing). Catalyzes the formation of porphobilinogen from two moles of 5-aminolevulinic acid. EC 4.2.1.24. PM78; was see under HYDRO-LYASES 1975-77 HN78(73); was see under HYDRO-LYASES 1975-77 MHÑAminolevulinic Acid Dehydratase ANdo not use /analogs RNEC 4.2.1.24 PIHydro-Lyases (66-72) MND8.586.520.497.137 XSAminolevulinate Hydro-Lyase; Porphobilinogen Synthase LH LS;  PM73 HN73(72) MHÑAminolevulinic Acid Synthetase ANdo not use /analogs RNEC 2.3.1.37 PIAcyltransferases (66-71) MND8.586.913.50.276 LH  MS(Aminooxy)acetic acid. Inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma aminobutyric acid in tissues. HN(75) MHÑAminooxyacetic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN645-88-5 PIAcetic Acids (72-74); Hydroxylamines (72-74) MND2.241.81.38.350; D2.92.570.50; D8.373.85 XSAminooxyacetate DMÑAcetic Acids LH LS LM  MHÑAminopeptidases ANdo not use /analogs RNEC 3.4.11. MND8.586.277.656.81 XUÑOxytocinase; ÑPyroglutamate Aminopeptidase LH LU;  MSPhenols substituted in any position by an amino group. PM79; PHENETIDINE was see under ANILINE COMPOUNDS 1975-78 HN79 MHÑAminophenols ANdo not use /analogs /biosyn /defic /physiol PIAmines (66-78); Aniline Compounds (66-78); Phenols (66-78) MND2.92.146.100; D2.755.50 XSHydroxyanilines XUÑPhenetidine LH LS LU  MSTheophylline compound with ethylenediamine. A soluble form of theophylline with the same pharmacological actions; used mainly in bronchial asthma and as myocardial stimulant. Synonyms: Aminocardol; Cardophylin; Phyllindon. MHÑAminophylline ANdo not use /biosyn /defic /physiol RN317-34-0 MND3.132.956.826.75; D3.438.759.758.824.751.75; D16.116.919.53; D18.918.882.53 LH  PM72 HN72(64) MHÑAminopropionitrile ANdo not use /biosyn /defic /physiol RN151-18-8 MND2.626.151 FXÑLathyrism LH LX  MHÑAminopterin ANdo not use /biosyn /defic /physiol RN54-62-6 MND3.438.733.631.192; D22.204.144.579.192; D26.87.393.52 LH  MSPyridines substituted in any position with an amino group. May be hydrogenated, but must retain at least one double bond. PM79; METHAPYRILENE was see under PYRIDINES 1975-78, was see under ANTIHISTAMINICS 1963-74; PHENAZOPYRIDINE & PYRILAMINE were see under PYRIDINES 1975-78 HN79 MHÑAminopyridines ANdo not use /analogs /biosyn /defic /physiol; = pyridinamines & pyridylamines PIAmines (66-78); Pyridines (66-78) MND2.92.80; D3.383.725.50 XUÑMethapyrilene; ÑPhenazopyridine; ÑPyrilamine LH LU; ;  MHÑAminopyrine ANdo not use /biosyn /defic /physiol; do not confuse DIPYRINE (X ref) with DIPYRONE (XU ref) RN58-15-1 MND3.383.694.50; D14.73.278.152.192; D26.74.75.204.192 XSAmidophenazon; Aminophenazone; Dimethylaminophenazone; Dipyrine XUÑDipyrone LH LS; ; ; LU  PM74 HN74(72) MHÑAminopyrine N-Demethylase ANdo not use /analogs RNEC 1.5.3.- PIOxidoreductases, N-Demethylating MND8.586.682.107.582.276 LH  MSQuinolines substituted in any position by one or more amino groups. PM75 HN75 MHÑAminoquinolines ANdo not use /analogs /biosyn /defic /physiol PIQuinolines (68-74) MND3.438.810.50 XUÑ4-Hydroxyaminoquinoline-1-Oxide LH LU  MS2-Amino-5-phenyl-2-oxazoline. An amphetamine-like anorectic agent; may cause pulmonary hypertension. HN(75) MHÑAminorex AND25-26 qualif; /analogs NIM only RN2207-50-3 PIAmines (72-74); Oxazoles (68-74) MND3.383.548.50; D26.128.127.35 XSAminoxafen DMÑOxazoles LH LS LM  OLuse AMINOSALICYLIC ACIDS to search AMINOSALICYLIC ACID back thru 1966 PM77; was AMINOSALICYLIC ACID 1963-76 HN77; was AMINOSALICYLIC ACID 1963-76 MHÑAminosalicylic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.106.505.700.50; D2.241.511.390.700.50; D2.755.410.700.50; D20.338.76 XUÑp-Aminosalicylic Acid LH LU  MHÑAminotransferases ANdo not use /analogs RNEC 2.6.1. MND8.586.913.140 XSTRANSAMINASES XUÑGlucosaminephosphate Isomerase (Glutamine-Forming); ÑGlutamate Synthase; ÑOrnithine Aminotransferase LH LS LU; ;  MS[2-Butyl-3-benzofuranyl]-[4-(beta-diethylaminoethoxy)-3,5-diiodophenyl]-ketone. An antianginal and antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting Na, K activated myocardial adenosine triphosphatase. There is a resulting decrease in heart rate and in vascular resistance. PM87; was see under BENZOFURANS 1975-86 HN87(75); was see under BENZOFURANS 1975-86 MHÑAmiodarone ANdo not use /biosyn /defic /physiol RN1951-25-3 PIBenzofurans (68-74); Diethylamines (74); Iodobenzoates (73-74) MND3.438.127.75; D18.97.75; D18.918.62 LH  PM64 HN64(63) MHÑAmitriptyline ANdo not use /biosyn /defic /physiol RN50-48-6 MND4.615.181.384.100; D15.236.122.140.108 LH  HN(72) MHÑAmitrole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN61-82-5 PIHerbicides (66-71); Triazoles (66-71) MND3.383.946.276; D5.723.366.55; D3.383.129.799.100 XSAminotriazole DMÑTriazoles LH LS LM  MHÑAmmonia ANdo not use /analogs /biosyn /defic /physiol RN7664-41-7 MND1.620.89 LH  PM73 HN73 MHÑAmmonia-Lyases ANdo not use /analogs RNEC 4.3.1. PILyases (66-72) MND8.586.520.161 XUÑAspartate Ammonia-Lyase; ÑEthanolamine Ammonia-Lyase; ÑHistidase; ÑPhenylalanine Ammonia-Lyase; ÑPorphobilinogen Deaminase LH LU; ; ; ;  MHÑAmmonium Chloride ANdo not use /analogs ( = AMMONIUM COMPOUNDS) /biosyn /defic /physiol RN12125-02-9 MND1.396.343.260.126; D1.620.89.276.151 LH  MHÑAmmonium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: AMMONIUM CPDS MND1.620.89.276; D2.92.102; D2.675.276 FXÑPYRIDINIUM COMPOUNDS; ÑQUINOLINIUM COMPOUNDS XUÑBenzethonium; ÑCetrimonium Compounds; ÑChlormequat; ÑEmepronium; ÑLissamine Green Dyes; ÑMcN A 343; ÑOxyphenonium Bromide LH LX; LU; ; ; ; ; ;  PM74 HN74(71) MHÑAmmonium Sulfate ANdo not use /analogs /biosyn /defic /physiol RN7783-20-2 PIAmmonium Compounds (66-70) MND1.620.89.276.276; D1.877.814.539.109 LH  MSTreatment by application of hot sand. HN(86)63 MHÑAmmotherapy ANdo not use /util except by MeSH definition MNE2.780.108.20; E2.780.480.20 XSBATHS, SAND; SAND BATHS DMÑHyperthermia, Induced LH LS; LM  MSPathologic loss of memory. May be of psychologic, organic or mixed origin. MHÑAmnesia ANdo not use /congen /drug eff /physiol /rad eff MNC10.597.79; C23.888.592.77; F3.126.185.597.193 XUÑAmnesia, Retrograde LH LU  MSAmnesia for events that occurred before the onset of amnesia. HN(76) MHÑAmnesia, Retrograde ANdo not use /drug eff /physiol /rad eff PIAmnesia (66-75) MNC10.597.79.60; C23.888.592.77.60; F3.126.185.597.193.150 DMÑAmnesia LH LM  PM73 HN73(71) MHÑAmniocentesis ANdo not use /util except by MeSH definition PIAmnion (66-70); Punctures (66-70) MNE1.223.894.632.152; E1.249.746.193 LH  MHÑAmnion ANnot restricted to mammals; intra-amniotic injections = AMNION + INJECTIONS; do not use /abnorm /embryol /growth /inj; amniotomy = AMNION /surg + probably LABOR, INDUCED MNA16.254.403.277 LH  PM74 HN74(71) MHÑAmnioscopy AN= exam of amnion & amniotic fluid: do not confuse with FETOSCOPY, exam of fetus; do not use /util except by MeSH definition PIAmnion (66-70); Endoscopy (66-70) MNE1.249.746.360; E1.418.65 LH  MSA disorder present in the newborn infant in which constriction rings or bands, causing soft tissue depressions, encircle digits, extremities or limbs and sometimes the neck, thorax or abdomen. They may be associated with intrauterine amputations. PM83 HN83 MHÑAmniotic Band Syndrome ANdo not use /congen & do not coord with INFANT, NEWBORN, DISEASES PIAmnion (66-82); specific anatomic heading/AB (66-82) MNC16.614.42 XSAmniotic Bands; Amputation, Intrauterine; Annular Grooves; Ring Constrictions, Intrauterine; Streeter Syndrome LH LS; ; ; ;  MHÑAmniotic Fluid ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; intra-amniotic injections do not go here: use AMNION + INJECTIONS; excess fluid & polyhydramnios = HYDRAMNIOS; oligohydramnios goes here MNA12.98; A16.254.72 FXÑEMBOLISM, AMNIOTIC FLUID; ÑHYDRAMNIOS LH LX;  MHÑAmobarbital ANdo not use /biosyn /defic /physiol RN57-43-2 MND3.383.742.698.253.77; D14.166.111.77; D14.591.220.77 XSAmylobarbitone; Barbamyl; Pentymal LH LS; ;  MHÑAmodiaquine ANdo not use /biosyn /defic /physiol RN86-42-0 MND3.438.810.50.60; D21.370.286.77 XSAmodiachin LH LS  PMENDOLIMAX was see under SARCODINA 1963-76 MHÑAmoeba ANdo not use /anat /blood-csf-urine /embryol; /drug eff: consider also AMEBICIDES; Naegleria goes here MNB1.841.656.89 XSAMEBA XUÑEndolimax LH LS LU  MS2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine. Antidepressant. Synonym: CL 67,772. HN(75) MHÑAmoxapine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN14028-44-5 PIDibenzoxazepines (71-74); Piperazines (71-74) MND3.494.347.50; D15.236.122.140.118 DMÑDibenzoxazepines LH LM  MSalpha-Amino-p-hydroxybenzyl penicillin trihydrate. Broad spectrum semisynthetic antibiotic similar to ampicillin except that its resistance to gastric acid permits higher serum levels with oral administration. PM80; was see under AMPICILLIN 1975-79 HN80(75); was see under AMPICILLIN 1975-79 MHÑAmoxicillin ANdo not use /biosyn /defic /physiol RN26787-78-0 PIAmines (72-74); Ampicillin (75-74); Penicillins (72-74) MND20.85.99.739.762.57.52 XSHydroxyampicillin LH LS  MSAMP aminohydrolase. Catalyzes the deamination of AMP to IMP. HN(75) MHÑAMP Deaminase ANdo not use /analogs RNEC 3.5.4.6 PIAdenosine Monophosphate (74); Aminohydrolases (74) MND8.586.277.151.653.60 XSAMP Aminase; Adenylate Deaminase DMÑNucleotide Deaminases LH LS; LM  OLsearch BUTANONES 1968-74 HN(75) MHÑAmphenone B ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2686-47-7 MND2.522.296.277 DMÑButanones LH LM  MHÑAmphetamine ANa specific chem: do not confuse with AMPHETAMINES; do not use /analogs ( = AMPHETAMINES) /biosyn /defic /physiol; N-methylamphetamine = METHAMPHETAMINE RN300-62-9 MND2.92.471.683.152.110; D15.128.82.152; D16.893.120.50; D26.128.127.127 XSDesoxynorephedrin; L-Amphetamine; Levoamphetamine; Phenopromin LH LS; ; ;  MSAmphetamine and its analogs and/or derivatives; sympathomimetic amines causing central nervous system excitation, vasopression, bronchodilation, and to varying degrees anorexia, analepsis, nasal decongestion and some smooth muscle relaxation; these agents may be used for fatigue, narcolepsy, parkinsonism, hypotension or appetite depression; since tolerance is quickly developed, they are potentially prone to abuse and psychic dependence. PM76 HN76; was NON MESH before 1976 MHÑAmphetamines ANdo not confuse with AMPHETAMINE, a specific chem; do not use /analogs /biosyn /defic /physiol; N-methylamphetamine = METHAMPHETAMINE PIAmphetamine (66-75) MND2.92.471.683.152; D15.128.82; D16.893.120; D26.128.127 XUÑ3,4-Methylenedioxyamphetamine; ÑDOM; Ñp-Chloroamphetamine; Ñp-Hydroxyamphetamine LH LU; ; ;  MHÑAmphibia ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.90 LH  MSVenoms produced by frogs, toads, salamanders, etc.; the venom glands are usually on the skin of the back and contain cardiotoxic glycosides, cholinolytics and a number of other bioactive materials, many of which have been characterized; used as arrow poisons. Includes bufogenin, bufotoxin, bufagin, bufotalin, histrionicotoxins, and pumiliotoxin. PM78 HN78 MHÑAmphibian Venoms ANdo not use /analogs /chem syn /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; coord IM with specific amphibian (IM or NIM) PIAmphibia (66-77); Venoms (66-77) MND24.185.965.33 XSFrog Venoms; Toad Venoms LH LS;  MSSuch mixtures of amphoteric electrolytes or buffers that provide a continuous range of pH in an electric field; used for separating proteins by their isoelectric points, i.e., by isoelectric focusing. HN(80) MHÑAmpholyte Mixtures AND25-26 qualif PIBuffers (66-79); Isoelectric Focusing (70-79) MND26.172.45 XSAmpholines; Carrier Ampholytes; Isoelectric Focusing Agents DMÑBuffers LH LS; ; LM  MHÑAmphotericin B ANdo not use /biosyn /defic /physiol RN1397-89-3 MND20.85.62.83; D20.136.73.83 LH  PM65 HN65(64) MHÑAmpicillin ANdo not use /biosyn /defic /physiol RN69-53-4 MND20.85.99.739.762.57 XSPENICILLIN, AMINOBENZYL XUÑPivampicillin; ÑTalampicillin LH LS LU;  PM73 HN73(66) MHÑAmplifiers ANNIM; no qualif MNE7.43; H1.288.110 LH  MS1-[(4-Amino-2-propyl-5-pyridinyl) methyl]-2-picolinium. Veterinary coccidiostat that interferes with thiamine metabolism; may cause thiamine deficiency. Synonyms: Amprol; Amprolvet; Anicoccid; mepyrium; Pancoxin. OLuse AMPROLIUM to search AMPROL back thru 1975 HN(81); was AMPROL see under PICOLINES 1979-80, was AMPROL see under PICOLINE 1975-78 MHÑAmprolium ANdo not use /biosyn /defic /physiol; /analogs NIM only RN137-88-2 PIAntiprotozoal Agents (66-71); Picolines (66-71) MND3.383.725.676.152; D21.370.400.100 DMÑPicolines LH LM  MHÑAmputation ANa surg procedure: do not confuse with AMPUTATION, TRAUMATIC; do not use /util except by MeSH definition MNE4.557.69 XUÑHemipelvectomy LH LU  HNwas in Cat E only 1963-81 MHÑAmputation Stumps ANrestrict to extremities: do not use for gastric stump, cervical stump & the like; no qualif MNC23.304.75; E4.557.69.194 FXÑPHANTOM LIMB LH LX  MSLoss of a limb or other bodily appendage by accidental injury. PM72 HN72 MHÑAmputation, Traumatic ANby accident or inj: do not confuse with AMPUTATION, a surg procedure; /surg: consider also REPLANTATION PIAmputation (66-71) MNC21.866.62 LH  MHÑAmputees ANonly /psychol; do not coord ARM (NIM) or LEG (NIM) unless specifically relevant MNM1.289.277 LH  MS4-Amino-1,5-dimethyl-2-phenyl-3H-pyrazol-one. Metabolite of aminopyrine with analgesic and anti-inflammatory properties; used as reagent for biochemical reactions producing peroxides or phenols; stimulates liver microsomes; also used to measure extracellular water. Synonyms: aminoazophene; 4-aminophenazone; Metapirazone; Solvapyrin A. HN(80) MHÑAmpyrone ANdo not use /biosyn /defic /physiol RN83-07-8 PIAntipyrine (66-74) /AA (75-79) MND3.383.694.65.60; D14.73.278.152.200; D26.74.75.204.200; D26.550.27 XSAminoantipyrine DMÑAntipyrine LH LS LM  MS5-Amino(3,4'-bipyridine)-6(1H)-one. A positive inotropic cardiotonic agent with vasodilator properties, phosphodiesterase inhibitory activity and stimulation of calcium ion influx into the cardiac cell. Its therapeutic use in congestive heart or left ventricular failure is associated with significant increases in cardiac index, reductions in pulmonary capillary wedge pressure and systemic vascular resistance and little or no change in mean arterial pressure. One of its more serious side effects is thrombocytopenia in some patients. PM87 HN87 MHÑAmrinone ANdo not use /biosyn /defic /physiol RN60719-84-8 PIAminopyridines (79-86); Pyridines (66-78) MND2.92.80.85; D3.383.725.50.85; D18.192.45; D18.222.45; D18.918.72 LH  MS4'-(9-Acridinylamino)methanesulfon-3-anisidide. Aminoacridine derivative which is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. PM87 HN87 MHÑAmsacrine ANdo not use /biosyn /defic /physiol RN51264-14-3 PIAcridines (66-79); Aminoacridines (80-86) MND3.494.46.250.225; D22.204.65 XSm-AMSA LH LS  MSD-Mandelonitrile-beta-D-glucosido-6 beta-D-glucoside. A cyanogenic glycoside found in the seeds of Rosaceae. Has been used with questionable results in the prevention of tumors and in cancer chemotherapy. OLuse AMYGDALIN to search LAETRILE back thru 1975 PM79; was see under NITRILES 1976-78; LAETRILE was see under NITRILES 1975-78 HN79(76); was see under NITRILES 1976-78; LAETRILE was see under NITRILES 1975-78 MHÑAmygdalin ANdo not use /defic /physiol; /biosyn permitted if by plant RN29883-15-6 PICyanides (66-67); Glycosides (66-75); Mandelic Acid (66-75); Nitriles (68-75) MND2.626.175; D9.203.408.348.50; D22.204.179.50 XSAmygdaloside; Laetrile; Mandelonitrile beta Gentiobioside LH LS; ;  MHÑAmygdaloid Body ANdo not use /innerv MNA8.186.211.577.90; A8.186.211.885.105.152 XSAmygdala LH LS  MHÑAmyl Nitrite ANdo not use /biosyn /defic /physiol MND18.918.79 LH  OLuse AMYLASES to search AMYLASE back thru 1966 PM78; was AMYLASE 1963-77 HN78; was AMYLASE 1963-77 MHÑAmylases ANdo not use /analogs; amylase isoenzymes: index under AMYLASES (IM) + ISOENZYMES (IM), not ISOAMYLASE RNEC 3.2.1. MND8.586.277.450.66 XSDIASTASE XUÑBeta-Amylase LH LS LU  OLuse AMYLOID to search AMYLOID SUBSTANCE back thru 1966 (as Cat C heading 1966-67) PM68; was AMYLOID SUBSTANCE 1963-67 HN68; was AMYLOID SUBSTANCE 1963-67 (Cat C heading only 1966-67, Cat A heading only 1963-64) MHÑAmyloid AN= amyloid substance; /biosyn /physiol permitted MND12.776.395.90 LH  MSAmyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It acts as an acute phase protein in the mouse, modulates immunologic responses in man, inhibits elastase, and has been suggested as an indicator of liver disease. PM87 HN87 MHÑAmyloid P Component AN/biosyn /physiol permitted PIAmyloid (66-86) MND12.776.124.50.90; D12.776.395.90.50 LH  MSA nonimmunoglobulin amyloid isolated from amyloid fibrils deposited in amyloidosis secondary to chronic inflammatory diseases such as rheumatoid arthritis. Antisera to amyloid protein AA have been used to detect a related serum protein SAA. PM87; was see under AMYLOID 1979-86 HN87(79); was see under AMYLOID 1979-86 MHÑAmyloid Protein AA AN/biosyn /physiol permitted; /blood: consider AMYLOID PROTEIN SAA PIAmyloid (66-78) MND12.776.124.50.95; D12.776.395.90.65 XSAmyloid A Protein; Amyloid Fibril Protein AA; Protein AA LH LS; ;  MSA serum protein believed to be a circulating precursor to amyloid protein AA. Present in low concentrations in normal sera, but found in much higher concentrations in sera of older persons and in patients with amyloidosis or with diseases known to predispose to amyloidosis. Very high levels of this protein have been reported during acute inflammatory episodes. Antisera to amyloid proten AA cross-react with protein SAA. PM87; was see under AMYLOID 1979-86 HN87(79); was see under AMYLOID 1979-86 MHÑAmyloid Protein SAA AN/biosyn /physiol permitted; do not use /blood PIAmyloid (66-78); Blood Proteins (66-78) MND12.776.124.75; D12.776.395.90.75 XSAmyloid Serum Protein SAA; Serum A Related Protein; Serum Amyloid Protein A LH LS; ;  MHÑAmyloidosis MNC15.378.147.780.100; C15.604.515.56; C18.452.648.111; C20.683.780.100 LH  PM74 HN74 MHÑAmylopectin RN9037-22-3 MND9.203.698.365.855.194 LH  PM74 HN74 MHÑAmylose RN9005-82-7 MND9.203.698.365.855.361 LH  MHÑAmyotonia Congenita ANdo not use /congen MNC5.651.661.83; C10.228.854.83; C10.668.83 XSMYATONIA CONGENITA; OPPENHEIM'S DISEASE LH LS;  MHÑAmyotrophic Lateral Sclerosis MNC5.651.661.139; C10.228.854.139; C10.668.139 XSLATERAL SCLEROSIS LH LS  MS2-(3-Pyridyl)piperidine. Botanical insecticide. HN(75) MHÑAnabasine ANdo not use /defic /physiol; /analogs NIM only RN494-52-0 PIAlkaloids (74); Piperidines (69-74); Pyridines (73-74) MND3.383.621.50; D5.723.491.324.50 XSNeonicotine DMÑPiperidines LH LS LM  PM64 HN64 MHÑAnabolic Steroids ANdo not use /analogs /biosyn /defic /physiol MND6.597.100.194 LH  HN(71) MHÑAnaerobiosis ANalmost never IM; only /drug eff /rad eff PIOxygen (66-70); appropriate heading/GD (66-70); appropriate heading/ME (66-70) MNG6.535.99 DMÑMetabolism LH LM  PM68 HN68 MHÑAnal Gland Neoplasms ANanimal only: do not use /vet; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); do not confuse with ANUS NEOPLASMS; coord with ANAL SACS for anal sac neoplasms PIAnus Neoplasms (66-67) MNC4.588.83 XSCircumanal Gland Neoplasms; Perianal Gland Neoplasms LH LS;  PM68 HN68 MHÑAnal Sacs ANin carnivores only; for neopl, coord with ANAL GLAND NEOPLASMS PIAnus (66-67); Carnivora (66-67) MNA13.73 LH  MSThe period of pregenital psychosexual development, usually from 1 to 3 years, in which the child has particular interest in the process of defecation and sensations connected with the anus. OLsearch PSYCHOSEXUAL DEVELOPMENT 1968-74 HN(75) MHÑAnal Stage ANno qualif MNF1.752.747.722.128; F2.739.794.793.128 DMÑPsychosexual Development LH LM  MHÑAnaleptics ANdo not use /analogs /biosyn /defic /physiol; consider also CENTRAL NERVOUS SYSTEM /drug eff & BRAIN /drug eff MND15.128 XSCentral Nervous System Stimulants LH LS  MHÑAnalgesia ANdo not use /util except by MeSH definition MNE3.91 FXÑPain LH LX  PM73 HN73(64) MHÑAnalgesia, Congenital ANdo not use /congen MNC10.772.590.66; C16.131.666.690.66 XSPAIN INSENSITIVITY, CONGENITAL LH LS  OLuse ANALGESICS to search ANALGESICS AND ANTIPYRETICS 1966-77 PM78; ANALGESICS AND ANTIPYRETICS was heading 1963-77 HN78; ANALGESICS AND ANTIPYRETICS was heading 1963-77 MHÑAnalgesics ANno qualif for analgesics when used with ANALGESIA; /ther use permitted for relief of pain in dis; do not use /analogs /biosyn /defic /physiol; consider also PAIN /drug ther MND14.73 XSAnodynes; Antinociceptive Agents LH LS;  MSNarcotic or opioid substances and synthetic and semisynthetic agents producing profound analgesia, drowsiness and changes in mood which may be pleasurable, therefore creating a potential for the abuse of these agents; the prototype of these is morphine to which all other analgesics are compared. PM75 HN75 MHÑAnalgesics, Addictive ANe.g., morphine; do not use /analogs /biosyn /defic /physiol PIAnalgesics (66-74) MND14.73.153 XSNarcotic Analgesics FXÑNarcotics LH LS LX  MSAgents that alleviate mild to moderate pain without causing loss of consciousness or habituation; most of these agents also reduce fever and inflammation, some with possibly undesirable side effects; many of these agents are sold over the counter. OLsearch ANTIPYRETICS under ANALGESICS 1966-77 PM75; ANTIPYRETICS was indexed under ANALGESICS AND ANTIPYRETICS 1963-77 HN75; ANTIPYRETICS was see ANALGESICS AND ANTIPYRETICS 1975-77, was see under ANALGESICS AND ANTIPYRETICS 1963-74 MHÑAnalgesics, Anti-Inflammatory ANfor antipyretics, consider also FEVER /drug ther; do not use /analogs /biosyn /defic /physiol PIAnalgesics (66-74) MND14.73.278 XSAntipyretics FXÑAnti-Inflammatory Agents; ÑAnti-Inflammatory Agents, Non-Steroidal; ÑFever LH LS LX; ;  PM73 HN73(64) MHÑAnalog-Digital Conversion ANno qualif MNL1.700.568.80.260.280.80 LH  PM74 HN74(68) MHÑAnalysis of Variance ANNIM; no qualif PIStatistics (66-67) MNH1.548.832.128 LH  MSThe third phase of cell division, in which the chromatids separate and migrate to opposite poles of the spindle. PM81; was see under CELL CYCLE 1978-80 HN81(78); was see under CELL CYCLE 1978-80 MHÑAnaphase AN3d phase of cell div; NIM specific cell when merely test cell; coord with specific cell /cytol; only /drug eff /rad eff; permitted with micro-organisms PICell Division (66-77); Meiosis (68-77); Mitosis (68-77) MNG4.335.135.220.225.60; G5.148.165.220.225.60; G7.553.135.220.225.60 LH  MSPeptides produced in the serum during complement activation. C3a and C5a from complement 3 and 5, respectively, have been studied extensively. They produce smooth muscle contraction and mast cell histamine release in vitro, affect platelet aggregation and act as mediators of the local inflammatory process. HN(77) MHÑAnaphylatoxins AN╥produced in the serum during complement activation╙; do not use /ad-poi-tox /analogs /blood /diag use /stand /supply PIComplement (68-76); Peptide Fragments (74-76); Peptides (66-76); specific complement (75-76) MND12.644.30; D12.776.124.486.274.30; D24.185.30 DMÑPeptides LH LM  MHÑAnaphylaxis AN= ╥anaphylactic reaction╙; /chem ind permitted but not for anaphylactic reactions to toxins & similar biol prod ( = /etiol) MNC20.543.480.99 XSSHOCK, ANAPHYLACTIC FXÑSRS-A LH LS LX  MSLoss of structural differentiation and useful function of neoplastic cells. PM77 HN77 MHÑAnaplasia ANIM GEN only; coord NIM with organ /pathol (IM); ╥anaplastic carcinoma╙ = CARCINOMA (IM): do not coord with ANAPLASIA unless anaplasia is particularly discussed MNC4.805.45; C23.739.65 LH  MHÑAnaplasma ANdo not use /blood-csf-urine; infection = ANAPLASMOSIS MNB3.700.651.129.278 LH  MSA family of bacteria which parasitize red blood cells and cause several animal diseases. PM75 HN75 MHÑAnaplasmataceae ANdo not use /blood-csf-urine PIBacteria (66-74) MNB3.700.651.129 LH  MSInfections with rickettsias of the family Anaplasmataceae. OLuse ANAPLASMATACEAE INFECTIONS & HAEMOBARTONELLA to search HAEMOBARTONELLOSIS 1977-79 PM77; EPERYTHROZOONOSIS was see under BARTONELLA INFECTIONS 1975-76; HAEMOBARTONELLOSIS was heading 1977-79 HN77; HAEMOBARTONELLOSIS was heading 1977-79 MHÑAnaplasmataceae Infections ANa rickettsial infection PIAnaplasmosis (66-76); Rickettsial Infections (75-76) MNC1.850.65 XSHaemobartonellosis XUÑEperythrozoonosis LH LS LU  MSA disease of cattle caused by parasitization of the red blood cells by rickettsia of the genus Anaplasma. PM68 HN68(66) MHÑAnaplasmosis ANusually animal: do not use /vet but check tag ANIMAL MNC1.850.65.64; C22.85 LH  MHÑAnatomy ANSPEC only: SPEC qualif; with organ or organism use /anat: Manual 19.4.6, 19.5+ MNG1.100 FXÑDISSECTION LH LX  MHÑAnatomy, Artistic ANSPEC; only /educ /hist; anatomical atlases go here (IM) + MEDICAL ILLUSTRATION (IM) MNG1.100.91; K1.93.410.100 LH  MHÑAnatomy, Comparative ANSPEC: IM, SPEC qualif; NIM coord, no qualif; do not check COMPARATIVE STUDY for, as a field, it is not a substitute for a comparison of two or more anatomical concepts ( = COMPARATIVE STUDY tag); Manual 18.13.4: relation to COMPARATIVE STUDY MNG1.100.154 LH  MHÑAnatomy, Regional ANSPEC; no qualif MNG1.100.216 LH  MHÑAnatomy, Veterinary ANSPEC; only /educ /hist MNG1.100.279 LH  MSThose support services other than room, board, and medical and nursing services that are provided to hospital patients in the course of care. They include such services as laboratory, radiology, pharmacy, and physical therapy services. HN(84) MHÑAncillary Services, Hospital ANonly /econ /hist /legis /man /stand /trends MNN2.278.354.60; N4.452.442.60 XSHospital Ancillary Services DMÑHospital Administration LH LS LM  MSAn enzyme fraction from the venom of the Malayan pit viper, Agkistrodon rhodostoma. It catalyzes the hydrolysis of a number of amino acid esters and a limited proteolysis of fibrinogen. It is used clinically to produce controlled defibrination in patients requiring anticoagulant therapy. OLuse ANCROD to search ARVIN back thru 1975 PM78; was ARVIN see under PEPTIDE PEPTIDOHYDROLASES 1975-77 HN78; was ARVIN see under PEPTIDE PEPTIDOHYDROLASES 1975-77 MHÑAncrod ANdo not use /analogs RNEC 3.4.21.28 PIPeptide Hydrolases (72-74); Peptide Peptidohydrolases (66-74); Venoms (72-74) MND8.586.277.656.732.50; D19.461.119.50; D24.185.965.850.210.55 XSArvin; Arvin IRC-50 LH LS;  MSA genus of nematode intestinal parasites which consists of several species. A. duodenale is the common hookworm in humans. A. braziliense, A. ceylonicum, and A. caninum occur primarily in cats and dogs. All have been known to occur in humans. MHÑAncylostoma ANdo not use /blood-csf-urine; note ANCYLOSTOMA AMERICANA = NECATOR, not ANCYLOSTOMA; infection = ANCYLOSTOMIASIS MNB1.500.294.360.80 XSHookworm, Old World; Uncinaria Duodenale LH LS;  MSA superfamily of nematode parasitic hookworms consisting of four genera - ANCYLOSTOMA, NECATOR, Bunostomum, and Uncinaria. ANCYLOSTOMA and NECATOR occur in humans and other mammals. Bunostomum is common in ruminants and Uncinaria in wolves, foxes, and dogs. OLuse ANCYLOSTOMATOIDEA to search HOOKWORMS back thru 1966 PM86; was HOOKWORMS 1963-85 HN86; was HOOKWORMS 1963-85 MHÑAncylostomatoidea ANdo not use /blood-csf-urine; note HOOKWORM, NEW WORLD = NECATOR, not HOOKWORMS; HOOKWORM, OLD WORLD = ANCYLOSTOMA, not HOOKWORMS; infection = HOOKWORM INFECTIONS but see note above MNB1.500.294.360 XSBunostomum; Hookworms; Uncinaria Stenocephala LH LS; ;  MSInfection of humans or animals with hookworms of the genus Ancylostoma. OLsearch HOOKWORM INFECTIONS 1966-67 PM68; was see under HOOKWORM INFECTION 1963-67 HN68; was see under HOOKWORM INFECTION 1963-67 MHÑAncylostomiasis ANAncylostoma americana infection = NECATORIASIS, not ANCYLOSTOMIASIS PIHookworm Infections (66-67) MNC3.335.508.455.154 LH  MHÑAndorra MNZ1.542.49 LH  MSCompounds which inhibit or antagonize the biosynthesis or actions of androgens. PM78 HN78 MHÑAndrogen Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: ANDROGEN ANTAG PIAndrogens (66-77); specific androgen MND6.347.65 XSAntiandrogens LH LS  MSCarrier proteins produced in the Sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. Participate in the transport of androgens; include also synthetic androgens binding proteins. OLuse ANDROGEN-BINDING PROTEINS to search ANDROGEN BINDING PROTEIN back thru 1980 PM86; was see under CARRIER PROTEINS 1982-85, was ANDROGEN BINDING PROTEIN see under CARRIER PROTEINS 1980-81 HN86(82); was see under CARRIER PROTEINS 1982-85, was ANDROGEN BINDING PROTEIN see under CARRIER PROTEINS 1980-81 MHÑAndrogen-Binding Proteins AN/biosyn /physiol permitted; do not use /analogs PICarrier Proteins (71-79); Proteins (66-70); Receptors, Androgen (77-79); Receptors, Endogenous Substances (73-76) MND6.472.866.900.75; D6.597.100.225; D12.776.157.65 LH  MHÑAndrogens AN/biosyn /physiol permitted; do not use /analogs; /antag = ANDROGEN ANTAGONISTS; /defic: consider also HYPOGONADISM & other gonadal disord in Cat C19; /chem syn permitted: do not convert to ANDROGENS, SYNTHETIC MND6.472.79; D6.472.866.154 LH  MSCompounds obtained by chemical synthesis which possess masculinizing activities, but differ in structure from naturally occurring androgens. PM75 HN75 MHÑAndrogens, Synthetic ANdo not use /analogs /biosyn /defic /physiol; /antag permitted: do not use ANDROGEN ANTAGONISTS; do not confuse with ANDROGENS /chem syn; DF: ANDROGENS SYN PIAndrogens (66-74) MND6.597.100 XSAndrogen Analogs LH LS  OLsearch ANDROSTENES 1973-74 PM75; was see under ANDROSTENES 1973-74 HN75; was see under ANDROSTENES 1973-74 MHÑAndrostadienes ANdo not use /analogs /biosyn /defic /physiol MND4.808.54.79.129 LH  PM68 HN68 MHÑAndrostanes ANdo not use /analogs /biosyn /defic /physiol; do not confuse with ANDROSTENES MND4.808.54 LH  MSAndrostanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups. PM80; 5-ANDROSTANE-3,17-DIOL was ANDROSTANEDIOL see under ANDROSTANES 1975-79 HN80 MHÑAndrostanols ANdo not use /analogs /biosyn /defic /physiol; do not confuse with ANDROSTENOLS PIAndrostanes (68-79); Hydroxysteroids (72-79); Steroids (66-67) MND4.808.54.40 XSHydroxyandrostanes XUÑ5-Androstane-3,17-diol LH LS LU  OLsearch ANDROSTENES 1973-74 PM75; was see under ANDROSTENES 1973-74 HN75; was see under ANDROSTENES 1973-74 MHÑAndrostatrienes ANdo not use /analogs /biosyn /defic /physiol MND4.808.54.79.229 LH  MSUnsaturated androstanes which are substituted with two hydroxy groups in any position in the ring system. OLsearch ANDROSTENOLS 1974 & ANDROSTENES 1973 PM75; was see under ANDROSTENOLS 1974, was see under ANDROSTENES 1973; METHANDRIOL was see under ANABOLIC STEROIDS 1964-74 HN75; was see under ANDROSTENOLS 1974, was see under ANDROSTENES 1973 MHÑAndrostenediols ANdo not use /analogs /biosyn /defic /physiol; do not confuse with ANDROSTANEDIOL PIAndrostenes (73); Androstenols (74) MND4.808.54.79.429.154 XUÑ5-Androstene-3,17-diol; ÑMethandriol LH LU;  PM74 HN74(73) MHÑAndrostenedione ANdo not confuse with androstanedione RN63-05-8 MND4.808.54.79.329; D4.808.578.502.112; D6.472.40.502.112; D6.472.79.112; D6.472.866.154.112 LH  PM73 HN73 MHÑAndrostenes ANdo not use /analogs /biosyn /defic /physiol; do not confuse with ANDROSTANES PIAndrostanes (68-72) MND4.808.54.79 LH  MSUnsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system. OLuse ANDROSTENOLS to search ANDROSTENOL back thru 1966 (as Prov 1966-73) PM74 HN74; was ANDROSTENOL 1963-73 (Prov) MHÑAndrostenols ANdo not confuse with ANDROSTANOLS; do not use /analogs /biosyn /defic /physiol MND4.808.54.79.429 XSHYDROXYANDROSTENES XUÑCyanoketone LH LS LU  MHÑAndrosterone AN/biosyn /physiol permitted RN53-41-8 MND4.808.54.40.129; D4.808.578.502.195; D6.472.40.502.195; D6.472.79.195; D6.472.866.154.195 LH  MHÑAnecdotes ANdo not use /hist MNK1.517.67 LH  MSA reduction in the number of circulating erythrocytes or in the quantity of hemoglobin. MHÑAnemia ANGEN & unspecified; note numerous main headings and see refs below MNC15.378.71 LH  MSA form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. MHÑAnemia, Aplastic ANhypoplastic goes here MNC15.378.71.85; C15.378.190.196 XUÑFanconi's Anemia LH LU  MSA familial disorder characterized by anemia with multinuclear erythroblasts, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors. HN(80) MHÑAnemia, Dyserythropoietic, Congenital ANdo not use /congen PIAnemia (66-79); Erythropoiesis (66-79) MNC15.378.71.141.150.95 XSDyserythropoietic Anemia, Congenital; HEMPAS DMÑAnemia, Hemolytic, Congenital LH LS; LM  MSAnemia due to decreased life span of erythrocytes. OLuse ANEMIA, HEMOLYTIC to search ANEMIA, HEMOLYTIC, ACQUIRED & ANEMIA, ACQUIRED HEMOLYTIC & ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC back thru 1966 PMANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67 HNANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67 MHÑAnemia, Hemolytic AN/congen & ╥hereditary╙ = ANEMIA, HEMOLYTIC, CONGENITAL MNC15.378.71.141 XSAnemia, Hemolytic, Acquired; Anemia, Microangiopathic; Jaundice, Hemolytic FXÑHemolysis LH LS; ; LX  MSAcquired hemolytic anemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red cells. OLuse ANEMIA, HEMOLYTIC, AUTOIMMUNE to search ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC back thru 1966 PM68; was ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-67 HN68; was ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-67 MHÑAnemia, Hemolytic, Autoimmune ANdo not use /congen MNC15.378.71.141.125; C20.111.196 XSANEMIA, HEMOLYTIC, IDIOPATHIC ACQUIRED; Cold Agglutinin Disease LH LS;  MSHemolytic anemia due to various intrinsic defects of the erythrocyte. OLuse ANEMIA, HEMOLYTIC, CONGENITAL to search ANEMIA, CONGENITAL HEMOLYTIC back thru 1966 PM68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64; ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC was heading 1968-81, was ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1965-67 HN68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64 MHÑAnemia, Hemolytic, Congenital ANdo not use /congen; ╥hereditary hemolytic anemia╙ goes here MNC15.378.71.141.150 FXÑMetabolism, Inborn Errors XUÑAnemia, Dyserythropoietic, Congenital; ÑAnemia, Hemolytic, Congenital Nonspherocytic LH LX LU;  MSAny one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis, and in which there is a defect of glycolysis in the erythrocyte. In some cases, pyruvate kinase deficiency has been demonstrated; in other cases, glucose-6-phosphate dehydrogenase deficiency has been demonstrated. OLuse ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC to search ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC back thru 1966 HN(82)68; was heading ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1965-67 MHÑAnemia, Hemolytic, Congenital Nonspherocytic ANdo not use /congen; DF: ANEMIA HEMOL CONGEN NONSPHER MNC15.378.71.141.150.100 DMÑAnemia, Hemolytic, Congenital LH LM  MSA condition due to insufficient supply of iron to the bone marrow for hemoglobin synthesis. MHÑAnemia, Hypochromic ANchlorosis goes here MNC15.378.71.196 XSIRON DEFICIENCY ANEMIA LH LS  MSAnemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH). MHÑAnemia, Macrocytic MNC15.378.71.252 FXÑFIGLU TEST XUÑAnemia, Megaloblastic LH LX LU  OLsearch ANEMIA, MACROCYTIC 1966-74 HN(75) MHÑAnemia, Megaloblastic MNC15.378.71.252.196 DMÑAnemia, Macrocytic LH LM  MSAnemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue. MHÑAnemia, Myelophthisic MNC15.378.71.307; C15.378.190.636.85 XSANEMIA, LEUKOERYTHROBLASTIC LH LS  PM68 HN68 MHÑAnemia, Neonatal ANdo not use /congen; check the tag INFANT, NEWBORN PIAnemia (66-67); Infant, Newborn, Diseases (66-67) MNC15.378.71.363; C16.614.53 LH  MHÑAnemia, Pernicious MNC15.378.71.252.363; C18.654.223.133.699.923.280 XSADDISON'S ANEMIA; ANEMIA, ADDISON'S FXÑSCHILLING TEST LH LS; LX  MSA severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy. OLsearch ANEMIA, APLASTIC 1975-85 PM86; was see ANEMIA, APLASTIC 1975-85 HN86; was see ANEMIA, APLASTIC 1975-85 MHÑAnemia, Refractory PIAnemia, Aplastic (66-85) MNC15.378.71.400; C15.378.190.625.62 XSRefractory Anemia LH LS  MSChronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells. PM86 HN86 MHÑAnemia, Refractory, with Excess of Blasts PIAnemia, Aplastic (66-85) MNC15.378.71.400.80; C15.378.190.625.62.80 XSLeukemia, Smouldering; RAEB; RAEM; Refractory Anemia with Excess of Blasts LH LS; ; ;  MSA disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs; the clinical expression of homozygosity for hemoglobin S. MHÑAnemia, Sickle Cell ANPL 92-294: Natl Sickle Cell Anemia Control Act; /drug ther: consider also ANTISICKLING AGENTS MNC15.378.71.141.150.150; C15.378.420.155 FXÑAntisickling Agents XUÑHemoglobin SC Disease; ÑSickle Cell Trait LH LX LU;  MSAnemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow. OLuse ANEMIA, SIDEROBLASTIC to search ANEMIA, SIDEROBLASTIC REFRACTORY back thru 1966 (as Prov 1966) PM67 HN67; was ANEMIA, SIDEROBLASTIC REFRACTORY 1963-66 (Prov) MHÑAnemia, Sideroblastic MNC15.378.71.419; C15.378.190.625.70 FXÑElliptocytosis, Hereditary; ÑFOLIC ACID DEFICIENCY; ÑPYRIDOXINE DEFICIENCY; ÑPyridoxine Deficiency; ÑSpherocytosis, Hereditary LH LX; ; ; ;  MSCongenital absence of the cranial vault, with cerebral hemispheres completely missing or reduced to small masses attached to the base of the skull. OLuse ANENCEPHALY to search ANENCEPHALUS back thru 1966 PM79; was ANENCEPHALUS 1966-78 HN79; was ANENCEPHALUS 1964-78 (Prov 1964-65) MHÑAnencephaly ANdo not use /congen MNC16.131.581.197; C16.131.666.680.196 XUÑHydranencephaly LH LU  MHÑAnesthesia ANdo not use /educ (= ANESTHESIOLOGY /educ) /instrum ( = ANESTHESIOLOGY /instrum) /man /sup /util; Manual 26.30; electric anesthesia = ELECTRONARCOSIS CATALOG: form qualif = ANESTHESIOLOGY /form MNE3.155 LH  MHÑAnesthesia Adjuvants ANdo not use /analogs /biosyn /defic /physiol MND14.120 LH  MH*Anesthesia and Analgesia (Non Mesh) MNE3 LH  MSHospital department responsible for the administration of functions and activities pertaining to the delivery of anesthetics. HN(Aug 77) MHÑAnesthesia Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: ANESTH DEP PIAnesthesiology (66-Jul 77); Hospital Departments (68-Jul 77) MNN2.278.354.422.70; N4.452.442.422.70 XSHospital Anesthesia Department; Hospital Anesthesia-Resuscitation Department DMÑHospital Departments LH LS; LM  MSThe period of emergence from general anesthesia, where different elements of consciousness return at different rates; the return of esthesia. HN(86) MHÑAnesthesia Recovery Period ANno qualif PIAnesthesia or specific (66-85); Postoperative Care (66-85) MNE3.160; E4.630.55 XSRecovery Period, Anesthesia DMÑPostoperative Period LH LS LM  MSEpidural anesthesia administered via the sacral canal. HN(75) MHÑAnesthesia, Caudal ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) MNE3.155.86.131.100 XSAnesthesia, Sacral Epidural DMÑAnesthesia, Epidural LH LS LM  MSInhalation anesthesia where the gases exhaled by the patient are rebreathed as some carbon dioxide is simultaneously removed and anesthetic gas and oxygen are added so that no anesthetic escapes into the room; used especially with explosive anesthetics to prevent fires where electrical sparking from instruments is possible. HN(87) MHÑAnesthesia, Closed-Circuit ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) PIAnesthesia, Inhalation (66-86) MNE3.155.197.197.280 XSAnesthesia, Rebreathing; Closed-Circuit Anesthesia DMÑAnesthesia, Inhalation LH LS; LM  MHÑAnesthesia, Conduction ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) MNE3.155.86 XSANESTHESIA, REGIONAL FXÑInjections, Epidural LH LS LX  MHÑAnesthesia, Dental ANIM; coord with specific type of anesthesia (IM); do not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) MNE3.155.141; E6.45 XSAnesthesia, Intraligamental, Dental LH LS  PM72 HN72(71) MHÑAnesthesia, Epidural ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) PIAnesthesia, Conduction (66-70); Anesthesia, Obstetrical (66-70) MNE3.155.86.131 XSANESTHESIA, EXTRADURAL; Anesthesia, Peridural FXÑInjections, Epidural; ÑInjections, Spinal XUÑAnesthesia, Caudal LH LS; LX; LU  MHÑAnesthesia, General ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) MNE3.155.197 LH  MSAnesthesia caused by the breathing of anesthetic gases or vapors or by insufflating anesthetic gases or vapors into the respiratory tract. MHÑAnesthesia, Inhalation ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) MNE3.155.197.197 XSInsufflation Anesthesia FXÑAdministration, Inhalation; ÑNebulizers and Vaporizers XUÑAnesthesia, Closed-Circuit LH LS LX; LU  MHÑAnesthesia, Intratracheal ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) MNE3.155.253 FXÑTrachea LH LX  MHÑAnesthesia, Intravenous ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) MNE3.155.308 LH  MHÑAnesthesia, Local ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition); ANESTHETICS, LOCAL is also available MNE3.155.86.231 LH  MHÑAnesthesia, Obstetrical ANIM; coord with specific type of anesthesia (IM); do not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition); Manual 26.30 MNE3.155.364 FXÑNATURAL CHILDBIRTH LH LX  MHÑAnesthesia, Rectal ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition) MNE3.155.197.364 FXÑAdministration, Rectal LH LX  MHÑAnesthesia, Spinal ANdo not use /educ (coord with ANESTHESIOLOGY /educ) /man /supply /util (except by MeSH definition); Manual 26.30 MNE3.155.86.331 FXÑInjections, Spinal LH LX  MSA specialty concerned with the study of anesthetics and anesthesia. MHÑAnesthesiology ANSPEC: SPEC qualif CATALOG: use with form qualif, instead of ANESTHESIA /form or ANESTHETICS /form MNG2.403.790.80 LH  MHÑAnesthetics ANno qualif for anesthetics when used to produce anesthesia; do not use /analogs /biosyn /defic /physiol; with type of anesthesia: Manual 26.30; policy: Manual 25.104-25.107 CATALOG: form qualif = ANESTHESIOLOGY /form MND14.166 XUÑAnesthetics, Dissociative LH LU  HN(71) MHÑAnesthetics, Dissociative ANdo not use /analogs /biosyn /defic /physiol PIAnesthetics (66-70) MND14.166.60 DMÑAnesthetics LH LM  MHÑAnesthetics, Local ANsee note on ANESTHETICS above MND14.211 XSAnesthetics, Conduction Blocking; Conduction Blocking Anesthetics LH LS;  MSPeriod of sexual inactivity between estrus periods in animals. HN(75) MHÑAnestrus ANanimal only; qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /rad eff MNG8.520.780.218.80 DMÑEstrus LH LM  MS5-(p-Methoxyphenyl)-3H-1,2-dithiole-3-thione. Choleretic, and used to allay dry mouth and constipation due to tranquilizers. Synonyms: Felviten; Heporal; Sulfarlem; Sufralem; Tiotrifar; Trithio. HN(77) MHÑAnethole Trithione ANdo not use /biosyn /defic /physiol; /analogs NIM only RN532-11-6 PIAnisoles (74-76); Heterocyclic Compounds (74-76); Thiones (74-75) MND2.355.601.200.100; D2.355.726.158.100; D2.755.75.100; D19.316.508.62 XSAnetholtrithion; Trithioanethol; Trithioparamethoxyphenylpropene DMÑAnisoles LH LS; ; LM  MSThe chromosomal constitution of cells which deviate from the normal by the addition or subtraction of chromosomes or chromosome pairs. In a normally diploid cell the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is monosomy (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromocsome is trisomy (symbol: 2N+1). Syn: aneusomy. PM68 HN68 MHÑAneuploidy ANno qualif PIChromosome Abnormalities (66-67) MNG5.148.266.131 LH  MSA sac formed by the dilatation of the wall of an artery, a vein, or the heart. MHÑAneurysm ANIM; coord with specific artery (IM) or precoord artery dis if available (IM); also available are AORTIC ANEURYSM, CEREBRAL ANEURYSM, CORONARY ANEURYSM, HEART ANEURYSM; berry aneurysm = CEREBRAL ANEURYSM; arteriovenous aneurysm = ARTERIOVENOUS FISTULA; aneurysmal bone cysts = BONE CYSTS but not also ANEURYSM; rupture: coord usually with RUPTURE, SPONTANEOUS (NIM) MNC14.907.55 LH  MSSplitting or dissection of an arterial wall by blood entering through an intimal tear or by interstitial hemorrhage. It is most common in the aorta. PM77 HN77 MHÑAneurysm, Dissecting ANmost commonly of aortic aneurysms but when aortic coord IM with AORTIC ANEURYSM (IM); for other arteries, coord IM with specific artery or precoord artery/diseases term (IM) PIAneurysm (66-76); Aortic Aneurysm (66-76) MNC14.907.55.50 XSDissecting Aneurysm LH LS  MSAneurysm due to growth of microorganisms in the arterial wall, or infection arising within preexisting arteriosclerotic aneurysms. OLuse ANEURYSM, INFECTED to search ANEURYSM, MYCOTIC back thru 1966 (as Prov 1966-69) PM87; was ANEURYSM, MYCOTIC 1970-86 HN87; was ANEURYSM, MYCOTIC 1964-86 (Prov 1964-69) MHÑAneurysm, Infected ANcoord IM with specific bacterial or fungal infect (IM); note X refs ANEURYSM, BACTERIAL & ANEURYSM, MYCOTIC: do not coord with BACTERIAL INFECTIONS or MYCOSES if the specific bacterium or fungus is not specified MNC1.539.69; C14.907.55.131 XSAneurysm, Bacterial; Aneurysm, Mycotic; MYCOTIC ANEURYSM FXÑEndocarditis, Bacterial LH LS; ; LX  MSA strong emotional feeling of displeasure aroused by being interfered with, injured or threatened. PM72 HN72(69) MHÑAnger ANhuman & animal; only /drug eff /physiol /rad eff PIHostility (68) MNF1.470.93 XUÑRage LH LU  MSThe symptom of paroxysmal pain consequent to myocardial ischemia usually of distinctive character, location and radiation, and provoked by a transient stressful situation during which the oxygen requirements of the myocardium exceed the capacity of the coronary circulation to supply it. MHÑAngina Pectoris MNC14.280.211.198 XSAngor Pectoris; Stenocardia FXÑChest Pain XUÑAngina, Unstable LH LS; LX LU  MSA clinical syndrome characterized by development of chest pain at rest with concomitant transient ST segment elevation in the electrocardiogram, but exercise capacity is well preserved. PM84; was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81 HN84(77); was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81 MHÑAngina Pectoris, Variant PIAngina Pectoris (66-76) MNC14.280.211.198.955; C14.280.211.215.955 XSPrinzmetal's Angina; Variant Angina Pectoris LH LS;  MSPrecordial pain at rest, which may precede a myocardial infarction. HN(84) MHÑAngina, Unstable PIAngina Pectoris (66-83); Angina Pectoris, Variant (77-83); Coronary Disease (66-83) MNC14.280.211.198.970 XSAngina, Preinfarction; Myocardial Preinfarction Syndrome DMÑAngina Pectoris LH LS; LM  MSRadiography of the heart and great vessels after injection of a contrast medium. MHÑAngiocardiography ANNIM; a specific x-ray (not radionuclide) technic: do not confuse with HEART /radiogr or CORONARY VESSELS /radiogr; coord with disease/radiogr; do not use /util except by MeSH definition MNE1.145.77.102; E1.145.569.73; E1.818.84.102 FXÑHeart LH LX  HN(73) MHÑAngiogenesis Factor ANdo not use /analogs /defic MND11.303.132; D24.185.348.157; D24.185.526.198 DMÑGrowth Substances LH LM  MSRadiography of blood vessels after injection of a contrast medium. MHÑAngiography ANNIM; GEN or unspecified; prefer /radiogr with specific blood vessels; do not use /util except by MeSH definition MNE1.145.77; E1.818.84 XSArteriography FXÑBlood Vessels LH LS LX  MHÑAngioid Streaks MNC11.768.94 FXÑRetina LH LX  MHÑAngiokeratoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant MNC4.557.690.70 LH  PM73 HN73 MHÑAngiokeratoma Corporis Diffusum ANdo not use /congen; /anal /blood supply /secret /ultrastruct permitted PIAngiokeratoma (66-72) MNC4.557.690.70.282; C18.452.648.556.641.803.198 XSFABRY'S DISEASE LH LS  MSSolitary or multiple benign cutaneous tumors comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells. PM85 HN85 MHÑAngiolymphoid Hyperplasia with Eosinophilia ANdo not use /anal /blood supply /secret /ultrastruct; DF: ALHE PIEosinophilia (66-84) MNC4.557.690.85; C15.378.553.231.85; C23.484.85 XSGranuloma, Pseudopyogenic; Kimura Disease LH LS;  MHÑAngioma, Sclerosing AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.108 LH  MHÑAngiomatosis ANcoord IM with precoord organ/neopl term (IM) MNC4.557.690.146 FXÑARTERIOVENOUS MALFORMATIONS; ÑTELANGIECTASIA, HEREDITARY HEMORRHAGIC XUÑHippel-Lindau Disease; ÑKlippel-Trenaunay Disease; ÑSturge-Weber Syndrome LH LX; LU; ;  MSRecurring attacks of transient edema suddenly appearing in areas of the skin or mucous membranes and occasionally of the viscera, often associated with dermatographism, urticaria, erythema, and purpura. MHÑAngioneurotic Edema MNC14.907.79; C17.174.948.66; C20.543.480.904.282 XSAngioedema; QUINCKE'S EDEMA; URTICARIA, GIANT FXÑEdema LH LS; ; LX  MSUse of a catheter for dilatation of an occluded artery. Used in treatment of arterial occlusive diseases including coronary disease, renal artery stenosis, and arterial occlusive diseases of the leg. PM82 HN82 MHÑAngioplasty, Transluminal ANdo not use /class /man /rehabil /supply /util (except by MeSH definition); coord IM with disease /ther (IM), not /surg PIArterial Occlusive Diseases (73-81); specific arterial occlusive disease; Catheterization (66-81); Dilatation (68-81); Heart Catheterization (76-81); specific artery MNE2.50 XSAngioplasty, Balloon; Balloon Angioplasty; Dilatation, Transluminal Arterial; Percutaneous Transluminal Angioplasty LH LS; ; ;  MSA genus of parasitic nematodes of the superfamily Metastrongyloidea. Two species, A. cantonensis and A. vasorum, infest the lungs of rats and dogs respectively. A. cantonensis is transmissible to man where it causes frequently fatal infection of the central nervous system. HN(81) MHÑAngiostrongylus ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) PIMetastrongyloidea (66-80) MNB1.500.294.588.80 DMÑMetastrongyloidea LH LM  MS5-Valine angiotensin II amide. The amide of bovine angiotensin II, and octapeptide used to increase blood pressure by vasoconstriction. Synonyms: angiotensin II amide; 1-asparagine-5-valine angiotensin II amide. OLsearch ANGIOTENSIN II 1966-74 HN(75)66-73 MHÑAngiotensin Amide AN/biosyn /physiol permitted RN53-73-6 PIAngiotensin II (66-74) MND12.644.456.73.41.50; D18.793.103.282; D24.185.798.32.41.50 DMÑAngiotensin II LH LM  MSThe decapeptide precursor of Angiotensin II, generated by the action of renin on Angiotensinogen; it has limited pharmacologic activity. PM87; was see under ANGIOTENSINS 1978-86 HN87(78); was see under ANGIOTENSINS 1978-86 MHÑAngiotensin I AN/biosyn /physiol permitted RN9041-90-1 PIAngiotensin II (66-77) MND12.644.456.73.21; D12.776.641.650.70.75; D24.185.798.32.21 LH  MSThe active form of angiotensin; an octapeptide found in blood; it is synthesized from angiotensin I and quickly destroyed; causes profound vasoconstriction with resulting increase in blood pressure. The clinically and experimentally used bovine form has valine in position 5 where the human form has isoleucine. OLuse ANGIOTENSIN II to search ANGIOTENSIN back thru 1966 PM74; was see under ANGIOTENSIN 1971-73, was see ANGIOTENSIN 1967-70; ANGIOTENSIN AMIDE was heading 1966-73; ANGIOTENSIN was heading 1964-73, was HYPERTENSIN 1963 (HYPERTENSIN was see ANGIOTENSIN 1964-65, was see ANGIOTENSIN AMIDE 1966-73) HN74; was see under ANGIOTENSIN 1971-73, was see ANGIOTENSIN 1967-70; ANGIOTENSIN was heading 1964-78, was HYPERTENSIN 1963 (HYPERTENSIN was see ANGIOTENSIN 1964-65, was see ANGIOTENSIN AMIDE 1966-73) MHÑAngiotensin II AN╥angiotensin╙ not specified as I, II or III is probably ANGIOTENSIN II but check text; also called ╥hypotensin╙; /biosyn /physiol permitted; RENIN-ANGIOTENSIN SYSTEM is also available RN11128-99-7 MND12.644.456.73.41; D12.776.641.650.70.78; D18.793.103; D24.185.798.32.41 XSAngiotensin XUÑ1-Sarcosine-8-Isoleucine Angiotensin II; ÑAngiotensin Amide; ÑAngiotensin III LH LS LU; ;  MS/Des-Asp(1)/-angiotensin II. A heptapeptide formed by the enzymatic hydrolysis of angiotensin II. It has greater activity than angiotensin II for stimulating aldosterone synthesis and in the release of prostaglandins but only 20% of the pressor activity. Synonym: Des-1-angiotensin II. HN(77) MHÑAngiotensin III AN/biosyn /physiol permitted RN12687-51-3 PIAngiotensin II (66-76) MND12.644.456.73.41.40; D12.776.641.650.70.80; D24.185.798.32.53 DMÑAngiotensin II LH LM  PM68 HN68(64) MHÑAngiotensinase ANdo not use /analogs RNEC 3.4.99.3 MND8.586.277.656.143 LH  MSAn alpha globulin of which a fragment of 14 amino acids is converted by renin to angiotensin I, the inactive precursor of angiotensin II. PM87; was see under ANGIOTENSINS 1975-86 HN87(75); was see under ANGIOTENSINS 1975-86 MHÑAngiotensinogen AN/biosyn /physiol permitted; do not use /analogs RN11002-13-4 PIAlpha Globulins (68-74); Angiotensin II (68-74); Protein Precursors (71-74) MND12.644.456.73.70; D12.776.811.70; D24.185.798.32.64 XSHypertensinogen; Renin-substrate LH LS;  MSBlood oligopeptides ranging in size from precursors with 14 amino acids to the active vasoconstrictor Angiotensin II with 8 amino acids, or their analogs or derivatives; the amino acid content varies with the species and changes in it produce antagonistic or inactive compounds. PM78 HN78 MHÑAngiotensins AN╥angiotensin╙ not specified as I, II or III is probably ANGIOTENSIN II but check text; /biosyn /physiol permitted; do not use /analogs; RENIN-ANGIOTENSIN SYSTEM is also available PIAngiotensin II (66-77); Angiotensin III (77) MND12.644.456.73; D12.776.641.650.70; D24.185.798.32 LH  MHÑAngola MNZ1.58.349.70 LH  PM72 HN72 MHÑAnguilla ANeels; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIEels (66-71) MNB2.493.338.282 LH  PM66 HN66 MHÑAnhydrides ANdo not use /analogs /biosyn /defic /physiol MND2.113 LH  MHÑAnilides ANdo not use /analogs /biosyn /defic /physiol MND2.65.199 XUÑCarboxin; ÑFlutamide; ÑPropanil LH LU; ;  MHÑAniline Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ANILINE CPDS MND2.92.146 XSPhenylamines XUÑBW 284 C 51; ÑBenzophenoneidum; ÑDiphenylamine LH LS LU; ;  MSA drug-metabolizing, cytochrome P-450 enzyme which catalyzes the hydroxylation of aniline to hydroxyaniline in the presence of reduced flavoprotein and molecular oxygen. HN(75); was see under HYDROXYLASES 1975-76 MHÑAniline Hydroxylase ANdo not use /analogs RNEC 1.14.14.- PIAniline Compounds (73-74); Hydroxylases (73-74) MND8.586.682.420.80.50 DMÑAryl Hydrocarbon Hydroxylases LH LM  MSN,N-bis(2-Chloroethyl)aniline. Alkylating anti-neoplastic agent effective in some mouse tumors, but less useful in man. HN(76) MHÑAniline Mustard ANdo not use /biosyn /defic /physiol; /analogs NIM only RN553-27-5 PIAniline Compounds (70-75); Nitrogen Mustard Compounds (70-75) MND2.455.526.728.650.50; D22.204.585.62 XSLymphochin; Lymphoquin DMÑNitrogen Mustard Compounds LH LS; LM  PM74 HN74 MHÑAnilino Naphthalenesulfonates ANdo not use /analogs /biosyn /defic /physiol MND2.241.866.540.244.639.282; D4.615.638.555.282; D2.886.610.244.639.282 LH  OLuse ANIMAL to search ANIMAL EXPERIMENTS back thru 1966 HN74; was ANIMAL EXPERIMENTS 1966-73 MHÑAnimal ANcheck tag only; Manual 18.7+, 22.33; relation to /vet: Manual 19.4.68; do not confuse with ANIMALS (B2) CATALOG: do not use: for indexers only LH  MSCommunication between animals involves the giving off by one individual of some chemical or physical signal, that, on being received by another, influences its behavior. PM68 HN68 MHÑAnimal Communication ANno qualif; VOCALIZATION, ANIMAL is also available; do not forget also to check tag ANIMAL PICommunication (66-67) MNF1.145.209.103 LH  PM66; was see under VETERINARY MEDICINE & ZOONOSES 1963-65 HN66; was see under VETERINARY MEDICINE & ZOONOSES 1963-65 MHÑAnimal Diseases ANavoid: too general; IM general only for unspecified animal & unspecified disease; NIM with specific animal (IM) for which no precoord animal/diseases term exists; do not use at all when a specific dis /vet is used; do not forget also to check tag ANIMAL; do not use /compl /vet (TN 193); policy: Manual 23.47-23.52; animal neopl: Manual 24.33-24.36; TN 136 CATALOG: form qualif = VETERINARY MEDICINE /form MNC22 FXÑVeterinary Medicine LH LX  PM68 HN68(66) MHÑAnimal Feed ANonly /ad-poi-tox /anal /econ /rad eff /stand /supply; TN 50: differentiate from ANIMAL NUTRITION & DIET MNJ1.341.52 XUÑSilage LH LU  MSThe science of breeding, feeding and care of domestic animals; includes housing and nutrition. PM76 HN76 MHÑAnimal Husbandry ANincludes animal ╥breeding, feeding & care ... housing & nutrition╙; do not confuse with VETERINARY MEDICINE; only /econ /hist /instrum /man /methods /stand PIAgriculture (66-75) MNJ1.40.90 FXÑVeterinary Medicine LH LX  MSProcedures for recognizing individual animals and certain identifiable characteristics pertaining to them; includes computerized methods, ear tags, etc. PM78 HN78 MHÑAnimal Identification Systems ANdoes not include classif or taxonomy: for individual animals only; only /econ /instrum /stand MNE5.35 LH  PM68 HN68 MHÑAnimal Nutrition ANno qualif; TN 50: differentiate from ANIMAL FEED & DIET PINutrition (66-67) MNG6.696.116 LH  MH*Animal Terms (Non Mesh) MNA13 LH  MSProcedures, such as tissue culture, mathematical models, etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories. PM85 HN85 MHÑAnimal Testing Alternatives ANno qualif MNH1.770.644.45; K1.316.70.70 XSAlternatives to Animal Testing LH LS  MSThe protection of animals in laboratories or other specific environments and the promotion of their health through better nutrition, housing, and care. This may be carried out through legislation or regulation. PM86 HN86 MHÑAnimal Welfare ANonly /hist; cruelty to animals goes here MNI1.880.604.80; K1.316.70.280 XSAnimal Care Committees; Animal Rights; Speciesism FXÑVivisection LH LS; ; LX  MHÑAnimals ANdo not confuse with check tag ANIMAL but when used do not forget to check also tag ANIMAL; avoid: too general; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; /surg: index SURGERY, VETERINARY (which is see under VETERINARY MEDICINE); see Manual index under Animal & all animal entries following for MEDLARS policies on animals; TN 2: animals as IM; TN 3: miscellaneous data MNB2.158 FXÑZoology LH LX  MSAnimals which have become adapted through breeding in captivity to a life intimately associated with man. MHÑAnimals, Domestic ANGEN; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; /surg: index SURGERY, VETERINARY (which is see under VETERINARY MEDICINE); PETS: TN 146; domestication goes here; do not forget also to check tag ANIMAL MNB2.158.116 XSPets LH LS  MHÑAnimals, Laboratory ANGEN; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not forget also to check tag ANIMAL MNB1.62; B2.158.199 XSLaboratory Animals LH LS  MHÑAnimals, Newborn ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not forget also to check tag ANIMAL MNB2.158.282 FXÑInfant, Newborn; ÑPregnancy, Animal LH LX;  PM68 HN68 MHÑAnimals, Poisonous ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag ANIMAL PIAnimals (66-67) MNB2.158.286 LH  MSYoung, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed. PM87; was see under ANIMALS 1979-86 HN87(79); was see under ANIMALS 1979-86 MHÑAnimals, Suckling ANsuckled by mother or by bottle; NIM: no qualif; when IM, only /anat /blood-csf-urine /class /growth /immunol /metab /microbiol /parasitol /physiol /surg; suckling of animals (the act, as in the eff of suckling on animal physiol) goes under LACTATION; do not forget also to check tag ANIMAL MNB2.158.291 LH  MSAnimals considered to be wild or feral or not adapted for domestic use. Does not include zoo animals. PM87; was see under ANIMALS 1978-86 HN87(78); was see under ANIMALS 1978-86 MHÑAnimals, Wild ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not forget also to check tag ANIMAL PIAnimals (66-77) MNB2.158.300 XSAnimals, Nondomestic LH LS  PM68 HN68 MHÑAnimals, Zoo ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not forget also to check tag ANIMAL PIAnimals (66-67) MNB2.158.448 LH  MSHigh molecular weight insoluble polymers which contain functional anionic groups that are capable of undergoing exchange reactions; used for ion exchange chromatography, as gastric antacids, hypocholesteremics, etc. OLsearch ION EXCHANGE RESINS 1966-74 HN(75) MHÑAnion Exchange Resins AND25-26 qualif MND26.572.133 XSAnion Exchangers DMÑIon Exchange Resins LH LS LM  PM74 HN74 MHÑAnions ANGEN or unspecified; avoid as too general: prefer specifics; do not use /analogs /biosyn /defic /physiol; use remaining permissible qualif discreetly: few apply MND1.248.497.158 LH  PM66 HN66(64) MHÑAniseikonia MNC11.744.116 LH  OLuse ANISOLES to search ANISOLE back thru 1971 (as Prov 1971-72) PM73 HN73; was ANISOLE 1971-72 (Prov) MHÑAnisoles ANdo not use /analogs /biosyn /defic /physiol PIEthers (66-70); Phenols (66-70) MND2.355.601.200; D2.355.726.158; D2.755.75 XSMethylphenyl Ethers XUÑAnethole Trithione LH LS LU  MS2-p-Methoxyphenylmethyl-3-acetoxy-4-hydroxypyrrolidine. An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system. HN(75) MHÑAnisomycin ANdo not use /defic /physiol; /analogs NIM only RN22862-76-6 PIAntibiotics (68-74); Pyrrolidines (68-74); Benzyl Compounds (72-74) MND3.383.773.50; D20.85.50 XSFlagecidin DMÑPyrrolidines LH LS LM  MHÑAnkle ANprimates only; any Cat A qualif; TN 238: differentiation from ANKLE JOINT & indexing instructions; use TARSUS, ANIMAL for non-primate vertebrates; TN 117: other animal joints; ankle bone = TARSAL BONES MNA1.378.592.116 LH  PM65 HN65 MHÑAnkle Joint ANprimates only; any Cat A qualif; TN 238: differentiation from ANKLE & indexing instructions; use TARSUS, ANIMAL for non-primate vertebrates; TN 117: other animal joints MNA2.835.583.62 LH  MHÑAnkylosis MNC5.550.69 LH  MHÑAnnelida AN/microbiol /parasitol permitted MNB1.91 LH  MSOccasions to commemorate an event or occasions designated for a specific purpose. HN(Aug 77) MHÑAnniversaries and Special Events ANNIM; no qualif; note X ref below: do not coord here for ANNIVERSARY REACTION; DF: ANNIVERSARIES MNK1.419.95; N4.452.822.70 XSDedications DMÑPublic Relations LH LS LM  MSAnnual statements concerning the administrative and operational functions of an institution or organization. HN(Aug 77) MHÑAnnual Reports ANNIM; no qualif; coord with specific organiz or society (IM) + geog MNN4.452.70 DMÑOrganization and Administration LH LM  PM65 HN65 MHÑAnodontia ANdo not use /congen; congen absence of one or more teeth: do not confuse with JAW, EDENTULOUS (total lack of teeth in either jaw through disease or extraction), JAW, EDENTULOUS, PARTIALLY (partial lack in either jaw) or MOUTH, EDENTULOUS (total lack of teeth in both jaws through disease or extraction) MNC16.131.314.904.116 XSHYPODONTIA LH LS  MSInability to name objects, although they are subjectively perceived. Also known as nominal aphasia. OLsearch APHASIA 1975-79 HN(80); was see APHASIA 1975-79 MHÑAnomia ANdo not use /drug eff /physiol /rad eff; do not confuse with ANOMIE below (╥state of social disorganization & demoralization in society...╙, often called ╥anomia╙); also called ╥nominal aphasia╙ PIAphasia (66-79) MNC10.597.257.543.74.65; C10.597.257.870.74.65; C23.888.592.257.543.74.65; C23.888.592.257.870.74.65; F3.126.219.543.74.65; F3.126.219.870.74.65 XSAphasia, Amnesic; Aphasia, Anomic DMÑAphasia LH LS; LM  MSA state of social disorganization and demoralization in society which is largely the result of disharmony between our cultural goals and our means for attaining them. This may be reflected in the behavior of the individual in many ways -- non-comformity, social withdrawal, deviant behavior, etc. PM71 HN71 MHÑAnomie ANno qualif; ╥state of social disorganization & demoralization in society...╙; sometimes called ╥anomia╙: do not confuse with ANOMIA above (╥inability to name objects╙) PISocial Behavior Disorders (69-70); Social Problems (68-70) MNF1.829.56; I1.880.578.283 XSSOCIAL DISORGANIZATION FXÑPERSONALITY DISORDERS; ÑSOCIAL BEHAVIOR DISORDERS LH LS LX;  MHÑAnonyms and Pseudonyms ANno qualif; DF: ANONYMS MNL1.143.506.598.400.556.283 XSPseudonyms LH LS  MHÑAnopheles AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 MNB1.131.617.289.610.233 LH  MHÑAnophthalmos ANdo not use /congen MNC16.131.384.159 LH  MSA suborder of insects comprising the sucking lice. PM72 HN72 MHÑAnoplura ANsucking lice; /microbiol /parasitol permitted PILice (66-71) MNB1.131.617.564.159 LH  MSLoss of appetite. HN(75) MHÑAnorexia ANdo not use /congen MNC23.888.102.100 DMÑAppetite Disorders LH LM  MSSyndrome marked by severe and prolonged loss of appetite with marked weight loss and other symptoms resulting from emotional conflict. MHÑAnorexia Nervosa ANdo not use /drug eff /physiol /rad eff MNF3.126.72.68 FXÑAppetite Disorders LH LX  PM66 HN66(63) MHÑAnosmia MNC10.597.751.117; C23.888.592.763.117 FXÑSmell LH LX  MSSuspension or cessation of ovulation in animals and humans. PM75 HN75 MHÑAnovulation ANhuman & animal; only Cat C qualif PIOvulation (66-74) MNC13.371.56.630.50; G8.520.440.508.80 LH  MHÑAnoxemia ANdifferentiate from ANOXIA MNC23.888.852.79.367 XSHYPOXEMIA LH LS  MHÑAnoxia ANdifferentiate from ANOXEMIA; fetal anoxia = FETAL ANOXIA; CEREBRAL ANOXIA is also available; restrict to dis or clin state in human & higher animals: do not confuse with anoxic or hypoxic state in lower animals or micro-organisms ( = OXYGEN or ANAEROBIOSIS); TN 145: ANOXIA & HYPOXIA see ANOXIA as clin entities in C23 & not for decrease of oxygen in tissues & cells ( = OXYGEN) MNC23.888.852.79 XSHYPOXIA; OXYGEN DEFICIENCY FXÑAtmospheric Pressure XUÑAltitude Sickness LH LS; LX LU  OLsearch DIPEPTIDES 1967-74 & PEPTIDES 1966 HN(75); was see under PEPTIDES 1963-66 MHÑAnserine ANdo not use /defic /physiol; /analogs NIM only RN584-85-0 MND12.644.456.345.159 DMÑDipeptides LH LM  MSVenoms from the superfamily Formicoidea, Ants; they may contain protein factors and toxins, histamine, enzymes and alkaloids and are often allergenic or immunogenic. HN(78) MHÑAnt Venoms ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS PIAnts (66-77); Venoms (66-77) MND24.185.965.65.55 XSFormicoidea Venoms DMÑArthropod Venoms LH LS LM  MSSubstances that counteract or neutralize acidity; they are used mainly for the treatment of gastrointestinal irritation or ulcers. MHÑAntacids ANdo not use /analogs /biosyn /defic /physiol MND19.316.203.59 LH  MHÑAntarctic Regions ANnote spelling: -ARCTIC: neither spelled nor pronounced ╥antartic╙ MNZ1.158 LH  MS2-[(N-Benzylanilino)methyl]-2-imidazoline hydrochloride. An antihistaminic. Sometimes used as the monohydrochloride and as the phosphate. Synonyms: Antistine;Antistin;Histotab;Antastan;Antasten;Antihistal;Ben-a-hist;Azolone. HN(75) MHÑAntazoline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN91-75-8 PIAniline Compounds (68-74); Benzyl Compounds (73-74); Imidazoles (68-75) MND3.383.374.40; D23.654.432.52 XSImidamine; Phenazoline DMÑImidazoles LH LS; LM  MSAny of various ruminant mammals of the order Bovidae; include numerous species in Africa and the American pronghorn. HN(75) MHÑAntelopes ANincludes dik-dik, eland, gazelle, gnu, hartebeest, impala, springbok, wildebeest; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.77.380.100 XSAntelopines; Caprines; Hippotragines DMÑArtiodactyla LH LS; ; LM  PM66; was see under AQUEOUS HUMOR 1963-65 HN66(64); was see under AQUEOUS HUMOR 1963-65 MHÑAnterior Chamber ANdo not confuse with ANTERIOR EYE SEGMENT; hemorrhage within anterior chamber = HYPHEMA MNA9.371.60.67 LH  MSRapid swelling, increased tension, pain, and ischemic necrosis of the muscles of the anterior tibial compartment of the leg, often following excessive exertion. HN72(81) MHÑAnterior Compartment Syndrome ANnote X ref: restricted to anterior muscle PIMuscular Diseases (66-71); Tibia (66-71); Vascular Diseases (66-71) MNC5.651.180.63; C14.907.553.241.63 XSANTERIOR TIBIAL SYNDROME DMÑCompartment Syndromes LH LS LM  MSThat part of the eyeball anterior to the lens. PM85 HN85 MHÑAnterior Eye Segment ANdo not confuse with ANTERIOR CHAMBER PIAnterior Chamber (66-84); Cornea (66-84); Eye (66-84) MNA9.371.60 LH  OLsearch MOTOR NEURONS 1966-74 HN(75)(64-72) MHÑAnterior Horn Cells ANA 11 qualif MNA8.663.496.284; A11.671.472.284 DMÑMotor Neurons LH LM  MHÑAnthelmintics ANdo not use /analogs /biosyn /defic /physiol; consider also HELMINTHIASIS /drug ther MND21.201 XSVERMIFUGES FXÑAnti-Infective Agents; ÑAntiprotozoal Agents; ÑAntiprotozoal Agents XUÑFilaricides LH LS LX; ; LU  MHÑAnthocyanins ANdo not use /analogs /biosyn /defic /physiol MND9.203.408.84; D11.557.124 LH  MHÑAnthracenes AND25-26 qualif MND4.615.117; D26.191.72 XUÑMaprotiline LH LU  MHÑAnthracosilicosis ANdo not use /chem ind; do not coord with OCCUPATIONAL DISEASES MNC8.381.655.845.201; C21.447.800.834.201 FXÑCoal Mining LH LX  MS1,8,9-Anthracenetriol. Topical agent with antiseptic properties used for dermatoses, especially psoriasis; may cause folliculitis. Synonym: Cygnolin. PM87; was see under ANTHRACENES 1975-86 HN87(75); was see under ANTHRACENES 1975-86 MHÑAnthralin AND25-26 qualif RN480-22-8 PIAnthracenes (68-74) MND4.615.117.50; D26.74.75.130; D26.74.148.100; D26.368.99.50 XSDithranol LH LS  MS5,10,11,11a-Tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c] -1,4-benzodiazepine-2-acrylamide. Broad spectrum antineoplastic antibiotic isolated from Streptomyces refuineus var. thermotolerans; it has low toxicity, some activity against trichomonas and endameba and inhibits RNA and DNA synthesis; binds irreversibly to DNA. HN(75) MHÑAnthramycin ANdo not use /defic /physiol; /analogs NIM only RN4803-27-4 PIAcrylamides (73-74); Benzodiazepinones (74); Pyrroles (72-74) MND3.438.79.80.70.50; D20.85.75.102; D22.204.106.114 DMÑBenzodiazepinones LH LM  MSN-(5'-Phosphoribosyl)-anthranilate:pyrophosphate phosphoribosyltransferase. Catalyzes the formation of N-5'-phosphoribosylanthranilic acid from anthranilate and phosphoribosylpyrophosphate, the first step in tryptophan synthesis in E. coli. Exists in a complex with anthranilate synthase (EC 4.1.3.27) in bacteria. HN(75) MHÑAnthranilate Phosphoribosyltransferase ANdo not use /analogs RNEC 2.4.2.18 PIAnthranilic Acids (72-74); Pentosephosphates (72-74); Pentosyltransferases (72-74); Pyrophosphoric Acids (72-74) MND8.586.600.75; D8.586.913.647.100 XSPhosphoribosylanthranilate Pyrophosphorylase DMÑPentosyltransferases LH LS LM  PM74 HN74 MHÑAnthranilate Synthase ANdo not use /analogs RNEC 4.1.3.27 MND8.586.520.567.175; D8.586.600.85 XSANTHRANILATE SYNTHETASE LH LS  OLuse ANTHRANILIC ACIDS to search ANTHRANILIC ACID back thru 1966 PM75; was ANTHRANILIC ACID 1963-74 HN75; was ANTHRANILIC ACID 1963-74 MHÑAnthranilic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.106.61.105 XSo-Aminobenzoic Acids; ortho-Aminobenzoic Acids XUÑ3-Hydroxyanthranilic Acid; ÑFloctafenine; ÑGlaphenine; ÑMeclofenamic Acid LH LS; LU; ; ;  PMEMODIN was see under CATHARTICS 1963-74 MHÑAnthraquinones ANdo not use /analogs /biosyn /defic /physiol MND4.615.117.159 XUÑCarmine; ÑEmodin LH LU;  MHÑAnthrax ANhuman & animal; /vet permitted MNC1.252.72 LH  MSA suborder of Primates consisting of two families of new world monkeys CALLITHRICIDAE and CEBIDAE, one family of old world monkeys CERCOPITHECIDAE, and one family of apes PONGIDAE. The human family, Hominidae, is also in the Anthropoidea suborder. OLto search ANTHROPOIDS use ANTHROPOIDEA back thru 1975 & PRIMATES 1966-74; use ANTHROPOIDEA to search MONKEYS back thru 1966 PM81; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80 HN81; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80 MHÑAnthropoidea ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; Man as a taxonomic entity or Man as an animal goes here but do not forget to check the tag HUMAN; Manual 22.28+ MNB2.649.801.201 XSMonkeys LH LS  MSThe science devoted to the comparative study of man. MHÑAnthropology ANIM as SPEC: SPEC qualif; NIM as coord with no qualif CATALOG: /geog /form MNF4.96.879.201; I1.76 LH  MSThe study of social phenomena which characterize the learned, shared, and transmitted social activities of a particular ethnic group. PM68 HN68 MHÑAnthropology, Cultural ANIM as SPEC: SPEC qualif; NIM as coord with no qualif; ethnography goes here CATALOG: /geog /form PIAnthropology (66-67); Australoid Race (66-67); Blacks (66-67); Caucasoid Race (66-67); Ethnology (66-67); Ethnopsychology (66-67); Mongoloid Race (66-67) MNI1.76.201 FXÑEthnopsychology LH LX  MSThe comparative science dealing with the physical characteristics of man as related to his origin, evolution, and development in his total environment. PM68 HN68 MHÑAnthropology, Physical ANIM as SPEC: SPEC qualif; NIM as coord, no qualif CATALOG: /geog /form PIAnthropology (66-67); Anthropometry (66-67); Australoid Race (66-67); Blacks (66-67); Caucasoid Race (66-67); Ethnology (66-67); Genetics, Medical (66-67); Mongoloid Race (66-67) MNI1.76.368 FXÑAnthropometry; ÑBiometry; ÑGenetics, Medical LH LX; ;  MHÑAnthropometry ANonly /hist /instrum /methods; primate only; consider also specific terms under BODY WEIGHTS AND MEASURES (NON MESH) at E5.118; SKINFOLD THICKNESS is also available MNE5.118.90 FXÑAnthropology, Physical; ÑCEPHALOMETRY LH LX;  PM67,63-65 HN67,63-65 MHÑAnthroposophy ANno qualif MNE2.924.80 LH  PM67 HN67(64) MHÑAnti-Antibodies ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine; only anti-immunoglobulin antibodies: anti-IGA antibodies, anti-IGG antibodies, etc.: coord IM with IGA (IM), IGG (IM), etc.; caution: anti-liver antibodies (& others of this type) = ANTIBODIES, not ANTI-ANTIBODIES. MND24.611.125.87 XSANTIGAMMA GLOBULIN ANTIBODIES; ANTIGLOBULINS LH LS;  MSAgents used for heart rate disorders or to prevent or allay cardiac arrhythmia; most of them depress the heart rate by slowing the impulse conduction rate and increasing refractive time. OLuse ANTI-ARRHYTHMIA AGENTS to search MYOCARDIAL DEPRESSANTS back thru 1966 PM76; was MYOCARDIAL DEPRESSANTS 1963-75 HN76; was NON MESH before 1976; MYOCARDIAL DEPRESSANTS was heading 1963-75 MHÑAnti-Arrhythmia Agents ANdo not use /analogs /biosyn /defic /physiol; consider also ARRHYTHMIA /drug ther MND18.97 XSAntifibrillatory Agents; Cardiac Depressants; Myocardial Depressants LH LS; ;  MHÑAnti-Infective Agents ANdo not use /analogs /biosyn /defic /physiol; consider also INFECTION /drug ther or its specifics MND20 FXÑAnthelmintics; ÑAntiprotozoal Agents; ÑAntiprotozoal Agents LH LX; ;  OLuse ANTI-INFECTIVE AGENTS, LOCAL to search ANTISEPTICS back thru 1966; search ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM under ANTI-INFECTIVE AGENTS 1966 PM67; ANTISEPTICS & ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66 HN67; ANTISEPTICS & ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66 MHÑAnti-Infective Agents, Local ANdo not use /analogs /biosyn /defic /physiol MND20.187 XSAntiseptics FXÑDermatologic Agents; ÑDisinfectants LH LS LX;  PM66 HN66 MHÑAnti-Infective Agents, Urinary ANdo not use /analogs /biosyn /defic /physiol; consider also URINARY TRACT INFECTIONS /drug ther MND19.770.56; D20.237 XSAntiseptics, Urinary LH LS  PM66 HN66(64) MHÑAnti-Inflammatory Agents AND25-26 qualif; consider also INFLAMMATION /drug ther MND26.74 XSAnti-Rheumatic Agents FXÑAnalgesics, Anti-Inflammatory; ÑFever; ÑGlucocorticoids, Synthetic LH LS LX; ;  MSAnti-inflammatory agents that are not steroids. PM87 HN87 MHÑAnti-Inflammatory Agents, Non-Steroidal ANGEN or unspecified: prefer specifics; D25-26 qualif PIAnti-Inflammatory Agents (66-86); Analgesics, Anti-Inflammatory (66-86) MND26.74.75 XSAspirin-Like Agents; Non-Steroidal Anti-Inflammatory Agents; Prostaglandin Synthesis Antagonists FXÑAnalgesics, Anti-Inflammatory LH LS; ; LX  MSAnti-inflammatory agents which are steroids. PM87 HN87 MHÑAnti-Inflammatory Agents, Steroidal ANGEN or unspecified; prefer specifics; D25-26 qualif PIAnti-Inflammatory Agents (66-86) MND26.74.125 XSSteroidal Anti-Inflammatory Agents FXÑGlucocorticoids, Synthetic LH LS LX  PM66 HN66 MHÑAnti-Inflammatory Agents, Topical AND25-26 qualif; consider also INFLAMMATION /drug ther MND26.74.148; D26.368.99 FXÑGlucocorticoids, Synthetic LH LX  MSVarious agents with different action mechanisms used to treat or ameliorate ulcers or irritation of the gastrointestinal tract. PM77 HN77 MHÑAnti-Ulcer Agents ANrestrict to gastrointestinal ulcers; do not use /analogs /biosyn /defic /physiol; consider also PEPTIC ULCER /drug ther & /drug ther with pertinent specifics PIAntacids (66-76); Gastrointestinal Agents (66-76) MND19.316.203 FXÑHistamine H2 Receptor Blockaders; ÑParasympatholytics LH LX;  MSA property of microorganisms which enables one microorganism to kill, injure, or inhibit the growth of a different microorganism. Includes microbial antagonism. PM72 HN72(65) MHÑAntibiosis ANmicro-organisms only; only /drug eff /rad eff MNG4.185.515.70 XSMicrobial Antagonism LH LS  MSAntibiotic obtained from a Streptomyces variant; possibly effective against Streptococcus pyogenes infections and may promote growth in poultry. Synonyms: Goldinomycin; 1-methylmocimycin; X 5108. HN(76) MHÑAntibiotic X 5108 ANdo not use /defic /physiol; /analogs NIM only RN12704-90-4 PIFurans (74-75); Pyridones (74-75) MND20.85.56 XSAurodox; Goldinodox DMÑAntibiotics LH LS; LM  MHÑAntibiotics ANdo not use /analogs /defic /physiol; /biosyn permitted only if by living matter; /pharm: resistance to antibiotics in general goes under ANTIBIOTIC RESISTANCE see DRUG RESISTANCE, MICROBIAL; preop use of antibiotics for prev of infect: index under ANTIBIOTICS /ther use or specific antibiotic /ther use (IM) + PREMEDICATION (IM); aminoglycoside antibiotics: index under ANTIBIOTICS (IM) + AMINOGLYCOSIDES ((NIM), using the same qualif for both MND20.85 XUÑAlamethicin; ÑAntibiotic X 5108; ÑBambermycins; ÑBongkrekic Acid; ÑButirosins; ÑEdeine; ÑHygromycin B; ÑKasugamycin; ÑNebramycin; ÑNigericin; ÑRibostamycin; ÑStreptolydigin; ÑStreptothricins; ÑThiostrepton LH LU; ; ; ; ; ; ; ; ; ; ; ; ;  PM67 HN67 MHÑAntibiotics, Antifungal ANGEN: prefer specifics; do not use /analogs /defic /physiol; do not use /biosyn unless by living matter PIAntibiotics (66); Antifungal Agents (66) MND20.85.62; D20.136.73 XUÑCandicidin; ÑCerulenin; ÑLucensomycin; ÑMycobacillin; ÑPyrrolnitrin LH LU; ; ; ;  PM67 HN67 MHÑAntibiotics, Antineoplastic ANGEN: prefer specifics; do not use /analogs /defic /physiol; do not use /biosyn unless by living matter; TN 4: relation to ANTINEOPLASTIC AGENTS PIAntibiotics (66); Antineoplastic Agents (66) MND20.85.75; D22.204.106 XSCytotoxic Antibiotics XUÑFormycins; ÑNeocarzinostatin; ÑPactamycin; ÑShowdomycin; ÑSparsomycin; ÑTenuazonic Acid LH LS LU; ; ; ; ;  MSSubstances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms and may be toxic. PM75 HN75 MHÑAntibiotics, Antitubercular ANGEN: prefer specifics; do not use /analogs /defic /physiol; do not use /biosyn unless by living matter PIAntibiotics (66-74); Antitubercular Agents (66-74) MND20.85.89; D20.338.135 LH  MSCompounds containing a four-membered ring with an amide nitrogen and a keto group; this configuration includes bacteriostatic, cell wall inhibiting antibiotics, such as penicillins and cephalosporins, their analogs and derivatives, such as the penem (or penam) compounds, clavulanic acids and monobactams; these are substrates for and may act as inhibitors of bacterial beta-lactamases. PM83 HN83 MHÑAntibiotics, Lactam ANGEN: prefer specifics; do not use /analogs /defic /physiol; do not use /biosyn unless by living matter PIAmides (66-73); Antibiotics (66-82); Lactams (74-82) MND20.85.99 XSAntibiotics, Beta-Lactam; Beta-Lactam Antibiotics LH LS;  PMREAGINS was see under IGE 1973-74, was heading 1972 MHÑAntibodies ANonly /admin /anal /csf /class /genet /immunol /isol /physiol /stand /urine; /biosyn = ANTIBODY FORMATION; ╥production╙ or ╥formation╙ or ╥response╙ = ANTIBODY FORMATION; ╥blocking antibodies╙ is ANTIBODIES (IM) + BINDING, COMPETITIVE (NIM); /defic = ANTIBODY DEFICIENCY SYNDROME; antibodies to IGA, IGG etc. = ANTI-ANTIBODIES (IM) + IGA, IGG, etc. (IM); ANTIBODY-TOXIN CONJUGATES is available as toxin carrier: see note there MND24.611.125 FXÑANTIGEN-ANTIBODY REACTIONS XUÑReagins LH LX LU  PM73 HN73 MHÑAntibodies, Bacterial ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine; coord IM with specific bacterium /immunol (IM); do not coord with ANTIBODY FORMATION for /biosyn PIAntibodies (66-72) MND24.611.125.139 XSBACTERIAL ANTIBODIES LH LS  PM73 HN73 MHÑAntibodies, Fungal ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine; coord IM with specific fungus /immunol (IM); do not coord with ANTIBODY FORMATION for /biosyn PIAntibodies (66-72) MND24.611.125.165 XSFUNGAL ANTIBODIES LH LS  OLuse ANTIBODIES, HETEROPHILE to search ANTIBODIES, HETEROTYPIC back thru 1966 (as Prov 1966-71) PM87; was ANTIBODIES, HETEROTYPIC 1972-86 HN87; was ANTIBODIES, HETEROTYPIC 1964-86 (Prov 1964-71) MHÑAntibodies, Heterophile ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine; xenoantibodies go here; do not coord with ANTIBODY FORMATION for /biosyn MND24.611.125.191 XSAntibodies, Heterotypic; Heterologous Antibodies; Heterophile Antibodies LH LS; ;  MSAntibodies produced by clones of cells such as those isolated after hybridization of activated B lymphocytes with neoplastic cells. These hybrids are often referred to as hybridomas. PM82 HN82 MHÑAntibodies, Monoclonal ANonly /admin /adv eff /anal /biosyn /csf /class /diag use /genet /immunol /isol /physiol /stand / ther use /tox /urine; do not coord with ANTIBODY FORMATION for biosyn; ANTIBODY-TOXIN CONJUGATES is available as a toxin carrier: see note there PIAntibodies (75-81); B Lymphocytes (75-81) MND24.611.125.200 XSMonoclonal Antibodies FXÑHybridomas LH LS LX  PM73 HN73 MHÑAntibodies, Neoplasm ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine; coord IM with required neopl coords with /immunol (IM); do not coord with ANTIBODY FORMATION for /biosyn PIAntibodies (66-72) MND24.611.125.217 XSNeoplasm Antibodies; Tumor Antibodies LH LS;  MSImmunoglobulins produced as a response to viral antigens; includes all classes of immunoglobulins elicited by all viral components. PM73 HN73 MHÑAntibodies, Viral ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine; coord IM with specific virus /immunol (IM); do not coord with ANTIBODY FORMATION for /biosyn PIAntibodies (66-72) MND24.611.125.243 XSVIRAL ANTIBODIES LH LS  MSA measure of the binding strength between antibody and a simple hapten or antigen determinant; it depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. Includes the concept of ╥avidity,╙ which refers to the strength of the antigen-antibody bond after formation of reversible complexes. PM79 HN79 MHÑAntibody Affinity ANonly /drug eff /rad eff; do not confuse with BINDING SITES, ANTIBODY or ANTIGENIC DETERMINANTS PIAntibodies (66-78); Antigen-Antibody Reactions (66-78); Antigenic Determinants (70-78); Binding Sites, Antibody (73-78) MNG4.610.143.125 XSAffinity, Antibody; Antibody Avidity; Avidity, Antibody LH LS; ;  MSThe phenomenon of immense variability characteristic of antibodies, which enables the immune system to react specifically against the essentially unlimited kinds of antigens it encounters. Antibody diversity is accounted for by three main theories: 1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; 2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and 3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of variable region gene segments during the differentiation of the antibody-producing cells. PM80 HN80 MHÑAntibody Diversity ANno qualif; for theories see MeSH definition PIAntibodies (66-69); Antibody Specificity (70-79) MNG4.610.51; G4.610.626.51; G5.511.51 XSGerm Line Theory LH LS  MHÑAntibody Formation ANonly /drug eff /rad eff; = ╥production of antibodies╙ or ╥antibody response╙; GEN only: do not use as coord for formation of specific antibodies; coord NIM with specific dis /immunol (IM): TN 242 MNG4.610.71 XSImmunity, Humoral LH LS  MSThe property of antibodies which enables them to react with some antigenic determinants and not with others; specificity is dependent on chemical composition, physical forces and molecular structure at the binding site. PM72 HN72(70) MHÑAntibody Specificity ANonly /drug eff /rad eff PIAntibodies (66-69) MNG4.610.106 LH  MSFluorescent antibody technic for visualizing antibody-bacteria complexes in urine. Presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively. HN(80) MHÑAntibody-Coated Bacteria Test, Urinary ANonly /instrum; DF: ACBU PIAntibodies, Bacterial (74-79); Bacteriuria (74-79); Pyelonephritis (74-79); Urinary Tract Infections (74-79) MNE1.223.495.348.50; E1.341.50; E5.478.348.50 DMÑFluorescent Antibody Technic LH LM  MSThe phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IgG whose Fc portion is intact. The effector cell is a ╥killer╙ cell possessing Fc receptors; it may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. PM78 HN78 MHÑAntibody-Dependent Cell Cytotoxicity ANonly /drug eff /rad eff PICytotoxicity Tests, Immunologic (71-77); Immunity, Cellular (70-77); Lymphocytes (66-77) MNG4.610.270.70 XSCytotoxicity, Antibody-Dependent Cell FXÑKiller Cells LH LS LX  MSCells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize. PM72 HN72(70) MHÑAntibody-Producing Cells ANA 11 qualif & /class PIAntibody Formation (66-69) MNA11.63; A15.382.520.118 XSAntibody-Secreting Cells; Immunoglobulin-Producing Cells; Immunoglobulin-Secreting Cells FXÑHemolytic Plaque Technic LH LS; ; LX  MSSemisynthetic conjugates of specific TOXINS with specific immunoglobulins, usually certain monoclonal antibodies raised against specific tissues, usually neoplastic. The antitumor immunoglobulin carries the toxin to the tumor where the toxin exerts its poisonous cytotoxic effects. Synonym: Toxin Carriers PM87 HN87 MHÑAntibody-Toxin Conjugates ANIM; only /admin /adv eff /anal /blood-csf-urine /class /immunol /isol /metab /pharm /stand /ther use; coord with specific toxin (IM) + specific antibody (NIM); also called ╥toxin carrier╙ PIAntibodies, Monoclonal (82-86); Antigens, Surface (79-86); Antitoxins (66-86); Cytotoxicity, Immunologic (78-86); Ricin (78-85) MND24.185.926.95; D24.611.125.355 XSAntibody-Toxin Hybrids; Hybrids, Toxin-Antibody; Immunotoxins; Toxin-Antibody Conjugates; Toxin-Antibody Hybrids; Toxins, Targeted LH LS; ; ; ; ;  MSAgents used to treat tapeworm infestations in man or animals. PM75 HN75 MHÑAnticestodal Agents ANdo not use /analogs /biosyn /defic /physiol; consider also CESTODA /drug eff or CESTODE INFECTIONS /drug ther or pertinent specifics PIAnthelmintics (66-74) MND21.201.412.100 XSTaeniacides LH LS  PM66 HN66(64) MHÑAnticholesteremic Agents ANdo not use /analogs /biosyn /defic /physiol; consider also HYPERCHOLESTEROLEMIA & specifics /drug ther MND10.162.202 XSCholesterol Inhibitors; HYPOCHOLESTEREMIC AGENTS LH LS;  MHÑAnticoagulants ANexogenous only: not for circulating natural anticoagulants ( = BLOOD COAGULATION); do not use /analogs /biosyn /defic /physiol; consider also BLOOD COAGULATION /drug eff & THROMBOSIS /drug ther or related dis with /drug ther MND19.461.119 LH  OLsearch RNA, TRANSFER 1974 HN(75) MHÑAnticodon ANIM; /drug eff /ultrastruct permitted; do not use /analogs /defic MND13.444.735.757.286 DMÑRNA, Transfer LH LM  MHÑAnticonvulsants ANdo not use /analogs /biosyn /defic /physiol; consider also CONVULSIONS /drug ther MND14.261 XSAntiepileptic Agents LH LS  OLto search THYMOLEPTICS use ANTIDEPRESSIVE AGENTS back thru 1979 & ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS 1969-78 PMTHYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78 HNTHYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78 MHÑAntidepressive Agents ANdo not use /analogs /biosyn /defic /physiol; consider also DEPRESSION /drug ther MND15.236.122 XSPSYCHIC ENERGIZERS; THYMOANALEPTICS; Thymoleptics LH LS; ;  MSSubstances which contain a fused three ring moiety and are used in the treatment of depression; they may block the reuptake of norepinephrine and have anticholinergic effects. PM75 HN75 MHÑAntidepressive Agents, Tricyclic ANdo not use /analogs /biosyn /defic /physiol PIAntidepressive Agents (68-74) MND15.236.122.140 XSTricyclic Antidepressive Agents LH LS  MSMiscellaneous agents found useful in the symptomatic treatment of diarrhea; they have no effect on the agent(s) that cause diarrhea, but merely alleviate it. OLsearch GASTROINTESTINAL AGENTS 1969-74 PM75; was see under GASTROINTESTINAL AGENTS 1969-74 HN75; was see under GASTROINTESTINAL AGENTS 1969-74 MHÑAntidiarrheals ANdo not use /analogs /biosyn /defic /physiol; consider also DIARRHEA /drug ther PIGastrointestinal Agents (67-74) MND19.316.161 LH  PM66 HN66(64) MHÑAntidotes AND25-26 qualif; consider also POISONING /drug ther MND26.61 FXÑCHELATING AGENTS; ÑCholinesterase Reactivators; ÑPoisoning LH LX; ;  MHÑAntiemetics ANdo not use /analogs /biosyn /defic /physiol; consider also NAUSEA /drug ther & VOMITING /drug ther MND23.136 LH  MSAgents that prevent fibrinolysis or lysis of a blood clot or thrombus; several endogenous antiplasmins are known; the drugs are used to control massive hemorrhage and in other coagulation disorders. PM66 HN66 MHÑAntifibrinolytic Agents ANdo not use /analogs /biosyn /defic /physiol MND19.461.270.463.91 XSAntifibrinolysins; Antiplasmins LH LS;  MSAgents used to prevent the formation of foam or to treat flatulence or bloat. HN(77) MHÑAntifoaming Agents AND25-26 qualif; consider also FLATULENCE /drug ther PISilicones (66-76); Surface-Active Agents (66-76) MND26.866.48 XSAntiflatulents; Defoaming Agents; Foam Retardants DMÑSurface-Active Agents LH LS; ; LM  OLuse ANTIFUNGAL AGENTS to search FUNGICIDES 1966-71 PM67; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66 HN67; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66 MHÑAntifungal Agents ANdo not use /analogs /biosyn /defic /physiol; used in ther: differentiate from FUNGICIDES, INDUSTRIAL; consider also FUNGI /drug eff & MYCOSES /drug ther or pertinent specifics MND20.136 XSFUNGICIDES, THERAPEUTIC FXÑFUNGICIDES, INDUSTRIAL LH LS LX  PM72 HN72(70) MHÑAntigen-Antibody Complex ANonly /anal /csf /genet /immunol /isol /metab /physiol /rad eff /urine PIAntibodies (66-69); Antigens (66-69) MND24.611.171 FXÑIMMUNE COMPLEX DISEASE XUÑImmunosorbents LH LX LU  MHÑAntigen-Antibody Reactions ANonly /drug eff /rad eff MNG4.610.143 FXÑANTIBODIES; ÑANTIGENS; ÑAntibodies; ÑAntigens; ÑBinding Sites, Antibody; ÑHYPERSENSITIVITY, IMMEDIATE LH LX; ; ; ; ;  MSImmunocompetent cells, usually Ia positive, that mediate the cellular immune response by processing and presenting antigens or mitogens which stimulate T cell activation. PM85 HN85 MHÑAntigen-Presenting Cells ANA 11 & /class PIAntigenic Determinants (70-84); Antigens, Immune Response (81-84); Lymphocyte Transformation (69-84); T Lymphocytes (73-84) MNA11.66; A15.382.66 XSAccessory Cells, Immunologic FXÑAntigens, Immune Response; ÑLymphocyte Transformation LH LS LX;  MSThe operative part of the hapten; the molecular or chemical configurations of any antigenic molecule which give it specificity in the antigen-antibody reaction. PM72 HN72(70) MHÑAntigenic Determinants ANonly /anal /genet /immunol /isol /rad eff; do not confuse with genetic determinants ( = GENES or specific); ANTIBODY AFFINITY is also available PIAntigens (66-69) MND24.611.216.119 XSAntigenic Specificity; Epitopes LH LS;  MHÑAntigens ANGEN or unspecified: prefer specifics; only /admin /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine MND24.611.216 FXÑANTIGEN-ANTIBODY REACTIONS XUÑVaccines, Synthetic LH LX LU  OLuse ANTIGENS, BACTERIAL to search BACTERIAL ANTIGENS 1971-72 (as Prov) PM73 HN73; was BACTERIAL ANTIGENS 1971-72 (Prov) MHÑAntigens, Bacterial ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord IM with specific bacterium /immunol (IM) PIAntigens (66-70); Polysaccharides, Bacterial (66-70) MND24.611.216.161 XSBACTERIAL ANTIGENS LH LS  PM73; TRICHOPHYTIN & HISTOPLASMIN were headings 1963-85 HN73 MHÑAntigens, Fungal ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord IM with specific fungus /immunol (IM) PIAntigens (66-72) MND24.611.216.202 XSFUNGAL ANTIGENS XUÑCoccidioidin; ÑHistoplasmin; ÑTrichophytin LH LS LU; ;  MSAny part or derivative of a helminth that elicits an immune reaction; the most often seen helminth antigens are those of the schistosomes. PM85 HN85 MHÑAntigens, Helminth ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord IM with specific helminth /immunol (IM) PIAntigens (66-84); Antigens, Surface (79-84) MND24.611.216.223 XSHelminth Antigens LH LS  PM72; FORSSMAN ANTIGEN was heading 1973-81 HN72(64) MHÑAntigens, Heterogenetic ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord IM with specific antigen/organism heading (IM) MND24.611.216.244 XUÑForssman Antigen LH LU  MSAntigens coded for by the immune response (Ir) genes (in the mouse); they are found on B lymphocytes, macrophages, epidermal cells and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The human Ir antigens are called HLA-D antigens. Synonyms: Ia-like antigens. PM81 HN81 MHÑAntigens, Immune Response ANGEN: prefer specifics; only /admin /anal /biosyn /caf /class /genet /immunol /isol /rad eff /stand /tox /urine PIHistocompatibility Antigens (73-80); HLA Antigens (75-80); Isoantigens (73-80) MND24.611.216.705.552.50 XSClass II Antigens; Ia Antigens; Ia-Like Antigens; Immune Response Antigens; Immune-Associated Antigens; Immune-Response-Associated Antigens FXÑAntigen-Presenting Cells LH LS; ; ; ; ; LX  MSA group of lymphocyte surface antigens differentially located on subpopulations of mouse lymphocytes. This localization has been useful in distinguishing different functional subpopulations of lymphocytes. For example, cytotoxic T cells bear primarily Lyt-23 on their surface and not Lyt-1, whereas helper cells bear Lyt-1 and not Lyt-23. PM82 HN82 MHÑAntigens, Ly ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PILymphocytes (66-81); T Lymphocytes (75-81) MND24.611.216.301.568 XSAntigen, Lyt-1; Ly Antigens; Lyt 1 Antigen LH LS; ;  MSProteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that cause the biosynthesis of antibodies; many of these are of either embryonic or viral origin. PM73 HN73 MHÑAntigens, Neoplasm ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord IM with required neopl coords with /immunol (IM) PIAntigens (66-72); Neoplasms/IM (66-72); specific neoplasm/IM (66-72) MND24.611.216.285 XSNeoplasm Antigens; Tumor Antigens LH LS;  MSAny part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. PM85 HN85 MHÑAntigens, Protozoan ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord IM with specific protozoan /immunol (IM) PIAntigens (66-84); Antigens, Surface (79-84) MND24.611.216.293 XSProtozoan Antigens LH LS  MSAntigens on surfaces of cells, including infectious or foreign cells or viruses; they are usually protein-containing groups on cell membranes or walls and may be isolated. PM79 HN79 MHÑAntigens, Surface ANonly /admin /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord NIM with specific antigen/organism heading (IM) PIAntigens (66-78); specific antigen MND24.611.216.301 XSSurface Antigens; Surface Markers, Immunological LH LS;  MSAntigens which may directly stimulate B lymphocytes without the cooperation ot T lymphocytes. PM82 HN82 MHÑAntigens, T-Independent ANonly /admin /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIAntibody Formation (69-71); Lymphocytes (69-72); B Lymphocytes (73-81); T Lymphocytes (73-81) MND24.611.216.324 XST-Independent Antigens; Thymus-Independent Antigens LH LS;  PM73 HN73 MHÑAntigens, Viral ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord IM with specific virus /immunol (IM) PIAntigens (66-72); Viruses/IM (66-72) MND24.611.216.327 XSVIRAL ANTIGENS LH LS  MSThose proteins recognized by antibodies from serum of animals bearing tumors induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation. PM84 HN84 MHÑAntigens, Viral, Tumor ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; coord IM with specific virus /immunol (IM); do not confuse X ref T ANTIGENS with ╥Tr antigens╙ ( = TRANSPLANTATION ANTIGENS see HISTOCOMPATIBILITY ANTIGENS) PIAntigens (66-72); Antigens, Neoplasm (73-83); Antigens, Viral (73-83) MND24.611.216.285.62; D24.611.216.327.62 XSAntigens, Neoplasm, Viral; Neoplasm Antigens, Viral; T Antigens; Tumor Antigens, Viral; Viral Tumor Antigens LH LS; ; ; ;  HN75 MHÑAntigua MNZ1.107.904.50 LH  MHÑAntihypertensive Agents ANdo not use /analogs /biosyn /defic /physiol; consider also HYPERTENSION /drug ther MND18.162 LH  PM72 HN72(66) MHÑAntilipemic Agents ANdo not use /analogs /biosyn /defic /physiol; consider also HYPERLIPIDEMIA & specifics /drug ther MND10.162 LH  MSSerum containing gamma globulins which are antibodies for lymphocyte antigens. It is used both as a test for histocompatibility and therapeutically in transplantation. OLsearch LYMPHOCYTOTOXINS under LYMPHOTOXINS 1978 PM70; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978 HN70(68); LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978 MHÑAntilymphocyte Serum ANdo not use /analogs /antag /biosyn /blood /chem syn /diag use /metab /physiol /pois /secret; antithymocyte & anti-theta serum: ANTILYMPHOCYTE SERUM (IM) + T LYMPHOCYTES /immunol (IM); for ╥lymphocytotoxins╙ check text: if antibody to lymphocytes index under ANTILYMPHOCYTE SERUM, if toxin released by lymphocyte index under LYMPHOTOXINS PIImmune Sera (66-67); Lymphocytes (66-67) MND22.569.137; D24.310.401.203; D24.611.125.573.203 XSAntilymphoblast Globulins; Antilymphocyte Antibodies; Antilymphocyte Globulin; Lymphocytotoxic Antibodies FXÑImmunosuppression; ÑImmunosuppressive Agents; ÑLymphocytes LH LS; ; ; LX; ;  MHÑAntimalarials ANdo not use /analogs /biosyn /defic /physiol; consider also PLASMODIUM /drug eff & MALARIA /drug ther or pertinent specifics MND21.370.286 LH  MHÑAntimetabolites ANdo not use /analogs /antag /biosyn /defic /physiol MND26.87 FXÑAntimetabolites, Antineoplastic LH LX  MSSubstances that, due to their close structural resemblance to normal physiological substances, combine with and thereby inhibit the enzyme required for normal functioning; a number of these substances have been found to be effective antineoplastic agents. PM75 HN75 MHÑAntimetabolites, Antineoplastic ANdo not use /analogs /antag /biosyn /defic /physiol; TN 4: relation to ANTINEOPLASTIC AGENTS PIAntineoplastic Agents (66-74) MND22.204.144 FXÑAntimetabolites LH LX  MHÑAntimony ANSb-121; do not use /analogs /biosyn /defic /physiol; Sb-123 = ANTIMONY (IM) + ISOTOPES (NIM); Sb-112-120, 122, 124-133 = ANTIMONY (IM) + RADIOISOTOPES (IM) RN7440-36-0 MND1.268.49; D1.552.70 XUÑAntimony Potassium Tartrate LH LU  MSAntimonial schistosomicide possibly useful against other parasites; has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects. Synonym: Tartrated antimony. HN(76) MHÑAntimony Potassium Tartrate ANdo not use /analogs /biosyn /defic /physiol RN28300-74-5 PIAntimony (69-75); Tartrates (69-75) MND1.552.70.75; D21.201.412.596.58 XSPotassium Antimonyltartrate; Tartar Emetic DMÑAntimony LH LS; LM  MSAntimony complexes where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate (gluconic acid diester with antimonic acid, trisodium salt nonahydrate; Myostibin; Pentostam; Solustibosan; Stibatin) is used in leishmaniasis. The trivalent gluconate (Triostam) is most frequently used in schistosomiasis. HN(77) MHÑAntimony Sodium Gluconates ANdo not use /analogs /biosyn /defic /physiol PIAntimony (70-75); Gluconates (70-76) MND1.552.70.95; D2.241.81.844.322.60; D2.241.511.902.322.60; D9.203.811.308.60; D21.201.412.596.64; D21.370.322 XSAntimony Gluconate Sodium; Stibogluconate Sodium DMÑGluconates LH LS; LM  PM66 HN66(64) MHÑAntimycin A ANdo not use /defic /physiol RN642-15-9 MND20.85.62.148; D20.136.73.148 LH  MSSubstances used in the treatment or control of nematode infestations; includes veterinary use. OLuse ANTINEMATODAL AGENTS to search NEMATOCIDES back thru 1974 PM76; was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75 HN76(75); was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75 MHÑAntinematodal Agents ANdo not use /analogs /biosyn /defic /physiol; consider also NEMATODA /drug eff & NEMATODE INFECTIONS /drug ther or pertinent specifics PIAnthelmintics (66-73) MND21.201.287 XSNematocides LH LS  MHÑAntineoplastic Agents ANdo not use /analogs /biosyn /defic /physiol; consider also NEOPLASMS /drug ther; /admin: various admin procedures are available, as PERFUSION, REGIONAL & INFUSIONS, INTRA-ARTERIAL; TN 4: definition & relation to antineopl antibiotics, phytogens & antimetabolites; for combined anticancer agents see term below MND22.204 FXÑAlkylating Agents; ÑInfusions, Intra-Arterial; ÑPerfusion, Regional LH LX; ;  MSDrug therapy of neoplasms with two or more chemicals simultaneously or sequentially; the drugs need not be in the same dosage form = DRUG COMBINATIONS. PM84 HN84 MHÑAntineoplastic Agents, Combined ANdo not use /analogs /biosyn /defic /physiol; TN 5: indexing instructions PIDrug Therapy, Combination (74-83) MND22.204.160; D26.394.310.58; E2.319.310.160 XSCombination Chemotherapy, Antineoplastic; Polychemotherapy, Neoplasm FXÑCombined Modality Therapy LH LS; LX  MSAgents, obtained from higher plants, that have demonstrable cytostatic or antineoplastic activity. OLuse ANTINEOPLASTIC AGENTS, PHYTOGENIC to search ANTINEOPLASTICS, PHYTOGENIC back thru 1975 PM76; was ANTINEOPLASTICS, PHYTOGENIC 1975 HN76; was ANTINEOPLASTICS, PHYTOGENIC 1975 MHÑAntineoplastic Agents, Phytogenic ANfrom plants of Cat B6 only, not from lower plants (Cat B5: algae & fungi); do not use /analogs /defic /physiol; /biosyn permitted if by plant; TN 4: coverage PIAntineoplastic Agents (66-74) MND22.204.179 XSAntineoplastics, Botanical LH LS  MH*Antineoplastics, Immunosuppressives (Non Mesh) MND22 LH  PM70 HN70(66) MHÑAntinuclear Factors ANonly /anal /biosyn /class /csf /genet /immunol /isol /physiol /urine MND24.611.125.308.204 XSANTIBODIES, ANTINUCLEAR FXÑCollagen Diseases; ÑLE Cells LH LS LX;  MHÑAntioxidants AND25-26 qualif MND26.100 FXÑFood Preservatives; ÑPHARMACEUTIC AIDS LH LX;  MSN(2)-(((1-Carboxy-2-phenylethyl)amino)carbonyl)- L-arginyl-N-(4-((aminoiminomethyl)amino)- 1-formylbutyl)-L-valinamide. An oligopeptide produced by various bacteria which acts as a protease inhibitor. HN(80) MHÑAntipain ANnothing to do with pain: a bacterial protease inhibitor; do not use /defic /physiol; /analogs NIM only RN37691-11-5 PIOligopeptides (73-79); Peptide Hydrolases/AI (68-78); Peptide Peptidohydrolases/AI (68-78); Peptides (66-72); Protease Inhibitors (79) MND8.373.745.95; D12.644.456.120 DMÑOligopeptides LH LM  OLconsider also PARASITES /DE & PARASITIC DISEASES /DT or their specifics; search PARASITICIDES under ANTIPROTOZOAL AGENTS 1966 HNPARASITICIDES was heading 1963-66 MH*Antiparasitic Agents (Non Mesh) MND21 LH  OLto search ANTIPARKINSON DRUGS use ANTIPARKINSON AGENTS back thru 1972 (as Prov 1972) & PARASYMPATHOLYTICS 1966-71 PM76; was ANTIPARKINSON DRUGS 1973-75, was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72 HN76; was ANTIPARKINSON DRUGS 1972-75 (Prov 1972), was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72 MHÑAntiparkinson Agents ANdo not use /analogs /biosyn /defic /physiol; consider also PARKINSON DISEASE /drug ther PIParasympatholytics (66-72); Parkinsonism/DT (66-72) MND14.307 FXÑParasympatholytics LH LX  MSA proteinase inhibitor in human plasma which inhibits efficiently the lysis of fibrin clots induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 which migrates in the alpha 2 region in immunoelectrophoresis. It is the principle plasmin inactivator in blood, rapidly forming a very stable complex with plasmin. PM80 HN80 MHÑAntiplasmin ANa specific proteinase inhibitor: do not confuse with ANTIPLASMINS see ANTIFIBRINOLYTIC AGENTS; do not use /analogs /antag /blood PIFibrinolysin/AI (68-79) MND8.373.745.100; D12.776.124.790.106.118; D12.776.377.715.85.118; D19.461.270.463.91.280 XSAlpha 2-Plasmin Inhibitor LH LS  MSAgents used to treat cestode, trematode or other flatworm infestations in man or animals. PM75 HN75 MHÑAntiplatyhelmintic Agents ANdo not use /analogs /biosyn /defic /physiol; consider also PLATYHELMINTHS /drug eff PIAnthelmintics (66-74) MND21.201.412 LH  OLuse ANTIPROTOZOAL AGENTS to search PARASITICIDES 1966 PM67; PARASITICIDES was heading 1963-66 HN67; PARASITICIDES was heading 1963-66 MHÑAntiprotozoal Agents ANdo not use /analogs /biosyn /defic /physiol; consider also PROTOZOA /drug eff & PROTOZOAN INFECTIONS /drug ther or pertinent specifics MND21.370 FXÑAnthelmintics; ÑAnti-Infective Agents; ÑAnti-Infective Agents LH LX; ;  MSAgents, usually topical, that relieve itching (pruritus). OLsearch DERMATOLOGIC AGENTS 1967-74 HN(75) MHÑAntipruritics AND25-26 qualif; consider also PRURITUS /drug ther MND26.368.163 DMÑDermatologic Agents LH LM  MHÑAntipyrine ANdo not use /biosyn /defic /physiol RN60-80-0 MND3.383.694.65; D14.73.278.152; D26.74.75.204 XSPhenazone XUÑAmpyrone LH LS LU  MHÑAntireticular Cytotoxic Serum ANdo not use /analogs /antag /biosyn /blood /chem syn /diag use /immunol /physiol /pois /secret MND24.310.401.371; D24.611.125.573.371 LH  MSThe destruction of germs causing disease. MHÑAntisepsis ANonly /hist /methods /stand; differentiate from ASEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion MNG3.850.180.150 XUÑAsepsis LH LU  MSAgents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. PM77 HN77 MHÑAntisickling Agents ANdo not use /analogs /biosyn /defic /physiol; consider also ANEMIA, SICKLE CELL /drug ther PIAnemia, Sickle Cell (66-76); Hemoglobins, Abnormal (66-74); Hemoglobin, Sickle (75-76) MND19.461.135 XSDesickling Agents FXÑAnemia, Sickle Cell LH LS LX  MSIndividuals who repeatedly come into conflict with society and who lack the capacity to form significant attachments or loyalties to others or to codes of living. OLuse ANTISOCIAL PERSONALITY DISORDER to search ANTISOCIAL PERSONALITY & SOCIOPATHIC PERSONALITY back thru 1966 PM81; was ANTISOCIAL PERSONALITY 1976-80, was SOCIOPATHIC PERSONALITY 1963-75 HN81; was ANTISOCIAL PERSONALITY 1976-80, was ANTISOCIAL PERSONALITY see under SOCIOPATHIC PERSONALITY 1969-75; SOCIOPATHIC PERSONALITY was heading 1963-75 MHÑAntisocial Personality Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.597.55 XSDyssocial Behavior; Personality Disorder, Antisocial; Psychopathic Personality; Sociopathic Personality FXÑSocial Behavior Disorders LH LS; ; ; LX  MSAgents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and blocks spermatogenesis. PM75 HN75 MHÑAntispermatogenic Agents ANdo not use /analogs /biosyn /defic /physiol; MeSH definition says ╥mechanical or chemical╙; consider also SPERMATOZOA /drug eff & SPERMATOGENESIS /drug eff, etc. PIContraceptive Agents (67-74); Spermatogenesis/DE (71-74) MND7.360.443.288 LH  MHÑAntistreptolysin ANdo not use /blood RN9006-92-2 MND24.611.125.139.288 LH  MSA plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes; it was formerly called Antithrombin II (AT II) which has now been shown to be identical to AT III; deficiency of AT III, hereditary or acquired, results in thromboembolism. OLuse ANTITHROMBIN III to search HEPARIN CO-FACTOR back thru 1966 (as Prov 66-74) PM79; was HEPARIN CO-FACTOR see under ALPHA GLOBULINS 1975-78 HN79; was HEPARIN CO-FACTOR see under ALPHA GLOBULINS 1975-78, was HEPARIN CO-FACTOR 1963-74 (Prov) MHÑAntithrombin III AN/biosyn /drug eff /physiol permitted; do not use /blood; Antithrombin II, formerly identified with HEPARIN CO-FACTOR, now identical to ANTITHROMBIN III RN9000-94-6 MND8.373.745.109.100; D12.776.124.790.106.125; D12.776.377.715.85.125; D19.461.119.71.46 XSAntithrombin II; Heparin Cofactor LH LS;  MSAny endogenous or administered substance that neutralizes the action of thrombin; six specific antithrombins were postulated formerly, only one of which is now recognized. OLuse ANTITHROMBINS to search ANTITHROMBIN back thru 1966 (as Prov 1966) PM76; was ANTITHROMBIN 1967-75 HN76; was ANTITHROMBIN 1964-75 (Prov 1964-66) MHÑAntithrombins ANdo not use /blood MND8.373.745.109; D19.461.119.71 LH  PM66; TOXINS AND ANTITOXINS was heading 1963-65 HN66; TOXINS AND ANTITOXINS was heading 1963-65 MHÑAntitoxins ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; coord IM with specific toxin (IM or NIM) MND24.310.121; D24.611.125.272 LH  OLconsider also TREPONEMA /DE & TREPONEMA PALLIDUM /DE or TREPONEMA INFECTIONS /DT or /DT with specific treponemal infect MH*Antitreponemal Agents (Non Mesh) MND20.288 LH  PM72 HN72(66) MHÑAntitrichomonal Agents ANdo not use /analogs /biosyn /defic /physiol; consider also TRICHOMONAS /drug eff & TRICHOMONAS INFECTIONS /drug ther or pertinent specifics MND21.370.370 LH  MHÑAntitubercular Agents ANdo not use /analogs /biosyn /defic /physiol; consider also MYCOBACTERIUM TUBERCULOSIS /drug eff & TUBERCULOSIS /drug ther MND20.338 XSTuberculostatic Agents LH LS  MHÑAntitussive Agents ANdo not use /analogs /biosyn /defic /physiol; consider also COUGH /drug ther MND23.338 FXÑCOUGH LH LX  PM65 HN65(63) MHÑAntivenins ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; coord IM with specific venom (IM or NIM); ther of snake bite: coord /ther use with SNAKE BITES /ther, not /drug ther MND24.310.121.163; D24.611.125.272.138 FXÑVenoms LH LX  MHÑAntiviral Agents ANdo not use /analogs /biosyn /defic /physiol; consider also VIRUSES /drug eff & VIRUS DISEASES /drug ther or pertinent specifics; do not confuse with VIRUS INHIBITORS (substances found in normal serum, body fluids, etc.) MND20.388 LH  OLsearch HORNS 1968-74 HN(75) MHÑAntlers MNA13.507.288 DMÑHorns LH LM  MHÑAnts AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 MNB1.131.617.479.205 LH  MSAn order of the class Amphibia, which includes several families of frogs and toads. They are characterized by well developed hind limbs adapted for jumping, fused head and trunk and webbed toes. The term ╥toad╥ is ambiguous and is properly applied only to the family Bufonidae. OLuse ANURA to search FROGS & TOADS back thru 1966 PM81; FROGS & TOADS were headings 1964-80 HN81; FROGS & TOADS were headings 1964-80 MHÑAnura ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAmphibia (66-80) MNB2.90.180 XSBombina; Frogs and Toads; Salientia; Toad, Fire-Bellied; Toads and Frogs LH LS; ; ; ;  MHÑAnuria MNC12.777.419.78 FXÑKidney Failure, Acute; ÑUrine XUÑOliguria LH LX; LU  MHÑAnus ANatresia or imperforate = ANUS, IMPERFORATE; inflammation = PROCTITIS; anal fistula = RECTAL FISTULA, not FISSURE IN ANO; anal canal goes here; do not confuse with anal gland in animals MNA3.492.411.495.767.288 XSAnal Sphincter LH LS  PM66 HN66 MHÑAnus Diseases ANinflamm dis = PROCTITIS; anal fistula = RECTAL FISTULA, not FISSURE IN ANO MNC6.405.469.860.101 LH  MHÑAnus Neoplasms ANdo not confuse with ANAL GLAND NEOPLASMS (in animals only); /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.476.411.792.288; C6.405.469.860.101.163 LH  PM66 HN66(64) MHÑAnus, Imperforate ANdo not use /congen; = anal atresia MNC16.131.314.94 LH  MSPersistent feeling of dread, apprehension, and impending disaster. MHÑAnxiety ANhuman & animal; do not use /drug eff /physiol /rad eff; note Cat Fl: differentiate from ANXIETY DISORDERS, Cat F3, a psychiatric diag MNF1.470.132; F3.126.56.100 LH  MSDisorders in which anxiety (persistent feelings of apprehension, tension, or uneasiness) is the predominant disturbance. OLuse ANXIETY DISORDERS to search NEUROSES, ANXIETY back thru 1966 PM81; was NEUROSES, ANXIETY 1963-80 HN81; was NEUROSES, ANXIETY 1963-80 MHÑAnxiety Disorders ANdo not use /drug eff /physiol /rad eff MNF3.709.438.180 XSAnxiety Neuroses; Anxiety States, Neurotic; Neuroses, Anxiety LH LS; ;  MSAnxiety due to fantasied injuries to or loss of the genitals. PM70 HN70(65) MHÑAnxiety, Castration ANdo not use /drug eff /physiol /rad eff MNF3.709.438.180.80 XSCASTRATION COMPLEX LH LS  MSAnxiety experienced by an individual upon separation from a person or object of particular significance to him. OLto search HOMESICKNESS use ANXIETY, SEPARATION back thru 1975 & EMOTIONS 1966-74 PM68; HOMESICKNESS was see under EMOTIONS 1963-74 HN68; HOMESICKNESS was see under ANXIETY, SEPARATION 1975-78, was see under EMOTIONS 1963-74 MHÑAnxiety, Separation ANdo not use /drug eff /physiol /rad eff PIAnxiety (66-67); Child Behavior Disorders (66-67); Child Psychology (66-67) MNF3.234.80; F3.709.438.180.110 XSHomesickness LH LS  MSThe main trunk of the systemic arteries. MHÑAorta AN/radiogr = AORTOGRAPHY; do not use /blood supply; /surg: consider also AORTOCORONARY BYPASS; inflammation = AORTITIS but note also AORTITIS, SYPHILITIC see SYPHILIS, CARDIOVASCULAR MNA7.231.114.56 XSAorta, Ascending LH LS  MSThe aorta from the diaphragm to the bifurcation into the right and left common iliac arteries. MHÑAorta, Abdominal ANdo not use /blood supply; coord NIM with aortic dis terms (IM) MNA7.231.114.56.205 LH  MSThe portion of the descending aorta proceeding from the arch of the aorta and extending to the diaphragm. MHÑAorta, Thoracic ANdo not use /blood supply; coord NIM with aortic dis terms (IM) MNA7.231.114.56.372 XSAorta, Descending; Aortic Arch LH LS;  MSAneurysm of the aorta. MHÑAortic Aneurysm ANlocate as AORTA, ABDOMINAL & AORTA, THORACIC (NIM); ruptured aneurysm: index under AORTIC RUPTURE only; for dissecting aneurysm of aorta coord IM with ANEURYSM, DISSECTING (IM) MNC14.907.55.239; C14.907.109.139 LH  PM65; TAKAYASU SYNDROME was see under AORTIC DISEASES 1963-64 HN65 MHÑAortic Arch Syndromes MNC14.907.109.239 XSAortitis Syndrome; PULSELESS DISEASE XUÑTakayasu Syndrome LH LS; LU  OLsearch PARAGANGLIA, NONCHROMAFFIN 1966-74 HN(75) MHÑAortic Bodies ANdo not use /innerv; do not confuse with PARA-AORTIC BODIES MNA8.99.651.164 DMÑParaganglia, Nonchromaffin LH LM  MSNarrowing of the lumen of the aorta, caused by deformity of the aortic media. MHÑAortic Coarctation ANdo not use /congen MNC14.280.400.90; C16.131.457.89 LH  MHÑAortic Diseases ANlocate as AORTA, ABDOMINAL or AORTA, THORACIC (NIM); inflamm dis = AORTITIS but note AORTITIS, SYPHILITIC see SYPHILIS, CARDIOVASCULAR MNC14.907.109 LH  MSTearing of aortic tissue. It may be rupture of an aneurysm or it may be due to trauma. MHÑAortic Rupture ANfor rupt aortic aneurysm (see C14 tree) but also for traum rupt of aorta; locate as AORTA, ABDOMINAL or AORTA, THORACIC (NIM) MNC14.907.109.139.289 LH  OLsearch CARDIOMYOPATHY, HYPERTROPHIC 1967-74 HN(75); was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85 MHÑAortic Subvalvular Stenosis MNC14.280.600.100.95 DMÑCardiomyopathy, Hypertrophic LH LM  MSThe valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. OLsearch AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966 PMAORTIC VALVE DISEASES was heading 1963-66 HNAORTIC VALVE DISEASES was heading 1963-66 MHÑAortic Valve ANdo not use /blood supply; atresia: index AORTIC VALVE /abnorm; stenosis = AORTIC VALVE STENOSIS; regurgitation, incompetence or insufficiency = AORTIC VALVE INSUFFICIENCY MNA7.541.510.110 LH  MSBackflow of blood from the aorta into the left ventricle, owing to imperfect functioning of the aortic semilunar valve. OLsearch AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966 PM67; AORTIC VALVE DISEASES was heading 1963-66 HN67; AORTIC VALVE DISEASES was heading 1963-66 MHÑAortic Valve Insufficiency ANimperfect closing of valve; /congen permitted PIHeart Valve Diseases (66) MNC14.280.484.95 XSAortic Incompetence; Aortic Valve Incompetence; REGURGITATION, AORTIC VALVE LH LS; ;  MSNarrowing of the aortic orifice of the heart or of the aorta itself. OLuse AORTIC VALVE STENOSIS to search AORTIC STENOSIS back thru 1966; search AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966 PM67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66 HN67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66 MHÑAortic Valve Stenosis AN/congen permitted; atresia = AORTIC VALVE /abnorm MNC14.280.484.150 XSAORTIC STENOSIS; Aortic Stenosis, Supravalvular; Discrete Subaortic Stenosis FXÑCardiomyopathy, Hypertrophic LH LS; ; LX  MSInflammation of the wall of the aorta. PM80 HN80 MHÑAortitis ANnote see refs below PIAortic Diseases (66-79); Arteritis (66-79) MNC14.907.109.320; C14.907.940.80 LH  PM73 HN73(72) MHÑAortocoronary Bypass ANdo not use /util except by MeSH definition PICoronary Disease/SU (66-71); Coronary Vessels/SU (66-71); Myocardial Infarct/SU (66-71) MNE4.752.376.719.289; E4.920.490.630.100 XSCORONARY ARTERY BYPASS FXÑCoronary Disease LH LS LX  PM66; was see under ANGIOGRAPHY 1963-65 HN66; was see under ANGIOGRAPHY 1963-65 MHÑAortography MNE1.145.77.181; E1.818.84.181 LH  MSA congenital anomaly in which there is abnormal communication between the ascending aorta and pulmonary artery just above the semilunar valves. HN(84) MHÑAortopulmonary Septal Defect ANdo not use /congen PIAorta/AB (66-83); Aorta, Thoracic/AB (66-83); Heart Defects, Congenital (66-83); Pulmonary Artery/AB (66-83) MNC14.280.400.560.98; C16.131.457.559.98 XSAorticopulmonary Septal Defect DMÑHeart Defects, Congenital LH LS LM  MSA genus of the family Cebidae with only one described species. It occurs in forested regions of Central and South America. Vocalizations occur primarily at night when they are active. OLuse AOTUS TRIVIRGATUS to search NIGHT MONKEYS back thru 1975 HN(81); was NIGHT MONKEYS see under MONKEYS 1975-80 MHÑAotus trivirgatus ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; DF: AOTUS MNB2.649.801.201.370.110 XSDouroucoulis; Monkey, Night; Monkey, Owl DMÑCebidae LH LS; ; LM  MSA highly neurotoxic polypeptide from the venom of the honey bee (Apis mellifera); it consists of 18 amino acids with two disulfide bridges and causes hyperexcitability resulting in convulsions and respiratory paralysis. HN(78) MHÑApamin ANdo not use /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; /analogs NIM only; do not confuse with drug Apamide ( = METHAMPHETAMINE) RN24345-16-2 PIBees (66-77); Venoms (66-77) MND24.185.965.65.115.60 DMÑBee Venoms LH LM  PM66 HN66(64) MHÑApatites ANdo not use /analogs /biosyn /defic /physiol MND1.552.539.288.475.89; D1.578.122; D1.696.620.603.325.164 LH  MS5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione. An anti-inflammatory agent used in the treatment of rheumatoid arthritis. HN(75) MHÑApazone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13539-59-8 PIDimethylamines (73-74); Malonates (73-74); Triazines (71-74) MND3.383.931.190; D14.73.278.172; D26.74.75.235 XSAzapropazone DMÑTriazines LH LS LM  MSA species of the C Group Bunyavirus genus from Brazil which produces fever, headache, and malaise. HN(75); was see under ARBOVIRUSES 1975-80 MHÑApeu Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with BUNYAVIRUS INFECTIONS (IM) MNB4.909.777.147.70 DMÑBunyaviridae LH LM  PM73 HN73(71) MHÑApgar Score ANno qualif PIInfant, Newborn (66-70); Physical Examination (66-70) MNE1.706.70 LH  MSAbsence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction when it is APHAKIA, POSTCATARACT. Mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION. PM78 HN78 MHÑAphakia ANabsence of lens from any cause (congen, inj, dis); /congen permitted; after cataract extract = APHAKIA, POSTCATARACT; ╥aphakic eye╙ is probably APHAKIA, POSTCATARACT; pseudophakia & pseudoaphakia: see note under LENS, CRYSTALLINE PILens, Crystalline (66-77) MNC11.510.103 FXÑLens, Crystalline LH LX  MSAbsence of the crystalline lens resulting from cataract extraction. PM78 HN78 MHÑAphakia, Postcataract AN╥aphakic eye╙ probably goes here unless truly congen ( = APHAKIA /congen); do not coord with CATARACT EXTRACTION unless particularly discussed PICataract Extraction (66-77); Lens, Crystalline (66-77) MNC11.510.103.110 FXÑCataract Extraction LH LX  MSGeneral term for all disturbances of language due to brain lesions but not a result of faulty innervation of the speech muscles, involvement of the organs of articulation, or general mental or intellectual deficiency. MHÑAphasia ANdo not use /drug eff /physiol /rad eff; ╥nominal aphasia╙ = ANOMIA MNC10.597.257.543.74; C10.597.257.870.74; C23.888.592.257.543.74; C23.888.592.257.870.74; F3.126.219.543.74; F3.126.219.870.74 XSDysphasia FXÑDominance, Cerebral XUÑAnomia; ÑAphasia, Acquired; ÑAphasia, Broca; ÑAphasia, Childhood; ÑAphasia, Wernicke LH LS LX LU; ; ; ;  MSAphasia resulting from a brain disease or injury. HN(80) MHÑAphasia, Acquired ANfrom brain dis or inj; do not use /drug eff /physiol /rad eff PIAphasia (66-79); Brain Injuries (66-79); Head Injuries (66-79) MNF3.126.219.543.74.70; F3.126.219.870.74.70 DMÑAphasia LH LM  MSLoss of ability of expression by written, spoken, manual and tactile speech symbols caused by damage in the motor cortex of the cortical association area for motor control of speech. HN(80) MHÑAphasia, Broca ANdo not use /drug eff /physiol /rad eff; subject understands language but cannot express it; note APHASIA, WERNICKE below PIAphasia (66-79) MNC10.597.257.543.74.73; C10.597.257.870.74.73; C23.888.592.257.543.74.73; C23.888.592.257.870.74.73; F3.126.219.543.74.73; F3.126.219.870.74.73 XSAgrammatism; Aphasia, Expressive; Aphasia, Motor; Aphasia, Nonfluent DMÑAphasia LH LS; ; ; LM  MSFailure to develop or extreme difficulty in using language and speech, in the absence of mental retardation, deafness or primary emotional disturbance. The main types are congenital, developmental and idiopathic acquired. HN(80) MHÑAphasia, Childhood ANGEN or unspecified aphasia only; for specific (Broca's, acquired, etc.) index only under the specific with CHILD tags; do not use /drug eff /physiol /rad eff; don't forget CHILD tags PIAphasia (66-79); specific age group MNF3.126.219.543.74.84; F3.126.219.870.74.84 DMÑAphasia LH LM  MSDifficulty in comprehension of written, spoken, manual and tactile speech symbols caused by damage of the temporoparietal cortex containing the sensory center for speech reception. HN(80) MHÑAphasia, Wernicke ANdo not use /drug eff /physiol /rad eff; subject does not understand language; note APHASIA, BROCA above PIAphasia (66-79) MNC10.597.257.543.74.90; C10.597.257.870.74.90; C23.888.592.257.543.74.90; C23.888.592.257.870.74.90; F3.126.219.543.74.90; F3.126.219.870.74.90 XSAphasia, Fluent; Aphasia, Receptive; Aphasia, Sensory DMÑAphasia LH LS; ; LM  MSSmall insects that suck the juices of plants; some genera are Asterochiton, Eriosoma, and Phylloxera. PM72 HN72 MHÑAphids AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 PIInsects (66-71) MNB1.131.617.412.165 XSLICE, PLANT; PLANT LICE LH LS;  HN(72) MHÑApholate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN52-46-0 PIAzirines (68-71); Chemosterilants (66-71) MND3.383.97.217.123; D5.723.141.140 DMÑAzirines LH LM  MSLoss of voice arising either from organic or psychic causes. OLsearch VOICE 1966-68 PM72; was see under VOICE 1963-71 HN72(69); was see under VOICE 1963-71 MHÑAphonia ANdo not use /drug eff /physiol /rad eff PIVoice (66-68) MNC9.400.940.160; C10.597.257.960.72; C23.888.592.257.960.72; F3.126.219.960.72 LH  MHÑAphorisms and Proverbs ANno qualif; includes fables & maxims; DF: APHORISMS MNK1.517.116 XSProverbs LH LS  MHÑAphrodisiacs AND25-26 qualif MND26.115 LH  PM65 HN65 MHÑApicoectomy ANdo not use /util except by MeSH definition MNE4.833.164; E6.397.102; E6.892.164 FXÑTooth Root LH LX  MSAn opisthobranch mollusc of the order Anaspidea; much used in studies of nervous system development on account of its large identifiable neurons. Aplysiatoxin and its derivatives are not biosynthesized by aplysia, but acquired by ingestion of Lyngbya (seaweed) species. PM78 HN78 MHÑAplysia AN/microbiol /parasitol permitted PIMollusca (66-77) MNB1.644.60 LH  MHÑApnea ANdo not confuse APNEA with other resp disord: use only when text uses APNEA; apnea neonatorum = APNEA + check tags INFANT, NEWBORN + HUMAN MNC8.618.85; C23.888.852.130 FXÑRespiration LH LX  MSLarge, branched, specialized sweat glands that empty into the upper portion of a hair follicle instead of directly onto the skin. OLsearch SWEAT GLANDS 1971-74 HN(75) MHÑApocrine Glands AN/secret: consider also SWEAT or SWEATING; TN 181 MNA1.835.858.206; A10.336.899.206 DMÑSweat Glands LH LM  OLsearch APOPROTEINS 1974 HN(75) MHÑApoenzymes ANIM; coord with specific enzyme (IM); do not use /analogs /defic /physiol MND12.776.70.290 DMÑApoproteins LH LM  OLsearch FERRITIN 1966-74 HN(75) MHÑApoferritin ANdo not use /defic /physiol RN9013-31-4 MND12.776.556.365.290 DMÑFerritin LH LM  MSThe protein components of lipoproteins which remain after the lipids to which the proteins are bound have been removed. They play an important role in lipid transport and metabolism. PM77 HN77 MHÑApolipoproteins ANdo not use /analogs PIApoproteins (72-76); Lipoproteins (66-76); specific lipoprotein (72-76) MND12.776.70.400 FXÑLipoproteins LH LX  MSLipoproteins found in human blood serum in the high density and very high density lipoprotein fraction (HDL, VHDL). They consist of several different polypeptides, the most important of which are apolipoprotein A-I and A-II. They maintain the structural integrity of the HDL particles and are activators of lecithin:cholesterol acyltransferase (LCAT). Atherosclerotic patients show low apolipoprotein A levels and these apolipoproteins are either absent or present in extremely low plasma concentration in Tangier disease. PM85 HN85 MHÑApolipoproteins A AN/biosyn /physiol permitted PIApolipoproteins (77-84) MND12.776.70.400.200 XSApo A; Apolipoprotein A LH LS;  MSStructural proteins of chylomicrons, VLDL and LDL. They are important in the secretion and transport of these lipoproteins and represent the binding proteins for the LDL receptor pathway. Atherosclerotic patients show high levels of Apo B in the blood while in the case of abetalipoproteinemia they are not detectable in serum. PM85 HN85 MHÑApolipoproteins B AN/biosyn /physiol permitted PIApolipoproteins (77-84) MND12.776.70.400.300 XSApo B; Apolipoprotein B LH LS;  MSLipoproteins located on the surface of VLDL. They are transferred to HDL throughout the catabolism of VLDL and affect lipoprotein lipase activity. A genetic lack of Apo C-II results in hyperglyceridemia and low levels of HDL. Another form of hyperglyceridemia with normal Apo C-II levels is caused by a high concentration of Apo C-III in VLDL. PM85 HN85 MHÑApolipoproteins C AN/biosyn /physiol permitted PIApolipoproteins (77-84) MND12.776.70.400.400 XSApo C; Apolipoprotein C LH LS;  MSProminent protein constituents of plasma VLDL, chylomicrons and a subfraction of HDL as well as of remnant lipoproteins which are derived from the lipoprotein lipase-mediated intravascular catabolism of triglyceride-rich lipoproteins. Apolipoproteins E are recognized by the LDL receptor and Apo E receptor. Any defect in the Apo E metabolism leads to increased plasma Apo E levels. A strong association has been found between high levels of Apo E and type III hyperlipoproteinemia. PM85 HN85 MHÑApolipoproteins E AN/biosyn /physiol permitted PIApolipoproteins (77-84) MND12.776.70.400.500 XSApo E; Apolipoprotein E LH LS;  OLto search APOMORPHINE DERIVATIVES use APOMORPHINE /AA back thru 1975 & APOMORPHINE 1969-74 PMAPOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77 HNAPOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77 MHÑApomorphine ANdo not use /biosyn /defic /physiol; apomorphine derivatives = APOMORPHINE /analogs RN58-00-4 MND3.132.70.290; D3.549.95.290; D23.555.206 LH  PM74 HN74(72) MHÑApoproteins ANdo not use /analogs PIEnzymes (66-71); Proteins (66-71); specific enzyme or protein MND12.776.70 XUÑApoenzymes LH LU  PM69 HN69 MHÑAporphines ANdo not use /analogs /biosyn /defic /physiol PIApomorphine (66-68) MND3.132.70; D3.549.95 XUÑBulbocapnine; ÑThalicarpine LH LU;  MSThe geographic area Appalachian Region in general and when the specific state or states are not indicated. Usually includes Kentucky, Pennsylvania, Tennessee, and West Virginia. HN75 MHÑAppalachian Region ANincludes northeast Ala, northwest Ga, northwest S Carolina, western N Carolina, eastern Ky, eastern Tenn, western Va, West Virginia, western Md, southwest Pa, south Ohio, south NY; specify as needed but use APPALACHIAN REGION when text uses the term CATALOG: use for 3 or more areas MNZ1.107.567.875.66 LH  MHÑAppendectomy ANdo not use /util except by MeSH definition MNE4.765.78 LH  MHÑAppendiceal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.476.411.184.290; C6.405.469.110.417.290 LH  MSAcute inflammation of the vermiform appendix. MHÑAppendicitis MNC6.405.469.110.207 LH  MHÑAppendix AN/surg: probably APPENDECTOMY; diseases: coord IM with CECAL DISEASES (NIM); inflammation = APPENDICITIS; epiploica goes under COLON & its inflamm goes under COLITIS MNA3.492.411.495.209.290 LH  MSNatural recurring desire for food. MHÑAppetite ANonly /drug eff /physiol /rad eff; /drug eff: consider also APPETITE DEPRESSANTS MNF2.830.71; G10.261.82 LH  MHÑAppetite Depressants AND25-26 qualif; consider also APPETITE /drug eff & OBESITY /drug ther MND26.128 XSANORECTICS FXÑObesity LH LS LX  MHÑAppetite Disorders MNC23.888.102; F3.126.72 XSEating Disorders FXÑANOREXIA NERVOSA XUÑAnorexia; ÑHyperphagia LH LS LX LU;  PM72 HN72(66) MHÑAppetite Regulation ANonly /drug eff /rad eff MNG10.261.82.290 LH  MSThe variable introductory phase of an instinctive behavior pattern or sequence, e.g., looking for food, or as in sequential courtship patterns prior to mating. PM68 HN68 MHÑAppetitive Behavior ANusually animal; nothing to do with APPETITE, the desire for food; only /drug eff /physiol /rad eff PIBehavior (66-67) MNF1.145.113.111 FXÑCEREMONIAL XUÑPredatory Behavior LH LX LU  MSThe different methods of scheduling patient visits, appointment systems, individual or group appointments, waiting times, waiting lists for hospitals, walk-in clinics, etc. PM68 HN68 MHÑAppointments and Schedules ANno qualif; DF: APPOINTMENTS PIOutpatient Clinics, Hospital (66-67) MNN4.452.95 XSPatient Appointments; Patient Schedules; Schedules, Patient XUÑWaiting Lists LH LS; ; LU  MSNeurological disorder characterized by the inability to perform purposeful movements although no muscular paralysis or sensory disturbance is present. MHÑApraxia ANdo not use /congen /drug eff /physiol /rad eff MNC10.597.123; C23.888.592.123; F3.126.720.103 LH  MSN-[3-(Diethylamino)propyl]N-phenyl-2-indamine. Cardiac depressant used in arrhythmias. Synonym: Ac 1802. HN(75) MHÑAprindine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN37640-71-4 PIAniline Compounds (74); Diethylamines (74); Indenes (73-75) MND4.615.486.487.60; D18.97.86 DMÑIndenes LH LM  PM74 HN74(72) MHÑAprocarb ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN114-26-1 PICarbamates (66-71); Insecticides (66-71) MND2.241.81.251.93; D5.723.491.408.207 XSPropoxur LH LS  MHÑAPT AND25-26 qualif RN7072-40-4 MND26.763.291 XSAMINOPROPYLISOTHIURONIUM COMPOUNDS LH LS  MSThe ability to acquire general or special types of knowledge or skill. OLuse APTITUDE to search TALENT back thru 1966 HNTALENT was see under APTITUDE 1963-78 MHÑAptitude ANonly /drug eff MNF2.784.629.131 XSABILITY; Talent LH LS;  MSPrimarily non-verbal tests designed to predict an individual's future learning ability or performance. MHÑAptitude Tests ANno qualif MNF4.711.141 FXÑEDUCATIONAL MEASUREMENT LH LX  MSCells derived from primitive cell types in the neural crest. During ontogeny they migrate to the foregut and specific locations of the neuroendocrine system. Properly located these cells form part of the normal hormone producing tissues of the neuroendocrine system. If misdirected these cells may become hyperplastic, adenomatous, or malignant. PM78 HN78 MHÑApud Cells ANnamed APUD from Amine Precursor Uptake & Decarboxylation; A 11 qualif; ╥endocrine cells╙ in Russian literature probably goes here MNA11.70 LH  MSA general term collectively applied to tumors associated with the apud cell series irrespective of their specific identification. PM78 HN78 MHÑApudoma ANfor derivation of word see note on APUD above; /anal /blood supply /secret /ultrastruct permitted; coord IM with organ /neopl term (IM) MNC4.70 LH  MSHydrolysate of DNA in which purine bases have been removed. HN(75) MHÑApurinic Acid AN/analogs NIM only RN11002-22-5 PIPolynucleotides (72-75); Pyrimidine Nucleotides (74) MND13.695.578.500.50; D13.695.740.50; D13.695.578.550.50 DMÑPolynucleotides LH LM  MSATP diphosphohydrolase. A calcium-activated enzyme which catalyzes the hydrolysis of ATP to yield AMP and orthophosphate. Also acts on ADP and other nucleoside triphosphates and diphosphates. HN(76) MHÑApyrase ANdo not use /analogs RNEC 3.6.1.5 PIAdenosine Triphosphate (74-75); Phosphatases (74-75) MND8.586.277.352.630.140 XSADPase; ATP Diphosphatase; Adenosine Diphosphatase DMÑPhosphatases LH LS; ; LM  MHÑAqueous Humor ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA9.371.60.67.70; A12.207.86 LH  MHÑArabia ANa historical term; do not confuse with SAUDI ARABIA; Manual 36.13 MNZ1.252.245.93; Z1.630.100 LH  MS9-(5-0-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine. Adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of vidarabine with antiviral and possbly antineoplastic properties. HN(79) MHÑArabinofuranosyladenine Monophosphate ANdo not use biosyn /defic /physiol; /analogs NIM only; DF: ARA AMP RN29984-33-6 PIAdenine Nucleotides (66-70); Adenosine Monophosphate (71-78); Vidarabine (75-78) MND13.695.65.50; D13.695.667.138.250; D20.388.975.50; D26.87.975.50 XSAdenine Arabinoside Monophosphate; Ara-AMP; Arabinosyladenine Monophosphate; Vidarabine Monophosphate DMÑArabinonucleotides LH LS; ; ; LM  MS4-Amino-1-(5-0-(hydroxy((hydroxy(phosphonooxy)phosphinyl) oxy)phosphinyl)-beta-D-arabinofuranosyl)-2(1H)-pyrimidinone. A triphosphate nucleotide analog of cytarabine, which is the biologically active form of cytarabine. Inhibits nuclear DNA synthesis. HN(79) MHÑArabinofuranosylcytosine Triphosphate ANdo not use /biosyn /defic /physiol; /analogs NIM only; DF: ARA CTP RN13191-15-6 PICytarabine (66-78) MND13.695.65.200; D13.695.740.246.50 XSAra-CTP; Arabinosylcytosine Triphosphate; Cytarabine Triphosphate; Cytosine Arabinoside Triphosphate DMÑArabinonucleotides LH LS; ; ; LM  MS1-beta-D-Arabinofuranosyluracil. A pyrimidine nucleoside formed in the body by the deamination of cytarabine. Synonym: NSC 68928. HN(76); 1976-77 was see under PYRIMIDINE NUCLEOSIDES MHÑArabinofuranosyluracil RN3083-77-0 PIArabinose (72-74) /AA (75); Nucleosides (72-74); Uracil (72-74); Uridine/AA (75) MND13.570.65.90; D13.570.685.852.150 XSAra-U; Arabinosyluracil; Arauridine; Sponguridine; Uracil Arabinofuranoside; Uracil Arabinoside DMÑUridine LH LS; ; ; ; ; LM  MSNucleosides containing arabinose as their sugar moiety. PM79 HN79 MHÑArabinonucleosides ANdo not use /analogs PINucleosides (66-78); specific nucleoside MND13.570.65 XSArabinofuranosylnucleosides LH LS  MSNucleotides containing arabinose as their sugar moiety. PM79 HN79 MHÑArabinonucleotides ANdo not use /analogs PINucleotides (66-78); specific nucleotide MND13.695.65 XSArabinofuranosylnucleotides XUÑArabinofuranosyladenine Monophosphate; ÑArabinofuranosylcytosine Triphosphate LH LS LU;  MHÑArabinose RN147-81-9 MND9.203.546.627.166 LH  MS9-(beta-D-Arabinofuranosyl)-9H-purine-6-thiol. Synonym: NSC 406,021. HN(75) MHÑArabinosyl-6-mercaptopurine ANdo not use /biosyn /defic /physiol RN892-49-9 PIArabinose (72-74); 6-Mercaptopurine (72-74); Purine Nucleosides (74) MND2.886.489.534.50; D3.438.759.534.50; D13.570.65.100; D13.570.583.185 DMÑ6-Mercaptopurine LH LM  MSThese enzymes catalyze the oxidation of arachidonic acid to hydroperoxyarachidonates (HPETES). These products are rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids (HETES). The positional specificity of the enzyme varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- . PM87 HN87 MHÑArachidonate Lipoxygenases ANdo not use /analogs RNEC 1.13.11.- PILipoxygenases (74-86); Oxygenases (66-73) MND8.586.682.690.433.50 XUÑArachidonate 12-Lipoxygenase; ÑArachidonate 15-Lipoxygenase; ÑArachidonate 5-Lipoxygenase LH LU; ;  MSThis enzyme catalyzes the oxidation of arachidonic acid to yield 12-hydroperoxyarachidonate (12-HPETE) which is rapidly converted by a peroxidase to 12-hydroxy-5,8,10,14-eicosatetraenoate (12-HETE). The 12-hydroperoxides are preferentially formed in platelets. EC 1.13.11.31. HN(87) MHÑArachidonate 12-Lipoxygenase ANdo not use /analogs RNEC 1.13.11.31 PILipoxygenases (74-86); Oxygenases (66-73) MND8.586.682.690.433.50.60 XS12-Lipoxygenase DMÑArachidonate Lipoxygenases LH LS LM  MSThis enzyme catalyzes the oxidation of arachidonic acid to yield 15-hydroperoxyarachidonate (15-HPETE) which is rapidly converted to 15-hydroxy-5,8,11,13-eicosatetraenoate (15-HETE). The 15-hydroperoxides are preferentially formed in neutrophils and lymphocytes. EC 1.13.11.33. HN(87) MHÑArachidonate 15-Lipoxygenase ANdo not use /analogs RNEC 1.13.11.33 PILipoxygenases (74-86); Oxygenases (66-73) MND8.586.682.690.433.50.65 XS15-Lipoxygenase DMÑArachidonate Lipoxygenases LH LS LM  MSThis enzyme catalyzes the oxidation of arachidonic acid to yield 5-hydroperoxyarachidonate (5-HPETE) which is rapidly converted by a peroxidase to 5-hydroxy-6,8,11,14-eicosatetraenoate (5-HETE). The 5-hydroperoxides are preferentially formed in leukocytes. EC 1.13.11.34. HN(87) MHÑArachidonate 5-Lipoxygenase ANdo not use /analogs RNEC 1.13.11.34 PILipoxygenases (74-86); Oxygenases (66-73) MND8.586.682.690.433.50.55 XS5-Lipoxygenase DMÑArachidonate Lipoxygenases LH LS LM  OLto search ARACHIDONIC ACID use ARACHIDONIC ACIDS back thru 1967 & FATTY ACIDS, ESSENTIAL 1966 PM75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66 HN75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66 MHÑArachidonic Acids ANdo not use /analogs PIFatty Acids, Essential (66) MND2.241.81.436.103; D10.516.251.265.166; D10.516.251.355.96 XSEicosatetraenoic Acids LH LS  MSMembers of the class Arachnida, especially spiders, scorpions, mites and ticks, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host. PM74 HN74(71) MHÑArachnid Vectors ANfor ticks & mites; specify if possible; in the rickettsial-tick-dog relationship, the tick is the arachnid vector, not the dog PIArthropod Vectors (66-70) MNB1.371.294.207 LH  MHÑArachnida ANIM; /microbiol /parasitol permitted MNB1.131.166 LH  MHÑArachnidism ANincludes scorpion stings but add SCORPIONS (NIM) MNC21.613.127.141 XSSPIDER BITE LH LS  MHÑArachnoid ANdo not use /innerv; inflammation = ARACHNOIDITIS MNA8.186.566.166 LH  PM67 HN67 MHÑArachnoiditis PIBrain Diseases (66); Meningitis (66) MNC10.228.228.507.97 FXÑArnold-Chiari Deformity LH LX  MS11 alpha-15(R or S)-Dihydroxy-15-methyl-9-oxo- prosta-5,13-dien-1-oic acid or methyl ester. This synthetic prostaglandin E analog or its methyl ester protects the gastric mucosa, prevents ulceration and promotes healing of peptic ulcers. The protective effect is independent of acid inhibition. The compounds are also potent inhibitors of pancreatic function and inhibit the growth of experimental tumors. Synonym: U 42842. HN(80) MHÑArbaprostil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN55028-70-1 PIProstaglandins (66-74); Prostaglandins E (75-77); Prostaglandins E, Synthetic (78-79); Prostaglandins, Synthetic (77) MND2.241.81.436.687.700.30; D10.516.251.355.708.700.30; D19.316.203.69; D24.185.798.575.750.600.69 XS15-Methylprostaglandin E2; 15-Methylprostaglandin E2 Methyl Ester; Methyldinoprostone DMÑProstaglandins E, Synthetic LH LS; ; LM  MSInfections caused by arthropod-borne viruses, general or unspecified. PM65; was ARBORVIRUS INFECTIONS 1963-64 HN65; was ARBORVIRUS INFECTIONS 1963-64 MHÑArbovirus Infections ANGEN; consider also 2 major groups, BUNYAVIRUS INFECTIONS & TOGAVIRUS INFECTIONS or specifics MNC2.81 LH  MSArthropod-borne viruses. Most arboviruses fall into the family Togaviridae, which includes two genera of arboviruses: the group A arboviruses, called Alphaviruses, and the group B arboviruses, called Flaviviruses. Many of the Bunyaviridae are also arboviruses with small numbers existing in other virus families. OLuse ARBOVIRUSES to search ARBOVIRUS back thru 1966 PM75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64 HN75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64 MHÑArboviruses ANGEN: consider also 2 major groups, BUNYAVIRIDAE & TOGAVIRIDAE; from ARthropod-BOrne; do not use /blood-csf-urine /cytol MNB4.909.80 XSArthropod-Borne Viruses LH LS  OLsearch PLANTS, MEDICINAL 1966-74 HN(75); was see under UVA URSI 1963-75 MHÑArbutin ANdo not use /defic /physiol; /analogs NIM only RN497-76-7 MND9.203.408.348.75 DMÑGlycosides LH LM  MSA proposed group of organisms phylogenetically distinct from the eubacteria. They are characterized by 1) the presence of characteristic tRNAs and ribosomal RNAs, 2) the absence of peptidoglycan cell walls, 3) the presence of ether-linked lipids built from branched-chain subunits, and 4) their occurrence in unusual habitats. The group encompasses three distinct subgroups: the METHANOGENS, the extreme halophiles (HALOBACTERIACEAE, HALOBACTERIUM), and the extreme thermoacidophiles (THERMOPLASMA and Sulfobolus). HN(81) MHÑArchaebacteria ANdo not use /blood-csf-urine PIBacteria (66-80) MNB3.107 DMÑBacteria LH LM  MSThe scientific study of past societies through artifacts, fossils, etc. MHÑArchaeology ANIM; no qualif; pre-Columbian: nothing later MNI1.76.201.208 FXÑPALEOGRAPHY LH LX  MSDesigns for approaching areas inside or outside facilities. HN(Aug 77) MHÑArchitectural Accessibility ANonly /econ /stand PIArchitecture (66-Jul 77) MNJ1.86.339.70 XSBarriers, Architectural; Facility Access; Ramps DMÑFacility Design and Construction LH LS; ; LM  MHÑArchitecture ANIM; only /hist /stand MNJ1.86 FXÑHEALTH FACILITY PLANNING LH LX  MHÑArchives ANno qualif; for ╥medical archives╙ do not coord with MEDICINE MNK1.419.152; L1.346.208 LH  MHÑArctic Regions MNZ1.208 LH  MSA nucleus located in the middle hypothalamus in the most ventral part of the third ventricle near the entrance of the infundibular recess. Its small cells are in close contact with the ependyma. PM83 HN83 MHÑArcuate Nucleus ANin the HYPOTHALAMUS, MIDDLE; do not use /innerv PIHypothalamus (66-82) MNA8.186.211.385.357.352.81 XSInfundibular Nucleus LH LS  HN(64) MHÑArcus Senilis MNC11.204.104 DMÑEye Diseases LH LM  MSEducation centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act. HN(75) MHÑArea Health Education Centers ANdo not use /educ /methods; DF: AHEC MNI2.783.660.125 DMÑSchools, Health Occupations LH LM  MSA small genus of East Indian palms (Palmae) whose leaves and nuts yield ARECOLINE; used as masticatory, stimulant, and astringent in folk medicine. HN(86)63 MHÑAreca ANdo not use /isol /pathogen MNB6.560.77 XSBETEL DMÑPlants, Medicinal LH LS LM  MSMethyl 1,2,5,6-tetrahydro-1-methylnicotinate. A cholinergic alkaloid and ganglionic stimulant obtained from the betel nut (Areca catechu), fruit of a palm tree; used in the form of various salts as parasympathomimetic and vermifuge, especially in veterinary practice; as euphoriant in the Pacific islands. Synonyms: Anthelin; Cestarsol; Nemural; Tenoban. OLsearch NICOTINIC ACID 1969-71 & PARASYMPATHOMIMETICS 1966-68 PM73; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68 HN73(72); was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68 MHÑArecoline AN do not use /biosyn /defic /physiol RN63-75-2 PINicotinic Acids (69-72); Parasympatholytics (66-68) MND3.66.515.292; D3.132.80; D3.383.725.547.292; D16.698.167 XSArecholin; Methylarecaidin LH LS;  MSRNA viruses about 100 millimicrons in diameter, named for their sandy appearance. OLuse ARENAVIRIDAE to search ARENAVIRUSES back thru 1978 PM81; was ARENAVIRUSES 1978-80; HEMORRHAGIC FEVER VIRUSES, AMERICAN was see under RNA VIRUSES 1977, was HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, was HEMORRHAGIC FEVER VIRUS see under ARBOVIRUS 1973-74; LASSA VIRUS was see under RNA VIRUSES 1972-77 HN81; was ARENAVIRUSES 1978-80 MHÑArenaviridae ANseen in texts also as Areno-; from Latin arenosus, sandy, from granular appearance; do not use /blood-csf-urine /cytol; infection = ARENAVIRUS INFECTIONS PIRNA Viruses (66-77) MNB4.909.777.80 XUÑHemorrhagic Fever Viruses, American; ÑLassa Virus LH LU;  MSVirus diseases caused by the Arenaviridae. PM81 HN81 MHÑArenavirus Infections PIArenaviridae (78-80); Virus Diseases (66-80) MNC2.782.82 LH  MHÑArgentina MNZ1.107.757.77 LH  MHÑArginase ANdo not use /analogs; /defic: consider also ARGININE /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 3.5.3.1 MND8.586.277.913.292 LH  MHÑArginine AN/biosyn /defic /physiol permitted RN7004-12-8 MND12.125.95.104; D12.125.142.87 XUÑArgininosuccinic Acid; ÑBenzoylarginine Nitroanilide; ÑBenzoylarginine-2-Naphthylamide; ÑHomoarginine; ÑTosylarginine Methyl Ester LH LU; ; ; ;  MSPeptidyl-L-arginine hydrolase. Removes C-terminal arginine from peptides and proteins. Inactivates bradykinin by this action. OLuse ARGININE CARBOXYPEPTIDASE to search KININASE I back thru 1973 (as Prov 1973-74) HN(75); KININASE I was see under CARBOXYPEPTIDASE 1975-81, was Prov 1973-74 MHÑArginine Carboxypeptidase AN do not use /analogs RNEC 3.4.17.3 PIArginine (72-74); Carboxypeptidases (72-74); Peptides (72-74) MND8.586.277.656.245.70 XSCarboxypeptidase N; Kininase I DMÑCarboxypeptidases LH LS; LM  MSATP:L-arginine N(omega)-phosphotransferase. Catalyzes the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. EC 2.7.3.3. HN(79) MHÑArginine Kinase ANdo not use /analogs RNEC 2.7.3.3 PIArginine (66-78); Phosphotransferases (66-73); Phosphotransferases, ATP (74-78) MND8.586.913.696.729.55 DMÑPhosphotransferases, ATP LH LM  MSL-Argininosuccinate arginine-lyase. An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease argininosuccinic acidemia in man. HN(75) MHÑArgininosuccinate Lyase ANdo not use /analogs; /defic: consider also ARGININOSUCCINIC ACID /urine (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 4.3.2.1 PIArginine (73-74); Lyases (73-74); Succinates (73-74) MND8.586.520.190 XSArgininosuccinase DMÑLyases LH LS LM  MSL-Citrulline:L-aspartate ligase (AMP-forming). Catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. An enzyme of the urea cycle. Absence or defect yields the metabolic disease citrullinemia in man. HN(75) MHÑArgininosuccinate Synthetase AN do not use /analogs; /defic: consider also CITRULLINE /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 6.3.4.5 PIArginine (73-74); Ligases (73-74); Succinates (73-74) MND8.586.464.155 DMÑLigases LH LM  MSN-[(4-Amino-4-carboxybutyl)amidino]-L-aspartic acid. This amino acid is present in unusually large amounts in the blood, urine and cerebrospinal fluid of individuals suffering from argininosuccinic aciduria. It is also formed during the urea cycle from citrulline, aspartate and ATP. This reaction is catalyzed by argininosuccinic acid synthetase. HN(76) MHÑArgininosuccinic Acid RN2387-71-5 PIArginine (71-74) /AA (75); Succinates (71-75) MND2.241.81.337.817.75; D12.125.95.104.75 DMÑArginine LH LM  MSL-Arginine:tRNA-Arg ligase (AMP-forming). Activates arginine with its specific transfer RNA. HN(75) MHÑArginyl T RNA Synthetase AN do not use /analogs RNEC 6.1.1.19 PIAmino Acyl T RNA Synthetases (73-74); Arginine (73-74) MND8.586.464.136.60 DMÑAmino Acyl T RNA Synthetases LH LM  MSCys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly, with disulfide at Cys. The usual mammalian antidiuretic hormone, a cyclic octapeptide with arginine in position 8 of the chain; obtained from bovine posterior pituitary; used to treat diabetes insipidus and as hemostatic due to its vasoconstrictor action. OLuse ARGIPRESSIN to search ARGININE VASOPRESSIN back thru 1975 PM79; was ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78 HN79; was ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78 MHÑArgipressin AN /biosyn /physiol permitted RN113-79-1 PIArginine (66-74); Vasopressins (66-74) MND6.472.734.692.781.100; D12.644.456.925.100; D12.776.641.650.900.50; D19.770.896.36 XSArginine Vasopressin; Vasopressin, Arginine LH LS;  MHÑArgon ANAr-40; do not use /analogs /biosyn /defic /physiol; Ar-36, 38 = ARGON (IM) + ISOTOPES (NIM); Ar-35, 37, 39, 41, 42 = ARGON (IM) + RADIOISOTOPES (IM) RN7440-37-1 MND1.268.60; D1.362.641.113 LH  MHÑArgyria ANdo not use /chem ind MNC17.621.166; C21.613.68 LH  MHÑArizona MNZ1.107.567.875.76 LH  MHÑArkansas MNZ1.107.567.875.85 LH  MHÑArm ANprimates only; for whole arm or upper arm (FOREARM is available); for bone use HUMERUS; /inj = ARM INJURIES; TN 117: extremities of humans & animals; NIM when merely locational as in skin dis (IM) MNA1.378.209 XSExtremity, Upper; Upper Extremity FXÑForelimb LH LS; LX  OL╥arm bones╙ is indexed ARM, FOREARM or the specific arm bones MH*Arm Bones (Non Mesh) MNA2.835.232.87 LH  MHÑArm Injuries ANGEN or unspecified; consider also /inj with specific bones of arm; also available are FOREARM INJURIES, HAND INJURIES, FINGER INJURIES, WRIST INJURIES & many specific organ/fract precoords MNC21.866.88 LH  MSBurrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates; widely distributed in the warmer parts of the Americas. HN(75) MHÑArmadillos ANIM; when IM only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.314.100 DMÑEdentata LH LM  MHÑArmenia ANa historical term; do not confuse with ARMENIAN S.S.R. MNZ1.252.245.99 LH  OLuse ARMENIAN S.S.R. to search ARMENIAN SSR back thru 1975 HN82; was ARMENIAN SSR 1975-81 MHÑArmenian S.S.R. MNZ1.252.878.930.100; Z1.950.930.100 LH  MSEthyl-p-nitrophenyl ethylphosphonate. An organophosphorus reversible cholinesterase inhibitor; also affects presynaptic membrane and inhibits postsynaptic membrane cholinoreceptors. Previously used as a miotic. HN(79) MHÑArmin ANdo not use /biosyn /defic /physiol; /analogs NIM only PICholinesterase Inhibitors (66-78); Nitrobenzenes (66-78); Organophosphorus Compounds (71-78) MND2.705.65; D8.373.275.100; D16.698.410.85 DMÑOrganophosphorus Compounds LH LM  MHÑArnold-Chiari Deformity ANdo not use /congen MNC16.131.666.680.291 FXÑARACHNOIDITIS; ÑPLATYBASIA LH LX;  MSIndustrial chemicals which have become widespread environmental pollutants. Each aroclor is a mixture of chlorinated biphenyls (1200 series) or chlorinated terphenyls (5400 series) or a combination of both (4400 series). OLsearch POLYCHLOROBIPHENYL COMPOUNDS 1973-74 HN(75) MHÑAroclors ANdo not use /analogs /biosyn /defic /physiol; TN 111: eff on insects MND2.455.526.439.773.292; D2.455.526.439.785.292; D5.284.125 DMÑPolychlorobiphenyl Compounds LH LM  MSAn enzyme from human placenta which converts androgens to estrogens by desaturating ring A of the steroid. PM86; was see under OXIDOREDUCTASES 1975-85 HN86(75); was see under OXIDOREDUCTASES 1975-85 MHÑAromatase ANdo not use /analogs RNEC 1.- PIAndrostanes (72-74); Estrogens (72-74); Oxidoreductases (72-74) MND8.586.682.170 LH  MSAromatic-L-amino acid carboxy-lyases. An enzyme group with broad specificity. Decarboxylates a range of aromatic amino acids including dopa, tryptophan and hydroxytryptophan. EC 4.1.1.28. PM80; DOPA DECARBOXYLASE was heading 1963-79 HN80 MHÑAromatic Amino Acid Decarboxylases ANdo not use /analogs; DF: AAAD RNEC 4.1.1.28 PIDopa Decarboxylase (66-79) MND8.586.520.258.90 XSAmino Acid Decarboxylases, Aromatic XUÑDopa Decarboxylase LH LS LU  MSCortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system. PM66 HN66(64) MHÑArousal ANhuman & animal; only /drug eff /physiol /rad eff MNF2.830.104; G11.561.65 XSVigilance, Cortical LH LS  MHÑArrhenoblastoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS (IM) MNC4.557.576.136 LH  MSAny variation from the normal rhythm of the heart beat. MHÑArrhythmia ANGEN: prefer specifics; /drug ther: consider also ANTI-ARRHYTHMIA AGENTS MNC14.280.67 FXÑHeart Conduction System XUÑAsystole; ÑLong QT Syndrome LH LX LU;  MSIrregularity of the heart rate related to functioning of the sinoatrial node. MHÑArrhythmia, Sinus MNC14.280.67.93 XSSINUS ARRHYTHMIA LH LS  MS(4-Aminophenyl)-arsonic acid monosodium salt. An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals. HN(79) MHÑArsanilic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only PIArsenicals (66-78) MND2.691.88.30 XSAtoxyl DMÑArsenicals LH LS LM  MS([(p-Carbamoylphenyl)arsylene]dithio)diacetic acid. Proposed chemotherapeutic agent against filaria and trichomonas. Synonyms: Caparside; Caparsolate. HN(75) MHÑArsenamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN531-72-6 PIArsenicals (69-74); Benzamides (73-74); Sulfides (73-74) MND2.691.88.40; D21.201.287.278.40 XSThiacetarsamide; Thioarsenite DMÑArsenicals LH LS; LM  OLsearch ARSENIC 1968-74 HN(75) MHÑArsenates ANdo not use /analogs /biosyn /defic /physiol MND1.81.209 DMÑArsenic LH LM  MS2,7-Bis-(arsonophenylazo)- 1,8-dihydroxynaphthalene-3,6-disulfonic acid. Metallochrome indicator that changes color when complexed to the calcium ion under physiological conditions; used to measure local calcium ion concentrations in vivo. HN(80) MHÑArsenazo III ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1668-00-4 PIArsenicals (66-79); Azo Compounds (66-79); Dyes (66-79); Indicators and Reagents (66-79) MND2.172.40; D2.691.88.44; D26.408.82; D26.550.35 DMÑAzo Compounds LH LM  MHÑArsenic ANAs-75; do not use /analogs /biosyn /defic /physiol; As-69-81, except As-75 = ARSENIC (IM) + RADIOISOTOPES (IM) RN7440-38-2 MND1.81; D1.268.67 XUÑArsenates LH LU  MHÑArsenicals ANdo not use /analogs /biosyn /defic /physiol MND2.691.88; D8.373.830.126 XUÑArsanilic Acid; ÑArsenamide; ÑCacodylic Acid; ÑMelarsoprol; ÑRoxarsone LH LU; ; ; ;  OLuse ARSPHENAMINE to search ARSPHENAMINES back thru 1966 PM68; was ARSPHENAMINES 1963-67 HN68; was ARSPHENAMINES 1963-67 MHÑArsphenamine ANdo not use /biosyn /defic /physiol RN139-93-5 MND2.691.88.50; D20.288.293 LH  MHÑArt ANonly /hist; consider also MEDICINE IN ART, MEDICAL ILLUSTRATION & ANATOMY, ARTISTIC; note heading below MNK1.93 XUÑPaintings; ÑSculpture LH LU;  MSThe use of art as an adjunctive therapy in the treatment of neurological, mental or behavioral disorders. PM74 HN74 MHÑArt Therapy ANSPEC qualif MNE2.831.100; F4.754.70 LH  MSA genus of crustaceans of the order Anostraca found in briny pools and lakes and often cultured for fish food. It has 168 chromosomes and differs from most crustaceans in that its blood contains hemoglobin. PM79 HN79 MHÑArtemia ANused in genet & hematol studies; /microbiol /parasitol permitted PICrustacea (66-78); Shrimp (72-78) MNB1.131.365.60 XSBrine Shrimp LH LS  MSUse for material on arterial occlusive disease in general or for which there is no specific heading. PM73 HN73 MHÑArterial Occlusive Diseases ANIM for general or specific artery occlusion (as POPLITEAL ARTERY (IM) + ARTERIAL OCCLUSIVE DISEASES (IM) or CAROTID ARTERY DISEASES (IM) + ARTERIAL OCCLUSIVE DISEASES (IM) ); TN 11: obliterative arterial dis PIVascular Diseases (66-72) MNC14.907.137 XSArterial Obstructive Diseases XUÑFibromuscular Dysplasia; ÑMoyamoya Disease LH LS LU;  MSThe vessels carrying blood away from the heart. MHÑArteries ANIM GEN only; NIM as coord to indicate specific artery, as ╥pancreatic artery╙ = PANCREAS /blood supply (IM) + ARTERIES (NIM); do not use /blood supply; /radiogr = ARTERIOGRAPHY; /surg: consider also ENDARTERECTOMY; inflammation = ARTERITIS; arterial blood: index only if significant & coord BLOOD (NIM) + ARTERIES or specific artery (NIM); arterial pressure = BLOOD PRESSURE (IM) only: specify specific artery only if pertinent MNA7.231.114 XUÑArterioles LH LU  MSAbnormal communication between two arteries; it may result from injury or occur as a congenital abnormality. PM87 HN87 MHÑArterio-Arterial Fistula AN/congen permitted; coord IM with specific arteries or precoord artery/dis term (IM) PIspecific arteries (66-86) MNC14.907.150; C16.131.110 FXÑFistula LH LX  MSThe smallest divisions of the arteries located between the muscular arteries and the capillaries. HN(78) MHÑArterioles ANIM GEN only; NIM as coord with specific organ /blood supply (IM); do not use /blood supply PIArteries (66-77); specific artery MNA7.231.114.60; A7.231.432.200 DMÑArteries LH LM  PMFATTY STREAK, ARTERIAL (now see ATHEROSCLEROSIS, an XU below) was heading 1973-83 MHÑArteriosclerosis ANCORONARY ARTERIOSCLEROSIS & CEREBRAL ARTERIOSCLEROSIS are also available; TN 11: relation to ╥obliterative arterial disease╙ MNC14.907.137.126 FXÑDIET, ATHEROGENIC XUÑAtherosclerosis LH LX LU  MSArteriosclerosis in which proliferation of the intima leads to occlusion of the lumen of the arteries. MHÑArteriosclerosis Obliterans ANTN 11: relation to other obliterative arterial dis MNC14.907.137.126.114 LH  MSA vessel that directly interconnects an artery and a vein, and that acts as a shunt to bypass the capillary bed. Not to be confused with surgical anastomosis, nor with arteriovenous fistula. PM66 HN66(64) MHÑArteriovenous Anastomosis ANdo not use /blood supply; note category: do not confuse with ARTERIOVENOUS FISTULA; Manual 23.25.4 MNA7.231.432.209 LH  MSAn abnormal communication between an artery and a vein. OLuse ARTERIOVENOUS FISTULA to search FISTULA, ARTERIOVENOUS back thru 1966 PM67; was FISTULA, ARTERIOVENOUS 1963-66 HN67; was FISTULA, ARTERIOVENOUS 1963-66 MHÑArteriovenous Fistula ANalso called ╥arteriovenous aneurysm╙; do not confuse with ARTERIOVENOUS ANASTOMOSIS (Cat A); coord IM with specific artery + specific vein (IM); Manual 23.25.2-23.25.4; /congen = ARTERIOVENOUS MALFORMATIONS; congen cerebral arteriovenous fistula = CEREBRAL ARTERIOVENOUS MALFORMATIONS; surgically created arteriovenous fistula = ARTERIOVENOUS SHUNT, SURGICAL MNC14.907.161 XSAneurysm, Arteriovenous FXÑARTERIOVENOUS MALFORMATIONS; ÑFistula LH LS LX;  PM73 HN73(69) MHÑArteriovenous Malformations ANdo not use /congen; coord IM with specific artery /abnorm (IM) + specific vein /abnorm (IM) or specific available precoord arterial or venous abnorm (IM); Manual 23.25.5 PIArteriovenous Fistula/CN (66-68) MNC16.131.150 XSARTERIOVENOUS ANEURYSM, CONGENITAL; Aneurysm, Arteriovenous, Congenital FXÑANGIOMATOSIS; ÑARTERIOVENOUS FISTULA; ÑAngiomatosis; ÑArteriovenous Fistula; ÑHEMANGIOMA LH LS; LX; ; ; ;  PM70 HN70 MHÑArteriovenous Shunt, Surgical ANdo not use /util except by MeSH definition; Manual 23.25.6 PIArteries/SU (66-69); ARTERIOVENOUS FISTULA MNE4.752.814.143 LH  MHÑArteritis MNC14.907.184; C14.907.940.90 LH  PMARTHRITIS, ADJUVANT was ADJUVANT ARTHRITIS see under ARTHRITIS, RHEUMATOID 1975-76 MHÑArthritis ANpolyarthritis goes here but polyarthrite chronique evolutive (PCE) = ARTHRITIS, RHEUMATOID; septic arthritis = ARTHRITIS, INFECTIOUS; tends to be chronic so do not coord with CHRONIC DISEASE; gouty arthritis: coord IM with GOUT (IM); psoriatic arthritis: coord IM with PSORIASIS (IM); degenerative arthritis = OSTEOARTHRITIS CATALOG: form qualif = RHEUMATOLOGY /form MNC5.550.114 XUÑArthritis, Adjuvant LH LU  MSAn arthritis experimentally induced in animals with Freund's adjuvant. OLuse ARTHRITIS, ADJUVANT to search ADJUVANT ARTHRITIS back thru 1975 HN(77); was ADJUVANT ARTHRITIS see under ARTHRITIS, RHEUMATOID 1975-76 MHÑArthritis, Adjuvant ANexper in animals PIArthritis, Rheumatoid (66-74); Arthritis (66-74) MNC5.550.114.15 XSAdjuvant Arthritis DMÑArthritis LH LS LM  MSArthritis caused by infectious agents. PM65 HN65 MHÑArthritis, Infectious ANcoord IM with specific infection (IM) & site (IM); septic arthritis goes here MNC1.539.100; C5.550.114.99 LH  MHÑArthritis, Juvenile Rheumatoid MNC5.550.114.154.114; C5.799.114.114; C20.111.199.114; C23.205.200.732.99.114 XSStill's Disease LH LS  MHÑArthritis, Rheumatoid ANin children = ARTHRITIS, JUVENILE RHEUMATOID; includes PCE: polyarthrite chronique evolutive; tends to be chronic so do not coord with CHRONIC DISEASE MNC5.550.114.154; C5.799.114; C20.111.199; C23.205.200.732.99 LH  MHÑArthrobacter ANin soil MNB3.100.200.143 LH  MHÑArthrodesis ANdo not use /util except by MeSH definition; vertebral or spinal arthrodesis = SPINAL FUSION MNE4.557.126 LH  MSRoentgenography of a joint, usually after injection of either positive or negative contrast medium. PM86 HN86 MHÑArthrography ANdo not use /util except by MeSH definition PIspecific joint/RA (67-85); Radiography (66-85) MNE1.818.93 LH  PM65 HN65(63) MHÑArthrogryposis ANdo not use /congen MNC5.550.150; C5.651.102; C16.131.621.77 XSARTHROMYODYSPLASIA, CONGENITAL; Amyoplasia Congenita; GUERIN-STERN SYNDROME; MYODYSTROPHIA FETALIS DEFORMANS LH LS; ; ;  MHÑArthropathy, Neurogenic MNC5.550.186 XSCHARCOT'S JOINT LH LS  MSSurgical reconstruction of a joint to relieve pain or restore motion. MHÑArthroplasty ANsurg reconstruct of a joint; total or partial joint replacement = JOINT PROSTHESIS or its specifics; joint revision = ARTHROPLASTY (IM) + REOPERATION (NIM); do not use /util except by MeSH definition MNE4.557.168 LH  MSArthropods, other than insects and arachnids, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host. PM64 HN64 MHÑArthropod Vectors ANthe vector is the arthropod carrying the organism, not the animal carrying the arthropod MNB1.371.294 LH  MSVenoms from animals of the phylum Arthropoda; those most investigated are from scorpions and spiders of class Arachnidae; and ant, bee and wasp families of the Insecta order Hymenoptera; the venoms contain protein toxins, enzymes, other bioactive substances and may be lethal to man. PM78 HN78 MHÑArthropod Venoms ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; coord IM with specific arachnid or insect (IM or NIM) but note available specifics: ANT VENOMS, BEE VENOMS, SCORPION VENOMS, SPIDER VENOMS & WASP VENOMS & their indentions PIArthropods (66-77); Venoms (66-77) MND24.185.965.65 XUÑAnt Venoms; ÑSpider Venoms LH LU;  MHÑArthropods AN/microbiol /parasitol permitted MNB1.131 LH  MSEndoscopic examination of the interior of a joint. PM82 HN82 MHÑArthroscopy ANNIM; do not use /util except by MeSH definition PIEndoscopy (66-81); Joint Diseases (66-81); Knee Injuries (66-81); Knee Joint (66-81); other joint heading MNE1.418.100 LH  MSA dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage and vascular necrosis. PM66 HN66(64) MHÑArthus Phenomenon MNC20.543.480.186 LH  MSDisorders of speech sound production characterized by substitution, omission and distortion of sounds. PM79 HN79 MHÑArticulation Disorders ANnote categories: ╥articulation╙ refers to speech, not to joints; do not use /drug eff /physiol /rad eff MNC10.597.257.870.80; C23.888.592.257.870.80; F3.126.219.870.80; F3.305.100 XSMisarticulation LH LS  MSThe study and implementation of technics and methods for designing computer systems to perform functions normally associated with human intelligence such as understanding language, learning, reasoning, problem solving, etc. PM86 HN86 MHÑArtificial Intelligence ANno qualif PIComputers (66-85) MNL1.700.568.110.65 XSComputer Reasoning; Computer Vision Systems; Knowledge Acquisition (Computer); Knowledge Bases (Computer); Knowledge Representation (Computer) XUÑNatural Language Processing LH LS; ; ; ; LU  MHÑArtificial Limbs ANonly /econ /hist /psychol /rehabil /stand /supply /vet; coord ARM or LEG (NIM) if pertinent MNE4.557.210; E4.659.94; E7.858.82.127; E7.858.442.127; E7.858.565.94 XSEXTREMITIES, ARTIFICIAL LH LS  MHÑArtificial Organs ANonly /econ /hist /psychol /stand /supply /vet; usually to replace function, as HEART, ARTIFICIAL or KIDNEY, ARTIFICIAL: do not confuse with PROSTHESIS which is usually cosmetic; not for injections, like silicones, to replace substance MNE7.858.82 LH  MHÑArtiodactyla ANGEN: prefer specifics; includes bison, giraffe, hippopotamus, peccary; IM, when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.77 XUÑAntelopes; ÑCamelids, New World LH LU;  MSHydroxylases which utilize reduced flavin or flavoprotein as one donor and incorporate one atom of oxygen. They act on many aromatic compounds. They are a component part of the mixed function oxidase system and are important for the oxidation of many drugs and toxins such as phenobarbital, carcinogens and insecticides. An aspect of EC 1.14.14.1. PM75; ANILINE HYDROXYLASE & BENZOPYRENE HYDROXYLASE were see under HYDROXYLASES 1975-76 HN75 MHÑAryl Hydrocarbon Hydroxylases ANdo not use /analogs RNEC 1.14.14.- PIHydroxylases (71-74); Polycyclic Hydrocarbons (74) MND8.586.682.420.80 XUÑAniline Hydroxylase; ÑBenzopyrene Hydroxylase LH LU;  PM74 HN74 MHÑAryl Sulfonates ANdo not use /analogs /biosyn /defic /physiol MND2.241.866.540.244; D2.886.610.244 LH  MSAcetyl-CoA:arylamine N-acetyltransferase. Enzymes which catalyze the transfer of acetyl groups from acetyl-CoA to arylamines. Has wide specificity for aromatic amines, particularly serotonin. Can also catalyze acetyl transfer between arylamines without CoA. EC 2.3.1.5. HN(80) MHÑArylamine Acetyltransferases ANdo not use /analogs RNEC 2.3.1.5 PIAcetyltransferases (73-79); Acyltransferases (66-72); Serotonin (66-74) /AA (75-79); specific amine MND8.586.913.50.134.80 XSArylamine Acetylases; Serotonin Acetyltransferase DMÑAcetyltransferases LH LS; LM  MSCatalyzes the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A,B and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy. HN(75) MHÑArylsulfatases ANdo not use /analogs RNEC 3.1.6.1 PIPhenols (73-74); Sulfatases (73-74) MND8.586.277.352.827.70 XSArylsulfate sulfohydrolases DMÑSulfatases LH LS LM  MSOne of a pair of small pyramidal cartilages that articulate with the lamina of the cricoid cartilage. The corresponding vocal ligament and several muscles are attached to it. HN(80) MHÑArytenoid Cartilage PILaryngeal Cartilages (66-79) MNA2.165.507.83; A4.329.591.85 DMÑLaryngeal Cartilages LH LM  MSFibrous incombustible minerals composed of magnesium and calcium silicates with or without other elements; relatively inert chemically; used in thermal insulation and fireproofing; inhalation of dust causes asbestosis and later lung and gastrointestinal neoplasms. Synonyms: amianthus; amosite; chrysotile; crocidolite. PM70 HN70(69) MHÑAsbestos ANdo not use /analogs /biosyn /defic /physiol; /adv eff: consider also ASBESTOSIS; disease coord with ASBESTOS /adv eff is dis /etiol, not dis /chem ind RN1332-21-4 PIMinerals (66-68) MND1.578.210; D26.191.81 FXÑSilicon LH LX  MHÑAsbestosis ANdo not use /chem ind; do not coord with OCCUPATIONAL DISEASES MNC8.381.655.115; C21.447.800.127 LH  MHÑAscariasis ANcaused by Ascaris, a nematode; do not confuse with ACARIASIS, mite infestation or ASCARIDIASIS, infection with ASCARIDIA MNC3.335.508.70 XUÑToxascariasis; ÑToxocariasis LH LU;  MSA genus of nematode worms; Ascaridia lineata is an important intestinal parasite of domestic fowl. PM72 HN72 MHÑAscaridia ANa genus of nematodes; do not use /blood-csf-urine; infection = ASCARIDIASIS (do not confuse with ASCARIASIS or ACARIASIS) PINematoda (66-71) MNB1.500.294.433.82 LH  MSInfection with nematodes of the genus Ascaridia. OLsearch ASCARIASIS 1968-74 HN(75); was see under ASCARIASIS 1968-78 MHÑAscaridiasis ANcaused by ASCARIDIA; do not confuse with ASCARIASIS (caused by ASCARIS) or ACARIASIS (caused by ACARI or ACARUS) MNC3.335.508.80 DMÑNematode Infections LH LM  MSA superfamily of polymyarian nematode worms. OLuse ASCARIDOIDEA to search ASCAROIDEA back thru 1975 PM86; was ASCAROIDEA 1975-85 HN86; was ASCAROIDEA 1975-85 MHÑAscaridoidea ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM); Anisakis goes here PINematoda (66-74) MNB1.500.294.433 LH  MHÑAscaris ANa genus of nematodes; do not confuse with ASCARIDIA, another genus, both belonging to the superfamily of ASCARIDOIDEA; do not confuse with ACARI (mites & ticks) or ACARUS (mites); do not use /blood-csf-urine; infection = ASCARIASIS MNB1.500.294.433.108 LH  MSAccumulation of free fluid within the peritoneal cavity. MHÑAscites ANdo not index here for routine liver cirrhosis or Ehrlich ascites tumor; text must discuss ascites especially; chylous ascites: index CHYLOPERITONEUM MNC23.91 LH  MSThe serous fluid which accumulates in the peritoneal cavity in ascites. OLuse ASCITIC FLUID to search PERITONEAL FLUID back thru 1968 PM68 HN68; was in Cat A 1968-83; PERITONEAL EFFUSION was PERITONEAL FLUID see under ASCITIC FLUID 1968-83 MHÑAscitic Fluid AN/anal /cytol /pathol permitted PIAscites (66-67) MNC23.91.127 XSPeritoneal Effusion FXÑExudates and Transudates LH LS LX  OLuse ASCOMYCETES to search ARTHRODERMA, COCHLIOBOLUS & SCLEROTINIA back thru 1975 PMMONOSPORIUM (M. APIOSPERMUM is see PSEUDALLESCHERIA, an XU below) was heading 1963-85 HNARTHRODERMA, COCHLIOBOLUS & SCLEROTINIA were see under ASCOMYCETES 1975-85 MHÑAscomycetes ANGEN: prefer specifics; do not use /anat /embryol /microbiol /parasitol MNB5.354.107 XSArthroderma; Cochliobolus; Sclerotinia XUÑChaetomium; ÑPseudallescheria; ÑSphaeriales LH LS; ; LU; ;  MSL-Ascorbate:oxygen oxidoreductase. Converts ascorbic acid to dehydroascorbic acid. HN(75) MHÑAscorbate Oxidase ANdo not use /analogs RNEC 1.10.3.3 PIAscorbic Acid (73-74); Oxidoreductases (73-74) MND8.586.682.180 XSAscorbase; Ascorbino Dehydrogenase DMÑOxidoreductases LH LS; LM  PM/therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965 HN/therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965 MHÑAscorbic Acid AN/defic = ASCORBIC ACID DEFICIENCY or SCURVY RN50-81-7 MND2.241.81.844.107; D2.241.511.902.107; D9.203.811.100; D11.786.100 XSVITAMIN C XUÑDehydroascorbic Acid LH LS LU  MHÑAscorbic Acid Deficiency ANconsider also SCURVY MNC18.654.223.133.115 LH  MSThe prevention of access of infecting organisms to the locus of potential infection. OLsearch ANTISEPSIS 1966-74 HN(75) MHÑAsepsis ANonly /hist /methods /stand; differentiate from ANTISEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion MNG3.850.180.150.170 DMÑAntisepsis LH LM  MHÑAsia ANeach Asiatic country is available as a term; note also geog subdiv below MNZ1.252 LH  MSArea of the USSR that includes Kirghiz S.S.R., Tadzhik S.S.R., Turkmen S.S.R., and Uzbek S.S.R. HN82 MHÑAsia, Central MNZ1.252.878.100; Z1.950.100 LH  MHÑAsia, Southeastern MNZ1.252.145 LH  MHÑAsia, Western ANMIDDLE EAST is also available MNZ1.252.245 LH  MSEndogenous glycoproteins from which sialic acid has been removed by the action of sialidases. They bind tightly to their cell surface receptor which is located on hepatocyte plasma membranes. After internalization by adsorptive endocytosis they are delivered to lysosomes for degradation. Therefore receptor-mediated clearance of asialoglycoproteins is an important aspect of the turnover of plasma glycoproteins. They are elevated in serum of patients with hepatic cirrhosis or hepatitis. PM85 HN85 MHÑAsialoglycoproteins AN/biosyn /physiol permitted; do not use /analogs PIGlycoproteins (66-84) MND12.776.395.140 LH  MSPersons living in the United States having origins in any of the original peoples of the Far East, Southeast Asia, the Pacific Islands, or the Indian subcontinent. PM81 HN81 MHÑAsian Americans ANUS residents of Asiatic culture or origin; Asian includes Far East, Southeast Asia, Pacific Islands & the Indian subcontinent; only /class /hist /psychol; despite X refs specify NIM CHINA /ethnol, JAPAN /ethnol or other Asiatic country with /ethnol when pertinent PIEthnic Groups (68-74); United States (66-80); specific state (66-80); specific Asia heading (66-74) /EH (75-80) MNI1.76.201.450.416.50; I1.880.143.522.50; M1.194.50 XSChinese Americans; Japanese Americans LH LS;  MS1,1-Diphenyl-3-piperidinobutan-1-ol. Nonspecific spasmolytic with a mechanism of action different from that of papaverine. HN(76) MHÑAspaminol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN17435-91-5 PIAlcohols, Butyl (74-75); Benzyl Compounds (74-75); Piperidines (74-75) MND3.383.621.75; D16.653.87 DMÑPiperidines LH LM  PM68 HN68 MHÑAsparaginase ANdo not use /analogs RNEC 3.5.1.1 PIAmidohydrolases (66-67) MND8.586.277.87.116; D22.204.222 LH  MHÑAsparagine AN/biosyn /physiol permitted RN7006-34-0 MND12.125.119.107 LH  MSL-Aspartate:ammonia ligase (AMP-forming). Catalyzes the formation of asparagine from ammonia and aspartic acid, in the presence of ATP. HN(75) MHÑAsparagine Synthetase ANdo not use /analogs RNEC 6.3.1.1 PIAmmonia (73-74); Aspartic Acid (73-74); Ligases (73-74) MND8.586.464.165 DMÑLigases LH LM  MS3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester. Flavoring agent sweeter than sugar, metabolized as phenylalanine and aspartic acid. Synonyms: AMP; Equa; NutraSweet; Tri-Sweet. HN(75) MHÑAspartame ANdo not use /biosyn /defic /physiol; /analogs NIM only RN22839-47-0 PIAspartic Acid (74); Dipeptides (74-75); Phenylalanine (74) MND9.818.100; D12.644.456.345.190; D26.456.609.100 XSAspartylphenylalanine Methyl Ester DMÑDipeptides LH LS LM  MHÑAspartate Aminotransferase AN/blood = SGOT /blood (not just SGOT); do not use /analogs RNEC 2.6.1.1 MND8.586.913.140.345 XSGLUTAMIC-OXALOACETIC TRANSAMINASE; SGOT LH LS;  MSCatalyzes the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms. HN(75) MHÑAspartate Ammonia-Lyase ANdo not use /analogs RNEC 4.3.1.1 PIAmmonia-Lyases (73-74); Aspartic Acid (73-74) MND8.586.520.161.80 XSAspartase; Fumaric Aminase DMÑAmmonia-Lyases LH LS; LM  PM73 HN73 MHÑAspartate Carbamoyltransferase ANdo not use /analogs RNEC 2.1.3.2 MND8.586.600.116; D8.586.913.197 XSAspartate Transcarbamylase LH LS  MSATP:L-aspartate 4-phosphotransferase. Catalyzes the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine. HN(75) MHÑAspartate Kinase ANdo not use /analogs RNEC 2.7.2.4 PIAspartic Acid (74); Phosphotransferases, ATP (74) MND8.586.913.696.729.65 XSAspartokinase DMÑPhosphotransferases, ATP LH LS LM  PM65 HN65 MHÑAspartate Semialdehyde Dehydrogenase ANdo not use /analogs RNEC 1.2.1.11 MND8.586.682.75.211 XSSEMIASPARTATE ALDEHYDE DEHYDROGENASE LH LS  MHÑAspartic Acid AN/biosyn /physiol permitted RN56-84-8 MND12.125.119.170 XUÑPotassium Magnesium Aspartate LH LU  MSAn enzyme complex consisting of aspartokinase, EC 2.7.2.4, and homoserine dehydrogenase, EC 1.1.1.3. The complex has been isolated from E. coli and consists of four identical subunits with a molecular weight of 85,000. The enzyme complex is involved in the biosynthesis of amino acids of the aspartate family. HN(76) MHÑAspartokinase Homoserine Dehydrogenase ANdo not use /analogs PIAlcohol Oxidoreductases (73-75); Aspartic Acid (73-75); Homoserine (73-75); Multienzyme Complexes (73-75); Phosphotransferases, ATP (74-75) MND8.586.600.130; D8.586.682.47.370.60; D8.586.913.696.729.65.60 DMÑMultienzyme Complexes LH LM  MSL-Aspartate:tRNA-Asp ligase (AMP-forming). Activates aspartic acid with its specific transfer RNA. HN(75) MHÑAspartyl T RNA Synthetase ANdo not use /analogs RNEC 6.1.1.12 PIAmino Acyl T RNA Synthetases (73-74); Aspartic Acid (73-74) MND8.586.464.136.80 DMÑAmino Acyl T RNA Synthetases LH LM  MS1-L-beta-Aspartamido-2-acetamido-1,2-dideoxy-beta-D-glucose amidohydrolase. Catalyzes the release of aspartic acid from aspartyl-N-acetylglucosamine. HN(75) MHÑAspartylglucosylaminase ANdo not use /analogs RNEC 3.5.1.26 PIAmidohydrolases (70-74); Aspartic Acid (70-74); Glucosamine (70-74) MND8.586.277.87.125 XSAspartylglucosaminidase; Aspartylglucosylamine Deaspartylase; Aspartylglycosamine Amidohydrolase DMÑAmidohydrolases LH LS; ; LM  MHÑAspergillosis ANspecify species (NIM) if pertinent; coord IM with precoord organ/dis term (IM) but note entry below: LUNG DISEASES, FUNGAL (IM) permitted as coord for non-allergic pulm aspergillosis MNC1.703.78 LH  MSAspergillosis of the lung occurring in an individual with long-standing bronchial asthma. It is characterized by pulmonary infiltrates, eosinophilia, elevated serum IgE and immediate type skin reactivity to aspergillus antigen. PM79 HN79 MHÑAspergillosis, Allergic Bronchopulmonary ANdo not coord with BRONCHIAL DISEASES nor with LUNG DISEASES, FUNGAL: see note above; DF: BRONCHOPULM ASPERG PIAspergillosis (66-78); Lung Diseases, Fungal (66-78); Respiratory Hypersensitivity (66-78) MNC1.703.78.74; C8.381.472.90; C8.674.60; C8.730.435.90; C20.543.480.680.85 XSAllergic Bronchopulmonary Aspergillosis; Bronchopulmonary Aspergillosis LH LS;  MSA genus of fungi of the family Moniliaceae. MHÑAspergillus ANGEN; do not use /anat /embryol /microbiol /parasitol; infection = ASPERGILLOSIS MNB5.354.381.546.81 XUÑAspergillus ochraceus; ÑAspergillus oryzae LH LU;  MSA species of imperfect fungus which grows on peanuts and other plants and produces the carcinogenic substance aflatoxin; it is also used in the production of the antibiotic Flavicin. PM74 HN74(72) MHÑAspergillus Flavus ANproduces aflatoxin; do not use /anat /embryol /microbiol /parasitol PIAspergillus (66-71) MNB5.354.381.546.81.170 FXÑAflatoxins LH LX  MSA species of imperfect fungi from which the antibiotic Fumigatin is obtained; its spores may cause respiratory infection in birds and mammals. PM74 HN74(72) MHÑAspergillus Fumigatus ANdo not use /anat /embryol /microbiol /parasitol; infection: coord NIM with ASPERGILLOSIS (IM) PIAspergillus (66-71) MNB5.354.381.546.81.295 LH  MSA species of imperfect fungi from which the antibiotic Nidulin is obtained. PM74 HN74(72) MHÑAspergillus Nidulans ANdo not use /anat /embryol /microbiol /parasitol; infection: coord NIM with ASPERGILLOSIS (IM) PIAspergillus (66-71) MNB5.354.381.546.81.420 LH  MSA fungus causing smut or black mold of several fruits, vegetables, etc. PM78; was see under ASPERGILLUS 1975-77 HN78(75); was see under ASPERGILLUS 1975-77 MHÑAspergillus niger ANfruit & vegetable mold; do not use /anat /embryol /microbiol /parasitol PIAspergillus (66-74) MNB5.354.381.546.81.450 LH  MSA deuteromycetous fungal species that produces ochratoxins and contaminates cereals and coffee beans. HN(86) MHÑAspergillus ochraceus ANdo not use /anat /embryol /microbiol /parasitol; produces ochratoxins PIAspergillus (66-85) MNB5.354.381.546.81.480 DMÑAspergillus LH LM  MSFungus present on most agricultural seeds and often responsible for the spoilage of seeds in bulk storage; also used in the production of fermented food or drink, especially in Japan. HN(75) MHÑAspergillus oryzae ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.81.500 DMÑAspergillus LH LM  MHÑAsphyxia ANin newborn inf = ASPHYXIA NEONATORUM + tag INFANT, NEWBORN; choking: use AIRWAY OBSTRUCTION MNC21.866.103; C23.240.95 XSSUFFOCATION LH LS  MHÑAsphyxia Neonatorum ANdo not use /congen; tag INFANT, NEWBORN MNC16.614.92 FXÑFetal Anoxia LH LX  HN(66) MHÑAspiration ANno qualif; note categ & read definition; differentiate from ASPIRATION, MECHANICAL & DRAINAGE MNG9.772.521.145 DMÑRespiration LH LM  MSStrong desires to accomplish something; usually pertaining to greater values or high ideals. PM75 HN75 MHÑAspirations (Psychology) ANno qualif; DF: ASPIRATIONS PIMotivation (66-74) MNF1.658.100; F2.784.629.155 LH  PM65; was ACETYLSALICYLIC ACID 1963-64 HN65; was ACETYLSALICYLIC ACID 1963-64 MHÑAspirin ANdo not use /biosyn /defic /physiol RN50-78-2 MND2.241.223.106.505.700.75; D2.241.511.390.700.75; D2.755.410.700.75; D14.73.278.861.212; D26.74.75.832.63 XSACETYLSALICYLIC ACID LH LS  MSStrongly insistent, self-assured, and demanding behavior. PM80 HN80 MHÑAssertiveness ANno qualif; assertiveness training: coord IM with BEHAVIOR THERAPY (IM) PIAggression (66-79) MNF1.145.40 LH  PM67 HN67 MHÑAssisted Circulation ANdo not use /util except by MeSH definition; do not confuse with EXTRACORPOREAL CIRCULATION or its specifics PIHeart, Mechanical (66) MNE4.50 XUÑHeart-Assist Devices LH LU  MSA functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established. PM66 HN66(65) MHÑAssociation ANno qualif MNF2.463.425.69; F4.754.919.346 FXÑWORD ASSOCIATION TESTS LH LX  MSThe principle that items experienced together enter into a connection, so that one tends to reinstate the other. OLsearch LEARNING 1966-74 HN(75) MHÑAssociation Learning ANonly /drug eff /physiol /rad eff MNF2.463.425.69.296 DMÑLearning LH LM  MHÑAstatine ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-68-8 MND1.248.497.158.75; D1.287.110; D1.396.129 LH  MHÑAsthenia ANNEUROCIRCULATORY ASTHENIA also exists MNC23.888.139 FXÑNEURASTHENIA LH LX  OLuse ASTHENOPIA to search EYESTRAIN back thru 1966 PMEYESTRAIN was heading 1963-67 HNEYESTRAIN was heading 1963-67 MHÑAsthenopia MNC11.83 XSEYESTRAIN LH LS  MSA form of bronchial disorder associated with airway obstruction, marked by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi. MHÑAsthma ANdo not coord with BRONCHIAL DIS for ASTHMA, BRONCHIAL (see X refs below) MNC8.127.108; C8.381.495.108; C8.674.95; C20.543.480.680.95 XSAsthma, Bronchial; Bronchial Asthma XUÑAsthma, Exercise-Induced; ÑStatus Asthmaticus LH LS; LU;  MSAsthma attacks following a period of exercise. HN(79) MHÑAsthma, Exercise-Induced PIAsthma (66-78); Bronchial Spasm (66-78); Exertion (66-78) MNC8.127.108.110 XSBronchospasm, Exercise-Induced; Exercise-Induced Asthma; Exercise-Induced Bronchospasm DMÑAsthma LH LS; ; LM  MHÑAstigmatism MNC11.744.212 LH  MHÑAstringents AND25-26 qualif MND26.368.233 XSAntiperspirants LH LS  OLsearch NEUROGLIA 1966-74 PM79; was see under NEUROGLIA 1963-78 HN79(75); was see under NEUROGLIA 1963-78 MHÑAstrocytes ANA 11 qualif only & /class PINeuroglia (66-74) MNA11.671.603.213 LH  MHÑAstrocytoma AN= grade I & II; grade III & IV = GLIOBLASTOMA MULTIFORME; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.329.171 LH  MHÑAstrology ANno qualif MNK1.672.296 LH  MHÑAstronomy ANonly /hist /educ /instrum MNH1.91 LH  MSSmall (approximately 28nm diameter) circular viruses sometimes showing a star-shaped surface configuration, found in stools of vertebrates with infantile gastroenteritis. Their relationship to other viruses is as yet undetermined. HN(79) MHÑAstroviruses ANnamed for its star shape; do not use /blood-csf-urine /cytol; infection: coord NIM with VIRUS DISEASES (IM) PIDiarrhea, Infantile (75-78); Vertebrate Viruses (75-78); Vertebrate Viruses, Unclassified (75-78) MNB4.909.920.120 DMÑVertebrate Viruses, Unclassified LH LM  OLsearch ARRHYTHMIA 1968-74 HN(75) MHÑAsystole MNC14.280.67.146 DMÑArrhythmia LH LM  MHÑAtaxia ANenzootic = SWAYBACK; /familial: consider also SPINOCEREBELLAR DEGENERATIONS MNC10.597.559.77; C23.888.592.574.84 LH  MSA syndrome characterized by choreoathetosis beginning in childhood, progressive cerebellar ataxia, telangiectasis of conjunctiva and skin, slowly progressive mental deterioration and increasing cerebellar degeneration. PM68 HN68 MHÑAtaxia Telangiectasia PIAtaxia (66-67) MNC10.228.140.252.253.871.171; C14.907.823.213; C20.673.290 XSLOUIS-BAR SYNDROME LH LS  MHÑAtelectasis AN= lung collapse, any part of the lung MNC8.381.69 LH  MS4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl acetamide hydrochloride. A cardioselective beta-adrenergic receptor blockader possessing properties and potency similar to propranolol, but without a negative inotropic effect. OLuse ATENOLOL to search ICI 66082 back thru 1975 PM84; was see under PROPANOLAMINES 1978-83, was ICI 66082 see under PROPANOLAMINES 1975-77 HN84(78); was see under PROPANOLAMINES 1978-83, was ICI 66082 see under PROPANOLAMINES 1975-77 MHÑAtenolol ANdo not use /biosyn /defic /physiol RN29122-68-7 PIAcetamides (74); Phenyl Ethers (74); Propanolamines (74) MND2.33.329.624.85; D2.92.63.624.85; D16.848.215.113 XSICI 66082 LH LS  MSA common form of arteriosclerosis characterized by deposits of plaques (atheromas) containing lipids, carbohydrates, blood and blood products, fibrous tissue, and calcium deposits. These plaques are found in the intima of large and medium-sized arteries. OLsearch ARTERIOSCLEROSIS 1966-74; use ARTERIOSCLEROSIS to search ATHEROMA back thru 1970 (as Prov 1970-74) & FATTY STREAK, ARTERIAL back thru 1966 (as Prov 1966-72) HN(75); ATHEROMA (Prov 1970-74) was see under ARTERIOSCLEROSIS 1970-83; FATTY STREAK, ARTERIAL was heading 1964-83 (Prov 1964-72) MHÑAtherosclerosis MNC14.907.137.126.259 XSAtheroma; Fatty Streak, Arterial DMÑArteriosclerosis LH LS; LM  MHÑAthetosis ANchoreoathetosis = CHOREA (IM) + ATHETOSIS (IM) MNC10.597.559.108; C23.888.592.574.122 LH  MSInjuries incurred during participation in competitive or non-competitive sports. PM68 HN68 MHÑAthletic Injuries ANcoord IM with specific sport (IM) + specific inj (IM); Manual 30.31: relation to SPORTS MEDICINE; consider also TENNIS ELBOW but see note there PISport Medicine (66-67); Sports (66-67) MNC21.866.115 FXÑSports; ÑSports Medicine LH LX;  MHÑAtlantic Islands MNZ1.295 LH  HN87 MHÑAtlantic Ocean MNZ1.756.92 LH  MSThe joint involving the atlas and axis bones. PM83 HN83 MHÑAtlanto-Axial Joint ANany Cat A qualif PIAtlas (66-82); Axis (66-82) MNA2.835.583.97 LH  MHÑAtlanto-Occipital Joint ANany Cat A qualif MNA2.835.583.101 XSATLOIDO-OCCIPITAL JOINT LH LS  MHÑAtlas ANa bone; do not confuse with ATLASES: see note below MNA2.835.232.834.151.213 LH  MHÑAtlases ANa cataloging term; do not confuse with ATLAS, a bone; use for geographic atlases only: anatomical atlases go under MEDICAL ILLUSTRATION (IM) + ANATOMY, ARTISTIC (IM) MNL1.178.682.192.836.147 LH  PM74 HN74(72) MHÑAtmosphere ANno qualif PIAir (66-71); Extraterrestrial Environment (66-71) MNG3.230.300.100 LH  PM73 HN73 MHÑAtmosphere Exposure Chambers ANdo not use /educ /instrum /man /methods /mortal /nurs /psychol /rehabil /trends MNE7.79 XSCHAMBERS, ATMOSPHERE EXPOSURE FXÑEnvironment, Controlled LH LS LX  MSThe pressure at any point in an atmosphere due solely to the weight of the atmospheric gases above the point concerned. MHÑAtmospheric Pressure ANno qualif; consider also ALTITUDE MNG3.230.300.100.185 FXÑANOXIA; ÑBarotrauma; ÑDECOMPRESSION SICKNESS; ÑHYPERBARIC OXYGENATION; ÑPressure XUÑAir Pressure; ÑVacuum LH LX; ; ; ; LU;  MSATP:citrate oxaloacetate-lyase. In the presence of ATP and CoA, this enzyme catalyzes the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP and orthophosphate. This reaction represents an important step in fatty acid biosynthesis. EC 4.1.3.8. PM77; was see under KETOACID-LYASES 1975-76 HN77(73); was see under KETOACID-LYASES 1975-76 MHÑATP Citrate Lyase ANdo not use /analogs RNEC 4.1.3.8 PILyases (66-72) MND8.586.520.567.213 XSCitrate Cleavage Enzyme LH LS  MS1-(5'-Phosphoribosyl)-ATP:pyrophosphate phosphoribosyltransferase. Catalyzes the first step of the pathway for histidine biosynthesis in Salmonella typhimurium. Molecular weight approximately 215,000. ATP reacts reversibly with 5-phosphoribosyl 1-pyrophosphate to yield N-1-(5'-phosphoribosyl)-ATP and pyrophosphate. HN(76) MHÑATP Phosphoribosyltransferase ANdo not use /analogs RNEC 2.4.2.17 PIAdenosine Triphosphate (72-75); Pentosephosphates (71-75); Pentosyltransferases (71-75); Pyrophosphoric Acids (71-75) MND8.586.913.647.125 XSPhosphoribosyl ATP Pyrophosphorylase DMÑPentosyltransferases LH LS LM  MSCatalyzes reversibly the transfer of a pyrophosphate group from ATP to the 3'-OH group of GDP or GTP with the formation of guanosine 3'-diphosphate 5'-diphosphate or guanosine 3'-diphosphate 5'-triphosphate and AMP. The enzyme, also called stringent factor, is located in the re1A gene in stringent strains of bacteria. The above synthesis is induced by mRNA and uncharged tRNA which is bound to the aminoacyl-t-RNA binding site of the ribosome by a codon-specific association. EC 2.7.6.-. HN(80) MHÑATP-Guanosine Phosphate Pyrophosphotransferase ANdo not use /analogs RNEC 2.7.6.- PIAdenosine Triphosphate (66-79); Bacterial Proteins (66-79); Guanine Nucleotides (66-79); Phosphotransferases (66-73); Phosphotransferases, ATP (74-79); Pyrophosphates (66-79); Ribosomal Proteins (75-79) MND8.586.913.696.729.75 XSStringent Factor DMÑPhosphotransferases, ATP LH LS LM  MS15 alpha-Hydroxy-2-[[2-O-)3-methyl-1-oxobutyl)-3,4-di-O-sulfo-alpha-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid dipotassium salt. A toxic glycoside from Atractylis gummifera which inhibits the transfer of ADP and ATP across the mitochondrial membrane by a specific carrier. Also inhibits oxidative phosphorylation of externally added ADP in isolated mitochondria. HN(75) MHÑAtractyloside AN/analogs NIM only RN17754-44-8 PIGlycosides (68-75); Phenanthrenes (73-74) MND9.203.408.105 XSAtractylic Acid DMÑGlycosides LH LS LM  MS2-(2-Carboxyethyl)-1,2,3,4-tetrahydro- 6,7-dimethoxy-2-methyl-1-veratrylisoquinoline pentamethylene ester. A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate, currently available non-depolarizing neuromuscular blocking agents. It can be used in patients with myasthenia gravis, dystrophia myotonica, cardiovascular, and hepatic diseases. PM87 HN87 MHÑAtracurium ANdo not use /biosyn /defic /physiol RN64228-79-1 PIIsoquinolines (66-86) MND3.438.531.70; D17.563.367.85 XSAtracurium Besylate; Atracurium Dibesylate LH LS;  PM74 HN74(72) MHÑAtrazine ANdo not use /biosyn /defic /physiol RN1912-24-9 PIHerbicides (66-71); Triazines (66-71) MND3.383.931.247; D5.723.366.477.213 LH  MSDisorder of cardiac rhythm characterized by rapid, irregular atrial impulses and ineffective atrial contractions. OLuse ATRIAL FIBRILLATION to search AURICULAR FIBRILLATION back thru 1966 PM84; was AURICULAR FIBRILLATION 1963-83 HN84; was AURICULAR FIBRILLATION 1963-83 MHÑAtrial Fibrillation ANdo not confuse with ATRIAL FLUTTER MNC14.280.67.198 XSAuricular Fibrillation LH LS  MSRapid, irregular atrial contractions due to an abnormality of atrial excitation. OLuse ATRIAL FLUTTER to search AURICULAR FLUTTER back thru 1966 PM84; was AURICULAR FLUTTER 1963-83 HN84; was AURICULAR FLUTTER 1963-83 MHÑAtrial Flutter ANdo not confuse with ATRIAL FIBRILLATION MNC14.280.67.248 XSAuricular Flutter LH LS  MSA small nodular mass of specialized muscle fibers located in the interatrial septum near the opening of the coronary sinus; it gives rise to the atrioventricular bundle of the conduction; system of the heart. OLsearch HEART CONDUCTION SYSTEM 1966-74 HN(75) MHÑAtrioventricular Node ANdo not use /blood supply /innerv MNA7.541.409.147 DMÑHeart Conduction System LH LM  MHÑAtrophy ANNIM; coord with organ/pathol (IM) MNC23.739.102 LH  MS8-Methyl-8-azabicyclo(3,2,1)oct-3-yl-ester of endo-alpha-(hydroxymethyl)benzeneacetic acid. A toxic alkaloid, originally from Atropa belladonna, but found in other plants, mainly Solanaceae; used as anticholinergic, especially antimuscarinic, agent for relaxation of smooth muscle, to increase heart rate or to dilate the pupil; available in many different forms. Synonyms: genatropine; methylatropine, tropine tropate; Metropine; Ekomine; Eumydrin; Tropinox; Atropisol; Enuretol; X-trol. OLto search HYOSCYAMINE use ATROPINE back thru 1975 & BELLADONNA 1966-74 PMHYOSCYAMINE was see under BELLADONNA 1963-75 HNHYOSCYAMINE was see under BELLADONNA 1963-75 MHÑAtropine ANdo not use /biosyn /defic /physiol; /analogs = ATROPINE DERIVATIVES RN51-55-8 MND3.132.760.180.297; D3.132.889.180.297; D3.605.869.189; D16.653.865.62 XSHyoscyamine LH LS  MSAnalogs and derivatives of atropine. OLsearch TROPANES 1969-74 PM78; was see under ATROPINE 1975-77, was see under TROPANES 1969-74; N-ISOPROPYLATROPINE was see under ATROPINE 1975-77 HN78(75); was see under ATROPINE 1975-77, was see under TROPANES 1969-74 MHÑAtropine Derivatives ANdo not use /analogs /biosyn /defic /physiol PIAtropine (66-74); Tropanes (66-74) MND3.132.889.180.297.297; D3.605.869.189.297 XUÑN-Isopropylatropine LH LU  MSParticular loci in both bacterial and phage DNA molecules at which phage DNA is integrated into the bacterial DNA by recombination between these sites. HN(80) MHÑAttachment Sites (Microbiology) ANonly /drug eff /rad eff; DF: ATT SITES PIColiphages (66-79); DNA, Viral (66-79); Lysogeny (68-79); Recombination, Genetic (68-79) MNG4.185.515.591.68; G5.386.521.68 DMÑLysogeny LH LM  MSFocusing on certain aspects of current experience to the exclusion of others; the act of heeding or taking notice or concentrating. MHÑAttention ANonly /drug eff /physiol /rad eff MNF2.830.104.214 XSConcentration LH LS  MSA child behavior disorder in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Onset is before the age of seven. OLuse ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY to search HYPERKINETIC SYNDROME back thru 1981 & MINIMAL BRAIN DYSFUNCTION back thru 1969 (as Prov 1969-72) PM84; was HYPERKINETIC SYNDROME 1981-83, was MINIMAL BRAIN DYSFUNCTION 1973-80 HN84; was HYPERKINETIC SYNDROME 1981-83, was MINIMAL BRAIN DYSFUNCTION 1969-80 (Prov 1969-72) MHÑAttention Deficit Disorder with Hyperactivity ANdo not use /drug eff /physiol /rad eff; do not confuse with HYPERKINESIS: note X refs under both PIBrain Damage, Chronic (66-68) MNF3.234.96 XSBrain Dysfunction, Minimal; Hyperkinetic Syndrome; Minimal Brain Dysfunction LH LS; ;  MSAn enduring, learned predisposition to behave in a consistent way toward a given class of objects; a persistent mental and/or neural state of readiness to react to a certain class of objects, not as they are but as they are conceived to be. PM65; was see under BEHAVIOR 1963-64 HN65(64); was see under BEHAVIOR 1963-64 MHÑAttitude ANno qualif MNF1.145.76; F1.829.92 FXÑPUBLIC OPINION; ÑSET (PSYCHOLOGY) XUÑPermissiveness LH LX; LU  MSAttitudes of personnel toward their patients, other professionals, toward the medical care system, etc. PM68 HN68 MHÑAttitude of Health Personnel ANno qualif; attitude to anything, but consider also various professional-patient-relation headings PIAttitude (66-67) MNF1.145.76.147; F1.829.92.214 LH  MSThe attitude and behavior associated with an individual using the computer. PM87 HN87 MHÑAttitude to Computers ANno qualif MNF1.145.76.180 FXÑComputers LH LX  MSConceptual response of the individual to the various aspects of death, which are based on his psychosocial and cultural experience. PM74 HN74 MHÑAttitude to Death ANno qualif MNF1.145.76.247 FXÑDeath LH LX  MSLayman attitudes toward health, disease and the medical care system. PM68 HN68 MHÑAttitude to Health ANno qualif; includes attitude to dis PIAttitude (66-67) MNF1.145.76.347; F1.829.92.380 FXÑConsumer Participation; ÑPATIENT DROPOUTS; ÑPatient Participation; ÑPublic Opinion; ÑSick Role LH LX; ; ; ;  MSMicroorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics. PM75 HN75 MHÑAtypical Bacterial Forms ANdo not use /blood-csf-urine PIBacteria (66-74) MNB3.110 LH  MSAuditory and visual instructional materials. MHÑAudio-Visual Aids ANonly /class /econ /hist /stand /supply /trends /util (if by MeSH definition); TEACHING MATERIALS is also available MNI2.903.847.297; L1.178.147 XSVISUAL AIDS LH LS  PM65 HN65 MHÑAudioanalgesia ANdo not use /util except by MeSH definition MNE3.91.214 LH  MSThe study of hearing and hearing impairment. OLsearch HEARING 1966-74 PM78; was see under HEARING 1963-74 HN78; was see under HEARING 1963-74 MHÑAudiology ANSPEC: SPEC qualif; do not confuse with HEARING (physiol process) or HEARING TESTS or AUDIOMETRY (a specific type of hearing test); Amer Speech & Hear Assoc: index under AUDIOLOGY (IM) + SPEECH PATHOLOGY (IM) + SOCIETIES (IM) + UNITED STATES (NIM) CATALOG: use with form qualif instead of HEARING /form or HEARING DISORDERS /form PIHearing (66-77) MNG2.20 LH  MHÑAudiometry ANdo not use /util except by MeSH definition; a specific type of hearing test: do not use as a general term for ╥the measurement of hearing╙ ( = HEARING TESTS); ACOUSTIC IMPEDANCE TESTS is also available MNE1.276.299.375.297 FXÑAUDITORY THRESHOLD XUÑAudiometry, Pure-Tone LH LX LU  MSA form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Also known as electric response audiometry. PM86; was see under AUDIOMETRY 1980-85 HN86(80); was see under AUDIOMETRY 1980-85 MHÑAudiometry, Evoked Response ANdo not use /util except by MeSH definition; also called ╥electric response audiometry╙ PIAudiometry (66-79); Evoked Potentials (67-79) MNE1.276.299.375.297.45 XSAudiometry, Electroencephalic Response; Electrocochleography; Evoked Response Audiometry LH LS; ;  MSMeasurement of hearing based on the use of pure tones of various frequencies and intensities as auditory stimuli. HN(80) MHÑAudiometry, Pure-Tone ANdo not use /util except by MeSH definition; note X ref: spell in titles & transl with accents: Bekesy PIAudiometry (66-79) MNE1.276.299.375.297.92 XSAudiometry, Bekesy DMÑAudiometry LH LS LM  MSMeasurement of the ability to hear speech under various conditions of intensity and noise interference using sound-field as well as earphones and bone oscillators. PM80 HN80 MHÑAudiometry, Speech PIAudiometry (66-79); Speech (66-79) MNE1.276.299.375.297.105 LH  PM70 HN70(68) MHÑAuditory Cortex ANdo not use /innerv; dis: coord NIM with AUDITORY DISEASES, CENTRAL (IM) PICerebral Cortex (66-67); Hearing (66-67) MNA8.186.211.885.213.863.297 FXÑAuditory Diseases, Central LH LX  MSDiseases of the auditory pathways from the bulbar cochlear nuclei to the auditory cortex in the temporal lobe. Structures involved include the medial and lateral lemnisci, inferior colliculus, and the medial geniculate nucleus. PM80 HN80 MHÑAuditory Diseases, Central ANdis of auditory nerve pathways; coord IM with site (NIM) MNC9.218.807.186; C10.228.140.68 FXÑAuditory Cortex; ÑAuditory Pathways LH LX;  MSLoss of sensitivity to sounds as a result of auditory stimulation, manifesting as a temporary shift in auditory threshold. The temporary threshold shift, TTS, is expressed in decibels. PM80 HN80 MHÑAuditory Fatigue ANonly /drug eff /physiol /rad eff PIAuditory Threshold (68-79); Fatigue (66-79); Hearing (66-67) MNF2.463.593.71.173.95 XSTemporary Threshold Shift, Auditory LH LS  PM72 HN72(71) MHÑAuditory Pathways ANdo not use /innerv; dis: coord NIM with AUDITORY DISEASES, CENTRAL (IM) PIAuditory Cortex (68-70); Central Nervous System (66-70) MNA8.612.220.110 FXÑAuditory Diseases, Central LH LX  MSThe process whereby auditory stimuli are selected, organized and interpreted by the organism; includes speech discrimination. PM68 HN68(67) MHÑAuditory Perception ANonly /drug eff /physiol /rad eff; differentiate from HEARING: aud percept takes place in the brain, hearing takes place in the ear: TN 98 PIHearing (66); Perception (66) MNF2.463.593.71; G11.561.796.263.260 FXÑHearing XUÑSound Localization LH LX LU  MSDisorders of auditory perception manifesting as difficulties with auditory memory, speech perception and sound localization. Lesions are usually in the temporal lobe. HN(80) MHÑAuditory Perceptual Disorders ANdo not use /drug eff /physiol /rad eff PIAuditory Perception (67-79); Hearing (66); Perception (66-68); Perceptual Disorders (69-79) MNC9.218.807.186.94; C10.228.140.68.94; F3.126.185.794.151 DMÑPerceptual Disorders LH LM  MSThe audibility limit of discriminating sound intensity and pitch. PM68 HN68 MHÑAuditory Threshold ANonly /drug eff /physiol /rad eff PIHearing (66-67) MNF2.463.593.71.173; F2.463.593.710.190 FXÑAudiometry LH LX  MS(1-Thio-beta-D-glucopyranosato) (triethylphosphine)gold 2,3,4,6-tetraacetate. An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious. PM87 HN87 MHÑAuranofin ANdo not use /biosyn /defic /physiol RN34031-32-8 PIGold (66-74); Gold Thioglucose/analogs & derivatives (75-86) MND1.552.322.80; D2.691.100; D26.74.75.240; D26.74.75.570.200 LH  PM73 HN73(65) MHÑAurantin ANdo not use /defic /physiol RN522-16-7 MND20.85.75.135; D22.204.106.152 LH  MS3-[Bis(3-carboxy-4-hydroxyphenyl)methylene]-6-oxo-1,4-cyclohexadiene-1-carboxylic acid. A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt(aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods and tissues. HN(75) MHÑAurintricarboxylic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4431-00-9 PIBenzoates (72-74); Cyclohexanecarboxylic Acids (69-74); Phenols (72-74) MND2.241.223.268.70 XSAurintricarboxylate DMÑCyclohexanecarboxylic Acids LH LS LM  MSVery toxic and complex pyrone derivatives from the fungus Calcarisporium arbuscula; bind to and inhibit mitochondrial ATP-ase, thereby uncoupling oxidative phosphorylation; used as biochemical tool. OLuse AUROVERTINS to search AUROVERTIN back thru 1975 HN(80); was AUROVERTIN see under ANTIBIOTICS 1975-79 MHÑAurovertins ANdo not use /analogs /defic /physiol PIAntibiotics (68-74) MND3.383.663.75; D8.373.936.100; D26.550.43 DMÑPyrans LH LM  MSAct of listening for sounds within the body. MHÑAuscultation ANNIM; consider also HEART AUSCULTATION; /instrum: stethoscope goes here or under HEART AUSCULTATION /instrum; Doppler stethoscope: index under AUSCULTATION /instrum (IM) + ULTRASONIC DIAGNOSIS (IM) MNE1.706.110 LH  MHÑAustralia ANaborigines are of the AUSTRALOID RACE MNZ1.338 XSTasmania LH LS  MSA racial group which is a subdivision of the Caucasoid Stock. Includes the Australian Aborigines, the Veddahs of Ceylon, the Pre-Dravidian people of India and the Ainu of Japan. OLuse AUSTRALOID RACE to search AUSTRALIAN RACE back thru 1966 PM78; was AUSTRALIAN RACE 1963-77 HN78; was AUSTRALIAN RACE 1963-77 MHÑAustraloid Race ANIM; only /class /hist; includes Ainus, Australian aborigines, Pre-Dravidians, Veddahs; specify geog if pertinent; policy on race: Manual 30.10-30.12 MNI1.76.368.763.148 LH  MHÑAustria MNZ1.542.88 LH  MSThe personality pattern or syndrome consisting of behavioral and attitudinal characteristics reflecting a preoccupation with the factors of power and authority in interpersonal relationships. MHÑAuthoritarianism ANno qualif MNF1.752.98 LH  MHÑAuthorship ANidentity or establishment of being the author; do not confuse with WRITING or PUBLISHING: see notes there; no qualif MNL1.143.506.423.906.215 LH  MSDomination by subjective, self-centered trends of thought or behavior. MHÑAutism ANdo not use /drug eff /physiol /rad eff MNF1.145.92; F2.463.785.111; F3.126.108 LH  MSA syndrome beginning in infancy and characterized by a lack of responsiveness to other people, gross impairment in verbal and nonverbal communication skills, and bizarre responses to the environment. OLto search AUTISM, EARLY INFANTILE use AUTISM, INFANTILE back thru 1971 & SCHIZOPHRENIA, CHILDHOOD 1968-70 PM81; was AUTISM, EARLY INFANTILE 1971-80, was AUTISM, EARLY INFANTILE see under SCHIZOPHRENIA, CHILDHOOD 1968-70 HN81; was AUTISM, EARLY INFANTILE 1971-80, was AUTISM, EARLY INFANTILE see under SCHIZOPHRENIA, CHILDHOOD 1968-70 MHÑAutism, Infantile ANdo not use /drug eff /physiol /rad eff PIAutism (66-70); Schizophrenia, Childhood (66-70) MNF3.709.680.500.60 XSKanner's Syndrome LH LS  PM67 HN67 MHÑAutoanalysis ANNIM; only /instrum /methods /stand PIAutomation (66); Chemistry, Analytical (66); Computers (66) MNE5.59 FXÑAutomation; ÑChemistry, Analytical LH LX;  MHÑAutoantibodies ANonly /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine; produced by body's own tissue in response to AUTOANTIGENS; autoimmunity goes here or under AUTOIMMUNE DISEASES: do not confuse with ANTI-ANTIBODIES MND24.611.125.308 FXÑAutoimmune Diseases LH LX  PM87; was see under ANTIGENS 1973-86 HN87(73); was see under ANTIGENS 1973-86 MHÑAutoantigens ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /tox /urine; tissue antigens causing endogenous production of AUTOANTIBODIES PIAntigens (66-72) MND24.611.216.422 LH  MHÑAutobiography ANIM as literary form only; NIM for specific biographee; no qualif; Manual 17.4.5, 32.11; includes memoirs MNK1.517.211.215 LH  MSTechnic based on muscle relaxation during self-hypnotic exercises; used in conjunction with psychotherapy. PM66 HN66(63) MHÑAutogenic Training ANSPEC qualif MNF4.754.103 FXÑSuggestion LH LX  MHÑAutoimmune Diseases ANGEN or unspecified; coord IM with specific dis (IM), even one indented here in Cat C20 when that dis is discussed as an autoimmune dis; autoimmunity goes here or under AUTOANTIBODIES MNC20.111 FXÑAUTOANTIBODIES LH LX  MSThe apparent movement of a small stationary spot of light seen in the darkness. OLsearch ILLUSIONS 1968-74 HN(75) MHÑAutokinetic Effect ANonly /drug eff /physiol /rad eff MNF2.463.593.446.215 DMÑIllusions LH LM  MSThe spontaneous disintegration of tissues or cells by the action of their own autogenous enzymes. PM72 HN72(68) MHÑAutolysis PIPostmortem Changes (66-67) MNC23.240.224.617.236; C23.739.131 LH  MSData processing largely performed by automatic means. MHÑAutomatic Data Processing ANGEN & unspecified only: prefer specific informatics & computer terms available; only /econ /hist /instrum /man /methods /stand /trends; do not use /util MNL1.700.568.110.85 XSBar Codes; Computer Data Processing; Data Processing, Automatic; ELECTRONIC DATA PROCESSING; Information Processing, Automatic; Optical Readers LH LS; ; ; ; ;  MHÑAutomation ANfor automation as a concept in technol: not for ╥automated╙ equipment or ╥automated╙ processes & technics ( = specific technic without AUTOMATION coord unless especially discussed); only /econ /hist /instrum /stand MNJ1.897.104 FXÑAUTOANALYSIS LH LX  MSAutomatic, mechanical, and apparently undirected behavior which is outside of conscious control. MHÑAutomatism ANdo not use /drug eff /physiol /rad eff MNF2.463.425.179.149; F3.126.720.174 LH  MSGovernment required written and driving test given to individuals prior to obtaining an operator's license. MHÑAutomobile Driver Examination ANno qualif MNI3.125.299 LH  MSThe effect of environmental or physiological factors on the driver and driving ability. Included are driving fatigue, and the effect of drugs, disease, and physical handicaps on driving. PM67 HN67(64) MHÑAutomobile Driving ANno qualif MNI3.125 FXÑACCIDENTS, TRAFFIC LH LX  HNwas in Cat G only 1968-74, was in Cat G & J 1963-67 MHÑAutomobile Exhaust ANonly /ad-poi-tox /anal /prev MND5.284.101.143.149; G3.850.460.100.165 LH  MHÑAutomobiles ANonly /econ /hist /stand /supply MNJ1.937.149 LH  OLuse AUTONOMIC AGENTS to search AUTONOMIC DRUGS back thru 1966 PM82; was AUTONOMIC DRUGS 1963-81 HN82; was AUTONOMIC DRUGS 1963-81 MHÑAutonomic Agents ANGEN: avoid; prefer specifics; do not use /analogs /biosyn /defic /physiol MND16 LH  PM71 HN71 MHÑAutonomic Fibers, Postganglionic ANdo not use /innerv PIGanglia, Autonomic (66-70) MNA8.99.94; A8.663.542.100; A11.671.78 LH  PM71 HN71 MHÑAutonomic Fibers, Preganglionic ANdo not use /innerv PIGanglia, Autonomic (66-70) MNA8.99.139; A8.663.542.122; A11.671.107 XSB Fibers LH LS  MSInterruption of sympathetic pathways, by local injection of an anesthetic agent, at any of four levels: peripheral nerve block, sympathetic ganglion block, extradural block, and subarachnoid block. MHÑAutonomic Nerve Block ANNERVE BLOCK is also available; coord with substance (with no qualif) used to induce the block if particularly discussed MNE3.155.86.711.299 XSSympathetic Nerve Block LH LS  MHÑAutonomic Nervous System ANdo not use /innerv; dysfunction = AUTONOMIC NERVOUS SYSTEM DISEASES but consider also DYSAUTONOMIA, FAMILIAL MNA8.99 LH  PM81 HN81; was AUTONOMIC SYSTEM DISEASES (NON MESH) before 1981 MHÑAutonomic Nervous System Diseases ANautonomic dysfunction goes here but consider also DYSAUTONOMIA, FAMILIAL; DF: ANS DIS PIAutonomic Nervous System (66-80); Nervous System Diseases (66-80) MNC10.120 XUÑShy-Drager Syndrome LH LU  MSThe segregation and degradation of damaged or unwanted cytoplasmic constituents by autophagic vacuoles (cytolysosomes) composed of lysosomes containing cellular components in the process of digestion; it plays an important role in metamorphosis of amphibians, in the removal of bone by osteoclasts, and in the degradation of normal cell components in nutritional deficiency states. HN(79) MHÑAutophagocytosis ANonly /drug eff /rad eff PIAutolysis (68-78); Lysosomes (66-78); Phagocytosis (66-78) MNG4.335.487.350.91 DMÑPhagocytosis LH LM  MSPostmortem examination of the body. MHÑAutopsy ANNIM; no qualif when NIM; when IM, only /econ /hist /instrum /methods /stand /vet; not an automatic routine coord for postmortem pathol ( = /pathol): discussion must be on autopsy as a procedure MNE5.70; I1.198.560.120 LH  OLuse AUTORADIOGRAPHY to search RADIOAUTOGRAPHY back thru 1966 PM73; was RADIOAUTOGRAPHY 1963-72 HN73; was RADIOAUTOGRAPHY 1963-72 MHÑAutoradiography ANNIM, usually no qualif MNE5.909.262.105; E5.909.432.132 XSRADIOAUTOGRAPHY LH LS  MSSuggestion coming from the subject himself. OLsearch SUGGESTION 1966-74 HN(75) MHÑAutosuggestion ANno qualif MNF4.754.424.771.299 DMÑSuggestion LH LM  OLsearch PLANT GROWTH REGULATORS 1966-74 HN(75) MHÑAuxins AND25-26 qualif MND11.303.760.120 DMÑPlant Growth Regulators LH LM  MSA treatment that suppresses undesirable behavior by simultaneously exposing the subject to unpleasant consequences. PM70 HN70 MHÑAversive Therapy ANSPEC qualif PIBehavior Therapy (66-69) MNF4.754.137.174 LH  MSA DNA Virus causing arthritis in chicks. HN(75); was see under POXVIRUSES 1975-80 MHÑAvian Arthritis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with POXVIRUS INFECTIONS (IM) MNB4.909.204.783.150 DMÑPoxviridae LH LM  MSThe cause of an infection primarily in young chicks. HN(75) MHÑAvian Encephalomyelitis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENTEROVIRUS INFECTIONS (IM) MNB4.909.777.618.284.100 XSEpidemic Tremor Virus DMÑEnteroviruses LH LS LM  MSA virus causing infections in chickens and possibly pheasants; chicks up to 4 weeks old are the most severely affected. HN(75); was see under CORONAVIRUSES 1975-80 MHÑAvian Infectious Bronchitis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with CORONAVIRUS INFECTIONS (IM) MNB4.909.777.199.100 XSInfectious Bronchitis Virus of Birds DMÑCoronaviridae LH LS LM  MSA virus found on every continent and affecting mainly chickens and occasionally pheasants. HN(75); was see under HERPESVIRUSES 1975-80 MHÑAvian Infectious Laryngotracheitis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with HERPESVIRUS INFECTIONS (IM) MNB4.909.204.382.80 DMÑHerpesviridae LH LM  MHÑAvian Leukosis ANdo not use /vet; don't forget also BIRDS (NIM) & check tag ANIMAL MNC2.782.815.96; C2.928.120; C4.557.337.372.216; C4.619.531.216; C4.619.935.120; C22.131.94 XSLEUKOSIS, AVIAN LH LS  MSA group of viruses producing latent or manifest lymphoid leukosis in fowl. OLuse AVIAN LEUKOSIS VIRUSES to search AVIAN LEUKOSIS VIRUS, LEUKEMIA VIRUS, AVIAN & LYMPHOMATOSIS VIRUS, AVIAN back thru 1966 PM75; was AVIAN LEUKOSIS VIRUS 1963-74 HN75; was AVIAN LEUKOSIS VIRUS 1963-74; LEUKEMIA VIRUS, AVIAN & LYMPHOMATOSIS VIRUS, AVIAN were see under AVIAN LEUKOSIS VIRUSES 1975-77, were see under AVIAN LEUKOSIS VIRUS 1963-74 MHÑAvian Leukosis Viruses ANdo not use /blood-csf-urine /cytol; infection = AVIAN LEUKOSIS MNB4.909.574.807.112.175; B4.909.777.731.112.175 XSLeukemia Virus, Avian; Lymphomatosis Virus, Avian; Rous-Associated Virus XUÑErythroblastosis Virus, Avian; ÑMyeloblastosis Virus, Avian LH LS; ; LU;  MSA group of closely related Retroviridae, which give rise to malignant diseases of various sorts in wild birds and domestic fowl. PM66 HN66 MHÑAvian Leukosis-Sarcoma Viruses ANdo not use /blood-csf-urine /cytol; infection = AVIAN LEUKOSIS or AVIAN SARCOMA MNB4.909.574.807.112; B4.909.777.731.112 LH  MSAn RNA Virus which causes a fowl infection. HN(75); was see under LEUKOVIRUSES 1978-80, was see under LEUKEMOGENIC VIRUSES 1975-77 MHÑAvian Reticuloendotheliosis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) (not with AVIAN LEUKOSIS) + neopl terms if pertinent MNB4.909.574.807.190; B4.909.777.731.150 XST Virus DMÑRetroviridae LH LS LM  OLuse AVIAN SARCOMA to search ROUS SARCOMA back thru 1966 PM83; was ROUS SARCOMA 1963-82 HN83; was ROUS SARCOMA 1963-82 MHÑAvian Sarcoma AN/anal /blood supply /secret /ultrastruct permitted; do not use /vet MNC2.782.815.105; C2.928.135; C4.557.863.782.95; C4.619.857.95; C4.619.935.135 XSRous Sarcoma; Sarcoma, Rous LH LS;  MSViruses producing sarcomata and other tumors in chickens and other fowl and also in pigeons, ducks and rats. OLuse AVIAN SARCOMA VIRUSES to search ROUS SARCOMA VIRUS back thru 1966 PM83; was ROUS SARCOMA VIRUS 1963-82 HN83; was ROUS SARCOMA VIRUS 1963-82 MHÑAvian Sarcoma Viruses ANdo not use /blood-csf-urine /cytol; infection = AVIAN SARCOMA MNB4.909.574.807.112.195; B4.909.777.731.112.195 XSChicken Tumor 1 Virus; Rous Sarcoma Virus FXÑSarcoma XUÑChicken Sarcoma Virus B77 LH LS; LX LU  MSDesign, development, manufacture, and operation of heavier-than-air aircraft. OLuse AVIATION to search PARACHUTING back thru 1966 PMPARACHUTING was heading 1963-82 HNPARACHUTING was heading 1963-82 MHÑAviation ANfor med, physiol, psychol aspects of flying index AEROSPACE MEDICINE; only /econ /hist /instrum /man /stand; consider also AIRCRAFT; Manual 28.10 MNJ1.95 XSParachuting FXÑACCELERATION; ÑGRAVITATION LH LS LX;  OLsearch OVALBUMIN 1969-72 PM87; was see under OVALBUMIN 1969-86 HN87(73); was see under OVALBUMIN 1969-86 MHÑAvidin ANdo not use /defic /physiol RN1405-69-2 MND12.776.34.614.300; D12.776.256.317.663.300; D12.776.395.175 LH  MHÑAvitaminosis ANincludes hypovitaminosis; GEN: prefer specifics: avitaminosis A = VITAMIN A DEFICIENCY, etc. MNC18.654.223.133 XSVITAMIN DEFICIENCY LH LS  MSA response to a cue that is instrumental in avoiding a noxious experience. MHÑAvoidance Learning ANonly /drug eff /physiol /rad eff MNF2.463.425.97 FXÑESCAPE REACTION LH LX  MHÑAwards and Prizes ANIM; no qualif; awards & prizes in field of medicine: do not coord with MEDICINE but coord with specific med specialty or other field (IM); medals goes under NUMISMATICS; DF: AWARDS CATALOG: /geog /form MNK1.150 LH  MSThe act of ╥taking account╙ of an object or state of affairs; does not imply assessment of the qualitites or nature of the object nor attention. OLsearch COGNITION 1969-74 HN(75) MHÑAwareness ANonly /drug eff /physiol /rad eff MNF2.463.188.150 DMÑCognition LH LM  MHÑAxilla AN╥axillary lymph nodes╙ = LYMPH NODES (IM) + AXILLA (NIM, no qualif) MNA1.133 LH  MSThe continuation of the subclavian artery; it distributes over the upper limb, axilla, chest and shoulder. MHÑAxillary Artery ANdo not use /blood supply MNA7.231.114.85 LH  MSThe venous trunk of the upper limb; a continuation of the basilar and brachial veins running from the lower border of the teres major muscle to the outer border of the first rib where it becomes the subclavian vein. MHÑAxillary Vein ANdo not use /blood supply MNA7.231.908.77 LH  MHÑAxis MNA2.835.232.834.151.383 XSEPISTROPHEUS XUÑOdontoid Process LH LS LU  MHÑAxons ANA 11 qualif except /cytol; nerve fibers: NERVE FIBERS; giant squid axon: coord IM with SQUID (NIM) MNA8.663.542.145; A11.671.137 LH  MSThe continuous flow of new cytoplasm down the axon of a nerve cell. PM72 HN72(69) MHÑAxoplasmic Flow ANonly /drug eff /rad eff; also called axoplasmic streaming, axoplasmic transport PIAxons (66-68); Cytoplasmic Streaming (67-68) MNG4.335.418.300 LH  MSN,N-Bis(o-chlorobenzyl)-trans-1,4-cyclohexanebis(methylamine). An anticholesteremic agent which inhibits sterol biosynthesis in animals. HN(75) MHÑAY 9944 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN366-93-8 PIBenzyl Compounds (72-74); Cyclohexanes (68-74); Methylamines (72-74) MND2.455.426.392.368.367.100; D10.162.202.100 DMÑCyclohexanes LH LM  PM74 HN74(72) MHÑAza Compounds ANdo not confuse with AZO COMPOUNDS; do not use /analogs /biosyn /defic /physiol; DF: AZA CPDS PIspecific parent compound MND2.145 LH  MS17-[[3-(Dimethylamino)propyl]methylamino]-androst-5-en-3-ol. Diaza derivative of cholesterol which acts as a hypocholesteremic agent by blocking delta-24-reductase, which causes the accumulation of desmosterol. Induces myotonia. It is also used as an avian chemosterilant. Synonym: SC-12937. HN(78) MHÑAzacosterol ANdo not use /biosyn /defic /physiol RN313-05-3 PIAza Compounds (72-77); Cholesterol (66-77) MND4.808.247.222.284.70; D4.808.247.808.197.70; D10.516.851.208.70 XS20,25-Diazacholesterol DMÑCholesterol LH LS LM  PM74 HN74(72) MHÑAzacytidine ANdo not use /biosyn /defic /physiol RN320-67-2 PINucleosides (66-71); Triazines (66-71) MND2.145.150; D13.570.685.245.217; D13.570.800.286.300; D26.87.30 LH  MHÑAzaguanine ANdo not use /biosyn /defic /physiol RN134-58-7 MND2.145.250; D3.438.759.758.399.454.300; D22.204.144.116; D26.87.36 XSGuanazolo LH LS  MS4'-Fluoro-[4-(2-pyridyl)-1-piperazinyl)butyrophenone. A tranquilizing agent used in psychoses. HN(75) MHÑAzaperone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1649-18-9 PIButyrophenones (71-74); Piperazines (71-74); Pyridines (71-74) MND2.522.352.110; D15.236.872.331.241.95 DMÑButyrophenones LH LM  MHÑAzaserine ANdo not use /defic /physiol; /biosyn permitted RN115-02-6 MND12.125.262; D20.85.62.217; D20.85.75.166; D20.136.73.217; D22.204.106.180; D22.204.144.149; D22.569.250; D26.87.60 XSAzeserine LH LS  MSSteroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with nitrogen atoms. HN(75) MHÑAzasteroids ANdo not use /analogs /biosyn /defic /physiol PISteroids (68-74) MND4.808.925.100 DMÑSteroids, Heterocyclic LH LM  PM66 HN66(64) MHÑAzathioprine ANdo not use /biosyn /defic /physiol RN446-86-6 MND3.438.759.534.90; D22.204.144.183; D22.569.351; D26.87.72 LH  PM73 HN73(72) MHÑAzauridine ANdo not use /biosyn /defic /physiol RN39455-15-7 PIAntimetabolites (66-71); Uridine (66-71) MND2.145.451; D13.570.685.852.176; D13.570.800.892.176; D22.204.144.216; D26.87.95 LH  MHÑAzepines ANdo not use /analogs /biosyn /defic /physiol MND3.383.66 XSHexamethyleneimines XUÑCaprolactam; ÑClotiazepam; ÑDilazep; ÑMeptazinol; ÑOxazepines; ÑZolazepam LH LS LU; ; ; ; ;  OLuse AZERBAIJAN S.S.R. to search AZERBAIJAN back thru 1966 HN82; was AZERBAIJAN 1963-81 MHÑAzerbaijan S.S.R. ANuse this spelling in translations regardless of transliteration MNZ1.252.878.930.120; Z1.950.930.120 LH  MS2-Azetidinecarboxylic Acid. A proline analog. Acts as a stoichiometric replacement of proline causing the production of abnormal proteins having impaired biological activity. HN(75) MHÑAzetidinecarboxylic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2517-04-6 PIAzetines (74-75); Imino Acids (74) MND2.241.81.583.100; D2.491.485.100; D3.383.82.301.100; D12.125.72.401.200 DMÑAzetines LH LM  OLsearch AZETINES 1974 HN(75) MHÑAzetidines ANdo not confuse with AZETINES; do not use /analogs /biosyn /defic /physiol MND3.383.82.301 DMÑAzetines LH LM  PM74 HN74 MHÑAzetines ANdo not confuse with AZETIDINES; do not use /analogs /biosyn /defic /physiol MND3.383.82 XUÑAzetidinecarboxylic Acid; ÑAzetidines LH LU;  MHÑAzides ANdo not use /analogs /biosyn /defic /physiol MND2.159 LH  HN(72) MHÑAzinphosmethyl ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN86-50-0 PIInsecticides (66-71) MND2.719.94; D5.723.491.657.101 DMÑInsecticides, Organothiophosphate LH LM  OLsearch AZIRINES 1966-74 HN(75)66-67 MHÑAziridines ANdo not confuse with AZIRINES; do not use /analogs /biosyn /defic /physiol MND3.383.97.217 XSEthyleneimines DMÑAzirines LH LS LM  PM68; AZIRIDINES was heading 1966-67 HN68 MHÑAzirines ANdo not confuse with AZIRIDINES; do not use /analogs /biosyn /defic /physiol MND3.383.97 XUÑApholate; ÑAziridines; ÑCarbazilquinone; ÑTepa LH LU; ; ;  MSA semisynthetic ampicillin-derived acylureido penicillin proposed for opportunistic Pseudomonas infections in debilitated patients. PM85 HN85 MHÑAzlocillin ANdo not use /biosyn /defic /physiol RN37091-66-0 PIPenicillins (66-84) MND20.85.99.739.762.57.94 LH  MHÑAzo Compounds ANdo not confuse with AZA COMPOUNDS; do not use /analogs /biosyn /defic /physiol; DF: AZO CPDS MND2.172 XUÑAmaranth; ÑAmido Black; ÑArsenazo III; ÑAzoxymethane; ÑCycasin; ÑDiamide; ÑDiazoacetylglycine Amide; ÑDiazooxonorleucine; ÑDithizone; ÑEvans Blue; ÑFormazans; ÑMethylazoxymethanol Acetate; ÑTartrazine; Ño-Aminoazotoluene; Ñp-Aminoazobenzene; Ñp-Azobenzenearsonate LH LU; ; ; ; ; ; ; ; ; ; ; ; ; ; ;  PM66 HN66(64) MHÑAzocines ANdo not use /analogs /biosyn /defic /physiol MND3.383.113 LH  MHÑAzoles ANdo not use /analogs /biosyn /defic /physiol MND3.383.129 XUÑTetrazoles LH LU  MHÑAzores MNZ1.295.218 LH  MHÑAzotobacter ANin soil & water MNB3.400.122.170 LH  MSA family of motile, Gram-negative bacteria found in soil and water and capable of fixing atmospheric nitrogen. OLuse AZOTOBACTERACEAE to search AZOMONAS back thru 1976 & AZOMONAS AGILIS back thru 1972 (as Prov 1972-74) PM75; AZOMONAS was heading 1976-81; AZOMONAS AGILIS was see under AZOMONAS 1976-81, was AZOTOBACTER AGILIS see under AZOTOBACTER 1975 HN75; AZOMONAS was heading 1976-81; AZOMONAS AGILIS was see under AZOMONAS 1976-81, was AZOTOBACTER AGILIS see under AZOTOBACTER 1975, was AZOTOBACTER AGILIS 1972-74 (Prov) MHÑAzotobacteraceae ANin soil & water PIBacteria (66-74) MNB3.400.122 XSAzomonas LH LS  MSA potent carcinogen and neurotoxic compound. Particularly effective in inducing colon carcinomas. HN(75) MHÑAzoxymethane AND25-26 qualif; /analogs NIM only RN25843-45-2 PIAzo Compounds (73-75); Nitrogen Oxides (73-74) MND2.172.80; D26.191.90 DMÑAzo Compounds LH LM  MSA monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum; it is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys; it may cause a superinfection with gram-positive organisms. PM86 HN86 MHÑAztreonam ANdo not use /defic /physiol; do not use /biosyn unless by living matter RN78110-38-0 PIAntibiotics (66-82); Antibiotics, Lactam (83-85) MND20.85.99.598.92 LH  MSGreen crystals or powder used as biological stains. HN(76) MHÑAzure Stains AND25-26 qualif PIDimethylamines (74-75); Imines (74-75); Phenothiazines (69-75); Stains and Staining (66-75) MND3.494.741.80; D26.408.86 XSGiemsa Stain DMÑPhenothiazines LH LS LM  MSA bacterial protein from Pseudomonas, Bordetela or Alcaligenes which operates as an electron transfer unit associated with the cytochrome chain. The protein has a molecular weight of approximately 16,000, contains a single copper atom, is intensively blue and has a fluorescence emission band centered at 308nm. HN(75) MHÑAzurin AN/analogs NIM only RN12284-43-4 PIBacterial Proteins (70-74); Copper (70-74); Metalloproteins (73-74) MND12.776.97.100; D12.776.556.80 DMÑBacterial Proteins LH LM  MSA vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava. MHÑAzygos Vein ANdo not use /blood supply MNA7.231.908.106 LH  PM73 HN73 MHÑB Lymphocytes ANA 11 qualif & /class; also called B-cells; involved in antibody formation PILymphocytes (66-72) MNA11.63.438; A11.118.637.555.438; A15.145.229.637.555.438; A15.382.490.520.438; A15.382.520.118.438; A15.382.520.520.438 XSBURSA-DEPENDENT LYMPHOCYTES FXÑLymphocyte Cooperation LH LS LX  MSA genus of tick-borne protozoan parasites which infest the red blood cells of wild and domestic mammals; there are 72 recognized species, and the distribution is world-wide. PM74 HN74 MHÑBabesia ANdo not use /anat /blood-csf-urine /embryol; infection = BABESIOSIS MNB1.841.762.70 XSPiroplasma LH LS  MSA group of tick-borne diseases of cattle, sheep, goats, horses, swine, dogs and cats; caused by protozoans of the genus Babesia, which parasitize the red blood cells, producing hemolysis. OLuse BABESIOSIS to search BABESIASIS back thru 1968 PM82; was BABESIASIS 1968-81 HN82; was BABESIASIS 1968-81 MHÑBabesiosis ANusually animal: do not use /vet but check tag ANIMAL PIProtozoan Infections (66-67) MNC3.752.113; C22.674.710.122 XSBabesiasis; Piroplasmosis LH LS;  MSAn abnormal reflex consisting of dorsiflexion of the big toe on stimulation of the sole of the foot. OLsearch REFLEX, ABNORMAL 1968-74 HN(75) MHÑBabinski Reflex ANno qualif MNC10.597.704.384; C23.888.592.717.384; E1.236.563.642.558.301; E1.706.592.642.558.301 DMÑReflex, Abnormal LH LM  MSA family of bacteria which produce endospores - mostly saprophytes from soil, but a few are insect or animal parasites or pathogens. PM75 HN75 MHÑBacillaceae ANpathogenic & non-pathogenic PIBacteria (66-74) MNB3.300.158 LH  MHÑBacillus ANspecific genus: do not confuse with ╥bacillus╙ as ╥bacterium╙; do not use /blood-csf-urine MNB3.300.158.218 LH  MHÑBacillus Anthracis ANdo not use /blood-csf-urine; infection = ANTHRAX MNB3.300.158.218.151 LH  MHÑBacillus Cereus ANin soil, dust, plants MNB3.300.158.218.252 LH  MHÑBacillus Megaterium ANsame as B. megatherium; in soil, water, dust, decomposing material MNB3.300.158.218.352 LH  MSA species of Gram variable bacteria found in soil and spoiled food products. PM75 HN75 MHÑBacillus stearothermophilus ANin soil & spoiled food PIBacillus (66-74) MNB3.300.158.218.442 LH  MHÑBacillus Subtilis ANin soil, dust, decomposing matter MNB3.300.158.218.452 LH  MSA species of Gram variable bacteria which may be pathogenic for certain insects. Used for the Biological control of the Gypsy moth. PM75 HN75 MHÑBacillus thuringiensis ANpathogenic for insects PIBacillus (66-74) MNB3.300.158.218.500 LH  MHÑBacitracin ANdo not use /defic /physiol RN1405-87-4 MND20.85.119 LH  MHÑBack ANa region; in humans, the posterior trunk from the neck to the pelvis; prefer a more specific term if possible MNA1.176 LH  HNLUMBAGO was see under BACKACHE 1963-82 MHÑBackache ANconsidered chronic so do not coord with CHRONIC DISEASE; ╥lombo-sciatique╙ in French texts is indexed here + SCIATICA MNC10.597.617.152; C23.888.592.612.107 XSLow Back Pain; Lumbago LH LS;  MSRadiation from sources other than the source of interest; it is due to cosmic rays and natural radioactivity in the environment. HN(71); was see under RADIATION 1975 MHÑBackground Radiation ANonly /adv eff (with caution) PIRadiation (66-70); Radioactivity (66-70) MNH1.671.768.513.115 XSNatural Radiation DMÑRadiation, Ionizing LH LS LM  MS4-Amino-3-(4-chlorophenyl)butanoic acid. GABA derivative that inhibits neurotransmission; used in spasticity, especially that due to spinal cord damage. Synonyms: BA 34,647; Lioresal. PM80; was see under AMINOBUTYRIC ACIDS 1975-79 HN80(75); was see under AMINOBUTYRIC ACIDS 1975-79 MHÑBaclofen ANdo not use /biosyn /defic /physiol RN1134-47-0 PIAminobutyric Acids (72-74); Chlorobenzenes (74) MND2.241.81.161.125.439.200; D17.426.52 XSBaclophen; Chlorophenyl GABA LH LS;  OLuse BACTERIA to search GRAM NEGATIVE BACTERIA & GRAM POSITIVE BACTERIA 1973-75 PMSCHIZOMYCETES was heading 1975; GRAM NEGATIVE BACTERIA & GRAM POSITIVE BACTERIA were headings 1973-75 HNGRAM NEGATIVE BACTERIA & GRAM POSITIVE BACTERIA were headings 1973-75 MHÑBacteria ANGEN: avoid; prefer specifics; Manual 22.2 for qualif; relation to bact dis: Manual 22.14-22.16; TN 201: use of Bergey; TN 209: presence of bacteria in organs vs infection; note many precoord BACT- terms, direct as BACTERIAL PROTEINS, indirect, as ANTIBODIES, BACTERIAL; use Permuted MeSH for total coverage; enteric bacteria: possibly ENTEROBACTERIACEAE but try E COLI or other specific enteric bact; ╥coliform bacteria╙ = COLIFORM BACILLI see ENTEROBACTERIACEAE; presence of bacteria in blood = BACTEREMIA see SEPTICEMIA: see note there; BACTERIAL PILI & FIMBRIAE, BACTERIAL see PILI, BACTERIAL are also available MNB3 FXÑMicrobiology XUÑArchaebacteria; ÑSchizomycetes LH LX LU;  PM84 HN84 MHÑBacteria, Aerobic ANGEN: avoid; prefer specifics; do not use as a routine coord for an aerobic bact; do not use /blood-csf-urine; infection: coord NIM with BACTERIAL INFECTIONS (IM) PIAerobiosis (71-83); Bacteria (66-83) MNB3.120 XSAerobic Bacteria LH LS  PM84 HN84 MHÑBacteria, Anaerobic ANGEN: avoid; prefer specifics; do not use as a routine coord for an anaerobic bact; facultatively anaerobic bact: index only here & not also under BACTERIA, AEROBIC; do not use /blood-csf-urine; infection: coord NIM with BACTERIAL INFECTIONS (IM) PIAnaerobiosis (71-83); Bacteria (66-83) MNB3.130 XSAnaerobic Bacteria LH LS  MSPhysicochemical property of piliated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity. PM87 HN87 MHÑBacterial Adhesion ANonly /drug eff /rad eff PIAdhesiveness (69-86); Bacteria (66-86); Pili, Bacterial (80-86) MNG4.185.515.100 XSAdhesion, Bacterial FXÑPili, Bacterial LH LS LX  MH*Bacterial and Fungal Diseases (Non Mesh) MNC1 LH  MSInfections by bacteria, general or unspecified. PM72 HN72 MHÑBacterial Infections ANGEN: prefer specifics; many texts saying ╥sepsis╙ mean BACTERIAL INFECTIONS: check text; TN 209: differentiation from presence of bacteria in organs PIInfection (66-71) MNC1.252 LH  MSProteins isolated from the outer membrane of gram-negative bacteria; for outer membrane proteins of gram-positive bacteria use the term bacterial envelope proteins (NM). PM85 HN85 MHÑBacterial Outer Membrane Proteins ANdo not use /analogs /defic /physiol; coord IM with specific protein (IM) + specific gram-negative bacterium (IM) PIBacterial Proteins (66-84); Membrane Proteins (77-84) MND12.776.97.120; D12.776.543.100 XSOMP Proteins; Outer Membrane Proteins, Bacterial LH LS;  MHÑBacterial Proteins ANdo not use /analogs /defic /physiol; coord IM with specific protein (IM) + specific bacterium (IM); note BACTERIAL OUTER MEMBRANE PROTEINS above MND12.776.97 XSProteins, Bacterial XUÑAzurin; ÑFlagellin; ÑThioredoxin LH LS LU; ;  MSToxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. PM77 HN77; was NON MESH before 1977 MHÑBacterial Toxins ANGEN or unspecified: prefer specifics; coord IM with specific bacterium (IM); do not use /analogs /defic /diag use /physiol /secret ; /antag permitted but consider also ANTITOXINS PIBacteria (66-76); Toxins (66-76) MND24.185.926.123 XUÑExfoliatins LH LU  PM65 HN65 MHÑBacterial Vaccines ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; for specifics not indented here coord IM with specific bacterium /immunol (IM) MND24.310.894.135 LH  MSPhotosynthetic pigment in which pyrrole ring II is more reduced than plant chlorophylls. Different photosynthetic bacteria have different species of bacteriochlorophyll. HN(75) MHÑBacteriochlorophylls ANdo not use /analogs /defic /physiol PIChlorophyll (74) MND11.557.727.220.100; D11.557.727.640.220.100 DMÑChlorophyll LH LM  MSSubstances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species; they are protein or lipopolysaccharide-protein complexes; used in taxonomy of bacteria. PM68; MEGACINS was MEGACIN see under BACTERIOCINS 1968-78, was MEGACIN see under ANTIBIOTICS 1966-67; PYOCINS was PYOCIN see under BACTERIOCINS 1968-78, was PYOCIN see under ANTIBIOTICS 1966-67 HN68(65) MHÑBacteriocins ANdo not use /analogs /defic /physiol MND20.85.133; D24.310.125 XUÑCloacin; ÑMegacins; ÑPyocins LH LU; ;  MHÑBacteriological Technics ANonly /instrum /stand /vet CATALOG: do not use /laboratory manuals MNE5.909.560.150 FXÑCULTURE MEDIA LH LX  MHÑBacteriology ANSPEC: SPEC qualif; /methods = BACTERIOLOGICAL TECHNICS MNG1.273.540.177 LH  MHÑBacteriolysis ANonly /drug eff /rad eff MNG4.185.515.123 FXÑLYSOSTAPHIN LH LX  MHÑBacteriophage Typing ANonly /instrum /methods; policy: Manual 22.24.4 MNE5.909.560.150.150 XSBacteriocin Typing LH LS  MSViruses whose host is a bacterial cell. OLuse BACTERIOPHAGES to search BACTERIOPHAGE back thru 1966 PM75; was BACTERIOPHAGE 1963-74 HN75; was BACTERIOPHAGE 1963-74 MHÑBacteriophages AN= ╥bacterial virus╙; do not use /cytol; coord with specific bacterium (NIM) but note precoord phage terms; policy: Manual 22.24.3 MNB4.123 FXÑLysogeny LH LX  MSA rhodopsin-like protein found in the purple membrane of Halobacterium halobium. Its molecular weight is 26,000 and it is bound to retinal in a 1:1 ratio. It has photoreactions similar to those observed in rhodopsin. PM87; was see under CAROTENOIDS 1976-86 HN87(76); was see under CAROTENOIDS 1976-86 MHÑBacteriorhodopsin ANnothing to do with rhodopsin in the retina; /biosyn /physiol permitted RN53026-44-1 PIBacterial Proteins (74-75); Retinal Pigments (74-75) MND2.455.849.131.125; D11.557.261.125; D12.776.97.125 XSPurple Membrane LH LS  MSThe presence of bacteria in the urine with or without consequent urinary tract infection. Since BACTERIURIA is a clinical entity, the term does not preclude the use of URINE/microbiology for technical discussions on the isolation and segregation of bacteria in the urine. PM66 HN66(64) MHÑBacteriuria ANTN 190: differentiate from URINE /microbiol; coord IM with specific bacterium with probably /isol (IM) MNC1.539.895.219; C12.777.892.219 FXÑUrine LH LX  MSA family of Gram-negative bacteria found primarily in the intestinal tracts and mucous membranes of warm-blooded animals; sometimes pathogenic. PM75 HN75 MHÑBacteroidaceae ANdo not use /blood-csf-urine PIBacteria (66-74) MNB3.425.194 LH  MHÑBacteroides ANdo not use /blood-csf-urine; infection = BACTEROIDES INFECTIONS MNB3.425.194.152 XUÑBacteroides corrodens; ÑBacteroides melaninogenicus LH LU;  MSGram-negative bacteria isolated from infections of the respiratory and intestinal tracts and from the buccal cavity, intestinal tract and urogenital tract; probably part of the normal flora of man and animals. HN(76) MHÑBacteroides corrodens ANdo not use /blood-csf-urine; infection: coord NIM with BACTEROIDES INFECTIONS (IM) MNB3.425.194.152.300 XSEikenella corrodens DMÑBacteroides LH LS LM  MSGram-negative bacteria occurring in the lower intestinal tracts of man and other animals; the most common species of anaerobic bacteria isolated from human soft tissue infections. PM76 HN76 MHÑBacteroides fragilis ANdo not use /blood-csf-urine; infection: coord NIM with BACTEROIDES INFECTIONS (IM) PIBacteroides (66-75) MNB3.425.194.152.400 LH  MSInfections with bacteria of the genus Bacteroides. PM68 HN68 MHÑBacteroides Infections PIBacteroides (66-67) MNC1.252.109 LH  MSGram-negative bacteria isolated from the mouth, urine, feces, and infections of the mouth, soft tissue, respiratory tract, urogenital tract, and intestinal tract; pathogenic, but usually in association with other kinds of organisms. HN(76) MHÑBacteroides melaninogenicus ANdo not use /blood-csf-urine; infection: coord NIM with BACTEROIDES INFECTIONS (IM) PIBacteroides (66-75) MNB3.425.194.152.600 DMÑBacteroides LH LM  MHÑBahamas MNZ1.107.904.108 LH  HN75 MHÑBahrain MNZ1.252.245.93.150; Z1.630.100.150 LH  OLuse BALANITIS to search KRAUROSIS PENIS back thru 1966 PMKRAUROSIS PENIS was see under BALANITIS 1963-85 HNKRAUROSIS PENIS was see under BALANITIS 1963-85 MHÑBalanitis MNC12.294.494.136 XSKraurosis Penis LH LS  MHÑBalantidiasis MNC3.752.146 LH  MHÑBalantidium ANdo not use /anat /blood-csf-urine /embryol; infection = BALANTIDIASIS MNB1.841.184.153 LH  MSA tubulointerstitial disease of unknown etiology occurring in a limited geographic area including adjacent regions of Romania, Bulgaria, and Yugoslavia. HN(82) MHÑBalkan Nephropathy ANdo not specify geog unless particularly discussed PIKidney Diseases (66-81); Nephritis (66-75); Nephritis, Interstitial (69-81); Pyelonephritis (66-69) MNC12.777.419.570.643.150 XSEndemic Nephropathy, Balkan; Nephropathy, Balkan DMÑNephritis, Interstitial LH LS; LM  MSTechnic of graphic representation of the movements of the body imparted by the ballistic forces (recoil and impact) associated with cardiac contraction and ejection of blood and with the deceleration of blood flow through the large blood vessels. These movements, quantitatively very minute, are translated by a pickup device (transducer) into an electrical potential which is suitably amplified and recorded on a conventional electrocardiograph or other recording machine. MHÑBallistocardiography ANdo not use /util except by MeSH definition MNE1.145.569.136 FXÑHeart LH LX  MSTherapy by various hot or warm baths in natural mineral waters, spas, or ╥cures╙; includes not only bathing in, but also drinking the waters; does not include whirlpool baths which is HYDROTHERAPY. MHÑBalneology ANonly /econ /hist /trends; -ology on BATHS & mineral springs, spas & ╥cures╙; includes bathing or drinking MINERAL WATERS; balneotherapy goes here unless specifically an indention under BALNEOLOGY; differentiate from HYDROTHERAPY where emphasis is on plain water (not natural mineral water; see note there) MNE2.780.108 XSBalneotherapy FXÑHEALTH RESORTS; ÑMINERAL WATERS LH LS LX;  MHÑBalsams AND25-26 qualif MND25.786.219 LH  MSThe geographic area of the Baltic States in general or when the specific countries or country are not indicated. Usually includes, Denmark, Finland, Germany, Poland, and Sweden. HN75 MHÑBaltic States AN= ESTONIA, LATVIA & LITHUANIA collectively MNZ1.542.248.950.140; Z1.950.140 LH  MSAntibiotic complex containing mainly Moenomycins A and C; obtained from Streptomyces bambergiensis; used as feed additive and growth promoter in poultry, swine and cattle. Synonyms: Flavomycin; Menomycin. HN(79) MHÑBambermycins AN/biosyn /physiol permitted; do not use /analogs /defic PIAntibiotics (66-78); Glycolipids (66-78) MND20.85.134 XSFlavophospholipols; Moenomycins DMÑAntibiotics LH LS; LM  MHÑBamethan ANdo not use /biosyn /defic /physiol RN3703-79-5 MND2.33.329.291.129; D2.92.63.291.129; D2.92.471.683.219; D16.893.116.348.115 XSButylnorsynephrin LH LS  MSThe major integral transmembrane protein of the erythrocyte membrane. It exists as a dimer and provides a channel for the transport of anions across the membrane. PM84 HN84 MHÑBand 3 Protein AN/biosyn /physiol permitted PIBlood Proteins (66-83); Membrane Proteins (77-83) MND12.776.124.110; D12.776.543.110 XSErythrocyte Membrane Band 3 Protein LH LS  MHÑBandages ANonly /adv eff /stand /supply /vet; spray-on bandages = OCCLUSIVE DRESSINGS MNE7.101 XSDRESSINGS XUÑBiological Dressings LH LS LU  HN73 MHÑBangladesh MNZ1.252.245.131 LH  HN75 MHÑBarbados MNZ1.107.904.140 LH  MHÑBarbering ANonly /econ /hist MNJ1.576.82 LH  MS5,5-Diethylbarbituric acid. Long acting barbiturate that depresses most metabolic processes at high doses; used as hypnotic and sedative; may induce dependence; also used in veterinary practice for central nervous system depression. Synonyms: Darmonal; Malonal; Sedeval; Uronal; Verletten; Veronal. HN(76) MHÑBarbital ANdo not use /biosyn /defic /physiol; /analogs NIM only RN57-44-3 PIBarbiturates (68-75) MND3.383.742.698.253.150; D14.591.220.102 XSBarbitone; Diemal; Diethylmalonylurea; Ethylbarbital DMÑBarbiturates LH LS; ; ; LM  PM/adverse effects /poisoning /toxicity were BARBITURATE TOXICOLOGY 1963-65 HN/ad-poi-tox was BARBITURATE TOXICOLOGY 1963-65 MHÑBarbiturates ANGEN; prefer specifics; do not use /analogs /biosyn /defic /physiol MND3.383.742.698.253; D14.166.111; D14.261.164; D14.591.220 XUÑAllobarbital; ÑBarbital; ÑBucolome; ÑButabarbital; ÑCyclobarbital; ÑHeptabarbital; ÑIpronal; ÑMetharbital; ÑMurexide LH LU; ; ; ; ; ; ; ;  MHÑBarium ANBa-138; do not use /analogs /biosyn /defic /physiol; Ba-130, 132, 134-137 = BARIUM (IM) + ISOTOPES (NIM); Ba-126-129, 131, 133, 139-143 = BARIUM (IM) + RADIOISOTOPES (IM); barium enema = BARIUM SULFATE /diag use + ENEMA RN7440-39-3 MND1.248.497.300.333.95; D1.268.83; D1.552.539.124 LH  MHÑBarium Sulfate ANdo not use /analogs /biosyn /defic /physiol; for enema use BARIUM SULFATE /diag use, not BARIUM RN7727-43-7 MND1.552.539.124.303; D1.877.814.539.219; D26.298.105 LH  MSAnnual grasses (Graminea) whose grains are used as food and for malting and distillation; Hordeum vulgare and Hordeum distichon are the more useful species. OLsearch CEREALS 1966-84 HN(75); was see under GRAIN 1963-84 MHÑBarley ANas plant & food; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.253.116; J1.341.182.116 XSHordeum DMÑCereals LH LS LM  MSVarious marine crustaceans, free swimming in the larval state, but permanently fixed as adults; there are some 800 described species, grouped in several genera, including Lepas, Balanus, and Scalpellum. PM72 HN72 MHÑBarnacles AN/microbiol /parasitol permitted PICrustacea (66-71) MNB1.131.365.124 LH  MSInjury following pressure changes; includes injury to the eustachian tube, ear drum, lung and stomach. PM79 HN79 MHÑBarotrauma ANinj caused by pressure changes: not restricted to ear; IM; coord with organ inj by pressure with /inj; also available are BLAST INJURIES & DECOMPRESSION SICKNESS PIDecompression Sickness (66-78); Pressure (66-78) MNC21.866.120 FXÑAtmospheric Pressure LH LX  PM72 HN72(65) MHÑBarre-Lieou Syndrome ANuse accents in translations: Barre-Lieou MNC5.550.114.606.761.303; C5.799.613.678.303; C5.878.741.303; C10.120.253 XSPosterior Cervical Sympathetic Syndrome LH LS  MSEctopic gastric mucosa in the lower esophagus that often becomes ulcerated (Barrett ulcer), leading to stricture formation (ESOPHAGEAL STENOSIS). HN(81) MHÑBarrett Esophagus ANnote categ; do not use /congen PIEsophageal Stenosis (66-80); Esophagitis, Peptic (66-80) MNC6.306.102; C16.131.314.102 XSEsophagus, Barrett DMÑEsophageal Diseases LH LS LM  MHÑBartholin's Glands MNA5.360.319.887.220; A10.336.95 FXÑExocrine Glands LH LX  MHÑBartonella ANdo not use /blood-csf-urine; infection = BARTONELLA INFECTIONS MNB3.700.651.254.220 LH  MSUse for material for infections by Bartonellaceae in general or for which there is no specific heading. MHÑBartonella Infections MNC1.850.115.117 XSCarrion's Disease; Oroya Fever; Verruga Peruana LH LS; ;  MSA family of small Gram-negative bacteria which are parasites of erythrocytes in man and other vertebrates and the etiologic agents of several diseases. PM75 HN75 MHÑBartonellaceae ANdo not use /blood-csf-urine PIBacteria (66-74) MNB3.700.651.254 LH  MSInfections with rickettsias of the Family Bartonellaceae. PM77 HN77 MHÑBartonellaceae Infections ANa rickettsial infection PIBartonella Infections (64-76); Rickettsial Infections (64-76) MNC1.850.115 LH  OLsearch HYPERALDOSTERONISM 1973-74 HN(75) MHÑBartter's Disease MNC19.53.181.604.304 DMÑHyperaldosteronism LH LM  MSHereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant. HN(80) MHÑBasal Cell Nevus Syndrome ANcoord IM with precoord organ/neopl (IM or NIM) only if pertinent; do not confuse X ref GORLIN SYNDROME (also called Gorlin-Goltz syndrome) with GOLTZ-GORLIN SYNDROME see FOCAL DERMAL HYPOPLASIA PIBone Cyst (66-79); Carcinoma, Basal Cell (66-79); Jaw Diseases (67-79); specific jaw disease; Jaw Neoplasms (67-79); specific jaw neoplasm; Skin Neoplasms (66-79); Syndrome (72-79) MNC4.182.89.530.690.150; C4.557.117.110.150; C5.116.99.105; C5.500.470.690.150; C16.131.77.130 XSGorlin Syndrome; Nevoid Basal Cell Carcinoma Syndrome; Nevus Syndrome, Basal Cell DMÑCarcinoma, Basal Cell LH LS; ; LM  OLuse BASAL GANGLIA to search GANGLIA, BASAL & CLAUSTRUM back thru 1966 PM82; was GANGLIA, BASAL 1963-81 HN82; was GANGLIA, BASAL 1963-81; CLAUSTRUM was see under GANGLIA, BASAL 1963-78 MHÑBasal Ganglia ANdo not use /innerv; BASAL GANGLIA DISEASES is also available MNA8.186.211.885.105 XSBASAL NUCLEI; Claustrum XUÑSubstantia Innominata LH LS; LU  OLuse BASAL GANGLIA DISEASES to search EXTRAPYRAMIDAL DISORDERS back thru 1972 (as Prov 1972-73) PM79; was EXTRAPYRAMIDAL DISORDERS 1974-78; HALLERVORDEN-SPATZ SYNDROME was see under BRAIN DISEASES 1975-78 HN79; was EXTRAPYRAMIDAL DISORDERS 1972-78 (Prov 1972-73) MHÑBasal Ganglia Diseases PIMovement Disorders (66-71); specific anatomic site MNC10.228.140.79 XSExtrapyramidal Disorders XUÑHallervorden-Spatz Syndrome; ÑMeige Syndrome LH LS LU;  MSHeat production, or its measurement, of an organism at the lowest level of cell chemistry in an inactive, awake, fasting state. May be determined directly by means of a calorimeter or indirectly by calculating the heat production from an analysis of the end products of oxidation within the organism or from the amount of oxygen utilized. Syn: basal metabolic rate; BMR. MHÑBasal Metabolism ANresting state only; energy expenditure, energy cost = ENERGY METABOLISM; only /drug eff /rad eff MNE1.197.882.220; G6.535.335.154 FXÑCALORIMETRY LH LX  MSThe relative amounts of the complementary purines and pyrimidines in a nucleic acid, usually expressed in mole percent. PM80 HN80 MHÑBase Composition ANIM general only; NIM with specific nucleic acid (IM); only /drug eff /rad eff; do not confuse with BASE SEQUENCE: sequ = order in which arranged, comp = what components & how many MNG6.184.124 XSBase Pairs; Base Ratio LH LS;  MSThe sequence of purines and pyrimidines in nucleic acids and polynucleotides; also called nucleotide or nucleoside sequence. PM78; was see under BIOCHEMISTRY 1975-77 HN78(71); was see under BIOCHEMISTRY 1975-77 MHÑBase Sequence ANIM general only; NIM with specific nucleic acid (IM); only /drug eff /rad eff; do not confuse with BASE COMPOSITION: comp = what components & how many, sequ = order in which arranged; also called nucleotide or nucleoside sequence PINucleotides/AN (66-70); Polynucleotides (66-70); specific nucleic acid MNG5.331.112; G6.184.130 XUÑSequence Homology, Nucleic Acid LH LU  MSA competitive nine member team sport including softball. Strike Threeeee. HN(77) MHÑBaseball ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); Manual 30.31+; includes softball PISports (66-76) MNI3.450.642.845.110 DMÑSports LH LM  PM67 HN67(65) MHÑBasement Membrane ANNIM; do not use /abnorm /growth /inj /innerv; basal lamina goes here MNA10.272.220; A10.615.179 LH  MSOne of the Associated Soviet Socialist Republics situated in the western portion of the USSR. HN75 MHÑBashkiria MNZ1.542.248.950.820.150; Z1.950.820.150 LH  OLuse BASIDIOMYCETES to search MUSHROOMS back thru 1966 PMMUSHROOMS was heading 1963-85; SCHIZOPHYLLUM was see under AGARICACEAE 1975-85 HNMUSHROOMS was heading 1963-85 MHÑBasidiomycetes ANGEN: prefer specifics; do not use /anat /embryol /microbiol /parasitol; note X MUSHROOMS: pois = MUSHROOM POISONING MNB5.354.179 XSMushrooms XUÑPolyporaceae; ÑSchizophyllum; ÑUstilaginales; ÑUstilago LH LS LU; ; ;  MSThe artery formed by the union of the right and left vertebral arteries; it runs from the lower to the upper border of the pons, where it bifurcates into the two posterior cerebral arteries. MHÑBasilar Artery ANdo not use /blood supply MNA7.231.114.106 LH  OLsearch LABYRINTH 1966-74 HN(75) MHÑBasilar Membrane MNA9.246.631.125 DMÑLabyrinth LH LM  HN(87) MHÑBasketball ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); Manual 30.31+ PIAthletic Injuries (68-86); Sports (66-86) MNI3.450.642.845.117 DMÑSports LH LM  MSGranular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes. MHÑBasophils ANrestrict to leukocytes: not for ╥basophilic╙ when referring only to staining ( = STAINS AND STAINING); A 11 qualif & /class MNA11.118.637.415.120; A15.145.229.637.415.120; A15.382.490.315.120 LH  MSCommon name for fish belonging to the order Perciformes and occurring in three different families. HN(87) MHÑBass ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.602.105 XSDicentraorchus; Micropterus; Morone DMÑPerciformes LH LS; ; LM  MHÑBathing Beaches ANonly /stand MNG3.850.860.410.110 LH  MHÑBaths ANat home or in hosp, usually not plain water (see note on HYDROTHERAPY), usually with additives; do not confuse with BALNEOLOGY (see note there); general only or unspecified; prefer specifics; only /adv eff /econ /hist /methods /psychol /util (if by MeSH definition); bathing in seawater is probably THALASSOTHERAPY MNE2.780.108.110 LH  MHÑBaths, Finnish ANonly /econ /hist /psychol /stand MNE2.780.108.115 XSSAUNA LH LS  MSBatrachotoxin is the 20-alpha-bromobenzoate of batrachotoxin A; they are toxins from the venom of a small Colombian frog, Phyllobates aurotaenia, cause release of acetylcholine, destruction of synaptic vesicles and depolarization of nerve and muscle fibers. PM74 HN74 MHÑBatrachotoxins ANfrom frogs; do not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTITOXINS MND24.185.965.33.112 LH  MSRepeated physical injuries inflicted on the child by the parent, parents, or surrogate parent; often triggered by the child's minor and normal irritating behavior. OLsearch CHILD ABUSE 1966-74 HN(75) MHÑBattered Child Syndrome ANno qualif MNI1.880.787.293.292.304 DMÑChild Abuse LH LM  MS1,4-Dihydro-2,6-dimethyl-5-nitro-4- (2-(trifluoromethyl)phenyl)-3-pyridinecarboxylic acid methyl ester. A dihydropyridine derivative, which in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. PM87 HN87 MHÑBay K 8644 ANdo not use /biosyn /defic /physiol RN71145-03-4 PINifedipine/analogs & derivatives (75-86); Pyridines (66-74) MND3.383.725.547.75; D18.793.110 LH  OLsearch PROBABILITY 1968-74 HN(75) MHÑBayes Theorem ANno qualif MNH1.548.832.672.137 XSBayesian Analysis; Bayesian Forecast; Bayesian Method; Bayesian Prediction DMÑProbability LH LS; ; ; LM  MSActive immunizing agent; a viable attenuated strain of Mycobacterium tuberculosis, var. bovis which confers immunity to mycobacterial infections; used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Synonyms: Calmette's Vaccine; Tuberculosis Vaccine. OLuse BCG VACCINE to search TUBERCULOSIS VACCINES & BCG VACCINATION back thru 1966 PM79; was see under TUBERCULOSIS VACCINES 1974-78; TUBERCULOSIS VACCINES was heading 1965-78; BCG VACCINATION was heading 1963-79 HN79(75); was see under TUBERCULOSIS VACCINES 1974-78; TUBERCULOSIS VACCINES was heading 1965-78; BCG VACCINATION was heading 1963-79 MHÑBCG Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; BCG vaccination in prev of tuberc = BCG VACCINE (IM) + TUBERCULOSIS /prev (IM); BCG ther of various diseases = BCG VACCINE /ther use (IM) + dis /ther (IM) MND24.310.894.135.128; D24.611.59.102 XSBacillus Calmette Guerin Vaccine; Calmette Guerin Bacillus Vaccine; Tuberculosis Vaccines LH LS; ;  MSA genus of bacteria capable of developing within other bacteria. PM77 HN77 MHÑBdellovibrio AN╥a genus of bacteria capable of developing within other bacteria╙ PIBacteria (66-76) MNB3.825.115 LH  PM68 HN68 MHÑBeak PIBirds (66-67) MNA13.114 LH  MSLarge heavy mammals of the family Ursidae feeding largely on fruit and insects as well as flesh. HN(75) MHÑBears ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.147.125 DMÑCarnivora LH LM  MSCharacteristics or attributes of persons or things which elicit pleasurable feelings. OLsearch ESTHETICS 1966-74 HN(75)63-66 MHÑBeauty ANno qualif MNF2.463.785.477.304; K1.752.210.304 DMÑEsthetics LH LM  MHÑBeauty Culture ANno qualif MNJ1.576.112 LH  MSA syndrome of multiple defects characterized primarily by umbilical hernia, macroglossia, and gigantism and secondarily by visceromegaly, hypoglycemia, ear abnormalities, etc. Also called Exomphalos-Macroglossia-Gigantism (EMG) Syndrome. PM83 HN83 MHÑBeckwith-Wiedemann Syndrome ANdo not use /congen & do not coord with INFANT, NEWBORN, DISEASES PIAbnormalities, Multiple (68-82); Gigantism (66-82); Hernia, Umbilical (66-82); Macroglossia (75-82); Tongue/AB (66-74) MNC16.131.77.133 LH  MS9-Chloro-11 beta,17,21-trihydroxy-16 beta-methyl-pregna-1,4-diene-3,20-dione 17,21-dipropionate. An anti-inflammatory, synthetic glucocorticoid. Used topically as an anti-inflammatory agent and in aerosol form for the treatment of asthma. PM77; was see under METHYLPREDNISOLONE 1975-76 HN77(73); was see under METHYLPREDNISOLONE 1975-76 MHÑBeclomethasone ANdo not use /biosyn /defic /physiol RN4419-39-0 PIPregnanetriol (66-72) MND4.808.745.432.769.125; D4.808.883.154; D6.597.481.364.117; D6.597.481.561.353.90; D6.597.481.561.478.90; D16.116.112; D26.74.125.117; D26.74.125.447.117; D26.74.148.447.117; D26.368.99.447.117 XSBeclomethasone Dipropionate LH LS  MSThe reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds. HN(82) MHÑBed Conversion ANonly /econ /legis PIBed Occupancy (78-81); Hospital Planning (68-81) MNN3.349.650.250.80 XSBeds, Swing; Swing Beds DMÑHealth Facility Planning LH LS; LM  MSA measure of inpatient health facility use based upon the average number or proportion of beds occupied for a given period of time. PM78 HN78 MHÑBed Occupancy ANno qualif; coord IM with specific hosp or department (IM) + geog if pertinent; HOSPITAL BED CAPACITY & specific bed capacities are also available MNN2.278.50 LH  MSConfinement of an individual to bed for therapeutic or experimental reasons. PM77 HN77 MHÑBed Rest ANonly /adv eff /econ /methods /psychol /util (if by MeSH definition); do not confuse with IMMOBILIZATION: TN 166 PIImmobilization (66-76); Rest (66-76) MNE2.75 FXÑRest LH LX  MHÑBedbugs AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 MNB1.131.617.412.304 XSCIMEX LH LS  PM68 HN68(63) MHÑBedding and Linens ANonly /econ /stand /supply /util; includes all bedclothes + towels, washcloths, gowns, pajamas; DF: BEDDING MNE7.430.137; J1.494.221 XSLinens FXÑLaundry Service, Hospital LH LS LX  MHÑBeds ANonly /stand /supply /vet MNE7.430.220 XSMattresses LH LS  MSVenoms obtained from Apis mellifera (Honey bee) and related species; they contain various enzymes, polypeptide toxins and other substances, some of which are allergenic or immunogenic or both; formerly used in rheumatism to stimulate the pituitary-adrenal system. Apitoxin goes here. PM78; MELITTEN was see under VENOMS 1975-77 HN78 MHÑBee Venoms ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS PIBees (66-77); Venoms (66-77) MND24.185.965.65.115 XSApis Venoms XUÑApamin; ÑMelitten; ÑWasp Venoms LH LS LU; ;  MHÑBeer ANonly /ad-poi-tox /anal /hist /rad eff /stand /supply MNJ1.125.91.221 LH  MHÑBees AN/microbiol /parasitol permitted; does not include WASPS; for stings, coord IM with INSECT BITES AND STINGS (IM); royal jelly goes here; PROPOLIS, a resinous substance from beehives, is also available MNB1.131.617.479.387 FXÑHONEY LH LX  MHÑBeetles AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111; fireflies go here MNB1.131.617.155.304 LH  MSA family of Gram-negative bacteria usually found in marine or fresh water. PM76 HN76 MHÑBeggiatoaceae ANin water, soil & decomposing matter PIBacteria (66-75) MNB3.350.300.170 LH  MSThe observable response a person makes to any situation. MHÑBehavior ANhuman only: animal behavior = BEHAVIOR, ANIMAL; only /drug eff /physiol /rad eff; ╥behavior therapy╙ = BEHAVIOR THERAPY CATALOG: do not use /in inf ( = CHILD BEHAVIOR) /in adolesc ( = ADOLESCENT BEHAVIOR) MNF1.145 FXÑGENETICS, BEHAVIORAL LH LX  OLpre-explosion = BEHAVIOR AD BEHAVIOR MECHANISMS (PX) MH*Behavior and Behavior Mechanisms (Non Mesh) MNF1 LH  MSThe application of modern theories of learning and conditioning in the treatment of behavior disorders. OLuse BEHAVIOR THERAPY to search BEHAVIOR MODIFICATION back thru 1974 PM66 HN66(64); BEHAVIOR MODIFICATION was see under BEHAVIOR THERAPY 1974-78 MHÑBehavior Therapy ANSPEC qualif; assertiveness training: coord IM with ASSERTIVENESS (IM) MNF4.754.137 XSBehavior Modification; CONDITIONING THERAPY XUÑDesensitization (Psychology); ÑImplosive Therapy LH LS; LU;  MSThe observable response an animal makes to any situation. PM64 HN64 MHÑBehavior, Animal ANonly /drug eff /physiol /rad eff; TN 18: MeSH headings of interest in animal studies CATALOG: form qualif = ETHOLOGY /form MNF1.145.113 FXÑEthology XUÑEliminative Behavior, Animal LH LX LU  OLpre-explosion = BEHAVIORAL AD MENTAL DISORDERS (PX) MH*Behavioral and Mental Disorders (Non Mesh) MNF3 LH  MSThe interdisciplinary field concerned with the development and integration of behavioral and biomedical science knowledge and techniques relevant to health and illness and the application of this knowledge and these techniques to prevention, diagnosis, treatment, and rehabilitation. PM83 HN83 MHÑBehavioral Medicine ANSPEC: SPEC qualif MNF4.96.80; G2.403.90 LH  MSDisciplines concerned with the study of human and animal behavior. PM69 HN69 MHÑBehavioral Sciences ANSPEC: SPEC qualif PIBehavior (66-69); specific discipline MNF4.96 LH  MH*Behavioral Symptoms (Non Mesh) MNF3.126 LH  MSA psychologic theory developed by James B. Watson concerned with studying and measuring behaviors that are observable. MHÑBehaviorism ANa school of psychology: do not confuse with BEHAVIOR; only /hist MNF2.739.138 LH  MHÑBehcet's Syndrome ANin translations spell Behcet's, not Behcet's MNC7.465.75; C11.941.500.800.116; C11.941.879.800.116; C17.66 XSTRIPLE SYMPTOM COMPLEX LH LS  MSA nonvenereal infection with an organism indistinguishable from Treponema pallidum; it is transmitted by nonsexual body contact. The primary lesions are in the mouth followed by lesions in the axillae, inguinal region and rectum; a latent period is followed by destruction of skin and bones. OLsearch TREPONEMAL INFECTIONS 1966-74 HN(75)63-67 MHÑBejel MNC1.252.847.840.155 DMÑTreponemal Infections LH LM  MHÑBelgium MNZ1.542.115 LH  OLuse BELIZE to search BRITISH HONDURAS back thru 1966 HN78; was BRITISH HONDURAS 1966-77 MHÑBelize MNZ1.107.169.133 XSBritish Honduras LH LS  MSA species of very poisonous Solanaceous plants yielding ATROPINE (hyoscyamine), SCOPOLAMINE, and other BELLADONNA ALKALOIDS, used to block the muscarinic autonomic nervous system. HN(86)63 MHÑBelladonna ANplant only: note BELLADONNA ALKALOIDS below; do not use /isol /pathogen MNB6.560.104; B6.660.105 XSAtropa Belladonna; Deadly Nightshade DMÑPlants, Toxic LH LS; LM  MSAlkaloids obtained from various plants, especially the deadly nightshade (Atropa belladonna), variety acuminata; atropine, hyoscyamine and scopolamine are classical, specific antimuscarinic agents with many pharmacologic actions; used mainly as antispasmodics. OLsearch TROPANES 1969-74 PM76; was see under BELLADONNA 1975-76, was see under TROPANES 1969-74 HN76(75); was see under BELLADONNA 1975-76, was see under TROPANES 1969-74 MHÑBelladonna Alkaloids ANdo not use /analogs /defic /physiol PIBelladonna (68-74); Tropanes (68-74) MND3.132.760.180; D3.132.889.180 LH  PMETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963 HNETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963 MHÑBemegride ANdo not use /biosyn /defic /physiol RN64-65-3 MND3.383.725.791.100; D15.128.224.149 XSETHYLMETHYLGLUTARIMIDE; Methetharimide LH LS;  MHÑBenactyzine ANdo not use /biosyn /defic /physiol RN302-40-9 MND2.241.223.601.238.306.140; D2.241.511.85.140; D15.236.872.331.111 LH  MHÑBence Jones Protein ANonly /anal /blood /biosyn /class /csf /genet /immunol /isol /metab /urine RN9006-99-9 MND12.776.124.486.485.900.120; D12.776.124.790.651.900.120; D12.776.377.715.548.900.120 LH  MSN,N-dimethyl-3-3-(1-benzylcycloheptyloxy)-propylamine. A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Synonyms: Fludilat; Halidor. HN(75) MHÑBencyclane ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2179-37-5 PIBenzyl Compounds (72-74); Cycloheptanes (71-74); Dimethylamines (74) MND2.455.426.392.368.284.100; D18.192.150; D18.918.150 DMÑCycloheptanes LH LM  MSA psychological test consisting of nine geometric designs on cards. The subject is asked to redraw them from memory after each one is presented individually. Synonym: Bender Visual Motor Gestalt Test. MHÑBender-Gestalt Test ANno qualif MNF4.711.513.180; F4.711.647.138 LH  MHÑBendroflumethiazide ANdo not use /biosyn /defic /physiol RN73-48-3 MND3.438.174.138; D18.162.276.126; D19.770.224.578.126 XSBendrofluazide LH LS  MSA genus of gram-negative facultatively anaerobic rods of the family Vibrionaceae found in fresh or sea water and formerly classified under Achromobacteriaceae. HN(78)63-65 MHÑBeneckea ANin fresh & sea water; formerly classed under Achromobacteriaceae PIAchromobacteriaceae (75-77); Bacteria (66-72); Gram-Negative Anaerobic Bacteria (76-77); Vibrionaceae (76-77) MNB3.475.900.160 DMÑVibrionaceae LH LM  OLuse BENIN to search DAHOMEY back thru 1966 HN80; was DAHOMEY 1966-79 MHÑBenin MNZ1.58.432.187 XSDahomey LH LS  MSMethyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate. A systemic agricultural fungicide used for control of certain fungal diseases of stone fruit. Frequently encountered synonym: Benlate. HN(75) MHÑBenomyl ANdo not use /biosyn /defic /physiol; /analogs NIM only RN17804-35-2 PIBenzimidazoles (72-74); Carbamates (72-74) MND2.241.81.251.125; D3.438.103.140; D5.723.288.100 DMÑCarbamates LH LM  MS4-Acetamidophenyl-O-acetylsalicylate. An ester of aspirin(acetylsalicylic acid) and paracetamol(para-acetamidophenol)with analgesic, antipyretic and anti-inflammatory activity, used in the treatment of rheumatoid diseases. It has less severe side effects than aspirin. Synonyms: Benoral; Fenasprate; Salipran. OLuse BENORILATE to search BENORYLATE back thru 1975 HN(80); was BENORYLATE see under SALICYLATES 1975-79 MHÑBenorilate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5003-48-5 PIAcetanilides (72-74); Salicylates (72-74) MND2.65.199.92.100; D2.241.223.106.505.700.100; D2.241.511.390.700.710.100; D2.755.410.700.710.100; D14.73.278.861.245; D26.74.75.832.118 XSBenorylate DMÑSalicylates LH LS LM  PM66 HN66 MHÑBenperidol ANdo not use /biosyn /defic /physiol RN2062-84-2 MND2.522.352.155; D15.236.872.331.241.155 LH  MSDL-Serine 2-(2,3,4-trihydroxybenzyl)hydrazide. An inhibitor of dopa decarboxylase used in parkinsonism to decrease dosage of levodopa. Synonym: Modopar. OLuse BENSERAZIDE to search SERYLTRIHYDROXY BENZYLHYDRAZINE back thru 1973 (as Prov 73-74) HN(79); was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1975-78, was SERYLTRIHYDROXY BENZYLHYDRAZINE 1973-74 (Prov) MHÑBenserazide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN322-35-0 PIBenzene (66-67); Benzene Derivatives (68-71); Benzyl Compounds (72); Hydrazines (66-72); Serine (66-72) MND2.442.175; D8.373.125; D14.307.140 XSRO 4-4602; Serazide; Seryltrihydroxybenzylhydrazine DMÑHydrazines LH LS; ; LM  OLsearch ALUMINUM SILICATES 1966-72 PM73; was see ALUMINUM SILICATES 1963-72 HN73; was see ALUMINUM SILICATES 1963-72 MHÑBentonite ANdo not use /analogs /biosyn /defic /physiol RN1302-78-9 PIAluminum Silicates (66-72) MND1.552.45.189.222; D1.836.189.222 XSMontmorrillonite LH LS  PM74 HN74(72) MHÑBenzaldehydes ANdo not use /analogs /biosyn /defic /physiol PIAldehydes (66-71) MND2.47.222 LH  MSA mixture of alkylbenzyldimethylammonium compounds; bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes; as surgical antiseptic; as preservative and emulsifier in drugs and cosmetics. Synonyms: Cequartyl; Germinol; Germitol; Osvan; Roccal; Rodalon; Zephirol. OLuse BENZALKONIUM COMPOUNDS to search BENZALKONIUM & BENZALKONIUM CHLORIDE back thru 1966 PM84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1968-80, was BENZALKONIUM CHLORIDE see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963 HN84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1964-80 (Prov 1964-67) see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963 MHÑBenzalkonium Compounds AND25-26 qualif MND2.92.102.80; D2.675.276.80; D20.187.83; D26.866.265.105 XSBenzalkonium LH LS  OLuse BENZAMIDES to search TRIMETHOBENZAMIDE 1966-84 PM73; TRIMETHOBENZAMIDE was heading 1963-84 HN73; TRIMETHOBENZAMIDE was heading 1963-84 MHÑBenzamides ANdo not use /analogs /biosyn /defic /physiol PIAmides (66-72); Benzoates (66-72) MND2.65.277; D2.241.223.106.162 XUÑDeet; ÑDinitolmide; ÑTiapride LH LU; ;  MSAmidines substituted with a benzene group. Benzamidine and its derivatives are known as peptidase inhibitors. HN(75) MHÑBenzamidines ANdo not use /analogs /biosyn /defic /physiol PIAmidines (72-74); Benzene Derivatives (72-74) MND2.78.100 DMÑAmidines LH LM  MHÑBenzanthracenes AND25-26 qualif MND4.615.117.306; D26.191.72.122 XUÑPerylene LH LU  PM68 HN68 MHÑBenzazepines ANdo not use /analogs /biosyn /defic /physiol MND3.438.79 LH  MS3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone. Uricosuric that acts by increasing uric acid clearance; used in gout. Synonyms: Desuric; Exurate; MJ 10061; L 2214; Minuric; Uracovac. HN(75) MHÑBenzbromarone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3562-84-3 PIBenzoates (71-74); Benzofurans (71-74); Bromine (73-74) MND3.438.127.110; D14.73.278.398.946.124; D26.74.75.574.946.124 DMÑBenzofurans LH LM  MSCyclohexatriene. Toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation; used as solvent in industry, in paints, varnishes, laquer thinners, gasoline, etc.; causes CNS damage acutely and bone marrow damage chronically and is carcinogenic; formerly used as parasiticide. Synonyms: coal naphtha; phenyl hydride; pyrobenzole. MHÑBenzene ANdo not confuse with benzil or benzal; do not use /biosyn /defic /physiol; /analogs = BENZENE DERIVATIVES RN71-43-2 MND2.455.426.559.222; D26.191.101 XSBenzol LH LS  PM68 HN68 MHÑBenzene Derivatives ANdo not use /analogs /biosyn /defic /physiol PIBenzene (66-67) MND2.455.426.559.389 LH  MHÑBenzene Hexachloride ANdo not confuse with HEXACHLOROBENZENE; do not use /biosyn /defic /physiol; TN 111 for eff on insects RN58-89-9 MND2.455.526.439.99; D5.723.491.491.122 XSHEXACHLOROCYCLOHEXANE; LINDANE; gamma-Benzene Hexachloride LH LS; ;  PM74 HN74 MHÑBenzenesulfonates ANdo not use /analogs /biosyn /defic /physiol MND2.241.866.540.244.222; D2.455.426.559.389.97; D2.886.610.244.222 XUÑCalcium Dobesilate; ÑEthamsylate; ÑPolyanethol Sulfonate; ÑSulfanilic Acids; ÑTiron LH LU; ; ; ;  MSBenzyldimethyl (2-(2-(p-1,1,3,3-tetramethylbutylphenoxy)ethoxy) ethyl)ammonium. Bactericidal cationic quaternary ammonium surfactant used as topical anti-infective agent; in medicaments, deodorants, mouthwashes, etc., and as a disinfectant of apparatus, etc., in the food processing and pharmaceutical industry and surgery; also as a preservative; toxic orally due to neuromuscular blockade. Synonyms: Anzol; Hyamine 1622; Phemeride; Phemerol; Phemithyn; Quatrachlor; Septin, Solamin; Teramine. OLuse BENZETHONIUM to search BENZETHONIUM COMPOUNDS back thru 1975 HN(81); was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80 MHÑBenzethonium AND26-26 qualif; /analogs NIM only RN121-54-0 PIAmmonium Compounds (69-74); Benzyl Compounds (71-74); Phenyl Ethers (74) MND2.92.102.90; D2.675.276.90; D20.187.100; D26.866.265.110 DMÑAmmonium Compounds LH LM  MSCompounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed. PM75 HN75 MHÑBenzhydryl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BENZHYDRYL CPDS PIBenzene Derivatives (68-74); Benzyl Compounds (72-74) MND2.455.426.559.389.115 XSDiphenylmethyl Compounds XUÑMethylenebis(chloroaniline) LH LS LU  MSP-Diaminobiphenyl. Very toxic industrial chemicals; absorbed through the skin, cause lethal blood, bladder, liver and kidney damage and are potent, broad spectrum carcinogens in most species. Synonym: 4,4'-Diphenyldiamine. OLto search BENZIDINE use BENZIDINES back thru 1975 & BIPHENYL COMPOUNDS 1966-74 PM77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74; 3,3'-DIAMINOBENZIDINE & DIANISIDINE were see under AMINOBIPHENYL COMPOUNDS 1975-76 HN77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74 MHÑBenzidines ANdo not use /analogs /biosyn /defic /physiol MND2.455.426.559.389.185.100; D26.191.111 XSBianilines; Biphenyldiamines XUÑ3,3'-Diaminobenzidine; Ñ3,3'-Dichlorobenzidine; ÑDianisidine LH LS; LU; ;  MHÑBenzilates ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.601.238.306; D2.241.511.85 LH  MHÑBenzimidazoles ANdo not use /analogs /biosyn /defic /physiol MND3.438.103 XUÑCambendazole; ÑClemizole; ÑEtonitazene; ÑFenbendazole; ÑHoe 33258 LH LU; ; ; ;  MS2-Ethyl-3-benzofuranyl-4-hydroxy-3,5-diiodopheyl ketone. A uricosuric agent that probably inhibits urate reabsorption; it has also been used as a coronary vasodilator. It may interfere with blood clotting and thyroid function. Synonyms: Dilafurane; Dila-Vasal; Algocor; Amplivix; Cardivix. HN(75) MHÑBenziodarone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN68-90-6 PIBenzofurans (68-74); Iodobenzoates (74) MND3.438.127.125; D14.73.278.398.946.128; D18.918.163; D26.74.75.574.946.128 DMÑBenzofurans LH LM  MSPotent mutagen and carcinogen. PM85 HN85 MHÑBenzo(a)pyrene ANdo not use /biosyn /defic /physiol RN50-32-8 PIBenzopyrenes (66-84) MND4.615.799.306.300; D5.569.468.300; D26.191.126 XS3,4-Benzopyrene LH LS  MHÑBenzoates ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.106 XUÑDicamba; ÑHexobendine; ÑTrimebutine LH LU; ;  PM65; was ETHYL AMINOBENZOATE 1963-64 HN65; was ETHYL AMINOBENZOATE 1963-64 MHÑBenzocaine ANdo not use /biosyn /defic /physiol RN94-09-7 MND2.241.223.106.61.75.100; D14.211.83 XSBensokain; ETHYL AMINOBENZOATE; Ethoform LH LS; ;  PM68 HN68 MHÑBenzocycloheptenes ANdo not use /analogs /biosyn /defic /physiol MND4.615.181 LH  MSSubstances with a benzodiazepine ring structure widely used to treat anxiety and neuroses; they also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants and anesthesia adjuvants. PM75 HN75 MHÑBenzodiazepine Tranquilizers ANdo not use /analogs /biosyn /defic /physiol PIBenzazepines (68-73); Benzodiazepinones (74); Tranquilizing Agents (66-74) MND15.236.872.659.191 XUÑBromazepam; ÑCamazepam; ÑClorazepate Dipotassium; ÑEstazolam; ÑMedazepam; ÑTemazepam LH LU; ; ; ; ;  MSA two-ring heterocyclic compound consisting of a benzene ring fused to a diazepine ring. Permitted is any degree of hydrogenation, any substituents and any H-isomer. PM75 HN75 MHÑBenzodiazepines ANdo not confuse with BENZODIAZEPINONES; do not use /analogs /biosyn /defic /physiol PIBenzazepines (68-74) MND3.438.79.80 LH  PM74 HN74 MHÑBenzodiazepinones ANdo not confuse with BENZODIAZEPINES; do not use /analogs /biosyn /defic /physiol MND3.438.79.80.70 XUÑAnthramycin LH LU  MSPotent arylhydrocarbon hydroxylase inhibitors. Also inhibit the binding of nucleic acids to benzopyrenes and related compounds. Include all isomers; the 7,8-isomer is most frequently encountered. HN(79) MHÑBenzoflavones ANdo not use /analogs /biosyn /defic /physiol PIFlavones (66-78) MND3.438.150.266.450.175; D8.373.150 DMÑFlavones LH LM  PM66 HN66 MHÑBenzofurans ANdo not use /analogs /biosyn /defic /physiol MND3.438.127 XSCoumarones XUÑBenzbromarone; ÑBenziodarone; ÑUsnic Acid LH LS LU; ;  MHÑBenzoin AND25-26 qualif RN119-53-9 MND25.786.389 LH  MS5-Benzenesulfonamido-1,3,4-thiadiazole-2-sulfonamide. Selective renal carbonic anhydrase inhibitor; may also be of use in certain cases of respiratory failure. Synonym: W 1803. HN(76) MHÑBenzolamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3368-13-6 PISulfonamides (70-75); Thiadiazoles (72-75) MND2.65.884.120; D2.886.590.700.120; D3.383.871.867.120; D8.373.220.200; D19.770.224.266.155 XSCL 11366 DMÑThiadiazoles LH LS LM  OLto search BENZOMORPHAN use BENZOMORPHANS back thru 1975, MORPHINANS 1973-74 & BRIDGED COMPOUNDS 1966-72 HN(85); was BENZOMORPHAN see under MORPHINANS 1973-84, was BENZOMORPHAN see under BRIDGED COMPOUNDS 1966-72 MHÑBenzomorphans ANdo not use /analogs /biosyn /defic /physiol MND3.132.610.422.106 DMÑMorphinans LH LM  MS4,4'-bis-(Dimethylamino)-benzophenonimide. An aniline dye used as a disinfectant and an antiseptic agent; it is weakly fluorescing and binds specifically to certain proteins. HN(75) MHÑBenzophenoneidum ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2465-27-2 PIAniline Compounds (69-74); Imines (72-74); Dimethylamines (74) MND2.92.146.215; D26.408.124 XSAuramine O; Pyoctanium aureum DMÑAniline Compounds LH LS; LM  PM68 HN68 MHÑBenzophenones ANdo not use /analogs /biosyn /defic /physiol PIKetones (66-67) MND2.522.223 LH  PM66 HN66 MHÑBenzopyrans ANdo not confuse with BENZOPYRENES; do not use /analogs /biosyn /defic /physiol MND3.438.150 XUÑCentchroman; ÑChromans; ÑCitrinin; ÑEllagic Acid; ÑHematoxylin; ÑVisnadin LH LU; ; ; ; ;  MSA drug-metabolizing, cytochrome P-448 enzyme which catalyzes the hydroxylation of benzopyrene to 3-hydroxybenzopyrene in the presence of reduced flavoprotein and molecular oxygen. Also acts on certain anthracene derivatives. An aspect of EC 1.14.14.1. HN(75); was see under HYDROXYLASES 1975-76 MHÑBenzopyrene Hydroxylase ANdo not use /analogs RNEC 1.14.14.- PIBenzopyrenes (68-74); Hydroxylases (68-74) MND8.586.682.420.80.110 XSBenzopyrene-3-Monooxygenase DMÑAryl Hydrocarbon Hydroxylases LH LS LM  MHÑBenzopyrenes ANdo not confuse with BENZOPYRANS; do not use /analogs /biosyn /defic /physiol MND4.615.799.306; D26.191.788.112 LH  MS2-Hydroxy-2-ethyl-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11B-hexahydro-2H-benzo(A)quinolizine. Proposed catecholamine depletor. HN(75) MHÑBenzoquinolizine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN303-75-3 PIQuinolizines (70) MND3.438.834.200 XSRO 4-1284 DMÑQuinolizines LH LS LM  MHÑBenzothiadiazines ANdo not use /analogs /biosyn /defic /physiol MND3.438.174 LH  PM68 HN68 MHÑBenzothiepins ANdo not use /analogs /biosyn /defic /physiol MND3.438.197 LH  PM66 HN66 MHÑBenzoxazoles ANincludes benzoxazolines, benzoxazolidines; do not use /analogs /biosyn /defic /physiol MND3.438.221 XUÑChlorzoxazone LH LU  PM68 HN68 MHÑBenzoxepins ANdo not use /analogs /biosyn /defic /physiol MND3.438.245 LH  MSA peroxide derivative which has been used topically for burns and as a dermatologic agent in the treatment of acne and poison ivy; also as bleach in the food industry. Synonyms: Benoxyl; Lucidol; Persadox; Vanair; Vanoxide. HN(76) MHÑBenzoyl Peroxide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN94-36-0 PIBenzoates (72-75); Peroxides (72-75) MND1.655.498.631.150; D2.241.223.106.218; D26.368.627.131 XSBenzoyl Superoxide DMÑPeroxides LH LS LM  MSN-benzoyl-L-arginine-p-nitroanilide. A chromogenic substrate which permits direct measurement of peptide hydrolase activity, e.g. papain and trypsin, by colorimetry. The substrate liberates p-nitroaniline as a chromogenic product. HN(75) MHÑBenzoylarginine Nitroanilide ANdo not use /biosyn /defic /physiol; DF: BAPA PIArginine (71-74); Anilides (71-74); Nitro Compounds (71-74); Benzamides (74) MND2.65.199.200; D12.125.95.104.100 DMÑArginine LH LM  MSN-[4-Guanidino-1-(2-naphthylcarbamoyl)butyl]-DL-benzamide. An enzyme substrate which permits the measurement of peptide hydrolase activity, e.g. trypsin and thrombin. The enzymes liberate 2-naphthylamine, which is measured by colorimetric procedures. OLuse BENZOYLARGININE-2-NAPHTHYLAMIDE to search BENZOYLARGININE BETA NAPHTHYLAMIDE back thru 1976 HN(77); was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976 MHÑBenzoylarginine-2-Naphthylamide ANdo not use /biosyn /defic /physiol; DF: BANA RN305-09-9 PIArginine (73-74) /AA (75); Benzamides (74-75); Naphthalenes (73-75) MND2.65.300; D12.125.95.104.95 XSBenzoylarginine beta-Naphthylamide DMÑArginine LH LS LM  MSThe benzoic acid ester of choline. HN(76) MHÑBenzoylcholine RN2208-04-0 PICholine (68-74) /AA (75); Benzoates (72-75) MND2.92.102.232.100; D2.241.223.106.210; D2.675.276.232.100 DMÑCholine LH LM  HN(66) MHÑBenzphetamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN156-08-1 MND2.92.471.683.152.619.307; D16.893.120.596.117; D26.128.127.585.257 DMÑPhenethylamines LH LM  HN(72) MHÑBenztropine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN86-13-5 PIANTIPARKINSON DRUGS; TROPANES MND3.132.889.244; D3.605.869.270; D14.307.223 DMÑTropanes LH LM  MS1-Benzyl-3-(3-dimethylamino)-propoxy)-1H-indazole monohydrochloride. An analgesic, antipyretic and anti-inflammatory agent used to reduce post-surgical and post-traumatic pain and edema and promote healing. HN(75) MHÑBenzydamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN642-72-8 PIBenzyl Compounds (71-74); Dimethylamines (73-74); Indazoles (73-74); Pyrazoles (68-73) MND3.383.694.487.130; D3.438.449.130; D14.73.278.200; D26.74.75.264 XSBenzindamine DMÑPyrazoles LH LS LM  MSAlcohols derived from the aryl radical C7H7 and defined by C7H80. Permitted are any substituents on the benzene ring. HN(75) MHÑBenzyl Alcohols ANdo not use /analogs /biosyn /defic /physiol PIAlcohols (72-74); Benzyl Compounds (72-74) MND2.33.390; D2.455.426.559.389.140.200 XSPhenylcarbinols; Phenylmethanols DMÑBenzyl Compounds LH LS; LM  PM72 HN72(71) MHÑBenzyl Compounds ANdo not confuse with benzil; do not use /analogs /biosyn /defic /physiol; DF: BENZYL CPDS PIBenzene Derivatives (68-70) MND2.455.426.559.389.140 XUÑBenzyl Alcohols LH LU  MS1,1'-Bis(phenylmethyl)4,4'-bipyridinium dichloride. Oxidation-reduction indicator. HN(75) MHÑBenzyl Viologen ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13096-46-3 PIBenzyl Compounds (72-74); Pyridinium Compounds (70-74) MND3.383.725.762.925.100 DMÑPyridinium Compounds LH LM  MSAn aspect of monoamine oxidase, EC 1.4.3.4. Catalyzes the oxidation of benzylamine to form benzaldehyde, ammonia and hydrogen peroxide. HN(75) MHÑBenzylamine Oxidase ANdo not use /analogs RNEC 1.4.3.- PIBenzyl Compounds (73-74); Monoamine Oxidase (73-74) MND8.586.682.135.697.100 DMÑMonoamine Oxidase LH LM  MSToluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. PM87; was see under AMINES 1976-86 HN87(76); was see under AMINES 1976-86 MHÑBenzylamines ANdo not use /analogs /biosyn /defic /physiol PIAmines (69-75); Benzyl Compounds (74-75) MND2.92.200; D2.455.426.559.389.140.210 XSPhenylmethylamine; alpha-Aminotoluene LH LS;  MSCompounds containing the PhCH= radical. PM75 HN75 MHÑBenzylidene Compounds AN= benzals; do not use /analogs /biosyn /defic /physiol; DF: BENZYLIDENE CPDS PIBenzene Derivatives (68-74) MND2.455.426.559.389.150 LH  MHÑBephenium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BEPHENIUM CPDS MND2.92.102.102; D2.675.276.102; D21.201.287.90 LH  MS5,6-Dihydro-9,10-dimethoxybenzo[g][1,3]benzodioxolo[5,6-a] quinolizinium hydroxide. An alkaloid from Hydrastis canadensis L., Berberidaceae. Also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal. Synonym: Umbellatine. HN(76) MHÑBerberine ANdo not use /defic /physiol; /analogs NIM only RN2086-83-1 PIBerbines (72-75); Dioxolanes (75); Dioxoles (72-74) MND3.132.117.100; D3.549.168.100 DMÑBerbines LH LM  PM69 HN69 MHÑBerbines ANdo not use /analogs /biosyn /defic /physiol PIAlkaloids (66-68) MND3.132.117; D3.549.168 XUÑBerberine LH LU  MHÑBeriberi ANconsider also THIAMINE DEFICIENCY MNC18.654.223.133.699.827.223 LH  MHÑBerkelium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-40-6 MND1.287.143; D1.552.517.150 LH  MHÑBerlin ANincludes East or West Berlin MNZ1.433.128; Z1.542.315.182 LH  MHÑBermuda MNZ1.295.390 LH  MSA familial bleeding disorder characterized by a long bleeding time, unusually large platelets, and impaired prothrombin consumption. HN(86) MHÑBernard-Soulier Syndrome PIBlood Platelet Disorders (67-85) MNC15.378.463.205.120 XSGiant Platelet Syndrome DMÑBlood Platelet Disorders LH LS LM  MSA lung disease caused by exposure to metallic beryllium or its soluble salts. PM79 HN79 MHÑBerylliosis ANdo not use /chem ind; do not coord with OCCUPATIOAL DISEASES PILung Diseases (66-78); Occupational Diseases (66-78); Pneumoconiosis (66-78) MNC8.381.655.205; C21.447.800.225 XSBeryllium Disease LH LS  MHÑBeryllium ANBe-9; do not use /analogs /biosyn /defic /physiol; Be-6-8, 10, 11 = BERYLLIUM (IM) + RADIOISOTOPES (IM); /ad-poi-tox: consider also BERYLLIOSIS RN7440-41-7 MND1.248.497.300.333.140; D1.268.93; D1.552.539.199 LH  OLuse BETA GLOBULINS to search BETA GLOBULIN back thru 1966 PM75; was BETA GLOBULIN 1965-74 HN75; was BETA GLOBULIN 1963-74 (Prov 1963-64) MHÑBeta Globulins ANdo not use /analogs /blood; do not confuse with beta 2 A-globulin or beta 2 M-globulin ( = BETA 2 MICROGLOBULIN) MND12.776.124.790.223; D12.776.377.715.182 XUÑBeta Trace Protein LH LU  MSA stream of positive or negative electrons ejected with high energy from a disintegrating atomic nucleus; most biomedically used isotopes emit negative particles (electrons or negatrons, rather than positrons). Cathode rays are low energy negative electrons produced in cathode ray tubes, also called television tubes or oscilloscopes. OLto search CATHODE RAYS use BETA RAYS back thru 1976 & RADIATION 1966-75 PM85; CATHODE RAYS was see under RADIATION, IONIZING 1976-84, was see under RADIATION 1963-75 HN85; CATHODE RAYS was see under RADIATION, IONIZING 1976-84, was see under RADIATION 1963-75 MHÑBeta Rays ANNIM: Manual 19.4.52 PIElectrons (66-84); Elementary Particles (70-84); Radiation (66-84) MNH1.671.579.182; H1.671.768.513.125 XSBeta Particles; Cathode Rays LH LS;  MSWaves in the electroencephalogram which have a frequency of greater than 13 cycles per second. HN(75) MHÑBeta Rhythm ANno qualif MNE1.236.257.401.250; E1.399.277.250 XSElectroencephalography, Beta Rhythm DMÑElectroencephalography LH LS LM  MSA low molecular weight protein (31,000) consisting of a single polypeptide chain and migrating in the tau fraction of the beta globulin region. Present in many human organs and tissues but found in highest concentrations in CSF and genital organs. HN(77) MHÑBeta Trace Protein ANdo not use /analogs /blood PIBeta Globulins (74-76) MND12.776.124.790.223.175; D12.776.377.715.182.175 DMÑBeta Globulins LH LM  MSA protein of approximately 11,000 molecular weight associated with the outer membrane of many cells including lymphocytes. It is present in small amounts in serum csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinemia, renal failure, or kidney transplants. PM84; was see under BETA GLOBULINS 1975-83 HN84(75); was see under BETA GLOBULINS 1975-83 MHÑBeta 2 Microglobulin AN/biosyn /physiol permitted; do not use /analogs /blood PIBeta Globulins (73-74) MND12.776.124.790.223.100; D12.776.377.715.182.100 LH  MS1,4-alpha-D-Glucan maltohydrolase. Catalyzes the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. EC 3.2.1.2. HN(78) MHÑBeta-Amylase ANdo not use / analogs RNEC 3.2.1.2 PIAmylases (66-77) MND8.586.277.450.66.100 DMÑAmylases LH LM  MSbeta-D-Galactoside galactohydrolases. A group of enzymes which catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. EC 3.2.1.23. HN(78) MHÑBeta-Galactosidases ANdo not use /analogs; /defic: consider also LACTOSE INTOLERANCE RNEC 3.2.1.23 PIGalactosidases (66-77) MND8.586.277.450.410.100 XSLactases DMÑGalactosidases LH LS LM  MSbeta-D-Glucoside glucohydrolases. Catalyze the hydrolysis of terminal non-reducing beta-D-glucose residues with release of beta-glucose. EC 3.2.1.21. HN(78) MHÑBeta-Glucosidases ANdo not use / analogs RNEC 3.2.1.21 PIGlucosidases (66-77) MND8.586.277.450.420.100 XSCellobiases DMÑGlucosidases LH LS LM  MSEnzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. EC 3.5.2.- PM79; CEPHALOSPORINASE was see under AMIDOHYDROLASES 1968-78; PENICILLINASE was heading 1963-78 HN79 MHÑBeta-Lactamases ANdo not use /analogs RNEC 3.5.2.- PIAmidohydrolases (66-78); Cephalosporinase (75-78); Penicillinase (66-78) MND8.586.277.87.180 XUÑCephalosporinase LH LU  MSThe enzyme hydrolyzes terminal non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. Acts on glucosides, galactosides, and several oligosaccharides. Hexosaminidase A cleaves GM2, GA2, globosides, and hexosamine oligosaccharides. Deficiency of this isoenzyme causes Tay-Sachs disease. Hexosaminidase B cleaves all the above substrates except GM2. A deficiency of both A and B causes Sandhoff disease. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease. EC 3.2.1.52 PM87 HN87 MHÑBeta-N-Acetylhexosaminidase ANdo not use /analogs; do not confuse with ACETYLGLUCOSAMINIDASE RNEC 3.2.1.52 PIGlycoside Hydrolases (66-70); Hexosaminidases (71-86) MND8.586.277.450.483.180; D8.586.348.150 XSBeta-Hexosaminidase; Hex A; Hex B; Hexosaminidase; Hexosaminidase A; Hexosaminidase B; Hexosaminidase Isoenzymes LH LS; ; ; ; ; ;  MSA platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and measurement of progress of thromboembolic disorders. PM87; was see under BETA GLOBULINS 1980-86 HN87(80); was see under BETA GLOBULINS 1980-86 MHÑBeta-Thromboglobulin AN/biosyn /physiol permitted; do not use /analogs /blood; DF: BETA TG PIBeta Globulins (66-79) MND12.776.124.790.223.160; D12.776.377.715.182.160 LH  MS2-[2-(Methylamino)ethyl]pyridine. A physiological histamine analog vasodilator agent used in Meniere's disease and in vascular headaches; may exacerbate bronchial asthma and peptic ulcer. Synonyms: Mersilon; PT-9; Serc; Simmenier. HN(67) MHÑBetahistine AN/analogs NIM only RN5638-76-6 MND3.383.725.86; D8.373.164; D18.918.169 DMÑPyridines LH LM  PM68 HN68(64) MHÑBetaine RN107-43-7 MND2.92.102.125; D2.675.276.125; D10.642.100 XSLYCINE; OXYNEURINE LH LS;  PM64 HN64(63) MHÑBetamethasone ANdo not use /biosyn /defic /physiol RN378-44-9 MND4.808.745.432.769.199; D4.808.908.93; D6.597.481.561.353.120; D6.597.481.561.478.113; D26.74.125.123; D26.74.125.447.123; D26.74.148.447.123; D26.368.99.447.123 XSBetadexamethasone; Flubenisolone XUÑBetamethasone 17-Valerate; ÑClobetasol LH LS; LU;  MS9-Fluoro-11 beta,17,21-trihydroxy-16 beta-methylpregna-1,4-diene-3,20-dione-17-valerate. A synthetic glucocorticoid with high topical anti-inflammatory activity and relatively low systemic anti-inflammatory activity. Synonyms: Betnesol-V; Betneval; Betnovate; Celestan-V; Celestoderm-V; Ecoval 70; Rinderon V; Valisone-Cream. HN(76) MHÑBetamethasone 17-Valerate ANdo not use /biosyn /defic /physiol RN2152-44-5 PIBetamethasone (74) /AA (75); Valerates (74-75) MND4.808.745.432.769.199.150; D4.808.908.93.150; D6.597.481.561.353.120.150; D6.597.481.561.478.113.150; D26.74.125.123.120; D26.74.125.447.123.120; D26.74.148.447.123.120; D26.368.99.447.123.120 XSFlubenisolonvalerate DMÑBetamethasone LH LS LM  MS3-(Beta-Aminoethyl)pyrazole. A drug used clinically to test gastric secretory function. Synonym: Histalog. HN(75) MHÑBetazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN105-20-4 PIEthylamines (72-74); Pyrazoles (68-74) MND3.383.694.100; D19.316.220 XSAmetazole DMÑPyrazoles LH LS LM  OLuse BETHANECHOL COMPOUNDS to search BETHANECHOL back thru 1966 (as Prov 66-67) & URECHOLINE CHLORIDE back thru 1968 PM68 HN68; was BETHANECHOL 1964-67 (Prov); URECHOLINE was URECHOLINE CHLORIDE see under BETHANECHOL COMPOUNDS 1968-76 MHÑBethanechol Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BETHANECHOL CPDS MND2.92.102.148; D2.675.276.148; D16.698.245 XSUrecholine LH LS  MS1-Benzyl-2,3-dimethylguanidine sulfate. A guanidinium anti-hypertensive agent which acts by blocking adrenergic transmission. The precise mode of action is not clear. HN(75) MHÑBethanidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN55-73-2 PIBenzyl Compounds (72-74); Guanidines (68-74) MND2.78.370.120; D16.848.415.125; D18.162.75 DMÑGuanidines LH LM  MHÑBeverages ANonly /ad-poi-tox /anal /class /rad eff /stand /supply; orange & grapefruit juices: coord IM with CITRUS FRUITS (IM) MNJ1.125 XSHerbal Teas; Teas, Medicinal XUÑCarbonated Beverages LH LS; LU  MS2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)- 2-methylpropionic acid. Antilipemic agent which lowers cholesterol and triglycerides. It decreases low density lipoproteins and increases high density lipoproteins. PM84 HN84 MHÑBezafibrate ANdo not use /biosyn /defic /physiol RN41859-67-0 PIBenzamides (77-78); Clofibrate/AA (78-83); Phenylbutyrates (77-78) MND2.241.81.161.325.140; D2.241.81.465.240.230.140; D10.162.260 LH  MSConcretions of swallowed hair, fruit or vegetable fibers, or similar substances found in the alimentary canal. MHÑBezoars ANcoord IM with organ (IM), not organ/dis: Manual 21.39, 23.21 MNC21.866.392.183 XSHair Balls; Trichobezoars LH LS;  MHÑBhutan MNZ1.252.245.162 LH  PM68 HN68 MHÑBibenzyls ANdo not use /analogs /biosyn /defic /physiol MND2.455.426.559.389.140.308 LH  MHÑBible ANno qualif; Old and New Testament only: does not include Koran (index under ISLAM + specific aspect discussed in article); includes Talmud MNK1.517.172 LH  MHÑBibliography ANIM; no qualif; policy: Manual 33.4-33.5, 36.22; TN 121: differentiate from LITERATURE; med bibliogr: see note on BIBLIOGRAPHY OF MEDICINE MNL1.178.682.99; L1.453.183 FXÑDOCUMENTATION LH LX  MHÑBibliography of Medicine ANGEN; SPEC; med bibliogr goes here for general articles only; do not use for specific medical subjects: use BIBLIOGRAPHY instead; no qualif CATALOG: /geog /form MNL1.178.682.99.308; L1.453.183.224 LH  PMINSCRIPTIONS was heading 1963-65 HNINSCRIPTIONS was heading 1963-65 MHÑBibliography, Descriptive ANcataloging term; no qualif MNL1.453.183.190 LH  MHÑBibliography, National ANcataloging term: no qualif CATALOG: /geog /form MNL1.178.682.99.183 LH  MSA form of supportive psychotherapy in which the patient is given carefully selected material to read. MHÑBibliotherapy ANno qualif MNE2.831.169; F4.754.168 FXÑBooks LH LX  MHÑBicarbonates ANdo not use /analogs /biosyn /defic /physiol MND1.154.453.183 LH  MS6(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g) isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one. Isoquinoline alkaloid from Dicentra cucullaria and other plants; inhibits GABA and thus causes convulsions; used as GABA blockader in CNS research. PM80; was see under ISOQUINOLINES 1975-79 HN80(75); was see under ISOQUINOLINES 1975-79 MHÑBicuculline ANdo not use /defic /physiol RN485-49-4 PIAlkaloids (72-74); Dioxoles (72-74); Isoquinolines (71-74) MND3.132.130; D3.438.531.100; D15.128.224.175 LH  PM65 HN65 MHÑBicuspid MNA14.254.860.94 XSPREMOLAR LH LS  HN(83) MHÑBicycling ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) or ACCIDENTS, TRAFFIC (IM) + specific inj (IM); Manual 30.31+; note BICYCLE ERGOMETRY TEST above PIExercise Test (66-82); Exertion (66-82) MNI3.450.642.845.140 DMÑSports LH LM  OLsearch BRIDGED COMPOUNDS 1966-74 HN(75) MHÑBicyclo Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BICYCLO CPDS MND2.219.308; D4.615.236.308 DMÑBridged Compounds LH LM  MSA rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium; a genus of the family Actinomycetaceae. Inhabits the intestines and feces of humans as well as the human vagina. PM84 HN84 MHÑBifidobacterium ANdo not use /blood-csf-urine; infection: coord NIM with ACTINOMYCETALES INFECTIONS (IM) PIActinomycetaceae (75-83); Actinomycetales (67-74) MNB3.100.67.137.230 LH  PM66 HN66(65) MHÑBiguanides ANdo not use /analogs /biosyn /defic /physiol MND2.78.370.141 XUÑBuformin LH LU  MHÑBile ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; stasis = CHOLESTASIS; drugs stimulating or increasing flow of bile = CHOLAGOGUES AND CHOLERETICS MNA12.838.87 LH  MHÑBile Acids and Salts AN/biosyn /physiol permitted; do not use /analogs; DF: BILE ACIDS MND19.316.246; D19.316.508.147 XSBile Salts LH LS  MSMinute intercellular channels that occur between liver cells and carry bile towards interlobar bile ducts. Also called bile capillaries. OLsearch BILE DUCTS, INTRAHEPATIC 1980 HN(81); was see BILE DUCTS, INTRAHEPATIC 1980 MHÑBile Canaliculi ANalso called ╥bile capillaries╙ PIBile Ducts, Intrahepatic (66-80) MNA3.159.183.158.125; A3.620.150.125 DMÑBile Ducts, Intrahepatic LH LM  PM80 HN80 MHÑBile Duct Diseases ANinflamm dis = CHOLANGITIS; calculi = CHOLELITHIASIS (IM) + BILE DUCT DISEASES (NIM) or specific bile duct (NIM) PIBile Ducts (66-79); specific bile duct; Biliary Tract Diseases (66-79); Cholestasis (66-79) MNC6.130.120 LH  MHÑBile Duct Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific bile duct (IM) + histol type of neopl (IM) MNC4.588.274.120.250; C6.130.120.120 LH  MSImpairment of bile flow through the hepatic, cystic, or common bile ducts or Vater's ampulla. Synonym: surgical jaundice. PM80 HN80 MHÑBile Duct Obstruction, Extrahepatic ANcoord IM with specific bile duct (IM) or specific precoord bile duct dis (IM) PIBiliary Tract Diseases (66-79); Bile Ducts (66-79); specific extrahepatic bile duct; Cholestasis (66-79) MNC6.130.120.150; C6.130.450.150; C23.888.498.250.150 XSBiliary Stasis, Extrahepatic; Cholestasis, Extrahepatic; Jaundice, Cholestatic, Extrahepatic; Jaundice, Obstructive, Extrahepatic LH LS; ; ;  MHÑBile Ducts AN/abnorm: BILIARY ATRESIA is also available; /radiogr = CHOLANGIOGRAPHY; inflammation = CHOLANGITIS; calculi = CHOLELITHIASIS (IM) + BILE DUCT DISEASES (NIM) MNA3.159.183 LH  MSPassages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct. MHÑBile Ducts, Intrahepatic ANdo not confuse with HEPATIC DUCT, COMMON, the external junction of right & left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES (NIM); neopl: coord IM with BILE DUCT NEOPLASMS (IM); inflammation: coord IM with CHOLANGITIS (IM); BILE DUCT OBSTRUCTION, INTRAHEPATIC see CHOLESTASIS, INTRAHEPATIC is also available MNA3.159.183.158; A3.620.150 XUÑBile Canaliculi LH LU  MHÑBile Pigments AN/biosyn /physiol permitted; do not use /analogs MND11.557.193 LH  MSReflux of bile mainly into the upper digestive tract, but also into the pancreas. HN(81) MHÑBile Reflux PIBile (66-80); Gastritis (66-80) MNC6.130.140; C6.405.748.240.140 DMÑBiliary Tract Diseases LH LM  MSAtresia of the biliary tract, most commonly the the extrahepatic bile ducts. PM87 HN87 MHÑBiliary Atresia ANdo not use /congen PIBile Ducts/abnormalities (66-86) MNC6.130.161; C16.131.314.125 LH  MHÑBiliary Dyskinesia MNC6.130.184 LH  MSAbnormal passage communicating with the biliary tract. MHÑBiliary Fistula ANfistula policy: Manual 23.25+ MNC6.130.246 FXÑFistula LH LX  MHÑBiliary Tract AN/abnorm: BILIARY ATRESIA is also available; /radiogr permitted but CHOLECYSTOGRAPHY for gallbladder x-ray & CHOLANGIOGRAPHY for bile duct x-ray are available; calculi = CHOLELITHIASIS MNA3.159 FXÑCHOLAGOGUES AND CHOLERETICS; ÑCHOLANGIOGRAPHY; ÑCHOLECYSTOGRAPHY LH LX; ;  PM66 HN66 MHÑBiliary Tract Diseases ANGEN: prefer specifics; BILIARY ATRESIA is also available; inflamm dis = CHOLECYSTITIS or CHOLANGITIS; calculi= CHOLELITHIASIS MNC6.130 FXÑCHOLANGIOGRAPHY XUÑBile Reflux LH LX LU  PM80 HN80 MHÑBiliary Tract Neoplasms ANGEN: prefer specifics; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIBile Duct Neoplasms (66-79); Gallbladder Neoplasms (66-79) MNC4.588.274.120; C6.130.320 LH  MHÑBilirubin AN/biosyn /physiol permitted RN635-65-4 MND11.557.193.184 FXÑHYPERBILIRUBINEMIA XUÑBiliverdine LH LX LU  MS1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of amphibia and of birds, but not in normal human bile or serum. HN(76) MHÑBiliverdine ANin amphibia & birds but not in normal human bile; /biosyn /physiol permitted RN114-25-0 PIBilirubin (69-75) MND11.557.193.184.200 XSDehydrobilirubin; Ooecyan; Uteroverdine DMÑBilirubin LH LS; ; LM  MSThe reactive parts of a macromolecule that directly participate in its specific combination with another molecule. PM68 HN68 MHÑBinding Sites ANNIM; only /drug eff /rad eff; note category; restrict to site of binding: do not use as substitute for chem or metab mechanism of binding; do not coord with RECEPTORS terms unless the site of binding is particularly discussed PIAntigen-Antibody Reactions (66-67); Enzymes (66-67) MNG6.184.154 XSACTIVE SITE; COMBINING SITE; REACTIVE SITE XUÑAllosteric Site LH LS; ; LU  MSLocal surface sites on antibodies which react with antigen determinant sites on antigens; they are the variable region of the Fab fragment of the immunoglobulin. PM73 HN73; was in Cat D only 1973-76 MHÑBinding Sites, Antibody ANonly /drug eff /genet /rad eff; ANTIBODY AFFINITY is also available PIAntibodies (66-72); Antigens (66-72); Binding Sites (68-72) MND24.611.125.345; G4.610.143.232; G6.184.154.408 XSANTIBODY BINDING SITES FXÑAntigen-Antibody Reactions LH LS LX  PM73 HN73 MHÑBinding, Competitive ANNIM; only /drug eff /rad eff; ╥blocking antibodies╙ is ANTIBODIES (IM) + BINDING, COMPETITIVE (NIM) PIBinding Sites (68-72) MNG6.184.154.309 XSCOMPETITIVE BINDING LH LS  MHÑBiobibliography ANno qualif; IM; Manual 33.6 CATALOG: /geog /form /lang MNL1.178.682.99.434; L1.453.183.392 LH  MH*Biochemical Phenomena (Non Mesh) MNG6.184 LH  OLpre-explosion = BIOCHEM PHENOM METAB (PX) MH*Biochemical Phenomena, Metabolism, Nutrition (Non Mesh) MNG6 LH  MHÑBiochemistry ANSPEC only: do not use as NIM coord for chemistry of biol matter MNG1.201; H1.181.122 LH  PM73 HN73(72) MHÑBiocompatible Materials AND25-26 qualif PIProsthesis (66-71) MND25.130 XSBIOMATERIALS FXÑImplants, Artificial LH LS LX  MSThe series of processes by which living organisms degrade pollutant chemicals, organic wastes, pesticides, and implantable materials. PM78; was see under SANITARY ENGINEERING 1975-77 HN78(69); was see under SANITARY ENGINEERING 1975-77 MHÑBiodegradation ANNIM when specific substance is IM; only /drug eff /rad eff; do not confuse with BIOTRANSFORMATION: see note there PIBiophysics (66-68); Sanitary Engineering (66-68); appropriate material MNG3.850.860.510.90; G4.185.149 LH  MSImplantable devices which convert biological energy (chemical energy of the metabolism of continuously regenerating body fluids or mechanical energy of periodic movements) to electrical energy. Include biogalvanic cells, biofuel cells, ionic concentration cells. PM74 HN74 MHÑBioelectric Energy Sources ANdo not use /instrum /methods /util (except by MeSH definition); includes biofuels, ionic concentration cells, biogalvanic cells, etc. MNE7.690.150 XSBIOLOGICAL ENERGY SOURCES; POWER SOURCES, BIOELECTRIC FXÑElectricity LH LS; LX  MSA branch of applied ethics which studies the value implications of practices and developments in the life sciences. PM78 HN78 MHÑBioethics ANonly /hist PIEthics, Medical (66-77) MNK1.316.70 LH  MSA process which utilizes instrumentation to give a person immediate and continuing signals of change in his bodily function of which he is usually unaware. PM77 HN77 MHÑBiofeedback (Psychology) ANonly /drug eff /instrum /physiol /rad eff; differentiate from FEEDBACK as a physiol concept (G) & as an information concept (L); DF: BIOFEEDBACK PIFeedback (66-76) MNF2.830.120; F4.754.137.350; F4.754.180 XSFeedback, Psychophysiologic LH LS  MHÑBioflavonoids ANdo not use /analogs MND9.203.408.134; D11.786.170 XSVITAMIN P COMPLEX XUÑDiosmin; ÑEsculin; ÑHesperidin LH LS LU; ;  MSThe origin of life. Includes studies of the potential basis for life in organic compounds; excludes studies of the development of altered forms of life through mutation and natural selection, which is EVOLUTION. MHÑBiogenesis ANno qualif; do not confuse with EVOLUTION, the developmt of changed forms through natural selection & mutation MNG4.185.194 XSOrigin of Life LH LS  PM73 HN73(71) MHÑBiogenic Amines ANdo not use /analogs; these biogenic amines are all MeSH terms: cadaverine, catecholamines, choline, histamine, putrescine, spermidine, spermine, sphingosine, taurine PIAmines (66-70) MND2.92.211 LH  MHÑBiography ANbiog as a subject, not for biogs of persons: Manual 32.10; do not confuse with check tags HISTORICAL BIOGRAPHY or CURRENT BIOG-OBIT (Manual 17.2+ & 17.3+); IM; no qualif; memoirs as a subject go here or under AUTOBIOGRAPHY if pertinent CATALOG: /geog /form MNK1.517.211 LH  MHÑBiological Assay ANassays using living-matter intermediate; check text: not all ╥bioassays╙ are MeSH term BIOLOGICAL ASSAY; only /instrum /methods; Manual 22.27 MNE5.91 XSBioassay LH LS  MSThe extent to which the active ingredient of a drug dosage form can be absorbed and made available to the target tissue in the active form. OLto search BIOLOGIC AVAILABILITY & PHYSIOLOGIC AVAILABILITY use BIOLOGICAL AVAILABILITY back thru 1975 & BIOPHARMACEUTICS 1970-74; to search AVAILABILITY EQUIVALENCY use BIOLOGICAL AVAILABILITY back thru 1980 PM79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; AVAILABILITY EQUIVALENCY & PHYSIOLOGIC AVAILABILITY were see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOLOGICAL AVAILABILITY 1980-86 HN79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86 MHÑBiological Availability ANNIM with specific drug /metab (IM); no qualif PIBiopharmaceutics (70-74); Chemical Pharmaceutics (66-69); Drug Compounding (66-69); Drugs (66-69); Pharmacology (66-69) MNG12.91.259 XSAvailability Equivalency; Bioavailability; Physiologic Availability LH LS; ;  MSThe physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioral phenomena in plants and animals. The pineal gland, which receives input from the optic nerves and connects to the hypothalamus, may be the biological clock in humans. Syn: Endogenous Zeitgeber. PM67 HN67(64) MHÑBiological Clocks ANIM; only /drug eff /rad eff MNG7.450.125 XSBiological Oscillators; Oscillators, Endogenous; Pacemakers, Biological FXÑPeriodicity LH LS; ; LX  MSHuman or animal tissue used as temporary wound coverings. HN(78) MHÑBiological Dressings AN╥human or animal tissue used as temporary wound covering╙; do not specify source unless especially discussed & do not coord with TRANSPLANTATION, HETEROLOGOUS; note X refs below; only /adv eff /stand /supply /vet PIBandages (66-77); Skin/TR (66-77) MNE7.101.150 XSAllograft Dressings; Amniotic Membrane Dressings; Dressings, Biological; Heterograft Dressings; Homograft Dressings; Pig Skin Dressings; Porcine Xenograft Dressings; Xenograft Dressings DMÑBandages LH LS; ; ; ; ; ; ; LM  MH*Biological Factors (Non Mesh) MND24.185 LH  MH*Biological Phenomena (Non Mesh) MNG4.185 LH  MH*Biological Phenomena, Cell Physiology, Immunity (Non Mesh) MNG4 LH  MHÑBiological Products ANincludes serums, vaccines, antitoxins, tissue & hormonal prep; D25-26 qualif; with disease, do not use /drug ther: use /ther MND24.310 XSBiologics XUÑPicibanil LH LS LU  MSAn interdisciplinary science concerned with studies of the biological bases of behavior - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness. PM84 HN84 MHÑBiological Psychiatry ANSPEC only: SPEC qualif PIPsychiatry (66-83) MNF4.96.544.90; G2.403.642.100 XSPsychiatry, Biological LH LS  OL'biological sciences' is indexed under BIOLOGY MH*Biological Sciences (Non Mesh) MNG1 LH  OLconsider also BIOLOGICAL PRODUCTS /TU or /TU with specific biol prod MH*Biological Therapy (Non Mesh) MNE2.95 LH  MSThe movement of materials across cell membranes and epithelial layers, usually by diffusion. PM66 HN66(64) MHÑBiological Transport ANalmost never IM; coord NIM with substance /metab (IM); only /drug eff /rad eff; consider also MATERNAL-FETAL EXCHANGE MNG6.535.166 XSTRANSPORT, BIOLOGICAL FXÑCell Membrane Permeability; ÑPERMEASES LH LS LX;  MSThe movement of materials across cell membranes and epithelial layers against a concentration gradient, requiring the expenditure of metabolic energy; also called biological or metabolic pumps. PM66 HN66 MHÑBiological Transport, Active ANalmost never IM; only /drug eff /rad eff MNG6.535.166.310 XSACTIVE TRANSPORT; UPHILL TRANSPORT FXÑTransmitter Uptake Inhibitors, Neuronal LH LS; LX  MSWarfare involving the use of living organisms, as disease etiologic agents against men, animals, or plants. OLuse BIOLOGICAL WARFARE to search BACTERIAL WARFARE back thru 1966 HNBACTERIAL WARFARE was see under BIOLOGICAL WARFARE 1963-78 MHÑBiological Warfare ANonly /hist /methods MNI1.880.735.944.226 XSBacterial Warfare LH LS  MHÑBiology ANSPEC: SPEC qualif MNG1.273 LH  PM68 HN68 MHÑBiomechanics ANNIM; any principle of mechanics in human or animal physiology; no qualif PIBiophysics (66-67) MNG1.344.185; H1.671.100.131 FXÑPhysical Medicine LH LX  MH*Biomedical and Dental Materials (Non Mesh) MND25 LH  MSApplication of principles and practices of engineering science to biomedical research and health care. PM68 HN68 MHÑBiomedical Engineering ANonly /econ /educ /hist /instrum /man /stand /trends MNG2.77; J1.293.143 XSClinical Engineering FXÑELECTRONICS, MEDICAL; ÑMedical Informatics Applications LH LS LX;  MSThat branch of statistics used to analyze and manipulate data obtained from biological systems. MHÑBiometry ANNIM; only /instrum /methods MNH1.548.832.160 XSBiostatistics FXÑAnthropology, Physical; ÑStatistics; ÑVital Statistics LH LS LX; ;  MSA genus of planorbid freshwater snails, species of which are intermediate hosts of schistosoma mansoni. OLuse BIOMPHALARIA to search AUSTRALORBIS GLABRATUS back thru 1972 PM72 HN72; AUSTRALORBIS GLABRATUS was see under BIOMPHALARIA 1972-78 MHÑBiomphalaria ANfreshwater snail; /microbiol /parasitol permitted PISnails (66-71) MNB1.644.776.185 XSAustralorbis LH LS  MSThe study of systems, particularly electronic systems, which function after the manner of, or in a manner characteristic of, or resembling living systems. Also, the science of applying biological technics and principles to the design of electronic systems. PM70 HN70(66) MHÑBionics ANno qualif MNG1.344.310; H1.671.100.202 FXÑCYBERNETICS; ÑModels, Biological LH LX;  PM70 HN70 MHÑBiopharmaceutics ANno qualif; IM general only; NIM with specific drug /metab (IM); array of biopharmaceutics terms: Bull 102 (Oct 77) PIChemistry, Pharmaceutical (66-69); Drug Compounding (66-69); Drugs (66-69); Pharmacology (66-69) MNG12.91 FXÑChemistry, Pharmaceutical; ÑDrug Compounding LH LX;  MHÑBiophysics ANprinciples of physics applied to human or animal biology; SPEC qualif as IM; no qualif when NIM coord; Manual 29.11 MNG1.344; H1.671.100 LH  OLsearch MACROMOLECULAR SYSTEMS 1968-74 HN(75) MHÑBiopolymers ANNIM; no qualif MND12.472.310 DMÑMacromolecular Systems LH LM  MSProsthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1) mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2) chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. PM79 HN79 MHÑBioprosthesis ANIM; coord IM with specific prosth term (IM), as BIOPROSTHESIS + HEART VALVE PROSTHESIS; do not specify source of biol material unless especially discussed & do not coord with TRANSPLANTATION, HETEROLOGOUS; note X refs below; only /adv eff /stand /supply /vet PIHeart Valve Prosthesis (66-78) MNE4.659.140; E7.450.100; E7.858.565.140 XSGlutaraldehyde-Stabilized Grafts; Heterograft Bioprosthesis; Porcine Xenograft Bioprosthesis; Xenograft Bioprosthesis LH LS; ; ;  MSRemoval and pathologic examination of specimens in the form of small pieces of tissue from the living body. MHÑBiopsy ANIM general only; NIM with specific organ /pathol (IM) + dis /pathol (IM); only /adv eff /econ /instrum /methods /vet MNE1.223.88; E1.223.894.143; E4.74 LH  PM73 HN73 MHÑBiopsy, Needle ANNIM; only /adv eff /instrum /methods /vet PIBiopsy (66-72) MNE1.223.894.143.310; E1.223.894.632.310 XSASPIRATION BIOPSY; PUNCTURE BIOPSY LH LS;  MS1-(2-Amino-4-hydroxy-6-pteridinyl)-1,2-propanediol. A natural product that has been considered as a growth factor for some insects. PM87; was see under PTERIDINES 1975-86 HN87(75); was see under PTERIDINES 1975-86 MHÑBiopterin AN/defic /physiol permitted RN22150-76-1 PIPropanediols (72-74); Pteridines (70-74) MND3.438.733.100; D8.176.90; D11.303.180 LH  MSThe application of engineering and technological principles to the life sciences. PM87 HN87 MHÑBiotechnology ANonly /econ /hist /instrum /man /stand MNG1.550; J1.897.120 FXÑGenetic Intervention; ÑRecombinant Proteins LH LX;  MHÑBiotin AN/defic /physiol permitted; /ther use: coord disease with /drug ther, not /diet ther RN58-85-5 MND8.176.96; D11.786.708.118 XSVITAMIN H LH LS  MSThe chemical alteration of an exogenous substance by or in a biological system. PM70 HN70(66) MHÑBiotransformation ANrestrict to chem changes of exogenous substances; IM general only; NIM with specific drug /metab (IM); only /drug eff /rad eff; do not confuse with BIODEGRADATION: reduction of ╥pollutant chemicals, organic wastes, pesticides & implantable materials╙; array of biotransform terms: Bull 102 (Oct 77); note X ref; ╥inactivating biotransformation╙ = METABOLIC DETOXICATION, DRUG MNG6.535.202; G12.122 XSMetabolic Activation LH LS  HN(66) MHÑBiperiden ANdo not use /biosyn /defic /physiol; /analogs NIM only RN514-65-8 MND3.383.621.110; D16.653.137 DMÑPiperidines LH LM  MHÑBiphenyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BIPHENYL CPDS MND2.455.426.559.389.185 LH  MSA major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. OLuse BIPOLAR DISORDER to search PSYCHOSES, MANIC-DEPRESSIVE back thru 1966 & DEPRESSION, BIPOLAR back thru 1973 PM81; was PSYCHOSES, MANIC-DEPRESSIVE 1963-80 HN81; was PSYCHOSES, MANIC-DEPRESSIVE 1963-80; DEPRESSION, BIPOLAR was see under PSYCHOSES, MANIC-DEPRESSIVE 1973-76 MHÑBipolar Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.680.80.200 XSAffective Psychosis, Bipolar; Depression, Bipolar; Manic-Depressive Psychosis; Psychosis, Manic-Depressive LH LS; ; ;  MHÑBird Diseases ANdo not use /compl /vet; don't forget also BIRDS (NIM) for general or unspecified but specific bird (IM) & check tag ANIMAL; differentiate from POULTRY DISEASES on basis of definition of BIRDS & POULTRY below under BIRDS MNC22.131 LH  MSA respiratory disorder due to an acquired hypersensitivity to the dust of bird droppings. HN(77) MHÑBird Fancier's Lung PIFarmer's Lung (66-76); Respiratory Hypersensitivity (66-76) MNC8.674.55.125; C20.543.480.680.75.125; C21.447.125 XSBudgerigar Fancier's Lung; Pigeon Breeder's Lung DMÑALVEOLITIS, EXTRINSIC ALLERGIC LH LS; LM  MHÑBirds ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; NIM when merely exper animal; differentiate from POULTRY: ╥birds╙ in barnyard, hatchery, butcher shop = POULTRY, ╥birds╙ in zoos, parks, forests, pet shops = BIRDS MNB2.248 LH  PM68 HN68(64) MHÑBirefringence ANNIM; no qualif MNH1.671.606.116 XSBIREFRACTION; DOUBLE REFRACTION LH LS;  MSAn official certification by a physician recording the individual's birth date, place of birth, parentage and other required identifying data which are filed with the local registrar of vital statistics. MHÑBirth Certificates ANIM; no qualif MNN4.452.859.132 LH  MSMechanical or anoxic trauma incurred by the infant during labor and delivery. The presence of specific results of such trauma, such as BRAIN DAMAGE, CHRONIC or RETROLENTAL FIBROPLASIA does not preclude the use of the term BIRTH INJURIES. OLuse BIRTH INJURIES to search BIRTH INJURY back thru 1966 PM73; was BIRTH INJURY 1963-72 HN73; was BIRTH INJURY 1963-72 MHÑBirth Injuries ANdo not use /congen MNC16.614.131; C21.866.141 FXÑDelivery LH LX  MSInterval between onset of sexual relations by a woman and the birth of her first child and intervals between successive births. Includes use of family planning to control birth intervals. PM80 HN80 MHÑBirth Intervals ANno qualif; may be used in physiol or family planning context PIFamily Characteristics (68-79); Family Planning (68-79) MNN2.421.143.401.90 XSBirth Spacing; Child Spacing LH LS;  MSThe sequence in which children are born into the family. MHÑBirth Order ANIM; no qualif MNF1.829.263.132 LH  MSThe number of births in a given population per year or other unit of time. OLsearch POPULATION & VITAL STATISTICS 1966 PM67; was see under POPULATION & VITAL STATISTICS 1963-66 HN67; was see under POPULATION & VITAL STATISTICS 1963-66 MHÑBirth Rate ANno qualif CATALOG: /geog /form PIPopulation (66); Vital Statistics (66) MNN1.224.935.161 LH  MHÑBirth Weight ANIM; only /drug eff /rad eff MNG7.553.481.398.186 FXÑFetal Macrosomia; ÑInfant, Low Birth Weight LH LX;  MSsym Dichloromethyl ether. A substance that is an irritant to the eyes and respiratory tract and may be carcinogenic. OLuse BIS(CHLOROMETHYL) ETHER to search DICHLOROMETHYL ETHER back thru 1975 HN(79); was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78 MHÑBis(Chloromethyl) Ether ANdo not use /biosyn /defic /physiol; /analogs NIM only RN542-88-1 PIEthers (66-73); Methyl Chloride (66-74); Methyl Ethers (74) MND2.355.601.250; D26.191.141 XSChloromethyl Ether; Dichloromethyl Ether DMÑMethyl Ethers LH LS; LM  HN(72) MHÑBisacodyl ANdo not use /biosyn /defic /physiol; /analogs NIM only RN603-50-9 PICathartics (66-71); Cresols (66-71) MND2.755.239.132; D19.316.396.160 DMÑCresols LH LM  MHÑBishydroxycoumarin ANdo not use /biosyn /defic /physiol RN66-76-2 MND3.438.150.446.520.203; D8.373.936.161; D19.461.119.196.475.118 XSDICOUMARIN; DICUMAROL LH LS;  MHÑBismuth ANBi-209; do not use /analogs /biosyn /defic /physiol; Bi-199-208, 210-215 = BISMUTH (IM) + RADIOISOTOPES (IM) RN7440-69-9 MND1.268.103; D1.552.105 LH  MHÑBismuth-Arsenic Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BISMUTH ARSENIC CPDS MND1.81.394; D1.552.105.311 LH  MS3-Phospho-D-glyceroyl-phosphate: 3-phospho-D-glycerate phosphotransferase. Catalyzes the transfer of phosphate from C-3 of 1,3-diphosphoglycerate to C-2 of 3-phosphoglycerate, forming 2,3-diphosphoglycerate. Synonym: 3-phosphoglycerate (1-2)-phosphomutase. HN(75) MHÑBisphosphoglyceromutase ANdo not use /analogs RNEC 2.7.5.4 PIDiphosphoglyceric Acids (73-74); Phosphotransferases (73-74) MND8.586.913.696.100 XSDiphosphoglyceromutase DMÑPhosphotransferases LH LS LM  MSThe force applied by the masticatory muscles in dental occlusion. HN(84) MHÑBite Force ANnote category; no qualif PIDental Occlusion (66-83); Dental Stress Analysis (68-83); Mastication (66-83); Masticatory Muscles (66-83) MNE6.276.125 XSMasticatory Force; Occlusal Force DMÑDental Occlusion LH LS; LM  MHÑBites and Stings ANsnake bites = SNAKE BITES; spider bites = ARACHNIDISM; tick bites = TICKS (IM) + BITES AND STINGS (IM) (not TICK TOXICOSES unless paralysis or toxicosis results); coord IM with biter (IM); INSECT BITES AND STINGS is also available; DF: BITES MNC21.613.127; C21.866.153 XSStings FXÑAllergens XUÑBites, Human LH LS LX LU  MSBites inflicted by humans. HN(72) MHÑBites, Human ANthe human is biting, not being bitten; don't forget to check tag HUMAN PIBites and Stings (66-71) MNC21.866.153.311 DMÑBites and Stings LH LM  MS2,2'-Thiobis(4,6-dichlorophenol). Halogenated disinfectant; used against trematode and cestode infestations. Synonyms: Actamer; Bitin; Lorothidol. HN(75) MHÑBithionol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN97-18-7 PIChlorobenzenes (74); Phenols (71-74); Sulfides (71-74) MND2.755.120; D21.201.412.180 DMÑPhenols LH LM  PM68 HN68 MHÑBiureas ANdo not use /analogs /biosyn /defic /physiol PIHydrazines (66-67) MND2.948.117 LH  MSImidodicarbonic diamide. Used as feed supplement for sheep and cattle since it is a good non-protein nitrogen source; in strongly alkaline solution biuret gives a violet color with copper sulfate. Synonyms: allophanic acid amide; ureidoformamide. HN(75) MHÑBiuret ANdo not use /biosyn /defic /physiol; see note below RN108-19-0 PIAmides (74); Urea (68-74) MND2.948.130; D26.550.81 XSAllophanamide; Carbamylurea DMÑUrea LH LS; LM  MSA reaction characterized by a violet color upon the addition of copper sulfate to all compounds with two amide or peptide bonds linked directly or through an intermediate carbon atom. Used in the detection and estimation of proteins and peptides having more than two amino acids. HN(75) MHÑBiuret Reaction ANdo not confuse with BIURET: biuret reaction or method no longer uses BIURET as signif reagent MNE5.196.85 DMÑChemistry, Analytical LH LM  MSA virus of typically polyoma-like appearance cross-reacting immunologically with SV40. HN(75); was see under POLYOMA VIRUS 1975-77 MHÑBK Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) MNB4.909.204.585.615.300; B4.909.574.204.711.615.300 DMÑPolyomaviruses LH LM  MSA venomous New World spider with an hourglass-shaped red mark on the abdomen. HN(75) MHÑBlack Widow Spider AN/microbiol /parasitol permitted; bite: coord IM with ARACHNIDISM (IM) MNB1.131.166.803.200 XSLatrodectus mactans DMÑSpiders LH LS LM  MSAn ethnic group belonging to the Negroid race. OLuse BLACKS to search NEGROES back thru 1966 PM76; was NEGROES 1963-75 HN76; was NEGROES 1963-75 MHÑBlacks ANblacks as cultural, social, sociol, polit, psychol entity; differentiate from NEGROID RACE as genetic & physiol entity; IM; specify geog if pertinent; only /class /hist /psychol; Manual 30.14; also 30.8-30.12 MNI1.76.201.450.416.100; I1.880.143.522.100; M1.194.100 XSNegroes FXÑNEGROID RACE LH LS LX  MSA complication of falciparum malaria, characterized by the passage of dark red to black urine. Synonym: hemolytic malaria. OLsearch MALARIA 1966-74 HN(75) MHÑBlackwater Fever MNC3.752.552.228 DMÑMalaria LH LM  MHÑBladder ANinflammation = CYSTITIS; ADMINISTRATION, INTRAVESICAL is available; consider terms under VESICO MNA5.810.161 FXÑCYSTOSCOPY; ÑURINARY CATHETERIZATION LH LX;  OLto search for chem composition of bladder calculi, use BLADDER CALCULI/anal back thru 1987 & BLADDER CALCULI/metab 1966-86 MHÑBladder Calculi ANchem composition of calculi: use /anal; /ultractruct permitted MNC12.777.103.124; C12.777.809.186 LH  MHÑBladder Diseases ANGEN: prefer specifics; inflamm dis = CYSTITIS MNC12.777.103 LH  PM65 HN65(63) MHÑBladder Exstrophy ANnote spelling: not ext- ; do not use /congen MNC16.131.666.680.836.144; C16.131.939.132 LH  MHÑBladder Fistula ANfistula policy: Manual 23.25+ MNC12.777.103.187; C12.777.850.312 XSVESICAL FISTULA FXÑFistula LH LS LX  MHÑBladder Neck Obstruction MNC12.777.103.249; C12.777.767.700.150 LH  MHÑBladder Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945.947.125; C12.777.103.312 LH  MHÑBladder, Neurogenic MNC10.597.192; C12.777.103.374; C23.888.592.162 LH  MSInsertion of an endosseous implant with a narrow wedge-shaped infrastructure extending through the oral mucosa into the mouth and bearing openings or vents through which tissue grows to obtain retention. OLsearch DENTAL IMPLANTATION 1974 HN(79); ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974 MHÑBlade Implantation ANdo not use /util except by MeSH definition PIDental Implantation (66-76); Dental Implantation, Endosseous (77-78) MNE4.833.800.310.310.150; E6.231.310.340; E6.780.314.310.340; E6.892.800.310.310.150 DMÑDental Implantation, Endosseous LH LM  MSRapid increase in the proportion of blast cells in the blood and bone marrow. PM87 HN87 MHÑBlast Crisis ANIM; coord with specific neopl term /pathol (IM) MNC4.805.152.110 XSBlast Phase; Blast Transformation LH LS;  MSInjuries resulting when a person is struck by particles impelled with violent force from an explosion. OLuse BLAST INJURIES to search BLAST INJURY back thru 1966 PM73; was BLAST INJURY 1963-72 HN73; was BLAST INJURY 1963-72 MHÑBlast Injuries ANdo not use /chem ind /compl /congen MNC21.866.120.126 FXÑExplosions LH LX  MSA genus of aquatic fungi of the order Blastocladiales, subdivision Mastigomycotina, used in the study of zoospore formation. OLsearch PHYCOMYCETES 1966-74 HN(75); was see under PHYCOMYCETES 1963-85 MHÑBlastocladiella ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.730.576.162 DMÑMastigomycotina LH LM  MSThe post-morula stage of the mammalian embryo in which a fluid-filled cavity, enclosed primarily by trophoblast, contains an inner cell mass which becomes the embryonic disc. PM74 HN74 MHÑBlastocyst ANA 11 qualif; /transpl: coord BLASTOCYST (NIM with no qualif) + EMBRYO TRANSFER (IM); do not confuse with BLASTOCYTES see BLASTOMERES MNA16.254.85 XSBlastula; Embryo, Preimplantation FXÑPreimplantation Phase LH LS; LX  MSA single layer of cells produced by cleavage of the fertilized ovum and forming the outer cells of the blastula. OLsearch GERM LAYERS 1968-74 PM80; was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74 HN80(75); was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74 MHÑBlastoderm ANA 11 qualif except /cytol PIBlastocyst (75-79); Germ Layers (66-74) MNA16.254.85.67 LH  MSThe undifferentiated cells formed by cleavage of the fertilized ovum. Includes cells in the cleavage, morula, and blastula stages of the embryo. PM80 HN80 MHÑBlastomeres ANA 11 qualif; do not confuse X ref BLASTOCYTES with BLASTOCYST PIBlastocyst (74-79); Cell Division (66-79); Zygote (75-79) MNA11.104; A16.254.90 XSBlastocytes LH LS  MSA deuteromycetous fungal genus, a species of which, Blastomyces dermatitidis, causes blastomycosis. MHÑBlastomyces ANdo not use /anat /embryol /microbiol /parasitol; check fungus tool for specific species wrongly called Blastomyces; infection = BLASTOMYCOSIS MNB5.354.381.125 LH  MHÑBlastomycosis MNC1.703.128 XSBlastomycosis, North American LH LS  MSDuration of blood flow after skin puncture. Used as a measure of capillary and platelet function. Synonyms: aspirin tolerance test; Duke method; Ivy method; template bleeding time. HN(80) MHÑBleeding Time ANNIM; only /vet PIBlood Coagulation (66-79); Blood Coagulation Tests (66-79); Blood Platelet Disorders (66-79); Blood Platelets (66-79); Thrombocytosis (66-79); Thrombocytopenia (66-79) MNE1.223.459.770.150 DMÑPlatelet Function Tests LH LM  MSA group of related glycopeptide antibiotics from Streptomyces verticillus; they inhibit DNA metabolism and are used as antineoplastics, especially for solid tumors. Synonyms: Blenoxane; Bleo; NSC 125066. OLuse BLEOMYCINS to search BLEOMYCIN back thru 1972 (as Prov 1972-73) PM81; was BLEOMYCIN 1974-80; PHLEOMYCINS was PHLEOMYCIN see under ANTIBIOTICS 1975-80 HN81; was BLEOMYCIN 1972-80 (Prov 1972-73) MHÑBleomycins ANdo not use /analogs /defic /physiol PIAntibiotics, Antineoplastic (67-70) MND20.85.75.236; D22.204.106.244 XUÑPhleomycins LH LU  HN(65) MHÑBlepharitis MNC11.338.133 DMÑEyelid Diseases LH LM  MSDrooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle. PM67 HN67(65) MHÑBlepharoptosis MNC11.338.204 XSPTOSIS, EYELID LH LS  MSExcessive winking; tonic or clonic spasm of the orbicularis oculi muscle. HN(75) MHÑBlepharospasm MNC11.338.250 DMÑEyelid Diseases LH LM  MSMalabsorption, especially of vitamin B12 or folic acid, due to metabolic competition by bacteria proliferating in a segment of small intestine excluded from normal peristaltic movement; it may occur as a postoperative complication of side-to-side anastomosis of intestine, as a result of intestinal diverticula, fistula, etc. PM73 HN73(69) MHÑBlind Loop Syndrome PIMalabsorption Syndromes (66-68) MNC6.405.469.637.145; C18.452.603.145 LH  MHÑBlindness ANfor Braille coord IM with SENSORY AIDS (IM) + READING (IM) MNC10.597.751.941.162; C11.966.162; C23.888.592.763.941.162 XSAMAUROSIS FXÑSENSORY AIDS LH LS LX  MSBrief closing of the eyelids; either normal periodic closing, as a protective measure, or by voluntary action. PM81 HN81 MHÑBlinking ANonly /drug eff /rad eff; voluntary & involuntary blinking; winking goes here PIEyelids (66-80); Reflex (66-80) MNG11.561.730.127; G11.697.182 XSOrbicularis Oculi Reflex; Reflex, Blink; Reflex, Corneal; Reflex, Orbicularis Oculi LH LS; ; ;  MHÑBlister AN╥fever blister╙ = HERPES LABIALIS MNC17.816.187 XSBULLA; VESICATION LH LS;  MHÑBlood ANGEN only as a substance: TN 24: BLOOD as IM; prefer /blood but not for hemodynamics: Manual 23.39; when IM, only /drug eff /metab /microbiol /parasitol /physiol /rad eff; /anal = BLOOD CHEMICAL ANALYSIS but use caution; general only, not for specific substances in the blood ( = /blood); /cytol = BLOOD CELLS; /enzymol = ENZYMES /blood or specific enzymes /blood; reinfusion = BLOOD TRANSFUSION, AUTOLOGOUS; venous blood: probably not indexed as being the usual sampling method but if significant coord BLOOD (NIM) + VEINS or specific vein (NIM); arterial blood: index only if significant & coord BLOOD (NIM) + ARTERIES or specific artery (NIM); ╥blood picture╙ = probably BLOOD CELLS or BLOOD CELL COUNT: TN 27; OCCULT BLOOD is also available; hemofiltration goes here (IM) + ULTRAFILTRATION (IM); hemospermia: index under SEMEN (IM) + BLOOD (IM); consider also terms under HEM-, HEMO-, HEMAT- CATALOG: form qualif = HEMATOLOGY /form MNA12.207.152; A15.145 FXÑHEMATOPOIESIS LH LX  MSNative bactericidal property of blood due to normally occurring antibacterial substances such as beta lysin, leukin, etc. PM70 HN70(65) MHÑBlood Bactericidal Activity ANonly /drug eff /rad eff; restrict to bactericidal: not for viricidal (see note under VIRUS INHIBITORS) or fungicidal (probably fungus (IM) + BLOOD /physiol (IM) ) MNG4.610.575.204; G9.188.145 LH  MSCenters for collecting, characterizing and storing human blood. MHÑBlood Banks ANonly /hist /man /organ /stand /supply /util MNN2.278.920.200 LH  MHÑBlood Cell Count ANNIM; only /econ /instrum /methods /vet; TN 27: BLOOD CELL COUNT as ╥blood picture╙; leukocyte count = LEUKOCYTE COUNT; erythrocyte count = ERYTHROCYTE COUNT; eosinophil count = LEUKOCYTE COUNT + EOSINOPHILS; platelet count = PLATELET COUNT MNE1.223.459.107; G7.380.107 XSBlood Cell Number FXÑCell Count LH LS LX  MHÑBlood Cells ANGEN; ╥blood picture╙ probably goes here or under BLOOD CELL COUNT; A 11 qualif & /class MNA11.118; A15.145.229 XUÑHemocytes LH LU  MHÑBlood Chemical Analysis ANGEN only: prefer specific substance with /blood; emphasis is on technic: not for ╥blood chemistry╙; when general & IM, only /econ /instrum /methods /vet; when not to use: Manual 25.44 & TN 25 MNE1.223.174.229 LH  MHÑBlood Circulation ANgeneral or unspecified, systemic; note specific indentions in tree; only /drug eff /rad eff; Manual 21.4.2-21.6; blood circ is a physiol, not hematol, concept: with diseases, coord IM with disease /physiopathol, not /blood (IM); circulatory failure or circulatory collapse = SHOCK MNG9.330.163 FXÑHYPEREMIA; ÑISCHEMIA; ÑPLETHYSMOGRAPHY LH LX; ;  MSDetermination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points. MHÑBlood Circulation Time ANNIM; only /vet; coord with disease /physiopathol, not /blood MNE1.145.153 LH  MHÑBlood Coagulation ANonly /drug eff /rad eff; /drug eff: consider also COAGULANTS & ANTICOAGULANTS; coord BLOOD COAGULATION in diseases with disease /blood, not /physiopathol MNG9.188.560.150 FXÑHEMOSTATICS LH LX  MHÑBlood Coagulation Disorders ANGEN: prefer specifics; TN 227, 228 for specifics & coords; coord IM with coag factor (IM); note that blood coag disord in C15 are mostly hemorrhagic: consider also the formation of thrombi (THROMBOSIS, EMBOLISM & specifics) as also a blood coag disord in C14 MNC15.378.463.134 LH  MHÑBlood Coagulation Factors ANGEN: prefer specifics; only /anal /biosyn /genet /immunol /isol /physiol /rad eff /ther use; factor I = FIBRINOGEN, II = PROTHROMBIN, III = THROMBOPLASTIN, IV = CALCIUM; FACTOR V-FACTOR XIII are main headings; defic: TN 227; platelet factors & defic: TN 228 MND12.776.124.125; D19.461.270.229 XSCoagulation Factors XUÑPlatelet Factor 3 LH LS LU  MSLaboratory tests for evaluating the individual's clotting mechanism. MHÑBlood Coagulation Tests ANGEN: prefer specifics; NIM; only /instrum /methods /vet; coord with disease /blood, not /physiopathol MNE1.223.459.153 XUÑPartial Thromboplastin Time; ÑThrombin Time; ÑWhole Blood Coagulation Time LH LU; ;  MSAny procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor. PM86; PLATELETPHERESIS was see under CELL SEPARATION 1981-85, was see under BLOOD TRANSFUSION 1979-80, was see PLASMAPHERESIS 1978 HN86; was NON MESH before 1986 MHÑBlood Component Removal ANGEN or unspecified only; prefer specifics LEUKAPHERESIS, PLASMAPHERESIS, PLATELETPHERESIS; do not use /util except by MeSH definition; erythrocytapheresis, erythrapheresis: coord with ERYTHROCYTES /transpl MNE2.110 XSApheresis; Pheresis FXÑCell Separation XUÑPlateletpheresis LH LS; LX LU  MHÑBlood Donors ANIM; only /psychol MNM1.898.313 LH  MSA value equal to the total volume flow divided by the cross-sectional area of the vascular bed. HNwas in Cat E only 1963-85 MHÑBlood Flow Velocity ANNIM; only /drug eff /rad eff /vet; coord with disease /physiopathol, not /blood MNE1.145.198; G9.330.612.95 LH  MSMeasurement of blood gas. MHÑBlood Gas Analysis ANNIM; only /instrum /methods /vet; coord with disease /blood, not /physiopathol MNE1.223.174.229.134; E1.302.796.139 LH  MSThe noninvasive measurement or determination of the partial pressure (tension) of oxygen and/or carbon dioxide locally in the capillaries of a tissue by the application to the skin of a special set of electrodes. These electrodes contain photoelectric sensors capable of picking up the specific wavelengths of radiation emitted by oxygenated versus reduced hemoglobin. PM87 HN87 MHÑBlood Gas Monitoring, Transcutaneous ANNIM; only /instrum /methods /vet; coord with disease /blood, not /physiopathol; when IM, do not coord with OXYGEN /blood or CARBON DIOXIDE /blood; DF: TCPO2 PICarbon Dioxide/blood (66-86); Monitoring, Physiological (66-86); Oxygen/blood (66-86); Partial Pressure (66-86) MNE1.145.175; E1.223.174.229.134.125 XSCarbon Dioxide Partial Pressure Determination, Transcutaneous; Cutaneous Oximetry; Oximetry, Transcutaneous; Oxygen Partial Pressure Determination, Transcutaneous; Transcutaneous Blood Gas Monitoring; Transcutaneous Capnometry; Transcutaneous Oximetry LH LS; ; ; ; ; ;  OLuse BLOOD GLUCOSE to search BLOOD SUGAR back thru 1966 PM80; was BLOOD SUGAR 1963-79 HN80; was BLOOD SUGAR 1963-79 MHÑBlood Glucose ANdo not use /blood-csf-urine MND9.203.147 XSBlood Sugar; Glucose, Blood FXÑGLUCOSE TOLERANCE TEST; ÑHYPERGLYCEMIA; ÑHYPOGLYCEMIA LH LS; LX; ;  MHÑBlood Group Incompatibility ANcoord IM with specific blood group (IM) MNC15.378.120; C20.188 FXÑBlood Transfusion LH LX  MSTesting erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. PM80 HN80 MHÑBlood Grouping and Crossmatching ANonly /hist /instrum /methods /vet; DF: BLOOD GROUPING PIBlood Group Incompatibility (66-79); Blood Groups (66-79); specific blood-group system; Blood Transfusion (66-79); Paternity (66-79) MNE1.223.459.180; E1.223.495.468.180 XSBlood Typing; Crossmatching, Blood FXÑImmunologic Technics LH LS; LX  MHÑBlood Groups ANonly /genet /immunol; blood group of animal = animal /blood, not /immunol; blood group in a disease = disease /blood, not /immunol nor /familial; TN 230 MND24.611.216.705.230; G4.610.241; G9.188.229 FXÑCONSANGUINITY; ÑCOOMBS' TEST; ÑISOANTIBODIES; ÑISOANTIGENS; ÑIsoantibodies; ÑIsoantigens; ÑPATERNITY XUÑDuffy Blood-Group System; ÑI Blood-Group System; ÑKell Blood-Group System; ÑKidd Blood-Group System; ÑP Blood-Group System LH LX; ; ; ; ; ; LU; ; ; ;  OLconsider also BLOOD /PH or /PH with specific elements of the blood MH*Blood Physiology (Non Mesh) MNG9.188 LH  OLuse BLOOD PLATELET DISORDERS to search THROMBOCYTOPATHY back thru 1966 PM67; THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66 HN67(64); THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66 MHÑBlood Platelet Disorders ANdo not use as coord for platelet factor defic: use BLOOD COAGULATION DISORDERS (TN 228) MNC15.378.463.205 XSThrombocytopathy XUÑBernard-Soulier Syndrome; ÑPlatelet Storage Pool Deficiency; ÑThrombasthenia LH LS LU; ;  MHÑBlood Platelets ANA 11 qualif & /class; THROMBOCYTOPENIA & THROMBOCYTOSIS are also available; platelet factors & defic: TN 228; /transpl: consider also PLATELETPHERESIS MNA11.118.188; A15.145.229.188; A15.382.188 XSPLATELETS; THROMBOCYTES FXÑPLATELET ADHESIVENESS; ÑPlatelet Aggregation; ÑPlatelet Count; ÑPlatelet Function Tests LH LS; LX; ; ;  MHÑBlood Preservation ANpreserv of whole blood or specific cellular elements (coord IM with specific cell (IM) ); only /econ /hist /instrum /methods /stand /vet; cryopreservation of blood: coord IM with FREEZING (NIM) MNE5.760.833.230 LH  MHÑBlood Pressure ANGEN; ╥arterial╙ pressure = BLOOD PRESSURE & not also ARTERIES unless a specific artery; pressure within a specific vessel: coord vessel /physiol (IM) + BLOOD PRESSURE (NIM); ╥venous╙ pressure = VENOUS PRESSURE or CENTRAL VENOUS PRESSURE; ╥systolic╙ pressure: do not index under SYSTOLE (NIM) unless particularly discussed; only /drug eff /rad eff; blood pressure is a physiol, not hematol, concept: with diseases, coord IM with disease /physiopathol, not /blood (IM); blood pressure vs HYPERTENSION & HYPOTENSION: Manual 23.38 MNG9.330.612.114 FXÑPressure LH LX  MSTechnics for measuring blood pressure. MHÑBlood Pressure Determination ANNIM; only /instrum /methods /vet; see note on BLOOD PRESSURE MNE1.145.244; E1.706.157 LH  MHÑBlood Protein Disorders ANGEN: avoid: prefer specifics MNC15.378.147 FXÑImmunologic Diseases LH LX  MSElectrophoresis applied to blood proteins. MHÑBlood Protein Electrophoresis ANNIM; electrophoresis of hemoglobin goes here + HEMOGLOBINS /anal; only /instrum /methods /vet MNE1.223.174.229.206 FXÑElectrophoresis; ÑIMMUNOELECTROPHORESIS LH LX;  MHÑBlood Proteins ANGEN: avoid: prefer specifics; /drug eff permitted for this and all indentions; do not use /analogs /blood-csf-urine /pharm; electrophoresis = BLOOD PROTEIN ELECTROPHORESIS; TN 224; TN 226: gammopathies; paraproteins: index PARAPROTEINS MND12.776.124 XSPLASMA PROTEINS; SERUM PROTEINS FXÑProtein Binding LH LS; LX  MSMeasurement of rate of settling of erythrocytes in anticoagulated blood. Syn: erythrocyte sedimentation rate; ESR. MHÑBlood Sedimentation ANNIM; no qualif; coord with disease /blood, not /physiopathol MNE1.223.459.199 XSERYTHROCYTE SEDIMENTATION LH LS  MHÑBlood Specimen Collection ANonly /econ /instrum /methods /stand /vet MNE1.223.894.230 LH  MSAntigenic characteristics identified from blood stains; primary value in criminal cases. MHÑBlood Stains ANno qualif MNI1.198.560.206 LH  MSSubstances that can carry oxygen to and carbon dioxide away from the tissues when introduced into the blood stream; used to replace hemoglobin in severe hemorrhage; also to perfuse isolated organs; the best known are perfluorocarbon emulsions and various hemoglobin solutions. Synonyms: artificial erythrocytes; artificial hemoglobin. OLsearch PLASMA SUBSTITUTES 1966-80 PM81; was see PLASMA SUBSTITUTES 1963-80 HN81; was see PLASMA SUBSTITUTES 1963-80 MHÑBlood Substitutes ANcarry O2 to & CO2 from tissue: see MeSH definition; do not confuse with PLASMA SUBSTITUTES which replace plasma; D25-26 qualif PIErythrocytes (68-80); Hemoglobins (68-80); Plasma Substitutes (68-80) MND19.461.140 XSBlood, Artificial; Erythrocyte Substitutes; Hemoglobin Substitutes; Red Cell Substitutes FXÑFluorocarbons; ÑPlasma Substitutes LH LS; ; ; LX;  PMPLATELETPHERESIS was see PLASMAPHERESIS 1978 MHÑBlood Transfusion ANTN 186: differentiate among various ╥transfusion╙ concepts; do not use /util except by MeSH definition; for whole blood or blood components; transfused cells: index under cell term /transpl (IM) + BLOOD TRANSFUSION (IM) but not transpl type unless pertinent MNE2.95.135 FXÑBLOOD GROUP INCOMPATIBILITY LH LX  PM71 HN71 MHÑBlood Transfusion, Autologous ANdo not use /util except by MeSH definition PIBlood Transfusion (66-70) MNE2.95.135.164 XSAutotransfusion LH LS  PM68 HN68(65) MHÑBlood Transfusion, Intrauterine ANTN 186: differentiate among various ╥transfusion╙ concepts; do not use /util except by MeSH definition MNE2.95.135.264 XSFETAL TRANSFUSION; INTRAUTERINE TRANSFUSION LH LS;  PM67 HN67(64) MHÑBlood Urea Nitrogen ANnote category; no qualif; often correct for foreign ╥azotemia╙ MNE1.223.174.229.277; E1.341.453.189 XSBUN FXÑUrea LH LS LX  MHÑBlood Vessel Prosthesis ANdo not use /instrum /methods /util (except by MeSH definition) MNE4.659.164; E7.450.130; E7.858.565.164 XSVascular Prosthesis LH LS  MSAny of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). PM/transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65 HN/transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65 MHÑBlood Vessels ANGEN only: prefer specifics; prefer /blood supply with Cat A terms: Manual 21.4+; do not use /blood supply; /radiogr = ANGIOGRAPHY; /surg = VASCULAR SURGERY; permeability = CAPILLARY PERMEABILITY; consider also VASOMOTOR SYSTEM & all related terms; inflammation = VASCULITIS or its specifics, ARTERITIS & PHLEBITIS; vascular compression syndromes: index under VASCULAR DISEASES (IM) + CONSTRICTION, PATHOLOGIC & coord with specific blood vessel if pertinent (IM); consider also terms under VAS- MNA7.231 FXÑANGIOGRAPHY; ÑVASCULAR RESISTANCE; ÑVASCULAR SURGERY XUÑVasa Nervorum LH LX; ; LU  MHÑBlood Viscosity ANonly /drug eff /rad eff; coord IM with disease /blood (IM), not /physiopathol MNG9.188.272; G9.330.612.164 FXÑViscosity LH LX  MSVolume of circulating blood. It is the sum of the plasma volume and erythrocyte volume. MHÑBlood Volume ANonly /drug eff /rad eff; PLASMA VOLUME, ERYTHROCYTE VOLUME & ERYTHROCYTE VOLUME, PACKED are also available; coord IM with disease /physiopathol (IM), not /blood MNG9.188.313; G9.330.612.214 LH  MSMethod for determining the circulating blood volume by introducing a known quantity of foreign substance into the blood and determining its concentration some minutes later when thorough mixing has occurred. From these two values the blood volume can be calculated by dividing the quantity of injected material by its concentration in the blood at the time of uniform mixing. Generally expressed as cubic centimeters or liters per kilogram of body weight. MHÑBlood Volume Determination ANNIM; only /instrum /methods /vet; coord with disease /physiopathol, not /blood MNE1.145.289 LH  PM66; was HEMATO-ENCEPHALIC BARRIER 1963-65 HN66; was HEMATO-ENCEPHALIC BARRIER 1963-65 MHÑBlood-Brain Barrier ANonly /drug eff /rad eff MNG11.561.107; G12.155 XSHEMATO-ENCEPHALIC BARRIER FXÑCerebrospinal Fluid LH LS LX  MSSpecialized nonfenestrated tightly-joined endothelial cells that form a transport barrier for certain substances between the retinal capillaries and the retinal tissue. PM87 HN87 MHÑBlood-Retinal Barrier ANonly /drug eff /rad eff PIRetina (66-86); Retinal Vessels (66-86) MNG11.697.199; G12.165 LH  MSSelective transport mechanisms by which the cells of the seminiferous epithelium are provided with a biochemical environment of special composition and stability. PM76; was see under TESTIS 1975 HN76(75); was see under TESTIS 1975 MHÑBlood-Testis Barrier ANonly /drug eff /rad eff PITestis (66-74) MNG6.535.166.310.100; G12.175 LH  MHÑBloodletting ANdo not use /util except by MeSH definition MNE2.117 XSPhlebotomy; Venesection LH LS;  MSAn autosomal recessive disorder characterized by telangiectatic erythema of the face, photosensitivity, dwarfism, and other abnormalities. PM82 HN82 MHÑBloom Syndrome ANdo not use /congen PIAbnormalities, Multiple (68-81); Dwarfism (66-81); Facial Dermatoses (66-81); Telangiectasis (66-81) MNC16.131.77.137 XSBloom-Torre-Machacek Syndrome LH LS  MSA prepaid health insurance plan for hospital costs and related services; usually excludes physicians' services. OLsearch INSURANCE, HOSPITALIZATION 1968-74 HN(75) MHÑBlue Cross ANonly /econ /hist /legis /organ /stand /trends /util; specify geog if possible MNN3.219.521.576.343.492.231 DMÑInsurance, Hospitalization LH LM  MSA prepaid health insurance plan for costs of physicians' services. OLsearch INSURANCE, PHYSICIAN SERVICES 1968-74 HN(75) MHÑBlue Shield ANonly /econ /hist /legis /organ /stand /trends /util; specify geog if possible MNN3.219.521.576.343.616.315 DMÑInsurance, Physician Services LH LM  MSA reovirus infection, chiefly of sheep, characterized by a swollen blue tongue, catarrhal inflammation of upper respiratory and gastrointestinal tracts, and often by inflammation of sensitive laminae of the feet and coronet. PM74 HN74(68) MHÑBlue Tongue ANusually animal: do not use /vet but check tag ANIMAL; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES PISheep Diseases (66-67); Virus Diseases/VE (66-67) MNC2.782.791.315; C2.81.125; C22.836.120 LH  MSA virus causing a serious disease in sheep, especially lambs; may also infect wild ruminants and other domestic animals. HN(75); was see under REOVIRUSES 1975-80 MHÑBlue Tongue Virus ANdo not use /blood-csf-urine /cytol MNB4.909.777.714.250 XSOvine Catarrhal Fever Virus DMÑReoviridae LH LS LM  MSInvoluntary reddening, especially of the face, associated with feelings of embarrassment, confusion or shame. MHÑBlushing ANonly /drug eff /physiol; note category: do not confuse with FLUSHING MNF1.145.209.530.136; F2.830.158 FXÑFlushing LH LX  MSThe total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal. PM73; only radioactive substances 1973-77 HN73(71); only radioactive substances 1971-77 MHÑBody Burden ANNIM; not restricted to radioactive substances: applicable to chemical, metal or radioactive substances; for ╥drug residues╙ coord NIM with DRUGS (IM) or specific drug (IM) but note PESTICIDE RESIDUES is available; no qualif PIRadiation Monitoring (66-70) MNE5.799.638.231; G3.850.810.370.180; H1.671.768.765.588.165 LH  MHÑBody Composition ANonly /drug eff /rad eff MNG6.184.179 LH  MHÑBody Constitution ANno qualif MNE1.706.189; G7.265 XSBody Size LH LS  MSThe two phases between which water and other body fluids are distributed: extracellular and intracellular. HN(78) MHÑBody Fluid Compartments ANonly /drug eff /rad eff PIBody Fluids (66-77); Body Water (74-77) MNA12.207.180; G6.184.179.180 DMÑBody Fluids LH LM  MHÑBody Fluids ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; interstitial fluid: index EXTRACELLULAR FLUID (see EXTRACELLULAR SPACE) MNA12.207 FXÑDEHYDRATION; ÑRADIOISOTOPE DILUTION TECHNIC XUÑBody Fluid Compartments; ÑIntracellular Fluid LH LX; LU;  MHÑBody Height ANhuman only; for height or length of animals use animal /anat (IM) + BIOMETRY (NIM); only /drug eff /rad eff MNE1.706.189.190; E5.118.176; G7.553.481.231 LH  MSA term for the concept which each individual has of his own body as an object in and bound by space, independently and apart from all other objects. MHÑBody Image ANno qualif MNF2.463.593.112 FXÑSelf Concept LH LX  MH*Body Regions (Non Mesh) MNA1 LH  PM70 HN70(67) MHÑBody Surface Area ANonly /vet PIAnthropometry (66) MNE1.706.189.315; E5.118.231 LH  MHÑBody Temperature ANonly /drug eff /rad eff MNE1.706.220; G7.315 XSOrgan Temperature FXÑFEVER; ÑTHERMOGRAPHY; ÑTHERMOMETERS; ÑTemperature LH LS LX; ; ;  OL╥changes in body temp╙ is indexed BODY TEMPERATURE unless a specific indention MH*Body Temperature Changes (Non Mesh) MNC23.888.189 LH  MHÑBody Temperature Regulation ANonly /drug eff /rad eff MNG7.315.232; G7.621.265 XSHEAT LOSS; HEAT PRODUCTION; THERMOREGULATION LH LS; ;  PM74 HN74(72) MHÑBody Water ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; do not confuse with EXTRACELLULAR FLUID see EXTRACELLULAR SPACE PIBody Fluids (66-71); Water (66-71) MNA12.207.200 FXÑWater LH LX  MHÑBody Weight ANonly /drug eff /rad eff MNE1.706.189.440; E5.118.287; G7.553.481.398 XSWeight Gain; Weight Loss LH LS;  OL╥changes in body weight╙ is indexed BODY WEIGHT unless a specific indention MH*Body Weight Changes (Non Mesh) MNC23.888.220 LH  OLconsider also BIOMETRY MH*Body Weights and Measures (Non Mesh) MNE5.118 LH  MHÑBolivia MNZ1.107.757.136 LH  MS2-L-Glutamine-6-L-asparagine-alytesin. A tetradecapeptide obtained from the skins of toads Bombina bombina and B. variegata; affects vascular and other smooth muscle, gastric secretion and renal circulation and function. PM86; was see under PEPTIDES 1975-85 HN86(75); was see under PEPTIDES 1975-85 MHÑBombesin ANdo not use /defic /physiol RN31362-50-2 PIAnura (66-74); Peptides (66-74) MND12.644.75; D12.776.641.650.85; D19.316.274; D24.185.965.33.137 LH  PM72 HN72(71) MHÑBonding, Dental ANonly /instrum /methods /stand PISurface Properties (66-70) MNE6.95 FXÑDental Materials; ÑOrthodontic Appliances XUÑAcid Etching, Dental LH LX; LU  MSThe emotional attachment of individuals to pets. HN(83) MHÑBonding, Human-Pet ANno qualif; coord with specific animal pet (IM or NIM); check tags ANIMAL & HUMAN MNF2.739.794.624.120 XSAnimal-Human Bonding; Human-Pet Bonding; Pet-Human Bonding DMÑObject Attachment LH LS; ; LM  PM/transplantation was BONE TRANSPLANTATION 1963-65 HN/transplantation was BONE TRANSPLANTATION 1963-65 MHÑBone and Bones ANbone tissue goes here; /cytol: consider also OSTEOBLASTS, OSTEOCLASTS, OSTEOCYTES; /embryol: consider also OSTEOGENESIS; /growth = BONE DEVELOPMENT & consider also GROWTH PLATE; /surg: consider also OSTEOTOMY or ARTHRODESIS or FRACTURE FIXATION & its specifics; osteosynthesis not one of the preceding terms goes under BONE AND BONES /surg; /transpl: may refer to a whole bone or a segment of bone but do not coord with TRANSPLANTATION, HOMOLOGOUS or TRANSPLANTATION, AUTOLOGOUS unless particularly discussed; differentiate from SKELETON which is almost never used: restrict SKELETON to bone arrangement as a whole & not for ╥skeletal╙ in titles which usually means ╥bone╙, ╥bone tissue╙ or ╥osseous╙: ( = BONE AND BONES); ╥disappearing bone╙ = OSTEOLYSIS, ESSENTIAL; inflammation = OSTEITIS; necrosis = OSTEONECROSIS; ╥bone minerals╙ = BONE AND BONES (IM) + MINERALS (IM) or specific mineral (IM); consider other terms under OSTEO- & OSTEI- & under OSSI- MNA2.835.232; A10.165.265 FXÑCalcification, Physiologic LH LX  PM72 HN72 MHÑBone Cements AND25-26 qualif PITissue Adhesives (66-71) MND25.720.716.822.300; D26.16.125 FXÑTissue Adhesives LH LX  PM67 HN67(64) MHÑBone Conduction ANconduction of sound or vibration to the cochlea; only /drug eff /rad eff MNG11.561.796.263.398 FXÑHearing LH LX  OLuse BONE CYSTS to search BONE CYST back thru 1966 PM80; was BONE CYST 1963-79 HN80; was BONE CYST 1963-79 MHÑBone Cysts ANneoplastic or non-neoplastic: check text; aneurysmal bone cyst goes here but not also under ANEURYSM: see Dorland; if neoplastic, coord IM with precoord organ/neopl term (but not BONE NEOPLASMS) (IM); if non-neoplastic, coord IM with precoord organ/dis term (but not BONE DISEASES) (IM) MNC4.182.89; C4.557.499.93; C5.116.70 XSSubchondral Cysts LH LS  PM65 HN65 MHÑBone Development ANonly /drug eff /rad eff; covers bone develop from fetus to adult: do not confuse with OSTEOGENESIS ( = histiogenesis & ossification) MNG7.553.121; G11.427.111 FXÑGROWTH PLATE LH LX  MHÑBone Diseases AN╥disappearing bone╙ = OSTEOLYSIS, ESSENTIAL; TN 143: do not confuse with OSTEOPATHY see OSTEOPATHIC MEDICINE, the specialty dealing with bone dis; inflamm dis = OSTEITIS MNC5.116 LH  PM70; HYPERTELORISM was see under CRANIOFACIAL DYSOSTOSIS 1963-84 HN70 MHÑBone Diseases, Developmental PIBone Diseases (66-69) MNC5.116.99 XSBone Dysplasias FXÑConnective Tissue Diseases; ÑGrowth Disorders XUÑHypertelorism LH LS LX; LU  MH*Bone Diseases, Endocrine (Non Mesh) MNC5.116.132 LH  MH*Bone Diseases, Infectious (Non Mesh) MNC5.116.165 LH  PM80 HN80; was NON MESH before 1980 MHÑBone Diseases, Metabolic PIBone Diseases (66-79) MNC5.116.198 XSOsteopenia LH LS  OLsearch LEG LENGTHENING under LEG LENGTH INEQUALITY 1966-71 (as Prov 1966) PM72; LEG LENGTHENING was heading 1967-71 HN72; LEG LENGTHENING was heading 1964-71 (Prov 1964-66) MHÑBone Lengthening ANonly /adv eff /instrum /methods /psychol /rehabil /vet PILeg Length Inequality (66-71); Osteotomy (66-71); specific bone/SU (66-71) MNE4.557.273 FXÑLeg Length Inequality LH LX  OLuse BONE MARROW /CY + BONE MARROW /qualif to search BONE MARROW CELLS /same qualif 1966-77, e.g., search BONE MARROW CELLS /DE under BONE MARROW /CY + BONE MARROW /DE PM65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65 HN65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65 MHÑBone Marrow AN/anal: consider BONE MARROW EXAMINATION; /cytol: myelopoiesis goes here; inflammation = OSTEOMYELITIS; fibrosis = MYELOFIBROSIS; consider terms under MYEL- but do not confuse words containing ╥myelo-╙ for spinal cord with ╥myelo-╙ for bone marrow MNA15.382.216 XSMARROW LH LS  OL= BONE MARROW /CY; see note under BONE MARROW for searching BONE MARROW CELLS 1966-77 HNwas BONE MARROW CELLS 1965-77 MH*Bone Marrow Cells (Non Mesh) MNA11.148; A15.378.316 LH  MHÑBone Marrow Diseases ANinflamm dis = OSTEOMYELITIS MNC15.378.190 LH  MSRemoval of bone marrow and evaluation of its histologic picture. MHÑBone Marrow Examination ANNIM; only /instrum /methods /vet MNE1.223.459.246 LH  PM72 HN72 MHÑBone Matrix ANdo not use /abnorm /growth /inj /innerv PIBone and Bones (66-71) MNA10.165.265.166 LH  PM74 HN74(71) MHÑBone Nails ANonly /adv eff /stand /vet; pins go here, not under BONE SCREWS; note BONE WIRES below MNE7.450.160; E7.858.442.660.149 LH  MHÑBone Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific bone (IM) + histol type of neopl (IM) MNC4.588.149; C5.116.231 LH  PM74 HN74(71) MHÑBone Plates ANonly /adv eff /stand /vet MNE7.450.180; E7.858.442.660.232 LH  MSRenewal or repair of lost bone tissue; excludes CALLUS formed after bone fracture but not yet replaced by hard bone. PM65 HN65 MHÑBone Regeneration ANonly /drug eff /rad eff; not for callus formation (index under CALLUS with required qualif) & not for fracture healing ( = FRACTURES (IM) + WOUND HEALING (NIM) ) MNG4.185.753.166; G11.427.156 FXÑCALLUS LH LX  PM65; OSTEOLYSIS, ESSENTIAL was see under BONE DISEASES 1967-79 HN65(64) MHÑBone Resorption ANfrom Cat G, only /drug eff /rad eff; bone loss not specified as in see refs does not go here: index under BONE DISEASES, METABOLIC MNC5.116.264; G11.427.201 XSAlveolar Bone Loss; Bone Loss, Alveolar; Bone Loss, Osteoclastic; Bone Loss, Periodontal; Osteoclastic Bone Loss; Periodontal Bone Loss LH LS; ; ; ; ;  PM74 HN74(71) MHÑBone Screws ANonly /adv eff /stand /vet; pins go under BONE NAILS, not here PIFracture Fixation (66-70); Fracture Fixation, Internal (70); Fracture Fixation, Intramedullary (70) MNE7.450.200; E7.858.442.660.315 LH  MSSteel wire, often threaded through the skin, soft tissues, and bone, used to fix broken bones; Kirschner's wires or apparatus also includes the application of traction to the healing bones through the wires. HN(86) MHÑBone Wires ANonly /adv eff /stand /vet; pins go under BONE NAILS PIFracture Fixation, Internal (70-85) MNE7.858.442.660.383 DMÑOrthopedic Fixation Devices LH LM  MSAn antibiotic produced by Pseudomonas cocovenenans. It inhibits adenine nucleotide afflux from mitochondria by enhancing membrane binding. HN(75) MHÑBongkrekic Acid ANdo not use /defic /physiol; /analogs NIM only RN11076-19-0 PIAntibiotics (73-74); Carboxylic Acids (73-74); Pseudomonas (68-74) MND20.85.140 DMÑAntibiotics LH LM  MHÑBonnevie-Ullrich Syndrome ANdo not use /congen MNC16.131.77.167 LH  MHÑBook Classification ANIM; only /econ /hist /methods /stand /trends MNL1.300.250.150 LH  MHÑBook Collecting ANonly /hist MNL1.40 LH  MHÑBook Imprints ANonly /hist MNL1.178.682.192.122 LH  MHÑBook Industry ANonly /econ /hist /man /organ /stand /trends; consider also PUBLISHING CATALOG: /geog /form MNJ1.576.154; L1.737.150 LH  MHÑBook Ornamentation ANno qualif MNL1.178.682.192.178 LH  MHÑBook Prices ANno qualif MNL1.737.150.340.250 LH  MHÑBook Reviews ANdo not index book reviews; use for articles on book reviews as a subject; no qualif MNL1.178.682.150 LH  MHÑBook Selection ANno qualif MNL1.453.220 LH  MHÑBookbinding ANonly /econ /hist /methods /stand /trends MNL1.737.150.317 LH  MHÑBookplates ANonly /hist MNL1.178.682.192.234 LH  PM64 HN64 MHÑBooks ANNOT for specific books ( = LITERATURE or its indentions); NOT for lists of books ( = BIBLIOGRAPHY or its indentions): for books as a means of communication or as a subject (╥books as carriers of germs╙): Manual 33.11; relation to LITERATURE: Manual 33.11, relation to MANUSCRIPTS: Manual 33.12; no qualif MNL1.178.682.192 FXÑBIBLIOTHERAPY XUÑTextbooks LH LX LU  MHÑBooks, Illustrated ANonly /hist MNL1.178.147.117; L1.178.682.192.289 XSBOOK ILLUSTRATION; ILLUSTRATED BOOKS LH LS;  MHÑBookselling ANonly /econ /hist /methods /stand /trends CATALOG: /geog /form MNL1.737.150.340 LH  PM68 HN68 MHÑBoranes ANincludes borides; do not confuse with BORATES or BORNANES; do not use /analogs /biosyn /defic /physiol PIBoron (66-67) MND1.125.150 LH  MHÑBorates ANdo not use /analogs /biosyn /defic /physiol MND1.125.234.317 LH  MSCongenital disorder of lambs caused by a virus closely related to or identical with certain strains of bovine viral diarrhea virus. HN(85) MHÑBorder Disease ANusually animal: do not use /vet but check tag ANIMAL; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES PIBovine Diarrhea Virus (75-84); Sheep Diseases (66-84) MNC2.782.930.120; C22.836.160 DMÑSheep Diseases LH LM  MSA disorder characterized by instability in several areas--interpersonal relationships, marked shifts in mood, and uncertainty about identity issues--which causes impairment in social or occupational functioning or subjective distress. HN(81) MHÑBorderline Personality Disorder AN╥borderline╙ is a psychiatric diag: follow text; do not use /drug eff /physiol /rad eff MNF3.709.597.90 XSPersonality Disorder, Borderline DMÑPersonality Disorders LH LS LM  MHÑBordetella ANdo not use /blood-csf-urine MNB3.400.209 LH  MSInfections with bacteria of the genus Bordetella, general or unspecified. PM72 HN72 MHÑBordetella Infections PIBordetella (66-71) MNC1.252.143 LH  MHÑBordetella Pertussis ANdo not use /blood-csf-urine; infection = WHOOPING COUGH MNB3.400.209.317 XSHAEMOPHILUS PERTUSSIS FXÑPERTUSSIS VACCINE; ÑPertussis Toxins LH LS LX;  MSA psychological state resulting from any activity that lacks motivation, or from enforced continuance in an uninteresting situation. PM69 HN69 MHÑBoredom ANno qualif PIMotivation (66-68) MNF1.470.192 LH  PM68 HN68 MHÑBoric Acids ANdo not use /analogs /biosyn /defic /physiol PIBorates (66-67) MND1.29.260.93; D1.125.234 LH  PM68 HN68 MHÑBorinic Acids ANdo not use /analogs /biosyn /defic /physiol; do not confuse with BORONIC ACIDS PIBoron (66-67) MND1.29.260.118; D1.125.317 LH  MSAn encephalomyelitis of horses, sheep and cattle caused by an RNA virus. PM70 HN70 MHÑBorna Disease ANusually animal: do not use /vet but check tag ANIMAL PICattle Diseases (66-69); Encephalomyelitis (66-69); Horse Diseases (66-69); Virus Diseases (66-69) MNC2.81.135; C22.152 LH  MSA virus causing a disease of horses and other domestic animals and possibly deer; occurs in Europe, N. Africa, and the Near East. HN(75); was see under ENCEPHALITIS VIRUSES 1977-80, was see under ARBOVIRUSES 1975-76 MHÑBorna Disease Virus ANdo not use /blood-csf-urine /cytol MNB4.909.920.140 XSEnzootic Encephalomyelitis Virus; Near East Equine Encephalomyelitis Virus DMÑVertebrate Viruses, Unclassified LH LS; LM  PM74 HN74(72) MHÑBornanes ANdo not confuse with BORANES; includes bornenes; do not use /analogs /biosyn /defic /physiol PIBridged Compounds (66-70); Camphor (66-70); Terpenes (70-71) MND2.455.849.618.234 XSCAMPHANES LH LS  MHÑBorneo MNZ1.252.145.103 LH  PM73 HN73(71) MHÑBorohydrides ANdo not use /analogs /biosyn /defic /physiol PIBoron Compounds (68-70) MND1.125.400 LH  MHÑBoron ANB-11; do not use /analogs /biosyn /defic /physiol; B-10 = BORON (IM) + ISOTOPES (NIM); B-8, 9, 12, 13 = BORON (IM) + RADIOISOTOPES (IM) RN7440-42-8 MND1.125; D1.268.116; D1.937.94 LH  PM68; BORIC ACID ESTERS was see under BORIC ACIDS 1968-74 HN68 MHÑBoron Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BORON CPDS PIBoron (66-67) MND2.203 XUÑTetraphenylborate LH LU  PM68 HN68 MHÑBoronic Acids ANdo not use /analogs /biosyn /defic /physiol; do not confuse with BORINIC ACIDS PIBoron (66-67) MND1.29.260.143; D1.125.483 LH  MSA genus of Gram-negative, anaerobic, helical bacteria, various species of which produce relapsing fever in man and other animals. Many species of Borrelia are referred to the genus SPIROCHAETA by the European literature. MHÑBorrelia ANdo not use /blood-csf-urine; infection = BORRELIA INFECTIONS; B. recurrentis infection = RELAPSING FEVER MNB3.851.595.193 LH  MHÑBorrelia Infections MNC1.252.847.193 LH  HN70 MHÑBoston PIMassachusetts (66-69) MNZ1.107.567.875.481.318; Z1.433.210 LH  MHÑBotany ANSPEC: SPEC qualif MNG1.273.118 FXÑPLANTS LH LX  MHÑBotswana MNZ1.58.349.144 LH  MSUse of nursing bottles for feeding. Applies to humans and animals. PM75 HN75 MHÑBottle Feeding ANhuman & animal; only /adv eff /econ /methods /psychol /trends /vet PIInfant Nutrition (66-74) MNE2.421.150 LH  PM73 HN73(72) MHÑBotulinum Antitoxin ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox PIAntitoxins (66-71) MND24.611.125.272.268 LH  MSToxins produced by Clostridium botulinum; there are at least seven different substances, most being proteins; they have neuro-, entero- and hemotoxic properties, are immunogenic and include the most potent poisons known. OLuse BOTULINUM TOXINS to search BOTULINUM TOXIN back thru 1969 (as Prov 1969-71) PM78; was BOTULINUM TOXIN 1972-77 HN78; was BOTULINUM TOXIN 1969-77 (Prov 1969-71) MHÑBotulinum Toxins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also BOTULINUM ANTITOXIN PIClostridium Botulinum (66-68); Toxins (66-68) MND16.653.147; D24.185.926.123.179 XSBotulin; Clostridium Botulinum Toxins FXÑBotulism; ÑClostridium Botulinum LH LS; LX;  MHÑBotulism MNC1.252.217.151; C21.613.415.151 FXÑBotulinum Toxins LH LX  MSA febrile disease of the Mediterranean area, the Crimea, Africa and India, due to infection with Rickettsia conorii. OLsearch RICKETTSIAL INFECTIONS 1966-74 PM87; was see under RICKETTSIACEAE INFECTIONS 1977-86, was see under RICKETTSIAL DISEASES 1965-76, was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64 HN87(75); was see under RICKETTSIACEAE INFECTIONS 1977-86, was see under RICKETTSIAL DISEASES 1965-76, was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64 MHÑBoutonneuse Fever ANcaused by Rickettsia conorii MNC1.850.810.800.135 LH  MSA virus of the Pestivirus genus causing diarrhea, fever, oral ulcerations and various necrotic lesions among cattle and other domestic animals. HN(75); was see under RNA VIRUSES 1975-80 MHÑBovine Diarrhea Virus ANdo not use /blood-csf-urine /cytol; infection = BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE MNB4.909.777.923.723.133 XSDiarrhea Virus, Bovine; Mucosal Disease Virus DMÑPestiviruses LH LS; LM  MSA virus which seems to cause a form of bovine lymphosarcoma; cultures often reveal the presence of C-type particles. OLuse BOVINE LEUKEMIA VIRUS to search CATTLE LEUKEMIA VIRUS back thru 1975 HN(77); was see under LEUKOVIRUSES 1978-80, was see under LEUKEMOGENIC VIRUSES 1977, was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76 MHÑBovine Leukemia Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM) MNB4.909.574.807.250; B4.909.777.731.250 XSCattle Leukemia Virus DMÑRetroviridae LH LS LM  MSA virus producing large numbers of warts on calves; connective tissue proliferation is an important component of the warts. HN(75); was see under PAPILLOMA VIRUSES 1975-77 MHÑBovine Papillomatosis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) MNB4.909.204.585.460.200; B4.909.574.204.711.460.200 XSBovine Papular Dermatitis Virus; Bovine Wart Virus DMÑPapillomaviruses LH LS; LM  MSA virus causing mammillitis in cattle in Britain and South Africa. OLsearch ALLERTON VIRUS INFECTIONS under LUMPY SKIN DISEASE 1970-76 HN(75); was see under HERPESVIRUSES 1975-80; ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76 MHÑBovine Ulcerative Mammillitis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with HERPESVIRUS INFECTIONS (IM) MNB4.909.204.382.110 XSAllerton Virus; BHM Virus; Bovine Herpes Mammillitis Virus; Bovine Herpesvirus 2 DMÑHerpesviridae LH LS; ; ; LM  HN(72) MHÑBovine Virus Diarrhea-Mucosal Disease ANdo not use /vet; don't forget also CATTLE (NIM) & check tag ANIMAL; DF: BVD DIS PICattle Diseases (66-71); Virus Diseases/VE (66-71) MNC2.782.930.140; C22.196.106 DMÑCattle Diseases LH LM  MSAn epidermal hyperplasia which may progress to squamous cell carcinoma. OLsearch CARCINOMA, SQUAMOUS CELL 1969-74 HN(75); was see under CARCINOMA, EPIDERMOID 1969-80 MHÑBowen's Disease ANIM; coord with SKIN NEOPLASMS (IM) MNC4.557.117.490.318; C17.882.137 DMÑCarcinoma, Squamous Cell LH LM  MSA two-person sport in which the fists are skillfully used to attack and defend. MHÑBoxing ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM) MNI3.450.642.845.210 LH  MHÑBraces ANonly /adv eff /class /stand /vet; orthodontic brackets goes under ORTHODONTIC APPLIANCES MNE7.858.442.743.319 LH  MSThe continuation of the axillary artery; it branches into the radial and ulnar arteries. MHÑBrachial Artery ANdo not use /blood supply MNA7.231.114.139 LH  MHÑBrachial Plexus ANdo not use /innerv MNA8.796.828.169 LH  MSA collective term for interstitial, intracavity, and surface radiotherapy. Radiotherapy with small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. PM80 HN80 MHÑBrachytherapy ANa type of radiother; only /adv eff /class /econ /hist /instrum /methods /psychol /stand /vet; curietherapy goes here PINeoplasms/RT (66-79); specific neoplasm/RT; Radioisotopes/AD/TU (66-79); specific radioisotope/AD/TU (66-79); Radiotherapy (66-79) MNE2.810.150 XSImplant Radiotherapy; Plaque Therapy, Radioisotope; Radioisotope Brachytherapy; Radiotherapy, Interstitial; Radiotherapy, Intracavity; Radiotherapy, Surface LH LS; ; ; ; ;  MHÑBradycardia ANTN 99: BRADYCARDIA vs HEART RATE MNC14.280.67.319 LH  MHÑBradykinin AN/biosyn /physiol permitted RN58-82-2 MND12.644.320.169; D12.644.456.193; D12.776.641.650.90; D24.185.798.354.169 LH  PM/enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65 HN/enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65 MHÑBrain ANGEN; /anal = BRAIN CHEMISTRY; /blood supply: consider also CEREBROVASCULAR CIRCULATION, CEREBRAL ARTERIES, CEREBRAL VEINS, CRANIAL SINUSES; /cytol: do not routinely convert to NEURONS; /drug eff: consider terms in D14 & D15; /inj = BRAIN INJURIES; do not use /innerv; /surg: consider also PSYCHOSURGERY; /transpl: permitted only NIM for invertebrates; for vertebrates index as NERVE TISSUE /transpl (IM) or NEURONS /transpl (IM) + BRAIN (NIM) or specific part of brain /transpl (IM or NIM); inflammation = ENCEPHALITIS & its specifics; infarct = CEREBRAL INFARCTION; malacia = ENCEPHALOMALACIA; brain-isolated, encephale isole, cerveau isole: index DECEREBRATE STATE; consider also terms under CEREBR- & ENCEPHAL- MNA8.186.211 XSCEREBRUM LH LS  MHÑBrain Abscess ANSUBDURAL EMPYEMA is also available MNC1.539.26.194; C10.228.140.116; C10.228.228.114 XSABSCESS, CEREBRAL LH LS  PM65 HN65 MHÑBrain Chemistry ANonly /drug eff /rad eff; TN 29: differentiate from BRAIN /metab; consider also /anal with specific parts of the brain but probably as NIM with BRAIN CHEMISTRY (IM) if site is merely locational & illustrative MNG6.184.202 FXÑChemistry LH LX  MSTransient or prolongued unconsciousness with or without impairment of higher mental functions and/or brain stem functions, due to a violent blow to the head. PM65 HN65(63) MHÑBrain Concussion ANbrain contusion goes here & do not coord with CONTUSIONS: see Dorland under concussion of the brain MNC21.866.460.152.194; C21.866.974.150 LH  MHÑBrain Damage, Chronic MNC10.228.140.140 LH  MSTotal cessation of brain function for 24 hours as manifested by absence of spontaneous movement, absence of spontaneous respiration, and absence of all brain stem reflexes. PM72 HN72(69) MHÑBrain Death ANno qualif PIDeath (66-68) MNC23.240.169 LH  MHÑBrain Diseases ANGEN; prefer specifics; inflamm dis = ENCEPHALITIS & its specifics; cerebromalacia = ENCEPHALOMALACIA; infarct = CEREBRAL INFARCTION MNC10.228.140 FXÑOrganic Mental Disorders, Psychotic LH LX  MSMetabolic disorders which lead to pathological changes and/or functional deviations of the brain. PM77 HN77; was NON MESH before 1977 MHÑBrain Diseases, Metabolic ANGEN; avoid: prefer specifics PIBrain Diseases (66-76) MNC10.228.140.163 XUÑKinky Hair Syndrome; ÑLeigh Disease LH LU;  PM65 HN65(64) MHÑBrain Edema MNC10.228.140.187 FXÑEdema LH LX  MSAcute injuries to the brain, general or unspecified. OLuse BRAIN INJURIES to search BRAIN INJURIES, ACUTE & BRAIN INJURY, ACUTE back thru 1966 PM81; was BRAIN INJURIES, ACUTE 1973-80, was BRAIN INJURY, ACUTE 1963-72 HN81; was BRAIN INJURIES, ACUTE 1973-80, was BRAIN INJURY, ACUTE 1963-72 MHÑBrain Injuries ANGEN or unspecified; consider also /inj with specific parts of the brain; ╥cranio-cerebral inj╙ probably goes here only & not also under HEAD INJURIES or SKULL /inj MNC21.866.460.152 LH  PM68 HN68(64) MHÑBrain Mapping ANonly /instrum /methods MNE5.132 FXÑStereotaxic Technics LH LX  MHÑBrain Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific site in brain (IM) + histol type of neopl (IM) MNC4.588.614.195; C10.228.140.211 LH  MHÑBrain Stem ANdo not use /innerv MNA8.186.211.132 LH  MHÑBranchial Region ANincludes branchial arch & branchial cleft; do not use /abnorm /embryol /growth /inj; branchial arch syndrome: index under BRANCHIAL REGION (IM) + SYNDROME (NIM) MNA16.254.160 LH  MHÑBranchioma ANneoplastic; includes branchial cleft cyst, branchial inclusion cyst, branchial chondroma, branchial fistula; /anal /blood supply /secret /ultrastruct permitted; coord IM with HEAD AND NECK NEOPLASMS (IM) MNC4.182.117 XSBRANCHIAL CYST LH LS  MSA large genus of edible, Cruciferous herbs including the large species Brassica oleracea - cabbage, cauliflower, broccoli, brussel sprouts, kale, and collard greens (all are the same species) and turnips (B. napa), rutabagas (B. napobrassica), rapeseed (B. napus), and mustards (B. nigra and B. alba). PM78; MUSTARD was heading 1963-85 HN78 MHÑBrassica ANincludes CABBAGE, kale, turnips, RAPESEED & MUSTARD; do not use /isol /pathogen; for Brassica plants as vegetables index here & do not add VEGETABLES PIPlants (66-77); Plants, Edible (66-77) MNB6.510.92 XSCabbage; Rapeseed XUÑMustard LH LS; LU  MHÑBrazil MNZ1.107.757.176 LH  MHÑBread ANonly /ad-poi-tox /anal /class /stand /supply MNJ1.341.108 LH  MHÑBreast ANhuman only; animal is MAMMAE or UDDER; /radiogr = MAMMOGRAPHY; /surg: consider also MASTECTOMY; inflammation = MASTITIS; tuberc of breast = MASTITIS (IM) + TUBERCULOSIS (IM), not TUBERCULOSIS, ENDOCRINE; breast cyst = FIBROCYSTIC DISEASE OF BREAST; self-examination: coord IM with PALPATION (IM) MNA1.236; A10.336.153 XSMAMMARY GLANDS FXÑExocrine Glands; ÑLACTATION; ÑMASTECTOMY XUÑNipples LH LS LX; ; LU  MHÑBreast Diseases ANinflamm dis = MASTITIS; tuberc of breast = MASTITIS (IM) + TUBERCULOSIS (IM), not TUBERCULOSIS, ENDOCRINE; cystic dis = FIBROCYSTIC DISEASE OF BREAST; breast cyst = FIBROCYSTIC DISEASE OF BREAST MNC19.146 LH  MHÑBreast Feeding ANhuman only; no qualif MNG6.696.571.236 FXÑMILK, HUMAN LH LX  MHÑBreast Neoplasms ANhuman only; for animal use MAMMAE + NEOPLASMS or MAMMARY NEOPLASMS, EXPERIMENTAL alone: Manual 24.33-24.36; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.180; C19.146.170 LH  MSAny tests done on exhaled air. PM74 HN74 MHÑBreath Tests ANonly /instrum /methods MNE1.223.125 XSBreathalyzer Tests FXÑRespiration LH LS LX  MSTherapeutic exercises aimed to deepen inspiration or expiration or even to alter the rate and rhythm of respiration. MHÑBreathing Exercises ANonly /adv eff MNE2.831.578.391.320 FXÑRespiration LH LX  OLsearch LABOR PRESENTATION 1966-74 PM85; was see under LABOR PRESENTATION 1963-84 HN85(75); was see under LABOR PRESENTATION 1963-84 MHÑBreech Presentation ANno qualif; check the tags FEMALE & PREGNANCY PILabor Presentation (66-74) MNG8.520.769.362.150 XSFetal Presentation, Breech; Labor Presentation, Breech; Presentation, Breech LH LS; ;  MHÑBreeding ANanimals & plants only; no qualif MNG5.414.133; E5.820.150 XUÑEstrus Detection LH LU  MHÑBrenner Tumor ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS (IM) MNC4.557.537.130 LH  MHÑBretylium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BRETYLIUM CPDS MND2.92.102.175; D2.675.276.175; D16.848.415.141; D18.97.138; D18.162.93 XUÑBretylium Tosylate LH LU  MS(o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate. An agent that blocks the release of adrenergic transmitters from nerve endings; in addition to other actions; it was formerly used as an antihypertensive agent, but is now being proposed as an effective anti-arrhythmic. Synonyms: Bretylan; Darenthin; Ornid. HN(76) MHÑBretylium Tosylate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN61-75-6 PIAryl Sulfonates (74-75); Bretylium Compounds (69-75) MND2.92.102.175.150; D2.675.276.175.150; D16.848.415.141.129; D18.97.138.129; D18.162.93.129 DMÑBretylium Compounds LH LM  MSGram-positive organisms found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter. MHÑBrevibacterium ANin soil, water, dairy prod & decaying matter MNB3.100.200.230 LH  MHÑBridged Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: BRIDGED CPDS MND2.219; D4.615.236 XUÑBicyclo Compounds LH LU  MSRecrudescent typhus. OLsearch TYPHUS, EPIDEMIC LOUSE-BORNE 1966-74 HN(75); was see under TYPHUS 1963-76 MHÑBrill's Disease MNC1.850.810.800.950.135 DMÑTyphus, Epidemic Louse-Borne LH LM  MSA fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. HN(75) MHÑBrinolase ANdo not use /analogs RNEC 3.4.99.- PIAspergillus/EN (72-74); Peptide Hydrolases (72-74) MND8.586.277.656.200; D19.461.427.200 XSBrinase DMÑPeptide Hydrolases LH LS LM  MHÑBritish Columbia MNZ1.107.567.176.160 LH  OLsearch ADNEXA UTERI 1966-74 HN(75) MHÑBroad Ligament ANinflammation = PARAMETRITIS MNA5.360.319.114.170 DMÑAdnexa Uteri LH LM  MHÑBroadsides ANno qualif MNL1.178.682.236 LH  MSalpha-(Aminooxy)-6-bromo-m-cresol. A histidine decarboxylase inhibitor. Synonyms: NSD-1055;CL 54998; Contramine. HN(75) MHÑBrocresine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN555-65-7 PICresols (68-74); Hydroxylamines (71-74) MND2.755.239.180; D8.373.190 DMÑCresols LH LM  HN(71) MHÑBromates ANdo not use /analogs /biosyn /defic /physiol PIBromine (66-70) MND1.248.497.158.129.237; D1.396.237.237; D1.655.498.106 DMÑBromine LH LM  MS7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one. A tranquilizing agent. HN(75) MHÑBromazepam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1812-30-2 PIBenzodiazepinones (74); Pyridines (74) MND3.438.79.80.70.110; D15.236.872.659.191.141 DMÑBenzodiazepine Tranquilizers LH LM  MSalpha,alpha-Bis(3,5-dibromo-4-hydroxy-o-tolyl)-alpha-hydroxytoluenesulfonic acid, gamma-sultone. A chemical indicator reagent. HN(75) MHÑBromcresol Green AND25-26 qualif; /analogs NIM only RN76-60-8 PIBromine (72-74); Cresols (69-74); Tosyl Compounds (74) MND2.455.426.559.389.832.140; D2.755.239.190; D2.886.590.887.140; D26.550.90 XSTetrabromocresolsulfonphthalein DMÑCresols LH LS LM  MSalpha-(5-Bromo-4-hydroxy-m-tolyl)-alpha-(3-bromo-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidine)-o-toluenesulfonic acid. A chemical indicator reagent. HN(75) MHÑBromcresol Purple AND25-26 qualif; /analogs NIM only RN115-40-2 PIBromine (73-74); Cresols (69-74); Tosyl Compounds (73-74) MND2.455.426.559.389.832.150; D2.755.239.195; D2.886.590.887.150; D26.550.100 DMÑCresols LH LM  PM67; was see under PEPTIDE PEPTIDOHYDROLASES 1963-66 HN67(65); was see under PEPTIDE PEPTIDOHYDROLASES 1963-66 MHÑBromelains ANdo not use /analogs /defic /physiol RNEC 3.4.22.4 MND8.586.277.656.732.96; D26.74.75.293 XSBromelins LH LS  PM74 HN74 MHÑBromhexine ANdo not use /biosyn /defic /physiol RN3572-43-8 MND2.92.146.271; D2.92.384.175; D23.338.454.321 XUÑAmbroxol LH LU  MHÑBromides ANonly for inorganic cpds or bromide ion; do not use /analogs /biosyn /defic /physiol MND1.248.497.158.129.404; D1.396.237.404 LH  MHÑBromine ANBr-79; do not use /analogs /biosyn /defic /physiol; Br-81 = BROMINE (IM) + ISOTOPES (NIM); Br-74-78, 80, 82-90 = BROMINE (IM) + RADIOISOTOPES (IM) RN7726-95-6 MND1.248.497.158.129; D1.268.125; D1.396.237; D1.937.123 XUÑBromates LH LU  MS(2-Bromo-3-methylbutyryl)urea. A sedative and mild hypnotic with potentially toxic effects. Synonyms: Bromural. HN(75) MHÑBromisovalum ANdo not use /biosyn /defic /physiol RN496-67-3 PIUrea (69-74); Valerates (72-74) MND2.948.160; D14.591.745.95 XSBromisoval; Bromovalcarbamide; Bromovalerylurea; Bromvaleton; Bromyl DMÑUrea LH LS; ; ; ; LM  MSDerivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms. PM75 HN75 MHÑBromobenzenes ANdo not use /analogs /biosyn /defic /physiol PIBromine (73-74); Hydrocarbons, Halogenated (69-74) MND2.455.426.559.389.220; D2.455.526.368.150 LH  MSBenzoic acid or benzoic acid esters substituted with one or more bromine atoms. PM75 HN75 MHÑBromobenzoates ANdo not use /analogs /biosyn /defic /physiol PIBenzoates (66-74) MND2.241.223.106.225 LH  MS2-Bromo-alpha-ergocryptine. A semisynthetic ergot alkaloid with dopaminergic action; it suppresses prolactin secretion and is used to treat amenorrhea, galactorrhea and female infertility; proposed for Parkinson disease. Synonyms: CB 154; Parlodel. OLuse BROMOCRIPTINE to search 2-BROMOERGOCRYPTINE back thru 1975 PM81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76 HN81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76 MHÑBromocriptine ANdo not use /biosyn /defic /physiol RN25614-03-3 PIErgot Alkaloids (66-74) MND3.132.327.287.131; D3.549.439.131; D6.347.150; D16.538.267.131 XS2-Bromoergocryptine; Bromocryptin LH LS;  MS5-Bromo-2'-deoxycytidine. Can be incorporated into DNA in the presence of DNA polymerase, replacing dCTP. HN(75) MHÑBromodeoxycytidine ANdo not use /biosyn /defic /physiol RN1022-79-3 PIBromine (74); Deoxycytidine (74) MND13.570.230.329.100; D13.570.685.245.500.250 DMÑDeoxycytidine LH LM  MS5-Bromo-2'-deoxyuridine. A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite; it causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent, but is used mainly as a research tool. Synonyms: NSC 38297. PM66 HN66(65) MHÑBromodeoxyuridine ANdo not use /biosyn /defic /physiol RN59-14-3 MND13.570.230.430.196; D13.570.685.852.300.150; D26.87.122 XSBUDR; Bromouracil Deoxyriboside; Broxuridine LH LS; ;  MSN-Bromosuccinimide. Synonym: NBS HN(75) MHÑBromosuccinimide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN39660-53-2 PIBromine (72-74); Succinimides (72-74) MND2.241.81.337.817.687.150; D2.478.770.150; D3.383.773.812.852.150 XSSuccinbromimide DMÑSuccinimides LH LS LM  MSA potent liver poison. In rats, bromotrichloromethane produces about three times the degree of liver microsomal lipid peroxidation as does carbon tetrachloride. HN(76) MHÑBromotrichloromethane ANdo not use /biosyn /defic /physiol RN75-62-7 PIBromine (74-75); Chloroform (74) /AA (75) MND2.455.526.368.200; D2.455.526.439.224.200 XSTrichlorobromomethane DMÑChloroform LH LS LM  MS5-Bromo-2,4(1H,3H)pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA; used mainly as mutagen although its deoxyriboside is used to treat neoplasms. Synonym: 5-bromouracil. PM74 HN74(71) MHÑBromouracil ANdo not use /biosyn /defic /physiol RN51-20-7 PIUracil (66-70) MND3.383.742.698.875.237; D26.87.131 LH  MS2-[p-Bromo-alpha-(2-dimethylaminoethyl)benzyl]pyridine. Histamine H1 blocker used in allergies, rhinitis, urticaria. Synonyms: Dimegan; Dimetane; Dimotane; Dimotapp; Ilvin. HN(66) MHÑBrompheniramine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN86-22-6 MND3.383.725.620.129; D23.654.432.718.126 XSPara-Bromdylamine; p-Bromdylamine DMÑPyridines LH LS; LM  MSalpha,alpha-Bis(3,5-dibromo-4-hydroxyphenyl)-alpha-hydroxy-o-toluenesulfonic acid, gamma-sultone. A chemical indicator reagent. Synonym: Albutest. HN(75) MHÑBromphenol Blue AND25-26 qualif; /analogs NIM only RN115-39-9 PIBromine (72-74); Phenols (69-74); Tosyl Compounds (72-74) MND2.455.426.559.389.832.180; D2.755.150; D2.886.590.887.180; D26.550.106 DMÑPhenols LH LM  MSalpha,alpha-Bis(6-bromo-5-hydroxycarvacryl)-alpha-hydroxy-o-toluenesulfonic acid, gamma-sultone. a chemical indicator reagent. HN(75) MHÑBromthymol Blue AND25-26 qualif RN76-59-5 PIThymol (74); Tosyl Compounds (74) MND2.455.426.559.389.832.200; D2.455.849.856.200; D2.886.590.887.200; D26.550.110 XSDibromothymolsulfonphthalein DMÑThymol LH LS LM  MSThe larger air passages of the lungs arising from the terminal bifurcation of the trachea. MHÑBronchi AN/drug eff: consider also BRONCHODILATOR AGENTS; /radiogr = BRONCHOGRAPHY; inflammation = BRONCHITIS; dilatation = BRONCHIECTASIS; bronchial tuberc or tuberc bronchitis: index under TUBERCULOSIS, PULMONARY & not also under BRONCHI or BRONCHITIS unless particularly discussed MNA4.411.237 XSBronchioles LH LS  MSLeft bronchial arteries arise from the thoracic aorta, the right from the first aortic intercostal or the upper left bronchial artery; they supply the bronchi and the lower trachea. PM66 HN66(63) MHÑBronchial Arteries ANdo not use /blood supply MNA7.231.114.158 LH  MHÑBronchial Diseases AN╥bronchial asthma╙: note see ref above; inflamm dis = BRONCHITIS MNC8.127 LH  MSAn abnormal passage or communication between a bronchus and another part of the body. MHÑBronchial Fistula ANfistula policy: Manual 23.25+ MNC8.127.196 FXÑFistula LH LX  MHÑBronchial Neoplasms ANnot for bronchial carcinoma ( = CARCINOMA, BRONCHIAL see CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS), nor bronchogenic carcinoma (= CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS) nor bronchiolar carcinoma (= CARCINOMA, BRONCHIOLAR + LUNG NEOPLASMS); /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.894.797.520.140; C8.381.540.125 LH  MSTests involving inhalation of allergens, nebulized or in dust form, or nebulized pharmacologically active solutions (e.g., histamine, methacholine) or control solutions, followed by assessment of respiratory function. Used in diagnosis of asthma. PM80 HN80 MHÑBronchial Provocation Tests ANdiag of asthma; only /adv eff /instrum /methods; DF: BP TESTS PIAllergens (66-79); Asthma (66-79); Bronchi (66-79); Histamine (66-79); Respiratory Function Tests (66-79); specific respiratory function test MNE1.302.796.170 XSAllergen Bronchial Provocation Tests; Antigen Bronchial Provocation Tests; Inhalation Provocation Tests; Provocation Tests, Bronchial LH LS; ; ;  MSSpasmodic contraction of the smooth muscle of the bronchi. PM64 HN64(63) MHÑBronchial Spasm MNC8.127.321 XSBronchospasm LH LS  MSPersistent abnormal dilatation of the bronchi. MHÑBronchiectasis MNC8.127.384 LH  MSAn acute inflammatory disease of the upper respiratory tract, caused by paramyxoviruses, and occurring primarily in infants and young children; the viruses most commonly implicated are parainfluenza type 3 and respiratory syncytial virus. OLuse BRONCHIOLITIS, VIRAL to search BRONCHIOLITIS 1966 (as Prov) PM67 HN67; was BRONCHIOLITIS 1964-66 (Prov) MHÑBronchiolitis, Viral ANcoord IM with specific virus dis (IM) MNC2.109; C8.127.446.321; C8.730.99.321 LH  MHÑBronchitis ANtuberc bronchitis: index under TUBERCULOSIS, PULMONARY & not also under BRONCHITIS unless particularly discussed MNC8.127.446; C8.381.495.146; C8.730.99 LH  PM65 HN65(63) MHÑBronchodilator Agents ANdo not use /analogs /biosyn /defic /physiol; consider also BRONCHI /drug eff MND16.116 FXÑHistamine H1 Receptor Blockaders LH LX  MSA usually spherical cyst, arising as an embryonic out-pouching of the foregut or trachea; generally found in the mediastinum or lung; usually asymptomatic unless it becomes infected. PM87 HN87 MHÑBronchogenic Cyst ANnon-neoplastic; /anal /blood supply /secret /ultrastruct permitted PIBronchial Diseases (66-86); Cysts (66-86); Mediastinal Cyst (66-86) MNC4.182.195; C16.131.180 XSBronchial Cyst LH LS  MSRadiography of the bronchial tree after injection of a contrast medium. PM64 HN64(63) MHÑBronchography ANNIM; do not use /util except by MeSH definition MNE1.302.171; E1.818.870.238 LH  MHÑBronchopneumonia ANdo not make a diagnosis: use term as used by author MNC8.127.509; C8.381.677.127 LH  MSA chronic lung disease appearing in certain newborn infants treated for respiratory distress syndrome with mechanical ventilation and elevated concentration of inspired oxygen. PM82 HN82 MHÑBronchopulmonary Dysplasia ANafter ther of RESPIRATORY DISTRESS SYNDROME so do not coord with it; do not use /congen; check tags HUMAN & INFANT, NEWBORN PILung Diseases (66-81); Respiratory Tract Diseases (66-81) MNC8.381.125; C16.614.521.125 LH  MSA developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung. PM65 HN65(64) MHÑBronchopulmonary Sequestration ANdo not use /congen MNC16.131.214 XSPULMONARY SEQUESTRATION LH LS  MSEndoscopic examination of the bronchi. MHÑBronchoscopy ANNIM; do not use /util except by MeSH definition MNE1.302.272; E1.418.148 LH  MSSpirometric technic in which the volume of air breathed in the right and left lung is recorded separately. MHÑBronchospirometry ANNIM; only /instrum /methods MNE1.302.796.733.322 LH  PM72 HN72(68) MHÑBrown Fat ANhuman & animal PIAdipose Tissue (66-67) MNA10.165.114.322 FXÑAdipose Tissue LH LX  MHÑBrucella ANdo not use /blood-csf-urine; infection = BRUCELLOSIS MNB3.400.285.285 LH  MHÑBrucella Abortus ANdo not use /blood-csf-urine; infection = probably BRUCELLOSIS, BOVINE but for man or other animals coord NIM with BRUCELLOSIS (IM) MNB3.400.285.285.322 LH  MHÑBrucella Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.135.134 LH  MSA family of Gram-negative bacteria containing numerous parasites and pathogens of warm-blooded animals, including man. HN(76)75 MHÑBrucellaceae ANdo not use /blood-csf-urine PIBacteria (66-74) MNB3.400.285 DMÑGram-Negative Aerobic Bacteria LH LM  MHÑBrucellosis MNC1.252.167 XSMALTA FEVER; UNDULANT FEVER LH LS;  MHÑBrucellosis, Bovine ANdo not use /vet; in cattle only: if transmitted to man, use BRUCELLOSIS for the human; don't forget also CATTLE (NIM) & check tag ANIMAL MNC1.252.167.322; C22.21.322; C22.196.148 XSBANG'S DISEASE LH LS  MS10,11-Dimethoxystrychnine. Very toxic alkaloid from Nux vomica similar to strychnine; used as reagent in analytical chemistry; also known as 2,3-dimethoxystrychnine. HN(75) MHÑBrucine AND25-26 qualif RN357-57-3 PIMethyl Ethers (74); Strychnine (72-74) MND3.132.820.140; D15.128.224.899.140; D26.550.120 XSDimethoxystrychnine DMÑStrychnine LH LS LM  MSA filarial worm of Southeast Asia, producing filariasis and elephantiasis in various mammals including man; formerly included in the genus Wuchereria. OLsearch FILARIOIDEA 1969-74 PM86; was see under FILARIOIDEA 1969-85 HN86(75); was see under FILARIOIDEA 1969-85 MHÑBrugia ANdo not use /blood-csf-urine; infection: coord NIM with ELEPHANTIASIS, FILARIAL (IM) MNB1.500.294.530.88 LH  HN75 MHÑBrunei MNZ1.252.145.130 LH  OLsearch DUODENUM 1966-74 HN(75) MHÑBrunner's Glands MNA3.492.411.620.270.322 DMÑDuodenum LH LM  PM65; was see under MASTICATION 1963-64 HN65; was see under MASTICATION 1963-64 MHÑBruxism MNC7.793.99 LH  MHÑBryozoa AN/microbiol /parasitol permitted MNB1.217 LH  MS5-Butyl-1-cyclohexylbarbituric acid. Proposed anti-inflammatory agent with possible analgesic properties. Synonym: Butymidin. OLuse BUCULOME to search PARAMIDINE back thru 1975 HN(78); was PARAMIDINE see under BARBITURATES 1975-77 MHÑBucolome ANdo not use /biosyn /defic /physiol; /analogs NIM only RN841-73-6 PIBarbiturates (72-74); Cyclohexanes (72-74) MND3.383.742.698.253.168; D14.73.278.221; D26.74.75.298 DMÑBarbiturates LH LM  MS2-Cyano-2-propenoic acid 2-methylpropyl ester. Cyanoacrylate tissue adhesive also used to occlude blood vessels supplying neoplastic or other diseased tissue. Synonyms: IBC; isobutyl-2-cyanoacrylate. OLto search ISOBUTYLCYANOACRYLATE use BUCRYLATE back thru 1975 & CYANOACRYLATES 1972-74 HN(80); was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79 MHÑBucrylate AND25-26 qualif; /analogs NIM only RN1069-55-2 MND2.241.81.69.366.200; D25.720.259.341.110; D25.919.367.341.110 XSIsobutylcyanoacrylate DMÑCyanoacrylates LH LS LM  MHÑBuddhism ANonly /hist MNK1.844.117 LH  MSA detailed financial plan for carrying out specific activities for a certain period of time; includes proposed income and expenditures. HN(78) MHÑBudgets ANonly /legis /stand /trends MNN3.219.463.60 XSBudgetary Control DMÑFinancial Management LH LS LM  PM68 HN68 MHÑBufanolides ANincludes bufenolides, bufadienolides, bufatrienolides; do not use /analogs /biosyn /defic /physiol MND4.808.122 XUÑProscillaridin LH LU  MS4-Butoxy-N-hydroxy-benzeneacetamide. Anti-inflammatory analgesic with antipyretic action; used topically, orally or rectally. Synonyms: Droxaryl; Feximac; Mofenar; Parfenac. HN(75) MHÑBufexamac AND25-26 qualif; /analogs NIM only RN2438-72-4 PIHydroxamic Acids (71-74); Phenylacetates (71-74) MND2.92.570.394.150; D2.241.511.372.150; D26.368.99.130 DMÑHydroxamic Acids LH LM  PM68 HN68 MHÑBuffaloes ANwater buffaloes: does not include bison ( = ARTIODACTYLA); Bubalus & Syncerus species go here; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIArtiodactyla (66-67); Cattle (66-67) MNB2.649.77.380.135 LH  PM67 HN67(64) MHÑBuffers ANalmost never IM; no qualif MND26.172; G6.184.29.322; G7.621.110.322; G9.188.51.322; H1.181.529.428.405 FXÑPreservation, Biological XUÑAmpholyte Mixtures LH LX LU  MSA species of the true toads, Bufonidae, found in South America. PM72 HN72 MHÑBufo Arenarum ANSo. Amer. toad; usually NIM, no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.210.80 XSToad, Argentine LH LS  MSA species of the true toads, Bufonidae, widely distributed in the United States and Europe. PM72 HN72 MHÑBufo Bufo ANcommon U.S. & European toad; usually NIM, no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.210.108 XSToad, Common LH LS  MSA species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals. PM72 HN72 MHÑBufo Marinus ANusually NIM, no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.210.580 XSToad, Giant; Toad, Marine LH LS;  MSThe family of true toads belonging to the order Anura. The genera include Bufo, Ansonia, Nectophrynoides, and Atelopus. OLuse BUFONIDAE to search BUFO back thru 1972 PM81; was BUFO 1972-80 HN81; was BUFO 1972-80 MHÑBufonidae ANtoads including genera Bufo, Ansonia, Nectophrynoides & Atelopus; usually NIM, no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.210 XSBufo; Toads, True LH LS;  MS1-Butylbiguanide. A biguanide, oral hypoglycemic agent which inhibits gluconeogenesis, increases glycolysis and decreases glucose oxidation. HN(75) MHÑBuformin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN692-13-7 PIBiguanides (68-74); Butanes (73-74) MND2.78.370.141.75; D9.482.140 XSButylbiguanide DMÑBiguanides LH LS LM  MS3-(2-dimethylaminoethyl)-5-hydroxyindole. Hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants and mammals, especially schizophrenic brains, plasma and urine; misused as psychedelic; used as tool in CNS studies. Synonym: 5-hydroxy-N,N-dimethyltryptamine. OLsearch HALLUCINOGENS 1966-74 HN(75); was see under HALLUCINOGENS 1966-74 MHÑBufotenin ANdo not use /defic /physiol; /biosyn permitted if by toads, mushrooms, etc. RN487-93-4 MND3.438.473.914.237.150; D3.438.473.914.814.150; D15.236.372.163; D24.185.965.33.163 XSDimethylserotonin; Mappine DMÑSerotonin LH LS; LM  MSStandards or regulations for construction which are designed to ensure safety against electrical hazards, fires, etc. HN(84) MHÑBuilding Codes ANonly /econ /hist /legis /trends PIFacility Design and Construction (67-83); Hospital Design and Construction (66-83); Safety (75-83) MNN2.278.200.100 DMÑFacility Design and Construction LH LM  MS(S)-6,7,7a,8-Tetrahydro-11-methoxy-7-methyl-5H-benzo(g)1,3-benzodioxolo(6,5,4-de)quinolin-12-o1. Alkaloid from Corydalis cava and other plants; induces catalepsy probably due to its antagonism of DOPAMINE; formerly used to treat tremors and nystagmus, now mainly in the study of catalepsy and dopamine mechanisms. Synonym: bulbokapnin. HN(75) MHÑBulbocapnine ANdo not use /defic /physiol; /analogs NIM only RN298-45-3 PIApomorphine (66-68); Aporphines (69-74); Dioxoles (68-74) MND3.132.70.350; D3.549.95.350; D15.236.132 DMÑAporphines LH LM  MHÑBulbourethral Glands MNA5.360.444.123; A10.336.197 XSCOWPER'S GLANDS FXÑExocrine Glands LH LS LX  MHÑBulgaria ANin translations use spelling: People's Republic, not Peoples' nor Peoples MNZ1.542.248.208 LH  MSEpisodic binge eating associated with the fear of not being able to stop eating, depressed mood, and self-deprecating thoughts. Binges are frequently terminated by self-induced vomiting. The bulimic episodes are not due to ANOREXIA NERVOSA or any known physical disorder. OLsearch HYPERPHAGIA 1981-86 PM87; was see HYPERPHAGIA 1981-86 HN87; was see HYPERPHAGIA 1981-86 MHÑBulimia PIHyperphagia (81-86) MNF3.126.72.208.80 LH  MSA genus of small freshwater snails of the order Pulmonata, found throughout Africa and the Middle East, where it is a vector of Schistosoma haematobium. PM72 HN72 MHÑBulinus ANfreshwater snail; /microbiol /parasitol permitted PISnails (66-71) MNB1.644.776.323 LH  MS3-Butylamino-4-phenoxy-5-sulfamylbenzoic acid. A sulfamyl diuretic. HN(75) MHÑBumetanide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN28395-03-1 PIBenzoates (74); Butylamines (74); Diuretics, Sulfamyl (74); Phenyl Ethers (74) MND2.65.884.150; D2.886.590.700.150; D19.770.224.516.135 DMÑDiuretics, Sulfamyl LH LM  MSN-Butyl-N-(2-(diethylamino)ethyl)-1-naphthamide. Prolongs myocardial refractory period and stabilizes cell membranes; proposed as antiarrhythmic. Synonyms: Meregon; EU 16738. HN(78) MHÑBunaftine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN32421-46-8 PIButylamines (66-77); Naphthalenes (66-77) MND4.615.638.120; D18.97.145 XSBunaphtide DMÑNaphthalenes LH LS LM  MSSmall band of specialized cardiac muscle fibers that originates in the atrioventricular node and extends into the membranous part of the interventricular septum. OLsearch HEART CONDUCTION SYSTEM 1966-74 HN(75) MHÑBundle of His ANdo not use /blood supply /innerv MNA7.541.409.273 XSAtrioventricular Bundle DMÑHeart Conduction System LH LS LM  MHÑBundle-Branch Block MNC14.280.67.558.323 XSFascicular Block LH LS  MSNeurotoxic proteins from the venom of the Banded or Formosan krait (Bungarus multicinctus, an Elapid snake); alpha bungarotoxin blocks the acetylcholine receptors and has been used to isolate and study them; beta and gamma bungarotoxins act presynaptically causing acetylcholine release and depletion; both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other Elapid venoms. PM74 HN74(73) MHÑBungarotoxins ANfrom the krait, a snake; do not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; alpha-bungarotoxin & beta-bungarotoxin go here MND16.653.154; D24.185.965.850.325.139 LH  MS2-[3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy]benzonitrile. A beta adrenergic receptor blockader with weak antiarrhythmic activity and minor ability to decrease the heart rate. HN(75) MHÑBunitrolol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN34915-68-9 PIButylamines (74); Nitriles (74); Propanolamines (74) MND2.33.329.624.120; D2.92.63.624.120; D16.848.215.120 XSKo 1366 DMÑPropanolamines LH LS LM  PM73 HN73(72) MHÑBunolol ANdo not use /biosyn /defic /physiol RN27591-01-1 PIAmino Alcohols (66-71); Sympatholytics (66-71) MND2.33.329.624.144; D2.92.63.624.144; D16.848.215.197 LH  MSHookworm infection by the genus Bunostomum. Occurs primarily in ruminants. PM68 HN68 MHÑBunostomiasis ANusually animal: do not use /vet but check tag ANIMAL; for organism index ANCYLOSTOMATOIDEA (IM) + BUNOSTOMIASIS (NIM) PIHookworm Infections (66-67) MNC3.335.508.455.161; C22.674.377.163 LH  MSA large group of viruses from many parts of the world assigned to the Bunyavirus genus of the family Bunyaviridae. HN(75); was see under ARBOVIRUSES 1975-80 MHÑBunyamwera Group Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with BUNYAVIRUS INFECTIONS (IM) MNB4.909.777.147.147 XSBunyamwera Virus; Calovo Virus; Chittoor Virus DMÑBunyaviridae LH LS; ; LM  MSA family of viruses, mainly arboviruses, consisting of a single strand of RNA. Virions are enveloped particles 90-100 nm diameter. So far there is only one genus, Bunyavirus, also known as the Bunyamwera supergroup. PM81; APEU VIRUS, BUNYAMWERA GROUP VIRUSES, CAPIM GROUP VIRUSES, CONGO VIRUS, GUAMA GROUP VIRUSES & SIMBU GROUP VIRUSES were see under ARBOVIRUSES 1975-80; CALIFORNIA GROUP VIRUSES was see under ENCEPHALITIS VIRUSES 1977-80, was CALIFORNIA VIRUS see under ARBOVIRUSES 1975-76; PAPPATACI FEVER VIRUS & RIFT VALLEY FEVER VIRUS were see under ARBOVIRUSES 1975-80, were see under ARBOVIRUS 1965-74, were see under ARBORVIRUSES 1963-64 HN81 MHÑBunyaviridae ANthe Bunyamwera supergroup goes here; do not use /blood-csf-urine /cytol; infection = BUNYAVIRUS INFECTIONS PIArboviruses (66-80); Bunyamwera Group Viruses (75-80) MNB4.909.777.147 XUÑApeu Virus; ÑBunyamwera Group Viruses; ÑCalifornia Group Viruses; ÑCongo Virus; ÑGuama Group Viruses; ÑPappataci Fever Virus; ÑRift Valley Fever Virus; ÑSimbu Group Viruses LH LU; ; ; ; ; ; ;  MSVirus diseases caused by the Bunyaviridae. PM81 HN81 MHÑBunyavirus Infections PIArbovirus Infections (66-80) MNC2.782.147 LH  PM73 HN73(71) MHÑBupivacaine ANdo not use /biosyn /defic /physiol RN2180-92-9 PIAnesthetics, Local (66-70) MND2.65.199.239; D3.383.621.758.323; D14.211.128 LH  MS1-(tert-Butylamino)-3-((6-chloro-m-tolyl)oxy)-2-propanol. Betablocker proposed for cardiac arrhythmia, angina pectoris, glaucoma and as antithrombotic. Synonyms: B 1312; Betadran; Batadrenol; Bupranol; KL 255; Looser. HN(79) MHÑBupranolol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23284-25-5 PIAmino Alcohols (66-74); Propanolamines (74-78) MND2.33.329.624.160; D2.92.63.624.160; D16.848.215.205 DMÑPropanolamines LH LM  MS17-(Cyclopropylmethyl)alpha-(1,1-dimethylethyl)-4,5-epoxy -18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol. A long-acting narcotic analgesic similar to morphine, but also possesses narcotic antagonist action; used in severe pain. Synonyms: CL 112302; M 6029; NIH 8805; RX6029; UM 952. PM87; was see under MORPHINANS 1979-86 HN87(79); was see under MORPHINANS 1979-86 MHÑBuprenorphine ANdo not use /biosyn /defic /physiol RN52485-79-7 PIDihydromorphinone (66-68); Morphinans (69-78); Morphine (66-68) MND3.132.610.422.150; D3.549.686.150; D3.605.497.150; D14.73.153.125; D14.712.125 LH  OLsearch MORTUARY PRACTICE 1966-74 HN(75) MHÑBurial ANonly /econ /hist MNG2.438.173 DMÑMortuary Practice LH LM  MSN-Methyl-N'-(4-[4-(5)-imidazolyl]butyl) thiourea. A blockader of histamine H(2)-receptors which competitively and specifically blocks the stimulating effect of histamine on areas such as gastric secretion which are not affected by H(1)-receptor agonists. HN(75) MHÑBurimamide ANdo not use /biosyn /defic /physiol RN34970-69-9 PIImidazoles (72-74); Thiourea (72-74) MND2.886.904.200; D2.948.898.200; D19.316.203.142; D23.654.443.142 DMÑThiourea LH LM  OLuse BURKINA FASO to search UPPER VOLTA back thru 1966 HN86; was UPPER VOLTA 1963-85 MHÑBurkina Faso MNZ1.58.432.195 XSUpper Volta LH LS  MSA malignant lymphosarcoma prevalent among children in tropical Africa, from which Epstein-Barr antigens have been consistently isolated. PM68 HN68(65) MHÑBurkitt's Lymphoma ANcaused by EPSTEIN-BARR VIRUS (also called Burkitt's lymphoma virus: for hist of viral term see note under EPSTEIN-BARR VIRUS) MNC2.256.466.114; C4.557.386.480.165; C15.604.515.569.480.165; C20.683.515.761.480.165 XSAfrican Lymphoma; Burkitt's Tumor; Lymphoma, Burkitt's LH LS; ;  MHÑBurma MNZ1.252.145.144 LH  MSSpecialized hospital facilities which provide intensive care for burn patients. HN(82) MHÑBurn Units ANdo not use /educ /methods PIIntensive Care Units (66-81) MNN2.278.388.493.160 XSBurn Centers DMÑIntensive Care Units LH LS LM  HN(68) MHÑBurning Mouth Syndrome PIMouth Diseases (66-67) MNC7.465.114 DMÑMouth Diseases LH LM  MSAn excessive stress reaction to one's occupational or professional environment. It is manifested by feelings of emotional and physical exhaustion coupled with a sense of frustration and failure. HN(83) MHÑBurnout, Professional ANCat F3 qualif only & even those with discretion PIStress, Psychological (69-82) MNF2.830.900.110; F3.126.903.110 DMÑStress, Psychological LH LM  MHÑBurns ANGEN; ╥thermal injury╙; /chem ind = BURNS, CHEMICAL; EYE BURNS & SUNBURN are also available; burn shock: coord IM with SHOCK, TRAUMATIC (IM) MNC21.866.200 LH  MHÑBurns, Chemical ANdo not use /chem ind; chem eye burns = BURNS, CHEMICAL (IM) + EYE BURNS /chem ind (IM) MNC21.866.200.156 LH  MHÑBurns, Electric MNC21.866.200.239; C21.866.324.323 LH  MHÑBurns, Inhalation ANdo not use /chem ind MNC21.866.200.322 XSSmoke Inhalation LH LS  PM66 HN66(65) MHÑBursa of Fabricius ANusually NIM MNA13.163; A15.382.520.604.114 FXÑThymus Gland LH LX  PM65 HN65 MHÑBursa, Synovial ANinflammation = BURSITIS MNA2.835.583.156 LH  MHÑBursitis MNC5.550.251 LH  MHÑBurundi MNZ1.58.183.187 LH  MSLH-RH, 6-(0-(1,1-dimethylethyl)-D-serine)- 9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate salt. Potent LH-RH or GnRH agonist. Has potential use as a female or male contraceptive and has also been used in the treatment of prostatic carcinoma. PM84 HN84 MHÑBuserelin Acetate ANdo not use /biosyn /defic /physiol RN68630-75-1 PIFSH (66-73); LH (66-73); LH-FSH Releasing Hormone/AA (74-83); Pituitary Hormone Releasing Hormones (68-73) MND6.472.709.429.150 XSBuserelin; HOE 766; Ser-(t-Bu)6-Des-Gly(10)-LH-RH Ethylamide LH LS; ;  MHÑBusulfan ANdo not use /biosyn /defic /physiol RN55-98-1 MND2.241.866.540.121.537.200; D2.455.326.146.92.537.200; D2.455.326.146.571.537.200; D2.886.610.121.537.200; D22.204.232 XSBusulphan LH LS  MS5-sec-Butyl-5-ethylbarbituric acid. Intermediate duration barbiturate used as a hypnotic or sedative; may induce dependence. Do not confuse with butobarbital (butethal). Synonyms: Asturidon; Butased; Butisol; Loubard; Nervan; Prelital. HN(76) MHÑButabarbital ANdo not confuse with ╥butobarbital╙; do not use /biosyn /defic /physiol; /analogs NIM only RN143-81-7 PIBarbiturates (69-75) MND3.383.742.698.253.175; D14.591.220.136 XSButabarbitone; Secbutabarbital; Secumalum DMÑBarbiturates LH LS; ; LM  PM65 HN65 MHÑButacaine ANdo not use /biosyn /defic /physiol RN149-16-6 MND2.241.223.106.61.75.125; D14.211.156 XSButaprobenz; Butocain LH LS;  MS3-alpha-tert-Butyl-2,3,4,4a-beta,8,9,13b-alpha 14-octahydro-1H-benzo[6,7]-cyclohepta[1,2,3-de]pyrido -[2,1-alpha] isoquinolin-3-ol. A benzocycloheptapyridoisoquinolinol that has actions similar to those of major tranquilizers; proposed as antipsychotic, especially in schizophrenia. Synonym: AY 23,028. HN(78) MHÑButaclamol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN36504-94-6 PIDibenzocycloheptenes (68-77) MND4.615.181.384.230; D15.236.872.331.178 DMÑDibenzocycloheptenes LH LM  MSFour carbon unsaturated hydrocarbons containing two double bonds. OLuse BUTADIENES to search BUTADIENE back thru 1966 PM78; was BUTADIENE 1963-77 HN78; was BUTADIENE 1963-77 MHÑButadienes ANdo not use /analogs /biosyn /defic /physiol MND2.455.326.271.665.146.240 XUÑChloroprene LH LU  MS5-(2-Dibutylaminoethylamino)-3-phenyl-1,2,4-oxadiazole. Vasodilator agent: proposed for disorders of peripheral circulation. Synonyms: Adrevil; LA 1221; Surem; Surheme. HN(75) MHÑButalamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN22131-35-7 PIButylamines (72-74); Ethylamines (72-74); Oxadiazoles (72-74) MND3.383.548.580.100; D18.918.172 DMÑOxadiazoles LH LM  MS4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom. PM75 HN75 MHÑButanediols ANdo not use /analogs /biosyn /defic /physiol PIGlycols (69-74) MND2.33.618.125 XSButylene Glycols; Dihydroxybutanes LH LS;  PM73 HN73 MHÑButanes ANdo not use /analogs /biosyn /defic /physiol; does not include butenes ( = ALKENES); CYCLOBUTANES is also available PIAlkanes (66-72) MND2.455.326.146.216 XSIsobutanes LH LS  PM68 HN68 MHÑButanones ANdo not use /analogs /biosyn /defic /physiol PIKetones (66-67) MND2.522.296 XUÑAcetoin; ÑAmphenone B; ÑDiacetyl LH LU; ;  PM73 HN73(64) MHÑButaperazine ANdo not use /biosyn /defic /physiol RN653-03-2 MND3.494.741.135; D15.236.872.331.628.141 LH  MSA water soluble aminoglycosidic antibiotic complex isolated from fermentation filtrates of Bacillus circulans. Two components (A and B) have been separated from the complex. Both are active against many gram-positive and some gram-negative bacteria. HN(75) MHÑButirosins ANdo not use /analogs /defic /physiol PIAntibiotics (73-74); Aminoglycosides (74) MND9.203.408.51.120; D20.85.145 DMÑAntibiotics LH LM  MS17-(Cyclobutylmethyl)-morphinan-3,14-diol. Synthetic morphinan analgesic with narcotic antagonist action; used in severe pain. Synonym: BC 2627. HN(79) MHÑButorphanol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN42408-82-2 PIMorphinans (69-78) MND3.132.610.422.165; D3.549.686.165; D3.605.497.165; D14.73.335; D14.712.135 DMÑMorphinans LH LM  HN(73) MHÑButoxamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2922-20-5 PIAdrenergic Beta Receptor Blockaders (69-72); Amino Alcohols (66-72); Antilipemic Agents (66-72) MND2.33.329.624.180; D2.92.63.624.180; D16.848.215.223 DMÑPropanolamines LH LM  MHÑButter ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply RN8029-34-3 MND10.516.212.302.199; J1.341.273.174 LH  MSSlender-bodies diurnal insects having large, broad wings often strikingly colored and patterned. HN(75) MHÑButterflies AN/microbiol /parasitol permitted MNB1.131.617.561.200 DMÑLepidoptera LH LM  MHÑButtocks ANfew qualif apply; usually NIM as site MNA1.258 XSGLUTEAL REGION LH LS  PM66 HN66 MHÑButylamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.264 LH  MStert-Butyl-4-methoxyphenol. Mixture of 2- and 3-tertbutyl-4-methoxyphenols; antioxidant used in foods, cosmetics and pharmaceuticals; may inhibit carcinogenesis. Synonyms: AMIF-72; Embanox; Nepantiox; BHA; Nipantiol; Tenox. OLsearch ANISOLES 1973-74 PM87; was see under ANISOLES 1973-86 HN87(75); was see under ANISOLES 1973-86 MHÑButylated Hydroxyanisole ANdo not use /biosyn /defic /physiol RN25013-16-5 MND2.355.601.200.324; D2.355.726.158.324; D2.755.75.241; D26.471.385.148 XSButylhydroxyanisole LH LS  MS2,6-Bis(1,1-dimethyl)-4-methylphenol. Antioxidant used in foods, cosmetics, petroleum products, etc.; may inhibit some and facilitate other neoplasms. Synonyms: BHT; Dalpac; DBPC; Impruvol; Ionol; Sustane; Vionol. OLsearch CRESOLS 1973-74 PM80; was see under CRESOLS 1973-79 HN80(75); was see under CRESOLS 1973-79 MHÑButylated Hydroxytoluene ANdo not use /biosyn /defic /physiol RN128-37-0 PICresols (66-74) MND2.755.239.216; D26.471.385.153 XSButylhydroxytoluene LH LS  MSN-Butyl-N-(4-hydroxybutyl)nitrosamine. Substituted carcinogenic nitrosamine. HN(75) MHÑButylhydroxybutylnitrosamine AND25-26 qualif; /analogs NIM only RN3817-11-6 PIAlcohols, Butyl (74); Nitrosamines (74) MND2.654.442.100; D26.191.646.142 DMÑNitrosamines LH LM  MSScopolamine-N-butyl bromide. Anticholinergic quarternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine and biliary tracts and to facilitate radiologic visualisation of the gastrointestinal tract. Synonyms: Buscapina; Buscapin; Buscol; Scobutil; Scopolan. HN(76); was see under SCOPOLAMINE 1976-77 MHÑButylscopolammonium Bromide ANdo not use /biosyn /defic /physiol RN149-64-4 PIBromine (72-74); Scopolamine (69-75); Scopolamine Derivatives (75) MND3.132.889.848.661.200; D3.605.869.900.700.200; D16.653.396.128; D16.653.865.826.128 XSHyoscinbutylbromide; Scopolaminebutylbromide DMÑScopolamine Derivatives LH LS; LM  MHÑButyrates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.161; D2.241.81.465.240; D10.516.251.400.240 XUÑButyric Acids; ÑClofenapate; ÑCrotonates; ÑCrotonic Acids LH LU; ; ;  MS4-carbon saturated monocarboxylic acids. HN(75) MHÑButyric Acids ANdo not use /analogs /biosyn /defic /physiol PIButyrates (68-74) MND2.241.81.161.325; D2.241.81.465.240.230; D10.516.251.400.240.230 XSButanoic Acids DMÑButyrates LH LS LM  MSThose butyrophenone derivatives used in the treatment of psychoses; the actions resemble those of other major tranquilizers. PM79 HN79 MHÑButyrophenone Tranquilizers ANdo not use /analogs /biosyn /defic /physiol PIButyrophenones (66-78); Tranquilizing Agents (66-74); Tranquilizing Agents, Major (75-78) MND15.236.872.331.241 LH  PM66 HN66 MHÑButyrophenones ANdo not use /analogs /biosyn /defic /physiol MND2.522.352 XUÑAcetabutone; ÑAzaperone LH LU;  MSAn aspect of cholinesterase (EC 3.1.1.8). HN(75) MHÑButyrylcholinesterase ANdo not use /analogs; /antag = CHOLINESTERASE INHIBITORS (IM) + BUTYRYLCHOLINESTERASE (NIM with no qualif) RNEC 3.1.1.- PIButyrates (73-74); Cholinesterases (73-74) MND8.586.277.352.100.170.250 DMÑCholinesterases LH LM  MSN,N,N-Trimethyl-2-((1-oxobutyl)thio)-ethanaminium. A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity. HN(75) MHÑButyrylthiocholine ANdo not use /biosyn /defic /physiol RN4555-00-4 PIButyrates (72-74); Choline (68-74); Sulfhydryl Compounds (72-74) MND2.92.102.232.800.200; D2.675.276.232.800.200 DMÑCholine LH LM  MS1,3-Di(p-N1,3-Di(p=N-allyl-N-methylaminophnyl)pentane-3-one. Proposed cholinesterase inhibitor. HN(75) MHÑBW 284 C 51 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN402-40-4 PIAniline Compounds (71-74); Allyl Compounds (71-74); Ketones (71-74) MND2.92.146.290 DMÑAniline Compounds LH LM  OLuse BYELORUSSIAN S.S.R. to search BELORUSSIA back thru 1966 HN82; was BELORUSSIA 1963-81 MHÑByelorussian S.S.R. MNZ1.542.248.950.160; Z1.950.160 XSBelorussian S.S.R.BELORUSSIAN SSR LH LS  MSAn airway obstruction due to the dust inhaled during the processing of cotton. PM74 HN74(69) MHÑByssinosis ANdo not use /chem ind; pneumoconiosis from cotton dust fibers; do not coord with OCCUPATIONAL DISEASES PIPneumoconiosis (66-68) MNC8.381.655.287; C21.447.800.323 LH  MSA 31-amino acid peptide which connects the A and B chains of proinsulin. The exact composition of the peptide is species dependent. In beta cells proinsulin is enzymatically converted to insulin with the liberation of the C-peptide. An immunoassay has been developed for assessing pancreatic beta cell secretory function in diabetic patients in whom circulating insulin antibodies and exogenous insulin interfere with insulin immunoassay. PM84; was see under PEPTIDES 1977-83 HN84(77); was see under PEPTIDES 1977-83 MHÑC-Peptide ANfrom proinsulin only: not for peptide fragments from other proteins ( = PEPTIDE FRAGMENTS) PIPeptides (73-76); Proinsulin (75-76) MND6.472.610.575.788.250; D12.644.100; D12.776.811.706.250 XSConnecting Peptide LH LS  MHÑC-Reactive Protein ANdo not use /blood RN9007-41-4 MND12.776.34.145; D12.776.124.50.120; D12.776.124.486.157 LH  MSOncogenic RNA viruses which produce tumors in various species; they include the avian, murine and feline tumor viruses. The C-type particle is an extremely complex virion, which matures by budding from the cell membrane; the viral envelope is almost entirely composed of material from the host cell membrane, and the core is surrounded by a hexagonal capsid. PM74 HN74(72) MHÑC-Type Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) + neopl terms if pertinent PIOncogenic Viruses (66-71); RNA Viruses (66-71); specific virus MNB4.909.574.807.270; B4.909.777.731.270 LH  MSA tree of the Theobroma family or its seeds which are used in making cocoa and chocolate. OLuse CACAO to search CHOCOLATE & COCOA back thru 1966 HN(86)63; CHOCOLATE & COCOA were see under CACAO 1963-84 MHÑCacao ANas plant & as chocolate or cocoa; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply; coord (IM) with CANDY (IM) for chocolate candy or with BEVERAGES (IM) for chocolate drinks MNB6.510.103; J1.341.131 XSChocolate; Cocoa; Theobroma DMÑPlants, Edible LH LS; ; LM  MHÑCachexia ANpituitary cachexia = HYPOPITUITARISM MNC23.888.220.174 LH  MSHydroxydimethylarsine oxide. Herbicide. HN(75) MHÑCacodylic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN75-60-5 PIArsenicals (69-74) MND2.691.88.100; D5.723.366.150 DMÑArsenicals LH LM  MHÑCadaver ANIM; use of cadaveric organs in transpl is NIM; do not use for post mortem studies ( = probably AUTOPSY if as a technic); not for routine postmortem pathol ( = probably /pathol); must be on cadaver as a corpse; no qualif MNC23.240.224 LH  HN(73) MHÑCadaverine ANdo not use /defic /physiol; /analogs NIM only RN462-94-2 PIAmines (66-72); Polyamines (71-72) MND2.92.782.258.174 DMÑDiamines LH LM  OLsearch CADMIUM /PO under CADMIUM POISONING back thru 1966 PM/poisoning ( = CADMIUM POISONING as of 1977) was used for indexing 1966-76 HN/poisoning was used for indexing 1966-76 MHÑCadmium ANCd-114; do not use /analogs /biosyn /defic /physiol /pois ( = CADMIUM POISONING); Cd-106, 108, 110-113, 116 = CADMIUM (IM) + ISOTOPES (NIM); Cd-103-105, 107, 109, 115, 117-119 = CADMIUM (IM) + RADIOISOTOPES (IM) RN7440-43-9 MND1.248.497.300.333.199; D1.268.134; D1.552.129 LH  MSPoisoning occurring after exposure to cadmium compounds or fumes; may cause gastrointestinal syndromes, anemia, or pneumonitis. OLuse CADMIUM POISONING to search CADMIUM /PO back thru 1966 PM77; was CADMIUM /poisoning 1966-76 HN77; was CADMIUM /poisoning 1966-76 MHÑCadmium Poisoning ANdo not use /chem ind; occup cadmium pois: coord IM with OCCUPATIONAL DISEASES (IM) but not also ENVIRONMENTAL EXPOSURE (see note there) MNC21.613.165 XSItai-Itai LH LS  MSA genus of small free-living nematodes. Two species, C. elegans and C. briggsae are much used in studies of genetics, development, aging, muscle chemistry, and neuroanatomy. PM79 HN79 MHÑCaenorhabditis ANa nematode used in exper PINematoda (66-78) MNB1.500.294.470 LH  MSA specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian; it is similar in action and composition to cholecystokinin; stimulates gastric, biliary, and pancreatic secretion and certain smooth muscle; used in paralytic ileus and as diagnostic aid in pancreatic malfunction. Synonyms: Ceosumin; FI 6934; Takus. PM74 HN74(72) MHÑCaerulein AN/biosyn /physiol permitted; do not confuse X ref CERULEIN with CERULENIN RN17650-98-5 PIGastrointestinal Agents (67-71); Peptides (66-71) MND12.644.456.241; D19.316.325 XSCerulein; Ceruletide LH LS;  MS3,4-Dihydroxycinnamic acids. A class of phenolic acids related to chlorogenic acid,p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation. HN(75) MHÑCaffeic Acids ANdo not use /analogs /biosyn /defic /physiol PICinnamates (68-74); Catechol (72-74) MND2.241.223.201.170 DMÑCinnamates LH LM  MHÑCaffeine ANdo not use /defic /physiol RN58-08-2 MND3.132.956.200; D3.438.759.758.824.175; D15.128.138 FXÑCoffee LH LX  MHÑCalcaneus ANthe heel-bone: differentiate from HEEL, the area MNA2.835.232.484.801.241 FXÑHeel LH LX  MS9,10-Secocholesta-5,7,10(19)-triene-3,25-diol. Major circulating metabolite of vitamin D3 produced in the liver. Best indicator of the body's vitamin D stores. Effective in the treatment of rickets, osteomalacia both in azotemic and non-azotemic patients; also has mineralizing properties. PM83 HN83 MHÑCalcifediol RN19356-17-3 PICholecalciferols (66-72); Hydroxycholecalciferols (72-82) MND4.808.247.222.159.478.250; D4.808.247.808.146.478.250; D4.808.812.221.478.250; D10.516.851.152.478.250; D11.786.763.196.478.250 XS25-Hydroxycholecalciferol; 25-Hydroxyvitamin D3 LH LS;  MSProcess by which organic tissue becomes hardened by the physiologic deposit of calcium salts. PM65; was CALCIFICATION 1963-64 HN65; was CALCIFICATION 1963-64 MHÑCalcification, Physiologic ANonly /drug eff /rad eff; BONE DEVELOPMENT, OSTEOGENESIS & TOOTH CALCIFICATION are also available MNG6.184.227; G7.553.121.175; G11.427.111.175 FXÑBone and Bones LH LX  MSPathologic deposition of calcium salts in tissues. PMCALCIPHYLAXIS was heading 1965-83 MHÑCalcinosis ANmost texts will say ╥calcification╙; coord IM with organ/diseases term (IM) MNC18.452.174.130 XSCALCIFICATION, PATHOLOGIC FXÑCHONDROCALCINOSIS XUÑCalciphylaxis LH LS LX LU  MSCondition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification. HN(84)65(63) MHÑCalciphylaxis MNC18.452.174.130.186 DMÑCalcinosis LH LM  OLuse CALCITONIN to search THYROCALCITONIN back thru 1966 PM74,66-67; was THYROCALCITONIN 1968-73 HN74,66-67; was THYROCALCITONIN 1968-73 & 1964-65 (Prov 1964-65) MHÑCalcitonin AN/biosyn /physiol permitted RN9007-12-9 MND6.472.150; D12.644.65; D12.776.641.650.95 XSTHYROCALCITONIN FXÑUltimobranchial Body LH LS LX  MS1 alpha,25-Dihydroxycholecalciferol. Physiologically active form of vitamin D. Formed in kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (calcifediol). Its production is stimulated by low blood calcium levels and parathyroid hormone. It increases intestinal absorption of calcium and phosphorus and in concert with parathyroid hormone increases bone resorption. It is used in the treatment of chronic kidney failure, hypoparathyroidism, osteomalacia, and osteoporosis. PM82 HN82 MHÑCalcitriol AN/biosyn /physiol permitted; /defic permitted but coord IM with VITAMIN D DEFICIENCY (IM) RN32222-06-3 PICholecalciferols (66-72); Dihydroxycholecalciferols (73-81); Hydroxycholecalciferols (72-73) MND4.808.247.222.159.478.300; D4.808.247.808.146.478.300; D4.808.812.221.478.387.300; D10.516.851.152.478.387.300; D11.786.763.196.478.387.300 XS1 alpha,25-Dihydroxycholecalciferol; 1 alpha,25-Dihydroxyvitamin D3; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D3 LH LS; ; ;  PM/metabolism was CALCIUM METABOLISM 1965 HN/metabolism was CALCIUM METABOLISM 1965 MHÑCalcium ANCa-40; /physiol permitted; do not use /analogs /biosyn; /antag permitted but consider also CALCIUM CHANNEL BLOCKERS; /blood: note see related terms; /defic: consider also HYPOCALCEMIA & note CALCIUM, DIETARY below; /metab: consider also CALCIUM CHANNELS see ION CHANNELS & see note there; metab disord = CALCIUM METABOLISM DISORDERS; isotopes & radioisotopes: see below RN7440-70-2 MND1.248.497.300.333.241; D1.268.141; D1.552.539.288 XSFactor IV FXÑHYPERCALCEMIA; ÑHYPOCALCEMIA LH LS LX;  PM65 HN65 MHÑCalcium Carbonate ANdo not use /analogs /biosyn /defic /physiol RN471-34-1 MND1.154.453.325; D1.552.539.288.175 LH  MSA class of drugs which act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. Since they are inducers of vascular and other smooth muscle relaxation, they are used in the drug therapy of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms. OLuse CALCIUM CHANNEL BLOCKERS to search CALCIUM ANTAGONISTS, EXOGENOUS back thru 1982 PM83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982 HN83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982 MHÑCalcium Channel Blockers AND25-26 qualif PICalcium (66-67) /AI (68-81); Ion Channels (79-81) MND18.192 XSCalcium Antagonists, Exogenous; Calcium Blockaders, Exogenous; Calcium Inhibitors, Exogenous; Channel Blockers, Calcium FXÑIon Channels LH LS; ; ; LX  PM65 HN65 MHÑCalcium Chloride ANdo not use /analogs /biosyn /defic /physiol RN10043-52-4 MND1.396.343.260.275; D1.552.539.288.225 LH  MS2,5-Dihydroxy-benzenesulfonic acid, calcium salt. A drug used to reduce hemorrhage in diabetic retinopathy. Synonym: Doxium. HN(75) MHÑCalcium Dobesilate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN20123-80-2 PIBenzenesulfonates (74); Hydroquinones (72-74) MND2.241.866.540.244.222.120; D2.455.426.559.389.97.120; D2.886.610.244.222.120; D19.461.270.463.155 DMÑBenzenesulfonates LH LM  PM65 HN65 MHÑCalcium Fluoride ANdo not use /analogs /biosyn /defic /physiol RN7789-75-5 MND1.396.514.348.325; D1.552.539.288.325 LH  MSD-Gluconic acid calcium salt (2:1). The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states. Synonyms: Calciofon; Calglucon; Ebucin; Glucal; Glucobiogen. HN(79) MHÑCalcium Gluconate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN299-28-5 PICalcium (66-78); Gluconates (66-78) MND1.552.539.288.350; D2.241.81.844.322.200; D2.241.511.902.322.200; D9.203.811.308.200 DMÑGluconates LH LM  PM67 HN67 MHÑCalcium Hydroxide ANdo not use /analogs /biosyn /defic /physiol RN1305-62-0 PICalcium (66); Hydroxides (66) MND1.455.275; D1.552.539.288.375 FXÑDental Cavity Lining; ÑDental Pulp Capping LH LX;  MHÑCalcium Isotopes ANCa-42-44, 46, 48; NIM; no qualif MND1.496.98; D1.552.539.288.425 LH  MHÑCalcium Metabolism Disorders ANGEN or unspecified: prefer specifics MNC18.452.174 XUÑDecalcification, Pathologic LH LU  MSEthanedioic acid calcium salt. The calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi. PM79 HN79 MHÑCalcium Oxalate ANdo not use /biosyn /defic /physiol RN25454-23-3 PICalcium (66-78); Oxalates (66-78) MND1.552.539.288.460; D2.241.81.337.635.220 LH  PM65 HN65(64) MHÑCalcium Phosphates ANdo not use /analogs /biosyn /defic /physiol MND1.552.539.288.475; D1.696.620.603.325 LH  MSAn inorganic pyrophosphate which affects calcium metabolism in mammals. Abnormalities in its metabolism occur in some human diseases notably hypophosphatasia and pseudogout. HN(77) MHÑCalcium Pyrophosphate ANdo not use /analogs /biosyn /defic RN10086-45-0 PIPyrophosphates (66-76) MND1.552.539.288.475.300; D1.696.620.603.700.720.300 XSCalcium Diphosphate DMÑPyrophosphates LH LS LM  OLsearch CALCIUM ISOTOPES 1966-73 PM74 HN74 MHÑCalcium Radioisotopes ANCa-37-39, 41, 45, 47, 49, 50; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) MND1.496.98.325; D1.496.749.113; D1.552.539.288.525 LH  MSCalcium salt of sulfuric acid. Exists in various states of hydration; the hemihydrate is plaster of paris, the dihydrate is gypsum. Used in building materials, as dessicant, in dentistry as impression material, cast or die and in medicine as immobilizing cast and as tablet excipient. Synonyms: anhydrous sulfate of lime; Drierite; gips; gypsite; karstenite; plaster; selenite; alabaster. OLuse CALCIUM SULFATE to search PLASTER OF PARIS back thru 1966 PM80; PLASTER OF PARIS was heading 1963-79 HN80; PLASTER OF PARIS was heading 1963-79 MHÑCalcium Sulfate ANdo not use /analogs /biosyn /defic /physiol RN7778-18-9 MND1.552.539.288.600; D1.877.814.539.300; D25.150 XSDental Stone, Artificial; Gypsum; Plaster of Paris LH LS; ;  MSA protein that plays a fundamental role in the Vitamin D mediated transport of calcium in reptiles, amphibians, birds and mammals. It is found in the intestine, kidneys, egg shell gland, brain and possibly other organs. Its molecular weight is species dependent. PM87; was see under CALCIUM-BINDING PROTEINS 1980-86, was see under CARRIER PROTEINS 1979 HN87(79); was see under CALCIUM-BINDING PROTEINS 1980-86, was see under CARRIER PROTEINS 1979 MHÑCalcium-Binding Protein, Vitamin D-Dependent AN/biosyn /physiol permitted; do not use /analogs /defic; DF: CABP PICalcium (66-78); Carrier Proteins (71-78); Protein Binding (66-78); Vitamin D (66-78) MND12.776.157.125.130 XSVitamin D-Dependent Calcium-Binding Protein LH LS  MSProteins to which calcium ions are bound. They can act as transport proteins, regulator proteins or activator proteins. PM80; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT & CALCIUM-DEPENDENT REGULATOR were see under CARRIER PROTEINS 1979 HN80 MHÑCalcium-Binding Proteins AN/biosyn /physiol permitted; do not use /analogs PICalcium (66-79); Carrier Proteins (71-79); Proteins (66-70) MND12.776.157.125 XSCalcium Transport Proteins LH LS  MHÑCalcium, Dietary ANonly /admin /adv eff (coord with disease /etiol, not /chem ind) /anal /class /metab /pharm /stand /ther use; /defic = CALCIUM /defic MND1.552.539.288.275 XSDIETARY CALCIUM LH LS  OLto search for chem composition of calculi, use CALCULI/anal back thru 1987 & CALCULI/metab 1966-86 MHÑCalculi ANcoord IM with organ/diseases term (IM); chem composition of calculi: use /anal; /ultrastruct permitted; chemolysis of calculi: coord dis with /ther, not /drug ther; consider specifics: BLADDER CALCULI, CHOLELITHIASIS, COMMON BILE DUCT CALCULI, KIDNEY CALCULI, SALIVARY DUCT CALCULI, URETERAL CALCULI, URINARY CALCULI MNC23.146 FXÑLithotripsy LH LX  MSDetermination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. HN(78) MHÑCalibration ANNIM; coord with specific scale (IM) if relevant; only /stand MNE5.140; H1.939.155 DMÑWeights and Measures LH LM  MSA genus of Picornaviridae producing disease in terrestrial and marine mammals; it differs notably from the other genera of Picornaviridae in having larger virions and in the distinctive ╥chunky╙ arrangements of the capsomers. Some authorities question its inclusion among the Picornaviridae. Caliciviruses include the vesicular exanthema virus of swine, the San Miguel sea lion virus, and the feline caliciviruses. OLuse CALICIVIRIDAE to search CALICIVIRUSES & FELINE CALICIVIRUS back thru 1975 PM82; was CALICIVIRUSES 1979-81; FELINE CALICIVIRUS was see under PICORNAVIRUSES 1975-78 HN82; was CALICIVIRUSES 1979-81; FELINE CALICIVIRUS was see under PICORNAVIRUSES 1975-78 MHÑCaliciviridae ANfrom ╥calic-╙, cup, from its cup-like appearance under staining; do not use /blood-csf-urine /cytol; infection: coord NIM with PICORNAVIRUS INFECTIONS (IM) PIPicornaviridae (66-78) MNB4.909.777.162 XSFeline Caliciviruses LH LS  MHÑCalifornia MNZ1.107.567.875.127 LH  MSIncludes one or several viruses in the Bunyavirus genus of the Bunyaviridae family. OLuse CALIFORNIA GROUP VIRUSES to search CALIFORNIA VIRUS back thru 1975 HN(77); was see under ENCEPHALITIS VIRUSES 1977-80 CALIFORNIA VIRUS see under ARBOVIRUSES 1975-76 MHÑCalifornia Group Viruses ANdo not use /blood-csf-urine /cytol; infection = ENCEPHALITIS, CALIFORNIA MNB4.909.777.147.160; B4.909.777.270.100 XSBrooks Virus; California Encephalitis Virus; Encephalitis Virus, California; Jamestown Canyon Virus; La Crosse Virus; Tahyna Virus DMÑBunyaviridae LH LS; ; ; ; ; LM  MHÑCalifornium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-71-3 MND1.287.183; D1.552.517.200 LH  MSA family of the Primate order consisting of five genera of marmosets: Callimico (Goelde's marmoset), CALLITHRIX (short-tusked marmoset), Cebuella (pygmy marmoset), Leontideus (golden marmoset) and SAGUINUS (cotton-top marmoset). The members of this family inhabit the tropical forests of South America and Panama. OLuse CALLITHRICIDAE to search MARMOSETS & CALLIMICO back thru 1975 PM81; was MARMOSETS 1975-79; CALLIMICO was see under MONKEYS 1975-80 HN81; was MARMOSETS 1975-79; CALLIMICO was see under MONKEYS 1975-80 MHÑCallithricidae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIAnthropoidea (66-74) MNB2.649.801.201.280 XSCallimico; Cebuella; Leontideus; Marmosets; Tamarins XUÑCallithrix; ÑSaguinus LH LS; ; ; ; LU;  MSA genus of Callithricidae occurring in forests of Brazil and Bolivia and containing eight species. They are C. jacchus (common marmoset), C. argentata (black-tailed marmoset), C. chrysoleuca (yellow-legged or golden marmoset), C. aurita (white-eared marmoset), C. flaviceps (buff-headed marmoset), C. penicillata (black-pencilled or black-eared marmoset), C. geoffroyi (white fronted or Geoffrey's marmoset) and C. santaremensis (Santarem marmoset). HN(81) MHÑCallithrix ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PICallithricidae (75-80) MNB2.649.801.201.280.262 XSCallithrix jacchus; Hapale; Marmoset, Common; Marmoset, Short-Tusked DMÑCallithricidae LH LS; ; ; LM  MHÑCallosities ANcallous goes here: do not confuse with CALLUS, post-fract bone formation MNC17.98 XUÑCorns LH LU  OLsearch FRACTURES 1966-72 PM73; was see under FRACTURES 1963-72 HN73; was see under FRACTURES 1963-72 MHÑCallus ANpost-fract bone formation; do not confuse with ╥callous╙ ( = CALLOSITIES); do not use /abnorm /growth /inj /innerv PIFractures (66-72) MNA10.165.265.276 FXÑBone Regeneration; ÑFractures LH LX;  MSA heat stable, low molecular weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels. Synonym: CDR. OLuse CALMODULIN to search CALCIUM-DEPENDENT REGULATOR back thru 1979 PM84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83, was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979 HN84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83, was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979 MHÑCalmodulin AN/biosyn /physiol permitted; do not use /analogs /defic PICalcium (66-78); Carrier Proteins (71-78); Enzyme Activation (69-78) MND12.776.157.125.140 XSCalcium-Dependent Activator Protein; Calcium-Dependent Regulator LH LS;  MSProteins which bind calmodulin. They are found in many tissues and have a variety of functions including F-actin cross-linking properties, inhibition of cyclic nucleotide phosphodiesterase and calcium and magnesium ATPases. Calcineurin, a specific calmodulin-binding protein from brain, has phosphoprotein phosphatase activity. PM86 HN86 MHÑCalmodulin-Binding Proteins AN/biosyn /physiol permitted PICalcium-Binding Proteins (80-85); Carrier Proteins (66-79); Phosphoprotein Phosphatases (82-85) MND8.586.277.352.630.654.380; D12.776.157.125.140.150 XSCalcineurin; Caldesmon; Calspectin LH LS; ;  MSTotal number of calories taken in daily whether ingested or by parenteral routes. PM84; was see under DIET 1977-83 HN84(77); was see under DIET 1977-83 MHÑCaloric Intake ANIM; only /drug eff /rad eff PIDiet (66-76); Nutrition (66-76) MNG6.696.384.160 LH  MSElicitation of a rotatory nystagmus by stimulating the semicircular canals with water or air which is above or below body temperature. In warm caloric stimulation a rotatory nystagmus is developed toward the side of the stimulated ear; in cold, away from the stimulated side. Absence of nystagmus indicates the labyrinth is dead. HN(75) MHÑCaloric Tests ANonly /instrum /methods MNE1.276.299.816.250 DMÑVestibular Function Tests LH LM  PM67 HN67(65) MHÑCalorimetry ANNIM; only /instrum /methods MNE5.145; E5.196.131; H1.181.278.134; H1.671.136 FXÑBasal Metabolism; ÑHeat XUÑCalorimetry, Differential Scanning; ÑCalorimetry, Indirect LH LX; LU;  MSDifferential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample. HN(77) MHÑCalorimetry, Differential Scanning ANNIM; only /instrum /methods PICalorimetry (66-76) MNE5.196.131.310; E5.196.370.310; H1.181.278.134.240 XSDifferential Thermal Analysis, Calorimetric DMÑCalorimetry LH LS LM  MSCalculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange. HN(75) MHÑCalorimetry, Indirect ANNIM; only /instrum /methods MNE5.145.250; H1.181.278.134.250 XSCalorimetry, Respiration DMÑCalorimetry LH LS LM  MSCysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including neuropeptides, cytoskeletal proteins, proteins from smooth muscle, cardiac muscle, liver, platelets and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. PM86 HN86 MHÑCalpain AN/biosyn /physiol permitted RNEC 3.4.22.17 PIPeptide Peptidohydrolases (66-85) MND8.586.277.656.732.120 XSCalcium-Activated Neutral Protease; Calcium-Dependent Neutral Proteinase LH LS;  MSAcidic protein found in sarcoplasmic reticulum that binds calcium to the extent of 700-900 nmoles/mg. Plays role of sequestering calcium transported to the interior of the intracellular vesicle. HN(76) MHÑCalsequestrin AN/biosyn /physiol permitted; /analogs NIM only PICalcium (74-75); Muscle Proteins (74-75) MND12.776.210.500.220 DMÑMuscle Proteins LH LM  MS17beta-Hydroxy-7 beta, 17-dimethylandrost-4-ene-3-one. Non-androgenic steroid; nontoxic and possible effective against breast neoplasms. HN(75) MHÑCalusterone ANdo not use /biosyn /defic /physiol RN17021-26-0 PIMethane (73-74); Methyltestosterone (72-74) MND4.808.54.79.429.824.150; D6.597.100.622.180; D22.204.332 DMÑMethyltestosterone LH LM  MSA genus of bacteria causing granuloma inguinale and other granulomatous lesions. PM77,63-65 HN77,63-65 MHÑCalymmatobacterium ANdo not use /blood-csf-urine; infection: probably GRANULOMA INGUINALE or other granuloma, otherwise coord NIM with BACTERIAL INFECTIONS (IM) PIBacteria (66-76); Granuloma Inguinale (66-76) MNB3.475.160 XSDonovania LH LS  MS7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H- 1,4-benzodiazepin-2-one dimethylcarbamate. A benzodiazepine used as a minor tranquilizer; it is the dimethyl carbamate salt of temazepam. Synonyms: B 5833; SB 5833. HN(77) MHÑCamazepam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN36104-80-0 PIBenzodiazepine Tranquilizers (75-76); Benzodiazepinones (74-76); Carbamates (66-76) MND3.438.79.80.70.880.130; D15.236.872.659.191.845.153 DMÑBenzodiazepine Tranquilizers LH LM  MSIsopropyl 2(4-triazolyl)-5-benzimidazolecarbamate. A nematocide effective against a variety of gastrointestinal parasites in cattle, sheep and horses. HN(75) MHÑCambendazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26097-80-3 PIBenzimidazoles (71-74); Carbamates (72-74); Thiazoles (71-74) MND3.438.103.190; D21.201.287.149 DMÑBenzimidazoles LH LM  MHÑCambodia MNZ1.252.145.182 XSKampuchea; Khmer Republic LH LS;  MSRuminant mammals of South America; related to camels. HN(75) MHÑCamelids, New World ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.77.380.175 XSAlpacas; Guanacos; Llamas DMÑArtiodactyla LH LS; ; LM  PM68 HN68 MHÑCamels ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIArtiodactyla (66-67) MNB2.649.77.380.201 XSDromedary LH LS  MHÑCameroon MNZ1.58.100.109 LH  MHÑCamphor AND25-26 qualif RN76-22-2 MND2.455.849.618.234.326 LH  MSLiving outdoors as a recreational activity. MHÑCamping ANno qualif MNI3.450.642.159 LH  PM73 HN73 MHÑCamptothecin ANdo not use /defic /physiol; /biosyn permitted if by plant RN7689-03-4 PIAlkaloids (66-72); Antineoplastic Agents (66-72) MND3.132.151; D22.204.179.159 LH  MSA genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man; some species are pathogenic. PM76 HN76 MHÑCampylobacter ANdo not use /blood-csf-urine; infection = CAMPYLOBACTER INFECTIONS PIVibrio (68-75) MNB3.825.850.300 LH  MSA species of bacteria present in, or causing infertility and/or abortion in, man and many kinds of animals and birds. OLuse CAMPYLOBACTER FETUS to search VIBRIO FETUS back thru 1972 (as Prov 1972-73) PM84; was see under CAMPYLOBACTER 1976-83, was heading VIBRIO FETUS 1974-75 HN84(76); was see under CAMPYLOBACTER 1976-83, was VIBRIO FETUS 1972-75 (Prov 1972-73) MHÑCampylobacter fetus ANdo not use /blood-csf-urine; causes abortion in cattle & sheep; infection: coord NIM with CAMPYLOBACTER INFECTIONS (IM) PIVibrio (66-71) MNB3.825.850.300.817 XSCampylobacter jejuni; Vibrio fetus LH LS;  MSInfections with bacteria of the genus Campylobacter. PM77 HN77 MHÑCampylobacter Infections PIVibrio (66-67); Vibrio Infections (68-76) MNC1.252.177 LH  MHÑCanada ANeach of the provinces is available as a heading MNZ1.107.567.176 LH  PM68 HN68 MHÑCanaries ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIBirds (66-67) MNB2.248.159 LH  MHÑCanavanine ANdo not use /defic /physiol RN543-38-4 MND12.125.311 LH  MSInstitutions specializing in the care of cancer patients. HN(Aug 77) MHÑCancer Care Facilities ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util MNN2.278.421.556.70 XSHospitals, Cancer DMÑHospitals, Special LH LS LM  MSMixture of antifungal heptaene macrolides from Streptomyces griseus or Actinomyces levoris; used topically in candidiasis. Synonyms: Candimon; Candeptin; Vanobid. OLuse CANDICIDIN to search LEVORIN back thru 1978 HN(75); LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81 MHÑCandicidin ANdo not use /defic /physiol; /analogs NIM only RN1403-17-4 PIAntibiotics, Antifungal (70-74); Polyenes (74) MND20.85.62.310; D20.136.73.310 XSLevorin DMÑAntibiotics, Antifungal LH LS LM  OLuse CANDIDA to search TORULOPSIS back thru 1972 (as Prov 1972-73) PMTORULOPSIS was heading 1974-85 HNTORULOPSIS was heading 1972-85 (Prov 1972-73) MHÑCandida ANdo not use /anat /embryol /microbiol /parasitol; Candida utilis = TORULOPSIS; infection = CANDIDIASIS & do not bother to coord with CANDIDA or CANDIDA ALBICANS; do not confuse MONILIA see CANDIDA with MONILIALES see HYPHOMYCETES MNB5.354.381.546.147; B5.354.930.176 XSMONILIA; Torulopsis LH LS;  MSA unicellular budding fungus which is the etiologic agent of moniliasis, aka candidiasis. PM73 HN73(72) MHÑCandida Albicans ANdo not use /anat /embryol /microbiol /parasitol; infection = CANDIDIASIS & do not bother to coord with CANDIDA ALBICANS PICandida (66-71) MNB5.354.381.546.147.326; B5.354.930.176.326 LH  OLuse CANDIDIASIS to search MONILIASIS back thru 1966 PM81; was MONILIASIS 1963-80 HN81; was MONILIASIS 1963-80 MHÑCandidiasis ANdo not bother to coord with CANDIDA or CANDIDA ALBICANS MNC1.703.160 XSMoniliasis XUÑCandidiasis, Chronic Mucocutaneous LH LS LU  MSClinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. May be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy. HN(81) MHÑCandidiasis, Chronic Mucocutaneous ANdo not bother to coord with CANDIDA or CANDIDA ALBICANS PICandidiasis (66-80); Candidiasis, Cutaneous (66-80) MNC1.703.160.165; C1.703.295.165; C17.838.208.165 DMÑCandidiasis LH LM  OLuse CANDIDIASIS, CUTANEOUS to search MONILIASIS, CUTANEOUS back thru 1966 PM81; was MONILIASIS, CUTANEOUS 1963-80 HN81; was MONILIASIS, CUTANEOUS 1963-80 MHÑCandidiasis, Cutaneous ANdo not bother to coord with CANDIDA or CANDIDA ALBICANS MNC1.703.160.170; C1.703.295.170; C17.838.208.170 XSMoniliasis, Cutaneous LH LS  OLuse CANDIDIASIS, ORAL to search MONILIASIS, ORAL back thru 1966 PM81; was MONILIASIS, ORAL 1963-80 HN81; was MONILIASIS, ORAL 1963-80 MHÑCandidiasis, Oral ANdo not bother to coord with CANDIDA or CANDIDA ALBICANS MNC1.703.160.180; C7.465.130 XSMoniliasis, Oral; Thrush LH LS;  OLuse CANDIDIASIS, VULVOVAGINAL to search MONILIASIS, VULVOVAGINAL back thru 1966 PM81; was MONILIASIS, VULVOVAGINAL 1963-80 HN81; was MONILIASIS, VULVOVAGINAL 1963-80 MHÑCandidiasis, Vulvovaginal ANdo not bother to coord with CANDIDA or CANDIDA ALBICANS; monilial vaginitis goes here (consider a synonym) MNC1.703.160.190; C13.371.894.190; C13.371.944.190 XSMoniliasis, Vulvovaginal LH LS  MHÑCandy ANonly /ad-poi-tox /anal /class /hist /stand /supply MNJ1.341.152 LH  MSSticks used as walking aids. May have three or four prongs at the end of the shaft. HN(75) MHÑCanes ANonly /stand /supply MNE7.858.442.250 XSWalking Sticks DMÑOrthopedic Equipment LH LS LM  MSA virus which causes a disease in newborn puppies. HN(75); was see under HERPESVIRUSES 1975-80 MHÑCanine Tracheobronchitis Virus ANdo not use /blood-csf-urine /cytol; infect: coord NIM with HERPESVIRUS INFECTIONS (IM) MNB4.909.204.382.200 XSCanine Herpesvirus DMÑHerpesviridae LH LS LM  MS2-(3-Methyl-6-(1-methylethenyl)-3-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol. Compound isolated from Cannabis sativa extract. It shows greater anticonvulsant activity than other cannabinoids, resembling the hydantoins as to mechanism of action. HN(75); was see under CANNABIS 1975-76 MHÑCannabidiol ANdo not use /defic /physiol; /analogs NIM only RN13956-29-1 PICannabis (73-74); Resorcinol (69-74); Terpenes (73-74) MND2.455.849.90.100; D14.261.235 DMÑCannabinoids LH LM  MSCompounds extracted from Cannabis sativa L. and metabolites having the cannabinoid structure. Most active constituents are tetrahydrocannabinol, cannabinol and cannabidiol. PM77; CANNABIDIOL was see under CANNABIS 1975-76 HN77 MHÑCannabinoids ANdo not use /analogs /defic /physiol PICannabis (66-76) MND2.455.849.90; D15.236.372.211 FXÑCannabis XUÑCannabidiol; ÑCannabinol LH LX LU;  MS6,6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]-pyran-1-ol. A pharmacologically active constituent of Cannabis sativa L. HN(77) MHÑCannabinol ANdo not use /defic /physiol; /analogs NIM only RN521-35-7 PICannabis (66-76); Tetrahydrocannabinol (75-76) MND2.455.849.90.110 DMÑCANNABINOIDS LH LM  HNwas in Cat B & D 1963-76 MHÑCannabis ANplant only; = hemp also; do not coord with SMOKING for smoking marihuana & do not routinely add CANNABIS ABUSE unless discussed in article; use qualif with caution: e.g., /adv eff cannot be used with Cat B; do not use /isol /pathogen; for chemicals derived from CANNABIS, consider CANNABINOIDS; marihuana ther of dis = CANNABIS with no qualif (IM) + dis /drug ther (IM) MNB6.560.139 XSHASHISH; MARIHUANA FXÑCannabinoids LH LS; LX  MSThe excessive use of cannabis with associated psychological symptoms and impairment in social or occupational functioning. PM81 HN81 MHÑCannabis Abuse AN╥excess use of cannabis with assoc psychol sympt & impairment in social or occup functioning╙; see note on CANNABIS above; do not use /chem ind /drug eff /physiol /rad eff PICannabis (66-80); Substance Abuse (68-80) MNF3.709.597.780.610.200 XSMarihuana Abuse LH LS  MSIndividuals who eat other individuals of their own species. PM77 HN77 MHÑCannibalism ANno qualif MNF1.145.113.188; I1.76.201.450.324.150; F1.145.140 LH  MSPotassium 17-hydroxy-3-oxo-17 alpha-pregna-4,6-diene-21-carboxylate. A synthetic pregnadiene compound with anti-aldosterone activity. HN(75) MHÑCanrenoate Potassium ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2181-04-6 PICarboxylic Acids (74); Ketosteroids (74); Pregnadienes (74) MND4.808.745.432.100; D6.347.50.200 XSPotassium Canrenoate DMÑPregnadienes LH LS LM  MS17-Hydroxy-3-oxo-17 alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone. A synthetic pregnadiene compound with anti-aldosterone activity. HN(75) MHÑCanrenone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN976-71-6 PILactones (74); Ketosteroids (74); Pregnadienes (74) MND4.808.745.432.100.90; D6.347.50.200.210 DMÑPregnadienes LH LM  MSHexahydro-3a-alpha,7a-alpha-dimethyl-4-beta-epoxy-isobenzofuuran-1,3-dione. Toxic compound from the Spanish Fly or Blistering Beetle (Lytta (Cantharis) vesicatoria) and other insects; formerly an irritant, vesicant and rubefacient paste of whole insects called Cantharides; now used to produce skin inflammation; causes gastroenteritis, nephritis and circulatory failure if absorbed. Synonyms: cantharides camphor; Cantharone; Kantaridin. OLuse CANTHARIDIN to search CANTHARIDES back thru 1966 PM79; was CANTHARIDES 1963-78 HN79; was CANTHARIDES 1963-78 MHÑCantharidin AND25-26 qualif RN56-25-7 MND24.185.926.275.162; D26.585.176 XSCantharides LH LS  MSA psychotic disorder characterized by the patient's conviction that certain important or familiar persons in his environment are not real but are ╥doubles╙ of themselves or imposters. HN(82) MHÑCapgras Syndrome ANdo not use /drug eff /physiol /rad eff PIPsychoses (66-81) MNF3.709.680.420 DMÑPsychotic Disorders LH LM  MSA genus of trichuroid nematodes parasitic in the liver and intestines of many mammals and birds. Two species C. hepatica and C. philippinensis produce often fatal infections in man. OLsearch TRICHUROIDEA 1966-74; to search HEPATICOLA HEPATICA use CAPILLARIA back thru 1975 & TRICHUROIDEA 1966-74 HN(75); was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66 MHÑCapillaria ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.780.80 XSHepaticola Hepatica DMÑTrichuroidea LH LS LM  MSThe minute vessels that connect the arterioles and venules. MHÑCapillaries ANIM GEN only; NIM as coord with specific organ /blood supply; do not use /blood supply; not for lymphatic capillaries; ANGIOGENESIS FACTOR is available MNA7.231.432.410 LH  MHÑCapillarity ANNIM; no qualif MNH1.181.529.875.327 LH  PM70 HN70(68) MHÑCapillary Fragility ANonly /drug eff /rad eff PICapillaries (66-67); Capillary Resistance (66-67) MNE1.145.347; G9.330.277 XSCapillary Resistance, Hematologic LH LS  MHÑCapillary Permeability ANonly /drug eff /rad eff; ╥vascular permeability╙ goes here MNG6.535.166.310.202; G9.330.377 XSPERMEABILITY, CAPILLARY LH LS  HN(86)63 MHÑCapillary Resistance ANonly /drug eff /rad eff MNG9.330.612.931.327 DMÑVascular Resistance LH LM  MSThose funds disbursed for facilities and equipment. HN(Aug 77) MHÑCapital Expenditures AN/legis /stand /trends permitted but /legis /stand NIM only MNN3.219.90 DMÑEconomics LH LM  MSInstitutional funding for facilities and for equipment which becomes a part of the assets of the institution. HN(80) MHÑCapital Financing ANdo not use /man /supply /util (except by MeSH definition) PIFinancial Management (78-79) MNN3.219.463.85 XSFinancing, Capital; Funding, Capital DMÑFinancial Management LH LS; LM  MSThe use of the death penalty for certain crimes. MHÑCapital Punishment ANonly /hist /legis; ╥electrocution╙ goes here but not also under the electricity aspect unless particularly discussed MNI1.880.604.160 XSDEATH PENALTY LH LS  MSA method of payment of health services in which an individual or institutional provider is paid a fixed, per capita amount without regard to actual number or nature of services provided each patient. HN(Aug 77) MHÑCapitation Fee AN╥capitation╙ refers to ╥a fixed per capita amt without regard to no. or nature of serv provided╙; only /class /hist /legis /stand /trends MNN3.219.442.90 XSFee, Capitation DMÑFees and Charges LH LS LM  MSPneumoconiosis associated with rheumatoid arthritis. HN(84)63 MHÑCaplan's Syndrome ANdo not use /chem ind; do not coord with OCCUPATIONAL DISEASES MNC5.550.114.154.219; C5.799.114.219; C8.381.655.361; C21.447.800.409; C23.205.200.732.99.219 DMÑPneumoconiosis LH LM  MSA gram-negative gliding bacterium isolated from the oral cavity; a pathogen for periodontitis. HN(82) MHÑCapnocytophaga ANan oral bacterium; do not use /blood-csf-urine PIBacteroides (75-81); Cytophagaceae (75-81) MNB3.350.300.245.340 DMÑCytophagaceae LH LM  PM74 HN74(72) MHÑCapreomycin ANdo not use /defic /physiol RN11003-38-6 PIAntitubercular Agents (66-71) MND20.85.89.148; D20.338.135.139 XSCapromycin LH LS  MHÑCaproates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.193; D2.241.81.465.326; D10.516.251.400.326 XSHexanoates XUÑHexanoic Acids; ÑPenicillic Acid LH LS LU;  MSHexahydro-2H-azepin-2-one. Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation. HN(75) MHÑCaprolactam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN105-60-2 PIAzepines (68-74) MND2.65.589.200; D3.383.66.150; D3.383.411.200 XSAminocaproic Lactam DMÑAzepines LH LS LM  MHÑCaprylates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.222; D2.241.81.407.177; D10.516.251.122 XSOctanoates XUÑOctanoic Acids LH LS LU  MSTrans-8-Methyl-N-vanillyl-6-nonenamide. Cytotoxic alkaloid from various species of Capsicum (pepper, paprika), of the Solanaceae; causes pain, irritation and inflammation;, due to substance P depletion from sensory (afferent) nerve fibers; used mainly to study the physiology of pain and in the form of CAPSICUM as a counterirritant and gastrointestinal stimulant. PM84; was see under FATTY ACIDS, UNSATURATED 1975-83 HN84(75); was see under FATTY ACIDS, UNSATURATED 1975-83 MHÑCapsaicin ANdo not use /defic /physiol RN404-86-4 PIAlkaloids (66-74); Amides (66-74); Capsicum (66-74); Catechols (66-74); Fatty Acids, Unsaturated (73-74) MND2.241.81.436.180; D3.132.760.200; D10.516.251.355.190 LH  MSA genus of Solanaceous herbs or shrubs that yield CAPSAICIN; several varieties have sweet or pungent edible fruits and are used as vegetables or condiments. HN(86)63 MHÑCapsicum AN= a genus of pepper as food, condiment & rubefacient; includes red pepper, paprika, tabasco, green pepper, jalapeno but black pepper & white pepper (genus Piper) go under CONDIMENTS; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.135; B6.560.147; J1.341.241.133 XSCayenne Pepper DMÑPlants, Edible LH LS LM  MSThe protein coat of the more complex viruses. It consists of many clusters of protein subunits called capsomers. PM84; was see under VIRAL PROTEINS 1975-83 HN84(75); was see under VIRAL PROTEINS 1975-83 MHÑCapsid AN/biosyn /physiol permitted; do not use /analogs PIViral Proteins (68-74) MND12.776.964.250; B4.950.250 LH  MHÑCapsules ANIM for general only: only /adv eff /anal (with caution) /stand /supply; NIM with no qualif when specific drug is IM; note X ref MICROCAPSULES but note MICROENCAPSULATION see DRUG COMPOUNDING MND26.394.225.153 XSMicrocapsules LH LS  PM74 HN74(72) MHÑCaptan ANdo not use /biosyn /defic /physiol RN133-06-2 PIAntifungal Agents (66-71); Indoles (66-71); Pesticides (66-71) MND3.438.473.133; D5.723.288.140 LH  MSD-3-Mercapto-2-methylpropanoyl-L-proline. An orally active inhibitor of angiotensin I-converting enzyme. Reduces elevated blood pressure by inhibiting the renin-angiotensin system; also inhibits pressure responses to exogenous angiotensin I. PM86; was see under PROLINE 1980-85 HN86(80); was see under PROLINE 1980-85 MHÑCaptopril ANdo not use /biosyn /defic /physiol PIKininase II/AI (73-79); Peptide Peptidohydrolases (66-67) /AI (68-72); Proline (66-74) /AA (75-79) MND8.373.745.270; D12.125.72.401.623.270; D18.162.135 XSSQ 14225 LH LS  MHÑCarbachol ANdo not use /biosyn /defic /physiol RN51-83-2 MND16.698.327 XSCarbamylcholine LH LS  MSMethyl 3-(2-quinoxalinylmethylene)carbazate N(1),N(4)-dioxide. Bacteriostatic. Synonyms: Mecadox; Fortrigo; GS-6244. HN(75) MHÑCarbadox ANdo not use /biosyn /defic /physiol; /analogs NIM only RN6804-07-5 PICarbamates (69-74); Quinoxalines (73-74) MND2.241.81.251.140; D3.438.857.140; D20.187.130 DMÑQuinoxalines LH LM  OLuse CARBAMATES to search TYBAMATE back thru 1966 PMTYBAMATE was heading 1973-84 HNTYBAMATE was heading 1965-84 (Prov 1965-72) MHÑCarbamates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.251 XUÑBenomyl; ÑCarbamyl Phosphate; ÑPyridinolcarbamate; ÑThiophanate LH LU; ; ;  PM72 HN72(68) MHÑCarbamazepine ANdo not use /biosyn /defic /physiol RN298-46-4 PIAnticonvulsants (66-67); Azepines (66-67) MND3.494.240.127; D14.261.244 LH  MSPhosphate salt of carbamic acid. HN(75) MHÑCarbamyl Phosphate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN590-55-6 PICarbamates (73-74); Organophosphorus Compounds (73-74) MND2.241.81.251.145; D2.705.130 DMÑCarbamates LH LM  MSCarbon dioxide:ammonia ligase (ADP-forming, carbamate-phosphorylating). Catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. EC 6.3.4.16 formerly EC 2.7.2.5. HN(75); was see under PHOSPHOTRANSFERASES, ATP 1975-80 MHÑCarbamyl Phosphate Synthase (Ammonia) ANdo not use /analogs; /defic: consider AMMONIA /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM); DF: AMMONIA CP SYNTHASE RNEC 6.3.4.16 PIAmmonia (74); Carbamates (74); Phosphotransferases, ATP (74) MND8.586.464.250 DMÑLigases LH LM  MSCarbon dioxide:L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating). Catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. EC 6.3.5.5 formerly EC 2.7.2.9. HN(75); was see under PHOSPHOTRANSFERASES, ATP 1975-80 MHÑCarbamyl Phosphate Synthase (Glutamine) ANdo not use /analogs; DF: GLUTAMINE CP SYNTHASE RNEC 6.3.5.5 PICarbamates (74); Glutamine (74); Phosphotransferases, ATP (74) MND8.586.464.255 DMÑLigases LH LM  PM74 HN74(72) MHÑCarbanilides ANdo not use /analogs /biosyn /defic /physiol PIUrea (70-71) MND2.65.199.326; D2.948.684.202 XSDiphenylurea Compounds XUÑImidocarb; ÑNicarbazin LH LS LU;  MS2-[2((Aminocarbonyl)oxy)-1-methoxyethyl]-3,6-bis(1-aziridinyl)-5-methyl-2,5-cyclohexadiene-1,4-one. An alkylating agent structurally similar to mitomycin C found to be effective in the treatment of leukemia and various other neoplasms in mice; It causes leukemia and thrombocytopenia in almost all human patients. HN(75) MHÑCarbazilquinone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN24279-91-2 PIAzirines (71-74); Quinones (71-74); Carbamates (72-74) MND2.806.180; D3.383.97.217.300; D22.204.337 XSCarboquinone; Carboquone DMÑAzirines LH LS; LM  MS3-Hydroxy-1-methyl-5,6-indolinedione-5-semicarbazone. A hemostatic which increases capillary resistance and activates platelet factors. Synonym: Adrenoxyl. OLto search CARBAZOCHROME SALICYLATE use CARBAZOCHROME back thru 1975 & HEMOSTATICS 1966-74 HN(76); was see under INDOLES 1976; CARBAZOCHROME SALICYLATE was see under ADRENOCHROME 1975-79, was see under HEMOSTATICS 1963-74 MHÑCarbazochrome ANdo not use /biosyn /defic /physiol RN69-81-8 PIAdrenochrome (68-74) /AA (75); Semicarbazones (72-75) MND3.438.473.25.160; D19.461.270.463.194 XSAdrenochrome Semicarbazone; Carbazochrome Salicylate DMÑAdrenochrome LH LS; LM  OLsearch AZOLES 1966-68 PM69; was see under AZOLES 1963-68 HN69; was see under AZOLES 1963-68 MHÑCarbazoles ANdo not use /analogs /biosyn /defic /physiol PIAzoles (66-68) MND3.494.148 LH  MSN-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo (3,2,0)hept-6-yl)2-phenylmalonamic acid. Broad spectrum semisynthetic penicillin derivative used parenterally; susceptible to gastric juice and penicillinase; may damage platelet function. Synonyms: Anabactyl; Carbecin; Geopen; Microcillin; Pyopen. PM73 HN73(71) MHÑCarbenicillin ANdo not use /defic /physiol RN4697-36-3 PIPenicillins (66-70) MND20.85.99.739.762.161 XSCarboxybenzyl Penicillin XUÑCarfecillin LH LS LU  MS3-beta-Hydroxy-11-oxoolean-12-en-30-oic acid hydrogen succinate. An agent derived from licorice root; used for the treatment of ulcers of the alimentary tract, especially stomach; frequent antidiuretic side effects, but otherwise low in toxicity. Synonyms: Biogastrone; Bioral; Duogastrone; Sanodin. HN(75); was see under TRITERPENES 1975-78 MHÑCarbenoxolone ANdo not use /defic /physiol; /biosyn permitted if by plant RN5697-56-3 PIGlycyrrhiza (66-74); Succinates (74); Triterpenes (74) MND2.455.849.919.300.250; D19.316.203.168 XSCarbenoxalone DMÑGlycyrrhetinic Acid LH LS LM  MSS-alpha-Hydrazino-3,4-dihydroxy-alpha-methylbenzene-propionic acid monohydrate. Inhibitor of dopa decarboxylase; given in conjunction with dopa for parkinsonism. Synonyms: Lodosin; Lodosyn; Sinemet. OLuse CARBIDOPA to search METHYLDOPAHYDRAZINE back thru 1973 (as Prov 1973-74) PM80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79 HN80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79, was METHYLDOPAHYDRAZINE 1973-74 (Prov) MHÑCarbidopa ANdo not use /biosyn /defic /physiol RN38821-49-7 PIDopa (72-74); Hydrazines (72-74); Methyldopa (72-74) MND2.92.311.242.538.200; D2.442.200; D8.373.210; D14.307.232 XSMK-485; MK-486; Methyldopahydrazine LH LS; ;  PM73 HN73(68) MHÑCarbimazole ANdo not use /biosyn /defic /physiol RN22232-54-8 PIImidazoles (66-67); Thyroid Antagonists (66-67) MND3.383.374.108; D6.347.789.140 LH  MSCationic dyes used for differential staining of biological materials. Synonym: Stains-all. HN(76) MHÑCarbocyanines AND25-26 qualif PIAlkenes (72-75); Quinolines (72-75) MND3.438.810.150; D26.550.150 DMÑQuinolines LH LM  MS3-(Carboxymethylthio)alanine. Formed when iodoacetic acid reacts with sulfhydryl groups in proteins. Anti-infective nasal spray with mucolytic and expectorant action. Synonyms: Loviscol; Mucodyne; Rhinathiol; Thiodril. OLuse CARBOCYSTEINE to search CARBOXYMETHYLCYSTEINE back thru 1975 HN(80); was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79 MHÑCarbocysteine ANdo not use /biosyn /defic /physiol RN2387-59-9 PIAmino Acids, Dicarboxylic (74); Amino Acids, Sulfur (74) MND12.125.119.270; D12.125.166.230.310; D23.338.454.452 XSCarboxymethylcysteine DMÑCysteine LH LS LM  PM73 HN73 MHÑCarbodiimides ANdo not use /analogs /biosyn /defic /physiol; do not confuse CARBODIIMIDES (a group term) with ╥carbodiimide╙ (a specific chemical) PIImines (66-72) MND2.491.203 XUÑCME-Carbodiimide; ÑDicyclohexylcarbodiimide; ÑEthyldimethylaminopropyl Carbodiimide LH LU; ;  HN(72) MHÑCarbofuran ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN1563-66-2 PICarbamates (66-71); Insecticides (66-71) MND2.241.81.251.156; D5.723.491.408.327 DMÑInsecticides, Carbamate LH LM  MSThe characteristic 3-dimensional shape of a carbohydrate. PM80 HN80 MHÑCarbohydrate Conformation ANIM general only; coord NIM with specific carbohydrate (IM); only /drug eff /rad eff; do not confuse CARBOHYDRATE LINKAGE see CARBOHYDRATE CONFORMATION with CARBOHYDRATE SEQUENCE: conform = spatial or 3-dimensional struct, sequ = order in which components are arranged PIMolecular Conformation (73-79) MNG6.184.580.235 XSCarbohydrate Linkage LH LS  MSReversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2.; and 1.1.99. PM78; FRUCTURONATE REDUCTASE, PHOSPHOGLYCERATE DEHYDROGENASE, TAGATURONATE REDUCTASE & URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE were see under ALCOHOL OXIDOREDUCTASES 1975-77 HN78 MHÑCarbohydrate Dehydrogenases ANdo not use /analogs RNEC 1.1. PIAlcohol Oxidoreductases (66-77) MND8.586.682.47.150 XSCarbohydrate Oxidoreductases XUÑFructuronate Reductase; ÑGalactose Dehydrogenases; ÑGlucose Dehydrogenases; ÑUridine Diphosphate Glucose Dehydrogenase LH LS LU; ; ;  PM73 HN73 MHÑCarbohydrate Isomerases ANdo not use /analogs RNEC 5.- PIIsomerases (66-72) MND8.586.399.278 XUÑInositol-1-Phosphate Synthase; ÑMannosephosphate Isomerase; ÑTriosephosphate Isomerase; ÑUridine Diphosphate Glucose Epimerase LH LU; ; ;  PM65 HN65 MHÑCarbohydrate Metabolism, Inborn Errors ANdo not use /congen; coord IM with specific carbohydrate /metab (IM); DF: CARB METAB INBORN ERR MNC18.452.648.202 XUÑFructose Intolerance LH LU  MSThe sequence of carbohydrates within polysaccharides, glycoproteins and glycolipids. PM80 HN80 MHÑCarbohydrate Sequence ANIM for general only; coord NIM with specific carbohydrate (IM); only /drug eff /rad eff; do not confuse with CARBOHYDRATE LINKAGE see CARBOHYDRATE CONFORMATION: sequ = order in which components are arranged, conform = spatial or 3-dimensional struct MNG6.184.235 LH  PM/metabolism was CARBOHYDRATE METABOLISM 1963-65 HN/metabolism was CARBOHYDRATE METABOLISM 1963-65 MHÑCarbohydrates ANGEN only; avoid: prefer specifics; do not use /analogs; glucides go here but could also be GLYCOSIDES; DIETARY CARBOHYDRATES is also available; table sugar = SUCROSE MND9.203 XSSUGARS LH LS  MH*Carbohydrates and Hypoglycemic Agents (Non Mesh) MND9 LH  MSA group of pyridoindole compounds. Allowed are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. PM86; was see under INDOLES 1975-85 HN86(75); was see under INDOLES 1975-85 MHÑCarbolines ANdo not use /analogs /biosyn /defic /physiol PIIndoles (69-74); Pyridines (69-74) MND3.383.725.150; D3.438.473.155 LH  MHÑCarbon ANC-12; do not use /analogs /biosyn /defic /physiol; isotopes: see below RN7440-44-0 MND1.154; D1.268.150 XUÑGraphite LH LU  MHÑCarbon Dioxide ANdo not use /analogs /defic; in respiration, /physiol permitted; /metab permitted for cell & tissue resp & non-lung tissue but do not use /metab for gas exchange in lung ( = PULMONARY GAS EXCHANGE) or blood CO2 transport ( = /blood) MND1.154.140; D1.655.498.149 XSCARBONIC ANHYDRIDE FXÑHYPERCAPNIA LH LS LX  MHÑCarbon Disulfide ANdo not use /analogs /biosyn /defic /physiol RN75-15-0 MND1.154.203; D1.877.522.307.328; D2.886.200.150 LH  MHÑCarbon Isotopes ANC-13; NIM; no qualif MND1.154.266; D1.496.123 LH  MHÑCarbon Monoxide AN/pois = CARBON MONOXIDE POISONING; /tox permitted but consider also CARBON MONOXIDE POISONING; do not use /analogs RN630-08-0 MND1.154.328; D1.655.498.185 LH  MSToxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide. OLuse CARBON MONOXIDE POISONING to search ILLUMINATING GAS POISONING back thru 1969 HNILLUMINATING GAS POISONING was see under CARBON MONOXIDE POISONING 1969-78 MHÑCarbon Monoxide Poisoning ANdo not use /chem ind MNC21.613.455.245 XSIlluminating Gas Poisoning LH LS  OLsearch CARBON ISOTOPES 1966-73 PM74 HN74 MHÑCarbon Radioisotopes ANC-10,11,14-16; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) MND1.154.391; D1.496.123.328; D1.496.749.154 LH  MHÑCarbon Tetrachloride AN/pois = CARBON TETRACHLORIDE POISONING; /tox permitted but consider also CARBON TETRACHLORIDE POISONING; do not use /analogs; DF: CCL4 RN56-23-5 MND2.455.526.439.143 LH  MHÑCarbon Tetrachloride Poisoning ANdo not use /chem ind; DF: CCL4 POIS MNC21.613.177 LH  OLsearch BEVERAGES 1966-74 HN(75) MHÑCarbonated Beverages ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNJ1.125.220 DMÑBeverages LH LM  PMCARBONIC ACID was see under CARBON DIOXIDE 1963-74 MHÑCarbonates ANdo not use /analogs /biosyn /defic /physiol MND1.154.453; D1.248.497.158.165 XUÑCarbonic Acid LH LU  OLsearch CARBON DIOXIDE 1966-74 HN(75); was see under CARBON DIOXIDE 1963-74 MHÑCarbonic Acid ANdo not use /analogs /biosyn /defic /physiol RN463-79-6 MND1.154.453.453 DMÑCarbonates LH LM  MHÑCarbonic Anhydrase ANdo not use /analogs; /antag = CARBONIC ANHYDRASE INHIBITORS RNEC 4.2.1.1 MND8.586.520.497.245 LH  PM65 HN65(64) MHÑCarbonic Anhydrase Inhibitors ANdo not use /analogs /antag; DF: CARBONIC ANHYDRASE INHIB MND8.373.220; D19.770.224.266 LH  MSAn uncoupler of electron transport dependent ATP synthesis and photophosphorylation. HN(75) MHÑCarbonyl Cyanide m-Chlorophenyl Hydrazone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN555-60-2 PIChlorobenzenes (74); Hydrazones (72-74); Nitriles (70-74) MND2.442.288.200; D2.626.260; D8.373.936.250 XSCCCP; Carbonyl Cyanide meta-Chlorophenyl Hydrazone DMÑNitriles LH LS; LM  MS((4-(Trifluoromethoxy)phenyl)hydrazono-propanedinitrile. One of a group of compounds called uncoupling agents which inhibit energy metabolism. HN(75) MHÑCarbonyl Cyanide p-Trifluoromethoxyphenylhydrazone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN370-86-5 PIHydrazones (73-74); Nitriles (73-74) MND2.626.270; D2.442.288.220; D8.373.936.270 XSCarbonyl Cyanide para-Trifluoromethoxyphenylhydrazone; FCCP DMÑNitriles LH LS; LM  MS9 alpha, 11 alpha,15(R or S)-Trihydroxy-15-methyl- prosta-5Z,13E-dien-1-oic acid. An abortifacient effective in both the first and second trimester of pregnancy. Synonyms: Prostin/M15; U 32921; U 36384; U 32921E. HN(80) MHÑCarboprost ANdo not use /biosyn /defic /physiol; /analogs NIM only RN35700-23-3 PIProstaglandins (66-74); Prostaglandins F (75-77); Prostaglandins F, Synthetic (78-79); Prostaglandins, Synthetic (77) MND2.241.81.436.687.700.75; D7.131.100.200; D10.516.251.355.708.700.75; D24.185.798.575.750.800.75 XS15-Methylprostaglandin F2alpha; 15-Methylprostaglandin F2alpha Methyl Ester; Methyldinoprost DMÑProstaglandins F, Synthetic LH LS; ; LM  MS5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide. A systemic agricultural fungicide and seed treatment agent. Frequently encountered synonym: Vitavax HN(75) MHÑCarboxin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5234-68-4 PIAnilides (72-74); Oxathiins (72-74) MND2.65.199.350; D3.383.517.200; D5.723.288.170 DMÑAnilides LH LM  OLuse CARBOXY-LYASES & LIGASES to search CARBOXYLASES 1966-74 PM64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963 HN64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963 MHÑCarboxy-Lyases ANdo not use /analogs RNEC 4.1.1. MND8.586.520.258 XSDECARBOXYLASES XUÑHistidine Decarboxylase; ÑIndole-3-Glycerol-Phosphate Synthase; ÑOrotidine-5'-Phosphate Decarboxylase; ÑPhosphoenolpyruvate Carboxylase; ÑPyruvate Decarboxylase; ÑS-Adenosylmethionine Decarboxylase; ÑUroporphyrinogen Decarboxylase LH LS LU; ; ; ; ; ;  PM87; was see under HEMOGLOBINS 1975-86 HN87(73); was see under HEMOGLOBINS 1975-86 MHÑCarboxyhemoglobin ANdo not use /blood; /analogs NIM only RN9061-29-4 MND12.776.124.400.141; D12.776.422.512.149 XSCarbomonoxyhemoglobin LH LS  PM73 HN73(71) MHÑCarboxylic Acids ANdo not confuse with carbocyclic acids (ACIDS, CARBOCYCLIC (NON MESH)); do not use /analogs /biosyn /defic /physiol PIAcids (66-70); Fatty Acids (66-70) MND2.241 XUÑEsters LH LU  MSEnzymes which catalyze the hydrolysis of carboxylic acid esters with the formation of an alcohol and a carboxylic acid anion. PM76; ALDONOLACTONASE, CHOLESTEROL ESTERASE, DEHYDROASCORBATASE, MONOACYLGLYCEROL LIPASES & NAPHTHOL AS D ESTERASE were see under ESTERASES 1975 HN76 MHÑCarboxylic Ester Hydrolases ANdo not use /analogs RNEC 3.1.1 PIEsterases (72-75) MND8.586.277.352.100 XSCarboxylesterases XUÑCholesterol Esterase; ÑDehydroascorbatase; ÑMonoacylglycerol Lipases LH LS LU; ;  MSPolycarboxymethyl ether of cellulose. Used as emulsifier, thickener, suspending agent, etc. in cosmetics and pharmaceuticals; in research as culture medium, in chromatography, as stabilizer for reagents; therapeutically as bulk laxative with antacid properties. Synonyms: Cellolax; Cethylose; CMC; CM-cellulose; Polycell. OLsearch METHYLCELLULOSE 1966-74 HN(75) MHÑCarboxymethylcellulose AND25-26 qualif RN9004-32-4 PIMethylcellulose (66-74) MND9.203.698.365.180.663.329; D19.316.396.618.329; D26.698.179 XSCarboxymethyl Cellulose DMÑMethylcellulose LH LS LM  MSEnzyme produced by Streptomyces strain R61 which catalyzes the peptide cross-linking of nascent cell-wall peptidoglycan. PM87; was see under CARBOXYPEPTIDASES 1975-86 HN87(75); was see under CARBOXYPEPTIDASES 1975-86 MHÑCarboxypeptidase Transpeptidase ANdo not use /analogs RNEC 3.4.17.8 PIAcyltransferases (74); Carboxypeptidases (74); Peptidoglycan (74) MND8.586.277.656.245.200; D8.586.913.50.325 XSD-Alanine Carboxypeptidase; D-D Carboxypeptidase; Muramoylpentapeptide Carboxypeptidase LH LS; ;  MHÑCarboxypeptidases ANdo not use /analogs; CARBOXYPEPTIDASE N = ARGININE CARBOXYPEPTIDASE RNEC 3.4. MND8.586.277.656.245 XUÑArginine Carboxypeptidase; ÑPteroyl Polyglutamate Hydrolase LH LU;  PM73 HN73(63) MHÑCarbromal ANdo not use /biosyn /defic /physiol RN77-65-6 MND2.948.190; D14.591.745.114 LH  MHÑCarbuncle ANusually caused by Staph; consider also FURUNCULOSIS; malignant carbuncle = ANTHRAX MNC1.252.868.820.160; C17.838.820.160 LH  MHÑCarbutamide ANdo not use /biosyn /defic /physiol RN339-43-5 MND2.886.590.795.204; D2.948.828.204; D9.482.179 XSAminophenurobutane; Butylcarbamide; Glybutamide; Sulfaninylbutylurea LH LS; ; ;  PM74 HN74(73) MHÑCarcinoembryonic Antigen ANonly /admin /adv eff /anal /csf /genet /immunol /isol /rad eff /stand /tox /urine; DF: CEA MND24.611.216.285.329 LH  MHÑCarcinogens AND25-26 qualif except /adv eff /pois; be careful: ╥carcinogenic effect╙ of a drug or chem is probably neopl term(s) /chem ind + drug or chem named (with required qualif) & not CARCINOGENS MND26.191 XSOncogens; Tumor Initiators; Tumor Promoters FXÑAlkylating Agents; ÑAminobiphenyl Compounds; ÑCocarcinogenesis; ÑOncogenic Viruses LH LS; ; LX; ; ;  MSCarcinogenic substances which are found in the environment. PM75 HN75 MHÑCarcinogens, Environmental AND25-26 qualif PICarcinogens (66-74) MND5.569.162 LH  OLsearch MALIGNANT CARCINOID SYNDROME 1966-74 HN(75)(64-72) MHÑCarcinoid Heart Disease MNC4.557.112.524.329; C14.280.129 DMÑMalignant Carcinoid Syndrome LH LM  OLuse CARCINOID TUMOR to search ARGENTAFFINOMA back thru 1966 PM68; was ARGENTAFFINOMA 1963-67 HN68; was ARGENTAFFINOMA 1963-67 MHÑCarcinoid Tumor ANbenign or malignant but consider also MALIGNANT CARCINOID SYNDROME (result of serotonin in gen circ in liver metastasis of carcinoid tumor); /anal /blood supply /secret /ultrastruct permitted MNC4.557.112 XSARGENTAFFINOMA LH LS  MHÑCarcinoma ANdo not use for ╥cancer╙ routinely: use only for carcinoma as a histological type: Manual 24.7; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); ╥anaplastic carcinoma╙ = CARCINOMA (IM): do not coord with ANAPLASIA unless anaplasia is particularly discussed MNC4.557.117 XSEpithelioma LH LS  PM73 HN73 MHÑCarcinoma in Situ AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) PICarcinoma (66-72) MNC4.557.117.327 LH  MHÑCarcinoma 256, Walker ANdo not use /vet; /anal /blood supply /secret /ultrastruct permitted MNC4.557.117.45; C4.619.45 XSCARCINOSARCOMA 256, WALKER LH LS  MHÑCarcinoma, Basal Cell AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); ╥rodent ulcer╙ goes here but do not coord with ULCER MNC4.557.117.110 XSEpithelioma, Basal Cell XUÑBasal Cell Nevus Syndrome LH LS LU  MHÑCarcinoma, Basosquamous AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.117.141 LH  MHÑCarcinoma, Bronchiolar AN/anal /blood supply /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS (IM) MNC4.588.894.797.520.140.180 LH  MHÑCarcinoma, Bronchogenic AN/anal /blood supply /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS (IM), not BRONCHIAL NEOPLASMS MNC4.588.894.797.520.140.280 XSCarcinoma, Bronchial LH LS  MHÑCarcinoma, Brown-Pearce ANdo not use /vet; /anal /blood supply /secret /ultrastruct permitted MNC4.557.117.172; C4.619.124 XSEPITHELIOMA, BROWN-PEARCE LH LS  MHÑCarcinoma, Ductal AN/anal /blood supply /secret /ultrastruct permitted; coord IM with BREAST NEOPLASMS (IM) MNC4.557.117.234 XUÑPaget's Disease of Breast LH LU  MSA transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse; it grows in both solid and ascitic forms. MHÑCarcinoma, Ehrlich Tumor ANdo not use /vet; /anal /blood supply /secret /ultrastruct permitted; do not also index under ASCITES MNC4.557.117.265; C4.619.169 XSEHRLICH ASCITES TUMOR LH LS  MHÑCarcinoma, Krebs 2 AN/anal /blood supply /secret /ultrastruct permitted; do not use /vet MNC4.557.117.358; C4.619.214 LH  MSAdenocarcinoma in which the cells secrete mucin. OLuse CARCINOMA, MUCINOUS to search CARCINOMA, COLLOID back thru 1966. PM81; CARCINOMA, COLLOID was heading 1963-80 HN81; CARCINOMA, COLLOID was heading 1963-80 MHÑCarcinoma, Mucinous ANalso called ╥mucoid╙ or ╥mucous╙ carcinoma; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.117.390; C4.557.576.197 XSCarcinoma, Colloid LH LS  MSA heterogeneous aggregate of at least three distinct histological types of lung cancer including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy, and the potential for cure with surgical resection in a fraction of patients. PM87 HN87 MHÑCarcinoma, Non-Small Cell Lung AN/anal /blood supply /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS (IM); DF: NSCLC PILung Neoplasms (66-86) MNC4.557.117.415; C4.588.894.797.520.180 XSNon-Small Cell Lung Carcinoma LH LS  MSCarcinoma composed of small undifferentiated cells. PM74 HN74(72) MHÑCarcinoma, Oat Cell AN/anal /blood supply /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS (IM) PICarcinoma, Bronchogenic (66-71) MNC4.557.117.421 XSCarcinoma, Reserve Cell; Carcinoma, Small Cell; RESERVE CELL CARCINOMA LH LS; ;  MHÑCarcinoma, Papillary AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.117.452 LH  MSTumors arising from the renal tubular epithelium. PM85 HN85 MHÑCarcinoma, Renal Cell AN/anal /blood supply /secret /ultrastruct permitted; coord IM with KIDNEY NEOPLASMS (IM) PIAdenocarcinoma (66-84); Kidney Neoplasms (66-84) MNC4.557.576.36.270 XSAdenocarcinoma, Renal Cell; Carcinoma, Hypernephroid; Grawitz Tumor; Hypernephroma LH LS; ; ;  MHÑCarcinoma, Scirrhous AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.117.483 XUÑLinitis Plastica LH LU  MSCarcinoma derived from stratified squamous epithelium; may also occur in sites where glandular or columnar epithelium is normally present. OLuse CARCINOMA, SQUAMOUS CELL to search CARCINOMA, EPIDERMOID back thru 1966 PM81; was CARCINOMA, EPIDERMOID 1963-80 HN81; was CARCINOMA, EPIDERMOID 1963-80 MHÑCarcinoma, Squamous Cell AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.117.490 XSCarcinoma, Epidermoid XUÑBowen's Disease LH LS LU  MHÑCarcinoma, Transitional Cell AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.117.514 LH  MHÑCarcinosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.160; C4.557.863.130 LH  PM68 HN68 MHÑCardanolides ANdo not use /analogs /defic /physiol; do not confuse with CARDENOLIDES MND4.808.155 LH  MSC(23) steroids with a methyl group at C-10 and C-13 and a five-membered lactone at C-17. Must have at least one double bond in the molecule. Include cardadienolides and cardatrienolides. PM77 HN77 MHÑCardenolides ANincludes cardadienolides & cardatrienolides; do not use /analogs /defic /physiol; do not confuse with CARDANOLIDES PICardanolides (68-76) MND4.808.155.160 LH  MHÑCardia ANadjective form = ╥cardial╙: do not confuse with ╥cardiac╙ (heart); diseases: coord NIM with STOMACH DISEASES (IM); neoplasms: coord NIM with STOMACH NEOPLASMS (IM) + histol type of neopl (IM) MNA3.492.766.163 LH  MSInstitutions specializing in the care of patients with heart disorders. HN(Aug 77) MHÑCardiac Care Facilities ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util MNN2.278.421.556.110 DMÑHospitals, Special LH LM  MSSubstances obtained from species of Digitalis, Strophanthus and other plants that contain specific steroid glycosides or their semisynthetic derivatives that are used in congestive heart failure; they increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. MHÑCardiac Glycosides ANdo not use /analogs /biosyn /defic /physiol MND9.203.408.180; D18.222.175 XSCardiotonic Steroids LH LS  MSThe volume of blood passing through the heart per unit of time; usually expressed as liters per minute not to be confused with stroke volume (volume per beat). PM67 HN67(64) MHÑCardiac Output ANa physiol concept: do not confuse with CARDIAC OUTPUT, LOW, a C14 disease below; only /drug eff /rad eff MNE1.145.569.205; G9.330.612.280 LH  MSA state of subnormal or depressed cardiac output, usually seen in patients with heart failure secondary to coronary artery, hypertensive, primary myocardial, valvular or pericardial disease. PM80 HN80 MHÑCardiac Output, Low ANnote category: do not confuse with CARDIAC OUTPUT, a physiol concept above; also called ╥low cardiac output syndrome╙ so do not add SYNDROME PICardiac Output (66-79) MNC14.280.148 XSLow Cardiac Output LH LS  MSRegulation of the rate of contraction of the heart muscles by an artificial pacemaker. PM78 HN78 MHÑCardiac Pacing, Artificial ANdo not use /util except by MeSH definition; do not use /instrum ( = PACEMAKER, ARTIFICIAL) PIPacemaker, Artificial (66-77) MNE2.145 XSPacing, Cardiac, Artificial FXÑElectric Stimulation; ÑPacemaker, Artificial LH LS LX;  MHÑCardiac Tamponade ANcompression of heart from pericardial effusion or hemopericardium MNC14.280.155 FXÑPericardial Effusion LH LX  PM72 HN72(68) MHÑCardiac Volume ANonly /drug eff /rad eff; STROKE VOLUME is also available PICardiac Output (66-67); Heart/PH (66-67) MNG9.330.612.330 LH  MSA type of impedance plethysmography in which bioelectrical impedance is measured between electrodes positioned around the neck and around the lower thorax. Principally used to calculate stroke volume and cardiac volume but also related to myocardial contractility, thoracic fluid content, and circulation to the extremities. HN(79) MHÑCardiography, Impedance ANNIM; do not use /util except by MeSH definition PICardiac Output (66-78); Plethysmography, Impedance (66-78) MNE1.145.569.240; E1.145.811.611.250; E1.725.528.250 XSImpedance, Transthoracic; Plethysmography, Impedance, Transthoracic DMÑPlethysmography, Impedance LH LS; LM  OLsearch CARDIOLIPINS & PHOSPHATIDYLGLYCEROLS 1975-76 PM73; DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76 HN73(72); DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76 MHÑCardiolipins ANdo not use /analogs /defic /physiol PIPhospholipids (66-71) MND10.516.695.300.700.780.200; D24.611.216.621.330 XSDiphosphatidylglycerols LH LS  MSThe study of the heart, its physiology, and its functions. MHÑCardiology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of HEART /form or HEART DISEASES /form MNG2.403.776.409.163 XSCardiovascular Disease (Specialty) FXÑCARDIOVASCULAR DISEASES; ÑHEART DISEASES; ÑVASCULAR DISEASES LH LS LX; ;  MSCardiomyopathy resulting from 1) a toxic effect of alcohol on the myocardium, 2) thiamine deficiency due to malnutrition in alcoholics, 3) a toxic effect of cobalt additives in beer in heavy beer drinkers. This disease is usually manifested by dyspnea and palpitations with cardiomegaly and congestive heart failure. PM79 HN79 MHÑCardiomyopathy, Alcoholic PIAlcoholism (66-78); Heart Diseases (66-78); Myocardial Diseases (66-78) MNC14.280.600.57; C21.613.53.270.250 XSAlcoholic Cardiomyopathy LH LS  MSA syndrome characterized by cardiac enlargement and congestive heart failure; probably represents the end result of many forms of myocardial damage produced by a variety of toxic, metabolic, or infectious agents. PM86; was see under HEART FAILURE, CONGESTIVE 1984-85 HN86(84); was see under HEART FAILURE, CONGESTIVE 1984-85 MHÑCardiomyopathy, Congestive ANdo not confuse with HEART FAILURE, CONGESTIVE PIHeart Failure, Congestive (66-83); Myocardial Diseases (79-83) MNC14.280.409.160; C14.280.434.160; C14.280.600.70 XSCardiomyopathy, Dilated; Congestive Cardiomyopathy; Dilated Cardiomyopathy LH LS; ;  MSA myocardial disease characterized by hypertrophy, involving mainly the interventricular septum, interfering with left ventricular emptying. OLuse CARDIOMYOPATHY, HYPERTROPHIC to search IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS back thru 1966 PM86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85 HN86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85 MHÑCardiomyopathy, Hypertrophic ANDF: SUBVALV STENOSIS MNC14.280.600.100 XSAsymmetric Septal Hypertrophy; Cardiomyopathy, Hypertrophic Obstructive; Idiopathic Hypertrophic Subaortic Stenosis; Idiopathic Hypertrophic Subvalvular Stenosis; SUBVALVULAR STENOSIS, IDIOPATHIC HYPERTROPHIC FXÑAortic Valve Stenosis XUÑAortic Subvalvular Stenosis; ÑPulmonary Subvalvular Stenosis LH LS; ; ; ; LX LU;  MSMyocardial disease in which the ventricular walls are excessively rigid, impeding ventricular filling; it is marked by abnormal diastolic function but by normal or nearly normal systolic function. PM86 HN86 MHÑCardiomyopathy, Restrictive PIMyocardial Diseases (79-85) MNC14.280.600.160 LH  MSDiversion of the flow of blood from the entrance of the right atrium directly to the aorta via an oxygenator thus bypassing both the heart and lungs. OLsearch EXTRACORPOREAL CIRCULATION 1967-74 PM77; was see under EXTRACORPOREAL CIRCULATION 1967-76 HN77(75); was see under EXTRACORPOREAL CIRCULATION 1967-76 MHÑCardiopulmonary Bypass AN/instrum = HEART, MECHANICAL; do not use /util except by MeSH definition PIExtracorporeal Circulation (67-76) MNE4.292.413 XSHeart-Lung Bypass FXÑHeart, Mechanical LH LS LX  MSAgents that have a tonic effect on the heart or increase cardiac output; they may be glycosidic steroids related to Digitalis products, sympathomimetics, or other; used after myocardial infarcts, cardiac surgery, in shock or congestive heart failure. PM80 HN80 MHÑCardiotonic Agents ANdo not use /analogs /biosyn /defic /physiol PICardiac Glycosides (66-79); Sympathomimetics (66-79); specific drug or agent MND18.222 XSCardiac Stimulants; Inotropic Agents, Positive Cardiac; Myocardial Stimulants LH LS; ;  MSAgents that affect the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. OLconsider also CARDIOVASCULAR SYSTEM /DE PM79 HN79; was NON MESH before 1979 MHÑCardiovascular Agents ANdo not use /analogs /biosyn /defic /physiol MND18 LH  MHÑCardiovascular Diseases ANGEN: avoid; prefer specifics MNC14 FXÑCardiology LH LX  MSThe heart and the blood vessels by which blood is pumped and circulated through the body. MHÑCardiovascular System ANGEN; do not use /blood supply; do not use /abnorm: prefer HEART DEFECTS, CONGENITAL or specific artery or vein with /abnorm MNA7 LH  OLconsider also CARDIOVASCULAR SYSTEM /PH or /PH with specific cardiovasc organs MH*Cardiovascular System Physiology (Non Mesh) MNG9.330 LH  MSSelection of a type of occupation or profession. PM83; was see under CHOICE BEHAVIOR 1981-82 & DECISION MAKING 1975-80 HN83(75); was see under CHOICE BEHAVIOR 1981-82 & DECISION MAKING 1975-80 MHÑCareer Choice ANno qualif MNF2.463.785.373.346.400 LH  MSThe upward or downward mobility in an occupation or the change from one occupation to another. PM74 HN74(72) MHÑCareer Mobility ANno qualif CATALOG: /geog /form PIHealth Occupations (66-71); Occupations (66-71); specific occupation MNN1.824.547.330; N4.452.677.300 LH  MSN-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo (3,2,0)hept-beta-yl)2-phenylmalonamic acid 1-phenyl ester. The phenyl ester of carbenicillin that, upon oral administration, is broken in the intestinal mucosa to the active antibacterial; used for urinary tract infections. Synonyms: BRL 3475; Uticillin. HN(78) MHÑCarfecillin ANdo not use /biosyn /defic /physiol RN27025-49-6 PICarbenicillin (73-77); Penicillins (66-72) MND20.85.99.739.762.161.365 XSCarbenicillin Phenyl Sodium DMÑCarbenicillin LH LS LM  OLsearch REINDEER 1968-74 HN(75) MHÑCaribou ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.77.380.373.644.331 DMÑReindeer LH LM  MHÑCaricatures ANno qualif MNK1.93.206 XUÑCartoons LH LU  PM65 HN65 MHÑCariogenic Agents AND25-26 qualif; consider also DENTAL CARIES /etiol MND25.187 FXÑDIET, CARIOGENIC; ÑDental Caries LH LX;  PM65 HN65 MHÑCariostatic Agents AND25-26 qualif; consider also DENTAL CARIES /prev or /drug ther MND25.223 FXÑDental Caries; ÑFLUORIDATION LH LX;  MHÑCarisoprodol ANdo not use /biosyn /defic /physiol RN78-44-4 MND2.241.81.251.165; D17.426.574.331 XSCarisoprodate; Isobamate; Isomeprobamate; Isopropylmeprobamate LH LS; ; ;  MSThe aluminum-calcium lake of carminic acid; a glucosidal red coloring matter from the insect Coccus cacti L.; used in foods, pharmaceuticals, toiletries, etc., as a dye; also a microscopic stain and biological marker. Synonyms: C. I. Natural Red 4; C.I. 75470. HN(76) MHÑCarmine AND25-26 qualif; /analogs NIM only RN1260-17-9 PIAluminum (72-75); Anthraquinones (72-75); Calcium (72-75) MND4.615.117.159.200; D26.408.168; D26.471.355.168 XSCoccinellin; Natural Red 4 DMÑAnthraquinones LH LS; LM  PM73 HN73(72) MHÑCarmustine ANdo not use /biosyn /defic /physiol RN154-93-8 PIAlkylating Agents (66-71); Nitroso Compounds (66-71); Urea (66-71) MND2.654.692.247; D2.948.594.247; D22.204.342 XSBCNU LH LS  PM66; was see under VITAMIN B COMPLEX 1963-65 HN66(64); was see under VITAMIN B COMPLEX 1963-65 MHÑCarnitine AN/biosyn /physiol permitted RN541-15-1 MND11.786.708.168 XSVITAMIN B T XUÑAcetylcarnitine; ÑPalmitoylcarnitine LH LS LU;  MSAcetyl Co A:carnitine O-acetyltransferase. Catalyzes the formation of O-acetylcarnitine from acetyl-CoA plus carnitine. HN(75) MHÑCarnitine Acetyltransferase ANdo not confuse with CARNITINE ACYLTRANSFERASES; do not use /analogs RNEC 2.3.1.7 PIAcetyltransferases (73-74); Carnitine (73-74) MND8.586.913.50.134.150; D8.586.913.50.350.170 DMÑAcetyltransferases LH LM  MSCarnitine acyltransferases in the inner mitochondrial membrane catalyze reversible transfer of acyl groups from acylCoA to L-carnitine and thereby mediate the transport of activated fatty acids through that membrane. HN(75) MHÑCarnitine Acyltransferases ANdo not confuse with CARNITINE ACETYLTRANSFERASE; do not use /analogs RNEC 2.3.1.- PIAcyltransferases (72-74) MND8.586.913.50.350 DMÑAcyltransferases LH LM  MSPalmitoyl-CoA:L-carnitine O-palmitoyltransferase. Catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. HN(75) MHÑCarnitine Palmitoyltransferase ANdo not use /analogs RNEC 2.3.1.21 PIAcyltransferases (73-74); Palmitic Acids (73-74); Carnitine (73-74) MND8.586.913.50.350.200 DMÑAcyltransferases LH LM  MHÑCarnivora ANGEN; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; in addition to the XU's below, tigers, panthers, cougars, leopards, jaguars, pandas, etc. go here; here also are wolves, jackals, hyenas, civets, coyotes, martens (includes badgers, MINK, OTTERS, SKUNKS, sables, weasels & wolverines) MNB2.649.147 XUÑBears; ÑCheetahs; ÑFerrets; ÑLions; ÑMongoose; ÑOtters; ÑSkunks LH LU; ; ; ; ; ;  OLsearch DIPEPTIDES 1967-74 & PEPTIDES 1966 HN(75); was see under PEPTIDES 1963-66 MHÑCarnosine ANdo not use /defic /physiol; /analogs NIM only RN305-84-0 MND12.644.456.345.331; D12.776.641.650.100 DMÑDipeptides LH LM  MHÑCarotene RN36-88-4 MND2.455.849.131.247; D11.557.261.206 LH  MHÑCarotenoids ANdo not use /analogs MND2.455.849.131; D11.557.261 LH  MSEither of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery. MHÑCarotid Arteries ANdo not use /blood supply; /radiogr: consider also CEREBRAL ANGIOGRAPHY MNA7.231.114.186 LH  MHÑCarotid Artery Diseases ANGEN or unspecified; coord IM with CAROTID ARTERY, INTERNAL or CAROTID ARTERY, EXTERNAL (NIM) if pertinent MNC10.228.140.300.123; C14.907.253.123 LH  PM64 HN64 MHÑCarotid Artery Thrombosis ANcoord IM with CAROTID ARTERY, EXTERNAL (NIM) or CAROTID ARTERY, INTERNAL (NIM) if pertinent MNC10.228.140.300.123.331; C10.228.140.300.378.206; C14.907.253.123.331; C14.907.854.213.206 LH  MSBranch of the common carotid artery which supplies the exterior of the head, the face, and the greater part of the neck. PM74 HN74(72) MHÑCarotid Artery, External ANdo not use /blood supply; disease: coord NIM with CAROTID ARTERY DISEASES (IM) PICarotid Arteries (66-71) MNA7.231.114.186.206 LH  MSBranch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose. PM74 HN74(72) MHÑCarotid Artery, Internal ANdo not use /blood supply; disease: coord NIM with CAROTID ARTERY DISEASES (IM) PICarotid Arteries (66-71) MNA7.231.114.186.331 LH  MHÑCarotid Body ANdo not use /innerv MNA8.99.651.331; A8.796.511.725.154.331 XSGLOMUS CAROTICUM LH LS  MHÑCarotid Body Tumor AN/anal /blood supply /secret /ultrastruct permitted; organ/neopl & histol coords not necessary MNC4.557.652.798.248; C4.557.690.387.156 LH  MSThe dilated portion of the common carotid artery at its bifurcation into external and internal carotids. It contains baroreceptors which, when stimulated, cause slowing of the heart, vasodilatation, and a fall in blood pressure. MHÑCarotid Sinus ANdo not use /blood supply MNA7.231.114.186.456 FXÑPRESSORECEPTORS LH LX  OLsearch CYPRINIDAE 1968-74 HN(75) MHÑCarp ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.200.244.248 XSCarassius carassius; Cyprinus DMÑCyprinidae LH LS; LM  PM72 HN72 MHÑCarpal Bones ANthe 8 bones of the wrist of which SEMILUNAR BONE is available; do not confuse with WRIST (the area) or WRIST JOINT; see note on CARPUS, ANIMAL; /inj permitted: not necessarily WRIST INJURIES PIWrist (66-71); Wrist Joint (66-71) MNA2.835.232.87.144 LH  PM65 HN65(63) MHÑCarpal Tunnel Syndrome MNC10.772.491.206 FXÑMEDIAN NERVE LH LX  OLsearch FORELIMB 1968-74 HN(75) MHÑCarpus, Animal ANTN 117 & table: animal extremities MNA13.395.248 DMÑForelimb LH LM  PM66 HN66(64) MHÑCarrageenan ANdo not use /defic /physiol; seen in texts also as carrageenin RN9000-07-1 MND9.203.698.152 FXÑSeaweed LH LX  PM73 HN73(71) MHÑCarrier Proteins ANdo not use /analogs /defic; do not confuse BINDING PROTEINS (X ref) with PROTEIN BINDING; do not use CARRIER PROTEINS if the protein functions as a receptor: use instead the pertinent RECEPTORS term PIProtein Binding (66-70); Proteins (66-70) MND12.776.157 XSBinding Proteins; Transport Proteins FXÑProtein Binding; ÑReceptors, Transferrin LH LS; LX;  MSA condition in which a human who is not himself sick harbors an infective organism which may cause disease in those to whom it is transmitted. PM65 HN65(63) MHÑCarrier State ANIM; disease carriers, not genetic carriers ( = HETEROZYGOTE DETECTION); coord with disease, not organism; do not use /chem ind /compl /congen /embryol /etiol /familial /hist /mortal /radiogr /radionuclide /radiother /rehabil /surg MNC1.539.158 FXÑDisease Reservoirs LH LX  MS5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]- 3,4-dihydro-2(1H)-quinolinone. Beta adrenergic blocker proposed as antiarrhythmic or antihypertensive. Synonym: Abbott 43326; OPC 1085. HN(79) MHÑCarteolol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN51781-06-7 PIAmino Alcohols (66-72); Bunolol (73-78); Quinolines (66-78) MND2.33.329.624.210; D2.92.63.624.210; D16.848.215.250 DMÑPropanolamines LH LM  MS4-Methyl-3-(2-(propylamino)propionamido)-2-thiophene carboxylic acid methyl ester. Thiophene containing local anesthetic pharmacologically similar to mepivacaine. Synonyms: Hoe 045; Hoe 40045; Ultracain(e). HN(79) MHÑCarticaine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23964-57-0 PIThiophenes (66-78) MND3.383.903.150; D14.211.198 DMÑThiophenes LH LM  MHÑCartilage ANnote CARTILAGE, ARTICULAR below; inflammation (chondritis) is likely to be OSTEOCHONDRITIS; consider also terms under CHONDR MNA2.165; A10.165.382 FXÑCHONDROITIN; ÑLARYNGEAL CARTILAGES LH LX;  PM68 HN68 MHÑCartilage Diseases ANGEN; inflamm dis (chondritis) is likely to be OSTEOCHONDRITIS PICartilage (66-67); Cartilage, Articular (66-67); Osteochondritis (66-67) MNC5.182; C23.205.182 FXÑELLIS-VAN CREVELD SYNDROME; ÑEPIPHYSES, SLIPPED; ÑOSTEOCHONDRITIS LH LX; ;  PM65 HN65 MHÑCartilage, Articular ANinflammation (chondritis) is likely to be OSTEOCHONDRITIS MNA2.165.165; A2.835.583.192; A10.165.382.332 LH  OLsearch CARICATURES 1966-74 HN(75) MHÑCartoons ANno qualif MNK1.93.206.332 DMÑCaricatures LH LM  MS8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahyhdro-1,6,8,11-tetrahydroxy-5,12-naphthacenedione. Very toxic anthracycline type antibiotic related to daunorubucin, obtained from Actinomadura carminata; used in soft tissue neoplasms and leukemias. Synonyms: demethyldaunomycin; demethyldaunorubicin; desmethyldaunorubicin; NSC 180024. OLuse CARUBICIN to search CARMINOMYCIN back thru 1975 HN(84); was CARMINOMYCIN see under DAUNORUBICIN 1980-83, was CARMINOMYCIN see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79 MHÑCarubicin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN39472-31-6 PIAntibiotics, Antineoplastic (67-74); Aminoglycosides (74); Naphthacenes (66-74) MND20.85.75.354.168; D22.204.106.356.168 XSCarminomycin; Karminomycin DMÑDaunorubicin LH LS; LM  MHÑCarvacrol ANdo not use /biosyn /defic /physiol RN499-75-2 MND2.455.849.182 LH  MSDried bark of a buckthorn (Rhamnus purshiana) that contains the anthraquinone emodin; used as a laxative. Synonyms: casakol; Pericolace; Peristim; sacred bark. OLsearch CATHARTICS 1966-74 HN(75) MHÑCascara AND25-26 qualif RN8047-27-6 MND4.615.117.159.205; D19.316.396.247 XSCasanthranol DMÑCathartics LH LS LM  HN66; for articles that were case reports 1967-75, that contained case reports 1966 MHÑCase Report ANcheck tag only; any article containing a case report is checked here: policy: Manual 18.11+; ╥review & case rep╙: Manual 12.2.10; permitted for vet case rep but not for historical articles; case reports as a form of writing or their value is indexed under MEDICAL RECORDS or specific records term (IM) CATALOG: do not use: for indexers only LH  OLuse CASEINS to search CASEIN back thru 1966 PM82; was CASEIN 1963-81 HN82; was CASEIN 1963-81 MHÑCaseins ANdo not use /analogs /defic /physiol MND12.776.256.626.207 LH  MSAny of several species of the tropical plant, family Euphorbiaceae, that grow starchy roots used for food; Manihot esculenta is most often used, but contains high amounts of hydrogen cyanide and few essential nutrients. HN(86)63 MHÑCassava ANdo not use /isol /pathogen MNB6.510.198 XSMANIOC; Manihot; Tapioca DMÑPlants, Edible LH LS; ; LM  MSLeguminous plants Cassia senna L. (or C. acutifolia) and C. angustifolia that contain anthraquinones which are used as laxatives. HN(78) MHÑCassia ANplant from which SENNA is derived; do not use /isol /pathogen PISenna (66-77) MNB6.560.546.160 DMÑPlants, Medicinal LH LM  OLsearch RICINUS 1966-74 HN(75) MHÑCastor Bean ANdo not use /isol /pathogen MNB6.660.751.332 DMÑRicinus LH LM  MHÑCastor Oil AND25-26 qualif RN8001-79-4 MND10.516.212.507.300; D10.516.627.700.132; D19.316.396.280; J1.740.400.200; J1.740.700.200 FXÑRicinus LH LX  MSSurgical removal or artificial destruction of gonads. MHÑCastration ANGEN or unspecified: prefer OVARIECTOMY or ORCHIECTOMY; do not use /util except by MeSH definition MNE4.779.282; E4.887.165 FXÑEUNUCHISM LH LX  MSStiff dressings made of bandage impregnated with plaster of paris or other hardening material used for immobilization of various parts of the body in cases of fractures, dislocations, and infected wounds. MHÑCasts, Surgical ANonly /adv eff /stand /vet; ╥cast syndrome╙ (duodenal compression caused by wearing a body cast) = SUPERIOR MESENTERIC ARTERY SYNDROME if confirmed by text but do not index under CASTS, SURGICAL /adv eff unless particularly discussed MNE7.858.442.660.414 XSPLASTER CASTS LH LS  MHÑCat Diseases ANdo not use /compl /vet; don't forget also check tags CATS (NIM) & ANIMAL MNC22.180 LH  MHÑCat-Scratch Disease MNC2.158; C15.604.315.249 XSInoculation Lymphoreticulosis LH LS  MHÑCatalase ANdo not use /analogs; /defic: consider also CATALASE /blood (IM) + METABOLISM, INBORN ERRORS (IM) RNEC 1.11.1.6 MND8.586.682.732.332 LH  MSSustained immobility of postures or physical attitude. MHÑCatalepsy ANdo not use /congen /drug eff /physiol /rad eff MNF3.126.720.270 LH  MHÑCataloging ANIM; only /econ /hist /methods /stand /trends MNL1.300.250 LH  MSOrdered compilations of item descriptions and sufficient information to afford access to them. MHÑCatalogs ANno qualif MNL1.178.682.290 LH  MHÑCatalogs, Booksellers' ANno qualif CATALOG: /geog /form MNL1.178.682.290.183.249 LH  MHÑCatalogs, Commercial ANno qualif CATALOG: /geog /form MNL1.178.682.290.183 FXÑEquipment and Supplies LH LX  MHÑCatalogs, Drug ANno qualif CATALOG: /geog /form MNL1.178.682.290.283 XSDRUG CATALOGS LH LS  MHÑCatalogs, Library ANno qualif CATALOG: /geog /form MNL1.178.682.290.383 LH  MHÑCatalogs, Publishers' ANno qualif CATALOG: /geog /form MNL1.178.682.290.183.416 LH  MHÑCatalogs, Union ANno qualif CATALOG: /geog /form MNL1.178.682.290.483 LH  MHÑCatalysis ANNIM; no qualif MNH1.181.122.249; H1.181.529.145 LH  MSMomentary loss of skeletal muscle tone with resulting weakness and postural collapse. MHÑCataplexy ANdo not use /congen /drug eff /physiol /rad eff MNC10.228.140.725.254; C10.597.232; C23.888.592.192; F3.126.720.333 FXÑNarcolepsy LH LX  MHÑCataract AN/surg = CATARACT EXTRACTION; pseudophakia & pseudoaphakia go here if crystalline lens is replaced by fibrous, fatty or osseous tissue MNC11.510.245 XSLENS OPACITIES LH LS  MHÑCataract Extraction ANENZYMATIC ZONULOLYSIS, a specific type of cataract extraction is available; do not use /util except by MeSH definition MNE4.792.208 FXÑAphakia, Postcataract; ÑLenses, Intraocular LH LX;  MSAn acute or prolonged illness usually considered to be life-threatening or with the threat of serious residual disability. Treatment may be radical and is frequently costly. PM82 HN82 MHÑCatastrophic Illness ANonly /class /econ /legis /mortal /nurs /occur /ther MNC23.280.150; N1.407.306.240 FXÑInsurance, Major Medical LH LX  MSA state characterized by immobility with muscular rigidity or inflexibility and at times by excitability. MHÑCatatonia ANdo not use /drug eff /physiol /rad eff MNF3.126.720.396 LH  PM74 HN74 MHÑCatatoxic Steroids ANdo not use /analogs /biosyn /defic /physiol; note CATATOXIC STEROID 1 above MND4.808.183; D6.597.225 LH  MSA geographic area defined and served by a health program or institution. PM78 HN78 MHÑCatchment Area (Health) ANonly /econ /legis; specify geog; DF: CATCHMENT AREA CATALOG: /geog /form MNN1.696.100; N3.349.650.95 XSHealth Service Area LH LS  MS3,3',4',5,7-Flavanpentol. Extracted from Uncaria gambier, Acacia catechu and other plants; it stabilizes collagen and is therefore used in tanning and dyeing; it prevents capillary fragility and abnormal permeability, but was formerly used as an antidiarrheal. Synonyms: Cachou; Cashoo; Cutch. PM87; was see under BENZOPYRANS 1977-86 HN87(77); was see under BENZOPYRANS 1977-86 MHÑCatechin ANfrom plants; do not use /defic /physiol; /biosyn permitted if by plant RN154-23-4 PIBenzopyrans (73-76); Catechols (73-76) MND3.438.150.240.190 XSCatechinic Acid; Catechu; Catechuic Acid; Cyanidanol-3 LH LS; ; ;  MS2- or 4-Hydroxyestrogens. They are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an estrogenic action or interaction with the catecholaminergic system. PM82 HN82 MHÑCatechol Estrogens AN/biosyn /physiol permitted; do not use /analogs PICatechols (66-81); Estrogens (66-81); specific estrogen MND2.755.166.175; D6.472.265.175; D6.472.866.540.175 XSEstrogens, Catechol LH LS  PM74 HN74(72) MHÑCatechol Methyltransferase ANdo not use /analogs RNEC 2.1.1.6 PIMethyltransferases (71); Transferase (66-71) MND8.586.913.517.183 LH  MHÑCatecholamines AN/biosyn /physiol permitted; do not use /analogs /defic; if only EPINEPHRINE & NOREPINEPHRINE are discussed index under each & not also here MND2.92.311 XSSYMPATHINS LH LS  OLuse CATECHOLS to search CATECHOL back thru 1966 PM75; was CATECHOL 1963-74 HN75; was CATECHOL 1963-74 MHÑCatechols ANdo not use /analogs /biosyn /defic /physiol MND2.755.166 XSPyrocatechols; o-Dihydroxybenzenes; ortho-Dihydroxybenzenes XUÑ3-Methoxy-4-Hydroxyphenylethanol; ÑCurcumin; ÑNordihydroguaiaretic Acid; ÑRimiterol LH LS; ; LU; ; ;  MSCommon name to express the order Siluriformes. This order contains many families and over 2,000 species, including venomous species. Heteropneustes and Plotosus genera have dangerous stings and are aggressive. Most species are passive stingers. PM87 HN87 MHÑCatfish ANNIM when exper animal; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.80 XSCatfish, Freshwater; Eels, Catfish; Heteropneustes; Plotosus; Silurid XUÑIctaluridae LH LS; ; ; ; LU  MSSterile collagen strands obtained from healthy mammals; used as absorbable surgical ligatures; frequently impregnated with chromium or silver for increased strength; tends to cause tissue reaction. HN(79) MHÑCatgut ANonly /adv eff /stand /util (if by MeSH definition) PISutures (66-78) MND24.310.132; E7.858.784.250 DMÑSutures LH LM  OLsearch ABREACTION 1969-74 HN(75) MHÑCatharsis ANno qualif MNF4.754.919.107.333 DMÑAbreaction LH LM  MHÑCathartics AND25-26 qualif MND19.316.396 XSLAXATIVES; PURGATIVES XUÑCascara LH LS; LU  MSA lysosomal cysteine proteinase which hydrolyzes proteins, with a specificity resembling that of papain. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in demyelination, emphysema, rheumatoid arthritis, and neoplastic infiltration. EC 3.4.22.1. PM87 HN87 MHÑCathepsin B AN/biosyn /physiol permitted RNEC 3.4.22.1 PICathepsins (66-86) MND8.586.277.656.732.133.200 LH  MSIntracellular proteinase found in a variety of tissue. It has specificity similar to, but narrower than that of pepsin A. Involved in catabolism of cartilage and connective tissue. Formerly EC 3.4.4.23. PM85 HN85 MHÑCathepsin D AN/biosyn /physiol permitted RNEC 3.4.23.5 PICathepsins (66-84) MND8.586.277.656.732.133.250 LH  MSDipeptidylpeptide hydrolases. Intracellular acidic proteinases found in aqueous extracts of a variety of animal tissue. OLuse CATHEPSINS to search CATHEPSIN back thru 1966 PM79; was CATHEPSIN 1965-78 HN79; was CATHEPSIN 1963-78 (Prov 1963-64) MHÑCathepsins AN/biosyn /physiol permitted; do not use /analogs RNEC 3.4.- MND8.586.277.656.732.133 LH  MHÑCatheterization ANdo not use /util except by MeSH definition; see cross-refs below; Swan-Ganz: index under HEART CATHETERIZATION /instrum MNE5.157 XSCannulation LH LS  MSCatheters designed to be left within an organ or passage for an extended period of time. OLto search INDWELLING CATHETER use CATHETERS, INDWELLING back thru 1975 & URINARY CATHETERIZATION 1966-74 PM78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77 HN78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77 MHÑCatheters, Indwelling ANNIM; do not use /instrum /methods /util (except by MeSH definition); when IM, coord with specific site (NIM) if pertinent PICatheterization (66-74); Heart Catheterization (66-74); Urinary Catheterization (66-74) MNE7.145 XSArterial Lines; Intra-Arterial Lines FXÑInfusion Pumps LH LS; LX  MSAttachment, conscious or unconscious, of emotional feeling and significance to an idea, object or most commonly a person. OLsearch DISPLACEMENT (PSYCHOLOGY) 1974 HN(75) MHÑCathexis ANno qualif MNF1.145.299.333; F3.407.246.333 DMÑDisplacement (Psychology) LH LM  MHÑCatholicism ANonly /hist MNK1.844.188.250 LH  MSHigh molecular weight insoluble polymers which contain functional cationic groups that are capable of undergoing exchange reactions; used in various types of chromatography; also to treat hyperkalemia. OLsearch ION EXCHANGE RESINS 1966-74 HN(75) MHÑCation Exchange Resins AND25-26 qualif MND26.572.283 XSCation Exchangers DMÑIon Exchange Resins LH LS LM  MSPostively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. PM78 HN78 MHÑCations ANGEN or unspecified; avoid as too general: prefer specifics; do not use /analogs /biosyn /defic /physiol; use remaining permissible qualif discreetly: few apply PICations, Divalent (73-77); Cations, Monovalent (73-77); Ions (66-77) MND1.248.497.300 LH  MSPositively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis. PM73 HN73 MHÑCations, Divalent ANNIM: avoid as IM except when general only: prefer specifics; do not use /analogs /biosyn /defic /physiol; use remaining permissible qualif discreetly: few apply PIIons (66-72); Metals (66-72); specific element MND1.248.497.300.333 LH  MSPositively charged atoms, radicals or group of atoms with a valence of plus 1, which travel to the cathode or negative pole during electrolysis. PM73 HN73 MHÑCations, Monovalent ANNIM: avoid as IM except when general only: prefer specifics; do not use /analogs /biosyn /defic /physiol; use remaining permissible qualif discreetly: few apply PIIons (66-72); Metals (66-72); specific element MND1.248.497.300.459 LH  MHÑCats ANcheck tag: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; not for LIONS, tigers, jaguars, leopards, panthers, etc. ( = CARNIVORA); CAT DISEASES is also available; consider also terms under FELINE MNB2.649.147.167 LH  MSSelf report questionnaire which yields 16 scores on personality traits, such as reserved vs. outgoing, humble vs. assertive, etc. OLsearch PERSONALITY INVENTORY 1968-74 HN(75) MHÑCattell Personality Factor Questionnaire ANno qualif MNF4.711.647.513.146 DMÑPersonality Inventory LH LM  MHÑCattle ANcheck tag: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; not all Bovidae: only cows, yaks & zebus MNB2.649.77.380.271 LH  MHÑCattle Diseases ANdo not use /compl /vet; don't forget also check tag tags CATTLE (NIM) & ANIMAL MNC22.196 XUÑBovine Virus Diarrhea-Mucosal Disease LH LU  MSA major racial group distinguished by classification according to physical features. OLuse CAUCASOID RACE to search CAUCASIAN RACE back thru 1966 PM78; was CAUCASIAN RACE 1963-77 HN78; was CAUCASIAN RACE 1963-77 MHÑCaucasoid Race ANincludes Europeans, Hamites, Indo-Dravidians, Lapps, Middle East natives, Polynesians; do not index here routinely: use only when point of article in a racial (i.e., genetic or physiol) context; specify geog if pertinent; differentiate from WHITES (a cultural or ethnic concept; see note there); Manual 30.15: restricted indexing; Manual 30.10-.12: policy on race & sample indexing; only /class /hist MNI1.76.368.763.284 FXÑWhites LH LX  OLuse CAUDA EQUINA to search FILUM TERMINALE back 1966 HNFILUM TERMINALE was see under CAUDA EQUINA 1963-78 MHÑCauda Equina ANdo not use /innerv; diseases: coord IM with PERIPHERAL NERVE DISEASES (NIM); neoplasms: coord IM with PERIPHERAL NERVE NEOPLASMS (IM); cauda equina syndrome: coord IM with NERVE COMPRESSION SYNDROMES (IM) MNA8.796.728.250 XSFilum Terminale LH LS  MHÑCaudate Nucleus ANdo not use /innerv MNA8.186.211.885.105.487.184 LH  OLsearch NEURALGIA 1966-70 HN(71) MHÑCausalgia ANGEN (IM) but coord with specific nerve if needed (IM) PINeuralgia (66-70) MNC10.772.537.184 DMÑNeuralgia LH LM  MHÑCaustics AND25-26 qualif; caustic inj: coord CAUSTICS /adv eff + BURNS, CHEMICAL + organ /inj; see also note on ESOPHAGEAL STENOSIS MND1.455.384; D26.209 XUÑLye LH LU  MHÑCautery ANdo not use /util except by MeSH definition; coord Cat A or C term with /surg; electrocautery & galvanocautery = ELECTROCOAGULATION MNE2.154 LH  MSAn irregularly shaped venous space in the dura mater at either side of the sphenoid bone. MHÑCavernous Sinus ANdo not use /blood supply MNA7.231.908.224.334 LH  MSThe family of new world monkeys consisting of 11 genera and many species. They inhabit forests from Mexico to Argentina and are the largest family of South American monkeys. The genera are: ALOUATTA (howler monkey), AOTUS (night or owl monkey), Ateles (spider monkey), Brachyteles (woolly spider monkey), Cacajao (ukaris), Callicebus (titi or widow monkey), CEBUS (capuchin monkey), Chiroptes (red-backed sakis), Lagothrix (woolly monkey), Pithecia (sakis) and SAIMIRI (squirrel monkey). PM81; ALOUATTA was HOWLER MONKEYS see under MONKEYS 1975-80, AOTUS TRIVIRGATUS was NIGHT MONKEYS see under MONKEYS 1975-80; SAIMIRI was SQUIRREL MONKEYS see under MONKEYS 1975-80 HN81; ALOUATTA was HOWLER MONKEYS see under MONKEYS 1975-80; AOTUS TRIVIRGATUS was NIGHT MONKEYS see under MONKEYS 1975-80; SAIMIRI was SQUIRREL MONKEYS see under MONKEYS 1975-80 MHÑCebidae ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.370 XSAteles; Lagothrix; Monkey, Spider; Monkey, Woolly; Monkeys, New World; Platyrrhina XUÑAlouatta; ÑAotus trivirgatus; ÑCebus; ÑSaimiri LH LS; ; ; ; ; LU; ; ;  MSA genus of the family Cebidae consisting of four species which are divided into two groups, the tufted and untufted. C. apella has tufts of hair over eyes and sides of the head. The remaining species are without tufts - C. capucinus, C. nigrivaltatus, and C. albifrons. Cebus occurs in forests of Central and South America. HN(81) MHÑCebus ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIAnthropoidea (66-80) MNB2.649.801.201.370.320 XSMonkey, Capuchin; Monkey, Ring-Tail DMÑCebidae LH LS; LM  MHÑCecal Diseases ANGEN: prefer specifics; cecitis = CECAL DISEASES (IM) + INFLAMMATION (NIM) MNC6.405.469.110 LH  MHÑCecal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.476.411.184; C6.405.469.110.417 LH  MHÑCecum ANcecitis = CECAL DISEASES (IM) + INFLAMMATION (NIM) MNA3.492.411.495.209 LH  MS3-Chloro-7-D-(2-phenylglycinamido)-3-cephem- 4-carboxylic acid. Semisynthetic broad spectrum, antibiotic derivative of cephalexin proposed for oral use. Synonyms: Compound 99638; Lilly 99638. HN(80) MHÑCefaclor ANdo not use /biosyn /defic /physiol RN53994-73-3 PICephalosporins (66-79) MND20.85.99.180.200.156 DMÑCephalexin LH LM  MS7-[[Amino(4-hydroxyphenyl)acetyl]amino]-3-methyl- 8-oxo-5-thia-l-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid monohydrate. Long-acting, broad-spectrum, water-soluble, cephalexin derivative cephalosporin proposed especially for children with upper respiratory infections. Synonyms: Duricef; 4-hydroxycephalexin; Ultracef. PM84 HN84 MHÑCefadroxil ANdo not use /biosyn /defic /physiol RN50370-12-2 PICephalexin (72-74); Cephalexin/AA (75-83); Cephalosporins (66-71) MND20.85.99.180.200.162 LH  MS7-D-Mandelamido-3-[[(1-methyl-1H-tetrazol-5-yl)thio] methyl]-3-cephem-4-carboxylic acid. Semisynthetic wide spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance; used also as naftate. PM84; was see under CEPHALOSPORINS 1978-83 HN84(78); was see under CEPHALOSPORINS 1978-83 MHÑCefamandole ANdo not use /biosyn /defic /physiol RN34444-01-4 PICephalosporins (66-77) MND20.85.99.180.160 LH  MS(6R,7R)-7-[(R)-2-Amino-2-(p-hydroxyphenyl)acetamido] -8-oxo-3-[(v-triazol-4-ylthio)methyl]cephalosporanic acid. Orally active semisynthetic cephalosporin antibiotic with broad spectrum activity. Synonyms: BL S640; S 640P; SK&F 60771. HN(78) MHÑCefatrizine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN51627-14-6 PICephalosporins (66-77) MND20.85.99.180.200.162.168 DMÑCephalosporins LH LM  MS3[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[2-(1H-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Semisynthetic cephalosporin analogue with broad spectrum antibiotic action due to inhibition of bacterial cell wall synthesis; attains high serum levels and is excreted quickly via urine; side effects similar to those of other cephalosporins. Synonyms: Ancef; Cefamedin; Gramaxin; Kefzol; Totacef. PM80; was see under CEPHALOSPORINS 1975-79 HN80(75); was see under CEPHALOSPORINS 1975-79 MHÑCefazolin ANdo not use /biosyn /defic /physiol RN25953-19-9 PICephalosporins (70-74); Sulfides (73-74); Tetrazoles (73-74); Thiadiazoles (73-74) MND20.85.99.180.170 XSCephazolin LH LS  MS7-[[[((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl) amino](4-hydroxyphenyl)-acetyl]amino]-3- [((1-methyl-1H-tetrazol-5-yl)thio)methyl]-8- oxo-5-thia-azabicyclo(4.2.0)oct-2-ene-carboxylic acid monosodium. Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase; proposed especially against Pseudomonas infections. PM84 HN84 MHÑCefoperazone ANdo not use /biosyn /defic /physiol RN62893-19-0 PICephalosporins (66-83) MND20.85.99.180.160.211 LH  MS3[(Acetyloxy)methyl]-7-[((2-amino-4-thiazolyl) (methoxyimino)-acetyl)amino]-8-oxo-5-thia- 1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid. Semisynthetic broad spectrum cephalosporin proposed for Pseudomonas infections. Synonyms: HR 756; RU 24756. PM82 HN82 MHÑCefotaxime ANdo not use /biosyn /defic /physiol RN64485-93-4 PICephalosporins (66-81) MND20.85.99.180.190.223 LH  MS3-Carbamoyloxymethyl-7-alpha-methoxy-7-[2-(2-thienyl)acetamido]3-cephem-4-carboxylic acid. Semisynthetic cephamycin antibiotic resistant to beta-lactamase. Synonyms: Mefoxin; MK 306. PM80; was see under CEPHALOSPORINS 1975-79 HN80(75); was see under CEPHALOSPORINS 1975-79 MHÑCefoxitin ANdo not use /biosyn /defic /physiol RN35607-66-0 PICarbamates (74); Cephalosporins (74) MND20.85.99.180.220.180 LH  MSA pyridinium-substituted semisynthetic, broad spectrum antibacterial used especially for Pseudomonas infections in debilitated patients. PM85 HN85 MHÑCefsulodin ANdo not use /biosyn /defic /physiol RN52152-93-9 PICephalosporins (66-84) MND20.85.99.180.185 LH  MSSemisynthetic, broad spectrum antibacterial derived from cephaloridine and used especially for Pseudomonas and other Gram-negative infections in debilitated patients. PM85 HN85 MHÑCeftazidime ANdo not use /biosyn /defic /physiol RN72558-82-8 PICephalosporins (66-84) MND20.85.99.180.210.120 LH  MSBroad spectrum cephalosporin antibiotic with a very long half-life and high penetrability to usually inaccessible infections, including those involving the meninges, eyes, inner ears, and urinary tract. PM86 HN86 MHÑCeftriaxone ANdo not use /defic /physiol RN73384-59-5 PICefotaxime (82-85); Cephalosporins (66-81) MND20.85.99.180.190.223.228 LH  MS(6R,7R)-3-Carbamoyloxymethyl-7-[(2Z)-2-(2-furyl)- 2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acid. Broad spectrum cephalosporin antibiotic resistant to beta-lactamase; proposed for infections with Gram negative and Gram positive organisms, gonorrhea and haemophilus. HN(80) MHÑCefuroxime ANdo not use /biosyn /defic /physiol; /analogs NIM only RN55268-75-2 PICephalosporins (66-79) MND20.85.99.180.190.223.235 DMÑCephalosporins LH LM  MSThe arterial trunk that arises from the abdominal aorta and after a short course divides into the left gastric, common hepatic and splenic arteries. MHÑCeliac Artery ANdo not use /blood supply MNA7.231.114.207 LH  MSA disease characterized by intestinal malabsorption and precipitated by gluten-containing foods. The intestinal mucosa shows loss of villous structure. OLuse CELIAC DISEASE to search SPRUE back thru 1966 PMSPRUE was heading 1963-81 HNSPRUE was heading 1963-81 MHÑCeliac Disease ANin children or adults MNC6.405.469.637.250; C18.452.603.250 XSGluten Enteropathy; Sprue; Steatorrhea LH LS; ;  MHÑCeliac Plexus ANdo not use /innerv MNA8.99.219 XSSolar Plexus LH LS  MSAdherence of cells to surfaces or to other cells. PM72 HN72(70) MHÑCell Adhesion ANNIM; only /drug eff /rad eff; permitted with micro-organisms but BACTERIAL ADHESION is available PICytology (66-69) MNG4.335.117 LH  MSThe phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type. PM68 HN68(65) MHÑCell Aggregation ANNIM; only /drug eff /rad eff; not for micro-organisms MNG4.335.283.251 LH  MSAny of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. PM78 HN78 MHÑCell Communication ANby direct physical contact or by chemical signals; ╥cell-to-cell interaction╙ goes here; only /drug eff /rad eff; not for micro-organisms PIIntercellular Junctions (70-77) MNG4.335.122 FXÑIntercellular Junctions LH LX  MSA partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc. PM78 HN78 MHÑCell Compartmentation ANonly /drug eff /rad eff; permitted with micro-organisms MNG4.335.125 FXÑCell Nucleus; ÑOrganoids LH LX;  OLuse CELL COUNT to search CELL NUMBER back thru 1978 PM73; CELL NUMBER was heading 1978-79 HN73(69); CELL NUMBER was heading 1978-79 MHÑCell Count ANNIM; only /drug eff /instrum /methods /rad eff /vet; not for micro-organisms; cell density goes here PICytology (66-68) MNE5.909.262.195; G7.380 XSCell Number FXÑBlood Cell Count; ÑSperm Count LH LS LX;  MSThe complex series of phenomena, occurring between the end of one cell division and the end of the next, by which cellular material is divided between daughter cells. PM78; METAPHASE was see MITOSIS 1975-77 HN78 MHÑCell Cycle ANNIM specific cell when merely test cell; coord with specific cell /cytol; only /drug eff /rad eff; permitted with micro-organisms; for various phases see note on CELL DIVISION; INTERPHASE is also available: see X refs there; M phase = M PERIOD see MITOSIS PICell Division (66-77); Meiosis (68-77); Mitosis (68-77) MNG4.335.135; G5.148.165; G7.553.135 XSCytokinetics LH LS  MSProgressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialized cells, tissues, and organs. PM66 HN66(64) MHÑCell Differentiation ANNIM; only /drug eff /rad eff; cell differentiation is a normal process in morphogenesis: do not confuse with CYTOPATHOGENIC EFFECT, VIRAL or CELL TRANSFORMATION, NEOPLASTIC; the specific differentiating cell: coord CELL DIFFERENTIATION with specific cell /cytol, not /growth; not for micro-organisms MNG4.335.151; G7.553.196 FXÑEmbryo; ÑGene Expression Regulation XUÑEmbryonic Induction LH LX; LU  MSThe fission of a cell. MHÑCell Division ANNIM; only /drug eff /rad eff; coord with specific cell /cytol; permitted with micro-organisms; cell proliferation = CELL DIVISION; 1st phase = PROPHASE, 2d phase = METAPHASE, 3d phase = ANAPHASE, final phase = TELOPHASE; INTERPHASE (a stage of CELL CYCLE, not CELL DIVISION) is also available: see X refs there; M = M PERIOD see MITOSIS MNG4.335.135.220; G5.148.165.220; G7.553.135.220 XSCleavage, Cell; Cytokinesis FXÑCleavage Stage, Ovum LH LS; LX  MH*Cell Division Phases (Non Mesh) MNG4.335.135.220.225; G5.148.165.220.225; G7.553.135.220.225 LH  MSPreparations of cell constituents or subcellular materials, isolates or substances. HN(77) MHÑCell Extracts ANextracts of cells or cell fractions containing uncharacterized factors; do not confuse with chemical substances ╥extracted╙ from cells; do not use /analogs /biosyn /blood-csf-urine /defic /diag use /metab /physiol /secret; not for micro-organisms PITissue Extracts (66-76) MND24.185.893.162 DMÑTissue Extracts LH LM  PM73 HN73(71) MHÑCell Fractionation ANseparation of cell components within the cell: do not confuse with CELL SEPARATION; NIM, no qualif; when IM, only /instrum /methods; permitted with micro-organisms PICytology (66-70) MNE5.909.262.251 FXÑSUBCELLULAR FRACTIONS LH LX  MSFusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization. PM73 HN73(71) MHÑCell Fusion ANNIM; only /drug eff /rad eff; not for micro-organisms; somatic cells only: not for sperm-ovum fusion ( = fertilization) PICytology (66-70) MNE5.909.262.307; G4.335.217 FXÑHYBRID CELLS LH LX  PM72 HN72(69) MHÑCell Line ANalmost never IM; no qualif when NIM, A 11 qualif when IM; TN 183: relation to CELLS, CULTURED & TISSUE CULTURE; policy: Manual 21.57, 22.26.1 PITissue Culture (66-68) MNA11.251.210 FXÑTissue Culture LH LX  PM65 HN65(64) MHÑCell Membrane ANNIM: coord with specific cell /ultrastruct (IM); IM only if point of article irrespective of identity of cell /ultrastruct (NIM); A 11 qualif except /cytol; permitted with micro-organisms; INTRACELLULAR MEMBRANES & NUCLEAR MEMBRANE are also available MNA11.195 XSPLASMA MEMBRANE FXÑMEMBRANE POTENTIALS; ÑMembrane Fluidity; ÑMembrane Lipids; ÑMembrane Proteins; ÑMembranes; ÑOSMOTIC FRAGILITY LH LS LX; ; ; ; ;  MSA quality of cell membranes which permits the passage of solvents and solutes into and out of cells. PM65 HN65 MHÑCell Membrane Permeability ANonly /drug eff /rad eff; permitted with micro-organisms MNG4.335.250; G6.535.166.310.335 XSPERMEABILITY, CELL MEMBRANE FXÑBIOLOGICAL TRANSPORT LH LS LX  PM72 HN72(71) MHÑCell Migration Inhibition ANno qualif; leukocyte migration test goes here + LEUKOCYTES /immunol; macrophage migration test goes here + MACROPHAGES /immunol PICell Movement (68-70); Hypersensitivity, Delayed (66-70); Lymphocytes/IM (66-70); Tissue Culture (66-70) MNE1.223.495.168; E5.478.168 FXÑHypersensitivity, Delayed; ÑMacrophage Migration Inhibitory Factors LH LX;  MSThe movement of cells from one location to another. Includes movement of micro-organisms. Syn: cell migration, cell motility, cell locomotion. PM70 HN70(68) MHÑCell Movement ANNIM; only /drug eff /rad eff; for any cell, macro- or micro-organism PICytology (66-67); specific cell or tissue/CY (66-67) MNG4.335.283 XSLocomotion, Cell; Migration, Cell; Motility, Cell; Movement, Cell LH LS; ; ;  PM67 HN67(65) MHÑCell Nucleolus ANA 11 qualif except /cytol; NUCLEOLUS ORGANIZER REGION is also available MNA11.223.210 XSPLASMOSOME LH LS  MHÑCell Nucleus ANA 11 qualif except /cytol; nuclear cloning: index under CELL NUCLEUS /transpl (IM) + CLONE CELLS (IM): TN 237 MNA11.223 FXÑCell Compartmentation; ÑCytology; ÑKARYOMETRY LH LX; ;  OLconsider also CELLS /physiol or /physiol with specific cells MH*Cell Physiology (Non Mesh) MNG4.335 LH  PM74 HN74(72) MHÑCell Separation ANseparation of 2 or more cells; do not confuse with CELL FRACTIONATION; NIM, no qualif; IM, only /instrum /methods; not for micro-organisms; flow cell sorting & fluorescence-activated cell sorting: coord with FLOW CYTOMETRY MNE5.909.262.363 XSCell Isolation; Cell Segregation FXÑBlood Component Removal; ÑPlasmapheresis LH LS; LX;  MSThe span of viability of a cell. PM76; was see under CYTOLOGY 1975 HN76(71); was see under CYTOLOGY 1975 MHÑCell Survival ANNIM; only /drug eff /rad eff; cell viability goes here; erythrocyte survival = ERYTHROCYTE AGING; not for micro-organisms PICytology (66-70); specific cell (66-70) MNG4.335.316 XSCell Aging; Cell Death LH LS;  MSCell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize and kill. PM70 HN70(68) MHÑCell Transformation, Neoplastic ANonly /anal /chem ind /class /drug eff /immunol /metab /pathol /rad eff /secret /ultrastruct; do not confuse with CELL DIFFERENTIATION, a normal process in morphogenesis PINeoplasms (66-67); Neoplasms, Experimental (66-67) MNC4.805.152; C23.739.166; G4.335.349 XSNeoplastic Transformation, Cell LH LS  MSAn inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties, induced by infection with transforming virus. PM78 HN78 MHÑCell Transformation, Viral ANonly /drug eff /rad eff; ╥changes in cell divis & growth ... & cell surface properties, induced by infection with transforming virus╙: do not confuse with CYTOPATHOGENIC EFFECT, VIRAL, morphol changes in cells or tissue during virus cultivation PICell Transformation, Neoplastic (68-77); Cytopathogenic Effect, Viral (66-67); Neoplasms, Experimental (66-67) MNG4.185.515.160; G5.920.360 LH  PM67 HN67(66) MHÑCell Wall ANNIM; A 11 qualif except /cytol MNA11.195.185 FXÑMembranes LH LX  HN(67) MHÑCell-Free System ANNIM; only /drug eff /rad eff; not for micro-organisms MNA11.904.168 DMÑSubcellular Fractions LH LM  MS4-0-beta-D-Glucopyranosyl-D-glucopyranoside. A disaccharide consisting of two glucose units in beta (1-4) glycosidic linkage. Obtained from the partial hydrolysis of cellulose. HN(79) MHÑCellobiose ANdo not use /biosyn /defic /physiol; /analogs NIM only RN16462-44-5 PIDisaccharides (66-78) MND9.203.698.365.180.180; D9.203.698.629.305.200 DMÑDisaccharides LH LM  MHÑCellophane ANonly /adv eff /stand /tox RN9005-81-6 MND25.720.157.252; J1.637.118 FXÑCellulose LH LX  OLsearch CYTOLOGY 1966-71 PM72; was see under CYTOLOGY 1963-71 HN72; was see under CYTOLOGY 1963-71 MHÑCells ANGEN: avoid: /cytol is available with Cat A & B, as liver cell or hepatocyte = LIVER/cytol; TN 34: cell changes; B-cells = B-LYMPHOCYTES, T-cells = T-LYMPHOCYTES, red cells = ERYTHROCYTES, white cells = LEUKOCYTES, islet cells = ISLANDS OF LANGERHANS; cell cycle, cell stages = CELL CYCLE; cell synchronization: index under CYTOLOGICAL TECHNICS (NIM) CATALOG: form qualif = CYTOLOGY /form PICytology (66-71) MNA11 XUÑEukaryotic Cells; ÑProkaryotic Cells LH LU;  PM72 HN72 MHÑCells, Cultured ANnot for bact or other micro-organisms; almost never IM; no qualif when NIM; A 11 qualif when IM; TN 35: definition & use; TN 183: relation to tissue culture; cell density in cultures & cell culture density: coord with CELL COUNT (NIM) PITissue Culture (66-71) MNA11.251 FXÑTissue Culture LH LX  PM72 HN72(70) MHÑCellular Inclusions ANA 11 qualif except /cytol; /class permitted; not for micro-organisms PICytoplasmic Granules (66-69) MNA11.278 XSINCLUSION BODIES LH LS  MS1,4-(1,3;1,4)-beta-D-Glucan-4-glucanhydrolase. Enzyme isolated from fungi and bacteria. Catalyzes the endohydrolysis of 1,4-beta-glucosidic linkages in cellulose, lichenin and cereal beta-glucans. EC 3.2.1.4. PM77 HN77(73) MHÑCellulase ANdo not use /analogs RNEC 3.2.1.4 PIGlycoside Hydrolases (66-72) MND8.586.277.450.162 XSEndo-1,4-Beta Glucanase LH LS  OLuse CELLULITIS to search PHLEGMON back thru 1966 PMPHLEGMON was heading 1963-78 HNPHLEGMON was heading 1963-78 MHÑCellulitis AN╥inflammation of loose connective tissue╙; note online entry; ╥cellulite╙ in Amer or Eng lit is indexed under OBESITY (IM) + ADIPOSE TISSUE (IM), in French lit ╥cellulite╙ can be ╥cellulite╙ or CELLULITIS MNC1.539.181; C17.838.138; C23.205.185 XSPhlegmon LH LS  PMCELLULOSE, OXIDIZED was see under HEMOSTATICS 1963-75 MHÑCellulose ANdo not use /defic /physiol RN9004-34-6 MND9.203.698.365.180; D25.720.157 FXÑCELLOPHANE; ÑPAPER XUÑCellulose, Oxidized; ÑDEAE-Cellulose LH LX; LU;  MSPolyanhydroglucuronic Acid. A cellulose of varied carboxyl content retaining the fibrous structure; used as local hemostatic, as matrix for normal blood coagulation. Synonyms: HemoPak; Oxycel. OLsearch HEMOSTATICS 1966-74 HN(75); was see under HEMOSTATICS 1963-75 MHÑCellulose, Oxidized AND25-26 qualif RN9032-53-5 MND9.203.698.365.180.200; D19.461.270.463.252 XSAbsorbable Cellulose; Carboxycellulose; Cellulosic Acid DMÑCellulose LH LS; ; LM  PM67 HN67(65) MHÑCementation ANonly /adv eff /instrum /methods /stand MNE5.170 FXÑDENTAL CEMENTS LH LX  OLsearch ODONTOGENIC TUMORS 1966-71 HN(72); was see under ODONTOGENIC TUMOR 1975-79 MHÑCementoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) PIOdontogenic Tumors (66-71) MNC4.557.537.789.250; C5.500.499.690.250 DMÑOdontogenic Tumors LH LM  MS3,4-trans-2,2-Dimethyl-3-phenyl-4-p-(beta-pyrrolidinoethoxy)phenyl-7-methoxychroman. A non-steroidal anti-fertility agent with anti-hormonal properties. HN(75) MHÑCentchroman ANdo not use /biosyn /defic /physiol; /analogs NIM only RN31477-60-8 PIBenzopyrans (74); Phenyl Ethers (74); Pyrrolidines (74) MND3.438.150.240.225; D6.347.300.230; D7.360.276.310.360.230 DMÑBenzopyrans LH LM  MSAn agency of the Public Health Service which conducts and supports programs for the prevention and control of disease, and provides consultation and assistance to health departments and other countries. OLuse CENTERS FOR DISEASE CONTROL (U.S.) to search CENTER FOR DISEASE CONTROL & UNITED STATES CENTER FOR DISEASE CONTROL back thru 1978 PM83; was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81 HN83; was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81 MHÑCenters for Disease Control (U.S.) ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: CDC CATALOG: use NAF entry MNN3.540.427.300.425.80 XSUnited States Centers for Disease Control XUÑNational Institute for Occupational Safety and Health LH LS LU  MHÑCentral African Republic MNZ1.58.100.211 LH  MHÑCentral America MNZ1.107.169 LH  MHÑCentral Nervous System ANtext must discuss both brain & spinal cord; prefer BRAIN or SPINAL CORD; neural tube: index CENTRAL NERVOUS SYSTEM /embryol; ╥CNS effects╙ or ╥central effects╙ of drugs in texts usually means BRAIN /drug eff, not CNS /drug eff; /drug eff: consider terms in D14 & D15; CNS stimulants = ANALEPTICS MNA8.186 XUÑOlfactory Pathways LH LU  MSAgents acting on the central nervous system; those agents that affect the mood and possibly behavior are psychotropics and agents, that increase the electrical activity of the nervous system are analeptics; they are chemically and pharmacologically unrelated. OLconsider also CENTRAL NERVOUS SYSTEM /DE & BRAIN /DE PM79 HN79; was NON MESH before 1979 MHÑCentral Nervous System Agents ANdo not use /analogs /biosyn /defic /physiol; DF: CNS AGENTS MND15 LH  MSAgents that depress the electrical activity of the central nervous system or any of its subdivisions. These do not cause psychological or mood depression. OLconsider also CENTRAL NERVOUS SYSTEM /DE + DEPRESSION, CHEMICAL or BRAIN /DE + DEPRESSION, CHEMICAL PM79 HN79; was NON MESH before 1979 MHÑCentral Nervous System Depressants ANdo not use /analogs /biosyn /defic /physiol; DF: CNS DEPRESS MND14 LH  MHÑCentral Nervous System Diseases ANtext must discuss both brain & spinal cord diseases; prefer specifics; DF: CNS DIS MNC10.228 XUÑHigh Pressure Nervous Syndrome LH LU  OL╥central nervous system infections╙ is indexed CENTRAL NERVOUS SYSTEM DISEASES + specific infection term MH*Central Nervous System Infections (Non Mesh) MNC10.228.228 LH  MSHospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment. OLuse CENTRAL SUPPLY, HOSPITAL to search HOSPITAL CENTRAL SUPPLY back thru 1968 PM78; was HOSPITAL CENTRAL SUPPLY 1968-77 HN78; was HOSPITAL CENTRAL SUPPLY 1968-77 MHÑCentral Supply, Hospital ANonly /econ /man /organ /stand /trends /util; do not confuse with CENTRALIZED HOSPITAL SERVICES MNN2.278.354.422.260; N4.452.442.422.260 XSHospital Central Supply LH LS  PM70 HN70 MHÑCentral Venous Pressure ANonly /drug eff /rad eff PIBlood Pressure (66-69); Veins (66-69) MNG9.330.612.114.732.336 XSVENOUS PRESSURE, CENTRAL LH LS  MSThe coordination of services in one area of a facility to improve efficiency. HN(Aug 77) MHÑCentralized Hospital Services ANonly /econ /hist /legis /man /organ /stand /trends /util; do not confuse with CENTRAL SUPPLY, HOSPITAL MNN2.278.354.110; N4.452.442.110 XSHospital Services, Centralized DMÑHospital Administration LH LS LM  MHÑCentrifugation ANNIM; only /instrum /methods MNE5.181 FXÑROTATION LH LX  PM68 HN68(66) MHÑCentrifugation, Density Gradient ANNIM; only /instrum /methods; index sucrose density gradient centrif here but ignore SUCROSE MNE5.181.724.336; E5.196.941.336; H1.181.278.938.336 XUÑCentrifugation, Isopycnic LH LU  OLsearch CENTRIFUGATION, DENSITY GRADIENT 1968-74 HN(75) MHÑCentrifugation, Isopycnic ANNIM; only /instrum /methods MNE5.181.724.336.253; E5.196.941.336.253; H1.181.278.938.336.253 DMÑCentrifugation, Density Gradient LH LM  PM68 HN68(66) MHÑCentrifugation, Zonal ANNIM; only /instrum /methods MNE5.181.724.336.336; E5.196.941.336.419; H1.181.278.938.336.419 LH  MSSelf-replicating, short, fibrous, rod-shaped organelles. Each centriole is a short cylinder containing nine pairs of peripheral microtubules, arranged so as to form the wall of the cylinder. PM85; was see under ORGANOIDS 1979-84 HN85(79); was see under ORGANOIDS 1979-84 MHÑCentrioles ANA 11 qualif except /cytol PIMitosis (68-78); Organoids (66-78) MNA11.368.702.130 LH  MSThe clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. HN(78) MHÑCentromere ANA 11 qualif except /cytol PIChromosomes (66-77) MNA11.223.475.135 DMÑChromosomes LH LM  HN(65); was see under ACETIC ACIDS 1968-74 MHÑCentrophenoxine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3685-84-5 MND2.241.511.316.169; D15.128.185 XSMeclofenoxate DMÑGlycolates LH LS LM  MSSodium 7-(2-cyanoacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.O]oct-2-ene-2-carboxylate acetate (ester). Derivative of 7-aminocephalosporanic acid. Synonyms:BA 36278A; Celospor. HN(75) MHÑCephacetrile ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23239-41-0 PIAcetamides (73-74); Cephalosporins (73-74); Nitriles (73-74) MND20.85.99.180.190 XSCefacetrile DMÑCephalosporins LH LS LM  PM73 HN73(72) MHÑCephalexin ANdo not use /biosyn /defic /physiol RN15686-71-2 PICephalosporins (66-71) MND20.85.99.180.200 XUÑCefaclor LH LU  PM73 HN73(72) MHÑCephaloglycin ANdo not use /biosyn /defic /physiol RN3577-01-3 MND20.85.99.180.200.181 LH  PM65 HN65 MHÑCephalometry ANliving skull only; for dead skull, use CRANIOMETRY; do not restrict to radiogr cephalometry & do not restrict to dental; NIM; only /instrum /methods MNE1.706.273; E5.118.364 FXÑAnthropometry; ÑCRANIOLOGY; ÑMaxillofacial Development LH LX; ;  PM68 HN68(66) MHÑCephaloridine ANdo not use /biosyn /defic /physiol RN50-59-9 MND20.85.99.180.210 LH  OLsearch AMIDOHYDROLASES 1968-74 HN(75); was see under AMIDOHYDROLASES 1968-78 MHÑCephalosporinase ANdo not use /analogs RNEC 3.5.2.6 MND8.586.277.87.180.229 XSbeta-Lactamase II DMÑBeta-Lactamases LH LS LM  MSA group of broad spectrum antibiotics first isolated from the Mediterranean fungus Acremonium (Cephalosporium acremonium); they contain the beta-lactam moiety thia-azabicyclo-octene-carboxylic acid also called 7-aminocephalosporanic acid. PM66 HN66(65) MHÑCephalosporins ANdo not use /analogs /defic /physiol MND20.85.99.180 XUÑCefatrizine; ÑCefuroxime; ÑCephacetrile; ÑCephapirin; ÑCephradine LH LU; ; ; ;  PM66 HN66(63) MHÑCephalothin ANdo not use /biosyn /defic /physiol RN153-61-7 MND20.85.99.180.190.243 XSCefalotin; Sodium Cephalothin LH LS;  MSNaturally produced family of beta-lactam cephalosporin-type antibiotics having 7-methoxy group and posessing marked resistance to action of beta-lactamases from gram-positive and gram-negative organisms. PM84; was see under CEPHALOSPORINS 1975-83 HN84(75); was see under CEPHALOSPORINS 1975-83 MHÑCephamycins ANdo not use /analogs /defic /physiol PICephalosporins (74); Methyl Ethers (74) MND20.85.99.180.220 LH  MS7-[alpha-(4-Pyridylthio)-acetamido]cephalosporanic acid sodium salt. Cephalosporin antibiotic, partly plasma bound. HN(75) MHÑCephapirin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN21593-23-7 PIAcetamides (72-74); Cephalosporins (72-74); Pyridines (72-74); Sulfides (72-74) MND20.85.99.180.190.259 DMÑCephalosporins LH LM  MS7-[D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido]-3-methyl-8-oxo-5-thia-l-aza-bicyclo[4.2.O]octo-2-ene-2-carboxylic acid monohydrate. An antibiotic. HN(75) MHÑCephradine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN38821-53-3 PICephalosporins (72-74); Cyclohexane (72-74) MND20.85.99.180.200.193 DMÑCephalosporins LH LM  PM73 HN73(67) MHÑCeramics ANonly /adv eff /anal /class /hist /stand /supply PIChemical Industry (66); Dental Materials (66); Minerals (66) MND25.264; J1.637.153 LH  MSD-Galactosyl-D-galactosyl-D-glucosylceramide galactohydrolase. Catalyzes the hydrolysis of a ceramidetrihexoside to a ceramidedihexoside plus galactose. HN(75) MHÑCeramide Trihexosidase ANdo not use /analogs RNEC 3.2.1.47 PIGalactosidase (72-74); Cerebrosides (72-74) MND8.586.277.450.410.150 XSGalactosylgalactosylglucosylceramidase DMÑGalactosidases LH LS LM  PM72 HN72 MHÑCeramides ANdo not use /analogs; carbohydrate ceramides: index under CEREBROSIDES (one carbohydrate group) or GLYCOSPHINGOLIPIDS (more than one carbohydrate group) PIAmino Alcohols (66-71); Fatty Acids (66-71); Glycols (66-71) MND10.516.808.187 LH  MSA family of the order Diptera. Includes the insect vector Culicoides which transmits filarial parasites pathogenic to man and other primates. OLuse CERATOPOGONIDAE to search CULICOIDES back thru 1966; search MIDGES under DIPTERA 1975-80 PM81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80 HN81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80 MHÑCeratopogonidae ANgnats: do not confuse CULICOIDES with CULEX, mosquito; do not use /drug eff with insecticides: TN 111; /microbiol /parasitol permitted; gall midges: index under DIPTERA MNB1.131.617.289.208 XSCulicoides; Leptoconops; Midges, Biting LH LS; ;  MSThe family of old world monkeys and baboons consisting of 14 genera and many species. They occur in Africa and part of Asia. The genera are: MACACA (macaques), Cercocebus (mangabeys), PAPIO (baboons, hamadryas, mandrills and drills), THEROPITHECUS (gelada baboon), Cercopithecus Miopithecus (talapoin monkey), Allenopithecus (Allen's monkey), ERYTHEROCEBUS PATAS (patas monkey), Presbytis (langur), Pygathrix (douc langur), Rhinopithecus, Simias, Nasalis (proboscis monkey) and COLOBUS (colobus monkey). PM81; COLOBUS was see under MONKEYS 1975-80; PATAS MONKEYS was see under MONKEYS 1975-80; ERYTHROCEBUS was PATAS MONKEYS see under MONKEYS 1975-80; THEROPITHECUS GELADA was GELADA see under MONKEYS 1975-80 HN81 MHÑCercopithecidae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; mangabeys go here MNB2.649.801.201.468 XSCatarrhina; Langurs; Miopithecus talapoin; Monkey, Talapoin; Monkeys, Old World; Presbytis; Pygathrix XUÑColobus; ÑErythrocebus patas; ÑTheropithecus gelada LH LS; ; ; ; ; ; LU; ;  MSA genus of Old World monkeys found in Africa although some species have been introduced into the WEst Indies. PM75 HN75 MHÑCercopithecus ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIMonkeys (66-74) MNB2.649.801.201.468.480 XUÑCercopithecus aethiops LH LU  MSA species of Cercopithecus containing three subspecies--aethiops, pygerythrus and sabeus. They occur in the forests and savannahs of Africa. OLuse CERCOPITHECUS AETHIOPS to search CERCOPITHECUS PYGERYTHRUS & CERCOPITHECUS SABEUS back thru 1975 HN(81); CERCOPITHECUS PYGERYTHRUS & CERCOPITHECUS SABEUS were see under CERCOPITHECUS 1975-80 MHÑCercopithecus aethiops ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.468.480.110 XSCercopithecus pygerythrus; Cercopithecus sabeus; Monkey, African Green; Monkey, Green; Monkey, Grivet DMÑCercopithecus LH LS; ; ; ; LM  MSThose grasses, family Graminea, that yield edible seeds; the food grains. OLuse CEREALS to search GRAIN, MALT & OATS back thru 1966 PMGRAIN & MALT were headings 1963-84; BARLEY, MILLET, OATS & RYE were see under GRAIN 1963-84 HNGRAIN & MALT were headings 1963-84; OATS was see under GRAIN 1963-84 MHÑCereals ANthe plant, seed or grain; do not restrict to processed grain or cereals such as breakfast food; only /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNB6.510.253; J1.341.182 XSGrain; Malt; Oats XUÑBarley; ÑMillet; ÑRye LH LS; ; LU; ;  PM68 HN68 MHÑCerebellar Ataxia ANdentate cerebellar ataxia = CEREBELLAR DYSSYNERGIA; do not use /familial ( = SPINOCEREBELLAR DEGENERATIONS) PIAtaxia (66-67); Cerebellar Diseases (66-67) MNC10.228.140.252.253 XSATAXIA, CEREBELLAR XUÑCerebellar Dyssynergia LH LS LU  MHÑCerebellar Cortex ANdo not use /innerv MNA8.186.211.212.212 LH  MHÑCerebellar Diseases ANGEN: prefer specifics MNC10.228.140.252 LH  HN(70) MHÑCerebellar Dyssynergia ANdentate cerebellar ataxia PICerebellar Diseases (66-69) MNC10.228.140.252.253.871.337 XSRamsay Hunt Syndrome DMÑCerebellar Ataxia LH LS LM  MHÑCerebellar Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.614.195.254; C10.228.140.211.254; C10.228.140.252.420 LH  PM71 HN71 MHÑCerebellar Nuclei ANdo not use /innerv; n. emboliformis, fastigii & globosus go here PICerebellum (66-70) MNA8.186.211.212.337 LH  MHÑCerebellopontile Angle ANdo not use /innerv; diseases: coord IM with CEREBELLAR DISEASES (NIM); neopl: coord (IM) with CEREBELLAR NEOPLASMS (IM) + histol type of neopl (IM) MNA8.186.211.212.462 LH  MHÑCerebellum ANdo not use /innerv; cerebellar artery = CEREBELLUM /blood supply (IM) + ARTERIES (NIM) MNA8.186.211.212 LH  MSA saccular aneurysm of a cerebral artery, usually at the junction of vessels in the circle of Willis, having a narrow opening into the artery. OLuse CEREBRAL ANEURYSM to search BERRY ANEURYSM back thru 1969 HNBERRY ANEURYSM was see under CEREBRAL ANEURYSM 1969-78 MHÑCerebral Aneurysm ANcongen cerebral arteriovenous aneurysm = CEREBRAL ARTERIOVENOUS MALFORMATIONS MNC10.228.140.300.170; C14.907.55.387; C14.907.253.170 XSBerry Aneurysm; INTRACRANIAL ANEURYSM LH LS;  MSRadiography of the vascular system of the brain after injection of a contrast medium. MHÑCerebral Angiography ANNIM; do not use /util except by MeSH definition MNE1.145.77.300; E1.236.257.170; E1.236.688.187; E1.818.84.300; E1.818.573.187 LH  MHÑCerebral Anoxia MNC10.228.140.300.212; C14.907.253.212 LH  PM71 HN71 MHÑCerebral Aqueduct ANdo not use /innerv PICerebral Ventricles (66-70) MNA8.186.211.276.187 XSAQUEDUCT OF SYLVIUS LH LS  MSThe arteries supplying the cerebral cortex. MHÑCerebral Arteries ANfor cerebral arteries in general or unspecified or for specific cerebral arteries not in MeSH or as coord (IM) for arteries of specific parts of brain indented under CEREBRAL CORTEX in tree (IM); not as coord for non-cerebrum parts of the brain, as cerebellar artery ( = CEREBELLUM /blood supply (IM) + ARTERIES (NIM), not CEREBRAL ARTERIES); do not use /blood supply; /abnorm: consider also CEREBRAL ARTERIOVENOUS MALFORMATIONS; /radiogr = CEREBRAL ANGIOGRAPHY MNA7.231.114.228 LH  MHÑCerebral Arteriosclerosis MNC10.228.140.300.254; C14.907.137.126.372; C14.907.253.254 LH  PM73 HN73 MHÑCerebral Arteriovenous Malformations ANdo not use /congen PIArteriovenous Fistula/CN (66-72); Cerebrovascular Disorders (66-72) MNC10.228.140.300.295; C14.907.253.295; C16.131.150.338 XSAneurysm, Arteriovenous, Congenital, Cerebral; Arteriovenous Aneurysm, Congenital, Cerebral; Arteriovenous Malformations, Cerebral; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS LH LS; ; ;  MHÑCerebral Artery Diseases ANGEN: prefer specifics; see note under CEREBRAL ARTERIES for scope of ╥cerebral arteries╙ MNC10.228.140.300.337; C14.907.253.337 LH  MSThe this layer of grey matter on the surface of the cerebral hemisphere that develops from the telencephalon and folds into gyri. It reaches its highest development in man and is responsible for intellectual faculties and higher mental functions. OLuse CEREBRAL CORTEX to search INSULA OF REIL back thru 1968 HNINSULA OF REIL was see under CEREBRAL CORTEX 1968-78 MHÑCerebral Cortex ANdo not use /innerv; /surg: probably CEREBRAL DECORTICATION MNA8.186.211.885.213 XSInsula of Reil FXÑELECTROENCEPHALOGRAPHY; ÑSPREADING CORTICAL DEPRESSION LH LS LX;  MSPartial or total removal, ablation, or destruction of the cerebral cortex; may be chemical; do not use with animals that do not possess a cortex, i.e., use only with mammals. OLuse CEREBRAL DECORTICATION to search CEREBRAL CORTEX DECORTICATION back thru 1966 PM82; was CEREBRAL CORTEX DECORTICATION 1965-81 HN82; was CEREBRAL CORTEX DECORTICATION 1965-81 MHÑCerebral Decortication AN╥partial or total removal, ablation or destruction of the cerebral cortex; may be chemical╙; usually exper; coord IM or NIM with specific part of brain with probably /physiol (IM) MNE4.530.138 LH  MHÑCerebral Embolism and Thrombosis ANDF: CEREBRAL EMBOLISM MNC10.228.140.300.378; C14.907.253.378; C14.907.854.213 XUÑWallenberg's Syndrome LH LU  MHÑCerebral Hemorrhage MNC10.228.140.300.420; C14.907.253.420; C23.542.115 XSHEMORRHAGE, CEREBRAL LH LS  MSInfarction of brain tissue. PM79 HN79 MHÑCerebral Infarction ANDF: CEREBRAL INFARCT PIBrain (66-78); Cerebral Embolism and Thrombosis (66-78); Infarction (66-78) MNC10.228.140.300.449; C14.907.253.449 LH  MSDeficiency in blood supply to the brain. PM79 HN79 MHÑCerebral Ischemia ANclin or exper; note CEREBRAL ISCHEMIA, TRANSIENT below; do not confuse with CEREBRAL ANOXIA PIBrain/BS (66-78); Cerebrovascular Disorders (66-78); Ischemia (66-78) MNC10.228.140.300.459; C14.907.253.459 LH  MSNonconvulsive, reversible, focal neurologic deficits lasting minutes up to about 24 hours, resulting mainly from arteriosclerosis, emboli or hypertensive episodes. Also known as transient ischemic attacks (TIA). MHÑCerebral Ischemia, Transient ANclin or exper; ╥nonconvulsive, reversible, focal╙, lasting from a few minutes up to 24 hrs; note 2d X ref also called TIA MNC10.228.140.300.459.278; C14.907.253.459.278 XSCEREBRAL VASOSPASM; Transient Ischemic Attack LH LS;  OLsearch PARALYSIS, SPASTIC under MUSCLE SPASTICITY 1966-78 PMPARALYSIS, SPASTIC was heading 1963-78 HNPARALYSIS, SPASTIC was heading 1963-78 MHÑCerebral Palsy ANspasticity in cerebral palsy: do not index under MUSCLE SPASTICITY unless especially discussed & then only NIM MNC10.228.140.140.254 XSLITTLE'S DISEASE LH LS  MSMicrosurgical revascularization to improve intracranial circulation. Usually involves joining the extracranial circulation to the intracranial circulation but may include extracranial revascularization (e.g., subclavian-vertebral artery bypass, subclavian-external carotid artery bypass). Performed by joining two arteries (direct anastomosis or use of graft) or free autologous transplantation of highly vascularized tissue to the surface of the brain. PM80 HN80 MHÑCerebral Revascularization ANdo not use /util except by MeSH definition PIArterial Occlusive Diseases/SU (73-79); Brain/BS (66-79); Cerebral Arteries/SU (66-79); Cerebrovascular Circulation (66-79); Cerebrovascular Disorders/SU (66-79); specific cerebrovascular disorder/SU (66-79); Temporal Arteries/SU (66-79) MNE4.494.150; E4.752.814.300 XSBrain Revascularization; EC-IC Arterial Bypass; Extracranial-Intracranial Arterial Bypass; Microsurgical Revascularization, Cerebral; STA-MCA Bypass LH LS; ; ; ;  OLuse CEREBRAL SCLEROSIS, DIFFUSE to search PELIZAEUS-MERZBACHER DISEASE back thru 1966 HNPELIZAEUS-MERZBACHER DISEASE was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-78 MHÑCerebral Sclerosis, Diffuse MNC10.228.140.276; C10.228.337.144 XSPelizaeus-Merzbacher Disease XUÑAdrenoleukodystrophy LH LS LU  MSVeins draining the cerebrum. PM87 HN87 MHÑCerebral Veins ANdo not use /blood supply MNA7.231.908.155 XSBasal Vein; Pial Vein; Sylvian Vein; Thalamostriate Vein; Vein of Galen LH LS; ; ; ;  MHÑCerebral Ventricle Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.614.195.421; C10.228.140.211.421 LH  MHÑCerebral Ventricles ANdo not use /innerv; /radiogr = VENTRICULOGRAPHY, CEREBRAL; ventriculitis: coord IM with ENCEPHALITIS (IM) MNA8.186.211.276 XSForamen of Monro FXÑInjections, Intraventricular LH LS LX  MSCerebroside-3-sulfate-3-sulfohydrolase. Catalyzes the hydrolysis of cerebroside 3-sulfate (sulfatide) to yield a cerebroside and inorganic sulfate. A marked deficiency of arylsulfatase A, which is considered the heat-labile component of cerebroside sulfatase, has been demonstrated in all forms of metachromatic leukodystrophy. PM87; was see under SULFATASES 1976-86 HN87(76); was see under SULFATASES 1976-86 MHÑCerebroside Sulfatase ANdo not use /analogs RNEC 3.1.6.8 PIArylsulfatases (75); Sulfatases (72-74) MND8.586.277.352.827.70.250 XSArylsulfatase A; Sulfatidate Sulfatase LH LS;  MHÑCerebrosides ANdo not use /analogs /defic MND10.516.390.470.213; D10.516.808.530.288 XUÑGalactosylceramides; ÑGlucosylceramides LH LU;  MHÑCerebrospinal Fluid ANIM as substance only: only /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; with diseases & drugs, use /csf as qualif: Manual 19.5+, 19.4.11; csf production = /physiol, not secret; csf pressure = INTRACRANIAL PRESSURE MNA12.207.268 FXÑBLOOD-BRAIN BARRIER LH LX  MHÑCerebrospinal Fluid Proteins ANIM & coord with specific protein /csf (IM); do not use /analogs /defic MND12.776.178 LH  PM72 HN72(69) MHÑCerebrospinal Fluid Shunts ANdo not use /util except by MeSH definition; NIM destination of shunt PICerebral Ventricles (66-68); Hydrocephalus/SU (66-68) MNE4.530.188 LH  MHÑCerebrospinal Otorrhea MNC9.218.151; C21.866.460.254 LH  MHÑCerebrospinal Rhinorrhea MNC9.603.138; C21.866.460.337 LH  MSThe circulation of blood through the vessels of the brain. PM64 HN64 MHÑCerebrovascular Circulation ANconsider also BRAIN /blood supply; only /drug eff /rad eff MNG9.330.163.159 LH  MHÑCerebrovascular Disorders ANGEN; note X ref APOPLEXY but PITUITARY APOPLEXY is available CATALOG: /radiogr /radionuclide /surg permitted MNC10.228.140.300; C14.907.253 XSApoplexy; Stroke LH LS;  MSA series of actions, sometimes symbolic actions which may be associated with a behavior pattern, and are often indispensable to its performance. PM68 HN68 MHÑCeremonial ANhuman & animal; no qualif PIAnthropology (66-67); Behavior, Animal (66-67); Culture (66-67); Sex Behavior (66-67) MNF1.145.161; I1.76.201.450.172 FXÑAPPETITIVE BEHAVIOR LH LX  MHÑCerium ANCe-140; do not use /analogs /biosyn /defic /physiol RN7440-45-1 MND1.268.167; D1.552.550.120 LH  MHÑCerium Isotopes ANCe-136, 138, 142; NIM; no qualif MND1.496.156; D1.552.550.120.339 LH  MSUnstable isotopes of cerium that decay or disintegrate spontaneously emitting radiation. Ce 131-135, 137-139 and 141-148 are radioactive isotopes of cerium. OLsearch CERIUM ISOTOPES 1966-74 PM75 HN75 MHÑCerium Radioisotopes ANCe-132-135, 137, 139, 141, 143-148; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PICerium (66-74); Isotopes (66-74); Radioisotopes (66-74) MND1.496.156.300; D1.496.749.185; D1.552.550.120.400 LH  MSA naturally occurring lipid pigment with histochemical characteristics similar to lipofuscin. It accumulates in various tissues in certain experimental and pathological conditions. HN(75) MHÑCeroid ANdo not use /defic /physiol; /analogs NIM only PIPigments (70-74) MND10.516.150; D11.557.300 DMÑPigments LH LM  MSA certificate issued by a governmental body to an individual or organization proposing to construct or modify a health facility, or to offer a new or different service. The process of issuing the certificate is also included. HN(Aug 77) MHÑCertificate of Need ANregional or area needs, not personal or financial need; only /econ /legis /stand /trends; specify geog CATALOG: /geog /form MNN3.349.650.120 XSNeed Certification, Health Care DMÑRegional Health Planning LH LS LM  MSCompliance with a set of standards defined by non-governmental organizations; certification is applied for by individuals on a voluntary basis and represents a professional status when achieved; e.g., certification for a medical specialty. PM68 HN68 MHÑCertification ANonly /class /econ /hist /legis /stand /trends; by the profession; certif by various bds can go here but consider also LICENSURE; note SPECIALTY BOARDS is available; coord IM with specialty or discipline (IM); specify geog PIAccreditation (66-67) MNN3.706.110.120 XUÑSpecialty Boards LH LU  MS2,3-Epoxy-4-oxo-7,10-dodecadionamide. Antifungal antibiotic from several species, including Acremonium (Cephalosporium), Acrocylindrum, and Helicoceras; inhibits the biosynthesis of several lipids by interfering with enzyme function; used as biochemical tool. HN(75) MHÑCerulenin ANdo not use /defic /physiol; /analogs NIM only; do not confuse with CERULEIN see CAERULEIN RN17397-89-6 PIAntibiotics, Antifungal (73-74); Ethers, Cyclic (73-74); Fatty Acids, Unsaturated (74) MND2.241.81.436.200; D20.85.62.320 DMÑAntibiotics, Antifungal LH LM  MHÑCeruloplasmin ANdo not use /blood RNEC 1.16.3.1 MND8.586.682.226; D12.776.124.50.130; D12.776.124.790.106.214; D12.776.157.160; D12.776.377.715.85.214; D12.776.556.151 FXÑCopper LH LX  MHÑCerumen ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.838.147 FXÑEar Canal; ÑWaxes LH LX;  MHÑCervical Plexus ANdo not use /innerv MNA8.796.828.289 LH  OLsearch SCALENUS ANTICUS SYNDROME 1966-74 HN(75); was see under SCALENUS ANTICUS SYNDROME 1963-82 MHÑCervical Rib Syndrome MNC10.772.491.915.339 DMÑThoracic Outlet Syndrome LH LM  MHÑCervical Vertebrae ANdo not use as site to locate intraspinal inject or spinal cord inj: restrict to cerv vert as the bones themselves; inflammation = CERVICAL VERTEBRAE (IM) + SPONDYLITIS (IM) MNA2.835.232.834.151 LH  MHÑCervicitis MNC13.371.852.150.150 LH  PM65 HN65 MHÑCervico-Brachial Neuralgia MNC10.772.537.289 LH  PM66 HN66 MHÑCervix Diseases ANinflamm dis = CERVICITIS MNC13.371.852.150 LH  MSA spectrum of histologic changes in the epithelium of the cervix uteri which may begin as a superficial lesion and progress to invasive carcinoma. PM84; was see under CERVIX NEOPLASMS 1977-83 HN84(77); was see under CERVIX NEOPLASMS 1977-83 MHÑCervix Dysplasia AN/anal /blood supply /secret /ultrastruct permitted PICervix Diseases (66-76); Cervix Neoplasms (66-76) MNC4.588.945.418.948.170.170; C4.834.160; C13.371.852.150.190 LH  MHÑCervix Erosion MNC13.371.852.150.220 LH  MHÑCervix Hypertrophy MNC13.371.852.150.250 LH  MSHabitual abortion in which painless bloodless dilatation of the cervix in the second trimester of pregnancy is followed by rupture of membranes and expulsion of a fetus so immature that it usually dies. PM73 HN73 MHÑCervix Incompetence ANcheck tags FEMALE & PREGNANCY PIAbortion, Habitual (66-72); Cervix Diseases (66-72) MNC13.371.852.150.280; C13.703.39.89.339 LH  MHÑCervix Mucus ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; ╥fern test╙ & ╥palm-leaf reaction╙ go here MNA12.838.503.339 LH  MHÑCervix Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945.418.948.170; C13.371.852.150.310 LH  MHÑCervix Uteri ANinflammation = CERVICITIS MNA5.360.319.679.256 LH  MSExtraction of the fetus by means of abdominal hysterotomy. MHÑCesarean Section ANdo not use /util except by MeSH definition; check the tags FEMALE & PREGNANCY; repeat cesareans: coord IM with REOPERATION (NIM); anesthesia in cesareans: coord IM with ANESTHESIA, OBSTETRICAL (IM) MNE4.819.774.457.145 XSDelivery, Abdominal LH LS  MHÑCesium ANCs-133; do not use /analogs /biosyn /defic /physiol RN7440-46-2 MND1.248.497.300.459.134; D1.268.173; D1.552.528.160 LH  MHÑCesium Isotopes ANNIM; no qualif MND1.496.180; D1.552.528.160.340 LH  MSUnstable isotopes of cesium that decay or disintegrate spontaneously emitting radiation. Cs 123, 125-132 and 134-145 are radioactive isotopes of cesium. OLsearch CESIUM ISOTOPES 1966-74 PM75 HN75 MHÑCesium Radioisotopes ANCs-123,125-32,134-144; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PICesium Isotopes (66-74); Radioisotopes (66-74) MND1.496.180.300; D1.496.749.190; D1.552.528.160.400 LH  MSA subclass of segmented worms comprising the tapeworms. OLuse CESTODA to search RAILLIETINA back thru 1966 PM65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1979-85, was indexed under CESTODA 1975-78 HN65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1978-85 MHÑCestoda ANGEN; IM; do not use /blood-csf-urine; infection = CESTODE INFECTIONS; /drug eff: consider also ANTICESTODAL AGENTS MNB1.500.736.215 XSRaillietina; TAPEWORMS XUÑMesocestoides; ÑSpirometra LH LS; LU;  OLuse CESTODE INFECTIONS to search CENURIASIS, DIPYLIDIASIS & RAILLIETINIASIS back thru 1968 PM65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS & RAILLIETINIASIS were headings 1968-85 HN65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS & RAILLIETINIASIS were headings 1968-85 MHÑCestode Infections ANGEN only; prefer specifics; /drug ther: consider also ANTICESTODAL AGENTS MNC3.335.190 XSBertielliasis; Cenuriasis; Coenuriasis; Dipylidiasis; Raillietiniasis; Tapeworm Infection LH LS; ; ; ; ;  MHÑCetacea ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.189 XUÑWhales LH LU  MSalpha-Hexadecyl-omega-hydroxypoly(oxy-1,2-ethanediyl). Non-ionic surfactant of the polyethylene glycol family; used as solubilizer and emulsifying agent in foods, cosmetics and pharmaceuticals, often as an ointment base; also as a research tool. Synonyms: Brij 52; Brij 56; Brij 58; Lubrol W. HN(75) MHÑCetomacrogol AND25-26 qualif; /analogs NIM only RN9004-95-9 PIPolyethylene Glycols (74) MND2.33.618.690.200; D25.720.741.250; D26.866.762.171 XSPolyethylene Glycol Cetyl Ether DMÑPolyethylene Glycols LH LS LM  MSCetyltrimethylammonium compounds which have cationic detergent, antiseptic and disinfectant activities; used in pharmaceuticals, foods and cosmetics as a preservative; on skin, mucous membranes, etc., as an antiseptic or a cleanser; also as an emulsifier; toxic orally due to neuromuscular blockade. Synonyms: Bromat; Cetab; Cetavlon; Cetylamine; Gomaxine; Lissolamine; Micol; Quamonium; Seboderm. HN(75) MHÑCetrimonium Compounds AND25-26 qualif; do not use /analogs; DF: CETRIMONIUM CPDS PIAmmonium Compounds (68-74); Alkanes (72-74) MND2.92.102.190; D2.675.276.190; D20.187.137; D26.866.265.190 XSCetrimides; Cetyltrimethylammonium Compounds DMÑAmmonium Compounds LH LS; LM  MS1-Hexadecylpyridinium, as bromide, chloride or other salt. Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; also as a mouthwash and lozenges. Synonyms: Biosept; Ceepryn; Cepacol; Cetamium; Dobendan; Germidin; Pristacin; Pyrisept. HN(72) MHÑCetylpyridinium AN= Cepacol; do not use /biosyn /defic /physiol; /analogs NIM only RN7773-52-6 PIAnti-Infective Agents, Local (66-71); Pyridinium Compounds (68-71); Surface-Active Agents (66-71) MND3.383.725.762.232; D20.187.145; D26.866.265.200 DMÑPyridinium Compounds LH LM  PM69 HN69 MHÑCevanes ANdo not use /analogs /biosyn /defic /physiol PIVeratrum (66-68) MND3.132.920.256; D3.549.256 XUÑGermine Acetates LH LU  MHÑChad MNZ1.58.100.340 LH  MSA genus of ascomycetous fungi of the family Chaetomiaceae, order Sordariales including several that are destructive to paper, plastics, and other materials. HN(75) MHÑChaetomium ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.150 DMÑAscomycetes LH LM  MSCardiomyopathy with conduction defects and cardiac enlargement characteristic of the last phase of South American trypanosomiasis. PM81 HN81 MHÑChagas Cardiomyopathy ANcoord IM with specific heart disease (NIM) PIHeart Diseases (66-80); specific heart disease; Trypanosomiasis, South American (66-80) MNC3.752.935.885.190; C14.280.600.190 XSCardiomyopathy, Chagas; Trypanosomiasis, Cardiovascular LH LS;  MS1,3-Diphenyl-2-propen-1-one. HN(75) MHÑChalcone ANdo not use /biosyn /defic /physiol; /analogs NIM only; do not confuse with CHALONES RN94-41-7 PIAlkenes (73-74); Propiophenones (69-74) MND2.522.818.220 XSBenzalacetophenone; Benzylideneacetophenone DMÑPropiophenones LH LS; LM  PM72 HN72(69) MHÑChalones ANdo not use /analogs; do not confuse with CHALCONE PIGlycoproteins (66-68); Mitosis (68) MND11.303.290; D24.185.348.340 LH  MSThe primary sore of syphilis, a painless indurated, eroded papule, occurring at the site of entry of the infection. OLsearch SYPHILIS 1966-74 HN(75) MHÑChancre ANprimary lesion of syphilis: do not confuse with CHANCROID (caused by Haemophilus ducreyi) MNC1.252.847.840.744.161 DMÑSyphilis LH LM  MHÑChancroid ANcaused by Haemophilus ducreyi; do not confuse with CHANCRE, the primary lesion of syphilis MNC1.252.433.257; C1.539.780.173 LH  MHÑChannel Islands MNZ1.542.363.161 XSAlderney Island; Guernsey Island; Jersey Island LH LS; ;  MSHospital department which administers religious activities within the hospital, e.g., pastoral care, religious services. HN(Aug 77) MHÑChaplaincy Service, Hospital ANonly /econ /legis /man /organ /stand /trends /util MNN2.278.354.422.270; N4.452.442.422.270 XSHospital Chaplaincy Service DMÑHospital Departments LH LS LM  MSIn current usage, approximately equivalent to personality. The sum of the relatively fixed personality traits and habitual modes of response of an individual. MHÑCharacter ANno qualif MNF1.752.190 LH  MHÑCharcoal AND25-26 qualif only RN16291-96-6 MND26.61.362; D26.228; J1.637.189 LH  OLsearch MUSCULAR ATROPHY 1966-74 HN(75) MHÑCharcot-Marie Disease MNC5.651.661.468.340; C10.228.854.468.340; C10.668.468.340 DMÑMuscular Atrophy LH LM  MSSocial welfare organizations with programs designed to assist individuals in times of need. MHÑCharities ANonly /hist /legis CATALOG: /geog /form MNI1.880.787.190 LH  MSA form of phagocyte bactericidal dysfunction characterized by large abnormal lysosomes, partial oculocutaneous albinism, susceptibility to infection, and a high incidence of lymphoproliferative neoplasia. The disease is transmitted by non-sex-linked inherited, and similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle. PM71 HN71 MHÑChediak-Higashi Syndrome PIImmunologic Deficiency Syndromes (68-70); Leukocytes (66-70) MNC15.378.553.774.257; C20.673.774.257 FXÑALEUTIAN MINK DISEASE; ÑAlbinism; ÑAleutian Mink Disease LH LX; ;  MHÑCheek ANfor that external portion of face or that internal portion of mouth; NIM for hamster cheek pouch; buccal mucosa = MOUTH MUCOSA (IM) + CHEEK (NIM); cheek bone fracture = ZYGOMATIC FRACTURES MNA1.456.505.173; A14.194 XSBUCCA LH LS  MHÑCheese ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNJ1.341.273.290 LH  MSLong-legged, swift-moving felines from Africa (and formerly Asia) about the size of a small leopard. HN(75) MHÑCheetahs ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.147.200 DMÑCarnivora LH LM  MHÑCheilitis MNC7.465.409.215 LH  PMHEAVY METAL DETOXICANTS was heading 1963-65 HNHEAVY METAL DETOXICANTS was heading 1963-65 MHÑChelating Agents AND25-26 qualif; IRON CHELATES is also available MND26.241 XSCOMPLEXONS FXÑAntidotes; ÑIron Chelates LH LS LX;  MSApplication of a cauterant to the skin for the purpose of causing a superficial destruction of the epidermis and upper layers of the dermis. After healing, the treated area has new epithelium. PM77 HN77 MHÑChemexfoliation ANdo not use /man /supply /util (except by MeSH definition) PIFace (66-76); Skin (66-76); Skin Diseases (66-76); Surgery, Plastic (66-76) MNE4.860.250 XSChemical Face Peeling LH LS  PM66 HN66 MHÑChemical Engineering ANonly /econ /hist MNJ1.293.257 LH  MHÑChemical Industry ANonly /econ /hist /stand MNJ1.576.207 LH  MSTactical warfare using incendiary mixtures, smokes, or irritant, burning, or asphyxiating gases.  MHÑChemical Warfare ANno qualif MNI1.880.735.944.340 FXÑDECONTAMINATION; ÑGAS POISONING LH LX;  PM68 HN68 MHÑChemical Warfare Agents AND25-26 qualif PIChemical Warfare (66-67); Gases (66-67) MND26.253 FXÑTear Gases LH LX  MH*Chemical, Pharmacologic Phenomena (Non Mesh) MNG12 LH  MHÑChemistry ANNIM as coord for ╥chemistry╙ or ╥chemical structure╙ of a specific drug or chemical: TN 37 & Manual 25.41; when NIM, no qualif; when IM, SPEC: SPEC qualif; as IM: Manual 29.6 MNH1.181 FXÑALCHEMY; ÑBRAIN CHEMISTRY; ÑNEUROCHEMISTRY LH LX; ;  MHÑChemistry, Agricultural ANas SPEC, only /educ /hist /instrum /man /methods; as coord, NIM with no qualif; Manual 29.7 MNH1.181.216 XSAgricultural Chemistry LH LS  MHÑChemistry, Analytical ANSPEC: TN 37; never use as substitute for or reinforcement of /anal: Manual 25.41, 29.8; as SPEC, only /educ /hist /instrum /man /methods; do not use as NIM coord MNE5.196; H1.181.278 FXÑAUTOANALYSIS; ÑCHEMISTRY, CLINICAL XUÑBiuret Reaction; ÑDifferential Thermal Analysis; ÑFractionation; ÑThermogravimetry LH LX; LU; ; ;  MSAnalytical chemistry applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy. PM67 HN67(66) MHÑChemistry, Clinical ANSPEC: TN 37; do not use as NIM coord; as SPEC, only /educ /hist /instrum /man /methods /trends MNE1.223.174; H1.181.341 FXÑChemistry, Analytical LH LX  PM66 HN66 MHÑChemistry, Organic ANSPEC: TN 37; do not use as NIM coord; as SPEC, only /educ /hist /instrum /man /methods; when not to use: Manual 25.41, 29.9 MNH1.181.404 XUÑAcetylation; ÑDecarboxylation; ÑEsterification; ÑHydrogenation; ÑHydroxylation; ÑPhosphorylation LH LU; ; ; ; ;  MHÑChemistry, Pharmaceutical ANSPEC: only /educ /hist /instrum /man /methods; permitted as NIM coord, no qualif; Manual 29.7; drug formulation goes here but DRUG COMPOUNDING is also available MNH1.181.466 FXÑBIOPHARMACEUTICS LH LX  PM65 HN65 MHÑChemistry, Physical ANSPEC: only /educ /hist /instrum /man /methods; permitted as NIM coord, no qualif; Manual 29.7 MNH1.181.529 XUÑHydrogen Bonding; ÑHydrolysis LH LU;  OLsearch RECEPTORS, SENSORY 1966-67 PM68; was see under RECEPTORS, NEURAL 1963-67 HN68; was see under RECEPTORS, NEURAL 1963-67 MHÑChemoreceptors ANdo not use /innerv; differentiate from RECEPTORS, DRUG: TN 160 PIReceptors, Sensory (66-67) MNA8.796.511.725.154 FXÑChemotaxis LH LX  PM72 HN72(66) MHÑChemosterilants ANdo not use /analogs /biosyn /defic /physiol MND5.723.141 FXÑInsect Control; ÑMosquito Control; ÑPest Control, Biological LH LX; ;  MSChemical substances that attract or repel cells or organisms; especially those factors released as a result of tissue injury, invasion or immunologic activity, that attract leukocytes, macrophages or other cells to the site of infection or insult. PM80 HN80 MHÑChemotactic Factors AN/biosyn /physiol permitted; do not use /analogs PIChemotaxis (66-79); Chemotaxis, Leukocyte (77-79) MND24.185.125 XSChemotaxins; Cytotaxinogens; Cytotaxins; Peptides, Chemotactic FXÑChemotaxis; ÑPheromones XUÑChemotactic Factors, Eosinophil; ÑChemotactic Factors, Macrophage LH LS; ; ; LX; LU;  MSCytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ECF-A, released mainly by mast cells. HN(80) MHÑChemotactic Factors, Eosinophil ANchemotactic substances attracting eosinophils, not liberated by eosinophils; /biosyn /physiol permitted; do not use /analogs; DF: ECF A PIChemotaxis (66-79); Chemotaxis, Leukocyte (77-79); Eosinophils (66-79) MND24.185.125.320 XSEosinophil Chemotactic Factors; Eosinophil Chemotaxins DMÑChemotactic Factors LH LS; LM  MSCytotaxins liberated from normal or invading cells that specifically attract macrophages; they may be lymphokines, products of antigen, antibody and complement interactions or other. HN(80) MHÑChemotactic Factors, Macrophage ANchemotactic substances attracting macrophages, not liberated by macrophages; /biosyn /physiol permitted; do not use /analogs PIChemotaxis (66-79); Chemotaxis, Leukocyte (77-79); Macrophages (66-79) MND24.185.125.585 XSMacrophage Chemotactic Factors; Macrophage Chemotaxins DMÑChemotactic Factors LH LS; LM  MSThe movement of cells or organisms toward or away from a substance in response to its concentration gradient. PM70 HN70(65) MHÑChemotaxis ANonly /drug eff /rad eff MNG4.335.283.424 FXÑChemoreceptors; ÑChemotactic Factors LH LX;  MSThe movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. PM77 HN77 MHÑChemotaxis, Leukocyte ANonly /drug eff /rad eff; coord IM with specific type of leukocyte (NIM) PIChemotaxis (66-76) MNG4.335.283.424.233 XSLeukotaxis LH LS  MS3-alpha,7-alpha-Dihydroxy-5-beta-cholanic acid. A bile acid, usually conjugated with either glycine or taurine; acts as detergent to solubilize fats for intestinal absorption; reabsorbed by small intestine; used as cholagogue, choleretic laxative and to prevent or dissolve gallstones. PM74 HN74(73) MHÑChenodeoxycholic Acid AN/biosyn /physiol permitted RN474-25-9 PIBile Acids and Salts (66-72) MND4.808.221.430.342.300; D19.316.246.175 XSChenic Acid; Chenodeoxycholate; Chenodiol; Gallodesoxycholic Acid XUÑGlycochenodeoxycholic Acid; ÑTaurochenodeoxycholic Acid LH LS; ; ; LU;  PM65 HN65 MHÑCherubism MNC5.116.99.708.375.199; C5.500.174 LH  MSPressure, burning, or numbness in the chest. PM87 HN87 MHÑChest Pain ANusually non-cardiac; cardiac = probably ANGINA PECTORIS PIPain (66-86); Thorax (66-86) MNC23.888.592.612.195 FXÑAngina Pectoris LH LX  MHÑChewing Gum ANonly /ad-poi-tox /anal /hist /stand /supply MNJ1.341.205 LH  MSBreathing characterized by rhythmic waxing and waning of the depth of respiration, with regularly recurring periods of apnea; seen especially in coma resulting from disorders of the central nervous system. HN(66); was see under RESPIRATION 1966-76 MHÑCheyne-Stokes Respiration MNC8.618.182; C23.888.852.227 DMÑRespiration Disorders LH LM  MSPersistent lactation and amenorrhea following pregnancy. PM65 HN65(64) MHÑChiari-Frommel Syndrome MNC13.703.844.506.192; C19.146.556.217 XSFROMMEL'S DISEASE LH LS  MHÑChicago MNZ1.107.567.875.370.342; Z1.433.305 LH  PM64 HN64 MHÑChick Embryo ANcheck tag: no qualif; when IM, only /anal /cytol /drug eff /enzymol /growth /immunol /metab /microbiol /parasitol /physiol /rad eff; chick embryo heart = CHICK EMBRYO + HEART /embryol (not FETAL HEART); /transpl permitted for chick embryo transfer: do not use EMBRYO TRANSFER since this is mammalian only MNA13.350.150; A16.254.300.200 XSEmbryo, Chick LH LS  MSA nondefective strain of avian sarcoma virus. HN(75); was see under ROUS SARCOMA VIRUS 1975-82 MHÑChicken Sarcoma Virus B77 ANdo not use /blood-csf-urine /cytol; infection: coord NIM with AVIAN SARCOMA (IM) MNB4.909.574.807.112.195.200; B4.909.777.731.112.195.200 XSAvian Sarcoma Virus B77 DMÑAvian Sarcoma Viruses LH LS LM  MHÑChickenpox MNC2.256.466.175 XSVARICELLA LH LS  PM68 HN68 MHÑChickens ANIM; when IM, only /anat /blood-csf-urine /class /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not use /embryol ( = CHICK EMBRYO); diseases: coord IM with POULTRY DISEASES (IM); canned chicken: see note on POULTRY PRODUCTS PIPoultry (66-67) MNB2.248.617.192 LH  MSAn Alphavirus (group A arbovirus) causing an acute dengue-like fever. PM66 HN66(64) MHÑChikungunya Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TOGAVIRUS INFECTIONS (IM) MNB4.909.777.923.54.198 LH  MSRecurrent localized itching, swelling and painful erythema on the fingers, toes or ears, produced by exposure to cold. Synonym: pernio. OLsearch FROSTBITE 1966-74 HN(75) MHÑChilblains MNC21.866.417.217 DMÑFrostbite LH LM  MHÑChild ANage 6-12 yr; IM only as psychol & sociol or social entity: Manual 18.5.11, 34.10; no qualif; /psychol = CHILD PSYCHOLOGY (Manual 34.12) but consider also CHILD BEHAVIOR & other specifics; NIM as check tag: Manual 18.5+; as student: Manual 34.22 MNM1.471.392 FXÑONLY CHILD LH LX  MSEmotional, nutritional, or physical maltreatment of the child usually by a parent or parent substitute. PM65 HN65(64) MHÑChild Abuse ANonly /legis /prev /psychol; check also tag CHILD or specific MNF3.126.842.89.110; I1.198.240.258; I1.880.787.293.292 XSChild Neglect XUÑBattered Child Syndrome LH LS LU  MSSexual maltreatment of the child or minor. PM87 HN87 MHÑChild Abuse, Sexual ANonly /legis /prev /psychol; check also tag CHILD or specific PIChild Abuse (66-86); Sex Offenses (68-86) MNF3.126.842.89.110.80; I1.198.240.258.80 XSChild Molestation, Sexual; Molestation, Sexual, Child; Sexual Abuse, Child LH LS; ;  MSPromotion and protection of the rights of children; frequently through a legal process. PM75 HN75 MHÑChild Advocacy ANonly /legis; rights of children; check also tag CHILD or specific PIChild Welfare (66-74) MNI1.880.604.473.300; I1.880.787.293.350; N3.706.437.300 LH  MSAny observable response or action of a child. PM68 HN68 MHÑChild Behavior ANonly /drug eff; check also tag CHILD or specific PIBehavior (66-67); Child Psychology (66-67) MNF1.145.179 LH  MSDisturbances considered to be of pathological degree based on age and stage appropriateness; to include e.g. conduct disturbances, and anaclitic depression. Does not include psychoneuroses, psychoses, or a personality disorder with fixed patterns. MHÑChild Behavior Disorders ANdo not use /drug eff /physiol /rad eff; check also tag CHILD or specific MNF3.234 XSConduct Disorders, Child LH LS  MSCare of children in the home or institution. MHÑChild Care ANin home or institution; only /hist /methods /organ /stand /trends; check also tag CHILD or specific; INFANT CARE is also available MNN2.421.88 XSPUERICULTURE FXÑCHILD REARING LH LS LX  MSFacilities which provide care for the pre-school child. PM73 HN73 MHÑChild Day Care Centers ANonly /class /hist /legis /man /stand /supply /trends /util; check also tag CHILD or specific CATALOG: /geog /form PIChild Care (66-72); Child Welfare (66-72) MNI1.880.787.293.392 FXÑNURSERIES LH LX  MSThe continuous sequential physiological and psychological maturing of the child from birth through adolescence; includes healthy responses to situations. Growth in stature or size is indexed under GROWTH. PM68 HN68 MHÑChild Development ANonly /drug eff /physiol; check also tag CHILD or specific PIBehavior (66-67); Child Psychology (66-67); Growth (66-67) MNF1.525.200 FXÑCHILD PSYCHOLOGY; ÑGROWTH; ÑMOTOR SKILLS; ÑMotor Skills; ÑPERSONALITY DEVELOPMENT LH LX; ; ; ;  MSDisorders in which there is a delay in development based on that expected for a given age level or stage of development. Biological and nonbiological factors are involved in these disorders. OLuse CHILD DEVELOPMENT DISORDERS to search CHILD DEVELOPMENT DEVIATIONS back thru 1968 PM81; was CHILD DEVELOPMENT DEVIATIONS 1968-80 HN81; was CHILD DEVELOPMENT DEVIATIONS 1968-80 MHÑChild Development Disorders ANdo not use /drug eff /physiol /rad eff; check also tag CHILD or specific PIChild Behavior Disorders (66-67); Child Psychology (66-67) MNF3.305 XSChild Development Deviations; Child Development Disorders, Specific; Developmental Delay Disorders LH LS; ;  MSSevere distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements. PM81 HN81 MHÑChild Development Disorders, Pervasive AN╥pervasive╙ is a psychiatric diag: follow text; do not use /drug eff /physiol /rad eff; check also tag CHILD or specific MNF3.709.680.500 XSPervasive Child Development Disorders LH LS  MSThe psychiatric, sociological and psychological study and treatment of the developing child with emphasis on preventive or prophylactic measures focused on the familial, educational and socio-environmental milieu of the child. MHÑChild Guidance ANonly /econ /educ /man /stand; check also tag CHILD or specific MNF2.784.629.272; F4.408.192 LH  MSFacilities which administer the delivery of mental health counseling services to children. OLsearch COMMUNITY MENTAL HEALTH SERVICES 1967-74 HN(75); was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78 MHÑChild Guidance Clinics ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util; check also tag CHILD or specific CATALOG: /geog /form MNN2.278.35.158.300 DMÑCommunity Mental Health Centers LH LM  MSOrganized services to provide health care for children. OLuse CHILD HEALTH SERVICES to search INFANT HEALTH SERVICES & WELL CHILD CONFERENCE back thru 1968 PM68 HN68; INFANT HEALTH SERVICES & WELL CHILD CONFERENCE were see under CHILD HEALTH SERVICES 1968-78 MHÑChild Health Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util; check also tag CHILD or specific CATALOG: /geog /form PIChild Care (66-67); Child Welfare (66-67) MNN2.421.143.130 XSInfant Health Services; Well Child Conference LH LS;  MSThe language and sounds expressed by a child at a particular maturational stage in development. OLsearch LANGUAGE DEVELOPMENT 1968-74 HN(75) MHÑChild Language ANno qualif; check also tag CHILD or specific MNF1.525.200.310.250 DMÑLanguage Development LH LM  MSNutrition of children aged 2-12 years. PM67 HN67 MHÑChild Nutrition ANno qualif; check also tag CHILD or specific; INFANT NUTRITION is also available; adolescent nutrition does not go here:index under ADOLESCENCE (IM) + NUTRITION (IM) PINutrition (66) MNG6.696.259 LH  MSThe medical science that deals with the origin, diagnosis, prevention and treatment of mental disorders in children. MHÑChild Psychiatry ANSPEC: SPEC qualif; not for mental disord in children ( = MENTAL DISORDERS (IM) + CHILD or other child check tag (NIM) ): Manual 27.9 MNF4.96.544.193; G2.403.642.130; G2.403.790.600.258 LH  MSThe study of normal and abnormal behavior of children. MHÑChild Psychology ANSPEC but also the way a normal child thinks & acts; GEN only: consider also /psychol with specific child terms (e.g., CHILD, ABANDONED /psychol, ONLY CHILD /psychol); SPEC qualif; Manual 27.11, 27.12, 34.12; check also tag CHILD or specific MNF4.96.628.193 XSInfant Psychology FXÑChild Development LH LS LX  MSReactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns. OLsearch CHILD BEHAVIOR DISORDERS 1968-74 PM84; was see under CHILD BEHAVIOR DISORDERS 1968-83 HN84(75); was see under CHILD BEHAVIOR DISORDERS 1968-83 MHÑChild Reactive Disorders ANdo not use /drug eff /physiol /rad eff; child reaction to separation from parents: index under ANXIETY, SEPARATION; check also tag CHILD or specific MNF3.234.193 LH  MSThe training or bringing-up of children by parents or parent-substitutes; also used for discussions or studies of child rearing practices in different societies, at different economic levels, in different ethnic groups, etc. PM68 HN68(64) MHÑChild Rearing ANonly /hist; check also tag CHILD or specific MNF1.318 FXÑChild Care; ÑSOCIALIZATION LH LX;  MSOrganized efforts by communities or organizations to improve the health and well-being of the child. MHÑChild Welfare ANonly /hist /legis /stand /trends; check also tag CHILD or specific CATALOG: /geog /form MNI1.880.787.293 FXÑFOSTER HOME CARE XUÑInfant Welfare LH LX LU  MSA child who is deserted by parents or parent substitutes without regard for its future care. PM72 HN72(69) MHÑChild, Abandoned ANonly /educ /legis /psychol; check also tag CHILD or specific PIChild (66-68) MNI1.880.787.293.192; M1.471.392.163 LH  MSA child who deviates from the average in mental, physical, or social characteristics to such an extent that he requires a modification of services in order to develop his maximum potential. OLsearch CHILD, GIFTED & MENTAL RETARDATION 1968-74 & MENTAL RETARDATION 1966-67 PM75; was see under CHILD, GIFTED & MENTAL RETARDATION 1969-74, was see under MENTAL RETARDATION (but EXCEPTIONAL CHILD was see under CHILD, GIFTED) 1968, was see under MENTAL RETARDATION 1967, was see under MENTAL DEFICIENCY 1966 HN75; was see under CHILD, GIFTED & MENTAL RETARDATION 1969-74, was see under MENTAL RETARDATION (but EXCEPTIONAL CHILD was see under CHILD, GIFTED) 1968, was see under MENTAL RETARDATION 1967, was see under MENTAL DEFICIENCY 1966 MHÑChild, Exceptional ANonly /educ /psychol; ╥child who deviates from the average╙: consider also CHILD, GIFTED & MENTAL RETARDATION; check also tag CHILD or specific MNM1.471.392.234; F2.784.629.228 FXÑMainstreaming (Education) LH LX  MSA child whose intelligence is in the upper two percent of the total population of his age; a child having outstanding ability in any respect. PM66 HN66 MHÑChild, Gifted ANonly /educ /psychol; check also tag CHILD or specific MNF2.784.629.228.350; M1.471.392.234.342 XSGIFTED CHILD LH LS  PM67 HN67(65) MHÑChild, Hospitalized ANnot for dis in child in hosp for diag or ther: use only for hospitalized child as a psychol, sociol or social entity; only /educ /pyschol; check also tag CHILD or specific MNM1.471.392.305; M1.643.259 XSHOSPITALIZED CHILD FXÑHospitalization LH LS LX  MSThe normal or defective child who is being cared for in an institution either because he is homeless or requires special care. PM67 HN67(65) MHÑChild, Institutionalized ANonly /educ /legis /psychol; check also tag CHILD or specific MNI1.880.787.293.493; M1.471.392.377 XSINSTITUTIONALIZED CHILD FXÑInstitutionalization LH LS LX  PM66 HN66 MHÑChild, Preschool ANage 2-5 yr; IM only as psychol & sociol or social entity: Manual 18.5.11, 34.10; NIM as check tag: Manual 18.5+; no qualif for IM but psychol of the preschool child = CHILD PSYCHOLOGY (IM) & check the tag CHILD, PRESCHOOL: Manual 34.12 MNM1.471.392.448 LH  MSThe child who is not wanted by one or both parents. PM78 HN78 MHÑChild, Unwanted ANonly /legis /psychol; check also tag CHILD or specific PIParent-Child Relations (66-77); Pregnancy, Unwanted (73-77) MNI1.880.787.293.680; M1.471.392.465 LH  MHÑChile MNZ1.107.757.235 LH  MSAn individual whose body contains cell populations derived from different zygotes. OLsearch MOSAICISM 1967-74 PM78; was see under MOSAICISM 1967-77 HN78(75); was see under MOSAICISM 1967-77 MHÑChimera ANonly /drug eff /rad eff PIGenetics (66); Mosaicism (66-77) MNG5.148.630.218 LH  MSThis single species of Chimpansee, a member of the Pongidae family, lives in the tropical forests of Africa. The small or pygmy chimpansee, paniscus, is considered by some to be a subspecies of troglodytes and by others to be a separate genus, Bonobo. It is stated that this animal is the most intelligent of the apes. OLuse CHIMPANSEE TROGLODYTES to search CHIMPANZEES back thru 1972 PM81; was CHIMPANZEES 1972-80 HN81; was CHIMPANZEES 1972-80 MHÑChimpansee troglodytes ANan ape, not a monkey; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; DF: CHIMPANSEE PIPongidae (66-71) MNB2.649.801.201.600.180 XSChimpanzee; Pan LH LS;  MHÑChin MNA1.456.505.259 FXÑMandible LH LX  MHÑChina ANin translations use spelling: People's Republic of China, not Peoples' nor Peoples MNZ1.252.474.164 XSInner Mongolia; Mainland China; Manchuria; Sinkiang; Tibet LH LS; ; ; ;  MSA genus of the family Chinchillidae which consists of three genera: Lagidium, Lagostomus, and Chinchilla. Used extensively in biomedical research. OLuse CHINCHILLA to search CHINCHILLAS back thru 1968 PM82; was CHINCHILLAS 1968-81 HN82; was CHINCHILLAS 1968-81 MHÑChinchilla ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIRodentia (66-67) MNB2.649.865.328 LH  MSA family of the order Diptera. Salivary glands of the genus Chironomus are used in studies of cellular genetics and biochemistry. OLsearch MIDGES under DIPTERA 1975-80 HN(81); MIDGES was see under DIPTERA 1975-80 MHÑChironomidae ANIM; /microbiol /parasitol permitted; do not use /drug eff with insecticides: TN 111; gall midges: index under DIPTERA PIDiptera (75-80) MNB1.131.617.289.260 XSChironomus; Midges, Nonbiting; Smittia DMÑDiptera LH LS; ; LM  MHÑChiropractic ANonly /econ /educ /hist /instrum /man /methods /psychol /stand /trends MNE2.175; G2.110 LH  MHÑChiroptera ANincludes flying foxes & vampires; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.649.225 XSBATS LH LS  PM72 HN72(67) MHÑChitin ANin shell of crustacea, insects & in some fungi RN1398-61-4 PIPolysaccharides (66) MND9.203.698.211 LH  MSUDP-2-acetamido-2-deoxy-D-glucose:chitin 4-beta-acetamidodeoxyglucosyltransferase. Converts UDP glucosamine into chitin and UDP. HN(75); was see under HEXOSYLTRANSFERASES 1975-78 MHÑChitin Synthase ANdo not use /analogs RNEC 2.4.1.16 PIChitin (74); Glucosamine (74); Hexosyltransferses (74); Uridine Diphosphate Sugars (74) MND8.586.913.407.323.330 XSChitin UDP Acetylglucosaminyltransferase; Trans-N-Acetylglucosaminosylase DMÑGlucosyltransferases LH LS; LM  MHÑChitinase ANdo not use /analogs RNEC 3.2.1.14 MND8.586.277.450.207 LH  OLsearch MIYAGAWANELLA & PSITTACOSIS-LYMPHOGRANULOMA GROUP VIRUSES under CHLAMYDIA back thru 1966 PMMIYAGAWANELLA was heading 1963-75; PSITTACOSIS-LYMPHOGRANULOMA GROUP VIRUSES was see under MIYAGAWANELLA 1963-75 HNMIYAGAWANELLA was heading 1963-75; PSITTACOSIS-LYMPHOGRANULOMA GROUP VIRUSES was see under CHLAMYDIA 1976-78, was see under MIYAGAWANELLA 1963-75 MHÑChlamydia ANdo not use /blood-csf-urine; infection = CHLAMYDIA INFECTIONS; note specifics with their infections below MNB3.700.300.394.260 XSMiyagawanella; Psittacosis-Lymphogranuloma Group LH LS;  MSInfections with organisms of the genus Chlamydia, general or unspecified. OLuse CHLAMYDIA INFECTIONS to search MIYAGAWANELLA INFECTIONS back thru 1967 PM67; MIYAGAWANELLA INFECTIONS was heading 1967-76 HN67; MIYAGAWANELLA INFECTIONS was heading 1967-76 MHÑChlamydia Infections ANnote specifics with their infections below PIConjunctivitis (66); Trachoma (66) MNC1.850.200.195 XSMiyagawanella Infections LH LS  MSParasitic organisms of cells of vertebrates having been detected in over 100 species of birds, most domesticated and many wild mammals; generally produce systemic infections in a broad range of hosts. OLto search ORNITHOSIS VIRUS use CHLAMYDIA PSITTACI back thru 1975 & CHLAMYDIA 1966-74 PM76; was ORNITHOSIS VIRUS see under MIYAGAWANELLA 1963-75 HN76; was ORNITHOSIS VIRUS see under MIYAGAWANELLA 1963-75 MHÑChlamydia psittaci ANdo not use /blood-csf-urine; infection = ORNITHOSIS PIChlamydia (66-74) MNB3.700.300.394.260.300 XSOrnithosis Virus LH LS  MSThe etiological agent of a variety of ocular and urogenital diseases. OLsearch CHLAMYDIA 1966-75 PM76; TRACHOMA VIRUS was see CHLAMYDIA 1963-74 HN76; TRACHOMA VIRUS was see CHLAMYDIA 1963-74 MHÑChlamydia trachomatis ANnote category: a bacterium, not a virus; infections: coord NIM with CHLAMYDIA INFECTIONS (IM) unless text says TRACHOMA or LYMPHOGRANULOMA VENEREUM or CONJUNCTIVITIS, INCLUSION PIChlamydia (66-75) MNB3.700.300.394.260.900 XSTrachoma Virus LH LS  MSA family of Gram-negative coccoid microorganisms containing the genus Chlamydia and several genera incertae sedis. PM76; was see under RICKETTSIA 1975 HN76(64); was see under RICKETTSIA 1975 MHÑChlamydiaceae ANdo not use /blood-csf-urine MNB3.700.300.394 XSBasophilic Viruses LH LS  MSInfections with rickettsias of the Family Chlamydiaceae. PM77 HN77 MHÑChlamydiaceae Infections ANa rickettsial infection PIChlamydia Infections (67-76); Rickettsial Infections (66-76) MNC1.850.200 LH  MSGram-negative parasites of vertebrates in which they may cause various diseases; occasionally found in arthropods. PM76 HN76 MHÑChlamydiales PIBacteria (66-74); Micotatobiotes (75) MNB3.700.300 LH  MSSolitary biflagellated green algae common in fresh water and damp soil; sometimes a pest around filtration plants. PM74 HN74(72) MHÑChlamydomonas ANbiflagellate green algae; do not use /anat /embryol /microbiol /parasitol PIAlgae, Green (70-71) MNB5.104.234.344 LH  MHÑChloral Hydrate ANdo not use /biosyn /defic /physiol RN302-17-0 MND14.591.745.165 LH  MHÑChloralose ANdo not use /biosyn /defic /physiol RN15879-93-3 MND2.455.526.439.927.200; D9.203.408.348.150; D14.591.745.200 XSAnhydroglucochloral; Glucochloral LH LS;  MS4-[Bis(2-chloroethyl)amino]benzenebutanoic acid. A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease and others; less toxic than most other nitrogen mustards. Synonyms: Amboclorin; CB 1348; Chlorbutinum; chloroaminophene; Ekloril; Leukeran; Lympholysin; NSC 3088. MHÑChlorambucil ANdo not use /biosyn /defic /physiol RN305-03-3 MND2.455.526.728.650.156; D22.204.585.186 XUÑPrednimustine LH LU  MHÑChloramines ANdo not use /analogs /biosyn /defic /physiol MND2.65.884.344; D2.886.590.700.344 LH  MHÑChloramphenicol ANdo not use /biosyn /defic /physiol RN56-75-7 MND2.33.618.706.300; D20.85.215 XSCloranfenicol; Kloramfenikol; Levomycetin LH LS; ;  MS2,3,5,6-Tetrachloro-1,4-benzoquinone. A quinone fungicide used for treatment of seeds and foliage. Synonyms: Spergon; Coversan; Reranil; Vulklor. HN(76) MHÑChloranil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN118-75-2 PIChlorine (74-75); Quinones (68-75) MND2.806.210; D5.723.288.200 DMÑQuinones LH LM  PM73 HN73(71) MHÑChlorates ANdo not use /analogs /biosyn /defic /physiol PIChlorine (66-70) MND1.248.497.158.210.260; D1.396.343.177; D1.655.498.236 LH  MS1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine. Histamine H1 blocker used both orally and topically in allergies; also for the prevention of motion sickness. Synonyms: Alergicide; Di-Paralene; Histantine; Trihistan. PM74 HN74(64) MHÑChlorcyclizine ANdo not use /biosyn /defic /physiol RN82-93-9 MND3.383.606.260; D23.654.432.162 XSChlorocyclizin; Histachlorazine LH LS;  MHÑChlordan ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN12789-03-6 MND2.455.526.439.180; D5.723.491.491.193 LH  MHÑChlordiazepoxide ANdo not use /biosyn /defic /physiol; Librium goes here RN58-25-3 MND3.438.79.80.150; D15.236.872.659.191.165; D17.426.177 XSMethaminodiazepoxide LH LS  MSNonmotile unicellular green algae potentially valuable as a source of high grade protein and B-complex vitamins. PM74 HN74(72) MHÑChlorella ANunicellular green algae; do not use /anat /embryol /microbiol /parasitol PIAlgae, Green (70-71) MNB5.104.234.469 LH  MS2-Chloro-1-(2,4-dichlorophenyl)ethenyl diethyl phosphate. An organophorphorus insecticide; has cholinesterase inhibitory action. Synonyms: C-8949; GC-4072; SD-7859; Birlane; chlorfenvinfos; chlorphenvinfos; chlorphenvinphos; Sapecron. HN(80) MHÑChlorfenvinphos ANdo not use /biosyn /defic /physiol; /analogs NIM only RN470-90-6 PIInsecticides (66-72); Insecticides, Organophosphate (73-79); Organophosphorus Compounds (71-79); Phosphoric Acids (66-70); Vinyl Compounds (71-74) MND2.705.150; D5.723.491.574.130 DMÑInsecticides, Organophosphate LH LM  MS1,1-Hexamethylenebis(5-(p-chlorophenyl) biguanide)dihydrochloride. Disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque. Synonyms: Hibiclens; Hibitane; Lisium; Nolvasan; Rotersept; Sterilon. PM80; was see under BIGUANIDES 1975-79 HN80(75); was see under BIGUANIDES 1975-79 MHÑChlorhexidine ANdo not use /biosyn /defic /physiol RN55-56-1 PIBiguanides (68-74); Chlorobenzenes (74) MND2.78.370.141.100; D20.187.182 LH  MSChloride:hydrogen-peroxide oxidoreductase. Catalyzes the chlorination of a range of organic molecules, forming stable carbon-chloride bonds. HN(76) MHÑChloride Peroxidase ANdo not use /analogs RNEC 1.11.1.10 PIChlorine (73-75); Peroxidases (73-75) MND8.586.682.732.360 XSChloroperoxidase DMÑPeroxidases LH LS LM  MHÑChlorides ANonly for inorganic cpds or chloride ion; /physiol permitted; do not use /analogs /biosyn /defic MND1.248.497.158.210.427; D1.396.343.260 LH  MHÑChlorine ANCl-35; do not use /analogs /biosyn /defic /physiol; Cl-37 = CHLORINE (IM) + ISOTOPES (NIM); Cl-34, 36, 38-40 = CHLORINE (IM) + RADIOISOTOPES (IM) RN7782-50-5 MND1.248.497.158.210; D1.268.184; D1.396.343 LH  MHÑChlorisondamine ANdo not use /biosyn /defic /physiol RN69-27-2 MND2.92.102.200; D2.675.276.200; D16.653.396.144; D18.162.139 LH  PM66 HN66(64) MHÑChlormadinone ANdo not use /biosyn /defic /physiol RN1961-77-9 MND4.808.745.432.144; D4.808.883.294; D6.597.799.146; D7.360.276.210.443.706.139 LH  HN(72) MHÑChlormequat ANdo not use /biosyn /defic /physiol; /analogs NIM only RN999-81-5 PIAmmonium Compounds (66-71); Plant Growth Regulators (66-71) MND2.92.102.207; D2.675.276.207; D11.303.760.236 DMÑAmmonium Compounds LH LM  PM66; was see under DIURETICS, MERCURIAL 1963-65 HN66(64); was see under DIURETICS, MERCURIAL 1963-65 MHÑChlormerodrin ANdo not use /biosyn /defic /physiol RN62-37-3 MND2.691.750.100.229; D19.770.224.391.165 XSChlormeroprin LH LS  MS4-Chloro-N,alpha-dimethylbenzeneethanamine. Pharmacologically less active analog of methylamphetamine that possesses antiserotonergic properties. Synonyms: p-chloro-N-methylamphetamine; S 33; PCMA. HN(75) MHÑChlormethamphetamine ANdo not use /biosyn /defic /physiol RN1199-85-5 PIChlorine (66-74); Methamphetamine (66-74) MND2.92.471.683.152.619.380; D23.846.151 XS4-Chloromethamphetamine; Parachloromethamphetamine DMÑMethamphetamine LH LS; LM  PM68 HN68 MHÑChlormethiazole ANdo not use /biosyn /defic /physiol RN533-45-9 PIHypnotics and Sedatives (66-67); Thiazoles (66-67) MND3.383.871.180; D14.591.745.236 XSCHLORETHIAZOLE LH LS  MHÑChlormezanone ANdo not use /biosyn /defic /physiol RN80-77-3 MND3.383.855.150; D15.236.872.659.269; D17.426.219 XSChlormethazanone LH LS  MHÑChloroacetophenone AND25-26 qualif RN1341-24-8 MND2.522.120.345; D5.569.734.498.697.345; D26.897.345 XSMACE LH LS  PM74 HN74 MHÑChlorobenzenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.426.559.389.261; D2.455.526.439.202 XUÑHexachlorobenzene LH LU  MSBenzoic acid or benzoic acid esters substituted with one or more chlorine atoms. PM75 HN75 MHÑChlorobenzoates ANdo not use /analogs /biosyn /defic /physiol PIBenzoates (66-74) MND2.241.223.106.260 LH  MHÑChlorobutanol ANdo not use /biosyn /defic /physiol RN57-15-8 MND2.33.210.345; D2.33.440.220; D2.33.555.233.345; D10.516.289.233.345 XSAcetonchloroform; Chlorbutol; Trichlorbutanol LH LS; ;  MHÑChloroform ANdo not use /biosyn /defic /physiol RN67-66-3 MND2.455.526.439.224; D14.166.182 XUÑBromotrichloromethane LH LU  MHÑChlorogenic Acid ANdo not use /biosyn /defic /physiol RN327-97-9 MND2.241.223.268.220 LH  MHÑChloroguanide ANdo not use /biosyn /defic /physiol RN500-92-5 MND2.78.370.141.125; D21.370.286.195; D26.87.185 XSChlorguanid; Chloriguane; Proguanil LH LS; ;  MSAliphatic alcohols which are substituted with chlorine. PM75 HN75 MHÑChlorohydrins ANdo not use /analogs /biosyn /defic /physiol PIAlcohols (66-74) MND2.33.440 XSChlorhydrins XUÑEpichlorohydrin; ÑEthylene Chlorohydrin; Ñalpha-Chlorohydrin LH LS LU; ;  PM66 HN66(64) MHÑChloromercuribenzoates ANdo not use /analogs /biosyn /defic /physiol PIBENZOATES MND2.241.223.106.604.261; D2.691.750.740.644.261; D8.373.830.699.261 LH  MSMercuriphenols substituted with one or more chlorine atoms and one or more nitro groups. They are sulfhydryl reagents which act as chromophoric probes in enzymes and other proteins. HN(77); was see under PHENYL MERCURY COMPOUNDS 1977-79 MHÑChloromercurinitrophenols ANdo not use /analogs /biosyn /defic /physiol PIMercury (68-76); Nitrophenols (68-76); Organometallic Compounds (68-76) MND2.691.750.740.225; D8.373.830.240 DMÑPhenylmercury Compounds LH LM  MSChloro(p-sulfophenyl)mercury. Cytotoxic sulfhydryl reagent; inhibits several subcellular metabolic systems; used as a tool in cellular physiology. Synonym: PCMPS. HN(75); was see under PHENYL MERCURY COMPOUNDS 1977-79, was see under ORGANOMETALLIC COMPOUNDS 1975-76 MHÑChloromercuriphenylsulfonate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN554-77-8 PIBenzene (66-67); Benzenesulfonates (74); Mercury (66-74); Organometallic Compounds (68-74); Sulfonic Acids (66-73) MND2.241.866.540.244.222.150; D2.455.426.559.389.97.150; D2.691.750.740.250; D2.886.610.244.222.150; D8.373.830.260; D26.550.844.150 XSChloromercuribenzenesulfonate; PCMBS DMÑPhenylmercury Compounds LH LS; LM  MSChloromethyl methyl methoxychloromethane. An alpha halo ether alkylating agent used widely in the chemical and plastics industries; it causes lung hyperplasias and neoplasms and skin neoplasms. Synonym: CMME. HN(77) MHÑChloromethyl Methyl Ether ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-30-2 PIEthers (73); Methyl Chloride (73-74); Methyl Ethers (74-76) MND2.355.601.300; D26.191.171 XSMethoxychloromethane; Methyl Chloromethyl Ether DMÑMethyl Ethers LH LS; LM  MSPhenols substituted with one or more chlorine atoms in any position. PM77; PENTACHLOROPHENOL was see under PHENOLS 1971-76 HN77 MHÑChlorophenols ANdo not use /analogs /biosyn /defic /physiol PIChlorobenzenes (74-76); Phenols (64-76) MND2.455.426.559.389.261.190; D2.755.190 XSHydroxychlorobenzenes XUÑPentachlorophenol LH LS LU  MHÑChlorophyll AN/biosyn /physiol permitted RN1406-65-1 MND11.557.727.220; D11.557.727.640.220 FXÑPHOTOSYNTHESIS XUÑBacteriochlorophylls; ÑChlorophyllides; ÑPheophytins; ÑProtochlorophyllide LH LX LU; ; ;  MSProducts of the hydrolysis of chlorophylls, in which the phytic acid side chain has been removed and the carboxylic acids saponified. HN(75) MHÑChlorophyllides ANdo not use /analogs /defic /physiol PIChlorophyll (72-74) MND11.557.727.220.180; D11.557.727.640.220.180 DMÑChlorophyll LH LM  MSChlorophyll-containing plastids functioning in photosynthesis. PM66 HN66(64) MHÑChloroplasts ANA 11 qualif except /cytol; /class permitted; coord IM with PLANTS, ALGAE or specific plant or alga usually NIM MNA11.368.702.140 XSGrana FXÑPHOTOSYNTHESIS LH LS LX  MS2-Chloro-1,3-butadiene. Toxic, possibly carcinogenic, monomer of neoprene, a synthetic rubber; causes damage to skin, lungs, CNS, kidneys, liver, blood cells and fetuses. Synonym: 2-chlorobutadiene. HN(79) MHÑChloroprene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN126-99-8 PIButadienes (66-78); Neoprene (75-78) MND2.455.326.271.665.146.280 DMÑButadienes LH LM  MHÑChloroquine ANdo not use /biosyn /defic /physiol RN54-05-7 MND3.438.810.50.180; D21.370.107.185; D21.370.286.245 LH  MS8-Hydroxyquinolinols chlorinated on the number 5 and/or 7 carbon atom(s). They are antibacterial, antiprotozoal, and antidiarrheal, especially in amebiasis; also used as antiseborrheic; mostly used topically, also as animal feed additive; may cause optic and other neuropathies; most frequently as combination with other agents. HN(65); was see under HYDROXYQUINOLINES back thru 1975 MHÑChloroquinolinols ANdo not use /analogs /biosyn /defic /physiol MND3.438.810.350.350.150; D21.370.107.230 DMÑHydroxyquinolines LH LM  PM/adverse effects /poisoning /toxicity were CHLOROTHIAZIDE TOXICOLOGY 1963-65 HN/ad-poi-tox was CHLOROTHIAZIDE TOXICOLOGY 1963-65 MHÑChlorothiazide ANdo not use /biosyn /defic /physiol RN58-94-6 MND3.438.174.261; D18.162.276.237; D19.770.224.578.237 XSChlorthiazid LH LS  PM65 HN65(64) MHÑChlorotrianisene ANdo not use /biosyn /defic /physiol RN569-57-3 MND6.597.350.200; D6.597.378.166 XSTrianisoestrol LH LS  MSN'-(4-Chloro-o-tolyl)-N,N-dimethylformamidine. An acaricide used against many organophosphate and carbamate resistant pests. It acts as an uncoupling agent and monoamine oxidase inhibitor. HN(75) MHÑChlorphenamidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN6164-98-3 PIAmidines (71-74); Toluene (72-74) MND2.78.200; D5.723.491.200 XSChlordimeform DMÑAmidines LH LS LM  PM74 HN74(64) MHÑChlorphenesin ANdo not use /biosyn /defic /physiol RN104-29-0 MND2.33.618.706.345 LH  MS2-[p-Chloro-alpha-(2-dimethylaminoethyl)benzyl]pyridine. Histamine H1 blocker widely used in allergic reactions, hay fever, rhinitis, urticaria; also in animals; available as the racemic mixture, dextro or levo forms, maleate or tannate salts. Synonyms: Allergisan; Chlortrimeton, Cloropiril; Histadur; Piriton; Teldrin. PM65 HN65(63) MHÑChlorpheniramine ANdo not use /biosyn /defic /physiol RN132-22-9 MND3.383.725.620.165; D23.654.432.718.198 XSCHLORPROPHENPYRIDAMINE; Chlorphenamine LH LS;  HN(66) MHÑChlorphentermine ANdo not use /biosyn /defic /physiol RN461-78-9 MND2.92.471.683.152.766.262; D26.128.127.751.345 DMÑPhentermine LH LM  PM/adverse effects /poisoning /toxicity were CHLORPROMAZINE TOXICOLOGY 1963-65 HN/ad-poi-tox was CHLORPROMAZINE TOXICOLOGY 1963-65 MHÑChlorpromazine ANdo not use /biosyn /defic /physiol RN50-53-3 MND3.494.741.198; D15.236.872.331.628.208 LH  MHÑChlorpropamide ANdo not use /biosyn /defic /physiol RN94-20-2 MND2.886.590.795.283; D2.948.828.283; D9.482.246 XSClorpropamid LH LS  HN(72) MHÑChlorpropham ANdo not use /biosyn /defic /physiol; /analogs NIM only RN101-21-3 PICarbamates (66-71); Herbicides (66-71) MND2.241.81.251.200; D5.723.366.448.196 DMÑHerbicides, Carbamate LH LM  MHÑChlorprothixene ANdo not use /biosyn /defic /physiol RN113-59-7 MND3.494.953.704.250; D15.236.872.659.321 LH  MS5,7-Dichloro-2-methyl-8-quinolinol. Local anti-infective agent used for skin, gastrointestinal, and vaginal infections with fungi, protozoa, and certain bacteria; also in animals causes CNS damage and is not administered parenterally; also used as antiseptic, fungistat, or deodorant. HN(83)63 MHÑChlorquinaldol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN72-80-0 MND3.438.810.350.350.150.160; D20.136.172 XSChlorchinaldol DMÑHydroxyquinolines LH LS LM  MHÑChlortetracycline ANdo not use /defic /physiol RN57-62-5 MND20.85.868.146 LH  MHÑChlorthalidone ANdo not use /biosyn /defic /physiol RN77-36-1 MND2.65.884.365; D2.886.590.700.365; D19.770.224.516.196 XSChlorphthalidolone; Phthalamudine LH LS;  HN(66) MHÑChlorzoxazone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN95-25-0 MND3.438.221.346; D17.426.950.346 DMÑBenzoxazoles LH LM  MSCongenital bony or membranous occlusion of one or both choanae, due to failure of the embryonic bucconasal membrane to rupture. PM86 HN86 MHÑChoanal Atresia ANdo not use /congen PINasal Cavity/AB (75-85); Nose/AB (66-74) MNC9.603.171; C16.131.621.99 LH  MSThe act of making a selection among two or more alternatives, usually after a period of deliberation. OLsearch DECISION MAKING 1974 PM79; was see under DECISION MAKING 1974-78; CAREER CHOICE was see under DECISION MAKING 1975-80 HN79(75); was see under DECISION MAKING 1974-78 MHÑChoice Behavior ANonly /drug eff /physiol /rad eff PIDecision Making (74) MNF2.463.785.373.346 LH  MHÑCholagogues and Choleretics ANdo not use /analogs /biosyn /defic /physiol; DF: CHOLAGOGUES MND19.316.508 XSCholeretics FXÑBiliary Tract LH LS LX  PM68 HN68 MHÑCholanes ANdo not confuse with CHOLENES; do not use /analogs /biosyn /defic /physiol MND4.808.221 LH  MHÑCholangiography ANdo not use /util except by MeSH definition MNE1.184.138; E1.818.701.196 FXÑBiliary Tract; ÑBiliary Tract Diseases LH LX;  MHÑCholangioma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific bile duct (IM) + BILE DUCT NEOPLASMS (IM) MNC4.557.576.237 LH  MSFiberoptic endoscopy designed for duodenal observation and cannulation of Vater's ampulla, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy may be performed during this procedure. PM81 HN81 MHÑCholangiopancreatography, Endoscopic Retrograde ANdo not use /util except by MeSH definition PICholangiography (66-80); Endoscopy (66-80); Pancreas (66-80) MNE1.184.138.195; E1.418.201; E1.818.701.196.195 XSERCP; Endoscopic Retrograde Cholangiopancreatography LH LS;  MSInflammation of a bile duct. MHÑCholangitis MNC6.130.120.200 LH  OLuse CHOLECALCIFEROLS to search CHOLECALCIFEROL & VITAMIN D 3 back thru 1966 PM75; was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66 HN75; was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66 MHÑCholecalciferols ANdo not use /analogs; /defic permitted but coord IM with VITAMIN D DEFICIENCY (IM) MND4.808.247.222.159; D4.808.247.808.146; D4.808.812.221; D10.516.851.152; D11.786.763.196 XSVitamin D 3 LH LS  MHÑCholecystectomy ANdo not use /util except by MeSH definition MNE4.765.172 FXÑGallbladder LH LX  MSInflammation of the gallbladder. MHÑCholecystitis MNC6.130.564.263 XSEmpyema, Gallbladder LH LS  MSRadiography of the gallbladder after ingestion of a contrast medium. MHÑCholecystography ANdo not use /util except by MeSH definition MNE1.184.179; E1.818.701.296 FXÑBiliary Tract; ÑGallbladder LH LX;  MSA 33 amino acid peptide secreted by the upper intestinal mucosa and also found in the CNS; may be the neuroregulator in olfaction; causes gall bladder contraction, release of pancreatic exocrine (or digestive) enzymes and affects other gastrointestinal functions; may be the mediator of satiety. OLuse CHOLECYSTOKININ to search PANCREOZYMIN back thru 1966 (as Prov 1966) PMPANCREOZYMIN was heading 1967-76 HNPANCREOZYMIN was heading 1963-76 (Prov 1963-66), was see under GASTROINTESTINAL HORMONES 1963-66 MHÑCholecystokinin AN/biosyn /physiol permitted RN9011-97-6 MND6.472.317.152; D12.644.120; D12.776.641.650.105; D16.538.198; D19.316.629.159 XSPancreozymin LH LS  MSPresence or formation of gallstones. OLto search for chem composition of biliary calculi, use CHOLELITHIASIS/anal back thru 1987 & CHOLELITHIASIS/metab 1966-86 MHÑCholelithiasis ANcalculi of gallbladder or bile ducts; assume to be of gallbladder & do not coord with GALLBLADDER DISEASES; calculi of bile ducts: coord IM with BILE DUCT DISEASES (NIM) but calculi of specific bile duct, coord IM with specific duct (IM); chem composition of calculi: use /anal; /ultrastruct permitted; note COMMON BILE DUCT CALCULI is available MNC6.130.409; C6.130.564.300 XSBILIARY CALCULI; GALLSTONES LH LS;  MSSteroids with methyl groups at C-10 and C-13 and a branched five-carbon chain at C-17. Must have at least one double bond in the ring system. OLsearch CHOLANES 1973-74 PM75; was see under CHOLANES 1973-74 HN75; was see under CHOLANES 1973-74 MHÑCholenes ANdo not confuse with CHOLANES or CHOLINE; includes choladienes, cholatrienes; do not use /analogs /biosyn /defic /physiol PICholanes (68-74) MND4.808.221.263 LH  MHÑCholera MNC1.252.959.347 LH  MSThe exotoxin from Vibrio cholerae; it is a protein that consists of two major components, the heavy (H) or A peptide and the light light (L) or B peptide or choleragenoid which binds the whole protein to cell membranes, is nontoxic, but immunogenic; the A fragment causes cholera, probably due to the activation of adenylate cyclase; it consists of two polypeptide fragments. PM78 HN78 MHÑCholera Toxin ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS RN9012-63-9 PIBacterial Proteins (66-77); Bacterial Toxins (77); Enterotoxins (66-77); Toxins (66-67) MND24.185.926.123.194 XSCholeragen; Choleragenoid FXÑVibrio cholerae LH LS; LX  PM65 HN65 MHÑCholera Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.135.222 LH  MSSteroids with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. Must have two double bonds in the ring system. OLsearch CHOLESTENES 1974 PM75; was see under CHOLESTENES 1974 HN75; was see under CHOLESTENES 1974 MHÑCholestadienes ANdo not confuse with CHOLESTADIENOLS; do not use /analogs /defic /physiol PICholestenes (73-74) MND4.808.247.222.222 LH  PM74; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66 HN74 MHÑCholestadienols ANdo not confuse with CHOLESTADIENES; do not use /analogs /defic /physiol MND4.808.247.222.222.347 XUÑDehydrocholesterols LH LU  PM68 HN68 MHÑCholestanes ANdo not confuse with CHOLESTENES; do not use /analogs /defic /physiol MND4.808.247 XUÑCholestanones LH LU  MSCholestanes substituted in any position with one or more hydroxy groups. Found in feces and bile. In contrast to bile acids and salts, they are not reabsorbed. PM78 HN78 MHÑCholestanols ANdo not use /analogs; beta-cholestanol = BETA-CHOLESTANOL (see DIHYDROCHOLESTEROL) PICholestanes (68-77); Sterols (64-77) MND4.808.247.100 XSBile Alcohols; Hydroxycholestanes LH LS;  MSCholestanes substituted with any number of keto groups. HN(75) MHÑCholestanones ANdo not confuse with CHOLESTENONES; includes cholestanediones, cholestanetriones; do not use /analogs /defic /physiol PICholestanes (68-74) MND4.808.247.125 DMÑCholestanes LH LM  MSImpairment of biliary flow at any level from the hepatocyte to Vater's ampulla. OLuse CHOLESTASIS to search JAUNDICE, OBSTRUCTIVE back thru 1966 PM72; JAUNDICE, OBSTRUCTIVE was heading 1963-79 HN72(69); JAUNDICE, OBSTRUCTIVE was heading 1963-79 MHÑCholestasis AN╥mechanical jaundice╙ goes here MNC6.130.450; C23.888.498.250 XSBile Duct Obstruction; Biliary Stasis; Jaundice, Cholestatic; Jaundice, Obstructive LH LS; ; ;  MSIntrahepatic impairment of bile flow. Usually due to liver cell damage, but may be due to obstruction of intrahepatic bile ducts. Synonyms: hepatocellular jaundice; medical jaundice. PM80 HN80 MHÑCholestasis, Intrahepatic ANalso called hepatocellular jaundice & medical jaundice PIBile Ducts, Intrahepatic (66-79); Cholestasis (66-79); Liver (66-79) MNC6.130.450.250; C6.552.150; C23.888.498.250.250 XSBile Duct Obstruction, Intrahepatic; Biliary Stasis, Intrahepatic; Jaundice, Cholestatic, Intrahepatic; Jaundice, Obstructive, Intrahepatic LH LS; ; ;  MHÑCholesteatoma ANnon-neoplastic: coord IM with organ /dis heading; /anal /blood supply /secret /ultrastruct permitted MNC4.557.576.261 LH  MSSteroids with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. Must have one or more than two double bonds in the ring system. PM73; INOKOSTERONE was see under INVERTEBRATE HORMONES 1972-74 HN73 MHÑCholestenes ANdo not confuse with CHOLESTANES; includes cholestatrienes; do not use /analogs /defic /physiol PICholestanes (68-72) MND4.808.247.222 XUÑCholestenones LH LU  MSCholestenes with one or more double bonds and substituted by any number of keto groups. HN(75) MHÑCholestenones ANdo not confuse with CHOLESTANONES; includes cholestenediones, cholestenetriones; do not use /analogs /defic /physiol PICholestenes (73-74) MND4.808.247.222.265 DMÑCholestenes LH LM  OLuse CHOLESTEROL to search BLOOD CHOLESTEROL 1966-67 PM/blood was BLOOD CHOLESTEROL 1963-67; DIHYDROCHOLESTEROL was see under CHOLESTANES 1969-72, was see under STEROLS 1967-68 HN/blood was BLOOD CHOLESTEROL 1963-67 MHÑCholesterol AN/antag = ANTICHOLESTEREMIC AGENTS; /biosyn /physiol permitted; /blood: consider also HYPERCHOLESTEROLEMIA & specifics; cholesterol granuloma = CHOLESTEROL + GRANULOMA; dietary cholesterol = CHOLESTEROL, DIETARY; 24-DEHYDROCHOLESTEROL = DESMOSTEROL; OXOCHOLESTEROLS = KETOCHOLESTEROLS; note CHOLESTEROL, DIETARY & CHOLESTEROL HDL & CHOLESTEROL LDL below RN57-88-5 MND4.808.247.222.284; D4.808.247.808.197; D10.516.851.208 XUÑ19-Iodocholesterol; ÑAzacosterol; ÑDihydrocholesterol; ÑKetocholesterols LH LU; ; ;  MSAcyl-CoA:cholesterol O-acyltransferase. Catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa and aorta of many mammalian species. PM85; was see under ACYLTRANSFERASES 1976-84 HN85(76); was see under ACYLTRANSFERASES 1976-84 MHÑCholesterol Acyltransferase ANdo not use /analogs RNEC 2.3.1.26 PIAcyltransferases (73-75); Cholesterol (73-75); Coenzyme A (73-75) MND8.586.913.50.380 XSAcyl-CoA-Cholesterol Acyltransferase LH LS  MSMulti-enzyme complex required for the conversion of cholesterol to adrenal cortex hormones. Releases methylpentanoate or isocaproaldehyde and pregnenolone. Contains cytochrome P-450, a flavoprotein, a non-heme iron protein and NADPH. HN(75) MHÑCholesterol Desmolase ANdo not use /analogs RNEC 1.14.15.6 PICholesterol (71-74); Multienzyme Complexes (73-74); Oxidoreductases (71-74) MND8.586.600.200; D8.586.682.250 XSCholesterol Side Chain Cleavage Enzyme DMÑOxidoreductases LH LS LM  MSSterol-ester hydrolase. Catalyzes the hydrolysis of cholesterol and some other sterol esters, to liberate cholesterol plus a fatty acid anion. HN(75); was see under ESTERASES 1975 MHÑCholesterol Esterase ANdo not use /analogs RNEC 3.1.1.13 PIEsterases (73-74); Cholesterol (73-74) MND8.586.277.352.100.150 DMÑCarboxylic Ester Hydrolases LH LM  MSFatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. PM78; was see under CHOLESTEROL 1976-77 HN78(76); was see under CHOLESTEROL 1976-77 MHÑCholesterol Esters ANdo not use /analogs /defic /physiol PICholesterol (66-77); Esters (68-77) MND4.808.247.222.284.200; D4.808.247.808.197.200; D10.516.851.208.250 LH  MSCholesterol:oxygen oxidoreductase. Catalyzes the oxidation of cholesterol in the presence of molecular oxygen to 4-cholesten-3-one and hydrogen peroxide. The enzyme is not specific for cholesterol, but will also oxidize other 3-hydroxysteroids. EC 1.1.3.6. HN(78) MHÑCholesterol Oxidase ANdo not use /analogs RNEC 1.1.3.6 PICholesterol (66-77); Hydroxysteroid Dehydrogenases (66-77) MND8.586.682.47.436.350.150 DMÑ3-Hydroxysteroid Dehydrogenases LH LM  MSCholesterol,NADPH: oxygen oxidoreductase (7-hydroxylating). Catalyzes the hydroxylation of cholesterol to cholest-5-en-3 beta,7 alpha-diol. HN(75) MHÑCholesterol-7-Hydroxylase ANdo not use /analogs RNEC 1.14.13.17 PICholesterol (74); Steroid Hydroxylases (74) MND8.586.682.420.783.200 DMÑSteroid Hydroxylases LH LM  PM73 HN73 MHÑCholesterol, Dietary ANonly /admin /adv eff (coord with disease /etiol, not /chem ind) /anal /class /metab /pharm PICholesterol (66-72); Dietary Fats (66-72) MND10.516.212.302.347; D10.516.851.208.222 XSDIETARY CHOLESTEROL FXÑDiet, Atherogenic LH LS LX  MSPolystyro-trimethylammonium hydroxide. Strongly basic anion exchange resin that exchanges chloride ions with bile salts, thus decreasing their concentration and that of cholesterol; used as hypocholesteremic, in diarrhea, biliary obstruction and as antipruritic. Synonyms: Cuemid; MK 135; Quantalan; Questran. PM66 HN66(64) MHÑCholestyramine AND25-26 qualif RN11041-12-6 MND10.162.202.159; D25.720.716.579.159; D26.572.133.397 XSColestyramin; MK-135 LH LS;  MS3-alpha, 7-alpha, 12-alpha-Trihydroxy-5-beta-cholanic acid. Bile acids in man, usually conjugated with glycine or taurine; acts as detergent to solubilize fats for intestinal absorption; reabsorbed by the small intestine; used as laxative, cholagogue and choleretic. Synonyms: Colalin; Hypocholate; Cholagit. OLto search CHOLIC ACID use CHOLIC ACIDS back thru 1973 (as Prov 1973) & BILE ACIDS AND SALTS 1966-72 PM75; was CHOLIC ACID 1974, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73 HN75; was CHOLIC ACID 1973-74 (Prov 1973), was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73 MHÑCholic Acids ANdo not use /analogs; /biosyn /physiol permitted; cholic acid glycine conjugate = GLYCOCHOLIC ACID; cholic acid taurine conjugate = TAUROCHOLIC ACID PIBile Acids and Salts (66-72) MND4.808.221.430; D19.316.246.225 XSCholalic Acids; Cholates LH LS;  MHÑCholine AN/biosyn /physiol permitted; /defic = CHOLINE DEFICIENCY RN62-49-7 MND2.33.329.291.211; D2.92.63.291.211; D2.92.102.232; D2.675.276.232; D10.642.197 XSBursine; Fagine; Vidine XUÑAcetylthiocholine; ÑBenzoylcholine; ÑButyrylthiocholine; ÑCytidine Diphosphate Choline; ÑPhosphorylcholine; ÑPropylbenzilylcholine Mustard; ÑThiocholine LH LS; ; LU; ; ; ; ; ;  MSAcetyl-CoA;choline O-acetyltransferase. Catalyzes the formation of acetylcholine from acetyl-CoA and choline. PM78; was see under ACETYLTRANSFERASES 1975-77 HN78(75); was see under ACETYLTRANSFERASES 1975-77 MHÑCholine Acetyltransferase ANdo not use /analogs RNEC 2.3.1.6 PIAcetyltransferases (73-74); Choline (66-74); Transferases (66-72) MND8.586.913.50.134.180 XSCholine Acetylase LH LS  PM67 HN67(64) MHÑCholine Deficiency MNC18.654.223.133.699.160 LH  MSATP:choline phosphotransferase. This enzyme is active in the first step of the choline phosphoglyceride (lecithin) biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of ATP. Ethanolamine and its methyl and ethyl derivatives can also act as acceptors. HN(76) MHÑCholine Kinase ANdo not use /analogs RNEC 2.7.1.32 PICholine (74-75); Phosphotransferases, ATP (74-75) MND8.586.913.696.729.150 XSATP Choline Transphosphatase DMÑPhosphotransferases, ATP LH LS LM  MSCDPcholine:1,2-diacylglycerol cholinephosphotransferase. Catalyzes the synthesis of phosphatidylcholines from CDPcholine and 1,2-diacylglycerols. HN(75) MHÑCholinephosphotransferase ANdo not use /analogs RNEC 2.7.8.2 PICholine (73-74); Cytosine Nucleotides (73-74); Glycerides (73-74); Phosphotransferases (73-74) MND8.586.913.696.150 XSPhosphorylcholine Glyceride Transferase DMÑPhosphotransferases LH LS LM  MSNerve fibers liberating acetylcholine at the synapse after an impulse. PM77 HN77 MHÑCholinergic Fibers ANdo not use /innerv PIParasympathetic Nervous System (66-76) MNA8.99.698.200; A8.663.542.234 LH  OLuse CHOLINESTERASE INHIBITORS to search CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE back thru 1971 (as Prov 1971-74) PM65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted 1965) HN65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83, were Prov 1971-74; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted 1965) MHÑCholinesterase Inhibitors ANdo not use /analogs /antag /biosyn /defic /physiol; DF: CHOLINESTERASE INHIB MND8.373.275; D16.698.410 XSANTICHOLINESTERASE AGENTS; Acetylcholinesterase Inhibitors FXÑINSECTICIDES LH LS; LX  PM72 HN72(71) MHÑCholinesterase Reactivators ANdo not use /analogs /biosyn /defic /physiol; note X refs below PIAcetylcholinesterase (66-70); Cholinesterases (66-70); Oximes (66-70); Pralidoxime Compounds (66-70); Pyridines (66-70); Pyridinium Compounds (68-70) MND8.515.347; D16.653.211 XSInsecticides, Organophosphate, Antagonists; Insecticides, Organothiophosphate, Antagonists FXÑAntidotes LH LS; LX  OLuse CHOLINESTERASES to search CHOLINESTERASE back thru 1966 PM75; was CHOLINESTERASE 1963-74 HN75; was CHOLINESTERASE 1963-74 MHÑCholinesterases ANdo not use /analogs; /antag = CHOLINESTERASE INHIBITORS; reactivation: index under CHOLINESTERASE REACTIVATORS RNEC 3.1.1.8 MND8.586.277.352.100.170 XUÑButyrylcholinesterase; ÑPseudocholinesterase LH LU;  MSdelta 4,5-beta-O-Glucuronosyl-(1,4)-2-acetamido-2-deoxy-D-galactose-4-sulfate 4-sulfohydrolase. An arylsulfatase, which catalyzes the hydrolysis of the 4-sulfate groups of the disaccharide repeating units from chondroitin sulfate N-acetylgalactosamine 4-sulfate. The deficiency of chondro-4-sulfatase has been proposed as the defect in Maroteaux-Lamy syndrome (mucopolysaccharidosis VI). HN(76) MHÑChondro-4-Sulfatase ANdo not use /analogs RNEC 3.1.6.9 PIChondroitin (74-75); Sulfatases (74-75) MND8.586.277.352.827.70.275 XSArylsulfatase B DMÑSulfatases LH LS LM  MHÑChondroblastoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.152 LH  PM72 HN72 MHÑChondrocalcinosis PICalcinosis (66-71); Joint Diseases (66-71) MNC5.550.114.264 XSPSEUDOGOUT FXÑCalcinosis LH LS LX  OLuse CHONDRODYSPLASIA PUNCTATA to search CHONDRODYSTROPHIA CALCIFICANS CONGENITA back thru 1966 (as Prov 1966) PM85; was CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1967-84 HN85; was CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1964-84 (Prov 1964-66) MHÑChondrodysplasia Punctata ANdo not use /congen MNC5.116.99.708.195 XSChondrodystrophia Calcificans Congenita; Conradi-Hunermann Syndrome; DYSPLASIA EPIPHYSIALIS PUNCTATA; EPIPHYSES, STIPPLED; STIPPLED EPIPHYSES LH LS; ; ; ;  MHÑChondroitin AN/biosyn /physiol permitted; CHONDROITIN SULFATE B = DERMATAN SULFATE RN9007-27-6 MND9.203.698.582.160 FXÑCartilage XUÑChondroitin Sulfates; ÑDermatan Sulfate LH LX LU;  MSEnzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C. HN(76) MHÑChondroitin Lyases ANdo not use /analogs RNEC 4.2.2.- PIChondroitin (70-75); Lyases (70-74); Polysaccharide-Lyases (75) MND8.586.520.726.180.175 XSChondroitin ABC Lyase; Chondroitin AC Lyase; Chondroitin B Lyase; Chondroitin Eliminase; Chondroitin Sulfate Lyase DMÑChondroitinases LH LS; ; ; ; LM  MSDerivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A or chondroitin-4-sulfate and chondroitin sulfate C or chondroitin-6-sulfate have the sulfate esterified in the 4 and 6 positions, respectively. Chondroitin sulfate B (beta heparin; dermatan sulfate) is a misnomer and this compound is not a true chondroitin sulfate. HN(76) MHÑChondroitin Sulfates ANdo not use /analogs; 4-sulfate = CHONDROITIN SULFATE A, 6-sulfate = CHONDROITIN SULFATE C; CHONDROITIN SULFATE B = DERMATAN SULFATE PIChondroitin (71-75); Sulfuric Acids (71-75) MND9.203.698.582.160.280 XSChondroitin Sulfate A; Chondroitin Sulfate C DMÑChondroitin LH LS; LM  MSEnzymes which catalyze the elimination of glucuronate residues from chondroitin A,B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. PM76 HN76 MHÑChondroitinases ANdo not use /analogs PIChondroitin (70-75); Lyases (70-74); Polysaccharide-Lyases (75); Sulfatases (70-75) MND8.586.277.352.827.180; D8.586.520.726.180 XUÑChondroitin Lyases; ÑChondroitinsulfatase LH LU;  MSChondroitinsulfate sulfohydrolase. Catalyzes the hydrolysis of the 6-sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate G. HN(76) MHÑChondroitinsulfatase ANdo not use /analogs RNEC 3.1.6.4 PIChondroitin (70-75); Sulfatases (70-75) MND8.586.277.352.827.180.175 DMÑChondroitinases LH LM  MHÑChondroma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.180; C4.557.537.198 LH  MHÑChondrosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.208; C4.557.863.173 LH  PM65 HN65(63) MHÑChorda Tympani Nerve ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.324.264 LH  MSThe tendinous cords that connect each cusp of the two atrioventricular valves to appropriate papillary muscles in the heart ventricles, preventing the valves from reversing themselves when the ventricles contract. MHÑChordae Tendineae ANdo not use /blood supply; for disease, coord IM with HEART DISEASES (IM) MNA7.541.510.240 LH  MHÑChordata AN/microbiol /parasitol permitted MNB1.272 LH  MHÑChordoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.218 LH  PM66 HN66(63) MHÑChordotomy ANalso called cordotomy; do not use /util except by MeSH definition MNE4.530.324.169 FXÑSpinal Cord LH LX  MHÑChorea ANnote entry below; choreoathetosis = CHOREA (IM) + ATHETOSIS (IM) MNC10.228.140.79.255; C10.597.559.284; C23.888.592.574.288 LH  MHÑChorioadenoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE & PREGNANCY MNC4.557.537.949.223; C13.703.720.949.223 LH  MSAn inflammatory process involving the chorion, its fetal blood vessels, the umbilical cord, and the amnion by extension of the inflammation, as it has no blood supply. This inflammatory process is potentially fatal to mother and fetus. PM85 HN85 MHÑChorioamnionitis ANdo not use /congen PIAmnion (66-84); Chorion (75-84); Fetal Membranes, Premature Rupture (75-84); Pregnancy Complications, Infectious (66-84) MNC13.703.277.30; C13.703.420.339.260; C13.703.590.268; C16.614.330.30 XSAmnionitis LH LS  MHÑChoriocarcinoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE & PREGNANCY MNC4.557.537.949.348; C13.703.720.949.348 LH  MSThe outermost extraembryonic membrane. OLsearch FETAL MEMBRANES 1966-74 PM78; was see under FETAL MEMBRANES 1963-77 HN78(75); was see under FETAL MEMBRANES 1963-77 MHÑChorion ANdo not use /abnorm /embryol /growth /inj PIFetal Membranes (66-74) MNA16.254.403.473 LH  MSThe threadlike, vascular projections of the chorion which enter into the formation of the placenta. PM85; was see under PLACENTA 1975-84 HN85(75); was see under PLACENTA 1975-84 MHÑChorionic Villi ANA 11 qualif except /cytol PIFetal Membranes (66-74); Placenta (66-74) MNA16.254.403.473.200; A16.759.189 XSPlacental Villi LH LS  MHÑChorioretinitis MNC11.768.773.348; C11.941.198.200 LH  MSAn isomerase which catalyzes the conversion of chorismic acid to prephenic acid. Molecular weight approximately 55,000. HN(75) MHÑChorismate Mutase ANdo not use /analogs RNEC 5.4.99.5 PICyclohexanecarboxylic Acids (69-74); Isomerases (69-74); Vinyl Compounds (72-74) MND8.586.399.310 XSChorismate Pyruvatemutase DMÑIsomerases LH LS LM  MStrans-3[1-Carboxyvinyl-oxy]-4-hydroxy-1,5-cyclohexadiene-1-carboxylic acid. HN(75) MHÑChorismic Acid ANdo not use /defic /physiol; /analogs NIM only RN617-12-9 PICyclohexanecarboxylic Acids (69-74); Vinyl Compounds (72-74) MND2.241.223.268.250 DMÑCyclohexanecarboxylic Acids LH LM  MSA mass of histologically normal tissue present in an abnormal location. MHÑChoristoma ANcoord aberrant or heterotopic tissue of an organ under the organ without qualif, e.g., heterotopic pancreatic tissue in the duodenum = CHORISTOMA (IM) + DUODENAL NEOPLASMS (IM) + PANCREAS (no qualif) (IM); /anal /blood supply /secret /ultrastruct permitted MNC4.131 XSAberrant Tissue; Ectopic Tissue; Heterotopic Tissue LH LS; ;  MHÑChoroid ANin the eye: do not confuse with CHOROID PLEXUS (in the brain); inflammation = CHOROIDITIS or CHORIORETINITIS; diseases: coord IM with UVEAL DISEASES (NIM) MNA9.371.894.223 LH  MHÑChoroid Neoplasms ANof the eye: do not confuse with neopl of CHOROID PLEXUS ( = CHOROID PLEXUS (IM) + CEREBRAL VENTRICLE NEOPLASMS (IM) ); /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.364.978.223; C11.319.494.198; C11.941.855.198 LH  MHÑChoroid Plexus ANin the brain: do not confuse with CHOROID (in the eye); do not use /innerv; neopl = CHOROID PLEXUS (IM) + CEREBRAL VENTRICLE NEOPLASMS (IM) MNA8.186.211.276.298 LH  HN(87) MHÑChoroidal Hemorrhage PIChoroid (66-86); Hemorrhage (66-86) MNC11.290.195; C11.941.177; C23.542.290.195 DMÑEye Hemorrhage LH LM  PM66 HN66(64) MHÑChoroiditis ANof the eye, not of the choroid plexus; consider also CHORIORETINITIS MNC11.941.198 LH  MHÑChristian Science ANonly /hist MNK1.844.188.431 LH  MHÑChristianity ANonly /hist; Mormons go here MNK1.844.188 XSJehovah's Witnesses; Protestantism; Stigmatization LH LS; ;  MHÑChristmas Disease ANnamed for the first patient studied in detail, not the Holy Day MNC15.378.463.134.210 XSFactor IX Deficiency; Hemophilia B LH LS;  MSGranules in the adrenal glands and various other organs, which are concerned with the synthesis, storage, metabolism, and secretion of epinephrine and norepinephrine. HN(78) MHÑChromaffin Granules ANA 11 qualif except /cytol PIChromaffin System (66-77); Cytoplasmic Granules (66-77) MNA6.224.207; A11.368.246.207 DMÑChromaffin System LH LM  MSThe cells of the body which stain with chromium salts. They occur along the sympathetic nerves, in the adrenal gland and in various other organs. MHÑChromaffin System MNA6.224 XSARGENTAFFIN SYSTEM XUÑChromaffin Granules; ÑEnterochromaffin Cells; ÑPara-Aortic Bodies; ÑParaganglia, Chromaffin LH LS LU; ; ;  MSBenzopyrans saturated in the 2 and 3 positions. HN(75) MHÑChromans ANdo not confuse with CHROMONES; do not use /analogs /biosyn /defic /physiol PIBenzopyrans (68-74) MND3.438.150.240 XSDihydrobenzopyrans DMÑBenzopyrans LH LS LM  MHÑChromates ANdo not use /analogs /biosyn /defic /physiol MND1.552.165.199 XUÑPotassium Dichromate LH LU  MSGenerally strictly anaerobic organisms found in the anaerobic and sulfide-containing parts of all kinds of aquatic environments. OLuse CHROMATIACEAE to search THIORHODACEAE back thru 1975 PM76; was THIORHODACEAE 1975 HN76; was THIORHODACEAE 1975 MHÑChromatiaceae ANin mud & water containing sulfides PIBacteria (66-74) MNB3.650.700.300 XSThiorhodaceae LH LS  PM68 HN68 MHÑChromatids ANA 11 qualif except /cytol; SISTER CHROMATID EXCHANGE is available PIChromosomes (66-67) MNA11.223.475.144 LH  PM72 HN72 MHÑChromatin ANA 11 qualif except /cytol /pathol; /isol permitted (Cat D) PIChromosomes (66-71); Sex Chromatin (66-71) MNA11.223.349; D12.776.664.224 LH  MHÑChromatium ANin water MNB3.650.700.300.349 LH  PM66 HN66 MHÑChromatography ANNIM; only /instrum /methods; on Sephadex G = GEL FILTRATION (see CHROMATOGRAPHY, GEL); on DEAE Sephadex = CHROMATOGRAPHY, ION EXCHANGE MNE5.196.181; H1.181.278.186 LH  PM74 HN74(72) MHÑChromatography, Affinity ANNIM; only /instrum /methods PIChromatography (66-71); appropriate substances used for binding MNE5.196.181.400.170; H1.181.278.186.400.170 LH  MSA method of gel filtration (chromatography) using agarose, the non-ionic component of agar, for the separation of compounds with molecular weights up to several million. HN(75) MHÑChromatography, Agarose ANNIM; only /instrum /methods MNE5.196.181.400.250.200; H1.181.278.186.400.250.200 DMÑChromatography, Gel LH LM  PM70 HN70 MHÑChromatography, DEAE-Cellulose ANNIM; only /instrum /methods; do not confuse with chromatography on DEAE Sephadex ( = CHROMATOGRAPHY, ION EXCHANGE) PIChromatography (66-69) MNE5.196.181.400.383.349; H1.181.278.186.400.383.349 XSDEAE-CELLULOSE CHROMATOGRAPHY LH LS  MSFractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. PM66 HN66 MHÑChromatography, Gas ANNIM; only /instrum /methods MNE5.196.181.349; H1.181.278.186.312 XSChromatography, Gas-Liquid XUÑFlame Ionization LH LS LU  MSChromatography on non-ionic gels without regard to the mechanism of solute discrimination. OLuse CHROMATOGRAPHY, GEL to search GEL FILTRATION back thru 1966 & CHROMATOGRAPHY, EXCLUSION back thru 1973 PM76; was GEL FILTRATION 1966-75 HN76; was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75 MHÑChromatography, Gel ANNIM; only /instrum /methods MNE5.196.181.400.250; H1.181.278.186.400.250 XSChromatography, Exclusion; Chromatography, Gel Permeation; Chromatography, Molecular Sieve; Gel Filtration XUÑChromatography, Agarose LH LS; ; ; LU  MSLiquid chromatographic technics which feature high inlet pressures, high sensitivity, and high speed. OLuse CHROMATOGRAPHY, HIGH PRESSURE LIQUID to search CHROMATOGRAPHY, HIGH SPEED LIQUID back thru 1976 PM81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80 HN81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80 MHÑChromatography, High Pressure Liquid ANNIM; only /instrum /methods; DF: HPLC PIChromatography (66-75) MNE5.196.181.400.300; H1.181.278.186.400.300 XSChromatography, High Performance Liquid; Chromatography, High Speed Liquid; Chromatography, Liquid, High Pressure LH LS; ;  PM66 HN66 MHÑChromatography, Ion Exchange ANNIM; only /instrum /methods MNE5.196.181.400.383; H1.181.278.186.400.383 LH  MSChromatographic technics in which the mobile phase is a liquid. PM76 HN76 MHÑChromatography, Liquid ANNIM; only /instrum /methods; note CHROMATOGRAPHY, GAS-LIQUID & CHROMATOGRAPHY, GAS-LIQUID-MASS SPECTROMETRY above PIChromatography (66-75) MNE5.196.181.400; H1.181.278.186.400 LH  PM66 HN66 MHÑChromatography, Paper ANNIM; only /instrum /methods MNE5.196.181.400.454; H1.181.278.186.400.454 LH  PM66 HN66 MHÑChromatography, Thin Layer ANNIM; only /instrum /methods MNE5.196.181.400.537; H1.181.278.186.400.537 LH  MSAny pigmentary cell or color-producing plastid. MHÑChromatophores ANA 11 qualif; /class permitted MNA11.436.265 FXÑPigmentation LH LX  MHÑChromium ANCr-52; do not use /analogs /biosyn /defic /physiol; isotopes: see below RN7440-47-3 MND1.268.195; D1.552.165; D1.937.177 LH  MSSpecific alloys not less than 85% chromium and nickel or cobalt, with traces of either nickel or cobalt, molybdenum, and other substances; used in partial dentures, orthopedic implants, etc. Synonyms: Durallium; Ticonium. OLuse CHROMIUM ALLOYS to search CHROMIUM-COBALT ALLOYS back thru 1966 PM82; was CHROMIUM-COBALT ALLOYS 1965-81; VITALLIUM was heading 1963-64 HN82; was CHROMIUM-COBALT ALLOYS 1965-81 MHÑChromium Alloys AND25-26 qualif MND1.552.33.182; D1.552.165.299; D25.58.224; D25.339.208.224 XSChromium-Cobalt Alloys; Chromium-Nickel Alloys; Cobalt-Chromium Alloys; Nickel-Chromium Alloys FXÑDental Materials XUÑVitallium LH LS; ; ; LX LU  MHÑChromium Isotopes ANCr-50,53,54; NIM; no qualif MND1.496.212; D1.552.165.399 LH  OLsearch CHROMIUM ISOTOPES 1966-73 PM74 HN74 MHÑChromium Radioisotopes ANCr-48-49,51,55,56; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) MND1.496.212.349; D1.496.749.213; D1.552.165.499 LH  MHÑChromobacterium ANin soil & water MNB3.475.200 LH  MHÑChromoblastomycosis MNC1.703.295.182; C17.838.208.241 XSChromomycosis; DERMATITIS VERRUCOSA LH LS;  MSColorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens). PM81 HN81 MHÑChromogenic Compounds AN╥colorless ... precursors that may be transformed ... into colored cpds; used in biochem assays & ... as indicators╙; D25-26 qualif; DF: CHROMOGENIC CPDS MND26.550.152 XSChromogenic Substrates LH LS  HN(73) MHÑChromogranins ANdo not use /analogs /defic PIChromaffin System (66-72); Nerve Tissue Proteins (66-72) MND12.776.521.170; D12.776.641.199 DMÑNerve Tissue Proteins LH LM  MSA complex of several closely related glycosidic antibiotics from Streptomyces griseus; the major component, chromomycin A3, is used as a fluorescent stain of DNA where it attaches and inhibits RNA synthesis; also used as antineoplastic agent, especially for solid tumors. Synonyms: NSC 58514. PM73 HN73(72) MHÑChromomycins ANdo not use /analogs /defic /physiol PIAntibiotics, Antineoplastic (67-71) MND20.85.75.302; D22.204.106.307; D26.408.348.199 XUÑToyomicin LH LU  MS[(3-(2-(Diethylamino)-ethyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]acetic acid ethyl ester hydrochloride. A coronary vasodilator agent. Synonyms: Intensain; AG-3: A-27053; Cardiocap; Intencordin. HN(75) MHÑChromonar ANdo not use /biosyn /defic /physiol; /analogs NIM only RN804-10-4 PICoumarins (70-74); Diethylamines (74); Glycolates (70-74) MND3.438.150.446.280; D18.918.175 XSCarbochromen; Carbocromen DMÑCoumarins LH LS; LM  MHÑChromones ANdo not confuse with CHROMANS; do not use /analogs /biosyn /defic /physiol MND3.438.150.266 XS1,4-Benzopyrones LH LS  MSNucleoproteins which in contrast to histones are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens. PM77 HN77 MHÑChromosomal Proteins, Non-Histone AN/biosyn /physiol permitted; do not use /analogs PIChromosomes (66-76); Nucleoproteins (66-76) MND12.776.664.235 XSNon-Histone Chromosomal Proteins FXÑGene Expression Regulation LH LS LX  MSDeviations from the normal number or structure of chromosomes, not necessarily associated with disease. PM68 HN68 MHÑChromosome Aberrations ANnote category: structural or numerical deviations not necessarily manifesting as disease or patent abnormality; coord IM with specific numbered chromosome or sex chromosome (IM) but not with CHROMOSOMES, HUMAN; no qualif PIChromosome Abnormalities (66-67) MNG5.148.266 XUÑRing Chromosomes LH LU  OLuse CHROMOSOME ABNORMALITIES to search AUTOSOME ABNORMALITIES back thru 1968 PM64; AUTOSOME ABNORMALITIES was heading 1968-80 HN64; AUTOSOME ABNORMALITIES was heading 1968-80 MHÑChromosome Abnormalities ANnote category: structural or numerical deviations manifesting as disease or abnormality; coord IM with specific numbered chromosome (IM) but not with CHROMOSOMES, HUMAN; coord IM with specific dis (IM); SEX CHROMOSOME ABNORMALITIES is also available; do not use /compl /congen /surg /ther MNC16.131.280 XSAutosome Abnormalities FXÑCytogenetics; ÑGenetics, Medical; ÑKARYOTYPING; ÑMental Retardation; ÑSEX CHROMATIN LH LS LX; ; ; ;  MSStaining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping. PM79 HN79 MHÑChromosome Banding ANonly /methods PIChromosome Aberrations (68-78); Chromosomes (66-78); specific chromosome; Stains and Staining (66-78); specific dye MNE5.393.120; E5.909.262.380; E5.909.715.250 XSBanding, Chromosome LH LS  MSActual loss of a portion of the chromosome. PM78; was see under CHROMOSOME ABERRATIONS 1975-77 HN78(75); was see under CHROMOSOME ABERRATIONS 1975-77 MHÑChromosome Deletion ANno qualif; for coord see note on CHROMOSOME ABERRATIONS above PIChromosome Aberrations (68-74); Chromosome Abnormalities (66-67) MNG5.148.266.300 XSGene Deletion; Monosomy, Partial; Partial Monosomy XUÑMonosomy LH LS; ; LU  MSHeritable sensitive regions of chromosomes which show up in vitro as non-staining bands. They are associated with chromosome breakage and other aberrations, and, when located on sex chromosomes, they produce phenotypic abnormalities. No abnormal phenotype has been definitely identified with autosomal fragile sites, but some rare autosomal recessive disorders may be due to homozygosity for fragile sites. Fragile sites are designated by the letters ╥fra╙ followed by the designation for the specific chromosome and locus. PM82 HN82 MHÑChromosome Fragile Sites ANno qualif; seen in titles as ╥fra╙ (e.g., fra(X) ) & ╥chromosome fragility╙; FRAGILE X SYNDROME is available PIChromosome Aberrations (68-81); Chromosomes (66-67) MNG5.148.266.312 XSFragile Sites, Chromosome LH LS  PM67 HN67(65) MHÑChromosome Mapping ANno qualif MNE5.393.183 FXÑCytogenetics; ÑGenetic Marker LH LX;  MHÑChromosomes ANA 11 qualif except /cytol; /abnorm /pathol = CHROMOSOME ABNORMALITIES or CHROMOSOME ABERRATIONS; for CHROMOSOMES & its specifics below or CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES in a tissue in a disease, coord IM with tissue /ultrastruct (IM) + dis /familial (IM); /class = probably KARYOTYPING; note numbered pairs below: these are HUMAN only MNA11.223.475 FXÑKARYOTYPING XUÑCentromere LH LX LU  PM68 HN68 MHÑChromosomes, Bacterial ANA 11 qualif except /cytol; coord IM with specific bact /ultrastruct (IM) PIChromosomes (66-67) MNA11.223.475.190 FXÑGenetics, Microbial LH LX  MSThe structures within the human cell nucleus that contain the hereditary material, DNA. PM78 HN78 MHÑChromosomes, Human ANGEN only: prefer specifics; IM; A 11 qualif except /cytol; do not coord with pre-coord chromosome terms, such as CHROMOSOME ABERRATIONS, CHROMOSOMAL PROTEINS, NON-HISTONE, etc.: check tag HUMAN will serve for these PIChromosomes (66-77) MNA11.223.475.480 LH  PM87 HN87 MHÑChromosomes, Human, Pair 1 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 1-3 (68-86) MNA11.223.475.480.235.240 XSChromosome 1 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 10 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 6-12 (68-86) MNA11.223.475.480.325.350 XSChromosome 10 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 11 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 6-12 (68-86) MNA11.223.475.480.325.355 XSChromosome 11 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 12 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 6-12 (68-86) MNA11.223.475.480.325.360 XSChromosome 12 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 13 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 13-15 (68-86) MNA11.223.475.480.370.375 XSChromosome 13 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 14 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 13-15 (68-86) MNA11.223.475.480.370.380 XSChromosome 14 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 15 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 13-15 (68-86) MNA11.223.475.480.370.385 XSChromosome 15 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 16 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 16-18 (68-86) MNA11.223.475.480.415.420 XSChromosome 16 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 17 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 16-18 (68-86) MNA11.223.475.480.415.425 XSChromosome 17 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 18 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 16-18 (68-86) MNA11.223.475.480.415.430 XSChromosome 18 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 19 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 19-20 (68-86) MNA11.223.475.480.460.465 XSChromosome 19 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 2 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 1-3 (68-86) MNA11.223.475.480.235.245 XSChromosome 2 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 20 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 19-20 (68-86) MNA11.223.475.480.460.470 XSChromosome 20 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 21 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 21-22 (68-86) MNA11.223.475.480.505.510 XSChromosome 21 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 22 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM); PHILADELPHIA CHROMOSOME is available PIChromosomes, Human, 21-22 (68-86) MNA11.223.475.480.505.515 XSChromosome 22 FXÑPhiladelphia Chromosome LH LS LX  PM87 HN87 MHÑChromosomes, Human, Pair 3 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 1-3 (68-86) MNA11.223.475.480.235.250 XSChromosome 3 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 4 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 4-5 (68-86) MNA11.223.475.480.280.285 XSChromosome 4 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 5 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 4-5 (68-86) MNA11.223.475.480.280.290 XSChromosome 5 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 6 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 6-12 (68-86) MNA11.223.475.480.325.330 XSChromosome 6 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 7 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 6-12 (68-86) MNA11.223.475.480.325.335 XSChromosome 7 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 8 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 6-12 (68-86) MNA11.223.475.480.325.340 XSChromosome 8 LH LS  PM87 HN87 MHÑChromosomes, Human, Pair 9 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes, Human, 6-12 (68-86) MNA11.223.475.480.325.345 XSChromosome 9 LH LS  PM68 HN68 MHÑChromosomes, Human, 1-3 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes (66-67) MNA11.223.475.480.235 XSChromosomes A LH LS  PM68 HN68 MHÑChromosomes, Human, 13-15 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes (66-67) MNA11.223.475.480.370 XSChromosomes D LH LS  PM68 HN68 MHÑChromosomes, Human, 16-18 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes (66-67) MNA11.223.475.480.415 XSChromosomes E LH LS  PM68 HN68 MHÑChromosomes, Human, 19-20 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes (66-67) MNA11.223.475.480.460 XSChromosomes F LH LS  PM68 HN68 MHÑChromosomes, Human, 21-22 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes (66-67) MNA11.223.475.480.505 XSChromosomes G FXÑPhiladelphia Chromosome LH LS LX  PM68 HN68 MHÑChromosomes, Human, 4-5 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes (66-67) MNA11.223.475.480.280 XSChromosomes B LH LS  PM68 HN68 MHÑChromosomes, Human, 6-12 ANIM; only /ultrastruct; coord with specific chromosome term, espec CHROMOSOME ABERRATIONS or CHROMOSOME ABNORMALITIES (IM) PIChromosomes (66-67) MNA11.223.475.480.325 XSChromosomes C LH LS  PM70 HN70(65) MHÑChronaxy ANonly /drug eff /rad eff MNG11.561.168 FXÑElectric Stimulation LH LX  MSDisease which persists over a long period of time. MHÑChronic Disease ANIM GEN only; only /class /econ /mortal /nurs /occur /psychol /rehabil /ther; usually NIM; no qualif when NIM; Manual 23.23+ MNC23.280.176; N1.407.306.350 LH  MSThe study of biological systems as affected by time; aging, biological rhythms, and cyclic phenomena are included; statistical computer-aided mathematical procedures are used to describe, in mathematical terminology, various biological functions over time. PM86 HN86 MHÑChronobiology ANonly /drug eff /rad eff PIBiological Clocks (66-85); Periodicity (66-85) MNG7.450 LH  MHÑChronology ANno qualif; used more by Catalogers than Indexers; do not confuse with TIME, TIME FACTORS or TIME PERCEPTION: CHRONOLOGY is usually for data or events arranged in order of time or occurrence MNH1.862.200; L1.80 LH  MS1,2-Benzphenanthrenes. Polycyclic hydrocarbons obtained from coal tar. HN(76) MHÑChrysenes ANdo not use /analogs /biosyn /defic /physiol PIPhenanthrenes (69-75) MND4.615.723.180 DMÑPhenanthrenes LH LM  MSA deuteromycetous fungal genus which causes adiaspiromycosis, a pulmonary mycosis of man and rodents. OLuse CHRYSOSPORIUM to search EMMONSIA & GLENOSPORELLA back thru 1975 HN(86); EMMONSIA & GLENOSPORELLA were see under MONILIALES 1975-85 MHÑChrysosporium ANdo not use /embryol /microbiol /parasitol; infection: coord NIM with MYCOSES (IM) PIFungi (66-85); Hyphomycetes (66-85) MNB5.354.381.546.170 XSEmmonsia; Glenosporella DMÑHyphomycetes LH LS; LM  MHÑChyle ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; chylous ascites: index CHYLOPERITONEUM; chylous peritonitis = CHYLOPERITONEUM; chyluria: index CHYLE (IM) + URINE (NIM) MNA12.207.630.350; A15.382.520.436.350 LH  MHÑChylomicrons ANdo not use /analogs /defic MND10.516.532.183; D12.776.521.242 LH  MHÑChyloperitoneum ANchylous ascites & chylous peritonitis go here MNC6.772.145 LH  MHÑChylothorax MNC8.528.142 FXÑLymphatic Diseases LH LX  MSA peptide peptidohydrolase with cysteine at the active center from papaya. Preferential cleavage at glutamic and aspartic acid residues. Also catalyzes the synthesis of hippuryl-aniline. Formerly EC 3.4.4.11 PM86; was see under PEPTIDE PEPTIDOHYDROLASES 1975-85 HN86(75); was see under PEPTIDE PEPTIDOHYDROLASES 1975-85 MHÑChymopapain ANdo not use /biosyn /defic /physiol RNEC 3.4.22.6 PIPapain (73-74) MND8.586.277.656.732.160 FXÑIntervertebral Disk Chemolysis LH LX  MHÑChymotrypsin AN/biosyn /defic /physiol permitted; /antag: consider also ALPHA 1-ANTICHYMOTRYPSIN; do not use /analogs; chymotrypsin in ENZYMATIC ZONULOLYSIS: the usual method of performing this type of cataract extraction: do not index CHYMOTRYPSIN unless particularly discussed; alpha-chymotrypsin goes here RNEC 3.4.21.1 MND8.586.277.656.732.176 FXÑPancreatic Juice LH LX  PM72 HN72 MHÑChymotrypsinogen ANdo not use /analogs RN9035-75-0 PIChymotrypsin (66-71); Enzyme Precursors (66-71) MND8.444.184 FXÑPancreatic Juice LH LX  MSEthylmercury(2-mercapto-5-benzoxazolecarboxylic acid)sodium salt. Tissue preservative. HN(75); was see under ETHYL MERCURY COMPOUNDS 1975-79 MHÑCialit ANdo not use /biosyn /defic /physiol; /analogs NIM only RN16509-11-8 PIBenzoxazoles (72-74); Ethylmercury Compounds (72-74); Sulfides (72-74) MND2.691.750.100.347.350; D3.438.221.370 DMÑEthylmercury Compounds LH LM  MHÑCicatrix ANonly Cat C qualif MNA10.424.351; C17.120 XSSCARS FXÑWound Healing LH LS LX  MSA toxin found in flesh of marine animals, especially some fishes, at some times, in some localities; it is probably of algal origin, causes paresthesia, gastrointestinal symptoms, neuromuscular blockade and respiratory paralysis, due to interference with membrane function; the poisoning is also called ciguatera. HN(78) MHÑCiguatoxin ANfrom a West Indies word for fish poisoning (cigua = a type of snail); do not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTITOXINS; coord IM with source of ciguatoxin (IM or NIM) RN11050-21-8 PIFishes, Poisonous (68-77); Marine Toxins (74-77); Toxins (66-73) MND24.185.926.580.160 XSCiguatera DMÑMarine Toxins LH LS LM  PM65 HN65(64) MHÑCilia ANIM GEN only; NIM when specific organ is IM; A 11 qualif except /cytol; do not confuse with the protozoa CILIATA or with the Latin plural of EYELASHES MNA11.368.702.783.267 FXÑEPITHELIUM LH LX  MHÑCiliary Body ANinflammation: consider CILIARY BODY (IM) + UVEITIS (IM) or UVEITIS, ANTERIOR (IM) (but not also CILIARY BODY); dis = CILIARY BODY (IM) + UVEAL DISEASES (IM); neopl = CILIARY BODY (IM) + UVEAL NEOPLASMS (IM) + histol type of neopl (IM) MNA9.371.60.200 LH  MSDisorders characterized by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as Kartagener triad, chronic respiratory disorders, chronic sinusitis, and/or chronic otitis. PM84 HN84 MHÑCiliary Motility Disorders ANciliary refers to nasal, paranasal sinus, respiratory & sometimes spermatozoon cilia; also called ╥ciliary dyskinesia╙ PICilia (66-83); Kartagener Triad (66-83); Nasal Mucosa (66-83) MNC8.200; C9.150 XSImmotile Cilia Syndrome LH LS  MSA class of protozoa characterized by the presence of cilia throughout the life cycle. OLuse CILIATA to search SUCTORIA back thru 1966 PMSUCTORIA was heading 1963-84 HNSUCTORIA was heading 1963-84 MHÑCiliata ANdo not confuse with CILIA; GEN: avoid; prefer specifics; do not use /anat /blood-csf-urine /embryol MNB1.841.184 XSSuctoria LH LS  MS1-Cyano-2-methyl-3[2-[[(5-methylimidazol-4-yl)methyl] thio]ethyl]guanidine. Blockader of histamine H2 receptors; decreases gastric acid secretion; used to treat gastrointestinal ulcers. Synonym: SK&F 92334. PM84; was see under GUANIDINES 1978-83 HN84(78); was see under GUANIDINES 1978-83 MHÑCimetidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN51481-61-9 PIGuanidines (66-77); Imidazoles (66-77) MND2.78.370.200; D3.383.374.130; D19.316.203.219; D23.654.443.186 LH  MS2'-[[3-(Dimethylamino)propyl]thio]cinnamanilide monohydrochloride. A serotonin antagonist with limited antihistaminic, anticholinergic and immunosuppressive activity. HN(75) MHÑCinanserin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1166-34-3 PIAnilides (69-74); Cinnamates (69-74); Sulfides (74) MND2.241.223.201.200; D23.846.216 DMÑCinnamates LH LM  MSA genus of rubiaceous South American trees that yields the toxic CINCHONA ALKALOIDS from their bark; QUININE, QUINIDINE, chinconine, cinchonidine and others are used to treat malaria and cardiac arrhythmias. HNwas in Cat B & D 1963-76 MHÑCinchona ANplant only: note CINCHONA ALKALOIDS below; do not use /isol /pathogen MNB6.560.206; B6.915.206 LH  MSAlkaloids extracted from various species of Cinchona. PM77 HN77 MHÑCinchona Alkaloids ANGEN or unspecified: prefer specific indentions; do not use /analogs /defic /physiol PICinchona (66-76) MND3.132.206 LH  MHÑCinchophen ANdo not use /biosyn /defic /physiol RN132-60-5 MND3.438.810.170; D14.73.278.253; D26.74.75.317 XSAciphenochinolium LH LS  PM66 HN66(64) MHÑCineangiography ANdo not use /util except by MeSH definition MNE1.145.77.385; E1.818.84.385; E1.818.179.351 FXÑMotion Pictures LH LX  OLuse CINERADIOGRAPHY to search CINEFLUOROGRAPHY back thru 1966 PM73; was CINEFLUOROGRAPHY 1963-72 HN73; was CINEFLUOROGRAPHY 1963-72 MHÑCineradiography ANdo not use /util except by MeSH definition MNE1.818.179 XSCINEFLUOROGRAPHY; RADIOCINEMATOGRAPHY FXÑMotion Pictures LH LS; LX  MHÑCinnamates ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.201 XUÑCaffeic Acids; ÑCinanserin; ÑCoumaric Acids LH LU; ;  OLsearch CONDIMENTS 1966-74 HN(75) MHÑCinnamon ANonly /ad-poi-tox /anal /hist /stand /supply MNJ1.341.241.212 DMÑCondiments LH LM  MS1-Cinnamyl-4-(diphenylmethyl)piperazine. Antihistaminic with considerable antiemetic properties; used mainly for vertigo and motion sickness. PM86; was see under PIPERAZINES 1975-85 HN86(75); was see under PIPERAZINES 1975-85 MHÑCinnarizine ANdo not use /biosyn /defic /physiol RN298-57-7 PICinnamates (71-74); Piperazines (68-74) MND3.383.606.290; D23.136.180; D23.654.432.187 LH  MS1-Ethyl-1,4-dihydro- 4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid. Synthetic antimicrobial related to oxolinic and nalidixic acids; used in urinary tract infections. Synonyms: Cinobac; Compound 64716. HN(80) MHÑCinoxacin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN28657-80-9 PIPyridazines (66-79) MND3.383.710.605.150; D20.237.161 XSAzolinic Acid DMÑPyridazines LH LS LM  MSThe only species of a cosmopolitan ascidian; useful as a research animal. HN(75) MHÑCiona intestinalis AN/microbiol /parasitol permitted MNB1.272.727.300 DMÑUrochordata LH LM  MS1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinolinecarboxylic acid. A carboxyquinoline antimicrobial agent which is effective against a wide range of microorganisms. It has been successfully and safely used in the treatment of resistant respiratory, skin, bone, joint, gastrointestinal, urinary, and genital infections. PM87 HN87 MHÑCiprofloxacin ANdo not use /biosyn /defic /physiol RN85721-33-1 PIQuinolines (66-86) MND3.438.810.180; D20.237.181; D20.400 LH  MSThe regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs and stimuli, hormone secretion, sleeping, feeding, etc. This rhythm seems to be set by a 'biological clock' which seems to be set by recurring daylight and darkness. OLuse CIRCADIAN RHYTHM to search DIURNAL RHYTHM back thru 1969 (as Prov 1969-74) PM66; DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85 HN66(64); DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85, was Prov 1969-74 MHÑCircadian Rhythm ANapprox 24-hour cycle; only /drug eff /rad eff MNG7.450.730.190 XSDiurnal Rhythm; Nyctohemeral Rhythm; Twenty-Four Hour Rhythm FXÑPERIODICITY XUÑActivity Cycles LH LS; ; LX LU  MSA polygonal anastomosis at the base of the brain formed by the internal carotid, the anterior and posterior cerebral arteries, the anterior communicating artery and the posterior communicating arteries. PM65 HN65 MHÑCircle of Willis ANdo not use /blood supply MNA7.231.114.228.351 XSWILLIS' CIRCLE LH LS  HN(70) MHÑCircular Dichroism ANNIM; no qualif PISpectrum Analysis (66-69) MNE5.196.867.151; H1.181.278.862.151 DMÑSpectrum Analysis LH LM  OLpre-explosion = CIRCULATORY, RESPIRATORY PHYSIOLOGY (PX) MH*Circulatory, Respiratory Physiology (Non Mesh) MNG9 LH  MSExcision of the prepuce or part of it. MHÑCircumcision ANfor male & female circumcision; only /adv eff /econ /hist /instrum /methods /psychol /util (if by MeSH definition) MNE4.887.774.692.226 FXÑPenis LH LX  MSDiamminedichloroplatinum. A simple platinum compound that may exist in either cis or trans form; the cis isomer has antineoplastic action and may enhance tumor antigenicity, due to binding to DNA; it also causes renal damage. OLuse CISPLATIN to search PLATINUM DIAMMINODICHLORIDE back thru 1974 & DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-83 PM84; was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83, was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83 HN84(81); was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83, was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83 MHÑCisplatin ANdo not use /biosyn /defic /physiol RN15663-27-1 PIAmines (66-73); Ammonium Compounds (66-73); Chlorides (66-73); Platinum (66-73) MND1.552.691.280; D1.620.89.276.280; D22.204.355 XSCis-Diamminedichloroplatinum(II); Cis-Dichlorodiammineplatinum(II); Platinum Diamminodichloride LH LS; ;  MHÑCisterna Magna ANdo not use /innerv MNA8.186.566.166.686.351 LH  MH*Cities (Non Mesh) MNZ1.433 LH  MSMethylbutenedioic acid. HN(75) MHÑCitraconic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN498-23-7 PIMaleates (69-74) MND2.241.81.337.502.240 XSMethylmaleic Acid DMÑMaleates LH LS LM  MS2-Methylmaleic anhydride. OLuse CITRACONIC ANHYDRIDES to search CITRACONIC ANHYDRIDE back thru 1975 HN(79); was CITRACONIC ANHYDRIDE see under FURANS 1977-78, was CITRACONIC ANHYDRIDE see under MALEATES 1975-76 MHÑCitraconic Anhydrides ANdo not use /analogs /biosyn /defic /physiol PIAnhydrides (69-74); Maleates (72-74) MND2.113.250; D3.383.312.250 XSMethylmaleic Anhydrides DMÑFurans LH LS LM  HN(73) MHÑCitrate Synthase ANdo not use /analogs RNEC 4.1.3.7 MND8.586.520.567.434 DMÑKetoacid-Lyases LH LM  OLuse CITRATES to search RENACIDIN back thru 1966 (as Prov 66-74) PMRENACIDIN was see under PHARMACEUTIC AIDS 1975-80 HNRENACIDIN was see under PHARMACEUTIC AIDS 1975-80, was Prov 1964-74 MHÑCitrates ANdo not use /analogs /defic /physiol MND2.241.81.901.434 LH  MSA series of reactions involving oxidation of a two-carbon acetyl unit to carbon dioxide and water with the production of high-energy phosphate bonds by means of tricarboxylic acid intermediate. OLuse CITRIC ACID CYCLE to search KREBS CYCLE back thru 1966 PM85; was KREBS CYCLE 1963-84 HN85; was KREBS CYCLE 1963-84 MHÑCitric Acid Cycle ANonly /drug eff /rad eff MNG6.535.280 XSKrebs Cycle; TRICARBOXYLIC ACID CYCLE LH LS;  MS4,6-Dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran-7-carboxylic acid. Antibiotic and mycotoxin from Aspergillus niveus and Penicillium citrinum. Synonym: Antimycin. HN(75) MHÑCitrinin ANdo not use /defic /physiol; /analogs NIM only RN518-75-2 PIBenzopyrans (69-74) MND3.438.150.320; D20.85.225 DMÑBenzopyrans LH LM  MSA genus of Gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon. OLsearch ESCHERICHIA 1974 PM79; was see under ENTEROBACTERIACEAE 1976-78, was see under ESCHERICHIA 1974-75 HN79(75); was see under ENTEROBACTERIACEAE 1976-78, was see under ESCHERICHIA 1974-75 MHÑCitrobacter ANin soil, water & sometimes intestines PIEnterobacteriaceae (66-74); Escherichia (66-74) MNB3.475.300.200 LH  MHÑCitrovorum Factor AN/biosyn /defic /physiol permitted RN51057-63-7 MND11.786.708.350.220 XSFOLINIC ACID; LEUCOVORIN; N(5)-Formyltetrahydrofolate FXÑTetrahydrofolates LH LS; ; LX  PM65; was see under AMINO ACIDS 1963-64 HN65(64); was see under AMINO ACIDS 1963-64 MHÑCitrulline RN372-75-8 MND12.125.95.226 LH  MSAny tree or shrub of the rue family or the fruit of these plants. MHÑCitrus Fruits ANas plant & fruit; only /ad-poi-tox /anal /class /hist /rad eff /stand /supply; orange & grapefruit juices: coord IM with BEVERAGES (IM) MNB6.510.380.175; J1.341.492.414 LH  MSComprehensive planning for the physical development of the city. MHÑCity Planning ANonly /hist /legis /stand /trends CATALOG: /geog /form MNI1.880.709.202 XSTOWN PLANNING; URBAN PLANNING LH LS;  MSPreventive emergency measures and programs designed to protect the individual or community in times of hostile attack. MHÑCivil Defense ANno qualif CATALOG: /geog /form MNI1.451.227 FXÑDisaster Planning LH LX  MSDeliberate and planned acts of unlawful behavior engaged in by aggrieved segments of the population in seeking social change. PM70 HN70(69) MHÑCivil Disorders ANonly /hist /legis /prev PIDisasters (66-68); Emergency Service, Hospital (66-68) MNI1.880.735.140 FXÑMass Behavior LH LX  MSLegal guarantee protecting the individual from attack on personal liberties, right to fair trial, right to vote, and freedom from discrimination on the basis of race, religion or national origin. PM68 HN68 MHÑCivil Rights ANonly /hist /legis; Public Law 93-579; consider also HUMAN RIGHTS & SOCIAL JUSTICE CATALOG: /geog /form PIInterpersonal Relations (66-67); Legislation (66-67) MNI1.880.604.473.352; N3.706.437.352 XSPrivacy Act FXÑRace Relations LH LS LX  MSThe distinctly human attributes and attainments of a particular society. MHÑCivilization ANonly /hist MNI1.76.201.450.226 LH  MSA deuteromycetous fungal genus including some economically important plant parasites. HN(75); was see under MONILIALES 1975-85 MHÑCladosporium ANdo not use /anat /embryol /microbiol /parasitol; infection = CLADOSPORIUM (NIM) + probably MYCOSES or TINEA (IM) MNB5.354.381.546.200 DMÑHyphomycetes LH LM  MSEquivalved edible marine molluscs that live wholly or partially in sand or mud; some genera are Mya, Venus, and Mactra. PM72 HN72 MHÑClams ANas animal & as food; IM; /microbiol /parasitol permitted PIMollusca (66-71) MNB1.644.173 FXÑShellfish LH LX  MHÑClassification ANGEN only, only /methods; prefer /class: Manual 19.5+; taxonomy & coding go here MNL1.100 LH  MSThe main structural coat protein of coated vesicles which play a key role in the intracellular transport between membranous organelles. Clathrin also interacts with cytoskeletal proteins. PM84 HN84 MHÑClathrin AN/biosyn /physiol permitted PIMembrane Proteins (77-83); Proteins (66-76) MND12.776.543.200 FXÑCoated Pits, Cell Membrane LH LX  MSA genus of ascomycetous fungi, family Clavicipitaceae, order Clavicipitales parasitic on various grasses; the sclerotia contain several toxic alkaloids. Claviceps purpurea on rye causes ergotism. OLsearch ASCOMYCETES 1966-73 PM74; was see under ASCOMYCETES 1963-73 HN74; was see under ASCOMYCETES 1963-73 MHÑClaviceps AN= ergot; do not use /anat /embryol /microbiol /parasitol MNB5.354.107.192 XSERGOT FUNGUS LH LS  MHÑClavicle MNA2.835.232.87.227 LH  MSThose beta lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects. PM83 HN83 MHÑClavulanic Acids ANdo not use /analogs /defic /physiol; /biosyn permitted if by living matter PIAmides (66-73); Amidohydrolases (66-78); Beta-Lactamases (79-82); Lactams (74-82); Penicillinase (66-78) MND8.373.285; D20.85.99.200 LH  MSThe earliest stage of the embryo, lasting from the first mitotic division of the fertilized ovum into two blastomeres to the formation of the morula, a compact mass of blastomeres. PM80 HN80 MHÑCleavage Stage, Ovum ANnote category; ╥earliest stage of the embryo╙; A 11 qualif PICell Division (66-79); Mitosis (68-79); Ovum (66-79); Zygote (75-79); specific organism/EM (66-79) MNA16.254.270 XSSegmentation Stage, Ovum FXÑCell Division XUÑMorula LH LS LX LU  PM65; was HARELIP 1963-64 HN65; was HARELIP 1963-64 MHÑCleft Lip ANdo not use /congen; when with CLEFT PALATE, do not also use ABNORMALITIES, MULTIPLE MNC16.131.314.687.164; C16.131.666.680.836.268 XSHARELIP LH LS  MHÑCleft Palate ANdo not use /congen; when with CLEFT LIP, do not also use ABNORMALITIES, MULTIPLE MNC16.131.314.687.185; C16.131.621.514.185; C16.131.666.680.836.351 LH  OLuse CLEIDOCRANIAL DYSPLASIA to search CLEIDOCRANIAL DYSOSTOSIS back thru l966 PM85; was CLEIDOCRANIAL DYSOSTOSIS 1963-84 HN85; was CLEIDOCRANIAL DYSOSTOSIS 1963-84 MHÑCleidocranial Dysplasia ANdo not use /congen MNC5.116.99.708.207; C16.131.621.168 XSCleidocranial Dysostosis; DYSOSTOSIS, CLEIDOCRANIAL LH LS;  MS2-[2-[1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine. Histamine H1 blocker used in hay fever, rhinitis, allergic skin conditions and pruritus; causes drowsiness. Synonyms: Agasten; HS 592; Tavegil; Tavist. OLuse CLEMASTINE to search MECLASTINE back thru 1973 (as Prov 1973-74) HN(79); was MECLASTINE see under PYRROLIDINES 1975-78, was MECLASTINE 1973-74 (Prov) MHÑClemastine ANdo not use /defic /physiol; /analogs NIM only RN15686-51-8 PIHistamine H1 Receptor Blockaders (66-72); Pyrrolidines (66-72) MND3.383.773.165; D23.654.432.199 XSMeclastine; Mecloprodin DMÑPyrrolidines LH LS; LM  MS1-(p-Chlorobenzyl)-2-(1-pyrrolidinylmethyl)benzimidazole. Histamine H1 blocker used to treat allergies; produces drowsiness, but little anticholinergic action. Synonyms: Allercur; Histacuran; Klemidox; Reactrol. HN(66) MHÑClemizole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN442-52-4 MND3.438.103.227; D23.654.432.212 DMÑBenzimidazoles LH LM  MS4-Amino-alpha-[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol. A substituted phenylaminoethanol that has beta2 adrenomimetic properties at very low doses; proposed as bronchodilator in asthma. Synonym: NAB 365. HN(78) MHÑClenbuterol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN37148-27-9 PIAmino Alcohols (66-72); Ethanolamines (73-77) MND2.33.329.291.231; D2.92.63.291.231; D16.116.169; D16.893.116.348.169 DMÑEthanolamines LH LM  PM73 HN73(69) MHÑClergy ANonly /hist /psychol PIappropriate religion heading MNM1.526.213 LH  MS6-Chloro-5-cyclohexyl-1,2-dihydro-1H-indene-1-carboxylic acid. An anti-inflammatory agent. OLuse CLIDANAC to search TAI 284 back thru 1975 HN(85); was TAI 284 see under INDENES 1975-84 MHÑClidanac AND25-26 qualif; /analogs NIM only RN34148-01-1 PICarboxylic Acids (72-74); Cyclohexanes (71-74); Indenes (71-74) MND4.615.486.487.150; D26.74.75.320 XSTai 284 DMÑIndenes LH LS LM  MHÑClimacteric ANqualif permitted: /blood-csf-urine /drug eff /ethnol /genet /immunol /metab /physiol /psychol /rad eff; ╥hot flushes╙ goes here; postmenopausal goes under MENOPAUSE MNG8.520.940.110 LH  MHÑClimate ANGEN; no qualif MNG3.230.300.100.250 FXÑACCLIMATIZATION XUÑMicroclimate LH LX LU  PM74 HN74(72) MHÑClindamycin ANdo not use /defic /physiol; = cleocin RN18323-44-9 PILincomycin (66-71) MND3.383.773.173; D20.85.467.352 LH  MSUsually refers to undergraduate medical education programs for second- , third- , and fourth-year students in which the students receive clinical training and experience in teaching hospitals or affiliated health centers. HN(83) MHÑClinical Clerkship ANonly /econ /hist /man /stand /trends PIEducation, Medical, Undergraduate (71-82) MNI2.358.399.450.110 DMÑEducation, Medical, Undergraduate LH LM  MSThe capability to perform acceptably those duties directly related to patient care. PM75 HN75 MHÑClinical Competence ANonly /legis /stand; competence in professional activities directly related to patient care: differentiate from PROFESSIONAL COMPETENCE which refers to competence not necessarily related to patient care PIEducational Measurement (66-74) MNI2.399.630.210 XSClinical Skills; Competence, Clinical LH LS;  MSComputer-based information systems designed to analyze and integrate laboratory data for the health care provider. HN(87) MHÑClinical Laboratory Information Systems MNL1.700.508.300.110 XSLaboratory Information Systems DMÑInformation Systems LH LS LM  MSPre-planned usually controlled studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs or technics in humans selected according to pre-determined criteria of eligibility and observed for pre-defined evidence of favorable and unfavorable effects. OLuse CLINICAL TRIALS to search CLINICAL RESEARCH 1966-79 PM80 HN80; CLINICAL RESEARCH was check tag 1965-79 MHÑClinical Trials ANhuman & vet animals only; IM GEN only; when IM, only /class /econ /instrum /methods /stand /trends /util (if by MeSH definition) /vet; NIM as coord for controlled studies meeting MeSH definition; when NIM, usually no qualif; do not index also under PLACEBOS unless placebos are particularly discussed; ╥multicenter trials╙ probably goes here; Manual 18.12, 26.36+, 29.17 PIDrug Evaluation (74-79) MNE5.337.250 XSControlled Clinical Trials; Drug Evaluation, FDA Phase III; Drug Evaluation, FDA Phase IV; Evaluation Studies, FDA Phase III; Evaluation Studies, FDA Phase IV LH LS; ; ; ;  MHÑClitoris MNA5.360.319.887.436 LH  MSThe common chamber into which the intestinal, urinary and genital tracts discharge in birds, reptiles, amphibians and many fishes; also a phylogenetically related embryonic structure in mammals. PM68 HN68 MHÑCloaca ANhuman & animal PIRectum (66-67) MNA13.223; A16.254.283 XUÑMalpighian Tubules LH LU  MSA bacteriocin produced by a plasmid that can occur in several bacterial strains; it is a basic protein of molecular weight 56,000 and exists in a complex with its immunity protein which protects the host bacterium from its effects. HN(80) MHÑCloacin ANdo not use /defic /physiol; /analogs NIM only RN37370-19-7 PIBacteriocins (66-79) MND20.85.133.190; D24.310.125.190 DMÑBacteriocins LH LM  MS21-Chloro-9 alpha-fluoro-11 beta,17 alpha-dihydroxy-16 beta-methyl-1,4-pregnadiene-3,20-dione. Topical corticosteroid that is absorbed faster than fluocinonide; used in psoriasis, but may cause marked adrenocortical suppression. Synonym: Dermovate. HN(77) MHÑClobetasol ANdo not use /biosyn /defic /physiol RN25122-41-2 PIBetamethasone (74-76); Propionates (74); Steroids, Chlorinated (74-75) MND4.808.908.93.250; D6.597.481.561.353.120.250; D6.597.481.561.478.113.250; D26.74.125.123.178; D26.74.125.447.123.178; D26.74.148.447.123.178; D26.368.99.447.123.178 DMÑBetamethasone LH LM  MSN,5-Bis(4-chlorophenyl)-3,5-dihydro-3- [(1-methylethyl)imino]-2-phenazine. A red antibacterial dye with anti-inflammatory action; used in the treatment of leprosy and certain skin diseases. Synonyms: Lampren(e); B663; G30320; NSC 141046; riminophenazine. PM74 HN74 MHÑClofazimine ANdo not use /biosyn /defic /physiol RN2030-63-9 MND3.494.704.353; D20.661.269 LH  MS2-[[4'-Chloro-(1,1'-biphenyl)-4-yl]oxy]-2-methyl-propanoic acid, methyl ester. An oral hypolipemic agent in dogs and rats. Synonym: ICI-55695. HN(75) MHÑClofenapate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN21340-68-1 PIBiphenyl Compounds (74); Butyrates (71-74); Ethers (72-74) MND2.241.81.161.375; D10.162.280 XSMethyl Clofenapate DMÑButyrates LH LS LM  MS2-(4-Chlorophenoxy)-N-[2-(diethylamino)ethyl]acetamide (clofexamide) compound with 4-butyl-1,2-diphenyl-3,5-pyrazolidinedione (phenylbutazone)(1:1). An analgesic and antipyretic with anti-inflammatory properties used in treatment of rheumatism. Synonym: Perclusone. HN(75) MHÑClofezone AND25-26 qualif RN17449-96-6 PIGlycolates (74); Phenylbutazone (72-74) MND2.241.511.316.200; D3.383.694.700.200; D14.73.278.152.684.150; D26.74.75.204.684.150 DMÑPhenylbutazone LH LM  PM72 HN72(69) MHÑClofibrate ANdo not use /biosyn /defic /physiol RN637-07-0 PIAnticholesteremic Agents (66-68); Propionates (66-68) MND2.241.81.161.390; D2.241.81.465.240.350; D10.162.202.228 XUÑClofibric Acid LH LU  MS2-(4-Chlorophenoxy)-2-methylpropionic acid. An antilipemic agent and the biologically active metabolite of clofibrate. Include the salts and esters of clofibric acid except CLOFIBRATE. HN(80) MHÑClofibric Acid ANdo not use /biosyn /defic /physiol RN882-09-7 PIClofibrate (69-74) /AA (75-79) MND2.241.81.161.325.200; D2.241.81.465.240.230.200; D10.162.202.228.200 XSClofibrinic Acid DMÑClofibrate LH LS LM  PM68 HN68(64) MHÑClomiphene ANdo not use /biosyn /defic /physiol RN911-45-5 MND7.552.344.510.228 XSChloramiphene; Clomifen LH LS;  MS3-Chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine monohydrochloride. Tricyclic antidepressant similar to imipramine. Synonym: Anafranil. OLto search CHLORIMIPRAMINE use CLOMIPRAMINE back thru 1975 & DIBENZAZEPINES 1968-74 PM80; was CHLORIMIPRAMINE see under DIBENZAZEPINES 1968-79 HN80(75); was CHLORIMIPRAMINE see under DIBENZAZEPINES 1968-79 MHÑClomipramine ANdo not use /biosyn /defic /physiol RN303-49-1 PIDibenzazepines (68-74) MND3.494.240.194; D15.236.122.140.175 XSChlorimipramine LH LS  MS5-(o-chlorophenyl)-1,3-dihydro-7nitro-2H-1,4-benzodiazepin-2-one. Broad spectrum anticonvulsant; used for status epilepticus. PM87; was see under BENZODIAZEPINONES 1975-86 HN87(75); was see under BENZODIAZEPINONES 1975-86 MHÑClonazepam ANdo not use /biosyn /defic /physiol RN1622-61-3 PIBenzodiazepinones (74); Chlorobenzenes (74); Nitro Compounds (74) MND3.438.79.80.70.150; D14.261.322 LH  PM68 HN68(64) MHÑClone Cells ANNIM; A 11 qualif & /class; cells derived by natural asexual reprod or by nuclear cloning; differentiate from CLONING, MOLECULAR (insertion of recombinant DNA): TN 237 MNA11.251.353 FXÑTissue Culture LH LX  MS2-(2,6-Dichloroanilino)2-imidazoline. Hypotensive agent that both blocks and stimulates the peripheral alpha adrenergic receptors; its hypotensive action is due to central action; also used in glaucoma and migraine. Synonyms: Catapres; Catapresan; Dixarit; Isoglaucon; St 155. PM73 HN73(72) MHÑClonidine ANdo not use /biosyn /defic /physiol RN4205-90-7 PIAntihypertensive Agents (66-71); Imidazoles (66-71) MND3.383.374.165; D18.162.170 LH  MSThe insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. PM80 HN80 MHÑCloning, Molecular ANonly /drug eff /methods /rad eff; TN 237: differentiation from CLONE CELLS & nuclear cloning PIDNA (66-76); DNA, Recombinant (77-79); Plasmids (75-79) MNE5.393.220; G5.331.120 XSMolecular Cloning FXÑCosmids; ÑDNA, Recombinant LH LS LX;  MS2-(3-Chloro-o-toluidino)nicotinic acid. Anti-inflammatory analgesic. HN(75) MHÑClonixin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN17737-65-4 PINicotinic Acids (71-74); Toluidines (73-74) MND3.66.515.375; D3.383.725.547.375; D14.73.278.272; D26.74.75.324 DMÑNicotinic Acids LH LM  MHÑClonorchiasis ANcaused by CLONORCHIS SINENSIS; OPISTHORCHIS SINENSIS infection = CLONORCHIASIS not OPISTHORCHIASIS): see note below MNC3.335.865.148 LH  MSA species of trematode flukes of the family Opisthorchidae. Many authorities consider this genus belonging to Opisthorchis. It is common in China and other Asiatic countries. Snails and fish are the intermediate hosts. OLsearch OPISTHORCHIS 1966-71 PM72; was see under OPISTHORCHIS 1963-71 HN72; was see under OPISTHORCHIS 1963-71 MHÑClonorchis Sinensis ANdo not use /blood-csf-urine; infection = CLONORCHIASIS; note X ref below: OPISTHORCHIS SINENSIS infection = CLONORCHIASIS PIOpisthorchis (66-71) MNB1.500.736.715.520.210 XSOpisthorchis Sinensis LH LS  PM74 HN74(64) MHÑClopamide ANdo not use /biosyn /defic /physiol RN636-54-4 MND2.65.884.390; D2.886.590.700.390; D19.770.224.516.303 LH  HN(63); was see under TRANQUILIZING AGENTS 1967-74 MHÑClopenthixol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN982-24-1 MND3.494.953.704.269; D15.236.872.331.325 DMÑThioxanthenes LH LM  MS3,5-Dichloro-2,6-dimethyl-4-pyridinol. A very effective anticoccidial agent used in poultry. Synonym: Coyden. HN(75) MHÑClopidol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2971-90-6 PIPyridines (73-74) MND3.383.725.180; D21.370.400.250 XSClopindol; Meticlorpindol DMÑPyridines LH LS; LM  MS7-(2-beta-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl) 3-alpha, 5-alpha-dihydroxycyclopentyl)-5-heptenoic acid. A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle. Synonyms: Estrumate; ICI 80,996. HN(79) MHÑCloprostenol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN40665-92-7 PIProstaglandins F (75-77); Prostaglandins F, Synthetic (78) MND2.241.81.436.687.700.100; D10.516.251.355.708.700.100; D24.185.798.575.750.800.100 DMÑProstaglandins F, Synthetic LH LM  MS7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid dipotassium salt. Water soluble benzodiazepine tranquilizer effective in anxiety; has also muscle relaxant and anticonvulsant actions. HN(75) MHÑClorazepate Dipotassium ANdo not use /biosyn /defic /physiol; /analogs NIM only RN57109-90-7 PIBenzazepines (71-74); Carboxylic Acids (71-74) MND3.438.79.80.180; D15.236.872.659.191.215 XSChlorazepate; Dipotassium Chlorazepate DMÑBenzodiazepine Tranquilizers LH LS; LM  MSN-[3-(2,4-Dichlorophenoxy)propyl]-N-methylprop-2-ynylamine. Antidepressive agent and monoamine oxidase inhibitor related to pargyline. HN(75) MHÑClorgyline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN17780-72-2 PIAlkynes (72-74); Phenyl Ethers (74); Propylamines (70-74) MND2.92.831.180; D8.373.616.150; D15.236.122.627.150 XSClorgilin DMÑPropylamines LH LS LM  MSThe lung volume at which the dependent lung zones cease to ventilate presumably as a result of airway closure. HN(78) MHÑClosing Volume ANNIM; no qualif PILung Volume Measurements (75-77); Respiratory Function Tests (66-74) MNE1.302.796.420.250; G9.772.521.203 DMÑLung Volume Measurements LH LM  PM66 HN66(63) MHÑClostridiopeptidase A ANdo not use /analogs RNEC 3.4.24.3 MND8.586.277.656.732.203 XSCOLLAGENASE LH LS  MHÑClostridium ANdo not use /blood-csf-urine; infection = CLOSTRIDIUM INFECTIONS or its specifics: see notes below on various species MNB3.300.158.436 LH  MHÑClostridium Botulinum ANdo not use /blood-csf-urine; infection = BOTULISM MNB3.300.158.436.228 FXÑBotulinum Toxins LH LX  MSInfections with bacteria of the genus Clostridium, general or unspecified. OLuse CLOSTRIDIUM INFECTIONS /VE to search HEMOGLOBINURIA, BACILLARY 1968-81 PM68; HEMOGLOBINURIA, BACILLARY was heading 1968-81 HN68; HEMOGLOBINURIA, BACILLARY was heading 1968-81 MHÑClostridium Infections ANGEN: prefer specifics PIClostridium (66-67) MNC1.252.217 XUÑEnterotoxemia LH LU  MHÑClostridium Perfringens ANdo not use /blood-csf-urine; infection = GAS GANGRENE if in text; otherwise coord NIM with CLOSTRIDIUM INFECTIONS (IM) MNB3.300.158.436.353 XSCLOSTRIDIUM WELCHII LH LS  MHÑClostridium Tetani ANdo not use /blood-csf-urine; infection = TETANUS MNB3.300.158.436.478 FXÑTetanus Toxin LH LX  MSRetraction of a clot resulting from contraction of platelet pseudopods attached to fibrin strands that is dependent on the contractile protein thrombosthenin. Used as a measure of platelet function. PM73 HN73(64) MHÑClot Retraction ANno qualif MNE1.223.459.770.250 LH  MS2-Chloro-11-(4-methyl-1-piperazinyl)dibenzo(b,f)(1,4)thiazepine. Antipsychotic similar to clozapine; also used in other mental states. Synonyms: Deliton; Etumine; HF 2159. OLsearch DIBENZOTHIAZEPINES 1968-74 HN(75) MHÑClothiapine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2058-52-8 MND3.494.276.270; D15.236.872.331.335 XSClotiapine DMÑDibenzothiazepines LH LS LM  MHÑClothing ANonly /adv eff /econ /hist /stand /supply; includes couture & fashion MNJ1.193 XSElastic Stockings; Stockings, Compression LH LS;  MS5-(2-Chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno-(2,3-e)-1,4-diazepin-2-one. Thienodiazepine derivative with actions similar to those of benzodiazepines; proposed as minor tranquilizer with muscle relaxing, anticonvulsant and taming actions. OLuse CLOTIAZEPAM to search Y 6047 back thru 1975 HN(78); was Y 6047 see under AZEPINES 1975-77 MHÑClotiazepam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN33671-46-4 PIAzepines (72-74); Thiophenes (72-74) MND3.383.66.175; D3.383.903.175; D15.236.872.659.366 XSY 6047 DMÑAzepines LH LS LM  MS1-(o-Chloro-alpha-diphenylbenzyl)imidazole. Broad spectrum antimycotic agent that can be used topically or orally with few side effects. HN(75) MHÑClotrimazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23593-75-1 PIImidazoles (71-74); Trityl Compounds (74) MND3.383.374.175; D20.136.234 DMÑImidazoles LH LM  PM67 HN67(65) MHÑCloxacillin ANdo not use /biosyn /defic /physiol RN61-72-3 MND20.85.99.739.681.205 XSChloroxacillin; SODIUM CLOXACILLIN XUÑFloxacillin LH LS; LU  MS8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4) diazepine. Tranquilizer used to treat schizophrenia; may have sedative properties. Synonym: Iprox HN(75) MHÑClozapine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5786-21-0 PIDibenzazepines (71-74); Piperazines (71-74) MND3.494.240.220; D15.236.872.331.345 DMÑDibenzazepines LH LM  MHÑClubfoot ANdo not use /congen MNC16.131.621.203; C23.304.351.229 XSTALIPES LH LS  OLsearch PROTAMINES 1966-74 HN(75) MHÑClupeine ANdo not use /defic /physiol; /analogs NIM only RN9007-31-2 MND12.776.664.750.270 DMÑProtamines LH LM  MSVascular headache, predominantly unilateral, usually associated with flushing, sweating, rhinorrhea and increased lacrimation; brief in duration and usually occurring in close-packed groups separated by long remissions. HN(78) MHÑCluster Headache ANcluster refers to occurrence in ╥groups separated by long remissions╙ PIHeadache (66-77); Vascular Headache (66-77) MNC10.228.140.300.937.210; C14.907.253.937.210; C23.888.592.612.429.814.210 DMÑVascular Headache LH LM  MS4-(2-((Cyclohexylimidocarbonyl)amino)ethyl)-4-methyl-morpholinium p-toluenesulfonate. HN(75) MHÑCME-Carbodiimide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2491-17-0 PICarbodiimides (74); Morpholines (74); Tosyl Compounds (74) MND2.491.203.340 DMÑCarbodiimides LH LM  MSSubstances that promote blood coagulation. OLsearch HEMOSTATICS 1966-74 PM75; was see under HEMOSTATICS 1963-74 HN75; was see under HEMOSTATICS 1963-74 MHÑCoagulants ANonly /admin /adv eff /anal /chem syn /class /isol /metab /pharm /rad eff /stand /supply /ther use /tox; consider also BLOOD COAGULATION /drug eff PIHemostatics (66-74) MND19.461.270 LH  OLto search STAPHYLOCOAGULASE use COAGULASE back thru 1968 & HYDROLASES 1966-67 PM66; was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67 HN66(64); was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67 MHÑCoagulase ANdo not use /analogs; staphylococcal clumping factor = COAGULASE MND24.310.200 XSSTAPHYLOCOAGULASE LH LS  MSA natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions. PM68 HN68(64); was in Cat J only 1964-81 MHÑCoal ANonly /anal /hist /stand /supply; /adv eff permitted but do not use for COAL MINING + PNEUMOCONIOSIS or ANTHRACOSILICOSIS unless particularly discussed as coal MNG3.230.132.258.108; J1.435.229 XUÑCoke LH LU  MHÑCoal Mining ANonly /econ /hist /instrum /methods /stand; consider also PNEUMOCONIOSIS but particularly SILICOSIS & ANTHRACOSILICOSIS MNJ1.576.670.354 FXÑAnthracosilicosis LH LX  MHÑCoal Tar AND25-26 qualif RN8007-45-2 MND26.368.627.229; D26.884.354 LH  MSSpecialized regions of the cell membrane composed of pits coated with a bristle covering made of the protein clathrin. These pits are the entry route for macromolecules bound by cell surface receptors. The pits are then internalized into the cytoplasm to form the receptosomes. HN(83) MHÑCoated Pits, Cell Membrane ANA 11 qualif except /cytol; DF: COATED PITS PICell Membrane (66-82); Endocytosis (73-82) MNA11.195.190; A11.368.702.801.190 XSBristle-Coated Pits; Cell Membrane Coated Pits FXÑClathrin DMÑReceptosomes LH LS; LX LM  MHÑCobalt ANCo-59; /defic /physiol permitted; do not use /analogs /biosyn RN7440-48-4 MND1.268.206; D1.552.181; D1.937.208 LH  MHÑCobalt Isotopes ANNIM; no qualif MND1.496.239; D1.552.181.354 LH  OLsearch COBALT ISOTOPES 1966-73 PM74 HN74 MHÑCobalt Radioisotopes ANCo-54-63 except Co-59; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use); often discussed with RADIOISOTOPE TELETHERAPY (IM) MND1.496.239.354; D1.496.749.256; D1.552.181.479 LH  PM74 HN74(72) MHÑCobamides ANdo not use /analogs PICoenzymes (66-71); Vitamin B 12 (66-71) MND8.176.175; D11.786.708.950.270 XSDEOXYADENOSINECOBALAMINS; Vitamin B 12 Coenzymes LH LS;  MSToxins, contained in cobra (Naja) venom that block cholinergic receptors; two specific proteins have been described, the small (short, Type I) and the large (long, Type II) which also exist in other Elapid venoms. HN(78) MHÑCobra Neurotoxins ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTITOXINS PIPeptides (66-75); Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) MND24.185.965.850.325.220.190 XSCobrotoxin DMÑCobra Venoms LH LS LM  MSVenoms from snakes of the genus Naja (family Elapidae); they contain many specific proteins that have cytotoxic, hemolytic, neurotoxic and other properties; like other Elapid venoms, they are rich in enzymes. Include cobramines, cobralysins. PM78 HN78 MHÑCobra Venoms ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS PISnake Venoms (75-77); Snakes (66-74); Toxins (66-77); Venoms (66-74) MND24.185.965.850.325.220 XSNaja Venoms XUÑCobra Neurotoxins; ÑDirect Lytic Factors LH LS LU;  MSAny of several South American shrubs of the Erythroxylon genus (and family) that yield COCAINE; the leaves are chewed with alum for CNS stimulation by the local people. MHÑCoca ANdo not use /isol /pathogen MNB6.560.216 XSErythroxylon LH LS  OLto search COCAINE DERIVATIVES use COCAINE /AA back thru 1975 & TROPANES 1969-74 PMCOCAINE DERIVATIVES was see under COCAINE 1975-77, was see under TROPANES 1969-74 HNCOCAINE DERIVATIVES was see under COCAINE 1975-77, was see under TROPANES 1969-74 MHÑCocaine ANdo not use /defic /physiol; cocaine derivatives = COCAINE /analogs; cocaine addiction = COCAINE (IM) + SUBSTANCE DEPENDENCE (IM) RN50-36-2 MND3.132.889.354; D3.605.869.388; D14.211.242; D15.236.122.251 LH  MSThe combination of two or more different factors in the production of cancer. PM77 HN77 MHÑCocarcinogenesis AN╥combination of two or more different factors in the production of cancer╙: nothing to do with NEOPLASMS, MULTIPLE PRIMARY; IM; no qualif PINeoplasms (66-76) MNC4.805.160; C23.739.170 FXÑCarcinogens; ÑDrug Synergism LH LX;  MSAn order of protozoans commonly parasitic in the epithelial cells of the intestinal tract but also found in the liver and other organs. OLsearch SPOROZOA 1966-74 PM79; was see under SPOROZOA 1963-78 HN79(75); was see under SPOROZOA 1963-78 MHÑCoccidia ANdo not use /anat /blood-csf-urine /embryol; infection = COCCIDIOSIS; /drug eff: consider also COCCIDIOSTATS; ╥coccidial╙ refers to COCCIDIA: do not confuse with ╥coccidioidal╙ (refers to COCCIDIOIDES, a fungus) PISporozoa (66-74) MNB1.841.762.167 XUÑCryptosporidium LH LU  MSA deuteromycetous fungal genus which causes coccidioidomycosis. MHÑCoccidioides ANa fungus: do not confuse with the sporozoon COCCIDIA; ╥coccidioidal╙ refers to COCCIDIOIDES: do not confuse with ╥coccidial╙ (refers to COCCIDIA); do not use /anat /embryol /microbiol /parasitol; infection = COCCIDIOIDOMYCOSIS MNB5.354.381.546.230 LH  MSA sterile solution containing the by-products of growth products of Coccidioides immitis, injected intracutaneously as a test for coccidioidomycosis. HN(75) MHÑCoccidioidin ANonly /admin /adv eff /anal /csf /class /immunol /isol /rad eff /stand /tox /urine RN12622-73-0 PIAntigens, Fungal (73-74); Coccidioides/IM (73-74) MND24.611.216.202.180 DMÑAntigens, Fungal LH LM  MHÑCoccidioidomycosis ANcaused by COCCIDIOIDES, not COCCIDIA MNC1.703.203 LH  MHÑCoccidiosis ANcaused by COCCIDIA, not COCCIDIOIDES; /drug ther: consider also COCCIDIOSTATS MNC3.752.259 XSEIMERIA INFECTIONS; ISOSPORA INFECTIONS LH LS;  MSAgents useful in the treatment or prevention of coccidiosis in man or animals. PM75 HN75 MHÑCoccidiostats ANdo not use /analogs /biosyn /defic /physiol; consider also COCCIDIA /drug eff & COCCIDIOSIS /drug ther (& not COCCIDIOIDES & COCCIDIOIDOMYCOSIS) PIAntiprotozoal Agents (69-74) MND21.370.400 XSAnticoccidial Agents LH LS  MHÑCoccyx ANa bone of the spine; do not confuse with COCCYGEAL REGION, merely locational MNA2.835.232.834.229 LH  PMCOCHLEAR DUCT was DUCTUS COCHLEARIS see under LABYRINTH 1963-78 MHÑCochlea ANdis: coord IM with LABYRINTH DISEASES (NIM) MNA9.246.631.246 XUÑCochlear Aqueduct; ÑCochlear Duct; ÑRound Window; ÑScala Tympani; ÑSpiral Ganglion; ÑSpiral Lamina; ÑStria Vascularis; ÑTectorial Membrane LH LU; ; ; ; ; ; ;  MSA channel containing perilymph passing through the temporal bone, connecting the scala tympani of the cochlea to the subarachnoid space. HN(79) MHÑCochlear Aqueduct ANdo not confuse with COCHLEAR DUCT PICochlea (66-78) MNA9.246.631.280 XSPerilymphatic Duct DMÑCochlea LH LS LM  MSSpiral tube in bony canal of the cochlea, lying on its outer wall between the scala vestibuli and scala tympani. OLto search DUCTUS COCHLEARIS use COCHLEAR DUCT back thru 1975 & LABYRINTH 1966-74 HN(79); was DUCTUS COCHLEARIS see under LABYRINTH 1963-78 MHÑCochlear Duct ANdo not confuse with COCHLEAR AQUEDUCT PILabyrinth (66-78) MNA9.246.631.246.292 XSDuctus Cochlearis; Scala Media DMÑCochlea LH LS; LM  MSAn electronic device implanted beneath the skin with electrodes to the cochlear nerve to create sound sensation in persons with sensorineural deafness. OLuse COCHLEAR IMPLANT to search AUDITORY PROSTHESIS back thru 1980 PM87; was AUDITORY PROSTHESIS 1980-86 HN87; was AUDITORY PROSTHESIS 1980-86 MHÑCochlear Implant ANdo not use /instrum /methods /util (except by MeSH definition); a subcutaneous electronic implant: do not confuse with French ╥prothese auditive╙ translated as ╥hearing aid╙ & indexed under HEARING AIDS PICochlea (66-79); Deafness (66-79); Electric Stimulation (66-79); Hearing Aids (66-79); Prosthesis (66-79) MNE4.659.216; E4.847.774.216; E7.296.319.216; E7.814.458.216; E7.858.565.216 XSCochlear Prosthesis; Implant, Cochlear LH LS;  MSThe electric response of the cochlear hair cells to acoustic stimulation. HN(80) MHÑCochlear Microphonic Potentials ANonly /drug eff /rad eff PIAction Potentials (67-79); Cochlea (66-79); Electrophysiology (66); Evoked Potentials (67-79) MNG7.453.697.100.300.369.223; G11.561.450.100.300.369.223 DMÑEvoked Potentials, Auditory LH LM  MHÑCochlear Nerve ANdo not use /innerv; dis = COCHLEAR NERVE (IM) + ACOUSTIC NERVE DISEASES (NIM); neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.125.271 LH  MSAn inherited disorder characterized by disproportionate dwarfism and premature senility, often accompanied by mental deficiency, photosensitivity, retinal degeneration, optic atrophy, cataracts, and partial deafness. HN(81) MHÑCockayne Syndrome PIDwarfism (66-80); Photosensitivity Disorders (66-80) MNC5.116.99.343.250; C16.131.77.250; C19.297.238; F3.709.346.120 XSDwarfism, Cachectic DMÑDwarfism LH LS LM  MSInsects of the family Blattidae, order Orthoptera; the most common cockroaches are Periplaneta american, the American cockroach; Blatta orientalis, the oriental cockroach; and Blatella germanica, the European cockroach. PM72 HN72 MHÑCockroaches AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 PIInsects (66-71) MNB1.131.617.678.108 XUÑPeriplaneta LH LU  MSA tropical palm tree, Cocos nucifera, that yields large, edible nuts from which oil and fiber are also obtained. HN(86)63; was in Cat J only 1963-80 MHÑCoconut ANas plant & food; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.645.271; J1.341.739.271 XSCocos DMÑNuts LH LS LM  OLsearch FISH OILS 1966-74 HN(75); was see under FISH LIVER OILS 1963-82 MHÑCod Liver Oil ANonly D25-26 qualif RN8001-69-2 MND10.516.212.302.380.360; D10.516.212.507.325; D10.516.627.430.354; J1.740.250.200; J1.740.350.300 DMÑFish Oils LH LM  OLto search CODEINE DERIVATIVES use CODEINE /AA back thru 1975 & MORPHINANS 1969-74 PMCODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74 HNCODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74 MHÑCodeine ANdo not use /biosyn /defic /physiol; codeine derivatives = CODEINE /analogs RN76-57-3 MND3.132.610.422.547.547.149; D3.549.686.575.547.204; D3.605.497.575.547.204; D14.73.153.616.547.204; D14.757.638.547.204; D23.338.246 XUÑHydrocodone; ÑOxycodone LH LU;  OLsearch RNA, MESSENGER 1974 HN(75) MHÑCodon ANIM; /drug eff /ultrastruct permitted; do not use /analogs /defic MND13.444.735.544.355 DMÑRNA, Messenger LH LM  MSA phylum of radially symmetrical invertebrates characterized by having a body composed of two layers of cells which comprise definite tissues. It includes hydroids, JELLYFISH, SEA ANEMONES and corals. MHÑCoelenterata AN/microbiol /parasitol permitted; ╥includes hydroids, JELLYFISH, SEA ANEMONES & corals╙; sea nettle & Portuguese man-of-war (Physalia) go under JELLYFISH MNB1.308 XUÑJellyfish; ÑSea Anemones LH LU;  MSVenoms from jellyfish, coral, sea anemone, etc. nematocysts; contain hemo-, cardio-, dermo- and neurotoxic substances and probably enzymes. Palytoxin, sarcophine and anthopleurine go here. PM78 HN78 MHÑCoelenterate Venoms ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; coord IM with specific coelenterate source (IM or NIM) PICoelenterata (66-77); Marine Toxins (74-77); Toxins (66-73); Venoms (66-77) MND24.185.926.580.230; D24.185.965.230 XSChironex Venoms; Jellyfish Venoms; Sea Anemone Venoms LH LS; ;  MHÑCoenzyme A AN/biosyn /physiol permitted RN85-61-0 MND8.176.211; D13.695.667.138.382; D13.695.827.68.382 XSCoA LH LS  PM73 HN73 MHÑCoenzyme A Synthetases ANdo not use /analogs RNEC 6.2.1. PILigases (66-72) MND8.586.464.271 XSAcyl CoA Synthetases; Acyl Coenzyme A Synthetases XUÑAcetyl Coenzyme A Synthetase; ÑSuccinyl Coenzyme A Synthetases LH LS; LU;  MHÑCoenzymes ANdo not use /analogs MND8.176 LH  MSThe process of compelling a person to act, or refrain from acting, contrary to his free choice often by use of threat of physical or moral force. PM78 HN78 MHÑCoercion ANno qualif MNF1.145.209.631.210; I1.880.630.200 LH  MSRubiaceous trees or shrubs, Coffea arabica and C. robusta, that yield CAFFEINE and THEOPHYLLINE. MHÑCoffee ANas plant & beverage; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.308; J1.125.318 XSCaffea; Coffea FXÑCAFFEINE LH LS; LX  MS3-beta-D-Ribofuranosyl-6,7,8-trihydroimidazo(4,5-d) (1,3)diazepin-8(R)-ol. A ribonucleoside antibiotic synergist and ADENOSINE DEAMINASE inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis; proposed as antineoplastic synergist and immunosuppressant. HN(79) MHÑCoformycin ANdo not use /defic /physiol; /analogs NIM only RN11033-22-0 PIAzepines (66-78); Nucleosides (66-70); Ribonucleosides (71-78) MND8.373.300; D13.570.800.250; D22.204.106.450.154; D22.569.450 DMÑRibonucleosides LH LM  MSIntellectual or mental process whereby an organism becomes aware of or obtains knowledge. MHÑCognition ANonly /drug eff /physiol /rad eff MNF2.463.188 XUÑAwareness LH LU  MSDisturbances in the mental process related to thinking, reasoning, and judgment. PM69 HN69 MHÑCognition Disorders ANdo not use /drug eff /physiol /rad eff PICognition (66-68); specific disorder MNF3.126.185 XUÑConfusion; ÑConsciousness Disorders; ÑOverinclusion; ÑResponse Interference LH LU; ; ;  MSMotivational state produced by inconsistencies between simultaneously held cognitions or between a cognition and behavior; e.g., smoking enjoyment and believing smoking is harmful are dissonant. PM69 HN69 MHÑCognitive Dissonance ANno qualif PICognition (66-68); Motivation (66-68) MNF2.463.188.305 FXÑMotivation LH LX  PM65 HN65 MHÑCoin Lesion, Pulmonary ANif neopl, coord IM with LUNG NEOPLASMS (NIM); if non-neopl, do not coord with LUNG DISEASES MNC4.588.894.797.520.405; C8.381.150 XSPULMONARY COIN LESION; PULMONARY NODULE, SOLITARY LH LS;  MSSexual intercourse. MHÑCoitus ANhuman only: animal = COPULATION; restrict to dictionary definition: for anal or oral sex index under SEX BEHAVIOR; no qualif MNF1.145.792.188; G8.520.900.100 LH  MSA contraceptive method whereby coitus is purposely interrupted in order to prevent ejaculation of semen into the vagina. PM75 HN75 MHÑCoitus Interruptus ANno qualif PIContraception (66-74); Coitus (66-74) MNE2.197.250; F1.145.792.188.300 LH  MSA residue of coal, left after dry (destructive) distillation, used as a fuel. OLsearch COAL 1968-74 HN(75); was in Cat J only 1975-81 MHÑCoke ANonly /adv eff /anal /hist /stand /supply MNG3.230.132.258.108.110; J1.435.229.355 DMÑCoal LH LM  MHÑColchicine ANdo not use /defic /physiol RN64-86-8 MND3.132.225; D14.73.278.398.218; D26.74.75.574.218 XUÑLumicolchicines LH LU  MSA genus of poisonous, liliaceous plants, Colchicum autumnale, the fall crocus or meadow saffron whose roots (corms) yield COLCHICINE; which is used as a biochemical tool and to treat gout; other members of this genus yield saffron dye, flavoring agents, and aromatics. HN(86)63 MHÑColchicum AN= meadow saffron; plant only: note COLCHICINE above; do not use /isol /pathogen MNB6.560.224 DMÑPlants, Medicinal LH LM  MHÑCold ANonly /adv eff /diag use /ther use; TN 44: differentiate from CRYOSURGERY; cooling of organs during surg goes under HYPOTHERMIA, INDUCED; ╥cryopreservation╙ goes under FREEZING; see other terms under CRYO- MNG3.230.300.100.725.710.300; H1.671.868.272 FXÑCryosurgery; ÑFROSTBITE; ÑHYPOTHERMIA; ÑHYPOTHERMIA, INDUCED; ÑIMMERSION FOOT; ÑREFRIGERATION; ÑSHIVERING; ÑTRENCH FOOT LH LX; ; ; ; ; ; ;  OLuse COLD CLIMATE to search POLAR REGIONS back thru 1966 HNPOLAR REGIONS was see under COLD CLIMATE 1963-77 MHÑCold Climate ANonly /adv eff; specify for Polar Region cold climate ARCTIC REGIONS or ANTARCTIC REGIONS if pertinent; specify other geog for cold climate if pertinent MNG3.230.300.100.250.275 XSPolar Regions LH LS  PM65 HN65 MHÑColectomy ANdo not use /util except by MeSH definition MNE4.765.219 LH  MSThe largest order of insects, comprising the beetles and weevils. PM75 HN75 MHÑColeoptera ANcomprising BEETLES & weevils; /microbiol /parasitol permitted PIInsects (66-74) MNB1.131.617.155 LH  MSTetraethylene pentamine polymer with 1-chloro-2,3-epoxypropane. Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic; also may reduce triglyceride levels. Synonyms: Colestid; U 26,597A. HN(75) MHÑColestipol AND25-26 qualif; /analogs NIM only RN50925-79-6 PIEthers, Cyclic (72-74); Polyamines (72-74); Polymers (71-74) MND2.92.782.200; D10.162.290; D25.720.200; D26.572.133.401 DMÑPolyamines LH LM  MHÑColic ANcoord IM with organ/diseases (IM), as renal colic = COLIC (IM) + KIDNEY DISEASES (IM), biliary colic = COLIC (IM) + BILIARY TRACT DISEASES or specific (IM) MNC23.888.592.612.216 XSAbdominal Cramps LH LS  MSPlasmids determining the potentiality of a bacterium to produce colicins. They are cytoplasmic elements whose integration into the bacterial chromosome has not been demonstrated except for the Col B and Col V factors. HN(78) MHÑColicin Factors ANonly /drug eff /rad eff PIColicins (66-77); Extrachromosomal Inheritance (68-77); Plasmids (75-77) MNG5.225.500.200 XSBacteriocin Factors; Col Factors DMÑPlasmids LH LS; LM  MSBacteriocins elaborated by strains of Escherichia coli and related species; they are proteins or protein-lipopolysaccharide complexes lethal to other strains of the same species. PM66 HN66(65) MHÑColicins ANdo not use /analogs /defic /physiol MND20.85.133.230; D24.310.125.230 XSColicines LH LS  MSA genus of birds (family Phasianidae) consisting of the bob-whites. HN(75) MHÑColinus ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; diseases: coord IM with BIRD DISEASES (IM) MNB2.248.801.300 XSBob-White DMÑQuail LH LS LM  MSColipase I and II, consisting of 94-95 and 84-85 amino acid residues, respectively, have been isolated from porcine pancreas. Their role is to prevent the inhibitory effect of bile salts on the lipase-catalyzed intraduodenal hydrolysis of dietary long-chain triglycerides. HN(76) MHÑColipases ANnot an enzyme despite -ase; /biosyn /physiol permitted; do not use /analogs PILipase (74-75); Proteins (74-75) MND12.776.200 DMÑProteins LH LM  MSViruses whose host is Escherichia coli. MHÑColiphages ANdo not use /cytol; LAMBDA PHAGE, PHAGE MU 1, PHAGE PHI X 174 & T-PHAGES are available MNB4.123.205 XSESCHERICHIA COLI PHAGES LH LS  MSCyclic polypeptide antibiotic from Bacillus colistinus; composed of Polymyxins E1 and E2 (or Colistins A, B and C) which act as detergents on cell membranes; less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Synonyms: Colisticin(e); colistin sulfomethate; Coly-Mycin; Totazina. MHÑColistin ANdo not use /defic /physiol RN1066-17-7 MND20.85.676.201 XSPolymyxin E LH LS  MHÑColitis ANENTEROCOLITIS (small & large intestinal inflamm) is also available MNC6.405.469.158.188 XUÑProctocolitis LH LU  MSInflammatory disease of unknown cause which involves the mucosa of the colon. Onset may be acute and fulminant, and its course often continues chronically in an intermittent or continuous form. Diarrhea is a common symptom and bleeding an almost constant concomitant symptom. MHÑColitis, Ulcerative ANusually chronic so do not coord with CHRONIC DISEASE; note X refs below: names are common in European literature: do not confuse with RECTOCOLITIS see PROCTOCOLITIS MNC6.405.469.158.188.231 XSRectocolitis, Hemorrhagic; Rectocolitis, Ulcerative XUÑMegacolon, Toxic LH LS; LU  MHÑCollagen AN/biosyn /physiol permitted; precursor = PROCOLLAGEN RN9007-34-5 MND12.776.860.177 FXÑConnective Tissue LH LX  MHÑCollagen Diseases ANGEN or unspecified; prefer specifics CATALOG: form qualif = RHEUMATOLOGY /form MNC23.205.200 FXÑANTINUCLEAR FACTORS; ÑRheumatology LH LX;  MHÑCollapse Therapy ANdo not use /util except by MeSH definition MNE4.920.800.250 FXÑTuberculosis, Pulmonary LH LX  MSCompensatory circulation developed in secondary vessels following obstruction of a main blood vessel. PM66 HN66(64) MHÑCollateral Circulation ANa naturally occurring physiol phenomenon: not for collateral restoration of funct by surg; only /drug eff /rad eff; consider also ANGIOGENESIS FACTOR MNG9.330.163.248 XSBLOOD CIRCULATION, COLLATERAL LH LS  MSThe process of negotiation between representatives of an employee organization, association or union, and representatives of the employer. PM71 HN71 MHÑCollective Bargaining ANonly /econ /hist /legis /methods /stand /trends /util PILabor Unions (66-70) MNN3.540.571.356; N4.452.677.356 LH  MSTest designed to identify students suitable for admission into a graduate or undergraduate curriculum. OLsearch EDUCATIONAL MEASUREMENT 1966-74 HN(75) MHÑCollege Admission Test ANno qualif MNI2.399.272 DMÑEducational Measurement LH LM  MSFracture of the lower end of the radius in which the lower fragment is displaced posteriorly. OLsearch RADIUS FRACTURES 1966-74 HN(75) MHÑColles' Fracture MNC21.866.405.638.356 DMÑRadius Fractures LH LM  MHÑCollodion AND25-26 qualif RN9004-70-0 MND25.720.157.439; D26.698.256 XSNitrocellulose LH LS  MSTwo-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out; the dispersing or continuous phase or medium envelops the particles of the discontinuous phase; all three states of matter can form colloids among each other. MHÑColloids ANIM for general only; only /adv eff /anal (with caution) /stand /supply; NIM with specific drug IM: no qualif MND26.394.225.220; H1.181.529.183 XUÑMicelles LH LU  PM73 HN73(65) MHÑColoboma ANdo not use /congen; coord IM with specific site in eye /abnorm (IM) MNC11.510.280; C16.131.384.356 LH  MSA genus of Old World monkeys which is found in Africa and includes 6 species. HN(75); was see under MONKEYS 1975-80 MHÑColobus ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.468.510 XSMonkey, Colobus DMÑCercopithecidae LH LS LM  MHÑColombia MNZ1.107.757.284 LH  MHÑColon ANtaenia coli or teniae coli goes here: do not confuse with Taenia, a genus of tapeworm; inflammation = COLITIS; /surg: do not confuse with specialty COLON AND RECTAL SURGERY (SPECIALTY) & consider also COLECTOMY or COLOSTOMY; ╥spastic colon╙ = COLONIC DISEASES, FUNCTIONAL, not SPASM nor COLITIS CATALOG: form qualif = COLON AND RECTAL SURGERY (SPECIALTY) /form MNA3.492.411.495.356 FXÑCOLOSTOMY LH LX  MSA surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the colon, rectum, and anal canal; replaced the Board of Proctology. OLuse COLON AND RECTAL SURGERY (SPECIALTY) to search PROCTOLOGY back thru 1966 PM80; was PROCTOLOGY 1963-79 HN80; was PROCTOLOGY 1963-79 MHÑColon and Rectal Surgery (Specialty) ANSPEC only; SPEC qualif; do not confuse with COLON /surg & RECTUM /surg DF: COLON RECTAL SURG CATALOG: use with form qualif instead of COLON /form or COLONIC DISEASES /form or RECTUM /form or RECTAL DISEASES /form MNG2.403.810.208 XSProctology; Rectal Surgery (Specialty) LH LS;  MHÑColonic Diseases ANinflamm dis = COLITIS CATALOG: form qualif = COLON AND RECTAL SURGERY (SPECIALTY) /form MNC6.405.469.158 LH  OLuse COLONIC DISEASES, FUNCTIONAL to search COLITIS, MUCOUS back thru 1966 PM65; was COLITIS, MUCOUS 1963-64 HN65; was COLITIS, MUCOUS 1963-64; COLITIS, MUCOUS was see under COLONIC DISEASES, FUNCTIONAL 1965-78 MHÑColonic Diseases, Functional MNC6.405.469.158.272 XSColitis, Mucous; Colon, Irritable; Irritable Bowel Syndrome LH LS; ;  PM64 HN64 MHÑColonic Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); note SIGMOID NEOPLASMS is available; /familial: consider also POLYPOSIS SYNDROME, FAMILIAL & COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS MNC4.588.274.476.411.306; C6.405.469.158.355 LH  PM84 HN84 MHÑColonic Polyps AN/anal /blood supply /secret /ultrastruct permitted PIColonic Neoplasms (66-83); Intestinal Polyps (68-83) MNC4.799.411.235; C6.405.469.158.360 LH  MSFunctional obstruction of the colon. HN(87) MHÑColonic Pseudo-Obstruction PIColonic Diseases (66-86); Intestinal Obstruction (66-86); Intestinal Pseudo-Obstruction, Idiopathic (81-86) MNC6.405.469.158.272.217; C6.405.469.531.560.217 XSOgilvie Disease; Pseudo-Obstruction, Colonic DMÑIntestinal Pseudo-Obstruction LH LS; LM  MSExamination of the luminal surface of the colon with a colonoscope. PM81 HN81 MHÑColonoscopy ANNIM; do not use /util except by MeSH definition PIColonic Diseases (66-80); Colonic Neoplasms (66-80); Endoscopy (66-80) MNE1.184.200; E1.418.213 LH  MSA cytologic technic for measuring the functional capacity of stem cells by assaying their activity. PM79 HN79 MHÑColony-Forming Units Assay ANno qualif; DF: CFU ASSAY PIBone Marrow (66-78); Erythropoiesis (66-78); Hematopoiesis (66-78); Hematopoietic Stem Cells (71-78); Spleen (66-78); specific blood cell MNE5.909.262.383 XSClonogenic Cell Assay; Stem Cell Assay FXÑHematopoietic Stem Cells XUÑTumor Stem Cell Assay LH LS; LX LU  MSA glycoprotein found in a subfraction of normal mammalian plasma and urine. The factor stimulates the proliferation of bone marrow cells in agar cultures and formation of colonies of granulocytes and/or macrophages. PM79; was see under GLYCOPROTEINS 1976-78 HN79(76); was see under GLYCOPROTEINS 1976-78 MHÑColony-Stimulating Factor ANdo not use /analogs /defic; coord IM with colonized cell (IM or NIM) if pertinent PIBone Marrow (66-75); Cell Division (66-75); Clone Cells (68-75); Glycoproteins (66-75) MND12.776.395.240; D24.185.152 LH  MHÑColor ANNIM; when IM, only /stand; differentiate from PIGMENTATION in that PIGMENTATION is related to biological PIGMENTS MNH1.671.606.217 LH  MHÑColor Blindness MNC10.597.751.941.256; C11.966.256; C23.888.592.763.941.256 LH  MSThe visual awareness of any particular hue or achromatic color. MHÑColor Perception ANsame as ╥color vision╙; only /drug eff /physiol /rad eff MNF2.463.593.932.217; G11.697.911.860.231 XSColor Vision LH LS  MHÑColor Perception Tests ANonly /instrum /methods MNE1.210.935.231 LH  MHÑColorado MNZ1.107.567.875.166 LH  MSA febrile illness characterized by chills, aches, vomiting, leucopenia, and sometimes encephalitis; caused by a reovirus transmitted by the tick Dermacentor andersoni. HN(66); was see under ARBOVIRUS INFECTIONS 1975-76 MHÑColorado Tick Fever MNC2.782.791.482; C2.81.220 DMÑReovirus Infections LH LM  MSA virus transmitted by the tick Dermacentor andersonii and causing fever, chills, aching head and limbs, and often vomiting; occurs in the Northwestern United States, except the Pacific Coast. HN(75); was see under REOVIRUSES 1975-80 MHÑColorado Tick Fever Virus ANdo not use /blood-csf-urine /cytol MNB4.909.777.714.300 DMÑReoviridae LH LM  MSA syndrome characterized by autosomal dominant inheritance, a low mean age (41 years) for occurrence of colon cancer, and a marked increase in the proportion of tumors in the proximal colon. PM87 HN87 MHÑColorectal Neoplasms, Hereditary Nonpolyposis AN/anal /blood supply /secret /ultrastruct permitted MNC4.588.274.476.411.306.310; C4.588.274.476.411.792.310; C4.700.250; C6.405.469.158.355.370; C16.466.700.250 XSHereditary Nonpolyposis Colorectal Neoplasms LH LS  MHÑColorimetry ANNIM; only /instrum /methods /stand MNE5.196.217; H1.181.278.223 LH  MHÑColostomy ANdo not use /util except by MeSH definition MNE4.765.259 XSAnus, Artificial FXÑColon LH LS LX  MHÑColostrum ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; check the tags FEMALE & PREGNANCY MNA12.838.194 FXÑLactation LH LX  MHÑColposcopy ANNIM; do not use /util except by MeSH definition MNE1.249.169; E1.418.221 LH  MSA profound state of unconsciousness; includes ╥stupor╙ from which the patient can be partially roused, as well as complete unconsciousness in which there is no response to sensory stimuli, even at the reflex level. MHÑComa ANincludes ╥stupor╙; HEPATIC COMA see HEPATIC ENCEPHALOPATHY, DIABETIC COMA, INSULIN COMA & entry below are also available MNC10.597.917.273; C23.888.592.925.273 XSVegetative State LH LS  PM68 HN68 MHÑComb and Wattles ANDF: COMB PIPoultry (66-67) MNA13.242 XSWattles LH LS  MSNeurotic reactions to unusual, severe, or overwhelming military stress. OLuse COMBAT DISORDERS to search NEUROSES, WAR back thru 1966 HN(81); was NEUROSES, WAR 1963-80 MHÑCombat Disorders ANdo not use /drug eff /physiol /rad eff; note category: do not confuse with war wounds ( = WOUNDS AND INJURIES or specific inj (IM) + WAR (IM or NIM) ) MNF3.709.438.180.680.110 XSNeuroses, War; War Neuroses DMÑStress Disorders, Post-Traumatic LH LS; LM  MSThe treatment of a disease or condition by several different means simultaneously or sequentially; chemoimmunotherapy, radioimmunotherapy, chemoradiotherapy, and cryochemotherapy are seen most frequently, but their combinations with each other and surgery are also used. PM84 HN84 MHÑCombined Modality Therapy ANalmost never IM; coordinate disease term with specific ther qualif (IM) + specific ther (IM or NIM): TN 6; for combined ther of drugs DRUG COMBINATIONS or DRUG THERAPY, COMBINATION is available, for combined anticancer ther ANTINEOPLASTIC AGENTS, COMBINED is available PIDrug Therapy, Combination (74-83) MNE2.186 XSMultimodal Treatment; Therapy, Combined Modality FXÑAntineoplastic Agents, Combined LH LS; LX  MHÑCommerce ANno qualif MNJ1.219 XSBUSINESS LH LS  MSThe non-profit, non-governmental organization which collects, processes and distributes data on hospital use. Two programs of the Commission are the Professional Activity Study and the Medical Audit Program. HN(Aug 77) MHÑCommission on Professional and Hospital Activities ANonly /hist /organ; add UNITED STATES (NIM); DF: CPHA CATALOG: use NAF entry MNN4.761.380.100 XSProfessional Activity Study DMÑMedical Audit LH LS LM  MSLegal process required for the institutionalization of a patient with severe mental problems. PM83; was see under FORENSIC PSYCHIATRY 1975-82 HN83(75); was see under FORENSIC PSYCHIATRY 1975-82 MHÑCommitment of Mentally Ill ANonly /econ /hist /legis /trends; do not coord with HOSPITALIZATION since this is inherent in the definition MNF4.96.544.335.200; N3.706.535.351.200 XSInvoluntary Commitment FXÑPatient Advocacy LH LS LX  MHÑCommon Bile Duct ANinflammation: coord IM with CHOLANGITIS (IM); choledochus or choledochal cyst (also called ╥cystic dilatation of the common bile duct╙ or ╥choledochocele╙) is indexed under COMMON BILE DUCT DISEASES (IM) + CYSTS (IM); if congen, add /congen to both MNA3.159.183.307 XSCHOLEDOCHUS LH LS  OLto search for chem composition of common bile duct calculi, use COMMON BILE DUCT CALCULI/anal back thru 1987 & COMMON BILE DUCT CALCULI/metab 1966-86 MHÑCommon Bile Duct Calculi ANchem composition of calculi: use /anal; /ultrastruct permitted MNC6.130.120.250.250; C6.130.409.357 XSBiliary Calculi, Common Bile Duct; Choledocholithiasis; Cholelithiasis, Common Bile Duct; Gallstones, Common Bile Duct LH LS; ; ;  MSDiseases of the common bile duct including Vater's ampulla and Oddi's sphincter. PM80 HN80 MHÑCommon Bile Duct Diseases ANcholedochal cysts or cystic dilatation of common bile duct: see note on COMMON BILE DUCT PIBiliary Tract Diseases (66-79); specific biliary tract disease; Common Bile Duct (66-79); Oddi's Sphincter (75-79); Vater's Ampulla (66-79) MNC6.130.120.250 LH  MSNeoplasms of the common bile duct including Vater's ampulla and Oddi's sphincter. PM80 HN80 MHÑCommon Bile Duct Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIBile Duct Neoplasms (66-79); Common Bile Duct (66-79) MNC4.588.274.120.250.250; C6.130.120.250.280 LH  MHÑCommon Cold AN╥cold sore╙ does not go here: = HERPES LABIALIS MNC2.782.687.207; C8.730.162 XSCOLD, COMMON; CORYZA, ACUTE LH LS;  MHÑCommunicable Disease Control ANonly /econ /hist /instrum /methods /trends; GEN only: prefer Cat C term with /prev CATALOG: /geog /form MNG3.850.180 FXÑDISEASE RESERVOIRS; ÑDISEASE VECTORS; ÑDisease Reservoirs LH LX; ;  MHÑCommunicable Diseases AN/prev = COMMUNICABLE DISEASE CONTROL for GEN only; do not confuse X ref INFECTIOUS DISEASES with INFECTION: see note there MNC1.539.221 XSInfectious Diseases FXÑDisease Outbreaks; ÑDisease Reservoirs LH LS LX;  MSThe exchange or transmission of ideas, attitudes or beliefs between individuals or groups. MHÑCommunication ANincludes personal & technological communication; telegraph goes here; ANIMAL COMMUNICATION is also available; only /hist MNF1.145.209; L1.143 FXÑLITERATURE XUÑCommunication Barriers; ÑDiffusion of Innovation LH LX LU;  MSEquipment that provides mentally or physically handicapped persons, who cannot speak effectively, with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers and speech synthesizers. The output of such aids includes written words, artificial speech, language signs, Morse code and pictures. HN(80) MHÑCommunication Aids for Handicapped ANonly /class /econ /hist /stand /supply /trends /util (if by MeSH definition) PICommunication (66-79); Nonverbal Communication (70-79) MNE7.796.250 XSCommunication Boards; Speech Synthesizers DMÑSelf-Help Devices LH LS; LM  MSThose factors, such as language or sociocultural relationships, which interfere in the meaningful interpretation and transmission of ideas between individuals or groups. HN(79) MHÑCommunication Barriers ANlanguage, cultural, sociol, etc., communication barriers; no qualif PICommunication (66-78) MNF1.145.209.213; L1.143.230 XSBarriers, Communication DMÑCommunication LH LS LM  MSUtilization of all available receptive and expressive modes for the purpose of achieving communication with the hearing impaired, such as gestures, postures, facial expression, types of voice, formal speech and non-speech systems, and simultaneous communication. HN(80) MHÑCommunication Methods, Total ANno qualif; restrict to commun with hearing-impaired; coord with specific hearing disord /rehabil PICommunication (66-79); Deafness (66) /RH (67-79) MNE2.831.671.221 XSTotal Communication Methods DMÑRehabilitation LH LS LM  OL╥communications media╙ is indexed COMMUNICATION MH*Communications Media (Non Mesh) MNL1.178 LH  MSDisorders characterized by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing. PM85 HN85 MHÑCommunicative Disorders ANGEN or unspecified: prefer specifics HEARING DISORDERS, LANGUAGE DISORDERS or SPEECH DISORDERS; do not use /congen /drug eff /physiol /rad eff PIHearing Disorders (66-84); Language Disorders (67-84); Speech Disorders (66-84) MNC10.597.257; C23.888.592.257; F3.126.219 LH  MSA totalitarian system of government in which a single authoritarian party controls state-owned means of production with the professed aim of establishing a classless society. MHÑCommunism ANonly /hist; specify geog if pertinent MNI1.696.232 LH  MSThe practice of dentistry concerned with preventive as well as diagnostic and treatment programs in a circumscribed population. OLsearch PUBLIC HEALTH DENTISTRY 1971-74 HN(75) MHÑCommunity Dentistry ANSPEC: SPEC qualif MNG2.163.876.770.357 DMÑPublic Health Dentistry LH LM  MSPersons trained to assist professional health personnel in communicating with residents in the community concerning needs and availability of health services. PM71 HN71 MHÑCommunity Health Aides ANdo not use /man /methods CATALOG: /geog /form PICommunity Health Services (66-70); Community Mental Health Services (67-70) MNM1.526.485.67.80; N2.350.84.149 XSBarefoot Doctors; Village Health Worker LH LS;  MSFacilities which administer the delivery of health care services to people living in a community or neighborhood. OLto search NEIGHBORHOOD HEALTH CENTERS use COMMUNITY HEALTH CENTERS back thru 1975 & COMMUNITY HEALTH SERVICES 1968-74 PM79; was NEIGHBORHOOD HEALTH CENTERS see under COMMUNITY HEALTH SERVICES 1968-78 HN79; was NEIGHBORHOOD HEALTH CENTERS see under COMMUNITY HEALTH SERVICES 1968-78 MHÑCommunity Health Centers ANdo not use /educ /methods CATALOG: /geog /form PICommunity Health Services (66-74) MNN2.278.35.128 XSNeighborhood Health Centers LH LS  MSGeneral and comprehensive nursing practice directed to individuals, families or groups as it relates to and contributes to the health of a population. Not an official program of a Public Health Department. PM77; was see under COMMUNITY HEALTH SERVICES 1975-76 HN77(75); was see under COMMUNITY HEALTH SERVICES 1975-76 MHÑCommunity Health Nursing ANSPEC qualif; do not confuse with PUBLIC HEALTH NURSING (a government function) CATALOG: /geog /form MNN2.421.143.150 XSHealth Visitors; Visiting Nurses LH LS;  MSDiagnostic, therapeutic and preventive health services provided for individuals in the community. PM67 HN67(65) MHÑCommunity Health Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form MNN2.421.143 XSCommunity Health Care FXÑHOSPITALS; ÑPublic Health Administration; ÑSocial Work LH LS LX; ;  MSA branch of medicine concerned with the total health of the individual within the home environment and in the community, and with the application of comprehensive care to the prevention and treatment of illness in the entire community. OLsearch COMPREHENSIVE HEALTH CARE 1970-74 PM77; was see under COMPREHENSIVE HEALTH CARE 1970-76 HN77(75); was see under COMPREHENSIVE HEALTH CARE 1970-76 MHÑCommunity Medicine ANSPEC only: SPEC qualif CATALOG: /geog /form MNG2.403.220 LH  MSFacilities which administer the delivery of psychologic and psychiatric services to people living in a neighborhood or community. OLsearch COMMUNITY MENTAL HEALTH SERVICES 1978 PM79; was see COMMUNITY MENTAL HEALTH SERVICES 1978; CHILD GUIDANCE CLINICS was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78 HN79; was see COMMUNITY MENTAL HEALTH SERVICES 1978 MHÑCommunity Mental Health Centers ANdo not use /educ /methods; DF: CMHC CATALOG: /geog /form PICommunity Mental Health Services (67-78) MNN2.278.35.158 XSCMHC XUÑChild Guidance Clinics LH LS LU  MSDiagnostic, therapeutic and preventive mental health services provided for individuals in the community. PM67 HN67 MHÑCommunity Mental Health Services ANPublic Laws 88-164 & 89-105; only /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form PIMental Health Services (66) MNF4.408.307; N2.421.143.183; N2.421.461.232 XSMental Health Services, Community FXÑREHABILITATION LH LS LX  MSTotal pharmaceutical services provided to the public through community pharmacies. OLsearch COMMUNITY PHARMACIES under PHARMACIES 1968-78 PM68; COMMUNITY PHARMACIES was see under PHARMACIES 1968-78 HN68; COMMUNITY PHARMACIES was see under PHARMACIES 1968-78 MHÑCommunity Pharmacy Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form PIPharmacies (66-67); Pharmacy (66-67) MNN2.421.143.221; N2.421.668.274 FXÑPharmacy LH LX  MSBranch of psychiatry concerned with the provision and delivery of a coordinated program of mental health care to a specified population. The foci included in this concept are: all social, psychological and physical factors related to etiology, prevention, and maintaining positive mental health in the community. OLuse COMMUNITY PSYCHIATRY to search PSYCHIATRY, COMMUNITY back thru 1971 (as Prov 1971-72) PM80; was PSYCHIATRY, COMMUNITY 1973-79 HN80; was PSYCHIATRY, COMMUNITY 1971-79 (Prov 1971-72) MHÑCommunity Psychiatry ANSPEC: SPEC qualif PIPsychiatry (66-70) MNF4.96.544.215; G2.403.642.150 XSPsychiatry, Community; Social Psychiatry XUÑPreventive Psychiatry LH LS; LU  MSThe interactions between members of a community and representatives of the institutions within that community. PM78 HN78 MHÑCommunity-Institutional Relations ANonly /econ /legis /stand /trends; specify institution (IM) + geog if pertinent CATALOG: /geog /form MNF1.829.674.210; N4.452.822.210 LH  HN66; restricted to comparison of drugs or technics only 1966-73 MHÑComparative Study ANcheck tag only; Manual 18.13+; do not use for comparison of subject & normal controls; relation to ANATOMY, COMPARATIVE; HISTOLOGY, COMPARATIVE; etc.: Manual 18.13.4 CATALOG: do not use: for indexers only LH  MSConditions in which increased pressure within a limited space compromises the circulation and function of tissue within that space. Mainly involves the leg but also the forearm, arm, thigh, shoulder, and buttock. Some of the causes of increased pressure are trauma, tight dressings, hemorrhage, and exercise. Sequelae include nerve compression, paralysis, and contracture. OLuse COMPARTMENT SYNDROMES to search VOLKMANN'S CONTRACTURE back thru 1966 PM81; VOLKMANN CONTRACTURE was heading VOLKMANN'S CONTRACTURE 1963-80; ANTERIOR COMPARTMENT SYNDROME was heading 1972-80 HN81; VOLKMANN CONTRACTURE was heading VOLKMANN'S CONTRACTURE 1963-80 MHÑCompartment Syndromes PIAnterior Compartment Syndrome (72-80); Ischemia (66-80); Muscles (66-80); Muscular Diseases (66-80) MNC5.651.180; C14.907.553.241 XSVolkmann Contracture FXÑNerve Compression Syndromes XUÑAnterior Compartment Syndrome LH LS LX LU  MSEducational programs designed to ensure that students attain prespecified levels of competence in a given field or training activity. Emphasis is on achievement or specified objectives. HN(79) MHÑCompetency-Based Education ANno qualif MNI2.158.210 XSEducation, Competency-Based DMÑCurriculum LH LS LM  MSThe direct struggle between individuals for environmental necessities or for a common goal. PM68 HN68 MHÑCompetitive Behavior ANhuman & animal; only /drug eff /physiol /rad eff PIBehavior (66-67); Behavior, Animal (66-67); Motivation (66-67) MNF1.145.224 LH  MSPricing statements presented by more than one party for the purpose of securing a contract. HN(86) MHÑCompetitive Bidding ANonly /legis /organ /stand /trends /util PIContract Services (78-85); Financial Management (78-85) MNN3.219.463.100.110 XSContract Bidding; Request for Proposal DMÑFinancial Management LH LS; LM  MHÑComplement ANonly /anal /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; /antag = COMPLEMENT INACTIVATORS RN9007-36-7 MND12.776.124.486.274; D24.611.333 LH  MSEnzymes present in the complement system which activate one or more components in the system. PM78 HN78 MHÑComplement Activating Enzymes ANdo not use /analogs RNEC 3.- PIComplement (68-77); specific complement (75-77); Esterases (66-77); Hydrolases (66-77); Serum Globulins (70-77) MND8.586.277.300; D12.776.124.486.274.860; D24.611.333.860 XUÑComplement 1 Esterase; ÑComplement 3 Convertase; ÑProperdin Factor D LH LU; ;  MSThe sequential activation of serum components C1 through C9, initiated by an erythrocyte-antibody complex or by microbial polysaccharides and properdin, and producing an inflammatory response. PM79 HN79 MHÑComplement Activation ANonly /drug eff /rad eff PIComplement (66-78); Complement Fixation Tests (66-78) MNG4.610.255 XUÑComplement Pathway, Alternative; ÑComplement Pathway, Classical LH LU;  MSSerologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. MHÑComplement Fixation Tests ANonly /instrum /methods /vet MNE1.223.495.826.208 XUÑConglutination Reaction LH LU  MSSerum proteins which act at key sites in the complement sequence to modulate or prevent the progression of the reaction. Absence of these factors leads to uncontrolled activation of the complement system with accompanying disease. Synonym: CINA. PM78 HN78 MHÑComplement Inactivators ANdo not use analogs; DF: COMPLEMENT INACT PIComplement (68-77); specific complement/AI (75-77) MND12.776.124.486.274.920; D24.611.333.920 XSComplement Inhibitors XUÑComplement 3 Nephritic Factor LH LS LU  MSThe complement activation sequence initiated by the activation of complement factor C3, which is triggered by the interaction of microbial polysaccharides and properdin without participation of an antigen-antibody reaction. HN(79) MHÑComplement Pathway, Alternative ANonly /drug eff /rad eff PIComplement (66-78); Complement Fixation Tests (66-78) MNG4.610.255.695 XSAlternative Complement Pathway; Properdin Pathway DMÑComplement Activation LH LS; LM  MSThe sequential activation of complement, initiated by antigen-antibody complex and the binding of complement factor C1q to the Fc region of the antibody. HN(79) MHÑComplement Pathway, Classical ANonly /drug eff /rad eff PIComplement (66-78); Complement Fixation Tests (66-78) MNG4.610.255.698 XSClassical Complement Pathway DMÑComplement Activation LH LS LM  MSThe first complement component to act in the cytolysis reaction; it is a trimolecular complex held together with Ca ions and when activated, has esterase activity which initiates the next step in the sequence. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 1 ANonly /anal /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; /antag = COMPLEMENT 1 INACTIVATORS; DF: C 1 PICalcium (66-74); Complement (68-74) MND12.776.124.486.274.50; D24.611.333.50 LH  MSThe activated form of complement 1 which has hydrolase activity. In the classical pathway, it splits first C4 and then C2 into active components, thereby generating a new enzyme referred to as EAC142 or C42 or C3 convertase. HN(78) MHÑComplement 1 Esterase ANdo not use /analogs RNEC 3.- PIComplement 1 (75-77); Esterases (66-77) MND8.586.277.300.250; D12.776.124.486.274.860.250; D24.611.333.860.250 XSC1 Esterase DMÑComplement Activating Enzymes LH LS LM  MSCompounds which inhibit, antagonize or inactivate Complement 1. A well-known inhibitor is a serum glycoprotein believed to be alpha-2-neuroaminoglycoprotein. It inhibits the activated (esterase) form of complement 1 as well as kinin-forming, coagulation and fibrinolytic systems. Deficiency of this inactivator has been found in patients with hereditary angioneurotic edema. PM78 HN78 MHÑComplement 1 Inactivators ANdo not use /analogs; DF: C 1 INACT PIComplement 1 (75-77); Enzyme Inhibitors (75-77); Enzymes (66-67) /AI (68-74); Glycoproteins (66-77) MND8.373.745.310; D12.776.124.486.274.920.250; D24.611.333.920.250 XSC1 Esterase Inactivators; C1 Esterase Inhibitors; C1 Inactivators; Complement 1 Inhibitors LH LS; ; ;  MSThe third component in the complement reaction sequence; it is a beta globulin with a molecular weight of 117,000, a serum concentration of 30 micrograms/ml and a sedimentation coefficient of 4. It activates C3. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 2 ANonly /anal /antag /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; DF: C 2 PIComplement (68-74); Magnesium (66-74); Protein Binding (66-74) MND12.776.124.486.274.150; D24.611.333.150 LH  MSThe fourth component to attach in the complement reaction sequence; it is a beta globulin with a sedimentation coefficient of 5.5, a molecular weight of 185,000 and a serum concentration of 1.3 micrograms/ml. Its fragments have anaphylatoxic, chemotactic and histaminic action and affect smooth muscle. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 3 ANonly /anal /antag /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; DF: C 3 PIAnaphylaxis (66-74); Chemotaxis (66-74); Complement (68-74); Immune Adherence Reaction (71-74); Neutrophils (66-74); Phagocytosis (66-74) MND12.776.124.50.140; D12.776.124.486.274.250; D24.611.333.250 LH  MSThe enzyme which in both the classical and alternate complement pathways cleaves complement 3 into anaphylatoxin (C3a) and C3b. HN(78) MHÑComplement 3 Convertase ANdo not use /analogs RNEC 3.- PIComplement 3 (75-77); Esterases (66-77); Peptide Peptidohydrolases (66-77) MND8.586.277.300.325; D12.776.124.486.274.860.325; D24.611.333.860.325 XSC3 Activator; C3 Convertase; EAC142 DMÑComplement Activating Enzymes LH LS; ; LM  MSA magnesium dependent factor found in serum of patients with chronic mesangioproliferative hypocomplementemic glomerulonephritis. It causes inactivation of C3 in the alternate pathway by cleaving C3 into two inactive fragments C3c and C3d, instead of the normal C3b. HN(78) MHÑComplement 3 Nephritic Factor ANdo not use /analogs PIBlood Proteins (66-77); Complement 3 (75-77) MND12.776.124.486.274.920.300; D24.611.333.920.300 XSC3 Nephritic Factor DMÑComplement Inactivators LH LS LM  MSThe larger fragment formed when C3 convertase splits C3 into anaphylatoxin and C3b. In both the classical and alternate pathway C3b participates in immune adherence and enhances phagocytosis. It also forms a cellular intermediate which continues the complement process. In the alternate pathways, C3b initiates a positive feedback activation of C3PAse. PM78 HN78 MHÑComplement 3b ANonly /anal /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; /antag = COMPLEMENT 3B INACTIVATORS; DF: C 3B PIComplement (68-74); Complement 3 (75-77) MND12.776.124.486.274.250.260; D24.611.333.250.260 LH  MSCompounds which inhibit, antagonize or inactivate Complement 3b. A well-known inhibitor is a beta globulin which cleaves C3b into inactive fragments C3c and C3d. C3bINA plays a key role in the regulation of the complement system by blocking the cytolytic sequence and preventing recruitment of the properdin amplification loop. PM78 HN78 MHÑComplement 3b Inactivators ANdo not use /analogs; DF: C 3B INACT PIComplement 3 (75-77); Serum Globulins (70-77) MND12.776.124.486.274.920.325; D24.611.333.920.325 XSC3B Inactivators; Complement 3b Inhibitors; Conglutinogen Activating Factors LH LS; ;  MSThe second component to react in the complement sequence; it is a beta globulin with a sedimentation coefficient of 18.7, a molecular weight of 240,000 and a serum concentration of 430 micrograms/ml; it is activated by complement 1 and serves as a receptor for C2. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 4 ANonly /anal /antag /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; DF: C 4 PIComplement (68-74); Protein Binding (66-74) MND12.776.124.486.274.350; D24.611.333.350 LH  MSThe fifth component in the complement reaction sequence, probably exists in a complex with C6 and C7; it is a beta globulin with a sedimentation coefficient of 10, serum concentration of 75 micrograms/ml and molecular weight of 180,000. It is activated by C423 and releases fragment with anaphylatoxic, chemotactic and histamine releasing action and affecting smooth muscle. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 5 ANonly /anal /antag /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; DF: C 5 PIComplement (68-74); Histamine Liberation (66-74) MND12.776.124.486.274.450; D24.611.333.450 LH  MSThe sixth component in the complement reaction sequence; it is a beta globulin with a sedimentation coefficient of 8.7, molecular weight of 120,000 at 60 micrograms/ml in serum; it may exist in a complex with C5 and C7 and is activated by the binding of C5. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 6 ANonly /anal /antag /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; DF: C 6 PIComplement (68-74) MND12.776.124.486.274.550; D24.611.333.550 LH  MSThe seventh component in the complement reaction sequence; it is a beta globulin probably in a complex with C5 and C6 and is activated by C5; the attachment of C7 renders the cell susceptible to lysis. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 7 ANonly /anal /antag /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; DF: C 7 PIChemotaxis (66-74); Complement (68-74); Neutrophils (66-74) MND12.776.124.486.274.650; D24.611.333.650 LH  MSThe next to the last essential component for cell lysis in the complement reaction sequence; it is a gamma globulin with a molecular weight of 150,000, a sedimentation coefficient of 8, present as a trace in serum; it can by inhibited, like complement 1, by cation chelators. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 8 ANonly /anal /antag /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; DF: C 8 PIBacteriolysis (66-74); Complement (68-74); Hemolysis (66-74) MND12.776.124.486.274.750; D24.611.333.750 LH  MSThe last component in the complement reaction sequence; it is an alpha globulin present in serum as a trace, with a molecular weight of 80,000 and a sedimentation coefficient of 4.5; for cell lysis, it can be replaced by a metal chelator. PM78; was see under COMPLEMENT 1975-77 HN78(75); was see under COMPLEMENT 1975-77 MHÑComplement 9 ANonly /anal /antag /biosyn /csf /defic /genet /immunol /isol /metab /physiol /rad eff; DF: C 9 PIBacteriolysis (66-74); Complement (68-74); Hemolysis (66-74); specific cell MND12.776.124.486.274.850; D24.611.333.850 LH  OLsearch ELASTICITY 1968-74 HN(75)(68-69) MHÑCompliance ANNIM; no qualif; note category: do not confuse with LUNG COMPLIANCE or PATIENT COMPLIANCE MNH1.671.231.358 DMÑElasticity LH LM  PM73 HN73(72) MHÑComposite Resins AND25-26 qualif PIDental Materials (66-71); Resins (66-71) MND25.339.149; D25.720.716.822.308 LH  PM66 HN66(63) MHÑCompound 48-80 AND25-26 qualif MND26.283 FXÑHistamine Liberation LH LX  MSProviding for the full range of dental health services for diagnosis, treatment, follow-up, and rehabilitation of patients. PM73 HN73 MHÑComprehensive Dental Care ANonly /econ /legis /man /methods /organ /stand /trends CATALOG: /geog /form PIComprehensive Health Care (68-71) MNN4.590.233.250 FXÑDental Care LH LX  MSProviding for the full range of personal health services for diagnosis, treatment, follow-up and rehabilitation of patients. PM68 HN68 MHÑComprehensive Health Care ANonly /econ /legis /man /methods /organ /stand /trends CATALOG: /geog /form PICommunity Health Services (66-67); specific service MNN4.590.233 LH  MSIrrational, irresistable, intrusive impulse to perform an act repetitively that is contrary to the person's ordinary wishes or standards. PM68 HN68 MHÑCompulsive Behavior ANdo not use /drug eff /physiol /rad eff MNF1.145.527.100; F3.126.517.100 FXÑObsessive-Compulsive Disorder XUÑObsessive Behavior LH LX LU  MSA personality disorder in which the following features are notable: restricted ability to express warm emotions, perfectionism, insistence that others do things as he or she wants, excessive devotion to work to the exclusion of pleasure, and indecisiveness. OLto search OBSESSIVE-COMPULSIVE PERSONALITY use COMPULSIVE PERSONALITY DISORDER back thru 1975 & COMPULSIVE BEHAVIOR 1969-74 HN(81); was OBSESSIVE-COMPULSIVE PERSONALITY see under PERSONALITY DISORDERS 1975-80, was OBSESSIVE-COMPULSIVE PERSONALITY see under COMPULSIVE BEHAVIOR 1969-74 MHÑCompulsive Personality Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.597.138 XSAnankastic Personality; Compulsive Personality; Obsessive-Compulsive Personality; Personality Disorder, Compulsive DMÑPersonality Disorders LH LS; ; ; LM  MSA self-learning technic, usually online, involving interaction of the student with programmed instructional materials. PM74 HN74 MHÑComputer Assisted Instruction ANonly /econ /hist /instrum /methods /stand /trends /util (if by MeSH definition); DIAGNOSIS, COMPUTER ASSISTED is also available MNI2.903.573.208; L1.700.568.180.300 XSProgrammed Instruction, Computerized; Self-Instruction Programs, Computerized LH LS;  MSA configuration of two or more computers linked to share information and resources. HN(87) MHÑComputer Communication Networks MNL1.700.568.80.110 XSComputer Network Management; Databases, Distributed; Distributed Systems; Network Communication Protocols; Telecommunication Networks DMÑComputer Systems LH LS; ; ; ; LM  MSThe process of pictorial communication, between human and computers, in which the computer input and output have the form of charts, drawings, or other appropriate pictorial representation. PM87 HN87 MHÑComputer Graphics ANIM; no qualif MNL1.700.568.110.108; L1.700.568.810.210.110 LH  MSGeneral learning, knowledge, and fluency with computer terms; also, becoming familiar with how computers operate and how they are programmed. PM87 HN87 MHÑComputer Literacy ANIM; no qualif MNL1.700.568.180.380 LH  MSComputer-based representation of physical systems and phenomena such as chemical processes. PM87 HN87 MHÑComputer Simulation ANIM; no qualif; coord IM with specific models heading (IM) MNL1.700.568.110.160 XSComputer Models; Models, Computer FXÑModels, Theoretical LH LS; LX  MSSystems composed of a computer or computers, peripheral equipment, such as disks, printers, and terminals. PM87 HN87 MHÑComputer Systems ANIM; no qualif MNL1.700.568.80 XSCathode Ray Tube Display; Computer Architecture; Computer System Evaluation; Computer Systems Development; Computer Systems Organization; Computer Terminals; Real Time Systems; Terminals, Computer; Video Display Terminal XUÑComputer Communication Networks; ÑLocal Area Networks LH LS; ; ; ; ; ; ; ; LU;  MSProcess of teaching a person to interact and communicate with a computer. PM87 HN87 MHÑComputer User Training ANIM; do not use /educ MNI2.903.80; L1.700.568.180.408 LH  OLuse COMPUTERS to search COMPUTERS, DIGITAL back thru 1966 PM66; COMPUTERS, DIGITAL was heading 1966-77 HN66(64); COMPUTERS, DIGITAL was heading 1964-77 (Prov 1964-65) MHÑComputers ANGEN; only /class /econ /hist /stand /supply; do not use /util; use of computers in medicine: do not coord with MEDICINE; for processing of data by computer, COMPUTER DATA PROCESSING see AUTOMATIC DATA PROCESSING is available MNL1.700.568.80.260 XSCalculators, Programmable; Computer Hardware; Computers, Digital; Hardware, Computer FXÑAttitude to Computers XUÑComputers, Mainframe; ÑMicrocomputers; ÑMinicomputers LH LS; ; ; LX LU; ;  PM66 HN66(64) MHÑComputers, Analog ANdo not use /util MNL1.700.568.80.260.230 LH  PM73 HN73(64) MHÑComputers, Hybrid ANdo not use /util MNL1.700.568.80.260.280 LH  MSLarge computers in both size and capacity. HN(87) MHÑComputers, Mainframe ANdo not use /util PIComputers (66-86) MNL1.700.568.80.260.308 DMÑComputers LH LM  PM87 HN87 MH*Computing Methodologies (Non MeSH) MNL1.700.568.110 LH  PM87 HN87 MH*Computing Milieu (Non MeSH) MNL1.700.568.180 LH  MSA glycoprotein albumin from hen's egg white. Has strong iron-binding affinity. HN(75) MHÑConalbumin ANdo not use /defic /physiol; /analogs NIM only RN1391-06-6 PIAlbumins (69-74); Egg Proteins (73-74) MND12.776.34.180; D12.776.256.317.180 XSOvotransferrin DMÑEgg Proteins LH LS LM  PM74 HN74(71) MHÑConcanavalin A ANdo not use /defic /physiol; DF: CON A RN11028-71-0 PILectins (66-70) MND12.776.765.179; D24.185.526.545.358; D24.310.545.358; D24.611.125.44.545.358 LH  MSFacilities in which war or political prisoners are confined. OLsearch PRISONS 1966-74 HN(75) MHÑConcentration Camps ANonly /hist MNI1.880.604.787.358 DMÑPrisons LH LM  MSA cognitive process involving the formation of ideas generalized from the knowledge of qualities, aspects, and relations of objects. MHÑConcept Formation ANonly /drug eff /physiol /rad eff MNF2.463.785.233 LH  MSReview of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodical review of services provided during the course of treatment. HN(Aug 77) MHÑConcurrent Review ANonly /legis /methods /stand /trends PIProfessional Standards Review Organizations (74-Jul 77); Utilization Review (68-Jul 77) MNN4.761.879.200 XSContinued Stay Review DMÑUtilization Review LH LS LM  OLuse CONDIMENTS to search CLOVE & SPICES back thru 1966 PMCLOVE was heading 1963-83; NUTMEG was see under HALLUCINOGENS 1975-77 HNCLOVE was heading 1963-83; SPICES was see under CONDIMENTS 1963-83 MHÑCondiments ANonly /ad-poi-tox /anal /class /hist /stand /supply MNJ1.341.241 XSClove; Spices FXÑGINSENG XUÑCinnamon LH LS; LX LU  MSA general term referring to the learning of some particular response. PM65; was CONDITIONED LEARNING 1963-64 HN65; was CONDITIONED LEARNING 1963-64 MHÑConditioning (Psychology) ANhuman & animal; only /drug eff /physiol /rad eff; DF: CONDITIONING MNF2.463.425.179 LH  MSLearning that takes place when a conditioned stimulus is paired with an unconditioned stimulus. OLuse CONDITIONING, CLASSICAL to search REFLEX, CONDITIONED back thru 1966 PM73; was REFLEX, CONDITIONED 1963-72 HN73(66); REFLEX, CONDITIONED was heading 1963-72 MHÑConditioning, Classical ANonly /drug eff /physiol /rad eff PIREFLEX, CONDITIONED MNF2.463.425.179.308 XSREFLEX, CONDITIONED LH LS  MSRelfex closure of the eyelid occurring as a result of classical conditioning. PM69 HN69 MHÑConditioning, Eyelid ANonly /drug eff /physiol /rad eff PIConditioning (Psychology) (66-68); Conditioning, Classical (66-68); Eyelids (66-68) MNF2.463.425.179.408 XSEYELID CONDITIONING LH LS  MSLearning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. PM68 HN68(65) MHÑConditioning, Operant ANhuman & animal; only /drug eff /physiol /rad eff MNF2.463.425.179.509 XSINSTRUMENTAL LEARNING LH LS  PM68 HN68 MHÑConductometry ANincludes conductometric titration; NIM; only /instrum /methods MNE5.196.246; H1.181.278.254; H1.181.529.307.180 LH  MSMalignant warts caused by a papillomavirus and characterized by a central core of connective tissue in a treelike structure covered with epithelium; commonest sites are genitalia, perianal region, between toes, oral commissures, and conjunctiva. PM72 HN72(64) MHÑCondylomata Acuminata ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC2.256.925.217; C2.928.914.217; C4.557.576.735.275; C4.619.935.914.227; C17.838.930.217 LH  MSEntrusted communication of information which is considered private and implies an ethical or legal principle. OLto search PRIVILEGED COMMUNICATION use CONFIDENTIALITY back thru 1975 & JURISPRUDENCE 1968-74 PM80; was PRIVILEGED COMMUNICATION 1975-79, was PRIVILEGED COMMUNICATION see under JURISPRUDENCE 1968-74 HN80; was PRIVILEGED COMMUNICATION 1975-79, was PRIVILEGED COMMUNICATION see under JURISPRUDENCE 1968-74 MHÑConfidentiality ANonly /legis; secrecy goes here PIJurisprudence (66-74) MNF1.145.209.230; F4.96.544.335.240; I1.880.604.583.80; N3.706.535.230 XSPatient Data Privacy; Privileged Communication FXÑEthics LH LS; LX  MSThe state of being simultaneously motivated by opposing or mutually exclusive impulses, desires or tendencies. PM68 HN68(65) MHÑConflict (Psychology) ANhuman & animal; no qualif; DF: CONFLICT MNF1.658.209 LH  MSA mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation. OLsearch COGNITION DISORDERS 1969-74 HN(75) MHÑConfusion ANdo not use /drug eff /physiol /rad eff MNF3.126.185.154 DMÑCognition Disorders LH LM  MSClumping, by serum from ruminants containing the globulin conglutinin, of sensitized cells or of antigen-antibody complexes which have absorbed complement. HN(75) MHÑConglutination Reaction ANno qualif MNE1.223.495.826.208.250 XSConglutinating Complement Absorption Test DMÑComplement Fixation Tests LH LS LM  MHÑCongo ANRepublic of Congo (capital at Brazzaville); do not confuse with Republic of the Congo (capital at Kinshasa, formerly Leopoldville ( = ZAIRE) MNZ1.58.100.361 XSCongo (Brazzaville) LH LS  MHÑCongo Red AND25-26 qualif RN573-58-0 MND26.408.192 LH  MSA virus of the Bunyavirus genus isolated from febrile patients in Africa; probably transmitted by ticks. HN(75); was see under ARBOVIRUSES 1975-80 MHÑCongo Virus ANdo not use /blood-csf-urine /cytol; infection: see next entry MNB4.909.777.147.185 XSHemorrhagic Fever Virus, Crimean DMÑBunyaviridae LH LS LM  MSConferences, conventions or formal meetings usually attended by delegates representing a special field of interest. OLuse CONGRESSES to search CONFERENCES back thru 1966 HNCONFERENCES was see under CONGRESSES 1963-77 MHÑCongresses ANonly /hist /organ; Manual 35.10+; TN 112: INTERNATIONAL COOPERATION not for international congresses MNN3.540.199 XSConferences FXÑInternational Cooperation LH LS LX  MSA parasexual mechanism in bacteria for achieving unidirectional transfer of all or part of the chromosome from an F+ or Hfr donor (╥male╥) to an F- (╥female╥) recipient. PM68 HN68 MHÑConjugation, Genetic ANonly /drug eff /rad eff PIGenetics (66-67) MNG5.386.192 XSBACTERIAL CONJUGATION FXÑCrosses, Genetic LH LS LX  MHÑConjunctiva ANinflammation = CONJUNCTIVITIS (consider also KERATOCONJUNCTIVITIS); do not confuse with ╥conjunctive tissue╙ in poorly translated texts: this is CONNECTIVE TISSUE, not CONJUNCTIVA MNA9.371.192 LH  PM81 HN81 MHÑConjunctival Diseases PIConjunctiva (66-80); Eye Diseases (66-80) MNC11.187 LH  PM81 HN81 MHÑConjunctival Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIConjunctiva (66-80); Eye Neoplasms (66-80) MNC4.588.364.235; C11.187.169; C11.319.217 LH  MHÑConjunctivitis MNC11.187.183 LH  MSEpidemic conjunctivitis caused by Enterovirus 70 and first described in Africa in 1969. Onset is explosive with eyelid and conjunctival edema peaking at 48 hours. PM86 HN86 MHÑConjunctivitis, Acute Hemorrhagic ANcaused by Enterovirus 70 so do not coord with ENTEROVIRUS INFECTIONS PIConjunctivitis (66-85); Disease Outbreaks (66-85); Enterovirus Infections (66-85); Hemorrhage (66-85) MNC2.190.216; C2.782.687.359.201; C11.187.183.240.216 LH  MSConjunctivitis due to hypersensitivity to various allergens. PM86 HN86 MHÑConjunctivitis, Allergic ANcoord IM with etiol of the allergy (IM) if specified PIConjunctivitis (66-85); Hypersensitivity (66-85) MNC11.187.183.200; C20.543.480.200 XSAllergic Conjunctivitis; Conjunctivitis, Giant Papillary; Conjunctivitis, Vernal; Keratoconjunctivitis, Vernal LH LS; ; ;  PM86 HN86 MHÑConjunctivitis, Bacterial ANcoord IM with specific bact/infect heading (IM) PIBacterial Infections or specifics (66-85); Conjunctivitis (66-85) MNC1.252.230; C11.187.183.220 XSBacterial Conjunctivitis LH LS  MSAn infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The aetiological agent is indistinguishable from Chlamydia trachomatis, and its natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously. PM67 HN67(65) MHÑConjunctivitis, Inclusion ANcaused by Chlamydia trachomatis MNC1.850.200.195.205; C11.187.183.220.180 XSBLENNORRHEA, INCLUSION LH LS  PM86 HN86 MHÑConjunctivitis, Viral ANcoord IM with specific virus/infect heading (IM) PIAdenovirus Infections (66-85); Conjunctivitis (66-85); Virus Diseases (66-85) MNC2.190; C11.187.183.240 XSViral Conjunctivitis LH LS  MHÑConnecticut MNZ1.107.567.875.177 LH  OLuse CONNECTIVE TISSUE /CY + CONNECTIVE TISSUE /qualif to search CONNECTIVE TISSUE /same qualif 1966-77, e.g., search CONNECTIVE TISSUE CELLS /DE under CONNECTIVE TISSUE /CY + CONNECTIVE TISSUE /DE PMCONNECTIVE TISSUE CELLS was heading 1965-77 HNCONNECTIVE TISSUE CELLS was heading 1965-77 MHÑConnective Tissue ANdo not use /abnorm /growth /inj /innerv; inflammation: consider CELLULITIS; interstitial cells go here but interstitial cells of testis = LEYDIG CELLS MNA10.165 FXÑCOLLAGEN LH LX  OL= CONNECTIVE TISSUE /CY; interstitial cells go under CONNECTIVE TISSUE /CY but interstitial cells of testis = LEYDIG CELLS; see note under CONNECTIVE TISSUE for searching CONNECTIVE TISSUE CELLS 1966-77 HNwas CONNECTIVE TISSUE CELLS 1965-77 MH*Connective Tissue Cells (Non Mesh) MNA11.329 LH  MSA heterogenous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides. PM80 HN80 MHÑConnective Tissue Diseases ANGEN or unspecified: prefer specifics; note & do not confuse with CONNECTIVE TISSUE DISEASE, MIXED above, a specific collagen dis entity PICollagen Diseases (66-79); Connective Tissue (66-79) MNC23.205 FXÑBone Diseases, Developmental LH LX  MHÑConsanguinity ANhuman only: for animals use INBREEDING; no qualif MNG5.358.209 FXÑBlood Groups; ÑFamily; ÑInbreeding LH LX; ;  MSThe cognitive and affective processes which constitute an internalized moral governor over an individual's moral conduct. OLsearch MORALS 1966-74 HN(75) MHÑConscience ANno qualif MNF1.829.500.359; K1.752.256.547.359; K1.316.630.350 DMÑMorals LH LM  MSSense of awareness of self and of the environment. MHÑConsciousness ANonly /drug eff /physiol /rad eff; transcendental meditation goes under RELAXATION TECHNICS MNF2.463.188.409; F2.830.233 FXÑUNCONSCIOUSNESS LH LX  MSOrganic mental disorders in which there is marked impairment of awareness. OLsearch COGNITION DISORDERS 1969-74 HN(75) MHÑConsciousness Disorders ANdo not use /drug eff /physiol /rad eff MNF3.126.185.199 DMÑCognition Disorders LH LM  MSPlanned management, use and preservation of energy resources. HN(80) MHÑConservation of Energy Resources ANonly /econ /hist /methods /trends PIConservation of Natural Resources (77-79) MNG3.230.80.78 XSEnergy Resources Conservation DMÑConservation of Natural Resources LH LS LM  MSThe protection, preservation, restoration and rational use of all resources in the total environment. PM77 HN77 MHÑConservation of Natural Resources ANonly /econ /hist /methods /trends MNG3.230.80 XSNatural Resources Conservation FXÑEcology XUÑConservation of Energy Resources LH LS LX LU  MSInfrequent or difficult evacuation of feces. MHÑConstipation MNC6.405.469.187 LH  MSThe fundamental principles and laws adopted by an organization for the regulation and governing of its affairs. HN(Aug 77) MHÑConstitution and Bylaws ANNIM; no qualif; coord with specific organiz or society (IM) + geog; DF: CONSTITUTION MNN4.452.150 XSBylaws DMÑOrganization and Administration LH LS LM  MSThe act of constricting. PM76; was see under PHYSIOLOGY 1975 HN76(68); was in Cat C & E 1968-75 (Prov 1968-74), was see under PHYSIOLOGY 1975 MHÑConstriction ANnever IM; no qualif; clamping goes here, not under LIGATION MNE5.225 LH  MSThe condition of an anatomical structure's being constricted beyond normal dimensions. OLsearch CONSTRICTION 1968-75 (as Prov 1968-74, as Cat C & E heading 1968-75) PM76; was included in CONSTRICTION see under PHYSIOLOGY 1975 HN76; was included in CONSTRICTION 1968-75 (Prov 1968-74, Cat C & E heading 1968-75) MHÑConstriction, Pathologic ANnever IM; when NIM use any Cat C qualif pertinent; includes ╥stenosis╙ PIConstriction (68-75) MNC23.739.220 LH  PM74 HN74(72) MHÑConstruction Materials ANonly /adv eff /econ /stand MNJ1.637.241 LH  MSIndividuals referred to for expert or professional advice or services. PM78 HN78 MHÑConsultants ANno qualif PIReferral and Consultation (68-77) MNM1.120 LH  MSThe promotion and support of consumers' rights and interests. PM82 HN82 MHÑConsumer Advocacy ANonly /legis PIConsumer Organizations (68-81); Consumer Participation (74-81); Consumer Satisfaction (68-81) MNI1.880.604.473.368; N3.706.437.368 LH  MSOrganized groups of users of goods and services. PM68 HN68 MHÑConsumer Organizations ANdo not use /util except by MeSH definition CATALOG: /geog /form MNN3.540.245 LH  MSCommunity or individual involvement in the decision-making process. PM74 HN74 MHÑConsumer Participation ANonly /econ /legis /methods /trends MNN2.421.143.262; N3.540.245.360 XSCommunity Action; Consumer Involvement FXÑAttitude to Health; ÑDelivery of Health Care; ÑPatient Care Planning LH LS; LX; ;  PM82 HN82 MHÑConsumer Product Safety ANno qualif PIAccident Prevention (66-81) MNG3.850.210 XSProduct Safety, Consumer; Safety, Consumer Product LH LS;  MSPatient satisfaction or dissatisfaction with a benefit or service received. PM68 HN68 MHÑConsumer Satisfaction ANonly /econ /legis /stand /trends PIAttitude (66-67) MNN4.452.822.360 XSPatient Satisfaction LH LS  MSAn act which constitutes the termination of a given instinctive behavior pattern or sequence. PM68 HN68 MHÑConsummatory Behavior ANmainly animal; conclusion of a series of responses: nothing to do with ╥consumption╙; only /drug eff /physiol /rad eff PIBehavior, Animal (66-67) MNF1.145.113.252 LH  MSArrest of cell locomotion or cell division when two cells come into contact. PM70 HN70(68) MHÑContact Inhibition ANonly /drug eff /rad eff PICytology (66-67) MNG4.335.355 LH  MHÑContact Lenses ANonly /adv eff /econ /psychol /stand /supply /vet MNE7.532.276 XSLenses, Contact LH LS  MSHydrophilic contact lenses worn for an extended period or permanently. HN(84) MHÑContact Lenses, Extended Wear ANonly /adv eff /econ /psychol /stand /supply /vet PIContact Lenses (66-69); Contact Lenses, Hydrophilic (71-83) MNE7.532.276.360.220 DMÑContact Lenses, Hydrophilic LH LM  PM74 HN74(71) MHÑContact Lenses, Hydrophilic ANonly /adv eff /econ /psychol /stand /supply /vet PIContact Lenses (66-70) MNE7.532.276.360 XSLenses, Contact, Hydrophilic; SOFT CONTACT LENSES XUÑContact Lenses, Extended Wear LH LS; LU  MSProvision of physical and biological barriers to the dissemination of potentially hazardous biologically active agents (bacteria, viruses, recombinant DNA, etc.). Physical containment involves the use of special equipment, facilities, and procedures to prevent the escape of the agent. Biological containment includes use of immune personnel and the selection of agents and hosts that will minimize the risk should the agent escape the containment facility. PM80 HN80 MHÑContainment of Biohazards ANonly /econ /instrum /methods /stand /trends; for procedures, facilities, programs & equipment for containing hazardous biologic agents; do not use for radiation ( = RADIATION PROTECTION); for recombinant DNA research: use only by MeSH definition: not for ethical, moral or religious aspects MNE5.235 XSBiohazards Containment LH LS  MSAn increasing negative shift of the cortical electrical potentials associated with an anticipated response to an expected stimulus; the electrical event indicative of a state of readiness or expectancy. Synonyms: Bereitschaftspotential; readiness potential. HN(71) MHÑContingent Negative Variation ANonly /drug eff /rad eff PIElectroencephalography (66-70); Electrophysiology (66-70) MNG7.453.276; G11.561.150 DMÑElectrophysiology LH LM  MSHealth care provided on a continuing basis from the initial contact with a physician or clinic and following the patient through all episodes of his medical care needs. OLsearch COMPREHENSIVE HEALTH CARE 1968-74 HN(75); was see under COMPREHENSIVE HEALTH CARE 1968-78 MHÑContinuity of Patient Care ANonly /econ /legis /trends MNN4.590.233.727.210 DMÑPrimary Health Care LH LM  MSUse of agents, devices, methods, or procedures which diminish the likelihood of or prevent conception. MHÑContraception ANonly /econ /hist /methods /psychol /trends /vet MNE2.197 FXÑFAMILY PLANNING XUÑContraception, Immunologic LH LX LU  MSBehavior patterns of those practicing contraception. PM75 HN75 MHÑContraception Behavior ANno qualif PIContraception (66-67); Sex Behavior (66-74) MNF1.145.792.210 LH  MSContraceptive methods utilizing immunologic processes. HN(75) MHÑContraception, Immunologic ANonly /methods MNE2.197.300 XSImmunocontraception DMÑContraception LH LS LM  PM67 HN67 MHÑContraceptive Agents ANchemical, not mechanical ( = CONTRACEPTIVE DEVICES); D25-26 qualif; pregnancy despite use = contraceptive term with no qualif, not with /adv eff PIContraceptive Devices (66) MND7.360 LH  MSChemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. PM75 HN75 MHÑContraceptive Agents, Female AND25-26 qualif; pregnancy despite use: see note on CONTRACEPTIVE AGENTS PIContraceptive Agents (67-74) MND7.360.276 FXÑVaginal Creams, Foams and Jellies LH LX  MSChemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading. PM75 HN75 MHÑContraceptive Agents, Male AND25-26 qualif; pregnancy despite use: see note on CONTRACEPTIVE AGENTS PIContraceptive Agents (67-74) MND7.360.443 LH  OLuse CONTRACEPTIVE DEVICES to search CONTRACEPTIVES 1966 PM67; was CONTRACEPTIVES 1963-66 HN67; was CONTRACEPTIVES 1963-66 MHÑContraceptive Devices ANmechanical devices, not chemicals ( = CONTRACEPTIVE AGENTS); only /adv eff /class /econ /hist /stand /supply /util (by MeSH definition); pregnancy despite use = contraceptive term with no qualif, not /adv eff MNE7.190 LH  MSContraceptive devices used by females. PM75 HN75 MHÑContraceptive Devices, Female ANmechanical devices, not chemicals; only /adv eff /class /econ /hist /stand /supply /util (by MeSH definition); pregnancy despite use = contraceptive term with no qualif, not /adv eff PIContraceptive Devices (66-74) MNE7.190.250 LH  MSContraceptive devices used by males. PM75 HN75 MHÑContraceptive Devices, Male ANmechanical devices, not chemicals; only /adv eff /class /econ /hist /stand /supply /util (by MeSH definition); pregnancy despite use = contraceptive term with no qualif, not /adv eff PIContraceptive Devices (66-74) MNE7.190.270 LH  MHÑContraceptives, Oral AND25-26 qualif; pregn: see note on CONTRACEPTIVE AGENTS MND7.360.276.210 XUÑContraceptives, Oral, Sequential LH LU  MSFixed drug combinations administered orally for contraceptive purposes. PM86; was see under CONTRACEPTIVES, ORAL 1976-85 HN86(76); was see under CONTRACEPTIVES, ORAL 1976-85 MHÑContraceptives, Oral, Combined AND25-26 qualif; pregn: see note on CONTRACEPTIVE AGENTS PIContraceptives, Oral (70-75); Drug Combinations (72-75) MND7.360.276.210.100 LH  MSOral contraceptives which owe their effectiveness to hormonal preparations. PM86; was see under CONTRACEPTIVES, ORAL 1975-85 HN86(75); was see under CONTRACEPTIVES, ORAL 1975-85 MHÑContraceptives, Oral, Hormonal AND25-26 qualif; pregn: see note on CONTRACEPTIVE AGENTS MND7.360.276.210.277 LH  MSDrugs administered orally and sequentially for contraceptive purposes. HN(76) MHÑContraceptives, Oral, Sequential AND25-26 qualif; pregn: see note on CONTRACEPTIVE AGENTS PIContraceptives, Oral (70-75) MND7.360.276.210.400 DMÑContraceptives, Oral LH LM  MSOral contraceptives which owe their effectiveness to synthetic preparations. PM86; was see under CONTRACEPTIVES, ORAL 1975-85 HN86(75); was see under CONTRACEPTIVES, ORAL 1975-85 MHÑContraceptives, Oral, Synthetic AND25-26 qualif; pregn: see note on CONTRACEPTIVE AGENTS; DF: CONTRACEPTIVES ORAL SYN MND7.360.276.210.443 LH  OLuse CONTRACEPTIVES, POSTCOITAL to search MORNING AFTER PILL back thru 1973 PM73 HN73(71); MORNING AFTER PILL was see under CONTRACEPTIVES, POSTCOITAL 1973-83 MHÑContraceptives, Postcoital AND25-26 qualif; pregn: see note on CONTRACEPTIVE AGENTS PIContraceptive Agents (67-70); Contraceptives, Oral (66-70) MND7.360.276.310 XSMorning After Pill; POSTCOITAL CONTRACEPTIVES XUÑContraceptives, Postcoital, Hormonal; ÑContraceptives, Postcoital, Synthetic LH LS; LU;  MSPostcoital contraceptives which owe their effectiveness to hormonal preparations. HN(75) MHÑContraceptives, Postcoital, Hormonal AND25-26 qualif; pregn: see note on CONTRACEPTIVE AGENTS MND7.360.276.310.235 DMÑContraceptives, Postcoital LH LM  MSPostcoital contraceptives which owe their effectiveness to synthetic preparations. HN(75) MHÑContraceptives, Postcoital, Synthetic AND25-26 qualif; pregn: see note on CONTRACEPTIVE AGENTS; DF: CONTRACEPTIVES POSTCOITAL SYN MND7.360.276.310.360 DMÑContraceptives, Postcoital LH LM  MSOutside services provided to an institution under a formal financial agreement. HN(78) MHÑContract Services ANonly /econ /legis /organ /trends PIEconomics (66-77) MNN3.219.463.100 DMÑFinancial Management LH LM  MSProteins which participate in contractile processes. Include MUSCLE PROTEINS as well as those found in other cells and tissues. In the latter, these proteins participate in localized contractile events in the cytoplasm, in motile activity and in cell-aggregation phenomena. PM77 HN77 MHÑContractile Proteins ANproteins involved in contractile processes; if in muscle use MUSCLE PROTEINS or specifics but not also here; /biosyn /physiol permitted; do not use /analogs PIProteins (66-76); specific protein MND12.776.210 LH  MHÑContracture ANIM; coord with specific muscle or other tissue or site (IM) but not with MUSCLES; also available are DUPUYTREN'S CONTRACTURE, HIP CONTRACTURE & VOLKMANN'S CONTRACTURE MNC5.550.323; C5.651.197 LH  MHÑContrast Media AND25-26 qualif except /diag use; /adv eff: consider also EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS MND26.298 XSRADIOPAQUE MEDIA FXÑExtravasation of Diagnostic and Therapeutic Materials; ÑRadiography LH LS LX;  MHÑContusions ANbruise; differentiate from ECCHYMOSIS: use term in the text; brain contusion: index under BRAIN CONCUSSION & not also here (see Dorland under concussion of the brain) MNC21.866.248 LH  MSThe period of recovery following an illness. MHÑConvalescence ANIM general only; NIM with specific dis; no qualif MNC23.280.224; N1.407.306.485 LH  MSThe turning inward of the lines of sight toward each other. HN(85) MHÑConvergence, Ocular ANonly /drug eff /rad eff; convergent squint = ESOTROPIA; convergence insufficiency = EXOTROPIA or STRABISMUS PIAccommodation, Ocular (66-84); Eye Movements (66-84); Fixation, Ocular (66-84) MNG11.697.384.217 DMÑEye Movements LH LM  MSThe predominant feature in this disorder is the loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need. OLuse CONVERSION DISORDER to search CONVERSION REACTION & HYSTERIA, CONVERSION back thru 1969, GLOBUS HYSTERICUS back thru 1974 & ASTASIA-ABASIA back thru 1970 PM81; was CONVERSION REACTION 1969-80 HN81; was CONVERSION REACTION 1969-80; GLOBUS HYSTERICUS was see under CONVERSION REACTION 1974-80; ASTASIA-ABASIA was see under CONVERSION REACTION 1970-78; HYSTERIA, CONVERSION was see under CONVERSION REACTION 1969-78 MHÑConversion Disorder ANdo not use /drug eff /physiol /rad eff PIHysteria (66-68) MNF1.393.181; F3.407.181; F3.709.438.710.380 XSAstasia-Abasia; Globus Hystericus; Hysteria, Conversion LH LS; ;  MSSubstances that act in the brain stem or spinal cord to produce tonic or clonic convulsions either by stimulating the motor fibers or by removing normal inhibitory tone; formerly used to stimulate respiration or as antidote to barbiturate overdose. OLsearch ANALEPTICS 1966-74 PM75; was see ANALEPTICS 1963-74 HN75; was see ANALEPTICS 1963-74 MHÑConvulsants ANdo not use /analogs /biosyn /defic /physiol; consider also CONVULSIONS /chem ind PIAnaleptics (66-74) MND15.128.224 LH  MSSeizures manifested by discontinuous involuntary skeletal muscular contractions, either brief contractions repeated at short intervals or longer ones interrupted by intervals of muscular relaxation. MHÑConvulsions AN/chem ind: consider also CONVULSANTS; /drug ther: consider also ANTICONVULSANTS: electroconvulsive shock = ELECTROSHOCK: do not coord with CONVULSIONS; audiogenic seizures = SEIZURES (IM) + ACOUSTIC STIMULATION (probably NIM) MNC10.597.742.286; C23.888.592.742.286 FXÑECLAMPSIA; ÑEpilepsy; ÑKindling (Neurology) LH LX; ;  MSSeizures occurring in young children during febrile episodes due to a low convulsive threshold. Usually a self-limiting disorder after the age of 5 years. PM82; was see under CONVULSIONS 1977-81 HN82(77); was see under CONVULSIONS 1977-81 MHÑConvulsions, Febrile PIConvulsions (66-76) MNC10.597.742.286.275; C23.888.592.742.286.275 LH  MSThe use of convulsive agents to favorably influence the course of a mental disorder; primarily used in the treatment of severe affective disorders and schizophrenia. OLuse CONVULSIVE THERAPY to search SHOCK THERAPY & SHOCK THERAPY, INSULIN back thru 1966 PM81; was SHOCK THERAPY 1963-80; SHOCK THERAPY, INSULIN was heading 1963-80 HN81; was SHOCK THERAPY 1963-80; SHOCK THERAPY, INSULIN was heading 1963-80 MHÑConvulsive Therapy ANSPEC qualif & /adv eff /mortal permitted; a psychother technic: do not confuse with CONVULSIONS /ther; do not confuse X ref SHOCK THERAPY with SHOCK /ther nor X ref INSULIN COMA THERAPY with INSULIN COMA /ther MNF4.881.200 XSInsulin Coma Therapy; Shock Therapy; Shock Therapy, Insulin LH LS; ;  MHÑCookery ANonly /econ /hist /stand; often the point of ╥cooking╙ is not COOKERY, but HEAT CATALOG: do not use /pop wks MNJ1.364.434.360; J1.576.416.277 FXÑDiet LH LX  MHÑCooking and Eating Utensils ANonly /econ /hist /stand; DF: COOKING UTENSILS MNJ1.364.236; J1.494.444 LH  MSHemagglutination test in which Coombs' reagent (antiglobulin, or anti-human globulin rabbit immune serum) is added to detect incomplete (non-agglutinating, univalent, blocking) antibodies coating erythrocytes. The direct test is applied to red cells which have been coated with antibody in vivo (e.g., in hemolytic disease of newborn, autoimmune hemolytic anemia, and transfusion reactions). The indirect test is applied to serum to detect the presence of antibody (e.g., in detection of incompatibility in cross-matching tests, detection and identification of irregular antibodies, and in detection of antibodies not identifiable by other means). MHÑCoombs' Test ANonly /instrum MNE1.223.495.826.461.361 XSANTIGLOBULIN TEST; Anti-Human Globulin Consumption Test; Antiglobulin Consumption Test FXÑBlood Groups LH LS; ; LX  MSThe interaction of two or more persons directed toward a common goal which is mutually beneficial. PM73 HN73(71) MHÑCooperative Behavior ANno qualif PIBehavior (66-70); Behavior, Animal (66-70) MNF1.145.256 XSCompliant Behavior LH LS  MHÑCopper ANCu-63; /defic /physiol permitted; do not use /analogs /biosyn; Cu-65 = COPPER (IM) + ISOTOPES (NIM); Cu-58-62, 64, 66-68 = COPPER (IM) + RADIOISOTOPES (IM) RN7440-50-8 MND1.248.497.300.333.318; D1.248.497.300.459.201; D1.268.219; D1.552.199; D1.937.241 FXÑCERULOPLASMIN LH LX  MSA genus of black-spored basidiomycetous fungi of the family Coprinaceae, order Agaricales; some species are edible. HN(75); was see under AGARICACEAE 1975-85 MHÑCoprinus ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.179.100.200 DMÑAgaricales LH LM  MSEating of excrement. PM70 HN70 MHÑCoprophagia ANhuman & animal; do not use /drug eff /physiol /rad eff PIFeces (66-69) MNF3.126.231 LH  MSCoproporphyrinogen:oxygen oxidoreductases (decarboxylating). One of the enzymes active in heme biosynthesis. Catalyzes the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen III by the conversion of two propionic acid groups to two vinyl groups. Can act under both aerobic and anaerobic conditions. HN(76) MHÑCoproporphyrinogen Oxidase ANdo not use /analogs RNEC 1.3.3.3 PICarboxy-Lyases (72-74); Coproporphyrins (75); Oxidoreductases (75); Porphyrins (72-74) MND8.586.682.263 XSCoproporphyrinogenase DMÑOxidoreductases LH LS LM  MSPorphyrinogens which are intermediates in the heme biosynthesis. They have four methyl and four propionic acid side chains attached to the pyrrole rings. Coproporphyrinogen I and III are formed in the presence of uroporphyrinogen decarboxylase from the corresponding uroporphyrinogen. They can yield coproporphyrins by autooxidation or protoporphyrin by oxidative decarboxylation. HN(76) MHÑCoproporphyrinogens ANdo not use /analogs /defic PIPorphyrinogens (75); Porphyrins (71-74) MND11.557.727.700.250 DMÑPorphyrinogens LH LM  MSPorphyrins with four methyl and four propionic acid side chains attached to the pyrrole rings. HN(75) MHÑCoproporphyrins ANdo not use /analogs PIPorphyrins (69-74) MND11.557.727.250 DMÑPorphyrins LH LM  MSSexual contact of a male with a receptive female usually followed by emission of sperm. Limited to non-human species. For humans use coitus. PM75 HN75 MHÑCopulation ANanimal only: for human, use COITUS; only /drug eff /physiol /rad eff PICoitus (66-74) MNF1.145.113.252.748.200; G8.520.900.110 LH  MSReproduction of data in a new location or other destination, leaving the source data unchanged, although the physical form of the result may differ from that of the source. MHÑCopying Processes ANdo not use /educ /organ /supply /util (except by MeSH definition) MNL1.240 XSDUPLICATING PROCESSES LH LS  MHÑCopyright ANonly /econ /hist /legis; specify geog MNL1.737.360 LH  MSA congenital anomaly characterized by the presence in the atrium of a perforated muscular membrane which separates the atrium into upper and lower chambers. PM87 HN87 MHÑCor Triatriatum ANdo not use /congen PIHeart Atrium (66-86); Heart Defects, Congenital (66-86) MNC14.280.400.200; C16.131.457.200 XSTriatrial Heart LH LS  MSTrehalose-6,6'-dimycolate. A toxic glycolipid of Mycobacterium tuberculosis. Induces cellular biochemical disfunction in animals; used as immunoadjuvant. OLuse CORD FACTORS to search CORD FACTOR back thru 1975 HN(80); was CORD FACTOR see under GLYCOLIPIDS 1975-79 MHÑCord Factors ANtoxic glycolipids from Mycobact tuberc; do not use /analogs /defic /physiol PIGlycolipids (71-74); Mycobacterium Tuberculosis (74); Trehalose (73-74) MND10.516.390.240; D24.185.926.123.208 XSTrehalose Dimycolates DMÑGlycolipids LH LS LM  OLuse CORIOLIS FORCE to search CORIOLIS EFFECT back thru 1966 (as Prov 1966-69) PM70 HN70; was CORIOLIS EFFECT 1964-69 (Prov) MHÑCoriolis Force ANno qualif MNH1.671.538.311 XSCoriolis Acceleration; Coriolis Effect; Coriolis Stimulation LH LS; ;  MSA genus of tall cereal grasses, Zea mays grown for its seed, used as food and animal fodder; also called Indian corn (American Indian), and maize. PM66; was see under GRAIN 1963-65 HN66(64); was see under GRAIN 1963-65 MHÑCorn ANas plant & food; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply; restrict to American corn, Zea mays: for ancient & non-American use of the word ╥corn╙ index under CEREALS MNB6.510.253.236; J1.341.182.236 XSMaize; Zea LH LS;  MSOil from corn or corn plant. HN(87) MHÑCorn Oil AND25-26 qualif RN8001-30-7 PIOils (66-86) MND10.516.212.302.380.370; D10.516.212.507.340; D10.516.627.700.240; J1.740.250.225; J1.740.700.240 XSMaize Oil DMÑPlant Oils LH LS LM  PM/transplantation was CORNEAL TRANSPLANTATION 1963-65 HN/transplantation was CORNEAL TRANSPLANTATION 1963-65 MHÑCornea ANinflammation = KERATITIS; neopl = CORNEAL DISEASES (IM) + EYE NEOPLASMS (IM) + histol type of neopl (IM); keratoplasty: index CORNEA /transpl but do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; see other corneal terms at KERAT MNA9.371.60.217 XUÑCorneal Stroma LH LU  MSDiseases of the cornea. PM76 HN76; was NON MESH before 1976 MHÑCorneal Diseases ANinflamm dis = KERATITIS & specific PICornea (66-75); specific corneal disease heading MNC11.204 LH  MHÑCorneal Dystrophies MNC11.204.236 XUÑFuchs' Endothelial Dystrophy LH LU  MHÑCorneal Opacity MNC11.204.299 LH  MSThe lamellated connective tissue constituting the thickest layer of the cornea between the Bowman and Descemet membranes. HN(83) MHÑCorneal Stroma PICornea (66-82) MNA9.371.60.217.228 DMÑCornea LH LM  PM65 HN65(64) MHÑCorneal Ulcer MNC11.204.564.225 FXÑUlcer LH LX  MSSelf-administered health questionnaire developed to obtain details of the medical history as an adjunct to the medical interview. Consists of 195 questions divided into eighteen sections; the first twelve deal with somatic complaints and the last six with mood and feeling patterns. Used also as a personality inventory or in epidemiologic studies. HN(75) MHÑCornell Medical Index ANno qualif MNE1.579.630 DMÑMedical History Taking LH LM  OLsearch CALLOSITIES 1966-74 HN(75) MHÑCorns MNC17.98.361 DMÑCallosities LH LM  MSAneurysm of a coronary vessel. PM87 HN87 MHÑCoronary Aneurysm PIAneurysm (66-86); Coronary Disease (66-86) MNC14.280.211.205; C14.907.55.395 XSAneurysm, Coronary LH LS  MSAtherosclerosis of the coronary arteries. OLsearch CORONARY DISEASE 1974-86 PM87; was ARTERIOSCLEROSIS, CORONARY see CORONARY DISEASE 1974-86 HN87; was ARTERIOSCLEROSIS, CORONARY see CORONARY DISEASE 1974-86 MHÑCoronary Arteriosclerosis PICoronary Disease (66-86) MNC14.280.211.210; C14.907.137.126.393 XSArteriosclerosis, Coronary; Atherosclerosis, Coronary; Coronary Atherosclerosis LH LS; ;  MSThe hospital unit in which patients with acute cardiac disorders receive intensive care. PM72 HN72(70) MHÑCoronary Care Units ANonly /econ /man /organ /stand /supply /util PICoronary Disease (66-69); Intensive Care Units (66-69) MNN2.278.388.493.211 LH  MSThe circulation of blood through the coronary vessels of the heart. PM72 HN72 MHÑCoronary Circulation ANonly /drug eff /rad eff PICoronary Vessels (66-71) MNG9.330.163.324 LH  MSDisorder of cardiac function due to an imbalance between myocardial function and the capacity of the coronary vessels to supply sufficient flow for normal function. MHÑCoronary Disease MNC14.280.211 XSCoronary Artery Disease; Coronary Heart Disease; Heart Disease, Ischemic; Ischemic Heart Disease FXÑAORTOCORONARY BYPASS; ÑMYOCARDIAL REVASCULARIZATION XUÑCoronary Thrombosis LH LS; ; ; LX; LU  MSPresence of a thrombus in a coronary artery. OLto search THROMBOSIS, CORONARY use CORONARY THROMBOSIS back thru 1987 & CORONARY DISEASE 1974-86 HN(87); was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86 MHÑCoronary Thrombosis ANdo not confuse ╥mural thrombus╙ with ╥coronary thrombosis╙: index under HEART DISEASE + THROMBOSIS PICoronary Disease (66-86) MNC14.280.211.212; C14.907.854.830.205 XSThrombosis, Coronary DMÑCoronary Disease LH LS LM  MSSpasm of the large- or medium-sized coronary arteries. PM82 HN82 MHÑCoronary Vasospasm MNC14.280.211.215 XSCoronary Artery Vasospasm LH LS  MHÑCoronary Vessel Anomalies ANdo not use /congen MNC14.280.400.210; C16.131.457.211 LH  MSThe veins and arteries of the heart. MHÑCoronary Vessels AN/abnorm = CORONARY VESSEL ANOMALIES; do not use /blood supply; consider also CORONARY CIRCULATION; /radiogr permitted: do not confuse with ANGIOCARDIOGRAPHY; coronary bypass = AORTOCORONARY BYPASS; coronary aneurysm = CORONARY ANEURYSM MNA7.231.114.269; A7.231.908.194 LH  MSSpherical RNA viruses including those causing avian infectious bronchitis, mouse hepatitis, transmissible gastroenteritis of swine, hemagglutinating encephalomyelitis of swine, and certain respiratory infections of man. OLuse CORONAVIRIDAE to search CORONAVIRUSES back thru 1974 PM81; was CORONAVIRUSES 1974-80; ENTERITIS VIRUS, TURKEY was see under REOVIRUSES 1975-80 HN81; was CORONAVIRUSES 1974-80 MHÑCoronaviridae ANdo not use /cytol MNB4.909.777.199 XUÑAvian Infectious Bronchitis Virus; ÑEnteritis Virus, Turkey; ÑGastroenteritis Virus of Swine LH LU; ;  MSInfections caused by coronaviruses. PM77 HN77 MHÑCoronavirus Infections PIVirus Diseases (68-76) MNC2.782.225 LH  MSPhysicians appointed to investigate all cases of sudden or violent death. MHÑCoroners and Medical Examiners ANIM; only /educ /hist /legis /psychol /stand /supply; DF: CORONERS MNM1.526.485.230; N2.350.205 XSMedical Examiners LH LS  MSPaired or fused ganglion-like bodies in the head of insects. The bodies secrete hormones important in the regulation of metamorphosis and the development of some adult tissues. PM77 HN77 MHÑCorpora Allata ANhormone-secreting bodies in head of insects; do not use /innerv PIJuvenile Hormones (72-76); Metamorphosis, Biological (66-76); Neurosecretion (66-67); Neurosecretory Systems (70-76) MNA8.713.100; A13.250 XSCorpus Allatum LH LS  MHÑCorpora Quadrigemina ANdo not use /innerv; corpora bigemina goes under OPTIC LOBE MNA8.186.211.132.659.237 XSQUADRIGEMINAL PLATE; TECTUM MESENCEPHALI LH LS;  MHÑCorpus Callosum ANdo not use /innerv MNA8.186.211.885.362 LH  MSThe yellow glandular mass formed in the ovary by an ovarian follicle that has ruptured and discharged its ovum. MHÑCorpus Luteum AN/cytol: consider also LUTEIN CELLS; /drug eff: consider also LUTEOLYTIC AGENTS MNA5.360.319.114.630.278; A6.407.312.497.278 XUÑLutein Cells LH LU  MHÑCorpus Luteum Hormones AN/biosyn /physiol permitted; do not use /analogs MND6.472.866.362 LH  MSPhysiologic and biochemical factors that maintain an actively functioning corpus luteum. PM76; was see under CORPUS LUTEUM 1975 HN76(75); was see under CORPUS LUTEUM 1975 MHÑCorpus Luteum Maintenance ANonly /drug eff /rad eff PICorpus Luteum (66-74) MNG8.520.769.100 XSLuteal Maintenance LH LS  MSInvolution and cessation of endocrine function of a corpus luteum. PM76; was see under CORPUS LUTEUM 1975 HN76(75); was see under CORPUS LUTEUM 1975 MHÑCorpus Luteum Regression ANonly /drug eff /rad eff PICorpus Luteum (66-74) MNG8.520.440.508.218 XSLuteal Regression LH LS  OLto search LENTICULAR NUCLEUS use CORPUS STRIATUM back thru 1974 & BASAL GANGLIA 1966-73 PM74; LENTICULAR NUCLEUS was see under GANGLIA, BASAL 1963-73 HN74(72); LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78, was see under GANGLIA, BASAL 1963-73 MHÑCorpus Striatum ANdo not use /innerv; do not confuse with STRIATE CORTEX see VISUAL CORTEX PIBasal Ganglia (66-71) MNA8.186.211.885.105.487 XSLenticular Nucleus LH LS  PM73 HN73(70) MHÑCorrosion ANalmost never IM; no qualif PIChemistry, Physical (66-69) MNH1.181.529.205 LH  OLuse CORTICAL SYNCHRONIZATION to search CORTICAL DESYNCHRONIZATION back thru 1972 (as Prov 1972-74) HN(72); CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1975-83, was Prov 1972-74 MHÑCortical Synchronization ANno qualif PIElectroencephalography (66-71) MNE1.236.257.401.487; E1.399.277.487 XSCortical Desynchronization DMÑElectroencephalography LH LS LM  MHÑCorticosterone AN/biosyn /physiol permitted RN50-22-6 MND4.808.745.745.654.237; D6.472.40.322.478.353.237; D6.472.40.668.478.561.445; D26.74.125.140 XUÑ18-Hydroxycorticosterone LH LU  OLuse CORTICOTROPIN RELEASING HORMONE to search CORTICOTROPIN RELEASING FACTOR back thru 1968 PM74; was CORTICOTROPIN RELEASING FACTOR 1968-73 HN74; was CORTICOTROPIN RELEASING FACTOR 1968-73 MHÑCorticotropin Releasing Hormone AN/biosyn /physiol permitted; DF: CRH RN9015-71-8 PIAdrenocorticotropic Hormone (66-67); Hypothalamo-Hypophyseal System/PH (66-67) MND6.472.709.195; D12.644.135; D12.776.641.650.125 XSACTH Releasing Factor LH LS  MSA basidiomycetous fungal genus of the family Cortinariaceae, order Agaricales, some species of which cause renal failure in man. HN(86) MHÑCortinarius ANdo not use /embryol /microbiol /parasitol PIBasidiomycetes (66-85); Mushroom Poisoning (68-85) MNB5.354.179.100.220 DMÑAgaricales LH LM  PM/adverse effects /poisoning /toxicity were CORTISONE TOXICOLOGY 1963-65; /therapeutic use was CORTISONE, THERAPEUTIC 1965 HN/ad-poi-tox was CORTISONE TOXICOLOGY 1963-65; /therapeutic use was CORTISONE, THERAPEUTIC 1965 MHÑCortisone AN/biosyn /physiol permitted; delta-cortisone = PREDNISONE RN53-06-5 MND4.808.745.745.183; D6.472.40.322.478.478.195; D26.74.125.145 XUÑTetrahydrocortisone LH LU  MS17,20 Beta,21-Trihydroxysteroid:NAD+ oxidoreductase. Catalyzes the interconversion of a ketone and hydroxy group at C-20 of cortisone and other 17,20,21-trihydroxy steroids. Synonym: 20 beta-hydroxysteroid dehydrogenase. HN(75) MHÑCortisone Reductase ANdo not use /analogs RNEC 1.1.1.53 PICortisone (72-74); Hydroxysteroid Dehydrogenases (72-74) MND8.586.682.47.436.400.150 XS20-Beta-Hydroxysteroid Dehydrogenase DMÑ20-Hydroxysteroid Dehydrogenases LH LS LM  MS17,21-Dihydroxypregn-4-ene-3,20-dione. A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities. HN(75) MHÑCortodoxone ANdo not use /defic /physiol; /analogs NIM only RN152-58-9 PI17-Hydroxycorticosteroids (74); Pregnenediones (74) MND4.808.745.745.654.252; D6.472.40.322.478.478.225 XS11-Deoxycortisol; 11-Desoxycortisone; Cortexolone DMÑ17-Hydroxycorticosteroids LH LS; ; LM  MSA family of bacteria including a number of important animal and plant parasites and pathogens - also found in dairy products and soil. HN(76)75 MHÑCorynebacteriaceae ANdo not use /blood-csf-urine PIBacteria (66-74) MNB3.100.200.312 DMÑCoryneform Group LH LM  MHÑCorynebacterium ANGEN; do not use /blood-csf-urine; infection = CORYNEBACTERIUM INFECTIONS unless DIPHTHERIA (if C. diphtheriae in man); Corynebacterium equi = RHODOCOCCUS, C. equi infection = RHODOCOCCUS (NIM) + ACTINOMYCETALES INFECTIONS (IM) MNB3.100.200.312.300 XUÑCorynebacterium Pyogenes LH LU  MHÑCorynebacterium Diphtheriae ANdo not use /blood-csf-urine; infection in man = DIPHTHERIA MNB3.100.200.312.300.313 FXÑDiphtheria Toxin LH LX  MSInfections with bacteria of the genus Corynebacterium. PM72; ERYTHRASMA was see under NOCARDIA INFECTIONS 1963-76 HN72 MHÑCorynebacterium Infections ANnote C. diphtheriae infection in man = DIPHTHERIA; Corynebacterium equi infection = RHODOCOCCUS (NIM) + ACTINOMYCETALES INFECTIONS (IM) PICorynebacterium (66-71) MNC1.252.246 XUÑErythrasma LH LU  MSA species of Corynebacterium isolated from abscesses of warm-blooded animals. HN(72) MHÑCorynebacterium Pyogenes ANdo not use /blood-csf-urine; infection: coord NIM with CORYNEBACTERIUM INFECTIONS (IM) PICorynebacterium (66-71) MNB3.100.200.312.300.513 DMÑCorynebacterium LH LM  MSA group of bacteria now designated as including non-sporing Gram-positive rods of irregular outline. PM76; CORYNEBACTERIACEAE was heading 1975 HN76 MHÑCoryneform Group ANBrevibacteriaceae indexed here PIBacteria (66-74); Corynebacteriaceae (75); Coryneform Group (75) MNB3.100.200 XUÑCorynebacteriaceae LH LU  MH*Cosmetic Technics (Non Mesh) MNE2.218 LH  MHÑCosmetics AND25-26 qualif only MND26.313; J1.516.213 LH  MSHigh energy radiation or particles from extraterrestrial space that strike the earth or atmosphere and may create secondary radiation by disrupting atmospheric particles. MHÑCosmic Radiation ANionizing; only /adv eff; TN 158: as coord with RADIATION EFFECTS; radiation policy: see Manual index under RADIATION & entries following MNG3.230.300.100.300; H1.671.768.513.235 LH  MSPlasmids containing at least one cos (cohesive-end site) of phage lamda. They are used as cloning vehicles for the study of aberrant eukaryotic structural genes and also as genetic vectors for introducing nucleic acid of transforming viruses into cultured cells. PM86 HN86 MHÑCosmids ANonly /drug eff /rad eff PICloning, Molecular (80-85); Genetic Vectors (80-85); Plasmids (78-85) MNG5.225.500.250; G5.386.401.250; G5.832.401.250 FXÑCloning, Molecular LH LX  MSThe assignment, to each of several particular cost-centers, of an equitable proportion of the costs of activities that serve all of them. Cost-center usually refers to institutional departments or services. HN(79) MHÑCost Allocation ANNIM; only /legis /methods /trends; ╥cost shifting╙ goes here PICosts and Cost Analysis (66-78) MNN3.219.151.80 XSCost Apportionment; Cost Shifting DMÑCosts and Cost Analysis LH LS; LM  MSThe relationship of the equivalent values of the benefits that are generated by a program to its costs. The benefit-to-cost ratio is a measure of total return expected per unit of money spent. PM76 HN76 MHÑCost Benefit Analysis ANNIM; only /legis /methods /trends PICosts and Cost Analysis (66-75) MNN3.219.151.125 XSCost Effectiveness LH LS  MSThe regulation or restraint of costs. PM80; was see under COSTS AND COST ANALYSIS 1979 HN80(79); was see under COSTS AND COST ANALYSIS 1979 MHÑCost Control ANNIM; only /legis /methods /trends PICosts and Cost Analysis (66-78) MNN3.219.151.160 XSCost Containment LH LS  MHÑCosta Rica MNZ1.107.169.238 LH  MSAbsolute, comparative or differential costs pertaining to services, institutions, resources, etc. PM66 HN66 MHÑCosts and Cost Analysis ANNIM; only /legis /methods /trends; ╥cost shifting╙: index under COST ALLOCATION; DF: COSTS MNN3.219.151 XUÑCost Allocation; ÑDirect Service Costs LH LU;  MSA synthetic polypeptide with adrenocorticotropic activity. OLto search TETRACOSACTIDE use COSYNTROPIN back thru 1975 & ADRENOCORTICOTROPIC HORMONE 1974 HN(75); TETRACOSACTIDE was see under CORTICOTROPIN 1974 MHÑCosyntropin ANdo not use /biosyn /defic /physiol RN16960-16-0 PIAdrenocorticotropic Hormone (71-74) MND6.472.734.525.183.250 XS1-24-ACTH; 1-24-Corticotropin; Tetracosactide; Tetracosactrin DMÑAdrenocorticotropic Hormone LH LS; ; ; LM  MS1-Methyl-5-(3-pyridyl)-2-pyrrolidinone fumarate. Stimulant proposed as antidepressant. Synonym: Scotine. HN(75) MHÑCotinine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN486-56-6 PIPyridines (74); Pyrrolidinones (69-74) MND3.383.773.812.180 DMÑPyrrolidinones LH LM  MSAny of the cultivated varieties of Gossypium, herbs or shrubs of the Malvaceae family that yield fiber for textiles and as absorbent dressings, oil from seeds, and various chemicals; the fibers cause BYSSINOSIS if inhaled over a period; GOSSYPOL is a male anti-fertility agent from COTTONSEED OIL. MHÑCotton ANas plant & textile; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply; lung dis from cotton dust = BYSSINOSIS MNB6.200; J1.637.879.238 XSGossypium LH LS  OLuse COTTONSEED OIL to search COTTONSEED back thru 1966 PM87; was COTTONSEED 1963-86 HN87; was COTTONSEED 1963-86 MHÑCottonseed Oil AND25-26 qualif; consider also GOSSYPOL MND10.516.212.302.380.380; D10.516.212.507.350; D10.516.627.700.263; J1.740.250.250; J1.740.700.260 XSCottonseed LH LS  MSA genus of birds (family Phasianidae) containing the common European and other Old World quails. HN(75) MHÑCoturnix ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; diseases: coord IM with BIRD DISEASES (IM) MNB2.248.801.350 XSJapanese Quail DMÑQuail LH LS LM  MHÑCough AN/drug ther: consider also ANTITUSSIVE AGENTS MNC8.618.248; C23.888.852.293 FXÑAntitussive Agents; ÑEXPECTORANTS LH LX;  HN(72) MHÑCoumaphos ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN56-72-4 PICoumarins (66-71) MND2.719.199; D3.438.150.446.912.326; D5.723.491.657.213 DMÑInsecticides, Organothiophosphate LH LM  MSHydroxycinnamic acid and its derivatives. Act as activators of the indoleacetic acid oxidizing system, thereby producing a decrease in the endogenous level of bound indoleacetic acid in plants. HN(76) MHÑCoumaric Acids ANdo not use /analogs PICinnamates (69-75) MND2.241.223.201.210 XSHydroxycinnamic Acids DMÑCinnamates LH LS LM  MHÑCoumarins ANdo not use /analogs /biosyn /defic /physiol MND3.438.150.446; D19.461.119.196 XS1,2-Benzopyrones XUÑChromonar; ÑCoumestrol LH LS LU;  MS2-(2,4-Dihydroxyphenyl)-6-hydroxy-3-benzofurancarboxylic acid gamma lactone. A coumarin derivative occurring naturally in forage crops. Has estrogenic activity. HN(75) MHÑCoumestrol ANdo not use /defic /physiol; /analogs NIM only RN479-13-0 PICoumarins (72-74); Benzofurans (72-74) MND3.438.150.446.350; D6.472.265.200 DMÑCoumarins LH LM  MSThe giving of advice and assistance to individuals with educational or personal problems. PM66 HN66(64) MHÑCounseling ANonly /econ /educ /hist /man /methods /stand /trends MNF2.784.176; F4.408.413; N2.421.143.303; N2.421.461.363 FXÑVOCATIONAL GUIDANCE LH LX  PM67 HN67(64) MHÑCountercurrent Distribution ANNIM; only /instrum MNE5.196.278; H1.181.278.287 LH  MSImmunoelectrophoresis in which immunoprecipitation occurs when antigen at the cathode is caused to migrate in an electric field through a suitable medium of diffusion against a stream of antibody migrating from the anode as a result of endosmotic flow. HN(76) MHÑCounterimmunoelectrophoresis ANonly /instrum /methods PIImmunoelectrophoresis (66-75) MNE1.223.495.826.769.611.250 XSElectrosyneresis; Immunoelectroosmophoresis; Immunoelectrophoresis, Countercurrent; Immunoelectrophoresis, Crossover DMÑImmunoelectrophoresis LH LS; ; ; LM  MSThe psychiatrist's conscious or unconscious emotional reaction to his patient. PM68 HN68 MHÑCountertransference (Psychology) ANno qualif; DF: COUNTERTRANSFERENCE PITransference (Psychology) (66-67) MNF4.754.919.864.363 LH  MSThe mutual attraction between individuals of the opposite sex. MHÑCourtship ANhuman & animal; no qualif MNF1.145.792.279 LH  MHÑCoxiella ANdo not use /blood-csf-urine; infection = Q FEVER MNB3.700.651.801.196 LH  MSOne of the two groups of coxsackieviruses; divided into several serotypes. Found in association with or implicated in diarrhea, herpangina, aseptic meningitis (A9), the common cold (A21), and degenerative lesions of striated muscle (A7). OLuse COXSACKIE A VIRUSES to search COXSACKIE A9 VIRUS back thru 1975; to search HERPANGINA VIRUS use COXSACKIE A VIRUSES back thru 1975 & COXSACKIEVIRUSES 1966-74 PM79; COXSACKIE A9 VIRUS was see under COXSACKIE VIRUSES 1975-78; HERPANGINA VIRUS was see under COXSACKIE VIRUSES 1963-78 HN79; COXSACKIE A9 VIRUS was see under COXSACKIE VIRUSES 1975-78; HERPANGINA VIRUS was see under COXSACKIE VIRUSES 1963-78 MHÑCoxsackie A Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with COXSACKIEVIRUS INFECTIONS (IM) & consider also HERPANGINA PICoxsackieviruses (66-78) MNB4.909.777.618.284.196.50 XSCoxsackie A9 Virus; Herpangina Virus LH LS;  MSOne of the two groups of coxsackieviruses; divided into several serotypes. Associated with epidemic pleurodynia (B1, B3), myocarditis and endocarditis (B3, B1), respiratory disorders (B3, B5), and kidney, pancreas, and liver disorders. OLto search PLEURODYNIA VIRUS use COXSACKIE B VIRUSES back thru 1975 & COXSACKIEVIRUSES 1966-74 PM79; PLEURODYNIA VIRUS was see under COXSACKIE VIRUSES 1963-78 HN79; PLEURODYNIA VIRUS was see under COXSACKIE VIRUSES 1963-78 MHÑCoxsackie B Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with COXSACKIEVIRUS INFECTIONS (IM) & consider also PLEURODYNIA, EPIDEMIC PICoxsackieviruses (66-78) MNB4.909.777.618.284.196.110 XSBornholm Disease Virus; Pleurodynia Virus LH LS;  MSA heterogenous group of infections produced by Coxsackieviruses, including herpangina, aseptic meningitis, a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia, and a serious myocarditis. OLuse COXSACKIEVIRUS INFECTIONS to search COXSACKIE VIRUS INFECTIONS back thru 1966 PM79; was COXSACKIE VIRUS INFECTIONS 1963-78 HN79; was COXSACKIE VIRUS INFECTIONS 1963-78 MHÑCoxsackievirus Infections MNC2.782.687.359.213 XUÑHand, Foot and Mouth Disease LH LU  MSA heterogenous group of enteroviruses found in association with various diseases in man and other animals; two groups (A and B) have been identified with a number of serotypes in each. The name is derived from a village in New York State where the virus was first identified. OLuse COXSACKIEVIRUSES to search COXSACKIE VIRUSES back thru 1966 PM79; was COXSACKIE VIRUSES 1963-78 HN79; was COXSACKIE VIRUSES 1963-78 MHÑCoxsackieviruses ANdo not use /blood-csf-urine /cytol; infection = COXSACKIEVIRUS INFECTIONS MNB4.909.777.618.284.196 LH  MSChiefly marine, largely carnivorous crustaceans including the genera Cancer, Uca, and Callinectes; includes crabs as food. PM72 HN72 MHÑCrabs ANas animal & food; IM; /microbiol /parasitol permitted PICrustacea (66-71) MNB1.131.365.256 FXÑShellfish LH LX  MSIncomplete fracture of any part of a tooth, characterized by pain during mastication and sensitivity to heat, cold, sweet or sour tastes, and alcohol; it is often undiagnosed because the tooth is usually X-ray negative and normal to pulp vitality tests. OLsearch TOOTH FRACTURES 1970-74 HN(75) MHÑCracked Tooth Syndrome MNC7.793.818.364; C21.866.405.863.364 DMÑTooth Fractures LH LM  HN(64) MHÑCranial Fossa, Posterior ANNIM as merely locational for, usually, lesions ╥within the posterior cranial cavity╙; articles are seldom on posterior cranial fossa as bone; when NIM to locate intracranial lesions, no qualif MNA2.835.232.781.176 DMÑSkull LH LM  PM81 HN81; was NON MESH before 1981 MHÑCranial Nerve Diseases ANcoord NIM with specific cranial nerve (IM) PICranial Nerves (66-80); specific cranial nerve; Peripheral Nerve Diseases (66-80) MNC10.772.204 LH  MSNeoplasms of any of the cranial nerves. PM78 HN78 MHÑCranial Nerve Neoplasms ANcoord IM with specific cranial nerve (IM) + histol type of neopl (IM); /anal /blood supply /secret /ultrastruct permitted PIPeripheral Nerve Neoplasms (66-77) MNC4.588.614.596.240; C10.772.204.192 LH  MHÑCranial Nerves ANdo not use /innerv; 1st cranial nerve = OLFACTORY NERVE, 2d = OPTIC NERVE, 3d = OCULOMOTOR NERVE, 4th = TROCHLEAR NERVE, 5th = TRIGEMINAL NERVE, 6th = ABDUCENS NERVE, 7th = FACIAL NERVE, 8th = ACOUSTIC NERVE, 9th = GLOSSOPHARYNGEAL NERVE, 10th = VAGUS NERVE, 11th = ACCESSORY NERVE, 12th = HYPOGLOSSAL NERVE MNA8.796.214 LH  MSLarge endothelium-lined venous channels situated between the two layers of the dura mater; they are devoid of valves. MHÑCranial Sinuses ANdo not use /blood supply; do not confuse with CEREBRAL VEINS MNA7.231.908.224 LH  MSA type of fibrous joint between bones of the head. HN(81) MHÑCranial Sutures ANnote categ: a fibrous joint in bones of head; do not confuse with SUTURES (E7) or SUTURE TECHNICS (E4) PISkull (66-80); specific skull bone MNA2.835.232.781.200 DMÑSkull LH LM  PMHALLERMANN'S SYNDROME was see under MANDIBULOFACIAL DYSOSTOSIS 1965-84 MHÑCraniofacial Dysostosis ANdo not use /congen; ╥craniofacial dysmorphism╙ does not go here: index under FACIAL BONES /abnorm + SKULL /abnorm but not also under ABNORMALITIES, MULTIPLE MNC5.116.99.370.231; C16.131.621.246 XSCROUZON'S DISEASE; DYSOSTOSIS, CRANIOFACIAL XUÑHallermann's Syndrome LH LS; LU  MSThe scientific study of variations in size, shape, and proportion of cranium. MHÑCraniology ANonly /hist MNI1.76.368.239 FXÑCEPHALOMETRY; ÑCRANIOMETRY; ÑCephalometry; ÑCraniometry LH LX; ; ;  MHÑCraniometry ANdead skull only; for living skull use CEPHALOMETRY; NIM; only /instrum /methods MNE5.118.364.364 FXÑCRANIOLOGY LH LX  MHÑCraniopharyngioma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with PITUITARY NEOPLASMS (IM) MNC4.557.537.274 XSSUPRASELLAR CYST LH LS  MSPremature closure of one or more sutures of the skull. OLuse CRANIOSYNOSTOSES to search OXYCEPHALY back thru 1966 HNOXYCEPHALY was see under CRANIOSYNOSTOSES 1963-78 MHÑCraniosynostoses ANdo not use /congen MNC5.116.99.370.894.232; C16.131.621.906.364 XSAcrocephaly; Oxycephaly LH LS;  PM65 HN65(64) MHÑCraniotomy ANdo not use /util except by MeSH definition MNE4.530.264 LH  MSVarious freshwater crustaceans resembling the lobster, but usually much smaller; common genera are Astacus, Cambarus, Oronectes, and Pacifastacus. Includes crayfish as food. PM72 HN72 MHÑCrayfish ANas animal & food; IM; /microbiol /parasitol permitted PICrustacea (66-71) MNB1.131.365.327 FXÑShellfish LH LX  OLuse CREATINE to search CREATINE AND CREATININE 1966-67 PM68; CREATINE AND CREATININE was heading 1963-67 HN68; CREATINE AND CREATININE was heading 1963-67 MHÑCreatine ANdo not confuse with CREATININE; CREATINE PHOSPHATE = PHOSPHOCREATINE RN57-00-1 MND2.78.370.280; D12.125.373 LH  MHÑCreatine Kinase ANdo not use /analogs RNEC 2.7.3.2 MND8.586.913.696.729.164 XSCREATINE PHOSPHOKINASE LH LS  MSThree isoenzymes of creatine kinase have been identified in human tissues: MM from skeletal muscle, MB from myocardial tissue and BB from nervous tissue. Plasma from healthy humans contains MM almost exclusively. Elevated MB creatine kinase activity is a possible indicator of myocardial injury. EC 2.7.3.2. PM80 HN80 MHÑCreatine Kinase Isoenzymes ANdo not use /analogs; CK BB, CK MB, CK MM, etc. go here; DF: CK ISOENZYMES RNEC 2.7.3.- PICreatine Kinase (66-79); Isoenzymes (66-79) MND8.586.348.200; D8.586.913.696.729.164.200 LH  OLsearch CREATINE AND CREATININE under CREATINE 1966-67 PM68; CREATINE AND CREATININE was heading 1963-67 HN68; CREATINE AND CREATININE was heading 1963-67 MHÑCreatinine ANdo not confuse with CREATINE RN60-27-5 MND3.383.374.207 LH  MSThe ability to construct new ideas or images. MHÑCreativeness ANhuman & animal (espec primates); no qualif MNF1.752.264; F2.463.785.302 LH  MSThe recognition of professional or technical competence through registration, certification, licensure, admission to association membership, the award of a diploma or degree, etc. PM80 HN80; was NON MESH before 1980 MHÑCredentialing ANonly /econ /hist /legis /methods /stand /trends /util MNN3.706.110 LH  OLsearch CRESOLS 1966-74 HN(75) MHÑCreosote ANdo not use /biosyn /defic /physiol; /analogs NIM only RN8021-39-4 MND2.755.239.327 DMÑCresols LH LM  MHÑCresols ANdo not use /analogs /biosyn /defic /physiol MND2.755.239 XUÑBisacodyl; ÑBrocresine; ÑBromcresol Green; ÑBromcresol Purple; ÑCreosote; ÑCyclofenil; ÑDinitrocresols; ÑTritolyl Phosphates LH LU; ; ; ; ; ; ;  MHÑCretinism MNC5.116.99.343.314; C5.116.132.256; C19.874.482.281 FXÑMental Retardation LH LX  MSAn infantile syndrome characterized by cat-like cry, failure to thrive, microcephaly, mental retardation, spastic quadriparesis, micro- and retrognathia, glossoptosis, bilateral epicanthus, hypertelorism, and tiny external genitalia; due to chromosomal abnormality. OLuse CRI-DU-CHAT SYNDROME to search CRYING CAT SYNDROME back thru 1966 PM77; was CRYING CAT SYNDROME 1964-76 HN77; was CRYING CAT SYNDROME 1964-76 MHÑCri-du-Chat Syndrome ANdo not use /congen /drug eff /physiol /rad eff MNC10.496.151; C16.131.77.262; F3.709.346.161 XSCrying Cat Syndrome LH LS  MSA family of the order Rodentia which includes 100 genera and many species. This family includes New World mice and rats, gerbils, hamsters, voles, and lemmings. They occur nearly world-wide. Some of the diseases transmitted from these rodents to man are sylvatic plague, tularemia, leptospirosis, and Rocky Mountain spotted fever. OLuse CRICETIDAE to search VOLES & MICROTUS back thru 1975 PM82; VOLES (with MICROTUS as see ref to it) was see under RODENTS 1975-81 HN82; VOLES (with MICROTUS as see ref to it) was see under RODENTS 1975-81 MHÑCricetidae ANincludes gerbils, hamsters, voles, lemmings & New World mice & rats; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; for X refs MICE, RED-BACKED, RATS, COTTON & other species commonly called ╥mouse╙ or ╥rat╙ but taxonomically CRICETIDAE, do not check tags MICE or RATS PIRats (66-81); Rodentia (66-81) MNB2.649.865.360 XSClethrionomys; Cricetids; Dicrostonyx; Lemmings; Lemmus; Mice, Red-Backed; Microtines; Microtus; Muskrats; Neotoma; Ondatra; Psammomys; Rats, Cotton; Sigmodon; Voles LH LS; ; ; ; ; ; ; ; ; ; ; ; ; ;  MSA genus of the family Cricetidae consisting of seven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. HN(78) MHÑCricetulus ANNIM; do not confuse with CRICETUS see HAMSTERS, CRICETINI see HAMSTERS or CRICETIDAE (the family); when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not forget also to check tag HAMSTERS PIHamsters (66-77) MNB2.649.865.360.458.340 XSHamsters, Armenian; Hamsters, Chinese; Hamsters, Grey DMÑHamsters LH LS; ; LM  MSThe small thick cartilage that forms the lower and posterior parts of the laryngeal wall. HN(79) MHÑCricoid Cartilage PILaryngeal Cartilages (66-78) MNA2.165.507.211; A4.329.591.211 DMÑLaryngeal Cartilages LH LM  MSA familial form of congenital hyperbilirubinemia, transmitted as an autosomal recessive trait; characterized by icterus and brain damage caused by a glucuronyl transferase deficiency in the liver and faulty bilirubin conjugation. OLsearch HYPERBILIRUBINEMIA, HEREDITARY 1966-74 HN(75) MHÑCrigler-Najjar Syndrome ANdo not use /congen MNC18.452.648.437.281; C23.888.498.329.396.281 DMÑHyperbilirubinemia, Hereditary LH LM  MSA violation of the criminal law, i.e., a breach of the conduct code specifically sanctioned by the state, which through its administrative agencies prosecutes offenders and imposes and administers punishments. PM68 HN68 MHÑCrime ANonly /class /hist /legis /prev /trends PICriminology (66-67) MNI1.198.240; I1.880.735.191 XUÑFraud LH LU  MSA branch of law that defines criminal offenses, regulates the apprehension, charging and trial of suspected persons and fixes the penalties and modes of treatment applicable to convicted offenders. HN(78) MHÑCriminal Law ANonly /hist; specify state or country PIJurisprudence (66-77); specific crime MNI1.198.290; I1.880.604.583.100 XSCriminal Justice DMÑJurisprudence LH LS LM  MSThe branch of psychology which investigates the psychology of crime with particular reference to the personality factors of the criminal. MHÑCriminal Psychology ANas SPEC, SPEC qualif; as psychol of the criminal mind, no qualif; consider also PRISONERS /psychol MNF2.784.240 XSPSYCHOLOGY, CRIMINAL LH LS  MSThe study of crime and criminals with special reference to the personality factors and social conditions leading toward, or away from crime. MHÑCriminology ANonly /educ /hist /man MNI1.198 LH  MSAssistance provided a patient and/or his family in temporarily resolving an immediate psychiatric problem. PM70 HN70 MHÑCrisis Intervention ANno qualif PICommunity Health Services (66-69); Community Mental Health Services (67-69); Emergency Medical Services (68-69); Mental Disorders/PC (66-69); Mental Health Services (66-69); Psychotherapy (66-69); Suicide/PC (66-69) MNF4.754.252 FXÑEmergencies LH LX  MSCardiac malformation characterized by an atrioventricular spatial relation that places or appears to place each ventricle in a contralateral position relative to its associated atrium. HN(87) MHÑCrisscross Heart ANdo not use /congen PIHeart Defects, Congenital (66-86) MNC14.280.400.220; C16.131.457.220 DMÑHeart Defects, Congenital LH LM  MSA genus of parasitic protozoans of the family Trypanosomidae, found in the digestive tract of invertebrates, especially insects. PM79 HN79 MHÑCrithidia ANa mastigophora used as source organism in immunol & other exper; do not use /anat /embryol PIMastigophora (66-78); Trypanosoma (66-78) MNB1.841.443.868.110 LH  MSHealth care provided to a critically ill patient. PM75 HN75 MHÑCritical Care ANonly /econ /legis /methods /organ /psychol /stand /trends PIIntensive Care Units (66-74); Nursing Care (66-74) MNE2.472.190; N2.421.589.230 XSIntensive Care FXÑEmergencies; ÑIntensive Care Units LH LS LX;  MSA specific stage in animal and human development during which certain types of behavior normally are shaped and molded for life. PM68 HN68 MHÑCritical Period (Psychology) ANhuman & animal; no qualif; DF: CRITICAL PERIOD MNF2.463.425.209 LH  MSGastrointestinal disorder characterized by chronic inflammatory infiltrates and fibrosis affecting all layers to the serosa and development of noncaseating granulomas. Most common site of involvement is the terminal ileum with the colon as the second most common. OLuse CROHN DISEASE to search ENTERITIS, REGIONAL back thru 1966 PM80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64 HN80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64 MHÑCrohn Disease ANaffects ileum & colon most frequently; coord IM with ILEITIS (NIM) or COLITIS (NIM) only if site is particularly discussed; usually chronic so do not coord with CHRONIC DISEASE MNC6.405.469.220 XSColitis, Granulomatous; Enteritis, Granulomatous; Enteritis, Regional; Ileitis, Regional; Ileitis, Terminal; Ileocolitis LH LS; ; ; ; ;  HN(65) MHÑCronolone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2529-45-5 MND4.808.745.745.654.281; D4.808.908.186; D6.597.799.193 XSFlurogestone DMÑPregnenediones LH LS LM  PM68 HN68 MHÑCrop, Avian PIBirds (66-67) MNA13.265 LH  MSThe circulation in a portion of the body of one individual of blood supplied from another individual. OLsearch PARABIOSIS 1970-74 HN(75); was in Cat G only 1975-78 MHÑCross Circulation ANonly /methods MNE5.660.365 DMÑParabiosis LH LM  MSAny infection which a patient contracts from another patient in a health-care institution. OLuse CROSS INFECTION to search HOSPITAL INFECTIONS back thru 1966 HNHOSPITAL INFECTIONS was see under CROSS INFECTION 1971-77 MHÑCross Infection ANCat C qualif only; any infect from one patient to another ╥in a health-care institution╙ MNC1.539.248; G3.850.460.250 XSHospital Infections; Nosocomial Infections FXÑPATIENT ISOLATORS; ÑPatient Isolation; ÑStaphylococcal Infections LH LS; LX; ;  MSSerological reactions in which an antiserum against one antigen reacts with a non-idential but closely related antigen. PM72 HN72(69) MHÑCross Reactions ANIM GEN only; NIM with specific antigen or antibody (IM); only /drug eff /rad eff PIAntigen-Antibody Reactions (66-68) MNG4.610.143.281 LH  MSStudies in which variables relating to a group of individuals are assessed at a single point in time. HN(75) MHÑCross Sectional Studies ANNIM; no qualif; specify geog if possible MNE5.318.150 XSPrevalence Studies DMÑEpidemiologic Methods LH LS LM  MSComparison of various psychological, sociological, or cultural factors in order to assess the similarities or diversities occurring in two or more different cultures or societies. PM68 HN68 MHÑCross-Cultural Comparison ANno qualif PIAnthropology (66-67); Culture (66-67); Sociology (66-67) MNI1.76.201.450.281; I1.880.143.257 XSTranscultural Studies LH LS  MSReagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. PM80 HN80 MHÑCross-Linking Reagents AND25-26 qualif PIIndicators and Reagents (66-79); Protein Binding (66-79) MND26.550.155 XSBifunctional Reagents LH LS  PM68 HN68 MHÑCrosses, Genetic ANno qualif; the result of breeding of 2 varieties of same species; do not confuse with CROSSING OVER, interchange of genes between homologous chromosomes PIGenetics (66-67) MNE5.393.281 FXÑCONJUGATION, GENETIC; ÑHYBRIDIZATION; ÑTRANSDUCTION, GENETIC; ÑTRANSFORMATION, GENETIC LH LX; ; ;  MSThe reciprocal exchange of segments at corresponding positions along pairs of homologous chromosomes by symmetrical breakage and crosswise rejoining. PM68 HN68 MHÑCrossing Over (Genetics) ANonly /drug eff /rad eff; = interchange of genes or segments between homologous chromosomes; do not confuse with CROSSES, GENETIC, the result of breeding 2 varieties of the same species; DF: CROSSING OVER PICytogenetics (67); Genetics (66-67) MNG5.148.301; G5.832.260 LH  MSVenoms from snakes of the family Crotalidae or Pit Vipers, mostly in the Americas, including rattlesnakes, cottonmouth, fer-de-lance, bushmaster, American copperhead; these venoms contain nontoxic proteins, cardio-, hemo-, cyto- and neuro- toxins and many enzymes, especially phospholipases A; many of the toxins have been characterized. Crotactin, crotalin, crotalotoxin, crotamin go here. PM78 HN78 MHÑCrotalid Venoms ANdo not use /analogs /chem syn /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; TN 241: common & scientific names of various crotalids PISnake Venoms (75-77); Snakes (66-74); Venoms (66-74) MND24.185.965.850.210 XSPit Viper Venoms; Rattlesnake Venoms XUÑCrotoxin LH LS; LU  MSViscous, nauseating oil obtained from the shrub Croton tiglium (Euphorbaceae); vesicant and skin irritant used as pharmacologic standard for skin inflammation and allergy; causes skin cancer; formerly used as emetic and cathartic with frequent mortality. Synonyms: Oleum crotonis; Tiglium oil. MHÑCroton Oil AND25-26 qualif RN8001-28-3 MND10.516.212.507.375; D10.516.627.700.315; D26.191.208; D26.368.238; J1.740.700.315 FXÑPhorbols LH LX  HN(73) MHÑCrotonates ANdo not use /analogs /biosyn /defic /physiol PIButyrates (66-72) MND2.241.81.161.430.250; D2.241.81.465.240.380.250; D10.516.251.355.240.250; D10.516.251.400.240.380.250 DMÑButyrates LH LM  MS2-Butenoic acids. 4-carbon monounsaturated monocarboxylic acids with the unsaturation in the 2 position. HN(75) MHÑCrotonic Acids ANdo not use /analogs /biosyn /defic /physiol PICrotonates (73-74) MND2.241.81.161.430; D2.241.81.465.240.380; D10.516.251.355.240; D10.516.251.400.240.380 XS2-Butenoic Acids DMÑButyrates LH LS LM  MSA specific complex of toxic proteins from the venom of Crotalus durissus terrificus (South American rattlesnake); it can be separated into a phospholipase A and crotapotin fragment; the latter consists of three different amino acid chains, potentiates the enzyme and is specifically neurotoxic. HN(78) MHÑCrotoxin ANdo not use /defic /diag use /physiol; /analogs NIM only; /antag permitted but consider also ANTIVENINS RN9007-40-3 PISnake Venoms (75-77); Snakes (66-74); Venoms (66-74) MND24.185.965.850.210.229 XSCrotapotin DMÑCrotalid Venoms LH LS LM  MSA condition characterized by resonant barking cough, hoarseness and persistant stridor; caused by allergy, foreign body, infection or neoplasm. It occurs chiefly in infants and children. OLsearch LARYNGITIS 1966-74 HN(75) MHÑCroup MNC9.400.535.365 DMÑLaryngitis LH LM  MSBehavior with respect to an excessive number of individuals, human or animal, in relation to available space. PM68 HN68 MHÑCrowding ANhuman & animal; only /physiol MNF1.145.875.281 FXÑPOPULATION DENSITY; ÑStress, Psychological LH LX;  PM65; CROWN AND BRIDGEWORK was heading 1963-64 HN65; CROWN AND BRIDGEWORK was heading 1963-64 MHÑCrowns ANnote categ: anatomical crown of tooth goes under TOOTH; only /adv eff /stand /util (if by MeSH definition) /vet MNE6.780.377.433.186 XSDental Crowns FXÑDENTAL PORCELAIN XUÑPost and Core Technic LH LS LX LU  MS4-tert-Butyl-2-chlorophenyl-N-methyl-O-methylphosphoramidate. An insecticide used extensively for the control of cattle grubs, cattle lice and hornflies. Synonym: Dowco 132. HN(76) MHÑCrufomate ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN299-86-5 PIInsecticides, Organophosphate (72-75); Methylamines (72-75) MND2.705.182; D5.723.491.574.150 DMÑInsecticides, Organophosphate LH LM  MSTrauma and ischemia of soft tissues, principally skeletal muscle, due to prolonged severe crushing of the tissues, leading to increased permeability of the cell membrane and to the release of potassium, enzymes and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia. OLsearch KIDNEY FAILURE, ACUTE 1966-74 HN(75); was see under KIDNEY FAILURE, ACUTE 1967-78, was see under ACUTE RENAL FAILURE 1963-66 MHÑCrush Syndrome MNC21.866.797.240; C23.888.789.843.240 DMÑShock, Traumatic LH LM  MHÑCrustacea AN= animal; coord IM with SHELLFISH (IM) as food; /microbiol /parasitol permitted; krill goes here MNB1.131.365 XSEuphausia; Nyctiphanes FXÑSHELLFISH LH LS; LX  MHÑCrutches ANonly /adv eff /stand MNE7.858.442.281 LH  MSPortal hypertension with extensive collateral circulation through the paraumbilical veins and abdominal vessels and associated with a vascular bruit over the distended veins. Distinction may be made between the disease (patent umbilical vein with absence of liver disease) and syndrome (paraumbilical vein involvement due to portal hypertension associated with liver cirrhosis). OLsearch LIVER CIRRHOSIS 1966-74 HN(75); was see under LIVER CIRRHOSIS 1963-78 MHÑCruveilhier-Baumgarten Syndrome MNC6.552.494.250 DMÑHypertension, Portal LH LM  MSTo utter an inarticulate, characteristic sound in order to communicate or express a feeling, or desire for attention. PM70 HN70 MHÑCrying ANonly /physiol PIChild Behavior (66-69); Infant, Newborn (66-69); Voice (66-69) MNF1.145.209.530.258; F1.525.200.310.300 FXÑVoice LH LX  MSA condition characterized by the presence of cryoglobulins in the blood. They are precipitated into the microvasculature on exposure to cold and cause restricted blood flow in exposed areas. PM85; was see under PARAPROTEINEMIAS 1982-84 HN85(82); was see under PARAPROTEINEMIAS 1982-84 MHÑCryoglobulinemia PIBlood Protein Disorders (66-75); Cryoglobulins (66-81); Paraproteinemias (76-81) MNC15.378.147.780.243; C20.683.780.250 LH  MHÑCryoglobulins ANdo not use /analogs /blood MND12.776.124.486.485.900.225; D12.776.124.790.651.900.225; D12.776.377.715.548.900.225 LH  PM72 HN72(67) MHÑCryoprotective Agents AND25-26 qualif PIFreezing (66) MND26.328 FXÑFreezing; ÑPreservation, Biological LH LX;  MSThe use of freezing as a special surgical technic to destroy or excise tissue. OLuse CRYOSURGERY to search CRYOGENIC SURGERY & CRYOTHERAPY back thru 1966 PM84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1967-83 HN84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1964-83 (Prov 1964-66) MHÑCryosurgery ANdestruction or excision of tissue by very low temp; do not use /util except by MeSH definition; coord IM with disease/surg (IM); differentiate from HYPOTHERMIA, INDUCED for cooling of organs during surgery MNE4.143 XSCryotherapy FXÑCold; ÑFreezing LH LS LX;  MHÑCryptococcosis MNC1.703.248 XSTORULOSIS LH LS  MHÑCryptococcus ANdo not use /anat /embryol /microbiol /parasitol; infection = CRYPTOCOCCOSIS MNB5.354.381.546.258; B5.354.930.316 XSTORULA XUÑCryptococcus Neoformans LH LS LU  MSA species of the fungus Cryptococcus, which causes cryptococcosis. HN(72) MHÑCryptococcus Neoformans ANdo not use /anat /embryol /microbiol /parasitol; infection = CRYPTOCOCCOSIS & do not bother to index C. NEOFORMANS PICryptococcus (66-71) MNB5.354.381.546.258.366; B5.354.930.316.366 DMÑCryptococcus LH LM  MHÑCryptorchism ANdo not use /congen; = ╥undescended testis╙ MNC16.131.939.258 LH  MSParasitic intestinal infection with severe diarrhea caused by a protozoan, Cryptosporidium; occurs in both animals and humans. PM85 HN85 MHÑCryptosporidiosis ANoften in animals: do not use /vet but check tag ANIMAL PICoccidiosis (66-84) MNC3.752.259.269; C22.674.710.235 LH  MSA coccidian parasite occurring in the intestines of many vertebrates including man. HN(85) MHÑCryptosporidium ANdo not use /anat /blood-csf-urine /embryol; infection = CRYPTOSPORIDIOSIS; /drug eff: consider also COCCIDIOSTATS PICoccidia (75-84) MNB1.841.762.167.87 DMÑCoccidia LH LM  PM68 HN68(64) MHÑCrystallins ANnot for crystalline lens ( = LENS, CRYSTALLINE); do not use /analogs /defic /physiol MND12.776.306.366 XSLENS PROTEINS LH LS  PM66 HN66(64) MHÑCrystallization ANNIM; no qualif MNE5.196.300; H1.181.278.300; H1.181.529.225 LH  MHÑCrystallography ANNIM; only /instrum /methods /stand MNE5.196.309; H1.181.278.319; H1.181.529.240 LH  MHÑCuba MNZ1.107.904.227 LH  MSSignals for an action; that specific portion of a perceptual field or pattern of stimuli to which a subject has learned to respond. PM66 HN66(64) MHÑCues ANno qualif MNF2.463.425.234 LH  MHÑCuldoscopy ANNIM; do not use /util except by MeSH definition MNE1.249.241; E1.418.268 LH  MHÑCulex ANmosquito: do not confuse with CULICOIDES, gnat; do not use /drug eff with insecticides: TN 111; /microbiol /parasitol permitted MNB1.131.617.289.610.416 LH  MSThose aspects or characteristics which identify a culture. OLsearch CULTURE 1968-74 HN(75) MHÑCultural Characteristics ANnot for microbial or tissue cultures; no qualif; CROSS-CULTURAL COMPARISON is also available MNI1.76.201.450.324; I1.880.143.329 DMÑCulture LH LM  MSThe absence of certain expected and acceptable cultural phenomena in the environment which results in the failure of the individual to communicate and respond in the most appropriate manner within the context of society. Language acquisition and language use are commonly used in assessing this concept. PM68 HN68 MHÑCultural Deprivation ANno qualif MNI1.880.143.400 XSCULTURAL DISADVANTAGEMENT FXÑMENTAL RETARDATION, PSYCHOSOCIAL; ÑPOVERTY LH LS LX;  MSThe continuous developmental process of a culture from simple to complex forms and from homogeneous to heterogeneous qualities. HN(78) MHÑCultural Evolution ANno qualif MNI1.76.201.450.370 DMÑCulture LH LM  MSA collective expression for all behavior patterns acquired and socially transmitted through symbols. Included are customs, traditions, and language. MHÑCulture ANnot for microbial or tissue cultures; no qualif; customs of a people go here; CROSS-CULTURAL COMPARISON is also available MNI1.76.201.450; I1.880.143 XUÑCultural Characteristics; ÑCultural Evolution LH LU;  MHÑCulture Media ANNIM; D25-26 qualif with caution; TN 183: relation to TISSUE CULTURE & CELLS, CULTURED MND26.342 FXÑBacteriological Technics LH LX  MSBis(Cyclohexylidene-hydrazide)oxalic acid. Copper chelator that inhibits monoamine oxidase and causes liver and brain damage. Synonym: Cuprizane. HN(75) MHÑCuprizone AND25-26 qualif; /analogs NIM only RN370-81-0 PICyclohexanes (69-74); Hydrazones (72-74) MND2.455.426.392.368.367.190; D26.241.150 XSBiscyclohexanone Oxaldihydrazone DMÑCyclohexanes LH LS LM  OLuse CURARE to search CURARIFORM ANTAGONISTS 1966-69 PMCURARIFORM ANTAGONISTS was heading 1963-69 HNCURARIFORM ANTAGONISTS was heading 1963-69 MHÑCurare ANdo not use /biosyn /defic /physiol; /analogs: consider also CURARE-LIKE AGENTS RN8063-06-7 MND3.132.267; D17.563.367.217 LH  OLsearch CURARIFORM DRUGS under MUSCLES 1966-69; search MUSCLE RELAXANTS under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 & MUSCLES 1966-69; search CURARIFORM ANTAGONISTS under CURARE 1966-69 PM70; CURARIFORM DRUGS was see MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69 HN70; CURARIFORM DRUGS was see under MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69 MHÑCurare-Like Agents ANdo not use /analogs /biosyn /defic /physiol; consider also CURARE /analogs PIMuscles (66-69) MND17.563.367 XSCURARIFORM DRUGS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PACHYCURARES LH LS; ;  MS1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione. A dye obtained from the root of Curcuma longa L., or tumeric; it is used in the preparation of curcuma paper and the detection of boron; may have choleretic properties. Synonyms: curcuma; Indian saffron; CI Natural Yellow; tumeric; C.I. 75300. HN(75) MHÑCurcumin AND25-26 qualif; /analogs NIM only RN458-37-7 PIAlkadienes (74); Catechols (66-74) MND2.755.166.200; D26.408.223 XSDiferuloylmethane; Turmeric Yellow DMÑCatechols LH LS; LM  PM65 HN65(64) MHÑCurettage ANdo not use /util except by MeSH definition; gingival curettage = SUBGINGIVAL CURETTAGE; DILATATION AND CURETTAGE is also available MNE4.157 LH  MHÑCurium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-51-9 MND1.287.246; D1.552.517.272 LH  MSDuodenal ulcer occurring in severe burns. HN(75) MHÑCurling's Ulcer ANdo not use /congen MNC6.405.469.275.520.200; C6.405.613.216.200 DMÑDuodenal Ulcer LH LM  HN66 MHÑCurrent Biog-Obit ANcheck tag only; ╥current╙ relates to date of journal (date of publication & year preceding), not to calendar year; 2 or more years before publication date is HISTORICAL BIOGRAPHY; check also tag HISTORY OF MEDICINE, 20TH CENT.; Manual 17.3+ CATALOG: do not use: for indexers only LH  MSA course of study offered by an educational institution. PM66 HN66 MHÑCurriculum ANno qualif MNI2.158 XUÑCompetency-Based Education LH LU  MHÑCushing's Syndrome MNC19.53.181.367 LH  PM65 HN65 MHÑCuspid MNA14.254.860.188 XSCANINE TOOTH LH LS  MSBoard, room, and other personal assistance services generally provided on a long term basis; excludes regular medical care. PM78 HN78 MHÑCustodial Care AN╥board, room & other personal assist serv╙; only /class /econ /hist /legis /man /methods /organ /stand /trends MNE2.472.215; N2.421.589.260 LH  OLuse CUTIS LAXA to search DERMATOLYSIS back thru 1966 PM68; was DERMATOLYSIS 1963-67 HN68; was DERMATOLYSIS 1963-67 MHÑCutis Laxa MNC17.150; C23.205.230 XSDERMATOLYSIS; Dermatomegaly LH LS;  MSA cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. Often occurs as the calcium salt. The citrated calcium salt is used in the treatment of alcoholism. Synonyms: Abstem; amidocyanogen; cyanogenamide; nitrolime; Temposil. HN(79) MHÑCyanamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN420-04-2 PIAmines (66-78); Cyanides (66-78) MND1.620.305.200 XSCalcium Carbimide; Calcium Cyanamide; Citrated Calcium Cyanamide DMÑCyanides LH LS; ; LM  MHÑCyanates ANincludes isocyanates; do not use /analogs /biosyn /defic /physiol MND1.248.497.158.262; D1.620.242 XUÑToluene Diisocyanate LH LU  MHÑCyanides ANincludes isocyanides; do not use /analogs /biosyn /defic /physiol; hydrogen cyanide = HYDROCYANIC ACID MND1.248.497.158.291; D1.620.305 XUÑCyanamide; ÑPotassium Cyanide; ÑSodium Cyanide LH LU; ;  MSA group of compounds having the general formula CH2=C(CN)-COOR; it polymerizes on contact with moisture; used as tissue adhesive; higher homologs have hemostatic and antibacterial properties. PM72 HN72 MHÑCyanoacrylates AND25-26 qualif PIAcetates (66-71); Acrylates (66-71); Tissue Adhesives (66-71) MND2.241.81.69.366; D25.720.259; D25.919.367 XUÑBucrylate LH LU  PM73 HN73(71) MHÑCyanogen Bromide ANdo not use /biosyn /defic /physiol RN506-68-3 PICyanides (66-70) MND1.396.237.404.367; D1.620.367 LH  MS2 alpha-Cyano-17 beta-hydroxy-4,4',17 alpha-trimethylandrost-5-ene-3-one. An androstenolone-nitrile compound with steroidogenesis-blocking activity. HN(75) MHÑCyanoketone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4248-66-2 PIAndrostenols (74); Nitriles (74); Ketosteroids (74) MND4.808.54.79.429.320 DMÑAndrostenols LH LM  MHÑCyanosis ANdo not use for cyanotic heart disease unless especially discussed MNC23.888.284 LH  MSThat branch of learning which brings together theories and studies on communication and control in living organisms and machines. MHÑCybernetics ANonly /hist MNL1.143.283 FXÑBIONICS LH LX  MSMethylazooxymethanol beta-D-glucoside. Carcinogenic and neurotoxic glycoside occurring in a number of plant species, including Cycas revoluta. HN(75) MHÑCycasin AND25-26 qualif; /analogs NIM only RN14901-08-7 PIAzo Compounds (70-74); Glucose (70-74); Methylglycosides (74) MND2.172.80.400.310; D26.191.243 DMÑAzo Compounds LH LM  MS6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid. Cyclohexylamido analog of penicillanic acid. HN(75) MHÑCyclacillin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3485-14-1 PICyclohexylamines (72-74); Penicillins (72-74) MND20.85.99.739.243 XSCiclacillin DMÑPenicillins LH LS LM  OLsearch SWEETENING AGENTS 1966-69 PM71; was CYCLAMATE see under SWEETENING AGENTS 1963-70 HN71(70); was CYCLAMATE see under SWEETENING AGENTS 1963-70; was in Cat D & J 1973-82, was in Cat D only 1963-72 MHÑCyclamates AND25-26 qualif PISweetening Agents (66-69) MND9.818.284; D26.456.609.284 LH  MS3,3,5-Trimethylcyclohexyl mandelate. Direct acting smooth muscle relaxant used to dilate blood vessels; may cause gastrointestinal distress and tachicardia. Synonyms: Cyclospasmol; Spasmocyclon. HN(75) MHÑCyclandelate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN456-59-7 PICyclohexanes (68-74); Mandelic Acids (68-74) MND2.241.223.475.180; D2.241.511.536.180; D18.918.195 DMÑMandelic Acids LH LM  PM73 HN73(64) MHÑCyclazocine ANdo not use /biosyn /defic /physiol RN3572-80-3 MND3.383.113.367; D14.73.153.159; D14.712.168 LH  PM68 HN68 MHÑCyclic N-Oxides ANdo not use /analogs /biosyn /defic /physiol PIOxides (66-67) MND3.661.243 XSHeterocyclic N-Oxides FXÑOxides XUÑTriacetoneamine-N-Oxyl LH LS LX LU  PM68 HN68 MHÑCyclic P-Oxides ANdo not use /analogs /biosyn /defic /physiol PIOxides (66-67) MND3.661.368 XSHeterocyclic P-Oxides FXÑOxides LH LS LX  PM68 HN68 MHÑCyclic S-Oxides ANdo not use /analogs /biosyn /defic /physiol PIOxides (66-67) MND3.661.493 XSHeterocyclic S-Oxides FXÑOxides LH LS LX  PM74 HN74(71) MHÑCyclization ANalmost never IM; no qualif PIChemistry, Organic (66-70) MNH1.181.404.325 LH  MHÑCyclizine ANdo not use /biosyn /defic /physiol RN82-92-8 MND3.383.606.320; D23.136.268; D23.654.432.227 LH  MS5-(1-Cyclohexen-1-yl)-5-ethylbarbituric acid. Short to intermediate duration barbiturate used as hypnotic and sedative; it decomposes quickly in storage, but its calcium salt is more stable. Synonyms: Cavonyl; Cyklodorm; Namuron; Phanodorn; Sonaform. HN(77) MHÑCyclobarbital ANdo not use /biosyn /defic /physiol; /analogs NIM only RN52-31-3 PIBarbiturates (68-76); Cyclohexanes (72-76) MND3.383.742.698.253.200; D14.591.220.246 XSCyclobarbitone; Hexemal; Tetrahydrophenobarbital DMÑBarbiturates LH LS; ; LM  PM74 HN74(72) MHÑCyclobutanes ANincludes cyclobutene; do not use /analogs /biosyn /defic /physiol PICycloparaffins (66-71) MND2.455.426.392.368.201 LH  MS2,2'-Anhydro-1-beta-D-arabinofuranosylcytosine. Congener of cytarabine that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action. Synonyms: Cyclo-C; NSC 145,668. HN(77) MHÑCyclocytidine ANdo not use /biosyn /defic /physiol RN31698-14-3 PIAnhydrides (74-75); Cytarabine (74-76); Cytidine (73) MND13.570.65.300.250; D13.570.685.245.453.250; D22.204.144.384.232; D26.87.242.232 XSAnhydro-Ara-C DMÑCytarabine LH LS LM  MSA homologous group of cyclic glucans consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. HN(80) MHÑCyclodextrins ANproduced by Bacillus species; do not use /analogs /defic /physiol PIDextrins (75-79); Polysaccharides (66-74) MND9.203.698.365.855.400.375 XSCycloamylose; Cycloheptaamylose DMÑDextrins LH LS; LM  HN(72) MHÑCyclofenil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2624-43-3 PICresols (69-71); Cyclohexanes (69-71); Phenols (69-71) MND2.755.239.402; D7.552.344.510.368 DMÑCresols LH LM  MS4,6-Diamino-1-(p-chlorophenyl)-1,2-dihydro-2,2-dimethyl-s-triazine compounds (2:1) with 4,4-methylenebis-(3-hydroxy-2-naphthoic acid). Antimalarial; metabolite of chloroguanide. Synonyms: Chlorazine; Camolar. HN(75) MHÑCycloguanil Pamoate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN609-78-9 PITriazines (72-74) MND3.383.931.285; D21.370.286.275; D26.87.393.210 XSCycloguanil Embonate DMÑTriazines LH LS LM  PM68 HN68 MHÑCycloheptanes ANincludes cycloheptenes, cycloheptadienes, cycloheptatrienes; do not use /analogs /biosyn /defic /physiol MND2.455.426.392.368.284 XUÑBencyclane; ÑTropolone LH LU;  PM68 HN68 MHÑCyclohexanecarboxylic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.268; D2.455.426.392.368.367.218 XUÑAbscissins; ÑAurintricarboxylic Acid; ÑChorismic Acid; ÑDicyclomine; ÑTilidine; ÑTranexamic Acid LH LU; ; ; ; ;  OLuse CYCLOHEXANES to search CYCLOHEXANE back thru 1966 PM75; was CYCLOHEXANE 1963-74 HN75; was CYCLOHEXANE 1963-74 MHÑCyclohexanes ANincludes cyclohexenes, cyclohexadienes; do not use /analogs /biosyn /defic /physiol MND2.455.426.392.368.367 XUÑAY 9944; ÑCuprizone; ÑCyclohexanones; ÑTiletamine LH LU; ; ;  OLuse CYCLOHEXANOLS to search CYCLOHEXANOL back thru 1972 (as Prov 1972-73) PM75; was CYCLOHEXANOL 1974 HN75; was CYCLOHEXANOL 1972-74 (Prov 1972-73) MHÑCyclohexanols ANdo not confuse with CYCLOHEXANONES; do not use /analogs /biosyn /defic /physiol PIAlcohols (66-71); Cyclohexanes (66-71) MND2.33.460; D2.455.426.392.368.367.318 XUÑTramadol LH LU  MSCyclohexane ring substituted by one or more ketones in any position. HN(75) MHÑCyclohexanones ANdo not confuse with CYCLOHEXANOLS; do not use /analogs /biosyn /defic /physiol PICyclohexanes (69-74); Ketones (69-74) MND2.455.426.392.368.367.340; D2.522.400 DMÑCyclohexanes LH LM  PM68 HN68(66) MHÑCycloheximide ANdo not use /biosyn /defic /physiol RN66-81-9 MND3.383.621.808.240; D20.85.62.340; D20.136.73.340 LH  OLuse CYCLOHEXYLAMINES to search CYCLOHEXYLAMINE back thru 1971 (as Prov 1971-72) PM75; was CYCLOHEXYLAMINE 1973-74 HN75; was CYCLOHEXYLAMINE 1971-74 (Prov 1971-72) MHÑCyclohexylamines ANdo not use /analogs /biosyn /defic /physiol PIAmines (66-70); Cyclohexanes (66-70) MND2.92.384; D2.455.426.392.368.367.418 LH  MS1-Aminocyclopentanecarboxylic acid. Amino acid formed by cyclization of leucine. Has cytostatic, immunosuppressive and antineoplastic activities. Frequently encountered synonym: NSC-1026. HN(75) MHÑCycloleucine ANdo not use /defic /physiol; /analogs NIM only RN52-52-8 PIAmino Acids (71-74); Cyclopentanes (70-74) MND2.455.426.392.368.450.350; D12.125.72.170 XS1-Aminocyclopentanecarboxylic Acid DMÑAmino Acids LH LS LM  MHÑCycloparaffins ANdo not use /analogs /biosyn /defic /physiol MND2.455.426.392.368 LH  OLuse CYCLOPENTANES to search CYCLOPENTANE back thru 1966 PM75; was CYCLOPENTANE 1966-74 HN75; was CYCLOPENTANE 1966-74 MHÑCyclopentanes ANincludes cyclopentenes, cyclopentadienes; do not use /analogs /biosyn /defic /physiol MND2.455.426.392.368.450 LH  MS6-Chloro-3-(cyclopentylmethyl)-3,4-dihydro-2H-1,2,4-benzo thiadiazine-7-sulfonamide 1,1-dioxide. Thiazide diuretic also used as an antihypertensive agent. HN(75) MHÑCyclopenthiazide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN742-20-1 PICyclic S-Oxides (74); Cyclopentanes (74); Diuretics, Thiazide (74) MND3.438.174.285; D18.162.276.249; D19.770.224.578.249 XSCyclomethiazide DMÑDiuretics, Thiazide LH LS LM  MS1-Hydroxy-alpha-phenylcyclopentaneacetic acid, 2-(dimethylamino) ethyl ester. Parasympatholytic, anticholinergic used solely to obtain mydriasis or cycloplegia; Synonyms: Cyclogyl; Mydrilate. HN(75) MHÑCyclopentolate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN512-15-2 PICyclopentanes (69-74); Dimethylamines (74); Phenylacetates (69-74) MND2.241.223.601.200; D16.483.200 DMÑPhenylacetates LH LM  MSN,N-Bis(2-chloroethyl)tetrahydro -2H-1,3,2-oxazaphosphorin-2-amine 2-oxide. Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide; used in lymphomas, leukemias, etc; its side effect, alopecia, has been made use of in defleecing sheep; may also cause sterility, terata, mutations and cancer. Synonyms: B 518; Clafen; cyclophosphan(e); Cytoxan; Endoxan; NSC 26271; Procytox; Sendoxan. MHÑCyclophosphamide ANdo not use /biosyn /defic /physiol; Endoxan is a trade name for this RN50-18-0 MND2.455.526.728.650.730.243; D2.705.670.243; D22.204.585.748.243; D22.569.518 LH  OLuse CYCLOPROPANES to search CYCLOPROPANE back thru 1966 PM75; was CYCLOPROPANE 1963-74 HN75; was CYCLOPROPANE 1963-74 MHÑCyclopropanes ANincludes cyclopropenes; do not use /analogs /biosyn /defic /physiol MND2.455.426.392.368.533; D14.166.234 XUÑHypoglycins LH LU  HN(65) MHÑCyclorphan ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4163-15-9 MND3.132.610.422.218; D3.549.686.229; D3.605.497.229; D14.712.189 DMÑMorphinans LH LM  MHÑCycloserine ANdo not use /defic /physiol; /biosyn permitted RN68-41-7 MND20.85.89.260; D20.338.135.306; D26.87.208 LH  MSA group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosupprpessive effects. Proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Synonyms: OL 27-400; S7481/F1; Antibiotic S7481-F1. PM82 HN82 MHÑCyclosporins ANdo not use /analogs /defic /physiol PIImmunosuppressive Agents (66-81); Peptides (66-70); Peptides, Cyclic (71-81) MND12.644.641.235; D22.569.550 XSCyclosporin A; Cyclosporines LH LS;  PM68 HN68 MHÑCyclosteroids ANdo not use /analogs /biosyn /defic /physiol MND4.808.294 LH  PM68 HN68 MHÑCyclostomes ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIEels (66-67) MNB2.493.181 XUÑHagfish; ÑLampreys LH LU;  MSA non-psychotic affective disorder characterized by periods of depression and hypomania. These may be separated by periods of normal mood. OLto search CYCLOTHYMIC PERSONALITY use CYCLOTHYMIC DISORDER back thru 1975 & PERSONALITY DISORDERS 1968-74 HN(81); was CYCLOTHYMIC PERSONALITY see under PERSONALITY DISORDERS 1968-80 MHÑCyclothymic Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.438.100.208 XSCyclothymic Personality DMÑAffective Disorders LH LS LM  MHÑCylindroma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.307 LH  MS3 beta,5,14-Trihydroxy-19-oxo-5 beta-=card-20(22)-enolide 3-D-cymaroside. A cardiotonic cardiac glycoside isolated from Strophanthus kombe Oliv. HN(75) MHÑCymarine ANdo not use /defic /physiol; /analogs NIM only RN508-77-0 PICardanolides (71-74); Cardiac Glycosides (74) MND4.808.155.160.861.250; D9.203.408.180.810.250; D18.222.175.810.250 XSTsimarin; h-Strophanthin; k-Strophanthin-alpha DMÑStrophanthins LH LS; ; LM  PM68 HN68 MHÑCyprinidae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; includes barbel, chub, dace, roach, shiner & tench; note MINNOWS below PIFishes (66-67) MNB2.493.200.244 XSMinnows XUÑCarp; ÑGoldfish; ÑZebrafish LH LS LU; ;  MSAn order of fish with 26 families and over 3,000 species. Included are loaches, suckers, minnows, carp, and electrophorus. PM87 HN87 MHÑCypriniformes ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not confuse with CYPRINODONTIFORMES MNB2.493.200 XSCatastomus; Loaches; Misgurus; Suckers (Fish) LH LS; ; ;  MSAn order of fish with about 12 families and numerous species of both egg laying and livebearing fish. Includes livebearers: jenynsiids (Jenynsiidae), four-eyed fishes (Anablepidae), guppies, mosquitofish, etc. (Poeciliidae and the Mexican livebearer (Goodeidae)). OLuse CYPRINODONTIFORMES to search MOSQUITO FISH back thru 1975 PM87; KILLIFISH & MOSQUITO FISH were see under FISHES 1975-86 HN87; MOSQUITO FISH was see under FISHES 1975-86 MHÑCyprinodontiformes ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not confuse with CYPRINIDAE or CYPRINIFORMES or CYPRINODON see KILLIFISH PIFishes (66-86) MNB2.493.280 XSCyprinodontid; Gambusia; Mosquito Fish; Platyfish; Xiphophorus XUÑKillifish; ÑOryzias; ÑPoecilia LH LS; ; ; ; LU; ;  MS4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine. A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. Synonyms: Anarexol; Antergan; Apetigen; Cyprodin; Periactin. MHÑCyproheptadine ANdo not use /biosyn /defic /physiol RN129-03-3 MND3.383.621.160; D4.615.181.384.340; D23.654.432.237; D23.846.237 LH  PM74 HN74(72) MHÑCyproterone ANdo not use /biosyn /defic /physiol RN2098-66-0 PIAndrogens/AI (68-71) MND4.808.745.432.219; D4.808.883.419; D6.347.65.260 LH  MHÑCyprus MNZ1.542.581.369 LH  MSA malignant neoplasm with accumulation of retained secretions to form cysts. MHÑCystadenocarcinoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.330 LH  MSA benign neoplasm with accumulation of retained secretions to form cysts. OLuse CYSTADENOMA to search CYSTADENOMA, MUCINOUS & CYSTADENOMA, PAPILLARY back thru 1966 PMCYSTADENOMA, MUCINOUS & CYSTADENOMA, PAPILLARY were headings 1963-81 HNCYSTADENOMA, MUCINOUS & CYSTADENOMA, PAPILLARY were headings 1963-81 MHÑCystadenoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.354 LH  MS2,2-Dithio-bis-(ethylamine). Radiation protective agent that interferes with sulfhydryl enzymes; may also protect against carbon tetrachloride liver damage. MHÑCystamine ANdo not confuse with CYSTEAMINE nor Cystamin (a urinary antiseptic); D25-26 qualif RN51-85-4 MND2.92.471.200; D26.763.483 XSCYSTINEAMINE; Decarboxycystine; Diaminodiethyldisulfide LH LS; ;  MS2-Aminoethyl dihydrogenphosphorothioate, sodium salt. Proposed as an adjuvant to cancer chemotherapy; may have radiation protective properties. HN(75) MHÑCystaphos ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3724-89-8 PIEthylamines (72-74); Organothiophosphorus Compounds (72-74) MND2.719.208; D26.763.488 DMÑOrganothiophosphorus Compounds LH LM  OLsearch AMINO ACIDS 1966-70 PM73; was see under AMINO ACIDS 1963-72 HN73(71); was see under AMINO ACIDS 1963-72 MHÑCystathionine RN56-88-2 PIAmino Acids (66-70) MND12.125.95.307; D12.125.119.307; D12.125.166.175 LH  MSA multifunctional pyridoxal phosphate enzyme. In the second stage of cysteine biosynthesis it catalyzes the reaction of homocysteine with serine to form cystathionine with the elimination of water. HN(75) MHÑCystathionine beta-Synthase ANdo not use /analogs; /defic: consider also HOMOCYSTINURIA RNEC 4.2.1.22 PIHomocysteine (73-74); Hydro-Lyases (73-74); Serine (73-74) MND8.586.520.497.290 XSSerine Sulfhydrase; beta-Thionase DMÑHydro-Lyases LH LS; LM  MSA multifunctional pyridoxal phosphate enzyme. In the final step in the biosynthesis of cysteine it catalyzes the cleavage of cystathionine to yield cysteine, ammonia and 2-ketobutyrate. HN(75) MHÑCystathionine gamma-Lyase ANdo not use /analogs; /defic: consider also CYSTATHIONINE /urine (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 4.4.1.1 PICysteine (73-74); Homoserine (73-74); Lyases (73-74) MND8.586.520.280 XSCystathionase; Cysteine Desulfhydrase; Cystine Desulfhydrase; Homoserine Deaminase; Homoserine Dehydratase; gamma-Cystathionase DMÑLyases LH LS; ; ; ; ; LM  MS2-Aminoethanetiol. A radiation protective agent that oxidizes in air to form cystamine; it can be given intravenously or orally to treat radiation sickness. Synonyms: Mercamin(e); Becaptan; MEA. OLto search CYSTEINAMINE use CYSTEAMINE back thru 1967 & MERCAPTOETHYLAMINES 1966 PMCYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66 HNCYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66 MHÑCysteamine ANdo not confuse with CYSTAMINE; D25-26 qualif RN60-23-1 MND2.92.471.562.369; D2.886.489.472.369; D26.763.494 XSCYSTEINAMINE; Mercaptamine LH LS;  MSBeta-Sulfoalanine. An amino acid with a C-terminal sulfonic acid group which has been isolated from human hair oxidized with permanganate. It occurs normally in the outer part of the sheep's fleece, where the wool is exposed to light and weather. HN(75) MHÑCysteic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13100-82-8 PIAlanine (74); Amino Acids, Sulfur (74) MND12.125.166.215 XS3-Sulfoalanine; beta-Sulfoalanine DMÑAmino Acids, Sulfur LH LS; LM  MHÑCysteine ANdo not confuse with CYSTINE RN4371-52-2 MND12.125.166.230 XUÑCarbocysteine LH LU  MSO-Acetyl-L-serine acetate-lyase (adding hydrogen sulfide). Catalyzes the biosynthesis of cysteine in microorganisms and plants from O-acetyl-L-serine and hydrogen sulfide. EC 4.2.99.8. HN(77) MHÑCysteine Synthase ANdo not use /analogs RNEC 4.2.99.8 PICysteine (66-76); Lyases (66-76); Serine (66-76) MND8.586.520.290 XSO-Acetylserine Sulfhydrylase DMÑLyases LH LS LM  MS5-S-Cysteinyldopa. Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in its diagnosis and for the detection of post-operative metastases. Believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells. HN(77) MHÑCysteinyldopa AN/biosyn /physiol permitted RN19641-92-0 PICysteine (66-76); Dopa (66-76) MND2.92.311.242.180; D12.125.72.573.400.180; D12.125.166.230.330 DMÑDopa LH LM  MHÑCystic Duct ANdiseases: coord IM with BILE DUCT DISEASES (NIM); neopl: coord IM with BILE DUCT NEOPLASMS (IM); inflammation: coord IM with CHOLANGITIS (IM); obstruct: coord IM with BILE DUCT OBSTRUCTION, EXTRAHEPATIC (IM); calculi: coord IM with CHOLELITHIASIS (IM) MNA3.159.183.419 LH  MSAn inherited disease of exocrine glands, affecting most characteristically the pancreas, respiratory system, and sweat glands, usually beginning in infancy and typified by chronic respiratory infections, pancreatic insufficiency, and susceptibility to heat prostration. Cirrhosis of liver occurring in childhood is common and may produce portal hypertension, splenomegaly, and hypersplenism. OLuse CYSTIC FIBROSIS to search PANCREATIC CYSTIC FIBROSIS back thru 1966 PM67; was PANCREATIC CYSTIC FIBROSIS 1963-66 HN67; was PANCREATIC CYSTIC FIBROSIS 1963-66 MHÑCystic Fibrosis ANa specific disease entity: do not use for fibrocystic states of various organs; do not use /congen MNC6.689.202; C8.381.187; C16.614.213 XSFIBROCYSTIC DISEASE OF PANCREAS; MUCOVISCIDOSIS; PANCREATIC CYSTIC FIBROSIS FXÑSWEATING LH LS; ; LX  MHÑCysticercosis MNC3.335.190.902.185 FXÑTaeniasis LH LX  MSThe larval form of various tapeworms of the genus Taenia. OLsearch TAENIA 1966-74 HN(75) MHÑCysticercus ANa tapeworm; do not use /blood-csf-urine; infection = CYSTICERCOSIS MNB1.500.736.215.895.286; B1.583.382.286 DMÑTaenia LH LM  MHÑCystine ANdo not confuse with CYSTEINE; /urine = CYSTINURIA RN24645-67-8 MND12.125.95.369; D12.125.119.369; D12.125.166.286 LH  MHÑCystinosis ANdo not use /congen MNC12.777.419.815.368; C18.452.648.851.368 LH  MSAn inherited abnormality of renal tubular transport of dibasic amino acids leading to massive urinary excretion of cystine, lysine, arginine, and ornithine. MHÑCystinuria ANdo not use /congen MNC12.777.419.815.191.250; C18.452.648.66.210.250; C18.452.648.851.191.250 FXÑUrine LH LX  MHÑCystitis ANconsider also PYELOCYSTITIS MNC12.777.103.495 LH  MHÑCystosarcoma Phyllodes ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with BREAST NEOPLASMS (IM) MNC4.557.537.300; C4.557.863.220 LH  MSEndoscopic examination of the interior of the bladder. MHÑCystoscopy ANNIM; do not use /util except by MeSH definition MNE1.341.220; E1.418.310 FXÑBladder LH LX  MHÑCysts ANnon-neoplastic; coord with organ/diseases term; specific terms indented under CYSTS are either neoplastic or non-neopl: check under each; epidermal or epidermoid cyst = EPIDERMAL CYST (non-neoplastic); intestinal gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS; simple mediastinal cyst adjacent to pericardium: index under MEDIASTINAL CYST & do not coord with PERICARDIUM; thymic cyst: index under MEDIASTINAL CYST & do not coord with THYMUS GLAND; congen cystic adenomatoid malform of lung = LUNG /abnorm & not also here nor under ADENOMA; breast cyst = FIBROCYSTIC DISEASE OF BREAST MNC4.182 LH  PM66 HN66 MHÑCytarabine ANdo not use /biosyn /defic /physiol RN147-94-4 MND13.570.65.300; D13.570.685.245.453; D20.388.320; D22.204.144.384; D26.87.242 XSARABINOSYLCYTOSINE; Ara-C; Arabinofuranosylcytosine; CYTOSINE ARABINOSIDE XUÑCyclocytidine LH LS; ; ; LU  OLsearch NUCLEOSIDES 1966-71 PM72; was see under NUCLEOSIDES 1963-71 HN72; was see under NUCLEOSIDES 1963-71 MHÑCytidine AN/biosyn /physiol permitted RN65-46-3 PINucleosides (66-71) MND13.570.685.245; D13.570.800.286 LH  MSCyclic cytidine monophosphates. Include both the 3',5' and 2',3'-isomers. The 3',5'-isomer is formed in mammalian tissue by the enzymatic conversion of cytidine triphosphate and may play a role in the bioregulation of proliferation of normal and malignant cells. The 2',3'-isomer is used as a substrate to assay ribonucleases. HN(80) MHÑCytidine Cyclic Monophosphate AN/biosyn /physiol permitted; DF: CYCL CMP PICytidine Monophosphate (66-74) /AA (75-79); Cytosine Nucleotides (66-79); Nucleotides, Cyclic (74-79) MND13.695.462.280; D13.695.740.246.125; D13.695.827.232.125 XSCyclic CMP; Cytidine Cyclic-2',3'-Monophosphate; Cytidine Cyclic-3',5'-Monophosphate DMÑCytosine Nucleotides LH LS; ; LM  MSCytidine aminohydrolase. Catalyzes the deamination of cytidine, forming uridine. HN(75) MHÑCytidine Deaminase ANdo not use /analogs RNEC 3.5.4.5 PIAminohydrolases (73-74); Cytidine (73-74) MND8.586.277.151.486.250 XSCytidine Aminohydrolase DMÑNucleoside Deaminases LH LS LM  MSCytidine 5'-(trihydrogen diphosphate). A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate. HN(78) MHÑCytidine Diphosphate AN/biosyn /physiol permitted; /analogs NIM only RN63-38-7 PICytosine Nucleotides (66-77) MND13.695.740.246.150; D13.695.827.232.150 XSCDP DMÑCytosine Nucleotides LH LS LM  MSCholine-cytidine-5'-pyrophosphate ester. Donor of choline in biosynthesis of choline-containing phosphoglycerides. Synonym: Nicholine. HN(75) MHÑCytidine Diphosphate Choline ANdo not use /defic /physiol RN987-78-0 PICholine (73-74); Cytosine Nucleotides (69-74) MND2.92.102.232.130; D2.675.276.232.130; D13.695.740.246.150.180; D13.695.827.232.150.180 XSCDP Choline; Citicoline DMÑCholine LH LS; LM  MSThe ester of diacylglycerol with the terminal phosphate of cytidine diphosphate. It serves as an intermediate in the biosynthesis of phosphatidylethanolamine and phosphatidylserine in bacteria. HN(75) MHÑCytidine Diphosphate Diglycerides ANdo not use /analogs PICytosine Nucleotides (72-74); Glycerophosphates (72-74); Phospholipids (72-74) MND9.203.408.620.569.200; D13.695.740.246.150.210; D13.695.827.232.150.210; D13.695.827.708.260 XSCDP Diacylglycerols; CDP Diglycerides; Cytidine Diphosphodiacylglycerols DMÑNucleoside Diphosphate Sugars LH LS; ; LM  MSCytidine (dihydrogen phosphate). A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. OLto search CYTIDYLIC ACIDS use CYTIDINE MONOPHOSPHATE back thru 1975 and CYTOSINE NUCLEOTIDES 1966-74 HN(78); was CYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77 MHÑCytidine Monophosphate AN/biosyn /physiol permitted; /analogs NIM only RN63-37-6 PICytosine Nucleotides (66-74) MND13.695.740.246.370; D13.695.827.232.370 XSCMP; Cytidylic Acid DMÑCytosine Nucleotides LH LS; LM  MSA nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. HN(75) MHÑCytidine Monophosphate N-Acetylneuraminic Acid AN/analogs NIM only RN3063-71-6 PICytosine Nucleotides (74); Neuraminic Acids (74) MND2.241.81.844.562.668.250; D2.241.511.902.562.668.250; D9.203.67.687.668.250; D9.203.811.589.668.250; D13.695.740.246.370.250; D13.695.827.232.370.250 XSCMP Acetylneuraminic Acid; CMP-NANA DMÑSialic Acids LH LS; LM  MSCytidine 5'-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety. Synonym: CRPPP. HN(78) MHÑCytidine Triphosphate AN/biosyn /physiol permitted; /analogs NIM only RN65-47-4 PICytosine Nucleotides (66-77) MND13.695.740.246.700; D13.695.827.232.700 XSCTP DMÑCytosine Nucleotides LH LS LM  PM74 HN74(73) MHÑCytochalasin B ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS RN14930-96-2 PIIndoles (66-72); specific fungus MND3.438.473.231.370; D24.185.926.587.370.370 LH  PM74 HN74(73) MHÑCytochalasins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS PIIndoles (66-72); specific fungus MND3.438.473.231; D24.185.926.587.370 LH  MSCytochromes (electron-transporting proteins) with protoheme or a related heme as the prosthetic group. The prosthetic group is not covalently bound to the protein moiety. PM83 HN83 MHÑCytochrome b AN/biosyn /physiol permitted; do not use /analogs RN9035-37-4 PICytochromes (66-82) MND8.262.200; D12.776.422.220.200 LH  PM73 HN73 MHÑCytochrome C AN/biosyn /physiol permitted; do not use /analogs RN9007-43-6 PICytochromes (66-72) MND8.262.286; D12.776.422.220.286 XSFerricytochrome C; Ferrocytochrome C XUÑCytochrome C-1 LH LS; LU  OLsearch CYTOCHROME C 1973-74 HN(75) MHÑCytochrome C-1 AN/biosyn /physiol permitted; do not use /analogs RN9035-42-1 MND8.262.286.370; D12.776.422.220.286.370 DMÑCytochrome C LH LM  MHÑCytochrome Oxidase ANdo not use /analogs RNEC 1.9.3.1 MND8.586.682.285 XSCytochrome C Oxidase; Cytochrome aa3 LH LS;  PM73 HN73 MHÑCytochrome P-450 AN/biosyn /physiol permitted; do not use /analogs RN9035-51-2 PICytochromes (66-72) MND8.262.453; D8.586.682.420.170; D12.776.422.220.453 LH  MSFerrocytochrome c:hydrogen-peroxide oxidoreductase. A hemeprotein which catalyzes the oxidation of ferrocytochrome c to ferricytochrome c in the presence of hydrogen peroxide. HN(76) MHÑCytochrome Peroxidase ANdo not use /analogs RNEC 1.11.1.5 PICytochrome C (74-75); Peroxidases (74-75) MND8.586.682.732.380 XSCytochrome C Peroxidase DMÑPeroxidases LH LS LM  PM74 HN74(73) MHÑCytochrome Reductases ANdo not use /analogs RNEC 1.6.2. PIOxidoreductases (66-72) MND8.586.682.608.191 XUÑNADH Dehydrogenase LH LU  MHÑCytochromes AN/biosyn /physiol permitted; do not use /analogs MND8.262; D12.776.422.220 LH  MHÑCytodiagnosis ANGEN; NIM; only /instrum /methods /trends /vet MNE1.223.230 FXÑCytological Technics LH LX  MSA branch of genetics which deals with the cytological and molecular behavior of genes and chromosomes during cell division. PM67 HN67 MHÑCytogenetics ANSPEC: avoid as coord; no qualif PIGenetics, Medical (66) MNG5.148 FXÑCHROMOSOME ABNORMALITIES; ÑCHROMOSOME MAPPING; ÑKARYOTYPING LH LX; ;  MSPlant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives. HN(75) MHÑCytokinins ANdo not use /analogs /defic /physiol PIAdenine (73-74); Plant Growth Regulators (73-74) MND11.303.760.265 DMÑPlant Growth Regulators LH LM  PM73 HN73 MHÑCytological Technics ANdo not use /methods /util; avoid: too general; usually NIM CATALOG: do not use /laboratory manuals PICytology (66-72) MNE5.909.262 FXÑCYTODIAGNOSIS LH LX  MHÑCytology ANSPEC only: prefer /cytol: Manual 19.5+; SPEC qualif; /methods = CYTOLOGICAL TECHNICS CATALOG: use with form qualif instead of CELLS /form MNG1.100.433 FXÑCELL NUCLEUS; ÑCYTOPLASM LH LX;  MSInfection with cytomegaloviruses, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the commonest site in children, the lungs in adults. MHÑCytomegalic Inclusion Disease MNC2.256.466.245 XSInclusion Disease; Salivary Gland Virus Disease LH LS;  MSA group of Herpesviridae infecting the salivary glands, liver, spleen, lungs and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. OLuse CYTOMEGALOVIRUSES to search SALIVARY GLAND VIRUSES back thru 1966 PM66 HN66(65); SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78 MHÑCytomegaloviruses ANdo not use /blood-csf-urine /cytol; infection = CYTOMEGALIC INCLUSION DISEASE MNB4.909.204.382.245 XSSalivary Gland Viruses LH LS  MSVisible morphologic changes in cells infected with viruses. Includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. Excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. PM68 HN68(64) MHÑCytopathogenic Effect, Viral ANNIM; only /drug eff /rad eff; do not confuse with CELL TRANSFORMATION, VIRAL: see note there MNE1.223.258; G4.185.515.227 XSCPE FXÑPLAQUE ASSAY LH LS LX  MHÑCytophaga ANin soil & seawater MNB3.350.300.245.370 LH  MSA family of Gram-negative bacteria found in soil and sea-water. PM75 HN75 MHÑCytophagaceae ANin soil & seawater PIBacteria (66-74) MNB3.350.300.245 XUÑCapnocytophaga LH LU  MSAn order of Gram-negative bacteria showing gliding motility on solid surfaces. PM76 HN76 MHÑCytophagales PIBacteria (66-74); Myxobacterales (75) MNB3.350.300 LH  MSA method for the study of certain organic compounds within cells, in situ, by measuring the light intensities of the selectively stained areas of cytoplasm; the compounds studied and their locations in the cells are made to fluoresce and are observed under a microscope. PM86 HN86 MHÑCytophotometry ANonly /instrum /methods PIFlow Cytometry (82-85); Photometry (66-85) MNE5.196.712.382.240; E5.909.262.386 XSMicrofluorometry LH LS  PM65; PROTOPLASM was heading 1963-64 HN65(64); PROTOPLASM was heading 1963-64 MHÑCytoplasm ANA 11 qualif except /cytol; protoplasm goes here MNA11.368 FXÑCytology LH LX  PM65 HN65(64) MHÑCytoplasmic Granules ANA 11 qualif except /cytol; /class permitted; zymogen granules: index under CYTOPLASMIC GRANULES (IM) + ENZYME PRECURSORS (IM) + specific enzyme (IM) MNA11.278.287; A11.368.246 XSSecretory Granules LH LS  MSThe movement of protoplasm within a cell. It serves as an internal transport system for moving essential substances throughout the cell, and in single-celled organisms, such as the amoeba, it is responsible for the movement of the entire cell. Syn: protoplasmic streaming. PM70 HN70(67) MHÑCytoplasmic Streaming ANonly /drug eff /rad eff; includes protoplasmic streaming PICytoplasm (66) MNG4.335.418 LH  MHÑCytosine AN/biosyn /physiol permitted; cytosine deoxyriboside, cytosine deoxyribonucleoside = DEOXYCYTIDINE; cytosine riboside, cytosine ribonucleoside = CYTIDINE RN71-30-7 MND3.383.742.698.421 LH  MHÑCytosine Nucleotides AN/biosyn /physiol permitted; do not use /analogs MND13.695.740.246; D13.695.827.232 XSCytidine Phosphates XUÑCytidine Cyclic Monophosphate; ÑCytidine Diphosphate; ÑCytidine Monophosphate; ÑCytidine Triphosphate LH LS LU; ; ;  MSMajor constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. PM85 HN85 MHÑCytoskeletal Proteins AN/biosyn /physiol permitted; do not use /analogs PICytoplasm (66-79); Cytoskeleton (77-84); Proteins or specific proteins (66-84) MND12.776.220 LH  MSThe network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm. OLuse CYTOSKELETON to search CYTOPLASMIC FILAMENTS back thru 1977 PM86; was CYTOPLASMIC FILAMENTS 1980-85, was MICROFILAMENTS see under CYTOPLASM 1977-79; MYOFILAMENTS (see MICROFILAMENTS, an XU below) & NEUROFILAMENTS & TONOFILAMENTS (both see INTERMEDIATE FILAMENTS, an XU below) were see CYTOPLASMIC FILAMENTS 1980-85 HN86; was CYTOPLASMIC FILAMENTS 1980-85, was MICROFILAMENTS see under CYTOPLASM 1977-79 MHÑCytoskeleton ANA 11 qualif except /cytol PICellular Inclusions (70-76); Cytoplasm (66-76); Organoids (66-76) MNA11.368.250 XSCytoplasmic Filaments; Cytoskeletal Filaments; Microtrabecular Lattice XUÑIntermediate Filaments; ÑMicrofilaments LH LS; ; LU;  PM73 HN73 MHÑCytosol ANA 11 qualif except /cytol PISubcellular Fractions (72) MNA11.904.287 LH  MSThe demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. PM73 HN73(71) MHÑCytotoxicity Tests, Immunologic ANNIM; only /instrum /methods PIspecific cell/IM (66-70); specific immune factor MNE1.223.495.245; E5.478.245 LH  MSThe phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T lymphocytes or by lymphoid or myeloid ╥killer╙ cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. PM78 HN78 MHÑCytotoxicity, Immunologic ANnote category: reserve for process: do not confuse with CYTOTOXICITY TESTS, IMMUNOLOGIC; only /drug eff /rad eff PICytotoxicity Tests, Immunologic (71-77); Immunity, Cellular (70-77); Lymphocytes (66-77); T Lymphocytes (73-79) MNG4.610.270 FXÑKiller Cells, Natural; ÑT Lymphocytes, Cytotoxic; ÑT Lymphocytes, Cytotoxic LH LX; ;  MSSubstances elaborated by microorganisms, plants or animals that are specifically toxic to individual cells; they may be involved in immunity or may be contained in venoms. PM78 HN78 MHÑCytotoxins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS; coord IM with source of cytotoxin (IM or NIM); cytotoxins are biol matter: do not confuse with antineoplastic agents called ╥cytotoxic drugs╙ PICytotoxicity Tests, Immunologic (73-77); Toxins (66-77); specific cell MND24.185.926.235 XSCytolysins LH LS  MHÑCzechoslovakia MNZ1.542.248.301 LH  OLuse D-AMINO ACID OXIDASE to search D-AMINOACID OXIDASE back thru 1966 PM74; was D-AMINOACID OXIDASE 1966-73 HN74; was D-AMINOACID OXIDASE 1963-73 (Prov 1963-65) MHÑD-Amino Acid Oxidase ANdo not use /analogs RNEC 1.4.3.3 MND8.586.682.135.125 XSDextro-Amino Acid Oxidase LH LS  MS5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide. An antineoplastic agent with significant activity against melanomas. Synonyms: DIC; NSC 45388. PM80; was see under TRIAZENES 1975-79 HN80(75); was see under TRIAZENES 1975-79 MHÑDacarbazine ANdo not use /biosyn /defic /physiol RN4342-03-4 PIAmides (66-74); Azo Compounds (66-72); Imidazoles (66-74); Triazenes (72-74) MND2.925.200; D3.383.374.240; D22.204.367 XSDTIC LH LS  MHÑDacryocystitis MNC11.496.221 LH  PM66 HN66 MHÑDactinomycin ANdo not use /defic /physiol RN50-76-0 MND20.85.75.41.371; D22.204.106.38.371 XSACTINOMYCIN D; Meractinomycin LH LS;  MSOne of the Associated Soviet Socialist Republics, situated on the Caspian Sea in South West USSR. HN75 MHÑDagestan MNZ1.542.248.950.820.310; Z1.950.820.310 LH  MHÑDairy Products ANonly /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply MNJ1.341.273 XUÑYogurt LH LU  MHÑDairying ANonly /econ /hist /instrum /methods /stand MNJ1.40.246; J1.576.266 LH  MS17 alpha-Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol. A synthetic steroid with anti-gonadotropic and anti-estrogenic activities. HN(75) MHÑDanazol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN17230-88-5 PIAlkynes (73-74); Hydroxysteroids (73-74); Oxazoles (73-74); Pregnadienes (73-74) MND4.808.745.432.235; D6.347.300.270 DMÑPregnadienes LH LM  MSThe use of dancing for therapeutic purposes. PM80 HN80 MHÑDance Therapy ANSPEC qualif PIDancing (66-79) MNE2.831.230; F4.754.278 LH  MSRhythmic and patterned body movements which are usually performed to music. MHÑDancing ANno qualif MNI3.450.642.287 LH  HN(70) MHÑDandy-Walker Syndrome ANdo not use /congen PICerebral Ventricles/AB (66-69); Hydrocephalus (66-69) MNC10.228.140.602.288 DMÑHydrocephalus LH LM  MSActions which have a high risk of being harmful or injurious to oneself or others. HN(78) MHÑDangerous Behavior ANno qualif PIViolence (68-77) MNF3.126.842.89.734.110 XSBehavior, Dangerous DMÑViolence LH LS LM  MS9,10-Dihydro-10-(1-methyl-4-piperidylidene)- 9-anthrol. Antagonist or inhibitor of serotonin, probably due to receptor blockade; proposed as antidepressant; used in the study of serotonergic mechanisms. HN(80) MHÑDanitracen ANdo not use /biosyn /defic /physiol; /analogs NIM only RN31232-26-5 PIAnthracenes (66-79); Piperidines (66-79) MND3.383.621.170; D4.615.117.500; D23.846.251 XSWA 335 DMÑPiperidines LH LS LM  PM72 HN72 MHÑDansyl Compounds AND25-26 qualif; DF: DANSYL CPDS PINaphthalenes (66-71); Sulfonic Acids (66-71) MND2.886.590.192; D4.615.638.204; D26.550.166 XSDimethylaminonaphthalenesulfonyl Compounds LH LS  MS1-[[5-(p-Nitrophenyl)furfurylidene]amino]hydantoin. Skeletal muscle relaxant that acts by interfering with calcium metabolism in the muscle fiber; used in spasticity and other neuromuscular abnormalities. Synonyms: Dantrium; F 368; F 440. PM80; was see under HYDANTOINS 1975-79 HN80(75); was see under HYDANTOINS 1975-79 MHÑDantrolene ANdo not use /biosyn /defic /physiol RN7261-97-4 PIHydantoins (66-74) MND3.383.374.411.287; D17.426.287 LH  MSA genus of minute freshwater brachiopod crustaceans of the order Cladocera. PM72 HN72 MHÑDaphnia AN/microbiol /parasitol permitted PICrustacea (66-71) MNB1.131.365.405 LH  PMDIASONE was see under SULFONES 1963-74 MHÑDapsone ANdo not use /biosyn /defic /physiol RN80-08-0 MND2.886.590.263; D20.661.370 XSDIAMINODIPHENYLSULFONE; SULFONYLDIANILINE XUÑAcedapsone LH LS; LU  PM72 HN72(68) MHÑDark Adaptation ANonly /drug eff /rad eff PIAdaptation, Ocular (66-67) MNG11.697.154.371 LH  MHÑDarkness ANonly /adv eff MNH1.671.606.288 LH  MSSystematic gathering of data for a particular purpose from various sources including questionnaires, interviews, observation, existing records, and electronic devices. Usually preliminary to statistical analysis of the data. PM80 HN80 MHÑData Collection ANonly /econ /hist /instrum /man /methods /stand /trends MNL1.280 XSSurvey Methods FXÑHealth Surveys; ÑMedical History Taking LH LS LX;  MSThe visual display of data in a man-machine system; an example is a cathode ray tube on which certain data can be called for from the computer and displayed on the screen. PM66 HN66(64) MHÑData Display ANno qualif MNF2.784.412.221; L1.700.568.810.210 XSINFORMATION DISPLAY LH LS  MSSoftware designed to store, manipulate, manage, and control data for specific uses. HN(87) MHÑDatabase Management Systems MNL1.700.508.300.680.110; L1.700.568.810.280; N4.452.515.110 DMÑSoftware LH LM  HN(67); was see under COMPUTERS 1967-74 MHÑDataphone ANonly /econ /legis /stand /supply /util (if by MeSH definition) PIComputers (66) MNL1.178.847.698.372 DMÑTelephone LH LM  MSVery toxic anthracycline aminoglycoside antibiotic isolated from Streptomyces peucetius and others, used in treatment of leukemias and other neoplasms. Synonyms: Cerubidine; Daunoblastin; Ondena; NSC 82151. OLuse DAUNORUBICIN to search DAUNOMYCIN back thru 1966 PM80; was DAUNOMYCIN 1966-79; CARMINOMYCIN was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79; NOGALAMYCIN was see under NAPHTHACENES 1976-80 HN80; was DAUNOMYCIN 1964-79 (Prov 1964-65) MHÑDaunorubicin ANdo not use /defic /physiol RN20830-81-3 MND9.203.408.51.212; D20.85.75.354; D22.204.106.356 XSDaunomycin; Rubidomycin; Rubomycin XUÑCarubicin; ÑNogalamycin LH LS; ; LU;  MSInstitutional health care of patients during the day. The patients return home at night. PM68 HN68 MHÑDay Care ANcare to patients hospitalized only during day-time hours; for children in day-care schools use CHILD DAY CARE CENTERS or SCHOOLS, NURSERY; only /econ /legis /methods /organ /psychol /stand /trends /util (if by MeSH definition) PIHalfway Houses (66-67); Outpatient Clinics, Hospital (66-67) MNE2.472.246; N2.421.589.309 LH  PM68 HN68(65) MHÑDDD ANdo not use /biosyn /defic /physiol; do not confuse with O,P-DDD; TN 111 for eff on insects RN72-54-8 MND2.455.526.439.294; D5.723.491.491.254 XSDICHLORODIPHENYLDICHLOROETHANE; TDE LH LS;  PM74 HN74(73) MHÑDDE ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN72-55-9 PIInsecticides (66-72) MND2.455.526.439.315; D5.723.491.491.287 XSDDX LH LS  MHÑDDT ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN50-29-3 MND2.455.526.439.337; D5.723.491.491.320 LH  MSSyndrome characterized by mental retardation and multiple abnormalities. PM66 HN66(64) MHÑDe Lange's Syndrome ANtypus degenerativus amstelodamensis; be careful: do not confuse with De Lange's congen musc hypertrophy: see syndrome book or Curr Med Inform & Terminol for descript; do not use /congen /drug eff /physiol /rad eff MNC10.496.193; C16.131.77.272; F3.709.346.189 LH  OLsearch CELLULOSE 1968-74 (as Prov 1968-69) HN(75)(68-69) MHÑDEAE-Cellulose ANdo not use /biosyn /defic /physiol RN9013-34-7 MND9.203.698.365.180.247 DMÑCellulose LH LM  MSDiethylaminoethyldextran. Used as a support for ion-exchange chromatography. HN(75); was see under DEXTRAN 1975-78 MHÑDEAE-Dextran ANdo not use /biosyn /defic /physiol; /analogs NIM only RN9015-73-0 PIDextrans (72-74); Diethylamines (74) MND9.203.698.365.272.250 DMÑDextrans LH LM  MSA condition in which the sense of hearing in both ears is not functional for ordinary purposes of life. The hearing level for speech is approximately 71 decibels I.S.O. (International Organization for Standardization) or 61 db A.S.A. (American Standards Association) or greater. Syn: severe hearing loss. OLuse DEAFNESS to search DEAF-MUTISM back thru 1966 PMDEAF-MUTISM was heading 1963-79 HNDEAF-MUTISM was heading 1963-79 MHÑDeafness ANtotal loss of hearing in both ears: differentiate from HEARING LOSS, BILATERAL ( = partial hearing loss in both ears), from HEARING LOSS, PARTIAL ( = ╥partial deafness╙ or ╥hard of hearing╙) & from HEARING DISORDERS ( = general or unspecified); see various specific terms under DEAFNESS, at ╥hearing loss╙ & at various indentions in Cat C9; differentiate DEAFNESS, SENSORINEURAL (X ref) (total deafness) from HEARING LOSS, SENSORINEURAL (partial sensorineural loss) MNC9.218.458.288; C10.597.257.443.271; C23.888.592.257.443.271 XSDeaf-Mutism; Deafness, Sensorineural; Hearing Loss, Extreme FXÑHEARING AIDS; ÑLipreading LH LS; ; LX;  MSSensorineural hearing loss which develops over a period of hours or a few days, varying in severity from mild to total. PM79 HN79 MHÑDeafness, Sudden PIDeafness (66-78) MNC9.218.458.288.460 XSSudden Deafness LH LS  PM74 HN74(71) MHÑDealkylation ANalmost never IM; no qualif; enzymatic dealkylation: coord NIM with specific enzyme (IM) + substrate (NIM) PIAlkylation (66-70) MNH1.181.404.371 LH  PM74 HN74(71) MHÑDeamination ANalmost never IM; no qualif; enzymatic deamination: coord NIM with specific enzyme (IM) + substrate (NIM) PIChemistry, Organic (66-70) MNH1.181.404.413 LH  MSN,N-Dimethyl-2-hydroxyethylamine. Possible acetylcholine precursor; used for general debility, mild depression and movement disorders; as various salts and drug combinations. Synonyms: Atrol; Deaner; Diforene; Otrun; Tonibral. HN(63) MHÑDeanol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN108-01-0 MND2.33.329.291.274; D2.92.63.291.274; D15.236.122.322 XSDimethylaminoethanol DMÑEthanolamines LH LS LM  MHÑDeath ANIM; no qualif; /mortal is available with Cat C, F, E; do not confuse with MORTALITY, a statist concept: DEATH is the biol or physiol, psychol, philosophical concept MNC23.240 FXÑATTITUDE TO DEATH; ÑHOMICIDE; ÑMORTUARY PRACTICE; ÑTERMINAL CARE XUÑThanatology LH LX; ; ; LU  MSOfficial records of individual deaths including the cause of death certified by a physician, and any other required identifying information. MHÑDeath Certificates ANonly /hist MNN4.452.859.264 LH  MHÑDeath, Sudden ANonly /etiol /occur /pathol /vet; consider also SUDDEN INFANT DEATH MNC23.240.322 FXÑRESUSCITATION LH LX  MHÑDebridement ANdo not use /util except by MeSH definition MNE4.176 FXÑWounds and Injuries LH LX  HN(73) MHÑDebrisoquin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1131-64-2 PIAntihypertensive Agents (66-72); Isoquinolines (69-72) MND3.438.531.205; D16.848.415.280; D18.162.212 DMÑIsoquinolines LH LM  PM65 HN65 MHÑDecalcification Technic ANonly /instrum CATALOG: do not use /laboratory manuals MNE5.909.432.288 LH  HN(65) MHÑDecalcification, Pathologic MNC18.452.174.289 DMÑCalcium Metabolism Disorders LH LM  MHÑDecamethonium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: DECAMETHONIUM CPDS MND2.92.102.558.372; D2.675.276.558.372; D17.688.538.372 LH  MSSalts and esters of the 10-carbon monocarboxylic acid-decanoic acid. HN(75) MHÑDecanoates ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74) MND2.241.81.407.250.200; D10.516.251.175.200 DMÑDecanoic Acids LH LM  MS10-carbon saturated monocarboxylic acids. PM75 HN75 MHÑDecanoic Acids ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74) MND2.241.81.407.250; D10.516.251.175 XSCapric Acids XUÑDecanoates LH LS LU  HN(71) MHÑDecarboxylation ANalmost never IM; no qualif; enzymatic decarboxylation: coord NIM with CARBOXY-LYASES (IM) + substrate (NIM) or specific carboxy-lyase (IM) PIChemistry, Organic (66-70) MNH1.181.404.454 DMÑChemistry, Organic LH LM  OLsearch ACCELERATION 1966-74 HN(75) MHÑDeceleration ANonly /adv eff MNH1.671.538.107.373 DMÑAcceleration LH LM  MSA peculiar neurologic condition elicited in vertebrates only as a consequence of the removal of the brain; it consists of exaggerated postures, grossly abnormal reflexes, convulsions, and extreme muscular rigidity and spasticity. MHÑDecerebrate State AN╥brain-isolated╙, ╥encephale isole╙, ╥pithed╙, ╥spinal╙ as in ╥spinal cat╙, ╥cerveau isole╙ go here MNC10.597.305; C23.888.592.298 XSRigidity, Decerebrate LH LS  MHÑDecidua ANcheck the tags FEMALE & PREGNANCY: ╥deciduoma╙ goes here but do not coord with a neopl heading MNA5.360.319.679.490.373; A16.759.289 LH  MSThe process of making a selective intellectual judgment when presented with several complex alternatives consisting of several variables, and usually defining a course of action or an idea. MHÑDecision Making ANread MeSH definition: do not use for a physician making a diagnostic decision on a disease: this is /diag or if GEN, DIAGNOSIS or DIAGNOSIS, DIFFERENTIAL; only /drug eff /physiol /rad eff MNF2.463.785.373 FXÑGame Theory; ÑPolicy Making LH LX;  MSUse of an interactive computer system designed to assist the physician or other health professional in choosing between certain relationships or variables for the purpose of making a diagnostic or therapeutic decision. PM87 HN87 MHÑDecision Making, Computer-Assisted ANno qualif PIComputer Programs (83-86); Computers (66-86); Decision Making (66-86) MNL1.700.508.100 XSComputer-Assisted Decision Making; Medical Decision Making, Computer-Assisted LH LS;  MSThe process by which decisions are made in an institution or other organization. PM86 HN86 MHÑDecision Making, Organizational ANno qualif PIDecision Making (66-85) MNN4.452.190 XSOrganizational Decision Making FXÑPolicy Making LH LS LX  MSComputer-based systems that enable management to interrogate the computer on an ad hoc basis for various kinds of information in the organization, which predict the effect of potential decisions. HN(87) MHÑDecision Support Systems, Management MNL1.700.508.300.680.135; N4.452.515.135 DMÑManagement Information Systems LH LM  MSA theoretical technic utilizing a group of related constructs to describe or prescribe how individuals or groups of people choose a course of action when faced with several alternatives and a variable amount of knowledge about the determinants of the outcomes of those alternatives. PM80 HN80 MHÑDecision Theory ANno qualif MNF4.669.880.308; H1.548.263 FXÑOperations Research LH LX  MSDecompression external to the body, most often the slow lessening of external pressure on the whole body (especially in caisson workers, deep sea divers, and persons who ascend to great heights) to prevent decompression sickness. Use also for sudden accidental decompression. Do not use for surgical (local) decompression or decompression applied through body openings. OLto search DECOMPRESSION, EXPLOSIVE use DECOMPRESSION back thru 1981 & ATMOSPHERIC PRESSURE 1966-80 (as Prov 1966-74) PM80; was see under PRESSURE 1975-79; DECOMPRESSION, EXPLOSIVE was indexed under ATMOSPHERIC PRESSURE 1975-80 HN80(75); was see under PRESSURE 1975-79; DECOMPRESSION, EXPLOSIVE was see ATMOSPHERIC PRESSURE 1978-80, was see under ATMOSPHERIC PRESSURE 1975-76, was Prov 1964-74 MHÑDecompression ANrestrict to ╥decompression external to the body╙: not for surg decompression ( = /surg); only /adv eff /instrum /methods /vet MNE5.245; H1.671.691.250 XSDecompression, Explosive XUÑLower Body Negative Pressure LH LS LU  MHÑDecompression Sickness MNC21.866.120.248 XSBends; Caisson Disease FXÑAerospace Medicine; ÑAtmospheric Pressure; ÑDiving LH LS; LX; ;  MHÑDecontamination ANonly /econ /hist /instrum /methods /stand MNG3.850.275 FXÑChemical Warfare LH LX  MSEthyl-6-(decyloxy)-7-ethoxy-4-hydroxy-3-quinolinecarboxylate. A coccidiostat for poultry. Synonym: Deccox. HN(75) MHÑDecoquinate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN18507-89-6 PIEthers (72-74); Carboxylic Acids (72-74); Quinolines (72-74) MND3.438.810.350.250; D21.370.400.300 DMÑHydroxyquinolines LH LM  MHÑDecubitus Ulcer MNC17.893.289 XSBEDSORES LH LS  MSDeductibles are the amounts paid by the insured under a health insurance contract before benefits become payable; coinsurance is the provision under which the insured pays part of the medical bill, usually according to a fixed percentage, when benefits become payable. PM68 HN68 MHÑDeductibles and Coinsurance ANonly /class /legis /trends; DF: DEDUCTIBLES PIInsurance, Health (66-67) MNN3.219.521.576.343.164 XSCoinsurance; Cost Sharing Insurance LH LS;  PM68 HN68 MHÑDeer ANincludes elk or wapiti, moose, REINDEER & CARIBOU; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIArtiodactyla (66-67) MNB2.649.77.380.373 LH  HN(72) MHÑDeet ANdo not use /biosyn /defic /physiol; /analogs NIM only RN134-62-3 PIBenzoates (66-71); Insect Repellents (66-71) MND2.65.277.194; D2.241.223.106.162.194; D5.723.441.373 DMÑBenzamides LH LM  MHÑDefecation ANonly /drug eff /rad eff; consider also CONSTIPATION & DIARRHEA MNG10.261.206 FXÑENCOPRESIS; ÑFECAL INCONTINENCE LH LX;  MSViruses which lack a complete genome so that they cannot completely replicate or cannot form a protein coat. Some are host-dependent defectives, i.e., they can replicate only in cell systems which provide the particular genetic function which they lack; others, called satellite viruses, are able to replicate only when their genetic defect is complemented by a helper virus. OLuse DEFECTIVE VIRUSES to search DEFECTIVE VIRUS back thru 1967 (as Prov 1967-72) PM75; was DEFECTIVE VIRUS 1973-74 HN75; was DEFECTIVE VIRUS 1967-74 (Prov 1967-72) MHÑDefective Viruses ANdo not use /cytol PIspecific virus MNB4.265 XSIncomplete Virus LH LS  MSUnconscious process used by an individual or a group of individuals in order to cope with impulses, feelings or ideas which are not acceptable at their conscious level; various types include reaction formation, projection and self reversal. MHÑDefense Mechanisms ANno qualif MNF1.393; F3.407 XUÑNegativism; ÑRationalization LH LU;  MSThe alterations of modes of medical practice, induced by the threat of liability, for the principle purposes of forestalling lawsuits by patients as well as providing good legal defense in the event that such lawsuits are instituted. HN(75) MHÑDefensive Medicine ANonly /econ /hist /legis /trends MNI1.880.604.583.524.300; N3.706.535.606.300 XSDefensive Practice DMÑMalpractice LH LS LM  PM65 HN65 MHÑDeferoxamine AND25-26 qualif RN70-51-9 MND26.241.194 XSDESFERRIOXAMINE LH LS  MHÑDeficiency Diseases ANGEN only: prefer /defic with specific Cat D terms; Manual 23.35+; TN 194: as NIM & differentiation from METABOLIC DISEASES or METABOLISM, INBORN ERRORS; do not confuse with NUTRITION DISORDERS: DEFICIENCY DISEASES results from deficient intake MNC18.654.223 LH  OLsearch HERBICIDES 1969-74 HN(75) MHÑDefoliants, Chemical ANdo not use /analogs /biosyn /defic /physiol MND5.723.366.181 DMÑHerbicides LH LM  MHÑDeglutition ANonly /drug eff /rad eff MNG10.261.248 XSSWALLOWING LH LS  MHÑDeglutition Disorders MNC6.306.199 XSDysphagia XUÑPlummer-Vinson Syndrome LH LS LU  MHÑDehydration ANnote category: a disease; differentiate from DESICCATION, a technic for removing moisture from matter; /ther: consider also ORAL REHYDRATION THERAPY see FLUID THERAPY; rehydration solutions: index under FLUID THERAPY & not also under SOLUTIONS MNC18.452.950.179 FXÑBody Fluids; ÑTHIRST LH LX;  MSCatalyzes the hydrolysis of the gamma lactone, dehydroascorbate, to diketogulonate. HN(75); was see under ESTERASES 1975 MHÑDehydroascorbatase ANdo not use /analogs RNEC 3.1.1.- PIAscorbic Acid (72-74); Esterases (72-74); Ketones (72-74) MND8.586.277.352.100.220 DMÑCarboxylic Ester Hydrolases LH LM  MSthreo-2,3-Hexodiulosonic acid gamma lactone. The reversibly oxidized form of ascorbic acid. Has antiscorbutic activity in man on oral ingestion. HN(75) MHÑDehydroascorbic Acid ANdo not use /biosyn /physiol RN490-83-5 PIAscorbic Acid (69-74) MND2.241.511.902.107.260; D2.540.260; D9.203.811.100.260; D11.786.100.260; D2.241.81.844.107.260 DMÑAscorbic Acid LH LM  MSCholesterol which has an additional double bond in any position. 24-Dehydrocholesterol is DESMOSTEROL. The other most prevalent dehydrocholesterol is the 7-isomer. This compound is a precursor of cholesterol and of vitamin D3. OLsearch DEHYDROCHOLESTEROL under CHOLECALCIFEROLS 1966 HN(78); DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66 MHÑDehydrocholesterols ANdo not confuse with DIHYDROCHOLESTEROL; 24-DEHYDROCHOLESTEROL is DESMOSTEROL; do not use /analogs PICholecalciferols (66); Cholestadienols (74-77); Cholesterol (66-77) MND4.808.247.222.222.347.200; D4.808.247.808.197.250; D10.516.851.208.320 DMÑCholestadienols LH LM  MS3,7,12-Triketo-5-beta-cholanic acid. Semisynthetic bile acid made from cholate; used as cholagogue, hydrocholeretic, diuretic and as diagnostic aid. Synonyms: Acolen; Bilidren; Decholin; Hykolex; Procholon; Roladek. MHÑDehydrocholic Acid ANdo not use /biosyn /defic /physiol RN81-23-2 MND4.808.221.430.265; D19.316.246.225.261 XSDehydrocholate; Ketocholanic Acid; Triketocholanic Acid; Trioxocholate LH LS; ; ;  MS2,3,-Dehydroemetine. Amebicide, derivative of emetine, but less cardiotoxic due to faster elimination from the body; it has also been used in Leishmaniasis and trematode infections and may have some antineoplastic action. Synonyms: Dametin; Efemetin; Mebadin. HN(76) MHÑDehydroemetine ANdo not use /biosyn /defic /physiol RN4914-30-1 PIEmetine (70-74) /AA(75) MND3.132.442.405.150; D3.438.531.321.150; D21.370.107.380.266 DMÑEmetine LH LM  MHÑDehydroepiandrosterone AN/physiol permitted RN53-43-0 MND4.808.54.79.429.373; D4.808.578.502.372; D6.472.40.502.372; D6.472.79.372; D6.472.866.154.372 XSDEHYDROISOANDROSTERONE; Prasteron LH LS;  MSThe practice of caring for individuals in the community, rather than in an institutional environment with resultant effects on the individual, the individual's family, the community, and the health care system. PM79 HN79 MHÑDeinstitutionalization AN╥caring for individuals in the community, rather than in an institutional environment╙; only /econ /hist /legis /methods /stand /trends /util (if by MeSH definition) MNN2.421.589.508.310 LH  OLsearch VESTIBULAR NUCLEI 1967-74 HN(75) MHÑDeiters Nucleus ANdo not use /innerv MNA8.186.211.132.810.616.270 DMÑVestibular Nuclei LH LM  MSA subjective feeling that an experience which is occurring for the first time has been experienced before. PM68 HN68 MHÑDeja Vu ANno qualif; in translations use accents: deja vu MNF3.126.185.597.457 LH  MHÑDelaware MNZ1.107.567.875.200 LH  MHÑDelayed-Action Preparations ANIM for general only: only /adv eff /anal (with caution) /stand /supply; NIM with specific drug IM: no qualif MND26.394.225.276 XSDepot Preparations; PROLONGED-ACTION PREPARATIONS; SUSTAINED-RELEASE PREPARATIONS; Timed-Release Preparations LH LS; ; ;  MSA disorder of the sensorium, in which orientation is impaired, the critical faculty blunted or lost and thought content is irrelevant and incoherent. MHÑDelirium ANthis is not the French ╥delire╙ ( = DELUSIONS); do not use /congen /drug eff /physiol /rad eff MNC10.597.332; C23.888.592.324; F3.126.185.259; F3.709.680.610.308 LH  MHÑDelivery ANthe MD or the baby, not the mother; mother is probably LABOR; only /instrum /methods /vet; ╥tokolysis╙: translate as ╥tocolysis╙ & index probably as LABOR, PREMATURE /prev MNE4.819.774.457 FXÑBIRTH INJURIES; ÑDYSTOCIA; ÑLabor Presentation XUÑHome Childbirth; ÑVersion, Fetal LH LX; ; LU;  MSConcerned with all aspects of providing and distributing health services to a patient population. PM71 HN71 MHÑDelivery of Health Care ANPublic Law 91-515; only /econ /legis /man /organ /stand /trends CATALOG: /geog /form PIPersonal Health Services (68-70) MNN4.590.374 XSDelivery of Dental Care; HEALTH CARE DELIVERY; Health Care Systems FXÑCONSUMER PARTICIPATION LH LS; ; LX  MSHospital units equipped for childbirth. HN(82) MHÑDelivery Rooms ANdo not use /educ /methods MNN2.278.388.700.310 DMÑOperating Rooms LH LM  MSAn iterative questionnaire designed to measure consensus among individual responses. HN(80) MHÑDelphi Technic ANto measure consensus; no qualif PIQuestionnaires (73-79) MNL1.280.800.310 DMÑQuestionnaires LH LM  MSA defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic active hepatitis. PM86 HN86 MHÑDelta Agent ANdo not use /blood-csf-urine /cytol; infection = DELTA INFECTION PIHepatitis B (77-85); Hepatitis B Antigens (77-85) MNB4.265.270; B4.909.403.270; B4.909.920.270 XSHepatitis D Virus LH LS  MSHepatitis caused by the delta agent in association with hepatitis B and chronic active hepatitis. It is endemic in some European countries and is seen in drug users, hemophiliacs, and polytransfused persons. PM86 HN86 MHÑDelta Infection ANa hepatitis caused by delta agent: note X refs PIHepatitis B (77-85); Hepatitis B Antigens (77-85); Hepatitis, Viral, Human (77-85) MNC2.440.270; C6.552.380.705.270 XSDelta Hepatitis; Delta Superinfection; Hepatitis D; Hepatitis, Delta LH LS; ; ;  MSWaves in the electroencephalogram which have a frequency of less than 4 cycles per second. HN(75) MHÑDelta Rhythm ANno qualif MNE1.236.257.401.530; E1.399.277.530 XSElectroencephalography, Delta Rhythm DMÑElectroencephalography LH LS LM  MSA nonapeptide which is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal. PM87 HN87 MHÑDelta Sleep-Inducing Peptide AN/biosyn /physiol permitted RN69431-45-4 PIOligopeptides (73-86); Peptides (66-72) MND12.644.456.300; D12.776.641.650.200 XSDSIP LH LS  MSA false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates. MHÑDelusions ANthis is the French ╥delire╙; do not use /drug eff /physiol /rad eff MNF3.126.185.304; F3.709.680.610.360 LH  PM73 HN73(72) MHÑDemecolcine ANdo not use /defic /physiol; /biosyn permitted if by plant; = colcemide RN477-30-5 PIAlkaloids (66-71); Antineoplastic Agents (66-71); Colchicine (66-71) MND3.132.225.374; D22.204.179.290 LH  MSAn organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The deficit is multifaceted and involves memory, judgment, and abstract thought. Behavioral and personality changes also occur. PM81 HN81 MHÑDementia ANdo not use /drug eff /physiol /rad eff MNF3.709.680.610.392 LH  MSAn organic mental disorder characterized by progressive brain deterioration and development of socially inappropiate and unacceptable behavior. It usually occurs in the fourth or fifth decade of life. OLuse DEMENTIA, PRESENILE to search PSYCHOSES, PRESENILE & PICK'S DISEASE OF BRAIN back thru 1966 PM67; PSYCHOSES, PRESENILE was heading 1963-72; PICK DISEASE OF BRAIN was PICK'S DISEASE OF BRAIN see under DEMENTIA, PRESENILE 1967-80, was PICK'S DISEASE OF BRAIN see under PSYCHOSES, PRESENILE 1963-66 HN67; PSYCHOSES, PRESENILE was heading 1963-72; PICK'S DISEASE OF BRAIN was see under DEMENTIA, PRESENILE 1967-80, was see under PSYCHOSES, PRESENILE 1963-66 MHÑDementia, Presenile ANdo not use /drug eff /physiol /rad eff MNC10.228.140.382; F3.709.680.610.392.300 XSDementia, Primary Degenerative, Presenile; Pick Disease of Brain; Psychoses, Presenile; Sclerosis, Presenile LH LS; ; ;  MSPsychotic organic mental disorder occurring usually after 65, and characterized by progressive dementia associated with generalized brain atrophy. OLuse DEMENTIA, SENILE to search PSYCHOSES, SENILE back thru 1966 PM79; was PSYCHOSES, SENILE 1963-78 HN79; was PSYCHOSES, SENILE 1963-78 MHÑDementia, Senile ANdo not use /drug eff /physiol /rad eff; senile only; presenile = DEMENTIA, PRESENILE MNC10.228.140.390; F3.709.680.610.392.360 XSDementia, Multi-Infarct; Dementia, Primary Degenerative, Senile; Psychoses, Senile LH LS; ;  MHÑDemethylchlortetracycline ANdo not use /defic /physiol RN127-33-3 MND20.85.868.224 XSDemeclocycline LH LS  MS7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one. Intermediate in the metabolism of diazepam to oxazepam; may have actions similar to those of diazepam. Synonyms: Desalkylprazepam; Desoxydemoxepam; Desoxydiazepam; Methyloxazepam; RO 5-2180. HN(77) MHÑDemethyldiazepam ANdo not use /biosyn /defic /physiol RN1088-11-5 PIDealkylation (73-75); Diazepam (73-76) MND3.438.79.80.70.216.250; D15.236.872.659.191.275.298 XSDealkylprazepam; Deoxydemoxepam; Desmethyldiazepam DMÑDiazepam LH LS; ; LM  MSA system of government in which there is free and equal participation by the people in the political decision-making process. MHÑDemocracy ANno qualif MNI1.696.374 LH  MSStatistical interpretation and description of a population with reference to distribution, composition or structure. MHÑDemography ANthe field of population studies; do not confuse with the POPULATION itself; no qualif CATALOG: /geog /form MNI1.782.616.249; N1.224 XSPopulation Distribution LH LS  OLuse DEMYELINATING DISEASES to search DEMYELINATION back thru 1966 PM79; was DEMYELINATION 1963-78; NEUROMYELITIS OPTICA was see under MULTIPLE SCLEROSIS 1963-78 HN79; was DEMYELINATION 1963-78 MHÑDemyelinating Diseases ANnot restricted to central nerv syst MNC10.228.337 XUÑNeuromyelitis Optica LH LU  PM65 HN65(64) MHÑDendrites ANA 11 qualif except /cytol; do not confuse with DENDRITIC CELLS MNA8.663.256; A11.671.240 LH  MSImmunocompetent cells of the lymphoid and hemopoietic systems and skin; also called interdigitating, reticular, and veiled cells. They function morphologically and phenotypically by presenting or processing antigens, thereby stimulating cellular immunity. PM87 HN87 MHÑDendritic Cells AN╥immunocompetent cells of the lymphoid & hemopoietic systems & skin╙; A 11 qualif; do not confuse with DENDRITES PIAntigen-Presenting Cells (85-86); Epidermis (78-86); Langerhans Cells (69-86); Lymph Nodes (75-86); Skin (66-86) MNA11.66.270; A11.436.270; A15.382.66.270 XSDendritic Cells, Follicular; Interdigitating Cells; Veiled Cells LH LS; ;  PM65 HN65(64) MHÑDenervation ANNIM when a study technic; do not use /util (except by MeSH definition); MUSCLE DENERVATION is also available MNE4.530.324 LH  MSAn acute infectious, eruptive, febrile disease caused by an arthropod-borne virus. MHÑDengue MNC2.81.270; C2.782.417.214; C2.782.930.270 XSHemorrhagic Fever, Dengue LH LS  MSA Flavivirus (group B arbovirus) which causes an acute febrile hemorrhagic disease in man. PM66; was see under ARBOVIRUS 1965, was see under ARBORVIRUSES 1963-64 HN66; was see under ARBOVIRUS 1965, was see under ARBORVIRUSES 1963-64 MHÑDengue Virus ANdo not use /blood-csf-urine /cytol; infection = DENGUE MNB4.909.777.923.377.270 XSBreakbone Fever Virus LH LS  MSRefusal to admit the truth or reality of a situation or experience. PM75 HN75 MHÑDenial (Psychology) ANno qualif; DF: DENIAL PIDefense Mechanisms (66-74) MNF1.393.200; F3.407.200 LH  MHÑDenmark MNZ1.542.808.224 XSFaeroe Islands LH LS  MSAnomaly of the tooth, found chiefly in upper lateral incisors; characterized by invagination of the enamel at the incisal edge. OLsearch TOOTH ABNORMALITIES 1966-74 HN(75) MHÑDens in Dente ANdo not use /congen MNC16.131.314.904.249 DMÑTooth Abnormalities LH LM  PM67 HN67(64) MHÑDensitometry ANNIM; only /instrum /methods; tomodensitometry seen in foreign lit is probably TOMOGRAPHY, X-RAY COMPUTED & if so use ╥x-ray computed tomography╙ in translations & not ╥tomodensitometry╙ MNE5.196.712.224 LH  PM67 HN67 MHÑDensitometry, X-Ray ANNIM; only /instrum /methods; ╥tomodensitometry╙ seen in foreign lit = probably TOMOGRAPHY, X-RAY COMPUTED: see note above PIPhotometry (66) MNE1.818.210; E5.196.712.224.375 LH  PM73 HN73 MHÑDental Alloys AND25-26 qualif PIAlloys (66-72); Dental Materials (66-72) MND1.552.33.291; D25.339.208 LH  PM65 HN65 MHÑDental Amalgam AND25-26 qualif RN8049-85-2 MND1.552.33.291.250; D1.552.504.291; D1.552.804.250; D25.339.208.291 LH  PM66 HN66 MHÑDental Arch MNA2.835.232.781.324.502.320; A14.521.320 FXÑAlveolar Process; ÑJaw LH LX;  MSMechanical devices that simulate the temporomandibular joints and jaws to which maxillary and mandibular casts are attached. The entire assembly attempts to reproduce the movements of the mandible and the various tooth-to-tooth relationships that accompany those movements. OLsearch DENTAL EQUIPMENT 1969-74 HN(77); ARTICULATORS, DENTAL was see under DENTAL EQUIPMENT 1969-74 MHÑDental Articulators ANdo not use /instrum /methods /util (except by MeSH definition) PIDental Equipment (66-76) MNE6.186.210; E7.222.210 XSArticulators DMÑDental Equipment LH LS LM  MSIndividuals who assist the dentist or the dental hygienist. MHÑDental Assistants ANassists a dentist or hygienist; dental nurses go here; note DENTAL AUXILIARIES below; do not use /man /methods /organ MNM1.526.485.67.105.250; N2.350.84.200.80 LH  MSPersonnel whose work is prescribed and supervised by the dentist. PM78 HN78; was ALLIED DENTAL PERSONNEL (NON MESH) before 1978 MHÑDental Auxiliaries ANdo not use /man /methods /organ PIAllied Health Personnel (71-77); Dental Assistants (66-77) MNM1.526.485.67.105; N2.350.84.200 XSDENTAL RECEPTIONISTS XUÑDenturists LH LS LU  PM64 HN64; was in Cat C only 1964-74 MHÑDental Calculus ANnote categories; from Cat A only /anal; tartar goes here MNA12.300.250; C7.793.208.250 FXÑDental Prophylaxis LH LX  MSUse for general articles on professional dental care. PM73 HN73 MHÑDental Care AN= professional care by a professional; ORAL HYGIENE = personal care by the subject himself; do not confuse with DENTISTRY: DENTISTRY is the dentist & the profession, DENTAL CARE is the patient & the service to him; GEN only: do not confuse with TOOTH DISEASES; only /econ /legis /man /methods /organ /psychol /stand /trends CATALOG: /geog /form MNE6.170; N2.421.196 FXÑCOMPREHENSIVE DENTAL CARE LH LX  MSDental care for the emotionally, mentally, or physically handicapped and chronically ill patient. PM80 HN80 MHÑDental Care for Handicapped ANhandicap can refer to emotional, mental, physical or chronic dis; only /econ /legis /man /methods /organ /psychol /stand /trends CATALOG: /geog /form PIDental Care (73-79); specific dentistry heading; specific mouth or tooth disease/PC/TH; Handicapped (66-79); specific handicap; Nursing Homes (66-79) MNE6.170.310; N2.421.196.308 XSDentistry for Handicapped FXÑHandicapped LH LS LX  OLuse DENTAL CARIES to search DENTAL CARIES CONTROL 1966 PMDENTAL CARIES CONTROL was heading 1965-66 HNDENTAL CARIES CONTROL was heading 1965-66 MHÑDental Caries AN/drug ther: consider also CARIOSTATIC AGENTS; /etiol: consider also CARIOGENIC AGENTS & DIET, CARIOGENIC; /occur: consider also DMF INDEX MNC7.793.180 XSWhite Spots, Dental FXÑCARIOGENIC AGENTS; ÑCARIOSTATIC AGENTS; ÑDIET, CARIOGENIC XUÑDental Fissures LH LS LX; ; LU  PM72 HN72(70) MHÑDental Caries Activity Tests ANonly /instrum /methods /stand PIDental Caries Susceptibility (66-69); Diagnosis, Oral (66-79) MNE6.342.250 LH  PM65 HN65 MHÑDental Caries Susceptibility ANno qualif; dental caries resistance goes here MNG10.549.140 LH  PM65 HN65 MHÑDental Casting Investment AND25-26 qualif MND25.339.250 LH  PM65 HN65 MHÑDental Casting Technic ANonly /instrum /stand CATALOG: do not use /laboratory manuals MNE6.780.250 LH  PM65 HN65 MHÑDental Cavity Lining ANonly /instrum /methods /stand MNE6.323.225 XSVarnish, Cavity FXÑCALCIUM HYDROXIDE LH LS LX  MHÑDental Cavity Preparation ANonly /adv eff /instrum /methods /stand; for both fillings & crowns MNE6.323.325 LH  PM72; was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64; POLYCARBOXYLATE CEMENT was see under ACRYLIC RESINS 1977-81, was see under ACRYLATES 1975-76 HN72(71); was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64 MHÑDental Cements AND25-26 qualif; do not confuse with DENTAL CEMENTUM (Cat A) or denture adhesives ( = DENTAL PROSTHESIS RETENTION + ADHESIVES) PICementation (66-70) MND25.339.291; D26.16.275 FXÑCementation XUÑGlass Ionomer Cements; ÑPolycarboxylate Cement LH LX LU;  MHÑDental Cementum ANdo not confuse with DENTAL CEMENTS (Cat D); pericementum = PERIODONTAL LIGAMENT MNA14.254.646.267; A14.254.860.232 XSCEMENTUM LH LS  MSFacilities where dental care is provided to patients. PM65 HN65 MHÑDental Clinics ANonly /econ /hist /legis /man /organ /stand /supply /trends /util MNN2.278.192.250 XSCLINICS, DENTAL FXÑOral Health; ÑPreventive Dentistry LH LS LX;  OLuse DENTAL DEPOSITS to search MATERIA ALBA back thru 1966 PM65; MATERIA ALBA was heading 1965-86 HN65; was in Cat C only 1965-74; MATERIA ALBA was heading 1965-86 MHÑDental Deposits ANnote categories; from Cat A only /anal; tartar = DENTAL CALCULUS MNA12.300; C7.793.208 XSMateria Alba LH LS  PM72 HN72 MHÑDental Devices, Home Care ANdo not use /instrum /methods /util (except by MeSH definition); dental floss, waterpicks, etc. go here; toothbrushes go under TOOTHBRUSHING PIDental Prophylaxis (66-71); Oral Health (66-71) MNE6.186.250; E6.761.726.292; E7.222.250 FXÑOral Hygiene LH LX  MHÑDental Enamel AN/embryol: consider also AMELOGENESIS MNA14.254.860.268 XSENAMEL FXÑAMELOBLASTS; ÑAMELOGENESIS LH LS LX;  PM66; was ENAMEL HYPOPLASIA 1965 HN66; was ENAMEL HYPOPLASIA 1965 MHÑDental Enamel Hypoplasia ANdo not use /congen MNC16.131.314.904.292 LH  OLsearch TOOTH PERMEABILITY 1966-74 HN(75) MHÑDental Enamel Permeability ANonly /drug eff /rad eff MNG10.549.879.292 DMÑTooth Permeability LH LM  PM65 HN65 MHÑDental Enamel Proteins ANcoord IM with specific protein (IM); do not use /analogs MND12.776.231 LH  PM65 HN65 MHÑDental Enamel Solubility ANonly /drug eff /rad eff MNG10.549.164 LH  PM65 HN65 MHÑDental Equipment ANdifferentiate from DENTAL INSTRUMENTS on basis of size (instrum are holdable in the hand); do not use /instrum /methods MNE6.186; E7.222 XUÑDental Articulators LH LU  MSUse for material on dental facilities in general or for which there is no specific heading. PM72 HN72 MHÑDental Facilities ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util PIHealth Facilities (68-71) MNN2.278.192 FXÑDental Service, Hospital LH LX  MSDeep grooves or clefts in the surface of teeth equivalent to class 1 cavities in Black's classification of dental caries. HN(87) MHÑDental Fissures PIDental Caries (66-86) MNC7.793.180.280 XSFissures, Dental DMÑDental Caries LH LS LM  PM70 HN70 MHÑDental Fistula ANfistula policy: Manual 23.25+ PIPeriapical Abscess (66-69) MNC7.465.187 FXÑFistula LH LX  MSServices designed to promote, maintain or restore dental health. PM78 HN78 MHÑDental Health Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form PIDental Care (73-77); Dental Service, Hospital (66-77) MNN2.421.240 LH  MSA systematic collection of factual data pertaining to dental or oral health and disease in a human population within a given geographic area. PM72 HN72 MHÑDental Health Surveys ANno qualif; specify geog CATALOG: /geog /form PIHealth Surveys (66-71) MNE6.208; G3.890.160; N1.224.458.251 FXÑOral Health XUÑDental Plaque Index; ÑOral Hygiene Index LH LX LU;  PM65 HN65 MHÑDental High Speed Equipment ANdo not use /instrum /methods MNE6.186.376; E7.222.376 LH  PM65 HN65 MHÑDental High Speed Technic ANonly /instrum /stand CATALOG: do not use /laboratory manuals MNE6.216 LH  MSPersons trained in an accredited school or dental college and licensed by the state in which they reside to provide dental prophylaxis under the direction of a licensed dentist. PM65 HN65 MHÑDental Hygienists ANtrained in accredited schools & licensed to practice DENTAL PROPHYLAXIS (see note there) under a licensed dentist; do not use /hist /man /methods MNM1.526.485.67.105.376; N2.350.84.200.110 LH  PM65 HN65 MHÑDental Implantation ANimplant of a foreign material into jaw tissue (gingival, subperiosteal or unspecified); differentiate from TOOTH REPLANTATION (reinsertion of a tooth lost by trauma or deliberate extraction); do not use /util except by MeSH definition; see specifics below MNE4.833.800.310; E6.231; E6.780.314; E6.892.800.310 XSDENTAL PROSTHESIS, SURGICAL LH LS  MSInsertion of an implant into the bone of the mandible or maxilla. The implant has an exposed head which protrudes through the mucosa and is a prosthodontic abutment. PM77 HN77 MHÑDental Implantation, Endosseous ANinsertion of implant into the bone tissue of the jaw; do not use /util except by MeSH definition PIDental Implantation (66-76) MNE4.833.800.310.310; E6.231.310; E6.780.314.310; E6.892.800.310.310 XSEndosseous Implantation XUÑBlade Implantation LH LS LU  MSInsertion of a tapered rod through the root canal into the periapical osseous structure to lengthen the existing root and provide individual tooth stabilization. OLuse DENTAL IMPLANTATION, ENDOSSEOUS, ENDODONTIC to search ENDODONTIC ENDOSSEOUS IMPLANTATION back thru 1971 PM77; was ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76 HN77; was ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76 MHÑDental Implantation, Endosseous, Endodontic ANinsertion of rod through root canal; do not use /util except by MeSH definition PIDental Implantation (66-70); Root Canal Therapy (66-70) MNE6.231.310.360; E6.397.345 XSEndodontic Endosseous Implantation; Endodontic Stabilization; Endosseous Implantation, Endodontic LH LS; ;  PM65 HN65 MHÑDental Impression Materials AND25-26 qualif MND25.339.334 FXÑSilicone Elastomers LH LX  PM65 HN65 MHÑDental Impression Technic ANonly /instrum /stand CATALOG: do not use /laboratory manuals MNE6.246 LH  PM65; MATRIX BANDS was MATRIX BAND see under DENTAL MATERIALS 1969-79 HN65 MHÑDental Instruments ANdifferentiate from DENTAL EQUIPMENT on the basis of size (instrum are holdable in the hand); do not use /instrum /methods /util (except by MeSH definition); reamers & broaches: index under ROOT CANAL THERAPY /instrum MNE6.186.501; E7.222.501 XUÑMatrix Bands LH LU  MSThe seepage of fluids, debris, and micro-organisms between the walls of a prepared dental cavity and the restoration. PM84 HN84 MHÑDental Leakage ANseepage of fluids, debris & micro-organisms into dental cavity restorations PIBonding, Dental (71-83); Composite Resins (72-83); Dental Restoration, Permanent (66-83) MNC7.793.221 LH  MHÑDental Materials AND25-26 qualif MND25.339 FXÑAcrylic Resins; ÑBONDING, DENTAL; ÑChromium Alloys; ÑDental Restoration, Permanent; ÑDental Restoration, Temporary; ÑInlays LH LX; ; ; ; ;  PM65 HN65 MHÑDental Models ANonly /stand MNE6.261 LH  PM65 HN65 MHÑDental Occlusion ANno qualif; Angle's class of occlusion: index MALOCCLUSION /class but see specific classes under MALOCCLUSION, ANGLE CLASS I, II & III; ╥occlusal plane╙ goes here MNE6.276; G10.549.202 FXÑJAW RELATION RECORD; ÑMalocclusion XUÑBite Force LH LX; LU  PM65 HN65 MHÑDental Occlusion, Balanced ANonly /stand MNE6.276.293 XSOCCLUSAL EQUILIBRATION LH LS  PM65 HN65 MHÑDental Occlusion, Centric ANonly /stand MNE6.276.459 XSCENTRIC RELATION LH LS  PM65 HN65 MHÑDental Occlusion, Traumatic MNC7.793.494.293 LH  MSThe room or rooms in which the dentist performs his services. OLuse DENTAL OFFICES to search DENTAL OFFICE back thru 1970 (as Prov 1970-71) PM72 HN72; was DENTAL OFFICE 1970-71 (Prov) MHÑDental Offices ANonly /econ /hist /organ /stand PIHealth Facilities (68-69) MNN2.278.192.377 LH  MSMesodermal tissue enclosed in the invaginated portion of the epithelial enamel organ and giving rise to the dentin and pulp. OLsearch TOOTH GERM 1966-74 HN(75) MHÑDental Papilla MNA14.254.860.851.252 DMÑTooth Germ LH LM  PM70 HN70 MHÑDental Pins ANdo not use /instrum /methods; includes pins, pegs & screws but not dowels (index under POST AND CORE TECHNIC) PIDental Cavity Preparation (66-69); Inlays (66-69) MNE6.292 LH  PM65 HN65(64); was in Cat C only 1964-74 MHÑDental Plaque ANnote categories; from Cat A only /anal MNA12.300.300; C7.793.208.377 LH  MSAn index which scores the degree of dental plaque accumulation. HN(83) MHÑDental Plaque Index ANno qualif PIDental Plaque (66-82); Periodontal Index (66-82) MNE6.208.250; G3.890.160.90; N1.224.458.251.250 DMÑDental Health Surveys LH LM  MSCreation of a smooth and glossy surface finish on a denture or amalgam. PM84 HN84 MHÑDental Polishing ANrestrict to polishing of dentures, amalgams & resins; tooth polishing: index under DENTAL PROPHYLAXIS or SCALING, DENTAL or TOOTHBRUSHING; only /econ /instrum /methods /stand PIDental Restoration, Permanent (66-83); Surface Properties (68-83) MNE6.298 XSBurnishing, Dental; Finishing, Dental LH LS;  PM65 HN65 MHÑDental Porcelain AND25-26 qualif RN12001-21-7 MND25.264.377; D25.339.376 XSPORCELAIN FXÑCrowns; ÑTooth, Artificial LH LS LX;  PM65 HN65 MHÑDental Prophylaxis ANalso called ╥dental hygiene╙; removal of calculus & stains by dentist or hygienist; only /instrum /methods /stand /trends MNE6.721.189; E6.761.227 FXÑDENTAL CALCULUS XUÑScaling, Dental LH LX LU  MHÑDental Prosthesis ANcoord IM or NIM with specific prosth (IM) or dent techn /instrum (IM); only /econ /stand /vet; labeling for ownership or identification = DENTURE IDENTIFICATION MARKING CATALOG: form qualif = PROSTHODONTICS /form MNE6.780.377 XSDentures FXÑProsthesis LH LS LX  PM70 HN70 MHÑDental Prosthesis Design ANdo not use /man /util PICleft Palate Prosthesis (66-69); Dental Prosthesis (66-69); Mandibular Prosthesis (67-69) MNE6.780.377.203 FXÑEquipment Design; ÑProsthesis Design LH LX;  PM74 HN74(72) MHÑDental Prosthesis Repair ANdo not use /man /util PIDental Prosthesis (66-71); specific dental prosthesis MNE6.780.377.241 LH  MSThe retention of a dental prosthesis in place by design, device, or adhesion. OLuse DENTAL PROSTHESIS RETENTION to search DENTURE RETENTION & DENTURE STABILITY back thru 1966 PM85; was DENTURE RETENTION 1965-84; DENTURE STABILITY was heading 1965-77 HN85; was DENTURE RETENTION 1965-84; DENTURE STABILITY was heading 1965-77 MHÑDental Prosthesis Retention ANno qualif; for denture fixative & adhesives, coord IM with ADHESIVES (IM) MNE6.780.377.260 XSDenture Retention; Denture Stability LH LS;  MHÑDental Pulp AN/surg = PULPECTOMY or PULPOTOMY; inflammation = PULPITIS MNA14.254.860.304 FXÑENDODONTICS; ÑPulpectomy; ÑPulpotomy LH LX; ;  PM65 HN65 MHÑDental Pulp Autolysis MNC7.793.237.190 LH  PM65 HN65 MHÑDental Pulp Calcification MNC7.793.237.252 XSDENTAL PULP STONES; DENTICLE LH LS;  MSApplication of a protective agent to an exposed pulp (direct capping) or the remaining thin layer of dentin over a nearly exposed pulp (indirect capping) in order to allow the pulp to recover and maintain its normal vitality and function. PM65 HN65 MHÑDental Pulp Capping ANonly /adv eff /econ /methods /stand MNE6.397.210 XSPulp Capping FXÑCALCIUM HYDROXIDE LH LS LX  PM65 HN65 MHÑDental Pulp Cavity MNA14.254.860.340 XSPULP CANAL; PULP CHAMBER; ROOT CANAL LH LS; ;  OLsearch DENTAL PULP MUMMIFICATION under DENTAL PULP 1966-69 PM70; DENTAL PULP MUMMIFICATION was heading 1965-69 HN70; DENTAL PULP MUMMIFICATION was heading 1965-69 MHÑDental Pulp Devitalization ANdevitalized tooth goes here PIDental Pulp (66-69) MNE6.397.778.377 LH  PM65 HN65 MHÑDental Pulp Diseases ANinflamm dis = PULPITIS MNC7.793.237 FXÑENDODONTICS LH LX  PM65 HN65 MHÑDental Pulp Exposure ANonly /adv eff /methods /stand MNE6.397.252 LH  PM65 HN65 MHÑDental Pulp Gangrene MNC7.793.237.315 XSPULP NECROSIS LH LS  PM65 HN65 MHÑDental Pulp Test ANonly /instrum /methods MNE6.342.377 FXÑEndodontics LH LX  MSData collected during dental examination for the purpose of study, diagnosis or treatment planning. PM67 HN67 MHÑDental Records ANonly /stand PIMedical Records (66) MNN4.452.859.341 LH  PM65 HN65 MHÑDental Restoration, Permanent ANonly /econ /methods /stand /trends; dent restoration unspecified probably goes here MNE6.323.428 XSDental Fillings, Permanent FXÑAcrylic Resins; ÑDental Materials LH LS LX;  PM65 HN65 MHÑDental Restoration, Temporary ANonly /econ /methods /stand /trends; dent restoration unspecified probably goes under DENTAL RESTORATION, PERMANENT MNE6.323.528 XSDental Fillings, Temporary FXÑACRYLIC RESINS; ÑDental Materials LH LS LX;  MSDense fibrous layer formed from mesodermal tissue that surrounds the epithelial enamel organ. The cells eventually migrate to the external surface of the newly formed root dentin and give rise to the cementoblasts that deposit cementum on the developing root, fibroblasts of the developing periodontal ligament, and osteoblasts of the developing alveolar bone. OLsearch TOOTH GERM 1966-74 HN(75) MHÑDental Sac MNA14.254.860.851.378 XSDental Follicle DMÑTooth Germ LH LS LM  MSHospital department providing dental care. OLuse DENTAL SERVICE, HOSPITAL to search HOSPITAL DENTAL SERVICE back thru 1966 PM78; was HOSPITAL DENTAL SERVICE 1963-77 HN78; was HOSPITAL DENTAL SERVICE 1963-77 MHÑDental Service, Hospital ANonly /econ /legis /man /organ /stand /trends /util MNN2.278.354.422.298; N2.421.240.200; N4.452.442.422.298 XSHospital Dental Service FXÑDental Facilities LH LS LX  MSPersonnel who provide dental service to patients in an organized facility, institution or agency. PM73 HN73 MHÑDental Staff ANonly /educ /legis /organ /psychol /stand /supply /util MNM1.526.485.290; N2.350.252 LH  MSDental personnel practicing in hospitals. OLuse DENTAL STAFF, HOSPITAL to search HOSPITAL DENTAL STAFF back thru 1971 PM78; was HOSPITAL DENTAL STAFF 1971-77 HN78; was HOSPITAL DENTAL STAFF 1971-77 MHÑDental Staff, Hospital ANonly /educ /legis /organ /psychol /stand /supply /trends /util MNM1.526.485.290.490; M1.526.485.740.322; N2.350.252.472; N2.350.685.110 XSHospital Dental Staff LH LS  PM72 HN72(68) MHÑDental Stress Analysis ANonly /instrum /methods PIDental Occlusion (66-69) MNE6.308 LH  MSIndividuals responsible for fabrication of dental appliances. PM65 HN65 MHÑDental Technicians ANexecutes dentists' prescripts for mechanical fabrication of dental appliances; only /educ /psychol /stand /supply /util MNM1.526.485.67.105.503; N2.350.84.200.175 LH  MSThe use of a layer of tooth-colored material, usually porcelain or acrylic resin, applied to the surface of crowns or pontics by fusion, cementation, or mechanical retention. PM84 HN84 MHÑDental Veneers ANdo not use /instrum /methods /util (except by MeSH definition) PICrowns (66-83); Dental Porcelain (66-83); Dental Prosthesis (66-69); Dental Prosthesis Design (70-83) MNE6.780.377.433.233 LH  MSAny preparations used for cleansing teeth; they usually contain an abrasive, detergent, binder and flavoring agent and may exist in the form of liquid, paste or powder; may also contain medicaments and caries preventives. MHÑDentifrices AND25-26 qualif MND25.376; D26.313.211; J1.516.278 XSPolishes, Dental FXÑMouthwashes XUÑDenture Cleansers; ÑToothpaste LH LS LX LU;  MSMost common follicular odontogenic cyst. Occurs in relation to a partially erupted or unerupted tooth with at least the crown of the tooth to which the cyst is attached protruding into the cystic cavity. May give rise to an ameloblastoma and, in rare instances, undergo malignant transformation. MHÑDentigerous Cyst ANnon-neoplastic; coord IM with precoord organ/dis term (IM) MNC4.182.89.530.690.310; C5.500.470.690.310 LH  MHÑDentin AN/embryol = DENTINOGENESIS; reparative dentin = DENTIN, SECONDARY; dentin bridge = DENTIN, SECONDARY; dentin hypersensitivity = DENTIN SENSITIVITY MNA14.254.860.376 FXÑODONTOBLASTS LH LX  PM65 HN65 MHÑDentin Dysplasia ANdo not use /congen MNC16.131.314.904.335 LH  OLsearch TOOTH PERMEABILITY 1966-74 HN(75) MHÑDentin Permeability ANonly /drug eff /rad eff MNG10.549.879.461 DMÑTooth Permeability LH LM  PM65 HN65 MHÑDentin Sensitivity ANnote category MNC7.793.266 LH  PM65 HN65 MHÑDentin Solubility ANonly /drug eff /rad eff MNG10.549.242 LH  PM65 HN65 MHÑDentin, Secondary ANCat A qualif; only /chem ind from Cat C MNA14.254.860.376.310; C7.793.237.378 LH  PM65 HN65 MHÑDentinogenesis ANonly /drug eff /rad eff MNG7.553.767.461 LH  PM65 HN65 MHÑDentinogenesis Imperfecta ANdo not use /congen MNC16.131.314.904.377 XSHEREDITARY OPALESCENT DENTIN FXÑOsteogenesis Imperfecta LH LS LX  MSThe psychological relations between the dentist and patient. PM65 HN65 MHÑDentist-Patient Relations ANno qualif MNF1.829.401.650.410 LH  MSThe profession concerned with the teeth, oral cavity, and associated structures, and the diagnosis and treatment of their diseases including prevention and the restoration of defective and missing tissue. OLuse DENTISTRY + AEROSPACE MEDICINE to search AVIATION DENTISTRY 1966-79 PMAVIATION DENTISTRY was heading 1965-79 HNAVIATION DENTISTRY was heading 1965-79 MHÑDentistry ANSPEC: SPEC qualif but /econ = ECONOMICS, DENTAL; /educ = EDUCATION, DENTAL; /hist = HISTORY OF DENTISTRY; /instrum = DENTAL INSTRUMENTS, DENTAL EQUIPMENT or other specifics; /legislation & jurisprudence = LEGISLATION, DENTAL or DENTISTRY (IM) + JURISPRUDENCE (IM) or FORENSIC DENTISTRY; do not use /supply /util; /man permissible but consider also DENTISTS /supply; ╥stomatology╙ as a field goes here but translate as ╥oral medicine╙; ╥stomatol dis╙ = MOUTH DISEASES; veterinary dentistry = DENTISTRY /*vet (IM) + VETERINARY MEDICINE (IM) CATALOG: use with form qualif instead of TOOTH /form or TOOTH DISEASES /form; do not use /in inf (= PEDODONTICS) /in old age ( = GERIATRIC DENTISTRY) MNE6; G2.163 XSOral Medicine LH LS  PM65 HN65; was in Cat E only 1972-79 MHÑDentistry, Operative ANSPEC; SPEC qualif; to restore tooth function (filling, inlay, etc.); do not confuse with SURGERY, ORAL (surg ther of dis, inj or defects of soft tissues of mouth or of jaws) MNE6.323; G2.163.180 LH  MSIndividuals licensed to practice dentistry. PM65 HN65 MHÑDentists AN/educ = EDUCATION, DENTAL; do not use /man CATALOG: /geog /form MNM1.526.485.330; N2.350.283 LH  MSFemale dentists. PM65 HN65 MHÑDentists, Women AN/educ = EDUCATION, DENTAL; do not use /man; Manual 34.17 CATALOG: /geog /form MNM1.526.485.330.310; M1.975.310; N2.350.283.378 LH  MHÑDentition ANdifferentiate from TOOTH: tooth is a unit, dentition is all the teeth together as a unit; only /drug eff /rad eff MNA14.254 FXÑTooth; ÑTooth, Deciduous LH LX;  PM73 HN73(71) MHÑDentition, Mixed ANsee note above PIDentition (66-70) MNA14.254.229 FXÑSERIAL EXTRACTION LH LX  PM65 HN65 MHÑDenture Bases ANonly /adv eff /econ /stand MNE6.780.377.281 LH  MSSubstances used to clean dentures; they are usually alkaline peroxides or hypochlorites, may contain enzymes and release oxygen. Use also for sonic action cleaners. HN(79) MHÑDenture Cleansers AND25-26 qualif; includes sonic-action cleansers PIDental Prosthesis (66-78); Dentifrices (66-78); Oral Hygiene (73-78) MND25.376.262 XSCleansers, Denture DMÑDentifrices LH LS LM  MSAny system of defining ownership of dentures or dental prostheses. PM84 HN84 MHÑDenture Identification Marking ANmarking of dentures or dent prostheses; only /econ /legis /methods PIDenture, Complete (66-83); Forensic Dentistry (66-83) MNE6.333 LH  PM65 HN65 MHÑDenture Liners ANonly /adv eff /econ /stand MNE6.780.377.357 FXÑSILICONE ELASTOMERS LH LX  PM65 HN65 MHÑDenture Rebasing ANonly /adv eff /econ /stand MNE6.780.377.471 XSDENTURE RELINING LH LS  PM65 HN65 MHÑDenture, Complete ANonly /adv eff /econ /stand; labeling for ownership or identification = DENTURE IDENTIFICATION MARKING MNE6.780.377.319 FXÑMOUTH, EDENTULOUS LH LX  PM65 HN65 MHÑDenture, Complete, Immediate ANonly /adv eff /econ /stand MNE6.780.377.319.254 FXÑAlveoloplasty LH LX  PM65 HN65 MHÑDenture, Complete, Lower ANonly /adv eff /econ /stand MNE6.780.377.319.379 LH  PM65 HN65 MHÑDenture, Complete, Upper ANonly /adv eff /econ /stand MNE6.780.377.319.504 LH  PM74 HN74 MHÑDenture, Overlay ANonly /adv eff /econ /stand MNE6.780.377.395 XSTELESCOPIC PROSTHESIS LH LS  PM65; CROWN AND BRIDGEWORK was heading 1963-64 HN65; CROWN AND BRIDGEWORK was heading 1963-64 MHÑDenture, Partial ANonly /adv eff /econ /stand; ╥pontics╙ goes here or under its specifics; labeling for ownership or identification = DENTURE IDENTIFICATION MARKING MNE6.780.377.433 XSDental Bridgework LH LS  PM65; CROWN AND BRIDGEWORK was heading 1963-64 HN65; CROWN AND BRIDGEWORK was heading 1963-64 MHÑDenture, Partial, Fixed ANonly /adv eff /econ /stand MNE6.780.377.433.271 LH  PM65; CROWN AND BRIDGEWORK was heading 1963-64 HN65; CROWN AND BRIDGEWORK was heading 1963-64 MHÑDenture, Partial, Immediate ANonly /adv eff /econ /stand MNE6.780.377.433.342 LH  PM65; CROWN AND BRIDGEWORK was heading 1963-64 HN65; CROWN AND BRIDGEWORK was heading 1963-64 MHÑDenture, Partial, Removable ANonly /adv eff /econ /stand MNE6.780.377.433.413 LH  PM65; CROWN AND BRIDGEWORK was heading 1963-64 HN65; CROWN AND BRIDGEWORK was heading 1963-64 MHÑDenture, Partial, Temporary ANonly /adv eff /econ /stand MNE6.780.377.433.484 LH  PM70 HN70 MHÑDenture, Precision Attachment ANonly /adv eff /stand PIDenture, Partial (66-69); Denture, Partial, Removable (66-69) MNE6.780.377.433.555 LH  MSDental auxiliaries who work with patients. Their duties include taking impressions and bite registrations for preparing and repairing dentures and fitting dentures. OLsearch DENTAL AUXILIARIES 1979 HN(80); was see DENTAL AUXILIARIES 1979 MHÑDenturists ANdent auxiliaries working with patients requiring dentures (prep, repair, fitting); do not use /man /methods /organ PIDental Auxiliaries (79); Dental Technicians (66-78) MNM1.526.485.67.105.550; N2.350.84.200.175.80 DMÑDental Auxiliaries LH LM  MHÑDeodorants AND25-26 qualif MND26.313.295; J1.516.329 LH  PM74; DEOXYGLUCOSE was see under GLUCOSE 1973-74, was see under HEXOSES 1967-72 HN74 MHÑDeoxy Sugars ANdo not use /analogs /biosyn /defic /physiol MND9.203.254 XUÑDeoxyglucose LH LU  MSAdenine nucleotides which contain deoxyribose as the sugar moiety. PM78 HN78 MHÑDeoxyadenine Nucleotides AN/biosyn /physiol permitted; do not use /analogs PIAdenine Nucleotides (64-77); Deoxyribonucleotides (73-77) MND13.695.201.100; D13.695.667.138.410 XSDeoxyadenosine Phosphates LH LS  PM73 HN73(71) MHÑDeoxyadenosine AN/biosyn /physiol permitted RN958-09-8 PIAdenosine (66-70) MND13.570.230.229; D13.570.583.138.325 XSCordycepin LH LS  MS3-alpha, 12-alpha-Dihydroxy-5-beta-cholanic acid. Bile acid formed by bacterial action from cholate; usually conjugated with glycine or taurine; acts as detergent to solubilize fats for intestinal absorption; reabsorbed itself; used as choleretic and detergent. PM74 HN74(73) MHÑDeoxycholic Acid AN/biosyn /physiol permitted RN83-44-3 PIBile Acids and Salts (66-72) MND4.808.221.430.342; D19.316.246.225.272 XSDeoxycholate; Desoxycholic Acid XUÑGlycodeoxycholic Acid; ÑTaurodeoxycholic Acid; ÑUrsodeoxycholic Acid LH LS; LU; ;  PM75 HN75(73) MHÑDeoxycytidine ANdo not use /defic /physiol RN951-77-9 PINucleosides (66-72) MND13.570.230.329; D13.570.685.245.500 XUÑBromodeoxycytidine LH LU  MSNTP:deoxycytidine 5'-phosphotransferase. Catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the Herpes simplex virus. EC 2.7.1.74. HN(79) MHÑDeoxycytidine Kinase ANdo not use /analogs RNEC 2.7.1.74 PIDeoxycytidine (73-78); Phosphotransferases (66-78) MND8.586.913.696.729.190 DMÑPhosphotransferases, ATP LH LM  MSDeoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2',3' or 5' positions. OLto search DEOXYCYTIDYLIC ACIDS use DEOXYCYTIDINE MONOPHOSPHATE back thru 1975 & CYTOSINE NUCLEOTIDES 1966-74 HN(78); was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77 MHÑDeoxycytidine Monophosphate AN/biosyn /physiol permitted; /analogs NIM only RN1032-65-1 PICytosine Nucleotides (66-74) MND13.695.201.150.200; D13.695.740.246.750.300 XSDCMP; Deoxycytidylic Acid DMÑDeoxycytosine Nucleotides LH LS; LM  MSdCMP aminohydrolase. Catalyzes the hydrolytic deamination of deoxycytidylic acid to deoxyuridylic acid and ammonia. Plays an important role in the regulation of the pool of deoxynucleotides in higher organisms. Also acts on some 5-substituted deoxycytidylic acids HN(76) MHÑDeoxycytidylate Deaminase ANdo not use /analogs RNEC 3.5.4.12 PIAminohydrolases (70-74); Cytosine Nucleotides (70-74); Deoxycytidine Monophosphate (75); Deoxyribonucleotides (73-74); Nucleotide Deaminases (75) MND8.586.277.151.653.200 XSDCMP Deaminase; Deoxycytidylate Aminohydrolase DMÑNucleotide Deaminases LH LS; LM  MSCytosine nucleotides which contain deoxyribose as the sugar moiety. PM78; DEOXYCYTIDINE MONOPHOSPHATE was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77 HN78 MHÑDeoxycytosine Nucleotides AN/biosyn /physiol permitted; do not use /analogs PICytosine Nucleotides (66-77); Deoxyribonucleotides (73-77) MND13.695.201.150; D13.695.740.246.750 XSDeoxycytidine Phosphates XUÑDeoxycytidine Monophosphate LH LS LU  MS4-[2-(Methylamino)ethyl]pyrocatechol. Sympathomimetic, vasoconstrictor agent. Synonym: Epinine. HN(75) MHÑDeoxyepinephrine ANdo not use /biosyn /defic /physiol RN501-15-5 PIDopamine (71-74); Methane (73-74) MND2.92.311.342.300; D2.92.311.461.200 XSDeoxyadrenaline; Desoxyadrenaline; Methyldopamine DMÑDopamine LH LS; ; LM  OLsearch GLUCOSE 1973-74 & HEXOSES 1967-72 HN(75); was see under GLUCOSE 1973-74, was see under HEXOSES 1967-72 MHÑDeoxyglucose AN/blood = DEOXYGLUCOSE /blood (NIM) + BLOOD GLUCOSE (IM); do not use /defic /physiol; /analogs NIM only RN154-17-6 MND9.203.254.229 DMÑDeoxy Sugars LH LM  MSGuanine nucleotides which contain deoxyribose as the sugar moiety. PM78 HN78 MHÑDeoxyguanine Nucleotides AN/biosyn /physiol permitted; do not use /analogs PIDeoxyribonucleotides (73-77); Guanine Nucleotides (66-77) MND13.695.201.175; D13.695.667.454.200 XSDeoxyguanosine Phosphates LH LS  MSA nucleoside consisting of the base guanine and the sugar deoxyribose. PM78 HN78 MHÑDeoxyguanosine AN/biosyn /physiol permitted RN961-07-9 PIDeoxyribonucleosides (73-77); Guanosine (72-77) MND13.570.230.360; D13.570.583.454.240 LH  MSCatalyzes the endonucleolytic cleavage to 5'-phospho-di- and oligonucleotide end products. The enzyme has preference for double-stranded DNA. Formerly EC 3.1.4.5. PM85 HN85 MHÑDeoxyribonuclease I ANdo not use /analogs RNEC 3.1.21.1 PIDeoxyribonucleases (66-82); Endodeoxyribonucleases (83-84); Endonucleases (73-82) MND8.586.277.352.630.553.190 XSDNase I LH LS  OLuse DEOXYRIBONUCLEASES to search DEOXYRIBONUCLEASE back thru 1966 PM83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65 HN83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65 MHÑDeoxyribonucleases ANdo not use /analogs; differentiate STREPTODORNASE referred to here and STREPTODORNASE AND STREPTOKINASE (see note there) RNEC 3.1.- MND8.586.277.352.630.553.200 XSDNAase; DNase; Desoxyribonucleases; Nucleases, DNA; STREPTODORNASE LH LS; ; ; ;  MSProteins found in the nucleus which are noncovalently bound to DNA or specific DNA. They are viscous materials of very high molecular weight. PM84; was see under NUCLEOPROTEINS 1976-83 HN84(76); was see under NUCLEOPROTEINS 1976-83 MHÑDeoxyribonucleoproteins ANdo not use /analogs /defic PIDNA (66-75); specific DNA; Nucleoproteins (66-75) MND12.776.664.275 LH  OLuse DEOXYRIBONUCLEOSIDES to search RIBONUCLEOSIDES, DEOXY back thru 1971 (as Prov 1971-72) PM73 HN73; was RIBONUCLEOSIDES, DEOXY 1971-72 (Prov) MHÑDeoxyribonucleosides ANdo not use /analogs /defic PINucleosides (66-72); specific nucleoside MND13.570.230 LH  OLuse DEOXYRIBONUCLEOTIDES to search RIBONUCLEOTIDES, DEOXY back thru 1971 (as Prov 1971-72) PM73 HN73; was RIBONUCLEOTIDES, DEOXY 1971-72 (Prov) MHÑDeoxyribonucleotides ANdo not use /analogs /defic PINucleotides (66-72); specific nucleotide MND13.695.201 LH  PM74 HN74 MHÑDeoxyribose RN533-67-5 MND9.203.254.330 LH  MSUracil nucleotides which contain deoxyribose as the sugar moiety. PM78; FLUORODEOXYURIDYLATE was see under URACIL NUCLEOTIDES 1975-77 HN78 MHÑDeoxyuracil Nucleotides AN/biosyn /physiol permitted; do not use /analogs PIDeoxyribonucleotides (73-77); Uracil Nucleotides (66-77) MND13.695.201.200; D13.695.740.850.210 XSDeoxyuridine Phosphates XUÑFluorodeoxyuridylate LH LS LU  PM66 HN66(64) MHÑDeoxyuridine RN951-78-0 MND13.570.230.430; D26.87.274; D13.570.685.852.300 LH  MSThe tendency of an individual or individuals to rely on others for advice, guidance or support. HN(75) MHÑDependency (Psychology) ANno qualif; DF: DEPENDENCY MNF1.752.330 DMÑPersonality LH LM  MSA personality disorder in which the individual passively allows others to assume responsiblity for major areas of his or her life because of lack of self-confidence and an inability to function independently. OLuse DEPENDENT PERSONALITY DISORDER to search PASSIVE-DEPENDENT PERSONALITY back thru 1975 HN(81); was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80 MHÑDependent Personality Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.597.160 XSPassive-Dependent Personality; Personality Disorder, Dependent DMÑPersonality Disorders LH LS; LM  MS11-beta,17-Dihydroxy-21-(4-methyl-1-piperazinyl) pregna-1,4-diene-3,20-dione. A water soluble, long acting prednisolone derivative used topically for skin conditions and parenterally as glucocorticoid. HN(78) MHÑDepersolone ANdo not use /biosyn /defic /physiol RN60-39-9 PIPiperazines (72-75); Prednisolone (66-77) MND4.808.745.432.769.795.200; D6.597.481.561.353.744.200; D6.597.481.561.478.702.200; D26.74.125.447.807.262; D26.74.125.744.807.262; D26.74.125.744.262; D26.74.148.447.807.262; D26.368.99.447.807.262 XSMethylpiperazinyl Deoxyprednisolone DMÑPrednisolone LH LS LM  MSA disorder in which there is an alteration in the perception or experience of the self so that the feeling of one's own reality is temporarily lost or changes (feelings of unreality). This is often accompanied by various sensory anesthesias and a feeling of not being in control of one's actions. OLuse DEPERSONALIZATION DISORDER to search DEPERSONALIZATION back thru 1966 PM81; was DEPERSONALIZATION 1963-80 HN81; was DEPERSONALIZATION 1963-80 MHÑDepersonalization Disorder ANdo not use /drug eff /physiol /rad eff MNF3.126.56.296; F3.709.438.416.408 XSDepersonalization LH LS  MSDecline in value of capital assets of a permanent or fixed nature over time with use. HN(78) MHÑDepreciation ANonly /legis /trends MNN3.219.463.30.120 DMÑAccounting LH LM  MSDepressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders. MHÑDepression ANhuman & animal; do not use /drug eff /physiol /rad eff; /drug ther: consider also ANTIDEPRESSIVE AGENTS; do not confuse this or X ref (depression of ╥moderate intensity╙) with DEPRESSIVE DISORDER (╥prominent & relatively persistent╙ depression): psychiatrists differentiate on basis of degree MNF3.126.56.463 XSDepressive Symptoms LH LS  PM68 HN68 MHÑDepression, Chemical ANnever IM; TN 49: definition & use as NIM MNG12.254 LH  MSMarked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation. OLuse DEPRESSION, INVOLUTIONAL to search PSYCHOSES, INVOLUTIONAL & MELANCHOLIA, INVOLUTIONAL back thru 1966 PM81; was PSYCHOSES, INVOLUTIONAL 1963-80 HN81; was PSYCHOSES, INVOLUTIONAL 1963-80; MELANCHOLIA, INVOLUTIONAL was see under PSYCHOSES, INVOLUTIONAL 1963-78 MHÑDepression, Involutional ANdo not use /drug eff /physiol /rad eff MNF3.709.680.80.300.400 XSMelancholia, Involutional; Paraphrenia, Involutional; Psychosis, Involutional LH LS; ;  MSAn affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. OLto search DEPRESSIVE NEUROSES use DEPRESSIVE DISORDER back thru 1981 & ADJUSTMENT DISORDERS 1969-80 PM81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES indexed under DEPRESSION, REACTIVE 1969-80 HN81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, was DEPRESSIVE NEUROSES see under DEPRESSION, REACTIVE 1969-78 MHÑDepressive Disorder ANdo not use /drug eff /physiol /rad eff; do not confuse with DEPRESSION or DEPRESSIVE SYMPTOMS: see note on DEPRESSION PIAdjustment Disorders (66-80); Depression (66-80) MNF3.709.438.100.410; F3.709.680.80.300 XSDepression, Endogenous; Depression, Neurotic; Depression, Unipolar; Depressive Syndrome; Dysthymic Disorder; Melancholia; Neurosis, Depressive; Unipolar Depression LH LS; ; ; ; ; ; ;  MSPerception of three-dimensionality. MHÑDepth Perception ANonly /drug eff /physiol /rad eff; disord of depth perception: coord IM with PERCEPTUAL DISORDERS (IM) MNF2.463.593.200; F2.463.593.932.869.255; G11.697.911.860.317 LH  MS1,1-Decamethylenebis(4-aminoquinaldinium). Topical bacteriostat, available as various salts; used in wound dressings and mouth infections; may also have antifungal action, but may cause skin ulceration. Synonyms: Dekadin; Dequalin; Dequavet; Efisol; Sorot. HN(76) MHÑDequalinium ANdo not use /biosyn /defic /physiol; /analogs NIM only RN6707-58-0 PIQuinolinium Compounds (70-75) MND3.438.810.824.200; D20.187.208 XSDechalinium; Dequalonum DMÑQuinolinium Compounds LH LS; LM  MHÑDermabrasion ANdo not use /util except by MeSH definition MNE4.860.296 LH  MSA large, widely distributed genus of ticks, including a number that infest man and other mammals, and several that are vectors of diseases such as tularemia, Rocky Mountain spotted fever, Colorado tick fever, and analplasmosis. HN(73) MHÑDermacentor AN/microbiol /parasitol permitted; tick D. andersoni transmits Rocky Mt spotted fever, Colo. tick fever & tularemia PITicks (66-72) MNB1.131.166.132.832.380 DMÑTicks LH LM  OLsearch CHONDROITIN 1972-74 HN(75) MHÑDermatan Sulfate ANdo not use /defic /physiol RN24967-94-0 MND9.203.698.582.160.380 XSChondroitin Sulfate B; beta-Heparin DMÑChondroitin LH LS; LM  MHÑDermatitis AN/chem ind = DERMATITIS MEDICAMENTOSA or DERMATITIS, CONTACT MNC17.174 LH  MHÑDermatitis Exfoliativa MNC17.174.318 LH  MHÑDermatitis Herpetiformis MNC17.816.318; C20.111.318 XSDUHRING'S DISEASE LH LS  MHÑDermatitis Medicamentosa ANdo not restrict to -itis: use as if ╥dermatoses╙; for any skin dis caused by ther agent whether prescribed by MD or not; do not use /chem ind MNC17.174.380; C20.543.206.380; C21.613.276.505 XSDRUG ERUPTIONS LH LS  MSA chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE) with increased susceptibility to allergic rhinitis, asthma, etc. Lichenification, excoriations, and crusting is mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. MHÑDermatitis, Atopic MNC17.174.193; C20.543.480.343 XSEczema, Atopic; Neurodermatitis, Atopic; Neurodermatitis, Disseminated LH LS; ;  MSA type of delayed hypersensitivity reaction in which sensitivity is manifested by skin reactivity to contact sensitizers. Use also for dermatitis caused by prolonged exposure to irritants not explained by delayed hypersensitivity mechanisms. MHÑDermatitis, Contact ANdo not use /chem ind; consider also OCCUPATIONAL DERMATITIS MNC17.174.255; C20.543.418.380 XSContact Dermatitis; DERMATITIS VENENATA; Eczema, Contact; Hypersensitivity, Contact; Sensitivity, Contact LH LS; ; ; ;  MSThe study of the patterns of ridges of the skin of the fingers, palms, toes, and soles. OLuse DERMATOGLYPHICS to search FINGERPRINTS & PLANTAR PRINTS back thru 1966 PM66; FINGERPRINTS was heading 1963-65 HN66; FINGERPRINTS was see DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78 MHÑDermatoglyphics ANonly /class /hist MNE5.256; I1.198.560.343 XSFingerprints; Plantar Prints LH LS;  PM67 HN67 MHÑDermatologic Agents AND25-26 qualif; consider also SKIN /drug eff & SKIN DISEASES /drug ther MND26.368 FXÑANTI-INFECTIVE AGENTS, LOCAL XUÑAntipruritics; ÑEmollients; ÑKeratolytic Agents LH LX LU; ;  MSA medical specialty concerned with the skin, its structure, functions, diseases, and treatment. MHÑDermatology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of SKIN /form or SKIN DISEASES /form MNG2.403.776.185 FXÑSKIN DISEASES LH LX  OLuse DERMATOMYCOSES to search DERMATOMYCOSIS back thru 1966 PM77; was DERMATOMYCOSIS 1963-76 HN77; was DERMATOMYCOSIS 1963-76 MHÑDermatomycoses MNC1.703.295; C17.838.208 XSSkin Diseases, Fungal LH LS  MHÑDermatomyositis MNC5.651.594.297; C17.185; C23.205.200.241 LH  MHÑDermatophytes ANdo not use /anat /embryol /microbiol /parasitol; dermatophytosis = DERMATOMYCOSES MNB5.354.318 LH  MSA tumor of developmental origin consisting of a wall formed of epithelium-lined connective tissue and containing epithelium, hair and other skin appendages. OLuse DERMOID CYST to search DERMOID back thru 1968 PMDERMOID was heading 1968-80 HNDERMOID was heading 1968-80 MHÑDermoid Cyst ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.182.201; C4.557.537.889.381 XSDermoid; Teratoma, Cystic; Teratoma, Mature LH LS; ;  MSSpecific substances elaborated by plants, microorganisms or animals that cause damage to the skin; they may be proteins or other specific factors or substances; constituents of spider, jellyfish or other venoms cause dermonecrosis and certain bacteria synthesize dermolytic agents. PM78 HN78 MHÑDermotoxins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS; coord IM with source of dermotoxin (IM or NIM); do not use for dermatoxicity of various chemicals & drugs ( = SKIN /drug eff or skin dis heading /chem ind + Cat D term /ad-poi-tox) PISkin (66-77); Toxins (66-77); specific skin heading MND24.185.926.275 XSDermatotoxins; Epidermotoxins LH LS;  PM74 HN74(64) MHÑDescemet's Membrane MNA9.371.60.217.271 XSLamina Elastica Posterior LH LS  MSA behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli. OLsearch BEHAVIOR THERAPY 1969-74 HN(75) MHÑDesensitization (Psychology) ANSPEC qualif; DF: DESENSITIZATION PSYCHOL MNF4.754.137.506 DMÑBehavior Therapy LH LM  MSImmunosuppression by repeated administration of antigen. The mechanism may involve the host's subsequent production of blocking antibodies. OLuse DESENSITIZATION, IMMUNOLOGIC to search DESENSITIZATION 1966-79 PM80; was DESENSITIZATION 1965-79 HN80; was DESENSITIZATION 1963-79 (Prov 1963-64) MHÑDesensitization, Immunologic ANdo not use /util except by MeSH definition; DF: DESENSITIZATION IMMUNOL MNE2.95.449.310; E5.478.610.310 XSHyposensitization Therapy FXÑHypersensitivity LH LS LX  MHÑDesert Climate ANonly /adv eff; specify geog if pertinent MNG3.230.300.100.250.325 FXÑHeat LH LX  MSRemoval of moisture from a substance (chemical, food, tissue, etc.). PM77 HN77 MHÑDesiccation ANnote category; differentiate from DEHYDRATION, a disease state MNE5.196.335; H1.181.278.330; H1.181.529.260 FXÑFreeze Drying LH LX  PM65 HN65(63) MHÑDesipramine ANdo not use /biosyn /defic /physiol RN50-47-5 MND3.494.240.281; D15.236.122.140.298 XSDESMETHYLIMIPRAMINE LH LS  MSDeacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis Lanata. Synonym: Cedilanid-D. HN(75) MHÑDeslanoside ANdo not use /defic /physiol; /analogs NIM only RN17598-65-1 PILanatosides (69-74) MND9.203.408.180.261.657.200; D18.222.175.324.542.200 XSDesacetyldigilanide C; Desacetyllanatoside C DMÑLanatosides LH LS; LM  MSAn intermediate filament protein found predominantly in smooth, skeletal, and cardiac muscle cells. Localized at the Z line. MW 50,000 to 55,000 is species dependent. PM85 HN85 MHÑDesmin AN/biosyn /physiol permitted PIIntermediate Filament Proteins (83-84); Muscle Proteins (66-82) MND12.776.220.475.200 XSSkeletin LH LS  MS1-Deamino-8-D-arginine vasopressin. Synthetic analog of argipressin with longer lasting and more potent antidiuretic action than argipressin; used to treat diabetes insipidus. Synonyms: Adiuretin SD; Desurin; Minirin; DDAVP; 1-(3-Mercaptopropionic acid)-8-D-arginine vasopressin. OLuse DESMOPRESSIN to search DEAMINO ARGININE VASOPRESSIN back thru 1975 PM86; was see under ARGIPRESSIN 1979-85, was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78 HN86(79); was see under ARGIPRESSIN 1979-85, was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78 MHÑDesmopressin ANdo not use /biosyn /defic /physiol RN16679-58-6 PIArginine (66-74); Vasopressins (66-74) MND6.472.734.692.781.100.250; D12.644.456.925.250; D19.770.896.36.260 XSDDAVP; Deamino Arginine Vasopressin; Vasopressin, Deamino Arginine LH LS; ;  MS4-(4-Amino-4-carboxybutyl)-1-(5-amino-5-carboxypentyl)-3,5-bis(3-amino-3-carboxypropyl)pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring. HN(75) MHÑDesmosine ANdo not use /defic /physiol; /analogs NIM only RN11003-57-9 PIAmino Acids (72-74); Pyridinium Compounds (70-74) MND3.383.725.762.300; D12.125.72.200 DMÑAmino Acids LH LM  PM72 HN72 MHÑDesmosomes ANA 11 qualif except /cytol PICell Membrane (66-71) MNA11.195.443.297 LH  OLsearch DEHYDROCHOLESTEROL under CHOLECALCIFEROLS 1966 PM74; DEHYDROCHOLESTEROL was see under VITAMIN D3 1963-66 HN74(72); DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66 MHÑDesmosterol ANdo not use /defic /physiol RN313-04-2 PISterols (66-71) MND4.808.247.222.222.347.231; D4.808.247.808.197.250.281; D10.516.851.208.320.297 XS24-Dehydrocholesterol LH LS  MS16-Hydroxyprednisolone 16,17-acetonide. Nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses. HN(75) MHÑDesonide AND25-26 qualif; /analogs NIM only RN638-94-8 PIAcetals (74); Ketosteroids (74); Pregnadienetriols (74) MND4.808.745.432.769.325; D26.74.125.200; D26.74.125.447.200; D26.74.148.447.200; D26.368.99.447.200 XSHydroxyprednisolonacetonide; Prednacinolon DMÑPregnadienetriols LH LS; LM  MS9-Fluoro-11-beta, 21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione. Topical anti-inflammatory glucocorticoid used in dermatoses, skin allergies, psoriasis, etc. Synonyms: A 41304; HOE 304; Esperson; Ibaril; Topicort; Topisolon. HN(79) MHÑDesoximetasone ANdo not use /biosyn /defic /physiol RN382-67-2 PIDexamethasone (66-78); Pregnadienediols (74); Steroids, Fluorinated (74) MND4.808.745.432.719.260; D4.808.908.238.250; D6.597.481.561.353.256.250; D26.74.125.252.240; D26.74.125.447.252.240; D26.74.148.447.252.240; D26.368.99.447.252.240 XSDeoxydexamethasone; Desoxymethasone DMÑDexamethasone LH LS; LM  MHÑDesoxycorticosterone ANdo not coord with ACETATES for DOCA; /biosyn /physiol permitted RN64-85-7 MND4.808.745.745.654.339; D6.472.40.668.478.298 XS21-Hydroxyprogesterone; CORTEXONE; DOCA; Deoxycorticosterone; Desoxycortone XUÑ18-Hydroxydesoxycorticosterone LH LS; ; ; ; LU  MHÑDesulfovibrio ANin soil, water, sewage, oil wells MNB3.425.400 LH  MSPurifying or cleansing agents, usually salts of long chain aliphatic bases or acids that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. HN63(81) MHÑDetergents AND25-26 qualif MND26.866.265; J1.516.381 XSCleansing Agents DMÑSurface-Active Agents LH LS LM  MHÑDeuterium AN= H2 or D; for heavy water; only /admin /adv eff /anal /diag use /metab /ther use RN7782-39-0 MND1.435.256; D1.496.289 XSDEUTERONS LH LS  MSA large and heterogenous group of fungi, whose common characteristic is the absence of a sexual state. Syn: fungi imperfecti. PM73 HN73 MHÑDeuteromycetes ANGEN: prefer specifics; do not use /anat /embryol /microbiol /parasitol PIFungi (66-72) MNB5.354.381 XSFUNGI IMPERFECTI LH LS  MSPorphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings. HN(75) MHÑDeuteroporphyrins ANdo not use /analogs PIPorphyrins (70-74) MND11.557.727.280 DMÑPorphyrins LH LM  MSCountries in the process of change directed toward economic growth; that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. PM71 HN71 MHÑDeveloping Countries ANIM; specify country or countries; only /class /hist PIInternational Cooperation (66-70); specific country MNI1.534.256 LH  MHÑDexamethasone ANdo not use /biosyn /defic /physiol RN50-02-2 MND4.808.745.432.769.344; D4.808.908.238; D6.597.481.561.353.256; D6.597.481.561.478.242; D26.74.125.252; D26.74.125.447.252; D26.74.148.447.252; D26.368.99.447.252 XSHEXADECADROL XUÑDesoximetasone; ÑDexamethasone Isonicotinate LH LS LU;  MS9-Fluoro-11 beta,17,21-trihydroxy-16 alpha-methyl-pregna-1,4-diene-3,20-dione-21-isonicotinate. Anti-inflammatory, antiallergic glucocorticoids; can be administered orally, by inhalation, locally and parenterally; may cause water and salt retention. Synonyms: Auxiloson; HE 111; Voren. HN(76) MHÑDexamethasone Isonicotinate ANdo not use /biosyn /defic /physiol RN2265-64-7 PIDexamethasone (72-74) /AA (75); Isonicotinic Acids (72-75) MND4.808.745.432.769.344.300; D4.808.908.238.300; D6.597.481.561.353.256.300; D6.597.481.561.478.242.300; D26.74.125.252.248; D26.74.125.447.252.248; D26.74.148.447.252.248; D26.368.99.447.252.248 DMÑDexamethasone LH LM  MS(+)-2-(1-Benzyl-4-piperidyl)-2-phenylglutarimide. Anticholinergic antiparkinson agent. Benzetimide is the (-)-enantimorph of Dexetimide. HN(75) MHÑDexetimide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN21888-98-2 PIBenzyl Compounds (72-74); Piperidones (72-74) MND3.383.621.808.250; D14.307.250; D16.653.280 XSBenzetimide; Dexbenzetimide DMÑPiperidines LH LS; LM  PM73 HN73(71) MHÑDextranase ANdo not use /analogs RNEC 3.2.1.11 PIGlycoside Hydrolases (66-70) MND8.586.277.450.283 LH  OLuse DEXTRANS to search DEXTRAN back thru 1966 PM79; was DEXTRAN 1963-78 HN79; was DEXTRAN 1963-78 MHÑDextrans ANdo not use /analogs /biosyn /defic /physiol MND9.203.698.365.272; D19.461.775.256 XUÑDEAE-Dextran LH LU  OLsearch POLYSACCHARIDES 1966-74 HN(75); was see under POLYSACCHARIDES 1963-78 MHÑDextrins ANdo not use /analogs /defic MND9.203.698.365.855.400 DMÑStarch XUÑCyclodextrins LH LM LU  OLuse DEXTROAMPHETAMINE to search DEXTRO AMPHETAMINE back thru 1966 PM77; was DEXTRO AMPHETAMINE 1963-76 HN77; was DEXTRO AMPHETAMINE 1963-76 MHÑDextroamphetamine ANdo not use /biosyn /defic /physiol RN51-64-9 MND2.92.471.683.152.297; D15.128.82.381; D16.893.120.267; D26.128.127.431 XSD-Amphetamine LH LS  MSLocation of the heart in the right hemithorax, with the apex directed to the right. HN(84)63 MHÑDextrocardia ANdo not use /congen MNC14.280.400.280; C16.131.457.282; C16.131.810.501.282 DMÑHeart Defects, Congenital LH LM  HN(72) MHÑDextromethorphan ANdo not use /biosyn /defic /physiol RN125-71-3 PIAntitussive Agents (66-71); Morphinans (69-71) MND3.132.610.422.463.382; D3.549.686.485.382; D3.605.497.485.382; D23.338.345 XSD-Methorphan DMÑLevorphanol LH LS LM  MHÑDextromoramide ANdo not use /biosyn /defic /physiol RN357-56-2 MND3.383.468.180; D14.73.153.215; D14.757.194 XSD-Moramide; Pyrrolamidol LH LS;  MSDextro form of levorphanol; has little narcotic or analgesic activity; used mainly as cough suppressant. Synonyms: Dextro-Dromoran; Ro 1-6794. HN(75) MHÑDextrorphan ANdo not use /biosyn /defic /physiol; /analogs NIM only RN125-73-5 PIMorphinans (69-74) MND3.132.610.422.235; D3.549.686.260; D3.605.497.260; D23.338.352 XSD-Dromoran; Destrorphanolum; Dextrodromoran DMÑMorphinans LH LS; ; LM  PM65 HN65 MHÑDextrothyroxine ANdo not use /biosyn /defic /physiol RN51-49-0 MND10.162.202.319 XSD-Thyroxine LH LS  MSA metabolic disorder due to disorders in the production or release of vasopressin. It is characterized by the chronic excretion of large amounts of low specific gravity urine and great thirst. MHÑDiabetes Insipidus MNC18.452.264; C19.700.482.215 LH  MSA heterogeneous group of disorders that share glucose intolerance in common. MHÑDiabetes Mellitus ANGEN: see specifics & pre-coords below; in pregnancy = PREGNANCY IN DIABETES: diabetes & obesity = OBESITY IN DIABETES; PREDIABETIC STATE is also available & includes subclinical diabetes; /diet ther = DIABETIC DIET; alloxan- & streptozotocin-induced diabetes: see note on DIABETES MELLITUS, EXPERIMENTAL below CATALOG: do not use /in inf ( = DIABETES MELLITUS, INSULIN-DEPENDENT) /in pregn ( = PREGNANCY IN DIABETES) MNC18.452.297; C19.246 FXÑPREDIABETIC STATE LH LX  MSDiabetes mellitus induced experimentally by administration of various diabetogenic agents or by pancreatectomy. OLuse DIABETES MELLITUS, EXPERIMENTAL to search ALLOXAN DIABETES back thru 1966 PM78; ALLOXAN DIABETES was heading 1963-77 HN78; ALLOXAN DIABETES was heading 1963-77 MHÑDiabetes Mellitus, Experimental ANindex alloxan or streptozotocin diabetes as DIABETES MELLITUS, EXPERIMENTAL (IM) + ALLOXAN or STREPTOZOTOCIN (NIM) only if the chem are particularly discussed; do not use /vet PIDiabetes Mellitus (66-77) MNC18.452.297.240; C19.246.240 XSAlloxan Diabetes; Streptozotocin Diabetes LH LS;  MSDiabetes mellitus characterized by insulin deficiency, sudden onset, severe hyperglycemia, rapid progression to ketoacidosis, and death unless treated with insulin. May occur at any age, but is most common in childhood or adolescence. OLuse DIABETES MELLITUS, INSULIN-DEPENDENT to search DIABETES MELLITUS, JUVENILE back thru 1966 PM84; was DIABETES MELLITUS, JUVENILE 1966-83 HN84; was DIABETES MELLITUS, JUVENILE 1966-83 MHÑDiabetes Mellitus, Insulin-Dependent AN╥sudden onset╙ (as opposed to maturity onset which goes under DIABETES MELLITUS, NON-INSULIN-DEPENDENT); despite X ref with ╥juvenile╙, ╥may occur at any age, but is most common in childhood or adolescence╙: check age in text for correct check tag MNC18.452.297.267; C19.246.267; C20.111.327 XSDiabetes Mellitus, Brittle; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Ketosis Prone; Diabetes Mellitus, Type 1; IDDM LH LS; ; ; ;  MSA disorder characterized by complete absence of subcutaneous adipose tissue, insulin-resistant diabetes with little tendency to ketoacidosis, hyperlipidemia with subcutaneous xanthomatosis, hepatomegaly, and an elevated basal metabolic rate. PM79 HN79 MHÑDiabetes Mellitus, Lipoatrophic PIDiabetes Mellitus (66-78); Lipodystrophy (66-78) MNC17.849.391.280; C18.452.297.280; C19.246.280 LH  MSDiabetes characterized by the ability to survive without ketoacidosis in the absence of insulin therapy. Is usually of slow onset with a tendency to obesity. PM84 HN84 MHÑDiabetes Mellitus, Non-Insulin-Dependent AN╥slow onset╙ (as opposed to sudden onset which goes under DIABETES MELLITUS, INSULIN-DEPENDENT); note X refs below PIDiabetes Mellitus (66-83) MNC18.452.297.300; C19.246.300 XSDiabetes Mellitus, Adult Onset; Diabetes Mellitus, Ketosis Resistant; Diabetes Mellitus, Stable; Diabetes Mellitus, Type 2; NIDDM LH LS; ; ; ;  MHÑDiabetic Angiopathies ANcoord IM with specific vascular dis (IM) MNC14.907.320; C18.452.297.312; C19.246.312 XSMICROANGIOPATHY, DIABETIC LH LS  MHÑDiabetic Coma MNC18.452.297.357; C19.246.357 XUÑHyperglycemic Hyperosmolar Nonketotic Coma LH LU  MHÑDiabetic Diet ANonly /adv eff /econ /stand /trends MNE2.293.257 LH  MSIncludes renal arteriosclerosis, renal arteriolosclerosis, Kimmelstiel-Wilson syndrome (intercapillary glomerulosclerosis), acute and chronic pyelonephritis, and kidney papillary necrosis in individuals with diabetes mellitus. OLuse DIABETIC NEPHROPATHIES to search KIMMELSTIEL-WILSON SYNDROME back thru 1966 PM65; KIMMELSTIEL-WILSON SYNDROME was heading 1963-76 HN65(64); KIMMELSTIEL-WILSON SYNDROME was heading 1963-76 MHÑDiabetic Nephropathies ANcoord IM with specific kidney dis (IM); Kimmelstiel-Wilson Syndrome indexed here PIKIDNEY DISEASES MNC12.777.419.192; C18.452.297.402; C19.246.402 XSGlomerulosclerosis, Diabetic LH LS  MHÑDiabetic Neuropathies ANcoord IM with specific neurol dis (IM) but do not coord with PERIPHERAL NERVE DISEASES for ╥diabetic peripheral neuropathy╙; diabetic ulcero-mutilating acropathy: index only under DIABETIC NEUROPATHIES MNC10.772.267; C18.452.297.447; C19.246.447 LH  MSRetinopathy associated with diabetes mellitus, which may be of the background type, progressively characterized by microaneurysms, interretinal punctuate macular edema, or of the proliferative type, characterized by neovascularization of the retina and optic disk, which may project into the vitreous, proliferation of fibrous tissue, vitreous hemorrhage, and retinal detachment. MHÑDiabetic Retinopathy ANdiabetic retinitis; do not coord with RETINITIS MNC11.768.257; C14.907.320.382; C18.452.297.312.382; C19.246.312.382 LH  MS2,3-Butanedione. Carrier of aroma of butter, vinegar, coffee, and other foods. HN(75) MHÑDiacetyl ANdo not use /biosyn /defic /physiol; /analogs NIM only RN431-03-8 MND2.522.296.400 XS2,3-Butanedione; Biacetyl; Diketobutane; Dimethyldiketone; Dimethylglyoxal DMÑButanones LH LS; ; ; ; LM  OLto search DIACETYLMORPHINE DERIVATIVES use DIACETYLMORPHINE /AA back thru 1975 & MORPHINANS 1969-74 PMDIACETYLMORPHINE DERIVATIVES was see under DIACETYLMORPHINE 1975-77, was see under MORPHINANS 1969-74 HNDIACETYLMORPHINE DERIVATIVES was see under DIACETYLMORPHINE 1975-77, was see under MORPHINANS 1969-74 MHÑDiacetylmorphine ANdo not use /defic /physiol; diacetylmorphine derivatives = DIACETYLMORPHINE /analogs RN561-27-3 MND3.132.610.422.547.547.267; D3.549.686.575.547.332; D3.605.497.575.547.332; D14.73.153.616.547.332; D14.757.638.547.332 XSDiamorphine; HEROIN LH LS;  MHÑDiagnosis ANGEN only; no qualif; prefer /diag with disease term: Manual 19.5+ MNE1 LH  OLemphasis here is on technic; consider also BRAIN DISEASES /DI or /DI with specific brain dis MH*Diagnosis, Brain (Non Mesh) MNE1.236.257 LH  OLemphasis here is on technic; consider also CARDIOVASCULAR DISEASES /DI or /DI with specific cardiovasc dis MH*Diagnosis, Cardiovascular (Non Mesh) MNE1.145 LH  MSApplication of computer programs designed to assist the physician in solving a diagnostic problem. PM73 HN73(69) MHÑDiagnosis, Computer Assisted ANGEN: prefer specifics; restrict to MeSH definition; IM; only /econ /hist /instrum /legis /methods /stand /trends /util (if by MeSH definition) /vet; COMPUTER-ASSISTED INSTRUCTION is also available PIComputers (66-68) MNE1.158; L1.700.508.100.158 XSComputer-Assisted Diagnosis; Signal Interpretation, Computer-Assisted LH LS;  MSDetermination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. MHÑDiagnosis, Differential ANNIM; no qualif; correct NIM coord for ╥mimicking╙, ╥simulating╙; Manual 26.19; DF: DIAG DIFFER MNE1.171 LH  OLemphasis here is on technic; consider also DIGESTIVE SYSTEM DISEASES /DI or /DI with specific digestive dis in C6 MH*Diagnosis, Digestive System (Non Mesh) MNE1.184 LH  OLemphasis here is on technic; consider also EAR DISEASES /DI or HEARING DISORDERS /DI or /DI with specific ear dis or hearing disord MH*Diagnosis, Ear (Non Mesh) MNE1.276.299 LH  OLemphasis here is on technic; consider also ENDOCRINE DISEASES /DI or /DI with specific endocr dis MH*Diagnosis, Endocrine (Non Mesh) MNE1.197 LH  OLemphasis here is on the technic; consider also EYE DISEASES /DI or VISION DISORDERS /DI or /DI with specific eye dis or vision disord MH*Diagnosis, Eye (Non Mesh) MNE1.210 LH  MSDiagnosis based on findings of laboratory tests. MHÑDiagnosis, Laboratory ANGEN: avoid: most diag is done in labs; use /diag + diag technic; do not use as NIM coord; when GEN & IM, only /econ /instrum /methods /stand /trends /util (if by MeSH definition) /vet; Manual 26.16 MNE1.223 XSLABORATORY DIAGNOSIS FXÑTECHNOLOGY, MEDICAL LH LS LX  OLemphasis here is on technic; consider also NERVOUS SYSTEM DISEASES /DI or /DI with specific nerv syst dis MH*Diagnosis, Neurologic (Non Mesh) MNE1.236 LH  OLemphasis here is on technic; consider also GENITAL DISEASES, FEMALE /DI or /DI with specific gynecol dis & PREGNANCY COMPLICATIONS /DI & /DI with specific pregn compl MH*Diagnosis, Ob-Gyn (Non Mesh) MNE1.249 LH  PM65 HN65 MHÑDiagnosis, Oral ANSPEC or GEN only; avoid as NIM coord: prefer /diag with specific mouth or tooth dis; includes both clinical & radiogr exam of mouth but for radiogr of teeth use RADIOGRAPHY, DENTAL; only /econ /instrum /methods /stand /trends /vet MNE1.262; E6.342 FXÑMouth Diseases; ÑOral Health LH LX;  OLemphasis here is on technic; consider also OTORHINOLARYNGOLOGIC DISEASES /DI or /DI with specific ORL dis MH*Diagnosis, Otorhinolaryngologic (Non Mesh) MNE1.276 LH  OLconsider also RADIOISOTOPES /DU or /DU with specific radioisotopes; /radionuclide is available with diseases MH*Diagnosis, Radioisotope (Non Mesh) MNE1.289 LH  OLemphasis here is on technic; consider also RESPIRATORY TRACT DISEASES /DI or /DI with specific resp dis MH*Diagnosis, Respiratory System (Non Mesh) MNE1.302 LH  PM66 HN66 MHÑDiagnosis, Surgical ANSPEC; avoid as NIM coord; only /econ /instrum /methods /stand /trends /vet MNE1.315; E4.200 LH  OLemphasis here is on technic; consider also UROLOGIC DISEASES /DI or /DI with specific urol dis MH*Diagnosis, Urologic (Non Mesh) MNE1.341 LH  PM73 HN73(70) MHÑDiagnostic Errors ANIM general only: TN 51; coord NIM with specific disease /diag (IM); only /vet; do not confuse with differ diag; text must state diag error PIDiagnosis (66-69) MNE1.354 LH  MSThe grouping of patients according to diagnosis, treatment, and age for the purpose of ascertaining cost data of these patient groups. Used by hospitals primarily as an insurance reimbursement mechanism. OLuse DIAGNOSTIC RELATED GROUPS to search CASE MIX back thru 1982 PM86; was CASE MIX see under COSTS AND COST ANALYSIS 1982-85 HN86; was see CASE MIX; CASE MIX was see under COSTS AND COST ANALYSIS 1982-85 MHÑDiagnostic Related Groups ANonly /hist /legis /methods /util PICosts and Cost Analysis (66-85) MNN2.421.589.473.100; N3.219.151.500; N3.219.521.710.305.200.80 XSCase Mix; DRG Diagnostic Related Groups XUÑSeverity of Illness Index LH LS; LU  MSOrganized services for the purpose of providing diagnosis to promote and maintain health. PM68 HN68 MHÑDiagnostic Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util PIDiagnosis (66-67); Physical Examination (66-67) MNN2.421.143.827.233; N2.421.726.233 LH  MSDiagnostic procedures, such as laboratory tests and x-rays, routinely performed on all individuals or specified categories of individuals in a specified situation, e.g., patients being admitted to the hospital. Includes routine tests administered to neonates. OLuse DIAGNOSTIC TESTS, ROUTINE to search PHYSICAL EXAMINATION, PREADMISSION back thru Aug 77 PM82; PHYSICAL EXAMINATION, PREADMISSION was see under PHYSICAL EXAMINATION Aug 77-81 HN82; PHYSICAL EXAMINATION, PREADMISSION was see under PHYSICAL EXAMINATION Aug 77-81 MHÑDiagnostic Tests, Routine ANonly /econ /instrum /methods /stand; do not confuse with PHYSICAL EXAMINATION or MASS SCREENING MNE1.360 XSAdmission Tests, Routine; Hospital Admission Tests; Physical Examination, Preadmission; Routine Diagnostic Tests LH LS; ; ;  MHÑDialysis ANNIM; only /instrum /methods /vet; ileal loop dialysis goes under HEMODIALYSIS; PERITONEAL DIALYSIS is also available; not for ╥dialysis retinae╙ ( = RETINAL PERFORATIONS) MNE5.196.353; H1.181.278.365; H1.181.529.272 LH  MSN,N'-[Oxybis(2,1-ethanediyloxy-4,1-phenylene)]bis-acetamide. Proposed anthelmintic; has been shown useful in fasciola infections in sheep. OLuse DIAMFENETIDE to search DIAMPHENETHIDE back thru 1975 HN(79); was DIAMPHENETHIDE see under ACETANILIDE 1975-78 MHÑDiamfenetide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN36141-82-9 PIAcetanilides (74); Ethyl Ethers (74); Phenyl Ethers (74) MND2.65.199.92.250; D21.201.412.257 XSDiamphenethide DMÑAcetanilides LH LS LM  MSTetramethyl diazenedicarboxamide. A sulfhydryl reagent which oxidizes sulfhydryl groups to the disulfide form. It is a radiation-sensitizing agent of anoxic bacterial and mammalian cells. HN(77) MHÑDiamide ANdo not use /biosyn /defic /physiol; /analogs NIM only; do not confuse with Diamide, a brand name of CHLORPROPAMIDE RN10465-78-8 PIAzo Compounds (66-76); Formamides (66-76) MND2.172.300; D8.373.830.290; D26.776.280; D26.550.844.271 DMÑAzo Compounds LH LM  PM74 HN74 MHÑDiamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.782.258 XUÑCadaverine LH LU  MS2,6-Diaminoheptanedioic acid HN(75); was see under PIMELIC ACIDS 1975-79 MHÑDiaminopimelic Acid AN/analogs NIM only RN583-93-7 PIAmino Acids, Diamino (74); Pimelic Acids (72-74) MND2.241.81.337.699.250; D12.125.95.390 DMÑAmino Acids, Diamino LH LM  MS1,2:5,6-Dianhydrodulcitol. One of the cytotoxic dihalohexitols that may have alkylating antineoplastic activity; causes bone marrow toxicity; the active form is thought to be the diepoxide. Synonyms: dulcitol diepoxide; galactitol diepoxide; NSC 132313. HN(79) MHÑDianhydrogalactitol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23261-20-3 PIAlcohols (66-71); Dulcitol (72-78); Ethers, Cyclic (66-78) MND2.33.800.256.350; D9.203.853.256.350; D22.204.396 XSDianhydrodulcitol; Diepoxydulcitol; Diepoxygalactitol DMÑSugar Alcohols LH LS; ; LM  MS3,3'-Dimethoxybenzidine. Highly toxic compound which can cause skin irritation and sensitization. It is used in manufacture of azo dyes. HN(75); was see under AMINOBIPHENYL COMPOUNDS 1975-76 MHÑDianisidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1331-53-9 PIAniline Compounds (69-74); Biphenyl Compounds (69-74); Anisoles (74) MND2.455.426.559.389.185.220 DMÑBenzidines LH LM  MHÑDiaper Rash MNC17.174.255.299; C20.543.418.380.299 LH  MHÑDiaphragm ANIM when organ of respiration; NIM in studies on muscle tissue; subdiaphragmatic abscess = SUBPHRENIC ABSCESS; paralysis = RESPIRATORY PARALYSIS MNA2.633.244; A2.633.740.244 LH  MHÑDiaphragmatic Eventration ANincludes ╥relaxatio╙; do not use /congen MNC16.131.314.244 LH  MSProgressive thickening of diaphyseal cortex of long bones. HN(75); was see under BONE DISEASES, DEVELOPMENTAL 1975-84 MHÑDiaphyseal Dysplasia, Progressive ANdo not use /congen MNC5.116.99.708.281 XSCamurati-Engelmann Syndrome; Engelmann's Disease DMÑOsteochondrodysplasias LH LS; LM  MSPassage of excessively liquid or excessively frequent stools. MHÑDiarrhea AN/drug ther: consider also ANTIDIARRHEALS; in infants = DIARRHEA, INFANTILE + appropriate check tags; rehydration solutions: index under FLUID THERAPY & not also SOLUTIONS MNC6.405.469.237 LH  MHÑDiarrhea, Infantile ANhuman only; restrict ╥infantile╙ to newborn inf & inf & don't forget infant check tags as pertinent MNC6.405.469.237.300 LH  MSTumor of the pancreatic delta cells producing massive, watery diarrhea, leading to hypokalemia and associated with the absence of gastric hypersecretion. High blood levels of vasoactive intestinal peptide (VIP) are found in many patients. HN(82) MHÑDiarrheogenic Tumor AN/anal /blood supply /secret /ultrastruct permitted; coord IM with PANCREATIC NEOPLASMS (IM); this is a delta cell tumor PIDiarrhea (66-81); Gastrointestinal Hormones (66-81); Islet Cell Tumor (66-81); Pancreatic Neoplasms (66-81); Vasoactive Intestinal Peptide (77-81) MNC4.557.576.600.261 XSPancreatic Cholera; Verner-Morrison Syndrome; Vipoma; Watery Diarrhea with Hypokalemic Alkalosis DMÑIslet Cell Tumor LH LS; ; ; LM  PM72 HN72(67) MHÑDiastema ANonly /etiol /physiopathol /prev /surg /ther PIDentition (66) MNA14.254.333; C7.793.494.466 FXÑLabial Frenum LH LX  MSPeriod of relaxation of the heart, especially the ventricles. HN(79) MHÑDiastole ANonly /drug eff /rad eff; diastolic pressure: index under BLOOD PRESSURE & do not add DIASTOLE (NIM) unless particularly discussed PIHeart (66-78); Heart Ventricle (66-78) MNG9.330.800.295 DMÑMyocardial Contraction LH LM  MSThe induction of local hyperthermia by either short radio waves or high-frequency sound waves. MHÑDiathermy ANdo not use /util except by MeSH definition MNE2.780.480.280 FXÑMicrowaves XUÑShort-Wave Therapy LH LX LU  MHÑDiatrizoate AND25-26 qualif RN117-96-4 MND2.241.223.106.530.718.200; D26.298.240 XSAmidotrezoate LH LS  MS3,5-Diacetamido-2,4,6-triiodobenzoic acid methyl glucamine salt. Versatile x-ray contrast medium for diagnostic radiology; can be administered by most routes. Synonyms: Angiografin; Cardiografin; Cystografin; Gastrografin; Hypaque Meglumine; Renografin; Urovist. OLuse DIATRIZOATE MEGLUMINE to search MEGLUMINE DIATRIZOATE back thru 1975 PM87; was see under DIATRIZOATE 1982-86, was MEGLUMINE DIATRIZOATE see under DIATRIZOATE 1975-81 HN87(82); was see under DIATRIZOATE 1982-86, was MEGLUMINE DIATRIZOATE see under DIATRIZOATE 1975-81 MHÑDiatrizoate Meglumine AND25-26 qualif RN131-49-7 PIAmino Sugars (72-74); Diatrizoate (71-74); Sorbitol (72-74) MND2.33.800.813.550.500; D2.241.223.106.530.718.210; D9.203.67.342.600.500; D9.203.853.813.550.500; D26.298.240.642 XSDiatrizoate Methylglucamine; Diatrizoic Acid Methylglucamine; Meglumine Diatrizoate; Methylglucamine Diatrizoate LH LS; ; ;  PM65 HN65(63) MHÑDiazepam ANdo not use /biosyn /defic /physiol; Valium goes here RN439-14-5 MND3.438.79.80.70.216; D15.236.872.659.191.275; D17.426.341 XUÑDemethyldiazepam LH LU  MSO,O-Diethyl O-(2-isopropyl-6-methyl-4-pyrimidyl)phosphorothioate. An organothiophosphorus insecticide. HN(75) MHÑDiazinon ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN333-41-5 PIInsecticides, Organothiophosphate (73-74); Pyrimidines (73-74) MND2.719.220; D5.723.491.657.235 DMÑInsecticides, Organothiophosphate LH LM  MSN-Diazoacetylglycine amide. Antineoplastic agent with both alkylating and immunosuppressive properties. HN(75) MHÑDiazoacetylglycine Amide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN817-99-2 PIAmides (70-74); Azo Compounds (70-74); Glycine (70-74) MND2.172.350; D12.125.481.200; D22.204.408; D22.569.580 DMÑAzo Compounds LH LM  PM68 HN68(67) MHÑDiazomethane ANdo not use /biosyn /defic /physiol RN334-88-3 PIMethane (66) MND2.172.383.383 LH  PM68 HN68 MHÑDiazonium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: DIAZONIUM CPDS MND2.172.383 LH  HN(65) MHÑDiazooxonorleucine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN764-17-0 MND2.172.508; D20.85.75.394; D22.204.106.393; D22.204.144.430; D26.87.286 DMÑAzo Compounds LH LM  PM67 HN67(63) MHÑDiazoxide ANdo not use /biosyn /defic /physiol RN364-98-7 MND18.162.246 LH  MS0-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1 6)-0-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythrohexopyranosyl-(1 4))-2-deoxy-D-streptamine. Analog of kanamycin with antitubercular as well as broad spectrum antimicrobial properties. OLuse DIBEKACIN to search DIDEOXYKANAMYCIN B back thru 1975 HN(85); was DIDEOXYKANAMYCIN B see under KANAMYCIN 1975-84 MHÑDibekacin ANdo not use /biosyn /defic /physiol RN34493-98-6 PIDeoxy Sugars (74); Kanamycin (73-74) MND9.203.408.51.476.200; D20.85.89.464.200; D20.338.135.501.200 XSDideoxykanamycin B DMÑKanamycin LH LS LM  PM66; was see under SYMPATHOLYTICS 1963-65 HN66(63); was see under SYMPATHOLYTICS 1963-65 MHÑDibenamine ANdo not use /biosyn /defic /physiol RN51-50-3 MND2.92.471.245; D16.848.115.196 LH  PM68 HN68 MHÑDibenzazepines ANdo not use /analogs /biosyn /defic /physiol MND3.494.240 XUÑClozapine; ÑDibenzepin; ÑLofepramine; ÑTrimipramine LH LU; ; ;  MS10-[2-(Dimethylamino)-ethyl]-5,10-dihydro-5-methyl-11H-dibenzo-[b,e][1,4]-diazepin-11-one monohydrate. Tricyclic antidepressant similar in action to imipramine. Synonyms: HF 1927; Neodalit; Neoveril. OLsearch DIBENZAZEPINES 1968-74 HN(75) MHÑDibenzepin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4498-32-2 MND3.494.240.334; D15.236.122.140.308 DMÑDibenzazepines LH LM  PM68 HN68 MHÑDibenzocycloheptenes ANdo not use /analogs /biosyn /defic /physiol MND4.615.181.384 XUÑButaclamol; ÑProtriptyline LH LU;  PM68 HN68 MHÑDibenzothiazepines ANdo not use /analogs /biosyn /defic /physiol MND3.494.276 XUÑClothiapine LH LU  PM68 HN68 MHÑDibenzothiepins ANdo not use /analogs /biosyn /defic /physiol MND3.494.311 XUÑDothiepin; ÑMethiothepin; ÑOxyprothepine LH LU; ;  PM68 HN68 MHÑDibenzoxazepines ANdo not use /analogs /biosyn /defic /physiol MND3.494.347 XUÑAmoxapine; ÑLoxapine; ÑSC 19220 LH LU; ;  PM68 HN68 MHÑDibenzoxepins ANdo not use /analogs /biosyn /defic /physiol MND3.494.382 LH  MS2,5-Dibromo-3-isopropyl-6-methyl-p-benzoquinone. At low concentrations, inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. HN(75) MHÑDibromothymoquinone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN29096-93-3 PIBromine (74); Quinones (73-74) MND2.806.280 DMÑQuinones LH LM  MHÑDibucaine ANdo not use /biosyn /defic /physiol RN85-79-0 MND2.65.355; D14.211.299 XSCincain; Cinchocain LH LS;  MSPhthalic acid, dibutyl ester. A plasticizer used in most plastics and found in water, air, soil, plants and animals; may have some adverse effects with long-term exposure. HN(77) MHÑDibutyl Phthalate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN84-74-2 PIPhthalic Acids (69-76) MND2.241.223.805.225; D25.700.261 XSButyl Phthalate DMÑPhthalic Acids LH LS LM  PM74 HN74 MHÑDibutyryl Cyclic AMP ANdo not use /biosyn /defic /physiol; DF: DIBU CYCL AMP RN362-74-3 MND13.695.462.180.384; D13.695.667.138.69.384; D13.695.827.68.69.384 XSDibutyryl Adenosine-3',5'-Monophosphate LH LS  MSN-(1-Oxobutyl)-cyclic 3',5'-(hydrogen phosphate)-2'-butanoate guanosine. A derivative of cyclic GMP. It has a higher resistance to extracellular and intracellular phosphodiesterase than cyclic GMP. HN(78); was see under GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79 MHÑDibutyryl Cyclic GMP ANdo not use /defic /physiol; DF: DIBU CYCL GMP RN32266-35-6 PIGuanosine Cyclic Monophosphate (71-77) MND13.695.462.537.350; D13.695.667.454.304.350; D13.695.827.426.304.350 XSDibutyryl Guanosine-3',5'-Monophosphate DMÑGuanosine Cyclic Monophosphate LH LS LM  HN(72) MHÑDicamba ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1918-00-9 PIBenzoates (66-71); Herbicides (66-71) MND2.241.223.106.312; D5.723.366.221 DMÑBenzoates LH LM  MS1,4-Dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylic acid diethyl ester. HN(75) MHÑDicarbethoxydihydrocollidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN632-93-9 PIDicarboxylic Acids (72-74); Pyridines (72-74) MND3.383.725.200 XSDiethoxycarbonyldihydrocollidine DMÑPyridines LH LS LM  PM68 HN68(65) MHÑDicarboxylic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.337 LH  MSA derivative of acetic acid which increases the activity of pyruvate dehydrogenase and rate of lipogenesis. HN(78) MHÑDichloroacetate AN/analogs NIM only RN13425-80-4 PIAcetates (66-77); Acetic Acids (68-77) MND2.241.81.38.209.220 XSDichloroacetic Acid DMÑAcetic Acids LH LS LM  MSToxic chlorinated unsaturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. Both isomers are toxic, but 1,1-dichloroethylene is the more potent CNS depressant and hepatotoxin. It is used in the manufacture of thermoplastic polymers. HN(76) MHÑDichloroethylenes ANdo not use /analogs /biosyn /defic /physiol; do not confuse with ETHYLENE DICHLORIDES PIEthylenes (74-75); Hydrocarbons, Chlorinated (74-75) MND2.455.326.271.367.300; D2.455.526.439.350 XSVinylidene Chlorides DMÑHydrocarbons, Chlorinated LH LS LM  OLuse DICHLOROISOPROTERENOL to search DICHLORISOPROTERENOL back thru 1966 PM68; was DICHLORISOPROTERENOL 1963-67 HN68; was DICHLORISOPROTERENOL 1963-67 MHÑDichloroisoproterenol ANdo not use /biosyn /defic /physiol RN59-61-0 MND2.33.329.291.439.384; D2.92.63.291.439.384; D2.92.471.683.342; D16.848.215.300 XSDCI LH LS  MSA diphosphonate which affects calcium metabolism. It is an effective inhibitor of bone resorption and soft tissue calcification. HN(77) MHÑDichloromethylene Diphosphonate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN10596-23-3 PIOrganophosphorus Compounds (72-76); Phosphonic Acids (66-76) MND2.705.206.200 DMÑDIPHOSPHONATES LH LM  MS2,2╥-methylene-bis-(4-chlorophenol). Nontoxic laxative vermicide effective for taenia infestation; tends to produce colic and nausea. PM75 HN75 MHÑDichlorophen ANdo not use /biosyn /defic /physiol RN97-23-4 PIPhenols (66-74) MND2.755.190.270; D21.201.412.100.334 LH  MS5,6-Dichloro-1-beta-D-ribofuranosyl-1H-benzimidazol (DRB). Inhibits selectively and reversibly the synthesis of two-thirds of nuclear heterogeneous RNA and approximately 95% of mRNA. DRB can markedly increase interferon production by poly I-C-induced human fibroblasts. Used as a tool in the study of intracellular mechanisms. Synonym: DRB. HN(79) MHÑDichlororibofuranosylbenzimidazole ANdo not use /biosyn /defic /physiol; /analogs NIM only; DF: DCRFB RN53-85-0 PIBenzimidazoles (66-78); Nucleosides (66-70); Ribonucleosides (71-78) MND13.570.800.330 XSDichlorobenzimidazole Riboside DMÑRibonucleosides LH LS LM  MHÑDichlorphenamide ANdo not use /biosyn /defic /physiol RN120-97-8 MND8.373.220.334; D19.770.224.266.334 XSDiclofenamid LH LS  PM73 HN73(71) MHÑDichlorvos AN= Dimethyl diChloro Vinyl phOSphate; do not use /biosyn /defic /physiol; TN 111 for eff on insects RN62-73-7 PIInsecticides (66-70); Organophosphorus Compounds (66-70) MND2.705.190; D5.723.491.574.190 XSDDVP LH LS  MSTests for central hearing disorders based on the competing message technic (binaural separation). HN(80) MHÑDichotic Listening Tests ANNIM; only /instrum /methods /stand PIAuditory Perception (67-79); Hearing (66); Laterality (66-79); Perception (66) MNE1.276.299.375.330 DMÑHearing Tests LH LM  MSSodium[o-(2,6-dichloroanilino)phenyl]acetate. Anti-inflammatory agent with antipyretic and analgesic actions; pharmacologically similar to indomethacin. Synonyms: GP 45,840; Voltaren. PM86; was see under PHENYLACETATES 1977-85 HN86(77); was see under PHENYLACETATES 1977-85 MHÑDiclofenac ANdo not use /biosyn /defic /physiol RN15307-86-5 PIAniline Compounds (73-75); Phenylacetates (73-76) MND2.241.223.601.210; D14.73.278.282; D26.74.75.334 XSDiclophenac LH LS  PM73 HN73(66) MHÑDicloxacillin ANdo not use /biosyn /defic /physiol RN3116-76-5 MND20.85.99.739.681.205.289 XSDichloroxacillin LH LS  MS4,4'-dichloro-alpha-(trichloromethyl)benzhydrol. Miticide. Synonyms: Kelthane; DTMC; FW-293 HN(75) MHÑDicofol ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN115-32-2 PIAlcohol, Ethyl (73-74); Insecticides, Organochlorine (73-74) MND5.723.491.491.350 DMÑInsecticides, Organochlorine LH LM  MSInfection with flukes of the genus Dicrocoelium. PM68 HN68 MHÑDicrocoeliasis PITrematode Infections (66-67) MNC3.335.865.224 LH  OLfamily of trematodes; infection: coord NIM with TREMATODE INFECTIONS (IM) MH*Dicrocoeliidae (Non Mesh) MNB1.500.736.715.300 LH  MSA genus of trematode liver flukes of the family Dicrocoeliidae which includes the species dendriticum and hospes. It occurs in the biliary passages or liver of many vertebrates including man. The intermediate hosts are mainly mollusks but occasionally ants. MHÑDicrocoelium ANdo not use /blood-csf-urine; infection = DICROCOELIASIS MNB1.500.736.715.300.308 LH  MHÑDictionaries ANIM; no qualif; policy & relation to lang: Manual 33.14 CATALOG: /form /lang MNL1.178.682.192.836.285 LH  MHÑDictionaries, Chemical ANIM; no qualif CATALOG: /form /lang MNL1.178.682.192.836.285.206 LH  MHÑDictionaries, Classical ANIM; no qualif MNL1.178.682.192.836.285.277 LH  MHÑDictionaries, Dental ANIM; no qualif CATALOG: /form /lang MNL1.178.682.192.836.285.348 LH  MHÑDictionaries, Medical ANIM; no qualif CATALOG: /form /lang MNL1.178.682.192.836.285.419; L1.178.682.192.836.842.385 LH  MHÑDictionaries, Pharmaceutic ANIM; no qualif CATALOG: /form /lang MNL1.178.682.192.836.285.490 LH  MHÑDictionaries, Polyglot ANIM; no qualif CATALOG: GEN only: for special subj fields use specific heading /multilingual (as DICTIONARIES, MEDICAL /multilingual) or SPEC heading /dictionaries - multilingual (as SCIENCE /dictionaries - multilingual; DERMATOLOGY /dictionaries - multilingual) MNL1.178.682.192.836.285.561 LH  MSNematodes parasitic in the bronchi of herbivorous animals. HN(75); was see under METASTRONGYLOIDEA 1975-85 MHÑDictyocaulus ANdo not use /blood-csf-urine; infection = DICTYOCAULUS INFECTION MNB1.500.294.746.300 DMÑTrichostrongyloidea LH LM  MSInfection with nematodes of the genus Dictyocaulus. OLuse DICTYOCAULUS INFECTION to search DICTYOCAULIASIS back thru 1968 PM82; was DICTYOCAULIASIS 1968-81 HN82; was DICTYOCAULIASIS 1968-81 MHÑDictyocaulus Infection ANusually animal: do not use /vet but check tag ANIMAL PINematode Infections (66-67) MNC3.335.508.239; C22.674.377.315 XSDictyocauliasis LH LS  MSA cellular slime mold, family Dictyosteliaceae, class Dictyosteliomycetes, whose natural habitat is decaying forest leaves, where it feeds on bacteria a useful experimental organism. PM79; was see under MYXOMYCETES 1975-78 HN79(75); was see under MYXOMYCETES 1975-78 MHÑDictyostelium ANdo not use /anat /embryol /microbiol /parasitol PIMyxomycetes (66-74) MNB5.354.618.300 LH  HN(73) MHÑDicyclohexylcarbodiimide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN538-75-0 MND2.491.203.385 DMÑCarbodiimides LH LM  MS(Bicyclohexyl)-1-carboxylic acid-2-(diethylamino)ethyl ester. Spasmolytic agent with little effect on glandular secretion, or the cardiovascular system; may have some local anesthetic properties; used in gastrointestinal, biliary and urinary tract spasms. Synonyms: Atumin; Bentyl; Diocyl; Merbentyl; Wyovin. HN(76) MHÑDicyclomine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN77-19-0 PICyclohexanes (72-75); Cyclohexanecarboxylic Acids (68-75); Diethylamines (74-75) MND2.241.223.268.300; D2.455.426.392.368.367.440; D16.653.299 XSDicycloverin DMÑCyclohexanecarboxylic Acids LH LS LM  MHÑDieldrin ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN60-57-1 MND2.455.526.439.371; D5.723.491.491.366 LH  MHÑDiencephalon ANdo not use /innerv MNA8.186.211.385 LH  MS4,4'-(Diethylideneethylene)diphenol. A synthetic, non-steroidal estrogen. HN(75) MHÑDienestrol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN84-17-3 PIAlkadienes (74); Phenols (69-74) MND2.755.290; D6.597.350.245; D6.597.378.240 DMÑPhenols LH LM  MHÑDientamoeba ANdo not use /anat /blood-csf-urine /embryol; infection = DIENTAMOEBIASIS MNB1.841.443.180 LH  MSInfection with protozoa of the genus Dientamoeba. OLsearch AMEBIASIS 1967-74 HN(75) MHÑDientamoebiasis MNC3.752.55.218 DMÑAmebiasis LH LM  MSPeriod of sexual quiescence separating phases of the estrous cycle in polyestrous animals. HN(75) MHÑDiestrus ANanimal only; qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /rad eff MNG8.520.780.218.200 DMÑEstrus LH LM  MHÑDiet ANonly /adv eff /stand /trends (but do not confuse with DIET FADS); differentiation among food & diet headings: Manual 31.5; in vet journals consider also ANIMAL FEED, SILAGE, ANIMAL NUTRITION, etc.; TN 50: animal diet; note diet terms below; consider also DIABETIC DIET MNE5.272; G6.696.384 FXÑCOOKERY; ÑFood; ÑNutrition LH LX; ;  MSDiets which become fashionable, but not necessarily nutritious. MHÑDiet Fads ANonly /adv eff /hist /psychol MNE2.924.270; I3.287 XSFOOD FADS LH LS  MSSystematic collections of factual data pertaining to the diet of a human population within a given geographic area. OLsearch NUTRITION SURVEYS 1966-74 HN(75) MHÑDiet Surveys ANno qualif; TN 97: caution against word ╥survey╙ MNG3.850.520.610.630.310; N1.224.458.696.385 DMÑNutrition Surveys LH LM  MHÑDiet Therapy ANGEN only: prefer /diet ther with disease term: Manual 19.5+; when GEN & IM, do not use /util except by MeSH definition MNE2.293 LH  PM67 HN67 MHÑDiet, Atherogenic ANno qualif PIArteriosclerosis (66); Diet (66) MNE5.272.260 FXÑArteriosclerosis; ÑCHOLESTEROL, DIETARY LH LX;  PM73 HN73(72) MHÑDiet, Cariogenic ANno qualif PIDental Caries (66-71); Diet (66-71) MNE5.272.385 FXÑCariogenic Agents; ÑDental Caries LH LX;  MHÑDiet, Reducing ANonly /adv eff /hist /psychol /stand /trends /vet; coord with specific dis /diet ther CATALOG: do not use /pop wks MNE2.293.385 FXÑObesity LH LX  OLuse DIET, SODIUM-RESTRICTED to search DIET, SALT-FREE back thru 1966 PM80; was DIET, SALT-FREE 1963-79 HN80; was DIET, SALT-FREE 1963-79 MHÑDiet, Sodium-Restricted ANonly /adv eff /hist /stand /trends; coord with specific dis /diet ther MNE2.293.510 XSDiet, Low-Salt FXÑSodium Chloride LH LS LX  PM64 HN64 MHÑDietary Carbohydrates ANonly /admin /adv eff (coord with disease /etiol, not /chem ind) /anal /class /metab /pharm /stand /ther use (coord with specific dis /diet ther); low-carbohydrate diet: use /admin MND9.203.301 LH  PM64 HN64 MHÑDietary Fats ANonly /admin /adv eff (coord with disease /etiol, not /chem ind) /anal /class /metab /pharm /stand /ther use (coord with specific disease /diet ther); low-fat diet: use /admin MND10.516.212.302 LH  MSUnsaturated fats or oils used in foods or as a food. PM87 HN87 MHÑDietary Fats, Unsaturated PIDietary Fats (66-86); Oils (66-86) MND10.516.212.302.380; J1.740.250 XSDietary Oils; Unsaturated Dietary Fats LH LS;  MSThe remnants of plant cell walls that are resistant to digestion by the alimentary enzymes of man. It is comprised of various polysaccharides and lignins. PM82; was see under CELLULOSE 1977-81 HN82(77); was see under CELLULOSE 1977-81 MHÑDietary Fiber ANonly /admin /adv eff (coord with disease /etiol, not /chem ind) /anal /class /metab /pharm /rad eff /stand /ther use (coord with specific dis /diet ther) /tox; low- or high-fiber diet: use /admin MND9.203.698.365.180.305; G6.696.384.280 XSRoughage LH LS  MHÑDietary Proteins ANonly /admin /adv eff (coord with disease /etiol, not /chem ind) /anal /class /metab /pharm /stand /ther use (coord with specific dis /diet ther); /defic = PROTEIN DEFICIENCY; low- or high-protein diet: use /admin; EGG PROTEINS, MILK PROTEINS & VEGETABLE PROTEINS and specifics are also available; for dietary plant proteins see note on PLANT PROTEINS MND12.776.256 FXÑPROTEIN DEFICIENCY LH LX  MSServices provided by dietitians or nutritionists to meet the nutritional needs of individuals, including consultation with other professional personnel. PM68 HN68 MHÑDietary Services ANemphasis on nutrition: differentiate from FOOD SERVICES, mere preparation & distribution of ╥ready-to-eat food╙; only /class /econ /hist /legis /man /organ /stand /supply /trends /util PIDietetics (66-67); Food Service, Hospital (66-67) MNN2.421.242 FXÑDietetics LH LX  MSThe study and regulation of the diet. MHÑDietetics ANonly /econ /educ /hist /man /trends; principles of nutrition applied to feeding persons or groups of persons MNG2.188 FXÑDIETARY SERVICES; ÑFood Service, Hospital LH LX;  MSPyrocarbonic acid diethyl ester. Preservative for wines, soft drinks, fruit juices. Gentle esterifying agent. Synonyms: Baycovin;Ue 5908. HN(75) MHÑDiethyl Pyrocarbonate AND25-26 qualif; /analogs NIM only RN1609-47-8 PIFormic Acids (74); Esters (74) MND2.241.81.504.560.250; D26.471.385.250 XSDiethyl Dicarbonate; Diethyl Oxydiformate; Pyrocarbonic Acid Diethyl Ester DMÑFormates LH LS; ; LM  PM74 HN74 MHÑDiethylamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.471.302 LH  MHÑDiethylcarbamazine ANdo not use /biosyn /defic /physiol RN90-89-1 MND2.241.81.251.240; D3.383.606.380; D21.201.287.278.386 XSCarbamazine LH LS  MSDiethyldithiocarbamic acid. A chelating agent. It has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of disulfiram and has varied neurobiological actions. PM87; was see under THIOCARBAMATES 1975-86 HN87(75); was see under THIOCARBAMATES 1975-86 MHÑDiethyldithiocarbamate AND25-26 qualif RN147-84-2 PIThiocarbamates (69-74) MND2.241.81.251.869.200; D2.241.866.653.200; D2.886.703.200; D26.241.255 LH  MSBis(2-ethylhexyl)phthalate. A plasticizer. HN(75) MHÑDiethylhexyl Phthalate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN117-81-7 PIEsters (74); Phthalic Acids (69-74) MND2.241.223.805.250; D25.700.282 XSDioctyl Phthalate DMÑPhthalic Acids LH LS LM  MSN-Nitrosodiethylamine. A nitrosamine derivative with alkylating, carcinogenic and mutagenic properties. PM86; was see under NITROSAMINES 1975-85 HN86(75); was see under NITROSAMINES 1975-85 MHÑDiethylnitrosamine AND25-D26 qualif RN55-18-5 PINitrosamines (69-74) MND2.654.442.200; D26.191.646.263 XSNitrosodiethylamine LH LS  MHÑDiethylpropion AND25-26 qualif RN90-84-6 MND2.92.471.308; D26.128.336 XSAmfepramon LH LS  MHÑDiethylstilbestrol ANdo not use /biosyn /defic /physiol RN56-53-1 MND2.455.426.559.389.724.225; D6.597.350.270; D6.597.378.278; D7.360.276.310.360.260 XSSTILBESTROL LH LS  MSTechnic by which phase transitions of chemical reactions can be followed by observation of the heat absorbed or liberated. HN(77) MHÑDifferential Thermal Analysis ANNIM; only /instrum /methods PIHeat (66-76); Temperature (66-76); Thermodynamics (66-76) MNE5.196.370 DMÑChemistry, Analytical LH LM  MSThe smallest difference which can be discriminated between two stimuli; one which is barely above the threshold. Synonyms: Just Noticeable Difference; Weber-Fechner Law. PM74 HN74(72) MHÑDifferential Threshold ANNIM; no qualif PIPsychophysics (70-71); appropriate perception or sensation heading MNF2.463.593.230; F2.463.593.710.370 XSDifference Limen; JUST NOTICEABLE DIFFERENCE; WEBER-FECHNER LAW FXÑPsychophysics LH LS; ; LX  MSA disease of elderly men characterized by large osteophytes that bridge vertebrae and ossification of ligaments and tendon insertions. HN(85) MHÑDiffuse Idiopathic Skeletal Hyperostosis ANDF: DISH PISpinal Diseases (66-84); Spinal Osteophytosis (66-84); Spondylitis, Ankylosing (66-84) MNC5.878.741.350 XSForestier Disease; Vertebral Ankylosing Hyperostosis DMÑSpinal Osteophytosis LH LS; LM  MSThe tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. PM70 HN70(68) MHÑDiffusion ANalmost never IM; no qualif PIBiophysics (66-67); Chemistry, Physical 66-67); specific substance MNG6.184.307; H1.671.100.349 LH  MSThe broad dissemination of new ideas, procedures, technics, materials and devices and the degree to which these are accepted and used. HN(80) MHÑDiffusion of Innovation ANno qualif MNL1.143.320 XSInnovation Diffusion DMÑCommunication LH LS LM  MS6-alpha,9-Difluoro-11-beta,21-dihydroxy-16-alpha- methylpregna 1,4-diene-3,20-dione. Topical glucocorticoid used in various dermatoses; is absorbed through skin, bound to plasma albumin and may cause adrenal suppression; also used as the valerate. Synonyms: Nerisona; Nerisone; SH K 183 MB; HK 183 MB; Temetex. HN(80) MHÑDiflucortolone ANdo not use /biosyn /defic /physiol RN2607-06-9 PIFluocortolone/AA (75-79); Glucocorticoids (67); Glucocorticoids, Topical (73-79); Pregnadienes (73); Pregnadienediols (74-79); Pregnanes (68-72) MND4.808.745.432.719.320.250; D4.808.908.405.250; D6.597.481.364.325.250; D6.597.481.561.353.480.250; D26.74.125.335.268; D26.74.125.447.335.268; D26.74.148.447.335.268; D26.368.99.447.335.268 DMÑFluocortolone LH LM  MS2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid. Salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of aspirin. Synonyms: Dolobid; MK 647. HN(80) MHÑDiflunisal ANdo not use /biosyn /defic /physiol; /analogs NIM only RN22494-42-4 PISalicylic Acids (66-79) MND2.241.223.106.505.700.300; D2.241.511.390.700.300; D2.755.410.700.300; D14.73.278.861.288; D26.74.75.832.288 DMÑSalicylic Acids LH LM  MSCongenital syndrome with the absence of the thymus and parathyroids causing impairment of cellular immunity. Immunoglobulin levels are normal. HN(77) MHÑDigeorge Syndrome ANalso called thymic dysplasia, thymic aplasia & thymic agenesis PIParathyroid Glands (66-76); Thymus Gland (66-76) MNC20.673.340 DMÑImmunologic Deficiency Syndromes LH LM  MHÑDigestion ANonly /drug eff /rad eff MNG10.261.302 LH  OLsearch GASTROINTESTINAL SYSTEM 1966-71 PM72; was see under GASTROINTESTINAL SYSTEM 1963-71 HN72; was see under GASTROINTESTINAL SYSTEM 1963-71 MHÑDigestive System ANGEN: prefer specifics PIGastrointestinal System (66-71) MNA3 LH  OLconsider also DIGESTIVE SYSTEM /AB & /AB with specific parts of the digest syst MH*Digestive System Abnormalities (Non Mesh) MNC16.131.314 LH  PM80 HN80; was NON MESH before 1980 MHÑDigestive System Diseases ANGEN or unspecified; refers to all organs of digestive tract: do not confuse with GASTROINTESTINAL DISEASES (stomach & intestines only) PIGastrointestinal Diseases (66-79) MNC6 LH  PM80 HN80; was NON MESH before 1980 MHÑDigestive System Neoplasms ANGEN or unspecified; refers to all organs of digestive tract: do not confuse with GASTROINTESTINAL NEOPLASMS (stomach & intestines only); /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIGastrointestinal Neoplasms (66-79) MNC4.588.274; C6.240 LH  OLconsider also DIGESTIVE SYSTEM /PH or /PH with specific digest organs MH*Digestive System Physiology (Non Mesh) MNG10.261 LH  MH*Digestive, Oral, Skin Physiology (Non Mesh) MNG10 LH  MSA genus of toxic herbaceous Eurasian plants of the Scrophulaceae; they yield cardiotonic glycosides; the most useful are Digitalis lanata and D. purpurea. MHÑDigitalis ANthe plant, not the drug: see below; ╥digitalis ther╙ = DIGITALIS with no qualif (IM) + dis /drug ther (IM); do not use /isol /pathogen MNB6.560.290; B6.660.282 XSFoxglove LH LS  MHÑDigitalis Glycosides ANthe pharmacological principle in Digitalis; do not use /analogs /defic /physiol MND9.203.408.180.261; D18.222.175.324 LH  MSA glycoside obtained from Digitalis purpurea; the aglycone is digitogenin which is bound to five sugars; it solubilizes lipids, especially in membranes and is used as a tool in cellular biochemistry, and reagent for precipitating cholesterol. It has no cardiac effects. PM79; was see under DIGITALIS GLYCOSIDES 1975-78 HN79(73); was see under DIGITALIS GLYCOSIDES 1975-78 MHÑDigitonin ANdo not use /defic /physiol RN11024-24-1 PIDigitalis Glycosides (66-72); Indicators and Reagents (66-72) MND9.203.408.180.261.236; D26.550.226 XSDigitin LH LS  MS3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin. OLsearch CARDANOLIDES 1968-74 PM77; was see under CARDANOLIDES 1968-76 HN77(75); was see under CARDANOLIDES 1968-76 MHÑDigitoxigenin ANdo not confuse with DIGOXIGENIN; do not use /defic /physiol RN143-62-4 PICardanolides (68-74) MND4.808.155.160.278.350 LH  MHÑDigitoxin ANdo not confuse with DIGOXIN; do not use /defic /physiol RN71-63-6 MND4.808.155.160.278; D9.203.408.180.261.336; D18.222.175.324.261 XUÑAcetyldigitoxins LH LU  OLsearch GLYCERIDES 1968-74 HN(75) MHÑDiglycerides ANdo not use /analogs /defic /physiol MND10.516.351.303 XSDiacylglycerols DMÑGlycerides LH LS LM  MS3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh. HN(77) MHÑDigoxigenin ANdo not confuse with DIGITOXIGENIN; /biosyn permitted if by plant RN1672-46-4 PICardanolides (68-74); Digoxin/AA (75-76) MND4.808.155.160.349.350 XSLanadigenin DMÑDigoxin LH LS LM  MSToxic cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN; used in congestive heart failure; inhibits ATPase, leading to cardiac arrhythmias and heart block. Synonyms: Cardioxil; Digacin; Lanicor; Lanoxin; Rougoxin; Vanoxin. MHÑDigoxin ANdo not confuse with DIGITOXIN; do not use /defic /physiol RN20830-75-5 MND4.808.155.160.349; D9.203.408.180.261.436; D18.222.175.324.386 XUÑAcetyldigoxins; ÑDigoxigenin; ÑMedigoxin LH LU; ;  MS1,4-Dihydrazinophthalazine. Proposed antihypertensive agent. Synonyms: Hipopresol; Nepresol; Nonpressine; Pressalin. HN(76) MHÑDihydralazine ANdo not use /biosyn /defic /physiol RN484-23-1 PIHeterocyclic Compounds (68-74); Hydrazines (68-75); Pyridazines (68-75) MND3.383.710.605.500.250; D18.162.450.250 DMÑHydralazine LH LM  MSDihydro analog of beta-erythroidine, which is isolated from the seeds and other plant parts of Erythrina sp. Leguminosae. It is an alkaloid with curarimimetic properties. HN(75) MHÑDihydro-beta-Erythroidine ANdo not use /defic /physiol; /analogs NIM only RN23255-54-1 PIAlkaloids (69-74); Indoles (69-74) MND3.132.285; D3.549.380 DMÑAlkaloids LH LM  MSL-5,6-Dihydro-orotate amidohydrolase. In the course of pyrimidine biosynthesis, this enzyme catalyzes the ring closure by removal of water from N-carbamoylaspartate to yield dihydro-orotic acid. EC 3.5.2.3. HN(77) MHÑDihydro-Orotase ANdo not use /analogs RNEC 3.5.2.3 PIAmidohydrolases (66-76); Orotic Acid (66-76) MND8.586.277.87.280 XSCarbamoylaspartic Dehydrase; Dihydro-Orotate Amidohydrolase DMÑAmidohydrolases LH LS; LM  MSL-5,6-Dihydro-orotate:oxygen oxidoreductase. In the course of pyrimidine biosynthesis, this enzyme catalyzes the oxidation of dihydro-orotic acid to orotic acid utilizing NAD+ as the ultimate electron receptor. This enzyme is a flavoprotein which contains both FAD and FMN as well as iron-sulfur centers. EC 1.3.3.1. HN(77) MHÑDihydro-Orotate Oxidase ANdo not use /analogs RNEC 1.3.3.1 PIOrotic Acid (66-76); Oxidoreductases (66-76) MND8.586.682.310 XSDihydro-Orotate Dehydrogenase; Orotate Reductase DMÑOxidoreductases LH LS; LM  MS1-((Methylethyl)amino)-3-(2-propylphenoxy)- 2-propanol. Hydrogenated alprenolol derivataive where the extra hydrogens are usually tritiums; this radiolabeled form of alprenolol, a beta adrenergic blocker, is used to label the beta adrenergic receptor for isolation and study. HN(80) MHÑDihydroalprenolol ANdo not use /biosyn /defic /physiol RN60106-89-0 PIAlprenolol (72-74) /AA (75-79); Sympatholytics (66-71) MND2.33.329.624.58.200; D2.92.63.624.58.200; D16.848.215.106.276 DMÑAlprenolol LH LM  HN(64); was see under CHOLESTANES 1969-72, was see under STEROLS 1967-68 MHÑDihydrocholesterol ANdo not confuse with DEHYDROCHOLESTEROLS; do not use /defic /physiol RN80-97-7 MND4.808.247.100.250; D4.808.247.808.197.303; D10.516.851.208.387 XSBeta-Cholestanol; Coprostanol DMÑCholesterol LH LS; LM  MS9,10 alpha-Dihydro-12'-hydroxy-2',5' alpha-bis(1-methylethyl)-ergotaman-3',6',18-trione. One of the three constituents of dihydroergotoxine, a hydrogenated ergot alkaloid with alpha blocking, antiserotonin and vasoactive properties; used in migraine and other peripheral vascular disorders. HN(77) MHÑDihydroergocornine ANdo not use /biosyn /defic /physiol RN25447-65-8 PIDihydroergotoxine (75-76); Ergot Alkaloids, Hydrogenated (66-76) MND3.132.327.412.315.261; D3.549.439.190.261; D16.848.115.287.329.215.216 DMÑDihydroergotoxine LH LM  MS9,10-alpha-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5' alpha-(phenylmethyl)-ergotaman-3',6',18-trione. One of the three constituents of dihydroergotoxine, a hydrogenated ergot alkaloid with alpha blocking, antiserotonergic, and vasoactive properties; used as antihypertensive and peripheral vascular disease. HN(75); was see under ERGOT ALKALOIDS 1975-76 MHÑDihydroergocristine ANdo not use /biosyn /defic /physiol RN17479-19-5 PIErgot Alkaloids, Hydrogenated (66-74) MND3.132.327.412.315.272; D3.549.439.190.272; D16.848.115.287.329.215.272 XSDihydroergokrystin DMÑDihydroergotoxine LH LS LM  MS9,10 alpha-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5' alpha-(2-methylpropyl)-ergotaman-3',6',18-trione. A component of dihydroergotoxine; a hydrogenated ergot alkaloid with alpha blocking and vasoactive properties; used mainly in migraine and other peripheral vascular disorders. HN(77) MHÑDihydroergocryptine ANdo not use /biosyn /defic /physiol RN25447-66-9 PIDihydroergotoxine (75-76); Ergot Alkaloids, Hydrogenated (66-76) MND3.132.327.412.315.283; D3.549.439.190.283; D16.848.115.287.329.215.283 XSDihydroergokriptin DMÑDihydroergotoxine LH LS LM  MS9,10-dihydro-12'-hydroxy-2'-methyl-5'-alpha-(phenylmethyl) ergotaman-3',6',18-trone. A derivative of ergotamine prepared by the catalytic hydrogenation of ergotamine. Used as a vasoconstrictor, specifically for the therapy of migraine. Synonyms: as the mesylate:Dihydergot; Orstanorm; DHE-45. OLsearch ERGOTAMINE 1966-74 PM78; was see under ERGOTAMINE 1963-77 HN78(75); was see under ERGOTAMINE 1963-77 MHÑDihydroergotamine ANdo not use /biosyn /defic /physiol RN511-12-6 PIErgotamine (66-74) MND3.132.327.287.362.412.387; D3.132.327.412.303; D3.549.439.362.412.387; D16.848.115.287.329.208 LH  MSA mixture of three different ergotaman-3',6',18-triones, commonly called dihydroergocornine, dihydroergocristine and dihydroergocryptine; the combination of ethanesulfonate salts is Hydergine and that of methanesulfonates is Redergam. OLuse DIHYDROERGOTOXINE to search DIHYDROERGOTOXIN back thru 1975; to search HYDERGINE use DIHYDROERGOTOXINE back thru 1975 & ERGOT ALKALOIDS, HYDROGENATED 1966-74 PM77; was DIHYDROERGOTOXIN see under ERGOT ALKALOIDS, HYDROGENATED 1975-76; HYDERGINE was see under ERGOT ALKALOIDS, HYDROGENATED 1963-76; DIHYDROERGOCRISTINE was see under ERGOT ALKALOIDS 1975-76 HN77; was DIHYDROERGOTOXIN see under ERGOT ALKALOIDS, HYDROGENATED 1975-76; HYDERGINE was see under ERGOT ALKALOIDS, HYDROGENATED 1963-76 MHÑDihydroergotoxine ANdo not use /biosyn /defic /physiol RN11032-41-0 PIErgot Alkaloids, Hydrogenated (73-74) MND3.132.327.412.315; D3.549.439.190; D16.848.115.287.329.215 XSErgoloid Mesylate; Hydergine XUÑDihydroergocornine; ÑDihydroergocristine; ÑDihydroergocryptine LH LS; LU; ;  PM66 HN66 MHÑDihydrofolate Dehydrogenase ANdo not use /analogs RNEC 1.5.13 MND8.586.682.107.262 LH  MS4,5-Epoxy-17-methylmorphinan-3,6-alpha-diol. Semisynthetic endorphin analgesic used in the study of narcotic receptors; has abuse potential. HN(79) MHÑDihydromorphine ANdo not use /biosyn /defic /physiol; /analogs NIM only; do not confuse with DIHYDROMORPHINONE RN509-60-4 PIMorphine (66-68); Morphine Derivatives (69-78) MND3.132.610.422.547.547.350; D3.549.686.575.547.420; D3.605.497.575.547.420; D14.73.153.616.547.385; D14.757.638.547.385 XSParamorphan DMÑMorphine Derivatives LH LS LM  MS4,5-alpha-Epoxy-3-hydroxy-17-methylmorphinan-6-one. Narcotic analgesic made from morphine used mainly as analgesic; has shorter action than morphine. Synonyms: Dilaudid; Dimorphone; Hymorphan; Laudicon; Lucodan; Novolaudon; Semcox. OLto search DIHYDROMORPHINONE DERIVATIVES use DIHYDROMORPHINONE /AA back thru 1975 & MORPHINANS 1969-74 PMDIHYDROMORPHINONE DERIVATIVES was see under DIHYDROMORPHINONE 1975-77, was see under MORPHINANS 1969-74 HNDIHYDROMORPHINONE DERIVATIVES was see under DIHYDROMORPHINONE 1975-77, was see under MORPHINANS 1969-74 MHÑDihydromorphinone ANdo not use /biosyn /defic /physiol; dihydromorphinone derivatives = DIHYDROMORPHINONE /analogs RN466-99-9 MND3.132.610.422.547.547.362; D3.549.686.575.547.437; D3.605.497.575.547.437; D14.73.153.616.547.437; D14.757.638.547.437 XSHydromorphon; Laudacon XUÑOxymorphone LH LS; LU  MS20 alpha-Hydroxypregn-4-en-3-one. A naturally occurring progesterone derivative with progestational activity. HN(75) MHÑDihydroprogesterone AN/biosyn /physiol permitted RN145-14-2 PIProgesterone (74) MND4.808.745.745.654.829.200; D6.472.798.773.200 XS20 alpha-Hydroxyprogesterone DMÑProgesterone LH LS LM  MSNADPH:6,7-dihydropteridine oxidoreductase. Catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine. HN(75) MHÑDihydropteridine Reductase ANdo not use /analogs RNEC 1.6.99.7 PINADH, NADPH Oxidoreductases (73-74); Pteridines (73-74) MND8.586.682.608.250 DMÑNADH, NADPH Oxidoreductases LH LM  MS2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine-diphosphate:4-aminobenzoate 2-amino-4-hydroxy-dihydropteridine-6-methenyltransferase. Catalyzes the formation of dihydropteroate from p-aminobenzoic acid and dihydropteridine-hydroxymethyl-pyrophosphate. HN(75) MHÑDihydropteroate Synthase ANdo not use /analogs RNEC 2.5.1.15 PIAminobenzoic Acids (69-74); Ligases (69-74); Pteridines (69-74) MND8.586.913.315 XSDihydropteroate Pyrophosphorylase; Dihydropteroate Synthetase DMÑTransferases LH LS; LM  MHÑDihydrostreptomycin ANdo not use /defic /physiol RN128-46-1 MND9.203.408.51.885.387; D20.85.89.790.387; D20.85.826.387; D20.338.135.810.387 LH  MHÑDihydrotachysterol ANdo not use /defic /physiol RN67-96-9 MND4.808.247.222.387; D4.808.247.808.337; D4.808.812.387; D10.516.851.359; D11.786.763.337 LH  MS1,3-Dihydroxy-2-propanone. A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. HN(75) MHÑDihydroxyacetone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN96-26-4 PIAcetone (69-74); Trioses (69-74) MND9.203.546.465.200; D9.203.546.894.200 DMÑTrioses LH LM  MS1,3-Dihydroxy-2-propanone monodihydrogen phosphate. An important intermediate in lipid biosynthesis and in glycolysis. HN(75) MHÑDihydroxyacetone Phosphate AN/biosyn /physiol permitted; /analogs NIM only RN57-04-5 PIAcetone (72-74); Organophosphorus Compounds (73-74); Trioses (72-74) MND9.203.894.150 DMÑTrioses LH LM  MSCholecalciferols substituted with two hydroxy groups in any position. PM83; was see under HYDROXYCHOLECALCIFEROLS 1975-82 HN83(73); was see under HYDROXYCHOLECALCIFEROLS 1975-82 MHÑDihydroxycholecalciferols ANdo not use /analogs; /physiol permitted MND4.808.247.222.159.478.387; D4.808.247.808.146.478.387; D4.808.812.221.478.387; D10.516.851.152.478.387; D11.786.763.196.478.387 XSDihydroxyvitamins D LH LS  MSBenzopyrene saturated in any two adjacent positions and substituted with two hydroxyl groups in any position. The majority of these compounds have carcinogenic or mutagenic activity. PM87 HN87 MHÑDihydroxydihydrobenzopyrenes ANdo not use /biosyn /defic /physiol; DF: DDBPS PIBenzopyrenes (66-86) MND4.615.799.306.400; D26.191.262 XSBenzopyrene Dihydrodiols; Dihydrobenzopyrene Diols; Dihydrodiolbenzopyrenes XUÑ7,8-Dihydro-7,8-Dihydroxybenzo(a)pyrene 9,10-Oxide LH LS; ; LU  MSTryptamine substituted with two hydroxyl groups in any position. Some are cytotoxic serotonin analogs that are preferentially taken up by serotonergic neurons and then destroy those neurons. PM78 HN78 MHÑDihydroxytryptamines ANdo not use /analogs /biosyn /defic /physiol PITryptamines (66-77) MND3.438.473.914.201; D23.846.282 XUÑ5,7-Dihydroxytryptamine LH LU  MS5,7-Diiodo-8-quinolinol. One of the halogenated 8-Quinolinols widely used as intestinal antiseptic, especially an antiamebic agent; also used topically in other infections; may cause CNS and eye damage; known by very many similar trade names, world wide. HN(83)63 MHÑDiiodohydroxyquin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN83-73-8 MND3.438.810.350.350.200; D21.370.107.317 XSDiiodohydroxyquinolin; Diodoxyquinoline; Iodoquinol DMÑHydroxyquinolines LH LS; ; LM  MSEndogenous thyronine derivatives formed by the deiodination of T3 or reverse T3. They are believed to stimulate thyroid hormone-regulated functions as weak agonists by acting via the same receptors that mediate T3 actions. Have been used to detect fetal or infantile hypothyroidism by determination of their concentration in amniotic fluid, maternal sera and cord sera. The 3,3'- and 3,5-isomers are known. HN(79) MHÑDiiodothyronines AN/biosyn /physiol permitted; do not use /analogs PIThyronines (66-78) MND6.472.931.812.741.180; D12.125.72.734.741.180 DMÑThyronines LH LM  MHÑDiiodotyrosine RN66-02-4 MND6.472.931.208; D12.125.72.917.262 XSIODOGORGOIC ACID LH LS  MSThe act of dilating. PM76; was see under PATHOLOGY 1975 HN76(68); was in Cat C & E 1968-75 (Prov 1968-74), was see under PATHOLOGY 1975 MHÑDilatation ANnever IM; when NIM, only /instrum /methods MNE5.284 LH  MSDilatation of the cervix uteri followed by a scraping of the endometrium with a curette. PM75 HN75 MHÑDilatation and Curettage ANdo not use /util except by MeSH definition; DF: D & C PICurettage (66-74) MNE4.157.310; E4.819.608.310 XUÑVacuum Curettage LH LU  MSThe condition of an anatomical structure's being dilated beyond normal dimensions. OLsearch DILATATION 1968-75 (as Prov 1968-74, as Cat C & E heading 1968-75) PM76; was included in DILATATION see under PATHOLOGY 1975 HN76; was included in DILATATION 1968-75 (Prov 1968-74, Cat C & E heading 1968-75) MHÑDilatation, Pathologic ANnever IM; when NIM use any Cat C qualif pertinent PIDilatation (68-75) MNC23.739.275 LH  MS3,3'-(Perhydro-1,4-diazepin-1,4-diyl)-bis-(propyl-3,4,5-trimethoxybenzoate). Coronary vasodilator with some antiarrhythmic activity. Synonyms: Cormelian; ASTA C 4898. HN(75) MHÑDilazep ANdo not use /biosyn /defic /physiol; /analogs NIM only RN35898-87-4 PIAzepines (72-74); Benzoates (72-74) MND3.383.66.200; D18.918.208 DMÑAzepines LH LM  MS3-Acetoxy-2,3-dihydro-5[2-(dimethylamino)ethyl]-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one. A benzothiazepine derivative with vasodilating action, due to its antagonism of the actions of the calcium ion in membrane functions; it is also teratogenic. OLuse DILTIAZEM to search CRD 401 back thru 1975 PM87; was see under BENZAZEPINES 1979-86, was CRD 401 see under BENZAZEPINES 1975-78 HN87(79); was see under BENZAZEPINES 1979-86, was CRD 401 see under BENZAZEPINES 1975-78 MHÑDiltiazem ANdo not use /biosyn /defic /physiol RN42399-41-7 PIAnisoles (73-74); Benzazepines (71-74); Dimethylamines (73-74) MND3.438.79.150; D18.192.282; D18.918.214 XSCRD 401 LH LS  MHÑDimenhydrinate ANdo not use /biosyn /defic /physiol RN523-87-5 MND2.92.471.314; D2.455.426.559.389.115.225; D23.136.337 XSDiphenhydramine Theoclate LH LS  MHÑDimercaprol AND25-26 qualif RN59-52-9 MND2.886.489.180; D26.241.279 XSBAL XUÑUnithiol LH LS LU  MSmeso-2,3-Dimercaptosuccinic acid. A mercaptodicarboxylate used as antidote to heavy metal poisoning because it forms strong chelates with them; its mercury chelate, labeled with technetium, is used in renal imaging. Synonyms: DMS; DTS; meso-dimercaptosuccinate; RO 1-7977; Suximer. HN(79) MHÑDimercaptosuccinic Acid AND25-26 qualif; /analogs NIM only; DF: DMSA RN304-55-2 PISuccinates (66-78); Sulfhydryl Compounds (66-78) MND2.241.81.337.817.180; D2.886.489.190; D26.241.291 XSSuccimer DMÑSulfhydryl Compounds LH LS LM  MS5,5-Dimethyl-2,4-oxazolidinedione. Anticonvulsant. Synonym: Eupractone. HN(75) MHÑDimethadione ANdo not use /biosyn /defic /physiol; /analogs NIM only RN695-53-4 PIOxazoles (70-74) MND3.383.548.175; D14.261.350 DMÑOxazoles LH LM  MS2-[1-(2-(2-Dimethylaminoethyl)inden-3-yl)ethyl]pyridine. Histamine H1 blocker with some anticholinergic action; used in allergic rhinitis and for pruritus; may cause drowsiness. Synonyms: Fenistil; Fenoseil; Forhistal; Su 6518; Triten. MHÑDimethindene ANdo not use /biosyn /defic /physiol RN5636-83-9 MND3.383.725.210; D4.615.486.250; D23.654.432.261 XSDIMETHPYRINDENE; FORHISTAL LH LS;  PM73 HN73(65) MHÑDimethisterone ANdo not use /biosyn /defic /physiol RN79-64-1 MND4.808.745.745.279; D6.597.799.241; D7.360.276.210.443.706.227 LH  PM74 HN74(72) MHÑDimethoate ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN60-51-5 PIInsecticides (66-71) MND2.719.245; D5.723.491.657.262 XSPHOSPHAMIDE LH LS  OLsearch PHENETHYLAMINES 1968-74 HN(75) MHÑDimethoxyphenylethylamine ANdo not use /biosyn /defic /physiol; /analogs NIM only MND2.92.471.683.386 DMÑPhenethylamines LH LM  MSHexanediimidic acid, dimethyl ester. Bifunctional cross-linking agent that links covalently free amino groups of proteins or polypeptides, including those in cell membranes; used as reagent or fixative in immunohistochemistry; proposed antisickling agent. Synonym: adipimidic acid; dimethyl ester. HN(78); was see under IMIDES 1978-79 MHÑDimethyl Adipimidate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13139-70-3 PIAdipic Acids (66-77); Imides (66-77) MND2.241.81.337.52.250; D2.478.400.175; D26.550.430.175 XSDimethyl Adipimate; Dimethyl Adipinamidate DMÑImidoesters LH LS; LM  MSThe methyl imidoester of suberic acid used to produce cross links in proteins. Each end of the imidoester will react with an amino group in the protein molecule to form an amidine. HN(75); was see under IMIDES 1975-79 MHÑDimethyl Suberimidate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN29878-26-0 PIDicarboxylic Acids (74); Imides (73-74) MND2.478.400.200; D26.550.430.200 XSBismethyl Suberimidate DMÑImidoesters LH LS LM  MSSulfinylbis(methane). Industrial solvent found to be useful as topical analgesic, anti-inflammatory and skin penetrant vehicle for other topical agents. Synonyms: Demasorb; Demeso; Dolicur; Dromisol; Hyadur; NSC 763; Somnipront; SQ 9453; Syntexan. PM65 HN65(64) MHÑDimethyl Sulfoxide AND25-26 qualif RN67-68-5 MND26.74.75.350; D26.74.148.200; D26.328.304; D26.368.99.415 XSDMSO; Dimexide LH LS;  MSDimethylallyldiphosphate:isopentenyldiphosphate dimethylallyltransferase. In the pathway of cholesterol biosynthesis, this enzyme catalyzes the condensation of isopentenyl pyrophosphate and dimethylallylpyrophosphate to yield pyrophosphate and geranylpyrophosphate. The enzyme then catalyzes the condensation of the latter compound with another molecule of isopentenyl pyrophosphate to yield pyrophosphate and farnesylpyrophosphate. EC 2.5.1.1. HN(79) MHÑDimethylallyltransferase ANdo not use /analogs RNEC 2.5.1.1 PIAllyl Compounds (71-78); Transferases (66-78) MND8.586.913.322 XSFarnesylpyrophosphate Synthetase; Geranylpyrophosphate Synthetase; Prenyltransferase DMÑTransferases LH LS; ; LM  PM74 HN74(72) MHÑDimethylamines ANdo not use /analogs /biosyn /defic /physiol PIMETHYLAMINES MND2.92.668.387 LH  MHÑDimethylaminoazobenzene ANusually NIM in DAB-induced exper cancer: no qualif; when IM, D25-26 qualif RN29387-92-6 MND26.408.262; D26.191.282 XSBUTTER YELLOW; DAB XUÑMethyldimethylaminoazobenzene LH LS; LU  MSDimethyldithiocarbamic acid. Acts as a dopamine-beta-hydroxylase inhibitor. Its salts are agricultural fungicides. It is inferior to diethyldithiocarbamate as a chelating agent. HN(75) MHÑDimethyldithiocarbamate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN79-45-8 PIThiocarbamates (66-74) MND2.241.81.251.869.210; D2.241.866.653.210; D2.886.703.210 DMÑThiocarbamates LH LM  PM66 HN66(63) MHÑDimethylformamide AND25-26 qualif RN68-12-2 MND2.65.463.387; D2.241.81.504.310.387 LH  MSHydrazines substituted with two methyl groups in any position. The 1,2-isomer has carcinogenic properties. OLuse DIMETHYLHYDRAZINES to search 1,2 DIMETHYLHYDRAZINE back thru 1975 HN(78); was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77 MHÑDimethylhydrazines AND25-26 qualif; do not use /analogs PIHydrazines (68-74) MND2.442.600.400; D26.191.302 DMÑMethylhydrazines LH LM  MSN-Nitrosodimethylamine. A nitrosamine derivative with alkylating, carcinogenic and mutagenic properties; causes serious liver damage and is a hepatocarcinogen in rodents. PM80; was see under NITROSAMINES 1975-79 HN80(75); was see under NITROSAMINES 1975-79 MHÑDimethylnitrosamine ANdo not use /biosyn /defic /physiol RN62-75-9 PIAmines (66-71); Dimethylamines (74); Methylamines (71-74); Nitrosamines (66-74) MND2.654.442.225; D26.191.646.308 XSNitrosodimethylamine LH LS  MSSilicone polymers which consist of silicon atoms substituted with methyl groups and linked by oxygen atoms. A series of biocompatible materials used as liquids, gels or solids; as film for artificial membranes, gels for implants and liquids for drug vehicles and as antifoaming agents. HN(75) MHÑDimethylpolysiloxanes AND25-26 qualif; do not use /analogs PISilicone Elastomers (72-74); Silicones (72-74) MND1.836.820.800.200; D25.845.760.200 XSDimethylsiloxanes; Polydimethylsiloxanes DMÑSilicones LH LS; LM  MS3(2-(Dimethylamino)ethyl)indole. N-methylated indoleamine, serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood and urine; may be implicated in schizophrenia. Synonyms: DMT; N,N-dimethyltryptamine. HN(73) MHÑDimethyltryptamine ANdo not use /defic /physiol; /analogs NIM only RN61-50-7 MND3.438.473.914.237; D15.236.372.317 DMÑTryptamines LH LM  MS1,2-Dimethyl-5-nitroimidazole. Used to treat histomoniasis in poultry. Synonym: Emtryl. HN(75) MHÑDimetridazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN551-92-8 PINitroimidazoles (74) MND2.640.672.200; D3.383.374.658.200; D21.370.475 DMÑNitroimidazoles LH LM  MSN-(4-Chlorophenyl)-N'-(2,6-difluorobenzoyl)urea. An insect growth regulator which interferes with the formation of the insect cuticle. It is effective in the control of mosquitoes and flies. HN(77) MHÑDimilin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN35367-38-5 PIInsect Control (74-76); Juvenile Hormones (75-76); Mosquito Control (74-76); Phenylurea Compounds (74-76) MND2.948.684.280; D6.472.445.573.666.170 XSTH 6040 DMÑJuvenile Hormones LH LS LM  MS4,4'-(Triazene-1,3-ylen)-bis-(benzamidine aceturate). An effective trypanocidal agent. HN(75) MHÑDiminazene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN536-71-0 PIAmidines (69-74); Triazenes (74) MND2.78.100.260; D2.925.240; D21.370.884.240 DMÑAmidines LH LM  MSSynthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes. PM84 HN84 MHÑDimyristoylphosphatidylcholine ANdo not use /biosyn /defic /physiol RN13699-48-4 PIMyristates (77-80); Phosphatidylcholines (80-83) MND10.516.695.300.700.710.200; D26.550.257 XSDimyristoyllecithin LH LS  MS3,5-Dinitro-o-toluamide. A coccidiostat for poultry. HN(75) MHÑDinitolmide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN148-01-6 PIBenzamides (74); Nitrobenzenes (74) MND2.65.277.225; D2.241.223.106.162.225; D21.370.400.310 XSDinitrotoluamide; Methyldinitrobenzamide DMÑBenzamides LH LS; LM  MSBenzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions. HN(77) MHÑDinitrobenzenes ANincludes ortho-, meta- & para-dinitrobenzenes; do not use /analogs /biosyn /defic /physiol PIDinitrophenols (66-76); Nitrobenzenes (66-76) MND2.455.426.559.389.565.225; D2.640.529.240 XSDinitrophenyl Compounds DMÑNitrobenzenes LH LS LM  MS1-Chloro-2,4-dinitrobenzene. A skin irritant which may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds. PM87; was see under NITROBENZENES 1975-86 HN87(75); was see under NITROBENZENES 1975-86 MHÑDinitrochlorobenzene AND25-26 qualif RN97-00-7 PIChlorine (71-74); Nitrobenzenes (71-74) MND2.455.426.559.389.261.250; D2.455.426.559.389.565.250; D2.455.526.439.202.200; D2.640.529.240.250; D24.611.216.621.350; D26.550.250 XSChlorodinitrobenzene; DNCB LH LS;  HN(72) MHÑDinitrocresols ANdo not use /analogs /biosyn /defic /physiol PICresols (66-71); appropriate action term MND2.640.280; D2.755.239.493 DMÑCresols LH LM  MSIrritants and reagents for labeling terminal amino acid groups. HN(75) MHÑDinitrofluorobenzene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN70-34-8 PIFluorine (69-74); Nitrobenzenes (69-74) MND2.455.426.559.389.565.280; D2.640.529.240.280 XSDNFB; Fluorodinitrobenzene DMÑNitrobenzenes LH LS; LM  PM64 HN64(63) MHÑDinitrophenols ANdo not use /analogs /biosyn /defic /physiol MND2.640.743.304; D2.755.566.304; D5.723.288.263; D8.373.936.338 LH  MSProtozoans of the class Phytomastigophora, found mainly in the oceans; characterized by the presence of transverse and longitudinal flagella which propel the organisms in a rotating manner through the water. OLto search DINOFLAGELLATES use DINOFLAGELLIDA back thru 1975 & MASTIGOPHORA 1969-74; to search RED TIDE use DINOFLAGELLIDA back thru 1975 & MASTIGOPHORA 1974; use DINOFLAGELLIDA to search GONYAULAX, GYMNODINIUM & PERIDINIUM back thru 1979 PM86; was DINOFLAGELLATES 1979-85, was DINOFLAGELLATES see under MASTIGOPHORA 1969-78; RED TIDE was heading 1979-85, was see under MASTIGOPHORA 1974-78; GONYAULAX, GYMNODINIUM & PERIDINIUM were see RED TIDE 1979-85 HN86; was DINOFLAGELLATES 1979-85, was DINOFLAGELLATES see under MASTIGOPHORA 1969-78; RED TIDE was heading 1975-85, was see under MASTIGOPHORA 1974-78; GONYAULAX, GYMNODINIUM & PERIDINIUM were see RED TIDE 1979-85 MHÑDinoflagellida ANdo not use /anat /blood-csf-urine /embryol PIMastigophora (66-74) MNB1.841.443.214 XSGonyaulax; Gymnodinium; Peridinium; Red Tide FXÑSaxitoxin LH LS; ; ; LX  MSInfections with the nematode Dioctophyma renale. PM68 HN68 MHÑDioctophyma Renale Infections ANusually animal: do not use /vet but check tag ANIMAL PINematode Infections (66-67) MNC3.335.508.268; C22.674.377.363 LH  MSBis(2-ethylhexyl) sulfosuccinates. All-purpose surfactants, wetting agents, solubilizers used in the drug, cosmetics and food industries; also in laxatives and as cerumenolytic. Exists as the sodium or calcium salt. Synonyms: Aerosol; Colace; Coprolax; Diosuccin; Laxinate; Molatoc; Softil; Waxol. For calcium salt: Surfak. HN(78) MHÑDioctyl Sulfosuccinates AND25-26 qualif PISuccinates (66-77); Surface-Active Agents (66-77) MND2.241.81.337.817.200; D19.316.396.298; D26.866.408 DMÑSuccinates LH LM  MS(25R)-Spirost-5-en-3-beta-ol. A steroid sapogenin which is isolated from various plants. Can be converted to ecdysone, pregnenolone, and progesterone. Synonym: nitogenin. HN(79) MHÑDiosgenin ANdo not use /defic /physiol; /analogs NIM only RN512-04-9 PIHydroxysteroids (72-75); Saponins (66-75); Spirostans (68-78) MND4.808.854.700.275 DMÑSapogenins LH LM  MS3',5,7-Trihydroxy-4'-methoxyflavone-7-rutinoside. A bioflavonoid that strengthens vascular walls. Synonyms: Daflon; 4601 SE HN(75) MHÑDiosmin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN520-27-4 PIBioflavonoids (73-74) MND9.203.408.134.200 XSBarosmin; Buchu Resin DMÑBioflavonoids LH LS; LM  OLsearch DIOXINS 1966-74 HN(75)63-67 MHÑDioxanes ANdo not use /analogs /biosyn /defic /physiol MND3.383.231.388 DMÑDioxins LH LM  PM68; DIOXANES was heading 1963-67 HN68 MHÑDioxins ANdo not use /analogs /biosyn /defic /physiol MND3.383.231 XUÑDioxanes; ÑTetrachlorodibenzodioxin LH LU;  OLsearch DIOXOLES 1968-74 HN(75) MHÑDioxolanes ANdo not use /analogs /biosyn /defic /physiol MND3.383.246.238 DMÑDioxoles LH LM  PM68 HN68 MHÑDioxoles ANdo not use /analogs /biosyn /defic /physiol PIHeterocyclic Compounds (66-67) MND3.383.246 XUÑDioxolanes; ÑSafrole LH LU;  MHÑDipeptidases ANdo not use /analogs RNEC 3.4.13. MND8.586.277.656.360 LH  PMANSERINE & CARNOSINE were see under PEPTIDES 1963-66 MHÑDipeptides ANdo not use /analogs /defic /physiol MND12.644.456.345 XUÑAnserine; ÑAspartame; ÑCarnosine; ÑGlycylglycine LH LU; ; ;  MSDipeptidylpeptide hydrolases. Enzymes which cleave dipeptides from the amino terminal of a polypeptide. Dipeptidyl peptidase I, II, III, IV are known. They hydrolyze the beta-naphthylamides of glycine-arginine, lysine-alanine, arginine-arginine and glycine-proline, respectively. Dipeptidyl peptidase I is cathepsin C. EC 3.4.14. PM86; was see under PEPTIDE PEPTIDOHYDROLASES 1980-85 HN86(80); was see under PEPTIDE PEPTIDOHYDROLASES 1980-85 MHÑDipeptidyl Peptidases ANdo not use /analogs RNEC 3.4.14. PICathepsins (66-79); Dipeptidases (66-79); Peptide Peptidohydrolases (66-79) MND8.586.277.656.732.240 XSDipeptidyl Aminopeptidases LH LS  MSA filarial nematode parasite of mammalian blood with the vector being a tick or small fly. OLuse DIPETALONEMA to search ACANTHOCHEILONEMA back thru 1966 PM86; was ACANTHOCHEILONEMA 1963-85 HN86; was ACANTHOCHEILONEMA 1963-85 MHÑDipetalonema ANdo not use /blood-csf-urine; infection = DIPETALONEMA INFECTIONS MNB1.500.294.530.208 XSAcanthocheilonema LH LS  MSInfections with nematodes of the genus Dipetalonema. OLto search ACANTHOCHEILONEMIASIS use DIPETALONEMA INFECTIONS 1975-85 & NEMATODE INFECTIONS 1967-74 HN(86); was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85, was ACANTHOCHEILONEMIASIS see under NEMATODE INFECTIONS 1967-74 MHÑDipetalonema Infections MNC3.335.508.361.70 XSAcanthocheilonemiasis DMÑFilariasis LH LS LM  MS2-Diphenylmethoxy-N,N-dimethylethylamine. Histamine H1 blocker with anticholinergic and sedative properties; it is used as an antiemetic, antitussive and for dermatoses and pruritus. Synonyms: Alledryl; Allergin; Benadryl; Dibondrin; Hista-Sed; Syntedril. MHÑDiphenhydramine ANdo not use /biosyn /defic /physiol RN58-73-1 MND2.92.471.320; D2.455.426.559.389.115.250; D23.654.432.279 XSBenhydramin; Diphenylhydramin LH LS;  PM68; DOPA OXIDASE & TYROSINASE were see TYROSINE DECARBOXYLASE 1963-67 HN68 MHÑDiphenol Oxidases ANdo not use /analogs RNEC 1.10.3.1 PIOxidoreductases (66-67); Tyrosine Decarboxylase (66-67) MND8.586.682.420.238 XUÑDopa Oxidase; ÑTyrosinase LH LU;  MS1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester. Meperidine congener used as an antidiarrheal, usually in combination with atropine; at high doses acts like morphine; its unesterified metabolite difenoxin has similar properties and is used similarly. Synonyms: CB 8049; FH 049-E; R 1132. HN(75) MHÑDiphenoxylate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN915-30-0 PIIsonipecotic Acids (70-74); Nitriles (74) MND3.66.399.300; D3.383.621.349.300; D14.757.471.275; D19.316.161.209 DMÑIsonipecotic Acids LH LM  PM68 HN68 MHÑDiphenylacetic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.601.238 LH  MSIn humans it may be irritating to mucous membranes. Methemoglobinemia has been produced experimentally. In veterinary use, it is one of active ingredients in topical agents for prevention and treatment of screwworm infestation. An indicator in tests for nitrate poisoning. HN(75) MHÑDiphenylamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN122-39-4 PIAniline Compounds (69-74) MND2.92.146.350 DMÑAniline Compounds LH LM  MSsym-Diphenylcarbazide. Used as an indicator in titrating iron and for the colorimetric determination of chromium and the detection of cadmium, mercury, magnesium, aldehydes and emetine. HN(75) MHÑDiphenylcarbazide AND25-26 qualif; /analogs NIM only RN140-22-7 PIBenzene Derivatives (72-74); Semicarbazides (72-74) MND2.845.250; D26.550.265 XS1,5-Diphenylcarbazide DMÑSemicarbazides LH LS LM  MS1,7-Diphenyl-1,3,5-hexatriene. A fluorescent compound that emits light only in specific configurations in certain lipid media; used as a tool in the study of membrane lipids. Synonyms: DPH; 1,6-diphenylhexatriene. HN(80) MHÑDiphenylhexatriene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1720-32-7 PIPolyenes (66-79); Spectrometry, Fluorescence (74-79) MND2.455.326.271.665.250; D26.408.348.249 DMÑPolyenes LH LM  MS5,5'-diphenyl-2-thiohydantoin. An inducer of microsomal drug-metabolizing enzymes. HN(75) MHÑDiphenylthiohydantoin ANdo not use /biosyn /defic /physiol RN21083-47-6 PIPhenytoin (72-74); Thiohydantoins (73-74) MND3.383.374.411.730.200; D3.383.374.411.868.350 DMÑPhenytoin LH LM  PM74 HN74(73) MHÑDiphosphoglyceric Acids ANdo not use /analogs /biosyn /defic /physiol PIGlyceric Acids (68-72); Organophosphorus Compounds (71-72) MND2.241.81.844.387.388; D2.241.511.902.387.388; D2.705.196; D9.203.811.366.388 XSBisphosphoglycerates LH LS  MSOrganic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. PM77 HN77 MHÑDiphosphonates ANdo not use /analogs /biosyn /defic /physiol PIOrganophosphorus Compounds (71-76); Phosphonic Acids (66-76) MND2.705.206 XUÑDichloromethylene Diphosphonate LH LU  MHÑDiphtheria MNC1.252.246.388 LH  MHÑDiphtheria Antitoxin ANfor ther (toxoid is for prev); only /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.121.388; D24.611.125.272.438 LH  MSA 60 kD single chain protein elaborated by Corynebacterium diphtheriae that causes the sign and symptoms of diphtheria; it can be broken into two unequal fragments, the smaller (A fragment) inhibits protein synthesis and is the lethal moiety that needs the larger (B fragment) for entry into cells. MHÑDiphtheria Toxin ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also DIPHTHERIA ANTITOXIN MND24.185.926.123.305 XSCorynebacterium Diphtheriae Toxin FXÑCorynebacterium Diphtheriae LH LS LX  MHÑDiphtheria Toxoid ANfor prev (antitoxin is for ther); only /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.794.263 XSDiphtheria Vaccine LH LS  MSInfection with tapeworms of the genus Diphyllobothrium. PM68 HN68 MHÑDiphyllobothriasis ANa tapeworm infection; consider also SPARGANOSIS (infection at larval stage) PICestode Infections (66-67) MNC3.335.190.304 LH  MSA genus of tapeworm containing several species which occurs in the intestine of fish, birds, and mammals including man. Infection in humans is usually by eating uncooked fish. The larval stage is known as SPARGANUM. MHÑDiphyllobothrium ANdo not use /blood-csf-urine; infection = DIPHYLLOBOTHRIASIS MNB1.500.736.215.228 LH  MSThe chromosomal constitution of somatic cells, in which each type of chromosome is represented twice. Symbol: 2N or 2X. PM68 HN68 MHÑDiploidy ANno qualif PIChromosomes (66-67) MNG5.148.777.264 LH  MHÑDiplopia MNC10.597.622.447.333; C10.597.751.941.339; C11.966.339; C23.888.592.636.447.333; C23.888.592.763.941.339 LH  MSA genus of the family Heteromyidae which contains 22 species. Their physiology is adapted for the conservation of water, and they seldom drink water. They occur in arid or desert habitats and travel by hopping on their hind limbs. OLuse DIPODOMYS to search KANGAROO RATS back thru 1975 HN(82); was KANGAROO RATS see under RODENTS 1975-81 MHÑDipodomys ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not confuse KANGAROO RATS with rat kangaroos ( = KANGAROOS); do not check tag RATS MNB2.649.865.510 XSKangaroo Rats; Rats, Kangaroo DMÑRodentia LH LS; LM  MS21-Cyclopropyl-6,7,8,14-tetrahydro-7 alpha-(1-hydroxy-1-methylethyl)-6,14-endo-ethanooripavine. Narcotic antagonist similar in action to naloxone; used to remobilize animals after etorphine neuroleptanalgesia and considered a specific antagonist to etorphine. Synonym: Revivon. HN(76) MHÑDiprenorphine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN14357-78-9 PICyclopropanes (73-75); Morphinans (73-75) MND3.132.610.422.250; D3.549.686.275; D3.605.497.280; D14.712.256 DMÑMorphinans LH LM  MSAn order of the class Insecta. Wings, when present, number two and distinguish Diptera from other insects called flies, while the halters, or reduced hindwings, separate Diptera from other insects having one pair of wings. Includes the families Calliphoridae, Oestridae, Phoridae, Sarcophagidae, Scatophagidae, Sciaridae, Simuliidae, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE, CHIRONOMIDAE, Culicidae (MOSQUITOES), Drosophilidae (include DROSOPHILA, DROSOPHILA MELANOGASTER), Glossinidae (include TSETSE FLIES), Muscidae (include HOUSEFLIES), and Psychodidae (includes PHLEBOTOMUS). OLuse DIPTERA to search FLIES 1966-80 PM81, 63-74; FLIES was heading 1975-80, was see under DIPTERA 1963-74; MIDGES (either MIDGES, BITING see CERATOPOGONIDAE or MIDGES, NONBITING see CHIRONOMIDAE, an XU below, as of 1981) was see under DIPTERA 1975-80; CERATOPOGONIDAE was see CULICOIDES 1975-80; CULICOIDES (see CERATOPOGONIDAE as of 1981) was heading 1963-80 HN81, 63-74; FLIES was heading 1975-80, was see under DIPTERA 1963-74 MHÑDiptera AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111; index caddisfly, dragonfly, mayfly & stonefly under INSECTS, firefly under BEETLES, sawfly & ichneumon fly under HYMENOPTERA; fruit fly (unspecified) = DROSOPHILA or DROSOPHILA MELANOGASTER MNB1.131.617.289 XSFlies, True XUÑChironomidae LH LS LU  PM66; was PERSANTIN 1963-65 HN66; was PERSANTIN 1963-65 MHÑDipyridamole ANdo not use /biosyn /defic /physiol RN58-32-2 MND3.383.621.190; D3.383.742.175; D18.918.222 LH  MSSodium(antipyrinylmethylamino)methanesulfonate monohydrate. Analgesic used for neuritis and arthritis; it may cause agranulocytosis. Synonyms: Narone; Novalgin; Pyralgin. HN(75) MHÑDipyrone AND25-26 qualif; do not confuse with DIPYRINE (see AMINOPYRINE) RN68-89-3 PIAntipyrine (72-74); Methanesulfonates (74) MND3.383.694.50.150; D14.73.278.152.192.320; D26.74.75.204.192.320 XSAnalgin; Metamizole; Methampyrone; Noramidopyrine Methanesulfonate DMÑAminopyrine LH LS; ; ; LM  HN(71) MHÑDiquat ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2764-72-9 PIHerbicides (66-70); Pyridinium Compounds (68-70) MND3.383.725.762.352; D5.723.366.313 DMÑPyridinium Compounds LH LM  MSMost abundant proteins in cobra (Naja of the Elapids) venom; basic polypeptides of 57 to 62 amino acids with four disulfide bonds and a molecular weight of less than 7000; causes skeletal and cardiac muscle contracture, interferes with neuromuscular and ganglionic transmission, depolarizes nerve, muscle and blood cell membranes, thus causing hemolysis. Synonyms: cobramine A; cobramine B; cobra cytotoxin; gamma toxin; membrane-active polypeptide. HN(78) MHÑDirect Lytic Factors ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS PIPeptides (66-77); Proteins (66-77); Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) MND24.185.965.850.325.220.260 XSCobra Cardiotoxin DMÑCobra Venoms LH LS LM  MSCosts which are directly identifiable with a particular service. OLsearch COSTS AND COST ANALYSIS 1968-74 HN(75) MHÑDirect Service Costs ANonly /class /legis /trends MNN3.219.151.472 XSCosts, Direct Service DMÑCosts and Cost Analysis LH LS LM  MHÑDirectories ANIM; no qualif; includes lists of members of societies & acad, etc.; policy: Manual 33.13; specify geog CATALOG: /geog /form MNL1.178.682.192.836.339 LH  MSA genus of filarial nematodes. Various immature species have been found to infect the eyes or subcutaneous tissue in humans. OLsearch FILARIOIDEA 1966-74 HN(75) MHÑDirofilaria ANdo not use /blood-csf-urine; infection = DIROFILARIASIS MNB1.500.294.530.230 DMÑFilarioidea LH LM  MSThe ╥heartworm╙ is a filarial parasite primarily of dogs but does occur in foxes, wolves, and humans. The parasite is transmitted by mosquitoes. HN(75) MHÑDirofilaria immitis ANdo not use /blood-csf-urine; infection = DIROFILARIASIS MNB1.500.294.530.230.200 XSDog Heartworm DMÑFilarioidea LH LS LM  MSInfection with nematodes of the species Dirofilaria, usually in animals, especially dogs, but occasionally in man. PM68 HN68 MHÑDirofilariasis PIFilariasis (66-67) MNC3.335.508.361.264 XSHEARTWORM DISEASE LH LS  MHÑDisability Evaluation ANno qualif MNE1.373 FXÑEligibility Determination; ÑRehabilitation; ÑVeterans Disability Claims; ÑWorkmen's Compensation LH LX; ; ;  PM74 HN74 MHÑDisaccharidases ANdo not use /analogs RNEC 3.2.1.- MND8.586.277.450.329 LH  MHÑDisaccharides ANGEN; prefer specifics; do not use /analogs /defic /physiol MND9.203.698.629.305 XUÑCellobiose; ÑIsomaltose; ÑLactulose; ÑMelibiose; ÑTrehalose LH LU; ; ; ;  PM72 HN72 MHÑDisarticulation ANdo not use /util except by MeSH definition PIAmputation (66-71) MNE4.557.69.472 LH  MSProcedures outlined for the care of casualities, and the maintenance of services in disasters. PM78 HN78 MHÑDisaster Planning ANonly /econ /methods /stand /trends; specify disaster (IM) if pertinent; specify geog if pertinent PIDisasters (66-77) MNG3.230.100.35 FXÑCivil Defense LH LX  PMRELIEF WORK was see under DISASTERS & INDIGENT CARE 1963-67 MHÑDisasters ANonly /econ /prev MNG3.230.100 XUÑNatural Disasters; ÑRelief Work LH LU;  MH*Disciplines, Tests, Therapy, Services (Non Mesh) MNF4 LH  MSDifferential response to different stimuli. OLuse DISCRIMINATION (PSYCHOLOGY) to search DISCRIMINATION 1966-77 PM78; was DISCRIMINATION 1966-77 HN78; was DISCRIMINATION 1966-77 MHÑDiscrimination (Psychology) ANnot for ╥discriminating tastes╙ & not for racial, religious or social discrimination ( = PREJUDICE); only /drug eff /physiol /rad eff; DF: DISCRIMINATION MNF2.463.593.257 LH  MSLearning that is manifested in the ability to respond differentially to various stimuli. MHÑDiscrimination Learning ANonly /drug eff /physiol /rad eff MNF2.463.425.280 LH  MSThe state of the organism when function is impaired. MHÑDisease ANGEN only as a physiol, pathol, philosophical concept, opposite ╥health╙; Manual 23.4.1-23.4.4; /diag = DIAGNOSIS, /diet ther = DIET THERAPY, /drug ther = DRUG THERAPY, /familial = HEREDITARY DISEASES, /immunol = IMMUNOLOGY or IMMUNITY, /mortal = MORTALITY, /nurs = NURSING CARE, /occur = MORBIDITY or EPIDEMIOLOGY, /pathol = PATHOLOGY, /prev = PREVENTIVE MEDICINE, /radiother = RADIOTHERAPY, /rehabil = REHABILITATION, /surg = SURGERY, OPERATIVE, /ther = THERAPEUTICS, /transm: permitted for general theory but consider COMMUNICABLE DISEASES as probably better; /vet = VETERINARY MEDICINE or ANIMAL DISEASES; /psychol permitted but consider also psychogenic origin of disease as PSYCHOPHYSIOLOGIC DISORDERS; only likely qualif are /class & /etiol: no others MNC23.280; N1.407.306 XUÑRecurrence; ÑRemission, Spontaneous; ÑSyndrome LH LU; ;  MSAnimal disease whose pathologic mechanisms are sufficiently similar to those of a different human disease for the animal disease to serve as a model. The animal disease may be either induced or naturally occurring so long as it is not the same clinical entity as the disease for which it serves as a model. E.g., scrapie is an animal model for multiple sclerosis, which has never been found or induced in an animal. PM70 HN70 MHÑDisease Models, Animal ANarticle must be on an anim dis as a model: not all articles on anim dis or exper dis are ╥disease models╙; IM or NIM; when IM, coord with specific dis (IM) + specific animal term if pertinent (IM); no qualif PIAnimal Diseases (66-69); Models, Biological (68-69) MNC23.280.329 FXÑModels, Biological LH LX  MSSudden increase in the incidence of a disease; includes epidemics. PM68 HN68(66) MHÑDisease Outbreaks ANIM; only /class /econ /hist /prev /vet; coord IM with specific dis /occur (IM) & specify geog CATALOG: /geog /form MNG3.850.290 XSEpidemics; Outbreaks FXÑCommunicable Diseases; ÑSpace-Time Clustering LH LS; LX;  MSAnimate or inanimate sources which harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs should be distinguished from vectors and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks. PM67 HN67(65) MHÑDisease Reservoirs ANIM; note category; differentiate from DISEASE VECTORS (B1 & B2): reservoirs can be animate or inanimate (like swamps, housedust, etc.); only /class /vet MNG3.850.295 FXÑCARRIER STATE; ÑCOMMUNICABLE DISEASE CONTROL; ÑCommunicable Diseases; ÑDISEASE VECTORS; ÑZOONOSES LH LX; ; ; ;  MSA constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. OLuse DISEASE SUSCEPTIBILITY to search DIATHESIS back thru 1966 PM81; was DIATHESIS 1963-80 HN81; was DIATHESIS 1963-80 MHÑDisease Susceptibility ANIM GEN only; NIM with no qualif when specific dis is IM; do not use /drug ther /radiother; use other Cat C qualif discreetly MNC23.280.341; G7.265.300 XSDiathesis FXÑHEMORRHAGIC DIATHESIS LH LS LX  MSInvertebrates or non-human vertebrates which transmit infective organisms from one host to another. For human vectors the preferred term is CARRIER STATE. PM67 HN67(65) MHÑDisease Vectors ANIM; see note on INSECT VECTORS & ARTHROPOD VECTORS; only /class /isol MNB1.371; B2.389 FXÑCommunicable Disease Control; ÑDisease Reservoirs LH LX;  MHÑDiseases in Twins ANIM; human only; no qualif; the disease may be in only one or in both twins; Manual 34.20 MNC23.280.368 FXÑGenetics, Medical; ÑTwins LH LX;  MH*Diseases of Body Regions (Non Mesh) MNC23.304 LH  OLsearch ANTI-INFECTIVE AGENTS, LOCAL 1966 PM67; was see ANTISEPTICS 1963-66 HN67; was see ANTISEPTICS 1963-66 MHÑDisinfectants ANdo not use /analogs /biosyn /defic /physiol PIAnti-Infective Agents, Local (66) MND20.187.222 FXÑAnti-Infective Agents, Local LH LX  OLsearch STERILIZATION 1966-74 HN(75)63-66 MHÑDisinfection ANonly /econ /hist /instrum /methods /stand; differentiate from STERILIZATION: DISINFECTION renders matter free of pathogens, STERILIZATION destroys all microbes; if in doubt, use the word of the text MNG3.850.180.800.250 DMÑSterilization LH LM  MHÑDislocations ANbones & joints only: not for lens ( = LENS DISLOCATION AND SUBLUXATION), testis, etc.; IM; Manual 23.30; luxation & subluxation go here MNC21.866.289 LH  MSDisodium-5,5'c-[(2-hydroxytrimethylene)dioxy]-bis[4-oxo-4H-1-benzopyran-2-carboxylate]. An inhibitor of the release of histamine and other spasmogenic slow-reacting substances; used as prophylactic in the treatment of allergic bronchial asthma. Synonyms: Aarane; FPL 670; Intal; Lomudal. PM73 HN73(71) MHÑDisodium Cromoglycate ANdo not use /biosyn /defic /physiol RN15826-37-6 PIChromones (66-70) MND3.438.150.266.390; D16.116.203; D23.654.246 XSCROMOLYN SODIUM; Sodium Cromoglycate LH LS;  PM84; was see under PYRIDINES 1975-83 HN84(72); was see under PYRIDINES 1975-83, was Prov 1972-74 MHÑDisopyramide ANdo not use /biosyn /defic /physiol RN3737-09-5 PIAnti-Arrhythmia Agents (66-71); Pyridines (66-71) MND3.383.725.227; D18.97.240 LH  MHÑDispensatories ANonly /hist /stand MNL1.178.682.192.836.390 LH  MSThe process by which an emotional or behavioral response that is appropriate for one situation appears in another situation for which it is inappropriate. PM68 HN68 MHÑDisplacement (Psychology) ANno qualif; DF: DISPLACEMENT PIBehavior (66-67); Psychoanalytic Interpretation (66-67) MNF1.145.299; F1.393.246; F3.407.246 XUÑCathexis; ÑScapegoating LH LU;  PM66 HN66 MHÑDisposable Equipment ANonly /econ /stand /supply /util (if by MeSH definition) /vet MNE7.252 LH  MHÑDissection ANonly /hist /instrum /methods /stand /vet MNE4.221 FXÑAnatomy LH LX  PM72 HN72(70) MHÑDisseminated Intravascular Coagulation ANdo not confuse with ERYTHROCYTE AGGREGATION, INTRAVASCULAR; DF: DISSEM INTRAVASC COAG PIBlood Coagulation Disorders (66-69) MNC15.378.463.134.307 XSCONSUMPTION COAGULOPATHY LH LS  MSDissertations embodying results of original research and especially substantiating a specific view, e.g., substantial papers written by candidates for an academic degree under the individual direction of a professor, papers written by undergraduates desirous of achieving honors or distinction. OLuse DISSERTATIONS, ACADEMIC to search THESES back thru 1966 HNTHESES was see under DISSERTATIONS, ACADEMIC 1963-78 MHÑDissertations, Academic ANonly /hist /stand MNL1.178.682.389 XSTheses LH LS  MSSudden temporary alterations in the normally integrative functions of consciousness. Psychogenic amnesia (amnesia not due to organic causes), psychogenic fugue (wandering away from one's home with assumption of a new identity), MULTIPLE-PERSONALITY DISORDER, and DEPERSONALIZATION DISORDER are in this group of disorders. OLuse DISSOCIATIVE DISORDERS to search DISSOCIATIVE REACTION & FUGUE back thru 1966 & DISSOCIATION back thru 1969 PM81; was DISSOCIATIVE REACTION 1968-80; FUGUE was heading 1963-67 HN81; was DISSOCIATIVE REACTION 1968-80; DISSOCIATION was see under DISSOCIATIVE REACTION 1969-78; FUGUE was see under DISSOCIATIVE REACTION 1968-78, was heading 1963-67 MHÑDissociative Disorders ANdo not use /drug eff /physiol /rad eff MNF1.393.282; F3.407.282; F3.709.438.416 XSDissociation; Fugue; Hysteria, Dissociative LH LS; ;  MSOligopeptides from Streptomyces distallicus; pyrrole derivatives with antiviral, antibacterial, antifungal and antineoplastic activities. Their binding to DNA inhibits synthesis of nucleic acids. HN(75) MHÑDistamycins ANdo not use /analogs /defic /physiol PIAmidines (72-74); Oligopeptides (73-74); Pyrroles (70-74) MND3.383.757.110; D12.644.456.365; D20.85.276 DMÑPyrroles LH LM  MSThe act of knowing or the recognition of a distance by recollective thought, or by means of a sensory process which is under the influence of set and of prior experience. PM66 HN66 MHÑDistance Perception ANonly /drug eff /physiol /rad eff MNF2.463.593.200.390; F2.463.593.932.869.255.390; G11.697.911.860.390 LH  MHÑDistemper ANdo not use /vet; don't forget also DOGS (NIM) or other animal + check tag ANIMAL but in cats = DISTEMPER, FELINE (IM) + CATS (NIM) + check tag ANIMAL MNC2.782.660.285; C22.268.265 LH  MSA species of the Morbillivirus genus causing distemper in dogs, wolves, foxes, racoons, and ferrets. PM66; was DISTEMPER VIRUS 1963-65 HN66; was DISTEMPER VIRUS 1963-65 MHÑDistemper Virus, Canine ANdo not use /blood-csf-urine /cytol MNB4.909.777.569.280 LH  MS3-Hydroxy-1-methylpyridinium bromide hexamethylenebis(methylcarbamate). Parasympathomimetic, reversible cholinesterase inhibitor, similar to neostigmine; used for postoperative intestinal and bladder atony, also in myasthenia gravis. HN(75) MHÑDistigmine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN15876-67-2 PICarbamates (72-74); Pyridinium Compounds (69-74) MND3.383.725.762.370; D16.698.410.282 XSHexamarium DMÑPyridinium Compounds LH LS LM  MHÑDistrict of Columbia MNZ1.107.567.875.225 LH  MSChemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. PM73 HN73(71) MHÑDisulfides ANdo not use /analogs /biosyn /defic /physiol PISulfides (66-70) MND1.248.497.158.874.390; D1.877.522.307; D2.886.200 LH  MHÑDisulfiram AND25-26 qualif RN97-77-8 MND2.241.81.251.869.200.250; D2.241.866.653.200.250; D2.886.703.200.250; D26.32.390 XSEthyldithiurame; TETRAETHYLTHIURAM DISULFIDE LH LS;  HN(72) MHÑDisulfoton ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN298-04-4 PIInsecticides (66-71) MND2.719.270; D5.723.491.657.291 DMÑInsecticides, Organothiophosphate LH LM  MS2,2'-(4,5-Diphenyl-2-oxazolylimino)diethanol. Anti-inflammatory agent with analgesic and antipyretic activity similar to phenylbutazone. Synonym: S 222. HN(77) MHÑDitazol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN18471-20-0 PIEthanolamines (74-75); Oxazoles (74-76) MND3.383.548.190; D14.73.278.298; D26.74.75.392 DMÑOxazoles LH LM  PM74; PHYTOL was see under TERPENES 1968-74 HN74 MHÑDiterpenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.849.291 XUÑDolichol; ÑPhytol LH LU;  MHÑDithiazanine ANdo not use /biosyn /defic /physiol RN7187-55-5 MND21.201.287.207 LH  OLsearch DITHIOTHREITOL 1972-74 HN(75) MHÑDithioerythritol ANdo not use /biosyn /defic /physiol RN6892-68-8 MND8.373.830.307.391; D9.203.853.175; D2.33.800.175 DMÑDithiothreitol LH LM  OLsearch SULFITES 1973-74 HN(75) MHÑDithionite ANdo not use /biosyn /defic /physiol; /analogs NIM only RN14844-07-6 MND1.877.855.565.307 DMÑSulfites LH LM  MS3,3'-Dithiobis-(6-nitrobenzoic acid). A standard reagent for the determination of reactive sulfhydryl groups by absorbance measurements. The color produced is due to the formation of a thio anion--3-carboxyl-4-nitrothiophenolate. Used primarily for the determination of sulfydryl and disulfide groups in proteins. HN(75) MHÑDithionitrobenzoic Acid AND25-26 qualif; /analogs NIM only RN69-78-3 PIBenzoates (69-74); Disulfides (72-74); Nitro Compounds (72-74) MND2.241.223.106.650.250; D26.550.272 XSDTNB; Ellman's Reagent DMÑNitrobenzoates LH LS; LM  PM72 HN72 MHÑDithiothreitol ANdo not use /biosyn /defic /physiol RN3483-12-3 PIAlcohols (66-71); Tetroses (66-71) MND8.373.830.307; D9.203.853.196; D2.33.800.196 XUÑDithioerythritol LH LU  MSPhenylazothionoformic acid 2-phenylhydrazine. Chelating agent used for heavy metal poisoning and assay; causes diabetes. OLsearch INDICATORS AND REAGENTS 1966-74 HN(75); was see under INDICATORS AND REAGENTS 1963-74 MHÑDithizone AND25-26 qualif; /analogs NIM only RN60-10-6 MND2.172.530; D2.442.726.200; D26.241.354; D26.550.276 XSDiphenylthiocarbazone DMÑAzo Compounds LH LS LM  MHÑDiuresis ANonly /drug eff /rad eff; /drug eff: consider also DIURETICS MNG8.852.241 FXÑKidney; ÑOSMOLAR CONCENTRATION LH LX;  MHÑDiuretics ANdo not use /analogs /biosyn /defic /physiol; consider also DIURESIS /drug eff MND19.770.224 LH  MHÑDiuretics, Mercurial ANdo not use /analogs /biosyn /defic /physiol MND19.770.224.391 XSMercurial Diuretics FXÑOrganometallic Compounds XUÑMersalyl LH LS LX LU  PM74 HN74 MHÑDiuretics, Osmotic ANdo not use /analogs /biosyn /defic /physiol MND19.770.224.453 XSOsmotic Diuretics LH LS  PM74 HN74 MHÑDiuretics, Sulfamyl ANdo not use /analogs /biosyn /defic /physiol PIDiuretics (66-73); Sulfonamides (66-73) MND19.770.224.516 XSSulfamyl Diuretics XUÑBumetanide; ÑIndapamide; ÑMefruside; ÑMetolazone; ÑXipamide LH LS LU; ; ; ;  PM74 HN74 MHÑDiuretics, Thiazide ANdo not use /analogs /biosyn /defic /physiol PIDiuretics (66-73); Thiadiazines (66-73); Thiazines (66-73) MND18.162.276; D19.770.224.578 XSBENZOTHIADIAZINE DIURETICS; Thiazide Diuretics XUÑCyclopenthiazide LH LS; LU  PM74 HN74(72) MHÑDiuron ANdo not use /biosyn /defic /physiol RN330-54-1 PIHerbicides (66-71); Urea (66-71) MND2.948.511.266; D5.723.366.506.266 XSDCMU LH LS  MHÑDiverticulitis ANIM; coord IM with precoord organ/dis terms (IM) or NIM with precoord DIVERTIC- terms in Permuted MeSH (IM) MNC23.329.391 LH  MSInflammatory complications of colonic diverticulosis in which diverticula may undergo perforation with abscess formation. MHÑDiverticulitis, Colonic MNC6.405.469.158.473 LH  MHÑDiverticulosis ANfor ╥diverticulum╙ or ╥diverticula╙; IM; coord IM with precoord organ/dis term (IM) but note that ESOPHAGEAL DIVERTICULA & STOMACH DIVERTICULA are available MNC23.329 LH  MSPresence of multiple herniations of the mucosa and submucosa of the colon through the circular muscle layer. MHÑDiverticulosis, Colonic MNC6.405.469.158.556 LH  MSA water sport in which the individual plunges into water in a prescribed manner; includes scuba and bell diving. HNwas in Cat G only 1975-80, was in Cat E only 1968-74, was in Cat E & J 1963-67 MHÑDiving ANhuman & animal; only /adv eff; includes scuba & bell diving MNG3.230.150.150; I3.450.642.845.869.110 FXÑDECOMPRESSION SICKNESS; ÑIMMERSION; ÑINERT GAS NARCOSIS; ÑNaval Medicine LH LX; ; ;  MSLegal dissolution of an officially recognized marriage relationship. MHÑDivorce ANonly /hist /legis /trends MNF1.829.263.315.266; I1.880.225.423.266; I1.880.735.255; N1.824.308.266 LH  MSA disturbed sense of relationship to space, manifesting as a sensation of unsteadiness or lightheadedness; it is not the same as VERTIGO, which is an illusion of movement. PM79 HN79 MHÑDizziness AN╥sensation of unsteadiness or lightheadedness╙: differentiate from VERTIGO, illusion of revolution in space, but use word of text PIVertigo (66-78) MNC10.597.751.237; C23.888.592.763.237 LH  MS╥Decayed, missing and filled teeth,╙ a routinely used statistical concept in dentistry. PM66 HN66 MHÑDMF Index ANno qualif MNE6.208.266; G3.890.160.100; N1.224.458.251.266 XSDECAYED, MISSING, AND FILLED TEETH LH LS  HN(72) MHÑDMPP ANdo not use /biosyn /defic /physiol; /analogs NIM only RN54-77-3 PIGanglionic Stimulants (71); Piperazines (66-71) MND3.383.606.390; D16.698.628.212 XSDimethylphenylpiperazinium DMÑPiperazines LH LS LM  MHÑDNA ANGEN: prefer specifics; /drug eff /ultrastruct permitted; do not use /analogs /defic; /biosyn permitted but consider also DNA REPLICATION; primer DNA = DNA, SINGLE-STRANDED; DNA models = DNA (IM) + MOLECULAR MODELS (IM) RN9007-49-2 MND13.444.308 XSDEOXYRIBONUCLEIC ACID; DNA, Double-Stranded; Z-DNA; complementary DNA FXÑGENETIC CODE; ÑNUCLEIC ACID DENATURATION; ÑNUCLEIC ACID HYBRIDIZATION; ÑRepetitive Sequences, Nucleic Acid LH LS; ; ; LX; ; ;  MSS-Adenosylmethionine:DNA (cytosine-5-)-methyltransferase. Catalyzes the transfer of a methyl group from S-adenosylmethionine to the 5 position of cytosine in DNA. PM86; was see under METHYLTRANSFERASES 1975-85 HN86(75); was see under METHYLTRANSFERASES 1975-85 MHÑDNA (Cytosine-5-)-Methyltransferase ANdo not use /analogs RNEC 2.1.1.37 PICytosine Nucleotides (73-74); DNA (73-74); Methyltransferases (73-74) MND8.586.913.517.220 XSDNA Methylase LH LS  MSDrug- or radiation-induced injuries in DNA that introduce deviations from its normal double-helical conformation. These changes include structural distortions which interfere with replication and transcription, as well as point mutations which disrupt base pairs and exert damaging effects on future generations through changes in DNA sequence. PM87 HN87 MHÑDNA Damage ANno qualif; coord IM with specific DNA (IM) PIDNA (66-86); DNA Repair (71-86); DNA Replication (68-86) MNG5.331.135; G5.632.135 XSDNA Injury LH LS  MSAn ATP-requiring enzyme which in the presence of magnesium ions introduces negative supertwists into closed and possibly linear duplex DNA. The enzyme is implicated in DNA replication and transcription. It causes the storage of mechanical strain energy in the superhelical turns of DNA at the expense of ATP hydrolysis. EC 3.1.-. PM80 HN80 MHÑDNA Gyrase ANdo not use /analogs RNEC 5.99.1.3 PIDNA (66-77); DNA Replication (68-79); DNA, Superhelical (78-79); DNA Untwisting Proteins (78-79) MND8.586.399.360 XSDNA Topoisomerase II; DNA Topoisomerase(ATP-hydrolysing); Eco DNA Topoisomerase II LH LS; ;  MSDiscrete transposable segments of DNA which can insert into chromosomal, phage, and plasmid DNA. Some insert at random, while others are site specific; most have not been found to exist except in the inserted state. Their insertion into a genome always produces a mutation (╥insertion mutation╙), and their excision frequently results in a loss of host genetic information. There are three classes of transposable elements: IS elements (insertion sequence elements) which are composed of between 700 and 1400 bases and contain no genes unrelated to insertion function; Tn elements, which are generally larger than 1400 bases and contain genes unrelated to insertion function; and episomes, which are complex, self-replicating elements, which may contain IS and Tn elements. OLuse DNA INSERTION ELEMENTS to search INSERTION SEQUENCE ELEMENTS & TN ELEMENTS back thru 1980 PM80; INSERTION SEQUENCE ELEMENTS was heading 1980 HN80; INSERTION SEQUENCE ELEMENTS was heading 1980; TN ELEMENTS was see under DNA INSERTION ELEMENTS 1980 MHÑDNA Insertion Elements ANonly /drug eff /rad eff PIBase Sequence (71-79); Mutation (66-79); Plasmids (75-79); Recombination, Genetic (68-79) MNG5.275.180; G5.331.112.250; G5.832.290 XSIS Elements; Insertion Elements, DNA; Insertion Sequence Elements; Mobile Genetic Elements; Tn Elements; Transposable Elements; Transposons FXÑDNA, Recombinant LH LS; ; ; ; ; ; LX  MSNucleosidetriphosphate:DNA deoxynucleotidylexotransferase. A non-template directed DNA polymerase normally found in vertebrate thymus and bone marrow. Catalyzes the elongation of oligo- or polydeoxynucleotide chains. Widely used as a tool in the differential diagnosis of acute leukemias in man. Synonym: terminal addition enzyme. EC 2.7.7.31. HN(79) MHÑDNA Nucleotidylexotransferase ANdo not use /analogs RNEC 2.7.7.31 PIDNA Nucleotidyltransferases (68-78); Transferases (66-67) MND8.586.913.696.445.308.200 XSTerminal Deoxyribonucleotidyl Transferase DMÑDNA Nucleotidyltransferases LH LS LM  OLuse DNA NUCLEOTIDYLTRANSFERASES to search DNA NUCLEOTIDYLTRANSFERASE back thru 1968 PM73; was DNA NUCLEOTIDYLTRANSFERASE 1968-72 HN73; was DNA NUCLEOTIDYLTRANSFERASE 1968-72 MHÑDNA Nucleotidyltransferases ANdo not use /analogs RNEC 2.7.7.- PINucleotidyltransferases (66-67) MND8.586.913.696.445.308 XUÑDNA Nucleotidylexotransferase LH LU  MSDeoxyribocyclobutadipyrimidine pyrimidine-lyase. Catalyzes the reactivation by light of UV-irradiated DNA. Breaks two carbon-carbon bonds in pyrimidine dimers in DNA. HN(75) MHÑDNA Photolyase ANdo not use /analogs RNEC 4.1.99.3 PIDNA (72-74); Lyases (72-74); Photochemistry (72-74) MND8.586.520.340 XSDNA Photoreactivating Enzyme; Deoxyribodipyrimidine Photolyase; Photoreactivating Enzyme DMÑLyases LH LS; ; LM  MSA DNA-dependent DNA polymerase characterized in prokaryotes and may be present in higher organisms. Has both 3'-5' and 5'-3' exonuclease activity. Cannot use native double-strand DNA as template-primer. It is not inhibited by sulfhydryl reagents. Active in both DNA synthesis and repair. EC 2.7.7.7. PM84; was see under DNA POLYMERASES 1977-83 HN84(77); was see under DNA POLYMERASES 1977-83 MHÑDNA Polymerase I ANdo not use /analogs RNEC 2.7.7.- PIDNA Nucleotidyltransferases (68-76) MND8.586.913.696.445.308.330 XSDNA Polymerase Beta; DNA-Dependent DNA Polymerase I; Pol I LH LS; ;  MSA DNA-dependent DNA polymerase characterized in E. coli and other lower organisms. May be present in higher organisms. Intrinsic molecular activity only 5% of that of DNA Polymerase I. Has 3'-5' exonuclease activity. Effective only on duplex DNA with gaps or single-strand ends of less than 100 nucleotides as template. Inhibited by sulfhydryl reagents. EC 2.7.7.7. PM84; was see under DNA POLYMERASES 1977-83 HN84(77); was see under DNA POLYMERASES 1977-83 MHÑDNA Polymerase II ANdo not use /analogs RNEC 2.7.7.- PIDNA Nucleotidyltransferases (68-76) MND8.586.913.696.445.308.350 XSDNA Polymerase Alpha; DNA-Dependent DNA Polymerase II; Pol II LH LS; ;  MSA DNA-dependent DNA polymerase characterized in E. coli and other lower organisms. May be present in higher organisms. Use also for a more complex form of DNA polymerase III designated as DNA polymerase III* or pol III* which is 15 times more active biologically than DNA polymerase I in the synthesis of DNA. Has both 3'-5' and 5'-3' exonuclease activities and is inhibited by sulfhydryl reagents. Has the same template-primer dependence as pol II. EC 2.7.7.7. HN(77) MHÑDNA Polymerase III ANdo not use /analogs RNEC 2.7.7.- PIDNA Nucleotidyltransferases (68-76) MND8.586.913.696.445.308.370 XSDNA Polymerase Gamma; DNA-Dependent DNA Polymerase III; Pol III DMÑDNA Polymerases LH LS; ; LM  MSDNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. EC 2.7.7.7. OLsearch DNA NUCLEOTIDYLTRANSFERASES 1968-76 PM77; was DNA POLYMERASE see DNA NUCLEOTIDYLTRANSFERASES 1973-76, was DNA POLYMERASE see DNA NUCLEOTIDYLTRANSFERASE 1968-72 HN77; was DNA POLYMERASE see DNA NUCLEOTIDYLTRANSFERASES 1973-76, was DNA POLYMERASE see DNA NUCLEOTIDYLTRANSFERASE 1968-72 MHÑDNA Polymerases ANdo not use /analogs RNEC 2.7.7.7 PIDNA Nucleotidyltransferases (68-76) MND8.586.913.696.445.308.300 XSDNA-Dependent DNA Polymerases XUÑDNA Polymerase III LH LS LU  MSThe reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule which contained damaged regions. The major repair mechanisms are excision repair, in which defective regions in one strand are excised and resynthesized using the complementary base pairing information in the intact strand; photoreactivation, in which the lethal and mutagenic effects of ultraviolet light are eliminated; and post-replication repair, in which the primary lesions are not repaired, but the gaps in one daughter duplex are filled in by incorporation of portions of the other (undamaged) daughter duplex. Excision repair and post-replication repair are sometimes referred to as ╥dark repair╥ because they do not require light. PM74 HN74(71) MHÑDNA Repair ANonly /drug eff /rad eff; coord IM with specific DNA (IM) PIDNA (66-70); DNA/BI (66-70) MNG5.331.187 FXÑPyrimidine Dimers XUÑSOS Response (Genetics) LH LX LU  MSThe process by which the two strands of a DNA double helix separate, allowing each strand to act as a template for the synthesis of a complementary strand by specific base pairing. Excludes VIRUS REPLICATION. PM68 HN68 MHÑDNA Replication ANonly /drug eff /rad eff; coord IM with specific DNA (IM); coord IM with VIRUS REPLICATION (IM) for DNA replic in viruses; consider also DNA /biosyn PIDNA/BI (66-67) MNG5.331.232 FXÑDNA Untwisting Proteins; ÑDNA Unwinding Proteins; ÑDNA-Binding Proteins; ÑVIRUS REPLICATION LH LX; ; ;  MSDeoxyribonucleatepolynucleotidohydrolase (ATP- and S-adenosyl-L-methionine-dependent). Catalyzes endonucleolytic cleavage of one duplex strand of DNA, followed by cleavage of a second strand to give double-stranded fragments. Has an absolute requirement for ATP (or deoxyATP) and S-adenosyl-L-methionine. OLuse DNA RESTRICTION ENZYMES to search DNA RESTRICTION ENZYME back thru 1975 PM79; was DNA RESTRICTION ENZYME 1978, was DNA RESTRICTION ENZYME see under ENDONUCLEASES 1975-77 HN79; was DNA RESTRICTION ENZYME 1978, was DNA RESTRICTION ENZYME see under ENDONUCLEASES 1975-77 MHÑDNA Restriction Enzymes ANdo not use /analogs; DNA restriction enzyme used as a DNA marker: coord probably NIM with GENETIC MARKER (IM); consider also RESTRICTION FRAGMENT LENGTH POLYMORPHISMS RNEC 3.1.23. PIDeoxyribonucleases (74); Endonucleases (74) MND8.586.277.352.630.553.240 XSRestriction Endonucleases LH LS  MSDNA viruses producing malignant tumors. Of the six major groupings of DNA viruses four contain members which are actually or potentially oncogenic: the Adenoviridae, the Herpesviridae, the Papovaviridae, and the Poxviridae. PM78 HN78 MHÑDNA Tumor Viruses ANGEN only: prefer specifics; do not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) PIDNA Viruses (66-77); Oncogenic Viruses (66-77) MNB4.909.204.210; B4.909.574.204 LH  MSProteins with enzymatic activity which relax superhelical turns formed during the unwinding of duplex DNA. They act by nicking one strand of supercoiled circular DNA, thus relieving torsional stress and then reseal the nick. This process takes place during replication. EC 3.1.- PM78 HN78 MHÑDNA Untwisting Proteins ANdo not use /analogs /defic RNEC 3.1.- PIDeoxyribonucleases (66-77); DNA, Circular ((73-77); Polynucleotide Synthetases (73-77); Proteins (66-77); specific protein MND8.586.277.352.630.200; D12.776.263 XSDNA Nicking-Closing Proteins; DNA Relaxing Enzymes; DNA Topoisomerase; DNA Topoisomerase I; DNA Untwisting Enzymes; Omega Proteins FXÑDNA Replication LH LS; ; ; ; ; LX  MSProteins which promote unwinding of duplex DNA during replication by binding cooperatively to single stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. EC 3.1.- PM78 HN78 MHÑDNA Unwinding Proteins ANdo not use /analogs /defic RNEC 3.1.- PIDeoxyribonucleases (66-77); Endonucleases (73-77); Proteins (66-77); specific protein MND8.586.277.352.630.210; D12.776.266 FXÑDNA Replication LH LX  OL╥DNA virus infections╙ is indexed DNA VIRUSES + VIRUS DISEASES MH*DNA Virus Infections (Non Mesh) MNC2.256 LH  MSViruses whose nucleic acid is DNA. PM66 HN66 MHÑDNA Viruses ANavoid: too general: specifics available; do not use /cytol; infection: coord NIM with VIRUS DISEASES (IM) MNB4.909.204 FXÑDNA, Viral LH LX  MSProteins which bind to DNA; includes proteins which bind to both double- and single-stranded DNA and specific DNA binding proteins in serum which can be used as markers for malignant diseases. OLto search DNA HELIX DESTABILIZING PROTEINS use DNA BINDING PROTEINS back thru 1984 and DNA UNWINDING PROTEINS 1979-83 PM84; DNA HELIX DESTABILIZING PROTEINS was see DNA UNWINDING PROTEINS 1977-83 HN84; DNA HELIX DESTABILIZING PROTEINS was see DNA UNWINDING PROTEINS 1977-83 MHÑDNA-Binding Proteins ANdo not use /analogs /defic PICarrier Proteins (78-81); DNA Unwinding Proteins (81-83) MND12.776.260 XSDNA Helix Destabilizing Proteins; Single-Stranded DNA Binding Proteins FXÑDNA Replication LH LS; LX  MHÑDNA, Bacterial ANIM; coord with specific bacterium (IM); /drug eff /ultrastruct permitted; do not use /analogs MND13.444.308.212 LH  PM74 HN74(73) MHÑDNA, Circular ANIM; /drug eff /ultrastruct permitted; do not use /analogs PIDNA (66-72); specific DNA MND13.444.308.283 LH  PM80 HN80 MHÑDNA, Fungal ANIM; coord with specific fungus (IM); /drug eff /ultrastruct permitted; do not use /analogs PIDNA (66-79) MND13.444.308.300 LH  PM74 HN74(73) MHÑDNA, Mitochondrial ANIM; /drug eff /ultrastruct permitted; do not use /analogs PIDNA (66-72); specific DNA; Mitochondria (66-72); specific mitochondria MND13.444.308.354 LH  MHÑDNA, Neoplasm ANIM; coord with specific neoplasm (IM); /drug eff /ultrastruct permitted; do not use /analogs MND13.444.308.425 FXÑNeoplasms LH LX  MSBiologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. PM77 HN77 MHÑDNA, Recombinant ANIM; /drug eff /ultrastruct permitted; do not use /analogs /genet; formed by in vitro joining of DNA from 2 different species: do not confuse with RECOMBINATION, GENETIC (within same species); do not use /stand: guidelines for preventing hazards of recombinant DNA research, coord IM with CONTAINMENT OF BIOHAZARDS (IM) if by MeSH definition (procedures, facilities, programs, equipmt, etc.); for ethical, moral or religious aspects of DNA research: coord with specific ethical, moral or religious aspect (IM) PIDNA (66-76); Recombination, Genetic (68-76) MND13.444.308.460 XSGenes, Spliced; Recombinant DNA FXÑCloning, Molecular; ÑDNA Insertion Elements; ÑGenetic Intervention; ÑGenetic Vectors; ÑTransformation, Genetic LH LS; LX; ; ; ;  MSDNA sequences encoding ribosomal RNA. These sequences regulate amplification and transcription initiation. PM85 HN85 MHÑDNA, Ribosomal ANIM; /drug eff /ultrastruct permitted; do not use /analogs PIDNA (66-84); Ribosomes (66-84) MND13.444.308.475 XSRibosomal DNA LH LS  MSA species of DNA, that is homogeneous, highly repetitive and different in base composition relative to the remainder of the organism's DNA. PM80; was see under DNA 1975-79 HN80(75); was see under DNA 1975-79 MHÑDNA, Satellite ANIM; /drug eff /ultrastruct permitted; do not use /analogs PIDNA (66-74) MND13.444.308.480 XSSatellite DNA LH LS  PM74 HN74(72) MHÑDNA, Single-Stranded ANIM; /drug eff /ultrastruct permitted; do not use /analogs PIDNA (66-71); DNA, Bacterial (66-71); DNA, Viral (66-71) MND13.444.308.497 LH  MSCircular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity. PM78 HN78 MHÑDNA, Superhelical ANIM; /drug eff /ultrastruct permitted; do not use /analogs PIDNA (66-77); DNA, Circular (73-77) MND13.444.308.283.250 XSDNA, Supercoiled; DNA, Supertwisted LH LS;  MHÑDNA, Viral ANIM; coord with specific virus (IM); /drug eff /ultrastruct permitted; do not use /analogs MND13.444.308.568 FXÑDNA VIRUSES; ÑGenes, Viral LH LX;  MS4-(2-[(3-(p-Hydroxyphenyl)-1-methylpropyl)amino]ethyl)=pyrocatechol. Beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia; proposed as a cardiotonic after myocardial infarction or open heart surgery. PM86; was see under CATECHOLAMINES 1976-85 HN86(76); was see under CATECHOLAMINES 1976-85 MHÑDobutamine ANdo not use /biosyn /defic /physiol RN34368-04-2 PICatecholamines (74-75); Phenethylamines (74-75); Phenols (74-75) MND2.92.311.220; D2.92.471.683.410; D16.893.116.348.275; D18.222.863.259 LH  PM66; was see under BIBLIOGRAPHY 1963-65 HN66; was see under BIBLIOGRAPHY 1963-65 MHÑDocumentation ANonly /econ /legis /methods /stand /trends; med docum: do not coord with MEDICINE MNL1.300 FXÑBibliography; ÑRecords LH LX;  MHÑDog Diseases ANdo not use /compl /vet; don't forget also DOGS (NIM) & check tag ANIMAL MNC22.268 LH  OLsearch SHARKS 1966-74 HN(75) MHÑDogfish ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.853.392 DMÑSharks LH LM  MHÑDogs ANcheck tag: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; TN 3: spelling of breeds; consider also terms under CANINE MNB2.649.147.308 LH  MSEicosamethyl octacontanonadecasen-1-o1. Polyprenol found in animal tissues that contains about 20 isoprene residues, the one carrying the alcohol group being saturated. HN(75) MHÑDolichol ANdo not use /defic /physiol; /analogs NIM only RN2067-66-5 PIDiterpenes (74); Fatty Alcohols (74) MND2.33.555.475; D2.455.849.291.250; D10.516.289.475 DMÑDiterpenes LH LM  MSA lipophilic glycosyl carrier of the monosaccharide mannose in the biosynthesis of oligosaccharide phospholipids and glycoproteins. HN(78) MHÑDolichol Monophosphate Mannose AN/analogs NIM only RN55598-56-6 PIDiterpenes (74); Dolichol (75-77); Hexosephosphates (66-77) MND2.455.849.690.700.700.250; D9.203.894.680.700.250; D10.516.390.700.700.250 XSDolichyl Mannopyranosyl Phosphate; Dolichyl Mannosyl Phosphate; Mannolipid; Mannosyl Phosphoryl Dolichol DMÑPolyisoprenyl Phosphate Sugars LH LS; ; ; LM  MSPhosphoric acid esters of dolichol. HN(78) MHÑDolichol Phosphates ANdo not use /analogs PIDiterpenes (74); Dolichol (75-77); Organophosphorus Compounds (71-77) MND2.33.555.475.500; D2.455.849.291.250.300; D2.455.849.690.250; D2.705.690.200; D10.516.289.475.500 DMÑPolyisoprenyl Phosphates LH LM  PM68 HN68 MHÑDolphins ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PICetacea (66-67) MNB2.649.189.267 XSPorpoises LH LS  HN(73) MHÑDOM ANdo not use /biosyn /defic /physiol; /analogs NIM only RN15588-95-1 MND2.92.471.683.152.391; D15.236.372.367 XS2,5-Dimethoxy-4-Methylamphetamine DMÑAmphetamines LH LS LM  MSRelationship between individuals when one individual threatens or becomes aggressive and the other individual remains passive or attempts to escape. OLsearch SOCIAL DOMINANCE 1968-74 HN(75); was see under DOMINANCE, SOCIAL 1968 MHÑDominance-Subordination ANhuman & animal; no qualif MNF1.145.843.309 DMÑSocial Dominance LH LM  MSDominance of one cerebral hemisphere over the other in cerebral functions. OLuse DOMINANCE, CEREBRAL to search DOMINANCE 1966 (as Prov); to search MIRROR WRITING use DOMINANCE, CEREBRAL back thru 1975 & HANDWRITING 1966-74 PM67; MIRROR WRITING was see under HANDWRITING 1963-75 HN67; was DOMINANCE 1965-66 (Prov); MIRROR WRITING was see under HANDWRITING 1963-75 MHÑDominance, Cerebral ANonly /drug eff /physiol /rad eff MNF2.830.297; G11.561.232 XSCEREBRAL DOMINANCE; Mirror Writing FXÑAphasia; ÑLATERALITY LH LS; LX;  MHÑDominican Republic MNZ1.107.904.309 LH  MS5-Chloro-1-[1-(3-(2-oxo-1-benzimidazolinyl) propyl)-4-piperidyl]-2-benzimidazolinone. Specific blocker of dopamine receptors; speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms. Synonyms: Motilium; R 33,812. PM82 HN82 MHÑDomperidone ANdo not use /biosyn /defic /physiol RN57808-66-9 PIAntiemetics (77-81); Benzimidazoles (77-81); Piperidines (77-81) MND3.383.621.210; D3.438.103.370; D23.136.342 LH  MS3,4-Dihydroxyphenylalanine. The racemic or dextro form of DOPA, an amino acid found in various legumes; the dextro form has little physiologic activity but the levo form is a very important physiologic mediator and precursor. MHÑDopa ANcheck text to see if LEVODOPA (L-DOPA) is not meant instead MND2.92.311.242; D12.125.72.573.400; D16.538.251 XSDihydroxyphenylalanine XUÑCysteinyldopa LH LS LU  HN(80)63 MHÑDopa Decarboxylase ANdo not use /analogs RNEC 4.1.1.- MND8.586.520.258.90.267 DMÑAromatic Amino Acid Decarboxylases LH LM  OLsearch TYROSINE DECARBOXYLASE 1966-67 HN(73); was see under TYROSINE DECARBOXYLASE 1963-67 MHÑDopa Oxidase ANdo not use /analogs RNEC 1.10.3.- PIDiphenol Oxidases (68-72); Tyrosine Decarboxylase (66-67) MND8.586.682.420.238.392 DMÑDiphenol Oxidases LH LM  MS4-(2-Aminoethyl)-1,2-benzenediol. Catecholamine alpha adrenergic; precursor of norepinephrine; also found in plants; a neuromediator in the extrapyramidal motor system; increases peripheral vascular resistance and increases cardiac output; used in cardiac emergencies, heart failure, hypotension and shock. Synonyms: Dynatra; Intropin. MHÑDopamine AN/biosyn /physiol permitted RN51-61-6 MND2.92.311.342; D16.538.267; D16.893.116.182.267; D18.222.863.267 XSHYDROXYTYRAMINE XUÑDeoxyepinephrine LH LS LU  PM73 HN73(71) MHÑDopamine beta-Hydroxylase ANdo not use /analogs RNEC 1.14.17.1 PIHydroxylases (66-70) MND8.586.682.420.292 LH  MSIllegitimate use of drugs for a desired effect in competitive sports; includes humans and animals. PM78 HN78 MHÑDoping in Sports ANhuman & animal; coord IM with animal doped (IM); only /legis /methods /prev MNI1.880.735.265 XSDrug Abuse, Sports FXÑSports LH LS LX  MSChanges in the observed frequency of waves (as sound, light, or radio waves) due to the relative motion of source and observer. HN(75) MHÑDoppler Effect ANno qualif; note DOPPLER ULTRASOUND see ULTRASONICS; Doppler flowmetry goes only under FLOWMETERS MNH1.671.150 XSDoppler Shift DMÑPhysics LH LS LM  MSAn aggregation of cells in the middle hypothalamus dorsal to the ventromedial nucleus and bordering the third ventricle. HN(83) MHÑDorsomedial Hypothalamic Nucleus ANdo not use /innerv PIHypothalamus (66-82) MNA8.186.211.385.357.352.270 XSHypothalamic Nucleus, Dorsomedial DMÑHypothalamus, Middle LH LS LM  MSA genetic regulatory mechanism which operates to equalize the phenotypic expression of characteristics determined by genes on the X chromosome so that they are equally expressed in the XY male and the XX female. PM82 HN82 MHÑDosage Compensation (Genetics) ANno qualif; DF: DOSAGE COMPENSATION PISex Chromosomes (68-81); X Chromosome (78-81) MNG5.331.380.235; G5.735.235 XSX Inactivation LH LS  MHÑDosage Forms ANGEN only: prefer specific drug with qualif /admin; no qualif; Manual 25.68; examine also indentions under DRUG ADMINISTRATION (NON MESH) in Cat E5 MND26.394.225; E5.916.250 FXÑDrug Administration Routes LH LX  MSThe relationship between the dose of an administered drug and the response of the organism to the drug. PM73 HN73 MHÑDose-Response Relationship, Drug ANno qualif; IM if general, NIM when coord for specific drug; DF: DOSE RESPONSE RELAT DRUG MNG12.297 LH  MSA specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue or cell. PM77 HN77 MHÑDose-Response Relationship, Immunologic ANno qualif; IM if general, NIM when coord for specific immunol concept; DF: DOSE RESPONSE RELAT IMMUNOL MNG4.610.300; G12.297.261 LH  MSThe relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. PM73 HN73 MHÑDose-Response Relationship, Radiation ANno qualif; IM if general, NIM when coord for specific radiation; DF: DOSE RESPONSE RELAT RAD PIRadiation Dosage (72); Radiotherapy Dosage (66-72) MNG3.850.810.250.180; H1.671.768.765.488.392; G12.297.804 FXÑRadiotherapy Dosage LH LX  MS3-Dibenzo(b,e)thiepin-11(6H)ylidene-N,N-dimethyl-1-propanamine. Tricyclic antidepressant with some tranquilizing action. Synonym: Prothiaden. OLto search PROTHIADENE use DOTHIEPIN back thru 1975 & DIBENZOTHIEPINS 1968-74 HN(79); was PROTHIADENE see under DIBENZOTHIEPINS 1968-78 MHÑDothiepin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN113-53-1 PIDibenzothiepins (68-74) MND3.494.311.250; D15.236.122.140.319 XSDosulepin; Prothiadene DMÑDibenzothiepins LH LS; LM  MSContradictions in verbal and behavioral communication between parent and child (patient) which entrap the child because he is unable to comment on the incongruity or to escape from the situation. HN(72) MHÑDouble Bind Theory ANno qualif PIPsychological Theory (66-71) MNF2.739.308 DMÑPsychological Theory LH LM  MSIncomplete transposition of the great vessels in which both the aorta and the pulmonary artery arise from the right ventricle, often associated with a subaortic ventricular septal defect. OLsearch TRANSPOSITION OF GREAT VESSELS 1984-86 PM87; was see TRANSPOSITION OF GREAT VESSELS 1984-86 HN87; was see TRANSPOSITION OF GREAT VESSELS 1984-86 MHÑDouble Outlet Right Ventricle ANdo not use /congen PITransposition of Great Vessels (66-86) MNC14.280.400.915.300; C16.131.457.914.300 XSTaussig-Bing Anomaly LH LS  MSA method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. HN(Aug 77); was in Cat E & H Aug 77-79 MHÑDouble-Blind Method ANIM only as a research technic; NIM here each time CLINICAL TRIALS is used NIM for double-blind studies; only /stand /util (if by MeSH definition); do not index also under PLACEBOS unless particularly discussed MNH1.770.644.728.300 DMÑResearch Design LH LM  MHÑDouglas' Pouch ANalso called cul-de-sac of Douglas; CULDOSCOPY is available MNA1.47.596.225 LH  MSA disease of horses and donkeys caused by Trypanosoma equiperdum. OLsearch TRYPANOSOMIASIS 1968-74 HN(75) MHÑDourine ANdo not use /vet but index also TRYPANOSOMIASIS /vet for IM; coord with HORSE DISEASES (IM) + HORSES (NIM) MNC3.752.935.226 DMÑTrypanosomiasis LH LM  MSMental retardation with characteristic facies with slanting palpebral fissures, and with trisomy usually of chromosome 21. OLuse DOWN'S SYNDROME to search MONGOLISM back thru 1966 PM75,63-64; was MONGOLISM 1965-74 HN75,63-64; was MONGOLISM 1965-74 MHÑDown's Syndrome ANdo not use /congen /drug eff /physiol /rad eff MNC10.496.250; C16.131.77.327; F3.709.346.200 XSMongolism LH LS  PM73 HN73(65) MHÑDoxapram ANdo not use /biosyn /defic /physiol RN309-29-5 MND3.383.773.812.226; D15.128.308 LH  PM74 HN74 MHÑDoxepin ANdo not use /biosyn /defic /physiol RN1668-19-5 MND3.494.382.393; D15.236.122.140.322; D15.236.872.659.413 LH  MS(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)-oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione. Antineoplastic antibiotic obtained from Streptomyces peuceticus; it is a hydroxy derivative of daunorubicin and is used both in leukemia and solid tumors. Synonyms: Adriablastina; 14-Hydroxydaunomycin. OLuse DOXORUBICIN to search ADRIAMYCIN back thru 1973 PM78; was ADRIAMYCIN 1973-77 HN78; was ADRIAMYCIN 1973-77 MHÑDoxorubicin ANdo not use /defic /physiol RN23214-92-8 PIAntibiotics, Antineoplastic (67-72) MND9.203.408.51.212.24; D20.85.75.354.295; D22.204.106.356.295 XSAdriamycin LH LS  PM73 HN73(71) MHÑDoxycycline ANdo not use /biosyn /defic /physiol RN564-25-0 PIOxytetracycline (66-70) MND20.85.868.293 LH  MS2-[alpha(2-Dimethylaminoethoxy)-alpha-methylbenzyl]pyridine. Histamine H1 blockers with pronounced sedative properties; used in allergies and as antitussive, antiemetic and hypnotic, also in animals; formerly used in parkinsonism. Synonyms: Decaminum; Decapryn; Doxised; Histadoxylamine; Mereprine. HN(72) MHÑDoxylamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN469-21-6 PIAntiparkinson Agents (72); Pyridines (72) MND3.383.725.259; D14.591.745.299; D23.654.432.301 DMÑPyridines LH LM  MHÑDracunculosis MNC3.335.508.299 XSGuinea Worm Infection LH LS  MSA genus of nematode parasites which inhabit the body cavity, serous membranes and connective tissues of vertebrates. The species parasitic in man is DRACUNCULUS MEDINENSIS. OLuse DRACUNCULUS to search DRACUNCULUS MEDINENSIS, GUINEA WORM & MEDINA WORM back thru 1966 PMDRACUNCULUS MEDINENSIS was see under DRACUNCULUS 1979-85, was GORDIUS MEDINENSIS see under DRACUNCULUS 1963-78; GUINEA WORM was see under DRACUNCULUS MEDINENSIS 1979-85, was see DRACUNCULUS 1968-78; MEDINA WORM was see DRACUNCULUS MEDINENSIS 1979-85 HNDRACUNCULUS MEDINENSIS was see under DRACUNCULUS 1979-85, was GORDIUS MEDINENSIS see under DRACUNCULUS 1963-78; GUINEA WORM was see under DRACUNCULUS MEDINENSIS 1979-85, was see DRACUNCULUS 1968-78; MEDINA WORM was see DRACUNCULUS MEDINENSIS 1979-85 MHÑDracunculus ANdo not use /blood-csf-urine; infection = DRACUNCULOSIS MNB1.500.294.490 XSDracunculus medinensis; Guinea Worm; Medina Worm LH LS; ;  MHÑDrainage ANnote category; ╥withdrawal of fluids & discharges╙; only /adv eff /instrum /methods /vet MNE4.237 LH  MSA system of artificial or natural drains, generally used for the disposal of liquid wastes. OLsearch SANITARY ENGINEERING 1966-74 PM75; was see under SANITARY ENGINEERING 1963-74 HN75; was see under SANITARY ENGINEERING 1963-74 MHÑDrainage, Sanitary ANonly /econ /instrum /methods /stand PISanitary Engineering (66-74) MNG3.850.860.510.150 LH  OLsearch LITERATURE 1966-74 HN(75) MHÑDrama ANonly /hist; coord IM with LITERATURE, MEDIEVAL (IM) or LITERATURE, MODERN (IM) MNK1.517.333 DMÑLiterature LH LM  MSA series of thoughts, images, or emotions occurring during sleep which are dissociated from the usual stream of consciousness of the waking state. MHÑDreams ANonly /drug eff /physiol /rad eff; consider also NIGHT TERRORS & PAVOR NOCTURNUS (both see SLEEP DISORDERS) MNF2.463.188.634.309; F2.830.855.268 XSNightmares LH LS  PM70 HN70(66) MHÑDrinking ANwater intake or water consumption goes here; not for alcohol consumption ( = ALCOHOL DRINKING); only /drug eff /rad eff when IM; when NIM in psychol articles, usually no qualif but consider also DRINKING BEHAVIOR; TN 55: differentiate from DRINKING BEHAVIOR MNG10.261.350 LH  MSBehaviors associated with the ingesting of water and other liquids; includes rhythmic patterns of drinking (time intervals - onset and duration), frequency and satiety. PM69 HN69 MHÑDrinking Behavior ANdoes not refer to drinking alcohol ( = ALCOHOL DRINKING); human & animal; only /drug eff /physiol /rad eff; TN 55: differentiate from DRINKING PIBehavior (66-68); Thirst (66-68) MNF1.145.317 LH  MSA state of internal activity of an organism that is a necessary condition before a given stimulus will elicit a class of responses; e.g., a certain level of hunger (drive) must be present before food will elicit an eating response. PM69; was see under MOTIVATION 1963-68 HN69(65); was see under MOTIVATION 1963-68 MHÑDrive ANhuman & animal; only /drug eff /physiol /rad eff; consider also INSTINCT & MOTIVATION MNF1.658.293 FXÑSEX LH LX  PM74 HN74(73) MHÑDroperidol ANdo not use /biosyn /defic /physiol RN548-73-2 MND2.522.352.343; D3.438.103.393; D15.236.872.331.241.343 XSDEHYDROBENZPERIDOL LH LS  MSA genus of small, two-winged flies. MHÑDrosophila AN/microbiol /parasitol permitted; NIM when merely research organism in genetic studies MNB1.131.617.289.308 XSFruit Flies LH LS  MSA species of fruit fly much used in genetics on account of the large size of its chromosomes. PM72 HN72 MHÑDrosophila Melanogaster AN/microbiol /parasitol permitted; NIM when merely research organism in genetic studies; DF: D MELANOGASTER PIDrosophila (66-71) MNB1.131.617.289.308.300 LH  MHÑDrowning ANonly Cat C qualif if pertinent MNC21.866.304; C23.240.393; G3.850.110.500 FXÑIMMERSION; ÑRESUSCITATION LH LX;  MSThe various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue. PM87; was DRUG ADMINISTRATION (NON MESH) before 1987 HN87; was DRUG ADMINISTRATION (NON MESH) before 1987 MHÑDrug Administration Routes ANGEN & unspecified: prefer specific; NIM; only /vet MNE5.300 FXÑDosage Forms LH LX  MSTime schedule for administration of a drug in order to achieve optimum effectiveness and convenience. PM75 HN75 MHÑDrug Administration Schedule ANNIM only; only /vet; coord NIM with drug term /admin (IM) PIspecific drug/AD (66-74) MNE5.309 XSAdministration Schedule, Drug LH LS  MSControl of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. OLuse DRUG AND NARCOTIC CONTROL to search NARCOTIC TRADE 1966-67 PM68; NARCOTIC TRADE was heading 1963-67 HN68; NARCOTIC TRADE was heading 1963-67 MHÑDrug and Narcotic Control ANPublic Law 91-513; only /econ /hist /legis /man /methods /organ; specify country or state; DF: DRUG CONTROL CATALOG: /geog /form MNI1.880.604.309; N4.452.706.310 XSNARCOTIC CONTROL FXÑLegislation, Drug; ÑSubstance Abuse LH LS LX;  PM68 HN68(66) MHÑDrug Antagonism ANGEN & IM only as pharmacol principle irrespective of specific drugs; prefer specific drug with /antag; no qualif; DF: DRUG ANTAG MNG12.361.310 FXÑNarcotic Antagonists LH LX  PM73 HN73(71) MHÑDrug Combinations ANIM when general; NIM when with specific drugs; differentiate from DRUG THERAPY, COMBINATION: drug combinations = 2 or more drugs in a single dosage form; combination ther = 2 or more drugs separately for a combined eff; no qualif PIDosage Forms (66-70) MND26.394.310 LH  MHÑDrug Compounding ANIM when general; only /econ /hist /methods /stand /vet; do not confuse with PRESCRIPTIONS (prescribing is by the MD, cpding by the pharmacist or drug co.) or with drug formulation (index CHEMISTRY, PHARMACEUTICAL) MNE5.916.270 XSMicroencapsulation FXÑBIOPHARMACEUTICS LH LS LX  OLuse DRUG CONTAMINATION to search DRUG ADULTERATION back thru 1966 PM74; DRUG ADULTERATION was heading 1963-76 HN74; DRUG ADULTERATION was heading 1963-76 MHÑDrug Contamination ANby organisms, dust, dirt, chemicals, etc.; only /econ /prev MNG3.850.360 XSDrug Adulteration LH LS  MSUse for pharmacologic studies (toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range) involving a small number of persons (FDA phase I) and initial drug trials conducted on a limited number of patients for diagnosis, therapy, or prevention of a specific disease (FDA phase II). PM74 HN74; was in Cat E & G 1974-79 MHÑDrug Evaluation ANIM when general; NIM when with specific drug; only /hist /instrum /methods /stand /trends /vet; differentiate from DRUG SCREENING: screening is pre-clin in exper animals or in vitro; evaluation is clin testing; differentiate also from CLINICAL TRIALS: see note there; note X refs below & DRUG EVALUATION, FDA PHASE III see CLINICAL TRIALS & DRUG EVALUATION, PRECLINICAL see DRUG SCREENING MNE5.337.310 XSDrug Evaluation, FDA Phase I; Drug Evaluation, FDA Phase II; Evaluation Studies, Drug, FDA Phase I; Evaluation Studies, Drug, FDA Phase II LH LS; ; ;  MSImmunologically mediated adverse reactions to medicinal substances used legally or illegally. PM66; was DRUG ALLERGY 1963-65 HN66; was DRUG ALLERGY 1963-65 MHÑDrug Hypersensitivity AN╥drug allergy╙; do not use /chem ind; use in conventional sense & not for allergy to every Cat D term: allergy to nickel is not NICKEL + DRUG HYPERSENSITIVITY: try DERMATITIS, CONTACT, OCCUPATIONAL DERMATITIS, etc.; Manual 23.34+ MNC20.543.206 LH  MSSmall containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. PM75 HN75 MHÑDrug Implants ANnot for radioisotope implants ( = RADIOISOTOPES or specific /admin or BRACHYTHERAPY (see X refs there) ) or prosthetic injections ( = PROSTHESIS + substance implanted); IM for general only, D25-26 qualif; NIM when specific chemical is IM, no qualif PIDelayed-Action Preparations (66-74) MND26.394.225.276.315 XSPellets, Drug LH LS  PM73 HN73(65) MHÑDrug Incompatibility ANIM when general; NIM when with specific drug; no qualif MNE5.916.290 LH  MHÑDrug Industry ANonly /econ /hist /stand; /instrum /methods: consider probably better TECHNOLOGY, PHARMACEUTICAL CATALOG: /geog /form MNJ1.576.318 FXÑTechnology, Pharmaceutical XUÑOrphan Drug Production LH LX LU  MSServices providing pharmaceutic and therapeutic drug information and consultation. PM81; was see under INFORMATION SERVICES 1977-80 HN81(77); was see under INFORMATION SERVICES 1977-80 MHÑDrug Information Services ANonly /class /econ /hist /legis /man /organ /stand /trends /supply /util CATALOG: /geog /form PIDrug Therapy (66-76); Drugs (66-76); Information Services (66-76) MNL1.453.270; N2.421.668.320 LH  PM72 HN72 MHÑDrug Interactions ANIM when general; NIM when with specific drugs; only /rad eff PIDrug Antagonism (66-71); Drug Synergism (66-71) MNG12.361 LH  MSUse of written, printed, or graphic materials upon or accompanying a drug container or wrapper. Includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information. PM68 HN68 MHÑDrug Labeling ANonly /econ /methods /stand /trends PIDrug Industry (66-67); Drug Therapy (66-67); Medication Errors (66-67) MNE5.780.310; E5.916.310; J1.576.318.311; J1.790.310 XSLabeling, Drug; Package Inserts, Drug; Product Labeling, Drug LH LS; ;  OLuse DRUG PACKAGING to search DRUG CONTAINERS AND CLOSURES back thru 1968 PM78; was DRUG CONTAINERS AND CLOSURES 1968-77 HN78; was DRUG CONTAINERS AND CLOSURES 1968-77 MHÑDrug Packaging ANonly /econ /methods /stand /trends PIDrug Industry (66-67); Pharmacy (66-67) MNE5.916.320; J1.576.318.321 XSDrug Containers and Closures; PACKAGING, DRUG LH LS;  PM72 HN72 MHÑDrug Resistance ANIM when general; NIM when with specific drug; only /genet /rad eff; differentiate from DRUG TOLERANCE MNG12.392 LH  MSThe ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents or antibiotics. This resistance may be acquired through plasmids containing RESISTANCE FACTORS. MHÑDrug Resistance, Microbial ANIM when general; NIM when with specific drug (IM) & specific micro-organism (virus, bacterium, protozoon & fungus) (IM); note X ref: do not coord with ANTIBIOTICS for general or unspecified articles on ╥antibiotic resistance╥; only /genet /rad eff MNG4.185.515.286; G5.386.310; G5.706.310; G12.392.269 XSAntibiotic Resistance FXÑMICROBIAL SENSITIVITY TESTS LH LS LX  MSPreclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. PM74 HN74; was in Cat E & G 1974-79 MHÑDrug Screening ANIM when general; NIM when with specific drug; only /hist /instrum /methods /stand /trends /vet; differentiate from DRUG EVALUATION: screening is pre-clin in exper animals or in vitro; evaluation is clin testing MNE5.337.477 XSDrug Evaluation, Preclinical; Evaluation Studies, Drug, Pre-Clinical LH LS;  PM68 HN68(65) MHÑDrug Stability ANIM when general; NIM when with specific drug (IM); no qualif; TN 60: interpretation of ╥drug╙ MNE5.916.330 LH  PM68 HN68 MHÑDrug Storage ANIM when general; NIM when with specific drug (IM); no qualif PIDrugs (66-67); Pharmacy Service, Hospital (66-67) MNE5.916.350 LH  PM66 HN66(65) MHÑDrug Synergism ANIM when general; NIM when with specific drugs (IM); only /rad eff MNG12.361.477 XSDRUG POTENTIATION FXÑCocarcinogenesis; ÑPesticide Synergists LH LS LX;  MHÑDrug Therapy ANGEN only: prefer /drug ther with disease term: Manual 19.5+; when GEN & IM, do not use /util except by MeSH definition MNE2.319 XSChemotherapy; PHARMACOTHERAPY FXÑMEDICATION ERRORS; ÑPharmacology LH LS; LX;  MSDrug therapy with two or more drugs given separately for a combined effect. PM74 HN74 MHÑDrug Therapy, Combination ANIM when general; NIM when with specific drugs; no qualif; differentiate from DRUG COMBINATIONS which = 2 or more drugs in a single dosage form; combin drug ther = 2 or more drugs given separately for a combined effect; TN 5: anticancer polychemother MNE2.319.310 XSCOMBINATION CHEMOTHERAPY; Polychemotherapy LH LS;  MSAdjunctive computer programs in providing drug treatment to patients. HN(87) MHÑDrug Therapy, Computer-Assisted ANIM; no qualif MNE2.319.335; L1.700.508.100.710.180 XSComputer-Assisted Drug Therapy; Protocol Drug Therapy, Computer-Assisted DMÑTherapy, Computer-Assisted LH LS; LM  MHÑDrug Tolerance ANIM when general; NIM when with specific drug; only /rad eff; differentiate from DRUG RESISTANCE MNG12.454 LH  OLconsider also DRUGS /TO & TOXICOLOGY for very general articles; consider also Cat C with /CI MH*Drug Toxicity (Non Mesh) MNC21.613.276 LH  MSThe utilization of drugs as reported in individual hospital studies, FDA studies, marketing or consumption, etc. Includes drug stockpiling, and patient drug profiles. DO NOT CONFUSE WITH DRUG METABOLISM. PM73 HN73(68) MHÑDrug Utilization ANNIM; only /econ /legis /trends; not for ╥use╙ in ther from patient's viewpoint ( = drug /ther use): for use by MDs, hosp, clinics, pharmacies, localities, etc.; includes over-use or over-prescription of a drug or drugs by a physician PIspecific drug; specific drug class MNN4.452.706.477 LH  MHÑDrugs ANGEN & unspecified only; do not use /analogs /antag ( = DRUG ANTAGONISM) /biosyn /pharm ( = PHARMACOLOGY) /physiol /pois ( = POISONING) /secret /ther use ( = DRUG THERAPY); /adv eff permitted but consider DRUG THERAPY /adv eff; /tox permitted but consider TOXICOLOGY; TN 59: drug names: use NOMENCLATURE; policy: Manual section 25; metab detoxication of drugs = METABOLIC DETOXICATION, DRUG; drug residues: index under BODY BURDEN (NIM) + DRUGS (IM) or specific drug (IM); array of drug metab terms: Bull 102 (Oct 77); drugs & action groups: TN 210 CATALOG: do not use /catalogs ( = CATALOGS, DRUG) MND26.394 FXÑPLANTS, MEDICINAL LH LX  PM74 HN74(73) MHÑDrugs, Non-Prescription AND25-26 qualif PIDrugs (66-72) MND26.394.393 XSOVER THE COUNTER DRUGS; Patent Medicines LH LS;  MHÑDry Ice ANonly /adv eff /ther use MND1.154.140.394; D1.655.498.149.394 XSCARBON DIOXIDE SNOW FXÑIce LH LS LX  PM65 HN65 MHÑDry Socket MNC7.465.227 XSALVEOLALGIA FXÑTOOTH EXTRACTION LH LS LX  PM66 HN66 MHÑDTPA AND25-26 qualif RN67-43-6 MND2.92.782.275; D2.241.81.38.420; D26.241.429 XSDIETHYLENETRIAMINE PENTAACETIC ACID; PENTETATES; Penthanil LH LS; ;  OLsearch OPHTHALMOPLEGIA 1966-74 HN(75); was see under OCULOMOTOR PARALYSIS 1966-78 MHÑDuane's Syndrome MNC10.772.204.510.395; C11.627.311 DMÑOphthalmoplegia LH LM  MSCauses an infection in ducklings 3 days to 3 weeks old with high mortality. HN(75) MHÑDuck Hepatitis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENTEROVIRUS INFECTIONS (IM) MNB4.909.777.618.284.250 XSHepatitis Virus, Duck DMÑEnteroviruses LH LS LM  PM68 HN68 MHÑDucks ANdomestic or wild; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; diseases: coord IM with POULTRY DISEASES (IM); diseases of wild ducks: coord IM with BIRD DISEASES (IM), not POULTRY DISEASES PIBirds (66-67); Poultry (66-67) MNB2.248.617.345 LH  MSA fetal blood vessel connecting the pulmonary artery with the descending aorta. MHÑDuctus Arteriosus ANnormal; abnormal is probably DUCTUS ARTERIOSUS, PATENT; do not use /blood supply MNA7.541.278.395; A16.378.303.395 LH  PM65 HN65(64) MHÑDuctus Arteriosus, Patent ANabnormal; do not use /congen; consider also PERSISTENT FETAL CIRCULATION SYNDROME MNC14.280.400.340; C16.131.457.345 LH  MSA blood group consisting mainly of the antigens Fy(a) and Fy(b), determined by allelic genes, the frequency of which varies profoundly in different races; amorphic genes are common. HN(76) MHÑDuffy Blood-Group System ANonly /genet /immunol; TN 230 PIBlood Groups (66-75) MND24.611.216.705.230.301; G4.610.241.301; G9.188.229.301 DMÑBlood Groups LH LM  HN(72) MHÑDulcitol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN608-66-2 PIAlcohols (66-71); Antineoplastic Agents (66-71); Carbohydrates (69-71); Galactose (66-71); Galactosemia (66-71); Hexoses (66-71) MND9.203.853.256; D2.33.800.256 XSGalactitol DMÑSugar Alcohols LH LS LM  MSGastrointestinal symptoms resulting from an absent or nonfunctioning pylorus. MHÑDumping Syndrome MNC6.405.650.310; C23.814.617.395 LH  MHÑDuodenal Diseases ANGEN; prefer specifics; inflamm dis = DUODENITIS; duodenal atresia = DUODENAL OBSTRUCTION /congen (IM) + INTESTINAL ATRESIA (IM) MNC6.405.469.275 LH  MHÑDuodenal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.476.411.445; C6.405.469.275.270 LH  MHÑDuodenal Obstruction ANobstruct of external or internal origin; duodenal compression by superior mesenteric artery = SUPERIOR MESENTERIC ARTERY SYNDROME; duodenal atresia = DUODENAL OBSTRUCTION /congen (IM) + INTESTINAL ATRESIA (IM) MNC6.405.469.275.395; C6.405.469.531.311 XUÑSuperior Mesenteric Artery Syndrome LH LU  MHÑDuodenal Ulcer ANperforation: coord IM with PEPTIC ULCER PERFORATION (IM); hemorrhage: coord IM with PEPTIC ULCER HEMORRHAGE (IM); ╥gastroduodenal ulcer╙ = GASTRODUODENAL ULCER see PEPTIC ULCER MNC6.405.469.275.520; C6.405.613.216 XUÑCurling's Ulcer LH LU  PM80 HN80 MHÑDuodenitis PIDuodenal Diseases (66-79); Enteritis (66-79) MNC6.405.469.275.600 LH  MSReflux of duodenal contents into the stomach. PM84 HN84 MHÑDuodenogastric Reflux ANnote category; duodenal reflux goes here PIDuodenal Diseases (66-83); Duodenum (66-83); Stomach (66-83); Stomach Diseases(66-83) MNC6.405.748.240 LH  MSExamination of the luminal surface of the duodenum with an endoscope. PM81 HN81 MHÑDuodenoscopy ANNIM; do not use /util except by MeSH definition PIDuodenum (66-80); Endoscopy (66-80) MNE1.184.250; E1.418.352 LH  PMDUODENAL INTUBATION was heading 1963-65 HNDUODENAL INTUBATION was heading 1963-65 MHÑDuodenum ANinflammation = DUODENITIS; fistula = DUODENAL DISEASES (IM) + INTESTINAL FISTULA (IM); duodenal atresia = DUODENAL OBSTRUCTION /congen (IM) + INTESTINAL ATRESIA (IM); duodenal juice = DUODENUM (IM) + INTESTINAL SECRETIONS (IM) (not DUODENUM /secret) MNA3.492.411.620.270 XUÑBrunner's Glands LH LU  MHÑDupuytren's Contracture MNC5.651.197.270; C23.205.270 LH  MHÑDura Mater ANdo not use /innerv MNA8.186.566.395 LH  PM74 HN74(71) MHÑDursban ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN2921-88-2 PIInsecticides (66-70) MND2.719.296; D5.723.491.657.320 XSCHLORPYRIFOS LH LS  MHÑDust ANhousedust goes here; coord with specific substance yielding dust: GOLD + DUST, COAL + DUST; only /adv eff /anal /prev; do not index here for specific dusts in pneumoconiosis: see note under PNEUMOCONIOSIS MNG3.850.460.100.210 FXÑAllergens; ÑPNEUMOCONIOSIS LH LX;  MSThe condition of being undersized resulting from premature arrest of skeletal growth; may be caused by insufficient secretion of growth hormone. MHÑDwarfism ANpituitary nanism = DWARFISM, PITUITARY MNC5.116.99.343; C19.297 XSNANISM FXÑGrowth Disorders XUÑCockayne Syndrome LH LS LX LU  MSA form of dwarfism due to absence or hypofunction of the anterior pituitary gland. MHÑDwarfism, Pituitary ANpituitary nanism goes here MNC5.116.99.343.445; C5.116.132.358; C19.297.312; C19.700.482.311 LH  PM65 HN65(63) MHÑDydrogesterone ANdo not use /biosyn /defic /physiol RN152-62-5 MND4.808.745.432.296; D6.597.799.276 XSIsopregnenone LH LS  MHÑDye Dilution Technic ANonly /instrum /vet CATALOG: do not use /laboratory manuals MNE1.145.643.312 LH  MHÑDyes ANusually non-biol: differentiate from PIGMENTS, largely biol; D25-26 qualif MND26.408 XSColoring Agents FXÑFood Coloring Agents; ÑSTAINS AND STAINING LH LS LX;  HN(73) MHÑDyfonate ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN944-22-9 MND2.719.318; D5.723.491.657.346 DMÑInsecticides, Organothiophosphate LH LM  MSA structural protein which forms the arms on the microtubule doublets of cilia and flagella. In the presence of divalent cations, dynein catalyzes the hydrolysis of ATP. This hydrolysis plays an important functional role in the motility process. HN(77) MHÑDynein AN/biosyn /physiol permitted; do not use /analogs RNEC 3.6.1.- PIAdenosine Triphosphatase (66-76); Proteins (66-76) MND8.586.277.352.630.114.250; D12.776.220.600.200; D12.776.275 DMÑAdenosine Triphosphatase LH LM  MSExtremely potent, widely distributed neuropeptide isolated originally from the pituitary gland. The peptide contains 17 amino acid residues and contains leucine enkephalin as its NH2-terminal sequence. Its physiological actions are similar to those of endorphin. PM85 HN85 MHÑDynorphin AN/biosyn /physiol permitted RN74913-18-1 PIEndorphins (Jul 77-84); Peptides (66-Jul 77) MND12.644.150.200; D12.776.641.650.240.200; D16.538.321.308 LH  MS7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine. Theophylline derivative broncho- and vasodilator; used in asthma, cardiac dyspnea, bronchitis. Synonyms: Astrophyllin; Dilor; glyfyllin; glyphylline; hyphylline; Lufylline; Neophylline; Neothylline; Thefylan. HN(80) MHÑDyphylline ANdo not use /biosyn /defic /physiol RN479-18-5 PITheophylline (66-74) /AA (75-79) MND3.438.759.758.824.751.250; D16.116.919.299; D18.918.882.299 XSDihydroxypropyltheophylline; Diprophylline DMÑTheophylline LH LS; LM  MSImpairment of motor control of speech due to faulty innervation of speech musculature or imperfect coordination of the musculature in complex acts. OLsearch SPEECH DISORDERS 1966-74 HN(79); was see under SPEECH DISORDERS 1963-74 MHÑDysarthria ANimpaired motor control of speech; do not use /drug eff /physiol /rad eff PISpeech Disorders (66-78) MNC10.597.257.870.309; C23.888.592.257.870.309; F3.126.219.870.309 DMÑSpeech Disorders LH LM  OLuse DYSAUTONOMIA, FAMILIAL to search AUTONOMIC DYSFUNCTION 1966-80 PM81; was AUTONOMIC DYSFUNCTION 1963-80 HN81; was AUTONOMIC DYSFUNCTION 1963-80 MHÑDysautonomia, Familial ANa disease entity: not for autonomic nerv system dysfunct ( = AUTONOMIC NERVOUS SYSTEM DISEASES); do not use /congen MNC10.120.309; C10.772.590.309; C16.131.666.690.309 XSRiley-Day Syndrome LH LS  MHÑDysentery MNC6.405.469.237.479 LH  MHÑDysentery, Amebic MNC3.432.396; C3.752.55.407.310; C6.405.469.237.479.312; C6.405.469.452.396 XSAMEBIASIS, INTESTINAL; Colitis, Amebic; Entamoebiasis, Intestinal; INTESTINAL AMEBIASIS LH LS; ; ;  MHÑDysentery, Bacillary ANcoord IM with specific Shigella species if pertinent (NIM) MNC1.252.310.229; C6.405.469.237.479.479 XSSHIGELLA INFECTIONS FXÑShigella LH LS LX  MSAn immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins. OLsearch IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-74 PM78; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77 HN78(75); was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77 MHÑDysgammaglobulinemia ANcoord IM with specific immunoglobulin /defic (IM); TN 225: relation to AGAMMAGLOBULINEMIA PIImmunologic Deficiency Syndromes (68-74); Immunity (66-70) MNC15.378.147.333; C20.673.430 LH  MSA tumor derived from undifferentiated germinal cells; it is usually found in the ovary or testis, but may also appear in the mediastinum or the retroperitoneum. Dysgerminomas of the testis are usually called seminomas. OLuse DYSGERMINOMA to search DISGERMINOMA back thru 1966 PM79; was DISGERMINOMA 1963-78 HN79; was DISGERMINOMA 1963-78 MHÑDysgerminoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.370 XSDisgerminoma; Seminoma LH LS;  OLsearch TASTE DISORDERS 1973-74 HN(75) MHÑDysgeusia MNC10.597.751.861.479; C23.888.592.763.861.479 DMÑTaste Disorders LH LM  MSAbnormal movements induced as an adverse reaction of drug therapy. One particular movement disorder is the ╥on-off╙ effect. PM77 HN77 MHÑDyskinesia, Drug-Induced ANdo not use /chem ind PIMovement Disorders (66-76) MNC10.228.140.79.333; C21.613.276.521 XSDyskinesia, Tardive LH LS  MSImpairment of the ability to learn to read, or to understand what one reads silently or aloud, independently of any speech defect. PM66; was see under READING 1963-65 HN66(63); was see under READING 1963-65, was in Cat F only 1963-79 MHÑDyslexia ANdo not use /drug eff /physiol /rad eff; this is congen (do not use /congen): differentiate from DYSLEXIA, ACQUIRED (caused by brain lesion) MNC10.597.257.543.307; C23.888.592.257.543.307; F3.126.219.543.307 XSDyslexia, Congenital; Dyslexia, Developmental; Reading Disability, Developmental FXÑLearning Disorders LH LS; ; LX  MSLoss of previously possessed reading facility due to a brain lesion; visual aphasia; word blindness. OLuse DYSLEXIA, ACQUIRED to search ALEXIA back thru 1966 PM77; was ALEXIA 1963-76 HN77; was ALEXIA 1963-76 MHÑDyslexia, Acquired ANdyslexia from brain lesion; do not use /congen /drug eff /physiol /rad eff MNC10.597.257.543.307.311; C23.888.592.257.543.307.311; F3.126.219.543.307.311 XSAlexia; Reading Disability, Acquired FXÑReading LH LS; LX  MSPainful menstruation. MHÑDysmenorrhea MNC13.371.491.346 LH  MSDefective bone formation involving individual bones, singly or in combination. PM85 HN85 MHÑDysostoses PIBone Diseases (66-69); Bone Diseases, Developmental (70-84) MNC5.116.99.370 LH  MSPainful sexual intercourse. PM67 HN67(63) MHÑDyspareunia ANdo not use /congen /drug eff /physiol /rad eff MNC13.371.665.313; C13.371.894.217; F3.126.286; F3.709.597.608.780.410 LH  MHÑDyspepsia MNC23.888.821.236 LH  MSA clinically distinguishable association of atypical precursor nevi and malignant melanoma. PM87 HN87 MHÑDysplastic Nevus Syndrome ANdo not use /anal /blood supply /secret /ultrastruct PIMelanoma (66-86); Nevus (66-86); Nevus, Pigmented (66-86) MNC4.557.433.305; C4.557.537.734.305; C4.700.305; C16.466.700.305 XSB-K Mole Syndrome; Familial Atypical Multiple Mole-Melanoma; Nevus Syndrome, Dysplastic LH LS; ;  MSDifficult or labored breathing. MHÑDyspnea ANdifficulty in breathing: do not confuse with APNEA or other resp disord; use only when text uses DYSPNEA MNC8.618.326; C23.888.852.371 FXÑRespiration LH LX  MHÑDyspnea, Paroxysmal MNC8.618.326.396; C14.280.434.313; C23.888.852.371.396 XSASTHMA, CARDIAC LH LS  MHÑDysprosium ANDy-164; do not use /analogs /biosyn /defic /physiol; Dy-156, 158, 160-163 = DYSPROSIUM (IM) + ISOTOPES (NIM); Dy-149-155, 157, 159, 165-167 = DYSPROSIUM (IM) + RADIOISOTOPES (IM) RN7429-91-6 MND1.268.260; D1.552.550.208 LH  MHÑDystocia MNC13.703.420.288 FXÑDelivery LH LX  MSAn abnormal movement manifesting as maintenance of a posture by exaggerated muscle tone, the posture being an extreme degree of either flexion or extension. Often affects the large axial muscles of the trunk and limb girdles. OLuse DYSTONIA to search MUSCLE DYSTONIA back thru 1979 PM82; was MUSCLE DYSTONIA 1979-81 HN82; was MUSCLE DYSTONIA 1979-81 MHÑDystonia ANdo not confuse with MUSCLE HYPERTONIA or MUSCLE HYPOTONIA; DYSTONIA MUSCULORUM DEFORMANS is also available PIMovement Disorders (66-78); Muscle Tonus (70-78) MNC10.597.559.309; C23.888.592.574.309 XSMuscle Dystonia LH LS  MHÑDystonia Musculorum Deformans MNC10.228.140.79.357 XSOPPENHEIM-ZIEHEN DISEASE; Torsion Dystonia LH LS;  OLuse EAR /AB & EAR, EXTERNAL /AB & EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70; in searching non-acquired ear abnormalities consider EAR DEFORMITIES, ACQUIRED 1966-74 PMEAR, EXTERNAL, DEFORMITY was heading 1966-70 HNEAR, EXTERNAL, DEFORMITY was heading 1966-70 MHÑEar ANGEN only or unspecified; prefer EAR, EXTERNAL; EAR, MIDDLE or LABYRINTH ( = internal ear); /abnorm permitted but note EAR DEFORMITIES, ACQUIRED; consider also terms under OTO MNA1.456.313; A9.246 LH  MHÑEar Canal MNA9.246.272.396 XSAuditory Canal, External FXÑCERUMEN LH LS LX  MSCartilages of the auricle (pinna) and the external acoustic meatus. HN(79) MHÑEar Cartilages AN/abnorm permitted for congen deform but acquired deform = EAR DEFORMITIES, ACQUIRED (IM) + EAR CARTILAGES (NIM) PICartilage (66-78); Ear, External (66-78) MNA2.165.207; A9.246.272.405 DMÑEar, External LH LM  MSDistortion or disfigurement of the ear caused by disease or injury after birth. OLuse EAR /AB & EAR, EXTERNAL /AB & EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70 PM71; was EAR, EXTERNAL, DEFORMITY 1963-70 HN71; was EAR, EXTERNAL, DEFORMITY 1963-70 MHÑEar Deformities, Acquired ANacquired through inj or dis; do not use /congen: = EAR, EXTERNAL /abnorm MNC9.218.271 LH  MSDiseases of the ear, general or unspecified. PM66 HN66 MHÑEar Diseases ANGEN only; NIM with coord for diseases of specific parts; inflamm dis = OTITIS and its specifics MNC9.218 FXÑOTORHINOLARYNGOLOGIC DISEASES LH LX  MSNeoplasms of the internal, external, or middle ear. PM66 HN66 MHÑEar Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific ear term (IM) + histol type of neopl (IM) MNC4.588.443.665.312; C9.218.334 LH  MHÑEar Ossicles MNA9.246.397.247 XSAuditory Ossicles FXÑSTAPES SURGERY XUÑIncus; ÑMalleus; ÑStapes LH LS LX LU; ;  MSPersonal devices for protection of the ears from loud or high intensity noise, water, or cold. Includes earmuffs and earplugs. HN(75); was in Cat E & J 1975-82 MHÑEar Protective Devices ANonly /econ /stand /supply /vet; includes earmuffs & earplugs MNE7.712.260 XSHearing Protective Devices DMÑProtective Devices LH LS LM  OLuse EAR /AB & EAR, EXTERNAL /AB & EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70; in searching non-acquired ear abnormalities consider EAR DEFORMITIES, ACQUIRED 1966-74 PMEAR, EXTERNAL, DEFORMITY was heading 1966-70 HNEAR, EXTERNAL, DEFORMITY was heading 1966-70 MHÑEar, External AN/abnorm permitted for congen deform but acquired deform = EAR DEFORMITIES, ACQUIRED; inflammation = OTITIS EXTERNA MNA9.246.272 XUÑEar Cartilages LH LU  MHÑEar, Middle AN/surg: consider TYMPANOPLASTY; inflammation = OTITIS MEDIA; inj caused by pressure = EAR, MIDDLE /inj (IM) + BAROTRAUMA (IM); middle ear effusions = OTITIS MEDIA MNA9.246.397 XSTYMPANIC CAVITY; TYMPANUM FXÑAcoustic Impedance Tests LH LS; LX  MSPain in the ear. PM83 HN83 MHÑEarache PIEar (66-82); Ear Diseases (66-82); Pain (66-82) MNC9.218.350; C23.888.592.612.290 XSOtalgia LH LS  MSProcedure characterized by a shorter period of hospitalization or recumbency or by more rapid mobilization than is normally practiced. PM76 HN76 MHÑEarly Ambulation ANonly /econ /methods /psychol /trends PIspecific heading/RH (66-75) MNE2.831.280 XSAmbulation, Early; Early Mobilization LH LS;  PM73 HN73(66) MHÑEating ANonly /drug eff /rad eff; the act of eating: do not confuse with FOOD (the substance eaten) or EATING BEHAVIOR (the manner of eating): TN 63 MNG10.261.396 LH  MSPleomorphic RNA virus which causes a form of African viral hemorrhagic fever first reported from an outbreak in the Yambuku area of Zaire in 1976. HN(80); was see under RHABDOVIRUSES 1980 MHÑEbola Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with HEMORRHAGIC FEVERS, VIRAL (IM) PIHemorrhagic Fevers, Viral (78-79); Rhabdoviridae (78-79); RNA Viruses (77-79) MNB4.909.777.750.210 DMÑRhabdoviridae LH LM  MSCongenital downward displacement of the tricuspid valve with the septal and posterior leaflets being attached to the wall of the right ventricle. MHÑEbstein's Anomaly ANdo not use /congen MNC14.280.400.395; C16.131.457.397 LH  MSA purplish patch on the skin due to a subcutaneous or intradermal hemorrhage. PM64 HN64 MHÑEcchymosis ANdifferentiate from CONTUSIONS: use term in the text MNC23.542.202 FXÑPurpura LH LX  MSSimple sweat glands that secrete sweat directly onto the skin. OLsearch SWEAT GLANDS 1971-74 HN(75) MHÑEccrine Glands AN/secret: see also SWEAT or SWEATING: TN 181 MNA1.835.858.480; A10.336.899.480 DMÑSweat Glands LH LM  PM67 HN67(64) MHÑEcdysone ANdo not confuse with ECDYSTERONE; do not use /defic RN3604-87-3 MND4.808.247.222.265.150; D6.472.445.573.230 XSMOLTING HORMONE LH LS  MS2 beta,3 beta,14,20,22R,25-Hexahydroxy-5 beta-cholest-7-en-6-one. An insect hormone which is active during the molting stage of the insect's development. OLsearch INVERTEBRATE HORMONES 1972-74 & CHOLESTANES 1969-71 PM77; was see under CHOLESTENES 1975-77, was see under INVERTEBRATE HORMONES 1972-74, was see under CHOLESTANES 1969-71 HN77(75); was see under CHOLESTENES 1975-77, was see under INVERTEBRATE HORMONES 1972-74, was see under CHOLESTANES 1969-71 MHÑEcdysterone ANdo not confuse with ECDYSONE; do not use /defic RN5289-74-7 PICholestanes (68-72); Ecdysone (66-74); Hormones (66); Insects (66); Invertebrate Hormones (67-74) MND4.808.247.222.265.180; D6.472.445.573.313 XS20-Hydroxyecdysone LH LS  MSAn oviparous burrowing mammal of the order Monotremata native to Australia, Tasmania, and New Guinea; has hair mingled with spines on upper part of body and is adapted for feeding on ants. HN(75) MHÑEchidna ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not confuse spiny ant-eater with ant-eater ( = EDENTATA) MNB2.649.627.300 XSSpiny Ant-eater DMÑMonotremata LH LS LM  MHÑEchinococcosis ANnote 2 specifics below MNC3.335.190.396 XSCYSTS, HYDATID; HYDATID CYST; HYDATIDOSIS LH LS; ;  MSHelminth infection of the liver caused by Echinococcus granulosus or Echinococcus multilocularis. MHÑEchinococcosis, Hepatic MNC3.335.190.396.314; C3.518.314; C6.552.664.272 XSHydatid Cyst, Hepatic; Hydatidosis, Hepatic LH LS;  MHÑEchinococcosis, Pulmonary MNC3.335.190.396.480; C3.582.314; C8.381.517.314 XSHydatid Cyst, Pulmonary; Hydatidosis, Pulmonary LH LS;  MHÑEchinococcus ANdo not use /blood-csf-urine; infection = ECHINOCOCCOSIS or its specifics MNB1.500.736.215.327 LH  MHÑEchinodermata ANincludes SEA URCHINS, STARFISH, sea lilies, sea cucumbers & brittle stars; /microbiol /parasitol permitted MNB1.408 XUÑSea Cucumbers LH LU  MSQuinomycin A. A toxic polypeptide quinoxaline antibiotic isolated from Streptomyces echinatus that binds to DNA and inhibits RNA synthesis; may have antitumor, antiviral and antibacterial activity. HN(76) MHÑEchinomycin ANdo not use /defic /physiol; /analogs NIM only RN512-64-1 PIAntibiotics (68-75); Quinoxalines (72-75); Peptides, Cyclic (75) MND3.438.857.200; D20.85.291 XSQuinomycin A DMÑQuinoxalines LH LS LM  MSA genus of intestinal flukes of the family Echinostomatidae which consists of many species. They occur in man and other vertebrates. The intermediate hosts are frequently mollusks. MHÑEchinostoma ANdo not use /blood-csf-urine; infection = ECHINOSTOMIASIS MNB1.500.736.715.360.310 LH  OLfamily of trematodes; infection: coord NIM with TREMATODE INFECTIONS (IM) MH*Echinostomatidae (Non Mesh) MNB1.500.736.715.360 LH  MSInfection by flukes of the genus Echinostoma. OLsearch TREMATODE INFECTIONS 1967-74 HN(75) MHÑEchinostomiasis MNC3.335.865.282 DMÑTrematode Infections LH LM  PM73 HN73(67) MHÑEchocardiography ANdo not use /util except by MeSH definition PIUltrasonics (66) MNE1.145.569.314; E1.947.314 XSDoppler Echocardiography FXÑUltrasonics LH LS LX  PM67 HN67(64) MHÑEchoencephalography ANdo not use /util except by MeSH definition MNE1.236.257.314; E1.947.481 FXÑUltrasonics LH LX  MSMeaningless repetition by a patient of words addressed to him. PM69 HN69(64) MHÑEcholalia ANdo not use /drug eff /physiol /rad eff MNC10.597.257.870.323; C23.888.592.257.870.323; F3.126.219.870.323 LH  MSAn auditory orientation mechanism involving the emission of high frequency sounds which are reflected back to the emitter (animal). HN(72) MHÑEcholocation ANanimal only; for human consider SOUND LOCALIZATION; only /drug eff /physiol /rad eff PIAuditory Perception (67-71); Orientation (66-71) MNF1.145.209.103.273; F2.830.606.314 DMÑOrientation LH LM  PM65 HN65 MHÑEchothiophate Iodide ANdo not use /biosyn /defic /physiol RN513-10-0 MND2.719.341; D8.373.275.314; D16.698.410.314 XSPHOSPHOLINE IODIDE LH LS  MSInfectious disease processes, including meningitis, diarrhea, and respiratory disorders, caused by echoviruses. OLuse ECHOVIRUS INFECTIONS to search ECHO VIRUS INFECTIONS back thru 1968 PM78; was ECHO VIRUS INFECTIONS 1968-77 HN78; was ECHO VIRUS INFECTIONS 1968-77 MHÑEchovirus Infections ANcoord IM with specific Echovirus (NIM) PIEnterovirus Infections (66-67) MNC2.782.687.359.347 LH  MSA prototype echovirus that has caused outbreaks of aseptic meningitis in children and adults. HN(75) MHÑEchovirus 6 ANdo not use /blood-csf-urine /cytol MNB4.909.777.618.284.314.225 XSBurgess Virus DMÑEchoviruses LH LS LM  MSA virus associated with outbreaks of aseptic meningitis. HN(75) MHÑEchovirus 9 ANdo not use /blood-csf-urine /cytol MNB4.909.777.618.284.314.250 DMÑEchoviruses LH LM  MSA group of enteroviruses isolated from man and originally thought not to be associated with disease, whence the name Enteric Cytopathic Human Orphan; however, several serotypes have been found to cause meningitis, diarrhea and respiratory disease. OLuse ECHOVIRUSES to search ECHO VIRUSES back thru 1966 PM78; was ECHO VIRUSES 1963-77 HN78; was ECHO VIRUSES 1963-77 MHÑEchoviruses ANfrom Enteric Cytopathic Human Orphan; do not use /blood-csf-urine /cytol MNB4.909.777.618.284.314 XSEcho Viruses XUÑEchovirus 6; ÑEchovirus 9 LH LS LU;  MHÑEclampsia ANPRE-ECLAMPSIA is available MNC13.703.799.314 FXÑConvulsions LH LX  MHÑEclecticism ANno qualif MNE2.924.328 LH  MHÑEcology ANIM when general only; NIM for organism-organism relationship but HOST-PARASITE RELATIONS is available; no qualif MNG1.273.248 XSBIONOMICS; Biomass FXÑConservation of Natural Resources LH LS; LX  MS1-[2,4-Dichloro-beta-[(p-chlorobenzyl)oxy]phenethyl]-imidazole. Broad spectrum antimycotic with some action against Gram positive bacteria; it is used topically in dermatomycoses also orally and parenterally. Synonyms: CC 2470; Pevaryl; R 14,827. HN(77) MHÑEconazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN27220-47-9 PIChlorobenzenes (74-75); Imidazoles (74-76) MND3.383.374.250; D20.136.263 DMÑImidazoles LH LM  MSThe effort of two or more parties to secure the business of a third party by offering the most favorable terms. HN(82) MHÑEconomic Competition ANonly /hist /legis /trends MNN3.219.188 XSCompetition, Economic DMÑEconomics LH LS LM  MSThe evaluation of the monetary value of a life lost or a life saved. HN(83) MHÑEconomic Value of Life AN╥the evaluation of the monetary value of a life lost or a life saved╙; no qualif MNN3.219.195 XSLife Valuation, Economic DMÑEconomics LH LS LM  MSThe science of utilization, distribution and consumption of services and materials. MHÑEconomics ANGEN or unspecified only: prefer /econ: Manual 19.5+; for purely economic aspects use ECONOMICS, for combination of social & economic aspects use SOCIOECONOMIC FACTORS; only /hist /legis /trends; array of econ terms from other categories: Bull 101 (Sep 77) CATALOG: /geog /form MNN3.219 XSConsumer Price Index FXÑEuropean Economic Community; ÑSOCIOECONOMIC FACTORS XUÑCapital Expenditures; ÑEconomic Competition; ÑEconomic Value of Life; ÑInflation, Economic LH LS LX; LU; ; ;  MSEconomic aspects of the dental profession and dental care. MHÑEconomics, Dental ANGEN or unspecified only: prefer /econ with specific dent subject: Manual 19.4.69; only /hist /trends CATALOG: /geog /form MNN3.219.224 FXÑOFFICE MANAGEMENT LH LX  MSEconomic aspects related to the management and operation of a hospital. MHÑEconomics, Hospital ANGEN or unspecified only: prefer /econ with specific hosp subject: Manual 19.4.69; only /hist /trends; consider also HOSPITAL PURCHASING CATALOG: /geog /form MNN3.219.262 XSHospital Economics LH LS  MSEconomic aspects of the medical profession and health care. MHÑEconomics, Medical ANGEN or unspecified only: prefer /econ with specific subject: Manual 19.4.69; only /hist /trends CATALOG: /geog /form MNN3.219.300 FXÑOFFICE MANAGEMENT LH LX  MSEconomic aspects of the nursing profession. PM66 HN66 MHÑEconomics, Nursing ANGEN or unspecified only: prefer /econ with specific nurs subject: Manual 19.4.69; only /hist /trends CATALOG: /geog /form MNN3.219.338 LH  MH*Economics, Organizations, Control (Non Mesh) MNN3 LH  MHÑEcthyma ANa form of impetigo MNC17.838.252 LH  MSAn infectious dermatitis of sheep and goats, affecting primarily the muzzle and lips; it is caused by a poxvirus and may be transmitted to man. OLsearch POXVIRUS INFECTIONS 1966-69 PM70; was ECTHYMA CONTAGIOSUM see under POXVIRUS INFECTIONS 1963-69 HN70; was ECTHYMA CONTAGIOSUM see under POXVIRUS INFECTIONS 1963-69 MHÑEcthyma, Contagious ANusually animal: do not use /vet but check tag ANIMAL; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES PIEcthyma (66-69); Poxvirus Infections (66-69); Sheep Diseases (66-69) MNC2.256.743.193; C22.836.259 XSCONTAGIOUS PUSTULAR DERMATITIS; DERMATITIS, CONTAGIOUS PUSTULAR; ORF LH LS; ;  MSThe outer of the three germ layers of the embryo. MHÑEctoderm ANdo not use /abnorm /embryol /growth /inj MNA16.254.425.273 LH  MSOpinions vary as to the scope of this concept. Here are some of them; (l) diseases consisting of hypotrichosis, hypodontia, onchodysplasia, and anhidrosis, (2) developmental hereditary diseases affecting the ectoderm, (3) congenital, non-progressive diseases involving the epidermis diffusely and at least one of its appendages. OLuse ECTODERMAL DYSPLASIA to search ECTODERMAL DEFECT, CONGENITAL back thru 1966 PM65; ECTODERMAL DEFECT, CONGENITAL was heading 1963-86 HN65; FOCAL DERMAL HYPERPLASIA was see under ECTODERMAL DEFECT, CONGENITAL 1985-86; ECTODERMAL DEFECT, CONGENITAL was heading 1963-86 MHÑEctodermal Dysplasia ANdo not use /congen MNC16.131.77.350; C16.131.831.350; C17.827.375 XSAnhidrotic Ectodermal Dysplasia; CHRIST-SIEMENS SYNDROME; Ectodermal Defect, Congenital XUÑFocal Dermal Hypoplasia LH LS; ; LU  MSEmbryonal development or fetal maturation that takes place in an artificial environment. PM75 HN75 MHÑEctogenesis ANgenesis in an artificial environment; only /drug eff /rad eff PIEmbryo (66-74) MNG7.553.350 LH  MSInfestations by parasites which live on the outside of the body of the host. PM68 HN68 MHÑEctoparasitic Infestations ANGEN only: prefer specifics; coord IM with ectoparasite (IM); refers to ectoparasite on, within or under the skin so do not coord with SKIN DISEASES, PARASITIC PIParasitic Diseases (66-67); specific parasite MNC3.211 FXÑSkin Diseases, Parasitic LH LX  MSCongenital displacement of the lens resulting from defective zonule formation. HN(78) MHÑEctopia Lentis ANcongen lens dislocation; do not use /congen PIEye Diseases (66-77); Lens, Crystalline (66-77) MNC11.510.598.373; C16.131.384.405 DMÑLens Dislocation and Subluxation LH LM  MSGross hypo- or aplasia of one or more long bones of one or more limbs; includes amelia, hemimelia and phocomelia. OLuse ECTROMELIA to search PHOCOMELIA back thru 1966 & SIRENOMELIA back thru 1967 PM67; PHOCOMELIA was heading 1963-66 HN67(63); PHOCOMELIA was see under ECTROMELIA 1967-78, was heading 1963-66; SIRENOMELIA was see under ECTROMELIA 1967-78 MHÑEctromelia ANrefers to arm or leg: see Dorland for definition & inclusions; do not use /congen MNC16.131.621.314 XSAMELIA; Phocomelia; Sirenomelia LH LS; ;  MHÑEctromelia Virus ANdo not use /blood-csf-urine /cytol; infection = probably ECTROMELIA, INFECTIOUS MNB4.909.204.783.220 XSMouse Pox Virus; POXVIRUS MURIS LH LS;  MSA viral infection of mice, causing edema and necrosis followed by limb loss. Synonym: mouse pox. OLsearch POXVIRUS INFECTIONS 1967-74 HN(75) MHÑEctromelia, Infectious ANmousepox; do not use /vet but index also under POXVIRUS INFECTIONS /vet for IM + RODENT DISEASES (IM); don't forget to check tag MICE MNC2.256.743.239 DMÑPoxvirus Infections LH LM  MHÑEctropion MNC11.338.362 LH  MHÑEcuador MNZ1.107.757.362 XSGalapagos Islands LH LS  MHÑEczema ANan indistinct concept: check text for more specific skin dis; if more specific term is not in text, do not make a diagnosis: index here MNC17.174.401; C20.543.480.366 LH  MSBasic peptide antibiotic from Bacillus brevis. Exhibits broad-spectrum antibacterial activity and inhibits bacterial DNA synthesis. HN(75) MHÑEdeine ANdo not use /defic /physiol; /analogs NIM only RN11006-90-9 PIAntibiotics (71-74); Peptides (72-74); Polyamines (73-74) MND20.85.295 DMÑAntibiotics LH LM  MHÑEdema ANcoord IM with organ/diseases term (IM); egg-white edema: coord IM with OVALBUMIN (NIM if indexed at all); angioedema & QUINCKE'S EDEMA = ANGIONEUROTIC EDEMA; EPH (Edema, Proteinuria, Hypertension) = PREGNANCY TOXEMIAS & do not index under EDEMA unless it is particularly discussed MNC23.360 XSDROPSY; HYDROPS FXÑANGIONEUROTIC EDEMA; ÑBRAIN EDEMA; ÑLARYNGEAL EDEMA; ÑLYMPHEDEMA; ÑMACULAR EDEMA, CYSTOID; ÑPAPILLEDEMA; ÑPULMONARY EDEMA LH LS; LX; ; ; ; ; ;  PM71 HN71 MHÑEdema Disease of Swine ANdo not use /vet; don't forget also SWINE (NIM) & check tag ANIMAL PIEdema/VE (66-70); Gastrointestinal Diseases/VE (66-70); Swine Diseases (66-70) MNC22.905.260 LH  OLsearch HEART FAILURE, CONGESTIVE 1966-74 HN(75) MHÑEdema, Cardiac MNC14.280.434.482 DMÑHeart Failure, Congestive LH LM  MHÑEdentata ANant-eaters, SLOTHS, ARMADILLOS, aardvarks (but not aard-wolf ( = CARNIVORA)); IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.314 XUÑArmadillos; ÑSloths LH LU;  OLsearch CURARIFORM ANTAGONISTS 1966-69; use EDROPHONIUM to search EDROPHONIUM CHLORIDE back thru 1966 (as Prov 1966-71) PM83; was see under CURARIFORM ANTAGONISTS 1963-69; EDROPHONIUM CHLORIDE was a heading 1972-82 HN83; was see under CURARIFORM ANTAGONISTS 1963-69; EDROPHONIUM CHLORIDE was a heading 1964-82 (Prov 1964-71) MHÑEdrophonium ANdo not use /biosyn /defic /physiol RN312-48-1 MND2.92.102.352; D2.675.276.352; D8.373.275.371; D16.698.410.324 XSEdrophonium Chloride LH LS  PM66; was EDATHAMIL 1963-65 HN66; was EDATHAMIL 1963-65 MHÑEDTA AND25-26 qualif RN60-00-4 MND2.92.782.258.368.250; D2.241.81.38.440; D26.241.504 XSEDATHAMIL; EDETATES; ETHYLENEDIAMINETETRAACETIC ACID; Tetracemate LH LS; ; ;  MSAcquisition of knowledge as a result of instruction in a formal course of study. MHÑEducation ANGEN only; only /econ /hist /legis /man /stand /trends; prefer /educ: Manual 19.5+; policy: Manual 30.20 CATALOG: /geog /form MNI2 XSCorrespondence Courses FXÑLEARNING; ÑRESEARCH SUPPORT; ÑTRAINING SUPPORT LH LS LX; ;  MSHospital department responsible for administering educational and training activities pertaining to health for patients and staff. HN(82) MHÑEducation Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: EDUC DEP MNN2.278.354.422.310; N4.452.442.422.310 XSHospital Education Department DMÑHospital Departments LH LS LM  MSThe teaching or training of those individuals with subnormal intellectual functioning. OLuse EDUCATION OF MENTALLY RETARDED to search EDUCATION OF MENTALLY DEFECTIVE back thru 1966 PM67; was EDUCATION OF MENTALLY DEFECTIVE 1963-66 HN67; was EDUCATION OF MENTALLY DEFECTIVE 1963-66 MHÑEducation of Mentally Retarded ANonly /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNF2.784.629.375; I2.233.213.400 XSEDUCATION OF MENTALLY DEFECTIVE FXÑMental Retardation LH LS LX  MSEducational programs designed to inform individuals of recent advances in their particular field of interest; does not lead to any formal advanced standing. PM66 HN66 MHÑEducation, Continuing ANformal or informal courses to advance or update knowledge: differentiate from EDUCATION, GRADUATE: formal prep for specialty training or advanced study leading to official certification or degree; only /econ /hist /legis /man /stand /trends; includes refresher courses CATALOG: /geog /form MNI2.358.212 XUÑEducation, Professional, Retraining LH LU  MSUse for articles concerning dental education in general. MHÑEducation, Dental ANonly /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.274 LH  MSEducational programs designed to inform dentists of recent advances in their fields. OLuse EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE to search EDUCATION, DENTAL, POSTGRADUATE 1966-74 PM66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965 HN66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965 MHÑEducation, Dental, Continuing ANdifferentiate from EDUCATION, DENTAL, GRADUATE: see note on EDUCATION, CONTINUING above; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.212.249; I2.358.274.316 LH  MSEducational programs for dental graduates entering a specialty; includes formal specialty training as well as academic work in the clinical and basic dental sciences, and may lead to board certification or an advanced dental degree. OLuse EDUCATION, DENTAL, GRADUATE & EDUCATION, DENTAL, CONTINUING to search EDUCATION, DENTAL, POSTGRADUATE 1966-74 PM66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965 HN66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965 MHÑEducation, Dental, Graduate ANdifferentiate from EDUCATION, DENTAL, CONTINUING: see note on EDUCATION, CONTINUING above; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.274.482; I2.358.337.249 LH  MSStudies beyond the bachelor's degree at an institution having graduate programs for the purpose of preparing for entrance into a specific field, and obtaining a higher degree. PM70 HN70(67) MHÑEducation, Graduate ANdifferentiate from EDUCATION, CONTINUING: see note on EDUCATION, CONTINUING above; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form PIEducation (66) MNI2.358.337 LH  MSUse for general articles concerning medical education. MHÑEducation, Medical ANonly /econ /hist /legis /man /stand /trends; Manual 34.22 CATALOG: /geog /form MNI2.358.399 LH  MSEducational programs designed to inform physicians of recent advances in their field. OLuse EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE to search EDUCATION, MEDICAL, POSTGRADUATE 1966-74 PM66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65 HN66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65 MHÑEducation, Medical, Continuing ANdifferentiate from EDUCATION, MEDICAL, GRADUATE: see note on EDUCATION, CONTINUING above; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.212.350; I2.358.399.250 LH  MSEducational programs for medical graduates entering a specialty; includes formal specialty training as well as academic work in the clinical and basic medical sciences, and may lead to board certification or an advanced medical degree. OLuse EDUCATION, MEDICAL, GRADUATE & EDUCATION, MEDICAL, CONTINUING to search EDUCATION, MEDICAL, POSTGRADUATE 1966-74 PM66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65 HN66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65 MHÑEducation, Medical, Graduate ANdifferentiate from EDUCATION, MEDICAL, CONTINUING: see note on EDUCATION, CONTINUING above; only /econ /hist /legis /man /stand /trends; Manual 34.22 CATALOG: /geog /form MNI2.358.337.350; I2.358.399.350 LH  MSThe period of medical education in a medical school; in the United States it follows the baccalaureate degree and precedes the granting of the M.D. PM73 HN73(71) MHÑEducation, Medical, Undergraduate ANonly /econ /hist /legis /man /stand /trends CATALOG: /geog /form PIEducation, Medical (66-70) MNI2.358.399.450 XUÑClinical Clerkship LH LU  OL╥non-professional education╙ is indexed EDUCATION MH*Education, Nonprofessional (Non Mesh) MNI2.233 LH  MSUse for general articles concerning nursing education. MHÑEducation, Nursing ANGEN: prefer specific; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.462 LH  MSA two-year program in nursing education in a community or junior college leading to an A.D. (Associate Degree). Graduates of this program are eligible for state examination for licensure as RN (Registered Nurse). OLsearch EDUCATION, NURSING, DEGREE PROGRAMS under EDUCATION, NURSING, BACCALAUREATE 1967-70 PM71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70 HN71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70 MHÑEducation, Nursing, Associate AN2-yr community or junior college program; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.462.233 LH  MSA four-year program in nursing education in a college or university leading to a B.S.N. (Bachelor of Science in Nursing). Graduates are eligible for state examination for licensure as RN (Registered Nurse). OLuse EDUCATION, NURSING, BACCALAUREATE to search EDUCATION, NURSING, DEGREE PROGRAMS 1967-70 PM71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70 HN71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70 MHÑEducation, Nursing, Baccalaureate AN4-yr program leading to BS; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.462.316 XSExternal Degree Programs, Nursing LH LS  MSEducational programs designed to inform nurses of recent advances in their fields. PM66 HN66 MHÑEducation, Nursing, Continuing ANdifferentiate from EDUCATION, NURSING, GRADUATE: see note on EDUCATION, CONTINUING above; special courses, workshops, etc.; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.212.450; I2.358.462.399 LH  MSPrograms usually offered in hospital schools of nursing leading to a registered nurse diploma (RN). Graduates are eligible for state examination for licensure as RN (Registered Nurse). PM67 HN67 MHÑEducation, Nursing, Diploma Programs AN2-3-yr program in hosp. school of nurs; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form PIEducation, Nursing (66) MNI2.358.462.482 LH  MSThose educational activities engaged in by holders of a bachelors degree in nursing, which are primarily designed to prepare them for entrance into a specific field of nursing, and may lead to board certification or a more advanced degree. PM66 HN66 MHÑEducation, Nursing, Graduate ANdifferentiate from EDUCATION, NURSING, CONTINUING: see note on EDUCATION, CONTINUING above; leads to MS or PhD; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.337.450; I2.358.462.565 LH  MSUse for general articles concerning education in the field of pharmacy. MHÑEducation, Pharmacy ANonly /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.525 LH  MSEducational programs designed to inform graduate pharmacists of recent advances in their particular field. PM68 HN68 MHÑEducation, Pharmacy, Continuing ANdifferentiate from EDUCATION, PHARMACY, GRADUATE: see note on EDUCATION, CONTINUING above; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form PIEducation, Pharmacy (66-67) MNI2.358.212.550; I2.358.525.317 LH  MSEducational programs for pharmacists who have a bachelor degree or a Doctor of Pharmacy degree entering a specific field of pharmacy; may lead to an advanced degree. PM68 HN68 MHÑEducation, Pharmacy, Graduate ANdifferentiate from EDUCATION, PHARMACY, CONTINUING: see note on EDUCATION, CONTINUING above; only /econ /hist /legis /man /stand /trends CATALOG: /geog /form PIEducation, Pharmacy (66-67) MNI2.358.337.550; I2.358.525.483 LH  MSPreparatory education meeting the requirements for admission to dental school. PM66 HN66 MHÑEducation, Predental ANonly /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.275 LH  MSPreparatory education meeting the requirements for admission to medical school. PM66 HN66 MHÑEducation, Premedical ANonly /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.316 LH  MH*Education, Professional (Non Mesh) MNI2.358 LH  MSEducational programs for individuals who have been inactive in their profession, or who wish to regain unused skills. HN(79) MHÑEducation, Professional, Retraining ANonly /econ /hist /legis /man /stand /trends; coord NIM with specific type (medical, dental, etc.) of continuing educ (IM) CATALOG: /geog /form MNI2.358.212.590 XSRetraining, Professional DMÑEducation, Continuing LH LS LM  MSEducation of the individual who markedly deviates intellectually, physically, socially, or emotionally from those considered to be normal, thus requiring special instruction. PM68 HN68(66) MHÑEducation, Special ANonly /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.233.213 FXÑHandicapped LH LX  MSUse for general articles concerning veterinary medical education. PM74 HN74 MHÑEducation, Veterinary ANonly /econ /hist /legis /man /stand /trends CATALOG: /geog /form MNI2.358.588 LH  MSThe assessing of academic or educational achievement; includes all aspects of testing and test construction. OLuse EDUCATIONAL MEASUREMENT to search GRADUATE RECORDS EXAMINATION back thru 1966 PM66 HNGRADUATE RECORDS EXAMINATION was see under EDUCATIONAL MEASUREMENT 1966-82 MHÑEducational Measurement ANonly /econ /methods MNI2.399 XSAssessment, Educational; Graduate Records Examination FXÑAptitude Tests XUÑCollege Admission Test; ÑSchool Admission Criteria; ÑSelf-Evaluation Programs LH LS; LX LU; ;  MSEducational attainment or level of education of individuals. PM68 HN68 MHÑEducational Status ANNIM; no qualif PISociology (66-67); Students (66-67) MNN1.824.196 XSIlliteracy LH LS  MSA personality inventory which is used to measure the major personal or social motives of individuals. HN(75) MHÑEdwards Personal Preference Schedule ANno qualif; DF: EPPS MNF4.711.647.513.200 DMÑPersonality Inventory LH LM  MHÑEels ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; ANGUILLA is available MNB2.493.338 LH  MSNerve structures through which impulses are conducted from a nerve center toward a peripheral site. PM76 HN76; was NON MESH before 1976 MHÑEfferent Pathways ANdo not use /innerv; coord NIM with origin (IM) + termination (IM) PINeurons, Efferent (69-75); specific central nervous system heading MNA8.612.380 LH  MSRatio of output to effort, or the ratio of effort produced to energy expended. HNwas in Cat F only 1963-81 MHÑEfficiency ANonly /drug eff /physiol /rad eff; note category: do not confuse with PHYSICAL FITNESS MNF2.784.692.351; N3.219.350 XSProductivity FXÑFATIGUE; ÑWork LH LS LX;  PM73 HN73 MHÑEgg Proteins ANdo not use /analogs /defic /physiol PIEgg White (66-72); Egg Yolk (66-72); Proteins (66-72) MND12.776.256.317 XUÑConalbumin; ÑOvomucin; ÑPhosvitin LH LU; ;  PM74 HN74 MHÑEgg Shell ANIM avian only if pertinent; NIM reptilian; do not use for lower animals; only /anal /ultrastruct MNA13.316 LH  MHÑEgg White ANwhite of egg as food or as distinct from EGG YOLK, or egg white from dietary, food technol or econ viewpoint; differentiate from OVALBUMIN, the chemical albumin in egg white; egg-white edema: coord EDEMA (IM) + OVALBUMIN (NIM if indexed at all); only /ad-poi-tox /anal /rad eff MNJ1.341.322.317 FXÑOVALBUMIN LH LX  HNwas in Cat J only 1963-76 MHÑEgg Yolk ANonly /ad-poi-tox /anal /rad eff MNA16.631.325; J1.341.322.484 LH  MHÑEggs ANdifferentiate from OVUM; eggs as food (chicken, duck, quail, etc. eggs); fish roe & reptile eggs go here; only /ad-poi-tox /anal /econ /rad eff /stand /supply MNJ1.341.322 FXÑPoultry Products LH LX  MSThe conscious portion of the personality structure which serves to mediate between the demands of the primitive instinctual drives, (the id), of internalized parental and social prohibitions or the conscience, (the superego), and of reality. OLto search SELF use EGO back thru 1975 & SELF CONCEPT 1966-68 PM68; SELF was not in system 1969-74, was heading 1965-68, was see under PERSONALITY 1963-64 HN68; SELF was not in system 1969-74, was heading 1965-68, was see under PERSONALITY 1963-64 MHÑEgo ANno qualif; egocentrism: index DEFENSE MECHANISMS PIDefense Mechanisms (66-67); Personality (66-67); Psychoanalytic Theory (66-67) MNF1.752.747.189; F2.739.794.206 XSSelf XUÑReality Testing LH LS LU  MSEthylenebis(oxyethylenenitrilo)tetraacetic acid; chelating agent relatively more specific for calcium and less toxic than EDTA; has been used used for urolithiasis. PM87; was see under ETHYLENE GLYCOLS 1975-86 HN87(75); was see under ETHYLENE GLYCOLS 1975-86 MHÑEGTA ANdo not use /biosyn /defic /physiol RN67-42-5 PIAcetic Acids (69-74); Glycols (69-74) MND2.33.618.250.260; D26.241.543 XSEthylene Glycol Tetraacetic Acid LH LS  MHÑEgypt MNZ1.58.266.317; Z1.630.360 XSUnited Arab Republic LH LS  MHÑEhlers-Danlos Syndrome MNC16.131.831.428; C17.827.428; C23.205.200.310 LH  MSSmall, often pleomorphic, coccoid to ellipsoidal organisms occurring intracytoplasmically in circulating lymphocytes; the etiologic agents of tick-borne diseases of dogs, cattle, sheep, goats, and horses. HN(73)63-65 MHÑEhrlichia ANdo not use /blood-csf-urine; pathogenic for animals, not man; infection: coord NIM with RICKETTSIACEAE INFECTIONS /vet (IM) MNB3.700.651.801.317 DMÑRickettsiaceae LH LM  MS20-carbon saturated monocarboxylic acids. PM75 HN75 MHÑEicosanoic Acids ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74); Fatty Acids, Nonesterified (68-74) MND2.241.81.407.300; D10.516.251.220 XSArachidic Acids XUÑPhytanic Acid LH LS LU  MSA visual image which is recalled in accurate detail; a sort of projection of an image on a mental screen. OLuse EIDETIC IMAGERY to search PHOTOGRAPHIC MEMORY back thru 1969 HNPHOTOGRAPHIC MEMORY was see under EIDETIC IMAGERY 1969-78 MHÑEidetic Imagery ANonly /drug eff /physiol /rad eff MNF2.463.593.292 XSMemory, Photographic LH LS  MSA genus of sporozoan parasites of the order Coccidia; various species are parasitic in the epithelial cells of the liver and intestines of man and other animals. MHÑEimeria ANdo not use /anat /blood-csf-urine /embryol; infection = EIMERIA INFECTIONS see COCCIDIOSIS MNB1.841.762.167.276 LH  MHÑEinsteinium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7429-92-7 MND1.287.302; D1.552.517.337 LH  MSDefect of the interventricular septum with severe pulmonary hypertension, hypertrophy of the right ventricle, and latent or overt cyanosis. MHÑEisenmenger Complex ANdo not use /congen MNC14.280.400.450; C16.131.457.451 XSEisenmenger Syndrome LH LS  MHÑEjaculation ANonly /drug eff /rad eff MNG8.520.900.138 LH  MHÑEjaculatory Ducts MNA5.360.444.251 LH  MHÑEl Salvador MNZ1.107.169.339 LH  MSInfection of wild elk and domestic sheep with adult worms or microfilariae of Elaeophora schneideri; characterized by ischaemic necrosis of the brain, blindness and dermatosis of the face. Synonyms: elaeophorosis, sorehead, clear-eyed blindness. OLsearch FILARIASIS 1969-74 HN(75) MHÑElaeophoriasis MNC3.335.508.361.339 DMÑFilariasis LH LM  MSVenoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral-, tiger- and Australian snakes, etc.; the venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic and neurotoxic factors, but fewer enzymes than Viper or Crotalid venoms; many of the toxins have been characterized. PM78 HN78 MHÑElapid Venoms ANdo not use /analogs /chem syn /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; note that BUNGAROTOXINS, COBRA TOXINS & other specifics are available; TN 241: common & scientific names of various elapids PISnake Venoms (75-77); Snakes (66-74); Venoms (66-74) MND24.185.965.850.325 LH  MHÑElastic Tissue ANdo not use /abnorm /growth /inj /innerv MNA10.165.551 LH  PM67 HN67(64) MHÑElasticity ANNIM; no qualif MNH1.671.231 XUÑCompliance LH LU  PM66 HN66(63) MHÑElastin AN/biosyn /physiol permitted RN9007-58-3 MND12.776.860.294 XUÑTropoelastin LH LU  MHÑElbow ANprimates only; any Cat A qualif; TN 238: differentiation from ELBOW JOINT & indexing instructions; TN 117: use FORELIMB for non-primate vertebrates; TENNIS ELBOW is available MNA1.378.209.235 LH  PM65 HN65 MHÑElbow Joint ANprimates only; any Cat A qualif; TN 238: differentiation from ELBOW & indexing instruction; TN 117: use FORELIMB (probably IM) + JOINTS (NIM) for non-primate vertebrates MNA2.835.583.290 LH  MSEmotional, nutritional, or physical maltreatment of the older person generally by family members or by institutional personnel. PM84 HN84 MHÑElder Abuse ANonly /legis /prev; check also tag AGED PIAged (66-83); Crime (68-83); Violence (68-83) MNF3.126.842.89.208; I1.198.240.275 XSAged Abuse LH LS  PM68 HN68 MHÑElectric Conductivity ANNIM; no qualif; electric capacitance, electric resistance, impedance go here PIElectricity (66-67); Electrophysiology (66-67) MNG7.453.401; H1.181.529.307.294; H1.671.252.277 LH  PM65 HN65(63) MHÑElectric Countershock ANdo not use /util except by MeSH definition MNE2.344 XSCardioversion; DEFIBRILLATION, ELECTRIC LH LS;  MSFishes which generate an electric discharge. The voltage of the discharge varies from weak to strong in various groups of fish. Electric organ and electroplax are of prime interest in this group. They occur in more than one family. PM87 HN87 MHÑElectric Fish ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not confuse with ELECTRIC EEL see ELECTROPHORUS MNB2.493.378 XSEigenmannia; Gymnotid; Mormyrid XUÑSkates (Fish) LH LS; ; LU  MSInjuries caused by electric currents; excludes burns, includes accidental electric shock. OLuse ELECTRIC INJURIES to search ELECTRIC INJURY back thru 1966 PM73; was ELECTRIC INJURY 1963-72 HN73; was ELECTRIC INJURY 1963-72 MHÑElectric Injuries ANdo not use /chem ind; consider also BURNS, ELECTRIC; accidental shock by electricity is ELECTRIC INJURIES, not ELECTROSHOCK (for exper shock by electricity usually in psychol lit); accidental electrocution goes here MNC21.866.324 LH  PM68 HN68(63) MHÑElectric Organ ANIM MNA13.332 LH  PM65 HN65(64) MHÑElectric Stimulation ANNIM; only /adv eff /instrum /methods; used therapeutically = ELECTROTHERAPY; consider also ELECTROSHOCK & ELECTRIC COUNTERSHOCK; cardioversion = CARDIOVERSION see ELECTRIC COUNTERSHOCK MNE5.723.402 XSSTIMULATION, ELECTRIC FXÑCHRONAXY; ÑCardiac Pacing, Artificial LH LS LX;  MSAn arrangement of wires distributing electricity. HN(Aug 77) MHÑElectric Wiring ANno qualif MNH1.671.252.310 DMÑElectricity LH LM  HNwas in Cat H only 1963-81 MHÑElectricity AN/adv eff: consider also ELECTRIC INJURIES; /diag use = ELECTRODIAGNOSIS; /ther use = ELECTROTHERAPY; impedance, capacitance, resistance: index under ELECTRIC CONDUCTIVITY; shock: see note under ELECTROSHOCK; ╥static electricity╙ and ╥electrostatics╙ go here MNG3.230.132.200; H1.671.252 FXÑBIOELECTRIC ENERGY SOURCES; ÑLIGHTNING XUÑElectric Wiring LH LX; LU  MSThe use of electric current applied through the skin across some part of the body to treat pain, usually in that part of the body. HN(84) MHÑElectroanalgesia AN╥applied through the skin╙: do not confuse with ELECTRONARCOSIS (╥through the brain╙); do not use /util except by MeSH definition; DF: TENS PIElectric Stimulation (66-83); Electrotherapy (66-83) MNE2.780.335.330; E3.91.336 XSAnalgesic Cutaneous Electrostimulation; Electric Stimulation, Transcutaneous; Percutaneous Electric Nerve Stimulation; Transcutaneous Electric Nerve Stimulation; Transdermal Electrostimulation DMÑElectrotherapy LH LS; ; ; ; LM  MSRecording of the moment-to-moment electromotive forces of the heart as projected onto various sites on the body's surface, delineated as a scalar function of time. MHÑElectrocardiography ANdo not use /util except by MeSH definition; consider also PRE-EXCITATION SYNDROMES & its indentions; Holter monitoring: coord with MONITORING, PHYSIOLOGIC; DF: ECG MNE1.145.569.359; E1.399.214 FXÑHeart LH LX  PM66 HN66 MHÑElectrochemistry ANNIM with no qualif; when IM, only /educ /hist /instrum MNH1.181.529.307 LH  MHÑElectrocoagulation ANIM; do not use /util except by MeSH definition; coord organ or disease with /surg; electrocautery & galvanocautery go here; thermocoagulation goes here MNE2.154.402 XSDIATHERMY, SURGICAL; SURGICAL DIATHERMY LH LS;  MSElectrically induced convulsions primarily used in the treatment of severe affective disorders and schizophrenia. OLuse ELECTROCONVULSIVE THERAPY to search SHOCK THERAPY, ELECTRIC back thru 1966 & ELECTROCONVULSIVE SHOCK 1966-67 PM81; was SHOCK THERAPY, ELECTRIC 1963-81; ELECTROCONVULSIVE SHOCK was heading 1966-67 HN81; was SHOCK THERAPY, ELECTRIC 1963-81; ELECTROCONVULSIVE SHOCK was heading 1966-67 MHÑElectroconvulsive Therapy ANSPEC qualif & /adv eff /mortal permitted; a psychother technic: do not confuse with ELECTROSHOCK, also called ╥electroconvulsive shock╙, an exper tool MNF4.881.200.583 XSConvulsive Therapy, Electric; ECT (Psychotherapy); Electroshock Therapy; Shock Therapy, Electric FXÑElectronarcosis LH LS; ; ; LX  PM72 HN72(68) MHÑElectrodes ANNIM; only /stand /vet PIEquipment and Supplies (66-67) MNE7.296; H1.671.252.402 XSAnode; Cathode LH LS;  PM73 HN73(71) MHÑElectrodes, Implanted ANNIM; only /stand /vet PIElectrodes (68-70) MNE7.296.319 LH  MSDiagnosis of disease states by recording the spontaneous electrical activity of tissues or organs or by the response to stimulation of electrically excitable tissue. MHÑElectrodiagnosis ANIM; do not use /util except by MeSH definition MNE1.399 LH  MSRecording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. MHÑElectroencephalography ANNIM; do not use /util except by MeSH definition; DF: EEG MNE1.236.257.401; E1.399.277 FXÑCerebral Cortex XUÑBeta Rhythm; ÑCortical Synchronization; ÑDelta Rhythm; ÑTheta Rhythm LH LX LU; ; ;  OLuse ELECTROGALVANISM, INTRAORAL to search ELECTROGALVANISM 1966-71 PM72; was ELECTROGALVANISM 1965-71 HN72; was ELECTROGALVANISM 1965-71 MHÑElectrogalvanism, Intraoral ANIM; no qualif MNE6.377 XSGalvanism, Oral LH LS  MHÑElectrokymography ANNIM; do not use /util except by MeSH definition MNE1.399.340; E1.528.402; E1.818.256 XSKYMOGRAPHY, RADIOGRAPHIC; ROENTGENKYMOGRAPHY LH LS;  MSDestruction by passage of a galvanic electric current, as in disintegration of a chemical compound in solution. MHÑElectrolysis ANonly /adv eff /hist /instrum /methods /stand /util (if by MeSH definition) MNH1.181.529.307.365 XUÑElectroplating LH LU  MHÑElectrolytes ANGEN: prefer specifics but use for more than three; do not use /analogs /biosyn /defic /physiol; /ther use: consider also ORAL REHYDRATION THERAPY see FLUID THERAPY MND1.248 FXÑFluid Therapy; ÑWATER-ELECTROLYTE BALANCE LH LX;  MSA field representing the joint interplay of electric and magnetic forces. HN(75) MHÑElectromagnetic Fields ANIM; do not use /educ /hist /man /stand MNH1.671.252.528.400; H1.671.493.403.400 DMÑElectromagnetics LH LM  MSPhenomena involving magnets, electric currents through conductors and the electric and magnetic fields thus produced, as in electric motors. PM73 HN73 MHÑElectromagnetics ANIM; do not use /educ /hist /man /stand; note entries above; electromagnetic frequency, energy & waves also go under RADIATION terms as above; MAGNETOMETRY see MAGNETICS is available PIElectricity (66-72); Magnetics (66-72) MNH1.671.252.528; H1.671.493.403 XUÑElectromagnetic Fields LH LU  MSRecording of the changes in electric potential of muscle by means of surface or needle electrodes. MHÑElectromyography ANNIM; do not use /util except by MeSH definition MNE1.399.403; E1.642.403 LH  MSIdentification and measurement of concentration of elements based on the fact that primary-emission x-rays emitted by an element excited by an electron beam have a wavelength characteristic of that element and an intensity related to its concentration. May be performed by an electron probe microanalyzer, an electron microscope microanalyzer, or by an electron microscope, or scanning electron microscope, fitted with an x-ray spectrometer. PM70 HN70(67) MHÑElectron Probe Microanalysis ANNIM; only /instrum /methods /stand; ╥x-ray microanalysis╙ probably goes here; x-ray spectrometry using any type of electron microscopy goes here PIElectrons (66); Spectrum Analysis (66) MNE5.196.867.800.360; E5.799.830.360; H1.181.278.862.800.360 XSMicroscopy, Electron, X-Ray Microanalysis; Spectrometry, X-Ray Emission, Electron Microscopic; Spectrometry, X-Ray Emission, Electron Probe; X-Ray Emission Spectrometry, Electron Microscopic; X-Ray Emission Spectrometry, Electron Probe; X-Ray Microanalysis, Electron Microscopic; X-Ray Microanalysis, Electron Probe LH LS; ; ; ; ; ;  PM66 HN66(64) MHÑElectron Spin Resonance ANNIM; only /instrum /methods /stand MNE5.196.867.303; H1.181.278.862.303; H1.671.579.340 XSElectron Paramagnetic Resonance; PARAMAGNETIC RESONANCE FXÑSpin Labels LH LS; LX  PM66 HN66(64) MHÑElectron Transport ANNIM; only /drug eff /rad eff; ╥respiratory chain╙ goes here; not for ╥proton transport╙ ( = BIOLOGICAL TRANSPORT or BIOLOGICAL TRANSPORT, ACTIVE (NIM) + PROTONS (IM)) MNG6.535.335.531.403 LH  MSProfound stupor produced by passing an electric current through the brain. MHÑElectronarcosis ANdo not use /util except by MeSH definition; current applied through the brain: do not confuse with ELECTROANALGESIA (╥applied through the skin╙) MNE3.340 XSAnesthesia, Electric; ELECTROANESTHESIA; ELECTROSLEEP; Electric Anesthesia FXÑElectroconvulsive Therapy; ÑElectrotherapy LH LS; ; ; LX;  MHÑElectronics ANonly /educ /hist /instrum /man /methods MNH1.288 FXÑTAPE RECORDING XUÑMiniaturization LH LX LU  PM68 HN68 MHÑElectronics, Medical ANonly /educ /hist /instrum /man /methods PIElectronics (66-67) MNH1.288.319 FXÑBiomedical Engineering LH LX  MSStable elementary particles having the smallest known negative charge, present in all elements; also called negatrons or positrons; the numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS or BETA RAYS, the latter being a high-energy biproduct of nuclear decay. MHÑElectrons ANGEN; no qualif MNH1.671.579.404.335 XSFast Electrons; Negatrons; Positrons LH LS; ;  MSRecording of nystagmus based on changes in the electrical field surrounding the eye produced by the difference in potential between the cornea and the retina. OLsearch ELECTROOCULOGRAPHY 1973-74 PM79; was see under ELECTROOCULOGRAPHY 1973-78 HN79(75); was see under ELECTROOCULOGRAPHY 1973-78 MHÑElectronystagmography ANNIM; do not use /util except by MeSH definition PIElectrooculography (73-74) MNE1.210.271.380; E1.276.299.816.435; E1.399.435 FXÑNystagmus; ÑNystagmus, Physiologic LH LX;  MSRecording of the average amplitude of the resting potential arising between the cornea and the retina in light and dark adaptation as the eyes turn a standard distance to the right and the left. The increase in potential with light adaptation is used to evaluate the condition of the retinal pigment epithelium. PM67 HN67(64) MHÑElectrooculography ANNIM; do not use /util except by MeSH definition MNE1.210.271.403; E1.399.466 XSEOG FXÑEye Movements LH LS LX  PMELECTROPHORESIS, PAPER was heading 1973-86; ELECTROPHORESIS, STARCH GEL was heading 1973-86 MHÑElectrophoresis ANNIM; only /instrum /methods /stand MNE5.196.401; H1.181.278.414; H1.181.529.307.437 XSIsotachophoresis FXÑBLOOD PROTEIN ELECTROPHORESIS; ÑIMMUNOELECTROPHORESIS XUÑElectrophoresis, Agar Gel; ÑElectrophoresis, Cellulose Acetate; ÑElectrophoresis, Paper; ÑElectrophoresis, Starch Gel LH LS LX; LU; ; ;  MSElectrophoresis in which agar gel is the diffusion medium. Use also for agarose gel as the diffusion medium. HN(75) MHÑElectrophoresis, Agar Gel ANNIM; only /instrum /methods /stand MNE5.196.401.153; H1.181.278.414.100; H1.181.529.307.437.100 XSElectrophoresis, Agarose Gel DMÑElectrophoresis LH LS LM  MSElectrophoresis in which cellulose acetate is the diffusion medium. HN(75) MHÑElectrophoresis, Cellulose Acetate ANNIM; only /instrum /methods /stand MNE5.196.401.200; H1.181.278.414.200; H1.181.529.307.437.200 DMÑElectrophoresis LH LM  OLuse ELECTROPHORESIS, DISC to search ELECTROPHORESIS, DISK back thru 1967 (as Prov 1967-69) HN(85)74; was ELECTROPHORESIS, DISK 1967-73 (Prov 1967-69) MHÑElectrophoresis, Disc ANNIM; only /instrum /methods /stand PIElectrophoresis (66) MNE5.196.401.402.236; H1.181.278.414.319.403; H1.181.529.307.437.319.403 DMÑElectrophoresis, Polyacrylamide Gel LH LM  HN(87)73(71) MHÑElectrophoresis, Paper ANNIM; only /instrum /methods /stand PIElectrophoresis (66-70) MNE5.196.401.319; H1.181.278.414.236; H1.181.529.307.437.236 DMÑElectrophoresis LH LM  PM73; ELECTROPHORESIS, DISC was heading 1974-84 HN73 MHÑElectrophoresis, Polyacrylamide Gel ANNIM; only /instrum /methods /stand PIAcrylamides (71-72); Electrophoresis (66-72); Electrophoresis, Disc (67-72) MNE5.196.401.402; H1.181.278.414.319; H1.181.529.307.437.319 XUÑElectrophoresis, Disc LH LU  HN(87)73(72) MHÑElectrophoresis, Starch Gel ANNIM; only /instrum /methods /stand PIElectrophoresis (66-69) MNE5.196.401.485; H1.181.278.414.402; H1.181.529.307.437.402 DMÑElectrophoresis LH LM  PM74 HN74 MHÑElectrophorus ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.200.328; B2.493.378.380 XSEel, Electric LH LS  MHÑElectrophysiology ANNIM; only /hist /instrum /methods; physiol in relation to electricity; coord NIM with organ /physiol or physiol process (IM) MNG1.344.528; G1.782.236; G7.453 XUÑContingent Negative Variation LH LU  MSCoating with a metal or alloy by electrolysis. HN(85) MHÑElectroplating ANonly /adv eff /hist /instrum /methods /stand /util (if by MeSH definition) PIElectrolysis (66-84); Metallurgy (66-84) MNH1.181.529.307.365.348 XSElectrodeposition; Metal Plating DMÑElectrolysis LH LS; LM  MSRecording of electric potentials in the retina after stimulation by light. MHÑElectroretinography ANNIM; only /instrum /methods MNE1.210.203; E1.399.528 FXÑRetina LH LX  MSInduction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. OLsearch ELECTROCONVULSIVE SHOCK under SHOCK THERAPY, ELECTRIC 1966-67 PM68; ELECTROCONVULSIVE SHOCK was heading 1966-67 HN68(64); ELECTROCONVULSIVE SHOCK was heading 1966-67 MHÑElectroshock ANexper shock by electricity, usually in psychol exper: do not confuse with ELECTRIC INJURIES or ELECTROCONVULSIVE THERAPY; for ╥electroconvulsive shock╙ but do not coord with CONVULSIONS; electrocountershock = ELECTRIC COUNTERSHOCK MNE5.723.402.403; F4.669.224 LH  PM65 HN65 MHÑElectrosurgery ANdo not use /util except by MeSH definition MNE4.262 LH  MSApplication of electric current in treatment without the generation of perceptible heat. Includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the threshold ofo the skin to pain. MHÑElectrotherapy ANdo not use /util except by MeSH definition MNE2.780.335 XSElectric Stimulation, Therapeutic FXÑElectronarcosis XUÑElectroanalgesia LH LS LX LU  PM65 HN65(63) MHÑEledoisin RN69-25-0 MND12.644.320.354; D24.185.798.354.354; D24.185.926.580.590.325; D24.185.965.590.325 LH  MSIndividual components of atoms, usually subatomic; subnuclear particles are usually detected only when the atomic nucleus decays and then only transiently, as most of them are unstable, often yielding pure energy without substance, i.e., radiation. OLuse ELEMENTARY PARTICLES to search BARYONS back thru 1975 PM75; BARYONS was heading 1975-84 HN75(71); BARYONS was heading 1975-84 MHÑElementary Particles ANno qualif; includes nucleons, quarks, gluons, neutrinos, strange particles, antiparticles PINuclear Physics (66-70) MNH1.671.579.404 XSFundamental Particles XUÑMesons LH LS LU  MHÑElements ANGEN only; no qualif; prefer specifics; ISOTOPES (little used) & RADIOISOTOPES & many specifics are also available; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope MND1.268 LH  OLthese are naturally radioactive; consider also RADIOISOTOPES & specifics MH*Elements, Radioactive (Non Mesh) MND1.287 LH  OLsearch FILARIASIS & LYMPHEDEMA 1966-74 HN(75); was see FILARIASIS & LYMPHEDEMA 1963-74 MHÑElephantiasis ANfor elephantiasis of any cause other than filarial; ELEPHANTIASIS, FILARIAL is available MNC15.604.496.320 DMÑLymphedema LH LM  HN(87) MHÑElephantiasis, Filarial ANspecify BRUGIA or WUCHERIA BANCROFTI (NIM) if relevent PIElephantiasis (75-86); Filariasis (66-86) MNC3.335.508.361.350; C15.604.496.320.350 XSFilarial Elephantiasis DMÑLymphedema LH LS LM  MHÑElephants ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.352 LH  MSMechanical ascending and descending devices which convey objects and/or people. HN(Aug 77) MHÑElevators and Escalators ANfor people or equipment; only /econ /stand; DF: ELEVATORS MNJ1.86.339.115 XSEscalators DMÑFacility Design and Construction LH LS LM  MSCriteria to determine eligibility of patients for medical care programs and services. PM68 HN68 MHÑEligibility Determination ANonly /econ /legis /methods /stand /trends PIPatients (66-67) MNN4.452.264 FXÑDISABILITY EVALUATION LH LX  MSBehavior associated with the elimination of feces and urine from the body. OLto search ELIMINATIVE BEHAVIOR use ELIMINATIVE BEHAVIOR, ANIMAL 1975-78 & BEHAVIOR, ANIMAL 1968-74 HN(79); was ELIMINATIVE BEHAVIOR see under BEHAVIOR, ANIMAL 1968-78 MHÑEliminative Behavior, Animal ANelimination of urine or feces; only /drug eff /physiol /rad eff MNF1.145.113.367 DMÑBehavior, Animal LH LM  MS2,3,7,8-Tetrahydroxy(1)benzopyrano(5,4,3-cde)(1)-benzopyran-5,10-dione. A fused four ring compound occurring free or combined in galls. Isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the blood clotting system which also causes kinin release; used in research and as a dye. HN(75) MHÑEllagic Acid ANdo not use /defic /physiol; /analogs NIM only RN476-66-4 PIBenzopyrans (69-74) MND3.438.150.500 XSBenzoaric Acid DMÑBenzopyrans LH LS LM  MSA group of antileukemic agents with immunosuppressive properties, isolated primarily from Ochrosia elliptica. They inhibit both DNA and RNA synthesis. HN(75) MHÑEllipticines ANdo not use /analogs /defic /physiol; /biosyn permitted if by plant PIAlkaloids (71-74); Carbazoles (71-74); Pyridines (72-74) MND3.132.305; D22.204.179.391; D22.569.726 DMÑAlkaloids LH LM  MSAn intrinsic defect of erythrocytes inherited as an autosomal dominant trait. The erythrocytes assume an oval or elliptical shape. PM65 HN65(64) MHÑElliptocytosis, Hereditary ANdo not use /congen MNC15.378.71.141.150.365 XSOvalocytosis, Hereditary FXÑANEMIA, SIDEROBLASTIC LH LS LX  PM65 HN65(63) MHÑEllis-Van Creveld Syndrome ANdo not use /congen MNC5.116.99.708.327; C16.131.77.350.398; C16.131.831.350.398; C17.827.375.398 XSCHONDROECTODERMAL DYSPLASIA FXÑCartilage Diseases LH LS LX  MHÑEmaciation MNC23.888.220.354 FXÑThinness LH LX  MSProcess of preserving a dead body to protect it from decay. MHÑEmbalming ANonly /econ /educ /hist /instrum /methods /stand MNG2.438.554 FXÑMUMMIES LH LX  MSFigures or symbols identifying or representing organizations or societies. OLuse EMBLEMS AND INSIGNIA to search CADUCEUS back thru 1966 (as Prov 1966-74) PM78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77; INSIGNIA AND DECORATIONS was heading 1963-65 HN78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77, was Prov 1966-74; INSIGNIA AND DECORATIONS was heading 1963-65 MHÑEmblems and Insignia ANonly /class /hist; GENEALOGY AND HERALDRY is also available; DF: EMBLEMS MNN3.540.828.210 XSCaduceus; Insignia LH LS;  MHÑEmbolism ANpulm embolism = PULMONARY EMBOLISM; cerebral embolism = CEREBRAL EMBOLISM AND THROMBOSIS MNC14.907.854.404 LH  MSEmbolism due to air bubbles entering the blood vessels after trauma or surgical procedures. MHÑEmbolism, Air MNC14.907.854.404.254 XSEmbolism, Gas LH LS  MHÑEmbolism, Amniotic Fluid MNC13.703.634.404; C14.583.404; C14.907.854.404.354 FXÑAmniotic Fluid LH LX  MHÑEmbolism, Fat MNC14.907.854.404.454 LH  MSMethod of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. Has been used in the treatment of spinal cord and cerebral arteriovenous malformations, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. PM76 HN76 MHÑEmbolization, Therapeutic ANdo not use /man /supply /util (except by MeSH definition); coord IM with disease /ther (IM), not /surg PIEmbolism (66-75); specific heading/SU (66-75); specific heading/TH (66-75) MNE2.520.360 LH  MSThe prenatal stage of mammalian development characterized by rapid morphological changes and the differentiation of basic structures. OLsearch PRENATAL INFLUENCES under PREGNANCY 1966-72 PMPRENATAL INFLUENCES was heading 1963-72 HNPRENATAL INFLUENCES was heading 1963-72 MHÑEmbryo ANmammalian only; human: 0-2 mos; IM when embryo itself as an organic entity or a tissue: TN 66; prefer /embryol with organs or organisms; do not use /abnorm /blood supply /embryol /growth /inj /innerv /pathol /physiopathol /secret; /transpl = EMBRYO TRANSFER if mammalian but if non-mammalian index EMBRYO, NON-MAMMALIAN /transpl; plant embryo = SEEDS; embryonic tissue or cells in tissue & cell cultures: coord EMBRYO + tissues or cell without qualif (not with /embryol) + culture term, all probably NIM (Manual 22.26.1); Manual 21.54+; TN 66: relation to /embryol CATALOG: form qualif = EMBRYOLOGY /form MNA16.254 FXÑCELL DIFFERENTIATION; ÑGESTATIONAL AGE XUÑNotochord LH LX; LU  MSDeath and resorption of the embryo that takes place at any developmental stage after ovum implantation and before the completion of organogenesis. Does not include fetal resorption. HN(75) MHÑEmbryo Resorption AN╥before completion of organogenesis╙: does not include fetal resorption = FETAL RESORPTION MNC13.703.243.200; C23.240.477.200 DMÑFetal Death LH LM  MSRemoval of a mammalian embryo from one environment and replacement in the same or a new environment. The embryo is usually in the pre-nidation phase, i.e., a blastocyst. Includes embryo or blastocyst transplantation or transfer after in vitro fertilization. Includes transfer of the inner cell mass of the blastocyst. Do not use for transfer of differentiated embryonic tissue, e.g., germ layer cells. PM80 HN80 MHÑEmbryo Transfer ANmammalian only; transfer of non-mammalian embryo = EMBRYO, NON-MAMMALIAN /transpl or CHICK EMBRYO /transpl PIBlastocyst/TR (74-79); Embryo/TR (66-79) MNE5.820.330 XSBlastocyst Transfer LH LS  MSThe embryo of species other than mammals. For the chicken, use the specific Chick, Embryo. PM75 HN75 MHÑEmbryo, Non-Mammalian ANIM only when point of article irrespective of species; if NIM coord with exper non-mammalian organism, EMBRYO or Cat A or Cat B term with /embryol is adequate; for chicken use CHICK EMBRYO; do not use /abnorm /embryol /growth /inj; /transpl permitted: do not use EMBRYO TRANSFER since this is restricted to mammalian embryos PIEmbryo (66-74) MNA13.350; A16.254.300 LH  MHÑEmbryology ANSPEC only, SPEC qualif; prefer /embryol: Manual 19.5+ CATALOG: use with form qualif instead of EMBRYO /form MNG1.100.529 LH  MSEmbryonic cell differentiation in which one group of cells evokes and controls the differentiation of other groups of cells. HN(75) MHÑEmbryonic Induction ANonly /drug eff /rad eff MNG7.553.196.300 DMÑCell Differentiation LH LM  OLconsider also /EM with Cat A & B terms MH*Embryonic Structures (Non Mesh) MNA16 LH  MSEthyldimethyl(1-methyl-3,3-diphenylpropyl)ammonium bromide. A parasympatholytic with anticholinergic and spasmolytic properties. HN(75) MHÑEmepronium ANdo not use /biosyn /defic /physiol; /analogs NIM only RN27892-33-7 PIAmmonium Compounds (70-74); Benzene Derivatives (74) MND2.92.102.370; D2.675.276.370; D16.653.330 XSCetiprin; Emepronium Bromide DMÑAmmonium Compounds LH LS; LM  MHÑEmergencies ANno qualif; EMERGENCY MEDICINE is the corresponding specialty; emergencies in specific dis: coord NIM with specific dis (IM); ╥drug emergencies╙: coord NIM with specific drug or chem with probably /pois (IM) MNC23.280.420 FXÑCrisis Intervention; ÑCritical Care; ÑEmergency Service, Hospital; ÑFIRST AID LH LX; ; ;  MSThe use of communication systems, such as telecommunication, to transmit emergency information to appropriate providers of health services. HN(80) MHÑEmergency Medical Service Communication Systems ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util; DF: EMSCS PICommunication (66-79); Emergency Medical Services (68-79); specific telecommunication MNN2.421.297.58 XSEMS Communication Systems; Emergency Care Information Systems DMÑEmergency Medical Services LH LS; LM  MSServices specifically designed, staffed, and equipped for the emergency care of patients. OLuse EMERGENCY MEDICAL SERVICES to search EMERGENCY HEALTH SERVICES back thru 1966 PM80; was EMERGENCY HEALTH SERVICES 1968-79 HN80; was EMERGENCY HEALTH SERVICES 1968-79 MHÑEmergency Medical Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util; Public Law 93-154 CATALOG: /geog /form PIEmergencies (66-67); First Aid (66-67) MNN2.421.297 XSEmergency Care; Emergency Health Services; Emergicenters; Prehospital Emergency Care FXÑFIRST AID XUÑEmergency Medical Service Communication Systems; ÑTriage LH LS; ; ; LX LU;  HN(69) MHÑEmergency Medical Tags ANno qualif PIEmergencies (66-68); Equipment and Supplies (66-68) MNE7.315 DMÑEquipment and Supplies LH LM  MSParamedical personnel trained to provide basic emergency care and life support under the supervision of physicians and/or nurses. These services may be carried out at the site of the emergency, in the ambulance, or in a health care institution. HN(79) MHÑEmergency Medical Technicians ANonly /class /econ /educ /hist /legis /psychol /stand /supply /trends /util PIAllied Health Personnel (71-78) MNM1.526.485.67.150; N2.350.84.315 XSParamedics, Emergency DMÑAllied Health Personnel LH LS LM  MSA branch of medicine concerned with an individual's resuscitation, transportation and care from the point of injury or beginning of illness through the hospital or other emergency treatment facility. PM77 HN77 MHÑEmergency Medicine ANSPEC: SPEC qualif; differentiate from EMERGENCIES, the patient MNG2.403.790.160 LH  MSHospital department responsible for the administration and provision of immediate medical or surgical care to the emergency patient. OLuse EMERGENCY SERVICE, HOSPITAL to search HOSPITAL EMERGENCY SERVICE back thru 1966 PM78; was HOSPITAL EMERGENCY SERVICE 1963-77 HN78; was HOSPITAL EMERGENCY SERVICE 1963-77 MHÑEmergency Service, Hospital ANonly /econ /legis /man /organ /stand /trends /util MNN2.278.354.422.336; N2.421.297.388; N4.452.442.422.336 XSEmergency Outpatient Unit; Hospital Emergency Service FXÑEmergencies LH LS; LX  MSOrganized services to provide immediate psychiatric care to patients with acute psychological disturbances. HN(76) MHÑEmergency Services, Psychiatric ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form PIEmergencies (66-75); Emergency Medical Services (68-75) MNF4.408.525; N2.421.297.200 DMÑMental Health Services LH LM  OL'emergency treatment' is indexed under EMERGENCIES MH*Emergency Treatment (Non Mesh) MNE2.365 LH  MHÑEmetics ANdo not use /analogs /biosyn /defic /physiol; consider also NAUSEA /chem ind & VOMITING /chem ind MND23.555 LH  MS3-Ethyl-2,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-(1,2,3,4-tetrahydto-6,7-dimethoxy-1-isoquinolyl-methyl)-1H-benzo(a)quinolizin. Principal alkaloid of IPECAC, from the ground roots of Uragoga (or Cephaelis) ipecacuanha or U. acuminata, of the Rubiaceae; used as amebicide in many different preparations; may cause serious cardiac, hepatic or renal damage and violent diarrhea and vomiting. MHÑEmetine ANdo not use /biosyn /defic /physiol RN483-18-1 MND3.132.442.405; D3.438.531.321; D21.370.107.380 XSIpecine; Methylcephaeline XUÑDehydroemetine LH LS; LU  MSThe process of leaving one's country to establish residence in a foreign country. MHÑEmigration and Immigration ANonly /hist /trends; DF: EMIGRATION CATALOG: /geog /form MNN1.696.596.321 XSImmigration LH LS  MS1,3,8-Trihydroxy-6-methylanthraquinone. Purgative anthraquinone found in several plants, especially Rhamnus frangula; formerly used as a laxative, now mainly as tool in toxicity studies. Synonyms: archin; frangulic acid. OLsearch CATHARTICS 1966-74 HN(75); was see under CATHARTICS 1963-74 MHÑEmodin AND25-26 qualif; /analogs NIM only RN518-82-1 MND4.615.117.159.260; D19.316.396.386 XSAloe-Emodin; Frangula Emodin; Rheum Emodin DMÑAnthraquinones LH LS; ; LM  MSOleagenous substances used topically to soothe, soften or protect skin or mucus membranes; also as vehicle for other dermatologic agents. OLsearch DERMATOLOGIC AGENTS 1967-74 HN(75) MHÑEmollients AND25-26 qualif MND26.368.405 DMÑDermatologic Agents LH LM  MSThose affective states which can be experienced and have arousing and motivational properties. MHÑEmotions ANhuman & animal; only /drug eff /physiol /rad eff; mourning & bereavement: index under GRIEF MNF1.470 XSFEELINGS FXÑAffective Symptoms; ÑMotivation XUÑIrritable Mood LH LS LX; LU  MSAn individual's objective and insightful awareness of the feelings and behavior of another person; to be distinguished from sympathy, which is usually nonobjective and noncritical. PM71 HN71 MHÑEmpathy ANno qualif PIEmotions (66-70) MNF1.752.355 LH  MSA pathological accumulation of air in tissues or organs. MHÑEmphysema ANalso available are PULMONARY EMPHYSEMA, MEDIASTINAL EMPHYSEMA & SUBCUTANEOUS EMPHYSEMA; be careful in foreign texts: often means diseases or technics starting ╥pneumo-╙ (as ╥mediastinal emphysema╙ = ╥pneumomediastinum╙) MNC23.390 FXÑPULMONARY EMPHYSEMA XUÑSubcutaneous Emphysema LH LX LU  MSRegulations or conditions imposed on employees by management in order to correct or prevent behaviors which are counterproductive to the organization. HN(82) MHÑEmployee Discipline ANonly /econ /legis /methods /trends PIPersonnel Management (66-81) MNN4.452.677.358 XSPersonnel Discipline DMÑPersonnel Management LH LS LM  MSFormal procedures whereby the employee expresses any dissatisfaction or feeling of injustice regarding the work situation. HN(Aug 77) MHÑEmployee Grievances ANonly /class /econ /legis /trends MNN4.452.677.362 XSGrievances, Employee DMÑPersonnel Management LH LS LM  MSPrograms designed by management to motivate employees to work more efficiently with increased productivity, and greater employee satisfaction. HN(79) MHÑEmployee Incentive Plans ANonly /econ /legis /man /stand /trends MNN4.452.677.368 XSIncentive Plans, Employee DMÑPersonnel Management LH LS LM  MSThe assessment of the functioning of an employee in relation to his work. HN(Aug 77) MHÑEmployee Performance Appraisal ANonly /econ /legis /methods /stand /trends MNN4.452.677.370 XSNurses Performance Evaluation; Performance Appraisal, Employee DMÑPersonnel Management LH LS; LM  MSThe state of being engaged in an activity or service for wages or salary. PM70 HN70 MHÑEmployment ANfor pay: differentiate from WORK (see note there); UNEMPLOYMENT is also available; JOB APPLICATION is also available; only /hist /stand /trends PIOccupations (66-69); Unemployment (66-69); Work (66-69) MNN1.824.245 XSEmployment Termination; Termination, Employment FXÑJob Satisfaction; ÑRehabilitation, Vocational LH LS; LX;  MSA condition, generally diagnosed radiographically, characterized by a defect in the diaphragma sellae such that the meninges extend down into the sella turcica and compress the pituitary against the wall of the sella. PM78 HN78 MHÑEmpty Sella Syndrome PISella Turcica (66-77) MNC19.700.320 FXÑSella Turcica LH LX  MSPresence of pus in a hollow organ or body cavity, particularly the pleural cavity. MHÑEmpyema ANin tuberc = EMPYEMA, TUBERCULOUS MNC1.539.307; C8.528.238; C8.730.237 XSEmpyema, Pleural; Pyothorax LH LS;  MSEmpyema due to Mycobacterium tuberculosis. HN(84)63 MHÑEmpyema, Tuberculous MNC1.252.40.552.846.877.405; C8.528.238.405; C8.528.928.405; C8.730.912.405 DMÑTuberculosis, Pleural LH LM  MSColloids of two immiscible liquids where either phase may be either fatty or aqueous; lipid-in-water emulsions are usually liquid, like milk or lotion and water-in-lipid emulsions tend to be creams. MHÑEmulsions ANIM for general only; only /adv eff /anal (with caution) /stand /supply; NIM when specific drug is IM, using no qualif; FAT EMULSIONS, INTRAVENOUS is also available MND26.394.225.220.345 LH  MS1-(N-(1-Carboxy-3-phenylpropyl)-L-alanyl) -L-proline 1'-ethyl ester. Orally active inhibitor of kininase II. Controls essential and renal hypertension, improves glomerular filtration rate and effective renal blood flow; decreases renal vascular resistance without producing adverse effects on salt and water excretion or body fluid composition. PM86 HN86 MHÑEnalapril ANdo not use /biosyn /defic /physiol RN75847-73-3 PIAntihypertensive Agents (66-85); Dipeptides (66-85); Kininase II/AI (74-85) MND8.373.745.340; D12.644.456.345.360; D18.162.335 XSEnalapril Maleate; MK-421 LH LS;  PM65 HN65 MHÑEnamel Cuticle MNA14.254.860.268.405 XSNasmyth's Membrane LH LS  MSEpithelial cells surrounding the dental papilla and differentiated into three layers: the inner enamel epithelium, consisting of ameloblasts which eventually form the enamel, and the enamel pulp and external enamel epithelium, both of which atrophy and disappear before and upon eruption of the tooth, respectively. OLsearch TOOTH GERM 1966-74 HN(75) MHÑEnamel Organ MNA14.254.860.851.530 DMÑTooth Germ LH LM  MSCyanoacrylate homopolymer. Tissue adhesive that is applied as a monomer to moist tissue and polymerizes to form a bond; slowly biodegradable and used in all kinds of surgery, including dental. OLuse ENBUCRILATE to search ENBUCRYLATE back thru 1980; to search BUTYLCYANOACRYLATE use ENBUCRILATE back thru 1975 & CYANOACRYLATES 1972-74 PM86; was ENBUCRYLATE 1980-85, was BUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79 HN86; was ENBUCRYLATE 1980-85, was BUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79 MHÑEnbucrilate AND25-26 qualif RN6606-65-1 PIAcrylates (66-71); Cyanoacrylates (72-74); Tissue Adhesives (66-71) MND2.241.81.69.366.350; D25.720.259.341; D25.919.367.341 XSButylcyanoacrylate LH LS  MHÑEncephalitis ANGEN; coord with specific organism /infection heading (IM); viral encephalitis (caused by ENCEPHALITIS VIRUSES, not just any virus) = probably ENCEPHALITIS, EPIDEMIC; ENCEPHALOMYELITIS & specifics & SUBACUTE SCLEROSING PANENCEPHALITIS (see note there) are also available MNC10.228.140.437; C10.228.228.245 LH  MHÑEncephalitis Periaxialis ANnote: no comma MNC10.228.140.276.238; C10.228.140.437.321; C10.228.337.144.280 XSSCHILDER'S DISEASE LH LS  MSA Flavivirus (group B arbovirus) in Central Europe causing a biphasic disease in man with an afebrile period between the first influenza-like fever and the second phase of meningitis or meningoencephalitis. OLuse ENCEPHALITIS VIRUS, CENTRAL EUROPEAN to search CENTRAL EUROPEAN ENCEPHALITIS VIRUS back thru 1975 HN(81); was CENTRAL EUROPEAN ENCEPHALITIS VIRUS see under ENCEPHALITIS VIRUSES, TICK-BORNE 1975-80 MHÑEncephalitis Virus, Central European ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENCEPHALITIS, TICK-BORNE (IM) MNB4.909.777.270.511.300; B4.909.777.923.377.350.330 XSBiundulant Meningo-Encephalitis Virus; Diphasic Milk Fever Virus; Tick-Borne Encephalitis Virus, Central European DMÑEncephalitis Viruses, Tick-Borne LH LS; ; LM  MSAn Alphavirus (group A arbovirus) thought to be normally a harmless parasite of many animals; infections in horses show a mortality of up to 90 percent and in humans up to 74 percent. HN(75); was see under ENCEPHALITIS VIRUSES 1975-80 MHÑEncephalitis Virus, Eastern Equine ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENCEPHALITIS, EQUINE (IM) MNB4.909.777.270.150; B4.909.777.923.54.320 XSEEE Virus; Eastern Equine Encephalitis Virus; Eastern Equine Encephalomyelitis Virus; Encephalomyelitis Virus, Eastern Equine DMÑAlphaviruses LH LS; ; ; LM  MSA Flavivirus (group B arbovirus) which is the etiologic agent of Japanese B encephalitis. PM73 HN73(71) MHÑEncephalitis Virus, Japanese ANdo not use /blood-csf-urine /cytol; infection = ENCEPHALITIS, JAPANESE B; DF: ENCEPH VIRUS JAPANESE PIEncephalitis Viruses (66-70) MNB4.909.637.256; B4.909.777.270.227; B4.909.777.923.377.320 LH  MSA Flavivirus (group B arbovirus) which is the etiologic agent of St. Louis encephalitis in the United States (except the East), Panama and Trinidad. HN(71); was see under ENCEPHALITIS VIRUSES 1975-80 MHÑEncephalitis Virus, St. Louis ANdo not use /blood-csf-urine /cytol; infection = ENCEPHALITIS, ST. LOUIS; DF: ENCEPH VIRUS ST LOUIS PIEncephalitis Viruses (66-70) MNB4.909.637.356; B4.909.777.270.298; B4.909.777.923.377.330 DMÑFlaviviruses LH LM  MSAn Alphavirus (group A arbovirus) which is the etiologic agent of equine encephalomyelitis in man and equines in parts of Central and South America. PM73 HN73(71) MHÑEncephalitis Virus, Venezuelan Equine ANdo not use /blood-csf-urine /cytol; infection = ENCEPHALITIS, VENEZUELAN EQUINE; DF: ENCEPH VIRUS VENEZ EQUINE PIEncephalitis Viruses (66-70) MNB4.909.777.270.369; B4.909.777.923.54.340 XSEncephalomyelitis Virus, Venezuelan Equine LH LS  MSAn Alphavirus (group A arbovirus) which is the etiologic agent of equine encephalomyelitis in man and equines in the United States, southern Canada, and parts of South America. PM73 HN73(71) MHÑEncephalitis Virus, Western Equine ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENCEPHALITIS, EQUINE (IM); DF: ENCEPH VIRUS WESTERN EQUINE PIEncephalitis Viruses (66-70) MNB4.909.777.270.440; B4.909.777.923.54.360 LH  MHÑEncephalitis Viruses ANGEN only: prefer specific; do not use /blood-csf-urine /cytol; infection = ENCEPHALITIS, EPIDEMIC MNB4.909.777.270 LH  MSA group of antigenically related Flaviviruses (group B arboviruses) which cause encephalitis and hemorrhagic fevers. PM66; LOUPING ILL VIRUS was see under ARBOVIRUS 1965-66, was see under ARBORVIRUSES 1963-64 HN66(65) MHÑEncephalitis Viruses, Tick-Borne ANdo not use /blood-csf-urine /cytol; infection = ENCEPHALITIS, TICK-BORNE MNB4.909.777.270.511; B4.909.777.923.377.350 XUÑEncephalitis Virus, Central European; ÑLouping Ill Virus; ÑPowassan Virus LH LU; ;  MSMosquito-borne infection with California group of the Bunyavirus genus. HN(75) MHÑEncephalitis, California MNC2.782.930.340; C2.81.343.340 DMÑEncephalitis, Epidemic LH LM  MHÑEncephalitis, Epidemic ANcaused by ENCEPHALITIS VIRUSES; not an ╥epidemic of encephalitis╙; note specific viral encephalitides below MNC2.81.343; C10.228.140.437.238; C10.228.228.245.322 FXÑParkinson Disease, Postencephalitic XUÑEncephalitis, California LH LX LU  MHÑEncephalitis, Japanese B MNC2.782.930.345; C2.81.343.345; C10.228.140.437.238.255; C10.228.228.245.322.280 LH  MHÑEncephalitis, Post-Vaccinal MNC10.228.140.437.404 XSVACCINATION ENCEPHALITIS FXÑHYPERSENSITIVITY, DELAYED LH LS LX  MHÑEncephalitis, St. Louis MNC2.782.930.350; C2.81.343.350; C10.228.140.437.238.356; C10.228.228.245.322.406 LH  MSA group of encephalitic and hemorrhagic diseases caused by Group B arboviruses (Flaviviruses). PM68 HN68(66) MHÑEncephalitis, Tick-Borne ANa viral dis; specify geog if pertinent MNC2.782.930.360; C2.81.343.360; C10.228.140.437.238.456; C10.228.228.245.322.531 XSEncephalitis, Central European; Far Eastern Russian Encephalitis LH LS;  PM74 HN74(73) MHÑEncephalitogenic Basic Proteins ANIM; do not use /analogs; coord with ENCEPHALOMYELITIS, ALLERGIC or other applic disease term if discussed (IM) PINerve Tissue Proteins (66-72) MND12.776.641.580.356 XSMyelin Basic Proteins FXÑEncephalomyelitis, Allergic LH LS LX  MSHernia of the brain, manifested by protrusion of brain substance through a congenital or traumatic opening of the skull. MHÑEncephalocele ANdo not use /congen; cerebellar hernia: coord IM with CEREBELLAR DISEASES (IM); meningoencephalocele: coord IM with MENINGOCELE (IM) MNC16.131.666.680.488 XSHERNIA, CEREBRAL LH LS  PM66 HN66(64) MHÑEncephalomalacia MNC10.228.140.461 XUÑLeukomalacia, Periventricular LH LU  MHÑEncephalomyelitis ANsame as myeloencephalitis; note specific human & animal types below MNC10.228.228.291; C10.228.440 XUÑEncephalomyelitis, Necrotizing Hemorrhagic LH LU  MSAn enterovirus of mice; infection is usually inapparent but occasionally causes a flaccid paralysis of the hind limbs. OLsearch ENTEROVIRUSES 1967-74 & POLIOVIRUS 1966 HN(75); was see under ENTEROVIRUS 1967-74, was see under POLIOVIRUS 1963-66 MHÑEncephalomyelitis Virus, Murine ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENTEROVIRUS INFECTIONS (IM) MNB4.909.777.618.284.405 XSMouse Encephalomyelitis Virus DMÑEnteroviruses LH LS LM  MSAn experimental demyelinating disease produced in animals by injections of myelin fractions in order to study the relationship between hypersensitivity and the demyelinating diseases. PM66 HN66(64) MHÑEncephalomyelitis, Allergic MNC10.228.337.267; C10.228.440.281; C20.111.489 XSEncephalomyelitis, Experimental Allergic FXÑENCEPHALITOGENIC BASIC PROTEINS LH LS LX  MSA picornavirus infection producing symptoms similar to poliomyelitis in pigs. PM70 HN70 MHÑEncephalomyelitis, Enzootic Porcine ANdo not use /vet; don't forget also SWINE (NIM) & check tag ANIMAL PIEnterovirus Infections (66-69); Swine Diseases (66-69) MNC2.782.687.359.456; C22.905.323 XSTALFAN DISEASE; Teschen Disease LH LS;  MHÑEncephalomyelitis, Equine ANhuman & animal; if in horses, coord with HORSE DISEASES (IM) + HORSES (NIM) & use /vet MNC2.81.355; C2.782.930.370; C10.228.228.291.323; C10.228.440.406 XSENCEPHALITIS, EQUINE XUÑEncephalomyelitis, Venezuelan Equine LH LS LU  HN(72) MHÑEncephalomyelitis, Necrotizing Hemorrhagic ANDF: ENCEPH NECRO HEMOR PIDemyelinating Diseases (66-71); Encephalomyelitis (66-71) MNC10.228.228.291.489; C10.228.337.323; C10.228.440.531 DMÑEncephalomyelitis LH LM  MSAn arthropod-borne viral encephalomyelitis of equidae and man. HN(76) MHÑEncephalomyelitis, Venezuelan Equine ANhuman & animal; if in horses, coord with HORSE DISEASES (IM) + HORSES (NIM) & use /vet PIEncephalomyelitis, Equine (66-75) MNC2.81.355.355; C2.782.930.370.370; C10.228.228.291.323.325; C10.228.440.406.325 XSEncephalitis, Venezuelan Equine DMÑEncephalomyelitis, Equine LH LS LM  MSSmall RNA viruses causing encephalomyelitis and myocarditis in rodents, pigs, and monkeys. Infection in man has been reported with CNS involvement but without myocarditis. OLuse ENCEPHALOMYOCARDITIS VIRUSES to search COLUMBIA-SK VIRUSES back thru 1966 PM65 HN65(63); COLUMBIA-SK VIRUSES was see under ENCEPHALOMYOCARDITIS VIRUSES 1965-78 MHÑEncephalomyocarditis Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENTEROVIRUS INFECTIONS (IM) MNB4.909.777.618.284.488 XSColumbia-SK Viruses LH LS  MSBenign growths of cartilage in the metaphyses of several bones. OLto search OLLIER'S DISEASE use ENCHONDROMATOSIS back thru 1985 & OSTEOCHONDRODYSPLASIAS 1966-84 HN(85); OLLIER'S DISEASE was see DYSCHONDROPLASIA 1963-84 MHÑEnchondromatosis ANdo not confuse X ref OLLIER'S DISEASE with Ollier's disease as Ollier-Klippel-Trenaunay disease ( = KLIPPEL-TRENAUNAY DISEASE) MNC5.116.99.708.338 XSMaffucci Syndrome; Ollier's Disease DMÑOsteochondrodysplasias LH LS; LM  MSIncontinence of feces not due to organic defect or illness. PM69 HN69(63) MHÑEncopresis AN= FECAL INCONTINENCE of psychol origin; do not use /drug eff /physiol /rad eff MNF3.126.316 FXÑDefecation; ÑFecal Incontinence LH LX;  MSA form of sensitivity training that emphasizes the experiencing of individual relationships within the group and that minimizes intellectual and didactic input. Focus is on the present. OLsearch SENSITIVITY TRAINING GROUPS 1972-74 HN(75) MHÑEncounter Groups ANno qualif MNF1.829.316.697.406; F4.754.864.581.813.406 DMÑSensitivity Training Groups LH LM  MHÑEncyclopedias ANno qualif MNL1.178.682.192.836.456 LH  PM67 HN67(65) MHÑEndarterectomy ANdo not use /util except by MeSH definition MNE4.752.814.456 LH  MHÑEndarteritis MNC14.907.184.281; C14.907.940.90.340 LH  MS1,3-Beta-D-Glucan glucanohydrolase. Hydrolyzes 1,3-beta-D-glucosidic linkages in 1,3-beta-D-glucans. Hydrolyzes laminarin, paramylon and pachyman. HN(75) MHÑEndo-1,3-beta-Glucanase ANdo not use /analogs; DF: ENDO GLUCANASE RNEC 3.2.1.39 PIGlycoside Hydrolases (69-74); Polysaccharides (69-74) MND8.586.277.450.375 XSLaminarinase; Oligo-1,3-Glucosidase DMÑGlycoside Hydrolases LH LS; LM  MSA spectrum of septal defects associated with persistence of the embryonic atrioventricular canal due to incomplete growth and fusion of the endocardial cushion. HN(83) MHÑEndocardial Cushion Defects ANdo not use /congen PIHeart Defects, Congenital (66-82) MNC14.280.400.560.350; C16.131.457.559.351 XSPersistent Common Atrioventricular Canal; Persistent Ostium Primum DMÑHeart Septal Defects LH LS; LM  MHÑEndocardial Fibroelastosis MNC14.280.600.281 LH  MHÑEndocarditis MNC14.280.282 LH  MHÑEndocarditis, Bacterial ANcoord with specific bacterium /infections heading (IM) if pertinent MNC1.252.300; C14.280.282.407 FXÑAneurysm, Infected LH LX  MHÑEndocarditis, Subacute Bacterial ANcoord with specific bacterium /infections heading (IM) MNC1.252.300.407; C1.252.890.240; C14.280.282.407.407 XSENDOCARDITIS LENTA LH LS  MSThe innermost layer of the heart, comprised of endothelial cells. MHÑEndocardium ANdo not use /blood supply; inflammation = ENDOCARDITIS & its specifics MNA7.541.207 LH  PM65; ENDOCRINE GLAND DISEASES was see under ENDOCRINOLOGY 1963-64 HN65; ENDOCRINE GLAND DISEASES was see under ENDOCRINOLOGY 1963-64 MHÑEndocrine Diseases ANGEN; hormonal defic: TN 194; endocr defic: probably a defic state from Cat C19; Manual 23.35.4 CATALOG: form qualif = ENDOCRINOLOGY /form MNC19 FXÑEndocrinology LH LX  OL╥endocrine neoplasms╙ is indexed ENDOCRINE DISEASES + NEOPLASMS or specific pre-coord endocrine gland/neopl term MH*Endocrine Gland Neoplasms (Non Mesh) MNC4.588.322 LH  MSDuctless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions. MHÑEndocrine Glands ANGEN: prefer specific; /physiol or /secret: consider also HORMONES; endocr defic: probably a defic state from Cat C19; ╥endocrine cells╙ in Russian literature is probably APUD CELLS; Manual 23.35.4 CATALOG: form qualif = ENDOCRINOLOGY /form MNA6.407 LH  MSThe system of glands that release their secretions (hormones) directly into the circulatory system. OL╥endocrine system╙ is indexed ENDOCRINE GLANDS MH*Endocrine System (Non Mesh) MNA6 LH  MSA subspecialty of internal medicine concerned with the metabolism, physiology, and disorders of the endocrine system. MHÑEndocrinology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of ENDOCRINE GLANDS /form or ENDOCRINE DISEASES /form MNG1.782.323; G2.403.776.409.323 XSEndocrinology and Metabolism (Specialty); Metabolism and Endocrinology (Specialty) FXÑENDOCRINE DISEASES LH LS; LX  MSCellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. PM76; was see under PHAGOCYTOSIS 1975 HN76(73); was see under PHAGOCYTOSIS 1975 MHÑEndocytosis ANonly /drug eff /rad eff PICells/PH (66-72) MNG4.335.487 FXÑReceptosomes LH LX  MSCatalyze the endonucleolytic cleavage of DNA. Include EC 3.1.21.-, EC 3.1.22.-, EC 3.1.23.- (DNA RESTRICTION ENZYMES), EC 3.1.24.- (DNA RESTRICTION ENZYMES), and EC 3.1.25.-. PM83 HN83 MHÑEndodeoxyribonucleases ANdo not use /analogs RNEC 3.1.- PIDeoxyribonucleases (66-82); Endonucleases (73-82); Phosphatases (66-72) MND8.586.277.352.630.553.270 LH  MSThe inner of the three germ layers of the embryo. MHÑEndoderm ANdo not use /abnorm /embryol /growth /inj; ENDODERMAL SINUS TUMOR (see below): coord IM with OVARIAN NEOPLASMS (IM) MNA16.254.425.407 LH  MSA dental specialty concerned with the maintenance of the dental pulp in a state of health and the treatment of the pulp cavity (pulp chamber and pulp canal). MHÑEndodontics ANSPEC: SPEC qualif; ENDODONTICS = the specialty, ROOT CANAL THERAPY = the patient MNE6.397; G2.163.876.213 FXÑDENTAL PULP DISEASES; ÑDENTAL PULP TEST; ÑDental Pulp; ÑDental Pulp Diseases; ÑTOOTH DISCOLORATION LH LX; ; ; ;  MSA genus of small amoebae of the order Amoebida found in the intestines of vertebrates and invertebrates. OLsearch SARCODINA 1966-74 HN(75); was see under SARCODINA 1963-76 MHÑEndolimax ANdo not use /anat /blood-csf-urine /embryol; infection: coord NIM with AMEBIASIS (IM) MNB1.841.656.89.325 DMÑAmoeba LH LM  OLsearch LABYRINTHINE FLUIDS 1966-74 HN(75) MHÑEndolymph ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; do not use for ╥endolymphatic injections╙ ( = INJECTIONS, INTRALYMPHATIC) MNA12.207.571.324 DMÑLabyrinthine Fluids LH LM  MSDuct connecting the endolymphatic sac with the membranous labyrinth. HN(79) MHÑEndolymphatic Duct PIEndolymph (75-78); Labyrinth (66-78); Labyrinthine Fluids (66-74) MNA9.246.631.360 DMÑLabyrinth LH LM  MSThe blind pouch at the end of the endolymphatic duct. HN(79) MHÑEndolymphatic Sac PIEndolymph (75-78); Labyrinth (66-78); Labyrinthine Fluids (66-74) MNA9.246.631.360.701 DMÑLabyrinth LH LM  MHÑEndometrial Hyperplasia MNC13.371.852.228 LH  MHÑEndometriosis ANneoplastic but nothing to do with ╥endometrial carcinoma╙: see below under ENDOMETRIUM; coord IM with precoord organ/neopl term (IM) MNC4.557.537.397 XSADENOMYOSIS LH LS  MHÑEndometritis ANuterine inflammation goes here, not under UTERINE DISEASES or ENDOMETRIUM + INFLAMMATION MNC13.371.852.299 LH  MHÑEndometrium ANendometrial carcinoma = UTERINE NEOPLASMS & do not use ENDOMETRIUM nor ENDOMETRIOSIS; inflammation = ENDOMETRITIS MNA5.360.319.679.490 LH  MSAn order of mostly saprophytic ascomycetous fungi. OLsearch ASCOMYCETES 1966-74; use ENDOMYCETALES to search ENDOMYCOPSIS back thru 1975; to search EREMOTHECIUM use ENDOMYCETALES back thru 1975 & ASCOMYCETES 1966-74 PM86; was see under ASCOMYCETES 1963-85; ENDOMYCOPSIS, HANSENULA, PICHIA, SACCHAROMYCOPSIS & SCHIZOSACCHAROMYCES were see under ASCOMYCETES 1975-85; EREMOTHECIUM was see under ASCOMYCETES 1963-85 HN86(75); was see under ASCOMYCETES 1963-85; ENDOMYCOPSIS was see under ASCOMYCETES 1975-85; EREMOTHECIUM was see under ASCOMYCETES 1963-85 MHÑEndomycetales ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.292 XSEndomycopsis; Eremothecium XUÑHansenula; ÑKluyveromyces; ÑPichia; ÑSaccharomycopsis; ÑSchizosaccharomyces LH LS; LU; ; ; ;  MSA disease characterized by thickening of the endocardium, and frequently the inner third of the myocardium. The left ventricle is most frequently involved. Cardiomegaly and congestive heart failure may also be present. PM65 HN65(63) MHÑEndomyocardial Fibrosis MNC14.280.600.406 LH  PM73 HN73 MHÑEndonucleases ANdo not use /analogs RNEC 3.1. PINucleotidyltransferases (66-72); Phosphatases (66-72) MND8.586.277.352.630.553.299 LH  PM65 HN65 MHÑEndoplasmic Reticulum ANA 11 qualif except /cytol MNA11.368.702.248 XSERGASTOPLASM LH LS  MSCatalyze the endonucleolytic cleavage of RNA. Include EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-. PM83; GUANYLORIBONUCLEASE was see under RIBONUCLEASES 1975-83 HN83 MHÑEndoribonucleases ANdo not use /analogs RNEC 3.1.- PIEndonucleases (73-82); Phosphatases (66-72); Ribonucleases (66-82) MND8.586.277.352.630.553.320 XUÑGuanyloribonuclease LH LU  MSEndogenous peptides with morphine-like actions found in the brain, cerebrospinal fluid and pituitary gland and other vertebrate organs; they are believed to be neuromodulators or possibly transmitters; specific endorphins are pentapeptides called ENKEPHALINS. PM78; was indexed under PEPTIDES Aug-Dec 1977 HN78(Aug 77); was see under PEPTIDES Aug-Dec 1977 MHÑEndorphins ANdo not use /analogs; /biosyn /physiol permitted PINerve Tissue Proteins (66-Jul 77); Peptides (66-Jul 77) MND12.644.150; D12.776.641.650.240; D16.538.321 XSOpiates, Endogenous; Opioid Peptides LH LS;  MHÑEndoscopy ANNIM; do not use /util except by MeSH definition MNE1.418 LH  MH*Endospore-Forming Bacteria (Non Mesh) MNB3.300 LH  PM74 HN74(72) MHÑEndosulfan ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN115-29-7 PIInsecticides (66-72) MND3.438.197.408; D5.723.491.491.422 LH  PM74 HN74(73) MHÑEndothelium ANNIM since specific organ should be IM but ╥vascular endothelium╙ as a functional concept is ENDOTHELIUM (IM); do not use /abnorm /growth /inj /innerv PIEpithelium (66-72) MNA10.272.491 LH  MSToxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. MHÑEndotoxins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS; coord IM with specific bacterium (IM with no qualif) but do not coord with BACTERIAL TOXINS MND24.185.926.310 FXÑLimulus Test LH LX  PM74 HN74(71) MHÑEndrin ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN72-20-8 PIInsecticides (66-72) MND2.455.526.439.416; D5.723.491.491.455 LH  MHÑEnema ANdo not use /util except by MeSH definition; barium enema: coord with BARIUM SULFATE /diag use, not BARIUM MNE2.385 LH  PM74,63-65 HN74,63-65 MHÑEnergy Metabolism ANonly /drug eff /rad eff MNG6.535.335 XSBioenergetics; Energy Expenditure LH LS;  PM68 HN68(65) MHÑEnergy Transfer ANNIM; only /drug eff /rad eff MNG6.184.348; H1.181.529.328; H1.671.100.442 XSLET LH LS  MSNatural energy sources of power supply. PM82 HN82 MHÑEnergy-Generating Resources ANonly /class /econ /util (if by MeSH definition) MNG3.230.132 FXÑPower Plants; ÑPower Sources XUÑSolar Energy LH LX; LU  MS2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether. An inhalation anesthetic. Synonym: Ethrane. PM80; was see under METHYL ETHERS 1975-79 HN80(75); was see under METHYL ETHERS 1975-79 MHÑEnflurane ANdo not use /biosyn /defic /physiol RN13838-16-9 PIAnesthesia, Inhalation (69-74); Anesthetics (69-74); Ethers (69-73); Hydrocarbons, Halogenated (69-74); Methyl Ethers (73-74) MND2.355.601.400; D14.166.293 LH  MHÑEngineering ANonly /econ /hist /instrum MNJ1.293 LH  MHÑEngland ANLONDON is also available MNZ1.542.363.300 LH  HN69 MHÑEnglish Abstract ANcheck tag only for Eng Abst of foreign articles only; do not confuse with author abstracts (Field 22); policy: Manual 17.6+ CATALOG: do not use: for indexers only LH  MHÑEngraving and Engravings ANno qualif; DF: ENGRAVING MNK1.93.346 FXÑPrinting LH LX  MSDNA sequences which increase the transcription of genes into messenger RNA. HN(85) MHÑEnhancer Elements (Genetics) ANonly /drug eff /rad eff; DF: ENHANCER ELEMENTS PIGene Expression Regulation (81-84); Genes (66-67); Genes, Regulator (68-84); Transcription, Genetic (73-84) MNG5.275.470.410; G5.331.380.418.410 DMÑGenes, Regulator LH LM  MSTyrosylglycylglycylphenylalanylleucine. Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is leucine. PM83 HN83 MHÑEnkephalin, Leucine AN/biosyn /physiol permitted; DF: LEU ENKEPHALIN RN58822-25-6 PIEnkephalins (Aug 77-82); Nerve Tissue Proteins (66-Jul 77); Peptides (66-Jul 77) MND12.644.150.250.400; D12.776.641.650.240.250.400; D16.538.321.345.555 XSLeucine Enkephalin LH LS  MSTyrosylglycylglycylphenylalanylmethionine. Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is methionine. PM83 HN83 MHÑEnkephalin, Methionine AN/biosyn /physiol permitted; DF: MET ENKEPHALIN RN58569-55-4 PIEnkephalins (Aug 77-82); Nerve Tissue Proteins (66-Jul 77); Peptides (66-Jul 77) MND12.644.150.250.450; D12.776.641.650.240.250.450; D16.538.321.345.600 XSMethionine Enkephalin LH LS  MSEndogenous pentapeptides or synthetic derivatives of these pentapeptides which mimic the action of morphine in the nervous system. Found in the brain and pituitary gland. May be synthesized in these organs or possibly degraded from larger peptides called ENDORPHINS, which have similar physiological actions. PM83; was see under ENDORPHINS Aug 1977-82 HN83(Aug 77); was see under ENDORPHINS Aug 1977-82 MHÑEnkephalins ANdo not use /analogs; /biosyn /physiol permitted PINerve Tissue Proteins (66-Jul 77); Oligopeptides (73-Jul 77) MND12.644.150.250; D12.776.641.650.240.250; D16.538.321.345 LH  MSL-3-Hydroxyacyl-CoA hydro-lyases. Catalyze reversibly the hydration of unsaturated fatty acyl CoA to yield beta-hydroxyacyl CoA. Key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. Have broad specificity, but are most active with crotonyl CoA. EC 4.2.1.17. HN(78) MHÑEnoyl CoA Hydratases ANdo not use /analogs RNEC 4.2.1.17 PICoenzyme A (66-77); Hydro-Lyases (66-77) MND8.586.520.497.308 XS3-Hydroxyacyl Coa Hydrolyases; 3-Hydroxyacyl Dehydratases; Beta-Hydroxyacyl Dehydratases; Crotonase; Enoyl Hydrase DMÑHydro-Lyases LH LS; ; ; ; LM  MHÑEntamoeba ANdo not use /anat /blood-csf-urine /embryol; infection = ENTAMOEBIASIS MNB1.841.656.89.335 LH  MHÑEntamoeba Histolytica ANdo not use /anat /blood-csf-urine /embryol; infection = ENTAMOEBIASIS MNB1.841.656.89.335.330 XSENDAMOEBA HISTOLYTICA LH LS  MSInfection with amoebae of the genus Entamoeba. Infection with E. histolytica causes DYSENTERY, AMEBIC and LIVER ABSCESS, AMEBIC. OLsearch AMEBIASIS 1966-74 HN(75) MHÑEntamoebiasis MNC3.752.55.407 DMÑAmebiasis LH LM  MSNutritional support given via the enteral route. Includes oral feeding, sip feeding, and tube feeding using nasogastric, gastrostomy, and jejunostomy tubes. OLuse ENTERAL FEEDING to search TUBE FEEDING back thru 1966 PM80; was TUBE FEEDING 1966-79 HN80; was TUBE FEEDING 1964-79 (Prov 1964-65) MHÑEnteral Feeding ANdo not use /util except by MeSH definition; coord IM with dis /ther (IM), not dis /diet ther; do not confuse with PARENTERAL FEEDING or PARENTERAL HYPERALIMENTATION; enteral feeding ╥includes oral feeding, sip feeding & tube feeding using nasogastric, gastrostomy & jejunostomy tubes╙ MNE2.421.360 XSEnteral Hyperalimentation; Hyperalimentation, Enteral; Tube Feeding FXÑFood, Formulated; ÑGastrostomy; ÑIntubation, Gastrointestinal LH LS; ; LX; ;  MHÑEnteritis AN╥inflammation of small intestine╙ only, GEN or unspecified; DUODENITIS & ILEITIS are available; jejunitis: coord JEJUNAL DISEASES (IM) + ENTERITIS (NIM); ╥inflammatory bowel disease╙ is probably CROHN DISEASE or COLITIS, ULCERATIVE: check text; ENTEROCOLITIS is also available MNC6.405.469.314 LH  MSA virus causing enteritis in turkeys and pullets. Fluorescent antibody tests indicate that it is a coronavirus. HN(75); was see under REOVIRUSES 1975-80 MHÑEnteritis Virus, Turkey ANdo not use /blood-csf-urine /cytol; infection = ENTERITIS, TRANSMISSIBLE, OF TURKEYS MNB4.909.777.199.325 XSBluecomb Virus; Transmissible Enteritis Virus of Turkeys DMÑCoronaviridae LH LS; LM  MSAn acute, highly contagious virus disease of turkeys characterized by chilling, anorexia, decreased water intake, diarrhea, dehydration and weight loss; the infectious agent is thought to be a coronavirus. PM76 HN76 MHÑEnteritis, Transmissible, of Turkeys ANdo not use /vet; don't forget also TURKEYS (NIM) & check tag ANIMAL PIPoultry Diseases (66-75) MNC2.782.225.325; C22.131.220 XSBluecomb of Turkeys; Transmissible Enteritis of Turkeys LH LS;  MSGram-negative gas-producing rods found in feces of man and other animals, sewage, soil, water, and dairy products. OLuse ENTEROBACTER to search AEROBACTER & AEROBACTER AEROGENES back thru 1966 HN(78); was AEROBACTER see under ENTEROBACTERIACEAE 1976-77, was AEROBACTER 1963-75; AEROBACTER AEROGENES was see AEROBACTER 1976-77, was heading 1963-75 MHÑEnterobacter ANin feces, soil & water; infection: coord NIM with ENTEROBACTERIACEAE INFECTIONS (IM) MNB3.475.300.275 XSAerobacter; Aerobacter aerogenes DMÑEnterobacteriaceae LH LS; LM  PMAEROBACTER (now see ENTEROBACTER, an XU below) & AEROBACTER AEROGENES (now see ENTEROBACTER, an XU below) were headings 1963-75 MHÑEnterobacteriaceae ANdo not use /blood-csf-urine; ╥enterobacteria╙ & ╥enteric bacteria╙ unspecified go here; Paracolobactrum goes here; note X ref below MNB3.475.300 XSColiform Bacilli XUÑEnterobacter LH LS LU  MSInfections with bacteria of the family Enterobacteriaceae. Syn: enterobacterial infections. PM68 HN68 MHÑEnterobacteriaceae Infections AN╥enterobacterial╙ infections goes here PIEnterobacteriaceae (66-67) MNC1.252.310 LH  MSA genus of intestinal nematode worms which includes the pinworm or threadworm Enterobius vermicularis. OLuse ENTEROBIUS to search OXYURIS VERMICULARIS back thru 1966 HNOXYURIS VERMICULARIS was see under ENTEROBIUS 1963-78 MHÑEnterobius ANdo not use /blood-csf-urine; infection = ENTEROBIASIS MNB1.500.294.599.308 XSOxyuris Vermicularis; Pinworms; Threadworms LH LS; ;  MSN,N',N╥-(2,6,10-Trioxacyclododecane-3,7,11-triyl)tris[2,3-dihydroxybenzamide]) An iron-binding cyclic trimer of 2,3-dihydroxy-N-benzoyl-L-serine. Enterobactin is a stereoisomer of the above. HN(75) MHÑEnterochelin ANdo not use /biosyn /defic /physiol RN28384-96-5 PIBenzoates (71-74); Catechol (71-74); Serine (71-74) MND1.552.412.470.300; D12.125.837.300 XSEnterobactin DMÑSerine LH LS LM  MSCells of the intestinal mucosa containing granules that stain with chromium salts. OLsearch CHROMAFFIN SYSTEM 1968-74 HN(75) MHÑEnterochromaffin Cells ANA 11 qualif MNA6.224.358; A11.436.280; A15.382.250 XSArgentaffin Cells DMÑChromaffin System LH LS LM  MSInflammation of the intestinal mucosa of the small and large bowel. PM85 HN85 MHÑEnterocolitis AN╥inflammation of...small & large╙ intestines; see also note on ENTERITIS PIColitis (66-84); Enteritis (66-84) MNC6.405.469.158.188.400; C6.405.469.314.307 LH  MSAcute inflammation of the small and large intestinal mucosa with formation of pseudomembranous plaques over superficial ulceration. Commonly associated with antibiotic therapy and Clostridium difficile is often implicated. In infants it is known as necrotizing enterocolitis. OLuse ENTEROCOLITIS, PSEUDOMEMBRANOUS to search ENTEROCOLITIS, ACUTE back thru 1966 PM85; was ENTEROCOLITIS, ACUTE 1963-84 HN85; was ENTEROCOLITIS, ACUTE 1963-84 MHÑEnterocolitis, Pseudomembranous ANnote X ref CLOSTRIDIUM ENTEROCOLITIS, often caused by Clostridium difficile: for organism other than C. difficile coord with organism (NIM) but not also CLOSTRIDIUM INFECTIONS MNC1.252.217.310; C6.405.469.158.188.400.408; C6.405.469.314.307.491 XSAntibiotic-Associated Colitis; Clostridium Enterocolitis; Colitis, Pseudomembranous; Enterocolitis, Necrotizing LH LS; ; ;  MSPostulated gastrointestinal hormone secreted mainly by the duodenum in presence of fats; inhibits both the motility and acid secretion of the stomach. OLsearch GASTROINTESTINAL HORMONES 1966-74 HN(75) MHÑEnterogastrone AN/biosyn /physiol permitted; /analogs NIM only RN9007-67-4 MND6.472.317.325; D12.644.165; D19.316.629.346 DMÑGastrointestinal Hormones LH LM  MSGlucagon-like polypeptide compound secreted in the intestinal tract. Does not share a common receptor site with pancreatic glucagon. Has glycogenolytic activity. HN(79) MHÑEnteroglucagon AN╥glucagon-like╙, not pancreatic glucagon; /biosyn /physiol permitted; /analogs NIM only RN62340-29-8 PIGastrointestinal Hormones (66-78); Peptides (66-78) MND6.472.317.335; D12.644.168; D19.316.629.355 XSGut Glucagon DMÑGastrointestinal Hormones LH LS LM  MSRecycling through liver by excretion in bile, reabsorption from intestines into portal circulation, passage back into liver, and re-excretion in bile. PM75 HN75 MHÑEnterohepatic Circulation ANa metab concept, not a hemodynamic circ concept; bile-to-intestines-to-portal circ-to-liver-to-bile; only /drug eff /rad eff PIBile (66-74); Bile Acids and Salts (66-74); Intestinal Absorption (66-74); Intestine, Small (66-74); Intestines (66-74); Liver (66-74); Liver Circulation (66-74) MNG6.535.355 LH  HN(73) MHÑEnteropeptidase ANdo not use /analogs RNEC 3.4.21.9 MND8.586.277.656.732.284 DMÑPeptide Peptidohydrolases LH LM  MSDisease caused by the liberation of exotoxins of Clostridium perfringens in the intestines of sheep, goats, cattle, foals, and piglets. Type B enterotoxemia in lambs is lamb dysentery; type C enterotoxemia in mature sheep produces ╥struck╥, and in calves, lambs and piglets it produces hemorrhagic enterotoxemia; type D enterotoxemia in sheep and goats is pulpy-kidney disease or overeating disease. HN(69) MHÑEnterotoxemia ANanimal only: do not use /vet but check tag ANIMAL; coord IM with precoord animal/dis term (IM) + animal (NIM) or with animal (IM) in absence of precoord PIClostridium Infections/VE (66-68) MNC1.252.217.325; C22.313 DMÑClostridium Infections LH LM  MSSubstances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. OLuse ENTEROTOXINS to search ENTEROTOXIN back thru 1966 (as Prov 1966-67) PM68 HN68; was ENTEROTOXIN 1964-67 (Prov) MHÑEnterotoxins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS; coord IM with specific bacterium (IM or NIM) MND24.185.926.330 FXÑSTAPHYLOCOCCAL FOOD POISONING LH LX  MHÑEnterovirus Infections MNC2.782.687.359 XUÑSwine Vesicular Disease LH LU  OLuse ENTEROVIRUSES to search ENTEROVIRUS back thru 1966 PM75; was ENTEROVIRUS 1963-74; ENCEPHALOMYELITIS VIRUS, MURINE was see under ENTEROVIRUS 1967-74, was see under POLIOVIRUS 1963-66 HN75; was ENTEROVIRUS 1963-74 MHÑEnteroviruses ANdo not use /blood-csf-urine /cytol MNB4.909.777.618.284 XUÑAvian Encephalomyelitis Virus; ÑDuck Hepatitis Virus; ÑEncephalomyelitis Virus, Murine; ÑEnteroviruses, Porcine LH LU; ; ;  MSViruses causing mild to severe diseases among pigs in Europe; mild strains are also probably present in Canada, U.S., and Australia. HN(75) MHÑEnteroviruses, Porcine ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENTEROVIRUS INFECTIONS (IM) MNB4.909.777.618.284.600 XSECSO Viruses; Enteric Cytopathic Swine Orphan Virus; Porcine Enteroviruses; Talfan Disease Virus; Teschen Disease Virus DMÑEnteroviruses LH LS; ; ; ; LM  MHÑEntomology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of INSECTS /form MNG1.273.943.409 LH  MSA genus of fungi, subdivision Zygomycotina and order Entomorphthorales, primarily parasites of insects and spiders, but which have been found to cause mycotic infections of the nose in man and horses. HN(75); was see under ZYGOMYCETES 1979-85, was see under PHYCOMYCETES 1975-78 MHÑEntomophthora ANdo not use /anat /embryol /microbiol /parasitol; infection: coord NIM with MYCOSES (IM) MNB5.354.730.944.300 DMÑZygomycotina LH LM  MHÑEntropion MNC11.338.443 LH  MSInvoluntary passage of urine continued past the usual age of establishing bladder control; often used with specific reference to involuntary urination during sleep. MHÑEnuresis ANdo not use /congen /drug eff /physiol /rad eff MNC12.777.934.284; F3.126.328 LH  MSCyclic basic peptide related to tuberactinomycin. Isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus. It is an antitubercular agent with less ototoxicity than tuberactinomycin. OLuse ENVIOMYCIN to search TUBERACTINOMYCIN-N back thru 1975 HN(81); was TUBERACTINOMYCIN-N see under ANTIBIOTICS, ANTITUBERCULAR 1975-80 MHÑEnviomycin ANdo not use /defic /physiol; /analogs NIM only RN33103-22-9 PIAntibiotics (66-74); Peptides (66-74) MND20.85.89.910.345; D20.338.135.922.345 XSTuberactinomycin N DMÑViomycins LH LS LM  MHÑEnvironment ANno qualif CATALOG: /geog /form MNG3.230 FXÑSocial Environment LH LX  MH*Environment and Public Health (Non Mesh) MNG3 LH  MSThe structuring of the environment to permit or promote specific patterns of behavior. PM74 HN74(72) MHÑEnvironment Design ANonly /stand /trends PIEnvironment (66-71); appropriate psychosocial heading MNG3.230.200; I1.283; I1.880.709.359 LH  PM73 HN73 MHÑEnvironment, Controlled ANno qualif PIEnvironment (66-72) MNG3.230.150 XSLaminar Air-Flow Areas FXÑATMOSPHERE EXPOSURE CHAMBERS; ÑINCUBATORS LH LS LX;  MSThe exposure of a subject to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. PM74 HN74(67) MHÑEnvironmental Exposure ANno qualif; NIM when specific substance is IM; may or may not result in a disease; usually in an occup environ; consider also OCCUPATIONAL DISEASES & do not add ENVIRONMENTAL EXPOSURE PIspecific agent; specific environment heading MNG3.850.460.350 FXÑEnvironmental Monitoring; ÑOccupational Diseases XUÑMaximum Permissible Exposure Level LH LX; LU  MSThe science of controlling or modifying those conditions, influences or forces surrounding man which relate to promoting, establishing and maintaining health. MHÑEnvironmental Health ANno qualif CATALOG: /geog /form MNG2.229; G3.300 FXÑACCIDENTS LH LX  MSThe study of microorganisms living in a variety of environments (air, soil, water, etc.) and their pathogenic relationship to other organisms including man. PM85 HN85; was NON MESH before 1985 MHÑEnvironmental Microbiology ANIM; no qualif; coord with specific microbe (IM) MNG3.850.425 LH  MSThe monitoring of the level of toxicants, pollutants, or other harmful chemicals in the environment or workplace by measuring the amounts of these toxicants in the bodies of people and animals in that environment, among other methods; the measurement of ENVIRONMENTAL EXPOSURE; humans and animals are used as indicators of toxic levels of undesirable chemicals. PM86 HN86 MHÑEnvironmental Monitoring ANonly /econ /instrum /methods /stand /trends PIEnvironmental Exposure (67-85) MNG3.850.460.350.80 XSBiological Monitoring; Ecological Monitoring; Epidemiological Monitoring; Monitoring, Environmental FXÑEnvironmental Exposure LH LS; ; ; LX  MSSubstances which pollute the environment. Use for environmental pollutants in general or for which there is no specific heading. PM75 HN75 MHÑEnvironmental Pollutants ANonly /ad-poi-tox /anal /isol; in addition to AIR POLLUTANTS, RADIOACTIVE POLLUTANTS, SOIL POLLUTANTS & WATER POLLUTANTS & their specifics, CARCINOGENS, ENVIRONMENTAL is also available PIEnvironmental Pollution (71-74) MND5.284 LH  MH*Environmental Pollutants, Pesticides (Non Mesh) MND5 LH  PM74 HN74(71) MHÑEnvironmental Pollution ANonly /adv eff /anal /econ /prev; array of environ pollut terms from other categories: Bull 95 (Mar 77) CATALOG: /geog /form PIEnvironment (66-70) MNG3.850.460 LH  MHÑEnzymatic Zonulolysis ANIM; do not coord with CHYMOTRYPSIN (the usual enzyme in this technic) unless specifically discussed; do not use /util except by MeSH definition MNE4.792.208.409 LH  MSConversion of an inactive form of an enzyme to one possessing metabolic activity; includes 1) activation by ions (activators), 2) activation by cofactors (coenzymes), and 3) conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. PM76; was see under BIOCHEMISTRY 1975 HN76(69); was see under BIOCHEMISTRY 1975 MHÑEnzyme Activation ANIM for general only; NIM with specific enzyme (IM); only /drug eff /rad eff; ╥enzyme reactivation╙: coord IM with specific enzyme /metab (IM) + ENZYME REACTIVATORS (IM) if discussed (see note there) PIspecific enzyme MNG6.184.368 LH  MSAn increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. PM68 HN68(66) MHÑEnzyme Induction ANIM for general only; NIM with specific enzyme /biosyn (IM); only /drug eff /rad eff MNG5.331.380.294 FXÑStimulation, Chemical LH LX  MSCompounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. OLsearch ENZYMES /AI 1968-74 & ENZYMES 1966-67 PM75,64-67 HN75,64-67 MHÑEnzyme Inhibitors ANGEN only; prefer /antag with specific enzyme; do not use /analogs /antag /biosyn /defic /physiol; DF: ENZYME INHIB PIEnzymes (66-67); Enzymes/AI (68-74) MND8.373 LH  MHÑEnzyme Precursors ANIM; coord with specific enzyme (IM); do not use /analogs; zymogen granules: index under ENZYME PRECURSORS (IM) + CYTOPLASMIC GRANULES (IM) + specific enzyme (IM) MND8.444 XSProenzymes; Zymogens FXÑProtein Precursors XUÑProperdin Factor B LH LS; LX LU  MSCompounds which restore enzymatic activity by removing an inhibitory group bound to the reactive site of the enzyme. PM75 HN75 MHÑEnzyme Reactivators ANdo not use /analogs /biosyn /defic /physiol; coord IM with specific enzyme (IM) but CHOLINESTERASE REACTIVATORS is available for reactivators of CHOLINESTERASES & ACETYLCHOLINESTERASE (see note there) PIEnzymes (66-74) MND8.515 LH  MSThe non-synthesis of an enzyme due to the absence or lowered level of an effector substance, usually a metabolite, whose presence would cause depression of the gene responsible for enzyme synthesis. PM66 HN66(64) MHÑEnzyme Repression ANIM for general only; NIM with specific enzyme /biosyn (IM); only /drug eff /rad eff MNG5.331.380.340 LH  MSThe extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. PM87 HN87 MHÑEnzyme Stability ANIM for general only; NIM with specific enzyme (IM); only /drug eff /rad eff PIDrug Stability (66-86); Hydrogen-Ion Concentration (66-86); Kinetics (66-86); Temperature (66-86) MNE5.916.360; G6.184.378 FXÑEnzymes, Immobilized LH LX  MHÑEnzyme Tests ANIM; see Manual 26.17 for definition; coord with specific enzyme (with pertinent qualif) (IM) + disease /diag (IM), not disease /enzymol; only /instrum /methods /stand /vet MNE1.223.174.493 LH  MSAny analytical method that involves any pair of covalently linked enzyme and antibody where both the enzyme and antibody retain their biological activities and either the enzyme or the antibody is bound to an immunosorbent. The product of the action of the enzyme then quantifies whatever was assayed. PM86; was see under IMMUNOENZYME TECHNICS 1977-85 HN86(77); was see under IMMUNOENZYME TECHNICS 1977-85 MHÑEnzyme-Linked Immunosorbent Assay ANNIM; only /instrum; IMMUNOSORBENTS is also available PIImmunoassay (66-76); Serodiagnosis (66-76) MNE1.223.495.567.350.360; E1.223.495.567.380.360; E5.478.567.350.360; E5.478.567.380.360 XSELISA LH LS  MHÑEnzymes ANGEN only: avoid; prefer /enzymol: Manual 19.5+; do not use /analogs /antag ( = ENZYME INHIBITORS); /defic permitted but specific enzyme /defic is more likely; /diag use: very unlikely: probably incorrect for ENZYME TESTS; TN 222: indexing policy & specific enzyme defic, also Manual 23.35.3; policy: Manual 25.75-25.85; EMIT (enzyme multiplied immunoassay technic) is indexed under IMMUNOENZYME TECHNICS; index enzyme substrate as NIM without qualif (Manual 25.79); SUBSTRATE SPECIFICITY, restricted to enzymes, also available; ╥enzyme activation╙ = ENZYME ACTIVATION; ╥enzyme reactivation╙: coord ENZYME ACTIVATION (IM) + specific enzyme /metab (IM) + ENZYME REACTIVATORS (IM) if discussed (see note there) MND8.586 LH  MH*Enzymes, Coenzymes, Enzyme Inhibitors (Non Mesh) MND8 LH  MSEnzymes which are immobilized on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity. Since they can be reused continuously, immobilized enzymes have found wide application in the industrial, medical and research fields. PM77 HN77 MHÑEnzymes, Immobilized ANdo not use /analogs /biosyn /defic /physiol PIspecific enzyme MND8.586.180 XSImmobilized Enzymes FXÑEnzyme Stability; ÑMicrospheres LH LS LX;  MS2',4',5',7'-Tetrabromo-3',6'-dihydroxyspiro (isobenzofuran-1(3H),9'-(9H)xanthen)-3-one disodium salt. Versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain and counterstain with Hematoxylin; also in special culture media. Synonums: bromoeosine; bromofluoresceic acid; C.I. 45380; C.I. Acid Red 87; D & C Red No. 22; eosin w/s. PM79 HN79 MHÑEosin AND25-26 qualif; do not confuse with EOSINE BLUISH (see PHLOXINE B) RN548-26-5 PIFluoresceins (66-78); Stains and Staining (66-78) MND26.408.348.514.323 XSEosine Yellowish; Tetrabromofluorescein LH LS;  MSAbnormal increase in eosinophils in the blood, tissues or organs. MHÑEosinophilia ANfor eosinophilic states (as eosinophilic gastritis, eosinophilic meningitis) coord IM with disease (IM) but note entries below; ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA is also available MNC15.378.553.231 LH  MHÑEosinophilic Granuloma MNC5.116.391; C15.378.553.231.348; C15.604.667.490.360; C23.484.243 XSGRANULOMA, EOSINOPHILIC LH LS  MSGranular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. MHÑEosinophils ANrestrict to leukocytes: not for ╥eosinophilic╙, stainable with eosin ( = STAINS AND STAINING + EOSIN); A 11 qualif & /class; eosinophilic states: see note under EOSINOPHILIA; eosinophil count: coord with LEUKOCYTE COUNT MNA11.118.637.415.345; A15.145.229.637.415.345; A15.382.490.315.251 LH  MHÑEpendyma MNA8.186.211.276.460; A8.561.326; A10.755.260 LH  MHÑEpendymoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.226 LH  MHÑEperythrozoon ANdo not use /blood-csf-urine; infection = EPERYTHROZOONOSIS MNB3.700.651.129.493 LH  MSInfection with Eperythrozoon species. HN(75); was see under BARTONELLA INFECTIONS 1975-76 MHÑEperythrozoonosis ANhas nothing to do with ZOONOSES: is the -osis for Eperythrozoon MNC1.850.65.335 DMÑAnaplasmataceae Infections LH LM  MHÑEphedrine ANdo not use /biosyn /defic /physiol RN299-42-3 MND2.33.329.624.302; D2.92.63.624.302; D16.116.243; D16.893.341; D18.793.302 XSIsoephedrine; Pseudoephedrine LH LS;  MSA rhabdovirus infection of cattle, characterized by respiratory symptoms, increased oropharyngeal secretions and lacrimation, joint pains, tremor and stiffness. PM70 HN70 MHÑEphemeral Fever ANanimal only: do not use /vet but check tag ANIMAL; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES PIArbovirus Infections (66-69); Cattle Diseases (66-69) MNC2.782.292; C22.196.274 XSTHREE DAY SICKNESS LH LS  MS1-Chloro-2,3-epoxypropane. A chlorinated epoxy compound. Has shown anti-fertility activity in males. HN(75) MHÑEpichlorohydrin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN106-89-8 PIChlorine (73-74); Ethers, Cyclic (69-74); Propane (73-74) MND2.33.440.310; D2.355.291.411.400; D7.360.443.350 DMÑChlorohydrins LH LM  PM67 HN67(65) MHÑEpidemiologic Methods ANIM general only; NIM with specific study IM; only /vet MNE5.318; G3.850.520 FXÑMASS SCREENING XUÑCross Sectional Studies LH LX LU  MSField of medicine concerned with the determination of causes, incidence, and characteristic behavior of disease outbreaks affecting human populations; also the interrelationships of host, agent, and environment as related to the distribution and control of disease. MHÑEpidemiology ANSPEC only, SPEC qualif; note also EPIDEMIOLOGIC METHODS above; epidemiol of specific dis = /occur CATALOG: /geog /form MNG2.403.290 LH  MSIntradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules. OLuse EPIDERMAL CYST to search SEBACEOUS CYST back thru 1966 PM72; SEBACEOUS CYST was heading 1963-83 HN72(65); SEBACEOUS CYST was heading 1963-83 MHÑEpidermal Cyst ANnon-neoplastic; coord IM with organ/diseases term (IM); /anal /blood supply /secret /ultrastruct permitted MNC4.182.254 XSEpidermoid Cyst; Pilar Cyst; Sebaceous Cyst LH LS; ;  MSSingle chain, nonhelical, acidic polypeptide of about 52 amino acids found in most mammals; promotes growth of, and cell proliferation in, certain tissues, especially epidermal structures and inhibits acid secretion by the stomach; used to treat gastrointestinal ulcers. OLuse EPIDERMAL GROWTH FACTOR-UROGASTRONE to search EPIDERMAL GROWTH FACTORS back thru 1977; to search UROGASTRONE use EPIDERMAL GROWTH FACTOR-UROGASTRONE back thru 1975 & GASTROINTESTINAL HORMONES 1966-74 PM81; was EPIDERMAL GROWTH FACTORS see under PEPTIDES 1977-81; UROGASTRONE was see under GASTROINTESTINAL HORMONES 1963-81 HN82; was EPIDERMAL GROWTH FACTORS see under PEPTIDES 1977-81; UROGASTRONE was see under GASTROINTESTINAL HORMONES 1963-81 MHÑEpidermal Growth Factor-Urogastrone ANdo not use /analogs /defic; DF: EGFUG PIGastrointestinal Hormones (66-74); Growth Substances (66-76); Peptides (66-76) MND6.472.317.350; D12.644.170; D19.316.629.360; D24.185.348.360 XSUrogastrone LH LS  MSAn exfolliative disease of skin, characterized by flaccid bullae and spreading erythema so that the skin has the appearance of being scalded; caused by staphylococcal toxins and by a toxic reaction to various drugs. PM65 HN65(64) MHÑEpidermal Necrolysis, Toxic ANdo not use /chem ind MNC17.174.380.410; C20.543.206.380.410; C21.613.276.505.410 XSLYELL'S SYNDROME LH LS  MSNonvascular layer of the skin. Made up, from within outward, of five layers: 1) basal layer (stratum basale epidermidis), 2) spinous layer (stratum spinosum epidermidis), 3) granular layer (stratum granulosum epidermidis), 4) clear layer (stratum lucidum epidermidis), and 5) horny layer (stratum corneum epidermidis). PM78 HN78 MHÑEpidermis ANemphasis of article or discuss must be on this outermost avascular layer of the skin as epidermis & not as substitute for SKIN; most clin articles will be on SKIN; only /anal /anat /cytol /drug eff /enzymol /metab /pathol /physiol /rad eff /ultrastruct PISkin (66-77) MNA10.272.497 LH  PM70 HN70 MHÑEpidermitis, Exudative, of Swine ANdo not use /vet; don't forget also SWINE (NIM) & check tag ANIMAL PISwine Diseases (66-69) MNC22.905.382 XSGREASY PIG DISEASE LH LS  MSAn autosomal recessive trait with impaired cell-mediated immunity. Infections occur with about 15 human papillomaviruses, four of which lead to skin neoplasms. Disease begins in childhood with red papules and later spreads over the body as gray/yellow scales. PM87 HN87 MHÑEpidermodysplasia Verruciformis PIPapillomaviruses (78-86); Skin Diseases (66-86); Skin Neoplasms (68-86); Tumor Virus Infections (72-86); Warts (66-86) MNC2.256.925.345; C2.928.914.345; C4.619.935.914.345; C17.838.930.345 XSLewandowsky-Lutz Disease LH LS  MHÑEpidermolysis Bullosa MNC16.131.831.493; C17.816.410; C17.827.493 XSAcantholysis Bullosa LH LS  MSA deuteromycetous fungal genus which grows in the epidermis and is the cause of tinea. MHÑEpidermophyton ANdo not use /anat /embryol /microbiol /parasitol; infection = EPIDERMOPHYTOSIS MNB5.354.318.286; B5.354.381.546.340 LH  MHÑEpididymis ANNIM when used in fat-pad tissue studies; diseases: coord IM with TESTICULAR DISEASES (NIM); inflammation = EPIDIDYMITIS MNA5.360.444.849.286 LH  MHÑEpididymitis MNC12.294.199 LH  MSSpace between the dura mater and the walls of the vertebral canal. HN(79) MHÑEpidural Space ANNIM: usually locational so few qualif apply; do not use /innerv PIDura Mater (66-78); Meninges (66-78); Spinal Canal (66-78); Spinal Cord (66-78) MNA2.835.232.834.803.350 DMÑSpinal Canal LH LM  MSThin leaf-shaped cartilage, covered with mucous membrane, at the root of the tongue, which folds back over the entrance to the larynx, covering it, during the act of swallowing. MHÑEpiglottis ANinflammation = EPIGLOTTITIS MNA2.165.507.411; A4.329.591.411 LH  HN(84) MHÑEpiglottitis PILaryngitis (66-83) MNC8.730.368.351 DMÑLaryngitis LH LM  MHÑEpilepsy ANGEN; note specifics below; jacksonian epilepsy = JACKSONIAN SEIZURE MNC10.228.140.490 FXÑConvulsions; ÑKindling (Neurology) LH LX;  MSSeizures with a specific site of origin. OLsearch JACKSONIAN SEIZURE 1970-76 PM77; was indexed under JACKSONIAN SEIZURE 1970-76 HN77; was see JACKSONIAN SEIZURE 1975-76, was see under JACKSONIAN SEIZURE 1970-74 MHÑEpilepsy, Focal PIJacksonian Seizure (66-76) MNC10.228.140.490.207 XSEpilepsy, Partial LH LS  OL╥generalized╙ as opposed to ╥focal╙ ( = EPILEPSY, FOCAL) MH*Epilepsy, Generalized (Non Mesh) MNC10.228.140.490.234 LH  MHÑEpilepsy, Grand Mal ANcalled ╥major epilepsy╙ MNC10.228.140.490.234.225 LH  MSA progressive encephalopathy characterized by myoclonic jerks, mental retardation and ataxia. Occurs usually at puberty. The most significant pathological findings are Lafora's inclusion bodies, which contain mucopolysaccharides. PM77 HN77 MHÑEpilepsy, Myoclonus PIEpilepsy (66-76); Myoclonus (66-76) MNC10.228.140.490.234.248 XSLafora Disease; Lundborg-Unverricht Syndrome; Myoclonic Epilepsy, Progressive LH LS; ;  MHÑEpilepsy, Petit Mal ANcalled ╥minor epilepsy╙; PETIT MAL STATUS is see STATUS EPILEPTICUS MNC10.228.140.490.234.270 XSAbsence; Akinetic Petit Mal; Pyknolepsy LH LS; ;  PM64 HN64 MHÑEpilepsy, Temporal Lobe MNC10.228.140.490.207.301 XSEPILEPSY, PSYCHIC EQUIVALENT; EPILEPSY, PSYCHOMOTOR; Epilepsy, Abdominal; Epilepsy, Partial Complex; Epilepsy, Uncinate LH LS; ; ; ;  MHÑEpilepsy, Traumatic AN= ╥post-traumatic╙ MNC10.228.140.490.283; C21.866.460.152.411 LH  OLsearch ISOMERASES 1966-74 HN(75) MHÑEpimerases ANdo not use /analogs /defic /physiol RNEC 5.1.- MND8.586.399.461 DMÑIsomerases LH LM  MS3-Methoxy-estra-1,3,5(10)-triene-16 alpha,17 alpha-diol. A synthetic steroid with estrogenic activity. HN(75) MHÑEpimestrol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7004-98-0 PIEstranes (72-74); Hydroxysteroids (72-74); Methyl Ethers (72-74) MND4.808.365.415.200; D6.597.378.340 DMÑEstrenes LH LM  MS4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol. The active sympathomimetic hormone from the adrenal medulla in most species; stimulates both the alpha and beta adrenergic systems; causes systemic vasoconstriction and gastrointestinal relaxation; stimulates the heart, dilates bronchi and cerebral vessels; used in asthma and cardiac failure and to delay absorption of local anesthetics. Synonyms: Adnephrin; Adrenal; Drenamist; Epinal; Epirenan; Hemostatin; Levorenin; Nephidrine; Renoform; Supracapsulin; Suprarenin. MHÑEpinephrine AN/biosyn /physiol permitted RN51-43-4 MND2.92.311.461; D16.116.327; D16.538.348; D16.893.116.182.348; D16.893.116.348.286; D18.222.863.348 XSADRENALINE XUÑMetanephrine LH LS LU  MHÑEpiphyses MNA2.835.232.251 LH  PM67 HN67 MHÑEpiphyses, Slipped PIBone Diseases (66); Epiphyses (66) MNC5.116.425 XSEPIPHYSIOLYSIS FXÑCartilage Diseases LH LS LX  MS4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine. A pyrimidinyl pyrazole with possible antipyretic, analgesic and anti-inflammatory activity. Synonyms: Anti-Inflammatory 553; DA 389; Mebron. HN(76) MHÑEpirizole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN18694-40-1 PIPyrazoles (72-75); Pyrimidines (72-75) MND3.383.694.200; D3.383.742.200; D14.73.278.309; D26.74.75.420 XSMepirizole; Methopyrimazole DMÑPyrazoles LH LS; LM  MSAn incision of the posterior vaginal wall and a portion of the pudenda which enlarges the vaginal introitus to facilitate delivery and prevent lacerations. MHÑEpisiotomy ANdo not use /util except by MeSH definition MNE4.819.774.457.328 LH  MHÑEpispadias ANdo not use /congen MNC16.131.666.680.836.493; C16.131.939.374 LH  MSA form of gene interaction whereby one gene interferes with the phenotypic expression of another nonallelic gene or genes. Genes whose expression is altered by nonallelic genes are said to be ╥hypostatic╙ or to exhibit ╥hypostasis╙. PM79 HN79 MHÑEpistasis, Genetic ANno qualif PIGenes, Dominant (68-78); Genetics (66-67); Phenotype (68-78) MNG5.735.340 XSDeviation, Epistatic; Epistatic Deviation; Genes, Epistatic; Genes, Hypostatic; Hypostasis, Genetic; Interaction Deviation LH LS; ; ; ; ;  MHÑEpistaxis MNC9.603.261; C23.542.244 XSNOSEBLEED LH LS  MS17 alpha-Hydroxy-androst-4-ene-3-one. A naturally occurring stereoisomer of testosterone with androgenic activity. HN(75) MHÑEpitestosterone AN/biosyn /physiol permitted RN481-30-1 PITestosterone (69-74) MND4.808.54.79.429.824.275; D6.472.79.864.250; D6.472.866.154.864.250 DMÑTestosterone LH LM  OLsearch PERIODONTIUM 1969-74 HN(75) MHÑEpithelial Attachment MNA14.254.646.374 DMÑPeriodontium LH LM  OL= EPITHELIUM /CY; see note under EPITHELIUM for searching EPITHELIAL CELLS 1966-77 HNwas EPITHELIAL CELLS 1965-77 (Prov 1965-71) MH*Epithelial Cells (Non Mesh) MNA11.436 LH  OLuse EPITHELIUM /CY + EPITHELIUM /qualif to search EPITHELIAL CELLS /same qualif 1972-77, e.g., search EPITHELIAL CELLS /DE under EPITHELIUM /CY + EPITHELIUM /DE PMEPITHELIAL CELLS was heading 1972-77 HNEPITHELIAL CELLS was heading 1972-77 MHÑEpithelium ANalmost never IM: IM probably the specific organ; do not use /abnorm /class /growth /inj /innerv MNA10.272 FXÑCilia LH LX  HN(72) MHÑEPN ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN2104-64-5 PIInsecticides (66-71) MND2.719.376; D5.723.491.657.386 DMÑInsecticides, Organothiophosphate LH LM  MHÑEponyms ANIM; no qualif MNL1.143.506.598.400.556.536 LH  MSCatalyze reversibly the formation of an epoxide or arene oxide from a glycol or aromatic diol, respectively. OLuse EPOXIDE HYDROLASES to search EPOXIDE HYDRATASES back thru 1975 PM81; was EPOXIDE HYDRATASES 1978-80, was EPOXIDE HYDRATASES see under HYDRO-LYASES 1975-77 HN81; was EPOXIDE HYDRATASES 1978-80, was EPOXIDE HYDRATASES see under HYDRO-LYASES 1975-77 MHÑEpoxide Hydrolases ANdo not use /analogs RNEC 3.3.2.3 PIEthers, Cyclic (64-74); Hydro-Lyases (66-74) MND8.586.277.340 XSEpoxide Hydrases; Epoxide Hydratases LH LS;  OLsearch ETHERS, CYCLIC 1966-74 HN(75) MHÑEpoxy Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: EPOXY CPDS MND2.355.291.411 XSEpoxides DMÑEthers, Cyclic LH LS LM  PM68 HN68(66) MHÑEpoxy Resins AND25-26 qualif MND25.720.716.822.461 LH  MSA species of Herpesviridae cultivated from cultures of Burkitt's lymphoma; thought to be the causative agent of infectious mononucleosis. OLuse EPSTEIN-BARR VIRUS to search BURKITT'S LYMPHOMA VIRUS back thru 1969 (as Prov 1969-72) PM78; was BURKITT'S LYMPHOMA VIRUS 1973-77 HN78; was BURKITT'S LYMPHOMA VIRUS 1969-77 (Prov 1969-72) MHÑEpstein-Barr Virus ANdo not use /blood-csf-urine /cytol; infection = BURKITT'S LYMPHOMA or INFECTIOUS MONONUCLEOSIS or HERPESVIRUS INFECTIONS (IM) + EPSTEIN-BARR VIRUS (NIM) or TUMOR VIRUS INFECTIONS (IM) + EPSTEIN-BARR VIRUS (NIM) PIHerpesviridae (66-68); specific disease/MI (66-68) MNB4.909.204.382.275; B4.909.574.204.290 XSBurkitt Herpesvirus; Burkitt's Lymphoma Virus; E-B VIRUS; EBV; Infectious Mononucleosis Virus LH LS; ; ; ;  MS3-Hydroxyestra-1,3,5(10),6,8-pentaen-17-one. A naturally occurring steroid with estrogenic activity obtained from the urine of pregnant mares. HN(75) MHÑEquilenin AN/biosyn /physiol permitted; /analogs NIM only; do not confuse with EQUILIN RN517-09-9 PIEstranes (73-74); Hydroxysteroids (74); 17-Ketosteroids (69-74) MND4.808.365.415.215; D4.808.578.502.470; D6.472.265.240; D6.472.866.540.240 DMÑ17-Ketosteroids LH LM  MHÑEquilibrium ANonly /drug eff /rad eff MNG11.427.342; G11.561.796.541.328 LH  MS3-Hydroxyestra-1,3,5(10)7-tetraen-17-one. A naturally occurring steroid with estrogenic activity obtained from the urine of pregnant mares. HN(75) MHÑEquilin AN/biosyn /physiol permitted; /analogs NIM only; do not confuse with EQUILENIN RN474-86-2 PIEstranes (73-74); Hydroxysteroids (74); 17-Ketosteroids (69-74) MND4.808.365.415.220; D4.808.578.502.475; D6.472.265.245; D6.472.866.540.245 DMÑ17-Ketosteroids LH LM  MSA species of Herpesviridae causing coital exanthema in horses. HN(75); was see under HERPESVIRUSES 1975-80 MHÑEquine Coital Exanthema Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with HERPESVIRUS INFECTIONS (IM) MNB4.909.204.382.300 XSCoital Exanthema Virus, Equine; ECE Virus DMÑHerpesviridae LH LS; LM  MSAn unclassified virus disease of equines, characterized by intermittent fever, depression, weakness and anemia. PM70 HN70 MHÑEquine Infectious Anemia ANdo not use /vet; don't forget also HORSES (NIM) & check tag ANIMAL PIHorse Diseases (66-69); Virus Diseases (66-69) MNC2.782.327; C2.839.375; C22.488.304 XSSwamp Fever LH LS  MSA spherical virus causing acute and chronic infection in horses; chronic infection often consists of acute episodes with remissions and has been reported in man. MHÑEquine Infectious Anemia Virus ANdo not use /blood-csf-urine /cytol; DF: EQUINE INFECT ANEMIA VIRUS MNB4.909.777.287 XSSwamp Fever Virus LH LS  MSThe etiologic agent of a disease in horses causing abortion. May also cause respiratory catarrh in young horses. HN(75); was see under HERPESVIRUSES 1975-80 MHÑEquine Rhinopneumonitis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with HERPESVIRUS INFECTIONS (IM) MNB4.909.204.382.325 XSEquine Abortion Virus; Equine Herpesvirus 1 DMÑHerpesviridae LH LS; LM  MSThis virus causes a disease of horses with rhinitis, pharyngitis, and fever. HN(75) MHÑEquine Rhinovirus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with PICORNAVIRUS INFECTIONS (IM) MNB4.909.777.618.775.400 XSEquine Respiratory Virus; Rhinovirus, Equine DMÑRhinoviruses LH LS; LM  OLpre-explosion = EQUIPMENT AD SUPPLIES (PX) MHÑEquipment and Supplies ANGEN only: prefer /instrum: Manual 19.5+; when GEN & IM, only /econ /stand /vet; Manual 26.34+; DF: EQUIPMENT MNE7 XSAPPARATUS AND INSTRUMENTS; Devices; Medical Devices FXÑCATALOGS, COMMERCIAL XUÑEmergency Medical Tags LH LS; ; LX LU  OLuse EQUIPMENT AND SUPPLIES, HOSPITAL to search HOSPITAL EQUIPMENT AND SUPPLIES back thru 1966 PM78; was HOSPITAL EQUIPMENT AND SUPPLIES 1963-77 HN78; was HOSPITAL EQUIPMENT AND SUPPLIES 1963-77 MHÑEquipment and Supplies, Hospital ANcovers wide range from furnaces to surgical dressings; only /econ /stand /supply; /organ = MATERIALS MANAGEMENT, HOSPITAL; DF: EQUIPMENT HOSPITAL MNE7.430 XSHospital Equipment and Supplies FXÑPurchasing, Hospital LH LS LX  MSThe presence of an infectious agent on instruments, prostheses, or other inanimate articles. PM85 HN85 MHÑEquipment Contamination ANonly /econ /prev MNG3.850.540 LH  PM82 HN82 MHÑEquipment Design ANNIM; coord with specific equip (IM) or specific techn /instrum (IM); only /econ /stand /vet MNE5.320 XSDesign, Equipment; Device Design; Medical Device Design FXÑDental Prosthesis Design; ÑProsthesis Design LH LS; ; LX;  MSFailure of equipment to perform up to standards. May be due to defects or improper use. PM82 HN82 MHÑEquipment Failure ANNIM; coord with specific equip (IM) or specific techn /instrum (IM); only /econ /vet MNE5.325 XSDefects, Equipment; Device Failure; Equipment Alarm Systems; Failure, Equipment; Malfunction, Equipment; Medical Device Failure; Misuse, Equipment XUÑProsthesis Failure LH LS; ; ; ; ; ; LU  MSFreedom of equipment from actual or potential hazards. PM82 HN82 MHÑEquipment Safety ANNIM; coord with specific equip (IM) or specific techn /instrum (IM) MNE5.330 XSDevice Safety; Hazards, Equipment; Medical Device Safety; Safety, Equipment LH LS; ; ;  MSToxins isolated from the venom of Laticauda semifasciata, a sea snake (Hydrophid); immunogenic, basic polypeptides of 62 amino acids, folded by four disulfide bonds, block neuromuscular end-plates irreversibly, thus causing paralysis and severe muscle damage; they are similar to Elapid neurotoxins. HN(73); was see under SNAKE VENOMS 1975-77 MHÑErabutoxins ANtoxins from venom of a sea snake; do not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS MND24.185.965.850.480.345 DMÑHydrophid Venoms LH LM  MHÑErbium ANEr-166; do not use /analogs /biosyn /defic /physiol; Er-162, 164, 167, 168, 170 = ERBIUM (IM) + ISOTOPES (NIM); Er-158-161, 163, 165, 169, 171, 172 = ERBIUM (IM) + RADIOISOTOPES (IM) RN7440-52-0 MND1.268.282; D1.552.550.255 LH  OLuse ERGOCALCIFEROL to search VITAMIN D 2 back thru 1966 PM67; was VITAMIN D 2 1963-66 HN67; was VITAMIN D 2 1963-66 MHÑErgocalciferol AN/defic permitted but coord also with VITAMIN D DEFICIENCY (NIM) RN50-14-6 MND4.808.247.222.474; D4.808.247.808.412; D4.808.812.537; D10.516.851.439; D11.786.763.462 XSCALCIFEROL; VITAMIN D 2 LH LS;  PM69 HN69 MHÑErgolines ANdo not use /analogs /biosyn /defic /physiol PIErgonovine (66-68); Ergot Alkaloids (66-68); Ergotamine (66-68); Lysergic Acid Diethylamide (66-68); Methylergonovine (66-68); Methysergide (66-68) MND3.132.327.287; D3.549.439 XUÑLergotrile Mesylate; ÑLisuride; ÑLysergic Acid; ÑMethergoline; ÑNicergoline LH LU; ; ; ;  OLto search ERGONOVINE DERIVATIVES use ERGONOVINE /AA back thru 1975 & ERGOLINES 1969-74 PM65; ERGONOVINE DERIVATIVES was see under ERGONOVINE 1975-77, was see under ERGOLINES 1969-74 HN65; ERGONOVINE DERIVATIVES was see under ERGONOVINE 1975-77, was see under ERGOLINES 1969-74 MHÑErgonovine ANdo not use /biosyn /defic /physiol; ergonovine derivatives = ERGONOVINE /analogs RN60-79-7 MND3.132.327.287.262; D3.549.439.262; D6.472.583.328 XSERGOMETRINE; Ergobasin; Ergometrin LH LS; ;  OLsearch VITAMIN D 1967-71 & ERGOCALCIFEROL 1966 PM74; was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66 HN74(72); was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66 MHÑErgosterol ANdo not use /defic /physiol RN57-87-4 PIErgocalciferol (66); Vitamin D (67-71) MND4.808.247.222.537; D4.808.247.808.756.287; D11.786.763.562 LH  MHÑErgot Alkaloids ANdo not use /analogs /defic /physiol; /pois = ERGOTISM MND3.132.327; D16.848.115.287 LH  MHÑErgot Alkaloids, Hydrogenated ANdo not use /analogs /biosyn /defic /physiol MND3.132.327.412; D16.848.115.287.329 LH  MHÑErgotamine ANdo not use /biosyn /defic /physiol; /analogs = ERGOTAMINE DERIVATIVES RN113-15-5 MND3.132.327.287.362; D3.549.439.362; D16.848.115.287.495 LH  MSAnalogs and derivatives of ergotamine. OLsearch ERGOLINES 1969-74 PM78; was see under ERGOTAMINE 1975-77, was see under ERGOLINES 1969-74 HN78(75); was see under ERGOTAMINE 1975-77, was see under ERGOLINES 1969-74 MHÑErgotamine Derivatives ANdo not use /analogs /biosyn /defic /physiol PIErgolines (69-74); Ergotamine (66-74) MND3.132.327.287.362.412; D3.549.439.362.412 LH  MHÑErgothioneine ANdo not use /biosyn /defic /physiol RN497-30-3 MND2.886.489.225; D3.132.327.537 XSTHIONEINE LH LS  MHÑErgotism AN= ergot poisoning; do not use /chem ind MNC21.613.327; C21.613.756.262 FXÑMycotoxins LH LX  MHÑErotica ANonly /hist MNL1.178.362 XSPORNOGRAPHY LH LS  MScis-13-Docosenoic Acids. 22-Carbon monounsaturated, monocarboxylic acids. HN(75) MHÑErucic Acids ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids, Unsaturated (73-74) MND2.241.81.436.250; D10.516.251.355.300 XSDocosenoic Acids DMÑFatty Acids, Unsaturated LH LS LM  MHÑEructation MNC23.888.821.297 XSBELCHING LH LS  MHÑErwinia ANin plants MNB3.475.300.300 LH  MHÑErysipelas ANcaused by a Streptococcus; do not confuse with ERYSIPELOID, caused by Erysipelothrix; do not confuse with SWINE ERYSIPELAS, also an Erysipelothrix infection MNC1.252.890.328; C17.838.292 LH  MHÑErysipeloid ANcaused by ERYSIPELOTHRIX; do not confuse with ERYSIPELAS, caused by a Streptococcus MNC1.252.334.329 LH  MHÑErysipelothrix ANdo not use /blood-csf-urine; infection = ERYSIPELOTHRIX INFECTIONS MNB3.500.463 LH  MSInfections with bacteria of the genus Erysipelothrix. PM68; SWINE ERYSIPELAS was see under ERYSIPELOID 1963-67 HN68 MHÑErysipelothrix Infections ANusually animal: do not use /vet but check tag ANIMAL PIErysipeloid (66-67) MNC1.252.334; C22.331 XUÑSwine Erysipelas LH LU  MHÑErythema ANredness of the skin from various causes: do not confuse with ERYTHRODERMA & do not make diagnoses: use the word of the text; note specifics below; prickly heat: index under MILIARIA MNC17.229 LH  MSTuberculosis cutis indurativa; hard subcutaneous nodules that frequently break down, forming necrotic ulcers. Synonym: Bazin's disease. OLsearch TUBERCULOSIS, CUTANEOUS 1966-74 HN(75) MHÑErythema Induratum MNC1.252.40.552.846.583.329; C17.838.887.329 DMÑTuberculosis, Cutaneous LH LM  MHÑErythema Multiforme MNC17.816.475 FXÑREITER'S DISEASE LH LX  MHÑErythema Nodosum ANerythema nodosum leprosum (ENL) = ERYTHEMA NODOSUM (IM) + LEPROSY (IM) MNC17.229.413 LH  MSA chronic bacterial infection of major folds of the skin, caused by Corynebacterium minutissimum. OLsearch NOCARDIA INFECTIONS 1966-74 HN(75); was see under NOCARDIA INFECTIONS 1963-76 MHÑErythrasma MNC1.252.246.430 DMÑCorynebacterium Infections LH LM  MSA genus of leguminous shrubs or trees, mainly tropical, yielding certain alkaloids, lectins, and other useful compounds. HN(86)63 MHÑErythrina ANdo not use /isol /pathogen MNB6.560.331 DMÑPlants, Medicinal LH LM  PM73 HN73(65) MHÑErythritol ANdo not use /biosyn /defic /physiol RN149-32-6 MND9.203.853.329; D2.33.800.329 LH  MHÑErythrityl Tetranitrate ANdo not use /biosyn /defic /physiol RN7297-25-8 MND18.918.287 LH  MSA virus causing progressive anemia and weakness in domestic and wild fowl. OLsearch AVIAN LEUKOSIS VIRUSES 1966-74 HN(75); was see under AVIAN LEUKOSIS VIRUS 1963-74 MHÑErythroblastosis Virus, Avian ANdo not use /blood-csf-urine /cytol; infection: coord NIM with AVIAN LEUKOSIS (IM) MNB4.909.574.807.112.175.263; B4.909.777.731.112.175.263 DMÑAvian Leukosis Viruses LH LM  MHÑErythroblastosis, Fetal ANdo not use /congen; erythroblastosis, non-fetal may be ERYTHREMIC MYELOSIS but be careful; do not confuse with HEMORRHAGIC DISEASE OF NEWBORN MNC13.703.277.60; C15.378.120.413; C16.614.304; C16.614.330.60; C20.188.413 XSHEMOLYTIC DISEASE OF NEWBORN; ICTERUS GRAVIS NEONATORUM FXÑJAUNDICE, NEONATAL; ÑRH Isoimmunization; ÑRH-HR Blood-Group System LH LS; LX; ;  MSImmature nucleated erythrocytes. PM84; was see under ERYTHROCYTES 1975-83 HN84(75); was see under ERYTHROCYTES 1975-83 MHÑErythroblasts ANA 11 qualif & /class PIErythrocytes (66-74) MNA11.118.413.200; A15.145.229.413.200 LH  MSA genus of the family Cercopithecidae consisting of one species. Patas prefers flat open arid country in Africa. OLuse ERYTHROCEBUS PATAS to search PATAS MONKEYS back thru 1975 HN(81); was PATAS MONKEYS see under MONKEYS 1975-80 MHÑErythrocebus patas ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.468.602 XSMonkey, Patas DMÑCercopithecidae LH LS LM  MSHigh molecular weight (1,500,000 to 3,000,000) hemoglobins found in the plasma of many polychete and oligochete annelid worms and various mollusks. They bind one mole of oxygen per heme and function as oxygen carriers. HN(77) MHÑErythrocruorins ANin plasma of various annelids & mollusks; do not use /analogs /blood PIHemeproteins (73-76) MND12.776.124.400.220; D12.776.422.512.260 DMÑHemoglobins LH LM  MSAggregation of erythrocytes probably resulting from changes in the negative surface charge (zeta potential) of the cells caused by the dielectric effect of proteins in the surrounding plasma, especially asymmetric macromolecules like fibrinogen and gamma globulin. PM76 HN76 MHÑErythrocyte Aggregation ANonly /drug eff /rad eff; coord with disease /blood, not disease /physiopathol PIErythrocytes (66-75) MNE1.223.459.360; G9.188.420 LH  PM65 HN65(64) MHÑErythrocyte Aggregation, Intravascular ANdo not confuse with DISSEMINATED INTRAVASCULAR COAGULATION MNC15.378.329 XSIntravascular Agglutination LH LS  PM67 HN67(65) MHÑErythrocyte Aging ANonly /drug eff /rad eff; = erythrocyte survival; coord with disease /blood, not /physiopathol MNG9.188.454 LH  MHÑErythrocyte Count ANNIM; only /drug eff /instrum /methods /rad eff /vet; coord with disease /blood, not /physiopathol MNE1.223.459.107.330; G7.380.107.330 XSErythrocyte Number LH LS  MSAbility of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature. PM85 HN85 MHÑErythrocyte Deformability ANnote category: ╥ability of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature╙; only /drug eff /rad eff; do not confuse with ERYTHROCYTES, ABNORMAL: deformability is a normal desirable characteristic of erythrocytes; coord with disease /blood, not /physiopathol PIErythrocytes (66-84); Erythrocytes, Abnormal (68-84) MNG9.188.470 XSErythrocyte Filterability LH LS  MSPathologic inclusions occurring in erythrocytes. OLsearch ERYTHROCYTES, ABNORMAL 1968-74 HN(75) MHÑErythrocyte Inclusions ANA 11 qualif except /cytol MNA11.118.413.330.340; A15.145.229.413.330.340 XSHowell-Jolly Bodies DMÑErythrocytes, Abnormal LH LS LM  MSQuantification of size and cell hemoglobin content or concentration of the erythrocyte, usually derived from erythrocyte count, blood hemoglobin concentration, and hematocrit. Includes the mean cell volume (MCV), mean cell hemoglobin (MCH), and mean cell hemoglobin concentration (MCHC). Use also for cell diameter and thickness. PM80 HN80 MHÑErythrocyte Indices ANemphasis here is on determinative technics; do not confuse with ERYTHROCYTES /cytol where emphasis is on structure; MCV for mean cell volume or mean corpuscular volume goes here; only /drug eff /rad eff /vet; coord with disease /blood, not /physiopathol PIErythrocyte Count (66-79); Erythrocyte Volume (78-79); Erythrocytes (66-79); Erythrocytes, Abnormal (68-79); Hematocrit (66-79); Hemoglobins (66-79) MNE1.223.459.380; G9.188.490 XSErythrocyte Hemoglobin, Mean Cell; Erythrocyte Size Determination; Erythrocyte Volume, Mean Cell; Hemoglobin, Erythrocyte, Mean Cell; Red Cell Indices LH LS; ; ; ;  MSThe semipermeable outer portion of the red corpuscle. It is known as a 'ghost' after hemolysis. PM84; was see under ERYTHROCYTES 1977-83 HN84(77); was see under ERYTHROCYTES 1977-83 MHÑErythrocyte Membrane ANA 11 qualif except /cytol PIErythrocytes (66-76) MNA11.118.413.270; A11.195.356; A15.145.229.413.270 XSErythrocyte Ghost; Red Cell Ghost LH LS;  MSVolume of circulating erythrocytes. Usually measured by radioisotope dilution technic. PM78 HN78 MHÑErythrocyte Volume ANonly /drug eff /rad eff; restrict to total amt of circulating erythrocytes: do not use for size of individual erythrocytes (use ERYTHROCYTES /cytol); note ERYTHROCYTE VOLUME, PACKED below & ERYTHROCYTE INDICES with its X refs above; coord with disease /blood, not /physiopathol PIErythrocytes (66-77) MNG9.188.313.370; G9.330.612.214.370 XSRed Cell Mass LH LS  MHÑErythrocytes AN/abnorm = ERYTHROCYTES, ABNORMAL; /cytol: consider also X refs under ERYTHROCYTE INDICES; do not use /inj; A 11 qualif & /class; /pathol permitted: do not equate with ERYTHROCYTES, ABNORMAL; nucleated erythrocytes in circulating blood = ERYTHROCYTES /pathol; packed red cell volume = HEMATOCRIT; ERYTHROCYTE DEFORMABILITY is available: see definition above; pure or primary red cell aplasia = RED CELL APLASIA, PURE; erythrocyte antibodies = BLOOD GROUPS /immunol & do not index under ERYTHROCYTES MNA11.118.413; A15.145.229.413 LH  PM68; MEGALOBLASTS was see under ERYTHROCYTES 1963-74 HN68 MHÑErythrocytes, Abnormal ANA 11 qualif & /class; = abnorm of size & shape; do not equate with ERYTHROCYTES /pathol: see above; coord with disease /blood, not /compl PIErythrocytes (66-67) MNA11.118.413.330; A15.145.229.413.330 XUÑAcanthocytes; ÑErythrocyte Inclusions; ÑMegaloblasts; ÑSpherocytes LH LU; ; ;  MHÑErythroderma ANredness of the skin: do not confuse with ERYTHEMA & do not make diagnoses: use the word of the text MNC17.240 LH  MSA myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. OLuse ERYTHROLEUKEMIA to search ERYTHREMIC MYELOSIS back thru 1966 PM73; ERYTHREMIC MYELOSIS was heading 1963-83 HN73(68); ERYTHREMIC MYELOSIS was heading 1963-83 MHÑErythroleukemia ANFriend erythroleukemia cells: coord IM with FRIEND VIRUS (NIM) PIErythremic Myelosis (66-67) MNC4.834.276; C15.378.190.636.276 XSDi Guglielmo's Disease; Erythremic Myelosis LH LS;  MSDisease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness. MHÑErythromelalgia MNC14.907.375 XSErythermalgia LH LS  MHÑErythromycin ANdo not use /defic /physiol RN114-07-8 MND20.85.312 XUÑErythromycin Estolate LH LU  MSLauryl sulfate salt of propionic ester of erythromycin. Found to cause jaundice. Essential hepatotoxic property is due to the propionyl ester linkage at the 2' position. Synonyms: Eromycin; Ilosone; Lauromicina. HN(75) MHÑErythromycin Estolate ANdo not use /biosyn /defic /physiol RN3521-62-8 PIErythromycin (70-74); Propionates (74); Sodium Dodecyl Sulfate (74) MND20.85.312.300 XSErythromycin Propionate Dodecyl Sulfate; Erythromycin Propionate Lauryl Sulfate DMÑErythromycin LH LS; LM  MHÑErythroplasia ANprecancerous dis of the mucous membranes MNC4.834.288 LH  MHÑErythropoiesis ANonly /drug eff /rad eff MNG9.188.544.414 LH  MHÑErythropoietin AN/biosyn /physiol permitted RN11096-26-7 MND24.185.251 LH  MSA 4-carbon aldose sugar. Include both D and L isomers. HN(75) MHÑErythrose ANdo not use /defic /physiol; /analogs NIM only RN1758-51-6 PITetroses (69-74) MND9.203.546.805.250 DMÑTetroses LH LM  MS2',4',5',7'-Tetraiodofluorescein, disodium salt. A vital stain and coloring agent used in dentistry to disclose plaque; as tissue stain and dye in foods and pharmaceuticals; may inhibit some enzymes; is preferentially absorbed by certain tumor cells. Synonyms: FD&C Red No. 3; C.I. Acid Red 51; C.I. 45430; erythrosine BS; erythrosine B. HN(79) MHÑErythrosine AND25-26 qualif; /analogs NIM only; do not confuse with Erythrocin, a brand of ERYTHROMYCIN RN568-63-8 PIFluoresceins (66-78) MND26.408.348.514.335 XSTetraiodofluorescein DMÑFluoresceins LH LS LM  MSInnate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy. OLuse ESCAPE REACTION to search FLIGHT REACTION back thru 1968 PM68 HN68; FLIGHT REACTION was see under ESCAPE REACTION 1968-78 MHÑEscape Reaction ANhuman & animal; only /drug eff /physiol /rad eff PIBehavior, Animal (66-67); Fear (66-67) MNF1.145.113.448; F1.145.367 XSFlight Reaction FXÑAvoidance Learning LH LS LX  PMALKALESCENS-DISPAR GROUP was see under SHIGELLA 1974, was see under ENTEROBACTERIACEAE 1968-73 MHÑEscherichia ANdo not use /blood-csf-urine MNB3.475.300.325 XUÑAlkalescens-Dispar Group LH LU  MHÑEscherichia Coli ANdo not use /blood-csf-urine; COLIFORM BACILLI see ENTEROBACTERIACEAE; DF: E COLI MNB3.475.300.325.300 LH  MHÑEscherichia Coli Infections ANDF: E COLI INFECTIONS or E COLI INFECT MNC1.252.310.330 LH  MSAescigenin-(2-methyl-3-acetoxybutyrate)-(2-xylosido 4-glucosidoglucuronoside). Saponin occurring in the seed of the horse chestnut tree. Inhibits edema formation and decreases vascular fragility. Synonyms: Feparil; Reparil; Aescusan. HN(75) MHÑEscin ANdo not use /defic /physiol; /analogs NIM only RN6805-41-0 PIGlycosides (71-74); Saponins (71-75) MND9.203.408.782.250 XSAescin DMÑSaponins LH LS LM  OLsearch BIOFLAVONOIDS 1966-74 HN(75) MHÑEsculin AN/analogs NIM only RN531-75-9 MND9.203.408.134.289; D11.786.170.264 DMÑBioflavonoids LH LM  MSAn ethnic group of the Mongoloid racial stock inhabiting primarily arctic areas. MHÑEskimos ANIM; only /class /hist /psychol; Eskimos are of the MONGOLOID RACE; specify geog if pertinent; as ethnic group: Manual 30.8-30.10, 34.9 MNI1.76.201.450.416.247; I1.880.143.522.247; M1.194.247 LH  MSDisorder of lower esophagogastric motility due to failure of the lower esophageal sphincter to relax with swallowing. Associated with degeneration of the ganglion cells of the myenteric plexus or of the vagal motor nuclei. OLuse ESOPHAGEAL ACHALASIA to search CARDIOSPASM back thru 1966 PM85; was ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-84, was ACHALASIA see under CARDIOSPASM 1963-73; CARDIOSPASM was heading 1963-84 HN85; was ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-84, was ACHALASIA see under CARDIOSPASM 1963-73; CARDIOSPASM was heading 1963-84 MHÑEsophageal Achalasia ANX ref CARDIOSPASM refers to spasm of the cardia, not the heart; not for esophageal spasm: index under ESOPHAGEAL DISEASES (IM) + SPASM (NIM) MNC6.306.300 XSAchalasia, Esophageal; Cardiospasm; Megaesophagus LH LS; ;  MSSubmucosal varices of the lower esophagus or gastric fundus mucosa, frequently caused by the development of portal collateral vessels consequent to portal hypertension. OLuse ESOPHAGEAL AND GASTRIC VARICES to search ESOPHAGEAL VARICES back thru 1966 PM85; was ESOPHAGEAL VARICES 1963-84 HN85; was ESOPHAGEAL VARICES 1963-84 MHÑEsophageal and Gastric Varices ANdo not specify esophageal or gastric aspect unless particularly discussed; hemorrhaging esophageal or gastric varices: coord IM with HEMORRHAGE, GASTROINTESTINAL (IM) MNC6.306.582; C6.552.494.414; C14.907.489.430.414 XSEsophageal Varices; Gastric Varices LH LS;  PM70 HN70(66) MHÑEsophageal Atresia ANdo not use /congen MNC16.131.314.330 FXÑEsophageal Diseases LH LX  MHÑEsophageal Cyst AN/anal /blood supply /secret /ultrastruct permitted MNC4.182.281; C6.306.316 LH  PM66 HN66 MHÑEsophageal Diseases ANinflamm dis = ESOPHAGITIS; hemorrhage: coord IM with HEMORRHAGE, GASTROINTESTINAL (NIM); esophageal spasm: coord IM with SPASM (NIM); esophageal varix or varices = ESOPHAGEAL AND GASTRIC VARICES & see note there MNC6.306 FXÑESOPHAGEAL ATRESIA XUÑBarrett Esophagus LH LX LU  MSSaccular, outward protrusions of all or a portion of the esophageal wall from the lumen of the esophagus. MHÑEsophageal Diverticula ANinflamm divertic or diverticulitis: coord IM with DIVERTICULITIS (NIM) MNC6.306.354 XSDiverticulosis, Esophageal LH LS  MSAbnormal passage communicating with the esophagus. MHÑEsophageal Fistula ANfistula policy: Manual 23.25+; esophagotracheal fistula = TRACHEOESOPHAGEAL FISTULA MNC6.306.392 FXÑFistula LH LX  MHÑEsophageal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.306; C4.588.443.353; C6.306.430 LH  MHÑEsophageal Perforation ANcaused by dis or inj; esophageal rupture does not go here: index ESOPHAGUS /inj (IM) + RUPTURE (NIM) or ESOPHAGEAL DISEASES (IM) + RUPTURE, SPONTANEOUS (NIM) MNC6.306.468; C21.866.348 LH  MSStricture of the esophagus. MHÑEsophageal Stenosis ANcaustic stenosis is indexed ESOPHAGEAL STENOSIS /chem ind + BURNS, CHEMICAL; esophageal stricture goes here MNC6.306.544 LH  MSInflammation, acute or chronic, of the esophagus caused by bacteria, chemicals, or trauma. MHÑEsophagitis ANnote ESOPHAGITIS, REFLUX & ESOPHAGITIS, PEPTIC below MNC6.306.620 LH  MSInflammation of the esophagus caused by reflux of acid-peptic gastric juice. MHÑEsophagitis, Peptic MNC6.306.780.414; C6.405.613.306 XSEsophagitis, Reflux LH LS  PM66 HN66(64) MHÑEsophagogastric Junction ANdiseases: coord IM with ESOPHAGEAL DISEASES (NIM); neopl: coord IM with STOMACH NEOPLASMS or ESOPHAGEAL NEOPLASMS (IM) depending on text MNA3.365.414; A3.492.766.330 XSEsophageal Sphincter LH LS  MHÑEsophagoplasty ANdo not use /util except by MeSH definition MNE4.765.355 LH  MSEndoscopic examination of the esophagus. MHÑEsophagoscopy ANNIM; do not use /util except by MeSH definition MNE1.184.289; E1.418.393 LH  MHÑEsophagus AN/blood supply: esophageal varix or varices = ESOPHAGEAL AND GASTRIC VARICES & see note there; /surg: consider also ESOPHAGOPLASTY; inflammation = ESOPHAGITIS; hemorrhage = ESOPHAGEAL DISEASES (IM) + HEMORRHAGE, GASTROINTESTINAL (NIM); rupture: index under ESOPHAGUS /inj (IM) + RUPTURE (NIM) or ESOPHAGEAL DISEASES (IM) + RUPTURE, SPONTANEOUS (NIM); esophageal spasm: index under ESOPHAGEAL DISEASES (IM) + SPASM (NIM); esophageal stricture = ESOPHAGEAL STENOSIS; peristalsis of the esophagus = ESOPHAGUS /physiol (IM) + PERISTALSIS (NIM); esophageal intubation = ESOPHAGUS (IM) + INTUBATION (IM); esophageal obturator airway = ESOPHAGUS (IM) + INTUBATION /instrum (IM) MNA3.365 LH  MSStrabismus in which the deviating eye looks inwards towards the nose. OLsearch STRABISMUS 1975-79 HN(80); was see STRABISMUS 1975-79 MHÑEsotropia ANdo not confuse with EXOTROPIA PIStrabismus (66-79) MNC11.841.352 XSConvergent Strabismus; Strabismus, Convergent DMÑStrabismus LH LS; LM  MS8-Chloro-6-phenyl-4H-s-trizolo[4,3-a][1,4]benzodiazepine. A benzodiazepine with anticonvulsant, hypnotic and muscle relaxant properties. Has been shown in some cases to be more potent than diazepam or nitrazepam. OLuse ESTAZOLAM to search D 40TA back thru 1975 HN(80); was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79 MHÑEstazolam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN29975-16-4 PIBenzazepines (72-74); Triazoles (72-74) MND3.438.79.80.250; D15.236.872.659.191.344 XSD 40TA DMÑBenzodiazepine Tranquilizers LH LS LM  MHÑEsterases ANdo not use /analogs /defic /physiol RNEC 3.1. MND8.586.277.352 LH  MSThe process of converting an acid into an alkyl or aryl derivative. Most frequently the process consists of the reaction of an acid with an alcohol in the presence of a trace of mineral acid as catalyst or the reaction of an acyl chloride with an alcohol. Esterification can also be accomplished by enzymatic processes. HN(76) MHÑEsterification ANalmost never IM; no qualif PIEsters (68-75) MNH1.181.404.475 DMÑChemistry, Organic LH LM  HN(68) MHÑEsters ANNIM; avoid qualif: never use /analogs: Manual 25.30 PIspecific acid; specific alcohol MND2.241.400 DMÑCarboxylic Acids LH LM  MSEstra-1,3,5(10)-triene-3,15 alpha,16 alpha,17 beta-tetrol. A metabolite of estradiol in man, with estrogenic properties. HN(75) MHÑEstetrol ANdo not use /biosyn /defic /physiol RN15183-37-6 PIEstriol (73-74) MND4.808.365.415.331.320; D6.472.265.365.320; D6.472.866.540.365.320 DMÑEstriol LH LM  MSThe branch of philosophy dealing with the nature of the beautiful; includes beauty, esthetic experience, esthetic judgment, esthetic aspects of medicine, etc. OLuse ESTHETICS to search BEAUTY 1966 PM67; was BEAUTY 1963-66 HN67; was BEAUTY 1963-66 MHÑEsthetics ANonly /class /hist MNF2.463.785.477; K1.752.210 XUÑBeauty LH LU  PM65 HN65 MHÑEsthetics, Dental ANonly /class /hist /stand MNE6.420 LH  HN(66) MHÑEstivation ANonly /drug eff /rad eff MNG7.62.415 DMÑAdaptation, Physiological LH LM  MHÑEstonia MNZ1.542.248.950.140.360; Z1.950.140.360 LH  PM/therapeutic use was ESTRADIOL, THERAPEUTIC 1965 HN/therapeutic use was ESTRADIOL, THERAPEUTIC 1965 MHÑEstradiol AN/physiol permitted; /antag = ESTRADIOL ANTAGONISTS RN50-28-2 MND4.808.365.415.248; D6.472.265.265; D6.472.866.540.265 XS17Beta-Estradiol; Estradiol Benzoate; Estradiol-17Beta LH LS; ;  MSCompounds which inhibit or antagonize the biosynthesis or action of estradiol. PM78 HN78 MHÑEstradiol Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: ESTRADIOL ANTAG PIEstradiol (66-77) MND6.347.300.292 LH  MSCatalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. OLuse ESTRADIOL DEHYDROGENASES to search ESTRADIOL DEHYDROGENASE back thru 1975 HN(78); was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77 MHÑEstradiol Dehydrogenases ANdo not use /analogs RNEC 1.1.1.62 PIHydroxysteroid Dehydrogenase (73-74); Estradiol (73-74) MND8.586.682.47.436.375.280 DMÑ17-Hydroxysteroid Dehydrogenases LH LM  MSEstra-1,3,5(10)-triene-3,17-diol-3-N(bis-[2-chloroethyl]) carbamate-17-dihydrogenphosphate. A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. Synonyms: Estracyt; NSC 89199; Leo 299. OLuse ESTRAMUSTINE to search ESTRAMUSTINPHOSPHATE back thru 1975 HN(80); was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79 MHÑEstramustine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2998-57-4 PICarbamates (72-74); Estranes (72-74); Nitrogen Mustard Compounds (72-74); Organophosphorus Compounds (73-74) MND2.455.526.728.650.275; D4.808.365.415.248.320; D22.204.585.342 XSEstramustinphosphate DMÑNitrogen Mustard Compounds LH LS LM  PM68 HN68 MHÑEstranes ANdo not confuse with ESTRENES; do not use /analogs /biosyn /defic /physiol MND4.808.365 XS19-Norandrostanes LH LS  MSSteroids with methyl groups at carbon-13, with no carbon at carbon 10 and with no more than one carbon at carbon-17. Must contain one or more double bonds. OLsearch ESTRANES 1973-74 PM75; was see under ESTRANES 1973-74 HN75; was see under ESTRANES 1973-74 MHÑEstrenes ANdo not confuse with ESTRANES; do not use /analogs /biosyn /defic /physiol PIEstranes (68-74) MND4.808.365.415 XS19-Norandrostenes XUÑAllylestrenol; ÑEpimestrol; ÑTrenbolone LH LS LU; ;  MHÑEstriol AN/physiol permitted RN50-27-1 MND4.808.365.415.331; D6.472.265.365; D6.472.866.540.365 XUÑEstetrol LH LU  MSCompounds which inhibit or antagonize the action or biosynthesis of estrogen. PM78 HN78 MHÑEstrogen Antagonists ANdo not use /analogs /biosyn /defic /physiol; DF: ESTROGEN ANTAG PIEstrogens (66-77); specific estrogen MND6.347.300 XSAntiestrogens LH LS  MHÑEstrogenic Substances, Conjugated ANdo not use /analogs /defic /physiol MND6.472.265.465; D6.472.866.540.465 XUÑPremarin LH LU  PM/therapeutic use was ESTROGENS, THERAPEUTIC 1965 HN/therapeutic use was ESTROGENS, THERAPEUTIC 1965 MHÑEstrogens AN/biosyn /physiol permitted; do not use /analogs; /antag = ESTROGEN ANTAGONISTS; /defic: consider also HYPOGONADISM & other gonadal disorders in Cat C19; /chem syn permitted: do not convert to ESTROGENS, SYNTHETIC MND6.472.265; D6.472.866.540; D7.360.276.210.277.332 LH  MSNon-steroidal compounds with estrogenic activity. PM75 HN75 MHÑEstrogens, Non-Steroidal ANdo not use /analogs /biosyn /defic /physiol PIEstrogens (66-74) MND6.597.350 LH  MSCompounds obtained by chemical synthesis which possess estrogenic activity, but differ in structure from naturally occurring estrogens. PM75 HN75 MHÑEstrogens, Synthetic ANdo not use /analogs /biosyn /defic /physiol; /antag permitted: do not use ESTROGEN ANTAGONISTS; do not confuse with ESTROGENS /chem syn; DF: ESTROGENS SYN PIEstrogens (66-74) MND6.597.378; D7.360.276.210.443.332 XSEstrogen Analogs LH LS  MHÑEstrone AN/physiol permitted RN53-16-7 MND4.808.365.415.414; D4.808.578.502.497; D6.472.40.502.497; D6.472.265.565; D6.472.866.540.565 XUÑHydroxyestrones LH LU  MHÑEstrus ANmammal only except human; qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /rad eff; note spelling: estrous cycle but estrus MNG8.520.780.218 XSEstrous Cycle XUÑAnestrus; ÑDiestrus; ÑMetestrus; ÑProestrus LH LS LU; ; ;  MSMethods for recognition of the state of estrus. HN(75) MHÑEstrus Detection ANanimal only; only /instrum /methods MNE5.820.150.360 DMÑBreeding LH LM  MSOccurrence or induction of estrus in all of the females in a group at the same time, applies only to animals. PM76; was see under ESTRUS 1975 HN76(75); was see under ESTRUS 1975 MHÑEstrus Synchronization ANanimal only; only /drug eff /rad eff PIEstrus (66-74) MNE5.820.150.370; G8.520.780.218.268 LH  MS1-Ethyl-4-[(1-methylethylidene)hydrazino]-1H-pyrazolo (3,4-b)pyridine-5-carboxylic acid, ethyl ester. A potent phosphodiesterase inhibitor. OLuse ETAZOLATE to search SQ 20009 back thru 1976 HN(80); was SQ 20009 see under NICOTINIC ACIDS 1976-79 MHÑEtazolate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN35838-58-5 PIHydrazines (73-75); Nicotinic Acids (75); Pyrazoles (73-75); Pyridines (73-74) MND3.66.515.400; D3.383.725.547.400; D8.373.735.400 XSSQ 20009 DMÑNicotinic Acids LH LS LM  MS6,9-Diamino-2-ethoxyacridine lactate. A topically applied anti-infective agent. Synonyms: Acrolactine; Ethodin; Hectalin; Rimaon; Rivanol. HN(75) MHÑEthacridine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN442-16-0 PIAcridines (68-74); Lactates (68-74); Diamines (73-74) MND3.494.46.250.450; D20.187.255 DMÑAcridines LH LM  PM66 HN66(63) MHÑEthacrynic Acid ANdo not use /biosyn /defic /physiol RN58-54-8 MND19.770.224.658 LH  PM68 HN68(63) MHÑEthambutol ANdo not use /biosyn /defic /physiol RN74-55-5 MND2.92.782.258.368.265; D20.338.316 LH  MS1-[p-(2-Diethylaminoethoxy)phenyl]-2-(p-methoxyphenyl)-1-phenylethanol. A non-steroidal estrogen antagonist. HN(75) MHÑEthamoxytriphetol ANdo not use /biosyn /defic /physiol RN67-98-1 PIAlcohol, Ethyl (69-74); Phenyl Ethers (74); Diethylamines (74) MND2.33.57.270; D6.347.300.300 DMÑAlcohol, Ethyl LH LM  MS2,5-Dihydroxybenzenesulfonic acid compound with diethylamine (1:1). Benzenesulfonate derivative used as a systemic hemostatic. Synonyms: Aglumin; Altodar; Dicynene; Dicynone; E141; MD 141. HN(75) MHÑEthamsylate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2624-44-4 PIBenzenesulfonates (74); Hydroquinones (74) MND2.241.866.540.244.222.250; D2.455.426.559.389.97.250; D2.886.610.244.222.250; D19.461.270.463.340 XSCyclonamine DMÑBenzenesulfonates LH LS LM  PM73 HN73 MHÑEthane ANdo not use /biosyn /defic /physiol RN74-84-0 PIAlkanes (66-72) MND2.455.326.146.379 LH  MSCatalyzes the deamination of ethanolamine to acetaldehyde. HN(75) MHÑEthanolamine Ammonia-Lyase ANdo not use /analogs RNEC 4.3.1.7 PIAmmonia-Lyases (73-74); Ethanolamines (73-74) MND8.586.520.161.300 XSEthanolamine Deaminase DMÑAmmonia-Lyases LH LS LM  MSCDPethanolamine:1,2-diacylglycerol ethanolaminephosphotransferase. Catalyzes reversibly the transfer of phosphoethanolamine from CDP-ethanolamine to diacylglycerol to yield phosphatidylethanolamine (cephalin) and CMP. The enzyme is found in the endoplasmic reticulum. Synonym: phosphoethanolamine transferase. EC 2.7.8.1. HN(79) MHÑEthanolaminephosphotransferase ANdo not use /analogs RNEC 2.7.8.1 PIAmino Alcohols (66-72); Ethanolamines (73-78); Phosphotransferases (66-78) MND8.586.913.696.220 DMÑPhosphotransferases LH LM  PM73 HN73 MHÑEthanolamines ANdo not use /analogs /biosyn /defic /physiol PIAmino Alcohols (66-72) MND2.33.57.291; D2.33.329.291; D2.92.63.291 XSAminoethanols XUÑClenbuterol; ÑDeanol; ÑMidodrin LH LS LU; ;  PM66 HN66(63) MHÑEthchlorvynol ANdo not use /biosyn /defic /physiol RN113-18-8 MND2.33.440.335; D14.591.745.379 XSEthchlorovynol; Ethchlorvinol LH LS;  MS1,N-6-Ethenoadenosine triphosphate. A fluorescent analog of adenosine triphosphate. HN(75) MHÑEthenoadenosine Triphosphate ANdo not use /biosyn /defic /physiol PIAdenosine Triphosphate (72-74); Imidazoles (72-74) MND13.695.667.138.236.250; D13.695.827.68.236.250 DMÑAdenosine Triphosphate LH LM  OLsearch ETHYL ETHERS 1966-74 HN(75)63-64; was see under ETHYL ETHER 1965-73 MHÑEther, Ethyl AN= ╥ether╙; do not use /biosyn /defic /physiol; /analogs NIM only RN60-29-7 MND2.355.417.332; D14.166.302 XSDiethyl Ether; Ethyl Ether DMÑEthyl Ethers LH LS; LM  PMETHOGLUCID was see under ALKYLATING AGENTS 1967-74 MHÑEthers ANnot for ╥ether╙ (= ETHER, ETHYL); do not use /analogs /biosyn /defic /physiol MND2.355 XUÑEthoglucid LH LU  MHÑEthers, Cyclic ANdo not use /analogs /biosyn /defic /physiol MND2.355.291 XUÑEpoxy Compounds LH LU  MSThe philosophy or code pertaining to what is ideal in human character and conduct. MHÑEthics ANonly /class /hist; coord with religion (IM or NIM) or geog if pertinent MNF1.829.233; K1.316; K1.752.256 XSDeontological Ethics; Metaethics; Situational Ethics; Teleological Ethics; Utilitarianism FXÑConfidentiality; ÑHuman Rights XUÑEthics, Institutional LH LS; ; ; ; LX; LU  MHÑEthics, Dental ANonly /hist; specify geog if pertinent MNK1.316.333.266; K1.752.622.416 LH  MSThe moral and ethical obligations or responsibilities of institutions. HN(Aug 77) MHÑEthics, Institutional ANonly /hist; coord IM with type of institution (IM); specify geog if pertinent MNK1.316.190 DMÑEthics LH LM  MHÑEthics, Medical ANonly /hist; specify geog if pertinent MNK1.316.333.366; K1.752.667.416 FXÑHUMAN EXPERIMENTATION XUÑHelsinki Declaration LH LX LU  MHÑEthics, Nursing ANonly /hist; specify geog if pertinent MNK1.316.333.466; K1.752.712.416 XSNursing Ethics LH LS  OLuse ETHICS, PHARMACY to search ETHICS, PHARMACEUTICAL back thru 1966 PM68; was ETHICS, PHARMACEUTICAL 1963-67 HN68; was ETHICS, PHARMACEUTICAL 1963-67 MHÑEthics, Pharmacy ANonly /hist; specify geog if pertinent MNK1.316.333.566 LH  PM68 HN68 MHÑEthics, Professional ANonly /hist; specify geog if pertinent PIEthics (66-67) MNK1.316.333 LH  PM74 HN74(72) MHÑEthidium ANdo not use /biosyn /defic /physiol RN3546-21-2 PIAntiprotozoal Agents (66-71); Antiviral Agents (66-71); Phenanthridines (69-71); appropriate enzyme/AI (68-71) MND3.494.633.416; D8.373.379; D21.370.884.266 XSEthidium Bromide LH LS  MHÑEthinyl Estradiol ANdo not use /biosyn /defic /physiol RN57-63-6 MND4.808.668.651.568.291; D6.597.378.379; D7.360.276.210.443.332.291 XSETHYNYL ESTRADIOL LH LS  OLuse ETHIODIZED OILS to search ETHIODOL back thru 1966 (as Prov 1966-72) PM78; was ETHIODOL 1973-77 HN78; was ETHIODOL 1964-77 (Prov 1964-72) MHÑEthiodized Oils AND25-26 qualif MND1.396.661.601.300; D10.516.627.700.550.300; D26.298.423.416; J1.740.700.550.300 XSEthiodol LH LS  MSS-2-(3-Aminopropylamino)ethyl phosphorothioic acid. A phosphorothioate proposed as a radiation-protective agent; it causes splenic vasodilation and may block autonomic ganglia. OLuse ETHIOFOS to search WR 2721 back thru 1977 HN(85); was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-84 MHÑEthiofos ANdo not use /biosyn /defic /physiol; /analogs NIM only RN20537-88-6 PIDiamines (74-76); Organothiophosphorus Compounds (72-76) MND2.719.400; D26.763.500 XSGammaphos; WR 2721 DMÑOrganothiophosphorus Compounds LH LS; LM  PM64; was ETHIONIAMIDE 1963 HN64; was ETHIONIAMIDE 1963 MHÑEthionamide ANdo not use /biosyn /defic /physiol RN536-33-4 MND3.66.349.220; D3.383.725.394.220; D20.338.366 XSAmidazine; Ethioniamide LH LS;  MS2-Amino-4-(ethylthio)butyric acid. Antimetabolite, methionine antagonist that interferes with amino acid incorporation into proteins and with cellular ATP utilisation; also produces liver neoplasms. MHÑEthionine RN13073-35-3 MND12.125.166.388; D26.87.325; D26.191.325 LH  MHÑEthiopia MNZ1.58.183.229 XSEritrea LH LS  PM65 HN65 MHÑEthisterone ANdo not use /biosyn /defic /physiol RN434-03-7 MND4.808.745.745.379; D6.597.799.322 XSANHYDROHYDROXYPROGESTERONE; PREGNENINOLONE LH LS;  OLuse ETHMOID BONE to search CRIBRIFORM PLATE back thru 1966 HNCRIBRIFORM PLATE was see under ETHMOID BONE 1963-78 MHÑEthmoid Bone ANfractures: coord ETHMOID BONE /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with SKULL NEOPLASMS (IM) MNA2.835.232.781.292 XSCribriform Plate LH LS  MSNumerous small thin-walled spaces or air cells in the ethmoid bone, where they form an ethmoidal labyrinth. MHÑEthmoid Sinus ANinflammation or sinusitis: coord NIM with SINUSITIS (IM); fractures: coord ETHMOID SINUS /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with PARANASAL SINUS NEOPLASMS (IM) MNA4.621.267 LH  MSA group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. PM68 HN68 MHÑEthnic Groups ANIM; only /class /hist /psychol; policy: Manual 30.8-.10, specify geog: Manual 36.8; with /hist: Manual 34.9; with /psychol: Manual 30.9 & see ETHNOPSYCHOLOGY below; don't forget /ethnol is available with Cat Z; Bedouins goes here CATALOG: /geog /form PIEthnology (66-67) MNI1.76.201.450.416; I1.880.143.522; M1.194; N1.224.317 XSNATIONALITY XUÑGypsies LH LS LU  MSThe comparative and theoretical study of culture; often synonymous with cultural anthropology. MHÑEthnology ANonly /educ /hist; Manual 30.6, 30.7; don't forget /ethnol with Cat Z: Manual 19.4.27, 30.9, 30.13 MNI1.76.201.450.457 LH  MSComparative psychology of races and peoples, especially of non-literate peoples. MHÑEthnopsychology ANIM, GEN only; SPEC qualif; for psychol of specific ethnic group, index under ethnic group or race /psychol (IM), as ╥psychol of Italo-Americans╙ = ETHNIC GROUPS /psychol (IM) + ITALY /ethnol (NIM) + UNITED STATES (NIM); Manual 27.16 MNF4.96.628.317 FXÑANTHROPOLOGY, CULTURAL LH LX  MS1,2:15,16-Diepopxy-4,7,10,13-tetraoxahexadecane. Alkylating antineoplastic agent used especially in bladder neoplasms; toxic to har follicles, gastro-intestinal tract and vasculature. Synonyms: AY 62013; Epodil; Epodyl; ICI 32865. HN(65); was see under ALKYLATING AGENTS 1967-74 MHÑEthoglucid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1954-28-5 MND2.355.354; D22.204.416 DMÑEthers LH LM  MSThe discipline pertaining to the study of animal behavior. PM69 HN69 MHÑEthology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of BEHAVIOR, ANIMAL /form PIBehavior, Animal (66-68) MNF4.96.208 FXÑBEHAVIOR, ANIMAL LH LX  MS4-Acetamido-2-ethoxybenzoic acid methyl ester. Inhibitor of folate metabolism; used as a coccidiostat in poultry. HN(77) MHÑEthopabate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN59-06-3 PIAcetamides (73-75); Aminobenzoic Acids (64-76); Benzoates (66-75) MND2.241.223.106.61.300; D21.370.400.348 DMÑAminobenzoic Acids LH LM  HN(72) MHÑEthopropazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN522-00-9 PIAntiparkinson Agents (72); Phenothiazines (72) MND3.494.741.290; D14.307.499; D16.653.342 DMÑPhenothiazines LH LM  PM65 HN65(63) MHÑEthosuximide ANdo not use /biosyn /defic /physiol RN77-67-8 MND2.241.81.337.817.687.333; D2.478.770.333; D3.383.773.812.852.333; D14.261.770.333 XSEthosuccimid LH LS  HN(66) MHÑEthotoin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN86-35-1 MND3.383.374.411.499; D14.261.447.500 DMÑHydantoins LH LM  MS6-Ethoxy-1,2-dihydro-2,2,4-trimethylquinoline. Antioxidant; also a post-harvest dip to prevent scald on apples and pears. Synonyms: Santoquin; Stop-Scald. HN(75) MHÑEthoxyquin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN91-53-2 PIEthyl Ethers (73-74); Quinolines (70-74) MND3.438.810.200 DMÑQuinolines LH LM  MS6-Ethoxy-2-benzothiazolesulfonamide. Carbonic anhydrase inhibitor used as diuretic; also in glaucoma; may cause hypokalemia. Synonyms: Ethamide; Glaucotensil. OLsearch CARBONIC ANHYDRASE INHIBITORS 1966-74 HN(75); was see under CARBONIC ANHYDRASE INHIBITORS 1965-74 MHÑEthoxzolamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN452-35-7 PICarbonic Anhydrase Inhibitors (66-74); Thiazoles (66-74) MND8.373.220.467; D19.770.224.266.467 XSEthoxyzolamide DMÑThiazoles LH LS LM  MHÑEthyl Biscoumacetate ANdo not use /biosyn /defic /physiol RN548-00-5 MND3.438.150.446.520.451; D19.461.119.196.475.349 XSCarbethoxydicoumarol; Ethyldicoumarol LH LS;  MHÑEthyl Chloride ANdo not use /biosyn /defic /physiol RN75-00-3 MND2.455.526.439.447; D14.166.312 LH  OLuse ETHYL ETHERS to search ETHYL ETHER 1966-73 PM74; was ETHYL ETHER 1965-73 HN74; was ETHYL ETHER 1965-73 MHÑEthyl Ethers AN╥ether╙ = ETHER, ETHYL; do not use /analogs /biosyn /defic /physiol MND2.355.417 XSEthoxy Compounds XUÑEther, Ethyl LH LS LU  MSMethanesulfonic acid, ethyl ester. An antineoplastic with alkylating properties. Also acts as a mutagen by effecting damage to DNA. PM80; was see under METHANESULFONATES 1975-79 HN80(75); was see under METHANESULFONATES 1975-79 MHÑEthyl Methanesulfonate ANdo not use /biosyn /defic /physiol RN62-50-0 PIAlkanes (66-73); Methane (66-73); Methanesulfonates (74); Sulfonic Acids (66-73) MND2.241.866.540.121.537.300; D2.455.326.146.92.537.300; D2.455.326.146.571.537.300; D2.886.610.121.537.300; D22.204.418 XSEthyl Mesilate; Ethylmesylate; Ethylmethane Sulfonate; Mesilate, Ethyl LH LS; ; ;  MHÑEthylamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.471 LH  MS1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide. Carbodiimide cross-linking reagent. HN(75) MHÑEthyldimethylaminopropyl Carbodiimide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1892-57-5 PICarbodiimides (73-74); Dimethylamines (73-74) MND2.491.203.425 DMÑCarbodiimides LH LM  MS2-Chloroethanol. Used as a solvent, in the manufacture of insecticides, and for treating sweet potatoes before planting. May cause nausea, vomiting, pains in head and chest, stupefaction. Irritates mucous membranes and causes kidney and liver degeneration. HN(75) MHÑEthylene Chlorohydrin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-07-3 PIAlcohol, Ethyl (69-74); Chlorine (71-74) MND2.33.57.310; D2.33.440.350 XS2-Chlorethanol; 2-Chloroethyl Alcohol DMÑChlorohydrins LH LS; LM  MS1,2-Dibromoethane. Soil fumigant, insecticide, nematocide. In humans causes severe burning of skin, irritation of eyes and respiratory tract. Prolonged inhalation may cause liver necrosis; also used in gasoline; have caused liver and lung cancers in rodents. Synonyms: Bromofume; dibromethane; Dowfume W85; ethylene bromide; glycol dibromide; Soilfume; sym-dibromoethane. OLuse ETHYLENE DIBROMIDES to search ETHYLENE DIBROMIDE back thru 1975 HN77; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76 MHÑEthylene Dibromides ANdo not use /analogs /biosyn /defic /physiol PIBromine (66-73); Hydrocarbons (66); Ethane (74); Hydrocarbons, Brominated (74); Hydrocarbons, Halogenated (66-73) MND2.455.526.368.250; D5.723.491.491.480 XS1,2-Dibromoethanes DMÑHydrocarbons, Brominated LH LS LM  MSToxic, chlorinated, saturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. The latter is considerably more toxic. It has a sweet taste, ethereal odor and has been used as a fumigant and intoxicant among sniffers. Has many household and industrial uses. HN(76) MHÑEthylene Dichlorides ANdo not use /analogs /biosyn /defic /physiol; do not confuse with DICHLOROETHYLENES PIChlorine (74-75); Ethane (74) /AA (75) MND2.455.326.146.379.350; D2.455.526.439.458 XSDichloroethanes DMÑHydrocarbons, Chlorinated LH LS LM  MS1,2-Ethanediol. An ethylene compound substituted with two hydroxyl groups. OLsearch GLYCOLS 1966-74 PM75; was ETHYLENE GLYCOL see under GLYCOLS 1963-74 HN75; was ETHYLENE GLYCOL see under GLYCOLS 1963-74 MHÑEthylene Glycols ANdo not use /analogs /biosyn /defic /physiol PIGlycols (66-74) MND2.33.618.250 XSDihydroxyethanes; Ethanediols LH LS;  MHÑEthylene Oxide ANdo not use /biosyn /defic /physiol RN75-21-8 MND2.355.291.411.417 LH  MSThiocarbamate derivatives whose salts are fungicides. HN(77) MHÑEthylenebis(dithiocarbamates) ANdo not use /analogs /biosyn /defic /physiol PIThiocarbamates (66-76) MND2.241.81.251.869.265; D2.241.866.653.265; D2.886.703.265 DMÑThiocarbamates LH LM  MHÑEthylenediamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.782.258.368 XUÑTriethylenetetramine LH LU  MSEthylenes are derivatives of ethylene which is a simple organic gas of biological origin with many industrial and biological uses; ethylene is becoming less important as an inhalation anesthetic, because it is flammable. Synonyms: ethene; elayl; olefiant gas. OLuse ETHYLENES to search ETHYLENE back thru 1966 PM75; was ETHYLENE 1963-74 HN75; was ETHYLENE 1963-74 MHÑEthylenes ANdo not use /analogs /defic /physiol MND2.455.326.271.367; D14.166.343 FXÑPOLYETHYLENES LH LX  MS2-Imidazolidinethione. A degradation product of ethylenebis(dithiocarbamate) fungicides. It has been found to be carcinogenic and to cause thyroid hyperplasia. HN(77) MHÑEthylenethiourea ANdo not use /biosyn /defic /physiol; /analogs NIM only RN96-45-7 PIImidazoles (74-76); Thiones (74-75); Thiourea (66-76) MND3.383.374.257; D26.191.335 XSImidazolidinethione DMÑImidazoles LH LS LM  PM65 HN65 MHÑEthylestrenol ANdo not use /biosyn /defic /physiol RN965-90-2 MND4.808.668.651.693.223; D6.597.100.194.239 LH  PM66 HN66(64) MHÑEthylmaleimide ANdo not use /biosyn /defic /physiol RN128-53-0 MND2.241.81.337.502.524.418; D2.478.440.418; D3.383.757.399.418; D8.373.830.417 LH  OLuse ETHYLMERCURY CHLORIDE to search ETHYL MERCURY CHLORIDE back thru 1972 (as Prov 1972-74) HN(80); was ETHYL MERCURY CHLORIDE see under ETHYL MERCURY COMPOUNDS 1975-79, was ETHYL MERCURY CHLORIDE 1972-74 (Prov) MHÑEthylmercury Chloride ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-27-7 PIAntifungal Agents (66-71); Mercury (66-71); Mercury Poisoning (66-71); Organometallic Compounds (68-71) MND2.691.750.100.347.417; D5.723.288.50.355.417 XSEthyl Mercury Chloride DMÑEthylmercury Compounds LH LS LM  OLuse ETHYLMERCURY COMPOUNDS to search ETHYL MERCURY COMPOUNDS back thru 1972 (as Prov 1972-73) PM80; was ETHYL MERCURY COMPOUNDS 1974-79 HN80; was ETHYL MERCURY COMPOUNDS 1972-79 (Prov 1972-73) MHÑEthylmercury Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ETHYLMERCURY CPDS PIAntifungal Agents (66-71); Mercury (66-71); Organometallic Compounds (68-71) MND2.691.750.100.347; D5.723.288.50.355 XSEthyl Mercury Compounds; Ethylmercurials XUÑCialit; ÑEthylmercury Chloride; ÑThimerosal LH LS; LU; ;  MS7,8-Didehydro-4,5-alpha-epoxy-3-ethoxy-17-methylmorphinan-6-alpha-ol. Narcotic analgesic and antitussive; metabolized in the liver by ETHYLMORPHINE-N-DEMETHYLASE and used as indicator of liver function. Synonyms: Chloronyl; Cosylan; Diolan; Dionin; Etylin; Tionidel. HN(78) MHÑEthylmorphine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN76-58-4 PIMorphinans (69-74); Morphine (66-68); Morphine Derivatives (75-77) MND3.132.610.422.547.547.430; D3.549.686.575.547.460; D3.605.497.575.547.460; D14.73.153.616.547.487; D14.757.638.547.487 XSCodethyline; Ethomorphine DMÑMorphine Derivatives LH LS; LM  MSA drug-metabolizing enzyme of the hepatic microsomal oxidase system which catalyzes the oxidation of the N-methyl group of ethylmorphine with the formation of formaldehyde. HN(75) MHÑEthylmorphine-N-Demethylase ANdo not use /analogs RNEC 1.5.3.- PIMorphinans (73-74); Oxidoreductases, N-Demethylating (73-74) MND8.586.682.107.582.400 DMÑOxidoreductases, N-Demethylating LH LM  MS1-Ethyl-1-nitrosourea. A nitrosourea compound with alkylating, carcinogenic and mutagenic properties. PM86; was see under NITROSOUREA COMPOUNDS 1975-85 HN86(75); was see under NITROSOUREA COMPOUNDS 1975-85 MHÑEthylnitrosourea AND25-D26 qualif RN759-73-9 PINitrosourea Compounds (73-74) MND2.654.692.300; D2.948.594.310; D26.191.345 XSNitrosoethylurea LH LS  MSalpha[(Ethylamino)methyl]-m-hydroxybenzyl alcohol. Proposed sympathomimetic; used to treat orthostatic hypotension. Synonyms: Effortil; Effontil; Ethyl Adrianol; Kertasin; Pressoton. HN(76) MHÑEthylphenylephrine ANdo not use /biosyn /defic /physiol RN709-55-7 PIEthanolamines (70-74); Phenethylamines (70-74); Phenols (74); Phenylephrine/AA (75) MND2.33.329.291.617.300; D2.92.63.291.617.300; D16.893.116.182.726.356; D16.893.116.348.356 XSEthylnormetaoxedrin; Ethylnorphenylephrine; Etilefrin DMÑPhenylephrine LH LS; ; LM  PM68 HN68(64) MHÑEthynodiol Diacetate ANdo not use /biosyn /defic /physiol RN297-76-7 MND4.808.668.651.693.279; D6.597.799.350; D7.360.276.210.443.706.303 LH  MS2-(Ethylpropylamino)-2',6'-butyroxylidide. Local anesthetic with rapid onset and long action, similar to bupivacaine. Synonyms: Duranest; W 19053. HN(76) MHÑEtidocaine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN36637-18-0 PIAcetanilides (73-74)/AA(75); Ethylamines (74-75); Propylamines (73-75) MND2.65.199.92.325; D14.211.357 DMÑAcetanilides LH LM  MS1-Ethyl-N,N'-dimethyl-1H-imidazole-4,5-dicarboxamide. Russian drug with adrenergic properties. Synonyms: Aethimazole; Ethylnorantifeine. HN(75) MHÑEtimizol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN64-99-3 PIAmides (72-74); Dicarboxylic Acids (72-74); Imidazoles (72-74) MND3.383.374.260 XSEthymisole DMÑImidazoles LH LS LM  MS3-alpha-Hydroxy-5-beta-androstan-17 one. A ketosteroid of mainly human origin; causes fever, immunostimulation and leukocytosis; used to evaluate adrenal cortex function, bone marrow performance and in neoplastic disease for immunostimulation. Synonym: 5-isoandrosterone. PM65 HN65(63) MHÑEtiocholanolone ANdo not use /defic /physiol RN53-42-9 MND4.808.54.40.368; D4.808.578.502.583; D6.472.40.502.583; D6.472.79.500; D6.472.866.154.500; D24.185.733.418 LH  MSPorphyrins with four methyl and four ethyl side chains attached to the pyrrole rings. HN(75) MHÑEtioporphyrins ANdo not use /analogs PIPorphyrins (66-74) MND11.557.727.340 DMÑPorphyrins LH LM  MS(+)-1-(alpha-Methylbenzyl)-imidazol-5-carboxylic acid ethyl ester. Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation or the cardiovascular system; proposed as induction anesthetic. Synonym: R 16,659. PM86; was see under IMIDAZOLES 1977-85 HN86(77); was see under IMIDAZOLES 1977-85 MHÑEtomidate ANdo not use /biosyn /defic /physiol RN33125-97-2 PIBenzyl Compounds (69-75); Imidazoles (69-76) MND3.383.374.265; D14.166.346 LH  MS2-((4-Ethoxyphenyl)methyl)-N,N-diethyl-5-nitro-1H- benzimidazole-1-ethanamine. Narcotic analgesic similar to morphine in action; used mainly to study narcotic habituation, tolerance and withdrawal in laboratory animals. Synonyms: Aethonitazen; etobedolum; etanitazinum; Ba 20684; C 20410; NIH 7607. HN(79) MHÑEtonitazene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN911-65-9 PIBenzimidazoles (66-78) MND3.438.103.425; D14.757.314 XSEtonitazin DMÑBenzimidazoles LH LS LM  MS4'-Demethyl-9-(4,6-O-ethylidene-beta- D-glucopyranosyl)-epipodophyllotoxin. Semisynthetic derivative of podophyllotoxin that inhibits the entry of cells into mitosis, causes a decrease in DNA synthesis, and is effective against some neoplasms. Synonym: NSC 141,540. OLuse ETOPOSIDE to search VP 16-213 back thru 1976 PM87; was see under PODOPHYLLOTOXIN 1981-86, was VP 16-213 see under PODOPHYLLOTOXIN 1976-80 HN87(81); was see under PODOPHYLLOTOXIN 1981-86, was VP 16-213 see under PODOPHYLLOTOXIN 1976-80 MHÑEtoposide ANdo not use /defic /physiol; /biosyn permitted if by plant RN33419-42-0 PIGlucosides (75); Glycosides (73-74); Podophyllotoxin (73-74) /AA (75) MND22.204.179.612.696.339 XSDemethyl Epipodophyllotoxin Ethylidine Glucoside; VP 16-213 LH LS;  MS6,7,8,14-Tetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine. Narcotic analgesic analog of morphinans. HN(75) MHÑEtorphine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN14521-96-1 PIAlcohols, Amyl (73-74); Morphinans (69-74) MND3.132.610.422.270; D3.549.686.320; D3.605.497.320; D14.73.153.265; D14.757.342 XSM99 DMÑMorphinans LH LS LM  MS(+)-2-(2-Ethyl-2-phenyl-1,3-dioxolan-4-yl)-piperidine hydrochloride. Dissociative anesthetic with some cardio-vascular effects. HN(75) MHÑEtoxadrol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN28189-85-7 PIDioxoles (71-74); Piperidines (71-74) MND3.383.246.238.300; D3.383.621.240; D14.166.351 DMÑPiperidines LH LM  MStrans-9-(4-Methoxy-2,3,6-trimethylphenyl)- 3,7-dimethyl-2,4,6,8-nonatetraenoic acid ethyl ester. An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia; may be teratogenic. OLuse ETRETINATE to search RO 10-9359 back thru 1980 PM84; was RO 10-9359 see under TRETINOIN/analogs & derivatives 1980-83 HN84; was RO 10-9359 see under TRETINOIN/analogs & derivatives 1980-83 MHÑEtretinate ANdo not use /biosyn /defic /physiol RN54350-48-0 PITretinoin/AA (75-79); Vitamin A (66-74) MND2.455.849.291.700.780.300; D11.557.261.700.780.300; D26.368.627.666.300 XSRo 10-9359 LH LS  OLuse EUBACTERIUM to search BUTYRIBACTERIUM back thru 1966 PM76; was BUTYRIBACTERIUM 1963-75 HN76; was BUTYRIBACTERIUM 1963-75 MHÑEubacterium ANdo not use /blood-csf-urine MNB3.100.600.500 XSButyribacterium LH LS  MSA genus of Australian trees of the Myrtaceae family that yields gums, oils, and resins which are used as flavoring agents, astringents, aromatics and formerly to treat diarrhea, asthma, bronchitis, and respiratory tract infections. HN(86)63 MHÑEucalyptus ANdo not use /isol /pathogen MNB6.560.343; B6.915.343 DMÑTrees LH LM  MHÑEugenics ANno qualif MNG5.358.368 FXÑGENETIC COUNSELING; ÑGenetics, Medical LH LX;  MHÑEugenol ANdo not use /biosyn /defic /physiol RN97-53-0 MND2.455.849.368; J1.740.700.375 XSClove Oil; Oil of Cloves LH LS;  MHÑEuglena ANdo not use /anat /embryol /microbiol /parasitol MNB1.841.443.320; B5.104.523 LH  MSA species of freshwater flagellate protozoan commonly found in stagnant water. PM72 HN72 MHÑEuglena Gracilis ANdo not use /anat /embryol /microbiol /parasitol PIEuglena (66-71) MNB1.841.443.320.418; B5.104.523.418 LH  MSCells of the higher organisms, containing a true nucleus bounded by a nuclear membrane. HN(78) MHÑEukaryotic Cells ANA 11 qualif with discretion PIappropriate cell, organism, subcellular fraction, or process MNA11.450 DMÑCells LH LM  MHÑEunuchism AN = eunuchoidism; male only; HYPOGONADISM in males permitted: do not interpret as EUNUCHISM: use terminol of author; check tags HUMAN and MALE MNC19.391.482.293 FXÑCastration LH LX  MSAn exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states. MHÑEuphoria ANonly /drug eff /physiol /rad eff MNF1.470.323 LH  MHÑEurope ANeach European country is available as a heading MNZ1.542 LH  MHÑEurope, Eastern ANin translations use spelling: People's Republic, not Peoples' nor Peoples MNZ1.542.248 LH  MSPrimarily an economic union with the principle objectives of free movement of goods, capital and labor. Professional services, social, medical and paramedical, are subsumed under labor. PM76 HN76 MHÑEuropean Economic Community ANonly /hist CATALOG: use NAF entry PIEconomics (66-75); International Cooperation (66-75) MNI1.534.300 XSCommon Market; European Common Market FXÑEconomics LH LS; LX  MHÑEuropium ANEu-153; do not use /analogs /biosyn /defic /physiol; Eu-151 = EUROPIUM (IM) + ISOTOPES (NIM); Eu-144-150, 152, 154-160 = EUROPIUM (IM) + RADIOISOTOPES (IM) RN7440-53-1 MND1.268.294; D1.552.550.292 LH  MHÑEustachian Tube AN╥eustachian╙ is not capitalized in titles or transls MNA9.246.397.369 XSAuditory Tube LH LS  MHÑEuthanasia ANhuman & animal; only /hist /psychol /vet MNC23.240.415 XSMERCY KILLING XUÑEuthanasia, Passive LH LS LU  MSThe withdrawing or withholding of extraordinary means used to prolong life. HN(78) MHÑEuthanasia, Passive ANhuman only; ╥withdrawing or withholding extraordinary means╙ of prolonging life; only /econ /hist /psychol PIEthics, Medical (66-77); Euthanasia (66-77) MNC23.240.415.500 XSAllowing to Die DMÑEuthanasia LH LS LM  MSAbnormalities in thyroid hormone and thyroid stimulating hormone levels, often simulating hypothyroidism, in euthyroid patients suffering some other illness, such as diabetes mellitus or liver cirrhosis. PM87 HN87 MHÑEuthyroid Sick Syndromes ANabnorm thyroid-related hormone levels ╥in euthyroid patients suffering from some other illness╙ MNC19.874.255 XSHigh T4 Syndrome; Low T3 Syndrome; Low T3 and T4 Syndrome LH LS; ;  MSGrowth of a superabundance of algae and other microscopic plant life usually from an enrichment of a natural body of water by the addition of dissolved nutrients, especially nitrogen and phosphorus. It may be natural, induced (water pollution), or controlled (harvesting phytoplankton for food in an aquaculture system). PM76 HN76 MHÑEutrophication ANonly /drug eff /rad eff PIWater Microbiology (66-75); Water Pollution, Chemical (75) MNG4.185.320 XSAlgal Bloom FXÑPlankton; ÑWater Pollution, Chemical LH LS LX;  MSUse for studies determining the effectiveness or value of processes, programs, personnel, and equipment, or for material on conducting such studies. For drugs and devices consider CLINICAL TRIALS, DRUG EVALUATION, and DRUG SCREENING. PM74 HN74(71)(66-67) MHÑEvaluation Studies ANNIM; no qualif; ╥use for studies determining the effectiveness or value of processes, personnel, and equipment╙: do not use for ╥precision╙ or ╥accuracy╙ of various technics; do not use for evaluation of drugs: see all see refs below MNE5.337 XUÑProduct Surveillance, Postmarketing LH LU  MS4,4'-bis(7-(1-Amino-8-hydroxy-2,4-disulfo)naphthylazo)-3,3'-bitolyl tetrasodium salt. An azo dye used in blood volume and cardiac output measurement by the dilution method; it is very soluble, strongly bound to plasma albumin and disappears very slowly. Synonyms: C.I. 2386; C.I. Direct Blue 53; Chlorazol Sky Blue FF; Diamine Sky Blue FF. HN(76) MHÑEvans Blue AND25-26 qualif; /analogs NIM only RN314-13-6 PIAzo Compounds (69-75); Naphthalenesulfonates (74-75) MND2.172.560; D2.241.866.540.244.639.400; D2.886.610.244.639.400; D4.615.638.555.400; D26.408.325 XSAzovan Blue; Azovanum Caeruleum; Diazobleu; T 1824 DMÑAzo Compounds LH LS; ; ; LM  MSThe electric response evoked in the cerebral cortex by stimulation of sensory perceptors or some point on the sensory pathway leading from the receptor to the cortex. PM68 HN68(67) MHÑEvoked Potentials ANNIM; only /drug eff /rad eff PIElectrophysiology (66) MNG7.453.697.100.300; G11.561.450.100.300 XSAntidromic Potentials LH LS  MSThe electric response evoked in the cerebral cortex by acoustic stimulation or stimulation of the auditory pathways. PM80 HN80 MHÑEvoked Potentials, Auditory ANIM; only /drug eff /rad eff PIAcoustic Stimulation (72-79); Auditory Perception (67-79); Electrophysiology (66); Evoked Potentials (67-79); Hearing (66); Perception (66); Sound (66-71) MNG7.453.697.100.300.369; G11.561.450.100.300.369 XSAuditory Evoked Potentials XUÑCochlear Microphonic Potentials LH LS LU  MSThe electric response evoked in the cerebral cortex by stimulation of afferent pathways from peripheral nerves to cerebrum. PM82 HN82 MHÑEvoked Potentials, Somatosensory ANIM; only /drug eff /rad eff PIEvoked Potentials (67-81); Somatosensory Cortex (71-81) MNG7.453.697.100.300.800; G11.561.450.100.300.800 XSSomatosensory Evoked Potentials LH LS  MSThe electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways. PM82 HN82 MHÑEvoked Potentials, Visual ANIM; only /drug eff /rad eff PIEvoked Potentials (67-81); Photic Stimulation (72-81); Visual Cortex (68-81); Visual Perception (66-81) MNG7.453.697.100.300.880; G11.561.450.100.300.880; G11.697.330 XSVisual Evoked Response LH LS  MSThe process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics. MHÑEvolution ANno qualif: Man: see note under PRIMATES MNG4.185.349 LH  MHÑExanthema ANa skin eruption usually chem or viral induced; note EXANTHEMA SUBITUM below; WISSLER'S SYNDROME is also available MNC1.539.359; C17.257 LH  MHÑExanthema Subitum MNC2.321; C17.257.335 XSROSEOLA INFANTUM LH LS  MSRepetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria. OLuse EXCHANGE TRANSFUSION, WHOLE BLOOD to search EXCHANGE TRANSFUSION 1966-80 PM81; was EXCHANGE TRANSFUSION 1963-80 HN81; was EXCHANGE TRANSFUSION 1963-80 MHÑExchange Transfusion, Whole Blood ANdo not use /util except by MeSH definition; do not confuse with PLASMA EXCHANGE (removal & replacement of plasma); TN 186: differentiate from BLOOD TRANSFUSION, AUTOLOGOUS; DF: EXCHANGE TRANSFUSION MNE2.95.135.469 LH  MSUsually inert substances added to a prescription in order to provide suitable consistency to the dosage form; a binder, matrix, base or diluent in pills, tablets, creams, salves, etc. OLsearch PHARMACEUTIC AIDS 1968-74 PM80; was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74 HN80(75); was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74 MHÑExcipients AND25-26 qualif PIPharmaceutic Aids (68-74); Pharmacy (66-67); Vehicles (66-74) MND26.698.931.419 XSEmulsifying Agents; Stabilizing Agents; Suspending Agents LH LS; ;  MSHemodynamic, respiratory, and cardiac function observed following measured strenuous exercise. This test is most frequently used in cardiology in conjunction with an electrocardiogram. PM66 HN66(63) MHÑExercise Test ANNIM; not restricted to use with ECG; do not confuse with HEART FUNCTION TESTS + EXERTION; do not use /util except by MeSH definition MNE1.145.569.418 XSBicycle Ergometry Test LH LS  MSMotion of the body or its parts to relieve symptoms or to improve function, including prescribed physical conditioning leading to PHYSICAL FITNESS, but NOT PHYSICAL EDUCATION AND TRAINING. MHÑExercise Therapy AN╥exercise╙ is not ╥exercise therapy╙: use EXERTION; do not use /util except by MeSH definition MNE2.780.351; E2.831.578.391 XSPhysical Conditioning, Human FXÑPhysical Fitness LH LS LX  OLsearch EXERCISE under EXERTION & SPORTS 1966-74 PMEXERCISE was see under EXERTION & SPORTS 1963-74 HNEXERCISE was see under EXERTION & SPORTS 1963-74; EXERCISE, ISOMETRIC was see under EXERTION 1977-83 MHÑExertion ANonly /drug eff /rad eff; TN 166: exertion as a control state, opposite ╥at rest╙ MNG11.427.394 XSEFFORT; Exercise, Physical; PHYSICAL EFFORT FXÑFATIGUE; ÑSPORTS; ÑWORK LH LS; ; LX; ;  MSProtein exotoxins from Staphylococcus aureus, phage type II, which cause epidermal necrolysis; they are proteins with a molecular weight of 26,000 to 32,000; they cause a condition variously called: Scaled Skin, Lyell or Ritter Syndrome, epidermal exfoliative disease, toxic epidermal necrolysis, etc. HN(78) MHÑExfoliatins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS PIBacterial Proteins (66-76); Bacterial Toxins (77); Staphylococcal Infections (66-77); Toxins (66-76) MND24.185.926.123.353; D24.185.926.275.353 XSDermolysins; Epidermolysins; Epidermolytic Toxins; Exfoliative Toxins DMÑBacterial Toxins LH LS; ; ; LM  MSA disorder in which the act of exposing the genitals to an unsuspecting stranger produces sexual excitement with no attempt at further sexual activity with the stranger. OLsearch PARAPHILIAS 1968-74 HN(75); was see under SEX DEVIATION 1968-80 MHÑExhibitionism ANdo not use /drug eff /physiol /rad eff MNF3.709.597.608.700.190 DMÑParaphilias LH LM  MHÑExhibits ANno qualif MNL1.178.147.269 LH  MSA philosophical doctrine basic to Existential Psychology or Existential Psychiatry. It focuses on the individual's subjective awareness of his style of existence, his intimate interaction with himself, and his environment. OLuse EXISTENTIALISM to search EXISTENTIAL PSYCHOLOGY back thru 1974 HNEXISTENTIAL PSYCHOLOGY was see under EXISTENTIALISM 1974-78 MHÑExistentialism ANonly /hist MNF2.739.418; F4.754.709.294; K1.752.304 XSExistential Psychology LH LS  MS1,4-alpha-D-Glucan glucohydrolase. Catalyzes the hydrolysis of terminal 1,4-linked alpha-D-glucose residues successively from non-reducing ends of polysaccharide chains with the release of beta-glucose. Also able to hydrolyze 1,6-alpha-glucosidic bonds when the next bond in sequence is 1,4. EC 3.2.1.3. HN(78) MHÑExo-1,4-alpha-Glucosidase ANdo not use / analogs; /defic: consider also GLYCOGENOSIS 2 RNEC 3.2.1.3 PIGlucosidases (66-77) MND8.586.277.450.420.200 XSAcid Maltase; Amyloglucosidase; Gamma-Amylase; Glucoamylase; Lysosomal Alpha-Glucosidase DMÑGlucosidases LH LS; ; ; ; LM  PM70 HN70(67) MHÑExocrine Glands ANGEN: prefer specifics; do not use /abnorm /growth /inj /innerv PIspecific anatomic part (66); specific animal (66) MNA10.336 FXÑBARTHOLIN'S GLANDS; ÑBREAST; ÑBULBOURETHRAL GLANDS; ÑLACRIMAL APPARATUS; ÑMAMMAE; ÑPANCREAS; ÑPERIANAL GLANDS; ÑPROSTATE; ÑSALIVARY GLANDS; ÑSEBACEOUS GLANDS; ÑSWEAT GLANDS XUÑScent Glands LH LX; ; ; ; ; ; ; ; ; ; LU  MSCellular release of secretory products within membrane-limited vesicles or granules. PM76; was see under CELLS 1975 HN76(73); was see under CELLS 1975 MHÑExocytosis ANonly /drug eff /rad eff PICells/SE (66-72) MNG4.335.532 LH  MSCatalyze the exonucleolytic cleavage of DNA. Include EC 3.1.11.-. PM83 HN83 MHÑExodeoxyribonucleases ANdo not use /analogs RNEC 3.1.- PIDeoxyribonucleases (66-82); Exonucleases (73-82); Phosphatases (66-72) MND8.586.277.352.630.553.370 LH  MSCoding regions of messenger RNA included in the genetic transcript which survive the processing of RNA in cell nuclei to become part of a spliced messenger of structural RNA in the cytoplasm. OLsearch BASE SEQUENCE 1980-86 PM87; was see BASE SEQUENCE 1980-86 HN87; was see BASE SEQUENCE 1980-86 MHÑExons ANonly /drug eff /rad eff PIBase Sequence (77-86); Genes (77-80); Genes, Structural (77-86) MNG5.331.112.350; G6.184.130.350 LH  PM73 HN73 MHÑExonucleases ANdo not use /analogs RNEC 3.1. PINucleotidyltransferases (66-72); Phosphatases (66-72) MND8.586.277.352.630.553.382 LH  MSA normally saprophytic dematiaceous deuteromycetous fungal genus of the class Hyphomycetes, order Hyphomycetales. Infections in humans include phaeohyphomycosis, peritonitis, and chromoblastomycosis. HN(86) MHÑExophiala ANdo not use /embryol /microbiol /parasitol; infection: coord NIM with MYCOSES (IM) PIDeuteromycetes (66-85); Hyphomycetes (66-85) MNB5.354.381.546.355 XSCladosporium werneckii; Phialaphora jeanselmei; Phialophora gougerotii; Wangiella DMÑHyphomycetes LH LS; ; ; LM  MHÑExophthalmos MNC11.280 LH  MSCatalyze the exonucleolytic cleavage of RNA. Include EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. PM83 HN83 MHÑExoribonucleases ANdo not use /analogs RNEC 3.1.- PIExonucleases (73-82); Phosphatases (66-72); Ribonucleases (66-82) MND8.586.277.352.630.553.395 LH  MHÑExostoses ANcartilaginous & osteocartilaginous exostoses: index under CHONDROMA MNC5.116.466 LH  PM68 HN68 MHÑExostoses, Multiple PIExostoses (66-67) MNC5.116.99.708.351 XSCHONDRODYSPLASIA, HEREDITARY DEFORMING; DIAPHYSEAL ACLASIS; Giedion-Langer Syndrome LH LS; ;  MSToxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. PM78 HN78 MHÑExotoxins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS: coord IM with source of exotoxin (IM or NIM) PIBacterial Toxins (77); Toxins (66-77); specific bacterium MND24.185.926.350 LH  MSStrabismus in which the deviating eye turns templeward. HN(83) MHÑExotropia ANdo not confuse with ESOTROPIA PIStrabismus (66-82) MNC11.841.380 XSDivergent Strabismus; Exodeviation; Strabismus, Divergent DMÑStrabismus LH LS; ; LM  MHÑExpectorants AND25-26 qualif MND23.338.454 XSMUCOLYTIC AGENTS FXÑCough LH LS LX  MSUsually refers to planned scientific data-gathering excursions. MHÑExpeditions ANIM; only /hist MNI3.883.420 LH  MSThe amounts spent by individuals, groups, nations, private or public organizations for total health care and/or its various components. PM68 HN68 MHÑExpenditures, Health ANonly /class /legis /trends CATALOG: /geog /form PIEconomics (66-67); Economics, Medical (66-67) MNN3.219.398 LH  MSComputer programs based on knowledge developed from consultation with experts on a problem, and processing and/or formalizing this knowledge in such a manner that the problems may be solved. PM87 HN87 MHÑExpert Systems ANIM; restrict to field of computer programs & artificial intelligence; no qualif MNL1.700.568.110.65.190 LH  MSPresentation of pertinent medical data by a qualified medical specialist before a court. PM66 HN66 MHÑExpert Testimony ANonly /econ /legis /methods /stand /trends /util MNI1.880.604.583.232; N3.706.535.253 LH  MSThe extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is ERV. HN(75) MHÑExpiratory Reserve Volume ANNIM; no qualif; in texts as ERV MNE1.302.796.420.360 DMÑLung Volume Measurements LH LM  MSTendency to explore or investigate a novel environment; considered a motivation not clearly distinguishable from curiosity. OLuse EXPLORATORY BEHAVIOR to search BEHAVIOR, EXPLORATORY back thru 1966 & CURIOSITY back thru 1969 PM68; was BEHAVIOR, EXPLORATORY 1965-67 HN68; was BEHAVIOR, EXPLORATORY 1965-67; CURIOSITY was see under EXPLORATORY BEHAVIOR 1969-78 MHÑExploratory Behavior ANhuman & animal; only /drug eff /physiol /rad eff MNF1.145.387; F1.658.370 XSCuriosity; Novelty-Seeking Behavior LH LS;  MHÑExplosions ANonly /econ /prev MNG3.230.100.90 FXÑBLAST INJURIES LH LX  MSThe procedure of presenting the conditioned stimulus without reinforcement to an organism previously conditioned; also the diminution of a conditioned response resulting from this procedure. PM65; was EXTINCTION LEARNING 1963-64 HN65; was EXTINCTION LEARNING 1963-64 MHÑExtinction (Psychology) ANonly /drug eff /physiol /rad eff; DF: EXTINCTION MNF2.463.425.770.232 LH  MSA meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere. PM84 HN84 MHÑExtracellular Matrix ANA 11 qualif except /cytol PICells, Cultured (72-83); Extracellular Space (66-83) MNA11.470.310 XSMatrix, Extracellular LH LS  MSInterstitial space between cells, occupied by fluid as well as amorphous and fibrous substances. PM66; EXTRACELLULAR FLUID was see under BODY FLUIDS 1963-65 HN66(64); EXTRACELLULAR FLUID was see under BODY FLUIDS 1963-65 MHÑExtracellular Space ANonly /anal /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff; interstitial fluid goes here; do not confuse X ref EXTRACELLULAR FLUID with BODY WATER MNA11.470; A12.207.395 XSEXTRACELLULAR FLUID; Intercellular Space LH LS;  MSTransmission of hereditary characters by non-chromosomal replicating cytoplasmic structures such as mitochondria, plastids, and plasmids. PM68 HN68 MHÑExtrachromosomal Inheritance ANonly /drug eff /rad eff PIGenetics (66-67) MNG5.225 LH  MSDiversion of blood flow through a circuit located outside the body but continuous with the bodily circulation. OLsearch HEART, MECHANICAL 1966 PM67; was see under HEART, MECHANICAL 1963-66 HN67; was see under HEART, MECHANICAL 1963-66 MHÑExtracorporeal Circulation AN╥diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation╙; GEN & unspecified: prefer specifics; do not confuse with CARDIOPULMONARY BYPASS or ASSISTED CIRCULATION; do not use /util except by MeSH definition PIHeart, Mechanical (66) MNE4.292 LH  MSExtraction of the fetus by means of obstetrical instruments. MHÑExtraction, Obstetrical ANdo not use /util except by MeSH definition MNE4.819.774.457.392 FXÑObstetrical Forceps XUÑVacuum Extraction, Obstetrical LH LX LU  MSVoluntary sexual intercourse between a married person and someone other than the spouse. HN(75) MHÑExtramarital Relations ANno qualif MNF1.145.792.295 DMÑSex Behavior LH LM  MSExtraoral devices for applying force to the dentition in order to avoid some of the problems in anchorage control met with in intermaxillary traction and to apply force in directions not otherwise possible. HN(77) MHÑExtraoral Traction Appliances ANdo not use /instrum /methods /util (except by MeSH definition) PIOrthodontic Appliances, Removable (71-76) MNE6.658.453.578.360 XSChincap, Orthodontic; Face Bow, Orthodontic; Headgear, Orthodontic DMÑOrthodontic Appliances, Removable LH LS; ; LM  MHÑExtrapyramidal Tracts ANdo not use /innerv MNA8.186.854.253; A8.612.380.239 LH  MSPremature contraction of the heart that is independent of the normal rhythm and arises in response to an impulse in some part of the heart other than the sinoatrial node. MHÑExtrasystole MNC14.280.67.470 XSPremature Beat LH LS  MHÑExtraterrestrial Environment ANno qualif; space itself or moon or other planets than Earth MNG3.230.150.200; G3.230.230 FXÑSpace Flight LH LX  MSThe escape of diagnostic or therapeutic material from the vessel into which it is introduced into the surrounding tissue or body cavity. OLuse EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS to search EXTRAVASATION OF CONTRAST MEDIA back thru 1981 PM85; was EXTRAVASATION OF CONTRAST MEDIA 1981-1984 HN85; was EXTRAVASATION OF CONTRAST MEDIA 1981-1984 MHÑExtravasation of Diagnostic and Therapeutic Materials ANnote categ: use only sensible qualif; do not use /chem ind /familial; DF: EXTRAVASATION PIContrast Media (66-80); organ or disease/RA (67-80) MNC21.866.371; C23.399 XSExtravasation of Contrast Media FXÑContrast Media; ÑRadiography LH LS LX;  MSA state in which attention is largely directed outward from the self. OLuse EXTRAVERSION (PSYCHOLOGY) to search EXTROVERSION (PSYCHOLOGY) back thru 1968 PM78; was EXTROVERSION (PSYCHOLOGY) 1968-77 HN78; was EXTROVERSION (PSYCHOLOGY) 1968-77 MHÑExtraversion (Psychology) ANno qualif; DF: EXTRAVERSION PIPersonality (66-67); Psychoanalytic Theory (66-67) MNF1.752.747.246; F2.739.794.253 LH  MHÑExtremities ANTN 75: extremities of animals; TN 117: joints of animals & table of human, primate & non-primate extremities; ulcero-mutilating acropathy: diabetic = DIABETIC NEUROPATHIES, alcoholic = ALCOHOLISM + PERIPHERAL NERVE DISEASES, hereditary = NEUROPATHY, HEREDITARY SENSORY MNA1.378 XSLIMBS LH LS  MHÑExudates and Transudates ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; middle ear effusions = OTITIS MEDIA, SEROUS; DF: EXUDATES MNA12.383 XSTransudates FXÑAscitic Fluid; ÑPERICARDIAL EFFUSION; ÑPleural Effusion LH LS LX; ;  MHÑEye ANarray of eye terms from all categories: Bull 94 (Feb 77); /inj = EYE INJURIES; inflamm of eye = OPHTHALMIA or better -ITIS specifics in C11; eye drops = OPHTHALMIC SOLUTIONS; dryness of the eyes = XEROPHTHALMIA; eye fatigue = EYESTRAIN see ASTHENOPIA; consider terms under OCUL- , OPHTHALM- , OPT- & VIS- CATALOG: form qualif = OPHTHALMOLOGY /form MNA1.456.505.420; A9.371 FXÑINTRAOCULAR PRESSURE; ÑREFRACTION, OCULAR; ÑVISION LH LX; ;  OLconsider also EYE /AB & /AB with specific parts of the eye MH*Eye Abnormalities (Non Mesh) MNC16.131.384 LH  MSCenters for storing various parts of the eye for future use. OLsearch TISSUE BANKS 1966-74 HN(75) MHÑEye Banks ANdo not use /educ MNN2.278.920.421 DMÑTissue Banks LH LM  MHÑEye Burns ANchem burns of eye = EYE BURNS /chem ind (IM) + BURNS, CHEMICAL (IM) MNC21.866.200.503; C21.866.460.589.338.366.337 LH  MSColor of the iris. PM76 HN76 MHÑEye Color AN= color of iris, not the color of the eye as in disease; only /drug eff /genet /rad eff PIColor (66-75) or; Eye (66-75); Iris (66-75) or; Pigmentation (66-75) MNG4.185.672.360; G11.697.340 LH  PM65; was see under OPHTHALMOLOGY 1963-64 HN65; was see under OPHTHALMOLOGY 1963-64 MHÑEye Diseases ANGEN; NIM when specific organ part of eye is IM CATALOG: form qualif = OPHTHALMOLOGY /form MNC11 FXÑOphthalmology XUÑArcus Senilis LH LX LU  MHÑEye Foreign Bodies MNC21.866.460.589.338.366.504; C21.866.392.421 LH  PM87 HN87 MHÑEye Hemorrhage ANGEN or unspecified; CHOROIDAL HEMORRHAGE, HYPHEMA, RETINAL HEMORRHAGE & VITREOUS HEMORRHAGE are also available PIEye or specifics (66-86); Eye Diseases (66-86); Hemorrhage (66-86) MNC11.290; C23.542.290 XSHemophthalmos XUÑChoroidal Hemorrhage LH LS LU  MHÑEye Injuries ANGEN or unspecified; consider also /inj with specific parts of eye; note EYE BURNS is available MNC21.866.460.589.338.366 LH  MHÑEye Manifestations ANeye manifest of non-eye diseases; avoid: prefer more specific terms; no qualif; Manual 23.36+; TN 239: differentiation from EYE DISEASES & when not to use MNC11.300; C23.888.357 LH  MHÑEye Movements ANonly /drug eff /rad eff; do not equate with nystagmography which can be recording of eye movement (EYE MOVEMENTS or ELECTRONYSTAGMOGRAPHY) in physiol exper or in disease or recording of eye movement in NYSTAGMUS, a specific eye disease (NYSTAGMUS + EYE MOVEMENTS or ELECTRONYSTAGMOGRAPHY) MNE1.210.271; G11.697.384 FXÑELECTROOCULOGRAPHY; ÑNYSTAGMUS; ÑSLEEP, REM XUÑConvergence, Ocular; ÑPursuit, Smooth; ÑSaccades LH LX; ; LU; ;  MHÑEye Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific site in eye (IM) + histol type of neopl (IM); CHOROID NEOPLASMS is available MNC4.588.364; C11.319 LH  MSPersonal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation. HN(75); was in Cat E & J 1975-82 MHÑEye Protective Devices ANonly /econ /stand /supply /vet MNE7.712.300 XSGoggles; Safety Glasses; Safety Lenses DMÑProtective Devices LH LS; ; LM  MHÑEye Proteins ANIM; coord with specific protein (IM) & specific part of eye (IM); /physiol permitted; do not use /analogs /defic MND12.776.306 LH  MHÑEye, Artificial ANonly /adv eff /hist /psychol /rehabil /stand MNE4.659.371; E4.792.421; E7.858.565.371 XSOCULAR PROSTHESIS LH LS  MHÑEyebrows MNA1.456.505.420.338; A1.835.288.296 LH  MHÑEyeglasses ANprescription & sun glasses go here but not goggles ( = EYE PROTECTIVE DEVICES); only /econ /hist /stand /supply MNE7.532.504 XSGLASSES; SPECTACLES LH LS;  MHÑEyelashes MNA1.456.505.420.504.421; A1.835.288.421; A9.371.337.338 LH  PM70 HN70 MHÑEyelid Diseases ANGEN; many specifics are available; inflamm dis = BLEPHARITIS PIEye Diseases (66-69); Eyelids (66-69); Skin Diseases (66-69) MNC11.338 XUÑBlepharitis; ÑBlepharospasm LH LU;  PM70 HN70 MHÑEyelid Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIEye Neoplasms (66-69); Eyelids (66-69); Facial Neoplasms (66-69); Skin Neoplasms (66-69) MNC4.588.364.421; C11.319.421; C11.338.526 LH  MHÑEyelids ANptosis = BLEPHAROPTOSIS; inflammation = BLEPHARITIS; spasm = BLEPHAROSPASM; ╥third eyelid╙ = NICTITATING MEMBRANE MNA1.456.505.420.504; A9.371.337 FXÑNICTITATING MEMBRANE XUÑMeibomian Glands LH LX LU  MSA plasmid whose presence in the cell, either extrachromosomal or integrated into the bacterial chromosome, determines the ╥sex╙ of the bacterium, host chromosome mobilization, transfer via conjugation of genetic material, and the formation of sex pili. OLuse F FACTOR to search SEX FACTORS, BACTERIAL back thru 1978 PM78; was see under CONJUGATION, GENETIC 1975-77; SEX FACTOR, BACTERIAL was SEX FACTORS, BACTERIAL see under PLASMIDS 1978-83 HN78(75); was see under CONJUGATION, GENETIC 1975-77; SEX FACTOR, BACTERIAL was SEX FACTORS, BACTERIAL see under PLASMIDS 1978-83 MHÑF Factor ANsex factor of bacteria; only /drug eff /rad eff PIConjugation, Genetic (68-74); Genetics (66-67) MNG5.225.500.300; G5.386.192.300 XSFertility Factor; Resistance Transfer Factor; Sex Factor F; Sex Factor, Bacterial LH LS; ; ;  MHÑFace ANusually NIM as site; soft parts = FACE, bones = FACIAL BONES or specifics; /growth = MAXILLOFACIAL DEVELOPMENT; /inj = FACIAL INJURIES; facial fractures: see note on FACIAL BONES; craniofacial dysmorphism: see note also on FACIAL BONES MNA1.456.505 LH  MSCongenital or acquired asymmetry of the face. PM77 HN77 MHÑFacial Asymmetry ANcongen or acquired; if congen use /congen; do not confuse with FACIAL HEMIATROPHY; hemifacial microsomia goes here PIFace (66-76) MNC23.304.280 LH  MHÑFacial Bones ANconsider specifics; do not confuse with FACE (locational & soft tissue) or its specifics; fractures: coord FACIAL BONES /inj (IM) + SKULL FRACTURES (IM); craniofacial dysmorphism: index under FACIAL BONES /abnorm + SKULL /abnorm but not also under ABNORMALITIES, MULTIPLE MNA2.835.232.781.324 LH  MHÑFacial Dermatoses ANconsider synonym for dermatitis of face & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH; does not include neopl of face ( = FACIAL NEOPLASMS) MNC17.271 LH  MSObservable changes of expression in the face in response to emotional stimuli. Facies, the characteristic expression of a particular condition, is also included in this concept. PMFACIES was see under FACIAL EXPRESSION 1963-73 HNFACIES was see under FACIAL EXPRESSION 1963-73 MHÑFacial Expression ANhuman & animal; no qualif MNE1.706.389; F1.145.209.530.385 XUÑSmiling LH LU  MHÑFacial Hemiatrophy ANdo not confuse with FACIAL ASYMMETRY; hemifacial microsomia goes under FACIAL ASYMMETRY MNC23.304.280.150 XSROMBERG'S DISEASE LH LS  MHÑFacial Injuries ANGEN or unspecified for soft tissue or bony portions of face; consider also /inj with FACIAL BONES or specific facial bones; fractures: see note on FACIAL BONES; TN 115: use of FACIAL INJURIES & jaw inj MNC21.866.460.589.338 LH  PM65 HN65 MHÑFacial Muscles MNA2.633.338; A14.363 XSMimetic Muscles LH LS  MHÑFacial Neoplasms ANusually of soft part of face; not for facial bone neopl ( = FACIAL BONES or specific facial bones (IM) + SKULL NEOPLASMS (IM) ); HEAD AND NECK NEOPLASMS is also available; /anal /blood supply /secret /ultrastruct permitted; coord IM with site (NIM) as merely locational + histol type of neopl (IM) MNC4.588.443.392 LH  MHÑFacial Nerve AN7th cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.324 XUÑGeniculate Ganglion LH LU  PM81 HN81 MHÑFacial Nerve Diseases PIFacial Nerve (66-80); Peripheral Nerve Diseases (66-80) MNC10.772.204.266 LH  MHÑFacial Neuralgia MNC10.772.204.266.234; C10.772.537.472 FXÑFacial Pain LH LX  MSPain in the face including the orofacial and craniofacial regions. PM86 HN86 MHÑFacial Pain PIFace (66-85); Facial Neuralgia (66-85); Pain (66-85); Temporomandibular Joint Syndrome (73-85); Trigeminal Neuralgia (66-85) MNC7.465.300; C10.597.617.363; C23.888.592.612.340 XSPain, Facial FXÑFacial Neuralgia; ÑTemporomandibular Joint Syndrome; ÑTrigeminal Neuralgia LH LS LX; ;  MHÑFacial Paralysis MNC10.597.622.214; C10.772.204.266.297; C23.888.592.636.214 XSBELL'S PALSY LH LS  MH*Facilities, Manpower and Services (Non Mesh) MNN2 LH  MSArchitecture, exterior and interior design, and construction of facilities other than hospitals, e.g., dental schools, medical schools, ambulatory care clinics, and specified units of health care facilities. PM73 HN73(67) MHÑFacility Design and Construction ANonly /econ /hist /legis /man /trends; /stand: consider also BUILDING CODES; TN 104: differentiate from HEALTH FACILITY PLANNING; DF: FACILITY DESIGN CATALOG: /geog /form PIArchitecture (66) MNJ1.86.339; N2.278.200 FXÑHealth Facility Planning XUÑArchitectural Accessibility; ÑBuilding Codes; ÑElevators and Escalators; ÑFloors and Floorcoverings; ÑInterior Design and Furnishings; ÑLocation Directories and Signs; ÑParking Facilities LH LX LU; ; ; ; ; ;  MSFormal voluntary or governmental procedures and standards required of hospitals, health or other facilities to improve operating efficiency, and for the protection of the consumer. PM78 HN78 MHÑFacility Regulation and Control ANonly /econ /stand; coord IM with facility (IM); DF: FACILITY REGULATION CATALOG: /geog /form MNN3.706.280 LH  MSDisorders characterized by physical or psychological symptoms that are not real, genuine, or natural, and which are under voluntary control. PM81 HN81 MHÑFactitious Disorders ANdo not use /drug eff /physiol /rad eff; differentiate from SOMATOFORM DISORDERS: factitious are phys or psychol sympt under voluntary control, somatoform are phys sympt linked to psychol factors but not under voluntary control MNF3.709.438.500 XSGanser Syndrome; Pseudodementia; Pseudopsychosis LH LS; ;  MHÑFactor Analysis, Statistical ANa specific statist technic: not a synonym for ╥analysis of various factors...╙; NIM; no qualif MNH1.548.832.373 LH  MHÑFactor IX ANdo not use /blood; /defic = CHRISTMAS DISEASE RN9001-28-9 MND12.776.124.125.375; D19.461.270.229.371 XSCHRISTMAS FACTOR; PTC; Plasma Thromboplastin Component LH LS; ;  MHÑFactor V ANdo not use /blood; /defic = FACTOR V DEFICIENCY RN9001-24-5 MND12.776.124.125.300; D19.461.270.229.365 XSAC-GLOBULIN; Proaccelerin LH LS;  PM73; was see under HYPOPROTHROMBINEMIAS 1963-72 HN73(64); was see under HYPOPROTHROMBINEMIAS 1963-72 MHÑFactor V Deficiency MNC15.378.463.134.676.339 LH  MHÑFactor VII ANdo not use /blood; /defic = FACTOR VII DEFICIENCY RN9001-25-6 MND12.776.124.125.325; D19.461.270.229.367 XSPROCONVERTIN; STABLE FACTOR LH LS;  OLuse FACTOR VII DEFICIENCY to search HYPOPROCONVERTINEMIA back thru 1966 PM85; was HYPOPROCONVERTINEMIA 1963-84 HN85; was HYPOPROCONVERTINEMIA 1963-84 MHÑFactor VII Deficiency MNC15.378.463.134.350 XSHypoproconvertinemia LH LS  MHÑFactor VIII ANdo not use /blood; /defic = HEMOPHILIA MND12.776.124.125.350; D19.461.270.229.369 XSANTIHEMOPHILIC FACTOR; THROMBOPLASTINOGEN LH LS;  MHÑFactor X ANdo not use /blood; /defic = FACTOR X DEFICIENCY RN9001-29-0 MND12.776.124.125.400; D19.461.270.229.373 XSAutoprothrombin III; STUART FACTOR; STUART-PROWER FACTOR LH LS; ;  OLsearch HYPOPROTHROMBINEMIAS 1966-74 HN(75) MHÑFactor X Deficiency MNC15.378.463.134.676.505 DMÑHypoprothrombinemias LH LM  PM68 HN68(64) MHÑFactor XI ANdo not use /blood; /defic = FACTOR XI DEFICIENCY RN9013-55-2 MND12.776.124.125.425; D19.461.270.229.375 XSPLASMA THROMBOPLASTIN ANTECEDENT LH LS  PM73 HN73(66) MHÑFactor XI Deficiency MNC15.378.463.134.395 XSHemophilia C; PTA DEFICIENCY LH LS;  PM66 HN66(64) MHÑFactor XII ANdo not use /blood; /defic = FACTOR XII DEFICIENCY RN9001-30-3 MND12.776.124.125.450; D19.461.270.229.377 XSHAGEMAN FACTOR LH LS  MSA condition marked by greatly prolonged clotting time of the blood, due to the inherited deficiency of the plasma protein factor XII, of a patient with no personal or family history of hemorrhagic diathesis. PM78 HN78 MHÑFactor XII Deficiency PIBlood Coagulation Disorders (66-77); Factor XII (66-77) MNC15.378.463.134.420 XSHageman Trait LH LS  PM70 HN70(64) MHÑFactor XIII ANdo not use /blood; /defic = FACTOR XIII DEFICIENCY RN9013-56-3 MND12.776.124.125.475; D19.461.270.229.379 XSFIBRIN STABILIZING FACTOR; FIBRINASE; Fibrinoligase; LAKI-LORAND FACTOR LH LS; ; ;  PM73 HN73 MHÑFactor XIII Deficiency PIHemorrhagic Diathesis (66-72) MNC15.378.463.134.450 LH  MSThe teaching staff and members of the administrative staff having academic rank in an educational institution. OLuse FACULTY to search FACULTY, PHARMACY back thru 1968 PM68; FACULTY, PHARMACY was heading 1968-85 HN68; FACULTY, PHARMACY was heading 1968-85 MHÑFaculty ANnot for Faculte de Medecine nor Facultad de Medicina ( = SCHOOLS, MEDICAL); only /stand /supply /util; do not confuse FACULTY with ╥teacher╙ ( = TEACHING): FACULTY suggests differentiation from student or administrator, teacher suggests the one who imparts knowledge (Manual 30.25); Manual 30.23, 34.23 PITeaching (66-67) MNI2.463; M1.526.339; N2.350.359 XSFaculty, Pharmacy LH LS  MSThe teaching staff and members of the administrative staff having academic rank in a dental school. PM66 HN66 MHÑFaculty, Dental ANonly /stand /supply /util; Manual 30.23, 34.23 MNI2.463.273; M1.526.339.273; M1.526.485.360; N2.350.359.273 LH  MSThe teaching staff and members of the administrative staff having academic rank in a medical school. PM66 HN66 MHÑFaculty, Medical ANonly /stand /supply /util; Manual 30.23, 34.23; see also note under FACULTY above MNI2.463.373; M1.526.339.373; M1.526.485.375; N2.350.359.373 LH  MSThe teaching staff and members of the administrative staff having academic rank in a nursing school. PM66 HN66 MHÑFaculty, Nursing ANonly /stand /supply /util; Manual 30.23, 34.23 MNI2.463.473; M1.526.339.473; M1.526.485.390; N2.350.359.473 LH  MHÑFAD RN146-14-5 MND8.176.315; D13.695.667.138.506; D13.695.827.68.506 XSFLAVIN-ADENINE DINUCLEOTIDE LH LS  MSThe condition of an individual who is two standard deviations below the mean of weight or persistently below his own growth curve. Height and head circumference may also be affected. It may be due to organic disorders and/or psychosocial problems. PM84 HN84 MHÑFailure to Thrive ANdo not use /congen PIGrowth Disorders (69-83) MNC23.509.350 LH  PM80 HN80 MHÑFallopian Tube Diseases ANinflamm dis = SALPINGITIS PIAdnexal Diseases (66-79); Fallopian Tubes (66-79) MNC13.371.56.390 LH  MHÑFallopian Tube Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945.418.365; C13.371.56.390.390 LH  MSMethods for assessing the patency of the fallopian tubes. PM75 HN75 MHÑFallopian Tube Patency Tests ANNIM; only /instrum /methods PIFallopian Tubes (66-74); Hysterosalpingography (66-74); Infertility, Female/DI (66-74) MNE1.249.390; E5.820.390 LH  MHÑFallopian Tubes ANmammalian only; /radiogr = HYSTEROSALPINGOGRAPHY; inflammation = SALPINGITIS; tubal sterilization = STERILIZATION, TUBAL; ╥fallopian╙ is not capitalized in titles or transls MNA5.360.319.114.373 XSOVIDUCTS, MAMMALIAN FXÑHYSTEROSALPINGOGRAPHY; ÑSTERILIZATION, TUBAL LH LS LX;  PM73 HN73(70) MHÑFalse Negative Reactions ANNIM; no qualif PIDiagnosis (66-69) MNE1.223.338; E1.354.340 FXÑPredictive Value of Tests LH LX  PM70 HN70(68) MHÑFalse Positive Reactions ANNIM; no qualif PIspecific disease/DI (66-67); specific test (66-67) MNE1.223.366; E1.354.506 FXÑPredictive Value of Tests LH LX  MSA socially sanctioned unit consisting of parents or parent substitutes and children. MHÑFamily ANno qualif; ╥family tree╙ = PEDIGREE (usually NIM); X ref FAMILY LIFE CYCLES refers to stages through which the family evolves (e.g., marriage, childbearing & death): do not confuse with LIFE CHANGE EVENTS MNF1.829.263; I1.880.225 XSFamily Life Cycles; Family Relationship FXÑCONSANGUINITY XUÑFamily Health; ÑNuclear Family LH LS; LX LU;  MSSize and composition of the family; includes marital status. PM68 HN68 MHÑFamily Characteristics ANno qualif PIFamily (66-67) MNF1.829.263.315; I1.880.225.423; N1.824.308 XSFamily Size LH LS  MSThe health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members. HN(79) MHÑFamily Health ANno qualif PIFamily (66-78); Health (66-78) MNI1.880.225.435; N1.407.540.205 DMÑFamily LH LM  MSPrograms or services designed to assist the family in controlling reproduction by either improving or diminishing fertility. OLuse FAMILY PLANNING to search BIRTH CONTROL back thru 1966 PM68; BIRTH CONTROL was see under CONTRACEPTION 1975, was see under FAMILY PLANNING 1968-74, was heading 1963-67 HN68; BIRTH CONTROL was see under CONTRACEPTION 1975, was see under FAMILY PLANNING 1968-74, was heading 1963-67 MHÑFamily Planning ANonly /hist /trends CATALOG: /geog /form MNN2.421.143.401 XSBirth Control; PLANNED PARENTHOOD FXÑCONTRACEPTION; ÑPopulation Control XUÑKnowledge, Attitudes, Practice LH LS; LX; LU  MSA medical specialty concerned with the provision of continuing, comprehansive primary health care for the entire family. OLuse FAMILY PRACTICE to search GENERAL PRACTICE back thru 1966 PM78; was indexed under GENERAL PRACTICE 1969-77; GENERAL PRACTICE was heading 1963-77 HN78; was see under GENERAL PRACTICE 1975-77, was see GENERAL PRACTICE 1969-74; GENERAL PRACTICE was heading 1963-77 MHÑFamily Practice ANSPEC: SPEC qualif; articles with titles reading, e.g., ╥cortisone in general practice╙ are indexed under FAMILY PRACTICE as NIM if indexed there at all: use circumspectly; consider also COMPREHENSIVE HEALTH CARE MNG2.403.776.230 XSGeneral Practice FXÑPhysicians, Family LH LS LX  OL'family relations' is indexed under FAMILY MH*Family Relations (Non Mesh) MNF1.829.263.370 LH  MSA form of group psychotherapy; treatment of more than one member of the family simultaneously in the same session. PM68 HN68(65) MHÑFamily Therapy ANSPEC qualif MNF4.754.864.581.273 LH  MHÑFamous Persons ANIM; no qualif; Manual 17.2.7-.9; when not to use: 17.2.5 MNK1.517.211.506; M1.228 LH  MSConstellation of clinical and laboratory manifestations produced by generalized proximal tubular insufficiency in the presence of normal, or nearly normal, glomerular filtration. PM65; LIGNAC-FANCONI SYNDROME was LIGNAC-FANCONI DISEASE see under METABOLIC DISEASES 1963-64 HN65; LIGNAC-FANCONI SYNDROME was LIGNAC-FANCONI DISEASE see under METABOLIC DISEASES 1963-64 MHÑFanconi Syndrome ANTN 79: Fanconi syndromes not in MeSH: how to index MNC5.116.198.816.651.299; C12.777.419.250; C18.452.174.845.651.299; C18.452.648.618.236 XSDE TONI-DEBRE-FANCONI SYNDROME; LIGNAC-FANCONI SYNDROME; Proximal Renal Tubular Dysfunction LH LS; ;  MSCongenital hypoplastic anemia, probably hereditary, with multiple abnormalities. HN(75) MHÑFanconi's Anemia ANdo not use /congen MNC15.378.71.85.400 XSAnemia, Fanconi DMÑAnemia, Aplastic LH LS LM  MSN-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide. Potent nitrofuran derivative tumor initiator; causes bladder tumors in all animals studied; is mutagenic to many bacteria. HN(75) MHÑFANFT AND25-26 qualif; /analogs NIM only RN24554-26-5 PIFormamide (72-74); Nitrofurans (72-74); Thiazoles (70-74) MND2.640.600.290; D3.383.312.649.290; D3.383.871.250; D26.191.365 DMÑThiazoles LH LM  MSAn imagined sequence of events or mental images, e.g., daydreams. OLuse FANTASY to search DAY DREAMS back thru 1968 PM68 HN68; DAY DREAMS was see under FANTASY 1968-78 MHÑFantasy ANno qualif PIImagination (66-67) MNF1.393.351; F2.463.188.634.507 XSDay Dreams LH LS  HN67 MHÑFar East MNZ1.252.474 LH  MSSystemic and pulmonary reactions resulting from inhalation of dust from mouldy hay, threshing dust, or mouldy straw, by persons who have become hypersensitive to antigens in the dust. PM65 HN65(63) MHÑFarmer's Lung MNC8.674.55.365; C20.543.480.680.75.365; C21.447.80.365 LH  OLuse FARNESOL to search FARNESYL COMPOUNDS 1966-67 (as Prov) PM68 HN68; was FARNESYL COMPOUNDS 1965-67 (Prov) MHÑFarnesol ANdo not use /defic /physiol RN4602-84-0 MND2.33.555.600; D2.455.849.765.424; D10.516.289.600 LH  MHÑFascia MNA2.340 XUÑFascia Lata LH LU  HN(72) MHÑFascia Lata PIFascia (66-71); Thigh (66-71) MNA2.340.424 DMÑFascia LH LM  MSInvoluntary contraction of groups (fasciculi) of muscle fibers, usually at intervals of a half second or more. PM87; was see under NEUROLOGIC MANIFESTATIONS 1982-86, was see under MOVEMENT DISORDERS 1979-81 HN87(79); was see under NEUROLOGIC MANIFESTATIONS 1982-86, was see under MOVEMENT DISORDERS 1979-81 MHÑFasciculation MNC10.597.370; C23.888.592.370 XSMyokymia LH LS  MSInflammation of the fascia. There are three major types: 1) Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma. Some consider it a variant of scleroderma; 2) Necrotizing fasciitis, a serious fulminating infection causing extensive necrosis of superficial fascia. The organism is usually a beta hemolytic streptococcus; 3) Nodular/Pseudosarcomatous/Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm. It is not malignant but is sometimes mistaken for fibrosarcoma. PM81 HN81 MHÑFasciitis ANsee MeSH definition for major types; eosinophilic fasciitis: coord IM with EOSINOPHILIA (IM); necrotizing fasciitis: coord IM with NECROSIS (NIM) PIEosinophilia (66-80); Eosinophils (66-80); Fascia (66-80); Inflammation (66-80); Necrosis (66-80) MNC5.321 LH  MSA genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man. MHÑFasciola ANdo not use /blood-csf-urine; infection = FASCIOLIASIS MNB1.500.736.715.408.380 LH  MSThis species is commonly called the sheep liver fluke. It occurs in the biliary passages, liver, and gallbladder during various stages of development. Snails and aquatic vegetation are the intermediate hosts. Occasionally seen in man, but is most common in sheep and cattle. MHÑFasciola hepatica ANliver fluke; do not use /blood-csf-urine; infection: coord NIM with FASCIOLIASIS (IM) MNB1.500.736.715.408.380.420 LH  MSHelminth infection of the liver caused by species of Fasciola. MHÑFascioliasis ANcaused by FASCIOLA; do not confuse with FASCIOLOIDIASIS (caused by Fascioloides) or FASCIOLOPSIASIS (caused by Fasciolopsis) MNC3.335.865.354; C3.518.424; C6.552.664.424 LH  MSA family of flukes of the class Trematoda occurring primarily in the liver of animals and man. There are six genera: Fasciola, Fasciolopsis, Fascioloides, Tenuifasciola, Parafasciolopsis, and Protofasciola. The adult form of Fasciolopsis occurs in the intestines of pigs and man. OLuse FASCIOLIDAE to search FASCIOLOPSIS back thru 1966 PM82; FASCIOLOPSIS was heading 1963-81 HN82; FASCIOLOPSIS was heading 1963-81 MHÑFasciolidae ANfamily of trematodes; do not use /blood-csf-urine; infection: coord NIM with TREMATODE INFECTIONS (IM) but note specific FASCIOL- disease terms PITrematoda (66-81) MNB1.500.736.715.408 XSFascioloides; Fasciolopsis LH LS;  MSInfection of cattle and other herbivores with the giant liver fluke Fascioloides magna; characterized by extensive descruction of the liver parenchyma. PM68 HN68 MHÑFascioloidiasis ANusually animal: caused by FASCIOLOIDES; do not use /vet but check tag ANIMAL; do not confuse with FASCIOLIASIS (caused by FASCIOLA) or FASCIOLOPSIASIS (caused by FASCIOLOPSIS) PITrematode Infections (66-67) MNC3.335.865.399; C22.674.377.444 LH  MSNeutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts. HN(71) MHÑFast Neutrons ANNIM; only /adv eff /ther use PINeutrons (66-70) MNH1.671.579.404.645.368 DMÑNeutrons LH LM  MHÑFasting ANhuman & animal; only /adv eff /psychol; differs from STARVATION in matter of degree: TN 80; FOOD DEPRIVATION is also available MNE5.272.549 FXÑHUNGER; ÑSTARVATION; ÑStarvation LH LX; ;  MSA nutritional reservoir of fatty tissue found mainly in insects and amphibians. HN(80) MHÑFat Body ANin amphibia & insects; do not use /abnorm /growth /inj /innerv PIAdipose Tissue (66-79) MNA10.165.114.365; A13.365 DMÑAdipose Tissue LH LM  MSEmulsions of fats or lipids used primarily in parenteral feeding. PM79 HN79 MHÑFat Emulsions, Intravenous AND25-26 qualif PIDietary Fats (66-78); Fats (66-78); Lipids (66-78); Oils (66-78) MND10.516.212.302.450; D26.394.225.220.345.375 XSLipid Emulsions, Intravenous FXÑParenteral Feeding LH LS LX  MSA condition in which the neutral fats in the cells of adipose tissue are split into fatty acids and glycerol. HN(77) MHÑFat Necrosis PINecrosis (66-76) MNC23.739.638.365 XSSteatonecrosis DMÑNecrosis LH LS LM  MSInteraction between the father and the child. PM68 HN68 MHÑFather-Child Relations ANhuman only; no qualif PIParent-Child Relations (66-67) MNF1.829.263.370.290.110 LH  MSMale parents, human or animal. PM78 HN78 MHÑFathers ANhuman & animal; only /psychol (consider also FATHER-CHILD RELATIONS) PIFather-Child Relations (68-77); Male (66-77); Paternal Behavior (69-77) MNF1.829.263.500.320.100; I1.880.225.500.340.210; M1.620.390 LH  MSExhaustion of strength; weariness from exertion. MHÑFatigue ANdo not use for fatigue of isolated muscle fibers in physiol exper; eye fatigue = ASTHENOPIA MNC23.888.391 XSLassitude FXÑEfficiency; ÑExertion LH LS LX;  MSFatigue arising in consequence of mental effort. MHÑFatigue, Mental ANdo not use /drug eff /physiol /rad eff MNF3.126.354 LH  PM/metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65 HN/metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65 MHÑFats ANtable fats only or fats ╥outside the body╙; differentiate from LIPIDS (╥inside the body╙ but not body fat which = ADIPOSE TISSUE); do not use /analogs /biosyn /blood-csf-urine /defic /physiol; do not confuse with DIETARY FATS MND10.516.212 LH  MHÑFats, Unsaturated ANdo not use /analogs /biosyn /blood-csf-urine /defic /physiol MND10.516.212.507 XSOils, Unsaturated; Unsaturated Fats; Unsaturated Oils LH LS; ;  MSCatalyze the conversion of saturated fatty acid CoA complexes to unsaturated fatty acid CoA complexes in the presence of any acceptor. Include EC 1.3.1.8, EC 1.3.99.3 and EC 1.14.99.5. PM74 HN74(73) MHÑFatty Acid Desaturases ANdo not use /analogs RNEC 1.14.99.- MND8.586.682.420.375 XSACYL COA DESATURASES; Acyl CoA Dehydrogenases; Enoyl CoA Reductases XUÑStearyl-CoA Desaturase LH LS; ; LU  PM72 HN72(71) MHÑFatty Acid Synthetase Complex ANdo not use /analogs RNEC 6.- PIFatty Acids/BI (66-70); Ligases (66-70) MND8.586.464.397; D8.586.600.317 LH  PM/metabolism was FATTY ACID METABOLISM 1965; SODIUM MORRHUATE was see under SCLEROSING SOLUTIONS 1963-74 HN/metabolism was FATTY ACID METABOLISM 1965 MHÑFatty Acids AN╥esterified╙, ╥saturated╙ goes here; do not use /analogs /defic MND2.241.81.407; D10.516.251 XUÑProstanoic Acids; ÑSodium Morrhuate LH LU;  MHÑFatty Acids, Essential ANdo not use /analogs MND10.516.251.265 LH  PM68 HN68(66) MHÑFatty Acids, Nonesterified ANdo not use /analogs /defic MND10.516.251.310 XSFATTY ACIDS, FREE; FREE FATTY ACIDS; NEFA LH LS; ;  PM73; RICINOLEIC ACIDS was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under FATTY ACIDS, UNSATURATED 1975-80, was see under SCLEROSING SOLUTIONS 1963-74 HN73 MHÑFatty Acids, Unsaturated ANdo not use /analogs /defic PIFatty Acids, Essential (66-72) MND2.241.81.436; D10.516.251.355 XUÑ5,8,11,14-Eicosatetraynoic Acid; Ñ8,11,14-Eicosatrienoic Acid; ÑErucic Acids; ÑRicinoleic Acids; ÑSorbic Acid LH LU; ; ; ;  PM73 HN73 MHÑFatty Acids, Volatile AN= ╥short-chain╙ fatty acids; do not use /analogs /defic PIFatty Acids (66-72) MND2.241.81.465; D10.516.251.400 LH  PM72; SODIUM TETRADECYL SULFATE was SODIUM TETRADECYL SULFATES see under SCLEROSING SOLUTIONS 1963-74 HN72 MHÑFatty Alcohols ANdo not use /analogs /defic /physiol PIAlcohols (66-71) MND2.33.555; D10.516.289 XUÑLauryl Alcohol; ÑSodium Tetradecyl Sulfate LH LU;  MSFat accumulation in the liver. MHÑFatty Liver MNC6.552.241 LH  MSFatty liver in alcoholics; potentially reversible and may be associated with alcoholic hepatitis or cirrhosis. PM78 HN78 MHÑFatty Liver, Alcoholic PIAlcoholism (66-77); Fatty Liver (66-77) MNC6.552.241.390; C6.552.645.390; C21.613.53.270.645.390 XSAlcoholic Fatty Liver LH LS  MSHemolytic anemia due to the ingestion of fava beans or after inhalation of pollen from the Vicia fava plant by persons with glucose-6-phosphate dehydrogenase deficient erythrocytes. MHÑFavism MNC15.378.71.141.150.480.370; C15.378.71.141.370; C21.613.415.341; C21.613.756.375 LH  HN(64) MHÑFavre-Racouchot Syndrome MNC17.285 DMÑSkin Diseases LH LM  MS1,1'-Azobis]3-methyl-2-phenyl-1H-imidazo(1,2-a)pyridin-4-ium]dibromide. A rapid-acting, short-lasting competitive nondepolarizing neuromuscular blocking agent. Its action is rapidly and completely reversed by neostigmine. OLuse FAZADINIUM to search AH 8165 back thru 1975 HN(79); was AH 8165 see under PYRIDINIUM COMPOUNDS 1975-78 MHÑFazadinium ANdo not use /biosyn /defic /physiol; /analogs NIM only RN49564-56-9 PIAzo Compounds (66-74); Imidazoles (66-74); Pyridinium Compounds (68-74) MND3.383.725.762.420; D17.563.367.364 XSAH 8165 DMÑPyridinium Compounds LH LS LM  MSThe affective response to an actual current external danger which subsides with the elimination of the threatening condition. MHÑFear ANhuman & animal; only /drug eff /physiol /rad eff MNF1.470.361 FXÑPhobic Disorders XUÑPanic LH LX LU  MSStudies to determine the advantages or disadvantages, practicability or capability of accomplishing a projected plan, study or project. PM80 HN80 MHÑFeasibility Studies ANno qualif MNH1.770.644.300 LH  PM66 HN66(63) MHÑFeathers MNA13.370 FXÑAllergens LH LX  MSFailure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus. PM70 HN70(66) MHÑFecal Incontinence ANof organic origin: differentiate from ENCOPRESIS, of psychol origin MNC6.405.469.860.300 FXÑDefecation; ÑENCOPRESIS LH LX;  MHÑFeces ANonly /anal /cytol /enzymol /microbiol /parasitol (often + PARASITE EGG COUNT); consider also DEFECATION, CONSTIPATION, DIARRHEA, FECES, IMPACTED & FECAL INCONTINENCE; fecalith: index FECES, IMPACTED; fecal blood: index under OCCULT BLOOD & not also here MNA12.459 FXÑMELENA; ÑManure LH LX;  MSFormation of a large firm mass of stood in the rectum or distal colon. PM64 HN64 MHÑFeces, Impacted ANfecalith goes here MNC6.405.469.531.424 LH  MSA listing of established professional service charges, for specified dental and medical procedures. PM68 HN68 MHÑFee Schedules ANonly /class /legis /stand /trends PIEconomics (66-67) MNN4.452.313 FXÑFEES AND CHARGES LH LX  MSThe situation in which some aspect of the output regulates the state of the system. PM65 HN65 MHÑFeedback ANNIM; no qualif; BIOFEEDBACK (F) is also available MNF4.669.260; G7.621.475; L1.143.283.425 LH  MSBehavioral responses or sequences associated with eating; modes of feeding, rhythmic patterns of eating (time intervals - onset and duration). OLuse FEEDING BEHAVIOR to search FEEDING PATTERNS back thru 1969 PM69 HN69; FEEDING PATTERNS was see under FEEDING BEHAVIOR 1969-78 MHÑFeeding Behavior ANhuman & animal; only /drug eff /physiol /rad eff; = manner of eating or feeding (TN 63): differentiate from EATING, the act of eating or feeding; permitted for feeding behavior of insects, as mosquitoes on skin, ticks sucking blood, maggots on flesh, etc., but NIM with feeding organism IM PIBehavior (66-68); Nutrition (66-68) MNF1.145.407 XSEATING BEHAVIOR; Feeding Patterns LH LS;  MH*Feeding Methods (Non Mesh) MNE2.421 LH  MSAmounts charged to the patient as payor for health care services. PM68 HN68 MHÑFees and Charges ANonly /class /hist /legis /stand /trends; DF: FEES PIEconomics (66-67) MNN3.219.442 XSCHARGES FXÑFee Schedules; ÑRate Setting and Review XUÑCapitation Fee LH LS LX; LU  MSAmounts charged to the patient as payor for dental services. PM68 HN68 MHÑFees, Dental ANonly /class /hist /legis /stand /trends CATALOG: /geog /form PIEconomics, Dental (66-67) MNN3.219.224.426; N3.219.442.301 LH  MSAmounts charged to the patient as payor for medical services. PM68 HN68 MHÑFees, Medical ANonly /class /hist /legis /stand /trends CATALOG: /geog /form PIEconomics, Medical (66-67) MNN3.219.300.426; N3.219.442.426 XSFee for Service, Medical LH LS  MSAmounts charged to the patient or third party payor for prescription medication; includes the pharmacist's professional fee and cost of ingredients, containers, etc. PM68 HN68 MHÑFees, Pharmaceutical ANonly /class /hist /legis /stand /trends CATALOG: /geog /form PIPharmacy (66-67); Prescriptions (66-67) MNN3.219.442.551 FXÑPharmacy Administration XUÑPrescription Fees LH LX LU  MSA virus isolated from fibrosarcomata in cats and having virions like leukovirus C particles. HN(75); was see under LEUKOVIRUSES 1978-80, was see under LEUKEMOGENIC VIRUSES 1975-77 MHÑFeline Fibrosarcoma Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) + neopl terms if pertinent PIC-Type Viruses (74); Cats (69-74); Fibrosarcoma (69-74); Oncogenic Viruses (70-74); Retroviridae (70-74); Vertebrate Viruses, Unclassified (70-74) MNB4.909.574.807.300; B4.909.777.731.300 XSFibrosarcoma Virus, Feline DMÑRetroviridae LH LS LM  MSA highly contagious DNA virus infection of the cat family and of mink, characterized by fever, enteritis and bone marrow changes. Syn: feline panleukopenia, feline distemper, feline ataxia, feline agranulocytosis, cat fever, cat plague, show fever, enteritis of mink. PM70 HN70 MHÑFeline Infectious Enteritis ANdo not use /vet; don't forget also CATS (NIM) & check tag ANIMAL; in minks, coord with MINK (IM) PICat Diseases (66-69); Virus Diseases (66-69) MNC2.256.700.363; C22.180.426 XSDistemper, Feline; Enteritis, Infectious, of Mink; Panleukopenia, Feline LH LS; ;  MSA virus chiefly affecting young cats in endemic areas, but all felines are susceptible, even lions and tigers. Also affects mink and raccoons. HN(75); was see under PARVOVIRUSES 1975-80 MHÑFeline Infectious Enteritis Virus ANdo not use /blood-csf-urine /cytol; infection = FELINE INFECTIOUS ENTERITIS MNB4.909.204.671.400 XSInfectious Enteritis Virus of Mink; Infectious Enteritis Virus, Feline; Panleukopenia Virus of Cats DMÑParvoviridae LH LS; ; LM  MSAn RNA virus causing leukemia or lymphosarcoma in cats; may also infect other animals. PM73 HN73 MHÑFeline Leukemia Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM) PIRetroviridae (66-72) MNB4.909.574.807.426; B4.909.777.731.426 XSCat Leukemia Virus; Feline Lymphoma Virus LH LS;  MSStipends or grants-in-aid granted by foundations or institutions to individuals for study. OLto search FELLOWSHIPS & SCHOLARSHIPS use FELLOWSHIPS AND SCHOLARSHIPS back thru 1975 & TRAINING SUPPORT 1966-74 PM79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS & SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78 HN79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS & SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78 MHÑFellowships and Scholarships ANno qualif; specify agency or govt & geog if possible; DF: FELLOWSHIPS PITraining Support (66-74) MNH1.770.878.276; N3.219.483.838.276 XSScholarships LH LS  MHÑFelty's Syndrome MNC5.550.114.154.389; C5.799.114.389; C20.111.199.389; C23.205.200.732.99.389 LH  MS2-L-Phenylalanine-8-L-lysine vasopressin. Synthetic analog of lypressin with more vasoconstrictor than antidiuretic action; used as hemostatic. Synonyms: Octopressin; PLV 2. OLuse FELYPRESSIN to search PHELYPRESSIN back thru 1966 HN(79); was PHELYPRESSIN see under VASOPRESSIN 1975-78, was PHELYPRESSIN 1965-74 (Prov) MHÑFelypressin ANdo not use /biosyn /defic /physiol RN56-59-7 MND6.472.734.692.781.400.350; D12.644.456.925.325; D18.793.370; D19.770.896.540.599 XSOctapressin; Phelypressin; Phenylalanine Lysine Vasopressin; Vasopressin, Phenylalanyl-Lysyl DMÑLypressin LH LS; ; ; LM  HN66 MHÑFemale ANcheck tag only; do not confuse with WOMEN, little used by comparison; see note there & Manual 18.9.6, 34.18; Manual 18.9+, 35.8.1 CATALOG: do not use: for indexers only LH  MH*Female Genital Diseases and Pregnancy Complications (Non Mesh) MNC13 LH  PM72 HN72(67) MHÑFeminization ANdevelop of female secondary sex characteristics in the male; check the tag MALE PISex Characteristics (66) MNC19.391.301 LH  MSThe main artery of the thigh, a continuation of the external iliac artery. MHÑFemoral Artery ANdo not use /blood supply MNA7.231.114.351 LH  MSFractures of the femur. MHÑFemoral Fractures ANof femoral shaft only; intertrochanteric fract does not go here: index under HIP FRACTURES MNC21.866.405.207; C21.866.558.276 LH  MSFractures of the short, constricted portion of the thigh bone between the femur head and the trochanters. Excludes intertrochanteric fractures. MHÑFemoral Neck Fractures ANintertrochanteric fract does not go here: index under HIP FRACTURES MNC21.866.405.207.425.278; C21.866.558.276.425.278 LH  MHÑFemoral Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific FEMUR HEAD or FEMUR NECK (NIM) as merely locational + histol type of neopl (IM) MNC4.588.149.276; C5.116.231.343 LH  MHÑFemoral Nerve ANdo not use /innerv MNA8.796.828.569.301 LH  MSThe vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein. MHÑFemoral Vein ANdo not use /blood supply MNA7.231.908.314 LH  MHÑFemur ANtrochanter, intertrochanteric & subtrochanteric go here; fractures: FEMORAL FRACTURES & FEMORAL NECK FRACTURES are available but see note under HIP FRACTURES; do not index under FEMUR when THIGH is meant: see note there MNA2.835.232.484.247 LH  MHÑFemur Head ANfract = FEMUR HEAD /inj (IM) + HIP FRACTURES (IM); avascular or aseptic necrosis of hip goes under FEMUR HEAD NECROSIS MNA2.835.232.484.247.343 LH  MSAseptic or avascular necrosis of the femur head. the major types are idiopathic (primary), as a complication of fractures or dislocations, and LEGG-PERTHES DISEASE. PM73; LEGG-PERTHES DISEASE was see under OSTEOCHONDRITIS 1963-78 HN73 MHÑFemur Head Necrosis ANavascular or aseptic necrosis goes here without coords for avascular, aseptic or necrosis PIBone Diseases (66-72); Femur Head (66-72); Necrosis (66-72) MNC5.116.852.175; C23.739.638.732.368 XUÑLegg-Perthes Disease LH LU  MHÑFemur Neck ANfract = FEMORAL NECK FRACTURES MNA2.835.232.484.247.510 LH  MSMethyl-5-(phenylthio)-2-benzimidazolecarbamate. Antinematodal benzimidazole used in veterinary medicine. Synonym: HOE 881. HN(77) MHÑFenbendazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN43210-67-9 PIBenzimidazoles (74-76); Carbamates (74-76); Sulfides (74) MND2.241.81.251.320; D3.438.103.450; D21.201.287.269 DMÑBenzimidazoles LH LM  PM74 HN74(72) MHÑFenchlorphos ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN299-84-3 PIInsecticides (66-71) MND2.719.435; D5.723.491.657.452 XSRonnel LH LS  MSN-(3,3-Diphenylpropyl)-alpha-methylbenzylamine. Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents. Synonyms: HK 137; phenaxazan; phenoxan; Sensit. HN(80) MHÑFendiline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13042-18-7 PIPhenethylamines (66-79) MND2.92.471.683.450; D18.97.360; D18.192.360; D18.918.360 DMÑPhenethylamines LH LM  MHÑFenestration ANof labyrinth only, not other organs; do not use /util except by MeSH definition MNE4.847.774.277 FXÑOtosclerosis LH LX  PM72 HN72(66) MHÑFenfluramine ANdo not use /biosyn /defic /physiol RN458-24-2 MND2.92.471.683.467; D16.893.368; D26.128.477 XUÑNorfenfluramine LH LU  PM74 HN74(72) MHÑFenitrothion ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN122-14-5 PIInsecticides (66-71) MND2.719.456; D5.723.491.657.477 XSMETHYLNITROPHOS; NITROPHOS LH LS;  MS2-(3-phenoxyphenyl)-propionic acid. Anti-inflammatory analgesic and antipyretic highly bound to plasma proteins; pharmacologically similar to aspirin, but causes less gastrointestinal bleeding. HN(75) MHÑFenoprofen ANdo not use /biosyn /defic /physiol; /analogs NIM only RN31879-05-7 PIAnti-Inflammatory Agents (72-74); Ethers (72); Phenyl Ethers (74); Phenols (73); Propionates (72-74) MND2.241.223.701.350; D14.73.278.315; D26.74.75.484 DMÑPhenylpropionates LH LM  MS3,5-Dihydroxy-alpha[[(p-hydroxy-alpha-methylphenethyl)amino]methyl]benzyl alcohol. Adrenergic beta-2 agonist used as a bronchodilator. Synonyms: Th 1165a; Berotec. PM86; was see under ETHANOLAMINES 1975-85 HN86(75); was see under ETHANOLAMINES 1975-85 MHÑFenoterol ANdo not use /biosyn /defic /physiol RN13392-18-2 PIOrciprenaline (73-74); Phenols (73-74) MND2.33.329.291.330; D2.92.63.291.330; D16.116.365; D16.893.116.348.365 LH  MS8-Phenyl-1-oxa-3,8-diazaspiro(4.5)decan-2-one monohydrochloride. Bronchodilator agent used in asthma. Synonym: Viarespan. HN(75) MHÑFenspiride ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5053-06-5 PIOxazoles (72-74); Piperidines (72-74); Spiro Compounds (72-74) MND3.383.548.250; D3.383.621.260; D4.615.885.335; D16.116.370 DMÑSpiro Compounds LH LM  HN(72) MHÑFensulfothion ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN115-90-2 PIInsecticides (66-71) MND2.719.478; D5.723.491.657.502 DMÑInsecticides, Organothiophosphate LH LM  PM66 HN66 MHÑFentanyl ANdo not use /biosyn /defic /physiol RN437-38-7 MND14.73.153.301; D14.757.360 XSPHENTANYL LH LS  PM74 HN74(72) MHÑFenthion ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN55-38-9 PIInsecticides (66-71) MND2.719.499; D5.723.491.657.527 XSMERCAPTOPHOS LH LS  MHÑFermentation ANonly /drug eff /rad eff MNG6.184.405 LH  MHÑFermium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-72-4 MND1.287.349; D1.552.517.394 LH  MSNADPH:ferredoxin oxidoreductase. Catalyzes the oxidation and reduction of ferredoxin or adrenodoxin in the presence of NADP. HN(75) MHÑFerredoxin-NADP Reductase ANdo not use /analogs RNEC 1.18.1.2 PINADH, NADPH Oxidoreductases (74); Ferredoxins (74) MND8.586.682.608.300 XSAdrenodoxin Reductase DMÑNadh, Nadph Oxidoreductases LH LS LM  PM66 HN66(64) MHÑFerredoxins ANdo not use /analogs MND12.776.157.435.319; D12.776.556.580.302; D12.776.765.319; D12.776.97.350 XUÑMolybdoferredoxin; ÑRubredoxins LH LU;  MSSemidomesticated variety of European polecat much used for hunting rodents and/or rabbits and as a laboratory animal. HN(75) MHÑFerrets ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.147.400 DMÑCarnivora LH LM  MSCompounds containing trivalent iron. OLsearch IRON 1966-74 PM87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74 HN87(75); was see under IRON 1975-86 FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74 MHÑFerric Compounds ANdo not use /analogs /biosyn /defic /physiol; = iron(III) or Fe(III), as Fe2O3, FeCl3; iron(II) or Fe(II) = FERROUS COMPOUNDS; DF: FERRIC CPDS PIIron (66-74) MND1.552.412.220; D19.461.543.321 LH  MSA cyclic peptide consisting of three residues of delta-N-hydroxy-delta-N-acetylornithine. It acts as an iron transport agent in Ustilago sphaerogena. HN(75) MHÑFerrichrome ANdo not use /defic /physiol; /analogs NIM only RN15630-64-5 PIHydroxamic Acids (72-74); Iron Chelates (72-74); Peptides, Cyclic (73-74) MND2.92.570.394.380; D2.241.511.372.380; D12.644.641.380 DMÑHydroxamic Acids LH LM  PM66 HN66 MHÑFerricyanides ANdo not use /analogs /biosyn /defic /physiol; do not confuse with FERROCYANIDES MND1.552.412.288; D1.620.305.344 XUÑNitroprusside LH LU  MHÑFerritin RN9007-73-2 MND12.776.556.365 FXÑIron XUÑApoferritin LH LX LU  MSProtoheme ferro-lyase. An enzyme widely distributed in cells and tissues. It is located in the inner mitochondrial membrane and catalyzes the formation of heme from protoporphyrin IX and ferrous ions during the terminal step in the heme biosynthetic pathway. EC 4.99.1.1. HN(77) MHÑFerrochelatase ANdo not use /analogs RNEC 4.99.1.1 PIIron (66-76); Lyases (66-76); Porphyrins (66-76); Protoporphyrins (75-76) MND8.586.520.390 XSHeme Synthetase; Porphyrin-Metal Chelatase DMÑLyases LH LS; LM  PM66 HN66 MHÑFerrocyanides ANdo not use /analogs /biosyn /defic /physiol; do not confuse with FERRICYANIDES; ╥ferrocyanide reaction╙ = PRUSSIAN BLUE REACTION MND1.552.412.344; D1.620.305.510 LH  MSCompounds containing divalent iron. OLsearch IRON 1966-74 PM87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1964-74 HN87(75); was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74 MHÑFerrous Compounds ANdo not use /analogs /biosyn /defic /physiol; = iron(II) or Fe(II), as FeO, FeCl2; iron(III) or Fe(III) = FERRIC COMPOUNDS; DF: FERROUS CPDS PIIron (66-74) MND1.552.412.370; D19.461.543.326 LH  MS3-(2-Pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine. A ferroin compound that forms a stable magenta colored solution with the ferrous ion; the complex has an absorption peak at 562nm and is used as a reagent and indicator for iron. HN(76) MHÑFerrozine AND25-26 qualif; /analogs NIM only RN28048-33-1 PIBenzenesulfonates (74-75); Pyridines (72-75); Triazines (72-75) MND2.241.866.540.244.222.280; D2.455.426.559.389.97.280; D2.886.610.244.222.300; D3.383.931.320; D26.241.608; D26.550.308 DMÑTriazines LH LM  MHÑFertility ANIM for human, other mammals, birds & fish, NIM for animals lower than fish, plants & micro-organisms; only /drug eff /rad eff; INFERTILITY & its specifics are available; /drug eff: consider also FERTILITY AGENTS MNG8.520.227 XSFecundity LH LS  PM73 HN73 MHÑFertility Agents ANdo not use /analogs /biosyn /defic /physiol; consider also FERTILITY /drug eff PIFertility/DE (66-72); Gonadotropins (66-72); Ovulation/DE (66-72) MND7.552 LH  MSCompounds which increase the capacity to conceive in females. PM75 HN75 MHÑFertility Agents, Female ANdo not use /analogs /biosyn /defic /physiol PIFertility Agents (73-74) MND7.552.344 XUÑFertility Agents, Female, Hormonal; ÑFertility Agents, Female, Synthetic LH LU;  MSHormonal preparations which increase the capacity to conceive in females. HN(75) MHÑFertility Agents, Female, Hormonal ANdo not use /analogs MND7.552.344.344 DMÑFertility Agents, Female LH LM  MSSynthetic chemical compounds which increase the capacity to conceive in females. HN(75) MHÑFertility Agents, Female, Synthetic ANdo not use /analogs /biosyn /defic /physiol; DF: FERTIL AGENTS FEMALE SYN MND7.552.344.510 DMÑFertility Agents, Female LH LM  MSCompounds which increase the capacity of the male to induce conception. PM75 HN75 MHÑFertility Agents, Male ANdo not use /analogs /biosyn /defic /physiol PIFertility Agents (73-74) MND7.552.510 XUÑFertility Agents, Male, Hormonal; ÑFertility Agents, Male, Synthetic LH LU;  MSHormonal preparations which increase the capacity of the male to induce conception. HN(75) MHÑFertility Agents, Male, Hormonal ANdo not use /analogs MND7.552.510.344 DMÑFertility Agents, Male LH LM  MSSynthetic chemical compounds which increase the capacity of the male to induce conception. HN(75) MHÑFertility Agents, Male, Synthetic ANdo not use /analogs /biosyn /defic /physiol; DF: FERTIL AGENTS MALE SYN MND7.552.510.510 DMÑFertility Agents, Male LH LM  OLuse FERTILIZATION to search FERTILIZATION, DELAYED & FERTILIZATION, POLYSPERMIC back thru 1975 HNFERTILIZATION, DELAYED & FERTILIZATION, POLYSPERMIC were see under FERTILIZATION 1975-84 MHÑFertilization ANonly /drug eff /rad eff; physiol fertiliz only: note FERTILIZATION IN VITRO (G8 & E5) below; conception goes here MNG8.520.277 XSFertilization, Delayed; Fertilization, Polyspermic FXÑGERM CELLS LH LS; LX  MSFertilization of an egg outside the body when the egg is normally fertilized in the body. OLto search TEST TUBE BABIES use FERTILIZATION IN VITRO 1979 & ECTOGENESIS 1978 PMApr 79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see ECTOGENESIS 1978-Mar 79 HN79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see ECTOGENESIS 1978 MHÑFertilization in Vitro ANonly /drug eff /instrum /methods /rad eff; do not check the tags IN VITRO, PREGNANCY or FEMALE; consider also EMBRYO TRANSFER PIEctogenesis (75-79); Fertilization (66-79) MNE5.820.490; G8.520.277.320 XSTest-Tube Fertilization LH LS  MHÑFertilizers ANonly /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply MNJ1.40.427 LH  MSA genus of poisonous, umbelliferous plants, including Ferula asafoetida, that yields pungent oils and resins used formerly as carminatives and now as cat and dog repellants; a related plant, F. galbanum is used similarly. HN(86)63 MHÑFerula ANdo not use /isol /pathogen MNB6.560.373; B6.660.357 XSAsafoetida; Fennel DMÑPlants, Toxic LH LS; LM  MSA disorder occurring in children born to alcoholic women who continue to drink heavily during pregnancy. Common abnormalities are growth deficiency (prenatal and postnatal), altered morphogenesis, mental deficiency, and characteristic facies - small eyes and flattened nasal bridge. Fine motor dysfunction and tremulousness are observed in the newborn. PM79 HN79; was in Cat C & F 1979-80 MHÑFetal Alcohol Syndrome ANdo not use /chem ind /congen PIAlcoholism (66-78) MNC13.703.277.80; C16.614.330.80; C21.613.53.270.397 FXÑAlcoholism LH LX  MSFetal oxygen deficiency. PM75 HN75 MHÑFetal Anoxia ANdo not use /congen; do not confuse with ASPHYXIA NEONATORUM PIFetal Diseases (66-74) MNC13.703.277.100; C16.614.330.100 XSAnoxia, Fetal FXÑAsphyxia Neonatorum LH LS LX  MSBlood of the fetus. PM75 HN75 MHÑFetal Blood ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff PIUmbilical Cord (66-74) MNA12.207.152.200; A15.145.300; A16.378.200 XSCord Blood; Umbilical Cord Blood LH LS;  MSDeath of the young developing in utero. MHÑFetal Death ANonly Cat C qualif but must refer to fetus only & not to mother so many qualif do not apply: do not use /congen /diet ther /drug ther /mortal /nurs /psychol /radiother /rehabil /surg /ther /transm; death of fetus in utero = FETAL DEATH, not ABORTION; perinatal death can go here but consider also INFANT MORTALITY; fetal resorption = FETAL RESORPTION CATALOG: /geog /form MNC13.703.243; C23.240.477; N1.224.935.698.302 XSSTILLBIRTH FXÑInfant Mortality XUÑEmbryo Resorption; ÑFetal Resorption LH LS LX LU;  MSMorphologic and physiologic growth and development of the embryo or fetus. PM85 HN85 MHÑFetal Development ANonly /drug eff /rad eff; do not coord with EMBRYO /physiol unless embryo is particularly discussed PIFetus/PH (66-84); Growth (66-84) MNG8.520.288 XSEmbryo Development LH LS  OLsearch PRENATAL INFLUENCES under PREGNANCY 1966-72 PMPRENATAL INFLUENCES was heading 1963-72 HNPRENATAL INFLUENCES was heading 1963-72 MHÑFetal Diseases ANGEN: prefer specifics; do not use /congen; FETAL DISTRESS is available; TN 82: do not confuse with RESPIRATORY DISTRESS SYNDROME; ╥fetal malnutrition╙ goes under PLACENTAL INSUFFICIENCY; anoxia = FETAL ANOXIA: do not confuse with ASPHYXIA NEONATORUM CATALOG: form qualif = PERINATOLOGY /form MNC13.703.277; C16.614.330 XSEmbryopathies FXÑABNORMALITIES LH LS LX  MSAdverse or threatening condition of the fetus identified by fetal bradycardia or tachycardia and passage of meconium in vertex presentation. PM75 HN75 MHÑFetal Distress ANdo not confuse with RESPIRATORY DISTRESS SYNDROME (postnatal); do not use /congen PIFetal Diseases (66-74) MNC13.703.277.200; C16.614.330.200 LH  MSThe failure of a fetus to maintain its expected growth potential at any gestational stage. PM78 HN78 MHÑFetal Growth Retardation ANdo not use /congen; note short form IUGR below PIFetal Diseases (66-77); Growth (66-71); Growth Disorders (72-77) MNC13.703.277.370; C16.614.330.370; C23.509.370 XSGrowth Retardation, Intrauterine; IUGR; Intrauterine Growth Retardation FXÑInfant, Small for Gestational Age LH LS; ; LX  MSThe heart of a fetus. MHÑFetal Heart ANmammals only; use all pertinent qualif (except /blood supply) & do not coord with MYOCARDIUM for HEART/MYOCARDIUM restrictions; TN 195: not for chick embryo heart ( = CHICK EMBRYO + HEART /embryol) MNA7.541.278; A16.378.303 LH  MHÑFetal Hemoglobin ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /physiol /physiol /rad eff /urine; DF: HBF RN9007-74-3 MND12.776.124.400.303; D12.776.422.512.320 XSHEMOGLOBIN F LH LS  MSA complication of gestational diabetes mellitus or prolonged pregnancy. A macrosomic fetus is defined as weighing more than 4000 grams. PM87 HN87 MHÑFetal Macrosomia ANfetus ╥weighing more than 4000 grams╙; do not confuse with INFANT, POSTMATURE (born after 42 wks of gestation) PIBirth Weight (66-86); Fetal Diseases (66-86); Infant, Newborn, Diseases (66-86); Pregnancy in Diabetes (66-86) MNC13.703.277.570; C13.703.766.570; C16.614.330.570; C18.452.297.820.570; C19.246.820.570 XSMacrosomia, Fetal FXÑBirth Weight LH LS LX  MSThin layers of tissue which surround the embryo or fetus and provide for its nutrition, respiration, excretion and protection; they are the yolk sac, allantois, amnion, and chorion. MHÑFetal Membranes ANmammalian only but specifics may be used with non-mammalian (e.g., CHICK EMBRYO); induced rupture = LABOR, INDUCED; premature rupture = FETAL MEMBRANES, PREMATURE RUPTURE; rupture in normal labor = FETAL MEMBRANES (IM) + LABOR (IM); do not use /abnorm /embryol /growth /inj MNA16.254.403 XUÑAllantois LH LU  MSSpontaneous rupture of amniotic sac before the onset of uterine contractions. PM75 HN75 MHÑFetal Membranes, Premature Rupture ANdo not use /congen PIFetal Membranes (66-74) MNC13.703.420.339 XSPROM (Pregnancy) LH LS  MSPhysiologic or biochemical monitoring of the fetus. Usually done during labor and may be in conjunction with monitoring of uterine activity. May also be prenatal as when the mother is undergoing surgery. PM78 HN78 MHÑFetal Monitoring ANonly /adv eff /instrum /methods /stand /util (if by MeSH definition) /vet PIFetal Heart (66-77); Fetus (66-77); Labor (66-77); Monitoring, Physiologic (66-77) MNE1.249.400; E1.621.390 XSMonitoring, Fetal FXÑLabor; ÑSignal Processing, Computer-Assisted LH LS LX;  MSMotion of the fetus perceived by the mother and felt by palpation of the abdomen. PM85 HN85 MHÑFetal Movement ANonly /drug eff /rad eff PIFetus/PH (66-84); Movement (66-84) MNG7.553.370.300; G8.520.288.210 LH  MSFunctional competence of specific fetal organs or body systems. In humans, usually assessed by analysis of amniotic fluid, as in the assessment of fetal lung maturity by analysis for components of pulmonary surfactant. PM81 HN81 MHÑFetal Organ Maturity ANonly /drug eff /rad eff; coord NIM with organ /embryol (IM) PIAmniotic Fluid (66-80); Fetus (66-80); Lung (66-80); other specific organ; Respiratory Distress Syndrome (66-80) MNG8.520.288.290 XSFetal Maturity, Functional LH LS  OLuse FETAL PROTEINS to search FETAL GLOBULINS back thru 1970 PM84; was FETAL GLOBULINS 1970-83 HN84; was FETAL GLOBULINS 1970-83 MHÑFetal Proteins ANdo not use /analogs /blood PIAlpha Globulins (66-69); Serum Globulins (66-69) MND12.776.320 XSFetal Globulins LH LS  MSDeath and resorption of the fetus at any stage after the completion of organogenesis. Does not include embryo resorption. HN(76) MHÑFetal Resorption ANdo not use /congen PIFetal Death (66-75) MNC13.703.243.300; C23.240.477.300 DMÑFetal Death LH LM  MSThe potential of the fetus-in-utero to survive after birth. PM78 HN78 MHÑFetal Viability ANonly /drug eff /rad eff PIFetus (66-77) MNG7.553.370; G8.520.288.320 LH  MSA condition in which inanimate objects are utilized as a preferred or exclusive method of stimulating erotic arousal. OLsearch PARAPHILIAS 1968-74 HN(75); was see under SEX DEVIATION 1968-80 MHÑFetishism (Psychiatric) ANdo not use /drug eff /physiol /rad eff; belief in religious or magic fetishes goes under RELIGION, SUPERSTITION & its indentions, ANTHROPOLOGY, CULTURAL or other pertinent term; DF: FETISHISM MNF3.709.597.608.700.260 DMÑParaphilias LH LM  PM68 HN68 MHÑFetofetal Transfusion ANdo not use /congen; TN 186: differentiate among various ╥transfusion╙ concepts PIAnemia (66-67); Infant, Newborn, Diseases (66-67) MNC15.378.71.363.344; C16.614.53.344 XSCROSS TRANSFUSION, INTRAUTERINE; Intrauterine Cross-Transfusion; Twin Transfusion Syndrome LH LS; ;  PM68 HN68(66) MHÑFetomaternal Transfusion ANdo not use /congen; TN 186: differentiate among various ╥transfusion╙ concepts; transfer of immunity from mother to fetus = IMMUNITY, MATERNALLY-ACQUIRED MNC15.378.71.363.511; C16.614.53.511 LH  MSEndoscopic visualization of the fetus through an abdominal and uterine entry. HN(77) MHÑFetoscopy ANNIM; do not use /man /supply /util (except by MeSH definition); do not confuse with AMNIOSCOPY, exam of amnion & amniotic fluid PIEndoscopy (66-76); Prenatal Diagnosis (73-76) MNE1.249.746.450; E1.418.426 DMÑPrenatal Diagnosis LH LM  OLsearch PRENATAL INFLUENCES under PREGNANCY 1966-72 PMPRENATAL INFLUENCES was heading 1963-72 HNPRENATAL INFLUENCES was heading 1963-72 MHÑFetus ANmammalian only; human: 3d month to term; do not use /abnorm /blood supply /embryol /growth /inj /innerv /physiopathol /secret; fetal growth = FETAL DEVELOPMENT; resorption = FETAL RESORPTION; distress = FETAL DISTRESS but do not confuse with RESPIRATORY DISTRESS SYNDROME (postnatal); anoxia = FETAL ANOXIA: do not confuse with ASPHYXIA NEONATORUM; FETUS and PREGNANCY: Manual 18.4.3, 21.55.1; definition & use: 21.53; specialty for fetus-newborn inf-mother = PERINATOLOGY; TEST-TUBE FERTILIZATION see FERTILIZATION IN VITRO; retained fetus: index under ABORTION, MISSED; mummified fetus goes here (not under FETAL DEATH) but consider also ABORTION, MISSED; lithopedion: coord FETUS (IM) + CALCINOSIS (IM); ╥fetal malnutrition╙ goes under PLACENTAL INSUFFICIENCY; fetal organs & tissues in tissue & cell cultures: coord FETUS + organ or tissue without qualif (not with /embryol) + culture term, all probably NIM (Manual 22.26.1); TN 66: relation to /embryol CATALOG: form qualif = PERINATOLOGY /form MNA16.378 FXÑGestational Age; ÑMaternal-Fetal Exchange LH LX;  MHÑFever AN/ther = treatment of FEVER: differentiate from FEVER THERAPY see HYPERTHERMIA, INDUCED ( = high body temp induced to treat dis); /chem ind: consider also HYPERTHERMIA, INDUCED or PYROGENS; /drug ther: consider also see related's below MNC23.888.189.344 XSHyperthermia; Pyrexia FXÑAnalgesics, Anti-Inflammatory; ÑAnti-Inflammatory Agents; ÑBody Temperature; ÑHeat-Shock Proteins LH LS; LX; ; ;  MSFever in which the etiology cannot be ascertained. PM74 HN74(71) MHÑFever of Unknown Origin ANreferred to as FUO; for ultimate determ of cause or origin coord FEVER OF UNKNOWN ORIGIN /etiol (IM) (not /diag) + disease /compl (IM) (not /diag) PIFever (66-70) MNC23.888.189.344.345 LH  PM73 HN73(70) MHÑFiber Optics ANonly /instrum PIOptics (66-69) MNH1.671.606.400 LH  MHÑFibrin ANdo not use /blood RN9001-31-4 MND12.776.124.270; D19.461.270.463.400 LH  MSSoluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Synonyms: FDP; fibrinolytic degradation products; fibrin(ogen) degradation products; fibrin(ogen) derivatives. PM76 HN76 MHÑFibrin Fibrinogen Degradation Products ANdo not use /analogs /blood /defic; in texts as FDP; DF: FFDP PIFibrin/ME (70-75); Fibrinogen/ME (70-75) MND12.776.124.270.300; D12.776.811.300.290; D19.461.119.71.374 XSAntithrombin VI; Fibrin Fibrinogen Split Products LH LS;  OLuse FIBRIN FOAM to search FIBRIN FILM AND FOAM back thru 1966 (as Prov 1966-72) PM73; was FIBRIN FILM AND FOAM see under HEMOSTATICS 1963-72 HN73; was FIBRIN FILM AND FOAM 1963-72 (Prov) see under HEMOSTATICS MHÑFibrin Foam ANdo not use /analogs /biosyn /defic RN9007-75-4 PIHemostatics (66-72) MND19.461.270.463.400.428 LH  MHÑFibrinogen ANdo not use /blood; /defic = AFIBRINOGENEMIA RN9001-32-5 MND12.776.124.50.250; D12.776.124.125.500; D12.776.811.300; D19.461.270.229.385; D19.461.270.463.456 XSFactor I XUÑFibrinopeptides A; ÑFibrinopeptides B LH LS LU;  MSProduct of the lysis of plasminogen (profibrinolysin) by plasminogen activators; composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000; the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin; quickly inactivated by antiplasmins. Synonyms: Actase; Lysofibrin; serum tryptase; Thrombolysin. MHÑFibrinolysin ANdo not use /blood RNEC 3.4.21.7 MND8.586.277.656.732.328; D19.461.427.303 XSPLASMIN; Thrombolysin LH LS;  MHÑFibrinolysis ANonly /drug eff /rad eff MNG9.188.560.150.390 LH  MSFibrinolysin or agents that convert plasminogen to fibrinolysin; they may be endogenous or exogenous like the bacterial enzymes used in thrombembolism. PM66 HN66 MHÑFibrinolytic Agents ANdo not use /analogs /antag ( = ANTIFIBRINOLYTIC AGENTS) /biosyn /defic /physiol MND19.461.427 XSANTITHROMBOTIC AGENTS; THROMBOLYTIC AGENTS LH LS;  MSTwo small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin. Each peptide chain contains 18 amino acid residues. The removal of fibrinopeptides A is required for blood coagulation. HN(76) MHÑFibrinopeptides A ANdo not use /analogs /blood /defic PIFibrinogen (68-75); Peptides (68-75) MND12.644.200; D12.776.124.270.310; D12.776.811.300.310 DMÑFibrinogen LH LM  MSTwo small peptide chains removed from the N-terminal segment of the beta chains of fibrinogen by the action of thrombin. Each peptide chain contains 20 amino acid residues. The removal of fibrinopeptides B is not required for coagulation. HN(76) MHÑFibrinopeptides B ANdo not use /analogs /blood /defic PIFibrinogen (68-75); Peptides (68-75) MND12.644.205; D12.776.124.270.320; D12.776.811.300.320 DMÑFibrinogen LH LM  MSPeptide isolated from the pituitary gland and from the brain. Potent mitogen which stimulates growth of a variety of mesodermal cells including chondrocytes, granulosa, and endothelial cells. May be active in wound healing and animal limb regeneration. PM84 HN84 MHÑFibroblast Growth Factor AN/biosyn /physiol permitted RN62031-54-3 PIFibroblasts (74-83); Growth Substances (74-83); Mitogens (74-83); Nerve Tissue Proteins (74-83); Peptides (74-83); Pituitary Hormones (74-83) MND11.303.400; D12.644.212; D24.185.348.383 LH  MSConnective tissue cells which differentiate into chondroblasts, collagenoblasts, and osteoblasts. PM65 HN65(64) MHÑFibroblasts ANNIM; A 11 qualif MNA11.329.228; A11.872.228 LH  MSA chronic disorder comprised of three variants which range from lesions consisting primarily of an overgrowth of fibrous tissue to those characterized by dominance of the proliferation of the epithelial parenchyma to a form of dysplasia characterized by both stromal and epithelial hyperplasia with the formation of cysts. PM84; was see under BREAST DISEASES 1980-83 HN84(80); was see under BREAST DISEASES 1980-83 MHÑFibrocystic Disease of Breast ANcommonly chronic so do not coord with CHRONIC DISEASE; ╥breast cyst╙ goes here PIBreast Diseases (66-79) MNC4.182.289; C19.146.378 XSAdenosis of Breast; Breast Dysplasia; Cystic Disease of Breast; Fibrocystic Mastopathy; Mammary Dysplasia; Mastitis, Cystic LH LS; ; ; ; ;  MHÑFibroin AN/biosyn /physiol permitted RN9007-76-5 MND12.776.860.392 LH  MHÑFibroma ANnot for uterine fibroma ( = LEIOMYOMA + UTERINE NEOPLASMS); desmoid goes here; fibromatosis goes here but note FIBROMATOSIS GINGIVAE; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.316 FXÑTUBEROUS SCLEROSIS LH LX  PM65 HN65 MHÑFibromatosis Gingivae ANdo not use /congen MNC16.131.314.687.304 LH  MSAn idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to stenosis of small and medium-sized arteries. Most commonly affected are the renal arteries; involvement of the axillary, iliac, basilar, carotid, hepatic and intracranial arteries have been reported. HN(78) MHÑFibromuscular Dysplasia ANaffects musculature of arterial walls: do not confuse with various musc dis in Cat C5; coord IM with specific artery or pre-coord arterial dis (IM) PIArterial Occlusive Diseases (73-77); Carotid Artery Diseases (66-77); Renal Artery Obstruction (66-77); Vascular Diseases (66-77) MNC14.907.137.372 DMÑArterial Occlusive Diseases LH LM  MSGlycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Synonyms: CSP; galactoprotein a; Gap a; large external transformation-sensitive proteins; SFA; Zeta. PM80 HN80 MHÑFibronectins AN/biosyn /physiol permitted; do not use /analogs PICryoglobulins (66-79); Glycoproteins (66-79); Membrane Proteins (77-79) MND12.776.377.715.390; D12.776.395.350; D12.776.543.350 XSCold-Insoluble Globulins; LETS Proteins LH LS;  MHÑFibrosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); fibrosarcoma of breast = CYSTOSARCOMA PHYLLODES; odontogenic fibrosarcoma = ODONTOGENIC TUMORS MNC4.557.499.344; C4.557.863.304 LH  MSAny pathological condition where fibrous connective tissue invades any organ; usually as a consequence of inflammation or other injury. PM87 HN87 MHÑFibrosis ANNIM only as pathol process with no qualif: coord with Cat A term /pathol (IM); also available are CYSTIC FIBROSIS, ENDOMYOCARDIAL FIBROSIS, MYELOFIBROSIS, ORAL SUBMUCOUS FIBROSIS, PULMONARY FIBROSIS & RETROPERITONEAL FIBROSIS PIspecific organ/pathology MNC23.420 XSCirrhosis LH LS  MHÑFibrositis MNC5.651.324; C5.799.321; C23.205.200.732.321 XSRHEUMATISM, MUSCULAR FXÑMyofascial Pain Syndromes LH LS LX  OLuse FIBROUS DYSPLASIA OF BONE to search FIBROUS DYSPLASIA 1966 (as Prov); search ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966 PM67; ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66 HN67; was FIBROUS DYSPLASIA 1963-66 (Prov); ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66 MHÑFibrous Dysplasia of Bone ANGEN or unspecified; note cross-refs & annotations above & below; periapical fibrous dysplasia = CEMENTOMA MNC5.116.99.708.375 XSOSTEITIS FIBROSA DISSEMINATA XUÑFibrous Dysplasia, Monostotic; ÑFibrous Dysplasia, Polyostotic LH LS LU;  OLsearch FIBROUS DYSPLASIA OF BONE 1967-74; search ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966 HN(75); ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66 MHÑFibrous Dysplasia, Monostotic ANJaffe-Lichtenstein usually goes here but check text for possible ╥polyostotic╙ MNC5.116.99.708.375.372 DMÑFibrous Dysplasia of Bone LH LM  OLsearch FIBROUS DYSPLASIA OF BONE 1967-74; search ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966 HN(75); ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66 MHÑFibrous Dysplasia, Polyostotic ANalso called Albright syndrome; sometimes Jaffe-Lichtenstein (usually monostotic) goes here: check text MNC5.116.99.708.375.381 XSMcCune-Albright Syndrome DMÑFibrous Dysplasia of Bone LH LS LM  MHÑFibula MNA2.835.232.484.321 LH  MSA sulfhydryl proteinase with cysteine at the active site from ficus latex. Preferential cleavage is at tyrosine and phenylalanine residues. Acts on a wide variety of protein substrates. Formeryl EC 3.4.4.12 HN(75) MHÑFicin ANdo not use /analogs RNEC 3.4.22.3 PIPeptide Peptidohydrolases (71-74) MND8.586.277.656.732.350 DMÑPeptide Peptidohydrolases LH LM  MSbeta-D-Fructofuranosyl alpha-D-glucopyranoside polymer. A sucrose polymer of high molecular weight. HN(75) MHÑFicoll ANdo not use /biosyn /defic /physiol; /analogs NIM only RN25702-74-3 PIPolysaccharides (71-74); Propanediols (74); Sucrose (71-74) MND9.203.698.330 DMÑPolysaccharides LH LM  MS7H-Furo[3,2-g][1]benzopyran-7-one. Proposed anthelmintic obtained from Psoralea corylifolia and other plants. HN(75); was see under COUMARINS 1975-78 MHÑFicusin ANdo not confuse synonym PSORALEN, this specific drug, with PSORALENS; do not use /analogs ( = PSORALENS) /defic /physiol RN66-97-7 PICoumarins (66-74); Furans (66-74) MND3.438.150.446.750.480 XSPsoralen DMÑPsoralens LH LS LM  MSThe ability to respond to segments of the perceptual experience rather than to the whole. PM72 HN72 MHÑField Dependence-Independence ANno qualif PIPerception (66-71); Visual Perception (66-71) MNF2.463.593.343; F2.463.593.932.345 LH  PM66 HN66(64) MHÑFIGLU Test ANonly /instrum /stand MNE1.223.459.404 XSFORMIMINOGLUTAMIC ACID TEST FXÑAnemia, Macrocytic; ÑFolic Acid Deficiency LH LS LX;  MSA perceptual phenomenon used by Gestalt psychologists to demonstrate that events in one part of the perceptual field may effect perception in another part. MHÑFigural Aftereffect ANonly /drug eff /physiol /rad eff; usually involves displacement of afterimage of geometric pattern in shape & space: differentiate from AFTERIMAGE; while both are in the field of perception, AFTERIMAGE is likely to be in ophthalmol jrnls, FIGURAL AFTEREFFECT, in psychol jrnls MNF2.463.593.932.401; G11.697.911.860.492 LH  HN75 MHÑFiji MNZ1.782.590.373 LH  PMDIPETALONEMA INFECTIONS was ACANTHOCHEILONEMIASIS see under NEMATODE INFECTIONS 1967-74 MHÑFilariasis ANGEN: prefer specifics; if specific is not in MeSH, coord IM with specific filarial nematode under FILARIOIDEA (NIM) MNC3.335.508.361 XSFILARIOIDEA INFECTIONS XUÑDipetalonema Infections; ÑElaeophoriasis; ÑLoaiasis; ÑMansonelliasis; ÑSetariasis LH LS LU; ; ; ;  HN(73) MHÑFilaricides ANdo not use /analogs /biosyn /defic /physiol MND21.201.287.278 DMÑAnthelmintics LH LM  MHÑFilarioidea ANinfection = FILARIASIS but see note there MNB1.500.294.530 XUÑDirofilaria; ÑDirofilaria immitis; ÑMicrofilaria LH LU; ;  MSCollections of related records treated as a unit; ordering of such files. OLuse FILING to search FILES AND FILING back thru 1966 PM85; was FILES AND FILING 1963-84 HN85; was FILES AND FILING 1963-84 MHÑFiling ANIM; only /econ /methods /stand /trends MNL1.300.390 LH  MS4,6,8,10,12,14,16,27-octahydroxy-3-(1-hydroxyhexyl)-17,28-dimethoxyloxacyclooctacosa-17,19,21,23,25-pentaen-2-one. A complex of polyene, lactone, macrolide antibiotics obtained from Streptomyces filipinensis; Filipin III alters membrane function by interfering with membrane sterols, inhibits mitochondrial respiration, and is proposed as an antifungal agent. Filipins I, II, and IV are less important. Synonyms: desoxylagosin; filimarisin; filipin III; NSC 3364; U 5956. HN(75) MHÑFilipin ANdo not use /defic /physiol; /analogs NIM only RN480-49-9 PIFatty Acids, Essential (66-71); Fatty Acids, Unsaturated (72-74); Lactones (66-74); Polyenes (66-74) MND20.85.62.400; D20.136.73.400 DMÑPolyenes LH LM  MSUse of a device (film badge) for measuring exposure of individuals to radiation. It is usually made of metal, plastic, or paper and loaded with one or more pieces of x-ray film. OLuse FILM DOSIMETRY to search FILM BADGE back thru 1971 (as Prov 1971-73) PM79; was FILM BADGE 1974-78 HN79; was FILM BADGE 1971-78 (Prov 1971-73) MHÑFilm Dosimetry ANonly /econ /hist /instrum /methods /stand /util (if by MeSH definition) PIRadiation Monitoring (66-70) MNE5.799.638.420; G3.850.810.370.310; H1.671.768.765.588.379 XSFilm Badge Dosimetry LH LS  OLuse FILTRATION to search FILTERS back thru 1966 PM70; FILTERS was see under FILTRATION 1970-74, was heading 1963-69 HN70; FILTERS was see under FILTRATION 1970-74, was heading 1963-69 MHÑFiltration ANNIM; only /instrum /methods; includes filtration of fluids, gases & radiations; filters: index FILTRATION /instrum; hemofiltration does not go here: index under BLOOD (IM) + ULTRAFILTRATION (IM) MNE5.196.454; H1.181.278.469; H1.181.529.365; H1.671.100.534 LH  MSAn examination, review and verification of all financial accounts. HN(78) MHÑFinancial Audit ANonly /econ /legis /methods /stand /trends /util MNN3.219.463.30.160 DMÑAccounting LH LM  MSThe obtaining and management of funds for institutional needs and responsibility for fiscal affairs. PM78 HN78 MHÑFinancial Management ANonly /econ /legis /methods /stand /trends MNN3.219.463 XSEndowments FXÑIncome XUÑBudgets; ÑCapital Financing; ÑCompetitive Bidding; ÑContract Services; ÑFinancial Management, Hospital; ÑFinancing, Construction; ÑFund Raising; ÑLeasing, Property; ÑRisk Management LH LS LX LU; ; ; ; ; ; ; ;  MSThe obtaining and management of funds for hospital needs and responsibility for fiscal affairs. HN(82) MHÑFinancial Management, Hospital ANonly /econ /legis /methods /stand /trends PIFinancial Management (78-81) MNN2.278.354.180; N3.219.463.280; N4.452.442.180 XSHospital Financial Management DMÑFinancial Management LH LS LM  MH*Financial Support (Non Mesh) MNN3.219.483 LH  MSFunding resources and procedures for capital improvement or the construction of facilities. HN(78) MHÑFinancing, Construction ANonly /class /econ /legis /methods /organ /stand /trends /util PIFinancing, Government (68-77) MNN3.219.463.300 XSBond Issues, Construction; Construction Loans DMÑFinancial Management LH LS; LM  MSFederal, state or local government organized methods of financial assistance. PM68 HN68 MHÑFinancing, Government ANonly /class /econ /legis /methods /organ /stand /trends /util; specify geog for the govt CATALOG: /geog /form PISocial Welfare (66-67) MNN3.219.521.346 XSFinancing, Public; Grants and Subsidies, Government; Hill-Burton Act; Subsidies, Government LH LS; ; ;  MSAll organized methods of funding. PM68 HN68 MHÑFinancing, Organized ANonly /class /econ /legis /methods /organ /stand /trends /util CATALOG: /geog /form PIInsurance (66-67) MNN3.219.521 LH  MSPayment by an individual or his family for health care services which are not covered by a third party payor, either insurance or medical assistance. PM68 HN68 MHÑFinancing, Personal ANonly /class /econ /legis /methods /stand /trends /util CATALOG: /geog /form PIEconomics (66-67) MNN3.219.559 XSPERSONAL EXPENDITURES LH LS  MHÑFinger Injuries ANconsider also THUMB /inj MNC21.866.448.429 LH  PM65 HN65 MHÑFinger Joint ANprimates only: TN 117; any Cat A qualif; /inj = FINGER INJURIES; TN 238: differentiation from FINGERS & indexing instructions MNA2.835.583.345 XUÑMetacarpophalangeal Joint LH LU  MHÑFingers ANprimates only: TN 117; any Cat A qualif; /inj = FINGER INJURIES but consider also THUMB /inj; TN 238: differentiation from FINGER JOINT & indexing instructions; NIM when merely locational as in HAND DERMATOSES (IM) MNA1.378.209.455.430 LH  MSSucking of the finger - one of the most common manipulations of the body found in young children. MHÑFingersucking ANdo not use /drug eff /physiol /rad eff MNF1.145.466.263; F3.234.193.308.428 XSTHUMBSUCKING LH LS  MHÑFinland MNZ1.542.808.380 LH  MSAutomatic or hand operated equipment used to control and extinguish fires. HN(Aug 77) MHÑFire Extinguishing Systems ANno qualif PIFires (66-Jul 77) MNG3.230.100.120.110 DMÑFires LH LM  MSSmall-arms weapons; handguns, pistols, revolvers, etc. PM87 HN87 MHÑFirearms ANonly /class /hist; ballistics goes here only if pertinent to nature of firearm; wound ballistics goes under WOUNDS, GUNSHOT & FORENSIC MEDICINE if pertinent MNJ1.335 XSGuns; Rifles; Shotguns FXÑWounds, Gunshot LH LS; ; LX  MHÑFires ANonly /econ /prev MNG3.230.100.120 XUÑFire Extinguishing Systems LH LU  MSA compulsion to set fires. HN(76); was see under COMPULSIVE BEHAVIOR 1976-80 MHÑFiresetting Behavior ANdo not use /drug eff /physiol /rad eff PIFires (66-75) MNF3.709.597.460.308 XSArson; Pyromania DMÑImpulse Control Disorders LH LS; LM  MHÑFirst Aid ANonly /vet CATALOG: do not use /pop wks MNE2.365.305 FXÑEmergencies; ÑEmergency Medical Services; ÑWounds and Injuries LH LX; ;  PM72 HN72(70) MHÑFish Diseases ANdo not use /compl /vet; don't forget also FISHES (NIM) or specific fish also (IM) & check tag ANIMAL PIAnimal Diseases (66-69); Fishes (66-69) MNC22.362 LH  OLsearch FISH PRODUCTS 1968-74 HN(75) MHÑFish Flour ANonly /ad-poi-tox /anal /rad eff /stand /supply MNJ1.341.370.430 DMÑFish Products LH LM  OLuse FISH OILS to search FISH LIVER OILS back thru 1966 PM83; was FISH LIVER OILS 1963-82 HN83; was FISH LIVER OILS 1963-82 MHÑFish Oils ANonly D25-26 qualif; coord IM with specific fish (NIM) MND10.516.627.430; J1.341.370.550; J1.740.350 XSFish Liver Oils XUÑCod Liver Oil LH LS LU  MSFood products manufactured from fish (e.g., fish flour, fish meal). PM68 HN68 MHÑFish Products AN╥food products manufactured from fish (e.g., fish flour, fish meal)╙ but for canned fish coord FISHES (IM) or specific fish (IM) + FOOD PRESERVATION (IM); coord IM with fish source (NIM); only /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply PIFishes (66-67) MNJ1.341.370 XUÑFish Flour LH LU  MSVenoms produced by fishes, including sharks and sting rays, usually delivered by spines; they contain various substances, including very labile toxins that affect the heart specifically and all muscle generally. PM78 HN78 MHÑFish Venoms ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS PIFishes (66-77); Venoms (66-77) MND24.185.926.580.370; D24.185.965.370 FXÑFishes, Poisonous LH LX  MHÑFisheries ANonly /econ /hist /stand CATALOG: /geog /form MNJ1.576.383 LH  OLuse FISHES to search FISH back thru 1966; use FISHES to search STICKLEBACKS back thru 1975 PM68; was FISH 1963-67 HN68; was FISH 1963-67; STICKLEBACKS was see under FISHES 1975-86 MHÑFishes ANincludes teleosts & elasmobranchs; GEN; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; canned fish: see FISH PRODUCTS above MNB2.493 XSSticklebacks XUÑTuna LH LS LU  PM68 HN68 MHÑFishes, Poisonous ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-67) MNB2.158.286.400; B2.493.392 FXÑFish Venoms; ÑTETRODOTOXIN LH LX;  MSA longitudinal, elliptical or rounded defect in the anoderm extending part or all the way from the anal verge to the pectinate line. Synonyms: anal fissure; anal ulcer. MHÑFissure in Ano ANnot for anal fistula nor fistula in ano ( = RECTAL FISTULA) MNC6.405.469.860.101.430 FXÑFistula LH LX  MHÑFistula ANpolicy: Manual 23.25+; anal fistula or fistula in ano: index RECTAL FISTULA, not FISSURE IN ANO; artificial fistula: Manual 23.25.7; ECK FISTULA (see PORTACAVAL SHUNT, SURGICAL) is also available MNC23.439 FXÑARTERIOVENOUS FISTULA; ÑArterio-Arterial Fistula; ÑBILIARY FISTULA; ÑBLADDER FISTULA; ÑBRONCHIAL FISTULA; ÑDENTAL FISTULA; ÑESOPHAGEAL FISTULA; ÑFISSURE IN ANO; ÑGASTRIC FISTULA; ÑINTESTINAL FISTULA; ÑOROANTRAL FISTULA; ÑPANCREATIC FISTULA; ÑRECTAL FISTULA; ÑRECTOVAGINAL FISTULA; ÑSALIVARY GLAND FISTULA; ÑTRACHEOESOPHAGEAL FISTULA; ÑURINARY FISTULA; ÑVAGINAL FISTULA; ÑVESICOVAGINAL FISTULA LH LX; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;  PM68 HN68(64) MHÑFixation, Ocular ANonly /drug eff /rad eff MNG11.697.384.253 XSOCULAR FIXATION LH LS  MSAgents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements. Great numbers of different agents are used; some are also decalcifying and hardening agents; they must quickly kill and coagulate living tissue. Synonym: Pickling Agents. OLsearch HISTOLOGICAL TECHNICS 1974 PM77; was see under HISTOLOGICAL TECHNICS 1974 HN77; was see under HISTOLOGICAL TECHNICS 1974 MHÑFixatives ANdo not use in biol preservations; do not restrict to histol technics: may be microbiol technics also; D25-26 qualif PIHistological Technics (66-76) MND26.422 FXÑPreservation, Biological LH LX  MSStable, synthetic analog of methionine enkephalin. Actions are similar to those of methionine enkephalin. Its effects can be reversed by narcotic antagonists such as naloxone. PM84 HN84 MHÑFK 33-824 ANdo not use /biosyn /physiol RN64854-64-4 PIEnkephalin, Methionine/AA (83); Enkephalins (78-82) MND12.644.150.250.450.250; D16.538.321.345.600.350 XSDAMME LH LS  MSBis[(3-methyl-1-imidazolidinyl)thiocarbonyl]disulfide. An inhibitor of the last step of noradrenaline biosynthesis. Synonym: Bis(4-methyl-1-homopiperazinyl)thiuram disulfide. HN(75) MHÑFLA 63 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26087-98-9 PIDisulfides (72-74); Imidazoles (72-74) MND3.383.374.275 DMÑImidazoles LH LM  PM65 HN65(64) MHÑFlagella ANA 11 qualif except /cytol; do not confuse with FLAGELLATA (see below) MNA11.368.702.783.513 LH  MSA protein with a molecular weight of 40,000 isolated from bacterial flagella. At appropriate pH and salt concentration three flagellin monomers can spontaneously reaggregate to form structures which appear identical to intact flagella. HN(75) MHÑFlagellin ANdo not use /defic /physiol; /analogs NIM only RN12777-81-0 PIBacterial Proteins (72-74) MND12.776.97.380 DMÑBacterial Proteins LH LM  MSA complication of multiple rib fractures, rib and sternum fractures, or thoracic surgery; in which a portion of the chest wall becomes isolated from the thoracic cage and exhibits paradoxical respiration. HN(80) MHÑFlail Chest PIRib Injuries (66-79); Thoracic Injuries (66-79) MNC21.866.891.315 XSStove-in Chest DMÑThoracic Injuries LH LS LM  MSPyrolysis of organic compounds at the temperature of a hydrogen-air flame to produce ionic intermediates which can be collected and the resulting ion current measured by gas chromatography. HN(75) MHÑFlame Ionization ANNIM; only /instrum /methods MNE5.196.181.349.390; H1.181.278.186.312.300 DMÑChromatography, Gas LH LM  MSMaterials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm. PM78 HN78; was in Cat D & J 1978-82 MHÑFlame Retardants ANonly /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply /util (if by MeSH definition) PIFires (66-77); specific substance MND26.439 XSFire Retardants; Fireproofing Agents LH LS;  MSCommon name for the order Pleuronectiformes. A very distinctive group in that during development they become asymmetrical, i.e., one eye migrates to lie adjacent to the other. They swin on the eyeless side. Flounder, sole, and turbot along with several others are included in this order. PM87 HN87 MHÑFlatfishes ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; largely food fish; FLOUNDER is available PIFishes (66-86) MNB2.493.418 XSPlaice; Pleuronectiformes; Sole; Turbot XUÑFlounder LH LS; ; ; LU  MHÑFlatfoot ANcongen or acquired MNC5.334.347; C23.304.351.372.347 LH  MHÑFlatulence AN/drug ther: consider also ANTIFOAMING AGENTS; flatus goes here but see note on ╥intestinal gases╙ under GASES MNC23.888.821.360 LH  MHÑFlavins ANdo not use /analogs MND11.557.405 LH  MSA genus of Togaviridae, also known as Group B arboviruses, serologically related to each other but not to other Togaviridae. Most are arboviruses transmitted by mosquitoes or ticks. The type species is the yellow fever virus. OLsearch ARBOVIRUSES 1978-80; use FLAVIVIRUSES to search KYASANUR FOREST DISEASE VIRUS back thru 1975; to search MURRAY VALLEY ENCEPHALITIS VIRUS use FLAVIVIRUSES back thru 1981, ENCEPHALITIS VIRUSES 1977-80 & ARBOVIRUSES 1975-76 PM81; was see ARBOVIRUSES 1978-80; ENCEPHALITIS VIRUS, ST. LOUIS was see under ENCEPHALITIS VIRUSES 1975-80; KYASANUR FOREST DISEASE VIRUS was see under FLAVIVIRUSES 1981-85; was see under ARBOVIRUSES 1975-80; LANGAT VIRUS was see under ARBOVIRUSES 1975-80; MURRAY VALLEY ENCEPHALITIS VIRUS was see ENCEPHALITIS VIRUSES 1977-80, was see ARBOVIRUSES 1975-76 HN81; was see ARBOVIRUSES 1978-80; KYASANUR FOREST DISEASE VIRUS was see under FLAVIVIRUSES 1981-85, was see under ARBOVIRUSES 1975-80; MURRAY VALLEY ENCEPHALITIS VIRUS was see ENCEPHALITIS VIRUSES 1977-80, was see ARBOVIRUSES 1975-76. MHÑFlaviviruses ANone of the Togaviridae; do not use /blood-csf-urine /cytol; infection: coord NIM with TOGAVIRUS INFECTIONS (IM) PIArboviruses (66-80) MNB4.909.777.923.377 XSArboviruses, Group B; Kyasanur Forest Disease Virus; Murray Valley Encephalitis Virus XUÑEncephalitis Virus, St. Louis; ÑLangat Virus LH LS; ; LU;  MHÑFlavobacterium ANin soil & water MNB3.475.400 LH  MSA low-molecular weight (16,000) iron-free flavoprotein containing one molecule of flavin mononucleotide (FMN). Isolated from bacteria grown on an iron-deficient medium. It can replace ferrodoxin in all the electron-transfer functions in which the latter is known to serve in bacterial cells. HN(77) MHÑFlavodoxin ANfrom bacteria; /analogs NIM only PIBacterial Proteins (72-76); Flavoproteins (70-76) MND12.776.97.400; D12.776.331.400 DMÑFlavoproteins LH LM  PMQUERCETIN was see under BIOFLAVONOIDS 1963-74 MHÑFlavones ANdo not use /analogs /defic /physiol MND11.786.170.381; D3.438.150.266.450 XUÑBenzoflavones; ÑFlavoxate; ÑIsoflavones; ÑQuercetin; ÑSilymarin LH LU; ; ; ;  PM73 HN73(71) MHÑFlavoproteins ANdo not use /analogs /defic PIFAD (66-70); FMN (66-70); Proteins (66-70); specific protein or enzyme MND12.776.331 XUÑFlavodoxin LH LU  OLuse FLAVORING AGENTS to search VANILLIN 1966-83 MHÑFlavoring Agents AND25-26 qualif MND26.456; J1.341.390 LH  MS2-Piperidinoethyl-3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride. Flavone derivative with some analgesic and local anesthetic action, but considerable smooth muscle relaxant activity; used to treat neurogenic bladder and other smooth muscle spasms. Synonyms: DW 61; Peflate; Rec 7-0040; Urispadol; Urispas. HN(77) MHÑFlavoxate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN15301-69-6 PICarboxylic Acids (72-74); Flavones (69-76); Piperidines (72-76) MND3.438.150.266.450.300; D16.653.375 DMÑFlavones LH LM  MSParasitic, blood-sucking, wingless insects comprising the order Siphonaptera. OLuse FLEAS to search SIPHONAPTERA back thru 1975 PMSIPHONAPTERA was heading 1975-79 HNSIPHONAPTERA was heading 1975-79 MHÑFleas ANdo not use /drug eff for insecticides: TN 111; /microbiol /parasitol permitted MNB1.131.617.364 XSAphaniptera; Siphonaptera LH LS;  MSN-(2-Piperidylmethyl)-2,5- bis(2,2,2-trifluoroethoxy) benzamide. A potent anti-arrhythmia agent, which is particularly effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Due to its negative inotropic effects, it is clinically useful in patients with impaired ventricular function or chronic congestive heart failure. PM87 HN87 MHÑFlecainide ANdo not use /biosyn /defic /physiol RN54143-55-4 PIPiperidines (66-86) MND3.383.621.270; D18.97.375 LH  MSThe point or frequency at which all flicker of an intermittent light stimulus disappears. MHÑFlicker Fusion ANonly /drug eff /physiol /rad eff; also called flicker fusion frequency (FFF) MNE1.210.331; F2.463.593.932.458; G11.697.911.860.556 LH  PM74 HN74(72) MHÑFlight, Animal ANno qualif PILocomotion (66-71); specific animal MNG11.427.614.281 LH  HN(72) MHÑFlocculation ANalmost never IM; no qualif PIPrecipitation (66-71) MNH1.181.529.741.347 DMÑPrecipitation LH LM  PM73 HN73 MHÑFlocculation Tests ANNIM; only /instrum /methods /vet PIPrecipitin Tests (66-72); Serodiagnosis (66-72) MNE1.223.495.826.769.306 LH  MS2-[(8-(Trifluoromethyl)-4-quinolinyl) amino]benzoic acid 2,3-dihydroxypropyl ester. Anti-inflammatory analgesic similar in action to aspirin; inhibits prostaglandin synthesis. Synonyms: Duralgin; Idarac; Novodolan; R 4318; RU 15750. HN(79) MHÑFloctafenine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23779-99-9 PIAnthranilic Acids (66-78); Quinolines (66-78) MND2.241.223.106.61.105.420; D14.73.278.318 DMÑAnthranilic Acids LH LM  MSThe surface of a structure upon which one stands or walks. HN(Aug 77) MHÑFloors and Floorcoverings ANfor houses, commerc estab, hosp, institutions, etc.; only /econ /stand; DF: FLOORS MNJ1.86.339.140 XSCarpets DMÑFacility Design and Construction LH LS LM  MHÑFlorida MNZ1.107.567.875.274 LH  MSCommon name for two families of fish belonging to the order Pleuronectiformes and are described as left-eye flounders and right-eye flounders. The latter is more commonly used in research. HN(87) MHÑFlounder ANNIM when exper animal; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.418.438 XSPlatichthys; Pleuronectes; Pseudopleuronectes DMÑFlatfishes LH LS; ; LM  MHÑFlour ANwheat or other grains; only /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNJ1.341.409 LH  MSTechnic using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. PM82 HN82 MHÑFlow Cytometry ANonly /instrum /methods; flow cell sorting & fluorescence-activated cell sorting: coord with CELL SEPARATION MNE5.196.712.382.240.350; E5.909.262.386.350 XSCytofluorometry, Flow; Cytometry, Flow; Microfluorometry, Flow LH LS; ;  OLsearch BLOOD FLOW VELOCITY 1966-71 PM74; was see under BLOOD FLOW VELOCITY 1963-71 HN74; was see under BLOOD FLOW VELOCITY 1963-71 MHÑFlowmeters ANdo not use /instrum /methods /util (except by MeSH definition) MNE7.373 XSAnemometers; Doppler Velocimeters; Laser Velocimeters; Velocimeters; Velocity Meters FXÑRheology LH LS; ; ; ; LX  MS6-[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-[3.2.0]heptane-2-carboxylic acid. Antibiotic analog of cloxacillin. Synonym: Floxapen. HN(75) MHÑFloxacillin ANdo not use /biosyn /defic /physiol RN5250-39-5 PICloxacillin (74); Halogens (74) MND20.85.99.739.681.205.379 XSFlucloxacillin; Fluorochloroxacillin DMÑCloxacillin LH LS; LM  PM87; was see under CYTOSINE 1972-86 HN87(72); was see under CYTOSINE 1972-86 MHÑFlucytosine ANdo not use /biosyn /defic /physiol RN2022-85-7 PIAntifungal Agents (66-71); Cytosine (66-71) MND3.383.742.698.421.431; D20.136.295; D26.87.372 XS5-Fluorocytosine LH LS  MHÑFludrocortisone ANdo not use /biosyn /defic /physiol RN127-31-1 MND4.808.745.745.654.430; D4.808.908.323; D6.597.481.561.353.369; D6.597.481.561.478.348; D6.597.648.431; D26.74.125.275 XS9-Fluorocortisol LH LS  PM73 HN73(65) MHÑFlufenamic Acid AND25-26 qualif RN530-78-9 MND2.241.223.106.61.105.431; D14.73.278.321; D26.74.75.514 LH  MSTherapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to water-electrolyte balance. Fluids may be administered intravenously, orally, by intermittent gavage, or by hypodermoclysis. PM79 HN79 MHÑFluid Therapy AN╥to restore volume & composition of body fluids...with respect to water-electrolyte balance╙; for other nourishment use PARENTERAL FEEDING or specifics; do not use /util except by MeSH definition; coord IM with dis /ther (IM), not dis /diet ther; do not specify route of admin unless particularly significant (& then only NIM); rehydration solutions go here & not also under SOLUTIONS PIElectrolytes (66-78); Infusions, Parenteral (66-78); Water-Electrolyte Balance (66-78) MNE2.319.360 XSOral Rehydration Therapy; Rehydration; Rehydration, Oral FXÑElectrolytes; ÑInfusions, Parenteral; ÑWater-Electrolyte Balance LH LS; ; LX; ;  MH*Fluids and Secretions (Non Mesh) MNA12 LH  MSEthyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo (1,5-a)(1,4)benzodiazepine-3-carboxylate. A potent benzodiazepine receptor blockader. Since it reverses the sedative and other actions of benzodiazepine tranquilizers, it has been suggested as an antidote to benzodiazepine tranquilizer overdoses. PM87 HN87 MHÑFlumazepil ANdo not use /biosyn /defic /physiol RN78755-81-4 PIAzepines (66-73); Benzodiazepinones (74-86) MND3.438.79.80.70.305; D26.61.380 XSRo 15-1788 LH LS  PM72 HN72(66) MHÑFlumethasone ANdo not use /biosyn /defic /physiol RN2135-17-3 MND4.808.745.432.769.465; D4.808.908.359; D6.597.481.561.353.431; D6.597.481.561.478.403; D26.74.125.280 XSFluorodexamethasone LH LS  MS1-(Bis-(4-fluorophenyl)methyl) -4-cinnamylpiperazine. Flunarizine is a selective calcium entry blocker with calmodulin binding properties. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. PM87 HN87 MHÑFlunarizine ANdo not use /biosyn /defic /physiol RN52468-60-7 PICinnarizine/analogs & derivatives (75-86); Piperazines (66-74) MND3.383.606.450; D18.192.375 LH  MS5-(o-Fluorphenyl)-2,3-dihydro-1-methyl-7-nitro-1H-1,4-benzodiazepin-2-one. Minor Tranquilizer with pharmacologic actions similar to those of other benzodiazepines. Synonyms: Rohypnol; RO 5-4200. PM84; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83 HN84(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-83 MHÑFlunitrazepam ANdo not use /biosyn /defic /physiol RN1622-62-4 PIBenzodiazepinones (74); Fluorobenzenes (74); Nitro Compounds (74) MND3.438.79.80.70.320; D15.236.872.659.191.365 XSFluridrazepam LH LS  PM65 HN65(63) MHÑFluocinolone Acetonide ANdo not use /biosyn /defic /physiol RN67-73-2 MND4.808.745.432.370; D4.808.908.394; D6.597.481.364.306; D6.597.481.561.353.460; D6.597.481.561.478.420; D26.74.125.306; D26.74.125.447.306; D26.74.148.447.306; D26.368.99.447.306 XSFluortriamcinolone Acetonide XUÑFluocinonide LH LS LU  MS6 alpha,9-Difluoro-11 beta,16 alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone,21-acetate. A topical glucocorticoid used in the treatment of eczemas. Frequently encountered synonyms: Lidex; Metosyn; Topsym; Topsyne. HN(75) MHÑFluocinonide ANdo not use /biosyn /defic /physiol RN356-12-7 PIAcetic Acids (72-74); Fluocinolone Acetonide (72-74) MND4.808.745.432.370.325; D4.808.908.394.300; D6.597.481.364.306.300; D6.597.481.561.353.460.300; D6.597.481.561.478.420.300; D26.74.125.306.389; D26.74.125.447.306.389; D26.74.148.447.306.389; D26.368.99.447.306.389 XSFluocinolide DMÑFluocinolone Acetonide LH LS LM  MS6 alpha-Fluoro-11 beta,21-dihydroxy-16 alpha-methylpregna-1,4-diene-3,20-diono. A topical glucocorticoid with anti-inflammatory activity; used also as caproate, acetate and trimethylacetate. Synonyms: SH 742; SH 770; Ficoid; Ultralan oral; Ultralanum; fluocortolone hexanoate; fluocortolone trimethylacetate. PM80; was see under PREGNADIENEDIOLS 1975-79 HN80(75); was see under PREGNADIENEDIOLS 1975-79 MHÑFluocortolone AND25-26 qualif; /analogs NIM only RN152-97-6 PIKetosteroids (74); Pregnadienediols (74); Steroids, Fluorinated (74) MND4.808.745.432.719.320; D4.808.908.405; D6.597.481.364.325; D6.597.481.561.353.480; D26.74.125.335; D26.74.125.447.335; D26.74.148.447.335; D26.368.99.447.335 XSFluocortolone Caproate; Fluocortolone Pivalate; Fluormethyldehydrocorticosterone XUÑDiflucortolone LH LS; ; LU  MHÑFluorenes ANdo not confuse with FLUORINE; D25-26 qualif; do not use /analogs MND4.615.389; D26.191.372 XUÑTilorone LH LU  MS4-Phenylspiro[furan-2(3H),1'-phthalan]-3,3'-dione. A nonfluorescent reagent for the detection of primary amines, peptides and proteins. The reaction products are highly fluorescent. Synonym: Fluram. HN(75) MHÑFluorescamine AND25-26 qualif; /analogs NIM only RN38183-12-9 PIBenzofurans (74); Spiro Compounds (73-74) MND4.615.885.345; D26.550.330 DMÑSpiro Compounds LH LM  MSVisualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. Used especially in studying the retinal and uveal vasculature. OLuse FLUORESCEIN ANGIOGRAPHY to search FLUORESCENCE ANGIOGRAPHY & FUNDUS FLUORESCENCE ANGIOGRAPHY back thru 1973 PM79; was FLUORESCENCE ANGIOGRAPHY 1973-78 HN79; was FLUORESCENCE ANGIOGRAPHY 1973-78; FUNDUS FLUORESCENCE PHOTOGRAPHY was see under FLUORESCENCE ANGIOGRAPHY 1973-78 MHÑFluorescein Angiography ANonly /instrum /methods /vet; coord disease with /diag, not /radiogr since this is not a radiogr technic PIFluoresceins (66-72); Photography (66-72) MNE1.145.496; E1.210.380 XSFluorescence Angiography; Fundus Fluorescence Photography FXÑRetinal Vessels LH LS; LX  MHÑFluoresceins AND25-26 qualif MND26.408.348.514 XUÑErythrosine; ÑMerbromine; ÑPhloxine B LH LU; ;  MSThe property of emitting radiation while being irradiated; the radiation emitted is usually of longer wavelength than that incident or absorbed; a substance can be irradiated with invisible radiation and emit visible light; x-ray fluorescence is used in diagnosis. MHÑFluorescence ANno qualif; IM for principle of physics but be careful of use of word describing many technics as in entries below; fluorescence-activated cell sorting: index under CELL SEPARATION + FLOW CYTOMETRY MNH1.671.768.369 LH  MSMeasurement of the polarization of fluorescent light from solutions or microscopic specimens. Used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction including dye and coenzyme binding, and the antigen-antibody reaction. PM79 HN79 MHÑFluorescence Polarization ANNIM; only /instrum /methods; coord NIM with FLUORESCENT ANTIBODY TECHNIC or MICROSCOPY, FLUORESCENCE if pertinent PIFluorometry (66-78); Spectrometry, Fluorescence (72-78) MNE5.196.712.382.390 LH  MHÑFluorescent Antibody Technic ANsynonyms: immunofluorescence, Coon's technic, fluorescent protein tracing; only /instrum CATALOG: do not use /laboratory manuals MNE1.223.495.348; E5.478.348 XSIMMUNOFLUORESCENCE TECHNIC XUÑAntibody-Coated Bacteria Test, Urinary LH LS LU  MSDyes that emit light when exposed to light; the wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags; used as markers in biochemistry and immunolog. MHÑFluorescent Dyes AND25-26 qualif MND26.408.348 XSFluorescent Probes; Fluorochromes LH LS;  PM65 HN65 MHÑFluoridation ANonly /econ /hist /instrum /methods /stand /trends; /adv eff permitted but more likely is FLUORIDES /adv eff or specific fluoride terms /adv eff; = ╥fluoridation of water supply╙ so do not also coord with WATER SUPPLY MNE6.761.382; G3.850.860.510.565.200; G3.890.235 FXÑCariostatic Agents LH LX  MHÑFluoride Poisoning ANdo not use /chem ind MNC21.613.380 LH  MHÑFluorides ANonly for inorganic cpds or fluoride ion; do not use /analogs; /admin: consider also FLUORIDES, TOPICAL; /pois = FLUORIDE POISONING MND1.248.497.158.385.432; D1.396.514.348 XUÑSulfur Hexafluoride; ÑTin Fluorides LH LU;  MSFluorides, usually as pastes or gels, used for topical application to reduce the incidence of dental caries. PM65 HN65 MHÑFluorides, Topical AND25-26 qualif; fluoride-containing toothpastes: index TOOTHPASTE (IM) + FLUORIDES (IM), not here MND25.223.432 LH  MHÑFluorine ANF-19; do not use /analogs /biosyn /defic /physiol; F-17, 18, 20-22 = FLUORINE (IM) + RADIOISOTOPES (IM) RN7782-41-4 MND1.248.497.158.385; D1.268.314; D1.396.514; D1.937.338 LH  MHÑFluoroacetates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.38.209.348 XUÑTrifluoroacetic Acid LH LU  PM74 HN74 MHÑFluorobenzenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.526.510.432 LH  PM66 HN66 MHÑFluorocarbon Polymers AND25-26 qualif MND25.720.395 XSFluorinated Polymers; Fluorocarbon Resins FXÑHydrocarbons, Fluorinated LH LS; LX  MSLiquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. Use this term for fluorocarbon emulsions and fluorocarbon blood substitutes. PM77; was see under FLUOROCARBON POLYMERS 1975-76; PERFLUOROBUTYL TETRAHYDROFURAN was see under FURANS 1975-77 HN77(75); was see under FLUOROCARBON POLYMERS 1975-76 MHÑFluorocarbons ANdo not confuse with HYDROCARBONS, FLUORINATED; D25-26 qualif; do not use /analogs PIFluorocarbon Polymers (74-76); Freons (74-76); Hydrocarbons, Fluorinated (74-76) MND2.375; D3.300; D4.615.400 XSFluorocarbon Emulsions; Perfluorocarbons FXÑBlood Substitutes XUÑPerfluorobutyl Tetrahydrofuran LH LS; LX LU  MHÑFluorodeoxyuridine ANdo not use /biosyn /defic /physiol RN50-91-9 MND13.570.230.430.432; D13.570.685.852.300.350; D20.388.365; D22.204.144.512; D26.87.381 XSFUDR; Floxuridine LH LS;  MS5-Fluoro-2'-deoxyuridylate. An inhibitor of thymidylate synthetase. Formed from 5-fluorouracil or 5-fluorodeoxyuridine. HN(75); was see under URACIL NUCLEOTIDES 1975-77 MHÑFluorodeoxyuridylate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN134-46-3 PIDeoxyribonucleotides (73-74); Fluorine (72-74); Uracil Nucleotides (72-74) MND13.695.201.200.270; D13.695.740.850.210.200 DMÑDeoxyuracil Nucleotides LH LM  MHÑFluorometholone ANdo not use /biosyn /defic /physiol RN426-13-1 MND4.808.745.432.719.349; D4.808.908.431; D6.597.481.364.370; D6.597.481.561.353.500; D6.597.481.561.478.460; D26.74.125.370; D26.74.125.447.370; D26.74.148.447.370; D26.368.99.447.370 LH  PM66 HN66(64) MHÑFluorometry ANNIM; only /instrum /methods; fluorescence spectrometry = SPECTROMETRY, FLUORESCENCE; ╥fluorimetry╙ goes here MNE5.196.712.382 LH  MSProduction of an image when x-rays strike a fluorescent screen. MHÑFluoroscopy ANNIM; do not use /util except by MeSH definition MNE1.818.312 XUÑPhotofluorography LH LU  MHÑFluorouracil ANdo not use /biosyn /defic /physiol RN51-21-8 MND3.383.742.698.875.404; D22.204.144.545; D26.87.387 LH  MSN-Methyl-3-phenyl-3-[(alpha, alpha, alpha-trifluoro-p-tolyl)oxy]propylamine. Inhibitor of neuronal serotonin reuptake and action; proposed as antidepressant or analgesic; used mainly to study serotonin metabolism. Synonym: Lilly 110140. HN(79) MHÑFluoxetin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN54910-89-3 PIPhenyl Ethers (74-78); Propylamines (66-78) MND2.92.831.280; D23.846.365 DMÑPropylamines LH LM  MHÑFluoxymesterone ANdo not use /biosyn /defic /physiol RN76-43-7 MND4.808.54.79.429.154.349; D4.808.908.466; D6.597.100.194.289 XSFluoximesteron LH LS  MS4-[3-[2-(Trifluoromethyl)thioxanthene-9-ylidene]propyl]-1-piperazineethanol. Major tranquilizer used in schizophrenia. Synonym: Fluanxol. HN(75) MHÑFlupenthixol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2709-56-0 PIAlcohol, Ethyl (70-74); Piperazines (70-74); Thioxanthenes (74) MND3.494.953.704.360; D3.383.606.460; D15.236.872.331.390 DMÑThioxanthenes LH LM  MHÑFluphenazine ANdo not use /biosyn /defic /physiol RN69-23-8 MND3.494.741.326; D15.236.872.331.628.340 XSFlufenazin LH LS  PM65 HN65 MHÑFluprednisolone ANdo not use /biosyn /defic /physiol RN53-34-9 MND4.808.745.432.769.795.307; D4.808.908.502; D6.597.481.561.353.744.349; D6.597.481.561.478.702.349; D26.74.125.744.349 LH  PM65 HN65(63) MHÑFlurandrenolone ANdo not use /biosyn /defic /physiol RN1524-88-5 MND4.808.745.745.654.473; D4.808.908.537; D6.597.481.364.432; D6.597.481.561.353.520; D6.597.481.561.478.480; D26.74.125.432; D26.74.125.447.432; D26.74.148.447.432; D26.368.99.447.432 XSFludroxycortid; Flurandrenolide LH LS;  MS7-Chloro-1-[2-(diethylamino)ethyl] -5-(o-fluorophenyl) 1,3-dihydro-2H-1,4-benzodiazepin-2-one. Diazepam derivative benzodiazepine used mainly as hypnotic. Synonyms: Dalmane; Dalmodorm; Felison; RO 5-6901; Somlan. PM80; was see under BENZODIAZEPINE TRANQUILIZERS 1975-79 HN80(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-79 MHÑFlurazepam ANdo not use /biosyn /defic /physiol RN17617-23-1 PIBenzazepines (70-73); Benzodiazepinones (74); Hypnotics and Sedatives (67-74) MND3.438.79.80.70.348; D14.591.745.431; D15.236.872.659.191.395 LH  MS2-(2-Fluorobiphenyl-4-yl)propionic acid. Anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series; proposed antirheumatic. Synonym: BTS 18322. HN(76) MHÑFlurbiprofen ANdo not use /biosyn /defic /physiol; /analogs NIM only; do not confuse with fluprofen RN5104-49-4 PIBiphenyl Compounds (73-75); Fluorine (73-75); Propionates (73-75) MND2.241.81.751.700.350; D14.73.278.328; D26.74.75.552 DMÑPropionates LH LM  PM73 HN73 MHÑFlurothyl ANdo not use /biosyn /defic /physiol RN333-36-8 PIAnaleptics (66-72); Ethers (66-72) MND2.355.417.515; D15.128.224.388 LH  PM73 HN73(64) MHÑFluroxene ANdo not use /biosyn /defic /physiol RN406-90-6 MND2.355.435; D14.166.386 LH  MSTransient redness of the face and neck caused by cutaneous vasodilation due to a variety of causes, such as menopause, drugs, alcohol, and carcinoid tumors. Does not include BLUSHING. PM84 HN84 MHÑFlushing ANonly likely qualif are /etiol /physiopathol /pathol /ther; do not confuse with BLUSHING MNC23.888.398 FXÑBlushing LH LX  MS8-[4,4-Bis(p-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro-(4.5)decan-4-one. Long acting injectable antipsychotic agent used for chronic schizophrenia. HN(75) MHÑFluspirilene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1841-19-6 PIFluorobenzenes (74); Piperidines (72-74); Spiro Compounds (69-74) MND3.383.374.290; D3.383.621.280; D4.615.885.350; D15.236.872.331.400 XSSpirodiflamine DMÑSpiro Compounds LH LS LM  MS4'-Nitro-3'-trifluoromethylisobutyranilide. An antiandrogen with about the same potency as cyproterone in rodent and canine species. Synonym: SCH-13521. HN(75) MHÑFlutamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13311-84-7 PIAnilides (73-74); Nitro Compounds (73-74); Hydrocarbons, Fluorinated (74) MND2.65.199.420; D6.347.65.340 XSSCH 13521 DMÑAnilides LH LS LM  MHÑFMN RN146-17-8 MND8.176.360; D13.695.827.349 XSFLAVIN MONONUCLEOTIDE LH LS  MSLipid-laden macrophages, originating from monocytes or from smooth muscle cells. HN(77) MHÑFoam Cells ANA 11 qualif PIMacrophages (66-76) MNA11.329.372.368; A11.733.397.368; A15.382.680.397.368; A15.382.812.522.368 DMÑMacrophages LH LM  MSThis agent is the commonest contaminant of monkey-kidney cultures; not known to be pathogenic. HN(75); was see under LEUKOVIRUSES 1978-80, was see under LEUKEMOGENIC VIRUSES 1975-77 MHÑFoamy Virus ANdo not use /blood-csf-urine /cytol PIRNA Viruses (75-74) MNB4.909.777.731.440 XSFoamy Agent DMÑRetroviridae LH LS LM  MSA genetic skin disease characterized by hypoplasia of the dermis, herniations of fat, and hand anomalies. HN(85); was see under ECTODERMAL DEFECT, CONGENITAL 1985-86 MHÑFocal Dermal Hypoplasia ANdo not confuse X ref GOLTZ-GORLIN SYNDROME with Gorlin-Goltz syndrome which is same as GORLIN SYNDROME see BASAL CELL NEVUS SYNDROME PIAbnormalities, Multiple (68-84); Skin (66-84); Skin Diseases (66-84) MNC5.116.99.370.380; C16.131.77.350.424; C16.131.831.350.424; C17.827.375.424 XSDermal Hypoplasia, Focal; Goltz-Gorlin Syndrome DMÑEctodermal Dysplasia LH LS; LM  MHÑFocal Infection ANIM; coord with precoord organ/dis site of infection (IM) + name of infection (IM) MNC1.539.392 LH  MSSecondary or systemic infections due to dissemination throughout the body of microorganisms whose primary focus of infection lies in the periodontal tissues. PM64 HN64 MHÑFocal Infection, Dental ANIM; coord with precoord organ/dis site of infection (IM) + name of infection (IM) MNC1.539.392.433; C7.793.348 XSDental Focal Infection LH LS  OLuse FOLIC ACID/AA to search HOMOFOLIC ACID 1975-84 PMHOMOFOLIC ACID was heading 1975-84 HNHOMOFOLIC ACID was heading 1975-84 MHÑFolic Acid AN/antag = FOLIC ACID ANTAGONISTS; /defic = FOLIC ACID DEFICIENCY; /biosyn permitted for bact & yeasts; /physiol permitted RN59-30-3 MND3.438.733.631.400; D11.786.708.328; D12.125.119.511.400; D19.461.543.349 XSPTEROYLGLUTAMIC ACID; VITAMIN M XUÑPteroylpolyglutamic Acids LH LS; LU  MHÑFolic Acid Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: FOLIC ACID ANTAG MND22.204.144.579; D26.87.393 LH  PM66 HN66(64) MHÑFolic Acid Deficiency MNC18.654.223.133.699.308 FXÑANEMIA, SIDEROBLASTIC; ÑFIGLU TEST LH LX;  MSThe common orally transmitted traditions, myths, festivals, songs, superstitions, and stories of all peoples. MHÑFolklore ANno qualif MNI1.76.201.450.515 LH  MSThe degeneration and resorption of an ovarian follicle before it reaches maturity and ruptures. HN(85) MHÑFollicular Atresia ANnote category; only /drug eff /rad eff PIGraafian Follicle (66-84); Ovulation (66-84) MNG8.520.440.310.358 XSAtresia, Follicular DMÑFollicular Phase LH LS LM  MSCyst due to the occulsion of the duct of a follicle or small gland. PM87 HN87 MHÑFollicular Cyst ANnon-neoplastic; /anal /blood supply /secret /ultrastruct permitted MNC4.182.300 LH  MSThe period of the menstrual cycle that begins with menstruation and ends with ovulation. OLuse FOLLICULAR PHASE to search MENSTRUATION, FOLLICULAR PHASE back thru 1975 PM85; was MENSTRUATION, FOLLICULAR PHASE see under MENSTRUATION 1975-84 HN85(75); was MENSTRUATION, FOLLICULAR PHASE see under MENSTRUATION 1975-84 MHÑFollicular Phase ANonly /drug eff /rad eff MNG8.520.440.310 XSMenstrual Cycle, Follicular Phase; Menstruation, Follicular Phase; Preovulatory Phase XUÑFollicular Atresia LH LS; ; LU  OLuse FOLLICULITIS to search SYCOSIS back thru 1966 PMSYCOSIS was heading 1963-77 HNSYCOSIS was heading 1963-77 MHÑFolliculitis ANinflammation of hair follicles MNC17.805.305.383 XSSycosis XUÑAcne Keloid LH LS LU  PM67 HN67(65) MHÑFollow-Up Studies ANIM general only; NIM with specific study IM; no qualif; TN 86: definition & use: usually epidemiol in concept; relation to age tag: Manual 18.5.13, relation to CASE REPORT: Manual 18.11.6 MNE5.318.420.390 LH  MS3'-Chloro-2'-[methyl[(morpholinocarbonyl)methyl]amino]methylbenzanilide hydrochloride. Antitussive agent. Synonyms: Noleptan; PB 89. HN(75) MHÑFominoben ANdo not use /biosyn /defic /physiol; /analogs NIM only RN18053-31-1 PIAnilides (72-74); Methylamines (72-74); Morpholines (72-74) MND3.383.468.300; D23.338.500 DMÑMorpholines LH LM  MHÑFood ANonly /econ /stand; /adv eff = probably FOOD HYPERSENSITIVITY or FOOD POISONING; /anal = FOOD ANALYSIS; /pois = FOOD POISONING; /rad eff: probably FOOD IRRADIATION or FOOD CONTAMINATION, RADIOACTIVE; /supply = FOOD SUPPLY; Manual 31.5-31.12; food intake = EATING; food consumption = FOOD or EATING or FOOD SUPPLY; food for animals = ANIMAL FEED; refeeding after starvation goes here; differentiation from DIET & NUTRITION: see note under NUTRITION & Manual 31.5 MNJ1.341 FXÑDIET; ÑNutrition; ÑPLANTS, EDIBLE LH LX; ;  MSSubstances which are of little or no nutritive value, but are used in the processing or storage of foods or animal feed, especially in the developed countries; includes ANTIOXIDANTS, FOOD PRESERVATIVES, FOOD COLORING AGENTS, FLAVORING AGENTS, ANTI-INFECTIVE AGENTS (both plain and LOCAL), VEHICLES, EXCIPIENTS and other similarly used substances. Many of the same substances are PHARMACEUTIC AIDS when added to pharmaceuticals rather than to foods. MHÑFood Additives AND25-26 qualif MND26.471; J1.341.430 FXÑPharmaceutic Aids LH LX  MHÑFood Analysis ANGEN only; prefer /anal with specific food item in Cat J; only /instrum /methods /stand MNE5.362; J1.409.266 LH  MSNatural or synthetic dyes used as coloring agents in processed foods. PM75 HN75 MHÑFood Coloring Agents AND25-26 qualif; natural or synthetic PIFood Additives (66-74) MND26.471.355 XSColoring Agents, Food FXÑDyes LH LS LX  MSThe presence in food of harmful, unpalatable, or otherwise objectionable foreign substances, e.g. chemicals, microorganisms or diluents, before, during, or after processing or storage. MHÑFood Contamination ANonly /anal /econ /prev; coord IM with specific food item probably NIM; contamination by dirt, dust, chemicals & toxic substances, organisms (but don't forget also FOOD MICROBIOLOGY exists) MNG3.850.460.400 XSFood Adulteration LH LS  MHÑFood Contamination, Radioactive ANonly /anal /econ /prev; do not confuse with FOOD IRRADIATION: food preservation by irradiation MNG3.850.810.125; G3.850.460.400.250 LH  MSThe withholding of food in a structured experimental situation. PM69 HN69 MHÑFood Deprivation ANhuman & animal; consider also FASTING & STARVATION; /physiol permitted for physiol & metab eff PIHunger (66-68); Motivation (66-68) MNF1.658.433 FXÑHunger; ÑStarvation LH LX;  MSMechanical food dispensing machines. HN(Aug 77) MHÑFood Dispensers, Automatic ANonly /class /econ /stand /util MNJ1.364.434.420; J1.576.416.420 XSVending Machines, Food DMÑFood Services LH LS LM  MSAcquired or learned food preferences. OLuse FOOD HABITS to search DIETARY HABITS back thru 1969 PM69 HN69; DIETARY HABITS was see under FOOD HABITS 1969-78 MHÑFood Habits ANonly /drug eff /ethnol /physiol /psychol /rad eff CATALOG: /geog /form PIDiet (66-68); Ethnology (66-68); Food (66-68); Nutrition Surveys (66-68) MNF1.145.407.432; F1.145.466.349 XSDietary Habits LH LS  MSAny aspect of the operations in the preparation, transport, storage, packaging, wrapping, exposure for sale, service or delivery of food. MHÑFood Handling ANincludes prep, processing, handling, transport, packaging, serving, delivering, etc.; only /econ /instrum /methods /stand MNJ1.364.434; J1.576.416 XSFood Processing LH LS  MSGastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens ingested in food. PM66; was FOOD ALLERGY 1963-65 HN66; was FOOD ALLERGY 1963-65 MHÑFood Hypersensitivity AN╥food allergy╙; do not use /chem ind; coord IM with specific food /adv eff (IM): Manual 31.12 MNC20.543.309 LH  MHÑFood Inspection ANonly /econ /hist /methods /stand CATALOG: /geog /form MNG3.850.860.275; J1.409.350 LH  MHÑFood Irradiation ANfood preservation by irradiation: do not confuse with FOOD CONTAMINATION, RADIOACTIVE; only /adv eff /econ /hist /methods /stand MNJ1.409.599.309 XSFood, Irradiated LH LS  MSUse of written, printed, or graphic materials upon or accompanying a food or its container or wrapper. Includes ingredients, nutritional value, directions, warnings, and other relevant information. PM74 HN74 MHÑFood Labeling ANonly /econ /hist /instrum /methods /stand /trends MNE5.780.390; J1.409.433; J1.790.390 XSLabeling, Food; Nutrition Labeling; Product Labeling, Food LH LS; ;  PM66 HN66 MHÑFood Microbiology ANIM; no qualif; coord (IM) with specific microbe (IM) + specific food item (IM or NIM depending upon significance); don't forget FOOD CONTAMINATION also exists MNG1.273.540.371; G3.850.425.200; G3.850.460.400.300; J1.409.516 LH  MHÑFood Poisoning ANGEN only; prefer /pois with specific food items in Cat J: Manual 31.11; do not use /chem ind; MUSHROOM POISONING, PLANT POISONING, SALMONELLA FOOD POISONING & STAPHYLOCOCCAL FOOD POISONING are also available MNC21.613.415 LH  MSThe selection of one food over another. PM69 HN69 MHÑFood Preferences ANhuman & animal; only /drug eff /rad eff PIBehavior (66-68); Behavior, Animal (66-68); Diet (66-68); Food (66-68) MNF1.145.407.516 XSFOOD SELECTION LH LS  MHÑFood Preservation ANonly /adv eff /econ /hist /instrum /methods /stand MNJ1.409.599 XSFood, Canned; Food, Dried; Food, Preserved; PRESERVATION, FOOD XUÑFrozen Foods LH LS; ; ; LU  MSSubstances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. PM75 HN75 MHÑFood Preservatives AND25-26 qualif PIFood Additives (66-74) MND26.471.385 FXÑAntioxidants LH LX  MSHospital department which manages and supervises the dietary program in accordance with the patients' requirements. OLuse FOOD SERVICE, HOSPITAL to search HOSPITAL FOOD SERVICE back thru 1966 PM78; was HOSPITAL FOOD SERVICE 1963-77 HN78; was HOSPITAL FOOD SERVICE 1963-77 MHÑFood Service, Hospital ANonly /econ /legis /man /organ /stand /trends /util MNN2.278.354.422.374; N2.421.242.472; N4.452.442.422.374 XSHospital Food Service FXÑDietetics; ÑFood Services LH LS LX;  MSFunctions, equipment and facilities concerned with the preparation and distribution of ready-to-eat food. PM76 HN76; was FOOD SERVICE (NON MESH) before 1976 MHÑFood Services ANincludes food distribution programs, food stamp plans, school lunches, child feeding programs; only /class /econ /man /stand /util; do not confuse with DIETARY SERVICES where nutrition is emphasized MNJ1.364 XSMeals on Wheels FXÑFood Service, Hospital XUÑFood Dispensers, Automatic; ÑMenu Planning LH LS LX LU;  MHÑFood Supply ANonly /econ /hist /stand CATALOG: /geog /form MNJ1.387 LH  MSThe application of knowledge to the food industry. PM76 HN76; was NON MESH before 1976 MHÑFood Technology ANIM; usually in ref to the food industry & food manufacture or prep on a large scale; covers aroma, flavor, color, texture, temperature, preparability, cookability, packaging, etc.; only /educ /hist /instrum /man /stand CATALOG: /geog /form MNJ1.409 XSTechnology, Food LH LS  MSThe productive enterprises concerned with food processing. MHÑFood-Processing Industry ANonly /econ /hist /stand MNJ1.576.416.428 LH  MSFood and dietary formulations. Includes imitation foods such as egg, meat, and dairy substitutes, nutritionally complete formulas such as elemental (chemically defined, defined formula) diets, synthetic and semisynthetic diets, space diets, weight reduction formulas, tube-feeding diets, and complete liquid diets, and supplemental liquid and solid diets. OLuse FOOD, FORMULATED to search FOOD, ARTIFICIAL & FOODS, ARTIFICIAL back thru 1972 (as Prov 1972-74) PM80; was FOOD, ARTIFICIAL 1979, was FOOD, ARTIFICIAL see under FOOD 1975-78 HN80; was FOOD, ARTIFICIAL 1979, was FOOD, ARTIFICIAL see under FOOD 1975-78, was FOOD, ARTIFICIAL 1973-74 (Prov), was FOODS, ARTIFICIAL 1972 (Prov) MHÑFood, Formulated ANonly /ad-poi-tox /anal /econ /rad eff /stand /supply; includes imitation eggs, meat, dairy prod, space diets, weight reduction formulas, tube-feeding diets; does not include infant formulas and baby foods ( = INFANT FOOD) PIFood (66-71); specific component MNJ1.341.449 XSDiet, Chemically Defined; Diet, Elemental; Diet, Formula; Diet, Synthetic; Dietary Formulations FXÑEnteral Feeding LH LS; ; ; ; LX  OLuse FOOD, FORTIFIED to search FOODS, FORTIFIED back thru 1970 (as Prov 1970-72) PM73 HN73; was FOODS, FORTIFIED 1970-72 (Prov) MHÑFood, Fortified ANonly /ad-poi-tox /anal /econ /rad eff /stand /supply PIFood (66-69) MNJ1.341.468 XSEnriched Food; Food, Supplemented LH LS;  MHÑFoot ANvertebrates only: for invertebrates use EXTREMITIES: TN 117; /abnorm permitted but note FOOT DEFORMITIES, ACQUIRED; dis of foot = FOOT DISEASES; skin dis on foot = FOOT DERMATOSES; neopl of foot: use neopl coords (IM) + FOOT DISEASES (IM); foot ulcer: index under FOOT DISEASES (IM) + probably SKIN ULCER (IM) but not LEG ULCER; foot prints (like finger prints) = PLANTAR PRINTS MNA1.378.592.350 LH  MSDistortion or disfigurement of the foot, or a part of the foot, acquired through disease or injury after birth. PM71 HN71 MHÑFoot Deformities, Acquired ANdo not use /congen; congen foot deform = FOOT /abnorm PIFoot Diseases (66-70) MNC5.334; C23.304.351.372 LH  MSSkin diseases of the foot, general or unspecified. PM66 HN66 MHÑFoot Dermatoses ANGEN & coord for specific diseases of the foot (except for those indented under FOOT DISEASES in C23); not as coord for neoplasms of the foot (use neopl coords (IM) with FOOT DISEASES (IM)); consider synonym for dermatitis of foot & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH MNC17.305; C23.304.351.434 LH  MHÑFoot Diseases ANskin dis on foot = FOOT DERMATOSES; neopl of foot: use neopl coords (IM) + FOOT DISEASES (IM); foot ulcer: index under FOOT DISEASES (IM) + probably SKIN ULCER (IM) but not LEG ULCER MNC23.304.351 FXÑPodiatry LH LX  PM70 HN70 MHÑFoot Rot ANanimal only; do not use /vet but check tag ANIMAL PICattle Diseases (66-69); Foot Diseases (66-69); Sheep Diseases (66-69); Swine Diseases (66-69) MNC22.394 LH  MHÑFoot-and-Mouth Disease ANdo not use /vet but check tag ANIMAL; do not confuse with HAND, FOOT AND MOUTH DISEASE, a Coxsackie virus infect; DF: FOOT MOUTH DIS MNC2.782.687.484; C22.380 LH  MHÑFoot-and-Mouth Disease Virus ANdo not use /blood-csf-urine /cytol; infection = FOOT-AND-MOUTH DISEASE; DF: FOOT MOUTH DIS VIRUS MNB4.909.777.618.434 LH  MSThe American or Canadian version of the game using an oval ball and 11- or 12-man teams. PM76 HN76 MHÑFootball ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); does not include rugby (index SPORTS) PISports (66-75) MNI3.450.642.845.300 LH  MHÑForamen Magnum MNA2.835.232.781.572.434 LH  MSMeasurements of rates of airflow during a forced vital capacity determination. PM75 HN75 MHÑForced Expiratory Flow Rates ANa vital capacity test; NIM; no qualif; note specifics below PIRespiratory Airflow (71-74); Spirometry (66-74) MNE1.302.796.624.390 XSExpiratory Forced Flow Rates XUÑMaximal Expiratory Flow Rate; ÑMaximal Expiratory Flow-Volume Curves; ÑMaximal Midexpiratory Flow Rate; ÑPeak Expiratory Flow Rate LH LS LU; ; ;  MSMeasure of the maximum amount of air during a forced vital capacity determination that can be expelled in a given number of seconds. Usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although sometimes given as a percentage of forced vital capacity. PM75 HN75 MHÑForced Expiratory Volume ANNIM; no qualif; in texts as FEV PISpirometry (66-74); Vital Capacity (69-74) MNE1.302.796.624.430 XSForced Vital Capacity, Timed; Timed Vital Capacity; Vital Capacity, Timed LH LS; ;  MHÑForearm ANprimates only: use FORELIMB for non-primate vertebrates & EXTREMITIES for invertebrates: TN 117; /inj = FOREARM INJURIES; for bones use RADIUS or ULNA; NIM when merely locational as in skin dis (IM) MNA1.378.209.350 LH  MHÑForearm Injuries ANGEN & unspecified for soft tissue & bones; consider also /inj with specific bones & also specific fracture terms; available also are HAND INJURIES, FINGER INJURIES & WRIST INJURIES MNC21.866.88.268 LH  MSThe prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. OLuse FORECASTING to search FUTUROLOGY back thru 1971 PM80; was FUTUROLOGY 1971-79 HN80; was FUTUROLOGY 1971-79 MHÑForecasting ANIM general only; consider also as IM coord with specific subject /trends (IM) if future is particularly significant: Manual 19.4.75; only /methods MNI1.320 XSFuturology LH LS  MSThe part of the face above the eyes. PM77 HN77 MHÑForehead ANNIM as locational, no qualif; IM, only /abnorm /anat /blood supply /growth /inj /innerv /surg PIFace (66-76) MNA1.456.505.580 LH  MHÑForeign Bodies ANcoord IM with organ (IM), not organ/dis: Manual 21.39, 23.21; avoid most qualif: usually only /compl /diag /occur /radiogr /surg /ther /vet apply; EYE FOREIGN BODIES is available; note FOREIGN BODY MIGRATION & FOREIGN BODY REACTION below MNC21.866.392 XUÑForeign Body Migration LH LU  MSMigration of a foreign body from its original location to some other location in the body. HN(75) MHÑForeign Body Migration ANonly /compl /diag /occur /radiogr MNC21.866.392.500 DMÑForeign Bodies LH LM  MSChronic inflammation and granuloma formation around irritating foreign bodies. PM74 HN74(72) MHÑForeign Body Reaction ANnote category: in presence of a dis, use /etiol, not /compl PIForeign Bodies (66-71) MNC21.866.392.560; C23.739.487.351 LH  MSPhysicians who hold degrees in medical schools in countries other than the ones in which they practice. PM70 HN70(68) MHÑForeign Medical Graduates ANdo not use /man /methods; specify geog CATALOG: /geog /form PIPhysicians (66-67) MNM1.526.407.435; M1.526.485.810.390; N2.350.402.435; N2.350.759.310 FXÑInternational Educational Exchange LH LX  MSPersons who have acquired academic or specialized training in countries other than that in which they are working. Excludes physicians. PM71 HN71 MHÑForeign Professional Personnel ANdo not use /man /methods; specify geog CATALOG: /geog /form PIHealth Manpower (68-70) MNM1.526.407; N2.350.402 LH  PM68 HN68 MHÑForelimb ANnon-primate vertebrates only; for invertebrates use EXTREMITIES; TN 75: animal extremities; TN 117: table of animal extremities PIExtremities (66-67) MNA13.395 FXÑArm XUÑCarpus, Animal LH LX LU  MSThe application of dental knowledge to questions of law. OLuse FORENSIC DENTISTRY & FORENSIC MEDICINE to search CRIMINAL INVESTIGATION 1966-74 PM65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64 HN65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64 MHÑForensic Dentistry ANSPEC qualif; see note on FORENSIC MEDICINE MNG2.163.285; I1.198.435 FXÑJURISPRUDENCE LH LX  MSThe application of medical knowledge to questions of law. OLuse FORENSIC MEDICINE & FORENSIC DENTISTRY to search CRIMINAL INVESTIGATION 1966-74 PM65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64 HN65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64 MHÑForensic Medicine ANSPEC qualif; for crime or identification: differentiate from JURISPRUDENCE, usually civil suits; ballistics goes here & under WOUNDS, GUNSHOT if pertinent MNG2.403.790.200; I1.198.560 XSLegal Medicine FXÑJURISPRUDENCE LH LS LX  MSPsychiatry in its legal aspects, including criminology, penology, commitment of mentally ill, the psychiatrist's role in compensation cases, the problems of releasing information to the court, and of expert testimony. OLuse FORENSIC PSYCHIATRY to search JURISPRUDENCE, PSYCHIATRIC back thru 1967; search CRIMINAL INVESTIGATION under FORENSIC DENTISTRY & FORENSIC MEDICINE 1966-74 PM69; was JURISPRUDENCE, PSYCHIATRIC 1967-68; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64 HN69; was JURISPRUDENCE, PSYCHIATRIC 1967-68; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64 MHÑForensic Psychiatry ANSPEC qualif MNF4.96.544.335; G2.403.642.208; I1.198.560.469; I1.880.604.583.310; N3.706.535.351 XSJURISPRUDENCE, PSYCHIATRIC XUÑInsanity Defense LH LS LU  MSThe sensory discrimination of a pattern shape or outline. OLuse FORM PERCEPTION to search CONTOUR PERCEPTION back thru 1970 HNCONTOUR PERCEPTION was see under FORM PERCEPTION 1970-78 MHÑForm Perception ANonly /drug eff /physiol /rad eff MNF2.463.593.373; F2.463.593.932.869.435; G11.697.911.860.622 XSContour Perception FXÑVISUAL ACUITY XUÑPattern Recognition, Visual LH LS LX LU  MHÑFormaldehyde ANdo not use /biosyn /defic /physiol; Sargenti method in root canal ther uses N2, a cpd of formaldehyde, lead, mercury & bismuth: index N2 here only RN50-00-0 MND2.47.407 XSFormalin LH LS  HN(64) MHÑFormamidase ANdo not use /analogs RNEC 3.5.1.9 MND8.586.277.87.398 DMÑAmidohydrolases LH LM  OLuse FORMAMIDES to search FORMAMIDE back thru 1966 (as Prov 1966-72) PM75; was FORMAMIDE 1973-74 HN75; was FORMAMIDE 1964-74 (Prov 1964-72) MHÑFormamides AND25-26 qualif MND2.65.463; D2.241.81.504.310 LH  MSFormate:NAD+ oxidoreductases. Flavoproteins which catalyze reversibly the reduction of carbon dioxide to formate. Many compounds can act as acceptors, but the only physiologically active acceptor is NAD. The enzymes are active in the fermentation of sugars and other compounds to carbon dioxide and are the key enzymes in obtaining energy when bacteria are grown on formate as the main carbon source. Have been purified from bovine blood. EC 1.2.2.1 uses ferricytochrome b1 as the acceptor. EC 1.2.1.2 uses NAD as the acceptor. HN(80) MHÑFormate Dehydrogenases ANdo not use /analogs RNEC 1.2.1.2 PIAldehyde Oxidoreductases (73-79); Formates (66-67); Formic Acids (68-79); Oxidoreductases (66-72) MND8.586.682.75.400 XSFormate Hydrogenlyases DMÑAldehyde Oxidoreductases LH LS LM  MHÑFormates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.504.435 XUÑDiethyl Pyrocarbonate LH LU  MSColored azo compounds formed by the reduction of tetrazolium salts. Employing this reaction, oxidoreductase activity can be determined quantitatively in tissue sections by allowing the enzymes to act on their specific substrates in the presence of tetrazolium salts. HN(75) MHÑFormazans AND25-26 qualif; do not use /analogs PIAzo Compounds (72-74); Formic Acids (72-74) MND2.172.600; D26.550.355 DMÑAzo Compounds LH LM  OLsearch FORMIC ACIDS 1968-74 HN(75) MHÑFormic Acid Esters ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.504.560 DMÑFormic Acids LH LM  PM68 HN68 MHÑFormic Acids ANdo not use /analogs /biosyn /defic /physiol PIFormates (66-67) MND2.241.81.504 XUÑFormic Acid Esters LH LU  MS2-(Formylazo)glutaric acid. Measurement of this acid in the urine after oral administration of histidine provides the basis for the diagnostic test of folic acid deficiency and of megaloblastic anemia of pregnancy. HN(75) MHÑFormiminoglutamic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN816-90-0 PIAzo Compounds (71-74); Glutarates (70-74) MND2.241.81.337.351.300 XSFIGLU DMÑGlutarates LH LS LM  PM73 HN73(72) MHÑFormocresols ANdo not use /analogs /biosyn /defic /physiol PICresols (66-71); Formaldehyde (66-71) MND2.47.407.518; D2.755.239.611 LH  MSO,O-Dimethyl S-(N-formyl-N-methylcarbamoylmethyl) phosphorodithioate. An organothiophosphorus systemic insecticide and acaricide. Synonym: Anthio. HN(76) MHÑFormothion ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN2540-82-1 PICarbamates (74-75); Insecticides, Organothiophosphate (74-75) MND2.719.530; D5.723.491.657.545 DMÑInsecticides, Organothiophosphate LH LM  MSA management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records. HN(Aug 77) MHÑForms and Records Control ANonly /man /methods /stand /trends; coord NIM with specific records heading (e.g., MEDICAL RECORDS, NURSING RECORDS) (IM); DF: FORMS CONTROL MNN4.452.758.572.180 XSRecords Control DMÑOffice Management LH LS LM  MSCurrent pharmaceutical compendia including drug formulas. MHÑFormularies ANIM; only /class /hist /stand CATALOG: /geog /form MNL1.178.682.192.836.535; N4.452.350 LH  MHÑFormularies, Dental ANIM; only /class /hist /stand CATALOG: /geog /form MNL1.178.682.192.836.535.310 LH  MHÑFormularies, Homeopathic ANIM; only /class /hist /stand MNL1.178.682.192.836.535.435 FXÑHomeopathy LH LX  MSFormularies concerned with pharmaceuticals prescribed in hospitals. PM68 HN68 MHÑFormularies, Hospital ANIM; only /class /hist /stand CATALOG: /geog /form PIFormularies (66-67) MNL1.178.682.192.836.535.561; N4.452.350.436 FXÑPharmacy and Therapeutics Committee LH LX  MSPyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties. HN(75) MHÑFormycins ANdo not use /analogs /defic /physiol PIAntibiotics, Antineoplastic (73-74); Ribonucleotides (73-74); Pyrimidines (73-74); Pyrimidinones (73-74); Pyrazoles (73-74) MND13.570.685.350; D13.570.800.410; D20.85.75.480; D22.204.106.450 DMÑAntibiotics, Antineoplastic LH LM  MSFormate: tetrahydrofolate ligase (ADP-forming). Catalyzes the formation of 10-formyltetrahydrofolate from formate and tetrahydrofolate in the presence of ATP. This enzyme has been found in pigeon liver, human erythrocytes and some microorganisms. HN(75) MHÑFormyltetrahydrofolate Synthetase ANdo not use /analogs RNEC 6.3.4.3 PIFormic Acids (69-74); Ligases (69-74); Tetrahydrofolates (72-74) MND8.586.464.430 XSTetrahydrofolate Formylase DMÑLigases LH LS LM  MSTetrahydrofolates which are substituted by a formyl group at either the nitrogen atom in the 5 position or the nitrogen atom in the 10 position. N(5)-Formyltetrahydrofolate is the citrovorum factor while the N(10)-formyltetrahydrofolate is an active coenzyme which functions as a carrier of the formyl group in a number of enzymatic reactions. HN(76) MHÑFormyltetrahydrofolates ANdo not use /analogs PICitrovorum Factor (66-75) MND8.176.840.300; D11.786.708.350 XSFormyltetrahydrofolic Acids DMÑTetrahydrofolates LH LS LM  MSPotent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant Coleus forskohlii. Has antihypertensive, positive ionotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. PM86 HN86 MHÑForskolin ANdo not use /biosyn /defic /physiol RN66428-89-5 PIDiterpenes (74-85); Terpenes (66-73) MND2.455.849.291.300 XSColeonol LH LS  OLsearch HAPTENS 1966-72 HN(82)73(66 only); was see under HAPTENS 1965-72 MHÑForssman Antigen ANonly /admin /adv eff /anal /csf /class /immunol /isol /rad eff /stand /tox /urine RN9013-60-9 MND24.611.216.244.436 DMÑAntigens, Heterogenetic LH LM  MS(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid. Antibiotic produced by Streptomyces fradiae. PM86; was see under ANTIBIOTICS 1975-85 HN86(75); was see under ANTIBIOTICS 1975-85 MHÑFosfomycin ANdo not use /defic /physiol RN23155-02-4 PIAntibiotics (71-74); Ethers, Cyclic (71-74); Organophosphorus Compounds (73-74) MND2.705.265; D20.85.335 XSPhosphonomycin LH LS  MSAny hydrocarbon deposit that may be used for fuel; examples are petroleum, coal, and natural gas. OLuse FOSSIL FUELS to search FUELS 1966-81 (as Prov 1966-67, as Cat J heading 1966-81) PM82; was FUELS 1968-81 HN82; was FUELS (Cat J heading only) 1966-81 (Prov 1966-67) MHÑFossil Fuels ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNG3.230.132.258; J1.435 XSGas, Natural LH LS  MSRemains, impressions, or traces of animals or plants of past geological times which have been preserved in the earth's crust. OLsearch PALEONTOLOGY 1966-74 HN(75) MHÑFossils ANno qualif; do not routinely check tags HISTORICAL ARTICLE + ANCIENT: check only when the hist & ancient med aspects are particularly discussed MNI1.76.368.584.311 DMÑPaleontology LH LM  MSPrivate families who care for neglected children or patients unable to care for themselves. MHÑFoster Home Care ANnot restricted to children; only /econ /legis /methods /organ /psychol /stand /trends MNE2.472.352; N2.421.143.452 FXÑChild Welfare LH LX  MSOrganizations established by endowments with provision for future maintenance. MHÑFoundations ANonly /class /hist /legis /organ MNN3.219.483.311; N3.540.630.180 LH  PM73 HN73 MHÑFourier Analysis ANno qualif MNH1.548.386 LH  OLsearch MACULA LUTEA 1968-74 HN(75) MHÑFovea Centralis MNA9.371.729.522.436 DMÑMacula Lutea LH LM  MSInfection of domestic and wild fowl and other birds with avian orthomyxovirus type A. OLsearch ORTHOMYXOVIRUS INFECTIONS 1966-69 PM70; was see under MYXOVIRUS INFECTIONS 1963-69 HN70; was see under MYXOVIRUS INFECTIONS 1963-69 MHÑFowl Plague ANdo not use /vet; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMAL PIOrthomyxovirus Infections (66-69); Poultry Diseases (66-69) MNC2.782.620.375; C22.131.276 XSFOWL PEST LH LS  MSA poxvirus infection of poultry and other birds characterized by the formation of wart-like nodules on the skin and diphtheritic necrotic masses (cankers) in the upper digestive and respiratory tracts. Syn: bird pox, epithelioma contagiosum, fowl diphtheria, variola avium. PM70 HN70 MHÑFowl Pox ANdo not use /vet; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMAL PIPoultry Diseases (66-69); Poxvirus Infections (66-69) MNC2.256.743.366; C22.131.321 XSBIRD POX LH LS  MSThe etiologic agent of a disease in birds. HN(75); was see under POXVIRUSES 1975-80 MHÑFowl Pox Virus ANdo not use /blood-csf-urine /cytol; infection = FOWL POX MNB4.909.204.783.275 XSBird Pox Virus; Poxvirus avium DMÑPoxviridae LH LS; LM  MHÑFox-Fordyce Disease MNC17.805.843.286 LH  PM68 HN68 MHÑFoxes ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PICarnivora (66-67) MNB2.649.147.435 LH  OLsearch PRECIPITATION 1966-74 HN(75) MHÑFractional Precipitation ANNIM; no qualif MNH1.181.529.741.519 DMÑPrecipitation LH LM  OLsearch CHEMISTRY, ANALYTICAL 1966-74 (as Prov 1966) HN(75)(64-66) MHÑFractionation ANalmost never IM; only /instrum /methods MNE5.196.489; H1.181.278.505 DMÑChemistry, Analytical LH LM  MHÑFracture Fixation ANTN 87: various types of fracture surg & related MeSH terms; osteosynthesis in fract surg goes under FRACTURE FIXATION, INTERNAL or FRACTURE FIXATION, INTRAMEDULLARY MNE4.557.435 LH  PM72 HN72(70) MHÑFracture Fixation, Internal ANdo not use /util except by MeSH definition; TN 87; osteosynthesis in fracture surg goes here or below PIFracture Fixation (66-69) MNE4.557.435.436 XSOsteosynthesis, Fracture LH LS  PM70 HN70 MHÑFracture Fixation, Intramedullary ANdo not use /util except by MeSH definition; TN 87: definition; intramedullary osteosynthesis goes here PIFracture Fixation (66-69); specific fracture/SU (66-69) MNE4.557.435.436.436 XSINTRAMEDULLARY NAILING; NAILING, INTRAMEDULLARY; Osteosynthesis, Fracture, Intramedullary LH LS; ;  MHÑFractures ANIM; coord with specific organ/inj (IM) but note many precoord organ/fract terms; /surg & /ther permitted; ╥pathological fracture╙ = FRACTURES, SPONTANEOUS; blow-out fract: index under ORBITAL FRACTURES; TN 87: various types of fract surg; healing: coord IM with WOUND HEALING (NIM); Manual 23.30 MNC21.866.405 FXÑCallus LH LX  MSFractures in which the break in bone is not accompanied by an external wound. PM86; was see under FRACTURES 1975-85 HN86(73); was see under FRACTURES 1975-85, was Prov 1973-74 MHÑFractures, Closed ANIM; coord with precoord organ/fract term (IM), as ╥closed fract of tibia╙ = FRACTURES, CLOSED (IM) + TIBIAL FRACTURES (IM); if no precoord organ/fract term is available, coord IM with organ /inj (IM), as ╥closed fract of fibula╙ = FRACTURES, CLOSED (IM) + FIBULA /inj (IM) MNC21.866.405.248 LH  MSFractures in which there is an external wound communicating with the break of the bone. PM78 HN78(73) MHÑFractures, Open ANIM; coord with specific organ/inj or precoord organ/fract term (IM) PIFractures (66-72) MNC21.866.405.279 XSFractures, Compound LH LS  MHÑFractures, Spontaneous ANIM; also called ╥pathological fracture╙; coord with specific organ /inj or organ/fract term (IM) MNC21.866.405.310 LH  MHÑFractures, Ununited ANIM; coord with specific organ/inj or precoord organ/fract term (IM) MNC21.866.405.341 LH  MSA condition characterized genotypically by a fragile site on the X chromosome (Xq27 or Xq28). Phenotypically, affected males usually, but not invariably, are mentally retarded (IQ between 30 and 70), have speech defects, enlarged ears, jaws and hands, and frequently macro-orchidism. Female carriers are usually normal, but may exhibit some degree of mental retardation. HN(83) MHÑFragile X Syndrome ANdo not use /congen /drug eff /physiol /rad eff; do not coord with INFANT, NEWBORN, DISEASES PIMental Retardation/FG (66-82); Sex Chromosomes (68-82); X Chromosome (78-82) MNC16.131.280.748.360; F3.709.346.220 DMÑSex Chromosome Abnormalities LH LM  PM68 HN68(63) MHÑFramycetin ANdo not use /defic /physiol RN119-04-0 MND9.203.408.51.321; D20.85.538.436 XSNeomycin B LH LS  MHÑFrance ANPARIS is also available; Corsica goes here MNZ1.542.286 LH  MSAn organism frequently found in natural waters; can be parasitic on man, other mammals, birds, and arthropods. PM76 HN76 MHÑFrancisella ANdo not use /blood-csf-urine PIPasteurella (66-75) MNB3.400.340 LH  MSThe etiologic agent of tularemia in man and other warm-blooded animals. OLuse FRANCISELLA TULARENSIS to search PASTEURELLA TULARENSIS back thru 1966 PM76; was PASTEURELLA TULARENSIS 1963-75 HN76; was PASTEURELLA TULARENSIS 1963-75 MHÑFrancisella tularensis ANinfection = TULAREMIA; do not use /blood-csf-urine MNB3.400.340.590 XSPasteurella tularensis LH LS  MHÑFrancium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-73-5 MND1.248.497.300.459.321; D1.287.380; D1.552.528.328 LH  MSA genus of poisonous, rhamnaceous trees, including Rhamnus frangula or R. purshiana, alder buckthorn; they yield EMODIN and CASCARA, among other useful chemicals; another species, the tullidora, causes serious neuropathies. HN(86)63 MHÑFrangula ANdo not use /isol /pathogen MNB6.560.389; B6.660.373; B6.915.389 XSBuckthorn; Karwinskia; Rhamnus; Tullidora DMÑPlants, Toxic LH LS; ; ; LM  MSExploitation through misrepresentation of the facts or concealment of the purposes of the exploiter. HN(Aug 77) MHÑFraud ANno qualif MNI1.198.240.300 DMÑCrime LH LM  MSSpontaneous verbalization of whatever comes to mind. PM69 HN69 MHÑFree Association ANno qualif PIAssociation (66-68) MNF4.754.709.437 XSASSOCIATION, FREE LH LS  PM76 HN76(67) MHÑFree Radicals ANalmost never IM; no qualif PIChemistry (66); Chemistry, Physical (66); Electron Spin Resonance (66) MND1.339; D2.389 LH  MSThe rights of individuals to act and make decisions without external constraints. HN(78) MHÑFreedom ANno qualif PICivil Rights (68-77); Human Rights (73-77); Philosophy (66-77) MNI1.880.604.473.380; N3.706.437.380 DMÑHuman Rights LH LM  MSA condition occurring in dizygotic twins of different sexes in cattle, when anastomoses of placental vessels permits interchange of hormones and cells during fetal life; the female calf is a sterile intersex due to passage of androgens from the male, and both calves are blood cell chimeras with immune tolerance, due to interchange of cells in utero. PM70 HN70 MHÑFreemartinism ANanimal only: do not use /vet but check tag ANIMAL; only Cat C qualif; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES PICattle (66-69); Infertility, Female (66-69) MNC22.196.339; G5.148.630.437 XSWHITE HEIFER DISEASE FXÑMosaicism LH LS LX  MHÑFreeze Drying ANNIM; only /instrum /methods MNE5.760.312 XSLYOPHILIZATION FXÑDesiccation LH LS LX  PM73 HN73(69) MHÑFreeze Etching ANNIM; only /instrum /methods PIFreezing (66-68); Histological Technics (66-68); Microscopy, Electron (66-68) MNE5.909.262.390.390 LH  MSPreparation for electron microscopy of minute replicas of exposed surfaces of the cell which have been ruptured in the frozen state. The specimen is frozen, then cleaved under high vacuum at the same temperature. The exposed surface is shadowed with carbon and platinum and coated with carbon to obtain a carbon replica. PM75 HN75 MHÑFreeze Fracturing ANonly /instrum /methods /stand PIFreeze Etching (69-74) MNE5.909.262.390 LH  PM67 HN67(64) MHÑFreezing ANNIM; no qualif; cryopreservation goes here (NIM) + PRESERVATION, BIOLOGICAL or specific (IM) MNH1.671.868.272.437 FXÑCryoprotective Agents; ÑCryosurgery; ÑICE; ÑREFRIGERATION LH LX; ; ;  MHÑFrench Guiana MNZ1.107.757.435 LH  MSA group of halogenated hydrocarbons, usually based on methane, containing one or more fluorine and/or halogen atoms. OLto search FREON use FREONS back thru 1975 & HYDROCARBONS, HALOGENATED 1973-74 PM77; was FREON see under HYDROCARBONS, HALOGENATED 1973-76 HN77; was FREON see under HYDROCARBONS, HALOGENATED 1973-76 MHÑFreons ANdo not confuse X refs here with FLUOROCARBONS (for perfluorinated cpds); D25-26 qualif; do not use /analogs MND2.455.526.258 XSFluorocarbon Aerosols; Fluorocarbon Propellants LH LS;  HN(72) MHÑFresh Water ANonly /anal; rivers, ponds, lakes, groundwater PIWater (66-71) MNG3.230.700.250 DMÑWater LH LM  MSPhilosophic formulations which are basic to psychoanalysis. Some of the conceptual theories developed were of the libido, repression, regression, transference, id, ego, superego, Oedipus Complex, etc. OLsearch PSYCHOANALYTIC THEORY 1969-74 HN(75) MHÑFreudian Theory ANIM; no qualif MNF2.739.794.297 DMÑPsychoanalytic Theory LH LM  PM64 HN64(63) MHÑFreund's Adjuvant ANdo not use /immunol RN9007-81-2 MND24.611.59.437 LH  MHÑFriedreich's Ataxia ANdo not confuse with FRIEDREICH'S DISEASE MNC10.228.140.252.253.871.562 XSHEREDITARY SPINAL SCLEROSIS; SCLEROSIS, HEREDITARY SPINAL LH LS;  MSA virus producing leukemia of the reticulum cell type with massive infiltration of liver, spleen and bone marrow; infects DBA/2 and Swiss mice. PM66 HN66 MHÑFriend Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM); Friend erythroleukemia cells: coord (IM) with LEUKEMIA, EXPERIMENTAL (IM) + ERYTHROLEUKEMIA (IM) + CELL LINE (NIM) MNB4.909.574.807.674.632.287; B4.909.777.731.674.632.287; B4.909.777.779.674.632.287 XSRowson-Parr Virus LH LS  MSPsychogenically inhibited female sexual response manifested by a variety of difficulties ranging from complete lack of sexual response to incomplete orgastic climax. MHÑFrigidity ANdo not use /congen /drug eff /physiol /rad eff MNC13.371.665.520; F3.126.387; F3.709.597.608.780.480 LH  MHÑFrontal Bone ANfractures: coord FRONTAL BONE /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with SKULL NEOPLASMS (IM) MNA2.835.232.781.375 LH  MHÑFrontal Lobe ANdo not use /innerv; dis: coord IM with BRAIN DISEASES (NIM); neopl: coord IM with BRAIN NEOPLASMS (IM) MNA8.186.211.885.213.270 XSBroca Area LH LS  MSOne of the paired, but seldom symmetrical, air spaces located between the inner and outer compact layers of the frontal bone. MHÑFrontal Sinus ANinflammation or sinusitis: coord NIM with SINUSITIS (IM); fractures: coord FRONTAL SINUS /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with PARANASAL SINUS NEOPLASMS (IM) MNA4.621.387 LH  MSDamage to tissues as the result of low environmental temperatures. MHÑFrostbite MNC21.866.417 FXÑCold XUÑChilblains LH LX LU  OLsearch FOOD PRESERVATION 1966-74 HN(75)(64-67) MHÑFrozen Foods ANonly /adv eff /rad eff /stand MNJ1.409.599.437 XSFood, Frozen DMÑFood Preservation LH LS LM  OLsearch MICROTOMY 1966-74 HN(75) MHÑFrozen Sections ANno qualif MNE5.909.432.707.437 DMÑMicrotomy LH LM  MSPolysaccharides composed of D-fructose units. HN(75) MHÑFructans ANdo not use /analogs /defic /physiol PIFructose (73-74); Polysaccharides (73-74) MND9.203.698.350 XSLevans DMÑPolysaccharides LH LS LM  MSDuring glycolysis, fructokinases catalyze the phosphorylation of fructose at carbon atom 1 (EC 2.7.1.3) or carbon atom 6 (EC 2.7.1.4) in the presence of ATP with the formation of fructose 1-phosphate or fructose 1-phosphate or fructose 6-phosphate, respectively. EC 2.7.1.3; EC 2.7.1.4. HN(79) MHÑFructokinases ANdo not use /analogs RNEC 2.7.1.- PIPhosphotransferases (66-73); Phosphotransferases, ATP (74-78) MND8.586.913.696.729.270 XSKetohexokinases DMÑPhosphotransferases, ATP LH LS LM  MHÑFructose RN30237-26-4 MND9.203.546.359.250; D9.203.546.465.354 XSLEVULOSE LH LS  OLsearch CARBOHYDRATE METABOLISM, INBORN ERRORS 1966-74 HN(75)(64-66) MHÑFructose Intolerance ANdo not use /congen MNC18.452.648.202.271 DMÑCarbohydrate Metabolism, Inborn Errors LH LM  OLuse FRUCTOSEDIPHOSPHATE ALDOLASE to search ALDOLASE back thru 1966 PM74; ALDOLASE was heading 1963-75 HN74(73); ALDOLASE was heading 1963-75 MHÑFructosediphosphate Aldolase ANdo not use /analogs RNEC 4.1.2.13 MND8.586.520.110.563 XSAldolase LH LS  MSDiphosphoric acid esters of fructose. The fructose-1,6-diphosphate isomer is most prevalent. It is an important intermediate in the glycolysis process. HN(78) MHÑFructosediphosphates ANdo not use /analogs /biosyn /defic /physiol PIFructosephosphates (71-77); Hexosediphosphates (73-77) MND9.203.894.417.313.300; D9.203.894.417.592.300 DMÑHexosediphosphates LH LM  PM73 HN73(71) MHÑFructosephosphates ANdo not use /analogs PIFructose (66-70); Hexosephosphates (66-70) MND9.203.894.417.313 LH  MSD-Mannonate:NAD+ oxidoreductase. Catalyzes the reversible oxidation of mannonate to fructuronate in the presence of NAD. Also reduces D-tagaturonate to D-altronate. HN(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77 MHÑFructuronate Reductase ANdo not use /analogs RNEC 1.1.1.57 PIAlcohol Oxidoreductases (74); Uronic Acids (74) MND8.586.682.47.150.225 XSMannonate Oxidoreductase DMÑCarbohydrate Dehydrogenases LH LS LM  OLuse FRUIT to search APPLE, APRICOT, BANANA, BERRIES & GRAPES back thru 1966 HN66; APPLE, APRICOT, BANANA & BERRIES were see under FRUIT 1963-82; GRAPES was heading 1963-82 MHÑFruit ANas plant & food; only /ad-poi-tox /anal /rad eff /stand /supply; fruit as plant tissue: Manual 31.9 MNB6.510.380; J1.341.492 XSApple; Apricot; Banana; Berries; Grapes LH LS; ; ; ;  MSThe motivational and/or affective state resulting from being blocked, thwarted, disappointed or defeated. MHÑFrustration ANhuman & animal; no qualif MNF1.470.405 LH  MHÑFSH AN/biosyn /physiol permitted MND6.472.351.576.288; D6.472.734.525.343.288 XSFollicle-Stimulating Hormone LH LS  MS5-Fluoro-1-(tetrahydro-2-furyl)-uracil. Congener of fluorouracil with comparable antineoplastic action; suggested especially for the treatment of breast neoplasms. PM86; was see under FLUOROURACIL 1977-85 HN86(77); was see under FLUOROURACIL 1977-85 MHÑFtorafur ANdo not use /biosyn /defic /physiol RN17902-23-7 PIFluorouracil (72-76); Furans (72-76) MND3.383.742.698.875.404.400; D22.204.144.545.390; D26.87.387.390 XSFlorafur; Fluorofur LH LS;  OLsearch CORNEAL DYSTROPHIES 1966-74 HN(75) MHÑFuchs' Endothelial Dystrophy MNC11.204.236.438 DMÑCorneal Dystrophies LH LM  PM66 HN66(63) MHÑFucose RN3713-31-3 MND9.203.254.488; D9.203.546.359.313 XSDEOXYGALACTOSE LH LS  MSalpha L-fucoside fucohydrolase. Catalyzes the hydrolysis of an alpha L-fucoside to yield an alcohol and L-fucose. Deficiency of this enzyme can cause alpha-fucosidosis. PM78; was see under DISACCHARIDASES 1975-77 HN78(75); was see under DISACCHARIDASES 1975-77 MHÑFucosidase ANdo not use /analogs; /defic: consider also FUCOSIDOSIS RNEC 3.2.1.51 PIFucose (66-74); Glycoside Hydrolases (66-74) MND8.586.277.450.400 LH  MSAn autosomally recessive inherited metabolic disorder in which deficiency of alpha-1-fucosidase activity results in accumulation of fucose-containing sphingolipids, glycoproteins, and mucopolysaccharides in lysosomes. PM85 HN85 MHÑFucosidosis ANdo not use /congen PICarbohydrate Metabolism, Inborn Errors (66-84); Fucose (66-84); Fucosidase (75-84) MNC10.496.600.385; C18.452.648.625.385 LH  MSUDP-2-acetamido-2-deoxy-D-galactose:O-alpha-L-fucosyl-(1,2)-D-galactose acetamidodeoxygalactosyltransferase. Catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosyl-galactosides as acceptors. HN(75); was see under HEXOSYLTRANSFERASES 1975-78 MHÑFucosyl Galactose Acetylgalactosaminyltransferase ANdo not use /analogs RNEC 2.4.1.40 PIGalactosamine (71-74); Hexosyltransferases (73-74); Oligosaccharides (70-74) MND8.586.913.407.310.280 DMÑGalactosyltransferases LH LM  MSCatalyze the transfer of fucose from a nucleoside diphosphate fucose to an acceptor molecule which is frequently another carbohydrate, a glycoprotein or a glycolipid molecule. Elevated activity of some fucosyltransferases in human serum may serve as an indicator of malignancy. Includes EC 2.4.1.65; EC 2.4.1.68; EC 2.4.1.69; EC 2.4.1.89. HN(79) MHÑFucosyltransferases ANdo not use /analogs RNEC 2.4.1.- PIHexosyltransferases (72-78); Transferases (66-71) MND8.586.913.407.290 DMÑHexosyltransferases LH LM  MSLiquid products burned to generate heat; includes heating oils, stove oils, and furnace oils. OLsearch PETROLEUM 1968-74 HN(75); was in Cat J only 1975-81 MHÑFuel Oils ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNG3.230.132.258.630.500; J1.435.723.313; J1.740.400.700.350 DMÑPetroleum LH LM  MSL-Malate hydro-lyase. Catalyzes the reversible hydration of fumaric acid to yield L-malic acid. One of the citric acid cycle enzymes. EC.4.2.1.2. PM78; was see under HYDRO-LYASES 1975-77 HN78(73); was see under HYDRO-LYASES 1975-77 MHÑFumarate Hydratase ANdo not use /analogs RNEC 4.2.1.2 PIHydro-Lyases (66-72) MND8.586.520.497.410 XSFumarase LH LS  MHÑFumarates ANdo not use /analogs /defic /physiol MND2.241.81.337.302 LH  MHÑFumigation ANonly /adv eff /econ /hist /instrum /methods /stand MNG3.850.180.400 LH  MSThe volume of air remaining in the lungs at the end of a normal, quiet expiration. It is the sum of the residual volume and the expiratory reserve volume. Common abbreviation is FRC. HN(75) MHÑFunctional Residual Capacity ANNIM; no qualif; in texts as FRC MNE1.302.796.420.390 DMÑLung Volume Measurements LH LM  MSUsually organized community efforts to raise money to promote financial programs of institutions; includes individual gifts. HN(78) MHÑFund Raising ANonly /econ /legis /man /methods /organ /stand /trends /util MNN3.219.463.360 XSGifts, Financial; Philanthropic Funds DMÑFinancial Management LH LS; LM  MHÑFundus Oculi ANno qualif; what is seen through an ophthalmoscope: do not confuse with RETINA & RETINAL VESSELS, the correct terms with subheadings, not FUNDUS OCULI; early coord for fundus fluorescent angiography: see hist notes under FLUORESCEIN ANGIOGRAPHY MNA9.371.729.313 FXÑOPHTHALMOSCOPY LH LX  MSThose customs and ceremonies pertaining to the dead. OLuse FUNERAL RITES to search MORTUARY CUSTOMS back thru 1966 PM83; was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82 HN83(75); was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82 MHÑFuneral Rites ANonly /hist MNI1.76.201.450.550 XSMortuary Customs LH LS  PM73 HN73 MHÑFungal Proteins ANdo not use /analogs /defic /physiol; coord IM with specific protein (IM) + specific fungus (IM) PIFungi (66-72); Proteins (66-72) MND12.776.354 XSFungal Peptides LH LS  PM65 HN65 MHÑFungal Vaccines ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; coord IM with specific fungus /immunol (IM) MND24.310.894.354 LH  MHÑFungi ANGEN only: prefer specifics: Manual 22.32; do not use /anat /embryol /microbiol /parasitol; /drug eff: consider also ANTIFUNGAL AGENTS & FUNGICIDES, INDUSTRIAL; fungal dis = MYCOSES, fungal dis of skin = DERMATOMYCOSES; see Fungus Key for fungi not in MeSH; Myxomycotina is indexed as FUNGI MNB5.354 FXÑAllergens; ÑMicrobiology LH LX;  OLsearch FUNGICIDES under ANTIFUNGAL AGENTS 1966-71 PM72; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66 HN72; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66 MHÑFungicides, Industrial ANdo not use /analogs /biosyn /defic /physiol; differentiate from therapeutic fungicides ( = ANTIFUNGAL AGENTS) PIAntifungal Agents (66-71) MND5.723.288 FXÑAntifungal Agents LH LX  MSA developmental anomaly in which the lower sternum is posteriorly dislocated and concavely deformed, resulting in a funnel-shaped thorax. MHÑFunnel Chest ANdo not use /congen MNC16.131.621.386 XSPectus Excavatum LH LS  MS1-[3-(5-Nitro-2-furyl)allylidenamino]hydantoin. Nitrofuran derivative anti-infective agent used for urinary tract infections. Synonyms: F 35. HN(78) MHÑFuragin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1672-88-4 PIHydantoins (66-77); Nitrofurans (66-77) MND2.640.600.308; D3.383.312.649.308; D20.187.277 XSFurazidin DMÑNitrofurans LH LS LM  MHÑFuraldehyde ANdo not use /biosyn /defic /physiol RN98-01-1 MND2.47.466; D3.383.312.355 XSFURFURAL LH LS  PMCITRACONIC ANHYDRIDES was CITRACONIC ANHYDRIDE see under MALEATES 1975-76 MHÑFurans ANdo not use /analogs /biosyn /defic /physiol MND3.383.312 XUÑ4-Butyrolactone; ÑCitraconic Anhydrides; ÑMaleic Anhydrides; ÑNafronyl LH LU; ; ;  MHÑFurazolidone ANdo not use /biosyn /defic /physiol RN67-45-8 MND2.640.600.313; D3.383.312.649.313; D20.187.298; D20.237.649.313; D21.370.370.313 XSNifurazolidone LH LS  MS4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid. A sulfamyl saluretic and diuretic; it has a fast onset and short duration of action and is used in edema and chronic renal insufficiency. Synonyms: Errolon; Fusid; Lasix; Salix. PM67 HN67(65) MHÑFurosemide ANdo not use /biosyn /defic /physiol RN54-31-9 MND2.65.884.725.300; D2.886.590.700.725.300; D19.770.224.516.488 XSFrusemid; Fursemide LH LS;  MSN-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-N-[4-hydroxy-1-methyl-2-[(tetrahydrofurfuryl)dithio]-1-butenyl]formamide. Compound used for therapy of thiamine deficiency; may have analgesic or antipyretic properties. Synonyms: Ditefin; Diteftin; Adventan. OLuse FURSULTIAMIN to search THIAMINE TETRAHYDROFURFURYL DISULFIDE back thru 1975 HN(79); was THIAMINE TETRAHYDROFURFURYL DISULFIDE see under PYRIMIDINES 1975-78 MHÑFursultiamin AN/analogs NIM only; DF: TTFD RN804-30-8 PIDisulfides (73-74); Furans (73-74); Pyrimidines (73-74) MND3.383.742.225 XSThiamine Tetrahydrofurfuryl Disulfide DMÑPyrimidines LH LS LM  MHÑFurunculosis ANcaused by Staph; consider also CARBUNCLE, also usually caused by Staph (but not malignant carbuncle which = ANTHRAX) MNC1.252.868.820.387; C17.838.820.387 XSBOILS LH LS  MSalpha-2-Furyl-5-nitro-2-furanacrylamide. Used formerly as antimicrobial food additive; causes mutations in many cell cultures and may be carcinogenic. Synonym: AF2. HN(78) MHÑFurylfuramide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3688-53-7 PIAcrylamides (73-77); Acrylates (66-72); Nitrofurans (66-77) MND2.640.600.330; D3.383.312.649.330; D26.471.385.379 DMÑNitrofurans LH LM  MS5-n-Bitylpicolinic acid. Agent isolated from Fusarium oxysporum; may have antihypertensive properties. HN(75) MHÑFusaric Acid ANdo not use /defic /physiol; /analogs NIM only RN536-69-6 PIPicolinic Acids (69-74) MND3.66.707.200; D3.383.725.705.200 DMÑPicolinic Acids LH LM  MHÑFusarium ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.366 LH  MSTwo teeth united during development by the union of their tooth germs; the teeth may be joined by the enamel of their crowns, by their root dentin, or by both. OLsearch TOOTH ABNORMALITIES 1966-74 HN(75) MHÑFused Teeth ANdo not use /congen MNC16.131.314.904.479 DMÑTooth Abnormalities LH LM  PM65 HN65 MHÑFusidic Acid ANdo not use /defic /physiol RN6990-06-3 MND4.808.247.222.222.347.389; D4.808.247.808.489; D20.85.351 XSFUCIDIN LH LS  OLuse FUSOBACTERIUM to search SPHAEROPHORUS back thru 1966 PMSPHAEROPHORUS was see under BACTEROIDACEAE 1976, was heading 1963-75 HNSPHAEROPHORUS was heading 1963-76, was see under BACTEROIDACEAE 1976 MHÑFusobacterium ANdo not use /blood-csf-urine; infection = FUSOBACTERIUM INFECTIONS MNB3.425.194.389 XSSphaerophorus LH LS  MSInfections with bacteria of the genus Fusobacterium. OLuse FUSOBACTERIUM INFECTIONS to search SPHAEROPHORUS INFECTIONS back thru 1968 PM77; was SPHAEROPHORUS INFECTIONS 1968-76 HN77; was SPHAEROPHORUS INFECTIONS 1968-76 MHÑFusobacterium Infections PIFusobacterium (66-67) MNC1.252.375 XSNecrobacillosis; Sphaerophorus Infections LH LS;  MSA species of Gram-negative non-spore-forming bacteria isolated from the natural cavities of man and other animals and from necrotic lesions, abscesses, and blood. OLuse FUSOBACTERIUM NECROPHORUM to search SPHAEROPHORUS NECROPHORUS back thru 1975 PM76; was SPHAEROPHORUS NECROPHORUS see under SPHAEROPHORUS 1975 HN76; was SPHAEROPHORUS NECROPHORUS see under SPHAEROPHORUS 1975 MHÑFusobacterium necrophorum ANdo not use /blood-csf-urine; infection: coord FUSOBACTERIUM INFECTIONS (IM) + FUSOBACTERIUM NECROPHORUM (NIM) PIFusobacterium (66-74) MNB3.425.194.389.400 XSSphaerophorus necrophorus LH LS  MSDouble layered inflatable suits which when inflated, exert pressure on the lower part of the wearer's body. Used to improve or stabilize the circulatory state, i.e., to prevent hypotension, control hemorrhage, and regulate blood pressure. PM76; was see under CLOTHING 1975 HN76(75); was see under CLOTHING 1975 MHÑG Suits ANonly /adv eff /stand; MAST suit (Military or Medical Anti-Shock Trousers) goes here (do not add MILITARY MEDICINE); DF: MAST PIClothing (66-74); Protective Clothing (70-74) MNE7.390 XSAnti-Shock Trousers; Antigravity Suits; Gravity Suits; Military Anti-Shock Trousers; Pneumatic Suits; Pressure Suits LH LS; ; ; ; ;  MSGalactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)-galactosyl-glucosylceramide. This ganglioside is present in abnormally large amounts in neurons and in elevated levels in liver and kidney due to a deficiency of beta-galactosidase in the genetically determined disease GM1-gangliosidosis. Synonym: Ganglioside A(2). PM86; was see under GANGLIOSIDES 1977-85 HN86(77); was see under GANGLIOSIDES 1977-85 MHÑG(M1) Ganglioside ANdo not use /defic; G(M1) gangliosidosis: coord NIM with GANGLIOSIDOSIS (IM) RN37758-47-7 PIGangliosides (66-76) MND10.516.390.470.440.390; D10.516.808.530.490.390 XSMonosialosyl Tetraglycosyl Ceramide LH LS  MSCeramide-glucose-galactose-(acetylneuraminic acid)-acetylgalactosamine. This is the defective ganglioside manifested in Tay-Sachs disease. HN(75) MHÑG(M2) Ganglioside ANdo not use /defic; /analogs NIM only; G(M2) gangliosidosis type I = TAY-SACHS DISEASE, type II = SANDHOFF DISEASE RN19600-01-2 PIGangliosides (74) MND10.516.390.470.440.400; D10.516.808.530.490.400 XSTay-Sachs Disease Ganglioside DMÑGangliosides LH LS LM  MSN-Acetylneuraminyl-galactosyl-glucosylceramide. This ganglioside is present in abnormally large amounts in the brain and liver due to a deficient biosynthetic enzyme, G(M3):UDP-N-acetylgalactosaminyltransferase. Deficiency of this enzyme prevents the formation of G(M2) ganglioside from G(M3) ganglioside and is the cause of an anabolic sphingolipidosis. HN(77) MHÑG(M3) Ganglioside ANdo not use /defic; /analogs NIM only; G(M3) gangliosidosis: coord NIM with GANGLIOSIDOSIS (IM) PIGangliosides (66-76) MND10.516.390.470.440.410; D10.516.808.530.490.510 XSHematoside; Sialyllactosylceramide DMÑGangliosides LH LS; LM  MS4-Aminobutanoic Acid. Endogenous inhibitor of neurotransmission in vertebrate CNS and arthropod neuromuscular junction; its blockade results in convulsions; proposed as antihypertensive and sedative; used as a tool in neurophysiology. Synonyms: Encefalon; Gammalon; Gammarex; Mielogen. OLsearch AMINOBUTYRIC ACIDS 1966-74 PM79; was see under AMINOBUTYRIC ACIDS 1975-78, was see under AMINOBUTYRIC ACID 1963-74 HN79(75); was see under AMINOBUTYRIC ACIDS 1975-78, was see under AMINOBUTYRIC ACID 1963-74 MHÑGABA AN/biosyn /physiol permitted RN56-12-2 PIAminobutyric Acids (66-74) MND2.241.81.161.125.439; D12.125.190.522; D16.538.85.395 XS4-Aminobutyric Acid; Gamma-Aminobutyric Acid LH LS;  MHÑGabon MNZ1.58.100.405 LH  MHÑGadolinium ANGd-158; do not use /analogs /biosyn /defic /physiol; Gd-154-157, 160 = GADOLINIUM (IM) + ISOTOPES (NIM); Gd-145-153, 159, 161 = GADOLINIUM (IM) + RADIOISOTOPES (IM) RN7440-54-2 MND1.268.327; D1.552.550.344 LH  MSContraction of the constrictor muscle of the pharynx elicited by stimulation of sensory receptors on the soft palate, by psychic stimuli, or systemically by drugs. HN(71) MHÑGagging ANonly /drug eff /rad eff PIReflex (66-70) MNC23.888.821.414; G11.561.730.251 XSReflex, Pharyngeal DMÑReflex LH LS LM  MSManner or style of walking. MHÑGait ANno qualif; differentiate from LOCOMOTION: gait is the way one locomotes MNE1.706.437; G11.427.614.389 LH  MSPolysaccharides composed of repeating galactose units. Can consist of branched or unbranched chains in any linkages. PM79 HN79 MHÑGalactans ANdo not use /analogs /defic /physiol PIGalactose (66-78); Polysaccharides (66-78) MND9.203.698.360 XSPolygalactoses LH LS  MSATP: D-galactose 1-phosphotransferase. An enzyme which catalyzes reversibly the formation of galactose 1-phosphate and ADP from ATP and D-galactose. Galactosamine can also act as the acceptor. A deficiency of this enzyme results in galactosemia. EC 2.7.1.6. PM79 HN79 MHÑGalactokinase ANdo not use /analogs; /defic: consider also GALACTOSEMIA RNEC 2.7.1.6 PIGalactose (66-78); Phosphotransferases (66-73); Phosphotransferases, ATP (74-78) MND8.586.913.696.729.280 LH  OLsearch LACTATION DISORDERS 1966-74 HN(75) MHÑGalactorrhea ANin both sexes & not necessarily related to pregn; usually check tags PREGNANCY & FEMALE also MNC13.703.844.506.389; C19.146.556.439 DMÑLactation Disorders LH LM  PM73 HN73(71) MHÑGalactosamine ANdo not use /defic /physiol RN7535-00-4 PIHexosamines (66-70) MND9.203.67.342.356 XUÑAcetylgalactosamine LH LU  PM73 HN73(71) MHÑGalactosaminidase ANdo not use /analogs RNEC 3.2.1.- PIGlycoside Hydrolases (66-70) MND8.586.277.450.483.356 LH  MHÑGalactose AN/blood = GALACTOSEMIA; POLYGALACTOSES (see GALACTANS) is available RN26566-61-0 MND9.203.546.359.377 LH  MSD-Galactose:NAD(P)+ 1-oxidoreductases. Catalyzes the oxidation of D-galactose in the presence of NAD+ or NADP+ to D-galactono-gamma-lactone and NADH or NADPH. Includes EC 1.1.1.48 and EC 1.1.1.120. HN(78) MHÑGalactose Dehydrogenases ANdo not use /analogs RNEC 1.1.1. PIAlcohol Oxidoreductases (66-77) MND8.586.682.47.150.250 XSGalactose Oxidoreductases DMÑCarbohydrate Dehydrogenases LH LS LM  MSGalactose:oxygen 6-oxidoreductase. Oxidizes galactose in the presence of molecular oxygen to D-galacto-hexodialdose. A copper protein. PM78; was see under ALCOHOL OXIDOREDUCTASES 1975-77 HN78(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77 MHÑGalactose Oxidase ANdo not use /analogs RNEC 1.1.3.9 PIAlcohol Oxidoreductases (66-77); Galactose (66-74) MND8.586.682.47.210 LH  MHÑGalactosemia MNC18.452.648.202.355 LH  MSUTP:galactose-1-phosphate uridylyltransferase. Catalyzes the synthesis of UDPgalactose from UTP and galactose-1-phosphate. Present in low levels in fetal and infant liver, but increases with age. Enables galactosemic infants who survive to develop the capacity to metabolize galactose. HN(75) MHÑGalactosephosphate Uridylyltransferase ANdo not use /analogs; /defic: consider also GALACTOSEMIA RNEC 2.7.7.10 PIGalactose (74); Hexosephosphates (74); Nucleotidyltransferases (74); Uracil Nucleotides (74) MND8.586.913.696.445.400 XSUDP Galactose Pyrophosphorylase DMÑNucleotidyltransferases LH LS LM  MSPhosphoric acid esters of galactose. HN(78) MHÑGalactosephosphates ANdo not use /analogs /biosyn /defic /physiol PIGalactose (66-77); Hexosephosphates (66-77) MND9.203.894.417.370 DMÑHexosephosphates LH LM  OLuse GALACTOSIDASES to search GALACTOSIDASE back thru 1966 PM75; was GALACTOSIDASE 1963-74 HN75; was GALACTOSIDASE 1963-74 MHÑGalactosidases ANdo not use /analogs; note ALPHA- & BETA-GALACTOSIDASES as see unders below RNEC 3.2.1.- MND8.586.277.450.410 FXÑGangliosidosis XUÑAlpha-Galactosidases; ÑBeta-Galactosidases; ÑCeramide Trihexosidase; ÑGalactosylceramidase LH LX LU; ; ;  MSGlycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of galactose with an alcohol to form an acetal. Include both alpha- and beta-galactosides. HN(75) MHÑGalactosides ANdo not use /analogs /biosyn /defic /physiol PIGalactose (66-74); Glycosides (66-74) MND9.203.408.320 DMÑGlycosides LH LM  MSGalactosyl-N-acylsphingosine galactohydrolase. Hydrolyzes galactose from ceramide monohexosides. HN(75) MHÑGalactosylceramidase ANdo not use /analogs RNEC 3.2.1.46 PICerebrosides (72-74); Galactose (72-74); Glycoside Hydrolases (72-74) MND8.586.277.450.410.400 XSGalactocerebrosidase DMÑGalactosidases LH LS LM  MSCerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy. HN(79) MHÑGalactosylceramides ANdo not use /analogs /defic PICeramides (72-78); Cerebrosides (66-78); Glycosphingolipids (75-78) MND10.516.390.470.213.450; D10.516.808.530.288.450 XSGalactocerebrosides; Galactosyl Ceramides DMÑCerebrosides LH LS; LM  MSEnzymes which catalyze the transfer of galactose from a nucleoside diphosphate galactose to an acceptor molecule which is frequently another carbohydrate. PM76; CHITIN SYNTHASE & FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE were see under HEXOSYLTRANSFERASES 1975-78 HN76 MHÑGalactosyltransferases ANdo not use /analogs RNEC 2.4.1. PIGalactose (72-75); Hexosyltransferases (72-75) MND8.586.913.407.310 XUÑFucosyl Galactose Acetylgalactosaminyltransferase; ÑGlycoprotein beta-Galactosyltransferase LH LU;  MSA genus of the family Lorisidae having four species which inhabit the forests and bush regions of Africa south of the Sahara and some nearby islands. The four species are G. alleni, G. crassicaudatus, G. demidovii, and G. senegalensis. There is another genus, Euoticus, containing two species which some authors have included in the Galago genus. OLuse GALAGO to search GALAGOS back thru 1975 PM81; was GALAGOS 1978-80, was GALAGOS see under MONKEYS 1975-77 HN81; was GALAGOS 1978-80, was GALAGOS see under MONKEYS 1975-77 MHÑGalago ANa loris (prosimian); IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIAnthropoidea (66-74) MNB2.649.801.700.572.408 XSBush Babies; Euoticus LH LS;  MHÑGalanthamine ANdo not use /biosyn /defic /physiol RN357-70-0 MND3.132.369; D8.373.275.467; D16.698.410.396 XSGalantamin; Lycoremine LH LS;  MHÑGallamine Triethiodide ANdo not use /biosyn /defic /physiol RN65-29-2 MND2.92.102.400; D2.675.276.400; D17.563.367.389 XSGallamine; Gallamonium Iodide LH LS;  MHÑGallbladder AN/radiogr = CHOLECYSTOGRAPHY; /surg: consider also CHOLECYSTECTOMY; gallstones or gallbladder calculi = CHOLELITHIASIS; inflammation = CHOLECYSTITIS; from refs here it is apparent that the Greek counterpart of gallbladder is CHOLECYST- MNA3.159.439 FXÑCholecystectomy; ÑCholecystography LH LX;  MHÑGallbladder Diseases ANinflamm dis = CHOLECYSTITIS MNC6.130.564 LH  MHÑGallbladder Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.120.401; C6.130.564.522 LH  MHÑGallic Acid ANdo not use /biosyn /defic /physiol RN149-91-7 MND2.241.223.106.505.350; D2.241.511.390.350; D2.755.410.350 XUÑPropyl Gallate LH LU  MHÑGallium ANGa-69; do not use /analogs /biosyn /defic /physiol RN7440-55-3 MND1.268.334; D1.552.289 LH  MSStable gallium atoms which have the same atomic number as the element gallium, but differ in atomic weight. Gallium (Ga) 71 is a stable gallium isotope. PM75 HN75 MHÑGallium Isotopes ANGa-71; NIM; no qualif PIGallium (66-74); Isotopes (74); Radioisotopes (66-73) MND1.496.360; D1.552.289.400 LH  MSUnstable isotopes of gallium that decay or disintegrate spontaneously emitting radiation. Gallium (Ga) 64-68, 70 and 72-76 are radioactive isotopes of gallium. PM75 HN75 MHÑGallium Radioisotopes ANGa-64-68, 70, 72-76; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIGallium (66-74); Radioisotopes (66-74) MND1.496.360.400; D1.496.749.360; D1.552.289.700 LH  MS3,4,5-Trimethoxy-alpha-(1-methylethyl)-alpha-[3-[methyl-[3-(3,4,5-trimethoxyphenyl)propyl]amino]-propyl]benzeneacetonitrile. Coronary vasodilator which is an analog of iproveratril (verapamil) with one more methoxy group on the benzene ring. OLuse GALLOPAMIL to search D 600 back thru 1975 PM87; was see under VERAPAMIL 1984-86, was D 600 see under IPROVERATRIL 1975-83 HN87(84); was see under VERAPAMIL 1984-86, was D 600 see under IPROVERATRIL 1975-83 MHÑGallopamil ANdo not use /biosyn /defic /physiol RN16662-47-8 PIIproveratril (73-74) MND2.92.471.683.953.395; D18.97.953.395; D18.192.953.395; D18.918.925.395 XSD 600 LH LS  MSA change in electrical resistance of the skin, occurring in emotion and in certain other conditions. MHÑGalvanic Skin Response ANonly /drug eff /physiol /rad eff MNF2.830.702.315; F4.669.332; G10.795.261 XSELECTRODERMAL RESPONSE; Electric Conductance, Skin; REFLEX, PSYCHOGALVANIC; Skin Electric Conductance LH LS; ; ;  MSInfestation by mites of the Gamasides group. OLsearch MITE INFESTATIONS 1968-74 HN(75) MHÑGamasoidiasis MNC3.211.394.290 DMÑMite Infestations LH LM  MHÑGambia MNZ1.58.432.322 LH  MSAn activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money. HN(79)68 MHÑGambling ANonly /psychol MNF1.145.722.408; F3.709.597.460.372 DMÑRisk-Taking LH LM  MSA mathematical theory that deals with action in a conflict situation as if it were a game in which each player seeks to maximize his opponent's losses. OLuse GAME THEORY to search PRISONER'S DILEMMA back thru 1969 PM69 HN69; PRISONER'S DILEMMA was see under GAME THEORY 1969-78 MHÑGame Theory ANno qualif PIGroup Processes (66-68); Interpersonal Relations (66-68); Operations Research (66-68) MNF4.669.880.402; H1.548.490 XSPrisoner's Dilemma FXÑDecision Making; ÑOperations Research; ÑProblem Solving XUÑGames, Experimental LH LS LX; ; LU  MSGames designed to provide information on hypotheses, policies, procedure or strategies. OLsearch GAME THEORY 1969-74 HN(75) MHÑGames, Experimental ANno qualif MNF4.669.880.402.360; H1.548.490.356 DMÑGame Theory LH LM  MSThe first phase of sexual reproduction which involves the transforming of certain cells in the parent into specialized reproductive cells. PM85 HN85 MHÑGametogenesis ANonly /drug eff /rad eff MNG8.520.310 LH  OLuse GAMMA GLOBULINS to search GAMMA GLOBULIN back thru 1966; search GAMMA GLOBULIN DEFICIENCY under AGAMMAGLOBULINEMIA 1966-77 PM75; was GAMMA GLOBULIN 1963-74; /deficiency was GAMMA GLOBULIN DEFICIENCY see under AGAMMAGLOBULINEMIA 1963-67; IMMUNE SERUM GLOBULIN was heading 1965 HN75; was GAMMA GLOBULIN 1963-74; /deficiency was GAMMA GLOBULIN DEFICIENCY see under AGAMMAGLOBULINEMIA 1963-67; IMMUNE SERUM GLOBULIN was heading 1965 MHÑGamma Globulins ANdo not use /antag /blood; /defic = AGAMMAGLOBULINEMIA or DYSGAMMAGLOBULINEMIA (TN 225); do not use /ther use: index under IMMUNIZATION, PASSIVE for ther with gamma globulins in general or unspecified; anti-gamma globulin antibodies = ANTI-ANTIBODIES (IM) + GAMMA GLOBULINS (IM); TN 224: relation to IMMUNOGLOBULINS; gammopathies or gammapathies (excessive immunoglobulins in blood) = HYPERGAMMAGLOBULINEMIA: see note there & TN 226; various gamma globulins: TN 224 MND12.776.124.790.522; D12.776.377.715.440 LH  MSVery powerful and penetrating, high-energy electromagnetic radiation of shorter wavelength than that of x-rays; emitted by a decaying nucleus, usually between 0.01 and 10 MeV; also called nuclear x-rays. OLsearch RADIATION 1966-74 HN(75); was see under RADIATION 1963-75 MHÑGamma Rays ANNIM: Manual 19.4.52, 21.17, 28.17; TN 158: how to index gamma rays MNH1.671.768.513.400 DMÑRadiation, Ionizing LH LM  MSL-Glutamate:L-cysteine gamma-ligase (ADP-forming). One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of gamma-glutamyl-cysteine from glutamate and cysteine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.2. HN(77) MHÑGamma-Glutamyl-Cysteine Synthetase ANdo not use /analogs RNEC 6.3.2.2 PICysteine (73-76); Glutamates (73-76); Peptide Synthetases (73-76) MND8.586.464.677.500 DMÑPeptide Synthetases LH LM  MS(Gamma-L-glutamyl)-L-amino-acid gamma-glutamyltransferase (cyclizing). Catalyzes the synthesis of pyroglutamate from a gamma-glutamyl-amino acid, also releasing the free amino acid. The enzyme acts on derivatives of glutamate, 2-aminobutyrate, alanine and glycine. The enzyme has been proposed to have a role in a gamma-glutamyl cycle for amino acid transport into cells in the intestines. HN(75) MHÑGamma-Glutamylcyclotransferase ANdo not use /analogs RNEC 2.3.2.4 PIAcyltransferases (70-74); Glutamates (70-74); Pyrrolidonecarboxylic Acid (72-74) MND8.586.913.50.550 DMÑAcyltransferases LH LM  MSCatalyzes reversibly the transfer of a glutamyl group from a glutamyl-peptide and an amino acid to a peptide and a glutamyl-amino acid. OLuse GAMMA-GLUTAMYLTRANSFERASE to search GLUTAMYL TRANSPEPTIDASE back thru 1972 PM84; was GLUTAMYL TRANSPEPTIDASE 1972-83 HN84; was GLUTAMYL TRANSPEPTIDASE 1972-83 MHÑGamma-Glutamyltransferase ANdo not use /analogs RNEC 2.3.2.2 PIAcyltransferases (66-71) MND8.586.913.50.574 XSGlutamyl Transpeptidase LH LS  MHÑGanglia ANdo not use /innerv; dorsal root ganglia = GANGLIA, SPINAL; wrist ganglion is indexed under WRIST (IM) + SYNOVIAL CYST (IM); ganglionectomy: see note below at GANGLIA, SYMPATHETIC MNA8.340 LH  MHÑGanglia, Autonomic ANdo not use /innerv MNA8.99.370; A8.340.315 LH  MSGanglia of the parasympathetic nervous system including the ciliary, pterygopalatine, submandibular and otic ganglia and others. PM80 HN80 MHÑGanglia, Parasympathetic ANdo not use /innerv; includes ciliary, pterygopalatine, submandibular, otic ganglia PIGanglia, Autonomic (66-79); Parasympathetic Nervous System (66-79) MNA8.99.370.405; A8.99.698.405; A8.340.315.405 XSParasympathetic Ganglia LH LS  MHÑGanglia, Spinal ANdo not use /innerv MNA8.340.565; A8.796.728.523 XSDorsal Root Ganglia LH LS  MSGanglia of the sympathetic nervous system including the cervical, mesenteric and celiac ganglia and others. OLto search SYMPATHETIC GANGLIA use GANGLIA, SYMPATHETIC back thru 1980 & GANGLIA, AUTONOMIC 1966-79; to search CELIAC GANGLIA use GANGLIA, SYMPATHETIC back thru 1980 & CELIAC PLEXUS 1966-79 PM80; SYMPATHETIC GANGLIA was indexed under GANGLIA, AUTONOMIC 1963-79; CELIAC GANGLIA was indexed under CELIAC PLEXUS 1963-79 HN80; SYMPATHETIC GANGLIA was see GANGLIA, AUTONOMIC 1975-79, was see under GANGLIA, AUTONOMIC 1963-74; CELIAC GANGLIA was see CELIAC PLEXUS 1975-79, was see under CELIAC PLEXUS 1963-74 MHÑGanglia, Sympathetic ANdo not use /innerv; includes cervical, mesenteric, celiac, stellate ganglia; ganglionectomy: index under SYMPATHECTOMY & not also here unless particularly discussed PIGanglia, Autonomic (66-79); Sympathetic Nervous System (66-79) MNA8.99.370.411; A8.99.893.477; A8.340.315.477 XSCeliac Ganglia; Sympathetic Ganglia LH LS;  MHÑGanglioneuroma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.289 LH  OLuse GANGLIONIC BLOCKADERS to search GANGLIONIC-BLOCKING AGENTS back thru 1966 PM70; was GANGLIONIC-BLOCKING AGENTS 1963-69 HN70; was GANGLIONIC-BLOCKING AGENTS 1963-69 MHÑGanglionic Blockaders ANdo not use /analogs /biosyn /defic /physiol MND16.653.396 XSGANGLIONIC BLOCKING AGENTS; GANGLIOPLEGIC AGENTS LH LS;  PM72 HN72(71) MHÑGanglionic Stimulants ANdo not use /analogs /biosyn /defic /physiol PIAutonomic Agents (66-70) MND16.698.628 XSNicotinic Agents LH LS  MHÑGangliosides ANdo not use /analogs MND10.516.390.470.440; D10.516.808.530.490 XUÑG(M2) Ganglioside; ÑG(M3) Ganglioside LH LU;  MSA group of fatal inherited ganglioside storage diseases with onset in infancy or childhood and characterized by accumulation of a specific ganglioside caused by absence or severe deficiency of specific enzymes. They involve mental and motor deterioration, autosomal recessive inheritance, and neuronal lipoidosis. PM76 HN76 MHÑGangliosidosis ANdo not use /congen /drug eff /physiol /rad eff; coord IM with specific ganglioside above (NIM) but note specifics below PILipoidosis (66-75); Gangliosides (66-75) MNC10.228.140.163.300; C10.496.253; C18.452.648.556.641.803.350; F3.709.346.250 FXÑGalactosidases; ÑHexosaminidases LH LX;  MHÑGangrene ANIM for general or for gangrene process; NIM as coord for /pathol, with no qualif MNC23.739.638.395 LH  OLsearch REFUSE DISPOSAL 1966-74 HN(75) MHÑGarbage ANno qualif MNG3.850.860.510.460.205 DMÑRefuse Disposal LH LM  MSAn autosomal dominant disease featuring multiple colonic polyposis with malignant tendency, subcutaneous fibromata and lipomata, exostoses and osteomas of the skull and facial bones, and epidermal inclusion cysts. PM81 HN81 MHÑGardner Syndrome ANdo not use /anal /blood supply /congen /secret /ultrastruct PIColonic Neoplasms (66-80); Intestinal Polyps/FG (68-80); Neoplasms, Multiple Primary (66-80) MNC4.700.392; C4.799.411.393; C6.405.469.583.393; C16.131.77.393; C16.466.700.392 LH  MSAllium sativum; one of the Liliaceae used as condiment and home remedy for everything from nervousness to worms; contains allicin, the pungent active ingredient which may reduce blood cholesterol and inhibit platelet aggregation. MHÑGarlic ANas plant & condiment; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.26.423; B6.560.401; J1.341.241.413 XSAllium sativum LH LS  MHÑGas Gangrene ANcaused by Clostridium perfringens but all C. perfringens infections need not be gas gangrene MNC1.252.217.440 LH  MHÑGas Poisoning ANdo not use /chem ind MNC21.613.455 FXÑChemical Warfare LH LX  MHÑGases AN/pois = GAS POISONING; do not use /analogs /defic /physiol; does not include natural gas ( = GAS, NATURAL see FOSSIL FUELS); gas embolism = EMBOLISM, AIR; intestinal gases = GASES + INTESTINES /physiol unless clinically referred to as FLATULENCE (Cat C) MND1.362 LH  MSGases which are members of the zero group of the periodic system. These gases do not react chemically. PM76 HN76; was RARE GASES (NON MESH) before 1976 MHÑGases, Rare ANdo not use /analogs /biosyn /defic /physiol PIGases (66-75) MND1.362.641 XSGases, Inert; Rare Gases LH LS;  MSVolative flammable fossil fuel (liquid hydrocarbons) derived from crude petroleum by processes such as distillation reforming, polymerization, etc. OLsearch PETROLEUM 1966-74 HN(75); was in Cat J only 1975-81 MHÑGasoline ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNG3.230.132.258.630.540; J1.435.723.441; J1.740.400.700.400 DMÑPetroleum LH LM  MHÑGastrectomy ANincludes partial, total & subtotal; do not use /util except by MeSH definition MNE4.765.419 FXÑPOSTGASTRECTOMY SYNDROMES; ÑPeptic Ulcer; ÑStomach LH LX; ;  MSHydrochloric acid present in gastric juice. OLto search HYDROCHLORIC ACID, GASTRIC use GASTRIC ACID back through 1981 and GASTRIC JUICE 1969-80 PM81; was HYDROCHLORIC ACID, GASTRIC see GASTRIC JUICE 1969-80 HN81; was HYDROCHLORIC ACID, GASTRIC see GASTRIC JUICE 1969-80 MHÑGastric Acid ANonly /metab /physiol /secret; /anal = GASTRIC ACIDITY DETERMINATION; hyperacidity: index under GASTRIC ACID /secret PIGastric Juice (66-80) MNA12.838.307.603 XSHydrochloric Acid, Gastric FXÑAchlorhydria; ÑHydrochloric Acid; ÑParietal Cells, Gastric LH LS LX; ;  MSGastric analysis for determination of free acid or total acid. MHÑGastric Acidity Determination ANNIM; only /instrum /vet MNE1.184.357; E1.223.411 LH  MSThe evacuation of food from the stomach into the duodenum. PM78 HN78 MHÑGastric Emptying ANonly /drug eff /rad eff PIGastrointestinal Motility (66-77); Stomach (66-77) MNG10.261.482.400 FXÑPylorus LH LX  MSAbnormal passage communicating with the stomach. MHÑGastric Fistula ANfistula policy: Manual 23.25+ MNC6.405.748.297 FXÑFistula; ÑGASTROSTOMY LH LX;  MSThe superior portion of the body of the stomach above the level of the cardiac notch. PM81 HN81 MHÑGastric Fundus ANNIM when merely locational; neopl of gastric fundus: coord NIM with STOMACH NEOPLASMS (IM) + histol type of neopl (IM) PIStomach (66-80) MNA3.492.766.419 LH  MSA gastrointestinal hormone consisting of a 43 amino acid polypeptide (molecular weight 5105). Inhibits gastric secretion and motility and stimulates release of insulin. PM86; was see under GASTROINTESTINAL HORMONES 1977-85 HN86(77); was see under GASTROINTESTINAL HORMONES 1977-85 MHÑGastric Inhibitory Polypeptide AN/biosyn /physiol permitted; do not use /analogs; DF: GIP RN59392-49-3 PIGastrointestinal Hormones (74-76); Peptides (74-76) MND6.472.317.400; D12.644.220; D12.776.641.650.300; D19.316.629.398 XSGlucose-Dependent Insulinotropic Peptide LH LS  MHÑGastric Juice ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff; /secret permitted but consider GASTRIC MUCOSA /secret if pertinent, and not STOMACH /secret; note GASTRIC ACID above; absence of gastric HCl = ACHLORHYDRIA; hyperacidity: index under GASTRIC ACID /secret MNA12.838.307 FXÑPEPSIN; ÑPEPSINOGEN LH LX;  PM66 HN66(63) MHÑGastric Lavage ANdo not use /util except by MeSH definition MNE5.510.441 XSLAVAGE, GASTRIC LH LS  MHÑGastric Mucin AN/biosyn /physiol permitted RN9007-86-7 MND12.776.395.560.631.300 LH  PM64 HN64 MHÑGastric Mucosa AN/secret permitted but consider GASTRIC JUICE /secret if pertinent, but not STOMACH /secret; mucosal neopl: coord NIM with STOMACH NEOPLASMS (IM) + histol type of neopl (IM) MNA3.492.766.440; A10.615.550.291 XSGastric Glands LH LS  MSGastric mucosal invagination of the esophagus, the pylorus, or the stoma of a surgically created gastroduodenostomy or gastrojejunostomy. MHÑGastric Mucosa Prolapse MNC6.405.748.333 LH  MSGastrointestinal hormones which excite the secretion of gastric juices. OLuse GASTRINS to search GASTRIN back thru 1966 PM78; was GASTRIN 1963-77 HN78; was GASTRIN 1963-77 MHÑGastrins AN/biosyn /physiol permitted; do not use /analogs; gastrin pentapeptide = PENTAGASTRIN; gastrin tetrapeptide = TETRAGASTRIN MND6.472.317.413; D12.644.224; D12.776.641.650.320; D19.316.629.441 XUÑTetragastrin LH LU  MHÑGastritis MNC6.405.748.369 XUÑGastritis, Atrophic; ÑGastritis, Hypertrophic LH LU;  MSChronic gastritis with mucosal atrophy. HN(81) MHÑGastritis, Atrophic ANa chronic dis: do not coord with CHRONIC DISEASE PIAtrophy (66-80); Gastritis (66-80) MNC6.405.748.369.394 DMÑGastritis LH LM  MSGastritis with hypertrophy of gastric mucosa folds. Symptoms include vomiting, diarrhea, weight loss, excessive mucus secretion, and hypoproteinemia. HN(81) MHÑGastritis, Hypertrophic PIGastritis (66-80); Hypertrophy (66-80) MNC6.405.748.369.410 XSMenetrier Disease DMÑGastritis LH LS LM  OLsearch EPIDEMIC GASTROENTERITIS VIRUS under VERTEBRATE VIRUSES, UNCLASSIFIED 1966-67 PMEPIDEMIC GASTROENTERITIS VIRUS was heading 1966-67 HNEPIDEMIC GASTROENTERITIS VIRUS was heading 1966-67 MHÑGastroenteritis MNC6.405.236 LH  MSA virus causing a disease usually fatal to pigs under 3 weeks old. HN(75); was see under CORONAVIRUSES 1975-80 MHÑGastroenteritis Virus of Swine ANdo not use /blood-csf-urine /cytol; infection = GASTROENTERITIS, TRANSMISSIBLE, OF SWINE MNB4.909.777.199.400 XSTGE Virus; Transmissible Gastroenteritis Virus of Swine DMÑCoronaviridae LH LS; LM  MSA coronavirus causing a fatal gastroenteritis in piglets and a chronic gastroenteritis in adult pigs. PM70 HN70 MHÑGastroenteritis, Transmissible, of Swine ANdo not use /vet; don't forget also SWINE (NIM) & check tag ANIMAL PISwine Diseases (66-69) MNC2.782.225.400; C22.905.469 XSTRANSMISSIBLE GASTROENTERITIS OF SWINE LH LS  MSA subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures (esophagus, liver, gallbladder, and pancreas). MHÑGastroenterology ANSPEC: SPEC qualif; ╥hepatology╙ seen in foreign lit goes here CATALOG: use with form qualif instead of GASTROINTESTINAL SYSTEM /form or GASTROINTESTINAL DISEASES /form MNG2.403.776.409.440 FXÑGASTROINTESTINAL DISEASES LH LX  MHÑGastroenterostomy ANrestrict to specific surg procedure: do not use as a coord for various parts of the intestines, as duodenostomy ( = DUODENUM /surg); do not use /util except by MeSH definition MNE4.765.457 LH  MSReflux of acid-peptic gastric juice and/or duodenal contents (bile acids, pancreatic juice) into the distal esophagus, commonly due to incompetence of the lower esophageal sphincter. Use also for gastric regurgitation, an extension of this process with entry of fluid into the pharynx or mouth. OLuse GASTROESOPHAGEAL REFLUX to search ESOPHAGEAL REFLUX back thru 1966 & REGURGITATION, GASTRIC back thru 1967 PM84; was ESOPHAGEAL REFLUX 1966-83; REGURGITATION, GASTRIC was see ESOPHAGEAL REFLUX 1979-83, was heading 1967-78 HN84; was ESOPHAGEAL REFLUX 1964-83 (Prov 1964-65); REGURGITATION, GASTRIC was see ESOPHAGEAL REFLUX 1979-83, was heading 1967-78 MHÑGastroesophageal Reflux ANnote ESOPHAGITIS, REFLUX see ESOPHAGITIS, PEPTIC MNC6.306.780 XSEsophageal Reflux; Regurgitation, Gastric LH LS;  OLuse GASTROINTESTINAL AGENTS to search CAROB FLOUR back thru 1966 (as Prov 1966-74) and DIGESTANTS back thru 1967 PM67; DIGESTANTS was heading 1967-86 HN67; CAROB FLOUR was see under GASTROINTESTINAL AGENTS 1975, was Prov 1964-74; DIGESTANTS was heading 1967-86 MHÑGastrointestinal Agents ANdo not use /analogs /biosyn /defic /physiol MND19.316 XSDigestants LH LS  MSThe residue of ingested substances in the gastrointestinal tract. Excludes natural secretions and FECES. PM85 HN85 MHÑGastrointestinal Contents ANonly /anal; do not coord with STOMACH or specific intestine unless particularly discussed MNA12.464 XSStomach Contents LH LS  PM65 HN65 MHÑGastrointestinal Diseases ANGEN: prefer specifics; inflamm dis = GASTROENTERITIS CATALOG: form qualif = GASTROENTEROLOGY /form MNC6.405 FXÑGastroenterology LH LX  PMGASTRONE was see under MUCOPOLYSACCHARIDES 1964-76 MHÑGastrointestinal Hormones AN/biosyn /physiol permitted; do not use /analogs MND6.472.317; D19.316.629 XSEnteric Hormones; Intestinal Hormones FXÑIntestinal Secretions XUÑEnterogastrone; ÑEnteroglucagon LH LS; LX LU;  PM66 HN66 MHÑGastrointestinal Motility ANonly /drug eff /rad eff; not necessary to specify STOMACH or INTESTINES as coord; coord with specific intestine /physiol if pertinent (IM); GASTRIC EMPTYING is available MNG10.261.482 XSINTESTINAL MOTILITY XUÑPeristalsis LH LS LU  MHÑGastrointestinal Neoplasms ANGEN: prefer specific precoord; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.476; C6.405.282 LH  MHÑGastrointestinal System ANGEN: prefer specifics; /surg: consider also GASTROENTEROSTOMY; inflammation = GASTROENTERITIS CATALOG: form qualif = GASTROENTEROLOGY /form MNA3.492 LH  MSEndoscopic examination of the interior of the stomach. MHÑGastroscopy ANNIM; do not use /util except by MeSH definition MNE1.184.399; E1.418.458 LH  PM67 HN67(65) MHÑGastrostomy ANdo not use /util except by MeSH definition MNE4.765.496 FXÑEnteral Feeding; ÑGastric Fistula LH LX;  MSThe early embryonic stage following the blastula, characterized by morphogenetic cell movements, cell differentiation, and the formation of the three germ layers. PM80 HN80 MHÑGastrula AN╥early embryonic stage following the blastula╙; A 11 qualif PIspecific organism/EM (66-79) MNA16.254.412 XSArchenteron; Blastopore; Gastrocoele; Primitive Gut; Primitive Streak LH LS; ; ; ;  MSHereditary disorder of glucocerebroside metabolism, usually occurring in infancy, and characterized by mental retardation, bulbar palsy, opisthotonus and enlargement of the spleen and liver. MHÑGaucher's Disease ANdo not use /congen /drug eff /physiol /rad eff MNC15.604.667.358; C18.452.648.556.641.803.441; F3.709.346.282 LH  PM68 HN68 MHÑGeese ANdomestic or wild; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; diseases: coord IM with POULTRY DISEASES (IM) PIBirds (66-67); Poultry (66-67) MNB2.248.617.492 LH  MS5,9,13-Trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester. A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue. Synonyms: Andoin; DA 688; Gefarnil; Gepharnate; Improfarm; Nolesil; Ulco; Ulsanax. HN(78) MHÑGefarnate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN51-77-4 PIAlkenes (66); Farnesol (66-69); Fatty Acids (69-73); Fatty Acids, Unsaturated (73-77); Terpenes (69-77) MND2.241.81.436.310; D2.455.849.440; D10.516.251.355.350; D19.316.203.397 XSGeranyl Farnesylacetate DMÑTerpenes LH LS LM  PM66; was see under PRECIPITIN TESTS 1963-65 HN66(63); was see under PRECIPITIN TESTS 1963-65 MHÑGel Diffusion Tests ANNIM; only /instrum /methods /vet; Ouchterlony goes here MNE1.223.495.826.769.442 XSIMMUNODIFFUSION LH LS  MHÑGelatin ANdo not use /biosyn /defic /physiol RN9000-70-8 MND12.776.860.476 LH  OLuse GELATIN SPONGE, ABSORBABLE to search GELFOAM back thru 1966 (as Prov 1966-72) PM78; was GELFOAM 1973-77, was GELFOAM see under HEMOSTATICS 1963-72 HN78; was GELFOAM 1964-77 (Prov 1964-72), was GELFOAM see under HEMOSTATICS 1963-72 MHÑGelatin Sponge, Absorbable AND25-26 qualif MND19.461.270.463.525 XSGelfoam LH LS  MSColloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquifies; the resulting colloid is called a sol. MHÑGels ANIM for general only; only /adv eff /anal (with caution) /stand /supply; NIM with specific drug IM, no qualif MND26.394.225.220.442 LH  MSThose aspects of appearance and behavior which are attributed to masculinity or femininity and determined by cultural and familial factors to which the individual is exposed. Differentiated from biologically determined sex characteristics. HN(76) MHÑGender Identity ANpsychological; do not confuse with SEX CHARACTERISTICS (physiological); no qualif PIIdentification (Psychology) (68-75); Sex (68-75) MNF1.393.446.250; F1.752.747.385.200; F1.752.747.722.200; F2.739.794.793.200; F3.407.446.200 XSGender Role; Sex Role DMÑIdentification (Psychology) LH LS; LM  MSA selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Also: laboratory technics for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells or generation of extrachromosomal sequences from rolling circle replication. PM80 HN80 MHÑGene Amplification ANonly /drug eff /methods /rad eff PIGenes (66-67); Genes, Structural (68-79); Nucleic Acid Hybridization (71-79); Plasmids (75-79) MNE5.393.330; G5.331.380.350 LH  MSThe asymmetrical segregation of genes during replication which leads to the production of non-reciprocal recombinant strands and the apparent conversion of one allele into another. Thus, e.g., the meiotic products of an Aa individual may be AAAa or aaaA instead of AAaa, i.e., the A allele has been converted into the a allele or vice versa. PM80 HN80 MHÑGene Conversion ANonly /drug eff /rad eff PIMutation (66-79); Recombination, Genetic (68-79) MNG5.832.380 XSPolar Recombination; Polaron LH LS;  MSAny of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action at the level of transcription or translation. PM81 HN81 MHÑGene Expression Regulation ANonly /drug eff /rad eff PIGenes (66-80); Genes, Regulator (73-80); Transcription, Genetic (73-80); Translation, Genetic (73-80) MNG5.331.380 XSGene Action Regulation; Regulation of Gene Expression FXÑCell Differentiation; ÑChromosomal Proteins, Non-Histone; ÑTranscription Factors LH LS; LX; ;  MSThe proportion of one particular allelotype to the total of all alleles at this genetic locus in a breeding population. PM68 HN68 MHÑGene Frequency ANonly /drug eff /rad eff PIGenes (66-67); Genetics (66-67); Genetics, Population (66-67) MNG5.414.317 XSGenetic Drift LH LS  MSThe total genetic information possessed by the reproductive members of a population of sexually reproducing organisms. HN(78) MHÑGene Pool ANnot for micro-organisms; no qualif PIGene Frequency (68-77); Genetics, Population (66-77) MNG5.414.350 DMÑGenetics, Population LH LM  MHÑGenealogy and Heraldry ANIM; no qualif; genealogical trees in diseases = PEDIGREE (NIM); EMBLEMS AND INSIGNIA is also available; DF: GENEALOGY MNK1.419.359 XSHeraldry LH LS  MSThe sum of all nonspecific systemic reactions of the body to long-continued exposure to systemic stress. OLsearch STRESS & ADAPTATION, PHYSIOLOGICAL 1966-74 HN(75); was see under STRESS & ADAPTATION, PHYSIOLOGICAL 1963-74 MHÑGeneral Adaptation Syndrome ANdo not use /congen MNC23.280.853.442 DMÑStress LH LM  OL'general patient care' is indexed under NURSING CARE or under disease /NU MH*General Patient Care (Non Mesh) MNE2.472 LH  MSNonspecialized dental practice which is concerned with providing primary and continuing dental care. PM67 HN67 MHÑGeneral Practice, Dental ANSPEC: SPEC qualif; ╥extraction in general practice in dentistry╙ is GENERAL PRACTICE, DENTAL (NIM) if indexed there at all PIDentistry (66); Family Practice (66) MNG2.163.342 LH  MSThe phenomenon of an organism's responding to all situations similar to one in which it has been conditioned. PM65; was GENERALIZATION LEARNING 1963-64 HN65; was GENERALIZATION LEARNING 1963-64 MHÑGeneralization (Psychology) ANonly /drug eff /physiol /rad eff; DF: GENERALIZATION MNF2.463.425.357 LH  MSThe principle that after an organism learns to respond in a particular manner to a stimulus, that stimulus is effective in eliciting similar responses. PM69 HN69(65) MHÑGeneralization, Response ANonly /drug eff /physiol /rad eff MNF2.463.425.357.359 LH  MSThe tendency to react to stimuli that are different from, but somewhat similar to, the stimulus used as a conditioned stimulus. PM69 HN69(65) MHÑGeneralization, Stimulus ANonly /drug eff /physiol /rad eff MNF2.463.425.357.526 LH  MSSpecific sequences of nucleotides along a molecule of DNA (or, in the case of some viruses, RNA) which represent the functional units of heredity. PM65; was see under CHROMOSOMES 1963-64 HN65; was see under CHROMOSOMES 1963-64 MHÑGenes ANonly /drug eff /rad eff; locus = CHROMOSOME MAPPING; flow = GENETICS, POPULATION; interaction = PHENOTYPE; product = TRANSLATION, GENETIC; lethal = GENES, LETHAL; suppressor genes: index under SUPPRESSION, GENETIC; restorer genes: index under SUPPRESSION, GENETIC; repressor genes = GENES, REGULATOR; lac gene = LAC OPERON but consider also LAC FACTORS or LAC REPRESSORS (see note on REPRESSOR PROTEINS) CATALOG: form qualif = GENETICS or GENETICS, BEHAVIORAL or GENETICS, BIOCHEMICAL or GENETICS, MEDICAL or GENETICS, MICROBIAL or GENETICS, POPULATION with form qualif MNG5.275 LH  PM82 HN82 MHÑGenes, Bacterial ANonly /drug eff /rad eff; coord IM with specific bacterium /genet (IM) PIGenes (66-81); specific bacterium/GE (78-81) MNG5.275.201 LH  MSGenes that are reflected in the phenotype both in the homozygous and the heterozygous state. PM68 HN68 MHÑGenes, Dominant ANonly /drug eff /rad eff PIGenes (66-67) MNG5.275.304 LH  MSThe genetic material of fungi. PM84 HN84 MHÑGenes, Fungal ANonly /drug eff /rad eff; coord IM with specific fungus /genet (IM) PIDNA, Fungal (80-83); Genes (66-77); specific fungus/GE (78-79) MNG5.275.320 LH  MSHighly conserved DNA sequences which have been identified in specific gene transcripts ranging from those of Drosophila melanogaster to mouse and human. Homeo box loci map to evolutionarily related regions on mutant genes and imply a common role in embryonic development. PM87 HN87 MHÑGenes, Homeo Box ANonly /drug eff /rad eff PIAlleles (68-75); Drosophila Melanogaster (72-86); Genes, Structural (83-86); Morphogenesis (83-86) MNG5.275.330; G5.331.380.400 XSGenes, Homeotic; Homeo Box Sequence; Homeotic Genes LH LS; ;  MSGenes whose products, expressed in immunocompetent cells, control the cellular and humoral responses to specific antigens. PM78 HN78 MHÑGenes, Immune Response ANonly /drug eff /rad eff PIGenes (66-77); Genes, Structural (68-77) MNG4.610.626.580.348; G5.275.348; G5.511.580.348 XSImmune Response Genes; Ir Genes LH LS;  MSGenes which result in the premature death of the organism; dominant lethal genes kill heterozygotes, whereas recessive lethal genes kill only homozygotes. PM68 HN68 MHÑGenes, Lethal ANonly /drug eff /rad eff; lethal genotype goes here PIGenes (66-67) MNG5.275.359 LH  MSGenes that are reflected in the phenotype only in the homozygous state. PM68 HN68 MHÑGenes, Recessive ANonly /drug eff /rad eff PIGenes (66-67) MNG5.275.415 LH  MSGenes which regulate or circumscribe the activity of other genes; specifically, genes which code for a protein, the repressor, which regulates the genetic transcription of the structural genes in an operon by binding to the operator. PM68 HN68 MHÑGenes, Regulator ANonly /drug eff /rad eff PIGenes (66-67) MNG5.275.470; G5.331.380.418 XSTranscriptional Regulatory Elements XUÑEnhancer Elements (Genetics); ÑTerminator Regions (Genetics) LH LS LU;  MSReiterated genes are present in multiple copies either clustered on the same chromosome or dispersed on different chromosomes. They are descended by duplication and variation from an ancestral gene. Examples include genes encoding histones, hemoglobins, immunoglobulins, actins, heat shock proteins, and phaseolins, as well as ribosomal RNA and transfer RNA genes. PM87 HN87 MHÑGenes, Reiterated ANonly /drug eff /rad eff; REPETITIVE SEQUENCES, NUCLEIC ACID is also available PIGenes (66-70); Genes, Bacterial (82-86); Genes, Structural (71-86); Genes, Viral (78-86) MNG5.275.483; G5.331.423 XSGene Clusters; Gene Duplication; Multigene Family LH LS; ;  MSGenes that code for proteins required for the enzymatic and structural functions of cells; e.g., bacterial genes and genes coding for ribosomal and transfer RNA. PM68 HN68 MHÑGenes, Structural ANonly /drug eff /rad eff PIGenes (66-67) MNG5.275.526; G5.331.463 XSCistron LH LS  MSBiologically functional sequences of DNA chemically synthesized in vitro. PM80 HN80 MHÑGenes, Synthetic ANonly /drug eff /rad eff; DF: GENES SYN PIDeoxyribonucleotides (73-79); DNA/CS (70-79); DNA, Recombinant (77-79); Genes, Structural (70-79); Oligodeoxyribonucleotides/CS (76-79) MNG5.275.582 LH  MSThe hereditary material of viruses, consisting in all DNA and some RNA viruses of a single molecule of nucleic acid and in some RNA viruses of several separate pieces of RNA. PM78 HN78 MHÑGenes, Viral ANonly /drug eff /rad eff; coord IM with specific virus /genet (IM) PIDNA, Viral (66-77); RNA, Viral (66-77) MNG5.275.605 XSGenomes, Viral; Viral Genes; Viral Genomes FXÑDNA, Viral; ÑRNA, Viral LH LS; ; LX;  MSThe precise protocol stored in the nucleic acid of the gene, according to which an exact sequence of nucleotide base pairs is transcribed into a molecule of messenger RNA to be translated into the amino acid sequence of a peptide. PM66 HN66(64) MHÑGenetic Code ANonly /drug eff /rad eff MNG5.331.508 FXÑDNA LH LX  PM68 HN68 MHÑGenetic Complementation Test ANno qualif PIGenetics (66-67) MNE5.393.281.526 LH  MSAdvising families of the risks involved pertaining to birth defects, in order that they may make an informed decision on current or future pregnancies. PM73 HN73 MHÑGenetic Counseling ANno qualif PICounseling (66-72); Eugenics (66-72) MNG5.358.493; N2.421.143.401.526 FXÑEugenics; ÑGENETIC TECHNICS; ÑPRENATAL DIAGNOSIS LH LX; ;  MSDirected modification of the gene complement of a living organism by such technics as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. PM73 HN73; was in Cat E & G 1973-79 MHÑGenetic Intervention ANonly /hist /instrum /methods /psychol /trends /util (if by MeSH definition) /vet; TEST-TUBE FERTILIZATION see FERTILIZATION IN VITRO is available PIEugenics (66-72); Genetics, Medical (66-72) MNE5.393.420 XSGenetic Engineering FXÑBiotechnology; ÑDNA, Recombinant; ÑIndustrial Microbiology XUÑSex Preselection LH LS LX; ; LU  MSA phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. PM80 HN80 MHÑGenetic Marker ANonly /drug eff /rad eff PIChromosome Mapping (66-79); Linkage (Genetics) (70-79); Phenotype (68-79); Recombination, Genetic (68-79) MNG5.735.450 XSChromosome Marker; DNA Marker; Marker, DNA; Marker, Genetic FXÑChromosome Mapping LH LS; ; ; LX  MSSearching a population for persons possessing certain genotypes or karyotypes that (1) are already associated with disease or predispose to disease, (2) may lead to disease in their descendants, or (3) produce other variations not known to be associated with disease. Includes prenatal genetic screening. PM78 HN78 MHÑGenetic Screening ANonly /instrum /methods /trends /vet PIGenetic Counseling (73-77); Genetics, Population (66-77); Hereditary Diseases (68-77); Mass Screening (68-77) MNE1.563.390; G3.850.520.610.580.120; N1.224.458.527.125; N2.421.143.827.233.443.125 FXÑHeterozygote Detection LH LX  PM73 HN73 MHÑGenetic Technics ANdo not use /man /methods /supply /util CATALOG: do not use /laboratory manuals MNE5.393 FXÑGenetic Counseling LH LX  MSVehicles suitable for the insertion, recombination, cloning and propagation of exotic fragments of DNA; they are primarily of two types: plasmids and phages. PM80 HN80 MHÑGenetic Vectors AN╥vehicles suitable for the insertion, recombination, cloning & propagation of exotic fragments of DNA╙; only /drug eff /rad eff; coord IM with specific bacterium + PLASMIDS or specific phage (IM or NIM) PIBacteriophages (66-79); Coliphages (66-79); DNA, Recombinant (77-79); Plasmids (75-79) MNG5.386.401; G5.832.401 XSVectors, Genetic FXÑDNA, Recombinant LH LS LX  MHÑGenetics ANGEN only: prefer /familial & genetic with diseases or /genet with organisms & chemicals: Manual 19.5+; when GEN & IM, only /hist; Manual 22.25; /methods = GENETIC TECHNICS CATALOG: use with form qualif instead of GENES /form MNG1.273.343; G5 XSHEREDITY FXÑHISTOCOMPATIBILITY TESTING LH LS LX  MSThe experimental study of the relationship between the genotype of an organism and its behavior. The scope includes the effects of genes on simple sensory processes to complex organization of the nervous system. PM68 HN68 MHÑGenetics, Behavioral ANonly /drug eff /rad eff; IM as SPEC only; prefer specific coords CATALOG: use with form qualif instead of GENES /form PIBehavior (66-67); Behavior, Animal (66-67); Genetics (66-67) MNF4.96.276; G5.303 XSPSYCHOGENETICS FXÑBehavior LH LS LX  MSA branch of genetics which deals with the chemical structure of the genes and with the mechanisms by which the genes control and regulate the structure and synthesis of proteins. PM68 HN68 MHÑGenetics, Biochemical ANonly /drug eff /rad eff; IM as SPEC only; prefer specific coords; array of biochem genet terms from all categories: Bull 119 (Mar 79) CATALOG: use with form qualif instead of GENES /form PIBiochemistry (66-67); Genetics (66-67) MNG5.331; G6.184.440 FXÑNUCLEIC ACIDS LH LX  MSA field of human genetics which entails the reliable prediction of certain human disorders as a function of the lineage and/or genetic makeup of any two parents or potential parents. OLuse GENETICS, MEDICAL to search GENETICS, HUMAN back thru 1966 PM80; was GENETICS, HUMAN 1963-79 HN80; was GENETICS, HUMAN 1963-79 MHÑGenetics, Medical ANSPEC; SPEC qualif; restrict to the field of human genetics dealing with genet or hered disord; see note on GENETICS above MNG2.403.388; G5.358 XSGenetics, Human FXÑAnthropology, Physical; ÑChromosome Abnormalities; ÑDiseases in Twins; ÑEugenics; ÑHereditary Diseases LH LS LX; ; ; ;  MSA branch of genetics which deals with the genetic mechanisms and processes of microorganisms. PM68 HN68 MHÑGenetics, Microbial ANGEN & unspecified only: prefer /genet with specific microbes: Manual 19.4.70; only /drug eff /rad eff; Manual 22.25; TN 196: avoid as an added coord with better specifics CATALOG: use with form qualif instead of GENES /form PIGenetics (66-67) MNG5.386 FXÑChromosomes, Bacterial LH LX  MSThe study of the genetic composition of populations and of the effects of factors such as selection, population size, mutation, migration, and genetic drift on the frequencies of various genotypes and phenotypes. PM66 HN66 MHÑGenetics, Population ANhuman & animal; only /drug eff /rad eff; genetic load & genetic equilibrium go here; specify geog: Manual 36.26 CATALOG: use with form qualif instead of GENES /form MNG5.414 XUÑGene Pool LH LU  MHÑGeniculate Bodies ANdo not use /innerv MNA8.186.211.385.826.701.444 LH  OLsearch FACIAL NERVE 1966-74 HN(75) MHÑGeniculate Ganglion ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.324.527 DMÑFacial Nerve LH LM  OLuse GENITAL DISEASES, FEMALE to search GYNECOLOGIC DISEASES back thru 1966 PM79; was GYNECOLOGIC DISEASES 1965-78 HN79; was GYNECOLOGIC DISEASES 1965-78 MHÑGenital Diseases, Female ANhuman & animal; GEN: prefer specifics CATALOG: /radiogr ( = GENITALIA, FEMALE /radiogr) /radionuclide ( = GENITALIA, FEMALE /radionuclide) /surg ( = GENITALIA, FEMALE /surg); form qualif = GYNECOLOGY /form MNC13.371 XSGynecologic Diseases FXÑGynecology LH LS LX  PM66 HN66 MHÑGenital Diseases, Male ANhuman & animal; GEN: prefer specifics MNC12.294 LH  OLuse GENITAL NEOPLASMS, FEMALE to search GYNECOLOGIC NEOPLASMS back thru 1966 PM79; was GYNECOLOGIC NEOPLASMS 1963-78 HN79; was GYNECOLOGIC NEOPLASMS 1963-78 MHÑGenital Neoplasms, Female ANhuman & animal; GEN or unspecified only: prefer specifics; coord IM with histol type of neopl (IM); /anal /blood supply /secret /ultrastruct permitted; /vet: consider also VENEREAL TUMORS, VETERINARY MNC4.588.945.418; C13.371.270 XSGynecologic Neoplasms LH LS  MSNeoplasms of the male genitalia. PM78 HN78 MHÑGenital Neoplasms, Male ANhuman & animal; GEN or unspecified only: prefer specifics PENILE NEOPLASMS, PROSTATIC NEOPLASMS, TESTICULAR NEOPLASMS; coord IM with histol type of neopl (IM); /anal /blood supply /secret /ultrastruct permitted; /vet: consider also VENEREAL TUMORS, VETERINARY PIUrogenital Neoplasms (66-77) MNC4.588.945.440; C12.294.260 LH  MHÑGenitalia ANGEN; note next two entries but prefer even better specifics MNA5.360 LH  MHÑGenitalia, Female ANGEN: prefer specifics; dis = GENITAL DISEASES, FEMALE; ╥accessory sex organs╙ goes here CATALOG: form qualif = GYNECOLOGY /form MNA5.360.319 FXÑHYSTEROSALPINGOGRAPHY LH LX  MHÑGenitalia, Male ANGEN: prefer specifics; dis = GENITAL DISEASES, MALE; ╥accessory sex organs╙ goes here MNA5.360.444 LH  MSThe genetic constitution of the individual; the characterization of the genes. PM68 HN68 MHÑGenotype ANNIM PIGenes (66-67); Genetics (66-67) MNG5.441 LH  MSA complex of three different closely related aminoglycoside sulfates, Gentamicins C1, C2 and C1(subA), obtained from Micromonospora purpurea and related species; they are broad-spectrum antibiotics, but may cause ear and kidney damage. Synonyms: Cidomycin; Garamycin; Gentalyn; Genticin; Refobacin. OLuse GENTAMICINS to search GENTAMICIN back thru 1966 PM78; was GENTAMICIN 1966-77 HN78; was GENTAMICIN 1963-77 (Prov 1963-65) MHÑGentamicins ANdo not use /analogs /defic /physiol MND9.203.408.51.374; D20.85.369 XSGentamycin LH LS  MHÑGentian Violet AND25-26 qualif RN548-62-9 MND20.187.331; D21.201.287.326; D26.408.735.527 XSCRYSTAL VIOLET; METHYL VIOLET; METHYLROSANILINE CHLORIDE LH LS; ;  MHÑGentisates ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.106.505.375; D2.241.511.390.375; D2.755.410.375 LH  OLrules on Cat Z terms as coords: Manual section 36; value to searchers: TN 215; geographical cross-refs to Cat Z terms: TN 231 MH*Geographicals (Non Mesh) MNZ1 LH  MHÑGeography ANfor Earth, Moon, etc.; must discuss geog features (lakes, streams, shores, mountains, plains, seas, etc.); not for epidemiol aspects of disease nor for occur of diseases in cities named in a country or a country ( = /occur); no qualif MNH1.374 FXÑMAPS LH LX  MHÑGeology ANfor Earth, Moon, etc. MNH1.419 LH  MHÑGeorgia ANU.S. only; do not confuse with GEORGIAN S.S.R. in Soviet Union MNZ1.107.567.875.296 LH  OLuse GEORGIAN S.S.R. to search GEORGIAN SSR & GEORGIA SSR back thru 1966 HN82; was GEORGIAN SSR 1967-81, was GEORGIA SSR 1963-66 MHÑGeorgian S.S.R. MNZ1.252.878.930.420; Z1.950.930.420 LH  MSInfection due to the fungus Geotrichum. HN(66) MHÑGeotrichosis MNC1.703.392 DMÑMycoses LH LM  MSA deuteromycetous fungal genus, various species of which have been isolated from pulmonary lesions. HN(75); was see under MONILIALES 1975-85 MHÑGeotrichum ANdo not use /anat /embryol /microbiol /parasitol; infection = GEOTRICHOSIS MNB5.354.381.546.380 DMÑHyphomycetes LH LM  MSA subfamily of the Cricetidae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys. OLuse GERBILLINAE to search GERBILS back thru 1968 PM82; was GERBILS 1968-81 HN82; was GERBILS 1968-81 MHÑGerbillinae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIRodentia (66-67) MNB2.649.865.360.400 XSGerbils; Jird; Meriones LH LS; ;  MSThe branch of dentistry concerned with the dental problems of older people. PM66 HN66 MHÑGeriatric Dentistry ANSPEC: SPEC qualif MNG2.163.394 LH  MSNursing care of the aged patient given in the home, the hospital, or special institutions such as nursing homes, psychiatric institutions, etc. PM67 HN67 MHÑGeriatric Nursing ANSPEC: SPEC qualif PIGeriatrics (66); Nursing (66); Nursing Care (66) MNG2.478.676.236; N2.421.533.245 LH  MSA subspecialty of Psychiatry concerned with the mental health of the aged. PM75 HN75 MHÑGeriatric Psychiatry ANSPEC: SPEC qualif, not for mental disorders in the aged ( = MENTAL DISORDERS (IM) + AGED (NIM) ): Manual 27.9 PIPsychiatry (66-74) MNF4.96.544.380; G2.403.642.260 XSPsychiatry, Geriatric; Psychogeriatrics LH LS;  MSThe branch of medicine concerned with the physiological and pathological aspects of the aged, including the clinical problems of senescence and senility. MHÑGeriatrics ANSPEC: SPEC qualif; when permitted for ╥geriatric dis╙: Manual 28.9; relation to AGED: Manual 34.14 CATALOG: use with form qualif instead of AGED /form MNG2.403.398 XSGerontology FXÑAged LH LS LX  MHÑGerm Cells ANGEN; prefer specific OVUM or SPERMATOZOA; A 11 qualif & /growth MNA5.360.490; A11.497 FXÑFertilization LH LX  MSThe three layers of cells comprising the early embryo. MHÑGerm Layers ANdo not use /abnorm /embryol /growth /inj /innerv MNA16.254.425 LH  MSAnimals not contaminated by or associated with any foreign organisms. MHÑGerm-Free Life ANIM; only /drug eff /rad eff MNG4.185.515.372 XSAXENIC ANIMALS; GNOTOBIOTICS XUÑSpecific Pathogen Free LH LS; LU  MHÑGermanium ANGe-74; do not use /analogs /biosyn /defic /physiol; Ge-70, 72, 73, 76 = GERMANIUM (IM) + ISOTOPES (NIM); Ge-65-69, 71, 75, 77, 78 = GERMANIUM (IM) + RADIOISOTOPES (IM) RN7440-56-4 MND1.268.345; D1.552.305 LH  MHÑGermany ANhistorical articles only: Manual 36.11; BERLIN is also available MNZ1.542.315 LH  MHÑGermany, East ANManual 36.11; BERLIN is also available; in German texts as DDR (Deutsche Demokratische Republik) MNZ1.542.248.420; Z1.542.315.445 XSDemocratic Republic of Germany LH LS  MHÑGermany, West ANManual 36.11; BERLIN is also available; in German texts as BRD (Bundesrepublik Deutschland) MNZ1.542.315.570 XSFederal Republic of Germany LH LS  MSGermine derivatives acetylated on any one or more of the hydroxy groups. These compounds are present in many polyester alkaloids which occur in Veratrum and Zygadenus species. They are used as antihypertensive agents, and in some cases, exhibit curare-like activity. HN(75) MHÑGermine Acetates ANdo not use /analogs /defic /physiol PIVeratrum (72-74) MND3.132.920.256.310; D3.549.256.310 XSGermine-3-monoacetate DMÑCevanes LH LS LM  MHÑGerstmann's Syndrome MNC10.597.44.445; C23.888.592.43.445 LH  MSA system which emphasizes that experience and behavior contain basic patterns and relationships which cannot be reduced to simpler components; that is, the whole is greater than the sum of its parts. OLsearch PSYCHOLOGICAL THEORY 1969-74 HN(75) MHÑGestalt Theory ANno qualif MNF2.739.527 DMÑPsychological Theory LH LM  MSA form of psychotherapy with emphasis on the interplay of organism and environment. Basic to this therapy is the development of awareness and maturity, as well as self-confidence. HN(73) MHÑGestalt Therapy ANSPEC qualif MNF4.754.360 DMÑPsychotherapy LH LM  MSAge of the conceptus. In humans, may be assessed by medical history, physical examination, early immunologic pregnancy tests, radiography, ultrasonography, and amniotic fluid analysis. PM70 HN70(68) MHÑGestational Age ANmammalian only; no qualif; for fetus, not mother; with PREGNANCY TRIMESTERS terms, specify trimester but do not also use GESTATIONAL AGE PIEmbryo (66-67); Fetus (66-67); Infant, Premature (66-67) MNG7.168.383; G7.553.417; G8.520.288.380 XSFetal Maturity, Chronologic FXÑEmbryo; ÑFetus; ÑInfant, Premature LH LS LX; ;  PM73 HN73(72) MHÑGestonorone Caproate ANdo not use /biosyn /defic /physiol RN1253-28-7 PIPregnanes (71) MND4.808.668.651.693.362; D4.808.745.745.654.527; D6.597.799.403 LH  MSMovement of a part of the body for the purpose of communication. OLsearch KINESICS 1968-74 & COMMUNICATION 1966-67 HN(75); was see under COMMUNICATION 1963-67 MHÑGestures ANno qualif MNF1.145.209.530.538.445 DMÑKinesics LH LM  MHÑGhana MNZ1.58.432.360 LH  MHÑGiant Cell Tumors ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); giant cell granuloma & central giant cell granuloma = GRANULOMA, GIANT CELL; osteoblastoclastoma: index here (IM) + OSTEOMA, OSTEOID (IM) + precoord organ/neopl term (IM) MNC4.557.499.388 LH  MSBenign lymphomatous tumors with a distinctive histological appearance; most commonly found in the mediastinum adjacent to the thymus gland. PM87 HN87 MHÑGiant Lymph Node Hyperplasia PIHyperplasia (66-86); Lymph Nodes (66-86) MNC4.400 XSAngiofollicular Lymphoid Hyperplasia; Castleman's Disease; Castleman's Tumor; GLNH; Hyperplasia, Giant Lymph Node; Lymph Node Hyperplasia, Giant LH LS; ; ; ; ;  MHÑGiardia ANdo not use /anat /blood-csf-urine /embryol; infection = GIARDIASIS MNB1.841.443.385 XSLamblia LH LS  MHÑGiardiasis MNC3.752.381 XSLAMBLIASIS LH LS  MSA genus of ascomycetous fungi of the family Hypocreaceae, order Hypocreales including several pathogens of grains and cereals; also the source of plant growth regulators such as gibberellin and gibberellic acid. HN(75) MHÑGibberella ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.501.400 DMÑHypocreales LH LM  MHÑGibberellins ANdo not use /analogs /defic MND11.303.760.408 LH  MHÑGibraltar MNZ1.542.335 LH  MSThe condition of abnormal overgrowth or excessive size of the whole body or any of its parts. MHÑGigantism MNC5.116.99.492; C5.116.132.479; C19.700.355.528 FXÑAdenoma, Eosinophilic; ÑGrowth Disorders LH LX;  MSA benign familial disorder, transmitted as an autosomal dominant trait; characterized by low-grade chronic hyperbilirubinemia with considerable daily fluctuations of the bilirubin level. OLsearch HYPERBILIRUBINEMIA, HEREDITARY 1966-74 HN(75) MHÑGilbert's Disease ANdo not use /congen MNC18.452.648.437.528; C23.888.498.329.396.528 DMÑHyperbilirubinemia, Hereditary LH LM  MSA syndrome beginning in early childhood characterized by repetitive tics, other movement disorders, uncontrollable grunts and other unintelligible sounds, and occasionally verbal obscenities. PM66 HN66(65) MHÑGilles de la Tourette's Disease ANdo not use /congen /drug eff /physiol /rad eff MNC10.228.140.79.450; F3.126.720.894.445 XSTourette Syndrome LH LS  PM68 HN68 MHÑGills PIBranchial Region (66-67); Fishes (66-67) MNA13.421 LH  MHÑGingiva AN/surg: prefer GINGIVOPLASTY or GINGIVECTOMY; ╥gingival curettage╙ = SUBGINGIVAL CURETTAGE; inflammation = GINGIVITIS; gingival recession goes under GINGIVAL DISEASES; gingival index: index under PERIODONTAL INDEX MNA14.254.646.480 XSGUMS LH LS  PM65 HN65 MHÑGingival Diseases ANinflamm dis = GINGIVITIS or PERICORONITIS MNC7.465.714.258 XSGingivosis XUÑGingival Recession LH LS LU  HN(72); was in Cat A & C 1972-83 MHÑGingival Exudate ANonly /enzymol /immunol /metab /microbiol /parasitol PIGingiva (66-72) MNC7.465.714.258.480.300 DMÑGingivitis LH LM  MSThe flowing of blood from the marginal gingival area, particularly the sulcus, seen in such conditions as gingivitis, marginal periodontitis, injury, and ascorbic acid deficiency. OLsearch HEMORRHAGE, ORAL 1967-74 HN(75) MHÑGingival Hemorrhage MNC7.465.316.446; C7.465.714.258.250; C23.542.544.446 XSHemorrhage, Gingival DMÑHemorrhage, Oral LH LS LM  PM65 HN65 MHÑGingival Hyperplasia ANdifferentiate from GINGIVAL HYPERTROPHY MNC7.465.714.258.267 LH  PM65 HN65 MHÑGingival Hypertrophy ANdifferentiate from GINGIVAL HYPERPLASIA MNC7.465.714.258.338 LH  PM74 HN74(71) MHÑGingival Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIGingival Diseases (66-70); Mouth Neoplasms (66-70) MNC4.588.443.591.402; C7.465.714.258.409 LH  MSAn abnormal extension of a gingival sulcus not accompanied by the apical migration of the epithelial attachment. OLsearch PERIODONTITIS 1968-74 HN(75); was see under PERIODONTITIS 1968-78 MHÑGingival Pocket ANPERIODONTAL POCKET is also available PIPeriodontitis (68-74) MNC7.465.714.258.480.360 XSPocket, Gingival DMÑGingivitis LH LS LM  MSThe exposure of root surface by an apical shift in the position of the gingiva. HN(85) MHÑGingival Recession PIGingival Diseases (66-84) MNC7.465.714.258.447 DMÑGingival Diseases LH LM  PM65 HN65 MHÑGingivectomy ANdo not use /util except by MeSH definition MNE4.833.400; E6.721.321; E6.892.400 LH  PMGINGIVAL POCKET was see under PERIODONTITIS 1968-78 MHÑGingivitis ANalso available is PERICORONITIS MNC7.465.714.258.480 XUÑGingival Exudate; ÑGingival Pocket LH LU;  MSAn acute or chronic gingival infection characterized by redness and swelling, necrosis extending from the interdental papillae along the gingival margins, pain, hemorrhage, necrotic odor, and often a pseudomembrane. The condition may extend to the oral mucosa, tongue, palate, or pharynx. OLuse GINGIVITIS, NECROTIZING ULCERATIVE to search VINCENT'S INFECTION back thru 1966 PM73; was VINCENT'S INFECTION 1963-72 HN73; was VINCENT'S INFECTIONS 1963-72 MHÑGingivitis, Necrotizing Ulcerative MNC1.539.424; C7.465.714.258.480.446 XSSTOMATITIS, ULCERATIVE; TRENCH MOUTH; VINCENT'S INFECTION LH LS; ;  PM65 HN65 MHÑGingivoplasty ANdo not use /util except by MeSH definition MNE4.833.410; E6.721.384; E6.892.410 LH  MSAn araliaceous genus of plants that contain a number of pharmacologically active agents, used as stimulants, sedatives, and tonics, especially in traditional medicine. Synonyms: schinseng; shinseng; ninjin. MHÑGinseng ANdo not use /isol /pathogen MNB6.560.434 XSEchinopanax; Panax FXÑCondiments LH LS; LX  PM68 HN68 MHÑGizzard PIBirds (66-67); Poultry (66-67); Stomach (66-67) MNA13.853.363 LH  MHÑGlanders ANusually animal: do not use /vet but check tag ANIMAL; don't forget also HORSES (NIM) but do not index under HORSE DISEASES MNC1.252.739.355; C22.488.409 LH  MSN-(7-Chloro-4-quinolyl)anthranilic acid 2,3-dihydroxypropyl ester. Proposed anti-inflammatory agent. Synonyms: Glifanan; Alcidon. HN(75) MHÑGlaphenine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3820-67-5 PIAnthranilic Acids (70-74); Quinolines (72-74); Glycols (72-74) MND2.241.223.106.61.105.445; D14.73.278.353; D26.74.75.563 XSGlafenine; Glycerylaminophenaquine DMÑAnthranilic Acids LH LS; LM  MSHard, amorphous, brittle, inorganic, usually transparent, polymerous silicate of basic oxides, usually potassium or sodium; used in the form of hard sheets, vessels, tubing, fibers, ceramics, beads, etc. MHÑGlass ANonly /anal /hist /rad eff /stand MND25.720.400; J1.637.361 LH  MSA polymer obtained by reacting polyacrylic acid with a special anion-leachable glass (alumino-silicate); the resulting cement is more durable and tougher than others in that the materials comprising the polymer backbone do not leach out. Synonym: Alumino-Silicate Polyacrylic Acid cement. HN(80) MHÑGlass Ionomer Cements AND25-26 qualif PICementation (66-71); Dental Cements (72-79) MND25.339.291.402 XSASPA Cement; Silicopolyacrylate Cement DMÑDental Cements LH LS; LM  MSA quassinoid (Simaroubolide) from Simaruba glauca, a tropical shrub; has been used as antiamebic agent and is found to be cytotoxic; possily of use in cancer chemotherapy. Synonyms: Glarubin; Glaumeba; MK 53. HN(66); was see under PYRANS 1975-80 MHÑGlaucarubin ANdo not use /defic /physiol; /analogs NIM only; /biosyn permitted if by plant RN1448-23-3 MND3.383.663.363; D21.370.107.511 XSKirondrin DMÑPhenanthrenes LH LS LM  MHÑGlaucoma ANdifferentiate from OCULAR HYPERTENSION (╥intraocular pressure above normal & which may lead to glaucoma╙) MNC11.381 FXÑIntraocular Pressure LH LX  MSGlaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris. PM82 HN82 MHÑGlaucoma, Open-Angle PIGlaucoma (66-81) MNC11.381.407 XSGlaucoma, Pigmentary; Glaucoma, Simple LH LS;  MSSimple protein, one of the prolamines, derived from the gluten of wheat, rye, etc. May be separated into 4 discrete electrophoretic fractions. It is the toxic factor associated with celiac disease. HN(75) MHÑGliadin ANdo not use /defic /physiol; /analogs NIM only RN9007-90-3 PIPlant Proteins (73-74) MND12.776.765.412.400 DMÑPlant Proteins LH LM  MSAn intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000. OLto search GLIAL INTERMEDIATE FILAMENT PROTEINS use GLIAL FIBRILLARY ACIDIC PROTEIN back thru 1985 & INTERMEDIATE FILAMENT PROTEINS 1983-84 PM85; was GLIAL INTERMEDIATE FILAMENT PROTEINS see INTERMEDIATE FILAMENT PROTEINS 1983-84 HN85; was GLIAL INTERMEDIATE FILAMENT PROTEINS see INTERMEDIATE FILAMENT PROTEINS 1983-84 MHÑGlial Fibrillary Acidic Protein AN/biosyn /physiol permitted; DF: GFAP PIIntermediate Filament Proteins (83-84); Nerve Tissue Proteins (66-84) MND12.776.220.475.400 XSGlial Intermediate Filament Proteins LH LS  PM73 HN73(71) MHÑGlibenclamide ANdo not use /biosyn /defic /physiol RN10238-21-8 PIHypoglycemia Agents (66-70) MND2.886.590.795.446; D2.948.828.446; D9.482.396 XSGLYBURIDE LH LS  MSendo, endo-1-[(1R)-(2-Hydroxy-3-bornyl)]-3-(p-tolylsulfonyl) urea. An oral, sulfonylurea hypoglycemic agent which stimulates insulin secretion. Synonyms: Ro-6-4563 and Glutril. HN(75) MHÑGlibornuride ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26944-48-9 PIBornanes (72-74); Sulfonylurea Compounds (71-74) MND2.886.590.795.460; D2.948.828.460; D9.482.400 DMÑSulfonylurea Compounds LH LM  MS1-(3-Azabicyclo[3,3,0]oct-3-yl)--3--(p-tolylsulfonyl) urea. An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. Synonyms: S-1702 and Diamicron. HN(75) MHÑGliclazide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN21187-98-4 PICyclopentanes (72-74); Pyrroles (72-74); Sulfonylurea Compounds (72-74) MND2.886.590.795.475; D2.948.828.475; D9.482.405 DMÑSulfonylurea Compounds LH LM  MH*Gliding Bacteria (Non Mesh) MNB3.350 LH  MHÑGlioblastoma Multiforme ANglioblastoma not specified as multiforme = GLIOMA; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.329.446 LH  MHÑGlioma ANbenign or malignant; glioblastoma goes here unless specified as multiforme ( = GLIOBLASTOMA MULTIFORME); perineural glioma = NEURILEMMOMA; retinal glioma or glioblastoma = RETINOBLASTOMA; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.329 LH  MSThe production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion. PM74 HN74(69) MHÑGliosis ANrefers to excess of astroglia PINeuroglia (66-68); appropriate heading/PA (66-68) MNC23.739.362 LH  MS2,3,5a,6-Tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione. Antibiotic substance produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium; inhibits viral reverse transcriptase and is proposed as an antiviral agent. OLuse GLIOTOXINS to search GLIOTOXIN back thru 1975 HN(81); was GLIOTOXIN see under ANTIBIOTICS 1975-80 MHÑGliotoxins ANdo not use /analogs /defic /physiol PIAlkaloids (69-74); Indoles (69-74); Piperazines (72-74); Disulfides (73-74) MND3.438.473.360; D20.388.401; D24.185.926.587.401 DMÑMycotoxins LH LM  MSN-[4-[beta-(5-Methylpyrazine-2-carboxamido)ethyl]-phenylsulfonyl]-N'-cyclohexylurea. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. HN(75) MHÑGlipizide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN29094-61-9 PICyclohexanes (71-74); Pyrazines (71-74); Sulfonylurea Compounds (71-74) MND2.886.590.795.500; D2.948.828.500; D9.482.415 XSGlidiazinamide; Glydiazinamide; Glypidizine DMÑSulfonylurea Compounds LH LS; ; LM  OLuse GLOBIN to search GLOBINS back thru 1966 (as Prov 1966-71) PM72 HN72; was GLOBINS 1965-71 (Prov) MHÑGlobin ANdo not use /analogs /blood RN9004-22-2 MND12.776.124.400.384 LH  MSGlycosphingolipids are ceramide tetrasaccharides containing N-acetylglucosamine (paragloboside) or N-acetylgalactosamine (globoside). Globoside is the P antigen on erythrocytes and paragloboside is an intermediate in the biosynthesis of erythrocyte blood group ABH and P 1 glycosphingolipid antigens. The accumulation of globoside in tissue, due to a defect in hexosaminidases A and B, is the cause of Sandhoff disease. HN(79) MHÑGlobosides AN/biosyn /physiol permitted; do not use /analogs PICerebrosides (72-78); Glycolipids (66-78); Glycosphingolipids (75-78) MND10.516.390.470.479; D10.516.808.530.510 XSCytolipins; Lacto-N-Neotetraosylceramide; Lacto-N-Tetraosylceramide DMÑGlycosphingolipids LH LS; ; LM  MHÑGlobulins ANGEN; /blood = SERUM GLOBULINS; do not use /analogs /defic /physiol; permeability globulins: index under SERUM GLOBULINS; EUGLOBULINS & PSEUDOGLOBULINS are see refs to SERUM GLOBULINS MND12.776.377 LH  MHÑGlobus Pallidus ANdo not use /innerv MNA8.186.211.885.105.487.397 LH  MHÑGlomangioma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.387 LH  PM66 HN66(65) MHÑGlomerular Filtration Rate ANNIM; only /drug eff /rad eff /vet MNE1.341.453.447; G8.852.397 LH  MSThe thin membrane which helps to support the capillary loops in a renal glomerulus. PM84 HN84 MHÑGlomerular Mesangium PIKidney Glomerulus (66-83) MNA5.810.453.736.520.380 XSMesangium, Glomerular LH LS  MSGlomerular disease characterized by an inflammatory reaction, with leukocyte infiltration and cellular proliferation of the glomeruli, or that appears to be the result of immune glomerular injury. OLsearch BRIGHT DISEASE under NEPHRITIS 1966-78 PMBRIGHT DISEASE was BRIGHT'S DISEASE see NEPHRITIS 1963-78 HNBRIGHT DISEASE was BRIGHT'S DISEASE see NEPHRITIS 1963-78 MHÑGlomerulonephritis ANnote see ref below: also called ╥minimal lesion glomerulonephritis╙ MNC12.777.419.570.363 XSBright Disease; Heymann Nephritis FXÑKIDNEY FAILURE, CHRONIC XUÑGlomerulosclerosis, Focal LH LS; LX LU  MSChronic form of glomerulonephritis characterized by recurring hematuria with only slight proteinuria and by deposits of IGA immunoglobulin in the mesangial areas of the renal glomeruli; usually occurs in young males. PM85 HN85 MHÑGlomerulonephritis, IGA ANdo not confuse X ref BERGER'S DISEASE with BUERGER'S DISEASE see THROMBOANGIITIS OBLITERANS PIGlomerulonephritis/IM (66-84); IGA/IM (73-84) MNC12.777.419.570.363.608; C20.111.525 XSBerger's Disease; IGA Glomerulonephritis; IGA Nephropathy; Nephropathy, IGA LH LS; ; ;  MSGlomerular disease characterized by focal and segmental areas of glomerular sclerosis, usually commencing in the juxtamedullary glomeruli and gradually spreading to involve other parts of the kidney, with eventual kidney failure. HN(77) MHÑGlomerulosclerosis, Focal PIKidney Glomerulus (66-76) MNC12.777.419.570.363.440 XSGlomerulonephritis, Focal Sclerosing; Hyalinosis, Segmental DMÑGlomerulonephritis LH LS; LM  OLsearch PARAGANGLIA, NONCHROMAFFIN 1966-74 HN(75) MHÑGlomus Jugulare ANdo not use /innerv MNA8.99.651.572 DMÑParaganglia, Nonchromaffin LH LM  OLsearch PARAGANGLIOMA, NONCHROMAFFIN 1968-74 HN(75) MHÑGlomus Jugulare Tumor AN/anal /blood supply /secret /ultrastruct permitted; organ/neopl & histol coords not necessary MNC4.557.652.798.530; C4.557.690.387.412 DMÑParaganglioma, Nonchromaffin LH LM  MSPain or burning sensations in the tongue. OLuse GLOSSALGIA to search GLOSSODYNIA back thru 1966 PM65 HN65; GLOSSODYNIA was see under GLOSSALGIA 1965-68 MHÑGlossalgia AN╥pain (glossalgia) or burning sensation (glossodynia) in the tongue╙ MNC7.465.910.280; C23.888.592.612.363 XSGlossodynia LH LS  PM65 HN65 MHÑGlossectomy ANdo not use /util except by MeSH definition MNE4.833.446; E6.892.446 FXÑTongue LH LX  MHÑGlossitis MNC7.465.910.363 LH  PM65 HN65 MHÑGlossitis, Benign Migratory MNC7.465.910.363.447 XSGEOGRAPHIC TONGUE; GLOSSITIS AREATA EXFOLIATIVA; TONGUE, GEOGRAPHIC LH LS; ;  MHÑGlossopharyngeal Nerve AN9th cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.387 LH  MSThe vocal apparatus of the larynx, consisting of the true vocal cords (plica vocalis) and the opening between them (rima glottidis). MHÑGlottis ANglottitis: coord NIM with LARYNGITIS (IM); stenosis = LARYNGOSTENOSIS MNA4.329.364 LH  MHÑGloves, Surgical ANonly /stand MNE7.858.273 LH  MS3-Ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone). Experimental antineoplastic agent that is most cytotoxic as a chelate with cupric ions, probably due to inhibition of cellular respiration; used as an anaplasmocide in cattle. Synonyms: BW 356-C-61; Contrapar; Ketohexal-bis(thiosemicarbasone); NSC82116; U7726. HN(76) MHÑGloxazone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2507-91-7 PIEthyl Ethers (74-75); Glyoxal (74) /AA (75); Thiosemicarbazones (74-75) MND2.47.644.400; D2.845.746.703.320; D2.886.803.320; D21.370.498; D22.204.420 XSKTS DMÑThiosemicarbazones LH LS LM  MSA blood glucose regulatory hormone secreted by the alpha cells of the pancreas; it is a 29 amino acid straight chain polypeptide of molecular weight 3485 that increases blood glucose and has other physiological effects. MHÑGlucagon AN/biosyn /physiol permitted; of pancreatic origin: do not confuse with ENTEROGLUCAGON secreted by the intestine RN9007-92-5 MND6.472.610.364; D12.644.227; D12.776.641.650.330; D19.316.629.451 LH  MSGlucagon-secreting tumor of the pancreatic alpha cells characterized by a distinctive rash, weight loss, stomatitis, glossitis, diabetes, hypoaminoacidemia, and normochromic normocytic anemia. OLsearch ISLET CELL TUMOR 1981 HN(82); was see ISLET CELL TUMOR 1981 MHÑGlucagonoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with PANCREATIC NEOPLASMS (IM) PIIslet Cell Tumor (66-81) MNC4.557.576.600.408 XSAlpha Cell Tumor DMÑIslet Cell Tumor LH LS LM  MSPolysaccharides composed of repeating glucose units. Can consist of branched or unbranched chains in any linkages. PM79 HN79 MHÑGlucans ANdo not use /analogs /defic /physiol PIGlucose (66-78); Polysaccharides (66-78) MND9.203.698.365 XSPolyglucoses LH LS  MSD-Glucaric acid. A sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups. HN(76) MHÑGlucaric Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN25525-21-7 PIAdipic Acids (70-75); Sugar Acids (74) MND2.241.81.844.300; D2.241.511.902.300; D9.203.811.295 XSGlucosaccharic Acid; L-Gularic Acid; Levo-Gularic Acid; Tetrahydroxyadipic Acid DMÑSugar Acids LH LS; ; ; LM  PM67 HN67 MHÑGlucocorticoids ANGEN: avoid: prefer specifics; /biosyn /physiol permitted; do not use /analogs; /admin: consider also GLUCOCORTICOIDS, TOPICAL; /chem syn permitted: do not convert to GLUCOCORTICOIDS, SYNTHETIC PIAdrenal Cortex Hormones (66) MND6.472.40.322 LH  MSSynthetic chemical compounds which increase gluconeogenesis, raising the concentration of liver glycogen and blood sugar, but differ in structure from naturally occurring glucocorticoids. PM75 HN75 MHÑGlucocorticoids, Synthetic ANdo not use /analogs /biosyn /defic /physiol; do not confuse with GLUCOCORTICOIDS /chem syn; DF: GLUCOCORTICOIDS SYN PIGlucocorticoids (67-74); Glucocorticoids, Topical (73-74) MND6.597.481 XSGlucocorticoid Analogs FXÑAnti-Inflammatory Agents; ÑAnti-Inflammatory Agents, Steroidal; ÑAnti-Inflammatory Agents, Topical LH LS LX; ;  PM73 HN73 MHÑGlucocorticoids, Topical AND25-26 qualif PIGlucocorticoids (67-72) MND6.597.481.364; D26.74.125.447; D26.74.148.447; D26.368.99.447 LH  PM65; was see under HEXOKINASE 1963-64 HN65; was see under HEXOKINASE 1963-64 MHÑGlucokinase ANdo not use /analogs RNEC 2.7.1.2 MND8.586.913.696.729.297 LH  MHÑGluconates ANdo not confuse with GLUCURONATES; do not use /analogs /defic /physiol MND2.241.81.844.322; D2.241.511.902.322; D9.203.811.308 XUÑAntimony Sodium Gluconates; ÑCalcium Gluconate LH LU;  PM67 HN67(65) MHÑGluconeogenesis ANonly /drug eff /rad eff MNG6.535.411 LH  MHÑGlucosamine ANdo not use /defic /physiol RN3416-24-8 MND9.203.67.342.531 XUÑAcetylglucosamine LH LU  MS2-Amino-2-deoxy-D-glucose-6-phosphate ketol-isomerase (amino-transferring). Catalyzes the synthesis of fructose-6-phosphate plus glutamine from glutamate plus glucosamine-6-phosphate. Formerly EC 2.6.1.16. Synonym: Glutamine:fructose-6-phosphate aminotransferase. HN(75) MHÑGlucosaminephosphate Isomerase (Glutamine-Forming) ANdo not use /analogs RNEC 2.6.1.16 PIAminotransferases (70-74); Carbohydrate Isomerases (74); Fructosephosphates (72-74); Glucosamine (74); Glutamine (70-74) MND8.586.399.278.430 XSGlucosamine Synthetase; Hexosephosphate Aminotransferase DMÑAminotransferases LH LS; LM  PM73 HN73(71) MHÑGlucosaminidase ANdo not use /analogs RNEC 3.2.1.- PIGlycoside Hydrolases (66-70) MND8.586.277.450.483.531 XUÑAcetylglucosaminidase LH LU  OLuse GLUCOSE to search GLUCOSE INJECTION 1966 PM/metabolism was GLUCOSE METABOLISM 1965; GLUCOSE INJECTION was heading 1963-66 HN/metabolism was GLUCOSE METABOLISM 1965; GLUCOSE INJECTION was heading 1963-66 MHÑGlucose AN/blood = BLOOD GLUCOSE & consider also HYPERGLYCEMIA & HYPOGLYCEMIA; /urine = GLYCOSURIA; /defic: consider also HYPOGLYCEMIA RN50-99-7 MND9.203.546.359.448 XSDEXTROSE XUÑGlucose Solution, Hypertonic LH LS LU  MSD-Glucose:1-oxidoreductases. Catalyzes the oxidation of D-glucose to D-glucono-gamma-lactone and reduced acceptor. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.47; EC 1.1.1.118; EC 1.1.1.119 and EC 1.1.99.10. HN(78) MHÑGlucose Dehydrogenases ANdo not use /analogs RNEC 1.1.1. PIAlcohol Oxidoreductases (66-77) MND8.586.682.47.150.270 XSGlucose Oxidoreductases DMÑCarbohydrate Dehydrogenases LH LS LM  PM64 HN64 MHÑGlucose Oxidase ANdo not use /analogs RNEC 1.1.3.4 MND8.586.682.47.239 LH  MSHypertonic glucose solution. HN(75) MHÑGlucose Solution, Hypertonic ANNIM; no qualif; when IM, use D25-25 qualif PIGlucose (69-74); Hypertonic Solutions (69-74) MND9.203.546.359.448.400; D26.394.225.766.314.420 DMÑGlucose LH LM  MSDetermination of whole blood or plasma sugar in a fasting state before and at prescribed intervals (usually 1/2 hr, 1 hr, 3 hr, 4 hr) after taking a specified amount (usually 100 gm orally) of glucose. MHÑGlucose Tolerance Test ANNIM; only /instrum /methods /vet MNE1.197.340; E1.223.174.229.482 FXÑBlood Glucose LH LX  PM65; was GLUCOSE PHOSPHATASES 1964 HN65; was GLUCOSE PHOSPHATASES 1964 MHÑGlucosephosphatase ANdo not use /analogs; /defic = GLUCOSEPHOSPHATASE DEFICIENCY RNEC 3.1.3.9 MND8.586.277.352.630.654.411 LH  PM65; VON GIERKE'S DISEASE was see GLYCOGENOSIS 1963-64 HN65(64); VON GIERKE'S DISEASE was see GLYCOGENOSIS 1963-64 MHÑGlucosephosphatase Deficiency MNC18.452.648.202.449.448 XSGlycogenosis 1; VON GIERKE'S DISEASE LH LS;  MHÑGlucosephosphate Dehydrogenase AN/defic = GPD DEFICIENCY; do not use /analogs; DF: GPD RNEC 1.1.1.49 MND8.586.682.47.150.300 LH  MSA disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of enzyme activity in erythrocytes, leading to hemolytic anemia. PM64 HN64 MHÑGlucosephosphate Dehydrogenase Deficiency ANDF: GPD DEFIC MNC15.378.71.141.150.480; C18.452.648.390 LH  PM65 HN65 MHÑGlucosephosphate Isomerase ANdo not use /analogs RNEC 5.3.1.9 MND8.586.399.278.448 XSPHOSPHOHEXOSE ISOMERASE; Phosphoglucose Isomerase LH LS;  MSUTP:alpha-D-glucose-1-phosphate uridylyltransferase. Catalyzes the formation of UDPglucose from UTP plus glucose 1-phosphate. HN(75) MHÑGlucosephosphate Uridylyltransferase ANdo not use /analogs RNEC 2.7.7.9 PIGlucosephosphates (72-74); Nucleotidyltransferases (72-74); Uridine Diphosphate Sugars (73-74) MND8.586.913.696.445.440 XSUDP Glucose Pyrophosphorylase DMÑNucleotidyltransferases LH LS LM  PM73 HN73(71) MHÑGlucosephosphates ANdo not use /analogs PIGlucose (66-70); Hexosephosphates (66-71) MND9.203.894.417.448 LH  OLuse GLUCOSIDASES to search GLUCOSIDASE back thru 1966 PM75; was GLUCOSIDASE 1963-74 HN75; was GLUCOSIDASE 1963-74 MHÑGlucosidases ANdo not use /analogs RNEC 3.2.1.- MND8.586.277.450.420 XUÑBeta-Glucosidases; ÑExo-1,4-alpha-Glucosidase; ÑGlucosylceramidase; ÑPhloretin Glucosidase LH LU; ; ;  OLsearch GLYCOSIDES 1966-74 HN(75) MHÑGlucosides ANdo not confuse with GLYCOSIDES; GEN; do not use /analogs /defic MND9.203.408.348 DMÑGlycosides LH LM  MSSubstituted thioglucosides. Found in rapeseed (Brassica campestris) products and related cruciferae. They are metabolized to a variety of toxic products which are most likely the cause of hepatocytic necrosis in animals and humans. HN(79) MHÑGlucosinolates ANdo not use /analogs /defic /physiol PIGlycosides (66-73); Thioglucosides (75-78); Thioglycosides (74) MND9.203.408.348.820.350; D9.203.408.903.703.350 DMÑThioglycosides LH LM  MSGlucosyl-N-acylsphingosine glucohydrolase. Hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in brain in Gaucher's disease. HN(75) MHÑGlucosylceramidase ANdo not use /analogs RNEC 3.2.1.45 PICerebrosides (70-74); Glucose (70-74); Glycoside Hydrolases (70-74) MND8.586.277.450.420.400 XSGlucocerebrosidase DMÑGlucosidases LH LS LM  MSCerebrosides which contain as their polar head group a glucose moiety bound in glycosidic linkage to the hydroxyl group of ceramides. Their accumulation in tissue, due to a defect in beta-glucosidase, is the cause of Gaucher's disease. HN(79) MHÑGlucosylceramides ANdo not use /analogs /defic PICeramides (72-78); Cerebrosides (66-78); Glycosphingolipids (75-78) MND10.516.390.470.213.490; D10.516.808.530.288.490 XSGlucocerebrosides; Glucosyl Ceramides DMÑCerebrosides LH LS; LM  MHÑGlucosyltransferases ANdo not use /analogs RNEC 2.4.1. MND8.586.913.407.323 XUÑ1,4-alpha-Glucan Branching Enzyme; ÑChitin Synthase; ÑGlycogen Debranching Enzyme; ÑStarch (Bacterial Glycogen) Synthase LH LU; ; ;  MHÑGlucuronates ANdo not confuse with GLUCONATES; do not use /analogs /defic MND2.241.81.844.915.400.448; D2.241.152.811.400.448; D2.241.511.902.915.400.448; D9.203.811.922.400.448 XSGLUCOSIDURONATES; Glucuronides LH LS;  MHÑGlucuronidase ANdo not use /analogs RNEC 3.2.1.31 MND8.586.277.450.426 LH  MSL-Glutamate-1-carboxy-lyase. A pyridoxal-phosphate protein. Catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GABA levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate and L-aspartate. PM84; was see under CARBOXY-LYASES 1975-83 HN84(75); was see under CARBOXY-LYASES 1975-83 MHÑGlutamate Decarboxylase ANdo not use /analogs RNEC 4.1.1.15 PICarboxy-Lyases (73-74); Glutamates (73-74) MND8.586.520.258.360 XSGlutamate Carboxy-Lyase LH LS  PM65 HN65 MHÑGlutamate Dehydrogenase ANdo not use /analogs RNEC 1.4.1.2 MND8.586.682.135.398 LH  MSL-glutamine:2-oxoglutarate aminotransferase (NADPH-oxidizing). Catalyzes the formation of 2 molecules of glutamate from glutamine plus alpha-ketoglutarate in the presence of NADPH. Synonyms: Glutamine(amide):2-oxoglutarate aminotransferase (NADP oxidoreductase); Glutamine(amide):alpha-ketoglutarate (NADP) amidotransferase oxidoreductase. Before 1978 EC number was EC 2.6.1.53. HN(75) MHÑGlutamate Synthase ANdo not use /analogs RNEC 1.4.1.13 PIAminotransferases (72-74); Glutamine (72-74); Ketoglutaric Acid (72-74); NADP (74) MND8.586.913.140.520 XSGlutamine Ketoglutarate Amidotransferase; Ketoglutarate Glutamine Amidotransferase DMÑAminotransferases LH LS; LM  MHÑGlutamates ANdo not use /analogs; POLYGLUTAMIC ACID is also available MND12.125.119.511 XUÑSodium Glutamate LH LU  MHÑGlutaminase ANdo not use /analogs RNEC 3.5.1.2 MND8.586.277.87.483 LH  MHÑGlutamine AN/biosyn /physiol permitted RN6899-04-3 MND12.125.119.574 XUÑProglumide LH LU  PM72 HN72 MHÑGlutamine Synthetase ANdo not use /analogs RNEC 6.3.1.2 PILigases (66-71) MND8.586.464.476 LH  MSL-Glutamate:tRNA-Glu ligase (AMP-forming). Activates glutamic acid with its specific transfer RNA. HN(75) MHÑGlutamyl T RNA Synthetase ANdo not use /analogs RNEC 6.1.1.17 PIAmino Acyl T RNA Synthetases (72-74); Glutamates (72-74) MND8.586.464.136.350 DMÑAmino Acyl T RNA Synthetases LH LM  HN(73) MHÑGlutaraldehyde ANdo not use /biosyn /defic /physiol; /analogs NIM only RN111-30-8 MND2.47.532 DMÑAldehydes LH LM  MHÑGlutarates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.337.351 XUÑ3-Hydroxy-3-Methylglutaric Acid; ÑFormiminoglutamic Acid LH LU;  MHÑGlutathione AN/biosyn /physiol permitted RN70-18-8 MND12.644.456.448 LH  MSGlutathione:hydrogen peroxide oxidoreductase. Catalyzes the oxidation of 2 moles of glutathione in the presence of hydrogen peroxide to yield oxidized glutathione and water. PM84; was see under PEROXIDASES 1975-83 HN84(75); was see under PEROXIDASES 1975-83 MHÑGlutathione Peroxidase ANdo not use /analogs RNEC 1.11.1.9 PIGlutathione (68-74); Peroxidases (68-74) MND8.586.682.732.500 LH  PM65 HN65 MHÑGlutathione Reductase ANdo not use /analogs RNEC 1.6.4.2 MND8.586.682.608.341 LH  MSgamma-L-Glutamyl-L-cysteine:glycine ligase (ADP-forming). One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of glutathione from gamma-glutamyl-cysteine and glycine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.3. HN(77) MHÑGlutathione Synthetase ANdo not use /analogs RNEC 6.3.2.3 PIGlutathione (73-76); Peptide Synthetases (73-76) MND8.586.464.677.530 DMÑPeptide Synthetases LH LM  MSTransferase which catalyze the addition of aliphatic, aromatic or heterocyclic radicals as well as epoxides and arene oxides to glutathione. Addition takes place at the sulfur atom. Also catalyze the reduction of polyol nitrate by glutathione to polyol and nitrite. EC 2.5.1.18. OLuse GLUTATHIONE TRANSFERASES to search LIGANDIN & GLUTATHIONE S-ARYLTRANSFERASE back thru 1975 PM77; LIGANDINS was LIGANDIN see under CARRIER PROTEINS 1975-76; GLUTATHIONE S-ARYLTRANSFERASE was see under TRANSFERASES 1975-76 HN77; LIGANDINS was LIGANDIN see under CARRIER PROTEINS 1975-76; GLUTATHIONE S-ARYLTRANSFERASE was see under TRANSFERASES 1975-76 MHÑGlutathione Transferases ANdo not use /analogs RNEC 2.5.1.18 PIGlutathione (70-76); Transferases (70-76) MND8.586.913.380 XSGlutathione S-Alkyltransferase; Glutathione S-Aryltransferase; Glutathione S-Epoxidetransferase; Ligandins; S-Hydroxyalkyl Glutathione Lyase LH LS; ; ; ;  MHÑGluten ANdo not use /defic /physiol RN8002-80-0 MND12.776.765.412 LH  MHÑGlutethimide ANdo not use /biosyn /defic /physiol RN77-21-4 MND3.383.621.808.425; D14.591.745.483 LH  MHÑGlyceraldehyde ANdo not use /defic /physiol RN367-47-5 MND2.47.587; D9.203.546.894.449 XUÑGlyceraldehyde 3-Phosphate LH LU  MS2-Hydroxy-3-(phosphonooxy)-propanal. An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis. HN(80) MHÑGlyceraldehyde 3-Phosphate AN/physiol permitted RN142-10-9 PIGlyceraldehyde (66-74) /AA (75-79) MND2.47.587.450; D9.203.546.894.449.450 XS3-Phosphoglyceraldehyde DMÑGlyceraldehyde LH LS LM  PM65 HN65 MHÑGlyceraldehydephosphate Dehydrogenase ANdo not use /analogs RNEC 1.2.1.9 MND8.586.682.75.532 XSPHOSPHOGLYCERALDEHYDE DEHYDROGENASE; TRIOSEPHOSPHATE DEHYDROGENASE LH LS;  PM68 HN68 MHÑGlyceric Acids ANdo not use /analogs /defic /physiol MND2.241.81.844.387; D2.241.511.902.387; D9.203.811.366 LH  MHÑGlycerides ANdo not use /analogs /defic /physiol MND10.516.351 XSMonoacylglycerols XUÑDiglycerides LH LS LU  MHÑGlycerin ANdo not use /biosyn /defic /physiol; glyceryl trioleate = TRIOLEIN RN56-81-5 MND2.33.800.421; D9.203.853.421; D26.328.532 XSGlycerol LH LS  MSATP:glycerol 3-phosphotransferase. Catalyzes the formation of glycerol 3-phosphate from ATP and glycerol. Dihydroxyacetone and L-glyceraldehyde can also act as acceptors; UTP (and, in the case of the yeast enzyme, ITP and GTP) can act as donors. Provides a way for glycerol derived from fats or glycerides to enter the glycolytic pathway. HN(75) MHÑGlycerol Kinase ANdo not use /analogs RNEC 2.7.1.30 PIGlycerin (73-74); Phosphotransferases (73-74); Phosphotransferases, ATP (74) MND8.586.913.696.729.320 XSGlycerokinase DMÑPhosphotransferases, Atp LH LS LM  MSAcyl-CoA:sn-glycerol-3-phosphate O-acyltransferase. Transfers acyl groups from acyl-CoA to glycerol-3-phosphate to form monoglyceride phosphates. Acts only with CoA derivatives of fatty acids of chain length above C-10. Also forms diglyceride phosphates. HN(75) MHÑGlycerolphosphate Acyltransferase ANdo not use /analogs RNEC 2.3.1.15 PIAcyltransferases (72-74); Glycerophosphates (72-74); Coenzyme A (72-74) MND8.586.913.50.600 XSStearyl-CoA Glycerophosphate Transstearylase DMÑAcyltransferases LH LS LM  PM65 HN65 MHÑGlycerolphosphate Dehydrogenase ANdo not use /analogs RNEC 1.1.- MND8.586.682.47.150.700.400 LH  MHÑGlycerophosphates ANdo not use /analog MND9.203.894.299; D10.516.695.300 XSPhosphoglycerides LH LS  MHÑGlyceryl Trinitrate ANdo not use /biosyn /defic /physiol RN55-63-0 MND18.918.365 XSNITROGLYCERIN LH LS  PM73 HN73(64) MHÑGlycerylphosphorylcholine RN563-24-6 MND9.203.894.299.449; D10.516.695.300.310 XSCHOLINE GLYCEROPHOSPHATE LH LS  MHÑGlycine AN/biosyn /physiol permitted RN56-40-6 MND12.125.481 XSAMINOACETIC ACID XUÑAllylglycine; ÑMethylglycine LH LS LU;  MSN-(3-alpha,7-alpha-Dihydroxy-5-beta-cholan-24-oyl)glycine. A bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt; it acts as detergent to solubilize fats for absorption and is itself absorbed; it is a cholagogue and choleretic. HN(78) MHÑGlycochenodeoxycholic Acid AN/biosyn /physiol permitted RN640-79-9 PIBile Acids and Salts (66-72); Chenodeoxycholic Acid (73-77); Glycine (66-72); Glycocholic Acid (73-77) MND4.808.221.430.342.300.400; D4.808.221.430.342.400.450; D4.808.221.430.484.430.420; D12.125.481.366.420.400; D19.316.246.175.393 XSChenodeoxycholylglycine; Glycine Chenodeoxycholate; Glycochenodeoxycholate DMÑChenodeoxycholic Acid LH LS; ; LM  MSN-Cholyl-glycine. Bile salt, conjugate of cholate and glycine, usually as the sodium salt; acts as detergent to solubilize fats for absorption and is itself absorbed; cholagogue and choleretic. PM78 HN78(73) MHÑGlycocholic Acid AN/biosyn /physiol permitted RN475-31-0 MND4.808.221.430.484; D12.125.481.366; D19.316.246.225.399 XSCholylglycine; Glycine Cholate; Glycocholate LH LS; ;  MSN-(3-alpha,12-alpha-Dihydroxy-5-beta-cholan-24-oyl)glycine. A bile salt formed in the liver by conjugation of deoxycholate with glycine, usually as the sodium salt; acts as a detergent to solubilize fats for absorption and is itself absorbed; cholagogue and choleretic. HN(78) MHÑGlycodeoxycholic Acid AN/biosyn /physiol permitted RN360-65-6 PIBile Salts and Acids (66-72); Deoxycholic Acid (73-77); Glycine (66-77); Glycocholic Acid (73-77) MND4.808.221.430.342.400; D4.808.221.430.484.430; D12.125.481.366.420; D19.316.246.225.272.411 XSDeoxycholylglycine; Glycine Deoxycholate; Glycodeoxycholate DMÑDeoxycholic Acid LH LS; ; LM  MHÑGlycogen AN/biosyn /physiol permitted; /metab: consider also GLYCOGEN STORAGE DISEASE see GLYCOGENOSIS & note specifics under GLYCOGENOSIS; don't forget LIVER GLYCOGEN is also available RN9005-79-2 MND9.203.698.365.388 LH  MSOligo-alpha-1,4-glucan:alpha-1,4-glucan-4-glycosyltransferase-amylo-1,6-glucosidase. Has both transferase and glucosidase properties. As a transferase it acts by moving malotriose or maltosyl residues from an oligosaccharide or glycogen to other linear or branched acceptors of suitable structure. As a glucosidase it slowly hydrolyzes glycogen to free glucose, liberating consecutive glucose units beginning at the outer, non-reducing termini. HN(76) MHÑGlycogen Debranching Enzyme ANdo not use /analogs PIGlucosidase (73-75); Glucosyltransferase (73-75); Glycogen (73-75) MND8.586.277.450.420.540; D8.586.913.407.323.350 XSTransfer-Glucosidase DMÑGlucosyltransferases LH LS LM  PM73 HN73(71) MHÑGlycogen Phosphorylase ANdo not use /analogs RNEC 2.4.1.1 PIGlucosyltransferases (66-70) MND8.586.913.407.323.366 XSGLUCAN PHOSPHORYLASE XUÑPhosphorylase a; ÑPhosphorylase b LH LS LU;  PM74 HN74(72) MHÑGlycogen Synthetase ANdo not use /analogs RNEC 2.4.1.11 PIGlucosyltransferases (66-71) MND8.586.913.407.323.533 XSGLYCOGEN SYNTHASE LH LS  MSCatalyzes the conversion of phosphorylated, inactive glycogen synthetase D to active dephospho glycogen synthetase I. HN(75); was see under PHOSPHOMONOESTERASES 1975-78 MHÑGlycogen Synthetase Phosphatase ANdo not use /analogs RNEC 3.1.3.42 PIGlycogen Synthetase (73-74) MND8.586.277.352.630.654.450 DMÑPhosphoprotein Phosphatases LH LM  MHÑGlycogenosis ANdo not use /congen MNC18.452.648.202.449 XSGlycogen Storage Disease XUÑGlycogenosis 2; ÑGlycogenosis 3; ÑGlycogenosis 4; ÑGlycogenosis 5; ÑGlycogenosis 6; ÑGlycogenosis 7; ÑGlycogenosis 8 LH LS LU; ; ; ; ; ;  MSGlycogenosis due to alpha-1,4,glucosidase (acid maltase) deficiency. Affects muscle, heart and other organs. HN(75) MHÑGlycogenosis 2 ANdo not use /congen PIGlucosidases/ME (66-74); Glycogenosis (66-74); Heart Diseases (66-74) MNC18.452.648.202.449.500 XSGeneralized Glycogenosis; Pompe's Disease DMÑGlycogenosis LH LS; LM  MSGlycogenosis due to amylo-1,6-glucosidase deficiency. HN(75) MHÑGlycogenosis 3 ANdo not use /congen PIGlucosidases/ME (66-74); Glycogenosis (66-74); Liver Diseases (66-74) MNC18.452.648.202.449.520 XSCori's Disease; Debrancher Deficiency; Forbes Disease; Limit Dextrinosis DMÑGlycogenosis LH LS; ; ; LM  MSGlycogenosis due to alpha-1,4,glucan-6-glucosyl transferase deficiency. HN(75) MHÑGlycogenosis 4 ANdo not use /congen PIGlucosyltransferases/ME (66-74); Glycogenosis (66-74); Liver Diseases (66-74) MNC18.452.648.202.449.540 XSAndersen's Disease; Brancher Deficiency Amylopectinosis DMÑGlycogenosis LH LS; LM  MSGlycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise. HN(75) MHÑGlycogenosis 5 ANdo not use /congen PIGlucosyltransferases/ME (66-74); Glycogenosis (66-74); Muscular Diseases (66-74) MNC18.452.648.202.449.560 XSMcArdle's Disease DMÑGlycogenosis LH LS LM  MSGlycogenosis due to liver phosphorylase deficiency. HN(75) MHÑGlycogenosis 6 ANdo not use /congen PIGlucosyltransferases/ME (66-74); Glycogenosis (66-74); Liver Diseases (66-74) MNC18.452.648.202.449.580 XSHers' Disease DMÑGlycogenosis LH LS LM  MSGlycogenosis due to muscle phosphofructokinase deficiency. HN(75) MHÑGlycogenosis 7 ANdo not use /congen PIGlycogenosis (66-74) MNC18.452.648.202.449.600 DMÑGlycogenosis LH LM  MSGlycogenosis due to liver phosphorylase kinase deficiency. HN(75) MHÑGlycogenosis 8 ANdo not use /congen PIGlycogenosis (66-74) MNC18.452.648.202.449.620 DMÑGlycogenosis LH LM  PMCENTROPHENOXINE was see under ACETIC ACIDS 1968-74 MHÑGlycolates ANdo not use /analogs /biosyn /defic /physiol MND2.241.511.316 FXÑPOLYGLYCOLIC ACID XUÑCentrophenoxine; ÑHalofenate; ÑMCPA; ÑPhenoxyacetates; ÑTicrynafen LH LX LU; ; ; ;  PM66; was see under LIPIDS 1963-65 HN66(63); was see under LIPIDS 1963-65 MHÑGlycolipids ANdo not use /analogs MND10.516.390 XUÑCord Factors LH LU  MHÑGlycols ANdo not use /analogs /biosyn /defic /physiol MND2.33.618 XUÑMethoxyhydroxyphenylglycol LH LU  PM66 HN66(64) MHÑGlycolysis ANonly /drug eff /rad eff MNG6.535.448 LH  MSProteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. PM73 HN73(71) MHÑGlycopeptides ANdo not use /analogs PIPeptides (66-70); Polysaccharides (66-70); specific polysaccharide MND12.644.233 LH  MSThe major sialoglycoprotein of the human erythrocyte membrane. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin and wheat germ agglutinin. HN(77) MHÑGlycophorin ANdo not use /analogs /blood PIErythrocytes (66-76); Glycopeptides (73-76); Glycoproteins (66-76); Neuraminic Acids (66-76); Sialic Acids (75-76) MND12.644.233.800.350; D12.776.124.300; D12.776.395.700.350 XSErythrocyte Sialoglycoprotein; MN Sialoglycoprotein; Red Blood Cell Membrane Sialoglycoprotein DMÑSialoglycoproteins LH LS; ; LM  MSUDPgalactose:2-acetamido-2-deoxy-D-glucosyl-glycopeptide galactosyltransferase. Catalyzes the transfer of galactose from UDP-galactose to a specific glycoprotein receptor--2-acetamido-2-deoxy-D-glucosyl-glycopeptide during glycopeptide synthesis. HN(76) MHÑGlycoprotein beta-Galactosyltransferase ANdo not use /analogs RNEC 2.4.1.38 PIGalactose (73-75); Glycoproteins (73-75); Hexosyltransferases (73-75) MND8.586.913.407.310.400 XSThyroid Galactosyltransferase DMÑGalactosyltransferases LH LS LM  PMTHROMBOPOIETIN was see under BLOOD PLATELETS 1975 MHÑGlycoproteins ANdo not use /analogs MND12.776.395 XUÑThrombopoietin; ÑUteroglobin LH LU;  HN(64) MHÑGlycopyrrolate AN/analogs NIM only RN596-51-0 MND2.92.102.425; D2.675.276.425; D3.383.773.342; D16.653.412 DMÑPyrrolidines LH LM  MSAn aminosugar containing polysaccharide. OLsearch MUCOPOLYSACCHARIDES 1969-74 PM77; was see under MUCOPOLYSACCHARIDES 1969-76 HN77(75); was see under MUCOPOLYSACCHARIDES 1969-76 MHÑGlycosaminoglycans ANdo not use /analogs PIMucopolysaccharides (66-74) MND9.203.698.582.388 LH  MHÑGlycoside Hydrolases ANdo not use /analogs RNEC 3.2.1. MND8.586.277.450 XSGlycosidases XUÑEndo-1,3-beta-Glucanase; ÑIduronidase; ÑIsoamylase; ÑOligo-1,6-Glucosidase; ÑPolygalacturonase; ÑXylosidases LH LS LU; ; ; ; ;  PMARBUTIN was see under UVA URSI 1963-75 MHÑGlycosides ANGEN; do not confuse with GLUCOSIDES; do not use /analogs /defic; glucides go here but could be CARBOHYDRATES MND9.203.408 XUÑArbutin; ÑAtractyloside; ÑGalactosides; ÑGlucosides; ÑMannosides; ÑNitrophenylgalactoside LH LU; ; ; ; ;  MSCeramides which contain one or more sugar moieties. PM75 HN75 MHÑGlycosphingolipids AN/biosyn /physiol permitted; do not use /analogs PIGlycolipids (66-74); Sphingolipids (72-74) MND10.516.390.470; D10.516.808.530 XSAsialogangliosides; Sphingoglycolipids XUÑGlobosides; ÑLactosylceramides; ÑTrihexosylceramides LH LS; LU; ;  MHÑGlycosuria ANTN 92: do not use GLUCOSE /urine; use GLYCOSURIA MNC18.452.398 FXÑUrine LH LX  PM65 HN65 MHÑGlycosuria, Renal MNC12.777.419.815.532; C18.452.398.450; C18.452.648.851.532 XSDIABETES, RENAL LH LS  MSThe chemical or biochemical addition of carbohydrate or glycosyl groups to other chemicals, especially peptides or proteins; glycosyl transferases are used. PM87 HN87 MHÑGlycosylation ANalmost never IM; no qualif PIGlycoproteins (66-86); Protein Processing, Post-Translational (83-86) MNH1.181.404.495 FXÑProtein Processing, Post-Translational LH LX  MSGlycine:tRNA-Gly ligase (AMP-forming). Activates glycine with its specific transfer RNA. HN(75) MHÑGlycyl T RNA Synthetase ANnote spacing; do not use /analogs RNEC 6.1.1.14 PIAmino Acyl T RNA Synthetases (72-74); Glycine (72-74) MND8.586.464.136.375 DMÑAmino Acyl T RNA Synthetases LH LM  OLsearch DIPEPTIDES 1968-74 HN(75) MHÑGlycylglycine AN/analogs NIM only RN556-50-3 MND12.644.456.345.575 DMÑDipeptides LH LM  MS3-beta-Hydroxy-11-oxoolean-12-en-30-oic acid. A product from Glycyrrhiza glabra L. Leguminosae with some antiallergic, antibacterial and antiviral properties; it is used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation. Synonyms: Biosone; Glycor; Ionopexan; Ritinsan. OLuse GLYCYRRHETINIC ACID to search ENOXOLONE back thru 1977 PM79; was ENOXOLONE see under TRITERPENES 1977-78; CARBENOXOLONE was see under TRITERPENES 1975-78 HN79; was ENOXOLONE see under TRITERPENES 1977-78 MHÑGlycyrrhetinic Acid ANdo not use /defic /physiol RN471-53-4 PIGlycyrrhiza (66-76); Triterpenes (74-76) MND2.455.849.919.300; D26.368.99.492 XSEnoxolone; Glycyrrhetic Acid; Rhetinic Acid; Uralenic Acid XUÑCarbenoxolone LH LS; ; ; LU  MSA genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivatives, CARBENOXOLONE for example; liquorice toxicity is manifested as hypokalemia, low blood potassium; liquorice is used as flavoring and aromatic in pharmaceuticals and as candy. MHÑGlycyrrhiza ANnote categ; do not use /isol /pathogen MNB6.560.546.445 XSLICORICE LH LS  MSN-[5-(2-Methoxyethoxy)-2-pyrimidinyl]benzenesulfonamide. A sulfonamide hypoglycemic agent which stimulates insulin secretion. HN(75) MHÑGlymidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN339-44-6 PIEthers (71-74); Pyrimidines (71-74); Sulfonamides (71-74) MND2.65.884.500; D2.886.590.700.500; D9.482.450 XSGlidiazine; Glycodiazine DMÑSulfonamides LH LS; LM  HN(73) MHÑGlyoxal ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-22-2 MND2.47.644 DMÑAldehydes LH LM  PM66 HN66 MHÑGlyoxylates ANdo not use /analogs /biosyn /defic /physiol MND2.241.152.367 LH  MSA genus of parasitic nematodes which occurs in mammals including man. Infection in humans is either by larvae penetrating the skin or by eating uncooked fish. OLsearch SPIRUROIDEA 1966-74 HN(75); was see under SPIRUROIDEA 1963-85 MHÑGnathostoma ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.722.118 DMÑThelazioidea LH LM  MSThe end-result or objective, which may be specified or required in advance. OLto search GOAL use GOALS back thru 1975 & MOTIVATION 1969-74 PM79; was GOAL see under MOTIVATION 1969-78 HN79; was GOAL see under MOTIVATION 1969-78 MHÑGoals ANno qualif PIMotivation (66-74) MNF1.658.500 LH  MHÑGoats ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; chamois goes here MNB2.649.77.380.513 LH  MSEnlargement of the thyroid gland. MHÑGoiter ANlingual goiter: index here to avoid complex coords; intrathoracic goiter = GOITER, SUBSTERNAL MNC19.874.283 LH  MSEnlargement of the thyroid gland in a significantly large fraction of a population group, generally considered to be due to insufficient iodine in the diet. PM72 HN72(69) MHÑGoiter, Endemic PIGoiter (66-68) MNC19.874.283.300 LH  PM73 HN73(71) MHÑGoiter, Nodular PIGoiter (66-71) MNC19.874.283.501 LH  MHÑGoiter, Substernal MNC19.874.283.601 XSGoiter, Intrathoracic LH LS  MHÑGold ANAu-197; IM; do not use /analogs /biosyn /defic /physiol; for isotopes see below RN7440-57-5 MND1.248.497.300.459.381; D1.268.357; D1.552.322 XUÑGold Thioglucose; ÑSodium Gold Thiosulfate LH LU;  PM65 HN65 MHÑGold Alloys ANIM; D25-26 qualif MND1.552.33.533; D1.552.322.343; D25.58.451; D25.339.208.534 LH  MHÑGold Colloid, Radioactive ANalso called radio-colloidal gold; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) RN10043-49-9 MND1.496.381.550.400; D1.496.749.410.400; D1.552.322.530.400 LH  MHÑGold Isotopes MND1.496.381; D1.552.322.485 LH  MSUnstable isotopes of gold that decay or disintegrate spontaneously emitting radiation. Au 186,188-196, 198-203 are radioactive isotopes of gold. OLsearch GOLD ISOTOPES 1966-74 PM75 HN75 MHÑGold Radioisotopes ANAu-185-196, 198-201, 203; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIGold Isotopes (66-74); Radioisotopes (66-74) MND1.496.381.550; D1.496.749.410; D1.552.322.530 LH  OLuse GOLD THIOGLUCOSE to search AUROTHIOGLUCOSE back thru 1973 (as Prov 1973-74) HN(79); was AUROTHIOGLUCOSE see under GOLD 1975-78, was AUROTHIOGLUCOSE 1973-74 (Prov) MHÑGold Thioglucose ANdo not use /biosyn /defic /physiol; /analogs NIM only RN12192-57-3 PIGold (66-72) MND1.552.322.550; D2.691.400; D26.74.75.570 XSAurothioglucose DMÑGold LH LS LM  PM74 HN74(73) MHÑGold Thiomalate ANdo not use /analogs /biosyn /defic /physiol RN12244-57-4 PIGold (66-72) MND1.552.322.556; D2.241.81.337.463.703.451; D2.691.426; D26.74.75.572 XSAurothiomalate LH LS  MSMandibulofacial dysostosis with congenital eyelid dermoids. HN(79) MHÑGoldenhar Syndrome ANdo not use /congen PIAbnormalities, Multiple (68-78); Mandibulofacial Dysostosis (66-78) MNC5.116.99.370.231.576.410; C16.131.621.246.650.307 XSOculoauriculovertebral Syndrome DMÑMandibulofacial Dysostosis LH LS LM  OLsearch CYPRINIDAE 1968-74 HN(75) MHÑGoldfish ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.200.244.248.480 XSCarassius auratus DMÑCyprinidae LH LS LM  MSA game whose object is to sink a ball into each of 9 or 18 successive holes on a golf course using as few strokes as possible. HN(76) MHÑGolf ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); Manual 30.31+ PISports (66-75) MNI3.450.642.845.400 DMÑSports LH LM  MHÑGolgi Apparatus ANA 11 qualif except /cytol MNA11.368.702.336 LH  OLsearch MECHANORECEPTORS 1972-74 & NERVE ENDINGS 1966-71 HN(75); was see under NERVE ENDINGS 1963-71 MHÑGolgi-Mazzoni Corpuscles ANdo not use /innerv MNA8.796.511.725.404.272 DMÑMechanoreceptors LH LM  OL╥gonadal disorders╙ is indexed GONADS + ENDOCRINE DISEASES (NIM) but consider also OVARIAN DISEASES & TESTICULAR DISEASES MH*Gonadal Disorders (Non Mesh) MNC19.391 LH  MSAny of several developmental anomalies involving the total or partial failure of the indifferent embryonic gonad to differentiate into ovary or testis. Includes gonadal agenesis. OLsearch TURNER'S SYNDROME 1967-79 & SEX DIFFERENTIATION DISORDERS 1966-79 PM80; was see TURNER'S SYNDROME 1967-79 HN80; was see TURNER'S SYNDROME 1967-79 MHÑGonadal Dysgenesis ANin male or female; do not use /congen; includes agenesis; do not use TESTIS or OVARY merely to denote sex: check tag MALE or FEMALE PISex Differentiation Disorders (66-79); Turner's Syndrome (67-79) MNC16.131.939.842.309 XUÑGonadal Dysgenesis, 46,XY; ÑGonadal Dysgenesis, Mixed LH LU;  MSA syndrome of gonadal dysgenesis in which there is a testis on one side and a ╥streak gonad╙ on the other. The phenotype is generally male, but may be female, since the individual is a mosaic; various karyotypes have been identified, including 45,XO/47,XYY; 45,XO/46,XY; 45,XO/46,XYo. HN(80); see history & online notes under GONADAL DYSGENESIS above MHÑGonadal Dysgenesis, Mixed ANin male or female: use genetic sex of subject & do not index under OVARY or TESTIS or both merely to denote sex: check tag MALE or FEMALE; do not use /congen PISex Differentiation Disorders (66-79); Turner's Syndrome (67-79) MNC16.131.280.748.391; C16.131.939.842.309.391; C19.391.391 XSMixed Gonadal Dysgenesis DMÑGonadal Dysgenesis LH LS LM  MSA syndrome characterized by ╥streak gonads╙ in a phenotypic female with a 46,XY karyotype. It is due to a mutation which inhibits the function of the Y-borne determinant that would normally cause the indifferent embryonic gonad to differentiate into testis. The streak gonad is incapable of ovulation or estrogen secretion. The syndrome is sometimes called ╥pure gonadal dysgenesis,╙ but this designation may also refer to the presence of streak gonads with a 46,XX karyotype. HN(80); see history & online notes under GONADAL DYSGENESIS above MHÑGonadal Dysgenesis, 46,XY ANcheck tags HUMAN & FEMALE & do not index under OVARY; do not use /congen PISex Differentiation Disorders (66-79); Turner's Syndrome (67-79) MNC16.131.280.748.388; C16.131.939.842.309.388; C19.391.388 XSSwyer Syndrome DMÑGonadal Dysgenesis LH LS LM  MHÑGonadotropins ANGEN; /biosyn /physiol permitted; do not use /analogs MND6.472.351 LH  MHÑGonadotropins, Chorionic AN/biosyn /physiol permitted; do not use /analogs MND6.472.351.326; D6.472.759.367; D6.472.785.400; D12.776.780.400 XSGonadotropins, Chorionic, Human; HCG LH LS;  OLuse GONADOTROPINS, EQUINE to search PREGNANT MARE'S SERUM back thru 1974 HNPREGNANT MARE'S SERUM was see under GONADOTROPINS, EQUINE 1974-76 MHÑGonadotropins, Equine ANdo not use /analogs /defic /physiol MND6.472.351.451 XSPMS; PMSG; Pregnant Mare's Serum LH LS; ;  MHÑGonadotropins, Pituitary AN/biosyn /physiol permitted; do not use /analogs MND6.472.351.576; D6.472.734.525.343; D7.552.344.344.451 LH  MSThe gamete-producing glands; OVARY or TESTIS. MHÑGonads ANGEN: prefer OVARY or TESTIS; disord: see specific gonadal disord in Cat C19; /abnorm: agenesis & dysgenesis: index under GONADAL DYSGENESIS & consider also SEX DIFFERENTIATION DISORDERS (C16); excision: see note under CASTRATION MNA5.360.576; A6.407.312 FXÑSEX REVERSAL, GONADAL LH LX  PM68 HN68 MHÑGonanes ANincludes gonenes, gonadienes, gonatrienes; do not use /analogs /biosyn /defic /physiol MND4.808.451 LH  MHÑGonioscopy ANNIM; do not use /util except by MeSH definition MNE1.210.451 LH  MHÑGonorrhea MNC1.252.391; C1.539.780.367 LH  MSA combination of pulmonary hemorrhage and glomerulonephritis. Also known as the lung purpura glomerulonephritis complex. It is considered by some to be a form of hypersensitivity reaction. PM66 HN66(65) MHÑGoodpasture's Syndrome MNC8.381.314; C12.777.419.570.363.451; C20.111.550 XSLung Purpura with Nephritis LH LS  MSThis single species of Gorilla, which is a member of the Pongidae family, is the largest and most powerful of the Primates. It is distributed in isolated scattered populations throughout forests of equatorial Africa. OLuse GORILLA GORILLA to search GORILLAS back thru 1975 PM81; was GORILLAS 1975-80 HN81; was GORILLAS 1975-80 MHÑGorilla gorilla ANthe largest ape; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; DF: GORILLA PIPongidae (66-74) MNB2.649.801.201.600.342 LH  MHÑGossypol ANin cottonseed; consider also COTTONSEED OIL RN303-45-7 MND2.455.849.919.330; D11.557.450 LH  MHÑGout AN/drug ther: consider also GOUT SUPPRESSANTS & its indentions; gouty arthritis: coord IM with ARTHRITIS (IM) MNC5.550.114.423; C5.799.414; C18.452.648.798.368 LH  MSAgents that increase uric acid excretion by the kidney, thereby reducing gouty tophy, or decrease uric acid producion, or alleviate the pain and inflammation of acute attacks of gout. PM75 HN75 MHÑGout Suppressants ANdo not use /analogs /biosyn /defic /physiol; consider also GOUT /drug ther PIUricosuric Agents (66-74) MND14.73.278.398; D26.74.75.574 LH  MSThe group in which legal authority is vested for the control of health-related institutions and organizations. PM68 HN68 MHÑGoverning Board ANcoord NIM with society, hosp or other organiz (IM); only /legis /organ /stand PIHospital Administration (66-67); Organization and Administration (66-67); Public Health Administration (66-67) MNN4.452.394 XSBOARD, GOVERNING XUÑTrustees LH LS LU  MSThe complex of political institutions, laws, and customs through which the function of governing is carried out in a specific political unit. MHÑGovernment AN╥government╙ as an abstract concept as opposed to the private citizen or private enterprises; no qualif; specify country or state CATALOG: /geog /form MNI1.409 XUÑState Government LH LU  MSAdministrative units of government responsible for policy making and management of governmental activities in the U.S. and abroad. PM68 HN68 MHÑGovernment Agencies ANonly /hist /organ; specify country or state CATALOG: /geog /form PIGovernment (66-67) MNN3.540.427 XUÑUnited States Environmental Protection Agency; ÑUnited States Federal Trade Commission LH LU;  OL╥government programs╙ is indexed GOVERNMENT with the locale specified if pertinent MH*Government Programs (Non Mesh) MNI1.451 LH  MHÑGovernment Publications ANno qualif CATALOG: /geog /form MNL1.178.682.492 LH  MSAn ovarian follicle in which the oocyte attains its full size and is surrounded by a thickened oolema (zona pellucida) at the periphery of the fluid-filled antrum. MHÑGraafian Follicle AN/cytol: consider also THECA CELLS, GRANULOSA CELLS; for follicular development use /physiol, not /growth MNA5.360.319.114.630.535; A6.407.312.497.535 FXÑOVUM LH LX  MSThe cause of an experimental myoleukemia in mice. HN(75) MHÑGraffi Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) MNB4.909.574.807.674.632.390; B4.909.777.731.674.632.390; B4.909.777.779.674.632.390 XSGraffi's Chloroleukemic Strain DMÑMouse Leukemia Viruses LH LS LM  MSThe induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. May be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. PM80 HN80 MHÑGraft Enhancement, Immunologic ANonly /methods /vet; to prevent graft rejection of normal or tumor tissue; do not coord with IMMUNOTHERAPY; DF: GRAFT ENHANCEMENT PIGraft Survival (77-79); Transplantation, Homologous (66-79); Transplantation Immunology (66-79) MNE2.95.449.440; E5.478.610.500 XSEnhancement of Grafts, Immunologic; Immunologic Enhancement of Grafts LH LS;  MSObstruction of flow in biological or prosthetic vascular grafts. PM85 HN85 MHÑGraft Occlusion, Vascular ANgraft may be biologic or prosthetic MNC23.814.395 XSVascular Graft Occlusion FXÑVascular Patency LH LS LX  MSAn immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. PM73 HN73(71) MHÑGraft Rejection ANonly /drug eff /rad eff; may be used with transpl neopl PITransplantation Immunology (66-70) MNG4.610.555.714.545.328 LH  MSThe survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. PM77 HN77 MHÑGraft Survival ANonly /drug eff /rad eff; may be used with transpl neopl PIGraft Rejection (71-76); Transplantation Immunology (66-72) MNG4.610.555.714.545.312 LH  MSThe clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation and eventual death brought about by the GRAFT VS HOST REACTION. OLuse GRAFT VS HOST DISEASE to search HOMOLOGOUS WASTING DISEASE back thru 1966 (as Prov 1966) PM84; was HOMOLOGOUS WASTING DISEASE 1967-83 HN84; was HOMOLOGOUS WASTING DISEASE 1964-83 (Prov 1964-66) MHÑGraft vs Host Disease MNC20.452 XSGraft-Versus-Host Disease; Homologous Wasting Disease; Runt Disease FXÑGRAFT VS HOST REACTION; ÑImmune Tolerance LH LS; ; LX;  MSAn immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE. PM70 HN70 MHÑGraft vs Host Reaction ANonly /drug eff /rad eff; do not confuse with HOST VS GRAFT REACTION nor with GRAFT VS HOST DISEASE above PIGraft vs Host Disease (66-69); Transplantation Immunology (66-69) MNG4.610.555.714.402 FXÑGraft vs Host Disease LH LX  MSA large group of aerobic bacteria which show up as pink (negative) when treated by the Gram staining method. PM76; ACHROMOBACTERIACEAE and BRUCELLACEAE were headings 1975 HN76 MHÑGram-Negative Aerobic Bacteria ANGEN only; prefer specifics PIBacteria (66-75) MNB3.400 XUÑAchromobacteriaceae; ÑBrucellaceae LH LU;  MSA large group of anaerobic bacteria which show up as pink (negative) when treated by the Gram staining method. PM76 HN76 MHÑGram-Negative Anaerobic Bacteria ANGEN only; prefer specifics PIBacteria (66-75) MNB3.425 LH  MSBacteria which lose crystal violet stain but are stained pink when treated by Gram's method. OLsearch BACTERIA 1973-75 PM84,73-75 HN84,73-75 MHÑGram-Negative Bacteria ANGEN: avoid; prefer specifics; do not use as a routine coord for a Gram-negative bact; do not use /blood-csf-urine; infection: coord NIM with BACTERIAL INFECTIONS (IM) PIBacteria (66-83) MNB3.440 LH  MSA large group of bacteria including those which oxidize ammonia or nitrite, metabolize sulfur and sulfur compounds, or deposit iron and/or manganese oxides. PM76; THIOBACTERIACEAE was heading 1975 HN76 MHÑGram-Negative Chemolithotrophic Bacteria ANGEN only; prefer specifics PIBacteria (66-72); Schizomycetes (73-74) MNB3.450 XUÑThiobacteriaceae LH LU  OLindexed under BACTERIA 1976-83 MH*Gram-Negative Facultatively Anaerobic Rods (Non Mesh) MNB3.475 LH  OLindexed under BACTERIA 1976-83 MH*Gram-Positive Asporogenous Rods (Non Mesh) MNB3.500 LH  MSBacteria which retain the crystal violet stain when treated by Gram's method. OLsearch BACTERIA 1973-75 PM84,73-75 HN84,73-75 MHÑGram-Positive Bacteria ANGEN: avoid; prefer specifics; do not use as a routine coord for a Gram-positive bact; do not use /blood-csf-urine; infection: coord NIM with BACTERIAL INFECTIONS (IM) PIBacteria (66-83) MNB3.510 LH  OLindexed under BACTERIA 1976-83 MH*Gram-Positive Cocci (Non Mesh) MNB3.525 LH  MSOne of the two principle components of tyrothricin, from Bacillus brevis; gramicidin C or S is a cyclic, ten amino acid polypeptide and gramicidins A, B, D, etc. seem to be linear polypeptides; used topically for Gram positive organisms; toxic to blood, liver, kidneys, meninges and the olfactory apparatus. Synonyms: Gramoderm; Neo-Polycin; Spectrocin. OLsearch TYROTHRICIN 1966-73 PM74; was see under TYROTHRICIN 1963-73 HN74; was see under TYROTHRICIN 1963-73 MHÑGramicidins ANdo not use /analogs /defic /physiol MND20.85.905.452; D20.187.925.412 LH  MHÑGranulation Tissue ANdo not use /abnorm /growth /inj /innerv MNA10.424 FXÑWound Healing LH LX  MSLeukocytes with abundant granules in the cytoplasm, which are divided into three groups: NEUTROPHILS, EOSINOPHILS, and BASOPHILS. OLsearch LEUKOCYTES 1968-74 PM79; was see under LEUKOCYTES 1968-78 HN79(75); was see under LEUKOCYTES 1968-78 MHÑGranulocytes ANA 11 qualif & /class PILeukocytes (66-74) MNA11.118.637.415; A15.145.229.637.415; A15.382.490.315 XSPromyelocytes LH LS  MHÑGranuloma ANnon-neoplastic; IM; coord with organ/dis (IM), not organ/neopl; malignant of nose = GRANULOMA, LETHAL MIDLINE; central giant cell granuloma & giant cell granuloma = GRANULOMA, GIANT CELL; granulomatous dis or granulomatous dis of childhood = GRANULOMATOUS DISEASE, CHRONIC; cholesterol granuloma = GRANULOMA (IM) + CHOLESTEROL (IM); talc granuloma = GRANULOMA /etiol (not /chem ind) + TALC /adv eff; xanthogranuloma = XANTHOMATOSIS (IM) + GRANULOMA (IM) MNC23.484; C23.739.487.451 FXÑTUBERCULOMA XUÑGranuloma, Plasma Cell LH LX LU  MHÑGranuloma Inguinale ANnon-neoplastic MNC1.252.411; C1.539.780.451; C17.838.384 XSGRANULOMA VENEREUM LH LS  MSA non-neoplastic inflammatory lesion containing large, multinucleated cells; includes reparative giant cell granuloma. OLuse GRANULOMA, GIANT CELL to search GRANULOMA, REPARATIVE GIANT CELL back thru 1966 PM74; was GRANULOMA, REPARATIVE GIANT CELL 1965-73 HN74; was GRANULOMA, REPARATIVE GIANT CELL 1965-73 MHÑGranuloma, Giant Cell ANnon-neoplastic; do not confuse with GIANT CELL TUMORS, benign or malignant neopl; coord IM with organ/dis (IM), not organ/neopl MNC5.500.368; C7.465.714.258.557; C23.484.368 XSEPULIS, GIANT CELL; GIANT CELL GRANULOMA LH LS;  MSA polypoid granulomatous projection into the lumen of the larynx HN(79) MHÑGranuloma, Laryngeal ANnon-neoplastic MNC8.618.846.414; C9.400.232; C23.484.400 XSLaryngeal Granuloma DMÑLaryngeal Diseases LH LS LM  MSA non-neoplastic disease of unknown etiology beginning with inflammation, ulceration and perforation of nose and palate and progressing to gradual destruction of midline facial structures. PM65; GRANULOMA GANGRAENESCENS & LETHAL MEDLINE GRANULOMA were see under WEGENER'S GRANULOMATOSIS 1963-64 HN65; GRANULOMA GANGRAENESCENS & LETHAL MIDLINE GRANULOMA were see under WEGENER'S GRANULOMATOSIS 1963-64 MHÑGranuloma, Lethal Midline ANnon-neoplastic MNC9.603.352; C23.484.451 XSGRANULOMA GANGRAENESCENS; LETHAL MIDLINE GRANULOMA LH LS;  MSA slow-growing benign pseudotumor in which plasma cells greatly outnumber the inflammatory cells. HN(84) MHÑGranuloma, Plasma Cell ANnon-neoplastic; IM; coord with organ/dis (IM), not organ/neopl PIGranuloma (66-83); Plasma Cells (66-83) MNC23.484.480 XSPlasma Cell Granuloma DMÑGranuloma LH LS LM  MSA recessive X-linked defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. OLsearch PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-74 PM78; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77 HN78(75); was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77 MHÑGranulomatous Disease, Chronic ANalso called granulomatous disease of childhood PIGranuloma (66-71); Immunologic Deficiency Syndromes (68-71); Phagocyte Bactericidal Dysfunction (72-77); Phagocytosis (66-71) MNC15.378.553.774.535; C20.673.774.535 LH  MHÑGranulosa Cell Tumor AN/anal /blood supply /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS (IM) MNC4.557.576.461 LH  MSCells of the membrana granulosa lining the vesicular ovarian follicle which become luteal cells after ovulation. PM78; was see under GRAAFIAN FOLLICLE 1975-77 HN78(75); was see under GRAAFIAN FOLLICLE 1975-77 MHÑGranulosa Cells ANA 11 qualif MNA5.360.319.114.630.535.200; A6.407.312.497.535.300; A11.436.300 LH  OLsearch CARBON 1966-74 HN(75) MHÑGraphite ANdo not use /analogs /biosyn /defic /physiol RN7782-42-5 MND1.154.640 DMÑCarbon LH LM  MSA large family, Graminea, of narrow-leaved herbaceous monocots; many grasses produce highly allergenic pollens and are hosts to cattle parasites and toxic fungi. MHÑGrasses ANa botanical term; use term of author; as plant tissue: Manual 31.9 MNB6.252 XSGraminea FXÑPOLLEN XUÑLolium LH LS LX LU  MSPlant-eating orthopterans having hindlegs adapted for jumping. There are several families and many genera. Some of the more common genera are: Melanoplus, the most common grasshopper; Conocephalus, the eastern meadow grasshopper; and Pterophylla, the true katydid. OLuse GRASSHOPPERS to search LOCUSTS back thru 1972 HN72; LOCUSTS was see under GRASSHOPPERS 1972-77 MHÑGrasshoppers ANIM; /microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 PIInsects (66-71) MNB1.131.617.678.369 XSLocusts LH LS  MSThyroid disorder characterized by exophthalmos, hypertrophy, and hyperplasia of the thyroid, thyrotoxicosis, and occasionally infiltrative dermopathy. OLuse GRAVES' DISEASE to search GOITER, EXOPHTHALMIC back thru 1966 PM87; was GOITER, EXOPHTHALMIC 1963-86 HN87; was GOITER, EXOPHTHALMIC 1963-86 MHÑGraves' Disease MNC11.280.390; C19.874.283.605; C19.874.397.370; C20.111.555 XSBASEDOW'S DISEASE; EXOPHTHALMIC GOITER; Goiter, Exophthalmic LH LS; ;  MHÑGravitation ANno qualif MNH1.671.323 XSG Force FXÑAviation LH LS LX  MHÑGreat Britain AN= ENGLAND, SCOTLAND & WALES strictly speaking; UNITED KINGDOM = GREAT BRITAIN + NORTHERN IRELAND, strictly speaking; available also are CHANNEL ISLANDS (see there for available X refs) & HEBRIDES MNZ1.542.363 XSUnited Kingdom LH LS  MSThe geographic area of the Great Lakes in general and when the specific state or states are not indicated. Usually includes Illinois, Michigan, New York, Ohio, Pennsylvania, and Wisconsin. HN75 MHÑGreat Lakes Region ANincludes Minn, Mich, Wisc, Ohio, Ill, Penna, Ind & NY; specify as needed but use GREAT LAKES REGION when text uses the term CATALOG: use for 3 or more states MNZ1.107.567.875.313 LH  MHÑGreece MNZ1.542.383 XSCrete LH LS  MHÑGreenland MNZ1.107.567.403 LH  MSNormal, appropriate sorrowful response to an immediate cause; self-limiting and gradually subsiding within a reasonable time. PM68 HN68 MHÑGrief ANhuman & animal; no qualif; mourning & bereavement go here MNF1.470.451 LH  MHÑGriseofulvin ANdo not use /defic /physiol RN126-07-8 MND20.85.62.480; D20.136.73.480 LH  MSThe external junctural region between the lower part of the abdomen and the thigh. PM81 HN81 MHÑGroin ANexternal only: do not confuse with INGUINAL CANAL, internal only; NIM when merely locational PIInguinal Canal (66-80) MNA1.47.365 LH  MSAn animal's cleaning and caring for the body surface; includes preening, the cleaning and oiling of feathers by birds. PM68 HN68 MHÑGrooming ANanimal only; only /drug eff /physiol /rad eff; for personal grooming of humans use HYGIENE PIBehavior, Animal (66-67) MNF1.145.113.111.453 XUÑPreening LH LU  MSAn RNA virus obtained from inbred mice with a high incidence of spontaneous lymphoid leukemia; infection is passed by ╥vertical╙ transmission from one generation to another through the ovum. PM66 HN66 MHÑGross Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) MNB4.909.574.807.674.632.403; B4.909.777.731.674.632.403; B4.909.777.779.674.632.403 LH  MSAn insurance plan covering wholly or partly the hospital costs. Employees (and their dependents) or other defined groups of individuals are insured under a single policy, issued to their employer or leader with individual certificates of insurance given to each insured individual or family. OLsearch INSURANCE, HOSPITALIZATION 1966-74 HN(75) MHÑGroup Hospitalization ANonly /econ /hist /legis /stand /trends /util MNN3.219.521.576.343.492.536 DMÑInsurance, Hospitalization LH LM  MSAny group of three or more full-time physicians organized in a legally recognized entity for the provision of health care services, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income. MHÑGroup Practice ANonly /hist /legis /organ /stand /trends; coord IM with med or other specialty (IM); do not confuse with PARTNERSHIP PRACTICE but do not interpret: use word of text MNN4.452.758.244 XUÑGroup Practice, Prepaid LH LU  MSAny group of three or more full-time dentists, organized in a legally recognized entity for the provision of dental care, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income. PM67 HN67 MHÑGroup Practice, Dental ANonly /hist /legis /organ /stand /trends; coord IM with specific dent specialty (IM); do not confuse with PARTNERSHIP PRACTICE, DENTAL but do not interpret: use word of text PIDentistry (66); Group Practice (66) MNN4.452.758.244.369 LH  MSAn organized group of three or more full-time physicians rendering services for a fixed prepayment. HN(80) MHÑGroup Practice, Prepaid ANonly /hist /legis /organ /stand /trends; coord IM with med or other specialty (IM) PIGroup Practice (66-79); Insurance, Health (66-79) MNN4.452.758.244.400 XSPrepaid Group Practice DMÑGroup Practice LH LS LM  MSThe procedures through which a group approaches, attacks, and solves a common problem. MHÑGroup Processes ANno qualif; differentiate from MASS BEHAVIOR: mass will probably be on a civil, pathol or mob level MNF1.829.316 FXÑSOCIAL CHANGE; ÑSociology LH LX;  MSThe informal or formal organization of a group of people based on a network of personal relationships which is influenced by the size and composition, etc., of the group. PM69 HN69(68) MHÑGroup Structure ANno qualif PIGroup Processes (66-67) MNF1.829.316.274 LH  MHÑGrowth ANGEN only, as a physiol process; use /growth with specific organ or organism: Manual 19.5+; when GEN & IM, only /drug eff /rad eff; TN 95; /drug eff: consider also GROWTH SUBSTANCES, GROWTH INHIBITORS & specifics MNG7.553.481 FXÑChild Development; ÑPERSONALITY DEVELOPMENT; ÑPersonality Development LH LX; ;  MH*Growth and Embryonic Development (Non Mesh) MNG7.553 LH  MSDeviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, maturation of features; includes both acceleration and retardation of growth. PM72 HN72(69) MHÑGrowth Disorders ANpredominantly related to bones & size; includes growth acceleration or retardation; do not confuse with NUTRITION DISORDERS (disord of assimilating & utilizing nutrients) PIGrowth (66-68) MNC23.509 FXÑBone Diseases, Developmental; ÑDwarfism; ÑGIGANTISM LH LX; ;  MSEndogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms. Do not use for PLANT GROWTH REGULATORS. PM79 HN79 MHÑGrowth Inhibitors ANinhib normal growth of human & animal cells & micro-organisms; do not confuse with PLANT GROWTH REGULATORS; do not use /analogs /antag /defic; /biosyn /physiol permitted if by living organisms; DF: GROWTH INHIB MND11.303.450; D24.185.348.402 XSCell Growth Inhibitors LH LS  MSThe area between the epiphysis and the diaphysis within which bone growth occurs. PM84 HN84 MHÑGrowth Plate PICartilage (66-83); Epiphyses (66-83) MNA2.835.232.251.352 XSCartilage, Epiphyseal; Epiphyseal Cartilage; Epiphyseal Plate FXÑBone Development LH LS; ; LX  MHÑGrowth Substances ANdo not use /analogs /antag ( = GROWTH INHIBITORS) MND11.303; D24.185.348 XSMitogens, Endogenous XUÑAngiogenesis Factor LH LS LU  MH*Growth Substances, Pigments, Vitamins (Non Mesh) MND11 LH  MSThe family Gryllidae consists of the common house cricket, Acheta domesticus, which is used in neurological and physiological studies. Other genera include Gryllotalpa (mole cricket); Gryllus (field cricket); and Oecanthus (tree cricket). HN(86) MHÑGryllidae ANIM; /microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 PIOrthoptera (75-85) MNB1.131.617.678.410 XSCrickets DMÑOrthoptera LH LS LM  MSGTP 7,8-8,9-dihydrolase. Hydrolyzes the imidazole ring of GTP, releasing carbon-8 as formate. Two C-N bonds are hydrolyzed and the pentase unit is isomerized. This is the first step in the synthesis of folic acid from GTP. HN(75) MHÑGTP Cyclohydrolase ANdo not use /analogs RNEC 3.5.4.16 PIAminohydrolases (74); Guanosine Triphosphate (74) MND8.586.277.151.300 XSGTP 8-Formylhydrolase; GTP Dihydrolase; GTP Ring-Opening Enzyme DMÑAminohydrolases LH LS; ; LM  MSHydrolyzes GTP to GDP. Provides energy for peptide chain elongation. HN(75) MHÑGTP Phosphohydrolase ANdo not use /analogs RNEC 3.6.1.- PIGuanosine Triphosphate (69-74); Phosphatases (69-74) MND8.586.277.352.630.350 XSGTPase; Guanosine Triphosphate Phosphohydrolase; Guanosinetriphosphatase DMÑPhosphatases LH LS; ; LM  MHÑGuaiac AND25-26 qualif RN9000-29-7 MND26.550.383 LH  MHÑGuaiacol ANdo not use /biosyn /defic /physiol RN90-05-1 MND2.355.601.536; D2.355.726.453; D2.755.75.536; D2.755.166.453; D23.338.454.578 LH  MS3-(2-Methoxyphenoxy)-1,2-propanediol. Expectorant that also has some muscle relaxing action; used in many cough preparations. Synonyms: Calmipan; Dilyn; Guiamar; Myocaine; Resyl; Robitussin; Tulyn. MHÑGuaiacol Glyceryl Ether AN= glycerol guaiacolate (an expectorant); D25-26 qualif RN93-14-1 MND2.355.601.536.400; D2.355.726.453.400; D2.755.75.536.400; D2.755.166.453.400; D23.338.454.578.453 XSGuaifenesin; Guaiphenesin LH LS;  HN75 MHÑGuam MNZ1.782.680.435 LH  MSA group of viruses of the Bunyavirus genus isolated from man, rodents, and mosquitoes in Brazil, Panama, and Trinidad. OLto search BERTIOGA VIRUS & BIMITI VIRUS use GUAMA GROUP VIRUSES back thru 1977 & ARBOVIRUSES 1975-76 HN(75); was see under ARBOVIRUSES 1975-80; BERTIOGA VIRUS & BIMITI VIRUS were see ARBOVIRUSES 1975-76 MHÑGuama Group Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with BUNYAVIRUS INFECTIONS (IM) MNB4.909.777.147.415 XSCatu Virus; Guama Virus DMÑBunyaviridae LH LS; LM  MS[(2,6-Dichlorobenzyldiene)amino]guanidine. Antihypertensive. HN(75) MHÑGuanabenz ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5051-62-7 PIGuanidines (73-74); Imines (73-74) MND2.78.370.435; D18.162.350 DMÑGuanidines LH LM  MS3,5-Diamino-1,2,4-triazole. A cytostatic triazole derivative which is not to be confused with guanazolo, the generic name for 8-azaguanine. HN(75) MHÑGuanazole ANdo not use /biosyn /defic /physiol; /analogs NIM only; do not confuse with GUANAZOLO ( = AZAGUANINE) RN1455-77-2 PIDiamines (72-74); Triazoles (72-74) MND3.383.129.799.500; D3.383.946.500; D22.204.430 DMÑTriazoles LH LM  MHÑGuanethidine ANdo not use /biosyn /defic /physiol RN55-65-2 MND2.78.370.460; D16.848.415.346; D18.162.384 LH  MHÑGuanidines ANdo not confuse with GUANINE; do not use /analogs /biosyn /defic /physiol MND2.78.370 XUÑAgmatine; ÑBethanidine; ÑGuanabenz; ÑGuanoxan; ÑMethylguanidine; ÑNetropsin; ÑRobenidine; ÑSulfaguanidine LH LU; ; ; ; ; ; ;  MHÑGuanine ANdo not confuse with GUANIDINES; /biosyn /physiol permitted; guanine riboside, guanine ribonucleoside = GUANOSINE RN73-40-5 MND3.438.759.758.399.454 LH  MSGuanine aminohydrolase. Catalyzes the deamination of guanine to form xanthine. HN(75) MHÑGuanine Deaminase ANdo not use /analogs RNEC 3.5.4.3 PIAminohydrolases (73-74); Guanine (73-74) MND8.586.277.151.350 XSGuanase; Guanine Aminase; Guanine Aminohydrolase DMÑAminohydrolases LH LS; ; LM  MSErythrocyte plasma membrane component of the receptor-adenylate cyclase complex. It acts as a GTPase. It mediates the response of adenylate cyclase to hormones, cholera toxin, and other endogenous substances which activate adenylate cyclase. PM85 HN85 MHÑGuanine Nucleotide Regulatory Protein AN/biosyn /physiol permitted PIAdenyl Cyclase (68-84); Carrier Proteins (66-84); Guanine Nucleotides (66-84); Guanosine Triphosphate (72-84); Receptors, Endogenous Substances (73-84) MND12.776.157.350; D12.776.543.750.350; D13.695.667.454.280; D13.695.827.426.280 XSGTP Binding Protein; GTP-Regulatory Protein LH LS;  MHÑGuanine Nucleotides AN/biosyn /physiol permitted; do not use /analogs MND13.695.667.454; D13.695.827.426 XSGuanosine Phosphates XUÑGuanosine Diphosphate; ÑGuanosine Monophosphate; ÑGuanosine Pentaphosphate; ÑGuanosine Tetraphosphate LH LS LU; ; ;  OLsearch NUCLEOSIDES 1966-71 PM72; was see under NUCLEOSIDES 1963-71 HN72; was see under NUCLEOSIDES 1963-71 MHÑGuanosine AN/biosyn /physiol permitted RN118-00-3 PINucleosides (66-71) MND13.570.583.454; D13.570.800.453 XUÑNucleoside Q LH LU  MSGuanosine, cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3' and 5' positions OLuse GUANOSINE CYCLIC MONOPHOSPHATE to search GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE back thru 1971 (as Prov 1971) PM80; GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE was heading 1972-79 HN80; GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE was heading 1971-79 (Prov 1971) MHÑGuanosine Cyclic Monophosphate AN/biosyn /physiol permitted; DF: CYCL GMP RN7665-99-8 PIGuanine Nucleotides (66-71) MND13.695.462.537; D13.695.667.454.304; D13.695.827.426.304 XSCyclic GMP; Guanosine Cyclic 2',3'-Monophosphate; Guanosine Cyclic 3',5'-Monophosphate XUÑDibutyryl Cyclic GMP LH LS; ; LU  MSGuanosine 5'-(trihydrogen diphosphate). A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: GRPP; guanosine pyrophosphate. HN(78) MHÑGuanosine Diphosphate AN/biosyn /physiol permitted; /analogs NIM only RN146-91-8 PIGuanine Nucleotides (66-77) MND13.695.667.454.340; D13.695.827.426.340 XSGDP DMÑGuanine Nucleotides LH LS LM  MSA nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins. HN(75) MHÑGuanosine Diphosphate Fucose AN/analogs NIM only RN15839-70-0 PIFucose (73-74); Guanine Nucleotides (73-74); Nucleoside Diphosphate Sugars (73-74) MND9.203.408.620.569.400.410; D13.695.667.454.340.350.400; D13.695.827.426.340.350.400; D13.695.827.708.400.410 XSGDP Fucose; Guanosine Diphosphofucose DMÑNucleoside Diphosphate Sugars LH LS; LM  MSA nucleoside diphosphate sugar which can be converted to the deoxy sugar GDPfucose, which provides fucose for lipopolysaccharides of bacterial cell walls. Also acts as mannose donor for glycolipid synthesis. HN(75) MHÑGuanosine Diphosphate Mannose AN/analogs NIM only RN18441-12-8 PIGuanine Nucleotides (73-74); Mannose (73-74); Nucleoside Diphosphate Sugars (73-74) MND9.203.408.620.569.400.500; D13.695.667.454.340.350.500; D13.695.827.426.340.350.500; D13.695.827.708.400.500 XSGDP Mannose; Guanosine Diphosphomannose; Guanosine Pyrophosphate Mannose DMÑNucleoside Diphosphate Sugars LH LS; ; LM  MSEsters formed between the aldehydic carbon of sugars and the terminal phosphate of guanosine diphosphate. HN(75) MHÑGuanosine Diphosphate Sugars ANdo not use /analogs PIGuanine Nucleotides (73-74); Nucleoside Diphosphate Sugars (73-74) MND9.203.408.620.569.400; D13.695.667.454.340.350; D13.695.827.426.340.350; D13.695.827.708.400 XSGDP Sugars DMÑNucleoside Diphosphate Sugars LH LS LM  MS5'-Guanylic Acid. A guanine nucleotide containing one phosphate group esterified to the sugar moiety. OLto search GUANYLIC ACIDS use GUANOSINE MONOPHOSPHATE back thru 1975 & GUANINE NUCLEOTIDES 1966-74 HN(78); was GUANYLIC ACIDS see under GUANINE NUCEOTIDES 1963-77 MHÑGuanosine Monophosphate AN/biosyn /physiol permitted; /analogs NIM only RN85-32-5 PIGuanine Nucleotides (66-74) MND13.695.667.454.400; D13.695.827.426.400 XSGMP; Guanylic Acid DMÑGuanine Nucleotides LH LS; LM  MSGuanosine 5'-triphosphate 2'(3')-diphosphate. A guanine nucleotide containing five phosphate groups. Three phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot II. HN(78) MHÑGuanosine Pentaphosphate AN/biosyn /physiol permitted; /analogs NIM only; DF: PPPGPP RN38918-96-6 PIGuanine Nucleotides (66-77) MND13.695.667.454.440; D13.695.827.426.440 DMÑGuanine Nucleotides LH LM  MSGuanosine 5'-diphosphate 2'(3')-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I. HN(78) MHÑGuanosine Tetraphosphate AN/biosyn /physiol permitted; /analogs NIM only; DF: PPGPP RN33503-72-9 PIGuanine Nucleotides (66-77) MND13.695.667.454.480; D13.695.827.426.480 DMÑGuanine Nucleotides LH LM  MSGuanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. PM72 HN72 MHÑGuanosine Triphosphate AN/biosyn /physiol permitted RN86-01-1 PIGuanine Nucleotides (66-71) MND13.695.667.454.504; D13.695.827.426.504 XSGTP XUÑGuanylyl Imidodiphosphate LH LS LU  MS(1,4-Benzodioxan-2-ylmethyl)guanidine sulfate. Antihypertensive agent similar in its mechanism of action to guanethidine; may cause liver damage. Synonyms: Envacar; Guanutil; Compound 1003. HN(76) MHÑGuanoxan ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2165-19-7 PIDioxans (75); Dioxins (69-74); Guanidines (69-75) MND2.78.370.470; D16.848.415.392; D18.162.392 DMÑGuanidines LH LM  PM73 HN73 MHÑGuanyl Cyclase ANdo not use /analogs RNEC 4.6.1.2 PINucleotidyltransferases (66-72) MND8.586.520.429 LH  MSRibonucleate 3'-guanylo-oligonucleotidohydrolase. Catalyzes endonucleolytic cleavage of RNA at the 3'-position of a guanylate residue. Formerly EC 2.7.7.26. Synonym: Aspergillus oryzae ribonuclease. HN(75); was see under RIBONUCLEASES 1975-83 MHÑGuanyloribonuclease ANdo not use /analogs RNEC 3.1.27.3 PIEndonucleases (74); Guanine Nucleotides (74); Ribonucleases (74) MND8.586.277.352.630.553.480 XSRNase T1
RNASET01; Ribonuclease N-1 DMÑEndoribonucleases LH LS; LM  MS1-Amidino-2-thiourea. May protect against hypoxic damage; proposed for treatment of shock due to trauma or blood loss; also stimulates paretic gastrointestinal system. Synonyms: guthimine; guthymine. HN(79) MHÑGuanylthiourea ANdo not use /biosyn /defic /physiol RN2114-02-5 PIThiourea (66-78) MND2.886.904.365; D2.948.898.365 XSGutimine DMÑThiourea LH LS LM  MS5'-Guanylic acid, monoanhydride with imidophosphoric acid. An analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. The nucleotide is a potent stimulator of adenylate cyclase. Synonyms: GMP-P(NH)P; GPP(NH)P. HN(78) MHÑGuanylyl Imidodiphosphate AN/biosyn /physiol permitted; DF: GPPNHP RN34273-04-6 PIGuanine Nucleotides (66-77); Guanosine Triphosphate (72-77) MND13.695.667.454.504.400; D13.695.827.426.504.400 DMÑGuanosine Triphosphate LH LM  MHÑGuatemala MNZ1.107.169.454 LH  MSSubjective feeling of having committed an error, offense or sin; unpleasant feeling of self-criticism. These result from acts, impulses, or thoughts contrary to one's personal conscience. MHÑGuilt ANno qualif MNF1.470.483 XUÑShame LH LU  MSA common name used for the family Caviidae of which the most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. MHÑGuinea Pigs ANcheck tag: no qualif; but when IM only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.865.550 XSCavia LH LS  OLuse GUINEA-BISSAU to search GUINEA 1966-82 HN80; was GUINEA 1966-79 MHÑGuinea-Bissau ANin Africa; = former Portuguese Guinea; former French Guinea (now Guinea): index under AFRICA, WESTERN; former Spanish Guinea (now Equatorial Guinea): index under AFRICA, CENTRAL; do not confuse with GUYANA in So. Amer MNZ1.58.432.402 LH  MSPowdered exudate from various Acacia species, especially A. senegal (Leguminosae); forms mucilage or syrup in water; used as suspending agent, excipient, emulsifier in foods and pharmaceuticals. Synonyms: Acacia syrup; Arabic gum; Australian gum; Gum ovaline; Gum Senegal; Indian gum. HN(80) MHÑGum Arabic AND25-26 qualif; pharmaceut agents made from various species of ACACIA (Cat B6) RN9000-01-5 PIAcacia (66-79); Polysaccharides (66-79) MND9.203.698.380; D26.698.931.419.399 XSAcacia Gum; Gum Acacia DMÑPolysaccharides LH LS; LM  MStrans-Polyisoprene. Coagulated latices from several species of Palaquium (Sapotaceae), tropical trees; it is the trans isomer of natural rubber; used as filling and impression material in dentistry and orthopedics and as an insulator in electronics; also as a rubber substitute. PM65 HN65 MHÑGutta-Percha AND25-26 qualif RN9000-32-2 MND25.339.859.495 LH  MHÑGuyana ANin So. Amer; = British Guiana; do not confuse with FRENCH GUIANA or with GUINEA-BISSAU in Africa MNZ1.107.757.488 LH  MSSystematic physical exercise; includes calisthenics. OLuse GYMNASTICS to search CALISTHENICS back thru 1966 HNCALISTHENICS was see under GYMNASTICS 1963-82 MHÑGymnastics ANonly /hist; a systematic set of exercises; differentiate from PHYSICAL EDUCATION AND TRAINING: instruction in hygiene as well as systematic exerc usually in formal setting; ╥corrective gymnastics╙ is probably EXERCISE THERAPY CATALOG: do not use /pop wks MNI2.233.543.454; I3.450.642.845.417 XSCalisthenics LH LS  MHÑGynandroblastoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS (IM) MNC4.557.576.486 LH  MH*Gynatresia (Non Mesh) MNC13.371.320 LH  MSA medical-surgical specialty concerned with the physiology and disorders primarily of the female genital tract, as well as female endocrinology and reproductive physiology. MHÑGynecology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of GENITALIA, FEMALE /form; do not use /radiogr ( = GENITALIA, FEMALE /radiogr) /radionuclide ( = GENITALIA, FEMALE /radionuclide) /surg ( = GENITALIA, FEMALE /surg) MNG2.403.810.310 FXÑGenital Diseases, Female LH LX  MHÑGynecomastia MNC19.146.404 LH  MSEthnic group coming originally from India and entering Europe in the 14th or 15th century. Many still maintain somewhat their itinerant life and tribal organization. HN(79) MHÑGypsies ANuse this spelling in translations; only /class /hist /psychol; specify geog PICaucasoid Race (66-78); Ethnic Groups (68-78); Ethnology (66-67) MNI1.76.201.450.416.280; I1.880.143.522.282; M1.194.265 DMÑEthnic Groups LH LM  MHÑGyrus Cinguli ANdo not use /innerv MNA8.186.211.577.330 XSCINGULATE GYRUS LH LS  MSA group of enzymes which are involved in the reversible synthesis of ATP and which transport protons from the cytoplasmic to the matrix side of the mitochondrial membrane. The flow of protons through the F(0) channel results in ATP synthesis by F1. OLuse H(+)-TRANSPORTING ATPASE to search ADENOSINE TRIPHOSPHATASE F1 back thru 1983 & CHLOROPLAST COUPLING FACTOR back thru 1978 PM84; was ADENOSINE TRIPHOSPHATASE F1 1983; CHLOROPLAST COUPLING FACTOR was heading 1978-83 HN84; was ADENOSINE TRIPHOSPHATASE F1 1983; CHLOROPLAST COUPLING FACTOR was heading 1978-83 MHÑH(+)-Transporting ATPase ANdo not use /analogs; DF: ATP SYNTHASE RNEC 3.6.1.34 PIAdenosine Triphosphatase (66-82) MND8.586.277.352.630.114.400 XSATPase F(0); ATPase F1; Adenosine Triphosphatase F1; Chloroplast Coupling Factor; Coupling Factor 1; F1 ATPase; F1F0 ATPase Complex; H(+)ATPase Complex LH LS; ; ; ; ; ; ;  OLsearch REFLEX, MONOSYNAPTIC 1970-74 HN(75) MHÑH-Reflex ANonly /drug eff /rad eff MNG11.561.730.643.474 DMÑReflex, Monosynaptic LH LM  MSA sex specific cell surface antigen produced by the sex determining gene of the Y chromosome in mammals; it causes syngeneic grafts from males to females to be rejected and interacts with somatic elements of the embryologic undifferentiated gonad to produce testicular organogenesis. PM79 HN79 MHÑH-Y Antigen ANmammals only; only /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIHistocompatibility (68-72); Histocompatibility Antigens (73-78) MND24.611.216.705.552.440 XSHY Antigen LH LS  MSThe major group of transplantation antigens in the mouse. PM78 HN78 MHÑH-2 Antigens ANmouse only; only /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIHistocompatibility (70-72); Histocompatibility Antigens (73-77); Transplantation Immunology (66-69) MND24.611.216.705.552.430 LH  MSAcquired or learned responses which are regularly manifested. OLuse HABITS to search HABIT back thru 1966 PM69; was HABIT 1963-68 HN69; was HABIT 1963-68 MHÑHabits ANno qualif; do not use for ╥drug habit╙ ( = SUBSTANCE ABUSE or SUBSTANCE DEPENDENCE) nor for ╥smoking habit╙ ( = SMOKING or TOBACCO USE DISORDER) MNF1.145.466; F3.234.193.308 XSHabit Disturbances LH LS  MSThe disappearance of responsiveness to accustomed stimulation. Does not include drug habituation. PM70 HN70(68) MHÑHabituation (Psychophysiology) AN only /drug eff /physiol /rad eff; DF: HABITUATION PILearning (66-67) MNF2.463.425.393; F2.830.422; G11.561.317 LH  MSInfection of equines by roundworms of the genus Habronema; includes cutaneous habronemiasis, also known as summer sores, bursati, granular dermatitis. PM68 HN68 MHÑHabronemiasis ANusually animal: do not use /vet but check tag ANIMAL; don't forget also HORSES (NIM) but do not index under HORSE DISEASES; for Habronema as IM, index SPIRUROIDEA (IM) + HABRONEMIASIS /parasitol (IM) PINematode Infections (66-67) MNC3.335.508.413; C22.488.489; C22.674.377.520 LH  MSA genus of the family Anaplasmataceae, parasitic on or within the erythrocytes of many vertebrate species. OLuse HAEMOBARTONELLA & ANAPLASMATACEAE INFECTIONS to search HAEMOBARTONELLOSIS 1977-79 PM80; HAEMOBARTONELLOSIS was heading 1977-79 HN80; HAEMOBARTONELLOSIS was heading 1977-79 MHÑHaemobartonella ANdo not use /blood-csf-urine; infection = HAEMOBARTONELLOSIS see ANAPLASMATACEAE INFECTIONS PIAnaplasmataceae (75-79); Anaplasmataceae Infections (77-79) MNB3.700.651.129.501 LH  MSInfection with nematodes of the genus Haemonchus, characterized by digestive abnormalities and anemia similar to that from hookworm infestation. OLsearch TRICHOSTRONGYLOIDIASIS 1968-74 HN(75) MHÑHaemonchiasis MNC3.335.508.909.330 DMÑTrichostrongyloidiasis LH LM  MSA genus of parasitic nematode worms which infest the duodenum and stomach of domestic and wild herbivores, which ingest it with the grasses they eat. Infestation of man is accidental. OLsearch TRICHOSTRONGYLOIDEA 1966-74 HN(75) MHÑHaemonchus ANdo not use /blood-csf-urine; infection = HAEMONCHIASIS MNB1.500.294.746.410 DMÑTrichostrongyloidea LH LM  MHÑHaemophilus ANuse this spelling in translations; do not use /blood-csf-urine; infection = HAEMOPHILUS INFECTIONS but check text for species & index by instructions on species below MNB3.475.500 XSHEMOPHILUS XUÑHaemophilus vaginalis LH LS LU  MHÑHaemophilus Ducreyi ANdo not use /blood-csf-urine; infection = CHANCROID MNB3.475.500.371 LH  MSInfections with bacteria of the genus Haemophilus. PM68 HN68 MHÑHaemophilus Infections ANcheck text for species & index by instructions on species above & below but note that MENINGITIS, HAEMOPHILUS is available PIHaemophilus (66-67) MNC1.252.433 LH  MHÑHaemophilus Influenzae ANdo not use /blood-csf-urine; infection: coord NIM with HAEMOPHILUS INFECTIONS (IM); vaccine: coord IM with BACTERIAL VACCINES (IM), not INFLUENZA VACCINE MNB3.475.500.538 LH  MSA bacterium isolated from the human vagina. HN(75) MHÑHaemophilus vaginalis ANdo not use /blood-csf-urine; infection: coord NIM with HAEMOPHILUS INFECTIONS (IM) MNB3.475.500.900 XSCorynebacterium vaginale; Gardnerella vaginalis DMÑHaemophilus LH LS; LM  MHÑHafnium ANHf-180; do not use /analogs /biosyn /defic /physiol; Hf-176-179 = HAFNIUM (IM) + ISOTOPES (NIM); Hf-168-175, 181-183 = HAFNIUM (IM) + RADIOISOTOPES (IM) RN7440-58-6 MND1.268.367; D1.552.337 LH  OLsearch CYCLOSTOMES 1968-74 HN(75) MHÑHagfish ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.181.371 DMÑCyclostomes LH LM  MSKeratinous filaments projecting from the skin, composed of a cylindrical shaft and a root. OLuse HAIR to search LANUGO back thru 1966 HNLANUGO was see under HAIR 1963-78 MHÑHair ANdo not use /blood supply /inj /innerv /physiopathol /secret /surg; includes fur of animals; abnormally pulling at one's hair = TRICHOTILLOMANIA; hair follicles are indexed here; inflammation of hair follicles = FOLLICULITIS (see note there) MNA1.835.288 XSLanugo LH LS  MSReceptors located in the cochlea which are sensitive to auditory stimuli or receptors located in the vestibular apparatus which are sensitive to changes in the position of the head. PM80; was see under MECHANORECEPTORS 1977-79 HN80(77); was see under MECHANORECEPTORS 1977-79 MHÑHair Cells ANnothing to do with HAIR: are receptors in the cochlea; do not use /innerv; use for hair cells unspecified or outer hair cells & note HAIR CELLS, INNER below PIOrgan of Corti (66-76) MNA8.796.511.725.404.307; A9.246.631.246.577.325 XUÑHair Cells, Inner LH LU  MSBulbous cells that are medially placed in one row in the organ of Corti. In contrast to the outer hair cells, the inner hair cells are fewer in number, have fewer sensory hairs and are less differentiated. HN(80) MHÑHair Cells, Inner ANsee note above; do not use /innerv PIHair Cells (77-79); Mechanoreceptors (77-79); Organ of Corti (66-76) MNA8.796.511.725.404.307.315; A9.246.631.246.577.325.315 DMÑHair Cells LH LM  MSColor of hair or fur. PM76 HN76 MHÑHair Color ANnatural color of human hair or animal fur; do not use for color of hair after dyeing; only /drug eff /genet /rad eff PIHair (66-75); Color (66-75); Pigmentation (66-75); Pigments (66-75) MNG4.185.672.490; G10.795.280 LH  MSDiseases affecting the orderly growth and persistence of hair. PM80 HN80; was HAIR FOLLICLE DISEASES (NON MESH) before 1980 MHÑHair Diseases PIHair (66-79); Skin Appendage Diseases (68-79) MNC17.805.305 LH  MSDyes used as cosmetics to change hair color either permanently or temporarily. HN(79); was see under COSMETICS 1979 MHÑHair Dyes AND25-26 qualif PICosmetics (66-78); Dyes (66-78); Hair (66-78); Hair Color (76-78) MND26.313.300.299; D26.408.355; J1.516.213.450.426 XSColoring Agents, Hair; Dyes, Hair; Hair Colorants DMÑHair Preparations LH LS; ; LM  MSHair grooming and cleansing aids or other products meant for topical application to hair, usually human; includes sprays, bleaches, conditioners, rinses, shampoos, nutrient lotions, etc. PM80; HAIR DYES was see under COSMETICS 1979 HN80 MHÑHair Preparations AND25-26 qualif; note HAIR DYES above PICosmetics (66-79); Hair (66-79) MND26.313.300; J1.516.213.450 XSCosmetics, Hair XUÑHair Dyes LH LS LU  MHÑHair Removal ANdo not use /util except by MeSH definition MNE2.218.372 XSDEPILATION; EPILATION; Electrolytic Depilation LH LS; ;  MHÑHaiti MNZ1.107.904.427 LH  MS21-Chloro-9-fluoro-11-beta,16-alpha, 17-trihydroxy-pregn-4-ene-3,20-dione cyclic 16, 17-acetal with acetone. Topical glucocorticoid used for dermatitis, eczema or psoriasis; causes skin irritation. Synonyms: Halciderm; Halog; SQ 18566. HN(79) MHÑHalcinonide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3093-35-4 PIPregnanes (68-73); Pregnenediones (74-78) MND4.808.745.745.654.570; D26.74.125.447.515; D26.74.125.515; D26.74.148.447.515; D26.368.99.447.515 DMÑPregnenediones LH LM  MSThe time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. PM74 HN74(71) MHÑHalf-Life ANalmost never IM; no qualif; may refer to radioactivity, metabolized substances or cells PITime (66-70); specific radioisotope, substance, or cell MNH1.862.405 LH  MSSpecialized residences for persons who do not require full hospitalization, and are not well enough to function completely within the community without professional supervision, protection and support. PM67 HN67(65) MHÑHalfway Houses ANdo not use /educ MNN2.278.825.408 FXÑAfter Care; ÑRehabilitation LH LX;  MHÑHalitosis MNC23.888.821.475 FXÑMouth Diseases LH LX  HN(65); was see under MANDIBULOFACIAL DYSOSTOSIS 1965-84 MHÑHallermann's Syndrome ANdo not use /congen MNC5.116.99.370.231.427; C16.131.621.246.330 DMÑCraniofacial Dysostosis LH LM  MSProgressive hereditary disorder with marked reduction in the number of myelin sheaths of the globus pallidus and substantia nigra with accumulation of iron pigment. Manifestations include dysarthria, progressive mental deterioration, and corticospinal and extrapyramidal motor signs. HN(65); was see under BRAIN DISEASES 1975-78 MHÑHallervorden-Spatz Syndrome ANdo not use /drug eff /physiol /rad eff MNC10.228.140.558; C10.228.140.79.493; F3.709.346.318 DMÑBasal Ganglia Diseases LH LM  MSSubjectively experienced sensation in the absence of an actual appropriate stimulus, but which is regarded by the individual as real. MHÑHallucinations ANdo not use /congen /drug eff /physiol /rad eff; /chem ind: consider also HALLUCINOGENS MNC10.597.439; C10.597.751.330; C23.888.592.763.307; F3.126.185.794.405 LH  MHÑHallucinogens ANdo not use /analogs /biosyn /defic /physiol; consider also HALLUCINATIONS /chem ind MND15.236.372 XSPSYCHEDELIC AGENTS; PSYCHOTOMIMETIC AGENTS LH LS;  MHÑHallux ANprimates only MNA1.378.592.350.792.456 LH  MSLateral displacement of the great toe, producing deformity of the first metatarsophalangeal joint with callous, bursa, or bunion formation over the bony prominence. PM67 HN67(63) MHÑHallux Valgus ANnote category MNC5.334.539; C23.304.351.372.539 XSBUNION LH LS  MSBacteria found in environments with high salt concentrations, such as some salt lakes or proteinaceous materials preserved with salt. PM76 HN76 MHÑHalobacteriaceae PIBacteria (66-74); Pseudomonadaceae (75) MNB3.400.410 LH  MHÑHalobacterium ANfound in salt waters & brines MNB3.400.410.420 LH  HN(73) MHÑHalofenate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26718-25-2 PIAnticholesteremic Agents (66-72); Antilipemic Agents (66-72); Glycolates (66-72) MND2.241.511.316.455; D10.162.202.456 DMÑGlycolates LH LM  MHÑHalogens ANdo not use /analogs /biosyn /defic /physiol MND1.396 LH  MHÑHaloperidol ANdo not use /biosyn /defic /physiol RN52-86-8 MND2.522.352.506; D15.236.872.331.241.506 LH  MHÑHalothane ANdo not use /biosyn /defic /physiol; when used as an anesthetic, use no qualif RN151-67-7 MND2.455.526.340; D14.166.438 XSBromchlortrifluorethane LH LS  MSA focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area. MHÑHamartoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.466 LH  MSA hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion; other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system. HN(87) MHÑHamartoma Syndrome, Multiple ANdo not use /anal /blood supply /secret /ultrastruct PIHamartoma (66-86); Neoplasms, Multiple Primary (66-86) MNC4.435; C4.651.435; C16.466.700.435 XSCowden's Disease; Multiple Hamartoma Syndrome DMÑNeoplasms, Multiple Primary LH LS; LM  MSA common name used to describe a subfamily of the Cricetidae. Three of the more common genera are Cricetus, Cricetulus, and Mesocricetus. HNCRICETUS was see under HAMSTERS 1963-81 MHÑHamsters ANcheck tag: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.865.360.458 XSCricetini; Cricetus; Djungarian; Djungarian Hamster; Phodopus XUÑCricetulus; ÑMesocricetus LH LS; ; ; ; LU;  OLuse HAND /AB & HAND DEFORMITIES, ACQUIRED to search HAND DEFORMITY 1966-70; in searching non-acquired hand abnormalities consider HAND DEFORMITIES, ACQUIRED 1966-72 PMHAND DEFORMITIES was heading 1966-70 HNHAND DEFORMITIES was heading 1966-70 MHÑHand ANprimates only; /inj = HAND INJURIES; /abnorm permitted but note HAND DEFORMITIES, ACQUIRED; skin dis of hand = HAND DERMATOSES: see note there MNA1.378.209.455 LH  MSDeformities of the hand, or a part of the hand, acquired after birth as the result of injury or disease. OLuse HAND /AB & HAND DEFORMITIES, ACQUIRED to search HAND DEFORMITIES 1966-70 PM71; was HAND DEFORMITIES 1963-70 HN71; was HAND DEFORMITIES 1963-70 MHÑHand Deformities, Acquired ANdo not use /congen; congen hand deform = HAND /abnorm MNC5.406; C23.304.428 LH  MHÑHand Dermatoses ANGEN & as coord for specific skin diseases of the hand but not as coord for neoplasms on the hand (use neopl coords (IM) with HAND (IM)); consider synonym for dermatitis of hand & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH MNC17.338 LH  MHÑHand Injuries ANconsider also METACARPUS /inj; FINGER INJURIES & WRIST INJURIES are also available MNC21.866.448 LH  MHÑHand-Schueller-Christian Syndrome MNC15.604.667.490.490 XSSCHUELLER-CHRISTIAN DISEASE LH LS  MSA mild, highly infectious viral disease of children, characterized by vesicular lesions in the mouth and on the hands and feet; caused by a Coxsackie A virus. OLsearch COXSACKIEVIRUS INFECTIONS 1970-74 HN(75); was see under COXSACKIE VIRUS INFECTIONS 1970-78 MHÑHand, Foot and Mouth Disease ANdo not confuse with FOOT-AND-MOUTH DISEASE; DF: HAND DISEASE MNC2.782.687.359.213.331 DMÑCoxsackievirus Infections LH LM  MSThose persons with physical disabilities which limit or preclude their participation in certain activities. MHÑHandicapped ANrestrict to phys handicap but prefer specifics (BLINDNESS, DEAFNESS, AMPUTEES, etc.); mentally handicapped = MENTAL RETARDATION, emotionally handicapped = MENTAL DISORDERS or specific; only /class /hist /psychol; /educ permitted but is probably EDUCATION, SPECIAL; /rehabil = REHABILITATION MNM1.289; N1.224.406 XSCRIPPLED; DISABLED; Disability, Physical; Physically Handicapped FXÑDental Care for Handicapped; ÑEducation, Special; ÑMainstreaming (Education); ÑREHABILITATION; ÑSelf-Help Devices LH LS; ; ; LX; ; ; ;  MSPhysical manipulation of animals and humans to induce a behavioral or other psychological reaction; in articles in experimental psychology, the animal is handled to induce a stress situation or to study the effects of ╥gentling╙ or ╥mothering╙. PM65 HN65(64) MHÑHandling (Psychology) ANhuman & animal; no qualif; DF: HANDLING MNF1.658.556 LH  PM82 HN82 MHÑHandwashing ANonly /methods PICross Infection/PC (66-81); Disinfection (75-81); Sterilization (66-74) MNG3.850.180.428 XSDisinfection, Hand; Surgical Scrub LH LS;  MHÑHandwriting ANno qualif; handwriting ╥disorders╙ goes here with no coord for disord MNL1.143.506.423.906.539 FXÑAgraphia LH LX  MSYeast-like fungi, of the family Saccharomycetaceae, order Endomycetales isolated from trees, bark beetles, fruit, and soil. HN(75); was see under ASCOMYCETES 1975-85 MHÑHansenula ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.292.420; B5.354.930.500 DMÑEndomycetales LH LM  MSThe number of chromosomes in the gametes, which is half the number normally found in somatic cells. Symbol: N. PM68 HN68 MHÑHaploidy ANno qualif PIChromosomes (66-67) MNG5.148.777.456 LH  MSThe genetic constitution of individuals with respect to one member of a pair of allelic genes; sets of single alleles or closely linked genes that tend to be inherited together, such as those of the major histocompatibility complex; portions of phenotypes determined by genes located on one of a pair of chromosomes. PM87 HN87 MHÑHaplotypes ANonly /drug eff /rad eff PIGenotype (68-86); Haploidy (68-86); specific histocompatibility antigen (75-86) MNG5.470 LH  MSHighly pleasant emotion characterized by outward manifestations of gratification; joy. PM74 HN74(70) MHÑHappiness ANno qualif; includes ╥joy╙ PIEmotions (66-69) MNF1.470.516 LH  PM65 HN65(64) MHÑHaptens ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine MND24.611.216.621 LH  MHÑHaptoglobins ANdo not use /analogs /blood MND12.776.124.50.300; D12.776.124.790.106.394; D12.776.377.715.85.394; D12.776.395.560.373 LH  OLsearch LACRIMAL APPARATUS 1969-74 HN(75) MHÑHarderian Gland MNA9.371.463.373 DMÑLacrimal Apparatus LH LM  PM65 HN65 MHÑHardness ANalmost never IM; no qualif MNH1.671.347 LH  PM72 HN72(64) MHÑHardness Tests ANNIM; only /instrum /methods /stand MNE5.417; H1.671.347.457 LH  MS4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole. Alkaloid isolated from seeds of Peganum harmala L., Zygophyllaceae. A CNS stimulant acting as a monoamine oxidase inhibitor. HN(75) MHÑHarmaline ANdo not confuse with HARMINE; do not use /defic /physiol; /analogs NIM only RN304-21-2 PIAlkaloids (70-74); Indoles (70-74); Pyridines (72-74) MND3.132.410; D3.494.500 XSDihydroharmine; Harmidine DMÑAlkaloids LH LS; LM  MS7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole. Alkaloid isolated from seeds of Peganum harmala L., Zygophyllaceae. Medical use as a CNS stimulant. HN(75) MHÑHarmine ANdo not confuse with HARMIDINE or HARMALINE; do not use /defic /physiol; /analogs NIM only RN442-51-3 PIAlkaloids (69-74); Indoles (69-74); Pyridines (69-74) MND3.132.415; D3.494.515; D15.236.372.454 XSBanisterine; Leucoharmine; Telepathine; Yageine DMÑAlkaloids LH LS; ; ; LM  MSSubstances isolated from the seeds of Cephalotaxus harringtonia, var. drupacea. They are esters of the alkaloid cephalotaxine and may be effective as antineoplastic agents. HN(77) MHÑHarringtonines ANfrom Cephalotaxus harringtonia seeds; do not use /analogs /defic /physiol; /biosyn permitted if by plant PIAlkaloids (72-76); Dioxoles (72-76) MND3.132.420; D22.204.179.424 XSCephalotaxine Alkaloids; Cephalotaxus Alkaloids DMÑAlkaloids LH LS; LM  MSA genus of free-living amoebae found in fresh water; the cysts usually pass harmlessly through the intestinal tract of man and may thus be found in feces. Occasionally, these organisms cause respiratory tract infections or generalized fatal meningoencephalitis. PM72 HN72 MHÑHartmannella ANdo not use /anat /blood-csf-urine /embryol; infection: coord NIM with AMEBIASIS (IM) PIAmoeba (66-71); Sarcodina (66-71) MNB1.841.656.89.430 LH  MSFamilial syndrome characterized clinically by a pellagrous rash, cerebellar ataxia, and mental retardation and biochemically by the loss of renal tubular and intestinal transport of neutral amino acids. PM65 HN65 MHÑHartnup Disease ANdo not use /congen /drug eff /physiol /rad eff MNC10.228.140.163.331; C10.496.313; C12.777.419.815.191.457; C18.452.648.66.210.490; C18.452.648.851.191.457; F3.709.346.342 LH  MSA type C mouse sarcoma virus first described by J.J.Harvey in 1964. HN(84) MHÑHarvey Sarcoma Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with SARCOMA, EXPERIMENTAL (IM) PIMouse Sarcoma Viruses (80-83); Mouse Tumor Viruses (66-79) MNB4.909.574.807.674.700.424; B4.909.777.731.674.700.424; B4.909.777.779.674.700.424 DMÑMouse Sarcoma Viruses LH LM  MSAn enduring attitude or sentiment toward persons or objects manifested by anger, aversion and desire for the misfortune of others. MHÑHate ANno qualif MNF1.470.548 LH  PM73 HN73(64) MHÑHaversian System ANdo not use /abnorm /growth /inj /innerv MNA10.165.265.507 LH  MHÑHawaii MNZ1.107.567.875.326; Z1.782.815.482 LH  MSA seasonal variety of allergic rhinitis, marked by acute conjunctivitis with lacrimation and itching, regarded as an allergic condition triggered by specific allergens. OLuse HAY FEVER to search RHINITIS, ALLERGIC 1966-79 PMRHINITIS, ALLERGIC was see HAY FEVER 1963-79 HNRHINITIS, ALLERGIC was see HAY FEVER 1963-79 MHÑHay Fever ANmay be caused by grasses, various types of pollen, etc.; note X ref: do not confuse with RHINITIS, ALLERGIC, NONSEASONAL MNC8.674.425; C9.603.799.407; C20.543.480.680.425 XSRhinitis, Allergic, Seasonal FXÑPOLLEN LH LS LX  MHÑHead ANusually NIM as site; soft parts = FACE, bony parts = SKULL; prefer specific indentions; /anat: consider also CEPHALOMETRY (living skull) & CRANIOMETRY (dead skull); /inj = HEAD INJURIES but consider also SKULL & FACIAL BONES & specifics under each with /inj; TN 96: relation to ╥skull injuries╙; Bull 93 (Jan 77): various types of head inj MNA1.456 LH  MSNeoplasms of the head and neck. OLuse HEAD AND NECK NEOPLASMS to search NECK NEOPLASMS back thru 1966 PM76; NECK NEOPLASMS was heading 1963-75 HN76; NECK NEOPLASMS was heading 1963-75 MHÑHead and Neck Neoplasms ANGEN: prefer FACIAL NEOPLASMS, SKULL NEOPLASMS & other specific organ/neopl terms pertinent to head & neck; /anal /blood /supply /secret /ultrastruct permitted; coord IM with histol type of neopl if possible; DF: HEAD NEOPLASMS or HEAD NEOPL MNC4.588.443 XSNeck Neoplasms LH LS  MHÑHead Injuries ANgeneral or unspecified; do not consider a substitute for /inj with various bones or other portions of the head; ╥cranio-cerebral inj╙ goes under BRAIN INJURIES only & not also here unless particularly discussed; TN 96: relation to SKULL /inj; TN 115: relation to ╥jaw injuries╙; Bull 93 (Jan 77): various types of head inj MNC21.866.460 LH  MSPersonal devices for protection of heads from impact, penetration from falling and flying objects, and from limited electric shock and burn. HN(75); was in Cat D & J 1975-82 MHÑHead Protective Devices ANonly /econ /stand /supply /vet MNE7.712.350 XSHelmets DMÑProtective Devices LH LS LM  MHÑHeadache ANMIGRAINE, VASCULAR HEADACHE & CLUSTER HEADACHE are also available but do not diagnose: use word of text MNC10.597.617.485; C23.888.592.612.429 LH  MSThe state of the organism when it functions optimally without evidence of disease. MHÑHealth ANno qualif; /educ = HEALTH EDUCATION; /man = HEALTH MANPOWER CATALOG: do not use /pop wks MNN1.407.540 XUÑHealth Status; ÑUrban Health LH LU;  MH*Health and Disease (Non Mesh) MNN1.407 LH  MSHealth insurance plans for employees, and generally including their dependents, usually on a cost-sharing basis with the employer paying a percentage of the premium. OLsearch INSURANCE, HEALTH 1968-74 HN(75) MHÑHealth Benefit Plans, Employee ANonly /econ /hist /legis /organ /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576.343.290; N4.452.677.392 XSCHAMPUS DMÑInsurance, Health LH LS LM  MSVoluntary groups of people representing diverse interests in the community such as hospitals, businesses, physicians and insurers with the principal objective to improve health care cost effectiveness. OLsearch HEALTH PLANNING ORGANIZATIONS 1984-85 HN(86); was see HEALTH PLANNING ORGANIZATIONS 1984-85 MHÑHealth Care Coalitions ANonly /econ /hist /legis /stand /trends /util PIHealth Planning Organizations (80-85) MNN3.219.151.160.400; N3.540.452.188 XSBusiness Coalitions (Health Care) DMÑHealth Planning Organizations LH LS LM  MSEducation which increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis. MHÑHealth Education ANonly /econ /hist /legis /man /methods /organ /stand /trends; educ of patients in & outside hosp = PATIENT EDUCATION; HEALTH PROMOTION is also available CATALOG: /geog /form; do not use /pop wks MNG3.850.630; I2.233.332; N2.421.143.827.407; N2.421.726.407 XSCommunity Health Education; Education, Health XUÑHealth Fairs LH LS; LU  MSEducation which increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of dental health on a personal or community basis. PM65 HN65 MHÑHealth Education, Dental ANonly /econ /hist /legis /man /methods /organ /stand /trends CATALOG: /geog /form; do not use /pop wks MNG3.890.410; I2.233.332.374; N2.421.143.827.407.457; N2.421.726.407.457 FXÑPreventive Dentistry; ÑPublic Health Dentistry LH LX;  MSInstitutions which provide medical or health-related services. PM68; HEALTH FACILITY CLOSURE was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82 HN68 MHÑHealth Facilities ANonly /class /econ /hist /legis /organ /stand /supply /trends /util CATALOG: /geog /form PIspecific facility MNN2.278 FXÑHealth Facility Planning XUÑHealth Facilities, Proprietary; ÑHealth Facility Closure; ÑHealth Facility Environment; ÑHealth Facility Merger; ÑHealth Facility Moving; ÑMaternal-Child Health Centers; ÑMedical Office Buildings; ÑPatients' Rooms; ÑPhysicians' Offices LH LX LU; ; ; ; ; ; ; ;  MSHealth care institutions operated by private groups or corporations for a profit. HN(Aug 77) MHÑHealth Facilities, Proprietary AN╥operated by private groups or corporations for a profit╙; only /class /econ /hist /legis /organ /stand /supply /trends /util CATALOG: /geog /form MNN2.278.215 DMÑHealth Facilities LH LM  MSManagerial personnel responsible for implementing policy and directing the activities of health care facilities such as nursing homes. PM78 HN78 MHÑHealth Facility Administrators ANdo not use /man /methods MNM1.526.70.490; M1.526.485.430; N2.350.45.100 XUÑHospital Administrators LH LU  MSThe closing of any health facility, e.g., health centers, residential facilities, and hospitals. OLuse HEALTH FACILITY CLOSURE to search HOSPITAL CLOSURE back thru Aug 1977 HN(83); was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82 MHÑHealth Facility Closure ANno qualif PIHospital Administration (66-Jul 77) MNN2.278.218 XSHospital Closure DMÑHealth Facilities LH LS LM  MSPhysical surroundings or conditions of a hospital or other health facility and influence of these factors on patients and staff. HN(80) MHÑHealth Facility Environment ANdo not use /man /methods /organ /supply /util (except by MeSH definition) MNN2.278.220 DMÑHealth Facilities LH LM  MSThe combining of administrative and organizational resources of two or more health care facilities. HN(Aug 77) MHÑHealth Facility Merger ANdo not use /educ /methods MNN2.278.235 XSAcquisition, Health Facility; Health Facility Acquisition; Hospital Merger; Merger, Health Facility DMÑHealth Facilities LH LS; ; ; LM  MSThe relocation of health care institutions or units thereof; includes equipment relocation. HN(Aug 77) MHÑHealth Facility Moving ANdo not use /educ /methods MNN2.278.255 XSHospital Moving; Moving, Health Facility DMÑHealth Facilities LH LS; LM  MSAreawide planning for health care institutions on the basis of projected consumer need. PM68 HN68 MHÑHealth Facility Planning ANonly /econ /legis /stand /trends; TN 104: differentiate from FACILITY DESIGN AND CONSTRUCTION CATALOG: /geog /form PIHospital Design and Construction (66-67) MNN3.349.650.250 XSHealth Facility Conversion; PLANNING, HEALTH FACILITY FXÑArchitecture; ÑFacility Design and Construction; ÑHealth Facilities XUÑBed Conversion LH LS; LX; ; LU  MSThe physical space or dimensions of a facility; may be indicated by bed capacity. PM68 HN68 MHÑHealth Facility Size ANonly /econ /legis /stand /trends PIHospitals (66-67) MNN2.278.306 LH  MSCommunity health education events focused on prevention of disease and promotion of health through audiovisual exhibits. HN(83) MHÑHealth Fairs ANonly /econ /hist /man /organ /stand /trends PIExhibits (66-82); Health Education (66-82) MNI2.233.332.390; N2.421.143.827.407.478; N2.421.726.407.478 DMÑHealth Education LH LM  MSU.S. Federal Government Health Insurance Act of 1966, providing for hospital and extended care benefits under the Social Security System. Amended by Public Law 92-603, 1972. Synonym: Medicare. OLuse HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 to search HEALTH INSURANCE FOR AGED, TITLE l8 back thru 1966 (as Prov 1966) PM79; was HEALTH INSURANCE FOR AGED, TITLE 18 1967-78 HN79; was HEALTH INSURANCE FOR AGED, TITLE 18 1966-78 (Prov 1966) MHÑHealth Insurance for Aged and Disabled, Title 18 ANU.S. only: for Canada index under NATIONAL HEALTH PROGRAMS + CANADA; specify geog; only /econ /hist /legis /util; Public Law 89-97; DF: HEALTH INSURANCE FOR AGED CATALOG: /geog by state /form MNN3.219.521.346.506.564.457; N3.219.521.576.343.332 XSInsurance, Health, for Aged and Disabled; MEDICARE FXÑAged LH LS; LX  MSSystems of health care, providing for comprehensive services for enrolled members for a fixed prepaid annual fee. Specifically, provide outpatient and hospital services through a single organization and a single payment mechanism. PM74 HN74(71) MHÑHealth Maintenance Organizations ANonly /class /econ /hist /legis /organ /stand /supply /trends /util; DF: HMO CATALOG: /geog /form PIGroup Practice (66-70); Insurance, Health (66-70) MNN4.452.758.244.541 XSGroup Health Organizations, Prepaid; Prepaid Group Health Organizations FXÑInsurance, Health LH LS; LX  MSIndividuals working in the health occupations. PM68 HN68 MHÑHealth Manpower ANGEN only: prefer /manpower with specific headings; when GEN & IM, do not use /educ (= HEALTH OCCUPATIONS /educ) /manpower /organ CATALOG: /geog /form PIHealth Occupations (66-67) MNN2.350 XSHealth Occupations Manpower; Health Personnel LH LS;  MSUse for general material on health occupations and professions; includes allied health occupations. OLuse HEALTH OCCUPATIONS to search HEALTH PROFESSIONS back thru 1966 PM68; was HEALTH PROFESSIONS 1963-67 HN68; was HEALTH PROFESSIONS 1963-67 MHÑHealth Occupations ANonly /econ /educ /hist /stand /trends; /man = HEALTH MANPOWER; for health aides try HEALTH MANPOWER or ALLIED HEALTH PERSONNEL or PHYSICIANS' ASSISTANTS CATALOG: /geog /form MNG2 XSALLIED HEALTH OCCUPATIONS; HEALTH PROFESSIONS FXÑOccupations LH LS; LX  OL╥health personnel╙ is indexed under HEALTH MANPOWER or ALLIED HEALTH PERSONNEL MH*Health Personnel (Non Mesh) MNM1.526.485 LH  MSThe science concerned with problems of radiation protection relevant to reducing or preventing radiation exposure, and the effects of ionizing radiation on humans and their environment. PM73 HN73(67) MHÑHealth Physics ANno qualif PIRadiation Protection (66) MNG2.229.333; H1.671.368 XSRADIOLOGIC PHYSICS FXÑRADIATION MONITORING; ÑRADIATION PROTECTION; ÑRADIOMETRY LH LS LX; ;  MSThose actions designed to carry out recommendations pertaining to health plans or programs. HN(80) MHÑHealth Plan Implementation ANonly /econ /hist /legis /stand /trends; specify geog PIHealth Planning (68-79) MNN3.349.300 DMÑHealth Planning LH LM  MSPlanning for needed health and/or welfare services and facilities. OLuse HEALTH PLANNING to search HEALTH AND WELFARE PLANNING back thru 1968 PM79; was HEALTH AND WELFARE PLANNING 1968-78 HN79; was HEALTH AND WELFARE PLANNING 1968-78 MHÑHealth Planning ANonly /econ /hist /legis /organ /stand /trends; Public Law 91-515; see NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 for Public Law 93-641; specify geog & add UNITED STATES (NIM) for STATE HEALTH PLANNING, UNITED STATES CATALOG: /geog /form PISocial Medicine (66-67); Social Welfare (66-67) MNN3.349 XSHealth and Welfare Planning; Planning, Health and Welfare; State Health Planning, United States FXÑPUBLIC HEALTH; ÑPlanning Technics; ÑPublic Health XUÑHealth Plan Implementation; ÑHealth Planning Guidelines; ÑHealth Planning Technical Assistance; ÑHealth Priorities LH LS; ; LX; ; LU; ; ;  MSOrganized groups serving in advisory capacities related to health planning activities. HN(80) MHÑHealth Planning Councils ANonly /class /econ /hist /legis /organ /stand /trends /util; Public Law 93-641; specify geog PIHealth Planning (68-79) MNN3.540.452.210 XSNational Council on Health Planning and Development; Statewide Health Coordinating Councils DMÑHealth Planning Organizations LH LS; LM  MSRecommendations for directing health planning functions and policies. May be mandated by PL93-641 and issued by the Department of Health, Education and Welfare for use by state and local planning agencies. HN(80) MHÑHealth Planning Guidelines ANno qualif PIHealth Planning (68-79) MNN3.349.315 XSGuidelines for Health Planning DMÑHealth Planning LH LS LM  MSOrganizations involved in all aspects of health planning activities. PM80; STATE HEALTH PLANNING AGENCIES, UNITED STATES (now see STATE HEALTH PLANNING AND DEVELOPMENT AGENCIES, an XU below) was see HEALTH SYSTEMS AGENCIES 1979 HN80 MHÑHealth Planning Organizations ANonly /class /econ /hist /legis /organ /stand /trends /util; specify geog CATALOG: /geog /form MNN3.540.452 XSCenters for Health Planning XUÑHealth Care Coalitions; ÑHealth Planning Councils; ÑState Health Planning and Development Agencies LH LS LU; ;  MSFinancial resources provided for activities related to health planning and development. PM80 HN80 MHÑHealth Planning Support ANonly /class /econ /legis /trends /util CATALOG: /geog /form PIFinancing, Government (68-79); Health Planning (68-79) MNN3.219.483.408 XSGrants and Subsidies, Health Planning; Subsidies, Health Planning LH LS;  MSThe provision of expert assistance in developing health planning programs, plans as technical materials, etc., as requested by Health Systems Agencies or other health planning organizations. HN(80) MHÑHealth Planning Technical Assistance ANonly /econ /hist /legis /stand /trends MNN3.349.325 XSTechnical Assistance for Health Planning DMÑHealth Planning LH LS LM  MSDecisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system. PM80 HN80 MHÑHealth Policy ANonly /econ /hist /legis /trends; specify state or country or other body if pertinent CATALOG: /geog /form PINational Health Programs (77-79); Public Policy (78-79) MNI1.880.604.710.608.400; N3.706.710.608.428 XSNational Health Policy FXÑPolicy Making LH LS LX  MSPreferentially rated health-related activities or functions to be used in establishing health planning goals; may refer specifically to PL93-641. HN(80) MHÑHealth Priorities ANonly /econ /hist /legis /trends MNN3.349.330 XSPriorities, Health DMÑHealth Planning LH LS LM  MSEncouraging consumer behaviors most likely to optimize health potentials (physical and psychosocial) through health information, preventive programs, and access to medical care. PM80 HN80 MHÑHealth Promotion ANonly /econ /educ /hist /legis /methods /organ /trends /util CATALOG: /geog /form MNN2.370 XSPromotion of Health; Wellness Programs LH LS;  MHÑHealth Resorts ANonly /class /econ /hist /stand /trends; sanatoria & sanitaria (often used interchangeably) can go here but consider also HOSPITALS, SPECIAL CATALOG: /geog /form MNG3.850.860.410.250 XSRESORTS FXÑBalneology LH LS LX  MSAvailable manpower, facilities, revenue, equipment and supplies to produce requisite health care and services. PM78 HN78 MHÑHealth Resources ANonly /class /econ /legis /stand /supply /trends /util; specify geog CATALOG: /geog /form MNN3.349.340 LH  MSUse for general articles concerning health services. PM74 HN74 MHÑHealth Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util (if by MeSH definition) CATALOG: /geog /form MNN2.421 XUÑHealth Services Misuse LH LU  MSThe physical or economic availability of health services to individuals or groups. PM78 HN78 MHÑHealth Services Accessibility ANonly /econ /legis /stand /trends; specify geog CATALOG: /geog /form PIDelivery of Health Care (71-77); Health Services (74-77) MNN4.590.374.200 XSAccessibility of Health Services; Availability of Health Services FXÑMedically Underserved Area LH LS; LX  MH*Health Services Administration (Non Mesh) MNN4 LH  MSUse for general articles discussing health services which pertain to the elderly. PM80 HN80 MHÑHealth Services for the Aged ANonly /class /econ /hist /legis /man /organ /supply /trends /util (if by MeSH definition); coord IM with specific serv (IM or NIM) if pertinent CATALOG: /geog /form PIAged (66-79); Health Services (74-79); specific health service MNN2.421.320 XSGeriatric Health Services FXÑAged LH LS LX  MSExcessive or unnecessary utilization of health services by patients or physicians. HN(Aug 77) MHÑHealth Services Misuse ANmisuse, overuse or abuse by patient or physician; only /econ /legis /trends MNN2.421.380 XSAbuse of Health Services; Misuse of Health Services; Overutilization of Health Services DMÑHealth Services LH LS; ; LM  MSHealth services required by a population or community; also health services that the population or community is able and willing to pay for. Includes the identification and assessment of the needs as measured by objective criteria and standards. HN(Aug 77); was see under HEALTH PLANNING 1979, was see under HEALTH AND WELFARE PLANNING Aug 77-78 MHÑHealth Services Needs and Demand ANonly /econ /legis /trends; specify geog; DF: HEALTH SERVICES NEEDS MNN3.349.380.420 XSAssessment of Health Care Needs; Determination of Health Care Needs DMÑHealth Services Research LH LS; LM  MSResearch concerned with the organization, administration, needs, and functioning of health services rather than with health services dealing with physiology or medicine. Excludes biomedical research. PM80; HEALTH SERVICES NEEDS AND DEMAND was see under HEALTH PLANNING 1979, was see under HEALTH AND WELFARE PLANNING 1978 HN80 MHÑHealth Services Research ANonly /econ /hist /legis /man /methods /organ /stand /trends /util CATALOG: /geog /form PIHealth Services (74-79); Research (66-79) MNN3.349.380 XSHealth Care Research; Medical Care Research; Research, Health Services XUÑHealth Services Needs and Demand LH LS; ; LU  MSHealth care provided to specific cultural or tribal peoples which incorporates local customs, beliefs, and taboos. PM81; was see under HEALTH SERVICES 1977-80 HN81(Aug 77); was see under HEALTH SERVICES Aug 1977-80 MHÑHealth Services, Indigenous AN╥health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs & taboos╙; only /class /econ /hist /legis /man /organ /stand /supply /trends /util (if by MeSH definition); specify ethnic group (IM) + geog CATALOG: /geog /form MNN2.421.330 FXÑMedicine, Traditional LH LX  MSThe level of health of the individual, group or population as subjectively assessed by the individual or by more objective measures. OLsearch HEALTH 1979 HN(80); was see HEALTH 1979 MHÑHealth Status ANno qualif PIHealth (66-79); Health Status Indicators (75-79); Health Surveys (66-79) MNN1.407.540.280 XSLevel of Health DMÑHealth LH LS LM  MSThe measurement of the health status for a given population using a variety of indices, including morbidity, mortality and available health resources. HN(75) MHÑHealth Status Indicators ANno qualif MNG3.850.520.610.520; N1.224.458.470 XSHealth Risk Appraisal; Health Status Index DMÑHealth Surveys LH LS; LM  MSA systematic collection of factual data pertaining to health and disease in a human population within a given geographic area. OLuse HEALTH SURVEYS to search SANITARY SURVEYS 1966 PMSANITARY SURVEYS was heading 1963-66 HNSANITARY SURVEYS was heading 1963-66 MHÑHealth Surveys ANno qualif; TN 97: misuse of ╥surveys╙ CATALOG: /geog /form MNG3.850.520.610; N1.224.458 FXÑData Collection; ÑSampling Studies XUÑHealth Status Indicators LH LX; LU  MSHealth planning and resources development agencies which function in each health service area of the United States (PL 93-641). PM78 HN78 MHÑHealth Systems Agencies ANdo not use /educ /methods; Public Law 93-641; specify geog & add UNITED STATES (NIM) for STATE HEALTH PLANNING AND DEVELOPMENT AGENCIES PIHealth Planning (68-77) MNN3.540.452.508.440 XSComprehensive Health Planning Agencies LH LS  MSStatements of goals for the delivery of health services pertaining to the Health Systems Agency service area, established under PL 93-641, and consistent with national guidelines for health planning. HN(80); was see under State Health Plans 1980 MHÑHealth Systems Plans ANonly /econ /hist /legis /organ /stand /trends /util; Public Law 93-641; specify geog & add UNITED STATES also MNN3.349.650.270 XSComprehensive Health Plans, Local DMÑRegional Health Planning LH LS LM  MSThe sensation of sound. MHÑHearing ANonly /drug eff /physiol /rad eff; differentiate from AUDITORY PERCEPTION: aud percept takes place in the brain, hearing takes place in the ear: TN 98; PSYCHOACOUSTICS is also available; Amer Speech & Hear Assoc: index under AUDIOLOGY (IM) + SPEECH PATHOLOGY (IM) + SOCIETIES (IM) + UNITED STATES (NIM) CATALOG: form qualif = AUDIOLOGY /form MNF2.830.816.263; G11.561.796.263 FXÑAcoustic Stimulation; ÑAuditory Perception; ÑBone Conduction LH LX; ;  MHÑHearing Aids ANdo not use /instrum /man /methods /mortal /nurs /util (except by MeSH definition); ╥hearing aid╙ is correct transl for ╥prothese auditive╙, not ╥auditory prosthesis╙ unless you mean COCHLEAR IMPLANT MNE7.814.458 XSEar Molds FXÑDeafness LH LS LX  MHÑHearing Disorders ANGEN & unspecified; consider also DEAFNESS (see note there) & HEARING LOSS, PARTIAL (see note there) & their indentions CATALOG: form qualif = AUDIOLOGY /form MNC9.218.458; C10.597.257.443; C23.888.592.257.443 LH  MSPartial hearing loss in both ears. HN(79) MHÑHearing Loss, Bilateral AN= ╥partial hearing loss in both ears╙: differentiate from DEAFNESS, total hearing loss in both ears PIDeafness (66-78) MNC9.218.458.500.403 DMÑHearing Loss, Partial LH LM  MSHearing loss due to central nervous system disease, anywhere in the auditory pathways from the cochlear nucleus of the pons to the auditory cortex. HN(79) MHÑHearing Loss, Central ANhearing loss caused by brain dis PIDeafness (66-78) MNC9.218.458.500.481.432; C9.218.807.186.432; C10.228.140.68.432 DMÑHearing Loss, Sensorineural LH LM  MSHearing loss due to interference with the acoustic transmission of sound to the cochlea. The interference is in the outer or middle ear. HN(79) MHÑHearing Loss, Conductive ANnote X ref PIDeafness (66-78) MNC9.218.458.500.437 XSDeafness, Conductive DMÑHearing Loss, Partial LH LS LM  MSHearing loss without a physical basis. Often the result of malingering or hysteria. Also called psychogenic hearing loss. HN(79) MHÑHearing Loss, Functional PIDeafness (66-78) MNC9.218.458.500.442; F3.126.420 XSHearing Loss, Nonorganic DMÑHearing Loss, Partial LH LS LM  MSHearing loss in frequencies above 1000 hertz. HN(79) MHÑHearing Loss, High-Frequency PIDeafness (66-78) MNC9.218.458.500.448 DMÑHearing Loss, Partial LH LM  MSHearing loss from exposure to noise. The loss is often in the frequency range 4000-6000 hertz. OLuse HEARING LOSS, NOISE-INDUCED to search ACOUSTIC TRAUMA back thru 1966 PM79; was ACOUSTIC TRAUMA 1963-78 HN79; was ACOUSTIC TRAUMA 1963-78 MHÑHearing Loss, Noise-Induced ANdoes not = NOISE /adv eff: consider this an alternate PIAcoustic Trauma (64-78); Deafness (64-78); Noise (64-78) MNC9.218.458.500.481.460 XSAcoustic Trauma FXÑNoise LH LS LX  MSA condition in which the sense of hearing, although defective, is functional with or without a hearing aid. The hearing level for speech is approximately 40-70 decibels I.S.O. (International Organization for Standardization) or 30-60 db A.S.A. (American Standards Association). Syn: hard of hearing. PM79 HN79 MHÑHearing Loss, Partial AN╥hard of hearing╙ & ╥partial deafness╙; defective hearing in one ear: differentiate from HEARING LOSS, BILATERAL (╥partial hearing loss in both ears╙) PIDeafness (66-78); Hearing Disorders (66-78) MNC9.218.458.500; C10.597.257.443.439; C23.888.592.257.443.439 XSDeafness, Partial XUÑHearing Loss, Bilateral; ÑHearing Loss, Conductive; ÑHearing Loss, Functional; ÑHearing Loss, High-Frequency LH LS LU; ; ;  MSHearing loss resulting from damage to the sensory mechanism internal from the oval and round windows. PM79; PRESBYCUSIS was see under DEAFNESS 1975-78 HN79 MHÑHearing Loss, Sensorineural ANpartial loss; differentiate from DEAFNESS, SENSORINEURAL, total loss PIDeafness (66-78) MNC9.218.458.500.481 XUÑHearing Loss, Central; ÑPresbycusis LH LU;  MHÑHearing Tests ANNIM; only /instrum /methods /stand MNE1.276.299.375 XUÑDichotic Listening Tests LH LU  MSThe hollow, muscular organ that maintains the circulation of the blood. MHÑHeart ANheart as pump, not tissue (MYOCARDIUM); only /anat /drug eff /embryol (FETAL HEART also exists) /growth /innerv (HEART CONDUCTION SYSTEM also exists) /microbiol /parasitol /physiol (see also MYOCARDIAL CONTRACTION & G9.330.612.280 & below) /physiopathol /rad eff /radiogr /radionuclide /transpl; /abnorm = HEART DEFECTS, CONGENITAL; /blood supply = CORONARY VESSELS & consider also CORONARY CIRCULATION; /drug eff: consider also MYOCARDIAL DEPRESSANTS see ANTI-ARRHYTHMIA AGENTS & CARDIOTONIC AGENTS; /inj = HEART INJURIES; /radiogr permitted: do not confuse with ANGIOCARDIOGRAPHY; /surg = HEART SURGERY; /transpl: do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; hypertrophy = HEART ENLARGEMENT; inotropism: INOTROPISM, CARDIAC see MYOCARDIAL CONTRACTION & INOTROPIC AGENTS, POSITIVE CARDIAC are available but see MYOCARDIAL CONTRACTION note, chronotropism: see HEART RATE note; DIASTOLE & SYSTOLE are available; heart-lung prep: index HEART /physiol (probably NIM); Manual 21.48+; carditis = MYOCARDITIS; mural thrombosis: index HEART DIS (IM) + THROMBOSIS (IM); consider terms under CARDI- & MYOCARD- CATALOG: form qualif = CARDIOLOGY /form MNA7.541 FXÑAngiocardiography; ÑBallistocardiography; ÑElectrocardiography LH LX; ;  MHÑHeart Aneurysm ANof myocardium only; CORONARY ANEURYSM is available MNC14.280.358; C14.907.55.608 LH  MHÑHeart Arrest MNC14.280.383 XSCARDIAC ARREST; Cardiopulmonary Arrest LH LS;  MHÑHeart Arrest, Induced ANnote category: a technic, not a disease; do not use /util except by MeSH definition; do not coord with HYPOTHERMIA, INDUCED unless this is particularly discussed; index solutions used to induce arrest without qualif MNE4.752.376.374; E4.920.490.460 XSCardiac Arrest, Induced; Cardioplegia LH LS;  MSThe upper right and left chambers of the heart. PM68 HN68(66) MHÑHeart Atrium ANNIM: Manual 21.51; do not use /blood supply MNA7.541.358 LH  MSAct of listening for sounds within the heart. MHÑHeart Auscultation ANconsider also PHONOCARDIOGRAPHY; do not use /util except by MeSH definition; /instrum: stethoscope goes here or under AUSCULTATION /instrum if not heart MNE1.145.569.499; E1.706.110.458 XUÑHeart Murmurs; ÑHeart Sounds LH LU;  MHÑHeart Block MNC14.280.67.558 XSAtrioventricular Block; Auriculo-Ventricular Dissociation XUÑSinoatrial Block LH LS; LU  MSTechnic of introducing a catheter into the cardiac chambers and great vessels by way of a vein or artery or direct needle puncture. MHÑHeart Catheterization ANdo not use /util except by MeSH definition MNE1.145.569.540 XSCATHETERIZATION, HEART FXÑPulmonary Wedge Pressure LH LS LX  MSAn impulse-conducting system composed of modified cardiac muscle and having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. MHÑHeart Conduction System ANdo not use /blood supply /innerv; disord = ARRHYTHMIA or HEART BLOCK & their specifics MNA7.541.409 XSBundle of Kent FXÑArrhythmia XUÑAtrioventricular Node; ÑBundle of His; ÑPurkinje Fibers LH LS LX LU; ;  MSImperfections or malformations of the heart, existing at birth. PMDEXTROCARDIA was heading 1963-83 MHÑHeart Defects, Congenital ANGEN only; do not use as coord for specific term /abnorm; ╥congenital cardiovascular defects╙ goes here; do not use /congen; cyanotic defects probably go here but do not also index under CYANOSIS unless especially discussed MNC14.280.400; C16.131.457 XSEctopia Cordis; HEART ABNORMALITIES XUÑAortopulmonary Septal Defect; ÑCrisscross Heart; ÑDextrocardia; ÑLevocardia LH LS; LU; ; ;  MHÑHeart Diseases ANusually dis of function: differentiate from MYOCARDIAL DISEASES, dis of myocardial tissue (see note there); /congen = HEART DEFECTS, CONGENITAL; cyanotic heart dis is probably HEART DEFECTS, CONGENITAL & not CYANOSIS unless especially discussed; parasitic dis of the heart: coord PARASITIC DISEASES or specific parasitic dis (IM) with MYOCARDIAL DISEASES (IM), not HEART DISEASES; heart dis, unspecified or specific, with rheumatic fever is probably RHEUMATIC HEART DISEASE: see note there CATALOG: form qualif = CARDIOLOGY /form MNC14.280 FXÑCardiology; ÑNEUROCIRCULATORY ASTHENIA XUÑPostpericardiotomy Syndrome LH LX; LU  MHÑHeart Enlargement AN= ╥heart hypertrophy╙; for ventric hypertrophy do not coord with HEART VENTRICLE MNC14.280.409 LH  MHÑHeart Failure, Congestive ANincludes ╥heart decompensation╙ (scompenso di cuore); do not confuse with CARDIOMYOPATHY, CONGESTIVE MNC14.280.434 XUÑEdema, Cardiac LH LU  MHÑHeart Function Tests ANonly /instrum /methods /vet MNE1.145.569 LH  MHÑHeart Injuries ANcoord IM with specific part of heart /inj (NIM) MNC21.866.473; C21.866.891.375 XSCardiac Rupture, Traumatic; Heart Rupture, Traumatic LH LS;  MHÑHeart Massage ANdo not use /util except by MeSH definition MNE2.365.647.375; E4.752.376.458; E4.920.490.490 LH  OLsearch HEART AUSCULTATION 1972-74 HN(75) MHÑHeart Murmurs ANcoord with specific heart valve disease (IM); consider also PHONOCARDIOGRAPHY; TN 13; stethoscope: index under HEART AUSCULTATION /instrum MNE1.145.569.499.376.459 DMÑHeart Auscultation LH LM  MHÑHeart Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific site in heart (NIM) + histol type of neopl (IM) MNC4.588.894.309; C14.280.459 LH  PM66 HN66(64) MHÑHeart Rate ANonly /drug eff /rad eff; TN 99: relation to ╥bradycardia╙ & ╥tachycardia╙; policy: Manual 23.38; chronotropic action of drugs = HEART RATE /drug eff (IM) + drug with /pharm (IM) + STIMULATION, CHEMICAL (NIM) for positive chronotropic action & DEPRESSION, CHEMICAL (NIM) for negative; for inotropic action see note on MYOCARDIAL CONTRACTION MNG9.330.612.509 LH  PM87 HN87 MHÑHeart Rate, Fetal ANmammals only; only /drug eff /rad eff PIFetal Heart (66-86); Heart Rate (66-86) MNG9.330.612.509.430 XSFetal Heart Rate LH LS  MSLaceration or tearing of the walls of the heart, of the interatrial or interventricular septum, of the papillary muscles or chordae tendineae, or of any of the valves of the heart. Rupture may be due to a variety of pathological entities; however, the majority are secondary to myocardial infarction. PM78 HN78 MHÑHeart Rupture ANrupt of any part of heart; coord IM with specific part (IM) if pertinent; usually caused by myocard infarct; traumatic rupt = HEART INJURIES PIHeart Diseases (66-77); Myocardial Infarction (66-77); Rupture, Spontaneous (66-77) MNC14.280.470 XSCardiac Rupture XUÑHeart Rupture, Post-Infarction LH LS LU  MSRupture of the heart after myocardial infarction. HN(87) MHÑHeart Rupture, Post-Infarction ANdo not coord with MYOCARDIAL INFARCTION unless specifically discussed PIHeart Rupture (78-86); Myocardial Infarction (79-86) MNC14.280.470.475 XSPost-Infarction Heart Rupture DMÑHeart Rupture LH LS LM  MSDefects in the cardiac septa, resulting in abnormal communications between the opposite chambers of the heart. PM64 HN64 MHÑHeart Septal Defects ANnot for all septal abnorm: see Dorland under defect for definition; do not use /congen MNC14.280.400.560; C16.131.457.559 XUÑEndocardial Cushion Defects LH LU  MSDefects in the septum between the atria of the heart, due to failure of fusion between either the septum secundum or the septum primum and the endocardial cushions. PM64; LUTEMBACHER'S SYNDROME was see under HEART DEFECTS, CONGENITAL 1963 HN64 MHÑHeart Septal Defects, Atrial ANnot for all atrial septum abnorm: see Dorland under defect for definition; do not use /congen MNC14.280.400.560.375; C16.131.457.559.376 XSForamen Ovale, Patent XUÑLutembacher's Syndrome; ÑTrilogy of Fallot LH LS LU;  MSCongenital defects in the septum between the cardiac ventricles, most often due to failure of the bulbar septum to completely close the interventricular foramen. PM64 HN64 MHÑHeart Septal Defects, Ventricular ANnot for all ventric septum abnorm: see Dorland under defect for definition; do not use /congen MNC14.280.400.560.540; C16.131.457.559.542 LH  MSThe thin membranous structure between the two heart atria or the thick muscular structure between the two heart ventricles. PMHEART SEPTUM, ATRIAL & HEART SEPTUM, VENTRICULAR were headings 1963 HNHEART SEPTUM, ATRIAL & HEART SEPTUM, VENTRICULAR were headings 1963 MHÑHeart Septum AN/abnorm permitted but consider also HEART SEPTAL DEFECTS & its specifics; do not use /blood supply; heart septal dis: coord IM with MYOCARDIAL DISEASES (NIM) MNA7.541.459 XSForamen Ovale LH LS  OLsearch HEART AUSCULTATION 1966-74 HN(75) MHÑHeart Sounds ANconsider also PHONOCARDIOGRAPHY; stethoscope: index under HEART AUSCULTATION /instrum MNE1.145.569.499.376; G9.330.612.515 DMÑHeart Auscultation LH LM  MSUse for general articles concerning surgical procedures on the heart. HNwas in Cat E & G 1968-79 MHÑHeart Surgery ANGEN only: do not use for surg of specific part of heart ( = specific heart term /surg) or specific heart dis ( = disease /surg); do not use /util except by MeSH definition MNE4.752.376; E4.920.490 LH  OLuse HEART VALVE DISEASES to search AORTIC VALVE DISEASES 1966 PM67; AORTIC VALVE DISEASES was heading 1963-66 HN67; AORTIC VALVE DISEASES was heading 1963-66 MHÑHeart Valve Diseases ANIM GEN only; coord NIM with specific valve (IM) PIHeart Diseases (66); specific heart valve disease MNC14.280.484 XUÑTricuspid Valve Prolapse LH LU  PM65 HN65 MHÑHeart Valve Prosthesis ANIM + coord with specific valve (NIM); only /adv eff /class /econ /hist /mortal /nurs /psychol /rehabil /stand /supply /util (if by MeSH definition) /vet; for bioprostheses coord IM with BIOPROSTHESIS (IM) & do not specify source of biol material unless especially discussed MNE4.659.459; E4.920.490.520; E7.450.500; E7.858.565.509 LH  MSFlaps of tissue that prevent regurgitation of blood from the ventricles to the atria or from the pulmonary arteries or aorta to the ventricles. MHÑHeart Valves ANGEN; do not use /blood supply MNA7.541.510 LH  MSThe lower right and left chambers of the heart; the right pumping venous blood into the lungs, the left pumping oxygenated blood into the systemic arterial circulation. PM68 HN68(66) MHÑHeart Ventricle ANNIM: Manual 21.51; do not use /blood supply; do not use for ventric hypertrophy: HEART ENLARGEMENT is adequate MNA7.541.560 LH  MSSmall pumps, often implantable, designed for temporarily assisting the heart, usually the left ventricle, to pump blood; they consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors; the devices are used after myocardial infarction or to wean the repaired heart from the heart-lung machine after open-heart surgery. HN(86) MHÑHeart-Assist Devices ANdo not use /instrum /methods /util (except by MeSH definition) PIAssisted Circulation (67-85); Heart, Artificial (67-85); Pacemaker, Artificial (66-85) MNE4.50.430 XSArtificial Ventricle; Heart Ventricle, Artificial; Pumps, Heart-Assist; Vascular-Assist Devices; Ventricle-Assist Device DMÑAssisted Circulation LH LS; ; ; ; LM  PM67 HN67 MHÑHeart, Artificial ANimplanted pump replacing whole or part of heart: do not confuse with HEART, MECHANICAL (external heart-lung machine); do not use /instrum /methods /util (except by MeSH definition) PIArtificial Organs (66); Heart, Mechanical (66) MNE7.450.470; E7.858.82.374; E7.858.565.458 LH  MHÑHeart, Mechanical ANexternal heart-lung machine: do not confuse with HEART, ARTIFICIAL (implanted pump replacing whole or part of heart); do not use /instrum /methods /util (except by MeSH definition) MNE7.858.82.458 XSHEART-LUNG MACHINE FXÑCardiopulmonary Bypass; ÑOXYGENATORS LH LS LX;  MSSubsternal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus. Syn: pyrosis. PM64 HN64 MHÑHeartburn MNC23.888.821.525 XSPYROSIS LH LS  MSA tick-borne septicemic disease of ruminants caused by Cowdria ruminantium. PM70 HN70 MHÑHeartwater Disease ANusually animal: do not use /vet but check tag ANIMAL; do not index under RICKETTSIACEAE INFECTIONS PICattle Diseases (66-69); Rickettsial Infections (66-69) MNC1.850.810.440; C22.434 LH  MHÑHeat ANdifferentiate from HEATING (the environment); only /adv eff /diag use /ther use; /ther use: consider also HYPERTHERMIA, INDUCED; thermocoagulation goes under ELECTROCOAGULATION MNG3.230.300.100.725.710.380; H1.671.868.543; H1.671.912.460 FXÑCalorimetry; ÑDesert Climate; ÑTROPICAL CLIMATE; ÑWATER POLLUTION, THERMAL LH LX; ; ;  MHÑHeat Exhaustion ANincludes heatstroke but don't forget SUNSTROKE is available MNC21.866.486 LH  MSProteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. PM84 HN84 MHÑHeat-Shock Proteins AN/biosyn /physiol permitted; do not use /analogs PIHeat (66-83); Proteins (66-83) MND12.776.410 XSStress Proteins FXÑFever LH LS LX  MHÑHeating ANthe environment: differentiate from HEAT, the principle of physics; only /econ /instrum /methods /stand /trends; /adv eff permitted but do not confuse with HEAT /adv eff MNG3.230.150.300 LH  MSA disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the N (amino) terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross links to the light chains. The defect arises through faulty coupling of the variable (V) and constant (C) region genes. PM66 HN66(64) MHÑHeavy Chain Disease ANspecify the immunoglobulin fragment coord NIM, as alpha chain dis = HEAVY CHAIN DISEASE (IM) + IMMUNOGLOBULINS, ALPHA CHAIN (NIM) MNC15.378.147.460; C15.378.147.780.490; C15.604.515.435; C20.683.780.490 XSFranklin's Disease FXÑIMMUNOGLOBULIN FRAGMENTS LH LS LX  MHÑHebrides MNZ1.542.363.423 LH  PM72 HN72 MHÑHedgehogs ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIInsectivora (66-71) MNB2.649.473.376 LH  MHÑHeel ANprimates only MNA1.378.592.350.377 FXÑAchilles Tendon; ÑCalcaneus; ÑTALUS LH LX; ;  PM68 HN68(63) MHÑHeinz Bodies ANA 11 qualif except /cytol MNA11.118.413.330.340.335; A15.145.229.413.330.340.335 LH  PM68 HN68(65) MHÑHela Cells ANalmost never IM; no qualif when NIM, A 11 qualif when IM; check HUMAN but do not check FEMALE & do not add CERVIX NEOPLASMS MNA11.251.210.460; A11.251.353.460 LH  MSA genus of tall, erect American herbs of the Compositae; the seeds yield oil and are used as food and animal feed; the roots of Helianthus tuberosum (Jerusalem artichoke) are edible. MHÑHelianthus ANdo not use /isol /pathogen; for sunflower seeds coord IM with SEEDS (IM); do not confuse X ref JERUSALEM ARTICHOKE with plain artichoke (index probably VEGETABLES) MNB6.510.500 XSJerusalem Artichoke; Sunflower LH LS;  MSA superfamily of parasitic nematodes which were formerly considered a part of Trichostrongyloidea. It includes the following genera: Heligmosomum, Nematospiroides, and NIPPOSTRONGYLUS. The hosts are rodents. PM86 HN86 MHÑHeligmosomatoidea ANa superfamily of nematodes; do not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.550 XUÑNematospiroides dubius LH LU  OLsearch SUNLIGHT 1966-74 HN(75); was see under PHYSICAL THERAPY 1975-85, was see under SUNLIGHT 1963-74 MHÑHeliotherapy ANdo not use /util except by MeSH definition MNE2.780.750.430 XSSunbathing DMÑPhototherapy LH LS LM  MHÑHelium ANHe-4; do not use /analogs /biosyn /defic /physiol; He-3 = HELIUM (IM) + ISOTOPES (NIM); He-5, 6, 8 = HELIUM (IM) + RADIOISOTOPES (IM) RN7440-59-7 MND1.268.378; D1.362.641.352 LH  MSA genus of chiefly Eurasian and African land snails including the principal edible snails as well as several pests of cultivated plants. PM78; was see under SNAILS 1975-77 HN78(75); was see under SNAILS 1975-77 MHÑHelix (Snails) AN/microbiol /parasitol permitted; DF: HELIX PISnails (66-74) MNB1.644.776.450 LH  MHÑHelminthiasis ANGEN; /drug ther: consider also ANTHELMINTICS MNC3.335 XUÑNematomorpha Infections LH LU  OLexper or vet; consider also HELMINTHIASIS /VE & /VE with specific helminth infect MH*Helminthiasis, Animal (Non Mesh) MNC22.674.377 LH  MSA deuteromycetous fungal genus including both saprophytes and plant parasites. HN(75); was see under MONILIALES 1975-85 MHÑHelminthosporium ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.420 DMÑHyphomycetes LH LM  OLuse HELMINTHS to search ASCHELMINTHES back thru 1976 PMASCHELMINTHES was heading 1976-85 HNASCHELMINTHES was heading 1976-85 MHÑHelminths ANGEN; prefer specifics; do not use /blood-csf-urine; infection = HELMINTHIASIS MNB1.500 XSAschelminthes; Gordius; Nematomorpha LH LS; ;  MSSubpopulations of T lymphocytes which cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper T cells cooperate with B cells to produce antibody to thymus-dependent antigens and with other subpopulations of T cells to initiate a variety of cell-mediated immune functions. OLsearch T LYMPHOCYTES 1979-82 & LYMPHOCYTE COOPERATION 1978 PM83; was see T-LYMPHOCYTES 1979-82, was see LYMPHOCYTE COOPERATION 1978 HN83; was see T-LYMPHOCYTES 1979-82, was see LYMPHOCYTE COOPERATION 1978 MHÑHelper Cells ANA 11 qualif & /class PIAntibody Formation (72-73); T Lymphocytes (73-82) MNA11.118.637.555.604.800.370; A15.145.229.637.555.604.370; A15.382.490.520.604.800.370; A15.382.520.520.604.800.370 XSInducer Cells; T Lymphocytes, Helper; T Lymphocytes, Inducer FXÑInterleukin 2; ÑLymphocyte Cooperation LH LS; ; LX;  MSViruses which enable defective viruses to replicate or to form a protein coat by complementing the missing gene function of the defective (satellite) virus. Helper and satellite may be of the same or different genus. OLuse HELPER VIRUSES to search HELPER VIRUS back thru 1967 (as Prov 1967-72) PM75; was HELPER VIRUS 1973-74 HN75; was HELPER VIRUS 1967-74 (Prov 1967-72) MHÑHelper Viruses ANdo not use /cytol PIspecific virus MNB4.423 LH  MSBehaviors associated with the giving of assistance or aid to individuals. PM79; was see under SOCIAL BEHAVIOR 1975-78 HN79(75); was see under SOCIAL BEHAVIOR 1975-78 MHÑHelping Behavior ANno qualif PIInterpersonal Relations (69-74); Social Behavior (69-74); specific interpersonal relations heading MNF1.145.813.225; F1.829.759.225 LH  MSA psychological response to adverse situations from which there appears to be no escape or to tasks and problems which appear to have no solution. PM83 HN83 MHÑHelplessness, Learned ANonly /psychol MNF3.126.430 XSLearned Helplessness LH LS  OLsearch ETHICS, MEDICAL 1969-74 HN(75) MHÑHelsinki Declaration ANonly /hist MNK1.316.333.366.377; K1.752.667.416.377 DMÑEthics, Medical LH LM  MSThe adherence of red cells to other cells, such as virus- or mycoplasm-infected cells, or to substances such as tuberculin. PM72 HN72(70) MHÑHemadsorption ANonly /drug eff /rad eff; do not confuse with HEMOSORPTION see HEMOPERFUSION; mixed hemadsorption assay goes here PIHemagglutination (66-69) MNG4.185.515.423 LH  PM73 HN73(63) MHÑHemadsorption Inhibition Tests ANNIM; only /instrum /methods /vet MNE1.223.495.826.360 LH  MHÑHemagglutination ANonly /drug eff /rad eff; intravascular hemagglutination = ERYTHROCYTE AGGREGATION, INTRAVASCULAR MNG4.610.143.100.200 LH  MSSerologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. MHÑHemagglutination Inhibition Tests ANNIM; only /instrum /methods /vet MNE1.223.495.826.411 LH  PM66 HN66 MHÑHemagglutination Tests ANNIM; only /instrum /methods /vet MNE1.223.495.826.461 LH  MSAgglutination of erythrocytes by a virus. PM70 HN70 MHÑHemagglutination, Viral ANonly /drug eff /rad eff PIHemagglutination (66-69) MNG4.185.515.459 LH  MSAgents that cause agglutination of red blood cells; includes antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral or parasitic blood agglutinins, etc. OLsearch ANTIBODIES 1966-74 PM81; was see under AGGLUTININS 1975-80, was indexed under ANTIBODIES 1963-74. HN81(75); was see under AGGLUTININS 1975-80, was see under ANTIBODIES 1968-74, was see ANTIBODIES 1963-67 MHÑHemagglutinins ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine; restrict to erythrocytes: leukoagglutinins are indexed under AGGLUTININS (IM) + LEUKOCYTES or specific with /immunol (IM) PIAntibodies (66-74) MND24.611.125.44.377 LH  PM72; was see under ANTIGENS 1968-71 HN72(67); was see under ANTIGENS 1968-71 MHÑHemagglutinins, Viral ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIAntigens (66) MND24.611.216.327.461; D24.611.125.44.377.416 LH  MHÑHemangioendothelioma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.439 LH  MHÑHemangioma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); De Morgan spot goes here MNC4.557.690.477 XSAngioma FXÑArteriovenous Malformations LH LS LX  MHÑHemangioma, Cavernous AN= cavernous angioma; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.477.461 LH  MHÑHemangiopericytoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.515 LH  MSMalignant tumor formed by proliferation of endothelial and fibroblastic tissue. OLuse HEMANGIOSARCOMA to search ANGIOSARCOMA back thru 1966 PM86; was ANGIOSARCOMA 1963-85 HN86; was ANGIOSARCOMA 1963-85 MHÑHemangiosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.525; C4.557.863.402 XSAngiosarcoma LH LS  MSBleeding into the joints which arises either from trauma or spontaneously in patients with hemophilia. PM67 HN67(64) MHÑHemarthrosis MNC5.550.459; C23.542.321 FXÑHemophilia LH LX  MSVomiting of blood. MHÑHematemesis MNC6.405.348.336; C6.405.937.378; C23.542.516.336 LH  MSAgents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes; used in the treatment of anemias. PM75 HN75 MHÑHematinics ANdo not use /analogs /biosyn /defic /physiol PIAnemia/DT (66-74) MND19.461.543 XSHematopoietic Agents LH LS  MHÑHematocele MNC12.294.287; C23.542.349 LH  MSCollection of blood usually menstrual in the vagina. PM79 HN79 MHÑHematocolpos AN╥collection of blood (usually menstrual) in the vagina╙ PIVagina/AB (66-78); Vaginal Diseases (66-78) MNC13.371.320.480; C13.371.894.300 LH  MHÑHematocrit ANNIM; only /instrum /methods /vet MNE1.223.459.481 XSErythrocyte Volume, Packed LH LS  OLconsider also BLOOD COAGULATION /DE MH*Hematologic Agents (Non Mesh) MND19.461 LH  PM65; was BLOOD DISEASES see under HEMATOLOGY 1963-64 HN65; was BLOOD DISEASES see under HEMATOLOGY 1963-64 MHÑHematologic Diseases ANGEN CATALOG: form qualif = HEMATOLOGY /form MNC15.378 XSBlood Diseases FXÑHematology LH LS LX  MSTests used in hematologic diagnosis. PM78 HN78; was NON MESH before 1978 MHÑHematologic Tests ANGEN: prefer specifics; does not include BLOOD CHEMICAL ANALYSIS or SERODIAGNOSIS; NIM; do not use /util except by MeSH definition PIHematology (66-77) MNE1.223.459 XSBlood Tests LH LS  MH*Hematologic, Gastric, Renal Agents (Non Mesh) MND19 LH  MSA subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood forming tissues. MHÑHematology ANSPEC:SPEC qualif; immunohematology is indexed under BLOOD GROUPS CATALOG: use with form qualif instead of BLOOD /form or HEMATOLOGIC DISEASES /form MNG2.403.776.409.543 FXÑHEMATOLOGIC DISEASES LH LX  MHÑHematoma ANIM; not a neoplasm: coord with organ /dis or organ /hemorrhage term (IM) MNC23.542.376 LH  MHÑHematoma, Epidural MNC10.228.140.300.420.336; C14.907.253.420.336; C23.542.115.336 LH  MHÑHematoma, Subdural MNC10.228.140.300.420.462; C14.907.253.420.462; C23.542.115.462 LH  MSCollection of blood in the uterine cavity. PM79; was see under UTERINE DISEASES 1975-78 HN79(75); was see under UTERINE DISEASES 1975-78 MHÑHematometra AN╥collection of blood in the uterine cavity╙; do not confuse with UTERINE HEMORRHAGE PIUterine Diseases (66-74) MNC13.371.320.500 LH  MHÑHematopoiesis ANonly /drug eff /rad eff; ERYTHROPOIESIS is available; leukopoiesis: coord IM with LEUKOCYTES (IM) MNG9.188.544 FXÑBlood LH LX  MSThe formation and development of blood cells outside the bone marrow, as in the spleen, liver, or lymph nodes. PM87 HN87 MHÑHematopoiesis, Extramedullary ANonly /drug eff /rad eff; for splenic, hepatic or lymphatic hematopoiesis do not coord with SPLEEN/physiol, LIVER/physiol or LYMPH NODES/physiol unless particularly discussed & then probably NIM PIHematopoiesis (66-86); Hematopoietic Stem Cells (71-86) MNG9.188.544.463 LH  MSProgenitor cells from which all blood cells derive. PM72 HN72(71) MHÑHematopoietic Stem Cells ANA 11 qualif PIBone Marrow/CY (66-70) MNA11.148.378; A11.872.378; A15.378.316.378 XSColony-Forming Units, Hematopoietic; Stem Cells, Hematopoietic FXÑColony-Forming Units Assay LH LS; LX  MHÑHematopoietic System AN/physiol: consider also HEMATOPOIESIS MNA15.378 LH  MSPhotochemotherapy using visible light, usually red, topically or delivered locally by fiberoptic probe to tissues sensitized with hematoporphyrins. HN(86) MHÑHematoporphyrin Photoradiation ANIM; coord with disease /drug ther (IM), not /radiother PIHematoporphyrins (80-85); Photochemotherapy (78-85); Phototherapy (81-85) MNE2.780.740.435 XSPhotochemotherapy, Hematoporphyrin; Photoradiation, Hematoporphyrin DMÑPhotochemotherapy LH LS; LM  MSIron-free derivatives of heme with 4 methyl groups, 2 hydroxyethyl groups and 2 propionic acid groups attached to the pyrrole rings. OLuse HEMATOPORPHYRINS to search HEMATOPORPHYRIN back thru 1966 (as Prov 1966-73) PM80; was HEMATOPORPHYRIN 1974-79 HN80; was HEMATOPORPHYRIN 1965-79 (Prov 1965-73) MHÑHematoporphyrins ANdo not use /analogs /blood MND11.557.727.462 LH  MS7,11b-Dihydrobenz(b)indeno(1,2-d)pyran-3,4,6a,9,10(6H)-pentol. A dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain im microscopy and in the manufacture of ink. Synonyms: Black 1; CI Natural Black 1; C.I. 75290; Haematoxylin; Haematoxylum; Logwood extract; Steam Black. HN(75) MHÑHematoxylin AND25-26 qualif; /analogs NIM only RN517-28-2 PIBenzopyrans (69-74); Indenes (73-74) MND3.438.150.600; D26.408.401 XSHydroxybrazilin DMÑBenzopyrans LH LS LM  MHÑHematuria MNC12.777.295; C23.542.404 FXÑUrine LH LX  MHÑHeme ANdo not use /blood RN14875-96-8 MND11.557.727.640.587 XSFerroprotoporphyrin; Protoheme XUÑHemin LH LS; LU  MSHaem, hydrogen-donor:oxygen oxidoreductase (alpha-methene-oxidizing, hydroxylating). A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. EC 1.14.99.3. HN(80) MHÑHeme Oxygenase ANdo not use /analogs RNEC 1.14.99.3 PIHeme (66-79); Hydroxylases (66-79); Oxygenases (66-79) MND8.586.682.420.410 XSHaem Oxygenase DMÑHydroxylases LH LS LM  PM73 HN73 MHÑHemeproteins ANdo not use /analogs /blood PIBlood Proteins (66-72); Heme (66-72); Proteins (66-72) MND12.776.422 XUÑLeghemoglobin; ÑMethemalbumin; ÑMetmyoglobin LH LU; ;  MHÑHemeralopia MNC11.966.462 XSDAY BLINDNESS LH LS  MSA non-heme iron protein consisting of eight apparently identical subunits each containing 2 iron atoms. It binds one molecule of oxygen per pair of iron atoms and functions as a respiratory protein. HN(75) MHÑHemerythrin AN/biosyn /physiol permitted; /analogs NIM only PICarrier Proteins (73-74); Iron (73-74); Metalloproteins (73-74) MND12.776.157.400; D12.776.556.440 DMÑMetalloproteins LH LM  MHÑHemianopsia MNC10.597.751.941.512; C11.966.512; C23.888.592.763.941.512 LH  MH*Hemic and Immune Systems (Non MeSH) MNA15 LH  MH*Hemic and Lymphatic Diseases (Non Mesh) MNC15 LH  MS2,2'-(p-Biphenyl)-bis-(2-hydroxy-4,4-dimethylmorpholinium). A quaternary ammonium that inhibits the synthesis of acetylcholine; the bromide is used as anticholinergic. PM72 HN72 MHÑHemicholinium 3 ANdo not use /biosyn /defic /physiol RN312-45-8 PIMorpholines (66-71) MND2.92.102.435; D2.675.276.435; D16.653.429 LH  OLsearch HEME 1968-74 HN(75) MHÑHemin ANdo not use /blood RN16009-13-5 MND11.557.727.640.587.462 XSFerriprotoporphyrin; Hematin DMÑHeme LH LS; LM  MSAmputation of a lower limb through the sacroiliac joint. HN(75) MHÑHemipelvectomy ANdo not use /util except by MeSH definition MNE4.557.69.600 DMÑAmputation LH LM  MHÑHemiplegia MNC10.597.622.295; C23.888.592.636.312 XSHEMIPARESIS LH LS  MSA large order of insects comprising the true bug, as bedbugs and cinch bugs, and closely related insects, including aphids. PM75 HN75 MHÑHemiptera ANtrue bugs as BEDBUGS, cinch bugs, APHIDS; /microbiol /parasitol permitted PIInsects (66-74) MNB1.131.617.412 LH  MSHemorrhage in or through the biliary tract. The blood may drain into the intestine or form clots within the biliary tract. Causes include trauma, inflammation, cholelithiasis, vascular disease, or neoplasms. PM80 HN80 MHÑHemobilia ANalso called ╥hematobilia╙ PIBiliary Tract Diseases (66-79); Hemorrhage (66-79); Hemorrhage, Gastrointestinal (66-79); Hepatic Artery (66-79); Liver/IN (66-79) MNC6.130.650; C23.542.425 XSBiliary Tract Hemorrhage; Hemorrhage, Biliary Tract LH LS;  MHÑHemochromatosis MNC18.452.648.618.337 XSDIABETES, BRONZE LH LS  PM68 HN68(64) MHÑHemocyanin ANdo not use /blood RN9013-72-3 MND11.557.482; D12.776.124.337; D12.776.422.412; D12.776.556.462 LH  MSAny blood or formed element especially in invertebrates. HN(77) MHÑHemocytes ANinvertebrates only; A 11 qualif; check tag ANIMAL PIBlood Cells (66-76); Hemolymph (66-76) MNA11.118.480; A15.145.229.480 DMÑBlood Cells LH LM  PM67 HN67 MHÑHemodialysis ANdo not use /util except by MeSH definition; /instrum = KIDNEY, ARTIFICIAL; hemofiltration does not go here: index under BLOOD (IM) + ULTRAFILTRATION (IM) but if performed simultaneously or sequentially with HEMODIALYSIS add it (IM or NIM) PIDialysis (66); Kidney, Artificial (66) MNE2.510; E4.320 XSDIALYSIS, EXTRACORPOREAL; EXTRACORPOREAL DIALYSIS FXÑKIDNEY, ARTIFICIAL; ÑKidney Failure, Acute; ÑKidney Failure, Chronic; ÑKidney, Artificial LH LS; LX; ; ;  MSHospital units in which care is provided the hemodialysis patient; includes hemodialysis centers in hospitals. HN(82) MHÑHemodialysis Units, Hospital ANonly /class /econ /legis /man /organ /stand /trends /util; restrict to hosps: non-hosp = HEMODIALYSIS + AMBULATORY CARE FACILITIES but note HEMODIALYSIS, HOME below PIHemodialysis (74-81); Hospital Units (74-81) MNN2.278.388.200 XSHospital Hemodialysis Units; Renal Dialysis Units, Hospital DMÑHospital Units LH LS; LM  MSLong-term maintenance hemodialysis in the home. PM73 HN73 MHÑHemodialysis, Home ANdo not use /util except by MeSH definition; /instrum permitted if not KIDNEY, ARTIFICIAL PIHemodialysis (66-72); Home Care Services (66-72); Home Nursing (66-72); Kidney, Artificial (66-72); Peritoneal Dialysis (66-72) MNE2.510.462; E4.320.490; N2.421.143.524.337 XSHOME HEMODIALYSIS; Renal Dialysis, Home LH LS;  MSReduction of blood viscosity usually by the addition of cell free solutions. Used clinically l) in states of impaired microcirculation, 2) for replacement of intraoperative blood loss without homologous blood transfusion, and 3) in cardiopulmonary bypass and hypothermia. PM79 HN79 MHÑHemodilution ANdo not use /util except by MeSH definition PIBlood Viscosity (66-78); Blood Volume (66-78); Cardiopulmonary Bypass (72-78); Extracorporeal Circulation (67-78); Plasma Substitutes (66-78) MNE2.514 LH  PM66 HN66(64) MHÑHemodynamics ANIM systemic hemodynamics, NIM regional hemodynamics; only /drug eff /rad eff; as /physiol, not /blood: Manual 19.4.9, 23.39 MNG9.330.612 LH  MSNormal adult human hemoglobin. The globin moiety consists of two alpha and two beta chains. PM79; was see under HEMOGLOBINS 1977-78 HN79(77); was see under HEMOGLOBINS 1977-78 MHÑHemoglobin A ANnormal adult hemoglobin; only /anal /biosyn /csf /class /genet /immunol /isol /metab /physiol /rad eff /urine (coord NIM with HEMOGLOBINURIA (IM)); DF: HBA RN9034-51-9 PIHemoglobins (66-76) MND12.776.124.400.405; D12.776.422.512.380 XUÑHemoglobin A2 LH LU  MSMinor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time. PM82 HN82 MHÑHemoglobin A, Glycosylated ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /physiol /rad eff /urine; DF: HBA GLYCOSYLATED PIHemoglobin A (77-81); Hemoglobins (66-76) MND9.203.408.375; D12.776.124.400.405.440; D12.776.422.512.380.440 XSGlycohemoglobin A; Glycosylated Hemoglobin A; Hb A1c; HbA1; Hemoglobin A(1) LH LS; ; ; ;  MSAn adult hemoglobin component normally present in hemolysates from human erythrocytes in concentrations of about 3%. The hemoglobin is composed of two alpha chains and two delta chains. The percentage of HbA2 varies in some hematologic disorders, but is about double in beta-thalassemia. HN(79) MHÑHemoglobin A2 ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /physiol /rad eff /urine (coord NIM with HEMOGLOBINURIA (IM)); DF: HBA2 RN9034-53-1 PIHemoglobins (66-76); Hemoglobin A (77-78) MND12.776.124.400.405.400; D12.776.422.512.380.400 DMÑHemoglobin A LH LM  MHÑHemoglobin C ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /rad eff /urine (coord IM with HEMOGLOBINURIA (IM)); DF: HBC RN9008-00-8 MND12.776.124.400.463.338; D12.776.422.512.426.338 LH  MSA disease characterized by compensated hemolysis with a normal hemoglobin level or a mild to moderate anemia. There may be intermittent abdominal discomfort, splenomegaly, and slight jaundice. PM72 HN72(66) MHÑHemoglobin C Disease ANdo not use /congen; do not confuse with HEMOGLOBIN SC DISEASE MNC15.378.420.463; C15.378.71.141.150.490 LH  MSAn abnormal hemoglobin resulting from the substitution of lysine for glutamic acid at position 26 of the beta chain of the globin moiety. Occurs most frequently in Southeast Asia and is associated with microcythemia, target cell formation and mild hemolytic anemia. HN(77) MHÑHemoglobin E ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /rad eff /urine (coord IM with HEMOGLOBINURIA (IM)); DF: HBE RN9034-61-1 PIHemoglobins, Abnormal (66-76) MND12.776.124.400.463.375; D12.776.422.512.426.375 DMÑHemoglobins, Abnormal LH LM  HN(73) MHÑHemoglobin H ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /rad eff /urine (coord IM with HEMOGLOBINURIA (IM)); DF: HBH RN9034-79-1 MND12.776.124.400.463.463; D12.776.422.512.426.463 DMÑHemoglobins, Abnormal LH LM  MSA group of abnormal hemoglobins with similar electrophoretic characteristics. They have faster electrophoretic mobility and different amino acid substitutions in either the alpha or beta chains than normal adult hemoglobin. Some of the variants produce hematologic abnormalities, others result in no clinical disorders. HN(77) MHÑHemoglobin J ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /rad eff /urine (coord IM with HEMOGLOBINURIA (IM)); DF: HBJ RN58128-48-6 PIHemoglobins, Abnormal (66-76) MND12.776.124.400.463.480; D12.776.422.512.426.480 DMÑHemoglobins, Abnormal LH LM  MSA group of abnormal hemoglobins in which amino acid substitutions take place in either the alpha or beta chains but near the heme iron. This results in facilitated oxidation of the hemoglobin to yield excess methemoglobin which leads to cyanosis. HN(77) MHÑHemoglobin M ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /rad eff /urine (coord IM with HEMOGLOBINURIA (IM)); DF: HBM RN9083-28-7 PIHemoglobins, Abnormal (66-76) MND12.776.124.400.463.510; D12.776.422.512.426.510 DMÑHemoglobins, Abnormal LH LM  MSOne of the sickle cell disorders characterized by the presence of both hemoglobin S and hemoglobin C. It is similar to, but less severe than sickle cell anemia. HN(84) MHÑHemoglobin SC Disease ANdo not use /congen; do not confuse with HEMOGLOBIN C DISEASE PIAnemia, Sickle Cell (66-83); Hemoglobin C Disease (66-83) MNC15.378.71.141.150.150.440; C15.378.420.155.440 XSSC Disease; Sickle Cell Hemoglobin C Disease DMÑAnemia, Sickle Cell LH LS; LM  MSAn abnormal hemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anemia. OLuse HEMOGLOBIN, SICKLE to search HEMOGLOBIN S 1973-74 (as Prov) PM77 HN77(75); was HEMOGLOBIN S 1973-74 (Prov) MHÑHemoglobin, Sickle ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /rad eff /urine (coord IM with HEMOGLOBINURIA (IM)); hemoglobin S disease = ANEMIA, SICKLE CELL; DF: HBS PIHemoglobins, Abnormal (66-72) MND12.776.124.400.463.588; D12.776.422.512.426.588 XSHemoglobin S LH LS  MSMeasurement of hemoglobin concentration in blood. MHÑHemoglobinometry ANNIM; only /instrum /methods /vet; do not equate with HEMOGLOBINS /anal; note ERYTHROCYTE MEAN CELL HEMOGLOBIN see ERYTHROCYTE INDICES is available MNE1.223.459.528 LH  PM68 HN68 MHÑHemoglobinopathies ANdo not confuse with HEMOGLOBINS, ABNORMAL (D12): use term in the text; coord IM with specific abnormal hemoglobin (IM) but HEMOGLOBIN C DISEASE, THALASSEMIA (hemoglobin H disease) & ANEMIA, SICKLE CELL (hemoglobin S disease) are available MNC15.378.420 LH  OLuse HEMOGLOBINS to search HEMOGLOBIN back thru 1966 PM75; was HEMOGLOBIN 1963-74 HN75; was HEMOGLOBIN 1963-74 MHÑHemoglobins ANonly /anal (do not equate with HEMOGLOBINOMETRY & note above HEMOGLOBIN, ERYTHROCYTE MEAN CELL) /biosyn /csf /class /genet /immunol /isol /metab /physiol /rad eff; /urine = HEMOGLOBINURIA; Bohr effect is indexed OXYHEMOGLOBINS /metab (IM) + PH (NIM) MND12.776.124.400; D12.776.422.512 XUÑErythrocruorins LH LU  MHÑHemoglobins, Abnormal ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /rad eff /urine (coord IM with HEMOGLOBINURIA (IM)); do not confuse with HEMOGLOBINOPATHIES: use term in the text MND12.776.124.400.463; D12.776.422.512.426 XUÑHemoglobin E; ÑHemoglobin H; ÑHemoglobin J; ÑHemoglobin M LH LU; ; ;  MSThe presence of free hemoglobin in the urine. MHÑHemoglobinuria ANnote entry below MNC12.777.337; C15.378.71.141.510 FXÑUrine LH LX  MSDisorder characterized by intravascular hemolysis and hemoglobinuria. Some cases occur on exposure to cold and are due to the presence of an autohemolysin in the serum. Other cases are more marked during or immediately after sleep and are considered to be due to an acquired intracorpuscular defect. OLuse HEMOGLOBINURIA, PAROXYSMAL to search MARCHIAFAVA-MICHELI SYNDROME back thru 1966 PM78; was MARCHIAFAVA-MICHELI SYNDROME 1963-77 HN78; was MARCHIAFAVA-MICHELI SYNDROME 1963-77 MHÑHemoglobinuria, Paroxysmal ANalso called ╥paroxysmal nocturnal hemoglobinuria╙ so ignore ╥nocturnal╙ MNC15.378.71.141.510.460; C15.378.190.625.460 XSMarchiafava-Micheli Syndrome LH LS  MHÑHemolymph ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; coord substance in hemolymph with substance /blood MNA12.207.152.379; A13.453 LH  MSPlasmids controlling the synthesis of hemolysin by bacteria. HN(78) MHÑHemolysin Factors ANonly /drug eff /rad eff PIHemolysins (66-77); Plasmids (66-77) MNG5.225.500.430 XSHly Factors DMÑPlasmids LH LS LM  MSSubstances, usually of biological origin, that destroy blood cells; they may be antibodies or other immunologic factors, toxins, enzymes, etc.; hemotoxins are toxic to blood in general, including the clotting mechanism; hematotoxins may refer to the hematopoietic system. MHÑHemolysins ANonly /anal /biosyn /csf /class /genet /immunol /isol /metab /physiol /rad eff MND24.185.926.235.440; D24.611.125.525 XSHemotoxins LH LS  MHÑHemolysis ANonly /drug eff /rad eff; hemolysis in gel = HEMOLYTIC PLAQUE TECHNIC MNG4.610.143.545 FXÑAnemia, Hemolytic; ÑOSMOTIC FRAGILITY LH LX;  PM73 HN73(69) MHÑHemolytic Plaque Technic ANonly /instrum; hemolysis in gel goes here CATALOG: do not use /laboratory manuals PIAntibody Formation (66-68) MNE1.223.495.421; E5.478.421 XSJERNE'S PLAQUE TECHNIC FXÑAntibody-Producing Cells LH LS LX  MSSyndrome of hemolytic anemia, thrombocytopenia, and acute renal failure, with pathological finding of thrombotic microangiopathy in kidney and renal cortical necrosis. PM74 HN74(72) MHÑHemolytic-Uremic Syndrome PIAnemia, Hemolytic (66-71); Uremia (66-71) MNC12.777.419.936.463; C15.378.71.141.610; C15.378.463.205.313 XSGASSER'S SYNDROME LH LS  MSRemoval of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). HN78 MHÑHemoperfusion ANdo not use /util except by MeSH definition; do not confuse with HEMODIALYSIS or PERFUSION or PERFUSION, REGIONAL; hemofiltration does not go here: index under BLOOD (IM) + ULTRAFILTRATION PIHemodialysis (67-77); Kidney, Artificial (66-77); Perfusion (66-77) MNE4.292.510 XSHemosorption LH LS  MHÑHemoperitoneum MNC6.772.303; C23.542.461 LH  PM74 HN74(71) MHÑHemopexin ANdo not use /blood RN9013-71-2 PIBeta Globulins (66-70); Heme (66-70) MND12.776.124.50.350; D12.776.124.790.223.338; D12.776.377.715.182.338; D12.776.395.401 LH  MHÑHemophilia ANdo not use /congen; ╥vascular hemophilia╙ = VON WILLEBRAND'S DISEASE; hemophilia A goes here but note B & C below MNC15.378.463.134.546 FXÑHEMARTHROSIS LH LX  MHÑHemopneumothorax MNC8.528.338; C23.542.572.463 LH  MHÑHemoptysis MNC8.381.348; C23.542.488 LH  MHÑHemorrhage ANGEN; see specifics & cross-refs below; coord IM with organ/dis precoord (IM), not organ /blood supply; consider also terms for presence of blood within cavities, as HEMOTHORAX, HEMATOCOLPOS, etc.; TN 197: coord for various HEMORRHAGE terms MNC23.542 LH  MHÑHemorrhage, Gastrointestinal ANcoord IM with specific intestinal dis (IM), as colonic hemorrhage = HEMORRHAGE, GASTROINTESTINAL (IM) + COLONIC DISEASES (IM); rectal bleeding: see note under RECTUM MNC6.405.348; C23.542.516 LH  MSBleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums; the term should not be used for the escape of blood from the mouth due to internal injuries. PM67 HN67 MHÑHemorrhage, Oral ANnot hemorrh from the mouth but hemorrh of oral tissue PIHemorrhage (66); specific disease or procedure MNC7.465.316; C23.542.544 XUÑGingival Hemorrhage LH LU  MHÑHemorrhage, Postpartum ANcheck tags FEMALE & PREGNANCY MNC13.703.420.427; C13.703.844.339; C23.542.946.339 LH  MHÑHemorrhagic Diathesis MNC15.378.463 FXÑDisease Susceptibility LH LX  MHÑHemorrhagic Disease of Newborn ANdo not confuse with HEMOLYTIC DISEASE OF NEWBORN (i.e., ERYTHROBLASTOSIS, FETAL) MNC15.378.463.841.464; C16.614.378 LH  MSAn RNA virus first identified during the Korean war; this is a highly specific virus, causing severe kidney damage and should not be used as a general term for viruses causing hemorrhagic fevers. OLto search EPIDEMIC HEMORRHAGIC FEVER VIRUS use HEMORRHAGIC FEVER VIRUS, EPIDEMIC back thru 1975 & ARBOVIRUSES 1966-74 PM87; was see under RNA VIRUSES 1978-86, was see under ARBOVIRUSES 1977, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUS 1965-74, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1963-64 HN87(77); was see under RNA VIRUSES 1978-86, was see under ARBOVIRUSES 1977, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUS 1965-74, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBORVIRUSES 1963-64 MHÑHemorrhagic Fever Virus, Epidemic ANdo not use /blood-csf-urine /cytol; infection: terminology here is confused so correlate infecting virus in text with MeSH hemorrh fever terms MNB4.909.777.147.441 XSHFRS Virus; Hantaan Virus; Hemorrhagic Fever Virus, Korean; Hemorrhagic Fever with Renal Syndrome Virus; Hemorrhagic Nephroso-Nephritis Virus LH LS; ; ; ;  MSA group of antigenically and morphologically related Arenaviridae associated with human hemorrhagic fevers in Central and South America. OLsearch ARBOVIRUSES 1973-74 HN(75); was see under ARENAVIRUSES 1978-80, was see under RNA VIRUSES 1977, was HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, was HEMORRHAGIC FEVER VIRUS see under ARBOVIRUS 1973-74 MHÑHemorrhagic Fever Viruses, American ANdo not use /blood-csf-urine /cytol; infection = HEMORRHAGIC FEVER, AMERICAN PIArboviruses (66-74) MNB4.909.777.80.430 XSAmapari Virus; Hemorrhagic Fever Virus, Argentinian; Hemorrhagic Fever Virus, Bolivian; Junin Virus; Machupo Virus DMÑArenaviridae LH LS; ; ; ; LM  MSDiseases caused by American hemorrhagic fever viruses. OLuse HEMORRHAGIC FEVER, AMERICAN to search HEMORRHAGIC FEVER, ARGENTINIAN & HEMORRHAGIC FEVER, BOLIVIAN back thru 1975; search HEMORRHAGIC FEVERS, VIRAL 1966-76 PM77; HEMORRHAGIC FEVER, ARGENTINIAN & HEMORRHAGIC FEVER, BOLIVIAN were see under EPIDEMIC HEMORRHAGIC FEVER 1975-76; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76 HN77; HEMORRHAGIC FEVER, ARGENTINIAN & HEMORRHAGIC FEVER, BOLIVIAN were see under EPIDEMIC HEMORRHAGIC FEVER 1975-76; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76 MHÑHemorrhagic Fever, American ANcaused by various American hemorrh fever viruses: see a list of several under HEMORRHAGIC FEVER VIRUSES, AMERICAN below PIHemorrhagic Fevers, Viral (66-76) MNC2.782.417.400; C2.782.82.440 XSHemorrhagic Fever, Argentinian; Hemorrhagic Fever, Bolivian LH LS;  MSA disease caused by the Congo virus. OLsearch HEMORRHAGIC FEVERS, VIRAL 1966-76 PM78; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76 HN78(77); was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76 MHÑHemorrhagic Fever, Crimean ANcaused by CONGO VIRUS, an arbovirus PIHemorrhagic Fevers, Viral (66-76) MNC2.782.147.444; C2.81.444; C2.782.417.412 XSCongo Virus Infection LH LS  MSA disease caused by the epidemic hemorrhagic fever virus. OLsearch HEMORRHAGIC FEVERS, VIRAL 1966-76 PM77; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76 HN77; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76 MHÑHemorrhagic Fever, Epidemic ANcausative agent: see note under HEMORRHAGIC FEVER VIRUS, EPIDEMIC PIHemorrhagic Fevers, Viral (66-76) MNC2.782.417.415 XSHemorrhagic Fever, Korean; Hemorrhagic Nephroso-Nephritis LH LS;  MSInfection with the Omsk hemorrhagic fever virus. OLsearch HEMORRHAGIC FEVERS, VIRAL 1966-76 PM78; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76 HN78(77); was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76 MHÑHemorrhagic Fever, Omsk ANcausative agent: index under ARBOVIRUSES PIHemorrhagic Fevers, Viral (66-76) MNC2.782.930.460; C2.81.460; C2.782.417.435 LH  MSA group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivities, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with renal syndrome is HEMORRHAGIC FEVER, EPIDEMIC. OLuse HEMORRHAGIC FEVERS, VIRAL to search EPIDEMIC HEMORRHAGIC FEVER 1966-76; search specifics 1977 PM78; was EPIDEMIC HEMORRHAGIC FEVER 1963-76; several specifics became headings & x-refs as of 1977 HN78; was EPIDEMIC HEMORRHAGIC FEVER 1963-76; several specifics became headings & x-refs as of 1977 MHÑHemorrhagic Fevers, Viral ANGEN only: prefer specifics; if renal involvement, dis is probably HEMORRHAGIC FEVER, EPIDEMIC (note X ref below) PIspecific hemorrhagic fever (77) MNC2.782.417 LH  MSAny of several diseases usually caused by Pasteurella multocida, marked by the presence of hemorrhagic areas in the subcutaneous tissues, serous membranes, muscles, lymph glands, and throughout the internal organs. OLsearch PASTEURELLA INFECTIONS 1968-74 HN(75) MHÑHemorrhagic Septicemia MNC1.252.662.297 DMÑPasteurella Infections LH LM  MSVaricosities of the hemorrhoidal venous plexuses. MHÑHemorrhoids MNC6.405.469.860.401; C14.907.449 LH  PM66 HN66(63) MHÑHemosiderin ANdo not use /blood RN9011-92-1 MND12.776.556.526 FXÑIron; ÑSIDEROSIS LH LX;  MSConditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the reticuloendothelial system, without demonstrable tissue damage. MHÑHemosiderosis MNC23.566 FXÑSiderosis LH LX  MSThe process which spontaneously arrests the flow of blood from vessels carrying blood under pressure. Accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements, and the process of blood or plasma coagulation. HNwas in Cat E only 1963-75 MHÑHemostasis ANnote Cat G; differentiate from HEMOSTATIC TECHNICS, Cat E; coord HEMOSTASIS in diseases with disease /blood, not /physiopathol MNG9.188.560 LH  MSControl of bleeding during or after surgery. OLsearch HEMOSTASIS 1966-75 (as Cat E heading) PM76; was indexed under HEMOSTASIS 1963-75 HN76; was indexed under HEMOSTASIS 1963-75 (Cat E heading) MHÑHemostasis, Surgical AN= perop or postop control of bleeding; do not use /util except by MeSH PIHemostasis (66-75) MNE2.520.490; E4.350 LH  MSTechnics for controlling bleeding. OLsearch HEMOSTASIS 1966-75 (as Cat E heading) PM76; was indexed under HEMOSTASIS 1963-75 HN76; was indexed under HEMOSTASIS 1963-75 (Cat E heading) MHÑHemostatic Technics ANdifferentiate from HEMOSTASIS, a physiol process in Cat G; do not use /methods /util (unless by MeSH definition) CATALOG: do not use /laboratory manuals PIHemostasis (66-75) MNE2.520 LH  MHÑHemostatics ANonly /admin /adv eff /anal /chem syn /class /isol /metab /pharm /rad eff /stand /supply /ther use /tox MND19.461.270.463 FXÑBlood Coagulation LH LX  MHÑHemothorax MNC8.528.380; C23.542.572 LH  MSHexamethylphosphoric triamide. Chemosterilant. Synonyms: Hexamethylphosphoramide; HMPA. HN(75) MHÑHempa ANdo not use /biosyn /defic /physiol; /analogs NIM only RN680-31-9 PIDimethylamines (72-74); Organophosphorus Compounds MND2.705.320; D5.723.141.300 XSHexametapol DMÑOrganophosphorus Compounds LH LS LM  MSA highly acidic mucopolysaccharide of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges; the molecular weight ranges from six to twenty thousand; occurs in and obtained from liver, lung, mast cells, etc. of vertebrates; function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. PM/therapeutic use was HEPARIN, THERAPEUTIC 1965 HN/therapeutic use was HEPARIN, THERAPEUTIC 1965 MHÑHeparin AN/antag = HEPARIN ANTAGONISTS; beta-heparin = DERMATAN SULFATE RN9005-49-6 MND9.203.698.582.464; D19.461.119.380 XSAlpha-Heparin; Heparinic Acid LH LS;  MHÑHeparin Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: HEPARIN ANTAG MND19.461.270.546 LH  MHÑHeparinoid RN9010-06-4 MND19.461.119.463 LH  HN(72) MHÑHeparitin Sulfate ANdo not use /analogs RN9050-30-0 PIMucopolysaccharides (66-71) MND9.203.698.582.527 XSHeparan Sulfate DMÑMucopolysaccharides LH LS LM  MHÑHepatectomy ANdo not use /util except by MeSH definition MNE4.765.556 FXÑLIVER REGENERATION LH LX  MSA branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder and greater omentum. MHÑHepatic Artery ANdo not use /blood supply MNA7.231.114.407 FXÑLIVER CIRCULATION LH LX  MSPredominantly extrahepatic bile duct which is formed by the junction of the right and left hepatic ducts, which are predominantly intrahepatic, and, in turn, joins the cystic duct to form the common bile duct. OLuse HEPATIC DUCT, COMMON to search HEPATIC DUCT 1966-79 PM80; was HEPATIC DUCT 1963-79 HN80; was HEPATIC DUCT 1963-79 MHÑHepatic Duct, Common ANan external bile duct formed by junction of right & left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES (NIM); neopl: coord IM with BILE DUCT NEOPLASMS (IM); inflammation: coord IM with CHOLANGITIS (IM); obstruct: coord IM with BILE DUCT OBSTRUCTION, EXTRAHEPATIC (IM); calculi: coord (IM) with CHOLELITHIASIS (IM) MNA3.159.183.615 XSCommon Hepatic Duct LH LS  MSAll stages in the onset and development of coma (prodrome, impending coma, stupor, and coma) occurring in advanced liver disease. OLuse HEPATIC ENCEPHALOPATHY to search HEPATIC COMA back thru 1966 PM84; was see HEPATIC COMA 1975-83; HEPATIC COMA was heading 1963-83 HN84; was see HEPATIC COMA 1975-83; HEPATIC COMA was heading 1963-83 MHÑHepatic Encephalopathy ANalso called portosystemic encephalopathy MNC6.552.313 XSHepatic Coma LH LS  MHÑHepatic Vein Thrombosis MNC6.552.347; C14.907.854.830.381 XSBUDD-CHIARI SYNDROME; CHIARI'S SYNDROME FXÑHepatic Veno-Occlusive Disease LH LS; LX  MSVeins which drain the liver. MHÑHepatic Veins ANdo not use /blood supply MNA7.231.908.380 FXÑLIVER CIRCULATION LH LX  MSBlockage of the small or medium-sized hepatic veins due to nonthrombotic subendothelial edema which may progress to fibrosis. PM87 HN87 MHÑHepatic Veno-Occlusive Disease ANDF: HVOD PIHepatic Vein Thrombosis (66-86); Hepatic Veins (66-86); Liver/blood supply (66-86) MNC6.552.360; C14.907.460 XSVeno-Occlusive Disease of Liver FXÑHepatic Vein Thrombosis LH LS LX  MSInflammation of the liver and liver disease involving degenerative or necrotic alterations of hepatocytes. MHÑHepatitis AN/chem ind = HEPATITIS, TOXIC but note HEPATITIS, ALCOHOLIC is also available; /vet = HEPATITIS, ANIMAL or HEPATITIS, VIRAL, ANIMAL; viral hepatitis = HEPATITIS, VIRAL, HUMAN or HEPATITIS, VIRAL, ANIMAL or specifics MNC6.552.380 LH  MSHepatitis caused by hepatitis virus A. May be transmitted through fecal contamination of food or water. OLuse HEPATITIS A to search HEPATITIS, INFECTIOUS back thru 1966 PM77; was HEPATITIS, INFECTIOUS 1963-76 HN77; was HEPATITIS, INFECTIOUS 1963-76 MHÑHepatitis A MNC2.440.420; C6.552.380.705.422 XSHepatitis, Infectious LH LS  MSAn enterovirus causing infectious hepatitis transmitted through fecal contamination of food or water. OLuse HEPATITIS A VIRUS to search HEPATITIS VIRUS, INFECTIOUS back thru 1966 PM77; was HEPATITIS VIRUS, INFECTIOUS 1966-76 HN77; was HEPATITIS VIRUS, INFECTIOUS 1966-76 MHÑHepatitis A Virus ANdo not use /blood-csf-urine /cytol; infection = HEPATITIS A MNB4.909.403.400; B4.909.777.618.284.640 XSHepatitis Virus, Infectious LH LS  MSImmunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. PM85 HN85 MHÑHepatitis Antibodies ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine; coord IM with specific virus /immunol (IM) or specific viral hepatitis /immunol (IM); do not coord with ANTIBODY FORMATION for /biosyn PIAntibodies, Viral (73-84) MND24.611.125.243.450; D24.611.125.550 XSAntibodies, Hepatitis LH LS  MSHepatitis caused by hepatitis virus B. May be transmitted by transfusion of contaminated blood or blood products. OLuse HEPATITIS B to search HEPATITIS, HOMOLOGOUS SERUM 1966-76 PM77; was HEPATITIS, HOMOLOGOUS SERUM 1963-76 HN77; was HEPATITIS, HOMOLOGOUS SERUM 1963-76 MHÑHepatitis B MNC2.440.435; C6.552.380.705.437 LH  MSAntibodies to the hepatitis B antigens, including antibodies to the surface (Australia) and core of the Dane particle and those to the ╥e╙ antigens. OLuse HEPATITIS B ANTIBODIES to search ANTI-AUSTRALIA ANTIGEN back thru 1973 (as Prov 1973-74) PM84; was see under ANTIBODIES, VIRAL 1978-83, was ANTI-AUSTRALIA ANTIGEN see under ANTIBODIES, VIRAL 1975-77 HN84(78); was see under ANTIBODIES, VIRAL 1978-83; was ANTI-AUSTRALIA ANTIGEN see under ANTIBODIES, VIRAL 1975-77, was ANTI-AUSTRALIA ANTIGEN 1973-74 (Prov) MHÑHepatitis B Antibodies ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine PIHepatitis B (66); Hepatitis B Virus (67-72); Immune Sera (66-72) MND24.611.125.243.450.504 XSAnti-Australia Antigens; Anti-HBAg; Anti-Hepatitis B Antigens LH LS; ;  MSAntigens of the virion of Hepatitis B or the Dane particle, its surface, core and other associated antigens, like the ╥e╙ antigen. OLuse HEPATITIS B ANTIGENS to search HEPATITIS B ANTIGEN back thru 1973; to search AUSTRALIA ANTIGEN use HEPATITIS B ANTIGENS & HEPATITIS B SURFACE ANTIGENS 1977, HEPATITIS B ANTIGENS 1973-76 & HEPATITIS B VIRUS 1970-72; search HEPATITIS ASSOCIATED ANTIGEN under HEPATITIS B VIRUS 1970-72 PM78; was HEPATITIS B ANTIGEN with AUSTRALIA ANTIGEN see HEPATITIS B ANTIGEN 1977; AUSTRALIA ANTIGEN was heading 1973-76 with HEPATITIS B ANTIGEN see AUSTRALIA ANTIGEN 1974-76 & HEPATITIS ASSOCIATED ANTIGEN see AUSTRALIA ANTIGEN 1973-75; AUSTRALIA ANTIGEN was see HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72; HEPATITIS ASSOCIATED ANTIGEN was see under HEPATITIS VIRUS, HOMOLOGOUS SERUM 1970-72 HN77; AUSTRALIA ANTIGEN (see HEPATITIS B SURFACE ANTIGENS as of 1981) was see HEPATITIS B SURFACE ANTIGEN 1978-80, was see HEPATITIS B ANTIGENS 1977, was heading 1973-76 with HEPATITIS B ANTIGEN see AUSTRALIA ANTIGEN 1974-76 & HEPATITIS ASSOCIATED ANTIGEN see AUSTRALIA ANTIGEN 1973-75; AUSTRALIA ANTIGEN was see HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72; HEPATITIS ASSOCIATED ANTIGEN was Prov 1970-72, was see under HEPATITIS VIRUS, HOMOLOGOUS SERUM 1970-72 MHÑHepatitis B Antigens ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIHepatitis B Virus (66-72) MND24.611.216.327.500 XSHBAg LH LS  MSThe hepatitis B antigen within the core of the Dane particle. OLuse HEPATITIS B CORE ANTIGENS to search HEPATITIS B CORE ANTIGEN back thru 1977 PM85; was HEPATITIS B CORE ANTIGEN 1977-84 HN85; was HEPATITIS B CORE ANTIGEN 1977-84 MHÑHepatitis B Core Antigens ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIHepatitis B Antigens (73-76); Hepatitis B Virus (70-72) MND24.611.216.327.500.450 XSHBcAg LH LS  MSA closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. PM87; was see under HEPATITIS B ANTIGENS 1981-86 HN87(81); was see under HEPATITIS B ANTIGENS 1981-86 MHÑHepatitis B e Antigens ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIHepatitis B Antigens (73-80); Hepatitis B Virus (66-72) MND24.611.216.327.500.469 XSE Antigens; HBeAg LH LS;  MSThose hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles; several subspecificities of the surface antigen are known; formerly called the Australia antigen. OLuse HEPATITIS B SURFACE ANTIGENS to search HEPATITIS B SURFACE ANTIGEN back thru 1977; to search AUSTRALIA ANTIGEN use HEPATITIS B SURFACE ANTIGENS & HEPATITIS B ANTIGENS 1977, HEPATITIS B ANTIGENS 1973-76 & HEPATITIS B VIRUS 1970-72 PM81; was HEPATITIS B SURFACE ANTIGEN 1977-80; see hist of AUSTRALIA ANTIGEN under HEPATITIS B ANTIGENS HN81; was HEPATITIS B SURFACE ANTIGEN 1977-80; see hist of AUSTRALIA ANTIGEN under HEPATITIS B ANTIGENS MHÑHepatitis B Surface Antigens ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIHepatitis B Antigens (73-77); Hepatitis B Virus (70-72) MND24.611.216.327.500.475 XSAustralia Antigen; HBsAg LH LS;  MSAn uncharacterized virus causing homologous serum hepatitis. OLuse HEPATITIS B VIRUS to search HEPATITIS VIRUS, HOMOLOGOUS SERUM back thru 1966; to search DANE PARTICLE use HEPATITIS B VIRUS back thru 1981 & HEPATITIS B ANTIGENS 1977-80 PM77; was HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; DANE PARTICLE was see HEPATITIS B ANTIGENS 1977-80 HN77; was HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; DANE PARTICLE was see HEPATITIS B ANTIGENS 1977-80 MHÑHepatitis B Virus ANdo not use /blood-csf-urine /cytol; infection = HEPATITIS B MNB4.909.403.425; B4.909.920.399 XSDane Particle; Hepatitis Virus, Homologous Serum LH LS;  MSA species of Adenoviridae which causes fever, edema, vomiting and diarrhea in dogs, and encephalitis in foxes. PM66 HN66 MHÑHepatitis Virus, Infectious Canine ANdo not use /blood-csf-urine /cytol; infection = HEPATITIS, INFECTIOUS CANINE; DF: HEPATITIS VIRUS CANINE or HEPATITIS VIRUS INFECT CANINE MNB4.909.204.97.548; B4.909.403.615 LH  MSA species of the Coronavirus genus causing hepatitis in mice; four strains have been identified as MHV 1, MHV 2, MHV 3, and MHV 4 (aka JHM) which is neurotropic and causes disseminated encephalomyelitis with demyelination as well as focal liver necrosis. PM66 HN66 MHÑHepatitis Virus, Mouse ANdo not use /blood-csf-urine /cytol; infection: coord NIM with HEPATITIS, VIRAL, ANIMAL (IM) + check tag MICE for probable exper study MNB4.909.403.760; B4.909.777.199.460; B4.909.777.779.340 LH  OLuse HEPATITIS VIRUSES to search HEPATITIS VIRUS, MARMOSET back thru 1975 PMHEPATITIS VIRUS, MARMOSET was see under HEPATITIS VIRUSES 1975-85 HNHEPATITIS VIRUS, MARMOSET was see under HEPATITIS VIRUSES 1975-85 MHÑHepatitis Viruses ANGEN; prefer specifics; do not use /blood-csf-urine /cytol; infection: index under one of the numerous pertinent viral hepatitis terms above MNB4.909.403 XSHepatitis Virus, Marmoset LH LS  MSAn acute or chronic degenerative and inflammatory lesion of the liver in the alcoholic which is potentially progressive or reversible; it does not necessarily include steatosis, fibrosis, or cirrhosis of alcoholics, although it is frequently associated with these conditions. PM78 HN78 MHÑHepatitis, Alcoholic ANconsidered chronic so do not coord with CHRONIC DISEASE PIAlcoholism (66-77); Hepatitis (66-77); Hepatitis, Toxic (66-77) MNC6.552.380.290; C6.552.645.490; C21.613.53.270.645.490 XSAlcoholic Hepatitis LH LS  MHÑHepatitis, Animal ANexper or vet, GEN or unspecified; don't forget to check tag ANIMAL; prefer specific hepatitis heading with check tag ANIMAL & do not coord here: if specific hepatitis is exper, use only check tag ANIMAL but if specific hepatitis is vet, use specific hepatitis /vet (IM) + precoord animal/dis term (IM) + check tag ANIMAL MNC6.552.380.315; C22.467 LH  MSA continuing inflammatory lesion of the liver with a potential to progress to a more severe disease, including cirrhosis, to continue unchanged or to subside (spontaneously or with treatment). Most patients have a history of viral hepatitis. PM83 HN83 MHÑHepatitis, Chronic Active ANusually caused by viral hepatitis: coord (IM) with specific viral hepatitis (IM) if pertinent but do not use /compl; chronic hepatitis from other dis = HEPATITIS (IM) + dis /compl (IM) + CHRONIC DISEASE (NIM); chronic alcoholic hepatitis = HEPATITIS, ALCOHOLIC PIHepatitis (66-82); Hepatitis B (66-82) MNC6.552.380.705.460 LH  MSAn adenovirus infection causing fever, edema, vomiting and diarrhea in dogs, especially puppies; in foxes it causes acute encephalitis with convulsions, paralysis, coma and death. OLuse HEPATITIS, INFECTIOUS CANINE to search HEPATITIS, CANINE INFECTIOUS back thru 1971 PM82; was HEPATITIS, CANINE INFECTIOUS 1971-81 HN82; was HEPATITIS, CANINE INFECTIOUS 1971-81 MHÑHepatitis, Infectious Canine ANdo not use /vet; don't forget also DOGS (NIM) & check tag ANIMAL; DF: HEPATITIS INFECT CANINE PIHepatitis, Animal (66-70) MNC2.256.76.381; C2.407.432; C6.552.380.315.430.440; C22.268.465; C22.467.435.442 LH  MSHepatitis caused by true hepatotoxins and drugs which induce a hypersensitivity reaction. MHÑHepatitis, Toxic ANdo not use /chem ind; note HEPATITIS, ALCOHOLIC MNC6.552.380.615; C21.613.512 LH  MSViral hepatitis in animals. PM77 HN77 MHÑHepatitis, Viral, Animal ANnot restricted to hepatitis caused by hepatitis viruses: use also for hepatitis caused by other viruses; exper or vet but do not use /vet; don't forget to check tag ANIMAL PIHepatitis, Animal (66-76) MNC2.407; C6.552.380.315.430; C22.467.435 LH  MSViral hepatitis in man. PM77 HN77 MHÑHepatitis, Viral, Human ANnot restricted to hepatitis caused by hepatitis viruses: use also for hepatitis caused by other viruses; coord IM with precoord virus dis term (IM) PIHepatitis A (66-76) MNC2.440; C6.552.380.705 XUÑHepatitis, Viral, Non-A, Non-B LH LU  MSA form of hepatitis, similar to type B post-transfusion hepatitis, but caused by a virus which is serologically distinct from the agents of hepatitis A and B, and which may persist in the blood of chronic asymptomatic carriers. HN(80) MHÑHepatitis, Viral, Non-A, Non-B ANthis name will be used in the article: follow the text PIHepatitis (72-79); Hepatitis, Viral, Human (77-79) MNC2.440.951; C6.552.380.705.600 XSHepatitis C DMÑHepatitis, Viral, Human LH LS LM  MSAutosomal recessive inborn error of metabolism involving the transport and storage of copper in the body. PM64; was HEPATO-LENTICULAR DEGENERATION 1963 HN64; was HEPATO-LENTICULAR DEGENERATION 1963 MHÑHepatolenticular Degeneration MNC6.552.413; C10.228.140.79.501; C10.228.140.163.381; C18.452.648.618.403 XSPROGRESSIVE LENTICULAR DEGENERATION; PSEUDOSCLEROSIS; WILSON'S DISEASE LH LS; ;  MHÑHepatoma ANhuman & vet only: note below HEPATOMA, EXPERIMENTAL see LIVER NEOPLASMS, EXPERIMENTAL for exper anim; /anal /blood supply /secret /ultrastruct permitted; coord IM with LIVER NEOPLASMS (IM) MNC4.557.576.521 LH  MSEnlargement of the liver. PM66 HN66(63) MHÑHepatomegaly ANNIM when symptom MNC6.552.446 LH  MSRenal failure in those with liver disease, usually liver cirrhosis or obstructive jaundice. Historically called Heyd disease, urohepatic syndrome, or bile nephrosis. HN(87) MHÑHepatorenal Syndrome PIKidney Diseases (66-86); Kidney Failure, Acute (67-86); Kidney Failure, Chronic (66-86); Liver Cirrhosis (66-86); Liver Diseases (66-86); Syndrome (72-86) MNC6.552.465; C12.777.419.291 DMÑKidney Diseases LH LM  MS4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid. A dipolar ionic buffer. HN(75) MHÑHEPES AND25-26 qualif; /analogs NIM only RN7365-45-9 PIAlcohol, Ethyl (71-74); Alkyl Sulfonates (74); Piperazines (70-74) MND2.241.866.540.121.450; D3.383.606.500; D26.172.400 XSN-2-Hydroxyethylpiperazine-N'-2'-Ethanesulfonic Acid DMÑPiperazines LH LS LM  MS5-(1-Cyclohepten-1-yl)-5-ethylbarbituric acid. Intermediate or short duration barbiturate used mainly for sedation and hypnosis. Do not confuse with heptobarbital. Synonyms: Medomin; Heptadorm; Heptobarb. HN(76) MHÑHeptabarbital ANdo not confuse with ╥heptobarbital╙ (index BARBITURATES); do not use /biosyn /defic /physiol; /analogs NIM only RN509-86-4 PIBarbiturates (69-75); Cycloheptanes (69-75) MND3.383.742.698.253.300; D14.166.111.295; D14.591.220.295 XSHeptabarbitone DMÑBarbiturates LH LS LM  PM73 HN73(71) MHÑHeptachlor ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN76-44-8 PIInsecticides (66-70) MND2.455.526.439.516; D5.723.491.491.545 XUÑHeptachlor Epoxide LH LU  OLsearch HEPTACHLOR 1973-74 HN(75) MHÑHeptachlor Epoxide ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN1024-57-3 MND5.723.491.491.545.465 DMÑHeptachlor LH LM  MS6-Amino-2-methyl-2-heptanol. Myocardial stimulant with some vasodilatory action; may also relieve bronchospasm. Synonyms: Cortensor; Heptamyl; Heptylon; Izoktamil. HN(76) MHÑHeptaminol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN372-66-7 PIAlcohols, Octyl (73-75); Amino Alcohols (69-75) MND2.33.329.350; D2.92.63.350; D16.893.439; D18.222.863.433 DMÑAmino Alcohols LH LM  MSSeven-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. PM78 HN78 MHÑHeptanes ANdo not use /analogs /biosyn /defic /physiol; does not include heptenes ( = ALKENES), heptadienes ( = ALKADIENES), or heptatrienes ( = POLYENES); CYCLOHEPTANES is also available PIAlkanes (66-77); Hydrocarbons (66-77) MND2.455.326.146.485 XSIsoheptanes LH LS  MSSalts and esters of the 7-carbon saturated monocarboxylic acid--hepatanoic acid. HN(75) MHÑHeptanoates ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (69-74) MND2.241.81.407.380.350; D10.516.251.450.400 XSEnanthates DMÑHeptanoic Acids LH LS LM  MS7-carbon saturated monocarboxylic acids. PM75 HN75 MHÑHeptanoic Acids ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74) MND2.241.81.407.380; D10.516.251.450 XUÑHeptanoates LH LU  MHÑHeptoses ANGEN; do not use /analogs MND9.203.546.286 XUÑMannoheptulose LH LU  MHÑHerbicides ANdo not use /admin /analogs /biosyn /defic /physiol MND5.723.366 XUÑDefoliants, Chemical LH LU  MSHerbicides which owe their activity to the carbamate moiety in the molecule. PM75 HN75 MHÑHerbicides, Carbamate ANdo not use /admin /analogs /biosyn /defic /physiol PIHerbicides (66-74) MND5.723.366.448 XUÑChlorpropham LH LU  MSHerbicides which owe their activity to the triazine moiety in the molecule. PM75 HN75 MHÑHerbicides, Triazine ANdo not use /admin /analogs /biosyn /defic /physiol PIHerbicides (66-74) MND5.723.366.477 XUÑPrometryne; ÑSimazine LH LU;  MSHerbicides which owe their activity to the urea moiety in the molecule. PM75 HN75 MHÑHerbicides, Urea ANdo not use /admin /analogs /biosyn /defic /physiol PIHerbicides (66-74) MND5.723.366.506 XUÑLinuron LH LU  MSAny plant designated as herb by any source; formerly, those angiosperms that have little or no woody tissue and die at the end of the growing season, especially in the temperate zones where winter cold suspends plant growth; also plants used for their aromatic, savory, or medicinal properties. OLuse HERBS to search THYME back thru 1966 HNTHYME was heading 1963-82 MHÑHerbs ANas plant, flavoring & drug; note category; do not use /isol /pathogen; medicinal herbs in general or specific medicinal herbs go only under PLANTS, MEDICINAL & not also under HERBS; ther use of HERBS in general goes under MEDICINE, HERBAL but ther use of a specific medicinal herb in MeSH goes under specific plant name; see note on MEDICINE, HERBAL MNB6.316 XSThyme LH LS  PM68 HN68 MHÑHereditary Diseases ANGEN only: prefer /familial with specific diseases; do not use /congen /compl; Manual 23.28.1; relation to congen dis: Manual 19.4.29; X-linked diseases in general = HEREDITARY DISEASES (IM) + X CHROMOSOME (IM) + LINKAGE (NIM), a specific X-linked dis = disease (IM) + X CHROMOSOME (NIM) + LINKAGE (NIM) PIGenetics, Medical (66-67) MNC16.466 FXÑGenetics, Medical LH LX  OLuse HERMAPHRODITISM to search INTERSEXUALITY back thru 1966 (as Prov 1966) HNINTERSEXUALITY was Prov 1964-66 MHÑHermaphroditism ANpermissible for biol hermaphroditism in lower organisms despite categ; do not use /congen; for check tag use genetic sex for higher animals but do not check sex tags for lower organisms MNC16.131.939.842.316; C19.391.403 XSINTERSEXUALITY LH LS  MSProtrusion of a loop or knuckle of an organ or tissue through an abnormal opening. MHÑHernia ANNIM coord with specific organ/dis (IM); note many types of HERNIA below; herniated disk = INTERVERTEBRAL DISK DISPLACEMENT MNC6.405.396; C23.592 XSEnterocele FXÑTRUSSES XUÑHernia, Obturator LH LS LX LU  MSA transdiaphragmatic herniation or evisceration (in the absence of a sac) of some part of the abdominal contents into the thoracic cavity. OLuse HERNIA, DIAPHRAGMATIC to search DIAPHRAGMATIC HERNIA back thru 1966 PM80; was DIAPHRAGMATIC HERNIA 1963-79 HN80; was DIAPHRAGMATIC HERNIA 1963-79 MHÑHernia, Diaphragmatic MNC6.306.700; C6.405.396.216 XSDiaphragmatic Hernia XUÑHernia, Hiatal LH LS LU  OLuse HERNIA, DIAPHRAGMATIC, TRAUMATIC to search DIAPHRAGMATIC HERNIA, TRAUMATIC back thru 1966 PM80; was DIAPHRAGMATIC HERNIA, TRAUMATIC 1963-79 HN80; was DIAPHRAGMATIC HERNIA, TRAUMATIC 1963-79 MHÑHernia, Diaphragmatic, Traumatic MNC21.866.17.258 XSDiaphragmatic Hernia, Traumatic LH LS  OLuse HERNIA, FEMORAL to search FEMORAL HERNIA back thru 1966 PM80; was FEMORAL HERNIA 1963-79 HN80; was FEMORAL HERNIA 1963-79 MHÑHernia, Femoral MNC6.405.396.342 XSFemoral Hernia LH LS  MSHerniation of the lower esphagus and/or portion of the stomach through the esophageal hiatus. OLto search HIATAL HERNIA use HERNIA, HIATAL back thru 1975 & HERNIA, DIAPHRAGMATIC 1966-74 HN(80); was HIATAL HERNIA see under DIAPHRAGMATIC HERNIA 1963-79 MHÑHernia, Hiatal MNC6.306.700.490; C6.405.396.216.467 XSHiatal Hernia DMÑHernia, Diaphragmatic LH LS LM  OLuse HERNIA, INGUINAL to search INGUINAL HERNIA back thru 1966 PM80; was INGUINAL HERNIA 1963-79 HN80; was INGUINAL HERNIA 1963-79 MHÑHernia, Inguinal MNC6.405.396.489 XSInguinal Hernia LH LS  MSHernia through the obturator foramen. OLuse HERNIA, OBTURATOR to search OBTURATOR HERNIA back thru 1975 HN(80); was OBTURATOR HERNIA see under HERNIA 1975-79 MHÑHernia, Obturator MNC6.405.396.600 XSObturator Hernia DMÑHernia LH LS LM  OLuse HERNIA, UMBILICAL to search UMBILICAL HERNIA back thru 1966 PM80; was UMBILICAL HERNIA 1963-79 HN80; was UMBILICAL HERNIA 1963-79 MHÑHernia, Umbilical MNC6.405.396.806; C16.614.390 XSExomphalos; Omphalocele; Umbilical Hernia LH LS; ;  OLuse HERNIA, VENTRAL to search VENTRAL HERNIA back thru 1966 PM80; was VENTRAL HERNIA 1963-79 HN80; was VENTRAL HERNIA 1963-79 MHÑHernia, Ventral ANabdominal hernia goes here MNC6.405.396.897 XSVentral Hernia LH LS  MSStrong dependence, both physiological and emotional, upon heroin. OLuse HEROIN DEPENDENCE to search HEROIN ADDICTION back thru 1973 (as Prov 1973) PM81; was HEROIN ADDICTION 1974-80 HN81; was HEROIN ADDICTION 1973-80 (Prov 1973) MHÑHeroin Dependence ANsee note under MORPHINE DEPENDENCE; do not use /chem ind /drug eff /physiol /rad eff PIDiacetylmorphine (66-72); Morphine Dependence (66-72); Substance Dependence (66-72) MNF3.709.597.780.660.400.110 LH  MHÑHerpangina ANcaused by Coxsackie A virus MNC2.782.687.359.213.466 LH  MSHerpes simplex of the genitals. PM82 HN82 MHÑHerpes Genitalis PIGenital Diseases, Female (66-81); Genital Diseases, Male (66-81); Herpes Simplex (66-81) MNC2.256.466.382.290; C12.294.300; C13.371.350 XSHerpes Simplex, Genital LH LS  MSAn itching polymorphous bullous eruption which occurs in pregnancy or the puerperium and which recurs in successive pregnancies. HN(76) MHÑHerpes Gestationis ANdon't forget check tag PREGNANCY (NIM) + FEMALE + PREGN COMPL INFECT (IM) PIDermatitis Herpetiformis (66-75) MNC17.816.540 DMÑSkin Diseases, Bullous LH LM  MHÑHerpes Labialis ANcold sore & fever blister; restrict to lips & nares; STOMATITIS, HERPETIC (oral cavity) is also available MNC2.256.466.382.316; C7.465.409.466; C17.838.424.382 XSHerpes Simplex, Labial LH LS  MHÑHerpes Simplex ANnote Cat C; caused by HERPES SIMPLEX VIRUS ( = HERPESVIRUS HOMINIS); herpes recurrens goes here MNC2.256.466.382; C17.838.424 LH  MHÑHerpes Zoster ANcaused by HERPES ZOSTER VIRUS (see VARICELLA-ZOSTER VIRUS) MNC2.256.466.423 XSSHINGLES; ZONA; ZOSTER LH LS; ;  MHÑHerpes Zoster, Ocular ANsee note above MNC2.256.466.423.466; C11.419 LH  OLuse HERPESVIRIDAE to search HERPESVIRUSES & HERPESVIRUS back thru 1966 PM81; was HERPESVIRUSES 1975-80, was HERPESVIRUS 1963-74; ALLERTON VIRUS INFECTIONS (ALLERTON VIRUS is see BOVINE ULCERATIVE MAMMILITIS VIRUS, an XU below) was indexed under LUMPY SKIN DISEASE 1970-76 HN81; was HERPESVIRUSES 1975-80, was HERPESVIRUS 1963-74 MHÑHerpesviridae ANnote many specific XU refs below & see refs above; do not use /blood-csf-urine /cytol MNB4.909.204.382 XUÑAvian Infectious Laryngotracheitis Virus; ÑBovine Ulcerative Mammillitis Virus; ÑCanine Tracheobronchitis Virus; ÑEquine Coital Exanthema Virus; ÑEquine Rhinopneumonitis Virus; ÑHerpesvirus Simian B; ÑLeopard Frog Carcinoma Virus; ÑMarmoset Virus LH LU; ; ; ; ; ; ;  MHÑHerpesvirus Hominis ANdo not use /blood-csf-urine /cytol; infection = HERPES SIMPLEX MNB4.909.204.382.404 XSFever Blister Virus; HERPES SIMPLEX VIRUS; Herpes Labialis Virus LH LS; ;  PMALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76 MHÑHerpesvirus Infections ANGEN or unspecified; prefer specifics; herpes recurrens goes under HERPES SIMPLEX MNC2.256.466 LH  MSA virus isolated from squirrel monkeys; produces malignant lymphomata in inoculated marmosets or owl monkeys. PM80; was see under HERPESVIRUSES 1975-79 HN80(75); was see under HERPESVIRUSES 1975-79 MHÑHerpesvirus Saimiri ANdo not use /blood-csf-urine /cytol; infection: coord NIM with HERPESVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) PIHerpesviridae (66-74) MNB4.909.204.382.450; B4.909.574.204.300 LH  MSA species of Herpesviridae which causes vesicular lesions of the mouth in monkeys; when transmitted to man it causes an acute encephalitis or encephalomyelitis, which is nearly always fatal. Syn: Herpesvirus simiae. HN(71); was see under HERPESVIRUSES 1975-80 MHÑHerpesvirus Simian B ANdo not use /blood-csf-urine /cytol; infection: coord NIM with HERPESVIRUS INFECTIONS (IM) PIHerpesviridae (66-70) MNB4.909.204.382.466 DMÑHerpesviridae LH LM  OLsearch BIOFLAVONOIDS 1966-74 HN(75) MHÑHesperidin AN/analogs NIM only RN520-26-3 MND9.203.408.134.466; D11.786.170.516 DMÑBioflavonoids LH LM  PM72 HN72(68) MHÑHeterochromatin ANA 11 qualif except /cytol /pathol; /isol permitted (Cat D) PIChromosomes (66-67) MNA11.223.349.383; D12.776.664.224.466 LH  MHÑHeterocyclic Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: HETEROCYCLIC CPDS MND3 XUÑOxathiins LH LU  MH*Heterocyclic Cpds, Bridged Ring (Non Mesh) MND3.605 LH  MH*Heterocyclic Cpds, 1-Ring (Non Mesh) MND3.383 LH  MH*Heterocyclic Cpds, 2-Ring (Non Mesh) MND3.438 LH  MH*Heterocyclic Cpds, 3-Ring (Non Mesh) MND3.494 LH  MH*Heterocyclic Cpds, 4 or More Rings (Non Mesh) MND3.549 LH  MSOxides of a ring compound having atoms other than carbon in its ring. PM75 HN75 MHÑHeterocyclic Oxides ANdo not use /analogs /biosyn /defic /physiol; note specific cross-refs below PIHeterocyclic Compounds (66-74); Oxides (66-74) MND3.661 LH  MSA family of intestinal flukes of the class Trematoda which occurs in animals and man. Some of the genera are Heterophyes, Metagonimus, Cryptocotyle, Stellantchasmus, and Euryhelmis. OLto search HETEROPHYES use HETEROPHYIDAE back thru 1975 & TREMATODA 1966-74; use HETEROPHYIDAE to search METAGONIMUS back thru 1966 PM82; HETEROPHYES was see under TREMATODA 1963-81; METAGONIMUS was heading 1963-81 HN82; HETEROPHYES was see under TREMATODA 1963-81; METAGONIMUS was heading 1963-81 MHÑHeterophyidae ANfamily of trematodes; do not use /blood-csf-urine; infection: coord NIM with TREMATODE INFECTIONS (IM) PITrematoda (66-81) MNB1.500.736.715.465 XSHeterophyes; Metagonimus LH LS;  MSAn individual having different alleles at one or more loci in homologous chromosome segments. PM68 HN68 MHÑHeterozygote ANno qualif PIGenes (66-67); Genetics (66-67) MNG5.441.383 XSCarriers, Genetic; Genetic Carriers LH LS;  MSIdentification of genetic carriers for a given trait. PM79 HN79 MHÑHeterozygote Detection ANonly /instrum /methods PIHeterozygote (68-78) MNE5.393.450 XSCarriers, Genetic, Detection; Genetic Carriers, Detection FXÑGenetic Screening LH LS; LX  MSAn agricultural fungicide and seed treatment agent. HN(75) MHÑHexachlorobenzene ANdo not confuse with BENZENE HEXACHLORIDE; do not use /biosyn /defic /physiol; /analogs NIM only RN118-74-1 PIChlorobenzenes (74) MND5.723.288.440; D2.455.426.559.389.261.400; D2.455.526.439.202.400 XSHCB DMÑChlorobenzenes LH LS LM  MHÑHexachlorophene ANdo not use /biosyn /defic /physiol RN70-30-4 MND20.187.409 LH  MSN,N,N',N'-tetramethyl-1,6-hexanediamine polymer with 1,3-dibromopropane. Synthetic polymer which agglutinates red blood cells; used as a heparin antagonist. Synonym: Polybrene. HN(75) MHÑHexadimethrine AND25-26 qualif; /analogs NIM only RN9011-04-5 PIHydrocarbons, Brominated (74); Polyamines (72-74); Polymers (72-74) MND2.92.782.420; D19.461.270.546.350; D25.720.470 XSHexadimethrine Bromide DMÑPolyamines LH LS LM  MHÑHexamethonium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: HEXAMETHONIUM CPDS MND2.92.102.558.592; D2.675.276.558.592; D16.653.396.438.550; D17.688.538.592; D18.162.419 LH  MS2,4,6-Tris(dimethylamino)-1,3,5-triazine. Alkylating agent proposed as an antineoplastic. Synonym: Hemel. HN(75) MHÑHexamethylmelamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN645-05-6 PIDimethylamines (73-74); Triazines (70-74) MND3.383.931.380; D22.204.436 DMÑTriazines LH LM  MSSix-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. Various polyneuropathies are caused by hexane poisoning. PM78 HN78 MHÑHexanes ANdo not use /analogs /biosyn /defic /physiol; does not include hexenes ( = ALKENES), hexadienes ( = ALKADIENES), or hexatrienes ( = POLYENES); CYCLOHEXANES is also available PIAlkanes (66-77); Hydrocarbons (66-77) MND2.455.326.146.500 XSIsohexanes LH LS  OLsearch CAPROATES 1968-74 HN(75) MHÑHexanoic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.193.467; D2.241.81.465.326.467; D10.516.251.400.326.467 DMÑCaproates LH LM  MS6-carbon straight-chain or branched ketones. HN(75) MHÑHexanones ANdo not use /analogs /biosyn /defic /physiol PIKetones (66-74) MND2.522.520 XSButyl Methyl Ketones; Ethyl Propyl Ketones DMÑKetones LH LS; LM  MHÑHexestrol ANdo not use /biosyn /defic /physiol RN84-16-2 MND6.597.378.501; D6.597.350.500 XSDihydrodiethylstilbestrol LH LS  PM73 HN73(66) MHÑHexetidine ANdo not use /biosyn /defic /physiol RN141-94-6 MND3.383.742.279; D20.136.407; D20.187.464 LH  MHÑHexobarbital ANdo not use /biosyn /defic /physiol RN56-29-1 MND3.383.742.698.253.317; D14.166.111.317 LH  MSN,N'-Dimethyl-N,N'-bis[3-(3,4,5-trimethoxybenzoyloxy) propyl]ethylenediamine. A potent vasoactive agent that dilates cerebral and coronary arteries, but slightly constricts femoral arteries. Without any effects on heart rate, blood pressure or cardiac output. Synonyms: Andiamine; Corimon; Ustinom. HN(75) MHÑHexobendine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN54-03-5 PIBenzoates (69-74); Ethylenediamines (71-74) MND2.241.223.106.490; D18.918.415 DMÑBenzoates LH LM  MHÑHexokinase ANdo not use /analogs RNEC 2.7.1.1 MND8.586.913.696.729.367 LH  MSN,N'-Hexamethylenebis(2-amino-1-(3,4-dihydroxy-phenyl)ethanol). Stimulant of adrenergic beta 2 receptors; used as a bronchodilator and antiasthmatic agent. HN(75) MHÑHexoprenaline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3215-70-1 PICatechol (73-74); Ethanolamines (73-74); Phenethylamines (72-74) MND2.92.471.683.530; D16.116.444; D16.893.116.348.387 DMÑPhenethylamines LH LM  MHÑHexosamines ANdo not use /analogs MND9.203.67.342 LH  PM73 HN73(71) MHÑHexosaminidases ANdo not use /analogs RNEC 3.2.1.- PIGlycoside Hydrolases (66-70) MND8.586.277.450.483 FXÑGangliosidosis LH LX  OLuse HEXOSEDIPHOSPHATASE to search FRUCTOSE DIPHOSPHATASE back thru 1973 (as Prov 1973) PM65 HN65; FRUCTOSE DIPHOSPHATASE was heading 1973 (Prov) MHÑHexosediphosphatase ANdo not use /analogs RNEC 3.1.3.11 MND8.586.277.352.630.654.501 XSFRUCTOSEDIPHOSPHATASE LH LS  PM73 HN73 MHÑHexosediphosphates ANdo not use /analogs PIHexosephosphates (66-72) MND9.203.894.417.592 XUÑFructosediphosphates LH LU  MSUDPglucose:alpha-D-galactose-1-phosphate uridylyltransferase. Catalyzes the transfer of UMP from UDPglucose to galactose 1-phosphate, forming UDPgalactose and glucose 1-phosphate. Deficiency in this enzyme is the major cause of galactosemia. HN(75) MHÑHexosephosphate Uridylyltransferase ANdo not use /analogs RNEC 2.7.7.12 PIGalactose (70-74); Hexosephosphates (70-74); Nucleotidyltransferases (70-74); Uridine Diphosphate Sugars (70-74) MND8.586.913.696.445.480 XSPhosphogalactose Uridyl Transferase; Uridyl Transferase DMÑNucleotidyltransferases LH LS; LM  MHÑHexosephosphates ANdo not use /analogs MND9.203.894.417 XUÑGalactosephosphates; ÑMannosephosphates LH LU;  MHÑHexoses ANGEN only: prefer specifics; do not use /analogs MND9.203.546.359 LH  PM72 HN72 MHÑHexosyltransferases ANdo not use /analogs RNEC 2.4.1. PITransferases (66-71) MND8.586.913.407 XUÑFucosyltransferases; ÑMannosyltransferases LH LU;  MSTerm used to designate tetrahydroxy aldehydic acids obtained by oxidation of hexose sugars, i.e. glucuronic acid, galacturonic acid, etc. Historically, the name hexuronic acid was originally given to ascorbic acid. HN(75) MHÑHexuronic Acids ANdo not use /analogs /defic /physiol PIUronic Acids (71-74) MND2.241.81.844.915.400; D2.241.152.811.400; D2.241.511.902.915.400; D9.203.811.922.400 XSHexouronic Acids DMÑUronic Acids LH LS LM  MHÑHexylresorcinol ANdo not use /biosyn /defic /physiol RN136-77-6 MND2.755.852.467; D21.201.287.382; D21.201.412.382; D20.187.482 LH  MSA natural physiological process in many warm-blooded animals; it includes stupor, lowering of body temperature, and a depression of other vital signs; it is induced by cold, hunger, or certain hormones. MHÑHibernation ANanimal only; a natural physiological process; only /drug eff /rad eff; hibernating gland = BROWN FAT MNG7.62.592; G7.315.232.450 LH  MHÑHiccup MNC23.888.821.578 LH  MSTumor of the skin the components of which resemble epithelial elements of sweat glands. MHÑHidradenoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.576.547 XSSyringoma, Chondroid LH LS  MSSocial rank-order established by certain behavioral patterns. OLsearch SOCIAL DOMINANCE 1968-74 HN(75); was see under DOMINANCE, SOCIAL 1968 MHÑHierarchy, Social ANhuman & animal; no qualif MNF1.145.843.551 DMÑSocial Dominance LH LM  MSGroup of non-histone proteins found in chromatin. Their role has not been definitely established, but they are believed to have a role in matrix stabilization, protection of single-stranded DNA, and are required for transcription. PM85 HN85 MHÑHigh Mobility Group Proteins AN/biosyn /physiol permitted; do not use /analogs PIChromosomal Proteins, Non-Histone (77-84); Nucleoproteins (66-81) MND12.776.664.235.400 XSHMG Proteins LH LS  MSA syndrome of tremors, nausea, dizziness, and decreased motor and mental performance which develops in those who dive deeply (c. 1000 ft) usually breathing a mixture of oxygen and helium. Nitrogen is not a factor as it is in INERT GAS NARCOSIS. HN(86) MHÑHigh Pressure Nervous Syndrome ANin divers; do not confuse with INERT GAS NARCOSIS; DF: HPNS PIAtmospheric Pressure (66-85); Central Nervous System Diseases (66-85); Diving (66-85); Pressure (66-85); Syndrome (72-85) MNC10.228.470; C21.447.410 DMÑCentral Nervous System Diseases LH LM  PM65 HN65(64) MHÑHigher Nervous Activity ANonly /drug eff /rad eff; this expression is found intact as ╥vysshaia nervnaia deiatel'nost╙ in Russian neurophysiol lit MNG11.561.353 LH  PM68 HN68 MHÑHindlimb ANnon-primate vertebrates only; NIM: TN 75; TN 117: table of animal extremities PIExtremities (66-67); Leg (66-67) MNA13.473 FXÑLeg XUÑHock; ÑStifle; ÑTarsus, Animal LH LX LU; ;  MHÑHip ANthe region or area; do not confuse with HIP JOINT or PELVIC BONES (os coxae); any Cat A qualif; /inj is probably HIP DISLOCATION or HIP FRACTURES; aseptic or avascular necrosis = FEMUR HEAD NECROSIS; coxarthrosis = HIP JOINT + OSTEOARTHRITIS; TN 117: use for human & other vertebrates; TN 238: differentiation from HIP JOINT & indexing instructions MNA1.378.592.467 XSCOXA LH LS  MHÑHip Contracture MNC5.550.323.468; C5.651.197.468 LH  MHÑHip Dislocation AN/congen = HIP DISLOCATION, CONGENITAL MNC21.866.289.384; C21.866.558.418 LH  MHÑHip Dislocation, Congenital ANdo not use /congen; /vet permitted but see below MNC16.131.621.449 XSHIP DYSPLASIA, CONGENITAL XUÑHip Dysplasia, Canine LH LS LU  MSA hereditary disease of the hip joints in dogs. Signs of the disease may be evident any time after 4 weeks of age. HN(76) MHÑHip Dysplasia, Canine ANdo not use /congen /vet; don't forget check tags ANIMAL & DOGS (NIM) PIHip Dislocation, Congenital/VE (66-75) MNC16.131.621.449.455; C22.268.485 DMÑHip Dislocation, Congenital LH LM  MSFractures of the femur head, the femur neck, the trochanters, or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region. For the fractures of the femur neck the specific term FEMORAL NECK FRACTURES is available. PM78 HN78 MHÑHip Fractures ANGEN or unspecified; trochanteric, intertrochanteric & subtrochanteric fract go here; fract below subtrochant = FEMORAL FRACTURES; FEMORAL NECK FRACTURES is available; femur head fract = FEMUR HEAD /inj (IM) + HIP FRACTURES (IM); acetabular fract = ACETABULUM /inj (IM) + FRACTURES (IM) PIFemoral Fractures (66-77); Fractures (66-77) MNC21.866.405.207.425; C21.866.558.276.425 LH  PM65 HN65 MHÑHip Joint ANany Cat A qualif; /inj is probably HIP DISLOCATION or HIP FRACTURES; coxarthrosis = HIP JOINT (IM) + OSTEOARTHRITIS (IM); TN 117: use for human & other vertebrates; TN 238: differentiation from HIP & indexing instructions MNA2.835.583.411 LH  MSPartial or total replacement of the hip joint. PM80 HN80 MHÑHip Prosthesis ANdo not use /instrum /methods /util (except by MeSH definition) PIArthroplasty (66-79); Hip (66-79); Hip Joint (66-79); Joint Prosthesis (71-79); Prosthesis (66-70) MNE4.557.168.530.490; E4.659.550.490; E7.450.530.530; E7.858.442.499.490; E7.858.565.600.490 XSArthroplasty, Replacement, Hip; Femoral Head Prosthesis LH LS;  OLsearch ANGIOMATOSIS 1966-74 HN(75) MHÑHippel-Lindau Disease MNC4.557.690.146.343 DMÑAngiomatosis LH LM  MHÑHippocampus ANdo not use /innerv MNA8.186.211.577.405 LH  MHÑHippocratic Oath ANno qualif MNK1.316.333.366.551; K1.752.667.416.551 LH  MHÑHippurates ANdo not use /analogs /biosyn /defic /physiol MND2.65.277.431; D2.241.223.106.162.431; D2.241.607.360 LH  MSCongenital megacolon due to absence of myenteric ganglion cells in a distal segment of the large intestine. OLsearch MEGACOLON 1966-82 PM83; was HIRSCHSPRUNG'S DISEASE see MEGACOLON 1963-82 HN83; was HIRSCHSPRUNG'S DISEASE see MEGACOLON 1963-82 MHÑHirschsprung Disease ANdo not use /congen & do not coord with INFANT, NEWBORN, DISEASES; acquired megacolon = MEGACOLON PIMegacolon (66-82) MNC6.405.469.158.701.439; C16.131.314.439 XSMegacolon, Congenital LH LS  MSExcess hair in females and children with an adult male pattern of distribution. Does not include hypertrichosis, which is localized (as in chronic low-grade trauma, hamartomas, and nevi) or generalized excess hair. PM66; was see under HYPERTRICHOSIS 1963-65 HN66(64); was see under HYPERTRICHOSIS 1963-65 MHÑHirsutism AN╥excess hair in females & child with an adult male pattern distrib╙; differentiate from HYPERTRICHOSIS, ╥localized or generalized excess hair╙ MNC17.805.305.470; C19.391.922.468 FXÑHypertrichosis LH LX  MHÑHirudin ANdo not use /biosyn /defic /physiol RN8001-27-2 MND19.461.119.550 LH  MSPersons living in the United States of Mexican, Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin. Does not include Brazilian Americans or Portuguese Americans. PM78 HN78 MHÑHispanic Americans ANUS residents of Mexican, Puerto Rican, Cuban, Cent American, South American or other Spanish culture or origin; does not include Brazilian Americans ( = UNITED STATES + BRAZIL /ethnol) nor Portuguese Americans ( = UNITED STATES + PORTUGAL /ethnol); only /class /hist /psychol; despite X refs specify NIM MEXICO /ethnol, PUERTO RICO /ethnol or other Hispanic country with /ethnol when pertinent PIEthnic Groups (68-77); Mexico (66-77); Puerto Rico (66-77); United States (66-77); specific state (66-77) MNI1.76.201.450.416.350; I1.880.143.522.350; M1.194.285 XSMexican Americans; Puerto Ricans; Spanish Americans LH LS; ;  MHÑHistaminase ANdo not use /analogs RNEC 1.4.3.6 MND8.586.682.135.518 XSDIAMINE OXIDASE LH LS  OLsearch HISTAMINE /AI under HISTAMINE H1 RECEPTOR BLOCKADERS 1966-76 PM/antagonists & inhibitors was ANTIHISTAMINICS 1963-76 HN/antagonists & inhibitors was ANTIHISTAMINICS 1963-76 MHÑHistamine AN/antag = HISTAMINE ANTAGONISTS if general & unspecified or HISTAMINE H1 RECEPTOR BLOCKADERS for classical ╥antihistamine╙ or HISTAMINE H2 RECEPTOR BLOCKADERS if so specified; /biosyn /physiol permitted but with caution; /secret = HISTAMINE LIBERATION; do not use /defic RN51-45-6 MND2.92.471.440; D3.383.374.373; D24.185.798.300 FXÑHYPERSENSITIVITY, IMMEDIATE LH LX  MSSubstances that prevent or antagonize the action of histamine by either inhibiting the release of histamine or by blocking the histamine receptors so that histamine cannot act; classical antihistaminics block the histamine H1 receptors only. OLsearch HISTAMINE H1 RECEPTOR BLOCKADERS 1966-76 PM77; was see ANTIHISTAMINICS 1963-76 HN77; was see ANTIHISTAMINICS 1963-76 MHÑHistamine Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; consider also HISTAMINE H1 RECEPTOR BLOCKADERS & HISTAMINE H2 RECEPTOR BLOCKADERS; DF: HISTAMINE ANTAG PIHistamine H1 Receptor Blockaders (66-76) MND23.654 LH  MSClassical antihistaminics; compounds that antagonize or prevent the action of histamine mainly in immediate hypersensitivity, i.e. in the bronchi, capillaries and some other smooth muscles; they are used to prevent or allay motion sickness, seasonal rhinitis and allergic dermatitis and to induce somnolence. OLuse HISTAMINE H1 RECEPTOR BLOCKADERS to search ANTIHISTAMINICS back thru 1966 PM77; was ANTIHISTAMINICS 1963-76 HN77; was ANTIHISTAMINICS 1963-76 MHÑHistamine H1 Receptor Blockaders ANdo not use /analogs /biosyn /defic /physiol; DF: RECEPT BLOCK H1 MND23.654.432 XSAntihistaminics FXÑBronchodilator Agents; ÑHypersensitivity, Immediate; ÑHypnotics and Sedatives LH LS LX; ;  MSAgents that antagonize or prevent the action of histamine in some smooth muscles, capillaries, heart and exocrine glands, especially stomach; they are used in the treatment of gastrointestinal ulcers. PM77 HN77 MHÑHistamine H2 Receptor Blockaders ANdo not use /analogs /biosyn /defic /physiol; DF: RECEPT BLOCK H2 MND23.654.443 FXÑAnti-Ulcer Agents LH LX  MHÑHistamine Liberation ANonly /drug eff /rad eff MNG4.610.431 FXÑCompound 48-80 LH LX  MSS-Adenosylmethionine:histamine N-methyltransferase. Catalyzes the transfer of a methyl group from S-adenosylmethionine to histamine, forming N-methylhistamine, the major metabolite of histamine in man. HN(75) MHÑHistamine Methyltransferase ANdo not use /analogs RNEC 2.1.1.8 PIHistamine (73-74); Methyltransferases (73-74) MND8.586.913.517.350 DMÑMethyltransferases LH LM  HN(73) MHÑHistidase ANalso for histidinase, histidine deaminase, histidine ammonia-lyase; do not use /analogs; /defic: consider also HISTIDINE /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 4.3.1.3 MND8.586.520.161.468 DMÑAmmonia-Lyases LH LM  MHÑHistidine AN/biosyn /defic /physiol permitted RN7006-35-1 MND12.125.72.329; D12.125.142.308 XUÑMethylhistidines LH LU  MSCatalyzes the decarboxylation of histidine to histamine and carbon dioxide. Requires pyridoxal phosphate in animal tissues, but not in microorganisms. HN(75) MHÑHistidine Decarboxylase ANdo not use /analogs RNEC 4.1.1.22 PICarboxy-Lyases (73-74); Histidine (73-74) MND8.586.520.258.390 XSHistidine Carboxy-Lyase DMÑCarboxy-Lyases LH LS LM  MSbeta-Amino-1H-imidazole-4-propanol. The penultimate step in the pathway of histidine biosynthesis. Oxidation of the alcohol group on the side chain gives the acid group forming histidine. Histidinol has also been used as an inhibitor of protein synthesis. HN(75) MHÑHistidinol ANdo not use /defic /physiol; /analogs NIM only RN501-28-0 PIAmino Alcohols (72-74); Imidazoles (72-74) MND2.33.329.624.380; D2.92.63.624.380; D3.383.374.385 XSHistidol DMÑImidazoles LH LS LM  MSHistidinol-phosphate phosphohydrolase. Catalyzes the hydrolysis of histidinol-phosphate to histidinol. One of the regulatory enzymes in histidine biosynthesis. HN(75) MHÑHistidinolphosphatase ANdo not use /analogs RNEC 3.1.3.15 PIAmino Alcohols (72-74); Imidazoles (72-74); Phosphatases (73-74) MND8.586.277.352.630.654.530 XSHistidinol Phosphate Phosphatase DMÑPhosphomonoesterases LH LS LM  MSL-Histidine:tRNA-His ligase (AMP-forming). Activates histidine with its specific transfer RNA. HN(75) MHÑHistidyl T RNA Synthetase ANdo not use /analogs; note spacing RNEC 6.1.1.21 PIAmino Acyl T RNA Synthetases (72-74); Histidine (72-74) MND8.586.464.136.400 DMÑAmino Acyl T RNA Synthetases LH LM  PM65 HN65(64) MHÑHistiocytes ANA 11 qualif & /class; lipid histiocytosis = NIEMANN-PICK DISEASE MNA11.329.372.385; A11.733.397.385; A15.382.680.397.385; A15.382.812.522.385 FXÑRETICULOENDOTHELIAL SYSTEM LH LX  PM68 HN68 MHÑHistiocytoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); histiocytoma unspecified = FIBROMA, histiocytoma, fibrous = HISTIOCYTOMA, histiocytoma cutis = ANGIOMA, SCLEROSING PIAngioma, Sclerosing (66-67); Lymphoma, Histiocytic (66-67) MNC4.557.499.438 LH  MSGroup of disorders of histiocyte proliferation which includes Letterer-Siwe Disease, Hand-Schueller-Christian Syndrome, and Eosinophilic Granuloma. OLsearch RETICULOENDOTHELIOSIS 1966-74 PM76; was see under RETICULOENDOTHELIOSIS 1965-75 HN76(75); was see under RETICULOENDOTHELIOSIS 1965-75 MHÑHistiocytosis X ANcoord with precoord organ/dis term (IM); note present indentions under HISTIOCYTOSIS X & under RETICULOENDOTHELIOSIS; histiocytosis not specified as X goes under RETICULOENDOTHELIOSIS PIReticuloendotheliosis (66-74) MNC15.604.667.490 LH  MSA rare, usually rapidly progressive disorder, characterized by abrupt onset, fever, weight loss, hepato-splenomegaly, pancytopenia, and lymphadenopathy. PM87 HN87 MHÑHistiocytosis, Malignant ANdo not use /anal /blood supply /secret /ultrastruct PIReticuloendotheliosis (66-86) MNC4.557.386.345 XSReticulosis, Histiocytic Medullary LH LS  MSThe degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. PM70 HN70(68) MHÑHistocompatibility ANonly /drug eff /rad eff PITransplantation Immunology (66-67) MNG4.610.555.714.519 XSTISSUE COMPATIBILITY LH LS  MSAntigens found on most vertebrate cells that are genetically determined by the Major Histocompatibility Complexes (MAC); they are glycoproteins determining tissue type for transplantations and provoking allograft rejections. PM73 HN73 MHÑHistocompatibility Antigens ANnon-human only: for human use HLA ANTIGENS; only /admin /adv eff /anal /csf /class /immunol /isol /rad eff /stand /tox /urine; /genet permitted but consider also MAJOR HISTOCOMPATIBILITY COMPLEX PIHistocompatibility (70-72); Immunology; Transplantation; Transplantation Immunology (66-69) MND24.611.216.705.552 XSLD Antigens; Leukocyte Antigens; SD Antigens; TRANSPLANTATION ANTIGENS LH LS; ; ;  PM70 HN70(68) MHÑHistocompatibility Testing ANonly /instrum /methods /vet PITransplantation Immunology (66-67) MNE1.223.495.468; E5.478.468 XSCrossmatching, Tissue; Tissue Typing FXÑGenetics; ÑTransplantation; ÑTransplantation Immunology LH LS; LX; ;  OLuse HISTOCYTOCHEMISTRY to search CYTOCHEMISTRY & HISTOCHEMISTRY back thru 1966 PM67; CYTOCHEMISTRY was heading 1966; HISTOCHEMISTRY was heading 1964-66; PERIODIC ACID-SCHIFF REACTION was see under STAINS AND STAINING 1977-78 HN67; CYTOCHEMISTRY was heading 1966; HISTOCHEMISTRY was heading 1964-66 MHÑHistocytochemistry AN= histochem or cytochem or both; NIM usually with no qualif; SPEC qualif when IM; histochem of disease is disease /metab; Manual 26.28 MNE5.909.262.607; E5.909.432.551; G1.201.344 XSCytochemistry XUÑPeriodic Acid-Schiff Reaction; ÑPrussian Blue Reaction LH LS LU;  MHÑHistological Technics ANdo not use /methods /util (except by MeSH definition) CATALOG: do not use /laboratory manuals MNE5.909.432 LH  MHÑHistology ANSPEC only: SPEC qualif; prefer /anat & histol with specific organs & organisms: Manual 19.5+; /methods = HISTOLOGICAL TECHNICS MNG1.100.656 LH  MHÑHistology, Comparative ANIM: SPEC only, SPEC qualif; usually NIM coord: no qualif; Manual 18.13; more likely is tag COMPARATIVE STUDY with specific A or B term with /anat & histol MNG1.100.656.469 LH  MSHydrolyzes N-acetyl groups on histones. HN(75) MHÑHistone Deacetylase ANdo not use /analogs RNEC 3.5.1.- PIAcetic Acids (71-74); Amidohydrolases (71-74); Histones (71-74) MND8.586.277.87.520 DMÑAmidohydrolases LH LM  MSAn aspect of protein kinase (EC 2.7.1.37) in which histones are phosphorylated in the presence of ATP. HN(75); was see under PROTEIN KINASE 1975-79 MHÑHistone Kinase ANdo not use /analogs RNEC 2.7.1.70 PIHistones (74); Protein Kinases (74) MND8.586.913.696.729.726.400 DMÑProtein Kinases LH LM  MHÑHistones ANdo not use /analogs; H1, H2a, H2b, H3, etc. go here MND12.776.664.469 LH  MHÑHistoplasma ANdo not use /anat /embryol /microbiol /parasitol; infection = HISTOPLASMOSIS MNB5.354.381.546.440 LH  HN(86)63 MHÑHistoplasmin ANonly /admin /adv eff /anal /csf /class /immunol /isol /rad eff /stand /tox /urine RN9008-05-3 MND24.611.216.202.386 DMÑAntigens, Fungal LH LM  MHÑHistoplasmosis MNC1.703.450 LH  HN66 MHÑHistorical Article ANcheck tag only; Manual 17.1+ CATALOG: do not use: for indexers only LH  HN66 MHÑHistorical Biography ANcheck tag only; ╥historical╙ relates to date of journal (death 2 or more years before date of publication), not to calendar year; death during year of publication & year preceding is CURRENT BIOG-OBIT; Manual 17.2+ CATALOG: do not use: for indexers only LH  MHÑHistoriography AN= the writing of histories; no qualif MNK1.419.441 LH  MHÑHistory ANSPEC only; no qualif; prefer /hist for specific subjects: Manual 19.5+; IM as subject: Manual 32.3; Saints: TN H MNK1.419 LH  PM65 HN65 MHÑHistory of Dentistry ANGEN only; prefer /hist with specific dent term (IM) & do not coord here at all or under DENTISTRY /hist; no qualif; Manual 32.7, 32.8 CATALOG: /geog /form MNK1.419.497 LH  MHÑHistory of Medicine ANno qualif; Manual 18.14+; policy: Manual 32.4-.6; hist check tags: Manual 18.14+; Avicenna (Ibn Sina): see note under MEDICINE, ARABIC CATALOG: /geog /form MNK1.419.552 LH  MHÑHistory of Medicine, Ancient ANIM; no qualif; check tag when not point of article; Saints: TN H; Byzantium or Byzantine Empire: do not locate by modern geog country CATALOG: /geog /form MNK1.419.552.285 LH  MHÑHistory of Medicine, Medieval ANIM; 500-1450 AD; no qualif; check tag when not point of article; Avicenna (Ibn Sina): see note under MEDICINE, ARABIC: TN 12; Saints: TN H; Byzantium or Byzantine Empire: do not locate by modern geog country CATALOG: /geog /form MNK1.419.552.298 LH  MHÑHistory of Medicine, Modern AN1450-present; avoid as NIM: prefer one or all specific indentions; for IM see Manual 18.14.7 CATALOG: /geog /form MNK1.419.552.550 LH  PM64; was HISTORY OF MEDICINE, XV CENT. 1963 HN64; was HISTORY OF MEDICINE, XV CENT. 1963 MHÑHistory of Medicine, 15th Cent. ANIM; no qualif; check tag when not point of article CATALOG: /geog /form MNK1.419.552.318 LH  PM64; was HISTORY OF MEDICINE, XVI CENT. 1963 HN64; was HISTORY OF MEDICINE, XVI CENT. 1963 MHÑHistory of Medicine, 16th Cent. ANIM; no qualif; check tag when not point of article CATALOG: /geog /form MNK1.419.552.352 LH  PM64; was HISTORY OF MEDICINE, XVII CENT. 1963 HN64; was HISTORY OF MEDICINE, XVII CENT. 1963 MHÑHistory of Medicine, 17th Cent. ANIM; no qualif; check tag when not point of article CATALOG: /geog /form MNK1.419.552.385 LH  PM64; was HISTORY OF MEDICINE, XVIII CENT. 1963 HN64; was HISTORY OF MEDICINE, XVIII CENT. 1963 MHÑHistory of Medicine, 18th Cent. ANIM or NIM: Manual 18.14+, 32.4-.6; no qualif; check tag when not point of article CATALOG: /geog /form MNK1.419.552.418 LH  PM64; was HISTORY OF MEDICINE, XIX CENT. 1963 HN64; was HISTORY OF MEDICINE, XIX CENT. 1963 MHÑHistory of Medicine, 19th Cent. ANNIM; no qualif; check tag when not point of article CATALOG: /geog /form MNK1.419.552.451 LH  PM64; was HISTORY OF MEDICINE, XX CENT. 1963 HN64; was HISTORY OF MEDICINE, XX CENT. 1963 MHÑHistory of Medicine, 20th Cent. ANNIM; no qualif; check tag when not point of article CATALOG: /geog /form MNK1.419.552.484 LH  PM66 HN66 MHÑHistory of Nursing ANGEN only; prefer /hist with specific nurs term (IM) & do not coord here at all or under NURSING /hist; no qualif; Manual 18.14+, 32.7-.8 CATALOG: /geog /form MNK1.419.608 LH  MSA personality disorder characterized by overly reactive and intensely expressed behavior, overly dramatic and prone to exaggeration, emotional excitability, and disturbances in interpersonal relationships. OLuse HISTRIONIC PERSONALITY DISORDER to search HYSTERICAL PERSONALITY back thru 1969 PM81; was HYSTERICAL PERSONALITY 1969-80 HN81; was HYSTERICAL PERSONALITY 1969-80 MHÑHistrionic Personality Disorder ANdo not use /drug eff /physiol /rad eff PIHysteria (66-68) MNF3.709.597.357 XSHysterical Personality; Personality Disorder, Histrionic; Personality, Hysterical LH LS; ;  MSAntigens determined by the Human Leukocyte Locus A, the major histocompatibility locus in man; they are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation and are associated with certain diseases. OLto search HL-A ANTIGENS & HL-A use HLA ANTIGENS back thru 1975 & HISTOCOMPATIBILITY ANTIGENS 1974 PM82; was HL-A ANTIGENS 1978-81, was HL-A see under HISTOCOMPATIBILITY ANTIGENS 1974-77 HN82; was HL-A ANTIGENS 1978-81, was HL-A see under HISTOCOMPATIBILITY ANTIGENS 1974-77 MHÑHLA Antigens ANhuman only; HLA goes here; note HLA-D ANTIGENS below; only /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIHistocompatibility (70-72); Histocompatibility Antigens (73-74) MND24.611.216.705.552.450 XSClass I Human Antigens; Human Class I Antigens; LD Antigens, Human; SD Antigens, Human LH LS; ; ;  MSHuman immune-response or Class II antigens found mainly, but not exclusively on B lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. OLsearch ANTIGENS, IMMUNE RESPONSE 1981-86 PM87; was see ANTIGENS, IMMUNE RESPONSE 1981-86 HN87; was see ANTIGENS, IMMUNE RESPONSE 1981-86 MHÑHLA-D Antigens ANGEN; prefer specifics; only /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIAntigens, Immune Response (81-86) MND24.611.216.705.552.50.400; D24.611.216.705.552.450.400 XSClass II Human Antigens; HLA-D-Related Antigens; HLA-Dw Antigens; Human Class II Antigens; Ia-Like Antigens, Human; Immune Response-Associated Antigens, Human; Immune-Associated Antigens, Human; Immune-Response Antigens, Human XUÑHLA-DP Antigens; ÑHLA-DQ Antigens; ÑHLA-DR Antigens LH LS; ; ; ; ; ; ; LU; ;  MSA group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprized of alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HN(87) MHÑHLA-DP Antigens ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIAntigens, Immune Response (81-86) MND24.611.216.705.552.50.420; D24.611.216.705.552.450.420 XSHLA-PL Antigens; HLA-SB Antigens DMÑHLA-D Antigens LH LS; LM  MSA group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprized of alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HN(87) MHÑHLA-DQ Antigens ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIAntigens, Immune Response (81-86) MND24.611.216.705.552.50.430; D24.611.216.705.552.450.430 XSHLA-DC Antigens; HLA-MB Antigens DMÑHLA-D Antigens LH LS; LM  MSA group of D-related human leukocyte antigens that are polymorphic glycoproteins found on lymphoid cells; they consist of alpha and beta chains and their inheritance differs from that of the DQ and DP antigens; their presence seems to be associated with certain skin diseases, like pemphigus vulgaris, dermatitis herpetiformes, and type I diabetes. HN(87) MHÑHLA-DR Antigens ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /rad eff /stand /tox /urine PIAntigens, Immune Response (81-86) MND24.611.216.705.552.50.440; D24.611.216.705.552.450.440 XSHLA-BR Antigens; HLA-MT Antigens DMÑHLA-D Antigens LH LS; LM  MHÑHoarseness ANfor other qualities of voice VOICE QUALITY & VOICE DISORDERS are available MNC8.618.445; C9.400.940.490; C10.597.257.960.475; C23.888.592.257.960.475; C23.888.852.490 LH  MSLeisure activities engaged in for pleasure. MHÑHobbies ANno qualif MNI3.450.642.469 LH  OLsearch HINDLIMB 1968-74 HN(75) MHÑHock ANNIM; TN 102 & 117: table of animal extremities MNA13.473.345 DMÑHindlimb LH LM  MSA game in which 2 parties of players provided with curved or hooked sticks seek to drive a ball or puck through opposite goals; applies to either ice hockey or field hockey. HN(76) MHÑHockey ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); Manual 30.31+ PISports (66-75) MNI3.450.642.845.475 XSIce Hockey DMÑSports LH LS LM  MSA malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. MHÑHodgkin's Disease ANneoplastic MNC4.557.386.355; C15.604.515.569.475; C20.683.515.761.355 XSGranuloma, Hodgkin's; Granuloma, Malignant; Lymphogranuloma, Malignant LH LS; ;  MS2-[2-(4-Hydroxyphenyl)-6-benzimidazolyl]-6-(1-methyl-4-piperazyl)-benzimidazole trihydrochloride. A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis. HN(77) MHÑHoe 33258 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23491-45-4 PIBenzimidazoles (71-76); Phenols (72-75); Piperazines (71-75) MND3.438.103.500; D21.201.287.278.455; D26.408.348.600 DMÑBenzimidazoles LH LM  MHÑHog Cholera ANdo not use /vet; swine fever = HOG CHOLERA (caused by HOG CHOLERA VIRUS) but do not confuse with AFRICAN SWINE FEVER (caused by AFRICAN SWINE FEVER VIRUS) or swine plague (caused by Pasteurella multocida & indexed as HEMORRHAGIC SEPTICEMIA /vet (IM) + SWINE DISEASES (IM) + SWINE (NIM) ); don't forget also SWINE (NIM) & check tag ANIMAL MNC2.782.930.480; C22.905.553 LH  MSA species of the Pestivirus genus causing exceedingly contagious and fatal hemorrhagic disease of swine. PM79 HN79 MHÑHog Cholera Virus ANdo not use /blood-csf-urine /cytol; infection = HOG CHOLERA; do not confuse synonym SWINE FEVER VIRUS with AFRICAN SWINE FEVER VIRUS PIHog Cholera (66-78); RNA Viruses (66-78) MNB4.909.777.923.723.470 XSSwine Fever Virus LH LS  MSDays commemorating events; also vacation periods. OLuse HOLIDAYS to search FESTIVALS back thru 1966 HNFESTIVALS was see under HOLIDAYS 1963-82 MHÑHolidays ANno qualif MNI3.450.345 XSFestivals LH LS  MSHealth as viewed from the perspective that man and other organisms function as complete, integrated units rather than as aggregates of separate parts. PM80 HN80 MHÑHolistic Health ANonly /hist; also called ╥holistic medicine╙ MNK1.752.667.710 LH  MHÑHolmium ANHo-165; do not use /analogs /biosyn /defic /physiol; Ho-151-170, except Ho-165 = HOLMIUM (IM) + RADIOISOTOPES (IM) RN7440-60-0 MND1.268.394; D1.552.550.406 LH  PM74 HN74(69) MHÑHolography ANonly /instrum /methods /stand PILasers (66-68); Photography (66-68) MNE5.712.345; H1.671.606.799.345 FXÑLasers LH LX  MSA highly toxic saponin occurring in the tropical sea cucumber, Holothuriodeae, phylum Echinodermata. This marine toxin is an anionic surfactant, hemolyzing red blood corpuscles. It acts irreversibly to destroy the excitability at cholinergic neuromuscular junctions. HN(75) MHÑHolothurin ANdo not use /defic /physiol; /analogs NIM only RN11029-72-4 PIEchinodermata (70-74); Saponins (70-74); Steroids (72-74); Toxins (70-74) MND9.203.408.782.350; D24.185.926.580.450 DMÑSaponins LH LM  MSPersonality evaluation based on the scoring of several variables as a result of the subject's responses in perceiving 47 inkblot plates. OLsearch INK BLOT TESTS 1969-70 HN(71) MHÑHoltzman Inkblot Test ANno qualif PIInk Blot Tests (66-70) MNF4.711.647.622.341.387 DMÑInk Blot Tests LH LM  MSCommunity health services providing coordinated multiple service home care to the patient in his home. OLuse HOME CARE SERVICES to search HOME CARE SERVICE back thru 1966 PM67; was HOME CARE SERVICE 1966 HN67; was HOME CARE SERVICE 1966 MHÑHome Care Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form MNN2.421.143.524 XSDomiciliary Care; Home Health Agencies XUÑHomemaker Services LH LS; LU  MSChildbirth taking place in the home. HN(83) MHÑHome Childbirth ANonly /instrum /methods PIDelivery (66-82) MNE4.819.774.457.450 XSChildbirth at Home; Delivery, Home DMÑDelivery LH LS; LM  MSNursing care of the patient in his home by members of the family. PM66; was NURSING, HOME 1963-65 HN66; was NURSING, HOME 1963-65 MHÑHome Nursing ANby non-professionals only (family, friends, etc.): do not confuse with HOME CARE SERVICES (by professional: visiting nurse, public health nurse, etc.); only /econ /educ /legis /man /psychol /stand /trends CATALOG: do not use /pop wks MNE2.472.611.470; N2.421.143.524.470; N2.421.533.320 XSNURSING, HOME LH LS  MSRefers to the area about the animal's home which is traversed by the animal in its normal activities for food gathering, mating, and caring for young. PM68 HN68 MHÑHome Range ANno qualif PIBehavior, Animal (66-67) MNF1.145.113.646 LH  MSPersons who have no permanent residence; excludes nomadic peoples. PM86 HN86 MHÑHomeless Persons ANnot for nomads; only /psychol PITransients and Migrants (66-85) MNM1.325 XSStreet People LH LS  MSNon-medical support services, such as food preparation and bathing, given by trained personnel to disabled, sick or convalescent individuals in their home. HN(73) MHÑHomemaker Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util PIHome Care Services (66-72) MNN2.421.143.524.595 DMÑHome Care Services LH LM  MHÑHomeopathy ANIM; SPEC: SPEC qualif MNE2.924.490 FXÑFORMULARIES, HOMEOPATHIC; ÑPHARMACOPOEIAS, HOMEOPATHIC LH LX;  MHÑHomeostasis ANonly /drug eff /rad eff MNG7.621 XSAutoregulation LH LS  MSGeriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required. OLuse HOMES FOR THE AGED to search OLD AGE HOMES back thru 1966 PM68; was OLD AGE HOMES 1963-67 HN68; was OLD AGE HOMES 1963-67 MHÑHomes for the Aged ANdo not use /educ; nursing homes for the aged: coord IM with NURSING HOMES (IM) CATALOG: /geog /form MNN2.278.825.462 XSContinuing Care Retirement Centers; Life Care Centers, Retirement; OLD AGE HOMES FXÑAged LH LS; ; LX  MSThe killing of one person by another. MHÑHomicide ANno qualif MNC23.240.571; I1.198.240.470 XSMURDER FXÑDeath LH LS LX  MSN-6-(Aminoiminomethyl)-lysine. HN(75) MHÑHomoarginine ANdo not use /biosyn /defic /physiol RN13094-78-5 PIAminocaproic Acids (72-74); Guanidines (72-74) MND12.125.95.104.400 DMÑArginine LH LM  MHÑHomocysteine ANdo not confuse with HOMOCYSTINE RN454-28-4 MND12.125.166.498 XUÑS-Adenosylhomocysteine LH LU  PM73 HN73(67) MHÑHomocystine ANdo not confuse with HOMOCYSTEINE; /urine = HOMOCYSTINURIA RN462-10-2 PIAminobutyric Acids (66) MND12.125.95.533; D12.125.119.658; D12.125.166.554 LH  MSInborn error of sulfur amino acid metabolism characterized by elevated levels of homocystine in the plasma and urine. Predominant clinical feature is mental retardation. A deficiency in cystathionine synthase exists in the most common form of the disease. PM69 HN69(67) MHÑHomocystinuria ANdo not use /congen /drug eff /physiol /rad eff PIAmino Acid Metabolism, Inborn Errors (66); Mental Retardation (66) MNC10.228.140.163.428; C10.496.363; C18.452.648.66.470; C23.205.428; F3.709.346.378 LH  PM73 HN73(71) MHÑHomogentisic Acid ANdo not use /biosyn /defic /physiol RN451-13-8 PIPhenylacetates (66-70) MND2.241.223.601.421 LH  PM73 HN73(71) MHÑHomoserine RN498-19-1 PIAmino Acids (66-70); Hydroxybutyrates (66-70) MND12.125.526 LH  MSHomoserine:NAD+ oxidoreductase. Catalyzes the reduction of aspartic beta-semialdehyde to homoserine, which is the branch point in biosynthesis of methionine, lysine, threonine and leucine from aspartic acid. HN(75) MHÑHomoserine Dehydrogenase ANdo not use /analogs RNEC 1.1.1.3 PIAlcohol Oxidoreductases (73-74); Homoserine (73-74) MND8.586.682.47.370 DMÑAlcohol Oxidoreductases LH LM  MSSexual attraction or relationship between members of the same sex. OLuse HOMOSEXUALITY to search HOMOSEXUALITY, FEMALE & LESBIANISM back thru 1968 PMHOMOSEXUALITY, FEMALE was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY, FEMALE 1976-80, was see under HOMOSEXUALITY 1968-75 HNHOMOSEXUALITY, FEMALE was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY, FEMALE 1976-80, was see under HOMOSEXUALITY 1968-75 MHÑHomosexuality ANno qualif; check tags MALE or FEMALE; note category; differentiate from HOMOSEXUALITY, EGO-DYSTONIC: read MeSH definition MNF1.145.792.320 XSLesbianism LH LS  MSHomosexuality characterized by the individual's desire to acquire or increase heterosexual arousal so that heterosexual relationships can be initiated and maintained. There is also a sustained pattern of homosexual arousal that the individual explicitly states has been unwanted and a persistent source of distress. PM81 HN81 MHÑHomosexuality, Ego-Dystonic ANdo not use /drug eff /physiol /rad eff PIHomosexuality (66-80) MNF3.709.597.608.480 XSLesbianism, Ego-Dystonic LH LS  PM68 HN68 MHÑHomosteroids ANdo not use /analogs MND4.808.496 LH  PM86; was see under PHENYLACETATES 1975-85 HN86(73); was see under PHENYLACETATES 1975-85, was Prov 1973-74 MHÑHomovanillic Acid ANdo not use /biosyn /defic /physiol RN306-08-1 MND2.241.223.601.521 LH  MSAn individual in which both alleles at a given locus are identical. PM68 HN68 MHÑHomozygote ANno qualif PIGenes (66-67); Genetics (66-67) MNG5.441.554 LH  MHÑHonduras MNZ1.107.169.534 LH  MHÑHoney ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNJ1.341.544 FXÑBees LH LX  MHÑHong Kong MNZ1.252.474.363 LH  PM68 HN68 MHÑHoof and Claw ANfor cat & dog claws (nails): not for chicken claws (whole foot); DF: HOOF PIFoot (66-67); specific animal MNA13.491 XSCLAW LH LS  MSInfection of humans or animals with hookworms other than those caused by the genus Ancylostoma, Bunostoma, or Necator, for which the specific terms ANCYLOSTOMIASIS, BUNOSTOMIASIS and NECATORIASIS are available. OLuse HOOKWORM INFECTIONS to search HOOKWORM INFECTION back thru 1966 PM73; was HOOKWORM INFECTION 1963-72 HN73; was HOOKWORM INFECTION 1963-72 MHÑHookworm Infections ANGEN: prefer specifics; New World hookworm infection = NECATORIASIS, Old World hookworm infection = ANCYLOSTOMIASIS MNC3.335.508.455 LH  MHÑHordeolum MNC1.252.868.820.464; C11.338.648 XSSTYE LH LS  MSChemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones or the action of hormones upon their specific sites. PM75 HN75 MHÑHormone Antagonists ANdo not use /analogs /antag /defic /physiol; DF: HORMONE ANTAG PIHormones/AI (68-74) MND6.347 LH  MHÑHormones ANGEN only: prefer specifics; /biosyn /physiol permitted; /defic: see TN 194; /secret: TN 105; do not use /analogs /antag ( = HORMONE ANTAGONISTS); /chem syn permitted: do not convert to HORMONES, SYNTHETIC MND6.472 XUÑParotin LH LU  PM68 HN68 MHÑHormones, Ectopic AN/biosyn /physiol permitted; do not use /analogs /defic; coord IM with specific hormone (IM) + ectopic site (IM) or neopl term (IM) if applicable PIspecific hormone MND6.472.397 FXÑNEOPLASTIC ENDOCRINE-LIKE SYNDROMES LH LX  MH*Hormones, Substitutes, Antagonists (Non Mesh) MND6 LH  MSSynthetic chemical compounds which mimic the activity of hormones produced in the body, but differ in structure from naturally occurring hormones. PM75 HN75 MHÑHormones, Synthetic ANdo not use /analogs /biosyn /defic /physiol; do not confuse with HORMONES /chem syn; DF: HORMONES SYN PIHormones (66-74) MND6.597 XSHormone Analogs LH LS  MHÑHorner's Syndrome MNC10.120.522; C11.627.555; C11.716.555 LH  PM68 HN68 MHÑHorns ANanimal anat only: not for cutaneous horn ( = SKIN DISEASES or SKIN /abnorm); horn cancer: coord IM with NEOPLASMS /vet (IM) + histol type of neopl /vet (IM) PIspecific animal (66-67) MNA13.507 XUÑAntlers LH LU  MHÑHorse Diseases ANdo not use /compl /vet; don't forget also HORSES (NIM) & check tag ANIMAL MNC22.488 LH  MSAn enzyme isolated from horseradish which is able to act as an antigen. It is frequently used as a histochemical tracer for light and electron microscopy. Its antigenicity has permitted its use as a combined antigen and marker in experimental immunology. HN(76) MHÑHorseradish Peroxidase ANNIM; do not use /analogs RNEC 1.11.1.- PIPeroxidases (72-75); Plants (72-75) MND8.586.682.732.512 DMÑPeroxidases LH LM  MHÑHorses ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; does not include zebras nor mules ( = PERISSODACTYLA); consider also terms under EQUINE MNB2.649.709.472 LH  MSAn arthropod subclass (Xiphosura) comprised of the North American (Limulus) and Asiatic (Tachypleus) genera of horseshoe crabs. OLuse HORSESHOE CRABS to search LIMULUS back thru 1977 PM78; was LIMULUS see under ARTHROPODS 1977 HN78; was LIMULUS see under ARTHROPODS 1977 MHÑHorseshoe Crabs AN/microbiol /parasitol permitted PIArachnida (66-76); Arthropods (66-76); Crustacea (66-76) MNB1.131.450 XSCrabs, Horseshoe; Limulus; Tachypleus; Xiphosura FXÑLimulus Test LH LS; ; ; LX  MSFacilities or services which are especially devoted to providing palliative and supportive care to the patient with a terminal illness, and the patient's family. PM80; was see under HOSPITALS, SPECIAL 1978-79 HN80(Aug 77); was see under HOSPITALS, SPECIAL Aug 77-79 MHÑHospices AN╥palliative & supportive care to the dying patient & his family╙; only /class /econ /hist /legis /man /organ /stand /supply /trends /util (if by MeSH definition); specify geog CATALOG: /geog /form PIHospitals, Special (68-Jul 77) MNN2.278.421.556.210; N2.421.143.550 FXÑTerminal Care LH LX  MSManagement of the internal organization of the hospital. MHÑHospital Administration ANonly /econ /educ /hist /legis /man /stand /trends CATALOG: /geog /form MNG2.309; N2.278.354; N4.452.442 XSHospital Organization and Administration FXÑPROFESSIONAL STAFF COMMITTEES XUÑAncillary Services, Hospital; ÑCentralized Hospital Services; ÑHospital Distribution Systems; ÑHospital Restructuring; ÑHospital Shops; ÑHospital-Physician Joint Ventures LH LS LX LU; ; ; ; ;  MSManagerial personnel responsible for implementing policy and directing the activities of hospitals. HN(78) MHÑHospital Administrators ANdo not use /man /methods PIHospital Administration (66-77) MNM1.526.70.490.490; M1.526.485.430.490; M1.526.485.740.380; N2.350.45.100.80; N2.350.685.160 DMÑHealth Facility Administrators LH LM  MSVolunteer organizations whose members perform work for the hospital without compensation. HN(Aug 77) MHÑHospital Auxiliaries ANonly /educ /stand /supply /util MNN2.350.952.473.110 DMÑHospital Volunteers LH LM  MSDenotes the number of beds which a hospital has been designed and constructed to contain. May also refer to the number of beds set up and staffed for use. OLsearch HEALTH FACILITY SIZE 1968-74 PM78; was see under HEALTH FACILITY SIZE 1968-77 HN78(75); was see under HEALTH FACILITY SIZE 1968-77 MHÑHospital Bed Capacity ANno qualif; specify geog; BED OCCUPANCY is also available for actual no. of beds occupied; DF: HOSP BED CAPAC PIHealth Facility Size (68-74) MNN2.278.306.472 XSBed Capacity, Hospital XUÑHospital Bed Capacity, 100 to 299; ÑHospital Bed Capacity, 300 to 499; ÑHospital Bed Capacity, 500 and over; ÑHospital Bed Capacity, under 100 LH LS LU; ; ;  OLsearch HOSPITAL BED CAPACITY, UNDER 200 under HOSPITAL BED CAPACITY, 100 TO 299 1978-79 HN(80); HOSPITAL BED CAPACITY, UNDER 200 was heading 1978-79 MHÑHospital Bed Capacity, under 100 ANno qualif; specify geog; DF: HOSP BED CAPAC UNDER 100 PIHospital Bed Capacity (75-77); Hospital Bed Capacity, 100 to 299 (78-79) MNN2.278.306.472.80 DMÑHospital Bed Capacity LH LM  OLuse HOSPITAL BED CAPACITY, 100 TO 299 to search HOSPITAL BED CAPACITY, UNDER 200 1978-79 HN(80); was HOSPITAL BED CAPACITY, UNDER 200 see under HOSPITAL BED CAPACITY 1978-79 MHÑHospital Bed Capacity, 100 to 299 ANno qualif; specify geog; DF: HOSP BED CAPAC 100 PIHospital Bed Capacity (75-77) MNN2.278.306.472.120 DMÑHospital Bed Capacity LH LM  OLuse HOSPITAL BED CAPACITY, 300 TO 499 to search HOSPITAL BED CAPACITY, 200 TO 499 1978-79 HN(80); was HOSPITAL BED CAPACITY, 200 TO 499 see under HOSPITAL BED CAPACITY 1978-79 MHÑHospital Bed Capacity, 300 to 499 ANno qualif; specify geog; DF: HOSP BED CAPAC 300 PIHospital Bed Capacity (75-77) MNN2.278.306.472.180 DMÑHospital Bed Capacity LH LM  HN(78) MHÑHospital Bed Capacity, 500 and over ANno qualif; specify geog; DF: HOSP BED CAPAC 500 PIHospital Bed Capacity (75-77) MNN2.278.306.472.300 DMÑHospital Bed Capacity LH LM  MSThe transmission of messages to staff and patients within a hospital. PM73 HN73(64) MHÑHospital Communication Systems ANonly /man /stand /util MNN2.278.354.322; N4.452.442.322 LH  MSMajor administrative divisions of the hospital. PM68 HN68 MHÑHospital Departments ANonly /class /econ /legis /man /organ /stand /trends /util; DF: HOSP DEP PIHospital Administration (66-67) MNN2.278.354.422; N4.452.442.422 XUÑAdmitting Department, Hospital; ÑAnesthesia Department, Hospital; ÑChaplaincy Service, Hospital; ÑEducation Department, Hospital; ÑMedical Records Department, Hospital; ÑNuclear Medicine Department, Hospital; ÑObstetrics and Gynecology Department, Hospital; ÑOccupational Therapy Department, Hospital; ÑPathology Department, Hospital; ÑPhysical Therapy Department, Hospital; ÑRadiology Department, Hospital; ÑRespiratory Therapy Department, Hospital; ÑSocial Work Department, Hospital; ÑSurgery Department, Hospital; ÑUrology Department, Hospital LH LU; ; ; ; ; ; ; ; ; ; ; ; ; ;  MSThe architecture, functional design and construction of hospitals. OLuse HOSPITAL DESIGN AND CONSTRUCTION to search HOSPITAL PLANNING AND CONSTRUCTION 1966-67 PM68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67 HN68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67 MHÑHospital Design and Construction ANonly /econ /hist /legis /man /stand /trends; differentiate from HOSPITAL PLANNING (develop of plans at a community, state, regional or natl level): HOSPITAL DESIGN AND CONSTRUCTION refers to architecture & decor; DF: HOSPITAL DESIGN CATALOG: /geog /form MNJ1.86.339.250; N2.278.200.403 XSHospital Renovation LH LS  MSSystems for delivering hospital supplies, food, laundry, etc. to patient care areas. HN(75) MHÑHospital Distribution Systems ANwithin a hosp or between hosps; do not use /methods /supply MNN2.278.354.446; N4.452.442.450 DMÑHospital Administration LH LM  MSIntegrated computer-assisted system designed to store, manipulate, and retrieve information concerned with administrative and clinical aspects of providing medical services in the hospital. PM87 HN87 MHÑHospital Information Systems MNL1.700.508.300.408; N4.452.442.452 XSMulti-Hospital Information Systems XUÑOperating Room Information Systems; ÑRadiology Information Systems LH LS LU;  MSAreawide planning for hospitals or planning of a particular hospital unit on the basis of projected consumer need. Do not use for hospital design and construction or for architectural plans. OLsearch HOSPITAL PLANNING AND CONSTRUCTION under HOSPITAL DESIGN AND CONSTRUCTION 1966-67 PM68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67 HN68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67 MHÑHospital Planning ANonly /econ /hist /legis /organ /stand /trends; differentiate from HOSPITAL DESIGN AND CONSTRUCTION (architecture & decor): HOSPITAL PLANNING is for develop of plans at a community, state, regional or natl level CATALOG: /geog /form PIHospital Design and Construction (66-67) MNN3.349.650.250.200 XSRegional Hospital Planning LH LS  MSCompilation of data on hospital activities and programs; excludes patient medical records. OLsearch MEDICAL RECORDS 1966-74 HN(75); was see under MEDICAL RECORDS 1963-78 MHÑHospital Records ANonly /class /econ /legis /stand; RECORDS CONTROL is also available (probably NIM when coord) MNN4.452.859.380 DMÑRecords LH LM  MSReorganization of the hospital corporate structure. HN(84) MHÑHospital Restructuring ANonly /econ /legis /stand /trends PIFinancial Management (78-83); Hospital Administration (66-83) MNN2.278.354.460; N4.452.442.454 XSHospital Diversification; Hospital Reorganization DMÑHospital Administration LH LS; LM  MSCooperation among hospitals for the purpose of sharing various departmental services, e.g., pharmacy, laundry, data processing, etc. PM72 HN72(68) MHÑHospital Shared Services ANonly /class /econ /hist /legis /man /organ /stand /trends /util PIHospital Administration (66-67); specific department MNN2.278.354.480; N4.452.442.458; N4.452.540.308 LH  MSStores located in hospitals selling merchandise or services for the convenience of patients, staff and visitors. HN(Aug 77) MHÑHospital Shops ANonly /econ /legis /man /stand /trends /util MNN2.278.354.520; N4.452.442.461 XSHospital Gift Shops DMÑHospital Administration LH LS LM  MSThose areas of the hospital organization not considered departments which provide specialized patient care. Includes various hospital special care wards. OLuse HOSPITAL UNITS to search WARDS, HOSPITAL back thru 1974 PM74 HN74; WARDS, HOSPITAL was see under HOSPITAL UNITS 1974-78 MHÑHospital Units ANonly /class /econ /legis /man /organ /stand /trends /util; special care wards go here or specific unit; consider also PATIENTS' ROOMS & see X refs there MNN2.278.388 XSCancer Care Units XUÑHemodialysis Units, Hospital; ÑSelf-Care Units LH LS LU;  MSIndividuals who donate their services to the hospital. PM66 HN66(65) MHÑHospital Volunteers ANonly /econ /educ /legis /psychol /stand /util MNM1.526.485.740.400; M1.955.473; N2.350.952.473 XUÑHospital Auxiliaries; ÑPatient Escort Service LH LU;  MSA formal financial agreement made between one or more physicians and a hospital to provide ambulatory alternative services to those patients who do not require hospitalization. HN(86) MHÑHospital-Physician Joint Ventures ANonly /econ /hist /legis /stand /trends /util; DF: JOINT VENTURES PIHospital Restructuring (84-85); Medical Staff, Hospital (78-85) MNN2.278.354.460.380; N4.452.442.454.380 XSJoint Ventures, Hospital-Physician DMÑHospital Administration LH LS LM  MSThe confinement of a patient in a hospital. MHÑHospitalization ANonly /econ /legis /trends; being in a hosp or being placed in a hosp: do not confuse with PATIENT ADMISSION, PATIENT READMISSION; LENGTH OF STAY & PATIENT DISCHARGE are also available; INSTITUTIONALIZATION is also available MNN2.421.589.473 FXÑChild, Hospitalized LH LX  MSUse for general articles on institutions with an organized medical staff which provide medical care to patients. MHÑHospitals AN/econ = ECONOMICS, HOSPITAL; /instrum = EQUIPMENT AND SUPPLIES, HOSPITAL; /legislation & jurisprudence = LEGISLATION, HOSPITAL or HOSPITALS (IM) + JURISPRUDENCE (IM); /organ = HOSPITAL ADMINISTRATION; do not use /educ; note specific hosp depts & specific types of hosp available; hosp admission, discharge & readmiss are available as PATIENT ADMISSION, PATIENT DISCHARGE & PATIENT READMISSION (see notes under each); specify geog: Manual 36.19 CATALOG: /geog /form MNN2.278.421 FXÑCommunity Health Services XUÑHospitals, Group Practice; ÑHospitals, Packaged; ÑHospitals, Proprietary; ÑHospitals, Rural; ÑHospitals, Satellite; ÑHospitals, Urban; ÑHospitals, Voluntary LH LX LU; ; ; ; ; ;  PM74 HN74 MHÑHospitals, Animal ANdo not use /educ /methods; specify geog CATALOG: /geog /form MNG3.230.150.360.250.200 LH  MSHospitals which provide care to patients with long term illnesses. HN(77) MHÑHospitals, Chronic Disease ANdo not use /educ /methods; coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog PIHospitals, Special (68-77) MNN2.278.421.556.200 DMÑHospitals, Special LH LM  MSInstitutions with permanent facilities and organized medical staff which provide the full range of hospital services primarily to a neighborhood area. PM73 HN73 MHÑHospitals, Community ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog CATALOG: /geog /form PICommunity Health Services (66-72); Hospitals (66-72) MNN2.278.421.306 LH  MSHospitals which provide care to the patient for the period following an acute illness until health is restored. MHÑHospitals, Convalescent ANdo not use /educ /methods; coord IM with special hosp or med specialty (IM or NIM) or with hosp ownership term (e.g., HOSPITALS, COUNTY) (IM or NIM) if pertinent; specify geog CATALOG: /geog /form MNN2.278.421.556.294 LH  MSHospitals controlled by the county government. HN(78) MHÑHospitals, County ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog MNN2.278.421.510.100 DMÑHospitals, Public LH LM  MSGovernment controlled hospitals which represent the major health facility for a designated geographic area. HN(78) MHÑHospitals, District ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog MNN2.278.421.510.140 DMÑHospitals, Public LH LM  MSHospitals controlled by agencies and departments of the U.S. federal government. HN(78) MHÑHospitals, Federal ANUS only; do not use /educ /methods; add UNITED STATES + state for location if pertinent MNN2.278.421.510.180 DMÑHospitals, Public LH LM  MSLarge hospitals with a resident medical staff which provides continuous care to maternity, surgical and medical patients. PM68 HN68 MHÑHospitals, General ANdo not use /educ /methods; coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog CATALOG: /geog /form PIHospitals (66-67) MNN2.278.421.389 LH  MSHospitals organized and controlled by a group of physicians who practice together and provide each other with mutual support. HN(Aug 77) MHÑHospitals, Group Practice ANonly /class /econ /hist /organ /stand /supply /trends /util; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog PIGroup Practice (66-Jul 77); Hospitals (66-Jul 77) MNN2.278.421.395 DMÑHospitals LH LM  MSSpecial hospitals which provide care to women during pregnancy and parturition. OLsearch HOSPITALS, SPECIAL 1968-74 HN(75) MHÑHospitals, Maternity ANdo not use /educ /methods; coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog MNN2.278.421.556.366 DMÑHospitals, Special LH LM  MSHospitals which provide care for the military personnel and usually for their dependents. HN(78) MHÑHospitals, Military ANdo not use /educ /methods; add UNITED STATES if US or other country, + state for Amer location MNN2.278.421.510.180.250 XSHospitals, Air Force; Hospitals, Army; Hospitals, Navy DMÑHospitals, Public LH LS; ; LM  MSHospitals controlled by the city government. HN(78) MHÑHospitals, Municipal ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify city if in MeSH or state, province or country if city is not in MeSH MNN2.278.421.510.210; N2.278.421.660.400 XSHospitals, City, Public-Owned DMÑHospitals, Public LH LS LM  MSHospitals providing care utilizing the generally accepted medical and surgical methods but with emphasis on the osteopathic system of therapy. HN(82) MHÑHospitals, Osteopathic ANdo not use /educ /methods; coord IM with hosp ownership term (e.g., HOSPITALS, PROPRIETARY) (IM or NIM) if pertinent; specify geog PIHospitals, Special (68-81); Osteopathic Medicine (66-81) MNN2.278.421.556.386 DMÑHospitals, Special LH LM  MSHospital equipment and supplies, packaged for long-term storage, sufficient to set up a general hospital in an emergency situation. Also called Packaged Disaster Hospitals, and, formerly, Civil Defense Emergency Hospitals. HN(67) MHÑHospitals, Packaged ANonly /class /econ /hist /organ /stand /supply /trends /util; specify geog PIHospitals (66) MNE7.430.473; N2.278.421.473 DMÑHospitals LH LM  MSSpecial hospitals which provide care for ill children. OLsearch HOSPITALS, SPECIAL 1968-74 HN(75) MHÑHospitals, Pediatric ANdo not use /educ /methods; coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog MNN2.278.421.556.437 DMÑHospitals, Special LH LM  MSPrivately organized and controlled hospitals which are operated for a profit. These include hospitals which are investor owned or chain operated. HN(75) MHÑHospitals, Proprietary ANprivately organized & controlled hosp operated for profit; coord NIM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE) or med specialty (IM or NIM) if pertinent; only /class /econ /hist /organ /stand /supply /trends /util; specify geog MNN2.278.215.110; N2.278.421.490 XSHospitals, Private, for Profit DMÑHospitals LH LS LM  MSSpecial hospitals which provide care to the mentally ill patient. MHÑHospitals, Psychiatric ANdo not use /educ /methods; coord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog; orderlies & ward attendants go under PSYCHIATRIC AIDES CATALOG: /geog /form MNN2.278.421.556.508 XSMENTAL HOSPITALS LH LS  MSHospitals controlled by various types of government, i.e., city, county, district, state or federal. PM78 HN78 MHÑHospitals, Public ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog CATALOG: /geog /form MNN2.278.421.510 XUÑHospitals, County; ÑHospitals, District; ÑHospitals, Federal; ÑHospitals, Military; ÑHospitals, Municipal; ÑHospitals, State LH LU; ; ; ; ;  MSHospitals located in a rural area. HN(86) MHÑHospitals, Rural ANdo not use /educ /methods; coord IM with special hosp or med specialty (IM or NIM) if pertinent; specify geog PIHospitals (66-85); Rural Health (66-85); Rural Population (68-85) MNN2.278.421.518 XSRural Hospitals DMÑHospitals LH LS LM  MSThose hospitals which are extensions of a main hospital and are wholly or partly administered by that hospital. HN(Aug 77) MHÑHospitals, Satellite ANonly /class /econ /hist /organ /stand /supply /trends /util; coord IM with hosp ownership term (e.g., HOSPITALS, FEDERAL; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) or specialty hosp or specialty (IM or NIM) if relevant; specify geog MNN2.278.421.530 XSHospitals, Branch DMÑHospitals LH LS LM  MSHospitals which provide care for a single category of illness with facilities and staff directed toward a specific service. PM68 HN68 MHÑHospitals, Special ANdo not use /educ /methods; coord IM with med special (IM) & hosp ownership term (e.g., HOSPITALS, COUNTY) (IM or NIM) if pertinent; specify geog; veterinary = HOSPITALS, ANIMAL; sanatoria & sanitaria (often used interchangeably) can go here but consider also HEALTH RESORTS CATALOG: /geog /form PIHospitals (66-67) MNN2.278.421.556 XUÑCancer Care Facilities; ÑCardiac Care Facilities; ÑHospitals, Chronic Disease; ÑHospitals, Maternity; ÑHospitals, Osteopathic; ÑHospitals, Pediatric LH LU; ; ; ; ;  MSHospitals controlled by agencies and departments of the state government. HN(78) MHÑHospitals, State ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify state if US, province if Canada, or other country MNN2.278.421.510.300 DMÑHospitals, Public LH LM  MSHospitals engaged in educational and research programs, as well as providing medical care to the patients. PM68 HN68 MHÑHospitals, Teaching ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog; consider also INTERNSHIP AND RESIDENCY CATALOG: /geog /form PIHospitals (66-67) MNN2.278.20.300; N2.278.421.639 XUÑHospitals, University LH LU  MSHospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research. OLto search UNIVERSITY HOSPITALS use HOSPITALS, UNIVERSITY back thru 1975 & HOSPITALS, TEACHING 1968-74 HN(78); was UNIVERSITY HOSPITALS see under HOSPITALS, TEACHING 1968-77 MHÑHospitals, University ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog MNN2.278.20.300.310; N2.278.421.639.725 DMÑHospitals, Teaching LH LM  MSHospitals located in metropolitan areas. HN(86) MHÑHospitals, Urban ANdo not use /educ /methods; coord IM with special hosp or med specialty (IM or NIM) if pertinent; specify geog PIHospitals (66-85); Urban Health (79-85); Urban Population (68-85) MNN2.278.421.660 XSHospitals, City, Non-Public Owned; Hospitals, Metropolitan; Urban Hospitals DMÑHospitals LH LS; ; LM  MSHospitals providing medical care to veterans of wars. MHÑHospitals, Veterans ANdo not use /educ /methods; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, PSYCHIATRIC; etc.) or med specialty (IM or NIM) if pertinent; specify geog CATALOG: /geog /form MNN2.278.421.510.180.400 XSVeterans Hospitals LH LS  MSNongovernmental, nonprofit hospitals; included in this category are hospitals owned and/or operated by churches, philanthropic foundations, fraternal societies, etc. HN(79) MHÑHospitals, Voluntary ANonly /class /econ /hist /organ /stand /supply /trends /util; coord NIM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE) or med specialty (IM or NIM) if pertinent; specify geog MNN2.278.421.700; N3.540.630.310 XSHospitals, Private, Nonprofit DMÑHospitals LH LS LM  MSThe immune responses of a host to a graft. A specific response is graft rejection. PM77 HN77 MHÑHost vs Graft Reaction ANonly /drug eff /rad eff; do not confuse with GRAFT VS HOST REACTION (Cat G) nor GRAFT VS HOST DISEASE (Cat C) PIGraft Rejection (71-76); Transplantation Immunology (66-72) MNG4.610.555.714.545 LH  MSThe interactions between two organisms, one of which lives at the expense of the other. PM80 HN80 MHÑHost-Parasite Relations ANno qualif; coord NIM with host /parasitol (IM) + parasite /physiol or other more specific qualif (IM) PIspecific host, organ, disease/PS (75-79) MNG4.185.410 XSParasite-Host Relations LH LS  MSTendency to feel anger toward and to seek to inflict harm upon a person or group. PM68 HN68 MHÑHostility ANonly /drug eff PIHate (66-67) MNF1.470.596 LH  MSVisits to the patient's home by professional personnel for the purpose of diagnosis and/or treatment. PM68 HN68 MHÑHouse Calls ANonly /econ /trends /util MNN4.452.758.307 LH  MSFlies of the species Musca domestica (family Muscidae), which infest human habitations throughout the world and often act as carriers of pathogenic organisms. MHÑHouseflies ANIM; /microbiol /parasitol permitted; do not use /drug eff for eff of insecticides: TN 111; note MUSCA DOMESTICA below but other Musca species & genera of family Muscidae go under DIPTERA MNB1.131.617.289.474 XSMusca Domestica LH LS  MSMore or less permanent items in the home, such as furniture, appliances, etc. PM76 HN76; was NON MESH before 1976 MHÑHousehold Articles AN╥more or less permanent items in the home╙ (as furniture, rugs, etc.): do not confuse with HOUSEHOLD PRODUCTS (substances & material used in ╥housekeeping or personal routine╙); only /class /stand /supply MNJ1.494 XSHousehold Equipment LH LS  MSSubstances or materials used in the course of housekeeping or personal routine. PM75 HN75 MHÑHousehold Products ANonly /ad-poi-tox /anal /class /stand /supply; these are consumable: differentiate from HOUSEHOLD ARTICLES, more or less permanent PIspecific product MNJ1.516 XSHousehold Supplies LH LS  MSThe care and management of property. PM73 HN73 MHÑHousekeeping ANonly /man /methods /stand /trends MNN2.508 LH  MSHospital department which manages and provides the required housekeeping functions in all areas of the hospital. OLuse HOUSEKEEPING, HOSPITAL to search HOSPITAL HOUSEKEEPING back thru 1966 PM78; was HOSPITAL HOUSEKEEPING 1963-77 HN78; was HOSPITAL HOUSEKEEPING 1963-77 MHÑHousekeeping, Hospital ANonly /econ /legis /man /methods /organ /stand /trends MNN2.278.354.422.412; N2.508.472; N4.452.442.422.412 XSHospital Housekeeping LH LS  MSLiving facilities for humans. MHÑHousing ANonly /econ /stand /trends CATALOG: /geog /form MNG3.230.150.360; N1.696.324 XSFamily-Patient Lodging; Patient-Family Lodging FXÑUrban Renewal LH LS; LX  PM72 HN72 MHÑHousing, Animal ANonly /econ /stand /trends PIAnimals, Laboratory (66-71); Housing (66-71) MNG3.230.150.360.250 LH  MSInfections caused by the HTLV retroviruses: includes human T-cell leukemia-lymphoma, adult T-cell leukemia, and ACQUIRED IMMUNODEFICIENCY SYNDROME. PM87 HN87 MHÑHTLV Infections ANHTLV-I infect goes here; HTLV-II infect = LEUKEMIA, HAIRY CELL; HTLV-III = AIDS; DF: HTLV INFECT PIHuman T-Cell Leukemia Virus (84-86); Retrovirus Infections (81-86) MNC2.782.815.483; C20.673.483 XSAdult T-Cell Leukemia-Lymphoma; Human T-Cell Leukemia-Lymphoma; Leukemia, Adult T-Cell; T-Cell Leukemia, Adult LH LS; ; ;  MSThe human T-cell lymphotropic retrovirus that causes AIDS, lymphadenopathy, immune thrombocytopenic purpura, and opportunistic infections. PM87 HN87 MHÑHTLV-III ANdo not use /blood-csf-urine /cytol; infection = AIDS PIHuman T-Cell Leukemia Virus (84-86) MNB4.909.574.807.505.483; B4.909.777.731.505.483 XSAIDS Virus; Human Immunodeficiency Viruses; Human T-Cell Leukemia Virus Type III; Human T-Cell Lymphotropic Virus Type III; Human T-Lymphotropic Virus Type III; LAV-HTLV-III; Lymphadenopathy-Associated Virus LH LS; ; ; ; ; ;  HN66 MHÑHuman ANcheck tag only; Manual 18.8+ CATALOG: do not use: for indexers only LH  MH*Human Activities (Non Mesh) MNI3 LH  MSContinuous sequential changes which occur in the physiological and psychological functions during the individual's life. PM78 HN78 MHÑHuman Development ANno qualif MNF1.525 LH  MSThe science of designing, building or equipping mechanical devices or artificial environments to the anthropometric, physiological, or psychological requirements of the people who will use them. OLuse HUMAN ENGINEERING to search ENGINEERING PSYCHOLOGY back thru 1969 HNENGINEERING PSYCHOLOGY was see under HUMAN ENGINEERING 1969-78 MHÑHuman Engineering ANno qualif; ╥medical ergonomics╙: index here but do not coord with MEDICINE MNF2.784.412; J1.293.556 XSEngineering Psychology; Ergonomics FXÑPSYCHOLOGY, INDUSTRIAL LH LS; LX  PM66 HN66 MHÑHuman Experimentation ANIM for moral, legal, ethical, sociolog, religious aspect of experiments on humans; coord IM with aspect (IM); not for exper dis or exper ther in human volunteers ( = check tag HUMAN); no qualif MNE5.445 FXÑEthics, Medical; ÑInformed Consent LH LX;  MSThe rights of the individual to cultural, social, economic and educational opportunities as provided by society, e.g., right to work, right to education and right to social security. PM73 HN73 MHÑHuman Rights ANonly /hist /legis; consider also CIVIL RIGHTS & WOMEN'S RIGHTS PICivil Rights (68-72) MNI1.880.604.473; N3.706.437 FXÑEthics XUÑFreedom; ÑSocial Justice LH LX LU;  MSA type C retrovirus isolated from patients with T-lymphoproliferative malignancy. It may be implicated in acquired immunodeficiency syndrome (AIDS). PM84 HN84 MHÑHuman T-Cell Leukemia Virus ANdo not use /blood-csf-urine /cytol; infection = HTLV INFECTIONS; HTLV-I = HTLV INFECTIONS; HTLV-II = LEUKEMIA, HAIRY CELL; HTLV-III = AIDS PILeukemia (66-83); T Lymphocytes (73-83); Lymphoma (66-83); Retroviridae (81-83) MNB4.909.574.807.505; B4.909.777.731.505 XSHTLV; Human T-Cell Leukemia-Lymphoma Virus; Leukemia Virus, Human T-Cell LH LS; ;  MSAn ethical system which emphasizes human values and the personal worth of each individual; also concern for the dignity and freedom of humankind. PM78 HN78 MHÑHumanism ANonly /hist PIEthics (66-77); Ethics, Medical (66-77); Philosophy (66-77); Philosophy, Medical (66-77) MNK1.316.400; K1.752.256.120 LH  MHÑHumanities ANno qualif MNK1 LH  MHÑHumeral Fractures ANfract of humerus except of proximal humerus ( = SHOULDER FRACTURES which includes humeral head, neck & tuberosities) MNC21.866.88.390; C21.866.405.410 LH  MHÑHumerus ANdisloc at shoulder = SHOULDER DISLOCATION: do not add HUMERUS MNA2.835.232.87.412 LH  MHÑHumic Acids AND25-26 qualif MND26.525 LH  MHÑHumidity ANonly /adv eff /prev MNG3.230.150.372; G3.230.300.100.725.310 LH  MHÑHungary ANin translations use spelling: People's Republic, not Peoples' nor Peoples MNZ1.542.248.495 LH  MSA strong desire for food. MHÑHunger ANonly /drug eff /physiol /rad eff MNF1.658.293.391 FXÑFOOD DEPRIVATION; ÑFasting; ÑSTARVATION; ÑStarvation LH LX; ; ;  OLuse HUNTINGTON CHOREA to search CHOREA, HEREDITARY back thru 1966 PM77; was CHOREA, HEREDITARY 1963-76 HN77; was CHOREA, HEREDITARY 1963-76 MHÑHuntington Chorea ANdo not use /congen MNC10.228.140.79.255.492 XSChorea, Hereditary LH LS  PM65 HN65 MHÑHutchinson's Teeth ANdo not use /congen MNC1.252.847.840.744.729.475; C16.131.314.904.557 LH  PM65 HN65 MHÑHyalin Substance ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.580 LH  MHÑHyaline Membrane Disease ANdo not use /congen; check tags HUMAN & INFANT, NEWBORN MNC8.381.801.475; C8.618.801.475; C16.614.521.563.475 FXÑRESPIRATORY DISTRESS SYNDROME LH LX  MHÑHyaluronic Acid RN9004-61-9 MND9.203.698.582.600 LH  MHÑHyaluronidase ANdo not use /analogs RNEC 3.2.1.35 MND8.586.277.450.529; D8.586.520.726.475 LH  PM72 HN72 MHÑHybrid Cells ANA 11 qualif; not for micro-organisms PIHybridization (66-71); Tissue Culture (66-71) MNA11.251.600 XSSOMATIC CELL HYBRIDS FXÑCell Fusion LH LS LX  MSThe adaptive superiority of heterozygous genotypes with respect to one or more characters in comparison with the corresponding homozygotes. HN(68) MHÑHybrid Vigor ANonly /drug eff /rad eff; ╥heterosis╙ goes here PIHybridization (66-67) MNG5.414.413.475 DMÑHybridization LH LM  MHÑHybridization ANonly /drug eff /rad eff MNG5.414.413 FXÑCrosses, Genetic XUÑHybrid Vigor LH LX LU  MSCells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure or ╥monoclonal╙ antibodies or T cell products, identical to those produced by the immunologically competent parent, and continually grow and divide as the neoplastic parent. PM82 HN82 MHÑHybridomas ANnote categ: not a tumor but ╥cells artif created by fusion of activated lymphocytes with neoplastic cells╙; A 11 qualif & /class PICell Fusion (75-81); Cell Line (75-81); Clone Cells (75-81); Hybrid Cells (75-81) MNA11.251.353.485; A11.251.600.485 FXÑAntibodies, Monoclonal LH LX  MS1-[[2-(diethylamino)ethyl]amino]-4-(hydroxymethyl)thioxanthen-9-one. Potentially toxic, but effective antischistosomal agent; metabolite of lucanthone. Synonyms: Etrenol. HN(75) MHÑHycanthone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3105-97-3 PIEthylenediamines (74); Thioxanthenes (74) MND3.494.953.704.450; D21.201.412.596.320 DMÑThioxanthenes LH LM  MHÑHydantoins ANdo not use /analogs /biosyn /defic /physiol MND3.383.374.411; D14.261.447 XUÑEthotoin; ÑMephenytoin; ÑPhenylthiohydantoin; ÑThiohydantoins LH LU; ; ;  MHÑHydatidiform Mole ANalso called molar pregnancy & hydatid mole but has nothing to do with hydatid cyst ( = ECHINOCOCCOSIS or specific); /anal /blood supply /secret /ultrastruct permitted; coord IM with UTERINE NEOPLASMS (IM); malignant or invasive hydatidiform mole = CHORIOADENOMA; check the tags FEMALE & PREGNANCY MNC4.557.537.949.600; C13.703.720.949.485 LH  MSA genus of freshwater coelenterates, of interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals. PM72 HN72 MHÑHydra AN/microbiol /parasitol permitted; HYDRA may be used for the class Hydrozoa PICoelenterata (66-71) MNB1.308.475 LH  MHÑHydralazine ANdo not use /biosyn /defic /physiol RN86-54-4 MND3.383.710.605.500; D18.162.450 XSHydrallazin XUÑDihydralazine LH LS LU  MHÑHydramnios ANpolyhydramnios goes here; oligohydramnios: index under AMNIOTIC FLUID MNC13.703.357 FXÑAmniotic Fluid LH LX  HN(64); was see under ANENCEPHALUS 1967-78 MHÑHydranencephaly ANdo not use /congen MNC16.131.666.680.196.475 DMÑAnencephaly LH LM  MHÑHydrarthrosis MNC5.550.509 LH  MHÑHydrazines ANdo not confuse with HYDRAZONES; do not use /analogs /biosyn /defic /physiol MND2.442 XUÑBenserazide; ÑTodralazine LH LU;  PM74 HN74(72) MHÑHydrazones ANdo not confuse with HYDRAZINES; do not use /analogs /biosyn /defic /physiol PIHydrazines (66-71); specific hydrazine MND2.442.288 LH  MHÑHydro-Lyases ANdo not use /analogs; do not confuse with HYDROLASES RNEC 4.2.1. MND8.586.520.497 XSDEHYDRATASES; HYDRASES XUÑCystathionine beta-Synthase; ÑEnoyl CoA Hydratases; ÑPrephenate Dehydratase; ÑPropanediol Dehydratase; ÑUrocanase; ÑUroporphyrinogen III Synthase LH LS; LU; ; ; ; ;  MHÑHydroa Vacciniforme MNC17.608.326 LH  MHÑHydrocarbons ANGEN; do not use /analogs /biosyn /defic /physiol; POLYCYCLIC HYDROCARBONS (D4) & CYCLOPARAFFINS (D2) are also available MND2.455 LH  OL╥acyclic hydrocarbons╙ is indexed HYDROCARBONS or specifics MH*Hydrocarbons, Acyclic (Non Mesh) MND2.455.326 LH  OLdo not confuse with HYDROCARBONS, ACYCLIC (NON MESH); ╥alicyclic hydrocarbons╙ is indexed HYDROCARBONS or CYCLOPARAFFINS MH*Hydrocarbons, Alicyclic (Non Mesh) MND2.455.426.392 LH  OL╥aromatic hydrocarbons╙ is indexed HYDROCARBONS or POLYCYCLIC HYDROCARBONS & specifics MH*Hydrocarbons, Aromatic (Non Mesh) MND2.455.426.559 LH  PM74 HN74 MHÑHydrocarbons, Brominated ANdo not use /analogs /biosyn /defic /physiol MND2.455.526.368 XSBrominated Hydrocarbons XUÑEthylene Dibromides LH LS LU  PM74 HN74 MHÑHydrocarbons, Chlorinated ANdo not use /analogs /biosyn /defic /physiol MND2.455.526.439 XSCHLORINATED HYDROCARBONS XUÑDichloroethylenes; ÑEthylene Dichlorides; ÑMethylene Chloride; ÑTrichloroepoxypropane; ÑTrichloroethanes LH LS LU; ; ; ;  OL╥cyclic hydrocarbons╙ is indexed HYDROCARBONS or specifics; consider also POLYCYCLIC HYDROCARBONS (D4) and CYCLOPARAFFINS (D2) MH*Hydrocarbons, Cyclic (Non Mesh) MND2.455.426 LH  PM74 HN74 MHÑHydrocarbons, Fluorinated ANdo not use /analogs /biosyn /defic /physiol; do not confuse with FLUOROCARBONS MND2.455.526.510 XSFLUORINATED HYDROCARBONS FXÑFluorocarbon Polymers LH LS LX  PM66 HN66 MHÑHydrocarbons, Halogenated ANGEN; do not use /analogs /biosyn /defic /physiol MND2.455.526 XSHALOGENATED HYDROCARBONS LH LS  PM74 HN74 MHÑHydrocarbons, Iodinated ANdo not use /analogs /biosyn /defic /physiol MND2.455.526.581 XSIODINATED HYDROCARBONS LH LS  MHÑHydrocele MNC12.294.340 LH  MHÑHydrocephalus ANdo not use /congen MNC10.228.140.602; C16.614.414 XUÑDandy-Walker Syndrome; ÑHydrocephalus, Normal Pressure LH LU;  HN(71) MHÑHydrocephalus, Normal Pressure ANHakim's syndrome PIHydrocephalus (66-70) MNC10.228.140.602.559 DMÑHydrocephalus LH LM  MHÑHydrochloric Acid ANHCl; not for gastric HCl (see immed below); do not use /analogs ( = CHLORIDES or specific chloride) /biosyn /defic /physiol; = ╥chlorhydrate╙ in foreign texts: translate as ╥hydrochloric acid╙, not ╥chlorhydrate╙ RN7647-01-0 MND1.29.260.326; D1.396.343.475 XSHydrogen Chloride FXÑGastric Acid LH LS LX  MHÑHydrochlorothiazide ANdo not use /biosyn /defic /physiol RN58-93-5 MND3.438.174.261.476; D18.162.276.237.476; D19.770.224.578.237.476 LH  MS4,5 alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one. Narcotic analgesic related to codeine, but more potent and more addicting by weight; used also as cough suppressant; Synonyms: Calmodid; Dicodid; Dicodrine; Hydrokon; Norgan. HN(76) MHÑHydrocodone ANdo not confuse HYDROCODONE see references with OXYCODONE see references; do not use /biosyn /defic /physiol RN125-29-1 PICodeine/AA (75); Ethers, Cyclic (73-74); Morphinans (70-74) MND3.132.610.422.547.547.540; D3.549.686.575.547.204.540; D3.605.497.575.547.204.540; D14.73.153.616.547.204.540; D14.757.638.547.204.450; D23.338.246.450 XSDihydrocodeinone; Hydrocodeinonebitartrate; Hydrocon DMÑCodeine LH LS; ; LM  PM/adverse effects /poisoning /toxicity were HYDROCORTISONE TOXICOLOGY 1963-65 HN/ad-poi-tox was HYDROCORTISONE TOXICOLOGY 1963-65 MHÑHydrocortisone AN/biosyn /physiol permitted; /admin: consider also HYDROCORTISONE, TOPICAL RN50-23-7 MND4.808.745.745.654.600; D6.472.40.322.478.353.476; D6.472.40.322.478.478.392; D26.74.125.539 XSCORTISOL XUÑTetrahydrocortisol LH LS LU  MHÑHydrocortisone, Topical ANdo not use /analogs /biosyn /defic /physiol; if an analog of hydrocortisone is to be admin topically, index under /analogs with HYDROCORTISONE instead MND4.808.745.745.654.600.476; D6.597.481.364.539; D26.74.125.447.539; D26.74.125.539.539; D26.74.148.447.539; D26.368.99.447.539 LH  MHÑHydrocyanic Acid ANdo not use /analogs ( = CYANIDES) /biosyn /defic /physiol RN74-90-8 MND1.620.539 XSHydrogen Cyanide LH LS  MHÑHydroflumethiazide ANdo not use /biosyn /defic /physiol RN135-09-1 MND3.438.174.475; D18.162.276.439; D19.770.224.578.439 XSTRIFLUOROMETHYLHYDROTHIAZIDE LH LS  MSA solution of hydrogen fluoride in water. It is a colorless fuming liquid which can cause painful burns. Synonyms: Phthoric Acid; fluohydric acid; fluorhydric acid. PM77 HN77(72) MHÑHydrofluoric Acid ANdo not use /analogs ( = FLUORIDES or specific fluoride) /biosyn /defic /physiol RN7664-39-3 PIAcids (66-71); Fluorides (66-71) MND1.29.260.351; D1.396.514.559 XSHydrogen Fluoride LH LS  MHÑHydrogen ANH or H1; H2 or 2H (superscript) = DEUTERIUM, H2 (subscript) = HYDROGEN; H3 or 3H = TRITIUM; do not use /analogs /biosyn /defic /physiol; prod of H ions = probably PH RN1333-74-0 MND1.248.497.300.459.451; D1.268.406; D1.435 LH  MSA low-energy attractive force between hydrogen and another element; plays a major role in determining the properties of water, proteins, and other compounds. HN(75) MHÑHydrogen Bonding ANNIM; no qualif MNH1.181.529.400 DMÑChemistry, Physical LH LM  MHÑHydrogen Peroxide ANdo not use /analogs ( = PEROXIDES) /biosyn /defic /physiol RN7722-84-1 MND1.655.498.631.327 LH  PM73 HN73(71) MHÑHydrogen Sulfide ANdo not use /analogs ( = SULFIDES or SULFHYDRYL COMPOUNDS or specifics) /biosyn /defic /physiol RN7783-06-4 PIHydrogen (66-70); Sulfides (66-70) MND1.877.522.560 LH  MHÑHydrogen-Ion Concentration ANNIM; no qualif; DF: PH MNH1.181.529.428 XUÑIsoelectric Point LH LU  MSFerredoxin:H+ oxidoreductase. Enzyme found in bacteria. Catalyzes the reduction of ferredoxin and other substances in the presence of molecular hydrogen. It is involved in the electron transport in bacterial photosynthesis. Formerly EC 1.98.1.1, EC 1.12.1.1, and EC 1.12.7.1. PM85 HN85 MHÑHydrogenase ANdo not use /analogs RNEC 1.18.3.1 PIOxidoreductases (66-84) MND8.586.682.400 LH  HN(71) MHÑHydrogenation ANalmost never IM; no qualif PIChemistry, Organic (66-70); Hydrogen (66-70) MNH1.181.404.600 DMÑChemistry, Organic LH LM  MSA genus incertae sedis of gram negative rods found in soil and water and characterized by the ability to grow in substrates containing no organic matter and to use elemental hydrogen as the source of energy for growth. HN(76)63 MHÑHydrogenomonas ANin soil MNB3.400.750.690.500 DMÑPseudomonas LH LM  MHÑHydrolases ANdo not use /analogs; do not confuse with HYDRO-LYASES RNEC 3. MND8.586.277 LH  HN(71) MHÑHydrolysis ANalmost never IM; no qualif PIChemistry, Physical (66-70) MNH1.181.529.444 DMÑChemistry, Physical LH LM  MHÑHydronephrosis MNC12.777.419.307 LH  MSVenoms of sea snakes, Hydrophiidae, found around Pacific islands; the venoms contain less and fewer enzymes and more neuro- or myotoxins than land snakes; the neurotoxic proteins are similar to Elapid small, short or Type I neurotoxins; some have been characterized. PM78; ERABUTOXINS was see under SNAKE VENOMS 1975-77 HN78 MHÑHydrophid Venoms ANdo not use /analogs /chem syn /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; TN 241: common & scientific names of various hydrophids (sea snakes) PISnake Venoms (75-77); Snakes (66-74); Venoms (66-74) MND24.185.965.850.480 XSSea Snake Venoms XUÑErabutoxins LH LS LU  MHÑHydrophthalmos ANdo not use /congen MNC11.381.477; C16.614.438 LH  MHÑHydropneumothorax MNC8.528.434 LH  PM66; was see under PHENOLS 1963-65 HN66(63); was see under PHENOLS 1963-65 MHÑHydroquinones ANdo not use /analogs /biosyn /defic /physiol MND2.755.393 XSp-Dihydroxybenzenes; para-Dihydroxybenzenes LH LS;  HN(73) MHÑHydrostatic Pressure ANIM; only /adv eff PIPressure (66-72) MNH1.671.691.352 DMÑPressure LH LM  MSExternal application of water for therapeutic purposes. MHÑHydrotherapy ANdo not use /util except by MeSH definition; external with natural water only, with emphasis on water temperature & motion of water (note X ref WHIRLPOOL BATHS); do not confuse with BALNEOLOGY (see note there); if in doubt, use word of text MNE2.780.450 XSWhirlpool Baths LH LS  MHÑHydrothorax MNC8.528.476 LH  OLuse HYDROXAMIC ACIDS to search HYDROXAMIC ACID back thru 1966 PM75; was HYDROXAMIC ACID 1963-74 HN75; was HYDROXAMIC ACID 1963-74 MHÑHydroxamic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.92.570.394; D2.241.511.372 XUÑBufexamac; ÑFerrichrome LH LU;  MHÑHydroxides ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.459; D1.455 LH  MHÑHydroxocobalamin RN13422-51-0 MND11.786.708.950.560; D19.461.543.901.477 XSHydroxycobalamin LH LS  MSOrganic compounds containing both the hydroxyl and carboxyl radicals. PM75 HN75 MHÑHydroxy Acids ANdo not use /analogs /biosyn /defic /physiol PICarboxylic Acids (71-74); Fatty Acids (66-74) MND2.241.511 LH  MSN-Fluoren-2-yl-acetohydroxamic acid. A fluorene derivative with carcinogenic action. Synonyms: N-Hydroxy-2-acetylaminofluorene; N-Hydroxy-2-fluorenylacetamide. HN(75); was see under FLUORENES 1975-79 MHÑHydroxyacetylaminofluorene AND25-26 qualif RN53-95-2 PIFluorenes (66-74); Hydroxamic Acids (66-74) MND2.65.64.150.400; D2.241.81.38.108.80.400; D4.615.389.50.400; D26.191.372.16.478 XSHydroxyfluorenylacetamide DMÑ2-Acetylaminofluorene LH LS LM  OLuse HYDROXYAPATITES to search HYDROXYAPATITE back thru 1964 (as Prov 1966) PM75; was HYDROXYAPATITE 1967-74 HN75; was HYDROXYAPATITE 1964-74 (Prov 1964-66) MHÑHydroxyapatites ANdo not use /analogs /biosyn /defic /physiol MND1.552.539.288.475.89.470; D1.578.122.477; D1.696.620.603.325.164.477 LH  MSBenzoic acid substituted by one or more hydroxy groups in any position on the benzene ring. PM75; VANILLIC ACID was see under BENZOATES 1968-74 HN75 MHÑHydroxybenzoic Acids ANdo not use /analogs /biosyn /defic /physiol PIBenzoates (66-74); Phenols (66-74) MND2.241.223.106.505; D2.241.511.390; D2.755.410 XUÑVanillic Acid LH LU  PM65 HN65 MHÑHydroxybutyrate Dehydrogenase ANdo not use /analogs RNEC 1.1.1.30 MND8.586.682.47.393 LH  MHÑHydroxybutyrates ANdo not use /analogs /defic /physiol MND2.241.81.161.627; D2.241.511.401 XUÑSodium Oxybate LH LU  MHÑHydroxychloroquine ANdo not use /biosyn /defic /physiol RN118-42-3 MND3.438.810.50.460; D21.370.286.245.477 XSHydroxychlorochin; Oxychlorochin; Oxychloroquine LH LS; ;  OLuse HYDROXYCHOLECALCIFEROLS to search HYDROXYCHOLECALCIFEROL back thru 1972 (as Prov 1972) PM75; was HYDROXYCHOLECALCIFEROL 1973-74 HN75; was HYDROXYCHOLECALCIFEROL 1972-74 (Prov 1972) MHÑHydroxycholecalciferols ANdo not use /analogs; /physiol permitted MND4.808.247.222.159.478; D4.808.247.808.146.478; D4.808.812.221.478; D10.516.851.152.478; D11.786.763.196.478 XSHydroxyvitamins D LH LS  OLto search HYDROXYCHOLESTEROL use HYDROXYCHOLESTEROLS back thru 1975 & CHOLESTEROL 1973-74 PM78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77 HN78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77 MHÑHydroxycholesterols ANdo not use /analogs /defic /physiol PICholesterol (66-77) MND4.808.247.222.284.478; D4.808.247.808.197.561; D10.516.851.208.603 LH  PM73 HN73(72) MHÑHydroxycorticosteroids ANdo not use /analogs /defic /physiol; /chem syn permitted: do not convert to HYDROXYCORTICOSTEROIDS, SYNTHETIC PIAdrenal Cortex Hormones (66-71); Glucocorticoids (67-71); Mineralocorticoids (67-71) MND6.472.40.322.478; D6.472.40.668.478 FXÑHydroxysteroids LH LX  MSSynthetic chemical steroids which mimic the activity of the hydroxycorticosteroids obtained from the adrenal cortex, but differ in structure from the naturally occurring hydroxycorticosteroids. The steroid molecule must be substituted with one or more hydroxyl groups. PM75 HN75 MHÑHydroxycorticosteroids, Synthetic ANdo not use /analogs /biosyn /defic /physiol; do not confuse with HYDROXYCORTICOSTEROIDS /chem syn; DF: HYDROXYCORTICOSTEROIDS SYN PIHydroxycorticosteroids (72-74) MND6.597.481.561 XSHydroxycorticosteroid Analogs LH LS  MHÑHydroxydione ANdo not use /biosyn /defic /physiol RN303-01-5 MND4.808.745.558.394; D14.166.489 LH  MSDopamines with a hydroxy group substituted in one or more positions. OLuse HYDROXYDOPAMINES to search HYDROXYDOPAMINE back thru 1973 PM82; was HYDROXYDOPAMINE 1973-81 HN82; was HYDROXYDOPAMINE 1973-81 MHÑHydroxydopamines ANdo not use /biosyn /defic /physiol PIDopamine (66-72); Phenethylamines (66-72) MND2.92.311.342.478; D16.848.415.441 LH  MSEicosatetraenoic acids substituted in any position by one or more hydroxy groups. They are important intermediates in a series of biosynthetic processes leading from arachidonic acid to a number of biologically active compounds such as prostaglandins, thromboxanes, and leukotrienes. PM85 HN85 MHÑHydroxyeicosatetraenoic Acids ANdo not use /analogs PIArachidonic Acids (67-84); Fatty Acids, Essential (66-67) MND2.241.81.436.103.450; D10.516.251.355.96.450 XSHETE LH LS  MS3-Hydroxyestra-1,3,5(10)-trien-17-one. Estrone which is substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens. HN(77) MHÑHydroxyestrones ANdo not use /analogs PIEstrone (72-76); Hydroxysteroids (72-75) MND4.808.365.415.414.400; D4.808.578.502.497.400; D6.472.866.540.175.450 DMÑEstrone LH LM  MSA derivative of starch used as a plasma substitute in the treatment of hemorrhage. HN(75) MHÑHydroxyethyl Starch ANdo not use /biosyn /defic /physiol RN9005-27-0 PIAlcohol, Ethyl (71-74); Starch (71-74) MND9.203.698.365.855.500; D19.461.775.400 DMÑStarch LH LM  MSMonohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders. HN(75) MHÑHydroxyethylrutoside ANdo not use /biosyn /defic /physiol PIAlcohol, Ethyl (72-74); Rutin (72-74) MND9.203.408.134.779.400 DMÑRutin LH LM  PM66 HN66(64) MHÑHydroxyindoleacetic Acid ANdo not use /defic /physiol; DF: HIAA RN1321-73-9 MND3.66.288.478; D3.438.473.404.478 LH  MHÑHydroxylamines ANdo not use /analogs /defic /physiol MND2.92.570 LH  MHÑHydroxylases ANdo not use /analogs; do not confuse with HYDRO-LYASES RNEC 1.14. MND8.586.682.420 XUÑ4-Hydroxybenzoate-3-Monooxygenase; ÑHeme Oxygenase; ÑLysine Hydroxylase LH LU; ;  HN(71) MHÑHydroxylation ANalmost never IM; no qualif; enzymatic hydroxylation: coord NIM with HYDROXYLASES (IM) + substrate (NIM) or specific hydroxylase (IM) PIChemistry, Organic (66-70) MNH1.181.404.643 DMÑChemistry, Organic LH LM  PM73 HN73(71) MHÑHydroxylysine RN28902-93-4 PILysine (66-70) MND12.125.95.647.478 LH  PM72 HN72 MHÑHydroxymercuribenzoates ANdo not use /analogs /biosyn /defic /physiol PIBenzoates (66-71); Mercury (66-71); Organometallic Compounds (68-71) MND2.241.223.106.505.450; D2.691.750.740.644.561; D2.241.511.390.450; D2.755.410.450; D8.373.830.699.561 LH  MSMevalonate:NAD(P) oxidoreductase (CoA-acylating). In the biosynthesis of cholesterol, these enzymes catalyze the reduction of one of the carboxyl groups of beta-hydroxy, beta-methylglutaryl CoA to yield mevalonic acid. EC 1.1.1.34 requires NADP, EC 1.1.1.88 requires NAD. PM78; was see under ALCOHOL OXIDOREDUCTASES 1975-77 HN78(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77 MHÑHydroxymethylglutaryl CoA Reductases ANdo not use /analogs; DF: HMG COA REDUCTASES RNEC 1.1.1.88 PIAlcohol Oxidoreductases (66-77); Glutarates (66-74); Mevalonic Acid (66-74) MND8.586.682.47.385.415 LH  MS3-Hydroxy-3-methylglutaryl-CoA acetoacetyl-CoA-lyase (CoA-acetylating). Catalyzes the synthesis of hydroxymethylglutaryl-CoA from acetyl-CoA and acetoacetyl-CoA. This is a key enzyme in steroid biosynthesis. HN(75) MHÑHydroxymethylglutaryl CoA Synthase ANdo not use /analogs; DF: HMG COA SYNTHASE RNEC 4.1.3.5 PICoenzyme A (73-74); Glutarates (73-74); Ketoacid-Lyases (73-74) MND8.586.520.567.500 DMÑKetoacid-Lyases LH LM  MS4-Hydroxy-2-penten-1-al. May possess antineoplastic properties. HN(75) MHÑHydroxypentenal ANdo not use /biosyn /defic /physiol; /analogs NIM only RN16931-17-2 PIAldehydes (71-74); Alcohols, Amyl (74) MND2.47.660 DMÑAldehydes LH LM  MS6(p-Hydroxyphenylazo)-uracil. Inhibitor of DNA replication in gram-positive bacteria. HN(75) MHÑHydroxyphenylazouracil ANdo not use /biosyn /defic /physiol PIAzo Compounds (72-74); Phenols (72-74); Uracil (72-74) MND3.383.742.698.875.480 DMÑUracil LH LM  PM72 HN72(64) MHÑHydroxypregnenolone ANdo not use /defic /physiol RN12041-98-4 MND4.808.745.745.725.395; D6.472.40.322.478.478.477 LH  OLuse HYDROXYPROGESTERONES to search HYDROXYPROGESTERONE back thru 1966 PM78; was HYDROXYPROGESTERONE 1963-77 HN78; was HYDROXYPROGESTERONE 1963-77 MHÑHydroxyprogesterones ANdo not use /analogs /defic /physiol MND4.808.745.745.654.829.395; D6.472.798.773.478 LH  MHÑHydroxyproline RN51-35-4 MND12.125.72.401.623.478 XSOxyproline LH LS  MHÑHydroxypropiophenone ANdo not use /biosyn /defic /physiol RN1321-48-8 MND2.522.818.561 LH  MSCatalyzes reversibly the oxidation of hydroxyl groups of prostaglandins. PM78; was see under ALCOHOL OXIDOREDUCTASES 1975-77 HN78(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77 MHÑHydroxyprostaglandin Dehydrogenases ANdo not use /analogs; DF: HYDROXYPG DEHYDROGENASES RNEC 1.1.1.- PIAlcohol Oxidoreductases (66-77); Prostaglandins (66-74) MND8.586.682.47.428 LH  MSThe 8-hydroxy derivatives inhibit various enzymes and their halogenated derivatives, though neurotoxic, are used as topical anti-infective agents, among other uses. OLuse HYDROXYQUINOLINES to search CHINIOFON back thru 1966 PMCHINIOFON, DIIODOHYDROXYQUIN, IODOCHLORHYDROXYQUIN & CHLORQUINALDOL were headings 1963-82 HNCHINIOFON was heading 1963-82 MHÑHydroxyquinolines ANdo not use /analogs /biosyn /defic /physiol PIQuinolines (66-74) MND3.438.810.350 XSQuinolinols XUÑ8-Hydroxyquinoline; ÑChloroquinolinols; ÑChlorquinaldol; ÑDecoquinate; ÑDiiodohydroxyquin; ÑIodochlorhydroxyquin LH LS LU; ; ; ; ;  OLuse HYDROXYSTEROID DEHYDROGENASES to search HYDROXYSTEROID DEHYDROGENASE back thru 1966 PM74; was HYDROXYSTEROID DEHYDROGENASE 1965-73 HN74; was HYDROXYSTEROID DEHYDROGENASE 1965-73 MHÑHydroxysteroid Dehydrogenases ANdo not use /analogs RNEC 1.1.1.- MND8.586.682.47.436 LH  PM74 HN74(72) MHÑHydroxysteroids ANdo not use /analogs PIappropriate steroid class MND4.808.528 FXÑHYDROXYCORTICOSTEROIDS LH LX  MS17 beta-Hydroxy-4-androsten-3-one. Testosterone which is substituted by one or more hydroxyl groups in any position. HN(77) MHÑHydroxytestosterones ANdo not use /analogs PIHydroxysteroids (72-75); Testosterone (72-76) MND4.808.54.79.429.824.375 DMÑTestosterone LH LM  PM65 HN65(63) MHÑHydroxytryptophan MND12.125.72.859.479 XS5-HTP LH LS  MS5-Hydroxy-indole-3-ethanol. HN(75) MHÑHydroxytryptophol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN154-02-9 PIAlcohol, Ethyl (72-74); Indoles (70-74) MND3.438.473.385 DMÑIndoles LH LM  PM68 HN68(67) MHÑHydroxyurea ANdo not use /biosyn /defic /physiol RN127-07-1 PIAntineoplastic Agents (66); Urea (66) MND2.948.395; D22.204.442 XSHydroxycarbamid LH LS  MHÑHydroxyzine ANdo not use /biosyn /defic /physiol RN68-88-2 MND15.236.872.659.544 LH  MHÑHygiene ANno qualif; industrial hygiene = OCCUPATIONAL MEDICINE; mental hygiene = MENTAL HEALTH MNG3.850.670 LH  MSAntibiotic substance produced by Streptomyces hygroscopicus. Used as an anthelmintic against swine infections by large roundworms, nodular worms and whipworms. HN(75) MHÑHygromycin B ANdo not use /defic /physiol; /analogs NIM only RN31282-04-9 PIAntibiotics (70-74); Aminoglycosides (74) MND9.203.408.51.420; D20.85.407; D21.201.287.410 DMÑAntibiotics LH LM  MSA genus of the family Pongidae consisting of six species. The members of this genus inhabit rain forests in southeast Asia. They are arboreal and differ from other anthropoids in the great length of their arms and very slender bodies and limbs. Their major means of locomotion is by swinging from branch to branch by their arms. Hylobates means dweller in the trees. Some authors refer to Symphalangus as Hylobates. OLuse HYLOBATES to search GIBBONS back thru 1975 HN(81); was GIBBONS see under APES 1975-80 MHÑHylobates ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.600.680 XSGibbon; Siamang; Symphalangus DMÑPongidae LH LS; ; LM  MS7-Hydroxy-4-methylcoumarin. A coumarin derivative possessing properties as a spasmolytic, choleretic and light-protective agent. It is also used in analytical chemistry for the determination of nitric acid. HN(75); was see under COUMARINS 1975-76 MHÑHymecromone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN90-33-5 PICoumarins (69-74) MND3.438.150.446.912.530; D19.316.508.485; D26.550.420 XSImecromone; Methylumbelliferone; Resocyanine DMÑUmbelliferones LH LS; ; LM  MHÑHymen MNA5.360.319.779.479 LH  MSInfection with tapeworms of the genus Hymenolepis. PM68 HN68 MHÑHymenolepiasis PICestode Infections (66-67) MNC3.335.190.519 LH  MSA genus of small tapeworms of birds and mammals. OLsearch CESTODA 1966-74 PM79; was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64 HN79(75); was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64 MHÑHymenolepis ANdo not use /blood-csf-urine; infection = HYMENOLEPIASIS PICestoda (66-74) MNB1.500.736.215.454 LH  MSAn extensive order of highly specialized insects including bees, wasps, and ants. PM75 HN75 MHÑHymenoptera ANincludes ANTS, BEES, WASPS; /microbiol /parasitol permitted PIInsects (66-74); specific insect MNB1.131.617.479 XUÑWasps LH LU  MHÑHyoid Bone ANmylohyoid ridge or groove is indexed under MANDIBLE MNA2.835.232.409 XSLINGUAL BONE LH LS  MHÑHyperaldosteronism MNC19.53.181.604 XSALDOSTERONISM; CONN'S DISEASE XUÑBartter's Disease LH LS; LU  OLsearch HYPERESTHESIA 1966-74 HN(75) MHÑHyperalgesia MNC10.597.751.437.479; C23.888.592.763.312.518 DMÑHyperesthesia LH LM  PM65 HN65(64) MHÑHyperbaric Oxygenation ANdo not use /util except by MeSH definition; coord IM with disease /ther (IM), not /drug ther MNE2.880.690.490 XSOXYGENATION, HYPERBARIC FXÑAtmospheric Pressure LH LS LX  MHÑHyperbilirubinemia AN/congen = HYPERBILIRUBINEMIA, HEREDITARY; neonatal = JAUNDICE, NEONATAL; Rotor's syndrome is indexed under HYPERBILIRUBINEMIA, HEREDITARY MNC23.888.498.329 FXÑBilirubin LH LX  MSInborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood. PM65 HN65 MHÑHyperbilirubinemia, Hereditary ANdo not use /congen; Rotor's syndrome goes here MNC18.452.648.437; C23.888.498.329.396 XUÑCrigler-Najjar Syndrome; ÑGilbert's Disease LH LU;  MSAbnormally high level of calcium in the blood. OLuse HYPERCALCEMIA to search MILK-ALKALI SYNDROME back thru 1966 PMMILK-ALKALI SYNDROME was see under CALCINOSIS 1975-77 HNMILK-ALKALI SYNDROME was see under HYPERCALCEMIA 1978-83, was see under CALCINOSIS 1975-77 MHÑHypercalcemia ANX ref is also called Burnett's syndrome or milk-drinker's syndrome MNC18.452.174.451; C18.452.950.340 XSMilk-Alkali Syndrome FXÑCalcium LH LS LX  MSAbnormal increase in the amount of carbon dioxide in the blood to the point where the partial pressure of carbon dioxide in the arterial blood exceeds 50 mm of mercury. PM68 HN68(66) MHÑHypercapnia MNC8.618.846.478; C23.888.852.544 FXÑCarbon Dioxide LH LX  OLsearch TOOTH DISEASES 1969-74 HN(75) MHÑHypercementosis MNC7.793.422 DMÑTooth Diseases LH LM  MSAbnormally high levels of cholesterol in the blood. OLuse HYPERCHOLESTEROLEMIA to search HYPERCHOLESTEREMIA back thru 1966; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 PM80; was HYPERCHOLESTEREMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) HN80; was HYPERCHOLESTEREMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) MHÑHypercholesterolemia MNC18.452.494.396 XSHypercholesteremia LH LS  MSA familial disorder characterized by increased plasma concentration of cholesterol carried in low density lipoproteins (LDL) and by a deficiency in a cell surface receptor which regulates LDL degradation and cholesterol synthesis; frequently associated with arcus senilis and premature atherosclerosis. OLsearch HYPERLIPOPROTEINEMIA under HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 PM80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) HN80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) MHÑHypercholesterolemia, Familial PIHypercholesterolemia (66-79); Hyperlipidemia (66-79) /FG (66-79) MNC18.452.648.556.481.475 XSHyperbetalipoproteinemia; Hypercholesterolemia, Essential; Hyperlipoproteinemia Type II LH LS; ;  MHÑHyperemesis Gravidarum ANcheck tags FEMALE & PREGNANCY MNC6.405.937.562; C13.703.799.562 LH  MHÑHyperemia MNC14.371 FXÑBlood Circulation LH LX  MHÑHyperesthesia MNC10.597.751.437; C23.888.592.763.312 XUÑHyperalgesia LH LU  PM72 HN72(69) MHÑHypergammaglobulinemia ANcoord IM with specific immunoglobulin (IGA, IGD, IGE, IGG or IGM) (IM); for light-chain gammopathy see TN 226; for heavy-chain gammopathy index under HEAVY CHAIN DISEASE (IM) + specific heavy chain (IMMUNOGLOBULIN, ALPHA CHAIN; IMMUNOGLOBULIN, DELTA CHAIN, etc.) (NIM) (TN 226) PIBlood Protein Disorders (66-68) MNC15.378.147.542; C20.683.460 XUÑMonoclonal Gammopathies, Benign LH LU  MHÑHyperglycemia ANobese hyperglycemic mice go under MICE, OBESE: do not index under HYPERGLYCEMIA or OBESITY unless particularly discussed as disease; Somogyi effect or rebound hyperglycemia: index under HYPERGLYCEMIA /chem ind + DIABETES MELLITUS /drug ther + INSULIN /adv eff MNC18.452.460 FXÑBlood Glucose LH LX  MSA syndrome consisting of extreme hyperglycemia, serum hyperosmolarity and dehydration in the absence of ketosis and acidosis. HN(77) MHÑHyperglycemic Hyperosmolar Nonketotic Coma ANDF: HHNC or HHNK PIDiabetic Coma (66-76); Hyperglycemia (66-76); Osmolar Concentration (70-76) MNC18.452.297.357.490; C19.246.357.490 XSComa, Hyperglycemic Hyperosmolar Nonketotic DMÑDiabetic Coma LH LS LM  MSExcessive sweating. OLsearch SWEATING 1966-75 PM76; was see under SWEATING 1963-75 HN76; was see under SWEATING 1963-75 MHÑHyperhidrosis PISweating (66-75) MNC17.805.843.350 FXÑSweating LH LX  MHÑHyperinsulinism MNC19.458 FXÑPancreatic Diseases LH LX  MHÑHyperkalemia MNC18.452.950.396 XSHYPERPOTASSEMIA FXÑPotassium LH LS LX  MSExcessive motor activity. OLto search HYPERKINESIA use HYPERKINESIS back thru 1969 & MOVEMENT DISORDERS 1966-68 PM69; was HYPERKINESIA see under MOVEMENT DISORDERS 1963-68 HN69; was HYPERKINESIA see under MOVEMENT DISORDERS 1963-68 MHÑHyperkinesis ANhuman & animal; do not use /drug eff /physiol /rad eff; MOTOR ACTIVITY is also available: see note there PIMovement Disorders (66-67) MNF1.145.632.480; F3.126.720.605 XSHyperactivity, Motor LH LS  MSAn excess of lipids in the blood. OLuse HYPERLIPIDEMIA to search HYPERLIPEMIA back thru 1966; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 PM80; was HYPERLIPEMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79; HYPERCHOLESTEREMIA, ESSENTIAL FAMILIAL was see under HYPERLIPEMIA, ESSENTIAL FAMILIAL 1963-74; HYPERLIPOPROTEINEMIA, FAMILIAL was see HYPERLIPEMIA, ESSENTIAL FAMILIAL 1974-79 HN80; was HYPERLIPEMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79; HYPERCHOLESTEREMIA, ESSENTIAL FAMILIAL was see under HYPERLIPEMIA, ESSENTIAL FAMILIAL 1963-74; HYPERLIPOPROTEINEMIA, FAMILIAL was see HYPERLIPEMIA, ESSENTIAL FAMILIAL 1974-79 MHÑHyperlipidemia AN/drug ther: consider also ANTILIPEMIC AGENTS MNC18.452.494 XSHyperlipemia LH LS  MSA disorder genetically distinct from the other inherited hyperlipidemias characterized by the type II or type IV lipoprotein pattern (the pattern may change from time to time and the lipid level may be normal at one time and abnormal at another time). OLsearch HYPERLIPOPROTEINEMIA under HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 PM80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) HN80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) MHÑHyperlipidemia, Familial Combined ANfamilial or acquired MNC18.452.648.556.481.480 XSHyperlipidemia, Multiple Lipoprotein-Type LH LS  MSMetabolic disease characterized by elevated plasma cholesterol and/or triglyceride levels; the inherited form is atttibuted to a single gene mechanism. OLsearch HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 PM80; was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) HN80; was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) MHÑHyperlipoproteinemia ANfamilial or acquired; note specific Types I-V below PIHyperlipidemia (66-79) MNC18.452.494.481; C18.452.648.556.481 XUÑLipoprotein Lipase Deficiency, Familial LH LU  MSA rather uncommon form of familial hyperlipemia characterized by the presence of lipoproteins of abnormal composition. The main abnormal lipoproteins are called beta-VLDL and have a different apoprotein content and a higher proportion of cholesterol relative to triglyceride than normal VLDL. OLsearch HYPERLIPOPROTEINEMIA under HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 PM80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) HN80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) MHÑHyperlipoproteinemia Type III PIHyperlipidemia (66-79) /FG (66-79) MNC18.452.648.556.481.485 XSBroad Beta Disease; Dysbetalipoproteinemia LH LS;  MSA familial disorder characterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in VLDL; considered to be an autosomal dominant trait. OLsearch HYPERLIPOPROTEINEMIA under HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 PM80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) HN80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) MHÑHyperlipoproteinemia Type IV PIHyperlipidemia (66-79) MNC18.452.648.556.481.490 XSHyperprebetalipoproteinemia; Hypertriglyceridemia, Familial LH LS;  MSA severe familial adult-onset hypertriglyceridemia different from that due to lipoprotein lipase deficiency. OLsearch HYPERLIPOPROTEINEMIA under HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 PM80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) HN80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) MHÑHyperlipoproteinemia Type V PIHyperlipidemia (66-79) MNC18.452.648.556.481.495 XSHyperlipemia, Mixed LH LS  MHÑHypernatremia MNC18.452.950.452 FXÑSodium LH LX  MHÑHyperopia MNC11.744.479 XSHYPERMETROPIA LH LS  OLuse HYPEROSTOSIS FRONTALIS INTERNA to search LEONTIASIS OSSIUM back thru 1966 PMLEONTIASIS OSSIUM was heading 1963-84 HNLEONTIASIS OSSIUM was heading 1963-84 MHÑHyperostosis Frontalis Interna MNC5.116.99.708.486 XSLeontiasis Ossium; Morgagni-Stewart-Morel Syndrome LH LS;  PM64 HN64 MHÑHyperostosis, Cortical Congenital ANdo not use /congen MNC5.116.99.708.479; C16.614.465 XSCaffey-De Toni-Silvermann Syndrome; INFANTILE CORTICAL HYPEROSTOSIS LH LS;  MSExcretion of an excessive amount of oxalate in the urine. PM87 HN87 MHÑHyperoxaluria PIOxalates/urine (66-86) MNC18.452.648.202.490 XSOxaluria XUÑHyperoxaluria, Primary LH LS LU  MSEither of two genetic disorders characterized by urinary excretion of large amounts of oxalate, with nephrolithiasis, nephrocalcinosis, early onset of renal failure, and often a generalized deposit of calcium oxalate, resulting from a defect in glyoxalate metabolism. HN(87) MHÑHyperoxaluria, Primary ANdo not use /congen MNC12.777.419.320; C18.452.648.202.490.490 XSOxaluria, Primary DMÑHyperoxaluria LH LS LM  MHÑHyperparathyroidism MNC19.642.355 FXÑOSTEITIS FIBROSA CYSTICA LH LX  PM70 HN70 MHÑHyperparathyroidism, Secondary PIHyperparathyroidism (66-69) MNC19.642.355.480 LH  MSIngestion of a greater than optimal quantity of food. HN(81) MHÑHyperphagia ANdo not use /drug eff /physiol /rad eff PIAppetite Disorders (66-80); Eating (66-80); Feeding Behavior (69-80) MNF3.126.72.208 XSOvereating DMÑAppetite Disorders LH LS LM  MSA state of increased activity of the pituitary gland. PM67 HN67(65) MHÑHyperpituitarism MNC19.700.355 LH  MSAn increase in the number of cells in a tissue or organ, not due to tumor formation; differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. PM65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64 HN65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64 MHÑHyperplasia ANNIM; coord with organ /pathol (IM); also available are ENDOMETRIAL HYPERPLASIA, GINGIVAL HYPERPLASIA & THYMUS HYPERPLASIA; congen adrenal hyperplasia = ADRENAL HYPERPLASIA, CONGENITAL but non-congen adrenal hyperplasia = ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM); GIANT LYMPH NODE HYPERPLASIA is also available MNC23.739.423 FXÑPRECANCEROUS CONDITIONS LH LX  MSIncreased levels of prolactin in the blood. PM86 HN86 MHÑHyperprolactinemia PIProlactin/BL (66-85) MNC18.452.500 LH  MSAltered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. PM66; was ALLERGY 1963-65 HN66; was ALLERGY 1963-65 MHÑHypersensitivity ANIM; use qualif with caution; /chem ind = DRUG HYPERSENSITIVITY; atopic = HYPERSENSITIVITY, IMMEDIATE; to food = FOOD HYPERSENSITIVITY; to light = PHOTOSENSITIVITY DISORDERS; RESPIRATORY HYPERSENSITIVITY is also available CATALOG: form qualif = ALLERGY AND IMMUNOLOGY MNC20.543 XSALLERGY FXÑDesensitization, Immunologic LH LS LX  MSAn increased reactivity to specific antigens mediated not by antibodies but by cells. PM66 HN66(65) MHÑHypersensitivity, Delayed ANIM; use qualif with caution; /chem ind: coord IM with DRUG HYPERSENSITIVITY or specifics (IM) MNC20.543.418 XSTUBERCULIN-TYPE HYPERSENSITIVITY FXÑCell Migration Inhibition; ÑEncephalitis, Post-Vaccinal; ÑImmunity, Cellular LH LS LX; ;  MSHypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. PM66 HN66(65) MHÑHypersensitivity, Immediate ANIM; use qualif with caution; /chem ind: coord IM with DRUG HYPERSENSITIVITY or specifics (IM) MNC20.543.480 XSAtopic Hypersensitivity FXÑAntigen-Antibody Reactions; ÑHistamine; ÑHistamine H1 Receptor Blockaders LH LS LX; ;  MSExcessive need to sleep. HN(75) MHÑHypersomnia ANdo not use /congen /drug eff /physiol /rad eff MNC10.597.785.200; C23.888.592.796.200; F3.126.821.320 DMÑSleep Disorders LH LM  MSCondition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy. OLuse HYPERSPLENISM to search ANEMIA, SPLENIC back thru 1966 PMANEMIA, SPLENIC was heading 1963-81 HN66; ANEMIA, SPLENIC was heading 1963-83, was see under HYPERSPLENISM 1982-83 MHÑHypersplenism MNC15.604.744.293 XSAnemia, Splenic LH LS  MSAbnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid. OLsearch CRANIOFACIAL DYSOSTOSIS 1966-74 HN(75); was see under CRANIOFACIAL DYSOSTOSIS 1963-84 MHÑHypertelorism ANdo not use /congen MNC5.116.99.507; C16.131.621.246.480 DMÑBone Diseases, Developmental LH LM  MSPersistently high arterial blood pressure. Currently accepted threshold levels are 140 mm Hg systolic and 90 mm Hg diastolic pressure. MHÑHypertension ANonly blood pressure; not for intracranial or intraocular pressure; relation to BLOOD PRESSURE: Manual 23.38; /drug ther: consider also ANTIHYPERTENSIVE AGENTS; Goldblatt kidney or Goldblatt hypertension is HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR; hypertension with kidney dis is probably HYPERTENSION, RENAL, not HYPERTENSION; EPH (Edema, Proteinuria, Hypertension) = PREGNANCY TOXEMIAS & do not index under HYPERTENSION unless it is particularly discussed; venous hypertension: index under VENOUS PRESSURE (IM) & do not coord with HYPERTENSION MNC14.907.489 XSBLOOD PRESSURE, HIGH FXÑVASCULAR RESISTANCE LH LS LX  MSSevere hypertension characterized by papilledema and necrosis of small arteries and arterioles. The diastolic pressure is generally greater than 130 mm Hg. MHÑHypertension, Malignant ANmalignant does not refer to neoplasm: refers to severe hypertension with papilledema & arterial necrosis MNC14.907.489.330 LH  MSAbnormally increased pressure in the portal venous system; frequently seen in cirrhosis of the liver and in other conditions which cause obstruction of the portal vein. PMCRUVEILHIER-BAUMGARTEN SYNDROME was see under LIVER CIRRHOSIS 1963-78 MHÑHypertension, Portal MNC6.552.494; C14.907.489.430 FXÑPortasystemic Shunt, Surgical XUÑCruveilhier-Baumgarten Syndrome LH LX LU  MSIncreased pressure within the pulmonary circulation, usually secondary to cardiac or pulmonary disease. OLuse HYPERTENSION, PULMONARY to search AYERZA'S SYNDROME back thru 1966 HNAYERZA'S SYNDROME was heading 1963-83 MHÑHypertension, Pulmonary MNC14.907.489.531 XSAyerza's Syndrome LH LS  MSHypertension due to renal diseases, especially chronic parenchymal disease. Excludes HYPERTENSION, RENOVASCULAR. MHÑHypertension, Renal ANcoord IM with specific kidney dis (IM) if pertinent; Goldblatt hypertension or Goldblatt kidney is HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR MNC12.777.419.331; C14.907.489.631 LH  MSHypertension due to compression or obstruction of the renal artery or its branches. PM84; was see under HYPERTENSION, RENAL 1979-83 HN84(79); was see under HYPERTENSION, RENAL 1979-83 MHÑHypertension, Renovascular ANhypertension caused by compression or obstruct of renal artery or branches: do not routinely index also under RENAL ARTERY or RENAL ARTERY OBSTRUCTION; Goldblatt hypertension or Goldblatt kidney = HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR PIHypertension, Renal (66-78) MNC12.777.419.331.490; C14.907.489.631.485 XSHypertension, Goldblatt LH LS  MSAbnormally high temperature intentionally induced in living things regionally or whole body; most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. OLuse HYPERTHERMIA, INDUCED to search FEVER THERAPY back thru 1966 PM84; was FEVER THERAPY 1963-83; AMMOTHERAPY was heading 1963-85 HN84; was FEVER THERAPY 1963-83 MHÑHyperthermia, Induced ANhigh body temp induced to treat dis; differentiate X ref FEVER THERAPY from FEVER /ther ( = treatment of fever); only /adv eff /hist /instrum /methods /mortal /nurs /psychol /rehabil /util (if by MeSH definition) /vet; coord IM with disease /ther (IM); do not index under specific type of induction unless the point of the article & then probably only NIM MNE2.780.480 XSFever Therapy; Hyperthermia, Local; Hyperthermia, Therapeutic; Thermotherapy XUÑAmmotherapy LH LS; ; ; LU  MSExcessive functional activity of the thyroid gland. MHÑHyperthyroidism ANTHYROTOXICOSIS & THYROID CRISIS are available: do not make a diagnosis: use term of author MNC19.874.397 FXÑLONG-ACTING THYROID STIMULATOR LH LX  MSExcess of thyroxine in the blood. PM87 HN87 MHÑHyperthyroxinemia PIThyroxine/blood (66-86) MNC19.874.410 LH  MHÑHypertonic Solutions ANGEN; NIM; no qualif when NIM coord; qualif is usually attached to specific drug in solution; when IM, D25-26 qualif; don't forget SALINE SOLUTION, HYPERTONIC & GLUCOSE SOLUTION, HYPERTONIC MND26.394.225.766.314 LH  MSLocalized (as in chronic low-grade trauma, hamartomas, and nevi) or generalized excess hair. Does not include hirsutism, which is excess hair in females and children with an adult male pattern of distribution. MHÑHypertrichosis AN╥localized or generalized excess hair╙: differentiate from HIRSUTISM, ╥excess hair in females & child with an adult male pattern distrib╙; do not confuse with HYPOTRICHOSIS MNC17.805.305.531 FXÑHIRSUTISM LH LX  MSGeneral increase in bulk of a part or organ, not due to tumor formation, nor to an increase in the number of cells, which is HYPERPLASIA. PM65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64 HN65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64 MHÑHypertrophy ANNIM; coord with organ /pathol; cardiac hypertrophy = HEART ENLARGEMENT but note see refs at ╥Cardiomyopathy╙; also available are CERVIX HYPERTROPHY, GINGIVAL HYPERTROPHY, PROSTATIC HYPERTROPHY MNC23.739.451 LH  MSIncreased alveolar ventilation relative to metabolic carbon dioxide production, so that alveolar carbon dioxide pressure tends to fall below normal. PM64 HN64 MHÑHyperventilation ANrespiratory, not environmental; hyperventilation syndrome: coord IM with /psychol + emotional aspect (IM or NIM) MNC8.618.501; C23.888.852.591 LH  MSA symptom complex resulting from ingestion of excessive amounts of vitamin A. PM87 HN87 MHÑHypervitaminosis A PIVitamin A (66-86) MNC18.452.512 LH  MHÑHypesthesia MNC10.597.751.480; C23.888.592.763.397 LH  OLuse HYPHEMA to search HYPHEMIA 1966 PM67; was HYPHEMIA 1966 HN67; was HYPHEMIA 1966 MHÑHyphema AN= hemorrhage into the anterior chamber of the eye MNC11.290.484; C23.542.290.484 LH  MSOne of two classes of the fungi Deuteromycetes. Most are anamorphs (i.e. asexual forms) of Ascomycetes. OLuse HYPHOMYCETES to search MADURELLA & MONILIALES back thru 1966 & BOTRYTIS, GLIOCLADIUM & VERTICILLIUM back thru 1975 PM86; was MONILIALES 1963-85; MADURELLA was heading 1963-85; EMMONSIA & GLENOSPORELLA (both see CHRYSOSPORIUM, an XU below), ALTERNARIA, CLADOSPORIUM, GEOTRICHUM, HELMINTHOSPORIUM, RHODOTORULA, STACHYBOTRYS & TRICHODERMA were see under MONILIALES 1975-85; PARACOCCIDIOIDES was see under PHYCOMYCETES 1975-85; RHIZOCTONIA was see under DEUTEROMYCETES 1975-85 HN86; was MONILIALES 1963-85; MADURELLA was heading 1963-85; BOTRYTIS, GLIOCLADIUM & VERTICILLIUM were see under MONILIALES 1975-85 MHÑHyphomycetes ANGEN only: prefer specifics; do not use /anat /embryol /microbiol /parasitol; do not confuse MONILIALES see HYPHOMYCETES with MONILIA see CANDIDA; infection: coord NIM with MYCOSES (IM): it is not MONILIASIS which is a fungal dis caused only by CANDIDA, formerly called Monilia MNB5.354.381.546 XSBotrytis; Gliocladium; Madurella; Moniliales; Verticillium XUÑAlternaria; ÑChrysosporium; ÑCladosporium; ÑExophiala; ÑGeotrichum; ÑHelminthosporium; ÑPaecilomyces; ÑParacoccidioides; ÑRhizoctonia; ÑRhodotorula; ÑStachybotrys; ÑTrichoderma; ÑTrichosporon LH LS; ; ; ; LU; ; ; ; ; ; ; ; ; ; ; ;  MSA state of increased receptivity to suggestion and direction, initially induced by the influence of another person. OLuse HYPNOSIS to search MESMERISM back thru 1966 HNMESMERISM was see under HYPNOSIS 1963-78 MHÑHypnosis ANonly /hist /instrum /methods MNF4.754.424 XSMesmerism LH LS  PM65 HN65 MHÑHypnosis, Anesthetic ANdo not use /util except by MeSH definition MNE3.155.675 LH  PM65 HN65 MHÑHypnosis, Dental ANdo not use /util except by MeSH definition MNE3.155.141.481; E3.155.675.481; E6.45.481 LH  MHÑHypnotics and Sedatives ANGEN; do not use /analogs /biosyn /defic /physiol; DF: HYPNOTICS MND14.591 XSSedatives FXÑHistamine H1 Receptor Blockaders; ÑTranquilizing Agents LH LS LX;  MSA disease in which the low density lipoprotein (beta-lipoprotein) concentrations are far below normal. HN(78); was see under HYPOLIPOPROTEINEMIAS 1978-79 MHÑHypobetalipoproteinemia ANdo not confuse with ABETALIPOPROTEINEMIA PIBlood Protein Disorders (66-77); Lipid Metabolism, Inborn Errors (66-77); Lipoproteins (66-77); Lipoproteins, LDL (72-77) MNC18.452.648.556.485.440 DMÑHypolipoproteinemia LH LM  MHÑHypocalcemia MNC18.452.174.509; C18.452.950.509 FXÑCalcium LH LX  MSOxyacids of chlorine containing monovalent chlorine. Act as oxidizing or reducing agents. PM77; was see under ACIDS 1975-76 HN77(75); was see under ACIDS 1975-76 MHÑHypochlorous Acids ANdo not use /analogs /biosyn /defic /physiol PISodium Hypochlorite (66-74) MND1.29.260.365; D1.396.343.490; D1.655.498.400 LH  MSPersistent overconcern with the state of physical or emotional health accompanied by various bodily complaints without demonstrable organic pathology. OLuse HYPOCHONDRIASIS to search HYPOCHONDRIACAL NEUROSES back thru 1969 HNNEUROSIS, HYPOCHONDRIACAL was HYPOCHONDRIACAL NEUROSES see HYPOCHONDRIASIS 1979-80, was HYPOCHONDRIACAL NEUROSES see under HYPOCHONDRIASIS 1969-78 MHÑHypochondriasis ANdo not use /drug eff /physiol /rad eff MNF3.126.451; F3.709.438.710.560 XSNeurosis, Hypochondriacal LH LS  MSAn order of Ascomycetes including a number of species which are parasitic on higher plants, insects or fungi; other species are saprophytic. OLsearch ASCOMYCETES 1966-74 PM75; was see under ASCOMYCETES 1963-74 HN75; was see under ASCOMYCETES 1963-74 MHÑHypocreales ANdo not use /anat /embryol /microbiol /parasitol PIAscomycetes (66-74) MNB5.354.107.501 XUÑGibberella LH LU  MSInfestation with larvae of the genus Hypoderma, the warble fly. PM68 HN68 MHÑHypodermyiasis ANHypoderma is indexed under DIPTERA PIMyiasis (66-67) MNC3.211.503.398 LH  MHÑHypogastric Plexus ANdo not use /innerv MNA8.99.456 LH  MHÑHypoglossal Nerve AN12th cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.459 LH  MHÑHypoglycemia MNC18.452.528 FXÑBlood Glucose XUÑInsulin Coma LH LX LU  MSAgents which lower the blood glucose level. OLuse HYPOGLYCEMIC AGENTS to search ANTIDIABETICS back thru 1966 PM76; was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75 HN76; was NON MESH 1975, was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75 MHÑHypoglycemic Agents ANdo not use /analogs /biosyn /defic /physiol MND9.482 XSAntidiabetics LH LS  MSMethylene cyclopropyl alanine and congeners isolated from the unripe edible fruit of the akee plant (Blighia sapida); hypoglycin B is the gamma-glutamyl congener of hypoglycin A; they are very toxic and teratogenic, causing a fall in blood glucose due to the interference of fatty acid and leucine metabolism which leads to vomiting, liver damage, convulsions and death; the syndrome is called Jamaican Vomiting Sickness. HN(77) MHÑHypoglycins AN/biosyn permitted if by plant; do not use /analogs /defic physiol; /pois: coord IM with PLANT POISONING (IM) if Jamaican vomiting sickness PIAlanine (73-76); Cyclopropanes (70-76) MND2.455.426.392.368.533.450; D24.185.926.412 DMÑCyclopropanes LH LM  MSCondition resulting from or characterized by abnormally decreased functional activity of the gonads, with retardation of growth and sexual development. OLuse HYPOGONADISM to search INFANTILISM 1966-83 PMINFANTILISM, GENITAL & INFANTILISM, SEXUAL were heading INFANTILISM 1963-83 HNINFANTILISM, GENITAL & INFANTILISM, SEXUAL were heading INFANTILISM 1963-83 MHÑHypogonadism ANfor male or female; do not routinely interpret hypogonadism in male as EUNUCHISM: use terminology of author MNC19.391.482 XSInfantilism, Genital; Infantilism, Sexual LH LS;  MSAbnormally diminished perspiration. OLuse HYPOHIDROSIS to search ANHIDROSIS back thru 1975 PM76; was ANHIDROSIS 1975 HN76; was ANHIDROSIS 1975 MHÑHypohidrosis PIEctodermal Dysplasia (66-74); Sweating (66-74) MNC17.805.843.370 XSAnhidrosis FXÑSweating LH LS LX  MHÑHypokalemia MNC18.452.950.565 XSHYPOPOTASSEMIA FXÑPotassium LH LS LX  MSThe presence of abnormally low levels of lipoproteins in the serum. OLuse HYPOLIPOPROTEINEMIA to search HYPOLIPOPROTEINEMIAS back thru 1978 PM80; was HYPOLIPOPROTEINEMIAS 1978-79 HN80; was HYPOLIPOPROTEINEMIAS 1978-79 MHÑHypolipoproteinemia ANhypolipoproteinemia, VLDL (hypoprebetalipoproteinemia): coord IM with LIPOPROPROTEINS, VLDL /blood (IM); hypolipoproteinemia, HDL (hypoalphalipoproteinemia): coord IM with LIPOPROTEINS, HDL /blood (IM); familial hypoalphalipoproteinemia = TANGIER DISEASE; hypolipoproteinemia, LDL = HYPOBETALIPOPROTEINEMIA PIBlood Protein Disorders (66-77); Hypoproteinemia (66-77); Lipid Metabolism, Inborn Errors (66-77); Lipoproteins (66-77); Lipoproteins, HDL (72-77) MNC18.452.648.556.485 XUÑHypobetalipoproteinemia; ÑLecithin Acyltransferase Deficiency; ÑTangier Disease LH LU; ;  MHÑHyponatremia MNC18.452.950.620 FXÑSodium LH LX  MHÑHypoparathyroidism MNC19.642.482 LH  HN(85) MHÑHypopharyngeal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIHypopharynx (79-84); Pharyngeal Neoplasms (66-84) MNC4.588.443.665.710.485; C9.775.549.485 DMÑPharyngeal Neoplasms LH LM  MSLaryngeal part of the pharynx. PM79 HN79 MHÑHypopharynx PIPharynx (66-78) MNA14.724.490 LH  PM72 HN72(66) MHÑHypophosphatasia ANdefic of blood phosphatases; do not use /congen MNC5.116.198.816.651.482; C18.452.174.845.651.482; C18.452.648.618.482 LH  MSFamilial disorder characterized by hypophosphatemia associated with decreased renal tubular reabsorption of inorganic phosphorus. Sometimes associated with osteomalacia or rickets which do not respond to the usual doses of vitamin D. PM65 HN65 MHÑHypophosphatemia, Familial ANa clin entity: not for decreased blood phosphate levels ( = PHOSPHATES /blood) MNC12.777.419.815.647; C18.452.648.618.544; C18.452.648.851.647 XSDiabetes, Phosphate; Phosphate Diabetes LH LS;  MHÑHypophysectomy ANdo not use /class /man /rehabil /supply /util (except by MeSH definition) MNE4.530.482; E4.779.532 FXÑPituitary Gland; ÑPituitary Irradiation XUÑHypophysectomy, Chemical LH LX; LU  MSTotal or subtotal destruction of the pituitary gland by chemical injection. Usually achieved by injection of ethyl alcohol via trans-sphenoidal cannulation under stereotaxic control. Performed for treatment of intractable pain. HN(82) MHÑHypophysectomy, Chemical ANdo not use /class /man /rehabil /supply /util (except by MeSH definition); coord IM with disease /ther (IM), not /surg; usually performed with ethyl alcohol so do not index under ALCOHOL, ETHYL unless particularly discussed PIAlcohol, Ethyl (77-81); Hypophysectomy (77-81); Pain, Intractable (77-81); Pituitary Gland/DE (77-81) MNE4.779.532.490 DMÑHypophysectomy LH LM  MSDiminution or cessation of the pituitary function resulting from surgical or radiation ablation, from nonsecretory pituitary tumors, from metastatic tumors, from infarction, and from a number of infiltrative or granulomatous processes. OLuse HYPOPITUITARISM to search SIMMONDS' DISEASE back thru 1966 & SHEEHAN'S SYNDROME back thru 1966 (as Prov 1966-74) PMSIMMONDS' DISEASE was heading 1963-67; SHEEHAN'S SYNDROME was see under SIMMONDS' DISEASE 1963-67 HNSIMMONDS' DISEASE was see under HYPOPITUITARISM 1968-78, was heading 1963-67; SHEEHAN'S SYNDROME was see under HYPOPITUITARISM 1975-78, was Prov 1964-74, was see under SIMMONDS' DISEASE 1963-67 MHÑHypopituitarism MNC19.700.482 XSSheehan's Syndrome; Simmonds' Disease LH LS;  PM65 HN65(63) MHÑHypoproteinemia MNC15.378.147.607 FXÑPROTEIN-LOSING ENTEROPATHIES LH LX  MHÑHypoprothrombinemias MNC15.378.463.134.676 XUÑFactor X Deficiency LH LU  MHÑHypospadias ANdo not use /congen MNC16.131.939.516 LH  MHÑHypotension ANonly blood pressure; not for intracranial pressure; postural = HYPOTENSION, ORTHOSTATIC; relation to BLOOD PRESSURE: Manual 23.38 MNC14.907.514 XSBLOOD PRESSURE, LOW LH LS  MHÑHypotension, Controlled ANnote category: a technic; do not use /util except by MeSH definition MNE3.545 LH  MHÑHypotension, Orthostatic ANpostural hypotension goes here MNC14.907.514.482 LH  MSLoose heterogeneous collection of cells in the anterior hypothalamus, continuous rostrally with the medial and lateral preoptic areas and caudally with the tuber cinereum. PM83 HN83 MHÑHypothalamic Area, Anterior ANdo not use /innerv PIHypothalamus (66-82); Hypothalamus, Anterior (75-82) MNA8.186.211.385.357.342.63 XSAnterior Hypothalamic Area; Anterior Hypothalamic Nucleus LH LS;  MSAn area in the middle hypothalamus continuous rostrally with the lateral preoptic area and caudally with the tegmentum mesencephali. It contains the tuberomammillary and lateral tuberal nuclei. PM83 HN83 MHÑHypothalamic Area, Lateral ANin the HYPOTHALAMUS, MIDDLE; do not use /innerv PIHypothalamus (66-82) MNA8.186.211.385.357.352.543 XSLateral Hypothalamic Area; Lateral Hypothalamic Nucleus LH LS;  OLuse HYPOTHALAMIC DISEASES to search FROEHLICH'S SYNDROME back thru 1966 PM81; FROEHLICH'S SYNDROME was heading 1963-84 HN81; FROEHLICH'S SYNDROME was heading 1963-84 MHÑHypothalamic Diseases ANcoord IM with specific part of hypothalamus (NIM) PIBrain Diseases (66-80); Hypothalamus (66-80) MNC10.228.140.617 XSFroehlich's Syndrome LH LS  MSHormones isolated from the hypothalamus which exercise control over other organs, primarily the pituitary gland. Well-known members include certain pituitary hormone releasing hormones and pituitary hormone release inhibiting hormones. Vasopressin and oxytocin which are found in the posterior pituitary may also be secreted by the hypothalamus. PM79 HN79 MHÑHypothalamic Hormones ANGEN or unspecified; prefer specifics; /biosyn /physiol permitted; do not use /analogs; consider also PITUITARY HORMONE RELEASING HORMONES & PITUITARY HORMONE RELEASE INHIBITING HORMONES & their specifics PIHormones (66-78); Hypothalamus (66-78); Pituitary Hormones (72-78); specific hormone MND6.472.420 LH  PM81 HN81 MHÑHypothalamic Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with site in hypothalamus (NIM) + histol type of neopl (IM) PIBrain Neoplasms (66-80); Hypothalamus (66-80) MNC4.588.614.195.486; C10.228.140.211.477; C10.228.140.617.477 LH  MSA neuroendocrine system of neurons, fiber tracts, endocrine tissue and blood vessels which produces and releases pituitary hormones into the systemic circulation. PM65 HN65 MHÑHypothalamo-Hypophyseal System ANhypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM; emphasis here is on interrelation between hypothalamus & pituitary: do not use as a substitute for HYPOTHALAMUS & PITUITARY GLAND as entities; restrict use to MeSH definition MNA6.407.747.357; A6.688.357; A8.186.211.385.357.332; A8.713.357 FXÑPITUITARY HORMONE RELEASING HORMONES LH LX  MHÑHypothalamus ANdo not use /innerv; note hypothalamus-pituitary heading above MNA8.186.211.385.357; A8.186.211.577.482 XUÑHypothalamus, Posterior; ÑTuber Cinereum LH LU;  MSThe anterior portion of the hypothalamus. PM83; was see under HYPOTHALAMUS 1975-82 HN83(75); was see under HYPOTHALAMUS 1975-82 MHÑHypothalamus, Anterior ANdo not use /innerv; diseases: coord NIM with HYPOTHALAMIC DISEASES (IM) MNA8.186.211.385.357.342 XSHypothalamus, Supraoptic LH LS  MSThat middle portion of the hypothalamus containing the arcuate, dorsomedial, ventromedial nuclei, and the lateral hypothalamic area. OLuse HYPOTHALAMUS, MIDDLE to search HYPOTHALAMUS, MEDIAL back thru 1975 PM83; was HYPOTHALAMUS, MEDIAL see under HYPOTHALAMUS 1975-82 HN83; was HYPOTHALAMUS, MEDIAL see under HYPOTHALAMUS 1975-82 MHÑHypothalamus, Middle ANdo not use /innerv; diseases: coord NIM with HYPOTHALAMIC DISEASES (IM) MNA8.186.211.385.357.352 XSHypothalamus, Infundibular; Hypothalamus, Medial XUÑDorsomedial Hypothalamic Nucleus LH LS; LU  MSThe posterior portion of the hypothalamus. HN(75) MHÑHypothalamus, Posterior ANdo not use /innerv; diseases: coord NIM with HYPOTHALAMIC DISEASES (IM) MNA8.186.211.385.357.362 DMÑHypothalamus LH LM  MSLower than normal body temperature, especially in warm-blooded animals; in man usually accidental or unintentional. MHÑHypothermia ANnote term below; relation to BODY TEMPERATURE: for principle see Manual 23.38 MNC23.888.189.565 FXÑCold LH LX  MSAbnormally low body temperature intentionally induced in warm-blooded animals by artificial means. OLuse HYPOTHERMIA, INDUCED to search ANESTHESIA, REFRIGERATION & HIBERNATION, ARTIFICIAL back thru 1966; use HYPOTHERMIA, INDUCED + STOMACH (NIM) to search GASTRIC HYPOTHERMIA back thru 1966 PMANESTHESIA, REFRIGERATION & HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1966-83 HNANESTHESIA, REFRIGERATION & HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1964-83 (Prov 1964-65) MHÑHypothermia, Induced ANinduced by cold or by drugs; cooling of organs during surg or for ther goes here; do not use /util except by MeSH definition MNE3.607 XSAnesthesia, Refrigeration; Cryoanesthesia; Gastric Hypothermia; Hibernation, Artificial FXÑCold; ÑRefrigeration LH LS; ; ; LX;  MHÑHypothyroidism MNC19.874.482 LH  PM66 HN66(65) MHÑHypotonic Solutions ANGEN; NIM; no qualif when NIM for qualif is usually attached to specific drug in solution; when IM, D25-26 qualif MND26.394.225.766.399 LH  OLsearch ALOPECIA 1966-74 HN(75) MHÑHypotrichosis ANdo not confuse with HYPERTRICHOSIS MNC17.805.305.122.608 DMÑAlopecia LH LM  MSA condition in which the amount of air entering the pulmonary alveoli is reduced. PM70 HN70(66) MHÑHypoventilation ANrespiratory, not environmental MNC8.618.846.565; C23.888.852.638 LH  MSCatalyzes the conversion of 5-phosphoribosyl 1-pyrophosphate and hypoxanthine or guanine or 6-mercapto-purine to the corresponding 5'-mono-nucleotides and pyrophosphate. The enzyme is important in purine bioxynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the Lesch-Nyhan syndrome, while partial deficiency results in overproduction of uric acid. PM75 HN75 MHÑHypoxanthine Phosphoribosyltransferase ANdo not use /analogs; /defic: consider also LESCH-NYHAN SYNDROME or GOUT; DF: HGPRTASE RNEC 2.4.2.8 PIPentosephosphates (72-74); Pentosyltransferases (72-74) MND8.586.913.647.450 XSHypoxanthine-Guanine Phosphoribosyltransferase; IMP Pyrophosphorylase FXÑLesch-Nyhan Syndrome LH LS; LX  PM66 HN66(64) MHÑHypoxanthines ANdo not use /analogs /defic; hypoxanthine riboside, hypoxanthine ribonucleoside = INOSINE MND3.438.759.758.399 LH  MSAny of certain small mammals of the order Hyracoidea. HN(75) MHÑHyraxes AN also ╥hyraces╙; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.400 DMÑMammals LH LM  MSExcision of the uterus. MHÑHysterectomy ANdo not use /util except by MeSH definition; abdominal: do not coord with ABDOMEN; vaginal = HYSTERECTOMY, VAGINAL MNE4.819.608.399; E4.887.690.399 FXÑUterus XUÑHysterectomy, Vaginal LH LX LU  MSRemoval of the uterus through the vagina. HN(75) MHÑHysterectomy, Vaginal ANdo not use /util except by MeSH definition MNE4.819.608.399.490 XSColpohysterectomy DMÑHysterectomy LH LS LM  MSA chronic, but fluctuating, disorder beginning in early life and characterized by recurrent and multiple somatic complaints for which medical attention is sought, but which are not apparently due to physical illness. OLuse HYSTERIA to search HYSTERICAL NEUROSES back thru 1969 HNHYSTERICAL NEUROSES was see under HYSTERIA 1969-78 MHÑHysteria ANdo not use /drug eff /physiol /rad eff MNF3.126.473 XSHysterical Neuroses LH LS  MSRadiography of the uterus and fallopian tubes after the injection of a contrast medium. MHÑHysterosalpingography ANdo not use /util except by MeSH definition MNE1.249.420; E1.818.389 XSSALPINGOGRAPHY FXÑFallopian Tubes; ÑGenitalia, Female; ÑUterus LH LS LX; ;  MSA blood group related both to the ABO and P systems that includes several different antigens found in most people on erythrocytes, in milk and saliva; the antibodies react only at low temperatures. HN(76) MHÑI Blood-Group System ANonly /genet /immunol; TN 230 PIBlood Groups (66-75) MND24.611.216.705.230.501; G4.610.241.501; G9.188.229.501 DMÑBlood Groups LH LM  MHÑIatrogenic Disease ANIM for general or as coord with specific iatrogenic dis; article must discuss dis as iatrogenic: do not routinely index adv eff of drugs or procedures as iatrogenic; only /occur (for statistics, not for causes) /prev MNC23.280.537 LH  MS7-Ethyl-6,6a,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido(1',2':1,2)azepino(4,5-b)indole. One of several indole alkaloids extracted from Tabernanthe iboga, Baill.; it causes central nervous system stimulation changes blood pressure and may be hallucinogenic. HN(76) MHÑIbogaine ANdo not use /defic /physiol; /analogs NIM only RN83-74-9 PIAlkaloids (69-75); Azepines (75); Benzazepines (69-74); Indoles (72-75) MND3.132.430; D3.438.473.390; D15.236.372.492 XS12-Methoxyibogamine DMÑAlkaloids LH LS LM  MSalpha-Amino-3-hydroxy-5-isoxazoleacetic acid. Neurotoxic isoxazole substance found in Amanita muscaria and A. pantherina; causes motor depression, ataxia and changes in mood, perceptions and feelings. HN(76) MHÑIbotenic Acid ANdo not use /defic /physiol; /analogs NIM only RN2552-55-8 PIAmmonium Compounds (73-75); Mushrooms (73-75); Oxazoles (73-75) MND3.383.548.320; D15.236.372.501; D24.185.926.587.475 DMÑOxazoles LH LM  MS2-(p-isobutylphenyl)propionic acid. An anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis. Synonyms: Brufen; Motrin. PM78; was see under PHENYLPROPIONATES 1975-77 HN78(75); was see under PHENYLPROPIONATES 1975-77 MHÑIbuprofen ANdo not use /biosyn /defic /physiol RN15687-27-1 PIPropionates (72-74) MND2.241.223.701.430; D14.73.278.450; D26.74.75.588 LH  MHÑIce ANonly /adv eff /anal MNG3.230.700.300 FXÑDry Ice; ÑFreezing LH LX;  MHÑIce Cream ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNJ1.341.273.533 LH  MHÑIceland MNZ1.542.433 LH  MHÑIchthammol AND25-26 qualif RN8029-68-3 MND20.187.508; D26.368.546 XSIchthammonium; Ichthosulfol LH LS;  MSAny of several generalized skin disorders characterized by dryness, roughness and scaliness, due to hypertrophy of the stratum corneum epidermis. OLto search ERYTHRODERMA ICHTHYOSIFORME use ICHTHYOSIS & SKIN DISEASES, BULLOUS 1975-78 & ICHTHYOSIS 1966-74 PMERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78 HNERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78 MHÑIchthyosis ANXERODERMA as dryness of skin is so indexed if terms ╥xeroderma╙, ╥ichthyosis╙ or other clue appear in text, otherwise dryness of skin is indexed under SKIN DISEASES; do not confuse X ref SJOGREN-LARSSON SYNDROME with SJOGREN'S SYNDROME MNC16.131.831.512; C16.614.492; C17.428.333 XSErythroderma Ichthyosiforme, Nonbullous; Sjogren-Larsson Syndrome; XERODERMA LH LS; ;  MS6-Chloro-9-[[3-[(2-chloroethyl)ethylamino]propyl]amino]-2-methoxyacridine dihydrochloride. A monofunctional quinacrine mustard compound which acts both as an alkylating agent and as a mutagen. HN(75) MHÑICR 170 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN146-59-8 PIAcridines (71-74); Nitrogen Mustard Compounds (71-74) MND2.455.526.728.650.400; D3.494.46.250.530; D22.204.585.498 XSAcridine Mustard DMÑNitrogen Mustard Compounds LH LS LM  MSMore commonly known family of North American freshwater catfishes. Consists of five genera with several species two of which are eyeless. HN(87) MHÑIctaluridae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.80.148 XSAmeurius; Ictalurus DMÑCatfish LH LS; LM  MSThe part of the personality structure which harbors the unconscious instinctive desires and strivings of the individual. PM68 HN68 MHÑId ANno qualif PIPersonality (66-67); Psychoanalytic Theory (66-67) MNF1.752.747.347; F2.739.794.371 LH  MHÑIdaho MNZ1.107.567.875.361 LH  MSA defense mechanism by which an individual unconsciously endeavors to pattern himself after another; also important in the development of the personality, particularly the superego or conscience, which is modeled largely on parental behavior. OLsearch DEFENSE MECHANISMS 1966-67 PM68; was IDENTIFICATION see under DEFENSE MECHANISMS 1963-67 HN68; was IDENTIFICATION see under DEFENSE MECHANISMS 1963-67 MHÑIdentification (Psychology) ANno qualif; DF: IDENTIFICATION PIDefense Mechanisms (66-67); Personality (66-67) MNF1.393.446; F1.752.747.385; F3.407.446 XUÑGender Identity LH LU  MSChaotic concept of self wherein one's role in life appears to be an insoluble dilemma often expressed by isolation, withdrawal, rebellion and extremism. PM73 HN73(71) MHÑIdentity Crisis ANno qualif PIDefense Mechanisms (66-67); Identification (Psychology) (68-70); Self Concept (66-70) MNF1.752.747.423 LH  MSIditol:NAD+ 5-oxidoreductase. An alcohol oxidoreductase which catalyzes the oxidation of L- or D-iditol to L- or D-sorbose in the presence of NAD. Acts also on glucitol to form fructose and on other closely related sugar alcohols. EC 1.1.1.14 and EC 1.1.1.15. HN(77); was see under ALCOHOL OXIDOREDUCTASES 1977 MHÑIditol Dehydrogenase ANdo not use /analogs RNEC 1.1.1.14 PIAlcohol Oxidoreductases (66-76); specific polyol MND8.586.682.47.150.700.475 XSSorbitol Dehydrogenase DMÑSugar Alcohol Dehydrogenases LH LS LM  MHÑIdoxuridine ANdo not use /biosyn /defic /physiol RN54-42-2 MND13.570.230.430.609; D13.570.685.852.300.400; D20.388.534; D26.87.496 XS5-Iodo-2-Deoxyuridine; IUDR; Iododeoxyuridine LH LS; ;  MSAn enzyme which specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter's syndrome, which is characterized by an excess of dermatan sulfate and heparan sulfate. HN(76) MHÑIduronate Sulfatase ANdo not use /analogs RNEC 3.1.6.- PIIduronic Acid (75); Sulfatases (72-75); Uronic Acids (72-75) MND8.586.277.352.827.500 XSHunter Corrective Factor; Iduronatesulfate Sulfohydrolase; Sulfoiduronate Sulfatase DMÑSulfatases LH LS; ; LM  MSComponent of dermatan sulfate. Differs in configuration from glucuronic acid only at the C-5 position. HN(75) MHÑIduronic Acid ANdo not use /defic /physiol; /analogs NIM only RN3402-98-0 PIUronic Acids (71-74) MND2.241.81.844.915.400.500; D2.241.152.811.400.500; D2.241.511.902.915.400.500; D9.203.811.922.400.500 DMÑUronic Acids LH LM  MSMucopolysaccharide alpha-L-iduronohydrolase. Hydrolyzes iduronosidic linkages in desulfated dermatan. Deficiency of this enzyme produces Hurler's syndrome. HN(75) MHÑIduronidase ANdo not use /analogs RNEC 3.2.1.76 PIGlycoside Hydrolases (72-74); Hexoses (72-74); Uronic Acids (72-74) MND8.586.277.450.560 DMÑGlycoside Hydrolases LH LM  MS3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide. Positional isomer of cyclophosphamide which is active as an alkylating agent and an immunosuppressive agent. Synonyms: Asta A 4942; NSC-109724. PM86; was see under CYCLOPHOSPHAMIDE 1975-85 HN86(75); was see under CYCLOPHOSPHAMIDE 1975-85 MHÑIfosfamide ANdo not use /biosyn /defic /physiol RN3778-73-2 PICyclic P-Oxides (72-74); Ethylamines (72-74); Oxazines (72-74) MND2.455.526.728.650.730.500; D2.705.670.243.500; D3.383.533.500; D22.204.585.748.243.511; D22.569.518.511 XSIsofosfamide; Isophosphamide LH LS;  PM73 HN73(71) MHÑIgA ANonly /admin /anal /biosyn /class /csf /genet /immunol /isol /metab /physiol /ther use /urine; /defic = IGA /defic (IM) + DYSGAMMAGLOBULINEMIA (IM) (TN 225); gammopathy: indexing instructions in TN 226; Am allotype goes here (IM) + IMMUNOGLOBULIN ALLOTYPES (IM); IGA1, IGA2, etc. go here; ╥salivary IGA╙: index IGA, SECRETORY (IM) + SALIVA (IM); ╥IGA in tears╙: index IGA, SECRETORY (IM) + TEARS (IM) PIImmunoglobulins (70) MND12.776.124.486.485.400; D12.776.124.790.651.369; D12.776.377.715.548.359; D24.611.125.600.681.26 LH  MSThe principle Ig found in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. It is composed of two to four molecules of 7S IgA and one molecule each of J Chain and secretory component (SC), also called secretory piece. Molecular weight appr. 400,000. PM84; was see under IGA 1976-83 HN84(76); was see under IGA 1976-83 MHÑIgA, Secretory ANonly /anal /biosyn /class /csf /genet /immunol /isol /metab /physiol /urine; salivary IGA: index IGA, SECRETORY (IM) + SALIVA (IM or NIM); IGA in tears: index IGA, SECRETORY (IM) + TEARS (IM); do not use /defic: TN 225 PIColostrum (73-75); IgA (73-75); Immunoglobulin Fragments (73-75) MND12.776.124.486.485.400.350; D12.776.124.790.651.369.350; D12.776.377.715.548.359.350; D24.611.125.600.681.26.30 XSColostral IgA; IgA, Exocrine; SIgA; Secretory IgA LH LS; ; ;  PM73 HN73(71) MHÑIgD ANonly /admin /anal /biosyn /class /csf /genet /immunol /isol /metab /physiol /ther use /urine; /defic = IGD /defic (IM) + DYSGAMMAGLOBULINEMIA (IM) (TN 225); gammopathy: indexing instructions in TN 226; IGD1, IGD2, etc. go here PIImmunoglobulins (70) MND12.776.124.486.485.456; D12.776.124.790.651.414; D12.776.377.715.548.421; D24.611.125.600.681.251 LH  PM73 HN73(71) MHÑIgE ANonly /admin /anal /biosyn /class /csf /genet /immunol /isol /metab /physiol /ther use /urine; /defic = IGE /defic (IM) + DYSGAMMAGLOBULINEMIA (IM) (TN 225); gammopathy: indexing instructions in TN 226 RN37341-29-0 PIImmunoglobulins (70) MND12.776.124.486.485.511; D12.776.124.790.651.459; D12.776.377.715.548.484; D24.611.125.600.681.312 LH  OLuse IGG to search GAMMA GLOBULIN, 7S back thru 1966 PM73; GAMMA GLOBULIN, 7S was heading 1965-81 HN73(71); GAMMA GLOBULIN, 7S was heading 1965-81 MHÑIgG ANonly /admin /anal /biosyn /class /csf /genet /immunol /isol /metab /physiol /ther use /urine; /defic = IGG /defic (IM) + DYSGAMMAGLOBULINEMIA (IM) (TN 225); gammopathy: indexing instructions in TN 226; Gm and Inv (or Km) allotypes go here (IM) + IMMUNOGLOBULIN ALLOTYPES (IM); IGG1, IGG2, etc. go here PIImmunoglobulins (70) MND12.776.124.486.485.567; D12.776.124.790.651.504; D12.776.377.715.548.546; D24.611.125.600.681.393 XSGamma Globulin, 7S LH LS  OLuse IGM to search GAMMA GLOBULIN, 19S back thru 1966 PM73; GAMMA GLOBULIN, 19S was heading 1965-81 HN73; GAMMA GLOBULIN, 19S was heading 1965-81 MHÑIgM ANonly /admin /anal /biosyn /class /csf /genet /immunol /isol /metab /physiol /ther use /urine; /defic = IGM /defic (IM) + DYSGAMMAGLOBULINEMIA (IM) (TN 225); gammopathy: indexing instructions in TN 226; IGM1, etc. go here PIImmunoglobulins (70) MND12.776.124.486.485.622; D12.776.124.790.651.549; D12.776.377.715.548.609; D24.611.125.600.681.574 XSGamma Globulin, 19S LH LS  MSLarge herbivorous tropical American lizards. HN(75) MHÑIguanas ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.833.393.500 DMÑLizards LH LM  MSDiseases of the ileum including the ileocecal valve. PM80 HN80 MHÑIleal Diseases ANinflamm dis = ILEITIS PIIleum (66-79); Intestinal Diseases (66-79); specific intestinal disease MNC6.405.469.420 LH  MSNeoplasms of the ileum including the ileocecal valve. PM80 HN80 MHÑIleal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIIleum (66-79); Intestinal Neoplasms (66-79) MNC4.588.274.476.411.501; C6.405.469.420.501 LH  MHÑIleitis MNC6.405.469.420.520 LH  MHÑIleocecal Valve ANdiseases: coord IM with ILEAL DISEASES (NIM); neopl: coord IM with ILEAL NEOPLASMS (IM); ileocecal intussusception or invagination: index under ILEOCECAL VALVE (IM) + INTUSSUSCEPTION (IM) + ILEAL DISEASES (NIM) but not also CECAL DISEASES MNA3.492.411.620.484.400 LH  MHÑIleostomy ANdo not use /util except by MeSH definition; restrict to ileal stoma on abdom wall: do not use for jejuno-ileal bypass in obesity ther ( = ILEUM /surg) MNE4.765.614 FXÑIleum LH LX  MHÑIleum ANdo not confuse with ILEUS or ILIUM; /surg: consider ILEOSTOMY; inflammation = ILEITIS; ileocecal intussusception or invagination: index under ILEOCECAL VALVE (IM) + INTUSSUSCEPTION (IM) + ILEAL DISEASES (NIM); ileocolic intussusception: index under ILEAL DISEASES (IM) + INTUSSUSCEPTION (IM) but not also COLONIC DISEASES; ileum as smooth muscle is probably MUSCLE, SMOOTH (IM) + ILEUM (NIM); jejuno-ileal bypass or shunt or jejuno-ileostomy in obesity: index under JEJUNOILEAL BYPASS & not also under OBESITY (note XR ref) MNA3.492.411.620.484 FXÑILEOSTOMY LH LX  MSEither of two large arteries originating from the abdominal aorta; they supply blood to the pelvis, abdominal wall and legs. MHÑIliac Artery ANdo not use /blood supply MNA7.231.114.444 LH  MSA vein on either side of the body which is formed by the union of the external and internal iliac veins and passes upward to join with its fellow of the opposite side to form the inferior vena cava. MHÑIliac Vein ANdo not use /blood supply MNA7.231.908.427 LH  MHÑIlium ANpart of the hip; do not confuse with ILEUM, part of the small intestine MNA2.835.232.611.434 LH  MSUse for articles on the unmarried mother and/or the child born to her. MHÑIllegitimacy ANthe child or the unwed parents (coord with PARENTS (IM) ); only /hist /legis /trends MNI1.880.225.465; I1.880.735.424 LH  MHÑIllinois ANCHICAGO is also available MNZ1.107.567.875.370 LH  MSThe misinterpretation of a real external, sensory experience. MHÑIllusions ANonly /drug eff /physiol /rad eff MNC10.597.751.525; F2.463.593.446; F3.126.185.794.534; C23.888.592.763.525 XUÑAutokinetic Effect; ÑOptical Illusions LH LU;  MSImprovement of the quality of a picture by various technics, including computer processing. PM73 HN73(72) MHÑImage Enhancement ANonly /instrum /methods /stand PIPhotography (66-70); Technology, Radiologic (66-70) MNE5.712.484; H1.671.606.799.484; L1.700.568.110.308.380 FXÑRADIOGRAPHIC IMAGE ENHANCEMENT; ÑSubtraction Technic LH LX;  MSComputer systems developed to aid in the interpretation of ultrasound, radiographic images, etc. PM87 HN87 MHÑImage Interpretation, Computer-Assisted ANonly /instrum /methods /stand MNE1.158.600; E1.289.400; E1.947.600; L1.700.508.100.158.600 XSEchographic Interpretation, Computer-Assisted XUÑRadiographic Image Interpretation, Computer-Assisted LH LS LU  MSA technique of inputting two dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. PM87 HN87 MHÑImage Processing, Computer-Assisted ANonly /instrum /methods /stand MNL1.700.568.110.308 XSComputer-Assisted Image Processing; Image Analysis, Computer-Assisted; Image Reconstruction LH LS; ;  MSA new pattern of perceptual or ideational material derived from past experience. MHÑImagination ANonly /drug eff /physiol /rad eff MNF2.463.188.634 LH  PMNAPHAZOLINE was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74, was see under SYMPATHOMIMETICS 1963-66 MHÑImidazoles ANincludes imidazolines, imidazolidines; do not use /analogs /biosyn /defic /physiol MND3.383.374 XUÑAminoimidazole Carboxamide; ÑAntazoline; ÑClotrimazole; ÑEconazole; ÑEthylenethiourea; ÑEtimizol; ÑFLA 63; ÑHistidinol; ÑMetomidate; ÑNaphazoline; ÑOxymetazoline; ÑRO 20-1724; ÑUrocanic Acid LH LU; ; ; ; ; ; ; ; ; ; ; ;  MHÑImides ANdo not confuse with IMINES or AMIDES; do not use /analogs /biosyn /defic /physiol MND2.478 LH  MSN,N'-bis(3-(4,5-Dihydro-1H-imidazol-2-yl)phenyl)urea. Antiprotozoal agent used in veterinary medicine against blood parasites, especially babesia in livestock; causes kidney damage. Synonyms: 4 A 65; Imizol. HN(75) MHÑImidocarb ANdo not use /biosyn /defic /physiol; /analogs NIM only RN27885-92-3 PICarbanilides (74); Imidazoles (66-74); Urea (66-73) MND2.65.199.326.400; D2.948.684.202.400; D21.370.522 DMÑCarbanilides LH LM  MSEsters of the hypothetical imidic acids. They react with amines or amino acids to form amidines and are therefore used to modify protein structures and as cross-linking agents. PM80; DIMETHYL ADIPIMIDATE was see under IMIDES 1978-79; DIMETHYL SUBERIMIDATE was see under IMIDES 1975-79 HN80 MHÑImidoesters ANdo not use /analogs /biosyn /defic /physiol PIImides (66-79) MND2.478.400; D26.550.430 XSImidates XUÑDimethyl Adipimidate; ÑDimethyl Suberimidate LH LS LU;  MHÑImines ANdo not confuse with IMIDES or AMINES; do not use /analogs /biosyn /defic /physiol MND2.491 LH  PM74 HN74 MHÑImino Acids ANdo not confuse with AMINO ACIDS; do not use /analogs /biosyn /defic /physiol MND2.241.81.583; D2.491.485; D12.125.72.401 XSAmino Acids, Secondary LH LS  MHÑImipramine ANdo not use /biosyn /defic /physiol RN50-49-7 MND3.494.240.485; D15.236.122.140.511 XSImidobenzyle; Imizin LH LS;  MSThe mimicking of the behavior of one individual by another. PM68 HN68 MHÑImitative Behavior ANhuman & animal; only /drug eff /physiol /rad eff PIBehavior (66-67); Behavior, Animal (66-67) MNF1.145.510 LH  MSThe placing of a body or a part thereof into a liquid. PM67 HN67 MHÑImmersion ANonly /adv eff /physiopathol PIDiving (66) MNC21.866.522; E5.466 XSSUBMERSION FXÑDiving; ÑDrowning LH LS LX;  MHÑImmersion Foot MNC21.866.417.485; C23.304.351.547 FXÑCold LH LX  PM67 HN67(64) MHÑImmobilization ANno qualif; act of rendering whole or part of human or animal body immobile or for the state of immobility; deliberate or accidental; immobilization of animals for easy handling can go here if by tranquilizers or methods other than RESTRAINT, PHYSICAL (see note there); not for immobilization of fractures ( = FRACTURE FIXATION: see TN 87); TN 166: do not confuse with BED REST MNG11.427.505 FXÑMovement; ÑRestraint, Physical LH LX;  MSA method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. PM73 HN73(71) MHÑImmune Adherence Reaction ANonly /instrum /methods PIAntigen-Antibody Reactions (66-70) MNE1.223.495.525; E5.478.525 LH  MSDisease due to deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. PM74 HN74(72) MHÑImmune Complex Disease ANdis caused by ╥deposition of circulating antigen-antibody complexes with resultant damage to tissue╙; index ╥immune complex╙ as ANTIGEN-ANTIBODY COMPLEX PIImmunologic Diseases (71) MNC20.543.480.770.510 FXÑAntigen-Antibody Complex LH LX  OLuse IMMUNE SERA to search IMMUNE SERUMS back thru 1966 PM80; was IMMUNE SERUMS 1963-79; IMMUNE SERUM GLOBULIN was heading 1965 HN80; was IMMUNE SERUMS 1963-79; IMMUNE SERUM GLOBULIN was heading 1965 MHÑImmune Sera ANdo not use /analogs /antag /biosyn /blood /chem syn /diag use /metab /physiol /pois /secret /ther use ( = IMMUNIZATION, PASSIVE) MND24.310.401; D24.611.125.573 XSAntisera FXÑImmunization, Passive LH LS LX  MSCells, tissues, and organs, primarily of the lymphatic and reticuloendothelial systems, activated by substances recognized by the host as foreign. PM85 HN85 MHÑImmune System ANnote category; GEN: prefer specifics; /physiol: consider also IMMUNITY & its indentions PIAntibody Formation (66-84); Immunity (66-84); Immunity, Cellular (70-84); Lymphocyte Transformation (69-84); Lymphocytes (66-84); B Lymphocytes (73-84); T Lymphocytes (73-84) MNA15.382 LH  MSThe specific failure of a normally responsive individual to make an immune response to a known antigen. PM66 HN66(64) MHÑImmune Tolerance ANonly /drug eff /rad eff; ╥immunocompromised host╙ goes here or IMMUNOLOGIC DEFICIENCY SYNDROMES or AIDS: check text MNG4.610.484 XSImmunosuppression (Physiology) FXÑGraft vs Host Disease; ÑImmunosuppression LH LS LX;  MSNonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. OLsearch RADIATION IMMUNOLOGY under RADIATION EFFECTS 1966 PMRADIATION IMMUNOLOGY was heading 1964-66 HNRADIATION IMMUNOLOGY was heading 1964-66 MHÑImmunity ANIM GEN only for ╥immunity╙ or ╥immune process╙; NIM with specific disease /immunol (IM); only /drug eff /rad eff; ╥cell-mediated immunity╙ = IMMUNITY, CELLULAR; ╥immune response╙: index under ANTIBODY FORMATION (usually discusses B-lymphocytes) or IMMUNITY, CELLULAR (usually discusses T-lymphocytes); TN 242 CATALOG: form qualif = ALLERGY AND IMMUNOLOGY MNG4.610 FXÑIMMUNOLOGIC TECHNICS LH LX  MSResistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. PM67 HN67(65) MHÑImmunity, Active ANIM general only, NIM with specific disease /immunol (IM): TN 242; only /drug eff /rad eff MNG4.610.519 FXÑImmunotherapy LH LX  MSThose manifestations of the immune response which are mediated by antigen-sensitized lymphocytes derived from thymic-dependent processes, and which usually take place in the absence of circulating antibody. PM72 HN72(70) MHÑImmunity, Cellular ANIM general only, NIM with specific disease /immunol (IM): TN 242; only /drug eff /rad eff; ╥cell-mediated immunity╙ goes here PIImmunity (66-69) MNG4.610.555 FXÑHypersensitivity, Delayed; ÑT Lymphocytes XUÑImmunologic Surveillance LH LX; LU  MSResistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. OLuse IMMUNITY, MATERNALLY-ACQUIRED to search IMMUNITY, PASSIVE 1966-82 (as Prov 1966) PM83; was IMMUNITY, PASSIVE 1967-82 HN83; was IMMUNITY, PASSIVE 1966-82 (Prov 1966) MHÑImmunity, Maternally-Acquired ANof fetus by transplacental transfer or of neonate through colostrum or milk; do not add MATERNAL-FETAL EXCHANGE; note category: do not confuse with IMMUNIZATION, PASSIVE (Cat E); TN 242; only /drug eff /rad eff MNG4.610.570 XSFetal Immunity, Maternally-Acquired; Maternally-Acquired Immunity; Neonatal Immunity, Maternally-Acquired FXÑImmunization, Passive LH LS; ; LX  MSThe capacity of a normal organism to remain unaffected by microorganisms and their toxins. It is effected by non-specific mechanisms such as genetic endowment, naturally occurring antiviral and bactericidal substances, phagocytosis, and constitutional factors such as body temperature, oxygen tension and age. PM78 HN78 MHÑImmunity, Natural ANIM general only, NIM with specific disease /immunol (IM): TN 242; only /drug eff /rad eff PIImmunity (66-77); specific term/IM (66-77) MNG4.610.575 XSDisease Resistance; Immunity, Non-Specific; Resistance, Natural LH LS; ;  MSDeliberate stimulation of the host's immune response. Active immunization involves administration of antigens or immunologic adjuvants. Passive immunization involves administration of immune sera or lymphocytes or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). MHÑImmunization ANIM; do not use /util except by MeSH definition MNE2.95.377; E5.478.550; G3.770.670.310; G3.850.180.460 XSImmunologic Stimulation; Immunostimulation; Sensitization, Immunologic FXÑPreventive Health Services LH LS; ; LX  MSSchedule giving optimum times for primary and/or secondary immunization. MHÑImmunization Schedule ANno qualif MNE2.95.377.360 LH  MSTransfer of immunity from immunized to non-immune host by administration of serum antibodies, immune RNA or transplantation of lymphocytes (adoptive cell transfer). OLuse IMMUNIZATION, PASSIVE to search PASSIVE TRANSFER 1970-79 (as Prov 1970-72) and SEROTHERAPY back thru 1966 PM80; was PASSIVE TRANSFER 1973-79; SEROTHERAPY was heading 1963-82 HN80; was PASSIVE TRANSFER 1970-79 (Prov 1970-72); SEROTHERAPY was heading 1963-82 MHÑImmunization, Passive ANIM; note category: do not confuse with IMMUNITY, MATERNALLY-ACQUIRED (Cat G) nor X ref PASSIVE TRANSFER OF IMMUNITY with passive transfer of immune tolerance ( = IMMUNOSUPPRESSION) PIImmunity, Maternally-Acquired (66-69) MNE2.95.377.330; E5.478.550.520 XSAdoptive Cell Transfer; Hemotherapy; Immune RNA Manipulation; Immune Serum Globulin Therapy; Immunoglobulin Therapy; Immunotherapy, Passive; Normal Serum Globulin Therapy; Passive Antibody Transfer; Passive Transfer of Immunity; Serotherapy FXÑImmune Sera; ÑImmunity, Maternally-Acquired LH LS; ; ; ; ; ; ; ; ; LX;  MSAny immunization following a primary immunization and involving exposure to the same or a closely related antigen. PM73 HN73(71) MHÑImmunization, Secondary ANdo not use /util except by MeSH definition PIImmunization (66-70) MNE2.95.377.485; E5.478.550.550 XSBooster Immunization; IMMUNIZATION, BOOSTER LH LS;  PM67 HN67(66) MHÑImmunoassay ANNIM; only /instrum /methods; EMIT (enzyme multiplied immunoassay technic) is indexed under IMMUNOENZYME TECHNICS MNE1.223.495.567; E5.478.567 LH  MSA disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly. PM79 HN79 MHÑImmunoblastic Lymphadenopathy MNC15.604.515.509; C20.683.515.501 XSAngioimmunoblastic Lymphadenopathy; Lymphadenopathy, Immunoblastic LH LS;  PM66 HN66(64) MHÑImmunochemistry ANGEN; avoid as coord; SPEC qualif when IM; no qualif when NIM MNG1.201.486 FXÑIMMUNOLOGIC TECHNICS LH LX  MSThe ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen. PM80 HN80 MHÑImmunocompetence ANonly /drug eff /rad eff; ╥immunologically competent cells╙ = B-LYMPHOCYTES or T-LYMPHOCYTES but do not add IMMUNOCOMPETENCE PIAntibody Formation (66-79); Immunity (66-72); Immunity, Cellular (70-79); Lymphocytes (66-79); B Lymphocytes (73-79); T Lymphocytes (73-79) MNG4.610.612 XSCompetence, Immunologic; Immunologic Competence LH LS;  MHÑImmunoelectrophoresis ANonly /instrum /methods MNE1.223.495.826.769.611; H1.181.278.414.568; H1.181.529.307.437.568 FXÑBlood Protein Electrophoresis; ÑElectrophoresis XUÑCounterimmunoelectrophoresis; ÑImmunoelectrophoresis, Two-Dimensional LH LX; LU;  MSImmunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis. HN(76) MHÑImmunoelectrophoresis, Two-Dimensional ANonly /instrum /methods PIImmunoelectrophoresis (66-75) MNE1.223.495.826.769.611.520 XSImmunoelectrophoresis, Crossed DMÑImmunoelectrophoresis LH LS LM  MSImmunologic technics based on the use of 1) enzyme-antibody conjugates, 2) enzyme-antigen conjugates, 3) antienzyme antibody followed by its homologous enzyme, or 4) enzyme-antienzyme complexes. PM77 HN77 MHÑImmunoenzyme Technics ANNIM; only /instrum /stand; coord IM or NIM with specific enzyme with no qualif (NIM) but do not bother to add PEROXIDASES or specific; EMIT (enzyme multiplied immunoassay technic) goes here CATALOG: do not use /laboratory manuals PIEnzymes (66-76); Immunologic Technics (73-76); Peroxidases (66-76) MNE1.223.495.567.350; E5.478.567.350 XSAntibody Enzyme Technic, Unlabeled; Enzyme Immunoassay; Enzyme-Labeled Antibody Technic; Immunoassay, Enzyme; Immunoperoxidase Technics; Peroxidase-Antiperoxidase Complex Technic; Peroxidase-Labeled Antibody Technic LH LS; ; ; ; ; ;  MSA branch of genetics which deals with the genetic basis of the immune response. PM71 HN71 MHÑImmunogenetics ANGEN; avoid as coord; SPEC qualif when IM; no qualif when NIM PIAllergy and Immunology (66-70); Genetics (66-70) MNG4.610.626; G5.511 LH  MSHereditary serologic types based on antigenic differences in the light and heavy chains of immunoglobulins due to allelic genes in the gene loci coding the chains; the Inv system applies to the kappa light chains, the Gm system applies to the heavy chains of IgG. PM75 HN75 MHÑImmunoglobulin Allotypes ANonly /anal /biosyn /csf /class /genet /immunol /isol /urine; do not use /defic: TN 225; Am allotype goes here (IM) + IGA (IM); note specifics below; DF: IG ALLOTYPES PIAlleles (68-74); Antibody Specificity (70-74); Antigenic Determinants (70-74); Immunoglobulins (70-74); Isoantibodies (66-74) MND24.611.125.584; G4.610.626.500; G5.275.77.500; G5.511.500 XSAllotypes, Immunoglobulin; Allotypic Antibodies; Antibodies, Allotypic LH LS; ;  MSThat region of the Ig (antibody) molecule that is invariable in its amino acid sequence within any class of Ig's; it confers the biological specificity to the Ig and is grossly species specific; comprises the C-terminus half of the light chains and three quarters or more of the heavy chains, all of the Fc Fragment and the C-terminus half of the Fab Fragment. HN(79) MHÑImmunoglobulin Constant Region ANonly /drug eff /genet /immunol /isol /rad eff; do not use /defic: TN 225; DF: IG CONSTANT REGION PIGamma Globulins (66-71); Immunoglobulin Allotypes (75-78); Immunoglobulins (72-78); Immunoglobulins, Fc (73); specific immunoglobulin fragment (73-78) MND12.776.124.486.485.680.10; D24.611.125.600.626; D24.611.125.600.662.370.953 XSConstant Region, Ig DMÑImmunoglobulins LH LS LM  PM73; IMMUNOGLOBULINS, FC & IMMUNOGLOBULINS, FD were headings 1973-83 HN73 MHÑImmunoglobulin Fragments ANonly /anal /biosyn /class /csf /genet /immunol /isol /urine; do not use /defic: TN 225; DF: IG FRAGMENTS PIImmunoglobulins (70-72) MND12.776.124.486.485.680; D12.776.124.790.651.596; D12.776.377.715.548.673; D24.611.125.600.662 XSANTIBODY FRAGMENTS FXÑHeavy Chain Disease XUÑSecretory Component LH LS LX LU  MSHereditary allotypic markers associated with the heavy chain of IgG. PM87 HN87 MHÑImmunoglobulin Gm Allotypes ANonly /anal /biosyn /csf /class /genet /immunol /isol /urine; DF: IG GM ALLOTYPES PIAlleles (68-74); IgG (71-86); Immunoglobulin Allotypes (75-86) MND24.611.125.584.586; D24.611.125.600.681.393.495; G4.610.626.500.504; G5.275.77.500.495; G5.511.500.495 XSAllotypes, Ig Gm; Gm Allotypes LH LS;  MSUnique genetically controlled determinants present on antibodies whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the variable regions of both immunoglobin polypeptide chains. PM79 HN79 MHÑImmunoglobulin Idiotypes ANonly /anal /biosyn /csf /class /genet /immunol /isol /urine; do not use /defic: TN 225; DF: IG IDIOTYPES PIAnti-Antibodies (66-69); Antibody Specificity (70-78); Antigenic Determinants (70-78); Binding Sites, Antibody (73-78) MND24.611.125.588; G4.610.626.510; G5.511.510 XSAntibodies, Idiotypic; Idiotypes, Immunoglobulin; Idiotypic Antibodies LH LS; ;  MSHereditary allotypic markers associated with the light chain of IgG. PM87 HN87 MHÑImmunoglobulin Inv Allotypes ANonly /anal /biosyn /csf /class /genet /immunol /isol /urine; Km allotype goes here; DF: IG INV ALLOTYPES MND24.611.125.584.587; D24.611.125.600.681.393.500; G4.610.626.500.507; G5.275.77.500.505; G5.511.500.505 XSAllotypes, Ig Inv; Inv Allotypes LH LS;  MSThe classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties. PM87 HN87 MHÑImmunoglobulin Isotypes ANonly /anal /biosyn /csf /class /genet /immunol /isol /urine; do not use /defic: TN 225; DF: IG ISOTYPES PIImmunoglobulins(72-86) MND24.611.125.600.681 LH  MSThat region of the immunoglobulin (antibody) molecule that varies in its amino acid sequence and composition; it confers the antigenic specificity and is thought to comprise the binding site for the antigen; it is located at the N-terminus of the Fab fragment of the immunoglobulin. PM84; was see under BINDING SITES, ANTIBODY 1977-83 HN84(77); was see under BINDING SITES, ANTIBODY 1977-83 MHÑImmunoglobulin Variable Region ANonly /drug eff /genet /immunol /isol /rad eff; do not use /defic: TN 225; DF: IG VARIABLE REGION PIAntigenic Determinants (72-76); Binding Sites, Antibody (73-76); Immunoglobulin Fragments (73-76); Immunoglobulins, Fab (73-76) MND12.776.124.486.485.680.20; D24.611.125.345.952; D24.611.125.600.662.360.952; G6.184.154.408.952 XSVariable Region, Ig LH LS  PM72; IMMUNE SERUM GLOBULIN was heading 1965 HN72(70); IMMUNE SERUM GLOBULIN was heading 1965 MHÑImmunoglobulins ANGEN: prefer specifics; only /admin /anal /biosyn /class /csf /drug eff /genet /immunol /isol /metab /physiol /stand /urine; /ther use = IMMUNIZATION, PASSIVE for immunogloblins in general or unspecified; /defic permitted but consider also IMMUNOLOGIC DEFICIENCY SYNDROMES (TN 225); TN 224: hist & relation to gamma globulins; gammopathy or immunoglobulin excess: TN 226; allotypes = IMMUNOGLOBULIN ALLOTYPES or specifics PIGamma Globulins (66-69) MND12.776.124.486.485; D12.776.124.790.651; D12.776.377.715.548; D24.611.125.600 XUÑImmunoglobulin Constant Region LH LU  MSHeavy chains found in the Fab and Fc fragments of IgA. Molecular weight approximately 64,000. Contain about 450 amino acid residues arranged in four domains and an oligosaccharide component bound covalently to the Fc fragment. HN(76) MHÑImmunoglobulins, Alpha Chain ANonly /anal /biosyn /class /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathy or excess = IMMUNOGLOBULINS, ALPHA CHAIN (NIM) + HEAVY CHAIN DISEASE (IM): TN 226; DF: IG ALPHA CHAIN PIIgA (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) MND12.776.124.486.485.680.25; D12.776.124.790.651.596.25; D12.776.377.715.548.673.25; D24.611.125.600.662.430.58 DMÑImmunoglobulins, Heavy Chain LH LM  MSHeavy chains found in the Fab and Fc fragments of IgD. Molecular weight approximately 58,000. Contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment. HN(76) MHÑImmunoglobulins, Delta Chain ANonly /anal /biosyn /class /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathy or excess = IMMUNOGLOBULINS, DELTA CHAIN (NIM) + HEAVY CHAIN DISEASE (IM): TN 226; DF: IG DELTA CHAIN PIIgD (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) MND12.776.124.486.485.680.50; D12.776.124.790.651.596.50; D12.776.377.715.548.673.50; D24.611.125.600.662.430.264 DMÑImmunoglobulins, Heavy Chain LH LM  MSHeavy chains found in the Fab Fc fragments of IgE. Molecular weight approximately 75,000. Contain about 550 amino acid residues arranged in five domains and about three times more carbohydrate than the heavy chains of IgA, IgD and IgG. HN(76) MHÑImmunoglobulins, Epsilon Chain ANonly /anal /biosyn /class /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathy or excess = IMMUNOGLOBULINS, EPSILON CHAIN (NIM) + HEAVY CHAIN DISEASE (IM): TN 226; DF: IG EPSILON CHAIN PIIgE (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (750 MND12.776.124.486.485.680.75; D12.776.124.790.651.596.75; D12.776.377.715.548.673.75; D24.611.125.600.662.430.328 DMÑImmunoglobulins, Heavy Chain LH LM  MSFragments composed of one entire light chain and about half of one of the heavy chains, linked to each other by disulfide bonds; contains the antigen binding site which is the variable region of the immunoglobulin molecule. PM73 HN73 MHÑImmunoglobulins, Fab ANonly /anal /class /csf /genet /immunol /isol /urine; do not use /defic: TN 225; DF: IG FAB PIImmunoglobulins (70-72) MND12.776.124.486.485.680.100; D12.776.124.790.651.596.100; D12.776.377.715.548.673.100; D24.611.125.600.662.360 LH  PM87,73-83; was see under IMMUNOGLOBULIN FRAGMENTS 1984-86 HN87(84)73; was see under IMMUNOGLOBULIN FRAGMENTS 1984-86 MHÑImmunoglobulins, Fc ANonly /anal /class /csf /genet /immunol /isol /urine; do not use /defic: TN 225; DF: IG FC PIImmunoglobulins (70-72) MND12.776.124.486.485.680.150; D12.776.124.790.651.596.150; D12.776.377.715.548.673.150; D24.611.125.600.662.370 XSFC FRAGMENTS LH LS  MSHeavy chains found in the Fab and Fc fragments of IgG. Molecular weight approximately 53,000. Contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment. The gamma chains of the four IgG subgroups are not identicals, but resemble each other more closely than the heavy chains of a different immunoglobulin. HN(76) MHÑImmunoglobulins, Gamma Chain ANonly /anal /biosyn /class /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathy or excess = IMMUNOGLOBULINS, GAMMA CHAIN (NIM) + HEAVY CHAIN DISEASE (IM): TN 226; DF: IG GAMMA CHAIN PIIgG (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) MND12.776.124.486.485.680.250; D12.776.124.790.651.596.250; D12.776.377.715.548.673.250; D24.611.125.600.662.430.394 DMÑImmunoglobulins, Heavy Chain LH LM  MSMajor components of immunoglobulin molecules; polypeptide chains responsible for the biological and immunological properties of the different Ig's; two heavy and two light chains comprise one Ig molecule. They differ according to the class of Ig from which they were isolated, contain 450 to 550 amino acid residues per chain, have mol. wts. of 53,000 to 75,000. OLsearch IMMUNOGLOBULIN FRAGMENTS 1973-74 PM76; was IMMUNOGLOBULIN, HEAVY CHAIN see under IMMUNOGLOBULIN FRAGMENTS 1973-75 HN76(75); was IMMUNOGLOBULIN, HEAVY CHAIN see under IMMUNOGLOBULIN FRAGMENTS 1973-75 MHÑImmunoglobulins, Heavy Chain ANonly /anal /biosyn /class /csf /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathies: TN 226; HEAVY CHAIN DISEASE is also available (see note on HEAVY CHAIN DISEASE); DF: IG HEAVY CHAIN PIImmunoglobulin Fragments (73-74) MND12.776.124.486.485.680.298; D12.776.124.790.651.596.298; D12.776.377.715.548.673.298; D24.611.125.600.662.430 XUÑImmunoglobulins, Alpha Chain; ÑImmunoglobulins, Delta Chain; ÑImmunoglobulins, Epsilon Chain; ÑImmunoglobulins, Gamma Chain LH LU; ; ;  MSThe immunoglobulin fragment that is found in the light chain fractions of Secretory IgA and polymeric IgM in a ratio of one J Chain per one IgA dimer or one IgM pentamer; it is a polypeptide with a molecular weight of 26,000 and probably serves either to bind the components of the globulins together or to transfer the globulins across membranes. PM74 HN74(73) MHÑImmunoglobulins, J Chain ANonly /anal /biosyn /class /csf /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; DF: IG J CHAIN MND12.776.124.486.485.680.340; D12.776.124.790.651.596.340; D12.776.377.715.548.673.340; D24.611.125.600.662.522 XSJ Chains LH LS  MSOne of the light chains of the immunoglobulins. Molecular weight approximately 22,500. Comprise about 60% of light chains and can be recognized serologically and by their specific amino acid sequence. OLsearch IMMUNOGLOBULIN FRAGMENTS 1973-74 PM86; was see under IMMUNOGLOBULINS, LIGHT CHAIN 1976-85, was see under IMMUNOGLOBULIN FRAGMENTS 1973-75 HN86(75); was see under IMMUNOGLOBULINS, LIGHT CHAIN 1976-85, was see under IMMUNOGLOBULIN FRAGMENTS 1973-75 MHÑImmunoglobulins, Kappa Chain ANonly /anal /biosyn /class /csf /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathy or excess: indexing instructions in TN 226; DF: IG KAPPA CHAIN PIGamma Globulins (66-71); Immunoglobulin Fragments (73-74); Immunoglobulins (72) MND12.776.124.486.485.680.361; D12.776.124.790.651.596.361; D12.776.377.715.548.673.361; D24.611.125.600.662.553.532 LH  MSOne of the light chains of the immunoglobulins. Molecular weight approximately 22,500. Comprise about 40% of light chains and can be recognized serologically and by their specific amino acid sequence. OLsearch IMMUNOGLOBULIN FRAGMENTS 1973-74 PM87; was see under IMMUNOGLOBULINS, LIGHT CHAIN 1975-86, was see under IMMUNOGLOBULIN FRAGMENTS 1973-74 HN87(75); was see under IMMUNOGLOBULINS, LIGHT CHAIN 1975-86, was see under IMMUNOGLOBULIN FRAGMENTS 1973-74 MHÑImmunoglobulins, Lambda Chain ANonly /anal /biosyn /class /csf /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathy or excess: indexing instructions in TN 226; DF: IG LAMBDA CHAIN PIGamma Globulins (66-71); Immunoglobulin Fragments (73-74); Immunoglobulins (72) MND12.776.124.486.485.680.423; D12.776.124.790.651.596.423; D12.776.377.715.548.673.423; D24.611.125.600.662.553.548 LH  MSPolypeptide chains, consisting of 211 to 217 amino acid residues, isolated from immunoglobulins. Molecular weight approximately 22,500. There are two major types of light chains, kappa and lambda. In man they are found in a ratio of 60 to 40%, respectively. Both chains consist of linear repeating, similar, but not identical, segments of about 110 amino acid residues. In each segment a disulfide bond establishes a tightly folded approximately 60-membered loop or domain. Adjacent domains are linked by less tightly folded regions. Both light chains contain two such domains. Two light and two heavy chains make one immunoglobulin molecule, but both light chains in one Ig are of the same type. PM76; IMMUNOGLOBULINS, KAPPA CHAIN & IMMUNOGLOBULINS, LAMBDA CHAIN were see under IMMUNOGLOBULIN FRAGMENTS 1973-75 HN76 MHÑImmunoglobulins, Light Chain ANonly /anal /biosyn /class /csf /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathy or excess: indexing instructions in TN 226; DF: IG LIGHT CHAIN PIImmunoglobulin Fragments (73-75) MND12.776.124.486.485.680.500; D12.776.124.790.651.596.500; D12.776.377.715.548.673.500; D24.611.125.600.662.553 LH  MSHeavy chains found in the Fab and Fc fragments of IgM. Molecular weight appr. 70,000. Contain about 550 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IgG. PM87; was see under IMMUNOGLOBULINS, HEAVY CHAIN 1976-86 HN87(76); was see under IMMUNOGLOBULINS, HEAVY CHAIN 1976-86 MHÑImmunoglobulins, Mu Chain ANonly /anal /biosyn /class /csf /genet /immunol /isol /physiol /urine; do not use /defic: TN 225; gammopathy or excess = IMMUNOGLOBULINS, MU CHAIN (NIM) + HEAVY CHAIN DISEASE (IM): TN 226; DF: IG MU CHAIN PIIgM (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) MND12.776.124.486.485.680.550; D12.776.124.790.651.596.550; D12.776.377.715.548.673.550; D24.611.125.600.662.430.607 LH  MSImmunoglobulins bound to the surface of lymphocytes. PM75 HN75 MHÑImmunoglobulins, Surface ANonly /anal /biosyn /class /csf /genet /immunol /isol /metab /physiol /urine; do not use /defic: TN 225; DF: IG SURFACE PIImmunoglobulins (70-74) MND12.776.124.486.485.750; D24.611.125.600.700 XSMembrane-Bound Immunoglobulins FXÑImmunologic Capping LH LS LX  MH*Immunologic and Biologic Factors (Non Mesh) MND24 LH  MSThe process by which lymphoid cell surface immunoglobulin receptors, when exposed to bivalent anti-Ig antibodies, collect in patches and form a cap at one pole of the cell. The caps may then be endocytosed or shed into the environment in the form of antigen-antibody complexes. Capping has also been induced by lectins and antigens. PM78 HN78 MHÑImmunologic Capping ANonly /drug eff /rad eff PICell Membrane (66-77); Lymphocytes (66-77) MNG4.335.857.612; G4.610.143.612 XSCapping, Immunologic FXÑImmunoglobulins, Surface LH LS LX  MSSyndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. OLuse IMMUNOLOGIC DEFICIENCY SYNDROMES to search ANTIBODY DEFICIENCY SYNDROME back thru 1970 PM70 HN70(68); ANTIBODY DEFICIENCY SYNDROME was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77 MHÑImmunologic Deficiency Syndromes ANGEN or unspecified; for defic of specific immunoprotein, IMMUNOGLOBULINS or specific immunoglobulin, use specific with /defic; TN 223: definition & use; TN 225: differentiation from immunoglobulin defic; ╥immunocompromised host╙ goes here or AIDS or IMMUNE TOLERANCE: check text; Manual 23.35.2 PIImmunity (66-67) MNC20.673 XSAntibody Deficiency Syndrome XUÑDigeorge Syndrome LH LS LU  MSDisorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated or both. PM71 HN71 MHÑImmunologic Diseases ANGEN: prefer specifics CATALOG: form qualif = ALLERGY AND IMMUNOLOGY PIAllergy and Immunology (66-70) MNC20 FXÑBlood Protein Disorders LH LX  OLpre-explosion = IMMUNOLOGIC FACTORS (PX) MH*Immunologic Factors (Non Mesh) MND24.611 LH  MSThe altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. PM73 HN73(71) MHÑImmunologic Memory ANonly /drug eff /rad eff PIAntibody Formation (66-70) MNG4.610.662 LH  MSThe theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells. HN(80) MHÑImmunologic Surveillance ANa function of T-lymphocytes: nothing to do with epidemiol surveillance; only /drug eff /rad eff PIspecific cell, organ, neoplasm/TR MNG4.610.555.412 XSSurveillance, Immunologic DMÑImmunity, Cellular LH LS LM  OLuse IMMUNOLOGIC TECHNICS to search ANTIBODY DISSOCIATION 1971-82 (as prov 1971-72) PM73; ANTIBODY DISSOCIATION was heading 1973-82 HN73; ANTIBODY DISSOCIATION was heading 1971-82(Prov 1971-72) MHÑImmunologic Technics ANGEN: prefer specifics; NIM; do not confuse with IMMUNOLOGIC TESTS ( = immunol technics applied to diag); do not use /methods /util (except by MeSH definition) CATALOG: do not use /laboratory manuals MNE5.478 FXÑBlood Grouping and Crossmatching; ÑIMMUNOTHERAPY; ÑImmunity; ÑImmunochemistry; ÑImmunologic Tests; ÑPREGNANCY TESTS, IMMUNOLOGIC; ÑSERODIAGNOSIS XUÑLeukocyte Adherence Inhibition Test LH LX; ; ; ; ; ; LU  MSDiagnostic technics involving the demonstration or measurement of an immune response including antibody production or assay, antigen-antibody reactions, serologic cross reactivity, delayed hypersensitivity reactions, or heterogenetic responses. PM87 HN87 MHÑImmunologic Tests ANGEN: prefer specifics; NIM; do not confuse with IMMUNOLOGIC TECHNICS: see note above; do not use /util except by MeSH definition PIImmunologic Technics (73-86); Serodiagnosis (66-86); specific technic or test MNE1.223.495 XSDiagnosis, Immunological; Immunodiagnosis FXÑImmunologic Technics LH LS; LX  MSDisorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins. PM86 HN86 MHÑImmunoproliferative Disorders ANGEN or unspecified: prefer specifics MNC20.683 LH  MSA spectrum of conditions ranging from a benign plasma cell hyperplasia to a highly malignant lymphoma of the small intestine. PM87 HN87 MHÑImmunoproliferative Small Intestinal Disease PIHeavy Chain Disease (66-86); Intestinal Neoplasms (66-86); Lymphoma (66-86) MNC4.557.386.390; C6.405.469.436; C15.378.147.780.490.512; C15.604.515.435.512; C20.683.515.512; C20.683.780.490.512 XSAlpha Chain Disease; Heavy Chain Disease, IgA Type; IPSID; Lymphoma, Mediterranean LH LS; ; ;  OL╥immunoproteins╙ is indexed IMMUNOGLOBULINS or its specifics or other specifics here MH*Immunoproteins (Non Mesh) MND12.776.124.486 LH  MSTechnics for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. PM77 HN77 MHÑImmunosorbent Technics ANNIM; only /instrum; do not use /methods CATALOG: do not use /laboratory manuals PIAdsorption (66-76); specific heading/IP (69-76) MNE1.223.495.567.380; E5.478.567.380 XSImmunoadsorbent Technics LH LS  MSAn insoluble support for an antigen or antibody used to adsorb the homologous antibody or antigen from a mixture; the adsorbed entity may then be eluted in pure form for assay or analysis; many different substances are used, among them sepharose, glutaraldehyde, copolymers of anhydrides, polyacrylamides, etc. HN(77) MHÑImmunosorbents ANdo not use /analogs /biosyn /defic /physiol PIAbsorption (66-76); Adsorption (66-76); Antigen-Antibody Complex (70-76); Antigen-Antibody Reactions (66-76) MND24.611.171.501; D26.866.501 XSImmunoadsorbents DMÑAntigen-Antibody Complex LH LS LM  MSDeliberate prevention or diminution of the host's immune response. May be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. PM72 HN72(71) MHÑImmunosuppression ANnote category: ╥deliberate prevention or diminution of the host's response╙: do not confuse with IMMUNOSUPPRESSION (PHYSIOLOGY) see IMMUNE TOLERANCE (G4); ╥immunocompromised host╙ is probably IMMUNE TOLERANCE or IMMUNOLOGIC DEFICIENCY SYNDROMES or AIDS; do not use /util except by MeSH definition; OPPORTUNISTIC INFECTIONS is available if particularly discussed: see note there PIAntilymphocyte Serum (68-70); Immune Tolerance (66-70); Immunity (66-70); Immunosuppressive Agents (66-70) MNE2.95.449; E5.478.610 FXÑAntilymphocyte Serum; ÑImmune Tolerance; ÑTransplantation Immunology LH LX; ;  PM66 HN66(64) MHÑImmunosuppressive Agents ANdo not use /analogs /biosyn /defic /physiol MND22.569 FXÑAntilymphocyte Serum LH LX  MSManipulation of the host's immune system in treatment of disease. Use for active manipulation such as administration of antigens or immunologic adjuvants. Do not use for preventive immunization, immunosuppressive therapy to prevent graft rejection, and passive immunization. OLuse IMMUNOTHERAPY to search VACCINE THERAPY back thru 1966 PM73; VACCINE THERAPY was heading 1963-82 HN73; VACCINE THERAPY was heading 1963-82 MHÑImmunotherapy ANGEN only; do not use /util except by MeSH definition; for ther: coord IM with dis /ther (IM) PIspecific disease/TH (66-72) MNE2.95.520 FXÑImmunity, Active; ÑImmunologic Technics LH LX;  MSIMP:NAD+ oxidoreductase. Catalyzes the dehydrogenation of inosine 5'-phosphate to xanthosine 5'-phosphate in the presence of NAD. HN(75) MHÑIMP Dehydrogenase ANdo not use /analogs RNEC 1.2.1.14 PIInosine Nucleotides (74); Ketone Oxidoreductases (74) MND8.586.682.472.340 XSInosinic Acid Dehydrogenase DMÑKetone Oxidoreductases LH LS LM  MHÑImpetigo MNC1.252.868.820.504; C1.252.890.485; C17.838.820.504 LH  MSArtificial implants inserted into the body. PM81 HN81 MHÑImplants, Artificial ANdo not use /instrum /man /methods /psychol /rehabil /util (except by MeSH definition); coord IM with material with no qualif (IM); consider also PROSTHESIS & its indentions MNE7.450 FXÑBiocompatible Materials LH LX  MSA method for extinguishing anxiety by a saturation exposure to the feared stimulus situation or its substitute. HN(75) MHÑImplosive Therapy ANSPEC qualif MNF4.754.137.506.325 XSFlooding DMÑBehavior Therapy LH LS LM  MSThe inability of the male to perform sexual intercourse. MHÑImpotence ANdo not use /congen /drug eff /physiol /rad eff MNC12.294.644.486; F3.126.496; F3.709.597.608.780.580 LH  MSA particular kind of learning characterized by occurrence in very early life, rapidity of acquisition, and relative insusceptibility to forgetting or extinction; imprinted behavior includes most (or all) behavior commonly called instinctive, but imprinting is used purely descriptively. PM65 HN65(64) MHÑImprinting (Psychology) ANhuman & animal; only /drug eff /physiol /rad eff; DF: IMPRINTING MNF2.463.425.448 LH  MSThe essential features of this disorder are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others; an increased sense of tension prior to the act; and the experiencing of pleasure or gratification or release of tension at the time of committing the act. OLto search KLEPTOMANIA use IMPULSE CONTROL DISORDERS back thru 1981 & OBSESSIVE-COMPULSIVE DISORDER 1966-80 PM81; FIRESETTING BEHAVIOR was see under COMPULSIVE BEHAVIOR 1976-80; KLEPTOMANIA was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80 HNKLEPTOMANIA was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80 MHÑImpulse Control Disorders ANdo not use /drug eff /physiol /rad eff MNF3.709.597.460 XSKleptomania FXÑParaphilias; ÑSubstance Use Disorders XUÑFiresetting Behavior LH LS LX; LU  MSAn act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus. PM68 HN68 MHÑImpulsive Behavior ANdo not use /drug eff /physiol /rad eff PIBehavior (66-67) MNF1.145.527; F3.126.517 LH  HN66 MHÑIn Vitro ANcheck tag only; Manual 18.10+ CATALOG: do not use: for indexers only LH  MSHyponatremia and renal salt loss attributed to overexpansion of body fluids resulting from sustained release of antidiuretic hormone despite the absence of appropriate stimuli. PM79 HN79 MHÑInappropriate ADH Syndrome PIHyponatremia (66-78); Vasopressins (66-78) MNC18.452.950.626; C19.700.490 XSAntidiuretic Hormone, Inappropriate Secretion; SIADH; Schwartz-Bartter Syndrome FXÑVasopressins LH LS; ; LX  MSThe mating of plants or non-human animals which are closely related genetically; includes self-fertilization, sib mating, half-sib mating, and backcrossing. Inbreeding of humans is CONSANGUINITY. PM68 HN68 MHÑInbreeding ANanimal only: for humans use CONSANGUINITY; no qualif; restrict to inbreeding as a genetic concept or a technic: not a routine term for inbred animals; ╥half-sib mating╙ goes here PIGenetics (66-67); Genetics, Population (66-67) MNG5.414.133.403; E5.820.150.520 FXÑConsanguinity; ÑMICE, INBRED STRAINS; ÑRATS, INBRED STRAINS LH LX; ;  MSSexual intercourse between persons so closely related that they are forbidden by law to marry. PM67 HN67 MHÑIncest ANno qualif PIParaphilias (66) MNI1.880.735.442 LH  PM65 HN65 MHÑIncisor MNA14.254.860.521 LH  MSAn area showing altered staining behavior in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent ╥virus factories╥ in which viral nucleic acid or protein is being synthesized; others are merely artifacts of fixation and staining. PM66 HN66 MHÑInclusion Bodies, Viral ANA11 qualif except /cytol MNA11.278.570; G4.185.515.521 FXÑViruses LH LX  MSRevenues or receipts accruing from business enterprise, labor or invested capital. PM68 HN68 MHÑIncome ANno qualif; includes income from salaries, annuities, stocks, etc. but note SALARIES AND FRINGE BENEFITS is available; does not include fees charged ( = FEES AND CHARGES) CATALOG: /geog /form PISocial Conditions (66-67) MNN1.824.417 FXÑFinancial Management LH LX  MSTax on the net income of an individual, organization or business. MHÑIncome Tax ANIM; only /class /hist /legis /stand /trends; specify geog MNN3.219.900.250 LH  MSA genodermatosis occurring mostly in females characterized by skin changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of eye, teeth, central nervous system, and skin appendages. HN(87) MHÑIncontinentia Pigmenti PIPigmentation Disorders (66-86) MNC16.131.77.350.512; C16.131.831.350.512; C17.621.497; C17.827.375.512 XSBloch-Sulzberger Syndrome DMÑPigmentation Disorders LH LS LM  PM73 HN73 MHÑIncubators ANonly /econ /stand /supply /vet PIappropriate heading/IS (66-72) MNE7.461 FXÑEnvironment, Controlled LH LX  PM74 HN74 MHÑIncubators, Infant ANonly /econ /stand /supply MNE7.430.569; E7.461.487 FXÑInfant Care LH LX  MHÑIncunabula ANbefore 1501; IM; no qualif MNL1.178.682.192.515 LH  OLsearch EAR OSSICLES 1966-74 HN(75) MHÑIncus MNA9.246.397.247.362 DMÑEar Ossicles LH LM  OLsearch INDENES 1966-74 HN(75)63-67 MHÑIndans ANdo not use /analogs /biosyn /defic /physiol MND4.615.486.487 DMÑIndenes LH LM  MS4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide. A sulfamyl diuretic with about 16x the effect of furosemide. Has also been shown to be an effective antihypertensive agent in the clinic. Synonyms: SE 1520; S 1520. HN(75) MHÑIndapamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26807-65-8 PIBenzamides (74); Diuretics, Sulfamyl (74); Indoles (74) MND2.65.884.540; D2.886.590.700.540; D19.770.224.516.550 XSMetindamide DMÑDiuretics, Sulfamyl LH LS LM  HN(71) MHÑIndazoles ANdo not use /analogs /biosyn /defic /physiol PIPyrazoles (66-70) MND3.383.694.487; D3.438.449 DMÑPyrazoles LH LM  PM68; INDANS was heading 1963-67; NINHYDRIN was see under INDICATORS AND REAGENTS 1963-74 HN68 MHÑIndenes ANdo not use /analogs /biosyn /defic /physiol MND4.615.486 XUÑAprindine; ÑClidanac; ÑIndans; ÑNinhydrin; ÑSulindac LH LU; ; ; ;  MHÑIndia ANIndians are of CAUCASOID RACE unless otherwise specified MNZ1.252.245.393 LH  MHÑIndian Ocean Islands MNZ1.252.245.419 LH  MHÑIndiana MNZ1.107.567.875.382 LH  MSAn ethnic group belonging to the Mongoloid racial stock in Central America. Does not include Mexican Indians. PM78 HN78 MHÑIndians, Central American ANIM; only /class /hist /psychol; specify geog locale if possible; as ethnic group: Manual 30.8-30.10, 34.9; not for Indians of Mexico ( = INDIANS, NORTH AMERICAN + MEXICO) CATALOG: /geog /form PIIndians, South American (66-77) MNI1.76.201.450.416.385; I1.880.143.522.387; M1.194.370 XSAmerinds, Central American LH LS  MSAn ethnic group belonging to the Mongoloid racial stock in North America. MHÑIndians, North American ANIM; only /class /hist /psychol; specify geog locale if possible; as ethnic group: Manual 30.8-30.10, 34.9 CATALOG: /geog /form MNI1.76.201.450.416.403; I1.880.143.522.403; M1.194.403 XSAMERINDS, NORTH AMERICAN LH LS  MSAn ethnic group belonging to the Mongoloid racial stock in South America. MHÑIndians, South American ANIM; only /class /hist /psychol; specify geog locale if possible; as ethnic group: Manual 30.8-30.10, 34.9 CATALOG: /geog /form MNI1.76.201.450.416.486; I1.880.143.522.486; M1.194.486 XSAMERINDS, SOUTH AMERICAN LH LS  MHÑIndican ANdo not use /biosyn /defic /physiol RN1336-79-4 MND9.203.408.412 LH  PM67 HN67 MHÑIndicator Dilution Technics ANNIM; only /instrum /vet; DYE DILUTION TECHNIC and RADIOISOTOPE DILUTION TECHNIC are also available CATALOG: do not use /laboratory manuals PIDye Dilution Technic (66) MNE1.145.643 XSDILUTION TECHNICS LH LS  MHÑIndicators and Reagents ANNIM; D25-26 qualif except /diag use; DF: INDICATORS MND26.550 XSReagents FXÑReagent Kits, Diagnostic LH LS LX  MS3,3'-Dioxo-(delta-2,2'-biindoline)-5,5'-disulfonic acid disodium salt. Used as a dye in renal function testing and as a reagent for the detection of nitrates and chlorates and in the testing of milk. Synonyms: C.I. Acid Blue 74; C.I. Food Blue 1; C.I. 73015; FD&C Blue 2. HN(75) MHÑIndigo Carmine AND25-26 qualif; /analogs NIM only RN860-22-0 PIIndoles (69-74); Sulfonic Acids (69-74) MND3.438.473.396; D26.408.420 XSIndigotindisulfonate Sodium; Soluble Indigo Blue DMÑIndoles LH LS; LM  MHÑIndium ANIn-115; do not use /analogs /biosyn /defic /physiol; In-113 = INDIUM (IM) + ISOTOPES (NIM) but In-113m = INDIUM (IM) + RADIOISOTOPES (IM); In-106-112, 114, 116-124 = INDIUM (IM) + RADIOISOTOPES (IM) RN7440-74-6 MND1.268.424; D1.552.381 LH  MSThose psychological characteristics which differentiate individuals from one another. OLsearch PERSONALITY 1966-74 PM75; was see under PERSONALITY 1963-74 HN75; was see under PERSONALITY 1963-74 MHÑIndividuality ANno qualif PIPersonality (66-74) MNF1.752.488 XSIndividual Differences LH LS  MSA process of differentiation having for its goal the development of the individual personality. OLsearch PERSONALITY DISORDERS 1970-74 HN(75) MHÑIndividuation ANno qualif MNF1.752.747.466 DMÑPersonality Development LH LM  PM68 HN68(63) MHÑIndocyanine Green AND25-26 qualif RN3599-32-4 MND26.408.445 LH  MS1-(2'-Carboxyphenylamino)-1-deoxyribulose-5-phosphate carboxy-lyase (cyclizing). An enzyme in the tryptophan biosynthetic pathway. HN(75) MHÑIndole-3-Glycerol-Phosphate Synthase ANdo not use /analogs RNEC 4.1.1.48 PICarboxy-Lyases (70-74); Glycerophosphates (70-74); Indoles (70-74); Pentosephosphates (70-74) MND8.586.520.258.420 DMÑCarboxy-Lyases LH LM  OLuse INDOLEACETIC ACIDS to search INDOLEACETIC ACID back thru 1966 PM75; was INDOLEACETIC ACID 1963-74 HN75; was INDOLEACETIC ACID 1963-74 MHÑIndoleacetic Acids ANdo not use /analogs /biosyn /defic /physiol MND3.66.288; D3.438.473.404; D11.303.760.522 LH  MHÑIndoles ANincludes isoindoles; do not use /analogs /biosyn /defic /physiol MND3.438.473 XUÑAlcian Blue; ÑHydroxytryptophol; ÑIndigo Carmine; ÑIndoramin; ÑIprindole; ÑIsatin; ÑMazindol; ÑMolindone; ÑOxypertine; ÑOxyphenisatin Acetate; ÑSkatole; ÑSporidesmins LH LU; ; ; ; ; ; ; ; ; ; ;  PM66 HN66 MHÑIndolizines ANdo not use /analogs /biosyn /defic /physiol MND3.438.496 LH  PM66 HN66(64) MHÑIndomethacin ANdo not use /biosyn /defic /physiol RN53-86-1 MND3.438.473.420; D14.73.278.398.405; D14.73.278.466; D26.74.75.574.405; D26.74.75.594 LH  MHÑIndonesia AN= Malay Archipelago; Netherlands East Indies goes here; Indonesians are of MONGOLOID RACE unless otherwise specified MNZ1.252.145.380 XSIndonesian New Guinea; Irian Jaya; New Guinea, Indonesian; New Guinea, West; West Irian LH LS; ; ; ;  MHÑIndophenol ANdo not use /biosyn /defic /physiol RN500-85-6 MND2.755.446 XUÑ2,6-Dichloroindophenol LH LU  MS4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl) alpha-methylbenzeneacetic acid. Analgesic with anti-inflammatory properties; proposed for severe pain. Synonyms: Flosin; Flosint; Isindone; K 4277. HN(79) MHÑIndoprofen ANdo not use /biosyn /defic /physiol; /analogs NIM only RN31842-01-0 PIPhenylpropionates (74-78); Propionates (66-73) MND2.241.223.701.450; D14.73.278.483; D26.74.75.595 DMÑPhenylpropionates LH LM  MSN-[1-(2-Indol-3-ylethyl)-4-piperidyl]benzamide. Hypotensive agent with some anti-arrhythmic effects, used to treat essential hypertension. HN(75) MHÑIndoramin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26844-12-2 PIBenzamides (73-74); Indoles (71-74); Piperidines (71-74) MND2.65.277.480; D2.241.223.106.162.480; D3.383.621.320; D3.438.473.432; D18.162.495 DMÑIndoles LH LM  MSThe study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms. PM87 HN87 MHÑIndustrial Microbiology MNG1.273.540.460; J1.897.120.460 FXÑGenetic Intervention LH LX  MSOils which are used in industrial or commercial applications. OLto search POLISHES use INDUSTRIAL OILS back thru 1987 & OILS 1966-86 (as Prov 1966-74) PM87; POLISHES was see OILS 1978-86, was see under OILS 1975-77 HN87; POLISHES was see OILS 1978-86, was see under OILS 1975-77, was Prov 1966-74 MHÑIndustrial Oils ANonly /ad-poi-tox /anal /class /rad eff /stand /supply PIOils (66-86) MNJ1.740.400 XSCommercial Oils; Polishes LH LS;  PM66 HN66 MHÑIndustrial Waste ANonly /adv eff /anal /econ /prev MND5.284.404; G3.850.460.710.420 LH  PM73 HN73 MHÑIndustry ANno qualif; includes ╥industrialization╙; heavy industries (iron, steel, etc.) go under METALLURGY; COMMERCE is also available; relation to INDUSTRIAL MEDICINE (now OCCUPATIONAL MEDICINE) & OCCUPATIONAL DISEASES: Manual 31.13, 31.14 MNJ1.576 LH  MSProgressive mental disturbances and unconsciousness due to breathing mixtures of oxygen and inert gases (argon, helium, xenon, krypton, and atmospheric nitrogen) at high pressure. PM70 HN70(68) MHÑInert Gas Narcosis ANspecify gas (IM); do not use /chem ind PIspecific gas MNC21.447.426; C21.613.455.571 XSDEPTH INTOXICATION; NITROGEN NARCOSIS FXÑDiving LH LS; LX  MHÑInfant ANage 1-23 mo; IM as psychol & sociol or social entity: Manual 18.5.11, 34.10; NIM as check tag: 18.5.7, 18.5.8; no qualif IM; psychol of the infant = INFANT PSYCHOLOGY see CHILD PSYCHOLOGY & check the tag INFANT MNM1.471.392.520 LH  MSCare of infants in the home or institution. MHÑInfant Care ANin home or institutions; care of newborn inf in hosp = INFANT CARE (IM) + INFANT, NEWBORN (IM); only /methods /organ /stand /trends; check the tag INFANT MNN2.421.88.120 FXÑINCUBATORS, INFANT XUÑRooming-in Care LH LX LU  OLuse INFANT FOOD to search INFANT FOODS back thru 1970 (as Prov 1970-72) PM73 HN73; was INFANT FOODS 1970-72 (Prov) MHÑInfant Food ANonly /ad-poi-tox /anal /econ /rad eff /stand /supply; check the tag INFANT PIFood (66-69); Infant Nutrition (66-69) MNJ1.341.580 XSFOOD, INFANT LH LS  MSPerinatal, neonatal and infant deaths in a given population. MHÑInfant Mortality ANno qualif; largely a statist concept & not a substitute for /mortal with INFANT, NEWBORN, DISEASES or with specific dis in inf; specify geog; check the tag INFANT; perinatal mortality goes here but consider also FETAL DEATH CATALOG: /geog /form MNN1.224.935.698.489 FXÑFetal Death LH LX  MSNutrition of children from birth to 2 years of age. MHÑInfant Nutrition ANno qualif; check the tag INFANT MNG6.696.571 FXÑMILK; ÑMILK, HUMAN LH LX;  MHÑInfant Nutrition Disorders ANcheck the tag INFANT; infant toxicosis goes here MNC18.654.439 LH  MSOrganized efforts by communities or organizations to improve the health and well-being of the infant. OLsearch CHILD WELFARE 1966-74 HN(75) MHÑInfant Welfare ANonly /hist /legis /stand /trends; check the tag INFANT MNI1.880.787.539 DMÑChild Welfare LH LM  MSInfant having a birth weight of 2500 gm. (5 lb., 8 oz.) or less. PM77 HN77 MHÑInfant, Low Birth Weight ANborn weighing 2500 gms (5 lbs 8 oz) or less; qualif permitted as for INFANT, NEWBORN below; check tag INFANT, NEWBORN; DF: INFANT LBW PIBirth Weight (66-76); Infant, Newborn (66-76); Infant, Premature (66-76) MNM1.471.392.520.520.460 FXÑBirth Weight LH LX  MHÑInfant, Newborn ANfrom birth to 1 mo; IM; qualif permitted: /bloof-csf-urine /growth /immunol /metab /microbiol /parasitol /physiol /psychol; also a check tag; as IM: Manual 18.5.9, 34.11; specialty for only newborn inf = NEONATOLOGY, specialty for fetus-newborn inf-mother = PERINATOLOGY CATALOG: form qualif = NEONATOLOGY /form; when coord with FETUS, = PERINATOLOGY /form MNM1.471.392.520.520 FXÑAnimals, Newborn; ÑNeonatology XUÑInfant, Postmature LH LX; LU  MHÑInfant, Newborn, Diseases ANIM GEN only; for specific dis in newborn inf use specific dis (IM) + check tag INFANT, NEWBORN; do not use /compl /congen; check the tag INFANT, NEWBORN: Manual 18.5.10; relation to /congen: Manual 19.4.16; TN 109: relation to other Cat C16 terms CATALOG: form qualif = NEONATOLOGY /form; when coord with FETAL DISEASES, = PERINATOLOGY /form MNC16.614 LH  MSInfant born at or after 42 weeks of gestation. HN(75) MHÑInfant, Postmature ANIM; born after 42 wks gestation: do not confuse with FETAL MACROSOMIA (fetus ╥weighing more than 4000 grams╙); qualif permitted as for INFANT, NEWBORN above; check the tag INFANT, NEWBORN MNM1.471.392.520.520.500 DMÑInfant, Newborn LH LM  MSInfant born before 38 weeks of gestation. MHÑInfant, Premature ANIM; born before 38 wks gestation; qualif permitted as for INFANT, NEWBORN above; check the tag INFANT, NEWBORN MNM1.471.392.520.520.520 FXÑGESTATIONAL AGE; ÑLABOR, PREMATURE LH LX;  MHÑInfant, Premature, Diseases ANIM; do not use /compl /congen; check the tag INFANT, NEWBORN: Manual 18.5.10 MNC16.614.521 LH  MSInfant having a birth weight lower than expected for its gestational age. PM78; was see under INFANT, LOW BIRTH WEIGHT 1977 HN78(77); was see under INFANT, LOW BIRTH WEIGHT 1977 MHÑInfant, Small for Gestational Age ANborn weighing less than expected for age; qualif permitted as for INFANT, NEWBORN above; check the tag INFANT, NEWBORN; DF: INFANT SGA PIBirth Weight (66-76); Infant, Low Birth Weight (77); Infant, Newborn (66-76); Infant, Premature (66-76) MNM1.471.392.520.520.460.560 FXÑFetal Growth Retardation LH LX  MSThe practice of killing infants at birth or soon after. MHÑInfanticide ANonly /hist /legis /psychol; restrict to humans: do not use for the killing of young of other primates MNC23.240.571.489; I1.198.240.470.572 LH  MHÑInfarction ANIM; coord with organ /blood supply (IM): Manual 23.20; pulm infarct = PULMONARY EMBOLISM; cerebral infarct = CEREBRAL INFARCTION; heart infarct = MYOCARDIAL INFARCTION; DF: INFARCT MNC23.739.638.489 FXÑMyocardial Infarction; ÑSPLENIC INFARCTION LH LX;  MHÑInfection ANGEN only as concept of dis caused by organisms; many texts saying ╥infection╙ & many saying ╥sepsis╙ mean BACTERIAL INFECTIONS: check text (TN 185); ╥infectious disease╙ can be INFECTION but is more likely COMMUNICABLE DISEASES; policy: Manual 22.13-.19, 23.10, 23.11, 23.13; relation to organisms: Manual 22.12-.19 & TN 209; /drug ther: consider also ANTI-INFECTIVE AGENTS & specifics below it MNC1.539 LH  MSThe etiologic agent of an equine disease; abortion, pneumonia, or other infections may occur. OLuse INFECTIOUS ARTERITIS VIRUS, EQUINE to search INFECTIOUS ARTERITIS VIRUS OF HORSES back thru 1975 HN(81); was INFECTIOUS ARTERITIS VIRUS OF HORSES see under RNA VIRUSES 1975-80 MHÑInfectious Arteritis Virus, Equine ANdo not use /blood-csf-urine /cytol MNB4.909.777.360 XSEquine Arteritis Virus DMÑRNA Viruses LH LS LM  MSA herpesvirus infection of cattle characterized by inflammation and necrosis of the mucous membranes of the upper respiratory tract. PM78; was see under CATTLE DISEASES 1975-77 HN78(73); was see under CATTLE DISEASES 1975-77 MHÑInfectious Bovine Rhinotracheitis ANdo not use /vet; don't forget also CATTLE (NIM) & check tag ANIMAL PICattle Diseases (66-72); Infectious Bovine Rhinotracheitis Virus (66-72) MNC2.256.466.488; C22.196.429 LH  MSA species of Herpesviridae which causes rhinotracheitis in cattle. PM66 HN66 MHÑInfectious Bovine Rhinotracheitis Virus ANdo not use /blood-csf-urine /cytol; infection: see heading above MNB4.909.204.382.552 XSBovine Herpesvirus 1; IBR-IPV Virus; Infectious Pustular Vulvovaginitis Virus LH LS; ;  MSThe cause of an avian disease thought to be transmitted through contaminated feed or water. HN(75); was see under REOVIRUSES 1975-80 MHÑInfectious Bursal Agent ANdo not use /blood-csf-urine /cytol MNB4.909.777.714.375 XSAvian Nephrosis Virus; Gumboro Disease Virus DMÑReoviridae LH LS; LM  MHÑInfectious Mononucleosis MNC2.256.466.530; C15.378.553.381; C15.604.515.516; C20.683.515.515 XSGlandular Fever LH LS  PM71 HN71 MHÑInferior Colliculus ANdo not use /innerv PICorpora Quadrigemina (66-70) MNA8.186.211.132.659.237.364 XSCOLLICULUS, INFERIOR LH LS  MSThe inability to conceive or produce offspring. OLuse INFERTILITY to search STERILITY back thru 1966 PM83; was STERILITY 1963-82 HN83; was STERILITY 1963-82 MHÑInfertility ANGEN or unspecified; prefer the specifics MNC12.294.365; C13.371.365 XSSterility LH LS  MSInability of a woman to achieve conception. OLuse INFERTILITY, FEMALE to search STERILITY, FEMALE back thru 1966 PM83; was STERILITY, FEMALE 1963-82 HN83; was STERILITY, FEMALE 1963-82 MHÑInfertility, Female AN/chem ind permitted but not for testing of contraceptives MNC13.371.365.700 XSSterility, Female LH LS  MSInability of the male to effect conception. OLuse INFERTILITY, MALE to search STERILITY, MALE back thru 1966 PM83; was STERILITY, MALE 1963-82 HN83; was STERILITY, MALE 1963-82 MHÑInfertility, Male AN/chem ind permitted but not for testing of contraceptives MNC12.294.365.700 XSSterility, Male LH LS  MHÑInflammation ANIM general inflammatory process; look for specific inflamm dis in MeSH as -ITIS; NIM as coord for organ /dis not in MeSH as -ITIS; /drug ther: consider also ANTI-INFLAMMATORY AGENTS & its specifics; ACUTE PHASE REACTION (an early local inflammatory reaction to inj: see MeSH definition) is available; Manual 23.17, 23.18 MNC23.739.487 XUÑAcute Phase Reaction LH LU  MSAn increase in the volume of money and credit relative to available goods resulting in a substantial and continuing rise in the general price level. HN(80) MHÑInflation, Economic ANonly /hist /trends MNN3.219.680 XSEconomic Inflation DMÑEconomics LH LS LM  MSAn acute viral infection involving the respiratory tract. It is marked by inflammation of the nasal mucosa, the pharynx, and conjunctiva, and by headache and severe, often generalized, myalgia. OLuse INFLUENZA to search INFLUENZA, ASIAN 1966-80 PMINFLUENZA, ASIAN was heading 1963-80 HNINFLUENZA, ASIAN was heading 1963-80 MHÑInfluenza MNC2.782.620.505; C8.285 XSGRIPPE LH LS  MHÑInfluenza Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; coord IM with specific orthomyxovirus or orthomyxovirus infection (IM or NIM) if pertinent; not for Haemophilus influenzae vaccine ( = HAEMOPHILUS INFLUENZAE (IM) + BACTERIAL VACCINES (IM) ) MND24.310.894.899.302 LH  MSFacilities for collecting and organizing information. May be specialized by subject field, type of source material, persons served, location, or type of services. PM76 HN76; was NON MESH before 1976 MHÑInformation Centers ANdo not use /educ /methods /util (except by MeSH definition); med inform cent: do not coord with MEDICINE CATALOG: /geog /form PIInformation Services (66-75) MNL1.346 LH  MH*Information Science (Non Mesh) MNL1 LH  PM66 HN66 MHÑInformation Services ANonly /class /econ /hist /man /organ /stand /supply /trends /util; med inform serv: do not coord with MEDICINE CATALOG: /geog /form MNL1.453 XSInformation Dissemination FXÑLIBRARIES; ÑResearch LH LS LX;  MSIntegrated set of files, procedures, and equipment for the storage, manipulation, and retrieval of information. OLuse INFORMATION SYSTEMS to search INFORMATION RETRIEVAL SYSTEMS back thru 1966 PM82; was INFORMATION RETRIEVAL SYSTEMS 1966-81 HN82; was INFORMATION RETRIEVAL SYSTEMS 1966-81 MHÑInformation Systems ANonly /class /econ /hist /instrum /legis /man /organ /stand /supply /trends /util (if by MeSH definition); for automated systems do not coord with AUTOMATIC DATA PROCESSING; for medical information systems do not coord with MEDICINE MNL1.700.508.300 XSAncillary Information Systems; Data Banks; Data Systems; INFORMATION STORAGE AND RETRIEVAL; Information Retrieval Systems XUÑAmbulatory Care Information Systems; ÑClinical Laboratory Information Systems LH LS; ; ; ; LU;  MSAn interdisciplinary study dealing with the transmission of messages or signals, or the communication of information. Information theory does not directly deal with meaning or content, but with physical representations that have meaning or content; overlaps considerably with communication theory and CYBERNETICS. PM65 HN65(64) MHÑInformation Theory ANno qualif MNF4.669.880.483; L1.488 FXÑOperations Research LH LX  MSVoluntary authorization, given to the physician by the patient, with full comprehension of the risks involved, for diagnostic or investigative procedures and medical and surgical treatment. PM73 HN73(71) MHÑInformed Consent ANonly /hist /legis PIJurisprudence (66-70); Physician-Patient Relations (66-70) MNI1.880.604.583.427; N3.706.535.489 FXÑHUMAN EXPERIMENTATION; ÑTruth Disclosure LH LX;  MSThat portion of the electromagnetic spectrum usually sensed as heat; infrared wavelengths are longer than those of visible light, extending into the microwave frequencies; used therapeutically as heat, also to warm food in restaurants. MHÑInfrared Rays ANnon-ionizing; radiation policy: see Manual index under RADIATION & entries following; black light goes here or under ULTRAVIOLET RAYS depending on text but unspecified index under ULTRAVIOLET RAYS MNG3.230.300.100.725.525.400; H1.671.768.638.508 XSHeat Waves LH LS  MSFluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject over time (or infuse) agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agents and other drugs in thromboembolism, heart disease, diabetes mellitus, and other disorders; smaller versions of these pumps may be implanted. PM87 HN87 MHÑInfusion Pumps ANdo not use /instrum /man /methods /psychol /rehabil /util (except by MeSH definition); coord IM with drug /admin (IM); for small implanted infusion pumps do not coord with IMPLANTS, ARTIFICIAL PIInfusions, Intra-Arterial (78-86); Infusions, Parenteral (66-86); Perfusion, Regional (78-86) MNE7.505; E7.858.82.505 XSDrug Infusion Systems; Infusors; Intravenous Drug Delivery Systems; Perfusion Pumps; Pumps, Infusion FXÑCatheters, Indwelling LH LS; ; ; ; LX  MSRegional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. PM78 HN78 MHÑInfusions, Intra-Arterial ANdo not confuse with PERFUSION, REGIONAL (though both are used in cancer ther) or with INJECTIONS, INTRA-ARTERIAL; do not use /util except by MeSH definition PIInfusions, Parenteral (66-77); Injections, Intra-Arterial (66-77); Isolation Perfusion (66-77) MNE5.300.510.520 XSInfusions, Regional Arterial FXÑAntineoplastic Agents LH LS LX  MSThe long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. OLsearch INFUSIONS, PARENTERAL 1975-86 PM87; was see INFUSIONS, PARENTERAL 1975-86 HN87; was see INFUSIONS, PARENTERAL 1975-86 MHÑInfusions, Intravenous ANNIM; do not use /util except by MeSH definition; do not confuse with INJECTIONS, INTRAVENOUS PIInfusions, Parenteral (66-86) MNE5.300.510.590 XSDrip Infusions; Intravenous Drip; Intravenous Infusions LH LS; ;  MSThe administration through a needle or catheter of liquid medication, nutrient, or other fluid into a body cavity or vessel, usually over minutes or hours, either by gravity flow or often by infusion pumping. MHÑInfusions, Parenteral ANrestrict to method of admin of drugs & chemicals; not for replacement of fluids ( = FLUID THERAPY); note INTRAVENOUS INFUSIONS below: do not confuse with INJECTIONS, INTRAVENOUS or PARENTERAL FEEDING (for nourishment) MNE5.300.510 XSIntra-Abdominal Infusions; Intraperitoneal Infusions; Parenteral Infusions; Peritoneal Infusions FXÑFluid Therapy LH LS; ; ; LX  MHÑInguinal Canal ANinternal canal only: do not confuse with GROIN, external only MNA1.47.412 LH  MSGlyceroprotein hormone produced in the seminiferous tubules by the Sertoli cells in the male and by the granulosa cells in the female follicles. The hormone inhibits FSH and LH synthesis and secretion by the pituitary cells thereby affecting sexual maturation and fertility. PM83 HN83 MHÑInhibin AN/biosyn /physiol permitted RN57285-09-3 PIProteins (66-82); Testicular Hormones (75-82) MND6.472.866.640; D12.776.395.450 XSFolliculostatin LH LS  MSThe interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process. PM71 HN71 MHÑInhibition (Psychology) ANhuman & animal; no qualif; DF: INHIBITION PIConditioning (Psychology) (66-70); Learning (66-70); Psychoanalytic Theory (66-70) MNF1.145.544; F2.463.425.475; F2.739.794.405 XUÑProactive Inhibition; ÑReactive Inhibition LH LU;  MHÑInjections ANNIM; see specifics below; do not use /util except by MeSH definition; Manual 25.69, 26.35 MNE5.300.530 LH  MSThe injection of drugs, most often analgesics, into the spinal canal without puncturing the dura mater. PM87 HN87 MHÑInjections, Epidural ANNIM; do not use /util except by MeSH definition PIEpidural Space (79-86); Injections (66-86) MNE5.300.530.580.300 XSEpidural Injections; Extradural Injections; Peridural Injections FXÑAnesthesia, Conduction; ÑAnesthesia, Epidural LH LS; ; LX;  MHÑInjections, Intra-Arterial ANNIM; do not use /util except by MeSH definition; do not confuse with INFUSIONS, INTRA-ARTERIAL MNE5.300.530.370 LH  PM66 HN66(64) MHÑInjections, Intra-Articular ANNIM; do not use /util except by MeSH definition MNE5.300.530.380 LH  MSThe forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. HN(87)66(64) MHÑInjections, Intradermal ANNIM; do not use /util except by MeSH definition MNE5.300.530.620.410 DMÑInjections, Subcutaneous LH LM  PM73 HN73(64) MHÑInjections, Intralymphatic ANNIM; do not use /util except by MeSH definition; also called ╥endolymphatic injections╙: do not confuse with ENDOLYMPH MNE5.300.530.440 FXÑLYMPHOGRAPHY LH LX  MSForceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. MHÑInjections, Intramuscular ANNIM; do not use /util except by MeSH definition MNE5.300.530.460 LH  MSForceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. PM66 HN66(64) MHÑInjections, Intraperitoneal ANNIM; do not use /util except by MeSH definition MNE5.300.530.490 LH  MHÑInjections, Intravenous ANNIM; do not use /util except by MeSH definition; do not confuse with INFUSIONS, INTRAVENOUS ( = ╥long-term (minutes to hours) admin╙) MNE5.300.530.540 LH  MSInjections into the cerebral ventricles. PM76 HN76 MHÑInjections, Intraventricular ANbrain, not heart; do not use /util except by MeSH definition PICerebral Ventricles (66-75); Injections (66-75) MNE5.300.530.550 FXÑCerebral Ventricles LH LX  MSThe injection of solutions into the skin by compressed air devices so that only the solution pierces the skin. PM73 HN73(72) MHÑInjections, Jet ANdo not use /util except by MeSH definition PIInjections (66-71) MNE5.300.530.620.570 LH  OLuse INJECTIONS, SPINAL to search INJECTIONS, INTRATHECAL back thru 1966 PM87; was INJECTIONS, INTRATHECAL 1966-86 HN87; was INJECTIONS, INTRATHECAL 1963-86 (Prov 1963-65) MHÑInjections, Spinal ANNIM; do not use /util except by MeSH definition MNE5.300.530.580 XSInjections, Intraspinal; Injections, Intrathecal; Intraspinal Injections; Intrathecal Injections; Spinal Injections FXÑAnesthesia, Epidural; ÑAnesthesia, Spinal LH LS; ; ; ; LX;  MSForceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. PMINJECTIONS, INTRADERMAL was heading 1966-86 MHÑInjections, Subcutaneous ANNIM; do not use /util except by MeSH definition MNE5.300.530.620 XUÑInjections, Intradermal LH LU  MH*Injury, Occupational Dis, Poisoning (Non Mesh) MNC21 LH  MHÑInk ANno qualif MNJ1.637.439 LH  MSProjective tests utilizing ink blots to which a subject responds. They are used in personality diagnosis. PM68 HN68(64) MHÑInk Blot Tests ANonly /methods MNF4.711.647.622.341 XUÑHoltzman Inkblot Test LH LU  PM65 HN65 MHÑInlay Casting Wax AND25-26 qualif RN8024-51-9 MND25.339.334.574 FXÑWaxes LH LX  MSAn inlay is a restoration of metal, porcelain, or plastic made to fit a tapered cavity preparation, then cemented into the tooth. An onlay is a cast metal restoration which overlays cusps and is retained by frictional and mechanical factors. MHÑInlays ANonly /adv eff /class /hist /instrum /stand MNE6.323.428.491 XSDental Inlays; Onlays FXÑDental Materials LH LS; LX  MSThe first and largest artery branching from the aortic arch; distributes blood to the right side of the head and neck and to the right arm. MHÑInnominate Artery ANdo not use /blood supply MNA7.231.114.468 XSBRACHIOCEPHALIC TRUNK LH LS  MSLarge vein on either side of the root of the neck formed by the union of the internal jugular and subclavian veins; they drain blood from the head, neck and arms and unite to form the superior vena cava. MHÑInnominate Vein ANdo not use /blood supply MNA7.231.908.461 LH  MH*Inorganic Chemicals (Non Mesh) MND1 LH  OLsearch NUCLEOSIDES 1966-70 PM73; was see under NUCLEOSIDES 1963-71 HN73(71); was see under NUCLEOSIDES 1963-71 MHÑInosine AN/biosyn /physiol permitted RN58-63-9 PINucleosides (66-70) MND13.570.583.616; D13.570.800.573 XUÑIsoprinosine; ÑMethylthioinosine; ÑThioinosine LH LU; ;  MSAn inosine nucleotide which acts as a mild inhibitor of the hydrolysis of cycl AMP and cycl SMP and as an inhibitor of cat heart cycl AMP phosphodiesterase. OLuse INOSINE CYCLIC MONOPHOSPHATE to search INOSINE-3',5'-MONOPHOSPHATE back thru 1975 HN(80); INOSINE CYCLIC-3',5'-MONOPHOSPHATE was see under INOSINE NUCLEOTIDES 1975-79 MHÑInosine Cyclic Monophosphate AN/biosyn /physiol permitted; /analogs NIM only; DF: CYCL IMP RN3545-76-4 PIInosine Nucleotides (71-74); Nucleotides, Cyclic (74) MND13.695.462.600; D13.695.667.616.360; D13.695.827.519.360 XSCyclic IMP; Inosine Cyclic 2',3'-Monophosphate; Inosine Cyclic 3',5'-Monophosphate DMÑInosine Nucleotides LH LS; ; LM  MSInosine 5'-(trihydrogen diphosphate). An inosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: IRPP; inosine pyrophosphate. HN(78) MHÑInosine Diphosphate AN/biosyn /physiol permitted; /analogs NIM only RN86-04-4 PIInosine Nucleotides (71-77) MND13.695.667.616.400; D13.695.827.519.400 XSIDP DMÑInosine Nucleotides LH LS LM  MSInosine 5'-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. Synonyms: IMP. OLto search INOSINIC ACIDS use INOSINE MONOPHOSPHATE back thru 1975 & INOSINE NUCLEOTIDES 1974 HN(78); was INOSINIC ACIDS see under INOSINE NUCLEOTIDES 1974-77 MHÑInosine Monophosphate AN/biosyn /physiol permitted; /analogs NIM only RN131-99-7 PIInosine Nucleotides (71-74) MND13.695.667.616.500; D13.695.827.519.500 XSIMP; Inosinic Acid; Ribosylhypoxanthine Monophosphate DMÑInosine Nucleotides LH LS; ; LM  PM73 HN73(71) MHÑInosine Nucleotides AN/biosyn /physiol permitted; do not use /analogs PINucleotides (66-70) MND13.695.667.616; D13.695.827.519 XSInosine Phosphates XUÑInosine Cyclic Monophosphate; ÑInosine Diphosphate; ÑInosine Monophosphate; ÑInosine Triphosphate LH LS LU; ; ;  MSInosine 5'-(tetrahydrogen triphosphate). An inosine nucleotide containing three phosphate groups esterified to the sugar moiety. Synonym: IRPPP. HN(78) MHÑInosine Triphosphate AN/biosyn /physiol permitted; /analogs NIM only RN132-06-9 PIInosine Nucleotides (71-77) MND13.695.667.616.800; D13.695.827.519.800 XSITP DMÑInosine Nucleotides LH LS LM  MHÑInositol AN/biosyn /physiol permitted RN6917-35-7 MND9.203.853.519; D10.642.441; D11.786.708.415; D2.33.800.519 XSMyoinositol LH LS  MSPhosphoric acid esters of inositol. Includes mono- and polyphosphoric acid esters with the exception of inositol hexaphosphate which is PHYTIC ACID. HN(78) MHÑInositol Phosphates ANdo not use /analogs /biosyn /defic /physiol; hexaphosphate = INOSITOL HEXAPHOSPHATE (see PHYTIC ACID) PIInositol (66-77); Sugar Phosphates (74-77) MND2.33.800.519.400; D9.203.853.519.400; D9.203.894.480 DMÑSugar Phosphates LH LM  MS1L-Myo-Inositol-1-phosphate lyase (isomerizing). Catalyzes the formation of myo-inositol-1-phosphate from glucose-6-phosphate in the presence of NAD. Synonyms: Glucose-6-phosphate-myo-inositol-1-phosphate cyclase; D-glucose-6-phosphate cycloaldolase (NAD). HN(75) MHÑInositol-1-Phosphate Synthase ANdo not use /analogs RNEC 5.5.1.4 PICarbohydrate Isomerases (73-74); Inositol (73-74); Glucosephosphates (73-74) MND8.586.399.278.500 XSCycloaldolase; Inositol Cyclase; Myo-Inositol-1-Phosphate Synthase DMÑCarbohydrate Isomerases LH LS; ; LM  MSPersons admitted to health facilities which provide board and room, for the purpose of observation, care, diagnosis or treatment. HN(80) MHÑInpatients ANonly /psychol; inpatients as people or as a social, sociol, psychol, etc., group; do not confuse with HOSPITALIZATION PIHospitalization (66-79); Patients (66-79) MNM1.643.470 DMÑPatients LH LM  MSA legal concept that a person cannot be convicted of a crime if he lacked criminal responsibility by reason of insanity, which term is defined as a matter of law. OLto search MCNAUGHTON RULE use INSANITY DEFENSE back thru 1975 and FORENSIC PSYCHIATRY 1968-74 HN(85); was MCNAUGHTON RULE see under FORENSIC PSYCHIATRY 1969-84, was MCNAUGHTON RULE see under JURISPRUDENCE, PSYCHIATRIC 1968 MHÑInsanity Defense ANonly /hist MNF4.96.544.335.528; I1.198.560.469.528; I1.880.604.583.310.528; N3.706.535.351.528 XSMcNaughton Rule DMÑForensic Psychiatry LH LS LM  MHÑInsect Bites and Stings ANcoord IM with specific insect (IM); DF: INSECT BITES MNC21.613.127.441 LH  MHÑInsect Control ANonly /econ /hist /instrum /methods /stand /trends; for sexual sterilization of insects, coord specific insect (IM) + PEST CONTROL, BIOLOGICAL (IM) but not also STERILIZATION, SEXUAL (see note there) & not also INSECT CONTROL MNG3.850.180.600.310 FXÑChemosterilants; ÑINSECTICIDE RESISTANCE; ÑPest Control, Biological LH LX; ;  MSHormones secreted by insects. They influence their growth and development. Also synthetic substances that act like insect hormones. OLsearch INVERTEBRATE HORMONES 1967-74 PM77; was see under INVERTEBRATE HORMONES 1967-76 HN77(75); was see under INVERTEBRATE HORMONES 1967-76 MHÑInsect Hormones ANdo not use /analogs /defic PIInvertebrate Hormones (67-74) MND6.472.445.573 LH  MHÑInsect Repellents ANdo not use /analogs /biosyn /defic /physiol MND5.723.441 LH  MHÑInsect Vectors ANspecify both infecting organism & vector if pertinent; in the trypanosome-tsetse fly-cow relationship, the fly (not the cow) is the insect vector MNB1.371.294.574 LH  MHÑInsect Viruses ANdo not use /cytol MNB4.525 LH  MSThe development by insects of resistance to insecticides. OLuse INSECTICIDE RESISTANCE to search INSECTICIDES RESISTANCE back thru 1966 (as Prov 1966) PM67 HN67; was INSECTICIDES RESISTANCE 1964-66 (Prov) MHÑInsecticide Resistance ANIM when general; NIM when with specific insecticide (IM) & specific insect (IM); only /genet /rad eff MNG5.706.574; G12.392.491 FXÑInsect Control; ÑMosquito Control LH LX;  MHÑInsecticides ANGEN & unspecified: prefer specific or specific groups below; do not use /analogs /biosyn /defic /physiol; TN 111 for eff on insects; use for killing or control of ticks even though ticks are not insects MND5.723.491 FXÑCholinesterase Inhibitors LH LX  PM73 HN73 MHÑInsecticides, Botanical ANinsecticides derived from plants, not ╥effective on plant insects╙; do not use /analogs /defic /physiol; TN 111: eff on insects PIInsecticides (66-72); Pyrethrum (66-72) MND5.723.491.324 XSBOTANICAL INSECTICIDES LH LS  MSInsecticides, which owe their activity to the carbamate moiety in the molecule. PM75 HN75 MHÑInsecticides, Carbamate ANdo not use /analogs /biosyn /defic /physiol; TN 111: eff on insects PICarbamates (66-74); Insecticides (66-74) MND5.723.491.408 XUÑAldicarb; ÑCarbofuran; ÑMethiocarb; ÑMethomyl LH LU; ; ;  PM73 HN73 MHÑInsecticides, Organochlorine ANdo not use /analogs /biosyn /defic /physiol; TN 111: eff on insects PIInsecticides (66-72) MND5.723.491.491 XSORGANOCHLORINE INSECTICIDES XUÑDicofol; ÑKepone; ÑMirex; ÑPolychloropinene; ÑToxaphene LH LS LU; ; ; ;  PM73; INSECTICIDES, PHORPHORUS was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted and CHOLINESTERASE INHIBITORS became heading 1965) HN73; INSECTICIDES, PHOSPHORUS was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted and CHOLINESTERASE INHIBITORS became heading 1965) MHÑInsecticides, Organophosphate ANdo not use /analogs /biosyn /defic /physiol; /antag = CHOLINESTERASE REACTIVATORS; TN 111: eff on insects PIInsecticides (66-72); Organophosphorus Compounds (66-72) MND5.723.491.574 FXÑOrganophosphorus Compounds XUÑChlorfenvinphos; ÑCrufomate; ÑMevinphos; ÑMonocrotophos; ÑNaled; ÑPhosphamidon LH LX LU; ; ; ; ;  PM73; INSECTICIDES, PHOSPHORUS was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted & CHOLINESTERASE INHIBITORS became heading 1965) HN73; INSECTICIDES, PHOSPHORUS was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted & CHOLINESTERASE INHIBITORS became heading 1965) MHÑInsecticides, Organothiophosphate ANdo not use /analogs /biosyn /defic /physiol; /antag = CHOLINESTERASE REACTIVATORS; TN 111: eff on insects PIInsecticides (66-72); Organothiophosphorus Compounds (66-72) MND5.723.491.657 FXÑOrganothiophosphorus Compounds XUÑAbate; ÑAzinphosmethyl; ÑCoumaphos; ÑDiazinon; ÑDisulfoton; ÑDyfonate; ÑEPN; ÑFensulfothion; ÑFormothion; ÑMethyl Mercaptophos; ÑPhorate; ÑPhosmet; ÑPhosvel LH LX LU; ; ; ; ; ; ; ; ; ; ; ;  MHÑInsectivora ANIM, when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; includes MOLES, SHREWS, HEDGEHOGS & tenrecs; don't confuse with ant-eaters ( = EDENTATA) MNB2.649.473 XUÑMoles LH LU  MHÑInsects ANGEN: prefer specifics; /microbiol /parasitol permitted; /drug eff: TN 111 CATALOG: form qualif = ENTOMOLOGY /form MNB1.131.617 XUÑNymph LH LU  MHÑInsemination ANno qualif MNG8.520.392 LH  MSArtificial introduction of semen into the vagina for the purpose of inducing conception. MHÑInsemination, Artificial ANonly /econ /hist /instrum /methods /psychol /util (if by MeSH definition) /vet; TEST-TUBE FERTILIZATION see FERTILIZATION IN VITRO is available; also available are SEMEN PRESERVATION & SPERM BANKS MNE2.574; G5.414.133.575; G8.520.392.492; E5.820.520 XSArtificial Insemination; Eutelegenesis XUÑInsemination, Artificial, Heterologous; ÑInsemination, Artificial, Homologous LH LS; LU;  MSHuman artificial insemination in which the semen used is that of a man other than the woman's husband. HN(75) MHÑInsemination, Artificial, Heterologous ANhuman only: semen other than husband's; only /econ /instrum /methods /psychol /util (if by MeSH definition) MNE5.820.520.515; E2.574.515 XSInsemination, Artificial, Human Donor DMÑInsemination, Artificial LH LS LM  MSHuman artificial insemination in which the husband's semen is used. HN(75) MHÑInsemination, Artificial, Homologous ANhuman only; use of husband's semen; only /econ /instrum /methods /psychol /util (if by MeSH definition) MNE5.820.520.525; E2.574.525 XSInsemination, Artificial, Husband DMÑInsemination, Artificial LH LS LM  MSOn the job training programs for personnel carried out within an institution or agency; includes orientation programs. PM70 HN70(67) MHÑInservice Training ANonly /econ /legis /man /organ /stand /trends /util (if by MeSH definition) PIEducation, Continuing (66) MNI2.574 XSEmployee Orientation Programs; Orientation Programs, Employee LH LS;  MSInability to sleep. MHÑInsomnia ANinability to fall asleep or sleep: do not confuse with SLEEP DEPRIVATION, being deprived of sleep or prevented from sleeping; usually chronic so do not coord with CHRONIC DISEASE; do not use /drug eff /physiol /rad eff MNC10.597.785.367; C23.888.592.796.367; F3.126.821.408 FXÑWAKEFULNESS LH LX  MSThe maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the tidlal volume and the inspiratory reserve volume. Common abbreviation is IC. HN(75) MHÑInspiratory Capacity ANNIM; in texts as IC MNE1.302.796.420.500 DMÑLung Volume Measurements LH LM  MSThe extra volume of air that can be inspired with maximal effort after reaching the end of a normal, quiet inspiration. Common abbreviation is IRV. HN(75) MHÑInspiratory Reserve Volume ANNIM; in texts as IRV MNE1.302.796.420.540 DMÑLung Volume Measurements LH LM  MSThe administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops; also through a catheter, into a body space or cavity; differs from irrigation in that the irrigate is removed within minutes, but the instillate is left in place. PM87 HN87 MHÑInstillation, Drug ANNIM; no qualif MNE5.300.640 XSDrug Instillation LH LS  MSStereotyped patterns of response, characteristic of a given species, that has been phylogenetically adapted to a specific type of situation. OLto search FIXED ACTION PATTERN use INSTINCT back thru 1975 & BEHAVIOR, ANIMAL 1968-74; use INSTINCT to search INNATE BEHAVIOR back thru 1968 PMFIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78 HNFIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78; INNATE BEHAVIOR was see under INSTINCT 1968-78 MHÑInstinct ANhuman & animal; no qualif MNF1.658.642 XSFixed Action Pattern; Innate Behavior FXÑLIBIDO LH LS; LX  MSAdministrator-selected management groups who are responsible for making decisions pertaining to the provision of integrated direction for various institutional functions. HN(83) MHÑInstitutional Management Teams ANIM; only /econ /stand; toward integration of various institutional functions: do not confuse with PATIENT CARE TEAM (directed to personal care) MNN4.452.460 XSManagement Teams, Institutional DMÑOrganization and Administration LH LS LM  MSProfessional practice as an employee or contractee of a health care institution. PM68 HN68 MHÑInstitutional Practice ANonly /econ /legis /organ /stand /trends PIMedical Staff, Hospital (66-67) MNN4.452.758.367 LH  MSThe caring for individuals in institutions and their adaptation to routines characteristic of the institutional environment, and/or their loss of adaptation to life outside the institution. PM79 HN79 MHÑInstitutionalization ANonly /econ /legis /trends; HOSPITALIZATION is also available: see note there; DEINSTITUTIONALIZATION is also available; institutionalization of mentally ill: consider also COMMITMENT OF MENTALLY ILL see under FORENSIC PSYCHIATRY MNN2.421.589.508 FXÑChild, Institutionalized LH LX  MSThe act of blowing a powder, vapor, or gas into any body cavity for experimental, diagnostic, or therapeutic purposes. PM87 HN87 MHÑInsufflation ANfor air & other gases, powders, etc., do not use /util except by MeSH definition; for specific insufflation procedures consider other terms under PNEUMO- PIspecific gas; specific instrument; specific organ MNE1.484; E2.583; E5.484 LH  MHÑInsulin AN/biosyn /physiol permitted; /antag = INSULIN ANTAGONISTS; precursor = PROINSULIN; /admin: consider also INSULIN INFUSION SYSTEMS; /ther use: if by INSULIN INFUSION SYSTEMS use INSULIN INFUSION SYSTEMS & not also INSULIN /ther use RN9004-10-8 MND6.472.610.575; D9.482.500 FXÑNonsuppressible Insulin-Like Activity LH LX  MSCompounds which inhibit or antagonize the biosynthesis or action of insulin. PM78 HN78 MHÑInsulin Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: INSULIN ANTAG PIInsulin (66-77) MND6.347.420 LH  MHÑInsulin Antibodies ANonly /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine MND24.611.125.632 LH  HN(64) MHÑInsulin Coma ANcaused by excess exogenous insulin; do not use /chem ind MNC18.452.528.492 DMÑHypoglycemia LH LM  MSPortable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. PM82 HN82 MHÑInsulin Infusion Systems ANdo not use /instrum /man /methods /util (except by MeSH definition); does not include conventional insulin injections ( = INSULIN /admin + specific injection term); permitted as IM coord with DIABETES MELLITUS & specifics instead of INSULIN /ther use; for implantable insulin infusion devices do not coord with IMPLANTS, ARTIFICIAL; insulin patches do not go here: index INSULIN /admin (IM) + ADMINISTRATION, CUTANEOUS (NIM) PIArtificial Organs (73-81); Infusions, Parenteral (73-81); Insulin (73-81); Islands of Langerhans (73-81); Pancreas (73-81) MNE7.505.508; E7.858.82.505.508 XSBeta Cell, Artificial; Pancreas, Artificial Endocrine LH LS;  PM67 HN67(64) MHÑInsulin Resistance ANonly /genet /rad eff MNG12.392.617 LH  MSWell-characterized basic peptide believed to be secreted by the liver and circulating in the blood. It has growth regulating, insulin-like and mitogenic activities. The growth factor has a major but not absolute dependence on somatotropin. It is believed to be mainly active in adults in contrast to IGF-II which is a major fetal growth factor. OLsearch 61912-98-9 (RN) 1980-86 HN(86) MHÑInsulin-Like Growth Factor I AN/biosyn /physiol permitted RN67763-96-6 PIGrowth Substances (66-85); Insulin (66-85); Peptides (66-85); Somatomedins (73-85); Sulfation Factor (71-72) MND12.776.124.862.400; D12.776.641.650.710.400; D24.185.348.862.505 XSIGF-I; Somatomedin C DMÑSomatomedins LH LS; LM  MSWell-characterized neutral peptide believed to be secreted by the liver and circulating in the blood. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major but not absolute dependence on somatotropin. It is believed to be a major fetal growth factor in contrast to IGF-I which is a major growth factor in adults. OLsearch 61912-98-9 (RN) 1980-86 HN(86) MHÑInsulin-Like Growth Factor II AN/biosyn /physiol permitted RN67763-97-7 PIBlood Proteins (66-85); Growth Substances (66-85); Insulin (66-85); Peptides (66-85); Somatomedins (73-85); Sulfation Factor (71-72) MND12.776.124.862.425; D12.776.641.650.710.420; D24.185.348.862.508 XSIGF-II; Multiplication-Stimulating Activity; Somatomedin MSA DMÑSomatomedins LH LS; ; LM  MHÑInsulin, Isophane ANdo not use /biosyn /defic /physiol RN53027-39-7 MND6.472.610.575.408; D9.482.500.442 LH  MHÑInsulin, Lente ANdo not use /biosyn /defic /physiol RN8049-62-5 MND6.472.610.575.491; D9.482.500.542 LH  MHÑInsulin, Protamine Zinc ANdo not use /biosyn /defic /physiol RN9004-17-5 MND6.472.610.575.574; D9.482.500.642 LH  OLsearch PEPTIDE PEPTIDOHYDROLASES 1966-74 HN(75); was see under PEPTIDE PEPTIDOHYDROLASES 1963-74 MHÑInsulinase ANdo not use /analogs RNEC 3.4.99.10 MND8.586.277.656.520 DMÑPeptide Hydrolases LH LM  MSInsulin-secreting tumor of pancreatic beta cells. OLsearch ISLET CELL TUMOR 1979-81 HN(82); was see ISLET CELL TUMOR 1979-81 MHÑInsulinoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with PANCREATIC NEOPLASMS (IM) PIIslet Cell Tumor (66-81) MNC4.557.576.600.508 XSBeta Cell Tumor; Insuloma DMÑIslet Cell Tumor LH LS; LM  MSCoverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency. MHÑInsurance ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576 XUÑInsurance Carriers; ÑInsurance Claim Reporting LH LU;  MSServices or sum of money provided under stated circumstances under the terms of an insurance policy. PM78 HN78 MHÑInsurance Benefits ANonly /econ /hist /legis /stand /trends /util; coord IM with specific type of insurance (IM) + geog if pertinent; ╥coverage╙: index under specific type of insurance only, not here PIInsurance (66-77) MNN3.219.521.576.130 LH  MSOrganizations which assume the financial responsibility for the risks of policyholders. HN(Aug 77) MHÑInsurance Carriers ANonly /econ /hist /legis /stand /trends /util; specify geog if possible MNN3.219.521.576.160 XSInsurers DMÑInsurance LH LS LM  MSThe design, completion and filing of forms with the insurer. HN(Aug 77) MHÑInsurance Claim Reporting ANonly /econ /hist /legis /stand /trends /util MNN3.219.521.576.210 DMÑInsurance LH LM  MSReview of claims by insurance companies to assess utilization and necessity of various health care services. HN(86) MHÑInsurance Claim Review ANonly /econ /hist /legis /stand /trends /util PIInsurance, Health/UT (66-85); Insurance, Hospitalization/UT (66-85); Utilization Review (68-85) MNN3.219.521.576.343.424 XSInsurance Audit DMÑInsurance, Health LH LS LM  MSInsurance providing coverage for physical injury suffered as a result of unavoidable circumstances. MHÑInsurance, Accident ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576.343.409 XSACCIDENT INSURANCE LH LS  MSInsurance providing coverage for dental care. OLuse INSURANCE, DENTAL to search DENTAL CARE PLANS back thru 1966 & PREPAID DENTAL CARE back thru 1969 HNDENTAL CARE PLANS was see under INSURANCE, DENTAL 1963-78; PREPAID DENTAL CARE was see under INSURANCE, DENTAL 1969-78 MHÑInsurance, Dental ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576.343.450 XSDental Care Plans; Prepaid Dental Care LH LS;  MSInsurance providing coverage of medical, surgical or hospital care in general or for which there is no specific heading. MHÑInsurance, Health ANonly /econ /hist /legis /stand /trends /util; specify geog if possible; CHAMPUS: index under HEALTH BENEFIT PLANS, EMPLOYEE CATALOG: /geog /form MNN3.219.521.576.343 XSGroup Health Insurance; HEALTH INSURANCE; Health Insurance, Voluntary FXÑHEALTH MAINTENANCE ORGANIZATIONS; ÑPhysician's Practice Patterns XUÑHealth Benefit Plans, Employee; ÑInsurance Claim Review; ÑInsurance, Nursing Services; ÑInsurance, Surgical; ÑPreferred Provider Organizations LH LS; ; LX; LU; ; ; ;  MSPayment of charges by a health insurer either to the provider of the service or the insured. PM82; was indexed under INSURANCE, HEALTH Aug 77-81 HN82 (Aug 77); was see under INSURANCE, HEALTH Aug 77-81 MHÑInsurance, Health, Reimbursement ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.710 XSHealth Insurance Reimbursement; Reimbursement, Health Insurance; Third Party Payments LH LS; ;  MSHealth insurance providing benefits to cover or partly cover hospital expenses. MHÑInsurance, Hospitalization ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576.343.492 XSHOSPITALIZATION INSURANCE XUÑBlue Cross; ÑGroup Hospitalization LH LS LU;  MSInsurance against loss resulting from liability for injury or damage to the persons or property of others. MHÑInsurance, Liability ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576.443 XSNo Fault Insurance FXÑMalpractice LH LS LX  MSInsurance providing for payment of a stipulated sum to a designated beneficiary upon death of the insured. MHÑInsurance, Life ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576.543 LH  MSHealth insurance to provide full or partial coverage for long term home care services or for long term nursing care provided in a residential facility such as a nursing home. PM87 HN87 MHÑInsurance, Long Term Care ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form PIInsurance, Health (66-86); Long Term Care (68-86) MNN3.219.521.576.343.508 XSLong Term Care Insurance FXÑLong Term Care LH LS LX  MSInsurance providing a broad range of medical services and supplies, when prescribed by a physician, whether or not the patient is hospitalized; it frequently is an extension of a basic policy and benefits will not begin until the basic is exhausted. PM68 HN68 MHÑInsurance, Major Medical ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form PIInsurance, Health (66-67) MNN3.219.521.576.343.533 XSCOMPREHENSIVE HEALTH INSURANCE; Catastrophic Health Insurance; Insurance, Health, Catastrophic FXÑCatastrophic Illness LH LS; ; LX  MSInsurance providing benefits for the costs of care provided by nurses, especially nurse practitioners and nurse clinicians. HN(84) MHÑInsurance, Nursing Services ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576.343.545 DMÑInsurance, Health LH LM  MSInsurance providing for payment of services rendered by the pharmacist; preparation and distribution of medical products. PM68 HN68 MHÑInsurance, Pharmaceutical Services ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form PIPharmacy (66-67); Prescriptions (66-67) MNN3.219.521.576.343.575 XSDRUG BENEFIT PLANS; DRUG INSURANCE; PRESCRIPTION INSURANCE FXÑPharmacy Administration LH LS; ; LX  MSInsurance providing benefits for the costs of care by a physician which can be comprehensive or limited to surgical expenses or for care provided only in the hospital. It is frequently called ╥regular medical expense╙ or ╥surgical expense╙. PM68 HN68 MHÑInsurance, Physician Services ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form PIInsurance, Health (66-67) MNN3.219.521.576.343.616 XUÑBlue Shield LH LU  MSInsurance providing benefits to cover part or all of the psychiatric care. PM68 HN68 MHÑInsurance, Psychiatric ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form PIInsurance, Health (66-67) MNN3.219.521.576.343.658 LH  MSA specific type of health insurance which provides surgeons fees for specified amounts according to the type of surgery listed in the policy. OLsearch INSURANCE, HEALTH 1966-74 HN(75) MHÑInsurance, Surgical ANonly /econ /hist /legis /stand /trends /util; specify geog if possible CATALOG: /geog /form MNN3.219.521.576.343.700 DMÑInsurance, Health LH LM  MSThe ability to learn and to deal with new situations and to deal effectively with tasks involving abstractions. MHÑIntelligence ANonly /drug eff /rad eff MNF1.752.543 LH  MSStandardized tests that measure the present general ability or aptitude for intellectual performance. MHÑIntelligence Tests ANonly /stand MNF4.711.141.493 XSMENTAL TESTS XUÑStanford-Binet Test LH LS LU  MSHospital units providing continuous surveillance and care to acutely ill patients. PM66 HN66(63) MHÑIntensive Care Units ANdo not use /educ /methods MNN2.278.388.493 FXÑCritical Care XUÑBurn Units LH LX LU  MSHospital units providing continuing surveillance and care to acutely ill newborn infants. PM82 HN82 MHÑIntensive Care Units, Neonatal ANdo not use /educ /methods PIInfant, Newborn (66-81); Intensive Care Units (66-81) MNN2.278.388.493.380 XSNeonatal Intensive Care Units; Newborn Intensive Care Units LH LS;  MSAgents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning; used in the study of DNA. Synonyms: intercalators; intercalative compounds; intercalating ligands. PM80 HN80 MHÑIntercalating Agents ANagents ╥capable of inserting themselves ... between the successive bases in DNA╙; used in DNA studies; D25-26 qualif PIDNA (66-79); specific DNA; Nucleic Acid Conformation (72-79) MND26.550.435 LH  PM72 HN72(70) MHÑIntercellular Junctions ANA 11 qualif except /cytol PICell Membrane (66-69) MNA11.195.443 FXÑCell Communication LH LX  MHÑIntercostal Muscles MNA2.633.465; A2.633.740.465 LH  OLsearch THORACIC NERVES 1966-74 HN(75) MHÑIntercostal Nerves ANdo not use /innerv MNA8.796.828.854.410 DMÑThoracic Nerves LH LM  MSMeasurement of distances or movements by means of the phenomena caused by the interference of two rays of light (optical interferometry) or of sound (acoustic interferometry). PM77 HN77 MHÑInterferometry ANNIM; only /instrum /methods; coord with LIGHT (NIM) or SOUND (NIM) if specified; moire topography goes here + PHOTOGRAMMETRY PILasers (66-76); Optics (66-76) MNE5.490 LH  PM73 HN73 MHÑInterferon Inducers ANonly /anal /genet /immunol /isol /pharm /rad eff /ther use; DF: INTERFERON IND PIInterferons/BI (66-72) MND20.388.643.493; D24.611.558.493 LH  MSInterferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. PM83 HN83 MHÑInterferon Type I ANdo not use /analogs; /biosyn /physiol permitted after virus enters cell; see note on INTERFERONS below PIInterferons (66-82) MND12.776.468.500; D20.388.643.890; D24.611.558.890 XSInterferon, Alpha; Interferon, Beta; Interferon, Fibroblast; Interferon, Leukocyte; Interferon, Lymphoblast; Ro 22-8181 LH LS; ; ; ; ;  MSInterferon secreted by lymphocytes in response to various mitogenic and immune-specific stimuli including lectins, anti-lymphocyte globulins, and antigens. PM83 HN83 MHÑInterferon Type II ANdo not use /analogs; /biosyn /physiol permitted after virus enters cell; see note on INTERFERONS below PIInterferons (66-82) MND12.776.468.550; D20.388.643.893; D24.611.558.893 XSInterferon, Gamma; Interferon, Immune LH LS;  MSProteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. OLuse INTERFERONS to search INTERFERON back thru 1966 PM83; was INTERFERON 1963-82 HN83; was INTERFERON 1963-82 MHÑInterferons ANdo not use /analogs; /biosyn /physiol permitted; do not confuse with VIRUS INHIBITORS, substances found in normal serum, body fluids or tissue; ╥stimulators╙ or ╥inducers╙ = INTERFERON INDUCERS; coord IM with disease /ther (IM), not /drug ther MND12.776.468; D20.388.643; D24.611.558 FXÑVIRAL INTERFERENCE LH LX  MSThe interactions between representatives of institutions, agencies, or organizations. PM80 HN80 MHÑInterinstitutional Relations ANno qualif; coord IM with specific institution, agency or organization (IM) MNF1.829.674.400; N4.452.822.400 XSInteragency Relations LH LS  MSThe planning of the furnishings and decorations of an architectural interior. HN(Aug 77) MHÑInterior Design and Furnishings ANfor houses, commerc estab, hosp, institutions, etc.; only /econ /stand; DF: INTERIOR DESIGN MNJ1.86.339.290 XSFurniture DMÑFacility Design and Construction LH LS LM  MSSoluble factor produced by monocytes or macrophages which activates T lymphocytes and potentiates their response to mitogens or antigens. Its biological effects include the ability to replace macrophage requirements for T cell activation. The factor is distinct from Interleukin 2. PM83 HN83 MHÑInterleukin 1 ANonly /admin /adv eff /anal /biosyn /csf /class /genet /immunol /isol /physiol /ther use /urine PILymphocyte Transformation (72-82); Lymphocytes (66-71); Lymphokines (74-82); Macrophages (66-82); Toxins (66-73) MND24.611.595 XSLymphocyte Activating Factor FXÑMacrophages LH LS LX  MSSoluble substances elaborated by antigen-or mitogen-stimulated T lymphocytes which induce DNA synthesis in naive lymphocytes. OLuse INTERLEUKIN 2 to search MITOGENIC FACTORS, LYMPHOCYTE 1983-86 & MITOGENIC FACTOR 1978-82 PM87; was MITOGENIC FACTORS, LYMPHOCYTE 1983-86; was MITOGENIC FACTOR see under LYMPHOKINES 1978-82 HN87; was MITOGENIC FACTORS, LYMPHOCYTE 1983-86; was MITOGENIC FACTOR see under LYMPHOKINES 1978-82 MHÑInterleukin 2 ANonly /admin /adv eff /anal /biosyn /csf /class /genet /immunol /isol /physiol /ther use /urine PIMitogens (73-77) MND24.611.632.372 XSLymphocyte Mitogenic Factor; T Cell Growth Factor; TCGF FXÑHelper Cells LH LS; ; LX  MSA glycopeptide of 28,000 daltons, secreted by T cells and others; it stimulates the proliferation of several different types of blood cells, including histamine-releasing cells, granulocytes and erythrocytes. PM87 HN87 MHÑInterleukin 3 ANonly /admin /adv eff /anal /biosyn /csf /class /genet /immunol /isol /physiol /ther use /urine PIColony-Stimulating Factor (79-86); Glycoproteins (76-78); Lymphokines (74-86) MND24.185.152.599 XSBurst-Promoting Factor, Erythrocyte; Colony-Stimulating Factor 2 Alpha; Colony-Stimulating Factor, Granulocyte-Macrophage; Colony-Stimulating Factor, Macrophage-Granulocyte; Colony-Stimulating Factor, Mast Cell; Colony-Stimulating Factor, Multipotential; Erythrocyte Burst-Promoting Factor; Granulocyte-Macrophage Colony Stimulating Factor; Growth Factor, Mast Cell; Histamine-Producing Cell Stimulating Factor; Macrophage-Granulocyte Colony-Stimulating Factor; Mast Cell Colony-Stimulating Factor; Multipotential Colony-Stimulating Factor; P-Cell Stimulating Factor LH LS; ; ; ; ; ; ; ; ; ; ; ; ;  MHÑInterlibrary Loans ANonly /econ /hist /instrum /legis /methods /stand /trends /util MNL1.453.639.493; L1.583.464.493 LH  MSInstitutions which provide health-related care and services to individuals who do not require the degree of care which hospitals or skilled nursing facilities provide, but because of their physical or mental condition require care and services above the level of room and board. HN(79) MHÑIntermediate Care Facilities ANdo not use /educ /methods PINursing Homes (66-78) MNN2.278.825.610.480 DMÑNursing Homes LH LM  MSFilaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein. PM83 HN83 MHÑIntermediate Filament Proteins AN/biosyn /physiol permitted; do not use /analogs PIMuscle Proteins (66-82); Nerve Tissue Proteins (66-82); Peptides (66-82); Proteins (66-82) MND12.776.220.475 XSFibroblast Intermediate Filament Proteins LH LS  MSCytoplasmic filaments intermediate in diameter (about 10 nanometers) between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus. OLsearch CYTOSKELETON 1980-85 HN(86); was see CYTOPLASMIC FILAMENTS 1980-85 MHÑIntermediate Filaments ANA 11 qualif except /cytol PICytoplasm (75-76); Cytoskeleton (77-85) MNA11.368.250.410 XSNeurofilaments; Tonofilaments DMÑCytoskeleton LH LS; LM  MSA symptom complex characterized by leg pain and weakness brought on by walking, with the disappearance of the symptoms following a brief rest. MHÑIntermittent Claudication MNC14.907.137.126.669 LH  MSApplication of positive pressure to the inspiratory phase of spontaneous respiration. OLto search INTERMITTENT POSITIVE PRESSURE BREATHING (IPPB) use INTERMITTENT POSITIVE PRESSURE BREATHING back thru 1975 & POSITIVE PRESSURE RESPIRATION 1969-74 HN79; was INTERMITTENT POSITIVE PRESSURE BREATHING (IPPB) see under POSITIVE-PRESSURE RESPIRATION 1969-78 MHÑIntermittent Positive Pressure Breathing ANdo not use /util except by MeSH definition; do not confuse with next term below: IPPB is spontaneous, IPPV is on a ventilator MNE2.880.820.790.520 XSIPPB; Inspiratory Positive Pressure Breathing DMÑPositive Pressure Respiration LH LS; LM  MSApplication of positive pressure to the inspiratory phase when the patient has an artificial airway in place and is connected to a ventilator. HN(79) MHÑIntermittent Positive Pressure Ventilation ANdo not use /util except by MeSH definition; do not confuse with term above: IPPV is on a ventilator, IPPB is spontaneous PIIntermittent Positive Pressure Breathing (75-78); Positive Pressure Respiration (66-78) MNE2.880.820.790.550 XSIPPV; Inspiratory Positive Pressure Ventilation; Ventilation, Intermittent Positive Pressure DMÑPositive Pressure Respiration LH LS; ; LM  MSIndirect myocardial revascularization in which the internal mammary artery is implanted into the myocardium. HN(75) MHÑInternal Mammary Artery Implantation ANdo not use /util except by MeSH definition MNE4.752.376.719.520; E4.920.490.630.510 DMÑMyocardial Revascularization LH LM  MSDirect myocardial revascularization in which the internal mammary artery is anastomosed to the right coronary artery, circumflex artery, or anterior descending coronary artery. HN(75) MHÑInternal Mammary-Coronary Artery Anastomosis ANdo not use /util except by MeSH definition MNE4.752.376.719.570; E4.920.490.630.540 DMÑMyocardial Revascularization LH LM  MSA medical specialty concerned with the diagnosis and treatment of diseases of the internal organ systems of adults. MHÑInternal Medicine ANSPEC: SPEC qualif except /methods; as ╥internal diseases╙: Manual 28.9 MNG2.403.776.409 LH  MSA general principle that man's attempts to control his personal environment are influenced by internal or external factors. PM72 HN72 MHÑInternal-External Control ANno qualif PIPerception (66-71); Self Concept (69-71); Social Control, Informal (68-71) MNF1.829.379 XSLocus of Control LH LS  MSInternational organizations which provide health-related services. MHÑInternational Agencies ANdo not use /educ /supply; specify geog MNN3.540.514 LH  MSThe interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest. MHÑInternational Cooperation ANno qualif; do not index here for ╥international congresses╙: CONGRESSES is adequate (TN 112); specify geog MNI1.534 FXÑCongresses LH LX  MSAn international professional organization composed of one association per country for the purpose of improving and developing nursing's contribution to the promotion of health and care of the sick. HN(80) MHÑInternational Council of Nurses ANonly /hist /organ CATALOG: use NAF entry PIInternational Cooperation (66-79); Societies, Nursing (66-79) MNN3.540.828.672.463 DMÑSocieties, Nursing LH LM  MSThe exchange of students or professional personnel between countries done under the auspices of an organization for the purpose of further education. PM70 HN70(68) MHÑInternational Educational Exchange ANno qualif; specify geog PIInternational Cooperation (66-67) MNI1.534.494 FXÑFOREIGN MEDICAL GRADUATES LH LX  MSA system of physical units in which the fundamental quantities are length, time, mass, electric current, temperature, luminous intensity, and amount of substance, and the corresponding units are the meter, second, kilogram, ampere, kelvin, candela, and mole; it has been given official status and recommended for universal use by the General Conference on Weights and Measures. Also known as Systeme International d'Unites. Abbreviated SI. HN(79) MHÑInternational System of Units ANonly /hist /stand PIMetric System (74-78); Weights and Measures (66-78) MNH1.939.507 DMÑWeights and Measures LH LM  PM68 HN68 MHÑInterneurons ANA 11 qualif PINeurons (66-67) MNA8.663.409; A11.671.389 XSIntercalated Neuron LH LS  MSPrograms of training in medicine and medical specialties offered by hospitals for graduates of medicine to meet the requirements established by accrediting authorities. MHÑInternship and Residency ANmed & dent only; do not use /educ /man /util; ╥junior physicians╙ are not interns: index under MEDICAL STAFF, HOSPITAL; DF: INTERNSHIP MNI2.358.399.644 XSHouse Staff; Internship, Dental; Residency, Dental; Residency, Medical LH LS; ; ;  MSAdvanced programs of training to meet certain professional requirements in fields other than medicine or dentistry, e.g., pharmacology, nutrition, nursing, etc. PM78 HN78 MHÑInternship, Nonmedical ANdo not use /educ /man /util MNI2.358.750 XSResidency, Nonmedical LH LS  MSThe reciprocal interaction of two or more persons. PM64 HN64 MHÑInterpersonal Relations ANno qualif MNF1.829.401 XSSocial Interaction LH LS  MSThe interval between two successive cell divisions during which the chromosomes are not individually distinguishable and DNA replication occurs. PM81; was see under CELL CYCLE 1978-80 HN81(78); was see under CELL CYCLE 1978-80 MHÑInterphase ANthe interval between cell divisions; G0, G1, S & G2 go here; NIM specific cell when merely test cell; coord with specific cell /cytol; only /drug eff /rad eff; permitted with micro-organisms PICell Division (66-77); Mitosis (68-77) MNG4.335.135.500; G5.148.165.500; G7.553.135.500 XSG Periods; Resting Phase; S Period LH LS; ;  MSThe reciprocal interaction of two or more professional individuals. PM65 HN65 MHÑInterprofessional Relations ANno qualif MNF1.829.401.205 LH  MSStructures in fishes homologous to the cortical tissue of the mammalian adrenal gland; they are in close proximity to or imbedded in the kidney. OLsearch ADRENAL GLANDS 1968-74 HN(75) MHÑInterrenal Gland ANalso called interrenal body; in fish MNA6.407.71.619; A13.530 DMÑAdrenal Glands LH LM  MHÑIntertrigo MNC17.387 LH  MHÑIntervertebral Disk ANcoord IM with specific vertebrae (NIM); diseases: probably INTERVERTEBRAL DISK DISPLACEMENT but if not, index as INTERVERTEBRAL DISK (IM) + SPINAL DISEASES (IM); chemonucleolysis: index under probably INTERVERTEBRAL DISK DISPLACEMENT /drug ther (IM) + usually CHYMOPAPAIN /ther use (IM) MNA2.165.410; A2.835.232.834.432 XSDISK, INTERVERTEBRAL LH LS  MSThe dissolving of the nucleus pulposus of a displaced intervertebral disk, usually by the direct injection of a proteolytic enzyme, especially chymopapain, into the diseased disk. PM87 HN87 MHÑIntervertebral Disk Chemolysis ANdo not use /util except by MeSH definition PIChymopapain (75-86); Intervertebral Disk Displacement (66-86) MNE2.590 XSChemolysis, Intervertebral Disk; Chemonucleolysis; Discolysis; Nucleolysis, Intervertebral Disk FXÑChymopapain LH LS; ; ; LX  MHÑIntervertebral Disk Displacement AN= herniation or prolapse; coord IM with specific vertebrae (NIM); chemonucleolysis: index under INTERVERTEBRAL DISK DISPLACEMENT /drug ther, not /ther, + specific substance /ther use, usually CHYMOPAPAIN MNC5.878.307 XSDISK, HERNIATED FXÑSciatica LH LS LX  MSA directed conversation aimed at eliciting information for psychiatric diagnosis, evaluation, treatment planning, etc.; may be conducted by a social worker or psychologist. PM68 HN68(65) MHÑInterview, Psychological ANonly /methods MNF4.669.599 LH  MSConversations with an individual held in order to obtain information; includes school admission or job interviews. PM80 HN80 MHÑInterviews ANfor articles on how to conduct interviews, their value, behavior of participants, etc.: do not use or confuse with the rubric [interview] in titles of articles (Manual 14.5.1.8); only /methods /stand /util (if by MeSH definition) MNL1.280.520 LH  PM65 HN65 MHÑIntestinal Absorption ANonly /drug eff /rad eff MNG10.261.576 XSABSORPTION, INTESTINAL FXÑMALABSORPTION SYNDROMES LH LS LX  MHÑIntestinal Atresia ANdo not use /congen; coord IM with specific intestine /abnorm except for duodenum: index duodenal atresia as DUODENAL OBSTRUCTION /congen (IM) + INTESTINAL ATRESIA (IM) MNC16.131.314.466 LH  OLsearch INTESTINAL MICROORGANISMS under INTESTINES 1966-67 PMINTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflammatory disease is indexed here, was indexed under INTESTINAL DISEASES or ENTERITIS 1963-79 HNINTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflamm dis was indexed under ENTERITIS or INTESTINAL DISEASES 1966-79 MHÑIntestinal Diseases ANGEN: prefer specifics; inflamm dis = INTESTINAL DISEASES (IM) + INFLAMMATION (NIM) for general or unspecified inflamm dis; for specific prefer -ITIS terms in Cat C6; ╥inflammatory bowel disease╙ is probably CROHN DISEASE or COLITIS, ULCERATIVE; gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS MNC6.405.469 LH  MHÑIntestinal Diseases, Parasitic ANcoord with specific parasitic dis (IM) + specific intestine or precoord intestinal dis (IM) MNC3.432; C6.405.469.452 LH  MSAbnormal passage communicating with the intestines. MHÑIntestinal Fistula ANfistula policy: Manual 23.25+ MNC6.405.469.478 FXÑFistula LH LX  PM67 HN67(65) MHÑIntestinal Mucosa AN/cytol: consider also PEYER'S PATCHES; /secret = INTESTINAL MUCOSA /secret or INTESTINAL SECRETIONS but not INTESTINES /secret MNA3.492.411.369; A10.615.550.444 LH  MHÑIntestinal Neoplasms ANGEN: prefer specific precoord; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.476.411; C6.405.469.505 LH  MSAny impairment, arrest, or reversal of the normal anad flow of intestinal contents. MHÑIntestinal Obstruction ANcoord IM with specific precoord intestinal dis (IM) MNC6.405.469.531 XSILEUS; VOLVULUS LH LS;  MHÑIntestinal Perforation ANcaused by dis or inj; coord IM with specific intestine (IM) or specific precoord intestinal dis (IM); intestinal rupture does not go here: index with INTESTINES /inj or specific intestine /inj (IM) + RUPTURE (NIM) or specific intestine (IM) or specific precoord intestinal dis (IM) + RUPTURE, SPONTANEOUS (NIM) MNC6.405.469.557 LH  MSPedunculated or sessile growths arising from the intestinal mucosa and extending into the lumen. Includes intestinal polyposis. PM68 HN68 MHÑIntestinal Polyps ANcoord IM with organ/neopl, not organ/dis (IM); /familial: consider also POLYPOSIS SYNDROME, FAMILIAL, a colonic neopl dis PIIntestinal Diseases (66-67); Polyps (66-67) MNC4.799.411; C6.405.469.583 LH  MSObstruction of the intestines that is functional, not mechanical. OLuse INTESTINAL PSEUDO-OBSTRUCTION to search INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC back thru 1981 & PARALYTIC ILEUS back thru 1971 (as Prov 1971-74) PM87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86 HN87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86, was Prov 1971-74 MHÑIntestinal Pseudo-Obstruction ANcoord IM with specific precoord intestinal dis (IM) PIIntestinal Obstruction (66-80) MNC6.405.469.531.560 XSParalytic Ileus; Pseudo-Obstruction, Intestinal; Visceral Myopathy XUÑColonic Pseudo-Obstruction LH LS; ; LU  MHÑIntestinal Secretions ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.838.390 FXÑGASTROINTESTINAL HORMONES LH LX  OLsearch INTESTINAL MICROORGANISMS under INTESTINES 1966-67 PMINTESTINAL MICROORGANISMS was heading 1963-67 HNINTESTINAL MICROORGANISMS was heading 1963-67 MHÑIntestine, Large ANGEN: prefer specific; inflammation or inflamm dis = COLITIS or other large intestine -ITIS term in Cat C6 MNA3.492.411.495 LH  OLsearch INTESTINAL MICROORGANISMS under INTESTINES 1966-67 PMINTESTINAL MICROORGANISMS was heading 1963-67 HNINTESTINAL MICROORGANISMS was heading 1963-67 MHÑIntestine, Small ANGEN; /cytol: consider also PEYER'S PATCHES; inflammation = ENTERITIS but ENTEROCOLITIS, DUODENITIS & ILEITIS are available MNA3.492.411.620 LH  OLuse INTESTINES to search INTESTINAL MICROORGANISMS 1966-67 PM/microbiology was INTESTINAL MICROORGANISMS 1963-67 HN/microbiology was INTESTINAL MICROORGANISMS 1963-67 MHÑIntestines ANGEN; /secret = INTESTINAL MUCOSA /secret or INTESTINAL SECRETIONS; invagination = INTUSSUSCEPTION; /surg: consider also GASTROENTEROSTOMY; inflammation or inflamm dis: see note on INTESTINAL DISEASES; gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS; consider other terms under ENTER MNA3.492.411 LH  MSAssisted circulation in which a pumping unit synchronized with the patient's electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion. PM86; was see under ASSISTED CIRCULATION 1977-85 HN86(77); was see under ASSISTED CIRCULATION 1977-85 MHÑIntra-Aortic Balloon Pumping ANdo not use /man /supply /util (except by MeSH definition) PIAssisted Circulation (67-76) MNE4.50.520 XSPumping, Intra-Aortic Balloon LH LS  OLsearch BODY FLUIDS 1966-74 HN(75) MHÑIntracellular Fluid ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; do not confuse with interstitial fluid (index under EXTRACELLULAR SPACE) MNA12.207.515 DMÑBody Fluids LH LM  MSMembranes of subcellular structures. PM79 HN79 MHÑIntracellular Membranes AN╥membranes of subcellular structures╙; A 11 qualif except /cytol PIMembranes (66-78) MNA11.904.514 XSMembranes, Intracellular LH LS  MSA family of retrovirus-like genetic elements coding for virus-like particles found regularly in early rodent embryos (2-cell to blastocyst stage), but which, under certain circumstances such as DNA hypomethylation, are transcribed into a wide variety of neoplasms including plasmacytomas, neuroblastomas, rhabdomyosarcomas, teratocarcinomas, and colon carcinomas. HN(86) MHÑIntracisternal A-Particle Genes ANonly /drug eff /rad eff; ╥intracisternal╙ refers to the cisternae of the endoplasmic reticulum PIBase Sequence (80-85); Genes, Viral (80-85); Oncogenes (83-85); Repetitive Sequences, Nucleic Acid (81-85); Retroviridae (80-85) MNG5.275.740.791.645 XSGenes, Intracisternal A-Particle DMÑProto-Oncogenes LH LS LM  MHÑIntracranial Pressure ANalso called cerebrospinal or spinal fluid pressure; only /drug eff /rad eff; intracranial hypertension: note see ref above MNG11.561.402 FXÑPAPILLEDEMA; ÑSkull LH LX;  MSSkin tests in which the sensitizer is injected. OLsearch SKIN TESTS 1966-74 HN(75) MHÑIntradermal Tests ANonly /instrum /methods MNE1.223.495.862.345; E1.862.345 XSPassive Transfer Test; Prausnitz-Kustner Test DMÑSkin Tests LH LS; LM  MHÑIntraocular Pressure ANonly /drug eff /rad eff MNG11.697.600 XSOCULAR TENSION FXÑEye; ÑGLAUCOMA; ÑOcular Hypertension; ÑTONOMETRY LH LS LX; ; ;  MSPatient care procedures performed during the operation that are ancillary to the actual surgery. Includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests. PM80 HN80 MHÑIntraoperative Care ANduring surg; only /econ /methods /psychol /stand /trends /vet; DF: INTRAOP CARE MNE4.365 XSPeroperative Care LH LS  MSDisorders affecting patients during surgery. They may or may not be related to the disease for which the surgery is done. They may or may not be direct results of the surgery. PM80 HN80 MHÑIntraoperative Complications ANdo not use /chem ind /compl /congen /embryol /enzymol /familial /hist /immunol; for iatrogenic compl (as surg inj) or other: TN 179; coord NIM with Cat E4 term (IM) with or without /adv eff depending on its relation to the intraop compl: for policy apply principles of POSTOPERATIVE COMPLICATIONS, Manual 23.24+; DF: INTRAOP COMPL MNC23.612 XSPeroperative Complications FXÑSurgery, Operative LH LS LX  MSThe period during a surgical operation. HN(80) MHÑIntraoperative Period ANalmost never IM; only /mortal; DF: INTRAOP PERIOD MNE4.375 XSPeroperative Period DMÑSurgery, Operative LH LS LM  MSSpontaneous loss of intrauterine devices from the uterus. PM78; was see under INTRAUTERINE DEVICES 1975-77 HN78(75); was see under INTRAUTERINE DEVICES 1975-77 MHÑIntrauterine Device Expulsion ANonly /adv eff; DF: IUD EXPULSION PIIntrauterine Devices (67-74) MNE2.197.520 LH  PM67 HN67 MHÑIntrauterine Devices ANonly /adv eff /class /econ /stand /supply /util (if by MeSH definition); coord IM with material of which device is made (NIM); pregnancy despite use of IUD = IUD with no qualif, not IUD /adv eff; DF: IUD PIContraceptive Devices (66) MNE7.190.250.520 XSCONTRACEPTIVE DEVICES, INTRAUTERINE; Pessaries, Intracervical; Pessaries, Intrauterine LH LS; ;  MSIntrauterine contraceptive devices that depend on the release of metallic copper. PM78 HN78 MHÑIntrauterine Devices, Copper ANonly /adv eff /class /econ /stand /supply /util (if by MeSH definition); pregn despite use: see note under INTRAUTERINE DEVICES; DF: IUD COPPER PIIntrauterine Devices (67-77); Intrauterine Devices, Medicated (75-77) MNE7.190.250.520.520.520 LH  MSIntrauterine devices that release contraceptive agents. PM79; was see under INTRAUTERINE DEVICES 1975-78 HN79(75); was see under INTRAUTERINE DEVICES 1975-78 MHÑIntrauterine Devices, Medicated AN╥IUDs that release contraceptive agents╙; coord IM with specific contraceptive agent (IM); only /adv eff /class /econ /stand /supply /util (if by MeSH definition); pregn despite use: see note above; DF: IUD MEDICATED PIIntrauterine Devices (67-74) MNE7.190.250.520.520 LH  MHÑIntrinsic Factor AN/biosyn /defic /physiol permitted RN9008-12-2 MND12.776.395.560.494; D19.461.543.494 FXÑParietal Cells, Gastric LH LX  MSNon-coding, intervening sequences of DNA that are transcribed, but are removed from within the primary gene transcript and rapidly degraded, during maturation of messenger RNA. Most genes in the nuclei of eukaryotes contain introns, as do mitochondrial and chloroplast genes. OLsearch BASE SEQUENCE 1981-86 PM87; INTERVENING SEQUENCES & INTRONS were see BASE SEQUENCE 1981-86 HN87; INTERVENING SEQUENCES & INTRONS were see BASE SEQUENCE 1981-86 MHÑIntrons ANonly /drug eff /rad eff PIBase Sequence (77-86); Genes (77-80); Genes, Structural (77-86) MNG5.331.112.505; G6.184.130.505 XSIntervening Sequences LH LS  MSA state in which attention is largely directed inward upon one's self. PM68 HN68 MHÑIntroversion (Psychology) ANno qualif; DF: INTROVERSION PIPersonality (66-67) MNF1.752.747.511; F2.739.794.438 LH  PM66 HN66 MHÑIntubation ANdo not use /util except by MeSH definition; for intub proced in dis, coord with dis /ther, not /surg; esophageal intub = ESOPHAGUS (IM) + INTUBATION (IM), not INTUBATION, GASTROINTESTINAL; esophageal obturator airway = ESOPHAGUS (IM) + INTUBATION /instrum (IM); nasogastric intub = INTUBATION, GASTROINTESTINAL MNE5.497 LH  PM66; DUODENAL INTUBATION was heading 1963-65 HN66; DUODENAL INTUBATION was heading 1963-65 MHÑIntubation, Gastrointestinal ANdo not use /util except by MeSH definition; for intub in dis, coord with dis /ther, not /surg; esophageal intub & esophageal obturator airway do not go here: see note above; nasogastric intub goes here (do not coord with NOSE) MNE5.497.412 FXÑEnteral Feeding LH LX  MHÑIntubation, Intratracheal ANdo not use /util except by MeSH definition; for intub in dis, coord with dis /ther, not /surg MNE5.497.578 FXÑTrachea LH LX  MHÑIntussusception AN= invagination; coord IM with specific precoord intestinal dis term; ileocolic intussusception = ILEAL DISEASES (IM) + INTUSSUSCEPTION (IM) but not also COLONIC DISEASES; ileocecal intussusception = ILEOCECAL VALVE (IM) + INTUSSUSCEPTION (IM) + ILEAL DISEASES (NIM) but not also CECAL DISEASES; cecocolic intussusception = CECAL DISEASES (IM) + INTUSSUSCEPTION (IM) but not also COLONIC DISEASES MNC6.405.469.531.577 LH  MHÑInulin ANusually /diag use in KIDNEY FUNCTION TESTS; do not confuse with INSULIN RN9005-80-5 MND9.203.698.350.500 LH  MSMaterials and equipment in stock; includes drugs in pharmacies, blood in blood banks, etc. HN(78) MHÑInventories, Hospital ANonly /econ /methods /stand /trends MNN2.278.354.608.310; N4.452.442.475.310 DMÑMaterials Management, Hospital LH LM  MSAn aberration in which a chromosomal segment is deleted and reinserted in the same place but turned 180 degrees from its original orientation, so that the gene sequence for the segment is reversed with respect to that of the rest of the chromosome. OLsearch CHROMOSOME ABERRATIONS 1969-74 PM78; was see under CHROMOSOME ABERRATIONS 1969-77 HN78(75); was see under CHROMOSOME ABERRATONS 1969-77 MHÑInversion (Genetics) ANno qualif; DF: INVERSION PIChromosome Aberrations (68-74); Chromosome Abnormalities (66-67) MNG5.148.266.445 LH  PM67 HN67 MHÑInvertebrate Hormones ANdo not use /analogs /defic PIHormones (66); Insects (66) MND6.472.445 XSHORMONES, INVERTEBRATE LH LS  OLuse INVERTEBRATES to search BRACHIOPODA back thru 1966 & MESOZOA back thru 1977 PMBRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85 HNBRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85 MHÑInvertebrates ANavoid: too general; when necessary to use, IM with only /anat /class /embryol (with caution) /enzymol /growth /immunol /metab /microbiol /parasitol (with caution) /physiol; Nemertina goes here CATALOG: /geog /form MNB1 XSBrachiopoda; Mesozoa LH LS;  MSUse for articles on the investing of funds for income or profit. PM68 HN68(64) MHÑInvestments ANonly /class /legis /trends MNN3.219.702 LH  MSN-Acetyl-N-(3-amino-2,4,6-triiodophenyl)-2-methyl-beta-alanine. Iodobenzene derivative used as a contrast medium. Synonym: Cholebrine. HN(75) MHÑIocetamic Acid AND25-26 qualif; /analogs NIM only RN16034-77-8 PIAlanine (73-74); Iodobenzenes (73-74) MND2.455.426.559.389.454.270; D2.455.526.581.496.270; D26.298.320 DMÑIodobenzenes LH LM  MS3-Acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoic acid. Contrast media. Synonym: Uromiro. HN(75) MHÑIodamide AND25-26 qualif; /analogs NIM only RN440-58-4 PIAcetamides (74); Iodobenzoates (74) MND2.241.223.106.530.718.380; D26.298.350 DMÑIodobenzoates LH LM  HN(71) MHÑIodates ANdo not use /analogs /biosyn /defic /physiol PIIodine (66-70) MND1.248.497.158.507.412; D1.396.661.317; D1.655.498.423 DMÑIodine LH LM  MSIodide:hydrogen-peroxide oxidoreductase. A hemeprotein which catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. PM86; was see under PEROXIDASES 1976-85 HN86(76); was see under PEROXIDASES 1976-85 MHÑIodide Peroxidase ANdo not use /analogs; /defic: consider also IODOTYROSINE /metab (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) + CRETINISM RNEC 1.11.1.8 PIIodides (73-75); Iodotyrosine (73-75); Peroxidases (73-75) MND8.586.682.732.525 XSIodinase; Iodotyrosine Deiodase; Thyroid Peroxidase; Thyroxine 5'-Deiodinase LH LS; ; ;  MHÑIodides ANdo not use /analogs /biosyn /defic /physiol; inorganic cpds or iodide ion only MND1.248.497.158.507.579; D1.396.661.388 XUÑSodium Iodide LH LU  MHÑIodine ANI-127; /defic /physiol permitted; do not use /analogs /biosyn RN7553-56-2 MND1.248.497.158.507; D1.268.438; D1.396.661; D1.937.428 XUÑIodates; ÑIodophors LH LU;  OLsearch IODINE ISOTOPES, DIAGNOSTIC under IODINE RADIOISOTOPES /DU 1966-76 PM/diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65 HN/diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65 MHÑIodine Isotopes ANNIM; no qualif MND1.396.661.459; D1.496.448 LH  OLsearch IODINE ISOTOPES 1966-73; search IODINE ISOTOPES, DIAGNOSTIC under IODINE RADIOISOTOPES /DU 1966-76 PM74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65 HN74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65 MHÑIodine Radioisotopes ANI-117 thru I-139 except I-127; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) MND1.396.661.530; D1.496.448.496; D1.496.749.474 LH  MHÑIodipamide AND25-26 qualif RN606-17-7 MND26.298.388 XSAdipiodon LH LS  MHÑIodized Oils AND25-26 qualif MND1.396.661.601; D10.516.627.700.550; D26.298.423; J1.740.700.550 XSOILS, IODIZED XUÑLipiodol LH LS LU  MS2-Iodoacetamide. A sulfhydryl reagent. Its actions are similar to those of iodoacetate. HN(75) MHÑIodoacetamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN144-48-9 PIAmides (72-74); Iodoacetates (69-74) MND2.65.64.400; D2.241.81.38.108.400; D2.241.81.38.209.495.400; D8.373.830.578.400 DMÑIodoacetates LH LM  MHÑIodoacetates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.38.209.495; D8.373.830.578 XUÑIodoacetamide LH LU  PM73 HN73(72) MHÑIodobenzenes ANdo not use /analogs /biosyn /defic /physiol PIBenzene Derivatives (68-71) MND2.455.426.559.389.454; D2.455.526.581.496 XUÑIocetamic Acid; ÑIophendylate; ÑTyropanoate LH LU; ;  PM74 HN74(72) MHÑIodobenzoates ANdo not use /analogs /biosyn /defic /physiol PIBenzoates (66-71) MND2.241.223.106.530 XUÑIodamide; ÑIoglycamic Acid; ÑMetrizoate; ÑTriiodobenzoic Acids LH LU; ; ;  MS5-Chloro-7-iodo-8-quinolinol. A potentially neurotoxic 8-hydroxyquinoline derivative long used as topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. Synonyms: Vioform. HN(83)63 MHÑIodochlorhydroxyquin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN130-26-7 MND3.438.810.350.350.400; D21.370.107.651 XSChloroiodoquine; Clioquinol; Iodochloroxyquinoline DMÑHydroxyquinolines LH LS; ; LM  OLuse IODOHIPPURIC ACID to search RADIO-HIPPURAN & HIPPURAN back thru 1966 PM66; HIPPURAN was see under IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65 HN66; RADIO-HIPPURAN was see under IUDOHIPPURIC ACID 1966-77; HIPPURAN was see IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65 MHÑIodohippuric Acid AND25-26 qualif; Hippuran goes here RN147-58-0 MND2.65.277.431.579; D2.241.223.106.162.431.496; D2.241.607.360.579; D26.298.459 XSIodobenzoylglycine; Radio-Hippuran; SODIUM IODOHIPPURATE LH LS; ;  MSComplex of iodine and non-ionic surface-active agent acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. Synonyms: Iosan; Biopal; Tamed Iodine. HN(75) MHÑIodophors ANdo not use /analogs /biosyn /defic /physiol PIIodine (71-74) MND1.396.661.650 DMÑIodine LH LM  PM72 HN72(68) MHÑIodoproteins ANdo not use /analogs /defic PIIodine (66-67); Proteins (66-67) MND12.776.486 FXÑSERUM ALBUMIN, RADIO-IODINATED LH LX  MHÑIodopyracet AND25-26 qualif RN300-37-8 MND3.383.725.791.496.371; D26.298.495.371 XSDiodone LH LS  PM68; PROPYLIODONE was see under CONTRAST MEDIA 1963-74 HN68 MHÑIodopyridones AND25-26 qualif PIContrast Media (66-67) MND3.383.725.791.496; D26.298.495 XUÑPropyliodone LH LU  PM72 HN72(68) MHÑIodotyrosine RN29592-76-5 PIThyroid Hormones (66-67); Tyrosine (66-67) MND6.472.931.388; D12.125.72.917.496 LH  MS3,3'-[Oxybis((1-oxo-2,1-ethanediyl)imino)]bis(2,4,6-triiodo-benzoic acid). Radiopaque medium; a mixture of its meglumine and sodium salts is used to visualize the biliary tract. Synonyms: BE 419; Biligram; Bilivistan; SH 419. HN(75) MHÑIoglycamic Acid AND25-26 qualif; /analogs NIM only RN2618-25-9 PIAmides (66-74); Benzoates (66-73); Glycolates (66-74); Iodobenzoates (74) MND2.241.223.106.530.718.400; D26.298.510 XSIoglycamide DMÑIodobenzoates LH LS LM  MSN,N'-bis(2,3-dihydroxypropyl)-5- (N-(2,3-dihydroxypropyl)acetamido) -2,4,6-triiodoisophthalamide. An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. PM87 HN87 MHÑIohexol AND25-26 qualif RN66108-95-0 PITriiodobenzoic Acids (72-86) MND2.241.223.106.530.718.403; D26.298.525 LH  MSVoltage-dependent, ion-selective pores of membranes. PM79 HN79 MHÑIon Channels ANIM; A 11 qualif except /cytol; coord IM with specific ion /metab (IM); sodium pump can go here PICell Membrane (66-78); Electric Conductivity (68-78); Membrane Potentials (67-78) MNA11.507 XSCalcium Channels; Membrane Channels; Potassium Channels; Sodium Channels FXÑCalcium Channel Blockers LH LS; ; ; LX  MSThe use of special solid substances called ion exchange resins that contain certain loosely held small ions that easily exchange places with certain other small ions present in solutions washed over the resins. The technic is used in water purification and in research and in industry. MHÑIon Exchange ANNIM; no qualif MNG6.184.513; H1.181.529.479 LH  MSHigh molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions with either cations or anions. Synonym: Amberlite. MHÑIon Exchange Resins AND25-26 qualif MND26.572 XUÑAnion Exchange Resins; ÑCation Exchange Resins LH LU;  MSSubstances, usually antibiotics, which have the ability to carry mono- or divalent cations across lipid barriers including artificial and biological membranes. They act as uncoupling agents by preventing oxidative phosphorylation but without inhibiting respiration. PM76 HN76 MHÑIonophores ANdo not use /analogs /biosyn /defic /physiol; A-23187 & X 537 A (see LASALOCID) are available as specific ionophores PIAntibiotics (66-75); Biological Transport (66-75); Uncoupling Agents (72-75) MND8.373.936.500 LH  MHÑIons ANavoid: too general; GEN; no qualif; ╥ionic strength╙ = OSMOLAR CONCENTRATION; ionization chamber: index under RADIOMETRY /instrum MND1.248.497 LH  MSTherapeutic introduction of ions of soluble salts into tissues by means of electric current. It has nothing to do ION EXCHANGE or AIR IONIZATION, neither of which requires current. Synonyms: ion therapy; galvanoionization; ionic medication; medical ionization. MHÑIontophoresis ANdo not use /util except by MeSH definition MNE2.780.335.508; E5.300.650; H1.181.529.307.437.575 LH  MSN,N'-Bis(2-hydroxy-1-(hydroxymethyl)ethyl) -2,4,6-triiodo-5-lactamidoisophthalamide. An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures. Its non-ionic, water-soluble properties result in optimal imaging and reduced toxicity. PM87 HN87 MHÑIopamidol AND25-26 qualif RN62883-00-5 PIIothalamic Acid (68-74); Iothalamic Acid/analogs & derivatives (75-86) MND2.241.223.106.530.718.410; D26.298.566.450 LH  MHÑIopanoic Acid AND25-26 qualif RN96-83-3 MND2.455.426.559.389.454.385; D2.455.526.581.496.385; D26.298.531 XSIodopanoic Acid LH LS  MSEthyl-10(p-iodophenyl)undecylate. A mixture of isomers used as contrast medium, mainly for brain and spinal cord visualization. Synonyms: Ethiodan; Mulsopaque; Myelodil; Myodil; Neurotrast; Pantopaque. HN(75) MHÑIophendylate AND25-26 qualif; /analogs NIM only RN99-79-6 PIBenzene (66-67); Benzene Derivatives (68-72); Fatty Acids (66-74); Iodobenzenes (73-74) MND2.455.426.559.389.454.400; D2.455.526.581.496.400; D26.298.545 DMÑIodobenzenes LH LM  MS3-(Acetylamine)2,4,6-triiodo-5-[(methylamine) carbonyl]-benzoic acid with 1-deoxy-1-(methylamino)-D-glucitol. Radiopaque medium used for urography, angiography, venography, and myelography; highly viscous and bound to plasma proteins. Synonyms: Cysto-Conray; Conray; Contrix; Retro-Conray. OLuse IOTHALAMATE MEGLUMINE to search MEGLUMINE IOTHALAMATE back thru 1975 PM82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77 HN82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77 MHÑIothalamate Meglumine AND25-26 qualif RN13087-53-1 PIAdipic Acids (66-77); Iothalamic Acid (66-77); Sorbitol (66-77) MND2.33.800.813.550.600; D2.241.223.106.530.718.412; D9.203.67.342.600.600; D9.203.853.813.550.600; D26.298.566.470 XSIotalamate Meglumine; Iothalamic Acid Methylglucamine; Meglumine Iothalamate LH LS; ;  PM66 HN66(63) MHÑIothalamic Acid AND25-26 qualif RN2276-90-6 MND2.241.223.106.530.718.415; D26.298.566 XSIotalamic Acid; Methalamic Acid LH LS;  MHÑIowa MNZ1.107.567.875.400 LH  MSN-(2-Hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6 -triiodo-3-(N-methylacetamido)-5 -(methylcarbamoyl)benzamido) acetamido)isophthalamic acid. An effective, low-osmolar, ionic contrast medium used in various radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. PM87 HN87 MHÑIoxaglic Acid ANdo not use /biosyn /defic /physiol RN59017-64-0 PIBenzoates (66-71); Triiodobenzoic Acids (72-86) MND2.241.223.106.530.718.425; D26.298.575 XSIoxaglate; Ioxaglate, Meglumine; Ioxaglate, Sodium LH LS; ;  MSThe dried rhizomes of two different species, C. ipecacuanha and C. acuminata of Cephaelis (or Uragoga) of the Rubiaciae; they contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES; used widely as emetics, expectorants and amebicides, but may cause cardiac and renal damage. HNwas in Cat B & D 1966-77 MHÑIpecac ANdrug only; D25-26 qualif; X refs below are plant species yielding ipecac RN8012-96-2 MND3.132.442; D23.555.580 XSCephaelis; Uragoga LH LS;  MHÑIpodate AND25-26 qualif RN5587-89-3 MND2.455.426.559.389.454.450; D2.455.526.581.496.450; D26.298.602 XSIopodate; Sodium Ipodate LH LS;  HN(72) MHÑIprindole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5560-72-5 PIAntidepressive Agents (66-71); Indoles (66-71) MND3.438.473.469; D15.236.122.140.528 DMÑIndoles LH LM  MS5-Allyl-5-(2-hydroxypropyl)barbituric acid. A derivative of barbituric acid that isomerizes easily, totally lacks the hypnotic properties of other barbiturates and has instead tranquilizing activity; it is used in the treatment of headaches and as a tranquilizer. Synonyms: Axeen; Centralgyl; Centralgil; HH 184; Vasalgin; Axeen-Hommel. HN(76) MHÑIpronal ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2537-29-3 PIBarbiturates (70-75); Alcohol, Propyl (73-74) /AA(75); Allyl Compounds (73-75) MND3.383.742.698.253.370; D15.236.872.331.504 DMÑBarbiturates LH LM  MHÑIproniazid ANdo not use /biosyn /defic /physiol RN54-92-2 MND2.442.372; D3.66.349.390; D3.383.725.394.414; D8.373.616.347; D15.236.122.627.347; D20.338.499.372 LH  MS2-Isopropyl-1-methyl-5-nitroimidazole. An antihistomonal agent with low toxicity. It also promotes growth and feed utilization in poultry. Synonyms: Ipropran; NSC 109212; RO 7-1554. HN(75) MHÑIpronidazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN14885-29-1 PIImidazoles (66-73); Nitroimidazoles (74) MND2.640.672.400; D3.383.374.658.400; D21.370.527 DMÑNitroimidazoles LH LM  MHÑIran MNZ1.252.245.455; Z1.630.500 LH  MHÑIraq MNZ1.252.245.481; Z1.630.520 LH  MHÑIreland ANIrish Free State; Eire; capital, Dublin; differentiate from NORTHERN IRELAND MNZ1.542.467 XSEire LH LS  MHÑIridium ANIr-193; do not use /analogs /biosyn /defic /physiol; Ir-191 = IRIDIUM (IM) + ISOTOPES (NIM); Ir-182-190, 192, 194-198 = IRIDIUM (IM) + RADIOISOTOPES (IM) RN7439-88-5 MND1.268.445; D1.552.401 LH  MSLarge DNA viruses of insects and vertebrates. OLuse IRIDOVIRIDAE to search IRIDOVIRUSES back thru 1978 PM81; was IRIDOVIRUSES 1978-80; AFRICAN SWINE FEVER VIRUS was see under DNA VIRUSES 1975-77 HN81; was IRIDOVIRUSES 1978-80 MHÑIridoviridae ANdo not use /blood-csf-urine /cytol; infection: coord NIM with VIRUS DISEASES (IM) PIDNA Viruses (66-77); Insect Viruses (66-77) MNB4.525.490; B4.909.204.490 XUÑAfrican Swine Fever Virus LH LU  MHÑIris ANinflammation = IRITIS or IRIDOCYCLITIS see UVEITIS, ANTERIOR; neopl: coord IRIS DISEASES (IM) + UVEAL NEOPLASMS (IM) + histol type of neopl (IM); color = EYE COLOR MNA9.371.60.513 LH  PM81 HN81 MHÑIris Diseases PIIris (66-80); Uveal Diseases (66-80) MNC11.941.500 LH  MHÑIritis MNC11.941.500.547 LH  PM/metabolism was IRON METABOLISM 1963-65 HN/metabolism was IRON METABOLISM 1963-65 MHÑIron ANFe-56; Fe(II) = FERROUS COMPOUNDS, Fe(III) = FERRIC COMPOUNDS; /physiol permitted; do not use /analogs /biosyn; /defic: permitted but consider IRON DEFICIENCY ANEMIA; pneumoconiosis caused by iron particles = SIDEROSIS; see below for IRON ISOTOPES & IRON RADIOISOTOPES RN7439-89-6 MND1.248.497.300.333.496; D1.268.451; D1.552.412; D1.937.455 FXÑFerritin; ÑHemosiderin; ÑTransferrin LH LX; ;  MHÑIron Chelates ANdo not use /analogs /biosyn /defic /physiol MND1.552.412.470 FXÑChelating Agents LH LX  MHÑIron Isotopes ANFe-54, 57, 58; NIM; no qualif MND1.496.473; D1.552.412.581 LH  OLsearch IRON ISOTOPES 1966-73 PM74 HN74 MHÑIron Radioisotopes ANFe-52, 53, 55, 59-61; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) MND1.496.473.498; D1.496.749.514; D1.552.412.636 LH  MHÑIron-Dextran Complex ANdo not use /analogs /biosyn /defic /physiol RN9004-66-4 MND1.552.412.525; D19.461.543.321.498 XSDextran-Iron Complex LH LS  MSA group of proteins possessing only the iron-sulfur complex as the prosthetic group. These proteins participate in all major pathways of electron transport: photosynthesis, respiration, hydroxylation and bacterial hydrogen and nitrogen fixation. HN(77) MHÑIron-Sulfur Proteins AN/biosyn /physiol permitted; do not use /analogs PIIron (73-76); Metalloproteins (73-76); Sulfur (73-76) MND12.776.157.435; D12.776.556.580 DMÑMetalloproteins LH LM  MSThe washing of a body cavity or surface by flowing solution which is inserted and then removed. Any drug in the irrigation solution may be absorbed. MHÑIrrigation ANIM only as general procedure; NIM for irrigation of specific organ or site; do not use /util except by MeSH definition; includes LAVAGE but GASTRIC LAVAGE is available MNE5.510 XSDouching; Lavage LH LS;  MSAbnormal or excessive excitability with easily triggered anger, annoyance, or impatience. HN(85) MHÑIrritable Mood ANonly /drug eff /physiol MNF1.470.610 XSMood, Irritable DMÑEmotions LH LS LM  MSDrugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants. OLuse IRRITANTS to search RUBEFACIENTS & VESICANTS back thru 1966 HNRUBEFACIENTS & VESICANTS were see under IRRITANTS 1963-79 MHÑIrritants AND25-26 qualif; note X ref COUNTERIRRITANTS but use no qualif with it (i.e., adv eff of a counterirritant is COUNTERIRRITANTS, not COUNTERIRRITANTS /adv eff since this would print as a misleading IRRITANTS /adv eff) MND5.569.734.498; D26.585 XSCounterirritants; PUSTULANTS; Rubefacients; Vesicants LH LS; ; ;  OLsearch INDOLES 1966-74 HN(75) MHÑIsatin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN91-56-5 MND3.438.473.525 DMÑIndoles LH LM  MHÑIschemia ANIM; coord with specific organ /blood supply (IM): Manual 23.20; note ISCHEMIC HEART DISEASE below; CEREBRAL ISCHEMIA and CEREBRAL ISCHEMIA, TRANSIENT are also avaible MNC14.907.553 FXÑBlood Circulation LH LX  MHÑIschium MNA2.835.232.611.548 LH  MS2-Hydroxyethanesulfonic acid. Colorless, syrupy, strongly acidic liquid. Forms detergents with oleic acid. Irritating to skin and mucous membranes in humans. HN(75) MHÑIsethionic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-36-8 PIAlkyl Sulfonates (73-74); Alcohol, Ethyl (73-74) MND2.241.866.540.121.500; D2.455.326.146.92.500 XSHydroxyethylsulfonic Acid DMÑAlkyl Sulfonates LH LS LM  MSA monotheistic religion promulgated by the Prophet Mohammad with Allah as the deity. OLuse ISLAM to search MOHAMMEDANISM back thru 1966 PM76; was MOHAMMEDANISM 1963-75 HN76; was MOHAMMEDANISM 1963-75 MHÑIslam ANonly /hist MNK1.844.275 XSMohammedanism; Muslims LH LS;  MSIrregular microscopic structures, varying from a few to hundreds of cells, scattered throughout the pancreas and comprising its endocrine portion; there are three cell types: alpha--secreting glucagon, beta--secreting insulin, delta--secreting gastrin. MHÑIslands of Langerhans ANalso called islet cells; do not confuse with LANGERHANS CELLS (skin); delta cells go here; neopl = ISLET CELL TUMOR but see note there MNA3.734.414; A6.407.414 XSNesidioblasts; Pancreas, Endocrine; Pancreatic Alpha Cells; Pancreatic Beta Cells LH LS; ; ;  MSA tumor of the islands of Langerhans which may occur anywhere throughout the pancreas. MHÑIslet Cell Tumor ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with PANCREATIC NEOPLASMS (IM); note ALPHA CELL TUMOR see GLUCAGONOMA, BETA CELL TUMOR see INSULINOMA but delta cell tumor = DIARRHEOGENIC TUMOR or SOMATOSTATINOMA MNC4.557.576.600 XSNesidioblastoma XUÑDiarrheogenic Tumor; ÑGlucagonoma; ÑInsulinoma; ÑSomatostatinoma LH LS LU; ; ;  MSGlycogen 6-glucanohydrolase. Hydrolyzes 1,6-alpha-glucosidic branch linkages in glycogen, amylopectin and their beta-limit dextrins. Distinguished from pullulanase (EC 3.2.1.41) by its inability to attack pullulan and by feeble action of alpha-limit dextrins. Distinguished from amylopectin 6-glucanohydrolase (EC 3.2.1.69) by action on glycogen. With EC 3.2.1.69 gives the activity called ╥debranching enzyme╙. HN(75) MHÑIsoamylase ANdo not use /analogs; do not confuse with amylase isoenzymes (index under AMYLASES (IM) + ISOENZYMES (IM) ) RNEC 3.2.1.68 PIGlycoside Hydrolases (74); Polysaccharides (74) MND8.586.277.450.585 DMÑGlycoside Hydrolases LH LM  PM66 HN66(64) MHÑIsoantibodies ANonly /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine MND24.611.125.664 XSAlloantibodies FXÑBlood Groups LH LS LX  PM67 HN67(64) MHÑIsoantigens ANonly /admin /adv eff /anal /csf /class /genet /immunol /isol /rad eff /tox /urine MND24.611.216.705 XSAlloantigens FXÑBlood Groups LH LS LX  MHÑIsocarboxazid ANdo not use /biosyn /defic /physiol RN59-63-2 MND8.373.616.398; D15.236.122.627.398 LH  PM65 HN65(63) MHÑIsocitrate Dehydrogenase ANdo not use /analogs RNEC 1.1.1.41 MND8.586.682.47.497 LH  MSthreo-D-Isocitrate glyoxylate-lyase. A key enzyme in the glyoxylate cycle. Catalyzes the conversion of isocitrate to succinate and glyoxylate. EC 4.1.3.1. HN(77) MHÑIsocitrate Lyase ANdo not use /analogs RNEC 4.1.3.1 PIIsocitrates (73-76); Ketoacid-Lyases (73-76) MND8.586.520.567.525 XSIsocitrase; Isocitratase DMÑKetoacid-Lyases LH LS; LM  PM73 HN73(71) MHÑIsocitrates ANdo not use /analogs /biosyn /defic /physiol PITricarboxylic Acids (66-70) MND2.241.81.901.434.498 LH  MS2-(4-Amino-4-carboxybutyl)-1-(5-amino-5-carboxypentyl)-3,5-bis(3-amino-3-carboxypropyl)pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring. HN(75) MHÑIsodesmosine ANdo not use /defic /physiol; /analogs NIM only RN991-01-5 PIAmino Acids (72-74); Pyridinium Compounds (70-74) MND3.383.725.762.500; D12.125.72.415 DMÑAmino Acids LH LM  PM74 HN74(70) MHÑIsoelectric Focusing ANonly /instrum /methods /stand PIElectrophoresis (66-69) MNE5.196.401.663; H1.181.278.414.663; H1.181.529.307.437.663 XSElectrofocusing LH LS  MSThe pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum. HN(75) MHÑIsoelectric Point ANNIM; no qualif MNH1.181.529.428.500 DMÑHydrogen-Ion Concentration LH LM  PM67 HN67(65) MHÑIsoenzymes ANIM; coord with specific enzyme (IM); do not use /analogs MND8.586.348 LH  MS3,4-Dihydroxy-alpha-[1-(isopropylamino)propyl]benzyl alcohol. Adrenergic beta-2 stimulant used as bronchodilator for emphysema, bronchitis and asthma; has sympathomimetic side-effects. Synonyms: Asthmalitan; Bronkometer; Bronkosol; Dilabron; Neoisuprel; Numotac; WIN 3406. HN(75) MHÑIsoetharine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN530-08-5 PIAmino Alcohols (69-74); Catechols (69-74); Propylamines (72-74) MND2.33.329.400; D2.92.63.400; D16.116.490; D16.893.116.348.425 XSEtyprenalinum DMÑAmino Alcohols LH LS LM  MS3-Phenylchromones. Isomeric form of flavones in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. HN(75) MHÑIsoflavones ANdo not use /analogs /biosyn /defic /physiol PIFlavones (66-74) MND3.438.150.266.450.400 DMÑFlavones LH LM  MS1- chloro-2,2,2-trifluoroethyl difluoromethyl ether. A stable, non-explosive inhalation anesthetic, relatively free from significant side effects. Synonym: Forane. PM87; was see under METHYL ETHERS 1975-86 HN87(75); was see under METHYL ETHERS 1975-86 MHÑIsoflurane ANdo not use /biosyn /defic /physiol RN26675-46-7 PIEthers (71-74); Hydrocarbons, Fluorinated (74) MND2.355.601.570; D14.166.519 LH  MHÑIsoflurophate ANdo not use /biosyn /defic /physiol RN55-91-4 MND2.705.364; D8.373.275.581; D8.373.745.500; D16.698.410.505 XSDFP; DIISOPROPYLFLUOROPHOSPHATE; Fluostigmine LH LS; ;  MHÑIsoleucine AN/biosyn /defic /physiol permitted RN7004-09-3 MND12.125.142.383; D12.125.70.577 LH  MSL-Isoleucine:tRNA-Ile ligase (AMP-forming). Activates isoleucine with its specific transfer RNA. HN(75) MHÑIsoleucyl T RNA Synthetase ANdo not use /analogs; note spacing RNEC 6.1.1.5 PIAmino Acyl T RNA Synthetases (72-74); Isoleucine (72-74) MND8.586.464.136.450 DMÑAmino Acyl T RNA Synthetases LH LM  MS6-0-alpha-Glucopyranosyl-D-glucose. A disaccharide consisting of two glucose units in an alpha (1-6) glycosidic linkage. HN(79) MHÑIsomaltose ANdo not use /biosyn /defic /physiol; /analogs NIM only RN499-40-1 PIDisaccharides (66-78) MND9.203.698.365.410; D9.203.698.629.305.320 DMÑDisaccharides LH LM  MHÑIsomerases ANGEN only; see Tree D8 under ISOMERASES & choose the most specific; do not use /analogs /defic /physiol RNEC 5. MND8.586.399 XUÑ2-Acetolactate Mutase; ÑChorismate Mutase; ÑEpimerases; ÑMethylmalonyl CoA Mutase; ÑRacemases; ÑSteroid Isomerases LH LU; ; ; ; ;  PM74 HN74(71) MHÑIsomerism ANNIM; no qualif PIChemistry, Organic (66-70) MNH1.181.404.705 LH  MSMuscular contractions characterized by increase in tension without change in length. OLuse ISOMETRIC CONTRACTION to search EXERCISE, ISOMETRIC back thru 1977 HN(84); was EXERCISE, ISOMETRIC see under EXERTION 1977-83 MHÑIsometric Contraction ANno qualif PIExertion (66-76) MNG11.427.661.472 XSExercise, Isometric DMÑMuscle Contraction LH LS LM  PM/adverse effects /poisoning /toxicity were ISONIAZID TOXICOLOGY 1963-65 HN/ad-poi-tox was ISONIAZID TOXICOLOGY 1963-65 MHÑIsoniazid ANdo not use /biosyn /defic /physiol RN54-85-3 MND2.442.436; D3.66.349.410; D3.383.725.394.582; D20.338.499 XSISONICOTINIC ACID HYDRAZIDE LH LS  OLuse ISONICOTINIC ACIDS to search ISONICOTINIC ACID back thru 1966 PM75; was ISONICOTINIC ACID 1963-74 HN75; was ISONICOTINIC ACID 1963-74 MHÑIsonicotinic Acids ANdo not use /analogs /defic /physiol; hydrazide = ISONIAZID MND3.66.349; D3.383.725.394 XUÑProthionamide; ÑPyridoxic Acid LH LU;  PM68 HN68 MHÑIsonipecotic Acids ANdo not use /analogs /biosyn /defic /physiol MND3.66.399; D3.383.621.349 XUÑDiphenoxylate; ÑPirinitramide LH LU;  MSN(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is a member of the cytokinin family of plant growth regulators. HN(75) MHÑIsopentenyladenosine ANdo not use /defic /physiol RN7724-76-7 PIAdenosine (72-74); Alkenes (72-74) MND11.303.760.265.350; D13.570.583.138.500; D13.570.800.96.500 DMÑAdenosine LH LM  MSHypoxanthene riboside complexed with p-acetamidobenzoic acid-(2-dimethylamino-1-methylethyl)-ester. An Alkylamino-alcohol complex of inosine that may have some antiviral activity, probably due to its inhibition of viral protein synthesis and facilitation of the host's mRNA synthesis. Synonyms: NP 113; NPT 10381; Viruxan. HN(76) MHÑIsoprinosine ANdo not use /biosyn /defic /physiol RN36703-88-5 PIAcetanilides (74) /AA (75); Dimethylamines (74-75); Inosine (74) /AA (75) MND2.65.199.92.450; D13.570.583.616.450; D13.570.800.573.450; D20.388.651 XSInosiplex; Methisoprinol DMÑInosine LH LS; LM  PM65 HN65 MHÑIsopropamide Iodide ANdo not use /biosyn /defic /physiol RN71-81-8 MND2.92.102.450; D2.675.276.450; D16.653.513 LH  MSIsopropyl 1-thio-beta-D-galactopyranoside. HN(75) MHÑIsopropyl Thiogalactoside ANdo not use /biosyn /defic /physiol; /analogs NIM only RN367-93-1 PIGalactose (74); Thioglycosides (74) MND9.203.408.320.820.500; D9.203.408.903.600.500 DMÑThioglycosides LH LM  MS4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol. Isopropyl analog of epinephrine; beta sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc.; used mainly as bronchodilator and heart stimulant. Synonyms: Aludrone; Isorenin; Isuprel; Isopropydrin; Mistaprel; Norisodrine; Novodrine; Propal; Suscardia. MHÑIsoproterenol ANdo not use /biosyn /defic /physiol RN7683-59-2 MND2.33.329.291.439; D2.92.63.291.439; D2.92.311.649; D16.116.498; D16.893.116.348.436; D18.222.863.516 XSISOPRENALINE; Isopropylarterenol LH LS;  OLuse ISOQUINOLINES to search TYLOCREBRINE back thru 1972 PM69; TYLOCREBRINE was heading 1973-84 HN69; TYLOCREBRINE was heading 1972-84 (Prov 1972) MHÑIsoquinolines ANdo not use /analogs /biosyn /defic /physiol PIQuinolines (66-68) MND3.438.531 XUÑDebrisoquin; ÑSalsoline Alkaloids; ÑTretoquinol LH LU; ;  MS1,4:3,6-Dianhydro D-glucitol. Chemically inert osmotic diuretic used mainly to treat hydrocephalus; also used in glaucoma. HN(75) MHÑIsosorbide ANdo not use /biosyn /defic /physiol RN652-67-5 PIEthers, Cyclic (74); Sorbitol (74) MND2.33.800.813.480; D9.203.853.813.480; D19.770.224.453.758.500 DMÑSorbitol LH LM  PM74 HN74(66) MHÑIsosorbide Dinitrate ANdo not use /biosyn /defic /physiol RN87-33-2 MND2.33.800.813.480.500; D9.203.853.813.480.500; D18.918.498 LH  MSA genus of sporozoan parasites of the order Coccidia found in the intestines of birds, amphibians, reptiles and mammals including man. MHÑIsospora ANdo not use /anat /blood-csf-urine /embryol; infection = ISOSPORA INFECTIONS MNB1.841.762.167.437 LH  MS2-(10-undecen-1-yl)thiopseudourea iodide. Proposed topical anti-inflammatory agent that may release histamine if given intradermally. HN(76) MHÑIsothiuronium ANdo not use /biosyn /defic /physiol RN22584-04-9 PIThiourea (73-74) /AA (75); Undecyclenic Acids (73-75) MND2.886.904.390; D2.948.898.390; D26.74.148.512; D26.368.99.512 XSAHR-1911 DMÑThiourea LH LS LM  MSMuscle contraction with negligible change in the force of contraction but shortening of the distance between the origin and insertion. HN(84) MHÑIsotonic Contraction ANonly /drug eff /rad eff PIMuscle Contraction (66-83); Muscles (66-83) MNG11.427.661.493 DMÑMuscle Contraction LH LM  MHÑIsotonic Solutions ANGEN; NIM; no qualif when NIM coord; qualif is usually attached to specific drug in solution; when IM, only D25-26 qualif MND26.394.225.766.498 LH  MSTechnics of labeling a substance with a stable or radioactive isotope. Do not use for discussions involving labeled substances unless the methods of labeling aare substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. PM73 HN73(71) MHÑIsotope Labeling ANonly /instrum /methods /stand /vet; restrict to technics of labeling with isotopes (stable or radioactive): do not use for radioisotope tracer studies of ╥labeled╙ cells, microorganisms or chemicals ( = probably chemical /diag use (NIM) ), as Cr51-labeled erythrocytes = ERYTHROCYTES + CHROMIUM RADIOISOTOPES /diag use but not ISOTOPE LABELING PIspecific isotope MNE5.522 FXÑRadioisotopes LH LX  OLsearch RADIOISOTOPES 1966-73 PM74; was see under RADIOISOTOPES 1963-73 HN74; was see under RADIOISOTOPES 1963-73 MHÑIsotopes ANfor stable isotopes only: radioactive isotopes = RADIOISOTOPES; GEN: avoid as IM; NIM as coord; no qualif; Manual 25.86-.88, 25.96; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope MND1.496 LH  OLsearch OXAZOLES 1966-74 HN(75) MHÑIsoxazoles ANdo not use /analogs /biosyn /defic /physiol MND3.383.548.332 DMÑOxazoles LH LM  PM73 HN73(72) MHÑIsoxsuprine ANdo not use /biosyn /defic /physiol RN395-28-8 PIAmino Alcohols (66-71); Sympathomimetics (66-71) MND2.33.329.624.427; D2.92.63.624.427; D16.893.116.348.499 LH  MHÑIsrael MNZ1.252.245.509; Z1.630.540 LH  MHÑItaly MNZ1.542.489 XSSardinia LH LS  MSA mixture of ivermectin component B1a (RN 71827-03-7) and B1b (RN 70209-81-3), which is a semisynthetic product from Streptomyces avermitilis. A potent macrocyclic lactone disaccharide antiparasitic agent used to prevent and treat parasite infestations in animals. The compound has activity against internal and external parasites and has been found effective against arthropods, insects, nematodes, filarioidea, platyhelminths, and protozoa. PM87 HN87 MHÑIvermectin ANdo not use /defic /physiol; /biosyn permitted if by organism RN70288-86-7 PIAnthelmintics (66-86); Antinematodal Agents (74-86); Antiprotozoal Agents (66-86); Filaricides (73-86); Insecticides (66-86); Lactones (66-86) MND2.540.400; D5.723.491.700; D9.203.698.629.305.328; D21.201.287.278.460; D21.201.287.425; D21.201.412.425; D21.201.425; D21.370.625 LH  MHÑIvory Coast MNZ1.58.432.480 LH  MHÑJacksonian Seizure AN= jacksonian epilepsy MNC10.228.140.490.207.540 LH  MSA rare, usually fatal, transmissible encephalopathy due to a slow virus, occurring in middle life, in which there is partial degeneration of the pyramidal and extrapyramidal systems accompanied by progressive dementia and sometimes muscle wasting, tremor, athetosis, and spastic dysarthria. OLuse JAKOB-CREUTZFELDT SYNDROME to search CREUTZFELDT-JAKOB DISEASE back thru 1969 (as Prov 1969-72) PM81; was CREUTZFELDT-JAKOB DISEASE 1973-80 HN81; was CREUTZFELDT-JAKOB DISEASE 1969-80 (Prov 1969-72) MHÑJakob-Creutzfeldt Syndrome PICentral Nervous System Diseases (66-68) MNC2.839.500; C10.228.140.79.550; C10.228.140.382.220; C10.228.228.400; F3.709.680.610.392.300.110 XSCreutzfeldt-Jakob Syndrome LH LS  MHÑJamaica MNZ1.107.904.527 LH  MHÑJapan ANTOKYO is also available; Ainus are of AUSTRALOID RACE, not MONGOLOID RACE MNZ1.252.474.463 LH  MHÑJaundice ANGEN; see specifics below; ╥mechanical jaundice╙: index under CHOLESTASIS MNC23.888.498 XSICTERUS LH LS  MHÑJaundice, Chronic Idiopathic MNC18.452.648.499; C23.888.498.450 XSDUBIN-JOHNSON SYNDROME LH LS  MHÑJaundice, Neonatal ANdo not use /congen; check the tag INFANT, NEWBORN MNC16.614.555; C23.888.498.550 XSHyperbilirubinemia, Neonatal FXÑErythroblastosis, Fetal LH LS LX  PM65; was JAWS 1963-64 HN65; was JAWS 1963-64 MHÑJaw AN/abnorm = JAW ABNORMALITIES: /growth = MAXILLOFACIAL DEVELOPMENT; /injuries: TN 115; upper jaw = MAXILLA; lower jaw = MANDIBLE MNA2.835.232.781.324.502; A14.521 FXÑDental Arch; ÑTEMPOROMANDIBULAR JOINT LH LX;  PM66 HN66 MHÑJaw Abnormalities ANGEN only: prefer specifics: MAXILLA /abnorm or MANDIBLE /abnorm; do not use /congen MNC16.131.621.514 LH  MSSaccular lesions lined with epithelium and contained within pathologically formed cavities in the jaw; also nonepithelial cysts (pseudocysts) as they apply to the jaw, e.g., traumatic or solitary cyst, static bone cavity, and aneurysmal bone cyst. True jaw cysts are classified as odontogenic or nonodontogenic. PM80 HN80 MHÑJaw Cysts ANnon-neoplastic; coord IM with precoord organ/dis term (IM) PIBone Cysts (66-79); Cysts (66-79); Jaw Diseases (67-79); specific jaw disease; Jaw Neoplasms (67-79); specific jaw neoplasm MNC4.182.89.530; C5.500.470 LH  PM67 HN67 MHÑJaw Diseases ANGEN PIBone Diseases (66); Jaw (66); Mandible (66); Maxilla (66) MNC5.500 LH  MSFractures of the upper or lower jaw. PM66 HN66 MHÑJaw Fractures ANGEN MNC21.866.405.762.467; C21.866.460.589.338.500; C21.866.460.836.500 LH  PM67 HN67 MHÑJaw Neoplasms ANGEN: prefer specific precoord; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIJaw (66); Mandibular Neoplasms (66); Maxillary Neoplasms (66) MNC4.588.149.450; C5.500.499 LH  PM70 HN70 MHÑJaw Relation Record ANNIM; no qualif PIDental Occlusion (66-69) MNE6.520 XSBITE REGISTRATION FXÑDental Occlusion LH LS LX  MSUse for total absence of teeth from either the mandible or maxilla, but not both. Total absence of teeth from both is MOUTH, EDENTULOUS. Partial absence of teeth in either is JAW, EDENTULOUS, PARTIALLY. OLsearch MOUTH, EDENTULOUS 1966-79 PM80; was included in MOUTH, EDENTULOUS 1965-79 HN80; was included in MOUTH, EDENTULOUS 1965-79 MHÑJaw, Edentulous ANnote category: do not confuse with ANODONTIA (see note there); = total absence of teeth from mandible or maxilla; partial absence of teeth from mandible or maxilla = JAW, EDENTULOUS, PARTIALLY; total absence of teeth from both jaws = MOUTH, EDENTULOUS; coord IM with MANDIBLE (NIM) or MAXILLA (NIM); only /econ /etiol /microbiol /parasitol /pathol /physiopathol /prev /psychol /radiogr /radionuclide /rehabil /surg /vet PIMouth, Edentulous (66-79) MNC7.465.340 LH  MSAbsence of teeth from a portion of the mandible and/or maxilla. OLsearch MOUTH, EDENTULOUS 1966-79 PM80; was included in MOUTH, EDENTULOUS 1965-79 HN80; was included in MOUTH, EDENTULOUS 1965-79 MHÑJaw, Edentulous, Partially ANsee note above for definition; coord IM with MANDIBLE (NIM) or MAXILLA (NIM); only /econ /etiol /microbiol /parasitol /pathol /physiopathol /prev /psychol /radiogr /radionuclide /rehabil /surg /vet PIMouth, Edentulous (66-79) MNC7.465.360 LH  MSA human polyomavirus, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. HN(83) MHÑJC Virus ANnamed for patient from whom isolated: do not confuse with JAMESTOWN CANYON VIRUS; do not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) PIPapovaviridae (71-82); Polyomaviruses (71-82) MNB4.909.204.585.615.522 DMÑPolyomaviruses LH LM  MSAn irrational reaction compounded of grief, loss of self-esteem, enmity against the rival and self criticism. MHÑJealousy ANhuman & animal; no qualif MNF1.470.653 LH  PM80 HN80 MHÑJejunal Diseases ANinflamm dis or jejunitis: coord IM with ENTERITIS (NIM) PIIntestinal Diseases (66-79); specific intestinal disease; Jejunum (66-79) MNC6.405.469.600 LH  PM80 HN80 MHÑJejunal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIIntestinal Neoplasms (66-79); Jejunum (66-79) MNC4.588.274.476.411.523; C6.405.469.600.523 LH  MSA surgical procedure consisting of the anastomosis of the proximal part of the jejunum to the distal portion of the ileum, so as to bypass the nutrient-absorptive segment of the small intestine, to treat morbid obesity. PM86 HN86 MHÑJejunoileal Bypass ANin ther of obesity: note XR & do not coord with OBESITY; do not use /util except by MeSH definition PIIleum (66-85); Jejunum (66-85); Obesity (66-85) MNE4.765.626 XSIleojejunal Bypass; Intestinal Bypass FXÑObesity LH LS; LX  MHÑJejunum ANinflammation or jejunitis = JEJUNAL DISEASES (IM) + ENTERITIS (NIM); jejuno-ileal bypass or shunt or jejuno-ileostomy in obesity: index under JEJUNOILEAL BYPASS & not also under OBESITY (note XR ref) MNA3.492.411.620.625 LH  MSFree swimming marine coelenterates, mostly of the class Scyphozoa. OLsearch COELENTERATA 1975-77 HN(78); was see COELENTERATA 1975-77 MHÑJellyfish AN/microbiol /parasitol permitted; medusa, sea nettle & Portuguese man-of-war (Physalia) go here PICoelenterata (66-74) MNB1.308.495 XSScyphozoa DMÑCoelenterata LH LS LM  MSAn ethnic group with certain cultural and religious traditions. MHÑJews ANIM; only /class /hist /psychol; specify geog if relevant; as ethnic group: Manual 30.8-30.10, 34.9 MNI1.76.201.450.416.582; I1.880.143.522.582; M1.194.582 FXÑJUDAISM LH LX  MSProcess of applying for employment; written application for employment. HN(83) MHÑJob Application ANno qualif PIEmployment (70-82); Personnel Management (66-82) MNN4.452.677.400 XSEmployment Application; Resume, Job DMÑPersonnel Management LH LS; LM  MSStatement of the position requirements, qualifications for the position, wage range and any special conditions expected of the employee. HN(Aug 77) MHÑJob Description ANno qualif MNN4.452.677.410 XSPosition Description DMÑPersonnel Management LH LS LM  MSPersonal satisfaction relative to the work situation. PM76 HN76 MHÑJob Satisfaction ANno qualif PIPersonal Satisfaction (72-75) MNF1.145.76.747.150; F2.784.692.425 XSWork Satisfaction FXÑEmployment LH LS LX  MSA syndrome of leukocyte bactericidal defect in which polymorphonuclear leukocytes are capable of ingesting but not killing bacteria. It occurs only in girls and is transmitted as an autosomal recessive trait. OLsearch PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-74 HN(75) MHÑJob's Syndrome MNC15.378.553.774.535.500; C20.673.774.535.500 DMÑPhagocyte Bactericidal Dysfunction LH LM  MSRunning at a low rate of speed as a means of conditioning for other sports or for general health and well being. HN(76); was see under SPORTS 1976-79 MHÑJogging ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM) PIPhysical Fitness (66-75) MNI3.450.642.845.610.320 DMÑRunning LH LM  MSA private, voluntary, not-for-profit organization which establishes standards for the operation of health facilities and services, conducts surveys, and awards accreditation. HN(79) MHÑJoint Commission on Accreditation of Hospitals ANonly /hist /legis /organ; specify geog; DF: JCAH CATALOG: use NAF entry MNN3.706.110.70.410 DMÑAccreditation LH LM  PMSHOULDER ARTHROSES was heading 1963-64 HNSHOULDER ARTHROSES was heading 1963-64 MHÑJoint Diseases ANGEN; prefer specifics; inflamm dis = ARTHRITIS MNC5.550 XUÑJoint Loose Bodies LH LU  MSLack of stability of a joint or joint prosthesis. Factors involved are intra-articular disease and integrity of extra-articular structures such as joint capsule, ligaments, and muscles. PM83 HN83 MHÑJoint Instability ANnote categ PIJoint Diseases (66-82); Ligaments, Articular (66-82) MNC5.550.521 XSHypermobility, Joint; Instability, Joint; Laxity, Joint LH LS; ;  MSFibrous, bony, cartilaginous and osteocartilaginous fragments in a synovial joint. Major causes are osteochondritis dissecans, synovial chondromatosis, osteophytes, fractured articular surfaces and damaged menisci. HN(83) MHÑJoint Loose Bodies PIJoint Diseases (66-82); Knee Joint (66-82); Osteochondritis (66-82); Synovial Membrane (66-82) MNC5.550.535 XSLoose Bodies, Joint DMÑJoint Diseases LH LS LM  MSPartial or total replacement of a joint. PM71 HN71 MHÑJoint Prosthesis AN╥partial or total replacement of a joint╙; do not use /instrum /methods /util (except by MeSH definition); HIP PROSTHESIS & KNEE PROSTHESIS are also available PIProsthesis (66-70); specific joint MNE4.557.168.530; E4.659.550; E7.450.530; E7.858.442.499; E7.858.565.600 XSArthroplasty, Replacement LH LS  PMSTERNOCOSTAL JOINTS was see under RIBS 1963-78 MHÑJoints ANGEN; any Cat A qualif applicable; joints of animals: TN 117; differentiation of sites & joints: TN 238; inflammation = ARTHRITIS; /radiogr = ARTHROGRAPHY; /surg: consider also ARTHROPLASTY; joint revision: index as ARTHROPLASTY (IM) + REOPERATION (NIM) MNA2.835.583 XUÑSternocostal Joints LH LU  MHÑJordan MNZ1.252.245.536; Z1.630.560 LH  MSContent, management, editing, policies, and printing of dental periodicals such as journals, newsletters, tabloids, and bulletins. HN(64) MHÑJournalism, Dental ANwriting for or in dent publ or on dent subjects; dental journals go under PERIODICALS & required coord, not here; only /hist /stand MNL1.737.582 XSPeriodicals Publishing, Dental; Publishing, Dental Periodicals DMÑPublishing LH LS; LM  MHÑJudaism ANonly /hist MNK1.844.385 FXÑJEWS LH LX  MSThe process of discovering or asserting an objective or intrinsic relation between two objects or concepts; a faculty or power that enables a person to make judgments; the process of bringing to light and asserting the implicit meaning of a concept; a critical evaluation of a person or situation. PM66 HN66 MHÑJudgment ANno qualif MNF2.463.785.626 LH  MSVeins in the neck which drain the brain, face and neck into the innominate or subclavian veins. OLuse JUGULAR VEINS to search JUGULAR VEIN back thru 1966 PM78; was JUGULAR VEIN 1963-77 HN78; was JUGULAR VEIN 1963-77 MHÑJugular Veins ANdo not use /blood supply MNA7.231.908.498 LH  MSA theoretical psychoanalytical system centered around symbols of the unconscious with the unconscious material derived from two sources - the personal unconscious (repressed or forgotton experiences, thoughts and feelings) and the collective or objective unconscious (the universal inherited qualities which dispose the individual to behave as his ancestors). OLsearch PSYCHOANALYTIC THEORY 1969-74 HN(75) MHÑJungian Theory ANno qualif MNF2.739.794.471 DMÑPsychoanalytic Theory LH LM  MSThe application of the principles of law and justice to health and medicine. MHÑJurisprudence ANGEN only: prefer /legis (for /legislation & jurisprudence): Manual 19.5+; IM; only /hist; specify geog; = ╥medical jurisprudence╙: do not coord with MEDICINE; for civil suits: differentiate from FORENSIC MEDICINE which is for crime & identification CATALOG: /geog /form MNI1.880.604.583; N3.706.535 XSDue Process FXÑFORENSIC DENTISTRY; ÑFORENSIC MEDICINE; ÑForensic Dentistry; ÑForensic Medicine XUÑCriminal Law LH LS LX; ; ; LU  MSThe antisocial acts of children or persons under age which are illegal or lawfully interpreted as constituting delinquency. MHÑJuvenile Delinquency ANIM; only /econ /legis /occur /prev /psychol /rehabil /trends CATALOG: /geog /form MNF3.126.842.393; F3.234.451; I1.880.735.479 LH  MSCompounds, either natural or synthetic, which block development of the growing insect. PM72 HN72(66) MHÑJuvenile Hormones ANinsects only; do not use /analogs /defic MND6.472.445.573.666 XSInsect Growth Regulators XUÑDimilin; ÑMethoprene LH LS LU;  PM66 HN66(64) MHÑJuxtaglomerular Apparatus MNA5.810.453.736.520.520 FXÑRENIN LH LX  MSA flocculation test for syphilis. MHÑKahn Test ANonly /instrum /methods MNE1.223.495.826.769.306.501; E1.223.495.826.895.376 LH  MS2-Carboxy-4-isopropenyl-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex; pharmacologic analog of glutamate in the nervous system; may cause nerve degeneration. Synonyms: Digenin; Helminal; Kainamina; Pirvikain. PM86; was see under PYRROLIDINES 1978-85 HN86(78); was see under PYRROLIDINES 1978-85 MHÑKainic Acid ANdo not use /defic /physiol RN487-79-6 PIPyrrolidines (66-77) MND3.383.773.400; D21.201.287.435 XSDigenic Acid LH LS  PM66 HN66(64) MHÑKallidin AN/biosyn /physiol permitted RN342-10-9 MND12.644.320.551; D12.644.456.541; D24.185.798.354.551 LH  MSPeptidohydrolytic enzyme found in normal blood and urine; it is involved in blood coagulation and is formed from prekallikrein, probably by clotting factor XII; it is a potent vasodilator and hypotensive, increases vascular permeability and affects smooth muscle; it is thereby intimately involved in inflammation and allergic reactions. MHÑKallikrein AN/antag permitted but consider KALLIKREIN-TRYPSIN INACTIVATOR RNEC 3.4.21.8 MND8.586.277.656.732.426; D12.776.124.125.550; D19.461.270.229.533 XSKininogenase; Padutin XUÑPrekallikrein LH LS; LU  PM66 HN66 MHÑKallikrein-Trypsin Inactivator ANdo not use /analogs; DF: KALLIKREIN TRYPSIN INACT RN9004-04-0 MND8.373.745.896.584; D12.776.950.500 XSAprotinin; Basic Pancreatic Trypsin Inhibitor; Bovine Kunitz Pancreatic Trypsin Inhibitor; Kunitz Pancreatic Trypsin Inhibitor; Trypsin Inhibitor, Kunitz, Pancreatic LH LS; ; ; ;  MHÑKanamycin ANdo not use /defic /physiol RN59-01-8 MND9.203.408.51.476; D20.85.89.464; D20.338.135.501 XUÑDibekacin LH LU  MSHerbivorous leaping mammals of Australia, New Guinea, and adjacent islands. HN(75) MHÑKangaroos ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not confuse rat kangaroos with KANGAROO RATS see DIPODOMYS MNB2.649.573.500 XSQuokkas; Wallabies DMÑMarsupialia LH LS; LM  MHÑKansas MNZ1.107.567.875.413 LH  MHÑKaolin AND25-26 qualif RN1332-58-7 MND1.552.45.189.584; D1.578.500; D1.836.189.584; D19.316.161.418; D26.394.225.672.418 LH  MHÑKaposi's Varicelliform Eruption MNC2.256.466.382.451; C17.838.424.584 XSEczema Vaccinatum LH LS  MSPolysaccharide gum from Sterculia urens, an Indian tree; it is used as suspending or stabilizing agent in foods, cosmetics and pharmaceuticals; also as bulk-forming laxative, surgical lubricant and adhesive and in the treatment of skin ulcers. Synonyms: Kadaya; Kadillo; Kullo; Mucara; Sterculia. HN(78) MHÑKaraya Gum ANdo not use /analogs /defic /physiol; /biosyn permitted if by plant RN9000-36-6 PIPolysaccharides (66-77); Resins (66-77) MND9.203.698.450; D19.316.396.510; D26.698.931.419.510 XSGum Karaya; Sterculia DMÑPolysaccharides LH LS; LM  MHÑKartagener Triad ANdo not use /congen MNC8.200.531; C9.150.531; C16.131.810.501 LH  PM67 HN67(64) MHÑKaryometry ANNIM; only /instrum /methods /vet MNE5.909.262.695 FXÑCell Nucleus LH LX  PM67 HN67(65) MHÑKaryotyping ANNIM; only /instrum /methods /vet MNE5.393.500 FXÑChromosome Abnormalities; ÑChromosomes; ÑCytogenetics LH LX; ;  MS3-0-[2-Amino-4-[(carboxyiminomethyl)amino]-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranosyl]-D-chiroinositol. Experimental antimicrobial agent isolated from Streptomyces kasugaensis; used in pseudomonas infections; interferes with protein synthesis in susceptible Escherichia coli. HN(75) MHÑKasugamycin ANdo not use /defic /physiol; /analogs NIM only RN6980-18-3 PIAntibiotics (72-74); Inositol (72-74); Aminoglycosides (74) MND20.85.423 DMÑAntibiotics LH LM  MSRating scales designed to measure adjustment and social behavior of psychiatric patients in the community prior to release or during post-hospitalization period. OLsearch PSYCHIATRIC STATUS RATING SCALES 1971-74 HN(75) MHÑKatz Adjustment Scales ANno qualif; DF: KATZ ADJUSTMENT MNF4.586.334 DMÑPsychiatric Status Rating Scales LH LM  OLuse KAZAKH S.S.R. to search KAZAKHSTAN back thru 1966 HN82; was KAZAKHSTAN 1963-81 MHÑKazakh S.S.R. MNZ1.252.878.540; Z1.950.540 LH  MSA cell line derived from a human carcinoma of the nasopharynx, used as an assay for antineoplastic agents. PM85 HN85 MHÑKB Cells ANalmost never IM; no qualif when NIM, A 11 qualif when IM; check HUMAN but do not add NASOPHARYNGEAL NEOPLASMS PICell Line (69-84); Tissue Culture (66-71) MNA11.251.210.501; A11.251.353.501 LH  MSA triad of progressive external ophthalmoplegia, cardiomyopathy, and retinitis pigmentosa. HN(83) MHÑKearns Syndrome PIHeart Block (66-82); Ophthalmoplegia (66-82); Retinitis Pigmentosa (66-82) MNC11.627.627; C11.768.585.731.627 XSKearns-Sayre-Shy-Daroff Syndrome DMÑOphthalmoplegia LH LS LM  MSMultiple erythrocytic antigens that comprise at least three pairs of alternates and amorphs, determined by one complex gene or possibly several genes at closely linked loci; the system is important in transfusion reactions; its expression involves the X-chromosome. HN(76) MHÑKell Blood-Group System ANonly /genet /immunol; TN 230 PIBlood Groups (66-75) MND24.611.216.705.230.533; G4.610.241.533; G9.188.229.533 DMÑBlood Groups LH LM  MHÑKeloid MNC17.405 LH  MSA group of antigenically related tick-borne viruses found in Eastern Europe, Egypt, and Sudan. HN(75); was see under REOVIRUSES 1975-80 MHÑKemerovo Group Viruses ANdo not use /blood-csf-urine /cytol MNB4.909.777.714.400 DMÑReoviridae LH LM  MHÑKentucky MNZ1.107.567.875.422 LH  MHÑKenya MNZ1.58.183.377 LH  MSDecachlorooctahydro-1,3,4-metheno-2H-cyclobuta[CD]pentalen-2-one. A highly chlorinated polycyclic hydrocarbon insecticide whose large number of chlorine atoms makes it resistant to degradation. It has been shown to be toxic to mammals and causes abnormal cellular changes in laboratory animals. Synonym: GC-1,189. HN(77) MHÑKepone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN143-50-0 PIBridged Compounds (69-76); Insecticides, Organochlorine (73-76) MND2.455.526.439.550; D5.723.491.491.600 XSChlordecone DMÑInsecticides, Organochlorine LH LS LM  MSA sulfated mucopolysaccharide initially isolated from bovine cornea. At least two types are known. Type I, found mostly in the cornea, contains D-galactose and D-glucosamine-6-O-sulfate as the repeating unit; type II, found in skeletal tissues, contains D-galactose and D-galactosamine-6-O-sulfate as the repeating unit. HN(75) MHÑKeratan Sulfate AN/biosyn /physiol permitted; /analogs NIM only RN9056-36-4 PIMucopolysaccharides (70-74); Galactosamine (72-74) MND9.203.698.582.640 XSKeratosulfate DMÑMucopolysaccharides LH LS LM  MHÑKeratin AN/biosyn /physiol permitted; keratinocyte: coord IM with pertinent qualif + EPIDERMIS /cytol (IM) RN9008-18-8 MND12.776.220.475.450; D12.776.860.607 XSCytokeratin LH LS  MHÑKeratitis MNC11.204.564 LH  MHÑKeratitis, Dendritic MNC2.256.466.382.552; C11.204.564.418 XSHERPES SIMPLEX, OCULAR LH LS  MHÑKeratoacanthoma ANnote category: non-neoplastic; coord IM with precoord organ/dis term (IM) MNC17.417 LH  MHÑKeratoconjunctivitis MNC11.187.183.394; C11.204.564.585 XUÑKeratoconjunctivitis Sicca LH LU  MSDrying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. In association with xerostomia and polyarthritis it is called SJOGREN SYNDROME. HN(86) MHÑKeratoconjunctivitis Sicca ANif with xerostomia & polyarthritis, index as SJOGREN SYNDROME PIKeratoconjunctivitis (66-85) MNC11.187.183.394.550 DMÑKeratoconjunctivitis LH LM  MSTnfectious diseases of cattle, sheep, and goats, characterized by blepharospasm, lacrimation, conjunctivitis, and varying degrees of corneal opacity and ulceration. In cattle the causative agent is Moraxella bovis; in sheep, Mycoplasma, Rickettsia, Chlamydia, or Acholeplasma; in goats, Rickettsia. PM86 HN86 MHÑKeratoconjunctivitis, Infectious ANanimal only; do not use /vet but check tag ANIMAL; coord IM with organism/infect heading /vet (IM); DF: KERATOCONJUNCTIVITIS INFECT PIBacterial Infections (72-85); Cattle Diseases (66-85); Keratoconjunctivitis (66-85); Moraxella (66-85) MNC1.252.480; C11.187.183.394.520; C22.500 XSInfectious Keratoconjunctivitis LH LS  MHÑKeratoconus MNC11.204.627 LH  MSAgents that soften, separate and cause desquamation of the cornified epithelium or horny layer of skin; used to expose mycelia of infecting fungi or to treat corns, warts and certain other skin diseases. Synonym: skin peeling agents. OLsearch DERMATOLOGIC AGENTS 1967-74 HN(75) MHÑKeratolytic Agents AND25-26 qualif PIDermatologic Agents (67-74); Skin Diseases (66) MND26.368.627 XSDesquamating Agents DMÑDermatologic Agents LH LS LM  PMKERATOSIS BLENNORRHAGICA was see under GONORRHEA 1963-78 MHÑKeratosis ANporokeratosis goes here; oral keratosis = LEUKOPLAKIA, ORAL MNC17.428 XUÑKeratosis Blennorrhagica; ÑParakeratosis LH LU;  MSPustules and crusts, often associated with Reiter's disease; at one time incorrectly believed to be due to gonorrhea. OLsearch GONORRHEA 1966-74 HN(75); was see under GONORRHEA 1963-78 MHÑKeratosis Blennorrhagica MNC17.428.418 DMÑKeratosis LH LM  MHÑKeratosis Follicularis MNC17.428.452 XSDARIER'S DISEASE LH LS  PM74 HN74 MHÑKeratosis Palmaris et Plantaris ANporokeratosis palm. et plant. goes here MNC17.428.552 XSMELEDA DISEASE XUÑPapillon-Lefevre Disease LH LS LU  MSA procedure to treat myopia by cutting radial slits into the cornea to flatten it and thereby change its refractive properties. PM87 HN87 MHÑKeratotomy, Radial ANdo not use /util except by MeSH definition PICornea (66-86); Myopia (66-86) MNE4.792.535 XSRadial Keratotomy LH LS  MSA condition characterized by high levels of nonconjugated bilirubin in the blood with biliary pigmentation of certain nuclei in the brain and spinal cord and frequently resulting in cerebral palsy, mental retardation and hearing deficit. Commonly, a sequel to icterus gravis neonatorum. MHÑKernicterus ANdo not use /congen /drug eff /physiol /rad eff MNC10.228.140.163.501; C15.378.120.413.502; C16.614.304.502; C20.188.413.502; C23.888.498.329.585; F3.709.346.455 LH  MSA refined petroleum fraction used as a fuel as well as a solvent. OLuse KEROSINE to search KEROSENE back thru 1966 (as Prov 1966-74, as Cat D & H heading 1968-74, as Cat D heading 1966-67) HN(82); was KEROSENE (Cat J heading only 1975-81) see under PETROLEUM 1968-81, was Prov KEROSENE 1963-74 (Cat D & H heading 1968-74, Cat D heading only 1963-67) MHÑKerosine ANonly /ad-poi-tox /anal /hist /rad eff /stand /supply MNG3.230.132.258.630.600; J1.435.723.627; J1.740.400.700.450 DMÑPetroleum LH LM  OLuse KETAMINE to search CI-581 back thru 1969 (as Prov 69-72) PM73 HN73; was CI-581 1969-72 (Prov) MHÑKetamine ANdo not use /biosyn /defic /physiol RN6740-88-1 PIAnalgesics (66-71); Anesthetics (72); Cyclohexanes (68-72) MND2.455.426.392.368.367.652; D14.166.60.502 XSCI-581 LH LS  MS3-(2-(4-(4-Fluorobenzoyl)piperidinol) ethyl)-2,4(1H,3H)-quinazolinedione. A selective serotonin receptor blockader with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. PM87 HN87 MHÑKetanserin ANdo not use /biosyn /defic /physiol RN74050-98-9 PIPiperidines (66-86) MND3.383.621.365; D3.438.786.430; D23.846.535 LH  MHÑKeto Acids ANdo not use /analogs /defic /physiol MND2.241.607 LH  PM73 HN73 MHÑKetoacid-Lyases ANdo not use /analogs RNEC 4.1.3. PILyases (66-72) MND8.586.520.567 XUÑ2-Isopropylmalate Synthase; ÑAcetolactate Synthase; ÑCitrate Synthase; ÑHydroxymethylglutaryl CoA Synthase; ÑIsocitrate Lyase; ÑMalate Synthase LH LU; ; ; ; ;  MSCholesterol substituted in any position by a keto moiety. The 7-keto isomer inhibits the 3-hydroxy-3-methylglutaryl-CoA reductase activity and inhibits cholesterol uptake in coronary arteries and aortas in vitro. HN(80) MHÑKetocholesterols AN/biosyn /physiol permitted PICholesterol (66-74) /AA (75-79) MND4.808.247.222.265.450; D4.808.247.222.284.600; D4.808.247.808.197.600; D10.516.851.208.650 XSOxocholesterols DMÑCholesterol LH LS LM  MS1-Acetyl-4-[4-[(2-(2,4-dichlorophenyl)-2- (1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy] -phenyl]-cis-piperazine. Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. PM84 HN84 MHÑKetoconazole ANdo not use /biosyn /defic /physiol RN65277-42-1 PIImidazoles (66-83); Piperazines (66-83) MND3.383.606.560; D20.136.533 LH  HN(73) MHÑKetoglutarate Dehydrogenase Complex ANdo not use /analogs RNEC 1.2.4.2 MND8.586.600.465; D8.586.682.472.377 DMÑKetone Oxidoreductases LH LM  OLuse KETOGLUTARIC ACIDS to search KETOGLUTARIC ACID back thru 1966 PM75; was KETOGLUTARIC ACID 1963-77 HN75; was KETOGLUTARIC ACID 1963-74 MHÑKetoglutaric Acids ANdo not use /analogs /defic /physiol MND2.241.81.337.351.502; D2.241.607.465 XSOXOGLUTARATES LH LS  MHÑKetone Bodies ANdo not use /analogs /defic /physiol; acetonemia, acetonuria, ketonemia & ketonuria go here MND2.522.585 XSACETONE BODIES LH LS  PM73 HN73 MHÑKetone Oxidoreductases ANdo not use /analogs RNEC 1.2. PIOxidoreductases (66-72) MND8.586.682.472 XUÑIMP Dehydrogenase; ÑKetoglutarate Dehydrogenase Complex; ÑXanthine Dehydrogenase LH LU; ;  MHÑKetones ANdo not use /analogs /physiol; KETO ACIDS & KETOSES are also available; ketonemia & ketonuria go under KETONE BODIES MND2.522 XUÑHexanones; ÑMethyl N-Butyl Ketone; ÑPentanones LH LU; ;  MS3-Benzoyl-alpha-methyl-benzeneacetic acid. Ibuprofen type anti-inflammatory analgesic and antipyretic; proposed as anti-arthritic. Synonyms: Orudis; RP 19583; Alrheumat; Alrheumun; Profenid. HN(75); was see under BENZOPHENONES 1975-77 MHÑKetoprofen ANdo not use /biosyn /defic /physiol; /analogs NIM only RN22071-15-4 PIBenzophenones (68-74); Ketones (66-67); Propionates (66-67) MND2.241.223.701.480; D14.73.278.501; D26.74.75.597 XSBenzoylhydratropic Acid DMÑPhenylpropionates LH LS LM  PM74 HN74 MHÑKetoses ANdo not confuse with KETOSIS; do not use /analogs /defic /physiol MND9.203.546.465 XSKETO SUGARS LH LS  OLsearch ACIDOSIS 1966-74 HN(75) MHÑKetosis ANdo not confuse with KETOSES MNC18.452.76.176.652 DMÑAcidosis LH LM  OLsearch ACIDOSIS, DIABETIC 1973-74 HN(75) MHÑKetosis, Diabetic MNC18.452.76.176.110.502; C18.452.297.55.502; C19.246.55.502 DMÑAcidosis, Diabetic LH LM  PM74 HN74(71) MHÑKetosteroids AN/physiol permitted; do not use /analogs /defic PIappropriate steroid class MND4.808.578 LH  MS4,9-Dihydro-4-(1-methyl-4-piperidylidene)- 10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one. A cycloheptathiophene that interferes with histamine metabolism and blocks its type I receptors; proposed as bronchodilator and antiasthmatic and for rhinitis, skin allergies, and anaphylaxis. Synonyms: HC 20-511; Zaditen. PM82 HN82 MHÑKetotifen ANdo not use /biosyn /defic /physiol RN34580-13-7 PIPiperidines (66-81); Thiophenes (66-81) MND3.383.621.370; D3.383.903.370; D23.654.432.533 LH  MHÑKhellin ANdo not use /biosyn /defic /physiol RN82-02-0 MND18.918.543 XSVISAMMIN LH LS  MSA group of antigens consisting principally of Jk(a) and Jk(b), determined by allelic genes; amorphs are encountered; antibodies of these substances are usually weak and quite labile, stimulated by erythrocytes. HN(76) MHÑKidd Blood-Group System ANonly /genet /immunol; TN 230 PIBlood Groups (66-75) MND24.611.216.705.230.538; G4.610.241.538; G9.188.229.538 DMÑBlood Groups LH LM  PM/transplantation was KIDNEY TRANSPLANTATION 1963-65 HN/transplantation was KIDNEY TRANSPLANTATION 1963-65 MHÑKidney ANkidney tissue or cells in cultures: Manual 18.6.15, 18.7.2, 22.26.1, 26.33+; fetal or embryonic kidney tissue or cells in culture: do not use /embryol with KIDNEY; /blood supply: consider also RENAL CIRCULATION; /surg: consider NEPHRECTOMY; /transpl: do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; inflammation = NEPHRITIS; Goldblatt kidney = HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR; nephrostomy: index under URINARY DIVERSION (IM) + KIDNEY PELVIS (NIM); consider terms under REN- , NEPHR-, GLOMERUL- & PYEL- CATALOG: form qualif = NEPHROLOGY /form MNA5.810.453 FXÑDiuresis; ÑNEPHRECTOMY LH LX;  OLto search for chem composition of kidney calculi, use KIDNEY CALCULI/anal back thru 1987 & KIDNEY CALCULI/metab 1966-86 MHÑKidney Calculi ANchem composition of calculi: use /anal; /ultrastruct permitted MNC12.777.419.373; C12.777.809.503 LH  OLsearch KIDNEY PELVIS 1968-74 HN(75) MHÑKidney Calices MNA5.810.453.537.503 DMÑKidney Pelvis LH LM  PM70 HN70(67) MHÑKidney Concentrating Ability ANonly /drug eff /rad eff PIKidney/PH (66) MNG8.852.553 XSURINE CONCENTRATING ABILITY LH LS  PM74 HN74(73) MHÑKidney Cortex PIKidney (66-72) MNA5.810.453.324 LH  MSThe death of all the functioning renal cells of the kidney cortex with continued viability of the majority of the medullary units. Usually due to the arterial distribution peculiar to the kidney which makes the renal cortex more susceptible to diminished blood flow. OLuse KIDNEY CORTEX NECROSIS to search NECROSIS, RENAL CORTICAL back thru 1966 (as Prov 1966) PM67 HN67; was NECROSIS, RENAL CORTICAL 1964-66 (Prov) MHÑKidney Cortex Necrosis MNC12.777.419.393 XSRENAL CORTICAL NECROSIS LH LS  MHÑKidney Diseases ANGEN; inflamm dis = NEPHRITIS; consider diseases under NEPHR- & RENAL; ╥renal failure╙ not specified as ╥acute╙ or ╥chronic╙: check text for clues in notes under KIDNEY FAILURE, ACUTE & KIDNEY FAILURE, CHRONIC & if not able to determine, index as KIDNEY DISEASES; ╥end-stage renal disease╙: index under KIDNEY FAILURE, CHRONIC CATALOG: form qualif = NEPHROLOGY /form MNC12.777.419 FXÑNephrology XUÑHepatorenal Syndrome LH LX LU  MSA clinical syndrome characterized by a sudden decrease in glomerular filtration rate, often to values of less than 1 to 2 ml. per minute. Usually associated with oliguria (urine volumes of less than 400 ml. per day) and is always associated with biochemical consequences of the reduction in glomerular filtration rate such as a rise in blood urea nitrogen (BUN) and serum creatinine concentrations. OLuse KIDNEY FAILURE, ACUTE to search ACUTE RENAL FAILURE back thru 1966 PM67; was ACUTE RENAL FAILURE 1963-66 HN67; was ACUTE RENAL FAILURE 1963-66 MHÑKidney Failure, Acute ANclues for indexing: check text for cross-refs listed below & pois or trauma or ╥reversible╙ MNC12.777.419.433 XSRENAL FAILURE, ACUTE FXÑAnuria; ÑHEMODIALYSIS XUÑKidney Tubular Necrosis, Acute LH LS LX; LU  MSAn irreversible and usually progressive reduction in renal function in which both kidneys have been damaged by a variety of diseases to the extent that they are unable to adequately remove the metabolic products from the blood and regulated the body's electrolyte composition and acid-base balance. PM67 HN67(66) MHÑKidney Failure, Chronic ANclues for indexing: check text for cross-refs listed below & proteinuria or possible transpl or ╥irreversible╙; ╥end-stage renal disease╙ goes here MNC12.777.419.453 XSRENAL FAILURE, CHRONIC FXÑGlomerulonephritis; ÑHEMODIALYSIS; ÑPyelonephritis; ÑUREMIA LH LS LX; ; ;  MHÑKidney Function Tests ANonly /instrum /methods /vet MNE1.341.453 LH  MHÑKidney Glomerulus AN╥minimal change glomerular disease╙ = NEPHROSIS, LIPOID MNA5.810.453.736.520 LH  MSThe internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. PM79; was see under KIDNEY 1975-78 HN79(73); was see under KIDNEY 1975-78 MHÑKidney Medulla PIKidney (66-72) MNA5.810.453.466 XSKidney Papilla LH LS  MHÑKidney Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type neopl (IM) MNC4.588.945.947.535; C12.777.419.473 LH  MSA form of acute kidney disease characterized by necrosis of the renal papillae. It is most frequently associated with diabetes mellitus because of the severe vascular disease present in the arteries and capillaries, particularly in the kidney. There is usually a large component of infection present, and in non-diabetics pyelonephritis and obstructive uropathy are the usual etiologic agents. OLuse KIDNEY PAPILLARY NECROSIS to search PYELONEPHRITIS, ACUTE NECROTIZING back thru 1966 PM67; was PYELONEPHRITIS, ACUTE NECROTIZING 1963-66 HN67; was PYELONEPHRITIS, ACUTE NECROTIZING 1963-66 MHÑKidney Papillary Necrosis MNC12.777.419.493 XSNECROTIZING PYELONEPHRITIS; PYELONEPHRITIS, ACUTE NECROTIZING; RENAL PAPILLITIS, NECROTIZING LH LS; ;  MHÑKidney Pelvis ANdo not confuse with pelvic kidney ( = KIDNEY /abnorm); inflammation = PYELITIS; nephrostomy: index under URINARY DIVERSION (IM) + KIDNEY PELVIS (NIM); consider also terms under PYELO MNA5.810.453.537 XUÑKidney Calices LH LU  MSAcute kidney failure resulting from destruction of tubular epithelial cells. Commonly attributed to exposure to toxic agents or renal ischemia following severe trauma. OLto search LOWER NEPHRON NEPHROSIS use KIDNEY TUBULAR NECROSIS, ACUTE 1975-78 & KIDNEY FAILURE, ACUTE 1966-74 HN(75); LOWER NEPHRON NEPHROSIS was see under KIDNEY FAILURE, ACUTE 1971-78, was see KIDNEY FAILURE, ACUTE 1967-70, was see ACUTE RENAL FAILURE 1963-66 MHÑKidney Tubular Necrosis, Acute MNC12.777.419.433.503 XSLower Nephron Nephrosis DMÑKidney Failure, Acute LH LS LM  MHÑKidney Tubules MNA5.810.453.736.560 XUÑKidney Tubules, Collecting; ÑKidney Tubules, Distal; ÑLoop of Henle LH LU; ;  MSStraight tubes commencing in the radiate part of the kidney cortex where they receive the curved ends of the distal convoluted tubules. In the medulla the collecting tubules of each pyramid converge to join a central tube (duct of Bellini) which opens on the summit of the papilla. HN(79) MHÑKidney Tubules, Collecting PIKidney (66-78); Kidney Medulla (73-78); Kidney Tubules (66-78); Kidney Tubules, Distal (73-78) MNA5.810.453.736.560.510 XSKidney Collecting Ducts DMÑKidney Tubules LH LS LM  HN(73) MHÑKidney Tubules, Distal AN╥ascending tubules╙ PIKidney Tubules (66-72) MNA5.810.453.736.560.540 DMÑKidney Tubules LH LM  PM74 HN74(73) MHÑKidney Tubules, Proximal AN╥descending tubules╙ PIKidney Tubules (66-72) MNA5.810.453.736.560.570 LH  MHÑKidney, Artificial ANdo not use /instrum /methods /util (except by MeSH definition) MNE7.858.82.585 FXÑHemodialysis; ÑPERITONEAL DIALYSIS; ÑPeritoneal Dialysis LH LX; ;  MHÑKidney, Cystic ANdifferentiate from KIDNEY, POLYCYSTIC; /anal /blood supply /secret /ultrastruct permitted MNC4.182.394; C12.777.419.413 LH  MSKidney whose tissue is displaced by a large number of tightly packed cysts so that cystic volume predominates over the solid parts to a considerable degree. MHÑKidney, Polycystic ANdifferentiate from KIDNEY, CYSTIC; /anal /blood supply /secret /ultrastruct permitted MNC4.182.394.420; C12.777.419.413.420; C16.131.939.608 LH  MSCystic disease of the medullary portion of the renal pyramids; asymptomatic unless complicated by infection, calculi, or obstruction; should be distinguished from congenital polycystic disease of the kidneys. PM65 HN65 MHÑKidney, Sponge MNC4.182.394.586; C12.777.419.413.586 LH  OLsearch SILICA 1968-74 HN(75) MHÑKieselguhr ANdo not use /biosyn /defic /physiol RN61790-53-2 MND1.836.751.379 DMÑSilica LH LM  MSEffector cells bearing Fc receptors which mediate antibody-dependent cell toxicity. These may be lymphocytes, monocytes, macrophages or polynuclear leukocytes, depending on the identity of the target cell. PM78 HN78 MHÑKiller Cells AN lymphocytes, monocytes, macrophages or polynuclear leukocytes mediating ANTIBODY-DEPENDENT CELL CYTOTOXICITY; A 11 qualif & /class PILymphocytes (66-77); T Lymphocytes (73-77) MNA11.118.637.555.420; A15.145.229.637.555.420; A15.382.490.520.420; A15.382.520.520.420 XSK Cells FXÑAntibody-Dependent Cell Cytotoxicity LH LS LX  MSCells responsible for spontaneous cytotoxicity of a variety of tumor cells without prior immunization. These natural killer cells are found in non-immune humans and experimental animals and are distinct from killer cells (K cells) which mediate antibody-dependent cell cytotoxicity. PM83 HN83 MHÑKiller Cells, Natural ANcells spontaneously cytotoxic to tumor cells; A 11 qualif & /class PICytotoxicity, Immunologic (78-82); Immunity, Cellular (76-82); Killer Cells (78-82) MNA11.118.637.555.425; A15.145.229.637.555.425; A15.382.490.520.425; A15.382.520.520.425 XSNK Cells; Natural Killer Cells FXÑCytotoxicity, Immunologic LH LS; LX  MSSmall oviparous fishes usually striped or barred black; much used in mosquito control. HN(75); was see under FISHES 1975-86 MHÑKillifish ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.280.428 XSCyprinodon; Fundulus DMÑCyprinodontiformes LH LS; LM  MSA phenomenon in which there is a relatively profound alteration in brain function resulting from repeated electrical or chemical stimulation and culminating in the appearance of electrographic and behavioral convulsions whenever the stimulus is re-applied. Used as an experimental model for epilepsy. PM82 HN82 MHÑKindling (Neurology) ANonly /drug eff /rad eff; DF: KINDLING PIAmygdaloid Body (66-81); Convulsions (66-81); Electric Stimulation (66-81) MNG11.561.426 FXÑConvulsions; ÑEpilepsy; ÑModels, Neurological LH LX; ;  MSSystematic study of the body and the use of its static and dynamic position as a means of communication. PM68; GESTURES was see under COMMUNICATION 1963-67 HN68 MHÑKinesics ANno qualif; do not confuse with KINETICS or KINESIS: kinesics = ╥use of posture or gesture for communication╙ PIBehavior, Animal (66-67); Communication (66-67) MNF1.145.209.530.538 XSBody Language FXÑPosture XUÑGestures LH LS LX LU  MSLocomotor behavior not involving a steering reaction, but in which there may be a turning random in direction. Includes orthokinesis, the rate of movement and klinokinesis, the amount of turning, which are related to the intensity of stimulation. OLsearch ORIENTATION 1968-74 HN(75) MHÑKinesis ANonly /drug eff /physiol /rad eff; do not confuse with KINETICS or KINESICS MNF2.830.606.587 DMÑOrientation LH LM  MSThe sense by which muscular motion, weight, postion, etc., are perceived. MHÑKinesthesis ANonly /drug eff /physiol /rad eff; TN 129: definition & relation to MOTION PERCEPTION MNF2.830.816.541.504; G11.561.796.541.587 LH  PM66 HN66(64) MHÑKinetics ANalmost never IM; no qualif; do not confuse with KINESICS (╥use of posture or gesture for communication╙) or KINESIS; pharmacokinetics of chemicals and drugs is indexed under drug /metab (IM) + KINETICS (NIM): Bull 102 (Oct 77); cell kinetics = CYTOKINETICS see CELL CYCLE MNH1.671.434 LH  OLsearch PLANT GROWTH REGULATORS 1968-74 HN(75) MHÑKinetins AND25-26 qualif MND11.303.760.265.400 DMÑPlant Growth Regulators LH LM  PM67 HN67(64) MHÑKinetocardiography ANdo not use /util except by MeSH definition MNE1.145.569.627 XSACCELOGRAPHY; APEX CARDIOGRAPHY; VIBROCARDIOGRAPHY LH LS; ;  PM74 HN74(73) MHÑKininase II ANdo not use /analogs RNEC 3.4.15.1 PIPeptide Peptidohydrolases (66-72) MND8.586.277.656.732.454 XSANGIOTENSIN CONVERTING ENZYME; Tonin LH LS;  MSInert endogenous peptides present in most body fluids; certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Synonyms: prekinins; prokinins. PM74 HN74(72) MHÑKininogens ANdo not use /analogs /defic PIKinins (66-71); Proteins (66-71) MND12.644.320.654; D12.776.811.420; D24.185.798.354.654 LH  PM66 HN66(64) MHÑKinins ANdo not use /analogs MND12.644.320; D24.185.798.354 XUÑPhysalaemin LH LU  MSAn x-linked inherited disease with disturbance of intestinal absorption of copper, causing growth retardation, pili torti, progressive cerebral degeneration, mental retardation and other abnormalities. HN(77) MHÑKinky Hair Syndrome ANdo not use /congen PIBrain Diseases (66-76) MNC10.228.140.163.520; C18.452.648.618.590; C23.205.520; F3.709.346.465 XSMenkes Syndrome; Steely Hair Syndrome DMÑBrain Diseases, Metabolic LH LS; LM  OLuse KIRGHIZ S.S.R. to search KIRGHIZIA back thru 1966 HN82; was KIRGHIZIA 1963-81 MHÑKirghiz S.S.R. MNZ1.252.878.100.540; Z1.950.100.540 LH  MSA defective murine sarcoma virus capable of transforming mouse lymphoid cells and producing erythroid leukemia after superinfection with murine leukemia viruses. It has also been found to transform cultured human fibroblasts, rat liver epithelial cells, and rat adrenocortical cells. HN(80) MHÑKirsten Sarcoma Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with SARCOMA, EXPERIMENTAL (IM) PIMouse Sarcoma Viruses (75-79); Mouse Tumor Viruses (66-74) MNB4.909.574.807.674.700.540; B4.909.777.731.674.700.540; B4.909.777.779.674.700.540 DMÑMouse Sarcoma Viruses LH LM  MHÑKlebsiella ANdo not use /blood-csf-urine MNB3.475.300.500 XUÑKlebsiella Rhinoscleromatis LH LU  MSInfections with bacteria of the genus Klebsiella. PM68 HN68 MHÑKlebsiella Infections ANcoord IM with various species (NIM) PIKlebsiella (66-67) MNC1.252.310.503 LH  MSGram negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in man. PM74 HN74(72) MHÑKlebsiella Pneumoniae ANdo not use /blood-csf-urine; infection: coord NIM with KLEBSIELLA INFECTIONS (IM) PIKlebsiella (66-71) MNB3.475.300.500.600 XSKlebsiella aerogenes LH LS  MSA Gram-negative facultatively anaerobic rod-shaped bacterium found constantly and exclusively in patients with rhinoscleroma and their contacts. HN(72) MHÑKlebsiella Rhinoscleromatis ANdo not use /blood-csf-urine; infection: = probably RHINOSCLEROMA but if not, coord NIM with KLEBSIELLA INFECTIONS (IM) PIKlebsiella (66-71) MNB3.475.300.500.700 DMÑKlebsiella LH LM  MHÑKlinefelter's Syndrome ANin males; do not use /congen; = classic karyotype XXY; index here karyotypes XXXY, XXXXY, XXYY, XXXYY, XX/XXY, XX/YY, XY/XXY, XXY/XXXY, XXY/XXYY, XY/XXY/XXXY if called Klinefelter's syndrome by author but if not so named by author, index under SEX CHROMOSOME ABNORMALITIES MNC16.131.280.748.421; C16.131.939.842.454; C19.391.482.629 LH  MHÑKlippel-Feil Syndrome ANdo not use /congen MNC5.116.99.370.535; C16.131.621.551 XSDYSTROPHIA BREVICOLLIS CONGENITA LH LS  OLsearch ANGIOMATOSIS 1966-74 HN(75) MHÑKlippel-Trenaunay Disease MNC4.557.690.146.504 DMÑAngiomatosis LH LM  MSAn ascomycetous yeast of the fungal family Saccharomycetaceae, order Endomycetales. This genus is used in the study of genetic transformation and transcription. HN(86) MHÑKluyveromyces ANdo not use /embryol /microbiol /parasitol PIAscomycetes (66-85); Endomycetales (75-85) MNB5.354.107.292.536; B5.354.930.536 DMÑEndomycetales LH LM  MHÑKnee ANprimates only; any Cat A qualif; /inj = KNEE INJURIES but PATELLA /inj is also available; TN 238: differentiation from KNEE JOINT & indexing instructions MNA1.378.592.586 LH  MHÑKnee Injuries ANconsider also PATELLA /inj MNC21.866.558.554 LH  PM65 HN65 MHÑKnee Joint ANprimates only; any Cat A qualif; /inj = KNEE INJURIES; TN 238: differentiation from KNEE & indexing instructions MNA2.835.583.475 LH  MSPartial or total replacement of the knee joint. PM80 HN80 MHÑKnee Prosthesis ANdo not use /instrum /methods /util (except by MeSH definition) PIArthroplasty (66-79); Joint Prosthesis (71-79); Knee (66-79); Knee Joint (66-79); Prosthesis (66-70) MNE4.557.168.530.540; E4.659.550.540; E7.450.530.550; E7.858.442.499.540; E7.858.565.600.540 XSArthroplasty, Replacement, Knee LH LS  MSThe hypothesis that learning is facilitated when the learner is informed at each step about the progress he is making in his learning; also, the hypothesis that learning is facilitated when the learner is promptly informed whether a particular response is correct, and if incorrect, of the direction of error. The two usages refer to distinguishable situations and probably to different psychological processes. OLuse KNOWLEDGE OF RESULTS (PSYCHOLOGY) to search KNOWLEDGE OF RESULTS 1966-78 PM79; was KNOWLEDGE OF RESULTS 1965-78 HN79; was KNOWLEDGE OF RESULTS 1965-78 MHÑKnowledge of Results (Psychology) ANno qualif; DF: KNOWLEDGE OF RESULTS MNF2.463.425.770.379 LH  MSKnowledge and attitudes related to the practice of family planning; includes KAP surveys. HN(75) MHÑKnowledge, Attitudes, Practice ANno qualif; restrict to family planning, birth control & contraception articles; knowledge of physicians in non-contraception contexts is probably CLINICAL COMPETENCE; do not use for knowledge or attitude or practice in psychol literature ( = possibly KNOWLEDGE OF RESULTS or ATTITUDE or PRACTICE (PSYCHOLOGY) ); DF: KAP MNN2.421.143.401.625 DMÑFamily Planning LH LM  MHÑKorea MNZ1.252.474.538 XSNorth Korea; South Korea LH LS;  MHÑKraurosis Vulvae MNC13.371.944.338 LH  MSMucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and signet-ring-like cells. PM75 HN75 MHÑKrukenberg's Tumor ANcoord IM with OVARIAN NEOPLASMS (IM); /anal /blood supply /secret /ultrastruct permitted PIOvarian Neoplasms (66-74) MNC4.557.117.390.500; C4.557.576.197.500; C4.588.322.455.400; C4.588.945.418.685.538; C13.371.56.630.705.490 LH  MHÑKrypton ANKr-84; do not use /analogs /biosyn /defic /physiol; Kr-78, 80, 82, 83, 86 = KRYPTON (IM) + ISOTOPES (NIM); Kr-74-77, 79, 81, 85, 87-94 = KRYPTON (IM) + RADIOISOTOPES (IM) RN7439-90-9 MND1.268.465; D1.362.641.468 LH  PM73 HN73 MHÑKupffer Cells ANA 11 qualif; also called reticuloendothelial cells of liver PIMacrophages (66-72) MNA11.329.372.588; A11.733.397.588; A15.382.680.397.588; A15.382.812.522.588 LH  MHÑKuru MNC2.839.539; C10.228.228.435 LH  MHÑKuwait MNZ1.252.245.93.490; Z1.630.100.540 LH  MSIntradermal injection of a heated (pasteurized) saline suspension of sarcoid tissue obtained from a sarcoid spleen or lymph node. In patients with active sarcoidosis a dusky red nodule develops slowly over the next few weeks at the injection site. Histologic examination, an essential part of the complete test, reveals sarcoid tissue. HN(75) MHÑKveim Test ANonly /instrum MNE1.223.495.862.345.540; E1.862.345.540 DMÑSkin Tests LH LM  MHÑKwashiorkor MNC18.654.223.708.626.505; C18.654.439.505 LH  MSTick-borne arbovirus infection occurring in the Kyasanur Forest in India. PM78; was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76 HN78(75); was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76 MHÑKyasanur Forest Disease ANnote spelling: not Kyanasur PIArbovirus Infections (66-77); Hemorrhagic Fevers, Viral (66-74) MNC2.782.417.475; C2.782.930.540; C2.81.540 LH  MHÑKymography ANNIM; do not use /util except by MeSH definition MNE1.528 LH  MS3-Amino-1-(2-aminophenyl)-1-propanone. HN(75) MHÑKynuramine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN363-36-0 PIAmines (72-74); Propiophenones (72-74) MND2.522.818.600 XSDiaminopropiophenone DMÑPropiophenones LH LS LM  MHÑKynurenic Acid ANdo not use /biosyn /defic /physiol RN492-27-3 MND3.66.942.505; D3.438.810.350.400 LH  MHÑKynurenine RN343-65-7 MND12.125.608 LH  MHÑKyphosis MNC5.878.616.380 LH  PM66 HN66(64) MHÑL Cells ANalmost never IM; no qualif when NIM, A 11 qualif when IM; check tags ANIMAL & MICE MNA11.251.210.505; A11.329.228.505 LH  MSBacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (L bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain. PM66 HN66(65) MHÑL Forms ANdo not use /blood-csf-urine; coord IM with specific bacterium (IM) MNB3.110.422 LH  MS5-[1-Hydroxy-2(1-methyl-3-phenylpropylamino)ethyl]salicylamide. Blockader of both alpha and beta adrenergic receptors; proposed as an antihypertensive. Synonym: Ibidomide. OLuse LABETALOL to search AH 5158 back thru 1975 PM86; was see under ETHANOLAMINES 1978-85, was AH 5158 see under ETHANOLAMINES 1975-77 HN86(78); was see under ETHANOLAMINES 1978-85, was AH 5158 see under ETHANOLAMINES 1975-77 MHÑLabetalol ANdo not use /biosyn /defic /physiol RN36894-69-6 PIButylamines (74); Ethanolamines (74); Salicylamides (74) MND2.33.329.291.460; D2.92.63.291.460; D16.848.115.510; D16.848.215.455; D18.162.510 XSAH 5158 LH LS  PM65 HN65 MHÑLabial Frenum MNA14.549.336.505 XSFrenum, Labial FXÑDiastema LH LS LX  MHÑLabor ANqualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /psychol /rad eff; check tags FEMALE & PREGNANCY: /chem ind = LABOR, INDUCED; /drug eff: consider also LABOR, INDUCED & OXYTOCICS; ╥tokolysis╙: translate as ╥tocolysis╙ & index probably as LABOR, PREMATURE /prev MNG8.520.769.326 XSCHILDBIRTH; Parturition FXÑFetal Monitoring XUÑLabor Onset; ÑLabor Stage, First; ÑLabor Stage, Second; ÑLabor Stage, Third LH LS; LX LU; ; ;  PM64 HN64 MHÑLabor Complications ANdo not use /compl /congen /embryol /familial /hist /transm; check tags FEMALE & PREGNANCY; DF: LABOR COMPL MNC13.703.420 LH  MSThe establishment of regular uterine contractions together with beginning dilatation of the cervix. HN(75) MHÑLabor Onset ANhuman only; qualif permitted as for LABOR above; check tags FEMALE & PREGNANCY MNG8.520.769.326.200 DMÑLabor LH LM  MSThe part of the fetal body that is in advance in the birth canal. MHÑLabor Presentation ANno qualif; check tags FEMALE & PREGNANCY MNG8.520.769.362 XSFETAL PRESENTATION; PRESENTATION, FETAL FXÑDelivery LH LS; LX  MSPeriod from the onset of labor through complete dilatation of the cervix. OLuse LABOR STAGE, FIRST to search LABOR, FIRST STAGE back thru 1975 HN(77); was LABOR, FIRST STAGE see under LABOR 1975-76 MHÑLabor Stage, First ANhuman only; dilatation stage; qualif permitted as for LABOR above; check tags FEMALE & PREGNANCY MNG8.520.769.326.200.80 XSLabor, First Stage DMÑLabor LH LS LM  MSPeriod of labor from complete dilatation of the cervix through birth of the fetus. OLuse LABOR STAGE, SECOND to search LABOR, SECOND STAGE back thru 1975 HN(77); was LABOR, SECOND STAGE see under LABOR 1975-76 MHÑLabor Stage, Second ANhuman only; expulsion stage; qualif permitted as for LABOR above; check tags FEMALE & PREGNANCY MNG8.520.769.326.200.90 XSLabor, Second Stage DMÑLabor LH LS LM  MSPeriod of labor from birth of the fetus through expulsion or extraction of the placenta and membranes. OLuse LABOR STAGE, THIRD to search LABOR, THIRD STAGE back thru 1975 HN(77); was LABOR, THIRD STAGE see under LABOR 1975-76 MHÑLabor Stage, Third ANhuman only; placental stage: placenta & membrane expelled & uterine contraction completed; qualif permitted as for LABOR above; check tags FEMALE & PREGNANCY MNG8.520.769.326.200.110 XSLabor, Third Stage DMÑLabor LH LS LM  MSOrganizations comprised of wage and salary workers in health-related fields for the purpose of improving their status and conditions; includes labor union activities to provide health services to members. PM67 HN67(64) MHÑLabor Unions ANonly /class /econ /hist /legis /organ; COLLECTIVE BARGAINING & STRIKES, EMPLOYEE are also available MNN3.540.571 XSTRADE UNIONS LH LS  MSLabor that is brought about by artificial means. MHÑLabor, Induced ANonly /adv eff /methods /mortal /nurs /psychol /util (if by MeSH definition) /vet; check tags FEMALE & PREGNANCY; amniotomy in inducing labor: coord IM with AMNION /surg (IM) MNE4.819.774.457.533 FXÑOXYTOCICS LH LX  MSOnset of labor before term but after the fetus has become viable, usually sometime during the 29th through 38th week of gestation. PM67 HN67(64) MHÑLabor, Premature AN╥tokolysis╙: translate as ╥tocolysis╙ & index probably as LABOR, PREMATURE /prev; check tags FEMALE & PREGNANCY MNC13.703.453 FXÑInfant, Premature LH LX  MSFacilities equipped to carry out investigative procedures. MHÑLaboratories ANonly /class /econ /hist /man /organ /stand /supply /util MNN2.278.487 LH  MSFacilities in which the dentist or his auxiliaries perform services related to treatment not done directly in the patient's mouth. PM74 HN74(72) MHÑLaboratories, Dental ANonly /class /econ /hist /man /organ /stand /supply /util MNN2.278.192.631 LH  MSThe science and technology dealing with the procurement, breeding, care, health, and selection of animals used in biomedical research and testing. PM87 HN87 MHÑLaboratory Animal Science ANSPEC: SPEC qualif PIAnimals, Laboratory (66-86) MNG1.273.368 FXÑVeterinary Medicine LH LX  MSAccidentally acquired infection in laboratory workers. PM68 HN68(64) MHÑLaboratory Infection AN╥accidentally acquired infect in laboratory╙; IM; coord with specific infection (IM) + lab animal (IM) MNC1.539.503; C21.447.506 LH  MHÑLabyrinth AN/inj: pressure-induced inj = LABYRINTH /inj (IM) + BAROTRAUMA (IM), noise-induced inj = only HEARING LOSS, NOISE-INDUCED; inflammation = LABYRINTHITIS; neopl = LABYRINTH DISEASES (IM) + EAR NEOPLASMS (IM) + histol type of neopl (IM) MNA9.246.631 XSEAR, INTERNAL FXÑTemporal Bone XUÑBasilar Membrane; ÑEndolymphatic Duct; ÑEndolymphatic Sac LH LS LX LU; ;  MHÑLabyrinth Diseases ANinflamm dis = LABYRINTHITIS MNC9.218.568 XUÑLabyrinthitis LH LU  MSCells forming a framework supporting the organ of Corti. Specific cells are those of Claudius, Deiters and Hensen. HN(79) MHÑLabyrinth Supporting Cells ANA 11 qualif PICochlea (66); Organ of Corti (67-78) MNA9.246.631.246.577.543; A11.436.495 XSSupporting Cells, Labyrinth DMÑOrgan of Corti LH LS LM  MHÑLabyrinthine Fluids ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.207.571 XUÑEndolymph; ÑPerilymph LH LU;  MSInflammation of the inner ear. OLto search OTITIS INTERNA use LABYRINTHITIS back thru 1975 & LABYRINTH DISEASES 1966-74 HN(79); was OTITIS INTERNA see under LABYRINTH DISEASES 1963-78 MHÑLabyrinthitis MNC9.218.568.315 XSOtitis Interna DMÑLabyrinth Diseases LH LS LM  MSThe genetic unit consisting of three structural genes, an operator and a regulatory gene, which control the synthesis of beta-galactosidase, beta-galactoside permease and beta-thiogalactoside acetyltransferase. PM79 HN79 MHÑLac Operon ANnote category; only /drug eff /rad eff; consider also LAC REPRESSORS (see note on REPRESSOR PROTEINS) PILactose (66-78); Operon (69-78) MNG5.275.769.545 LH  OLsearch PAINT 1966-74 HN(75) MHÑLacquer ANonly /ad-poi-tox /anal /class /hist /stand /supply MNJ1.637.597.422 DMÑPaint LH LM  MHÑLacrimal Apparatus ANinflammation = DACRYOCYSTITIS; lacrimation: index TEARS /secret unless LACRIMAL APPARATUS /secret or LACRIMAL APPARATUS /physiol is particularly discussed; epiphora: index under LACRIMAL APPARATUS DISEASES MNA9.371.463; A10.336.422 FXÑExocrine Glands; ÑTEARS XUÑHarderian Gland; ÑNasolacrimal Duct LH LX; LU;  MSDiseases of the lacrimal apparatus. PM76 HN76; was NON MESH before 1976 MHÑLacrimal Apparatus Diseases ANinflamm dis = DACRYOCYSTITIS; epiphora goes here PILacrimal Apparatus (66-75); specific lacrimal apparatus disease heading MNC11.496 LH  MHÑLacrimal Duct Obstruction MNC11.496.456 LH  OLsearch ALBUMINS 1966-72 PM73; was see under ALBUMINS 1963-72 HN73; was see under ALBUMINS 1963-72 MHÑLactalbumin ANdo not use /defic /physiol RN9013-90-5 PIAlbumins (66-72) MND12.776.34.398; D12.776.256.626.506 LH  PM74 HN74(72) MHÑLactams ANdo not use /analogs /biosyn /defic /physiol PIAmides (66-71) MND2.65.589; D3.383.411 LH  MHÑLactate Dehydrogenase ANdo not use /analogs; DF: LDH RNEC 1.1.1.27 MND8.586.682.47.547 XSLACTIC CYTOCHROME REDUCTASE LH LS  PM67 HN67 MHÑLactate Dehydrogenase Isoenzymes ANdo not use /analogs; DF: LDH ISOENZYMES RNEC 1.1.1.- PILactate Dehydrogenase (66) MND8.586.348.423; D8.586.682.47.547.506 LH  MSAn unclassified RNA virus occurring in a number of transplantable mouse tumors. Synonyms: lactic dehydrogenase virus; Riley virus; LDH agent. OLto search RILEY VIRUS use LACTATE DEHYDROGENASE VIRUS back thru 1975, RNA VIRUSES 1969-74 & VERTEBRATE VIRUSES, UNCLASSIFIED 1967-68 PM77; was see under RNA VIRUSES 1969-76; RILEY VIRUS was see under RNA VIRUSES 1969-76 with LACTIC DEHYDROGENASE VIRUSES see RILEY VIRUS 1975-76, was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1967-68 HN77(75); was see under RNA VIRUSES 1969-76; RILEY VIRUS was see under RNA VIRUSES 1969-76 with LACTIC DEHYDROGENASE VIRUSES see RILEY VIRUS 1975-76, was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1967-68 MHÑLactate Dehydrogenase Virus ANdo not use /blood-csf-urine /cytol; DF: LDH VIRUS PIRNA Viruses (66-74) MNB4.909.777.401 XSLactic Dehydrogenase Virus; Riley Virus LH LS;  MHÑLactates ANdo not use /analogs /defic /physiol MND2.241.511.459 LH  MHÑLactation ANqualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /psychol /rad eff; check tags FEMALE & PREGNANCY (unless of course in the rare case of lactation without pregn which is indexed under GALACTORRHEA without tag PREGNANCY); ╥postpartum amenorrhea╙ is indexed under PUERPERIUM + AMENORRHEA & not LACTATION unless lactation is particularly discussed; ANIMALS, SUCKLING is available but the suckling of an animal (the act, as in the eff of suckling on animal physiol) goes here: human suckling goes under BREAST FEEDING; exper induced lactation unrelated to pregn (i.e., in non-pregn animals) goes here but do not check PREGNANCY MNG8.520.882.608 FXÑBreast; ÑColostrum; ÑMILK; ÑMILK, HUMAN XUÑLactation, Prolonged; ÑMilk Ejection LH LX; ; ; LU;  MSDisturbances of milk secretion in either sex, not necessarily related to pregnancy. MHÑLactation Disorders ANin both sexes & not necessarily related to pregn; usually check tags PREGNANCY & FEMALE also; consider also GALACTORRHEA MNC13.703.844.506; C19.146.556 XSHypogalactia XUÑGalactorrhea LH LS LU  MSProlongation of the lactational period. Do not confuse with Lactation Disorders. HN(75) MHÑLactation, Prolonged ANnote category: do not confuse with LACTATION DISORDERS; qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /psychol /rad eff; check tags FEMALE & PREGNANCY MNG8.520.882.608.410 DMÑLactation LH LM  MSA family of Gram-positive bacteria found regularly in the mouth and intestinal tract of man and other animals, in food and dairy products, and in fermenting vegetable juices; a few species are highly pathogenic. PM75 HN75 MHÑLactobacillaceae ANin food, dairy prod, plants, digestive system PIBacteria (66-74) MNB3.500.575 LH  MHÑLactobacillus ANdo not use /blood-csf-urine MNB3.500.575.444 LH  MHÑLactobacillus Acidophilus ANin feces of milk-fed subjects MNB3.500.575.444.423 LH  MSA rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cowdung, silage, and human mouth, human intestinal contents and stools, and the human vagina. PM74 HN74(72) MHÑLactobacillus Casei ANin milk & cheese PILactobacillus (66-71) MNB3.500.575.444.589 LH  HN(73) MHÑLactoferrin AN/biosyn /physiol permitted; /analogs NIM only MND12.776.157.470; D12.776.256.626.632.507; D12.776.377.457.507; D12.776.395.507; D12.776.556.632 DMÑLactoglobulins LH LM  OLuse LACTOGLOBULINS to search LACTOGLOBULIN back thru 1966 (as Prov 1966) PM67; was LACTOGLOBULIN see under GLOBULINS 1963-66 HN67; was LACTOGLOBULIN 1963-66 (Prov) see under GLOBULINS MHÑLactoglobulins AN/biosyn /physiol permitted; do not use /analogs MND12.776.256.626.632; D12.776.377.457 XUÑLactoferrin LH LU  MHÑLactones ANdo not use /analogs /defic /physiol MND2.540 XUÑPropiolactone; ÑVenturicidins LH LU;  MSAn enzyme derived from cow's milk. It catalyzes the radioiodination of tyrosine and its derivatives and of peptides containing tyrosine. HN(75) MHÑLactoperoxidase ANdo not use /analogs RNEC 1.11.1.- PIPeroxidases (69-74) MND8.586.682.732.550 DMÑPeroxidases LH LM  MHÑLactose ANdo not confuse with LACTULOSE; ╥lactose malabsorption╙ = LACTOSE INTOLERANCE; lac gene = LAC OPERON; consider also next entry & also LAC REPRESSORS (see note on REPRESSOR PROTEINS) RN63-42-3 MND9.203.698.629.305.340 LH  MSPlasmids which determine the ability of a bacterium to ferment lactose. HN(78) MHÑLactose Factors ANonly /drug eff /rad eff PILactose (66-77); Plasmids (75-77) MNG5.225.500.545 XSLac Factors DMÑPlasmids LH LS LM  MSThe disease state resulting from the absence of lactase enzyme in the musocal cells of the gastrointestinal tract, and therefore an inability to break down the disaccharide lactose in milk for absorption from the gastrointestinal tract. It is manifested by indigestion of a mild nature to severe diarrhea. It may be due to inborn defect genetically conditioned or may be acquired. PM67 HN67(64) MHÑLactose Intolerance ANdo not use /congen; lactose malabsorption goes here MNC6.405.469.637.506; C18.452.603.506; C18.452.648.202.589 LH  PM74 HN74(72) MHÑLactose Synthetase ANdo not use /analogs RNEC 2.4.1.22 PIGlucosyltransferases (66-71); Lactation (66-71); Ligases (66-71); Mammae (66-71); Transferases (66-71) MND8.586.600.541; D8.586.913.407.310.500 XUÑN-Acetyllactosamine Synthetase LH LU  PM74 HN74 MHÑLactose Tolerance Test ANNIM; only /instrum /methods /stand /vet MNE1.184.506; E1.223.174.229.612 LH  MSGlycosphingolipids which contain as their polar head group a lactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in lactosylceramide beta-galactosidase, is the cause of lactosylceramidosis. HN(79) MHÑLactosylceramides AN/biosyn /physiol permitted; do not use /analogs PICeramides (72-78); Cerebrosides (66-78); Glycosphingolipids (75-78) MND10.516.390.470.530; D10.516.808.530.530 XSLactosyl Ceramides DMÑGlycosphingolipids LH LS LM  MSS-Lactoyl-glutathione methylglyoxal-lyase (isomerizing). Catalyzes the interconversion of methylglyoxal and lactate, with glutathione serving as a coenzyme. HN(75) MHÑLactoyl Glutathione Lyase ANdo not use /analogs RNEC 4.4.1.5 PIGlutathione (73-74); Glyoxal (74); Lyases (73-74) MND8.586.520.600 XSGlyoxalase I; Methylglyoxalase DMÑLyases LH LS; LM  HN(73) MHÑLactulose ANdo not confuse with LACTOSE; /analogs NIM only RN4618-18-2 MND9.203.698.629.305.423; D19.316.396.521 DMÑDisaccharides LH LM  OLsearch RABBITS 1966-74 HN(75); was see under RABBITS 1963-74 MHÑLagomorpha ANGEN for hares, pikas & RABBITS; check text to see if it is RABBITS only; IM when not merely an exper animal; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not check tag RABBITS MNB2.649.521 DMÑMammals LH LM  MSA departure from the normal gait in animals. Synonym: Claudication PM76 HN76 MHÑLameness, Animal ANdo not use /vet but check tag ANIMAL PIGait (66-75) MNC22.510; C23.888.530 LH  MSA genus of seaweed. Dried pencil-like pieces may be inserted in the cervix where they swell as they absorb moisture, and thus dilate the cervix. HN(80) MHÑLaminaria ANdo not use /anat /embryol /microbiol /parasitol; for dried Laminaria for cervical dilat & ╥laminaria tent╙, use no qualif PISeaweed (66-79) MNB5.104.837.550 DMÑSeaweed LH LM  PM67 HN67(64) MHÑLaminectomy ANdo not use /util except by MeSH definition MNE4.530.557 FXÑSpinal Fusion; ÑSpine LH LX;  MSLarge, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cell to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. PM84 HN84 MHÑLaminin AN/biosyn /physiol permitted PIGlycoproteins (66-83); Membrane Proteins (77-83); Neoplasm Proteins (66-83) MND12.776.395.530; D12.776.543.500 LH  OLsearch CYCLOSTOMES 1968-74 HN(75) MHÑLampreys ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.181.590 DMÑCyclostomes LH LM  MHÑLanatosides ANdo not use /analogs /biosyn /defic /physiol MND9.203.408.180.261.657; D18.222.175.324.542 XSDIGILANIDES XUÑDeslanoside LH LS LU  MSA Flavivirus (group B arbovirus) first isolated from ticks in Malaya; It's comparatively low pathogenicity for mice and monkeys has suggested its possible use as an immunizing agent against other tick-borne viruses. HN(75); was see under ARBOVIRUSES 1975-80 MHÑLangat Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TOGAVIRUS INFECTIONS (IM) MNB4.909.777.923.377.550 DMÑFlaviviruses LH LM  PM73 HN73(69) MHÑLangerhans Cells ANA 11 qualif; cutaneous cells: do not confuse with ISLANDS OF LANGERHANS (pancreas) PICytoplasmic Granules (66-68); Epithelium (66-68); Skin (66-68) MNA11.436.270.545 LH  MSA verbal or nonverbal means of communicating ideas or feelings. MHÑLanguage ANwhat is spoken or written; do not confuse with LINGUISTICS (see note there) or SPEECH (language as it comes out of the mouth); no qualif; SIGN LANGUAGE is available MNF1.145.209.399; L1.143.506 LH  OL╥language arts╙ is indexed LANGUAGE or LINGUISTICS MH*Language Arts (Non Mesh) MNL1.143.506.423 LH  MSThe gradual expansion in complexity and meaning of symbols and sounds as perceived and interpreted by the individual through a maturational and learning process. Stages in development include babbling, cooing, word imitation with cognition and use of small sentences. PM68 HN68 MHÑLanguage Development ANno qualif PIChild Psychology (66-67); Language (66-67); Learning (66-67); Speech (66-67) MNF1.525.200.310 FXÑLearning; ÑPhonetics; ÑPsycholinguistics; ÑSpeech XUÑChild Language LH LX; ; ; LU  MSFailure to understand or speak the language at the expected age. Causal factors include slow maturation, hearing loss, brain injury, mental retardation and emotional disorders. PM86; was see under LANGUAGE DISORDERS 1980-85 HN86(80); was see under LANGUAGE DISORDERS 1980-85 MHÑLanguage Development Disorders ANdo not use /congen /drug eff /physiol /rad eff; do not confuse with LANGUAGE DISORDERS, disord of use or comprehension of language: LANGUAGE DEVELOPMENT DISORDERS is ╥failure to understand or speak the language at the expected age╙ PILanguage Development (68-79); Language Disorders (67-79) MNC10.597.257.543.562; C23.888.592.257.543.562; F3.126.219.543.562; F3.305.410 XSLanguage Delay LH LS  MSDisabilities related to both the sensory and motor aspects of language; includes impairments in understanding of written and spoken language, and impairments in speaking and writing language. PM67 HN67; was in Cat F only 1967-79 MHÑLanguage Disorders ANdo not use /congen /drug eff /physiol /rad eff; /ther: consider also LANGUAGE THERAPY; do not confuse with SPEECH DISORDERS: read differentiation of LANGUAGE & SPEECH above under LANGUAGE; do not confuse with LANGUAGE DEVELOPMENT DISORDERS: see note there PILanguage (66) MNC10.597.257.543; C23.888.592.257.543; F3.126.219.543 FXÑVerbal Behavior; ÑVerbal Learning LH LX;  MSTests designed to assess language behavior and abilities that include tests of vocabulary, comprehension, grammar and functional use of language, e.g., Development Sentence Scoring, Receptive-Expressive Emergent Language Scale, Parsons Language Sample, Utah Test of Language Development, Michigan Language Inventory and Verbal Language Development Scale, Illinois Test of Psycholinguistic Abilities, Northwestern Syntax Screening Test, Peabody Picture Vocabulary Test, Ammons Full-Range Picture Vocabulary Test, Assessment of Children's Language Comprehension. PM79 HN79 MHÑLanguage Tests ANonly /class /instrum /methods /stand /util (if by MeSH definition) PILanguage (66-78); Language Development (68-78) MNF4.711.400 XSLanguage Comprehension Tests; Vocabulary Tests LH LS;  MSRehabilitation of persons with language disorders or training of children with language development disorders. PM80 HN80 MHÑLanguage Therapy ANonly /econ /educ /hist /instrum /methods /psychol /trends; do not confuse with SPEECH THERAPY: LANGUAGE THERAPY is for LANGUAGE DISORDERS, SPEECH THERAPY is for SPEECH DISORDERS; coord IM with specific lang disord /ther, not /rehabil PILanguage Disorders (67-79); Speech Therapy (66-79) MNE2.831.727.344 XSLanguage Training LH LS  MHÑLanolin AND25-26 qualif RN8006-54-0 MND10.516.945.507; D26.368.405.424; D26.698.523.424 LH  PM74 HN74(72) MHÑLanosterol AN/biosyn permitted; do not use /defic /physiol RN79-63-0 PISterols (66-71) MND4.808.247.222.222.347.557; D4.808.247.808.607; D10.516.851.590 XSKRYPTOSTEROL LH LS  MHÑLanthanum ANLa-139; do not use /analogs /biosyn /defic /physiol; La-138 = LANTHANUM (IM) + ISOTOPES (NIM); La-126-137, 140-144 = LANTHANUM (IM) + RADIOISOTOPES (IM) RN7439-91-0 MND1.268.473; D1.552.550.474 LH  MHÑLaos MNZ1.252.145.435 LH  MHÑLaparotomy ANavoid: used too loosely in the literature; not a coord for operative surg on abdominal organs; restrict to technic of surg incision of abdom wall at any point; usually exploratory; prefer /surg with specific organs; only /adv eff /instrum /methods /vet MNE4.406 LH  MSWormlike or grublike stage, following the egg in the life cycle of insects, worms, and other metamorphosing animals. PM74 HN74(70) MHÑLarva ANNIM; only for metamorphosing animals (so correct for tadpoles); do not use /embryol with reference to larvae PIInsects (66-69); specific organism; Metamorphosis, Biological (66-69) MNB1.583.382 LH  MSA linear skin eruption gradually extending at one end while fading at the other; most often due to the presence of cat and dog hookworms, Ancylostoma braziliense, which burrow beneath the skin, but fail to reach the gut. MHÑLarva Migrans ANnote category: a disease; restrict to this dis to nematode infections MNC3.335.508.523; C3.858.424; C17.860.424 XSCREEPING ERUPTION LH LS  MSA condition produced in man by the prolonged migration of animal nematode larvae in extraintestinal tissues other than skin; characterized by persistent hypereosinophilia, hepatomegaly, and frequently pneumonitis, commonly caused by Toxocara canis and Toxocara cati. PM68 HN68 MHÑLarva Migrans, Visceral ANnote category: a disease; in human only, caused by Toxocara; in animal probably = TOXOCARIASIS PILarva Migrans (66-67) MNC3.335.508.70.457 LH  MSThe nine cartilages of the larynx, including the cricoid, thyroid and epiglottic, and two each of arytenoid, corniculate and cuneiform. MHÑLaryngeal Cartilages ANGEN: note specifics below; inflammation = LARYNGEAL PERICHONDRITIS; ╥Adam's apple╙ goes under THYROID CARTILAGE MNA2.165.507; A4.329.591 FXÑCartilage XUÑArytenoid Cartilage; ÑCricoid Cartilage; ÑThyroid Cartilage LH LX LU; ;  MSDisorders of the larynx, general or unspecified. PM66 HN66 MHÑLaryngeal Diseases ANinflamm dis = LARYNGITIS MNC9.400 FXÑOTORHINOLARYNGOLOGIC DISEASES XUÑGranuloma, Laryngeal LH LX LU  MHÑLaryngeal Edema MNC9.400.313 FXÑEdema LH LX  MSThe mucous lining of the larynx; mainly stratified squamous epithelium in the upper part and ciliated columnar in the lower part of the larynx. HN(79) MHÑLaryngeal Mucosa PILarynx (66-78); Mucous Membrane (66-78) MNA4.329.597; A10.615.550.543 DMÑLarynx LH LM  MSThe intrinsic muscles of the larynx are the aryepiglottic(us), arytenoid(eus), cricoarytenoid(eus), cricothyroid(eus), thyroarytenoid(eus), thyroepiglottic(us) and vocal(is). HN(79) MHÑLaryngeal Muscles PILarynx (66-78); Muscles (66-78) MNA2.633.528; A4.329.604 DMÑMuscles LH LM  MHÑLaryngeal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); laryngeal polyps = LARYNGEAL NEOPLASMS (IM) + POLYPS (IM) MNC4.588.443.665.543; C9.400.369 LH  PM65 HN65 MHÑLaryngeal Nerves ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.99.698.730.508; A8.796.214.936.508 XUÑRecurrent Laryngeal Nerve LH LU  MHÑLaryngeal Perichondritis MNC9.400.424 LH  MHÑLaryngectomy ANdo not use /util except by MeSH definition MNE4.847.369 FXÑSpeech, Alaryngeal LH LX  MHÑLaryngismus MNC8.618.573; C9.400.480 XSLARYNGOSPASM LH LS  MHÑLaryngitis MNC8.730.368; C9.400.535 XUÑCroup; ÑEpiglottitis LH LU;  MHÑLaryngoscopy ANNIM; do not use /util except by MeSH definition MNE1.276.591; E1.418.600 LH  MHÑLaryngostenosis ANnarrowing or stricture of larynx; do not confuse with spasmodic closure ( = LARYNGOSPASM or LARYNGISMUS) MNC9.400.591 LH  MSAn irregularly shaped, musculocartilaginous tubular structure, lined with mucous membrane, located at the top of the trachea and below the root of the tongue and the hyoid bone. It is the essential sphincter guarding the entrance into the trachea and functioning secondarily as the organ of voice. MHÑLarynx AN/innerv = LARYNGEAL NERVES; LARYNGEAL CARTILAGES is available; /surg: probably LARYNGECTOMY; inflammation = LARYNGITIS; ╥Adam's apple╙ goes under THYROID CARTILAGE MNA4.329 XUÑLaryngeal Mucosa LH LU  MSA device, activated electronically or by expired pulmonary air, which simulates laryngeal activity and enables a laryngectomized person to speak. Examples of the pneumatic mechanical device are the Tokyo and Van Hunen artificial larynges; of the electronic device, Western Electric electrolarynx, Tait oral vibrator, Cooper-Rand electrolarynx and the Ticchioni pipe. PM80 HN80 MHÑLarynx, Artificial ANdo not use /instrum /methods /util (unless by MeSH definition) PILarynx (66-79); Prosthesis (66-79); Speech, Alaryngeal (68-79) MNE4.659.581; E7.858.82.601; E7.858.565.639 XSLaryngeal Prosthesis; Voice Prosthesis FXÑSpeech, Alaryngeal LH LS; LX  MSCationic ionophore antibiotic obtained from Streptomyces lasaliensis that, among other effects, dissociates the calcium fluxes in muscle fibers; it is used as a coccidiostat, especially in poultry and proposed as an anti-arrhythmic and positive inotropic for the heart. Synonyms: Avatec; RO 2-2985; Antibiotic X537. OLuse LASALOCID to search X 537A back thru 1975 PM80; was indexed under ANTIBIOTICS 1975-79 HN80(78); was see under ANTIBIOTICS 1978-79, was X 537A see under ANTIBIOTICS 1975-77 MHÑLasalocid ANdo not use /defic /physiol RN25999-31-9 PIAntibiotics (73-74); Benzoates (73-74) MND8.373.936.500.400; D20.85.456; D21.370.400.547 XSX 537A LH LS  MSThe use of a laser to either vaporize surface lesions or to make bloodless cuts in tissue. PM87 HN87 MHÑLaser Surgery ANdo not use /util except by MeSH definition; coord IM with disease /surg (IM); laser surg of cataract = LASER SURGERY (IM) + CATARACT EXTRACTION (IM) PILasers/therapeutic use (66-86) MNE4.416 XSLaser Knife; Laser Scalpel; Microsurgery, Laser; Surgery, Laser; Vaporization, Laser LH LS; ; ; ;  MSDevices for coherent amplification of electromagnetic waves by stimulated emission of radiation which operate in the optical or infrared regions of the spectrum. Capable of producing immense heat and power when focused at close range, they are used in surgical procedures, in diagnosis, and in physiologic studies. Acronym for Light Amplification of Stimulated Emission of Radiation. OLuse LASERS/TU to search LASER COAGULATION back thru 1968 PM65; LASER COAGULATION was heading 1968-85 HN65(63); LASER COAGULATION was heading 1968-85 MHÑLasers ANonly /adv eff /class /diag use /hist /stand /supply /ther use /util (if by MeSH definition); lasers as surg = LASER SURGERY + disease /surg, not /radiother; low-intensity laser or multiple doses over time in ther = LASERS /ther use + disease /radiother; laser inj = LASERS /adv eff + organ /inj but do not coord with RADIATION INJURIES or any BURNS term; eff of laser as radiation: coord IM with Cat A, B or D term /rad eff (IM); do not index under source of light (ARGON, XENON, etc.) unless the point of the article & then probably NIM only, without qualif; laser surg of cataract = LASER SURGERY (IM) + CATARACT EXTRACTION (IM) MNH1.671.606.552.548; H1.671.768.638.548 FXÑHOLOGRAPHY LH LX  MSAn acute febrile human disease caused by the Lassa virus. PM77 HN77 MHÑLassa Fever PIHemorrhagic Fevers, Viral (66-76) MNC2.782.417.505; C2.782.82.545 LH  MSAn RNA virus which is the etiologic agent of Lassa fever. HN(72); was see under ARENAVIRUSES 1978-80, was see under RNA VIRUSES 1972-77 MHÑLassa Virus ANdo not use /blood-csf-urine /cytol; infection = LASSA FEVER PIRNA Viruses (66-71) MNB4.909.777.80.542 DMÑArenaviridae LH LM  MSThe period from about 5 to 7 years to adolescence when there is an apparent cessation of psychosexual development. OLsearch PSYCHOSEXUAL DEVELOPMENT 1968-74 HN(75) MHÑLatency Period (Psychology) ANno qualif; DF: LATENCY PERIOD MNF1.752.747.722.458; F2.739.794.793.458 DMÑPsychosexual Development LH LM  MSThe etiologic agent of infection in pregnant and suckling rats and hamsters. HN(75); was see under PARVOVIRUSES 1975-80 MHÑLatent Rat Virus ANdo not use /blood-csf-urine /cytol MNB4.909.204.671.500 XSH1 Virus; H3 Virus DMÑParvoviridae LH LS; LM  MSBehavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot. OLuse LATERALITY to search AMBIDEXTERITY back thru 1966 PMAMBIDEXTERITY was see under LATERALITY 1975-85, was see LATERALITY 1966-74 HNAMBIDEXTERITY was see under LATERALITY 1975-85, was see LATERALITY 1966-74 MHÑLaterality ANrestrict to neurol & psychol sense; for sidedness or laterality of dis, index dis /pathol or dis /physiopathol; for uni- or bilateral surg, use surg term /methods if pertinent; use entry vocab HANDEDNESS only with reference to primates; only /physiol MNF2.830.297.425; G11.561.232.508 XSAmbidexterity; HANDEDNESS FXÑDominance, Cerebral LH LS; LX  MSWhite, milky exudate from certain plants, now also synthetic; any aqueous colloid with particles of polymers in suspension; can be vulcanized to form elastomers (rubber); thin rubber sheeting is often called latex rubber. Synonyms: balata; chicle; guayule. OLsearch RUBBER 1966-80 (as Prov 1966); use LATEX + MICROSPHERES to search LATEX PARTICLES 1968-80 PM81; was see LATEX RUBBER (indexed under RUBBER as of 1968), was see under RUBBER 1963-67; LATEX PARTICLES was heading 1968-80 HN81(63-67); was see LATEX RUBBER 1968-80, was see under RUBBER 1963-67; LATEX PARTICLES was heading 1968-80 MHÑLatex ANnatural exudate from plants; can be synthesized; do not confuse with RUBBER, processed or synthetic; D25-26 qualif; /biosyn permitted if by plant PIRubber (66-80) MND25.720.540 XSLatices LH LS  PM65 HN65(64) MHÑLatex Fixation Tests ANNIM; only /instrum /methods /stand MNE1.223.495.826.558 XSLATEX AGGLUTINATION TESTS LH LS  MHÑLathyrism ANif nitrile-induced, index also under the nitrile, probably NIM MNC21.613.756.558 FXÑAminopropionitrile LH LX  MSThe geographic area of Latin America in general and when the specific country or countries are not indicated. Usually includes Central America, South America, Mexico, and the islands of the Caribbean. HN75 MHÑLatin America ANGEN: prefer specific country MNZ1.107.424 LH  MHÑLatvia MNZ1.542.248.950.140.560; Z1.950.140.560 LH  MSAn involuntary expression of merriment and pleasure; it includes the patterned motor responses as well as the inarticulate vocalization. MHÑLaughter ANno qualif MNF1.145.209.530.614; F1.470.693 LH  MHÑLaundering ANonly /econ /hist /methods /stand MNJ1.576.549 LH  MSHospital department which administers all activities pertaining to the hospital laundry service. PM80 HN80 MHÑLaundry Service, Hospital ANonly /econ /legis /man /organ /stand /trends /util PILaundering (66-79) MNN2.278.354.422.428; N4.452.442.422.428 XSHospital Laundry Service FXÑBedding and Linens LH LS LX  MSSalts and esters of the 12-carbon saturated monocarboxylic acid--lauric acid. HN(75) MHÑLaurates ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74) MND2.241.81.407.460.410; D10.516.251.500.410 XSDodecanoates DMÑLauric Acids LH LS LM  MSA hereditary syndrome of childhood, transmitted as an autosomal recessive trait, with obesity, retinitis pigmentosa, mental retardation, polydactyly, and hypogonadism as the main features. MHÑLaurence-Moon-Biedl Syndrome ANdo not use /congen /drug eff /physiol /rad eff MNC10.496.472; C16.131.77.509; F3.709.346.484 LH  MS12-Carbon saturated monocarboxylic acids. PM75 HN75 MHÑLauric Acids ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74) MND2.241.81.407.460; D10.516.251.500 XSDodecanoic Acids XUÑLaurates LH LS LU  MSn-Dodecyl alcohol. A saturated 12-carbon fatty alcohol. HN(75) MHÑLauryl Alcohol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN112-53-8 PIFatty Alcohols (72-74) MND2.33.555.700; D10.516.289.700 XSDodecanol; Dodecyl Alcohol DMÑFatty Alcohols LH LS; LM  MSA radioactive element discovered in 1961. It has the atomic number 103 and an atomic weight of 257. PM75 HN75 MHÑLawrencium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN22537-19-5 PIElements (66-74) MND1.287.474; D1.552.517.507 LH  PM65 HN65(63) MHÑLE Cells ANIM; no qualif; LE phenomenon goes here MNE1.223.459.619 FXÑAntinuclear Factors; ÑLupus Erythematosus, Systemic LH LX;  MHÑLead ANPb-208; do not use /analogs /biosyn /defic /physiol; /pois = LEAD POISONING; Pb-204, 206, 207 = LEAD (IM) + ISOTOPES (NIM); Pb-194-203, 205, 209-214 = LEAD (IM) + RADIOISOTOPES (IM) RN7439-92-1 MND1.268.481; D1.552.435 LH  MHÑLead Poisoning ANdo not use /chem ind; occup lead pois: coord IM with OCCUPATIONAL DISEASES (IM) but not also ENVIRONMENTAL EXPOSURE (see note there) MNC21.613.589 LH  MSThe function of directing or controlling the actions or attitudes of an individual or group with more or less willing acquiescence of the followers. MHÑLeadership ANno qualif MNF1.752.609 LH  MSRelatively permanent change in behavior that is the result of past experience or practice; also the acquisition of knowledge. MHÑLearning ANonly /drug eff /physiol /rad eff; more psychol than educ: Manual 30.26; ╥transfer of training╙ or ╥transfer of learning╙ goes under TRANSFER (PSYCHOLOGY) MNF2.463.425; F2.784.629.529 FXÑEducation; ÑLanguage Development XUÑAssociation Learning LH LX; LU  MSImpairment of learning ability due to emotional, environmental or physiological factors. PM66 HN66(64) MHÑLearning Disorders ANdo not use /drug eff /physiol /rad eff CATALOG: do not use /in inf ( = LEARNING DISORDERS) MNF3.126.185.529 FXÑDyslexia LH LX  MSContractual arrangement between the lessor (owner) and the lessee in which the use of equipment or facilities is granted to the lessee for a period of time and at a specified rate. HN(78) MHÑLeasing, Property ANonly /econ /legis /stand /trends MNN3.219.463.500 DMÑFinancial Management LH LM  MHÑLebanon MNZ1.252.245.597; Z1.630.580 LH  MSThe enzyme is secreted from the liver into the plasma of many mammalian species. It catalyzes the esterification of the hydroxyl group of lipoprotein cholesterol by the transfer of a fatty acid from the C-2 position of lecithin. In familial lecithin:cholesterol acyltransferase deficiency disease, the absence of the enzyme results in an excess of unesterified cholesterol in plasma. PM78; was see under ACYLTRANSFERASES 1975-77 HN78(75); was see under ACYLTRANSFERASES 1975-77 MHÑLecithin Acyltransferase ANdo not use /analogs; /defic = LECITHIN ACYLTRANSFERASE DEFICIENCY RNEC 2.3.1.43 PIAcyltransferases (66-74); Cholesterol (66-74); Phosphatidylcholines (66-74) MND8.586.913.50.625 XSLecithin Cholesterol Acyltransferase LH LS  MSA disease characterized by deficiency or low levels of plasma lecithin cholesterol acyl transferase. Clinical manifestations include corneal opacity, anemia and proteinuria. HN(78); was see under HYPOLIPOPROTEINEMIAS 1978-79 MHÑLecithin Acyltransferase Deficiency PIAcyltransferases (66-77); Lecithin Acyltransferase/DF (75-77); Lipid Metabolism, Inborn Errors (66-77); Lipoproteins (66-77) MNC18.452.648.556.485.448 DMÑHypolipoproteinemia LH LM  MSProtein or glycoprotein substances, usually of plant origin, that bind to sugar moieties in cell walls or membranes and thereby change the physiology of the membrane to cause agglutination, mitosis or other biochemical changes in the cell. OLuse LECTINS to search PLANT AGGLUTININS back thru 1966 & PHYTOMITOGENS back thru 1972 (as Prov 1972) PM79; was PLANT AGGLUTININS 1963-78; PHYTOMITOGENS was heading 1973-78 HN79; was PLANT AGGLUTININS 1963-78; PHYTOMITOGENS was heading 1972-78 (Prov 1972) MHÑLectins ANdo not use /defic /physiol; note specific available: LECTINS, KIDNEY BEAN; note below LECTINS, POKEWEED see POKEWEED MITOGENS; TN 244; indexing instructions MND24.185.526.545; D24.310.545; D24.611.125.44.545 XSAGGLUTININS, PLANT; HEMAGGLUTININS, PLANT; PHYTAGGLUTININS; Phytomitogens; Plant Agglutinins LH LS; ; ; ;  MHÑLeeches AN/microbiol /parasitol permitted MNB1.91.426 XSHIRUDINEA LH LS  MHÑLeg ANprimates only but see note on LEG INJURIES; for whole leg or lower leg (THIGH is available for upper leg); for bones use TIBIA or FIBULA; /inj = LEG INJURIES; TN 117: table of human, primate & non-primate extremities MNA1.378.592 XSExtremity, Lower; Lower Extremity FXÑHindlimb LH LS; LX  OL╥leg bones╙ is indexed LEG or the specific leg bones MH*Leg Bones (Non Mesh) MNA2.835.232.484 LH  MHÑLeg Dermatoses ANGEN & as coord for specific skin diseases of the leg but not as coord for neoplasms on the leg (use neopl coords (IM) with LEG (IM); consider synonym for leg dermatitis & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH MNC17.446 LH  MHÑLeg Injuries ANGEN or unspecified; consider also /inj with specific parts of the leg; /vet permitted for non-primates MNC21.866.558 LH  MSA condition in which one of a pair of legs fails to grow as long as the other. OLuse LEG LENGTH INEQUALITY to search LEG LENGTHENING 1966-71 (as Prov 1966) PM72; LEG LENGTHENING was heading 1967-71 HN72; LEG LENGTHENING was heading 1964-71 (Prov 1964-66) MHÑLeg Length Inequality ANcorrection of inequality: index under BONE LENGTHENING & do not coord with LEG LENGTH INEQUALITY MNC5.116.99.655; C23.304.537 FXÑBone Lengthening LH LX  MHÑLeg Ulcer ANif varicose, index instead under VARICOSE ULCER; do not use as coord for ╥foot ulcer╙: see note under FOOT; postphlebitis ulcer = POSTPHLEBITIC ULCER see POSTPHLEBITIC SYNDROME MNC17.893.592 LH  MSIndividuals who are legally designated to care for persons who are considered legally incapable of acting in behalf of themselves, e.g., minors and mental incompetents. PM78 HN78 MHÑLegal Guardians ANonly /psychol; specify state or country if pertinent MNM1.380 LH  MSA particular type of FEMUR HEAD NECROSIS occurring in children, mainly male, with a course of four years or so. OLsearch OSTEOCHONDRITIS 1966-74; to search COXA PLANA use LEGG-PERTHES DISEASE back thru 1975 & OSTEOCHONDRITIS 1966-74 HN(75); was see under OSTEOCHONDRITIS 1963-78; COXA PLANA was see under OSTEOCHONDRITIS 1963-78 MHÑLegg-Perthes Disease PIFemur Head (66-72); Femur Head Necrosis (73-74); Necrosis (66-72); Osteochondritis (66-74) MNC5.116.852.175.570 XSCoxa Plana DMÑFemur Head Necrosis LH LS LM  MSA hemoglobin-like oxygen-binding heme protein present in the nitrogen fixing root nodules of leguminous plants. The red pigment has a molecular weight approximately 1/4 that of hemoglobin and has been suggested to act as an oxido-reduction catalyst in the symbiotic nitrogen fixation. HN(75) MHÑLeghemoglobin ANdo not use /defic /physiol; /analogs NIM only PIHemeproteins (73-74); Plant Proteins (72-74) MND12.776.422.600; D12.776.765.500 DMÑHemeproteins LH LM  MSGram-negative aerobic rods, isolated from surface water, mud, or thermally polluted lakes or streams. It is pathogenic for man and it has no known soil or animal sources. PM81 HN81 MHÑLegionella ANdo not use /blood-csf-urine; infection = LEGIONELLOSIS but Legionella pneumophila infect = LEGIONNAIRES' DISEASE PIBacteria (78-80); Legionnaires' Disease (78-80) MNB3.400.480 LH  MSInfections by the bacteria Legionella. PM87 HN87 MHÑLegionellosis ANinfection by any species of Legionella except L. pneumophila ( = LEGIONNAIRES' DISEASE) PIBacterial Infections (72-86); Legionella (81-86); Legionnaires' Disease (78-86); Pneumonia (66-86) MNC1.252.500; C8.730.382 LH  MSAn acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache; named for an outbreak at the 1976 convention of the American Legion. OLuse LEGIONNAIRES' DISEASE to search back thru 1977 PM79; was see under RESPIRATORY TRACT INFECTIONS 1978 HN79(78); was see under RESPIRATORY TRACT INFECTIONS 1978 MHÑLegionnaires' Disease ANcaused by Legionella pneumophila: infect by other Legionella species = LEGIONELLOSIS PIBacterial Infections (76-78); Disease Outbreaks (76-78) MNC1.252.500.501; C8.730.382.380 LH  MSUse for articles concerning health-related laws and regulations in general or for which there is no specific heading. MHÑLegislation ANGEN or unspecified only: prefer /legis: Manual 19.5+; note specifics below; IM; only /hist /trends; specify country or state CATALOG: /geog /form MNN3.706.615 XSHealth Legislation LH LS  MSLaws and regulations pertaining to the field of dentistry, proposed for enactment or recently enacted by a legislative body. MHÑLegislation, Dental ANIM; only /hist /trends; specify country or state CATALOG: /geog /form MNN3.706.615.331 LH  MSLaws and regulations concerned with manufacturing, dispensing and marketing of drugs. OLsearch FOOD AND DRUG LAWS under LEGISLATION, DRUG 1968-78; search FOOD, DRUG AND COSMETIC ACT under LEGISLATION, DRUG back thru 1968 PM68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78 HN68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78; FOOD, DRUG AND COSMETIC ACT was see under LEGISLATION, DRUG 1968-77 MHÑLegislation, Drug ANIM; only /hist /trends; specify country or state CATALOG: /geog /form PILegislation, Medical (66-67) MNN3.706.615.402 XSDrug Laws; Drug Recall; Food, Drug and Cosmetic Act; Narcotic Laws FXÑDrug and Narcotic Control LH LS; ; ; LX  MSLaws and regulations concerned with industrial processing and marketing of foods. OLsearch FOOD AND DRUG LAWS under LEGISLATION, DRUG 1968-78 PM79; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78 HN79; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78 MHÑLegislation, Food ANIM; only /hist /trends; specify country or state CATALOG: /geog /form PILegislation, Drug (75-78) MNN3.706.615.412 XSFood Laws LH LS  MSLaws and regulations concerning hospitals, which are proposed for enactment or enacted by a legislative body. PM78 HN78 MHÑLegislation, Hospital ANIM; only /hist /trends; specify country or state CATALOG: /geog /form MNN3.706.615.420 LH  MSLaws and regulations, pertaining to the field of medicine, proposed for enactment or enacted by a legislative body. MHÑLegislation, Medical ANIM; only /hist /trends; specify country or state CATALOG: /geog /form MNN3.706.615.473 LH  MSLaws and regulations, pertaining to the field of nursing, proposed for enactment by a legislative body. PM66 HN66 MHÑLegislation, Nursing ANIM; only /hist /trends; specify country or state CATALOG: /geog /form MNN3.706.615.544 LH  MSLaws and regulations, pertaining to the field of pharmacy, proposed for enactment or enacted by a legislative body. PM68 HN68 MHÑLegislation, Pharmacy ANIM; only /hist /trends; specify country or state CATALOG: /geog /form PIPharmacy (66-67) MNN3.706.615.615 LH  MSLaws and regulations, pertaining to the field of veterinary medicine, proposed for enactment or enacted by a legislative body. MHÑLegislation, Veterinary ANIM; only /hist /trends; specify country or state CATALOG: /geog /form MNN3.706.615.686 LH  MSThe large family of plants, Leguminosae, including many with edible parts; most species harbor nitrogen-fixing bacteria on their roots; several species, like the vetches cause LATHYRISM, FAVISM and other forms of poisoning of cattle or people; other species yield useful materials like gums from ACACIA and various lectins, like PHYTOHEMAGGLUTININ from Phaseolus. PM78 HN78 MHÑLegumes ANas plant & food; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply; legumes as plant tissue: Manual 31.9 MNB6.510.570; B6.560.546; J1.341.956.570 XSBeans; Lathyrus; Lentils; Peas; Phaseolus LH LS; ; ; ;  MSA disease of pyruvate metabolism manifesting in infancy with psychomotor retardation, dysphagia, hypotonia, ataxia, weakness, external ophthalmoplegia, vision loss, hearing loss, and convulsions. Described by Leigh in 1951 and now thought to be an inherited enzyme defect. HN(85) MHÑLeigh Disease ANdo not use /congen PIBrain Diseases (66-84); Encephalomalacia (66-84); Pyruvate Carboxylase/DF (75-84) MNC10.228.140.163.535 XSEncephalomyelopathy, Subacute Necrotizing DMÑBrain Diseases, Metabolic LH LS LM  MHÑLeiomyoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); uterine fibroma goes here (IM) + UTERINE NEOPLASMS (IM) MNC4.557.614.322 LH  MHÑLeiomyosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.614.385; C4.557.863.410 LH  MHÑLeishmania ANdo not use /anat /blood-csf-urine /embryol; infection = LEISHMANIASIS or its specifics MNB1.841.443.868.488 XUÑLeishmania braziliensis LH LU  MSA parasitic hemoflagellate which infects man and animals. It causes both cutaneous and mucocutaneous leishmaniasis depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis subspecies include guyanensis, panamensis, and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana. HN(86) MHÑLeishmania braziliensis ANdo not use /anat /blood-csf-urine /embryol; infection = Leishmania braziliensis braziliensis infection = LEISHMANIASIS, MUCOCUTANEOUS but L. (braziliensis) guyanensis, L. (braziliensis) peruviana & L. (braziliensis) panamensis infection = LEISHMANIASIS, CUTANEOUS see LEISHMANIASIS PILeishmania (66-85) MNB1.841.443.868.488.80 XSLeishmania peruviana DMÑLeishmania LH LS LM  MSA parasitic hemoflagellate which infects man and animals and causes Visceral Leishmaniasis. The sandfly genera Phlebotomus and Lutzomyia are the vectors. PM86 HN86 MHÑLeishmania donovani ANdo not use /anat /blood-csf-urine /embryol; infection = LEISHMANIASIS, VISCERAL PILeishmania (66-85) MNB1.841.443.868.488.230 XSLeishmania chagasi; Leishmania infantum LH LS;  MSA parasitic hemoflagellate which infects man and animals including rodents. It causes Chiclero ulcer, a form of cutaneous leishmaniasis in the New World. The sandfly, Lutzomyia, appears to be the vector. PM86 HN86 MHÑLeishmania mexicana ANdo not use /anat /blood-csf-urine /embryol; infection = LEISHMANIASIS, CUTANEOUS see LEISHMANIASIS PILeishmania (66-85) MNB1.841.443.868.488.410 XSLeishmania enrietti LH LS  MSA parasitic hemoflagellate which infects man and rodents. It causes a disease called Oriental sore which is a form of cutaneous leishmaniasis of the Old World. PM86 HN86 MHÑLeishmania tropica ANdo not use /anat /blood-csf-urine /embryol; infection = ORIENTAL SORE see LEISHMANIASIS PILeishmania (66-85) MNB1.841.443.868.488.680 XSLeishmania major; Leishmania minor LH LS;  MSInfection with Leishmania tropica producing ulceration of the skin. Infection with L. brasiliensis produces LEISHMANIASIS, MUCOCUTANEOUS; infection with L. donovani produces LEISHMANIASIS, VISCERAL. OLuse LEISHMANIASIS to search ORIENTAL SORE back thru 1966 HNORIENTAL SORE was see under LEISHMANIASIS 1963-78 MHÑLeishmaniasis ANnote X ref LEISHMANIASIS, CUTANEOUS: do not coordinate with SKIN DISEASES, PARASITIC & do not confuse with LEISHMANIASIS, MUCOCUTANEOUS; American leishmaniasis probably goes here but check text for organism; tegumentary leishmaniasis = LEISHMANIASIS, CUTANEOUS see LEISHMANIASIS MNC3.752.508 XSLeishmaniasis, Cutaneous; Oriental Sore LH LS;  MHÑLeishmaniasis, Mucocutaneous ANcaused by LEISHMANIA BRAZILIENSIS but L. (braziliensis) guyanensis, L. (braziliensis) peruviana & L. (braziliensis) panamensis cause LEISHMANIASIS, CUTANEOUS see LEISHMANIASIS MNC3.752.508.385; C3.858.593; C17.860.593 LH  MHÑLeishmaniasis, Visceral ANcaused by L. donovani MNC3.752.508.510 XSKALA-AZAR LH LS  MSVoluntary use of free time for activities outside the daily routine. PM70 HN70 MHÑLeisure Activities ANno qualif PIHobbies (66-69); Recreation (66-69) MNI3.450 LH  MSThere are five species of this genus in the family Lemuridae. The species are L. catta (ring-tailed lemur), L. fulvus, L. macaco (acoumba or black lemur), L. mongoz (mongoose lemur), and L. variegatus (white lemur). Most members of this genus occur in forested areas on Madagascar and the Comoro Islands. OLuse LEMUR to search LEMURS back thru 1975 HN(81); was LEMURS see under PROSIMIANS 1975-80 MHÑLemur ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.700.508.490 DMÑLemuridae LH LM  MSA family of Primates of the suborder Prosimii containing seven genera which occurs on Madagascar and the Comoro Island. Most of the lemurs prefer wooded areas. The seven genera are Allocebus, Cheirogaleus, Hapalemur, LEMUR, Lepilemur, Microcebus and Phaner. PM81; LEMUR was LEMURS see under PROSIMIANS 1975-80 HN81 MHÑLemuridae ANprosimians; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.700.508 XSCheirogaleus; Lemur, Dwarf; Lemur, Mouse; Microcebus XUÑLemur LH LS; ; ; LU  MSThe period of confinement of a patient to a hospital or other health facility. PM72 HN72(69) MHÑLength of Stay ANonly /econ /legis /trends; length of stay in hosp, clinics, etc. PIHospitalization (66-68) MNN2.421.589.473.593 LH  MSThe noncellular outer covering of the crystalline lens, secreted by the embryonic anterior and posterior epithelium. The embryonic posterior epithelium later disappears. HN(83) MHÑLens Capsule, Crystalline PILens, Crystalline (66-82) MNA9.371.509.155 DMÑLens, Crystalline LH LM  MSThe portion of the crystalline lens surrounding the nucleus and bound anteriorly by the epithelium and posteriorly by the capsule. It contains lens fibers and amorphous, intercellular substance. HN(83) MHÑLens Cortex, Crystalline PILens, Crystalline (66-82) MNA9.371.509.225 DMÑLens, Crystalline LH LM  PM78 HN78 MHÑLens Diseases ANGEN or unspecified only: prefer specifics PIEye Diseases (66-77); Lens, Crystalline (66-77) MNC11.510 LH  MSDislocation (luxation)-complete rupture of the zonule with the lens displaced forward into the anterior chamber or backward into the vitreous body. Subluxation (partial dislocation)-incomplete rupture of the zonule with the displaced lens remaining behind the pupil. Known as ECTOPIA LENTIS if congenital. PM78 HN78 MHÑLens Dislocation and Subluxation ANspontaneous or traumatic; luxation = total disloc, subluxation = partial disloc; do not use /congen ( = ECTOPIA LENTIS); DF: LENS DISLOCATION PIEye Diseases (66-77); Eye Injuries (66-77); Lens, Crystalline (66-77) MNC11.510.598 XSDislocation, Lens; Subluxation, Lens XUÑEctopia Lentis LH LS; LU  MSThe core of the crystalline lens, surrounded by the cortex. HN(83) MHÑLens Nucleus, Crystalline PILens, Crystalline (66-82) MNA9.371.509.670 DMÑLens, Crystalline LH LM  MHÑLens, Crystalline ANof the eye; congen absence = APHAKIA /congen; postcataract aphakia or ╥aphakic eye after cataract╙ = APHAKIA, POSTCATARACT; traumatic disloc, luxation or sublux = LENS DISLOCATION AND SUBLUXATION; replacement by intraocular lens = LENSES, INTRAOCULAR; extraction = probably CATARACT EXTRACTION; pseudophakia & pseudo-aphakia go under CATARACT if lens is replaced by fibrous, fatty or osseous tissue but go under LENSES, INTRAOCULAR if lens is replaced by artificial lens; pseudophakos goes under LENSES, INTRAOCULAR MNA9.371.509 FXÑAphakia XUÑLens Capsule, Crystalline; ÑLens Cortex, Crystalline; ÑLens Nucleus, Crystalline LH LX LU; ;  MSPieces of glass or other transparent materials used for magnification or increased visual acuity. MHÑLenses ANonly /stand; for microscopes, magnifying glasses, telescopes, etc. but not for eyeglasses or sunglasses ( = EYEGLASSES); see next entry MNE7.532 FXÑOptics LH LX  MSArtificial implanted lenses, their insertion, or fixation. PM79 HN79 MHÑLenses, Intraocular ANartif lens: do not confuse with LENS, CRYSTALLINE (Cat A); commonly used after cataract extraction but do not coord with CATARACT EXTRACTION unless particularly discussed; pseudophakos, pseudophakia & pseudo-aphakia usually go here: see note on LENS, CRYSTALLINE; do not use /instrum /methods /util (except by MeSH definition) PICataract Extraction (66-78); Lenses (66-78); Prosthesis (66-78) MNE4.659.600; E4.792.600; E7.450.570; E7.532.570; E7.858.565.650 XSLens Implantation, Intraocular FXÑCataract Extraction LH LS LX  MSSmall circumscribed melanoses resembling, but differing histologically from, freckles. Includes senile lentigo ('liver spots') and nevoid lentigo (nevus spilus, lentigo simplex) or may occur in association with multiple congenital defects or congenital syndromes (e.g., Peutz-Jeghers syndrome). MHÑLentigo MNC17.621.530.550 LH  MSPolysaccharide isolated from Lentinus edodes, exact composition unknown; proposed as an antineoplastic agent. HN(75) MHÑLentinan ANdo not use /defic /physiol; /analogs NIM only RN37339-90-5 PIPolysaccharides (72-74) MND9.203.698.490 DMÑPolysaccharides LH LM  MSProbably the causative agent of adenomata or adenocarcinomata in the kidneys of certain frogs. HN(75); was see under HERPESVIRUSES 1975-80 MHÑLeopard Frog Carcinoma Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) + HERPESVIRUS INFECTIONS (IM) MNB4.909.204.382.600; B4.909.574.204.400 XSLucke Tumor Virus DMÑHerpesviridae LH LS LM  MSA residential treatment center for individuals with leprosy. MHÑLeper Colonies ANdo not use /educ /methods MNN2.278.524 LH  MSA large order of insects comprising the butterflies and moths. PM75 HN75 MHÑLepidoptera ANincludes BUTTERFLIES & MOTHS; don't forget SILKWORMS; /microbiol /parasitol permitted PIInsects (66-74) MNB1.131.617.561 XUÑButterflies; ÑMoths LH LU;  PM73 HN73(65) MHÑLepromin ANonly /admin /adv eff /anal /csf /class /immunol /isol /rad eff /stand /tox /urine; for lepromin test or lepromin reaction do not coord with SKIN TESTS RN11006-67-0 MND24.611.216.161.386 LH  MSSubstances that suppress Mycobacterium Leprae, ameliorate the clinical manifestations of leprosy and, or reduce the incidence and severity of leprous reactions. PM75 HN75 MHÑLeprostatic Agents AN-static or -cidal; do not use /analogs /biosyn /defic /physiol; consider also MYCOBACTERIUM LEPRAE /drug eff & LEPROSY /drug ther PIAnti-Infective Agents (66-74) MND20.661 XSAntileprotic Agents LH LS  MHÑLeprosy ANrat leprosy = MYCOBACTERIUM INFECTIONS (IM) + MYCOBACTERIUM LEPRAEMURIUM (NIM); /drug ther: consider also LEPROSTATIC AGENTS; ENL (erythema nodosum leprosum): index under ERYTHEMA NODOSUM (IM) + LEPROSY (IM) MNC1.252.40.552.386 XSHANSEN'S DISEASE LH LS  MSA genus of aerobic, helical spirochetes, some species of which are pathogenic, others free-living or saprophytic. MHÑLeptospira ANdo not use /blood-csf-urine; infection = LEPTOSPIROSIS MNB3.851.595.511 LH  MSA serological group of Leptospira found in dogs. MHÑLeptospira canicola ANdo not use /blood-csf-urine; infection: coord NIM with LEPTOSPIROSIS (IM) MNB3.851.595.511.427 LH  MSA genus of question mark-shaped aerobic spirochetes, which includes two formerly recognized genera: the parasitic L. icterohemorrhagiae and the saprophytic L. biflexa. OLuse LEPTOSPIRA INTERROGANS to search LEPTOSPIRA ICTEROHAEMORRHAGIAE back thru 1966 PM76; was LEPTOSPIRA ICTEROHAEMORRHAGIAE 1963-75 HN76; was LEPTOSPIRA ICTEROHAEMORRHAGIAE 1963-75 MHÑLeptospira interrogans ANdo not use /blood-csf-urine; infection = WEIL'S DISEASE MNB3.851.595.511.594 XSLeptospira icterohaemorrhagiae LH LS  MHÑLeptospirosis MNC1.252.847.511 LH  MHÑLeptothrix ANdo not use /blood-csf-urine MNB3.800.427 LH  MS2-Chloro-6-methylergoline-8-beta-acetonitrile monomethanesulfonate. An ergoline derivative which inhibits prolactin in vivo and in vitro. The prolactin inhibition is believed due to enhancement of dopaminergic function by the action of the drug on presynaptic dopaminergic sites. Synonyms: Lilly 79907; Lilly 83636. HN(79) MHÑLergotrile Mesylate AN=2-chloro-6-methylergoline-8-beta-acetonitrile monomethanesulfonate, often shortened in texts to ╥lergotrile╙; do not confuse with lergotrile (2-chloro-6-methylergoline-8-beta-acetonitrile); do not use /biosyn /defic /physiol; /analogs NIM only RN51473-23-5 PIAcetonitriles (75-78); Ergolines (69-78); Prolactin/AI (68-78) MND3.132.327.287.540; D3.549.439.540; D6.347.435 DMÑErgolines LH LM  MHÑLeriche's Syndrome MNC14.907.109.661; C14.907.137.427 LH  MSAn x-linked disease caused by a deficiency of an enzyme of purine metabolism, hypoxanthine-guanine phosphoribosyl transferase, and characterized by physical and mental retardation, hyperuricemia, self-mutilation, and choreoathetosis. PM73 HN73(71) MHÑLesch-Nyhan Syndrome ANdo not use /congen /drug eff /physiol /rad eff PIAthetosis (66-70); Mental Retardation (66-70); Purine-Pyrimidine Metabolism, Inborn Errors (66-70); Self Mutilation (66-70) MNC10.228.140.163.551; C10.496.509; C18.452.648.798.594; F3.709.346.508 FXÑHypoxanthine Phosphoribosyltransferase LH LX  MHÑLesotho MNZ1.58.349.451 LH  PM76; was see under TOXICOLOGY 1975 HN76(71); was see under TOXICOLOGY 1975 MHÑLethal Dose 50 ANalmost never IM; no qualif; DF: LD 50 or LD50 PIspecific drug/TO (66-70) MNG12.602 XSLD50 LH LS  MHÑLetterer-Siwe Disease MNC15.604.667.490.570 LH  MHÑLeucine AN/biosyn /defic /physiol permitted RN7005-03-0 MND12.125.142.441; D12.125.70.637 LH  PM65 HN65 MHÑLeucine Aminopeptidase ANdo not use /analogs RNEC 3.4.11.1 MND8.586.277.656.81.511 XUÑLeucyl-beta-Naphthylamidase LH LU  HN(73) MHÑLeucogenenol ANdo not use /defic /physiol; /analogs NIM only RN29101-95-9 PIAlcohols (71-72); Cyclohexanes (71-72); Penicillium (66-72); Spiro Compounds (71-72) MND4.615.885.511 DMÑSpiro Compounds LH LM  MSA large group of aminoglycosidic, lactone, macrolide antibiotics produced mainly by Streptomyces strains; used in Gram positive infections; pharmacologically similar to but less toxic than erythromycin. Synonyms: Ayermicina; Katasamycin; Sineptina; Stereomycin; Syneptin. OLuse LEUCOMYCINS to search CARBOMYCIN & SPIRAMYCIN back thru 1966, to search JOSAMYCIN, DEHYDRORELOMYCIN, MARIDOMYCIN, MARIDOMYCIN II & TYLOSIN back thru 1975 to search KITASAMYCINS back thru 1976 & to search JUVENIMYCINS, ROSAMYCINS & ROSARAMYCINS back thru 1979 PM81; was KITASAMYCINS see under ANTIBIOTICS 1976-80; CARBOMYCINS & SPIRAMYCINS were CARBOMYCIN & SPIRAMYCIN, respectively, 1963-80; JOSAMYCINS was JOSAMYCIN see under ANTIBIOTICS 1975-80; TYLOSINS was TYLOSIN (with DEHYDRORELOMYCIN as see ref to it) see under ANTIBIOTICS 1975-80; MARIDOMYCINS was see under ANTIBIOTICS 1978-80, was MARIDOMYCIN II see under ANTIBIOTICS 1975-77; ROSAMICINS (with JUVENIMYCINS & ROSARAMICINS as see refs to it 1979-80) was see under ANTIBIOTICS 1979-80 HN81; was KITASAMYCINS see under ANTIBIOTICS 1976-80; CARBOMYCINS & SPIRAMYCINS were CARBOMYCIN & SPIRAMYCIN, respectively, 1963-80; JOSAMYCINS was JOSAMYCIN see under ANTIBIOTICS 1975-80; TYLOSINS was TYLOSIN (with DEHYDRORELOMYCIN as see ref to it) see under ANTIBIOTICS 1975-80; MARIDOMYCINS was see under ANTIBIOTICS 1978-80, was MARIDOMYCIN II see under ANTIBIOTICS 1975-77; ROSAMICINS (with JUVENIMYCINS & ROSARAMICINS as see refs to it 1979-80) was see under ANTIBIOTICS 1979-80 MHÑLeucomycins ANdo not use /analogs /defic /physiol PIAminoglycosides (74-75); Antibiotics (70-75); Lactones (73-75) MND9.203.408.51.485; D20.85.461 XSCarbomycins; Dehydrorelomycins; Deltamycins; Josamycins; Juvenimycins; Kitasamycins; Maridomycins; Rosamicins; Rosamycins; Rosaramicins; Spiramycins; Tylosins LH LS; ; ; ; ; ; ; ; ; ; ;  MHÑLeuconostoc ANin plant & dairy products MNB3.525.800.511 LH  MSL-Leucine:tRNA-Leu ligase (AMP-forming). Activates leucine with its specific transfer RNA. HN(75) MHÑLeucyl T RNA Synthetase ANdo not use /analogs RNEC 6.1.1.4 PIAmino Acyl T RNA Synthetases (72-74); Leucine (72-74) MND8.586.464.136.480 DMÑAmino Acyl T RNA Synthetases LH LM  MSFrequently used to test for leucine aminopeptidase (EC 3.4.11.1) activity; hydrolyzes naphthylamides of leucine. HN(75) MHÑLeucyl-beta-Naphthylamidase ANdo not use /analogs RNEC 3.4.11.- PILeucine Aminopeptidase (74) MND8.586.277.656.81.150.400; D8.586.277.656.81.511.400 DMÑLeucine Aminopeptidase LH LM  MSThe preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. OLsearch PLASMAPHERESIS 1978 PM79; was see PLASMAPHERESIS 1978 HN79; was see PLASMAPHERESIS 1978 MHÑLeukapheresis ANdo not use /util except by MeSH definition PIBlood Transfusion (66-78); Cell Separation (72-78); Leukocytes (66-78) MNE2.110.570; E5.909.262.363.570 XSLeukocytapheresis; Leukopheresis; Lymphapheresis; Lymphocytapheresis LH LS; ; ;  MHÑLeukemia ANnote all the leukemia terms & cross-refs for the many types of leukemia; if not here, check Tumor Manual or Tumor Key; do not use /anal /blood supply /secret /ultrastruct; meningeal leukemia = LEUKEMIA (IM) + MENINGEAL NEOPLASMS (IM); radiation-induced = LEUKEMIA, RADIATION-INDUCED; leukemia-related terms from other categories: Bull 95 (Mar 77) MNC4.557.337 FXÑMyeloproliferative Disorders LH LX  MHÑLeukemia L1210 ANdo not use /anal /blood supply /secret /ultrastruct /vet MNC4.557.337.372.594; C4.619.531.594 LH  MSAn experimental lymphocytic leukemia of mice. HN(80) MHÑLeukemia L5178 ANdo not use /anal /blood supply /secret /ultrastruct /vet PILeukemia, Experimental (66-79); Lymphoma (66-79) MNC4.557.337.372.602; C4.619.531.602 XSLymphoma L5178 DMÑLeukemia, Experimental LH LS LM  MSAn experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. HN(80) MHÑLeukemia P388 ANdo not use /anal /blood supply /secret /ultrastruct /vet PILeukemia, Experimental (66-79); Neoplasms, Experimental (66-79) MNC4.557.337.372.782; C4.619.531.782 DMÑLeukemia, Experimental LH LM  MSLeukemia induced experimentally by administration of various leukemogenic agents, viruses, radiation or transplantation. MHÑLeukemia, Experimental ANincludes infection by oncogenic leukoviruses or leukemia viruses (NIM); do not use /anal /blood supply /secret /ultrastruct MNC4.557.337.372; C4.619.531 XUÑLeukemia L5178; ÑLeukemia P388 LH LU;  MSA neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of ╥hairy╙ or ╥flagellated╙ cells in the blood and bone marrow. PM78 HN78 MHÑLeukemia, Hairy Cell AN╥hairy╙ refers to flagellated appearance of the lymphoreticular cells; since the dis is chronic, do not coord with CHRONIC DISEASE; do not use /anal /blood supply /secret /ultrastruct PILeukemia (66-77); Reticuloendotheliosis (66-77); Spleen/PA (66-77); Splenomegaly (66-77) MNC4.557.337.415; C15.604.515.553; C20.683.515.517 XSHairy Cell Leukemia; Leukemic Reticuloendotheliosis; Reticuloendotheliosis, Leukemic LH LS; ;  PM67 HN67 MHÑLeukemia, Lymphoblastic ANdo not use /anal /blood supply /secret /ultrastruct PILeukemia, Lymphocytic (66) MNC4.557.337.428.511; C15.604.515.560.568; C20.683.515.528.511 XSLEUKEMIA, LYMPHOCYTIC, ACUTE FXÑLymphatic Diseases LH LS LX  MHÑLeukemia, Lymphocytic ANdo not use /anal /blood supply /secret /ultrastruct MNC4.557.337.428; C15.604.515.560; C20.683.515.528 XSLEUKEMIA, LYMPHOCYTIC, CHRONIC FXÑLymphatic Diseases LH LS LX  MSA disorder characterized by the presence of large numbers of tissue mast cells in the peripheral blood. PM87 HN87 MHÑLeukemia, Mast Cell ANdo not use /anal /blood supply /secret /ultrastruct PILeukemia (66-86); Mast Cells (66-86) MNC4.557.337.440 XSMast Cell Leukemia LH LS  MSNonlymphocytic leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. Myelofibrosis or increased bone marrow reticulin is common. PM87 HN87 MHÑLeukemia, Megakaryoblastic ANdo not use /anal /blood supply /secret /ultrastruct PIHemorrhagic Thrombocythemia (66-86); Thrombocythemia, Hemorrhagic (86) MNC4.557.337.450 XSMegakaryoblastic Leukemia LH LS  PM67 HN67 MHÑLeukemia, Monoblastic ANdo not use /anal /blood supply /secret /ultrastruct PILeukemia, Monocytic (66) MNC4.557.337.484.512; C20.683.515.584.512 XSLEUKEMIA, MONOCYTIC, ACUTE LH LS  MHÑLeukemia, Monocytic ANdo not use /anal /blood supply /secret /ultrastruct MNC4.557.337.484; C20.683.515.584 XSLEUKEMIA, MONOCYTIC, CHRONIC; LEUKEMIA, SCHILLING TYPE LH LS;  PM67 HN67 MHÑLeukemia, Myeloblastic ANdo not use /anal /blood supply /secret /ultrastruct PILeukemia, Myelocytic (66) MNC4.557.337.539.512; C20.683.515.639.612 XSLEUKEMIA, MYELOCYTIC, ACUTE LH LS  MHÑLeukemia, Myelocytic ANdo not use /anal /blood supply /secret /ultrastruct MNC4.557.337.539; C15.378.190.625.543; C20.683.515.639 XSLEUKEMIA, GRANULOCYTIC; LEUKEMIA, MYELOCYTIC, CHRONIC; LEUKEMIA, MYELOGENOUS, CHRONIC; LEUKEMIA, NAEGELI TYPE; Leukemia, Myelomonocytic LH LS; ; ; ;  PM67 HN67 MHÑLeukemia, Plasmacytic ANdo not use /anal /blood supply /secret /ultrastruct PILeukemia (66) MNC4.557.337.595; C20.683.515.695 LH  MHÑLeukemia, Radiation-Induced ANcoord IM with specific type of LEUKEMIA (IM); do not use /anal /blood supply /secret /ultrastruct; policy: Manual 24.41 MNC4.557.337.650; C4.682.512; C21.866.733.345 LH  PM67 HN67 MHÑLeukemia, Subleukemic ANdo not use /anal /blood supply /secret /ultrastruct PILeukemia (66) MNC4.557.337.706 XSLEUKEMIA, ALEUKEMIC LH LS  MHÑLeukemoid Reaction MNC15.378.190.636.484; C15.378.553.475.428 LH  OLuse LEUKOCIDINS to search LEUKOCIDIN back thru 1966 PM78; was LEUKOCIDIN 1965-77 HN78; was LEUKOCIDIN 1965-77 MHÑLeukocidins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS MND24.185.926.123.545; D24.185.926.235.545 LH  MSTest for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor. HN(77) MHÑLeukocyte Adherence Inhibition Test ANNIM; only /instrum; DF: LAI TEST PIImmunity, Cellular (70-76); Leukocytes (66-76) MNE1.223.495.640; E5.478.640 DMÑImmunologic Technics LH LM  MHÑLeukocyte Count ANNIM; only /drug eff /instrum /methods /rad eff /vet MNE1.223.459.107.595; G7.380.107.595 XSLeukocyte Number LH LS  MSMeasure of histocompatibility at the HL-A locus. Peripheral blood leukocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (as measured by tritiated thymidine update) whereas those from incompatible individuals will not. In the one-way MLC test the leukocytes from one of the individuals are inactivated (usually by treatment with mitomycin C or radiation). The untreated responding cells proliferate in response to foreign histocompatibility antigens on the treated stimulating cells. PM73 HN73 MHÑLeukocyte Culture Test, Mixed ANNIM; only /instrum /methods PIHistocompatibility Testing (68-72); Leukocytes (66-72) MNE1.223.495.468.429; E5.478.468.429 XSLymphocyte Culture Test, Mixed; Mixed Leukocyte Culture Test LH LS;  OL╥leukocyte disorders╙ is probably LEUKOPENIA or LEUKOCYTOSIS MH*Leukocyte Disorders (Non Mesh) MNC15.378.553 LH  MSProtein factor(s) released by sensitized lymphocytes (and possibly other cells) that inhibit the movement of leukocytes, especially polymorphonuclear cells, away from its site of release; assays for these are used as tests for cellular immunity; they are: Leukocyte Migration Capillary Tube Technic (LMCT) and Leukocyte Migration Agarose Technic (LMAT). HN(80) MHÑLeukocyte Migration Inhibitory Factors AN/biosyn /physiol permitted; do not use /analogs /defic; also called LIF; DF: LMIF PICell Migration Inhibition (71-73); Cell Movement (70-71); Lymphokines (74-79); Macrophage Migration Inhibitory Factor (74-79) MND24.611.632.428 XSMigration Inhibition Factors, Leukocyte DMÑLymphokines LH LS LM  MSWhite blood cells. MHÑLeukocytes ANA 11 qualif & /class; decrease in no. of leukocytes or leukocytopenia = LEUKOPENIA; increase in no. of leukocytes = LEUKOCYTOSIS; /transpl: consider also LEUKAPHERESIS; leukocyte migration test: index under LEUKOCYTES /immunol (IM) + CELL MIGRATION INHIBITION (IM) MNA11.118.637; A15.145.229.637; A15.382.490 FXÑPHAGOCYTOSIS LH LX  MHÑLeukocytosis ANincrease in no. of leukocytes MNC15.378.553.475 LH  MSAn inherited metabolic disorder of the nervous system, particulary the white matter; characterized histologically by a paucity of myelin and oligodendroglia, severe astrocytic gliosis, and massive infiltration with unique multinucleated globoid cells which are enriched in galactosylceramide. The primary genetic defect is a deficiency of galactosylceramide beta-galactosidase (galactosylceramidase). OLsearch LEUKODYSTROPHIES under CEREBRAL SCLEROSIS, DIFFUSE 1966-73 PM74; was KRABBE LEUKODYSTROPHY see under CEREBRAL SCLEROSIS, DIFFUSE 1963-73; LEUKODYSTROPHIES was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-73 HN74; was KRABBE LEUKODYSTROPHY see under CEREBRAL SCLEROSIS, DIFFUSE 1963-73; LEUKODYSTROPHIES was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-74 MHÑLeukodystrophy, Globoid Cell MNC10.228.140.276.428; C10.228.337.144.512; C18.452.648.556.641.803.585 XSKRABBE'S DISEASE LH LS  OLsearch LEUKODYSTROPHIES under CEREBRAL SCLEROSIS, DIFFUSE 1966-73 PM74; LEUKODYSTROPHIES was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-73 HN74; LEUKODYSTROPHIES was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-73 MHÑLeukodystrophy, Metachromatic MNC10.228.140.276.511; C10.228.337.144.637; C18.452.648.556.641.803.594 XSSULFATIDOSIS LH LS  HN(72) MHÑLeukoedema, Oral PIMouth Diseases (66-71) MNC7.465.385 DMÑMouth Diseases LH LM  PM73 HN73(71) MHÑLeukoencephalopathy, Progressive Multifocal PIDemyelinating Diseases (66-70) MNC10.228.337.484 LH  MSA disease of premature or newborn infants hypoxic and ischemic in nature and leading to infarction of brain white matter and cerebral ventricle enlargement. HN(87) MHÑLeukomalacia, Periventricular ANin premature inf & neonates; do not use /congen PICerebral Hemorrhage (66-86); Cerebral Ventricles (66-86); Encephalomalacia (66-86); Infant, Newborn (66-86); Infant, Premature, Diseases (66-86) MNC10.228.140.300.550; C10.228.140.461.550; C14.907.253.612; C16.614.521.450 XSEncephalomalacia, Periventricular; Periventricular Leukomalacia DMÑEncephalomalacia LH LS; LM  MHÑLeukopenia AN= leukocytopenia MNC15.378.553.546 LH  MHÑLeukoplakia ANneoplastic; coord IM with organ /neoplasms term (IM) MNC4.834.512 LH  PM72 HN72(70) MHÑLeukoplakia, Oral ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; oral keratosis goes here PILeukoplakia (66-69); Mouth Neoplasms (66-69) MNC4.588.443.591.545; C4.834.512.513; C7.465.565.429 LH  MHÑLeukorrhea MNC13.371.894.405 LH  MSLymphosarcoma accompanied by leukemia. OLuse LEUKOSARCOMA to search LEUCOSARCOMA back thru 1966 PM80; was LEUCOSARCOMA 1963-79 HN80; was LEUCOSARCOMA 1963-79 MHÑLeukosarcoma AN/anal /blood supply /secret /ultrastruct permitted MNC4.557.337.801; C4.557.863.436 LH  MS5(S),12(R)-Dihydroxy-6,8,10,14-Eicosatetraenoic Acid (LTB4). Synthesized in polymorphonuclear leukocytes from arachidonic acid by the lipoxygenase pathway. The leukotriene B group has chemotactic activity; promotes movement and aggregation of leukocytes and stimulates the chemo-attraction of leukocytes and their adherence to vascular endothelium; also stimulates neutrophil chemotaxis and adherence. PM83 HN83 MHÑLeukotrienes B AN/biosyn /physiol permitted; do not use /analogs PIArachidonic Acids (67-82) MND2.241.81.436.370; D10.516.251.355.415 XS5,12-HETE; 5,12-diHETE; Leukotriene B4 LH LS; ;  MSA group of acylated oligopeptides produced by Actinomycetes that function as protease inhibitors. They have been known to inhibit to varying degrees trypsin, plasmin, kallikrein, papain and the cathepsins. HN(75) MHÑLeupeptins ANdo not use /analogs /defic /physiol PIOligopeptides (73-74) MND8.373.745.535; D12.644.456.580 DMÑOligopeptides LH LM  PM65; was see under NARCOTIC ANTAGONISTS 1963-64 HN65; was see under NARCOTIC ANTAGONISTS 1963-64 MHÑLevallorphan ANdo not use /biosyn /defic /physiol RN152-02-3 MND3.132.610.422.413; D3.549.686.429; D3.605.497.429; D14.712.405 XSNaloxiphan LH LS  PM74 HN74 MHÑLevamisole ANdo not use /biosyn /defic /physiol RN14769-73-4 MND3.383.374.480; D3.383.871.346; D21.201.287.461 XSL-Tetramisole; Levotetramisole LH LS;  MSLocation of heart in left hemithorax with apex pointing to the left, but with situs inversus of other viscera and defects of the heart, or corrected transposition of great vessels. HN(75) MHÑLevocardia ANdo not use /congen MNC14.280.400.701; C16.131.457.700; C16.131.810.700 DMÑHeart Defects, Congenital LH LM  MS3-Hydroxy-L-tyrosine. The naturally occurring form of DOPA; a neurotransmitter, autonomic agent and precursor of catecholamines; found in most animals, also from Vicia faba, a bean; has anticholinergic and sympathomimetic properties; used mainly to treat parkinsonism. Synonyms: Bendopa; Biodopa; dihydroxyphenylalanine; Dopar; Larodopa; Weldopa. OLsearch DOPA 1972-74 PM75; was see DOPA 1972-74 HN75; was see DOPA 1972-74 MHÑLevodopa ANdo not use /biosyn /defic /physiol PIDopa (66-74) MND2.92.311.242.480; D12.125.72.573.400.500; D14.307.678; D16.538.251.575 XSL-Dopa LH LS  PM65; was LEVORPHAN see under MORPHINE 1963-64 HN65; was LEVORPHAN see under MORPHINE 1963-64 MHÑLevorphanol ANdo not use /biosyn /defic /physiol RN77-07-6 MND3.132.610.422.463; D3.549.686.485; D3.605.497.485; D14.73.153.429; D14.757.388 XSL-Dromoran; Levorphan XUÑDextromethorphan LH LS; LU  OLuse LEVULINIC ACIDS to search LEVULINIC ACID back thru 1966 PM75; was LEVULINIC ACID 1963-74 HN75; was LEVULINIC ACID 1963-74 MHÑLevulinic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.607.547 XUÑAminolevulinic Acid LH LU  MSA group of dominantly and independently inherited antigens associated with the ABO blood factors; they are glycolipids present in plasma and secretions that may adhere to the erythrocytes; the phenotype Le(b) is the result of the interaction of the Le gene [Le(a)] with the genes for the ABO blood groups. PM74 HN74(63) MHÑLewis Blood-Group System ANonly /genet /immunol; in an animal = animal /blood not /immunol; in a disease = disease /blood, not /immunol nor /familial; TN 230 MND24.611.216.705.230.544; G4.610.241.544; G9.188.229.544 XSLewis System LH LS  MHÑLeydig Cell Tumor ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with TESTICULAR NEOPLASMS (IM) in male or OVARIAN NEOPLASMS (IM) if in female MNC4.557.576.639 LH  MSCells in the interstitial tissue of the testis that are believed to furnish the internal secretion of that gland. PM68 HN68(64) MHÑLeydig Cells ANA 11 qualif; do not confuse interstitial cells here with interstitial cells of connective tissue ( = CONNECTIVE TISSUE /cytol) MNA5.360.444.849.513; A6.407.312.782.513; A11.593 XSTesticular Interstitial Cells LH LS  OLuse LH to search ICSH back thru 1966 PM68; was ICSH 1963-67 HN68; was ICSH 1963-67 MHÑLH AN/biosyn /physiol permitted; do not confuse LUTROPIN with luteotropin RN9002-67-9 MND6.472.351.576.463; D6.472.734.525.343.463; D12.776.641.650.400 XSICSH; INTERSTITIAL CELL-STIMULATING HORMONE; Luteinizing Hormone; Lutropin LH LS; ; ;  PM74 HN74 MHÑLH-FSH Releasing Hormone AN/biosyn /physiol permitted; DF: LHRH RN9034-40-6 MND6.472.709.429; D12.644.456.590; D12.776.641.650.410 XSFSH RELEASING HORMONE; LH Releasing Hormone; Luliberin LH LS; ;  MHÑLiberia MNZ1.58.432.527 LH  MSThe psychic drive or energy associated with sexual instinct in the broad sense (pleasure and love-object seeking). May also connote the psychic energy associated with instincts in general that motivate behavior. PM68 HN68 MHÑLibido ANonly /drug eff /physiol /rad eff MNF2.739.794.511 FXÑInstinct; ÑMotivation; ÑSex LH LX; ;  MSCollections of organized information for study and reference. MHÑLibraries ANIM; do not use /educ /instrum /methods; specify geog or other site CATALOG: /geog /form MNL1.346.596 FXÑInformation Services LH LX  PM65 HN65 MHÑLibraries, Dental ANIM; do not use /educ /instrum /methods; specify geog or other site CATALOG: /geog /form MNL1.346.596.363 LH  MHÑLibraries, Hospital ANIM; do not use /educ /instrum /methods; specify geog or other site CATALOG: /geog /form MNL1.346.596.463; N2.278.354.560; N4.452.442.468 LH  MHÑLibraries, Medical ANprivate & public libraries; includes private collections of books; IM; do not use /educ /instrum /methods; specify geog or other site CATALOG: /geog /form MNL1.346.596.563 XSLibraries, Health Science LH LS  PM67 HN67(65) MHÑLibraries, Nursing ANIM; do not use /educ /instrum /methods; specify geog or other site CATALOG: /geog /form MNL1.346.596.663 LH  MSPlanning, organizing, staffing, direction, and control of libraries. MHÑLibrary Administration ANonly /educ /man /stand MNL1.583.363 LH  MHÑLibrary Associations ANonly /hist /organ; med libr assoc: do not coord with MEDICINE CATALOG: /geog /form MNL1.583.390 FXÑSocieties LH LX  MSEducational institutions for individuals specializing in the field of Library Science. MHÑLibrary Schools ANonly /class /econ /hist /organ /stand /trends /supply; specify geog if pertinent MNI2.783.388; L1.583.430 XSSCHOOLS, LIBRARY LH LS  MSStudy or principles and practices of library care and administration. MHÑLibrary Science ANonly /hist /man /stand; med librarianship: do not coord with MEDICINE MNL1.583 XSLIBRARIANSHIP LH LS  MSServices offered to the library user. Include reference and circulation. PM76 HN76; was NON MESH before 1976 MHÑLibrary Services ANdo not use /educ /methods /util (except by MeSH definition) CATALOG: /geog /form PIspecific library or library science heading MNL1.453.639; L1.583.464 LH  MSCollection and analysis of data pertaining to operations of a particular library, library system, or group of independent libraries, with recommendations for improvement and/or ordered plans for further development. MHÑLibrary Surveys ANonly /econ /hist /methods /stand /trends /util CATALOG: /geog /form MNL1.583.564 LH  MSAcquisition, organization, and preparation of library materials for use. Include selection, acquisitions, and weeding; cataloging and classification; and preservation. PM76 HN76; was LIBRARY TECHNICAL PROCESSES (NON MESH) before 1976 MHÑLibrary Technical Services ANdo not use /educ /methods /supply /util (except by MeSH definition) CATALOG: /geog /form PIspecific library or library science heading MNL1.453.639.570; L1.583.464.570 LH  MHÑLibya MNZ1.58.266.513; Z1.630.600 LH  MSSmall, wingless, parasitic insects of the order Phthiraptera, composed of the suborders ANOPLURA (sucking lice), MALLOPHAGA (biting lice), and Rhynchophthirina (elephant-lice). OLuse LICE to search PHTHIRAPTERA back through 1975 PMPHTHIRAPTERA was heading 1975-79 HNPHTHIRAPTERA was heading 1975-79 MHÑLice AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111; sucking lice = ANOPLURA, biting lice = MALLOPHAGA, elephant-lice ( = Rhynchophthirina) goes here MNB1.131.617.564 XSPhthiraptera FXÑPEDICULOSIS LH LS LX  MSThe legal authority or formal permission from authorities to carry on certain activities which by law or regulation require such permission. It may be applied to licensure of institutions as well as individuals. MHÑLicensure ANby the state; differentiate from ACCREDITATION (by the profession); IM; only /hist; various boards can go here; specify geog CATALOG: /geog /form MNN3.706.110.510 XSInstitutional Personnel Licensure; Licenses; Licensure, Institutional, Personnel XUÑLicensure, Hospital LH LS; ; LU  MSThe granting of a license to practice dentistry. MHÑLicensure, Dental ANby the state; differentiate from ACCREDITATION (by the profession); IM; only /hist; various boards can go here; specify geog CATALOG: /geog /form MNN3.706.110.510.180 LH  MSThe granting of a license to a hospital. HN(Aug 77) MHÑLicensure, Hospital ANby the state: differentiate from ACCREDITATION (by the profession); IM; only /hist; specify geog CATALOG: /geog /form MNN3.706.110.510.290 XSHospital Licensure DMÑLicensure LH LS LM  MSThe granting of a license to practice medicine. MHÑLicensure, Medical ANby the state; differentiate from ACCREDITATION (by the profession); IM; only /hist; various boards can go here; specify geog CATALOG: /geog /form MNN3.706.110.510.410 LH  MSThe granting of a license to practice the profession of nursing. PM66 HN66 MHÑLicensure, Nursing ANby the state; differentiate from ACCREDITATION (by the profession); IM; only /hist; various boards can go here; specify geog CATALOG: /geog /form MNN3.706.110.510.490 LH  MSThe granting of a license to practice pharmacy. PM68 HN68 MHÑLicensure, Pharmacy ANby the state; differentiate from ACCREDITATION (by the profession); IM; only /hist; various boards can go here; specify geog CATALOG: /geog /form PIPharmacy (66-67) MNN3.706.110.510.560 LH  MHÑLichen Planus ANsometimes called simply ╥lichen╙: check text & its bibliog MNC17.462 LH  MHÑLichens ANplant, not skin disease; do not use /anat /embryol /microbiol /parasitol MNB5.513 LH  MHÑLidocaine ANdo not use /biosyn /defic /physiol RN137-58-6 MND2.65.199.92.500; D14.211.484; D18.97.464 XSLignocaine LH LS  MS4-[4,4-Bis(p-fluorophenyl)butyl]-1-piperazine aceto-2',6'-xylidine. Coronary vasodilator with some antiarrhythmic action. Synonyms: Clinium; Corflazine; Klinium; McN-JR-7904; R 7904. HN(73) MHÑLidoflazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3416-26-0 PIAcetic Acids (66-72); Amides (66-72); Piperazines (66-72); Xylenes (64-72) MND3.383.606.596; D18.918.575 XSOrdiflazine DMÑPiperazines LH LS LM  MSAscertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph. MHÑLie Detection ANno qualif MNF2.784.240.514; F2.830.512; I1.198.560.619 LH  MHÑLiechtenstein MNZ1.542.524 LH  MSThose occurrences, including social, psychological, and environmental, which require an adjustment or effect a change in an individual's pattern of living. PM77 HN77 MHÑLife Change Events ANno qualif; FAMILY LIFE CYCLES see FAMILY is also available for ╥transitional stages through which the family evolves...e.g., marriage, childbearing & death╙ PILife Style (72-76); Stress, Psychological (69-76) MNF1.829.458.410 XSLife Experiences; Stressful Events FXÑStress, Psychological LH LS; LX  MSA figure representing the number of years, based on known statistics, to which any person of a given age may reasonably expect to live. HNwas in Cat H & N 1979-81, was in Cat N only 1968-78, was in Cat G only 1967, was in Cat G & I 1963-66 MHÑLife Expectancy ANhuman & animal; no qualif MNN1.224.935.464 FXÑLongevity LH LX  OL╥life stages╙ is indexed under organism term with /GD MH*Life Stages (Non Mesh) MNB1.583 LH  MSThe individual's active adaptation to the social milieu, which develops as a unique, personal product of his need for integration into that social milieu and for differentiation from it. PM72 HN72(70) MHÑLife Style ANno qualif; consider also QUALITY OF LIFE PIPersonality Development (68-69) MNF1.829.458 FXÑSOCIAL ENVIRONMENT LH LX  MSCare provided patients requiring extraordinary therapeutic measures in order to sustain and prolong life. PM78 HN78 MHÑLife Support Care ANonly /econ /instrum /legis /man /methods /nurs /organ /psychol /stand /trends /util (if by MeSH definition) PIEthics, Medical (66-77); Life Expectancy (66-77); Longevity (66-77) MNE2.472.440; N2.421.589.581.325 XSExtraordinary Treatment LH LS  HN(66) MHÑLife Support Systems ANonly /econ /instrum /stand /util (if by MeSH definition) MNG3.230.150.200.250 DMÑSealed Cabin Ecology LH LM  MHÑLigaments ANIM; coord with site (IM); joint ligaments = LIGAMENTS, ARTICULAR MNA2.513 LH  PM65 HN65 MHÑLigaments, Articular ANIM; coord with specific joint (IM) MNA2.513.514; A2.835.583.512 LH  PM74 HN74(73) MHÑLigands ANIM for general only; usually NIM with specific metal IM; no qualif PIMetals (66-72); specific metal; Organometallic Compounds (68-72); specific organometallic compound MND1.552.451; D2.561 FXÑRadioligand Assay; ÑReceptors, Endogenous Substances LH LX;  OLuse LIGASES & CARBOXY-LYASES to search CARBOXYLASES 1966-74 PMCARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963; CARBAMYL PHOSPHATE SYNTHASE (AMMONIA) & CARBAMYL PHOSPHATE SYNTHASE (GLUTAMINE) were see under PHOSPHOTRANSFERASES, ATP 1975-80 HNCARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963 MHÑLigases ANdo not use /analogs RNEC 6. MND8.586.464 XUÑAcetyl CoA Carboxylase; ÑAdenylosuccinate Synthetase; ÑArgininosuccinate Synthetase; ÑAsparagine Synthetase; ÑCarbamyl Phosphate Synthase (Ammonia); ÑCarbamyl Phosphate Synthase (Glutamine); ÑFormyltetrahydrofolate Synthetase LH LU; ; ; ; ; ;  MSApplication of a ligature to tie a vessel or strangulate a part. PM77 HN77(71) MHÑLigation ANnever IM; only /adv eff /instrum /methods /vet; clamping does not go here: index under CONSTRICTION PISurgery, Operative (66-70); specific heading/SU (66-70) MNE4.426 LH  MSThat portion of the electromagnetic spectrum to which the human eye is sensitive; about 400 to 800 nanometers in wavelength, i.e., between the ultraviolet and infrared spectra. MHÑLight ANnon-ionizing; differentiate from LIGHTING (the environment); only /adv eff /diag use; /ther use = PHOTOTHERAPY (coord disease with /ther, not /radiother) but consider also PHOTOCHEMOTHERAPY & ULTRAVIOLET THERAPY; as radiation: TN 158; light scattering = SCATTERING, RADIATION (IM) + LIGHT (NIM); photoperiod is LIGHT & not necessarily PERIODICITY unless specifically discussed; LIGHT + PERIODICITY is not necessarily CIRCADIAN RHYTHM; luminance goes here or under LIGHTING but not under LUMINESCENCE; black light: index under INFRARED RAYS or ULTRAVIOLET RAYS depending on text but unspecified, index under ULTRAVIOLET RAYS MNH1.671.606.552; H1.671.768.638.552 XSLight, Visible; Photoradiation; Radiation, Visible FXÑLIGHTING; ÑPHOTIC STIMULATION; ÑPHOTOMETRY; ÑPhotochemotherapy; ÑPhotosensitivity Disorders; ÑPhototherapy; ÑSUNLIGHT LH LS; ; LX; ; ; ; ; ;  MSThe coagulation of tissue by an intense beam of light, including laser. MHÑLight Coagulation ANnon-ionizing; includes laser coagulation; do not use /util except by MeSH definition; coord with Cat A or C term with /surg MNE4.792.630 XSPHOTOCOAGULATION LH LS  MHÑLighting ANthe environment: differentiate from LIGHT, a principle of physics; only /econ /methods /stand /trends; /adv eff permitted but do not confuse with LIGHT /adv eff MNG3.230.150.410 XSILLUMINATION FXÑLight LH LS LX  MHÑLightning ANno qualif MNG3.230.300.100.725.375 FXÑElectricity LH LX  MHÑLignin RN9005-53-2 MND9.203.698.365.180.515; D25.720.549 LH  MHÑLimbic System ANdo not use /innerv MNA8.186.211.577 XSRHINENCEPHALON LH LS  MSSensitive method for detection of bacterial endotoxins and endotoxin-like substances that depends on the in vitro gelation of Limulus amebocyte lysate (LAL), prepared from the circulating blood (amebocytes) of the horseshoe crab, by the endotoxin or related compound. Used for detection of endotoxin in body fluids and parenteral pharmaceuticals. PM78 HN78 MHÑLimulus Test ANonly /instrum /vet PIEndotoxins (66-77) MNE1.223.530; E5.91.570; E5.909.560.150.570 FXÑEndotoxins; ÑHorseshoe Crabs LH LX;  PM66 HN66(64) MHÑLincomycin ANdo not use /defic /physiol RN154-21-2 MND9.203.408.465; D20.85.467 XSLincolnensin LH LS  PM65 HN65 MHÑLingual Frenum MNA14.549.885.431 XSFrenum, Lingual LH LS  HN(71) MHÑLingual Nerve ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) PIMandibular Nerve (66-70) MNA8.796.214.848.375.515 DMÑMandibular Nerve LH LM  PM67 HN67(65) MHÑLinguistics AN= science of LANGUAGE & SPEECH; do not confuse with LANGUAGE (what is spoken), SEMANTICS (hist or psychol study of language & meaning changes), NOMENCLATURE (names of things & etymology, the origin or words), PHONETICS (how words are sounded), LITERATURE (literary works), PHILOLOGY (study of literature or language as used in literature) or VOCABULARY (a person's stock of words); grammar, syntax, accent go here; only /hist MNL1.143.506.598 LH  MHÑLiniments ANIM for general only; only /adv eff /anal (with caution) /stand /supply; NIM with specific drug as IM, no qualif MND26.394.225.493 LH  OLsearch CARCINOMA, SCIRRHOUS 1966-74 HN(75) MHÑLinitis Plastica ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with STOMACH NEOPLASMS (IM) MNC4.557.117.483.515 DMÑCarcinoma, Scirrhous LH LM  MSThe association in inheritance of two or more non-allelic genes due to their being located more or less closely on the same chromosome. PM73 HN73(70) MHÑLinkage (Genetics) ANonly /drug eff /rad eff; DF: LINKAGE PIGenetics (66-69) MNG5.568 XUÑLod Score LH LU  OLuse LINOLEIC ACIDS to search LINOLEIC ACID back thru 1966 PM75; was LINOLEIC ACID 1963-74 HN75; was LINOLEIC ACID 1963-74 MHÑLinoleic Acids ANdo not confuse with LINOLENIC ACIDS; do not use /analogs MND2.241.81.436.390; D10.516.251.265.515; D10.516.251.355.432 LH  OLto search LINOLENIC ACID use LINOLENIC ACIDS back thru 1973 & FATTY ACIDS, ESSENTIAL 1966-72 PM75; was LINOLENIC ACID 1973-74, was LINOLENIC ACID see under FATTY ACIDS, ESSENTIAL 1963-72 HN75; was LINOLENIC ACID 1973-74, was LINOLENIC ACID see under FATTY ACIDS, ESSENTIAL 1963-72 MHÑLinolenic Acids ANdo not confuse with LINOLEIC ACIDS; do not use /analogs PIFatty Acids, Essential (66-72) MND2.241.81.436.453; D10.516.251.265.640; D10.516.251.355.487 LH  OLuse LINSEED OIL to search LINSEED back thru 1966 PM87; was LINSEED 1963-86 HN87; was LINSEED 1963-86 MHÑLinseed Oil ANnote category but use with reference to plant or oil; do not coord with OILS for linseed oil; only D25-26 qualif RN8001-26-1 MND10.516.212.507.550; D10.516.627.700.615; J1.740.400.425; J1.740.700.615 LH  HN(72) MHÑLinuron ANdo not use /biosyn /defic /physiol; /analogs NIM only RN330-55-2 PIHerbicides (66-71); Urea (66-71) MND2.948.511.515; D2.948.684.515; D5.723.366.506.515 DMÑHerbicides, Urea LH LM  MSLarge chiefly nocturnal mammals of the cat family found in Africa and southern Asia. HN(75) MHÑLions ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.147.600 DMÑCarnivora LH LM  MSEither of the two fleshy, full-blooded margins of the mouth. PM65; was LIPS 1963-64 HN65; was LIPS 1963-64 MHÑLip ANinflammation = CHEILITIS; cold sores & fever blisters = HERPES LABIALIS MNA1.456.505.631.515; A14.549.336 LH  PM72 HN72 MHÑLip Diseases ANinflamm dis = CHEILITIS; cold sores & fever blisters = HERPES LABIALIS PILip (66-71); Mouth Diseases (66-71) MNC7.465.409 LH  MHÑLip Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.591.550; C7.465.409.640 LH  MHÑLipase ANdo not use /analogs; /defic: consider also LIPID METABOLISM, INBORN ERRORS; LIPOPROTEIN LIPASE is also available RNEC 3.1.1.3 MND8.586.277.352.100.400 XSTriacylglycerol Lipase; Tributyrinase; Triglyceride Lipase LH LS; ;  MSLipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties. PM84; was see under LIPOPOLYSACCHARIDES 1977-83 HN84(77); was see under LIPOPOLYSACCHARIDES 1977-83 MHÑLipid A AN/analogs /biosyn /physiol permitted PILipids (72-76); Lipopolysaccharides (72-76) MND9.203.698.718.450.500; D10.516.494.500 LH  MSLayers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. PM80 HN80 MHÑLipid Bilayers ANdo not use /analogs /biosyn /defic /physiol /secret; coord IM with specific lipid (IM or NIM) PIMembranes, Artificial (66-79) MND10.516.570.510; H1.181.529.530.510 XSBilayers, Lipid LH LS  PM65 HN65 MHÑLipid Metabolism, Inborn Errors ANdo not use /congen; coord IM with specific lipid /metab (IM); DF: LIPID METAB INBORN ERR MNC18.452.648.556 LH  MSThe breakdown of stored triglyceride in adipose tissue with the release of free fatty acids and glycerol. Depot fat hydrolysis is catalyzed by a lipase in response to pituitary lipid mobilization factors (LMF), various hormones, serotoning, or hepatotoxins such as carbon tetrachloride. PM70 HN70 MHÑLipid Mobilization ANonly /drug eff /rad eff PILipids/ME (66-69) MNG6.535.585 LH  MSPeroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. PM80 HN80 MHÑLipid Peroxides ANdo not use /analogs PILipids (66-79); Peroxides (66-79) MND1.655.498.631.400; D10.516.440 LH  OLuse LIPIDS to search BLOOD LIPIDS 1966-67 PM/blood was BLOOD LIPIDS 1963-67; /metabolism was LIPID METABOLISM 1963-65 HN/blood was BLOOD LIPIDS 1963-67; /metabolism was LIPID METABOLISM 1963-65 MHÑLipids ANGEN or unspecified only: prefer specifics; differentiate from FATS (╥outside the body╙); /blood: consider also HYPERLIPIDEMIA & specifics; do not use /analogs MND10.516 LH  MH*Lipids and Antilipemic Agents (Non Mesh) MND10 LH  OLsearch IODIZED OILS 1966-74 HN(75) MHÑLipiodol AND25-26 qualif RN8002-46-8 MND1.396.661.601.432; D10.516.627.700.550.400; J1.740.700.550.400 DMÑIodized Oils LH LM  MSA flavoprotein which catalyzes the reduction of lipoamide by NADH to yield dihydrolipoamide and NAD+. The enzyme is a component of the multienzyme pyruvate dehydrogenase complex and 2-oxoglutarate dehydrogenase complex. Formerly EC 1.6.4.3. MHÑLipoamide Dehydrogenase ANdo not use /analogs RNEC 1.8.1.4 MND8.586.682.608.479 XSDiaphorase; Dihydrolipoamide Dehydrogenase; NAD Diaphorase; NADH Diaphorase LH LS; ; ;  MSA systemic mucopolysaccharidosis marked by progressive physical deterioration and mental retardation; usually manifests itself in the early months of life with death occurring by age 10. Symptoms include dwarfism, hepatosplenomegaly, gargoyle-like facies and noisy breathing. MHÑLipochondrodystrophy ANdo not use /congen /drug eff /physiol /rad eff MNC5.116.99.666; C5.116.198.349; C18.452.648.202.715.599; C23.205.615.536; F3.709.346.536 XSGARGOYLISM; HURLER'S DISEASE; Hunter's Syndrome; Mucopolysaccharidosis 1; Mucopolysaccharidosis 2; PFAUNDLER-HURLER SYNDROME LH LS; ; ; ; ;  MHÑLipodystrophy MNC17.849.391 LH  MHÑLipodystrophy, Intestinal MNC6.405.469.637.598; C18.452.603.598 XSWHIPPLE'S DISEASE LH LS  MSA naturally occurring lipid pigment with histochemical characteristics similar to ceroid. It accumulates in various normal tissues and apparently increases in quantity with age. HN(75) MHÑLipofuscin ANdo not use /defic /physiol; /analogs NIM only; ceroid-lipofuscinosis = NEURONAL CEROID-LIPOFUSCINOSIS PILipids (72-74); Pigments (72-74) MND10.516.460; D11.557.550 DMÑPigments LH LM  MHÑLipoic Acid RN62-46-4 MND8.176.515; D11.786.708.469 XSTHIOCTIC ACID LH LS  OLuse LIPOIDOSIS to search AMAUROTIC FAMILIAL IDIOCY back thru 1966 PMAMAUROTIC FAMILIAL IDIOCY was heading 1963-84 HNAMAUROTIC FAMILIAL IDIOCY was heading 1963-84 MHÑLipoidosis MNC18.452.648.556.641 XSAmaurotic Familial Idiocy; LIPIDOSIS XUÑLipoidproteinosis LH LS; LU  OLsearch LIPOIDOSIS 1966-74 HN(75) MHÑLipoidproteinosis MNC18.452.648.556.641.391 DMÑLipoidosis LH LM  MSThe hydrolysis of lipids. PM80 HN80 MHÑLipolysis ANonly /drug eff /rad eff; metabolic only: not for ╥suction lipolysis╙ of adipose tissue ( = ADIPOSE TISSUE /surg (IM) + SUCTION (NIM)) PILipid Mobilization (70-79); Lipids/ME (66-79) MNG6.535.590 LH  OLuse LIPOMA to search FATTY TUMOR back thru 1966 PMFATTY TUMOR was heading 1963-67 HNFATTY TUMOR was heading 1963-67 MHÑLipoma ANsolitary; multiple = LIPOMATOSIS; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.514 XSFATTY TUMOR LH LS  MHÑLipomatosis ANmultiple; solitary = LIPOMA; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) if relevant; note LIPOMATOSIS, MULTIPLE SYMMETRICAL below MNC4.557.499.514.516 XUÑLipomatosis, Multiple Symmetrical LH LU  MSMultiple circumscribed or encapsulated lipomas which may be distributed symmetrically or haphazardly or which may form a collar around the neck. HN(87) MHÑLipomatosis, Multiple Symmetrical AN/anal /blood supply /secret /ultrastruct permitted PILipoma (66-86); Lipomatosis (66-86) MNC4.557.499.514.516.550; C4.651.550 XSLipomatosis, Nodular Circumscribed; Madelung's Neck DMÑLipomatosis LH LS; LM  MHÑLipopolysaccharides ANdo not use /analogs; largely bacterial so do not coord with POLYSACCHARIDES, BACTERIAL for bacterial lipopolysaccharides; coord IM with specific bacterium (IM) MND9.203.698.718.450; D10.516.494; D24.611.216.161.616.525 LH  OLuse LIPOPROTEIN LIPASE to search HEPARIN-CLEARING FACTOR & LIPEMIA-CLEARING FACTOR back thru 1966 HNHEPARIN-CLEARING FACTOR & LIPEMIA-CLEARING FACTOR were see under LIPOPROTEIN LIPASE 1963-80 MHÑLipoprotein Lipase ANdo not use /analogs; /defic: consider also LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL RNEC 3.1.1.34 MND8.586.277.352.100.430 XSHeparin-Clearing Factor; Lipemia-Clearing Factor LH LS;  MSA rare familial condition characterized by massive chylomicronemia and decreased levels of other lipoproteins; due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyzes an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood. OLsearch HYPERLIPOPROTEINEMIA under HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79 HN(80); HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it) MHÑLipoprotein Lipase Deficiency, Familial PIHyperlipidemia/FG (66-79) MNC18.452.648.556.481.552 XSHyperchylomicronemia, Familial; Hyperlipoproteinemia Type I DMÑHyperlipoproteinemia LH LS; LM  MSAn abnormal lipoprotein which is present in large amounts in individuals suffering from obstructive liver diseases. It exists as a bilayer vesicle of equimolar phospholipids and unesterified cholesterol containing small amounts of plasma proteins (mainly albumin) in its internal aqueous compartment together with some apolipoproteins adsorbed on its surface. Separates with LDL by ultracentrifugation. PM80 HN80 MHÑLipoprotein-X AN/biosyn /physiol permitted PILipoproteins (66-79); Lipoproteins, LDL (72-79) MND10.516.532.400; D12.776.521.450 XSLP-X LH LS  MHÑLipoproteins ANdo not use /analogs; consider specifics below; /blood: consider also HYPERLIPOPROTEINEMIA; /defic: consider also HYPOLIPOPROTEINEMIAS & specifics; lipoproteinosis = LIPOIDPROTEINOSIS MND10.516.532; D12.776.521 FXÑApolipoproteins; ÑProteolipids LH LX;  PM74 HN74(72) MHÑLipoproteins, HDL ANdo not use /analogs; hyperalphalipoproteinemia = LIPOPROTEINS, HDL /blood (IM) + HYPERLIPOPROTEINEMIA (IM); hypoalphalipoproteinemia = LIPOPROTEINS, HDL /blood (IM) + HYPOLIPOPROTEINEMIAS (IM); familial hypoalphalipoproteinemia = TANGIER DISEASE; /defic: consider also HYPOLIPOPROTEINEMIAS PILipoproteins (66-71) MND10.516.532.432; D12.776.521.479 XSALPHA LIPOPROTEINS; HIGH DENSITY LIPOPROTEINS LH LS;  MSCholesterol which is contained in or bound to high density lipoproteins (HDL). High density lipoproteins transport cholesterol from peripheral tissues to the liver thereby acting as a scavenger to prevent excess accumulation and deposition of cholesterol in blood vessels. PM85 HN85 MHÑLipoproteins, HDL Cholesterol ANdo not use /analogs PICholesterol (66-84); Lipoproteins, HDL (72-84) MND10.516.532.432.400; D10.516.851.208.680; D12.776.521.479.470 XSCholesterol HDL; HDL Cholesterol LH LS;  PM74 HN74(72) MHÑLipoproteins, LDL ANdo not use /analogs; /defic: consider also HYPOBETALIPOPROTEINEMIA PILipoproteins (66-71) MND10.516.532.515; D12.776.521.550 XSBeta Lipoproteins; LOW DENSITY LIPOPROTEINS LH LS;  MSCholesterol which is contained in or bound to low density lipoproteins (LDL). LDL transport cholesterol to peripheral tissues and regulate de novo cholesterol synthesis at these sites. Atherosclerosis is caused by the deposit of cholesterol on the walls of blood vessels, because of high concentrations of LDL cholesterol in plasma. PM85 HN85 MHÑLipoproteins, LDL Cholesterol ANdo not use /analogs PICholesterol (66-84); Lipoproteins, LDL (72-84) MND10.516.532.515.500; D10.516.851.208.700; D12.776.521.550.500 XSCholesterol LDL; LDL Cholesterol LH LS;  PM74 HN74(72) MHÑLipoproteins, VLDL ANdo not use /analogs; hypoprebetalipoproteinemia = LIPOPROTEINS, VLDL /blood (IM) + HYPOLIPOPROTEINEMIAS (IM); /defic: consider also HYPOLIPOPROTEINEMIAS PILipoproteins (66-71) MND10.516.532.599; D12.776.521.622 XSPREBETA LIPOPROTEINS; VERY LOW DENSITY LIPOPROTEINS LH LS;  MHÑLiposarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.542; C4.557.863.467 LH  PM73 HN73 MHÑLiposomes ANnote categories; D25-26 qualif; /immunol permitted; when used as a vehicle in drug ther, index under drug /ther use (IM) + LIPOSOMES /admin (IM or NIM), not LIPOSOMES /ther use PIMembranes, Artificial (66-72) MND10.516.695.492; H1.181.529.530.517 LH  MHÑLipotropic Factors ANdo not use /analogs /biosyn /defic /physiol MND10.642 LH  PM74 HN74(65) MHÑLipotropin AN/biosyn /physiol permitted RN9035-55-6 MND6.472.734.525.480 XSBeta-Lipotropin LH LS  PM74 HN74 MHÑLipoxygenases ANdo not use /analogs RNEC 1.13.11.12 MND8.586.348.600; D8.586.682.690.433 LH  MSThe process by which an observer comprehends speech by watching the movements of the speaker's lips without hearing the speaker's voice. OLuse LIPREADING to search LIP READING back thru 1966 PM77; was LIP READING 1963-76 HN77; was LIP READING 1963-76 MHÑLipreading ANno qualif MNE2.831.671.432; L1.143.506.423.348 XSSpeechreading FXÑDeafness LH LS LX  MSGreen dyes containing ammonium and aryl sulfonate moieties that facilitate the visualization of tissues, if given intravenously; have mostly been used in the study of kidney physiology. Synonym: LG HN(76) MHÑLissamine Green Dyes AND25-26 qualif PIAmmonium Compounds (69-75) MND2.92.102.475; D2.241.866.540.244.500; D2.675.276.475; D2.886.610.244.500; D26.408.492 DMÑAmmonium Compounds LH LM  MSA genus of bacteria which may be found in the feces of animals and man, on vegetation, and in silage; parasitic on cold-blooded and warm-blooded animals, including man. PM76 HN76 MHÑListeria ANin feces, on plants, in silage PIBacteria (66-74); Corynebacteriaceae (75) MNB3.500.600 LH  MHÑListeria Infections ANsee note below & note that MENINGITIS, LISTERIA is available MNC1.252.514 LH  MHÑListeria Monocytogenes ANdo not use /blood-csf-urine; infection = LISTERIA INFECTIONS & do not bother to coord with L. monocytogenes MNB3.500.600.667 LH  MS3(9,10-Didehydro-6-methylergolin-8-alpha-yl) 1,1-diethylurea. An ergot derivative that antagonizes serotonin and possibly dopamine; proposed for migraine therapy. Synonyms: Lysenyl; Lyzenil; mesorgydine. HN(79) MHÑLisuride ANdo not use /biosyn /defic /physiol; /analogs NIM only RN18016-80-3 PIErgolines (69-78); Ergot Alkaloids (66-68) MND3.132.327.287.560; D3.549.439.560; D23.846.546 XSLysuride Hydrogen Maleate; Methylergol Carbamide DMÑErgolines LH LS; LM  MHÑLiterature ANthe body of literary works; only /hist; TN 121: differentiate from BIBLIOGRAPHY; relation to BOOKS: Manual 33.11; MEDICINE IN LITERATURE is also available CATALOG: /form /lang MNK1.517 FXÑCommunication XUÑDrama LH LX LU  MHÑLiterature, Medieval ANonly /hist; coord IM with POETRY (IM) or DRAMA (IM) CATALOG: /form /lang MNK1.517.495 LH  MHÑLiterature, Modern ANstarts with 15th cent; only /hist; coord IM with POETRY (IM) or DRAMA (IM) CATALOG: /form /lang MNK1.517.533 LH  MHÑLithium ANLi-7; do not use /analogs /biosyn /defic /physiol; Li-6 = LITHIUM (IM) + ISOTOPES (NIM); Li-5, 8, 9 = LITHIUM (IM) + RADIOISOTOPES (IM) RN7439-93-2 MND1.248.497.300.459.537; D1.268.495; D1.552.528.480; D15.236.872.270 LH  MS3-alpha-Hydroxy-5-beta-cholanic Acid. Bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine; acts as detergent to solubilize fats for absorption and is itself absorbed; used as cholagogue and choleretic. PM78 HN78(73) MHÑLithocholic Acid AN/biosyn /physiol permitted RN434-13-9 MND4.808.221.430.622; D19.316.246.175.551 XSLithocholate XUÑTaurolithocholic Acid LH LS LU  MSThe destruction of kidney, ureter or bladder stones or gallstones by physical forces, including crushing with a lithotriptor through a catheter; focused percutaneous ultrasound & focused hydraulic shock waves may be used without surgery; does not include dissolving stones by acids or litholysis. PM86 HN86 MHÑLithotripsy ANdo not use /util except by MeSH definition; litholysis (dissolving calculi by acid) is disease /ther, not LITHOTRIPSY PIElectrotherapy (66-85); Physical Therapy (66-85); Ultrasonic Therapy (66-85) MNE2.600 XSElectrohydraulic Shockwave Lithotripsy; Extracorporeal Shockwave Lithotripsy; Litholapaxy; Noninvasive Litholapaxy; Percutaneous Ultrasonic Lithotripsy; Ultrasonic Lithotripsy FXÑCalculi LH LS; ; ; ; ; LX  MHÑLithuania MNZ1.542.248.950.140.580; Z1.950.140.580 LH  MSThe number of offspring produced at one birth by an animal. PM76; was see under ANIMALS, NEWBORN 1975 HN76(75); was see under ANIMALS, NEWBORN 1975 MHÑLitter Size ANanimals only: see also note under TWINS; only /drug eff /rad eff; relation to PREGNANCY: Manual 28.33 PIAnimals, Newborn (66-74) MNG8.520.780.300 LH  PM/cytology was LIVER CYTOLOGY 1964-65; /enzymology was LIVER ENZYMOLOGY 1964-65; /physiology was LIVER FUNCTION 1964-65 HN/cytology was LIVER CYTOLOGY 1964-65; /enzymology was LIVER ENZYMOLOGY 1964-65; /physiology was LIVER FUNCTION 1964-65 MHÑLiver AN/blood supply: consider also LIVER CIRCULATION; /cytol: consider also KUPFFER CELLS; /surg: consider also HEPATECTOMY; inflammation = HEPATITIS & its specifics; hepatopancreas: index LIVER + PANCREAS but NIM; specialty ╥hepatology╙ seen in foreign lit goes under GASTROENTEROLOGY; consider terms under HEPAT- MNA3.620 LH  MHÑLiver Abscess MNC1.539.26.455; C6.552.597 XSABSCESS, HEPATIC LH LS  MSLiver abscess caused by Entamoeba histolytica. MHÑLiver Abscess, Amebic MNC3.518.600; C3.752.55.407.570; C6.552.597.517; C6.552.664.642 XSAMEBIASIS, HEPATIC; Entamoebiasis, Hepatic LH LS;  MSThe circulation of blood through the vessels of the liver. PM64 HN64 MHÑLiver Circulation ANconsider also LIVER /blood supply & ENTEROHEPATIC CIRCULATION (see note there); only /drug eff /rad eff MNG9.330.163.881.552 FXÑHEPATIC ARTERY; ÑHEPATIC VEINS; ÑHepatic Artery; ÑHepatic Veins; ÑPORTAL SYSTEM LH LX; ; ; ;  MSLiver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. OLuse LIVER CIRRHOSIS to search LIVER CIRRHOSIS, POSTNECROTIC 1966-77 PMLIVER CIRRHOSIS, POSTNECROTIC was heading 1963-77 HNLIVER CIRRHOSIS, POSTNECROTIC was heading 1963-77 MHÑLiver Cirrhosis ANdo not index ascites unless specifically pertinent MNC6.552.630 XSCIRRHOSIS, LIVER; Fibrosis, Liver; HEPATIC CIRRHOSIS; Liver Fibrosis LH LS; ; ;  MSLiver cirrhosis in alcoholics. PM78 HN78 MHÑLiver Cirrhosis, Alcoholic PIAlcoholism (66-77); Liver Cirrhosis (66-77) MNC6.552.630.380; C6.552.645.590; C21.613.53.270.645.550 XSAlcoholic Cirrhosis LH LS  MSLiver cirrhosis in which there is interference with intrahepatic bile flow. Includes primary biliary cirrhosis, an intrahepatic disturbance of bile secretion affecting predominantly middle-aged women and with segmental destruction and, later, absence of septal bile ducts (cirrhosis is the end stage); and secondary biliary cirrhosis, which is produced by prolonged mechanical obstruction of large intrahepatic or extrahepatic bile ducts. OLuse LIVER CIRRHOSIS, BILIARY to search LIVER CIRRHOSIS, OBSTRUCTIVE back thru 1966 PM78; was LIVER CIRRHOSIS, OBSTRUCTIVE 1963-77 HN78; was LIVER CIRRHOSIS, OBSTRUCTIVE 1963-77 MHÑLiver Cirrhosis, Biliary MNC6.130.450.250.250; C6.552.150.250; C6.552.630.400; C23.888.498.250.250.612 XSBILIARY CIRRHOSIS; Cholangitis, Chronic Nonsuppurative Destructive; Liver Cirrhosis, Obstructive LH LS; ;  MHÑLiver Cirrhosis, Experimental MNC6.552.630.467 LH  MHÑLiver Diseases ANGEN: prefer specifics; acute liver failure may go here unless HEPATIC ENCEPHALOPATHY is specifically pertinent; inflamm dis = HEPATITIS & its specifics; liver fibrosis: see note on fibrosis under LIVER above; /chem ind permitted but consider also HEPATITIS, TOXIC; specialty ╥hepatology╙ seen in foreign lit goes under GASTROENTEROLOGY MNC6.552 XUÑPeliosis Hepatis LH LU  MSLiver diseases associated with alcoholism. Usually the coexistence of two or more subentities, i.e., alcoholic fatty liver, alcoholic hepatitis, and alcoholic liver cirrhosis, but may be the general entity when subentities are not specified. PM79 HN79 MHÑLiver Diseases, Alcoholic ANGEN: specifics FATTY LIVER, ALCOHOLIC, HEPATITIS, ALCOHOLIC & LIVER CIRRHOSIS, ALCOHOLIC are available PIAlcoholism (66-78); Liver Diseases (66-78); specific liver disease MNC6.552.645; C21.613.53.270.645 XSAlcoholic Liver Diseases LH LS  MHÑLiver Diseases, Parasitic ANcoord IM with specific parasitic dis (IM) but note that also available are ECHINOCOCCOSIS, HEPATIC; FASCIOLIASIS & LIVER ABSCESS, AMEBIC MNC3.518; C6.552.664 LH  MSExtracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia. MHÑLiver Extracts ANextracts of liver or liver fractions containing uncharacterized factors; do not confuse with chemical substances ╥extracted╙ from the liver, as ╥peptides extracted from the mouse liver╙ ( = PEPTIDES /anal + LIVER /anal); do not use /analogs /biosyn /blood-csf-urine /defic /diag use /physiol /secret MND19.461.543.600; D24.185.893.351 LH  MHÑLiver Function Tests ANNIM; only /instrum /methods /vet MNE1.184.558 LH  MHÑLiver Glycogen AN/biosyn /physiol permitted MND9.203.698.365.388.518 LH  MHÑLiver Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM), including HEPATOMA (IM) MNC4.588.274.623; C6.552.697 LH  MSExperimentally induced tumors of the liver. OLuse LIVER NEOPLASMS, EXPERIMENTAL to search HEPATOMA, EXPERIMENTAL back thru 1979 PM85; was HEPATOMA, EXPERIMENTAL 1979-84 HN85; was HEPATOMA, EXPERIMENTAL 1979-84 MHÑLiver Neoplasms, Experimental ANanimal only; do not use /vet; /anal /blood supply /secret /ultrastruct permitted PIHepatoma (66-78); Liver Neoplasms (66-78); Neoplasms, Experimental (66-78) MNC4.588.274.623.460; C4.619.540 XSHepatoma, Experimental; Hepatoma, Morris; Hepatoma, Novikoff LH LS; ;  MSRepair or renewal of hepatic tissue. PM64 HN64 MHÑLiver Regeneration ANIM; only /drug eff /rad eff MNG4.185.753.468; G10.261.642 FXÑHepatectomy LH LX  MSDeoxy analogs of paromomycin with broad spectrum antimicrobial properties. HN(75) MHÑLividomycins ANdo not use /analogs /biosyn /defic /physiol PIParomomycin (73-74) MND9.203.408.51.699.400; D20.85.625.400 XSMannosyldeoxyparomomycin DMÑParomomycin LH LS LM  PM68 HN68 MHÑLizards ANincludes IGUANAS, geckos, chameleons, Gila monsters; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIReptiles (66-67) MNB2.833.393 XUÑIguanas LH LU  OLuse LOA to search LOA LOA back thru 1979 PMLOA LOA was see under LOA 1979-85 HNLOA LOA was see under LOA 1979-85 MHÑLoa ANdo not use /blood-csf-urine; infection = LOAIASIS MNB1.500.294.530.410 XSLoa loa LH LS  MSInfection with nematodes of the genus Loa. Also spelled Loiasis. OLsearch FILARIASIS 1967-74 HN(75) MHÑLoaiasis MNC3.335.508.361.518 DMÑFilariasis LH LM  MSA process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization. HN(82) MHÑLobbying ANno qualif PIPolitics (68-81) MNI1.738.610 DMÑPolitics LH LM  MHÑLobeline ANdo not use /biosyn /defic /physiol RN90-69-7 MND3.132.478; D3.383.621.418; D15.128.516; D16.698.628.410 LH  MSLarge marine decapod crustaceans of the family Homaridae, commonly used for food. PM72 HN72 MHÑLobsters ANas animal & food; /microbiol /parasitol permitted PICrustacea (66-71) MNB1.131.365.623 FXÑShellfish LH LX  MSA communications network connecting various hardware devices together within a building by means of a continuous cable or in-house voice data telephone system. HN(87) MHÑLocal Area Networks MNL1.700.568.80.110.600 DMÑComputer Systems LH LM  MSDirectory signs or listings of designated areas within or without a facility. OLuse LOCATION DIRECTORIES AND SIGNS to search LOCATION DIRECTORIES back thru Aug 77 HN(82); was LOCATION DIRECTORIES see under FACILITY DESIGN AND CONSTRUCTION Aug 77-81 MHÑLocation Directories and Signs ANonly /stand MNJ1.86.339.400 XSSigns and Location Directories DMÑFacility Design and Construction LH LS LM  MHÑLocomotion ANonly /drug eff /rad eff; differentiate LOCOMOTION (getting from one point to another) from GAIT (how a man or major animal gets there), MOVEMENT (without necessarily locomoting), MOTOR ACTIVITY (movement assoc with behavior); CELL MOVEMENT is available; locomotor activity = MOTOR ACTIVITY MNG11.427.614.568 LH  MSBluish region in the superior angle of the fourth ventricle floor, corresponding to melanin-like pigmented nerve cells which lie lateral to the ponto-mesencephalic central gray (griseum centrale). Also known as nucleus pigmentosus pontis, locus cinereus and locus ferrugineus. PM78 HN78 MHÑLocus Coeruleus ANin the 4th ventricle; also spelled locus caeruleus & locus ceruleus & also called nucleus pigmentosus pontis, locus cinereus, locus ferrugineus; do not use /innerv PICerebral Ventricles (66-77); Mesencephalon (66-77); Pons (66-77) MNA8.186.211.132.659.473; A8.186.211.132.810.616.352 LH  MSThe total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for ╥logarithmic odds.╙ HN(81) MHÑLod Score ANfor Logarithmic ODds: in genet a linkage relat among loci; no qualif PIGenetics (70-72); Linkage (Genetics) (70-80) MNG5.568.562 DMÑLinkage (Genetics) LH LM  MS4'-Chloro-2-[(3-(10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)-propyl) methylamino]acetophenone. Imipramine derivative tricyclic antidepressant with few anticholinergic properties; metabolized to desipramine. Synonyms: chopramin(e); Gamonil; Leo 640. HN(79) MHÑLofepramine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23047-25-8 PIDibenzazepines (69-78) MND3.494.240.520; D15.236.122.140.550 XSLopramine DMÑDibenzazepines LH LS LM  MHÑLogic ANno qualif MNK1.752.448 LH  MSCommon member of the Graminea family used as cattle fodder; harbors several toxic fungi and other parasites to livestock and people; produces allergenic compounds, especially in its pollen; the most often seen varieties are L. perenne, L. multiflorum, and L. rigidum. HN(86) MHÑLolium ANdo not use /isol /pathogen; do not confuse X ref RYE GRASS with RYE (genus Secale) PIGrasses (66-85); Rye (66-85) MNB6.252.561 XSRyegrass DMÑGrasses LH LS LM  MS1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea. An alkylating agent of value against both hematologic malignancies and solid tumors. Synonyms: Belustine; CeeNU; NSC 79037. PM84; was see under NITROSOUREA COMPOUNDS 1975-83 HN84(75); was see under NITROSOUREA COMPOUNDS 1975-83 MHÑLomustine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13010-47-4 PICyclohexanes (72-74); Nitrosourea Compounds (72-74) MND2.654.692.440; D2.948.594.440; D22.204.493 XSCCNU LH LS  MHÑLondon ANearly & modern LONDON: Manual 36.14 MNZ1.433.553; Z1.542.363.300.519 LH  MSThe state of feeling sad or dejected as a result of lack of companionship or being separated from others. OLsearch SOCIAL ISOLATION 1973-74 HN(75); was see under SOCIAL ISOLATION 1973-74 MHÑLoneliness ANno qualif MNF1.829.850.435; I1.880.683.435 DMÑSocial Isolation LH LM  MSSyndrome characterized by history of syncopal episodes and a long QT interval, sometimes leading to sudden death due to paroxysmal ventricular arrhythmia. When associated with autosomal recessive inheritance and congenital deafness, it is called the Jervell-Lange-Nielsen syndrome. When associated with autosomal dominant inheritance and no deafness is present, it is called the Romano Ward Syndrome. HN(86) MHÑLong QT Syndrome ANsee scope notes for features of X refs PIArrhythmia (66-85); Tachycardia (66-85) MNC14.280.67.565 XSJervell-Lange-Nielsen Syndrome; Romano-Ward Syndrome DMÑArrhythmia LH LS; LM  MSCare over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent or continuous care. PM68 HN68 MHÑLong Term Care ANNIM; only /econ /legis /methods /organ /psychol /stand /trends PIChronic Disease (66-67) MNE2.472.476; N2.421.589.581 FXÑInsurance, Long Term Care LH LX  MSAn immunoglobulin G, often found in the blood of hyperthyroid individuals; it stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission. PM68 HN68(65) MHÑLong-Acting Thyroid Stimulator AN/biosyn /physiol permitted RN9034-48-4 MND24.611.125.308.550; D24.611.125.600.681.393.550 XSLATS; THYROID STIMULATOR, LONG-ACTING FXÑHyperthyroidism LH LS; LX  MHÑLongevity ANhuman & animal; only /drug eff /rad eff MNG7.168.519 FXÑAged; ÑAged, 80 and over; ÑLIFE EXPECTANCY LH LX; ;  MSStudies in which variables relating to an individual or group of individuals are assessed over a period of time. PM79; was see under EPIDEMIOLOGIC METHODS 1975-78 HN79(75); was see under EPIDEMIOLOGIC METHODS 1975-78 MHÑLongitudinal Studies ANNIM; no qualif; specify geog if possible PIEpidemiologic Methods (66-74) MNE5.318.420 LH  HN(73) MHÑLoop of Henle PIKidney Tubules (66-72) MNA5.810.453.736.560.610 DMÑKidney Tubules LH LM  MS4-(p-Chlorophenyl)-4-hydroxy-N.N-dimethyl-alpha,alpha-diphenyl-1-piperidine butyramide hydrochloride. Synthetic anti-diarrheal agent with a long duration of action; it is not significantly absorbed from the gut, has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. Synonym: R 18533. HN(76) MHÑLoperamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN53179-11-6 PIAmides (74-75); Chlorobenzenes (74-75); Piperidines (74-75) MND3.383.621.440; D19.316.161.552 DMÑPiperidines LH LM  MS7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepine-2-one. Antianxiety agent with few side effects; also has hypnotic, anticonvulsant and considerable sedative properties; proposed as a preanesthetic agent. PM84; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83 HN84(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-83 MHÑLorazepam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN846-49-1 PIBenzodiazepinones (74); Chlorobenzenes (74) MND3.438.79.80.70.450; D14.591.745.538; D15.236.872.659.191.508 LH  MHÑLordosis ANdisease only; for lordosis in animal sex exper use POSTURE + SEX BEHAVIOR, ANIMAL MNC5.878.616.519 LH  MSA family of Primates of the suborder Prosimii containing six genera which occurs in parts of Africa, India, Asia, and the Philippines. The six genera are: Arctocebus (golden potto), GALAGO (bush babies), Loris (slender loris), Nycticebus (slow loris), and Perodicticus (potto). Lorises and pottos are relatively common except for Arctocebus, the golden potto. All are arboreal and nocturnal. PM81 HN81 MHÑLorisidae ANprosimians; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIProsimii (75-80) MNB2.649.801.700.572 XSLoris, Slow; Nycetibus; Perodicticus potto; Pottos LH LS; ; ;  MSA rating schedule designed to record descriptions of psychotic behavior and symptoms obtained through verbal reports to questions and observations of patient behavior. OLsearch PSYCHIATRIC STATUS RATING SCALES 1969-74 HN(75) MHÑLorr's Inpatient Multidimensional Psychiatric Rating Scale ANno qualif; DF: LORR MNF4.586.435 DMÑPsychiatric Status Rating Scales LH LM  MSThe perceived attribute of a sound which corresponds to the physical attribute of intensity. PM79 HN79 MHÑLoudness Perception ANonly /drug eff /physiol /rad eff PIAuditory Perception (67-78); Auditory Threshold (68-78) MNF2.463.593.71.576 LH  MHÑLouisiana MNZ1.107.567.875.447 LH  MSAn acute tick-borne arbovirus infection causing meningoencephalomyelitis of sheep. PM71 HN71 MHÑLouping Ill ANusually animal, generally sheep: do not use /vet but check tag ANIMAL; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES PIEncephalitis, Tick-Borne/VE (66-70); Sheep Diseases (66-70) MNC2.782.930.360.555; C2.81.343.360.555; C22.836.435 LH  MSA tick-borne Flavivirus (group B arbovirus) which causes ovine encephalomyelitis. OLsearch ENCEPHALITIS VIRUSES, TICK-BORNE 1967-74 & ARBOVIRUSES 1966 HN(75); was see under ARBOVIRUS 65-66, was see under ARBORVIRUSES 1963-64 MHÑLouping Ill Virus ANdo not use /blood-csf-urine /cytol; infection = LOUPING ILL MNB4.909.777.270.511.519; B4.909.777.923.377.350.560 DMÑEncephalitis Viruses, Tick-Borne LH LM  MSAffection; in psychiatry commonly refers to pleasure, particularly as it applies to gratifying experiences between members of the opposite sex. MHÑLove ANno qualif MNF1.470.734 LH  MSExternal decompression applied to the lower body. Used to study orthostatic intolerance, produce simulated hemorrhage in physiologic research, assess cardiovascular function, and reduce abdominal stress during childbirth. HN(80) MHÑLower Body Negative Pressure AN╥external decompression applied to the lower body╙; used in physiol research & ther; only /adv eff /instrum /methods /util (if by MeSH definition) /vet PIAtmospheric Pressure (66-79); Pressure (66-79) MNE5.245.570 XSAbdominal Decompression; Decompression, Abdominal DMÑDecompression LH LS; LM  MSA form of pre-excitation characterized by a short PR interval associated with a normal QRS complex. HN(86) MHÑLown-Ganong-Levine Syndrome ANnote X ref: normal PR interval & long QRS interval = PRE-EXCITATION, MAHAIN TYPE PIArrhythmia (66-85); Tachycardia (66-85); Tachycardia, Paroxysmal (66-85) MNC14.280.67.780.560 XSShort PR-Normal QRS Complex Syndrome DMÑPre-Excitation Syndromes LH LS LM  MS2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine. Antipsychotic agent used in schizophrenia; similar in action to other major tranquilizers. Synonyms: CL 71563; Loxitano; Loxapac; SUM 3170. HN(75) MHÑLoxapine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1977-10-2 PIDibenzoxazepines (71-74); Piperazines (71-74) MND3.494.347.500; D15.236.872.331.516 XSLoxapinsuccinate; Oxilapine DMÑDibenzoxazepines LH LS; LM  HN(64) MHÑLubrication ANNIM; no qualif MNH1.671.469 DMÑPhysics LH LM  OLuse LUCANTHONE to search MIRACIL 1966 PM67; was MIRACIL 1963-66 HN67; was MIRACIL 1963-66 MHÑLucanthone ANdo not use /biosyn /defic /physiol RN479-50-5 MND3.494.953.704.500; D21.201.412.596.331 XSTixantone LH LS  MS12-[3-[(3-amino-3,6-dideoxy-D-mannopyranosyl)oxy]-1,13-dihydroxy-4,6,8,10-heptadecatetraenyl]-4,5-epoxy-7,11-dihydroxy-9-oxo-2-tridecenedioic acid, omega-lactone. Antifungal antibiotic isolated from cultures of Streptomyces lucensis. Synonym: Etruscomycin. HN(75) MHÑLucensomycin ANdo not use /defic /physiol; /analogs NIM only RN13058-67-8 PIAntibiotics, Antifungal (71-74); Glycosides (72-74) MND9.203.408.51.515; D20.85.62.540; D20.136.73.540 XSLucimycin DMÑAntibiotics, Antifungal LH LS LM  PM68 HN68(63) MHÑLuciferase ANdo not use /analogs RNEC 1.13.12.- MND8.586.682.517 LH  MHÑLuciferin ANdo not use /defic /physiol MND12.776.532.400 LH  MHÑLudwig's Angina MNC1.539.535; C7.465.433 LH  MHÑLumbar Vertebrae ANdo not confuse with LUMBOSACRAL REGION which is merely locational; do not use as site to locate intraspinal inject or spinal cord inj: restrict to lumbar vert as the bones themselves; inflammation = LUMBAR VERTEBRAE (IM) + SPONDYLITIS (IM) MNA2.835.232.834.519 LH  MHÑLumbosacral Plexus ANdo not use /innerv MNA8.796.828.569 XSSACRAL PLEXUS LH LS  MHÑLumbosacral Region ANdo not confuse with LUMBAR VERTEBRAE or SACROCOCCYGEAL REGION: use term in the text; NIM when merely locational; pain = probably BACKACHE MNA1.176.519 XSLUMBAR REGION LH LS  MSN-(5,6,7,7b,8,10a-Hexahydro-1,2,3,9-Tetramethoxy- 8-oxobenzo(A) cyclopenta(3,4)cyclobuta(1,2-c)cyclopenten- 7-ylacetamide. Three, alpha, beta, and gamma isomers of ultraviolet degradation products of colchicine that lack many of the physiological actions of the parent; used as experimental control for colchicine actions. HN(80) MHÑLumicolchicines ANdo not use /analogs /defic /physiol; /biosyn permitted if by plant PIColchicine (66-74) /AA (75-79) MND3.132.225.500 DMÑColchicine LH LM  MSThe property of giving off light without emitting a corresponding degree of heat. OLuse LUMINESCENCE to search PHOSPHORESCENCE back thru 1966 HNPHOSPHORESCENCE was see under LUMINESCENCE 1963-78 MHÑLuminescence ANnon-ionizing; no qualif; luminance does not go here: index LIGHT or LIGHTING; note LUMINESCENT PROTEINS below MNH1.671.606.552.565 XSLight, Luminescent; Phosphorescence LH LS;  MSProteins which are involved in the phenomenon of light emission in living systems. Included are the ╥enzymatic╙ and ╥non-enzymatic╙ types of system with or without the presence of oxygen or co-factors. PM79; AEQUORIN was see under PROTEINS 1975-78 HN79 MHÑLuminescent Proteins AN/biosyn /physiol permitted; do not use /analogs /defic PILuminescence (66-78); Proteins (66-78) MND12.776.532 XSBioluminescent Proteins; Photoproteins XUÑAequorin LH LS; LU  MS5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxydation, used in chemical determinations. HN(75) MHÑLuminol AND25-26 qualif; /analogs NIM only; do not confuse with Luminal, a brand of PHENOBARBITAL RN521-31-3 PIPyridazines (68-74) MND3.383.710.350; D26.550.440 DMÑPyridazines LH LM  MSA poxvirus infection of cattle characterized by the appearance of nodules on all parts of the skin. PM70 HN70 MHÑLumpy Skin Disease ANusually animal: do not use /vet but check tag ANIMAL; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES PICattle Diseases (66-69); Virus Diseases (66-69) MNC2.256.743.494; C22.196.497 LH  MSThe etiologic agent of a cattle disease occurring in South and East Africa. HN(75); was see under POXVIRUSES 1975-80 MHÑLumpy Skin Disease Virus ANdo not use /blood-csf-urine /cytol; infection = LUMPY SKIN DISEASE MNB4.909.204.783.400 XSNeethling Virus DMÑPoxviridae LH LS LM  MSEither of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. MHÑLung AN/abnorm: congen cystic adenomatoid malform of lung goes here; /blood supply: consider also PULMONARY CIRCULATION; /surg: consider also PNEUMONECTOMY; inflammation = PNEUMONIA; collapse of lung = ATELECTASIS; consider other terms under PNEUMO- & PULM MNA4.411 FXÑAir Sacs; ÑPNEUMONECTOMY; ÑRESPIRATION LH LX; ;  MHÑLung Abscess MNC1.539.26.519; C8.381.449; C8.730.407 XSABSCESS, PULMONARY LH LS  PM70 HN70(68) MHÑLung Compliance ANonly /drug eff /rad eff PIElasticity (66-67); Lung/PH (66-67) MNE1.302.796.384; G9.772.521.420 LH  MHÑLung Diseases ANGEN; prefer specifics; inflamm dis = PNEUMONIA; lung collapse = ATELECTASIS; congen cystic adenomatoid malform of lung is indexed under LUNG /abnorm; COBP, COLD, COPD & CARA: see note on LUNG DISEASES, OBSTRUCTIVE below MNC8.381 XSPulmonary Diseases FXÑPULMONARY HEART DISEASE XUÑSilo Filler's Disease LH LS LX LU  MHÑLung Diseases, Fungal ANcoord IM with specific fungal disease (IM); ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY is available MNC1.703.534; C8.381.472; C8.730.435 LH  MSAny disorder marked by persistent obstruction of bronchial air flow. PM72 HN72(71) MHÑLung Diseases, Obstructive ANchronic in nature so do not coord with CHRONIC DISEASE; AIRWAY OBSTRUCTION is also available but chronic airway obstruction, chronic airflow obstruction & COAD (Chronic Obstructive Airway Disease) go here; COLD (Chronic Obstructive Lung Disease), COBP (Chronic Obstructive BronchoPneumopathy) & CARA (Chronic Aspecific Respiratory Affection) go here; note X refs below PILung Diseases (66-70) MNC8.381.495 XSCOPD; Chronic Obstructive Pulmonary Disease; Pulmonary Disease, Chronic Obstructive LH LS; ;  MHÑLung Diseases, Parasitic ANcoord IM with specific parasitic disease (IM) but note that available also are ECHINOCOCCOSIS, PULMONARY & PNEUMOCYSTIS CARINII PNEUMONIA MNC3.582; C8.381.517 LH  MHÑLung Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); congen cystic adenomatoid malform of lung does not go here: index under LUNG /abnorm MNC4.588.894.797.520; C8.381.540 XSPulmonary Neoplasms LH LS  MSAmount of air that the lungs may contain at various points in the respiratory cycle. PM75 HN75 MHÑLung Volume Measurements ANNIM; only /instrum /methods /vet; see FORCED EXPIRATORY FLOW RATES & FORCED EXPIRATORY VOLUME for more cross-refs PILung (66-74); Respiration (66-74); Respiratory Function Tests (66-74) MNE1.302.796.420 XSLung Capacities XUÑClosing Volume; ÑExpiratory Reserve Volume; ÑFunctional Residual Capacity; ÑInspiratory Capacity; ÑInspiratory Reserve Volume; ÑResidual Volume; ÑTidal Volume; ÑTotal Lung Capacity LH LS LU; ; ; ; ; ; ;  MHÑLupus ANa type of cutaneous tuberc MNC1.252.40.552.846.583.603; C17.838.887.603 XSLUPUS VULGARIS LH LS  MSLupus erythematosus that affects the skin in three forms - acute, aubacute, chronic (discoid). PM87 HN87 MHÑLupus Erythematosus, Cutaneous ANacute or subacute but chronic cutaneous = LUPUS ERYTHEMATOSUS, DISCOID PILupus Erythematosus, Discoid (66-86); Lupus Erythematosus, Systemic (66-86) MNC17.480 XSLupus Erythematosus, Subacute Cutaneous LH LS  MHÑLupus Erythematosus, Discoid ANdo not confuse with systemic or disseminated: discoid is usually in dermatol jrnls, systemic in arthritis or rheumat jrnls; when unspecified in title, ╥discoid╙ is usually discernible from text or bibliog refs; note X ref: do not confuse with LUPUS ERYTHEMATOSUS, CUTANEOUS MNC17.480.479 XSLupus Erythematosus, Chronic Cutaneous LH LS  MHÑLupus Erythematosus, Systemic ANif not specified as ╥systemic╙ it is still probably correct to index here, not also discoid MNC17.490; C20.111.590; C23.205.200.436 XSLIBMAN-SACKS DISEASE; LUPUS ERYTHEMATOSUS DISSEMINATUS FXÑLE CELLS LH LS; LX  MSGlomerulonephritis associated with systemic lupus erythematosus; classified into four histologic types: mesangial, focal, diffuse, and membranous. PM87 HN87 MHÑLupus Nephritis AN╥glomerulonephritis associated with systemic lupus erythematosus╙ PIGlomerulonephritis (66-86); Lupus Erythematosus, Systemic (66-86); Nephritis (66-86) MNC12.777.419.570.363.680; C20.111.590.560; C23.205.200.436.680 XSGlomerulonephritis, Lupus; Lupus Glomerulonephritis; Nephritis, Lupus LH LS; ;  MSA series of tests designed to assess neuropsychological function; used to diagnose specific cerebral dysfunction and also determines lateralization. HN(85) MHÑLuria-Nebraska Neuropsychological Battery ANno qualif; DF: LURIA PIPsychological Tests (66-84) MNF4.711.513.300 DMÑNeuropsychological Tests LH LM  MSThe period of the menstrual cycle that begins with ovulation and ends with menstruation. OLuse LUTEAL PHASE to search MENSTRUATION, LUTEAL PHASE back thru 1975 PM85; was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-84 HN85(75); was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-84 MHÑLuteal Phase ANonly /drug eff /rad eff MNG8.520.440.410 XSMenstrual Cycle, Luteal Phase; Menstruation, Luteal Phase; Postovulatory Phase LH LS; ;  MSThe cells of the corpus luteum which are derived from the granulosa cells and the theca cells of the Graafian follicle. HN(75) MHÑLutein Cells ANA 11 qualif MNA5.360.319.114.630.278.400; A6.407.312.497.278.400; A11.600 DMÑCorpus Luteum LH LM  MSA combination of atrial septal defect and mitral stenosis. OLsearch HEART SEPTAL DEFECTS, ATRIAL 1966-74 HN(75); was see under HEART DEFECTS, CONGENITAL 1963 MHÑLutembacher's Syndrome ANdo not use /congen MNC14.280.400.560.375.518; C16.131.457.559.376.520 DMÑHeart Septal Defects, Atrial LH LM  MSChemical compounds which cause corpus luteum regression. PM75 HN75 MHÑLuteolytic Agents ANdo not use /analogs /biosyn /defic /physiol; consider also CORPUS LUTEUM /drug eff & CORPUS LUTEUM REGRESSION PICorpus Luteum/DE (68-74) MND7.610; D7.360.276.450 LH  MHÑLutetium ANLu-175; do not use /analogs /biosyn /defic /physiol; Lu-167-174, 176-180 = LUTETIUM (IM) + RADIOISOTOPES (IM) RN7439-94-3 MND1.268.504; D1.552.550.518 LH  MSA complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor. PM76 HN76 MHÑLutheran Blood-Group System ANonly /genet /immunol; TN 230 PIBlood Groups (66-75) MND24.611.216.705.230.552; G4.610.241.552; G9.188.229.552 LH  MHÑLuxembourg MNZ1.542.550 LH  OLuse LYASES to search DESMOLASES back thru 1966 HNDESMOLASES was see under LYASES 1963-80 MHÑLyases ANdo not use /analogs RNEC 4. MND8.586.520 XSDesmolases XUÑAdenylosuccinate Lyase; ÑArgininosuccinate Lyase; ÑCystathionine gamma-Lyase; ÑCysteine Synthase; ÑDNA Photolyase; ÑFerrochelatase; ÑLactoyl Glutathione Lyase; ÑSulfhydrases; ÑTryptophanase; ÑTyrosine Phenol-Lyase LH LS LU; ; ; ; ; ; ; ; ;  OLsearch CAUSTICS 1966-74 HN(75) MHÑLye AND25-26 qualif MND1.455.384.520 DMÑCaustics LH LM  MSCommunication to others of what one knows to be untrue or contrary to fact; attempt to deceive. MHÑLying ANno qualif; LIE DETECTION is also available MNF3.126.842.483 LH  MSAn inflammatory disease of the skin, nervous system, and heart. A spirochete isolated from Ixodes dammini ticks has been implicated as the etiologic agent. Formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut. OLsearch ARTHRITIS, INFECTIOUS 1979-84 PM85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS 1979-84 HN85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS l979-84 MHÑLyme Disease PIArthritis, Infectious (79-84); Spirochaetales Infections (82-84) MNC1.252.847.193.569 LH  OLuse LYMECYCLINE to search TETRACYCLINE-L-METHYLENE LYSINE back thru 1966 (as Prov 1966-74) HN(78); was TETRACYCLINE-L-METHYLENE LYSINE see under TETRACYCLINE 1975-77, was TETRACYCLINE-L-METHYLENE LYSINE 1963-74 (Prov) MHÑLymecycline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN992-21-2 MND20.85.868.389 XSTetracycline-L-Methylene Lysine DMÑTetracyclines LH LS LM  MSA genus of dextrally coiled freshwater snails that includes some species of importance as intermediate hosts of parasitic flukes. PM72 HN72 MHÑLymnaea AN/microbiol /parasitol permitted PISnails (66-71) MNB1.644.776.645 LH  MHÑLymph ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.207.630; A15.382.520.436 LH  MHÑLymph Node Excision ANdo not use /util except by MeSH definition MNE4.446 LH  MHÑLymph Nodes AN/radiogr permitted: not necessarily LYMPHOGRAPHY; /surg: probably LYMPH NODE EXCISION or RADICAL NECK DISSECTION; ╥lymphadenopathy╙ is indexed under LYMPHATIC DISEASES but consider also IMMUNOBLASTIC LYMPHADENOPATHY, SEZARY SYNDROME & other specifics; GIANT LYMPH NODE HYPERPLASIA is also available; ╥axillary lymph nodes╙ = LYMPH NODES (IM) + AXILLA (NIM, no qualif); ╥cervical lymph nodes╙ = LYMPH NODES (IM) + NECK (NIM, no qualif); inflammation = LYMPHADENITIS MNA15.382.520.604.412 LH  MHÑLymphadenitis ANinflamm of lymph nodes: do not confuse with LYMPHANGITIS, inflamm of lymphatic vessels; consider also MESENTERIC LYMPHADENITIS MNC15.604.315 XSADENITIS LH LS  MHÑLymphangiectasis MNC15.604.360 LH  OLsearch PROTEIN-LOSING ENTEROPATHIES 1966-74 HN(75) MHÑLymphangiectasis, Intestinal MNC6.405.469.818.521; C18.452.805.521 DMÑProtein-Losing Enteropathies LH LM  MSA tumor composed of lymphatic tissue. OLuse LYMPHANGIOMA to search LYMPHANGIOENDOTHELIOMA back thru 1966 PMLYMPHANGIOENDOTHELIOMA was heading 1963-83 HNLYMPHANGIOENDOTHELIOMA was heading 1963-83 MHÑLymphangioma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.651 XSLymphangioendothelioma LH LS  MSA tumorlike condition characterized by smooth muscle and endothelium proliferation of lymphatic vessels and lymph nodes in the mediastinum and retroperitoneum, also in the lung. May be manifested by chylous pleural effusion and ascites. HN(80) MHÑLymphangiomyoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) PILymphangioma (66-79); Lymphatic Diseases (68-79) MNC4.557.690.660; C15.604.515.562; C20.683.515.710 XSLymphangioleiomyoma DMÑLymphoproliferative Disorders LH LS LM  MSA malignant tumor originating from the endothelial cells of lymphatic vessels. MHÑLymphangiosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.689; C4.557.863.496 XSLymphangioendothelioma, Malignant LH LS  OLuse LYMPHANGITIS /VE to search LYMPHANGITIS, EPIZOOTIC 1970-81 PMLYMPHANGITIS, EPIZOOTIC was heading 1970-81 HNLYMPHANGITIS, EPIZOOTIC was heading 1970-81 MHÑLymphangitis ANinflamm of lymphatic vessels; do not confuse with LYMPHADENITIS, inflamm of lymph nodes MNC15.604.406 LH  OLuse LYMPHATIC DISEASES to search LYMPHATISM back thru 1966 PM70; LYMPHATISM was heading 1963-78 HN70(68); LYMPHATISM was heading 1963-78 MHÑLymphatic Diseases AN╥lymphadenopathy╙ unspecified goes here but note LYMPHADENOPATHY SYNDROME see AIDS-RELATED COMPLEX & consider IMMUNOBLASTIC LYMPHADENOPATHY, SEZARY SYNDROME & other specifics indented here; inflamm dis = LYMPHANGITIS; ╥lymphatism╙ goes here PILymphatic System (66-67) MNC15.604 FXÑChylothorax; ÑLEUKEMIA, LYMPHOBLASTIC; ÑLEUKEMIA, LYMPHOCYTIC; ÑLYMPHOMA LH LX; ; ;  MSTransfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. MHÑLymphatic Metastasis ANNIM, no qualif; IM for GEN or lymphatic metastatic process; when IM, do not use /anal /blood supply /chem ind /compl /embryol /etiol /familial /hist /secret; policy on metastases: Manual 24.16-.23 MNC4.805.650.560 LH  MHÑLymphatic System AN╥lymphatic venules╙ and ╥lymphatic capillaries╙ go here & not under VENULES & CAPILLARIES (these are restricted to blood vessels); LYMPHOID TISSUE & LYMPH NODES are available; inflammation = LYMPHANGITIS; /radiogr = LYMPHOGRAPHY MNA15.382.520 LH  MSEdema due to obstruction of lymph vessels or disorders of the lymph nodes. OLuse LYMPHEDEMA/CN to search MILROY'S DISEASE back thru 1966 PMELEPHANTIASIS was see under FILARIASIS & LYMPHEDEMA 1963-74; MILROY'S DISEASE was heading 1963-83 HNMILROY'S DISEASE was heading 1963-83 MHÑLymphedema ANX ref MILROY'S DISEASE goes under LYMPHEDEMA/congen MNC15.604.496 XSMilroy's Disease FXÑEdema XUÑElephantiasis; ÑElephantiasis, Filarial LH LS LX LU;  MST-cell enhancement of the B-cell response to thymic-dependent antigens. PM78 HN78 MHÑLymphocyte Cooperation ANonly /drug eff /rad eff PILymphocytes (66-72); B-Lymphocytes (73-77); T-Lymphocytes (73-77) MNG4.335.650; G4.610.749 FXÑB Lymphocytes; ÑHelper Cells; ÑT Lymphocytes; ÑT Lymphocytes, Regulatory LH LX; ; ;  MSImmunosuppression by reduction of circulating lymphocytes. May be accomplished by thoracic duct drainage or administration of antilymphocyte serum. PM74 HN74(72) MHÑLymphocyte Depletion ANno qualif PIImmunosuppression (71) MNE2.95.449.521; E5.478.610.570 FXÑLymphopenia LH LX  MSMorphologic alteration of small lymphocytes in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically; induced by mitogens such as phytohemagglutinins as well as by specific antigens. May also occur in vivo, as in graft rejection. Syn: lymphocyte activation, lymphocyte stimulation, blastogenesis. PM72 HN72(69) MHÑLymphocyte Transformation ANonly /drug eff /rad eff; also called ╥lymphocyte stimulation╙, ╥lymphocyte activation╙, ╥blastogenesis╙ PILymphocytes/IM (66-68) MNE5.478.680; G4.610.555.714.671 XSLymphocyte Activation FXÑAntigen-Presenting Cells LH LS LX  MHÑLymphocytes ANA 11 qualif & /class; lymphocyte count = LYMPHOCYTES (IM) + LEUKOCYTE COUNT (IM); decrease in number = LYMPHOPENIA; excess number = LYMPHOCYTOSIS; subsets & subpopulations: index under LYMPHOCYTES /class & do not coord with LEUKOCYTE COUNT; the subset regulatory T lymphocytes = T LYMPHOCYTES, REGULATORY or its specific indentions; LYMPHOCYTE CULTURE TEST, MIXED is also available MNA11.118.637.555; A15.145.229.637.555; A15.382.490.520; A15.382.520.520 XSLymphoid Cells FXÑAntilymphocyte Serum LH LS LX  MSA class of lymphocytes characterized by the lack of surface markers specific for either T or B lymphocytes. PM82 HN82 MHÑLymphocytes, Null ANA 11 qualif & /class PILymphocytes (73-81); B Lymphocytes (73-81); T Lymphocytes (73-81) MNA11.118.637.555.615; A15.145.229.637.555.615; A15.382.490.520.615; A15.382.520.520.615 XSNull Cells LH LS  MHÑLymphocytic Choriomeningitis MNC2.782.82.580; C10.228.228.507.616.521 LH  MSThe virus producing an inapparent infection in naturally infected wild mice; causes a febrile meningoencephalitis in man. PM73 HN73(65) MHÑLymphocytic Choriomeningitis Virus ANdo not use /blood-csf-urine /cytol; DF: LYMPHOCYTIC CHORIO VIRUS MNB4.909.777.779.521; B4.909.777.80.565 LH  MHÑLymphocytosis ANincrease in number of lymphocytes MNC15.378.553.475.604 LH  MHÑLymphogranuloma Venereum MNC1.539.780.603; C1.850.200.195.560 XSLYMPHOGRANULOMA INGUINALE LH LS  PM64 HN64(63) MHÑLymphography AN= lymphangiography; NIM; do not use /util except by MeSH definition MNE1.818.453 FXÑInjections, Intralymphatic LH LX  MHÑLymphoid Tissue AN/radiogr permitted: not necessarily LYMPHOGRAPHY MNA10.549; A15.382.520.604 FXÑAdenoids; ÑSPLEEN; ÑTHYMUS GLAND; ÑTONSIL LH LX; ; ;  MSSoluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Synonyms: lymphocyte mediators; mediators of cellular immunity; humoral mediators of immunity. PM74 HN74 MHÑLymphokines AN/biosyn /physiol permitted; do not use /analogs MND24.611.632 XUÑLeukocyte Migration Inhibitory Factors LH LU  MSA general term for various neoplastic diseases of the lymphoid tissue. MHÑLymphoma AN╥malignant lymphoma╙ can go here; do not confuse with malignant lymphogranuloma ( = HODGKIN'S DISEASE); ╥non-Hodgkin's lymphoma╙ = LYMPHOMA, NON-HODGKIN'S or specific indentions; ╥Mediterranean lymphoma╙ = LYMPHOMA, MEDITERRANEAN see IMMUNOPROLIFERATIVE SMALL INTESTINAL DISEASE; ╥T-cell lymphoma╙: coord IM with T LYMPHOCYTES (NIM); /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.386; C15.604.515.569; C20.683.515.761 XSGerminoblastoma; Immunoblastoma; Reticulolymphosarcoma; Sarcoma, Germinoblastic; Sarcoma, Immunoblastic FXÑLymphatic Diseases LH LS; ; ; ; LX  MHÑLymphoma, Giant Follicular AN/anal /blood supply /secret /ultrastruct permitted MNC4.557.386.480.455; C15.604.515.569.480.455; C20.683.515.761.480.455 XSBRILL-SYMMERS DISEASE LH LS  MSA form of malignant lymphoma in which the malignant cells resemble histiocytes morphologically but are presently considered to be derived from lymphoid elements. OLuse LYMPHOMA, HISTIOCYTIC to search SARCOMA, RETICULUM CELL back thru 1966 PM87; SARCOMA, RETICULUM CELL was heading 1963-86 HN87; SARCOMA, RETICULUM CELL was heading 1963-86 MHÑLymphoma, Histiocytic AN/anal /blood supply /secret /ultrastruct permitted PILymphoma (66-86) MNC4.557.386.480.460; C15.604.515.569.480.460; C20.683.515.761.480.460 XSSarcoma, Reticulum Cell LH LS  MSA form of malignant lymphoma in which the predominating cell type belongs to the lymphocytic series. PM87 HN87 MHÑLymphoma, Lymphocytic AN/anal /blood supply /secret /ultrastruct permitted PILymphoma (66-86); Lymphoma, Non-Hodgkin's (66-86) MNC4.557.386.480.465; C15.604.515.569.480.465; C20.683.515.761.480.465 LH  MSA form of lymphoma that contains proliferations of both histiocytes and lymphocytes. PM87 HN87 MHÑLymphoma, Mixed AN/anal /blood supply /secret /ultrastruct permitted PILymphoma (66-86); Lymphoma, Giant Follicular (66-86) MNC4.557.386.480.470; C15.604.515.569.480.470; C20.683.515.761.480.470 LH  MSAny of a group of malignant tumors of lymphoid tissues that have several similarities to Hodgkin's disease, but are much less predictable in terms of patterns of spread and behavior. OLuse LYMPHOMA, NON-HODGKIN'S to search LYMPHOSARCOMA back thru 1966 PM87; LYMPHOSARCOMA was heading 1963-86 HN87; LYMPHOSARCOMA was heading 1963-86 MHÑLymphoma, Non-Hodgkin's AN/anal /blood supply /secret /ultrastruct permitted PILymphoma (66-86) MNC4.557.386.480; C15.604.515.569.480; C20.683.515.761.480 XSLymphosarcoma LH LS  MSA form of lymphoma in which relatively large stem cells with large nuclei, pale, scanty cytoplasm, and indistinct borders are predominant. PM87 HN87 MHÑLymphoma, Undifferentiated AN/anal /blood supply /secret /ultrastruct permitted PILymphoma (66-86) MNC4.557.386.480.475; C15.604.515.569.480.475; C20.683.515.761.480.475 LH  MSAn angiocentric and angiodestructive lymphoreticular proliferative disorder primarily involving the lungs. Histologically it simulates malignant lymphoma and in some cases may progress to lymphoma. PM80 HN80 MHÑLymphomatoid Granulomatosis AN/anal /blood supply /secret /ultrastruct permitted; if non-neopl, coord IM with precoord organ/dis term (IM); if neopl, coord IM with precoord organ/neopl term (IM) PIGranuloma (66-79); Lung Diseases (66-79); Lymphoma (66-79) MNC4.834.567; C15.604.515.571; C23.484.567 XSGranulomatosis, Lymphomatoid LH LS  MSReduction in the number of lymphocytes. PM70 HN70 MHÑLymphopenia ANdecrease in number of lymphocytes PILeukopenia (66-69); Lymphocytes (66-69) MNC15.378.553.546.605; C20.673.627 XSLymphocytopenia FXÑLYMPHOCYTE DEPLETION LH LS LX  MSDisorders characterized by proliferation of lymphoid tissue, general or unspecified. PM79 HN79 MHÑLymphoproliferative Disorders ANGEN or unspecified: prefer specifics MNC15.604.515; C20.683.515 XUÑLymphangiomyoma LH LU  MSSoluble substances released by lymphocytes activated by antigens, mitogens, etc., that are cytotoxic to other cells; involved in allergies and chronic inflammatory diseases. OLuse LYMPHOTOXINS to search LYMPHOTOXIN back thru 1974 & LYMPHOCYTOTOXINS 1978 PMwas LYMPHOTOXIN 1974-77; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978 HN78; was LYMPHOTOXIN 1974-77; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978 MHÑLymphotoxins ANdo not use /analogs /diag use /physiol; for ╥lymphocytotoxins╙ check text: if toxin released by lymphocyte index under LYMPHOTOXINS, if antibody to lymphocytes index under ANTILYMPHOCYTE SERUM MND24.185.926.235.565; D24.611.632.438 LH  PM65 HN65(64) MHÑLynestrenol ANdo not use /biosyn /defic /physiol RN52-76-6 MND4.808.668.651.693.494; D6.597.799.506; D7.360.276.210.443.706.452 XSEthinylestrenol LH LS  MSToxins isolated from any species of the seaweed Lyngbya or similar chemicals from other sources, including mollusks and micro-organisms; these have been found to be potent tumor promoters. PM85 HN85 MHÑLyngbya Toxins ANfrom seaweed originally; do not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTITOXINS; coord with source only if particularly discussed PIAlkaloids (66-84); Carcinogens (66-84); Indoles (66-84); Lactones (66-84); Marine Toxins (74-84); Toxins (66-84) MND24.185.926.580.565 LH  MS8-Lysyl vasopressin. The porcine antidiuretic hormone most frequently used clinically; a cyclic octapeptide with lysine in position 8 of the chain; used to treat diabetes insipidus and as hemostatic due to its vasoconstrictor action. Synonyms: Diapid; Insipidin; Lysine pitressin; Postacton; Syntopressin; Vasophysin. OLuse LYPRESSIN to search LYSINE VASOPRESSIN back thru 1975 PM79; was LYSINE VASOPRESSIN see under VASOPRESSIN 1975-78; FELYPRESSIN was PHELYPRESSIN see under VASOPRESSIN 1975-78 HN79; was LYSINE VASOPRESSIN see under VASOPRESSIN 1975-78 MHÑLypressin AN/biosyn /physiol permitted RN50-57-7 PILysine (66-74); Vasopressins (66-74) MND6.472.734.692.781.400; D12.644.456.925.480; D12.776.641.650.900.400; D19.770.896.540 XSLysine Vasopressin; Vasopressin, Lysine XUÑFelypressin LH LS; LU  OLsearch ERGOLINES 1969-74 HN(75) MHÑLysergic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN82-58-6 MND3.132.327.287.572; D3.549.439.572 DMÑErgolines LH LM  MSN,N-Diethyl-D-lysergamide. Semisynthetic derivative of ergot (Claviceps purpurea); affects the AUTONOMIC NERVOUS SYSTEM, especially serotonergic functions; potent psychotomimetic and analgesic; used mainly as serotonin antagonist. Synonyms: Delysid; LSD-25; N,N-Diethylsergamid. MHÑLysergic Acid Diethylamide ANdo not use /biosyn /defic /physiol RN50-37-3 MND3.132.327.287.572.522; D3.549.439.572.522; D15.236.372.542; D23.846.561 XSLSD; Lysergide XUÑ2-Bromolysergic Acid Diethylamide LH LS; LU  MHÑLysine AN/biosyn /defic /physiol permitted; POLYLYSINE is also available MND12.125.95.647; D12.125.142.497 XUÑLysinoalanine LH LU  MSPeptidyllysine,2-oxoglutarate:oxygen 5-oxidoreductase. A mixed function oxygenase which catalyzes the hydroxylation of peptidyllysine, usually in protocollagen, to peptidylhydroxylysine. The enzyme utilizes molecular oxygen with concomitant oxidative decarboxylation of the cosubstrate 2-oxoglutarate to succinate. EC 1.14.11.4. HN(77) MHÑLysine Hydroxylase ANdo not use /analogs RNEC 1.14.11.4 PIHydroxylases (66-76); Ketoglutaric Acids (66-76); Lysine (66-76) MND8.586.682.420.500 XSLysine 2-Oxoglutarate Dioxygenase; Protocollagen Lysyl Hydroxylase DMÑHydroxylases LH LS; LM  MSN(6)-(2-Amino-2-carboxyethyl)-L-lysine. An unusual amino acid, not a dipeptide, which has been found in proteins of cooked foods. It is formed in food that is heated or treated with alkali. Has been implicated in nephrocytomegalia in rats. HN(79) MHÑLysinoalanine ANdo not use /biosyn /defic /physiol RN18810-04-3 PIAlanine (66-78); Dipeptides (66-78); Lysine (66-78) MND12.125.42.475; D12.125.95.647.575 DMÑLysine LH LM  MSThe phenomenon by which a temperate phage incorporates itself into the DNA of a bacterial host, establishing a kind of symbiotic relation between prophage and bacterium which results in the perpetuation of the prophage in all the descendents of the bacterium until induction by various agents, such as ultraviolet radiaion, releases the phage, which then becomes virulent and lyses the bacterium. PM70 HN70(68) MHÑLysogeny ANonly /drug eff /rad eff PIBacteria (66-67); specific bacterium; Bacteriophages (66-67); specific bacteriophage; Bacteriolysis (66-67); specific bacteria MNG4.185.515.591; G5.386.521 XSProphage Integration FXÑBacteriophages XUÑAttachment Sites (Microbiology) LH LS LX LU  MSAcyl-CoA:1-acylglycero-3-phosphocholine-O-acyltransferase. This enzyme is localized predominantly within the plasma membrane of lymphocytes. It catalyzes the transfer of long chain fatty acids. preferentially unsaturated fatty acids, to lysophosphatides with the formation of 1,2-diacylglycero-3-phosphocholine and CoA. HN(76) MHÑLysolecithin Acyltransferase ANdo not use /analogs RNEC 2.3.1.23 PIAcyltransferases (72-75); Coenzyme A (73-75); Lysophosphatidylcholines (72-75) MND8.586.913.50.650 XSAcyl CoA Lysolecithin Acyltransferase DMÑAcyltransferases LH LS LM  MSDerivatives of phosphatidylcholines obtained by their partial hydrolysis which removes one of the fatty acid moieties. Synonym: lysolecithins. OLuse LYSOPHOSPHATIDYLCHOLINES to search LYSOLECITHIN back thru 1966 PM77; was LYSOLECITHIN 1963-76 HN77; was LYSOLECITHIN 1963-76 MHÑLysophosphatidylcholines ANdo not use /analogs /defic /physiol MND10.516.695.300.700.710.400 XSLysolecithins LH LS  MSLysolecithin acylhydrolase. Catalyzes the hydrolysis of a single fatty acid ester bond in lysoglycerophosphatidates with the formation of glyceryl phosphatidates and a fatty acid. EC 3.1.1.5. HN(80) MHÑLysophospholipase ANdo not use /analogs RNEC 3.1.1.5 PIPhospholipases (66-79) MND8.586.277.352.100.680.510 XSLecithinase B; Lysolecithinase; Phospholipase B DMÑPhospholipases LH LS; ; LM  PM65 HN65(64) MHÑLysosomes ANA 11 qualif except /cytol; /class permitted; lysosomal storage disease: probably METABOLISM, INBORN ERRORS or a specific indention there & do not index here unless LYSOSOMES is particularly discussed MNA11.368.702.452 LH  MSA mixture of three different proteolytic enzymes, two of which lyse bacterial walls; obtained from Staphylococcus staphylolyticus (S. epidermidis); it is very antigenic, but has been used in animals and topically in man against certain infections. PM73 HN73(65) MHÑLysostaphin ANdo not use /defic /physiol RNEC 3.4.- MND8.586.277.656.550; D20.85.479; D20.187.540 FXÑBacteriolysis LH LX  MSA copper containing enzyme which converts the epsilon amino groups of lysine or hydroxylysine to aldehydes. These form cross links in collagen molecules by reacting with each other to give Schiff bases. HN(75) MHÑLysyl Oxidase ANdo not use /analogs RNEC 1.4.- PIAmino Acid Oxidoreductases (72-74); Lysine (72-74) MND8.586.682.135.600 DMÑAmino Acid Oxidoreductases LH LM  MSL-Lysine:tRNA-Lys ligase (AMP-forming). Activates lysine with its specific transfer RNA. HN(75) MHÑLysyl T RNA Synthetase ANdo not use /analogs; note spacing RNEC 6.1.1.6 PIAmino Acyl T RNA Synthetases (72-74); Lysine (72-74) MND8.586.464.136.500 DMÑAmino Acyl T RNA Synthetases LH LM  MSA genus of the family Cercopithecidae consisting of 13 species which inhabits forests of Africa, Asia and the islands of Borneo, Philippines and Celebes. OLuse MACACA to search BARBARY APES back thru 1973 PM73 HN73(71); APE, BARBARY was BARBARY APES see under MACACA 1973-80 MHÑMacaca ANa monkey, not an ape; Celebes black ape goes here; usually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIAnthropoidea (66-70) MNB2.649.801.201.468.660 XSApe, Barbary; Macaque; Monkey, Japanese XUÑMacaca fascicularis; ÑMacaca mulatta; ÑMacaca nemestrina; ÑMacaca radiata LH LS; ; LU; ; ;  MSA species of the genus Macaca which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. OLuse MACACA FASCICULARIS to search CYNOMOLGUS MONKEYS back thru 1975 HN(81); was CYNOMOLGUS MONKEYS see under MACACA 1975-80 MHÑMacaca fascicularis ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.468.660.508 XSMonkey, Crab-Eating; Monkey, Cynomolgus DMÑMacaca LH LS; LM  MSA species of the genus Macaca occurring in India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. OLuse MACACA MULATTA to search RHESUS MONKEYS back thru 1975 HN(81); was RHESUS MONKEYS see under MACACA 1975-80 MHÑMacaca mulatta ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.468.660.540 XSMonkey, Rhesus DMÑMacaca LH LS LM  MSA species of the genus Macaca which occurs in Malaya, Sumatra and Borneo. It is one of the most arboreal species of Macaca. The tail is short and untwisted. HN(81) MHÑMacaca nemestrina ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIMacaca (71-80) MNB2.649.801.201.468.660.568 XSMonkey, Pig-Tailed DMÑMacaca LH LS LM  MSA species of macaque monkey. HN(75) MHÑMacaca radiata ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.468.660.590 XSMonkey, Bonnet DMÑMacaca LH LS LM  MSA Portuguese colony on the island of Macao and adjacent islands off the southeast coast of China. OLsearch PORTUGAL 1977 HN78; was see PORTUGAL 1977 MHÑMacao PIPortugal (66-77) MNZ1.252.474.580 LH  MSA personality dimension characterized by the manipulation of others. HN(79) MHÑMachiavellianism ANno qualif PIAuthoritarianism (66-78); Personality (66-78) MNF1.752.650 XSManipulation, Psychological DMÑPersonality LH LS LM  MHÑMacroglobulinemia MNC15.378.147.780.630; C15.604.515.573; C20.683.780.630 XSWALDENSTROM'S MACROGLOBULINEMIA LH LS  PM65 HN65 MHÑMacroglobulins ANonly /anal /biosyn /class /csf /genet /immunol /isol /metab /physiol /urine; ALPHA MACROGLOBULINS is also available MND12.776.124.790.720; D12.776.377.715.647 LH  OLsearch TONGUE /AB 1969-74 PM76; was see under TONGUE 1975, was see under TONGUE /abnormalities 1969-74 HN76(75); was see under TONGUE 1975, was see under TONGUE /abnormalities 1969-74 MHÑMacroglossia ANdo not use /congen PITongue/AB (69-74) MNC16.131.314.687.460 LH  PM66 HN66 MHÑMacromolecular Systems ANalmost never IM unless GEN only, irrespective of chemical; coord NIM with specific chem (IM); no qualif MND12.472 FXÑPOLYMERS XUÑBiopolymers LH LX LU  MSThe process of altering the morphology and functional activity of macrocytes so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. PM82 HN82 MHÑMacrophage Activation ANonly /drug eff /rad eff PIMacrophages (66-81) MNG4.610.770 LH  MSProteins released by sensitized lymphocytes and possibly other cells that inhibit the migration of macrophages away from the release site; the structure and chemical properties may vary with the species and type of releasing cell; some of these factors may be identical to the Macrophage Activating Factor. OLuse MACROPHAGE MIGRATION INHIBITORY FACTORS to search MIGRATION INHIBITORY FACTOR 1974-79 PM80; was MIGRATION INHIBITORY FACTOR 1974-79 HN80; was MIGRATION INHIBITORY FACTOR 1974-79 MHÑMacrophage Migration Inhibitory Factors AN/biosyn /physiol permitted; do not use /analogs /defic; also called MIF; DF: MMIF PICell Migraion Inhibition (72-73); Cell Movement (70-71) MND24.611.632.625 XSMigration Inhibition Factors, Macrophage FXÑCell Migration Inhibition LH LS LX  MHÑMacrophages ANA 11 qualif & /class; macrophage migration test: index under MACROPHAGES /immunol (IM) + CELL MIGRATION INHIBITION (IM) MNA11.329.372; A11.733.397; A15.382.680.397; A15.382.812.522 FXÑInterleukin 1; ÑPhagocytosis; ÑRETICULOENDOTHELIAL SYSTEM XUÑFoam Cells LH LX; ; LU  PM65 HN65 MHÑMacrostomia ANdo not use /congen MNC16.131.314.687.522 LH  MHÑMacula Lutea ANmacular dis: coord IM with RETINAL DISEASES (IM) MNA9.371.729.522 XUÑFovea Centralis LH LU  MSThickened areas of the saccule and utricle where the termination of the vestibular nerve occurs. HN(79); was see under LABYRINTH 1979-82 MHÑMaculae, Acoustic PILabyrinth (66-78) MNA9.246.631.800.576 DMÑSaccule and Utricle LH LM  MSDegenerative changes in the macula lutea of the retina. OLsearch RETINAL DEGENERATION 1970-74 PM79; was see under RETINAL DEGENERATION 1970-78 HN79(75); was see under RETINAL DEGENERATION 1970-78 MHÑMacular Degeneration ANincludes ╥macular dystrophy╙ PIRetinal Degeneration (70-78) MNC11.768.585.439 LH  MSMacular degeneration characterized by edema and cystic spaces which may lead to a macular depression or hole. PM84 HN84 MHÑMacular Edema, Cystoid ANan eye dis: a form of MACULAR DEGENERATION PIEdema (66-83); Macula Lutea (66-83) MNC11.768.585.439.245 XSCystoid Macular Edema FXÑEdema LH LS LX  OLuse MADAGASCAR to search MALAGASY REPUBLIC back thru 1966 HN80; was MALAGASY REPUBLIC 1964-79 MHÑMadagascar MNZ1.58.501 XSMalagasy Republic LH LS  MHÑMaduromycosis MNC1.252.40.692.606; C1.703.295.522; C17.838.208.557 XSMYCETOMA LH LS  MS4-(Aminomethyl)benzenesulfonamide. Toxic sulfonamide used as topical anti-infective, especially in burn therapy. Synonyms: Ambamide; Benzamsulfonamide; Emilene; Mefamide; Mesudrin; Paramenyl; Septicid; Sulfomyl. HN(75) MHÑMafenide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN138-39-6 PISulfonamides (70-74); Tosyl Compounds (73-74) MND2.65.884.570; D2.886.590.700.570; D20.890.210 XS4-Homosulfanilamide; Bensulfamide; Sulfabenzamine DMÑSulfonamides LH LS; ; LM  MSBeliefs and practices concerned with producing desired results through supernatural forces or agents as with the manipulation of fetishes or rituals. MHÑMagic ANno qualif; includes witchcraft MNI1.76.201.450.897.439 LH  MHÑMagnesium ANMg-24; /physiol permitted; do not use /analogs /biosyn; Mg-25, 26 = MAGNESIUM (IM) + ISOTOPES (NIM); Mg-20, 21, 23, 27, 28 = MAGNESIUM (IM) + RADIOISOTOPES (IM); /defic = MAGNESIUM DEFICIENCY RN7439-95-4 MND1.248.497.300.333.563; D1.268.513; D1.552.539.557; D1.937.507 XUÑMagnesium Hydroxide LH LU  MHÑMagnesium Deficiency MNC18.654.223.439 LH  MSA compound consisting of one magnesium and two hydroxide ions. Occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects. Synonyms: Magnesium hydrate; Magnesia Magma. HN(77) MHÑMagnesium Hydroxide ANdo not use /analogs /biosyn /defic /physiol RN1309-42-8 PIHydroxides (66-76); Magnesium (66-76) MND1.455.480; D1.552.539.557.350; D19.316.203.59.578; D19.316.396.562 XSBrucite; Milk Of Magnesia DMÑMagnesium LH LS; LM  MSMgO. Occurs in nature as the mineral periclase; in aqueous media combines quickly with water to form magnesium hydroxide; it is used as an antacid and mild laxative and has many nonmedicinal uses. Synonyms: Magnesia; Calcinated Magnesia. MHÑMagnesium Oxide ANdo not use /analogs /biosyn /defic /physiol RN1309-48-4 MND1.552.539.557.439; D1.655.498.486; D19.316.203.59.581; D19.316.396.566 LH  MHÑMagnesium Sulfate ANdo not use /analogs /biosyn /defic /physiol RN7487-88-9 MND1.552.539.557.606; D1.877.814.539.522; D19.316.396.570 LH  MHÑMagnetics ANno qualif MNH1.671.493 XSMagnetometry LH LS  MHÑMaine MNZ1.107.567.875.460 LH  MSMost frequently refers to the integration of a physically or mentally handicapped child into the regular class of normal peers and provision of the appropriately determined educational program. PM87 HN87 MHÑMainstreaming (Education) ANonly /econ /hist /legis PIEducation, Special/trends (68-86) MNI2.158.600; I2.233.213.600 FXÑChild, Exceptional; ÑHandicapped LH LX;  MSThe upkeep of property or equipment. PM73 HN73 MHÑMaintenance ANNIM; only /man /methods /stand /trends MNN2.628 LH  MSHospital department whose primary function is the upkeep and supervision of the buildings and grounds and the maintenance of hospital physical plant and equipment which requires engineering expertise. OLuse MAINTENANCE AND ENGINEERING, HOSPITAL to search MAINTENANCE, HOSPITAL & HOSPITAL MAINTENANCE back thru 1966 PM80; was MAINTENANCE, HOSPITAL 1978-79, was HOSPITAL MAINTENANCE 1963-77 HN80; was MAINTENANCE, HOSPITAL 1978-79, was HOSPITAL MAINTENANCE 1963-77 MHÑMaintenance and Engineering, Hospital ANonly /econ /legis /man /methods /organ /stand /trends; DF: MAINTENANCE HOSP or MAINTENANCE HOSPITAL MNN2.278.354.422.450; N2.628.472; N4.452.442.422.450 XSEngineering, Hospital; Hospital Engineering; Hospital Groundskeeping; Hospital Maintenance; Landscaping, Hospital LH LS; ; ; ;  MSThe genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte defined (LD) transplantation antigens, genes which control the structure of the immune response-associated (Ia) antigens, the immune response (Ir) genes which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement. Synonym: MHC. PM79 HN79 MHÑMajor Histocompatibility Complex ANonly /drug eff /rad eff PIHistocompatibility Antigens (73-78); HLA Antigens (75-78) MNG4.610.626.580; G5.511.580 XSHistocompatibility Complex LH LS  MSGeneral term for syndromes of malnutrition due to failure of normal intestinal absorption of nutrients. PM65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64 HN65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64 MHÑMalabsorption Syndromes MNC6.405.469.637; C18.452.603 FXÑINTESTINAL ABSORPTION XUÑShort Bowel Syndrome LH LX LU  MSThe formation of soft patches on the mucous membrane of a hollow organ, such as the urogenital tract or digestive tract. PM73 HN73(65) MHÑMalacoplakia MNC23.739.548 LH  OLuse MALARIA to search MALARIA CONTROL 1966 PMMALARIA CONTROL was heading 1963-66 HNMALARIA CONTROL was heading 1963-66 MHÑMalaria ANspecify Plasmodium species NIM if possible; tertian malaria: coord IM with PLASMODIUM VIVAX (NIM), quartan malaria: coord IM with PLASMODIUM MALARIAE (NIM); malariotherapy = HYPERTHERMIA, INDUCED: do not confuse with MALARIA /ther; /drug ther: consider also ANTIMALARIALS MNC3.752.552 XSPLASMODIUM INFECTIONS XUÑBlackwater Fever LH LS LU  MHÑMalaria, Avian ANdo not use /vet; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMAL; specific bird or fowl (IM) MNC3.752.552.606; C22.131.498 LH  MHÑMalassezia ANdo not use /anat /embryol /microbiol /parasitol; sometimes causes TINEA VERSICOLOR MNB5.354.381.546.522; B5.354.930.574 XSPityrosporum LH LS  MHÑMalate Dehydrogenase ANdo not use /analogs RNEC 1.1.1.37 MND8.586.682.47.605 XSMalic Enzyme LH LS  MSL-Malate glyoxylate-lyase (CoA-acetylating). An important enzyme in the glyoxylic acid cycle which reversibly catalyzes the synthesis of L-malate from acetyl-CoA and glyoxylate. EC 4.1.2.1. HN(77) MHÑMalate Synthase ANdo not use /analogs RNEC 4.1.3.2 PIKetoacid-Lyases (73-76); Malates (73-76) MND8.586.520.567.620 XSGlyoxylate Transacetylase; Malate Condensing Enzyme; Malate Synthetase DMÑKetoacid-Lyases LH LS; ; LM  MHÑMalates ANdo not confuse with MALEATES; do not use /analogs /biosyn /defic /physiol MND2.241.81.337.463; D2.241.511.505 LH  PM72 HN72 MHÑMalathion ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN121-75-5 PIPhosphates (66-71); Phosphoric Acids (68-71); Thiomalates (66-71) MND2.719.639; D5.723.491.657.648 LH  MHÑMalawi ANformerly Nyasaland MNZ1.58.349.540 XSNyasaland LH LS  MHÑMalaysia ANMalay Federation; Malay Archipelago = INDONESIA; Malaysians are of MONGOLOID RACE unless otherwise specified MNZ1.252.145.487 XSSarawak LH LS  HN66 MHÑMale ANcheck tag only; Manual 18.9+, 35.8.1 CATALOG: do not use: for indexers only LH  MHÑMaleates ANdo not confuse with MALATES; do not use /analogs /biosyn /defic /physiol MND2.241.81.337.502 XUÑCitraconic Acid LH LU  MScis-Butenedioic anhydride. Used in copolymerization reactions, in the Diels-Alder(diene)synthesis, in the preparation of resins, pharmaceuticals and agricultural chemicals. It is a powerful irritant and causes burns. OLuse MALEIC ANHYDRIDES to search MALEIC ANHYDRIDE back thru 1977 HN(79); was MALEIC ANHYDRIDE see under FURANS 1977-78 MHÑMaleic Anhydrides ANdo not use /analogs /biosyn /defic /physiol PIAnhydrides (66-76); Furans (64-76); Maleates (64-76) MND2.113.450; D3.383.312.520 XS2,5-Furandiones DMÑFurans LH LS LM  MS1,2-Dihydro-3,6-pyridazinedione. A herbicide and plant growth regulator; also used to control suckering of tobacco. Its residue in food and tobacco is highly toxic, causing CNS disturbances and liver damage. HN(77) MHÑMaleic Hydrazide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN123-33-1 PIHydrazines (66-76); Maleates (66-76); Pyridazines (66-76) MND3.383.710.400; D5.723.366.560 XSMaleic Acid Hydrazide DMÑPyridazines LH LS LM  PM74 HN74(72) MHÑMaleimides ANdo not use /analogs /biosyn /defic /physiol PIImides (66-71); Maleates (66-71) MND2.241.81.337.502.524; D2.478.440; D3.383.757.399 LH  MHÑMali MNZ1.58.432.571 LH  MHÑMalignant Carcinoid Syndrome ANdo not use /anal /blood supply; /secret /ultrastruct permitted MNC4.557.112.524 XUÑCarcinoid Heart Disease LH LU  MSA herpesvirus infection of cattle characterized by catarrhal inflammation of the upper respiratory and alimentary epithelia, keratoconjunctivitis, encephalitis and lymph node enlargement. Syn: bovine epitheliosis, snotsiekte. PM71 HN71 MHÑMalignant Catarrh ANusually animal: do not use /vet but check tag ANIMAL; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES PICattle Diseases (66-70); Herpesvirus Infections/VE (66-70) MNC2.256.466.606; C22.196.540 LH  MSRapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia. PM73 HN73 MHÑMalignant Hyperthermia ANfollows general anesthesia; do not use /chem ind PIAnesthesia, General (66-72); Fever (66-72) MNC23.814.424; C23.888.189.344.607 XSHyperpyrexia, Malignant; Hyperthermia, Malignant; MALIGNANT HYPERPYREXIA LH LS; ;  MSSimulation of symptoms of illness or injury with intent to deceive in order to obtain a goal, e.g., a claim of physical illness to avoid jury duty. MHÑMalingering ANdo not use /drug eff /physiol /rad eff MNF3.126.594 LH  OLsearch EAR OSSICLES 1966-74 HN(75) MHÑMalleus MNA9.246.397.247.524 DMÑEar Ossicles LH LM  MSA suborder of insects comprising the chewing lice, many of which are parasitic on wild birds and domestic fowl and on wild and domestic mammals. PM72 HN72 MHÑMallophaga AN/microbiol /parasitol permitted PILice (66-71) MNB1.131.617.564.524 LH  MSMucosal tears usually linear and confined to the esophagogastric junction but may be located in the fundus of the stomach or in the distal esophagus. Upper gastrointestinal bleeding from these lacerations is often precipitated by retching or vomiting. PM66 HN66(64) MHÑMallory-Weiss Syndrome MNC6.306.468.524 LH  MHÑMalocclusion ANnote Angle's classes below: index Angle's classification in general as MALOCCLUSION /class MNC7.793.494 XSTooth Crowding FXÑDental Occlusion; ÑORTHODONTICS, CORRECTIVE; ÑPROGNATHISM; ÑRETROGNATHISM; ÑTooth XUÑMalocclusion, Angle Class I; ÑMalocclusion, Angle Class II; ÑMalocclusion, Angle Class III LH LS LX; ; ; ; LU; ;  MSMalocclusion in which the mandible and maxilla are anteroposteriorly normal as reflected by the relationship of the first permanent molar (i.e., in neutroclusion), but in which individual teeth are abnormally related to each other. HN(79) MHÑMalocclusion, Angle Class I ANAngle refers to Edward Hartley Angle, Amer orthodontist PIMalocclusion (66-78) MNC7.793.494.610 XSAngle Class I DMÑMalocclusion LH LS LM  MSMalocclusion in which the mandible is posterior to the maxilla as reflected by the relationship of the first permanent molar (distoclusion). HN(79) MHÑMalocclusion, Angle Class II ANsee note on Angle above; consider also RETROGNATHISM PIMalocclusion (66-78) MNC7.793.494.630 XSAngle Class II DMÑMalocclusion LH LS LM  MSMalocclusion in which the mandible is anterior to the maxilla as reflected by the first relationship of the first permanent molar (mesioclusion). HN(79) MHÑMalocclusion, Angle Class III ANsee note on Angle under Class I above; consider also PROGNATHISM PIMalocclusion (66-78) MNC7.793.494.650 XSAngle Class III DMÑMalocclusion LH LS LM  MHÑMalonates ANdo not use /analogs /defic /physiol MND2.241.81.337.540 XUÑMalondialdehyde; ÑMethylmalonic Acid; ÑPhenylethylmalonamide LH LU; ;  MSThe dialdehyde of malonic acid. HN(75) MHÑMalondialdehyde ANdo not use /biosyn /defic /physiol; /analogs NIM only RN542-78-9 PIAldehydes (71-74); Malonates (71-74) MND2.47.700 XSMalonaldehyde; Propanedial DMÑMalonates LH LS; LM  MSS-Malonyl coenzyme A. A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems. HN(78) MHÑMalonyl Coenzyme A ANdo not use /analogs RN524-14-1 PICoenzyme A (66-77); Malonates (66-77) MND8.176.211.300.500; D13.695.667.138.382.300.500; D13.695.827.68.382.300.500 XSMalonyl CoA DMÑAcyl Coenzyme A LH LS LM  HN(64) MHÑMalpighian Tubules MNA13.574 DMÑCloaca LH LM  MSImproper, injurious or faulty care rendered by a health professional. MHÑMalpractice ANonly /econ /hist /legis /trends MNI1.880.604.583.524; N3.706.535.606 FXÑINSURANCE, LIABILITY XUÑDefensive Medicine LH LX LU  HN75 MHÑMalta MNZ1.542.581.600 LH  MHÑMaltose ANISOMALTOSE is available RN69-79-4 MND9.203.698.365.450; D9.203.698.629.305.523 LH  OLuse MAMMAE to search UDDER back thru 1968 PMUDDER was heading 1968-78 HNUDDER was heading 1968-78 MHÑMammae ANanimal only; inflammation = MASTITIS or MASTITIS, BOVINE; UDDER refers to ruminants only; for neoplasms do not use BREAST NEOPLASMS: coord IM with NEOPLASMS /vet (IM); MAMMARY NEOPLASMS, EXPERIMENTAL is available; Manual 24.33-24.36 MNA10.336.482; A13.589 XSMAMMARY GLANDS, ANIMAL; Udder FXÑExocrine Glands LH LS; LX  OLsearch SIRENIA under MAMMALS 1966-67 PMLAGOMORPHA was see under RABBITS 1963-74; SIRENIA was heading 1963-67 HNSIRENIA was heading 1963-67 MHÑMammals ANavoid: too general: prefer specifics; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; dugong, manatee, sea-cow go here MNB2.649 XUÑHyraxes; ÑLagomorpha LH LU;  MSArteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles and mammary gland. OLsearch THORACIC ARTERIES 1966-74 HN(75) MHÑMammary Arteries ANdo not use /blood supply MNA7.231.114.891.525 DMÑThoracic Arteries LH LM  MSAn RNA virus commonly latent in mice; it causes mammary adenocarcinoma when in a genetically susceptible strain of mice and when the appropriate hormonal influences operate. PM66 HN66 MHÑMammary Cancer Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with MAMMARY NEOPLASMS, EXPERIMENTAL (IM) MNB4.909.574.807.674.441; B4.909.777.731.674.441; B4.909.777.779.674.441 XSBITTNER VIRUS; MILK FACTOR; Mouse Mammary Tumor Virus LH LS; ;  MHÑMammary Neoplasms, Experimental ANanimal only; do not use /vet; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); do not coord with NEOPLASMS, EXPERIMENTAL MNC4.588.180.525; C4.619.590 LH  OLsearch HYPOTHALAMUS 1966-70 PM71; was see under HYPOTHALAMUS 1963-70 HN71; was see under HYPOTHALAMUS 1963-70 MHÑMammillary Bodies ANdo not use /innerv PIHypothalamus (66-70) MNA8.186.211.385.357.362.500 LH  PM66 HN66(64) MHÑMammography ANNIM; do not use /util except by MeSH definition MNE1.818.483 XUÑXeromammography LH LU  MSA system in which the functions of the man and the machine are interrelated and necessary for the operation of the system. PM70 HN70(66) MHÑMan-Machine Systems ANno qualif MNF2.784.412.575; J1.293.556.441; J1.897.441 LH  MSManagement review designed to evaluate efficiency and to identify areas in need of management improvement within the institution in order to ensure effectiveness in meeting organizational goals. HN(82) MHÑManagement Audit ANno qualif MNN4.452.500 XSOperational Audit DMÑOrganization and Administration LH LS LM  MSSystems designed to provide information primarily concerned with the administrative functions associated with the provision and utilization of services; also includes program planning, etc. PM87; was see under INFORMATION SYSTEMS 1983-86 HN87(83); was see under INFORMATION SYSTEMS 1983-86 MHÑManagement Information Systems ANonly /class /econ /hist /instrum /legis /man /organ /stand /supply /trends; for automated systems do not coord with AUTOMATIC DATA PROCESSING PIInformation Systems (66-82); Organization and Administration (68-82) MNL1.700.508.300.680; N4.452.515 XUÑDecision Support Systems, Management; ÑPersonnel Staffing and Scheduling Information Systems LH LU;  MSParticipation of employees with management as a labor-management team, in decisions pertaining to the operational activities of the organization or industry. HN(85) MHÑManagement Quality Circles ANonly /econ /legis /stand /trends PIPersonnel Management (66-84); Quality Assurance, Health Care (80-84) MNN4.452.677.420 XSQuality Circles DMÑPersonnel Management LH LS LM  OLuse MANDELIC ACIDS to search MANDELIC ACID back thru 1966 PM75; was MANDELIC ACID 1963-74 HN75; was MANDELIC ACID 1963-74 MHÑMandelic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.475; D2.241.511.536; D20.237.386 XUÑCyclandelate LH LU  MHÑMandible AN/growth: consider also MAXILLOFACIAL DEVELOPMENT; /inj = MANDIBULAR INJURIES; /innerv: consider also MANDIBULAR NERVE; mandibular foramen & mylohyoid ridge or groove go here; TEMPOROMANDIBULAR JOINT is available MNA2.835.232.781.324.502.632; A14.521.632 FXÑChin LH LX  PM65 HN65 MHÑMandibular Condyle MNA2.835.232.781.324.502.640; A14.521.632.600 LH  PM67 HN67 MHÑMandibular Diseases PIBone Diseases (66); Mandible (66) MNC5.500.607 LH  MSFractures of the lower jaw. PM66 HN66 MHÑMandibular Fractures MNC21.866.405.762.467.441; C21.866.460.589.338.500.441; C21.866.460.589.338.608.441; C21.866.460.836.500.441 LH  MHÑMandibular Injuries MNC21.866.460.589.338.608 LH  MHÑMandibular Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.149.450.400; C5.500.607.442 LH  MHÑMandibular Nerve ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM); inferior alveolar nerve goes here but superior alveolar nerve goes under MAXILLARY NERVE MNA8.796.214.848.375 XUÑLingual Nerve LH LU  PM67 HN67 MHÑMandibular Prosthesis ANto replace missing part of mandible: do not use for prosthetic replacement of teeth in mandible ( = DENTAL PROSTHESIS + MANDIBLE); do not use /instrum /methods /util (except by MeSH definition) PIProsthesis (66) MNE4.659.625; E4.833.566; E6.780.588; E6.892.566; E7.450.630; E7.858.565.675 LH  MHÑMandibulofacial Dysostosis ANdo not use /congen MNC5.116.99.370.231.576; C16.131.621.246.650 XSTreacher Collins Syndrome XUÑGoldenhar Syndrome LH LS LU  MSA genus of Eurasian, solanaceous herbs, Mandrake, that yield belladonna-like alkaloids; not to be confused with 'mandrake root', which is an American plant, PODOPHYLLUM. HN(86)63 MHÑMandragora ANEurasian mandrake: do not confuse with American mandrake ( = PODOPHYLLUM); do not use /isol /pathogen MNB6.660.569 XSMandrake, European DMÑPlants, Toxic LH LS LM  HN(72) MHÑManeb ANdo not use /biosyn /defic /physiol; /analogs NIM only RN12427-38-2 PIAntifungal Agents (66-71); Manganese (66-71); Pesticides (66-71); Thiocarbamates (66-71) MND2.241.81.251.869.265.441; D2.241.866.653.265.441; D2.886.703.265.441; D5.723.288.525 DMÑThiocarbamates LH LM  MHÑManganese ANMn-55; do not use /analogs /biosyn; /defic /physiol permitted; Mn-50-54, 56-58 = MANGANESE (IM) + RADIOISOTOPES (IM) RN7439-96-5 MND1.268.521; D1.552.484; D1.937.535 LH  MSAn affective psychotic disorder in which the predominant mood is either elevated, expansive, or irritable. Associated symptoms include hyperactivity, flight of ideas, inflated self-esteem, etc. PM84; was see under AFFECTIVE DISORDERS, PSYCHOTIC 1981-83 HN84(81); was see under AFFECTIVE DISORDERS, PSYCHOTIC 1981-83 MHÑManic Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.680.80.408 XSMania; Manic State LH LS;  MSTrue-false questionnaire made up of items believed to indicate anxiety, in which the subject answers verbally the statement that describes him. OLsearch PERSONALITY INVENTORY 1968-74 HN(75) MHÑManifest Anxiety Scale ANno qualif MNF4.711.647.513.463 XSTaylor Manifest Anxiety Scale DMÑPersonality Inventory LH LS LM  OLsearch MODELS, STRUCTURAL 1971-74 HN(75); was see under MODELS, STRUCTURAL 1971-83 MHÑManikins ANno qualif MNL1.178.147.545.129.400 XSMannequins DMÑModels, Anatomic LH LS LM  MHÑManipulation, Orthopedic ANdo not use /util except by MeSH definition MNE2.643; E4.557.607 XSOsteopathic Manipulation LH LS  MHÑManitoba MNZ1.107.567.176.410 LH  MSPolysaccharides consisting of mannose units. PM84; was see under POLYSACCHARIDES 1975-83 HN84(75); was see under POLYSACCHARIDES 1975-83 MHÑMannans ANdo not use /analogs /defic /physiol PIMannose (71-74); Polysaccharides (71-74) MND9.203.698.550 LH  MSKetonic amines prepared from the condensation of a ketone with formaldehyde and ammonia or a primary or secondary amine. A Mannich base can act as the equivalent of an alpha,beta unsaturated ketone in synthesis or can be reduced to form physiologically active amino alcohols. HN(77) MHÑMannich Bases ANIM general only; do not use /analogs /biosyn /defic /physiol PIAmines (66-76) MND2.92.650; D2.522.650 DMÑAmines LH LM  MHÑMannitol ANdo not use /biosyn /defic /physiol RN87-78-5 MND2.33.800.609; D9.203.853.609; D19.770.224.453.442 XUÑMitobronitol LH LU  PM65 HN65 MHÑMannitol Dehydrogenase ANdo not use /analogs RNEC 1.1.1.67 MND8.586.682.47.150.700.649 LH  MSPhosphoric acid esters of mannitol. HN(78) MHÑMannitol Phosphates ANdo not use /analogs /biosyn /defic /physiol PIMannitol (66-77); Sugar Phosphates (74-77) MND2.33.800.609.450; D9.203.853.609.450; D9.203.894.500 DMÑSugar Phosphates LH LM  MSManno-heptulose. A 7-carbon keto sugar having the mannose configuration. HN(75) MHÑMannoheptulose ANdo not use /defic /physiol; /analogs NIM only RN654-29-5 PIHeptoses (72-74); Ketoses (74) MND9.203.546.286.500; D9.203.546.465.500 XSMannoketoheptose DMÑHeptoses LH LS LM  MS1,6-Bis(2-chloroethylamino)-1,6-dideoxy-D-mannitol. Nitrogen mustard derivative alkylating agent used as antineoplastic; causes severe bone marrow depression and is a powerful vesicant. Synonyms: BCM; Degranol; Mannitlost; NSC 9698; Zitofenton. MHÑMannomustine ANdo not use /biosyn /defic /physiol RN576-68-1 MND2.455.526.728.650.463; D22.204.585.581 XSMannitol Nitrogen Mustard LH LS  MHÑMannose RN31103-86-3 MND9.203.546.359.588 LH  MSD-Mannose-6-phosphate ketol-isomerase. Catalyzes the reversible isomerization of D-mannose-6-phosphate to form D-fructose-6-phosphate. Important step in glycolysis process. EC 5.3.1.8. HN(78) MHÑMannosephosphate Isomerase ANdo not use /analogs RNEC 5.3.1.8 PICarbohydrate Isomerases (73-77) MND8.586.399.278.560 XSMannose-6-Phosphate Isomerase; Phosphomannose Isomerase DMÑCarbohydrate Isomerases LH LS; LM  MSPhosphoric acid esters of mannose. HN(78) MHÑMannosephosphates ANdo not use /analogs /biosyn /defic /physiol PIHexosephosphates (66-77); Mannose (66-77) MND9.203.894.417.650 DMÑHexosephosphates LH LM  MSalpha or beta-Mannoside mannohydrolases. Catalyzes the hydrolysis of terminal, non-reducing alpha or beta-D-mannose residues in mannosides. Deficiency of the alpha form can cause mannosidosis. PM78; was see under DISACCHARIDASES 1975-77 HN78(75); was see under DISACCHARIDASES 1975-77 MHÑMannosidases ANdo not use /analogs; alpha-mannosidase defic: consider also MANNOSIDOSIS RNEC 3.2.1. PIGlycoside Hydrolases (66-74); Mannose (66-74) MND8.586.277.450.625 LH  MSGlycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with an alcohol to form an acetal. Include both alpha- and beta-mannosides. HN(75) MHÑMannosides ANdo not use /analogs /defic /physiol PIGlycosides (66-74); Mannose (66-74) MND9.203.408.490 DMÑGlycosides LH LM  MSInborn error of metabolism marked by a defect in alpha-mannosidase activity that results in lysosomal accumulation of mannose-rich substrates; virtually all patients have psychomotor retardation, facial coarsening, and some degree of dysostosis multiplex. It is thought to be an autosomal recessive disorder. PM85 HN85 MHÑMannosidosis ANdo not use /congen PICarbohydrate Metabolism, Inborn Errors (66-84); Metabolism, Inborn Errors (66-84); Mannose (66-84); Mannosidases (75-84) MNC18.452.648.202.625; F3.126.720.650 LH  MSCatalyzes the transfer of mannose from a nucleoside diphosphate mannose to an acceptor molecule which is frequently another carbohydrate. Includes EC 2.4.1.32; EC 2.4.1.48; EC 2.4.1.54 and EC 2.4.1.57. HN(75) MHÑMannosyltransferases ANdo not use /analogs RNEC 2.4.1. PIHexosyltransferases (73-74); Mannose (73-74) MND8.586.913.407.550 DMÑHexosyltransferases LH LM  MHÑManometry ANNIM MNE5.559 FXÑPressure LH LX  MHÑMansonella ANdo not use /blood-csf-urine; infection = MANSONELLIASIS MNB1.500.294.530.438 XSAcanthocheilonema perstans; Dipetalonema perstans; Tetrapetalonema XUÑMansonella Ozzardi LH LS; ; LU  MSA filarial nematode parasite found in the mesentery and visceral fat of man, usually in Central and South America. OLto search FILARIA OZZARDI & FILARIA DEMARQUAYI use MANSONELLA OZZARDI back thru 1975 & MANSONELLA 1966-74 HN(75); was FILARIA OZZARDI see under MANSONELLA 1963-78; FILARIA DEMARQUAYI was see under MANSONELLA 1963-78 MHÑMansonella Ozzardi ANdo not use /blood-csf-urine; infection = MANSONELLIASIS MNB1.500.294.530.438.410 XSFilaria Demarquayi; Filaria Ozzardi DMÑMansonella LH LS; LM  MSInfection with Mansonella ozzardi. OLsearch FILARIASIS 1967-74 HN(75) MHÑMansonelliasis MNC3.335.508.361.588 DMÑFilariasis LH LM  MSMethod of nonverbal communication utilizing hand movements as speech equivalents. PM74; SIGN LANGUAGE was heading 1963-65 HN74(72) MHÑManual Communication ANno qualif PINonverbal Communication (70-71) MNE2.831.671.609; F1.145.209.530.702; L1.143.649.526 XUÑSign Language LH LU  PM74 HN74(69) MHÑManuals ANonly /stand PIBooks (66-68) MNL1.178.682.192.609 LH  OLsearch STERNUM 1966-74 HN(75) MHÑManubrium MNA2.835.232.904.766.442 DMÑSternum LH LM  MSAccumulations of solid or liquid animal excreta usually from stables and barnyards with or without litter material. PM79 HN79 MHÑManure ANIM; solid or liquid animal excreta with or without litter; includes slurry; only /anal /rad eff PIFeces (66-78) MNJ1.40.575 FXÑFeces LH LX  MHÑManuscripts ANIM; includes books prepared by hand before invention of printing; also handwritten or typescript drafts of pre-print papers, correspondence, diaries, notebooks, memoranda, etc.; no qualif; check century tag; Manual 33.12: relation to BOOKS MNL1.178.682.608 LH  MHÑManuscripts, Medical ANsee note above MNL1.178.682.608.526 LH  MSFamilial cerebral degenerative disease caused by a defect in branched chain amino acid metabolism and characterized by severe mental and motor retardation and urine with a maple-syrup-like odor. MHÑMaple Syrup Urine Disease ANdo not use /congen /drug eff /physiol /rad eff MNC10.228.140.163.608; C10.496.560; C18.452.648.66.608; F3.709.346.569 XSBranched-Chain Ketoaciduria FXÑUrine LH LS LX  MSN-Methyl-9,10-ethanoanthracene-9(10H)-propylamine. Proposed antidepressant; may have anxiolytic properties. Synonyms: Ludiomil; Ba 34,276. HN(75) MHÑMaprotiline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN10262-69-8 PIAnthracenes (72-74); Propylamines (72-74) MND4.615.117.600; D15.236.122.140.573 DMÑAnthracenes LH LM  MHÑMaps ANavoid: a cataloging term; possibly GEOGRAPHY might apply; no qualif MNL1.178.147.426 FXÑGeography LH LX  MSA virus associated with severe illness in workers handling tissues of African green monkeys. HN(75); was see under Rhabdoviruses 1978-80, was see under RNA VIRUSES 1975-77 MHÑMarburg Virus ANdo not use /blood-csf-urine; infection = MARBURG VIRUS DISEASE PIRNA Viruses (66-74) MNB4.909.777.750.490 XSFrankfurt-Marburg Syndrome Virus DMÑRhabdoviridae LH LS LM  MSAn RNA virus infection of rhesus, vervet, and squirrel monkeys transmissible to man. PM75 HN75 MHÑMarburg Virus Disease ANdisease of monkeys transmissible to man; do not use /vet but check tag ANIMAL PIVirus Diseases (66-74) MNC2.782.417.560; C22.576.500 LH  MSA lymphoproliferative disease of fowl caused by a herpesvirus. Syn: fowl paralysis, neurolymphomatosis. PM73 HN73(72) MHÑMarek's Disease ANdo not use /vet; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMAL; specific bird or fowl (IM) PIAvian Leukosis (66-71); Herpesvirus Infections (66-71); Poultry Diseases (66-71) MNC2.256.466.650; C2.928.489; C4.557.386.480.545; C4.619.935.489; C15.604.515.569.480.545; C20.683.515.761.480.545; C22.131.546 XSFowl Paralysis; Neurolymphomatosis LH LS;  MSA species of Herpesviridae which is the etiologic agent of a disease of domestic fowl and wild birds. PM75 HN75 MHÑMarek's Disease Virus ANdo not use /blood-csf-urine /cytol; infection: see heading & note above PIHerpesviridae (66-74) MNB4.909.204.382.675; B4.909.574.204.525 XSFowl Paralysis Virus; Neurolymphomatosis Virus LH LS;  MSAn hereditary disorder of connective tissue characterized by tall stature, elongated extremities, subluxation of the lens, dilatation of the ascending aorta, and ╥pigeon breast.╙ It is inherited as an autosomal dominant trait. OLuse MARFAN SYNDROME to search ARACHNODACTYLY back thru 1966 PM85; was ARACHNODACTYLY 1963-84 HN85; was ARACHNODACTYLY 1963-84 MHÑMarfan Syndrome ANdo not use /congen MNC5.116.99.674; C16.131.77.550; C23.205.200.441 XSArachnodactyly LH LS  MHÑMargarine ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply RN8029-82-1 MND10.516.212.302.651; J1.341.637 LH  MSPeptic ulcer at the esophagogastric mucosal junction. HN(64) MHÑMarginal Ulcer MNC6.405.613.489 DMÑPeptic Ulcer LH LM  MHÑMarine Biology ANSPEC: SPEC qualif; IM; marine = ocean or sea, not inland waterways, lakes, ponds ( = FRESH WATER (IM) + organism (IM) ) MNG1.273.476 FXÑOCEANOGRAPHY; ÑPLANKTON LH LX;  MSToxic or poisonous substances elaborated by marine flora or fauna. Include also specific, characterized poisons or toxins for which there is no more specific heading, like those from poisonous fishes. Clupeotoxin, pahutoxin, prymnesin, scombrotoxin go here. PM74 HN74 MHÑMarine Toxins ANincludes toxins from marine flora or fauna; do not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTITOXINS; coord IM with specific source (IM with no qualif); does not include venoms of sea snakes ( = SEA SNAKE VENOMS) MND24.185.926.580 XUÑCiguatoxin LH LU  MSA form of psychotherapy involving the husband and wife and directed to improving the marital relationship. OLuse MARITAL THERAPY to search MARRIAGE THERAPY back thru 1973 PM76; was MARRIAGE THERAPY 1973-75 HN76; was MARRIAGE THERAPY 1973-75 MHÑMarital Therapy ANSPEC qualif PIMarriage (66-72) MNF4.754.500 LH  MSApplication of marketing principles and techniques to maximize the use of health care resources. PM80; was see under HEALTH RESOURCES 1979 HN80(79); was see under HEALTH RESOURCES 1979 MHÑMarketing of Health Services ANdo not use /educ /methods MNN3.349.440 XSHealth Services Marketing LH LS  OLsearch PROBABILITY 1968-74 HN(75) MHÑMarkov Chains ANno qualif MNH1.548.832.672.442 DMÑProbability LH LM  MSA species of Herpesviridae isolated from marmosets and other monkeys. HN(75); was see under HERPESVIRUSES 1975-80 MHÑMarmoset Virus ANdo not use /blood-csf-urine /cytol MNB4.909.204.382.700 XSHerpes-T Virus; Herpesvirus platyrhinae DMÑHerpesviridae LH LS; LM  MSShortlegged, burrowing rodents which hibernate in winter. OLuse MARMOTA to search MARMOTS back thru 1975 HN(82); was MARMOTS see under RODENTS 1975-81 MHÑMarmota ANdo not confuse with MARMOSETS, a monkey; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.865.750.460 XSWoodchucks DMÑSciuridae LH LS LM  MSThe social institution involving legal and/or religious sanction whereby men and women are joined together for the purpose of founding a family unit. MHÑMarriage ANno qualif; PREMARITAL EXAMINATIONS is also available; NIM when parameter for ╥marital status╙ MNF1.829.263.315.526; I1.880.225.423.526; N1.824.308.526 XSMarital Relationship LH LS  MHÑMarsupialia ANincludes bandicoot, koala, phalanger, Tasmanian devil, wallaby, wallaroo & wombat; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.573 XUÑKangaroos LH LU  HN75 MHÑMartinique MNZ1.107.904.600 LH  MHÑMaryland MNZ1.107.567.875.472 LH  MHÑMasks ANincludes surgical masks; only /stand /supply MNE7.712.402 LH  MSPleasure derived from being subjected to physical or psychological pain whether inflicted by oneself or by others; includes sexual masochism. MHÑMasochism ANno qualif MNF3.709.597.608.700.490 LH  MSCollective behavior of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation. PM74 HN74 MHÑMass Behavior ANdifferentiate from GROUP PROCESSES: mass will probably be on a civil or pathol or mob level; no qualif MNF1.145.813.527; F1.829.759.527 FXÑCivil Disorders; ÑRIOTS LH LX;  MSX-ray screening of large groups of persons for diseases of the lung and heart by means of radiography of the chest. MHÑMass Chest X-Ray ANsee note under THORACIC RADIOGRAPHY; do not use /util except by MeSH definition MNE1.302.577; E1.563.443; E1.818.870.610; G3.850.520.610.580.300; N1.224.458.527.443; N2.421.143.827.233.443.443; N2.421.726.233.443.443 FXÑTuberculosis, Pulmonary LH LX  MSA microanalytical technic combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. PM77; was see under CHROMATOGRAPHY, GAS 1976 HN77(76); was see under CHROMATOGRAPHY, GAS 1976 MHÑMass Fragmentography ANNIM; only /instrum /methods; DF: GCMS PIChromatography, Gas (66-76); Spectrum Analysis, Mass (71-76) MNE5.196.181.349.500; E5.196.867.877.500; H1.181.278.186.312.500; H1.181.278.862.877.500 XSChromatography, Gas-Liquid-Mass Spectrometry; Chromatography, Gas-Mass Spectrometry; Chromatography, Mass; Spectrometry, Mass-Gas Chromatography; Spectrum Analysis, Mass-Gas Chromatography LH LS; ; ; ;  MSInstruments or technological means of communication that reach large numbers of people with a common message: press, radio, television, etc. PM80 HN80 MHÑMass Media ANIM with general reference to NEWSPAPERS, PERIODICALS, RADIO, TELEVISION, MOTION PICTURES, etc. as mass media; do not use as routine coord with the specific: coord only when specific is discussed as a mass medium, as ╥magazines as mass media╙; only /class /econ /hist /man /stand /util (if by MeSH definition) PICommunication (66-79); Newspapers (66-79); Periodicals (66-79); Radio (66-79); Television (66-79) MNL1.178.590 LH  MSOrganized periodic procedures performed on large groups of people for the purpose of detecting disease. OLuse MASS SCREENING to search MASS SCREENING TECHNICS back thru 1966 PM68; was MASS SCREENING TECHNICS 1963-67 HN68; was MASS SCREENING TECHNICS 1963-67 MHÑMass Screening ANonly /econ /hist /instrum /legis /methods /organ /stand /trends /vet; with disease, do not use /diag: use probably /prev or /occur MNE1.563; G3.850.520.610.580; N1.224.458.527; N2.421.143.827.233.443; N2.421.726.233.443 FXÑEpidemiologic Methods LH LX  MHÑMassachusetts ANBOSTON is also available MNZ1.107.567.875.481 LH  MSGroup of systematic and scientific manipulations of body tissues best performed with the hands for the purpose of affecting the nervous and muscular systems and the general circulation. MHÑMassage ANdo not use /util except by MeSH definition MNE2.780.580 LH  MSA masticatory muscle whose action is closing the jaws. HN(80) MHÑMasseter Muscle PIMasticatory Muscles (66-79); Muscles (66-79) MNA2.633.560.630; A14.530.630 DMÑMasticatory Muscles LH LM  MHÑMast Cells ANA 11 qualif & /class; note MAST CELL DISEASE see MASTOCYTOSIS above MNA11.329.427; A15.382.652 XSBasophils, Tissue LH LS  MHÑMastectomy ANdo not use /util except by MeSH definition MNE4.466 FXÑBreast LH LX  MHÑMastication ANonly /drug eff /rad eff MNG10.261.692; G10.549.429 XSCHEWING FXÑTooth LH LS LX  MHÑMasticatory Muscles ANGEN: prefer specific MNA2.633.560; A14.530 XUÑMasseter Muscle; ÑPterygoid Muscles; ÑTemporal Muscle LH LU; ;  MSA subdivision of the fungi, formerly included in the Phycomycetes. OLto search ALLOMYCES use MASTIGOMYCOTINA back thru 1975 & PHYCOMYCETES 1966-74 PM86; ALLOMYCES & BLASTOCLADIELLA were see under PHYCOMYCETES 1963-85; OOMYCETES was see under PHYCOMYCETES 1972-85; PHYTOPHTHORA & PYTHIUM were see under PHYCOMYCETES 1975-85 HN86; ALLOMYCES was see under PHYCOMYCETES 1963-85 MHÑMastigomycotina ANdo not use /embryol /microbiol /parasitol PIPhycomycetes (66-85) MNB5.354.730.576 XSAllomyces XUÑBlastocladiella; ÑOomycetes; ÑPhytophthora; ÑPythium LH LS LU; ; ;  MSA subphylum of flagellate Protozoa; contains two classes: Phytomastigophora and Zoomastigophora. OLuse MASTIGOPHORA to search CHILOMASTIX & ZOOMASTIGINA back thru 1966 PMCHILOMASTIX was heading 1963-85; ZOOMASTIGINA was see under MASTIGOPHORA 1966-85 HNCHILOMASTIX was heading 1963-85; ZOOMASTIGINA was see under MASTIGOPHORA 1966-85 MHÑMastigophora ANdo not use /anat /blood-csf-urine /embryol MNB1.841.443 XSChilomastix; Flagellata; Zooflagellata; Zoomastigina LH LS; ; ;  MSInflammatory disease of the breast, or mammary gland. MHÑMastitis ANcystic mastitis = FIBROCYSTIC DISEASE OF BREAST & do not coord with CHRONIC DISEASE MNC13.703.844.506.677; C19.146.677 LH  MHÑMastitis, Bovine ANdo not use /vet; don't forget also CATTLE (NIM) & check tags ANIMAL & FEMALE MNC19.146.677.527; C22.196.581 LH  MSA group of diseases resulting from proliferation of mast cells. OLsearch URTICARIA PIGMENTOSA 1975-86 PM87; was see URTICARIA PIGMENTOSA 1975-86 HN87; was see URTICARIA PIGMENTOSA 1975-86 MHÑMastocytosis ANnote see refs below PIUrticaria Pigmentosa (66-86) MNC17.508 XSMast Cell Disease; Mastocytoma, Benign LH LS;  MHÑMastoid ANinflammation = MASTOIDITIS; fractures: coord MASTOID /inj (IM) + SKULL FRACTURES (IM) MNA2.835.232.781.885.444 LH  MHÑMastoiditis MNC9.218.705.663.652 LH  MSSexual stimulation or gratification of the self. MHÑMasturbation ANhuman & animal; /physiopathol /psychol permitted MNF1.145.792.526; F3.709.597.460.600 LH  OLTN 124 MH*Materials (Non Mesh) MNJ1.637 LH  MSThe management of all procurement, distribution, and storage of equipment and supplies, as well as logistics management including laundry, processing of reusables, etc. OLuse MATERIALS MANAGEMENT, HOSPITAL to search HOSPITAL MATERIALS MANAGEMENT back thru 1976 PM78; was HOSPITAL MATERIALS MANAGEMENT see under HOSPITAL ADMINISTRATION 1976-77 HN78; was HOSPITAL MATERIALS MANAGEMENT see under HOSPITAL ADMINISTRATION 1976-77 MHÑMaterials Management, Hospital ANonly /econ /legis /man /methods /organ /stand /trends MNN2.278.354.608; N4.452.442.475 XSHospital Materials Management; Storerooms XUÑInventories, Hospital LH LS; LU  MSThe testing of materials and devices, especially those used for implants, prostheses, sutures, adhesives, etc., for hardness, strength, durability, safety, and efficacy. PM87 HN87 MHÑMaterials Testing ANonly /instrum /methods /stand /vet PIBiocompatible Materials (72-86); Stress, Mechanical (71-86) MNE5.916.600; E6.912.600 XSBiocompatible Materials Testing; Testing, Biocompatible Materials LH LS;  PM67 HN67(65) MHÑMaternal Age ANno qualif; relation to PREGNANCY: Manual 28.33 MNG7.168.590; G8.520.420 XUÑMaternal Age 35 and over LH LU  MSUse for problems of pregnancy occurring in a woman's late reproductive years. These include effect on the mother's physical and mental health as well as risks of perinatal mortality and fetal abnormality. HN(81) MHÑMaternal Age 35 and over ANno qualif; relation to PREGNANCY: Manual 28.33; DF: MATERNAL AGE 35 PIMaternal Age (66-80) MNG8.520.420.630 DMÑMaternal Age LH LM  MSThe behavior patterns associated with or characteristic of a mother. PM68 HN68 MHÑMaternal Behavior ANhuman & animal; no qualif PIBehavior, Animal (66-67); Parent-Child Relations (66-67) MNF1.145.597; F1.829.263.370.215 LH  MSProlonged separation of the offspring from the mother. PM69 HN69(66) MHÑMaternal Deprivation ANhuman & animal; no qualif MNF1.829.263.370.240 LH  MSOrganized services to provide health care to expectant and nursing mothers. PM68 HN68 MHÑMaternal Health Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util; specify geog CATALOG: /geog /form PIMaternal Welfare (66-67); Prenatal Care (66-67) MNN2.421.143.620 FXÑMaternal Welfare LH LX  MSMaternal deaths resulting from complications of pregnancy and childbirth in a given population. MHÑMaternal Mortality ANno qualif; largely statist, not for individual maternal deaths; specify geog CATALOG: /geog /form MNN1.224.935.698.653 LH  MSOrganized efforts by communities or organizations to improve the health and well-being of the mother. MHÑMaternal Welfare ANonly /hist /legis /stand /trends; specify geog CATALOG: /geog /form MNI1.880.787.678 FXÑMATERNAL HEALTH SERVICES LH LX  MSFacilities which administer the delivery of health care services to mothers and children. HN(79) MHÑMaternal-Child Health Centers ANdo not use /educ /methods PIChild Health Services (68-78); Maternal Health Services (68-78) MNN2.278.35.310 DMÑHealth Facilities LH LM  MHÑMaternal-Fetal Exchange ANonly /drug eff /rad eff; check the tags FEMALE & PREGNANCY; note that FETOMATERNAL TRANSFUSION (Cat C) & IMMUNITY, MATERNALLY-ACQUIRED (Cat G) exist MNG8.520.769.455 FXÑAbnormalities, Drug-Induced; ÑFetus; ÑPlacenta LH LX; ;  MSComputer-assisted interpretation and analysis of various mathematical functions related to a particular problem. PM87 HN87 MHÑMathematical Computing ANIM; no qualif MNH1.548.635; L1.700.568.110.680 XSStatistical Computing XUÑNumerical Analysis, Computer-Assisted LH LS LU  MHÑMathematics ANNIM; only /hist; includes arithmetic, geometry, calculus; differentiate from STATISTICS MNH1.548 LH  MSDevices which provide an artificial temporary wall, or matrix, used in filling a prepared cavity. OLto search MATRIX BAND use MATRIX BANDS back thru 1975 & DENTAL MATERIALS 1969-74 HN(80); was MATRIX BAND see under DENTAL MATERIALS 1969-79 MHÑMatrix Bands ANdo not use /instrum /methods MNE6.186.501.630; E7.222.501.630 DMÑDental Instruments LH LM  HN75 MHÑMauritania MNZ1.58.432.600 LH  MHÑMauritius MNZ1.252.245.419.600 XSAgalega Islands LH LS  MHÑMaxilla ANthe upper jaw only; check text for loose use of ╥maxillary╙ to mean ╥jaw╙, not precisely MAXILLA; /blood supply: consider also MAXILLARY ARTERY; /growth: consider also MAXILLOFACIAL DEVELOPMENT; /inj: consider also MAXILLOFACIAL INJURIES; /innerv: consider also MAXILLARY NERVE MNA2.835.232.781.324.502.645; A14.521.645 LH  MSA branch of the external carotid artery which distributes to the deep structures of the face (internal maxillary) and to the side of the face and nose (external maxillary). MHÑMaxillary Artery ANdo not use /blood supply MNA7.231.114.523 LH  PM67 HN67 MHÑMaxillary Diseases ANmust be of the MAXILLA, not for ╥jaws╙ ( = JAW DISEASES) PIBone Diseases (66); Maxilla (66) MNC5.500.693 LH  PM66 HN66 MHÑMaxillary Fractures ANmust be of the MAXILLA, not for ╥jaws╙ ( = JAW FRACTURES) MNC21.866.405.762.467.611; C21.866.460.589.338.500.611; C21.866.460.589.445; C21.866.460.836.500.611 LH  MHÑMaxillary Neoplasms ANmust be of the MAXILLA, not for ╥jaws╙ ( = JAW NEOPLASMS); /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.149.450.528; C5.500.693.528 LH  MHÑMaxillary Nerve ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM); superior alveolar nerve goes here but inferior alveolar nerve goes under MANDIBULAR NERVE MNA8.796.214.848.478 LH  MSOne of the paired paranasal sinuses, located in the body of the maxilla, communicating with the middle meatus of the nasal cavity. MHÑMaxillary Sinus ANinflammation or sinusitis: coord NIM with SINUSITIS (IM); fractures: coord MAXILLARY SINUS /inj (IM) + MAXILLARY FRACTURES (IM) MNA4.621.578 XSAntrum of Highmore; Maxillary Antrum LH LS;  HN(84) MHÑMaxillary Sinus Neoplasms ANcoord IM with histol type of neopl (IM); /anal /blood supply /secret /ultrastruct permitted PIParanasal Sinus Neoplasms (66-83) MNC4.588.443.665.650.693.575; C9.692.503.575 DMÑParanasal Sinus Neoplasms LH LM  PM65 HN65 MHÑMaxillofacial Development ANonly /drug eff /rad eff MNG7.553.121.478; G11.427.111.478 FXÑCephalometry LH LX  MSGeneral or unspecified injuries involving both the jaw and the face. PM65 HN65 MHÑMaxillofacial Injuries ANmaxillo- here may be either jaw; GEN or unspecified & involving both a jaw & the face: not a substitute for /inj with specific jaw or FACIAL INJURIES or FACIAL BONES /inj MNC21.866.460.589 LH  PM67 HN67(66) MHÑMaxillofacial Prosthesis ANmaxillo- here may be either jaw; do not use /util except by MeSH definition; not for outer ear replacements ( = EAR, EXTERNAL (IM) + PROSTHESIS (IM) ) or nose replacements ( = NOSE (IM) + PROSTHESIS (IM) ) MNE4.659.678; E4.833.610; E6.780.653; E6.892.610; E7.450.660; E7.858.565.728 LH  MSMeasurement of rate of airflow during the first liter expired after the first 200 ml have been exhausted during a forced vital capacity determination. Common abbreviations are MEFR, FEF 202-1200, and FEF 0.2-1.2. HN(75) MHÑMaximal Expiratory Flow Rate ANNIM; no qualif; in texts as MEFR & FEP MNE1.302.796.624.390.590 XSForced Expiratory Flow 0.2-1.2; Forced Expiratory Flow 200-1200 DMÑForced Expiratory Flow Rates LH LS; LM  MSCurves depicting maximal expiratory flow in liters/second at each point of lung inflation (expressed in liters or percentage of forced vital capacity) during a forced vital capacity determination. Common abbreviation is MEFV. HN(75) MHÑMaximal Expiratory Flow-Volume Curves ANNIM; no qualif; in texts as MEFV MNE1.302.796.624.390.630 DMÑForced Expiratory Flow Rates LH LM  MSMeasurement of rate of airflow over the middle half of a forced vital capacity determination (from the 25 percent level to the 75 percent level). Common abbreviations are MMFR and FEF 25%-75%. HN(75) MHÑMaximal Midexpiratory Flow Rate ANNIM; no qualif; in texts as MMFR & FEF MNE1.302.796.624.390.670 XSForced Expiratory Flow 025-075 Percent DMÑForced Expiratory Flow Rates LH LS LM  MSMeasure of the maximum amount of air that can be breathed in and blown out over a sustained interval such as 15 or 20 seconds. Common abbreviations are MVV and MBC. HN(75) MHÑMaximal Voluntary Ventilation ANNIM; no qualif; in texts as MVV & MBC MNE1.302.796.624.630 XSMaximal Breathing Capacity DMÑRespiratory Airflow LH LS LM  HN(69) MHÑMaximum Permissible Exposure Level ANNIM; no qualif; coord NIM with specific drug or substance (IM without qualif); DF: MPEL PIEnvironmental Health (66-68); appropriate environment heading; specific agent MNG3.850.460.350.210 XSMAC; Maximum Allowable Concentration; TLV; Threshold Limit Values DMÑEnvironmental Exposure LH LS; ; ; LM  MSAn ansa macrolide isolated from the East African shrubs Maytenus serrata and M. buchananii; has antineoplastic activity, probably due to its inhibition of DNA synthesis. HN(77) MHÑMaytansine ANdo not use /defic /physiol; /analogs NIM only; /biosyn permitted if by plant RN35846-53-8 PIMorpholines (66-75); Oxazines (76) MND3.383.533.580; D22.204.179.578 XSMaitansine DMÑOxazines LH LS LM  MS5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo(2,1-a)isoindol-5-ol. Tricyclic anorexigenic agent unrelated to and less toxic than amphetamine, but with some similar side effects. HN(75) MHÑMazindol AND25-26 qualif; /analogs NIM only RN22232-71-9 PIIndoles (72-74); Imidazoles (72-74) MND3.438.473.600; D26.128.630 DMÑIndoles LH LM  MS(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride. Proposed parasympathomimetic; muscarinic ganglion stimulant. HN(75) MHÑMcN A 343 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN55-45-8 PIAmmonium Compounds (68-74); Carbamates (68-74); Alkynes (72-74) MND2.92.102.515; D2.675.276.515; D16.698.628.450 DMÑAmmonium Compounds LH LM  MS4-Chloro-2-methylphenoxyacetic acid. Herbicide. Synonyms: Mephanac; Agroxone; Methoxone. HN(75) MHÑMCPA ANdo not use /biosyn /defic /physiol; /analogs NIM only RN94-74-6 PIGlycolates (69-74); Toluene (74) MND2.241.511.316.565; D5.723.366.580 XSMCP DMÑGlycolates LH LS LM  MHÑMeasles ANdo not confuse with RUBELLA (German measles); French for measles = rougeole (not rubeole which = RUBELLA), Ital for measles = rosolia (not rubeola which = RUBELLA) MNC2.782.660.585 XSRUBEOLA LH LS  PM64 HN64 MHÑMeasles Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.899.404 LH  MHÑMeasles Virus ANdo not use /blood-csf-urine /cytol MNB4.909.777.569.580 XSMorbilli Virus LH LS  MSThe edible portions of any animal used for food including domestic mammals (the major ones being cattle, swine, and sheep) along with poultry, fish, shellfish, and game. MHÑMeat ANIM; only /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply; coord with animal source of meat (NIM), as beef = MEAT (IM) + CATTLE (NIM), pork = MEAT (IM) + SWINE (NIM): Manual 31.10; canned meat = MEAT (IM) + source (NIM) + FOOD PRESERVATION (IM); note MEAT PRODUCTS, FISH PRODUCTS & POULTRY PRODUCTS are available: see notes there MNJ1.341.659 XUÑMeat Products LH LU  MSArticles of food which are derived by a process of manufacture from any portion of carcasses of any animal used for food (e.g., head cheese, sausage, scrapple). HN(78) MHÑMeat Products AN╥derived by a process of manufacture from any portion of carcasses of any animal╙ (e.g., sausage, scrapple) but for canned meat see note on MEAT; coord IM with animal source (NIM); only /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply MNJ1.341.659.600 DMÑMeat LH LM  MHÑMeat-Packing Industry ANonly /econ /hist /instrum /stand MNJ1.576.598 LH  MSMethyl-5-benzoyl-2-benzimidazolecarbamate. A nematocide in humans and animals. It accts by interfering with the carbohydrate metabolism and associated energy production of the parasite. PM86; was see under BENZIMIDAZOLES 1975-85 HN86(75); was see under BENZIMIDAZOLES 1975-85 MHÑMebendazole ANdo not use /biosyn /defic /physiol RN31431-39-7 PIBenzimidazoles (71-74); Benzoates (71-74); Carbamates (71-74) MND3.438.103.600; D21.201.287.500 LH  MHÑMecamylamine ANdo not use /biosyn /defic /physiol RN60-40-2 MND2.455.849.618.500; D16.653.396.379; D18.162.526 LH  PM71; GOLGI-MAZZONI CORPUSCLES & PACINIAN CORPUSCLES were see under NERVE ENDINGS 1963-71; NEUROTENDINOUS SPINDLES was see under RECEPTORS, NEURAL 1972-76, was see under NERVE ENDINGS 1963-71 HN71 MHÑMechanoreceptors ANdo not use /innerv PINerve Endings (66-70); Receptors, Sensory (66-70) MNA8.796.511.725.404 XSRECEPTORS, STRETCH FXÑProprioception XUÑGolgi-Mazzoni Corpuscles; ÑNeurotendinous Spindles; ÑPacinian Corpuscles; ÑPulmonary Stretch Receptors LH LS LX LU; ; ;  MS2-Chloro-N-(2-chloroethyl)-N-methylethanamine. Vesicant, necrotizing irritant destructive to mucous membranes; formerly used as war gas; the hydrochloride is antineoplastic in Hodgkin's disease and lymphomas; causes severe gastrointestinal and bone marrow damage. Synonyms: Carolysine; Cloramin; Dichloren; HN2; Mitomen; Mustargen; NSC 762; NSC 10107. OLuse MECHLORETHAMINE to search MECHLORETHAMINE OXIDE back thru 1966 PMMECHLORETHAMINE OXIDE was heading 1963-79 HNMECHLORETHAMINE OXIDE was heading 1963-79 MHÑMechlorethamine ANdo not use /biosyn /defic /physiol RN51-75-2 MND2.455.526.728.650.529; D22.204.585.602 XSChlorethazine; Chlormethine; Mechlorethamine Oxide; Mustine; NITROGEN MUSTARD LH LS; ; ; ;  MHÑMeckel's Diverticulum ANuse only Category C qualif; do not use /congen; Meckel's diverticulitis: coord IM with DIVERTICULITIS (IM) MNA3.492.411.620.484.612; C16.131.314.556 LH  MHÑMeclizine ANdo not use /biosyn /defic /physiol RN569-65-3 MND2.455.426.559.389.115.475; D3.383.606.650; D23.136.529 XSHistametizyn; Meclozine; Parachloramine LH LS; ;  MSN-(2,6-Dichloro-m-tolyl)anthranilic acid. A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis. HN(75) MHÑMeclofenamic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN644-62-2 PIAnthranilic Acids (69-74); Toluene (72-74) MND2.241.223.106.61.105.500; D14.73.278.537; D26.74.75.600 DMÑAnthranilic Acids LH LM  MHÑMeconium ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; check the tag INFANT, NEWBORN MNA12.459.529; A16.378.529 LH  MS7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine monohydrochloride. A benzodiazepine tranquilizer used in the treatment of anxiety. It has sedative, muscle relaxant and anticonvulsant properties. One of its metabolites is diazepam and one of its excretion products is oxazepam. Synonyms: Diepin; Elbrus; Medazepol; megasedan; Nobrium; Serenium. HN(75) MHÑMedazepam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2898-12-6 PIBenzazepines (70-74) MND3.438.79.80.550; D15.236.872.659.191.550 DMÑBenzodiazepine Tranquilizers LH LM  OLsearch HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974 PM83; was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82 HN83(75); was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82 MHÑMedian Eminence ANdo not use /innerv MNA8.186.211.385.357.579 LH  MSA complex of reciprocal connections between the hypothalamic nuclei and the tegmentum. HN(77) MHÑMedian Forebrain Bundle ANdo not use /innerv PIHypothalamus (66-76); Limbic System (66-76); Neural Pathways (74-76) MNA8.612.492 DMÑNEURAL PATHWAYS LH LM  MHÑMedian Nerve ANdo not use /innerv MNA8.796.828.169.379 FXÑCarpal Tunnel Syndrome LH LX  MHÑMediastinal Cyst ANnon-neoplastic; simple mediastinal cysts commonly adjacent to pericardium: index here but do not coord with PERICARDIUM; thymic cyst: index here but do not coord with THYMUS GLAND MNC4.182.444; C23.304.612.379 LH  MSDisorders of the mediastinum, general or unspecified. PM66 HN66 MHÑMediastinal Diseases ANinflamm dis = MEDIASTINITIS MNC23.304.612 LH  MSPresence of air in the mediastinal tissues due to leakage of air from the tracheobronchial tree, usually as a result of trauma. MHÑMediastinal Emphysema ANa disease: do not confuse with radiogr pneumomediastinum ( = PNEUMOMEDIASTINUM, DIAGNOSTIC) MNC23.304.612.479; C23.390.529 XSEmphysema, Mediastinal; PNEUMOMEDIASTINUM LH LS;  MHÑMediastinal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.894.479; C23.304.612.579 LH  MHÑMediastinitis MNC23.304.612.679 LH  PM74 HN74 MHÑMediastinoscopy ANdo not use /util except by MeSH definition MNE1.418.659 LH  MHÑMediastinum AN/radiogr is probably PNEUMOMEDIASTINUM, DIAGNOSTIC; inflammation = MEDIASTINITIS MNA1.911.529 FXÑPNEUMOMEDIASTINUM, DIAGNOSTIC LH LX  MSFinancing of medical care provided to public assistance recipients. PM68 HN68 MHÑMedical Assistance ANonly /econ /hist /legis /organ /trends /util; specify geog CATALOG: /geog /form PIPublic Health (66-67); Social Welfare (66-67) MNN3.219.521.346.506.564 LH  MSFederal-state programs established under Public Law Title XIX of the Social Security Act and/or the Kerr-Mills programs that finance payments to providers of health care services for persons eligible under the law. Also referred to as ╥Medicaid╙. OLto search DENTAL MEDICAID PROGRAM & DENTICAID use MEDICAL ASSISTANCE, TITLE 19 back thru 1974 & MEDICAL ASSISTANCE 1969-73 PM71; MEDICAID was see under MEDICAL ASSISTANCE 1969-70; DENTAL MEDICAID PROGRAM was see under MEDICAL ASSISTANCE, TITLE 19 1979-85, was DENTICAID see under MEDICAL ASSISTANCE, TITLE 19 1974-78, was DENTICAID see under MEDICAL ASSISTANCE 1969-73 HN71; MEDICAID was see under MEDICAL ASSISTANCE 1969-70; DENTAL MEDICAID PROGRAM was see under MEDICAL ASSISTANCE, TITLE 19 1979-85, was DENTICAID see under MEDICAL ASSISTANCE, TITLE 19 1974-78, was DENTICAID see under MEDICAL ASSISTANCE 1969-73 MHÑMedical Assistance, Title 19 ANonly /econ /hist /legis /util; specify geog; Public Law 89-97 CATALOG: /geog by state /form PIMedical Assistance (68-70) MNN3.219.521.346.506.564.655 XSDental Medicaid Program; MEDICAID LH LS;  MSA detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care. PM68 HN68 MHÑMedical Audit ANonly /methods /stand PIHospital Administration (66-67) MNN4.761.380 XUÑCommission on Professional and Hospital Activities LH LU  MSPhysicians employed by a medical facility who serve in a medical and administrative capacity as head of the organized medical staff and who also may serve as liaison for the medical staff with the administration and governing board. PM78 HN78 MHÑMedical Directors ANonly /educ /legis /psychol /stand /supply /util MNM1.526.70.630; M1.526.485.600; N2.350.45.250 LH  PM70 HN70(67) MHÑMedical History Taking ANonly /stand /vet PIDiagnosis (66) MNE1.579 FXÑData Collection; ÑMedical Records XUÑCornell Medical Index LH LX; LU  MSThe field which deals with illustrative clarification of biomedical concepts, as in the use of diagrams and drawings. MHÑMedical Illustration ANonly /educ /hist; MODELS, ANATOMIC is also available; anatomical atlases go here (IM) + ANATOMY, ARTISTIC (IM) MNG2.385; L1.178.147.480; K1.93.410 XSILLUSTRATION, MEDICAL LH LS  MSThe individual who is unable to provide himself and his dependents with adequate medical care, without depriving himself and his dependents of food, clothing, shelter, and other essentials of living. OLuse MEDICAL INDIGENCY to search INDIGENT CARE back thru 1966 PM68; was INDIGENT CARE 1963-67 HN68; was INDIGENT CARE 1963-67 MHÑMedical Indigency ANno qualif MNN1.824.460 XSINDIGENCY, MEDICAL; Indigent Care LH LS;  MSThe field of INFORMATION SCIENCE concerned with the analysis and dissemination of medical data through the application of computers to various aspects of health care and medicine. PM87 HN87 MHÑMedical Informatics ANSPEC: SPEC qualif PIInformation Systems (82-86) MNL1.700 XSClinical Informatics; Medical Computer Science; Medical Information Science LH LS; ;  MSAutomated systems applied to the patient care process including diagnosis, therapy, and systems of communicating medical data within the health care setting. PM87 HN87 MHÑMedical Informatics Applications ANno qualif MNL1.700.508 FXÑBiomedical Engineering LH LX  MSPrecise procedural mathematical and logical operations utilized in the study of medical information pertaining to health care. PM87 HN87 MHÑMedical Informatics Computing ANIM; no qualif MNL1.700.568 LH  MSTravel by a group of physicians to a foreign country for the purpose of making a special study or of undertaking a special project of a short-term duration; not to be confused with MISSIONS AND MISSIONARIES which covers permanent medical establishments and personnel maintained by religious organizations. OLuse MEDICAL MISSIONS, OFFICIAL to search MEDICAL MISSIONS 1966-73 PM74; MEDICAL MISSIONS was heading 1966-73 HN74; MEDICAL MISSIONS was heading 1966-73 MHÑMedical Missions, Official ANonly /hist; do not confuse with MISSIONS AND MISSIONARIES CATALOG: /geog /form MNI1.534.655 LH  MSOffice and laboratory facilities constructed for the use of physicians and other health personnel. HN(80) MHÑMedical Office Buildings ANonly /class /econ /hist /legis /organ /stand /supply /trends /util PIHealth Facilities (68-79) MNN2.278.562 DMÑHealth Facilities LH LM  MSA subspecialty of Internal Medicine concerned with the study of neoplasms. PM79 HN79 MHÑMedical Oncology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of NEOPLASMS /form PIInternal Medicine (66-78); Specialties, Medical (68-78) MNG2.403.776.409.708 XSOncology, Medical FXÑNeoplasms LH LS LX  MSIndividuals who receive patients in a medical office. OLsearch MEDICAL SECRETARIES 1968-74 HN(75) MHÑMedical Receptionists ANonly /educ /psychol /stand /supply /util MNM1.526.485.67.600.630; N2.350.84.529.530 DMÑMedical Secretaries LH LM  MSIndividuals professionally qualified in the management of patients' records. Use also for medical record technicians. OLuse MEDICAL RECORD ADMINISTRATORS to search MEDICAL RECORDS LIBRARIANS back thru 1966 PM77; was MEDICAL RECORDS LIBRARIANS 1963-76 HN77; was MEDICAL RECORDS LIBRARIANS 1963-76 MHÑMedical Record Administrators ANonly /educ /psychol /stand /supply /util; includes med rec librarians & med rec technicians MNM1.526.485.67.550; N2.350.84.487 LH  MSThe creation and maintenance of medical and vital records in multiple institutions in a manner that will facilitate the combined use of the records of identified individuals. HN(75) MHÑMedical Record Linkage ANno qualif MNN4.452.859.564.550 DMÑMedical Records LH LM  MSRecording of pertinent information concerning patient's illness or illnesses. MHÑMedical Records ANonly /stand; vet records = RECORDS (IM) + VETERINARY MEDICINE (IM); case reports as a form of medical presentation goes here or specific RECORDS term (IM); RECORDS CONTROL is also available (probably NIM when coord) MNN4.452.859.564 XSHealth Diaries; Health Records, Personal FXÑMEDICAL HISTORY TAKING XUÑMedical Record Linkage; ÑMedical Records, Problem Oriented LH LS; LX LU;  MSHospital department responsible for the creating, care, storage and retrieval of medical records. Also provides statistical information for the medical and administrative staff. HN(Aug 77) MHÑMedical Records Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: MED REC DEP MNN2.278.354.422.465; N4.452.442.422.465 XSHospital Medical Records Department DMÑHospital Departments LH LS LM  MSThe structuring of a patient's record according to a complete listing of his medical problems accompanied by progress notes for each problem. HN(75) MHÑMedical Records, Problem Oriented ANonly /stand; DF: POMR MNN4.452.859.564.600 DMÑMedical Records LH LM  MSIndividuals responsible for various duties pertaining to the medical office routine. MHÑMedical Secretaries ANonly /educ /psychol /stand /supply /util MNM1.526.485.67.600; N2.350.84.529 XUÑMedical Receptionists LH LU  MSProfessional medical personnel who provide care to patients in an organized facility, institution or agency. PM73 HN73 MHÑMedical Staff ANonly /educ /legis /organ /psychol /stand /supply /trends /util MNM1.526.485.630; N2.350.559 LH  MSThose rights or activities which are specific to members of the institution's medical staff, including the right to admit private patients. HN(Aug 77) MHÑMedical Staff Privileges ANonly /legis /trends PIHospital Administration (66-Jul 77); Medical Staff, Hospital (66-Jul 77) MNN2.350.559.472.600 XSMedical Staff Privileges, Nonphysician DMÑMedical Staff, Hospital LH LS LM  MSProfessional medical personnel approved to provide care to patients in a hospital. OLuse MEDICAL STAFF, HOSPITAL to search HOSPITAL MEDICAL STAFF back thru 1966 PM78; was HOSPITAL MEDICAL STAFF 1963-77 HN78; was HOSPITAL MEDICAL STAFF 1963-77 MHÑMedical Staff, Hospital ANonly /educ /legis /organ /psychol /stand /supply /trends /util; ╥junior physician╙ goes here; registrars in British hospitals go here MNM1.526.485.630.490; M1.526.485.740.422; N2.350.559.472; N2.350.685.200 XSAttending Physicians, Hospital; Hospital Medical Staff XUÑMedical Staff Privileges LH LS; LU  MSBlood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special disposal procedures. HN(78) MHÑMedical Waste ANonly /anal; dental waste such as amalgams, saliva, rinse water, etc. does not go here: use WASTE PRODUCTS PIRefuse Disposal (66-77) MNG3.850.460.710.460 XSPathological Waste DMÑWaste Products LH LS LM  MSA geographic location which has insufficient health resources (manpower and/or facilities) to meet the medical needs of the resident population. PM78 HN78 MHÑMedically Underserved Area ANno qualif; specify geog CATALOG: /geog /form MNN3.349.650.340 XSNational Health Service Corps; Physician Shortage Area FXÑHealth Services Accessibility LH LS; LX  PM67 HN67(66) MHÑMedication Errors ANno qualif MNE2.319.529 FXÑDrug Therapy; ÑMedication Systems, Hospital LH LX;  MSOverall systems, traditional or automated, to provide medication to patients. PM73 HN73 MHÑMedication Systems ANonly /econ /legis /organ /stand /trends MNN4.452.528 XSUnit Dose Drug Distribution Systems LH LS  MSOverall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician's order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient. OLuse MEDICATION SYSTEMS, HOSPITAL to search HOSPITAL MEDICATION SYSTEMS back thru 1968 PM78; was HOSPITAL MEDICATION SYSTEMS 1968-77 HN78; was HOSPITAL MEDICATION SYSTEMS 1968-77 MHÑMedication Systems, Hospital ANonly /econ /legis /organ /stand /trends PIPharmacy Service, Hospital (66-67) MNN2.278.354.645; N4.452.442.523; N4.452.528.473 XSHospital Drug Distribution Systems; Hospital Medication Systems FXÑMEDICATION ERRORS LH LS; LX  MSThe art and science of preventing, diagnosing, and treating disease, as well as the maintenance of health. MHÑMedicine ANmedicine only as a field, profession or discipline; very general; avoid; no qualif; /econ = ECONOMICS, MEDICAL; /educ = EDUCATION, MEDICAL; /hist = HISTORY OF MEDICINE; /legislation & jurisprudence = LEGISLATION, MEDICAL or JURISPRUDENCE or FORENSIC MEDICINE; /man = HEALTH MANPOWER; legal med = FORENSIC MEDICINE or JURISPRUDENCE CATALOG: do not use /terminology ( = NOMENCLATURE) MNG2.403 XSClinical Medicine LH LS  MHÑMedicine in Art ANno qualif MNK1.93.530 LH  MHÑMedicine in Literature ANno qualif; coord IM with med aspect (IM) + specific lit heading (IM) + literary type if pertinent (as POETRY, DRAMA, etc.) (IM) MNK1.517.584 LH  MHÑMedicine, Arabic ANno qualif; Manual 32.13; Avicenna (also called Ibn Sina) is indexed as Avicenna in field 15 + here + check tags HISTORICAL BIOGRAPHY + HISTORY OF MEDICINE, MEDIEVAL but do not locate by modern geog country: TN 12 CATALOG: /geog /form MNK1.419.552.643 LH  MSThe traditional Hindu system of medicine which is based on customs, beliefs, and practices of the Hindu culture. OLuse MEDICINE, AYURVEDIC to search MEDICINE, HINDU back thru 1966 PM81; was MEDICINE, HINDU 1964-80 HN81; was MEDICINE, HINDU 1964-80 MHÑMedicine, Ayurvedic ANno qualif; Manual 32.13 CATALOG: /geog /form MNK1.419.684.150 XSAyurvedic Medicine; Medicine, Hindu LH LS;  MSA system of traditional medicine which is based on the beliefs and practices of the Chinese culture. OLto search MEDICINE, CHINESE & CHINESE MEDICINE use MEDICINE, CHINESE TRADITIONAL 1975-83 & MEDICINE, ORIENTAL TRADITIONAL 1967-74 HN(84); was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83, was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80 MHÑMedicine, Chinese Traditional ANis not medicine in China ( = MEDICINE + CHINA): TN 125; no qualif; Manual 32.13; medicinal plants in Chinese med: coord IM with PLANTS, MEDICINAL (IM) & if an extract of the plant, add PLANT EXTRACTS (NIM): TN 247 MNK1.419.684.660.300 XSChinese Medicine, Traditional; Traditional Medicine, Chinese DMÑMedicine, Oriental Traditional LH LS; LM  MSUse of plants or herbs to treat diseases or to alleviate pain. OLuse MEDICINE, HERBAL to search HERBALISM back thru 1966 PM81; was HERBALISM 1963-80 HN81; was HERBALISM 1963-80 MHÑMedicine, Herbal ANno qualif; ╥use of plants or herbs to treat disease or to alleviate pain╙; general only: ther use of specific herbs or plants in MeSH go under specific term; herbals go here MNI1.76.201.450.654.400; K1.419.684.400 XSHerbalism FXÑPlants, Medicinal LH LS LX  MSA system of traditional medicine which is based on the customs, beliefs and practices of the Oriental people. OLuse MEDICINE, ORIENTAL TRADITIONAL to search MEDICINE, ORIENTAL 1966-83 PM84; was MEDICINE, ORIENTAL 1966-83 HN84; was MEDICINE, ORIENTAL 1966-83 MHÑMedicine, Oriental Traditional ANno qualif; do not use for ╥medicine in the Orient╙ ( = MEDICINE (IM) + country); specify Oriental country; Manual 32.13 CATALOG: /geog /form MNK1.419.684.660 XSOriental, Medicine Traditional; Traditional Medicine, Oriental XUÑMedicine, Chinese Traditional LH LS; LU  MSSystems of medicine based on cultural beliefs and practices handed down from generation to generation. Includes mystical and magical rituals, herbal therapy, and other treatments which may not be explained by modern medicine. OLto search MEDICINE, PRIMITIVE use MEDICINE, TRADITIONAL back thru 1966; to search FOLK MEDICINE use MEDICINE, TRADITIONAL back thru 1975 and FOLKLORE 1968-74 PM81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77 HN81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77 MHÑMedicine, Traditional ANincludes medicine among aborigines & other primitive cultures & folk medicine among non-primitive cultures; witch doctors, shamans, etc. go here; IM; specify geog; no qualif; consider also HEALTH SERVICES, INDIGENOUS (see note there) CATALOG: /geog /form MNI1.76.201.450.654; K1.419.684 XSEthnomedicine; Folk Medicine; Medicine, Folk; Medicine, Indigenous; Medicine, Primitive FXÑHealth Services, Indigenous LH LS; ; ; ; LX  MS3-beta,12-beta,14-beta-Trihydroxy-5-beta-card-20(22)-enolide-3-(4'''-0-methyltridigitoxoside). Semisynthetic digitalis glycoside; its cardiotonic action is prolonged by its demethylation to digoxin by the liver; used in congestive heart failure. Synonyms: Lanitop; 4'''0-methyldigoxin. HN(79) MHÑMedigoxin ANdo not use /biosyn /defic /physiol RN30685-43-9 PIDigoxin (66-78) MND4.808.155.160.349.500; D9.203.408.180.261.436.500; D18.222.175.324.595 XSBeta-Methyldigoxin; Metildigoxin DMÑDigoxin LH LS; LM  MHÑMediterranean Islands ANincludes only CYPRUS & MALTA; Corsica goes under FRANCE; SARDINIA see ITALY; SICILY is available MNZ1.542.581 LH  HN87 MHÑMediterranean Sea MNZ1.756.592 LH  MSA computerized biomedical bibliographic storage and retrieval system operated by the National Library of Medicine. PM78 HN78 MHÑMEDLARS-MEDLINE Information System ANonly /econ /hist /instrum /man /organ /trends /util (if by MeSH definition); add UNITED STATES; DF: MEDLARS PIInformation Systems (66-77); United States National Library of Medicine (66-77) MNL1.700.508.300.742.800 XSIndex Medicus; MEDLINE LH LS;  HN(72) MHÑMedrogestone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN977-79-7 PIPregnadienes (66-71); Progestational Hormones (66-71) MND4.808.745.432.481; D6.597.799.541 DMÑPregnadienes LH LM  MHÑMedroxyprogesterone ANdo not use /biosyn /defic /physiol RN520-85-4 MND4.808.745.745.654.829.614; D6.597.799.567; D7.360.276.210.443.706.506 XSMethylhydroxyprogesterone; Methypregnone LH LS;  MHÑMedulla Oblongata ANdo not use /innerv MNA8.186.211.132.810.406 XSMyelencephalon LH LS  MHÑMedulloblastoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with CEREBELLAR NEOPLASMS (IM) MNC4.557.652.479 LH  PM72 HN72(65) MHÑMefenamic Acid AND25-26 qualif RN61-68-7 MND14.73.278.547; D26.74.75.624 LH  MS4-Chloro-N(1)-methyl-N(1)-(tetrahydro-2-methylfurfuryl)-m-benezenedisulfonamide. Diuretic that affects the concentrating ability of the kidney, increases sodium chloride excretion, but may not spare potassium; inhibits carbonic anhydrases; may increase the blood uric acid level. Synonyms: B 1500; Baycaron; FBA 1500. HN(76) MHÑMefruside ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7195-27-9 PIDiuretics, Sulfamyl (74-75); Furans (72-75) MND2.65.884.575; D2.886.590.700.575; D19.770.224.516.592 DMÑDiuretics, Sulfamyl LH LM  MSBacteriocins elaborated by mutant strains of Bacillus megaterium; they are protein or protein-lipopolysaccharide complexes lethal to other strains of the same species. OLto search MEGACIN use MEGACINS back thru 1975, BACTERIOCINS 1968-74 & ANTIBIOTICS 1966-67 HN(79); was MEGACIN see under BACTERIOCINS 1968-78, was MEGACIN see under ANTIBIOTICS 1966-67 MHÑMegacins ANdo not use /analogs /defic /physiol PIAntibiotics (66-67); Bacteriocins (68-74); Megacin (75-78) MND20.85.133.531; D24.310.125.531 DMÑBacteriocins LH LM  MSPathological enlargement of the colon. MHÑMegacolon AN/congen = HIRSCHSPRUNG DISEASE MNC6.405.469.158.701 LH  OLsearch COLITIS, ULCERATIVE 1966-74 HN(75)(64-66) MHÑMegacolon, Toxic MNC6.405.469.158.188.231.531; C6.405.469.158.701.591 DMÑColitis, Ulcerative LH LM  MHÑMegakaryocytes ANA 11 qualif & /class; megakaryocytic leukemia = THROMBOCYTHEMIA, HEMORRHAGIC MNA11.148.614; A15.378.316.614 LH  OLsearch ERYTHROCYTES 1966-74 HN(75); was see under ERYTHROCYTES 1963-74 MHÑMegaloblasts ANA 11 qualif & /class MNA11.118.413.330.531; A15.145.229.413.330.531 DMÑErythrocytes, Abnormal LH LM  PM72 HN72(63) MHÑMegestrol ANdo not use /biosyn /defic /physiol RN3562-63-8 MND4.808.745.432.531; D6.597.799.593; D7.360.276.210.443.706.551 LH  MS1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. HN(77) MHÑMeglumine ANdo not use /biosyn /defic /physiol RN6284-40-8 PIAmino Sugars (71-76); Sorbitol (69-76) MND2.33.800.813.550; D9.203.67.342.600; D9.203.853.813.550 XSMethylglucamine DMÑSorbitol LH LS LM  OLsearch EYELIDS 1966-74 HN(75) MHÑMeibomian Glands ANcoord NIM with EYELID DISEASES (IM) or EYELID NEOPLASMS (IM); meibomian cyst (also called chalazion): index CYSTS (IM) + EYELID DISEASES (IM) + MEIBOMIAN GLANDS (NIM) MNA9.371.337.614; A10.336.827.600 DMÑEyelids LH LM  MSA syndrome characterized by blepharospasm and involuntary facial movements, in the absence of neuroleptic drug therapy. HN(85) MHÑMeige Syndrome ANnote X refs: do not confuse with Meige Syndrome of familial lymphedema ( = MILROY'S DISEASE see LYMPHEDEMA) nor with MEIGS' SYNDROME PIBlepharospasm (75-84); Dystonia (82-84); Facial Muscles (66-84) MNC10.228.140.79.590 XSBlepharospasm-Oromandibular Dystonia; Brueghel Syndrome DMÑBasal Ganglia Diseases LH LS; LM  MSAscites and hydrothorax associated with ovarian fibroma or other pelvic tumors.. PM65 HN65(64) MHÑMeigs' Syndrome ANnote apostrophe: s' , not 's; do not confuse with MEIGE SYNDROME MNC4.588.322.455.531; C4.588.945.418.685.595; C13.371.56.630.705.531 LH  MSA special method of cell division, occurring in maturation of the germ cells, by means of which each daughter nucleus receives half the number of chromosomes characteristic of the somatic cells of the species. PM68 HN68 MHÑMeiosis ANNIM specific cell when merely test cell; coord with specific cell /cytol; only /drug eff /rad eff; not for micro-organisms PICell Division (66-67) MNG4.335.135.220.531; G5.148.165.220.531; G7.553.135.220.531 XUÑSynaptonemal Complex LH LU  MSThe geographic area of the Mekong Valley in general or when the specific country or countries are not indicated. Usually includes Cambodia, Indochina, and Laos. HN75 MHÑMekong Valley MNZ1.252.145.530 LH  HN68 MHÑMelanesia ANincludes NEW CALEDONIA, FIJI, NEW GUINEA, NEW HEBRIDES, the Solomons, the Bismarcks; Melanesians are of Negroid race unless otherwise specified MNZ1.782.590 LH  OLuse MELANINS to search MELANIN back thru 1966 PM78; was MELANIN 1963-77 HN78; was MELANIN 1963-77 MHÑMelanins AN/biosyn /physiol permitted; do not use /analogs MND11.557.596 LH  PM72 HN72(69) MHÑMelanocytes ANA 11 qualif PIChromatophores (66-68) MNA11.436.613 XSMelanosomes LH LS  MHÑMelanoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); note MELANOMA, EXPERIMENTAL below MNC4.557.433 LH  PM87 HN87 MHÑMelanoma, Experimental AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) PIMelanoma (66-86) MNC4.557.433.600; C4.619.600 XSB16 Melanoma; Melanoma, Cloudman S91; Melanoma, Harding-Passey LH LS; ;  MSPigment cells containing melanin. OLsearch CHROMATOPHORES 1966-74 PM78; was see under CHROMATOPHORES 1963-77 HN78(75); was see under CHROMATOPHORES 1963-77 MHÑMelanophores ANA 11 qualif PIChromatophores (66-74) MNA11.436.265.531 LH  MSDisorders of increased melanin pigmentation that develop without preceding inflammatory disease. OLto search FRECKLES use MELANOSIS back thru 1980 & LENTIGO 1966-79 PMFRECKLES was see LENTIGO 1963-79 HNFRECKLES was see LENTIGO 1963-79 MHÑMelanosis ANmelanotic freckle or malignant freckle = NEVUS, PIGMENTED MNC17.621.530 XSChloasma; Freckles; Melasma LH LS; ;  MSp-[(4,6-diamino-s-triazin-2y1)amino]dithiobenzenearsonous acid-3-hydroxypropylene ester. Arsenical used in trypanosomiases; may cause fatal encephalopathy and other undesirable side effects. Synonyms: Arsobal; Mel-B. HN(75) MHÑMelarsoprol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN494-79-1 PIArsenicals (68-74); Triazines (68-74) MND2.691.88.500; D21.370.884.420 XSMelarsenoxid-BAL DMÑArsenicals LH LS LM  PM68 HN68(65) MHÑMelatonin RN73-31-4 MND3.438.473.914.481; D6.472.506 LH  MSBlack, tarry stools containing digested blood. MHÑMelena MNC6.405.348.531; C23.542.516.531 FXÑFeces; ÑOccult Blood LH LX;  HN(73) MHÑMelengestrol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5633-18-1 PIPregnadienes (66-72); Progestational Hormones (66-72) MND4.808.745.432.581; D6.597.799.619 DMÑPregnadienes LH LM  MS6-0-alpha-D-Galactopyranosyl-D-glucose. A disaccharide consisting of one galactose and one glucose moiety in an alpha (1-6) glycosidic linkage. HN(79) MHÑMelibiose ANdo not use /biosyn /defic /physiol; /analogs NIM only; do not confuse with MELIBIASES RN585-99-9 PIDisaccharides (66-78) MND9.203.698.629.305.540 DMÑDisaccharides LH LM  MHÑMelioidosis ANcaused by Pseudomonas pseudomallei; in India, Malay & Indonesia MNC1.252.739.531 LH  MSBasic polypeptide from the venom of the honey bee (Apis mellifera); it contains 62 amino acids, has cytolytic properties, causes contracture of muscle, releases histamine and disrupts surface tension, probably due to lysis of cell and mitochondrial membranes. Synonyms: melittin; melliten. HN(75); was see under VENOMS 1975-77 MHÑMelitten ANdo not use /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; /analogs NIM only RN20449-79-0 PIBees (73-74); Peptides (73-74); Venoms (73-74) MND24.185.965.65.115.580 XSMelittin; Mellitin DMÑBee Venoms LH LS; LM  PM64 HN64(63) MHÑMelkersson-Rosenthal Syndrome MNC7.465.466; C10.772.204.266.297.593 LH  MHÑMelorheostosis MNC5.116.99.708.702.593 LH  MS4-(Bis(2-chloroethyl)amino)phenylalanine. An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Synonyms: Alkeran; CB 3007; CB 3025; CB 3026; DL-PAM; D-PAM; L-PAM; medfalan; melfalan; merfalan; NSC 14210; NSC 35051; NSC 8806; Sarcoclorin. PMPEPTICHEMIO was see under NITROGEN MUSTARD COMPOUNDS 1975-80 MHÑMelphalan ANdo not use /biosyn /defic /physiol RN148-82-3 MND2.455.526.728.650.594; D22.204.585.613 XSMedphalan; Merphalan; Phenylalanine Mustard; SARCOLYSINE; SARKOLYSIN XUÑPeptichemio LH LS; ; ; ; LU  MS1,3-Dimethyl-5-aminoadamantane. Amantadine derivative that has some dopaminergic effects; proposed as an antiparkinson agent. OLuse MEMANTINE to search D 145 back thru 1976 HN(84); was D 145 see under AMANTADINE 1976-83 MHÑMemantine ANdo not use /biosyn /defic /physiol RN19982-08-2 PIAmantadine (74) /AA (75) MND2.219.75.80.600; D2.455.426.392.368.75.600; D4.615.236.75.80.600; D14.307.106.600 XS1,3-Dimethyl-5-Aminoadamantane; D 145 DMÑAmantadine LH LS; LM  MSThe motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, cholesterol concentration, and temperature. PM79 HN79 MHÑMembrane Fluidity ANIM; only /drug eff /rad eff; permitted with artif membranes PICell Membrane (66-78); Lipids (66-76); Membrane Lipids (77-78); Membranes (66-76); Phospholipids (66-76) MNG6.184.568 XSBilayer Fluidity FXÑCell Membrane LH LS LX  MSThe adherence of cell membranes, intracellular membranes, or artifical membrane models of either to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes. PM82 HN82 MHÑMembrane Fusion ANIM; only /drug eff /rad eff; coord with specific membrane & specific organism preferably NIM PICell Fusion (71-81); Cell Membrane (66-81) MNG4.335.670 LH  MSLipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation. PM77 HN77 MHÑMembrane Lipids AN/biosyn /physiol permitted; do not use /analogs PICell Membrane (66-76); Lipids (66-76); Membranes (68-76); Phospholipids (66-76) MND10.516.570 XSCell Membrane Lipids FXÑCell Membrane; ÑMembranes LH LS LX;  PM68 HN68(67) MHÑMembrane Potentials ANNIM; only /drug eff /rad eff PIElectrophysiology (66) MNG6.535.166.310.657; G7.453.697; G11.561.450; H1.671.100.708 XSResting Potentials FXÑCell Membrane LH LS LX  MSProteins which are found in membranes including cellular and intracellular membranes. They consist of two types: peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, drug, hormone and lectin receptors. PM77 HN77 MHÑMembrane Proteins AN/biosyn /physiol permitted; do not use /analogs PICell Membranes (66-76); Membranes (68-76); Proteins (66-76) MND12.776.543 XSCell Membrane Proteins FXÑCell Membrane; ÑMembranes LH LS LX;  MSThin layer of tissues which cover parts of the body, separate adjacent cavities or connect adjacent structures. PM68 HN68(66) MHÑMembranes ANalmost never IM: usually NIM coord with organ or tissue IM; do not use /abnorm /growth /inj /innerv; INTRACELLULAR MEMBRANES & NUCLEAR MEMBRANE are also available MNA10.615 FXÑCell Membrane; ÑCell Wall; ÑMembrane Lipids; ÑMembrane Proteins; ÑNEURILEMMA; ÑSYNOVIAL MEMBRANE LH LX; ; ; ; ;  MSArtificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis, monomolecular and bimolecular membranes used as models to simulate biological membranes. PM68 HN68(66) MHÑMembranes, Artificial ANIM; no qualif MNH1.181.529.530 LH  MSComplex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent and remote memory. MHÑMemory ANonly /drug eff /physiol /rad eff; ╥photographic memory╙ = MEMORY, PHOTOGRAPHIC (see EIDETIC IMAGERY); ╥recognition╙ goes here MNF2.463.425.540 XUÑRecall; ÑRetention (Psychology) LH LU;  MSDisturbances in registering an impression, in the retention of an acquired impression or in the recall of an impression. PM69 HN69 MHÑMemory Disorders ANdo not use /drug eff /physiol /rad eff PIAmnesia (66-68); Deja Vu (68); Memory (66-68) MNF3.126.185.597 LH  MSTemporary storage of information for a few seconds to hours, as opposed to long-term memory which refers to material stored for days, years, or a lifetime. OLuse MEMORY, SHORT-TERM to search IMMEDIATE RECALL back thru 1969 PM69 HN69; IMMEDIATE RECALL was see under MEMORY, SHORT-TERM 1969-78 MHÑMemory, Short-Term ANonly /drug eff /physiol /rad eff PIMemory (66-68) MNF2.463.425.540.407 XSImmediate Recall; Memory, Immediate LH LS;  MSHuman adult males. As cultural, psychological, sociological, political, and economic entity. PM80 HN80 MHÑMen ANfor men only as a cultural, social, sociol, polit, economic force; do not confuse with MALE for disease, organs, physiol, genetics, etc.; only /educ /psychol; check tags HUMAN & MALE; Manual 18.9.6, 34.18; do not use for mankind: see note on Man under PRIMATES PIMale (66-79) MNM1.390 LH  PM73 HN73(69) MHÑMenarche ANqualif permitted: /blood-csf-urine /drug eff /ethnol /genet /immunol /metab /physiol /psychol /rad eff PIMenstruation (66-68); Puberty (66-68) MNG8.520.940.508.410 LH  MHÑMendelevium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-11-1 MND1.287.519; D1.552.517.561 LH  MSA strain of encephalomyocarditis virus isolated from rodents and lagomorphs and occasionally causing febrile illness in man. PM73 HN73 MHÑMengo Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENTEROVIRUS INFECTIONS (IM) PIEncephalomyocarditis Viruses (66-72) MNB4.909.777.618.284.488.615 LH  MHÑMeniere's Disease ANspell with accents (Meniere's) in translations MNC9.218.568.382 XSVertigo, Aural LH LS  MSArteries which supply the dura mater. MHÑMeningeal Arteries ANdo not use /blood supply MNA7.231.114.545 LH  MSNeoplasms of the meninges; dura mater, pia mater, arachnoid. PM78 HN78 MHÑMeningeal Neoplasms ANcoord IM with histol type of neopl (IM); for intracranial or spinal meningioma, see note on MENINGIOMA; /anal /blood supply /secret /ultrastruct permitted; meningeal leukemia goes here (IM) + LEUKEMIA (IM) PIBrain Neoplasms (66-77); Meninges (66-77); Neoplasms (66-77) MNC4.588.614.580; C10.228.625 LH  MHÑMeninges ANdo not use /innerv; inflammation = MENINGITIS & its specifics MNA8.186.566 XUÑSubdural Space LH LU  MHÑMeningioma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with MENINGEAL NEOPLASMS (IM) but not with BRAIN NEOPLASMS nor SPINAL CORD NEOPLASMS for intracranial or spinal meningioma unless site is particularly discussed MNC4.557.652.513 LH  MHÑMeningism ANsympt of meningeal irritation without meningeal infect MNC10.228.637; C10.597.544; C23.888.592.544 LH  MHÑMeningitis ANGEN: prefer specifics; for pachymeningitis (DURA MATER) or leptomeningitis (ARACHNOID or PIA MATER) do not specify meninx unless particularly discussed; tuberculous meningitis = TUBERCULOSIS, MENINGEAL; purulent, suppurative or pyogenic: do not coord with SUPPURATION (NIM) unless particularly discussed: consider also various specific bacterial meningitis terms MNC10.228.228.507 XUÑMeningitis, Aseptic; ÑSubdural Effusion LH LU;  MSA meningeal reaction in the cerebrospinal fluid in the absence of an infecting organism. Can be due to a foreign substance, a diagnostic or therapeutic procedure or to a tumor or a septic focus within the skull or spinal canal. HN(77) MHÑMeningitis, Aseptic PIMeningitis (66-76) MNC10.228.228.507.248 DMÑMeningitis LH LM  MHÑMeningitis, Haemophilus MNC1.252.433.615; C10.228.228.507.393 LH  MHÑMeningitis, Listeria ANL. monocytogenes meningitis: do not bother to coord with LISTERIA MONOCYTOGENES unless organism is particularly discussed MNC1.252.514.533; C10.228.228.507.449 LH  OLuse MENINGITIS, MENINGOCOCCAL to search MENINGITIS, MENINGOCOCCIC back thru 1966 PM78; was MENINGITIS, MENINGOCOCCIC 1963-77 HN78; was MENINGITIS, MENINGOCOCCIC 1963-77 MHÑMeningitis, Meningococcal ANdo not bother to coord with NEISSERIA MENINGITIDIS unless organism is particularly discussed MNC1.252.549.449; C10.228.228.507.505 LH  MHÑMeningitis, Pneumococcal ANdo not bother to coord with STREPTOCOCCUS PNEUMONIAE unless organism is particularly discussed MNC1.252.890.670.595; C10.228.228.507.560 LH  MHÑMeningitis, Viral ANcoord IM with specific virus dis (IM) MNC2.587; C10.228.228.507.616 LH  MSHernial protrusion of the meninges through a defect in the skull or vertebral column. MHÑMeningocele ANdo not use /congen; meningoencephalocele: coord IM with ENCEPHALOCELE (IM) MNC16.131.666.680.598 LH  PMWATERHOUSE-FRIDERICHSEN SYNDROME was heading 1963-83 MHÑMeningococcal Infections ANnote MENINGITIS, MENINGOCOCCAL above MNC1.252.549 XUÑWaterhouse-Friderichsen Syndrome LH LU  MHÑMeningoencephalitis MNC10.228.140.437.615; C10.228.228.553 LH  MSA hernial protrusion of part of the meninges and substance of the spinal cord through a defect in the vertebral column. OLsearch SPINA BIFIDA 1966-74; to search MYELOCELE use MENINGOMYELOCELE back thru 1975 & SPINA BIFIDA 1966-74 PM78; was see under SPINA BIFIDA 1963-77 HN78(75); was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77 MHÑMeningomyelocele ANdo not use /congen; = myelomeningocele; X ref SPINA BIFIDA CYSTICA is also called spina bifida aperta or open spina bifida PISpina Bifida (66-74) MNC16.131.621.824.449; C16.131.666.680.836.843.449 XSMyelocele; Spina Bifida Cystica LH LS;  OLuse MENISCI, TIBIAL to search SEMILUNAR CARTILAGES back thru 1966 PM87; was SEMILUNAR CARTILAGES 1963-86 HN87; was SEMILUNAR CARTILAGES 1963-86 MHÑMenisci, Tibial MNA2.165.590; A2.835.583.475.590 XSSemilunar Cartilages; Tibial Menisci LH LS;  MHÑMenopause ANqualif permitted: /blood-csf-urine /drug eff /ethnol /genet /immunol /metab /physiol /psychol /rad eff; ╥postmenopausal╙ goes here; ╥hot flushes╙ goes under CLIMACTERIC MNG8.520.940.110.308 XUÑMenopause, Premature LH LU  MSPremature cessation of the menstrual function. HN(75) MHÑMenopause, Premature ANqualif permitted: /blood-csf-urine /drug eff /ethnol /genet /immunol /metab /physiol /psychol /rad eff MNG8.520.940.110.308.500 DMÑMenopause LH LM  MSExcessive menstrual flow. MHÑMenorrhagia MNC13.371.491.583; C13.371.852.691.449; C23.542.946.533 XSHypermenorrhea LH LS  PM73 HN73 MHÑMenotropins AN/biosyn /physiol permitted; do not use /analogs PIGonadotropins, Pituitary (66-72) MND6.472.351.576.583; D6.472.734.525.343.583; D7.552.344.344.451.533 XSFSH, Human; GONADOTROPINS, HUMAN MENOPAUSAL LH LS;  MSThe period of the regularly recurring physiologic changes in the endometrium occurring during the reproductive period in human females and some primates and culminating in partial sloughing of the endometrium (menstruation). PM85 HN85 MHÑMenstrual Cycle ANhuman & other primates only; non-primates = ESTRUS; only /drug eff /rad eff; do not confuse with MENSTRUATION PIMenstruation (66-84) MNG8.520.440 XSEndometrial Cycle; Menstrual Proliferative Phase; Menstrual Secretory Phase; Ovarian Cycle; Proliferative Phase; Secretory Phase LH LS; ; ; ; ;  MSThe normal physiologic discharge through the vagina of blood and mucosal tissues from the nonpregnant uterus. MHÑMenstruation ANhuman & other primates only; non-primates = ESTRUS; only /drug eff /rad eff; /drug eff: consider also MENSTRUATION INDUCING AGENTS; do not confuse with MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME is also available MNG8.520.440.428 LH  PMuse MENSTRUATION DISORDERS to search HYPOMENORRHEA, POLYMENORRHEA & MENSTRUATION, RETROGRADE back thru 1975 HNHYPOMENORRHEA, POLYMENORRHEA & MENSTRUATION, RETROGRADE were see under MENSTRUATION DISORDERS 1975-85 MHÑMenstruation Disorders ANhuman only MNC13.371.491 XSHypomenorrhea; Menstruation, Retrograde; Polymenorrhea XUÑOligomenorrhea LH LS; ; LU  MSChemical compounds which induce menstruation. PM75 HN75 MHÑMenstruation Inducing Agents ANdo not use /analogs /biosyn /defic /physiol; consider also MENSTRUATION /drug eff PIMenstruation/DE (68-74) MND7.650; D7.360.276.500 XSEmmenagogues LH LS  MSPsychiatric illness as manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. MHÑMental Disorders ANGEN: prefer specifics; do not use /drug eff /physiol /rad eff; ╥insanity╙ goes here MNF3.709 LH  MSThe use of suggestion or faith to cure disease, particularly physical illness. MHÑMental Healing ANonly /hist; ╥faith cure╙ goes here; do not confuse X ref SPIRITUAL HEALING with SPIRITUALISM MNE2.924.598 XSFaith Healing; Spiritual Healing LH LS;  MSThe state wherein the person is well adjusted. OLuse MENTAL HEALTH to search MENTAL HYGIENE back thru 1966 PM67; was MENTAL HYGIENE 1963-66 HN67; was MENTAL HYGIENE 1963-66 MHÑMental Health ANno qualif MNF2.418; F4.366; N1.407.540.408 XSMENTAL HYGIENE FXÑORTHOPSYCHIATRY LH LS LX  MSVoluntary organization which supports educational programs and research in psychiatry with the objective of the promotion of mental health. OLsearch VOLUNTARY HEALTH AGENCIES 1967-74 HN(75) MHÑMental Health Association ANonly /hist /organ; specify geog CATALOG: use NAF entry PICommunity Mental Health Services (67-74); Mental Disorders (66-74); Mental Health (66-74); Voluntary Health Agencies (66-74) MNN3.540.630.780.500 DMÑVoluntary Health Agencies LH LM  MSOrganized services to provide mental health care. OLuse MENTAL HEALTH SERVICES to search MENTAL HYGIENE SERVICES back thru 1966 PM67; was MENTAL HYGIENE SERVICES 1963-66 HN67; was MENTAL HYGIENE SERVICES 1963-66 MHÑMental Health Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util; COMMUNITY MENTAL HEALTH SERVICES & specifics are also available; Public Laws 89-105 & 89-164 CATALOG: /geog /form MNF4.408; N2.421.461 XSMENTAL HYGIENE SERVICES XUÑEmergency Services, Psychiatric LH LS LU  MSConceptual functions or thinking in all its forms. MHÑMental Processes ANonly /drug eff /physiol /rad eff MNF2.463 LH  MSSubnormal intellectual functioning which originates during the developmental period and is associated with impairment of one or more of the following: (1) maturation, (2) learning, (3) social adjustment. OLuse MENTAL RETARDATION to search IDIOCY & MENTAL DEFICIENCY back thru 1966 PM67; was MENTAL DEFICIENCY 1963-66; IDIOCY was heading 1963-84 HN67; was MENTAL DEFICIENCY 1963-66; IDIOCY was heading 1963-84 MHÑMental Retardation ANCateg C qualif only; do not use /congen; /rehabil permitted; /educ = EDUCATION OF MENTALLY RETARDED MNC10.496; F3.709.346 XSIdiocy; MENTAL DEFICIENCY FXÑChromosome Abnormalities; ÑCretinism; ÑEducation of Mentally Retarded; ÑMETABOLISM, INBORN ERRORS LH LS; LX; ; ;  MSMarginal or mild subnormal intellectual functioning due to cultural or environmental deprivation. It is usually associated with mental retardation of one or both parents and often with severe sensory deprivation in infancy and childhood. PM69 HN69 MHÑMental Retardation, Psychosocial ANdo not use /drug eff /physiol /rad eff PIMental Retardation (66-68) MNF3.709.346.598 FXÑCultural Deprivation; ÑSensory Deprivation LH LX;  MSStandardized clinical interview used to assess current psychopathology by scaling patient responses to the questions. OLsearch PSYCHIATRIC STATUS RATING SCALES 1969-74 HN(75) MHÑMental Status Schedule ANno qualif MNF4.586.574 DMÑPsychiatric Status Rating Scales LH LM  MHÑMenthol ANdo not use /biosyn /defic /physiol RN1490-04-6 MND2.455.849.533 LH  HN(Aug 77) MHÑMenu Planning ANdomestic, commercial, institutional, hosp, etc.; only /econ /stand /trends PIFood Service, Hospital (66-Jul 77); Food Services (Jan-Jul 77) MNJ1.364.510; N2.421.242.472.310 DMÑFood Services LH LM  MSPolyene antibiotic with unknown composition; obtained from Streptomyces aureofaciens; proposed as antifungal and or antiprotozoal agent. Synonyms: SPA-S 160; SN 654; Tricandil. OLuse MEPARTRICIN to search METHYL PARTRICIN back thru 1976 HN(81); was METHYL PARTRICIN see under POLYENES 1976-80 MHÑMepartricin ANdo not use /defic /physiol; /analogs NIM only RN11121-32-7 PIPolyenes (74-75) MND2.455.326.271.665.400; D20.85.500 XSMethylpartricin DMÑPolyenes LH LS LM  MHÑMeperidine ANdo not use /biosyn /defic /physiol RN57-42-1 MND3.66.399.450; D3.383.621.349.450; D14.73.153.491; D14.757.471 XSIsonipecain; Operidine; PETHIDINE XUÑPromedol LH LS; ; LU  MHÑMephenesin ANdo not use /biosyn /defic /physiol RN59-47-2 MND17.426.533 LH  MHÑMephentermine ANdo not use /biosyn /defic /physiol RN100-92-5 MND2.92.471.683.152.766.617; D16.893.120.739.592 LH  MS5-Ethyl-3-methyl-5-phenylhydantoin. Anticonvulsant effective in grand mal epilepsy; may cause blood dyscrasias. Synonyms: Epilan; Insulton; Mesantoin; methyl hydantoin; Phenantoin; Sacerno; Sedantional. HN(75) MHÑMephenytoin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN50-12-4 PIHydantoins (69-74) MND3.383.374.411.620; D14.261.447.630 XSMethoin; Methyl Phenetoin DMÑHydantoins LH LS; LM  PM73 HN73(63) MHÑMephobarbital ANdo not use /biosyn /defic /physiol; do not confuse with ╥mephebarbital╙ RN115-38-8 MND3.383.742.698.253.434; D14.166.111.434; D14.261.164.450; D14.591.220.434 XSMETHYLPHENOBARBITOL LH LS  MHÑMepivacaine ANdo not use /biosyn /defic /physiol RN96-88-8 MND14.211.531 XSCARBOCAINE LH LS  MHÑMeprobamate ANdo not use /biosyn /defic /physiol; Equanil & Miltown go here RN57-53-4 MND2.241.81.251.510; D15.236.872.659.655; D17.426.574 LH  MSm-(3-Ethyl-1-methylhexahydro-1H-azepin- 3-yl)phenol. Narcotic antagonist with analgesic properties; proposed for severe pain. Synonym: WY 22811. HN(80) MHÑMeptazinol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN54340-58-8 PIAzepines (66-79); Phenols (66-76) MND3.383.66.400; D14.73.588; D14.712.588 DMÑAzepines LH LM  MS[2,7-Dibromo-9-(o-carboxyphenyl)-6-hydroxy-3-oxo-3H-xanthen-5yl]hydroxymercury disodium salt. Popular topical antiseptic with weak antibacterial action; incompatible with local anethetics. Synonyms: Asceptichrome; Flavurol; Gynochrome; Mercuranine; mercurobromflurescein; Mercurocol; Septichrome. HN(75) MHÑMerbromine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN129-16-8 PIFluoresceins (69-74); Mercury (72-74) MND2.691.750.575; D20.187.560 XSMercuresceine; Mercurochrome DMÑFluoresceins LH LS; LM  PM66 HN66(64) MHÑMercaptoethanol ANdo not use /biosyn /defic /physiol RN60-24-2 MND2.33.57.534; D2.886.489.409 XUÑ2-Mercaptoethanesulfonate LH LU  MHÑMercaptoethylamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.471.562; D2.886.489.472 LH  MSSulfhydryl acylated derivative of glycine used in treatment of liver diseases, as a detoxicant and in therapy of myopia. Synonyms: Thiola; Thiola-Amp. HN(75) MHÑMercaptopropionylglycine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1953-02-2 PIAmino Acids, Sulfur (74); Glycine (74) MND12.125.166.650; D12.125.481.600 XSTiopronin DMÑAmino Acids, Sulfur LH LS LM  PM72 HN72 MHÑMercuribenzoates ANdo not use /analogs /biosyn /defic /physiol PIBenzoates (66-71); Chloromercuribenzoates (66-71); Mercury (66-71); Organometallic Compounds (68-71) MND2.241.223.106.604; D2.691.750.740.644; D8.373.830.699 LH  MSA highly toxic compound which volatilizes slightly at ordinary temperature and appreciably at 100 degrees. It is corrosive to mucous membranes and used as a topical antiseptic and disinfectant. PM85 HN85 MHÑMercuric Chloride ANdo not use /analogs /biosyn /defic /physiol RN7487-94-7 PIMercury (66-84) MND1.552.504.550; D20.187.570 XSMercury Dichloride LH LS  MHÑMercury ANHg-202; do not use /analogs /biosyn /defic /physiol /pois ( = MERCURY POISONING) RN7439-97-6 MND1.248.497.300.333.616; D1.268.536; D1.552.504 LH  PM68 HN68(67) MHÑMercury Isotopes ANHg-196,198-201,204; NIM; no qualif PIChlormerodrin (66); Diuretics, Mercurial (66); Mercury (66) MND1.496.532; D1.552.504.617 LH  MHÑMercury Poisoning ANGEN only: consider also /pois with specific mercury terms; do not use /chem ind; occup mercury pois: coord IM with OCCUPATIONAL DISEASES (IM) but not also ENVIRONMENTAL EXPOSURE (see note there) MNC21.613.647 XSMinamata Disease LH LS  MSUnstable isotopes of mercury that decay or disintegrate spontaneously emitting radiation. Hg 189-195, 197, 203, 205, and 206 are radioactive isotopes of mercury. OLsearch MERCURY ISOTOPES 1967-74 (as Prov 1967) PM75 HN75 MHÑMercury Radioisotopes ANHg-185-195, 197, 203, 205, 206; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIMercury Isotopes (68-74); Radioisotopes (68-74) MND1.496.532.500; D1.496.749.590; D1.552.504.700 LH  MHÑMermithoidea ANdo not use /blood-csf-urine; infection (probably accidental through food contam): coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.570 XSMermithid LH LS  PM74 HN74(71) MHÑMeromyosins ANdo not use /analogs /defic /physiol PIMuscle Proteins (66-70) MND12.776.210.500.497 LH  MS[3-[(2-(carboxymethoxy)benzoyl)amino] -2-methoxypropyl]hydroxymercury. Toxic thiol mercury salt formerly used as diuretic; it inhibits various biochemical functions, especially in mitochondria and is used to study those functions. Synonyms: Mercusal; Mersalin; Salurin; Salygran. OLsearch DIURETICS, MERCURIAL 1966-74 HN(75) MHÑMersalyl ANdo not use /biosyn /defic /physiol; /analogs NIM only RN492-18-2 MND2.691.750.100.710; D19.770.224.391.710 XSMercuramide DMÑDiuretics, Mercurial LH LS LM  MS3,4,5-Trimethoxyphenethylamine. Hallucinogenic alkaloid isolated from the flowering heads (PEYOTE) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as experimental psychotomimetic. Synonyms: trimethoxybenzeneethanamine; TMPEA; peyotl; Anhalonium. OLuse MESCALINE to search PEYOTE back thru 1966 HNPEYOTE was see under MESCALINE 1963-78 MHÑMescaline ANdo not use /defic /physiol RN54-04-6 MND2.92.471.683.635; D3.132.524; D15.236.372.599 XSMezcalin; Peyote; Trimethoxyphenethylamine LH LS; ;  MHÑMesencephalon ANdo not use /innerv MNA8.186.211.132.659 XSCerebral Peduncle; MIDBRAIN LH LS;  MHÑMesenchymoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.565 LH  MSArteries which arise from the abdominal aorta and distribute to most of the intestines. MHÑMesenteric Arteries ANdo not use /blood supply; occlusion or obstruction: coord NIM with MESENTERIC VASCULAR OCCLUSION (IM); embolism or thrombosis: index under MESENTERIC VASCULAR OCCLUSION (IM) + EMBOLISM or THROMBOSIS (IM) + MESENTERIC ARTERIES (NIM); duodenal compression by superior mesenteric artery = SUPERIOR MESENTERIC ARTERY SYNDROME MNA7.231.114.565 LH  MHÑMesenteric Cyst ANnon-neoplastic MNC4.182.473; C6.772.420 LH  MHÑMesenteric Lymphadenitis MNC6.772.465; C15.604.315.618 LH  MHÑMesenteric Vascular Occlusion ANobstruct of external or internal origin; coord IM with MESENTERIC ARTERIES (NIM) or MESENTERIC VEINS (NIM); embolism or thrombosis: see notes under MESENTERIC ARTERIES & MESENTERIC VEINS; coord IM with target organ losing its blood supply (COLON /blood supply, JEJUNUM /blood supply) (IM or NIM) only if particularly discussed; do not confuse with SUPERIOR MESENTERIC ARTERY SYNDROME (duodenal compression BY the superior mesenteric artery, not OF) MNC6.405.469.675; C6.772.510; C14.907.137.534 LH  MSVeins which return blood from the intestines; the inferior mesenteric vein empties into the splenic vein, the superior mesenteric vein joins the splenic vein to form the portal vein. MHÑMesenteric Veins ANdo not use /blood supply; occlusion or obstruction: coord NIM with MESENTERIC VASCULAR OCCLUSION (IM); venous thrombosis: index under MESENTERIC VASCULAR OCCLUSION (IM) + THROMBOSIS (IM) (not THROMBOPHLEBITIS - see note there) + MESENTERIC VEINS (NIM) MNA7.231.908.670.385 LH  MHÑMesentery ANavoid /blood supply: prefer MESENTERIC ARTERIES or MESENTERIC VEINS but for mesenteric circulation use SPLANCHNIC CIRCULATION; diseases: coord IM with PERITONEAL DISEASES (NIM); neopl: coord IM with PERITONEAL NEOPLASMS (IM) MNA1.47.596.451 LH  OLsearch TOOTH MIGRATION 1966-74 HN(75) MHÑMesial Movement of Teeth ANonly /class /etiol /radiogr MNC7.465.714.836.535; G10.549.803.535 DMÑTooth Migration LH LM  MSA genus of tapeworm, containing several species, found as adults in birds and mammals. The larvae or cysticercoid stage develop in invertebrates. Human infection has been reported and is probably acquired from eating inadequately cooked meat of animals infected with the second larval stage known as the tetrahythridium. OLuse MESOCESTOIDES to search MESOCESTROIDES back thru 1986 HN(87); was MESOCESTROIDES see under CESTODA 1986 MHÑMesocestoides ANdo not use /blood-csf-urine; infection: coord NIM with CESTODE INFECTIONS (IM) PICestoda (66-85) MNB1.500.736.215.520 DMÑCestoda LH LM  MSThe fold of peritoneum by which the colon is attached to the posterior abdominal wall. OLuse MESOCOLON to search MESOSIGMOID back thru 1966 HNMESOSIGMOID was see under MESOCOLON 1963-78 MHÑMesocolon MNA1.47.596.451.535 XSMesosigmoid LH LS  MSA genus of the family Cricetidae having only a single species, M. auratus. The present domesticated strains were developed from individuals brought from Syria. They are widely used in biomedical research. OLsearch HAMSTERS 1966-74 HN(75) MHÑMesocricetus ANNIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not forget also to check HAMSTERS MNB2.649.865.360.458.500 XSHamsters, Golden; Hamsters, Golden Syrian; Hamsters, Syrian DMÑHamsters LH LS; ; LM  MSThe middle germ layer of the embryo. MHÑMesoderm ANdo not use /abnorm /embryol /growth /inj; mesenchyme or mesenchyma goes here MNA16.254.425.660 LH  MSAny of several genital tract neoplasms, formerly considered to be derived from mesonephric rests. MHÑMesonephroma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); includes ENDODERMAL SINUS TUMOR & YOLK SAC TUMOR (X refs): coord these IM with OVARIAN NEOPLASMS (IM) if of ovary but other organ/neopl precoord if of other organ MNC4.557.537.585 XSEndodermal Sinus Tumor; Yolk Sac Tumor LH LS;  MSThe excretory organ of the embryo, collective Wolffian tubules, which forms the urogenital fold from which the reproductive organs develop. The mesonephros is the permanent kidney in fish and amphibians, but atrophies in reptiles, birds, and mammals. PM75 HN75 MHÑMesonephros ANdo not use /abnorm /embryol /growth /inj PIKidney (66-74) MNA16.254.500 XSWolffian Body LH LS  MSShort-lived elementary particles found in cosmic radiation or produced from nuclear disintegration; their mass is between that of protons and electrons and they can be negative, positive, or neutral. Pi-mesons (Pions) are heavier than mu-mesons (Muons) and are proposed for cancer radiotherapy, because their capture and disintegration by matter produces powerful, but short-lived secondary radiation. OLsearch ELEMENTARY PARTICLES 1975-84; to search MUONS use MESONS back thru 1985 & ELEMENTARY PARTICLES 1975-84 HN(85); was see ELEMENTARY PARTICLES 1975-84; MUONS was see ELEMENTARY PARTICLES 1975-84 MHÑMesons ANno qualif PIElementary Particles (75-84); Nuclear Physics (66-74) MNH1.671.579.404.600 XSMu-Mesons; Muons; Pi-Mesons; Pions DMÑElementary Particles LH LS; ; ; LM  MSPorphyrins with four methyl, two ethyl and two propionic acid side chains attached to the pyrrole rings. HN(75) MHÑMesoporphyrins ANdo not use /analogs PIPorphyrins (68-74) MND11.557.727.620 DMÑPorphyrins LH LM  PM73 HN73(72) MHÑMesoridazine ANdo not use /biosyn /defic /physiol RN5588-33-0 PIPhenothiazines (66-71); Tranquilizing Agents (66-71) MND3.494.741.470; D15.236.872.331.628.488 LH  MHÑMesothelioma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.588 LH  MS17 beta-Hydroxy-1 alpha-methyl-5 alpha-androstan-3-one. A synthetic steroid with anabolic and androgenic activities. HN(75) MHÑMesterolone ANdo not use /biosyn /defic /physiol RN1424-00-6 PIMethane (73-74); Stanolone (72-74) MND4.808.54.40.831.450; D6.597.100.194.400 DMÑStanolone LH LM  PM65 HN65(64) MHÑMestranol ANdo not use /biosyn /defic /physiol RN72-33-3 MND4.808.668.651.568.535; D6.597.378.640; D7.360.276.210.443.332.535 XSEthinyl Estradiol 3-Methyl Ether LH LS  MSThe volume of blood completely and irreversibly cleared of a substance (usually a hormone or steroid) by a metabolic process in unit time. PM68 HN68 MHÑMetabolic Clearance Rate ANNIM; only /drug eff /rad eff; not for metab rate: read restricted MeSH definition PIspecific heading/ME (66-67) MNE1.597; G6.535.640 LH  MSReduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action; includes those metabolic transformations that make the substance more soluble for faster renal excretion. OLsearch BIOTRANSFORMATION 1970-74 PM80; was see under BIOTRANSFORMATION 1970-79 HN80(75); was see under BIOTRANSFORMATION 1970-79 MHÑMetabolic Detoxication, Drug ANNIM with specific drug /metab (IM); for reduction of pharmacol activ of both toxic and non-toxic agents; ╥inactivating biotransformation╙ goes here, not under BIOTRANSFORMATION; only /rad eff MNG12.122.535 XSDetoxication, Drug, Metabolic; Drug Detoxication, Metabolic LH LS;  MHÑMetabolic Diseases ANGEN: prefer specifics; TN 194: differentiate from DEFICIENCY DISEASES; /congen = METABOLISM, INBORN ERRORS; ╥thesaurismosis╙, an old-fashioned term, goes here if general or unspecified MNC18.452 LH  PMTISSUE METABOLISM was heading 1963-65 HNTISSUE METABOLISM was heading 1963-65 MHÑMetabolism ANGEN only as the metabolic process irrespective of substance; prefer /metab with organs, organisms, diseases, substances: Manual 19.5+; when GEN & IM, only /drug eff /rad eff; drug metab terms: Bull 102 (Oct 77); do not confuse with next entry below MNG6.535 XUÑAerobiosis; ÑAnaerobiosis LH LU;  PM65 HN65 MHÑMetabolism, Inborn Errors ANGEN: prefer specific types; do not use /congen; TN 194: differentiate from DEFICIENCY DISEASES; TN 222: indexing enzyme defic; DF: METAB INBORN ERR MNC18.452.648 XSINBORN ERRORS OF METABOLISM FXÑAnemia, Hemolytic, Congenital; ÑMental Retardation LH LS LX;  MSThe articulation between a metacarpal bone and a phalanx. HN(77) MHÑMetacarpophalangeal Joint ANprimates only; any Cat A qualif PIFinger Joint (66-76); Metacarpus (66-76) MNA2.835.583.345.512 DMÑFinger Joint LH LM  MHÑMetacarpus ANnot restricted to primates MNA2.835.232.87.535 LH  PM65 HN65 MHÑMetal Metabolism, Inborn Errors ANdo not use /congen; coord IM with specific metal /metab (IM); DF: METAL METAB INBORN ERR MNC18.452.648.618 LH  MSPorphyrins which are combined with a metal ion. The metal is bound equally to all four nitrogen atoms of the pyrrole rings. They possess characteristic absorption spectra which can be utilized for identification or quantitative estimation of porphyrins and porphyrin-bound compounds. PM77 HN77 MHÑMetalloporphyrins ANdo not use /analogs; iron porphyrins = HEME or HEMIN, magnesium porphyrins = CHLOROPHYLL PIOrganometallic Compounds (68-76); Porphyrins (66-76); specific porphyrin MND11.557.727.640 LH  PM73 HN73 MHÑMetalloproteins ANdo not use /analogs PIProteins (66-72); specific metal MND12.776.556 XUÑHemerythrin; ÑIron-Sulfur Proteins LH LU;  MSA low molecular weight (appox. 10,000) protein occurring in cytoplasm of kidney cortex and liver. It is rich in cysteinyl residues and contains no aromatic amino acids. Metallothioein shows high affinity for bivalent heavy metals. PM84; was see under MATALLOPROTEINS 1975-83 HN84(75); was see under METALLOPROTEINS 1975-83 MHÑMetallothionein AN/biosyn /physiol permitted RN9038-94-2 PIMetalloproteins (73-74) MND12.776.556.670 LH  MHÑMetallurgy ANIM; only /econ /hist /instrum; heavy industries (iron, steel, etc.) go here MNJ1.576.634 LH  MHÑMetals ANGEN only; do not use /analogs /biosyn /defic /physiol; allergic reactions to metals is probably DERMATITIS, CONTACT, not DRUG HYPERSENSITIVITY MND1.552; J1.637.517 LH  MSA series of radioactive elements from actinum, atomic number 89, to and including lawrencium, atomic number 103. They are the theoretical analogs of the rare earth metal series. PM76 HN76; was NON MESH before 1976 MHÑMetals, Actinide ANGEN: prefer specifics; do not use /analogs /biosyn /defic /physiol PIMetals (66-75) MND1.552.517 XSActinides LH LS  MSMetals that constitute the first group in the periodic table. PM76 HN76; was NON MESH before 1976 MHÑMetals, Alkali ANdo not confuse with METALS, ALKALINE EARTH; GEN: prefer specifics; do not use /analogs /biosyn /defic /physiol PIMetals (66-75) MND1.552.528 LH  MSMetals that constitute the second group in the periodic table. PM76 HN76; was NON MESH before 1976 MHÑMetals, Alkaline Earth ANdo not confuse with METALS, ALKALI; GEN: prefer specifics; do not use /analogs /biosyn /defic /physiol PIMetals (66-75) MND1.552.539 LH  MSElements of the third long period of the periodic table from lanthanum, atomic number 57, to and including lutecium, atomic number 71. PM76 HN76; was NON MESH before 1976 MHÑMetals, Rare Earth ANGEN: prefer specifics; do not use /analogs /biosyn /defic /physiol PIMetals (66-75) MND1.552.550 XSLanthanides LH LS  MHÑMetamorphosis, Biological ANonly /drug eff /rad eff; Manual 22.5 MNG7.553.619 LH  MSalpha-(Methylaminomethyl)vanillyl alcohol. Product of epinephrine O-methylation; commonly occurring, pharmacologically and physiologically inactive metabolite of epinephrine. HN(75) MHÑMetanephrine ANdo not use /biosyn /defic /physiol RN5001-33-2 PIEpinephrine (74); Methyl Ethers (74) MND2.92.311.461.400 DMÑEpinephrine LH LM  MSThe second phase of cell division, in which the chromosomes line up across the equatorial plane of the spindle prior to separation. OLsearch MITOSIS 1975-77 PM81; was see under CELL CYCLE 1978-80, was see MITOSIS 1975-77 HN81(78); was see under CELL CYCLE 1978-80, was see MITOSIS 1975-77 MHÑMetaphase AN2d phase of cell div; NIM specific cell when merely test cell; coord with specific cell /cytol; only /drug eff /rad eff; permitted with micro-organisms PICell Division (66-74); Mitosis (68-77) MNG4.335.135.220.225.580; G5.148.165.220.225.580; G7.553.135.220.225.580 LH  MHÑMetaphysics ANno qualif MNK1.752.511 LH  MSA condition in which there is a change of one adult cell type to another similar adult cell type. MHÑMetaplasia ANNIM; coord with organ /pathol (IM); as general pathol process: Manual 23.16 MNC23.739.589 FXÑMYELOID METAPLASIA LH LX  MSalpha-(1-Aminoethyl)-3-hydroxybenzenemethanol. Alpha and beta sympathomimetic vasopressor similar to, but longer acting than, norepinephrine; used in hypotensive states and in circulatory failure. Synonyms: Aramine; Icoral B; Metaril; Pressonex; Pressoral. MHÑMetaraminol ANdo not use /biosyn /defic /physiol RN54-49-9 MND2.33.329.624.706.500; D2.92.63.624.706.500; D16.893.116.182.789.500; D18.222.863.585; D18.793.499 XSIsophenylephrine; Metaradrin; m-Hydroxynorephedrine; meta-Hydroxynorephedrine LH LS; ; ;  MHÑMetastrongyloidea ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.588 XUÑAngiostrongylus LH LU  OLsearch TOE JOINT 1966-74 HN(75) MHÑMetatarsophalangeal Joint ANany Cat A qualif; primates only MNA2.835.583.899.536 DMÑToe Joint LH LM  MHÑMetatarsus ANnot restricted to primates MNA2.835.232.484.499 LH  MSThe atmospheric phenomena which pertain to climate and weather. OLto search METEOROLOGY use METEOROLOGICAL FACTORS back thru 1975 & WEATHER 1966-74 PM77; was METEOROLOGY see under WEATHER 1963-76 HN77; was METEOROLOGY see under WEATHER 1963-76 MHÑMeteorological Factors ANno qualif PIWeather (66-74) MNG3.230.300 LH  MSShort period following estrus during which the phenomena of estrus subside in those animals in which pseudopregnancy does not occur. Does not apply to humans. HN(75) MHÑMetestrus ANanimal only; qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /rad eff MNG8.520.780.218.320 DMÑEstrus LH LM  MHÑMetformin ANdo not use /biosyn /defic /physiol RN657-24-9 MND2.78.370.141.450; D9.482.586 XSDimethylguanylguanidine LH LS  OLuse METHACHOLINE COMPOUNDS to search MECHOLYL BROMIDE back thru 1966 HNMECHOLYL BROMIDE was see under METHACHOLINE COMPOUNDS 1963-76 MHÑMethacholine Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: METHACHOLINE CPDS MND2.92.102.534; D2.675.276.534; D16.698.628.499 LH  MSAcrylic acids or acrylates which are substituted in the C-2 position with a methyl group. HN(75) MHÑMethacrylates ANdo not use /analogs /biosyn /defic /physiol; POLYMETHACRYLIC ACIDS is available PIAcrylates (68-74) MND2.241.81.69.600 DMÑAcrylates LH LM  PM68 HN68(65) MHÑMethacycline ANdo not use /biosyn /defic /physiol RN914-00-1 MND20.85.868.486 LH  MHÑMethadone ANdo not use /biosyn /defic /physiol; with disease term, use /rehabil rather than /drug ther RN76-99-3 MND2.522.675; D14.757.537 XSAmidone; Phenadone XUÑMethadyl Acetate LH LS; LU  MS6-(Dimethylamino)-4,4-diphenyl-3-heptanol acetate (ester). Narcotic analgesic with a long onset and duration of action; used mainly in the treatment of narcotic addiction. HN(75) MHÑMethadyl Acetate ANdo not use /biosyn /defic /physiol RN509-74-0 PIAcetic Acids (73-74); Methadone (73-74) MND14.757.537.570 XSAcemethadone; Acetylmethadol; Alphacetylmethadol; Amidolacetate; Levamethadyl DMÑMethadone LH LS; ; ; ; LM  MS1-Methyl-6-(1-methylallyl)-2,5-dithiobiurea. A dithiobiurea compound with anti-gonadotropic activity. HN(75) MHÑMethallibure ANdo not use /biosyn /defic /physiol RN926-93-2 PIAllyl Compounds (73-74); Thiourea (73-74) MND2.886.904.425; D2.948.898.425; D6.347.450 DMÑThiourea LH LM  MHÑMethamphetamine ANdo not use /biosyn /defic /physiol; = N-methylamphetamine RN537-46-2 MND2.92.471.683.152.619; D15.128.82.585; D16.893.120.596; D26.128.127.585 XSDEOXYEPHEDRINE XUÑChlormethamphetamine LH LS LU  OLsearch ANABOLIC STEROIDS 1966-74 HN(75); was see under ANABOLIC STEROIDS 1964-74 MHÑMethandriol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN521-10-8 MND6.597.100.194.429; D4.808.54.79.429.154.600 XSMethylandrostenediol DMÑAndrostenediols LH LS LM  PM65 HN65(63) MHÑMethandrostenolone ANdo not use /biosyn /defic /physiol RN72-63-9 MND4.808.54.79.129.453; D6.597.100.194.464 XSDehydromethyltestosterone; Methandienone LH LS;  MHÑMethane ANdo not use /defic /physiol; /biosyn permitted if by living matter RN74-82-8 MND2.455.326.146.571 XUÑTetranitromethane LH LU  PM74 HN74 MHÑMethanesulfonates ANdo not use /analogs /biosyn /defic /physiol MND2.241.866.540.121.537; D2.455.326.146.92.537; D2.455.326.146.571.537; D2.886.610.121.537 XSMethylenesulfonates LH LS  MSAnaerobic organisms which obtain energy by formation of methane via reduction of carbon dioxide and oxidation of hydrogen or compounds such as formate or via fermentation of compounds such as acetate and methanol. PM79 HN79 MHÑMethanogens ANnote categ; do not use /blood-csf-urine PIBacteria (66-78); Methane (66-78) MNB3.585 XSMethagens; Methanobacteria LH LS;  MHÑMethantheline ANdo not use /biosyn /defic /physiol RN5818-17-7 MND2.92.102.540; D2.675.276.540; D16.653.591 XSDixamon Bromide LH LS  MS2-[(2-Dimethylaminoethyl)-2-thenylamino]-pyridin e. Histamine H1 blocker with sedative action used in allergies, also topically, and as hypnotic. Synonyms: Dormin, Histadyl; Insomin; Lullamine; Tenalin; Thionylan; Restryl. OLsearch HISTAMINE H1 RECEPTOR BLOCKADERS 1966-74 HN(75); was see under PYRIDINES 1975-78, was see under ANTIHISTAMINICS 1963-74 MHÑMethapyrilene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN91-80-5 MND2.92.782.258.368.500; D3.383.725.50.440; D23.654.432.601 XSThenylpyramine DMÑAminopyridines LH LS LM  PM68 HN68 MHÑMethaqualone ANdo not use /biosyn /defic /physiol; Quaalude & Revonal go here RN72-44-6 PIHypnotics and Sedatives (66-67); Tranquilizing Agents (66-67) MND3.438.786.535; D14.591.745.642 XSMetolquizolone; Ortonal LH LS;  MS5,5-Diethyl-1-methylbarbituric acid. Long acting barbiturate that is demethylated to barbital in the liver; has broad-spectrum anticonvulsant action, but used mainly to treat myoclonic spasms in infants. Synonyms: Gemonil; Sch 412. HN(76) MHÑMetharbital ANdo not use /biosyn /defic /physiol; /analogs NIM only RN50-11-3 PIBarbiturates (68-75) MND3.383.742.698.253.465; D14.261.164.463 XSEndiemal; Metharbitone; Methobarbitone DMÑBarbiturates LH LS; ; LM  HN(63); was see under CARBONIC ANHYDRASE INHIBITORS 1965-74 MHÑMethazolamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN554-57-4 MND3.383.871.867.537; D8.373.220.687; D19.770.224.266.687 DMÑThiadiazoles LH LM  MSA 1:1 molar complex of heme or hematin and albumin formed after the dissociation of methemoglobin into heme or hematin and globin in plasma. This complex, which imparts a coffee-brown color to plasma, occurs in hemolytic and hemorrhagic disorders. Its presence in plasma is used as a test to differentiate between hemorrhagic and edematous pancreatitis. HN(77) MHÑMethemalbumin ANdo not use /analogs /blood PIHeme (66-76); Hemeproteins (73-76); Serum Albumin (66-76) MND12.776.34.841.350; D12.776.124.727.350; D12.776.422.680 DMÑHemeproteins LH LM  MHÑMethemoglobin AN/blood = METHEMOGLOBINEMIA RN9008-37-1 MND12.776.124.400.599; D12.776.422.512.571 XSFerrihemoglobin LH LS  MSAn erythrocyte enzyme which catalyzes the reduction of methemoglobin (ferrihemoglobin) to hemoglobin (ferrohemoglobin). Deficiency produces the inherited disease familial methemoglobinemia. In the absence of methemoglobin, the enzyme can also reduce methylene blue. HN(75) MHÑMethemoglobin Reductase ANdo not use /analogs; /defic: consider also METHEMOGLOBINEMIA RNEC 1.6.- PILipoamide Dehydrogenase (72-73); Methemoglobin (74); NADH, NADPH Oxidoreductases (74) MND8.586.682.608.500 XSNADH Methemoglobin Reductase DMÑNadh, Nadph Oxidoreductases LH LS LM  MHÑMethemoglobinemia MNC15.378.619 LH  MHÑMethenamine ANdo not use /biosyn /defic /physiol RN100-97-0 MND2.92.782.500; D20.237.454 XSAminoform; Hexamethylenetetramine; Hexamine LH LS; ;  PM66 HN66 MHÑMethenolone ANdo not use /biosyn /defic /physiol RN153-00-4 MND4.808.54.79.429.824.537; D6.597.100.194.500 LH  MSD-8-beta-[(Carbobenzoxyamino)methyl]-1,6-dimethyl-10-alpha-ergoline. Serotonin antagonist; used also in migraine therapy. Synonyms: Lyserdol; Liserdol HN(75) MHÑMethergoline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN17692-51-2 PIErgolines (71-74) MND3.132.327.287.630; D3.549.439.630; D23.846.589 XSMetergoline DMÑErgolines LH LS LM  MHÑMethicillin ANdo not use /biosyn /defic /physiol RN61-32-5 MND20.85.99.739.606 XSPENICILLIN, DIMETHOXYPHENYL LH LS  OLsearch THYROID ANTAGONISTS 1966-67 PM73; was see under THYROID ANTAGONISTS 1963-72 HN73(68); was see under THYROID ANTAGONISTS 1963-72 MHÑMethimazole ANdo not use /biosyn /defic /physiol RN60-56-0 PIImidazoles (66-67); Thyroid Antagonists (66-67) MND2.886.489.600; D3.383.374.535; D6.347.789.412 XSMethymazol; Thimazol LH LS;  MS4-(Methylthio)-3,5-xylyl-N-methylcarbamate. Insecticide, molluscacide, acaricide. Synonym: Mesurol. HN(75) MHÑMethiocarb ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN2032-65-7 PICarbamates (69-74); Xylenes (73-74) MND5.723.491.408.585; D5.723.596.585 DMÑInsecticides, Carbamate LH LM  MHÑMethionine AN/biosyn /defic /physiol permitted RN7005-18-7 MND10.642.687; D12.125.142.557; D12.125.166.676 XUÑN-Formylmethionine LH LU  MSATP:L-methionine S-adenosyltransferase. Catalyzes the synthesis of S-adenosylmethionine from methionine and ATP. Formerly EC 2.4.2.13. HN(75) MHÑMethionine Adenosyltransferase ANdo not use /analogs RNEC 2.5.1.6 PIAdenosine Triphosphate (72-74); S-Adenosylmethionine (73-74); Methionine (72); Transferases (72-74) MND8.586.913.500 XSS-Adenosylmethionine Synthetase DMÑTransferases LH LS LM  PM73 HN73(64) MHÑMethionine Sulfoximine ANdo not use /biosyn /defic /physiol RN1982-67-8 MND12.125.166.676.620 LH  MSL-Methionine:tRNA-Met ligase (AMP-forming). Activates methionine with its specific transfer RNA. HN(75) MHÑMethionyl T RNA Synthetase ANdo not use /analogs RNEC 6.1.1.10 PIAmino Acyl T RNA Synthetases (72-74); Methionine (72-74) MND8.586.464.136.530 DMÑAmino Acyl T RNA Synthetases LH LM  MS8-Methylthio-10-(4-methyl-1-piperazinyl)-10,11-dihydrodibenzo-(b,f)thiepin. Serotonin receptor blocker in the central nervous system used as antipsychotic. HN(76) MHÑMethiothepin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN20229-30-5 PIDibenzothiepins (68-75); Piperazines (73-75); Sulfides (73-75) MND3.494.311.520; D15.236.872.331.529; D23.846.600 XSMetitepine DMÑDibenzothiepins LH LS LM  MS1-Methylindole-2,3-dione 3-(thiosemicarbazone). An antiviral agent effective against pox viruses. Synonym: Marboran. HN(75) MHÑMethisazone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1910-68-5 PIIndoles (69-74); Thiosemicarbazones (71-74) MND2.845.746.703.450; D2.886.803.450; D3.438.473.615; D20.388.700 DMÑThiosemicarbazones LH LM  MHÑMethocarbamol ANdo not use /biosyn /defic /physiol RN532-03-6 MND2.241.81.251.515; D2.355.601.536.400.500; D2.755.75.536.400.500; D17.426.533.537 XSGuaiphenesin Carbamate LH LS  HN(67) MHÑMethods ANno qualif; prefer /methods, with correct category but do not index /methods routinely: the method should be discussed substantively; never IM; policy: Manual 19.4.35, 19.4.39, 26.14.1-.2; with /instrum: Manual 26.6 MNE5.581; H1.770.370 DMÑScience LH LM  MHÑMethohexital ANdo not use /biosyn /defic /physiol RN18652-93-2 MND3.383.742.698.253.488; D14.166.111.488; D14.591.220.488 XSEnallynymalum; Methohexitone LH LS;  MSS-Methyl N-[methylcarbamoyl)oxy]thioacetimidate. Insecticide. Synonym: Lannate. HN(75) MHÑMethomyl ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN16752-77-5 PICarbamates (71-74); Imines (71-74); Sulfides (71-74) MND5.723.491.408.600 DMÑInsecticides, Carbamate LH LM  MHÑMethonium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: METHONIUM CPDS MND2.92.102.558; D2.675.276.558; D16.653.396.438; D17.688.538 LH  MSIsopropyl-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate. Juvenile hormone analog and insect growth regulator used to control insects by disrupting metamorphosis. Has been effective in controlling mosquito larvae. Synonyms: ZR-515; Altosid. HN(75) MHÑMethoprene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN40596-69-8 PIFatty Acids, Unsaturated (73-74); Juvenile Hormones (73-75); Methyl Ethers (74) MND2.241.81.436.490; D6.472.445.573.666.500 DMÑJuvenile Hormones LH LM  MHÑMethotrexate ANdo not use /biosyn /defic /physiol RN59-05-2 MND22.204.144.579.621; D26.87.393.587 XSAMETHOPTERIN LH LS  OLuse METHOTRIMEPRAZINE to search LEVOMEPROMAZINE back thru 1966 PM68; was LEVOMEPROMAZINE 1963-67 HN68; was LEVOMEPROMAZINE 1963-67 MHÑMethotrimeprazine ANdo not use /biosyn /defic /physiol RN60-99-1 MND3.494.741.513; D15.236.872.331.628.513 XSLEVOMEPROMAZINE; Levomeprazin LH LS;  MHÑMethoxamine ANdo not use /biosyn /defic /physiol; do not confuse with methoxyamine RN390-28-3 MND2.33.329.624.536; D2.92.63.624.536; D2.92.471.683.661; D16.893.116.182.475; D18.793.572 XSMethoxamedrin LH LS  MS9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one. A furocoumarin obtained from several different plants, especially Psoralea corylifolia; used to increase skin pigmentation with sunlight; may cause skin burns, liver damage. Synonyms: Meladinin; Meloxine; Methoxa-Dome; Oxsoralen. MHÑMethoxsalen AND25-26 qualif; do not index here for use in PUVA THERAPY unless particularly discussed RN298-81-7 MND3.438.150.446.750.480.500; D26.313.855.538; D26.368.878.538 XS8-Methoxypsoralen; Ammoidin; Xanthotoxin LH LS; ;  PM74 HN74(72) MHÑMethoxychlor ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN72-43-5 PIInsecticides (66-72) MND2.455.526.439.610; D5.723.491.491.651 XSDIANISYL TRICHLOROETHANE LH LS  MSPotent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains; possibly involved in the etiology of schizophrenia. OLuse METHOXYDIMETHYLTRYPTAMINES to search METHOXYDIMETHYLTRYPTAMINE back thru 1980 HN(84); was METHOXYDIMETHYLTRYPTAMINE see under SEROTONIN 1980-83 MHÑMethoxydimethyltryptamines AN/biosyn /physiol permitted; do not use /analogs PIBufotenin (66-74) /AA (75-79); Dimethyltryptamine (73-79); Serotonin (66-74) /AA (75-79); Tryptamines (66-73) MND3.438.473.914.237.150.500; D3.438.473.914.814.150.500; D15.236.372.317.592; D16.538.852.592 XSMethylbufotenin DMÑSerotonin LH LS LM  PM65 HN65(63) MHÑMethoxyflurane ANdo not use /biosyn /defic /physiol RN76-38-0 MND2.355.417.600; D2.355.601.620; D14.166.578 XSMethofluranum LH LS  MS1-(4-Hydroxy-3-methoxyphenyl)-1,2-ethanediol. Synthesized by animals from endogenous epinephrine and norepinephrine; found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover. Synonyms: 3-methoxy-4-hydroxyphenylethyleneglycol; 4-hydroxy-3-methoxyphenylglycol; Vanylglycol. OLuse METHOXYHYDROXYPHENYLGLYCOL to search METHOXYHYDROXYPHENYL GLYCOL back thru 1973 (as Prov 1973-74) HN(77); was METHOXYHYDROXYPHENYL GLYCOL see under GLYCOLS 1975-76, was METHOXYHYDROXYPHENYL GLYCOL 1973-74 (Prov) MHÑMethoxyhydroxyphenylglycol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN534-82-7 PIGlycols (66-74) MND2.33.618.454 XSHydroxymethoxyphenylglycol; MHPG; MOPEG DMÑGlycols LH LS; ; LM  OLsearch TRYPTAMINES 1966-74 HN(75) MHÑMethoxytryptamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN608-07-1 MND3.438.473.914.588 DMÑTryptamines LH LM  PM65 HN65(63) MHÑMethyclothiazide ANdo not use /biosyn /defic /physiol RN135-07-9 MND3.438.174.620; D18.162.276.572; D19.770.224.578.572 LH  MHÑMethyl Chloride ANdo not use /biosyn /defic /physiol; do not confuse with METHYLENE CHLORIDE RN74-87-3 MND2.455.526.439.632 LH  OLuse METHYL ETHERS to search METHYL ETHER back thru 1972 (as Prov 1972-73) PM74 HN74; was METHYL ETHER 1972-73 (Prov) MHÑMethyl Ethers ANdo not use /analogs /biosyn /defic /physiol PIEthers (66-71) MND2.355.601 XUÑBis(Chloromethyl) Ether; ÑChloromethyl Methyl Ether LH LU;  MS(4-(para(Dimethylamino)-alpha-(para(dimethylamino)phenyl) benzylidene)-2,5-cyclohexadien-1-ylidene)dimethylammonium chloride ethobromide. Used as a biological stain and for the dyeing and printing of textiles. Usually compounded with zinc chloride. HN(75) MHÑMethyl Green AND25-26 qualif; /analogs NIM only RN82-94-0 PIRosaniline Dyes (72-74) MND26.408.735.600 DMÑRosaniline Dyes LH LM  HN(72) MHÑMethyl Mercaptophos ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN8022-00-2 PIInsecticides (66-71) MND2.719.675; D5.723.491.657.688 DMÑInsecticides, Organothiophosphate LH LM  MSMethanesulfonic acid, methyl ester. Alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. PM80; was see under METHANESULFONATES 1975-79 HN80(75); was see under METHANESULFONATES 1975-79 MHÑMethyl Methanesulfonate ANdo not use /biosyn /defic /physiol RN66-27-3 PIAlkanes (66-73); Methane (66-73); Methanesulfonates (74); Sulfonic Acids (66-73) MND2.241.866.540.121.537.450; D2.455.326.146.92.537.450; D2.455.326.146.571.537.450; D2.886.610.121.537.450; D22.204.525 XSMesilate, Methyl; Methyl Mesilate; Methylmesylate; Methylmethane Sulfonate LH LS; ; ;  MS2-Hexanone. An industrial solvent which causes nervous system degeneration. Synonym: MBK. HN(77) MHÑMethyl N-Butyl Ketone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN591-78-6 PIHexanones (75-76); Ketones (66-76) MND2.522.520.500 XS2-Hexanone; Butylmethyl Ketone DMÑKetones LH LS; LM  MSO,O-Dimethyl O-p-nitrophenylphosphorothioate. The methyl homolog of parathion. An effective, but highly toxic organothiophosphate insecticide. HN(75) MHÑMethyl Parathion ANdo not use /biosyn /defic /physiol RN298-00-0 PIParathion (73-74) MND2.719.746.500; D5.723.491.657.763.500 XSMetaphos; Parathion Methyl DMÑParathion LH LS; LM  PM73 HN73(71) MHÑMethylamines ANdo not use /analogs /biosyn /defic /physiol PIAmines (66-70) MND2.92.668 LH  PM68 HN68 MHÑMethylation ANalmost never IM; no qualif; enzymatic methylation: coord NIM with METHYLTRANSFERASES (IM) + substrate (NIM) or specific methyltransferase (IM) MNH1.181.404.146.538 LH  MS(Methyl-ONN-azoxy)-methanol acetate. The aglycone of cycasin. Acts as a potent carcinogen and neurotoxic compound. Inhibits hepatic DNA, RNA and protein synthesis. HN(75) MHÑMethylazoxymethanol Acetate AND25-26 qualif; /analogs NIM only RN592-62-1 PIAlcohol, Methyl (73-74); Azo Compounds (73-74) MND2.172.80.400; D26.191.243.586 DMÑAzo Compounds LH LM  MSMethylester of cellulose. Used as suspending agent in cosmetics, pharmaceutics and the chemical industry; therapeutically as bulk laxative. Synonyms: Cellumeth; Cologel; Hydrolose; Nicel; Tearisol. MHÑMethylcellulose ANdo not use /biosyn /defic /physiol RN9004-67-5 MND9.203.698.365.180.663; D19.316.396.618 XUÑCarboxymethylcellulose LH LU  MHÑMethylcholanthrene ANNIM; do not use /biosyn /defic /physiol; in exper cancer studies usually no qualif RN56-49-5 MND26.191.579 LH  MSN,N-Dimethyl-p-(m-tolylazo)aniline. Very potent liver carcinogen. Synonyms: MDAB; MeDAB; 3-methyl-DAB; 3'-methyl-4-dimethylaminoazobenzene. HN(75) MHÑMethyldimethylaminoazobenzene AND25-26 qualif RN55-80-1 PIDimethylaminoazobenzene (72-74); Methane (73-74) MND26.191.282.588 XSMeDAB DMÑDimethylaminoazobenzene LH LS LM  MS3-Hydroxy-alpha-methyl-L-tyrosine. Inhibitor of dopa decarboxylase; used to treat hypertension; may cause psychic disturbances, parasympathomimetic effects, and hepato-, nephro- and hemotoxicity. Synonyms: Aldoclor; Aldomet; Aldoril; Dopamet; Hydromet; Medomet; Methoplain; MK 351; Presinol. PM65 HN65(63) MHÑMethyldopa ANdo not use /biosyn /defic /physiol RN555-30-6 MND2.92.311.242.538; D12.125.72.573.400.600; D16.848.415.572; D18.162.558 XSAlphamethyldopa; Methyldopate LH LS;  MHÑMethylene Blue AND25-26 qualif RN61-73-4 MND3.494.741.517; D20.237.510; D26.408.537 XSMethylthionine Chloride; Swiss Blue LH LS;  MSHas been used as an inhalation anesthetic, A narcotic in high concentrations. Solvent for cellulose acetate. Synonym: Solaesthin. HN(75) MHÑMethylene Chloride ANdo not confuse with METHYL CHLORIDE; do not use /biosyn /defic /physiol; /analogs NIM only RN75-09-2 PIHydrocarbons, Chlorinated (74); Methane (74) MND2.455.526.439.642 XSDichloromethane; Methylene Bichloride; Methylene Dichloride DMÑHydrocarbons, Chlorinated LH LS; ; LM  MS4,4'-Methylene-bis(2-chloroaniline). Aromatic diamine used in the plastics industry as curing agent for epoxy resins and urethane rubbers; it causes bladder, liver, lung and other neoplasms. Synonyms: CLMDA; Quodorole; MOCA. HN(77) MHÑMethylenebis(chloroaniline) ANdo not use /biosyn /defic /physiol; /analogs NIM only RN101-14-4 PIAniline Compounds (74-76); Benzhydryl Compounds (75-76); Hydrocarbons, Chlorinated (74) MND2.92.146.500; D2.455.426.559.389.115.500; D26.191.588 XSMethylene Bis(chloroaniline) DMÑBenzhydryl Compounds LH LS LM  MS5,10-Methylenetetrahydrofolate:NADP+ oxidoreductase. Catalyzes the oxidation of methylenetetrahydrofolate to 5,10-methenyltetrahydrofolate. HN(75) MHÑMethylenetetrahydrofolate Dehydrogenase ANdo not use /analogs RNEC 1.5.1.15 PIOxidoreductases (73-74); Tetrahydrofolates (73-74) MND8.586.682.545 DMÑOxidoreductases LH LM  OLto search METHYLERGONOVINE DERIVATIVES use METHYLERGONOVINE /AA back thru 1975 & ERGOLINES 1969-74 PMMETHYLERGONOVINE DERIVATIVES was see under METHYLERGONOVINE 1975-77, was see under ERGOLINES 1969-74 HNMETHYLERGONOVINE DERIVATIVES was see under METHYLERGONOVINE 1975-77, was see under ERGOLINES 1969-74 MHÑMethylergonovine ANdo not use /biosyn /defic /physiol; methylergonovine derivatives = METHYLERGONOVINE /analogs RN113-42-8 MND3.132.327.287.262.455; D3.549.439.262.538 XSMethylergobasin; Methylergometrin LH LS;  OLsearch METHYLGLYCOSIDES 1974 HN(75) MHÑMethylgalactosides ANdo not use /analogs /biosyn /defic /physiol MND9.203.408.514.455; D9.203.408.320.500 XSMethylgalactopyranosides; Methylgalactose DMÑMethylglycosides LH LS; LM  OLsearch METHYLGLYCOSIDES 1974 HN(75) MHÑMethylglucosides ANdo not use /analogs /biosyn /defic /physiol MND9.203.408.514.622; D9.203.408.348.500 XSMethylglucopyranosides DMÑMethylglycosides LH LS LM  OLsearch GLYCINE 1966-74 HN(75) MHÑMethylglycine MND12.125.481.622 DMÑGlycine LH LM  PM74 HN74 MHÑMethylglycosides ANdo not use /analogs /biosyn /defic /physiol MND9.203.408.514 XUÑMethylgalactosides; ÑMethylglucosides; ÑMethylmannosides LH LU; ;  MSA product of putrefaction. Poisonous. HN(75) MHÑMethylguanidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN471-29-4 PIGuanidines (69-74) MND2.78.370.570 DMÑGuanidines LH LM  MSHistamine substituted in any position with one or more methyl groups; many of these are agonists for the H1 or H2, or both histamine receptors. PM77 HN77 MHÑMethylhistamines ANdo not use /analogs /biosyn /defic /physiol PIHistamine (70-76) MND2.92.471.440.500; D3.383.374.373.500; D24.185.798.300.581 LH  MSHistidine substituted in any position with one or more methyl groups OLuse METHYLHISTIDINES to search METHYLHISTIDINE back thru 1972 (as Prov 1972-74) HN(81); was METHYLHISTIDINE see under HISTIDINE 1975-80, was METHYLHISTIDINE 1972-74 (Prov) MHÑMethylhistidines ANdo not use /analogs /biosyn /defic /physiol PIHistidine (66-71) MND12.125.72.329.539 DMÑHistidine LH LM  MSHydrazines substituted by one or more methyl groups in any position. OLto search METHYLHYDRAZINE use METHYLHYDRAZINES back thru 1975 & HYDRAZINES 1967-74 PM78; was METHYLHYDRAZINE see under HYDRAZINES 1967-77; DIMETHYLHYDRAZINES was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77; MONOMETHYLHYDRAZINE was METHYLHYDRAZINE see under HYDRAZINES 1966-77 HN78; was METHYLHYDRAZINE see under HYDRAZINES 1967-77 MHÑMethylhydrazines ANdo not use /analogs /biosyn /defic /physiol PIHydrazines (66-74) MND2.442.600 XUÑDimethylhydrazines; ÑMonomethylhydrazine LH LU;  MSMethylpropanedioic acid. A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. HN(75) MHÑMethylmalonic Acid AN/biosyn /physiol permitted; /analogs NIM only RN516-05-2 PIMalonates (74) MND2.241.81.337.540.500 DMÑMalonates LH LM  MSCatalyzes the conversion of methylmalonyl-CoA to succinyl-CoA. Requires a cobamide coenzyme. A block in this enzymatic conversion leads to the metabolic disease, methylmalonic aciduria. HN(75) MHÑMethylmalonyl CoA Mutase ANdo not use /analogs; /defic: consider also METHYLMALONIC ACID /urine (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 5.4.99.2 PIIsomerases (69-74); Malonates (69-74) MND8.586.399.565 XSMethylmalonyl CoA Isomerase DMÑIsomerases LH LS LM  MSMannosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with methyl alcohol. Include both alpha- and beta-methylmannosides. HN(75) MHÑMethylmannosides ANdo not use /analogs /biosyn /defic /physiol PIMethylglycosides (74); Mannose (74) MND9.203.408.490.500; D9.203.408.514.700 XSMethylmannopyranosides DMÑMethylglycosides LH LS LM  OLuse METHYLMERCURY COMPOUNDS to search METHYL MERCURY COMPOUNDS back thru 1972 (as Prov 1972-73) PM80; was METHYL MERCURY COMPOUNDS 1974-79 HN80; was METHYL MERCURY COMPOUNDS 1972-79 (Prov 1972-73) MHÑMethylmercury Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: METHYLMERCURY CPDS PIAntifungal Agents (66-71); Mercury (66-71); Mercury Poisoning (66-71); Organometallic Compounds (68-71) MND2.691.750.100.738; D5.723.288.50.601 XSMethyl Mercury Compounds LH LS  MSMethyl-2-methyl-2-propenoate and polymer. The methyl ester of methacrylic acid that polymerizes easily and is used as a tissue cement, dental material, absorbent for biological substances, and as copolymer in plastics. OLto search METHYLMETHACRYLATE use METHYLMETHACRYLATES back thru 1972 (as Prov 1972) & ACRYLIC RESINS 1966-71 PM83; was METHYLMETHACRYLATE 1973-82, was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72 HN83; was METHYLMETHACRYLATE 1972-82 (Prov 1972), was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72 MHÑMethylmethacrylates AND25-26 qualif; includes polymeric form: note X ref PIAcrylic Resins (66-71) MND2.241.81.69.800.550; D25.720.716.822.111.650.605 XSPolymethylmethacrylate LH LS  MS1-Methyl-3-nitro-1-nitrosoguanidine. A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties. PM77; was see under NITROSOGUANIDINES 1975-76 HN77(75); was see under NITROSOGUANIDINES 1975-76 MHÑMethylnitronitrosoguanidine ANdo not use /biosyn /defic /physiol; DF: MNNG RN70-25-7 PINitro Compounds (73-74); Nitrosoguanidines (73-74) MND2.78.370.649.400; D2.654.567.400; D26.191.598 XSMethylnitrosonitroguanidine; Nitrosomethylnitroguanidine; Nitrosonitromethylguanidine LH LS; ;  MS1-Methyl-1-nitrosourea. A nitrosourea compound with alkylating, carcinogenic and mutagenic properties. PM86; was see under NITROSOUREA COMPOUNDS 1975-85 HN86(75); was see under NITROSOUREA COMPOUNDS 1975-85 MHÑMethylnitrosourea AND25-26 qualif RN684-93-5 PIMethane (73-74); Nitrosourea Compounds (73-74) MND2.654.692.480; D2.948.594.490; D26.191.612 XSNitrosomethylurea LH LS  OLsearch NORMETANEPHRINE 1966-74 HN(75); was see under NORMETANEPHRINE 1971-74, was see NORMETANEPHRINE 1966-70 MHÑMethylnorepinephrine ANdo not use /defic MND2.92.311.461.484.400 DMÑNorepinephrine LH LM  MSGram-negative bacteria utilizing only one-carbon organic compounds. OLuse METHYLOMONADACEAE to search METHANOMONADACEAE back thru 1975 PM76; was METHANOMONADACEAE 1975 HN76; was METHANOMONADACEAE 1975 MHÑMethylomonadaceae ANin soil & water PIBacteria (66-74) MNB3.400.500 XSMethane-Oxidizing Bacteria; Methanomonadaceae LH LS;  MS5-Methylphenazinium methosulfate. Used as an electron carrier in place of the flavine enzyme of Warburg in the hexosemonophosphate system and also in the preparation of succinic dehydrogenase. HN(75) MHÑMethylphenazonium Methosulfate AND25-26 qualif; /analogs NIM only RN299-11-6 PIPhenazines (70-74); Sulfuric Acids (72-74) MND3.494.704.550 XSPhenazine Methosulfate DMÑPhenazines LH LS LM  MHÑMethylphenidate ANdo not use /biosyn /defic /physiol; Ritalin goes here RN113-45-1 MND2.241.223.601.600; D3.383.621.460; D15.128.564 XSPhenidylate LH LS  MHÑMethylprednisolone ANdo not use /biosyn /defic /physiol RN83-43-2 MND4.808.745.432.769.795.539; D6.597.481.561.353.744.622; D6.597.481.561.478.702.622; D26.74.125.744.622 XUÑMethylprednisolone Succinate LH LU  MS11-beta,17-alpha,21-Trihydroxy-6-alpha-methyl- 1,4-pregnadiene-3,20-dione 21-succinate sodium salt. Water soluble salt of 6-alpha-methylprednisolone; a fast acting glucocorticoid used for cardiac, allergic and hypoxic emergencies. Synonyms: SoluMedrol; Urbason-Soluble; 6-alpha-methylprednisolone sodium hemisuccinate. HN(80) MHÑMethylprednisolone Succinate ANdo not use /biosyn /defic /physiol RN2375-03-3 PIMethylprednisolone (66-74) /AA (75-79); Succinates (66-79) MND4.808.745.432.769.795.550; D6.597.481.561.353.744.635; D6.597.481.561.478.702.635; D26.74.125.744.622.850 DMÑMethylprednisolone LH LM  MHÑMethyltestosterone ANdo not use /biosyn /defic /physiol RN58-18-4 MND4.808.54.79.429.824.664; D6.597.100.622 XUÑCalusterone LH LU  MS6-(Methylthio)-9-beta-D-ribofuranosylpurine. An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position. HN(75) MHÑMethylthioinosine ANdo not use /biosyn /defic /physiol RN342-69-8 PIInosine (72-74); Sulfides (72-74) MND13.570.583.616.900.500; D13.570.800.573.900.500; D13.570.900.800.500 XS6-Methylmercaptopurine Riboside DMÑInosine LH LS LM  MHÑMethylthiouracil ANdo not use /biosyn /defic /physiol RN56-04-2 MND3.383.742.698.875.842.455; D6.347.789.476 LH  PM72 HN72(71) MHÑMethyltransferases ANdo not use /analogs RNEC 2.1.1. PITransferases (66-70) MND8.586.913.517 XUÑAcetylserotonin Methyltransferase; ÑHistamine Methyltransferase; ÑTetrahydropteroylglutamate Methyltransferase LH LU; ;  OLuse METHYLTYROSINES to search METHYLTYROSINE back thru 1966 (as Prov 1966-67) PM68 HN68; was METHYLTYROSINE 1965-67 (Prov) MHÑMethyltyrosines ANdo not use /analogs MND12.125.72.917.664 LH  MSUrea compounds which are substituted with one or more methyl groups. PM75 HN75 MHÑMethylurea Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: METHYLUREA CPDS PIUrea (66-74) MND2.948.511 LH  OLsearch HYPNOTICS AND SEDATIVES 1966-71 PM73; was see under HYPNOTICS AND SEDATIVES 1963-72 HN73(72); was see under HYPNOTICS AND SEDATIVES 1963-72 MHÑMethyprylon ANdo not use /biosyn /defic /physiol RN125-64-4 PIHypnotics and Sedatives (66-71) MND3.383.621.808.622; D14.591.745.679 LH  MSN-[1-(Hydroxymethyl)propyl]-1-methyl-D-lysergamide. LSD congener ergot derivative; it antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids; used as prophylactic in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome; used as a maleate. Synonyms: Deseril; Desernil; Deserril; Sansert; UML 491. OLto search METHYSERGIDE DERIVATIVES use METHYSERGIDE /AA back thru 1975 & ERGOLINES 1969-74 PM65; METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77, was see under ERGOLINES 1969-74 HN65(63); METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77, was see under ERGOLINES 1969-74 MHÑMethysergide ANdo not use /biosyn /defic /physiol; methysergide derivatives = METHYSERGIDE /analogs RN361-37-5 MND3.132.327.287.689; D3.549.439.689; D23.846.611 XSDimethylergometrin; Methylmethylergonovine LH LS;  MS1-Methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]-ethyl]-2-thourea. A histamine H(2) receptor agonist which is an analog of burimamide. It specifically blocks the stimulating effect of histamine in areas not affected by H(1) receptor agonists. Synonym: SKF 92058. HN(75) MHÑMetiamide ANdo not use /biosyn /defic /physiol RN34839-70-8 PIImidazoles (74); Sulfides (74); Thiourea (74) MND2.886.904.455; D2.948.898.455; D19.316.203.591; D23.654.443.591 DMÑThiourea LH LM  MSMyoglobin which is in the oxidized ferric or hemin form. The oxidation causes a change in color from red to brown. HN(79) MHÑMetmyoglobin AN/biosyn /physiol permitted; /analogs NIM only; /urine = METMYOGLOBIN /urine (IM) + MYOGLOBINURIA (IM) RN12772-23-5 PIFerric Compounds (75-78); Hemeproteins (73-78); Myoglobin (66-78) MND12.776.422.690 XSFerrimyoglobin DMÑHemeproteins LH LS LM  PM74 HN74 MHÑMetoclopramide ANdo not use /biosyn /defic /physiol RN364-62-5 MND2.65.277.573; D2.241.223.106.162.573; D23.136.589 LH  MS7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazoline sulfonamide. A potent, long acting diuretic useful in chronic renal disease; also tends to lower blood pressure and increase potassium loss. Synonyms: SR 720-22; Zaroxolyn. HN(75) MHÑMetolazone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN17560-51-9 PIDiuretics, Sulfamyl (74); Quinazolines (71-74) MND2.65.884.600; D2.886.590.700.600; D3.438.786.560; D19.770.224.516.630 DMÑDiuretics, Sulfamyl LH LM  MS1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid, methyl ester. A hypnotic and sedative which may also function as an anesthetic. Synonyms: Hypnodil; R 7315. HN(75) MHÑMetomidate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5377-20-8 PIBenzyl Compounds (72-74); Carboxylic Acids (72-74); Imidazoles (72-74) MND3.383.374.543; D14.591.745.700 XSMethoximol DMÑImidazoles LH LS LM  MS1-Isopropylamino-3-[4-(2-methoxyethyl)-phenoxy]-2-propanol. Adrenergic beta-1 blocking agent with no stimulatory action; it is less bound to plasma albumin than alprenolol; may be useful in angina pectoris, hypertension or cardiac arrhythmias. PM84; was see under PROPANOLAMINES 1977-83 HN84(77); was see under PROPANOLAMINES 1977-83 MHÑMetoprolol ANdo not use /biosyn /defic /physiol RN37350-58-6 PIPhenyl Ethers (75); Propanolamines (74-76); Propylamines (74-76) MND2.33.329.624.550; D2.92.63.624.550; D16.848.215.469 XSH 93-26 LH LS  MSCollection of granular epithelial cells in the uterine muscle beneath the placenta that develop during pregnancy in certain species of animals. PM75 HN75 MHÑMetrial Gland ANfemale; animal only PIUterus (66-74) MNA13.600 LH  PM74 HN74 MHÑMetric System ANonly /class /hist /instrum /stand MNH1.939.539 LH  MSN-[2,4,6-Triiodo-(3-N-methylacetamido)-5-(acetamido-benzoyl)]glucosamine. New solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. Is also being used as a resorbable, non-ionic contrast mediium. PM78; was see under IODOBENZOATES 1975-77 HN78(75); was see under IODOBENZOATES 1975-77 MHÑMetrizamide ANdo not use /biosyn /defic /physiol RN31112-62-6 PIAcetamides (71-77); Benzamides (73-77); Glucosamine (66-77); Iodobenzoates (72-77) MND2.241.223.106.530.718.470; D9.203.408.51.545; D26.298.686 LH  MS3-Acetamido-2,4,6-triiodo-5-(N-methylacetamido)benzoate. Usually the sodium salt. Contrast medium suitable for angiography. Synonyms: Isopaque; NSC 107431; Ronpacon [a mixture of the calcium, sodium, and magnesium salts]; Triosil. HN(75) MHÑMetrizoate AND25-26 qualif; /analogs NIM only RN1949-45-7 PIDiatrizoate (72-74); Salts (72-74) MND2.241.223.106.530.718.480; D26.298.695 DMÑIodobenzoates LH LM  MS2-Methyl-5-nitroimidazole-1-ethanol. Antiprotozoal used in amebiasis, trichomoniasis, giardiasis and as treponemacide in livestock; also proposed as radiation sensitizer for hypoxic cells. Synonyms: Bayer 5630; Clont; Danizol; Flagyl; Gineflavin; Trichazol; Trivazol; Vagilen. PM65 HN65(64) MHÑMetronidazole ANdo not use /biosyn /defic /physiol RN443-48-1 MND2.640.672.500; D3.383.374.658.500; D21.370.370.664; D26.776.500 LH  MHÑMetrorrhagia MNC13.371.852.691.622; C23.542.946.664 LH  PM66 HN66(64) MHÑMetyrapone ANusually /diag use; do not use /defic /physiol RN54-36-4 MND3.383.725.463 XSMETHOPYRAPONE; Methbipyranone LH LS;  MHÑMevalonic Acid ANdo not use /defic /physiol RN150-97-0 MND2.241.511.579 LH  HN(73) MHÑMevinphos ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN7786-34-7 MND2.705.434; D5.723.491.574.456 DMÑInsecticides, Organophosphate LH LM  MHÑMexico ANpart of No. Amer., not So. Amer. nor Cent. Amer.; Indians of Mexico are indexed under MEXICO + INDIANS, NORTH AMERICAN: do not confuse with INDIANS, CENTRAL AMERICAN; for MEXICAN AMERICANS (see HISPANIC AMERICANS) coord MEXICO /ethnol (NIM) with HISPANIC AMERICANS (IM) MNZ1.107.567.589 LH  MS1-(2,6-Dimethylphenoxy)-2-propanamine. Antiarrhythmic agent pharmacologically similar to lignocaine; may have some anticonvulsant properties. PM87; was see under PROPYLAMINES 1975-86 HN87(75); was see under PROPYLAMINES 1975-86 MHÑMexiletine ANdo not use /biosyn /defic /physiol RN31828-71-4 PIPhenyl Ethers (74); Propylamines (72-74) MND2.92.831.500; D18.97.520 XSKO 1173 LH LS  MS3,3-Dimethyl-6-[[(((3-(methylsulfonyl)-2-oxo-1- imidazolidinyl)carbonyl)amino)-phenylacetyl]amino]- 7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid. Semisynthetic ampicillin-derived acylureidopenicillin; proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections. Synonym: Multocillin. PM84 HN84 MHÑMezlocillin ANdo not use /biosyn /defic /physiol RN51481-65-3 PIPenicillins (66-83) MND20.85.99.739.762.57.585 LH  MS1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]-pyrazino [1,2-a]azepine monohydrochloride. Proposed antidepressant, serotonin inhibitor with antihistaminic properties. Synonym: Org GB 94. PM87; was see under DIBENZAZEPINES 1975-86 HN87(75); was see under DIBENZAZEPINES 1975-86 MHÑMianserin ANdo not use /biosyn /defic /physiol RN24219-97-4 PIDibenzazepines (72-74); Pyrazines (72-74) MND3.494.240.550; D15.236.122.140.619; D23.846.622 LH  MSThe common name for the species Mus musculus. MHÑMice AN= MUS MUSCULUS only: for other species note MUS see MURIDAE; check tag: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.649.865.635.500 XSMice, House; Mice, Laboratory; Mus musculus LH LS; ;  PM74 HN74(72) MHÑMice, Inbred A ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.300 LH  PM74 HN74(72) MHÑMice, Inbred AKR ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.318 LH  PM74 HN74(72) MHÑMice, Inbred BALB C ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.338 LH  PM74 HN74(72) MHÑMice, Inbred CBA ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.440 LH  PM74 HN74(72) MHÑMice, Inbred C3H ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.388 LH  PM74 HN74(72) MHÑMice, Inbred C57BL ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.420 LH  PM74 HN74(72) MHÑMice, Inbred DBA ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.460 LH  MSHomozygous permanently near-hairless mice which lose their hair at about 10 days of age. OLto search HAIRLESS MICE use MICE, INBRED HRS back thru 1982 & MICE, NUDE 1975-81 PM82; HAIRLESS MICE was see MICE, NUDE 1975-81 HN82; HAIRLESS MICE was see MICE, NUDE 1975-81 MHÑMice, Inbred HRS ANusually NIM; no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not confuse X ref MICE, HAIRLESS with MICE, NUDE; do not forget also to check tag MICE MNB2.649.865.635.500.380.480 XSHairless Mice; Mice, Hairless LH LS;  PM74 HN74(72) MHÑMice, Inbred ICR ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; ICRC mice go here; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.510 LH  PM74 HN74(72) MHÑMice, Inbred NZB ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-71) MNB2.649.865.635.500.380.580 LH  MSGenetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. PM72 HN72 MHÑMice, Inbred Strains ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE; Manual 18.6.14 PIMice (66-71) MNB2.649.865.635.500.380 FXÑInbreeding LH LX  MSMyelin-deficient mutants which are from the inbred Tabby-Jimpy strain. HN(79) MHÑMice, Jimpy ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice, Inbred Strains (72-78) MNB2.649.865.635.500.440.430 DMÑMice, Neurologic Mutants LH LM  MSMice bearing mutant genes which are phenotypically expressed in the animals. PM79 HN79 MHÑMice, Mutant Strains ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE MNB2.649.865.635.500.440 LH  MSMice which carry mutant genes for neurologic defects or abnormlities. PM79 HN79 MHÑMice, Neurologic Mutants ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE; MICE, JIMPY & MICE, QUAKING, both neurol mutants, are available PIMice, Inbred Strains (72-78) MNB2.649.865.635.500.440.480 XSLurcher Mice; Nervous Mice; Reeler Mice; Staggerer Mice; Weaver Mice XUÑMice, Jimpy LH LS; ; ; ; LU  MSMutant mice homozygous for the recessive gene ╥nude╙ which fail to develop a thymus; useful in tumor studies and studies on immune responses. PM75 HN75 MHÑMice, Nude ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not confuse with MICE, HAIRLESS see MICE, INBRED HRS; do not forget also to check tag MICE; these are athymic mice PIMice (66-74) MNB2.649.865.635.500.440.500 XSNude Mice LH LS  MSIn a homozygous state these mutant mice exhibit marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility; may be inbred or hybrid. PM75 HN75 MHÑMice, Obese ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE; hyperglycemic mice go here & do not add HYPERGLYCEMIA or OBESITY unless particularly discussed as diseases PIMice (66-74) MNB2.649.865.635.500.440.530 XSObese Mice LH LS  MSMice homozygous for the mutant autosomal recessive gene, quaking (qk), associated with disorder in myelin formation and manifested by axial tremors. PM78 HN78 MHÑMice, Quaking ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag MICE PIMice (66-77); Mutation (66-77) MNB2.649.865.635.500.440.560 LH  MSElectrically charged colloidal particles or ions consisting of oriented molecules; aggregates of a number of molecules held loosely together by secondary bonds. HN(75) MHÑMicelles ANno qualif PIColloids (68-74) MNH1.181.529.183.500 DMÑColloids LH LM  MHÑMichigan MNZ1.107.567.875.502 LH  MS1-[2,4-Dichloro-beta-[(2,4-dichlorobenzyl)oxy]phenethyl]imidazole monitrate. An antifungal agent. Synonym: R 14,889. PM84; was see under IMIDAZOLES 1975-83 HN84(75); was see under IMIDAZOLES 1975-83 MHÑMiconazole ANdo not use /biosyn /defic /physiol RN22916-47-8 PIBenzyl Compounds (72-74); Ethers (71-74); Imidazoles (71-74) MND3.383.374.550; D20.136.580 LH  MSAny tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms. PM70 HN70 MHÑMicrobial Sensitivity Tests ANIM when general; NIM when with specific drug (IM) & specific micro-organisms (virus, bacterium, protozoan & fungus) (IM); only /instrum /methods /stand PIAntibiotics (66-69); Drug Resistance, Microbial (66-69) MNE5.909.560.150.630 XSBACTERIAL SENSITIVITY TESTS; Drug Sensitivity Assay, Microbial FXÑDrug Resistance, Microbial LH LS; LX  MH*Microbiologic Phenomena (Non Mesh) MNG4.185.515 LH  MSTechnics used in microbiology. PM78 HN78 MHÑMicrobiological Technics ANGEN or unspecified; bacteriologic technics = BACTERIOLOGICAL TECHNICS; virologic technics = VIROLOGY /methods; mycologic technics = MYCOLOGY /methods; parasitologic technics = PARASITOLOGY /methods; do not use /methods /util (except by MeSH definition) CATALOG: do not use /laboratory manuals PIMicrobiology (66-77); Mycology (66-77); Parasitology (66-77) MNE5.909.560 LH  MHÑMicrobiology ANSPEC only; SPEC qualif; prefer /microbiol with specific organ, higher animal & disease: Manual 19.5+; Microbiol includes protozoa but nothing higher; consider also AIR MICROBIOLOGY, FOOD MICROBIOLOGY, SOIL MICROBIOLOGY, WATER MICROBIOLOGY with specific organism; presence of microbes in the blood = /microbiol, not /blood; /methods = MICROBIOLOGICAL TECHNICS MNG1.273.540 FXÑBacteria; ÑFUNGI; ÑPROTOZOA; ÑVIRUSES LH LX; ; ;  MSMembrane-bound cytoplasmic particles containing enzymes and other substances. PM84; was see under ORGANOIDS 1975-83 HN84(73); was see under ORGANOIDS 1975-83 MHÑMicrobodies ANA 11 qualif except /cytol PIOrganoids (66-72) MNA11.368.702.515 XSPeroxisomes LH LS  MHÑMicrocephaly ANdo not use /congen MNC16.131.621.620 LH  MHÑMicrochemistry ANNIM; only /educ /instrum /methods MNE5.196.620; H1.181.278.638 LH  MSThe vascular network lying between the arterioles and venules; includes capillaries, metarterioles and arteriovenous anastomoses. Also, the flow of blood through this network. PM72 HN72(70) MHÑMicrocirculation ANIM GEN only; NIM as coord with specific organ /blood supply; Cat A qualif only; not for lymphatic microcirc ( = LYMPHATIC SYSTEM /physiol); Manual 21.5 PIBlood Circulation (66-69); Capillaries (66-69) MNA7.231.432; G9.330.163.645 LH  MSThe climate of a very small area. HN(75) MHÑMicroclimate ANno qualif; refers to climate in a limited geog or environ area, as in a forest or factory MNG3.230.300.100.250.450 DMÑClimate LH LM  MSA family of bacteria ranging from free living and saprophytic to parasitic and pathogenic forms. PM75 HN75 MHÑMicrococcaceae PIBacteria (66-74) MNB3.525.645 LH  PM73 HN73(65) MHÑMicrococcal Nuclease ANdo not use /analogs; DF: STAPH NUCLEASE RNEC 3.1.31.1 MND8.586.277.352.630.553.574 XSStaphylococcal Nuclease LH LS  MSA genus of spherical Gram-positive organisms found in soils and fresh water, and frequently on the skin of man and other animals. OLuse MICROCOCCUS & STREPTOCOCCACEAE to search GAFFKYA (all species) 1966-78 PMGAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75 HNGAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75 MHÑMicrococcus ANdo not use /blood-csf-urine MNB3.525.645.456 XSGaffkya Anaerobia; Gaffkya Tetragena LH LS;  MSSmall computers using LSI (large-scale integration) microprocessor chips as the CPU (central processing unit) and semiconductor memories for compact, inexpensive storage of program instructions and data. They are smaller and less expensive than minicomputers and are usually built into a dedicated system where they are optimized for a particular application. ╥Microprocessor╙ may refer to just the CPU or the entire microcomputer. HN(80) MHÑMicrocomputers ANonly /class /econ /hist /stand /supply; do not confuse with MINICOMPUTERS; personal computers go here PIComputers (66-79) MNL1.700.568.80.260.550 XSMicroprocessors DMÑComputers LH LS LM  PM73 HN73(71) MHÑMicroelectrodes ANNIM; only /stand /vet PIElectrodes (68-70) MNE7.296.623 XSELECTRODES, MINIATURIZED LH LS  PM85 HN85 MHÑMicrofilament Proteins AN/biosyn /physiol permitted; do not use /analogs MND12.776.220.525 XSActin-Binding Proteins LH LS  MSThe smallest of the cytoskeletal filaments. They are composed chiefly of actin and/or myosin. OLsearch CYTOSKELETON 1977-85 HN(86); was see CYTOPLASMIC FILAMENTS 1980-85, was see under CYTOPLASM 1977-79 MHÑMicrofilaments ANA 11 qualif except /cytol PICytoplasm (66-76); Cytoskeleton (77-85) MNA11.368.250.510 XSMyofilaments DMÑCytoskeleton LH LS LM  MSThe prelarval stage of Filarioidea in the blood and other tissues of mammals and birds; they are removed from these hosts by blood-sucking insects in which they metamorphose into mature larvae. OLsearch FILARIOIDEA 1966-74 HN(75) MHÑMicrofilaria ANdo not use /blood-csf-urine; check text: microfilaria as larval stage of a Filarioidea species or Microfilaria, loosely a genus; if larval, coord NIM with specific species (IM) MNB1.500.294.530.452; B1.583.382.470 DMÑFilarioidea LH LM  MHÑMicrofilming ANonly /econ /hist /instrum /legis /methods /stand /trends /util (if by MeSH definition) MNL1.240.630 FXÑPhotography LH LX  PM66 HN66(64) MHÑMicrognathism ANdo not use /congen MNC16.131.621.514.457 LH  PM73 HN73 MHÑMicroinjections ANdo not use /util except by MeSH definition PIInjections (66-72) MNE5.300.530.690 LH  PM73 HN73(64) MHÑMicromanipulation ANonly /instrum /methods MNE5.595.346 LH  MHÑMicromonospora ANin soil MNB3.100.67.500.457 LH  MSA family of Gram-positive saprophytic bacteria occurring in soil and aquatic environments. PM76 HN76 MHÑMicromonosporaceae ANin soil & water PIBacteria (66-74); Streptomycetaceae (75) MNB3.100.67.500 LH  HN68 MHÑMicronesia ANincludes the Carolines, Gilberts, Marianas (includes GUAM), Marshalls, Nauru & Paulau MNZ1.782.680 XSMariana Islands; Marshall Islands LH LS;  PM67 HN67(64) MHÑMicrophthalmos ANdo not use /congen MNC16.131.384.666 LH  PM73 HN73(72) MHÑMicropore Filters ANonly /stand; includes millipore filters PIFiltration (66-71) MNE7.560; H1.181.529.365.541 FXÑUltrafiltration LH LX  MSProduction of a radiographic image of a small or very thin object on fine-grained photographic film under conditions which permit subsequent microscopic examination or enlargement of the radiograph at linear magnifications of up to several hundred and with a resolution approaching the resolving power of the photographic emulsion (about 1000 lines per millimeter). MHÑMicroradiography ANonly /hist /instrum /methods /stand /vet MNE1.818.525 LH  MHÑMicroscopy ANroutine for histol & cytol studies so do not bother to index here at all; read Manual 26.31; only /hist /instrum /methods MNE5.595; H1.671.606.624 LH  MHÑMicroscopy, Electron ANNIM; only /hist /instrum /methods /stand; relation to /ultrastruct: Manual 26.31 & TN 195; transmission electron microscopy (TEM) goes here but scanning transmission electron microscopy (STEM) goes under MICROSCOPY, ELECTRON, SCANNING MNE5.595.402 XSELECTRON MICROSCOPY LH LS  PM72 HN72(69) MHÑMicroscopy, Electron, Scanning ANNIM; only /hist /instrum /methods /stand; scanning transmission electron microscopy (STEM) goes here: see note above PIMicroscopy, Electron (66-68) MNE5.595.402.541 LH  MHÑMicroscopy, Fluorescence ANNIM; only /hist /instrum /methods /stand MNE5.595.458 XSFLUORESCENCE MICROSCOPY LH LS  PM65 HN65(64) MHÑMicroscopy, Interference ANNIM; only /hist /instrum /methods /stand MNE5.490.630; E5.595.513 XSInterferometry, Microscopic; Microinterferometry LH LS;  MHÑMicroscopy, Phase Contrast ANNIM; only /hist /instrum /methods /stand MNE5.595.569 LH  PM67 HN67(64) MHÑMicroscopy, Polarization ANNIM; only /hist /instrum /methods /stand PIMICROSCOPY MNE5.595.624 LH  PM73 HN73 MHÑMicroscopy, Ultraviolet ANNIM; only /hist /instrum /methods /stand PIMicroscopy (66-72); Ultraviolet Rays (66-72) MNE5.595.680 XSULTRAVIOLET MICROSCOPY LH LS  PM65 HN65(64) MHÑMicrosomes ANA 11 qualif except /cytol MNA11.904.540 LH  PM70 HN70 MHÑMicrosomes, Liver ANA 11 qualif except /cytol PILiver (66-69); Microsomes (66-69) MNA3.620.573; A11.904.540.541 XSLIVER MICROSOMES LH LS  OLuse MICROSPHERES + LATEX to search LATEX PARTICLES 1968-80 PM74; LATEX PARTICLES was heading 1968-80 HN74(72); LATEX PARTICLES was heading 1968-80 MHÑMicrospheres ANNIM; no qualif; latex particles, spheres, beads go here but do not coord with LATEX unless particularly discussed; microcapsules as a dosage form: index under CAPSULES & not also here MNE7.579 FXÑEnzymes, Immobilized LH LX  MHÑMicrosporum ANdo not use /anat /embryol /microbiol /parasitol; infection: coord NIM with DERMATOMYCOSES (IM) MNB5.354.318.542; B5.354.381.546.560 XSNannizzia LH LS  HN(71) MHÑMicrostomia ANdo not use /congen PIMouth/IN (66-70); Mouth Abnormalities (66-70); Mouth Diseases (66-70) MNC7.465.497; C16.131.314.687.729 DMÑMouth Diseases LH LM  PM72 HN72(69) MHÑMicrosurgery ANonly /hist /instrum /methods /stand /util (if by MeSH definition) /vet PIMicroscopy (66-68); Surgery, Operative (66-68) MNE4.494 LH  MHÑMicrotomy ANonly /hist /instrum /methods /stand MNE5.909.432.707 XUÑFrozen Sections LH LU  MSProteins found in the microtubules. PM85 HN85 MHÑMicrotubule Proteins AN/biosyn /physiol permitted; do not use /analogs; TUBULIN is available PICytoplasm (77-79); Cytoskeleton (80-84); Proteins (66-84); Tubulin (75-84) MND12.776.220.600 LH  MSHigh molecular weight proteins found in the microtubules of the cytoskeletal system. Under certain conditions they are required for tubulin assembly into the microtubules and stabilize the assembled microtubules. PM85 HN85 MHÑMicrotubule-Associated Proteins AN/biosyn /physiol permitted; do not use /analogs PINerve Tissue Proteins (66-84); Proteins (66-84) MND12.776.220.600.450; D12.776.641.560 LH  MSThe largest of the cytoskeletal filaments. Composed primarily of subunits of the protein tubulin, they are involved in the maintenance of cell shape, and they form the mitotic spindle. PM72 HN72(70) MHÑMicrotubules ANA 11 qualif except /cytol PIOrganoids (66-69) MNA11.368.250.602 LH  MSMinute projections of cell membranes which greatly increase the surface area of the cell. PM84; was see under CELL MEMBRANE 1978-83 HN84(78); was see under CELL MEMBRANE 1978-83 MHÑMicrovilli ANNIM: coord with specific cell /ultrastructure (IM); IM only if point of article irrespective of identity of cell /ultrastructure (NIM); A 11 qualif except /cytol PICell Membrane (66-77); Intestinal Mucosa (66-77); Kidney Cortex (73-77); Kidney Tubules, Proximal (73-77) MNA11.195.590 XSBrush Border; Striated Border LH LS;  MSThat portion of the electromagnetic spectrum lying between UHF (ultrahigh frequency) radio waves and heat (infrared) waves; used to generate heat, especially in some types of diathermy; may cause heat damage to tissues. Synonyms:EHF waves; Extremely High Frequency radio waves. MHÑMicrowaves ANnon-ionizing; IM; only /adv eff /class /diag use /ther use; radiation policy: see Manual index under RADIATION & entries following; extremely high frequency waves go here but short wave, high frequency, ultrahigh frequency & very high frequency waves go under RADIO WAVES MNH1.671.768.638.605 FXÑDiathermy LH LX  MSThe geographic area of the Mid Atlantic Region in general or when the specific state or states are not indicated. Usually includes Delaware, Maryland, New York, New Jersey, and Pennsylvania. HN75 MHÑMid Atlantic Region ANincludes NY, NJ & Pa; specify each & use MID ATLANTIC REGION when text uses the term CATALOG: use must include all 3 states MNZ1.107.567.875.513 LH  MS8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo (1,5-a)(1,4)benzodiazepine. Midazolam is a short-acting water-soluble compound at pH less than 4, while at physiological pH the drug becomes lipid soluble. It is a hypnotic-sedative drug with anxiolytic and amnestic properties. It is used for sedation in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. Because of its short duration and cardiorespiratory stability it is particularly useful in poor-risk, elderly, and cardiac patients. Its pharmacological action is blocked by benzodiazepine receptor blockaders. PM87 HN87 MHÑMidazolam ANdo not use /biosyn /defic /physiol RN59467-70-8 PIAzepines (66-74); Benzodiazepines (75-86) MND3.438.79.80.575; D14.591.745.715; D15.236.872.659.191.575 LH  MHÑMiddle Age ANage 45-64; IM as a physiol, psychol, sociol entity: Manual 18.5.12, 34.13; NIM as check tag; only /psychol; Manual 34.10, 34.13 for indexing examples MNM1.471.116.630 LH  MSVentilation of the middle ear, usually by placement of tubes or grommets which pierce the tympanic membrane in the treatment of secretory (serous) otitis media. PM83 HN83 MHÑMiddle Ear Ventilation ANdo not use /util except by MeSH definition PIIntubation (66-82); Otitis Media (66-82); Tympanic Membrane (66-82) MNE4.847.774.472 XSGrommet Insertion; Tympanostomy Tube Insertion; Ventilation, Middle Ear LH LS; ;  MSThe countries of southwest Asia and northern Africa usually considered as extending from Libya on the west to Afghanistan on the east. HN82 MHÑMiddle East ANcountries from Libya east to Afghanistan, including Turkey PIAsia, Western (66-81); specific Middle East country MNZ1.630 LH  MHÑMiddle Lobe Syndrome MNC8.381.69.542 XSBROCK'S SYNDROME LH LS  MSdl-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethan-1-ol. An ethanolamine derivative acting as a vasoconstrictor agent in treatment of hypotension; it also has the properties of an adrenergic alpha receptor agonist. Synonyms: Gutron; ST-1085. HN(75) MHÑMidodrin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN42794-76-3 PIEthanolamines (73-74); Glycine (73-74); Hydroquinones (73-74) MND2.33.329.291.480; D2.92.63.291.480; D16.893.116.182.520 DMÑEthanolamines LH LM  MSThe practice of assisting women in childbirth. PM66; was MIDWIVES 1963-65 HN66; was MIDWIVES 1963-65 MHÑMidwifery ANSPEC: SPEC qualif; NURSE MIDWIVES is also available; HOME CHILDBIRTH is also available MNG2.478.676.416 XSTraditional Birth Attendant LH LS  MSA periodic vascular headache, usually temporal and unilateral in onset, commonly associated with irritability, nausea, vomiting, constipation or diarrhea, and often photophobia. MHÑMigraine MNC10.228.140.300.937.542; C14.907.253.937.542; C23.888.592.612.429.814.458 XSHEMICRANIA LH LS  MHÑMikulicz' Disease MNC7.465.815.355; C23.205.530 LH  MHÑMiliaria ANprickly heat goes here MNC17.805.843.492 LH  MSA treatment program based on manipulation of the patient's environment by the medical staff; the patient does not participate in planning the treatment regimen. PM69 HN69(67) MHÑMilieu Therapy ANSPEC qualif PIPsychotherapy (66) MNF4.754.864.392 LH  MSThe practice of dentistry as applied to special circumstances associated with military operations. PM65 HN65 MHÑMilitary Dentistry ANSPEC: SPEC qualif except /methods; specify country MNG2.163.592 LH  MHÑMilitary Hygiene ANSPEC: SPEC qualif except /methods; specify country MNG3.850.670.300 LH  MSThe practice of medicine as applied to special circumstances associated with military operations. MHÑMilitary Medicine ANSPEC: SPEC qualif except /methods; specify country; Manual 28.10; Uniformed Services University of the Health Sciences (USUHS), under US Dept of Defense, goes under SCHOOLS, MEDICAL (IM) + UNITED STATES (NIM) MNG2.403.458 FXÑSURVIVAL; ÑWOUNDS AND INJURIES LH LX;  MSThe practice of nursing in military environments. MHÑMilitary Nursing ANSPEC: SPEC qualif except /methods; specify country MNG2.478.676.458 XSNURSING, MILITARY AND NAVAL LH LS  MHÑMilitary Personnel ANtheir physiol & diseases go here: reserve MILITARY MEDICINE for the specialty; includes all uniformed personnel (Army, Navy, Air Force, Marines, Coast Guard, submariners); only /hist /psychol (but consider also the specialties PSYCHOLOGY, MILITARY & MILITARY PSYCHIATRY); specify country; Manual 28.10, 34.21 CATALOG: /geog /form MNM1.526.625 XSARMED FORCES PERSONNEL FXÑVeterans LH LS LX  MSBranch of psychiatry concerned with problems related to the prevention, diagnosis, etiology and treatment of mental or emotional disorders of Armed Forces personnel. OLuse MILITARY PSYCHIATRY to search PSYCHIATRY, MILITARY back thru 1966 PM80; was PSYCHIATRY, MILITARY 1963-79 HN80; was PSYCHIATRY, MILITARY 1963-79 MHÑMilitary Psychiatry ANSPEC only: SPEC qualif; not for MENTAL DISORDERS in soldiers, etc. MNF4.96.544.480; G2.403.642.508 XSPsychiatry, Military LH LS  OLuse MILITARY SCIENCE to search NAVAL SCIENCE back thru 1966 PMNAVAL SCIENCE was heading 1963-82 HNNAVAL SCIENCE was heading 1963-82 MHÑMilitary Science ANonly /hist; specify country MNJ1.675 XSNaval Science LH LS  MHÑMilk ANIM; coord with source of milk (NIM), as cow's milk = MILK (IM) + CATTLE (NIM), goat's milk = MILK (IM) + GOATS (NIM); only /ad-poi-tox /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret (consider also LACTATION); includes buttermilk; kefir indexed here; YOGURT is also available MNA13.622; J1.125.576; J1.341.273.692 FXÑInfant Nutrition; ÑLactation LH LX;  MSReflex in which tactile stimulation of nipples causes release of oxytocin which causes myoepithelial cells surrounding mammary alveoli to contract and expel the milk. Applies to humans and animals. HN(75) MHÑMilk Ejection ANhuman and animal; only /drug eff /rad eff MNG8.520.882.608.460 DMÑLactation LH LM  PM73 HN73 MHÑMilk Proteins ANdo not use /analogs /defic /physiol PIAlbumins (66-72); Caseins (66-72); Lactoglobulins (66-72) MND12.776.256.626 LH  MHÑMilk, Human ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret (consider also LACTATION); human milk banks go here but do not use qualif & do not coord with TISSUE BANKS MNA12.838.467 FXÑBreast Feeding; ÑInfant Nutrition; ÑLactation LH LX; ;  MSA pox-like disease occurring on the udders of cows from which it may be spread to the hands of milkers; it is often confused with cowpox, which is VACCINIA. OLsearch POXVIRUS INFECTIONS 1966-74 HN(75) MHÑMilker's Nodes MNC2.256.743.563 DMÑPoxvirus Infections LH LM  MSA genus of small cereal grasses, Panicum, used for forage and its grain for food. Synonym: Italian millet. OLsearch CEREALS 1966-84 HN(75); was see under GRAIN 1963-84 MHÑMillet ANas plant & food; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply; do not confuse Italian millet (MILLET) with pearl millet, Pennisetum (index under CEREALS) MNB6.510.253.480; J1.341.182.480 XSPanicum DMÑCereals LH LS LM  MS3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca. HN(75) MHÑMimosine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN500-44-7 PIAlanine (72-74); Pyridones (69-74) MND3.383.725.791.550; D12.125.42.500 XSLeucenine; Leucenol DMÑPyridones LH LS; LM  MSA mixture of liquid hydrocarbons obtained from petroleum; used as laxative, lubricant, ointment base, emollient. Synoyms: Alboline; Bandlube; Glymol; Kaydol; Nujol; Petrogalar; Saxol. PM66; was PETROLATUM, LIQUID 1963-65 HN66; was in Cat D only 1966-82, was PETROLATUM LIQUID in Cat D only 1963-65 MHÑMineral Oil AND25-26 qualif RN8020-83-5 MND19.316.396.656; D26.698.523.626; J1.740.400.700.500 XSLiquid Paraffin; PETROLATUM, LIQUID LH LS;  MHÑMineral Waters ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply; for drinking, with BALNEOLOGY probably better for bathing in mineral waters CATALOG: /geog /form MNJ1.125.648 FXÑBalneology; ÑWater LH LX;  PM67 HN67 MHÑMineralocorticoids ANGEN: avoid: prefer specifics; /biosyn /physiol permitted; do not use /analogs; /chem syn permitted: do not convert to MINERALOCORTICOIDS, SYNTHETIC PIAdrenal Cortex Hormones (66) MND6.472.40.668 LH  MSSynthetic chemical steroids which mimic the activity of the mineralocorticoids obtained from the adrenal cortex, but differ in structure from the naturally occurring mineralocorticoids. PM75 HN75 MHÑMineralocorticoids, Synthetic ANdo not use /analogs /biosyn /defic /physiol; do not confuse with MINERALOCORTICOIDS /chem syn; DF: MINERALOCORTICOIDS SYN PIMineralocorticoids (67-74) MND6.597.648 XSMineralocorticoid Analogs LH LS  PM/metabolism was MINERAL METABOLISM 1963-65 HN/metabolism was MINERAL METABOLISM 1963-65 MHÑMinerals ANGEN: prefer specifics; do not use /analogs /biosyn /physiol; trace minerals = TRACE ELEMENTS; ╥bone minerals╙ = MINERALS (IM) + BONE AND BONES (IM) MND1.578 LH  HN(66) MHÑMiniaturization ANonly /instrum /methods /stand MNH1.288.542 DMÑElectronics LH LM  MSSmall computers that lack the speed, memory capacity, and instructional capability of the full-size computer but usually retain its programmable flexibility. They are larger, faster, and more flexible, powerful, and expensive than microcomputers. HN(80) MHÑMinicomputers ANonly /class /econ /hist /stand /supply; do not confuse with MICROCOMPUTERS; personal computers: index under MICROCOMPUTERS PIComputers (66-79) MNL1.700.568.80.260.580 DMÑComputers LH LM  MHÑMining ANonly /econ /hist /instrum /methods /stand; coord IM with substance being mined (IM or NIM); COAL MINING is also available MNJ1.576.670 LH  PM68 HN68 MHÑMink ANIM; only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PICarnivora (66-67) MNB2.649.147.625 LH  MSMurine leukemia viruses discovered in 1976 by Hartley, Wolford, Old, and Rowe and so named because they characteristically alter cell foci in mink cell cultures. Types include AKR, Friend, Moloney, and Rauscher. HN(86) MHÑMink Cell Focus-Inducing Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) PIFriend Virus (66-85); Leukemia, Experimental (66-85); Mouse Leukemia Viruses (66-85) MNB4.909.574.807.674.632.580; B4.909.777.731.674.632.580; B4.909.777.779.674.632.580 XSMCF Viruses DMÑMouse Leukemia Viruses LH LS LM  MSThe cause of a relatively mild infection of mink. HN(75) MHÑMink Encephalopathy Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with VIRUS DISEASES (IM) MNB4.909.920.500 XSTransmissible Encephalopathy Virus of Mink DMÑVertebrate Viruses, Unclassified LH LS LM  MHÑMinnesota MNZ1.107.567.875.523 LH  HN(73) MHÑMinocycline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN10118-90-8 PITetracycline (66-72) MND20.85.868.543 DMÑTetracyclines LH LM  MSGenetic loci responsible for the encoding of histocompatibility antigens other than those encoded by the major histocompatibility complex. The antigens encoded by these genes are often responsible for graft rejection in cases where histocompatibility has been established by standard tests. The location of some of these loci on the X and Y chromosomes explains why grafts from males to females may be rejected while grafts from females to males are accepted. In the mouse roughly 30 minor histocompatibility loci have been recognized, comprising more than 500 genes. PM83 HN83 MHÑMinor Histocompatibility Loci ANonly /drug eff /rad eff PIH-2 Antigens (78-82); Histocompatibility Antigens (73-82); T Lymphocytes (73-82) MNG4.610.626.590; G5.511.590 XSHistocompatibility Loci, Minor LH LS  MSA subgroup having special characteristics within a larger group, often bound together by special ties which distinguish it from the larger group. PM68 HN68 MHÑMinority Groups ANonly /class /educ /hist /psychol PIAttitude (66-67); Blacks (66-67); Jews (66-67); Prejudice (66-67) MNI1.880.371; M1.403; N1.224.593 LH  PM86; was see under PYRIMIDINES 1975-85 HN86(72); was see under PYRIMIDINES 1975-85, was Prov 1972-74 MHÑMinoxidil ANdo not use /biosyn /defic /physiol RN38304-91-5 PIAntihypertensive Agents (66-71); Piperidines (66-71); Pyrimidines (66-71) MND3.383.621.493; D3.383.742.418; D18.162.586 LH  MSA virus prevalent in mouse colonies and found as a contaminant of many transplanted tumors or leukemias. Common abbreviation is MVM. HN(75); was see under PARVOVIRUSES 1975-80 MHÑMinute Virus of Mice ANdo not use /blood-csf-urine /cytol; infection: coord NIM with VIRUS DISEASES (IM) MNB4.909.204.671.550 DMÑParvoviridae LH LM  MHÑMiotics ANdo not use /analogs /biosyn /defic /physiol; do not confuse with ╥mitotic╙; consider also PUPIL /drug eff MND16.428 LH  HN(72) MHÑMirex ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN2385-85-5 PIInsecticides (66-72) MND2.455.526.439.659; D5.723.491.491.690 DMÑInsecticides, Organochlorine LH LM  MH*Miscellaneous Drugs and Agents (Non Mesh) MND26 LH  OLpre-explosion = MISCELLANEOUS TECHNICS (PX) MH*Miscellaneous Technics (Non Mesh) MNE5 LH  MS1-(2-Nitroimidazol-1-yl)-3-methoxy-2-propanol. A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation; may also be directly cytotoxic to hypoxic cells; proposed as antineoplastic. PM86; was see under NITROIMIDAZOLES 1979-85 HN86(79); was see under NITROIMIDAZOLES 1979-85 MHÑMisonidazole ANdo not use /biosyn /defic /physiol RN13551-87-6 PIImidazoles (66-73); Nitroimidazoles (74-78) MND2.640.672.530; D3.383.374.658.530; D22.204.530; D26.776.530 XSRO 07-0582 LH LS  MSTo be used for articles pertaining to medical activities carried out by personnel in institutions which are administered by a religious organization. MHÑMissions and Missionaries ANonly /class /hist /psychol /stand /supply /util; do not confuse with MEDICAL MISSIONS, OFFICIAL; DF: MISSIONS MNM1.526.682; N2.720 LH  MHÑMississippi MNZ1.107.567.875.532 LH  MHÑMissouri MNZ1.107.567.875.540 LH  MSInfestations with arthropods of the order Acarina other than the suborder Ixodides. OLuse MITE INFESTATIONS to search ACARIASIS back thru 1966; use MITE INFESTATIONS to search MANGE back thru 1968 PM68; was ACARIASIS 1963-67 HN68; was ACARIASIS 1963-67; MANGE was see under MITE INFESTATIONS 1968-76 MHÑMite Infestations MNC3.211.394 XSACARIASIS; Mange XUÑGamasoidiasis; ÑTrombiculiasis LH LS; LU;  MHÑMites AN/microbiol /parasitol permitted; infection = MITE INFESTATIONS; for miticides (chemicals killing or controlling mites) index under INSECTICIDES even though mites are not insects; mite vectors = ARACHNID VECTORS (IM) + MITES (IM); mite control: coord IM with TICK CONTROL (IM) MNB1.131.166.132.419 XSAcarus XUÑTrombiculid Mites LH LS LU  MSA tricyclic pentaglycosidic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA; used as fluorescent dye and as antineoplastic agent, especially in bone and testicular tumors; also used to reduce hypercalcemia, especially due to malignancies. Synonyms: A2371; NSC 24559; PA 144; LA 7017; Mithracin. PM73 HN73(71) MHÑMithramycin ANdo not use /defic /physiol RN18378-89-7 PIAntibiotics, Antineoplastic (67-70) MND20.85.75.302.419; D22.204.106.307.419; D26.408.348.199.598 XSAureolic Acid LH LS  MS1,6-Dibromo-1,6-dideoxy-D-mannitol. Brominated analog of mannitol which is an antineoplastic agent appearing to act as an alkylating agent. Synonyms: Myelobromol; DBM; NSC-94,100. HN(75) MHÑMitobronitol ANdo not use /biosyn /defic /physiol RN488-41-5 PIBromine (71-74); Mannitol (71-74) MND2.33.800.609.500; D9.203.853.609.500; D22.204.535 XSDibromomannitol DMÑMannitol LH LS LM  MHÑMitochondria ANA 11 qualif except /cytol; coord with organ /metab (IM) but not also organ /ultrastruct for metab studies, coord with organ /ultrastruct (IM) for morphol studies: TN 126; mitochondria of vasc or smooth musc tissue goes under MITOCHONDRIA, MUSCLE & do not coord with MUSCLE, SMOOTH or MUSCLE, SMOOTH, VASCULAR unless particularly discussed & then probably only NIM MNA11.368.702.564; A11.904.626 LH  MSThe mitochondria of the myocardium. PM78 HN78 MHÑMitochondria, Heart ANA 11 qualif except /cytol PIHeart (66-77); Mitochondria (66-77); Mitochondria, Muscle (68-77); Myocardium (66-77) MNA11.368.702.564.627.603; A11.904.626.627.603 XSHeart Mitochondria; Myocardial Mitochondria LH LS;  PM68 HN68 MHÑMitochondria, Liver ANA 11 qualif except /cytol PIMitochondria (66-67) MNA3.620.627; A11.368.702.564.461; A11.904.626.461 XSLIVER MITOCHONDRIA LH LS  PM68 HN68 MHÑMitochondria, Muscle ANA 11 qualif except /cytol; for skeletal & smooth musc mitochondria; myocardial mitochondria = MITOCHONDRIA, HEART; for vasc & smooth musc mitochondria see note on MITOCHONDRIA PIMitochondria (66-67); Muscle Contractioon (66-67); Muscles (66-67); Myocardium (66-67) MNA11.368.702.564.627; A11.904.626.627 XSSARCOSOMES LH LS  MSThe reversal of mitochondrial swelling by active contraction; it can be induced by ATP and is probably brought about by a specific contractile protein with ATPase activity. PM76; was see under MITOCHONDRIA 1975 HN76(69); was see under MITOCHONDRIA 1975 MHÑMitochondrial Contraction ANonly /drug eff /rad eff PIMitochondria (66-68); Mitochondria, Liver (68); Mitochondria, Muscle (68) MNG4.335.690 LH  MSIncrease in volume of mitochondria due to an influx of fluid; it occurs in hypotonic solutions due to osmotic pressure and in isotonic solutions as a result of altered permeability of the membranes of respiring mitochondria. PM76; was see under MITOCHONDRIA 1975 HN76(69); was see under MITOCHONDRIA 1975 MHÑMitochondrial Swelling ANonly /drug eff /rad eff PIMitochondria (66-68); Mitochondria, Liver (68); Mitochondria, Muscle (68) MNG4.335.723 LH  PM73 HN73(72) MHÑMitogens ANchem or drugs inducing mitosis; do not use /analogs /biosyn /defic /physiol PIMitosis/DE (66-71) MND24.185.526 LH  MS1,1-[(Methylethanediylidene)dinitrilo]diguanidine. Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase. Synonyms: NSC-32946; MGGH. PM86; was see under GUANIDINES 1975-85 HN86(75); was see under GUANIDINES 1975-85 MHÑMitoguazone ANdo not use /biosyn /defic /physiol RN459-86-9 PIAmidines (73-74); Hydrazones (73-74); Glyoxal (73-74) MND2.78.370.600; D22.204.540 XSMethyl-gag; Methylglyoxal Bis(guanylhydrazone) LH LS;  MS1,6-Dibromo-1,6-dideoxygalactitol. Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs. Synonyms: DBD; Dibromgalactitol; Elobromol; NSC 104800. OLuse MITOLACTOL to search DIBROMODULCITOL back thru 1974 PM81; was DIBROMODULCITOL 1974-80 HN81; was DIBROMODULCITOL 1974-80 MHÑMitolactol ANdo not use /biosyn /defic /physiol RN10318-26-0 PIAntineoplastic Agents (66-73); Bromine (66-73) MND2.33.800.256.500; D9.203.853.256.500; D22.204.545 XSDibromodulcitol LH LS  MSA group of methylazirino-pyrroloindolediones obtained from certain Streptomyces strains; very toxic antibiotics used as antineoplastic agents in some solid tumors. Porfiromycin and mitomycin C are the most useful members of the group. Synonyms: Ametycine; Mitocin C; MMC; Mutamycin; NSC 26980. OLuse MITOMYCINS to search MITOMYCIN back thru 1966 PM82; was MITOMYCIN 1963-81; PORFIROMYCIN was heading 1973-81 HN82; was MITOMYCIN 1963-81 MHÑMitomycins ANdo not use /analogs /biosyn /defic /physiol MND3.383.97.500; D20.85.75.584; D22.204.106.584 XUÑPorfiromycin LH LU  MSA method of indirect cell division by means of which the two daughter nuclei normally receive identical complements of the number of chromosomes of the somatic cells of the species. OLsearch CELL DIVISION 1966-67; to search KARYOKINESIS use MITOSIS back thru 1975 & CELL DIVISION 1966-74 PM68; was see under CELL DIVISION 1963-67; KARYOKINESIS was see under CELL DIVISION 1963-80 HN68; was see under CELL DIVISION 1963-67; KARYOKINESIS was see under CELL DIVISION 1963-80 MHÑMitosis ANonly /drug eff (consider also MITOGENS) /rad eff; mitotic apparatus goes here; coord with specific cell /cytol; permitted with micro-organisms PICell Division (66-67) MNG4.335.135.220.669; G5.148.165.220.669; G7.553.135.220.669 XSKaryokinesis; M Period XUÑMitotic Index LH LS; LU  MS1-Chloro-2-(2,2-dichloro)-1-(4-Chlorophenyl)ethylbenzene. A derivative of the insecticide DDD that specifically inhibits cells of the adrenal cortex and their production of hormones; used to treat adrenocortical tumors; causes CNS damage, but no bone marrow depression. Synonyms: CB 313; Lysoderm; NSC 38721. PM73 HN73 MHÑMitotane ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN53-19-0 PIDDD/PD (66-72) MND2.455.526.439.681; D5.723.491.491.723; D22.204.550 XSChloditan; o,p-DDD; ortho,para-DDD LH LS; ;  MSAn expression of the number of mitoses found in a stated number of cells. HN(75) MHÑMitotic Index MNE5.909.262.730; G4.335.135.220.669.600; G5.148.165.220.669.600; G7.553.135.220.669.600 DMÑMitosis LH LM  MSAn organelle consisting of three components: 1) the asters, which form around each centrosome; 2) the gelatinous spindle; and 3) the traction fibers, which connect the centromeres of the various chromosomes to either centrosome. PM84 HN84 MHÑMitotic Spindle Apparatus ANA 11 qualif except /cytol PICell Division (66-67); Mitosis (68-83) MNA11.368.702.581 XSSpindle Apparatus, Mitotic LH LS  MS1,4-Dihydroxy-5,8-bis ((2-((2-hydroxyethyl)amino)ethyl)amino) anthraquinone. An anthracenedione antineoplastic agent. It is particularly effective against advanced breast cancer, acute leukemia, and malignant lymphoma. It has mild side effects, especially with respect to nausea, vomiting, hair loss, and cardiotoxicity. PM87 HN87 MHÑMitoxantrone ANdo not use /biosyn /defic /physiol RN65271-80-9 PIAnthraquinones (66-86) MND4.615.117.159.500; D22.204.555 LH  MSThe valve between the left atrium and left ventricle of the heart. MHÑMitral Valve ANdo not use /blood supply; atresia: index MITRAL VALVE /abnorm; stenosis = MITRAL VALVE STENOSIS; regurgitation, incompetence or insufficiency = MITRAL VALVE INSUFFICIENCY MNA7.541.510.507 XSBICUSPID VALVE LH LS  OLuse MITRAL VALVE INSUFFICIENCY to search MITRAL INSUFFICIENCY back thru 1966 PM67; was MITRAL INSUFFICIENCY 1963-66 HN67; was MITRAL INSUFFICIENCY 1963-66 MHÑMitral Valve Insufficiency ANimperfect closing of valve; incompetence & regurgitation go here; /congen permitted MNC14.280.484.461 LH  MSAbnormal protrusion of one, or both, of the leaflets of the mitral valve into the left atrium during systole. This may be accompanied by mitral regurgitation, systolic murmur, nonejection click, or cardiac arrhythmia. PM79 HN79 MHÑMitral Valve Prolapse PIHeart Valve Diseases (67-78); Mitral Valve (66-78); Mitral Valve Insufficiency (66-78); Prolapse (77-78) MNC14.280.484.505 XSFloppy Mitral Valve; Mitral Click-Murmur Syndrome; Systolic Click-Murmur Syndrome LH LS; ;  OLuse MITRAL VALVE STENOSIS to search MITRAL STENOSIS back thru 1966 PM67; was MITRAL STENOSIS 1963-66 HN67; was MITRAL STENOSIS 1963-66 MHÑMitral Valve Stenosis AN/congen permitted; atresia = MITRAL VALVE /abnorm MNC14.280.484.517 LH  MSA syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon; differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a ╥speckled╙ epidermal nuclear staining pattern on direct immunofluorescence. PM79 HN79 MHÑMixed Connective Tissue Disease ANdisease entity: read definition & do not confuse with CONNECTIVE TISSUE DISEASES; DF: MCTD PICollagen Diseases (72-78); Lupus Erythematosus, Systemic (72-78); Scleroderma, Systemic (72-78) MNC23.205.200.451 XSConnective Tissue Disease, Mixed; Sharp Syndrome LH LS;  MSCatalyse the insertion of one oxygen atom of molecular oxygen into the organ substrate. Require a second substrate to donate electrons for the reduction of the second atom in the oxygen molecule to water. OLsearch OXIDOREDUCTASES 1973-74 PM84; was see under OXIDOREDUCTASES 1973-83 HN84(75); was see under OXIDOREDUCTASES 1973-83 MHÑMixed Function Oxidases ANdo not use /analogs RNEC 1.13.12. MND8.586.682.690.570 XSMixed Function Oxygenases LH LS  MHÑMixed Salivary Gland Tumor AN/anal /blood supply /secret /ultrastruct permitted; coord IM with SALIVARY GLAND NEOPLASMS (IM) + specific salivary gland (IM) or PAROTID NEOPLASMS (IM) MNC4.557.537.615 XSSalivary Gland Tumor, Mixed LH LS  MSA personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes. MHÑMMPI ANno qualif MNF4.711.647.513.607 XSMINNESOTA MULTIPHASIC PERSONALITY INVENTORY LH LS  MSA system of universal human blood group isoantigens with many associated subgroups; the M and N traits are codominant and the S and s traits are probably very closely linked alleles, including the U antigen. This system is most frequently used in paternity studies. PM76 HN76 MHÑMNSs Blood-Group System ANonly /genet /immunol; TN 230 PIBlood Groups (66-75) MND24.611.216.705.230.606; G4.610.241.606; G9.188.229.606 LH  MSMovable facilities in which diagnostic and therapeutic services are provided to the community. PM70 HN70 MHÑMobile Health Units ANonly /class /hist /legis /man /organ /stand /supply /trends /util PIHealth Facilities (68-69) MNN2.421.143.827.233.628; N2.421.726.233.628 LH  MSThree-dimensional representation to show anatomic structures. OLto search ANATOMIC MODELS use MODELS, ANATOMIC back thru 1975 & MODELS, STRUCTURAL 1968-74; to search MOULAGES use MODELS, ANATOMIC back thru 1975 & MEDICAL ILLUSTRATION 1966-74 PM84; was ANATOMIC MODELS see under MODELS, STRUCTURAL 1963-83; MANIKINS was see under MODELS, STRUCTURAL 1971-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83 HN84(75); was ANATOMIC MODELS see under MODELS, STRUCTURAL 1968-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83 MHÑModels, Anatomic ANno qualif; MANIKINS is also available; note X MOULAGES below MNL1.178.147.545.129 XSAnatomic Models; Moulages XUÑManikins LH LS; LU  MSTheoretical representations that simulate the behavior or activity of biological systems, processes or phenomena; includes the use of mathematical equations, computers and other electronic equipment. OLuse MODELS, BIOLOGICAL to search MODELS, BIOLOGIC back thru 1968 PM73; was MODELS, BIOLOGIC 1968-72 HN73; was MODELS, BIOLOGIC 1968-72 MHÑModels, Biological ANno qualif; TN 128: definition & relation to MODELS, THEORETICAL PIModels, Theoretical (66-67) MNH1.770.461.395 FXÑBionics; ÑDisease Models, Animal LH LX;  MSTheoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment. PM80 HN80 MHÑModels, Cardiovascular ANno qualif; apply TN 128 for relation to MODELS, THEORETICAL PIModels, Biological (68-79) MNH1.770.461.395.161 LH  MSTheoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers and other electronic equipment. PM68 HN68 MHÑModels, Chemical ANno qualif; TN 37: relation to MODELS, STRUCTURAL; TN 128: definition & relation to MODELS, THEORETICAL; DF: MODELS CHEM PIModels, Theoretical (66-67) MNH1.770.461.495 LH  MSTheoretical representations that simulate the behavior or activity of genetic processes or phenomena; includes the use of mathematical equations, computers and other electronic equipment. PM80 HN80 MHÑModels, Genetic ANno qualif; apply TN 128 for relation to MODELS, THEORETICAL; DF: MODELS GENET PIModels, Biological (68-79) MNG5.621; H1.770.461.395.397 LH  MSThree-dimensional representation of molecular structures. OLto search MOLECULAR MODELS use MODELS, MOLECULAR back thru 1975 & MODELS, STRUCTURAL 1969-74 PM84; was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83 HN84(75); was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83 MHÑModels, Molecular ANno qualif; TN 37: relation to MODELS, CHEMICAL MNL1.178.147.545.595 XSMolecular Models LH LS  MSTheoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers and other electronic equipment. OLuse MODELS, NEUROLOGICAL to search MODELS, NEUROLOGIC back thru 1968 PM77; was MODELS, NEUROLOGIC 1968-76 HN77; was MODELS, NEUROLOGIC 1968-76 MHÑModels, Neurological ANno qualif; TN 128: definition & relation to MODELS, THEORETICAL PIModels, Theoretical (66-67) MNH1.770.461.395.642 FXÑKindling (Neurology) LH LX  MSTheoretical representations that simulate psychological processes and/or social processes; includes the use of mathematical equations, computers and other electronic equipment. OLuse MODELS, PSYCHOLOGICAL to search MODELS, PSYCHOLOGIC back thru 1968 PM73; was MODELS, PSYCHOLOGIC 1968-72 HN73; was MODELS, PSYCHOLOGIC 1968-72 MHÑModels, Psychological ANno qualif; TN 128: definition & relation to MODELS, THEORETICAL; DF: MODELS PSYCHOL PIModels, Theoretical (66-67) MNF4.669.880.580; H1.770.461.695 FXÑPROBABILITY LEARNING LH LX  PM68 HN68 MHÑModels, Structural ANno qualif; TN 37: relation to MODELS, CHEMICAL; ╥phantoms╙ goes here MNL1.178.147.545 LH  MSTheoretical representations that simulate the behavior or activity of systems, processes or phenomena; includes the use of mathematical equations, computers and other electronic equipment. OLuse MODELS, THEORETICAL to search MODELS 1966-67 PM68; MODELS was heading 1966-67 HN68; MODELS was heading 1966-67 MHÑModels, Theoretical ANno qualif; TN 128: definition & relation to specifics above; physiol models are indexed under MODELS, BIOLOGICAL; models of social behavior are indexed under MODELS, PSYCHOLOGICAL MNH1.770.461 FXÑComputer Simulation; ÑSystems Theory LH LX;  PM65 HN65 MHÑMolar ANNIM when merely locational MNA14.254.860.615 LH  MSThe aftermost permanent tooth on each side in the maxilla and mandible. PM82 HN82 MHÑMolar, Third ANhuman only; IM PIMolar (66-81) MNA14.254.860.615.612 XSTooth, Wisdom LH LS  MHÑMolasses ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNJ1.341.694 LH  OLuse MOLDAVIAN S.S.R. to search MOLDAVIA back thru 1966 HN82; was MOLDAVIA 1963-81 MHÑMoldavian S.S.R. MNZ1.542.248.950.630; Z1.950.630 LH  PM70 HN70(68) MHÑMolecular Biology ANSPEC: SPEC qualif PIBiology (66-67) MNG1.273.595 LH  MSThe characteristic 3-dimensional shape of a molecule. PM73 HN73 MHÑMolecular Conformation ANNIM; only /rad eff; molec configuration & stereochemistry go here, molec structure does not ( = CHEMISTRY (NIM) ); peptide conformation = PEPTIDES or specific peptide (IM) + PROTEIN CONFORMATION (NIM), not MOLECULAR CONFORMATION MNG6.184.580; H1.181.529.559 LH  PM67 HN67(64) MHÑMolecular Weight ANalmost never IM; no qualif MNH1.181.529.574 LH  MSAny of numerous burrowing mammals found in temperate regions and having minute eyes often covered with skin. HN(75) MHÑMoles ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.473.450 DMÑInsectivora LH LM  HN(72) MHÑMolindone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7416-34-4 PIAntidepressive Agents (66-71); Indoles (66-71) MND3.438.473.629; D15.236.122.593 DMÑIndoles LH LM  OLmollis = soft, cutis = skin, with ref to its pliable cell boundary; includes the MYCOPLASMATALES MH*Mollicutes (Non Mesh) MNB3.600 LH  MHÑMollusca AN= animal; coord IM with SHELLFISH (IM) as food; /microbiol /parasitol permitted MNB1.644 FXÑSHELLFISH LH LX  MHÑMolluscacides ANdo not use /analogs /biosyn /defic /physiol; eff of molluscacides on mollusks is indexed under each without a qualif: cf TN 111 on insecticides/insects MND5.723.596 LH  MHÑMolluscum Contagiosum MNC2.256.743.611; C17.838.556 LH  MSA DNA Virus causing skin lesions in humans; it is transmitted by direct contact or from non-living reservoirs, such as books or clothing. PM66; was see under TUMOR VIRUSES (now see ONCOGENIC VIRUSES) 1963-65 HN66(63); was see under TUMOR VIRUSES (now see ONCOGENIC VIRUSES) 1963-65 MHÑMolluscum Contagiosum Virus ANdo not use /blood-csf-urine /cytol; infection = MOLLUSCUM CONTAGIOSUM MNB4.909.204.783.438; B4.909.574.204.546 LH  MSVenoms from mollusks, including the Conus and Octopus species; the venoms contain proteins, enzymes, choline derivatives, slow-reacting substances and several characterized polypeptide toxins that affect the nervous system. Cephalotoxin, venerupin, maculotoxin, surugatoxin, conotoxins, murexine go here. PM78 HN78 MHÑMollusk Venoms ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; coord IM with specific mollusk (IM or NIM) PIMollusca (66-77); Venoms (66-77) MND24.185.926.580.590; D24.185.965.590 XSConus Venoms; Octopus Venoms; Snail Venoms LH LS; ;  MSAn RNA virus, arising during the propagation of S37 mouse sarcoma, which causes lymphoid leukemia in mice; it also infects rats and newborn hamsters; it is apparently transmitted ╥vertically╙ to embryos in utero and through mother's milk. OLuse MOLONEY LEUKEMIA VIRUS to search MOLONEY VIRUS back thru 1966 PM85; was MOLONEY VIRUS 1966-84 HN85; was MOLONEY VIRUS 1966-84 MHÑMoloney Leukemia Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) MNB4.909.574.807.674.632.596; B4.909.777.731.674.632.596; B4.909.777.779.674.632.596 LH  MSA strain of murine sarcoma viruses isolated from a rhabdomyosarcoma by Moloney in 1966. HN(85) MHÑMoloney Sarcoma Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with SARCOMA, EXPERIMENTAL (IM) PIMouse Sarcoma Viruses (80-84) MNB4.909.574.807.674.700.630; B4.909.777.731.674.700.630; B4.909.777.779.674.700.630 DMÑMouse Sarcoma Viruses LH LM  MSN-Carboxy-3-morpholinosydnone imine ethyl ester. An effective, safe antianginal agent with beneficial hemodynamic effects in patients with heart failure complicating acute myocardial infarction. PM87 HN87 MHÑMolsidomine ANdo not use /biosyn /defic /physiol RN25717-80-0 PIMorpholines (66-82); Oxadiazoles (66-74); Sydnones (75-86) MND3.383.548.580.693.450; D18.918.585 XSMorsydomine; SIN-10 LH LS;  MHÑMolybdenum ANMo-98; do not use /analogs /biosyn /defic /physiol; Mo-92, 94-97, 100 = MOLYBDENUM (IM) + ISOTOPES (NIM); Mo-88-91, 93, 99, 101-105 = MOLYBDENUM (IM) + RADIOISOTOPES (IM) RN7439-98-7 MND1.268.554; D1.552.571; D1.937.582 LH  MSA non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of nitrogenase which is active in nitrogen fixation. Consists of two subunits with molecular weights of 59,500 and 50,700 respectively. HN(77) MHÑMolybdoferredoxin ANfrom bacteria; /analogs NIM only PIFerredoxins (66-76); Molybdenum (66-76) MND12.776.97.350.450; D12.776.157.435.319.450; D12.776.556.580.302.450 XSMolybdenum-Iron Protein DMÑFerredoxins LH LS LM  MHÑMonaco MNZ1.542.616 LH  MS2-[5-Ethyltetrahydro-5-[tetrahydro-3-methyl-5-[tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl]-2-furyl]-9-hydroxy-beta-methoxy-alpha,gamma,2,8-tetramethyl-1,6-dioxaspiro[4.5]decane-7-butyric acid. An antiprotozoal agent produced by Streptomyces cinnamonensis. It exerts its effect during the development of first-generation trophozoites into first-generation schizonts within the intestinal epithelial cells. Does not interfere with hosts' development of acquired immunity to the majority of coccidial species. Synonym: Coban. PM87; was see under FURANS 1975-86 HN87(75); was see under FURANS 1975-86 MHÑMonensin ANdo not use /defic /physiol RN17090-79-8 PIAntibiotics (72-74); Furans (74); Pyrans (74) MND3.383.312.600; D21.370.400.630 LH  MHÑMongolia AN= Outer Mongolia; INNER MONGOLIA is see CHINA MNZ1.252.474.651 LH  MSA major racial group distinguished by classification according to physical features. This group centers around the Pacific Ocean and includes the Malayan, Northern and Southern Chinese, Mongolian, Siberian, Eskimos, and American Indians. MHÑMongoloid Race ANIM; only /class /hist; specify geog if pertinent; includes Amer Indians, Chinese, Eskimos, Evenki, Indonesians, Japanese, Koreans, Malayans, Mongolians, Samoyedes, Tibetans, Tungus; Ainus of Japan go under AUSTRALOID RACE; policy on race: Manual 30.10-.12 MNI1.76.368.763.596 XSASIATIC RACE LH LS  MSAn agile, keen-sighted mammal of Asia and Africa that feeds on rodents and snakes. HN(75) MHÑMongoose ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.147.650 DMÑCarnivora LH LM  MSInfection of ruminants with tapeworms of the genus Moniezia. PM68 HN68 MHÑMonieziasis ANusually animal: do not use /vet but check tag ANIMAL; for organism index CESTODA (IM) + MONIEZIASIS (NIM) PICestode Infections (66-67) MNC3.335.190.628; C22.674.377.656 LH  MSA genus of roundworms of the phylum Acanthocephala, parasitic in rats, mice, hamsters, dogs and cats. Occasional infection in man produces inflammation and ulceration of the intestinal mucosa. OLsearch ACANTHOCEPHALA 1974 HN(75) MHÑMoniliformis ANdo not use /blood-csf-urine; infection: coord NIM with HELMINTHIASIS (IM) MNB1.500.132.546 DMÑAcanthocephala LH LM  MSThe continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. OLuse MONITORING, PHYSIOLOGIC to search MONITORING SYSTEMS 1966-77 PM78; MONITORING SYSTEMS was heading 1966-77 HN78; MONITORING SYSTEMS was heading 1966-77 MHÑMonitoring, Physiologic ANonly /instrum /methods /stand /util (if by MeSH definition) /vet; Holter monitoring: coord with ELECTROCARDIOGRAPHY; note see related: there emphasis is on the computer-assisted processing MNE1.621 XSPatient Monitoring FXÑSignal Processing, Computer-Assisted LH LS LX  MHÑMonkey Diseases ANdo not use /compl /vet; does not include diseases of chimpanzees: CHIMPANZEE is an ape, not monkey; don't forget to check tag ANIMAL MNC22.576 LH  MSA virus causing an epidemic disease among captive primates. HN(75); was see under POXVIRUSES 1975-80 MHÑMonkey Pox Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with POXVIRUS INFECTIONS (IM) MNB4.909.204.783.450 DMÑPoxviridae LH LM  MSGlycerol-monoester hydrolase. Catalyzes the hydrolysis of glycerol monoesters of long-chain fatty acids. HN(75); was see under ESTERASES 1975 MHÑMonoacylglycerol Lipases ANdo not use /analogs RNEC 3.1.1.23 PIEsterases (70-74); Glycerides (70-74) MND8.586.277.352.100.500 XSGlycerol Monoester Hydrolases; Monoglyceride Esterases; Monoglyceride Lipases DMÑCarboxylic Ester Hydrolases LH LS; ; LM  MHÑMonoamine Oxidase ANdo not use /analogs /antag ( = MONOAMINE OXIDASE INHIBITORS); DF: MAO RNEC 1.4.3.4 MND8.586.682.135.697 XUÑBenzylamine Oxidase LH LU  MHÑMonoamine Oxidase Inhibitors ANdo not use /analogs /antag /biosyn /defic /physiol; DF MAO INHIB MND8.373.616; D15.236.122.627 LH  MSMonocyclic, bacterially produced or semisynthetic beta-lactam antibiotics; they lack the double ring construction of the traditional beta-lactam antibiotics and can easily by synthesized; addition of therapeutically proven penicillin and cephalosporin side chains to the monobactam nucleus will yield other beta-lactamase-resistant and more efficaceous antibiotics. PM86 HN86 MHÑMonobactams ANdo not use /analogs /defic /physiol; do not use /biosyn unless by living matter PIAntibiotics (66-82); Antibiotics, Lactam (83-85) MND20.85.99.598 XSBeta-Lactams, Monocyclic; Monocyclic Beta-Lactams LH LS;  MSConditions characterized by the presence of a monoclonal serum (or urine) protein without clinical manifestations of plasma cell dyscrasia. HN(86) MHÑMonoclonal Gammopathies, Benign PIBlood Protein Disorders (66-68); Hypergammaglobulinemia (69-85) MNC15.378.147.542.640; C20.683.460.640; C20.683.780.640 XSBenign Monoclonal Gammopathies DMÑHypergammaglobulinemia LH LS LM  HN(72) MHÑMonocrotophos ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN6923-22-4 PIInsecticides (66-71) MND2.705.471; D5.723.491.574.519 DMÑInsecticides, Organophosphate LH LM  MHÑMonocytes ANA 11 qualif & /class MNA11.118.637.652; A11.733.547; A15.145.229.637.652; A15.382.490.652; A15.382.680.547; A15.382.812.547 LH  HN76; MONOGRAPH was citation type 1976-81 MHÑMonograph ANa citation type in Field 19 on data form for indexers; Manual section 37 LH  MSHydrazine substituted by one methyl group. OLto search METHYLHYDRAZINE use MONOMETHYLHYDRAZINE back thru 1975 & HYDRAZINES 1966-74 HN(78); was METHYLHYDRAZINE see under HYDRAZINES 1966-77 MHÑMonomethylhydrazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN60-34-4 MND2.442.600.601 XSMethylhydrazine DMÑMethylhydrazines LH LS LM  PM73 HN73(65) MHÑMonomycin ANdo not use /biosyn /defic /physiol RN54597-56-7 MND9.203.408.51.567; D20.85.513 LH  MSMembrane transport proteins which bind glucose and sodium ions and enter the cell together. The sodium ions are then pumped out of the cell by a sodium potassium ATPase. The rate and extent of the sugar transport depends on the sodium ion concentration. Inhibitors of the monosaccharide transport system are phlorizin, cytochalasin B, and inhibitors of the sodium potassium ATPase system. Insulin increases the rate of monosaccharide transport across the membrane into the cell. PM86 HN86 MHÑMonosaccharide Transport Proteins AN/biosyn /physiol permitted; restrict to glucose or hexose transport proteins PICarrier Proteins (73-85); Galactose (66-85); Glucose (66-85); Monosaccharides (66-85) MND12.776.157.590 XSGlucose Transport Protein; Glucose-Sodium Transport System; Hexose Transport Proteins; Sodium-Glucose Transport System LH LS; ; ;  MHÑMonosaccharides ANGEN: prefer specifics; do not use /analogs MND9.203.546 LH  MSThe condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1. HN(85) MHÑMonosomy ANnote category: ╥one chromosome of a pair is missing╙; no qualif; partial monosomy = MONOSOMY, PARTIAL see CHROMOSOME DELETION PIAneuploidy (68-84); Chromosome Aberrations (68-84); Chromosome Abnormalities (66-84); Chromosome Deletion (75-84) MNG5.148.266.300.560 DMÑChromosome Deletion LH LM  OLsearch MAMMALS 1966-67 PM75,63-67 HN75(73)63-67 MHÑMonotremata ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIMammals (66-72) MNB2.649.627 XUÑEchidna; ÑPlatypus LH LU;  MHÑMonsters ANdo not use /congen MNC16.131.581 LH  MHÑMontana MNZ1.107.567.875.552 LH  OLsearch OPERATIONS RESEARCH 1966-74 HN(75) MHÑMonte Carlo Method ANno qualif MNL1.906.575.422 DMÑOperations Research LH LM  MSFracture in the proximal half of the shaft of the ulna, with dislocation of the head of the radius. OLsearch ULNA FRACTURES 1973-74 HN(75) MHÑMonteggia's Fracture MNC21.866.405.908.547 DMÑUlna Fractures LH LM  MS[(4-piperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo]-2,2',2'',2'''-tetraethanol. Proposed antineoplastic agent; may have antiplatelet properties. OLuse MOPIDAMOL to search RA 233 back thru 1975 HN(85); was RA 233 see under PYRIMIDINES 1975-84 MHÑMopidamol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13665-88-8 PIEthanolamines (73-74); Piperidines (71-74); Pyrimidines (71-74) MND3.383.742.430; D22.204.565 XSRA 233 DMÑPyrimidines LH LS LM  MSThe prevailing temper or spirit of an individual or group in relation to the tasks or functions which are expected. MHÑMorale ANno qualif MNF1.829.477 LH  MSStandards of conduct as right or wrong. MHÑMorals ANno qualif MNF1.829.500; K1.316.630; K1.752.256.547 XUÑConscience LH LU  MS(E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(3-methyl-2-thienyl)vinyl]pyrimidine tartrate (1:1). Antinematodal agent used mainly for livestock. HN(75) MHÑMorantel ANdo not use /biosyn /defic /physiol; /analogs NIM only RN20574-50-9 PIPyrimidines (72-74); Thiophenes (72-74) MND3.383.742.440; D3.383.903.440; D21.201.287.505 DMÑPyrimidines LH LM  MHÑMoraxella ANcauses conjunctivitis; do not use /blood-csf-urine; infection: coord NIM with BACTERIAL INFECTIONS (IM) MNB3.400.699.400 LH  MSThe proportion of patients with a particular disease during a given year per given unit of population. MHÑMorbidity ANGEN only: no qualif; prefer /occur with diseases; specify geog if possible CATALOG: /geog /form MNN1.224.935.597 LH  MHÑMorocco MNZ1.58.266.629 LH  PM69; BENZOMORPHAN was see under BRIDGED COMPOUNDS 1966-72 HN69 MHÑMorphinans ANdo not use /analogs /biosyn /defic /physiol PICodeine (66-68); Diacetylmorphine (66-68); Dihydromorphinone (66-68); Morphine (66-68); Opium (66-68); Thebaine (66-68) MND3.132.610.422; D3.549.686; D3.605.497 XUÑBenzomorphans; ÑButorphanol; ÑCyclorphan; ÑDextrorphan; ÑDiprenorphine; ÑEtorphine; ÑNalbuphine LH LU; ; ; ; ; ;  MHÑMorphine ANdo not use /biosyn /defic /physiol; /analogs = MORPHINE DERIVATIVES RN57-27-2 MND3.132.610.422.547; D3.549.686.575; D3.605.497.575; D14.73.153.616.547; D14.757.638.547 LH  MSStrong dependence, both physiological and emotional, upon morphine. OLuse MORPHINE DEPENDENCE to search MORPHINE ADDICTION back thru 1966 PM81; was MORPHINE ADDICTION 1963-80 HN81; was MORPHINE ADDICTION 1963-80 MHÑMorphine Dependence ANmorphine only: not for the man-on-the-street heroin addict ( = HEROIN DEPENDENCE); do not use /chem ind /drug eff /physiol /rad eff MNF3.709.597.780.660.400.560 LH  MSAnalogs or derivatives of morphine. OLsearch MORPHINANS 1969-74 PM78; was see under MORPHINE 1975-77, was see under MORPHINANS 1969-74 HN78(75); was see under MORPHINE 1975-77, was see under MORPHINANS 1969-74 MHÑMorphine Derivatives ANdo not use /analogs /biosyn /defic /physiol PIMorphine (66-74); Morphinans (69-74) MND3.132.610.422.547.547; D3.549.686.575.547; D3.605.497.575.547 XUÑDihydromorphine; ÑEthylmorphine LH LU;  MS4-Dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-N-(morpholinomethyl)-1,11-dioxo-2-naphthacenecarboxamide. Analog of tetracycline. HN(75) MHÑMorphocycline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3098-60-0 PIMorpholines (71-74); Tetracycline (71-74) MND20.85.868.570 XSN-Methylmorpholinotetracycline DMÑTetracyclines LH LS LM  PM72 HN72(68) MHÑMorphogenesis ANNIM with specific organ or organism (IM); only /drug eff /rad eff; for uni- & multicellular organisms PIGrowth (66-67) MNG7.553.686 LH  MHÑMorpholines ANdo not use /analogs /biosyn /defic /physiol MND3.383.468 XSTetrahydro-1,4-Oxazines XUÑFominoben; ÑViloxazine LH LS LU;  MSAll deaths reported in a given population. MHÑMortality ANIM GEN only: no qualif; prefer /mortal with diseases: Manual 19.4.41, 19.5+; specify geog; for human & animal; a statistic concept, not for individual deaths in case reports; do not confuse with DEATH, the physiol dying or death CATALOG: /geog /form MNN1.224.935.698 XSDEATH RATE LH LS  MSActivities associated with the burial of the dead. Excludes cultural practices such as funeral rites. OLuse MORTUARY PRACTICE to search CEMETERIES & CREMATION back thru 1966 HNCEMETERIES & CREMATION were see under MORTUARY PRACTICE 1963-78 MHÑMortuary Practice ANonly /econ /hist /trends MNG2.438 XSCemeteries; Cremation; UNDERTAKING FXÑDeath XUÑBurial LH LS; ; LX LU  MSThe early embryo at the developmental stage in which the blastomeres, resulting from repeated mitotic divisions of the fertilized ovum, form a compact mass. HN(80) MHÑMorula ANA 11 qualif MNA16.254.270.550 DMÑCleavage Stage, Ovum LH LM  MSViruses which produce a mottled appearance of the leaves of plants. PM79; was see under PLANT VIRUSES 1975-78 HN79(73); was see under PLANT VIRUSES 1975-78 MHÑMosaic Viruses ANdo not use /cytol; alfalfa mosaic virus: coord with ALFALFA (NIM); don't forget TOBACCO MOSAIC VIRUS PIPlant Viruses (66-72) MNB4.715.464 LH  MSThe occurrence in an individual of two or more cell populations of differing chromosomal constitution, derived from a single zygote. PM67 HN67(64) MHÑMosaicism ANonly /drug eff /rad eff MNG5.148.630 FXÑFREEMARTINISM; ÑRADIATION CHIMERA LH LX;  HN66 MHÑMoscow MNZ1.433.653; Z1.542.248.950.820.630; Z1.950.820.630 LH  MHÑMosquito Control ANonly /econ /hist /instrum /methods /stand /trends MNG3.850.180.600.310.400 FXÑChemosterilants; ÑInsecticide Resistance; ÑPest Control, Biological LH LX; ;  MHÑMosquitoes ANGEN: prefer specifics; /microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111; mosquito bites = MOSQUITOES (IM) + INSECT BITES AND STINGS (IM) MNB1.131.617.289.610 LH  MSInteraction between the mother and the child. PM68 HN68 MHÑMother-Child Relations ANhuman only; no qualif PIParent-Child Relations (66-67) MNF1.829.263.370.290.170 LH  MSFemale parents, human or animal. PM78 HN78 MHÑMothers ANhuman & animal; only /psychol (consider also MOTHER-CHILD RELATIONS); permitted for legal aspects of establishing maternity (as counterpart of PATERNITY); note category: do not confuse with PREGNANCY, a physiol state PIFemale (66-77); Maternal Behavior (68-77); Mother-Child Relations (68-77) MNF1.829.263.500.320.200; I1.880.225.500.340.270; M1.620.630 XUÑSurrogate Mothers LH LU  MSInsects of the suborder Heterocera of the order Lepidoptera. HN(75) MHÑMoths AN/microbiol /parasitol permitted; don't forget SILKWORMS exists; TN 111 for eff of insecticides MNB1.131.617.561.650 DMÑLepidoptera LH LM  MSA 22 amino acid polypeptide (molecular weight 2700) isolated from the duodenum. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect. PM86; was see under GASTROINTESTINAL HORMONES 1977-85 HN86(77); was see under GASTROINTESTINAL HORMONES 1977-85 MHÑMotilin AN/biosyn /physiol permitted RN52906-92-0 PIGastrointestinal Hormones (72-76); Peptides (72-76) MND6.472.317.525; D12.644.355; D12.776.641.650.450; D19.316.629.601 LH  MSPhysical motion; i.e., a change in position of a body or subject because of an external force; to be distinguished from MOVEMENT, a process resulting from biological activity. OLsearch MOVEMENT 1966-67 PM68; was see under MOVEMENT 1963-67 HN68; was see under MOVEMENT 1963-67 MHÑMotion ANno qualif; a concept in physics: a bullet shot from a gun is MOTION: differentiate from MOVEMENT, a concept in physiol; see note there PIAcceleration (66-67); Kinetics (66-67); Movement (66-67) MNH1.671.538 FXÑMOVEMENT LH LX  MSThe real or apparent movement of objects through the visual field. MHÑMotion Perception ANonly /drug eff /physiol /rad eff; TN 129: relation to KINESTHESIS MNF2.463.593.533 LH  MHÑMotion Pictures ANonly /class /econ /hist /instrum /stand /supply /trends /util (if by MeSH definition) MNL1.178.147.598 FXÑCineangiography; ÑCineradiography; ÑPhotography LH LX; ;  MSSickness caused by motion, as sea sickness, train sickness, car sickness, and air sickness. OLuse MOTION SICKNESS to search AIRSICKNESS, CARSICKNESS & SEASICKNESS back thru 1966 HNAIRSICKNESS, CARSICKNESS & SEASICKNESS were see under MOTION SICKNESS 1963-78 MHÑMotion Sickness MNC9.218.568.498; C21.866.620 XSAirsickness; Carsickness; Seasickness LH LS; ;  MSThose factors which cause an organism to behave or act either in a goal-seeking or satisfying manner. May be influenced by physiological drives or by external stimuli. MHÑMotivation ANhuman & animal; only /drug eff /physiol /rad eff MNF1.658 XSIncentives FXÑCognitive Dissonance; ÑEmotions; ÑLIBIDO LH LS LX; ;  MSThe physical activity of an organism as a behavioral phenomenon. PM68 HN68 MHÑMotor Activity ANhuman & animal; only /drug eff /physiol /rad eff; = movement as associated with behavior: differentiate from MOVEMENT, a physiol process; TN 130: discussion on MOVEMENT; HYPERKINESIS is also available; animal running in exercise wheel goes here (unless better under EXERTION) PIBehavior (66-67); Behavior, Animal (66-67) MNF1.145.632; G11.427.614.698 LH  PM71 HN71 MHÑMotor Cortex ANdo not use /innerv PICerebral Cortex (66-70) MNA8.186.211.885.213.270.548 LH  OLsearch NEUROMUSCULAR JUNCTION 1968-74 HN(75) MHÑMotor Endplate ANdo not use /innerv; do not confuse with NERVE ENDINGS MNA8.796.511.479.563.548 DMÑNeuromuscular Junction LH LM  PM66 HN66(64) MHÑMotor Neurons ANA 11 qualif; motor neuron disease = MOTOR NEURONS (IM) + NEUROMUSCULAR DISEASES (IM) MNA8.663.496; A11.671.472 XUÑAnterior Horn Cells; ÑMotor Neurons, Gamma LH LU;  MSNeurons which terminate on the intrafusal fibers of the muscle spindle and synapse with terminals from the voluntary motor cortex so that the myotatic reflex may be under voluntary control. Includes gamma 1 and gamma 2 efferents. OLuse MOTOR NEURONS, GAMMA to search MOTOR NEURONS, GAMMA EFFERENT back thru 1975 HN(79); was MOTOR NEURONS, GAMMA EFFERENT see under MOTOR NEURONS 1975-78 MHÑMotor Neurons, Gamma ANA 11 qualif MNA8.663.496.500; A11.671.472.500 XSNeurons, Fusimotor; Neurons, Gamma Motor DMÑMotor Neurons LH LS; LM  MSPerformance of complex motor acts. MHÑMotor Skills ANonly /drug eff /physiol /rad eff MNF2.808.260 FXÑChild Development LH LX  MSTwo-wheeled, engine driven vehicles. PM87 HN87 MHÑMotorcycles ANonly /class /econ /hist /stand /supply PITransportation (76-86) MNJ1.937.605 XSMopeds LH LS  PM65 HN65 MHÑMottled Enamel ANdo not use /congen /chem ind; do not confuse with TOOTH DISCOLORATION MNC7.793.540 XSFluorosis, Dental LH LS  MSA sport involving mountain climbing techniques. MHÑMountaineering ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM) MNI3.450.642.845.582 FXÑAltitude LH LX  MSViruses producing leukemia in mice, commonly obtained by injecting filtrates of propagable tumors into newborn mice. The Gross strain occurs spontaneously in inbred mice, but none of the other strains occur naturally. PM66 HN66 MHÑMouse Leukemia Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) MNB4.909.574.807.674.632; B4.909.777.731.674.632; B4.909.777.779.674.632 XSThymic Group Viruses XUÑAKR Virus; ÑAbelson Leukemia Virus; ÑGraffi Virus; ÑMink Cell Focus-Inducing Viruses; ÑSpleen Focus-Forming Viruses LH LS LU; ; ; ;  MSA group of defective RNA tumor viruses which are capable of transforming cells, but which replicate and produce tumors only in the presence of related leukemia viruses. OLuse MOUSE SARCOMA VIRUSES to search MOUSE SARCOMA VIRUS back thru 1975 PM80; was MOUSE SARCOMA VIRUS see under MOUSE TUMOR VIRUSES 1975-79 HN80; was MOUSE SARCOMA VIRUS see under MOUSE TUMOR VIRUSES 1975-79 MHÑMouse Sarcoma Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with SARCOMA, EXPERIMENTAL (IM) PIMouse Tumor Viruses (66-74) MNB4.909.574.807.674.700; B4.909.777.731.674.700; B4.909.777.779.674.700 XUÑHarvey Sarcoma Virus; ÑKirsten Sarcoma Virus; ÑMoloney Sarcoma Virus LH LU; ;  MSViruses which cause solid tumors or leukemias in mice. PM66 HN66 MHÑMouse Tumor Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) MNB4.909.574.807.674; B4.909.777.731.674; B4.909.777.779.674 LH  OLuse MOUTH to search MOUTH MICROORGANISMS 1966-67 PM/microbiology was MOUTH MICROORGANISMS 1965-67 HN/microbiology was MOUTH MICROORGANISMS 1965-67 MHÑMouth AN/abnorm = MOUTH ABNORMALITIES; /surg permitted: do not confuse with SURGERY, ORAL, a dental speciality; ORAL MANIFESTATIONS is available but general only in non-oral dis; inflammation = STOMATITIS; mucositis: index under STOMATITIS (IM) + MOUTH MUCOSA (NIM); denture-sore mouth = STOMATITIS, DENTURE (IM) + specific denture term /adv eff (NIM); dryness of mouth = XEROSTOMIA; ╥stomatology╙ as speciality goes under ORAL MEDICINE see DENTISTRY & in translations as ╥oral medicine╙; mouth odors = HALITOSIS; consider other terms under ORAL, ORO- & STOMAT- MNA1.456.505.631; A14.549 LH  PM65 HN65 MHÑMouth Abnormalities ANdo not use /congen MNC16.131.314.687 LH  OLpre-explosion = MOUTH AD TOOTH DISEASES (PX) MH*Mouth and Tooth Diseases (Non Mesh) MNC7 LH  MSAbnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages. PM72 HN72(68) MHÑMouth Breathing ANnote category: use all pertinent qualif PIRespiration (66-67) MNC8.618.659; C23.888.852.749 LH  OLsearch MOUTH MICROORGANISMS under MOUTH 1966-67 PM65; was STOMATOLOGY 1963-64; MOUTH MICROORGANISMS was heading 1965-67 HN65; was STOMATOLOGY 1963-64; MOUTH MICROORGANISMS was heading 1965-67 MHÑMouth Diseases ANGEN only: prefer specifics; inflamm dis = STOMATITIS; mucositis: index under STOMATITIS (IM) + MOUTH MUCOSA (NIM); index here for ╥stomatol dis╙ of foreign lit MNC7.465 FXÑDiagnosis, Oral; ÑHALITOSIS; ÑMOUTH REHABILITATION; ÑORAL HEALTH XUÑBurning Mouth Syndrome; ÑLeukoedema, Oral; ÑMicrostomia; ÑOral Submucous Fibrosis LH LX; ; ; LU; ; ;  OLuse MOUTH FLOOR to search SUBLINGUAL REGION 1972-73 (as Prov) PM74 HN74; was SUBLINGUAL REGION 1972-73 (Prov) MHÑMouth Floor ANNIM when merely locational MNA14.549.441 XSFLOOR OF MOUTH; SUBLINGUAL REGION LH LS;  PM65 HN65 MHÑMouth Mucosa AN/surg: consider also VESTIBULOPLASTY; mucositis: coord NIM with STOMATITIS (IM) MNA10.615.550.599; A14.549.512 LH  MHÑMouth Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.591; C7.465.565 LH  OLconsider also MOUTH /PH or /PH with specific parts of the mouth MH*Mouth Physiology (Non Mesh) MNG10.549 LH  PM65 HN65 MHÑMouth Protectors ANonly /adv eff /stand /supply /util (if by MeSH definition) /vet MNE6.761.599; E7.712.549 XSMOUTHPIECES LH LS  PM65 HN65 MHÑMouth Rehabilitation ANGEN only; only /econ /instrum /methods /stand /trends; to restore mouth to optimal form & function (filling & replacing teeth, ther of mouth & tooth dis, etc.): prefer specifics in Cat E6 MNE6.584 FXÑMouth Diseases; ÑOral Health; ÑTooth Diseases LH LX; ;  MSHaving teeth in neither the mandible nor the maxilla. PM65; included total & partial edentulousness 1965-79 HN65; included total & partial edentulousness 1965-79 MHÑMouth, Edentulous ANtotal lack of teeth through disease or extraction; do not confuse with ANODONTIA (congen absence of one or more teeth); differentiate from JAW, EDENTULOUS & JAW, EDENTULOUS, PARTIALLY (see definitions under JAW, EDENTULOUS); only /econ /etiol /microbiol /parasitol /pathol /physiopathol /prev /psychol /radiogr /radionuclide /rehabil /surg /vet MNC7.465.340.630 FXÑDenture, Complete; ÑSurgery, Oral, Preprosthetic LH LX;  PM65 HN65 MHÑMouthwashes AND25-26 qualif MND25.583; D26.313.548; J1.516.599 FXÑDentifrices XUÑSaliva, Artificial LH LX LU  MHÑMovement ANonly /drug eff /rad eff; the physiol process of an organism in moving one or more parts: do not confuse with LOCOMOTION (see note there) or MOTION, a concept of physics or MOTOR ACTIVITY, movement associated with behavior; animal running in exercise wheel is probably MOTOR ACTIVITY or EXERTION; NIM for microorganisms; movement of cells = CELL MOVEMENT; probably NIM if specific organism is IM; TN 130: definition & examples MNG11.427.614 FXÑIMMOBILIZATION; ÑMOTION LH LX;  MHÑMovement Disorders ANdo not use /chem ind ( = DYSKINESIA, DRUG-INDUCED) MNC10.597.559; C23.888.592.574 XSDyskinesia FXÑPSYCHOMOTOR DISORDERS LH LS LX  MS7-[[Carboxy(4-hydroxyphenyl)acetyl]amino]-7- methoxy-3-[[(1-methyl-1H-tetrazol-5- yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct -2-ene-2-carboxylic acid disodium salt. Broad spectrum beta-lactam antibiotic similar in structure to the cephalosporins except for the substitution of oxa-azabicyclo for the thia-azabicyclo moiety of certain cephalosporins; proposed especially for the meningitides, because it passes the blood-brain barrier and for anaerobic infections. PM84 HN84 MHÑMoxalactam ANdo not use /biosyn /defic /physiol RN64952-97-2 PIAntibiotics (66-80); Cefamandole/AA (78-83); Cephalosporins (66-74); Cephamycins (75-77); Lactams (72-80) MND20.85.99.603 XS1-Oxacephalosporin LH LS  OLuse MOXIBUSTION to search MOXA 1966 PM67; was MOXA 1963-66 HN67; was MOXA 1963-66 MHÑMoxibustion ANonly /adv eff /hist /instrum /methods MNE2.684 LH  MSBilateral internal carotid artery occlusion with extensive intracranial collateral circulation. HN(78) MHÑMoyamoya Disease AN╥bilateral internal carotid artery occlusion with extensive intracranial collat circ╙; from a Japanese word for ╥hazy╙ with reference to its radiogr appearance PICarotid Artery Diseases (66-77); Cerebral Artery Diseases (66-77); Cerebrovascular Disorders (66-77) MNC14.907.137.615; C14.907.253.123.620 DMÑArterial Occlusive Diseases LH LM  MHÑMozambique MNZ1.58.349.603 LH  OLuse MSH to search INTERMEDIN back thru 1966 PM68; was INTERMEDIN 1963-67 HN68; was INTERMEDIN 1963-67 MHÑMSH AN/biosyn /physiol permitted; alpha-MSH, beta-MSH, etc. go here RN9002-79-3 MND6.472.734.525.583; D12.644.360; D12.776.641.650.460 XSINTERMEDINS; MELANOCYTE-STIMULATING HORMONES; Melanotropin LH LS; ;  MSAn oligopeptide hormone produced in the hypothalamus which inhibits the release of melanocyte stimulating hormone (MSH). PM75 HN75 MHÑMSH Release Inhibiting Hormone AN/biosyn /physiol permitted; ╥produced in the hypothalamus╙; DF: MSHRIH RN2002-44-0 PIHypothalamo-Hypophyseal System (66-74); Hypothalamus (66-74); Pituitary Hormone Releasing Hormone (71-74); MSH (66-74); Oligopeptides (73-74); Peptides (71-73) MND6.347.560.500; D12.644.363; D12.776.641.650.465 XSMSH Release Inhibiting Factor; Melanocyte-Stimulating Horm Release Inhibiting Hormone; Prolyl-Leucyl-Glycinamide LH LS; ;  MSA polypeptide hormone which originates in the hypothalamus and stimulates secretion of melanocyte-stimulating hormones in the pituitary gland. PM75 HN75 MHÑMSH Releasing Hormone AN/biosyn /physiol permitted; ╥originates in the hypothalamus╙; DF: MSHRH PIMSH/AI (68-74); Pituitary Hormone Releasing Hormones (68-74) MND6.472.709.500; D12.644.365; D12.776.641.650.470 XSMelanocyte-Stimulating Horm Releasing Hormone LH LS  OLuse MUCINS to search MUCIN back thru 1966 PM79; was MUCIN 1963-78 HN79; was MUCIN 1963-78 MHÑMucins AN/biosyn /physiol permitted; do not use /analogs MND12.776.395.560.631 LH  PM65 HN65 MHÑMucocele ANnon-neoplastic MNC4.182.511 FXÑRANULA LH LX  MSAn acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, edema or erythema of the extremities. PM84; was see under LYMPHATIC DISEASES 1977-83 HN84(77); was see under LYMPHATIC DISEASES 1977-83 MHÑMucocutaneous Lymph Node Syndrome ANDF: MLNS MNC14.907.184.520; C14.907.940.90.622; C15.604.560; C23.205.560 XSKawasaki Disease; Lymph Node Syndrome, Mucocutaneous LH LS;  MSInherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. Mental retardation and skeletal changes are common. PM77 HN77 MHÑMucolipidosis ANdo not use /congen PILipid Metabolism, Inborn Errors (66-76); Lipochondrodystrophy (66-76); Lipoidosis (66-76); Mucopolysaccharidosis (74-76) MNC10.496.600; C18.452.648.625; F3.709.346.625 XSI-Cell Disease; Lipomucopolysaccharidosis; Pseudo-Hurler Polydystrophy LH LS; ;  MSHeteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4 and 1,3 linkages. MHÑMucopolysaccharides ANdo not use /analogs MND9.203.698.582 XUÑHeparitin Sulfate; ÑKeratan Sulfate; ÑSchizophyllan LH LU; ;  PM74 HN74 MHÑMucopolysaccharidosis ANdo not use /congen MNC18.452.648.202.715; C23.205.615 XUÑMucopolysaccharidosis 3; ÑMucopolysaccharidosis 5; ÑMucopolysaccharidosis 6 LH LU; ;  MSMucopolysaccharidosis with heparitin sulfate in urine, progressive mental retardation and mild dwarfism and other skeletal disorders. HN(75) MHÑMucopolysaccharidosis 3 ANdo not use /congen PICarbohydrate Metabolism, Inborn Errors (66-76); Mental Retardation (66-76); Mucopolysaccharides/ME (66-74); Mucopolysaccharidosis (74) MNC18.452.648.202.715.650; C23.205.615.650 XSPolydystrophic Oligophrenia; Sanfilippo's Syndrome DMÑMucopolysaccharidosis LH LS; LM  MSA genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy and excessive urinary keratan sulfate. OLuse MUCOPOLYSACCHARIDOSIS 4 to search ECCENTROOSTEOCHONDRODYSPLASIA back thru 1966 PM80; was ECCENTROOSTEOCHONDRODYSPLASIA 1963-79 HN80; was ECCENTROOSTEOCHONDRODYSPLASIA 1963-79 MHÑMucopolysaccharidosis 4 ANdo not use /congen MNC5.116.99.682; C18.452.648.202.715.655; C23.205.615.655 XSEccentro-osteochondrodysplasia; Morquio Disease LH LS;  MSMucopolysaccharidosis with increased urinary chondroitin sulfate B, heparin sulfate, with corneal clouding, mild skeletal disorders, characteristic facies. HN(75) MHÑMucopolysaccharidosis 5 ANdo not use /congen PICarbohydrate Metabolism, Inborn Errors (66-74); Corneal Opacity (66-74); Mucopolysaccharides/ME (66-74); Mucopolysaccharidosis (74); Retinitis Pigmentosa (66-74) MNC18.452.648.202.715.660; C23.205.615.660 XSScheie's Syndrome DMÑMucopolysaccharidosis LH LS LM  MSMucopolysaccharidosis with excessive chondroitin sulfate B in urine, characterized by dwarfism and deafness. HN(75) MHÑMucopolysaccharidosis 6 ANdo not use /congen PICarbohydrate Metabolism, Inborn Errors (66-74); Chondroitin (66-74); Mucopolysaccharides/ME (66-74); Mucopolysaccharidosis (74) MNC18.452.648.202.715.670; C23.205.615.670 XSMaroteaux-Lamy Syndrome; Polydystrophic Dwarfism DMÑMucopolysaccharidosis LH LS; LM  MSConjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight. MHÑMucoproteins ANincludes mucoids & mucopeptides; do not use /analogs MND12.776.395.560 LH  MSA genus of zygomycetous fungi of the order Mucorales, primarily saprophytic, but may cause MUCORMYCOSIS in man from spores germinating in the lungs. MHÑMucor ANnote: a fungus; do not use /anat /embryol /microbiol /parasitol; infection = MUCORMYCOSIS MNB5.354.730.944.550.500 LH  MSAn order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases. OLsearch PHYCOMYCETES 1966-74 PM79; was see under PHYCOMYCETES 1963-78; PHYCOMYCES was see under PHYCOMYCETES 1975-85 HN79(75); was see under PHYCOMYCETES 1963-78 MHÑMucorales ANdo not use /anat /embryol /microbiol /parasitol; infection = MUCORMYCOSIS PIPhycomycetes (66-74) MNB5.354.730.944.550 XUÑPhycomyces LH LU  MHÑMucormycosis ANa mycosis caused by various MUCORALES MNC1.703.663 LH  MHÑMucous Membrane ANGEN only; almost never IM: coord NIM with specific organ (IM); = mucosa or mucosal tissue; do not use /abnorm /growth /inj /innerv MNA10.615.550 LH  PM66 HN66(63) MHÑMucus ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; mucus glands: index MUCUS (IM) + EXOCRINE GLANDS (IM) MNA12.838.503 LH  MHÑMud Therapy ANdo not use /util except by MeSH definition MNE2.780.108.610 XSFangotherapy; Mud Baths; Peat Therapy LH LS; ;  MSTwo ducts of the embryo which empty into the cloaca, and which in the female develop into vagina, uterus and oviducts; in the male they disappear except for the vestigial vagina masculina and the appendix testis. PM72 HN72(65) MHÑMullerian Ducts ANdo not use /abnorm /embryol /growth /inj MNA16.254.570 LH  MSInstitutional systems consisting of more than one health facility which have cooperative administrative arrangements through merger, affiliation, shared services, or other collective ventures. PM80 HN80 MHÑMulti-Institutional Systems ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form PIHospital Administration (66-79); Hospital Shared Services (68-79) MNN4.452.540 XSMultihospital Systems LH LS  PM73 HN73 MHÑMultienzyme Complexes ANdo not use /analogs PIspecific enzymes or enzyme groups MND8.586.600 XUÑAspartokinase Homoserine Dehydrogenase; ÑSucrase-Isomaltase Complex LH LU;  MSThe simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people. PM68 HN68 MHÑMultiphasic Screening ANonly /econ /instrum /methods /stand /trends PIDiagnosis (66-67); Mass Screening (66-67); Physical Examination (66-67) MNE1.563.633; G3.850.520.610.580.360; N1.224.458.527.633; N2.421.143.827.233.443.633; N2.421.726.233.443.633 XSAutomated Multiphasic Health Testing LH LS  MH*Multiple Birth Named Groups (Non Mesh) MNM1.438 LH  MSAbnormalities in carbohydrate and branched chain amino acid catabolism that are responsive to biotin therapy; may be due to deficiency of propionyl-CoA carboxylase, or methylcrotonyl-CoA carboxylase, or biotinidase, or propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase and pyruvate carboxylase. PM87 HN87 MHÑMultiple Carboxylase Deficiency ANdo not use /congen PIspecific enzyme/deficiency (75-86); specific enzyme (66-74) MNC18.452.648.66.620; C18.452.648.202.720 XSCarboxylase Deficiency, Multiple; Combined Carboxylase Deficiency LH LS;  MSA malignant tumor of plasma cells usually arising in the bone marrow; characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria, and anemia. MHÑMultiple Myeloma ANmyeloma unspecified is probably MULTIPLE MYELOMA; solitary myeloma = PLASMACYTOMA MNC4.557.386.720.550; C15.378.147.780.650; C20.683.515.761.720.550; C20.683.780.650 XSMYELOMA, PLASMA CELL FXÑMYELOMA PROTEINS LH LS LX  MSA progressive condition usually characterized by combined failure of the lungs, liver, kidney, and clotting mechanisms, usually postinjury or postoperative. PM83 HN83 MHÑMultiple Organ Failure ANIM; only /pathol /physiopathol MNC23.625 XSOrgan Failure, Multiple LH LS  MHÑMultiple Sclerosis MNC10.228.337.578; C20.111.610 XSSCLEROSIS, DISSEMINATED LH LS  MSA dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden. OLuse MULTIPLE-PERSONALITY DISORDER to search DUAL PERSONALITY & MULTIPLE PERSONALITIES back thru 1968 PM79; was MULTIPLE PERSONALITIES see under DUAL PERSONALITY 1968-78; DUAL PERSONALITY was heading 1968-78 HN79; was MULTIPLE PERSONALITIES see under DUAL PERSONALITY 1968-78; DUAL PERSONALITY was heading 1968-78 MHÑMultiple-Personality Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.438.416.520 XSDual Personality LH LS  MSBodies preserved either by the ancient Egyptian technique or due to chance under favorable climatic conditions. MHÑMummies ANno qualif; do not routinely check tags HISTORICAL ARTICLE + ANCIENT: check only when the hist & ancient med aspects are particularly discussed MNI1.76.368.584.709.500 FXÑEmbalming LH LX  MHÑMumps MNC2.782.660.625; C7.465.815.470.800.630 LH  PM72 HN72(69) MHÑMumps Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox PIMumps Virus (66-68); Viral Vaccines (66-68) MND24.310.894.899.488 LH  MHÑMumps Virus ANdo not use /blood-csf-urine /cytol MNB4.909.777.569.625 XSEpidemic Parotitis Virus; MYXOVIRUS PAROTITIDIS LH LS;  MSA factitious disorder characterized by habitual presentation for hospital treatment of an apparent acute illness, the patient giving a plausible and dramatic history, all of which is false. PM68 HN68(64) MHÑMunchausen Syndrome ANdo not use /drug eff /physiol /rad eff MNF3.709.438.500.620 XSHospital-Addiction Syndrome LH LS  MSUrban governmental functions. MHÑMunicipal Government ANno qualif; specify geog MNI1.409.550 LH  OLuse MURAMIC ACIDS to search MURAMIC ACID back thru 1973 (as Prov 1973-74) HN(75); was MURAMIC ACID 1973-74 (Prov) MHÑMuramic Acids ANdo not use /analogs /biosyn /defic /physiol PIAmino Sugars (66-70); Disaccharides (71-72); Glucosamine (66-72); Hexoseamines (66-72) MND2.241.81.844.520; D2.241.511.902.522; D9.203.67.550; D9.203.811.522 DMÑSugar Acids LH LM  MHÑMuramidase ANdo not use /analogs RNEC 3.2.1.17 MND8.586.277.450.642; D12.776.256.317.467 XSLYSOZYME LH LS  MS5,5'-Nitrilodibarbituric acid ammonium derivative. Used as an indicator for complexometric titrations. HN(75) MHÑMurexide AND25-26 qualif; /analogs NIM only RN3051-09-0 PIBarbiturates (69-74) MND3.383.742.698.253.500; D26.550.488 XSAcid Ammonium Purpurate; Ammonium Purpurate DMÑBarbiturates LH LS; LM  MSA family of the order Rodentia containing 100 genera including the two genera Mus and Rattus, from which the laboratory inbred strains are developed. Six subfamilies are Murinae, Dendromurinae, Otomyinae, Phloeomyinae, Rhynchomyinae, and Hydromyinae. This family includes Old World mice & rats.. PM82 HN82 MHÑMuridae ANa family of rodents including Old World mice & rats but see note on MICE & RATS; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not confuse X ref BANDICOOT RATS with bandicoot ( = MARSUPIALIA); do not check tags MICE or RATS for MURIDAE or any X ref below PIMice (66-81); Rats (66-81); Rodentia (66-81) MNB2.649.865.635 XSAcomys; Apodemus; Bandicoot Rats; Bandicota; Mastomys; Murids; Mus; Praomys; Rats, Bandicoot; Rattus LH LS; ; ; ; ; ; ; ; ;  MS2-Methyl-3-hydroxy-5(aminomethyl)tetrahydrofuran, trimethylammonium salt. The first parasympathomimetic substance ever studied; toxic alkaloid found in Amanita muscaria (Fly Agaric) and other fungi (Inocybe species); it causes profound parasympathetic activation that may end in convulsions and death; specific antidote is atropine. OLsearch PARASYMPATHOMIMETICS 1966-68 HN77; was see under PARASYMPATHOMIMETICS 1963-68 MHÑMuscarine ANan alkaloid: do not confuse with the dye muscarine; /biosyn permitted if by plant; do not use /defic /physiol RN300-54-9 PIAlkaloids (68-76); Ammonium Compounds (70-76); Furans (72-76); Mycotoxins (75-76); Parasympathomimetics (66-76) MND2.92.102.580; D2.675.276.580; D3.132.545; D16.698.632 LH  MS5-(Aminomethyl)-3-isoxazolol. Neurotoxic isoxazole isolated from Amanita muscaria and A. phalloides and also obtained by decarboxylation of ibotenic acid; strong GABA-mimetic used mainly as a tool in neuro- and psychophysiology. PM86; was see under OXAZOLES 1979-85 HN86(79); was see under OXAZOLES 1979-85 MHÑMuscimol ANdo not use /defic /physiol RN2763-96-4 PIMycotoxins (67-78); Oxazoles (66-78); Toxins (66) MND3.383.548.470; D16.538.85.395.615; D24.185.926.587.475.615 XSAgarin; Pantherine LH LS;  PM65 HN65(64) MHÑMuscle Contraction ANdo not use for HEART or MYOCARDIUM ( = MYOCARDIAL CONTRACTION) or UTERUS ( = UTERINE CONTRACTION); only /drug eff /rad eff; note MUSCLE RELAXATION as see under; muscle tension goes here MNG11.427.661 XSInotropism FXÑMyofibrils XUÑIsometric Contraction; ÑIsotonic Contraction; ÑMuscle Relaxation LH LS LX LU; ;  MHÑMuscle Cramp MNC5.651.475 XSCRAMP FXÑSpasm LH LS LX  PM65 HN65 MHÑMuscle Denervation ANonly /adv eff /instrum /methods MNE4.530.324.443 LH  MSAbnormal increase in muscle tone. PM79 HN79 MHÑMuscle Hypertonia ANnote category: not physiological PIMuscle Spasticity (77-78); Muscle Tonus (70-78); Spasm (66-76) MNC10.597.588; C23.888.592.588 LH  MSA diminution of the skeletal muscle tone with a diminished resistance to passive stretching. PM77 HN77 MHÑMuscle Hypotonia ANnote category: not physiological PIMuscular Diseases (66-76) MNC5.651.484; C10.597.559.596; C23.888.592.574.558 XSFlaccidity, Muscle; Muscle Flaccidity LH LS;  MHÑMuscle Proteins AN/biosyn /physiol permitted; do not use /analogs; for contractile proteins in muscle, index only under MUSCLE PROTEINS or specifics & not also under CONTRACTILE PROTEINS MND12.776.210.500 XUÑCalsequestrin; ÑParvalbumins LH LU;  OLsearch MUSCLE RELAXANTS under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 & MUSCLES 1966-69 PM70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69 HN70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69 MHÑMuscle Relaxants, Central ANfor skeletal muscle relaxants only: smooth muscle relaxants = PARASYMPATHOLYTICS; do not use /analogs /biosyn /defic /physiol PIMuscles (66-69) MND17.426 XSCENTRALLY ACTING MUSCLE RELAXANTS; Skeletal Muscle Relaxants LH LS;  MSThat phase of a muscle twitch during which a muscle returns to a resting position. HN(77) MHÑMuscle Relaxation ANonly /drug eff /rad eff; do not use as coord for relaxation of cardiac muscle ( = MYOCARDIAL CONTRACTION) PIMuscle Contraction (66-76) MNG11.427.661.554 DMÑMuscle Contraction LH LM  MSContinuous tonic contraction of skeletal muscle. PM73 HN73(72) MHÑMuscle Rigidity ANnote category PIMuscular Diseases (66-71) MNC5.651.504; C10.597.588.638; C23.888.592.588.638 LH  MSA combination of the symptoms of increased resistance to lengthening, hyperactive tendon reflexes, and clonus. Occurs in hemiplegia. OLuse MUSCLE SPASTICITY to search PARALYSIS, SPASTIC 1966-78 PM77; PARALYSIS, SPASTIC was heading 1963-78 HN77; PARALYSIS, SPASTIC was heading 1963-78 MHÑMuscle Spasticity ANskeletal muscle only; note category: not physiological; spastic paralysis: coord NIM with PARALYSIS (IM); spastic paraplegia: coord NIM with PARAPLEGIA (IM); spasticity in cerebral palsy: coord NIM with CEREBRAL PALSY only if musc spasticity is especially discussed PISpasm (66-76) MNC5.651.512; C10.597.588.652; C23.888.592.588.652 XSSpasticity, Muscle FXÑSpasm LH LS LX  PM72 HN72(70) MHÑMuscle Tonus ANonly /drug eff /rad eff; DYSTONIA (Cat C), MUSCLE HYPERTONIA (Cat C) & MUSCLE HYPOTONIA (Cat C) are also available PIMuscle Contraction (66-69) MNG11.427.706 LH  MHÑMuscle, Smooth ANdo not use /abnorm /growth /inj /innerv; coord IM with specific organ (NIM & then only if pertinent); ╥involuntary╙ muscle goes here MNA2.633.570; A10.690.467 LH  MSThe nonstriated, involuntary muscle tissue of blood vessels. PM80 HN80 MHÑMuscle, Smooth, Vascular ANdo not use /abnorm /growth /inj /innerv; coord IM with specific vein or artery (NIM & then only if pertinent) PIMuscle, Smooth (66-79) MNA2.633.570.491; A10.690.467.491 LH  PM/transplantation was MUSCLE TRANSPLANTATION 1963-65 HN/transplantation was MUSCLE TRANSPLANTATION 1963-65 MHÑMuscles ANIM; Manual 21.8, 21.9; as tissue: Manual 21.52; unspecified as smooth or striated, voluntary or involuntary or skeletal; specified as skeletal, striated or voluntary = MUSCLES; involuntary or smooth = MUSCLE, SMOOTH; rectus abdominis & other abdom muscles go under ABDOMINAL WALL; /innerv: consider also NEUROMUSCULAR JUNCTION & MUSCLE DENERVATION; /surg: consider also SURGICAL FLAPS but see note there; muscle spindles = NEUROMUSCULAR SPINDLES; nerve-muscle preparation: index under NEUROMUSCULAR JUNCTION; inflammation = MYOSITIS; muscle fibers: index under MUSCLES, not MYOFIBRILS; consider muscle concepts also under MYO MNA2.633; A10.690 FXÑSARCOLEMMA; ÑSARCOPLASMIC RETICULUM XUÑLaryngeal Muscles; ÑNeck Muscles; ÑPalatal Muscles; ÑPharyngeal Muscles; ÑStapedius LH LX; LU; ; ; ;  MHÑMuscular Atrophy MNC5.651.661.468; C10.228.854.468; C10.668.468 XUÑCharcot-Marie Disease LH LU  MHÑMuscular Diseases ANGEN; prefer specifics; inflamm dis = MYOSITIS MNC5.651 LH  MHÑMuscular Dystrophy ANdo not use /vet ( = MUSCULAR DYSTROPHY, ANIMAL) MNC5.651.661.523; C10.668.523 LH  PM70 HN70 MHÑMuscular Dystrophy, Animal ANexper or vet but do not use /vet; don't forget to check tag ANIMAL PIMuscular Dystrophy (66-69) MNC22.595 XUÑWhite Muscle Disease LH LU  MHÑMusculocutaneous Nerve ANdo not use /innerv MNA8.796.828.169.501 LH  OLconsider also MUSCLES /AB & BONE AND BONES /AB & /AB with specific muscle & bone terms MH*Musculoskeletal Abnormalities (Non Mesh) MNC16.131.621 LH  OL╥musculoskeletal diseases╙ is indexed MUSCULAR DISEASES + BONE DISEASES; pre-explosion = MUSCULOSKELETAL DISEASES (PX) MH*Musculoskeletal Diseases (Non Mesh) MNC5 LH  MHÑMusculoskeletal System ANGEN; must be both musculo + skeletal, otherwise prefer BONE AND BONES or MUSCLES; avoid qualif; try to use qualif with specific bone or muscle term MNA2 LH  OLconsider also MUSCULOSKELETAL SYSTEM /PH, MUSCLES /PH & BONE AND BONES /PH or /PH with specific muscle & bone terms MH*Musculoskeletal System Physiology (Non Mesh) MNG11.427 LH  MH*Musculoskeletal, Neural, Eye Physiology (Non Mesh) MNG11 LH  MHÑMuseums ANonly /hist; medical museums: do not coord with MEDICINE MNK1.419.152.552 LH  MSPoisoning from ingestion of mushrooms, primarily from, but not restricted to toxic varieties. PM68 HN68 MHÑMushroom Poisoning ANdo not use /chem ind; = pois by mushroom toxins; TN 133: relation to food pois from canned mushrooms PIFood Poisoning (66-67); Mushrooms (66-67) MNC21.613.415.551 XSFungus Poisoning; Mycotoxicosis FXÑMYCOTOXINS LH LS; LX  MHÑMusic ANonly /hist MNK1.602 LH  MSThe use of music as an adjunctive therapy in the treatment of neurological, mental or behavioral disorders. PM74 HN74 MHÑMusic Therapy ANSPEC qualif MNE2.831.440; F4.754.549 LH  MSMarine bivalve molluscs especially of the genus Mytilus or freshwater bivalve molluscs especially the genera Unio and Anodonta. Includes the edible mussel Mytilus edulis. PM72 HN72 MHÑMussels ANas animals & food; /microbiol /parasitol permitted PIMollusca (66-71) MNB1.644.444 XSMytilus FXÑShellfish LH LS LX  MSAny of several Brassica species of the Crucifer family; Brassica alba is white mustard, B. nigra is black, brown, or red mustard; grown both for mustard seed from which oil is extracted and for foliage or animal feed; formerly used as emetic, counter-irritant and carminative. HN(86)63 MHÑMustard ANas plant, condiment & ther agent; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.92.625; B6.560.610; J1.341.241.579 XSSinapis DMÑBrassica LH LS LM  PM68; MUSTARD GAS was heading 1963-67 HN68 MHÑMustard Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: MUSTARD CPDS MND2.455.526.728 XUÑMustard Gas LH LU  MS1,1-Thiobis(2-chloroethane). Severe irritant and vesicant of skin, eyes and lungs; may cause blindness and lethal lung edema; formerly used as war gas; proposed as cytostatic and for psoriasis. Synonyms: Psoriasin; Psoriazin; yellow cross liquid; Yperit(e). OLsearch MUSTARD COMPOUNDS 1966-74 HN(75)63-67 MHÑMustard Gas AND25-26 qualif RN505-60-2 MND2.455.526.728.468; D26.253.605 XSDichlorodiethyl Sulfide; Sulfur Mustard DMÑMustard Compounds LH LS; LM  MSTests of chemical substances and physical agents for mutagenic potential. Includes microbial, insect, mammalian cell, and whole animal tests. PM81 HN81 MHÑMutagenicity Tests ANNIM; only /instrum /methods PIMutagens (66-80); Mutation (66-80) MNE5.393.560 XSCarcinogenicity Tests; Genetic Toxicity Tests; Mutagen Screening LH LS; ;  MSPhysical or chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids; a clastogen is a specific mutagen that causes breaks in chromosomes. PM66 HN66(65) MHÑMutagens AND25-26 qualif; consider also MUTATION; ╥antimutagenic╙ is not MUTAGENS /antag: index under MUTATION (without qualif) MND5.569.468 XSClastogens LH LS  MSAny detectable and heritable change in the genetic material not caused by genetic segration or recombination, which is transmitted to daughter cells and to succeeding generations, providing it is not a dominant lethal factor. PM64 HN64 MHÑMutation ANno qualif; SUPPRESSION, GENETIC is also available MNG5.632 LH  MSAn inhibition, voluntary or involuntary, of speech. PM69; was see under DEAF-MUTISM & SPEECH DISORDERS 1963-68 HN69(65); was see under DEAF-MUTISM (now see DEAFNESS) & SPEECH DISORDERS 1963-68 MHÑMutism ANdo not use /congen /drug eff /physiol /rad eff MNC10.597.257.870.638; C23.888.592.257.870.638; F3.126.219.870.638 LH  MS3-Amino-1-(3,4-dichloro-alpha-methylbenzyl)- 2-pyrazolin-5-one. Pyrazole diuretic with long duration and high capacity of action; proposed for kidney failure and hypertension. HN(80) MHÑMuzolimine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN55294-15-0 PIPyrazoles (66-79) MND3.383.694.550; D19.770.224.680 XSBay G 2821 DMÑPyrazoles LH LS LM  MHÑMyasthenia Gravis MNC5.651.661.580; C10.668.580; C20.111.620 LH  MSCyclic polypeptide antibiotic isolated from culture filtrates of Bacillus subtilis. Acts as an antifungal agent. HN(75) MHÑMycobacillin ANdo not use /defic /physiol; /analogs NIM only RN18524-67-9 PIAntibiotics, Antifungal (71-74); Peptides, Cyclic (73-74) MND12.644.641.580; D20.85.62.580; D20.136.73.580 DMÑAntibiotics, Antifungal LH LM  MSA family of Gram-positive bacteria found in soil and dairy products and as parasites on animals, including man - several are important pathogens. PM75 HN75 MHÑMycobacteriaceae ANdo not use /blood-csf-urine PIBacteria (66-74) MNB3.100.67.552 LH  MHÑMycobacteriophages ANdo not use /cytol; specify species of Mycobacterium if possible MNB4.123.502 LH  MHÑMycobacterium ANGEN; do not use /blood-csf-urine; infection = MYCOBACTERIUM INFECTIONS; M. paratuberc = MYCOBACTERIUM (IM) + PARATUBERCULOSIS /microbiol (NIM) MNB3.100.67.552.552 XUÑMycobacterium phlei; ÑMycobacterium, Atypical LH LU;  MSA bacterium which produces tuberculosis in domestic fowl and other birds; in pigs may cause localized and sometimes disseminated disease: occurs occasionally in sheep, cattle and man. PM87; was see under MYCOBACTERIUM 1975-86 HN87(75); was see under MYCOBACTERIUM 1975-86 MHÑMycobacterium avium ANdo not use /blood-csf-urine; infection in birds = TUBERCULOSIS, AVIAN; infection in other animals = TUBERCULOSIS /vet (IM) + MYCOBACTERIUM AVIUM (NIM) MNB3.100.67.552.552.300 XSMAIC; MAIS; Mycobacterium avium-intracellulare; Mycobacterium avium-intracellulare-scrofulaceum Complex; Mycobacterium intracellulare LH LS; ; ; ;  MSThe bovine variety of tubercle bacillus. Called also Mycobacterium tuberculosis var. bovis. OLuse MYCOBACTERIUM BOVIS to search BCG back thru 1975 HNBCG was see under MYCOBACTERIUM BOVIS 1975-79 MHÑMycobacterium Bovis AN= M. tuberc. bovis; do not use /blood-csf-urine; infection = TUBERCULOSIS, BOVINE if in cattle, TUBERCULOSIS /vet (IM) + MYCOBACTERIUM BOVIS (NIM) if in other animals MNB3.100.67.552.552.402 XSBCG; Calmette-Guerin Bacillus LH LS;  MSInfections with organisms of the genus Mycobacterium, general or unspecified. PM64 HN64 MHÑMycobacterium Infections ANGEN; consider also TUBERCULOSIS MNC1.252.40.552 XUÑMycobacterium Infections, Atypical LH LU  MSInfections with so called atypical mycobacteria (tuberculoid bacilli) i.e.: M. kansii (Kansas), M. marinum, M, scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare, M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae). HN(77) MHÑMycobacterium Infections, Atypical ANsee MYCOBACTERIUM, ATYPICAL for a list of atypical Mycobact; atypical Mycobact infect of lung = TUBERCULOSIS, PULMONARY (IM) + MYCOBACTERIUM INFECTIONS, ATYPICAL (NIM) PIMycobacterium Infections (66-76) MNC1.252.40.552.475 XSTuberculoid Infections DMÑMycobacterium Infections LH LS LM  MHÑMycobacterium Leprae ANdo not use /blood-csf-urine; infection = LEPROSY; /drug eff: consider also LEPROSTATIC AGENTS MNB3.100.67.552.552.502 LH  MSThe etiologic agent of rat leprosy, aka murine leprosy. PM73 HN73 MHÑMycobacterium Lepraemurium ANdo not use /blood-csf-urine; infection = MYCOBACTERIUM INFECTIONS (IM) + MYCOBACTERIUM LEPRAEMURIUM (NIM); = rat leprosy bacillus PIMycobacterium (66-72) MNB3.100.67.552.552.602 LH  MSA saprophytic bacterium widely distributed in soil and dust and on plants. HN(75) MHÑMycobacterium phlei ANin soil, dust & plants MNB3.100.67.552.552.640 DMÑMycobacterium LH LM  MHÑMycobacterium Tuberculosis ANdo not use /blood-csf-urine; infection = TUBERCULOSIS; /drug eff: consider also ANTITUBERCULAR AGENTS; DF: M TUBERC MNB3.100.67.552.552.702 LH  MSSo called atypical species of the genus Mycobacterium. They are also called tuberculoid bacilli, i.e.: M. kansii (Kansas), M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare, M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae). HN(77) MHÑMycobacterium, Atypical ANdo not use /blood-csf-urine; also called tuberculoid bacilli; includes M. buruli, duvali, flavescens, fortuitum, gilvum, gordonae, kansii, marinum, obuense, szulgai, terrae, ulcerans, xenopi; infection = MYCOBACTERIUM INFECTIONS, ATYPICAL PIMycobacterium (66-76) MNB3.100.67.552.552.250 XSTuberculoid Bacillus DMÑMycobacterium LH LS LM  PM73 HN73 MHÑMycolic Acids ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-72) MND2.241.81.407.502; D2.241.511.621; D10.516.251.572 LH  PM72 HN72 MHÑMycology ANSPEC: SPEC qualif PIFungi (66-71); Mycoses (66-71) MNG1.273.540.553 LH  PM73 HN73(72) MHÑMycophenolic Acid RN24280-93-1 PIAntibiotics, Antineoplastic (67-71); Caproates (67-71) MND2.241.81.193.678; D10.516.251.618; D20.85.75.622; D22.204.106.641 LH  PMPLEUROPNEUMONIA-LIKE ORGANISMS was heading 1963-65 HNPLEUROPNEUMONIA-LIKE ORGANISMS was heading 1963-65 MHÑMycoplasma ANdo not use /blood-csf-urine; infection = MYCOPLASMA INFECTIONS MNB3.600.580.553.553 XSEATON AGENT; PLEUROPNEUMONIA-LIKE ORGANISMS; PPLO LH LS; ;  MSInfections with species of the genus Mycoplasma. Syn: PPLO infections, Eaton agent infections. PM68; PLEUROPNEUMONIA, CONTAGIOUS was see under ANIMAL DISEASES 1978, was see under MYCOPLASMA INFECTIONS 1968-77 HN68 MHÑMycoplasma Infections PIMycoplasma (66-67) MNC1.252.610.620 XUÑPleuropneumonia, Contagious LH LU  MSThe etiological agent of contagious pleuropheumonia of cattle and goats. PM74 HN74(72) MHÑMycoplasma Mycoides ANcauses pleuropneumonia in cattle & goats; infection: coord NIM with PLEUROPNEUMONIA, CONTAGIOUS (IM) PIMycoplasma (66-71) MNB3.600.580.553.553.634 LH  MSShort filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium; the etiologic agent of non-viral primary atypical pneumonia in man. PM80 HN80 MHÑMycoplasma Pneumoniae ANdo not use /blood-csf-urine; do not confuse with MYCOPLASMA PNEUMONIA, the dis; infection = PNEUMONIA, MYCOPLASMA PIMycoplasma (66-79) MNB3.600.580.553.553.650 LH  MSA family of Gram-negative, non-motile bacteria from human and animal sources; one saprophytic species is known. PM75 HN75 MHÑMycoplasmataceae PIBacteria (66-74) MNB3.600.580.553 LH  MSAn order of highly pleomorphic, Gram-negative bacteria including both pathogenic and saprophytic species. PM75 HN75 MHÑMycoplasmatales PIBacteria (66-74) MNB3.600.580 LH  MSInfections with bacteria of the order Mycoplasmatales. PM77 HN77 MHÑMycoplasmatales Infections PIBacterial Infections (70-76) MNC1.252.610 LH  MHÑMycoses ANGEN: prefer specifics; of skin = DERMATOMYCOSES; /drug ther: consider also ANTIFUNGAL AGENTS MNC1.703 XSFUNGUS DISEASES XUÑGeotrichosis; ÑPiedra LH LS LU;  MSA chronic malignant lymphoma of the skin. In the late stages the lymph nodes and viscera are affected. MHÑMycosis Fungoides ANcoord IM with precoord organ/neopl term (IM) MNC4.557.386.480.620; C15.604.515.569.480.620; C20.683.515.761.480.620 LH  PM67; GLIOTOXINS was GLIOTOXIN see under ANTIBIOTICS 1975-80 HN67 MHÑMycotoxins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS PICarcinogens (66); Fungi (66); Toxins (66) MND24.185.926.587 XSFUNGAL TOXINS FXÑErgotism; ÑMushroom Poisoning XUÑGliotoxins LH LS LX; LU  MSAgents that dilate the pupil; they may be either sympathomimetics or parasympatholytics. The latter cause cycloplegia or paralysis of accommodation at high doses and may precipitate glaucoma; used in eye diseases and to facilitate eye examination. OLuse MYDRIATICS to search CYCLOPLEGICS back thru 1966 PMCYCLOPLEGICS was heading 1963-78 HNCYCLOPLEGICS was heading 1963-78 MHÑMydriatics ANdo not use /analogs /biosyn /defic /physiol; consider also PUPIL /drug eff; for CYCLOPLEGICS consider also CILIARY BODY /drug eff MND16.483 XSCycloplegics LH LS  MSProteins found in the myelin sheath. They consist of three major proteins: The Folch-Pi-Lees proteolipid, the Wolfgram proteolipid and the encephalitogenic basic proteins or Al basic proteins. PM77 HN77 MHÑMyelin Proteins AN/biosyn /physiol permitted; do not use /analogs /defic; do not routinely coord with MYELIN SHEATH unless this is particularly discussed; myelin goes under MYELIN SHEATH, not here; note entry above PIMyelin Sheath (66-76); Nerve Tissue Proteins (66-76) MND12.776.641.580 LH  MHÑMyelin Sheath ANA 11 qualif; do not use /innerv; myelin goes here; myelination: index under MYELIN SHEATH/physiol MNA8.663.542.512.560; A10.755.503; A11.671.514.553 LH  MHÑMyelitis ANinflammation of the spinal cord: do not confuse with inflamm of the bone marrow ( = OSTEOMYELITIS); SMON (subacute-myelo-optico-neuropathy) is indexed here + OPTIC NEURITIS + SYNDROME MNC10.228.228.618; C10.228.854.525 XUÑMyelitis, Transverse LH LU  HN(71) MHÑMyelitis, Transverse PIDemyelinating Diseases (66-70); Myelitis (66-70) MNC10.228.228.618.553; C10.228.337.636; C10.228.854.525.553 DMÑMyelitis LH LM  MSA virus causing anemia in fowl. OLsearch AVIAN LEUKOSIS VIRUSES 1966-74 HN(75); was see under AVIAN LEUKOSIS VIRUS 1963-74 MHÑMyeloblastosis Virus, Avian ANdo not use /blood-csf-urine /cytol; infection: coord NIM with AVIAN LEUKOSIS (IM) MNB4.909.574.807.112.175.703; B4.909.777.731.112.175.703 XSAvian Myeloblastosis Virus DMÑAvian Leukosis Viruses LH LS LM  MSConditions in which the bone marrow shows qualitative and quantitative changes suggestive of a preleukemic process, but having a chronic course that does not necessarily terminate as acute leukemia. PM86 HN86 MHÑMyelodysplastic Syndromes PIAnemia, Aplastic (66-85); Bone Marrow Diseases (66-85); Leukemia, Myelocytic (66-85); Myeloproliferative Disorders (66-85); Preleukemia (77-85) MNC15.378.190.625 XSDysmyelopoietic Syndromes LH LS  MHÑMyelofibrosis MNC15.378.190.636.581 XSBone Marrow Fibrosis; Fibrosis, Bone Marrow; Myelosclerosis LH LS; ;  PM66 HN66(64) MHÑMyelography ANmyelo- here = spinal cord, not bone marrow; NIM; do not use /util except by MeSH definition MNE1.236.688.503; E1.818.573.503 XSCisternography, Myelographic FXÑSpinal Cord LH LS LX  PM64 HN64 MHÑMyeloid Metaplasia MNC15.378.190.636.636; C15.604.744.428 XSAGNOGENIC MYELOID METAPLASIA; MYELOSIS, NONLEUKEMIC FXÑMetaplasia LH LS; LX  PM72 HN72 MHÑMyeloma Proteins ANdo not use /analogs /defic /physiol PIMultiple Myeloma (66-71); Neoplasm Proteins (66-71); Serum Globulins (66-71) MND12.776.124.486.485.900.500; D12.776.124.790.651.900.500; D12.776.377.715.548.900.500; D12.776.624.553 FXÑMultiple Myeloma LH LX  MSA peroxidase from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. PM86; was see under PEROXIDASES 1975-85 HN86(75); was see under PEROXIDASES 1975-85 MHÑMyeloperoxidase ANdo not use /analogs RNEC 1.11.1.- PIPeroxidases (70-74) MND8.586.682.732.600 LH  MSDisorders in which one or more stimuli cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. PM70 HN70(66) MHÑMyeloproliferative Disorders ANGEN; prefer specifics MNC15.378.190.636 FXÑLEUKEMIA LH LX  PM65 HN65 MHÑMyenteric Plexus ANdo not use /innerv MNA8.99.573 XSAUERBACH'S PLEXUS LH LS  MSThe invasion of living tissues of man and other mammals by dipterous larvae. MHÑMyiasis MNC3.211.503 XUÑScrew Worm Infection LH LU  MHÑMyoblastoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.614.491 LH  MSContractile activity of the heart. PM75 HN75 MHÑMyocardial Contraction ANonly /drug eff /rad eff; inotropic action of drugs = MYOCARDIAL CONTRACTION /drug eff (IM) + drug with /pharm (IM) + STIMULATION, CHEMICAL (NIM) for positive inotropic action & DEPRESSION, CHEMICAL (NIM) for negative but note that INOTROPIC AGENTS, POSITIVE CARDIAC see CARDIOTONIC AGENTS is available; for chronotropic action see note on HEART RATE; relaxation of cardiac muscle: do not add MUSCLE RELAXATION PIHeart (66-74) MNG9.330.800 XSHeart Contractility; Inotropism, Cardiac XUÑDiastole; ÑSystole LH LS; LU;  MSA low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental hemorrhagic pancreatitis, severe ischemia, and postoligemic shock. HN(75) MHÑMyocardial Depressant Factor AN/biosyn /physiol permitted; /analogs NIM only; do not confuse with MYOCARDIAL DEPRESSANTS (see ANTI-ARRHYTHMIA AGENTS) PIPeptides (73-74) MND12.644.370 DMÑPeptides LH LM  MSDiseases of the myocardium. OLuse MYOCARDIAL DISEASES to search MYOCARDIAL DISEASES, PRIMARY & MYOCARDIAL DISEASES, SECONDARY back thru 1966 PM79; MYOCARDIAL DISEASES, PRIMARY & MYOCARDIAL DISEASES, SECONDARY were headings 1966-78 HN79; MYOCARDIAL DISEASES, PRIMARY was heading 1965-78 (Prov 1965); MYOCARDIAL DISEASES, SECONDARY was heading 1966-78 MHÑMyocardial Diseases ANdisease of myocardial tissue: differentiate from HEART DISEASES, diseases of function; for bact, parasitic & other infections of the myocardium, coord here (IM), not HEART DISEASES + infection (IM); CHAGAS CARDIOMYOPATHY is available but see note there for coords; CARDIOMYOPATHY, CONGESTIVE is also available MNC14.280.600 XSCardiomyopathies; Myocardial Diseases, Primary; Myocardial Diseases, Secondary; Myocardiopathies LH LS; ; ;  OLuse MYOCARDIAL INFARCTION to search MYOCARDIAL INFARCT back thru 1966 PM79; was MYOCARDIAL INFARCT 1963-78 HN79; was MYOCARDIAL INFARCT 1963-78 MHÑMyocardial Infarction ANdo not coord with ACUTE DISEASE for ╥acute infarct╙; HEART RUPTURE, POST-INFARCTION is available; DF: MYOCARDIAL INFARCT MNC14.280.211.637 FXÑInfarction LH LX  PM73 HN73 MHÑMyocardial Revascularization ANdo not use /util except by MeSH definition PICoronary Disease/SU (66-71); Coronary Vessels/SU (66-71); Myocardial Infarct/SU (66-71) MNE4.752.376.719; E4.920.490.630 FXÑCoronary Disease XUÑInternal Mammary Artery Implantation; ÑInternal Mammary-Coronary Artery Anastomosis LH LX LU;  MHÑMyocarditis ANcarditis goes here; Chagas' myocarditis = CHAGAS CARDIOMYOPATHY MNC14.280.600.625 LH  MSThe middle and thickest layer of the heart wall consisting of cardiac muscle. MHÑMyocardium ANthe heart as tissue, differentiated from the heart as a pump ( = HEART); only /anal /cytol /enzymol /immunol /metab /pathol /ultrastruct; /blood supply = CORONARY VESSELS; Manual 21.48; myocardial ischemia = CORONARY DISEASE; inflammation = MYOCARDITIS; myocardial perfusion imaging, myocardial perfusion scintigraphy, myocardial imaging = HEART /radionuclide, not MYOCARDIUM /radionuclide; consider also terms under CARDIAC & HEART MNA2.633.580; A7.541.704; A10.690.637 LH  MHÑMyoclonus ANfor ╥myoclonic seizure╙ (formerly = HYPSARRHYTHMIA) consider MYOCLONUS; EPILEPSY, MYOCLONUS; SPASMS, INFANTILE as of 1977 MNC5.651.536; C10.597.559.645; C23.888.592.574.608 LH  MSTumor composed of outgrowths of myoepithelial cells from the acini or, occasionally, the ducts of a sweat gland. MHÑMyoepithelial Tumor AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.644 XSMyoepithelioma LH LS  MSMuscular pain in numerous body regions that can be reproduced by pressure on trigger points, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT SYNDROME. PM82 HN82 MHÑMyofascial Pain Syndromes ANnote see ref above MNC5.651.651 XSTrigger Points, Myofascial FXÑFibrositis; ÑPain LH LS LX;  PM65 HN65 MHÑMyofibrils ANA 11 qualif except /cytol; does not include muscle fiber (index MUSCLES) MNA2.633.585; A11.368.702.619 FXÑMUSCLE CONTRACTION XUÑSarcomeres LH LX LU  MHÑMyoglobin AN/urine = MYOGLOBINURIA; /biosyn /physiol permitted MND12.776.422.704; D12.776.210.500.588 LH  HN(84)65(63) MHÑMyoglobinuria ANmyoglobinuria in rhabdomyolysis: index under RHABDOMYOLYSIS (IM) + MYOGLOBINURIA (NIM) only if myoglobinuria is particularly discussed MNC5.651.807.628 DMÑRhabdomyolysis LH LM  MHÑMyography ANdo not use /util except by MeSH definition MNE1.642 LH  MHÑMyoma ANuterine = LEIOMYOMA + UTERINE NEOPLASMS; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.614.554 LH  MSThe smooth muscle coat of the uterus, which forms the main mass of the organ. PM84; was see under UTERUS 1975-83 HN84(75); was see under UTERUS 1975-83 MHÑMyometrium ANcontraction = UTERINE CONTRACTION PIUterus (66-74) MNA2.633.570.500; A5.360.319.679.690; A10.690.467.500 XSUterine Muscle LH LS  MHÑMyopia MNC11.744.636 LH  HN(86)63 MHÑMyosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.664; C4.557.614.617; C4.557.863.579 DMÑSarcoma LH LM  OLsearch MUSCLE PROTEINS 1969-70 & ADENOSINE TRIPHOSPHATASE 1966-68 PM73; was see under MUSCLE PROTEINS 1969-72, was see ADENOSINE TRIPHOSPHATASE 1963-68 HN73(71); was see under MUSCLE PROTEINS 1969-72, was see ADENOSINE TRIPHOSPHATASE 1963-68 MHÑMyosin AN/biosyn /physiol permitted PIAdenosine Triphosphatase (66-68); Muscle Proteins (66-70) MND12.776.210.500.659; D12.776.220.525.475 LH  MSATP:myosin-light-chain 0-phosphotransferase. The enzyme phosphorylates myosin light chains in the presence of ATP to yield myosin-light chain phosphate and ADP. Requires calcium and calmodulin. The 20-kDA light chain is phosphorylated more rapidly than any other acceptor, but light chains from other myosins and myosin itself can act as acceptors. The enzyme plays a central role in the regulation of smooth muscle contraction. EC 2.7.1.117. PM87 HN87 MHÑMyosin-Light-Chain Kinase ANdo not use /analogs; DF: MLCK RNEC 2.7.1.117 PIPhosphotransferases, ATP (66-72); Protein Kinases (73-86) MND8.586.913.696.729.726.500 XSMyosin Kinase LH LS  OLuse MYOSITIS to search MYOSITIS, EOSINOPHILIC 1972-80 PMMYOSITIS, EOSINOPHILIC was heading 1970-80 HNMYOSITIS, EOSINOPHILIC was heading 1970-80 MHÑMyositis ANpolymyositis goes here MNC5.651.594 LH  MHÑMyositis Ossificans MNC5.651.594.638; C23.205.638 XSFibrodysplasia Ossificans Progressiva LH LS  MHÑMyotonia AN/congen = MYOTONIA CONGENITA MNC5.651.624 FXÑSpasm LH LX  MHÑMyotonia Atrophica MNC5.651.624.471; C5.651.661.638; C10.668.638 XSDYSTROPHIA MYOTONICA LH LS  MHÑMyotonia Congenita ANdo not use /congen MNC5.651.624.638; C5.651.661.693; C10.668.693 XSTHOMSEN'S DISEASE LH LS  PM66 HN66(64) MHÑMyringoplasty ANfor repair of tympanic membrane perf; do not use /util except by MeSH definition MNE4.847.774.505 LH  MSSalts and esters of the 14-carbon saturated monocarboxylic acid--myristic acid. HN(75) MHÑMyristates ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74) MND2.241.81.407.535.510; D10.516.251.640.610 XSTetradecanoates DMÑMyristic Acids LH LS LM  MS14-carbon saturated monocarboxylic acids. PM75 HN75 MHÑMyristic Acids ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74) MND2.241.81.407.535; D10.516.251.640 XSTetradecanoic Acids XUÑMyristates LH LS LU  MSA philosophy based upon spiritual intuition that is believed to transcend ordinary sensory experiences or understanding. MHÑMysticism ANno qualif MNK1.844.799.430 LH  MHÑMythology ANno qualif MNK1.517.647 LH  MHÑMyxedema ANpretibial = MYXEDEMA (IM) + LEG DERMATOSES (IM) MNC19.874.482.638 LH  MSAn order of rod-shaped, Gram-negative Gliding Bacteria, found in soil, water and decomposing matter. OLuse MYXOBACTERALES to search PODANGIUM & POLYANGIUM back thru 1966, POLYANGIACEAE back thru 1975 & SLIME BACTERIA back thru 1974 PM74; PODANGIUM was heading 1963-75; POLYANGIACEAE was heading 1975-81; POLYANGIUM was heading 1963-81 HN74; PODANGIUM was see under MYXOBACTERALES 1976-78, was heading 1963-75; POLYANGIACEAE was heading 1975-81; POLYANGIUM was heading 1963-81; SLIME BACTERIA was see under MYXOBACTERALES 1974-78 MHÑMyxobacterales ANin soil, water & decaying matter MNB3.350.638 XSPodangium; Polyangiaceae; Polyangium; Slime Bacteria LH LS; ; ;  MHÑMyxoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.635 LH  MSA species of the Leporipoxvirus genus causing infectious myxomatosis of rabbits. MHÑMyxoma Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) or index if pertinent under MYXOMATOSIS, INFECTIOUS instead MNB4.909.204.783.518 XSMyxomatosis Virus; POXVIRUS MYXOMATIS FXÑMYXOMATOSIS, INFECTIOUS LH LS; LX  MHÑMyxomatosis, Infectious ANusually animal: do not use /vet but check tag ANIMAL MNC2.256.743.665; C22.627 FXÑMYXOMA VIRUS LH LX  MSA division of organisms that exist vegetatively as complex mobile plasmodia, reproduce by means of spores, and have complex life cycles. They are usually classed as fungi, but some authorities, following de Bary, 1859, regard them as protozoans. OLuse MYXOMYCOTA to search MYXOMYCETES & SLIME MOLDS back thru 1966 PM86; was MYXOMYCETES 1963-85 HN86; was MYXOMYCETES 1963-85; SLIME MOLDS was see under MYXOMYCETES 1966-78 MHÑMyxomycota ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.618 XSMycetozoa; Myxomycetes; Slime Molds LH LS; ;  HN(86)63 MHÑMyxosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); myxosarcoma of breast = CYSTOSARCOMA PHYLLODES MNC4.557.499.663; C4.557.863.605 DMÑSarcoma LH LM  MSUDPgalactose:N-acetylglucosamine galactosyltransferase. The A protein of the lactose synthetase complex. In the presence of the B protein (lactalbumin) specificity is changed from N-acetylglucosamine to glucose. HN(75) MHÑN-Acetyllactosamine Synthetase ANdo not use /analogs RNEC 2.4.1.90 PIGlucosamine (73-74); Lactose Synthetase (73-74) MND8.586.913.407.310.500.50 XSUDP Galactose Acetylglucosamine Galactosyltransferase DMÑLactose Synthetase LH LS LM  MSAn autolytic enzyme bound to the surface of bacterial cell walls. It catalyzes the hydrolysis of the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell wall glycopeptides, particularly peptidoglycan. EC 3.5.1.28. HN(79) MHÑN-Acetylmuramoyl-L-Alanine Amidase ANdo not use /analogs RNEC 3.5.1.28 PIAlanine (66-78); Amidohydrolases (66-78); Muramic Acids (73-78) MND8.586.277.87.30 XSMucopeptide Amidohydrolase DMÑAmidohydrolases LH LS LM  MSEffective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells. HN(75) MHÑN-Formylmethionine ANdo not use /defic /physiol RN4289-98-9 PIFormic Acids (74); Methionine (74) MND12.125.166.676.450 DMÑMethionine LH LM  MSN-Formylmethionyl-leucyl-phenylalanine. A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. OLuse N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE to search N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE back thru 1984 PM85; was N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984 HN85; was N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984 MHÑN-Formylmethionine Leucyl-Phenylalanine ANdo not use /biosyn /defic /physiol; DF: FMLP RN59880-97-6 PIChemotactic Factors (80-83); Chemotaxis (70-79); Chemotaxis, Leucocyte (77-83); Cytology (66-69); N-Formylmethionine (75-83); Methionine (66-74); Oligopeptides (73-83); Peptides (66-72) MND12.125.166.676.450.440; D12.644.456.400; D24.185.125.320.685; D24.185.125.685 XSChemotactic Peptide; F-Met-Leu-Phe; N-Formyl-Methionyl-Leucyl-Phenylalanine LH LS; ;  MS3-alpha-Hydroxy-8-isopropyl-1-alpha-H,5-alpha-H-tropate tropanium bromide. Proposed bronchodilator.Synonym: SCH 1000. HN(75); was see under ATROPINE 1975-77 MHÑN-Isopropylatropine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN22254-24-6 PIAtropine (73-74); Propane (73-74) MND3.132.889.180.297.297.450; D3.605.869.189.297.450 XSIpratropium Bromide DMÑAtropine Derivatives LH LS LM  MS1-Nitrosopyrrolidine. Carcinogenic nitrosamine that may be formed from preservatives in meats during their preparation or in the liver during metabolism. HN(79) MHÑN-Nitrosopyrrolidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN930-55-2 PINitrosamines (66-78) MND2.654.442.550; D3.383.773.630; D26.191.646.661 DMÑNitrosamines LH LM  MHÑNAD ANNADH goes here; NADPH goes under NADP; NAD or NADP probably correct for indexing of pyridine nucleotides RN53-84-9 MND8.176.589; D13.695.667.138.694; D13.695.827.68.694 XSCOENZYME I; DIPHOSPHOPYRIDINE NUCLEOTIDE; DPN; NICOTINAMIDE-ADENINE DINUCLEOTIDE LH LS; ; ;  MSNAD+ glycohydrolase. Catalyzes the hydrolysis of NAD to nicotinamide and ADPribose. PM77; was see under NUCLEOSIDASES 1975-76 HN77(75); was see under NUCLEOSIDASES 1975-76 MHÑNAD Nucleosidase ANdo not use /analogs RNEC 3.2.2.5 PINucleosidases (73-74); NAD (73-74) MND8.586.277.450.737.400 XSDPNase; NADase LH LS;  MSNADH:(acceptor) oxidoreductase. A flavoprotein containing iron. Cytochromc c may act as receptor. Catalyzes the oxidation of NADH to NAD and reducted acceptor. EC 1.6.99.3. Formerly EC 1.6.2.1. HN(80) MHÑNADH Dehydrogenase ANdo not use /analogs; do not confuse with NADPH DEHYDROGENASE; do not confuse X ref NADH CYTOCHROME C REDUCTASE with NADPH CYTOCHROME C REDUCTASE RNEC 1.6.99.3 PICytochrome Reductases (73-79); Cytochrome c (73-79); NADH, NADPH Oxidoreductases (73-79); Oxidoreductases (66-72) MND8.586.682.608.191.475 XSCytochrome c Reductase; NADH Cytochrome c Reductase DMÑCytochrome Reductases LH LS; LM  MSCatalyzes the reduction of tetrazolium compounds in the presence of NADH. HN(75) MHÑNADH Tetrazolium Reductase ANdo not use /analogs RNEC 1.6.- PIOxidoreductases (73); NADH, NADPH Oxidoreductases (74); Tetrazolium Salts (73-74) MND8.586.682.608.530 DMÑNadh, Nadph Oxidoreductases LH LM  PM74; NADPH DEHYDROGENASE was OLD YELLOW ENZYME see under NADH, NADPH OXIDOREDUCTASES 1975-79, was OLD YELLOW ENZYME see under OXIDOREDUCTASES 1967-74; NADP DIAPHORASE (now see NADPH DEHYDROGENASE, an XU below) was see under LIPOAMIDE DEHYDROGENASE 1975-79 HN74(73) MHÑNADH, NADPH Oxidoreductases ANdo not use /analogs RNEC 1.6. PIOxidoreductases (66-72) MND8.586.682.608 XSOXIDOREDUCTASES, NADH, NADPH XUÑDihydropteridine Reductase; ÑFerredoxin-NADP Reductase; ÑMethemoglobin Reductase; ÑNADH Tetrazolium Reductase; ÑNADP Transhydrogenase; ÑNADPH Dehydrogenase; ÑNitrite Reductases; ÑThioredoxin Reductase (NADPH) LH LS LU; ; ; ; ; ; ;  MS5(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy) -1,2,3,4- tetrahydro-2,3-naphthaenediol. Non-selective beta adrenergic blockader with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. PM87 HN87 MHÑNadolol ANdo not use /biosyn /defic /physiol RN42200-33-9 PIAdrenergic Beta Receptor Blockaders (69-86); Propanolamines (74-86) MND2.33.329.624.580; D2.92.63.624.580; D16.848.215.485; D18.162.630 LH  MHÑNADP ANNADPH goes here; NADP or NAD probably correct for indexing of pyridine nucleotides RN53-59-8 MND8.176.625; D13.695.667.138.749; D13.695.827.68.749 XSCOENZYME II; NICOTINAMIDE-ADENINE DINUCLEOTIDE PHOSPHATE; TPN; TRIPHOSPHOPYRIDINE NUCLEOTIDE LH LS; ; ;  MSNADPH:NAD+ oxidoreductase. An enzyme present in the mitochondrial membrane of animals and in microorganisms. In the presence of energy (ATP) it catalyzes reversibly the reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes. EC 1.6.1.1. HN(79) MHÑNADP Transhydrogenase ANdo not use /analogs RNEC 1.6.1.1 PINADH, NADPH Oxidoreductases (73-78); Oxidoreductases (66-72) MND8.586.682.608.560 XSPyridine Nucleotide Transhydrogenase DMÑNADH, NADPH Oxidoreductases LH LS LM  MSNADPH:ferricytochrome oxidoreductase. A flavoprotein which catalyzes the reduction of ferricytochrome c in the presence of NADPH. Physiological acceptor is probably cytochrome P-450. EC 1.6.2.4 PM80; was see under CYTOCHROME REDUCTASES 1975-79 HN80(75); was see under CYTOCHROME REDUCTASES 1975-79 MHÑNADPH Cytochrome C Reductase ANdo not use /analogs RNEC 1.6.2.4 PICytochrome C (73-74); Cytochrome Reductases (73-74); Cytochromes (66-72); Oxidoreductases (66-74) MND8.586.682.608.191.500 XSFerrihemoprotein P-450 Reductase; NADPH Cytochrome P-450 Reductase LH LS;  MSNADPH:(acceptor) oxidoreductase. A flavoprotein which reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1. OLto search OLD YELLOW ENZYME use NADPH DEHYDROGENASE back thru 1975 & OXIDOREDUCTASES 1967-74; use NADPH DEHYDROGENASE to search NADP DIAPHORASE back thru 1975 HN(80); was OLD YELLOW ENZYME see under NADH, NADPH OXIDOREDUCTASES 1975-79, was OLD YELLOW ENZYME see under OXIDOREDUCTASES 1967-74; NADP DIAPHORASE was see under LIPOAMIDE DEHYDROGENASE 1975-79 MHÑNADPH Dehydrogenase ANdo not use /analogs; do not confuse with NADH DEHYDROGENASE RNEC 1.6.99.1 MND8.586.682.608.550 XSNADP Dehydrogenase; NADP Diaphorase; NADPH Diaphorase; Old Yellow Enzyme; TPN Diaphorase DMÑNADH, NADPH Oxidoreductases LH LS; ; ; ; LM  PM68 HN68(65) MHÑNafcillin ANdo not use /biosyn /defic /physiol RN147-52-4 MND20.85.99.739.637 XSNaphthamidopenicillin; Sodium Nafcillin LH LS;  HN(73) MHÑNafenopin ANdo not use /defic /physiol; /analogs NIM only RN3771-19-5 PIAnticholesteremic Agents (66-72); Antilipemic Agents (66-72); Propionates (66-72) MND2.241.81.751.700.600; D10.162.202.618 DMÑPropionates LH LM  HN(73) MHÑNafoxidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1845-11-0 MND3.383.773.589; D6.347.300.472 DMÑPyrrolidines LH LM  MS2-(Diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate oxalate. Possible vasodilator. Synonyms: Dusodril; Praxilene. HN(75) MHÑNafronyl ANdo not use /biosyn /defic /physiol; /analogs NIM only RN31329-57-4 PIDiethylamines (74); Furans (71-74); Naphthalenes (71-74); Propionates (71-74) MND3.383.312.620; D18.918.615 XSNafronyloxalate; Naftidrofuryl DMÑFurans LH LS; LM  MSA rapidly fatal trypanosomiasis of horses and other animals in Africa; it is caused by Trypanosoma brucei and transmitted by tse-tse flies. OLsearch TRYPANOSOMIASIS, AFRICAN 1972-74 & TRYPANOSOMIASIS, BOVINE 1968-72 HN(75); was see under TRYPANOSOMIASIS, BOVINE 1968-mid 72 MHÑNagana ANcaused by TRYPANOSOMA BRUCEI BRUCEI & TRYPANOSOMA CONGOLENSE in African animals; do not use /vet; for nagana in animals other than cattle coord IM with animal/dis precoord (IM) + animal (IM) + check tag ANIMAL + TRYPANOSOMIASIS, AFRICAN /vet (IM) but nagana in cattle = NAGANA (IM) + TRYPANOSOMIASIS, BOVINE (IM) + CATTLE (NIM) + check tag ANIMAL; do not specify Trypanosoma species unless particularly discussed MNC3.752.935.719.555; C22.674.710.500 DMÑTrypanosomiasis, African LH LM  MSCommon form of habitual body manipulation which is an expression of tension. MHÑNail Biting ANdo not use /congen /drug eff /physiol /rad eff MNF1.145.466.554; F3.234.193.308.600 XSONYCHOPHAGIA LH LS  MSDiseases of the nail plate and tissues surrounding it. Use only for primates. PM79 HN79; was NON MESH before 1979 MHÑNail Diseases ANprimates only; neopl: coord IM with NEOPLASMS (NIM) or histol type of neopl (IM) PINails (66-78) MNC17.805.506 LH  PM65 HN65(63) MHÑNail-Patella Syndrome ANdo not use /congen MNC16.131.77.606 XSOSTERREICHER SYNDROME; Osteo-Onychodysplasia, Hereditary; PELVIC HORN SYNDROME; TURNER-KIESER SYNDROME LH LS; ; ;  MHÑNails ANprimates only: use HOOF AND CLAW for other vertebrates: TN 117; /abnorm permitted but consider NAILS, MALFORMED MNA1.835.472 LH  MHÑNails, Ingrown MNC17.805.506.406 LH  MHÑNails, Malformed ANconsider also NAILS /abnorm MNC17.805.506.506 LH  MSAn arbovirus infection of sheep and goats transmitted by ticks; characterized by high fever and hemorrhagic gastroenteritis. PM70 HN70 MHÑNairobi Sheep Disease ANdo not use /vet; don't forget also SHEEP (NIM) & check tag ANIMAL PIArbovirus Infections (66-69); Sheep Diseases (66-69) MNC2.782.147.633; C2.81.633; C22.836.583 LH  HN(72) MHÑNalbuphine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN20594-83-6 PIMorphinans (66-71); Narcotic Antagonists (66-71) MND3.132.610.422.606; D3.549.686.639; D3.605.497.639; D14.712.590 DMÑMorphinans LH LM  HN(72) MHÑNaled ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN300-76-5 PIInsecticides (66-71) MND2.705.509; D5.723.491.574.583 DMÑInsecticides, Organophosphate LH LM  PM66 HN66(64) MHÑNalidixic Acid ANdo not use /biosyn /defic /physiol RN389-08-2 MND3.438.612.500; D20.237.583 XSNalidixin LH LS  MHÑNalorphine ANdo not use /biosyn /defic /physiol RN62-67-9 MND3.132.610.422.656; D3.549.686.694; D3.605.497.694; D14.712.661 XSALLYLNORMORPHINE LH LS  PM73 HN73(72) MHÑNaloxone ANdo not use /biosyn /defic /physiol RN465-65-6 PIMorphinans (69-71); Narcotic Antagonists (66-71) MND3.132.610.422.706; D3.549.686.750; D3.605.497.750; D14.712.732 LH  MS17-(Cyclopropylmethyl)-4,5 alpha-epoxy-3,14-dihydroxy-morphinan-6-one. Derivative of noroxymorphone or the N-cyclopropylmethyl congener of naloxone; a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone; proposed for the treatment of heroin addiction. PM86; was see under NALOXONE 1976-85 HN86(76); was see under NALOXONE 1976-85 MHÑNaltrexone ANdo not use /biosyn /defic /physiol RN16590-41-3 PICyclopropanes (73-75); Morphinans (73-74); Naloxone/AA (75) MND3.132.610.422.706.550; D3.549.686.750.550; D3.605.497.750.550; D14.712.732.735 XSEN 1639A LH LS  OLno qualif MH*Named Groups (Non Mesh) MNM1 LH  OLno qualif MH*Named Groups By Age (Non Mesh) MNM1.471 LH  MH*Named Groups By Occupation (Non Mesh) MNM1.526 LH  MHÑNames ANa cataloging term: avoid; no qualif CATALOG: /geog /form MNL1.143.506.598.400.556 LH  MSThe former German colony of South West Africa, mandated to South Africa 1920-1966, made a direct dependent of the United Nations October 1966; name changed from South West Africa to Namibia in 1968. HN78 MHÑNamibia ANformer name was South West Africa PIAfrica, Southern (66-77); South Africa (66-74) MNZ1.58.349.640 XSSouth West Africa LH LS  PM65; was NORTESTOSTERONE 1963-64 HN65; was NORTESTOSTERONE 1963-64 MHÑNandrolone ANdo not use /biosyn /defic /physiol RN434-22-0 MND4.808.365.415.638; D6.597.100.194.590 XSEstrenolone; NORTESTOSTERONE; Norandrostenolone LH LS; ;  HN(63); was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74, was see under SYMPATHOMIMETICS 1963-66 MHÑNaphazoline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN835-31-4 MND3.383.374.585; D18.793.952.633 DMÑImidazoles LH LM  PM66 HN66 MHÑNaphthacenes ANdo not use /analogs /biosyn /defic /physiol MND4.615.597 LH  PM68 HN68 MHÑNaphthaleneacetic Acids ANdo not use /analogs /biosyn /defic /physiol MND4.615.638.472 LH  MHÑNaphthalenes ANdo not use /analogs /biosyn /defic /physiol MND4.615.638 XUÑ1-Naphthylamine; Ñ2-Naphthylamine; ÑBunaftine; ÑTetrahydronaphthalenes LH LU; ; ;  PM74 HN74 MHÑNaphthalenesulfonates ANdo not use /analogs /biosyn /defic /physiol MND2.241.866.540.244.639; D4.615.638.555; D2.886.610.244.639 LH  MSHydrolytic enzyme activity used as a histocytochemical test for the presence of esterases in tissue. Substrate used is 3-hydroxy-4'-nitro-2-naphthanilide chloroacetate (naphthol AS-D). PM85; was see under CARBOXYLIC ESTER HYDROLASES 1976-84, was see under ESTERASES 1975 HN85(75); was see under CARBOXYLIC ESTER HYDROLASES 1976-84, was see under ESTERASES 1975 MHÑNaphthol AS D Esterase ANdo not use /analogs RNEC 3.1.- PIEsterases (71-74); Naphthols (72-74) MND8.586.277.352.100.550 XSANAE; Alpha-Naphthyl Acetate Esterase; Naphthol AS D Acetatesterase; Naphthol AS D Chloroacetate Esterase LH LS; ; ;  PM73 HN73(72) MHÑNaphthols ANdo not use /analogs /biosyn /defic /physiol PINaphthalenes (66-71) MND4.615.638.638 XSHydroxynaphthalenes LH LS  MHÑNaphthoquinones ANdo not use /analogs /biosyn /defic /physiol MND4.615.638.721 LH  MS4(1-Naphthylvinyl)pyridine hydrochloride. Cholinesterase inhibitor. Synonym: YuB 25. HN(75) MHÑNaphthylvinylpyridine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN16375-56-7 PINaphthalenes (71-74); Pyridines (71-74); Vinyl Compounds (71-74) MND3.383.725.495; D4.615.638.900 DMÑPyridines LH LM  MHÑNaphthyridines ANdo not use /analogs /biosyn /defic /physiol MND3.438.612 LH  MS2-(6-methoxy-2-naphthyl) propionate. An anti-inflammatory agent with analgesic properties proposed for use in the therapy of rheumatism and arthritis. Synonym: RS-3540. PM78; was see under NAPHTHALENEACETIC ACIDS 1975-77 HN78(75); was see under NAPHTHALENEACETIC ACIDS 1975-77 MHÑNaproxen ANdo not use /biosyn /defic /physiol RN22204-53-1 PIMethyl Ethers (73-74); Naphthalenes (72-74); Propionates (72-74) MND4.615.638.472.450; D14.73.278.573; D26.74.75.672 LH  MSA psychoanalytic term meaning self-love. PM68 HN68(66) MHÑNarcissism ANno qualif MNF2.739.794.582 LH  MSSleep disorder consisting of attacks of imperative drowsiness and sleep. PM67 HN67(63) MHÑNarcolepsy ANdo not use /congen /drug eff /physiol /rad eff MNC10.228.140.725; F3.126.821.640 FXÑCataplexy LH LX  MSIntravenous injections of sodium amytal or sodium pentothal to induce a state in which the patient is more relaxed and communicative. Narcosuggestion, narcosynthesis, and narcoanalysis are therapeutic processes using these drug adjuncts. OLuse NARCOTHERAPY to search NARCOSYNTHESIS back thru 1968 HNNARCOSYNTHESIS was see under NARCOTHERAPY 1968-78 MHÑNarcotherapy ANSPEC qualif MNF4.881.505.557 XSNarcosynthesis LH LS  MHÑNarcotic Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: NARCOTIC ANTAG MND14.712 FXÑDrug Antagonism LH LX  MSStrong dependence, both physiological and emotional, upon any derivative, synthetic or natural, of opium, or any substance that has the same pharmacologic effects. OLuse NARCOTIC DEPENDENCE to search NARCOTIC ADDICTION back thru 1980 PM81; was NARCOTIC ADDICTION 1980 HN81; was NARCOTIC ADDICTION 1980 MHÑNarcotic Dependence ANGEN or unspecified; restrict to only those narcotics indented under NARCOTICS (Cat D14); coord IM with specific narcotic (IM) but MORPHINE DEPENDENCE & HEROIN DEPENDENCE are also available; X ref OPIATE DEPENDENCE does not mean ╥opium╙: it refers to syn or nat opium deriv & other substances with similar eff; do not use /chem ind /drug eff /educ /instrum /physiol /rad eff PINarcotics (66-79); Opium (66-79); Substance Dependence (66-79) MNF3.709.597.780.660.400 XSOpiate Dependence LH LS  MSOriginally, agents that caused somnolence; now, any derivatives, natural or synthetic, of morphine or any substance that has the effects of morphine, i.e., cause analgesia, stupor, habituation, etc.; used mainly for relief of pain, cough and diarrhea. MHÑNarcotics AN/antag = NARCOTIC ANTAGONISTS; do not use /analogs /biosyn /defic /physiol; addiction to NARCOTICS = NARCOTIC DEPENDENCE; addiction to all narcotics indented under NARCOTICS = specific narcotic (IM) + NARCOTIC DEPENDENCE (IM); drug of abuse: Bull 102 (Oct 77) MND14.757 XSOpiates FXÑAnalgesics, Addictive; ÑSubstance Dependence LH LS LX;  MSEither of two small elongated rectangular bones that together form the bridge of the nose. OLsearch NOSE 1966-74 PM78; was see under NOSE 1963-77 HN78(75); was see under NOSE 1963-77 MHÑNasal Bone AN/abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; /surg: consider also RHINOPLASTY; fractures: coord NASAL BONE /inj (IM) + SKULL FRACTURES (IM) PINose (66-74) MNA2.835.232.781.324.665; A4.531.378 LH  MSThe proximal portion of the respiratory passages on either side of the nasal septum, lined with ciliated mucosa, extending from the nares to the pharynx. OLsearch NOSE 1966-74 PM78; was see under NOSE 1963-77 HN78(75); was see under NOSE 1963-77 MHÑNasal Cavity AN/abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; inflammation = RHINITIS; /secret = NASAL MUCOSA /secret PINose (66-74) MNA4.531.449 LH  MSThe mucous membrane lining the nasal cavity. MHÑNasal Mucosa AN/secret here, not NOSE; inflammation = RHINITIS MNA4.531.520; A10.615.550.707 LH  MHÑNasal Polyps ANneoplastic; /anal /blood supply /secret /ultrastruct permitted MNC4.799.640; C9.603.557 LH  MSApplication of allergens to the nasal mucosa. Interpretation includes observation of nasal symptoms, rhinoscopy, and rhinomanometry. Used in diagnosis of nasal hypersensitivity, including hay fever. PM80 HN80 MHÑNasal Provocation Tests ANdiag of nasal allergy; only /instrum /methods; DF: NP TESTS PIAllergens (66-79); Hay Fever (66-79); Nasal Mucosa (66-79) MNE1.276.660 XSProvocation Tests, Nasal LH LS  MSThe partition separating the two nasal cavities in the midplane, composed of cartilaginous, membranous and bony parts. MHÑNasal Septum MNA2.165.639; A4.531.591 XSVOMER LH LS  OLsearch LACRIMAL APPARATUS 1966-74 HN(75) MHÑNasolacrimal Duct MNA9.371.463.640 DMÑLacrimal Apparatus LH LM  MSGeneral or unspecified diseases of the nasopharynx. PM66 HN66 MHÑNasopharyngeal Diseases ANinflamm dis = NASOPHARYNGITIS MNC9.520 LH  MHÑNasopharyngeal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.665.650.632; C9.520.557 LH  MSInflammation of the nasopharynx. OLsearch PHARYNGITIS 1966-74 HN(75) MHÑNasopharyngitis MNC9.775.649.474 DMÑPharyngitis LH LM  MSThe nasal part of the pharynx, lying above the level of the soft palate. MHÑNasopharynx ANinflammation = NASOPHARYNGITIS MNA4.531.662; A14.724.557 XSRhinopharynx LH LS  OLsearch TOOTH, DECIDUOUS 1966-74 HN(75) MHÑNatal Teeth MNA14.254.860.815.557 DMÑTooth, Deciduous LH LM  MSA United States organization of distinguished scientists and engineers established for the purpose of investigating and reporting upon any subject of art or science as requested by any department of government. The National Research Council organized by NAS serves as the principal operating agency to stimulate and support research. OLuse NATIONAL ACADEMY OF SCIENCES (U.S.) to search NATIONAL ACADEMY OF SCIENCES back thru 1980 HN(82); was NATIONAL ACADEMY OF SCIENCES see under ORGANIZATIONS 1980-81 MHÑNational Academy of Sciences (U.S.) ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NON-US GOVT SUP; DF: NAS NRC CATALOG: use NAF entry MNN3.540.608 XSNational Research Council (U.S.); United States National Academy of Sciences DMÑOrganizations LH LS; LM  MSA center in the Public Health Service which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology. HN(82) MHÑNational Center for Health Care Technology ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF:NCHCT CATALOG: use NAF entry MNN3.540.427.300.425.150 XSUnited States Nat'l Center for Health Care Technology DMÑUnited States Public Health Service LH LS LM  MSA center in the Public Health Service which is primarily concerned with the collection, analyzing, and disseminating of health statistics on vital events and health activities to reflect the health status of people, health needs, and health resources. HN(82) MHÑNational Center for Health Statistics (U.S.) ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: NCHS CATALOG: use NAF entry MNN3.540.427.300.425.180 XSUnited States National Center for Health Statistics DMÑUnited States Public Health Service LH LS LM  PM78 HN78 MHÑNational Health Insurance, United States ANonly /econ /hist /legis /trends /util; add UNITED STATES (NIM); DF: NATL HEALTH INSUR US PINational Health Programs (75-77) MNN3.219.521.576.343.900; N3.349.550.610 XSFederal Health Insurance Plans, United States; United States National Health Insurance LH LS;  MSLegislation establishing a coordinated program in health planning and resource development with a federal agency overseeing the programs as developed by the states and health systems agencies. The resource development portion of the act grants funds for a variety of programs; includes funds for facilities and services. PM82 HN82 MHÑNational Health Planning and Resources Development Act of 1974 ANonly /econ /hist /legis; add UNITED STATES (NIM); DF: NATL HEALTH PLAN ACT PIHealth Planning (79-81) MNN3.349.510 XSHealth Planning Act 93-641; Health Planning and Resources Development Amendments of 1979, PL96-79; PL93-641; Public Law 93-641 LH LS; ; ;  MSA center in the Health Resources Administration Division of Planning Methods and Technology which provides access to current information on health planning and resources development. HN(80) MHÑNational Health Planning Information Center ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP CATALOG: use NAF entry MNN3.540.427.300.425.600.520 XSNHPIC; United States National Health Planning Information Center DMÑUnited States Health Resources and Services Administration LH LS; LM  MSComponents of a national health care system which administer specific services, e.g., national health insurance. OLsearch STATE MEDICINE 1966-74 PM77; was see under STATE MEDICINE 1963-76 HN77(75); was see under STATE MEDICINE 1963-76 MHÑNational Health Programs ANonly /hist /organ; specify country CATALOG: /geog /form MNN3.349.550 XSNational Health Insurance, Non-U.S. LH LS  MSAn institute of the Centers for Disease Control which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals. HN(84) MHÑNational Institute for Occupational Safety and Health ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: NIOSH CATALOG: use NAF entry MNN3.540.427.300.425.80.508 XSNational Institute for Occupational Safety and Health (U.S.) DMÑCenters for Disease Control (U.S.) LH LS LM  MSA component of the Alcohol, Drug Abuse and Mental Health Administration concerned with research, overall planning, promoting and administering mental health programs and research. OLto search UNITED STATES NATIONAL INSTITUTE OF MENTAL HEALTH & NATIONAL INSTITUTE OF MENTAL HEALTH use NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.) back thru 1975 & UNITED STATES ALCOHOL, DRUG ABUSE, and MENTAL HEALTH ADMINISTRATION 1973-74 HN(82); was UNITED STATES NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES ALCOHOL, DRUG ABUSE, and MENTAL HEALTH ADMINISTRATION 1978-81, was NATIONAL INSTITUTE OF MENTAL HEALTH see under ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77, was NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74 MHÑNational Institute of Mental Health (U.S.) ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: NIMH CATALOG: use NAF entry MNN3.540.427.300.425.250.400 XSUnited States National Institute of Mental Health DMÑUnited States Alcohol, Drug Abuse, and Mental Health Administration LH LS LM  MSAn agency of the Public Health Service concerned with overall planning, promoting, and administering programs pertaining to health and medical research. OLuse NATIONAL INSTITUTES OF HEALTH (U.S.) to search UNITED STATES NATIONAL INSTITUTES OF HEALTH back thru 1966 PM82; was UNITED STATES NATIONAL INSTITUTES OF HEALTH 1966-81 HN82; was UNITED STATES NATIONAL INSTITUTES OF HEALTH 1966-81 MHÑNational Institutes of Health (U.S.) ANonly /hist /organ; add UNITED STATES (NIM); note X ref NIH CONSENSUS DEVELOPMENT: include these words as part of a title when they appear in author position, in footnote or at end of article & index routinely under NIH (NIM) (TN 138); index NIH (IM) for Consensus Conference as an evaluation method; research support by this agency is checked as NIH/PHS SUP; DF: NIH CATALOG: use NAF entry MNN3.540.427.300.425.210 XSNIH Consensus Development; United States National Institutes of Health LH LS;  MSAn agency of the Public Health Service concerned with overall planning, promoting, and administering programs pertaining to various aspects of documentation and library services in the field of medicine. OLuse NATIONAL LIBRARY OF MEDICINE (U.S.) to search UNITED STATES NATIONAL LIBRARY OF MEDICINE back thru 1966 PM82; was UNITED STATES NATIONAL LIBRARY OF MEDICINE 1966-81 HN82; was UNITED STATES NATIONAL LIBRARY OF MEDICINE 1965-81 (Prov 1965) MHÑNational Library of Medicine (U.S.) ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: NLM CATALOG: use NAF entry MNL1.346.596.563.725; N3.540.427.300.425.210.350 XSUnited States National Library of Medicine LH LS  MHÑNatriuresis ANdifferentiate from SODIUM /urine in that in natriuresis emphasis is on the physiol process of urinary excretion of sodium; only /drug eff /rad eff; note NATRIURETIC HORMONE below MNG8.852.241.557 FXÑSodium LH LX  MSA low-molecular weight substance, possibly from the hypothalamus, which is released due to plasma volume expansion. It causes natriuresis in part by inhibiting sodium potassium ATPase. The development of hypertension may be the consequence of an abnormality in volume regulation induced by a defect in the renal response to the natriuretic effect of the natriuretic hormone. Do not confuse with atrial natriuretic hormone or cardionatrin which is a different, well characterized hormone. PM86 HN86 MHÑNatriuretic Hormone AN/biosyn /physiol permitted; do not confuse with NATRIURETIC PEPTIDES, ATRIAL below RN9088-07-7 PIBiological Products (66-80); Blood Proteins (66-85); Natriuresis (66-85); Proteins (66-85) MND6.472.540 XSNatriuretic Factor LH LS  MSA mixture of different-sized low molecular weight peptides derived from a common precursor and secreted by the heart auricles. All these peptides share a sequence of about 20 amino acids. They have potent natriuretic, diuretic, and vasoactive properties. PM86 HN86 MHÑNatriuretic Peptides, Atrial AN/biosyn /physiol permitted RN86903-70-0 PIMuscle Proteins (66-85) MND12.644.390; D12.776.210.500.680 XSAtrial Natriuretic Factor; Atrial Natriuretic Peptides; Atriopeptins; Auriculin; Cardionatrin I LH LS; ; ; ;  MSPsychophysical relaxation technics that are used to facilitate childbirth. MHÑNatural Childbirth ANonly /adv eff /hist /methods /nurs /psychol /trends; check tags FEMALE & PREGNANCY CATALOG: do not use /pop wks MNE4.819.774.457.696 FXÑAnesthesia, Obstetrical LH LX  MSSudden calamitous events producing great material damage, loss and distress; the result of natural phenomena such as earthquakes, floods, etc. OLto search FLOODS use NATURAL DISASTERS back thru 1975 & DISASTERS 1966-74 HN(72); FLOODS was see under DISASTERS 1963-81 MHÑNatural Disasters ANonly /econ /hist PIDisasters (66-71); specific environmental factor MNG3.230.100.200 XSEarthquakes; Floods; Hurricanes; Tornadoes; Volcanic Eruptions DMÑDisasters LH LS; ; ; ; LM  MSComputer processing of a language with rules that reflect and describe current usage rather than prescribed usage. HN(87) MHÑNatural Language Processing ANIM; no qualif MNL1.700.568.110.65.580 DMÑArtificial Intelligence LH LM  MHÑNaturopathy ANdo not use /util except by MeSH definition MNE2.924.667 LH  MHÑNausea AN/chem ind: consider also EMETICS; /drug ther: consider also ANTIEMETICS MNC23.888.821.712 LH  MSThe practice of medicine concerned with conditions affecting the health of individuals associated with the marine environment. MHÑNaval Medicine ANSPEC: SPEC qualif except /methods; Manual 28.10 MNG2.403.478 XSNautical Medicine FXÑDiving; ÑSHIPS LH LS LX;  MS7-Chloro-4-nitrobenz-2-oxa-1,3-diazole. Used as a protein reagent since the terminal N-NBD-protein conjugate possesses interesting fluoroscence and spectral properties. Has also been used as a covalent inhibitor of both beef heart mitochondrial ATPase and bacterial ATPase. HN(76) MHÑNBD Chloride ANdo not use /biosyn /defic /physiol; /analogs NIM only RN10199-89-0 PINitro Compounds (74-75); Oxadiazole (72-75) MND3.383.548.580.400 XSChloronitrobenzoxadiazole DMÑOxadiazoles LH LS LM  MSA complex of antibiotic substances produced by Streptomyces tenebrarius. HN(75) MHÑNebramycin ANdo not use /defic /physiol; /analogs NIM only RN11048-13-8 PIAntibiotics (71-74); Aminoglycosides (74) MND9.203.408.51.600; D20.85.533 DMÑAntibiotics LH LM  MHÑNebraska MNZ1.107.567.875.571 LH  MSDevices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor; used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. PM87 HN87 MHÑNebulizers and Vaporizers ANdo not use /instrum /man /methods /psychol /rehabil /util (except by MeSH definition) PIAerosols (66-86); Anesthesia, Inhalation (66-86); Volatilization (71-86) MNE7.605; E7.858.400 XSAtomizers; Inhalation Devices; Inhalators; Inhalers; Vaporizers FXÑAdministration, Intranasal; ÑAerosols; ÑAnesthesia, Inhalation; ÑRespiratory Therapy; ÑVolatilization LH LS; ; ; ; LX; ; ; ;  MSA genus of intestinal parasite worms which includes one of the most important hookworms of man: Necator americanus. The only other known species N. suillus has been recovered from pigs. MHÑNecator ANintestinal hookworm found in man & pig; note synonyms below; do not use /blood-csf-urine; infection = NECATORIASIS MNB1.500.294.360.400 XSAncylostoma Americana; Hookworm, New World; Necator Americanus; Uncinaria americana LH LS; ; ;  MSInfection of humans or animals with hookworms of the genus Necator. OLsearch HOOKWORM INFECTIONS 1967-74 PM79; was see under HOOKWORM INFECTIONS 1973-78, was see under HOOKWORM INFECTION 1967-72 HN79(75); was see under HOOKWORM INFECTIONS 1973-78, was see under HOOKWORM INFECTION 1967-72 MHÑNecatoriasis ANhuman & animal PIHookworm Infections (64-74); Hookworm Infections (73-78) MNC3.335.508.455.683 LH  MHÑNeck ANas a region & for soft parts but note that NECK MUSCLES is also available; bones = CERVICAL VERTEBRAE; ╥cervical lymph nodes╙ = LYMPH NODES (IM) + NECK (NIM) MNA1.598 LH  MSThe neck muscles consist of the platysma, splenius cervicis, sternocleidomastoid(eus), longus colli, the anterior, medius, and posterior scalenes, digastric(us), stylohyoid(eus), mylohyoid(eus), geniohyoid(eus), sternohyoid(eus), omohyoid(eus), sternothyroid(eus), and thyrohyoid(eus). HN(79) MHÑNeck Muscles PIMuscles (66-78); Neck (66-78) MNA2.633.591 DMÑMuscles LH LM  MHÑNecrobiosis Lipoidica ANalso called ╥necrosis lipoidica diabeticorum╙ so do not index also under DIABETES MELLITUS unless particularly discussed MNC17.849.495 LH  MHÑNecrosis ANIM for general or for necrotic process; NIM as coord for /pathol, with no qualif; bone necrosis = OSTEONECROSIS or OSTEORADIONECROSIS; FEMUR HEAD NECROSIS, KIDNEY CORTEX NECROSIS, KIDNEY PAPILLARY NECROSIS, KIDNEY TUBULAR NECROSIS, ACUTE & PULP NECROSIS are also available MNC23.739.638 XUÑFat Necrosis LH LU  MSA genus of the Proteidae family with five recognized species, which inhabit the Atlantic and Gulf drainages. PM81 HN81 MHÑNecturus ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIUrodela (66-80) MNB2.90.608.630.510 XSMudpuppy XUÑNecturus maculosus LH LS LU  MSA neotenic aquatic species of mudpuppy (Necturus) occurring from Manitoba to Louisiana and Texas. HN(81) MHÑNecturus maculosus ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIUrodela (66-80) MNB2.90.608.630.510.508 DMÑNecturus LH LM  PM73 HN73(71) MHÑNeedles ANonly /class /stand PIappropriate heading/IS (66-70) MNE7.612 LH  MS3,4,5,6-Tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine hydrochloride. Non-narcotic analgesic chemically similar to orphenadrine. Synonym: Acupan. HN(75) MHÑNefopam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13669-70-0 PIAzocines (72-74); Benzene Derivatives (72-74) MND3.383.113.767.500; D14.73.650 XSFenazoxine DMÑOxazocines LH LS LM  MSOpposition and resistance to suggestions or advice. Seen normally in late infancy. A common symptom of catatonic schizophrenia. OLsearch DEFENSE MECHANISMS 1966-74 HN(75) MHÑNegativism ANno qualif MNF1.393.556; F3.407.556 DMÑDefense Mechanisms LH LM  MSA major racial group distinguished by classification according to physical features. PM68 HN68 MHÑNegroid Race ANfor genetic, physical & physiol aspects of race; differenitate from BLACKS, cultural, social, sociol, psychol, etc.; IM; specify geog if pertinent; only /class /hist; includes Adamanese, Afr Bushmen, Half-Hamites, Hottentots, Melanesians, Negrillos, Negritos, Papuans, Pygmies, Semangs; policy on race: Manual 30.10-.12; also 30.14 PIBlacks (66-67) MNI1.76.368.763.708 FXÑBlacks LH LX  MHÑNeisseria ANdo not use /blood-csf-urine MNB3.400.699.474 LH  MHÑNeisseria Gonorrhoeae ANdo not use /blood-csf-urine; infection = GONORRHEA MNB3.400.699.474.474 XSGONOCOCCUS LH LS  MHÑNeisseria Meningitidis ANdo not use /blood-csf-urine; infection: probably MENINGITIS, MENINGOCOCCAL MNB3.400.699.474.641 XSMENINGOCOCCUS LH LS  MSA family of Gram-negative, parasitic bacteria including several important pathogens of man. PM75 HN75 MHÑNeisseriaceae ANdo not use /blood-csf-urine PIBacteria (66-74) MNB3.400.699 LH  MSA syndrome characterized by deep pigmentation and the presence of an ACTH-MSH secreting adenoma of the pituitary gland developing after adrenalectomy for Cushing's syndrome. At present it is not known whether the adenoma occurs de novo or represents enlargement of a previously undetected tumor. HN(78) MHÑNelson Syndrome ANdo not use /anal /blood supply /secret /ultrastruct despite its being in Cat C4 PIAdenoma (66-77); Pigmentation Disorders (66-77); Pituitary Neoplasms (66-77) MNC4.588.322.609.585; C19.700.734.585 DMÑPituitary Neoplasms LH LM  OLuse NEMATODA to search DIOCTOPHYMA & RHABDITOIDEA back thru 1966 and SIPUNCULIDA back thru 1980 PMDIOCTOPHYMA & RHABDITOIDEA were headings 1963-85; SIPUNCULIDA was heading 1980-84 HNDIOCTOPHYMA & RHABDITOIDEA were headings 1963-85; SIPUNCULIDA was heading 1980-84 MHÑNematoda ANGEN only; do not use /blood-csf-urine; infection = NEMATODE INFECTIONS; /drug eff: consider also ANTINEMATODAL AGENTS MNB1.500.294 XSDioctophyma; Rhabditis; Rhabditoidea; Sipunculida; Turbatrix XUÑTylenchoidea LH LS; ; ; ; LU  OLuse NEMATODE INFECTIONS to search ASPICULARIASIS back thru 1968 PMASCARIDIASIS was see under ASCARIASIS 1968-78; ASPICULARIASIS was heading 1968-85 HNASPICULARIASIS was heading 1968-85 MHÑNematode Infections ANGEN only: prefer specifics; /drug ther: consider also ANTINEMATODAL AGENTS; Anisakis infection: coord ASCARIDOIDEA (NIM) + NEMATODE INFECTIONS (IM) MNC3.335.508 XSAspiculariasis XUÑAscaridiasis; ÑStephanurus Dentatus Infection LH LS LU;  MSInfections with hairworms of the phylum Nematomorpha, due to ingestion of free living adults or insect-infested larvae in raw drinking water. OLsearch HELMINTHIASIS 1967-74 HN(75) MHÑNematomorpha Infections MNC3.335.608 DMÑHelminthiasis LH LM  MSA genus of intestinal nematode parasites which occur most commonly in mice. Infection is by ingesting larvae. This particular species is used extensively in immunological research. HN(86) MHÑNematospiroides dubius ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) PINematoda (66-85); Trichostrongyloidea (66-85) MNB1.500.294.550.510 XSHeligmosomoides polygyrus DMÑHeligmosomatoidea LH LS LM  MS5-(3-Amino-4-hydroxyphenylarseno)-2-hydroxyanilinomethylsulfoxylate. Very toxic former antisyphilitic agent still used occasionally for infections, including in animals; it produces skin sensitization and has become a tool in the study of immunologic tolerance as a hapten. Synonyms: Neosalvarsan; Novarsenobillon; Novarsan; Arsevan; Collunovar. MHÑNeoarsphenamine ANdo not use /biosyn /defic /physiol RN457-60-3 MND2.691.88.560; D20.288.293.558; D24.611.216.621.629 XSNeoarsenobenzol; Novarsenobenzene LH LS;  MSAn antitumor isolated from culture filtrate of the F-41 variant of Streptomyces carzinostaticus. It is a protein of known amino acid sequence with a molecular weight of approximately 11,500 possessing a regulatory function on the metabolism of DNA. In this process, which is first an inhibition of DNA biosynthesis followed by the degradation of DNA, it is analogous to the antibiotic mitomycin C, but of much higher molecular weight. Neocarzinostatin is also a potent cytostatic agent active against gram-positive organisms. HN(75) MHÑNeocarzinostatin ANdo not use /defic /physiol; /analogs NIM only RN9014-02-2 PIAntibiotics, Antineoplastic (71-74); Bacterial Proteins (74) MND12.776.97.630; D20.85.75.650; D22.204.106.670 DMÑAntibiotics, Antineoplastic LH LM  MHÑNeodymium ANNd-142; do not use /analogs /biosyn /defic /physiol; Nd-143, 145, 146, 148, 150 = NEODYMIUM (IM) + ISOTOPES (NIM); Nd-138-141, 144, 147, 149, 151 = NEODYMIUM (IM) + RADIOISOTOPES (IM) RN7440-00-8 MND1.268.572; D1.552.550.587 LH  MHÑNeomycin ANdo not use /defic /physiol RN1404-04-2 MND9.203.408.51.623; D20.85.538 XSNeamin; Neomycin A LH LS;  MHÑNeon ANNe-20; do not use /analogs /biosyn /defic /physiol; Ne-21, 22 = NEON (IM) + ISOTOPES (NIM); Ne-17-19, 23, 24 = NEON (IM) + RADIOISOTOPES (IM) RN7440-01-9 MND1.268.578; D1.362.641.592 LH  MH*Neonatal Diseases and Abnormalities (Non Mesh) MNC16 LH  MSA subspecialty of Pediatrics concerned with the newborn infant. PM77 HN77 MHÑNeonatology ANSPEC: SPEC qualif; differentiate from INFANT, NEWBORN, the physiol, psychol or social entity; differentiate from PERINATOLOGY: NEONATOLOGY is newborn inf only, PERINATOLOGY covers mother + fetus/infant CATALOG: use with form qualif instead of INFANT, NEWBORN /form or INFANT, NEWBORN, DISEASES /form PIPediatrics (66-76) MNG2.403.776.671.400 FXÑInfant, Newborn LH LX  MSExfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. PM66 HN66(65) MHÑNeoplasm Circulating Cells ANIM; no qualif MNC4.805.650.645 XSEmbolic Tumor Cells; Embolism, Tumor; Tumor Cells, Embolic LH LS; ;  MSAbility of neoplasms to infiltrate and actively destroy surrounding tissue. PM77 HN77 MHÑNeoplasm Invasiveness ANNIM: no qualif + neopl terms /pathol (IM); IM for GEN only or for invasive process; do not use for histologically invasive tumors (e.g., invasive fibroma = FIBROMA in Tumor Key); when IM, only likely qualif are /diag /pathol /physiopathol /ultrastruct MNC4.805.645; C23.739.650 XSInvasiveness, Neoplasm LH LS  MSThe transfer of a neoplasm in an organ or part of the body remote from the primary site. MHÑNeoplasm Metastasis ANGEN only for metastatic process or neoplasm metast in general; when IM for GEN only, only likely qualif are /diag /pathol /physiopathol /radiogr /radionuclide /ultrastruct; unlikely as NIM coord: prefer /second with organ/neopl & histol type for metastatic neopl; policy on metastasis & /second: Manual 19.4.76, 24.16-.23 MNC4.805.650 XSMetastasis LH LS  MHÑNeoplasm Proteins ANIM & coord with specific protein (IM) + specific histol type (IM) + specific organ/neoplasms term (IM); do not use /analogs MND12.776.624 LH  MSThe local recurrence of a neoplasm following treatment. PM66 HN66(64) MHÑNeoplasm Recurrence, Local ANIM; differentiation from NEOPLASMS, MULTIPLE PRIMARY: Manual 24.23 MNC4.805.655 LH  MSSpontaneous remission of a neoplasm. PM64 HN64 MHÑNeoplasm Regression, Spontaneous ANIM; no qualif; must be spontaneous: for regression or remission after ther use REMISSION INDUCTION MNC4.495; C4.805.670 XSNeoplasm Remission, Spontaneous; Remission, Spontaneous Neoplasm LH LS;  MSThe local implantation of tumor cells by contamination of instruments and surgical equipment by malignant cells during and after surgical resection, resulting in local growth of the cells and tumor formation. PM70 HN70(66) MHÑNeoplasm Seeding ANincludes seeding by surg, biopsy, palpation, etc.; IM; no qualif MNC4.805.650.830 LH  MSMethods which attempt to express in replicable terms the extent of the neoplasm in the patient. PM78 HN78 MHÑNeoplasm Staging AN= degree of spread of neopl (do not confuse with ╥grading╙ which = degree of malignancy); staging is given in roman numerals, grading in arabic; usually NIM with no qualif + neopl terms /pathol (IM); IM as technic & general only & when IM only /instrum /methods /stand /vet; relation to /pathol & differentiation from classification: TN 214 MNE1.670 XSCancer Staging; Staging, Neoplasm; Tumor Staging LH LS; ;  PM67 HN67(64) MHÑNeoplasm Transplantation ANNIM; Manual 24.31; DF: NEOPLASM TRANSPL or NEOPL TRANSPL MNE5.624 FXÑNeoplasms, Experimental; ÑTransplantation LH LX;  OLuse NEOPLASMS /CI or NEOPLASMS /ET to search CARCINOGENESIS 1977 PM/diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977 HN/diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977 MHÑNeoplasms ANavoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but ╥grading╙ = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.32-.36 or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /familial: consider also NEOPLASTIC SYNDROME, HEREDITARY; /immunol: consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /radiother: consider also BRACHYTHERAPY; do not use /second ( = NEOPLASM METASTASIS); metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; 1982 Tumor Key: TN Suppl CATALOG: form qualif = MEDICAL ONCOLOGY /form MNC4 XSCancer; Tumors FXÑDNA, Neoplasm; ÑMedical Oncology; ÑOncogenic Viruses; ÑPrecancerous Conditions; ÑRNA, Neoplasm LH LS; LX; ; ; ;  OLindexing policy: Manual section 24; use 1975 Tumor Key: TN Suppl for human & corresponding vet tumors only: does not contain exper tumors; TN 135: correct use of tissue type terms; restricted use: Manual 24.25 MH*Neoplasms By Histologic Type (Non Mesh) MNC4.557 LH  OLindexing policy: Manual section 24 MH*Neoplasms By Site (Non Mesh) MNC4.588 LH  MHÑNeoplasms, Connective Tissue ANneoplasms composed of connective tissue, NOT neoplasms located in connective tissue: TN 135; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); restricted use: Manual 24.25 MNC4.557.499; C23.205.689 LH  MHÑNeoplasms, Embryonal and Mixed ANneoplasms composed of embryonic tissue, NOT neoplasms located in embryonic tissue: TN 135; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); restricted use: Manual 24.25; DF: NEOPLASMS EMBRYONAL or NEOPL EMBRYONAL MNC4.557.537 LH  MHÑNeoplasms, Experimental ANIM GEN only; do not use as coord for cancer in animals; policy: Manual 24.26-.30; /chem ind: Manual 24.39; ╥spontaneous╙: Manual 24.37 MNC4.619 FXÑNEOPLASM TRANSPLANTATION; ÑTumor Virus Infections LH LX;  MHÑNeoplasms, Glandular Epithelial ANneoplasms composed of glandular tissue, NOT neoplasms located in various glands: TN 135; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); restricted use: Manual 24.25 MNC4.557.576 LH  MSCertain tumors that 1) arise in organs that are normally dependent on specific hormones and 2) are stimulated or caused to regress by manipulation of the endocrine environment. PM79 HN79 MHÑNeoplasms, Hormone-Dependent AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) + histol type (IM) + specific hormone (IM) MNC4.626 XSHormone-Dependent Neoplasms LH LS  MSFamilial disorders associated with tumors in two or more endocrine organs. OLuse NEOPLASMS, MULTIPLE ENDOCRINE to search ADENOMATOSIS, FAMILIAL ENDOCRINE back thru 1966 PM83; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82 HN83; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82 (Prov 1964) MHÑNeoplasms, Multiple Endocrine ANIM; coord with specific endocrine/neopl precoords (IM) + specific histol type (IM) if pertinent MNC4.588.322.440; C4.651.640; C4.700.640; C16.466.700.640 XSAdenomatosis, Familial Endocrine; MEA I; MEA II; MEA III; MEN I; MEN II; MEN III; Sipple Syndrome; Wermer Syndrome FXÑZOLLINGER-ELLISON SYNDROME LH LS; ; ; ; ; ; ; ; LX  PM65 HN65 MHÑNeoplasms, Multiple Primary ANIM; do not use /compl with specific multiple neopl terms to show multiplicity; differentiate from NEOPLASM RECURRENCE, LOCAL: Manual 24.23; note term above MNC4.651 XUÑHamartoma Syndrome, Multiple LH LU  MHÑNeoplasms, Muscle Tissue ANneoplasms composed of muscle tissue, NOT neoplasms located in muscles: TN 135; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); restricted use: Manual 24.25 MNC4.557.614 LH  MHÑNeoplasms, Nervous Tissue ANneoplasms composed of nerve tissue, NOT neoplasms located in the nervous system or nerves ( = NERVOUS SYSTEM NEOPLASMS): TN 135; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); restricted use: Manual 24.25 MNC4.557.652 LH  MHÑNeoplasms, Radiation-Induced ANIM; coord with specific histol type (IM) + organ/neopl term (IM); LEUKEMIA, RADIATION-INDUCED is also available; /anal /blood supply /secret /ultrastruct permitted; Manual 24.41 MNC4.682; C21.866.733.476 LH  MSMetastases in which the tissue of origin is unknown. PM87 HN87 MHÑNeoplasms, Unknown Primary ANIM; do not use /second; only likely qualif are /diag /pathol /physiopathol /ultrastruct /vet; coord with organ/neopl term with /second (IM) + histol type /second (IM) MNC4.805.650.895 XSNeoplasm Metastasis, Unknown Primary; Neoplasms, Occult Primary; Occult Primary Neoplasms; Unknown Primary Tumors LH LS; ; ;  MHÑNeoplasms, Vascular Tissue ANneoplasms composed of vascular tissue, NOT neoplasms located in vascular tissue: TN 135; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); restricted use: Manual 24.25 MNC4.557.690 LH  MSEndocrine syndromes due to hormone production by neoplasms of non-endocrine tissue, or by other than the usual endocrine tissues; often the first indication of a previously undetected neoplasm. PM73 HN73 MHÑNeoplastic Endocrine-Like Syndromes ANdo not use /anal /blood supply /second /secret /ultrastruct; coord IM with precoord organ/neopl term with /secret (IM) + histol type of neopl /secret (IM) + specific hormone /secret (IM) but note XU ACTH SYNDROME, ECTOPIC below PIHormones, Ectopic (68-72) MNC4.730.713; C19.576 XSEctopic Hormone Syndromes FXÑHORMONES, ECTOPIC XUÑACTH Syndrome, Ectopic LH LS LX LU  MH*Neoplastic Processes (Non Mesh) MNC4.805 LH  MSThe condition of a pattern of malignancies within a family, but not every individual necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance. PM87 HN87 MHÑNeoplastic Syndromes, Hereditary ANdo not use /anal /blood supply /secret /ultrastruct MNC4.700; C16.466.700 XSCancer Syndromes, Hereditary LH LS  MSPoly(2-chloro-1,3-butadiene). An oil-resistant synthetic rubber made by polymerization of chloroprene which is toxic to most body systems and may be carcinogenic. Synonym: Duprene. HN(75) MHÑNeoprene AND25-26 qualif; /analogs NIM only RN9010-98-4 PIButadienes (71-74); Polymers (71-74); Hydrocarbons, Chlorinated (74) MND2.455.326.271.665.480; D25.720.840.645 XSChloroprene Polymer; Polychloroprene DMÑPolyenes LH LS; LM  MHÑNeostigmine ANdo not use /biosyn /defic /physiol RN59-99-4 MND2.92.102.602; D2.675.276.602; D8.373.275.643; D16.698.410.698 XSSynstigmin LH LS  MSFormation of new blood vessels, especially capillaries, in ocular and neoplastic tissue, etc. PM80 HN80; was in Cat G 1980-82 MHÑNeovascularization ANonly likely qualif are /diag /pathol /physiopathol /radiogr /radionuclide; coord IM or NIM with organ /blood supply (IM); do not confuse with COLLATERAL CIRCULATION: neovasc is formation of new blood vessels, collat circ is circ through secondary channels after obstruct of principal vessel supplying a part MNC23.739.668 XSAngiogenesis LH LS  MHÑNepal MNZ1.252.245.674 LH  MSChemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index than the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam. OLto search TURBIDIMETRY use NEPHALOMETRY AND TURBIDIMETRY back thru 1975 & DENSITOMETRY 1969-74 PM81; was TURBIDIMETRY see under PHOTOMETRY 1975-80, was TURBIDIMETRY see under DENSITOMETRY 1969-74 HN81; was TURBIDIMETRY see under PHOTOMETRY 1975-80, was TURBIDIMETRY see under DENSITOMETRY 1969-74 MHÑNephelometry and Turbidimetry ANNIM; only /instrum /methods; DF: NEPHELOMETRY MNE5.196.712.650 XSTurbidimetry FXÑScattering, Radiation LH LS LX  MHÑNephrectomy ANdo not use /util except by MeSH definition MNE4.887.774.435 FXÑKidney LH LX  MHÑNephritis AN/familial: consider also NEPHRITIS, HEREDITARY MNC12.777.419.570 LH  MSHereditary disease characterized initially by hematuria and slowly progressing to renal insufficiency, sometimes associated with perceptual deafness and/or congenital ocular defects. OLuse NEPHRITIS, HEREDITARY to search ALPORT'S SYNDROME back thru 1966 (as Prov 1966-69) PM77; was ALPORT'S SYNDROME 1970-76 HN77; was ALPORT'S SYNDROME 1964-76 (Prov 1964-69) MHÑNephritis, Hereditary ANdo not use /congen MNC12.777.419.570.620; C16.131.939.742 XSAlport's Syndrome; Nephritis, Familial LH LS;  PM64 HN64 MHÑNephritis, Interstitial MNC12.777.419.570.643 XSINTERSTITIAL NEPHRITIS; Nephritis, Tubulointerstitial; Tubulointerstitial Nephritis XUÑBalkan Nephropathy LH LS; ; LU  MHÑNephroblastoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with KIDNEY NEOPLASMS (IM) MNC4.557.537.710 XSWILMS' TUMOR LH LS  MHÑNephrocalcinosis MNC12.777.419.590; C18.452.174.130.560 LH  MSA subspecialty of internal medicine concerned with the anatomy, physiology and pathology of the kidney. PM80 HN80 MHÑNephrology ANSPEC; SPEC qualif CATALOG: use with form qualif instead of KIDNEY /form or KIDNEY DISEASES /form PIKidney Diseases (66-79) MNG2.403.776.409.752 FXÑKidney Diseases LH LX  MSThe functional units of the kidney, consisting of the glomerulus and the attached tubule. PM79; was see under KIDNEY 1975-78 HN79(73); was see under KIDNEY 1975-78 MHÑNephrons PIKidney (66-72) MNA5.810.453.736 LH  MSHardening of the kidney due to overgrowth and contraction of interstitial connective tissue. MHÑNephrosclerosis MNC12.777.419.610; C14.907.489.631.560 LH  MSDescriptive histopathologic term for renal disease without an inflammatory component. MHÑNephrosis ANin this kidney dis, emphasis is on degen of tubules; do not diagnose: use term of text; LOWER NEPHRON NEPHROSIS is also available MNC12.777.419.630 LH  MSGlomerular disease causing heavy proteinuria characterized by absence of obvious histologic glomerular changes on light microscopy. Synonyms: minimal change glomerular disease; minimal change glomerulonephritis; minimal lesion glomerulonephritis. MHÑNephrosis, Lipoid MNC12.777.419.630.477 XSGlomerulonephritis, Minimal Change; Nephropathy, Minimal Change; Nephrotic Syndrome, Minimal Change LH LS; ;  MSThe insertion of a catheter through the skin and body wall into the kidney pelvis, mainly to provide urine drainage where the ureter is not functional; also used to remove or dissolve renal calculi and to diagnose ureteral obstruction. PM86 HN86 MHÑNephrostomy, Percutaneous ANdo not use /util except by MeSH definition PIUrinary Catheterization (66-85); Urinary Diversion (66-85) MNE1.341.642; E4.887.774.852.642 XSPercutaneous Nephrostomy LH LS  MSClinical association of heavy proteinuria, hypoalbuminemia, and generalized edema. MHÑNephrotic Syndrome MNC12.777.419.630.643 LH  MHÑNeptunium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7439-99-8 MND1.287.569; D1.552.517.621 LH  MSMethyl 7-(benzyloxy)-6-butyl-1,4-dihydro-4-oxo-3-quinolinecarboxylate. An anticoccidial agent. Synonym: Statyl. HN(75) MHÑNequinate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13997-19-8 PIBenzyl Compounds (73-74); Carboxylic Acids (73-74); Quinolines (73-74) MND3.438.810.450; D21.370.400.645 XSBenzoquate; Methylbenzoquate DMÑQuinolines LH LS; LM  PM74 HN74 MHÑNerve Block ANdo not use /util except by MeSH definition; do not use /pharm or /ther use with substance to induce block; don't forget AUTONOMIC NERVE BLOCK exists; coord with substance (with no qualif) used to induce the block if particularly discussed MNE3.155.86.711; E4.530.324.524 LH  OLuse NERVE COMPRESSION SYNDROMES to search NERVE COMPRESSION 1970-71 (as Prov) PM73 HN73(72); was NERVE COMPRESSION 1970-71 (Prov) MHÑNerve Compression Syndromes ANcoord IM with specific nerve (IM); ╥cauda equina syndrome╙: coord IM with CAUDA EQUINA (IM) PIPeripheral Nerve Diseases (66-69) MNC10.772.491 XSENTRAPMENT NEUROPATHY FXÑCompartment Syndromes LH LS LX  PM74 HN74(63) MHÑNerve Crush ANdo not use /util except by MeSH definition MNE4.530.324.595 LH  PM67 HN67(64) MHÑNerve Degeneration ANnote category; only /drug eff /rad eff MNG11.561.491 XSNEURON DEGENERATION XUÑNissl Degeneration; ÑRetrograde Degeneration; ÑWallerian Degeneration LH LS LU; ;  MHÑNerve Endings ANdo not use /innerv; ╙end organ╥ goes here; do not confuse with MOTOR ENDPLATE MNA8.796.511 FXÑNEURAL TRANSMISSION; ÑTASTE BUDS LH LX;  MSA slender process of a neuron, especially the prolonged axon which conducts nerve impulses. OLsearch NERVE FIBERS, MYELINATED 1969-71 (as Prov) PM77 HN77(69-71) MHÑNerve Fibers ANA 11 qualif except /cytol PINerve Fibers, Myelinated (69-76); Neurons (66-76) MNA8.663.542 XSC Fibers LH LS  PM74 HN74(72) MHÑNerve Fibers, Myelinated ANA 11 qualif except /cytol PINeurons (66-71); appropriate anatomic site MNA8.663.542.512; A11.671.514 XSA Fibers LH LS  MSFactors which enhance the growth potentialities of sensory and sympathetic nerve cells. OLuse NERVE GROWTH FACTORS to search NERVE GROWTH FACTOR back thru 1966 (as Prov 1966-71) PM80; was NERVE GROWTH FACTOR 1972-79 HN80; was NERVE GROWTH FACTOR 1966-79 (Prov 1966-71) MHÑNerve Growth Factors AN/biosyn /physiol permitted; do not use /analogs MND11.303.611; D12.776.641.600; D24.185.348.686 LH  HN(64) MHÑNerve Net ANdo not use /innerv; also called neural network MNA8.511 DMÑNervous System LH LM  MSRenewal or repair of damaged nervous tissue. PM66 HN66 MHÑNerve Regeneration ANonly /drug eff /rad eff MNG4.185.753.611; G11.561.513 LH  MHÑNerve Tissue ANnot for specific nerves or unspecified nerves ( = NERVOUS SYSTEM); do not use /innerv; nerve cell = NEURONS; nerve fiber = AXONS or NERVE FIBERS or NERVE FIBERS, MYELINATED (for dates see these terms); inflammation = NEURITIS MNA8.561; A10.755 LH  MSHighly acidic protein found in large concentration in the brain and believed to be glial in origin; also found in other organs in the body. PM84; was see under NERVE TISSUE PROTEINS 1975-83 HN84(73); was see under NERVE TISSUE PROTEINS 1975-83 MHÑNerve Tissue Protein S 100 AN/biosyn /physiol permitted; /analogs NIM only PINerve Tissue Proteins (66-72) MND12.776.641.611 XSAntigen S 100 LH LS  MHÑNerve Tissue Proteins ANIM & coord with specific protein (IM) + specific nerve or nerve tissue (IM); /biosyn /physiol permitted; do not use /analogs MND12.776.641 XUÑChromogranins LH LU  MHÑNervous System ANGEN only; /innerv is available for organs: Manual 21.7+; for ╥nerves╙ but not for a specific nerve nor NERVE TISSUE; available as a SPEC are NEUROANATOMY for NERVOUS SYSTEM /anat, NEUROCHEMISTRY for /anal, NEUROPHYSIOLOGY for /physiol, NEURORADIOGRAPHY for /radiogr, NEUROSURGERY for /surg; see other terms under NEUR- CATALOG: form qualif = NEUROLOGY /form MNA8 XUÑNerve Net LH LU  OLconsider also NERVOUS SYSTEM /AB & /AB with specific parts of the nerv syst MH*Nervous System Abnormalities (Non Mesh) MNC16.131.666 LH  PM65 HN65 MHÑNervous System Diseases ANGEN; inflamm dis = NEURITIS; nerve entrapments = NERVE COMPRESSION SYNDROMES; ╥diabetic neuropathy╙ & ╥diabetic peripheral neuropathy╙: index only under DIABETIC NEUROPATHIES; ulcero-mutilating acropathy: diabetic = DIABETIC NEUROPATHIES, alcoholic = ALCOHOLISM + PERIPHERAL NERVE DISEASES, hereditary = NEUROPATHY, HEREDITARY SENSORY CATALOG: form qualif = NEUROLOGY /form MNC10 FXÑNeurology LH LX  PM80 HN80; was NON MESH before 1980 MHÑNervous System Neoplasms ANGEN: prefer specific precoord; do not confuse with NEOPLASMS, NERVOUS TISSUE (neopl composed of nerve tissue; TN 135); /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIBrain Neoplasms (66-79); Neoplasms (66-79); Neoplasms, Experimental (66-79); Nervous System Diseases (66-79) MNC4.588.614; C10.551 LH  OLconsider also NERVOUS SYSTEM /PH & /PH with specific nerve syst terms; also NEUROPHYSIOLOGY, the specialty MH*Nervous System Physiology (Non Mesh) MNG11.561 LH  MSAnimal behavior associated with the nest; includes construction, effects of size and material; behavior of the adult during the nesting period and the effect of the nest on the behavior of the young. PM69 HN69(67) MHÑNesting Behavior ANanimal only; only /drug eff /physiol /rad eff PIBehavior, Animal (66) MNF1.145.113.252.478 LH  MHÑNetherlands MNZ1.542.651 LH  MHÑNetherlands Antilles MNZ1.107.904.644 LH  MSSemisynthetic 1-N-ethyl derivative of sisomycin, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. Synonym: SCH 20569. PM86; was see under GENTAMICINS 1979-85 HN86(79); was see under GENTAMICINS 1979-85 MHÑNetilmicin ANdo not use /biosyn /defic /physiol RN56391-56-1 PIGentamicins (66-74); Sisomicin (75-78) MND9.203.408.51.374.785.525; D20.85.369.785.645 LH  MSN'-(2-Carbamoylethyl)-4-[(2-guanidinoacetimidoyl)amino]-1,1'-dimethyl-N,4'-bi(pyrrole-2-carboxamide). Basic polypeptide isolated from Streptomyces netropsis; it has antibacterial, antifungal and antiviral properties and is used as a tool in the study of nucleic acids due to its strong, specific binding to the A-T areas of DNA. Synonyms: IA 887; T 1384. HN(77) MHÑNetropsin ANdo not use /defic /physiol; /analogs NIM only RN554-32-5 PIGuanidines (66-76); Pyrroles (66-76) MND2.78.370.630; D3.383.757.480; D12.644.456.640 XSSinanomycin DMÑGuanidines LH LS LM  PM65 HN65(64) MHÑNeural Analyzers ANdo not use /innerv; DF: NEURAL ANAL MNA8.186.667 XSANALYZERS, NEURAL LH LS  OLuse NEURAL CONDUCTION to search NERVE CONDUCTION back thru 1966 PM68; was NERVE CONDUCTION 1965-67; RECRUITMENT (NEUROLOGY) was see under NEURAL TRANSMISSION 1975-76 HN68; was NERVE CONDUCTION 1965-67 MHÑNeural Conduction ANalong a single nerve; differentiate from NEURAL TRANSMISSION (between nerves); only /drug eff /rad eff; consider also NEURAL INHIBITION MNG11.561.537 XSNERVE CONDUCTION FXÑNeurons XUÑRecruitment (Neurology); ÑRefractory Period, Neurologic; ÑWedensky Inhibition LH LS LX LU; ;  MSA strip of specialized ectoderm flanking each side of the embryonal neural plate, which after the closure of the neural tube, forms a column of isolated cells along the dorsal aspect of the neural tube. Most of the cranial and all of the spinal sensory ganglion cells arise by differentiation of neural crest cells. PM79 HN79 MHÑNeural Crest ANdo not use /abnorm /blood supply /embryol /growth /innerv /inj /pathol /physiopathol /secret PINervous System/EM (66-78) MNA16.254.600 LH  OLuse NEURAL INHIBITION to search INHIBITION, NEURAL back thru 1972 (as Prov 1972-73) PM74 HN74; was INHIBITION, NEURAL 1972-73 (Prov) MHÑNeural Inhibition ANonly /drug eff /rad eff PINeural Transmission (66-71); specific neuroanatomic site (66-71) MNG11.561.559 XSINHIBITION, NEURAL LH LS  MSNeural tracts connecting one part of the nervous system with another. OLuse NEURAL PATHWAYS to search NEURAL INTERCONNECTIONS back thru 1969 (as Prov 1969-74) PM77; was NEURAL INTERCONNECTIONS see under NERVOUS SYSTEM 1975-76 HN77; was NEURAL INTERCONNECTIONS see under NERVOUS SYSTEM 1975-76, was NEURAL INTERCONNECTIONS 1969-74 (Prov) MHÑNeural Pathways AN= ╥neural tracts╙; do not use /innerv; coord NIM with origin (IM) + termination (IM) MNA8.612 XUÑMedian Forebrain Bundle LH LU  OLuse NEURAL TRANSMISSION to search NEUROHUMORAL TRANSMISSION 1968 PM68; NEUROHUMORAL TRANSMISSION was heading 1968 HN68; NEUROHUMORAL TRANSMISSION was heading 1968 MHÑNeural Transmission ANbetween nerves; differentiate from NEURAL CONDUCTION (along a single nerve); only /drug eff /rad eff; consider also NEURAL INHIBITION; neuromusc transm = NEUROMUSCULAR JUNCTION /physiol + NEURAL TRANSMISSION PINeural Conduction (66-67) MNG11.561.582 XSNERVE TRANSMISSION FXÑNerve Endings LH LS LX  MSCongenital malformations of the nervous system due to closure failures of the neural tube. PM79 HN79 MHÑNeural Tube Defects ANdo not use /congen; do not confuse X ref MYELODYSPLASIA with ╥myelodysplastic syndrome╙, a defect of bone marrow formation (index under BONE MARROW DISEASES) PIAnencephaly (66-78); Central Nervous System (66-78); Spina Bifida (66-78) MNC16.131.666.680 XSDermal Sinus; Diastematomyelia; Myelodysplasia; Neurenteric Cyst LH LS; ; ;  MHÑNeuralgia ANIM; GEN; coord IM with specific nerve (IM) if pertinent MNC10.597.617.640; C10.772.537; C23.888.592.612.589 XUÑCausalgia LH LU  MHÑNeuraminic Acids ANdo not use /analogs MND2.241.81.844.562; D2.241.511.902.562; D9.203.67.687; D9.203.811.589 LH  MHÑNeuraminidase ANdo not use /analogs RNEC 3.2.1.18 MND8.586.277.450.692 XSSIALIDASE LH LS  MSA neurosis characterized by chronic fatigue and concomitant physiologic symptoms. MHÑNeurasthenia ANremember also NEUROCIRCULATORY ASTHENIA exists; do not use /drug eff /physiol /rad eff MNF3.709.438.100.410.500 XSNEURASTHENIC NEUROSES; NEUROSES, NEURASTHENIC FXÑAsthenia LH LS; LX  PM65 HN65 MHÑNeurilemma ANA 11 qualif MNA8.663.576; A10.755.612; A11.671.544 FXÑMembranes LH LX  MHÑNeurilemmoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); neurinoma, schwannoma & neurilemmosarcoma go here; ameloblastic neurilemmoma goes under ODONTOGENIC TUMORS; acoustic neurilemmoma = NEUROMA, ACOUSTIC MNC4.557.652.576 LH  MHÑNeuritis ANGEN (IM) but coord with specific nerve if needed (IM); of optic nerve = OPTIC NEURITIS; retrobulbar neuritis = OPTIC NEURITIS; SMON (subacute myelo-optico-neuropathy) is indexed OPTIC NEURITIS (IM) + MYELITIS (IM) + SYNDROME (NIM) MNC10.772.582 LH  MSAn autoimmune demyelinating disorder of peripheral nerves produced by injection of peripheral nerve tissue protein. PM82 HN82 MHÑNeuritis, Experimental Allergic PIMyelin Sheath (66-81); Neuritis (66-81); Peripheral Nerves (66-81) MNC10.772.582.412; C20.111.640 LH  MSStudy of the anatomy of the nervous system as a specialty or discipline. PM76 HN76 MHÑNeuroanatomy ANSPEC only, SPEC qualif; not for NERVOUS SYSTEM /anat CATALOG: use with form qualif instead of NERVOUS SYSTEM /anat /form PIspecific nervous system heading/AH (66-75) MNG1.100.700; G1.610.60 LH  PM86 HN86 MHÑNeurobiology ANSPEC: SPEC qualif MNG1.273.610; G1.610.80 XSCellular Neurobiology; Molecular Neurobiology LH LS;  MHÑNeuroblastoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); olfactory neuroblastoma = NEUROEPITHELIOMA, not NEUROBLASTOMA; retinal neuroblastoma = RETINOBLASTOMA, not NEUROBLASTOMA MNC4.557.652.609 LH  PM64 HN64 MHÑNeurochemistry ANSPEC: SPEC qualif; not for NERVE TISSUE /anal MNG1.201.687; G1.610.110 FXÑChemistry LH LX  MSA clinical syndrome characterized by palpitation, shortness of breath, labored breathing, subjective complaints of effort and discomfort; all following slight exertion. Other symptoms may be dizziness, tremulousness, sweating, and insomnia. Neurocirculatory asthenia is most typically seen as a form of anxiety neurosis. MHÑNeurocirculatory Asthenia ANremember NEURASTHENIA also exists; do not use /drug eff /physiol /rad eff MNF3.709.438.180.400 XSCardiac Neurosis; EFFORT SYNDROME; Hyperkinetic Heart Syndrome FXÑHeart Diseases LH LS; ; LX  MHÑNeurodermatitis MNC17.174.625 LH  PM68 HN68 MHÑNeuroeffector Junction ANdo not use /innerv PINerve Endings (66-67) MNA8.796.511.479; A11.195.443.645 LH  MSThe study of the anatomical and functional relationships between the nervous system and the endocrine system. PM86 HN86 MHÑNeuroendocrinology ANSPEC only, SPEC qualif; not for coord of NERVOUS SYSTEM + ENDOCRINE GLANDS nor for ENDOCRINE GLANDS /innerv MNG1.610.160; G1.782.323.200 LH  MHÑNeuroepithelioma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.642 LH  PM65 HN65 MHÑNeurofibrils ANA 11 qualif except /cytol; do not confuse with NERVE FIBERS; neurofibrillary or neurofibrillatory tangles goes here MNA8.663.609; A11.368.702.672; A11.671.573 LH  MHÑNeurofibroma ANsolitary; multiple = NEUROFIBROMATOSIS; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.675 LH  MSA congenital hereditary disorder characterized by developmental changes in the nervous system, muscles, bones and skin. There are multiple cutaneous tumors and tumors of the peripheral and central nervous system. Mental retardation may be associated with the tumors of the central nervous system. MHÑNeurofibromatosis ANmultiple; solitary = NEUROFIBROMA; do not use /drug eff /physiol /rad eff; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.675.562; C4.700.650; F3.709.346.672 XSRECKLINGHAUSEN'S DISEASE OF NERVE LH LS  MHÑNeuroglia ANA 11 qualif; do not use /innerv MNA11.671.603 XUÑOligodendroglia LH LU  MSA form of analgesia accompanied by general quiescence and psychic indifference to environmental stimuli, without loss of consciousness, and produced by the combined administration of a major tranquilizer (neuroleptic) and a narcotic. OLuse NEUROLEPTANALGESIA to search NEUROLEPTOANALGESIA back thru 1966 (as Prov 1966-67) PM79; was NEUROLEPTOANALGESIA 1968-78 HN79; was NEUROLEPTOANALGESIA 1966-78 (Prov 1966-67) MHÑNeuroleptanalgesia ANdo not use /util except by MeSH definition MNE3.91.646 LH  MSA rare potentially fatal syndrome which develops in patients on major tranquilizers. The dominant features are fever, autonomic symptoms, muscle rigidity, and other extrapyramidal symptoms. PM86; was see under BASAL GANGLIA DISEASES 1985 HN86(85); was see under BASAL GANGLIA DISEASES 1985 MHÑNeuroleptic Malignant Syndrome ANcaused by tranquilizing agents so do not use /chem ind PIBasal Ganglia Diseases (79-84); Fever (66-84); Malignant Hyperthermia (73-84); Muscle Rigidity (72-84); Tranquilizing Agents, Major (75-84) MNC10.228.140.79.635; C21.613.276.635 LH  PM66 HN66(64) MHÑNeurologic Examination ANNIM; only /instrum /methods /stand /vet MNE1.236.563; E1.706.592 LH  PMFASCICULATION was see under MOVEMENT DISORDERS 1979-81 MHÑNeurologic Manifestations ANneurol manifest of non-neural diseases; avoid: prefer more specific neurol term; no qualif; Manual 23.36+; TN 239: differentiation from NERVOUS SYSTEM DISEASES & when not to use MNC10.597; C23.888.592 LH  MSA medical specialty concerned with the study of the structures, functions, and diseases of the nervous system. MHÑNeurology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of NERVOUS SYSTEM /form or NERVOUS SYSTEM DISEASES /form MNG2.403.790.462 FXÑNERVOUS SYSTEM DISEASES LH LX  MHÑNeuroma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); ╥neurinoma╙ does not go here: index under NEURILEMMOMA but acoustic neurinoma = NEUROMA, ACOUSTIC MNC4.557.652.709 LH  MSA progressively enlarging tumor within the auditory canal arising from the eighth cranial nerve. PM78 HN78 MHÑNeuroma, Acoustic ANa neuroma of acoustic (8th) nerve; /anal /blood supply /secret /ultrastruct permitted; also called acoustic neurinoma, acoustic neurilemmoma, acoustic schwannoma PIAcoustic Nerve (66-77); Neurilemmoma (66-77) MNC4.557.652.576.15; C4.588.614.596.240.15; C9.218.807.23.675; C10.772.204.192.675 LH  OLconsider also NEUROMUSCULAR JUNCTION /DE & MUSCLES /DE MH*Neuromuscular Agents (Non Mesh) MND17 LH  MSDrugs which interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockaders or noncompetitive, depolarizing agents; both prevent acetylcholine from triggering the muscle contraction; they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. OLsearch CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 PM75; was see under CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 HN75; was see under CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 MHÑNeuromuscular Blocking Agents ANdo not use /analogs /biosyn /defic /physiol; consider also NEUROMUSCULAR JUNCTION /drug eff PIAutonomic Agents (66-74); Curare-Like Agents (70-74); Neuromuscular Depolarizing Agents (70-74) MND17.563 LH  OLsearch MUSCLE RELAXANTS under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 & MUSCLES 1966-69 PM70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69 HN70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69 MHÑNeuromuscular Depolarizing Agents ANdo not use /analogs /biosyn /defic /physiol; consider also NEUROMUSCULAR JUNCTION /drug eff PIMuscles (66-69) MND17.688 XSDEPOLARIZING MUSCLE RELAXANTS; LEPTOCURARES; Muscle Relaxants, Depolarizing LH LS; ;  PM71 HN71 MHÑNeuromuscular Diseases ANGEN PIMuscular Diseases (66-70); Nervous System Diseases (66-70) MNC5.651.661; C10.668 LH  OLuse NEUROMUSCULAR JUNCTION to search MYONEURAL JUNCTION back thru 1966 PM68; was MYONEURAL JUNCTION 1963-67 HN68; was MYONEURAL JUNCTION 1963-67 MHÑNeuromuscular Junction ANdo not use /innerv; /drug eff: consider also NEUROMUSCULAR BLOCKING AGENTS or NEUROMUSCULAR DEPOLARIZING AGENTS; neuromusc transm = NEUROMUSCULAR JUNCTION /physiol + NEURAL TRANSMISSION; nerve-muscle prep goes here MNA8.796.511.479.563; A11.195.443.645.563 XSMyoneural Junction FXÑReceptors, Cholinergic XUÑMotor Endplate LH LS LX LU  PM65; was see under NERVE ENDINGS 1963-64 HN65(63); was see under NERVE ENDINGS 1963-64 MHÑNeuromuscular Spindles ANdo not use /innerv MNA8.796.511.725.404.526 LH  MSA demyelinating disease of the optic nerve chiasma, optic tract and spinal cord characterized by acute bilateral optic neuritis and acute myelitis. OLsearch MULTIPLE SCLEROSIS 1966-74 HN(75)(63-66); was see under MULTIPLE SCLEROSIS 1963-78 MHÑNeuromyelitis Optica MNC10.228.337.689; C11.640.576.695 DMÑDemyelinating Diseases LH LM  MSA heritable lipidosis with cytoplasmic inclusions staining for ceroid and lipofuscin. Clinically the patient has progressive dementia, retinal degeneration, seizures, and myoclonic jerks. Formerly thought to be related to Tay-Sachs disease but biochemical defect is as yet undetermined. Named according to age of onset: Jansky-Bielschowsky disease, 2-4 years; Batten-Spielmeyer-Vogt disease, 5-11 years; and Kufs disease, adult. PM83 HN83 MHÑNeuronal Ceroid-Lipofuscinosis ANdo not use /congen /drug eff /physiol /rad eff PILipoidosis (66-82); Ceroid (75-82); Lipofuscin (75-82); Pigments (66-82) MNC10.228.140.163.660; C10.496.635; C18.452.648.556.641.509; F3.709.346.682 XSBatten-Spielmeyer-Vogt Disease; Ceroid-Lipofuscinosis, Neuronal; Jansky-Bielschowsky Disease ; Kufs Disease LH LS; ; ;  MSThe capacity of the nervous system to change its reactivity as the result of successive activations. PM82 HN82 MHÑNeuronal Plasticity ANonly /drug eff /rad eff PINeurons (66-81); Synapses (66-81); Visual Cortex (68-81); Visual Pathways (71-81) MNG11.561.594 XSPlasticity, Neuronal LH LS  OLto search NERVE CELLS use NEURONS back thru 1975 & NEUROGLIA & NEURONS 1966-74 PMNERVE CELLS was see under NEUROGLIA & NEURONS 1963-74 HNNERVE CELLS was see under NEUROGLIA & NEURONS 1963-74 MHÑNeurons ANA 11 qualif & /class; intercalated neurons = INTERNEURONS; do not use as a substitute or synonym for BRAIN /cytol; neurofibrillary or neurofibrillatory tangles goes under NEUROFIBRILS MNA8.663; A11.671 XSNerve Cells FXÑNEURAL CONDUCTION LH LS LX  MSNeurons which conduct nervous impulses from a receptor to a center. PM77 HN77(69) MHÑNeurons, Afferent ANA 11 qualif PINeurons (66-68) MNA8.663.643; A11.671.632 XSNeurons, Sensory LH LS  MSNeurons which conduct nervous impulses from a center to an organ of response. PM77 HN77(69) MHÑNeurons, Efferent ANA 11 qualif PINeurons (66-68) MNA8.663.676; A11.671.661 LH  MSHereditary and congenital diseases affecting peripheral sensory neurons. Classified into four types: I. hereditary sensory radicular neuropathy, II. congenital sensory neuropathy, III. familial dysautonomia or AUTONOMIC DYSFUNCTION, IV. familial sensory neuropathy with anhidrosis. PM79 HN79 MHÑNeuropathy, Hereditary Sensory ANdo not use /congen; hereditary ulcero-mutilating acropathy goes here PIPeripheral Nerve Diseases (66-78); Peripheral Nerves (66-78); Sensation (66-78) MNC10.772.590; C16.131.666.690 XSSensory Neuropathy, Hereditary LH LS  MSA 36-amino acid residue peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, grandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. PM87 HN87 MHÑNeuropeptide Y AN/biosyn /physiol permitted PINerve Tissue Proteins (66-86) MND12.644.400; D12.776.641.650.500 XSNeuropeptide Y-Like Immunoreactive Peptide LH LS  MSPeptides made by neurons, or peptides which if made by other tissues, affect neurons. Many act like neurotransmitters or like modulators of neurotransmitter action. They are involved in fundamental physiological functions as well as in memory and learning. PM87 HN87 MHÑNeuropeptides ANGEN: prefer specifics; /biosyn /physiol permitted PINerve Tissue Proteins (66-86) MND12.776.641.650; D16.538.672 LH  MSThe branch of pharmacology dealing especially with the action of drugs upon various parts of the nervous system. PM86 HN86 MHÑNeuropharmacology ANSPEC: SPEC qualif: not for NERVOUS SYSTEM /drug eff MNG1.610.208; G1.703.30; G2.628.280 LH  PM73 HN73 MHÑNeurophysins AN/biosyn /physiol permitted; do not use /analogs PINerve Tissue Proteins (66-72) MND12.776.157.597; D12.776.641.650.525 FXÑPituitary Hormones, Posterior LH LX  PM65 HN65 MHÑNeurophysiology ANSPEC only, SPEC qualif; not for NERVOUS SYSTEM /physiol CATALOG: use with form qualif instead of NERVOUS SYSTEM /physiol /form MNG1.610.268; G1.782.562 FXÑSENSATION LH LX  MSTests designed to assess neurological function associated with certain behaviors; used in diagnosing brain dysfunction or damage, and central nervous system disorders or injury. OLto search APHASIA TESTS use NEUROPSYCHOLOGICAL TESTS back thru 1979; to search MEMORY FOR DESIGNS TEST use NEUROPSYCHOLOGICAL TESTS back thru 1971 (as Prov 1971-72) PM85; MEMORY FOR DESIGNS TEST was heading 1973-84; APHASIA TESTS was see under LANGUAGE TESTS 1979-84; TRAIL MAKING TEST was see under PSYCHOLOGICAL TESTS 1971-84 HN85; was NON MESH before 1985; MEMORY FOR DESIGNS TEST was heading 1971-84 (Prov 1971-72); APHASIA TESTS was see under LANGUAGE TESTS 1979-84 MHÑNeuropsychological Tests ANonly /class /econ /instrum /methods /stand MNF4.711.513 XSAphasia Tests; Memory for Designs Test XUÑLuria-Nebraska Neuropsychological Battery; ÑTrail Making Test LH LS; LU;  MSA branch of psychology which investigates the correlation between experience or behavior and the basic neurophysiological processes. The term neuropsychology stresses the dominant role of the nervous system. It is a more narrowly defined field than physiological psychology or psychophysiology. PM85 HN85 MHÑNeuropsychology ANSPEC: IM, SPEC qualif; NIM coord, no qualif MNF4.96.795.600; G1.782.795.110 LH  PM73 HN73 MHÑNeuroradiography ANGEN or technical only: not coord for specific nerve /radiogr; NIM; do not use /util except by MeSH definition CATALOG: use with form qualif instead of NERVOUS SYSTEM /radiogr /form PIRadiography (66-72) MNE1.236.688; E1.818.573 LH  MH*Neuroregulator Blockaders (Non MeSH) MND23 LH  OLuse NEUROREGULATORS to search NEUROHUMORS back thru 1968 PM80; was NEUROHUMORS 1968-79 HN80; was NEUROHUMORS 1968-79 MHÑNeuroregulators AN/biosyn /physiol permitted; do not use /analogs PINerve Endings/PH (66-67); Neurosecretion (66-67); specific substance MND16.538 XSNerve Transmitter Substances; Neurohumors; Neuromodulators; Neurotransmitters FXÑSlow-Reacting Substances LH LS; ; ; LX  MSThe scientific disciplines concerned with the embryology, anatomy, physiology, biochemistry, pharmacology, etc., of the nervous sytem. PM86 HN86 MHÑNeurosciences ANGEN or unspecified; prefer specifics; SPEC: SPEC qualif MNG1.610 LH  PM65 HN65(64) MHÑNeurosecretion ANonly /drug eff /rad eff MNG11.561.606 FXÑNEUROSECRETORY SYSTEMS; ÑPITUITARY HORMONE RELEASING HORMONES LH LX;  MSA system of neurons that has the specialized function to produce and secrete hormones, and that constitutes, in whole or in part, an endocrine organ or system. OLuse NEUROSECRETORY SYSTEMS to search NEUROHEMAL ORGAN back thru 1970 PM70 HN70; NEUROHEMAL ORGAN was see under NEUROSECRETORY SYSTEMS 1970-83 MHÑNeurosecretory Systems ANdo not use /innerv /secret ( = probably /physiol or NEUROSECRETION) PINeurosecretion (66-69) MNA6.688; A8.713 XSCorpus Cardiacum; Neuroendocrine System; Neurohemal Organ FXÑNEUROSECRETION XUÑSubcommissural Organ; ÑSubfornical Organ LH LS; ; LX LU;  MHÑNeurospora ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.629 XUÑNeurospora Crassa LH LU  MSA species of ascomycetous fungi of the family Sordariaceae, order Sordariales much used in genetic and physiologic studies. HN(72) MHÑNeurospora Crassa ANdo not use /anat /embryol /microbiol /parasitol; DF: N CRASSA PINeurospora (66-71) MNB5.354.107.629.564 DMÑNeurospora LH LM  MSA surgical specialty concerned with the treatment of diseases and disorders of the brain, spinal cord, and peripheral and sympathetic nervous system. MHÑNeurosurgery ANSPEC: SPEC qualif; GEN only: not coord for specific nerve /surg, BRAIN /surg or /surg with specific parts of brain or NERVOUS SYSTEM /surg; /nurs /psychol /rehabil permitted CATALOG: use with form qualif instead of NERVOUS SYSTEM /surg /form MNE4.530; G2.403.810.425 LH  MHÑNeurosyphilis MNC1.252.847.840.744.456; C10.228.228.674 LH  OLsearch RECEPTORS, SENSORY 1972-74 & NERVE ENDINGS 1966-71 HN(75); was see under RECEPTORS, NEURAL 1972-76, was see under NERVE ENDINGS 1963-71 MHÑNeurotendinous Spindles ANdo not use /innerv MNA8.796.511.725.404.598 DMÑMechanoreceptors LH LM  MSA biologically active tridecapeptide isolated from the hypothalamus. PM78 HN78 MHÑNeurotensin AN/biosyn /physiol permitted RN39379-15-2 PIKinins (66-77); Nerve Tissue Proteins (66-77); Peptides (66-77) MND12.644.405; D12.776.641.650.550 LH  MSDisorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment. OLuse NEUROTIC DISORDERS to search NEUROSES back thru 1966 PM81; was NEUROSES 1963-80 HN81; was NEUROSES 1963-80 MHÑNeurotic Disorders ANdo not use /drug eff /physiol /rad eff MNF3.709.438 XSNeuroses; Psychoneuroses LH LS;  MSToxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system; most venoms contain neurotoxic substances; myotoxins seem to be included in this concept. PM78 HN78 MHÑNeurotoxins ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTITOXINS; coord IM with toxin or venom heading which is the source of the neurotoxin (e.g., SEA SNAKE VENOMS) (IM or NIM) but note that COBRA NEUROTOXINS is available; do not use for neurotoxicity of various chemicals & drugs ( = NERVOUS SYSTEM /drug eff or specific nerv syst term /drug eff or nervous system dis heading /chem ind + Cat D term /ad-poi-tox) PIToxins (66-77) MND24.185.926.640 XSExcitotoxins LH LS  MS3-Amino-7-dimethylamino-2-methylphenazine hydrochloride. A vital dye used as an indicator and biological stain. Various adverse effects have been observed in biological systems. HN(75) MHÑNeutral Red AND25-26 qualif; /analogs NIM only RN553-24-2 PIDimethylamines (73-74); Phenazines (69-74) MND3.494.704.600; D26.408.588; D26.550.500 XSC.I. Basic Red 5; Toluylene Red DMÑPhenazines LH LS; LM  MSTitration of an antiserum by testing a series of dilutions of virus or immune serum to a given end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). MHÑNeutralization Tests ANNIM; only /instrum /methods MNE1.223.495.826.664 LH  OLsearch ACTIVATION ANALYSIS 1967-74 HN(75) MHÑNeutron Activation Analysis ANNIM; only /instrum /methods MNE5.196.39.564; H1.181.278.41.564 DMÑActivation Analysis LH LM  MSElectrically neutral elementary particles found in all atomic nuclei except light hydrogen; the mass is equal to that of the proton and electron combined and they are unstable when isolated from the nucleus, undergoing beta decay. Slow, thermal, epithermal, and fast neutrons refer to the energy levels with which the neutrons are ejected from heavier nuclei during their decay. MHÑNeutrons ANno qualif MNH1.671.579.404.645 XUÑFast Neutrons LH LU  OLsearch AGRANULOCYTOSIS 1966-74 HN(75) MHÑNeutropenia MNC15.378.553.546.184.564 DMÑAgranulocytosis LH LM  MSGranular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. PM65 HN65 MHÑNeutrophils ANA 11 qualif & /class; decrease in no. = NEUTROPENIA; neutrophil chemotaxis: coord NIM with CHEMOTAXIS, LEUKOCYTE (IM) MNA11.118.637.415.583; A11.733.689; A15.145.229.637.415.583; A15.382.490.315.583; A15.382.680.689 XSLeukocytes, Polymorphonuclear LH LS  MHÑNevada MNZ1.107.567.875.586 LH  MHÑNevus ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); BASAL CELL NEVUS SYNDROME is also available MNC4.557.537.734 LH  MSA macular lesion on the side of the face, involving the conjunctiva and lids, as well as the adjacent facial skin, sclera, ocular muscles, and periosteum. Histological features vary from those of a mongolian spot to those of a blue nevus. HN(87) MHÑNevus of Ota ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) PINevus (66-86); Nevus, Pigmented (66-86) MNC4.557.537.734.540 XSOta's Nevus DMÑNevus, Pigmented LH LS LM  MHÑNevus, Pigmented ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.734.564 XUÑNevus of Ota LH LU  MHÑNew Brunswick MNZ1.107.567.176.494 LH  HN75 MHÑNew Caledonia MNZ1.782.590.620 LH  MSThe geographic area of New England in general and when the specific state or states are not indicated. Usually includes Connecticut, Maine, Massachusetts, Rhode Island, New Hampshire, and Vermont. HN75 MHÑNew England ANincludes Conn, Maine, Mass, NH, RI, & Vt; specify as needed & use NEW ENGLAND when text uses the term CATALOG: use for 3 or more states MNZ1.107.567.875.595 LH  MHÑNew Guinea MNZ1.782.590.694 LH  MHÑNew Hampshire MNZ1.107.567.875.603 LH  HN75 MHÑNew Hebrides MNZ1.782.590.736 LH  MHÑNew Jersey MNZ1.107.567.875.612 LH  MHÑNew Mexico MNZ1.107.567.875.620 LH  MHÑNew York AN= state; NEW YORK CITY is also available MNZ1.107.567.875.629 LH  MHÑNew York City MNZ1.107.567.875.629.565; Z1.433.741 LH  MHÑNew Zealand MNZ1.730 LH  MHÑNewcastle Disease ANdo not use /vet; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMAL; specific bird or fowl (IM) MNC2.782.660.645; C22.131.630 LH  MHÑNewcastle Disease Virus ANdo not use /blood-csf-urine /cytol MNB4.909.777.569.660 LH  MHÑNewfoundland MNZ1.107.567.176.540 XSLabrador LH LS  MHÑNewspapers ANonly /econ /hist /stand; med newspapers: do not coord with MEDICINE MNL1.178.682.829.481 LH  MS3-Pyridinecarboxylic acid. Water-soluble vitamin of the B complex occurring in various animal and plant tissues. Required by the body for the formation of coenzymes NAD and NADP. Has pellagra-curative, vasodilating, and anti-lipemic properties. OLsearch NICOTINIC ACIDS 1966-82 PM83; was see NICOTINIC ACIDS 1975-82 & NICOTINIC ACID 1963-74 HN83; was see NICOTINIC ACIDS 1975-82 & NICOTINIC ACID 1963-74 MHÑNiacin AN/biosyn /defic /physiol permitted; /ther use: coord disease with /drug ther, not /diet ther RN59-67-6 PINicotinic Acids (66-82) MND3.66.515.475; D3.383.725.547.475; D11.786.708.547.500 XSNicotinic Acid LH LS  MHÑNialamide ANdo not use /biosyn /defic /physiol RN51-12-7 MND8.373.616.565; D15.236.122.627.565 LH  MHÑNicaragua MNZ1.107.169.690 LH  MSAn equimolar complex of 4,4'-Dinitrocarbanilide and 2-Hydroxy-4,6-dimethylpyrimidine. A coccidiostat for poultry. Synonyms: Nicarb; Nicoxin; Nicrazin. HN(75) MHÑNicarbazin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN330-95-0 PICarbanilides (74); Pyrimidines (69-74) MND2.65.199.326.550; D2.948.684.202.550; D3.383.742.470; D21.370.400.660 DMÑCarbanilides LH LM  MS2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl)-3,5-pyridinedicarboxylate. A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. PM87 HN87 MHÑNicardipine ANdo not use /biosyn /defic /physiol RN55985-32-5 PINifedipine/analogs & derivatives (75-86); Pyridines (66-74) MND3.383.725.510; D18.162.640; D18.192.633; D18.918.623 LH  MS8 beta-(5-Bromonicotinoylhydroxymethyl)-1,6-dimethyl-10 alpha-methoxyergoline. An ergoline derivative with vasodilating and alpha receptor blocking activity. Synonym: Sermion. HN(75) MHÑNicergoline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN27848-84-6 PIErgolines (72-74); Nicotinic Acids (72-74) MND3.132.327.287.730; D3.549.439.730; D16.848.115.287.600 XSNimergoline DMÑErgolines LH LS LM  MS2,2-Bis-(hydroxymethyl)-propane-1,3-dioltetranicotinate. An ester of nicotinic acid which lowers cholesterol and triglycerides in total plasma and in the VLD and LD fractions. Synonym: Perycit. HN(77) MHÑNiceritrol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5868-05-3 PINicotinic Acids (71-76); Propanediols (71-76) MND3.66.515.500; D3.383.725.547.500; D10.162.500 XSPentaerythritol Tetranicotinate DMÑNicotinic Acids LH LS LM  MHÑNickel ANNi-58; do not use /analogs /biosyn /defic /physiol; Ni-60-62, 64 = NICKEL (IM) + ISOTOPES (NIM); Ni-56, 57, 59, 63, 65-67 = NICKEL (IM) + RADIOISOTOPES (IM) RN7440-02-0 MND1.268.591; D1.552.601 LH  MS5,5'-Dichloro-3,3'-dinitrobiphenyl-2,2'-diol. Proposed fasciolacide. Synonyms: Dertil; Bilevon; Bay 9015. HN(75) MHÑNiclofolan ANdo not use /biosyn /defic /physiol; /analogs NIM only RN10331-57-4 PIBiphenyl Compounds (72-74); Nitrophenols (72-74) MND2.455.426.559.389.185.600; D2.640.743.600; D2.755.566.600 XSDistolon; Menichlopholan DMÑNitrophenols LH LS; LM  OLuse NICLOSAMIDE to search YOMESAN back thru 1966 (as Prov 1966-72) PM78; was YOMESAN 1973-77 HN78; was YOMESAN 1963-77 (Prov 1963-72) MHÑNiclosamide ANdo not use /biosyn /defic /physiol RN50-65-7 MND2.65.199.860.470; D2.65.793.650.470; D21.201.287.548; D21.201.412.100.608 XSYomesan LH LS  MSNicotinamide amidohydrolase. Catalyzes the hydrolysis of nicotinamide to nicotinate and ammonia. HN(75) MHÑNicotinamidase ANdo not use /analogs RNEC 3.5.1.19 PIAmidohydrolases (72-74); Nicotinamide (72-74) MND8.586.277.87.610 XSNicotinamide Amidohydrolase; Nicotinamide Deamidase DMÑAmidohydrolases LH LS; LM  MHÑNicotinamide AN/analogs /defic permitted; /ther use: coord disease with /drug ther, not /diet ther RN98-92-0 MND3.66.515.530; D3.383.725.547.530; D11.786.708.547.565 XSNIACINAMIDE; VITAMIN PP XUÑ6-Aminonicotinamide LH LS; LU  MS3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN. PM77 HN77(72) MHÑNicotinamide Mononucleotide AN/biosyn /physiol permitted; DF: NMN RN1094-61-7 PINicotinamide (66-72); Ribonucleotides (66-72) MND13.695.827.648 LH  MHÑNicotine ANdo not use /defic /physiol RN54-11-5 MND3.132.760.570; D3.383.725.518; D16.653.396.515; D16.698.628.599 FXÑTobacco LH LX  OLuse NICOTINIC ACIDS to search NICOTINIC ACID back thru 1966 PM75; was NICOTINIC ACID 1963-74 HN75; was NICOTINIC ACID 1963-74 MHÑNicotinic Acids AN/biosyn /defic /physiol permitted; do not use /analogs; /ther use: coord disease with /drug ther, not /diet ther MND3.66.515; D3.383.725.547; D11.786.708.547 XUÑClonixin; ÑEtazolate; ÑNiceritrol; ÑNiflumic Acid; ÑPipemidic Acid; ÑPiromidic Acid LH LU; ; ; ; ;  MS3-Pyridinemethanol. Direct acting peripheral vasodilator that causes flushing and may decrease blood pressure. Used in vasospasm and threatened gangrene. Synonym: Roniacol. HN(75) MHÑNicotinyl Alcohol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN100-55-0 PIAlcohol, Methyl (69-74); Pyridines (69-74) MND3.383.725.565; D18.918.630 XSNicotinic Alcohol; Nicotinyltartrate; Pyridylcarbinol DMÑPyridines LH LS; ; LM  MHÑNictitating Membrane ANNIM; also called ╥third eyelid╙; ptosis of third eyelid: coord IM with EYELID DISEASES /vet (IM), not BLEPHAROPTOSIS MNA13.660 FXÑEyelids LH LX  MSAn autosomal recessive disorder of phospholipid metabolism with abnormal intracellular accumulation of sphingomyelin and characterized by mental deterioration, blindness, cherry red spot in the retina, hepatosplenomegaly, etc. MHÑNiemann-Pick Disease ANdo not use /congen /drug eff /physiol /rad eff MNC10.228.140.163.689; C15.604.667.730; C18.452.648.556.641.803.730; F3.709.346.698 LH  MS4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid methyl ester. A potent vasodilator agent with calcium antagonistic action. Useful anti-anginal agent that also lowers blood pressure. PM84; was see under PYRIDINES 1975-83 HN84(75); was see under PYRIDINES 1975-83 MHÑNifedipine ANdo not use /biosyn /defic /physiol RN21829-25-4 PIDicarboxylic Acids (72-74); Nitrobenzenes (72-74); Pyridines (72-74) MND3.383.725.575; D18.192.638; D18.918.638 LH  MS2-(3-trifluoromethylanilino)nicotinic acid. An analgesic and anti-inflammatory agent. Used in the treatment of rheumatoid arthritis. HN(75) MHÑNiflumic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4394-00-7 PIAniline Compounds (72-74); Nicotinic Acids (68-74) MND3.66.515.550; D3.383.725.547.550; D14.73.278.593; D26.74.75.687 DMÑNicotinic Acids LH LM  MS5-[(Methylthio)methyl]-3-[(5-nitrofurfurylidene)amino]-2-oxazolidinone. Local antiprotozoal and antifungal agent that may also be given orally; used for vaginal candidiasis and trichomoniasis. Synonyms: Macmiror; Magmilor; Polmiror; Thiodinone; Tydantil. HN(76) MHÑNifuratel ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4936-47-4 PINitrofurans (68-75); Oxazoles (68-75); Sulfides (72-75) MND2.640.600.410; D3.383.312.649.410; D20.136.642; D21.370.370.684 XSMethylmercadone; Thiodinon DMÑNitrofurans LH LS; LM  MS5-Nitro-2-furaldoxime. Topical anti-infective agent used in protozoal and fungal infections; proposed as a radiosensitizing agent for solid tumors. Synonym: Micofur. HN(76) MHÑNifuroxime ANdo not use /biosyn /defic /physiol; /analogs NIM only RN6236-05-1 PINitrofurans (73-75); Oximes (73-75) MND2.640.600.430; D3.383.312.649.430; D20.136.651; D26.776.638 DMÑNitrofurans LH LM  MS4-(5-Nitrofurfurylidenamino)-3-methylthiomorpholine-1,1-dioxide. Possibly effective against parasites. Synonyms: Lampit; Bayer 2502. HN(75) MHÑNifurtimox ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23256-30-6 PICyclic S-Oxides (73-74); Nitrofurans (71-74); Thiazines (73-74) MND2.640.600.480; D3.383.312.649.480; D3.383.855.400 DMÑNitrofurans LH LM  MHÑNiger ANdo not confuse with NIGERIA MNZ1.58.432.640 LH  MHÑNigeria ANdo not confuse with NIGER MNZ1.58.432.645 LH  MSSpiromacrolide antibiotic. HN(75) MHÑNigericin ANdo not use /defic /physiol; /analogs NIM only RN28380-24-7 PIAntibiotics (69-74); Carboxylic Acids (73-74) MND20.85.545 DMÑAntibiotics LH LM  MSInstitutional night care of patients. PM68 HN68 MHÑNight Care ANonly /econ /legis /methods /organ /psychol /stand /trends MNE2.472.564; N2.421.589.690 LH  MHÑNikethamide ANdo not use /biosyn /defic /physiol RN59-26-7 MND3.66.515.530.500; D3.383.725.547.530.500; D15.128.224.654 XSCorethamid; Diethylnicotinamid; Nizethamid LH LS; ;  MSIsopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl)-3,5-pyridinedicarboxylate. A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects, lowers blood pressure, and is effective in the therapy and/or prevention of cerebral vasospasm caused by stroke, cerebral hemorrhage, aneurysm, severe head injury, or cerebral ischemia. PM87 HN87 MHÑNimodipine ANdo not use /biosyn /defic /physiol RN66085-59-4 PINicotinic Acids (66-86) MND3.383.725.547.570; D18.162.644; D18.192.643; D18.918.640 LH  MS1-[2-(5-Nitroimidazole-1-yl)ethyl]morpholine. An antitrichomonal agent which is effective either topically or orally and whose urinary metabolites are also trichomonicidal. Synonym: Naxogin. HN(75) MHÑNimorazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN6506-37-2 PIMorpholines (71-74); Nitroimidazoles (74) MND2.640.672.580; D3.383.374.658.580; D21.370.370.690 XSNitrimidazine DMÑNitroimidazoles LH LS LM  MS2,2-Dihydroxy-1H-indene-1,3-(2H)-dione. Reagent toxic to skin and mucus membranes; used in chemical assay for peptide bonds, i.e., protein determinations; has radiosensitizing properties. Synonyms: 1,2,3-indantrione monohydrate; triketohydrindene monohydrate. OLsearch INDICATORS AND REAGENTS 1966-74 HN(75); was see under INDICATORS AND REAGENTS 1963-74 MHÑNinhydrin AND25-26 qualif; /analogs NIM only RN485-47-2 MND4.615.486.487.500; D26.550.541 XSIndantrione Monohydrate DMÑIndenes LH LS LM  MHÑNiobium ANNb-93; synonym: Columbium (Cb); do not use /analogs /biosyn /defic /physiol; Nb-88-92, 94-101 = NIOBIUM (IM) + RADIOISOTOPES (IM) RN7440-03-1 MND1.268.598; D1.552.613 LH  PM68 HN68 MHÑNipecotic Acids ANdo not use /analogs /biosyn /defic /physiol MND3.66.566; D3.383.621.566 LH  MSThe conic organs which usually give outlet to milk from the mammary glands. HN(75) MHÑNipples ANhuman & animal, male & female; for cow use UDDER; teat use UDDER; diseases: coord NIM with BREAST DISEASES (IM) MNA1.236.500; A10.336.153.500 DMÑBreast LH LM  MSA genus of intestinal nematode parasites belonging to the superfamily Heligmosomatoidea, which commonly occurs in rats but has been experimentally transmitted to other rodents and rabbits. Infection is usually through the skin. PM79; was see under HOOKWORMS 1975-78 HN79(75); was see under HOOKWORMS 1975-78 MHÑNippostrongylus ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) PIAncylostomatoidea (66-74) MNB1.500.294.550.548 XSRat Nematode LH LS  PM73 HN73(72) MHÑNiridazole ANdo not use /biosyn /defic /physiol RN61-57-4 PIAmebicides (66-71); Anthelmintics (66-71); Imidazoles (66-71); Thiazoles (66-71) MND3.383.374.626; D3.383.871.482; D21.201.412.596.441 LH  PM73 HN73 MHÑNisin ANdo not use /defic /physiol RN1414-45-5 PIAntibiotics (66-72) MND12.644.415; D20.85.559 LH  PM65 HN65(64) MHÑNissl Bodies ANA 11 qualif except /cytol MNA8.663.712; A11.368.702.248.441; A11.671.693 XSCHROMATIN, NERVE FXÑRNA LH LS LX  OLsearch NERVE DEGENERATION 1967-74 HN(75) MHÑNissl Degeneration ANonly /drug eff /rad eff MNG11.561.491.441 DMÑNerve Degeneration LH LM  MS1-Nitro-9-(3-N-dimethylaminopropylamino)acridine. Acridine antineoplastic agent used in mammary and ovarian tumors; it inhibits RNA synthesis. OLuse NITRACRINE to search C 283 back thru 1975 HN(85); was C 283 see under AMINOACRIDINES 1981-84, was C 283 see under ACRIDINES 1975-80 MHÑNitracrine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4533-39-5 PIAcridines (71-74); Nitro Compounds (72-74); Dimethylamines (73-74) MND3.494.46.250.650; D22.204.575 XSC 283; Ledakrin DMÑAminoacridines LH LS; LM  PM74 HN74(73) MHÑNitrate Reductases ANdo not use /analogs RNEC 1.- PIOxidoreductases (66-72) MND8.586.682.608.600 LH  MHÑNitrates ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.606; D1.620.754.399; D1.655.498.565.399 LH  PM74 HN74(72) MHÑNitrazepam ANdo not use /biosyn /defic /physiol RN146-22-5 PIBenzazepines (68-71); Hypnotics and Sedatives (66-71); Tranquilizing Agents (66-71) MND3.438.79.80.70.565; D15.236.872.659.191.600 XSNitrodiazepam LH LS  MSEthyl methyl 2,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl)-3,5-pyridinedicarboxylate. A slow-channel calcium blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive. PM87 HN87 MHÑNitrendipine ANdo not use /biosyn /defic /physiol RN39562-70-4 PINifedipine/analogs & derivatives (82-86); Pyridines (66-81) MND3.383.725.582; D18.162.648; D18.192.648; D18.918.642 LH  PM65 HN65 MHÑNitric Oxide ANdo not use /analogs /biosyn /defic /physiol RN10102-43-9 MND1.620.754.482; D1.655.498.565.482 LH  OLsearch CYANIDES 1966-67 PM68; was see under CYANIDES 1963-67 HN68; was see under CYANIDES 1963-67 MHÑNitriles ANdo not use /analogs /biosyn /defic /physiol PICyanides (66-67) MND2.626 XUÑAcrylonitrile; ÑCarbonyl Cyanide m-Chlorophenyl Hydrazone; ÑCarbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Ño-Chlorobenzylidene Malonitrile LH LU; ; ;  HN(73) MHÑNitrilotriacetic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN139-13-9 MND2.241.81.38.600 DMÑAcetic Acids LH LM  OLuse NITRITE REDUCTASES to search NITRITE REDUCTASE back thru 1973 (as Prov 1973-74) HN(75); was NITRITE REDUCTASE 1973-74 (Prov) MHÑNitrite Reductases ANdo not use /analogs RNEC 1. PIOxidoreductases (66-72) MND8.586.682.608.671 DMÑNADH, NADPH Oxidoreductases LH LM  MHÑNitrites ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.635; D1.620.754.565; D1.655.498.565.565 XUÑNitrous Acid; ÑSodium Nitrite LH LU;  PM74 HN74(71) MHÑNitro Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: NITRO CPDS PIspecific compound containing nitro group MND2.640 LH  MSOxidative enzyme which transforms p-nitroanisole into p-nitrophenol. HN(75) MHÑNitroanisole O-Demethylase ANdo not use /analogs RNEC 1.- PIAnisoles (74); Nitro Compounds (74); Oxidoreductases (74) MND8.586.682.670.550 DMÑOxidoreductases LH LM  MHÑNitrobacter ANin soil, fresh & sea water MNB3.450.504.483 LH  MSA family of Gram-negative bacteria which derive energy from the oxidation of ammonia to nitrite or nitrite to nitrate - commonly found in soil and fresh water. PM75 HN75 MHÑNitrobacteraceae ANin soil PIBacteria (66-74) MNB3.450.504 LH  MHÑNitrobenzenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.426.559.389.565; D2.640.529 XUÑDinitrobenzenes; ÑDinitrofluorobenzene; ÑTrinitrobenzenes; ÑTrinitrobenzenesulfonic Acid LH LU; ; ;  MSBenzoic acid or benzoic acid esters substituted with one or more nitro groups. PM75 HN75 MHÑNitrobenzoates ANdo not use /analogs /biosyn /defic /physiol PIBenzoates (68-74) MND2.241.223.106.650 XUÑDithionitrobenzoic Acid LH LU  MS3,3'-(3,3'-Dimethoxy-4,4'-biphenylene)bis (2-(p-nitrophenyl)-5-phenyl-2H-tetrazolium. Colorless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases, the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease. Synonyms: NBT; nitrotetrazolium blue; tetrazolium nitroblue. HN(75) MHÑNitroblue Tetrazolium AND25-26 qualif; /analogs NIM only; DF: NITRO BT RN298-83-9 PINitro Compounds (73-74); Tetrazolium Salts (72-74) MND3.383.129.617.700.500; D26.550.900.750 DMÑTetrazolium Salts LH LM  MHÑNitrofurans ANdo not use /analogs /biosyn /defic /physiol MND2.640.600; D3.383.312.649; D20.237.649 XUÑFuragin; ÑFurylfuramide; ÑNifuratel; ÑNifuroxime; ÑNifurtimox; ÑNitrovin; ÑSQ 18506 LH LU; ; ; ; ; ;  MHÑNitrofurantoin ANdo not use /biosyn /defic /physiol RN67-20-9 MND2.640.600.566; D3.383.312.649.566; D20.237.649.566 LH  MHÑNitrofurazone ANdo not use /biosyn /defic /physiol RN59-87-0 MND2.640.600.691; D3.383.312.649.691; D20.187.619; D20.237.649.691 XSNitrofural LH LS  MHÑNitrogen ANN-14; /physiol permitted; do not use /analogs /biosyn /defic RN7727-37-9 MND1.268.604; D1.620 LH  PM65 HN65(63) MHÑNitrogen Dioxide ANdo not use /analogs /biosyn /defic /physiol RN10102-44-0 MND1.620.754.648; D1.655.498.565.648 LH  MHÑNitrogen Fixation ANonly /drug eff /rad eff MNG4.185.515.671; G6.184.620 LH  MSStable nitrogen atoms which have the same atomic number as the element nitrogen, but differ in atomic weight. Nitrogen (N) 15 is a stable nitrogen isotope. PM73 HN73(71) MHÑNitrogen Isotopes ANN-15; NIM; no qualif PINITROGEN MND1.496.586; D1.620.691 LH  MSA group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen; formerly used as toxicants and vesicants, now as antineoplastic agents; they are also powerful mutagens, teratogens, immunosuppressants and carcinogens. MHÑNitrogen Mustard Compounds ANdo not confuse with NITROGEN MUSTARD, a specific chemical; do not use /analogs /biosyn /defic /physiol; DF: NITROGEN MUSTARD CPDS MND2.455.526.728.650; D22.204.585 FXÑAlkylating Agents XUÑAniline Mustard; ÑEstramustine; ÑICR 170 LH LX LU; ;  PM73 HN73(71) MHÑNitrogen Oxides ANdo not use /analogs /biosyn /defic /physiol PINitrogen (66-70); Oxides (66-70); Peroxides (66-70) MND1.620.754; D1.655.498.565; D5.284.101.143.517 LH  MSUnstable isotopes of nitrogen that decay or disintegrate spontaneously emitting radiation. N 12, 13, 16 and 17 are radioactive isotopes of nitrogen. OLsearch NITROGEN ISOTOPES 1971-74 (as Prov 1971-72) PM75 HN75 MHÑNitrogen Radioisotopes ANN-12, 13, 16, 17, 18; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PINitrogen Isotopes (71-74); Radioisotopes (71-74) MND1.496.586.520; D1.496.749.615; D1.620.800 LH  PM74 HN74 MHÑNitrogenase ANdo not use /analogs RNEC 1.18.2.1 MND8.586.682.647 LH  MS3-Nitro-4-hydroxy-5-iodophenylacetate. Also called 4-hydroxy-3-iodo-5-nitrophenylacetate. A haptenic determinant that can be radiolabeled and used as salts and derivatives for investigations of immunogenic specificity studies. HN(76) MHÑNitrohydroxyiodophenylacetate AND25-26 qualif; /analogs NIM only RN2646-51-7 PIIodine (72-75); Nitrophenols (72-75); Phenylacetates (74-75) MND2.640.743.610; D2.755.566.610; D24.611.216.621.641 XSNIP DMÑNitrophenols LH LS LM  PM74 HN74 MHÑNitroimidazoles ANdo not use /analogs /biosyn /defic /physiol MND2.640.672; D3.383.374.658 XUÑDimetridazole; ÑIpronidazole; ÑNimorazole; ÑOrnidazole; ÑRonidazole; ÑTinidazole LH LU; ; ; ; ;  MS1-[2-[p-[alpha(p-Methoxyphenyl)-beta-nitrostyryl]phenoxy]pyrrolidine monocitrate. A non-steroidal estrogen antagonist with anti-fertility activity. OLuse NITROMIFENE to search CI 628 back thru 1975 HN(79); was CI 628 see under PYRROLIDINES 1975-78 MHÑNitromifene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5863-35-4 PIAnisoles (72-74); Pyrrolidines (72-74); Styrenes (72-74) MND3.383.773.610; D6.347.300.500 XSCI 628; CN 5594527 DMÑPyrrolidines LH LS; LM  OLsearch ALKANES 1968-74 HN(75) MHÑNitroparaffins ANdo not use /analogs /biosyn /defic /physiol MND2.455.326.146.672; D2.640.720 DMÑAlkanes LH LM  MHÑNitrophenols ANdo not use /analogs /biosyn /defic /physiol MND2.640.743; D2.755.566 XUÑ2-Hydroxy-5-Nitrobenzyl Bromide; ÑNiclofolan; ÑNitrohydroxyiodophenylacetate; ÑNitroxinil LH LU; ; ;  MSCatalyzes the hydrolysis of nitrophenyl phosphates to nitrophenols. At acid pH it is probably acid phosphatase EC 3.1.3.2; and at alkaline pH it is probably EC 3.1.3.1, alkaline phosphatase. HN(75) MHÑNitrophenyl Phosphatase ANdo not use /analogs RNEC 3.1.3.41 PIAlkaline Phosphatase (72-74); Nitrophenols (72-74); Organophosphorus Compounds (73-74) MND8.586.277.352.630.654.650 DMÑPhosphomonoesterases LH LM  MSo-Nitrophenyl-beta-D-galactopyranoside. HN(75) MHÑNitrophenylgalactoside ANdo not use /biosyn /defic /physiol; /analogs NIM only RN28347-45-7 PIGalactose (70-74); Glycosides (70-74); Nitrophenols (73-74) MND9.203.408.320.550 XSNitrophenylgalactopyranoside DMÑGlycosides LH LS LM  MSSodium nitrosyl pentacyanoferrate (III). Powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function; also an indicator for free sulfhydryl groups in proteins. Synonym: Nipride. HN(75) MHÑNitroprusside AND25-26 qualif; /analogs NIM only RN15078-28-1 PIFerricyanides (66-74); Nitric Oxide (66-74) MND1.552.412.288.500; D1.620.305.344.500; D18.162.650; D18.918.644; D26.550.565 XSNitroferricyanide; Sodium Nitroprusside DMÑFerricyanides LH LS; LM  MSQuinolines substituted in any position by one or more nitro groups. PM75 HN75 MHÑNitroquinolines ANdo not use /analogs /biosyn /defic /physiol PIQuinolines (66-74) MND2.640.820; D3.438.810.470 XUÑ4-Nitroquinoline-1-Oxide; ÑOxamniquine LH LU;  MSEnzymes which reduce nitro groups. A variety of compounds can act as acceptors. If NADH or NADPH are the acceptors, the enzymes are classified as EC 1.6.6.- . HN(87) MHÑNitroreductases ANdo not use /analogs RNEC 1.7.- PIOxidoreductases (66-86) MND8.586.682.655 DMÑOxidoreductases LH LM  MHÑNitrosamines AND25-26 qualif MND2.654.442; D26.191.646 XUÑButylhydroxybutylnitrosamine; ÑN-Nitrosopyrrolidine LH LU;  MHÑNitroso Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: NITROSO CPDS MND2.654 LH  PM73 HN73(71) MHÑNitrosoguanidines ANdo not use /analogs /biosyn /defic /physiol PICarcinogens (66-70); Guanidines (66-70); Nitroso Compounds (66-70) MND2.78.370.649; D2.654.567 LH  MSN-Methyl-N-nitrosourethane. An alkylating carcinogen that produces gastrointestinal and probably lung and nervous system tumors. HN(75) MHÑNitrosomethylurethane ANdo not use /biosyn /defic /physiol RN615-53-2 PINitroso Compounds (72-74); Urethane (72-74) MND2.241.81.251.944.500; D2.654.585; D26.191.646.658 XSMethylnitrosourethane DMÑUrethane LH LS LM  MHÑNitrosomonas ANin soil MNB3.450.504.650 LH  PM73 HN73(71) MHÑNitrosourea Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: NITROSOUREA CPDS PINitroso Compounds (66-70); Urea (66-70) MND2.654.692; D2.948.594 XUÑSemustine LH LU  OLsearch NITRITES 1966-74 HN(75) MHÑNitrous Acid ANdo not use /analogs /biosyn /defic /physiol RN7782-77-6 MND1.620.754.565.567; D1.655.498.565.565.567 DMÑNitrites LH LM  MHÑNitrous Oxide ANdo not use /analogs /biosyn /defic /physiol RN10024-97-2 MND1.620.754.732; D1.655.498.565.732; D14.166.636 LH  MS[(3-(5-nitro-2-furyl)-1-(2-(5-nitro-2-furyl)vinyl)allylidene)amino]guanidine monohydrochloride. HN(75) MHÑNitrovin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN804-36-4 PIAmidines (71-74); Hydrazones (72-74); Nitrofurans (71-74) MND2.640.600.750; D3.383.312.649.750 DMÑNitrofurans LH LM  MS4-Hydroxy-3-iodo-5-nitrobenzonitrile. Proposed anthelmintic for fasciola and liver fluke infestations. Synonym: Trodax. HN(75) MHÑNitroxinil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1689-89-0 PINitriles (72-74); Nitrophenols (72-74) MND2.640.743.620; D2.755.566.620; D21.201.412.482 DMÑNitrophenols LH LM  MSATP:NMN adenylyltransferase. Catalyzes reversibly the transfer of the adenylyl moiety of ATP to the phosphoryl group of NMN to form NAD+ and pyrophosphate. The enzyme is found predominantly in the nuclei and catalyzes the final reaction in the major pathway for the biosynthesis of NAD in mammals. EC 2.7.7.1. HN(79) MHÑNMN Adenylyltransferase ANdo not use /analogs RNEC 2.7.7.1 PIAdenosine Triphosphate (66-78); Nicotinamide Mononucleotide (73-78); Nucleotidyltransferases (66-78); Transferases (66-67) MND8.586.913.696.445.600 XSNAD Pyrophosphorylase; Nicotinamide Mononucleotide Adenylyltransferase DMÑNucleotidyltransferases LH LS; LM  MHÑNobel Prize ANno qualif; a single prize is given for medicine & physiol but do not coord with either MEDICINE or PHYSIOLOGY MNK1.150.567 LH  MHÑNobelium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN10028-14-5 MND1.287.597; D1.552.517.658 LH  MHÑNocardia ANdo not use /blood-csf-urine; N. pretoriana = ACTINOMYCES; N. rhodnii = STREPTOMYCES; infection = NOCARDIA INFECTIONS MNB3.100.67.600.650 LH  MSA species of bacterium of the family Nocardiaceae, producing pulmonary infections in man. PM74 HN74(72) MHÑNocardia Asteroides ANdo not use /blood-csf-urine; infection: coord NIM with NOCARDIA INFECTIONS (IM) PINocardia (66-71) MNB3.100.67.600.650.567 XSACTINOMYCES ASTEROIDES LH LS  MHÑNocardia Infections MNC1.252.40.692 LH  MSAerobic Gram-positive actinomycetes found in soil and animal tissue; some species are the cause of infection in man and animals. PM76 HN76 MHÑNocardiaceae ANin soil, animals & man PIActinomycetaceae (75); Actinomycetales (66-74) MNB3.100.67.600 LH  MSNeuroreceptors for pain. PM78 HN78 MHÑNociceptors ANdo not use /innerv PINeurons, Afferent (69-77); Pain (66-77) MNA8.796.511.725.460 XSPain Receptors LH LS  OLsearch VAGUS NERVE 1966-74 HN(75) MHÑNodose Ganglion ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.936.692 DMÑVagus Nerve LH LM  MSProposed antineoplastic agent from a Streptomyces nogalater variant; it is a cytolytic antibiotic that inhibits DNA-dependent RNA synthesis by binding to DNA; has some antibacterial action. Synonym: U 15167. HN(76); was see under NAPHTHACENES 1976-80 MHÑNogalamycin ANdo not use /defic /physiol RN1404-15-5 PIAntibiotics (66); Antibiotics, Antineoplastic (67-75); Glycosides (66-75); Naphthacenes (66-75) MND4.615.597.550; D9.203.408.51.212.655; D20.85.75.354.655; D22.204.106.356.655 DMÑDaunorubicin LH LM  MHÑNoise ANrestrict to noise as a type of sound: do not use for ╥noise╙ as artifacts or interference with data in various technics or electrical interference ( = ELECTRICITY); only /adv eff (consider also HEARING LOSS, NOISE-INDUCED) /prev MNG3.230.400; G3.850.460.610; H1.671.31.675.567 FXÑAcoustic Stimulation; ÑHearing Loss, Noise-Induced; ÑSOUND XUÑNoise, Occupational; ÑNoise, Transportation LH LX; ; LU;  MSNoise present in occupational, industrial and factory situations. HN(79) MHÑNoise, Occupational ANonly /adv eff /econ /prev; coord IM with specific occupation (IM) if pertinent; consider also HEARING LOSS, NOISE-INDUCED PINoise (66-78); Occupational Medicine (66-78) MNG3.850.460.610.526 XSOccupational Noise DMÑNoise LH LS LM  MSNoise associated with transportation, particularly aircraft and automobiles. HN(79) MHÑNoise, Transportation ANonly /adv eff /econ /prev; coord IM with specific mode of transport (AIRCRAFT, AUTOMOBILES, RAILROADS, etc.) (IM); consider also HEARING LOSS, NOISE-INDUCED PIAircraft (66-78); Noise (66-78) MNG3.850.460.610.680 DMÑNoise LH LM  MHÑNoma MNC7.465.604 XSSTOMATITIS, GANGRENOUS LH LS  MHÑNomenclature ANIM; no qualif; Manual 33.15; etymology goes here; ╥medical nomenclature╙: do not coord with MEDICINE MNL1.143.506.598.400 LH  MS8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline. Isoquinoline derivative that prevents dopamine reuptake into synaptosomes; proposed as both antidepressant and antiparkinson agent. Synonym: HOE 984. PM86; was see under ISOQUINOLINES 1978-85 HN86(78); was see under ISOQUINOLINES 1978-85 MHÑNomifensine ANdo not use /biosyn /defic /physiol RN24526-64-5 PIIsoquinolines (69-77); Quinolines (66-68) MND3.438.531.535; D14.307.694; D15.236.122.654 LH  MS2-Chloro-10-(3-(hexahydropyrrolo(1,2-a) pyrazin-2-(1H)-oxopropyl-10H-phenothiazine. Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent. HN(79) MHÑNonachlazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN49780-10-1 PIPhenothiazines (66-78); Piperazines (66-78) MND3.494.741.550; D18.918.662 DMÑPhenothiazines LH LM  MSA procedure in which the therapist refrains from directing the client, but instead reflects back to the client what the latter has said, sometimes restating the client's remark. PM69 HN69(65) MHÑNondirective Therapy ANSPEC qualif MNF4.754.592 XSCLIENT-CENTERED THERAPY; ROGERIAN THERAPY LH LS;  MSThe failure of homologous chromosomes or chromatids to segregate during mitotic or meiotic cell division with the result that one daughter cell has two chromosomes or two chromatids and the other has none. PM82 HN82 MHÑNondisjunction, Genetic ANno qualif PICell Division (66-67); Chromosome Aberrations (68-81); Chromosomes (66-67); Meiosis (68-81) MNG5.148.266.645 LH  MSCysts formed from epithelial inclusions in the lines of fusion of the embryonic processes which form the jaws. Include nasopalatine or incisive canal cyst, incisive papilla cyst, globulomaxillary cyst, median palatal cyst, median alveolar cyst, median mandibular cyst, and nasoalveolar cyst. Synonyms: fissural cysts. PM65 HN65 MHÑNonodontogenic Cysts ANnon-neoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/dis term (IM) MNC4.182.89.530.660; C5.500.470.660 LH  MSA blood protein (NSILA) which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of Cohn fraction III, 10% of the activity is found in the supernatant (NSILA-S) and the remaining activity in the precipitate (NSILA-P). The latter is a large molecular compound, much less stable than the soluble fraction. NSILA-S is a more potent growth factor than insulin and exhibits sulfation activity. PM77 HN77 MHÑNonsuppressible Insulin-Like Activity ANnote category; a blood protein mimicking blood insulin; do not use /analogs /blood /defic PIBlood Proteins (66-76); Insulin (66-76) MND12.776.124.862.575; D24.185.348.862.655 XSNSILA; NSILA-P; NSILA-S FXÑInsulin LH LS; ; LX  MSTransmission of emotions, ideas, and attitudes between individuals in ways other than the spoken language. PM71 HN71(70) MHÑNonverbal Communication ANhuman only; for animals use ANIMAL COMMUNICATION or VOCALIZATION, ANIMAL; consider also MANUAL COMMUNICATION PICommunication (66-69); Verbal Behavior (66-69) MNF1.145.209.530; L1.143.649 LH  MSA multifaceted disorder due to a basic defect of connective tissue; characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, cryptorchidism, multiple cardiac abnormalities (most commonly including pulmonary valve stenosis), and some degree of mental retardation. The phenotype resembles that of Turner's syndrome; however Noonan syndrome occurs in both males and females, and no chromosomal abnormality has been found. Nevertheless, familial studies suggest that the trait is inherited as a autosomal dominant. PM79 HN79 MHÑNoonan Syndrome ANin males and females; do not use /congen PITurner's Syndrome (66-78) MNC16.131.621.650; C23.205.690 XSTurner's Syndrome, Male LH LS  MSAndrostanes in which ring contractions have occurred or which are lacking carbon-18. Permitted is any degree of unsaturation. Androstanes which are lacking carbon-19 are estranes. PM75 HN75 MHÑNorandrostanes ANdo not use /analogs /biosyn /defic /physiol; do not confuse with 19-NORANDROSTANES (see below) nor with 19-NORANDROSTENES (see below) PIAndrostanes (68-74); Norsteroids (68-74) MND4.808.668.100 LH  PM74 HN74(72) MHÑNorbornanes ANincludes norbornenes; do not use /analogs /biosyn /defic /physiol PIBridged Compounds (66-70); Camphor (66-70); Heterocyclic Compounds (66-70); Polycyclic Compounds (66-70); Terpenes (70-71) MND2.455.849.618 XSNORCAMPHANES LH LS  MS4,4'-(2,3-Dimethyltetramethylene)dipyrocatechol. A potent lipoxygenase inhibitor which interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils. HN(87) MHÑNordihydroguaiaretic Acid ANdo not use /biosyn /defic /physiol; DF: NDGA RN500-38-9 PICatechols (66-86) MND2.755.166.550; D8.373.650 DMÑCatechols LH LM  MS4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol. Precursor of epinephrine secreted by the adrenal medulla and endings of autonomic sympathetic nerves; also found in plants; the natural mediator of the sympathetic nervous system in vertebrates, affecting all autonomic functions; used to constrict blood vessels, increase blood pressure and redistribute blood flow. Synonyms: Adrenor; Aktamin; Binodrenal; Levophed. PMMETHYLNOREPINEPHRINE was indexed under NORMETANEPHRINE 1966-74; LEVONOREPINEPHRINE was heading 1963-65 HNLEVONOREPINEPHRINE was heading 1963-65 MHÑNorepinephrine AN/biosyn /physiol permitted RN51-41-2 MND2.92.311.461.484; D16.538.693; D16.893.116.182.568; D16.893.116.348.630; D18.222.863.630 XSARTERENOL; LEVARTERENOL; LEVONOREPINEPHRINE; NORADRENALINE XUÑMethylnorepinephrine LH LS; ; ; LU  MHÑNorethandrolone ANdo not use /biosyn /defic /physiol RN52-78-8 MND4.808.668.651.693.595; D6.597.100.194.637 XSEthylestrenolone; Ethylnortestosterone LH LS;  MHÑNorethindrone ANdo not use /biosyn /defic /physiol RN68-22-4 MND4.808.668.651.693.651; D6.597.799.682; D7.360.276.210.443.706.633 XSEthinylnortestosterone; NORETHISTERONE; Norpregneninolone LH LS; ;  MHÑNorethynodrel ANdo not use /biosyn /defic /physiol RN68-23-5 MND4.808.668.651.693.706; D6.597.799.708; D7.360.276.210.443.706.678 LH  MSalpha-Methyl-m-(trifluormethyl)phenethylamine. Proposed appetite depressants. HN(75) MHÑNorfenfluramine AND25-26 qualif RN1886-26-6 PIHydrocarbons, Fluorinated (74); Phenethylamines (73-74) MND2.92.471.683.467.500; D26.128.477.500 DMÑFenfluramine LH LM  MS1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinolinecarboxylic acid. Quinoline-derived synthetic antibacterial agent with a very broad spectrum of action; oral administration yields highly bactericidal plasma, tissue, and urine levels; it inhibits bacterial DNA-gyrase and is used in gastrointestinal, eye, and urinary infections. PM86 HN86 MHÑNorfloxacin ANdo not use /biosyn /defic /physiol RN70458-96-7 PIAnti-Infective Agents (66-85); Anti-Infective Agents, Urinary (66-85); Nalidixic Acid (66-85) MND3.438.612.500.450; D20.237.583.632; D20.665 LH  PM72 HN72 MHÑNorgestrel ANdo not use /biosyn /defic /physiol RN6533-00-2 PIContraceptives, Oral (66-71); Ketones (66-71); Pregnanes (68-71); Progestational Hormones (66-71) MND4.808.668.651.693.762; D6.597.799.734; D7.360.276.210.443.706.723 LH  MS17-Hydroxy-19-nor-17 alpha-pregna-4,9,11-trien-20-yn-3-one. A synthetic steroid with progestational and contraceptive activities. HN(75) MHÑNorgestrienone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN848-21-5 PIHydroxysteroids (73-74); Ketosteroids (73-74); Pregnatrienes (73-74); Norpregnanes (74) MND4.808.668.651.568.620; D6.597.799.742; D7.360.276.210.443.706.750 DMÑNorpregnatrienes LH LM  HN(72) MHÑNorleucine AN/analogs NIM only RN5157-09-5 PIAminocaproic Acids (66-71) MND12.125.213.568 DMÑAminocaproic Acids LH LM  PM66 HN66(63) MHÑNormetanephrine RN97-31-4 MND2.92.311.461.651 LH  MHÑNormethandrolone ANdo not use /biosyn /defic /physiol RN514-61-4 MND4.808.365.415.733; D6.597.799.760 XSMETHYLESTRENOLONE; METHYLNORTESTOSTERONE LH LS;  MSPregnadienes which have undergone ring contractions or are lacking carbon-18 or carbon-19. OLsearch NORPREGNANES 1974 PM75; was see under NORPREGNANES 1974 HN75; was see under NORPREGNANES 1974 MHÑNorpregnadienes ANdo not use /analogs PINorpregnanes (74) MND4.808.668.651.443 XUÑPromegestone LH LU  MSPregnanes which have undergone ring contractions or are lacking carbon-18 or carbon-19. Unsaturation in the steroid ring system is not permitted. PM74 HN74 MHÑNorpregnanes ANdo not use /analogs; do not confuse with NORPREGNENES MND4.808.668.651 LH  MSPregnatrienes which have undergone ring contractions or are lacking carbon-18 or carbon-19. OLsearch NORPREGNANES 1974 PM75; was see under NORPREGNANES 1974 HN75; was see under NORPREGNANES 1974 MHÑNorpregnatrienes ANdo not use /analogs PINorpregnanes (74) MND4.808.668.651.568 XUÑNorgestrienone; ÑQuinestrol; ÑR 2323 LH LU; ;  MSPregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19.. OLsearch NORPREGNANES 1974 PM75; was see under NORPREGNANES 1974 HN75; was see under NORPREGNANES 1974 MHÑNorpregnenes ANdo not confuse with NORPREGNANES; do not use /analogs PINorpregnanes (74) MND4.808.668.651.693 XUÑNorprogesterones LH LU  MSProgesterone which has undergone ring contraction or which is lacking carbon 18 or 19. HN(75) MHÑNorprogesterones ANdo not use /analogs /biosyn /defic /physiol PINorpregnanes (74); Progesterone (74) MND4.808.668.651.693.820 DMÑNorpregnenes LH LM  PM68 HN68 MHÑNorsteroids ANdo not use /analogs MND4.808.668 LH  MSalpha(Aminoethyl)para-hydroxybenzyl alcohol. Alpha adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also from invertebrate nervous systems; a neurotransmitter used to treat hypotension and a cardiotonic. It and its dextro, levo, ortho, and meta isomers are known as octopamines. Synonyms: dihydroxyphenethylamine; norsympatol; para-hydroxyphenethanolamine; Epirenor; ND 50; Norden; Norphen; WV 569. MHÑNorsynephrine AN/biosyn /physiol permitted RN104-14-3 MND2.33.329.291.525; D2.92.63.291.525; D2.92.471.683.725; D16.893.116.182.651; D18.222.863.651 XSp-Octopamine; para-Octopamine LH LS;  MHÑNorth America ANincludes Mexico MNZ1.107.567 LH  MHÑNorth Carolina MNZ1.107.567.875.641 LH  MHÑNorth Dakota MNZ1.107.567.875.650 LH  HN87 MHÑNorth Sea MNZ1.756.92.650 LH  MHÑNorthern Ireland ANcapital, Belfast; differentiate from IRELAND (Irish Free State, Eire) MNZ1.542.363.602 LH  PM68 HN68(65) MHÑNortriptyline ANdo not use /biosyn /defic /physiol RN72-69-5 MND4.615.181.384.535; D15.236.122.140.664 XSDesitriptyline; Desmethylamitriptylin LH LS;  MHÑNortropanes ANdo not use /analogs /biosyn /defic /physiol MND3.605.869.744 LH  MSAn unclassified virus isolated from the stools of school children in Norwalk, Ohio, who were suffering from gastroenteritis in 1968. Also called epidemic gastroenteritis virus and possibly may be a picornavirus or parvovirus. OLsearch EPIDEMIC GASTROENTERITIS VIRUS under VERTEBRATE VIRUSES, UNCLASSIFIED 1966-67 PM82; EPIDEMIC GASTROENTERITIS VIRUS was heading 1966-67 HN82; EPIDEMIC GASTROENTERITIS VIRUS was heading 1966-67 MHÑNorwalk Agent ANusually causes gastroenteritis; do not use /blood-csf-urine /cytol; infection: coord NIM with VIRUS DISEASES (IM) + probably GASTROENTERITIS (IM) PIGastroenteritis (66-81) MNB4.909.920.548 LH  MHÑNorway MNZ1.542.808.618 LH  MHÑNoscapine ANdo not use /biosyn /defic /physiol RN128-62-1 MND3.132.610.568; D3.438.531.567; D23.338.673 XSNARCOTINE LH LS  MSThe part of the respiratory system above the hard palate; includes the external nose and the nasal cavity. MHÑNose AN╥nose╙ unspecified as NASAL BONE or NASAL CAVITY; /abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; /secret = NASAL MUCOSA /secret; /surg: consider also RHINOPLASTY; consider also other terms under NAS & RHIN MNA1.456.505.733; A4.531 LH  MSDeformities of the nose acquired after birth from injury or disease. OLuse NOSE DEFORMITIES, ACQUIRED to search NOSE DEFORMITIES 1968-77 PM78; was NOSE DEFORMITIES 1968-77 HN78; was NOSE DEFORMITIES 1968-77 MHÑNose Deformities, Acquired AN= ╥acquired deformities╙ from inj or dis; do not use /congen: = NOSE /abnorm MNC9.603.619 LH  MSDisorders of the nose, general or unspecified. PM66 HN66 MHÑNose Diseases ANinflamm dis = RHINITIS MNC9.603 FXÑOTORHINOLARYNGOLOGIC DISEASES LH LX  MHÑNose Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific site in nose (NIM) + histol type of neopl (IM) MNC4.588.443.665.650; C9.603.669 LH  MSA genus (order: Microsporida; family: Nosematidae) consisting of seven species. This intracellular sporozoan parasite is found in the brain, heart, and kidneys of several mammals. Transmission is probably by ingestion of the spores. HN(82) MHÑNosema cuniculi ANdo not use /anat /blood-csf-urine /embryol; infection: coord NIM with PROTOZOAN INFECTIONS (IM) PIProtozoa (66-81); Sporozoa (66-81) MNB1.841.762.560 XSEncephalitozoon cuniculi DMÑSporozoa LH LS LM  MHÑNostrums AND25-26 qualif; a quack or secret remedy (Dorland); do not confuse with PATENT MEDICINES or DRUGS, NON-PRESCRIPTION MND26.394.651 FXÑQuackery LH LX  MSThe rod-shaped body, composed of cells derived from the mesoblast and defining the primitive axis of the embryo. In lower vertebrates it persists throughout life as the main axial support of the body, but in higher vertebrates it is replaced by the vertebral column. HN(79) MHÑNotochord ANdo not use /abnorm /blood supply /embryol /growth /inj /innerv /pathol /physiopathol /secret PIChick Embryo (66-78); Embryo (66-78) MNA16.254.610 DMÑEmbryo LH LM  MSA genus of the Salamandridae family in which the larvae transform into terrestrial eft (newt) stage and later into an aquatic adult. They occur from Canada to southern United States. HN(81) MHÑNotophthalmus viridescens ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PISalamandridae (75-80); Urodela (66-74) MNB2.90.608.700.480 XSDiemictylus viridescens; Newt, Red-Spotted; Triturus viridescens DMÑSalamandridae LH LS; ; LM  MHÑNova Scotia MNZ1.107.567.176.589 LH  MHÑNovobiocin ANdo not use /defic /physiol RN303-81-1 MND20.85.575 XSCrystallinic Acid; STREPTONIVICIN LH LS;  MH*Noxae (Non Mesh) MND5.569 LH  MS1-(Hydroxymethyl)-3-methyl-2-thiourea. Local antibacterial that probably acts by releasing formaldehyde in aqueous solutions; it is used for irrigation of infected body cavities - bladder, peritoneum, etc. and as a spray for burns. Synonyms: Gynaflex, Noxyflex. HN(76) MHÑNoxythiolin ANdo not use /biosyn /defic /physiol RN15599-39-0 PIAlcohol, Methyl (74) /AA (75); Thiourea (74) /AA (75) MND2.886.904.500; D2.948.898.500; D20.187.651 XSNoxitiolin DMÑThiourea LH LS LM  MSEnergy released by nuclear fission or nuclear fusion. OLuse NUCLEAR ENERGY to search ATOMIC ENERGY back thru 1966 (as Cat H heading 1966-81) PM82; was ATOMIC ENERGY 1963-81 HN82; was ATOMIC ENERGY (Cat H heading only) 1963-81 MHÑNuclear Energy ANno qualif MNG3.230.132.580; H1.671.579.580 XSAtomic Energy FXÑRADIATION PROTECTION; ÑRADIOACTIVE WASTE XUÑNuclear Fusion LH LS LX; LU  MSA family composed of husband and wife with their children. HN(75) MHÑNuclear Family ANhusband, wife & children: does not include grandparents; no qualif MNF1.829.263.500; I1.880.225.500 DMÑFamily LH LM  MSNuclear reaction in which the nucleus of a heavy atom such as uranium or plutonium is split into two approximately equal parts by a neutron, charged particle, or photon. PM74 HN74(71); was in Cat H only 1971-81 MHÑNuclear Fission ANno qualif; do not confuse with NUCLEAR FUSION PINuclear Energy (66-70) MNG3.230.132.580.500; H1.671.579.580.485 LH  MSThermonuclear reaction in which the nuclei of an element of low atomic weight unite under extremely high temperature and pressure to form a nucleus of a heavier atom. HN(71); was see under ATOMIC ENERGY 1975-81, was in Cat H only 1971-81 MHÑNuclear Fusion ANno qualif; do not confuse with NUCLEAR FISSION PINuclear Energy (66-70) MNG3.230.132.580.520; H1.671.579.580.652 DMÑNuclear Energy LH LM  PM66 HN66(65) MHÑNuclear Magnetic Resonance ANNIM; only /adv eff /diag use /instrum /methods; index under element or isotope used in performing the NMR only if pertinent (probably NIM); ╥magnetic resonance imaging╙ goes here; coord with disease /diag, not /radiogr nor /radionuclide; coord with organ /anat or /pathol as pertinent MNE1.688; E5.196.867.519; H1.181.278.862.519; H1.671.579.631 XSMagnetic Resonance; NMR Tomography; Tomography, NMR; Tomography, Proton Spin; Zeugmatography LH LS; ; ; ;  MSA specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds in a pharmaceutical form. PM67 HN67 MHÑNuclear Medicine ANSPEC: SPEC qualif except /methods PINuclear Energy (66); Nuclear Warfare (66); Radiation Injuries (66); Radioisotopes (66) MNG2.403.790.470 XSAtomic Medicine; Nuclear Radiology FXÑRADIOISOTOPES; ÑRadiobiology LH LS; LX;  MSHospital department responsible for the administration and management of nuclear medicine services. HN(82) MHÑNuclear Medicine Department, Hospital ANrestrict to radioisotope diag & ther serv: do not confuse with RADIOLOGY DEPARTMENT, HOSPITAL (x-ray & radiocobalt only); only /econ /legis /man /organ /stand /trends /util; DF: NUCLEAR MED DEP PIHospital Departments (68-81); Nuclear Medicine (67-81) MNN2.278.354.422.472; N4.452.442.422.472 DMÑHospital Departments LH LM  MSAn intracellular structure, consisting of two concentric membranes, enclosing the nucleoplasm and separating it from the cytoplasm. The areas where these two membranes fuse are called nuclear pore complexes. PM77 HN77 MHÑNuclear Membrane ANNIM; IM only if point of article irrespective of identity of cell (NIM); A 11 qualif except /cytol PICell Membrane (66-76); Cell Nucleus (66-76); Membranes (68-76) MNA11.223.650; A11.904.514.700 XSNuclear Envelope; Nuclear Pore LH LS;  MHÑNuclear Physics ANSPEC: SPEC qualif MNH1.671.579 LH  PM68 HN68(64) MHÑNuclear Reactors ANonly /econ /instrum /stand /supply; RADIONUCLIDE GENERATORS is also available MNH1.671.579.694; J1.724 LH  MSWarfare involving the use of nuclear weapons. OLuse NUCLEAR WARFARE to search ATOMIC WARFARE back thru 1966 PM82; was ATOMIC WARFARE 1963-81 HN82; was ATOMIC WARFARE 1963-81 MHÑNuclear Warfare ANno qualif; nuclear weapons testing goes here MNI1.880.735.944.600 XSAtomic Warfare FXÑRADIOACTIVE FALLOUT; ÑRadiation LH LS LX;  MSThe characteristic 3-dimensional shape of a nucleic acid or polynucleotide. Its secondary structure is due to the formation of hydrogen bonds between nucleotides, resulting in base pairing and areas with alpha helix structure. PM72 HN72 MHÑNucleic Acid Conformation ANIM; coord with DNA or RNA or specific (IM); only /drug eff /rad eff PINucleic Acids (66-71) MNG6.184.580.486 LH  MSDisorganization of secondary structures of nucleic acids through cleavage of hydrogen bonds and hydrophobic linkages. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible. PM70 HN70(67) MHÑNucleic Acid Denaturation ANIM; coord with DNA or RNA or specific (IM); only /drug eff /rad eff PIspecific nucleic acid MNG6.184.642 FXÑDNA; ÑRNA LH LX;  MSDouble-stranded nucleic acid molecules (DNA-DNA or DNA-RNA) which contain regions of nucleotide mismatches (non-complementary). In vivo, these heteroduplexes can result from mutation of genetic recombination; in vitro, they are formed by nucleic acid hybridization. Electron microscopic analysis of the resulting heteroduplexes facilitates the mapping of regions of base sequence homology of nucleic acids. PM80 HN80 MHÑNucleic Acid Heteroduplexes ANIM; coord with DNA or RNA or both (IM); do not use /analogs /defic PIBase Sequence (71-79); DNA (66-79); specific DNA; DNA Replication (68-79); Microscopy, Electron (66-79); Mutation (66-79); Nucleic Acid Hybridization (71-79); Recombination, Genetic (68-79); RNA (66-79); specific RNA MND13.444.500 XSHeteroduplexes, Nucleic Acid LH LS  MSFormation of base pairs by hydrogen bonds and hydrophobic linkage between two single strands of nucleic acids to produce a double-stranded molecule. This may be between two strands of DNA or between DNA and RNA. It generally results in the formation of helical structures. PM72 HN72(71) MHÑNucleic Acid Hybridization ANIM; coord with DNA or RNA or specific (IM); only /drug eff /rad eff PIDNA (66-70); RNA (66-70) MNG6.184.661 FXÑDNA; ÑRNA LH LX;  MSUse for nucleic acid precursors in general or for which there is no specific heading. PM75 HN75 MHÑNucleic Acid Precursors ANIM; coord with DNA or RNA or specific (IM); do not use /analogs /defic PINucleic Acids (68-74) MND13.400 LH  MSThe reformation of all, or part of, the native conformation of a nucleic acid molecule after the molecule has undergone denaturation. PM78; was see under NUCLEIC ACIDS 1975-77 HN78(71); was see under NUCLEIC ACIDS 1975-77 MHÑNucleic Acid Renaturation ANIM; coord with DNA or RNA or specific (IM); only /drug eff /rad eff PIDNA (66-70); Nucleic Acids (66-70); RNA (66-70) MNG6.184.680 LH  MHÑNucleic Acids ANGEN: prefer RNA & DNA whether Priority 1,2 or 3 article; do not use /analogs MND13.444 FXÑGenetics, Biochemical LH LX  MSThe chromsome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. PM80 HN80 MHÑNucleolus Organizer Region ANA 11 qualif except /cytol PICell Nucleolus (66-79); Chromosomes (66-79); Chromosomes, Human (78-79); specific human chromosome (68-79) MNA11.223.475.658; G5.275.658 XSNucleolar Organizer LH LS  MHÑNucleoproteins ANdo not use /analogs MND12.776.664 LH  MHÑNucleosidases ANdo not use /analogs RNEC 3.2.2. MND8.586.277.450.737 LH  MSCatalyze the hydrolysis of nucleosides with the elimination of ammonia. OLsearch AMINOHYDROLASES 1966-74 PM75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73 HN75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73 MHÑNucleoside Deaminases ANdo not confuse with NUCLEOTIDE DEAMINASES; do not use /analogs RNEC 3.5.4 PIAminohydrolases (66-74) MND8.586.277.151.486 XUÑAdenosine Deaminase; ÑCytidine Deaminase LH LU;  MSATP:nucleosidediphosphate phosphotransferases. Found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP with a nucleoside diphosphate, e.g., UDP to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6. HN(77) MHÑNucleoside Diphosphate Kinases ANdo not use /analogs RNEC 2.7.4.6 PINucleotides (66-76); Phosphotransferases (66-73); Phosphotransferases, ATP (74-76) MND8.586.913.696.729.500 DMÑPhosphotransferases, ATP LH LM  PM73 HN73(71) MHÑNucleoside Diphosphate Sugars ANdo not use /analogs /defic /physiol PIspecific carbohydrate; specific nucleotide MND9.203.408.620.569; D13.695.201.486; D13.695.827.708 XUÑAdenosine Diphosphate Glucose; ÑAdenosine Diphosphate Sugars; ÑCytidine Diphosphate Diglycerides; ÑGuanosine Diphosphate Fucose; ÑGuanosine Diphosphate Mannose; ÑGuanosine Diphosphate Sugars; ÑPoly Adenosine Diphosphate Ribose LH LU; ; ; ; ; ;  MSATP:nucleosidemonophosphate phosphotransferases. Catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP with a nucleoside monophosphate, e.g., UMP to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4. HN(77) MHÑNucleoside Monophosphate Kinases ANdo not use /analogs RNEC 2.7.4.4 PINucleotides (66-76); Phosphotransferases (66-73); Phosphotransferases, ATP (74-76) MND8.586.913.696.729.510 DMÑPhosphotransferases, ATP LH LM  MS7-(4,5-cis-Dihydroxy-1-cyclopenten- 3-ylaminomethyl)-7-deazaguanosine. A modified nucleoside which is present in the first position of the anticodon of tRNA-tyrosine, tRNA-histidine, tRNA-asparagine and tRNA-aspartic acid of many organisms. It is believed to play a role in the regulatory function of tRNA. Nucleoside Q can be further modified to nucleoside Q*, which has a mannose or galactose moiety linked to position 4 of its cyclopentenediol moiety. HN(80) MHÑNucleoside Q AN/biosyn /physiol permitted PIGuanosine (72-74) /AA (75-79); Nucleosides (66-71) MND13.570.583.454.500; D13.570.800.453.500 DMÑGuanosine LH LM  MHÑNucleosides ANnucleoside sequence = BASE SEQUENCE (NIM); do not use /analogs; nucleoside phosphates = NUCLEOTIDES MND9.203.408.595; D13.570 LH  MH*Nucleosides and Nucleotides (Non Mesh) MND13 LH  MSThe repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4. PM80 HN80 MHÑNucleosomes ANA 11 qualif except /cytol PICell Nucleus (66-79); Chromatin (72-79) MNA11.223.349.625; D12.776.664.224.550 LH  MHÑNucleotidases ANdo not use /analogs RNEC 3.1.3. MND8.586.277.352.630.654.675 LH  MSCatalyze the hydrolysis of nucleotides with the elimination of ammonia. OLsearch AMINOHYDROLASES 1966-74 PM75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73 HN75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73 MHÑNucleotide Deaminases ANdo not confuse with NUCLEOSIDE DEAMINASES; do not use /analogs RNEC 3.5.4 PIAminohydrolases (66-74) MND8.586.277.151.653 XUÑAMP Deaminase; ÑDeoxycytidylate Deaminase LH LU;  MSTwo-dimensional separation and analysis of nucleotides. PM87 HN87 MHÑNucleotide Mapping ANonly /instrum /methods PIChromatography, Paper (66-86); Electrophoresis, Paper (73-86) MNE5.196.181.400.454.655; E5.196.401.319.670; E5.196.680; H1.181.278.186.400.454.655; H1.181.278.414.236.670 XSFingerprints, Nucleotide LH LS  MHÑNucleotides ANpyridine nucleotides are probably NAD or NADP; nucleotide sequence = BASE SEQUENCE (NIM); do not use /analogs; /anal: consider also NUCLEOTIDE MAPPING MND9.203.408.620; D13.695 LH  PM74 HN74 MHÑNucleotides, Cyclic ANdo not use /analogs MND13.695.462 LH  OLuse NUCLEOTIDYLTRANSFERASES to search NUCLEOTIDYL TRANSFERASES back thru 1966 PM68; was NUCLEOTIDYL TRANSFERASES 1963-67 HN68; was NUCLEOTIDYL TRANSFERASES 1963-67 MHÑNucleotidyltransferases ANdo not use /analogs RNEC 2.7.7. MND8.586.913.696.445 XUÑAcylneuraminate Cytidylyltransferase; ÑAdenine Nucleotide Translocase; ÑGalactosephosphate Uridylyltransferase; ÑGlucosephosphate Uridylyltransferase; ÑHexosephosphate Uridylyltransferase; ÑNMN Adenylyltransferase; ÑPoly A Polymerase; ÑSulfate Adenylyltransferase LH LU; ; ; ; ; ; ;  MSThe largest neuronal nucleus in the septal region of the diencephalon. HN(78) MHÑNucleus Accumbens ANdo not use /innerv PICerebral Ventricles (66-77); Septal Nuclei (72-77) MNA8.186.211.577.851.664.568 DMÑSeptal Nuclei LH LM  MHÑNudism ANonly /hist MNI3.548 LH  MSComputer-assisted study of methods of obtaining useful quantitative solutions to problems that have been expressed mathematically. HN(87) MHÑNumerical Analysis, Computer-Assisted ANIM; no qualif MNL1.700.568.110.680.700 DMÑMathematical Computing LH LM  MSStudy of coins, tokens, medals, etc. However, it usually refers to medals pertaining to the history of medicine. HNwas in Cat I 1975-82, was in Cat E 1963-74 MHÑNumismatics ANincludes coins & medals; coin collecting as a hobby: coord IM with HOBBIES (IM); indexing policy: TN 245 MNK1.93.560 LH  MSNurses professionally qualified in administration. HN(82) MHÑNurse Administrators ANdo not use /man /methods; do not confuse with HEAD NURSES see NURSING, SUPERVISORY; in British jrnls ╥matron╙ goes here but nursing ╥sisters╙ go under NURSING, SUPERVISORY PIAdministrative Personnel (68-81); Nursing Service, Hospital (68-77) /OG (78-81) MNM1.526.70.670; M1.526.485.650.580; N2.350.45.310; N2.350.630.60 DMÑAdministrative Personnel LH LM  MSProfessional nurses who have completed postgraduate training in the administration of anesthetics and who function under the responsibility of the operating surgeon. OLuse NURSE ANESTHETISTS to search NURSE ANESTHETIST back thru 1975 PM77; was NURSE ANESTHETIST see under NURSES 1975-76 HN77; was NURSE ANESTHETIST see under NURSES 1975-76 MHÑNurse Anesthetists ANdo not use /man /methods MNM1.526.485.650.600; N2.350.630.180 LH  MSRegistered nurses who hold Master's degrees in nursing with an emphasis in clinical nursing and who function independently in coordinating plans for patient care. OLsearch NURSE PRACTITIONERS 1973-77 PM78; was NURSE CLINICIAN see NURSE PRACTITIONERS 1976-77, was NURSE CLINICIAN see NURSE PRACTITIONER 1973-75 HN78; was NURSE CLINICIAN see NURSE PRACTITIONERS 1976-77, was NURSE CLINICIAN see NURSE PRACTITIONER 1973-75 MHÑNurse Clinicians ANdo not use /man /methods PINurse Practitioners (73-77) MNM1.526.485.650.610; N2.350.630.200 XSClinical Nurse Specialists LH LS  MSProfessional nurses who have received postgraduate training in midwifery. OLuse NURSE MIDWIVES to search NURSE MIDWIFE back thru 1975 PM77; was NURSE MIDWIFE see under NURSES 1975-76 HN77; was NURSE MIDWIFE see under NURSES 1975-76 MHÑNurse Midwives ANdo not use /man /methods MNM1.526.485.650.620; N2.350.630.350 LH  MSNurses who are specially trained to assume an expanded role in providing medical care under the supervision of a physician. OLuse NURSE PRACTITIONERS to search NURSE PRACTITIONER back thru 1973 PM76; was NURSE PRACTITIONER 1973-75 HN76; was NURSE PRACTITIONER 1973-75 MHÑNurse Practitioners ANdo not use /man /methods MNM1.526.485.650.640; N2.350.630.487 LH  MSInteraction between the patient and nurse. MHÑNurse-Patient Relations ANno qualif MNF1.829.401.650.600 LH  MSFacilities which provide care for infants. PM73 HN73 MHÑNurseries ANonly /econ /legis /man /organ /stand /trends /util MNN2.278.617 FXÑChild Day Care Centers LH LX  MSHospital facilities which provide care for newborn infants. OLuse NURSERIES, HOSPITAL to search HOSPITAL NURSERIES back thru 1972 PM78; was HOSPITAL NURSERIES 1972-77 HN78; was HOSPITAL NURSERIES 1972-77 MHÑNurseries, Hospital ANonly /econ /legis /man /organ /stand /trends /util PICross Infection (66-71); Infant, Newborn, Diseases (66-71) MNN2.278.388.540; N2.278.617.473 XSHospital Nurseries LH LS  MSUse for articles on the registered nurse in general or for which there is no specific heading. PM67 HN67(65) MHÑNurses AN/educ = EDUCATION, NURSING; /hist = HISTORY OF NURSING; do not use /man /methods; relation to nurs specialties: Manual 34.17 CATALOG: /geog /form MNM1.526.485.650; N2.350.630 LH  MSNurses of the male sex. PM67 HN67 MHÑNurses, Male ANdo not use /hist /man /methods; relation to nurs specialties: Manual 34.17 PINursing (66) MNM1.390.660; M1.526.485.650.670; N2.350.630.653 LH  MSAllied health personnel who assist the professional nurse in routine duties. MHÑNurses' Aides ANdo not use /hist /man /methods MNM1.526.485.67.652; N2.350.84.611 LH  MSThe field of nursing care concerned with the promotion, maintenance, and restoration of health. MHÑNursing ANthe nursing profession only: NURSING CARE is for patients; /econ = ECONOMICS, NURSING; /educ = EDUCATION, NURSING, /hist = HISTORY OF NURSING; /legislation & jurisprudence = LEGISLATION, NURSING or NURSING (IM) + JURISPRUDENCE (IM); available is /nurs: Manual 19.5+ CATALOG: use with form qualif instead of NURSING CARE /form; do not use /in inf ( = PEDIATRIC NURSING) /in old age ( = GERIATRIC NURSING) MNG2.478 FXÑNURSING, PRIVATE DUTY; ÑNURSING, SUPERVISORY; ÑOFFICE NURSING LH LX; ;  MSEvaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning. PM87; was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79 HN87(80); was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79 MHÑNursing Assessment ANonly /econ /legis /man /methods /organ /stand /trends MNN4.590.233.508.480 XUÑNursing Diagnosis LH LU  MSA detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of nursing care. PM68 HN68 MHÑNursing Audit ANonly /methods /stand PINursing Service, Hospital (66-67) MNN4.761.520 LH  MSCare given to patients by nursing service personnel. PM66 HN66 MHÑNursing Care ANGEN & for patients only: NURSING is for the nursing profession; when GEN & IM, do not use /econ ( = ECONOMICS, NURSING) /educ ( = EDUCATION, NURSING) /hist ( = HISTORY OF NURSING) /legislation & jurisprudence ( = LEGISLATION, NURSING or NURSING (IM) + JURISPRUDENCE (IM) ) /man /supply /util; prefer /nursing: Manual 19.5+ CATALOG: form qualif = NURSING /form MNE2.472.611; N2.421.533 LH  MSConclusions derived from the nursing assessment which establishes a health status profile of the patient and from which nursing interventions may be ordered. OLsearch NURSING ASSESSMENT 1975-86 HN(87)(75-79); was see NURSING ASSESSMENT 1980-86, was see under NURSING CARE 1975-79 MHÑNursing Diagnosis ANonly /econ /legis /man /methods /organ /stand /trends PINursing Assessment (80-86) MNN4.590.233.508.480.110 XSDiagnosis, Nursing DMÑNursing Assessment LH LS LM  MSFacilities which provide nursing supervision and limited medical care to persons who do not require hospitalization. MHÑNursing Homes ANdo not use /educ; nursing homes for the aged: coord IM with HOMES FOR THE AGED (IM) CATALOG: /geog /form MNN2.278.825.610 XUÑIntermediate Care Facilities LH LU  MSThe sum total of nursing activities which includes assessment (identifying needs), intervention (ministering to needs), and evaluation (validating the effectiveness of the help given). PM80; NURSING ASSESSMENT was NURSING DIAGNOSIS see under NURSING CARE 1975-79 HN80 MHÑNursing Process AN╥total of nursing care activities╙; do not confuse with NURSING (the profession), NURSING CARE (the patient), NURSING SERVICES; only /econ /legis /man /methods /organ /stand /trends PINursing Care (66-79); Patient Care Planning (68-79) MNN4.590.233.508 LH  MSNotes recorded by nurses concerning the nursing care given to the patient including judgment of the patient's progress. PM67 HN67 MHÑNursing Records ANonly /stand; RECORDS CONTROL is also available (probably NIM when coord) PIMedical Records (66) MNN4.452.859.675 LH  MSThe hospital department which is responsible for the organization and administration of nursing activities. OLuse NURSING SERVICE, HOSPITAL to search HOSPITAL NURSING SERVICE back thru 1966 PM78; was HOSPITAL NURSING SERVICE 1963-77 HN78; was HOSPITAL NURSING SERVICE 1963-77 MHÑNursing Service, Hospital ANonly /econ /legis /man /organ /stand /trends /util MNN2.278.354.422.489; N2.421.539.180; N4.452.442.422.489 XSHospital Nursing Service LH LS  MSA general concept referring to the organization and administration of nursing activities. PM78 HN78 MHÑNursing Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form MNN2.421.539 LH  MSPersonnel who provide nursing service to patients in an organized facility, institution or agency. PM73 HN73 MHÑNursing Staff ANonly /educ /legis /organ /psychol /stand /supply /trends /util MNM1.526.485.680; N2.350.661 LH  MSPersonnel who provide nursing service to patients in a hospital. OLuse NURSING STAFF, HOSPITAL to search HOSPITAL NURSING STAFF back thru 1968 PM78; was HOSPITAL NURSING STAFF 1968-77 HN78; was HOSPITAL NURSING STAFF 1968-77 MHÑNursing Staff, Hospital ANonly /educ /legis /organ /psychol /stand /supply /trends /util PINursing Service, Hospital (66-67) MNM1.526.485.680.490; M1.526.485.740.523; N2.350.661.473; N2.350.685.250 XSHospital Nursing Staff LH LS  MSConcepts, definitions, and propositions applied to the study of various phenomena which pertain to nursing and nursing research. PM86 HN86 MHÑNursing Theory ANno qualif PIModels, Theoretical (68-85); Philosophy, Nursing (69-85) MNG2.478.408 LH  MSThe practice of nursing by licensed, non-registered persons qualified to provide routine care to the sick. MHÑNursing, Practical ANIM; only /econ /educ /hist /instrum /legis /man /methods /stand /trends /util MNG2.495; N2.421.533.520 LH  MSThe practice of nursing by a registered or licensed nurse to care for a specific patient in a health facility or in the home. Synonym: Private-practice Nursing. PM67 HN67 MHÑNursing, Private Duty ANIM; only /econ /hist /legis /man /methods /stand /trends /util PINursing (66) MNN4.452.758.486 FXÑNursing LH LX  MSAdministration of nursing services for one or more clinical units. PM66 HN66 MHÑNursing, Supervisory ANIM; only /econ /hist /legis /man /methods /organ /stand /trends /util; in British jnls nursing ╥sisters╙ go here but ╥matron╙ goes under NURSE ADMINISTRATORS MNN4.452.758.528 XSHead Nurses; Nurses, Head FXÑNursing LH LS; LX  MSCoordination of nursing services by various nursing care personnel under the leadership of a professional nurse. The team may consist of a professional nurse, nurses' aides, and the practical nurse. PM67 HN67(65) MHÑNursing, Team ANIM; only /econ /hist /legis /man /methods /organ /stand /trends /util; consider also PATIENT CARE TEAM MNN4.590.715.571 LH  MSThe science of food, the nutrients and other substances contained therein, their action, interaction, and balance in relation to health and disease. MHÑNutrition AN= why you eat & what happens to food after you eat it; FOOD = substance eaten; DIET = what you eat, when, how much, etc.; only /drug eff /educ /rad eff; don't forget CHILD NUTRITION & INFANT NUTRITION also available; adolescent nutrition = NUTRITION (IM) + ADOLESCENCE (IM); nutrition of animals = ANIMAL NUTRITION CATALOG: do not use /in inf ( = CHILD NUTRITION or INFANT NUTRITION) MNG2.513; G6.696 FXÑDiet; ÑFood LH LX;  OLto search MALNUTRITION use NUTRITION DISORDERS back thru 1967 & DEFICIENCY DISEASES 1966 PMMALNUTRITION was see under DEFICIENCY DISEASES 1963-66 HNMALNUTRITION was see under DEFICIENCY DISEASES 1963-66 MHÑNutrition Disorders ANdifferentiate from DEFICIENCY DISEASES (results from deficient intake) & METABOLIC DISEASES; fetal malnutrition = PLACENTA DISEASES MNC18.654 XSMalnutrition LH LS  MSA systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. MHÑNutrition Surveys ANno qualif; TN 97: caution against word ╥survey╙ CATALOG: /geog /form MNG3.850.520.610.630; N1.224.458.696 XUÑDiet Surveys LH LU  MH*Nutritional and Metabolic Diseases (Non Mesh) MNC18 LH  PM84; was see under NUTRITION 1975-83 HN84(68); was see under NUTRITION 1975-83, was Prov 1968-74 MHÑNutritional Requirements ANno qualif; NIM when specific nutrient is IM; not for nutritional requirements of bacteria, etc. ( = microorganism /growth or /metab or /physiol) PIspecific nutrient MNG6.696.736 LH  MSState of the body in relation to the consumption and utilization of nutrients, often evaluated by DIET SURVEYS or NUTRITION SURVEYS. PM87 HN87 MHÑNutritional Status ANonly /drug eff /rad eff; restrict to humans & Cat B2 MNG6.696.738; N1.407.540.280.408 LH  MSAn indication of the contribution of a food to the nutrient content of the diet. This value depends on the quantity of a food which is digested and absorbed and the amounts of the essential nutrients (protein, fat, carbohydrate, minerals, vitamins) which it contains. This value can be affected by soil and growing conditions, handling and storage, and processing. PM79 HN79 MHÑNutritive Value ANNIM; coord with specific food (IM); only /drug eff /rad eff PINutrition (66-78) MNG6.696.741 XSBiological Availability, Nutritional; Nutritional Availability LH LS;  MSDry fruit consisting of an edible kernel or meat enclosed in a woody or leathery shell. PMCOCONUT was heading 1963-85 MHÑNuts ANas seed & as tasty edible; only /ad-poi-tox /anal /class /stand /supply MNB6.510.645; J1.341.739 FXÑSeeds XUÑCoconut LH LX LU  MHÑNyctalopia MNC11.966.671 XSNIGHT BLINDNESS FXÑVitamin A Deficiency LH LS LX  PM73 HN73(72) MHÑNylidrin ANdo not use /biosyn /defic /physiol RN447-41-6 PIAmino Alcohols (66-71); Sympathomimetics (66-71) MND2.33.329.624.605; D2.92.63.624.605; D16.893.116.348.696 LH  MSPolymers where recurring amide groups comprise the main polymer chain; they may be amino acids, diamines, diacids or other and yield fibers, sheeting or extruded forms used in textiles, gels, filters, sutures, contact lenses and other biomaterials. Synonyms: Caprolan; Perlon; Quiana; Superpolyamid; Supramid; Trogamid; Ultramid; Zytel. OLuse NYLONS to search NYLON back thru 1966 PM80; was NYLON 1963-79 HN80; was NYLON in Cat D & J 1963-79 MHÑNylons ANonly /adv eff /anal /stand /supply /tox MND25.720.716.392; J1.637.879.571 XSPolyamides LH LS  MSThe immature stage in the life cycle of those orders of insects characterized by gradual metamorphosis, in which the young resemble the imago in general form of body, including compound eyes and external wings; also the 8-legged stage of mites and ticks that follows the first moult. HN(73) MHÑNymph ANNIM; for metamorphosing arthropods only; do not use /embryol with ref to nymph PIspecific arachnid; specific insect MNB1.583.571 DMÑInsects LH LM  MHÑNystagmus ANa disease; do not confuse with NYSTAGMUS, PHYSIOLOGIC below nor nystagmography, the recording of EYE MOVEMENTS or ELECTRONYSTAGMOGRAPHY MNC11.580 FXÑElectronystagmography; ÑEye Movements LH LX;  MSInvoluntary rhythmical movements of the eyes in the normal person. Either naturally occurring as in end-point (end-stage) nystagmus or induced by optokinetic drum, caloric test, or Barany rotating chair. PM83 HN83 MHÑNystagmus, Physiologic ANonly /drug eff /rad eff; do not confuse with NYSTAGMUS above, a disease; optokinetic & postrotatory go here; ELECTRONYSTAGMOGRAPHY is available PIEye Movements (66-82) MNG11.697.384.378 FXÑElectronystagmography LH LX  MHÑNystatin ANdo not use /defic /physiol RN1400-61-9 MND20.85.62.654; D20.136.73.654 LH  MS4-(o-Tolylazo)-o-toluidine. An azo dye with carcinogenic properties. Synonym: C.I. 11160B. HN(76) MHÑo-Aminoazotoluene AND25-26 qualif; /analogs NIM only RN97-56-3 PIAzo Compounds (68-75); Toluidines (72-75) MND2.172.37; D26.191.48; D26.408.78 XSC.I. Solvent Yellow 3; ortho-Aminoazotoluene DMÑAzo Compounds LH LS; LM  MS(o-Chlorobenzylidene)malonitrile. A riot control agent which causes temporary irritation of the eyes and the mucosal surface of the respiratory tract. HN(75) MHÑo-Chlorobenzylidene Malonitrile ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2698-41-1 PIBenzyl Compounds (72-74); Nitriles (70-74) MND2.626.310; D5.569.734.498.200 XSortho-Chlorobenzylidene Malonitrile DMÑNitriles LH LS LM  MSA reagent which forms fluorescent conjugation products with primary amines. Used for the detection of many biogenic amines, peptides and proteins in nanogram quantities in body fluids. HN(77) MHÑo-Phthalaldehyde ANdo not use /biosyn /defic /physiol; /analogs NIM only RN643-79-8 PIAldehydes (66-76); Phthalic Acids (66-76) MND2.47.750; D2.241.223.805.780; D26.550.587 XSOrtho-Phthalaldehyde DMÑAldehydes LH LS LM  MSIncrease in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. More than two times the ideal weight is considered OBESITY, MORBID. MHÑObesity ANdo not use Cat G qualif; /diet ther: consider also DIET, REDUCING; /drug ther: consider also APPETITE DEPRESSANTS; /surg: for removal of adipose tissue, differentiated from /ther for various shunting proced: note JEJUNOILEAL BYPASS but do not index also under OBESITY because of XR ref; obese hyperglycemic mice go under MICE, OBESE: do not index under OBESITY or HYPERGLYCEMIA unless particularly discussed as diseases MNC18.654.621; C23.888.220.621; G7.553.481.398.571 FXÑAppetite Depressants; ÑDiet, Reducing; ÑJejunoileal Bypass; ÑSKINFOLD THICKNESS LH LX; ; ;  MHÑObesity in Diabetes ANalso for ╥diabetes in obesity╙; coord IM with specific diabetes precoord (IM) if pertinent MNC18.452.297.681; C18.654.621.488; C19.246.681 LH  MSThe condition of weighing two or three, or more, times the ideal weight, so called because it is associated with many serious and life-threatening disorders. PM87 HN87 MHÑObesity, Morbid AN╥2, 3 or more times the ideal weight╙ PIObesity (66-86) MNC18.654.621.495 XSMorbid Obesity LH LS  OLuse OBIDOXIME to search TOXOGONIN back thru 1972 (as Prov 1972-74) HN(78); was TOXOGONIN see under OXIMES 1975-77, was TOXOGONIN 1972-74 (Prov) MHÑObidoxime ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7683-36-5 PICholinesterase Reactivators (71); Oximes (71) MND2.92.570.665.500; D3.383.725.762.600; D8.515.347.582.500; D16.653.211.498.368 XSToxogonin DMÑOximes LH LS LM  MSEmotional attachment to someone or something in the environment. PM69 HN69 MHÑObject Attachment ANno qualif PIParent-Child Relations (66-68); Psychoanalytic Theory (66-68) MNF2.739.794.624 XSBonding (Psychology); Bonds, Emotional; Object Relations; Symbiotic Relations (Psychology) XUÑBonding, Human-Pet LH LS; ; ; LU  MSPersistent, unwanted idea or impulse which is considered normal when it does not markedly interfere with mental processes or emotional adjustment. An example may be a song which is constantly running through your mind. OLsearch COMPULSIVE BEHAVIOR 1968-74; search OBSESSION under OBSESSIVE-COMPULSIVE DISORDER 1968-74 HN(75); OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78 MHÑObsessive Behavior ANdo not use /drug eff /physiol /rad eff MNF1.145.527.508; F3.126.517.508 DMÑCompulsive Behavior LH LM  MSAn anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension. OLuse OBSESSIVE-COMPULSIVE DISORDER to search NEUROSES, OBSESSIVE-COMPULSIVE back thru 1966 & OBSESSION 1966-78 PM81; was NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78 HN81; was NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78 MHÑObsessive-Compulsive Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.438.180.490 XSNeurosis, Obsessive-Compulsive FXÑCompulsive Behavior XUÑTrichotillomania LH LS LX LU  MSSurgical instrument designed to extract the newborn by the head from the maternal passages without injury to it or the mother. MHÑObstetrical Forceps ANdo not use /instrum /man /methods /mortal /nurs /util (except by MeSH definition) MNE7.858.670.571 FXÑExtraction, Obstetrical LH LX  MSNursing care given to the pregnant patient before, after or during childbirth. PM67 HN67 MHÑObstetrical Nursing ANSPEC: SPEC qualif PINursing (66); Nursing Care (66); Obstetrics (66) MNG2.478.676.570; N2.421.533.571 LH  MSA medical-surgical specialty concerned with management and care of women during pregnancy, parturition, and the puerperium. MHÑObstetrics ANSPEC: SPEC qualif; do not use for ╥obstetric diseases╙ ( = probably PREGNANCY COMPLICATIONS, etc.) MNG2.403.810.450 FXÑPREGNANCY COMPLICATIONS LH LX  MSHospital department responsible for the administration and the management of services provided for obstetric and gynecologic patients. HN(Aug 77) MHÑObstetrics and Gynecology Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: OBSTET GYNECOL DEP or OBSTETRICS DEPARTMENT PIGynecology (66-Jul 77); Hospital Departments (68-Jul 77); Obstetrics (66-Jul 77) MNN2.278.354.422.495; N4.452.442.422.495 XSHospital Obstetrics and Gynecology Department DMÑHospital Departments LH LS LM  MHÑObturator Nerve ANdo not use /innerv MNA8.796.828.569.572 LH  MHÑOccipital Bone ANfractures: coord OCCIPITAL BONE /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with SKULL NEOPLASMS (IM) MNA2.835.232.781.572 XSBASILAR BONE LH LS  MHÑOccipital Lobe ANdo not use /innerv; dis: coord IM with BRAIN DISEASES (NIM); neopl: coord IM with BRAIN NEOPLASMS (IM) MNA8.186.211.885.213.571 LH  PM67 HN67(63) MHÑOcclusive Dressings ANdo not use /instrum /man /methods /mortal /nurs /util (except by MeSH definition); spray-on dressings go here MNE7.101.572 XSBANDAGES, OCCLUSIVE; Dressings, Occlusive LH LS;  MSChemical, spectroscopic, or microscopic detection of extremely small amounts of blood. MHÑOccult Blood ANIM; no qualif; if fecal occult blood, do not coord with FECES MNE1.223.597 FXÑMELENA LH LX  MHÑOccultism ANno qualif MNK1.672 LH  MSThe branch of dentistry concerned with maintaining oral health of employees in occupational environments. OLuse OCCUPATIONAL DENTISTRY to search INDUSTRIAL DENTISTRY back thru 1965 PM82; was INDUSTRIAL DENTISTRY 1965-81 HN82; was INDUSTRIAL DENTISTRY 1965-81 MHÑOccupational Dentistry ANSPEC: SPEC qualif except /methods CATALOG: /geog /form MNG2.163.640 XSIndustrial Dentistry LH LS  MHÑOccupational Dermatitis ANdo not restrict to -itis: use as if ╥dermatoses╙; coord with specific skin dis with /chem ind; includes housewives' dermatoses caused by housekeeping agents MNC17.174.697; C21.447.697 XSINDUSTRIAL DERMATOSES LH LS  MHÑOccupational Diseases ANthe patient or disease: differentiate from INDUSTRY (the realm of labor, capital & trade) & INDUSTRIAL MEDICINE (now OCCUPATIONAL MEDICINE) (the med specialty): Manual 31.13, 31.14; coord IM with specific dis (IM); /chem ind permitted; do not add ENVIRONMENTAL EXPOSURE for dis resulting from the occup environment; ACCIDENTS, OCCUPATIONAL is also available MNC21.447 FXÑEnvironmental Exposure; ÑOccupational Medicine LH LX;  MSThe practice of nursing in the work environment. OLuse OCCUPATIONAL HEALTH NURSING to search INDUSTRIAL NURSING back thru 1966 PM79; was INDUSTRIAL NURSING 1963-78 HN79; was INDUSTRIAL NURSING 1963-78 MHÑOccupational Health Nursing ANSPEC: SPEC qualif CATALOG: /geog /form MNG2.478.676.590; N2.421.533.585 XSIndustrial Nursing LH LS  MSHealth services for employees, usually provided by the employer at the place of work. PM68 HN68 MHÑOccupational Health Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form PIOccupational Medicine (66-67) MNN2.421.143.740 XSEMPLOYEE HEALTH SERVICES; Employee Assistance Programs (Health Care) FXÑOccupational Medicine LH LS; LX  MSMedical specialty concerned with the promotion and maintenance of the physical and mental health of employees in occupational settings. OLuse OCCUPATIONAL MEDICINE to search INDUSTRIAL MEDICINE back thru 1966 PM79; was INDUSTRIAL MEDICINE 1963-78 HN79; was in Cat G & J 1979-82, was INDUSTRIAL MEDICINE in Cat G & J 1963-78 MHÑOccupational Medicine ANSPEC: SPEC qualif except /methods; Manual 31.14: relation to INDUSTRY & OCCUPATIONAL DISEASES CATALOG: /geog /form MNG2.403.790.548.510 XSIndustrial Medicine FXÑOCCUPATIONAL DISEASES; ÑOCCUPATIONAL HEALTH SERVICES; ÑOccupational Diseases; ÑPROTECTIVE DEVICES; ÑPublic Health LH LS LX; ; ; ;  MSThe field concerned with utilizing craft or work activities in the rehabilitation of patients. MHÑOccupational Therapy ANdo not use /util except by MeSH definition; coord IM with dis /rehabil (IM), not /ther MNE2.831.489; G2.532 LH  MSHospital department responsible for the administration and provision of any occupational or work activity for remedial purposes. HN(Aug 77) MHÑOccupational Therapy Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: OCCUP THER DEP PIHospital Departments (68-Jul 77); Occupational Therapy (66-Jul 77) MNN2.278.354.422.500; N4.452.442.422.500 XSHospital Occupational Therapy Department DMÑHospital Departments LH LS LM  MSUse for non-medical or non-health-related occupations in general or for which there is no specific heading. OLuse OCCUPATIONS to search OCCUPATIONS AND PROFESSIONS back thru 1966 PM68; was OCCUPATIONS AND PROFESSIONS 1963-67 HN68; was OCCUPATIONS AND PROFESSIONS 1963-67 MHÑOccupations ANonly /class /hist /stand /trends; OCCUPATIONS are not necessarily ╥industrial╙; relation to INDUSTRY, INDUSTRIAL MEDICINE (now OCCUPATIONAL MEDICINE) & OCCUPATIONAL DISEASES: Manual 31.13, 31.14 MNN1.824.547 XSVOCATIONS FXÑHEALTH OCCUPATIONS LH LS LX  PM68 HN68 MHÑOceanography ANonly /educ /instrum /man /methods PIMarine Biology (66-67); Submarine Medicine (66-67) MNH1.374.572 FXÑMARINE BIOLOGY; ÑSUBMARINE MEDICINE LH LX;  HN87 MHÑOceans and Seas ANdo not use /ethnol; for oceans & seas not main headings, index under OCEANS AND SEAS: do not coord with a geog land mass, e.g., Indian Ocean = OCEANS AND SEAS but not also India MNZ1.756 XSSeas LH LS  PM74 HN74(71) MHÑOchratoxins ANfrom Aspergillus; do not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS PICoumarins (66-70); Mycotoxins (67-70) MND3.438.150.446.677; D24.185.926.587.697 LH  MSDeposition of polymerized homogentisic acid as a brown-black pigment in the connective tissue. Occurs in alkaptonuria, but has also been observed in connection with exposure to certain chemicals (e.g., phenol, trinitrophenol, benzene derivatives). MHÑOchronosis MNC17.621.613; C18.452.648.66.187.572 LH  MSEight-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. PM78 HN78 MHÑOctanes ANdo not use /analogs /biosyn /defic /physiol; does not include octenes ( = ALKENES), octadienes ( = ALKADIENES), octatrienes or octatetraenes ( = POLYENES) PIAlkanes (66-77); Hydrocarbons (66-77) MND2.455.326.146.720 XSIsooctanes LH LS  OLsearch CAPRYLATES 1968-74 HN(75) MHÑOctanoic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.222.572; D2.241.81.407.177.572; D10.516.251.122.572 DMÑCaprylates LH LM  MSAn eight-armed cephaloped mollusc belonging to the order Octopoda; includes octopus as food. PM73 HN73 MHÑOctopus ANas animal & food; /microbiol /parasitol permitted PIMollusca (66-72) MNB1.644.535 LH  MSA condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma. PM83 HN83 MHÑOcular Hypertension AN╥intraocular pressure elevated above normal & which may lead to glaucoma╙: do not equate with GLAUCOMA PIGlaucoma (66-82); Intraocular Pressure (66-82) MNC11.600 XSGlaucoma, Suspect FXÑIntraocular Pressure LH LS LX  OLconsider also EYE /PH & /PH with specific parts of the eye MH*Ocular Physiology (Non Mesh) MNG11.697 LH  MSAutosomal recessive syndrome in which ocular signs include cataracts and glaucoma. The central nervous system defects are manifested by mental retardation and hypotonia, and the renal abnormalities consist of tubular and later glomerular insufficiency. HN(77) MHÑOculocerebrorenal Syndrome ANdo not use /congen PIAbnormalities, Multiple (68-76); Eye Diseases (66-76); Kidney Diseases (66-76) MNC10.496.670; C12.777.419.815.720; C16.131.77.661; C18.452.648.851.750; F3.709.346.710 XSLowe Syndrome DMÑRenal Tubular Transport, Inborn Errors LH LS LM  MHÑOculomotor Muscles AN/innerv = probably OCULOMOTOR NERVE but consider also ABDUCENS NERVE & TROCHLEAR NERVE; paralysis = OCULOMOTOR PARALYSIS (see OPHTHALMOPLEGIA) MNA2.633.600; A9.371.613 LH  MHÑOculomotor Nerve AN3d cranial nerve; do not use /innerv MNA8.796.214.588 LH  OLsearch VATER'S AMPULLA 1966-74 HN(75) MHÑOddi's Sphincter ANdiseases: coord IM with COMMON BILE DUCT DISEASES (NIM); inflammation: coord IM with CHOLANGITIS (IM); neopl: coord IM with COMMON BILE DUCT NEOPLASMS (IM) MNA3.159.183.307.731.572 DMÑVater's Ampulla LH LM  PM65 HN65 MHÑOdontoblasts ANA 11 qualif & /class MNA11.329.522 FXÑDentin LH LX  PM65 HN65 MHÑOdontogenesis ANonly /drug eff /rad eff MNG7.553.767 FXÑTooth; ÑTooth Germ LH LX;  PM65 HN65 MHÑOdontogenesis Imperfecta ANdo not use /congen; includes odontodysplasias MNC16.131.314.904.738 LH  MSCysts found in the jaws and arising from epithelium involved in tooth formation. Include follicular cysts (e.g., primordial cyst, dentigerous cyst, multiocular cyst), lateral periodontal cysts, and radicular cysts. May become keratinized (odontogenic keratocysts). Follicular cysts may give rise to ameloblastomas and, in rare cases, undergo malignant transformation. PM65 HN65 MHÑOdontogenic Cysts ANnon-neoplastic but calcifying odontogenic cyst = ODONTOGENIC TUMORS; /anal /blood supply /secret /ultrastruct permitted; coord IM with JAW DISEASES, MANDIBULAR DISEASES or MAXILLARY DISEASES (IM) MNC4.182.89.530.690; C5.500.470.690 LH  MSNeoplasms produced from tooth-forming tissues. OLuse ODONTOGENIC TUMORS to search ODONTOGENIC TUMOR & NEOPLASMS, DENTAL TISSUE back thru 1966 PM80; was ODONTOGENIC TUMOR 1963-79; NEOPLASMS, DENTAL TISSUE was heading 1963-79 HN80; was ODONTOGENIC TUMOR 1963-79; NEOPLASMS, DENTAL TISSUE was heading 1963-79 MHÑOdontogenic Tumors ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.789; C5.500.499.690 XSNeoplasms, Dental Tissue XUÑCementoma; ÑOdontoma LH LS LU;  MSThe toothlike process on the upper surface of the axis, which articulates with the atlas above. HN(85) MHÑOdontoid Process ANa part of the AXIS; not a dental term PIAxis (66-84) MNA2.835.232.834.151.383.668 XSDens Axis DMÑAxis LH LS LM  OLsearch ODONTOGENIC TUMORS 1966-74 HN(75); was see under ODONTOGENIC TUMOR 1975-79 MHÑOdontoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); do not confuse with ╥odontome╙, a form of developmental dental anomaly ( = TOOTH ABNORMALITIES) PIOdontogenic Tumors (66-74) MNC4.557.537.789.690; C5.500.499.690.690 DMÑOdontogenic Tumors LH LM  OLsearch CEPHALOMETRY 1969-72 PM79; was see under CEPHALOMETRY 1969-78 HN79(73); was see under CEPHALOMETRY 1969-78 MHÑOdontometry ANonly /instrum /methods PICephalometry (66-72); Dentition (66-72); Tooth (66-72); specific tooth heading MNE5.118.656; E6.623 LH  MHÑOdors ANonly /anal /prev; mouth odors = HALITOSIS MNG3.230.480 FXÑSMELL LH LX  MSAttachment of the child to the parent of the opposite sex, accompanied by envious and aggressive feelings toward the parent of the same sex. OLsearch PSYCHOANALYTIC THEORY 1966-74 HN(75) MHÑOedipus Complex ANno qualif MNF2.739.794.653 DMÑPsychoanalytic Theory LH LM  MSInfection of the intestinal tract with worms of the genus Oesophagostomum; occurs mainly in animals other than man. PM67 HN67 MHÑOesophagostomiasis PIHookworm Infections (66) MNC3.335.508.583 LH  MSA genus of nematodes of the family Strongyloidea, parasitic in the intestines of animals. The adults are usually free in the intestinal lumen; the larvae encyst in the wall. OLsearch ANCYLOSTOMATOIDEA 1966 PM67; was see under HOOKWORMS 1963-66 HN67; was see under HOOKWORMS 1963-66 MHÑOesophagostomum ANdo not use /blood-csf-urine; infection = OESOPHAGOSTOMIASIS PIAncylostomatoidea (66) MNB1.500.294.710.680 LH  MSUse of computers or computer systems for doing routine clerical work, e.g., billing, records pertaining to the administration of the office, etc. PM87 HN87 MHÑOffice Automation MNL1.700.508.300.680.708; N4.452.515.708 XSAutomation, Office; Electronic Mail LH LS;  MSPlanning, organizing, and administering activities in an office. MHÑOffice Management ANonly /econ /man /stand /trends MNN4.452.758.572 FXÑEconomics, Dental; ÑEconomics, Medical XUÑForms and Records Control LH LX; LU  MSNursing practice limited to assisting a physician in his private office. PM73 HN73(66) MHÑOffice Nursing ANonly /econ /man /stand /trends MNN4.452.758.613 FXÑNursing LH LX  MSVisits made by patients to health service providers' offices for diagnosis, treatment, and follow-up. PM84 HN84 MHÑOffice Visits ANonly /econ /trends /util MNN4.452.758.635 LH  MHÑOhio MNZ1.107.567.875.663 LH  PMSAFFLOWER OIL was see under FATTY ACIDS, ESSENTIAL 1963-74 MHÑOils ANGEN or unspecified: prefer specific oil groups & specific oils; D25-26 qualif; coord IM with source of oil (IM or NIM) MND10.516.627; J1.740 LH  MHÑOils, Volatile AND25-26 qualif; coord IM with source of oil (IM or NIM) MND10.516.627.675; J1.740.675 XSOils, Essential LH LS  MSVarious mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons; vehicles for medicinal substances intended for external application; there are four classes: hydrocarbon base, absorption base, water-removable base and water-soluble base; several are also emollients. OLsearch PHARMACEUTIC AIDS 1968-74 HN(75) MHÑOintment Bases ANIM for general only; NIM when specific drug is IM; when IM, D25-26 qualif; when NIM, no qualif MND26.698.523 DMÑPharmaceutic Aids LH LM  MSSemisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medicaments; ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Synonyms: salves; unctions; unguents. MHÑOintments ANIM for general only; when IM, only /adv eff /anal (with caution) /stand /supply; NIM coord, no qualif, with specific drug IM MND26.394.225.589 XSPastes LH LS  MHÑOklahoma MNZ1.107.567.875.672 LH  MSFinancial assistance for the impoverished elderly through public funding of programs, services and individual income supplements. OLsearch PUBLIC ASSISTANCE 1968-74 HN(75) MHÑOld Age Assistance ANonly /econ /hist /legis /organ /trends; specify geog MNN3.219.521.346.506.678 DMÑPublic Assistance LH LM  MHÑOleandomycin ANdo not use /defic /physiol RN3922-90-5 MND20.85.593 LH  MS3 beta-Hydroxyolean-12-en-28-oic acid. Occurs in leaves of Olea europaea, Viscum album L., and other higher plants. It is also the aglycone component of many saponins. HN(75); was see under TRITERPENES 1975-78 MHÑOleanolic Acid ANdo not use /defic /physiol; /analogs NIM only RN508-02-1 PICarboxylic Acids (74); Triterpenes (74) MND2.455.849.919.650.600 XSOleanol DMÑSapogenins LH LS LM  OLuse OLEIC ACIDS to search OLEIC ACID back thru 1966 PM75; was OLEIC ACID 1963-74 HN75; was OLEIC ACID 1963-74 MHÑOleic Acids ANdo not use /analogs; glycerol trioleate = TRIOLEIN; do not confuse X ref OCTADECENOIC ACIDS with OCTADECANOIC ACIDS see STEARIC ACIDS MND2.241.81.436.573; D10.516.251.355.601 XSOctadecenoic Acids LH LS  OLsearch LIMBIC SYSTEM 1966-71 PM74; was see under LIMBIC SYSTEM 1963-73 HN74(72); was see under LIMBIC SYSTEM 1963-73 MHÑOlfactory Bulb ANdo not use /innerv; neopl: coord IM with BRAIN NEOPLASMS (IM) + histol type of neopl (IM) PILimbic System (66-71) MNA8.186.211.577.636; A8.796.214.628.573 LH  MSThat portion of the nasal mucosa containing the sensory endings for olfaction; the organ of smell. PM72 HN72 MHÑOlfactory Mucosa PINasal Mucosa (66-71) MNA4.531.520.573; A9.623; A10.615.550.707.573 LH  MHÑOlfactory Nerve AN1st cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.628 LH  HN(72) MHÑOlfactory Pathways ANdo not use /innerv PICentral Nervous System (66-71); Smell (66-71); specific brain site MNA8.186.211.577.699; A8.612.220.640 DMÑCentral Nervous System LH LM  MSDextrin 6-alpha-glucanohydrolase. Catalyzes the endohydrolysis of 1,6-alpha-glucosidic linkages in isomaltose and dextrins produced from starch and glycogen by alpha-amylase. EC 3.2.1.10. HN(78) MHÑOligo-1,6-Glucosidase ANconsider also SUCRASE-ISOMALTASE COMPLEX; do not use /analogs; /defic: consider also SUCROSE /metab (IM) + CARBOHYDRATE METABOLISM, INBORN ERRORS (IM) RNEC 3.2.1.10 PIGlycoside Hydrolases (66-77) MND8.586.277.450.770 XSIsomaltase DMÑGlycoside Hydrolases LH LS LM  MSA class of annelid worms with few setae per segment; includes the earthworms such as Lumbricus and Eisenia. OLsearch ANNELIDA 1969-74; use OLIGOCHAETA to search EARTHWORMS back thru 1972 PM79; was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78 HN79(75); was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78 MHÑOligochaeta AN/microbiol /parasitol permitted PIAnnelida (66-74) MNB1.91.657 XSEarthworms LH LS  OLsearch NEUROGLIA 1966-74 HN(75) MHÑOligodendroglia AN= oligodendrocytes; do not use /innerv MNA11.671.603.657 DMÑNeuroglia LH LM  OLuse OLIGODENDROGLIOMA to search OLIGODENDROMA back thru 1966 PM68; was OLIGODENDROMA 1963-67 HN68; was OLIGODENDROMA 1963-67 MHÑOligodendroglioma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); oligodendroblastoma goes here MNC4.557.652.329.699 XSOLIGODENDROMA LH LS  MSA group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. PM86; was see under OLIGONUCLEOTIDES 1976-85 HN86(76); was see under OLIGONUCLEOTIDES 1976-85 MHÑOligodeoxyribonucleotides AN2-12 nucleotides; do not use /analogs /defic /physiol PIOligonucleotides (74-75) MND13.695.578.424.450 LH  MSAbnormally infrequent menstruation. Do not use for scanty menstrual flow (hypomenorrhea). HN(75) MHÑOligomenorrhea ANinfrequent menstruation; differentiate from HYPOMENORRHEA (scanty or shortlasting menstruation) MNC13.371.491.600 DMÑMenstruation Disorders LH LM  MSA closely related group of toxic substances elaborated by various strains of Streptomyces. They are 26-membered macrolides with lactone moieties and double bonds and inhibit various ATPases, causing uncoupling of phosphorylation from mitochondrial respiration. Used as tools in cytochemistry. Some specific oligomycins are RUTAMYCIN, peliomycin, and botrycidin (formerly venturicidin X). OLuse OLIGOMYCINS to search OLIGOMYCIN back thru 1966 PM82; was OLIGOMYCIN 1966-81; RUTAMYCIN was see under ANTIBIOTICS, ANTIFUNGAL 1975-81 HN82; was OLIGOMYCIN 1963-81 (Prov 1963-65) MHÑOligomycins ANdo not use /analogs /defic /physiol MND8.373.936.610 XUÑRutamycin LH LU  PM74 HN74(72) MHÑOligonucleotides AN2-12 nucleotides; do not use /analogs /defic /physiol MND13.695.578.424 LH  PM73 HN73 MHÑOligopeptides ANGEN; 2-12 amino acids (includes DIPEPTIDES, tripeptides, tetrapeptides, pentapeptides, etc.); do not use /analogs /defic /physiol; conformation: coord OLIGOPEPTIDES or specific peptide (IM) + PROTEIN CONFORMATION (NIM) PIPeptides (66-72) MND12.644.456 XUÑAntipain; ÑLeupeptins; ÑPepstatins; ÑPhalloidine; ÑTeprotide LH LU; ; ; ;  MSA group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties. PM86; was see under OLIGONUCLEOTIDES 1976-85 HN86(76); was see under OLIGONUCLEOTIDES 1976-85 MHÑOligoribonucleotides AN2-12 nucleotides; do not use /analogs /defic /physiol PIOligonucleotides (74-75) MND13.695.578.424.500 LH  MHÑOligosaccharides ANGEN; 3-12 sugar units but TRISACCHARIDES is available; do not use /analogs /defic /physiol MND9.203.698.629 XUÑRaffinose LH LU  MSDeficiency of the number of spermatozoa in semen. PM75 HN75 MHÑOligospermia ANdo not use /congen PISpermatozoa (66-74) MNC12.294.365.700.508 XSAzoospermia FXÑSpermatozoa LH LS LX  OLsearch ANURIA 1966-74 HN(75) MHÑOliguria MNC12.777.419.78.574 DMÑAnuria LH LM  MHÑOlivary Nucleus ANdo not use /innerv MNA8.186.211.132.810.406.574 XSBasal Nucleus, Olivary; Nucleus Basalis, Olivary LH LS;  MSA mixture of several closely related glycosidic antibiotics obtained from Actinomyces (or Streptomyces) olivoreticuli; used as fluorescent dye that binds to DNA and prevents both RNA and protein synthesis; also used as antineoplastic agent. OLuse OLIVOMYCINS to search OLIVOMYCIN back thru 1965 (as Prov 1966-71) PM81; was OLIVOMYCIN 1972-80 HN81; was OLIVOMYCIN 1965-80 (Prov 1965-71) MHÑOlivomycins ANdo not use /analogs /defic /physiol MND20.85.75.302.574; D22.204.106.307.574; D26.408.348.199.671 LH  MSA collection of diseases with atrophy of the cerebellum, pons, and inferior olives described in 1900 by Dejerine and Thomas. Signs and symptoms include ataxia of trunk and limbs, dysarthria, intention tremor, followed by generalized rigidity and dementia. HN(87) MHÑOlivopontocerebellar Atrophy ANDF: OPCA PIAtrophy (66-86); Brain Diseases (66-86); Cerebellar Ataxia (68-86); Cerebellar Diseases (66-86); Olivary Nucleus (66-86); Pons (66-86) MNC10.228.140.252.253.871.679 XSOlivopontocerebellar Degeneration DMÑSpinocerebellar Degenerations LH LS LM  OLuse OMAN to search MUSCAT & OMAN back thru 1975 HN79; was MUSCAT & OMAN 1975-78 MHÑOman MNZ1.252.245.93.600; Z1.630.100.690 XSMuscat and Oman LH LS  PM68 HN68 MHÑOmasum PIStomach (66-67) MNA13.869.524 LH  MHÑOmentum MNA1.47.596.573 LH  MS5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl) methyl)sulfinyl)benzimidazole. A highly effective inhibitor of gastric acid secretion used in the therapy of gastric ulcers and Zollinger-Ellison syndrome. The drug inhibits the H+,K+-ATPase in a pH-dependent manner. This ATPase is considered the proton pump in the secretory membrane of the parietal cell. PM87 HN87 MHÑOmeprazole ANdo not use /biosyn /defic /physiol RN73590-58-6 PIBenzimidazoles (66-86) MND3.438.103.675; D19.316.203.661 LH  MHÑOnchocerca ANdo not use /blood-csf-urine; infection = ONCHOCERCIASIS MNB1.500.294.530.510 LH  MHÑOnchocerciasis MNC3.335.508.361.699 LH  MSProducts of oncogenes. They usually have transforming and often protein kinase activities. PM86 HN86 MHÑOncogene Proteins, Viral ANIM; coord with specific virus (IM); do not use /analogs PIAntigens, Viral, Tumor (84-85); Viral Proteins (66-85) MND12.776.964.700 XSV-Onc Proteins; Viral Oncogene Proteins; Viral Transforming Proteins LH LS; ;  MSCellular or viral genes potentially capable of inducing oncogenic transformation. PM83 HN83 MHÑOncogenes ANonly /drug eff /rad eff; ONCOGENES cause neopl transform of cells; do not confuse with ONCOGENS see CARCINOGENS PIGenes (66-77); Genes, Viral (78-82) MNG5.275.740 XSCancer Genes; Myc Genes; Ras Genes; Src Genes LH LS; ; ;  MSViruses that produce tumors. PM66; was TUMOR VIRUSES 1963-65 HN66; was TUMOR VIRUSES 1963-65 MHÑOncogenic Viruses ANdo not use /blood-csf-urine /cytol; infection = TUMOR VIRUS INFECTIONS (IM) + neopl terms if pertinent MNB4.909.574 XSTUMOR VIRUSES FXÑCarcinogens; ÑNeoplasms; ÑTumor Virus Infections LH LS LX; ;  MSNursing care provided cancer patients; includes aspects of family functioning through education of both patient and family. The specialty of oncologic nursing focuses on cancer as a major health care problem. PM85 HN85 MHÑOncologic Nursing ANSPEC: SPEC qualif PINeoplasms/NU (75-84); Specialties, Nursing (71-84) MNG2.478.676.605; N2.421.533.600 XSNursing, Oncologic LH LS  MSViruses that will grow in and destroy tumor cells. PM66 HN66 MHÑOncolytic Viruses ANdo not use /blood-csf-urine /cytol MNB4.909.637 LH  PM68 HN68 MHÑOnium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ONIUM CPDS MND2.675 XUÑSulfonium Compounds LH LU  OLuse ONLINE SYSTEMS to search ON LINE SYSTEMS back thru 1971 (as Prov 1971-73) PM79; was ON LINE SYSTEMS 1974-78 HN79; was ON LINE SYSTEMS 1971-78 (Prov 1971-73) MHÑOnline Systems ANonly /econ /hist /instrum /man /organ /stand /supply /trends /util (if by MeSH definition) PIComputers (66-70) MNL1.700.508.300.742 XSOn-Line Systems LH LS  MSChild who has no siblings. PM68 HN68 MHÑOnly Child ANonly /psychol MNF1.829.263.500.280; I1.880.225.500.280; M1.471.392.750 FXÑChild LH LX  MHÑOntario MNZ1.107.567.176.639 LH  MSFemale germ cells in stages between the prophase of the first maturation division and the completion of the second maturation division. PM84; was see under OVUM 1975-83 HN84(75); was see under OVUM 1975-83 MHÑOocytes ANA 11 qualif & /growth PIOvum (66-74) MNA5.360.490.690.680; A11.497.497.600 XSOvocytes LH LS  MSThe formation, development and maturation of the female germ cell. PM75 HN75 MHÑOogenesis ANonly /drug eff /rad eff PIOvum (66-74) MNG8.520.310.500 LH  MSThe primitive differentiated female gametes which give rise to oocytes. HN(75) MHÑOogonia ANA 11 qualif & /growth MNA5.360.490.690.700; A11.497.497.650 DMÑOvum LH LM  MSA class of Mastigomycotina fungi infecting higher plants and also producing oomycoses in various animals including fish, horses and mules. OLsearch PHYCOMYCETES 1972-74 HN(75); was see under PHYCOMYCETES 1972-85 MHÑOomycetes ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.730.576.625 DMÑMastigomycotina LH LM  MHÑOophoritis MNC13.371.56.114.450; C13.371.56.630.450 LH  MSComputerized support systems for surgical reporting, coding of operative procedures by the surgeon, and administrative activities in the surgical suites. HN(87) MHÑOperating Room Information Systems MNL1.700.508.300.408.608; N4.452.442.452.600 DMÑHospital Information Systems LH LM  MSThe functions of the professional nurse in the operating room. PM74 HN74 MHÑOperating Room Nursing ANIM; only /econ /educ /hist /legis /man /methods /organ /stand /trends; DF: PERIOP NURS MNN2.421.533.625 XSPerioperative Nursing LH LS  MSSpecially trained personnel to assist in routine technical procedures in the operating room. PM71 HN71 MHÑOperating Room Technicians ANdo not use /man /methods PIOperating Rooms/MA (68-70) MNM1.526.485.67.700; N2.350.84.657 LH  MSFacilities equipped for performing surgery. MHÑOperating Rooms ANdo not use /educ /methods MNN2.278.388.700 FXÑSurgery, Operative XUÑDelivery Rooms LH LX LU  PM66; PROGRAMMING, LINEAR was see under OPERATIONS RESEARCH & PROGRAMMED INSTRUCTION 1966-68 HN66 MHÑOperations Research ANno qualif MNL1.906.575 FXÑDecision Theory; ÑGame Theory; ÑInformation Theory; ÑResearch XUÑMonte Carlo Method; ÑProbability Theory; ÑProgramming, Linear LH LX; ; ; LU; ;  MSDNA sequences which signal the initiation of transcription when derepressed. OLto search OPERATOR (GENETICS) use OPERATOR REGIONS (GENETICS) back thru 1986 & OPERON 1980-85 PM86; OPERATOR (GENETICS) was see OPERON 1980-85 HN86; OPERATOR (GENETICS) was see OPERON 1980-85 MHÑOperator Regions (Genetics) ANonly /drug eff /rad eff; DF: OPERATOR REGIONS PIGenes, Regulator (68-85); Operon (69-85) MNG5.275.470.700; G5.331.380.418.700 XSOperator (Genetics) LH LS  MSThe genetic unit consisting of a feedback system under the control of an operator gene, in which a structural gene transcribes its message in the form of mRNA upon blockade of a repressor produced by a regulator gene. PM72 HN72(69) MHÑOperon ANonly /drug eff /rad eff; LAC OPERON is also available PIGenetics, Biochemical (68) MNG5.275.769 LH  MHÑOphthalmia ANophthalmitis goes here; restrict to ophthalmia as a disease entity: do not use as coord for INFLAMMATION of specific parts of eye (e.g., scleritis = SCLERA (IM) + INFLAMMATION (NIM), not OPHTHALMIA); PANOPHTHALMITIS is also available: see note there MNC11.621 LH  MHÑOphthalmia Neonatorum ANdo not use /congen MNC1.252.391.658; C11.187.183.220.538; C16.614.677 LH  MHÑOphthalmia, Sympathetic MNC11.621.491; C11.941.683; C20.111.709 LH  MSArtery originating from the internal carotid artery and distributing to the eye, orbit and adjacent facial structures. MHÑOphthalmic Artery ANdo not use /blood supply MNA7.231.114.622 LH  MSPersons academically trained to care for patients with eye diseases or structural defects of the eye, under the supervision of an ophthalmologist. OLsearch PHYSICIANS' ASSISTANTS 1971-74 HN(75) MHÑOphthalmic Assistants ANdo not use /man /methods MNM1.526.485.67.740.690; N2.350.84.771.491 DMÑPhysicians' Assistants LH LM  MHÑOphthalmic Nerve ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.848.625 LH  OLuse OPHTHALMIC SOLUTIONS to search SOLUTIONS, OPHTHALMIC back thru 1966 PM67; was SOLUTIONS, OPHTHALMIC 1963-66 HN67; was SOLUTIONS, OPHTHALMIC 1963-66 MHÑOphthalmic Solutions AND25-26 qualif if IM & GEN; NIM coord, no qualif, specific drug IM MND26.394.225.766.657 XSEYEDROPS LH LS  PM67 HN67(64) MHÑOphthalmodynamometry ANdo not use /util except by MeSH definition MNE1.210.625 LH  MSA surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases. MHÑOphthalmology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of EYE /form or EYE DISEASES /form MNG2.403.810.468 FXÑEye Diseases; ÑORTHOPTICS; ÑVISION LH LX; ;  MSParalysis of the ocular muscles, innervated by the oculomotor, trochlear and abducens nerves. OLuse OPHTHALMOPLEGIA to search OCULOMOTOR PARALYSIS back thru 1966 PM79; was OCULOMOTOR PARALYSIS 1963-78 HN79; was OCULOMOTOR PARALYSIS 1963-78 MHÑOphthalmoplegia MNC10.597.622.447; C10.772.204.510; C11.627; C23.888.592.636.447 XSOculomotor Paralysis; Tolosa-Hunt Syndrome XUÑDuane's Syndrome; ÑKearns Syndrome LH LS; LU;  MSExamination of the interior of the eye with an ophthalmoscope. MHÑOphthalmoscopy ANdo not use /util except by MeSH definition MNE1.210.675 FXÑFUNDUS OCULI; ÑPAPILLEDEMA LH LX;  PM66 HN66 MHÑOpipramol ANdo not use /biosyn /defic /physiol RN315-72-0 MND3.494.240.625; D15.236.122.140.689 LH  MSInfection with flukes of the genus Opisthorchis. PM68 HN68 MHÑOpisthorchiasis ANcaused by genus OPISTHORCHIS but not OPISTHORCHIS SINENSIS ( = CLONORCHIS SINENSIS, causing CLONORCHIASIS) PITrematode Infections (66-67) MNC3.335.865.685 LH  MSA family of lanceolate liver flukes of the class Trematoda which occcurs in animals and man. There are several genera including Amphimerus, Cyclorchis, Delphinicola, Metorchis, Parametorchis, Phocitrema, Clonorchis, and Opisthorchis. PM82 HN82 MHÑOpisthorchidae ANfamily of trematodes; do not use /blood-csf-urine; infection: coord NIM with TREMATODE INFECTIONS (IM) PITrematoda (66-81) MNB1.500.736.715.520 LH  MSA genus of trematode liver flukes of the family Opisthorchidae. It consists of the following species: O. felineus, O. noverca (Amphimerus noverca), and O. viverrini. The intermediate hosts are snails, fish, and amphibia. MHÑOpisthorchis ANdo not use /blood-csf-urine; infection = OPISTHORCHIASIS but note OPISTHORCHIS SINENSIS see CLONORCHIS SINENSIS: O. sinensis infection = CLONORCHIASIS MNB1.500.736.715.520.700 XSOpisthorchis felineus; Opisthorchis viverrini LH LS;  MSAir dried exudate from the incised, unripe seed capsule of the opium poppy, Papaver somniferum, or its variant, P. Album; contains a great number of alkaloids that have various pharmacologic effects; used as analgesic, diaphoretic, and as antidiarrheal and antispasmodic. Synonyms: raw opium; gum opium; powdered opium. OLuse OPIUM to search PANTOPON back thru 1966 HNPANTOPON was see under OPIUM 1963-79 MHÑOpium ANdo not use /defic /physiol; opium addiction: coord IM with NARCOTIC DEPENDENCE (IM) RN8008-60-4 MND3.132.610; D14.73.153.616; D14.757.638 XSPapaveretum FXÑPapaver LH LS LX  PM68 HN68 MHÑOpossums ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIMarsupialia (66-67) MNB2.649.573.575 XSDIDELPHIS LH LS  MSAn infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. PM87 HN87 MHÑOpportunistic Infections AN╥an infect caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression╙; coord IM with specific infect (IM) PIAcquired Immunodeficiency Syndrome (83-86); Bacterial Infections (72-86); Infection (66-86); specific infection (66-86) MNC1.539.597; C2.597; C3.684 LH  PM65 HN65(64) MHÑOpsonins ANonly /admin /anal /biosyn /csf /class /genet /immunol /isol /physiol /urine MND12.776.124.486.657; D24.611.125.767 FXÑPHAGOCYTOSIS LH LX  MHÑOptic Atrophy AN= atrophy of optic nerve MNC10.772.204.576; C11.640.451 LH  PM66 HN66(64) MHÑOptic Chiasm ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.668.576 LH  MSThe portion of the optic nerve seen in the fundus with the ophthalmoscope, which is formed by the meeting of all the retinal nerve fibers. PM78; was see under OPTIC NERVE 1975-77 HN78(75); was see under OPTIC NERVE 1975-77 MHÑOptic Disk ANdo not use /innerv; swelling or edema of optic papilla = PAPILLEDEMA; neopl: coord IM with EYE NEOPLASMS (IM) + histol type of neopl (IM); optic nerve head goes here; do not confuse ╥optic cup╙ ( = EYE /embryol) with ╥optic disk cupping╙ ( = OPTIC DISK + GLAUCOMA) MNA8.796.214.668.650; A9.371.729.690 XSBlind Spot; Optic Papilla LH LS;  PM70 HN70(64) MHÑOptic Lobe ANdo not use /innerv MNA8.186.211.132.659.237.576; A13.686 XSCorpora Bigemina LH LS  MHÑOptic Nerve AN2d cranial nerve; do not use /innerv; neopl: coord OPTIC NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM); atrophy = OPTIC ATROPHY; neuritis = OPTIC NEURITIS; optic nerve head = OPTIC DISK MNA8.796.214.668 LH  MSDiseases of the optic nerve. PM76 HN76; was NON MESH before 1976 MHÑOptic Nerve Diseases ANSMON: see note on OPTIC NEURITIS; inflamm dis = OPTIC NEURITIS PIOptic Nerve (66-75); specific optic nerve disease heading MNC11.640 LH  MHÑOptic Neuritis AN= neuritis of optic nerve; SMON (Subacute Myelo-Optico-Neuropathy) is indexed here + MYELITIS + SYNDROME; retrobulbar neuritis goes here MNC10.772.204.638; C10.772.582.451; C11.640.576 LH  MSAn illusion of vision usually affecting spatial relations. OLsearch ILLUSIONS 1966-74 HN(75) MHÑOptical Illusions ANonly /drug eff /physiol /rad eff MNF2.463.593.446.659 DMÑIllusions LH LM  PM74 HN74(71) MHÑOptical Rotation ANNIM; no qualif PIChemistry, Physical (66-70) MNH1.671.606.714 LH  MSThe method of measuring the dispersion of an optically active molecule to determine the relative magnitude of right- or left-handed components and sometimes structural features of the molecule. PM70 HN70(68) MHÑOptical Rotatory Dispersion ANNIM; only /instrum /methods PISpectrum Analysis (66-67) MNE5.196.867.576; H1.181.278.862.576 LH  MHÑOptics ANonly /hist /instrum MNH1.671.606 FXÑLENSES; ÑVISION LH LX;  MSMeasurement of visual refractive power and the correction of visual defects with lenses or glasses. MHÑOptometry ANSPEC: SPEC qualif MNG2.553 LH  MSA pattern of personal traits determined by drives originating in the oral stage of psychosexual development. OLsearch PSYCHOANALYTIC THEORY 1968-74 HN(75) MHÑOral Character ANno qualif MNF2.739.794.684 DMÑPsychoanalytic Theory LH LM  MSThe normal functioning of the contents of the mouth without evidence of disease. PM65; DENTAL HYGIENE was heading 1963-64 HN65; DENTAL HYGIENE was heading 1963-64 MHÑOral Health ANdifferentiate from ORAL HYGIENE; oral health is the state of health of the mouth, good or bad; only /stand MNN1.407.540.576 FXÑDental Clinics; ÑDental Health Surveys; ÑDiagnosis, Oral; ÑMOUTH DISEASES; ÑMOUTH REHABILITATION; ÑMouth Diseases LH LX; ; ; ; ;  PM73; DENTAL HYGIENE was heading 1963-64 HN73; DENTAL HYGIENE was heading 1963-64 MHÑOral Hygiene ANdifferentiate from ORAL HEALTH; oral hyg is care by the person himself for maintaining good oral health (brushing, water-pick, floss, etc.); only /instrum /methods /stand /trends; differentiate also from DENTAL CARE, care by professionals PIOral Health (66-72) MNE6.761.726 FXÑDental Devices, Home Care LH LX  MSA combination of the debris index and the dental calculus index to determine the status of oral hygiene. OLsearch DENTAL HEALTH SURVEYS 1973-74 HN(75) MHÑOral Hygiene Index ANno qualif; specify geog MNE6.208.576; G3.890.160.168; N1.224.458.251.576 DMÑDental Health Surveys LH LM  MSDisorders of the mouth attendant upon systemic, non-oral disease. PM65 HN65 MHÑOral Manifestations ANoral manifest of non-oral disease; avoid: prefer more specific oral dis term; no qualif; Manual 23.36+; TN 239: differentiation from MOUTH DISEASES & when not to use MNC7.465.634; C23.888.636 LH  MSThe earliest of the stages of infantile psychosexual development, lasting from birth to 12 months or longer. OLsearch PSYCHOSEXUAL DEVELOPMENT 1968-74 HN(75) MHÑOral Stage ANno qualif MNF1.752.747.722.626; F2.739.794.793.626 XSOral Erotic Stage; Oral Sadistic Stage DMÑPsychosexual Development LH LS; LM  HN(68) MHÑOral Submucous Fibrosis PIMouth Diseases (66-67) MNC7.465.654 DMÑMouth Diseases LH LM  MHÑOrbit ANbony cavity & its contents except eyeball ( = EYE or specifics) MNA2.835.232.781.324.690 LH  MSDiseases of the bony orbit and contents except the eyeball. PM81 HN81 MHÑOrbital Diseases ANdis of bony cavity & its contents except eyeball ( = EYE DISEASES or specifics) PIEye Diseases (66-80); Orbit (66-80) MNC11.675 LH  MSFractures of the bones in the orbit, which include parts of the frontal, ethmoidal, lacrimal, and sphenoid bones and the maxilla and zygoma. HN(83) MHÑOrbital Fractures ANblow-out fract goes here; ZYGOMATIC FRACTURES & MAXILLARY FRACTURES are also available PIFractures (66-82); Orbit (66-82); Skull Fractures (66-82) MNC21.866.405.762.684 DMÑSkull Fractures LH LM  MSNeoplasms of the bony orbit and contents except the eyeball. MHÑOrbital Neoplasms ANneopl of bony cavity & its contents except eyeball ( = EYE NEOPLASMS or specifics); /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.149.721.656; C11.675.659 LH  MSThe surgical removal of one or both testicles. PM86 HN86 MHÑOrchiectomy ANdo not use /util except by MeSH definition; check tags MALE & ANIMAL or HUMAN PICastration (66-85) MNE4.779.282.679; E4.887.165.679; E4.887.679 XSCastration, Male; Orchidectomy FXÑTestis LH LS; LX  MHÑOrchitis MNC12.294.829.493 LH  PM72 HN72(65) MHÑOrciprenaline ANdo not use /biosyn /defic /physiol RN586-06-1 MND16.116.658; D16.893.116.348.701 XSMetaproterenol LH LS  MHÑOregon MNZ1.107.567.875.683 LH  MSA virus which causes a skin infection in natural hosts, usually young sheep, although man may contract local skin lesions by contact; the virus apparently persists in soil. HN(75); was see under POXVIRUSES 1975-80 MHÑOrf Virus ANdo not use /blood-csf-urine /cytol; infection = ORF MNB4.909.204.783.600 XSContagious Ecthyma Virus of Sheep; Contagious Pustular Dermatitis Virus of Sheep; Ecthyma Contagiosum Virus DMÑPoxviridae LH LS; ; LM  PM72 HN72(69) MHÑOrgan Culture ANNIM; only /instrum /methods; TN 35, TN 183: do not confuse with CELLS, CULTURED or TISSUE CULTURE PITissue Culture (66-68) MNE5.909.813.576 LH  PM68 HN68(65) MHÑOrgan of Corti ANdo not use /innerv MNA8.796.511.725.514; A9.246.631.246.577 XSCORTI'S ORGAN; SPIRAL ORGAN XUÑLabyrinth Supporting Cells LH LS; LU  OLsearch TISSUE PRESERVATION 1969-74 PM84; was see under TISSUE PRESERVATION 1970-83 HN84(75); was see under TISSUE PRESERVATION 1969-83 MHÑOrgan Preservation ANonly /instrum /methods /vet; cryopreservation of organ: coord IM with organ (IM with no qualif) + FREEZING (NIM) MNE5.760.833.660 LH  MSThe obtaining of organs for transplantation which includes methods of obtaining through programs, systems, or organizations. PM87 HN87 MHÑOrgan Procurement ANonly /econ /legis /methods /organ /stand /trends PITissue Donors (66-86) MNN2.421.559 XSOrgan Procurement Foundations; Organ Procurement Systems; Tissue Procurement FXÑTissue Donors LH LS; ; LX  MSRestriction of a characteristic or response to a particular organ of the body; it usually refers to that property of the immune response which differentiates one organ from another on the basis of antigen recognition, but the concept is not limited to immunology. PM67 HN67(64) MHÑOrgan Specificity ANIM GEN only; coord NIM with specific organ (IM); only /drug eff /rad eff; ╥tissue specificity╙ goes here if reasonable (i.e., liver tissue specificity = LIVER + ORGAN SPECIFICITY but connective tissue specificity is not CONNECTIVE TISSUE + ORGAN SPECIFICITY) MNG4.610.106.493 LH  PM66 HN66(65) MHÑOrgan Weight ANalmost never IM; note category: only /drug eff /rad eff; coord NIM with organ /anat (IM) (or /growth if pertinent) or disease /pathol (IM) MNE5.118.715; G7.553.481.690 LH  MH*Organic Chemicals (Non Mesh) MND2 LH  MSMental disorders associated with or caused by disturbance in the physiologic functioning of brain tissue without evidence of psychosis. OLto search NONPSYCHOTIC ORGANIC BRAIN SYNDROME use ORGANIC MENTAL DISORDERS back thru 1975 & MENTAL DISORDERS 1969-74 PM81; was NONPSYCHOTIC ORGANIC BRAIN SYNDROME see under MENTAL DISORDERS 1969-80 HN81; was NONPSYCHOTIC ORGANIC BRAIN SYNDROME see under MENTAL DISORDERS 1969-80 MHÑOrganic Mental Disorders ANdo not use /drug eff /physiol /rad eff; /chem ind = ORGANIC MENTAL DISORDERS, SUBSTANCE-INDUCED MNF3.709.508 XSMental Disorders, Organic; Organic Brain Syndrome, Nonpsychotic LH LS;  MSPsychotic manifestations associated with or resulting from a demonstrable physical disturbance of brain function such as tremor, infection, or injury. OLuse ORGANIC MENTAL DISORDERS, PSYCHOTIC to search PSYCHOSES, ORGANIC back thru 1969 & PSYCHOSES, TRAUMATIC back thru 1966 PM81; was PSYCHOSES, ORGANIC 1969-80; PSYCHOSES, TRAUMATIC was heading 1963-78 HN81; was PSYCHOSES, ORGANIC 1969-80; PSYCHOSES, TRAUMATIC was heading 1963-78 MHÑOrganic Mental Disorders, Psychotic ANpsychoses caused by brain dis, inj, infect, neopl; do not use /drug eff /physiol /rad eff PIPsychotic Disorders (66-68); specific disorder MNF3.709.680.610 XSClerambault Syndrome; Hallucinosis, Organic; Kandinsky Syndrome; Mental Disorders, Organic, Psychotic; Organic Brain Syndrome, Psychotic; Organic Hallucinosis; Psychoses, Organic; Psychoses, Traumatic FXÑBrain Diseases LH LS; ; ; ; ; ; ; LX  MSOrganic brain syndromes caused by the direct effects on the nervous system of various substances. These are distinguished from the substance use disorders that refer to the behavior associated with taking substances that affect the central nervous system. OLdo not search short forms ORGANIC MENTAL DIS SUBSTANCE INDUCED or ORGANIC MENTAL DISORDERS SUBSTANCE IND but short form ORGANIC MENTAL DIS SUBSTANCE IND permitted PM81 HN81 MHÑOrganic Mental Disorders, Substance-Induced ANdo not use /chem ind /drug eff /physiol /rad eff; coord IM with toxic substance /ad-poi/tox (IM) MNF3.709.508.490 XSMental Disorders, Organic, Substance-Induced; Organic Brain Syndrome, Substance-Induced; Organic Mental Disorders, Drug-Induced LH LS; ;  MSThe planning and managing of programs, services and resources. OLuse ORGANIZATION AND ADMINISTRATION to search ADMINISTRATIVE MANAGEMENT back thru l966; pre-explosion = ORGANIZATION AD ADMINISTRATION (PX) PM68; was ADMINISTRATIVE MANAGEMENT 1963-67 HN68; was ADMINISTRATIVE MANAGEMENT 1963-67 MHÑOrganization and Administration ANGEN only: prefer /organ: Manual 19.5+; almost never IM; only /econ /stand; DF: ORGAN ADMIN but do not confuse with ORGAN for ORGANIZATIONS MNN4.452 XSADMINISTRATION XUÑAnnual Reports; ÑConstitution and Bylaws; ÑInstitutional Management Teams; ÑManagement Audit; ÑOrganizational Innovation; ÑOrganizational Objectives LH LS LU; ; ; ; ;  MSFormal relationships established between otherwise independent organizations; includes affiliation agreements, interlocking boards, common controls, hospital medical school affiliations, etc. PM68 HN68 MHÑOrganizational Affiliation ANonly /econ /legis /trends PIspecific organization MNN4.452.602 LH  MSIntroduction of changes which are new to the organization and are created by management. HN(82) MHÑOrganizational Innovation ANNIM; coord with specific organiz (IM); only /econ; DF: ORGAN INNOVATION MNN4.452.610 XSOrganizational Change DMÑOrganization and Administration LH LS LM  MSThe purposes, missions, and goals of an individual organization or its units, established through administrative processes. Includes an organization's long-range plans and administrative philosophy. HN(82) MHÑOrganizational Objectives ANNIM; coord with specific organiz (IM); only /econ; DF: ORGAN OBJECTIVES MNN4.452.615 XSGoals, Organizational DMÑOrganization and Administration LH LS LM  MSAdministration and functional structures for the purpose of collectively systematizing activities for a particular goal. PM68 HN68 MHÑOrganizations ANonly /class /econ /hist /legis /stand /trends; has a limited use since there are other more specific terms available; read notes under SOCIETIES, SOCIETIES, MEDICAL & SOCIETIES, SCIENTIFIC for likely exclusions: ORGANIZATIONS tends to be for groups with a common goal based on interest, SOCIETIES tends to be for groups with common educ or professional status: TN 174; policy: Manual 35.11; specify geog: Manual 36.15; DF: ORGAN but do not confuse with ORGAN ADMIN for ORGANIZATION AND ADMINISTRATION CATALOG: /geog /form PIspecific organization MNN3.540 XUÑNational Academy of Sciences (U.S.) LH LU  MSOrganizations which are not operated for a profit and may be supported by endowments or private contributions. PM82 HN82 MHÑOrganizations, Nonprofit ANonly /class /econ /hist /legis /stand /trends MNN3.540.630 XSNonprofit Organizations LH LS  MSThose organ-like components of a cell which perform some individual function. Among these are the mitochondria, Golgi Apparatus, fibrils, endoplasmic reticulum and lysosomes. PM65; VACUOLES was see under CELLULAR INCLUSIONS 1974-76, was see under CYTOPLASM 1966-73 HN65 MHÑOrganoids ANA 11 qualif except /cytol; /class permitted; intracellular organelles go here MNA11.368.702 FXÑCell Compartmentation XUÑVacuoles LH LX LU  MSOrganic compounds which contain mercury as an integral part of the molecule. PM77 HN77 MHÑOrganomercury Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ORGANOMERCURY CPDS PIMercury (68-76); Organometallic Compounds (68-76) MND2.691.750 LH  PM68 HN68 MHÑOrganometallic Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ORGANOMETALLIC CPDS MND2.691 XSMetallo-Organic Compounds FXÑDiuretics, Mercurial XUÑTetraethyl Lead LH LS LX LU  PM72; PHOSPHORIC ACID ESTERS was see under PHOSPHORIC ACIDS 1968-71; PYROPHOSPHORIC ACID ESTERS was see under PYROPHOSPHORIC ACIDS 1968-74 HN72(71) MHÑOrganophosphorus Compounds ANincludes organophosphates, organopyrophosphorus cpds or organopyrophosphates; do not use /analogs /biosyn /defic /physiol; /antag permitted but consider also CHOLINESTERASE REACTIVATORS; DF: ORGANOPHOSPHORUS CPDS PIPhosphates (66-70); Phosphonic Acids (66-70); Phosphoric Acids (68-70); Phosphorous Acids (68-70); Phosphorus (66-70) MND2.705 XSPhosphates, Organic FXÑINSECTICIDES, ORGANOPHOSPHATE XUÑAminoethylphosphonic Acid; ÑArmin; ÑHempa; ÑPhosphonoacetic Acid; ÑPhosphoric Acid Esters; ÑSarin; ÑTetraisopropylpyrophosphamide LH LS LX LU; ; ; ; ; ;  MSOrganic compounds which contain platinum as an integral part of the molecule. PM78 HN78 MHÑOrganoplatinum Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ORGANOPLATINUM CPDS PIOrganometallic Compounds (68-77); Platinum (66-77) MND2.691.800 LH  MHÑOrganotherapy ANdo not use /util except by MeSH definition MNE2.95.682 LH  PM72 HN72(71) MHÑOrganothiophosphorus Compounds ANincludes organothiophosphates; do not use /analogs /biosyn /defic /physiol; /antag permitted but consider also CHOLINESTERASE REACTIVATORS; DF: ORGANOTHIOPHOSPHORUS CPDS PIPhosphates (66-70); Phosphonic Acids (66-70); Phosphoric Acids (68-70); Phosphorous Acids (68-70); Phosphorus (66-70) MND2.719 FXÑINSECTICIDES, ORGANOTHIOPHOSPHATE XUÑCystaphos; ÑEthiofos; ÑThiophosphoric Acid Esters LH LX LU; ;  MSOrganic compounds which contain tin in the molecule. Used widely in industry and agriculture. PM75 HN75 MHÑOrganotin Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: ORGANOTIN CPDS PIOrganometallic Compounds (74); Tin (74) MND2.691.850 LH  MSThe crisis of sexual excitement in either humans or animals. PM69 HN69 MHÑOrgasm ANonly /drug eff /physiol /rad eff MNF1.145.792.659; G8.520.900.400 LH  MSAwareness of oneself in relation to time, place and person. MHÑOrientation ANhuman & animal; only /drug eff /physiol /rad eff MNF1.58.577; F2.830.606 XUÑEcholocation; ÑKinesis LH LU;  MSalpha-Chloromethyl-2-methyl-5-nitro-1-imidazole ethanol. Nitroimidazole antiprotozoal agent used in ameba and trichomonas infections; it is partially plasma bound; also has radiation-sensitizing action. Synonyms: Tiberal. OLuse ORNIDAZOLE to search RO 7-0207 back thru 1975 HN(81); was RO 7-0207 see under NITROIMIDAZOLES 1975-80 MHÑOrnidazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN16773-42-5 PIAlcohol, Propyl (66-74); Imidazoles (66-73); Nitroimidazoles (74) MND2.640.672.700; D3.383.374.658.700; D21.370.107.675; D21.370.370.695 XSRO 7-0207 DMÑNitroimidazoles LH LS LM  MS8-L-Ornithine vasopressin. Synthetic analog of vasopressin with ornithine in position 8 of the cyclic octapeptide chain; used as local vasoconstrictor and hemostatic. Synonyms: Haesandon; POR 8. HN(79) MHÑOrnipressin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3397-23-7 PIOrnithine (66-78); Vasopressins (66-78) MND6.472.734.692.781.700; D12.644.456.925.700; D18.793.670; D19.770.896.670 XSOrnithine Vasopressin; Orpressin; Vasopressin, Ornithine DMÑVasopressins LH LS; ; LM  MHÑOrnithine RN7006-33-9 MND12.125.95.765 LH  MSOrnithine:2-oxo-acid aminotransferase. A pyridoxal phosphate enzyme which catalyzes the formation of glutamate gamma-semialdehyde and an L-amino acid from L-ornithine and a 2-keto-acid. HN(75) MHÑOrnithine Aminotransferase ANdo not use /analogs RNEC 2.6.1.13 PIAminotransferases (69-74); Ornithine (69-74) MND8.586.913.140.700 XSOrnithine Transaminase DMÑAminotransferases LH LS LM  PM65 HN65(64) MHÑOrnithine Carbamoyltransferase ANdo not use /analogs; /defic: consider also AMMONIA /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 2.1.3.3 MND8.586.913.593 LH  MSL-Ornithine carboxy-lyase. A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. Catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. PM84; was see under CARBOXY-LYASES 1975-83 HN84(75); was see under CARBOXY-LYASES 1975-83 MHÑOrnithine Decarboxylase ANdo not use /analogs RNEC 4.1.1.17 PICarboxy-Lyases (72-74); Ornithine (72-74) MND8.586.520.258.520 XSOrnithine Carboxy-lyase LH LS  MHÑOrnithosis MNC1.850.200.195.675 XSPSITTACOSIS LH LS  PM67 HN67 MHÑOroantral Fistula ANfistula policy: Manual 23.25+ PIFistula (66) MNC7.465.187.577 FXÑFistula LH LX  MSTwo syndromes of oral, facial and digital malformations. Type I (Papillon-Leage and Psaume syndrome, Gorlin-Psaume syndrome) is inherited as an X-linked dominant trait and is found only in females and XXY males. Type II (Mohr syndrome) is inherited as an autosomal recessive trait. OLuse OROFACIODIGITAL SYNDROMES to search OROFACIODIGITAL SYNDROME back thru 1966 HN(79); was OROFACIODIGITAL SYNDROME see under ABNORMALITIES, MULTIPLE 1975-78, was OROFACIODIGITAL SYNDROME 1964-74 (Prov) MHÑOrofaciodigital Syndromes ANdo not use /congen /drug eff /physiol /rad eff MNC5.116.99.370.652; C16.131.77.677 XSGorlin-Psaume Syndrome; Mohr Syndrome; Papillon-Leage and Psaume Syndrome DMÑAbnormalities, Multiple LH LS; ; LM  HN(85) MHÑOropharyngeal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PIOropharynx (79-84); Pharyngeal Neoplasms (66-84) MNC4.588.443.665.710.684; C9.775.549.685 DMÑPharyngeal Neoplasms LH LM  MSOral part of the pharynx. PM79 HN79 MHÑOropharynx ANinflammation: index under PHARYNGITIS & do not bother to coord with OROPHARYNX (NIM) unless particularly discussed PIPharynx (66-78) MNA14.724.603 LH  PM74 HN74 MHÑOrosomucoid ANdo not use /blood MND12.776.124.50.600; D12.776.124.790.106.640; D12.776.377.715.85.640; D12.776.395.560.742 XSACID SEROMUCOID; Alpha 1-Acid Glycoprotein; Alpha 1-Acid Seromucoid; Seromucoid; Serum Sialomucin LH LS; ; ; ;  MSOrotidine-5'-phosphate:pyrophosphate phosphoribosyltransferase. In the course of the pyrimidine nucleotide biosynthesis, this enzyme catalyzes the formation of orotidine 5'-phosphoric acid (orotidylic acid) from orotic acid and 5-phosphoribosyl-1-pyrophosphate. EC 2.4.2.10. HN(77) MHÑOrotate Phosphoribosyltransferase ANdo not use /analogs; /defic: consider also OROTIC ACID /urine (IM) + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS (IM) RNEC 2.4.2.10 PIPentosyltransferases (72-76); Pyrimidine Nucleotides (72-74); Ribonucleotides (72-74); Uracil Nucleotides (75-76) MND8.586.913.647.620 XSOrotidine-5'-Phosphate Pyrophosphorylase; Orotidylic Acid Phosphorylase DMÑPentosyltransferases LH LS; LM  MHÑOrotic Acid ANdo not use /defic /physiol RN65-86-1 MND3.66.627; D3.383.742.698.875.660 LH  MSOrotidine-5'-phosphate carboxy-lyase. Catalyzes the decarboxylation of orotidylic acid to yield uridylic acid in the final step of the pyrimidine nucleotide biosynthesis pathway. EC 4.1.1.23. HN(77) MHÑOrotidine-5'-Phosphate Decarboxylase ANdo not use /analogs; /defic: consider also OROTIC ACID /urine (IM) + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS (IM) RNEC 4.1.1.23 PICarboxy-Lyases (66-76); Pyrimidine Nucleotides (73-74); Ribonucleotides (73-74); Uracil Nucleotides (75-76) MND8.586.520.258.540 XSOrotidine Phosphate Carboxy-Lyase; Orotidylate Decarboxylase DMÑCarboxy-Lyases LH LS; LM  MSProduction of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others. HN(85) MHÑOrphan Drug Production ANonly /econ /hist /man /stand PIDrug Industry (66-84); Drugs (66-84); Legislation, Drug (68-84); Legislation, Medical (66-67) MNJ1.576.318.600 DMÑDrug Industry LH LM  MHÑOrphenadrine ANdo not use /biosyn /defic /physiol RN83-98-7 MND2.92.471.600; D2.455.426.559.389.115.600; D16.653.672; D17.426.660 XSMethyldiphenylhydramine LH LS  PM65 HN65 MHÑOrthodontic Appliances ANdo not use /instrum /methods /util (except by MeSH definition) MNE6.658.453 FXÑBonding, Dental XUÑOrthodontic Wires LH LX LU  PM73 HN73(71) MHÑOrthodontic Appliances, Removable ANdo not use /instrum /methods /util (except by MeSH definition) PIOrthodontic Appliances (66-70) MNE6.658.453.578 XUÑActivator Appliances; ÑExtraoral Traction Appliances LH LU;  MSWires of various dimensions and grades made of stainless steel or precious metal. Used in orthodontic treatment. HN(82) MHÑOrthodontic Wires ANdo not use /instrum /methods /util (except by MeSH definition) PIOrthodontic Appliances (66-81) MNE6.658.453.684 DMÑOrthodontic Appliances LH LM  MSA dental specialty concerned with the prevention and correction of dental and oral anomalies (malocclusion). MHÑOrthodontics ANSPEC: SPEC qualif; orthopedie dento-faciale in French titles is translated ╥orthodontics╙ & indexed here MNE6.658; G2.163.876.439 LH  PM65 HN65 MHÑOrthodontics, Corrective ANdo not use /util except by MeSH definition MNE6.658.578 FXÑMalocclusion LH LX  MSRecognition and elimination of potential irregularities and malpositions in the developing dentofacial complex. PM75 HN75 MHÑOrthodontics, Interceptive ANdo not use /util except by MeSH definition PIOrthodontics, Preventive (66-74) MNE6.658.641 LH  PM65 HN65 MHÑOrthodontics, Preventive ANdo not use /util except by MeSH definition MNE6.658.703 LH  MSThe use of very large doses of vitamins or other naturally occurring substances normally present in the body, frequently used in treatment of mental disorders. PM77 HN77 MHÑOrthomolecular Therapy ANSPEC qualif; /adv eff permitted PIAscorbic Acid (74-76); Vitamins (74-76) MNE2.319.630; F4.881.400 XSMegavitamin Therapy LH LS  MSA group of RNA viruses causing influenza. OLuse ORTHOMYXOVIRIDAE to search ORTHOMYXOVIRUSES INFLUENZA VIRUSES, MYXOVIRUSES & MYXOVIRUS back thru 1966 PM81; was ORTHOMYXOVIRUSES 1977-80 was INFLUENZA VIRUSES 1963-76, was MYXOVIRUSES 1975-76, was MYXOVIRUS 1963-74 HN81; was ORTHOMYXOVIRUSES 1977-80 was INFLUENZA VIRUSES 1963-76, was MYXOVIRUSES 1975-76, was MYXOVIRUS 1963-74 MHÑOrthomyxoviridae ANdo not use /blood-csf-urine /cytol; infection = ORTHOMYXOVIRUS INFECTIONS but consider also INFLUENZA (for human) & FOWL PLAGUE (for birds) MNB4.909.777.545 XSInfluenza Viruses; Myxoviruses XUÑOrthomyxoviruses Type C LH LS; LU  MSInfections with orthomyxoviruses. OLuse ORTHOMYXOVIRUS INFECTIONS to search MYXOVIRUS INFECTIONS back thru 1966 PM77; was MYXOVIRUS INFECTIONS 1963-76 HN77; was MYXOVIRUS INFECTIONS 1963-76 MHÑOrthomyxovirus Infections MNC2.782.620 LH  MSA species of Orthomyxoviridae causing influenza in birds. OLuse ORTHOMYXOVIRUS TYPE A, AVIAN to search FOWL PLAGUE VIRUS back thru 1966 PM77; was FOWL PLAGUE VIRUS 1963-76 HN77; was FOWL PLAGUE VIRUS 1963-76 MHÑOrthomyxovirus Type A, Avian ANdo not use /blood-csf-urine /cytol; infection = FOWL PLAGUE MNB4.909.777.545.650.640 XSFowl Plague Virus; Myxovirus Pestis-Galli LH LS;  MSAn etiologic agent of influenza and sometimes pneumonia in man. PM77; was see under INFLUENZA VIRUSES 1975-76 HN77(75); was see under INFLUENZA VIRUSES 1975-76 MHÑOrthomyxovirus Type A, Human ANdo not use /blood-csf-urine /cytol; infection = INFLUENZA PIOrthomyxoviridae (68-74) MNB4.909.777.545.650.660 XSInfluenza Virus Type A, Human; Myxovirus influenzae-A hominis LH LS;  MSA virus causing influenza and pneumonia in domestic pigs. OLuse ORTHOMYXOVIRUS TYPE A, PORCINE to search ORTHOMYXOVIRUS TYPE A, SWINE back thru 1975 HN(77); was ORTHOMYXOVIRUS TYPE A, SWINE see under INFLUENZA VIRUSES 1975-76 MHÑOrthomyxovirus Type A, Porcine ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ORTHOMYXOVIRUS INFECTIONS (IM) MNB4.909.777.545.650.680 XSInfluenza Virus, Porcine; Myxovirus influenzae-A suis; Porcine Influenza Virus Type A; Swine Influenza Virus DMÑOrthomyxoviruses Type A LH LS; ; ; LM  MSA type of Orthomyxoviridae. OLto search EQUINE INFLUENZA VIRUS use ORTHOMYXOVIRUSES TYPE A back thru 1980 & INFECTIOUS ARTERITIS VIRUS, EQUINE 1975-79 PM77; EQUINE INFLUENZA VIRUS was see INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-79; ORTHOMYXOVIRUS TYPE A, PORCINE was ORTHOMYXOVIRUS TYPE A, SWINE see under INFLUENZA VIRUSES 1975-76 HN77; EQUINE INFLUENZA VIRUS was see INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-79 MHÑOrthomyxoviruses Type A ANdo not use /blood-csf-urine /cytol; note specifics above; infection = ORTHOMYXOVIRUS INFECTIONS but consider also INFLUENZA (for human) & FOWL PLAGUE (for birds) PIOrthomyxoviridae (68-76) MNB4.909.777.545.650 XSEquine Influenza Virus; Influenza Viruses Type A XUÑOrthomyxovirus Type A, Porcine LH LS; LU  MSOrthomyxoviridae with distinct antigenic properties; they cause influenza and pneumonia. Epidemics are less likely than with type A and there have been no pandemics. PM85 HN85 MHÑOrthomyxoviruses Type B ANdo not use /blood-csf-urine /cytol; infection = ORTHOMYXOVIRUS INFECTIONS but consider also INFLUENZA PIOrthomyxoviridae (81-84) MNB4.909.777.545.690 XSInfluenza Viruses Type B LH LS  MSOrthomyxoviruses similar to Types A and B but less common, more stable, and more homogeneous. They have not been associated with epidemics but may cause mild influenza. HN(86) MHÑOrthomyxoviruses Type C ANdo not use /blood-csf-urine /cytol; infection = ORTHOMYXOVIRUS INFECTIONS but consider also INFLUENZA PIOrthomyxoviridae (81-85) MNB4.909.777.545.720 XSInfluenza Viruses Type C DMÑOrthomyxoviridae LH LS LM  MHÑOrthopedic Equipment ANdo not use /instrum /man /methods /util (except by MeSH definition) MNE7.858.442 XUÑCanes; ÑWalkers LH LU;  PM72 HN72(71) MHÑOrthopedic Fixation Devices ANdo not use /instrum /man /methods /util (except by MeSH definition); TN 124: /adv eff PIFracture Fixation/IS (66-70); Fracture Fixation, Intramedullary/IS (70); Orthopedic Equipment (66-70) MNE7.858.442.660 XUÑBone Wires LH LU  MSA surgical specialty which utilizes medical, surgical, and physical methods to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures. MHÑOrthopedics ANSPEC: SPEC qualif; /nurs permitted; /instrum = ORTHOPEDIC EQUIPMENT; IM as ╥orthopedic surgery╙: Manual 26.26; orthopedie dento-faciale in French titles is translated ╥orthodontics╙ & is indexed under ORTHODONTICS MNE4.557; G2.403.810.494 LH  MSThe study and treatment of human behavior problems utilizing principles derived from the behavioral, medical and social science with emphasis on promotion of mental health. PM74 HN74 MHÑOrthopsychiatry ANSPEC; SPEC qualif; MDs, psychologists, social workers, etc. MNF4.96.544.528 FXÑMENTAL HEALTH LH LX  MSAn order of insects consisting of several families and genera. The most commonly occurring families are: Acrididae (grasshoppers), Blattidae and Blatellidae (Oriental, American, and German COCKROACHES), and Gryllidae (crickets). OLuse ORTHOPTERA to search DICTYOPTERA back thru 1975 PM75; DICTYOPTERA was heading 1975-85 HN75; DICTYOPTERA was heading 1975-85 MHÑOrthoptera ANincludes LOCUSTS, crickets, GRASSHOPPERS, etc.; /microbiol /parasitol permitted PIInsects (66-74) MNB1.131.617.678 XSDictyoptera; Mantids; Praying Mantis XUÑGryllidae LH LS; ; LU  MSThe study and treatment of defects in binocular vision and the optic musculature or of faulty visual habits. MHÑOrthoptics ANSPEC: SPEC qualif; pleoptics goes here MNE2.730; G2.573 FXÑOphthalmology; ÑStrabismus LH LX;  MSApparatus used to support, align, prevent, or correct deformities or to improve the function of movable parts of the body. PM74 HN74(72) MHÑOrthotic Devices ANdo not use /instrum /man /methods /util; includes slings, BRACES, etc. PIOrthopedic Equipment (66-71) MNE7.858.442.743 XSOrthoses LH LS  MSA genus of Cyprinodontid fish which is an egg layer as opposed to others of the same order being livebearers; used extensively in testing carcinogens. HN(87) MHÑOryzias ANNIM when exper animal; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.280.608 XSMedaka DMÑCyprinodontiformes LH LS LM  MHÑOscillometry ANNIM; only /instrum /methods MNE5.654; H1.671.628 LH  MHÑOsmium ANOs-192; do not use /analogs /biosyn /defic /physiol; Os-184, 186-190, = OSMIUM (IM) + ISOTOPES (NIM); Os-181-183, 185, 191, 193-195 = OSMIUM (IM) + RADIOISOTOPES (IM) RN7440-04-2 MND1.268.622; D1.552.636 XUÑOsmium Tetroxide LH LU  MSVery toxic volatile oxide of osmium; used in industry as oxidizing agent; also as histological fixative and as synovectomy agent in arthritic joints; inhalation causes lung damage, vapor causes eye and skin damage. HN(79) MHÑOsmium Tetroxide ANdo not use /analogs /biosyn /defic /physiol RN20816-12-0 PIOsmium (66-78); Oxides (66-78) MND1.552.636.600 XSOsmic Acid DMÑOsmium LH LS LM  PM70 HN70(68) MHÑOsmolar Concentration ANNIM; no qualif; includes ╥ionic strength╙, ╥osmolality╙ PIOsmosis (66-67); Water-Electrolyte Balance (66-67) MNH1.181.529.623 XSOsmolarity FXÑDiuresis; ÑWater-Electrolyte Balance LH LS LX;  MHÑOsmosis ANNIM; only /drug eff /rad eff; osmotic shock: index under OSMOTIC PRESSURE MNG6.184.708; H1.181.529.687.495 LH  PM70 HN70(65) MHÑOsmotic Fragility ANNIM; only /drug eff /rad eff; do not coord with ERYTHROCYTES since this is defined in terms of erythrocytes MNE1.223.459.733; G9.188.702 XSSALINE FRAGILITY FXÑCell Membrane; ÑHemolysis LH LS LX;  PM74 HN74(68) MHÑOsmotic Pressure ANNIM; no qualif; osmotic shock goes here PIOsmosis (66-67) MNH1.181.529.687.661; H1.671.691.578 LH  MSAn implant use to replace one or more of the EAR OSSICLES. They are usually made of plastic (Plasti-Pore, Teflon), Gelfoam, ceramic, or stainless steel. PM87 HN87 MHÑOssicular Replacement Prosthesis ANdo not use /instrum /methods /util (except by MeSH definition) PIEar Ossicles (66-86); Prosthesis (66-86); Tympanoplasty (66-86) MNE4.659.700; E4.847.774.684; E7.450.684; E7.858.565.747 XSImplant, Middle Ear; Middle Ear Implant; PORP; Prosthesis, Ossicular; TORP LH LS; ; ; ;  MSThe development of bony substance in normally soft structures. PM65; OSSIFICATION was heading 1963-64 HN65; OSSIFICATION was heading 1963-64 MHÑOssification, Pathologic MNC23.739.686 FXÑSYNOSTOSIS LH LX  MHÑOsteitis ANalveolar osteitis = DRY SOCKET MNC5.116.165.412 LH  MHÑOsteitis Deformans MNC5.116.692; C23.205.692 XSPAGET'S DISEASE OF BONE LH LS  OLuse OSTEITIS FIBROSA CYSTICA to search OSTEITIS FIBROSA 1966 PM67; was OSTEITIS FIBROSA 1963-66 HN67; was OSTEITIS FIBROSA 1963-66 MHÑOsteitis Fibrosa Cystica MNC5.116.132.684 XSRECKLINGHAUSEN'S DISEASE OF BONE FXÑHyperparathyroidism LH LS LX  MHÑOsteoarthritis ANcheck text to see if ╥osteoarthrosis╙ goes here, otherwise index ╥osteoarthrosis╙ under BONE DISEASES + JOINT DISEASES; coxarthrosis = HIP JOINT (IM) + OSTEOARTHRITIS (IM) MNC5.550.114.606; C5.799.613 LH  PM65 HN65(64) MHÑOsteoarthropathy, Primary Hypertrophic MNC5.116.725; C5.550.648 XSPachydermoperiostosis LH LS  MHÑOsteoarthropathy, Secondary Hypertrophic MNC5.116.758; C5.550.684 XSCLUBBED FINGERS; MARIE-BAMBERGER DISEASE LH LS;  PM65 HN65(64) MHÑOsteoblasts ANA 11 qualif & /class MNA11.329.629 LH  OLuse OSTEOCHONDRITIS to search KIENBOECK'S DISEASE, KOEHLER'S DISEASE & OSGOOD-SCHLATTER DISEASE back thru 1966 HNKIENBOECK'S DISEASE, KOEHLER'S DISEASE & OSGOOD-SCHLATTER DISEASE were see under OSTEOCHONDRITIS 1963-78 MHÑOsteochondritis MNC5.116.791 XSKienboeck's Disease; Koehler's Disease; OSTEOCHONDROSIS; Osgood-Schlatter Disease FXÑCartilage Diseases XUÑOsteochondritis Dissecans LH LS; ; ; LX LU  MSA type of osteochondritis in which articular cartilage and associated bone becomes partially or totally detached to form joint loose bodies. Affects mainly the knee, ankle, and elbow joints. HN(85) MHÑOsteochondritis Dissecans PIOsteochondritis (66-84) MNC5.116.791.668 DMÑOsteochondritis LH LM  MSAbnormal development of cartilage and bone. OLuse OSTECHONDRODYSPLASIAS to search DYSCHONDROPLASIAS back thru 1966; to search SPONDYLOEPIPHYSEAL DYSPLASIA use OSTEOCHONDRODYSPLASIAS back thru 1985 & MUCOPOLYSACCHARIDOSIS 4 1968-84 PM85; DIAPHYSEAL DYSPLASIA, PROGRESSIVE was see under BONE DISEASES, DEVELOPMENTAL 1975-84; DYSCHONDROPLASIAS was heading DYSCHONDROPLASIA 1963-84; SPONDYLEPIPHYSEAL DYSPLASIA was see MUCOPOLYSACCHARIDOSIS 4 1980-84, was see ECCENTROOSTEOCHONDRODYSPLASIA 1968-79 HN85; DYSCHONDRODYSPLASIAS was heading DYSCHONDROPLASIA 1963-84; SPONDYLOEPIPHYSEAL DYSPLASIA was see MUCOPOLYSACCHARIDOSIS 4 1980-84, was see ECCENTROOSTEOCHONDRODYSPLASIA 1968-79 MHÑOsteochondrodysplasias PIBone Diseases (66-69); Bone Diseases, Developmental (70-84) MNC5.116.99.708 XSDyschondroplasias; Hyperostosis Corticalis Generalisata; Melnick-Needles Syndrome; Multiple Epiphyseal Dysplasia; Schwartz-Jampel Syndrome; Spondyloepiphyseal Dysplasia XUÑDiaphyseal Dysplasia, Progressive; ÑEnchondromatosis; ÑShort Rib-Polydactyly Syndrome; ÑThanatophoric Dysplasia LH LS; ; ; ; ; LU; ; ;  OLuse OSTEOCLASTS to search ODONTOCLASTS back thru 1966 PMODONTOCLASTS was heading 1965-77 HNODONTOCLASTS was heading 1965-77 MHÑOsteoclasts ANA 11 qualif & /class MNA11.329.679 XSOdontoclasts LH LS  PM65 HN65 MHÑOsteocytes ANA 11 qualif & /class MNA11.329.729 LH  MSThe histeogenesis of bone including ossification. It occurs continuously but particularly in the embryo and child and during fracture repair. OLuse OSTEOGENESIS to search OSSIFICATION, PHYSIOLOGIC back thru 1966 PM65; OSSIFICATION, PHYSIOLOGIC was heading 1965-84 HN65; OSSIFICATION, PHYSIOLOGIC was heading 1965-84 MHÑOsteogenesis ANonly /drug eff /rad eff; = histiogenesis of bone & ossification: do not confuse with BONE DEVELOPMENT ( = growth of bones & bone formation) MNG7.553.121.729; G11.427.111.729 XSOssification, Physiologic LH LS  MHÑOsteogenesis Imperfecta MNC5.116.99.708.685; C23.205.200.540 XSFRAGILITAS OSSIUM; LOBSTEIN'S DISEASE FXÑDentinogenesis Imperfecta LH LS; LX  OLsearch BONE RESORPTION 1966-74 PM87; was see under BONE RESORPTION 1966-86; OSTEOLYSIS, ESSENTIAL was see under BONE RESORPTION 1980-86, was see under BONE DISEASES 1967-79 HN87(75); was see under BONE RESORPTION 1966-86 MHÑOsteolysis ANonly Cat C qualif MNC5.116.264.579; G11.427.201.579 XUÑOsteolysis, Essential LH LU  MSSyndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive (Gorham disease), multicentric (Hajdu-Cheney syndrome, Winchester syndrome), or carpal/tarsal. HN(65); was see under BONE RESORPTION 1980-86, was see under BONE DISEASES 1967-79 MHÑOsteolysis, Essential AN╥cryptogenic osteolysis╙ & ╥disappearing bone╙ go here MNC5.116.99.736; C5.116.264.579.704 XSAcro-Osteolysis Syndromes; Gorham Disease; Hajdu-Cheney Syndrome; Osteolysis, Idiopathic Multicentric; Osteolysis, Massive DMÑOsteolysis LH LS; ; ; ; LM  MSTumor composed of bone tissue. MHÑOsteoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); osteoblastoclastoma: index under OSTEOMA, OSTEOID (IM) + GIANT CELL TUMORS (IM) + precoord organ/neopl term (IM) MNC4.557.499.714 LH  MSBenign circumscribed tumor of spongy bone occurring especially in the bones of the extremities and vertebrae, most often in young persons. MHÑOsteoma, Osteoid AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); osteoblastoclastoma: index here (IM) + GIANT CELL TUMORS (IM) + precoord organ/neopl term (IM) MNC4.557.499.714.579 XSGiant Osteoid Osteoma; Osteoblastoma LH LS;  MHÑOsteomalacia MNC5.116.198.495; C18.452.174.662; C18.654.223.133.770.496 LH  MHÑOsteomyelitis MNC5.116.165.495 LH  MSDeath of a bone or part of a bone either atraumatic or posttraumatic. PM77 HN77 MHÑOsteonecrosis ANOSTEORADIONECROSIS & FEMUR HEAD NECROSIS are available; aseptic or avascular necrosis of hip = FEMUR HEAD NECROSIS PIBone Diseases (66-76); Necrosis (66-76) MNC5.116.852; C23.739.638.732 XSNecrosis, Aseptic, of Bone; Necrosis, Avascular, of Bone LH LS;  MSA system of therapy and medicine based on the theory that the normal body is a vital mechanical organism whose structural and functional states are of equal importance and is capable of making its own remedies against infections and toxic conditions when there are favorable environmental circumstances and adequate nutrition. OLuse OSTEOPATHIC MEDICINE to search OSTEOPATHY back thru 1966 PM87; was OSTEOPATHY 1963-86 HN87; was OSTEOPATHY 1963-86 MHÑOsteopathic Medicine ANSPEC: SPEC qualif; OSTEOPATHY is not a substitute for BONE AND BONES /pathol; TN 143: do not confuse with BONE DISEASES MNG2.403.500 XSOsteopathy LH LS  MHÑOsteopetrosis MNC5.116.99.708.702.678 XSALBERS-SCHOENBERG DISEASE; OSTEOSCLEROSIS FRAGILIS LH LS;  HN(64); was see under BONE DISEASES 1967-69 MHÑOsteopoikilosis MNC5.116.99.708.702.685; C23.205.705 DMÑOsteosclerosis LH LM  MHÑOsteoporosis MNC5.116.198.579 XSBone Loss of Aging; Bone Loss, Perimenopausal; Bone Loss, Postmenopausal; Perimenopausal Bone Loss; Postmenopausal Bone Loss LH LS; ; ; ;  MSNecrosis of bone following radiation injury. HN(63) MHÑOsteoradionecrosis ANcoord IM with organ/dis (IM), not organ /inj MNC21.866.733.579 DMÑRadiation Injuries LH LM  PMOSTEOPOIKILOSIS was see under BONE DISEASES 1967-69 MHÑOsteosclerosis MNC5.116.99.708.702 XUÑOsteopoikilosis LH LU  PM65 HN65 MHÑOsteotomy ANdo not use /util except by MeSH definition MNE4.557.703 LH  MSA genus of parasitic nematodes occurring in the stomach of ruminants. PM86 HN86 MHÑOstertagia ANdo not use /blood-csf-urine; infection = OSTERTAGIASIS PITrichostrongyloidea (66-85) MNB1.500.294.746.432 LH  MSA disease of herbivorous mammals, particularly cattle and sheep, caused by stomach worms of the genus Ostertagia. OLsearch TRICHOSTRONGYLOIDIASIS 1968-74 HN(75) MHÑOstertagiasis MNC3.335.508.909.580 DMÑTrichostrongyloidiasis LH LM  MHÑOtitis ANGEN: note specifics below MNC9.218.705 LH  MHÑOtitis Externa MNC9.218.705.496 LH  OLuse OTITIS MEDIA to search GRADENIGO'S SYNDROME back thru 1966 HNGRADENIGO'S SYNDROME was see under OTITIS MEDIA 1963-81 MHÑOtitis Media ANnote XU below; nonsuppurative otitis media: index under OTITIS MEDIA WITH EFFUSION MNC9.218.705.663 XSGradenigo Syndrome XUÑOtitis Media, Suppurative LH LS LU  MSInflammation of the middle ear with a clear pale yellow-colored transudate. OLuse OTITIS MEDIA WITH EFFUSION to search OTITIS MEDIA, SEROUS back thru 1979 PM86; was OTITIS MEDIA, SEROUS see under OTITIS MEDIA 1979-85 HN86; was OTITIS MEDIA, SEROUS see under OTITIS MEDIA 1979-85 MHÑOtitis Media with Effusion ANalso called nonsuppurative otitis media PIOtitis Media (66-78) MNC9.218.705.663.683 XSOtitis Media, Secretory; Otitis Media, Serous LH LS;  MSInflammation of the middle ear with purulent discharge. HN(79) MHÑOtitis Media, Suppurative PIOtitis Media (66-78) MNC9.218.705.663.694 XSOtitis Media, Purulent DMÑOtitis Media LH LS LM  MSA surgical specialty concerned with the study and treatment of disorders of the ear, nose, and throat. OLuse OTOLARYNGOLOGY to search OTORHINOLARYNGOLOGY back thru 1966 PM80; was OTORHINOLARYNGOLOGY 1963-79 HN80; was OTORHINOLARYNGOLOGY 1963-79 MHÑOtolaryngology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of OTORHINOLARYNGOLOGIC DISEASES /form; do not use /radiogr (= OTORHINOLARYNGOLOGIC DISEASES /radiogr) /radionuclide ( = OTORHINOLARYNGOLOGIC DISEASES /radionuclide) /surg ( = OTORHINOLARYNGOLOGIC DISEASES /surg) MNG2.403.810.526 XSOtorhinolaryngology FXÑOTORHINOLARYNGOLOGIC DISEASES LH LS LX  MSA gelatinous membrane surmounting the acoustic maculae of the saccule and utricle and containing minute calciferous granules, known as otoconia, otoliths, or statoconia. HN(83) MHÑOtolithic Membrane PILabyrinth (66-82); Maculae, Acoustic (79-82); Saccule and Utricle (75-82) MNA9.246.631.800.576.680 XSOtoconia; Otoliths; Statoconia DMÑSaccule and Utricle LH LS; ; LM  MSGeneral or unspecified diseases of the ear, nose and throat. PM66 HN66 MHÑOtorhinolaryngologic Diseases ANGEN: prefer specific precoord; DF: ORL DIS CATALOG: form qualif = OTOLARYNGOLOGY /form; /radiogr /radionuclide /surg permitted MNC9 FXÑEar Diseases; ÑLaryngeal Diseases; ÑNose Diseases; ÑOtolaryngology; ÑPharyngeal Diseases LH LX; ; ; ;  MSUse for the general concept of ORL neoplasms or those for which no specific heading exists. PM84 HN84; was NON MESH before 1984 MHÑOtorhinolaryngologic Neoplasms ANGEN: prefer specific precoord; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); DF: ORL NEOPL PINeoplasms (66-83); Otorhinolaryngological Diseases (66-83) MNC4.588.443.665 LH  MHÑOtosclerosis MNC9.218.768 XSOtospongiosis FXÑFenestration; ÑSTAPES MOBILIZATION LH LS LX;  MSFish-eating mammals. HN(75) MHÑOtters ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.147.725 DMÑCarnivora LH LM  MS1 beta,3 beta,5,11 alpha,14,19-Hexahydroxy-5 beta-card-20(22)-enolide-3-L-rhamnoside. A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like digitalis. Synonyms: Gratibain; Astrobain; Purostrophan; Strophoperm. PM65; was see under STROPHANTHIN (now STROPHANTHINS) 1963-64 HN65(63); was see under STROPHANTHIN (now STROPHANTHINS) 1963-64 MHÑOuabain ANdo not use /defic /physiol RN630-60-4 MND4.808.155.160.861.600; D9.203.408.180.810.600; D18.222.175.810.580 XSAcocantherin; G-Strophanthin LH LS;  MSOutcome assessment is an evaluation procedure that focuses on the status of the patient at the end of an episode of care - presence of symptoms, level of activity and mortality. Process assessment evaluates what is done for the patient, diagnostically and therapeutically. PM79 HN79 MHÑOutcome and Process Assessment (Health Care) ANonly /econ /legis /methods /trends; X ref PATIENT OUTCOME ASSESSMENT is for admin aspects of patient assessment: do not use for outcome of therapy ( = probably PROGNOSIS): note category; DF: OUTCOME ASSESSMENT PIQuality of Health Care (68-78) MNN4.761.559 XSPatient Outcome Assessment; Process Assessment LH LS;  MSOrganized services in a hospital which provide medical care on an outpatient basis. OLuse OUTPATIENT CLINICS, HOSPITAL to search HOSPITAL OUTPATIENT CLINICS back thru 1968 & HOSPITAL OUTPATIENT SERVICE back thru 1966 PM78; was HOSPITAL OUTPATIENT CLINICS 1968-77, was HOSPITAL OUTPATIENT SERVICES 1963-67 HN78; was HOSPITAL OUTPATIENT CLINICS 1968-77, was HOSPITAL OUTPATIENT SERVICES 1963-67 MHÑOutpatient Clinics, Hospital ANonly /econ /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form MNN2.278.35.380; N2.278.354.422.527; N4.452.442.422.527 XSAmbulatory Care Facilities, Hospital; Hospital Outpatient Clinics FXÑAmbulatory Care LH LS; LX  MSPersons who receive ambulatory care at an outpatient department or clinic without room and board being provided. OLsearch AMBULATORY CARE 1978-79 HN(80); was see AMBULATORY CARE 1978-79 MHÑOutpatients ANonly /psychol; outpatients as people or as a social, sociol, psychol, etc., group; do not confuse the outpatient with the care given him ( = AMBULATORY CARE) PIAmbulatory Care (66-79) MNM1.643.630 DMÑPatients LH LM  MSFenestra of the vestibule; an oval opening in the medial wall of the middle ear leading into the vestibule. Normally it is covered by the base of the stapes. HN(79) MHÑOval Window ANdo not confuse with ROUND WINDOW in cochlea PIEar, Middle (66-78) MNA9.246.631.909.551 DMÑVestibular Apparatus LH LM  MHÑOvalbumin ANdo not use /defic /physiol; differentiate OVALBUMIN (the chemical albumin in egg white) from EGG WHITE (the food) RN9006-59-1 MND12.776.34.614; D12.776.256.317.663 FXÑEgg White LH LX  MSGeneral term for cysts and cystic diseases of the ovary. OLuse OVARIAN CYSTS to search CORPUS LUTEUM CYST back thru 1966 PM68; CORPUS LUTEUM CYST was heading 1963-84 HN68; CORPUS LUTEUM CYST was heading 1963-84 MHÑOvarian Cysts ANnon-neoplastic; polycystic ovarian disease, sclerocystic ovaries, sclerocystic ovarian degeneration & sclerocystic ovary syndrome = POLYCYSTIC OVARY SYNDROME PICysts (66-67); Ovarian Diseases (66-67) MNC4.182.612; C13.371.56.630.580 XSCorpus Luteum Cyst LH LS  PM66 HN66 MHÑOvarian Diseases ANinflamm dis = OOPHORITIS; sclerocystic ovarian degeneration & sclerocystic ovary syndrome = POLYCYSTIC OVARY SYNDROME MNC13.371.56.630 LH  MSMethods used for assessment of ovarian function. PM75 HN75 MHÑOvarian Function Tests ANNIM; only /instrum /methods /vet PIOvarian Diseases (66-74); Ovary (66-74) MNE1.197.530; E1.249.530 LH  MHÑOvarian Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); endodermal sinus tumor & yolk sac tumor = OVARIAN NEOPLASMS (IM) + MESONEPHROMA (IM) MNC4.588.322.455; C4.588.945.418.685; C13.371.56.630.705 LH  MSThe surgical removal of one or both ovaries. PM86 HN86 MHÑOvariectomy ANdo not use /util except by MeSH definition; check tags FEMALE & ANIMAL or HUMAN PICastration (66-85) MNE4.779.282.685; E4.819.608.685; E4.887.165.685; E4.887.685 XSCastration, Female; Oophorectomy FXÑOvary LH LS; LX  MSEither of the paired glands in the female that produce the female germ cells and secrete some of the female sex hormones. MHÑOvary AN/surg permitted but is probably OVARIECTOMY; /abnorm: agenesis or dysgenesis: coord OVARY /abnorm (IM) with GONADAL DYSGENESIS (IM); /cytol: consider also THECA CELLS; inflammation = OOPHORITIS; polycystic ovary, sclerocystic ovary = POLYCYSTIC OVARY SYNDROME MNA5.360.319.114.630; A5.360.576.497; A6.407.312.497 FXÑOvariectomy LH LX  MSA scale comprised of 16 relatively independent symptom areas to provide rapid assessment of change in primarily schizophrenic hospitalized patients. OLsearch PSYCHIATRIC STATUS RATING SCALES 1969-74 HN(75) MHÑOverall and Gorham Brief Psychiatric Rating Scale ANno qualif; DF: OVERALL GORHAM MNF4.586.704 DMÑPsychiatric Status Rating Scales LH LM  MSA cognitive disorder in which conceptual boundaries are not preserved, and irrelevant or distantly associated elements become part of the concept, making thought more abstract and disconnected. HN(72) MHÑOverinclusion ANno qualif PICognition Disorders (69-71) MNF3.126.185.690 DMÑCognition Disorders LH LM  MSLearning in which practice proceeds beyond the point where the act can just be performed with the required degree of excellence. PM67 HN67(64) MHÑOverlearning ANonly /drug eff /physiol /rad eff MNF2.463.425.612 LH  MHÑOviducts ANnon-mammals only MNA13.706 LH  PM74 HN74 MHÑOviposition ANonly /drug eff /rad eff; = ╥laying╙ or ╥depositing╙ eggs or ova; includes insects, birds & other oviparous animals; index ovipositor under specific insect only with /anat (IM) + OVIPOSITION (IM) MNG8.520.480 LH  MSA heterogeneous mixture of glycoproteins responsible for the gel structure of egg white. Has trypsin inhibiting activity. HN(75) MHÑOvomucin ANdo not use /analogs /defic RN37281-36-0 PIEgg Proteins (73-74) MND8.373.745.896.650; D12.776.256.317.675; D12.776.395.560.760 XSOvomucoid DMÑEgg Proteins LH LS LM  MSThe discharge of a secondary oocyte from a ruptured graafian follicle. MHÑOvulation ANonly /drug eff /rad eff MNG8.520.440.508 XUÑSuperovulation LH LU  MSMethods for recognition of the occurrence of ovulation. PM75 HN75 MHÑOvulation Detection ANNIM; only /instrum /methods /vet PIOvulation (66-74) MNE1.249.530.690; E5.820.690 LH  MSTechniques for the artifical induction of ovulation. PM78 HN78 MHÑOvulation Induction ANnote category: ╥artificial induction of ovulation╙; only /methods /vet PIAnovulation (75-77); Ovulation (66-77) MNE5.820.740 LH  MHÑOvum ANhuman, other vertebrates, invertebrates & plants; differentiate from EGGS (Cat J); A 11 qualif & /abnorm /growth; /transpl permitted but /transpl is not implantation ( = OVUM IMPLANTATION); fertilized ovum = ZYGOTE MNA5.360.490.690; A11.497.497; A16.631 XSEGG FXÑGRAAFIAN FOLLICLE XUÑOogonia; ÑZona Pellucida LH LS LX LU;  MSEndometrial implantation of the blastocyst. OLuse OVUM IMPLANTATION to search NIDATION back thru 1966 (as Prov 1966) PM85; was NIDATION 1967-84 HN85; was NIDATION 1965-84 (Prov 1965-66) MHÑOvum Implantation ANonly /drug eff /rad eff; don't forget also available are PREIMPLANTATION PHASE & POSTIMPLANTATION PHASE MNG8.520.500 XSIMPLANTATION, OVUM; Implantation, Blastocyst; Nidation XUÑOvum Implantation, Delayed LH LS; ; LU  MSDelay of embryonal development whereby the blastocyst remains in the uterine cavity for a variable period of time before attaching to the endometrium and continuing its development. OLuse OVUM IMPLANTATION, DELAYED to search NIDATION, DELAYED back thru 1975 HN(85); was NIDATION, DELAYED see under NIDATION 1975-84 MHÑOvum Implantation, Delayed ANonly /drug eff /rad eff MNG8.520.500.100 XSImplantation, Ovum, Delayed; Nidation, Delayed DMÑOvum Implantation LH LS; LM  MSTransport of ovum or zygote from site of ovulation to site of implantation. OLsearch OVUM 1974 PM76; was see under OVUM 1974-75 HN76(75); was see under OVUM 1974-75 MHÑOvum Transport ANonly /drug eff /rad eff PIOvum (66-74) MNG4.335.283.700; G8.520.277.360 LH  MSThe ownership of any health facility; includes proprietary, public, non-profit, secular, physician-owned, etc. PM68 HN68 MHÑOwnership ANonly /econ /legis /trends PIHospital Administration (66-67) MNN4.452.633 LH  PM66 HN66(64) MHÑOxacillin ANdo not use /biosyn /defic /physiol RN66-79-5 MND20.85.99.739.681 XSOxazocilline; PENICILLIN, METHYLPHENYLISOXAZOLYL; SODIUM OXACILLIN LH LS; ;  MHÑOxadiazoles ANdo not use /analogs /biosyn /defic /physiol MND3.383.548.580 XUÑButalamine; ÑNBD Chloride; ÑSydnones LH LU; ;  MHÑOxalates ANdo not use /analogs /biosyn /defic /physiol; /urine: HYPEROXALURIA & HYPEROXALURIA, PRIMARY are also available MND2.241.81.337.635 LH  PM66 HN66(64) MHÑOxaloacetates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.337.635.581; D2.241.607.686 XSKETOSUCCINATES; OXOSUCCINATES LH LS;  MSAmino-substituted glyoxylic acid derivative. HN(75) MHÑOxamic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN471-47-6 PIAmino Acids (72-74); Glyoxylates (72-74) MND2.241.152.367.600; D12.125.730 XSOxalamic Acid; Oxamidic Acid DMÑAmino Acids LH LS; LM  MS6-Hydroxymethyl-2-isopropylaminomethyl-7-nitro-1,2,3,4-tetrahydroquinoline. Proposed as anthelmintic or schistosomicide. Synonyms: UK 4271; 4261. HN(75) MHÑOxamniquine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN21738-42-1 PINitro Compounds (73-74); Propylamines (73-74); Quinolines (73-74) MND3.438.810.350.600; D3.438.810.470.600; D21.201.412.596.560 DMÑNitroquinolines LH LM  PM65 HN65(64) MHÑOxandrolone ANdo not use /biosyn /defic /physiol RN53-39-4 MND4.808.54.40.581; D6.597.100.194.686 XSANAVAR LH LS  HN(71) MHÑOxathiins ANdo not use /analogs /biosyn /defic /physiol PIHeterocyclic Compounds (66-70) MND3.383.517 DMÑHeterocyclic Compounds LH LM  PM68 HN68(65) MHÑOxazepam ANdo not use /biosyn /defic /physiol RN604-75-1 MND3.438.79.80.70.663; D15.236.872.659.191.686 LH  OLsearch AZEPINES 1974 HN(75) MHÑOxazepines ANdo not use /analogs /biosyn /defic /physiol MND3.383.66.498 DMÑAzepines LH LM  MHÑOxazines ANdo not use /analogs /biosyn /defic /physiol MND3.383.533 XUÑMaytansine; ÑSeclazone LH LU;  MSOne ring heterocyclic compounds defined by C6H7NO. Permitted are any degree of hydrogenation, any substituents and any ortho-fused or ortho-peri-fused ring systems. PM75 HN75 MHÑOxazocines ANdo not use /analogs /biosyn /defic /physiol PIAzocines (66-74) MND3.383.113.767 XUÑNefopam LH LU  PMTRIMETHADIONE was see under ANTICONVULSANTS 1963-74 MHÑOxazoles ANincludes oxazolines, oxazolidines; do not use /analogs /biosyn /defic /physiol MND3.383.548 XUÑAminorex; ÑDimethadione; ÑDitazol; ÑIbotenic Acid; ÑIsoxazoles; ÑOxazolone; ÑTrimethadione LH LU; ; ; ; ; ;  MS2-Phenyl-4-ethoxymethylene-5-oxazolone. Immunologic adjuvent and sensitizing agent. HN(75) MHÑOxazolone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN15646-46-5 PIEthyl Ethers (74); Oxazoles (74) MND3.383.548.620; D24.611.59.680 DMÑOxazoles LH LM  PM68 HN68 MHÑOxepins ANdo not use /analogs /biosyn /defic /physiol MND3.383.564 LH  MSCompounds which accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light. PM75 HN75 MHÑOxidants, Photochemical ANdo not use /analogs /biosyn /defic /physiol PIOxidation-Reduction (66-74); Photochemistry (71-74) MND5.284.101.143.631 LH  MHÑOxidation-Reduction ANIM for general only; only /drug eff /rad eff; NIM with no qualif with specific drug IM MNG6.535.335.531; H1.181.529.641 XSREDOX LH LS  MSElectron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds. PM66; was see under ENERGY METABOLISM 1963-65 HN66; was see under ENERGY METABOLISM 1963-65 MHÑOxidative Phosphorylation ANonly /drug eff /rad eff; DF: OX PHOS MNG6.535.335.631 FXÑUNCOUPLING AGENTS LH LX  PM74 HN74(72) MHÑOxidative Phosphorylation Coupling Factors ANdo not use /analogs; DF: OX PHOS COUPLING FACTORS PIOxidative Phosphorylation (66-71) MND12.776.691 LH  PM66 HN66 MHÑOxides ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.680.582; D1.655.498 FXÑCyclic N-Oxides; ÑCyclic P-Oxides; ÑCyclic S-Oxides LH LX; ;  PMDEHYDROGENASES & OXIDASES were headings 1963 HNDEHYDROGENASES & OXIDASES were headings 1963 MHÑOxidoreductases ANOXIDASES, REDUCTASES & DEHYDROGENASES are GEN only: see Tree D8 under OXIDOREDUCTASES for all indentions & choose the most specific; do not use /analogs /defic /physiol RNEC 1. MND8.586.682 XSDEHYDROGENASES; Oxidases; REDUCTASES XUÑAscorbate Oxidase; ÑCholesterol Desmolase; ÑCoproporphyrinogen Oxidase; ÑDihydro-Orotate Oxidase; ÑMethylenetetrahydrofolate Dehydrogenase; ÑNitroanisole O-Demethylase; ÑNitroreductases; ÑOxidoreductases, O-Demethylating; ÑPrephenate Dehydrogenase; ÑProstaglandin-13,14-Reductase; ÑProtein Disulfide Reductase (Glutathione); ÑSqualene Synthetase; ÑSuccinate Cytochrome C Oxidoreductase; ÑSulfite Oxidases; ÑSulfite Reductases LH LS; ; LU; ; ; ; ; ; ; ; ; ; ; ; ; ;  PM73 HN73 MHÑOxidoreductases, N-Demethylating ANdo not use /analogs /defic /physiol RNEC 1.5. PIOxidoreductases (66-72) MND8.586.682.107.582 XSN-Demethylases XUÑEthylmorphine-N-Demethylase LH LS LU  MSDrug metabolizing enzymes which oxidize methyl ethers. Usually found in liver microsomes. HN(75) MHÑOxidoreductases, O-Demethylating ANdo not use /analogs /defic /physiol RNEC 1.- PIOxidoreductases (68-74) MND8.586.682.670 XSO-Demethylases DMÑOxidoreductases LH LS LM  MHÑOximes ANdo not use /analogs /biosyn /defic /physiol MND2.92.570.665; D8.515.347.582; D16.653.211.498 XSHydroxyimino Compounds XUÑObidoxime; ÑTrimedoxime LH LS LU;  MSThe determination of oxygen saturation of blood either by withdrawing a sample and passing it through a classical photoelectric oximeter or by electrodes attached to some translucent part of the body like finger, earlobe, or skin fold. MHÑOximetry ANonly /instrum /methods /vet; for measuremt of blood oxygen using an oximeter: not a synonym for ╥oxygen measuremt╙ ( = OXYGEN /anal) MNE1.145.569.685; E1.145.175.685; E1.223.174.229.134.582; E1.302.796.139.582 LH  PM73 HN73(72) MHÑOxolinic Acid ANdo not use /biosyn /defic /physiol RN14698-29-4 PIAnti-Infective Agents, Urinary (66-71); Quinolines (66-71) MND3.438.810.519; D20.237.720 LH  MS2,4-Dihydroxy-6-carboxy-1,3,5-triazine. Antagonist of urate oxidase. HN(75) MHÑOxonic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN937-13-3 PITriazines (71-74) MND3.383.931.640 DMÑTriazines LH LM  PM73 HN73(72) MHÑOxotremorine ANdo not use /biosyn /defic /physiol RN70-22-4 PITremorine (66-71) MND3.383.773.812.498; D16.698.628.891.582 LH  PM73 HN73(72) MHÑOxprenolol ANdo not use /biosyn /defic /physiol RN6452-71-7 PIAmino Alcohols (66-71); Sympatholytics (66-71) MND2.33.329.624.651; D2.92.63.624.651; D16.848.215.539 LH  MS3,3',5,5',6-Pentachloro-2'-hydroxysalicylanilide. Anthelmintic used in grazing animals for fasciola and cestode infestations. Synonyms: Diplin; Zanil; Zanilox. HN(75) MHÑOxyclozanide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2277-92-1 PIChlorobenzenes (74); Salicylamides (71-74) MND2.65.199.860.500; D2.65.793.650.500; D21.201.412.529 DMÑSalicylamides LH LM  MS4,5-alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one. Semisynthetic derivative of codeine; narcotic analgesic more potent and addicting than codeine; marketed as the HCl, pectinate and bitartrate under many names. Synonyms: Dinarkon; Eucodal; Pancodine; Percodan; Thecodin HN(76) MHÑOxycodone ANdo not confuse OXYCODONE X refs with HYDROCODONE X refs; do not use /biosyn /defic /physiol RN76-42-6 PIEthers, Cyclic (74-75); Morphinans (69-75) MND3.132.610.422.547.547.670; D3.549.686.575.547.204.650; D3.605.497.575.547.204.650; D14.73.153.616.547.204.685; D14.757.638.547.204.685 XSDihydrohydroxycodeinone; Dihydrone; Hydroxycodeinon; Oxiconum; Oxycodeinon DMÑCodeine LH LS; ; ; ; LM  MSL-3[(beta-Hydroxy-alpha-methylphenethyl)amino]-3'-methoxypropiophenone. Vasodilator agent; myocardial depressant. Synonyms: Ildamen; Modacor. HN(75) MHÑOxyfedrine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN15687-41-9 PIPropanolamines (74); Propiophenones (71-74) MND2.33.329.624.675; D2.92.63.624.675; D2.522.818.800; D18.918.680 XSOxyphedrin DMÑPropiophenones LH LS LM  MHÑOxygen ANO-16; isotopes: see notes at OXYGEN ISOTOPES & OXYGEN RADIOISOTOPES; TN 145 for OXYGEN qualif; /defic = ANOXIA; /metab permitted but consider better OXYGEN CONSUMPTION; /physiol for O2 in pulm resp process but tissue resp = OXYGEN CONSUMPTION (TN 145); /ther use permitted but consider also OXYGEN INHALATION THERAPY & HYPERBARIC OXYGENATION; do not use /biosyn RN7782-44-7 MND1.248.497.158.680; D1.268.632; D1.655 LH  PM66; was see under ENERGY METABOLISM & TISSUE METABOLISM 1963-65 HN66; was see under ENERGY METABOLISM & TISSUE METABOLISM 1963-65 MHÑOxygen Consumption ANonly /drug eff /rad eff; TN 145: oxygen metab MNG6.535.723 LH  MHÑOxygen Inhalation Therapy ANdo not use /util except by MeSH definition MNE2.880.690 LH  MHÑOxygen Isotopes ANO-17,18; NIM; no qualif MND1.496.625; D1.655.665 LH  MSUnstable isotopes of oxygen that decay or disintegrate spontaneously emitting radiation. Oxygen 14, 15, 19 and 20 are radioactive isotopes of oxygen. OLsearch OXYGEN ISOTOPES 1966-74 PM75 HN75 MHÑOxygen Radioisotopes ANO-13-15, 19, 20; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIOxygen Isotopes (66-74); Radioisotopes (66-74) MND1.496.625.600; D1.496.749.635; D1.655.720 LH  MHÑOxygenases ANdo not use /analogs RNEC 1.13. MND8.586.682.690 XUÑ4-Hydroxyphenylpyruvate Dioxygenase; ÑProtocatechuate-3,4-Dioxygenase LH LU;  PM74 HN74(72) MHÑOxygenators ANonly /adv eff /class /stand /supply /util (if by MeSH definition) /vet PIHeart, Mechanical (66-71) MNE7.652 FXÑHeart, Mechanical LH LX  PM74 HN74(72) MHÑOxygenators, Membrane ANonly /adv eff /class /stand /supply /util (if by MeSH definition) /vet PIHeart, Mechanical (66-71); Membranes, Artificial (66-71) MNE7.652.582 LH  MSA compound formed by the combination of hemoglobin and oxygen. It is a complex in which the oxygen is bound directly to the iron without causing a change from the ferrous to the ferric state. OLuse OXYHEMOGLOBINS to search OXYHEMOGLOBIN back thru 1973 (as Prov 1973-74) PM79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76 HN79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76, was OXYHEMOGLOBIN 1973-74 (Prov) MHÑOxyhemoglobins ANdo not use /analogs /blood; Bohr effect is indexed OXYHEMOGLOBINS /metab (IM) + PH (NIM) PIHemoglobins (66-72) MND12.776.124.400.707; D12.776.422.512.687 LH  HN(66) MHÑOxymetazoline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1491-59-4 MND3.383.374.704; D18.793.952.664 DMÑImidazoles LH LM  PM65 HN65 MHÑOxymetholone ANdo not use /biosyn /defic /physiol RN434-07-1 MND4.808.54.40.632; D6.597.100.194.723 XSHydroxymetholone LH LS  HN(64) MHÑOxymorphone ANdo not use /biosyn /defic /physiol RN76-41-5 MND3.132.610.422.547.547.692; D3.549.686.575.547.437.707; D3.605.497.575.547.437.707; D14.73.153.616.547.437.582; D14.757.638.547.437.582 DMÑDihydromorphinone LH LM  MS5,6-Dimethoxy-2-methyl-3-[2-(4-phenyl-1-piperazinyl)ethyl]-indole. Antipsychotic agent also used in severe nourotic depression; it has potentially dangerous side effects, including hypotension and extrapyramidal dysfunction. Synonyms: Equipertine; Integrin. HN(75) MHÑOxypertine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN153-87-7 PIIndoles (69-74); Piperazines (72-74) MND3.383.606.745; D3.438.473.710; D15.236.872.331.578 DMÑIndoles LH LM  PM64 HN64(63) MHÑOxyphenbutazone ANdo not use /biosyn /defic /physiol RN129-20-4 MND3.383.694.700.640; D14.73.278.152.684.582; D14.73.278.398.946.743.683; D26.74.75.204.684.582; D26.74.75.574.946.743.683 XSHydroxyphenylbutazone LH LS  MS3,3-Bis(p-hydroxyphenyl)-2-indolinone acetate. Laxative that undergoes enterohepatic circulation; may cause jaundice. Synonyms: Isalax; Isocrin; Lavema; Prulet. OLuse OXYPHENISATIN ACETATE to search OXYPHENISATIN back thru 1975 HN(83); was OXYPHENISATIN see under INDOLES 1975-82 MHÑOxyphenisatin Acetate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN115-33-3 PIIndoles (69-74); Phenols (72-74) MND3.438.473.725; D19.316.396.725 XSDioxyphenylisatin; Oxyphenisatin; Phenolisatin DMÑIndoles LH LS; ; LM  HN(64) MHÑOxyphenonium Bromide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN50-10-2 MND2.92.102.648; D2.675.276.648; D16.653.688 DMÑAmmonium Compounds LH LM  MS8-Methylthio-10-[4-(3-hydroxypropyl)-1-piperazinyl]-10,11-dihydrodibenzo(b,f)thiepin. Antipsychotic agent similar in action to the phenothiazines. HN(77) MHÑOxyprothepine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN29604-16-8 PIAlcohol, Propyl (66-75); Dibenzothiepins (68-76); Piperazines (66-76) MND3.494.311.610; D15.236.872.331.584 DMÑDibenzothiepins LH LM  MS1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol. A xanthine oxidase inhibitor. HN(75) MHÑOxypurinol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2465-59-0 PIPyrazoles (73-74); Pyrimidines (73-74) MND3.383.694.650; D3.383.742.550; D8.373.710 XSAlloxanthine; Oxipurinol DMÑPyrimidines LH LS; LM  MHÑOxytetracycline AN/biosyn permitted; do not use /defic /physiol; Terramycin goes here RN79-57-2 MND20.85.868.633 XSHydroxytetracycline; Oxytetracid LH LS;  MS5-(2-Hydroxyethyl)-3-[(4-hydroxy-2-methyl-5-pyrimidinyl)methyl]-4-methylthiazolium chloride. Thiamine antagonist, antimetabolite. HN(75) MHÑOxythiamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN136-16-3 PIPyrimidines (74); Thiazoles (70-74) MND3.383.871.540; D26.87.683 XSHydroxythiamine DMÑThiazoles LH LS LM  MHÑOxytocics ANno qualif for oxytocics when used to induce labor; do not use /analogs /biosyn /defic /physiol MND6.472.583 FXÑLabor, Induced LH LX  MS3-Isoleucyl, 8-Leucyl-vasopressin, the nonapeptide posterior pituitary hormone that causes uterine contractions and stimulates lactation. Synonym: 8-Leucyl Vasotocin. MHÑOxytocin AN/biosyn /physiol permitted RN50-56-6 MND6.472.583.666; D6.472.734.692.433; D12.644.456.925.730; D12.776.641.650.900.700 XS3-Isoleucine,8-Leucine Vasopressin; Isoleucyl, Leucyl Vasopressin; Ocytocin; Vasopressin, Isoleucyl-Leucyl; Vasotocin, Leucyl; alpha-Hypophamine LH LS; ; ; ; ;  OLsearch AMINOPEPTIDASES 1969-72 HN(73) MHÑOxytocinase ANdo not use /analogs RNEC 3.4.11.3 MND8.586.277.656.81.708 XSCystine Arylamidase; Cystyl Aminopeptidase DMÑAminopeptidases LH LS; LM  MHÑOxyuriasis ANcaused by Enterobius or other genera of family OXYUROIDEA MNC3.335.508.619 XSENTEROBIASIS LH LS  MSA superfamily of parasitic nematodes consisting of several genera. Enterobius which occurs in humans and Oxyuris which occurs in horses are two of the most common. Other genera are: Skrjabinema, Passalurus, Dermatoxys, and Probstmayria. OLuse OXYUROIDEA to search SYPHACIA back thru 1966 PMSYPHACIA was see under OXYUROIDEA 1963-85 HNSYPHACIA was see under OXYUROIDEA 1963-85 MHÑOxyuroidea ANa superfamily of nematodes; do not use /blood-csf-urine; infection: coord NIM with OXYURIASIS (IM) MNB1.500.294.599 XSSyphacia LH LS  MSMarine bivalve molluscs of several genera (Ostrea, Crassostrea, Pinctada, Meleagrina) with rough irregular shell closed by a single adductor muscle. Includes oysters as food. PM72 HN72 MHÑOysters ANas animals & food; /microbiol /parasitol permitted PIMollusca (66-71) MNB1.644.617 FXÑShellfish LH LX  MHÑOzone ANdo not use /analogs /biosyn /defic /physiol RN10028-15-6 MND1.655.498.631.533 LH  MSA blood group related to the ABO, Lewis and I systems; at least five different erythrocyte antigens are possible, some very rare, others almost universal; multiple alleles are involved. HN(76) MHÑP Blood-Group System ANonly /genet /immunol PIBlood Groups (66-75) MND24.611.216.705.230.691; G4.610.241.691; G9.188.229.691 DMÑBlood Groups LH LM  MSp-(Phenylazo)aniline. Used in the form of its salts as a dye; also as an intermediate in manufacture of Acid Yellow, diazo dyes, and indulines. Synonym: C.I. 11000. HN(76) MHÑp-Aminoazobenzene AND25-26 qualif; /analogs NIM only RN60-09-3 PIAniline Compounds (73-75); Azo Compounds (69-75) MND2.172.32; D26.408.65 XSC.I. Solvent Yellow 1; para-Aminoazobenzene DMÑAzo Compounds LH LS; LM  MS4-Aminobenzoic acid. A member of the vitamin B complex; it is also employed as a sunscreening agent. The potassium salt is used therapeutically in fibrotic skin disorders. Synonyms: Paraminol; Presun. OLsearch AMINOBENZOIC ACIDS 1966-76 HN(77); was PARA-AMINOBENZOIC ACID see under AMINOBENZOIC ACID 1965-76, was PARA-AMINOBENZOIC ACID 1963-64 MHÑp-Aminobenzoic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN150-13-0 PIAminobenzoic Acids (66-76) MND2.241.223.106.61.75; D11.786.708.54.75; D26.368.878.56 XS4-Aminobenzoic Acid; PABA; para-Aminobenzoic Acid DMÑAminobenzoic Acids LH LS; ; LM  MSN-(4-Aminobenzoyl)glycine. Used as the sodium salt in renal function tests. Synonyms: Nephrotest. OLsearch AMINOHIPPURIC ACIDS 1966-76 HN(77); was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76, was PARA-AMINOHIPPURIC ACID 1963-64 MHÑp-Aminohippuric Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN61-78-9 PIAminohippuric Acids (66-76) MND2.65.277.431.192.100; D2.241.223.106.162.431.175; D2.241.607.360.192.100 XS4-Aminohippuric Acid; PAH; para-Aminohippuric Acid DMÑAminohippuric Acids LH LS; ; LM  MS4-Amino-2-hydroxybenzoic acid. An antitubercular agent often administered in association with isoniazid. The sodium salt of the drug is better tolerated than the free acid. Synonyms: Pamisyl; Rezipas. OLsearch AMINOSALICYLIC ACIDS 1966-76 HN(77); PAS was see under AMINOSALICYLIC ACID 1963-67; PARA-AMINOSALICYLIC ACID was see under AMINOSALICYLIC ACID 1963-76 MHÑp-Aminosalicylic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN65-49-6 PIAminosalicylic Acids (66-76) MND2.241.223.106.505.700.60; D2.241.511.390.700.50.60; D2.755.410.700.50.60; D20.338.76.75 XS4-Aminosalicylic Acid; PAS; para-Aminosalicylic Acid DMÑAminosalicylic Acids LH LS; ; LM  MS4,4'-Azodibenzenearsonic acid. Ahapten capable of eliciting both antibody formation and delayed hypersensitivity when bound to aromatic amino acids, polypeptides or proteins; used as an immunologic research tool. HN(76) MHÑp-Azobenzenearsonate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7334-23-8 PIArsenicals (72-75); Azo Compounds (72-75) MND2.172.45; D2.691.88.60; D24.611.216.621.97 XSAzophenylarsonate; para-Azobenzenearsonate DMÑAzo Compounds LH LS; LM  MSp-Chloro-alpha-methylphenethylamine. Chlorinated analog of amphetamine. Potent neurotoxin that depletes serotonin in the CNS and otherwise interferes with serotonergic function and that of other brain amines; used as tool in neuropharmacology, especially as serotonin antagonist. Synonym: PCA. HN(75) MHÑp-Chloroamphetamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN64-12-0 PIAmphetamine (66-74); Chlorine (66-74) MND2.92.471.683.152.200; D23.846.166 XSp-Chloramphetamine; para-Chloroamphetamine DMÑAmphetamines LH LS; LM  MSDL-3-(4-Chlorophenyl)alanine. Inhibitor of serotonin biosynthesis; used in Carcinoid Syndrome. Synonyms: CP 10,188; NSC 77,370. PM73 HN73(71) MHÑp-Chlorophenylalanine ANdo not use /biosyn /defic /physiol RN1991-78-2 PIPhenylalanine (66-70) MND12.125.72.573.345; D23.846.187 XSFenclonine; para-Chlorophenylalanine LH LS;  MS3-(p-Fluorophenyl)-alanine. HN(75) MHÑp-Fluorophenylalanine ANdo not use /biosyn /defic /physiol RN60-17-3 PIPhenylalanine (72-74); Fluorine (72-74) MND12.125.72.573.450 XSpara-Fluorophenylalanine DMÑPhenylalanine LH LS LM  MSp-(2-Aminopropyl)phenol. Amphetamine metabolite with both alpha and beta activity as adrenergic false transmitter; used as ophthalmic adrenomimetic. Synonyms: Paredrin; Paredrinex; Pedrolon; Pulsoton. HN(75) MHÑp-Hydroxyamphetamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN103-86-6 PIAmphetamine (73-74); Phenols (68-74) MND2.92.471.683.152.500; D16.893.116.182.356; D16.893.116.348.406; D18.222.863.480 XSHydroxyphenylisopropylamine; Methyltyramine; Norpholedrin; Oxyamphetamine; para-Hydroxyamphetamine DMÑAmphetamines LH LS; ; ; ; LM  MSalpha-(1-Aminoethyl)-p-hydroxybenzyl alcohol. Parahydroxy analog of phenylpropanolamine with properties as a sympathomimetic. HN(75) MHÑp-Hydroxynorephedrine ANdo not use /biosyn /defic /physiol RN552-85-2 PIPhenols (72-74); Phenylpropanolamine (72-74) MND2.33.329.624.706.400; D2.92.63.624.706.400 XSpara-Hydroxynorephedrine DMÑPhenylpropanolamine LH LS LM  MSA device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external). MHÑPacemaker, Artificial ANmay be temporary (external) or permanent (internal or internal-external); do not use /instrum /methods /util (except by MeSH definition); coord dis with /ther, not /surg for treatment with pacemaker MNE7.858.82.748 XSCardiac Pacemaker, Artificial FXÑCardiac Pacing, Artificial LH LS LX  OLuse PACIFIC ISLANDS to search SOUTH PACIFIC ISLANDS back thru 1967 HN78; was SOUTH PACIFIC ISLANDS 1967-77 MHÑPacific Islands ANincludes MELANESIA, MICRONESIA & POLYNESIA: see notes under each & indentions in trees MNZ1.782 LH  HN87 MHÑPacific Ocean MNZ1.756.700 LH  OLsearch MECHANORECEPTORS 1972-74 & NERVE ENDINGS 1966-71 HN(75); was see under NERVE ENDINGS 1963-71 MHÑPacinian Corpuscles ANdo not use /innerv MNA8.796.511.725.404.688 DMÑMechanoreceptors LH LM  MS[3-[(3-acetylphenyl)amino]-4-amino-5-[[(dimethylamino)-carbonyl]amino]-1,2-dihydroxy-5-(1-hydroxyethyl)-2-methylcyclopentyl]methyl 2-hydroxy-6-methylbenzoate. Antibiotic produced by Streptomyces pactum used as an antineoplastic agent; also used as a tool in biochemistry because it inhibits certain steps in protein synthesis. Synonyms: NSC 52947; U 15800. HN(75) MHÑPactamycin ANdo not use /defic /physiol; /analogs NIM only RN23668-11-3 PIAntibiotics, Antineoplastic (72-74) MND20.85.75.680; D22.204.106.700 DMÑAntibiotics, Antineoplastic LH LM  MSA deuteromycetous fungal genus occasionally causing human diseases such as pulmonary infections, mycotic keratitis, endocarditis, and opportunistic infections. HN(86) MHÑPaecilomyces ANdo not use /embryol /microbiol /parasitol; infection: coord NIM with MYCOSES (IM) PIHyphomycetes (66-85) MNB5.354.381.546.640 DMÑHyphomycetes LH LM  OLsearch CARCINOMA, DUCTAL 1966-74 HN(75) MHÑPaget's Disease of Breast ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with BREAST NEOPLASMS (IM) MNC4.557.117.234.666 DMÑCarcinoma, Ductal LH LM  MHÑPaget's Disease, Extra-Mammary ANneoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.117.234.500 LH  MSThe sensation of discomfort, distress or agony. MHÑPain ANIM, GEN only; avoid for pain in various dis unless specifically discussed as the physiol or physiopathol of PAIN; use only Cat C qualif; /diag: consider also PAIN MEASUREMENT but PAIN /diag is probably PAIN /etiol; /ther: consider also PALLIATIVE TREATMENT ( = pain relief without cure); abdominal pain = PAIN (IM) + ABDOMEN (IM) but do not confuse with ABDOMEN, ACUTE; chest pain = CHEST PAIN; chronic pain = PAIN (IM) + CHRONIC DISEASE (NIM): do not equate with PAIN, INTRACTABLE; policy: Manual 23.22+ MNC10.597.617; C23.888.592.612; F2.830.816.444; G11.561.796.444 FXÑAnalgesia; ÑMyofascial Pain Syndromes LH LX;  MSScales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis and therapy. PM87 HN87 MHÑPain Measurement ANonly /instrum /methods /vet PIPain (66-86) MNE1.236.563.540 XSAnalgesia Tests; Analogue Pain Scale; Formalin Test; McGill Pain Questionnaire; Nociception Tests; Tourniquet Pain Test; Visual Analogue Pain Scale FXÑSensory Thresholds LH LS; ; ; ; ; ; LX  MSPain which is difficult to control. PM74 HN74 MHÑPain, Intractable ANIM; usually chronic so do not coord with CHRONIC DISEASE but chronic pain = PAIN (IM) + CHRONIC DISEASE (NIM); PALLIATIVE TREATMENT is also available MNC10.597.617.791; C23.888.592.612.666 LH  MSPain during the period after surgery. PM74 HN74 MHÑPain, Postoperative ANIM; DF: PAIN POSTOP MNC23.814.533; C23.888.592.612.722 LH  OLuse PAINT to search VARNISH back thru 1966 HNVARNISH was see under PAINT 1963-78 MHÑPaint ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNJ1.637.597 XSVarnish XUÑLacquer LH LS LU  OLsearch ART 1966-74 HN(75) MHÑPaintings ANonly /hist MNK1.93.646 DMÑArt LH LM  MSIn animals, the social relationship established between a male and female for reproduction and may include raising of young. HN(75) MHÑPair Bond ANanimal only; no qualif MNF1.145.113.252.748.400 XSBond, Pair DMÑSex Behavior, Animal LH LS LM  MSLearning in which the subject must respond with one word or syllable when presented with another word or syllable. MHÑPaired-Associate Learning ANonly /drug eff /physiol /rad eff MNF2.463.425.952.500 LH  MHÑPakistan MNZ1.252.245.723 LH  PM73 HN73 MHÑPalatal Expansion Technic ANdo not use /util except by MeSH definition CATALOG: do not use /laboratory manuals PIOrthodontics, Corrective (66-72); Palate (66-72) MNE6.658.578.458 LH  MSThe muscles of the palate are the glossopalatine, palatoglossus, levator palati(ni), musculus uvulae, palatopharyngeus, and tensor palati(ni). HN(79) MHÑPalatal Muscles PIMuscles (66-78); Palate (66-78) MNA2.633.662; A14.549.617.623 DMÑMuscles LH LM  MHÑPalatal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.149.450.708; C4.588.443.591.692; C5.500.693.528.583; C7.465.565.666 LH  MSAn appliance that closes a cleft or fissure of the palate. OLuse PALATAL OBTURATORS to search CLEFT PALATE PROSTHESIS back thru 1966 PM83; was CLEFT PALATE PROSTHESIS 1966-82 HN83; was CLEFT PALATE PROSTHESIS 1966-82 MHÑPalatal Obturators ANdo not use /util except by MeSH definition MNE6.780.745 XSCleft Palate Prosthesis; Obturators, Palatal FXÑProsthesis LH LS; LX  MHÑPalate ANfor palate unspecified or for hard palate (palatine bone); note PALATE, SOFT below MNA2.835.232.781.324.502.658; A14.521.658; A14.549.617 LH  MSA movable fold suspended from the posterior border of the hard palate. The uvula hangs from the middle of the lower border. PM79 HN79 MHÑPalate, Soft PIPalate (66-78) MNA14.549.617.780 XSVelum Palatinum LH LS  MSThe study of the teeth of early forms of life through fossil remains. MHÑPaleodontology ANIM; only /educ /hist; check tags HISTORICAL ARTICLE & ANCIENT or MEDIEVAL; for prehist, ANCIENT tag is all right; paleodontology is for pre-Columbian, nothing later MNI1.76.368.584.583 FXÑTooth LH LX  MHÑPaleography ANIM; no qualif MNL1.143.506.423.906.539.500 FXÑArchaeology LH LX  MSThe study of early forms of life through fossil remains. MHÑPaleontology ANIM; only /educ /hist; do not routinely check tags HISTORICAL ARTICLE & ANCIENT or MEDIEVAL: check only when the hist & ancient or medieval med aspects are particularly discussed; for prehist, ANCIENT tag is all right; paleontology is for pre-Columbian, nothing later MNI1.76.368.584 XUÑFossils LH LU  MSThe study of disease in prehistoric times as revealed in bones, mummies, and archaelogic artifacts. MHÑPaleopathology ANIM; no qualif; check tags HISTORICAL ARTICLE & ANCIENT or MEDIEVAL; for prehist, ANCIENT tag is all right; paleopathol is for pre-Columbian, nothing later MNI1.76.368.584.709 LH  MHÑPalladium ANPd-106; do not use /analogs /biosyn /defic /physiol; Pd-102, 104, 105, 108, 110 = PALLADIUM (IM) + ISOTOPES (NIM); Pd-98-101, 103, 107, 109, 111-115 = PALLADIUM (IM) + RADIOISOTOPES (IM) RN7440-05-3 MND1.268.640; D1.552.653 LH  PM66 HN66(64) MHÑPalliative Treatment AN= pain relief without cure; coord IM with disease /ther or /surg or /drug ther or other specific qualif (IM); consider also PAIN /ther; only /econ /instrum /methods /psychol /trends /vet MNE2.472.666 FXÑTerminal Care LH LX  MHÑPallor MNC23.888.656 LH  MSSalts and esters of the 16-carbon saturated monocarboxylic acid--palmitic acid. HN(75) MHÑPalmitates ANdo not use /analogs /biosyn /defic /physiol PIFatty Acids (66-74) MND2.241.81.407.634.600; D10.516.251.694.600 XSHexadecanoates DMÑPalmitic Acids LH LS LM  OLuse PALMITIC ACIDS to search PALMITIC ACID back thru 1966 PM75; was PALMITIC ACID 1963-74 HN75; was PALMITIC ACID 1963-74 MHÑPalmitic Acids ANdo not use /analogs MND2.241.81.407.634; D10.516.251.694 XSHexadecanoic Acid XUÑPalmitates LH LS LU  MSPalmitoyl-CoA hydrolase. Catalyzes reversibly the hydrolysis of palmitoyl-CoA or other long chain acyl coenzyme A compounds to yield CoA and palmitate or other acyl esters. The enzyme is involved in the esterification of fatty acids to form triglycerides. Synonyms: acyl thioesterase; acyl thioester hydrolase. EC 3.1.2.2. HN(78) MHÑPalmitoyl CoA Hydrolase ANdo not use /analogs RNEC 3.1.2.2 PIThiolester Hydrolases (73-77) MND8.586.277.352.897.700 XSAcyl CoA Hydrolase; Fatty Acyl Thioesterase; Palmitoyl CoA Deacylase; Palmitoyl Coenzyme A Hydrolase; Palmitoyl Thioesterase DMÑThiolester Hydrolases LH LS; ; ; ; LM  MSS-Palmitoyl coenzyme A. A fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis. HN(78) MHÑPalmitoyl Coenzyme A ANdo not use /analogs RN1763-10-6 PICoenzyme A (66-77); Palmitates (75-77); Palmitic Acids (66-77) MND8.176.211.300.700; D13.695.667.138.382.300.700; D13.695.827.68.382.300.700 XSPalmitoyl CoA DMÑAcyl Coenzyme A LH LS LM  MS3-Carboxy-N,N,N-trimethyl-2-((1-oxohexadecyl)oxy)-1-propanaminium, hydroxide inner salt. A long-chain fatty acid ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids. HN(78) MHÑPalmitoylcarnitine AN/biosyn /physiol permitted RN1935-18-8 PICarnitine (66-77); Palmitic Acids (66-77) MND2.241.81.407.634.600.700; D11.786.708.168.700 XSPalmitylcarnitine DMÑCarnitine LH LS LM  MSApplication of fingers with light pressure to the surface of the body to determine consistence of parts beneath in physical diagnosis; includes palpation for determining the outlines of organs. MHÑPalpation ANonly /adv eff /instrum /methods /vet; do not confuse with ╥palpitation╙ ( = HEART RATE, ARRHYTHMIA or specific arrhythmia); coord IM for self-examination of breast MNE1.706.644 LH  MHÑPamphlets ANonly /hist MNL1.178.682.707 LH  MSWHO regional office for the Americas acting as a coordinating agency for the improvement of health conditions in the Hemisphere. The four main functions are: control or eradiation of communicable diseases, strengthening of national and local health services, education and training, and research. PM73 HN73 MHÑPan American Health Organization ANonly /hist /organ; DF: PAHO CATALOG: use NAF entry PIInternational Agencies (66-72); World Health Organization (66-72) MNN3.540.514.718.800.628 LH  MHÑPanama ANdo not confuse with PANAMA CANAL ZONE MNZ1.107.169.772 LH  MHÑPanama Canal Zone ANdo not confuse with PANAMA MNZ1.107.169.772.584 LH  MHÑPancoast's Syndrome MNC4.588.894.797.520.734 LH  MHÑPancreas ANalso called ╥exocrine pancreas╙; ╥endocrine pancreas╙ = PANCREAS, ENDOCRINE see ISLANDS OF LANGERHANS; /enzymol: consider also PANCREATIN for ╥pancreatic enzymes╙ particularly in ther; /surg: consider also PANCREATECTOMY; inflammation = PANCREATITIS; hepatopancreas: index LIVER + PANCREAS but NIM; pancreatic A, B, C, D cells: index under ISLANDS OF LANGERHANS MNA3.734; A10.336.583 FXÑExocrine Glands LH LX  PM67 HN67(65) MHÑPancreatectomy ANdo not use /util except by MeSH definition MNE4.765.752 LH  MHÑPancreatic Cyst ANnon-neoplastic; pancreatic pseudocyst = PANCREATIC PSEUDOCYST; /anal /blood supply /secret /ultrastruct permitted MNC4.182.640; C6.689.500 XUÑPancreatic Pseudocyst LH LU  PM66 HN66 MHÑPancreatic Diseases ANinflamm dis = PANCREATITIS MNC6.689 XSNesidioblastosis FXÑHYPERINSULINISM LH LS LX  MHÑPancreatic Ducts ANnote X ref DUODENAL PAPILLA, MINOR: do not confuse with DUODENAL PAPILLA, MAJOR see VATER'S AMPULLA; ╥duodenal papilla╙ unspecified is probably DUODENAL PAPILLA, MAJOR MNA3.734.667 XSDuodenal Papilla, Minor; Wirsung's Duct LH LS;  MSExtracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency. MHÑPancreatic Extracts ANextracts of pancreas or pancreatic fractions containing uncharacterized factors; do not confuse with chemical substances ╥extracted╙ from the pancreas, as ╥peptides extracted from the mouse pancreas╙ ( = PEPTIDES /anal + PANCREAS /anal); do not use /analogs /biosyn /blood-csf-urine /defic /diag use /physiol /secret; PANCREATIN, a pancreatic extract, is also available MND24.185.893.500 LH  MSAbnormal passage communicating with the pancreas. MHÑPancreatic Fistula ANfistula policy: Manual 23.25+ MNC6.689.583 FXÑFistula LH LX  MSTests based on the biochemistry and physiology of the exocrine pancreas and involving analysis of blood, duodenal contents, feces, or urine for products of pancreatic secretion. PM80 HN80 MHÑPancreatic Function Tests ANonly /instrum /methods /vet PIPancreas (66-79); Pancreatic Diseases (66-79); specific pancreatic disease MNE1.184.670 LH  PM74 HN74 MHÑPancreatic Hormones AN/biosyn /physiol permitted; do not use /analogs MND6.472.610 LH  MSAbsence of or reduced pancreatic exocrine secretion into the duodenum and resultant poor digestion of lipids, vitamins, nitrogen, and carbohydrates. PM81 HN81 MHÑPancreatic Insufficiency PIPancreatic Diseases (66-80); Pancreatitis (66-80) MNC6.689.612 LH  MHÑPancreatic Juice ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.838.567 FXÑChymotrypsin; ÑChymotrypsinogen; ÑTRYPSIN; ÑTRYPSINOGEN LH LX; ; ;  MHÑPancreatic Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.761; C6.689.667 LH  MSA 36 amino acid polypeptide with physiological regulatory functions. It is secreted by pancreatic tissue; plasma pancreatic polypeptide increases after ingestion of food, with age, and in disease states. A lack of pancreatic polypeptide in the Islets of Langerhans has been associated with the obese syndrome in rats and mice. PM79 HN79 MHÑPancreatic Polypeptide AN/biosyn /physiol permitted RN59763-91-6 PIHormones (66-73); Pancreatic Hormones (74-78); Peptides (66-78) MND6.472.610.700; D12.644.480; D12.776.641.650.600 LH  MSCyst-like space not lined by epithelium and contained within the pancreas. HN(81) MHÑPancreatic Pseudocyst PIPancreatic Cyst (66-80) MNC4.182.640.692; C6.689.500.692 DMÑPancreatic Cyst LH LM  MSPancreatic extract; dried, containing trypsin amylase and a lipase in specified activities; used as digestant in pancreatic malfunction. Synonyms: Diastase vera; Ilozyme; Pankrotanon; Panteric; Stamyl; Zypanar. PM67; was see PANCREATIC EXTRACTS 1963-66 HN67(64); was see PANCREATIC EXTRACTS 1963-66 MHÑPancreatin AN/biosyn /physiol permitted RNEC 3.- MND8.586.277.610; D24.185.893.500.720; D19.316.700 LH  MHÑPancreatitis ANtry to specify ACUTE DISEASE (NIM) for acute pancreatitis or CHRONIC DISEASE (NIM) for chronic pancreatitis MNC6.689.750 LH  PM65 HN65 MHÑPancreatopeptidase ANdo not use /analogs RNEC 3.4.21.11 MND8.586.277.656.732.560 XSELASTASE LH LS  PM74 HN74(72) MHÑPancuronium ANdo not use /biosyn /defic /physiol RN15500-66-0 PIAndrostanes (68-71); Curare-Like Agents (70-71) MND4.808.54.40.685; D17.563.367.635 LH  MSDeficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets. PM77 HN77 MHÑPancytopenia ANcombined defic of erythrocytes, leukocytes & platelets MNC15.378.700 LH  OLsearch VITAMIN B COMPLEX 1966-74 HN(75) MHÑPangamic Acid AN/defic permitted but coord with VITAMIN B DEFICIENCY (NIM) RN11006-56-7 MND11.786.708.596 XSVitamin B 15 DMÑVitamin B Complex LH LS LM  MSA state of extreme acute, intense anxiety accompanied by disorganization of personality function. OLsearch FEAR 1972-74 HN(75) MHÑPanic ANonly /drug eff /physiol /rad eff MNF1.470.361.585 DMÑFear LH LM  PM65; was PANNICULITIS 1963-64 HN65; was PANNICULITIS 1963-64 MHÑPanniculitis, Nodular Nonsuppurative MNC17.566 XSWEBER-CHRISTIAN DISEASE LH LS  MHÑPanophthalmitis ANinflamm of all struct of eye: a clin entity; do not use as a coord for inflamm of specific parts of eye: these are available as -ITIS headings in C11 MNC11.621.668 LH  MSA genus of cone-nosed bugs of the family Triatomidae (Reduviidae), species of which are vectors of Trypanosoma cruzi. OLsearch TRIATOMIDAE 1973-74 HN(75); was see under TRIATOMINAE 1973-78 MHÑPanstrongylus AN/microbiol /parasitol permitted MNB1.131.617.412.841.460 DMÑTriatomidae LH LM  MS2,4-Dihydroxy-N-[2-[(2-merceptoethyl)carbamoyl]ethyl]-3,3-dimethylbutyramide. An intermediate in the pathway of coenzyme A formation in mammalian liver and some microorganisms. HN(75) MHÑPantetheine ANdo not confuse with ╥pantethine╙; do not use /defic /physiol; /analogs NIM only RN496-65-1 PIPantothenic Acid (72-74); Sulfhydryl Compounds (72-74) MND2.886.489.700 DMÑSulfhydryl Compounds LH LM  MHÑPantothenic Acid AN/analogs /defic permitted; /ther use: coord disease with /drug ther, not /diet ther RN79-83-4 MND11.786.708.625 LH  MHÑPapain ANdo not use /analogs RNEC 3.4.22.2 MND8.586.277.656.732.585 LH  MSA genus of Eurasian herbaceous plants, the poppies (Papaveraceae) that yield OPIUM from the latex of the unripe seed pods; opium contains a great number of medically important alkaloids; poppy seeds (nontoxic) are used in cookery and for poppy seed oils. HN(86)63 MHÑPapaver ANdo not use /isol /pathogen MNB6.560.671 XSPoppy FXÑOPIUM DMÑPlants, Medicinal LH LS LX LM  MHÑPapaverine ANdo not use /biosyn /defic /physiol RN58-74-2 MND3.132.610.710; D3.438.531.667; D16.653.714 XUÑTetrahydropapaveroline LH LU  MHÑPaper ANonly /stand MNJ1.637.632 FXÑCellulose LH LX  MSConical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendinae. MHÑPapillary Muscles ANdo not use /blood supply; Manual 21.52 as test tissue; for dis of papillary muscles coord IM with MYOCARDIAL DISEASES MNA7.541.510.619 LH  MHÑPapilledema ANedema of the optic papilla MNC11.640.710 FXÑEdema; ÑIntracranial Pressure; ÑOphthalmoscopy LH LX; ;  MHÑPapilloma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); ╥laryngeal papilloma╙ = PAPILLOMA (IM) + LARYNGEAL NEOPLASMS (IM) MNC4.557.576.735 FXÑWARTS LH LX  MSA genus of Papovaviridae causing proliferation of epithelium, which may lead to malignancy. OLuse PAPILLOMAVIRUSES to search PAPILLOMA VIRUSES & PAPILLOMA VIRUS back thru 1966 PM78; was PAPILLOMA VIRUSES 1975-77, was PAPILLOMA VIRUS 1963-74 HN78; was PAPILLOMA VIRUSES 1975-77, was PAPILLOMA VIRUS 1963-74 MHÑPapillomaviruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) MNB4.909.204.585.460; B4.909.574.204.711.460 XSInfectious Human Wart Virus XUÑBovine Papillomatosis Virus; ÑShope Papilloma Virus LH LS LU;  OLsearch KERATOSIS PALMARIS ET PLANTARIS 1974 HN(75) MHÑPapillon-Lefevre Disease MNC17.428.552.586 DMÑKeratosis Palmaris Et Plantaris LH LM  MSA genus of the family Cercopithecidae consisting of seven names species. The species are P. ursinus (chacma baboon), P. cynocephalus (yellow baboon), P. papio (western or Guinea baboon), P. anubis (anubis or olive baboon), P. hamadryas (hamadryas or sacred baboon), P. sphinx (mandrill), and P. leucophaeus (drill). Some authors have recognized a separate genus for the drill and mandrill - Mandrillus. The Papio genus is geographically distributed through east and west Africa, Arabia, Egypt, and the Sudan. OLuse PAPIO to search BABOONS back through 1971 (as Prov 1971-72) PM81; was see under BABOONS 1973-80; BABOONS was heading 1973-80 HN81(75); was see under BABOONS 1973-80; BABOONS was heading 1971-80 (Prov 1971-72) MHÑPapio ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.468.690 XSBaboon; Drill; Hamadryas; Mandrill LH LS; ; ;  MSA family of actually or potentially oncogenic RNA viruses; divided into two genera: the PAPILLOMAVIRUSES and the POLYOMAVIRUSES. OLuse PAPOVAVIRIDAE to search PAPOVAVIRUSES & PAPOVAVIRUS back thru 1966 PM81; was PAPOVAVIRUSES 1975-80, was PAPOVAVIRUS 1965-74 HN81; was PAPOVAVIRUSES 1975-80, was PAPOVAVIRUS 1965-74 MHÑPapovaviridae ANfrom PApilloma-POlyoma-VAcuolating agent; do not confuse with PARVOVIRIDAE; do not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) + neopl terms if pertinent MNB4.909.204.585; B4.909.574.204.711 LH  MHÑPappataci Fever MNC2.782.147.700; C2.81.700 XSPhlebotomus Fever; SANDFLY FEVER LH LS;  MSA species of the Bunyaviridae family, transmitted by the sandfly, Phlebotomus papatasi, which causes a short febrile illness in man. OLsearch ARBOVIRUSES 1966-74 HN(75); was see under ARBOVIRUSES 1975-80 was see under ARBOVIRUS 1965-74, was see under ARBORVIRUSES 1963-64 MHÑPappataci Fever Virus ANdo not use /blood-csf-urine /cytol; infection = PAPPATACI FEVER MNB4.909.777.147.690 XSPhlebotomus Fever Virus; Sandfly Fever Virus DMÑBunyaviridae LH LS; LM  MSA country consisting of the eastern half of the island of New Guinea and adjacent islands, including New Britain, New Ireland, the Admiralty Islands, and New Hanover in the Bismarck Archipelago; Bougainville and Buka in the northern Solomon Islands; the D'Entrecasteaux and Trobriand Islands; Woodlark (Murua) Island; and the Louisiade Archipelago. It became independent on September 16, 1975. Formerly, the southern part was the Australian Territory of Papua, and the northern part was the UN Trust Territory of New Guinea, administered by Australia. They were administratively merged in 1949 and named Papua and New Guinea, and renamed Papua New Guinea in 1971. HN82 MHÑPapua New Guinea ANread MeSH definition for hist & geog scope; Papuans are of NEGROID RACE unless otherwise specified PINew Guinea (66-81) MNZ1.782.590.694.630 XSNew Guinea, East; New Guinea, Papua LH LS;  MSSmall masses of chromaffin cells found near the sympathetic ganglia along the abdominal aorta; they serve as chemoreceptors responsive to oxygen, carbon dioxide, and hydrogen ion concentration, that help to control respiration. OLsearch CHROMAFFIN SYSTEM 1966-74 HN(75) MHÑPara-Aortic Bodies ANdo not confuse with AORTIC BODIES MNA6.224.636 DMÑChromaffin System LH LM  MSA group of respiratory infections caused by four serologically distinct strains of paramyxoviruses. PM70; was see under MYXOVIRUS INFECTIONS (now ORTHOMYXOVIRUS INFECTIONS) 1963-69 HN70(63); was see under MYXOVIRUS INFECTIONS (now ORTHOMYXOVIRUS INFECTIONS) 1963-69 MHÑPara-Influenza ANcoord IM with specific virus type below (NIM) MNC2.782.660.725 LH  MSA species of the Paramyxovirus genus that includes the Sendai strain, which causes pneumonia in mice and pigs, and the haemadsorption virus 2 (HA2), which causes laryngo-tracheitis in man, especially children. OLuse PARA-INFLUENZA VIRUS TYPE 1 to search SENDAI VIRUS back thru 1966 PM77; was SENDAI VIRUS 1964-76 HN77; was SENDAI VIRUS 1964-76 MHÑPara-Influenza Virus Type 1 ANdo not use /blood-csf-urine /cytol; infection: coord NIM with PARA-INFLUENZA (IM) MNB4.909.777.569.720.715 XSHemagglutinating Virus of Japan; Influenza D Virus; Sendai Virus LH LS; ;  MSAn RNA Virus associated particularly with acute laryngotracheitis (croup) in children aged 6 months to 3 years. OLuse PARA-INFLUENZA VIRUS TYPE 2 to search ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS back thru 1975 HN(77); was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see under PARA-INFLUENZA VIRUSES 1975-76 MHÑPara-Influenza Virus Type 2 ANdo not use /blood-csf-urine /cytol; infection: coord NIM with CROUP (IM) if text confirms or PARA-INFLUENZA (IM) if not specified as CROUP or ╥acute laryngotracheobronchitis╙ MNB4.909.777.569.720.725 XSAcute Laryngotracheo-Bronchitis Virus DMÑPara-Influenza Viruses LH LS LM  MSA virus frequently isolated from small children with pharyngitis, bronchitis, and pneumonia, as well as from domestic animals; has been associated with 'shipping fever' in cattle. HN(75) MHÑPara-Influenza Virus Type 3 ANdo not use /blood-csf-urine /cytol; infection: coord NIM with PARA-INFLUENZA (IM) MNB4.909.777.569.720.735 XSHemadsorption Virus 1; Shipping Fever Virus DMÑPara-Influenza Viruses LH LS; LM  MHÑPara-Influenza Viruses ANdo not use /blood-csf-urine /cytol; infection = PARA-INFLUENZA MNB4.909.777.569.720 XUÑPara-Influenza Virus Type 2; ÑPara-Influenza Virus Type 3 LH LU;  OLuse PARABENS to search METHYLPARABEN back thru 1966 PM72; METHYLPARABEN was heading 1963-71 HN72(71); METHYLPARABEN was heading 1963-71 MHÑParabens AND25-26 qualif PIBenzoates (66-70) MND2.241.223.106.505.600; D2.241.511.390.600; D2.755.410.600; D26.698.586 XS4-Hydroxybenzoic Acids; para-Hydroxybenzoic Acids LH LS;  MSThe experimental joining of two individuals for the purpose of studying the effects of one on the other. HNwas in Cat G only 1963-78 MHÑParabiosis ANonly /methods MNE5.660 XUÑCross Circulation LH LU  MSA deuteromycetous fungal genus; P. brasiliensis is the etiologic agent of paracoccidioidomycosis. HN(72); was see under PHYCOMYCETES 1975-85, was Prov 1972-74 MHÑParacoccidioides ANdo not use /anat /embryol /microbiol /parasitol; infection = PARACOCCIDIOIDOMYCOSIS PIPhycomycetes (66-71) MNB5.354.381.546.648 DMÑHyphomycetes LH LM  MSA mycosis affecting the skin, mucous membranes, lymph nodes, and internal organs. It is caused by Paracoccidioides brasiliensis. Synonyms: South American blastomycosis; paracoccidioidal granuloma OLsearch BLASTOMYCOSIS 1966-74 PM77; was see under BLASTOMYCOSIS 1963-76 HN77(75); was see under BLASTOMYCOSIS 1963-76 MHÑParacoccidioidomycosis ANcaused by PARACOCCIDIOIDES PIBlastomycosis (66-74) MNC1.703.700 XSBlastomycosis, South American LH LS  MSGram-negative non-motile bacteria found in soil or brines. PM76 HN76 MHÑParacoccus ANin soil & brine PIMicrococcus (66-75) MNB3.400.725 LH  MSA species of bacteria isolated from soil. OLuse PARACOCCUS DENITRIFICANS to search MICROCOCCUS DENITRIFICANS back thru 1972 PM76; was MICROCOCCUS DENITRIFICANS 1972-75 HN76; was MICROCOCCUS DENITRIFICANS 1972-75 MHÑParacoccus denitrificans ANin soil PIMicrococcus (66-71) MNB3.400.725.540 XSMicrococcus denitrificans LH LS  MSA mixture of solid hydrocarbons obtained from petroleum; used as stiffening agent in ointments, as lubricant and topical anti-inflammatory. Synonyms: Cosmolloids; Gloken. HNwas in Cat D only 1963-82 MHÑParaffin AND25-26 qualif RN8002-74-2 MND26.698.636; J1.637.680.636 LH  MSSmall bodies containing chromaffin cells occurring outside of the adrenal medulla, most commonly near the sympathetic ganglia and in organs such as the kidney, liver, heart and gonads. OLsearch CHROMAFFIN SYSTEM 1966-74 HN(75) MHÑParaganglia, Chromaffin ANdo not use /innerv MNA6.224.736 DMÑChromaffin System LH LM  MHÑParaganglia, Nonchromaffin ANdo not use /innerv MNA8.99.651 XUÑAortic Bodies; ÑGlomus Jugulare LH LU;  MHÑParaganglioma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl heading (IM) MNC4.557.652.765 LH  MHÑParaganglioma, Nonchromaffin AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.652.798 XSCHEMODECTOMA XUÑGlomus Jugulare Tumor LH LS LU  MHÑParagonimiasis MNC3.335.865.741 LH  MSA genus of lung flukes of the family Troglotrematidae. This genus consists of several species one of which is P. westermani, a common lung fluke in man. Members of this and other species also occur in other mammals. MHÑParagonimus ANdo not use /blood-csf-urine; infection = PARAGONIMIASIS MNB1.500.736.715.800.610 LH  MHÑParaguay MNZ1.107.757.656 LH  OLsearch PSITTACINES 1968-74 HN(75) MHÑParakeets ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.248.710.503 DMÑPsittacines LH LM  OLsearch KERATOSIS 1968-74 HN(75) MHÑParakeratosis MNC17.428.736 DMÑKeratosis LH LM  MHÑParaldehyde ANdo not use /biosyn /defic /physiol RN123-63-7 MND2.47.64.586; D14.591.745.762 LH  OLsearch PARALYSIS, SPASTIC under MUSCLE SPASTICITY 1966-78 PMPARALYSIS, SPASTIC was heading 1963-78 HNPARALYSIS, SPASTIC was heading 1963-78 MHÑParalysis AN╥general paralysis of the insane╙ = PARESIS; spastic paralysis = PARALYSIS (IM) + MUSCLE SPASTICITY (NIM); flaccid paralysis = PARALYSIS (IM) + MUSCLE FLACCIDITY (NIM) MNC10.597.622; C23.888.592.636 XSParalysis, Pseudobulbar; Pseudobulbar Paralysis LH LS;  MHÑParalysis, Bulbar MNC10.597.622.502; C23.888.592.636.502 XSBULBAR PALSY LH LS  MHÑParalysis, Familial Periodic ANa specific disease entity: see Dorland; not for ╥a periodic paralysis of...╙ MNC5.651.661.780; C10.668.780; C18.452.648.618.711 LH  MHÑParalysis, Obstetric ANmaternal or neonatal; ccord IM with specific paralysis or birth inj (IM) MNC16.614.131.587; C21.866.141.587 LH  MHÑParamecium ANdo not use /anat /blood-csf-urine /embryol MNB1.841.184.637 LH  PM65 HN65(63) MHÑParamethasone ANdo not use /biosyn /defic /physiol RN53-33-8 MND4.808.745.432.769.692; D4.808.908.727; D6.597.481.561.353.649; D6.597.481.561.478.614; D26.74.125.727 LH  MHÑParametritis MNC13.371.56.114.587 XSCellulitis, Pelvic LH LS  MSA family of flukes of the class Trematoda which is found in the intestinal tract and liver of animals and man. Some of the genera are Homalagaster, Gastrodiscus, Paramphistomum, Watsonius, Nilocotyle, Gigantocotyle, Gastrothylax, Macropotrema, Ceylonocotyle, Zygocotyle, Cotylophoron, and Calicophoron. PM82 HN82 MHÑParamphistomatidae ANfamily of trematodes; do not use /blood-csf-urine; infection: coord NIM with TREMATODE INFECTIONS (IM) PITrematoda (66-81) MNB1.500.736.715.600 XSAmphistomidae; Paramphistomata; Paramphistomum LH LS; ;  MHÑParamyoclonus Multiplex MNC5.651.536.587; C10.668.797 XSFRIEDREICH'S DISEASE LH LS  MSSpherical viruses, somewhat larger than the orthomyxoviruses, containing single-stranded RNA. OLuse PARAMYXOVIRIDAE to search PARAMYXOVIRUSES back thru 1971 (as Prov 1971-72) PM81; was PARAMYXOVIRUSES 1973-80 HN81; was PARAMYXOVIRUSES 1971-80 (Prov 1971-72) MHÑParamyxoviridae ANdo not use /blood-csf-urine /cytol; infection = PARAMYXOVIRUS INFECTIONS PIOrthomyxoviridae (66-70) MNB4.909.777.569 LH  MSInfections with paramyxoviruses. PM77 HN77 MHÑParamyxovirus Infections PIOrthomyxovirus Infections (66-76) MNC2.782.660 LH  MSUse for general material on diseases of the paranasal sinuses or for specific diseases for which no main heading is provided. PM77 HN77; was NON MESH before 1977 MHÑParanasal Sinus Diseases PIParanasal Sinuses (66-76) MNC9.692 LH  MHÑParanasal Sinus Neoplasms ANcoord IM with specific sinus (IM) + histol type of neopl (IM); /anal /blood supply /secret /ultrastruct permitted; note that MAXILLARY SINUS NEOPLASMS is also available MNC4.588.443.665.650.693; C9.692.503 XUÑMaxillary Sinus Neoplasms LH LU  MSThe mucosa-lined air cavities in the facial and cranial bones which communicate with the nasal cavity. MHÑParanasal Sinuses ANGEN: prefer specifics; inflammation = SINUSITIS but do not add PARANASAL SINUSES for ╥paranasal╙ or ╥nasal╙ sinusitis MNA4.621 XSNASAL SINUSES LH LS  MSIn patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. PM80 HN80 MHÑParaneoplastic Syndromes ANdo not use /anal /blood supply /secret /ultrastruct MNC4.730 LH  MSBehavior exhibited by individuals who are overly suspicious. They do not have the constellation of symptoms characteristic of a paranoid personality disorder or a paranoid psychosis. PM79 HN79 MHÑParanoid Behavior ANdo not use /drug eff /physiol /rad eff PIParanoid Disorders (66-78); Paranoid Personality Disorder (69-78) MNF1.145.672; F3.126.680 LH  MSChronic mental disorder in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state. OLuse PARANOID DISORDERS to search PARANOIA back thru 1966 PM81; was PARANOIA 1963-80 HN81; was PARANOIA 1963-80 MHÑParanoid Disorders ANdo not use /drug eff /physiol /rad eff MNF3.709.680.700 XSParanoia; Paranoid Psychoses; Psychoses, Paranoid LH LS; ;  MSA personality disorder characterized by the avoidance of accepting deserved blame and an unwarranted view of others as malevolent. The latter is expressed as suspiciousness, hypersensitivity and mistrust. OLto search PARANOID PERSONALITY use PARANOID PERSONALITY DISORDER back thru 1975 & PARANOID DISORDERS 1969-74 HN(79); was PARANOID PERSONALITY see under PARANOIA 1969-78 MHÑParanoid Personality Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.597.508 XSPersonality Disorder, ParanoidPERSONALITY DIS PARANOID DMÑPersonality Disorders LH LS LM  PM74 HN74(72) MHÑParaoxon ANdo not use /biosyn /defic /physiol RN311-45-5 PIInsecticides (66-71) MND2.705.569; D5.723.491.574.670 LH  MSAbnormal sexual behavior manifested by unusual or bizarre imagery or acts that are necessary for sexual excitement. They tend to be involuntarily repetitive. OLuse PARAPHILIAS to search SEX DEVIATION back thru 1966 PM81; was SEX DEVIATION 1963-80 HN81; was SEX DEVIATION 1963-80 MHÑParaphilias ANdo not use /drug eff /physiol /rad eff MNF3.709.597.608.700 XSSex Deviations FXÑImpulse Control Disorders; ÑSEX OFFENSES XUÑExhibitionism; ÑFetishism (Psychiatric); ÑPedophilia; ÑVoyeurism LH LS LX; LU; ; ;  OLsearch PHIMOSIS 1966-74 HN(75) MHÑParaphimosis MNC12.294.494.684.587 DMÑPhimosis LH LM  OLsearch PARALYSIS, SPASTIC under MUSCLE SPASTICITY 1966-78 PMPARALYSIS, SPASTIC was heading 1963-78 HNPARALYSIS, SPASTIC was heading 1963-78 MHÑParaplegia ANalso available is QUADRIPLEGIA; spastic paraplegia = PARAPLEGIA (IM) + MUSCLE SPASTICITY (NIM) MNC10.597.622.669; C23.888.592.636.637 LH  MSA group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin. PM76 HN76 MHÑParaproteinemias PIBlood Protein Disorders (66-75); Immunoglobulins (70-75); specific immunoglobulin MNC15.378.147.780; C20.683.780 XSMonoclonal Gammopathies; Paraimmunoglobulinemias; Plasma Cell Dyscrasias LH LS; ;  MSAbnormal immunoglobulins synthesized by atypical cells of the reticuloendothelial system. Paraproteins containing only light chains lead to Bence Jones paraproteinemia, while the presence of only atypical heavy chains leads to heavy chain disease. Most of the paraproteins show themselves as an M-component (monoclonal gammopathy) in electrophoresis. Diclonal and polyclonal paraproteins are much less frequently encountered. PM76; was see under GLOBULINS 1963-65 HN76; was see under GLOBULINS 1963-65 MHÑParaproteins ANonly /anal /biosyn /class /csf /genet /immunol /isol /metab /urine PIBlood Protein Disorders (66-75); Immunoglobulins (70-75); specific immunoglobulin MND12.776.124.486.485.900; D12.776.124.790.651.900; D12.776.377.715.548.900 XUÑPyroglobulins LH LU  OLuse PARAPSORIASIS to search PARAKERATOSIS VARIEGATA back thru 1966 HNPARAKERATOSIS VARIEGATA was see under PARAPSORIASIS 1963-78 MHÑParapsoriasis MNC17.579 XSERYTHRODERMA, MACULOPAPULAR; Parakeratosis Variegata LH LS;  MSBranch of psychology that deals with paranormal behavior and events such as telepathy, precognition, and clairvoyance, which are not explicable by present day ╥natural laws╙. OLuse PARAPSYCHOLOGY to search CLAIRVOYANCE, EXTRASENSORY PERCEPTION & PSYCHICAL RESEARCH back thru 1966 HNCLAIRVOYANCE was see under PARAPSYCHOLOGY 1965-78; EXTRASENSORY PERCEPTION & PSYCHICAL RESEARCH were see under PARAPSYCHOLOGY 1963-78 MHÑParapsychology ANonly /educ /hist /instrum /methods; TELEPATHY is also available MNF2.607; F4.96.462 XSClairvoyance; Extrasensory Perception; Psychical Research LH LS; ;  PM73 HN73(71) MHÑParaquat ANdo not use /biosyn /defic /physiol RN4685-14-7 PIHerbicides (66-70); Pyridinium Compounds (68-70) MND3.383.725.762.621; D5.723.366.656 XSMethyl Viologen LH LS  PM74 HN74(71) MHÑParasite Egg Count ANNIM; only /instrum /methods /vet PIOvum (66-70); Parasites (66-70); specific parasite; specific specimen MNE1.223.640 LH  OLsearch PARASITICIDES under ANTIPROTOZOAL AGENTS 1966 PMPARASITICIDES was heading 1963-66 HNPARASITICIDES was heading 1963-66 MHÑParasites ANGEN or unspecified only: prefer specifics; for parasiticides, consider ANTI-INFECTIVE AGENTS, ANTHELMINTICS, ANTIPROTOZOAL AGENTS & their specifics; in lower animals: Manual 22.20; relation to parasitic diseases: Manual 22.12-.20; HOST-PARASITE RELATIONS is also available CATALOG: /geog /form MNB1.714 LH  OLsearch PARASITICIDES under ANTIPROTOZOAL AGENTS 1966 PMPARASITICIDES was heading 1963-66 HNPARASITICIDES was heading 1963-66 MHÑParasitic Diseases ANGEN: prefer specifics; relation to parasites: Manual 22.12-.20; parasitic dis not in MeSH: Manual 22.17, 22.18; parasitic dis of heart = PARASITIC DISEASES or specific parasitic dis (IM) + MYOCARDIAL DISEASES (IM), not HEART DISEASES MNC3 LH  OLexper or vet; consider also PARASITIC DISEASES /VE & /VE with specific parasitic dis MH*Parasitic Diseases, Animal (Non Mesh) MNC22.674 LH  PM67 HN67 MHÑParasitology ANSPEC only: SPEC qualif; prefer /parasitol with organs, higher animals & diseases: Manual 19.5+ PIParasites (66); Parasitic Diseases (66) MNG1.273.688 LH  MHÑParasympathetic Nervous System ANdo not use /innerv; /drug eff: consider also PARASYMPATHOMIMETICS & PARASYMPATHOLYTICS MNA8.99.698 LH  OLto search ANTISPASMODICS & SPASMOLYTICS use PARASYMPATHOLYTICS back thru 1970 & MUSCLES 1966-69 PMANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69 HNANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69 MHÑParasympatholytics ANdo not use /analogs /biosyn /defic /physiol; consider also PARASYMPATHETIC NERVOUS SYSTEM /drug eff MND16.653 XSANTIMUSCARINIC AGENTS; Anticholinergic Agents; Antispasmodics; CHOLINERGIC-BLOCKING AGENTS; Cholinolytics; PARASYMPATHETIC BLOCKING AGENTS; Spasmolytics FXÑAnti-Ulcer Agents; ÑAntiparkinson Agents LH LS; ; ; ; ; ; LX;  MHÑParasympathomimetics ANdo not use /analogs /biosyn /defic /physiol; consider also PARASYMPATHETIC NERVOUS SYSTEM /drug eff MND16.698 XSCHOLINOMIMETICS; Cholinergic Agents; MUSCARINIC AGENTS LH LS; ;  MHÑParathion ANdo not use /biosyn /defic /physiol; TN 111 for effect on insects RN56-38-2 MND2.719.746; D5.723.491.657.763 XUÑMethyl Parathion LH LU  PM66 HN66 MHÑParathyroid Diseases ANGEN MNC19.642 LH  MSTwo small paired endocrine glands in the region of the thyroid gland; they secrete parathyroid hormone and are concerned with the metabolism of calcium and phosphorus. MHÑParathyroid Glands MNA6.407.560 LH  OLuse PARATHYROID HORMONES to search PARATHYROID HORMONE back thru 1966 PM82; was PARATHYROID HORMONE 1963-81 HN82; was PARATHYROID HORMONE 1963-81 MHÑParathyroid Hormones AN/biosyn /physiol permitted; do not use /analogs; /defic: consider also HYPOPARATHYROIDISM MND6.472.638 LH  MHÑParathyroid Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.322.525; C19.642.713 LH  MHÑParatuberculosis ANusually animal: do not use /vet but check tag ANIMAL; caused by Mycobacterium paratuberculosis; index organism under MYCOBACTERIUM (IM) + PARATUBERCULOSIS /microbiol (NIM) MNC1.252.40.552.588; C22.688 XSJOHNE'S DISEASE LH LS  MHÑParatyphoid Fevers ANspecify Salmonella paratyphi species if possible (NIM) MNC1.252.310.821.438 LH  MSCauses a pock-like disease on udders of cows; may spread to milkers. HN(75); was see under POXVIRUSES 1975-80 MHÑParavaccinia Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with POXVIRUS INFECTIONS (IM) MNB4.909.204.783.625 XSMilker's Nodes Virus; Pseudo-Cowpox Virus DMÑPoxviridae LH LS; LM  MSNucleus in the anterior part of the hypothalamus. OLuse PARAVENTRICULAR HYPOTHALAMIC NUCLEUS to search PARAVENTRICULAR NUCLEUS back thru 1975 PM83; was PARAVENTRICULAR NUCLEUS see under HYPOTHALAMUS 1975-82 HN83; was PARAVENTRICULAR NUCLEUS see under HYPOTHALAMUS 1975-82 MHÑParaventricular Hypothalamic Nucleus ANdo not use /innerv MNA8.186.211.385.357.342.400 LH  MSThe interactions between parent and child. MHÑParent-Child Relations ANhuman only; no qualif MNF1.829.263.370.290 FXÑSOCIALIZATION LH LX  MHÑParenteral Feeding ANfor nourishment: differentiate from FLUID THERAPY (to replace fluids) or ENTERAL FEEDING (see note there) or INFUSIONS, PARENTERAL (merely a method of admin drugs & chemicals); do not use /util except by MeSH definition; coord IM with dis /ther (IM), not dis /diet ther MNE2.421.505 XSINTRAVENOUS FEEDING FXÑFat Emulsions, Intravenous LH LS LX  MSTotal parenteral nutrition for achieving and maintaining normal nitrogen balance by the intravenous infusion of a concentrated nutrient solution. Basic requirements of hyperalimentation solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. PM86; was see under PARENTERAL FEEDING 1975-85 HN86(75); was see under PARENTERAL FEEDING 1975-85 MHÑParenteral Hyperalimentation ANdo not use /util except by MeSH definition; coord IM with dis /ther (IM), not dis /diet ther MNE2.421.505.790 XSHyperalimentation, Parenteral; Intravenous Hyperalimentation; Total Parenteral Nutrition LH LS; ;  MSTo be used for natural, adoptive or substitute parents, and for articles concerning the concept of parenthood as in preparation for becoming a parent. PM69 HN69(67) MHÑParents ANonly /educ /psychol (consider also PARENT-CHILD RELATIONS); ╥unwed parent╙: coord IM with ILLEGITIMACY (IM); ╥single parent╙: coord IM with SINGLE PERSON (IM) PIFamily (66) MNF1.829.263.500.320; I1.880.225.500.340; M1.620 LH  MHÑParesis AN= general paralysis of the insane, as in syphilis; does not mean ╥generalized paralysis╙ (= PARALYSIS); remember that ╥paresis╙ is sometimes just ╥paralysis╙ in foreign lit MNC1.252.847.840.744.456.505; C10.228.228.674.505 XSGENERAL PARALYSIS; PARALYSIS, GENERAL LH LS;  MHÑParesthesia ANburning, tingling, prickling sensations go here MNC10.597.751.670; C23.888.592.763.587 LH  PM65 HN65(63) MHÑPargyline ANdo not use /biosyn /defic /physiol RN555-57-7 MND8.373.616.638; D15.236.122.627.638; D18.162.653 LH  MHÑParietal Bone ANfractures: coord PARIETAL BONE /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with SKULL NEOPLASMS (IM) MNA2.835.232.781.651 LH  MSCells of the gastric glands which secrete hydrochloric acid and intrinsic factor. PM84 HN84 MHÑParietal Cells, Gastric ANA 11 qualif PIGastric Acid (81-83); Gastric Juice (66-83); Gastric Mucosa (66-83); Stomach (66-83) MNA3.492.766.440.708; A11.436.708 XSGastric Parietal Cells; Oxyntic Cells FXÑGastric Acid; ÑIntrinsic Factor LH LS; LX;  MHÑParietal Lobe ANdo not use /innerv; dis: coord IM with BRAIN DISEASES (NIM); neopl: coord IM with BRAIN NEOPLASMS (IM) MNA8.186.211.885.213.670 LH  MHÑParis MNZ1.542.286.588; Z1.433.800 LH  PM70 HN70(65) MHÑParity ANhuman & animal; only /drug eff /rad eff; relation to PREGNANCY: Manual 28.33 MNG8.520.615 LH  MSIndoor or outdoor areas designated for the parking of vehicles. HN(Aug 77) MHÑParking Facilities ANonly /econ /stand MNJ1.86.339.490 DMÑFacility Design and Construction LH LM  OLuse PARKINSON DISEASE to search PARKINSONISM & PARALYSIS AGITANS back thru 1966 PM79; was PARKINSONISM 1967-78, was PARALYSIS AGITANS 1963-66 HN79; was PARKINSONISM 1967-78, was PARALYSIS AGITANS 1963-66 MHÑParkinson Disease AN/drug ther: consider also ANTIPARKINSON AGENTS; /chem ind = PARKINSON DISEASE, SYMPTOMATIC /chem ind MNC10.228.140.79.804 XSParalysis Agitans LH LS  OLuse PARKINSON DISEASE, POSTENCEPHALITIC to search PARKINSONISM, POSTENCEPHALITIC back thru 1967 PM79; was PARKINSONISM, POSTENCEPHALITIC 1967-78 HN79; was PARKINSONISM, POSTENCEPHALITIC 1967-78 MHÑParkinson Disease, Postencephalitic PIParkinson Disease (66) MNC10.228.140.79.804.832.751; C10.228.140.437.238.739 XSPostencephalitic Parkinsonism FXÑEncephalitis, Epidemic LH LS LX  MSSymptoms of parkinsonism induced by drugs, or following cerebral arteriosclerosis, brain tumor, or other central nervous system disorders except encephalitis, which is PARKINSONISM, POSTENCEPHALITIC. OLuse PARKINSON DISEASE, SYMPTOMATIC to search PARKINSONISM, SYMPTOMATIC back thru 1973 PM79; was PARKINSONISM, SYMPTOMATIC 1973-78 HN79; was PARKINSONISM, SYMPTOMATIC 1973-78 MHÑParkinson Disease, Symptomatic AN/chem ind permitted: coord IM with drug /ad-poi-tox (IM); coord IM with other cause (IM) PIParkinson Disease (66-72) MNC10.228.140.79.804.832 XSParkinsonian Syndrome LH LS  MHÑParomomycin ANdo not use /defic /physiol RN7542-37-2 MND9.203.408.51.699; D20.85.625; D21.370.107.789 XSAminosidine; Catenulin; Estomycin; Hydroxymycin; Neomycin E XUÑLividomycins LH LS; ; ; ; LU  MHÑParonychia MNC1.539.624; C17.805.506.639; C17.838.625 LH  PM80 HN80 MHÑParotid Diseases ANinflamm dis = PAROTITIS PIParotid Gland (66-79); Salivary Gland Diseases (66-79) MNC7.465.815.470 LH  MHÑParotid Gland ANinflammation = PAROTITIS MNA10.336.779.464; A14.549.760.464 LH  MHÑParotid Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.591.824.695; C7.465.815.470.770; C7.465.815.718.589 LH  HN(72) MHÑParotin AN/biosyn /physiol permitted; /analogs NIM only RN1392-81-0 PIHormones (66-71) MND6.472.664 DMÑHormones LH LM  MHÑParotitis AN╥epidemic parotitis╙ = MUMPS; ╥uveoparotitis╙ = UVEOPAROTID FEVER MNC7.465.815.470.800 LH  MHÑParovarian Cyst AN/anal /blood supply /secret /ultrastruct permitted MNC4.182.668; C13.371.56.739 LH  OLsearch PSITTACINES 1968-74 HN(75) MHÑParrots ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.248.710.672 DMÑPsittacines LH LM  MHÑParthenogenesis ANonly /drug eff /rad eff MNG8.520.689 LH  PM68 HN68(64) MHÑPartial Pressure ANNIM; no qualif MNH1.671.691.714 LH  MSTest of the intrinsic (factors VIII, IX, XI, and XII) and common (fibrinogen, prothrombin, factors V and X) pathways of coagulation in which a mixture of plasma and phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides) is recalcified and the time required for the appearance of fibrin strands measured. Activation may be provided by contact with the glass tube or exposure to activators (e.g., ellagic acid, particulate silicates such as diatomaceous earth or kaolin) before addition of the calcium chloride. Used as a screening test and to monitor heparin therapy. Synonyms: PTT, APTT. HN(80) MHÑPartial Thromboplastin Time ANNIM; only /vet PIBlood Coagulation Tests (66-79); Thromboplastin (66-79) MNE1.223.459.153.580 XSActivated Partial Thromboplastin Time; Cephalin-Kaolin Coagulation Time; Kaolin-Cephalin Coagulation Time; Thromboplastin Time, Partial DMÑBlood Coagulation Tests LH LS; ; ; LM  MSDevices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy. PM78 HN78 MHÑParticle Accelerators ANonly /class /hist /stand /supply /util (if by MeSH definition) PIFast Neutrons (71-77); Neutrons (66-77); Nuclear Medicine (67-77) MNH1.671.579.705 XSBetatrons; Cyclotrons; Linear Accelerators; Synchrocyclotrons; Synchrotrons LH LS; ; ; ;  PM73 HN73 MHÑParticle Size ANNIM; no qualif MNH1.181.529.665 LH  MSA voluntary contract between two or more doctors who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses. PM68 HN68 MHÑPartnership Practice ANonly /hist /legis /organ /stand /trends; coord IM with med or other specialty (IM); do not confuse with GROUP PRACTICE but do not interpret: use word of text PIGroup Practice (66-67); Group Practice, Dental (67) MNN4.452.758.671 XUÑPartnership Practice, Dental LH LU  MSA voluntary contract between two or more dentists who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses. HN(72) MHÑPartnership Practice, Dental ANonly /hist /legis /organ /stand /trends; coord IM with specific dent specialty (IM); do not confuse with GROUP PRACTICE, DENTAL but do not interpret: use word of text PIDentistry (66-71); specific dentistry specialty; Partnership Practice (68-71) MNN4.452.758.671.589 XSAssociateship Practice, Dental DMÑPartnership Practice LH LS LM  MSA disease of pregnant and lactating cows and ewes leading to generalized paresis and death. The disease which is characterized by hypocalcemia, occurs at or shortly after parturition in cows and within weeks before or after parturition in ewes. PM75 HN75 MHÑParturient Paresis ANanimal only, exper or vet; do not use /congen /vet; in cows & ewes: check tags ANIMAL + FEMALE + PREGNANCY & don't forget CATTLE DISEASES (IM) + CATTLE (NIM) or SHEEP DISEASES (IM) + SHEEP (NIM) PIHypocalcemia/VE (66-74) MNC22.695 XSMilk Fever, Animal LH LS  MSLow molecular weight, calcium binding muscle proteins. Their physiological function is possibly related to the contractile process. HN(77) MHÑParvalbumins AN/biosyn /physiol permitted; do not use /analogs PIMuscle Proteins (73-76) MND12.776.34.700; D12.776.210.500.750 DMÑMuscle Proteins LH LM  MSVery small DNA viruses unique among vertebrate viruses in that their genome is a single linear molecule of single-stranded DNA. Some members of the genus are independently infectious in some but not all cell systems; others (the Adeno-Associated Viruses) are ╥satellite╙ viruses that multiply only in the presence of a helper virus. OLuse PARVOVIRIDAE to search PARVOVIRUSES back thru 19174 PM81; was PARVOVIRUSES 1974-80; ALEUTIAN MINK DISEASE VIRUS was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85 HN81; was PARVOVIRUSES 1974-80 MHÑParvoviridae ANfrom parvo (small); PICODNAVIRUSES = pico (tiny) + DNA virus; do not confuse with PAPOVAVIRIDAE; do not use /blood-csf-urine /cytol; infection = PARVOVIRUS INFECTIONS MNB4.909.204.671 XSPicodnaviruses XUÑAleutian Mink Disease Virus; ÑFeline Infectious Enteritis Virus; ÑLatent Rat Virus; ÑMinute Virus of Mice LH LS LU; ; ;  PM84 HN84 MHÑParvovirus Infections PIDog Diseases (66-83); Parvoviridae (81-83); Virus Diseases (66-83) MNC2.256.700 LH  MSAn evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. PM67 HN67(65) MHÑPassive Cutaneous Anaphylaxis ANonly /drug eff /rad eff MNE1.223.495.862.539; E1.862.539; G4.610.143.754 XSANAPHYLAXIS, PASSIVE CUTANEOUS; PCA LH LS;  MSA personality disorder characterized by aggressive behavior manifested in passive ways, such as pouting, procastination, and stubbornness. These behaviors are the indirect expression of resistance to demands for adequate performance in both occupational and social functioning. OLto search PASSIVE-AGGRESSIVE PERSONALITY use PASSIVE-AGGRESSIVE PERSONALITY DISORDER back thru 1975 & PERSONALITY DISORDERS 1968-74 HN(81); was PASSIVE-AGGRESSIVE PERSONALITY see under PERSONALITY DISORDERS 1968-80 MHÑPassive-Aggressive Personality Disorder ANdo not use /drug eff /physiol /rad eff MNF3.709.597.562 XSPersonality Disorder, Passive-Aggressive DMÑPersonality Disorders LH LS LM  MHÑPasteurella ANdo not use /blood-csf-urine; infection = PASTEURELLA INFECTIONS or its specifics MNB3.475.600 LH  MSInfections with bacteria of the genus Pasteurella. PM64 HN64 MHÑPasteurella Infections ANGEN; prefer specifics MNC1.252.662 XSPasteurellosis XUÑHemorrhagic Septicemia; ÑShipping Fever LH LS LU;  MSCounseling or comfort given by ministers, priests, rabbis, etc., to those in need of help with emotional problems or stressful situations. OLuse PASTORAL CARE to search PSYCHOLOGY, PASTORAL back thru 1966 PM79; was PSYCHOLOGY, PASTORAL 1963-78 HN79; was PSYCHOLOGY, PASTORAL 1963-78 MHÑPastoral Care ANSPEC: SPEC qualif MNF2.784.176.560; F2.880.410 XSPsychology, Pastoral LH LS  MSSkin tests in which the sensitizer is applied to a patch of cotton cloth or gauze held in place for approximately 48-72 hours. Used for elicitation of a contact hypersensitivity reaction. OLsearch SKIN TESTS 1966-74 HN(75) MHÑPatch Tests ANonly /instrum /methods MNE1.223.495.862.640; E1.862.640 DMÑSkin Tests LH LM  MHÑPatella AN/inj permitted: do not convert to KNEE INJURIES MNA2.835.232.484.624 LH  MSExclusive legal rights or privileges applied to inventions, plants, etc. MHÑPatents ANonly /hist /legis MNI1.880.604.583.652 LH  MSAge of the father. PM77 HN77 MHÑPaternal Age ANno qualif MNG7.168.700 LH  MSThe behavior patterns associated with or characteristic of a father. PM69 HN69 MHÑPaternal Behavior ANhuman & animal; no qualif PIChild Psychology (66-68); Parent-Child Relations (66-68) MNF1.145.688; F1.829.263.370.330 LH  MSProlonged separation of the offspring from the father. PM69 HN69 MHÑPaternal Deprivation ANhuman & animal; no qualif MNF1.829.263.370.380 LH  MSEstablishing the father relationship of a man and a child. MHÑPaternity ANno qualif MNI1.198.560.766 FXÑBlood Groups LH LX  MH*Pathologic Processes (Non Mesh) MNC23.739 LH  MSA specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process. MHÑPathology ANSPEC only: SPEC qualif; prefer /pathol with organs & diseases: Manual 19.5+; definition of /pathol applicable to PATHOLOGY: Manual 21.23+, 23.3.1; ╥postmortem pathol╙: consider AUTOPSY or CADAVER or merely /pathol MNG2.403.790.480 LH  MSHospital department which administers and provides pathology services. HN(Aug 77) MHÑPathology Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: PATHOL DEP MNN2.278.354.422.535; N4.452.442.422.535 XSHospital Pathology Department DMÑHospital Departments LH LS LM  MSA subspecialty of pathology which deals with the laboratory analysis of specimens of human blood and other fluids. PM80 HN80 MHÑPathology, Clinical ANSPEC only: SPEC qualif; spec dealing with lab anal of human blood & other specimens; do not use as NIM coord: use /pathol with organs & diseases: Manual 19.5+ PIPathology (66-79) MNG2.403.790.480.522 LH  MSA dental specialty concerned with pathology of the oral cavity. PM70 HN70 MHÑPathology, Oral ANSPEC only: SPEC qualif; not for MOUTH /pathol nor MOUTH DISEASES PIPathology (66-69) MNE6.685; G2.163.876.506 LH  MSA field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment. MHÑPathology, Surgical ANSPEC only: SPEC qualif MNG2.403.790.480.600 LH  MSThe field of veterinary medicine concerned with the causes of and changes produced in the body by disease. MHÑPathology, Veterinary ANSPEC only; SPEC qualif; not a substitute for /pathol of organs or dis in vet animals nor for ANIMAL DISEASES or specific animal dis MNG2.956.465 LH  MSThe seeking and acceptance by patients of health service. PM75 HN75 MHÑPatient Acceptance of Health Care ANno qualif; DF: PATIENT ACCEPT PIAttitude to Health (68-74) MNF1.145.76.347.570 XSAcceptability of Health Care; Health Care Seeking Behavior LH LS;  MSThe process of accepting patients; includes patients accepted for medical and nursing care in a hospital or other health care institution. PM78 HN78 MHÑPatient Admission ANonly /econ /legis /trends; PATIENT READMISSION is available PIHospitalization (66-77) MNN2.421.589.473.650 LH  MSPromotion and protection of the rights of patients; frequently through a legal process. PM76 HN76 MHÑPatient Advocacy ANonly /econ /hist /legis /stand /trends PIHuman Rights (73-75) MNI1.880.604.473.600; N3.706.437.600 XSPatient Ombudsmen; Patient Representatives; Patients' Rights; Right to Treatment FXÑCommitment of Mentally Ill LH LS; ; ; LX  OL╥patient care╙ is indexed under the specifics here or NURSING CARE & its specifics MH*Patient Care Characteristics (Non Mesh) MNN2.421.589 LH  MH*Patient Care Management (Non Mesh) MNN4.590 LH  MSUsually a written medical and nursing care program designed for a particular patient. PM68 HN68 MHÑPatient Care Planning ANdo not use /educ /util (except by MeSH definition) MNN4.590.233.624 XSNursing Care Plans FXÑAfter Care; ÑConsumer Participation LH LS LX;  MSCare of patients by a multidisciplinary team usually organized under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient. PM68 HN68 MHÑPatient Care Team ANdo not use /man /supply /util (except by MeSH definition); consider also NURSING, TEAM PINursing, Team (66-67); Progressive Patient Care (66-67) MNN4.590.715 XSHEALTH CARE TEAM; Interdisciplinary Health Team; MEDICAL CARE TEAM LH LS; ;  MSVoluntary cooperation of the patient in following a prescribed regimen. OLto search PATIENT NON-COMPLIANCE use PATIENT COMPLIANCE back thru 1982 & PATIENT DROPOUTS 1975-81 PM75; PATIENT NON-COMPLIANCE was see PATIENT DROPOUTS 1975-81 HN75; PATIENT NON-COMPLIANCE was see PATIENT DROPOUTS 1975-81 MHÑPatient Compliance ANno qualif; voluntary cooperation of patient in following a prescribed regimen PICooperative Behavior (71-74) MNF1.145.256.400 XSPatient Cooperation; Patient Non-Compliance; Treatment Refusal FXÑPatient Dropouts LH LS; ; LX  MSAccounting procedures in determining credit status, and methods of obtaining payment. HN(78) MHÑPatient Credit and Collection ANonly /legis /methods /stand /trends; DF: PATIENT CREDIT MNN3.219.463.30.320 XSCredit and Collection, Patient DMÑAccounting LH LS LM  MSThe administrative process of discharging the patient, live or dead; includes patients discharged from the hospital or other health facility. PM78 HN78 MHÑPatient Discharge ANonly /econ /legis /trends PIHospitalization (66-77) MNN2.421.589.473.690 XSDischarge Planning LH LS  PM74 HN74 MHÑPatient Dropouts ANonly /psychol MNM1.643.673 FXÑAttitude to Health; ÑPatient Compliance LH LX;  MSThe teaching or training of patients concerning their own health needs. OLto search PATIENTS /ED use PATIENT EDUCATION back thru 1966 (with no qualif 1966-79) PM80; was PATIENTS /education 1966-79 HN80; was PATIENTS /education 1966-79 MHÑPatient Education ANonly /econ /hist /legis /man /methods /organ /stand /trends CATALOG: /geog /form MNI2.233.332.500; N2.421.143.827.407.680; N2.421.726.407.680 XSEducation of Patients LH LS  MSA special service provided by volunteers to accompany patients who need help in moving about the health facility. HN(Aug 77) MHÑPatient Escort Service ANonly /econ /legis /organ /stand /trends /util MNN2.350.952.473.310 DMÑHospital Volunteers LH LM  MSOrganized procedures for establishing patient identity, including use of bracelets, etc. PM78 HN78 MHÑPatient Identification Systems ANonly /stand; DF: PATIENT ID SYSTEMS MNN4.452.653 LH  MSIsolation of patients who are sources of or highly susceptible to infection. PM77 HN77 MHÑPatient Isolation ANonly /econ /instrum /methods /nurs /psychol /trends /util (if by MeSH definition); DF: PATIENT ISOL PIBacterial Infections/PC (72-76); Cross Infection (66-76); Patient Isolators (66-76) MNE2.770 XSIsolation, Patient FXÑCross Infection; ÑQuarantine LH LS LX;  PM68 HN68 MHÑPatient Isolators ANonly /econ /stand /supply; DF: do NOT shorten: short form can be confused with PATIENT ISOL above PICross Infection/PC (66-67); Equipment and Supplies, Hospital (66-67); Germ-Free Life (66-67) MNE7.430.755 XSLIFE ISLANDS FXÑCross Infection LH LS LX  MSPatient involvement in the decision-making process in matters pertaining to health. PM78 HN78 MHÑPatient Participation AN╥patient involvement in the decision-making process in matters pertaining to health╙; do not confuse with PATIENT COMPLIANCE (see note there); no qualif MNN2.421.143.262.300; N3.540.245.360.300 FXÑAttitude to Health LH LX  MSSubsequent admissions of a patient to a hospital or other health care institution for treatment. OLuse PATIENT READMISSION to search HOSPITAL READMISSION back thru 1970 (as Prov 1970-71) PM78; was HOSPITAL READMISSION 1972-77 HN78; was HOSPITAL READMISSION 1970-77 (Prov 1970-71) MHÑPatient Readmission ANonly /econ /legis /trends PIHospitalization (66-69) MNN2.421.589.473.750 XSHospital Readmission LH LS  MSInterfacility or intrahospital transfer of patients. Intrahospital transfer is usually to obtain a specific kind of care and interfacility transfer is usually for economic reasons as well as type of care provided. PM87 HN87 MHÑPatient Transfer AN╥interfacility or intrahospital transfer╙: do not confuse with TRANSPORTATION OF PATIENTS; only /econ /legis /methods /organ MNN2.421.589.473.800 XSPatient Dumping FXÑTransfer Agreement LH LS LX  OLsearch PATIENTS /ED under PATIENT EDUCATION back thru 1966 PM/education ( = PATIENT EDUCATION as of 1980) was used for indexing 1966-79; OUTPATIENTS was see AMBULATORY CARE 1978-79 HN/education was used for indexing 1966-79; was in Cat G & M 1963-67 MHÑPatients ANGEN only: note specific XU refs below; patients as people or as a social, sociol, psychol, etc., group; do not confuse the patient with the disease: the ╥tuberculotic patient╙ = TUBERCULOSIS & not also PATIENTS; only /psychol; /educ = PATIENT EDUCATION; Manual 34.19 MNM1.643 XUÑInpatients; ÑOutpatients LH LU;  MSRooms occupied by one or more individuals during a stay in a health facility; includes aspects of environment, design, care or economics. HN(80) MHÑPatients' Rooms ANdo not use /educ /man /methods /organ /supply /util (except by MeSH definition); note X ref WARDS, GENERAL but special care wards = HOSPITAL UNITS or specific PIHospital Units (74-79) MNN2.278.220.640 XSPrivate Rooms; Rooms, Patient; Semi-Private Rooms; Wards, General DMÑHealth Facilities LH LS; ; ; LM  PM73; was see under AUTOMATIC DATA PROCESSING 1968-72 HN78(66); was see under AUTOMATIC DATA PROCESSING 1968-72 MHÑPattern Recognition ANno qualif; not physiological: physiol pattern recognition is PATTERN RECOGNITION, VISUAL MNL1.725 LH  MSVisually perceived characters, shapes, displays or designs. OLsearch FORM PERCEPTION 1968-74 HN(75) MHÑPattern Recognition, Visual ANonly /drug eff /physiol /rad eff MNF2.463.593.932.869.435.673 DMÑForm Perception LH LM  MS4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one. A mycotoxin produced by several pecies of Aspergillus and Penicillium. It is found in unfermented apple and grape juice and field crops. It has antibiotic properties and has been shown to be carcinogenic, mutagenic and causes chromosome damage in biological systems. Frequently encountered synonyms: Clavacin; Claviform; Expansin; Mycoin; Penicidin. HN(75) MHÑPatulin ANdo not use /defic /physiol; /analogs NIM only RN149-29-1 PIFurans (66-74); Pyrans (66-74) MND3.383.663.670; D24.185.926.587.725; D26.191.708 DMÑPyrans LH LM  MSMeasurement of the maximum rate of airflow attained during a forced vital capacity determination. Common abbreviations are PEFR and PFR. HN(75) MHÑPeak Expiratory Flow Rate ANNIM; in texts as PEFR & PFR MNE1.302.796.624.390.790 XSExpiratory Peak Flow Rate DMÑForced Expiratory Flow Rates LH LS LM  MSA leguminous annual herb, Arachis hypogaea, that yields edible seeds containing high quality proteins, several lectins, and oils. HNwas in Cat J only 1963-80 MHÑPeanuts ANas plant & food; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.570.721; B6.510.645.721; J1.341.739.673; J1.341.956.570.721 XSArachis; Groundnuts LH LS;  MHÑPectins ANdo not use /analogs /defic /physiol MND9.203.698.670; D19.316.161.674; D19.461.775.591 LH  MHÑPectoralis Muscles MNA2.633.674 LH  MSPersons academically trained to provide medical care, under the supervision of a physician, to infants and children. OLsearch PHYSICIANS' ASSISTANTS 1971-74 HN(75) MHÑPediatric Assistants ANdo not use /man /methods MNM1.526.485.67.740.750; N2.350.84.771.674 DMÑPhysicians' Assistants LH LM  MSThe nursing care of children from birth to adolescence; it includes clinical and psychological aspects of nursing care. PM67 HN67 MHÑPediatric Nursing ANSPEC; SPEC qualif PINursing (66); Nursing Care (66); Pediatrics (66) MNG2.478.676.631; N2.421.533.691 LH  MSA medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence. MHÑPediatrics ANSPEC: SPEC qualif; when permitted for ╥pediatric dis╙: Manual 28.9 MNG2.403.776.671 LH  MHÑPediculosis ANinfestation with lice, not restricted to infestation with genus Pediculus; head lice: coord IM with SCALP (NIM) MNC3.211.641 FXÑLice LH LX  MSLice of the genus Pediculus. OLsearch LICE 1966-74 PM75; was see under LICE 1963-74 HN75; was see under LICE 1963-74 MHÑPediculus ANa genus of lice; /microbiol /parasitol permitted; infestation = PEDICULOSIS PILice (66-74) MNB1.131.617.564.159.716 LH  PM68 HN68 MHÑPedigree ANhuman & animal; NIM; no qualif; for ╥family tree╙ or genealogical trees PIGenetics (66-67); Genetics, Medical (66-67) MNE5.393.673 LH  MHÑPediococcus ANdo not use /blood-csf-urine MNB3.525.800.653 LH  MSA dental specialty that includes training the child to accept dentistry; restoring and maintaining the primary, mixed, and permanent dentitions in children; and prevention of caries and periodontal disease in children. PM65; was PEDODONTIA 1963-64 HN65; was PEDODONTIA 1963-64 MHÑPedodontics ANSPEC: SPEC qualif MNE6.701; G2.163.876.563 FXÑTOOTH, DECIDUOUS LH LX  MSA psychosexual disorder involving sexual activity with prepubertal children as the objects. It may involve fantasy or any form of heterosexual or homosexual intercourse. OLsearch PARAPHILIAS 1969-74 HN(75); was see under SEX DEVIATION 1969-80 MHÑPedophilia ANdo not use /drug eff /physiol /rad eff MNF3.709.597.608.700.580 DMÑParaphilias LH LM  MSGroup composed of associates of same species, approximately same age and usually of similar rank or social status. PM68 HN68 MHÑPeer Group ANno qualif PIGroup Processes (66-67) MNF1.829.316.483 LH  MSAn organized procedure carried out by a select committee of professionals in evaluating the performance of other professionals in meeting the standards of practice of their specialty; applies particularly to the provision of health care to patients. PM71 HN71 MHÑPeer Review ANonly /methods /stand /trends PIMedical Assistance (68-70); Quality of Health Care (68-70) MNN4.452.758.788.507; N4.761.610 LH  MHÑPelger-Huet Anomaly MNC15.378.553.696 LH  MSA condition in which microscopic pools of blood are present throughout the liver parenchyma, which may lead to congestion and necrosis. HN(81) MHÑPeliosis Hepatis PILiver Diseases (66-80) MNC6.552.802 DMÑLiver Diseases LH LM  MHÑPellagra ANconsider also VITAMIN B DEFICIENCY MNC18.654.223.133.699.529 LH  MHÑPelvic Bones AN╥cephalopelvic proportion╙: index under PELVIMETRY MNA2.835.232.611 LH  MHÑPelvic Exenteration ANdo not use /util except by MeSH definition MNE4.584 LH  MHÑPelvic Neoplasms ANinternal pelvic organs & region, not bones; if referring to pelvic region as an external site (as in skin lesions) ignore; GEN: prefer specific precoord; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl if possible (IM) MNC4.588.699 LH  MSMeasurement of the dimensions and capacity of the pelvis. MHÑPelvimetry ANNIM; do not use /util except by MeSH definition; ╥cephalopelvic proportion╙ goes here MNE1.249.591; E1.706.682; E5.118.785 LH  MHÑPelvis ANinternal pelvic region, not PELVIC BONES; if referring to pelvic region as an external site (as in skin lesions) ignore; /surg: consider also PELVIC EXENTERATION; pelvic disease is prob ADNEXITIS MNA1.673 LH  MS2-Imino-5-phenyl-4-oxazolidinone. Used as central nervous system stimulant in geriatrics, Minimal Brain Dysfunction, etc; also to treat hyperkinesis in children. Synonyms: Cylert; Deltamine; Hyton; Kethamid; Ronyl; Tradon; Volital. OLuse PEMOLINE to search PEMOLINE COMPOUNDS back thru 1966 (as Prov 66-69) PM79; was PEMOLINE COMPOUNDS 1970-78 HN79; was PEMOLINE COMPOUNDS 1966-78 (Prov 1966-69) MHÑPemoline ANdo not use /biosyn /defic /physiol RN2152-34-3 MND3.383.548.673; D15.128.710 XSPhenoxazole; Phenylisohydantoin LH LS;  MSA chronic blistering disease with predilection for mucous membranes and less frequently the skin and with a tendency to scarring. Sometimes called ocular pemphigoid because of involvement of the mucous membranes of the conjunctiva. HN(81) MHÑPemphigoid, Benign Mucous Membrane AN╥pemphigoid╙ unspecified goes under PEMPHIGOID, BULLOUS PISkin Diseases (66-75); Skin Diseases, Bullous (76-80) MNC17.816.670 XSPemphigoid, Cicatricial DMÑSkin Diseases, Bullous LH LS LM  MSA chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. HN(81) MHÑPemphigoid, Bullous AN╥pemphigoid╙ unspecified & parapemphigus go here PISkin Diseases (66-75); Skin Diseases, Bullous (76-80) MNC17.816.690; C20.111.730 DMÑSkin Diseases, Bullous LH LM  MHÑPemphigus ANdo not confuse with ╥pemphigoid╙: see two entries above MNC17.816.716; C20.111.736 LH  MHÑPempidine ANdo not use /biosyn /defic /physiol RN79-55-0 MND16.653.396.591; D18.162.679 LH  MS1-(tert-Butylamino)-3-(2-cyclopentylphenoxy)-2-propanol. Nonselective beta blocker used as antihypertensive; also has antianginal properties. Synonyms: Hoe 893d; 39893 D. HN(79) MHÑPenbutolol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN36507-48-9 PIAmino Alcohols (66-73); Propanolamines (74-78) MND2.33.329.624.690; D16.848.215.600 DMÑPropanolamines LH LM  MS1-4,4-bis(p-Fluorophenyl)butyl -4-(4-chloro-alpha,alpha,alpha-trifluoro-m-tolyl)-4-piperidinol. Long acting major tranquilizer used for maintainance or long-term therapy of schizophrenia and other psychoses. HN(75) MHÑPenfluridol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26864-56-2 PIHydrocarbons, Halogenated (71-74); Piperidines (71-74); Toluene (73-74) MND3.383.621.620; D15.236.872.331.615 DMÑPiperidines LH LM  PM64 HN64(63) MHÑPenicillamine ANdo not use /defic /physiol RN52-67-5 MND12.125.166.786; D26.241.768 XSDIMETHYLCYSTEINE; MERCAPTOVALINE LH LS;  OLuse PENICILLANIC ACIDS to search PENICILLANIC ACID back thru 1971 (as Prov 1971-72) PM75; was PENICILLANIC ACID 1973-74 HN75; was PENICILLANIC ACID 1971-74 (Prov 1971-72) MHÑPenicillanic Acids ANdo not use /analogs /defic /physiol; do not confuse with PENICILLIC ACID PIPenicillins (66-70); Thiazoles (66-70) MND3.438.671 LH  MS3-Methoxy-5-methyl-4-oxo-2,5-hexadienoic acid (in tautomeric equilibrium with its lactone). A mycotoxin with antibiotic and carcinogenic activity produced by various strains of Penicillium, by Aspergillus ochraceus and Aspergillus melleus. Has been found in tobacco, sausages and corn. HN(75) MHÑPenicillic Acid ANdo not confuse with PENICILLANIC ACIDS; do not use /defic /physiol; /analogs NIM only RN90-65-3 PICaproates (69-74); Keto Acids (72-74); Lactones (73-74) MND2.241.81.193.467.700; D24.185.926.587.735; D26.191.712 DMÑCaproates LH LM  MSPenicillin amidohydrolase. Catalyzes the hydrolysis of penicillin to penicin and a carboxylic acid anion. HN(75) MHÑPenicillin Amidase ANdo not use /analogs RNEC 3.5.1.11 PIAmidohydrolases (70-74); Penicillins (70-74) MND8.586.277.87.690 XSPenicillin Acylase; Penicillin Amidohydrolase DMÑAmidohydrolases LH LS; LM  PMPENICILLIN G, BENZATHINE & PENICILLIN G, PROCAINE were headings 1963-84 MHÑPenicillin G ANdo not use /biosyn /defic /physiol RN61-33-6 MND20.85.99.739.762 XSBENZYLPENICILLIN XUÑPenicillin G, Benzathine; ÑPenicillin G, Procaine; ÑSulbenicillin LH LS LU; ;  HN(85)63 MHÑPenicillin G, Benzathine ANdo not use /biosyn /defic /physiol RN1538-09-6 MND20.85.99.739.762.683 XSBenzathine Penicillin DMÑPenicillin G LH LS LM  HN(85)63 MHÑPenicillin G, Procaine ANdo not use /biosyn /defic /physiol RN6130-64-9 MND20.85.99.739.762.693 DMÑPenicillin G LH LM  MSNonsusceptibility of an organism to the action of penicillins. PM64 HN64 MHÑPenicillin Resistance ANonly /drug eff /genet /rad eff MNG4.185.515.286.592; G5.386.310.592; G5.706.310.592; G12.392.269.592 LH  MS3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1- azabicyclo/3.2.0/-heptane-2-carboxylic acid. Broadspectrum penicillin antibiotic used orally. OLuse PENICILLIN, PHENOXYMETHYL/AA to search PROPICILLIN 1966-84 (as Prov 1966-72) PMPROPICILLIN was heading 1973-84 HNPROPICILLIN was heading 1964-84 (Prov 1964-72) MHÑPenicillin, Phenoxymethyl ANdo not use /biosyn /defic /physiol RN87-08-1 MND20.85.99.739.773 XSPENICILLIN V LH LS  PM84,63-78; was see under BETA-LACTAMASES 1979-83 HN84(79)63; was see under BETA-LACTAMASES 1979-83 MHÑPenicillinase ANdo not use /analogs RNEC 3.5.2.6 MND8.586.277.87.180.697 XSBeta-Lactamase I LH LS  OLuse PENICILLINS to search PENICILLIN back thru 1966 & HETACILLIN 1974-84 PM75; was PENICILLIN 1963-74; /adverse effects /poisoning /toxicity were PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84 HN75; was PENICILLIN 1963-74; /ad-poi-tox was PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84 MHÑPenicillins ANcheck text for a specific if possible; do not use /analogs /defic /physiol MND20.85.99.739 XUÑCyclacillin; ÑTicarcillin LH LU;  MHÑPenicillium ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.662 XUÑPenicillium Chrysogenum LH LU  MSA deuteromycetous fungal species used in the production of penicillin. HN(72) MHÑPenicillium Chrysogenum ANdo not use /anat /embryol /microbiol /parasitol PIPenicillium (66-71) MNB5.354.381.546.662.592 DMÑPenicillium LH LM  PM66 HN66 MHÑPenile Diseases ANinflamm dis = BALANITIS MNC12.294.494 LH  MSThe state of the penis when the erectile tissue becomes filled with blood and causes the penis to become rigid and elevated. PM86 HN86 MHÑPenile Erection ANonly /drug eff /rad eff PIPenis (66-85) MNG8.520.900.460 XSTumescence, Penile LH LS  MHÑPenile Induration MNC12.294.494.508; C23.205.714 XSCAVERNITIS, FIBROUS; PEYRONIE'S DISEASE LH LS;  MHÑPenile Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945.440.715; C12.294.494.591 LH  MHÑPenis ANinflammation = BALANITIS MNA5.360.444.492 FXÑCircumcision LH LX  MHÑPennsylvania MNZ1.107.567.875.708 LH  MSFixed sums paid regularly to individuals. MHÑPensions ANno qualif MNN1.824.417.510 XSRetirement Benefits FXÑAged LH LS LX  HN(71); was see under PHENOLS 1971-76 MHÑPentachlorophenol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN87-86-5 PIHerbicides (66-70); Phenols (66-70) MND2.755.190.633; D5.723.366.690; D8.373.936.642 DMÑChlorophenols LH LM  MHÑPentaerythritol Tetranitrate ANdo not use /biosyn /defic /physiol RN78-11-5 MND2.33.618.706.690; D18.918.716 LH  PM73 HN73(72) MHÑPentagastrin ANdo not use /biosyn /defic /physiol RN5534-95-2 PIGastrointestinal Hormones (66-71); Peptides (66-71) MND6.472.317.413.593; D12.644.456.716; D19.316.629.441.593 LH  MSp,p'-(Pentamethylenedioxy)dibenzamidine. Antiprotozoal agent effective in trypanosomiasis, leishmaniasis and some fungal infections; may cause diabetes mellitus, central nervous system damage and other toxic effects. HN(75) MHÑPentamidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN100-33-4 PIAmidines (72-74); Phenyl Ethers (74) MND2.78.100.700; D21.370.750; D21.370.884.600 XSPentamidine Isethionate DMÑAmidines LH LS LM  MSFive-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. PM78 HN78 MHÑPentanes ANdo not use /analogs /biosyn /defic /physiol; does not include pentenes ( = ALKENES), pentadienes ( = ALKADIENES); CYCLOPENTANES is also available PIAlkanes (66-77); Hydrocarbons (66-77) MND2.455.326.146.770 XSIsopentanes LH LS  OLsearch VALERATES 1966-74 HN(75) MHÑPentanoic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.465.895.593; D2.241.81.944.509; D10.516.251.400.895.593 DMÑValerates LH LM  MS5-carbon straight-chain or branched-chain ketones. HN(75) MHÑPentanones ANdo not use /analogs /biosyn /defic /physiol PIKetones (66-74) MND2.522.720 XSDiethyl Ketones; Methyl Propyl Ketones DMÑKetones LH LS; LM  PM66 HN66(64) MHÑPentazocine ANdo not use /biosyn /defic /physiol RN359-83-1 MND3.132.610.422.106.700; D14.73.153.675 LH  MHÑPentobarbital ANdo not use /biosyn /defic /physiol RN76-74-4 MND3.383.742.698.253.593; D14.166.111.593; D14.591.220.593 XSMebubarbital; Mebumal LH LS;  MHÑPentolinium Tartrate ANdo not use /biosyn /defic /physiol RN52-62-0 MND16.653.396.643; D18.162.703 LH  MSA sulfated pentosyl polysaccharide with heparin-like properties used in treatment of thromboses, inflammation and as an enzyme inhibitor. Synonyms: Fibrase; Hemoclar; Tavan; CB 8061; SP 54. HN(75) MHÑPentosan Sulfuric Polyester AN/analogs NIM only RN11096-31-4 PIPolysaccharides (70-74); Sulfuric Acids (72-74) MND9.203.698.682; D19.461.119.655 XSPentosan Polysulfate; Polypentose Sulfate DMÑPolysaccharides LH LS; LM  MSA pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. PM85 HN85 MHÑPentosephosphate Pathway ANonly /drug eff /rad eff PIHexosephosphates (66-84); Pentosephosphates (66-84) MNG6.535.760 XSHexose Monophosphate Shunt; Pentose Phosphate Shunt; Pentose Shunt LH LS; ;  MHÑPentosephosphates ANdo not use /analogs; /metab: consider also PENTOSEPHOSPHATE PATHWAY MND9.203.894.643 XUÑPhosphoribosyl Pyrophosphate; ÑRibosemonophosphates; ÑRibulosephosphates LH LU; ;  MHÑPentoses ANGEN; do not use /analogs; pentose shunt, pentose pathway = PENTOSEPHOSPHATE PATHWAY MND9.203.546.627 XUÑXylulose LH LU  PM72 HN72 MHÑPentosyltransferases ANdo not use /analogs RNEC 2.4.2. PITransferases (66-71) MND8.586.913.647 XUÑATP Phosphoribosyltransferase; ÑAdenine Phosphoribosyltransferase; ÑAmidophosphoribosyltransferase; ÑAnthranilate Phosphoribosyltransferase; ÑOrotate Phosphoribosyltransferase; ÑPurine Nucleoside Phosphorylases; ÑThymidine Phosphorylase; ÑUridine Phosphorylase LH LU; ; ; ; ; ; ;  MS3,7-Dimethyl-1-(5-oxohexyl)xanthine. Theobromine derivative vasodilator agent that also inhibits phosphodiesterases; used mostly in peripheral vascular disturbances. Synonyms: BL 191; Trental. HN(77) MHÑPentoxifylline ANdo not use /biosyn /defic /physiol RN6493-05-6 PIXanthines (72-76) MND3.132.956.701.700; D3.438.759.758.824.651.700; D18.918.861.739 DMÑTheobromine LH LM  MS5-Hydroxymethyl-6-methyl- 2,4-(1H,3H)-pyrimidinedione. Uracil derivative used in combination with toxic antibiotics to lessen their toxicity; also to stimulate leukopoiesis and immunity. Synonyms: pentoksil; hydroxymethylmethyluracil. HN(80) MHÑPentoxyl ANdo not use /biosyn /defic /physiol RN147-61-5 PIUracil (66-74) /AA (75-79) MND3.383.742.698.875.700 DMÑUracil LH LM  MHÑPentylenetetrazole ANdo not use /biosyn /defic /physiol; Cardiazol & Metrazol go here RN54-95-5 MND3.383.66.600; D15.128.224.765 XSLEPTAZOLE; Pentamethylenetetrazole; Pentetrazole LH LS; ;  MHÑPepsin AN/biosyn /physiol permitted; do not use /analogs RNEC 3.4.23.1 MND8.586.277.656.732.618; D19.316.720 FXÑGastric Juice LH LX  PM72 HN72 MHÑPepsinogen AN/biosyn /physiol permitted; do not use /analogs RN9001-10-9 PIEnzyme Precursors (66-71); Pepsin (66-71) MND8.444.509 FXÑGastric Juice LH LX  MSN-acylated oligopeptides isolated from culture filtrates of Actinomycetes, which act specifically to inhibit acid proteases such as pepsin and renin. HN(75) MHÑPepstatins ANdo not use /analogs PIOligopeptides (73-74) MND8.373.745.725; D12.644.456.724 DMÑOligopeptides LH LM  MSUlcer that occurs in those portions of the alimentary tract which come into contact with gastric juice containing pepsin and acid. It occurs when the amount of acid and pepsin is sufficient to overcome the gastric mucosal barrier. MHÑPeptic Ulcer ANGEN: prefer STOMACH ULCER or DUODENAL ULCER but note GASTRODUODENAL ULCER = PEPTIC ULCER; stress ulcer: coord with STRESS or STRESS, PSYCHOLOGICAL (IM or NIM); /drug ther: consider also ANTI-ULCER AGENTS MNC6.405.613 XSGASTRODUODENAL ULCER FXÑGASTRECTOMY; ÑUlcer; ÑZOLLINGER-ELLISON SYNDROME XUÑMarginal Ulcer LH LS LX; ; LU  MHÑPeptic Ulcer Hemorrhage ANIM + coord with STOMACH ULCER /compl or DUODENAL ULCER /compl (IM) MNC6.405.348.718; C6.405.613.627; C23.542.516.718 XSHEMORRHAGE, PEPTIC ULCER LH LS  MSPenetration of a peptic ulcer through the stomach wall. May be free, i.e., at a point where the stomach wall faces a real or potential space,, or confined, i.e., at a point where the stomach wall is defended by contiguous or adjacent structures, such as the pancreas. MHÑPeptic Ulcer Perforation ANIM + coord with STOMACH ULCER /compl or DUODENAL ULCER /compl (IM) MNC6.405.613.698 LH  MSA mixture of six peptides of melphalan; used as a broad-spectrum antineoplastic due to its alkylating and antimetabolic actions; toxic to bone marrow, gastrointestinal system and vasculature. HN(75); was see under NITROGEN MUSTARD COMPOUNDS 1975-80 MHÑPeptichemio ANdo not use /biosyn /defic /physiol RN9076-25-9 PINitrogen Mustard Compounds (74); Peptides (74) MND2.455.526.728.650.594.690; D12.644.490; D22.204.585.613.698 DMÑMelphalan LH LM  PM73 HN73(71) MHÑPeptide Chain Elongation ANIM; coord with specific peptide (IM); only /drug eff /rad eff PIPeptides/BI (66-70) MNG5.331.914.543; G6.535.770.543 FXÑPEPTIDE ELONGATION FACTORS LH LX  PM73 HN73(71) MHÑPeptide Chain Initiation ANIM; coord with specific peptide (IM); only /drug eff /rad eff PIPeptides/BI (66-70) MNG5.331.914.643; G6.535.770.643 FXÑPEPTIDE INITIATION FACTORS LH LX  PM73 HN73(71) MHÑPeptide Chain Termination ANIM; coord with specific peptide (IM); only /drug eff /rad eff PIPeptides/BI (66-70) MNG5.331.914.743; G6.535.770.743 FXÑPEPTIDE TERMINATION FACTORS LH LX  MSA protein found in bacteria and eukaryotic cells which delivers aminoacyl-tRNA's to the A site of the ribosome. The aminoacyl-tRNA is first bound to a complex of elongation factor Tu containing a molecule of bound GTP. The resulting complex is then bound to the 70S initiation complex. Simultaneously the GTP is hydrolyzed and a Tu-GDP complex is released from the 70S ribosome. The Tu-GTP complex is regenerated from the Tu-GDP complex by the Ts elongation factor and GTP. PM86 HN86 MHÑPeptide Elongation Factor Tu AN/biosyn /physiol permitted; DF: EFTU PIBacterial Proteins (66-72); Peptide Elongation Factors (73-85); Peptides (66-72); Proteins (66-72) MND12.644.508.500 XSBacterial Elongation Factor Tu; Elongation Factor Tu LH LS;  PM73 HN73 MHÑPeptide Elongation Factors AN/biosyn /physiol permitted; do not use /analogs PIBacterial Proteins (66-72); Peptides (66-72); Proteins (66-72) MND12.644.508 FXÑPeptide Chain Elongation LH LX  PM74 HN74 MHÑPeptide Fragments ANdo not use /analogs MND12.644.541 FXÑPeptide Mapping LH LX  PMINSULINASE was see under PEPTIDE PEPTIDOHYDROLASES 1963-74 MHÑPeptide Hydrolases ANdo not use /analogs; /antag = PROTEASE INHIB RNEC 3.4. MND8.586.277.656 XSPROTEASES; PROTEOLYTIC ENZYMES XUÑBrinolase; ÑInsulinase; ÑReptilase LH LS; LU; ;  PM73 HN73 MHÑPeptide Initiation Factors AN/biosyn /physiol permitted; do not use /analogs PIBacterial Proteins (66-72); Peptides (66-72); Proteins (66-72) MND12.644.574 FXÑPeptide Chain Initiation LH LX  MSTwo-dimensional separation and analysis of peptides. PM87 HN87 MHÑPeptide Mapping ANonly /instrum /methods PIChromatography, Paper (66-86); Electrophoresis, Paper (73-86) MNE5.196.181.400.454.720; E5.196.401.319.720; E5.196.700; H1.181.278.186.400.454.720; H1.181.278.414.236.720 XSFingerprints, Peptide FXÑPeptide Fragments LH LS LX  MHÑPeptide Peptidohydrolases ANdo not use /analogs; /antag = PROTEASE INHIB RNEC 3.4. MND8.586.277.656.732 XSEndopeptidases; Proteinases XUÑAcrosin; ÑEnteropeptidase; ÑFicin; ÑProcollagen Peptidase LH LS; LU; ; ;  MSA 27-amino acid peptide with histidine at the N-terminal and isoleucine amide at the C-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory and central nervous sytems. PM87 HN87 MHÑPeptide PHI AN/biosyn /physiol permitted; not for dipeptide histidine-isoleucine PIGastrointestinal Hormones (66-86); Peptides (66-86) MND12.644.680; D12.776.641.650.610 XSNeuropeptide PHI 27; PHI Peptide; Peptide Histidine-Isoleucine; Peptide PHM LH LS; ; ;  OLconsider also PEPTIDES /BI & TRANSLATION, GENETIC MH*Peptide Synthesis (Non Mesh) MNG6.535.770 LH  PM73 HN73 MHÑPeptide Synthetases ANdo not use /analogs RNEC 6.3.2. PILigases (66-72) MND8.586.464.677 XUÑGamma-Glutamyl-Cysteine Synthetase; ÑGlutathione Synthetase LH LU;  PM73 HN73 MHÑPeptide Termination Factors AN/biosyn /physiol permitted; do not use /analogs PIBacterial Proteins (66-72); Peptides (66-72); Proteins (66-72) MND12.644.608 FXÑPeptide Chain Termination LH LX  MHÑPeptides ANdo not use /analogs /defic; /anal: consider also PEPTIDE MAPPING; GASTRIC INHIBITORY POLYPEPTIDE & PANCREATIC POLYPEPTIDE are also available; fewer than 13 amino acids = OLIGOPEPTIDES; peptide conformation: coord PEPTIDES or specific peptide (IM) + PROTEIN CONFORMATION (NIM); FUNGAL PEPTIDES see FUNGAL PROTEINS is available; ╥primary structure╙ = AMINO ACID SEQUENCE, ╥secondary structure╙ = PROTEIN CONFORMATION, ╥tertiary structure╙ = MACROMOLECULAR SYSTEMS - all NIM coords with specific peptide (IM) MND12.644 XSPOLYPEPTIDES XUÑAnaphylatoxins; ÑMyocardial Depressant Factor; ÑPolyglutamic Acid; ÑUrotensins LH LS LU; ; ;  PM73 HN73(71) MHÑPeptides, Cyclic ANdo not use /analogs /biosyn /defic /physiol PIPeptides (66-70) MND12.644.641 LH  PM73 HN73(71) MHÑPeptidoglycan ANa bact polysaccharide; coord IM with specific bacterium (IM) & do not coord with POLYSACCHARIDES, BACTERIAL; do not use /defic /physiol PIMucopolysaccharides (66-70); Polysaccharides, Bacterial (66-70) MND9.203.698.718.594; D12.644.233.594; D12.776.395.560.800; D24.611.216.161.616.594 XSMUREIN LH LS  MSA part of the 50 S ribosomal subunit in protein synthesis. Transfers aminoacyl-tRNA to formyl-methionine-tRNA or peptidyl-tRNA during peptide chain elongation. HN(75) MHÑPeptidyl Transferases ANdo not use /analogs RNEC 2.3.2.12 PIAcyltransferases (72-74); Peptides (72-74); Peptide Elongation Factors (73-74) MND8.586.913.50.800; D12.644.508.600 XSPeptidyl Translocases; Transpeptidases DMÑAcyltransferases LH LS; LM  MSA family of bacteria found in the mouth and intestinal and respiratory tracts of man and other animals; frequently in the human female urogenital tract. Also found in soil and on cereal grains. PM76 HN76 MHÑPeptococcaceae ANin man, animals, soil; do not use /blood-csf-urine PIBacteria (66-77); Lactobacillaceae (75); Micrococcaceae (75) MNB3.525.700 LH  MHÑPeptococcus ANdo not use /blood-csf-urine MNB3.525.700.593 LH  MHÑPeptones ANdo not use /analogs MND12.776.719 LH  MHÑPeptostreptococcus ANdo not use /blood-csf-urine MNB3.525.700.719 LH  MSEthaneperoxoic acid. Strong oxidizing agent. Liquid with an acrid odor that is corrosive to the skin. HN(75) MHÑPeracetic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN79-21-0 PIAcetic Acids (69-74); Peroxides (69-74) MND1.655.498.631.600; D2.241.81.38.700 XSAcetyl Hydroperoxide; Peroxyacetic Acid DMÑAcetic Acids LH LS; LM  MS10-[3-(4-Methyl-1-piperazinyl)propyl]phenothiazine. Major tranquilizer of the phenothiazine type. Synonyms: Pemazine; Pernazine; Psytomin; Taxilan. HN(76) MHÑPerazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN84-97-9 PIPhenothiazine Tranquilizers (73-75); Piperazines (72-75) MND3.494.741.575; D15.236.872.331.628.553 DMÑPhenothiazine Tranquilizers LH LM  MSThe process by which the nature and meaning of sensory stimuli are recognized and interpreted. MHÑPerception ANonly /drug eff /physiol /rad eff MNF2.463.593 FXÑSENSATION LH LX  MSThe tendency to perceive an incomplete pattern or object as complete or whole; includes Gestalt Law of Closure. OLuse PERCEPTUAL CLOSURE to search GESTALT LAW OF CLOSURE back thru 1969 PM69 HN69; GESTALT LAW OF CLOSURE was see under PERCEPTUAL CLOSURE 1969-78 MHÑPerceptual Closure ANonly /physiol PIForm Perception (66-68); Visual Perception (66-68) MNF2.463.593.932.677 XSGestalt Law of Closure; PERCEPTUAL COMPLETION PHENOMENA LH LS;  MSSelective perceiving such that the individual protects himself from becoming aware of something unpleasant or threatening, e.g., obscene words are not heard correctly, or violent acts are not seen accurately. PM70 HN70(65) MHÑPerceptual Defense ANno qualif MNF1.393.628; F3.407.628 LH  MSDisturbances in recognizing and interpreting sensory stimuli dependent upon one's previous experience. PM69 HN69 MHÑPerceptual Disorders ANdo not use /drug eff /physiol /rad eff PIAgnosia (66-68); Hallucinations (66-68); Illusions (66-68); Perception (66-68); Phantom Limb (66-68) MNF3.126.185.794 FXÑPerceptual Distortion XUÑAuditory Perceptual Disorders LH LX LU  MSLack of correspondence between the way a stimulus is commonly perceived and the way an individual perceives it under given conditions. PM69 HN69(67) MHÑPerceptual Distortion ANonly /physiol PIPerception (66) MNF2.463.593.603 FXÑPERCEPTUAL DISORDERS LH LX  MSThe interference of one perceptual stimulus with another causing a decrease or lessening in perceptual effectiveness. PM72 HN72 MHÑPerceptual Masking ANonly /physiol PIAuditory Perception (67-71); Auditory Threshold (68-71); Visual Perception (66-71) MNF2.463.593.71.594; F2.463.593.932.733 XSMasking, Perceptual LH LS  MSA common name for fish belonging to the order Perciformes with many genera and species. HN(87) MHÑPerch ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.602.600 XSCichlid Fish; Perca DMÑPerciformes LH LS; LM  MHÑPerchloric Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.494; D1.396.343.676; D1.655.498.631.644 LH  MSThis order is the most diversified of all fish orders and is the largest vertebrate order; includes many of the commonly known fish such as porgies, croakers, mullets, dolphin fish, etc. PM87 HN87 MHÑPerciformes ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; BASS and PERCH are also available PIFishes (66-86) MNB2.493.602 XSBluegill; Croakers; Dolphin Fish; Lyomis; Mullets; Porgies; Sparid Fish; Sparus; Sunfish XUÑBass; ÑPerch LH LS; ; ; ; ; ; ; ; LU;  MSAct of striking a part with short, sharp blows as an aid in diagnosing the condition beneath the sound obtained. MHÑPercussion ANonly /instrum /methods /vet MNE1.706.716 LH  MSTetrahydro-2-(nonafluorobutyl)-furan. Synonyms: FX-80; FC-80. HN(75); was see under FURANS 1975-77 MHÑPerfluorobutyl Tetrahydrofuran ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26446-59-3 PIFurans (71-74); Hydrocarbons, Fluorinated (74) MND2.375.750; D3.300.750; D3.383.312.710 XSFC-80; Perfluorochemical FC-80 DMÑFluorocarbons LH LS; LM  MHÑPerfume ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MND26.313.676; J1.516.694 LH  MHÑPerfusion ANdo not use /util MNE5.680 LH  MSNeoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part. OLuse PERFUSION, REGIONAL to search ISOLATION PERFUSION (now ISOLATION PERFUSION THERAPY see PERFUSION, REGIONAL) 1966-77 PM78; was ISOLATION PERFUSION 1964-77 HN78; was ISOLATION PERFUSION 1963-77 (Prov 1963) MHÑPerfusion, Regional ANrestricted to a special technic in cancer ther; do not use /util except by MeSH definition; do not confuse with INFUSIONS, INTRA-ARTERIAL which is also used in cancer ther; not for ╥isolated perfusion╙ or ╥perfusion of isolated organs╙ in physiological studies (index under PERFUSION + organ) MNE4.292.550; E5.300.690 XSIsolation Perfusion Therapy; Regional Perfusion FXÑAntineoplastic Agents LH LS; LX  MS8 beta-((Methylthio)methyl)-6-propylergoline. A long-acting dopamine agonist which is effective in the treatment of Parkinson's disease and hyperprolactinemia. It has also been observed to have antihypertensive effects. PM87 HN87 MHÑPergolide ANdo not use /biosyn /defic /physiol RN66104-22-1 PIErgolines (69-86); Ergot Alkaloids (66-86) MND3.132.327.287.800; D3.549.439.800; D14.307.725 XSPergolide Mesylate LH LS  MS2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort; may cause neuropathy and hepatitis. Synonyms: perhexilline; Pexid. PM84; was see under PIPERIDINES 1975-83 HN84(73); was see under PIPERIDINES 1975-83, was Prov 1973-74 MHÑPerhexiline ANdo not use /biosyn /defic /physiol RN6621-47-2 PIPiperidines (66-74) MND3.383.621.644; D18.192.754; D18.918.754 LH  PM68 HN68 MHÑPerianal Glands ANanimal only PIAnus (66-67) MNA10.336.635; A13.734 XSCIRCUMANAL GLANDS FXÑExocrine Glands LH LS LX  MSAcute abscess is severe local reaction to bacterial invasion of pulp tissue or an exacerbation of a chronic apical abscess or granuloma. Chronic abscess is long-standing low-grade infection resulting from pulp death or pre-existing acute apical abscess. PM65 HN65 MHÑPeriapical Abscess ANdo not confuse with PERIODONTAL ABSCESS: note X refs below MNC1.539.26.657; C7.465.690.700.700 XSAbscess, Periapical; Alveolar Abscess, Apical; Dentoalveolar Abscess, Apical; Periapical Periodontitis, Suppurative; Periodontitis, Apical, Suppurative LH LS; ; ; ;  MSDiseases of the periapical tissue. PM80 HN80 MHÑPeriapical Diseases ANinflamm dis = PERIAPICAL PERIODONTITIS PIPeriapical Tissue (72-79); Periodontal Diseases (66-79) MNC7.465.690 LH  MSChronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment. OLuse PERIAPICAL GRANULOMA to search GRANULOMA, PERIAPICAL back thru 1966 PM80; was GRANULOMA, PERIAPICAL 1965-79 HN80; was GRANULOMA, PERIAPICAL 1965-79 MHÑPeriapical Granuloma ANnon-neoplastic MNC7.465.690.700.740; C23.484.694 XSDENTAL GRANULOMA; Granuloma, Periapical; Periapical Periodontitis, Chronic Nonsuppurative; Periodontitis, Apical, Chronic Nonsuppurative LH LS; ; ;  MSInflammation of the periapical tissue. Use for general, unspecified, or acute nonsuppurative inflammation. Chronic nonsuppurative inflammation is PERIAPICAL GRANULOMA. Suppurative inflammation is PERIAPICAL ABSCESS. PM80 HN80 MHÑPeriapical Periodontitis ANGEN, unspecified or acute nonsuppurative; chronic nonsuppur = PERIAPICAL GRANULOMA; suppur = PERIAPICAL ABSCESS PIPeriodontal Diseases (66-79); Periodontitis (66-79) MNC7.465.690.700 XSPeriodontitis, Apical LH LS  MSTissue surrounding the apex of a tooth, including the apical portion of the periodontal membrane and alveolar bone. PM73 HN73(72) MHÑPeriapical Tissue ANdiseases = PERIAPICAL DISEASES; inflammation = PERIAPICAL PERIODONTITIS PIPeriodontium (66-71) MNA14.254.646.700 XSPeriodontium, Apical LH LS  MSCentral gray matter surrounding the cerebral aqueduct in the mesencephalon. Physiologically probably involved in rage reactions, the lordosis reflex, feeding responses, bladder tonus, and pain. PM83 HN83 MHÑPeriaqueductal Gray ANdo not use /innerv PIBrain (66-82); Cerebral Aqueduct (71-82); Mesencephalon (66-82) MNA8.186.211.132.659.822.595 XSMesencephalic Central Gray; Midbrain Central Gray LH LS;  MHÑPeriarteritis Nodosa MNC14.907.184.595; C14.907.940.90.720; C23.205.720 XSESSENTIAL POLYARTERITIS; NECROTIZING ARTERITIS; POLYARTERITIS NODOSA LH LS; ;  MHÑPeriarthritis MNC5.550.114.678; C5.550.251.595 LH  MSPresence of fluid within the pericardium. OLuse PERICARDIAL EFFUSION to search HEMOPERICARDIUM back thru 1969 PM66; HEMOPERICARDIUM was see under PERICARDIAL EFFUSION 1969-83, was in Cat A & C 1969-83 HN66; was in Cat A & C 1966-83 MHÑPericardial Effusion MNC14.280.695 XSHemopericardium FXÑCardiac Tamponade; ÑExudates and Transudates LH LS LX;  MHÑPericarditis MNC14.280.720 LH  PM64; PICK'S DISEASE OF HEART was see under PERICARDITIS 1963 HN64; PICK'S DISEASE OF HEART was see under PERICARDITIS 1963 MHÑPericarditis, Constrictive MNC14.280.720.595 XSCONSTRICTIVE PERICARDITIS; PICK'S DISEASE OF HEART LH LS;  MSInfection of the pericardium with tubercle bacilli; arises by contiguous extension of tuberculous lesions of the hilar or mediastinal lymph nodes or by pleuropulmonary tuberculosis. OLsearch TUBERCULOSIS, CARDIOVASCULAR 1966-74 HN(75) MHÑPericarditis, Tuberculous MNC1.252.40.552.846.561.595; C14.280.720.801; C14.826.595 DMÑTuberculosis, Cardiovascular LH LM  MSThe fibroserous sac surrounding the heart and the roots of the great vessels. MHÑPericardium ANdo not use /blood supply; inflammation = PERICARDITIS or its specifics; simple mediastinal cyst adjacent to pericardium = MEDIASTINAL CYST (do not coord with PERICARDIUM); epicardium goes here MNA7.541.795; A10.615.789.470 LH  PM65 HN65 MHÑPericoronitis MNC7.465.714.258.771 LH  OLsearch LABYRINTHINE FLUIDS 1966-74 HN(75) MHÑPerilymph ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.207.571.678 DMÑLabyrinthine Fluids LH LM  MSDetermination of the extent of the visual field for various types and intensities of stimuli. MHÑPerimetry ANdo not use /util except by MeSH definition MNE1.210.935.595 XSCampimetry FXÑVisual Fields LH LS LX  MSA field of medicine concerned with the mother, fetus and infant, usually for the first month of life. PM77 HN77 MHÑPerinatology ANSPEC: SPEC qualif; = mother + fetus/newborn inf: differentiate from NEONATOLOGY, the newborn inf only CATALOG: use with form qualif instead of FETAL DISEASES /form or FETAL DISEASES /form coord with INFANT, NEWBORN, DISEASES /form or FETUS /form coord with INFANT, NEWBORN /form PIObstetrics (66-76); Pediatrics (66-76) MNG2.403.776.671.500 FXÑPrenatal Care LH LX  MHÑPerinephritis MNC12.777.419.685 LH  MHÑPerineum MNA1.719 LH  MSA histochemical stain based on oxidation by periodic acid of a substance containing the 1,2 glycol grouping. The resulting dialdehyde reacts with Schiff reagent to form a colored product. Substances demonstrated include carbohydrates, mucins, matrix of cartilage, collagen, reticulum, basement membranes, fibrin, thyroid colloid, amyloid, glomerular hyaline deposits, and a number of other secretions or tissue constituents. HN(77); was see under STAINS AND STAINING 1977-78 MHÑPeriodic Acid-Schiff Reaction ANno qualif PIHistocytochemistry (66-76); Periodic Acids (66-76); Stains and Staining (66-76) MNE5.909.262.607.790; E5.909.432.551.790; E5.909.715.790 XSPAS Reaction DMÑHistocytochemistry LH LS LM  MHÑPeriodic Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.520; D1.396.661.771; D1.655.498.631.745 LH  MHÑPeriodic Disease ANa specific dis entity: see Dorland; not for periodically occurring dis ( = PERIODICITY (IM) + disease (IM)) MNC23.768 XSFamilial Mediterranean Fever; Mediterranean Fever, Familial LH LS;  MHÑPeriodicals ANIM; only /econ /hist /stand; med periodicals: do not coord with MEDICINE CATALOG: /geog /form MNL1.178.682.829.678 XSNewsletters LH LS  MSThe tendency of a phenomenon to recur a regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequent (ultradian). MHÑPeriodicity ANIM + coord with specific dis for periodically occurring dis (IM); no qualif; do not confuse with PERIODIC DISEASE, a specific clin entity: see Dorland MNG7.450.730; H1.862.645 XSBioperiodicity; Biorhythms; Cyclicity; Rhythmicity FXÑBiological Clocks; ÑCircadian Rhythm LH LS; ; ; LX;  MSLocalized circumscribed purulent area of inflammation in the periodontal tissue. A derivative of marginal periodontitis and commonly associated with suprabony and infrabony pockets and interradicular involvements, in contrast to periapical abscess which is attributable to pulp necrosis. OLto search ABSCESS, PERIODONTAL use PERIODONTAL ABSCESS back thru 1975 & PERIODONTITIS 1966-74 HN(80); was ABSCESS, PERIODONTAL see under PERIODONTITIS 1965-79 MHÑPeriodontal Abscess ANdo not confuse with PERIAPICAL ABSCESS: see X refs there MNC1.539.26.671; C7.465.714.533.650 XSAbscess, Periodontal DMÑPeriodontitis LH LS LM  PM65 HN65 MHÑPeriodontal Cyst ANnon-neoplastic; coord IM with precoord organ/dis term (IM) MNC4.182.89.530.690.790; C5.500.470.690.790; C7.465.714.470 LH  PM65; was PERIODONTAL DISEASE 1963-64 HN65; was PERIODONTAL DISEASE 1963-64 MHÑPeriodontal Diseases AN╥parodontosis╙ goes here; inflamm dis = PERIODONTITIS; periodont dis-related terms from other categories: Bull 94 (Feb 77) CATALOG: form qualif = PERIODONTICS /form MNC7.465.714 XSPyorrhea Alveolaris XUÑPeriodontosis LH LS LU  PM73 HN73(71) MHÑPeriodontal Dressings AND25-26 qualif PIDental Materials (66-70) MND25.339.719; E6.721.595 LH  MSA numerical rating scale for classifying the periodontal status of a person or population with a single figure which takes into consideration prevalence as well as severity of the condition. It is based upon probe measurement of periodontal pockets and on gingival tissue status. PM70 HN70(66) MHÑPeriodontal Index ANno qualif; includes gingival index: do not coord with GINGIVA unless particularly discussed; PBI or papillary bleeding index goes here MNE6.208.720; E6.721.658; G3.890.160.215; N1.224.458.251.720 LH  PM73 HN73(72) MHÑPeriodontal Ligament AN= alveolodental ligament or membrane; intraligamental anesthesia = ANESTHESIA, INTRALIGAMENTAL, DENTAL see ANESTHESIA, DENTAL PIPeriodontium (66-71) MNA14.254.646.771 LH  MSAn abnormal extension of a gingival sulcus accompanied by the apical migration of the epithelial attachment and bone resorption. HN(79) MHÑPeriodontal Pocket ANGINGIVAL POCKET is also available PIGingival Pocket (75-78); Periodontal Diseases (72-78); Periodontitis (66-78) MNC7.465.714.533.750 XSPocket, Periodontal DMÑPeriodontitis LH LS LM  PM66 HN66 MHÑPeriodontal Prosthesis ANdo not use /util except by MeSH definition MNE6.721.721 XUÑPeriodontal Splints LH LU  OLto search SPLINTS, PERIODONTAL use PERIODONTAL SPLINTS back thru 1975 & PERIODONTAL PROSTHESIS 1966-74 HN(80); was SPLINTS, PERIODONTAL see under PERIODONTAL PROSTHESIS 1966-79 MHÑPeriodontal Splints ANdo not use /util except by MeSH definition MNE6.721.721.680 XSSplints, Periodontal DMÑPeriodontal Prosthesis LH LS LM  MSA dental specialty concerned with the histology, physiology, and pathology of the tissues that support, attach, and surround the teeth, and of the treatment and prevention of disease affecting these tissues. PM65 HN65 MHÑPeriodontics ANSPEC: SPEC qualif CATALOG: use with form qualif instead of PERIODONTAL DISEASES /form MNE6.721; G2.163.876.623 LH  OLuse PERIODONTITIS to search PERICEMENTITIS back thru 1969 PM65 HN65; PERICEMENTITIS was see under PERIODONTITIS 1969-78 MHÑPeriodontitis MNC7.465.714.533 XSPericementitis FXÑSubgingival Curettage XUÑPeriodontal Abscess; ÑPeriodontal Pocket LH LS LX LU;  OLuse PERIODONTIUM to search TOOTH SUPPORTING STRUCTURES back thru 1966 PMTOOTH SUPPORTING STRUCTURES was heading 1965-67 HNTOOTH SUPPORTING STRUCTURES was heading 1965-67 MHÑPeriodontium ANinflammation = PERIODONTITIS MNA14.254.646 XSPARADENTIUM; TOOTH SUPPORTING STRUCTURES XUÑEpithelial Attachment LH LS; LU  MSSevere loss of attachment and destruction of bone adjacent to teeth in children, adolescents, or young adults. OLsearch PERIODONTAL DISEASES 1966-83 HN(84); was see PERIODONTAL DISEASES 1966-83 MHÑPeriodontosis PIPeriodontal Diseases (66-83) MNC7.465.714.533.800 XSPeriodontitis, Juvenile DMÑPeriodontal Diseases LH LS LM  MHÑPeriosteum ANdo not use /abnorm /growth /inj /innerv; inflammation = PERIOSTITIS; dental = PERIODONTAL LIGAMENT MNA10.165.265.746 LH  MHÑPeriostitis ANalveolar periostitis = DRY SOCKET MNC5.116.165.595 LH  MHÑPeripheral Nerve Diseases ANGEN: prefer specifics; IM for general or unspecified periph nerv dis; NIM coord with specific nerve (IM); ╥diabetic peripheral neuropathy╙: index only under DIABETIC NEUROPATHIES MNC10.772 LH  MHÑPeripheral Nerve Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with specific peripheral nerve (IM) + histol type of neopl (IM) MNC4.588.614.596; C10.772.643 LH  MHÑPeripheral Nerves ANGEN only; do not use as coord for specific nerves indexed with organ /innerv; do not use /innerv MNA8.796 LH  MSA genus of Blattidae containing several species with the most common being P. americana, the American cockroach. HN(75) MHÑPeriplaneta AN/microbiol /parasitol permitted MNB1.131.617.678.108.580 DMÑCockroaches LH LM  MHÑPerissodactyla ANincludes HORSES, asses, donkeys, zebras, tapirs, rhinoceroses; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.709 LH  OLsearch GASTROINTESTINAL MOTILITY 1967-74 HN(75) MHÑPeristalsis ANrestrict to digestive system, not other organs; only /drug eff /rad eff; esophageal peristalsis = ESOPHAGUS /physiol (IM) + PERISTALSIS (NIM) MNG10.261.482.596 DMÑGastrointestinal Motility LH LM  MSThe space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the stomach. The two sacs are connected by the foramen of Winslow, or epiploic foramen. MHÑPeritoneal Cavity AN╥peritoneal cells╙ = probably PERITONEAL CAVITY /cytol or ASCITIC FLUID /pathol if pertinent; /inj is probably PERITONEUM /inj MNA1.47.596.678 LH  PM66 HN66(64) MHÑPeritoneal Dialysis ANdo not use /class /man /rehabil /supply /util (except by MeSH definition) MNE2.510.721; E4.320.790 FXÑKIDNEY, ARTIFICIAL LH LX  MSPortable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution, usually five times a day. PM86; was see under PERITONEAL DIALYSIS 1982-85 HN86(82); was see under PERITONEAL DIALYSIS 1982-85 MHÑPeritoneal Dialysis, Continuous Ambulatory ANdo not use /class /man /rehabil /supply /util (except by MeSH definition); DF: CAPD PIAmbulatory Care (78-81); Peritoneal Dialysis (78-81) MNE2.472.106.790; E2.510.721.790; E4.320.790.790 LH  MHÑPeritoneal Diseases ANinflamm dis = PERITONITIS MNC6.772 LH  MHÑPeritoneal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.33.513; C6.772.616 LH  MSEndoscopic examination of the peritoneum. OLuse PERITONEOSCOPY to search LAPAROSCOPY back thru 1971 (as Prov 1971-72) PMLAPAROSCOPY was heading 1973-77 HNLAPAROSCOPY was heading 1971-77 (Prov 1971-72) MHÑPeritoneoscopy ANdo not use /util except by MeSH definition MNE1.418.764 XSLaparoscopy LH LS  MSAn operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. Used in treatment of intractable ascites. PM86; was see under VASCULAR SURGERY 1981-85 HN86(81); was see under VASCULAR SURGERY 1981-85 MHÑPeritoneovenous Shunt ANdo not use /util except by MeSH definition PIAscites (75-80); Jugular Veins (75-80); Peritoneal Cavity (75-80); Peritoneum (75-80); Vena Cava, Superior (75-80) MNE4.752.814.750; E4.765.790 XSAscites Shunt, Peritoneovenous; LeVeen Shunt LH LS;  MSEndothelial lining of the abdominal cavity, the parietal peritoneum covering the inside of the abdominal wall and the visceral peritoneum covering the bowel, the mesentery, and certain of the organs. The portion that covers the bowel becomes the serosal layer of the bowel wall. MHÑPeritoneum AN╥peritoneal cells╙ = probably PERITONEAL CAVITY /cytol or ASCITIC FLUID /pathol but not PERITONEUM /cytol; inflammation = PERITONITIS MNA1.47.596; A10.615.789.596 LH  MHÑPeritonitis ANtuberculous peritonitis = TUBERCULOSIS, PERITONEAL; chylous peritonitis = CHYLOPERITONEUM MNC6.772.661 LH  MHÑPermeability ANNIM; no qualif; vascular permeability: index CAPILLARY PERMEABILITY MNH1.181.529.687 LH  PM68 HN68(64) MHÑPermeases ANdo not use /analogs MND8.586.747 FXÑBiological Transport LH LX  MSThe attitude that grants freedom of expression and activity to another individual, but not necessarily with sanction or approval. HN(75) MHÑPermissiveness ANno qualif MNF1.145.76.675 DMÑAttitude LH LM  MSThe genus Peromyscus consists of 77 species. Two of these are widely used in medical research. They are: P. leucopus or the white footed mouse and P. maniculatus or the deer mouse. PM78 HN78 MHÑPeromyscus ANusually NIM; no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not check tag MICE PIMice (66-77) MNB2.649.865.360.510 XSMice, Deer; Mice, White-Footed LH LS;  PM72 HN72(71) MHÑPeroneal Nerve ANdo not use /innerv PILeg/IN (66-70); Spinal Nerves (66-70) MNA8.796.828.569.785.513 LH  MHÑPeroxidases ANdo not use /analogs RNEC 1.11.1. MND8.586.682.732 XUÑChloride Peroxidase; ÑCytochrome Peroxidase; ÑHorseradish Peroxidase; ÑLactoperoxidase LH LU; ; ;  MHÑPeroxides ANdo not use /analogs /biosyn /defic /physiol; HYDROGEN PEROXIDE & LIPID PEROXIDES are also available MND1.655.498.631 XUÑBenzoyl Peroxide LH LU  MHÑPerphenazine ANdo not use /biosyn /defic /physiol RN58-39-9 MND3.494.741.593; D15.236.872.331.628.594 LH  MSA syndrome of persistent pulmonary hypertension in the newborn infant, without demonstrable cardiac disease; characterized by cyanosis and acidosis, severe pulmonary vasoconstriction, hypertrophy of pulmonary arterial muscle, and elevated pulmonary vascular resistance, with resultant right-to-left shunting of blood through a patent ductus arteriosus and at times a patent foramen ovale. PM80 HN80 MHÑPersistent Fetal Circulation Syndrome ANdo not use /congen; check the tags HUMAN & INFANT, NEWBORN; DF: PFC SYNDROME PIDuctus Arteriosus, Patent (66-79); Hypertension, Pulmonary (66-79); Pulmonary Circulation (66-79) MNC14.907.489.531.694; C16.614.694 XSFetal Circulation, Persistent; Hypertension, Pulmonary, of Newborn, Persistent; Persistent Pulmonary Hypertension of Newborn LH LS; ;  MSHealth care provided to individuals. PM68 HN68 MHÑPersonal Health Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form PICommunity Health Services (66-67); specific care; specific service MNN2.421.631 LH  MSA subjective evaluation, judgment or attitude expressed by an individual with respect to the attainment of certain goals or needs based on his level of aspiration or expectation. PM72 HN72(70) MHÑPersonal Satisfaction ANno qualif PIAttitude (66-69) MNF1.145.76.747 LH  MSInvisible boundaries surrounding the individual's body which are maintained in relation to others. OLsearch SPATIAL BEHAVIOR 1974; to search BODY BUFFER ZONE use PERSONAL SPACE back thru 1975 & SPATIAL BEHAVIOR 1974 HN(75); BODY BUFER ZONE was see under SPATIAL BEHAVIOR 1974-78 MHÑPersonal Space ANno qualif MNF1.145.875.596 XSBody Buffer Zone; Privacy of Space DMÑSpatial Behavior LH LS; LM  MSBehavior-response patterns that characterize the individual. MHÑPersonality ANonly /drug eff MNF1.752 XUÑDependency (Psychology); ÑMachiavellianism; ÑTemperament LH LU; ;  MSThe determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term. PM68 HN68(66) MHÑPersonality Assessment ANby a professional; differentiate from PERSONALITY INVENTORY (by the person himself); no qualif MNF4.513 XUÑQ-Sort LH LU  MSGrowth of habitual patterns of behavior in childhood and adolescence. PM68 HN68 MHÑPersonality Development ANno qualif PIPersonality (66-67) MNF1.752.747 FXÑChild Development; ÑGROWTH; ÑGrowth; ÑSOCIALIZATION XUÑIndividuation LH LX; ; ; LU  MSA major deviation from normal patterns of behavior. OLuse PERSONALITY DISORDERS to search AS IF PERSONALITY back thru 1975 & IMPULSE-RIDDEN PERSONALITY & INADEQUATE PERSONALITY back thru 1968 PM68; COMPULSIVE PERSONALITY DISORDER was OBSESSIVE-COMPULSIVE PERSONALITY see under PERSONALITY DISORDERS 1975-80, was OBSESSIVE-COMPULSIVE PERSONALITY see under COMPULSIVE BEHAVIOR 1969-74; PARANOID PERSONALITY DISORDER was PARANOID PERSONALITY see under PARANOIA 1969-78 HN68; AS IF PERSONALITY was see under PERSONALITY DISORDERS 1975-78; IMPULSE-RIDDEN PERSONALITY & INADEQUATE PERSONALITY were see under PERSONALITY DISORDERS 1968-78 MHÑPersonality Disorders ANdo not use /drug eff /physiol /rad eff PIMental Disorders (66-67); Personality (66-67) MNF3.709.597 XSAs If Personality; Impulse-Ridden Personality; Inadequate Personality FXÑAnomie XUÑBorderline Personality Disorder; ÑCompulsive Personality Disorder; ÑDependent Personality Disorder; ÑParanoid Personality Disorder; ÑPassive-Aggressive Personality Disorder LH LS; ; LX LU; ; ; ;  MSCheck list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks. OLuse PERSONALITY INVENTORY to search MYERS-BRIGGS TYPE INDICATOR back thru 1969 PM68 HN68(66); MYERS-BRIGGS TYPE INDICATOR was see under PERSONALITY INVENTORY 1969-78 MHÑPersonality Inventory ANby the person himself: differentiate from PERSONALITY ASSESSMENT (by professionals); no qualif MNF4.711.647.513 XSMyers-Briggs Type Indicator XUÑCattell Personality Factor Questionnaire; ÑEdwards Personal Preference Schedule; ÑManifest Anxiety Scale; ÑTest Anxiety Scale LH LS LU; ; ;  MSStandardized objective tests designed to facilitate the evaluation of personality. OLsearch PSYCHOLOGICAL TESTS 1966-74 PM76; was see under PSYCHOLOGICAL TESTS 1963-74 HN76; was NON MESH 1975, was see under PSYCHOLOGICAL TESTS 1963-74 MHÑPersonality Tests ANonly /class /instrum /methods /stand MNF4.711.647 LH  MSManagement activities concerned with hospital employees. OLuse PERSONNEL ADMINISTRATION, HOSPITAL to search HOSPITAL PERSONNEL ADMINISTRATION back thru 1966 PM78; was HOSPITAL PERSONNEL ADMINISTRATION 1963-77 HN78; was HOSPITAL PERSONNEL ADMINISTRATION 1963-77 MHÑPersonnel Administration, Hospital ANonly /econ /legis /man /stand /trends MNN2.278.354.422.565; N4.452.442.422.565; N4.452.677.440 XSHospital Personnel Administration; Personnel, Hospital, Organization and Administration FXÑPersonnel Management LH LS; LX  MSDedication or commitment shown by employees to organizations or institutions where they work. HN(84) MHÑPersonnel Loyalty ANno qualif MNN4.452.677.460 DMÑPersonnel Management LH LM  MSPlanning, organizing and administering all activities related to personnel. MHÑPersonnel Management ANonly /econ /legis /man /methods /stand /trends MNN4.452.677 FXÑPersonnel Administration, Hospital XUÑEmployee Discipline; ÑEmployee Grievances; ÑEmployee Incentive Plans; ÑEmployee Performance Appraisal; ÑJob Application; ÑJob Description; ÑManagement Quality Circles; ÑPersonnel Loyalty; ÑPersonnel Selection; ÑPersonnel Staffing and Scheduling; ÑPersonnel Turnover; ÑStaff Development LH LX LU; ; ; ; ; ; ; ; ; ; ;  MSThe process of choosing employees for specific types of employment; includes recruitment. HN(Aug 77) MHÑPersonnel Selection ANonly /econ /educ /legis /man /methods /stand /trends MNN4.452.677.500 XSPersonnel Recruitment DMÑPersonnel Management LH LS LM  MSThe selection, appointing and scheduling of personnel. HN(75) MHÑPersonnel Staffing and Scheduling ANonly /stand /trends; DF: PERSONNEL STAFFING MNN4.452.677.650 XSStaffing and Scheduling DMÑPersonnel Management LH LS LM  MSComputer-based systems for use in personnel management in a facility, e.g., distribution of caregivers with relation to patient needs. HN(87) MHÑPersonnel Staffing and Scheduling Information Systems MNL1.700.508.300.680.800; N4.452.515.800 DMÑManagement Information Systems LH LM  MSA change or shift in personnel due to reorganization, resignation, or discharge. HN(83) MHÑPersonnel Turnover ANonly /econ /legis /trends MNN4.452.677.680 XSEmployee Turnover; Turnover, Personnel DMÑPersonnel Management LH LS; LM  MSThe manpower employed by the hospital. OLuse PERSONNEL, HOSPITAL to search HOSPITAL PERSONNEL back thru 1968 PM78; was HOSPITAL PERSONNEL 1968-77 HN78; was HOSPITAL PERSONNEL 1968-77 MHÑPersonnel, Hospital ANonly /educ /legis /psychol /stand /supply /trends /util; /organ = PERSONNEL ADMINISTRATION, HOSPITAL; consider also other terms under ADMINISTRATIVE PERSONNEL & ALLIED HEALTH PERSONNEL, etc.; ╥orderlies╙ & ╥ward attendants╙ unspecified go here except for PSYCHIATRIC AIDES (see note there) PIPersonnel Administration, Hospital (66-67) MNM1.526.485.740; N2.350.685 XSHospital Personnel LH LS  MSA mode of communication concerned with inducing or urging the adoption of certain beliefs, theories or lines of action by others. PM69 HN69 MHÑPersuasive Communication ANno qualif; consider also PSYCHOLOGICAL WARFARE & SUGGESTION PISuggestion (66-68) MNF1.145.209.631; L1.143.762 XSBrainwashing; PERSUASION LH LS;  MSAny of various biologically active proteins or toxins elaborated by Bordetella pertussis that cause the symptoms of whooping cough; some activate pancreatic islets, others inhibit the adenylate cyclase cascade and some cause lymphocytosis. PM86 HN86 MHÑPertussis Toxins ANdo not use /analogs /defic /diag use /physiol /secret RN70323-44-3 PIBacterial Proteins (66-85); Bacterial Toxins (77-85); Bordetella Pertussis (66-85); Toxins (66-76) MND24.185.926.123.720 XSBordetella Pertussis Toxins; IAP Pertussis Toxin; Islet-Activating Protein; Pertussigen FXÑBordetella Pertussis LH LS; ; ; LX  MHÑPertussis Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.135.535 FXÑBordetella Pertussis; ÑWhooping Cough LH LX;  MHÑPeru MNZ1.107.757.702 LH  MSDibenz(de, kl)anthracene. Polycyclic hydrocarbon soil and water pollutant; also used as fluorescent lipid probe in cytochemistry of membranes and other lipid structures; derivatives may be carcinogenic. Synonyms: peri-dinaphthalene. HN(79) MHÑPerylene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN198-55-0 PIBenzanthracenes (66-78); Polycyclic Hydrocarbons (74-78) MND4.615.117.306.700 XSPerilene DMÑBenzanthracenes LH LS LM  MHÑPessaries ANonly /adv eff /hist /stand /supply /vet; not restricted to contraception MNE7.858.499 XSVaginal Suppositories LH LS  MSThe reduction or regulation of the population of noxious, destructive, or dangerous insects or other animals. PM76 HN76; was NON MESH before 1976 MHÑPest Control ANonly /econ /hist /instrum /methods /stand /trends MNG3.850.180.600 LH  PM73 HN73 MHÑPest Control, Biological ANIM; coord with specific insect or other pest (IM) but not the precoords INSECT CONTROL & MOSQUITO CONTROL; only /econ /instrum /methods /stand /trends PIInsect Control (66-72); Mosquito Control (66-72); Rodent Control (66-72) MNG3.850.180.600.500 XSBIOLOGICAL PEST CONTROL FXÑChemosterilants; ÑInsect Control; ÑMosquito Control; ÑSterilization, Sexual LH LS LX; ; ;  PM73 HN73 MHÑPesticide Residues ANonly D25-26 qualif; not for drug residues: see note on BODY BURDEN PIPesticides (66-72) MND5.723.697; G3.850.460.670 LH  PM73 HN73(72) MHÑPesticide Synergists ANdo not use /analogs /biosyn /defic /physiol PIPesticides (66-71) MND5.723.748 FXÑDrug Synergism LH LX  MHÑPesticides ANvery general: prefer specifics or specific types; D25-26 qualif except /admin MND5.723 LH  MSA genus of Togaviridae, also known as mucosal disease virus group, that are not arthropod-borne. The type species is the bovine diarrhea virus. PM81; BOVINE DIARRHEA VIRUS was see under RNA VIRUSES 1975-80 HN81 MHÑPestiviruses ANone of the Togaviridae; do not use /blood-csf-urine /cytol; infection: coord NIM with TOGAVIRUS INFECTIONS (IM) MNB4.909.777.923.723 XUÑBovine Diarrhea Virus LH LU  MSA colloidal system of semisolid hydrocarbons obtained from petroleum; used as ointment base, topical protectant and lubricant. Synonyms: Cosmoline; Parenol; Saxoline; Stanolene; Vaseline. HNwas in Cat D only 1963-82 MHÑPetrolatum AND25-26 qualif RN8009-03-8 MND26.368.405.681; D26.698.523.685; J1.637.680.685 XSParaffin Jelly; Petroleum Jelly LH LS;  MSNaturally occurring complex liquid hydrocarbons which, after distillation, yield combustible fuels, petrochemicals, and lubricants. HNwas in Cat J only 1975-81, was in Cat D & J 1968-74, was in Cat D only 1963-67 MHÑPetroleum ANonly /ad-poi-tox /anal /class /hist /stand /supply MNG3.230.132.258.630; J1.435.723; J1.637.680; J1.740.400.700 XUÑFuel Oils; ÑGasoline; ÑKerosine LH LU; ;  MHÑPetrous Bone ANfractures: coord PETROUS BONE /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with SKULL NEOPLASMS (IM) MNA2.835.232.781.885.681 XSPETROUS PYRAMID LH LS  MSMultiple pigmented (melanin) macules of the skin and mouth mucosa and multiple polyposis of the small intestine. PM65; was see under POLYPI (now POLYPS) 1963-64 HN65; was see under POLYPI (now POLYPS) 1963-64 MHÑPeutz-Jeghers Syndrome MNC4.700.705; C4.799.411.598; C6.405.469.583.598; C16.466.700.705 LH  MSLymphoid tissue on the mucosa of the small intestine. PM85; was see under LYMPHOID TISSUE 1975-84 HN85(72); was see under LYMPHOID TISSUE 1975-84 MHÑPeyer's Patches PILymphoid Tissue (66-71) MNA10.549.598; A15.382.520.604.561 LH  MSA temperate inducible phage whose natural host is E. Coli K12. Its virion contains linear double-stranded DNA, except for 12 complementary bases at the 5' termini of the polynucleotide chains. The DNA circularizes on infection. OLto search BACTERIOPHAGE LAMBDA & LAMBDA PHAGE use PHAGE LAMBDA back thru 1980 & COLIPHAGES 1975-79 PM80; BACTERIOPHAGE LAMBDA & LAMBDA PHAGE were see COLIPHAGES 1975-79 HN80; BACTERIOPHAGE LAMBDA & LAMBDA PHAGE were see COLIPHAGES 1975-79 MHÑPhage Lambda ANdo not use /cytol PIColiphages (66-79) MNB4.123.205.545 XSBacteriophage Lambda; Coliphage Lambda; Lambda Phage LH LS; ;  MSA temperate coliphage composed of a linear double-stranded molecule of DNA, which is able to insert itself at random at any point on the host chromosome, frequently causing a mutation by interrupting the continuity of the bacterial operon at the site of insertion. PM80 HN80 MHÑPhage Mu 1 ANdo not use /cytol; do not confuse with PHAGE MU 2, an RNA phage PIColiphages (66-79) MNB4.123.205.610 XSBacteriophage Mu 1; Coliphage Mu 1; Mu 1 Phage LH LS; ;  MSThe prototype of the small virulent DNA coliphages, composed of a single strand of supercoiled circular DNA, which on infection, is converted to a double-stranded replicative form by a host enzyme. PM80 HN80 MHÑPhage Phi X 174 ANdo not use /cytol PIColiphages (66-79) MNB4.123.205.690 XSBacteriophage Phi X 174; Coliphage Phi X 174; Phi X 174 LH LS; ;  MSDisorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas. PM72 HN72 MHÑPhagocyte Bactericidal Dysfunction PIGranuloma (66-71); Immunologic Deficiency Syndromes (68-71); Phagocytosis (66-71) MNC15.378.553.774; C20.673.774 XUÑJob's Syndrome LH LU  PM73 HN73 MHÑPhagocytes ANA 11 qualif & /class PIPhagocytosis (66-72) MNA11.733; A15.382.680 FXÑReticuloendothelial System LH LX  MSThe engulfing of microorganisms, other cells, and foreign particles by phagocytic cells. MHÑPhagocytosis ANonly /drug eff /rad eff MNG4.335.487.350; G4.610.575.809; G9.188.763 FXÑLeukocytes; ÑMACROPHAGES; ÑOpsonins; ÑPhagosomes XUÑAutophagocytosis LH LX; ; ; LU  MSMembrane-bound cytoplasmic vesicles formed by invagination of phagocytized material. They fuse with lysosomes to form phagolysosomes in which the hydrolytic enzymes of the lysosome digest the phagocytized material. PM86 HN86 MHÑPhagosomes ANA 11 qualif except /cytol PILysosomes (66-85); Phagocytosis (66-85) MNA11.368.702.677 XSPhagolysosomes FXÑPhagocytosis LH LS LX  MSThe period of psychosexual development from 2 1/2 to 6 years during which sexual interest, curiosity, and pleasurable experience center about the genitals. OLsearch PSYCHOSEXUAL DEVELOPMENT 1968-74 HN(75) MHÑPhallic Stage ANno qualif MNF1.752.747.722.748; F2.739.794.793.748 DMÑPsychosexual Development LH LM  MSVery toxic polypeptide isolated mainly from Amanita phalloides (Agaricaceae) or death cup; causes fatal liver, kidney and CNS damage in mushroom poisoning; used in the study of liver damage. HN(75) MHÑPhalloidine ANdo not use /defic /physiol; /analogs NIM only RN17466-45-4 PIFood Poisoning (66-67); Mushroom Poisoning (68-74); Mushrooms (66-67); Peptides (66-72); Peptides, Cyclic (73-74) MND12.644.456.735; D12.644.641.735; D24.185.926.587.755 DMÑOligopeptides LH LM  MSThe feeling that an extremity which has been lost is still present. MHÑPhantom Limb ANdo not use /congen /drug eff /physiol /rad eff MNC10.597.44.723; C10.597.751.722; C23.888.592.43.723; C23.888.592.763.680; F3.126.185.794.748 FXÑAmputation Stumps LH LX  MSSubstances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include SOLVENTS, diluting agents, and suspending agents, and emulsifying agents. Also, ANTIOXIDANTS; PRESERVATIVES, PHARMACEUTICAL; DYES (coloring agents); FLAVORING AGENTS; VEHICLES; EXCIPIENTS; OINTMENT BASES. Synonyms: pharmaceutic necessities. PM68 HN68 MHÑPharmaceutic Aids AND25-26 qualif PIPharmacy (66-67); specific aid MND26.698 FXÑAntioxidants; ÑFood Additives XUÑOintment Bases; ÑPreservatives, Pharmaceutical LH LX; LU;  MSTotal pharmaceutical services provided by a qualified pharmacist. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist. PM68 HN68 MHÑPharmaceutical Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form PIPharmacy (66-67); Prescriptions (66-67) MNN2.421.668 LH  MSFacilities for the preparation and dispensing of drugs. OLuse PHARMACIES to search COMMUNITY PHARMACIES back thru 1968 HNCOMMUNITY PHARMACIES was see under PHARMACIES 1968-78 MHÑPharmacies ANthe place: do not confuse with PHARMACY, the field; do not use /educ CATALOG: /geog /form MNN2.278.678 XSCommunity Pharmacies LH LS  MSThose persons legally qualified by education and training to engage in the practice of pharmacy. PM68 HN68 MHÑPharmacists AN/educ = EDUCATION, PHARMACY; do not use /man /methods CATALOG: /geog /form PIPharmacy (66-67) MNM1.526.485.780; N2.350.720 LH  MSPersons who perform certain functions under the supervision of the pharmacist. PM71 HN71 MHÑPharmacists' Aides ANdo not use /man /methods PIHealth Manpower (68-70; Pharmacy (68-70) MNM1.526.485.67.763; N2.350.84.722 LH  MSA branch of genetics which deals with the genetic components of variability in individual responses to drugs. PM70 HN70(66) MHÑPharmacogenetics ANGEN: prefer specific drug & specific genetic aspect; only /rad eff MNG5.706 LH  MHÑPharmacognosy ANSPEC: SPEC qualif MNG1.273.118.598; G1.703.60 FXÑPLANTS, MEDICINAL LH LX  MSThe study of the origin, nature, properties, and actions of drugs and their effects on living organisms. MHÑPharmacology ANSPEC: SPEC qualif; the pharmacol of a drug or chem = Cat D term with /pharm; materia medica goes here (usually with /hist); /methods: consider TECHNOLOGY, PHARMACEUTICAL MNG1.703; G2.628 FXÑDrug Therapy LH LX  MSThe branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans. PM80 HN80 MHÑPharmacology, Clinical ANSPEC: SPEC qualif; do not use as NIM coord: the pharmacol of a drug or chem in humans = Cat D term with /pharm + HUMAN, not PHARMACOLOGY, CLINICAL PIPharmacology (66-79) MNG1.703.152 XSClinical Pharmacology LH LS  MHÑPharmacopoeias ANIM; specify country; only /hist /stand CATALOG: /geog /form MNL1.178.682.192.836.749 LH  MHÑPharmacopoeias, Homeopathic ANIM; only /hist /stand MNL1.178.682.192.836.749.599 FXÑHomeopathy LH LX  MSThe practice of compounding and dispensing medicinal preparations. MHÑPharmacy ANthe field: do not confuse with PHARMACIES; SPEC: SPEC qualif; /educ = EDUCATION, PHARMACY; /legislation & jurisprudence = LEGISLATION, PHARMACY or PHARMACY (IM) + JURISPRUDENCE (IM); /methods: consider TECHNOLOGY, PHARMACEUTICAL MNG2.646 FXÑCommunity Pharmacy Services; ÑPharmacy Service, Hospital; ÑPrescriptions, Drug; ÑTechnology, Pharmaceutical LH LX; ; ;  MSThe business and managerial aspects of pharmacy in its broadest sense. PM68 HN68 MHÑPharmacy Administration ANonly /econ /hist /legis /man /organ /stand /trends PIDrug Industry (66-67); Pharmacy (66-67) MNN4.452.706 FXÑFees, Pharmaceutical; ÑINSURANCE, PHARMACEUTICAL SERVICES LH LX;  MSAn advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department. PM68 HN68 MHÑPharmacy and Therapeutics Committee ANonly /econ /hist /legis /organ /stand /trends /util; DF: PHARM THER COMM or PHARMACY COMMITTEE PIPharmacy Service, Hospital (66-67) MNN4.452.758.788.682 XSDRUG COMMITTEE; FORMULARY COMMITTEE; THERAPEUTICS COMMITTEE FXÑFORMULARIES, HOSPITAL LH LS; ; LX  MSHospital department responsible for the receiving, storing, and distribution of pharmaceutical supplies. OLuse PHARMACY SERVICE, HOSPITAL to search HOSPITAL PHARMACY SERVICE back thru 1966 PM78; was HOSPITAL PHARMACY SERVICE 1963-77 HN78; was HOSPITAL PHARMACY SERVICE 1963-77 MHÑPharmacy Service, Hospital ANonly /econ /legis /man /organ /stand /trends /util MNN2.278.354.422.603; N2.421.668.556; N4.452.442.422.603 XSClinical Pharmacy Service; Hospital Pharmacy Service; Pharmacy Service, Clinical FXÑPharmacy LH LS; ; LX  MSGeneral or unspecified diseases of the pharynx. PM66 HN66 MHÑPharyngeal Diseases ANinflamm dis = PHARYNGITIS MNC9.775 FXÑOTORHINOLARYNGOLOGIC DISEASES LH LX  MSThe muscles of the pharynx are the inferior, middle and superior constrictors, salpingopharyngeus, and stylopharyngeus. HN(79) MHÑPharyngeal Muscles PIMuscles (66-78); Pharynx (66-78) MNA2.633.699; A14.724.617 DMÑMuscles LH LM  MHÑPharyngeal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.665.710; C9.775.549 XUÑHypopharyngeal Neoplasms; ÑOropharyngeal Neoplasms LH LU;  PM74 HN74(64) MHÑPharyngectomy ANdo not use /util except by MeSH definition MNE4.847.515 LH  MSInflammation of the throat. OLuse PHARYNGITIS to search SORE THROAT back thru 1966 HNSORE THROAT was see under PHARYNGITIS 1963-78 MHÑPharyngitis MNC8.730.541; C9.775.649 XSSore Throat XUÑNasopharyngitis LH LS LU  MHÑPharynx ANinflammation = PHARYNGITIS; /surg: consider also PHARYNGECTOMY; throat goes here but check to see if other concept is meant; sore throat = PHARYNGITIS; pharyngeal tonsil = ADENOIDS; HYPOPHARYNX, NASOPHARYNX & OROPHARYNX are also available MNA14.724 XSTHROAT LH LS  PM65; was ACETOPHENETIDIN 1963-64 HN65; was ACETOPHENETIDIN 1963-64 MHÑPhenacetin ANdo not use /biosyn /defic /physiol RN62-44-2 MND14.73.278.653 XSACETOPHENETIDIN LH LS  PMGLAUCARUBIN was see under PYRANS 1975-80 MHÑPhenanthrenes ANdo not use /analogs /biosyn /defic /physiol MND4.615.723 XUÑChrysenes; ÑGlaucarubin LH LU;  PM69 HN69 MHÑPhenanthridines ANdo not use /analogs /biosyn /defic /physiol MND3.494.633 XUÑPropidium LH LU  MHÑPhenanthrolines ANdo not use /analogs /biosyn /defic /physiol MND3.494.669 LH  MHÑPhenazines ANdo not use /analogs /biosyn /defic /physiol MND3.494.704 XUÑMethylphenazonium Methosulfate; ÑNeutral Red; ÑPyocyanine LH LU; ;  MHÑPhenazocine ANdo not use /biosyn /defic /physiol RN127-35-5 MND3.132.610.422.106.715; D14.73.153.723; D14.757.724 XSPhenbenzorphan; Phenethylazocine LH LS;  HN(65); was see under PYRIDINES 1975-78 MHÑPhenazopyridine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN94-78-0 MND3.383.725.50.610; D14.211.707 DMÑAminopyridines LH LM  MS1-(1-phenylcyclohexyl)piperidine. Analgesic anesthetic that causes psychoses and hallucinations in man; used to handle large, especially wild animals; a drug of abuse. Synonyms: angel dust; CI 395; GP 121; hog; PCP; peace pill; Sernyl; Sernylan. PM73; was see under PIPERIDINES 1969-72 was see under PIPERIDINES & ANESTHETICS 1968, was see under ANESTHETICS 1967. HN73(64); was see under PIPERIDINES 1969-72, was see under PIPERIDINES & ANESTHETICS 1968, was see under ANESTHETICS 1967 MHÑPhencyclidine ANdo not use /biosyn /defic /physiol RN77-10-1 PIAnesthetics (66-72); Piperidines (68-72) MND3.383.621.699; D14.166.60.748; D15.236.372.754 LH  MSThe misuse of phencyclidine with associated psychological symptoms and impairment in social or occupational functioning. PM81 HN81 MHÑPhencyclidine Abuse ANdo not use /chem ind /drug eff /physiol /rad eff PIPhencyclidine (66-80); Substance Abuse (68-80) MNF3.709.597.780.610.560 XSAngel Dust Abuse; PCP Abuse LH LS;  MHÑPhenelzine ANdo not use /biosyn /defic /physiol RN51-71-8 MND8.373.616.700; D15.236.122.627.700 XSFenelzin LH LS  PM74 HN74(72) MHÑPhenethanolamine N-Methyltransferase ANdo not use /analogs RNEC 2.1.1.28 PIMethyltransferases (71); Transferases (66-71) MND8.586.913.517.550 XSPhenylethanolamine N-Methyltransferase LH LS  MS2-Phenylethanol. Antimicrobial, antiseptic and disinfectant; used also as aromatic essence and preservative in pharmaceutics and perfumery. Synonyms: phenethanol; phenethylol. HN(75) MHÑPhenethyl Alcohol ANdo not use /biosyn /defic /physiol RN60-12-8 PIAlcohol, Ethyl (69-74); Benzene Derivatives (72-74) MND2.33.57.650; D20.187.675 XSBenzyl Carbinol; Phenylethanol; Phenylethyl Alcohol DMÑAlcohol, Ethyl LH LS; ; LM  OLuse PHENETHYLAMINES to search PHENYLETHYLAMINES back thru 1966 PM68; was PHENYLETHYLAMINES 1963-67 HN68; was PHENYLETHYLAMINES 1963-67 MHÑPhenethylamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.471.683 XSPHENYLETHYLAMINES XUÑ2-Hydroxyphenethylamine; ÑBenzphetamine; ÑDimethoxyphenylethylamine; ÑFendiline; ÑHexoprenaline; ÑSelegiline LH LS LU; ; ; ; ;  MSp-Aminophenyl ethyl ether. Used in the manufacture of acetophenetidin. HN(75); was see under ANILINE COMPOUNDS 1975-78 MHÑPhenetidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN156-43-4 PIAniline Compounds (69-74); Ethyl Ethers (74) MND2.92.146.100.700; D2.355.417.650; D2.355.726.750 XSAminophenetole; Ethoxyaniline DMÑAminophenols LH LS; LM  MHÑPhenformin ANdo not use /biosyn /defic /physiol RN114-86-3 MND2.78.370.141.700; D9.482.700 XSFenformin LH LS  MHÑPhenindione ANdo not use /biosyn /defic /physiol RN83-12-5 MND19.461.119.765 LH  MHÑPheniprazine ANdo not use /biosyn /defic /physiol RN55-52-7 MND8.373.616.750; D15.236.122.627.750 LH  MS2-[alpha-(2-Dimethylaminoethyl)benzyl]pyridine. Histamine H1 blocker with little sedative action; used in hay fever, rhinitis, allergic dermatoses and pruritus. Synonyms: Avil; Daneral; Inhiston; Trimeton; Tripoton. MHÑPheniramine ANdo not use /biosyn /defic /physiol RN86-21-5 MND3.383.725.620; D23.654.432.718 XSHistapyridamine; Propheniramine; Prophenpyridamine LH LS; ;  MHÑPhenmetrazine ANdo not use /biosyn /defic /physiol RN134-49-6 MND3.383.468.680; D26.128.750 XSDefenmetrazin; Fenmetrazin; Oxazimedrine; Phenmetraline LH LS; ; ;  MHÑPhenobarbital ANdo not use /biosyn /defic /physiol RN50-06-6 MND3.383.742.698.253.650; D14.166.111.650; D14.261.164.683; D14.591.220.650 XSPhenemal; Phenobarbitone; Phenylbarbital LH LS; ;  MHÑPhenolphthaleins AND25-26 qualif MND26.408.646.600; D26.550.620 XUÑPhenolsulfonphthalein; ÑThymolphthalein LH LU;  MHÑPhenols ANdo not use /analogs /biosyn /defic /physiol MND2.755 XUÑBithionol; ÑBromphenol Blue; ÑDienestrol; ÑProbucol LH LU; ; ;  MS4,4'-(3H-2,1-Benzoxathiol-3-ylidene)bisphenol S,S-dioxide. Red dye, pH indicator and diagnostic aid for determination of renal function; also used for studies of the gastrointestinal and other systems. Synonyms: Fenolipuna; phenolsulfonephthalein; Sulfonphthal; Sulphental; Sulphonthal. OLsearch PHENOLPHTHALEINS 1966-74 HN(75) MHÑPhenolsulfonphthalein AND25-26 qualif; /analogs NIM only RN143-74-8 PIPhenolphthaleins (66-74) MND26.408.646.600.517 XSPhenol Red DMÑPhenolphthaleins LH LS LM  MS1-(3-Hydroxy-3-phenylpropyl)-4-phenylpiperidine -4-carboxylid acid ethyl ester. Narcotic analgesic partly metabolised to meperidine in the liver; similar to morphine in action; used for neuroleptanalgesia, usually with droperidol. Synonyms: Lealgin; Operidine; R 1406. PM74 HN74(64) MHÑPhenoperidine ANdo not use /biosyn /defic /physiol RN562-26-5 MND3.66.399.600; D3.383.621.349.683; D14.73.153.765; D14.757.754 LH  MSThose phenothiazine derivatives used in the treatment of psychoses; these include most of the Major Tranquilizers. PM73 HN73 MHÑPhenothiazine Tranquilizers ANdo not use /analogs /biosyn /defic /physiol PIPhenothiazines (66-72); Tranquilizing Agents (66-72) MND15.236.872.331.628 XUÑPerazine; ÑPiperacetazine; ÑPipothiazine; ÑPipothiazine Palmitate LH LU; ; ;  MHÑPhenothiazines ANdo not use /analogs /biosyn /defic /physiol MND3.494.741 XUÑAzure Stains; ÑEthopropazine; ÑNonachlazine LH LU; ;  MSThe outward appearance of the individual; the product of interactions between genes and between the genotype and the environment. PM68 HN68 MHÑPhenotype ANNIM; no qualif; Pi phenotype is indexed under ALPHA 1-ANTITRYPSIN /defic + PHENOTYPE PIGenetics (66-67) MNG5.735 FXÑSOMATOTYPES LH LX  OLsearch GLYCOLATES 1966-74 HN(75) MHÑPhenoxyacetates ANdo not use /analogs /biosyn /defic /physiol MND2.241.511.316.682 DMÑGlycolates LH LM  MSN-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine. Alpha Adrenergic Blockader with long duration of action; also has antiserotonergic effects; used to treat hypertension and as peripheral vasodilator. Synonyms: Dibenyline; Dibenzyline; 688-A; SK&F 688-A. MHÑPhenoxybenzamine ANdo not use /biosyn /defic /physiol RN59-96-1 MND2.92.471.739; D16.848.115.538; D18.162.712; D23.846.739 XSBensylytum LH LS  MS3-(1-Phenylpropyl)-4-hydroxycoumarin. Long acting oral anticoagulant; may cause diarrhea. Synonyms: Liquamar; Marcoumar; Marcumar. HN(75); was see under COUMARINS 1975-76 MHÑPhenprocoumon ANdo not use /biosyn /defic /physiol; /analogs NIM only RN435-97-2 PIBenzene (66-67); Benzene Derivatives (68-71); Benzyl Compounds (72-76); Coumarins (66-74) MND3.438.150.446.520.750; D19.461.119.196.475.722 XSPhenprocoumalol; Phenprocoumarol; Phenylpropylhydroxycumarinum DMÑ4-Hydroxycoumarins LH LS; ; LM  PM74 HN74(66) MHÑPhentermine ANdo not use /biosyn /defic /physiol RN122-09-8 MND2.92.471.683.152.766; D15.128.82.726; D16.893.120.739; D26.128.127.751 XUÑChlorphentermine LH LU  MHÑPhentolamine ANdo not use /biosyn /defic /physiol RN50-60-2 MND3.383.374.754; D16.848.115.601; D18.162.721 XSFentolamin LH LS  PM74 HN74 MHÑPhenyl Ethers ANdo not use /analogs /biosyn /defic /physiol MND2.355.726 XSDiphenyl Oxides XUÑTriclosan LH LS LU  MHÑPhenylacetates ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.601 XUÑ3,4-Dihydroxyphenylacetic Acid; ÑAlclofenac; ÑCyclopentolate LH LU; ;  MHÑPhenylalanine AN/biosyn /defic /physiol permitted RN3617-44-5 MND12.125.72.573; D12.125.142.666 XUÑp-Fluorophenylalanine LH LU  MSL-Phenylalanine ammonia-lyase. Catalyzes the deamination of L-phenylalanine to form trans-cinnamate and ammonia. May also act on L-tyrosine. Since the enzyme deprives neoplasm of phenylalanine, it has been used experimentally in the treatment of acute lymphoblastic leukemia. Obtained from many plants. Synonyms: phenylalanine ammonium lyase; phenylalanine deaminase; tyrase; tyrosine ammonia (or ammonium) lyase. HN(75) MHÑPhenylalanine Ammonia-Lyase ANdo not use /analogs RNEC 4.3.1.5 PIAmmonia-Lyases (73-74); Phenylalanine (73-74) MND8.586.520.161.700; D22.204.650 DMÑAmmonia-Lyases LH LM  PM73 HN73(71) MHÑPhenylalanine Hydroxylase ANdo not use /analogs; /defic: consider also PHENYLKETONURIA RNEC 1.14.16.1 PIHydroxylases (66-70) MND8.586.682.420.601 LH  MSPhenylalanine:tRNA-Phe ligase (AMP-forming). Activates phenylalanine with its specific transfer RNA. HN(75) MHÑPhenylalanyl T RNA Synthetase ANdo not use /analogs; note spacing RNEC 6.1.1.20 PIAmino Acyl T RNA Synthetases (73-74); Phenylalanine (73-74) MND8.586.464.136.650 DMÑAmino Acyl T RNA Synthetases LH LM  MHÑPhenylbutazone ANdo not use /biosyn /defic /physiol RN50-33-9 MND3.383.694.700; D14.73.278.152.684; D14.73.278.398.946.743; D26.74.75.204.684; D26.74.75.574.946.743 XSDiphenylbutazone; Fenilbutazon XUÑClofezone; ÑPrenazone LH LS; LU;  MHÑPhenylbutyrates ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.651 LH  PM74 HN74 MHÑPhenylenediamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.146.651; D2.92.782.258.651 XUÑTetramethylphenylenediamine LH LU  MHÑPhenylephrine ANdo not use /biosyn /defic /physiol RN59-42-7 MND2.33.329.291.617; D2.92.63.291.617; D16.116.327.601; D16.893.116.182.726; D18.793.777 XSMETASYMPATOL; NEOSYNEPHRINE XUÑEthylphenylephrine LH LS; LU  MS2-Ethyl-2-phenylmalonamide. A metabolite of primidone. HN(75) MHÑPhenylethylmalonamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7206-76-0 PIAmides (72-74); Malonates (72-74) MND2.241.81.337.540.700 XSEthylphenylmalonamide; Phenylethylmalondiamide DMÑMalonates LH LS; LM  MSalpha-Oxo-benzeneacetaldehyde. A reagent which is highly selective for the modification of arginyl residues. It is used to selectively inhibit various enzymes and acts as an energy transfer inhibitor in photophosphorylation. HN(80) MHÑPhenylglyoxal ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1074-12-0 PIAldehydes (66-72); Glyoxal (73-74) /AA (75-79) MND2.47.644.620; D8.373.725; D26.550.642 DMÑAldehydes LH LM  OLuse PHENYLHYDRAZINES to search PHENYLHYDRAZINE back thru 1966 PM75; was PHENYLHYDRAZINE 1963-74 HN75; was PHENYLHYDRAZINE 1963-74 MHÑPhenylhydrazines ANdo not use /analogs /biosyn /defic /physiol MND2.442.726 LH  MSN-Isopropyl-N-phenyl-adenosine. Antilipemic agent. Synonym: TH 162. HN(75) MHÑPhenylisopropyladenosine ANdo not use /biosyn /defic /physiol RN29193-86-0 PIAdenosine (72-74); Propylamines (72-74) MND13.570.583.138.630; D13.570.800.96.630 XSIsopropylphenyladenosine DMÑAdenosine LH LS LM  MSAn inborn error of metabolism transmitted as a simple recessive autosomal Mendelian trait and characterized by an inability to convert phenylalanine to tyrosine resulting in hyperphenylalaninemia. The majority of patients are severely retarded. Attainment of normal or near normal intelligence is possible if dietary treatment is instituted in early infancy. MHÑPhenylketonuria ANdo not use /congen /drug eff /physiol /rad eff MNC10.228.140.163.766; C10.496.742; C18.452.648.66.766; F3.709.346.779 FXÑUrine LH LX  MSA phenyl mercury compound used mainly as a fungicide. Has also been used as a herbicide, slimicide and bacteriocide. HN(77); was see under PHENYL MERCURY COMPOUNDS 1977-79 MHÑPhenylmercuric Acetate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN62-38-4 PIMercury (68-76); Organometallic Compounds (68-76) MND2.691.750.740.760; D5.723.288.700.760 XSAcetoxyphenylmercury DMÑPhenylmercury Compounds LH LS LM  MSOrganic mercury compounds in which the mercury is attached to a phenyl group. Often used as fungicides and seed treatment agents. OLuse PHENYLMERCURY COMPOUNDS to search PHENYL MERCURY COMPOUNDS back thru 1977 PM80; was PHENYL MERCURY COMPOUNDS 1977-79; CHLOROMERCURIPHENYLSULFONATE was see under ORGANOMETALLIC COMPOUNDS 1975-76 HN80; was PHENYL MERCURY COMPOUNDS 1977-79 MHÑPhenylmercury Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: PHENYLMERCURY CPDS PIMercury (68-76); Organometallic Compounds (68-76) MND2.691.750.740; D5.723.288.700 XSPhenyl Mercury Compounds; Phenylmercurials XUÑChloromercurinitrophenols; ÑChloromercuriphenylsulfonate; ÑPhenylmercuric Acetate LH LS; LU; ;  MSalpha-Toluenesulfonyl fluoride. An enzyme inhibitor which inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex. HN(75) MHÑPhenylmethylsulfonyl Fluoride ANdo not use /biosyn /defic /physiol; /analogs NIM only RN329-98-6 PIBenzyl Compounds (73-74); Fluorine (74); Sulfones (73-74) MND2.886.590.625; D8.373.745.740 XSBenzenemethanesulfonyl Fluoride DMÑSulfones LH LS LM  PM74; was see under SYMPATHOMIMETICS 1963-73 HN74(63); was see under SYMPATHOMIMETICS 1963-73 MHÑPhenylpropanolamine ANdo not use /biosyn /defic /physiol RN14838-15-4 MND2.33.329.624.706; D2.92.63.624.706; D16.116.766; D16.893.116.182.789; D18.793.952.746 XSNorephedrine XUÑp-Hydroxynorephedrine LH LS LU  PM74; KETOPROFEN was see under BENZOPHENONES 1975-77 HN74 MHÑPhenylpropionates ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.701 XUÑFenoprofen; ÑIndoprofen; ÑKetoprofen; ÑSuprofen LH LU; ; ;  OLuse PHENYLPYRUVIC ACIDS to search PHENYLPYRUVIC ACID back thru 1966 PM75; was PHENYLPYRUVIC ACID 1963-74 HN75; was PHENYLPYRUVIC ACID 1963-74 MHÑPhenylpyruvic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.751; D2.241.607.812.601 LH  MS1-Phenyl-3-(2-thiazolyl)-2-thiourea. A dopamine-beta-hydroxylase inhibitor. Synonym: U-14,624. HN(75) MHÑPhenylthiazolylthiourea ANdo not use /biosyn /defic /physiol RN14901-16-7 PIPhenylthiourea (72-74); Thiazoles (72-74) MND2.886.904.601.600; D2.948.898.601.600 DMÑPhenylthiourea LH LM  MS3-Phenyl-2-thiohydantoin. Thiohydantoin benzene derivative. HN(75) MHÑPhenylthiohydantoin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2010-15-3 PIHydantoins (71-72); Thiohydantoins (73-74) MND3.383.374.411.868.650 DMÑHydantoins LH LM  PM66 HN66(64) MHÑPhenylthiourea ANdo not use /biosyn /defic /physiol RN103-85-5 MND2.886.904.601; D2.948.898.601 XSPHENYLTHIOCARBAMIDE XUÑPhenylthiazolylthiourea LH LS LU  PM74 HN74 MHÑPhenylurea Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: PHENYLUREA CPDS MND2.948.684 XSPHENYLCARBAMIDES LH LS  OLuse PHENYTOIN to search DIPHENYLHYDANTOIN back thru 1966 PM78; was DIPHENYLHYDANTOIN 1963-77 HN78; was DIPHENYLHYDANTOIN 1963-77 MHÑPhenytoin ANdo not use /biosyn /defic /physiol RN57-41-0 MND3.383.374.411.730; D14.261.447.710; D18.97.591 XSDiphenylhydantoin; Fenitoin; Phenantoin XUÑDiphenylthiohydantoin LH LS; ; LU  MHÑPheochromocytoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with ADRENAL GLAND NEOPLASMS (IM) MNC4.557.652.765.601 LH  MSChlorophylls from which the magnesium has been removed by treatment with weak acid. HN(75) MHÑPheophytins ANdo not use /analogs PIPorphyrins (71-74) MND11.557.727.220.700 DMÑChlorophyll LH LM  MSChemical substances which, when secreted by an individual into the environment, cause specific reactions in other individuals, usually of the same species. Allomones are repellent pheromones; restrict to multicellular organisms; kairomones go here. PM68 HN68 MHÑPheromones ANhuman, animal & plant; use only Cat D qualif; do not use /analogs; ╥sex pheromones╙: index under SEX ATTRACTANTS PIBehavior, Animal (66-67); Sex Behavior (66-67) MND24.185.641; F1.145.209.103.601 XSEctohormones; Semiochemicals FXÑChemotactic Factors XUÑSex Attractants LH LS; LX LU  MHÑPhialophora ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.706 LH  MSAn aberrant form of human chromosome 22 characterized by translocation of genetic material from chromosome 22, usually to the long arms of chromosome 9. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia. OLsearch CHROMOSOMES, HUMAN, 21-22 1978-85 PM86; was see CHROMOSOMES, HUMAN, 21-22 1978-85 HN86; was see CHROMOSOMES, HUMAN, 21-22 1978-85 MHÑPhiladelphia Chromosome ANnote category: an aberrant form of human chromosome 22; no qualif PIChromosome Abnormalities (66-67); Chromosomes (66-67); Chromosomes, Human, 21-22 (68-85); Leukemia, Myelocytic/FG (66-85) MNG5.148.266.764.680 XSPh1 Chromosome FXÑChromosomes, Human, 21-22; ÑChromosomes, Human, Pair 22 LH LS LX;  MSStudy of stamps or postal markings. Usually refers to the design and commemorative aspects of the stamp. HNwas in Cat I 1975-82, was in Cat E 1963-74 MHÑPhilately ANstamp collecting as a hobby: coord IM with HOBBIES (IM); indexing policy: TN 245 MNK1.93.660 XSPOSTAGE STAMPS LH LS  MHÑPhilippines ANbe careful: one -l-, two -pp MNZ1.252.145.671 LH  MHÑPhilology ANstudy of literature or language as used in literature; do not confuse with LITERATURE, literary works; no qualif CATALOG: /form /lang MNK1.517.732 LH  MHÑPhilology, Classical ANno qualif CATALOG: /form /lang MNK1.517.732.477 LH  MHÑPhilology, Oriental ANno qualif CATALOG: /form /lang MNK1.517.732.602 LH  MHÑPhilology, Romance ANno qualif CATALOG: /form /lang MNK1.517.732.727 LH  MHÑPhilosophy ANno qualif MNK1.752 XSHedonism; Stoicism LH LS;  PM74 HN74(71) MHÑPhilosophy, Dental ANno qualif PIPhilosophy (66-70); appropriate dental heading MNK1.752.622 LH  MHÑPhilosophy, Medical ANno qualif MNK1.752.667 LH  PM74 HN74(69) MHÑPhilosophy, Nursing ANno qualif PINursing (66-68); Philosophy (66-68) MNK1.752.712 LH  MHÑPhimosis MNC12.294.494.684 XUÑParaphimosis LH LU  MSInflammation of a vein. OLuse PHLEBITIS to search PERIPHLEBITIS back thru 1966 PMPERIPHLEBITIS was heading 1963-83 HNPERIPHLEBITIS was heading 1963-83 MHÑPhlebitis ANassume to be of the legs so do not coord with LEG; THROMBOPHLEBITIS is also available MNC14.907.681; C14.907.940.740 XSPeriphlebitis LH LS  PM66; was see under ANGIOGRAPHY 1963-65 HN66(63); was see under ANGIOGRAPHY 1963-65 MHÑPhlebography ANNIM; do not use /util except by MeSH definition MNE1.145.77.707; E1.818.84.707 XSVENOGRAPHY LH LS  MSA genus of Psychodidae which functions as the vector of a number of pathogenic organisms, including Leishmania donovani, Leishmania tropica, Bartonella bacilliformis, and the Pappataci fever virus. MHÑPhlebotomus ANa blood-sucking fly, the vector of PHLEBOTOMUS FEVER see PAPPATACI FEVER & other dis; /microbiol /parasitol permitted; do not use /drug eff with insecticides: TN 111 MNB1.131.617.289.781.602 LH  MSA water-soluble, copper-containing low molecular weight polypeptide obtained from the culture medium of Streptomyces verticillus. It is a specific inhibitor of DNA synthesis in bacteria and it has been found to act as an antitumor agent. Has also been used against rust fungi of plants. OLuse PHLEOMYCINS to search PHLEOMYCINS back thru 1975 HN(81); was PHLEOMYCIN see under ANTIBIOTICS 1975-80 MHÑPhleomycins ANdo not use /analogs /defic /physiol PIAntibiotics, Antineoplastic (71-74); Antibiotics (71-74); Peptides (71-74) MND20.85.75.236.758; D20.85.658; D22.204.106.244.758 DMÑBleomycins LH LM  PM73 HN73(63) MHÑPhloretin ANdo not use /biosyn /defic /physiol RN60-82-2 MND2.522.818.561.602; D2.755.684.602 XUÑPolyphloretin Phosphate LH LU  MSPhlorizin glucohydrolase. Catalyzes the hydrolysis of phlorizin to phloretin and glucose. It is found in the intestinal brush border membrane often in conjunction with lactase. EC 3.2.1.62. HN(78) MHÑPhloretin Glucosidase ANdo not use /analogs RNEC 3.2.1.62 PIGlucosidases (66-77) MND8.586.277.450.420.750 XSPhlorizin Hydrolase DMÑGlucosidases LH LS LM  MHÑPhlorhizin ANdo not use /biosyn /defic /physiol RN60-81-1 MND9.203.408.702 LH  MHÑPhloroglucinol AND25-26 qualif RN108-73-6 MND2.755.684; D26.550.667 LH  MS2',4',5',7'-Tetrabromo-4,5,6,7-tetrachlorofluorescein, disodium salt. A red fluorescein dye used as food color and histologic stain; may be cytotoxic, mutagenic and inhibit certain mitochondrial functions. Synonyms: Eosin(e) Blue; D and C Red No. 28; C.I. Acid Red 92; 11963 Red; C.I. 45410. HN(79) MHÑPhloxine B AND25-26 qualif; do not confuse X ref EOSINE BLUISH with EOSINE YELLOWISH see EOSIN RN18472-87-2 PIBromine (66-78); Chlorine (66-78); Fluoresceins (66-78) MND26.408.348.514.738; D26.471.355.738 XSAcid Red 92; Eosine Bluish DMÑFluoresceins LH LS; LM  MSAnxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable. OLuse PHOBIC DISORDERS to search PHOBIAS back thru 1966, PHOBIC NEUROSES back thru 1969 & CLAUSTROPHOBIA back thru 1968 PM81; was PHOBIAS 1963-80 HN81; was PHOBIAS 1963-80; PHOBIC NEUROSES was see under PHOBIAS 1969-80; CLAUSTROPHOBIA was see under PHOBIAS 1968-78 MHÑPhobic Disorders ANdo not use /drug eff /physiol /rad eff MNF3.709.438.180.508 XSClaustrophobia; Neuroses, Phobic; Phobia, School; Phobia, Social; Phobias; Phobic Neuroses FXÑFear XUÑAgoraphobia LH LS; ; ; ; ; LX LU  MSThe process of producing vocal sounds by means of vocal cords vibrating in an expiratory blast of air. HN(79) MHÑPhonation ANonly /drug eff /rad eff PISpeech (66-78); Vocal Cords (66-78); Voice (66-78) MNG9.772.862.793 DMÑVoice LH LM  MHÑPhonetics ANno qualif MNL1.143.506.598.518 XSSpeech Sounds FXÑLanguage Development LH LS LX  MSGraphic registration of the heart sounds picked up as vibrations and transformed by a piezoelectric crystal microphone into a varying electrical output according to the stresses imposed by the sound waves. The electrical output is amplified by a stethograph amplifier and recorded by a device incorporated into the electrocardiograph or by a multichannel recording machine. MHÑPhonocardiography ANNIM; consider also HEART AUSCULTATION; do not use /util except by MeSH definition MNE1.145.569.499.685 LH  HN(72) MHÑPhorate ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN298-02-2 PIInsecticides (66-71) MND2.719.783; D5.723.491.657.803 DMÑInsecticides, Organothiophosphate LH LM  MSTumor promoting compounds obtained from croton oil (Croton tiglium). PM86; was see under PHORBOLS 1975-85 HN86(75); was see under PHORBOLS 1975-85 MHÑPhorbol Esters AND25-26 qualif; do not use /analogs PICroton Oil (66-74); Diterpenes (74); Esters (74); Terpenes (66-73) MND2.455.849.291.500.510; D10.516.627.700.315.500; D26.191.208.744.742; J1.740.700.315.500 LH  MSThe parent alcohol of the tumor promoting compounds from croton oil (Croton tiglium). PM75 HN75 MHÑPhorbols AND25-26 qualif; do not use /analogs PIAlcohols (66-74); Croton Oil (66-74); Diterpenes (74); Terpenes (66-73) MND2.455.849.291.500; D26.191.208.744 FXÑCroton Oil LH LX  MHÑPhosgene AND25-26 qualif RN75-44-5 MND2.522.741; D26.253.710 LH  MSO,O-Dimethyl S-phthalimidomethyl phosphorodithioate. Organothiophosphorus insecticide. Synonyms: Prolate. OLuse PHOSMET to search IMIDAN back thru 1975 HN(75); was IMIDAN see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-78 MHÑPhosmet ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN732-11-6 PIIndoles (74); Insecticides, Organothiophosphate (74) MND5.723.491.657.818 XSImidan; Phthalophos DMÑInsecticides, Organothiophosphate LH LS; LM  HN(72) MHÑPhosphamidon ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN13171-21-6 PIInsecticides (66-71) MND2.705.614; D5.723.491.574.741 DMÑInsecticides, Organophosphate LH LM  MHÑPhosphatases ANGEN; don't forget ALKALINE PHOSPHATASE & ACID PHOSPHATASE are available; /defic: consider also HYPOPHOSPHATASIA; do not use /analogs RNEC 3.1.5. MND8.586.277.352.630 XSPHOSPHOHYDROLASES XUÑApyrase; ÑGTP Phosphohydrolase; ÑThiamine Triphosphatase LH LS LU; ;  MSAcetyl-CoA:orthophosphate acetyltransferase. Catalyzes the synthesis of acetylphosphate from acetyl-CoA and inorganic phosphate. Acetylphosphate serves as a high-energy phosphate compound. HN(75) MHÑPhosphate Acetyltransferase ANdo not use /analogs RNEC 2.3.1.8 PIAcetyltransferases (73-74); Phosphates (73-74); Acetyl Coenzyme A (73-74) MND8.586.913.50.134.700 XSPhosphoacylase; Phosphotransacetylase DMÑAcetyltransferases LH LS; LM  OLuse PHOSPHATES to search BLOOD PHOSPHATES 1966-67 & PHOSPHATES, INORGANIC back thru 1974 PM/blood was BLOOD PHOSPHATES 1963-67 HN/blood was BLOOD PHOSPHATES 1963-67; PHOSPHATES, INORGANIC was see under PHOSPHATES 1974-76 MHÑPhosphates AN/physiol permitted; /blood: consider also HYPOPHOSPHATEMIA, FAMILIAL; do not use /analogs; POLYPHOSPHATES is also available MND1.248.497.158.730; D1.696.620.603 XSPhosphates, Inorganic FXÑSugar Phosphates LH LS LX  MSL-alpha-Phosphatidate phosphohydrolase. A phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4. HN(79) MHÑPhosphatidate Phosphatase ANdo not use /analogs RNEC 3.1.3.4 PIPhosphatases (66-74); Phosphatidic Acids (75-78); Phospholipids (66-74); Phosphomonoesterases (75-78) MND8.586.277.352.630.654.685 XSPhosphatidate Phosphohydrolase DMÑPhosphomonoesterases LH LS LM  MSFatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups. OLsearch PHOSPHOLIPIDS 1966-74 PM77; was see under PHOSPHOLIPIDS 1963-76 HN77(75); was see under PHOSPHOLIPIDS 1963-76 MHÑPhosphatidic Acids AN/biosyn /physiol permitted; do not use /analogs PIPhospholipids (66-74) MND10.516.695.300.700 LH  MSDerivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a choline moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and choline and 2 moles of fatty acids. Synonyms: lecithins; choline phosphoglycerides. OLuse PHOSPHATIDYLCHOLINES to search PHOSPHATIDYL CHOLINE & LECITHINS back thru 1966 PM77; was PHOSPHATIDYL CHOLINE see under LECITHINS 1963-76; LECITHINS was heading 1963-76 HN77; was PHOSPHATIDYL CHOLINE see under LECITHINS 1963-76; LECITHINS was heading 1963-76 MHÑPhosphatidylcholines AN/biosyn /physiol permitted; do not use /analogs MND10.516.695.300.700.710 XSCholine Phosphoglycerides; Lecithins LH LS;  MSDerivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. Synonyms: cephalins; ethanolamine phosphoglycerides. OLuse PHOSPHATIDYLETHANOLAMINES to search PHOSPHATIDYL ETHANOLAMINE & CEPHALINS back thru 1966 PM77; was PHOSPHATIDYL ETHANOLAMINE see under CEPHALINS 1963-76; CEPHALINS was heading 1963-76 HN77; was PHOSPHATIDYL ETHANOLAMINE see under CEPHALINS 1963-76; CEPHALINS was heading 1963-76 MHÑPhosphatidylethanolamines AN/biosyn /physiol permitted; do not use /analogs MND10.516.695.300.700.750 XSCephalins; Ethanolamine Phosphoglycerides LH LS;  MSA nitrogen-free class of lipids present in animal, and particularly plant tissues, composed of one mole of glycerol and 1 or 2 moles of phosphatidic acid. Members of this group differ from one another in the nature of the fatty acids released on hydrolysis. OLuse PHOSPHATIDYLGLYCEROLS to search PHOSPHATIDYL GLYCEROL back thru 1975 PM77; was PHOSPHATIDYL GLYCEROL see under PHOSPHOLIPIDS 1975-76 HN77; was PHOSPHATIDYL GLYCEROL see under PHOSPHOLIPIDS 1975-76 MHÑPhosphatidylglycerols AN/biosyn /physiol permitted; do not use /analogs PIGlycerophosphates (72-74); Phospholipids (66-74) MND10.516.695.300.700.780 XSGlycerol Phosphoglycerides; Monophosphatidylglycerols LH LS;  MSDerivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and myo-inositol and 2 moles of fatty acids. Synonym: inositol phosphoglycerides. OLto search PHOSPHATIDYL INOSITOL use PHOSPHATIDYLINOSITOLS back thru 1975 & PHOSPHOINOSITIDES 1966-74 PM77; was PHOSPHATIDYL INOSITOL see under PHOSPHOINOSITIDES 1963-76 HN77; was PHOSPHATIDYL INOSITOL see under PHOSPHOINOSITIDES 1963-76 MHÑPhosphatidylinositols AN/biosyn /physiol permitted; do not use /analogs PIPhosphoinositides (66-74) MND10.516.695.300.700.800 XSInositol Phosphoglycerides LH LS  MSCatalyzes the formation of phosphatidylserine and CMP from CDPdiglyceride plus serine. HN(75) MHÑPhosphatidylserine Synthetase ANdo not use /analogs RNEC 2.7.8.8 PICephalins (72-74); Cytosine Nucleotides (72-74); Phosphotransferases (72-74) MND8.586.913.696.500 XSCDP Diglyceride Serine O-Phosphatidyltransferase DMÑPhosphotransferases LH LS LM  MSDerivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a serine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and serine and 2 moles of fatty acids. Synonyms: serine phosphoglycerides. OLto search PHOSPHATIDYL SERINE use PHOSPHATIDYLSERINES back thru 1975 & PHOSPHATIDYLETHANOLAMINES 1966-74 PM77; was PHOSPHATIDYL SERINE see under CEPHALINS 1963-76 HN77; was PHOSPHATIDYL SERINE see under CEPHALINS 1963-76 MHÑPhosphatidylserines AN/biosyn /physiol permitted; do not use /analogs PIPhosphatidylethanolamines (66-74) MND10.516.695.300.700.830 XSSerine Phosphoglycerides LH LS  MSVisual sensations arising from mechanical or electrical stimulation of the eyeball. HN(75) MHÑPhosphenes ANvisual sensations of the eyeball; only /drug eff /physiol /rad eff; do not confuse with PHOSPHINES MNF2.830.816.929.300; G11.561.796.929.300; G11.697.911.300 DMÑVision LH LM  PM65 HN65(63) MHÑPhosphines ANdo not use /analogs /biosyn /defic /physiol; do not confuse with PHOSPHENES MND1.696.391 LH  PM65; was PHOSPHINIC ACID 1963-64 HN65; was PHOSPHINIC ACID 1963-64 MHÑPhosphinic Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.553; D1.696.429 LH  PM68 HN68 MHÑPhosphinous Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.578; D1.696.467 LH  MS7-Phospho-2-keto-3-deoxy-D-arabino-heptonate D-erythrose-4-phosphate-lyase (pyruvate-phosphorylating). Catalyzes the formation of 7-phospho-2-keto-3-deoxy-D-arabinoheptonate from phosphoenolpyruvate and D-erythrose-4-phosphate. One of the first enzymes in the biosynthesis of tyrosine and phenylalanine. HN(75) MHÑPhospho-2-Keto-3-Deoxy-Heptonate Aldolase ANdo not use /analogs; DF: DAHP SYNTHASE RNEC 4.1.2.15 PIAldehyde-Lyases (72-74); Heptoses (72-74); Tetroses (72-74); Phosphoenolpyruvate (73-74) MND8.586.520.110.715 XS3-Deoxyarabinoheptulosonate 7-Phosphate Synthetase DMÑAldehyde-Lyases LH LS LM  MS3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms. HN(75) MHÑPhosphoadenosine Phosphosulfate AN/analogs NIM only; DF: PAPS RN482-67-7 PIAdenosine Monophosphate (73-78); Sulfuric Acids (73-74); Organophosphorus Compounds (73-74) MND13.695.667.138.850; D13.695.827.68.850 DMÑAdenine Nucleotides LH LM  PM66; was see under COENZYMES 1963-65 HN66(63); was see under COENZYMES 1963-65 MHÑPhosphocreatine RN67-07-2 MND12.125.373.603 XSCreatine Phosphate LH LS  MSCompounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Synonym: Antiphosphodiesterases. PM78 HN78 MHÑPhosphodiesterase Inhibitors ANdo not use /analogs /antag /biosyn /defic /physiol; DF: PHOSPHODIESTERASE INHIB PIPhosphodiesterases/AI (72-77) MND8.373.735 XSPhosphodiesterase Antagonists LH LS  PM73 HN73(72) MHÑPhosphodiesterases ANdo not use /analogs; /antag = PHOSPHODIESTERASE INHIBITORS RNEC 3.1.4. PIPhosphatases (66-71) MND8.586.277.352.630.553 XUÑSphingomyelin Phosphodiesterase LH LU  PM72 HN72 MHÑPhosphoenolpyruvate RN73-89-2 PIPhosphoric Acids (68-71); Pyruvates (66-71) MND2.241.511.701 LH  OLuse PHOSPHOENOLPYRUVATE CARBOXYKINASES to search PHOSPHOENOLPYRUVATE CARBOXYKINASE back thru 1973 (as Prov 1973) PM75; was PHOSPHOENOLPYRUVATE CARBOXYKINASE 1974 HN75; was PHOSPHOENOLPYRUVATE CARBOXYKINASE 1973-74 (Prov 1973) MHÑPhosphoenolpyruvate Carboxykinases ANdo not use /analogs; do not confuse with PHOSPHOENOLPYRUVATE CARBOXYLASE RNEC 4.1.1.32 PICarboxy-Lyases (66-72) MND8.586.520.258.603 LH  MSOrthophosphate:oxaloacetate carboxy-lyase (phosphorylating). An enzyme with high affinity for carbon dioxide. It catalyzes irreversibly the formation of oxaloacetate from phosphoenolpyruvate and carbon dioxide. This fixation of carbon dioxide in several bacteria and some plants is the first step in the biosynthesis of glucose. EC 4.1.1.31. HN(79) MHÑPhosphoenolpyruvate Carboxylase ANdo not use /analogs; do not confuse with PHOSPHOENOLPYRUVATE CARBOXYKINASES RNEC 4.1.1.31 PICarboxy-Lyases (66-78); Phosphoenolpyruvate (72-78) MND8.586.520.258.610 DMÑCarboxy-Lyases LH LM  MSThe bacterial sugar phosphotransferase system (PTS) catalyzes the transfer of the phosphoryl group from phosphoenolpyruvate to its sugar substrates (the PTS sugars) concomitant with the translocation of these sugars across the bacterial membrane. The phosphorylation of a given sugar requires four proteins, two general proteins, Enzyme I and HPr and a pair of sugar specific proteins designated as the Enzyme II complex. The PTS has also been implicated in the induction of synthesis of some catabolic enzyme systems required for the utilization of sugars that are not substrates of the PTS as well as the regulation of the activity of adenylate cyclase. EC 2.7.1.-. PM80; LACTOSE PHOSPHOTRANSFERASE was see under PHOSPHOTRANSFERASES 1975-79 HN80 MHÑPhosphoenolpyruvate Sugar Phosphotransferase System ANdo not use /analogs; DF: PEPPTS RNEC 2.7.1.- PIPhosphoenolpyruvate (72-79); Phosphoric Acids (68-71); Phosphotransferases (66-79) MND8.586.600.700; D8.586.913.696.580 XSPhosphoenolpyruvate Hexose Phosphotransferases LH LS  PM65 HN65 MHÑPhosphofructokinase ANdo not use /analogs RNEC 2.7.1.11 MND8.586.913.696.729.553 LH  MHÑPhosphoglucomutase ANdo not use /analogs RNEC 2.7.5.1 MND8.586.913.696.603 XSGLUCOSE PHOSPHOMUTASE LH LS  PM65 HN65 MHÑPhosphogluconate Dehydrogenase ANdo not use /analogs RNEC 1.1.1.43 MND8.586.682.47.150.600 LH  PM65 HN65 MHÑPhosphoglycerate Kinase ANdo not use /analogs RNEC 2.7.2.3 MND8.586.913.696.729.603 LH  MS2,3-Bisphospho-D-glycerate:2-phospho-D-glycerate phosphotransferase. Catalyzes the transfer of the 2-phospho group from 2,3-bisphosphoglycerate to a molecule of 2-phosphoglyceric acid, thus regenerating another 2,3-bisphosphoglyceric acid plus 2-phosphoglyceric acid. HN(75) MHÑPhosphoglyceromutase ANdo not use /analogs RNEC 2.7.5.3 PIDiphosphoglyceric Acids (73-74); Phosphotransferases (73-74) MND8.586.913.696.625 XSGlycerate (3-2)-Phosphomutase DMÑPhosphotransferases LH LS LM  MHÑPhosphoinositides AN/biosyn /physiol permitted; do not use /analogs MND10.516.390.680; D10.516.695.300.700.800.700 XSPhosphatidylinositol Phosphates LH LS  MSAn enzyme found in the alpha toxin of Clostridium welchii and other strains of clostridia and bacilli. It hydrolyzes glycerophosphatidates with the formation of 1,2-diacylglycerol and a phosphorylated nitrogenous base such as choline. EC 3.1.4.3. PM86; was see under PHOSPHOLIPASES 1980-85 HN86(80); was see under PHOSPHOLIPASES 1980-85 MHÑPhospholipase C ANdo not use /analogs RNEC 3.1.4.3 PIPhospholipases (66-79) MND8.586.277.352.100.680.700 XSAlpha-Toxin; Lecithinase C LH LS;  MSAn enzyme found mostly in plant tissue. It hydrolyzes glycerophosphatidates with the formation of a phosphatidic acid and a nitrogenous base such as choline. Also catalyzes transphosphatidylation reactions. EC 3.1.4.4. HN(80) MHÑPhospholipase D ANdo not use /analogs RNEC 3.1.4.4 PIPhospholipases (66-79) MND8.586.277.352.100.680.720 XSLecithinase D DMÑPhospholipases LH LS LM  MSCatalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.- OLuse PHOSPHOLIPASES to search PHOSPHOLIPASE & LECITHINASE back thru 1966 PM80; was PHOSPHOLIPASE 1963-79 HN80; was PHOSPHOLIPASE 1963-79; LECITHINASES was LECITHINASE see under PHOSPHOLIPASE 1963-79 MHÑPhospholipases ANdo not use /analogs RNEC 3.1.- MND8.586.277.352.100.680 XSLecithinases XUÑLysophospholipase; ÑPhospholipase D; ÑPhospholipases A LH LS LU; ;  MSPhosphatide acylhydrolases. Catalyze the hydrolysis of one of the acyl groups of phosphoglycerides or glycerophosphatidates. Phospholipase A1 hydrolyzes the acyl group attached to the 1-position (EC 3.1.1.32) and phospholipase A2 hydrolyzes the acyl group attached to the 2-position (EC 3.1.1.4). HN(80) MHÑPhospholipases A ANdo not use /analogs RNEC 3.1.1.- PIPhospholipases (66-79) MND8.586.277.352.100.680.750 XSLecithinase A1; Lecithinase A2; Phospholipase A1; Phospholipase A2 DMÑPhospholipases LH LS; ; ; LM  PM/metabolism was PHOSPHOLIPID METABOLISM 1965 HN/metabolism was PHOSPHOLIPID METABOLISM 1965 MHÑPhospholipids AN/biosyn /physiol permitted; do not use /analogs MND10.516.695 XSPHOSPHATIDES LH LS  MSA group of phosphatases which catalyze the hydrolysis of monophosphoric esters with the production of 1 mole of orthophosphate PM75 HN75 MHÑPhosphomonoesterases ANdo not use /analogs RNEC 3.1.3. PIPhosphatases (66-74) MND8.586.277.352.630.654 XSPhosphoric Monoester Hydrolases XUÑHistidinolphosphatase; ÑNitrophenyl Phosphatase; ÑPhosphatidate Phosphatase LH LS LU; ;  PM65 HN65 MHÑPhosphonic Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.604; D1.696.506 LH  MS(Carboxymethyl)phosphonic acid. Simple organo phosphorus compound that inhibits DNA polymerase, especially in viruses; used as antiviral agent. Synonym: Phosphonacetic Acid. HN(78) MHÑPhosphonoacetic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4408-78-0 PIOrganophosphorus Compounds (72-77) MND2.241.81.38.725; D2.705.644; D20.388.760 XSPhosphonoacetate DMÑOrganophosphorus Compounds LH LS LM  PM68 HN68 MHÑPhosphonous Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.629; D1.696.544 LH  MHÑPhosphopeptides ANdo not use /analogs MND12.644.717 LH  MSPhosphoprotein phosphohydrolases. Catalyze the dephosphorylation of phosphoproteins with the formation of a protein and orthophosphate. EC 3.1.3.16. PM78; GLYCOGEN SYNTHETASE PHOSPHATASE, PHOSPHORYLASE PHOSPHATASE & PYRUVATE DEHYDROGENASE PHOSPHATASE were see under PHOSPHOMONOESTERASES 1975-78 HN78 MHÑPhosphoprotein Phosphatases ANdo not use /analogs RNEC 3.1.3.16 PIPhosphomonoesterases (75-77); Phosphoproteins (71-77) MND8.586.277.352.630.654.700 XSPhosphoprotein Phosphohydrolases; Protein Phosphatases XUÑGlycogen Synthetase Phosphatase; ÑPhosphorylase Phosphatase; ÑPyruvate Dehydrogenase Phosphatase LH LS; LU; ;  OLsearch PROTEINS 1966-70 PM73; was see under PROTEINS 1963-72 HN73(71); was see under PROTEINS 1963-72 MHÑPhosphoproteins AN/physiol permitted; do not use /analogs PIPhosphoric Acids (68-70); Proteins (66-70) MND12.776.744 LH  PM73 HN73(64) MHÑPhosphopyruvate Hydratase ANdo not use /analogs RNEC 4.2.1.11 MND8.586.520.497.631 XSENOLASE; Neuron-Specific Enolase LH LS;  MSA group of nitrogen mustard compounds which are substituted with a phosphoramide group or its derivatives; they are usually cytotoxic and used as antineoplastic agents. PM79 HN79 MHÑPhosphoramide Mustards ANdo not use /analogs /biosyn /defic /physiol PICyclophosphamide (75-78); Nitrogen Mustard Compounds (66-74); Organophosphorus Compounds (72-74) MND2.455.526.728.650.730; D2.705.670; D22.204.585.748 LH  PM68 HN68 MHÑPhosphoranes ANdo not use /analogs /biosyn /defic /physiol MND1.696.582 LH  MS5-(Dihydrogen phosphate) 1-(trihydrogen diphosphate) D-ribofuranose. The key substance in the biosynthesis of histidine, tryptophan and purine and pyrimidine nucleotides. HN(75) MHÑPhosphoribosyl Pyrophosphate AN/analogs NIM only; DF: PRPP RN13270-65-0 PIOrganophosphorus Compounds (72-74); Pentosephosphates (72-74); Pyrophosphoric Acids (72-74) MND9.203.894.643.650 DMÑPentosephosphates LH LM  OLsearch ORGANOPHOSPHORUS COMPOUNDS 1972-74 & PHOSPHORIC ACIDS 1968-71 HN(75); was see under PHOSPHORIC ACIDS 1968-71 MHÑPhosphoric Acid Esters ANdo not use /analogs /defic /physiol MND2.705.673 DMÑOrganophosphorus Compounds LH LM  PM68 HN68 MHÑPhosphoric Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.654; D1.696.620 LH  PM68 HN68 MHÑPhosphorous Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.679; D1.696.658 LH  PM/metabolism was PHOSPHORUS METABOLISM 1965 HN/metabolism was PHOSPHORUS METABOLISM 1965 MHÑPhosphorus ANP-31; /physiol permitted; do not use /analogs /biosyn; /metab: disord = PHOSPHORUS METABOLISM DISORDERS RN7723-14-0 MND1.268.666; D1.696 LH  MHÑPhosphorus Isotopes ANNIM; no qualif MND1.496.669; D1.696.696 LH  MHÑPhosphorus Metabolism Disorders MNC18.452.750 LH  OLsearch PHOSPHORUS ISOTOPES 1966-73 PM74 HN74 MHÑPhosphorus Radioisotopes ANP-28 through 34 except P-31; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) MND1.496.669.604; D1.496.749.658; D1.696.734 LH  MSAn aspect of glycogen phosphorylase. A regulatory enzyme active during glycogen breakdown. Phosphorylase a is the phosphorylated and therefore more active form of glycogen phosphorylase. The phosphate groups are hydrolytically removed by phosphorylase phosphatase to form phosphorylase b and orthophosphate. EC 2.4.1.1. OLsearch GLYCOGEN PHOSPHORYLASE 1975-78 HN(79); was see GLYCOGEN PHOSPHORYLASE 1975-78 MHÑPhosphorylase a ANdo not use /analogs RNEC 2.4.1.- PIGlucosyltransferases (66-70); Glycogen Phosphorylase (71-78) MND8.586.913.407.323.366.700 DMÑGlycogen Phosphorylase LH LM  MSAn aspect of glycogen phosphorylase. A regulatory enzyme active during glycogen breakdown. This relatively inactive enzyme is reactivated to form phosphorylase a by phosphorylase kinase which catalyzes the enzymatic phosphorylation of the serine residues at the expense of ATP. EC 2.4.1.1. OLsearch GLYCOGEN PHOSPHORYLASE 1975-78 HN(79); was see GLYCOGEN PHOSPHORYLASE 1975-78 MHÑPhosphorylase b ANdo not use /analogs RN EC 2.4.1.- PIGlucosyltransferases (66-70); Glycogen Phosphorylase (71-78) MND8.586.913.407.323.366.710 DMÑGlycogen Phosphorylase LH LM  MHÑPhosphorylase Kinase ANdo not use /analogs RNEC 2.7.1.38 MND8.586.913.696.729.654 LH  MSPhosphorylase a phosphohydrolase. Deactivates the enzyme glycogen phosphophorylase a by releasing inorganic phosphate and phosphorylase b, the inactive form. HN(75); was see under PHOSPHOMONOESTERASES 1975-78 MHÑPhosphorylase Phosphatase ANdo not use /analogs RNEC 3.1.3.17 PIGlycogen Phosphorylase (73-74); Phosphatases (73-74) MND8.586.277.352.630.654.750 XSPR-Enzyme DMÑPhosphoprotein Phosphatases LH LS LM  MSThe introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorous moiety. HN(79) MHÑPhosphorylation ANalmost never IM; no qualif; enzymatic phosphorylation: coord NIM with PHOSPHOTRANSFERASES (IM) + substrate (NIM) or specific phosphotransferase (particularly KINASES or PROTEIN KINASES) (IM); OXIDATIVE PHOSPHORYLATION & PHOTOPHOSPHORYLATION are also available MNH1.181.404.780 DMÑChemistry, Organic LH LM  MS(2-Hydroxyethyl)trimethylammonium chloride phosphate. Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction. HN(75) MHÑPhosphorylcholine ANdo not use /biosyn /defic /physiol RN107-73-3 PICholine (69-74); Organophosphorus Compounds (73-74) MND2.92.102.232.700; D2.675.276.232.700 XSCholine Chloride Dihydrogen Phosphate; Choline Phosphate Chloride; Phosphorylcholine Chloride DMÑCholine LH LS; ; LM  MSDL-Serine, dihydrogen phosphate. The phosphoric acid ester of serine. Used as an identifier in the analysis of peptides, proteins and enzymes. HN(80) MHÑPhosphoserine ANdo not use /biosyn /defic /physiol RN17885-08-4 PIOrganophosphorus Compounds (71-78); Phosphoric Acid Esters (79); Phosphoric Acids (68-70); Serine (66-74) /AA (75-79) MND2.705.679; D12.125.837.800 XSSerine Phosphate DMÑSerine LH LS LM  MSL-Threonine, dihydrogen phosphate. The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins and enzymes. HN(80) MHÑPhosphothreonine ANdo not use /biosyn /defic /physiol RN1114-81-4 PIOrganophosphorus Compounds (71-78); Phosphoric Acid Esters (79); Phosphoric Acids (68-70); Threonine (66-74) /AA (75-79) MND2.705.683; D12.125.901.800 XSThreonine Phosphate DMÑThreonine LH LS LM  MHÑPhosphotransferases ANdo not use /analogs RNEC 2.7. MND8.586.913.696 XSTRANSPHOSPHORYLASES XUÑBisphosphoglyceromutase; ÑCholinephosphotransferase; ÑEthanolaminephosphotransferase; ÑPhosphatidylserine Synthetase; ÑPhosphoglyceromutase LH LS LU; ; ; ;  OLto search KINASES use PHOSPHOTRANSFERASES, ATP back thru 1977 & PHOSPHOTRANSFERASES 1966-76 PM74; KINASES was see PHOSPHOTRANSFERASES 1963-76 HN74; KINASES was see PHOSPHOTRANSFERASES 1963-76 MHÑPhosphotransferases, ATP ANKINASES is GEN only: prefer specifics; do not use /analogs RNEC 2.7. MND8.586.913.696.729 XSKinases XUÑATP-Guanosine Phosphate Pyrophosphotransferase; ÑAcetate Kinase; ÑAdenosine Kinase; ÑAdenylate Kinase; ÑArginine Kinase; ÑAspartate Kinase; ÑCholine Kinase; ÑDeoxycytidine Kinase; ÑFructokinases; ÑGlycerol Kinase; ÑNucleoside Diphosphate Kinases; ÑNucleoside Monophosphate Kinases; ÑPolynucleotide Hydroxylkinase; ÑPyridoxal Kinase; ÑPyruvate, Phosphate Dikinase; ÑRibosephosphate Pyrophosphokinase; ÑThiamine Pyrophosphokinase; ÑUridine Kinase LH LS LU; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;  PM68 HN68(64) MHÑPhosphotungstic Acid ANdo not use /analogs /biosyn /defic /physiol RN12067-99-1 MND1.552.912.604; D1.696.772 LH  MSO-(4-Bromo-2,5-dichlorophenyl)-O-methylphenyl phosphonothioate. An organothiophosphate insecticide. Synonyms: VCS-506; Leptophos. HN(75) MHÑPhosvel ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN21609-90-5 PIBenzene Derivatives (74); Insecticides, Organothiophosphate (73-74) MND2.719.800; D5.723.491.657.825 XSLeptophos DMÑInsecticides, Organothiophosphate LH LS LM  MSAn egg yolk phosphoglycoprotein which contains about 90% of the yolk protein phosphorus. It is synthesized in the liver of the hen and transferred to the developing oocyte, where it is bound to lipoproteins within the yolk granules. HN(75) MHÑPhosvitin AN/analogs NIM only RN9008-96-2 PIEgg Proteins (73-74); Phosphoproteins (73-74) MND12.776.256.317.700; D12.776.744.700 DMÑEgg Proteins LH LM  PM73 HN73(72) MHÑPhotic Stimulation ANonly /adv eff /instrum /methods; ╥visual stimulation╙ probably goes here but check text for possible non-light stimul PILight (66-71) MNE5.723.729 XSStimulation, Photic; Visual Stimulation FXÑLight LH LS; LX  MHÑPhotobacterium MNB3.475.900.604 LH  PM71 HN71 MHÑPhotochemistry ANIM when SPEC: only /instrum /methods; no qualif when NIM coord PILight (66-70) MNH1.181.529.711 LH  MSTherapy using oral or topical photosensitizing agents with subsequent exposure to light. PM78 HN78 MHÑPhotochemotherapy AN╥therapy using oral or topical photosensitizing agents with subsequent exposure to light╙; IM; coord with disease /drug ther (IM) PILight (66-77); Ultraviolet Therapy (66-77) MNE2.319.685; E2.780.740 XSPhotodynamic Therapy FXÑLight; ÑUltraviolet Therapy XUÑHematoporphyrin Photoradiation LH LS LX; LU  MSThe photography of images produced on a fluorescent screen by X-rays. HN(75) MHÑPhotofluorography ANNIM; only /hist /instrum /methods /stand /vet MNE1.818.312.700; H1.671.606.799.700 DMÑFluoroscopy LH LM  MSMaking measurements by the use of stereoscopic photographs. HN(75) MHÑPhotogrammetry ANonly /hist /instrum /methods /stand; moire topography goes here + INTERFEROMETRY MNE5.712.520; H1.671.606.799.715 XSStereophotogrammetry DMÑPhotography LH LS LM  MHÑPhotography ANonly /econ /hist /instrum /methods /stand /vet; moire topography: see note above MNE5.712; H1.671.606.799 FXÑMICROFILMING; ÑMOTION PICTURES XUÑPhotogrammetry LH LX; LU  PM74 HN74(71) MHÑPhotolysis ANno qualif PILight (66-70); Ultraviolet Rays (66-70) MNH1.181.529.711.480 LH  MHÑPhotometry ANNIM; only /hist /instrum /methods /stand MNE5.196.712 FXÑLight LH LX  MHÑPhotomicrography ANavoid: read Manual 26.32; when IM, only /hist /instrum /methods /stand; do not confuse with ╥microphotography╙ (MICROFILMING or PHOTOMICROGRAPHY: be careful) MNE5.595.799; E5.712.730; H1.671.606.799.730 LH  PM74 HN74(72) MHÑPhotophosphorylation ANonly /drug eff /rad eff PIPhotosynthesis (66-71) MNG6.535.335.755.605; H1.181.529.711.605 LH  PM71 HN71 MHÑPhotoreceptors ANdo not use /innerv PIReceptors, Sensory (66-70) MNA8.796.511.725.605 LH  MSAbnormality in response to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. Refers almost exclusively to skin photosensitivity including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. Do not use for photophobia or photosensitive epilepsy. OLuse PHOTOSENSITIVITY DISORDERS to search PHOTOSENSITIZATION back thru 1966 PM80; was PHOTOSENSITIZATION 1963-79 HN80; was PHOTOSENSITIZATION 1963-79 MHÑPhotosensitivity Disorders ANa skin disease entity: does not mean sensitivity to light of eye, plants, bacteria, etc. ( = LIGHT) MNC17.608; C20.543.667 XSDermatitis, Contact, Photosensitive; Dermatitis, Photocontact; Photoallergy; Photodermatitis; Phototoxicity FXÑLight LH LS; ; ; ; LX  MHÑPhotosynthesis ANonly /drug eff /rad eff MNG6.535.335.755; H1.181.529.711.730 FXÑChlorophyll; ÑChloroplasts LH LX;  MSTreatment of disease, especially neonatal jaundice and certain neoplasms, with visible light, including LASERS. OLto search LIGHT /TU use PHOTOTHERAPY back thru 1966 (with no qualif 1966-80) PM81; was LIGHT /therapeutic use 1966-80; HELIOTHERAPY was see under PHYSICAL THERAPY 1975-85 & SUNLIGHT 1963-74 HN81; was LIGHT /therapeutic use 1966-80 MHÑPhototherapy ANIM; coord disease with /ther, not /radiother; PHOTOCHEMOTHERAPY & ULTRAVIOLET THERAPY are also available PIJaundice, Neonatal/TH (66-80); Light/TU (67-80) MNE2.780.750 XSPhotoradiation Therapy FXÑLight XUÑHeliotherapy LH LS LX LU  MSA physiological community of gram-negative bacteria whose members can perform photosynthesis under anaerobic conditions. PM78 HN78; was NON MESH before 1978 MHÑPhototrophic Bacteria PIBacteria (66-77) MNB3.650 LH  MHÑPhrenic Nerve ANdo not use /innerv MNA8.796.828.289.605 LH  MHÑPhrenology ANno qualif MNK1.419.799 LH  OLsearch HETEROCYCLIC COMPOUNDS 1966-74 HN(75); was see under HETEROCYCLIC COMPOUNDS 1966-74 MHÑPhthalazines ANdo not use /analogs /biosyn /defic /physiol MND3.383.710.605 DMÑPyridazines LH LM  MSColored condensation products of phenols with phthalic anhydride; some are used in dye dilution methods to determine kidney or liver function; others are used as pH indicators in chemistry; phenolphthalein is an effective mild cathartic. PM75 HN75 MHÑPhthalein Dyes AND25-26 qualif PIDyes (66-74) MND26.408.646 LH  OLuse PHTHALIC ACIDS to search PHTHALIC ACID back thru 1966 PM75; was PHTHALIC ACID 1963-74 HN75; was PHTHALIC ACID 1963-74 MHÑPhthalic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.805 XUÑDibutyl Phthalate; ÑDiethylhexyl Phthalate; ÑPhthalic Anhydrides LH LU; ;  MSPhthalic acid anhydrides. Can be substituted on any carbon atom. Used extensively in industry and as a reagent in the acylation of amino- and hydroxyl groups. HN(79) MHÑPhthalic Anhydrides ANdo not use /analogs /biosyn /defic /physiol PIAnhydrides (66-78); Phthalic Acids (66-78) MND2.113.600; D2.241.223.805.800 DMÑPhthalic Acids LH LM  MSThe imide of phthalic acids. PM75 HN75 MHÑPhthalimides ANdo not use /analogs /biosyn /defic /physiol PIImides (66-74); Phthalic Acids (66-74) MND2.241.223.805.810; D2.478.600 LH  MSThe metal-free blue phycobilin pigment in a conjugated chromoprotein of blue-green algae. It functions as light-absorbing substance together with chlorophylls. HN(75) MHÑPhycocyanin ANdo not use /defic /physiol; /analogs NIM only RN11016-15-2 PIBile Pigments (71-74); Pigments (74); Plant Proteins (71-74) MND11.557.690; D12.776.765.650 DMÑPigments LH LM  MSThe metal-free red phycobilin pigment in a conjugated chromoprotein of red algae. It functions as a light-absorbing substance together with chlorophylls. HN(75) MHÑPhycoerythrin ANdo not use /defic /physiol; /analogs NIM only RN11016-17-4 PIBile Pigments (72-74); Pigments (74); Plant Proteins (72-74) MND11.557.705; D12.776.765.665 DMÑPigments LH LM  MSA genus of zygomycetous fungi, order Mucorales, forming mycelia having a metallic sheen; has been used for research on phototropism. HN(75); was see under PHYCOMYCETES 1975-85 MHÑPhycomyces ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.730.944.550.740 DMÑMucorales LH LM  MSA large group of lower fungi, including the common water, leaf, and bread molds; formerly considered a class, but now split into two subdivisions, Mastigomycotina and Zygomycotina. MHÑPhycomycetes ANGEN: prefer specifics; do not use /anat /embryol /microbiol /parasitol MNB5.354.730 LH  MSThe relationships of groups of organisms as reflected by their evolutionary history. OLsearch EVOLUTION 1967-74 PM78; was see under EVOLUTION 1967-77 HN78(75); was see under EVOLUTION 1967-77 MHÑPhylogeny ANno qualif PIEvolution (66-74) MNG4.185.349.605 LH  MSOligopeptide isolated from the skin of Physalaemus fuscumaculatus, a South American frog; it is a typical kinin, resembling SUBSTANCE P in structure and action; proposed as a sialagogue, antihypertensive and vasodilator. HN(77) MHÑPhysalaemin ANfrom frog skin; do not use /defic /physiol; /analogs NIM only RN2507-24-6 PIPeptides (69-76) MND12.644.320.800; D12.776.641.650.625; D24.185.798.354.728; D24.185.965.33.728 DMÑKinins LH LM  MSA large genus of slime molds, family Physarales, class Myxomycetes, having violet to brown spores. PM79; was see under MYXOMYCETES 1975-78 HN79(75); was see under MYXOMYCETES 1975-78 MHÑPhysarum ANdo not use /anat /embryol /microbiol /parasitol PIMyxomycetes (66-74) MNB5.354.618.700 LH  MSPhysical conditioning of domestic, laboratory, and zoo animals. Includes exercising of animals. PM76 HN76 MHÑPhysical Conditioning, Animal ANdomestic, veterinary & exper animals; do not use /vet; don't forget check tag ANIMAL; animal running in exercise wheel is probably MOTOR ACTIVITY or EXERTION MNE5.718 LH  MSInstructional programs in the care and development of the body, often in schools; does not include prescribed exercises, which is EXERCISE THERAPY. MHÑPhysical Education and Training ANonly /econ /hist /methods /stand /trends; differentiate from GYMNASTICS (see note there & EXERCISE THERAPY (prescribed exercise & physical activity); DF: PHYS ED or PHYSICAL EDUC or PHYSICAL EDUCATION CATALOG: /geog /form; do not use /pop wks MNI2.233.543 LH  MSThe time span between the beginning of physical activity by an individual and the termination because of exhaustion. PM77 HN77 MHÑPhysical Endurance ANonly /drug eff /rad eff; differs from PHYSICAL FITNESS in that here the emphasis is on ╥endurance╙ PIExertion (66-76); Fatigue (66-76) MNG11.427.394.625 FXÑPhysical Fitness LH LX  MSSystematic and thorough inspection of the patient for physical signs of disease or abnormality. MHÑPhysical Examination ANonly /econ /instrum /methods /stand /vet MNE1.706 LH  MSA state of well-being in which performance is optimal, often as a result of physical conditioning which may be prescribed for disease therapy. MHÑPhysical Fitness ANno qualif; EFFICIENCY (F2) is also available MNI3.621; N1.407.540.730 FXÑExercise Therapy; ÑPhysical Endurance LH LX;  MSA medical specialty concerned with the use of physical agents, mechanical apparatus, and manipulation in rehabilitating physically diseased or injured patients. MHÑPhysical Medicine ANSPEC: SPEC qualif MNG2.403.790.508 FXÑBiomechanics LH LX  OL╥physical science╙ or ╥physical sciences╙ is indexed under SCIENCE or the specific science (as CHEMISTRY, GEOLOGY, etc.) MH*Physical Sciences (Non Mesh) MNH1 LH  PM73 HN73 MHÑPhysical Stimulation ANNIM; only /adv eff /instrum /methods MNE5.723 XSSTIMULATION, PHYSICAL LH LS  MSThe restoration of function and the prevention of disability following disease or injury with the use of light, heat, cold, water, electricity, ultrasound, and exercise. PMHELIOTHERAPY was see under SUNLIGHT 1963-74 MHÑPhysical Therapy ANuse Cat E qualif; /educ permitted; do not use /util except by MeSH definition; coord IM with dis /rehabil (IM), not /ther MNE2.780; E2.831.578; G2.671 XSPhysiotherapy LH LS  MSHospital department which is responsible for the administration and provision of diagnostic and medical rehabilitation services to restore or improve the functional capacity of the patient. HN(Aug 77) MHÑPhysical Therapy Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: PHYS THER DEP PIHospital Departments (68-Jul 77); Physical Therapy (66-Jul 77) MNN2.278.354.422.615; N4.452.442.422.615 XSHospital Physical Therapy Department DMÑHospital Departments LH LS LM  MSThe physician's inability to practice medicine with reasonable skill and safety to the patient due to the physician's disability. Common causes include alcohol and drug abuse, mental illness, handicaps, and senility. PM81 HN81 MHÑPhysician Impairment ANonly /legis PIClinical Competence (75-80); Mental Disorders (66-80); specific mental disorder; Physicians (66-80) MNI1.880.604.583.524.528.500; N3.706.535.606.528.500 LH  MSThe interactions between physician and patient. MHÑPhysician-Patient Relations ANno qualif MNF1.829.401.650.675 XSDOCTOR-PATIENT RELATIONS FXÑTruth Disclosure LH LS LX  MSPatterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided. PM87 HN87 MHÑPhysician's Practice Patterns AN╥practice related to diag & treatment espec as influenced by cost of service requested & provided╙: do not confuse with PROFESSIONAL PRACTICE where emphasis is on the physician & his practice; only /econ /legis /stand /trends PICosts and Cost Analysis (66-86); Health Services Misuse (77-86); Professional Practice (68-86) MNN4.590.748 XSClinical Practice Variations FXÑInsurance, Health LH LS LX  MSThe expected and characteristic behavior of a physician as a member of the medical profession. HN(78) MHÑPhysician's Role ANno qualif; coord IM with area in which he is playing a role (IM), as ╥physician's role in community health nursing╙ = PHYSICIAN'S ROLE (IM) + COMMUNITY HEALTH NURSING (IM) PIRole (69-77) MNF1.829.316.616.500 DMÑRole LH LM  MSIndividuals licensed to practice medicine. MHÑPhysicians AN/educ = EDUCATION, MEDICAL or its specifics; do not use /man; Manual 34.15; in biographies: Manual 17.2.5; when not to use: Manual 35.11.1; ╥role of physician in ...╙ = PHYSICIAN'S ROLE: see note there; ╥junior physicians╙: index under MEDICAL STAFF, HOSPITAL CATALOG: /geog /form MNM1.526.485.810; N2.350.759 LH  MSThose physicians who have completed the education requirements specified by the American Academy of Family Physicians. PM74 HN74(72) MHÑPhysicians, Family AN/educ permitted: coord with specific type of educ; do not use /man PIFamily Practice (66-71); Physicians (66-71) MNM1.526.485.810.770; N2.350.759.606 XSGeneral Practitioners; Primary Care Physicians FXÑFamily Practice LH LS; LX  MSWomen licensed to practice medicine. MHÑPhysicians, Women AN/educ = EDUCATION, MEDICAL or its specifics; do not use /man; Manual 34.16 CATALOG: /geog /form MNM1.526.485.810.820; M1.975.790; N2.350.759.731 XSWOMEN PHYSICIANS LH LS  MSPersons academically trained to provide medical care under the supervision of a physician. Does not include nurses. Synonyms: Orthopedic Assistants, Anesthesia Assistants, Surgeon's Assistants, Doctor's Assistants, Medex. PM71 HN71 MHÑPhysicians' Assistants ANdo not use /man /methods; coord IM with specialty (IM); PARAMEDICS see ALLIED HEALTH PERSONNEL is available PIHealth Manpower (68-70); Physicians (68-70) MNM1.526.485.67.740; N2.350.84.771 XSAnesthesia Assistants; Feldshers; Medex; Physicians' Extenders XUÑOphthalmic Assistants; ÑPediatric Assistants LH LS; ; ; LU;  MSThe room or rooms in which the physician and his staff provide patient health care; includes all rooms in the physician's office suite. HN(80) MHÑPhysicians' Offices ANonly /class /econ /hist /legis /organ /stand /supply /trends /util (if by MeSH definition); restrict to physical office: includes reception rooms, examining rooms, treatment rooms, office, labs, etc.; not for articles with title reading, e.g., ╥office assessment of nutrition disord╙ or ╥office use of microscopes in otology╙ MNN2.278.692 DMÑHealth Facilities LH LM  MHÑPhysics ANwhen IM, only /educ /hist /instrum; may be used as NIM coord, without qualif; Manual 29.11 MNH1.671 XUÑDoppler Effect; ÑLubrication LH LU;  MHÑPhysiognomy ANno qualif; FACIAL EXPRESSION is also available MNE5.734 LH  MHÑPhysiology ANSPEC only: SPEC qualif; prefer /physiol with organs, organisms & psychol processes: Manual 19.5+ MNG1.782 LH  MHÑPhysiology, Comparative ANNIM; no qualif; IM when SPEC; Manual 18.13.4 MNG1.782.688 LH  OLpre-explosion = PHYSIOLOGY, GENERAL (PX) MH*Physiology, General (Non Mesh) MNG7 LH  MHÑPhysostigmine ANdo not use /biosyn /defic /physiol RN57-47-6 MND2.241.81.251.642; D3.132.656; D8.373.275.745; D16.698.410.745 XSESERINE LH LS  MS3,7,11,15-Tetramethylhexadecanoic acid. A 20-carbon branched chain fatty acid. In phytanic acid storage disease (Refsum's syndrome) this lipid may comprise as much as 30% of the total fatty acdis of the plasma. This is due to a phytanic acid alpha-hydroxylase deficiency. HN(75) MHÑPhytanic Acid AN/analogs NIM only RN14721-66-5 PIDiterpenes (74); Fatty Acids (70-74) MND2.241.81.407.300.700; D2.455.849.291.515; D10.516.251.220.700 DMÑEicosanoic Acids LH LM  PM66 HN66 MHÑPhytase ANdo not use /analogs RNEC 3.1.3.26 MND8.586.277.352.630.654.782 XSINOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE LH LS  OLsearch INOSITOL 1966-74; to search PHYTIN use PHYTIC ACID back thru 1975 & INOSITOL 1966-74 PM78; was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77 HN78(75); was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77 MHÑPhytic Acid ANdo not use /biosyn (unless by a plant) /defic /physiol RN83-86-3 PIInositol (66-77) MND2.33.800.519.400.700; D9.203.853.519.400.700; D9.203.894.480.700 XSInositol Hexaphosphate; Phytin LH LS;  MSA blue-green biliprotein widely distributed in the plant kingdom. HN(75) MHÑPhytochrome ANdo not use /defic /physiol; /analogs NIM only RN11121-56-5 PIBile Pigments (73-74); Plant Proteins (72-74) MND11.557.712; D12.776.765.675 DMÑPlant Proteins LH LM  MSMucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes; used mainly in the study of immune mechanisms and in cell culture. OLsearch LECTINS 1968-78 PM79; was indexed under PLANT AGGLUTININS 1968-78 HN79; was indexed under PLANT AGGLUTININS 1968-78 MHÑPhytohemagglutinins ANdo not use /defic /physiol PILectins (66-78) MND12.776.765.677; D24.185.526.545.711; D24.310.545.711; D24.611.125.44.545.711 XSKidney Bean Lectins; Lectins, Kidney Bean; Phaseolus Vulgaris Lectins LH LS; ;  OLsearch TERPENES 1968-74 HN(75); was see under TERPENES 1968-74 MHÑPhytol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN150-86-7 MND2.455.849.291.523 DMÑDiterpenes LH LM  MHÑPhytonadione AN/defic: coord IM with VITAMIN K DEFICIENCY (NIM) RN84-80-0 MND11.786.875.689; D19.461.270.546.861.689 XSVITAMIN K 1 LH LS  MSA Mastigomycotina genus of destructive parasitic fungi affecting numerous fruit, vegetable, and other crops. HN(75); was see under PHYCOMYCETES 1975-85 MHÑPhytophthora ANfruit & vegetable fungus; do not use /anat /embryol /microbiol /parasitol MNB5.354.730.576.625.725 DMÑMastigomycotina LH LM  MSMinute plant organisms which live in practically all natural waters. HN(71) MHÑPhytoplankton ANdo not use /anat /embryol /microbiol /parasitol PIPlankton (66-70) MNB5.692.606 DMÑPlankton LH LM  PM73 HN73 MHÑPhytosterols ANdo not use /analogs /defic /physiol PICholestanes (68-72); Sterols (68-72) MND4.808.247.808.756 XSPLANT STEROLS XUÑStigmasterol LH LS LU  MHÑPia Mater ANdo not use /innerv MNA8.186.566.731 LH  MSA craving for substances unsuitable as food. PM72 HN72(68) MHÑPica ANhuman & animal; do not use /congen /drug eff /physiol /rad eff PIAppetite Disorders (66-67) MNC23.888.102.689; F3.126.72.500 LH  MSYeast-like ascomycetous fungi of the family Saccharomycetaceae, order Endomycetales isolated from exuded tree sap. HN(75); was see under ASCOMYCETES 1975-85 MHÑPichia ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.292.700; B5.354.930.600 DMÑEndomycetales LH LM  MSA lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G; proposed as noncytotoxic antineoplastic agent due to its immune stimulating activity. OLuse PICIBANIL to search STREPTOCOCCAL PREPARATION OK-432 back thru 1978 HN(83); was STREPTOCOCCAL PREPARATION OK-432 see under BIOLOGICAL PRODUCTS 1978-82 MHÑPicibanil ANdo not use /defic /physiol; /analogs NIM only; DF: OK 432 or OK-432 RN39325-01-4 PIStreptococcus (66-77) MND22.204.670; D24.310.670 XSOK-432; Streptococcal OK-432; Streptococcal Preparation OK-432 DMÑBiological Products LH LS; ; LM  MSExtreme obesity with polycythemia, somnolence, hypoventilation, arterial unsaturation and hypercapnia, and pulmonary hypertension. OLuse PICKWICKIAN SYNDROME to search PICKWICK SYNDROME back thru 1966 (as Prov 1966-69) PM70 HN70; was PICKWICK SYNDROME 1964-69 (Prov) MHÑPickwickian Syndrome MNC8.618.85.852.741; C18.654.621.690 LH  HN(71) MHÑPicloram ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1918-02-1 PIHerbicides (66-70); Picolinic Acids (68-70) MND3.66.707.523; D3.383.725.705.523; D5.723.366.734 DMÑPicolinic Acids LH LM  OLuse PICOLINES to search PICOLINE back thru 1966 PM79; was PICOLINE 1963-78 HN79; was PICOLINE 1963-78 MHÑPicolines ANdo not use /analogs /biosyn /defic /physiol MND3.383.725.676 XUÑAmprolium LH LU  PM68 HN68 MHÑPicolinic Acids ANdo not use /analogs /biosyn /defic /physiol MND3.66.707; D3.383.725.705 XUÑFusaric Acid; ÑPicloram LH LU;  MSA family of RNA viruses named for its small size (It. pico - tiny). OLuse PICORNAVIRIDAE to search PICORNAVIRUSES & PICORNAVIRUS back thru 1966 PM81; was PICORNAVIRUSES 1975-80, was PICORNAVIRUS 1964-74 HN81; was PICORNAVIRUSES 1975-80, was PICORNAVIRUS 1964-74 MHÑPicornaviridae ANfrom pico (tiny) + RNA virus; do not use /blood-csf-urine /cytol MNB4.909.777.618 LH  PM80 HN80; was NON MESH before 1980 MHÑPicornavirus Infections PIPicornaviridae (66-79); Virus Diseases (66-79) MNC2.782.687 LH  MHÑPicrates ANdo not use /analogs /biosyn /defic /physiol MND2.640.743.690; D2.755.566.690 LH  MHÑPicrotoxin ANdo not use /biosyn /defic /physiol RN124-87-8 MND15.128.224.798 LH  PM65 HN65 MHÑPicryl Chloride ANdo not use /biosyn /defic /physiol RN88-88-0 MND2.455.426.559.389.565.607; D2.640.529.880.607 LH  MSEither of two diseases resulting from fungal infection of the hair shafts. Black piedra occurs mainly in and on the hairs of the scalp and is caused by Piedraia hortae; white piedra occurs in and on the hairs of the scalp, beard, moustache and genital areas and is caused by Trichosporon beigelii. OLsearch MYCOSES 1966-74 HN(75) MHÑPiedra MNC1.703.753 DMÑMycoses LH LM  PM65 HN65(64) MHÑPierre Robin Syndrome ANnote: no hyphen; do not use /congen MNC16.131.621.514.606 LH  PM68 HN68 MHÑPigeons ANincludes doves; IM except in psychol articles; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; NIM in psychol: no qualif PIBirds (66-67); Poultry (66-67) MNB2.248.523 LH  MSEpithelium in the retina, ciliary body, and iris containing pigment granules. PM76 HN76 MHÑPigment Epithelium of Eye ANdetachment = RETINAL DETACHMENT PICiliary Body (66-75); Iris (66-75); Retina (66-75); Retinal Degeneration (68-75); Retinal Diseases (72-75) MNA9.371.670; A10.272.640 XSRetinal Pigment Epithelium LH LS  MSColoration or discoloration of a part by a pigment. MHÑPigmentation ANonly /drug eff /genet /rad eff; differentiate from COLOR in that PIGMENTATION is related to biological PIGMENTS: COLOR need not involve these; SKIN PIGMENTATION is also available MNE1.706.760; G4.185.672 FXÑChromatophores LH LX  OLuse PIGMENTATION DISORDERS to search SCHAMBERG'S DISEASE back thru 1966 PMSCHAMBERG'S DISEASE was see under PIGMENTATION DISORDERS 1965-85 HNSCHAMBERG'S DISEASE was see under PIGMENTATION DISORDERS 1965-85 MHÑPigmentation Disorders ANdo not restrict to skin despite category; chlorosis: index under ANEMIA, HYPOCHROMIC MNC17.621 XSIncontinentia Pigmenti Achromians; Ito Syndrome; Schamberg's Disease XUÑIncontinentia Pigmenti LH LS; ; LU  MHÑPigments ANlargely biol: differentiate from DYES, usually non-biol; do not use /analogs /defic /physiol; ╥visual pigments╙ = RETINAL PIGMENTS MND11.557 XUÑCeroid; ÑLipofuscin; ÑPhycocyanin; ÑPhycoerythrin LH LU; ; ;  MSThin, hairlike appendages, 1 to 20 microns in length, present on the cells of Gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not confer motility, but being protein (pilin) in nature, they possess antigenic and haemagglutinating properties. They are of two types: ╥common╙ pili and sex or F pili. The common pili are of medical importance because they mediate the attachment of bacteria to cells; sex pili are present only on donor bacteria and are the organs associated with genetic transfer. PM80 HN80 MHÑPili, Bacterial ANA 11 qualif except /cytol PIBacterial Proteins (66-79); Cell Wall (66-79); specific bacterium MNA11.368.702.679 XSBacterial Pili; Fimbriae, Bacterial FXÑBacterial Adhesion LH LS; LX  MHÑPilocarpine ANdo not use /defic /physiol; /biosyn permitted if by plant RN92-13-7 MND3.132.672; D16.698.628.712 LH  MSInvoluntary erection or bristling of hairs. HN(72) MHÑPiloerection ANonly /drug eff PIHair (66-71); Reflex (66-71) MNF2.830.702.607; G10.795.499; G11.561.730.482 DMÑReflex LH LM  MSA hair-containing cyst or sinus, occurring chiefly in the coccygeal region. MHÑPilonidal Cyst ANno organ coord needed; do not use /congen MNC4.182.710 XSPilonidal Sinus LH LS  PM74 HN74(71) MHÑPilot Projects ANno qualif PIResearch (66-70) MNH1.770.644.524 LH  MSAmphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis; used for a variety of fungal infections, mainly topically. Synonyms: Myprozine; Pimafucin. PM73 HN73(66) MHÑPimaricin ANdo not use /defic /physiol RN7681-93-8 MND20.85.62.746; D20.136.73.746 XSNatamycin; Tennecetin LH LS;  OLuse PIMELIC ACIDS to search PIMELIC ACID back thru 1966 PM75; was PIMELIC ACID 1963-74 HN75; was PIMELIC ACID 1963-74 MHÑPimelic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.337.699 LH  PM73 HN73 MHÑPimozide ANdo not use /biosyn /defic /physiol RN2062-78-4 PIBenzimidazoles (66-72); Tranquilizing Agents (66-72) MND3.438.103.732; D15.236.872.331.690 LH  PM73 HN73 MHÑPindolol ANdo not use /biosyn /defic /physiol RN13523-86-9 PISympatholytics (66-72) MND2.33.329.624.748; D2.92.63.624.748; D16.848.215.607 XSPrindolol LH LS  MSA small conical midline body attached to the posterior part of the third ventricle and lying between the superior colliculi, below the splenium of the corpus callosum. MHÑPineal Body ANdo not use /innerv; neopl: do not consider PINEALOMA a synonym: coord PINEAL BODY (IM) with BRAIN NEOPLASMS (IM) + histol type of type (IM) MNA6.407.635; A6.688.733; A8.186.211.385.608; A8.713.733 XSEPIPHYSIS CEREBRI LH LS  MHÑPinealoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with BRAIN NEOPLASMS (IM); pinealoblastoma, pineoblastoma & pineocytoma go here MNC4.557.776 LH  PM68 HN68 MHÑPinnipedia ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PICarnivora (66-67) MNB2.649.754 XUÑSeals; ÑWalrus LH LU;  MSThe engulfing of liquids by cells by a process of invagination and closure of the cell membrane to form fluid-filled vacuoles. PM66 HN66(64) MHÑPinocytosis ANonly /drug eff /rad eff MNG4.335.487.370 LH  MHÑPinta MNC1.252.847.840.558; C17.838.670 LH  PM68 HN68 MHÑPipecolic Acids ANdo not use /analogs /biosyn /defic /physiol MND3.66.758; D3.383.621.758 LH  MS8-Ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido (2,3-d)pyrimidine-6-carboxylic acid. Antimicrobial against Gram negative and some Gram positive bacteria; protein bound and concentrated in bile and urine; used for gastrointestinal, biliary and urinary infections. HN(79) MHÑPipemidic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN51940-44-4 PINalidixic Acid (66-75); Nicotinic Acids (76-78); Piperazines (66-70) MND3.66.515.635; D3.383.606.765; D3.383.725.547.635; D20.237.765.745 XSPiperamic Acid DMÑNicotinic Acids LH LS LM  MS10-[3-[4-(2-Hydroxyethyl)piperidino]propyl[phenothiazin-2-yl methyl ketone. Major tranquilizer of the phenothiazine type. Synonyms: Guide; PC 1421. HN(75) MHÑPiperacetazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3819-00-9 PIPhenothiazine Tranquilizers (73-74); Piperidines (73-74) MND3.494.741.605; D15.236.872.331.628.615 DMÑPhenothiazine Tranquilizers LH LM  MS6-[[[((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl) amino]-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid. Semisynthetic, broad-spectrum, ampicillin-derived ureidopenicillin antibiotic proposed for Pseudomonas infections; also used in combination with other antibiotics. Synonym: CL 227,193. PM84 HN84 MHÑPiperacillin ANdo not use /biosyn /defic /physiol RN61477-96-1 PIPenicillins (66-83) MND20.85.99.739.762.57.746 LH  MHÑPiperazines ANdo not use /analogs /biosyn /defic /physiol MND3.383.606 XUÑDMPP; ÑHEPES; ÑLidoflazine; ÑPiribedil; ÑProspidium; ÑRazoxane; ÑTrimetazidine LH LU; ; ; ; ; ;  OLuse PIPERIDINES to search AZACYCLONOL back thru 1966 PMAZACYCLONOL was heading 1963-84; PIPEROXAN was not in system 1975-76, was see under SYMPATHOLYTICS 1963-74 HNAZACYCLONOL was heading 1963-84 MHÑPiperidines ANdo not use /analogs /biosyn /defic /physiol MND3.383.621 XUÑAnabasine; ÑAspaminol; ÑBiperiden; ÑDanitracen; ÑDexetimide; ÑEtoxadrol; ÑLoperamide; ÑPenfluridol; ÑPiperidones; ÑPiperoxan; ÑTibric Acid LH LU; ; ; ; ; ; ; ; ; ;  HN(71) MHÑPiperidones ANdo not use /analogs /biosyn /defic /physiol PIPiperidines (66-70) MND3.383.621.808 DMÑPiperidines LH LM  PM74 HN74(72) MHÑPiperonyl Butoxide ANdo not use /biosyn /defic /physiol RN51-03-6 PIDioxoles (68-71); Insecticides (66-71); Pesticides (66-71) MND3.383.246.558; D5.723.748.483 LH  MS1-(1,4-Benzodioxan-2-ylmethyl)piperidine hydrochloride. Benzodioxane alpha adrenergic blocking agent with considerable stimulatory action; formerly used to diagnose pheochromocytoma. Synonyms: Benodain(e); Forneau 933; 933 F. OLsearch SYMPATHOLYTICS 1966-74 HN(77); was see under SYMPATHOLYTICS 1963-74 MHÑPiperoxan ANdo not use /biosyn /defic /physiol; /analogs NIM only RN59-39-2 PIDioxanes (75); Dioxins (73-74); Piperidines (70-76); Sympatholytics (66-74) MND3.383.621.815; D16.848.115.624 XSBenzodioxane DMÑPiperidines LH LS LM  MSA family of the order Anura, distinguised by the lack of a tongue; includes four living genera of aquatic ╥toads╙. Two of the most familiar pipids are the popularly called Surinam ╥toad╙ (Pipapipa) and Xenopus laevis. PM81 HN81 MHÑPipidae ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.90.180.610 LH  PM73 HN73(67) MHÑPipobroman ANdo not use /biosyn /defic /physiol RN54-91-1 PIAntineoplastic Agents (66); Bromine (66); Piperazines (66); Propionates (66) MND3.383.606.773; D22.204.678 LH  MS10-[3-[4-(2-Hydroxyethyl)piperidino]propyl]-N,N-dimethylphenothiazine-2-sulfonamide. A member of the family of phenothiazine tranquilizers. Synonym: 19366 RP. HN(75) MHÑPipothiazine ANdo not use /biosyn /defic /physiol; /analogs NIM only PIPhenothiazine Tranquilizers (73-74); Piperidines (73-74); Sulfonamides (73-74) MND3.494.741.615; D15.236.872.331.628.625 DMÑPhenothiazine Tranquilizers LH LM  MS2-[1-[3-(2-Dimethylsulfamoylphenothiazin-10-yl)propyl]-piperidin-4-yl]palmitate. Palmitate ester of pipothiazine; member of phenothiazine family of tranquilizing agents. Synonyms: Pipotiazin retard; 19552 RP. HN(75) MHÑPipothiazine Palmitate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN37517-26-3 PIPalmitic Acids (73-74); Phenothiazine Tranquilizers (73-74); Piperidines (73-74); Sulfonamides (73-74) MND3.494.741.615.600; D15.236.872.331.628.625.600 DMÑPhenothiazine Tranquilizers LH LM  MHÑPipradrol ANdo not use /biosyn /defic /physiol RN467-60-7 MND3.383.621.820; D15.236.122.787 XSPipradol LH LS  MS2-Oxo-1-pyrrolidineacetamide. A compound which enhances learning and modifies memory-storage processes. Also protects against hypoxia-induced amnesia. HN(75) MHÑPiracetam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7491-74-9 PIAcetamides (73-74); Pyrrolidinones (71-74) MND2.65.64.650; D2.241.81.38.108.650; D3.383.773.812.555 DMÑPyrrolidinones LH LM  MS5,11-Dihydro-11-((4-methyl-1-piperazinyl) acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one. An antimuscarinic agent which inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as cimetidine and ranitidine. It is generally well tolerated by patients. PM87 HN87 MHÑPirenzepine ANdo not use /biosyn /defic /physiol RN28797-61-7 PIAzepines (66-73); Benzodiazepinones (74-86) MND3.438.79.80.70.750; D16.653.727; D19.316.203.727 LH  MS1-Piperonyl-4-(2-pyrimidinyl)piperazine. Dopaminergic agent proposed as vasodilator or antiparkinson drug. Synonyms: ET 495; EU 4200; Piprazine; pyrimidinyl piperonyl piperazine; Trivastal. HN(75) MHÑPiribedil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3605-01-4 PIDioxoles (71-74); Piperazines (71-74); Pyrimidines (71-74) MND3.383.606.790; D16.538.267.741 XSPiribendyl DMÑPiperazines LH LS LM  MS1'-(3-Cyano-3,3-diphenylpropyl)-(1,4'-bipiperidine)-4'-carboxamide. Diphenylpropylamine with intense narcotic analgesic activity of long duration; it is a derivative of meperidine with similar activity and usage. Synonyms: A65; Dipidolor; Piridolan; Pyrium; R 3365. HN(77) MHÑPirinitramide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN302-41-0 PIIsonipecotic Acids (69-76); Nitriles (71-76); Piperidines (71-75) MND3.66.399.650; D3.383.621.349.700; D14.73.153.784; D14.757.784 XSPiritramid DMÑIsonipecotic Acids LH LS LM  MS8-Ethyl-5,8-dihydro-5-oxo-2-(1-pyrrolidinyl)pyrido (2,3-d)pyrimidine-6-carboxylic acid. Antibacterial against mainly gram negative organisms; proposed for urinary tract infections. Synonyms: Panacid; PD 93. HN(79) MHÑPiromidic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN19562-30-2 PINicotinic Acids (76-78); Picolinic Acids (68-75); Pyrimidines (66-75); Pyrrolidines (66-78) MND3.66.515.650; D3.383.725.547.650; D20.237.765 DMÑNicotinic Acids LH LM  MS4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2- benzothiazine- 3-carboxamide 1,1-dioxide. A non-steroidal anti-inflammatory agent which is well established in the treatment of rheumatoid arthritis and osteoarthritis. Its usefulness has also been demonstrated in the treatment of musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. The drug has also been shown to be effective if administered rectally. Gastrointestinal complaints are the most frequently reported side effects. PM87 HN87 MHÑPiroxicam ANdo not use /biosyn /defic /physiol RN36322-90-4 PIThiazines (66-86) MND3.383.855.500; D14.73.278.690; D26.74.75.700 LH  MSAgents used to occlude dental enamel pits and fissures in the prevention of dental caries. PM80; was see under DENTAL MATERIALS 1975-79 HN80(72); was see under DENTAL MATERIALS 1975-79 MHÑPit and Fissure Sealants AND25-26 qualif; DF: PIT SEALANTS PIDental Materials (66-71) MND25.339.773 XSDental Sealants; Fissure Sealants; Sealants, Tooth LH LS; ;  HN75 MHÑPitcairn Island MNZ1.782.815.700 LH  MSThe ability to differentiate tones. MHÑPitch Discrimination ANonly /drug eff /physiol MNF2.463.593.71.700.408 LH  MSA dimension of auditory sensation varying with cycles per second of the sound stimulus. PM80 HN80 MHÑPitch Perception ANonly /drug eff /physiol PIAuditory Perception (67-79); Perception (66); Pitch Discrimination (66-79) MNF2.463.593.71.700 LH  MSSudden hemorrhage into or ischemic necrosis of a normal or adenomatous pituitary gland. PM87 HN87 MHÑPituitary Apoplexy PIPituitary Diseases (66-86); Pituitary Neoplasms (66-86) MNC19.700.725 XSApoplexy, Pituitary LH LS  PM66 HN66 MHÑPituitary Diseases ANGEN: prefer specifics; coord IM with specific part of pituitary (NIM); note PITUITARY APOPLEXY above MNC19.700 LH  OLuse PITUITARY FUNCTION TESTS to search PITUITARY GLAND FUNCTION TESTS back thru 1966 PM77,66-77; was PITUITARY GLAND FUNCTION TESTS 1968-76 HN77,66-67; was PITUITARY GLAND FUNCTION TESTS 1968-76 MHÑPituitary Function Tests ANonly /instrum /methods /vet; test of pituit funct or hormonal secretion: do not confuse with PITUITARY-ADRENAL FUNCTION TESTS, test of pituit funct in relation to adrenal funct or corticoid production MNE1.197.642 LH  MSA small, unpaired gland situated in the sella turcica tissue. It is connected to the hypothalamus by a short stalk. MHÑPituitary Gland ANGEN or unspecified: prefer PITUITARY GLAND, ANTERIOR or PITUITARY GLAND, POSTERIOR; pars distalis is indexed under PITUITARY GLAND, ANTERIOR; /rad eff: consider also PITUITARY IRRADIATION, a radiother procedure; /surg: probably HYPOPHYSECTOMY; consider also PITUITARY-ADRENAL SYSTEM & HYPOTHALAMO-HYPOPHYSEAL SYSTEM MNA6.407.747 XSHYPOPHYSIS FXÑHypophysectomy LH LS LX  MSThe glandular or anterior lobe of the pituitary gland. OLsearch PITUITARY GLAND 1966-74 PM78,63-67; was see under PITUITARY GLAND 1968-77 HN78(75)63-67; was see under PITUITARY GLAND 1968-77 MHÑPituitary Gland, Anterior ANdiseases: coord NIM with PITUITARY DISEASES or specific pituitary dis (IM) PIPituitary Gland (66-74) MNA6.407.747.608 XSAdenohypophysis LH LS  MSThe neural or post neural lobe of the pituitary gland. MHÑPituitary Gland, Posterior ANdiseases: coord NIM with PITUITARY DISEASES or specific pituitary dis (IM) MNA6.407.747.734 XSNeurohypophysis LH LS  MSPolypeptide hormones produced in the hypothalamus which inhibit the release of pituitary hormones. Use for PH-RIH in general or for which there is no specific heading. PM75 HN75 MHÑPituitary Hormone Release Inhibiting Hormones AN/biosyn /physiol permitted; do not use /analogs; DF: PHRIH PIPituitary Hormone Releasing Hormones (68-74) MND6.347.560; D12.644.720; D12.776.641.650.640 LH  OLuse PITUITARY HORMONE RELEASING HORMONES to search PITUITARY HORMONE RELEASING FACTORS back thru 1968 PM74; was PITUITARY HORMONE RELEASING FACTORS 1968-73 HN74; was PITUITARY HORMONE RELEASING FACTORS 1968-73 MHÑPituitary Hormone Releasing Hormones ANIM + coord with specific hormone (IM) but note many specific precoords available; /biosyn /physiol permitted; do not use /analogs; DF: PHRH PIHypothalamo-hypophyseal System/PH (66-67) MND6.472.709; D12.644.722; D12.776.641.650.645 XSGonadotropin Releasing Hormones FXÑHypothalamo-Hypophyseal System; ÑNeurosecretion LH LS LX;  PM72 HN72 MHÑPituitary Hormones ANGEN; /biosyn /physiol permitted; do not use /analogs; /defic: consider also HYPOPITUITARISM & its specifics MND6.472.734 LH  MHÑPituitary Hormones, Anterior ANGEN; /biosyn /physiol permitted; do not use /analogs MND6.472.734.525 LH  MHÑPituitary Hormones, Posterior ANGEN; /biosyn /physiol permitted; do not use /analogs MND6.472.734.692 FXÑNeurophysins XUÑPituitrin LH LX LU  OLuse PITUITARY IRRADIATION to search PITUITARY GLAND IRRADIATION back thru 1966 PM77,63-67; was PITUITARY GLAND IRRADIATION 1968-76 HN77,63-67; was PITUITARY GLAND IRRADIATION 1968-76 MHÑPituitary Irradiation ANionizing; a radiother procedure: do not confuse with eff of rad on pituitary ( = PITUITARY GLAND /rad eff); do not use /util except by MeSH definition MNE2.810.442 FXÑHypophysectomy LH LX  MHÑPituitary Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with site in pituitary (NIM) + histol type of neopl (IM) MNC4.588.322.609; C19.700.734 XUÑNelson Syndrome LH LU  PM68; ADRENAL CORTEX FUNCTION TESTS was heading 1963-67 HN68 MHÑPituitary-Adrenal Function Tests ANpituit funct in relation to adrenal funct or corticoid production: differentiate from PITUITARY FUNCTION TESTS, test of pituit funct or hormonal secretion; only /instrum /methods /vet PIPituitary Function Tests (66-67) MNE1.197.571 XUÑAdrenal Cortex Function Tests LH LU  MSThe interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. PM68 HN68(66); was in Cat G only 1966-74 MHÑPituitary-Adrenal System ANhypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM MNA6.407.691 LH  OLsearch PITUITARY HORMONES, POSTERIOR 1966-74 HN(75) MHÑPituitrin AN/biosyn /physiol permitted; /analogs NIM only RN8051-91-0 MND6.472.734.692.559 DMÑPituitary Hormones, Posterior LH LM  MHÑPityriasis MNC17.634 LH  OLto search PITYRIASIS RUBRA use PITYRIASIS RUBRA PILARIS back thru 1967 & DERMATITIS EXFOLIATIVA 1966 PM67; was PITYRIASIS RUBRA see under DERMATITIS EXFOLIATIVA 1963-66 HN67; was PITYRIASIS RUBRA see under DERMATITIS EXFOLIATIVA 1963-66 MHÑPityriasis Rubra Pilaris PIDermatitis Exfoliative (66) MNC17.634.609 LH  MSHydroxymethyl 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate pivalate (ester) hydrochloride. Pivalate ester analog of ampicillin. Synonyms: Pondicillin; Berocillin. HN(75) MHÑPivampicillin ANdo not use /biosyn /defic /physiol RN33817-20-8 PIAmpicillin (72-74); Valerates (73-74) MND20.85.99.739.762.57.774 XSAmpicillin Pivaloyl Ester DMÑAmpicillin LH LS LM  MS4-(9,10-Dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-1-methylpiperidine. Serotonin antagonist used against migraine and vascular headaches. HN(75) MHÑPizotyline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN15574-96-6 PIBenzocycloheptenes (73-74); Piperidines (72-74); Thiophenes (70-74) MND3.383.903.580; D14.73.721; D16.848.115.655; D23.846.756 XSPizotifen DMÑThiophenes LH LS LM  MHÑPlacebos ANusually NIM, no qualif; when IM, only /ther use; do not index routinely for articles on CLINICAL TRIALS, DOUBLE-BLIND METHOD, etc., unless particularly discussed; Manual 18.12.2 MND26.394.774 LH  MHÑPlacenta ANcheck the tags FEMALE & PREGNANCY; do not use /abnorm /embryol /growth /inj; placental serum or placental blood = PLACENTA + BLOOD; mole of placenta, invasive or destructive = CHORIOADENOMA; do not confuse PLACENTOME (X ref below: all fetal & maternal tissues involved in placentation) with placentoma (index under DECIDUA) or PLACENTOMA, NORMAL (X ref below) MNA16.759 XSPlacentoma, Normal; Placentome FXÑMaternal-Fetal Exchange LH LS; LX  MHÑPlacenta Accreta ANcheck the tags FEMALE & PREGNANCY MNC13.703.420.643; C13.703.590.609 LH  OLuse PLACENTA DISEASES to search PLACENTA DISORDERS back thru 1969 (as Prov 1969-72) PM80; was PLACENTA DISORDERS 1973-79 HN80; was PLACENTA DISORDERS 1969-79 (Prov 1969-72) MHÑPlacenta Diseases ANcheck the tags FEMALE & PREGNANCY; ╥fetal malnutrition╙ : index under PLACENTAL INSUFFICIENCY PIPlacenta (66-68); Pregnancy Complications (66-68) MNC13.703.590 XUÑPlacental Insufficiency LH LU  MHÑPlacenta Praevia ANcheck the tags FEMALE & PREGNANCY MNC13.703.420.714; C13.703.590.734 LH  MSExtracts prepared from placental tissue; they may contain specific but uncharacterized factors or proteins with specific activities. MHÑPlacental Extracts ANextracts of placenta or placental fractions; do not confuse with chemical substances ╥extracted╙ from the placenta, as ╥peptides extracted from the mouse placenta╙ ( = PEPTIDES /anal + PLACENTA /anal); do not use /analogs /biosyn /blood-csf-urine /defic /diag use /physiol /secret MND24.185.893.608 LH  MSMethods used for the assessment of placental function. PM75 HN75 MHÑPlacental Function Tests ANNIM; only /instrum /methods PIFetal Diseases/DI (66-74); Placenta (66-74); Placenta Diseases (69-74) MNE1.249.636 XSFetoplacental Function Tests LH LS  MHÑPlacental Hormones AN/biosyn /physiol permitted; do not use /analogs MND6.472.759 LH  MSFailure of the placenta to deliver an adequate supply of nutrients and oxygen to the fetus. HN(75); was see under PLACENTA DISORDERS 1975-79 MHÑPlacental Insufficiency ANcheck the tags FEMALE & PREGNANCY; ╥fetal malnutrition╙ goes here MNC13.703.590.800 DMÑPlacenta Diseases LH LM  PM72 HN72(68) MHÑPlacental Lactogen AN/biosyn /physiol permitted RN9035-54-5 PIPlacental Hormones (66-67) MND6.472.759.692; D6.472.785.650; D12.776.780.650 XSChorionic Somatomammotropin, Human; Lactogen Hormone, Placental; Mammotropic Hormone, Placental; PAPP-D; Somatomammotropin, Chorionic LH LS; ; ; ;  MSDevelopment of a site of fetomaternal union for physiologic exchange, a placenta or placenta-like organ. OL76; was see under PLACENTA 1975 HN76(75); was see under PLACENTA 1975 MHÑPlacentation ANonly /drug eff /rad eff; check the tags FEMALE & PREGNANCY PIPlacenta (66-74) MNG8.520.720 LH  MHÑPlague ANonly the historical plague: Pasteurella pestis or Yersinia pestis infection; equine plague = AFRICAN HORSE SICKNESS; swine plague = HEMORRHAGIC SEPTICEMIA /vet (IM) + SWINE DISEASES (IM) but do not confuse with African swine plague ( = AFRICAN SWINE FEVER); cat plague = FELINE INFECTIOUS ANEMIA; fowl plague = FOWL PLAGUE; cattle plague = RINDERPEST MNC1.252.310.980.745 LH  MHÑPlague Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.135.609 LH  MSNonparasitic free-living flatworms of the class Turbellaria. The most common genera are Dugesia, formerly Planaria, which livers in water, and Bipalium, which lives on land. Geoplana occurs in South America and California. OLsearch TURBELLARIA 1966-74 HN(75) MHÑPlanarians MNB1.500.736.847.610 XSDugesia DMÑTurbellaria LH LS LM  MHÑPlankton ANdo not use /anat /embryol /microbiol /parasitol MNB1.766; B5.692 FXÑEutrophication; ÑMarine Biology XUÑPhytoplankton; ÑZooplankton LH LX; LU;  MSProcedures, strategies, and theories of planning. PM80 HN80 MHÑPlanning Technics ANNIM; no qualif MNN4.452.718 XSPlanning Theories FXÑHealth Planning; ÑSocial Planning LH LS LX;  PM68 HN68 MHÑPlant Diseases ANno qualif; PLANT TUMORS is available PIPlants (66-67) MNJ1.40.735 LH  PM76; was see under PLANTS 1975 HN76(67); was see under PLANTS 1975 MHÑPlant Extracts ANIM GEN only; NIM when specific plant term is IM; only /adv eff /anal /class /immunol /metab /pharm /pois /rad eff /ther use /tox; /ther use: coord with disease /drug ther, not /ther; extracts of medicinal plants in Chinese med: coord NIM with MEDICINE, CHINESE TRADITIONAL (IM) + PLANTS, MEDICINAL (IM) or specific medicinal plant (IM): TN 247 PIPlants (66) MND24.310.674; D26.714 LH  MHÑPlant Growth Regulators AND25-26 qualif; /biosyn permitted if by micro-organism MND11.303.760 XSPLANT HORMONES; Phytohormones XUÑAuxins; ÑCytokinins; ÑKinetins LH LS; LU; ;  MSOils derived from plants or plant products. PM87; SESAME OIL was heading 1963-86 HN87 MHÑPlant Oils AND25-26 qualif; coord IM with specific plant source of oil (IM or NIM) but not PLANTS; ╥yusho poisoning╙: see note on RICE PIOils (66-86) MND10.516.627.700; J1.740.700 XSOils, Plant; Oils, Vegetable; Vegetable Oils XUÑCorn Oil; ÑSafflower Oil; ÑSesame Oil; ÑSoybean Oil LH LS; ; LU; ; ;  OLuse PLANT POISONING to search MILK SICKNESS back thru 1966 PMMILK SICKNESS was heading 1963-67 HNMILK SICKNESS was see under PLANT POISONING 1968-78, was heading 1963-67 MHÑPlant Poisoning ANhuman & animal; coord IM with specific plant (IM) + specific dis /etiol (IM); do not coord with food plants in Cat J: index under specific Cat J food plant /pois (IM), as FRUIT /pois or GARLIC /pois but not also here; do not use /chem ind; Jamaican vomiting sickness: index PLANT POISONING + HYPOGLYCINS /pois MNC21.613.756 XSMilk Sickness LH LS  MHÑPlant Proteins ANdo not use /analogs /defic /physiol; dietary plant proteins: coord IM with specific protein (IM) + DIETARY PROTEINS (IM); nutritive value of plant proteins: coord IM with specific protein (IM) + NUTRITIVE VALUE (NIM) but not also DIETARY PROTEINS MND12.776.765 XUÑAbrin; ÑGliadin; ÑPhytochrome; ÑPlastocyanin LH LU; ; ;  MHÑPlant Tumors ANonly /anal /chem ind /class /etiol /microbiol /parasitol /secret /ultrastruct MNC4.619.765 LH  MSViruses parasitic on plants higher than bacteria. OLuse PLANT VIRUSES to search PHYTOPHAGINEAE back thru 1966 HNPHYTOPHAGINEAE was see under PLANT VIRUSES 1963-78 MHÑPlant Viruses ANdo not use /cytol MNB4.715 XSPhytophagineae LH LS  MSThree different species of Plantago or plantain, P. psyllium, P. ovata and P. indica; the seeds swell in water and are used as laxatives. OLsearch PSYLLIUM 1966-77 (as Cat B & D heading) HN(78); was see PSYLLIUM 1963-77 (Cat B & D heading) MHÑPlantago ANdo not use /isol /pathogen; also available is PSYLLIUM, the seed of the Plantago; do not confuse X ref PLANTAIN with plantain banana (index under FRUIT) PIPsyllium (66-77) MNB6.560.690 XSPlantain DMÑPlants, Medicinal LH LS LM  OLuse PLANTS to search PYRETHRUM & SPHAGNUM back thru 1963 PMPYRETHRUM & SPHAGNUM were headings 1963-85 HNPYRETHRUM & SPHAGNUM were headings 1963-85 MHÑPlants ANGEN only: prefer specific groups below or specific plants in Cat B6; plants or ╥plant tissue╙: Manual 31.9; only /anal /anat /class /cytol /drug eff (consider also HERBICIDES) /embryol (consider also SEEDS) /enzymol /genet /growth (consider also PLANT GROWTH REGULATORS) /metab /microbiol /parasitol /physiol /rad eff /ultrastruct; policy: Manual 22.30, 36.25; flowers unspecified go under PLANTS or specific plant; TN 148: MeSH plant names; pollen goes under POLLEN only: see note there MNB6 XSSphagnum FXÑBotany XUÑPyrethrum LH LS LX LU  PMCACAO, CAPSICUM & CASSAVA were headings 1963-85 MHÑPlants, Edible ANas plants & food; prefer FRUIT (J) or VEGETABLES (J) if ascertainable; specify geog if pertinent; use qualif available to PLANTS with discretion MNB6.510 XSFOOD PLANTS FXÑFood XUÑCacao; ÑCapsicum; ÑCassava LH LS LX LU; ;  OLuse PLANTS, MEDICINAL to search AESCULUS, ASPIDIUM, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, POLYGONUM, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX & TAMARIND back thru 1966 PMAESCULUS, ARECA, CASTANEA, CHELIDONIUM, CHENOPODIUM, COCA, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, ERYTHRINA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, PAPAVER, POLYGONUM, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX, TAMARIND & VALERIAN were headings 1963-85; ADONIS, ASPIDIUM & OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85; ALOE & RHUBARB were headings 1963-77; PLANTAGO was see PSYLLIUM 1963-77 HNAESCULUS, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, POLYGONUM, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX & TAMARIND were headings 1963-85; ADONIS, ASPIDIUM & OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85 MHÑPlants, Medicinal ANspecify geog if pertinent; use qualif available to PLANTS with discretion; in addition to specific medicinal plants as XU below see many specifics in Cat B6 under PLANTS, MEDICINAL; medicinal plants in Chinese med: coord IM with MEDICINE, CHINESE TRADITIONAL (IM) & if an extract of the plant, add PLANT EXTRACTS (NIM): TN 247; TN 148: MeSH plant names CATALOG: /geog /form MNB6.560 XSAspidium; Chelidonium; Crataegus; Gentian; Herbs, Medicinal; Polygonum; Rosa FXÑAlkaloids; ÑDrugs; ÑMedicine, Herbal; ÑPharmacognosy XUÑAloe; ÑAreca; ÑCassia; ÑColchicum; ÑErythrina; ÑPapaver; ÑPlantago; ÑRhubarb; ÑValerian LH LS; ; ; ; ; ; LX; ; ; LU; ; ; ; ; ; ; ;  MSPlants or plant parts which are harmful to man or other animals. PM76; BELLADONNA, FERULA, FRANGULA, MANDRAGORA, PODOPHYLLUM & VERATRUM were headings 1963-85 HN76; was NON MESH before 1976 MHÑPlants, Toxic ANuse qualif available to PLANTS with discretion; PLANT POISONING is also available PIPlants (66-75) MNB6.660 XUÑBelladonna; ÑFerula; ÑFrangula; ÑMandragora; ÑPodophyllum; ÑVeratrum LH LU; ; ; ; ;  PM73 HN73 MHÑPlaque Assay ANfor viruses; for detecting antibody-producing cells; coord IM or NIM with specific virus /growth (IM); do not confuse with HEMOLYTIC PLAQUE TECHNIC in immunol; only /instrum /methods /vet PIVirus Cultivation (66-72) MNE5.909.560.970.790 FXÑCytopathogenic Effect, Viral LH LX  MHÑPlasma ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff; restrict to plasma for transfusions or plasma when compared with serum or blood cells or whole blood; substances in plasma = /blood, not PLASMA; policy: Manual 21.47, 25.49; for X ref FRESH FROZEN PLASMA do not coord with FREEZING nor BLOOD PRESERVATION MNA12.207.152.693; A15.145.693 XSBLOOD PLASMA; Fresh Frozen Plasma LH LS;  MHÑPlasma Cells ANnot for BLOOD CELLS; see Webster's definition; A 11 qualif & /class; plasma cell myeloma = MULTIPLE MYELOMA or PLASMACYTOMA (for solitary); plasma cell tumor = PLASMACYTOMA; plasma cell leukemia = LEUKEMIA, PLASMACYTIC MNA11.63.693; A11.329.810; A15.382.520.118.693 XSPLASMACYTES LH LS  MSRemoval of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. PM81 HN81 MHÑPlasma Exchange PIBlood Transfusion (68-80); Exchange Transfusion, Whole Blood (68-80); Plasmapheresis (68-80) MNE2.95.135.750 LH  MSAny liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other; these substances do not enhance the oxygen carrying capacity of blood, but merely replace the volume; also used to treat dehydration. MHÑPlasma Substitutes ANto replace plasma: do not confuse with BLOOD SUBSTITUTES which carry 02 to & CO2 from tissue; D25-26 qualif MND19.461.775 XSBlood Expanders; PLASMA VOLUME EXPANDERS FXÑBlood Substitutes LH LS; LX  MSVolume of plasma in the circulation. Usually measured by indicator dilution technics. PM70 HN70(66) MHÑPlasma Volume ANonly /drug eff /rad eff; coord IM with disease /physiopathol, not /blood MNG9.188.313.610; G9.330.612.214.610 XSBLOOD PLASMA VOLUME LH LS  MSAny discrete, presumably solitary, mass of neoplastic plasma cells either in bone marrow or various extramedullary sites. PM65; was PLASMOCYTOMA 1963-64 HN65; was PLASMOCYTOMA 1963-64 MHÑPlasmacytoma ANsolitary = PLASMACYTOMA; multiple = MULTIPLE MYELOMA; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.386.720; C20.683.515.761.720 LH  MHÑPlasmalogens AN/biosyn /physiol permitted; do not use /analogs /defic; do not confuse see reference here with specific phosphatidyl compounds in MeSH MND10.516.695.300.700.850 XSPhosphatidal Compounds LH LS  MSA procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. PM68 HN68(65) MHÑPlasmapheresis ANdo not use /util except by MeSH definition MNE2.110.770 FXÑCell Separation LH LX  MSAny extrachromosomal hereditary determinant. OLuse PLASMIDS to search EPISOMES back thru 1975 PM78; was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77 HN78(75); was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77 MHÑPlasmids ANonly /drug eff /rad eff; R PLASMIDS see R FACTORS is available PIExtrachromosomal Inheritance (68-74); Genetics (66-67) MNG5.225.500 XSEpisomes XUÑColicin Factors; ÑHemolysin Factors; ÑLactose Factors LH LS LU; ;  MSPrecursor of fibrinolysin (plasmin); a single chain beta globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin; used in wound debriding. Synonym: plasma trypsinogen. PM65 HN65(63) MHÑPlasminogen ANdo not use /analogs /blood RN9001-91-6 MND8.444.610; D19.461.427.600 XSPROFIBRINOLYSIN LH LS  MSProteolytic enzyme found in many tissues which converts plasminogen to plasmin. This activator is immunologically different from urokinase and in contrast to urokinase has fibrin-binding activity. Intravenous treatment with this agent produces prompt recanalization in more than half the patients with total coronary occlusion. PM86 HN86 MHÑPlasminogen Activator, Tissue-Type AN/biosyn /physiol permitted; DF: TTPA RNEC 3.4.21.- PIEnzyme Activation (74-75); Peptide Hydrolases (75); Plasminogen Activators (76-85) MND8.586.277.656.732.635.800 XSTissue-Type Plasminogen Activator LH LS  MSA heterogeneous group of proteolytic enzymes that convert plasminogen to plasmin. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Synonyms: cytofibrokinase; cytokinase; fibrokinase; plasminokinase; tissue activator. PM76 HN76 MHÑPlasminogen Activators ANdo not use /analogs; /biosyn /physiol permitted RNEC 3.4.21.- PIEnzyme Activation (74-75); Peptide Hydrolases (75); Plasminogen (74-75) MND8.586.277.656.732.635; D19.461.427.600.620 LH  MHÑPlasmodium ANdo not use /anat /blood-csf-urine /embryol; infection = MALARIA (IM) + specific genus (NIM) if pertinent; /drug eff: consider also ANTIMALARIALS MNB1.841.762.611 XSHaemamoeba XUÑPlasmodium gallinaceum LH LS LU  MSA sporozoan parasite of rodents transmitted by the mosquito Anopheles dureni. PM73 HN73 MHÑPlasmodium Berghei ANdo not use /anat /blood-csf-urine /embryol; infection; coord NIM with MALARIA (IM) PIPlasmodium (66-72) MNB1.841.762.611.461 LH  MHÑPlasmodium Falciparum ANdo not use /anat /blood-csf-urine /embryol; infection: coord NIM with MALARIA (IM) MNB1.841.762.611.561 LH  MSA sporozoan parasite which causes avian malaria, primarily in chickens, and is transmitted by the Aedes mosquito. HN(86) MHÑPlasmodium gallinaceum ANdo not use /anat /blood-csf-urine /embryol; infection = MALARIA, AVIAN (see note there) PIPlasmodium (66-85) MNB1.841.762.611.576 DMÑPlasmodium LH LM  MHÑPlasmodium Malariae ANdo not use /anat /blood-csf-urine /embryol; infection; coord NIM with MALARIA (IM) MNB1.841.762.611.661 LH  MHÑPlasmodium Vivax ANdo not use /anat /blood-csf-urine /embryol; infection; coord NIM with MALARIA (IM) MNB1.841.762.611.761 LH  MSMaterials incorporated mechanically in plastics (usually PVC) to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment. PM77 HN77 MHÑPlasticizers AND25-26 qualif PIPhthalic Acids (70-76) MND25.700 LH  HNwas in Cat D & J 1967-82, was in Cat J only 1963-66 MHÑPlastics ANonly /adv eff /anal /class /hist /stand /supply /tox MND25.720.716 XUÑPolypropylenes LH LU  MSA copper-containing plant protein that is a fundamental link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds. HN(75) MHÑPlastocyanin AN/analogs NIM only RN9014-09-9 PICopper (70-74); Plant Proteins (70-74) MND12.776.556.760; D12.776.765.680 DMÑPlant Proteins LH LM  MS2,3-Dimethyl-5-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexadiene-1,4-dione. Polyunsaturated side-chain quinone derivative which is an important link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds. HN(75) MHÑPlastoquinone ANdo not use /defic /physiol; /analogs NIM only RN4299-57-4 PIPlant Proteins (72-74); Quinones (72-74) MND2.806.700 DMÑQuinones LH LM  MSA phospholipid derivative formed by platelets, basophils, neutrophils, monocytes, and macrophages. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including hypotension, thrombocytopenia, neutropenia, and bronchoconstriction. PM83 HN83 MHÑPlatelet Activating Factor ANonly /anal /antag /biosyn /genet /immunol /isol /metab /physiol /rad eff PILysophosphatidylcholines (66-82) MND10.516.695.300.700.710.700; D12.776.124.125.730; D19.461.270.229.695; D24.185.125.585.695 XSAGEPC; Acetyl Glyceryl Ether Phosphorylcholine; PAF-Acether LH LS; ;  PM72 HN72(69) MHÑPlatelet Adhesiveness ANonly /drug eff /rad eff PIBlood Platelets (66-68) MNG9.188.560.780 FXÑAdhesiveness; ÑBlood Platelets; ÑPlatelet Membrane Glycoproteins LH LX; ;  MSThe attachment of platelets to one another. OLsearch PLATELET ADHESIVENESS 1974 PM76; was see under PLATELET ADHESIVENESS 1974-75 HN76(75); was see under PLATELET ADHESIVENESS 1974-75 MHÑPlatelet Aggregation ANonly /drug eff /rad eff PIBlood Platelets (66-74); Platelet Adhesiveness (69-74) MNG9.188.560.800 FXÑBlood Platelets; ÑPlatelet Membrane Glycoproteins LH LX;  PM80 HN80 MHÑPlatelet Count ANNIM; only /drug eff /instrum /methods /rad eff /vet PIBlood Cell Count (66-79); Blood Platelets (66-79) MNE1.223.459.107.700; E1.223.459.770.790; G7.380.107.740 XSBlood Platelet Count; Blood Platelet Number; Platelet Number FXÑBlood Platelets LH LS; ; LX  MSA lipoprotein with pronounced electronegative surface charge found in association with platelet membrane and platelet granules. In the sequence of blood coagulation reactions, it is required for activation of factor VIII and for the conversion of prothrombin to thrombin. HN(75) MHÑPlatelet Factor 3 ANonly /anal /antag /biosyn /genet /immunol /isol /physiol /rad eff; defic = THROMBOCYTOPATHY (TN 228) RN37270-93-2 PIBlood Coagulation Factors (74); Blood Platelets (74); Lipoproteins (74) MND10.516.532.760; D12.776.124.125.760; D12.776.521.800; D19.461.270.229.698 XSPF 3 DMÑBlood Coagulation Factors LH LS LM  MSA high molecular weight proteoglycan-platelet factor complex which is released from blood platelets by thrombin. It acts as a mediator in the heparin neutralizing capacity of the blood and plays a role in platelet aggregation. At high ionic strength (I=0.75), the complex dissociates into the active component (molecular weight 29,000) and the proteoglycan carrier (chondroitin 4-sulfate, molecular weight 350,000). The molecule exists in the form of a dimer consisting of 8 moles of platelet factor 4 and 2 moles of proteoglycan. PM84; was see under BLOOD COAGULATION FACTORS 1976-83 HN84(76); was see under BLOOD COAGULATION FACTORS 1976-83 MHÑPlatelet Factor 4 ANonly /anal /antag /biosyn /genet /immunol /isol /physiol /rad eff; /defic: index under BLOOD PLATELETS (IM) + BLOOD COAGULATION DISORDERS (IM) (TN 228) RN37270-94-3 PIBlood Coagulation Factors (73-75); Blood Platelets (74-75); Glycoproteins (74-75) MND9.203.698.735.800; D12.776.124.125.780; D12.776.395.650.700; D19.461.270.229.700 XSAntiheparin Factor; PF 4 LH LS;  PM80 HN80 MHÑPlatelet Function Tests ANNIM; only /instrum /methods /vet PIBlood Platelets (66-79); Platelet Adhesiveness (69-79); Platelet Aggregation (75-79) MNE1.223.459.770 FXÑBlood Platelets XUÑBleeding Time LH LX LU  MSPlatelet membrane glycoproteins have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. The platelet membrane glycoproteins, IIb and IIIa, form a calcium ion-dependent heterodimer complex that functions as the fibrinogen receptor in activated platelets to mediate platelet aggregation. A deficiency of this glycoprotein results in Glanzmann's thrombasthenia. Glycoprotein Ib has been identified as the platelet-binding site mediating the factor VIII/von Willebrand-factor-dependent adhesion of platelets to vascular endothelium. A deficiency of this glycoprotein results in Bernard-Soulier disease. PM87 HN87 MHÑPlatelet Membrane Glycoproteins AN/biosyn /physiol permitted PIGlycoproteins (66-86); Membrane Proteins (66-86) MND12.776.124.125.786; D12.776.395.625; D12.776.543.625 XSFibrinogen Receptor; Platelet Membrane Glycoprotein Complex IIb-IIIa; Platelet Membrane Glycoprotein Ib FXÑPlatelet Adhesiveness; ÑPlatelet Aggregation; ÑPlatelet Aggregation LH LS; ; LX; ;  MSA group of disorders characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored. HN(86) MHÑPlatelet Storage Pool Deficiency PIBlood Platelet Disorders (67-85) MNC15.378.463.205.735 XSStorage Pool Deficiency DMÑBlood Platelet Disorders LH LS LM  MSMitogenic peptide growth hormone carried in the alpha-granules of platelets. Released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. PM84 HN84 MHÑPlatelet-Derived Growth Factor AN/biosyn /physiol permitted PIBlood Proteins (77-83); Growth Substances (77-83); Peptides (77-83) MND11.303.780; D12.644.725; D12.776.124.625; D24.185.348.740 LH  MSThe preparation of platelet concentrates with the return of red cells and platelet-poor plasma to the donor. OLsearch PLASMAPHERESIS 1978 HN(79); was see under CELL SEPARATION 1981-85, was see under BLOOD TRANSFUSION 1979-80, was see PLASMAPHERESIS 1978 MHÑPlateletpheresis ANdo not use /util except by MeSH definition; removal of platelets & return of plateletless blood to donor: do not confuse with platelet transfusion ( = BLOOD PLATELETS (IM) + BLOOD TRANSFUSION (IM) ) PIBlood Platelets (66-78); Blood Transfusion (66-78); Cell Separation (72-78); Plasmapheresis (78) MNE2.110.790; E5.909.262.363.790 XSBlood Plateletpheresis; Thrombocytapheresis DMÑBlood Component Removal LH LS; LM  MHÑPlatinum ANPt-195; do not use /analogs /biosyn /defic /physiol; Pt-194, 196, 198 = PLATINUM (IM) + ISOTOPES (NIM); Pt-173-193, 197, 199, 200 = PLATINUM (IM) + RADIOISOTOPES (IM) RN7440-06-4 MND1.268.679; D1.552.691 LH  PM67 HN67 MHÑPlatybasia ANdo not use /congen PIOccipital Bone/AB (66) MNC16.131.621.724 XSBASILAR IMPRESSION FXÑArnold-Chiari Deformity LH LS LX  MSA phylum of acoelomate, bilaterally symmetrical flatworms, without a definite anus; includes three classes: Cestoda, Turbellaria, and Trematoda. PM65 HN65 MHÑPlatyhelminths ANdo not use /blood-csf-urine; infection = CESTODE INFECTIONS or TREMATODE INFECTIONS MNB1.500.736 XSFlatworms LH LS  MSA small aquatic oviparous mammal of the order Monotremata found in Australia and Tasmania. HN(75) MHÑPlatypus ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.627.600 XSDuckbilled Platypus; Duckmole DMÑMonotremata LH LS; LM  MSSpontaneous or voluntary recreational activities pursued for enjoyment and accessories or equipment used in the activities; includes games, toys, etc. OLuse PLAY AND PLAYTHINGS to search PLAY back thru 1966 PM78; was PLAY 1963-77 HN78; was PLAY 1963-77 MHÑPlay and Playthings ANno qualif; includes games; DF: PLAY CATALOG: use with age group qualif except /in inf MNI3.450.642.693 XSPuppets; Toys; Video Games LH LS; ;  MSA treatment technique utilizing play as a medium for expression and communication between patient and therapist. OLsearch ACTING OUT 1968 & PROJECTIVE TECHNICS 1966-67 PM69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNICS 1963-67 HN69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNICS 1963-67 MHÑPlay Therapy ANonly /econ /educ /hist /instrum /man /methods /stand CATALOG: use with age group qualif PIActing Out (68); Play (66-68); Projective Technics (66-67); Psychotherapy, Group (66-68) MNF4.754.664 LH  MSThe psychoanalytic concept that man instinctively seeks to avoid pain and discomfort and strives for gratification and pleasure. PM73 HN73(64) MHÑPleasure-Pain Principle ANno qualif MNF2.739.794.746 LH  MSRecording of change in the size of a part as modified by the circulation in it. MHÑPlethysmography ANNIM; do not use /util except by MeSH definition; ╥venous occlusion plethysmography╙ & ╥strain gauge plethysmography╙ go here MNE1.145.811; E1.725 FXÑBlood Circulation LH LX  PM66 HN66 MHÑPlethysmography, Impedance ANNIM; do not use /util except by MeSH definition; do not confuse RHEOGRAPHY (see X below) with ╥rheography╙ as a synonym for the study of flow dynamics of body & other fluids ( = RHEOLOGY) MNE1.145.811.611; E1.399.799; E1.725.528 XSRHEOGRAPHY XUÑCardiography, Impedance LH LS LU  PM73 HN73(71) MHÑPlethysmography, Whole Body ANdo not use /util except by MeSH definition PIPlethysmography (66-70); Respiratory Function Tests (66-70) MNE1.302.796.513; E1.725.694 LH  MSThe thin serous membrane enveloping the lungs and lining the thoracic cavity. MHÑPleura AN/surg: consider also PNEUMONOLYSIS; pleural cavity goes here; inflammation = PLEURISY MNA4.716; A10.615.789.736 LH  PM66 HN66 MHÑPleural Diseases ANinflamm dis = PLEURISY; pleural empyema = EMPYEMA or EMPYEMA, TUBERCULOUS MNC8.528 LH  MSPresence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. OLuse PLEURAL EFFUSION to search PLEURAL EFFUSIONS back thru 1966 PM68; was PLEURAL EFFUSIONS 1963-67 HN68; was in Cat A & C 1968-83, was PLEURAL EFFUSIONS in Cat A & C 1963-67 MHÑPleural Effusion MNC8.528.652 FXÑExudates and Transudates LH LX  MHÑPleural Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.894.662; C8.528.694 LH  MHÑPleurisy ANsame as ╥pleuritis╙ in foreign lit MNC8.528.735; C8.730.582 LH  MSA genus of aquatic newts belonging to the family Salamandridae and sometimes referred to as ╥spiny╙ tritons. There are two species P. waltilii and P. poireti. P. waltilii is commonly used in the laboratory. Since this genus adapts to aquarium living, it is easy to maintain in laboratories. HN(81) MHÑPleurodeles ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAmphibia (66-80); Salamandridae (75-80); Urodela (66-74) MNB2.90.608.700.540 DMÑSalamandridae LH LM  MHÑPleurodynia, Epidemic ANcaused by Coxsackie B virus MNC2.782.687.359.213.737 XSBORNHOLM DISEASE; MYALGIA, EPIDEMIC LH LS;  MHÑPleuropneumonia ANdo not make a diagnosis: use the term as used by the author MNC8.381.677.473 LH  MSA pleuropneumonia of cattle and goats caused by species of Mycoplasma. OLsearch MYCOPLASMA INFECTIONS 1968-74 HN(75); was see under ANIMAL DISEASES 1978, was see under MYCOPLASMA INFECTIONS 1968-77 MHÑPleuropneumonia, Contagious ANanimal only: do not use /vet but check tag ANIMAL; coord IM with precoord animal/dis term (IM) + animal (NIM) or with animal (IM) in absence of precoord MNC1.252.610.620.745; C22.717 DMÑMycoplasma Infections LH LM  MSThe degree of replication of the chromosome set in the karyotype. PM76 HN76; was NON MESH before 1976 MHÑPloidies ANonly /drug eff /rad eff PIspecific ploidies heading MNG5.148.777 LH  MSSyndrome of dysphagia with iron deficiency anemia and mucosal lesions of the mouth, pharynx, and esophagus. OLsearch DEGLUTITION DISORDERS 1966-74 HN(75) MHÑPlummer-Vinson Syndrome MNC6.306.199.612 DMÑDeglutition Disorders LH LM  MHÑPlutonium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-07-5 MND1.287.663; D1.552.517.734 LH  MHÑPneumatosis Cystoides Intestinalis MNC6.405.469.778 LH  MSPresence of air within the skull due to fistulous tract formation, penetrating wounds, fractures, erosions from tumors or infections, surgery, or may occur spontaneously. PM68 HN68(64) MHÑPneumocephalus MNC21.866.460.694 LH  MHÑPneumococcal Infections ANpneumococcal pneumonia = PNEUMONIA, LOBAR MNC1.252.890.670 FXÑStreptococcus pneumoniae LH LX  MSCondition characterized by permanent deposition of substantial amounts of particulate matter in the lungs, usually of occupational or environmental origin, and by the tissue reaction to its presence. OLuse PNEUMOCONIOSIS to search BAGASSOSIS back thru 1969 PM66; CAPLAN'S SYNDROME was heading 1963-83 HN66; BAGASSOSIS was see under PNEUMOCONIOSIS 1969-83 MHÑPneumoconiosis ANGEN or specific for which there is no term in MeSH; do not use /chem ind for a dust causing this dis: use /etiol; TN 151: compl of pneumoconiosis; index specific pneumoconioses for which there is no MeSH term here + substance yielding dust, as pneumoconiosis in gold mining: PNEUMOCONIOSIS (IM) + GOLD (IM) + MINING (IM); do not coord with OCCUPATIONAL DISEASES MNC8.381.655; C21.447.800 XSBagassosis FXÑDust XUÑCaplan's Syndrome LH LS LX LU  MSA species of protozoan causing interstitial plasma cell pneumonia and other infections in man, as well as infections in other animals. PM74 HN74 MHÑPneumocystis Carinii ANdo not use /anat /blood-csf-urine; infection = PNEUMONIA, PNEUMOCYSTIS CARINII MNB1.841.762.675 LH  OLsearch VENTRICULOGRAPHY, CEREBRAL 1966-68 PM72; was see under VENTRICULOGRAPHY 1963-71 HN72(69); was see under VENTRICULOGRAPHY 1963-71 MHÑPneumoencephalography ANdo not use /util except by MeSH definition PIVentriculography, Cerebral (66-68) MNE1.236.257.694; E1.236.688.662; E1.818.573.662; E1.818.649.529 XSCisternography, Pneumoencephalographic LH LS  MSDeliberate introduction of air or gas into the mediastinum as an aid to examination and diagnosis. MHÑPneumomediastinum, Diagnostic ANdo not use /util except by MeSH definition MNE1.739 FXÑMediastinum LH LX  MHÑPneumonectomy ANpartial or total; lobectomy goes here; do not use /util except by MeSH definition MNE4.920.800.780 FXÑLung; ÑTuberculosis, Pulmonary LH LX;  MHÑPneumonia ANfor ╥pneumonitis╙; pneumococcal pneumonia = PNEUMONIA, LOBAR MNC8.381.677; C8.730.610 LH  MSA type of pneumonia resulting from the aspiration of food, liquid, or gastric contents into the upper respiratory tract. PM67; PNEUMONIA, LIPID was heading 1963-83 HN67(66) MHÑPneumonia, Aspiration MNC8.381.677.529 XSAcid Aspiration Syndrome; Aspiration Pneumonia; Aspiration of Gastric Contents XUÑPneumonia, Lipid LH LS; ; LU  MSA cattle disease of uncertain cause, probably an allergic reaction. OLuse PNEUMONIA, ATYPICAL INTERSTITIAL, OF CATTLE to search PULMONARY ADENOMATOSIS, BOVINE back thru 1968 PM76; was PULMONARY ADENOMATOSIS, BOVINE 1968-75 HN76; was PULMONARY ADENOMATOSIS, BOVINE 1968-75 MHÑPneumonia, Atypical Interstitial, of Cattle ANdo not use /vet; don't forget also CATTLE (NIM) & check tag ANIMAL MNC22.196.690 XSAdenomatosis, Pulmonary, Bovine; Atypical Interstitial Pneumonia of Cattle; Emphysema, Acute Bovine Pulmonary; Fog Fever; Pulmonary Adenomatosis, Bovine LH LS; ; ; ;  MSPneumonia due to aspiration or inhalation of various oily or fatty substances. HN(84)63 MHÑPneumonia, Lipid MNC8.381.677.529.612 DMÑPneumonia, Aspiration LH LM  MHÑPneumonia, Lobar AN= pneumococcal pneumonia MNC1.252.890.670.750; C8.381.677.640; C8.730.610.462 XSPneumonia, Pneumococcal LH LS  MSInterstitial pneumonia caused by extensive infection of the lungs and bronchi, particularly the lower lobes of the lungs, by Mycoplasma pneumoniae. It may be distinguished from viral pneumonia by the presence of cold agglutinins. PM80 HN80 MHÑPneumonia, Mycoplasma ANcaused by MYCOPLASMA PNEUMONIAE; synonym is ╥primary atypical pneumonia╙ but do not confuse with ╥primary atypical viral pneumonia╙ ( = PNEUMONIA, VIRAL) PIMycoplasma (66-67); Mycoplasma Infections (68-79); Pneumonia (66-79) MNC1.252.610.620.760; C8.381.677.650; C8.730.610.500 XSMycoplasma Pneumonia LH LS  MSA pulmonary disease occurring in immunodeficient or malnourished patients or infants, characterized by dyspnea, tachypnea, and hypoxemia; it is caused by Pneumocystis carinii. OLuse PNEUMONIA, PNEUMOCYSTIS CARINII to search PNEUMONIA, INTERSTITIAL PLASMA CELL back thru 1966 PM85; was PNEUMONIA, INTERSTITIAL PLASMA CELL 1963-84 HN85; was PNEUMONIA, INTERSTITIAL PLASMA CELL 1963-84 MHÑPneumonia, Pneumocystis Carinii MNC3.582.695; C3.752.672; C8.381.517.695; C8.381.677.675 XSPNEUMOCYSTIS CARINII PNEUMONIA; Pneumonia, Interstitial Plasma Cell LH LS;  MSA disease caused by the visna-maedi viruses. It was formerly believed to be identical with ovine pulmonary adenomatosis (jaagsiekte) but is now recognized as a separate entity. OLsearch PULMONARY ADENOMATOSIS, OVINE 1968-74 PM76; MAEDI was see PULMONARY ADENOMATOSIS, OVINE 1968-74 HN76; MAEDI was see PULMONARY ADENOMATOSIS, OVINE 1968-74 MHÑPneumonia, Progressive Interstitial, of Sheep ANdo not use /vet; don't forget also SHEEP (NIM) & check tag ANIMAL PIPulmonary Adenomatosis, Ovine (68-75) MNC2.782.815.750; C22.836.660 XSMaedi; Progressive Interstitial Pneumonia of Sheep LH LS;  MHÑPneumonia, Rickettsial ANcoord IM with specific rickettsial infection (IM) MNC1.850.745; C8.381.677.696; C8.730.610.563 LH  MSPneumonia caused by Staphylococcus aureus; a frequent complication of viral influenza. PM68 HN68 MHÑPneumonia, Staphylococcal ANcoord IM with specific Staphylococcus (NIM); DF: PNEUMONIA STAPH or STAPH PNEUMONIA PIPneumonia (66-67); Staphylococcal Infections (66-67) MNC1.252.868.675; C8.381.677.751; C8.730.610.663 XSStaphylococcal Pneumonia LH LS  MHÑPneumonia, Viral ANcoord IM with specific viral dis (IM) MNC2.705; C8.381.677.807; C8.730.610.763 LH  MHÑPneumonolysis ANdo not use /util except by MeSH definition MNE4.920.800.810 LH  MHÑPneumopericardium MNC14.280.763 LH  MHÑPneumoperitoneum ANa disease; do not confuse with PNEUMOPERITONEUM, ARTIFICIAL, a radiogr technic MNC6.772.723 LH  MSDeliberate introduction of air into the peritoneal cavity. MHÑPneumoperitoneum, Artificial ANdo not use /util except by MeSH definition MNE1.753 LH  MSRadiography using air, oxygen, or some other gas as a contrast medium. PM74 HN74 MHÑPneumoradiography AN╥radiogr by air, oxygen or some other gas as the contrast medium╙: nothing to do with LUNG /radiogr; do not use /util except by MeSH definition MNE1.818.649 XSAir Radiography; Insufflation Radiography; Negative Contrast Radiography; Radiography, Insufflation LH LS; ; ;  MHÑPneumothorax ANa disease; do not confuse with PNEUMOTHORAX, ARTIFICIAL, a surg procedure MNC8.528.778 LH  MHÑPneumothorax, Artificial ANdo not use /util except by MeSH definition; in treating dis, coord Cat C term with /surg MNE4.920.800.250.790 LH  MSA specialty concerned with the diagnosis and treatment of foot disorders and injuries and anatomic defects of the foot. MHÑPodiatry ANSPEC: SPEC qualif; for /educ coords with med educ terms permitted MNG2.696 XSCHIROPODY FXÑFoot Diseases LH LS LX  MSCaustic extract from the roots of Podophyllum peltatum and P. emodi; contains podophyllotoxin and its congeners; very irritating to mucus membranes and skin, violent purgative that may cause CNS damage and teratogenesis; used as paint for warts, skin neoplasms and senile keratoses. PM72; was see under PODOPHYLLUM 1963-71 HN72(64); was see under PODOPHYLLUM 1963-71 MHÑPodophyllin ANdo not use /defic /physiol; /biosyn permitted if by plant RN9000-55-9 MND22.204.179.612; D26.368.627.624 LH  MSMain active constituent of the resin from the roots of may apple or mandrake (Podophyllum peltatum and P. emodi). It is a potent spindle poison, toxic if taken internally and was used as a cathartic; it is very irritating to skin and mucus membranes, has keratolytic actions, has been used to treat warts, keratoses and may have antineoplastic properties, as do some of its congeners and derivatives. OLuse PODOPHYLLOTOXIN to search EPIPODOPHYLLOTOXIN back thru 1975 PM73 HN73; EPIPODOPHYLLOTOXIN was see under PODOPHYLLOTOXIN 1975 MHÑPodophyllotoxin ANdo not use /defic /physiol; /biosyn permitted if by plant RN518-28-5 PIAlkaloids (66-72); Antineoplastic Agents (66-72) MND22.204.179.612.696; D26.368.627.624.696 XSEpipodophyllotoxin XUÑTeniposide LH LS LU  MSA genus of poisonous American herbs, family Berberidaceae; the roots yield PODOPHYLLOTOXINS and other pharmacologically important agents; formerly used as cholagogue and cathartic; do not confuse with MANDRAGORA. HN(86)63; was in Cat B & D 1963-77 MHÑPodophyllum ANplant only with PODOPHYLLIN the probable Cat D term; do not use /isol /pathogen; do not confuse X ref with MANDRAKE, EUROPEAN see MANDRAGORA (see note there) MNB6.560.706; B6.660.620 XSMandrake Root; Mandrake, American; May Apple DMÑPlants, Toxic LH LS; ; LM  MSA genus of live-bearing Cyprinodont fish known most commonly as guppy or molly. Some species are virtually all female and depend on sperm from other species to stimulate egg development. Poecilia is used in carcinogenicity studies as well as neurologic and physiologic research. HN(87) MHÑPoecilia ANNIM when exper animal; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.280.680 XSGuppy; Lebistes; Molly DMÑCyprinodontiformes LH LS; ; LM  MHÑPoetry ANonly /hist; coord IM with LITERATURE, MEDIEVAL (IM) or LITERATURE, MODERN (IM) MNK1.517.781 LH  HN(64) MHÑPoikiloderma Congenitale ANdo not use /congen MNC16.131.831.649; C16.614.739; C17.649 DMÑSkin Diseases LH LM  MSFacilities which provide information concerning poisons and treatment of poisoning in emergencies. PM66 HN66(64) MHÑPoison Control Centers ANdo not use /educ MNN2.278.726; N2.421.297.695 LH  MHÑPoison Ivy Dermatitis ANdo not use /chem ind MNC17.174.255.696; C20.543.418.380.696 XSRHUS DERMATITIS LH LS  MHÑPoisoning ANa dis concept: the field = TOXICOLOGY; IM; GEN only: Manual 23.32; prefer /pois with Cat D & J terms: Manual 19.5+, 19.4.50, 25.66; do not use /chem ind; /drug ther: consider also ANTIDOTES; sometimes called ╥toxicoses╙ (TN 185) & often called ╥intoxication╙ in foreign lit CATALOG: form qualif = TOXICOLOGY /form MNC21.613 XSIntoxication; Overdose FXÑAntidotes LH LS; LX  MHÑPoisons ANdo not use /adv eff /analogs /antag ( = ANTIDOTES) /biosyn /defic /diag use /physiol /pois /secret /ther use CATALOG: form qualif = TOXICOLOGY /form MND5.569.612 FXÑTOXICOLOGY LH LX  MSProteins isolated from the roots of pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes and induce activation of plasma cells. PM79 HN79 MHÑPokeweed Mitogens ANdo not use /analogs /defic /physiol; /biosyn permitted if by pokeweed PILectins (66-78); Mitogens (66-72) MND12.776.765.682; D24.185.526.545.742; D24.310.545.742; D24.611.125.44.545.742 XSLectins, Pokeweed; Pokeweed Lectins LH LS;  MHÑPoland ANin translations use spelling: People's Republic, not Peoples' nor Peoples MNZ1.542.248.679 LH  MSA syndrome which is characterized by symbrachydactyly and aplasia of the sternal head of pectoralis major. HN(85) MHÑPoland Syndrome ANabnorm of pectoralis musc with syndactyly, named for A. Poland, 19th cent physician; do not use /congen PIHand (66-84); Pectoralis Muscles (66-84); Syndactylia (67-84) MNC5.116.99.370.885.756 DMÑSyndactylia LH LM  OLsearch VECTORCARDIOGRAPHY 1966-74 HN(75)(65-73) MHÑPolarcardiography ANdo not use /util except by MeSH definition MNE1.145.569.359.731.614; E1.399.214.731.614 DMÑVectorcardiography LH LM  MSDecrease in the synthesis of proteins specified by genes distal to the operator and to the site of a nonsense, frameshift, deletion or insertion mutation in an operon. A mutation which produces polarity is called a polar mutation or a polarity mutation. HN(80) MHÑPolarity of Translation ANonly /drug eff /rad eff PIMutation (66-79); Operon (69-79); Transcription, Genetic (73-79); Translation, Genetic (73-79) MNG5.331.914.770 XSPolarity of Transcription DMÑTranslation, Genetic LH LS LM  MHÑPolarography ANNIM; do not use /util except by MeSH definition MNE5.196.749; H1.181.278.741; H1.181.529.307.719 LH  MH*Policies (Non Mesh) MNI1.880.604.710; N3.706.710 LH  MSThe decision process by which individuals, groups or institutions establish policies pertaining to plans, programs or procedures. PM80 HN80 MHÑPolicy Making ANno qualif MNN3.706.742 FXÑDecision Making; ÑDecision Making, Organizational; ÑHealth Policy; ÑPublic Policy LH LX; ; ;  MHÑPoliomyelitis ANof swine = ENCEPHALOMYELITIS, ENZOOTIC PORCINE MNC2.782.687.359.764; C10.228.228.769; C10.228.854.641 XSINFANTILE PARALYSIS LH LS  MHÑPoliomyelitis, Bulbar MNC2.782.687.359.764.614; C10.228.140.763; C10.228.228.769.614; C10.228.854.641.614 LH  MHÑPoliovirus ANdo not use /blood-csf-urine /cytol MNB4.909.777.618.284.779 XSBrunhilde Virus LH LS  MHÑPoliovirus Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.899.614 XSSALK VACCINE LH LS  MHÑPoliovirus Vaccine, Oral ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.899.614.614 XSSABIN VACCINE LH LS  MSSystems of government. PM80 HN80; was NON MESH before 1980 MHÑPolitical Systems ANonly /class /hist; specify geog; Nazism goes here PIPolitics (66-79) MNI1.696 LH  MSActivities concerned with governmental policies, functions, etc. MHÑPolitics ANno qualif; specify geog if pertinent CATALOG: /geog /form MNI1.738 XSPolitical Activity XUÑLobbying LH LS LU  MSThe male fertilizing element of flowering plants analogous to sperm in animals; released from the anthers as yellow dust, to be carried by insect or other vectors, including wind, to the ovary (stigma) of other flowers to produce the embryo enclosed by the seed; the pollens of many plants are allergenic. MHÑPollen ANonly /anal /enzymol /immunol /rad eff /ultrastruct; do not coord with PLANTS, HERBS, GRASSES or TREES unless the type is particularly discussed & then only NIM; ragweed pollen is indexed only under POLLEN MNB6.714; D24.611.216.63.614 FXÑGrasses; ÑHay Fever LH LX;  MHÑPolonium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-08-6 MND1.287.687; D1.725 LH  MSBis[hydroxyethylpoly(ethyleneoxy)-ethyl]polypropyleneglycol. A copolymer of polyethylene and polypropylene ether glycol. Non-ionic polyol surface-active agent used medically as a fecal softener and in cattle for prevention of bloat. Synonyms: Bloat Guard; Pluronic; SK&F 18,667; Tergitol; Therabloat. HN(75) MHÑPoloxalene AND25-26 qualif; /analogs NIM only RN9003-11-6 PIPolyethylene Glycols (74) MND2.33.618.690.650; D25.720.741.650; D26.866.762.750 XSOxyethylene Oxypropylene Polymer; Poloxalkol; Poloxamers; Polyoxyethylene Polyoxypropylene Polyoxyethylene Polymer DMÑPolyethylene Glycols LH LS; ; ; LM  MSA group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. PM76 HN76 MHÑPoly A ANdo not use /analogs /defic /physiol; do not confuse with POLY A-U RN24937-83-5 PIPolynucleotides (66-75) MND13.695.578.550.500 XSAdenine Polynucleotides; Polyadenylic Acids LH LS;  MSCatalyzes the synthesis of polyadenylic acid from ATP. May be due to the action of RNA polymerase (EC 2.7.7.6) or polynucleotide adenylyltransferase (EC 2.7.7.19). HN(75) MHÑPoly A Polymerase ANdo not use /analogs RNEC 2.7.7.19 PIAdenosine Triphosphate (72-74); Nucleotidyltransferases (72-74) MND8.586.913.696.445.650 XSPolyadenylate Polymerase; Polyadenylate Synthetase; Polynucleotide Adenylyltransferase DMÑNucleotidyltransferases LH LS; ; LM  PM74 HN74(72) MHÑPoly A-U ANdo not use /analogs /biosyn /defic /physiol; do not confuse with POLY A RN24936-38-7 PIInterferon Inducers (66-71); Polynucleotides (66-71) MND13.695.578.550.500.510; D13.695.578.550.750.510; D20.388.643.493.489; D24.611.558.493.489 LH  MSA polynucleotide formed from NAD in the presence of NAD nucleosidase. HN(75) MHÑPoly Adenosine Diphosphate Ribose AN/analogs NIM only RN26656-46-2 PIAdenosine Diphosphate (73-74); Nucleoside Diphosphate Sugars (73-74); Polynucleotides (73-74) MND9.203.408.620.569.70.600; D13.695.578.550.500.525; D13.695.827.708.70.600 XSPoly ADP Ribose DMÑNucleoside Diphosphate Sugars LH LS LM  MSAn enzyme isolated from the nuclei of a variety of cells. It catalyzes the incorporation of ADPribose groups of NAD+ into a homopolymer of repeating ADPribose units. OLsearch NAD NUCLEOSIDASE 1975-76 PM86; was see under NAD NUCLEOSIDASE 1977-85, was see NAD NUCLEOSIDASE 1975-76 HN86(77); was see under NAD NUCLEOSIDASE 1977-85, was see NAD NUCLEOSIDASE 1975-76 MHÑPoly ADP Ribose Polymerase ANdo not use /analogs RNEC 2.4.2.30 PINAD Nucleosidase (75-76); Nucleosidases (66-74) MND8.586.913.647.680 XSPoly ADP Ribose Synthetase LH LS  MSA group of cytosine ribonucleotides in which the phosphate residues of each cytosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. HN(76) MHÑPoly C ANdo not use /analogs /defic /physiol RN30811-80-4 PIPolynucleotides (66-75) MND13.695.578.550.560 XSCytosine Polynucleotides; Polycytidylic Acids DMÑPolyribonucleotides LH LS; LM  MSPolydeoxyribonucleotides made up of deoxyadenine nucleotides and thymine nucleotides. Present in DNA preparations isolated from crab species. Synthetic preparations have been used extensively in the study of DNA. HN(77) MHÑPoly dA-dT ANdo not use /analogs /defic /physiol RN26966-61-0 PIAdenine Nucleotides (66-76); Polynucleotides (66-76); Thymine Nucleotides (72-76) MND13.695.578.500.300 XSPoly(Deoxyadenylate-Thymidylate); Polydeoxyadenine Nucleotides-Polythymine Nucleotides DMÑPolydeoxyribonucleotides LH LS; LM  MSA group of guanine ribonucleotides in which the phosphate residues of each guanine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. HN(76) MHÑPoly G ANdo not use /analogs /defic /physiol RN25191-14-4 PIPolynucleotides (66-75) MND13.695.578.550.600 XSGuanine Polynucleotides; Polyguanylic Acids DMÑPolyribonucleotides LH LS; LM  MSA group of inosine ribonucleotides in which the phosphate residues of each inosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. HN(76) MHÑPoly I ANdo not use /analogs /defic /physiol; do not confuse with POLY I-C RN25249-22-3 PIPolynucleotides (66-75) MND13.695.578.550.650 XSInosine Polynucleotides; Polyinosinic Acids DMÑPolyribonucleotides LH LS; LM  PM73 HN73(71) MHÑPoly I-C ANdo not use /analogs /biosyn /defic /physiol; do not confuse with POLY I RN24939-03-5 PIInterferons/BI (66-70); Polynucleotides (66-70); specific action heading MND13.695.578.550.560.600; D13.695.578.550.650.600; D20.388.643.493.614; D24.611.558.493.614 LH  MSA group of thymine nucleotides in which the phosphate residues of each thymine nucleotide act as bridges in forming diester linkages between the deoxyribose moieties. HN(76) MHÑPoly T ANdo not use /analogs /defic /physiol RN25086-81-1 PIPolynucleotides (66-75) MND13.695.578.500.600 XSPoly dT; Polythymidylic Acids; Thymine Polynucleotides DMÑPolydeoxyribonucleotides LH LS; ; LM  PM74 HN74(72) MHÑPoly U ANdo not use /analogs /defic /physiol RN27416-86-0 MND13.695.578.550.750 XSPolyuridylic Acids; Uracil Polynucleotides LH LS;  PM72 HN72(71) MHÑPolyamines ANdo not use /analogs /biosyn /defic /physiol PIAmines (66-70) MND2.92.782 XUÑColestipol; ÑHexadimethrine LH LU;  MSMethoxypropenyl benzenesulfonic acid, sodium salt. Developed as an anticoagulant, but may cause intravascular coagulation in vivo due to protein precipitation in capillaries; used in vitro; it also decreases the antibacterial properties of blood and is used to enhance bacterial blood cultures. Synonyms: Grobax; Liquoid. HN(77) MHÑPolyanethol Sulfonate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN55963-78-5 PIBenzenesulfonates (74-76); Polymers (66-76); Sulfonic Acids (66-73) MND2.241.866.540.244.222.675; D2.455.426.559.389.97.675; D2.886.610.244.222.675; D25.720.722 DMÑBenzenesulfonates LH LM  MSBiphenyl compounds which are extensively brominated. Many of these compounds are toxic environmental pollutants. PM84; was see under BIPHENYL COMPOUNDS 1977-83 HN84(77); was see under BIPHENYL COMPOUNDS 1977-83 MHÑPolybromobiphenyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: POLYBROMOBIPHENYL CPDS PIBiphenyl Compounds (66-76); Hydrocarbons, Brominated (74-75) MND2.455.426.559.389.185.680; D2.455.526.368.700 LH  MSWatersoluble low molecular weight polymers of acrylic or methacrylic acid that form solid, insoluble products when mixed with especially prepared ZnO powder; the resulting cement adheres to dental enamel and is also used as a luting agent. HN(72); was see under ACRYLIC RESINS 1977-81, was see under ACRYLATES 1975-76 MHÑPolycarboxylate Cement AND25-26 qualif PIAcrylates (66-71); Dental Cements (71); Zinc (66-71) MND25.339.291.464 DMÑDental Cements LH LM  MSA class of marine annelid worms including sand worms, tube worms, fire worms, etc. PM75 HN75 MHÑPolychaeta AN/microbiol /parasitol permitted PIAnnelida (66-74) MNB1.91.700 LH  MSBiphenyl compounds which are extensively chlorinated. Many of these compounds are toxic environmental pollutants. PM73 HN73(71) MHÑPolychlorobiphenyl Compounds ANdo not use /analogs /biosyn /defic /physiol; ╥yusho poisoning╙: see note on RICE; DF: POLYCHLOROBIPHENYL CPDS PIBiphenyl Compounds (66-70) MND2.455.426.559.389.185.698; D2.455.526.439.773 XUÑAroclors LH LU  MSA polychlorinated mixture of isomeric trimethylbicycloheptenes. A chlorinated terpene insecticide used extensively in Russia and Eastern Europe. HN(77) MHÑPolychloropinene ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects PIInsecticides, Organochlorine (73-76); Terpenes (66-76) MND2.455.849.680; D5.723.491.491.825 DMÑInsecticides, Organochlorine LH LM  MSCompounds consisting of three benzene rings linked to each other in either ortho, meta or para positions and substituted with chlorine atoms. HN(75) MHÑPolychloroterphenyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: POLYCHLOROTERPHENYL CPDS PIChlorobenzenes (74); Hydrocarbons, Chlorinated (74); Polycyclic Compounds (74) MND2.455.426.559.389.805.700; D2.455.526.439.785 XSPolychlorotriphenyl Compounds DMÑTerphenyl Compounds LH LS LM  PM72 HN72(67) MHÑPolychondritis, Relapsing MNC5.182.531; C23.205.182.531 LH  PM66 HN66 MHÑPolycyclic Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: POLYCYCLIC CPDS MND4.490 LH  PM74 HN74 MHÑPolycyclic Hydrocarbons ANdo not use /analogs /biosyn /defic /physiol MND4 XSHydrocarbons, Polycyclic; Polynuclear Aromatic Hydrocarbons LH LS;  MH*Polycyclic Hydrocarbons, Aromatic (Non Mesh) MND4.615 LH  MSClinical symptom complex characterized by oligomenorrhea or amenorrhea, anovulation, and regularly associated with bilateral polycystic ovaries. OLuse POLYCYSTIC OVARY SYNDROME to search STEIN-LEVENTHAL SYNDROME back thru 1966 PM85; was STEIN-LEVENTHAL SYNDROME 1963-84 HN85; was STEIN-LEVENTHAL SYNDROME 1963-84 MHÑPolycystic Ovary Syndrome ANnon-neoplastic; also called ╥sclerocystic ovarian degeneration╙, ╥sclerocystic ovaries╙, ╥sclerocystic ovary syndrome╙ espec in Russian lit MNC4.182.612.765; C13.371.56.630.580.765 XSStein-Leventhal Syndrome LH LS  MHÑPolycythemia MNC15.378.738 XSERYTHROCYTOSIS LH LS  MHÑPolycythemia Vera MNC15.378.190.636.753 XSOSLER-VAQUEZ DISEASE LH LS  MSPoly(deoxyribonucleotide):poly(deoxyribonucleotide)ligases. Catalyze the joining of preformed deoxyribonucleotides in phosphodiester linkage during genetic processes during repair of a single-stranded break in duplex DNA. Include both EC 6.5.1.1 (ATP) and EC 6.5.1.2 (NAD). OLto search DNA LIGASES & DNA LIGASE use POLYDEOXYRIBONUCLEOTIDE SYNTHETASES back thru 1978 & POLYNUCLEOTIDE SYNTHETASES 1973-76 HN(78); DNA LIGASES was see POLYNUCLEOTIDE SYNTHETASES 1977, was DNA LIGASE see under POLYNUCLEOTIDE SYNTHETASES 1974-76, was heading 1975-76 & 1973 MHÑPolydeoxyribonucleotide Synthetases ANdo not use /analogs RNEC 6.5.1.- PIPolynucleotide Synthetases (74-77) MND8.586.464.754.600 XSDNA Joinases; DNA Ligases; DNA Repair Enzymes; Polydeoxyribonucleotide Ligases DMÑPolynucleotide Synthetases LH LS; ; ; LM  MSA group of 13 or more deoxyribonucleotides in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. PM76 HN76 MHÑPolydeoxyribonucleotides AN13 or more nucleotides; do not use /analogs /defic /physiol PIPolynucleotides (66-75) MND13.695.578.500 XUÑPoly T; ÑPoly dA-dT LH LU;  PM74 HN74 MHÑPolyenes ANdo not use /analogs /biosyn /defic /physiol; polyene antibiotics: index under ANTIBIOTICS (IM) + POLYENES (NIM), using the same qualif for both MND2.455.326.271.665 XUÑDiphenylhexatriene; ÑFilipin; ÑMepartricin; ÑNeoprene LH LU; ; ;  MSPolymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours. PM77 HN77 MHÑPolyesters ANdo not use /analogs /biosyn /defic /physiol PIPolymers (66-76) MND25.720.728 LH  MSalpha-Hydro-omega-hydroxypoly(oxy-1,2-ethanediyls). Additional polymers of ethylene oxide and water and their ethers. They vary in consistency from liquid to solid, depending on the molecular weight, indicated by a number following the name. Used as surfactants in industry, including foods, cosmetics and pharmaceutics; in biomedicine, as dispersing agents, solvents, ointment and suppository bases, vehicles, tablet excipients. Some specific groups are lauromagrogols, nonoxynols, octoxinols and poloxamers. Synonyms: Carbowax; Nycoline; Solbase; Triton. OLto search TRITONS use POLYETHYLENE GLYCOLS back thru 1975 & SURFACE-ACTIVE AGENTS 1966-74 PM74; TRITONS was heading 1975-82, was see under AMMONIUM COMPOUNDS 1975-78, was see under SURFACE-ACTIVE AGENTS 1963-74 HN74; TRITONS was heading 1975-82, was see under AMMONIUM COMPOUNDS 1975-78, was see under SURFACE-ACTIVE AGENTS 1963-74 MHÑPolyethylene Glycols AND25-26 qualif MND2.33.618.690; D25.720.741; D26.866.762 XSMacrogols; Polyoxyethylenes; Tritons XUÑCetomacrogol; ÑPoloxalene LH LS; ; LU;  MSA polyester polymer from terephthalic acid and ethylene glycol; it can be formed into tapes, films or pulled into fibers that are pressed into meshes or woven into fabrics. Synonyms: Dacron; Mersilene; Mylar; Terylene. PM73 HN73 MHÑPolyethylene Terephthalate AND25-26 qualif RN9003-68-3 PIPolymers (66-72) MND25.720.728.764 XSDACRON LH LS  MSStrongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin(e). HN(75) MHÑPolyethyleneimine AND25-26 qualif; /analogs NIM only RN9002-98-6 PIImines (73-74); Polyethylenes (73-74) MND2.455.326.271.665.550.600; D2.491.650; D25.720.716.507.600 XSPolyaziridine DMÑPolyethylenes LH LS LM  MSEthylene homopolymers. Synthetic thermoplastics that are tough, flexible, inert, and resistant to chemicals and electrical current; and as biocompatible material for prostheses and implants. Synonyms: ethene polymers; ethylene resins; Agilene, Alathon, Bakelite; Lupolen; Marlex; Polythene. MHÑPolyethylenes AND25-26 qualif MND2.455.326.271.665.550; D25.720.716.507 XSEthylene Polymers FXÑEthylenes XUÑPolyethyleneimine LH LS LX LU  MSPoly(1,4-alpha-D-galacturonide)glycanhydrolase. A cell wall degrading enzyme found in microorganisms and higher plants. Catalyzes the random hydrolysis of 1,4-alpha-D-galactosiduronic linkages in pectate and other galacturonans. EC 3.2.1.15. HN(77) MHÑPolygalacturonase ANin microorganisms & higher plants; do not use /analogs RNEC 3.2.1.15 PIGlycoside Hydrolases (66-76); Pectins (66-76); Uronic Acids (66-76) MND8.586.277.450.800 XSPectin Depolymerase; Pectinase DMÑGlycoside Hydrolases LH LS; LM  MSA 3.5 per cent colloidal solution containing urea cross-linked polymerized peptides. It has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. The polymeric solution is used as a plasma expander. HN(75) MHÑPolygeline AND25-26 qualif; /analogs NIM only RN9015-56-9 PIPeptides (72-74); Polymers (72-74) MND12.644.740; D19.461.775.665; D25.720.780 XSHaemaccel DMÑPolymers LH LS LM  MS2-Hydroxy-propanoic acid polymer with polymerized hydroxyacetic acid, which forms 3,6-dimethyl-1,4-dioxane-dione polymer with 1,4-dioxane-2,5-dione copolymer with molecular weight about 80,000 daltons. Synthetic, absorbable surgical suture material and mesh fabric; used especially in ophthalmic surgery. HN(79) MHÑPolyglactin 910 AND25-26 qualif RN34346-01-5 PIPolymers (66-78) MND25.720.728.772 XSGlycolic-Lactic Acid Polyester; Poly(Lactide-Co-Glycoside) DMÑPolymers LH LS; LM  MSA peptide which is a homopolymer of glutamic acid. HN(79) MHÑPolyglutamic Acid AN/analogs NIM only RN24938-00-9 PIGlutamates (66-78); Peptides (66-78) MND12.125.119.511.625; D12.644.748 DMÑPeptides LH LM  PM73 HN73 MHÑPolyglycolic Acid AND25-26 qualif RN26124-68-5 PIGlycolates (66-72) MND25.720.791 FXÑGlycolates LH LX  MSA group of insect viruses causing the formation of many-sided (polyhedral) inclusions in the nucleus or cytoplasm of infected cells. Virions of nuclear polyhedrosis viruses are rod-shaped; those of the cytoplasmic viruses are icosahedral. PM78; was see under INSECT VIRUSES 1975-77 HN78(73); was see under INSECT VIRUSES 1975-77 MHÑPolyhedrosis Viruses ANdo not use /cytol PIInsect Viruses (66-72) MNB4.525.615 XSCytoplasmic Polyhedrosis Viruses; Nuclear Polyhedrosis Viruses LH LS;  MSPoly(2-hydroxyethyl methacrylate). A biocompatible, hydrophilic, inert gel that is permeable to tissue fluids; used as embedding medium for microscopy, as coating for implants and prostheses, for contact lenses, as microspheres in adsorption research, etc. HN(78); was see under ACRYLIC RESINS 1978-80 MHÑPolyhydroxyethyl Methacrylate AND25-26 qualif; /analogs NIM only RN25249-16-5 PIAcrylates (66-74); Polyethylene Glycols (75-77); Polymers (66-74); Polymethacrylic Acids (75-77) MND2.33.618.690.675; D2.241.81.69.800.700; D25.720.716.822.111.650.750 XSGlycol Methacrylate Gel; Hydroxymethacrylate Gel; PHEMA; Poly Hema; Polyglycol Methacrylate DMÑPolymethacrylic Acids LH LS; ; ; ; LM  MSThese compounds function as activated monosaccharide carriers in the biosynthesis of glycoproteins and oligosaccharide phospholipids. Obtained from a nucleoside diphosphate sugar and a polyisoprenyl phosphate. HN(78) MHÑPolyisoprenyl Phosphate Monosaccharides ANdo not use /analogs PISugar Phosphates (74-77); specific sugar phosphate; Terpenes (66-77); specific terpene or terpene group MND2.455.849.690.700.700; D9.203.894.680.700; D10.516.390.700.700 XSIsoprenoid Phosphate Monosaccharides DMÑPolyisoprenyl Phosphate Sugars LH LS LM  MSThese compounds function as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. Include the pyrophosphates. HN(78) MHÑPolyisoprenyl Phosphate Oligosaccharides ANdo not use /analogs PISugar Phosphates (74-77); Terpenes (66-77); specific terpene or terpene group MND2.455.849.690.700.710; D9.203.894.680.710; D10.516.390.700.710 XSIsoprenoid Phosphate Oligosaccharides DMÑPolyisoprenyl Phosphate Sugars LH LS LM  MSThese compounds function as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. Include the pyrophosphates. PM78 HN78 MHÑPolyisoprenyl Phosphate Sugars ANdo not use /analogs PICarbohydrates (66-77); Sugar Phosphates (74-77); Terpenes (66-77); specific terpene groups or specific terpene; specific carbohydrate MND2.455.849.690.700; D9.203.894.680; D10.516.390.700 XSIsoprenoid Phosphate Sugars XUÑDolichol Monophosphate Mannose; ÑPolyisoprenyl Phosphate Monosaccharides; ÑPolyisoprenyl Phosphate Oligosaccharides LH LS LU; ;  MSPhosphoric or pyrophosphoric acid esters of polyisoprenoids. PM78 HN78 MHÑPolyisoprenyl Phosphates ANdo not use /analogs PIOrganophosphorus Compounds (71-77); Terpenes (66-77); specific terpene or terpene group MND2.455.849.690; D2.705.690 XSIsoprenoid Phosphates; Terpene Phosphates XUÑDolichol Phosphates LH LS; LU  MSA peptide which is a homopolymer of lysine. PM86; was see under PEPTIDES 1975-85 HN86(75); was see under PEPTIDES 1975-85 MHÑPolylysine ANdo not use /defic RN25104-18-1 PILysine (69-74); Peptides (73-74) MND12.125.95.647.750; D12.644.760 LH  HNwas in Cat D & J 1975-82, was in Cat D only 1963-74 MHÑPolymers AND25-26 qualif MND25.720 FXÑMacromolecular Systems XUÑPolygeline; ÑPolyglactin 910; ÑPyran Copolymer LH LX LU; ;  MSPoly-2-methylpropenoic acids. Used in the manufacture of methacrylate resins and plastics in the form of pellets and granules, as absorbent for biological materials and as filters; also as biological membranes and as hydrogens. Synonyms: methylacrylate polymer; poly(methylacrylate); acrylic acid methyl ester polymer. PM81; was see under ACRYLIC RESINS 1975-80; POLYHYDROXYETHYL METHACRYLATE was see under ACRYLIC RESINS 1978-80 HN81(75); was see under ACRYLIC RESINS 1975-80 MHÑPolymethacrylic Acids AND25-26 qualif; do not use /analogs PIAcrylates (66-74); Polymers (66-74) MND2.241.81.69.800; D25.720.716.822.111.650 XSMethacrylic Acid Polymers XUÑPolyhydroxyethyl Methacrylate LH LS LU  MSThe regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. Includes chromosome polymorphism. PM68 HN68 MHÑPolymorphism (Genetics) ANonly /drug eff /rad eff; DF: POLYMORPHISM PIGenetics (66-67); Genetics, Population (66-67) MNG5.414.615 XUÑRestriction Fragment Length Polymorphisms LH LU  PM65 HN65 MHÑPolymyalgia Rheumatica MNC5.651.742; C5.799.720; C23.205.200.732.720 XSFORESTIER-CERTONCINY SYNDROME; PSEUDOPOLYARTHRITIS, RHIZOMELIC; RHEUMATISM, PERI-EXTRA-ARTICULAR LH LS; ;  MSA mixture of polymyxins B1 and B2, obtained from Bacillus Polymyxa strains; they are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes; may be neurotoxic and nephrotoxic; used for infections with Gram negative organisms. OLto search AEROSPORIN use POLYMYXIN B back thru 1975 & POLYMYXINS 1966-74 HN(78); was AEROSPORIN see under POLYMYXIN 1971-77; was AEROSPORIN see POLYMYXIN 1963-70 MHÑPolymyxin B ANdo not use /defic /physiol; /analogs NIM only RN1404-26-8 MND20.85.676.768 XSAerosporin DMÑPolymyxins LH LS LM  MSBasic polypeptide antibiotics obtained from Bacillus polymyxa; they affect the cell membrane by detergent action and may cause neuromuscular and kidney damage; at least eight different members of the polymyxin group have been identified, each designated by a letter. OLuse POLYMYXINS to search POLYMYXIN back thru 1966 PM78; was POLYMYXIN 1963-77 HN78; was POLYMYXIN 1963-77 MHÑPolymyxins ANdo not use /analogs /defic /physiol MND20.85.676 XUÑPolymyxin B LH LU  OLto search EASTER ISLAND use POLYNESIA back thru 1978 & CHILE 1975-77 HN68; EASTER ISLAND was see CHILE 1975-77 MHÑPolynesia ANincludes the Australs, EASTER ISLAND, Ellices, Gambier, Marquesas, New Cooks, Phoenix, PITCAIRN ISLAND, TAHITI, Tokelaus, Tuamotus, Wallis and Futuna, TONGA, WESTERN SAMOA & HAWAII; Polynesians are of Caucasoid race unless otherwise specified MNZ1.782.815 XSEaster Island; Tahiti LH LS;  MHÑPolyneuritis MNC10.772.582.615 LH  MSATP:5'-dephosphopolynucleotide 5'-phosphotransferase. Catalyzes the transfer of phosphate to 5'-terminal hydroxyl groups of DNA and RNA. HN(75) MHÑPolynucleotide Hydroxylkinase ANdo not use /analogs RNEC 2.7.1.78 PIPhosphotransferases, ATP (74); Polynucleotides (74) MND8.586.913.696.729.690 XSPolynucleotide Kinase DMÑPhosphotransferases, ATP LH LS LM  OLsearch NUCLEOTIDYLTRANSFERASES 1966-71 & RNA NUCLEOTIDYLTRANSFERASES 1968-71 PM74; was see under NUCLEOTIDYLTRANSFERASES 1968-72, was see under NUCLEOTIDYL TRANSFERASES 1963-67 HN74(72); was see under NUCLEOTIDYLTRANSFERASES 1968-72, was see under NUCLEOTIDYL TRANSFERASES 1963-67 MHÑPolynucleotide Phosphorylase ANdo not use /analogs RNEC 2.7.7.8 PINucleotidyltransferases (66-71); RNA Nucleotidyltransferases (68-71) MND8.586.913.696.445.735.532 XSPOLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE LH LS  MSCatalyze the joining of preformed ribonucleotides or deoxyribonucleotides in phosphodiester linkage during genetic processes. OLuse POLYNUCLEOTIDE SYNTHETASES to search POLYNUCLEOTIDE SYNTHETASE (ATP) & POLYNUCLEOTIDE SYNTHETASE (NAD) back thru 1975 PM74 HN74; POLYNUCLEOTIDE SYNTHETASE (ATP) & POLYNUCLEOTIDE SYNTHETASE (NAD) were see under POLYNUCLEOTIDE SYNTHETASES 1975-77 MHÑPolynucleotide Synthetases ANdo not use /analogs RNEC 6.5.1. PILigases (66-73) MND8.586.464.754 XSPolynucleotide Ligases XUÑPolydeoxyribonucleotide Synthetases; ÑPolyribonucleotide Synthetase LH LS LU;  MHÑPolynucleotides AN13 or more units; do not use /analogs /defic MND13.695.578 XUÑApurinic Acid LH LU  MSA genus of potentially oncogenic viruses normally present in the host as a latent infection; their oncogenic powers are only revealed under artificial conditions in the laboratory. OLuse POLYOMAVIRUSES to search POLYOMA VIRUS back thru 1966 PM78; was POLYOMA VIRUS 1963-77 HN78; was POLYOMA VIRUS 1963-77 MHÑPolyomaviruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) MNB4.909.204.585.615; B4.909.574.204.711.615 XUÑBK Virus; ÑJC Virus LH LU;  MSA polymeric mixture of polyesters of phosphoric acid and phloretin. It blocks some cellular responses to prostaglandins. OLsearch PHLORETIN 1973-74 HN(75) MHÑPolyphloretin Phosphate ANdo not use /biosyn /defic /physiol RN9014-72-6 PIOrganophosphorus Compounds (72-74); Phloretin (73-74); Polymers (66-74) MND2.522.818.561.602.615; D2.755.684.602.615; D24.185.798.575.52.748; D25.720.795 DMÑPhloretin LH LM  MSLinear polymers in which orthophosphate residues are linked with energy-rich phosphoanhydride bonds. They are found in plants, animals and microorganisms. PM78; TIN POLYPHOSPHATES was see under PHOSPHATES 1977 HN78 MHÑPolyphosphates ANdo not use /analogs PIPhosphates (66-77) MND1.248.497.158.730.650; D1.696.620.603.700 XUÑTin Polyphosphates LH LU  MSThe chromosomal constitution of a cell containing multiples of the normal number of chromosomes; includes triploidy (symbol: 3N), tetraploidy (symbol: 4N), etc. PM68 HN68 MHÑPolyploidy ANno qualif PIChromosome Abnormalities (66-67); Chromosomes (66-67) MNG5.148.777.740 LH  MSA class of basidiomycetous fungi, order Aphyllophorales, living in decaying plant matter and timber. OLsearch BASIDIOMYCETES 1966-74 HN(75) MHÑPolyporaceae ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.179.760 XSLentinus; Shiitake Mushroom DMÑBasidiomycetes LH LS; LM  MSAn autosomal dominant polyposis syndrome in which the colon contains few to thousands of adenomatous polyps, often occurring by age 15 to 25. PM87 HN87 MHÑPolyposis Syndrome, Familial ANdo not use /anal /blood supply /secret /ultrastruct MNC4.700.740; C4.799.411.235.740; C6.405.469.158.360.740; C16.466.700.740 XSPolyposis Coli, Familial LH LS  MSPropylene or propene polymers. Thermoplastics that can be extruded into fibers, films or solid forms; used as copolymer in plastics, especially polyethylene; the fibers are used for fabrics, filters, surgical sutures, etc. Synonyms: Herculon; Hostalen; Moplen; Noblen; Polypro; Prolene. HN(75) MHÑPolypropylenes AND25-26 qualif; do not use /analogs PIAlkenes (72-74); Polymers (72-74) MND2.455.326.271.665.590; D25.720.716.550 XSPropene Polymers; Propylene Polymers DMÑPlastics LH LS; LM  PM65; was POLYPI 1963-64 HN65; was POLYPI 1963-64 MHÑPolyps ANneoplastic: coord with organ/neopl pre-coord; nasal = NASAL POLYPS; intestinal = INTESTINAL POLYPS; fibrous = FIBROMA; lymphoid = LYMPHOMA; laryngeal polyps = LARYNGEAL NEOPLASMS (IM) + POLYPS (IM); /anal /blood supply /secret /ultrastruct permitted; /familial: consider also POLYPOSIS SYNDROME, FAMILIAL but remember this is of the colon MNC4.799 LH  MHÑPolyradiculitis ANinflamm of several spinal nerve roots: do not confuse with POLYRADICULONEURITIS (inflamm of both spinal nerve roots & peripheral nerves) nor with RADICULITIS (inflamm of a single spinal nerve root) MNC10.772.582.763.616 LH  MSInflammation of many nerve roots and peripheral nerves. Guillain-Barre Syndrome is the commonest form. OLto search GUILLAIN-BARRE SYNDROME use POLYRADICULONEURITIS back thru 1979 & POLYRADICULITIS 1966-78 PM79; GUILLAIN-BARRE SYNDROME was see POLYRADICULITIS 1963-78 HN79; GUILLAIN-BARRE SYNDROME was see POLYRADICULITIS 1963-78 MHÑPolyradiculoneuritis ANinflamm of both spinal nerve roots & peripheral nerves; note ref to Guillain-Barre below; do not confuse with RADICULITIS (inflamm of a single spinal nerve root) nor with POLYRADICULITIS (inflamm of several spinal nerve roots) PIPolyradiculitis (66-78) MNC10.772.582.629 XSGuillain-Barre Syndrome LH LS  MSPoly(ribonucleotide):poly(ribonucleotide)ligase (AMP-forming). Catalyzes the conversion of linear RNA to a circular form by the transfer of the 5'-phosphate to the 3'-hydroxyl terminus. Also catalyzes the covalent joining of two polyribonucleotides in phosphodiester linkage. EC 6.5.1.3. HN(78) MHÑPolyribonucleotide Synthetase ANdo not use /analogs RNEC 6.5.1.3 PIPolynucleotide Synthetases (74-77) MND8.586.464.754.720 XSPolyribonucleotide Synthetases; RNA Ligase DMÑPolynucleotide Synthetases LH LS; LM  MSA group of 13 or more ribonucleotides in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties. PM76 HN76 MHÑPolyribonucleotides AN13 or more nucleotides; do not use /analogs /defic /physiol PIPolynucleotides (66-75) MND13.695.578.550 XUÑPoly C; ÑPoly G; ÑPoly I LH LU; ;  PM73 HN73 MHÑPolyribosomes ANA 11 qualif except /cytol; /class permitted MNA11.368.702.248.651.616 XSPOLYSOMES LH LS  MSA group of carbon-oxygen lyases. These enzymes catalyze the breakage of a carbon-oxygen bond in polysaccharides leading to an unsaturated product and the elimination of an alcohol. PM75 HN75 MHÑPolysaccharide-Lyases ANdo not use /analogs RNEC 4.2.2. PILyases (66-74) MND8.586.520.726 LH  PMXYLANS was XYLAN see under CELLULOSE 1963-74 MHÑPolysaccharides ANGEN; 13 or more units; do not use /analogs MND9.203.698 XSGLYCANS XUÑFicoll; ÑFructans; ÑGum Arabic; ÑKaraya Gum; ÑLentinan; ÑPentosan Sulfuric Polyester; ÑTragacanth; ÑXylans LH LS LU; ; ; ; ; ; ;  MHÑPolysaccharides, Bacterial ANIM + coord with specific bacterium (IM) + specific polysaccharide (IM); do not use /analogs; /immunol permitted; note specific bact polysaccharides LIPOPOLYSACCHARIDES & PEPTIDOGLYCAN MND9.203.698.718; D24.611.216.161.616 XSBacterial Polysaccharides XUÑProdigiozan LH LS LU  MSSorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives; complex mixtures of polyoxyethylene ethers used as emulsifiers or dispersing agents in pharmaceuticals. Synonyms: Monitan; Olothorb; Sorlate; Span. OLto search TWEENS use POLYSORBATES back thru 1975 & SURFACE-ACTIVE AGENTS 1966-74 PM81; was see under POLYETHYLENE GLYCOLS 1975-80; TWEENS was see under SURFACE-ACTIVE AGENTS 1963-74 HN81(75); was see under POLYETHYLENE GLYCOLS 1975-80; TWEENS was see under SURFACE-ACTIVE AGENTS 1963-74 MHÑPolysorbates AND25-26 qualif PIFatty Acids (66-73); Glycols (66-73); Hexoses (66-73); Polyethylene Glycols (74); Polyethylenes (66-73); Polymers (66-73); specific fatty acid (66-73) MND2.33.618.690.700; D25.720.741.700; D26.866.762.753 XSPolysorbate 20; Polysorbate 80; Sorbitan Derivatives; Tweens LH LS; ; ;  MSEthenyl-benzene homopolymer. Polymerized styrene; a clear, hard plastic used as biocompatible material, especially in dentistry; in industry as insulator, for injection molding and casting; as sheets, plates, rods, rigid forms and beads; also copolymerized with other materials, including elastomers. Synonyms: Dylene; polystyrene rubber; polystyrol; polyvinylbenzene; Styrofoam; Trycyte. MHÑPolystyrenes AND25-26 qualif MND2.455.426.559.389.150.600; D25.720.716.579; D25.720.840.771 FXÑStyrenes LH LX  MSHomopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron. OLsearch FLUOROCARBON POLYMERS 1966-72 PM73; was see under FLUOROCARBON POLYMERS 1966-72 HN73; was see under FLUOROCARBON POLYMERS 1966-72 MHÑPolytetrafluoroethylene AND25-26 qualif RN9002-84-0 PIFluorocarbon Polymers (66-72) MND25.720.395.616 XSFEP; FLUON; Politef; Polytef; TEFLON; TFE XUÑProplast LH LS; ; ; ; ; LU  PM65 HN65(64) MHÑPolythiazide ANdo not use /biosyn /defic /physiol RN346-18-9 MND3.438.174.781; D18.162.276.721; D19.770.224.578.721 LH  MSA group of thermoplastic or thermosetting polymers containing polyisocyanate; they may be hard and glossy forms; drawn into fibers; elastomeric or rubbery and flexible, or rigid foams. Used as rubber, for coatings, as fibers and foams; also used complexed in other polymers. Synonyms: Ostamer; Spandex; urethane rubber (or elastomer). PM68 HN68 MHÑPolyurethanes AND25-26 qualif PIUrethane (66-67) MND25.720.716.650; D25.720.840.782 XSPolyisocyanates FXÑUrethane LH LS LX  MHÑPolyuria MNC12.777.934.616 FXÑUrine LH LX  PM74 HN74(71) MHÑPolyvinyl Alcohol AND25-26 qualif RN9002-89-5 PIPolyvinyls (66-70) MND2.33.750; D2.455.326.271.884.533.532; D25.720.716.721.616 LH  MSChloroethene polymer. A polyvinyl resin used extensively in the manufacture of plastics, including medical devices, like tubing, packaging, and as rubber substitute; residues are present in human body tissues. Synonyms: PVC; Breon; Geon; Marvilon; Ultron; Vinylite. HN(75) MHÑPolyvinyl Chloride AND25-26 qualif; /analogs NIM only RN9002-86-2 PIHydrocarbons (66); Hydrocarbons, Chlorinated (74); Hydrocarbons, Halogenated (66-73); Polyvinyls (66-74) MND2.455.326.271.884.533.565; D25.720.716.721.812 XSChloroethylene Polymer; Polychloroethylene; Vinyl Chloride Polymer DMÑPolyvinyls LH LS; ; LM  MSPoly-2-vinylpyridine-N-oxide. Inhibits the cytotoxic action of quartz; delayed the development of experimental silicosis in rats. Synonym: Bay 3504. HN(75) MHÑPolyvinylpyridine N-Oxide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN9016-06-2 PICyclic N-Oxides (71-74); Polyvinyls (71-74); Pyridines (71-74) MND2.455.326.271.884.533.660; D3.383.725.740 DMÑPolyvinyls LH LM  MHÑPolyvinyls AND25-26 qualif MND2.455.326.271.665.616; D2.455.326.271.884.533; D25.720.716.721 XUÑPolyvinyl Chloride; ÑPolyvinylpyridine N-Oxide LH LU;  MHÑPompholyx MNC17.816.804 LH  MSA family of Primates consisting of five genera: HYLOBATES (gibbon), Symphalangus (siamang gibbon) which is sometimes included in HYLOBATES, PONGO (orangutan), CHIMPANSEE (chimpanzee), and GORILLA (gorilla). They inhabit forests in southeast Asia, equatorial Africa, Sumatra and Borneo. The members of this family are the closest living relatives of man. PM81; was APES 1964-80 HN81; was APES 1964-80 MHÑPongidae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; Manual 22.28+; Celebes black ape is not an ape: it is MACACA MNB2.649.801.201.600 XSApes XUÑHylobates; ÑPongo pygmaeus LH LS LU;  MSA single genus and species of orangutan belonging to the Pongidae family found only in lowland forests of Sumatra and Borneo. Among the Primates the orangutan is second in size only to the gorilla. HN(81) MHÑPongo pygmaeus ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; DF: PONGO PIPongidae (66-80) MNB2.649.801.201.600.790 XSOrangutan DMÑPongidae LH LS LM  MHÑPons ANdo not use /innerv MNA8.186.211.132.810.616 XSMetencephalon LH LS  MSThe continuation of the femoral artery coursing through the popliteal fossa; it divides into the anterior and posterior tibial arteries. MHÑPopliteal Artery ANdo not use /blood supply MNA7.231.114.681 LH  MSA synovial cyst in the popliteal space arising from the semimembranous bursa or the knee joint. HN(87) MHÑPopliteal Cyst ANnon-neoplastic; /anal /blood supply /secret /ultrastruct permitted PIKnee Joint (66-86); Synovial Cyst (66-86) MNC4.182.867.775 XSBaker's Cyst DMÑSynovial Cyst LH LS LM  MSThe vein formed by the union of the anterior and posterior tibial veins; it courses through the popliteal space and becomes the femoral vein. MHÑPopliteal Vein ANdo not use /blood supply MNA7.231.908.641 LH  MSThe total number of persons inhabiting a particular region or area. MHÑPopulation ANIM human, NIM animal; no qualif; differentiate from DEMOGRAPHY (the -ology of population) CATALOG: /geog /form MNI1.782.616; N1.224.716 LH  MH*Population Characteristics (Non Mesh) MNN1 LH  MSIncludes mechanisms or programs which control the numbers of individuals in a population of animals or humans. PM68 HN68 MHÑPopulation Control ANIM human, NIM animal; no qualif; specify geog; a broad plane: differentiate from FAMILY PLANNING, a personal level CATALOG: /geog /form PIAbortion, Legal (66-67); Family Planning (66-67); Population (66-67); Sterilization, Sexual (66-67) MNI1.782.616.616 FXÑAbortion, Legal; ÑFamily Planning; ÑSTERILIZATION, SEXUAL LH LX; ;  MSNumber of individuals in a population relative to space. PM68 HN68 MHÑPopulation Density ANIM human, NIM animal; no qualif; specify geog CATALOG: /geog /form PIDemography (66-67); Population (66-67) MNI1.782.616.249.617; N1.224.716.533 FXÑCrowding; ÑSOCIAL ISOLATION LH LX;  MSThe pattern of any process, or the interrelationship of phenomena, which affects growth or change within a population. PM76 HN76; was NON MESH before 1976 MHÑPopulation Dynamics ANIM human, NIM animal; no qualif; specify geog; GENETICS, POPULATION is also available CATALOG: /geog /form MNG3.850.750; I1.782 LH  MSIncrease, over a specific period of time, in the number of individuals living in a country or region. OLuse POPULATION GROWTH to search POPULATION EXPLOSION back thru 1968 PM68 HN68; POPULATION EXPLOSION was see under POPULATION GROWTH 1968-78 MHÑPopulation Growth ANIM human, NIM animal; no qualif; specify geog CATALOG: /geog /form PIDemography (66-67); Population (66-67) MNI1.782.616.742; N1.224.716.700 XSPopulation Explosion FXÑVital Statistics LH LS LX  PM67 HN67(65) MHÑPopulation Surveillance ANIM human, NIM animal; no qualif; specify geog CATALOG: /geog /form MNE5.318.533; G3.850.520.610.680 LH  MSToxic antibiotic of the mitomycin group, obtained from mitomycin C and also from Streptomyces ardus and other species; proposed as antineoplastic agent, with some antibiotic properties. Synonyms: N-methylmitomycin C; ENT 50825; U 14743; NSC 56410. HN(82)73 MHÑPorfiromycin ANdo not use /defic /physiol; /analogs NIM only RN801-52-5 PIAntibiotics, Antineoplastic (67-72) MND3.383.97.500.700; D20.85.75.584.750; D22.204.106.584.750 XSMethylmitomycin C DMÑMitomycins LH LS LM  MHÑPorifera ANthe sponges MNB1.802 LH  PM74 HN74(72) MHÑPorphobilinogen AN/biosyn /physiol permitted RN487-90-1 PIPorphyrins (66-71); Pyrroles (66-71) MND3.383.757.617 FXÑPorphyrins LH LX  MSPorphobilinogen ammonia-lyase (polymerizing). Catalyzes the formation of hydroxymethylbilane from four molecules of porphobilinogen. OLuse PORPHOBILINOGEN DEAMINASE to search UROPORPHYRINOGEN I SYNTHASE back thru 1975 HN(85); was UROPORPHYRINOGEN I SYNTHASE see under AMMONIA-LYASES 1975-84 MHÑPorphobilinogen Deaminase ANdo not use /analogs; /defic: consider also PORPHYRIA RNEC 4.3.1.8 PIAmmonia-Lyases (73-74); Porphobilinogen (73-74) MND8.586.520.161.750 XSPorphobilinogen Ammonia-Lyase; Uroporphyrinogen I Synthase DMÑAmmonia-Lyases LH LS; LM  MHÑPorphyria ANcutaneous porphyria or porphyria cutanea: coord IM with SKIN DISEASES (IM); hepatic porphyria: coord IM with LIVER DISEASES (IM) MNC17.849.617; C18.452.648.740 LH  MSColorless reduced precursors of porphyrins in which the pyrrole rings are linked by methylene (-CH2-) bridges. PM76; was see under PORPHYRINS 1975 HN76(75); was see under PORPHYRINS 1975 MHÑPorphyrinogens ANdo not use /analogs /defic PIPorphyrins (68-74) MND11.557.727.700 XUÑCoproporphyrinogens; ÑUroporphyrinogens LH LU;  MHÑPorphyrins ANdo not use /analogs; iron porphyrins = HEME or HEMIN, magnesium porphyrins = CHLOROPHYLL MND11.557.727 FXÑPORPHOBILINOGEN XUÑCoproporphyrins; ÑDeuteroporphyrins; ÑEtioporphyrins; ÑMesoporphyrins; ÑProtoporphyrins; ÑUroporphyrins LH LX LU; ; ; ; ;  MSSurgical portasystemic shunt between the portal vein and inferior vena cava. OLuse PORTACAVAL SHUNT, SURGICAL to search PORTACAVAL ANASTOMOSIS 1966-80 & ECK FISTULA back thru 1974 PM81; was PORTACAVAL ANASTOMOSIS 1963-80 HN81; was PORTACAVAL ANASTOMOSIS 1963-80; ECK FISTULA was see under PORTACAVAL ANASTOMOSIS 1974-80 MHÑPortacaval Shunt, Surgical ANdo not use /util except by MeSH definition; DF: PORTACAVAL SHUNT MNE4.752.814.790.790 XSEck Fistula LH LS  MSA system of vessels in which blood, after passing through one capillary bed, is conveyed through a second set of capillaries before it returns to the systemic circulation; especially the hepatic portal system. MHÑPortal System ANdo not use /blood supply; /radiogr: consider also PORTOGRAPHY MNA7.231.908.670 FXÑLiver Circulation LH LX  MSA short thick vein formed by union of the superior mesenteric vein and the splenic vein. MHÑPortal Vein ANdo not use /blood supply; /radiogr permitted but PORTOGRAPHY is more likely MNA7.231.908.670.567 LH  MSSurgical venous shunt between the portal and systemic circulation to effect decompression of the portal circulation. Performed primarily in treatment of bleeding esophageal varices resulting from portal hypertension. Types of shunt include portacaval, splenorenal, mesocaval, splenocaval, left gastric-caval (coronary-caval), portarenal, umbilicorenal, and umbilicocaval. PM81 HN81 MHÑPortasystemic Shunt, Surgical ANdo not use /util except by MeSH definition; see MeSH definition for types; DF: PORTASYSTEMIC SHUNT PIEsophageal and Gastric Varices/SU (66-80); Hypertension, Portal/SU (66-80); Portacaval Shunt, Surgical (66-80); Portal System/SU (66-80); specific portal system vein/SU (66-80) MNE4.752.814.790 XSPortosystemic Shunt, Surgical FXÑHypertension, Portal XUÑSplenorenal Shunt, Surgical LH LS LX LU  OLuse PORTOGRAPHY to search SPLENOPORTOGRAPHY back thru 1966 PM86; was SPLENOPORTOGRAPHY 1963-85 HN86; was SPLENOPORTOGRAPHY 1963-85 MHÑPortography ANNIM; do not use /util except by MeSH definition MNE1.145.77.756; E1.184.697; E1.818.84.707.756; E1.818.701.756 XSSplenoportography LH LS  MHÑPortraits ANno qualif; as IM, Manual 32.14; as NIM, Manual 32.14.1; TN 154: use and quality MNK1.93.742 LH  MHÑPortugal MNZ1.542.727 XSMadeira Island LH LS  MHÑPositive Pressure Respiration ANdo not use /util except by MeSH definition; continuous pos press resp goes here MNE2.880.820.790 XUÑIntermittent Positive Pressure Breathing; ÑIntermittent Positive Pressure Ventilation LH LU;  OLsearch CROWNS 1974 HN(75) MHÑPost and Core Technic ANonly /adv eff /stand /util (if by MeSH definition) /vet; dowels goes here but pins, pegs & screws go under DENTAL PINS; DF: POST TECHNIC MNE6.780.377.433.186.617 DMÑCrowns LH LM  MSThe functions and activities carried out by the U.S. Postal Service. MHÑPostal Service ANdo not use /educ; specify geog MNI1.451.617 LH  MSSequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (dumping syndrome and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies. MHÑPostgastrectomy Syndromes MNC6.405.650; C23.814.617 FXÑGastrectomy LH LX  MSThe time period between implantation and placentation. OLuse POSTIMPLANTATION PHASE to search POSTNIDATION PHASE & POSTNIDATION PHASE, ANIMAL back thru 1975 PM85; was POSTNIDATION PHASE 1980-84, was POSTNIDATION PHASE see under PREGNANCY TRIMESTER, FIRST 1976-79, was POSTNIDATION PHASE see under PREGNANCY, FIRST TRIMESTER 1975; POSTNIDATION PHASE, ANIMAL was see under PREGNANCY, ANIMAL 1975-79 HN85; was POSTNIDATION PHASE 1980-84, was POSTNIDATION PHASE see under PREGNANCY TRIMESTER, FIRST 1976-79, was POSTNIDATION PHASE see under PREGNANCY, FIRST TRIMESTER 1975; POSTNIDATION PHASE, ANIMAL was see under PREGNANCY, ANIMAL 1975-79 MHÑPostimplantation Phase ANhuman & animal; only /drug eff /rad eff; check the tags HUMAN or ANIMAL + FEMALE + PREGNANCY PIEmbryo (66-74); Mammals/EM (66-74); specific mammal/EM (66-74); Ovum Implantation (66-74) MNG8.520.500.670 XSPostnidation Phase LH LS  MSChanges that occur in bodies after death. OLuse POSTMORTEM CHANGES to search ADIPOCERE, ALGOR MORTIS, CRUOR, LIVOR MORTIS & MUMMIFICATION back thru 1970 PM70 HN70; ADIPOCERE, ALGOR MORTIS, CRUOR, LIVOR MORTIS & MUMMIFICATION were see under POSTMORTEM CHANGES 1970-78 MHÑPostmortem Changes ANnatural physiol changes after death; do not use for routine postmortem pathol ( = /pathol); no qualif PIDeath (66-69) MNC23.240.224.617 XSAdipocere; Algor Mortis; Cruor; Livor Mortis LH LS; ; ;  MSThe care provided a woman following the birth of a child. PM71 HN71 MHÑPostnatal Care ANonly /econ /legis /methods /organ /psychol /stand /trends /vet PIPuerperium (66-70) MNE2.472.741; N2.421.143.620.534 LH  MHÑPostoperative Care ANonly /econ /methods /psychol /stand /trends /vet; DF: POSTOP CARE MNE4.624 LH  MSDisorders affecting patients after surgery. They may or may not be related to the disease for which the surgery was done; and they may or may not be direct results of the surgery, but if the former, Postoperative Complications is only used in cases where there is no exact MeSH term for the surgical procedure. PM64 HN64 MHÑPostoperative Complications ANIM; coord with specific postop compl (IM); not restricted to immediate postop period; do not use /chem ind /compl /congen /embryol /enzymol /familial /hist /immunol; differentiate from Cat E4 terms with /adv eff: Manual 23.24+; DF: POSTOP COMPL MNC23.814 FXÑSurgery, Operative LH LX  MSThe period following a surgical operation. PM86; was see under SURGERY, OPERATIVE 1979-85 HN86(79); was see under SURGERY, OPERATIVE 1979-85, was in Cat E & H 1979-81 MHÑPostoperative Period ANalmost never IM; no qualif; DF: POSTOP PERIOD MNE4.630 XUÑAnesthesia Recovery Period LH LU  MSA febrile illness associated with pericardial and sometimes pleuropulmonary reaction that often follows extensive pericardiotomy. Syn: postcommissurotomy syndrome. HN(65) MHÑPostpericardiotomy Syndrome MNC14.280.793; C23.814.668 XSPostcommissurotomy Syndrome DMÑHeart Diseases LH LS LM  MSPost-thrombotic complications, including destruction of the valves of the deep veins and communication veins of the leg, and obliteration of the thrombosed veins rather than recanalization, resulting in chronic venous insufficiency, marked by edema, stasis dermatitis, and ulceration of the leg. PM87 HN87 MHÑPostphlebitic Syndrome PIPhlebitis (66-86); Thrombophlebitis (66-86); Varicose Ulcer (66-86); Venous Insufficiency (73-86) MNC14.907.681.760; C14.907.952.760 XSPostphlebitic Disease; Postphlebitic Ulcer LH LS;  MHÑPosture ANno qualif; postural hypotension = HYPOTENSION, ORTHOSTATIC CATALOG: do not use /pop wks MNG11.427.818 FXÑKinesics LH LX  MHÑPotassium ANK-39; /physiol permitted; /metab: consider also POTASSIUM CHANNELS see ION CHANNELS & see note there; do not use /analogs /biosyn /defic (= POTASSIUM DEFICIENCY); for isotopes, see below; /blood: note see relateds RN7440-09-7 MND1.248.497.300.459.683; D1.268.692; D1.552.528.652 FXÑHyperkalemia; ÑHypokalemia LH LX;  PM66 HN66(64) MHÑPotassium Chloride ANdo not use /analogs /biosyn /defic /physiol RN7447-40-7 MND1.396.343.260.668; D1.552.528.652.468 LH  MSA highly poisonous compound. An inhibitor of many metabolic processes, but has been shown to be an especially potent inhibitor of heme enzymes and hemeproteins. Used in many industrial processes. HN(79) MHÑPotassium Cyanide AND25-26 qualif RN151-50-8 PICyanides (66-78); Potassium (66-78) MND1.552.528.652.480; D1.620.305.700 DMÑCyanides LH LM  MHÑPotassium Deficiency ANconsider also HYPOKALEMIA MNC18.654.223.617 LH  MSBright orange-red crystals used in dyeing, staining, tanning leather, as bleach, oxidizer, depolarizer for dry cells, etc. Medically has been used externally as astringent, antiseptic, caustic. Internally, a corrosive poison. HN(75) MHÑPotassium Dichromate ANdo not use /analogs /biosyn /defic /physiol RN7778-50-9 PIChromates (69-74) MND1.552.165.199.700 XSPotassium Bichromate DMÑChromates LH LS LM  PM65 HN65 MHÑPotassium Iodide ANdo not use /analogs /biosyn /defic /physiol RN7681-11-0 MND1.396.661.388.618; D1.552.528.652.568 LH  MHÑPotassium Isotopes ANK-41; NIM; no qualif MND1.496.705; D1.552.528.652.668 LH  MSAn intra-extracellular electrolyte exchange agent with a variety of effects. Beneficial in cardiac insufficiency, potentiates the effect of cardiac glycosides by reducing their toxicity, has hypocholesteremic effects and potentiates the effects of calcium in disturbed calcium metabolism. Synonyms: Panangin; Tromcardin. HN(77) MHÑPotassium Magnesium Aspartate ANdo not use /biosyn /defic /physiol RN8076-65-1 PIAsparagine (72-73); Aspartic Acid (74-76); Magnesium (72-75); Potassium (72-75) MND12.125.119.170.700 XSPotassium Magnesium Asparaginate DMÑAspartic Acid LH LS LM  MHÑPotassium Permanganate ANdo not use /analogs /biosyn /defic /physiol RN7722-64-7 MND1.552.484.618; D1.552.528.652.768 LH  MSUnstable isotopes of potassium that decay or disintegrate spontaneously emitting radiation. Potassium (K) 37, 38, 40 and 42-45 are radioactive isotopes of potassium. OLsearch POTASSIUM ISOTOPES 1966-74 PM75 HN75 MHÑPotassium Radioisotopes ANK-37,38,40,42-45; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIPotassium Isotopes (66-74); Radioisotopes (66-74) MND1.496.705.700; D1.496.749.690; D1.552.528.652.800 LH  MSSolanum tuberosum, one of the annual, herbaceous, poisonous Solanaceae or its non-poisonous tubers which are highly nutritious as food crops of the temperate regions; the plant yields starch and other nutrients, a number of enzymes, alkaloids, and lectins; the berries are very toxic. PM86 HN86 MHÑPotatoes ANSolanum tuberosum only: does not include sweet potatoes (genus Ipomoea, index under VEGETABLES); do not use /isol /pathogen PIPlants (66-85); Plants, Edible (66-85); Vegetables (66-85) MNB6.510.782; J1.341.956.782 XSSolanum tuberosum LH LS  PM67 HN67(64) MHÑPotentiometry ANNIM; do not use /util except by MeSH definition MNE5.196.781; H1.181.278.774; H1.181.529.307.794 LH  MHÑPoultry ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; differentiate from BIRDS: ╥birds╙ in zoos, parks, forest, streets, pet shops = BIRDS, ╥birds╙ in barnyard, hatchery, butcher shop = POULTRY; definition: Manual 22.29; as food: Manual 31.10; canned poultry meat: see note on POULTRY PRODUCTS below MNB2.248.617 XSFOWLS, DOMESTIC LH LS  MHÑPoultry Diseases ANdo not use /compl /vet; don't forget also POULTRY (NIM) for general or unspecified but IM specific fowl & check tag ANIMAL; differentiate from BIRD DISEASES on basis of definition of BIRDS & POULTRY above under POULTRY MNC22.131.728 LH  MSFood products manufactured from poultry (e.g., liver pate). PM68 HN68 MHÑPoultry Products AN╥food products manufactured from poultry (e.g., liver pate)╙ but for canned poultry meat coord POULTRY or specific poultry (IM) + FOOD PRESERVATION; coord IM with poultry source (NIM); only /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply PIPoultry (66-67) MNJ1.341.805 FXÑEggs LH LX  MSA situation in which the level of living of an individual, family or group is below the standard of the community. It is often related to a specific income level. PM68 HN68 MHÑPoverty ANno qualif CATALOG: /geog /form MNI1.880.735.634; I1.880.840.535; N1.824.600 XSINDIGENCY FXÑCultural Deprivation XUÑPoverty Areas LH LS LX LU  MSCity, urban, rural or suburban areas which are characterized by severe economic deprivation and by accompanying physical and social decay. HN(80) MHÑPoverty Areas ANno qualif; specify geog PIPoverty (68-79) MNI1.880.840.535.550; N1.824.600.550 XSGhettos; Slums DMÑPoverty LH LS; LM  MS1-Ethenyl-2-pyrrolidinone homopolymer. A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander. Synonyms: Kollidon; Periston; Plasdone; Plasmosan; PVP; 143-RP. OLuse POVIDONE to search POLYVINYLPYRROLIDONE back thru 1966 PM81; was POLYVINYLPYRROLIDONE 1963-80 HN81; was POLYVINYLPYRROLIDONE 1963-80 MHÑPovidone AND25-26 qualif RN9003-39-8 MND2.455.326.271.884.533.699; D3.383.773.812.615; D19.461.775.741; D25.720.716.721.838; D26.698.716 XSPolyvidon; Polyvinylpyrrolidone XUÑPovidone-Iodine LH LS; LU  MS1-Ethenyl-2-pyrrolidone homopolymer complexed with iodine. An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucus membrane infections, also as aerosol; the iodine may be radiolabeled for research purposes. Synonyms: Betadine; Disadine; Isodine; Providine; PVP-iodine. HN(66); was see under POLYVINYLPYRROLIDONE 1975-80 MHÑPovidone-Iodine AND25-26 qualif RN25655-41-8 MND1.396.661.790; D2.455.326.271.884.533.710; D3.383.773.812.615.630; D20.187.698; D25.720.716.721.838.745 XSPolyvinylpyrrolidone Iodine DMÑPovidone LH LS LM  MSA Flavivirus (group B arbovirus) first isolated from a fatal case of encephalitis in Canada. HN(75) MHÑPowassan Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with ENCEPHALITIS, TICK-BORNE (IM) MNB4.909.777.270.511.700; B4.909.777.923.377.350.756 DMÑEncephalitis Viruses, Tick-Borne LH LM  MHÑPowders ANIM for general only: only /anal (with caution) /stand /supply; NIM with specific drug IM: no qualif; /adv eff permitted but be careful: it may be the adv eff of the drug in powder form, not the powder MND26.394.225.672 LH  MSUnits that convert some form of energy into electrical energy, such as hydroelectric or steam-generating stations, diesel-electric engines in locomotives, or nuclear power plants. PM77 HN77 MHÑPower Plants ANonly /econ /instrum /stand /supply; on an industrial & technol level: differentiate from POWER SOURCES PIAir Pollution (66-76); Nuclear Energy (66-76); Electricity (66-76); Nuclear Reactors (66-76); Occupational Medicine (66-76) MNH1.671.252.780; J1.780 XSElectric Power Plants; Hydroelectric Power Plants; Thermoelectric Power Plants FXÑEnergy-Generating Resources LH LS; ; LX  MSDevices that supply energy. PM77 HN77 MHÑPower Sources ANdo not use /instrum /methods /util (except by MeSH definition); BIOELECTRIC ENERGY SOURCES is also available; do not confuse with POWER PLANTS, on an industrial level PIspecific heading/IS (66-75) MNE7.690 FXÑEnergy-Generating Resources LH LX  OLuse POXVIRIDAE to search POXVIRUSES & POXVIRUS back thru 1966, & SWINEPOX VIRUS back thru 1975 PM81; was POXVIRUSES 1975-80, was POXVIRUS 1963-74; SWINEPOX VIRUS was see under POXVIRIDAE 1981-85, was see under POXVIRUSES 1975-80 HN81; was POXVIRUSES 1975-80, was POXVIRUS 1963-74; SWINEPOX VIRUS was see under POXVIRIDAE 1981-85, was see under POXVIRUSES 1975-80 MHÑPoxviridae ANdo not use /blood-csf-urine /cytol; infection = POXVIRUS INFECTIONS MNB4.909.204.783 XSSwinepox Virus XUÑAvian Arthritis Virus; ÑFowl Pox Virus; ÑLumpy Skin Disease Virus; ÑMonkey Pox Virus; ÑOrf Virus; ÑParavaccinia Virus; ÑRabbit Pox Virus; ÑShope Fibroma Virus LH LS LU; ; ; ; ; ; ;  MHÑPoxvirus Infections ANGEN: prefer specifics MNC2.256.743 FXÑSkin Diseases, Infectious XUÑEctromelia, Infectious; ÑMilker's Nodes LH LX LU;  MSPerformance of an act one or more times, with a view to its fixation or improvement; any performance of an act or behavior that leads to learning. PM66 HN66(64) MHÑPractice (Psychology) ANhuman & animal; no qualif; DF: PRACTICE PSYCHOL MNF2.463.425.674 LH  MSThe organization and operation of the business aspects of a dental practice. PM68 HN68 MHÑPractice Management, Dental ANonly /econ /stand /trends PIDentistry (66-67); Office Management (66-67) MNN4.452.758.572.535 LH  MSThe organization and operation of the business aspects of a physician's practice. PM68 HN68 MHÑPractice Management, Medical ANonly /econ /stand /trends PIOffice Management (66-67) MNN4.452.758.572.702 LH  PM74 HN74 MHÑPractolol ANdo not use /biosyn /defic /physiol RN6673-35-4 MND2.33.329.624.795; D2.92.63.624.795; D16.848.215.659 LH  MSA congenital disorder of unknown etiology characterized by mental retardation, muscular hypotonia, obesity, short stature, hypogonadism and frequently developing insulin-resistant diabetes. PM77 HN77 MHÑPrader-Willi Syndrome ANdo not use /congen /drug eff /physiol /rad eff PIAbnormalities, Multiple (68-76); Carbohydrate Metabolism, Inborn Errors (69-76); Hypogonadism (66-76); Mental Retardation (66-76); Obesity (66-76) MNC10.496.770; C16.131.77.730; C18.654.621.740; F3.709.346.790 LH  MS17R,21 alpha-Dihydroxy-4-propylajmalinium. Derivative of the rauwolfia alkaloid ajmaline; proposed as an antiarrhythmic agent; may cause liver damage. Synonyms: GT 1012; Neo-Gilurytmal. HN(80) MHÑPrajmaline AN/biosyn permitted if by plant; do not use /defic /physiol RN35080-11-6 PIAjmaline (71-74) /AA (75-79); Rauwolfia (66-71) MND3.132.973.641.119.650; D3.549.937.641.144.650; D16.848.415.804.28.612; D18.97.69.612 XSN-Propylajmaline; Prajmalium DMÑAjmaline LH LS; LM  MS2[(Hydroxyimino)methyl]-1-methylpyridinium. Various salts of a quaternary ammonium oxime that reconstitute inactivated acetylcholinesterase, especially at the neuromuscular junction; may cause neuromuscular blockade; used as antidote to organophosphorus poisoning, as the chloride, iodide, methanesulfonate (mesylate) or other salt. Synonyms: Contrathion; Protopam. PM65 HN65(63) MHÑPralidoxime Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: PRALIDOXIME CPDS MND2.92.570.665.535; D8.515.347.582.535; D16.653.211.498.535 XS2-PAM Compounds; Pyridine Aldoxime Methyl Compounds LH LS;  MHÑPraseodymium ANPr-141; do not use /analogs /biosyn /defic /physiol; Pr-134-140, 142-148 = PRASEODYMIUM (IM) + RADIOISOTOPES (IM) RN7440-10-0 MND1.268.699; D1.552.550.679 LH  PM73 HN73(72) MHÑPrazepam ANdo not use /biosyn /defic /physiol RN2955-38-6 PIBenzazepines (68-71); Muscle Relaxants, Central (70-71) MND3.438.79.80.70.784; D15.236.872.659.191.795; D17.426.742 LH  MS2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- 4H-pyrazino-(2,1-a)-isoquinolin-4-one. Anthelmintic used in most schistosome and many cestode infestations; may be given orally, parenterally or by nasal spray. Synonyms: Droncit; Embay 8440. PM86; was see under ISOQUINOLINES 1980-85 HN86(80); was see under ISOQUINOLINES 1980-85 MHÑPraziquantel ANdo not use /biosyn /defic /physiol RN55268-74-1 PIIsoquinolines (69-79); Pyrazines (66-79); Quinolines (66-68) MND3.438.531.690; D21.201.412.534 LH  MS1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-piperazine monohydrochloride. Hypotensive quinazoline derivative that dilates peripheral arterioles, possibly by interfering with the events at the alpha adrenergic receptor sites. Synonyms: CP-12,299-1; Minipress. PM86; was see under QUINAZOLINES 1977-85 HN86(77); was see under QUINAZOLINES 1977-85 MHÑPrazosin ANdo not use /biosyn /defic /physiol RN19216-56-9 PIPiperazines (74-76); Quinazolines (74-76) MND3.438.786.750; D16.848.115.673; D18.162.730 XSFurazosin LH LS  MSDevelopment of hypertension with proteinuria, edema, or both, due to pregnancy or the influence of a recent pregnancy. It occurs after the 20th week of gestation, but it may develop before this time in the presence of trophoblastic disease. OLsearch PREGNANCY TOXEMIAS 1966-74 PM79; was see under PREGNANCY TOXEMIAS 1963-78 HN79(75); was see under PREGNANCY TOXEMIAS 1963-78 MHÑPre-Eclampsia ANcheck tags FEMALE & PREGNANCY PIPregnancy Toxemias (66-74) MNC13.703.799.314.619 LH  MSConditions characterized by activation of the whole or some part of the ventricle by the atrial impulse earlier than would be expected if the impulse reached the ventricle by way of the normal specific conduction system only. PM86 HN86 MHÑPre-Excitation Syndromes ANGEN: prefer specifics; long QT = LONG QT SYNDROME; normal PR-long QRS = PRE-EXCITATION, MAHAIM TYPE; short PR-normal QRS = LOWN-GANONG-LEVINE SYNDROME; short PR, long QRS = WOLFF-PARKINSON-WHITE SYNDROME PIArrhythmia (66-85); Heart Conduction System (66-85); Tachycardia (66-85) MNC14.280.67.780 XUÑLown-Ganong-Levine Syndrome; ÑPre-Excitation, Mahaim Type LH LU;  MSA form of pre-excitation characterized by a normal PR interval and a long QRS interval with a delta wave. HN(86) MHÑPre-Excitation, Mahaim Type ANnormal PR interval & long QRS interval with delta wave; SHORT PR NORMAL QRS COMPLEX SYNDROME see LOWN-GANONG-LEVINE SYNDROME is available MNC14.280.67.780.770 XSMahaim Type Pre-Excitation DMÑPre-Excitation Syndromes LH LS LM  MSA tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease. PM84; was see under SERUM ALBUMIN 1975-83 HN84(75); was see under SERUM ALBUMIN 1975-83 MHÑPrealbumin AN/biosyn /physiol permitted; do not use /blood PIProtein Precursors (73-74); Serum Albumin (72-74) MND12.776.34.841.450; D12.776.124.727.450 XSProalbumin LH LS  MHÑPreanesthetic Medication ANdo not use /util except by MeSH definition MNE3.806; E4.641.619 FXÑPremedication LH LX  PM68 HN68 MHÑPrecancerous Conditions ANIM; do not use /compl for develop into cancer; coord IM with organ/neopl term (IM) MNC4.834 FXÑHyperplasia; ÑNeoplasms LH LX;  MSAn educational program designed to give the professionally trained student experience outside the academic environment working in the specialty area of his choice with a physician, dentist or other advisory supervisors. PM75 HN75 MHÑPreceptorship ANonly /econ /hist /man /stand /trends PIEducation, Dental (66-74); Education, Medical (66-74) MNI2.600 LH  PM66 HN66(64) MHÑPrecipitation ANNIM; no qualif MNH1.181.529.741 XUÑFlocculation; ÑFractional Precipitation LH LU;  MSSerologic tests in which a positive reaction manifested by precipitation occurs when a soluble antigen reacts with its antibody. MHÑPrecipitin Tests ANonly /instrum /methods /stand /vet MNE1.223.495.826.769 LH  MHÑPrecipitins ANonly /admin /anal /biosyn /csf /class /immunol /isol /urine MND24.611.125.837 LH  MSInstinctual behavior pattern in which food is obtained by killing and consuming other species. HN(75) MHÑPredatory Behavior ANanimal only; only /drug eff /physiol /rad eff MNF1.145.113.111.600; F1.145.113.252.520 DMÑAppetitive Behavior LH LM  PM68 HN68(65) MHÑPrediabetic State ANdo not use /compl for develop into diabetes; coord IM with specific diabetes precoord IM when pertinent; preclinical diabetes goes here MNC18.452.297.774; C19.246.774 FXÑDiabetes Mellitus LH LX  MSIn screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. PM87 HN87 MHÑPredictive Value of Tests ANno qualif MNE5.318.563; G3.850.520.820.210; H1.548.832.672.500 FXÑFalse Negative Reactions; ÑFalse Positive Reactions LH LX;  MS11-beta,17,21-Trihydroxypregna-1,4-diene- 3,20-dione 21-[4[p(bis(2- chloroethyl)amino)phenyl]butyrate]. Ester of chlorambucil and prednisolone; combination alkylating agent and synthetic steroid used in various leukemias and other neoplasms; causes gastrointestinal and bone marrow toxicity. Synonyms: EORTC 1502; Leo 1031; NSC 134087; Stereocyt. HN(80) MHÑPrednimustine ANdo not use /biosyn /defic /physiol RN29069-24-7 PIChlorambucil (66-74) /AA (75-79); Prednisolone (66-74) /AA (75-79) MND2.455.526.728.650.156.700; D4.808.745.432.769.795.700; D22.204.585.186.742 DMÑChlorambucil LH LM  PM/therapeutic use was PREDNISOLONE, THERAPEUTIC 1965 HN/therapeutic use was PREDNISOLONE, THERAPEUTIC 1965 MHÑPrednisolone AN/biosyn /physiol permitted; /admin: consider also PREDNISOLONE, TOPICAL RN50-24-8 MND4.808.745.432.769.795; D6.597.481.561.353.744; D6.597.481.561.478.702; D26.74.125.744 XUÑDepersolone LH LU  MHÑPrednisolone, Topical AND25-26 qualif MND4.808.745.432.769.795.744; D6.597.481.364.807; D26.74.125.447.807; D26.74.125.744.807; D26.74.148.447.807; D26.368.99.447.807 LH  PM/adverse effects /poisoning /toxicity were PREDNISONE TOXICOLOGY 1963-65; /therapeutic use was PREDNISONE, THERAPEUTIC 1965 HN/ad-poi-tox was PREDNISONE TOXICOLOGY 1963-65; /therapeutic use was PREDNISONE, THERAPEUTIC 1965 MHÑPrednisone AN/biosyn /physiol permitted RN53-03-2 MND4.808.745.432.719.702; D6.597.481.561.478.758; D22.204.717; D26.74.125.758 LH  MSThe smoothing or dressing of feathers with the bill. OLsearch GROOMING 1968-74 HN(75) MHÑPreening ANanimal; no qualif MNF1.145.113.111.453.619 DMÑGrooming LH LM  MSArrangements negotiated between a third party payor -- often a self-insured company or union trust fund -- and a group of health care providers (hospitals and physicians) who furnish services at lower than usual fees, and in return receive prompt payment and an expectation of an increased volume of patients. OLsearch INSURANCE, HEALTH 1984 HN(85); was see INSURANCE, HEALTH 1984 MHÑPreferred Provider Organizations ANonly /econ /hist /legis /stand /trends /util; specify geog if possible PIInsurance, Health (66-84) MNN3.219.521.576.343.750 DMÑInsurance, Health LH LM  PM74 HN74 MHÑPregnadienediols ANdo not use /analogs MND4.808.745.432.719 XSDIHYDROXYPREGNADIENES LH LS  PM73 HN73 MHÑPregnadienes ANdo not use /analogs PIPregnanes (66-72) MND4.808.745.432 XUÑCanrenoate Potassium; ÑCanrenone; ÑDanazol; ÑMedrogestone; ÑMelengestrol LH LU; ; ; ;  PM74 HN74 MHÑPregnadienetriols ANdo not use /analogs MND4.808.745.432.769 XSTRIHYDROXYPREGNADIENES XUÑDesonide LH LS LU  OLuse PREGNANCY to search PRENATAL INFLUENCES 1966-72 PMPRENATAL INFLUENCES was heading 1963-72 HNPRENATAL INFLUENCES was heading 1963-72 MHÑPregnancy ANIM for articles on normal pregn, NIM as check tag; when IM, qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /psychol /rad eff; policy: Manual 18.4+, 28.29-28.34; in children or adolescents, see note under PREGNANCY IN ADOLESCENCE; pregn despite use of contraceptives is PREGNANCY + contraceptive term with no qualif; check tag FEMALE also; molar pregn = HYDATIDIFORM MOLE; surrogate pregnancy = SURROGATE MOTHERS; note TEST-TUBE FERTILIZATION see FERTILIZATION IN VITRO; heterotopic pregnancy: see note under PREGNANCY, ECTOPIC; DF: PREGN CATALOG: do not use /in inf or /in adolesc ( = PREGNANCY IN ADOLESCENCE) or /in middle age ( = MATERNAL AGE 35 AND OVER) MNG8.520.769 FXÑPRENATAL CARE; ÑPSEUDOPREGNANCY XUÑPregnancy, Unwanted LH LX; LU  MHÑPregnancy Complications ANpregn in a dis or a dis in pregn; coord IM with dis (IM); do not use /compl /congen /embryol /familial /hist /transm; check tags FEMALE & PREGNANCY; Manual 18.4.7; DF: PREGN COMPL MNC13.703 FXÑObstetrics; ÑPREGNANCY, PROLONGED LH LX;  PM64 HN64 MHÑPregnancy Complications, Cardiovascular ANcoord IM with specific cardiovasc dis (IM); do not use /compl /congen /embryol /familial /hist /transm; check tags FEMALE & PREGNANCY; hemorrh during pregn goes here, not PREGN COMPL HEMATOL; Manual 18.4.7; DF: PREGN COMPL CARDIOVASC MNC13.703.634; C14.583 LH  PM64 HN64 MHÑPregnancy Complications, Hematologic ANfor disord of formed elements or coag processes of blood in pregn, not for excess or defic of substances in the blood (as HYPOKALEMIA + PREGN COMPL, not PREGN COMPL HEMATOL); coord IM with specific hematologic dis (IM); do not use /compl /congen /embryol /familial /hist /transm; check tags FEMALE & PREGNANCY; hemorrh during pregn goes under PREGNANCY COMPL CARDIOVASC, not here; Manual 18.4.7; DF: PREGN COMPL HEMATOL MNC13.703.667; C15.378.785 LH  MSInfections occurring during the course of pregnancy, or pregnancy during the course of an infectious disease. PM64 HN64 MHÑPregnancy Complications, Infectious ANcoord IM with specific infectious dis (IM); do not use /compl /congen /embryol /familial /hist /transm; check tags FEMALE & PREGNANCY; Manual 18.4.7; DF: PREGN COMPL INFECT MNC1.539.674; C13.703.700 LH  MSNeoplasms occurring during the course of pregnancy, or pregnancy during the course of a neoplastic disease. PM83 HN83 MHÑPregnancy Complications, Neoplastic ANcoord IM with specific histol type (IM) + precoord organ/neopl term (IM); do not use /compl /congen /embryol /familial /hist /transm; check tags FEMALE & PREGNANCY; Manual 18.4.7; DF: PREGN COMPL NEOPL PIPregnancy Complications (66-82); specific neoplasms MNC4.850; C13.703.720 LH  MSPregnancy in girls under 19. PM79 HN79 MHÑPregnancy in Adolescence ANpregn as a physiol, social, cultural, psychol probl in adolesc; IM; no qualif; includes pregn in children under 13; check tags HUMAN, FEMALE, PREGNANCY & ADOLESCENCE if 13-18 yrs old or specific child tag if under 13; do not confuse with PREGNANCY (IM) + ADOLESCENCE (NIM) where ADOLESCENCE is picked up as a check tag among other age groups in the article; DF: PREGN IN ADOLESCENCE CATALOG: do not use /in inf; includes childhood & adolescence PIAdolescence (66-78); Pregnancy (66-78) MNG8.520.420.770 XSAdolescent Pregnancy; Pregnancy, Adolescent; Pregnancy, Teenage; Teenage Pregnancy LH LS; ; ;  MHÑPregnancy in Diabetes ANfor also ╥diabetes in pregnancy╙; refers to DIABETES MELLITUS, not DIABETES INSIPIDUS; coord IM with specific diabetes precoord (IM) if pertinent; check tags FEMALE & PREGNANCY; DF: PREGN IN DIABETES MNC13.703.766; C18.452.297.820; C19.246.820 LH  MSPhysiological mechanisms that sustain the state of pregnancy. PM80; was see under PREGNANCY 1975-79 HN80(75); was see under PREGNANCY 1975-79 MHÑPregnancy Maintenance ANonly /drug eff /rad eff; physiol mechanisms sustaining pregn; check tags FEMALE & PREGNANCY; DF: PREGN MAINTENANCE MNG8.520.769.640 LH  MSProteins produced by organs of the mother or the placenta during pregnancy. They may be either pregnancy specific (present only during pregnancy) or pregnancy associated (always present during pregnancy, but may also be present in individuals undergoing estrogen therapy, taking oral contraceptives or in patients with certain malignancies.) PM80 HN80 MHÑPregnancy Proteins ANproteins produced by organs or placenta of pregn females, in small amts in non-pregn females, in women under estrogen ther or taking oral contraceptives or in women with certain cancers; /biosyn /physiol permitted; do not use /analogs; DF: PREGN PROTEINS PIPlacenta (66-79); Placental Hormones (66-79); Pregnancy (66-79); Proteins (66-79); specific protein MND6.472.785; D12.776.780 XSPlacental Proteins XUÑPregnancy Zone Proteins; ÑPregnancy-Associated Alpha Plasma Protein; ÑPregnancy-Associated Beta Plasma Protein; ÑPregnancy-Specific Beta 1-Glycoprotein LH LS LU; ; ;  MSTests to determine whether or not an individual is pregnant. MHÑPregnancy Tests ANonly /econ /instrum /methods /psychol /stand /vet; check tags FEMALE & PREGNANCY; DF: PREGN TESTS MNE1.223.700; E1.249.682 LH  PM73 HN73 MHÑPregnancy Tests, Immunologic ANonly /instrum /methods /stand /vet; check tags FEMALE & PREGNANCY; DF: PREGN TESTS IMMUNOL PIPregnancy Tests (66-72) MNE1.223.495.785; E1.223.700.620; E1.249.682.620 FXÑImmunologic Technics LH LX  MHÑPregnancy Toxemias AN= toxicosis of pregnancy; EPH (Edema, Proteinuria, Hypertension) goes here; check tags FEMALE & PREGNANCY; DF: PREGN TOXEMIAS MNC13.703.799 FXÑToxemia LH LX  MSPeriod of pregnancy from the first day of the last normal menstrual period through the completion of 14 weeks (98 days) of gestation. OLuse PREGNANCY TRIMESTER, FIRST to search PREGNANCY, FIRST TRIMESTER back thru 1975 PM76; was PREGNANCY, FIRST TRIMESTER 1975 HN76; was PREGNANCY, FIRST TRIMESTER 1975 MHÑPregnancy Trimester, First ANhuman only; 14 weeks (98 days); avoid as IM: usually NIM coord; check tags HUMAN & FEMALE & PREGNANCY; DF: PREGN TRIMESTER FIRST PIGestational Age (68-74); Pregnancy (66-74); Time Factors (67-74) MNG8.520.840.408 XSPregnancy, First Trimester; Trimester, First LH LS;  MSPeriod of pregnancy from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. OLuse PREGNANCY TRIMESTER, SECOND to search PREGNANCY, SECOND TRIMESTER back thru 1975 PM76; was PREGNANCY, SECOND TRIMESTER 1975 HN76; was PREGNANCY, SECOND TRIMESTER 1975 MHÑPregnancy Trimester, Second ANhuman only; 15-28 weeks (99-196 days); avoid as IM: usually NIM coord; check tags HUMAN & FEMALE & PREGNANCY; DF: PREGN TRIMESTER SECOND PIGestational Age (68-74); Pregnancy (66-74); Time Factors (67-74) MNG8.520.840.490 XSMidtrimester; Pregnancy, Second Trimester; Trimester, Second LH LS; ;  MSPeriod of pregnancy from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. OLuse PREGNANCY TRIMESTER, THIRD to search PREGNANCY, THIRD TRIMESTER back thru 1975 PM76; was PREGNANCY, THIRD TRIMESTER 1975 HN76; was PREGNANCY, THIRD TRIMESTER 1975 MHÑPregnancy Trimester, Third ANhuman only; 29-42 weeks (197-294 days); avoid as IM: usually NIM coord; check tags HUMAN & FEMALE & PREGNANCY; ╥at term╙: consider better LABOR; DF: PREGN TRIMESTER THIRD PIGestational Age (68-74); Pregnancy (66-74); Time Factors (67-74) MNG8.520.840.520 XSPregnancy, Third Trimester; Trimester, Third LH LS;  OLhuman only; specific trimesters are indexed only when the point of the article or substantively discussed: they are not sought out routinely or indexed when merely mentioned MH*Pregnancy Trimesters (Non Mesh) MNG8.520.840 LH  MSGlycoprotein with the electrophoretic mobility of an alpha 2-globulin. Found in small amounts in normal human plasma but in much larger volume in the plasma of pregnant women. Believed to be of maternal rather than placental origin. Has also been found in increased amounts in individuals undergoing estrogen therapy and is sometimes produced ectopically by tumors of non-placental origin. Synonyms: Alpha-2-pregnoglobulins; new serum alpa-macroglobulins; Xh. HN(80) MHÑPregnancy Zone Proteins AN/biosyn /physiol permitted; do not use /analogs /blood; DF: PREGN ZONE PROTEINS PIAlpha Globulins (66-79); Alpha Macroglobulins (76-79); Blood Proteins (66-79); Glycoproteins (66-79); Pregnancy (66-79) MND6.472.785.760; D12.776.780.760 XSPAAG; Pregnancy-Associated Alpha 2-Globulins; Pregnancy-Associated Alpha 2-Glycoproteins; Pregnancy-Associated Alpha 2-Macroglobulins; SP3 DMÑPregnancy Proteins LH LS; ; ; ; LM  MSAn alpha 2-macroglobulin, molecular weight approximately 750,000. Now believed to be a pregnancy specific protein. Its plasma levels increase steadily during the second trimester and continue to rise until the end of gestation. HN(80) MHÑPregnancy-Associated Alpha Plasma Protein AN/biosyn /physiol permitted; do not use /analogs /blood; DF: use X ref below PIAlpha Globulins (66-79); Alpha Macroglobulins (76-79); Blood Proteins (66-79); Glycoproteins (66-79); Pregnancy (66-79) MND6.472.785.700; D12.776.780.700 XSPAPP-A DMÑPregnancy Proteins LH LS LM  MSA beta globulin. Now believed to be a pregnancy specific protein. Its plasma levels increase steadily during pregnancy until the end of gestation. HN(80) MHÑPregnancy-Associated Beta Plasma Protein AN/biosyn /physiol permitted; do not use /analogs /blood; DF: use X ref below PIBeta Globulins (66-79); Blood Proteins (66-79); Glycoproteins (66-79); Pregnancy (66-79); Serum Globulins (66-79) MND6.472.785.710; D12.776.780.710 XSPAPP-B DMÑPregnancy Proteins LH LS LM  MSA glycoprotein with the electrophoretic mobility of a beta 1 globulin. It is produced by the placental trophoblast and secreted into the maternal bloodstream during pregnancy. It can be detected 18 days after ovulation and its concentration in plasma rises steadily until at the end of gestation it reaches 200 mg/ml. It has been proposed as a measure of placental function, for fertility control and is a candidate for an early pregnancy test. HN(80) MHÑPregnancy-Specific Beta 1-Glycoprotein AN/biosyn /physiol permitted; do not use /analogs /blood; DF: use X ref below PIBeta Globulins (66-79); Blood Proteins (66-79); Glycoproteins (66-79); Pregnancy (66-79); Serum Globulins (66-79) MND6.472.759.730; D6.472.785.730; D12.776.780.730 XSPAPP-C; SP1 DMÑPregnancy Proteins LH LS; LM  MHÑPregnancy, Abdominal ANcheck tags FEMALE & PREGNANCY; DF: PREGN ABDOMINAL MNC13.703.733.536 LH  MHÑPregnancy, Animal ANIM for articles on normal animal pregn but check also tag PREGNANCY; for NIM animal pregnancy do not index PREGNANCY, ANIMAL: merely check tag PREGNANCY; when IM, qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /rad eff; do not use /vet; check tags ANIMAL & FEMALE also; Manual 18.4.6; DF: PREGN ANIMAL MNG8.520.780 FXÑAnimals, Newborn LH LX  MHÑPregnancy, Ectopic ANcheck tags FEMALE & PREGNANCY; heterotopic = PREGNANCY (IM) + PREGNANCY, ECTOPIC or its specifics (IM) + site (NIM); DF: PREGN ECTOPIC MNC13.703.733 LH  MHÑPregnancy, Multiple ANhuman & animal; IM; this is the mother: TWINS, TRIPLETS, etc. is the offspring; specify TWINS, etc. NIM if pertinent; in ref to animals, do not use PREGNANCY, MULTIPLE for animals naturally having litters; consider LITTER SIZE; not for ╥heterotopic pregnancy╙: see note at PREGNANCY, ECTOPIC; only /drug eff /rad eff; check tags FEMALE & PREGNANCY; Manual 28.33, 34.20; DF: PREGN MULTIPLE MNG8.520.800 LH  MHÑPregnancy, Prolonged ANIM; qualif permitted: see note at PREGNANCY above; check tags FEMALE & PREGNANCY; DF: PREGN PROLONGED MNG8.520.769.689 FXÑPregnancy Complications LH LX  MHÑPregnancy, Tubal ANcheck tags FEMALE & PREGNANCY; DF: PREGN TUBAL MNC13.703.733.703 LH  HN(73) MHÑPregnancy, Unwanted ANno qualif; unplanned pregnancy = PREGNANCY, not PREGNANCY, UNWANTED; check tags HUMAN & FEMALE & PREGNANCY; DF: PREGN UNWANTED PIPregnancy (66-72) MNG8.520.850 DMÑPregnancy LH LM  MHÑPregnanediol AN/biosyn /physiol permitted RN26445-07-8 MND4.808.745.495; D6.472.798.470 LH  PM74 HN74 MHÑPregnanediones ANdo not use /analogs MND4.808.745.558 XSDIKETOPREGNANES LH LS  PM68 HN68 MHÑPregnanes ANdo not confuse with PREGNENES; do not use /analogs /physiol MND4.808.745 XUÑPregnanolone LH LU  PM66 HN66(64) MHÑPregnanetriol ANdo not use /biosyn /defic /physiol RN27178-64-9 MND4.808.745.620; D6.472.798.570 LH  MS3 alpha-Hydroxy-5 beta-pregnan-20-one. A pregnane found in urine of pregnant women and sows and having properties as an anesthetic and a hypnotic and sedative. HN(75) MHÑPregnanolone ANdo not confuse with PREGNENOLONE; do not use /biosyn /defic /physiol; /analogs NIM only RN128-20-1 PIHydroxysteroids (72-74); Ketosteroids (72-74); Pregnanes (69-74) MND4.808.745.640 DMÑPregnanes LH LM  PM73 HN73 MHÑPregnatrienes ANdo not use /analogs /physiol PIPregnanes (66-72) MND4.808.745.683 LH  PM74 HN74 MHÑPregnenediones ANdo not use /analogs MND4.808.745.745.654 XSDIKETOPREGNENES XUÑCronolone; ÑHalcinonide LH LS LU;  PM73 HN73 MHÑPregnenes ANdo not confuse with PREGNANES; do not use /analogs /physiol PIPregnanes (66-72) MND4.808.745.745 LH  MHÑPregnenolone ANdo not confuse with PREGNANOLONE; /biosyn /physiol permitted RN145-13-1 MND4.808.745.745.725; D6.472.40.322.478.745; D6.472.798.670 LH  PM74 HN74 MHÑPregnenolone Carbonitrile ANdo not use /biosyn /defic /physiol; DF: PCN RN1434-54-4 MND2.626.745; D4.808.183.620; D4.808.745.745.725.703; D6.597.225.620 LH  MSThe time period between fertilization and implantation. OLuse PREIMPLANTATION PHASE to search PRENIDATION PHASE & PRENIDATION PHASE, ANIMAL back thru 1975 PM85; was PRENIDATION PHASE 1980-84, was PRENIDATION PHASE see under PREGNANCY TRIMESTER, FIRST 1976-79, was PRENIDATION PHASE see under PREGNANCY, FIRST TRIMESTER 1975; PRENIDATION PHASE, ANIMAL was see under PREGNANCY, ANIMAL 1975-79 HN85; was PRENIDATION PHASE 1980-84, was PRENIDATION PHASE see under PREGNANCY TRIMESTER, FIRST 1976-79, was PRENIDATION PHASE see under PREGNANCY, FIRST TRIMESTER 1975; PRENIDATION PHASE, ANIMAL was see under PREGNANCY, ANIMAL 1975-79 MHÑPreimplantation Phase ANhuman & animal; only /drug eff /rad eff; check tags HUMAN or ANIMAL & FEMALE & PREGNANCY PIBlastocyst (74); Embryo (66-74); Mammals/EM (66-74); specific mammal/EM (66-74); Ovum Implantation (66-74); Ovum (66-74) MNG8.520.500.690 XSPrenidation Phase FXÑBlastocyst LH LS LX  MSA preconceived judgment made without adequate evidence and not easily alterable by presentation of contrary evidence. MHÑPrejudice ANno qualif MNF1.829.595 XSSocial Discrimination LH LS  MSA plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein was found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin or plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease. HN(76) MHÑPrekallikrein ANonly /anal /biosyn /genet /immunol /isol /physiol /rad eff RN9055-02-1 PIBlood Coagulation Factors (73-75); Enzyme Precursors (73-75); Kallikrein (73-75) MND8.444.675; D12.776.124.125.550.800; D19.461.270.229.533.731 XSFletcher Factor DMÑKallikrein LH LS LM  MSConditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria. PM77 HN77 MHÑPreleukemia ANdo not use /compl for develop into leukemia MNC4.834.770; C15.378.800 LH  OLsearch ESTROGENIC SUBSTANCES, CONJUGATED 1973-74 HN(75) MHÑPremarin ANdo not use /analogs /defic /physiol MND6.472.265.465.621; D6.472.866.540.465.621 DMÑEstrogenic Substances, Conjugated LH LM  MHÑPremarital Examinations ANonly /econ /methods /psychol /stand /trends MNE1.774 LH  PM73 HN73(69) MHÑPremedication AN/vet permitted; includes preop use of antibiotics for prev of infect: coord IM with antibiotic /ther use (IM) & do not index under PREOPERATIVE CARE PIspecific drug/TU (66-68) MNE2.319.703 FXÑPREANESTHETIC MEDICATION LH LX  MSA syndrome occurring most often during the last week of the menstrual cycle and ending soon after the onset of menses. Some of the symptoms are emotional instability, insomnia, headache, nausea, vomiting, abdominal distension, and painful breasts. OLuse PREMENSTRUAL SYNDROME to search PREMENSTRUAL TENSION back thru 1966 PM86; was PREMENSTRUAL TENSION 1963-85 HN86; was PREMENSTRUAL TENSION 1963-85 MHÑPremenstrual Syndrome MNC13.371.491.771 LH  MS1-(4-Hydroxyphenoxy)-3-(isopropylamino)-2- propanol. A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. The drug has also shown beta blocking activity with pronounced intrinsic sympathomimetic activity. It is effective in the treatment of acute cardiac failure, postmyocardial infarction low-output syndrome, and in reducing orthostatic hypotension in the Shy-Drager syndrome. PM87 HN87 MHÑPrenalterol ANdo not use /biosyn /defic /physiol RN57526-81-5 PIPractolol/analogs and derivatives (75-86); Propylamines (66-74) MND2.33.329.624.800; D2.92.63.624.800; D16.893.116.348.758; D18.222.863.758 LH  MSCare provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality. MHÑPrenatal Care ANonly /econ /legis /methods /organ /psychol /stand /trends /vet; check tags FEMALE & PREGNANCY MNE2.472.786; N2.421.143.620.704 FXÑPerinatology; ÑPregnancy LH LX;  PM73 HN73 MHÑPrenatal Diagnosis ANonly /econ /instrum /methods /trends /vet; check tags FEMALE & PREGNANCY; if a fetal dis is discussed, coord IM with FETAL DISEASES (IM) or FETAL DISEASES (IM) + specific fetal dis (IM) PIAmniocentesis (71-72); specific disease or abnormality/DI (66-72) MNE1.249.746 XSDiagnosis, Prenatal; INTRAUTERINE DIAGNOSIS FXÑGenetic Counseling XUÑFetoscopy LH LS; LX LU  MSDelayed effects on offspring of maternal or fetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc. OLsearch PRENATAL INFLUENCES under PREGNANCY 1966-72 PM82; PRENATAL INFLUENCES was heading 1963-72 HN82; PRENATAL INFLUENCES was heading 1963-72 MHÑPrenatal Exposure Delayed Effects ANrestrict to maternal & fetal: do not use for paternal (index probably under FATHERS (NIM); includes prenatal exposure to ╥drugs, radiation & other phys agents, manipulation, nutrition, stress, etc.╙; IM; no qualif; check tags FEMALE & PREGNANCY MNG8.520.860 LH  MS4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione. Anti-inflammatory pyrazole derivative. Synonyms: DA 2370; Zepelin. HN(75) MHÑPrenazone AND25-26 qualif RN30748-29-9 PIAlkenes (74); Pyrazoles (72-74); Terpenes (72-74) MND3.383.694.700.670; D14.73.278.152.684.600; D26.74.75.204.684.600 XSFenilprenazone; Feprazone; Phenylprenazone DMÑPhenylbutazone LH LS; ; LM  PM66; was SEGONTIN 1963-65 HN66; was SEGONTIN 1963-65 MHÑPrenylamine ANdo not use /biosyn /defic /physiol RN390-64-7 MND2.92.471.683.825; D18.192.786; D18.918.786 LH  MHÑPreoperative Care ANonly /econ /methods /psychol /stand /trends /vet; preop use of antibiotics for prev of infect: index under PREMEDICATION (IM) + antibiotic /ther use (IM) & not here; DF: PREOP CARE MNE4.641 LH  MSRegion of hypothalamus between the anterior commissure and optic chiasm. PM83; was see under HYPOTHALAMUS 1975-82 HN83(75); was see under HYPOTHALAMUS 1975-82 MHÑPreoptic Area ANdo not use /innerv MNA8.186.211.385.357.342.450 LH  MSCatalyzes the conversion of prephenate to phenylpyruvate with the elimination of water and carbon dioxide. In the enteric bacteria this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of phenylalanine. HN(75) MHÑPrephenate Dehydratase ANdo not use /analogs RNEC 4.2.1.51 PICyclohexanes (70-74); Hydro-Lyases (70-74); Pyruvates (70-74) MND8.586.399.685; D8.586.520.497.655 XSChorismate Mutase-Prephenate Dehydratase; Prephenate Hydro-lyase DMÑHydro-Lyases LH LS; LM  MSCatalyzes the conversion of phenate to p-hydroxyphenylpyruvate in the presence of NAD. In the enteric bacteria, this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of tyrosine. HN(75) MHÑPrephenate Dehydrogenase ANdo not use /analogs RNEC 1.3.1.12 PICyclohexanes (72-74); Oxidoreductases (72-74); Pyruvates (72-74) MND8.586.399.700; D8.586.682.770 XSChorismate Mutase-Prephenate Dehydrogenase DMÑOxidoreductases LH LS LM  MSProgressive bilateral loss of hearing that occurs in the aged. Syn: senile deafness. HN(72); was see under DEAFNESS 1975-78 MHÑPresbycusis PIDeafness (66-71) MNC9.218.458.500.481.772 DMÑHearing Loss, Sensorineural LH LM  MHÑPresbyopia MNC11.744.786 LH  OLsearch FEES, PHARMACEUTICAL 1968-74 HN(75) MHÑPrescription Fees ANonly /class /hist /legis /stand /trends MNN3.219.442.551.621 XSDispensing Fees DMÑFees, Pharmaceutical LH LS LM  MSDirections written for the preparation and adminstration of a drug. OLuse PRESCRIPTIONS, DRUG to search PRESCRIPTIONS 1966-77 PM78; was PRESCRIPTIONS 1963-77 HN78; was PRESCRIPTIONS 1963-77 MHÑPrescriptions, Drug ANonly /econ /hist /stand /vet; do not confuse the concept of ╥prescription╙ with the drug prescribed; probably GEN only, irrespective of specific drug prescribed ( = probably /admin & dosage); do not confuse with DRUG COMPOUNDING: prescribing is by the MD, cpding is by the pharmacist or drug co.; drug formulation is CHEMISTRY, PHARMACEUTICAL MNE2.319.720 FXÑPharmacy LH LX  MSWritten directions for preparation and/or administration/application of a non-drug remedy. Includes prescriptions for corrective lenses, self-help and orthopedic devices, and physical therapy and rehabilitation measures. PM78 HN78 MHÑPrescriptions, Non-Drug ANonly /econ /hist /stand /vet PIEyeglasses (66-77); Orthopedic Equipment (66-77); Orthotic Devices (72-74); Prescriptions (66-77) MNE2.790 LH  PM67 HN67(64) MHÑPreservation, Biological ANonly /instrum /methods /stand /vet; BLOOD PRESERVATION, ORGAN PRESERVATION and TISSUE PRESERVATION are also available; cryopreservation: coord IM with FREEZING (NIM) MNE5.760 FXÑBuffers; ÑCryoprotective Agents; ÑFixatives LH LX; ;  MSSubstances added to pharmaceutical preparations to protect them from chemical change or microbial action; includes antibiotics and antioxidants. OLsearch PHARMACEUTIC AIDS 1968-74 HN(75) MHÑPreservatives, Pharmaceutical AND25-26 qualif PIPharmaceutic Aids (68-74); Pharmacy (66-67) MND26.698.771 DMÑPharmaceutic Aids LH LM  PM65 HN65 MHÑPressoreceptors ANdo not use /innerv MNA8.99.893.814.621; A8.796.511.725.684 XSBARORECEPTORS FXÑCarotid Sinus LH LS LX  PM68 HN68(64) MHÑPressure ANNIM; only /adv eff; spinal or cerebrospinal fluid pressure = INTRACRANIAL PRESSURE MNH1.671.691 FXÑAtmospheric Pressure; ÑBlood Pressure; ÑManometry XUÑHydrostatic Pressure LH LX; ; LU  MSThe branch of dentistry concerned with the prevention of disease and the maintenance and promotion of oral health. PM65 HN65 MHÑPreventive Dentistry ANSPEC only: SPEC qualif; spec concerned with prev of tooth & mouth dis: do not confuse with TOOTH DISEASES /prev or MOUTH DISEASES /prev; see note under DENTAL CARE; for ╥see your dentist twice a year╙; do not confuse with DENTAL PROPHYLAXIS (see note there) or ORAL HYGIENE (see note there) MNE6.761; G2.163.721; G3.700 FXÑDental Clinics; ÑHealth Education, Dental LH LX;  MSServices designed for promotion of health and prevention of disease. PM68 HN68 MHÑPreventive Health Services ANonly /class /econ /hist /legis /man /organ /stand /supply /trends /util; HEALTH PROMOTION is also available CATALOG: /geog /form PIspecific disease/PC (66-67) MNN2.421.143.827; N2.421.726 FXÑImmunization LH LX  MSA medical specialty primarily concerned with prevention of disease and the promotion and preservation of health in the individual. MHÑPreventive Medicine ANSPEC only: SPEC qualif; for specific disease, use /prev: Manual 19.5+; HEALTH PROMOTION is also available; primary prev = PRIMARY PREVENTION, secondary prev = diag & ther, tertiary prev = REHABILITATION MNG2.403.790.548; G3.770 LH  MSA discipline concerned with the prevention of mental illness and the promotion of mental health. OLsearch COMMUNITY PSYCHIATRY 1973-74 HN(75); was see under PSYCHIATRY, COMMUNITY 1973-79 MHÑPreventive Psychiatry ANSPEC: SPEC qualif; do not confuse with MENTAL DISORDERS /prev or specific ment disor /prev or with MENTAL HEALTH MNF4.96.544.215.508; G2.403.642.150.580 DMÑCommunity Psychiatry LH LM  MHÑPriapism MNC12.294.494.786 LH  PM68 HN68(67) MHÑPrilocaine ANdo not use /biosyn /defic /physiol RN721-50-6 PIAnesthetics, Local (66) MND2.65.199.750; D14.211.756 XSPROPITOCAINE LH LS  MHÑPrimaquine ANdo not use /biosyn /defic /physiol RN90-34-6 MND21.370.286.572 LH  MSCare which provides basic health maintenance and therapeutic services, and coordination of all needed consultant and community services. PM74; CONTINUITY OF PATIENT CARE was see under COMPREHENSIVE HEALTH CARE 1968-78 HN74(72) MHÑPrimary Health Care ANonly /econ /hist /legis /man /methods /organ /stand /trends PIComprehensive Health Care (68-71) MNN4.590.233.727 XUÑContinuity of Patient Care LH LU  MSThe primary responsibility of one nurse for the planning, evaluation and care of a patient throughout the course of illness, convalescence and recovery. PM77 HN77 MHÑPrimary Nursing Care ANonly /econ /hist /legis /man /methods /organ /stand /trends PINursing Care (74-76); Primary Health Care (74-76) MNN2.421.533.760 LH  MSPrevention of disease or mental disorders in susceptible individuals or populations through promotion of health, including mental health, and specific protection, as in immunization, as distinguished from the prevention of complications or after-effects of existing disease. PM79 HN79 MHÑPrimary Prevention ANonly /econ /educ /hist /instrum /man /methods /stand /trends /util (if by MeSH definition) PIPreventive Health Services (68-78); Preventive Medicine (66-78); specific disease/PI MNF4.96.544.215.508.428; G3.770.670 XSPrevention, Primary LH LS  MHÑPrimates ANGEN only; see Tree; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; only human primate is Hominidae: see note on ANTHROPOIDEA MNB2.649.801 LH  MHÑPrimidone ANdo not use /biosyn /defic /physiol RN125-33-7 MND3.383.742.698.253.650.700; D14.261.649 XSDesoxyphenobarbital; Primaclone LH LS;  MHÑPrince Edward Island MNZ1.107.567.176.732 LH  MHÑPrinters' Marks ANonly /hist MNL1.178.682.192.122.622 LH  PMLITHOGRAPHY was heading 1963-65 HNLITHOGRAPHY was heading 1963-65 MHÑPrinting ANonly /econ /hist /man /methods /stand /trends CATALOG: /geog /form MNL1.737.787 FXÑEngraving and Engravings LH LX  MSSmall proteinaceous infective particles which cause SCRAPIE and JAKOB-CREUTZFELDT SYNDROME. PM86 HN86 MHÑPrions AN╥small proteinaceous infective particles which cause SCRAPIE & JAKOB-CREUTZFELDT SYNDROME╙; do not use /blood-csf-urine /cytol PIScrapie Prion (66-85); Viral Proteins (66-85) MNB4.775 LH  PM74 HN74(73) MHÑPrisoners ANonly /psychol; differentiate from CRIMINAL PSYCHOLOGY; hostages go here & add VIOLENCE only if particularly discussed PIPrisons (66-72) MNM1.729 LH  MSPenal institutions, or places of confinement for war prisoners. MHÑPrisons ANonly /class /hist /legis /stand CATALOG: /geog /form MNI1.880.604.787 XUÑConcentration Camps LH LU  MSPractice of a health profession by an individual, offering services on a person to person basis, as opposed to group or partnership practice. PM73 HN73(69) MHÑPrivate Practice ANonly /econ /man /organ /stand /trends /util (if by MeSH definition) PIDentistry (66-68); Dietetics (66-68); Family Practice (66-68); General Practice, Dental (67-68); Medicine (66-68); Office Management (66-68); Pediatrics (66-68); Physical Therapy (66-68); Professional Practice (68); Psychology, Clinical (66-68); specific discipline; specific specialty MNN4.452.758.745 LH  MSA precursor protein, MW 30,000, synthesized mainly in the anterior pituitary gland but also found in the hypothalamus, brain, and several peripheral tissues. It incorporates the amino acid sequences of ACTH and beta-lipotropin. These two hormones, in turn, contain the biologically active peptides MSH, corticotropin-like intermediate lobe peptide, alpha-lipotropin, endorphins, and methionine enkephalin. PM85 HN85 MHÑPro-Opiomelanocortin AN/biosyn /physiol permitted RN66796-54-1 PIPituitary Hormones, Anterior (66-84); Protein Precursors (73-84) MND6.472.734.525.690; D12.776.811.730 XSPOMC; Pro-Opiocortin LH LS;  MSThe state or process hypothesized to account for poorer learning rate of elements later in a series as compared to the learning rate of elements coming earlier in a series. OLsearch INHIBITION (PSYCHOLOGY) 1971-74 HN(75) MHÑProactive Inhibition ANno qualif MNF1.145.544.538; F2.463.425.475.538 DMÑInhibition (Psychology) LH LM  PM66 HN66(64) MHÑProadifen AND25-26 qualif RN302-33-0 MND2.241.81.944.550; D26.734 XSPropyladiphenin; SKF 525-A LH LS;  MSThe study of chance processes, or a relative frequency characterizing a chance process. OLuse PROBABILITY to search POISSON DISTRIBUTION back thru 1969 PM68 HN68(64); POISSON DISTRIBUTION was see under PROBABILITY 1969-78 MHÑProbability ANIM for probability as a statist concept; NIM as coord for relative frequency of occur of specific dis, physiol response, etc.; see note under RISK MNH1.548.832.672 XSPoisson Distribution XUÑBayes Theorem; ÑMarkov Chains; ÑRisk; ÑStochastic Processes LH LS LU; ; ;  MSUsually refers to the use of mathematical models in the prediction of learning to perform tasks based on the theory of probability applied to responses; it may also refer to the frequency of occurrence of the responses observed in the particular study. PM69 HN69(66) MHÑProbability Learning ANno qualif MNF2.463.425.701 FXÑModels, Psychological LH LX  OLsearch OPERATIONS RESEARCH 1966-74 HN(75) MHÑProbability Theory ANno qualif MNL1.906.575.622 DMÑOperations Research LH LM  MHÑProbenecid ANdo not use /biosyn /defic /physiol RN57-66-9 MND2.65.884.625; D2.886.590.700.625; D14.73.278.398.946.751; D19.770.750; D26.74.75.574.946.751 XSProbecid LH LS  MSA learning situation involving more than one alternative from which a selection is made in order to attain a specific goal. MHÑProblem Solving ANhuman & animal; only /drug eff /physiol /rad eff MNF2.463.425.725; F2.463.785.810 FXÑGame Theory LH LX  HN(73) MHÑProbucol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23288-49-5 PIAnticholesteremic Agents (66-72); Phenols (66-72) MND2.755.746; D10.162.202.747 DMÑPhenols LH LM  MS4-Amino-N-[2-(diethylamino)ethyl]benzamide. Derivative of procaine with less CNS action; used in cardiac arrhythmias. Synonyms: Novocainamid(e); Novocamid(e); Procamid(e); Procardyl; Pronestyl; Supicain(e) Amid(e). OLuse PROCAINAMIDE to search PROCAINE AMIDE back thru 1966 PM79; was PROCAINE AMIDE 1963-78 HN79; was PROCAINE AMIDE 1963-78 MHÑProcainamide ANdo not use /biosyn /defic /physiol RN51-06-9 MND2.241.223.106.61.75.690; D18.97.622 XSProcaine Amide XUÑAcetylprocainamide LH LS LU  MHÑProcaine ANdo not use /biosyn /defic /physiol; Novocaine goes here RN59-46-1 MND2.241.223.106.61.75.700; D14.211.785 LH  PM74 HN74(71) MHÑProcarbazine ANdo not use /biosyn /defic /physiol RN671-16-9 PIAntineoplastic Agents (66-70); Benzoates (66-70) MND2.65.277.727; D2.241.223.106.162.727; D22.204.727; D26.191.755 LH  MS2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropionic acid-1-methylethyl ester. An antilipemic agent which reduces both cholesterol and triglycerides in the blood. Synonyms: LF 178; Lipantyl. HN(80) MHÑProcetofen ANdo not use /biosyn /defic /physiol; /analogs NIM only RN49562-28-9 PIAntilipemic Agents (66-79); Propionates (66-79) MND2.241.81.751.650; D10.162.700 XSLipanthyl DMÑPropionates LH LS LM  MHÑProchlorperazine ANdo not use /biosyn /defic /physiol RN58-38-8 MND3.494.741.639; D15.236.872.331.628.642 LH  MSA biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal ends of the three polypeptide chains. Protocollagen, a precursor of procollagen consists of procollagen peptide chains in which proline and lysine have not yet been hydroxylated. PM77 HN77 MHÑProcollagen AN/biosyn /physiol permitted PICollagen (66-76); Protein Precursors (73-76) MND12.776.811.690; D12.776.860.177.600 XSProtocollagen LH LS  MSAn extracellular endopeptidase which excises a block of peptides at the amino terminal, nonhelical region of the procollagen molecule with the formation of collagen. Absence or deficiency of the enzyme causes accumulation of procollagen which results in the inherited connective tissue disorder--dermatosparaxis. EC 3.4.99.-. HN(77) MHÑProcollagen Peptidase ANdo not use /analogs RNEC 3.4.99.- PICollagen (66-76); Peptide Peptidohydrolases (66-76); Protein Precursors (73-76) MND8.586.277.656.732.660 DMÑPeptide Peptidohydrolases LH LM  MHÑProctitis MNC6.405.469.860.622 LH  MSInflammation of the rectum and colon. OLto search RECTOCOLITIS use PROCTOCOLITIS back thru 1975 & COLITIS 1966-74 HN(80); was RECTOCOLITIS see under COLITIS 1963-79 MHÑProctocolitis ANnote X ref RECTOCOLITIS but available also are RECTOCOLITIS, HEMORRHAGIC see COLITIS, ULCERATIVE & RECTOCOLITIS, ULCERATIVE see COLITIS, ULCERATIVE MNC6.405.469.158.188.767; C6.405.469.158.850.790; C6.405.469.860.622.790 XSProctosigmoiditis; Rectocolitis; Rectosigmoiditis DMÑColitis LH LS; ; LM  MSEndoscopic examination of the rectum. MHÑProctoscopy ANNIM; do not use /util except by MeSH definition MNE1.184.705; E1.418.790 LH  HN(66) MHÑProcyclidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN77-37-2 MND3.383.773.728; D16.653.763 DMÑPyrrolidines LH LM  MS4-Methoxy-5-[(5-methyl-4-pentyl-2H-pyrrol-2-ylidene) methyl]2,2'-bi-1H-pyrrole. A toxic, bright red tripyrrole pigment from Serratia marcescens and others; has antibacterial, anticoccidial, antimalarial and antifungal activities, but used mainly as biochemical tool. PM73 HN73(63) MHÑProdigiosin AN/biosyn permitted if by micro-organism; do not use /defic /physiol; do not confuse with PRODIGIOZAN RN82-89-3 MND3.383.757.748; D11.557.778; D20.85.690 LH  MSA bacterial polysaccharide isolated from Serratia marcescens and other bacteria. It is used in the treatment of a variety of bacterial and viral infections. HN(79) MHÑProdigiozan ANdo not use /defic /physiol; /analogs NIM only; do not confuse with PRODIGIOSIN RN9057-00-5 PIPolysaccharides, Bacterial (66-78); Prodigiosin (66-78) MND9.203.698.718.650; D20.85.698 DMÑPolysaccharides, Bacterial LH LM  MSUse of written, printed, or graphic materials upon or accompanying a product or its container or wrapper. Includes purpose, effect, description, directions, hazards, warnings, and other relevant information. PM79 HN79 MHÑProduct Labeling ANonly /econ /methods /stand /trends MNE5.780; J1.790 XSLabeling, Product; Package Inserts LH LS;  MSSurveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale. HN(83) MHÑProduct Surveillance, Postmarketing ANnot restricted to drugs; only /methods /stand /trends PIClinical Trials (66-82); Drug Therapy (66-82); specific drug/AE (66-82) MNE5.337.800 XSDrug Surveillance, Postmarketing; Postmarketing Product Surveillance DMÑEvaluation Studies LH LS; LM  MSPhase of the estrous cycle preceding estrus during which the Graafian follicle undergoes maturation. Applies to animals. HN(75) MHÑProestrus ANanimal only; qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /rad eff MNG8.520.780.218.468 DMÑEstrus LH LM  MSm-(1-Methyl-3-propyl-3-pyrrolidinyl)phenol hydrochloride. Synthetic narcotic that acts like pentazocine, but with a sharp onset and short duration of action; used as an analgesic. Synonyms: A 2205; CI 572. HN(76) MHÑProfadol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN428-37-5 PIPhenols (70-75); Pyrrolidines (72-75) MND3.383.773.760; D14.73.153.802 DMÑPyrrolidines LH LM  MSThe capability to perform the duties of one's profession generally, or to perform a particular professional task, with skill of an acceptable quality. PM79 HN79 MHÑProfessional Competence ANonly /legis /stand; competence in any profession or discipline: differentiate from CLINICAL COMPETENCE which is restricted to competence in professional activities directly related to patient care MNI2.399.630 XSCompetence, Professional LH LS  MSLegally authorized corporations owned and managed by one or more professionals (medical, dental, legal) in which the income is ascribed primarily to the professional activities of the owners or stockholders. HN(79) MHÑProfessional Corporations ANonly /class /econ /hist /legis /organ /stand /trends /util (if by MeSH definition); coord IM with PRACTICE MANAGEMENT, MEDICAL or PRACTICE MANAGEMENT, DENTAL (IM) for med or dent profess corp PIPractice Management, Dental (68-78); Practice Management, Medical (68-78); Professional Practice (68-78) MNN4.452.758.760 XSCorporate Practice DMÑProfessional Practice LH LS LM  MSThe inability of a health professional to provide proper professional care of patients due to his or her physical and/or mental disability. PM86 HN86 MHÑProfessional Impairment ANonly /legis PIAlcoholism (66-85); Substance Dependence (81-85) MNI1.880.604.583.524.528; N3.706.535.606.528 LH  MSUse for articles concerning professional activities related to health care in general or for which there is no specific heading. PM68 HN68 MHÑProfessional Practice ANonly /class /hist /legis /organ /stand /trends; /econ permitted but consider many specific economics terms available; PRACTICE MANAGEMENT, MEDICAL & PRACTICE MANAGEMENT, DENTAL are also available; do not confuse with PHYSICIAN'S PRACTICE PATTERNS: see note there PIOffice Management (66-67) MNN4.452.758 XUÑProfessional Corporations; ÑProfessional Practice Location LH LU;  MSGeographic area in which a professional person practices; includes primarily physicians and dentists. HN(83) MHÑProfessional Practice Location ANonly /econ /trends MNN4.452.758.772 DMÑProfessional Practice LH LM  MSOrganizations representing designated geographic areas which have contracts under the PRO program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by Medicare beneficiaries. Peer Review Improvement Act, PL 97-248, 1982. Synonym: PRO OLuse PROFESSIONAL REVIEW ORGANIZATIONS to search PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85 & PSRO 1973 (as Prov) PM86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85 HN86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85, was PSRO 1973 (Prov) MHÑProfessional Review Organizations ANdo not use /educ /util (except by MeSH definition) MNN4.761.673 XSPRO Professional Review Organizations; PSRO; Peer Review Organizations; Professional Standards Review Organizations; Utilization and Quality Control Peer Review Organizations LH LS; ; ; ;  MSCommittees of professional personnel, who have responsibility for determining policies, procedures, and controls related to professional matters in health facilities. PM68 HN68 MHÑProfessional Staff Committees ANonly /econ /hist /legis /organ /stand /trends /util PIHospital Administration (66-67); Hospitals (66-67) MNN4.452.758.788 XSInstitutional Review Board FXÑHospital Administration; ÑQuality of Health Care; ÑUTILIZATION REVIEW LH LS LX; ;  MSThe interactions between the professional person and the family. PM76 HN76 MHÑProfessional-Family Relations ANno qualif PIFamily (66-75) MNF1.829.401.550 LH  MSInteractions between health personnel and patients. PM68 HN68 MHÑProfessional-Patient Relations ANno qualif PIInterpersonal Relations (66-67) MNF1.829.401.650 FXÑTruth Disclosure LH LX  MS3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings. Synonyms: Isoflav. HN(75) MHÑProflavine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN92-62-6 PIAcridines (69-74); Diamines (74) MND3.494.46.250.720; D20.187.750 DMÑAcridines LH LM  MHÑProgeria MNC5.116.99.343.773; C5.116.132.799; C19.753 XSHutchinson-Gilford Syndrome LH LS  MHÑProgestational Hormones AN/biosyn /physiol permitted; do not use /analogs; /chem syn permitted: do not convert to PROGESTATIONAL HORMONES, SYNTHETIC MND6.472.798; D7.360.276.210.277.706 XSProgestins LH LS  MSCompounds obtained by chemical synthesis which possess progestational activity, but differ in structure from naturally occurring progestational hormones. PM75 HN75 MHÑProgestational Hormones, Synthetic ANdo not use /analogs /biosyn /defic /physiol; do not confuse with PROGESTATIONAL HORMONES /chem syn; DF: PROGESTATIONAL HORMONES SYN PIProgestational Hormones (66-74) MND6.597.799; D7.360.276.210.443.706 XSProgestational Hormone Analogs; Progestin Analogs; Progestins, Synthetic LH LS; ;  MHÑProgesterone AN/biosyn /physiol permitted RN57-83-0 MND4.808.745.745.654.829; D6.472.798.773; D6.472.866.362.623 XUÑDihydroprogesterone LH LU  MS3 Beta-Hydroxy-delta 5-steroid:NAD+ 3-oxidoreductase. Catalyzes the reduction of a 3 beta-hydroxy-delta 5-steroid to 3-oxo-delta 4-steroid in the presence of NAD. Converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione. HN(75) MHÑProgesterone Reductase ANdo not use /analogs RNEC 1.1.1.145 PIHydroxysteroid Dehydrogenases (72-74) MND8.586.682.47.436.350.700 XS3-Beta-Hydroxy-Delta-5-Steroid Dehydrogenase DMÑ3-Hydroxysteroid Dehydrogenases LH LS LM  MSA glycoprotein migrating as alpha 1 globulin. Molecular weight 70,000 to 120,000. The protein, which is present in increased amounts in the plasma during pregnancy, binds mainly progesterone, with other steroids including testosterone competing weakly. HN(77) MHÑProgesterone-Binding Globulin AN/biosyn /physiol permitted; /analogs NIM only PIAlpha Globulins (74-76); Progesterone (74-76); Serum Globulins (74-76) MND12.776.124.790.106.740; D12.776.377.715.85.740 XSTransprogestin DMÑAlpha Globulins LH LS LM  MS4-Benzamido-N,N-dipropylglutaramic acid. Exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. Frequently used synonym: Milid. HN(75) MHÑProglumide ANdo not use /biosyn /defic /physiol RN6620-60-6 PIBenzamides (74); Glutamine (72-74) MND12.125.119.574.700; D19.316.203.764 XSXylamide DMÑGlutamine LH LS LM  MHÑPrognathism ANdo not use /congen; consider also MALOCCLUSION, ANGLE CLASS III MNC16.131.621.514.705 FXÑMalocclusion LH LX  MHÑPrognosis ANalmost never IM; IM only when GEN; NIM with progn of specific dis (IM); despite categ, do not restrict to diagnosis: progn after surg is PROGNOSIS (NIM); no qualif MNE1.789 LH  MSA teaching method which employs self-instructional programs enabling the student to learn at his own pace. Teaching machines or programmed textbooks may be used. PM66 HN66 MHÑProgrammed Instruction ANonly /econ /methods /stand /trends MNI2.903.573 XSPROGRAMMED LEARNING; Self-Instruction Programs; Textbooks, Programmed LH LS; ;  MSSpecific languages used to prepare computer programs. PM87 HN87 MHÑProgramming Languages ANIM; no qualif; ARGUS, FORTRAN, COBOL, MAP, FAP, ALGOL, etc. go here MNL1.700.568.810.780 LH  MSA technic of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimized, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. Do not confuse with computer programming, although problems using linear programming technics may be programmed on a computer. OLsearch OPERATIONS RESEARCH 1969-74 & OPERATIONS RESEARCH & PROGRAMMED INSTRUCTION 1966-68 HN(75); was see under OPERATIONS RESEARCH & PROGRAMMED INSTRUCTION 1966-68 MHÑProgramming, Linear ANno qualif MNL1.906.575.748 DMÑOperations Research LH LM  MSOrganization of medical and nursing care according to the degree of illness and care requirements in the hospital; the elements are intensive care, intermediate care, self-care, long-term care, and organized home care. PM66 HN66(64) MHÑProgressive Patient Care ANonly /econ /hist /legis /man /methods /organ /stand /trends MNN4.590.233.799 LH  PM72 HN72 MHÑProinsulin AN/biosyn /physiol permitted; do not use /analogs RN9035-68-1 PIInsulin (66-71) MND6.472.610.575.788; D12.776.811.706 LH  MSA defense mechanism, operating unconsciously, whereby that which is emotionally unacceptable in the self is rejected and attributed (projected) to others. PM69 HN69 MHÑProjection ANno qualif PIDefense Mechanisms (66-68) MNF1.393.693; F3.407.693 LH  MSTechnics whereby personality attributes are revealed through the subject's responses to relatively unstructured, ambiguous or vague stimuli. These responses represent projections of the subject's own fears and needs. MHÑProjective Technics ANonly /class /hist /instrum CATALOG: do not use /laboratory manuals MNF4.711.647.622 XUÑRosenzweig Picture-Frustration Study; ÑSzondi Test LH LU;  MSCells, such as those of bacteria and the blue green algae, which lack a nuclear membrane so that the nuclear material is either scattered in the cytoplasm or collected in a nucleoid region. HN(78) MHÑProkaryotic Cells ANGEN: prefer BACTERIA or specific bact or ALGAE, BLUE-GREEN; A 11 qualif with discretion PIappropriate cell, organism, subcellular fraction, or process MNA11.760 DMÑCells LH LM  MHÑProlactin AN/biosyn /physiol permitted; /blood: consider also HYPERPROLACTINEMIA; prolactinoma: index under PROLACTIN /secret (IM) + PITUITARY NEOPLASMS /secret (IM) RN9002-62-4 MND6.472.351.576.773; D6.472.734.525.343.773; D12.776.641.650.670 XSLactogenic Hormone, Pituitary; Mammotropic Hormone, Pituitary; Mammotropin LH LS; ;  MSA polypeptide hormone produced in the hypothalamus which inhibits the release of prolactin. PM75 HN75 MHÑProlactin Release Inhibiting Hormone AN/biosyn /physiol permitted; ╥produced in the hypothalamus╙; DF: PRIH RN9034-47-3 PIPituitary Hormone Releasing Hormones (68-74); Prolactin (68-74) MND6.347.560.710; D12.776.641.650.680 LH  MSA polypeptide hormone which originates in the hypothalamus and stimulates the secretion of prolactin in the pituitary gland. OLsearch PITUITARY HORMONE RELEASING HORMONES 1968-74 PM75; was see under PITUITARY HORMONE RELEASING HORMONES 1974, was PROLACTIN RELEASING FACTOR see under PITUITARY HORMONE RELEASING FACTORS 1968-73 HN75; was see under PITUITARY HORMONE RELEASING HORMONES 1974, was PROLACTIN RELEASING FACTOR see under PITUITARY HORMONE RELEASING FACTORS 1968-73 MHÑProlactin Releasing Hormone AN/biosyn /physiol permitted; ╥originates in the hypothalamus╙; DF: PRH PIPituitary Hormone Releasing Hormones (68-74) MND6.472.709.622; D12.776.641.650.700 LH  MSThe protrusion of an organ or part of an organ into a natural or artificial orifice. PM77 HN77 MHÑProlapse ANnever IM; coord with organ/dis precoord (IM); no qualif; available also are ANUS PROLAPSE, GASTRIC MUCOSA PROLAPSE, MITRAL VALVE PROLAPSE, RECTAL PROLAPSE, UTERINE PROLAPSE, VAGINAL PROLAPSE MNC23.835 LH  MHÑProline RN147-85-3 MND12.125.72.401.623 LH  MSProlyl-glycyl-peptide,2-oxoglutarate:oxygen oxidoreductase. A mixed function oxygenase which catalyzes the hydroxylation of prolyl-glycyl-containing-peptide, usually in protocollagen, to a hydroxyprolyglycyl-containing-peptide. The enzyme utilizes molecular oxygen with a concomitant oxidative decarboxylation of 2-oxoglutarate to succinate. EC 1.14.11.2. PM74 HN74(72) MHÑProline Hydroxylase ANdo not use /analogs RNEC 1.14.11.2 PIHydroxylases (66-71) MND8.586.682.420.673 XSProline,2-Oxoglutarate Dioxygenase; Protocollagen Prolyl Hydroxylase LH LS;  MSThe first enzyme of the proline degradative pathway. It catalyzes the oxidation of proline to pyrroline-5-carboxylic acid in the presence of oxygen and water. The action is not reversible. The specific activity of proline oxidase increases with age. EC 1.5.3.-. HN(80) MHÑProline Oxidase ANdo not use /analogs RNEC 1.5.3.- PIAmine Oxidoreductases (75-79); Amino Acid Oxidoreductases (66-79); Oxidoreductases (66-79); Oxygenases (66-79) MND8.586.682.107.640 XSProline Dehydrogenase DMÑAmine Oxidoreductases LH LS LM  MHÑPromazine ANdo not use /biosyn /defic /physiol RN58-40-2 MND3.494.741.661; D15.236.872.331.628.666 LH  MS1,2,5-Trimethyl-4-phenyl-4-piperidinol propionate. Narcotic analgesic similar to meperidine; it exists in four stereoisomers, two of which, the beta (isopromedol) and the gamma (trimeperidine) are active. HN(78) MHÑPromedol ANdo not use /biosyn /defic /physiol RN64-39-1 PIMeperidine (75-77); Piperidines (66-74); Propionates (66-77) MND3.66.399.450.700; D3.383.621.349.450.700; D14.73.153.491.749; D14.757.471.749 XSDimethylmeperidine; Isopromedol; Trimeperidine DMÑMeperidine LH LS; ; LM  MS17-alpha-Methyl-17-beta-(1-oxopropyl)-estra-4,9-dien-3-one. A synthetic progestin which is useful for the study of progestin distribution and progestin tissue receptors as it is not bound by transcortin and binds to progesterone receptors with a higher association constant than progesterone. OLuse PROMEGESTONE to search R 5020 back thru 1979 HN(86); was R 5020 see under NORPREGNADIENES 1979-85 MHÑPromegestone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN34184-77-5 PINorpregnadienes (75-78); Pregnanes (68-74); Progestational Hormones (66-74); Progestational Hormones, Synthetic (75-78) MND4.808.668.651.443.680; D6.597.799.850 XS17,21-Dimethyl-19-Nor-4,9-Pregnadiene-3,20-dione; Promestone; R 5020 DMÑNorpregnadienes LH LS; ; LM  MS10-(2-Dimethylaminopropyl)phenothiazine. A phenothiazine derivative with histamine H1 blocking, anticholinergic and sedative properties; used as antiallergic, in pruritus, for motion sickness and sedation, also in animals. Synonyms: Diprozin; Phenergan; Prorex; Protazine; Provigan; Thiergan. MHÑPromethazine ANdo not use /biosyn /defic /physiol; Phenergan goes here RN60-87-7 MND2.92.831.690; D3.494.741.670; D23.136.724; D23.654.432.741 XSProzamine XUÑThiazinamium LH LS LU  MHÑPromethium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-12-2 MND1.287.718; D1.552.550.715 LH  HN(72) MHÑPrometryne ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7287-19-6 PIHerbicides (66-71); Triazines (66-71) MND3.383.931.674; D5.723.366.477.623 DMÑHerbicides, Triazine LH LM  MSDNA sequences which signal the initiation of transcription. OLto search PROMOTER (GENETICS) use PROMOTER REGIONS (GENETICS) back thru 1986 & OPERON 1980-85 PM85; PROMOTER (GENETICS) was see OPERON 1980-85 HN85; PROMOTER (GENETICS) was see OPERON 1980-85 MHÑPromoter Regions (Genetics) ANonly /drug eff /rad eff; DF: PROMOTER REGIONS PIGene Expression Regulation (81-84); Genes (66-67); Genes, Regulator (68-84); Operon (69-85); Transcription, Genetic (73-84) MNG5.275.470.710; G5.331.380.418.710 XSPromoter (Genetics) LH LS  PM73 HN73(71) MHÑPronase ANdo not use /analogs RNEC 3.4.24.- PIPeptide Hydrolases (66-70) MND8.586.277.656.818 LH  PM66 HN66(64) MHÑPronethalol ANdo not use /biosyn /defic /physiol RN54-80-8 MND2.33.329.291.678; D2.92.63.291.678; D16.848.215.706 XSNaphthylisoproterenol; Pronetalol LH LS;  MS2'-(2-Hydroxy-3-(propylamino) propoxy)-3-phenylpropiophenone. An antiarrhythmia agent which is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated. PM87 HN87 MHÑPropafenone ANdo not use /biosyn /defic /physiol RN54063-53-5 PIPropiophenones (66-86) MND2.522.818.830; D18.97.645 LH  MSThe deliberate attempt to influence attitudes and beliefs for furthering one's cause or damaging an opponent's cause. MHÑPropaganda ANno qualif MNF1.145.209.729; L1.143.790 LH  PM73 HN73 MHÑPropane ANdo not use /biosyn /defic /physiol RN74-98-6 PIAlkanes (66-72) MND2.455.326.146.800 LH  MS1,2-Propanediol hydro-lyase. Catalyzes the dehydration of 1,2-propanediol to propionaldehyde. HN(75) MHÑPropanediol Dehydratase ANdo not use /analogs RNEC 4.2.1.28 PIHydro-Lyases (72-74); Propanediols (72-74) MND8.586.520.497.675 XSDiol Dehydrase DMÑHydro-Lyases LH LS LM  MHÑPropanediols ANdo not use /analogs /biosyn /defic /physiol MND2.33.618.706 XSPropylene Glycols LH LS  PM70 HN70 MHÑPropanidid ANdo not use /biosyn /defic /physiol RN1421-14-3 PIAnesthetics (66-69) MND2.241.223.601.774; D14.166.751 LH  HN(72) MHÑPropanil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN709-98-8 PIAnilides (66-71); Herbicides (66-71) MND2.65.199.789; D5.723.366.780 DMÑAnilides LH LM  PM74 HN74 MHÑPropanolamines ANdo not use /analogs /biosyn /defic /physiol MND2.33.134.624; D2.33.329.624; D2.92.63.624 XSAminopropanols XUÑBunitrolol; ÑBupranolol; ÑButoxamine; ÑCarteolol; ÑPenbutolol; ÑSuloctidil; ÑToliprolol; ÑTrimepranol LH LS LU; ; ; ; ; ; ;  MSN-Methyl-N-(1-methylethyl)N-[2-((9H-xanthen- 9-ylcarbonyl)oxy)ethyl]-2-propanaminium. All-purpose anticholinergic similar to atropine; used mainly for smooth muscle spasms and gastric ulcers; may cause neuromuscular blockage. Synonyms: Ercotine; Pantheline; Pro-Banthine; Prodiamon; propantel; propantelina. OLuse PROPANTHELINE & METHANTHELINE to search PROPANTHELINE 1966-67; use PROPANTHELINE to search PROPANTHELINE BROMIDE back thru 1966 (as Prov 1966-71) PM81; was see under METHANTHELINE 1963-67; PROPANTHELINE BROMIDE was heading 1972-80 HN81; was see under METHANTHELINE 1963-67; PROPANTHELINE BROMIDE was heading 1964-80 (Prov 1964-71) MHÑPropantheline ANdo not use /biosyn /defic /physiol RN298-50-0 MND2.92.102.700; D2.675.276.700; D3.494.953.558; D16.653.774 LH  MHÑProperdin AN/biosyn /physiol permitted; do not use /blood RN11016-39-0 MND12.776.124.486.789; D12.776.124.790.223.624; D12.776.377.715.182.624; D24.611.779 LH  MSA glycine rich, heat labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor B is converted by Factor D to C3 convertase. HN(78) MHÑProperdin Factor B ANdo not use /analogs /blood PIComplement 3 (75-77); Enzyme Precursors (66-77); Glycoproteins (66-77) MND8.444.690; D12.776.124.486.274.980; D24.611.333.980 XSC3 Proactivator; C3PA; Complement 3 Proactivator DMÑEnzyme Precursors LH LS; ; LM  MSA serum protein which during the alternate pathway of complement activation converts the inactive properdin factor B to C3 convertase. HN(78) MHÑProperdin Factor D ANdo not use /analogs /blood RNEC 3.- PIEnzyme Precursors (66-77); Properdin (66-77); Serum Globulins (70-77) MND8.586.277.300.650; D12.776.124.486.274.860.650; D24.611.333.860.650 XSC3PA Convertase; C3PAse; GBGase; Proactivator Convertase DMÑComplement Activating Enzymes LH LS; ; ; LM  PM73 HN73(63) MHÑPropericiazine ANdo not use /biosyn /defic /physiol RN2622-26-6 MND3.494.741.682; D15.236.872.331.628.689 LH  MSThe first phase of cell division, in which the chromosomes become visible, the nucleus starts to lose its identity, the spindle appears, and the centrioles migrate toward opposite poles. PM81; was see under CELL CYCLE 1978-80 HN81(78); was see under CELL CYCLE 1978-80 MHÑProphase AN1st phase of cell div; NIM specific cell when merely test cell; coord with specific cell /cytol; only /drug eff /rad eff; permitted with micro-organisms PICell Division (66-77); Meiosis (68-77); Mitosis (68-77) MNG4.335.135.220.225.750; G5.148.165.220.225.750; G7.553.135.220.225.750 LH  MS3,8-Diamino-5-(3-(diethymethyammonio) propyl)-6-phenylphenanthridium. Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits. Synonyms: propidium diiodide; propidium iodide. HN(79) MHÑPropidium ANdo not use /biosyn /defic /physiol; /analogs NIM only RN36015-30-2 PIEthidium (74-78); Phenanthridines (69-78) MND3.494.633.700; D26.550.690 DMÑPhenanthridines LH LM  MS2-Oxetanone. Disinfectant used in vapor form to sterilize vaccines, grafts, etc; the vapor is very irritating and the liquid form is carcinogenic. Synonym: Betaprone. HN(75) MHÑPropiolactone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN57-57-8 PILactones (69-74); Propionates (72-74) MND2.540.600; D20.187.762; D26.191.766 XSBeta-Propiolactone; Propanolide DMÑLactones LH LS; LM  PM73 HN73(66) MHÑPropiomazine ANdo not use /biosyn /defic /physiol RN362-29-8 MND3.494.741.702; D15.236.872.331.628.712 LH  MHÑPropionates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.465.706; D2.241.81.751; D10.516.251.400.706 XUÑFlurbiprofen; ÑNafenopin; ÑProcetofen; ÑPropionic Acids LH LU; ; ;  MSA family of Gram-positive bacteria found in dairy products or in the intestinal tracts of animals. PM75 HN75 MHÑPropionibacteriaceae ANin dairy products or intestinal tracts of animals; do not use /blood-csf-urine PIBacteria (66-74) MNB3.100.600 LH  MHÑPropionibacterium ANin dairy products MNB3.100.600.625 LH  MSA bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses; a common contaminant of clinical specimens, presumably from the skin of patients or attendants. OLto search CORYNEBACTERIUM ACNES & CORYNEBACTERIUM PARVUM (as Prov 1972-74) use PROPIONIBACTERIUM ACNES back thru 1975 & CORYNEBACTERIUM 1972-74 PM76; CORYNEBACTERIUM ACNES & CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1975 HN76; CORYNEBACTERIUM ACNES & CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1975, were Prov 1972-74 MHÑPropionibacterium acnes ANdo not use /blood-csf-urine; infection: coord NIM with BACTERIAL INFECTIONS (IM) PICorynebacterium (66-74) MNB3.100.600.625.100 XSCorynebacterium acnes; Corynebacterium parvum LH LS;  MS3-carbon saturated monocarboxylic acids. HN(75) MHÑPropionic Acids ANdo not use /analogs /biosyn /defic /physiol; propionic acidemia: index PROPIONIC ACIDS /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) PIPropionates (66-74) MND2.241.81.465.706.700; D2.241.81.751.700; D10.516.251.400.706.700 DMÑPropionates LH LM  MHÑPropiophenones ANdo not use /analogs /biosyn /defic /physiol MND2.522.818 XUÑChalcone; ÑKynuramine; ÑOxyfedrine; ÑTolperisone LH LU; ; ;  MSPolymer of polytetrafluoroethylene and carbon filaments; porous biocompatible material used in orofacial and middle ear reconstruction and as coating for metal implants. HN(80) MHÑProplast AND25-26 qualif PICarbon (66-79); Fluorocarbon Polymers (66-72); Polytetrafluoroethylene (73-79) MND25.720.395.616.755 DMÑPolytetrafluoroethylene LH LM  MSResinous substance obtained from beehives; contains many different substances which may have antimicrobial or antimycotic activity topically; its extracts are called propolis resin or balsam. Synonyms: bee bread; hive dross; bee glue. HN(79) MHÑPropolis ANobtained from beehives, also called bee bread, bee glue; D25-26 qualif RN9009-62-5 PIBees (66-78); Resins (66-78) MND25.786.762 DMÑResins LH LM  PM65 HN65 MHÑPropoxycaine ANdo not use /biosyn /defic /physiol RN86-43-1 MND2.241.223.106.61.75.720; D14.211.815 XSPropoxyprocaine LH LS  MSAlpha[2-(Dimethylamino)-1-methylethyl]alpha-phenylbenzene ethanol propanoate ester. The dextro form is a semisynthetic analgesic similar to but weaker than morphine; used for moderate pain; the levo form has no analgesic action, but may be antitussive. Synonyms: Algafan; Darvon; Dolene; Femadol; Harmar; Propox; Proxagesic. PM65; DEXTRO PROPOXYPHENE was heading 1963-64 HN65; DEXTRO PROPOXYPHENE was heading 1963-64 MHÑPropoxyphene ANdo not use /biosyn /defic /physiol RN469-62-5 MND2.241.81.751.725; D14.73.153.831 XSD-Propoxyphene; Dextropropoxyphene; Levopropoxyphene XUÑPropoxyphene Napsylate LH LS; ; LU  MS(+)-alpha-4(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate (ester) mono-2-naphthalenesulfonate monohydrate. Less potent, but less irritating analog of propoxyphene, used as analgesic; the dextro isomer has little antitussive action, but the levo is mainly used as an antitussive; side effects and toxicity as for propoxyphene HCl. Synonyms: Napsalgesic; Darvon N. HN(76) MHÑPropoxyphene Napsylate ANdo not use /biosyn /defic /physiol RN17140-78-2 PINaphthalenesulfonates (74-75); Propoxyphene (69-74) /AA (75) MND2.241.81.751.725.500; D14.73.153.831.750 DMÑPropoxyphene LH LM  PM67 HN67(65) MHÑPropranolol ANdo not use /biosyn /defic /physiol RN525-66-6 MND2.33.329.624.836; D2.92.63.624.836; D16.848.215.748; D18.97.675; D18.162.738; D18.918.792 XSDexpropranolol LH LS  MSThe mechanism involved in the self-regulation of posture and movement through stimuli originating in the receptors imbedded in the joints, tendons, muscles, and labyrinth. PM73 HN73 MHÑProprioception ANonly /drug eff /rad eff PIEquilibrium (66-72); Kinesthesis (66-72) MNF2.830.816.541; G11.561.796.541 FXÑMechanoreceptors LH LX  MSn-Propyl gallate. Antioxidant for foods, fats, oils, ethers, emulsions, waxes, transformer oils. Synonyms: Progallin P; Tenox PG. HN(75) MHÑPropyl Gallate ANdo not use /biosyn /defic /physiol RN121-79-9 PIAlcohol, Propyl (74); Gallic Acid (73-74) MND2.241.223.106.505.350.600; D2.241.511.390.350.600; D2.755.410.350.600 DMÑGallic Acid LH LM  MSCatalyzes the transfer of the propylamine moiety from 5'-deoxy-5'-S-(3-methylthiopropylamine)sulfonium adenosine to putrescine in the biosynthesis of spermidine. The enzyme has a molecular weight of approximately 73,000 and is composed of two subunits of equal size. HN(75) MHÑPropylamine Transferase ANdo not use /analogs; do not confuse X ref SPERMIDINE SYNTHASE with SPERMINE SYNTHASE RNEC 2.5.1.16 PIPropylamines (72-74); Spermidine (72-74); Transferases (72-74) MND8.586.913.710 XSAminopropyltransferase; Spermidine Synthase; Spermidine Synthetase DMÑTransferases LH LS; ; LM  PM66 HN66 MHÑPropylamines ANdo not use /analogs /biosyn /defic /physiol MND2.92.831 XUÑClorgyline; ÑFluoxetin; ÑPropylhexedrine LH LU; ;  MS2-[(2-Chloroethyl)propylamino]benzilate. Analog of benzilylcholine mustard, an alkylating nitrogen mustard analog that binds specifically and irreversibly to cholinergic muscarinic receptors and is used as an affinity label to isolate and study the receptors. Synonyms: PBCM; PRBCM. HN(77) MHÑPropylbenzilylcholine Mustard ANdo not use /biosyn /defic /physiol RN36167-80-3 PIBenzilates (74-75); Choline (74-76); Mustard Compounds (74-76) MND2.92.102.232.720; D2.455.526.728.650.740; D2.675.276.232.720; D16.653.783; D26.550.20.754 DMÑCholine LH LM  MSN,alpha-Dimethlcyclohexaneethylamine. Alpha-adrenergic stimulant used extensively in nasal decongestant inhalers; the hydrochloride salt may be useful as an appetite depressant. Synonyms: Benzedres; Eventyl; Eventin. HN(76) MHÑPropylhexedrine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN101-40-6 PICyclohexanes (68-75); Propylamines (73-75) MND2.92.831.720; D16.893.116.182.795; D18.793.952.762 XSCyclexedrine; Isopropylhexedrine DMÑPropylamines LH LS; LM  MSPropyl 3,5-diiodo-4-oxo-1(4H)-pyridine acetate. Radiopaque medium usually in oil; used in bronchography. Synonyms: Dionosil; propiliodon; Propylix. OLsearch CONTRAST MEDIA 1966-74 HN(75); was see under CONTRAST MEDIA 1963-74 MHÑPropyliodone AND25-26 qualif; /analogs NIM only RN587-61-1 MND3.383.725.791.496.750; D26.298.801 XSPropiodone DMÑIodopyridones LH LS LM  MHÑPropylthiouracil ANdo not use /biosyn /defic /physiol RN51-52-5 MND3.383.742.698.875.842.708; D6.347.789.625; D26.87.748 LH  MS[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide. Cardiotonic glycoside isolated from Scilla maritima var. alba (Squill). Synonyms: Talusin; Tradenal; Caradrin; Sandoscill. HN(75) MHÑProscillaridin ANdo not use /defic /physiol; /analogs NIM only RN466-06-8 PIBufanolides (70-74); Plants, Medicinal (70-74) MND4.808.122.580; D9.203.408.180.660; D18.222.175.701 XSDesglucotransvaaline; Proscillaridin A; Scillarenin Rhamnoside DMÑBufanolides LH LS; ; LM  MSA suborder of Primates consisting of the following six families: Daubentoniidae, Indriidae, LEMURIDAE, LORISIDAE, Tarsiidae, and TUPAIIDAE. OLuse PROSIMII to search PROSIMIANS back thru 1975 PM81; was PROSIMIANS 1975-80 HN81; was PROSIMIANS 1975-80 MHÑProsimii ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIPrimates (66-74) MNB2.649.801.700 XSIndri; Indriidae; Lemuriformes; Lemuroidea; Tarsiidae; Tarsius LH LS; ; ; ; ;  MSThis commission is charged with evaluating issues and factors which affect the implementation of the PROSPECTIVE PAYMENT SYSTEM. HN(87) MHÑProspective Payment Assessment Commission ANdo not use /educ /man /methods /supply /util PIProspective Payment System (86) MNN3.219.521.710.305.200.605 XSPROPAC DMÑProspective Payment System LH LS LM  MSA system wherein reimbursement rates are set, for a given period of time, prior to the circumstances giving rise to actual reimbursement claims. OLuse PROSPECTIVE PAYMENT SYSTEM to search REIMBURSEMENT, PROSPECTIVE back thru 1979 PM87; was see under REIMBURSEMENT MECHANISMS 1986, was REIMBURSEMENT, PROSPECTIVE see under REIMBURSEMENT MECHANISMS 1979-85 HN87(86); was see under REIMBURSEMENT MECHANISMS 1986, was REIMBURSEMENT, PROSPECTIVE see under REIMBURSEMENT MECHANISMS 1979-85 MHÑProspective Payment System ANdo not use /educ /man /methods /supply /util MNN3.219.521.710.305.200 XSProspective Pricing; Prospective Reimbursement; Reimbursement, Prospective XUÑProspective Payment Assessment Commission LH LS; ; LU  PM67 HN67(65) MHÑProspective Studies ANIM general only; NIM with specific study IM; no qualif MNE5.318.420.790 LH  MS3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride. An antineoplastic dispiropiperazine derivative. HN(75) MHÑProspidium ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23476-83-7 PIAlcohol, Propyl (72-74); Piperazines (71-74); Spiro Compounds (71-74) MND3.383.606.810; D4.615.885.700; D22.204.738 XSProspidin DMÑPiperazines LH LS LM  MSCompounds which inhibit the action of prostaglandins. PM75 HN75 MHÑProstaglandin Antagonists ANdo not use /analogs /antag /defic; /biosyn /physiol permitted if by living organism; DF: PG ANTAG PIProstaglandins/AI (68-74) MND24.185.798.575.52 XSProstaglandin Inhibitors LH LS  MSPrecursors in the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. They are physiologically active compounds, having effect on vascular and airway smooth muscles, platelet aggregation etc. PM78 HN78 MHÑProstaglandin Endoperoxides AN/biosyn /physiol permitted; do not use /analogs ( = PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC); /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; DF: PG ENDOPEROXIDES PIPeroxides (66-77); Prostaglandins (66-77) MND2.241.81.436.687.25; D10.516.251.355.708.25; D24.185.798.575.64 XUÑProstaglandins G; ÑProstaglandins H LH LU;  MSSynthetic compounds which are analogs of the naturally occurring prostaglandin endoperoxides and which mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds. PM78 HN78 MHÑProstaglandin Endoperoxides, Synthetic ANdo not use /analogs /biosyn /defic /physiol; coord IM with specific syn prostaglandin (NIM); DF: PG ENDOPEROXIDES SYN PIEthers, Cyclic (66-77); Peroxides (66-77); Prostaglandins (66-76); Prostaglandins, Synthetic (77) MND2.241.81.436.687.700.250; D10.516.251.355.708.700.250; D24.185.798.575.750.200 XSProstaglandin Endoperoxide Analogs LH LS  MSAn enzyme complex which catalyzes the formation of prostaglandins from the appropriate unsaturated fatty acid, molecular oxygen and a reduced acceptor. PM78; was see under HYDROXYLASES 1975-77 HN78(75); was see under HYDROXYLASES 1975-77 MHÑProstaglandin Synthase ANdo not use /analogs; DF: PG SYNTHASE RNEC 1.14.99.1 PIHydroxylases (74-77); Multienzyme Complexes (73-74); Oxygenases (71-73); Prostaglandins (71-74) MND8.586.600.720; D8.586.682.420.715 XSCyclooxygenase; Fatty Acid Cyclo-Oxygenase; PGH Synthase; Prostaglandin Endoperoxide Synthetase; Prostaglandin H Synthase; Prostaglandin Synthetase LH LS; ; ; ; ;  MSAn enzyme active in prostaglandin E and F catabolism. It catalyzes the reduction of the double bond at the 13-14 position of the 15-ketoprostaglandins. Uses NADPH as cofactor. EC 1.3.1.-. HN(78) MHÑProstaglandin-13,14-Reductase ANdo not use /analogs; DF: PG REDUCTASE RNEC 1.3.1.- PIOxidoreductases (66-77); Prostaglandins (66-77); specific prostaglandin (75-77) MND8.586.682.780 XSProstaglandin delta-13-Reductase DMÑOxidoreductases LH LS LM  PM66 HN66(63) MHÑProstaglandins ANGEN or unspecified only: prefer specifics; /biosyn /physiol permitted; do not use /analogs ( = PROSTAGLANDINS, SYNTHETIC) /antag ( = PROSTAGLANDIN ANTAGONISTS); /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC MND2.241.81.436.687; D10.516.251.355.708; D24.185.798.575 XUÑProstaglandins B LH LU  MS15 alpha-Hydroxy-9-oxo-10,13-trans-prostadienoic acid (PGA(1)); 15 alpha-hydroxy-9-oxo-5,10-cis,13-trans-prostatrienoic acid (PGA(2)). PGA(1) and PGA(2) as well as their 19-hydroxy derivatives are found in many organs and tissues. PM75 HN75 MHÑProstaglandins A AN/biosyn /physiol permitted; do not use /analogs ( = PROSTAGLANDINS A, SYNTHETIC); /chem syn permitted: do not convert to PROSTAGLANDINS A, SYNTHETIC; DF: PGA PIProstaglandins (66-74) MND2.241.81.436.687.50; D10.516.251.355.708.100; D24.185.798.575.100 LH  MSAnalogs or derivatives of prostaglandins A which do not occur naturally in the body. Do not use for the chemical synthesis of hormonal PGA. PM78 HN78 MHÑProstaglandins A, Synthetic ANdo not use /analogs /biosyn /defic /physiol; DF: PGA SYN PIProstaglandins A (75-77); Prostaglandins, Synthetic (77) MND2.241.81.436.687.700.350; D10.516.251.355.708.700.350; D24.185.798.575.750.400 XSProstaglandin A Analogs LH LS  MSPhysiologically active prostaglandins found in many tissues and organs. They are potent pressor substances and have many other physiological activities. HN(78) MHÑProstaglandins B AN/biosyn /physiol permitted; do not use /analogs (coord NIM with PROSTAGLANDINS, SYNTHETIC (IM)); /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC: DF: PGB PIProstaglandins (66-77) MND2.241.81.436.687.75; D10.516.251.355.708.150; D24.185.798.575.130 DMÑProstaglandins LH LM  MSPhysiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation and have potential antithrombotic effects. PM84; was see under PROSTAGLANDINS 1978-83 HN84(78); was see under PROSTAGLANDINS 1978-83 MHÑProstaglandins D AN/biosyn /physiol permitted; do not use /analogs (coord NIM with PROSTAGLANDINS, SYNTHETIC (IM)); /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC; DF: PGD PIProstaglandins (66-77) MND2.241.81.436.687.100; D10.516.251.355.708.200; D24.185.798.575.230 LH  MS11 alpha,15 alpha-dihydroxy-9-oxo-13-trans-prostenoic acid (PGE(1)); 11 alpha,15 alpha-dihydroxy-9-oxo-5-cis, 13-trans-prostadienoic acid (PGE(2)); 11 alpha,15 alpha-dihydroxy-9-oxo-5-17-cis,13-trans-prostatrienoic acid (PGE(3)). PGE(1), (2), and (3) are found in many organs and tissue. They have many physiological activities. PM75 HN75 MHÑProstaglandins E AN/biosyn /physiol permitted; do not use /analogs ( = PROSTAGLANDINS E, SYNTHETIC); /chem syn permitted: do not convert to PROSTAGLANDINS E, SYNTHETIC: DF: PGE PIProstaglandins (66-74) MND2.241.81.436.687.150; D10.516.251.355.708.250; D24.185.798.575.250 LH  MSAnalogs or derivatives of prostaglandins E which do not occur naturally in the body. Do not use for the chemical synthesis of hormonal PGE. PM78 HN78 MHÑProstaglandins E, Synthetic ANdo not use /analogs /biosyn /defic /physiol; DF: PGE SYN PIProstaglandins E (75-77); Prostaglandins, Synthetic (77) MND2.241.81.436.687.700.450; D10.516.251.355.708.700.450; D24.185.798.575.750.600 XSProstaglandin E Analogs XUÑ16,16-Dimethylprostaglandin E2; ÑArbaprostil LH LS LU;  MS9 alpha,11 alpha,15-trihydroxy-13-trans-prostenoic acid (PGF(1)); 9 alpha,11 alpha,15 alpha-trihydroxy-5-cis,13-trans-prostadienoic acid (PGF(2)); 9 alpha,11 alpha,15 alpha-trihydroxy-5,17-cis,13-trans-prostatrienoic acid (PGF(3)). PGF(1), (2), and (3) are found in many organs and tissues. They have many physiological activities. PM75 HN75 MHÑProstaglandins F AN/biosyn /physiol permitted; do not use /analogs ( = PROSTAGLANDINS F, SYNTHETIC); /chem syn permitted: do not convert to PROSTAGLANDINS F, SYNTHETIC; DF: PGF PIProstaglandins (66-74) MND2.241.81.436.687.250; D10.516.251.355.708.400; D24.185.798.575.400 LH  MSAnalogs or derivatives of prostaglandins F which do not occur naturally in the body. Do not use for the chemical synthesis of hormonal PGF. PM78 HN78 MHÑProstaglandins F, Synthetic ANdo not use /analogs /biosyn /defic /physiol; DF: PGF SYN PIProstaglandins F (75-77); Prostaglandins, Synthetic (77) MND2.241.81.436.687.700.500; D10.516.251.355.708.700.500; D24.185.798.575.750.800 XSProstaglandin F Analogs XUÑCarboprost; ÑCloprostenol LH LS LU;  MSA group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. Most frequently encountered member of this group is the prostaglandin G2. HN(78) MHÑProstaglandins G AN/biosyn /physiol permitted; do not use /analogs (coord NIM with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC (IM)); /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; DF: PGG PIPeroxides (66-77); Prostaglandins (66-77) MND2.241.81.436.687.25.600; D10.516.251.355.708.25.600; D24.185.798.575.64.397 DMÑProstaglandin Endoperoxides LH LM  MSA group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. Most frequently encountered member of this group is the prostaglandin H2. HN(78) MHÑProstaglandins H AN/biosyn /physiol permitted; do not use /analogs (coord NIM with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC (IM)); /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; DF: PGH PIPeroxides (66-77); Prostaglandins (66-77) MND2.241.81.436.687.25.650; D10.516.251.355.708.25.650; D24.185.798.575.64.444 DMÑProstaglandin Endoperoxides LH LM  MS9-Deoxy-6,9-alpha-epoxy-delta-5-PGF(1)-alpha. Biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue. It is a potent inhibitor of platelet aggregation. PM84; was see under PROSTAGLANDINS 1978-83 HN84(78); was see under PROSTAGLANDINS 1978-83 MHÑProstaglandins X AN/biosyn /physiol permitted; do not use /analogs (coord NIM with PROSTAGLANDINS, SYNTHETIC (IM)); /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC; DF: PGX or PGI PIProstaglandins (66-77) MND2.241.81.436.687.900; D10.516.251.355.708.900; D24.185.798.575.982 XSProstacyclins; Prostaglandins I; Prostaglandins I2 LH LS; ;  MSCompounds obtained by chemical synthesis which are analogs or derivatives of naturally occurring prostaglandins and which have similar biological action. PM77 HN77 MHÑProstaglandins, Synthetic ANGEN or unspecified only: prefer specifics; for synthetic prostaglandins not precoord, coord specific non-synthetic (natural) prostaglandin term (NIM) + PROSTAGLANDINS, SYNTHETIC (IM); DF: PG SYN PIProstaglandins (66-76); specific prostaglandin; Fatty Acids, Unsaturated (75-76) MND2.241.81.436.687.700; D10.516.251.355.708.700; D24.185.798.575.750 XSProstaglandin Analogs LH LS  MS2-Octylcyclopentaneheptanoic acid. A saturated carbon-20 cyclic fatty acid. The parent compound of the prostaglandins. HN(75) MHÑProstanoic Acids ANdo not confuse with ╥prostenoic acids╙; /biosyn /physiol permitted; do not use /analogs PICyclopentanes (71-74); Fatty Acids (71-74); Prostaglandins (71-74) MND2.241.81.407.700; D10.516.251.740 DMÑFatty Acids LH LM  MHÑProstate ANadenoma = PROSTATIC HYPERTROPHY; /surg: probably PROSTATECTOMY; inflammation = PROSTATITIS MNA5.360.444.575; A10.336.707 FXÑExocrine Glands LH LX  MHÑProstatectomy ANdo not use /util except by MeSH definition; transurethral: do not coord with URETHRA (NIM); retropubic: do not coord with PUBIC BONE MNE4.887.774.692.625 LH  PM66 HN66 MHÑProstatic Diseases ANinflamm dis = PROSTATITIS; adenoma = PROSTATIC HYPERTROPHY; prostatism = PROSTATIC HYPERTROPHY MNC12.294.565 LH  MHÑProstatic Hypertrophy AN╥prostatic adenoma╙, ╥prostatic hyperplasia╙ & prostatism go here MNC12.294.565.500 LH  MHÑProstatic Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); ╥prostatic adenoma╙ does not go here: = PROSTATIC HYPERTROPHY MNC4.588.945.440.770; C12.294.565.625 LH  MHÑProstatitis MNC12.294.565.750 LH  MHÑProsthesis ANdo not use /instrum /methods /util (except by MeSH definition); coord IM with prosthetic material (do not use /ther use) (IM or NIM); ear & nose prostheses: coord with EAR, EXTERNAL & NOSE; BIOPROSTHESIS (see note there) & IMPLANTS, ARTIFICIAL are also available MNE4.659; E7.858.565 FXÑDental Prosthesis; ÑPalatal Obturators; ÑProsthodontics LH LX; ;  PM74 HN74(71) MHÑProsthesis Design ANNIM; coord with specific prosth (IM) or specific techn /instrum (IM); only /econ /stand /vet PIProsthesis (66-70); specific prosthesis MNE4.659.825 FXÑDental Prosthesis Design; ÑEquipment Design LH LX;  MSMalfunction of implantation shunts, valves, etc., and prosthesis loosening, migration. and breaking. HN(86) MHÑProsthesis Failure ANNIM; coord with specific prosthesis with no qualif (IM); only /econ /vet PIPostoperative Complications (66-85); Prosthesis Design (71-85) MNC23.814.760; E5.325.771 XSProsthesis Loosening DMÑEquipment Failure LH LS LM  MSA dental specialty concerned with the restoration and maintenance of oral function by the replacement of missing teeth and structures by artificial devices or prostheses. PM65 HN65 MHÑProsthodontics ANSPEC: SPEC qualif; SURGERY, ORAL, PREPROSTHETIC is also available CATALOG: use with form qualif instead of DENTAL PROSTHESIS /form MNE6.780; G2.163.876.708 FXÑProsthesis LH LX  MSThe practice of indulging in promiscuous sexual relations for money. MHÑProstitution ANonly /hist /legis CATALOG: /geog /form MNF1.145.792.790; I1.880.735.679 LH  MHÑProtactinium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol RN7440-13-3 MND1.287.741; D1.552.517.778 LH  MHÑProtamines ANdo not use /analogs /biosyn /defic /physiol MND12.776.664.750; D19.461.270.546.500 XUÑClupeine; ÑSalmine LH LU;  MSCompounds which inhibit or antagonize biosynthesis or actions of proteases. Synonym: Antiproteases. PM79 HN79 MHÑProtease Inhibitors ANdo not use /analogs /antag /biosyn /defic /physiol; DF: PROTEASE INHIB PIPeptide Hydrolases/AI (68-78); Peptide Peptidohydrolases/AI (68-78) MND8.373.745 XSPeptidase Inhibitors; Peptide Hydrolase Inhibitors; Peptide Peptidohydrolase Inhibitors; Protease Antagonists LH LS; ; ;  MSClothing designed to protect the individual against known hazards to which he will be exposed. PM70 HN70 MHÑProtective Clothing ANonly /econ /stand /supply PIClothing (66-69) MNE7.712.751; J1.193.542 LH  MSDevices designed to provide personal protection against injury to individuals exposed to hazards in industry, sports, aviation, or daily activities. PM70; GAS MASKS (now see RESPIRATORY PROTECTIVE DEVICES, an XU below) was see under MASKS 1968-74, was heading 1963-67 HN70; was in Cat E & J 1970-82 MHÑProtective Devices ANonly /econ /stand /supply /vet PIAccident Prevention (66-69); Athletic Injuries (68-69); Aerospace Medicine (66-69); Clothing (66-69); Occupational Medicine (66-69) MNE7.712 XSSAFETY DEVICES FXÑAccident Prevention; ÑAerospace Medicine; ÑOccupational Medicine; ÑRestraint, Physical; ÑSports Medicine XUÑEar Protective Devices; ÑEye Protective Devices; ÑHead Protective Devices; ÑRespiratory Protective Devices LH LS LX; ; ; ; LU; ; ;  MSThe Proteidae family of permanently larval aquatic salamanders consists of two living genera - Necturus (mudpuppy) of the eastern United States and Proteus (the European olm). PM81 HN81 MHÑProteidae ANnote categ: a family of aquatic salamanders; usually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.90.608.630 LH  MSS-Adenosylmethionine:protein-arginine methyltransferase. Catalyzes the methylation of arginine residues of proteins to yield N-mono- and N,N-dimethylarginine. This enzyme is found in many organs, primarily brain and spleen. EC 2.1.1.23. HN(77) MHÑProtein Arginine Methyltransferase ANdo not use /analogs RNEC 2.1.1.23 PIArginine (66-76); Methyltransferases (71-76); Proteins (66-76); specific protein MND8.586.913.517.610.100 XSProtein Methylase I; Protein Methyltransferase I DMÑPROTEIN METHYLTRANSFERASES LH LS; LM  PM70 HN70(66) MHÑProtein Binding ANNIM; only /drug eff /rad eff; restrict to the chem or metab binding mechanism; coord NIM with substance being bound /metab (IM) + specific protein /metab (IM); do not use with RECEPTORS terms unless the substance bound to the receptor is a protein & the binding mechanism is discussed; do not confuse with BINDING PROTEINS see CARRIER PROTEINS; METALLOPROTEINS is also available MNG6.184.775 FXÑBlood Proteins; ÑCarrier Proteins; ÑThyroxine-Binding Protein LH LX; ;  MSA vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation. Its congenital deficiency is responsible for thrombotic diathesis. Acquired protein C deficiencies also have been found, e.g., low plasma levels of protein C have been found in certain liver and renal diseases. The deficiency of protein C can be treated by coagulants such as coumarin or heparin. PM87 HN87 MHÑProtein C ANdo not use /blood; /biosyn /defic /physiol permitted PIBlood Proteins (66-86); Glycoproteins (66-86) MND8.444.705; D12.776.124.650; D12.776.395.635; D19.461.119.780 XSProtein C Antigen LH LS  MSThe characteristic 3-dimensional shape of a protein, imposed upon it by the secondary and tertiary structure of the peptide chain. Secondary structure is due to the formation of hydrogen bonds between components of the peptide chain and frequently results in the formation of an alpha helix. Tertiary structure refers to the folding of the polypeptide chain to produce the compact structure of the native protein. PM72 HN72 MHÑProtein Conformation ANIM general only; coord NIM with specific protein (IM); only /drug eff /rad eff; peptide conformation = PEPTIDES or specific peptide (IM) + PROTEIN CONFORMATION (NIM); secondary & tertiary structure of proteins go here PIProteins (66-71) MNG6.184.580.709 LH  MHÑProtein Deficiency ANIM + coord with specific protein /defic (IM); consider also PROTEIN-CALORIE MALNUTRITION MNC18.654.223.708 FXÑDietary Proteins LH LX  PM66 HN66(64) MHÑProtein Denaturation ANIM general only; coord NIM with specific protein (IM); only /drug eff /rad eff MNG6.184.794 LH  MSGlutathione:protein-disulfide oxidoreductase. Catalyzes the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates. HN(75) MHÑProtein Disulfide Reductase (Glutathione) ANdo not use /analogs RNEC 1.8.4.2 PIGlutathione (72-74); Glutathione Reductase (74); Insulin (72-74); Oxidoreductases (72-74) MND8.586.682.790 XSGlutathione Insulin Transhydrogenase; Glutathione Protein Disulfide Oxidoreductase DMÑOxidoreductases LH LS; LM  MSThe formation of a protein consisting of two or more polypeptide chains from separate and different polypeptide chains. PM78 HN78 MHÑProtein Hybridization ANIM general only; coord NIM with specific protein (IM); only /drug eff /rad eff PIspecific protein MNG6.184.800 LH  MHÑProtein Hydrolysates ANthis is a ther agent & nutrient: do not confuse with the hydrolysis of proteins ( = PROTEINS + HYDROLYSIS (NIM)); do not use /analogs /defic /physiol MND12.776.796 LH  MSThis enzyme phosphorylates proteins in the presence of physiological concentrations of calcium and membrane phospholipids. The additional presence of diacylglycerols markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by phorbol esters and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. PM86 HN86 MHÑProtein Kinase C ANdo not use /analogs RNEC 2.7.1.- PIProtein Kinases (73-85) MND8.586.913.696.729.726.650 XSCalcium-Activated Phospholipid-Dependent Kinase; Calcium-Phospholipid Dependent Protein Kinase LH LS;  OLuse PROTEIN KINASES to search PROTEIN KINASE back thru 1973 (as Prov 1973) PM80; was PROTEIN KINASE 1974-79 HN80; was PROTEIN KINASE 1973-79 (Prov 1973) MHÑProtein Kinases ANdo not use /analogs RNEC 2.7.1.37 MND8.586.913.696.729.726 XSCyclic AMP-Dependent Protein Kinase XUÑHistone Kinase LH LS LU  MSS-Adenosylmethionine:protein-lysine methyltransferase. Catalyzes the methylation of the epsilon amino group of lysine residues of proteins to yield epsilon mono-, di-, and trimethyllysine. This enzyme is present in many organs, however, histones are a major substrate. It is localized exclusively in the nuclei. EC 2.1.1.43. HN(77) MHÑProtein Lysine Methyltransferase ANdo not use /analogs RNEC 2.1.1.43 PILysine (66-76); Methyltransferases (71-76); Proteins (66-76); specific protein MND8.586.913.517.610.400 XSProtein Methylase III; Protein Methyltransferase III DMÑPROTEIN METHYLTRANSFERASES LH LS; LM  MSEnzymes which catalyze the methylation of amino acids after their incorporation into a polypeptide chain. S-Adenosyl-L-methionine acts as the methylating agent. EC 2.1.1. PM77 HN77 MHÑProtein Methyltransferases ANdo not use /analogs RNEC 2.1.1 PIS-Adenosylmethionine (71-76); Methyltransferases (71-76); Proteins (66-76); specific protein MND8.586.913.517.610 XSProtein Methylases XUÑProtein Arginine Methyltransferase; ÑProtein Lysine Methyltransferase; ÑProtein O-Methyltransferase LH LS LU; ;  MSS-Adenosylmethionine:protein O-methyltransferase. Catalyzes the transfer of methyl groups from S-adenosylmethionine to free carboxyl groups of a protein molecule forming methyl esters. EC 2.1.1.24. HN(77) MHÑProtein O-Methyltransferase ANdo not use /analogs RNEC 2.1.1.24 PIS-Adenosylmethionine (71-76); Methyltransferases (71-76); Proteins (66-76); specific protein MND8.586.913.517.610.500 XSProtein Carboxylmethyltransferase; Protein Methylase II; Protein Methyltransferase II DMÑPROTEIN METHYLTRANSFERASES LH LS; ; LM  PM73 HN73 MHÑProtein Precursors ANIM; coord with specific protein (IM); do not use /analogs PIProteins (66-70); specific protein MND12.776.811 FXÑEnzyme Precursors LH LX  MSAny of various enzymically catalyzed post-translational modifications of peptides or proteins in the cell of origin; includes carboxylation, hydroxylation, acetylation, phosphorylation, methylation, glycosylation, oxidation-reduction, degradation and lysis, peptide bond formation, and changes in molecular weight and electrophoretic motility. PM83 HN83 MHÑProtein Processing, Post-Translational ANonly /drug eff /rad eff; coord IM with specific protein /metab (IM); DF: PROTEIN PROC POST TRANS PITranslation, Genetic (73-82) MNG5.331.380.791; G5.331.914.791 XSPost-Translational Protein Modification FXÑGlycosylation LH LS LX  MHÑProtein-Bound Iodine Test ANonly /instrum /methods /vet; protein-bound iodine = IODINE /blood + BLOOD PROTEINS (NIM) + PROTEIN BINDING (NIM) but serum PBI is probably PROTEIN-BOUND IODINE TEST MNE1.197.882.709; E1.223.174.229.802; E1.289.438 FXÑThyroxine-Binding Protein LH LX  PM74 HN74(72) MHÑProtein-Calorie Malnutrition ANconsider also KWASHIORKOR PIInfant Nutrition Disorders (66-71); Nutrition Disorders (66-71) MNC18.654.223.708.626 XSMarasmus LH LS  MSCatalyzes the reaction of protein glutamine and an alkylamine to yield protein N(5)-alkylglutamine and ammonia. The gamma-carboxamide groups of peptide-bound glutamine residues act as acyl donors, and the 6-amino groups of protein- and peptide-bound lysine residues act as acceptors, to give intra- and inter-molecular N(6)-(5-glutamyl)-lysine crosslinks. In the epidermis these cross-linked proteins are involved in the formation of the cornified envelope of the stratum corneum cells. PM86 HN86 MHÑProtein-Glutamine Gamma-Glutamyltransferase ANdo not use /analogs RNEC 2.3.2.13 PIAcyltransferases (66-85) MND8.586.913.50.825 XSGlutaminyl-Peptide Gamma-Glutamyltransferase; Transglutaminase LH LS;  MSSeries of gastrointestinal disorders which share in common the excessive loss of protein, mainly albumin, across the gut wall. This occurs in the stomach (Menetrier disease), as well as the small bowel (intestinal lymphangiectases, assorted inflammatory states). It is also occasionally associated with congestive heart failure (again a small bowel protein loss). PM66 HN66 MHÑProtein-Losing Enteropathies MNC6.405.469.818; C18.452.805 XSENTEROPATHY, EXUDATIVE; Idiopathic Hypercatabolic Hypoproteinemia FXÑHypoproteinemia XUÑLymphangiectasis, Intestinal LH LS; LX LU  MSCatalyzes phosphorylation of tyrosine residues in proteins, with ATP or other nucleotides as phosphate donors. PM86 HN86 MHÑProtein-Tyrosine Kinase ANdo not use /analogs RNEC 2.7.1.112 PIPhosphotransferases (66-72); Protein Kinases (73-85) MND8.586.913.696.729.726.700 XSTyrosine Protein Kinase; Tyrosine Specific Protein Kinase LH LS;  PM/metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64 HN/metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64 MHÑProteins ANGEN only: prefer specific proteins or specific precoord organ /proteins (EYE PROTEINS, etc.) or microbial proteins (BACTERIAL PROTEINS, etc.) & others; /biosyn: consider also PEPTIDE CHAIN INITIATION & related terms in Cat G5; /blood = BLOOD PROTEINS; /csf = CEREBROSPINAL FLUID PROTEINS; /urine = PROTEINURIA; /defic = PROTEIN DEFICIENCY; DIETARY PROTEINS is also available; do not use /analogs; ╥primary structure╙ = AMINO ACID SEQUENCE, ╥secondary structure╙ = PROTEIN CONFORMATION, ╥tertiary structure╙ = PROTEIN CONFORMATION, ╥quaternary structure╙ = MACROMOLECULAR SYSTEMS - all NIM coords with specific protein (IM) MND12.776 XUÑColipases LH LU  MHÑProteinuria ANfor clin state or varying levels of urinary protein: PROTEINS /urine is invalid; EPH (Edema, Proteinuria, Hypertension) = PREGNANCY TOXEMIAS & do not index under PROTEINURIA unless it is particularly discussed MNC12.777.584 FXÑUrine LH LX  MSProteoglycans found in cartilage. They consist of several chondroitin sulfate molecules linked to protein(s) by neutral sugar linkage regions. HN(76); was see under MUCOPOLYSACCHARIDES 1976 MHÑProteochondroitin Sulfates ANdo not use /analogs PIChondroitin (73-74); Mucoproteins (73-74) MND9.203.698.735.830; D12.776.395.650.750 DMÑProteoglycans LH LM  MSGlycoproteins which have a very high polysaccharide content. OLsearch MUCOPOLYSACCHARIDES 1973-74 PM77; was see under MUCOPOLYSACCHARIDES 1975-76; PROTEOCHONDROITIN SULFATES was see under MUCOPOLYSACCHARIDES 1976 HN77(75); was see under MUCOPOLYSACCHARIDES 1975-76 MHÑProteoglycans ANdo not use /analogs PIMucopolysaccharides (66-74) MND9.203.698.735; D12.776.395.650 XUÑProteochondroitin Sulfates LH LU  MSProtein-lipid combinations abundant in brain tissue, but also present in a wide variety of animal and plant tissues. In contrast to lipoproteins, they are insoluble in water, but soluble in a chloroform-methanol mixture. The protein moiety has a high content of hydrophobic amino acids. The associated lipids consist of a mixture of phosphoglycerides, cerebrosides and sulfatides, while lipoproteins contain phospholipids, cholesterol and triglycerides. PM77 HN77 MHÑProteolipids ANdo not confuse with LIPOPROTEINS; do not use /analogs /defic PILipoproteins (66-76); specific lipoprotein MND10.516.730; D12.776.816 FXÑLipoproteins LH LX  MHÑProteus ANGEN; do not use /blood-csf-urine; infection = PROTEUS INFECTIONS; see notes below on various species MNB3.475.300.600 XUÑProvidencia LH LU  MHÑProteus Infections ANGEN; coord IM with various species (NIM) MNC1.252.310.708 LH  PM74 HN74(72) MHÑProteus Mirabilis ANdo not use /blood-csf-urine; infection: coord NIM with PROTEUS INFECTIONS (IM) PIProteus (66-71) MNB3.475.300.600.501 LH  PM74 HN74(72) MHÑProteus Vulgaris ANdo not use /blood-csf-urine; infection: coord NIM with PROTEUS INFECTIONS (IM) PIProteus (66-71) MNB3.475.300.600.626 LH  MS2-Propylthioisonicotinamide. Antitubercular agent similar in action and side effects to ethionamide; used mostly in combination with other agents. Synonyms: Ektebin; Protiomide; Trevintix. HN(75) MHÑProthionamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN14222-60-7 PIIsonicotinic Acids (70-74); Sulfides (72-74) MND3.66.349.570; D3.383.725.394.675; D20.338.722 DMÑIsonicotinic Acids LH LM  MHÑProthrombin ANdo not use /blood /defic ( = HYPOPROTHROMBINEMIAS) RN9001-26-7 MND8.444.709; D12.776.124.125.800; D19.461.270.229.740; D19.461.270.792 XSFactor II LH LS  MSMeasurement of clotting time of plasma recalcified in the presence of excess tissue thromboplastin. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X. Used for monitoring anticoagulant therapy with coumarins. Modifications using specific thromboplastic reagents are the Thrombotest and Russell's viper venom time. Synonym: Quick test. MHÑProthrombin Time ANonly /vet; thrombotest goes here MNE1.223.459.153.627 XSRussell's Viper Venom Time LH LS  MSProducts of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. PM86 HN86 MHÑProto-Oncogene Proteins, Cellular AN/biosyn /physiol permitted; do not use /analogs PICell Differentiation (66-85); Gene Expression Regulation (81-85); Oncogenes (83-85); Proteins (66-85) MND12.776.820 XSC-Onc Proteins; Cellular Proto-Oncogene Proteins LH LS;  MSNormal cellular genes homologous to viral oncogenes. OLsearch ONCOGENES 1983-85 PM86; was see ONCOGENES 1983-85 HN86; was see ONCOGENES 1983-85 MHÑProto-Oncogenes AN╥normal cellular genes homologous to viral oncogenes╙; only /drug eff /rad eff PIGenes (66-77); Genes, Viral (78-82); Oncogenes (83-85) MNG5.275.740.791 XUÑIntracisternal A-Particle Genes LH LU  MSProtocatechuate:oxygen 3,4-oxidoreductase (decyclizing). Catalyzes the oxidation of protocatechuate to 3-carboxy-cis-cis-muconate in the presence of molecular oxygen. Contains ferric ion. Formerly 1.99.2.3 and 1.13.1.3 HN(75) MHÑProtocatechuate-3,4-Dioxygenase ANdo not use /analogs RNEC 1.13.11.3 PIBenzoates (72-74); Oxygenases (72-74) MND8.586.682.690.700 DMÑOxygenases LH LM  MS[3,4-Didehydro-9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoato(2)-N(23),N(24),N(25),N(26)]magnesium. A photo-active pigment localized in prolamellar bodies occurring within the proplastids of dark-grown bean leaves. In the process of photoconversion, the highly fluorescent protochlorophyllide is converted to chlorophyll. HN(75) MHÑProtochlorophyllide ANdo not use /defic /physiol RN20369-67-9 PIChlorophyll (72-74); Porphyrins (72-74) MND11.557.727.220.725; D11.557.727.640.220.725 XSProtochlorophyllide A DMÑChlorophyll LH LS LM  MSStable elementary particles having the smallest known positive charge, found in the nuclei of all elements; proton mass is less than that of a neutron; a proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. PM66 HN66 MHÑProtons ANno qualif; PIXE or proton-induced x-ray emission: index under SPECTROMETRY, X-RAY EMISSION (IM) + PROTONS (NIM) MNH1.671.579.404.765 XSHydrogen Ions LH LS  PM66 HN66(64) MHÑProtoplasts ANA 11 qualif except /cytol; /class permitted MNA11.789 LH  MSPorphyrins with four methyl, two vinyl and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin and most of the cytochromes. HN(75) MHÑProtoporphyrins ANdo not use /analogs PIPorphyrins (68-74) MND11.557.727.725 DMÑPorphyrins LH LM  MSAn achlorophyllous mutant of the green alga Chlorella. It is found in decayed matter, water, sewage and soil and produces cutaneous and disseminated infections in various vertebrates including man. It infects the skin, lymph nodes, eye, myocardium, kidney, muscle, and bovine mammary gland. PM80 HN80 MHÑPrototheca ANa mutant of green alga Chlorella; do not use /anat /embryol /microbiol /parasitol; infection by Prototheca: coord IM with INFECTION (NIM) + precoord organ/dis or organ/infection term (IM) PIAlgae (66-79); Algae, Green (70-79) MNB5.104.234.469.801 LH  MSMixtures of closely related hypotensive alkaloids from Veratrum album (Liliaceae); used as various salts in hypertension; the active ingredients in Cryptenamine. Synonyms: Alkavevril; Protalba; Proverin(e); Tensatrin; Unitensin; Veralba. OLuse PROTOVERATRINES to search PROTOVERATRINE A back thru 1966; to search PROTOVERATRINE A DERIVATIVES use PROTOVERATRINES back thru 1980, PROTOVERATRINES /AA 1978-79 & CEVANES 1969-77; search PROTOVERATRINE under VERATRUM 1966-68; to search CRYPTENAMINE use PROTOVERATRINES back thru 1975 & VERATRUM 1966-74 HN(80); PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74 MHÑProtoveratrines ANdo not use /analogs /defic /physiol MND3.132.920.256.543; D3.549.256.543; D18.162.955.710 XSCryptenamine; Neoprotoveratrin; Protoverin; Veratetrin DMÑVeratrum Alkaloids LH LS; ; ; LM  MHÑProtozoa ANGEN; avoid: prefer specifics; do not use /anat /embryol; infection = PROTOZOAN INFECTIONS; /drug eff: consider also ANTIPROTOZOAL AGENTS MNB1.841 FXÑMicrobiology LH LX  OLuse PROTOZOAN INFECTIONS to search BESNOITIASIS & HISTOMONIASIS back thru 1968 PMBESNOITIASIS was heading 1968-84; HISTOMONIASIS was heading 1968-85 HNBESNOITIASIS was heading 1968-84; HISTOMONIASIS was heading 1968-85 MHÑProtozoan Infections ANGEN; prefer specifics; /drug ther: consider also ANTIPROTOZOAL AGENTS MNC3.752 XSBesnoitiasis; Histomoniasis LH LS;  OLexper or vet; consider also PROTOZOAN INFECTIONS /VE & /VE with specific protozoan infect MH*Protozoan Infections, Animal (Non Mesh) MNC22.674.710 LH  MSN-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine hydrochloride. Tricyclic antidepressant similar in action and side effects to imipramine; may produce excitation. Synonyms; Vivactil; Concordin. HN(75) MHÑProtriptyline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN438-60-8 PIDibenzocycloheptenes (69-74); Propylamines (69-74) MND4.615.181.384.650; D15.236.122.140.792 DMÑDibenzocycloheptenes LH LM  PM68 HN68 MHÑProventriculus ANavian only; non-avian: use DIGESTIVE SYSTEM PIBirds (66-67); Poultry (66-67); Stomach (66-67) MNA13.853.710 LH  MSGram-negative rods isolated from human urine and feces. OLsearch PROTEUS 1974 HN(75) MHÑProvidencia ANdo not use /blood-csf-urine; infection: coord NIM with PROTEUS INFECTIONS (IM) MNB3.475.300.600.752 XSProteus Inconstans DMÑProteus LH LS LM  MSMan's use of space as a specialized elaboration of culture. OLsearch SPATIAL BEHAVIOR 1968-74 HN(75) MHÑProxemics ANno qualif MNF1.145.875.709; I1.880.894.627 DMÑSpatial Behavior LH LM  MSA syndrome characterized by abdominal wall musculature deficiency, cryptorchism, and urinary tract abnormalities. The syndrome derives its name from its characteristic distended abdomen with wrinkled skin. PM82 HN82 MHÑPrune Belly Syndrome ANdo not use /congen PIAbdominal Wall/AB (66-81); Abnormalities, Multiple (68-81); Cryptorchism (66-81); Urogenital System/AB (66-81) MNC16.131.77.745 LH  MHÑPrurigo MNC17.674 LH  MHÑPruritus ANnote spelling: -itus, not -itis; /drug ther: consider also ANTIPRURITICS MNC17.685 XSITCHING LH LS  MSIntense chronic itching in the anal area. MHÑPruritus Ani ANnote spelling: -itus, not -itis MNC6.405.469.860.101.752; C17.685.544 LH  MHÑPruritus Vulvae ANnote spelling: -itus, not -itis MNC13.371.944.626; C17.685.710 LH  MSThe reaction of potassium ferrocyanide with ferric iron to yield a dark blue precipitate at the sites of the ferric iron. Used to determine ferric iron in tissues, particularly in the diagnosis of disorders of iron metabolism. Synonym: ferrocyanide reaction. HN(79) MHÑPrussian Blue Reaction ANNIM; no qualif; also called ╥ferrocyanide reaction╙ PIDyes (66-78); Ferrocyanides (66-78) MNE5.909.262.607.810; E5.909.432.551.810; E5.909.715.810 DMÑHistocytochemistry LH LM  MSAscomycetous fungi, family Microascaceae, order Microascales, commonly found in the soil. They are causative agents of mycetoma, maduromycosis, and other infections in humans. OLuse PSEUDALLESCHERIA to search MONOSPORIUM 1966-85 HN(86); MONOSPORIUM was heading 1963-85 MHÑPseudallescheria ANdo not use /embryol /microbiol /parasitol; infection = probably MADUROMYCOSIS PIAscomycetes (66-85); Maduromycosis (66-85); Mycoses (66-85) MNB5.354.107.780 XSAllescheria; Monosporium apiospermum; Petriellidium DMÑAscomycetes LH LS; ; LM  MHÑPseudarthrosis ANdo not index under FRACTURES, UNUNITED unless particularly discussed MNC21.866.405.341.627 LH  MSAn aspect of cholinesterases. OLsearch CHOLINESTERASES 1966-74 HN(75); was see under CHOLINESTERASE 1963-74 MHÑPseudocholinesterase ANdo not use /analogs; /antag = CHOLINESTERASE INHIBITORS (IM) + PSEUDOCHOLINESTERASE (NIM with no qualif) RNEC 3.1.1.- MND8.586.277.352.100.170.710 DMÑCholinesterases LH LM  OLsearch HERMAPHRODITISM 1966-72 PM73; was see under HERMAPHRODITISM 1963-72 HN73; was see under HERMAPHRODITISM 1963-72 MHÑPseudohermaphroditism ANdo not use /congen; check tag will be genetic sex, not sex of patient as presented PIHermaphroditism (66-72) MNC16.131.939.842.316.627; C19.391.403.627 LH  PM65 HN65(63) MHÑPseudohypoparathyroidism ANdo not confuse with PSEUDOPSEUDOHYPOPARATHYROIDISM MNC5.116.198.709; C18.452.174.766; C18.452.648.618.815 LH  MSA family of Gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens. PM75 HN75 MHÑPseudomonadaceae PIBacteria (66-74) MNB3.400.750 LH  PMHYDROGENOMONAS was heading 1963-75 MHÑPseudomonas ANdo not use /blood-csf-urine; P. pyocyanea = PSEUDOMONAS AERUGINOSA; infection = PSEUDOMONAS INFECTIONS; P. pseudomallei infection = MELIOIDOSIS MNB3.400.750.690 XUÑHydrogenomonas LH LU  MHÑPseudomonas Aeruginosa ANdo not use /blood-csf-urine; also called ╥Pseudomonas pyocyanea╙; infection = PSEUDOMONAS INFECTIONS & do not bother to coord with Ps. aerug. unless pertinent MNB3.400.750.690.544 LH  MSA species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquify gelatin. PM74 HN74(72) MHÑPseudomonas Fluorescens ANin soil & water PIPseudomonas (66-71) MNB3.400.750.690.710 LH  MHÑPseudomonas Infections ANsee note under PSEUDOMONAS AERUGINOSA; Pseudomonas pseudomallei infect = MELIOIDOSIS MNC1.252.739 LH  MSThe accumulation in the peritoneal cavity of large quantities of mucoid or mucinous material secondary to the rupture of a mucinous tumor of the ovary or a mucocele of the appendix. PM87 HN87 MHÑPseudomyxoma Peritonei ANdo not use /anal /blood supply /secret /ultrastruct PIAscitic Fluid (68-86); Peritoneal Neoplasms (66-86) MNC4.588.33.513.780; C23.91.780 XSAscites, Gelatinous LH LS  PM72 HN72(70) MHÑPseudopodia ANA 11 qualif except /cytol PIOrganoids (66-69) MNA11.368.702.783 LH  HNwas in Cat G only 1968-78, was in Cat F only 1963-67 MHÑPseudopregnancy ANnote categ: use sensible Cat C qualif; do NOT check tag PREGNANCY MNC13.371.580; G8.520.870 XSPSEUDOCYESIS FXÑPregnancy LH LS LX  PM65 HN65(63) MHÑPseudopseudohypoparathyroidism ANdo not confuse with PSEUDOHYPOPARATHYROIDISM MNC5.116.198.709.628 LH  MHÑPseudorabies ANusually animal: do not use /vet but check tag ANIMAL MNC2.256.466.793; C22.742 XSAUJESZKY'S DISEASE LH LS  MSA species of Herpesviridae producing a usually fatal encephalomyelitis in cattle, sheep, dogs, cats, foxes and mink. OLsearch HERPESVIRIDAE 1966-74 PM80; was see under HERPESVIRUSES 1975-79, was see under HERPESVIRUS 1963-74 HN80(75); was see under HERPESVIRUSES 1975-79, was see under HERPESVIRUS 1963-74 MHÑPseudorabies Virus ANdo not use /blood-csf-urine /cytol; infection = PSEUDORABIES PIHerpesviridae (66-74) MNB4.909.204.382.753 XSAujeszky's Disease Virus; Herpesvirus suis LH LS;  PM73 HN73(64) MHÑPseudotumor Cerebri ANnote category: non-neopl MNC10.228.140.801 XSBENIGN INTRACRANIAL HYPERTENSION; INTRACRANIAL HYPERTENSION, BENIGN LH LS;  HN(72) MHÑPseudouridine ANdo not use /defic /physiol; /biosyn permitted for micro-organisms RN1445-07-4 PIUridine (66-71) MND13.570.685.852.628; D13.570.800.892.628 DMÑUridine LH LM  MHÑPseudoxanthoma Elasticum MNC16.131.831.766; C17.827.766 XSGRONBLAD-STRANDBERG SYNDROME LH LS  PM66 HN66(63) MHÑPsilocybine ANdo not use /defic /physiol RN520-52-5 MND3.438.473.914.700; D15.236.372.828 LH  PM68 HN68 MHÑPsittacines ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; includes also macaws PIBirds (66-67) MNB2.248.710 XUÑParakeets; ÑParrots LH LU;  MSCoumarin derivatives found in many different plants, especially Psoralea corylifolia (Legume), used for skin diseases, especially vitiligo and as sunscreens; they interact with nucleic acids and are also used as research tools. PM79; FICUSIN & TRIOXSALEN were see under COUMARINS 1975-78 HN79 MHÑPsoralens ANdo not use /analogs /defic /physiol; do not confuse with the specific drug PSORALEN see FICUSIN; do not index here for psoralens in PUVA THERAPY unless particularly discussed PICoumarins (66-78); Furans (66-78) MND3.438.150.446.750 XSFurocoumarins XUÑFicusin; ÑTrioxsalen LH LS LU;  MHÑPsoriasis ANof mouth or tongue = LEUKOPLAKIA, ORAL; psoriatic arthritis: coord IM with ARTHRITIS (IM) MNC17.697 LH  MSPersons who assist in the routine care of psychiatric persons, usually under the supervision of the nursing department. PM71 HN71 MHÑPsychiatric Aides ANdo not use /man /methods; includes orderlies & ward attendants; coord IM with HOSPITALS, PSYCHIATRIC or PSYCHIATRIC DEPARTMENT, HOSPITAL (IM or NIM) if pertinent PIHealth Manpower (68-70); Psychiatry (68-70) MNM1.526.485.67.652.628; N2.350.84.835 LH  MSHospital department responsible for the organization and administration of psychiatric services. OLuse PSYCHIATRIC DEPARTMENT, HOSPITAL to search HOSPITAL PSYCHIATRIC DEPARTMENTS back thru 1966 PM78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77 HN78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77 MHÑPsychiatric Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; orderlies & ward attendants go under PSYCHIATRIC AIDES; DF: PSYCHIATR DEP MNN2.278.354.422.641; N4.452.442.422.641 XSHospital Psychiatric Department LH LS  MSA specialty concerned with the application of psychiatric principles in caring for the mentally ill. Also, includes nursing care provided the mentally ill patient. MHÑPsychiatric Nursing ANSPEC: SPEC qualif MNF4.96.544.628; G2.478.676.710; N2.421.533.778 LH  MSStandardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. OLuse PSYCHIATRIC STATUS RATING SCALES to search FACTOR CONSTRUCT RATING SCALES back thru 1973 PM69 HN69; FACTOR CONSTRUCT RATING SCALES was see under PSYCHIATRIC STATUS RATING SCALES 1973-78 MHÑPsychiatric Status Rating Scales ANno qualif; DF: PSR SCALES PIPsychological Tests (66-68) MNF4.586 XSFactor Construct Rating Scales (FCRS) XUÑKatz Adjustment Scales; ÑLorr's Inpatient Multidimensional Psychiatric Rating Scale; ÑMental Status Schedule; ÑOverall and Gorham Brief Psychiatric Rating Scale; ÑWittenborn Scales LH LS LU; ; ; ;  MSThe medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders. MHÑPsychiatry ANSPEC only: SPEC qualif; do not confuse with MENTAL DISORDERS CATALOG: do not use /in adolesc ( = ADOLESCENT PSYCHIATRY) /in inf ( = CHILD PSYCHIATRY) MNF4.96.544; G2.403.642; G2.403.790.600 LH  MSThe science pertaining to the interrelationship of psychologic phenomena and the individual's response to the physical properties of sound. PM72 HN72(68) MHÑPsychoacoustics ANIM; no qualif PIAcoustics (66-67); Auditory Perception (67) MNF4.96.753.628; H1.671.31.503; H1.671.720.628 LH  MSA branch of science developed by Freud and his followers for the study of mental processes and behavior essentially utilizing free association to formulate the key concepts of unconscious motivation, conflict, and symbolism. MHÑPsychoanalysis ANSPEC only: SPEC qualif; as ther = PSYCHOANALYTIC THERAPY MNF4.96.544.779 LH  MSUtilization of Freudian theories to explain various psychologic aspects of art, literature, biographical material, etc. MHÑPsychoanalytic Interpretation ANIM; no qualif; /hist = PSYCHOANALYSIS /hist; differentiate from PSYCHOANALYTIC THEORY in that the theory is on a more universal level MNF4.628 LH  MSConceptual system developed by Freud and his followers in which unconscious motivations are considered to shape normal and abnormal personality development and behavior. PM66 HN66 MHÑPsychoanalytic Theory ANIM; no qualif; /hist = PSYCHOANALYSIS /hist; differentiate from PSYCHOANALYTIC INTERPRETATION in that the theory is on a more universal, less subjective level MNF2.739.794 XUÑFreudian Theory; ÑJungian Theory; ÑOedipus Complex; ÑOral Character LH LU; ; ;  MSA form of psychiatric treatment, based on Freudian principles, which seeks to eliminate or diminish the undesirable effects of unconscious conflicts by making the patient aware of their existence, origin, and inappropriate expression in current emotions and behavior. MHÑPsychoanalytic Therapy ANIM; only /class /educ /man /methods /stand; /hist = PSYCHOANALYSIS /hist MNF4.754.709 XSBalint Psychoanalytic Therapy LH LS  MSPsychodids are small, hairy, moth-like, blood-sucking flies which are of considerable public health importance as vectors of certain pathogenic organisms. Important disease related genera are Phlebotomus, Lutzomyia, and Sergentomyia. OLto search SANDFLIES use PSYCHODIDAE back thru 1973 & PHLEBOTOMUS 1966-72 PM85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72 HN85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72 MHÑPsychodidae AN/microbiol /parasitol permitted; do not use /drug eff with insecticides: TN 111 PIPhlebotomus (66-72) MNB1.131.617.289.781 XSLutzomyia; Moth Flies; Sandflies; Sergentomyia LH LS; ; ;  MSPrimarily a technique of group psychotherapy which involves a structure, directed, and dramatized acting out of the patient's personal and emotional problems. MHÑPsychodrama ANSPEC qualif MNF4.754.864.581.679 FXÑActing Out XUÑRole Playing LH LX LU  MSA discipline concerned with relations between messages and the characteristics of individuals who select and interpret them; it deals directly with the processes of encoding (phonetics) and decoding (psychoacoustics) as they relate states of messages to states of communicators. PM67 HN67 MHÑPsycholinguistics ANSPEC: IM, SPEC qualif; coord with specific linguistic & psychol concepts (IM); NIM coord, no qualif PILanguage (66) MNF2.694; F4.96.586; L1.143.506.598.628 FXÑLanguage Development LH LX  OLpre-explosion = PSYCHOLOGIC PROCESSES PRINCIPLES (PX) MH*Psychologic Processes and Principles (Non Mesh) MNF2 LH  OLconsider also PSYCHOLOGY /MT or /MT with specific PSYCHOLOGY indentions MH*Psychological Technics (Non Mesh) MNF4.669 LH  MSStandardized tests designed to measure abilities, as in intelligence, aptitude, and achievement tests, or to evaluate personality traits. MHÑPsychological Tests ANonly /class /econ /instrum /methods /stand MNF4.711 LH  MSPrinciples applied to the analysis and explanation of psychological or behavioral phenomena. PM69 HN69 MHÑPsychological Theory ANno qualif PIPsychology (66-68) MNF2.739 XUÑDouble Bind Theory; ÑGestalt Theory LH LU;  MSThe manipulation of psychological influences, primarily concerned with morale, to strengthen the ability of one's own country and weaken the enemy. MHÑPsychological Warfare ANno qualif; consider also PERSUASIVE COMMUNICATION MNI1.880.735.944.711 LH  MSThe science dealing with the study of mental processes and behavior in man and animals. MHÑPsychology ANSPEC: IM, SPEC qualif; prefer /psychol: Manual 19.5+; NIM for ╥psychological aspects of╙ terms not in Cat C, E1-6 & F3: no qualif; as NIM: Manual 27.10 CATALOG: do not use /in adolesc ( = ADOLESCENT PSYCHOLOGY) /in inf ( = CHILD PSYCHOLOGY) MNF4.96.628 LH  MSThe science which utilizes psychologic principles to derive more effective means in dealing with practical problems. MHÑPsychology, Applied ANSPEC: SPEC qualif MNF2.784 LH  MSThe branch of psychology concerned with psychological methods of recognizing and treating behavior disorders. MHÑPsychology, Clinical ANSPEC: SPEC qualif MNF4.96.628.579 LH  MSThe branch of psychology concerned with similarities or differences in the behavior of different animal species or of different races or peoples. MHÑPsychology, Comparative ANSPEC: IM, SPEC qualif; NIM coord, no qualif; do not check COMPARATIVE STUDY for as a field it is not a substitute for a comparison of two or more psychol concepts ( = COMPARATIVE STUDY tag): Manual 18.13.4 MNF4.96.628.629 LH  MSThe branch of psychology concerned with psychological aspects of teaching and the formal learning process in school. MHÑPsychology, Educational ANSPEC: SPEC qualif MNF2.784.629; F4.96.628.679 LH  MSThe branch of psychology which seeks to learn more about the fundamental causes of behavior by studying various psychologic phenomena in controlled experimental situations. MHÑPsychology, Experimental ANSPEC: SPEC qualif; avoid as NIM coord MNF4.96.628.729 LH  MSThe branch of applied psychology concerned with the application of psychologic principles and methods to industrial problems including selection and training of workers, working conditions, etc. MHÑPsychology, Industrial ANSPEC: SPEC qualif MNF2.784.692; F4.96.628.779 FXÑHuman Engineering LH LX  MSA branch of psychology in which there is collaboration between psychologists and physicians in the management of medical problems. Differs from clinical psychology which is concerned with the diagnosis and treatment of behavior disorders. PM83 HN83 MHÑPsychology, Medical ANSPEC: SPEC qualif MNF4.96.628.808; G2.720 XSMedical Psychology LH LS  MSThe branch of applied psychology concerned with psychological aspects of selection, assignment, training, morale, etc., of armed forces personnel. MHÑPsychology, Military ANSPEC: SPEC qualif; consider also MILITARY PERSONNEL /psychol MNF2.784.754 XSMILITARY PSYCHOLOGY LH LS  MSThe branch of psychology concerned with the effects of group membership upon the behavior, attitudes and beliefs of an individual. MHÑPsychology, Social ANSPEC: IM, SPEC qualif; NIM coord, no qualif MNF1.829; F4.96.628.829 XSSOCIAL PSYCHOLOGY FXÑRACE RELATIONS LH LS LX  MSAssessment of psychological variables by the application of mathematical procedures. MHÑPsychometrics ANSPEC: SPEC qualif; NIM coord: no qualif; includes statist analysis of psychol tests, validation, applic of statist theory or formulae to psychol MNF4.711.780 FXÑStatistics LH LX  MSRestlessness; a psychomotor expression of emotional tension. PM78 HN78 MHÑPsychomotor Agitation ANdo not use /drug eff /physiol /rad eff PIMotor Activity (68-77); Psychomotor Disorders (69-77) MNF3.126.720.710 XSAgitation, Psychomotor; Excitement, Psychomotor; Restlessness LH LS; ;  MSPsychogenic disturbances in motor aspects of behavior. PM69 HN69 MHÑPsychomotor Disorders ANdo not use /drug eff /physiol /rad eff PIMovement Disorders (66-68); specific disorders MNF3.126.720 FXÑMovement Disorders LH LX  MSThe coordination of a sensory or ideational (cognitive) process and a motor activity. PM83 HN83 MHÑPsychomotor Performance ANonly /drug eff /physiol /rad eff PIMotor Skills (66-82); Visual Perception (66-82) MNF2.808 XSPerceptual Motor Performance; Sensory Motor Performance; Visual Motor Coordination LH LS; ;  MSThe study of significant causes and processes in the development of mental illness. MHÑPsychopathology ANSPEC: IM, SPEC qualif; NIM coord, no qualif; do not confuse with MENTAL DISORDERS: Manual 27.15 MNF4.96.670 LH  MSThe study of the effects of drugs on mental and behavioral activity. MHÑPsychopharmacology ANSPEC: IM, SPEC qualif; NIM coord, no qualif; Manual 27.14: relation to PSYCHOTROPIC DRUGS MNF4.96.712; F4.881.505; G1.703.546; G2.628.546 FXÑPsychotropic Drugs LH LX  MSThe science dealing with the correlation of the physical characteristics of a stimulus, e.g., frequency or intensity, with the response to the stimulus, in order to assess the psychologic factors involved in the relationship. PM70 HN70 MHÑPsychophysics ANSPEC: IM, SPEC qualif; NIM coord, no qualif; PSYCHOACOUSTICS is also available PIPerception (66-69) MNF4.96.753; H1.671.720 FXÑDifferential Threshold LH LX  MSSerious disturbances of any organ system which are considered to be of psychogenic origin. PM68 HN68 MHÑPsychophysiologic Disorders ANfor ╥psychosomatic╙ or ╥psychogenic╙ diseases; differentiate from PSYCHOSOMATIC MEDICINE which is the field; differentiate from SOMATOFORM DISORDERS: somatoform are symptoms of organic disease without actual disease, psychophysiol are actual diseases of psychol origin or exacerbation; coord IM with specific dis /psychol (IM); do not use /drug eff /physiol /rad eff; do not use /compl for the psychosomatic manifest, i.e., psychosomatic asthma = ASTHMA + PSYCHOPHYSIOLOGIC DISORDERS not PSYCHOPHYSIOLOGIC DISORDERS /compl; Manual 27.13 CATALOG: form qualif = PSYCHOSOMATIC MEDICINE /form PIPsychosomatic Medicine (66-67) MNF3.709.630 XSPsychosomatic Disorders LH LS  MSThe study of the physiological basis of human and animal behavior. MHÑPsychophysiology ANSPEC: SPEC qualif; NIM as coord but use /physiol with F1 & F2 terms & /psychol with C & F3 terms; no qualif when NIM coord; Manual 27.13 MNF2.830; F4.96.795; G1.782.795 XSPSYCHOLOGY, PHYSIOLOGICAL LH LS  MSA group of mental disorders associated with organic brain damage and caused by poisoning from alcohol. Included in this group are: delirium tremens, Korsakoff syndrome, and often alcoholic hallucinosis. MHÑPsychoses, Alcoholic ANdo not use /chem ind /drug eff /physiol /rad eff MNC21.613.53.270.630; F3.709.680.610.580.510 XUÑAlcohol Withdrawal Delirium LH LU  MSPsychotic organic mental disorders resulting from toxic effect of drugs and chemicals. OLuse PSYCHOSES, SUBSTANCE-INDUCED to search PSYCHOSES, TOXIC back thru 1966 PM81; was PSYCHOSES, TOXIC 1963-80 HN81; was PSYCHOSES, TOXIC 1963-80 MHÑPsychoses, Substance-Induced ANdo not use /chem ind /drug eff /physiol /rad eff MNC21.613.809; F3.709.680.610.580 XSPsychoses, Drug; Psychoses, Toxic LH LS;  MSThe stages of development of the psychological aspects of sexuality from birth to adulthood; i.e., oral, anal, genital, and latent periods. PM68 HN68 MHÑPsychosexual Development ANno qualif PIChild Psychology (66-67); Sex Behavior (66-67) MNF1.752.747.722; F2.739.794.793 FXÑSex XUÑAnal Stage; ÑLatency Period (Psychology); ÑOral Stage; ÑPhallic Stage LH LX LU; ; ;  MSSexual disorders which are assumed to be due to psychological factors. They include transsexualism, the paraphilias, and the psychosexual dysfunctions--dyspareunia, frigidity, and impotence. PM81 HN81 MHÑPsychosexual Disorders ANdo not use /drug eff /physiol /rad eff; see Tree for scope; differentiate from PSYCHOSEXUAL DYSFUNCTIONS which are restricted to sex dysfunct related to coitus MNF3.709.597.608 XUÑPsychosexual Dysfunctions LH LU  MSThe essential feature of these dysfunctions is inhibition in the appetitive or psychophysiological changes that characterize the complete sexual response cycle. This cycle includes the following phases: appetitive, excitement, orgasm, and resolution (relaxation). HN(81) MHÑPsychosexual Dysfunctions ANdo not use /drug eff /physiol /rad eff; differentiate from PSYCHOSEXUAL DISORDERS: see note there MNF3.709.597.608.780 XSSexual Dysfunctions, Psychological DMÑPsychosexual Disorders LH LS LM  MS2-Amino-3-hydroxy-4-octadecenyl-beta-D-galactopyranoside. An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then, itself reacts with fatty acid-Coenzyme A to form the cerebroside. HN(75) MHÑPsychosine AN/biosyn /physiol permitted RN2238-90-6 PIGalactose (72-74); Glycosides (74); Sphingosine (72-74) MND2.33.329.291.846.700; D2.92.63.291.846.700; D9.203.408.730 XSGalactosylsphingosine; Sphingosine Galactoside DMÑSphingosine LH LS; LM  MSThe absence of appropriate stiumli in the physical or social environment which are necessary for the emotional, social, and intellectual development of the individual. PM72 HN72(69) MHÑPsychosocial Deprivation ANno qualif PICultural Deprivation (68) MNF1.829.628; I1.880.143.806 LH  MSA system of medicine which aims at discovering the exact nature of the relationship of the emotions and bodily function, affirming the principle that the mind and body are one. MHÑPsychosomatic Medicine ANSPEC: SPEC qualif; differentiate from PSYCHOPHYSIOLOGIC DISORDERS, the patient; also Manual 27.13 CATALOG: use with form qualif instead of PSYCHOPHYSIOLOGIC DISORDERS /form MNF4.96.544.830 LH  MSTreatment of chronic, severe and intractable psychiatric disorders by surgical removal or interruption of certain areas or pathways in the brain, especially in the prefrontal lobes. MHÑPsychosurgery ANSPEC qualif; coord with specific lobe (NIM); /adv eff /methods /mortal /psychol /rehabil permitted MNE4.530.730; F4.881.630 XSGyrectomy; Leucotomy; Leukotomy; Lobotomy; Topectomy LH LS; ; ; ;  MSA generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication. MHÑPsychotherapy ANSPEC qualif MNF4.754 XUÑGestalt Therapy; ÑPsychotherapy, Rational-Emotive LH LU;  MSAny form of psychotherapy designed to produce therapeutic change within a minimal amount of time; generally not more than 20 sessions. PM73 HN73 MHÑPsychotherapy, Brief ANSPEC qualif PIPsychotherapy (66-72) MNF4.754.738 XSSHORT TERM PSYCHOTHERAPY LH LS  MSA form of therapy in which two or more patients participate under the guidance of one or more psychotherapists for the purpose of treating emotional disturbances, social maladjustments and psychotic states. MHÑPsychotherapy, Group ANSPEC qualif; differentiate from multiple: group = more than one patient, multiple = more than one therapist MNF4.754.864.581 XSGroup Therapy LH LS  MSThe use of more than one therapist at one time in individual or group psychotherapy. PM73 HN73 MHÑPsychotherapy, Multiple ANSPEC qualif; differentiate from group: multiple = more than one therapist, group = more than one patient PIPsychotherapy (66-72); Psychotherapy, Group (66-72) MNF4.754.766 LH  MSThe replacement of illogical and unrealistic ideas with more realistic and adaptive ones through direct intervention and confrontation by the therapist. HN(77) MHÑPsychotherapy, Rational-Emotive ANSPEC qualif PIPsychotherapy (66-76) MNF4.754.785 XSPsychotherapy, Rational; Rational-Emotive Psychotherapy DMÑPsychotherapy LH LS; LM  MSDisorders in which there is gross impairment in reality testing. The individual incorrectly evaluates his or her perception and thoughts and makes incorrect inferences about reality even in the face of contrary evidence. Delusions or hallucinations are present. OLuse PSYCHOTIC DISORDERS to search PSYCHOSES back thru 1966 PM81; was PSYCHOSES 1963-80 HN81; was PSYCHOSES 1963-80 MHÑPsychotic Disorders AN/chem ind = PSYCHOSES, SUBSTANCE-INDUCED; do not use /drug eff /physiol /rad eff; puerperal psychoses = PSYCHOTIC DISORDERS (IM) + PUERPERAL DISORDERS (IM); psychoses or psychotic disord in children = CHILD DEVELOPMENT DISORDERS, PERVASIVE CATALOG: do not use /in inf ( = CHILD DEVELOPMENT DISORDERS, PERVASIVE) MNF3.709.680 XSPsychoses; Psychosis, Brief Reactive; Schizoaffective Disorder; Schizophreniform Disorders XUÑCapgras Syndrome LH LS; ; ; LU  MSDrugs with an effect on psychic function, behavior or experience; drugs exerting an effect upon the mind; substances capable of modifying mental activity. OLsearch ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS 1974 PM75; was see under ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS 1974 HN75; was see under ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS 1974 MHÑPsychotropic Drugs ANdo not use /analogs /biosyn /defic /physiol; relation to PSYCHOPHARMACOLOGY: Manual 27.14; drugs of abuse: Bull 102 (Oct 77) MND15.236 XSPsychoactive Agents; Psychopharmaceuticals FXÑPsychopharmacology LH LS; LX  MSDried, ripe seeds of Plantago psyllium, P. indica and P. ovata (Plantaginaceae); plantain seeds swell in water and are used as demulcents and bulk laxatives. Synonyms: Arcolax; Coreline; Isogel; Metamucil; Konsyl; Visiblin. HNwas in Cat B & D 1963-77 MHÑPsyllium ANdrug only, with PLANTAGO the plant source; do not use /analogs /defic /physiol; /biosyn permitted if by plant RN8063-16-9 MND19.316.396.777 XSIspaghula LH LS  PM66 HN66 MHÑPteridines ANdo not use /analogs /biosyn /defic /physiol MND3.438.733 XSPYRAZINOPYRIMIDINES LH LS  MHÑPterins ANdo not use /analogs /biosyn /defic /physiol MND3.438.733.631; D11.557.831 LH  MSCatalyzes the hydrolysis of pteroylpolyglutamic acids in gamma linkage to pterolylmonoglutamic acid and free glutamic acid. HN(75) MHÑPteroyl Polyglutamate Hydrolase ANdo not use /analogs RNEC 3.4.22.12 PICarboxypeptidases (72-74); Folic Acid (72-74); Glutamates (72-74) MND8.586.277.656.245.750 XSConjugase; Folate Conjugase; Folyl Conjugate Synthetase; Gamma-Glutamyl Hydrolase; gamma-Glutamyl Carboxypeptidase DMÑCarboxypeptidases LH LS; ; ; ; LM  MSDerivatives of folic acid (pteroylglutamic acid). In gammaglutamyl linkage they are found in many tissues. They are converted to folic acid by the action of pteroylpolyglutamate hydrolase or synthesized from folic acid by the action of folate polyglutamate synthetase. Synthetic pteroylpolyglutamic acids, which are in alpha-glutamyl linkage, are active in bacterial growth assays. HN(79) MHÑPteroylpolyglutamic Acids AN/biosyn /physiol permitted; do not use /analogs PIFolic Acid (66-78); Glutamates (66-78) MND11.786.708.328.700 XSFolate Polyglutamates; Polyglutamate Folates DMÑFolic Acid LH LS; LM  MHÑPterygium ANa disease, not a structure MNC11.187.781 LH  MSTwo of the masticatory muscles: the internal, or medial, pterygoid muscle and external, or lateral, pterygoid muscle. Action of the former is closing the jaws and that of the latter is opening the jaws, protruding the mandible, and moving the mandible from side to side. HN(80) MHÑPterygoid Muscles ANmasticatory muscles opening, closing & moving jaws forward or sideways PIFacial Muscles (66-79); Masticatory Muscles (66-79); Muscles (66-79) MNA2.633.560.790; A14.530.790 DMÑMasticatory Muscles LH LM  MHÑPuberty ANhuman only; qualif permitted: /blood-csf-urine /drug eff /ethnol /genet /immunol /metab /physiol /psychol /rad eff; for animal use AGING, GROWTH or SEX MATURATION MNG7.168.818; G8.520.940.508 LH  MSUnusually late sexual maturity. PM81 HN81 MHÑPuberty, Delayed ANhuman only PIPuberty (66-80) MNC19.391.690 LH  MSUnusually early sexual maturity. MHÑPuberty, Precocious ANhuman only MNC19.391.693 FXÑAdrenal Hyperplasia, Congenital LH LX  MHÑPubic Bone MNA2.835.232.611.781 LH  MHÑPubic Symphysis MNA2.835.583.656 FXÑSYMPHYSIOTOMY LH LX  MSFinancial assistance to impoverished persons for the essentials of living through federal, state or local government programs. PM68 HN68 MHÑPublic Assistance ANonly /econ /hist /legis /organ /trends; specify geog CATALOG: /geog /form PIPublic Health (66-67); Social Welfare (66-67) MNN3.219.521.346.506 FXÑSocial Welfare XUÑOld Age Assistance LH LX LU  MH*Public Facilities (Non Mesh) MNG3.850.860.410 LH  MSBranch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state or municipal level. MHÑPublic Health ANonly /econ /educ /hist /man /trends; a venerable hist & modern concept of the health & health problems of ╥the public╙: do not confuse with NATIONAL HEALTH PROGRAMS CATALOG: /geog /form MNG2.403.790.548.560; G3.850 FXÑHealth Planning; ÑOccupational Medicine; ÑSOCIAL MEDICINE; ÑZOONOSES LH LX; ; ;  MSManagement of public health organizations or agencies. MHÑPublic Health Administration ANSPEC: SPEC qualif except /educ CATALOG: /geog /form MNN4.452.794 FXÑCommunity Health Services LH LX  MSA dental specialty concerned with the prevention of disease and the maintenance of oral health through promoting organized dental health programs at a community, state, or federal level. MHÑPublic Health Dentistry ANSPEC: SPEC qualif CATALOG: /geog /form MNG2.163.876.770; G3.890 FXÑHealth Education, Dental XUÑCommunity Dentistry LH LX LU  MSThe field of nursing focusing on the health of the community through educational and preventive programs, as well as providing treatment and diagnostic services. MHÑPublic Health Nursing ANSPEC: SPEC qualif CATALOG: /geog /form MNG2.478.676.755 LH  MSHousing subsidized by tax funds, usually intended for low income persons or families. PM68 HN68 MHÑPublic Housing ANonly /hist /stand /trends CATALOG: /geog /form PIHousing (66-67); Social Welfare (66-67) MNN1.696.324.631 LH  MSThe attitude of a significant portion of a population toward any given proposition, based upon a measurable amount of factual evidence, and involving some degree of reflection, analysis and reasoning. PM68 HN68 MHÑPublic Opinion ANno qualif PIAttitude (66-67) MNF1.829.651; I1.880.630.548 FXÑAttitude; ÑAttitude to Health LH LX;  MSA course or method of action selected, usually by a government, from among alternatives to guide and determine present and future decisions. PM78 HN78 MHÑPublic Policy ANno qualif; specify state or country or other body if pertinent CATALOG: /geog /form MNI1.880.604.710.608; N3.706.710.608 XSSocial Policy FXÑPolicy Making LH LS LX  MSThe attitudes and judgments of the public toward an organization or an individual. MHÑPublic Relations ANonly /econ /trends MNF1.829.674; N4.452.822 XSNews Media Relations XUÑAnniversaries and Special Events LH LS LU  MH*Publications (Non Mesh) MNL1.178.682 LH  MHÑPublishing ANthe industry & the dissemination of knowledge & research: do not confuse with WRITING (the act, profession or product) or with AUTHORSHIP (identity as author); only /econ /hist /legis /man /methods /stand /trends; med publishing: do not coord with MEDICINE; consider also BOOK INDUSTRY CATALOG: /geog /form MNL1.737 XUÑJournalism, Dental LH LU  MHÑPuerperal Disorders ANcheck the tags FEMALE & PREGNANCY; puerperal psychoses: coord IM with PSYCHOTIC DISORDERS (IM) MNC13.703.844 LH  MHÑPuerperal Infection ANcheck the tags FEMALE & PREGNANCY MNC1.539.674.715; C13.703.700.715; C13.703.844.757 LH  MSPeriod from delivery of the placenta until return of the reproductive organs to their normal nonpregnant morphologic state. In humans, generally lasts for six to eight weeks. MHÑPuerperium ANhuman & animal; check the tags FEMALE & PREGNANCY: Manual 18.4.3; qualif permitted: /blood-csf-urine /drug eff /immunol /metab /physiol /psychol /rad eff; puerperal psychoses = PUERPERAL DISORDERS (IM) + PSYCHOTIC DISORDERS (IM); ╥postpartum amenorrhea╙ is indexed under PUERPERIUM (IM) + AMENORRHEA (IM) & not LACTATION unless lactation is particularly discussed MNG8.520.882 XSPostpartum Period LH LS  MHÑPuerto Rico ANfor Puerto Rico as a geog entity (as in epidemiol articles) & for Puerto Ricans in Puerto Rico; for Puerto Ricans living in the United States as an ethnic group, coord PUERTO RICO /ethnol (NIM) + HISPANIC AMERICANS (IM) MNZ1.107.904.770 LH  MSA pulmonary disease of sheep characterized by hyperplasia and hypertrophy of septal cells of the lung. Syn: jaagsiekte, epizootic adenomatosis. PM68 HN68 MHÑPulmonary Adenomatosis, Ovine ANdo not use /vet; don't forget also SHEEP (NIM) & check tag ANIMAL; DF: PULM ADENOMATOSIS OVINE PISheep Diseases (66-67) MNC2.256.466.838; C22.836.715 XSADENOMATOSIS, PULMONARY, OVINE; Jaagsiekte LH LS;  MHÑPulmonary Alveolar Proteinosis MNC8.381.719 LH  MSSmall polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. PM66 HN66(64) MHÑPulmonary Alveoli MNA4.411.715 LH  MSThe short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. MHÑPulmonary Artery ANdo not use /blood supply MNA7.231.114.715 LH  MSThe circulation of blood through the lungs. MHÑPulmonary Circulation ANconsider also LUNG /blood supply; only /drug eff /rad eff MNG9.330.163.808 FXÑVENTILATION-PERFUSION RATIO LH LX  PM72 HN72(71) MHÑPulmonary Diffusing Capacity ANonly /drug eff /rad eff PIDiffusion (68-70); Respiration (66-70); Respiratory Function Tests (66-70) MNE1.302.796.568.572; G9.772.521.602.600 LH  MHÑPulmonary Edema ANincludes congestion MNC8.381.742 FXÑEdema LH LX  MHÑPulmonary Embolism ANincludes thrombosis, thromboembolism & infarct MNC14.907.854.404.782 LH  MSCondition of the lungs characterized by increase beyond normal in the size of air spaces distal to the terminal bronchioles, either from dilatation of the alveoli or from destruction of their walls. MHÑPulmonary Emphysema MNC8.381.495.632 XSEmphysema, Pulmonary FXÑEmphysema LH LS LX  MSA disease characterized by pulmonary infiltrations of eosinophils and blood eosinophilia. OLuse PULMONARY EOSINOPHILIA to search LOEFFLER'S SYNDROME back thru 1966 PM82; LOEFFLER SYNDROME was heading LOEFFLER'S SYNDROME 1963-81 HN82; LOEFFLER SYNDROME was heading LOEFFLER'S SYNDROME 1963-81 MHÑPulmonary Eosinophilia PIEosinophilia (66-81); Lung Diseases (66-81) MNC8.381.750; C15.378.553.231.750 XSEosinophilia, Pulmonary; Eosinophilia, Tropical; Eosinophilic Pneumonia; Loeffler Syndrome; Pneumonia, Eosinophilic LH LS; ; ; ;  MSChronic inflammation and progressive fibrosis of the pulmonary alveolar walls, with steadily progressive dyspnea, resulting finally in death from oxygen lack or right heart failure. MHÑPulmonary Fibrosis ANusually chronic so do not coord with CHRONIC DISEASE MNC8.381.765 XSAlveolitis, Fibrosing; Hamman-Rich Syndrome; Lung Disease, Interstitial; PNEUMONIA, INTERSTITIAL; Pneumonitis, Interstitial LH LS; ; ; ;  MSThe exchange of oxygen and carbon dioxide between alveolar air and pulmonary capillary blood. PM83 HN83 MHÑPulmonary Gas Exchange ANonly /drug eff /rad eff; do not coord with OXYGEN or CARBON DIOXIDE unless particularly discussed MNE1.302.796.568; G9.772.521.602 LH  MHÑPulmonary Heart Disease MNC14.280.832 XSCor Pulmonale FXÑLung Diseases LH LS LX  HN(71) MHÑPulmonary Stretch Receptors ANdo not use /innerv PILung/IR (66-70) MNA8.796.511.725.404.808 DMÑMechanoreceptors LH LM  MSStenosis of the conus arteriosus (infundibulum) with or without involvement of the pulmonary valve; usually associated with a defect in the interventricular septum. OLsearch CARDIOMYOPATHY, HYPERTROPHIC 1967-74 HN(75); was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85 MHÑPulmonary Subvalvular Stenosis MNC14.280.600.100.715 XSInfundibular Stenosis, Pulmonary; Obstructive Subaortic Conus; Pulmonary Infundibular Stenosis DMÑCardiomyopathy, Hypertrophic LH LS; ; LM  MSLipoproteins in which the lipid moiety is based mainly on lecithin and other phospholipids. May also contain small amounts of prostaglandins and other compounds. Composition is species dependent. They are secreted by the mitochondria of type II alveolar cells. Surfactants regulate the surface tension of the mucoid layer lining the alveoli. Absence of the surfactants in premature infants results in hyaline membrane disease and in adults in atelectasis. Synthetic pulmonary surfactants have also been prepared and are used therapeutically. OLuse PULMONARY SURFACTANTS to search PULMONARY SURFACTANT back thru 1971 (as Prov 1971-72) PM87; was PULMONARY SURFACTANT 1973-86 HN87; was PULMONARY SURFACTANT 1971-86 (Prov 1971-72) MHÑPulmonary Surfactants AN/biosyn /physiol permitted PIPulmonary Alveoli (66-70); Surface-Active Agents (66-70) MND10.516.532.780; D10.516.695.300.700.870; D12.776.521.825; D24.185.701 XSPulmonary Surfactant; Surfactant, Pulmonary FXÑSurface-Active Agents LH LS; LX  MSA valve situated at the entrance to the pulmonary trunk from the right ventricle. MHÑPulmonary Valve ANdo not use /blood supply; atresia: index PULMONARY VALVE /abnorm; stenosis = PULMONARY VALVE STENOSIS; regurgitation, incompetence or insufficiency = PULMONARY VALVE INSUFFICIENCY MNA7.541.510.738 LH  PM67 HN67 MHÑPulmonary Valve Insufficiency ANimperfect closing of valve; incompetence & regurgitation go here; /congen permitted PIHeart Diseases (66); Pulmonary Valve (66) MNC14.280.484.660 LH  OLuse PULMONARY VALVE STENOSIS to search PULMONARY STENOSIS back thru 1966 PM67; was PULMONARY STENOSIS 1963-66 HN67; was PULMONARY STENOSIS 1963-66 MHÑPulmonary Valve Stenosis AN/congen permitted; atresia = PULMONARY VALVE /abnorm MNC14.280.484.716 XSPULMONARY STENOSIS LH LS  MSThe veins that return the oxygenated blood from the lungs to the left atrium of the heart. MHÑPulmonary Veins ANdo not use /blood supply MNA7.231.908.713 LH  MSObstruction of the small and medium-sized pulmonary veins by fibrous proliferation of the intima and media or by thrombosis or a combination of both. PM87 HN87 MHÑPulmonary Veno-Occlusive Disease ANDF: PVOD PIPulmonary Veins (66-86); Vascular Diseases (66-86) MNC8.381.780; C14.907.690 LH  MSThe blood pressure as recorded after wedging a catheter in a small pulmonary artery; believed to reflect the pressure in the pulmonary capillaries. PM81 HN81 MHÑPulmonary Wedge Pressure ANonly /drug eff /rad eff PIBlood Pressure (66-80); Pulmonary Circulation (66-80) MNG9.330.612.114.695 XSPulmonary Artery Wedge Pressure; Pulmonary Capillary Wedge Pressure; Pulmonary Venous Wedge Pressure; Wedge Pressure FXÑHeart Catheterization LH LS; ; ; LX  PM65 HN65 MHÑPulpectomy ANremoval of pulp from pulp chamber & root canal: differentiate from PULPOTOMY; do not use /util except by MeSH definition MNE6.397.633 FXÑDental Pulp LH LX  PM65 HN65(63) MHÑPulpitis MNC7.793.237.820 LH  PM65 HN65 MHÑPulpotomy ANremoval of coronal portion of pulp: differentiate from PULPECTOMY; do not use /util except by MeSH definition MNE6.397.695 FXÑDental Pulp LH LX  MSRhythmic, intermittent propagation of a fluid through a vessel or piping system, in contrast to constant, smooth propagation, which produces laminar flow. The quality of blood flow, whether smooth (laminar) or pulsatile, is important to the integrity of the tissues being artificially perfused by various heart assist devices or in regional perfusion. HN(87) MHÑPulsatile Flow ANonly /drug eff /rad eff PIBlood Flow Velocity (66-86); Models, Biological (66-79); Models, Cardiovascular (80-86); Rheology (66-86) MNG9.330.612.725; H1.671.799.775 XSFlow, Pulsating; Perfusion, Pulsatile DMÑRheology LH LS; LM  MHÑPulse ANonly /drug eff /rad eff MNE1.145.569.798; E1.706.817; G9.330.612.733 LH  MSUse of a pulse of X-rays or fast electrons to generate free radicals for spectroscopic examination. HN(75) MHÑPulse Radiolysis ANonly /instrum /methods MNE5.196.867.660; H1.181.278.862.600 DMÑSpectrum Analysis LH LM  MHÑPunched-Card Systems ANonly /econ /hist /instrum /trends /util (if by MeSH definition) MNL1.700.568.110.85.800 LH  MHÑPunctures ANdo not use /util except by MeSH definition MNE1.223.894.632 LH  MSThe application of an unpleasant stimulus or penalty for the purpose of eliminating or correcting undesirable behavior. MHÑPunishment ANhuman & animal; no qualif MNF2.463.425.770.571; I1.880.630.716 LH  MSAn inactive stage between the larval and adult stages in the life cycle of insects. PM74 HN74(70) MHÑPupa ANNIM; for metamorphosing insects only: do not use /embryol with ref to pupae PIInsects (66-69); specific insect; Metamorphosis, Biological (66-69) MNB1.583.758 LH  MHÑPupil ANof eye: do not use for STUDENTS; only contraction & dilatation of pupil go here: everything else is probably IRIS; only /drug eff (consider also MIOTICS & MYDRIATICS) /physiol /rad eff MNA9.371.60.513.784 FXÑREFLEX, PUPILLARY LH LX  OL╥abnormal pupil reactions╙ is indexed under PUPIL; see note under PUPIL above MH*Pupil Reactions, Abnormal (Non Mesh) MNC11.716 LH  MSHospital department responsible for the purchasing of supplies and equipment. OLuse PURCHASING, HOSPITAL to search HOSPITAL PURCHASING back thru 1966 PM78; was HOSPITAL PURCHASING 1963-77 HN78; was HOSPITAL PURCHASING 1963-77 MHÑPurchasing, Hospital ANonly /econ /legis /man /methods /organ /stand /trends MNN2.278.354.422.679; N4.452.442.422.679 XSHospital Purchasing FXÑEquipment and Supplies, Hospital LH LS LX  MSPurine nucleoside:orthophosphate ribosyltransferase. Catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. HN(75) MHÑPurine Nucleoside Phosphorylases ANdo not use /analogs RNEC 2.4.2.1 PIPentosyltransferases (73-74); Phosphates (73-74); Purine Nucleosides (73-74) MND8.586.913.647.700 XSInosine Phosphorylase DMÑPentosyltransferases LH LS LM  PM74 HN74 MHÑPurine Nucleosides ANdo not use /analogs /defic /physiol MND13.570.583 LH  PM74 HN74(72) MHÑPurine Nucleotides ANdo not use /analogs /defic /physiol PINucleotides (66-71) MND13.695.667 LH  PM65 HN65 MHÑPurine-Pyrimidine Metabolism, Inborn Errors ANdo not use /congen; coord IM with specific purine /metab (IM) or pyrimidine /metab (IM); DF: PP METAB INBORN ERR MNC18.452.648.798 LH  MHÑPurines ANdo not use /analogs /defic /physiol MND3.438.759 XUÑZeatin LH LU  PM68 HN68 MHÑPurinones ANdo not use /analogs /biosyn /defic /physiol PIKetones (66-67); Purines (66-67) MND3.438.759.758 LH  PM65 HN65(64) MHÑPurkinje Cells ANin cerebellum: do not confuse with PURKINJE FIBERS (heart); A 11 qualif MNA8.186.211.212.212.633; A8.663.812; A11.671.789 LH  MSModified cardiac muscle fibers composing the terminal portion of the heart conduction system. OLsearch HEART CONDUCTION SYSTEM 1968-74 HN(75) MHÑPurkinje Fibers ANin heart: do not confuse with PURKINJE CELLS in cerebellum; do not use /blood supply /innerv MNA7.541.409.683 DMÑHeart Conduction System LH LM  MS3'-[2-Amino-3-(4-methoxyphenoxy)-1-oxopropyl)- amino]-3'-deoxy-N,N-dimethyladenosine. An antibiotic from Streptomyces alboniger that inhibits protein synthesis by binding to RNA; proposed antineoplastic and antitrypanosomal agent; used in research as inhibitor of protein synthesis. Synonyms: CL 13900; 3123 L; P 638; Stylomycin. PM65 HN65(63) MHÑPuromycin ANdo not use /defic /physiol RN53-79-2 MND9.203.408.51.788; D20.85.707; D26.87.762 XUÑPuromycin Aminonucleoside LH LU  MS3'-Amino-3'-deoxy-N,N-dimethyladenosine. Puromycin derivative which lacks the methoxyphenylalanyl group on the amine of the sugar ring. It is an antibiotic with antineoplastic properties; causes nephrosis. Synonyms: ARDMA; NSC 3056; Stylomycin aminonucleoside. HN(75) MHÑPuromycin Aminonucleoside ANdo not use /biosyn /defic /physiol RN58-60-6 PIAntibiotics, Antineoplastic (72-74); Amino Sugars (74); Deoxyadenosine (72-74) MND9.203.408.51.788.650; D13.570.230.229.650; D20.85.707.700; D22.204.106.779; D22.204.144.779; D26.87.762.650 DMÑPuromycin LH LM  MSA group of disorders characterized by purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. MHÑPurpura ANGEN or unspecified; prefer specifics MNC15.378.463.597 XSPetechiae FXÑEcchymosis LH LS LX  MHÑPurpura, Hyperglobulinemic MNC15.378.147.780.630.790; C15.378.463.597.550; C20.683.780.630.790 XSWALDENSTROM'S HYPERGLOBULINEMIC PURPURA LH LS  MSA form of nonthrombocytopenic purpura probably due to a vasculitis of unknown cause, associated with a variety of clinical symptoms including urticaria and erythema, arthropathy and arthritis, gastrointestinal symptoms, and renal involvement. PM75 HN75 MHÑPurpura, Schoenlein-Henoch PIPurpura (66-74) MNC15.378.463.597.580 XSAllergic Purpura; Anaphylactoid Purpura; Henoch Purpura; Rheumatoid Purpura; Schoenlein-Henoch Purpura; Vasculitis, Hemorrhagic LH LS; ; ; ; ;  MSAny form of purpura in which the platelet count is decreased. OLuse PURPURA, THROMBOCYTOPENIC to search PURPURA, THROMBOPENIC back thru 1966 PM86; was PURPURA, THROMBOPENIC 1963-85 HN86; was PURPURA, THROMBOPENIC 1963-85 MHÑPurpura, Thrombocytopenic MNC15.378.463.205.855.700; C15.378.463.597.700 XSPurpura, Thrombopenic; WERLHOF'S DISEASE LH LS;  MSA disease characterized by thrombocytopenia, hemolytic anemia, bizarre neurological manifestations, azotemia, fever, and thromboses in terminal arterioles and capillaries. OLuse PURPURA, THROMBOTIC THROMBOCYTOPENIC to search PURPURA, THROMBOTIC THROMBOPENIC back thru 1966 PM86; was PURPURA, THROMBOTIC THROMBOPENIC 1965-85 HN86; was PURPURA, THROMBOTIC THROMBOPENIC 1965-85 MHÑPurpura, Thrombotic Thrombocytopenic ANalso called Moschkowitz syndrome MNC15.378.463.205.855.759; C15.378.463.597.716 XSPurpura, Thrombotic Thrombopenic LH LS  MSEye movements that are slow, continuous, and conjugate and occur when a fixed object is moved slowly. HN(84) MHÑPursuit, Smooth ANonly /drug eff /rad eff PIEye Movements (66-83) MNG11.697.384.453 DMÑEye Movements LH LM  OLsearch CORPUS STRIATUM 1974 & BASAL GANGLIA 1966-73 PM79; was see under CORPUS STRIATUM 1974-78, was see under GANGLIA, BASAL 1963-73 HN79(75); was see under CORPUS STRIATUM 1974-78, was see under GANGLIA, BASAL 1963-73 MHÑPutamen ANdo not use /innerv PICorpus Striatum (74); Basal Ganglia (66-73) MNA8.186.211.885.105.487.784 LH  PM73 HN73(72) MHÑPutrescine ANdo not use /defic /physiol RN110-60-1 PIAmines (66-71); Butylamines (70-71); Polyamines (71) MND2.92.782.258.784 LH  MSPhotochemotherapy using a psoralen compound as the photosensitizing agent and ultraviolet light type A (UVA). PM86; was see under PHOTOCHEMOTHERAPY 1981-85 HN86(Mar 81); was see under PHOTOCHEMOTHERAPY 1981-85 MHÑPUVA Therapy ANphotochemother with a psoralen cpd & ultraviolet light type A (UVA); IM; do not use /util unless by MeSH definition; coord with disease /drug ther (IM); do not index under psoralen cpd or UV angle unless particularly discussed PICoumarins (66-74); Ficusin (75-Feb 81); Methoxsalen (66-Feb 81); Photochemotherapy (78-Feb 81); Psoralens (79-Feb 81); Trioxsalen (75-Feb 81); Ultraviolet Therapy (66-Feb 81) MNE2.780.740.770 XSPsoralen Ultraviolet A Therapy LH LS  MHÑPyelitis AN= kidney pelvis inflammation MNC12.777.419.744 LH  MHÑPyelocystitis AN= inflammation of kidney pelvis + bladder MNC12.777.419.744.550 XSCYSTOPYELITIS LH LS  MHÑPyelonephritis AN= inflammation of kidney & its pelvis MNC12.777.419.570.643.790; C12.777.419.744.717 XSPyonephrosis FXÑKidney Failure, Chronic LH LS LX  MSAn inflammatory condition of the kidney most commonly resulting in a grossly enlarged and nonfunctioning kidney associated with stones and infection. PM86 HN86 MHÑPyelonephritis, Xanthogranulomatous PIPyelonephritis (66-85); Xanthomatosis (66-85) MNC12.777.419.570.643.790.810; C12.777.419.744.717.810 LH  PM73 HN73 MHÑPyloric Antrum ANNIM; usually merely locational PIPylorus (66-72); Stomach (66-72) MNA3.492.766.716 XSAntrum, Pyloric; GASTRIC ANTRUM LH LS;  MSObstruction of the pyloric canal. MHÑPyloric Stenosis ANfor hypertrophic, coord IM with HYPERTROPHY (NIM) MNC6.405.748.597 LH  MHÑPylorus ANNIM; usually locational MNA3.492.766.799 FXÑGastric Emptying LH LX  MSBacteriocins elaborated by mutant strains of Pseudomonas aeruginosa; they are protein or protein-lipopolysaccharide complexes lethal to other strains of the same or related species. OLto search PYOCIN use PYOCINS back thru 1975, BACTERIOCINS 1968-74 & ANTIBIOTICS 1966-67 HN(79); was PYOCIN see under BACTERIOCINS 1968-78, was PYOCIN see under ANTIBIOTICS 1966-67 MHÑPyocins ANdo not use /analogs /defic /physiol PIAntibiotics (66-67); Pyocin (68-78) MND20.85.133.759; D24.310.125.759 DMÑBacteriocins LH LM  MS1-Hydroxy-5-methylphenazinium inner salt. Antibiotic pigment produced by Pseudomonas aeruginosa. HN(75) MHÑPyocyanine ANdo not use /defic /physiol; /analogs NIM only RN85-66-5 PIPhenazines (69-74) MND3.494.704.700; D11.557.860 DMÑPhenazines LH LM  MHÑPyoderma AN╥any purulent skin dis╙ but do not make diagnoses: use term of text; subcorneal pustular dermatosis goes under SKIN DISEASES, BULLOUS MNC1.539.800.634; C17.838.722 LH  MHÑPyramidal Tracts ANdo not use /innerv MNA8.186.854.633; A8.612.380.730 XSCorticospinal Tracts; Decussation, Pyramidal LH LS;  MS2,5-Furandione polymer with 1,1'-oxybis(ethene). Copolymer of divinyl ether and maleic anhydride; immunostimulant with antineoplastic and anti-infective properties; used also in combination with other antineoplastic agents. Synonyms: DIVEMA; MVE; NSC 46015; Pyran XA 124-177. HN(75) MHÑPyran Copolymer AND25-26 qualif; /analogs NIM only RN27100-68-1 PIFurans (74); Polymers (74); Pyrans (74) MND3.383.663.705; D25.720.830; D22.204.750 XSDivinyl Ether Maleic Anhydride Copolymer; Maleic Anhydride Divinyl Ether; Maleic Anhydride Vinyl Ether; Vinyl Ether Maleic Anhydride Polymer DMÑPolymers LH LS; ; ; LM  PMAUROVERTINS was AUROVERTIN see under ANTIBIOTICS 1975-79 MHÑPyrans ANdo not confuse with PYRENES or PYRONES; do not use /analogs /biosyn /defic /physiol MND3.383.663 XUÑAurovertins; ÑPatulin; ÑPyrones LH LU; ;  PM74 HN74 MHÑPyrantel ANdo not use /biosyn /defic /physiol RN15686-83-6 MND3.383.742.634; D3.383.903.634; D21.201.287.648 XUÑPyrantel Pamoate; ÑPyrantel Tartrate LH LU;  MS(E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl)-vinyl]pyrimidine 4,4'-methylenebis[3-hydroxy-2-naphthoate](1:1). Broad spectrum antinematodal anthelmintic used also in veterinary medicine. HN(75) MHÑPyrantel Pamoate ANdo not use /biosyn /defic /physiol RN22204-24-6 PINaphthalenes (74); Pyrantel (74) MND3.383.742.634.600; D3.383.903.634.600; D21.201.287.648.775 XSPyrantel Embonate DMÑPyrantel LH LS LM  MS(E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine tartrate (1:1). Broad spectrum anthelmintic for livestock. Synonym: Banminth. HN(75) MHÑPyrantel Tartrate ANdo not use /biosyn /defic /physiol RN33401-94-4 PIPyrantel (74); Tartrates (74) MND3.383.742.634.670; D3.383.903.634.670; D21.201.287.648.780 DMÑPyrantel LH LM  MHÑPyrazinamide ANdo not use /biosyn /defic /physiol RN98-96-4 MND3.383.679.750; D20.338.734 LH  MHÑPyrazines ANdo not confuse with PYRIDAZINES; do not use /analogs /biosyn /defic /physiol MND3.383.679 LH  MHÑPyrazoles ANincludes pyrazolines & pyrazolidines; do not use /analogs /biosyn /defic /physiol MND3.383.694 XUÑBenzydamine; ÑBetazole; ÑEpirizole; ÑIndazoles; ÑMuzolimine LH LU; ; ; ;  PM74 HN74 MHÑPyrenes ANdo not confuse with PYRANS or PYRONES; do not use /analogs /biosyn /defic /physiol MND4.615.799; D26.191.788 LH  MSThe active insecticidal constituent of pyrethrum flowers. Pyrethrin I is the pyretholone ester of chrysanthemummonocarboxylic acid and pyrethrin II is the pyretholone ester of chrysanthemumdicarboxylic acid monomethyl ester. PM77 HN77 MHÑPyrethrins ANdo not use /analogs /defic /physiol; TN 111: eff on insects PIInsecticides, Botanical (73-76); Pyrethrum (66-76) MND2.455.849.700; D5.723.491.324.550 LH  MSSpecies cinerafolium vis. and coccineum Willd. of the Chrysanthemum (Compositae); the flowers contain PYRETHRINS, cinerolones and chrysanthemines which are powerful contact INSECTICIDES. HN(86)63; was in Cat B & D 1963-76 MHÑPyrethrum ANplant only: note PYRETHRINS above; do not use /isol /pathogen MNB6.781 XSChrysanthemum; Marguerite DMÑPlants LH LS; LM  PMPHTHALAZINES was see under HETEROCYCLIC COMPOUNDS 1966-74 MHÑPyridazines ANdo not confuse with PYRAZINES; do not use /analogs /biosyn /defic /physiol MND3.383.710 XUÑCinoxacin; ÑLuminol; ÑMaleic Hydrazide; ÑPhthalazines LH LU; ; ;  MHÑPyridines ANdo not use /analogs /biosyn /defic /physiol; pyridine nucleotides will probably be NAD or NADP MND3.383.725 XUÑ2,2'-Dipyridyl; ÑBetahistine; ÑBrompheniramine; ÑClopidol; ÑDicarbethoxydihydrocollidine; ÑDoxylamine; ÑNaphthylvinylpyridine; ÑNicotinyl Alcohol; ÑPyrithioxin; ÑQuinolinic Acids; ÑTriprolidine; ÑTropicamide; ÑZolimidine LH LU; ; ; ; ; ; ; ; ; ; ; ;  PM68 HN68 MHÑPyridinium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: PYRIDINIUM CPDS PIAmmonium Compounds (66-67); Pyridines (66-67) MND3.383.725.762 FXÑAmmonium Compounds XUÑBenzyl Viologen; ÑCetylpyridinium; ÑDiquat; ÑDistigmine; ÑFazadinium; ÑPyrithiamine; ÑViologens LH LX LU; ; ; ; ; ;  HN(73) MHÑPyridinolcarbamate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1882-26-4 MND2.241.81.251.723; D10.162.718 DMÑCarbamates LH LM  OLuse PYRIDONES to search PYRIDINONES back thru 1966 PM68; was PYRIDINONES 1966-67 HN68; was PYRIDINONES 1966-67 MHÑPyridones ANdo not use /analogs /biosyn /defic /physiol MND3.383.725.791 XSPYRIDINONES XUÑMimosine LH LS LU  PM65; PYRIDOSTIGMINE was see under PARASYMPATHOMIMETICS 1963-64 HN65; PYRIDOSTIGMINE was see under PARASYMPATHOMIMETICS 1963-64 MHÑPyridostigmine Bromide ANdo not use /biosyn /defic /physiol RN101-26-8 MND3.383.725.762.740; D8.373.275.829; D16.698.410.778 LH  PM74 HN74(72) MHÑPyridoxal RN66-72-8 PIPicolines (66-71); Pyridoxine (66-71) MND3.383.725.676.635; D11.786.708.704 LH  MSATP:pyridoxal 5-phosphotransferase. Catalyzes reversibly the phosphorylation of pyridoxal in the presence of ATP with the formation of pyridoxal 5-phosphate and ADP. Pyridoxine, pyridoxamine and various derivatives can also act as acceptors. EC 2.7.1.35. HN(79) MHÑPyridoxal Kinase ANdo not use /analogs RNEC 2.7.1.35 PIPhosphotransferases (66-73); Phosphotransferases, ATP (74-78); Pyridoxal (72-78) MND8.586.913.696.729.775 XSPyridoxamine Kinase; Pyridoxine Kinase DMÑPhosphotransferases, ATP LH LS; LM  MHÑPyridoxal Phosphate RN54-47-7 MND3.383.725.676.635.600; D8.176.740 LH  PM74 HN74(72) MHÑPyridoxamine RN85-87-0 PIPicolines (66-71); Pyridoxine (66-71) MND3.383.725.676.760; D11.786.708.733 LH  MSPyridoxaminephosphate: oxygen oxidoreductase (deaminating). Catalyzes the deamination of pyridoxaminephosphate to pyridoxal phosphate. A flavoprotein which also oxidizes pyridoxine-5-phosphate and pyridoxine. HN(75) MHÑPyridoxaminephosphate Oxidase ANdo not use /analogs RNEC 1.4.3.5 PIOxidoreductases (73-74); Pyridoxamine (73-74) MND8.586.682.107.680 XSPyridoxinephosphate Oxidase DMÑAmine Oxidoreductases LH LS LM  MS3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinic acid. Chief metabolic product of pyridoxine, pyridoxal and pyridoxamine in urine. HN(75) MHÑPyridoxic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN82-82-6 PIAlcohol, Methyl (74); Isonicotinic Acids (69-74) MND3.66.349.600; D3.383.725.394.700 XSPyridoxinecarboxylic Acid DMÑIsonicotinic Acids LH LS LM  MHÑPyridoxine AN/defic = PYRIDOXINE DEFICIENCY RN65-23-6 MND11.786.708.762 XSVitamin B 6 LH LS  MHÑPyridoxine Deficiency MNC18.654.223.133.699.635 FXÑAnemia, Sideroblastic LH LX  MS2-[(2-dimethylaminoethyl)(p-methoxybenzyl)amino]pyridine. Antihistamine. Has mild hypnotic properties and some local anesthetic action; used for allergies (including skin eruptions) both parenterally and locally; available in nonprescription medicines. Synonyms: Neo Antergan; Anthistan; Histalon. HN(75); was see under PYRIDINES 1975-78 MHÑPyrilamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN91-84-9 PIBenzyl Compounds (72-74); Ethylenediamines (72-74); Pyridines (70-74) MND3.383.725.50.805; D23.654.432.763 XSMepyramine; Pyranisamine DMÑAminopyridines LH LS; LM  MHÑPyrimethamine ANdo not use /biosyn /defic /physiol RN58-14-0 MND3.383.742.675; D21.370.286.635 LH  MSFound in DNA chains damaged by ultraviolet irradiation. Consist of two adjacent pyrimidine nucleotides, usually thymine nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers stop DNA replication. PM77 HN77 MHÑPyrimidine Dimers ANdo not use /analogs PIPyrimidine Nucleotides (74-76); Thymine Nucleotides (72-76) MND13.695.578.424.600; D13.695.740.600 XSThymine Dimers FXÑDNA Repair LH LS LX  PM74 HN74 MHÑPyrimidine Nucleosides ANdo not use /analogs MND13.570.685 LH  PM74 HN74(72) MHÑPyrimidine Nucleotides ANdo not use /analogs PINucleotides (66-71) MND13.695.740 LH  OLuse PYRIMIDINES to search THONZYLAMINE back thru 1972 PMTHONZYLAMINE was heading 1973-84 HNTHONZYLAMINE was heading 1972-84 (Prov 1972) MHÑPyrimidines ANdo not use /analogs /defic /physiol MND3.383.742 XUÑFursultiamin; ÑMopidamol; ÑMorantel; ÑOxypurinol; ÑTrapidil LH LU; ; ; ;  PM68 HN68(66) MHÑPyrimidinones ANdo not use /analogs /biosyn /defic /physiol MND3.383.742.698 XSPyrimidones LH LS  MS1-[(4-Amino-2-methyl)-5-pyrimidylmethyl]-2-methyl-3-(beta-hydroxyethyl)pyridinium. Thiamine antagonist due to its inhibition of thiamine pyrophosphorylation; used to produce thiamine deficiency. HN(77) MHÑPyrithiamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN534-64-5 PIPyridinium Compounds (74-76); Pyrimidines (74-76) MND3.383.725.762.760; D3.383.742.715; D26.87.783 XSHeterovitamin B 1; Neopyrithiamine DMÑPyridinium Compounds LH LS; LM  MS3,3'-(Dithiodimethylene)bis[5-hydroxy-6-methyl-4-pyridinemethanol. Neurotropic agent. Reduces permeability of blood-brain barrier to phosphate. Has no vitamin B6 activity. Synonyms: Bonifen; Encephabol HN(75) MHÑPyrithioxin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1098-97-1 PIDisulfides (74); Pyridines (74) MND3.383.725.812 XSDipyridoxolyldisulfide; Piritoxina; Pyridoxinedisulfide; Pyritinol DMÑPyridines LH LS; ; ; LM  MS3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolodinium bromide. Quarternary ammonium anticholinergic agent more specific for the gastrointestinal tract than atropine; poorly absorbed, if given orally. Synonyms. Padrin; Riabal. HN(76) MHÑPyrodifenium Bromide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4630-95-9 PIAmmonium Compounds (71-75); Pyrrolidines (71-75) MND3.383.773.800; D16.653.790 XSPrifinium Bromide DMÑPyrrolidines LH LS LM  MHÑPyrogallol ANdo not use /biosyn /defic /physiol RN87-66-1 MND2.755.800 LH  MSSubstances capable of increasing body temperature; they may be of microbial origin, often polysaccharides and may contaminate distilled water. MHÑPyrogens ANdo not use /analogs /defic /physiol; /biosyn permitted but be careful; consider also FEVER /chem ind or HYPERTHERMIA, INDUCED MND9.203.698.761; D24.185.733 LH  MSAtypical gamma immunoglobulins characterized by their irreversible heat denaturation at 56-degreeC. Pyroprecipitation is inhibited at pH below 3 and above 9. The presence of pyroglobulins in the serum is the cause of pyroglobulinemia. They are frequently present in multiple myeloma and the pyroglobulin precipitate binds complement, reacts with rheumatoid factor, produces passive cutaneous anaphylaxis, generalized passive anaphylaxis and passive Arthus-type reactions. HN(76) MHÑPyroglobulins ANonly /anal /biosyn /class /csf /immunol /isol /metab /physiol /urine PIHeat (72-75); Immunoglobulins (72-75); Precipitation (72-75) MND12.776.124.486.485.900.700; D12.776.124.790.651.900.700; D12.776.377.715.548.900.700 DMÑParaproteins LH LM  MSL-Pyroglutamyl-peptide hydrolase. Hydrolyzes amino-terminal pyroglutamyl residues from peptides. HN(75) MHÑPyroglutamate Aminopeptidase ANdo not use /analogs RNEC 3.4.19.3 PIAminopeptidases (70-74); Pyrrolidonecarboxylic Acid (72-74) MND8.586.277.656.81.760 XSPyrrolidonecarboxylate Peptidase; Pyrrolidonyl Peptidase DMÑAminopeptidases LH LS; LM  MSHydrolyzes pyroglutamic acid in the presence of ATP to glutamate plus ADP and inorganic phosphate. Deficiency leads to pyroglutamic acidurea. HN(75) MHÑPyroglutamate Hydrolase ANdo not use /analogs RNEC 3.5.2.- PIAmidohydrolases (74); Pyrrolidonecarboxylic Acid (74) MND8.586.277.87.760 XSOxoprolinase DMÑAmidohydrolases LH LS LM  OLsearch PYRANS 1966-74 HN(75) MHÑPyrones ANdo not use /analogs /biosyn /defic /physiol MND3.383.663.718 DMÑPyrans LH LM  MS[6-(Dimethylamino0-3H-xanthen-3ylidine]dimethylammonium chloride. Xanthene dye used as a bacterial and biological stain. Synonyms: Pyronin; Pyronine G; Pyronine Y. Use also for Pyronine B. which is diethyl-rather than dimethylamino-. HN(75) MHÑPyronine AND25-26 qualif; /analogs NIM only RN92-32-0 PIAmmonium Compounds (69-74); Xanthenes (71-74) MND3.494.953.570; D26.408.680 DMÑXanthenes LH LM  OLuse PYROPHOSPHATASES to search PYROPHOSPHATASE back thru 1966 PM73; was PYROPHOSPHATASE 1963-72 HN73; was PYROPHOSPHATASE 1963-72 MHÑPyrophosphatases ANdo not use /analogs RNEC 3.6.1. MND8.586.277.352.630.785 XUÑThiamine Pyrophosphatase LH LU  MHÑPyrophosphates ANdo not use /analogs MND1.248.497.158.730.650.670; D1.696.620.603.700.720 XUÑCalcium Pyrophosphate LH LU  PM68 HN68 MHÑPyrophosphoric Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.735; D1.696.841 LH  MHÑPyrroles ANdo not use /analogs /biosyn /defic /physiol MND3.383.757 XUÑDistamycins; ÑTolmetin LH LU;  PM66 HN66 MHÑPyrrolidines ANdo not use /analogs /biosyn /defic /physiol; do not confuse with PYRROLIDONES or PYRROLIDINONES MND3.383.773 XUÑAnisomycin; ÑClemastine; ÑGlycopyrrolate; ÑNafoxidine; ÑNitromifene; ÑProcyclidine; ÑProfadol; ÑPyrodifenium Bromide LH LU; ; ; ; ; ; ;  OLuse PYRROLIDINONES to search PYRROLIDONES back thru 1966 PM68; was PYRROLIDONES 1963-67 HN68; was PYRROLIDONES 1963-67 MHÑPyrrolidinones ANdo not use /analogs /biosyn /defic /physiol; pyrrolidinediones = SUCCINIMIDES; do not confuse with PYRROLIDINES MND3.383.773.812 XSPYRROLIDONES XUÑCotinine; ÑPiracetam; ÑPyrrolidonecarboxylic Acid LH LS LU; ;  HN(72) MHÑPyrrolidonecarboxylic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN98-79-3 PIAmino Acids (66-71); Pyrrolidinones (66-71) MND3.383.773.812.718; D12.125.72.401.761 XSPyroglutamic Acid DMÑPyrrolidinones LH LS LM  MSL-Proline:NAD(P)+oxidoreductases. Catalyzes the reduction of 1-pyrroline carboxylate to proline in the presence of NAD(P)H. Includes both the 2-oxidoreductase (EC 1.5.1.1) and the 5-oxidoreductase (EC 1.5.1.2). The former also reduces 1-piperidine-2-carboxylate to pipecolate and the latter also reduces 1-pyrroline-3-hydroxy-5-carboxylate to hydroxyproline. HN(77) MHÑPyrroline Carboxylate Reductases ANdo not use /analogs RNEC 1.5.1.- PIAmine Oxidoreductases (75-76); Oxidoreductases (66-74) MND8.586.682.107.695 DMÑAmine Oxidoreductases LH LM  MSAlkaloids found in various species of Senecio and other plants; there are at least ten different chemicals, many of them hepatotoxic, teratogenic and carcinogenic; the plants may cause damage in grazing herds, but no longer have medical use. PM73 HN73(71) MHÑPyrrolizidine Alkaloids ANdo not use /analogs /biosyn /defic /physiol PIAlkaloids (66-70); Heterocyclic Compounds (66-70) MND3.132.716; D26.191.795 XSSenecio Alkaloids FXÑSenecio LH LS LX  MS3-Chloro-4-(3-chloro-2-nitrophenyl)pyrrole. Antifungal antibiotic isolated from Pseudomonas pyrrocinia. Mainly effective against Trichophyton, Microsporium, Epidermophyton, and Penicillium. HN(75) MHÑPyrrolnitrin ANdo not use /defic /physiol; /analogs NIM only RN1018-71-9 PIAntibiotics, Antifungal (72-74); Pyrroles (69-74); Nitrobenzenes (72-74) MND3.383.757.770; D20.85.62.800; D20.136.73.800 DMÑAntibiotics, Antifungal LH LM  MS1-Ketopropionaldehyde. HN(75) MHÑPyruvaldehyde ANdo not use /biosyn /defic /physiol; /analogs NIM only RN78-98-8 PIGlyoxal (73-74) MND2.47.644.650 XSAcetylformaldehyde; Methylglyoxal; Oxopropanal DMÑAldehydes LH LS; ; LM  PM74 HN74 MHÑPyruvate Carboxylase ANdo not use /analogs RNEC 6.4.1.1 MND8.586.464.830 LH  MSCatalyzes the decarboxylation of an alpha keto acid to an aldehyde and carbon dioxide. Thiamine pyrophosphate is an essential cofactor. In lower organisms, which ferment glucose to ethanol and carbon dioxide, the enzyme irreversibly decarboxylates pyruvate to acetaldehyde. HN(75) MHÑPyruvate Decarboxylase ANdo not use /analogs RNEC 4.1.1.1 PICarboxy-Lyases (73-74); Pyruvates (73-74) MND8.586.520.258.650 XS2-Oxo Acid Carboxy-Lyase; Pyruvic Decarboxylase; alpha-Carboxylase; alpha-Ketoacid Carboxylase DMÑCarboxy-Lyases LH LS; ; ; LM  PM74 HN74(73) MHÑPyruvate Dehydrogenase Complex ANdo not use /analogs PIOxidoreductases (66-72); Pyruvate Oxidase (66-72); Pyruvates (66-72) MND8.586.600.741 LH  MSCatalyzes the hydrolytic removal of a phosphate on a specific seryl hydroxyl group of pyruvate dehydrogenase, reactivating the enzyme complex. HN(75); was see under PHOSPHOMONOESTERASES 1975-78 MHÑPyruvate Dehydrogenase Phosphatase ANdo not use /analogs RNEC 3.1.3.43 PIKetone Oxidoreductases (73-74); Phosphatases (72-74); Pyruvates (73-74) MND8.586.277.352.630.654.820 DMÑPhosphoprotein Phosphatases LH LM  PM65 HN65 MHÑPyruvate Kinase ANdo not use /analogs RNEC 2.7.1.40 MND8.586.913.696.729.786 LH  PM65 HN65 MHÑPyruvate Oxidase ANdo not use /analogs RNEC 1.2.3.3 MND8.586.682.472.636 LH  MSATP:pyruvate, orthophosphate phosphotransferase. Catalyzes the reaction of ATP, pyruvate and orthophosphate to form AMP plus phosphoenolpyruvate plus pyrophosphate. HN(75) MHÑPyruvate, Phosphate Dikinase ANdo not use /analogs RNEC 2.7.9.1 PIPhosphates (74); Phosphotransferases, ATP (74); Pyruvates (74) MND8.586.913.696.729.800 XSPhosphoenolpyruvate Synthetase; Phosphopyruvate Dikinase DMÑPhosphotransferases, ATP LH LS; LM  MHÑPyruvates ANdo not use /analogs /defic /physiol MND2.241.607.812 LH  MHÑPyrvinium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: PYRVINIUM CPDS MND3.438.810.824.700; D21.201.287.683 XSPyrrovinyquinium; Viprynium LH LS;  MSA Mastigomycotina genus of destructive root-parasitic fungi including forms that cause damping-off of seedlings. HN(75); was see under PHYCOMYCETES 1975-85 MHÑPythium ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.730.576.625.750 DMÑMastigomycotina LH LM  MHÑPyuria MNC1.539.895.719; C12.777.892.719 FXÑUrine LH LX  MSCatalyzes the replication of the RNA of coliphage Q beta. HN(75) MHÑQ beta Replicase ANdo not use /analogs RNEC 2.7.7.- PIColiphages (73-74); RNA Polymerases (73-74); Virus Replication (73-74) MND8.586.913.696.445.735.630 DMÑRNA Nucleotidyltransferases LH LM  MHÑQ Fever ANcaused by Coxiella burnetii MNC1.850.810.795 LH  MSA personality assessment technique in which the subject or observer indicates the degree to which a standardized set of descriptive statements actually describes the subject. The term reflects ╥sorting╥ procedures occasionally used with this technique. OLsearch PERSONALITY ASSESSMENT 1970-74 HN(75) MHÑQ-Sort ANno qualif MNF4.513.636 DMÑPersonality Assessment LH LM  HN75 MHÑQatar MNZ1.252.245.93.700; Z1.630.100.800 LH  MSThe fraudulent misrepresentation of the diagnosis and treatment of disease. MHÑQuackery ANonly /hist /legis MNI1.880.735.728 FXÑNostrums; ÑTherapeutic Cults LH LX;  MSParalysis of all four limbs. PM67 HN67(64) MHÑQuadriplegia MNC10.597.622.760; C23.888.592.636.786 XSLocked-In Syndrome; TETRAPLEGIA LH LS;  MHÑQuadruplets ANhuman only: for animals use LITTER SIZE; only /psychol; relation to PREGNANCY: Manual 28.33 MNG8.520.800.508; M1.438.486 LH  PM73 HN73 MHÑQuail ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; diseases: coord IM with BIRD DISEASES (IM); note JAPANESE QUAIL see COTURNIX is available PIBirds (66-72); Poultry (66-72) MNB2.248.801 XUÑColinus; ÑCoturnix LH LU;  MSActivities and programs intended to assure the quality of care in either a defined medical setting or a program. OLto search QUALITY ASSURANCE PROGRAM use QUALITY ASSURANCE, HEALTH CARE back thru 1980 & QUALITY OF HEALTH CARE 1978-79 PM80; QUALITY ASSURANCE PROGRAM was see QUALITY OF HEALTH CARE 1978-79 HN80; QUALITY ASSURANCE PROGRAM was see QUALITY OF HEALTH CARE 1978-79 MHÑQuality Assurance, Health Care ANonly /econ /legis /trends; DF: QUAL ASSUR CATALOG: /geog /form PIQuality of Health Care (68-79) MNN4.761.700 LH  PM74 HN74(71) MHÑQuality Control ANNIM; no qualif MNJ1.897.608 FXÑReference Standards LH LX  MSThe levels of excellence which characterize the health service or health care provided based on accepted standards of quality. PM68 HN68 MHÑQuality of Health Care ANonly /econ /legis /trends CATALOG: /geog /form PIspecific care; specific service MNN4.761 FXÑPROFESSIONAL STAFF COMMITTEES; ÑSOCIAL CONTROL, FORMAL LH LX;  MSA generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical; political, moral and social environment. PM77 HN77(75) MHÑQuality of Life ANno qualif; consider also LIFE STYLE MNI1.800; K1.752.770 LH  MSThe theory that the radiation and absorption of energy take place in definite quantities called quanta (E) which vary in size and are defined by the equation E=hv in which h is Planck's constant and v is the frequency of the radiation. PM67 HN67(64) MHÑQuantum Theory ANno qualif MNH1.671.579.800 LH  MHÑQuarantine ANonly /econ /hist MNG3.850.180.700 FXÑPatient Isolation LH LX  OLsearch SILICA 1966-74 HN(75)63-64 MHÑQuartz ANdo not use /biosyn /defic /physiol RN14808-60-7 MND1.836.751.636 DMÑSilica LH LM  MHÑQuebec MNZ1.107.567.176.791 LH  OLsearch BIOFLAVONOIDS 1966-74 HN(75); was see under BIOFLAVONOIDS 1963-74 MHÑQuercetin ANdo not use /defic /physiol; /analogs NIM only RN117-39-5 MND11.786.170.381.636; D3.438.150.266.450.600 DMÑFlavones LH LM  OLuse QUESTIONNAIRES to search QUESTIONNAIRE back thru 1967 (as Prov & Cat E heading 1967-72) PM73 HN73; was in Cat E only 1973-79; was QUESTIONNAIRE 1967-72 (Prov in Cat E only) MHÑQuestionnaires ANNIM; no qualif MNL1.280.800 XUÑDelphi Technic LH LU  MHÑQuinacrine ANdo not use /biosyn /defic /physiol RN83-89-6 MND3.494.46.250.760; D21.201.287.716; D21.201.412.100.686; D21.370.286.686; D22.204.777 XSChinacrin; MEPACRINE XUÑQuinacrine Mustard LH LS; LU  MS2-Methoxy-6-chloro-9-[4-bis(beta-chloroethyl)amino-1-methylbutylamino]acridine. Nitrogen mustard analog of quinacrine used primarily as a stain in the studies of chromosomes and chromatin. Fluoresces by reaction with nucleic acids in chromosomes. HN(75) MHÑQuinacrine Mustard AND25-26 qualif RN4213-45-0 PIMustard Compounds (73-74); Quinacrine (73-74) MND2.455.526.728.650.760; D3.494.46.250.760.750; D26.408.348.760 DMÑQuinacrine LH LM  OLsearch QUINOLINES 1969-74 HN(75) MHÑQuinaldines ANdo not use /analogs /biosyn /defic /physiol MND3.438.810.637 DMÑQuinolines LH LM  PM66 HN66(65) MHÑQuinazolines ANdo not use /analogs /biosyn /defic /physiol MND3.438.786 LH  HN(72) MHÑQuinestrol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN152-43-2 PIContraceptives, Oral (66-71); Estrogens (66-71) MND4.808.668.651.568.762; D6.597.378.813; D7.360.276.210.443.332.762 XSEthinyl Estradiol 3-Cyclopentyl Ether DMÑNorpregnatrienes LH LS LM  PM74 HN74(64) MHÑQuinic Acid ANdo not use /biosyn /defic /physiol RN77-95-2 MND2.241.223.106.777; D2.241.223.268.637; D2.241.511.764 LH  MHÑQuinidine ANdo not use /biosyn /defic /physiol RN56-54-2 MND3.132.206.636; D3.438.810.699; D3.605.687.637; D18.97.787 LH  MHÑQuinine ANdo not use /defic /physiol; /biosyn permitted if by plant RN130-95-0 MND3.132.206.719; D3.438.810.762; D3.605.687.762; D21.370.286.737 LH  MHÑQuinolines ANdo not confuse with QUINOLIZINES; do not use /analogs /biosyn /defic /physiol MND3.438.810 XUÑCarbocyanines; ÑEthoxyquin; ÑNequinate; ÑQuinaldines; ÑQuipazine LH LU; ; ; ;  OLsearch PYRIDINES 1966-74 HN(75) MHÑQuinolinic Acids ANdo not use /analogs /biosyn /defic /physiol MND3.383.725.822 DMÑPyridines LH LM  PM68 HN68 MHÑQuinolinium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: QUINOLINIUM CPDS PIAmmonium Compounds (66-67); Quinolines (66-67) MND3.438.810.824 FXÑAmmonium Compounds XUÑDequalinium LH LX LU  MHÑQuinolizines ANdo not confuse with QUINOLINES; do not use /analogs /biosyn /defic /physiol MND3.438.834 XUÑBenzoquinolizine LH LU  MSNAD(P)H:(quinone acceptor) oxidoreductases. Includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 requires NADH, is inhibited by dicoumarol. EC 1.6.99.5 requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol. PM86; was see under NADH, NADPH OXIDOREDUCTASES 1975-85 HN86(75); was see under NADH, NADPH OXIDOREDUCTASES 1975-85 MHÑQuinone Reductases ANdo not use /analogs RNEC 1.6.99. PINADH, NADPH Oxidoreductases (73-74); Vitamin K (73-74) MND8.586.682.608.800 XSDT-Diaphorases; Menadione Reductases; Menaquinone Reductases; NAD(P)H Dehydrogenases(Quinone); Phylloquinone Reductases LH LS; ; ; ;  MHÑQuinones ANdo not use /analogs /biosyn /defic /physiol MND2.806 XUÑChloranil; ÑDibromothymoquinone; ÑPlastoquinone LH LU; ;  PM66 HN66 MHÑQuinoxalines ANdo not use /analogs /biosyn /defic /physiol MND3.438.857 XUÑCarbadox; ÑEchinomycin LH LU;  MHÑQuintuplets ANhuman only; for animals use LITTER SIZE; only /psychol; relation to PREGNANCY: Manual 28.33 MNG8.520.800.550; M1.438.587 LH  MHÑQuinuclidines ANdo not use /analogs /biosyn /defic /physiol MND3.605.687 XUÑAceclidine; ÑQuinuclidinyl Benzilate LH LU;  MS1-Azabicyclo(2.2.2)oct-3-yl-alpha-hydroxy- alpha-phenyl ester of benzeneacetic acid. Hallucinogenic anticholinergic agent with a high affinity for muscarinic receptors; used to study those receptors and their ligands. Synonyms: RO 2-3308; QNB. HN(80) MHÑQuinuclidinyl Benzilate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN6581-06-2 PIBenzilates (66-79); Quinuclidines (66-79) MND2.241.223.601.238.306.740; D2.241.511.85.740; D3.605.687.800; D16.653.795 DMÑQuinuclidines LH LM  MS2-(1-Piperazinyl)quinoline. Pharmacologic congener of serotonin; contracts smooth muscle and has actions similar to those of tricyclic antidepressants; also proposed as oxytocic. HN(78) MHÑQuipazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4774-24-7 PIQuinolines (66-77) MND3.438.810.850; D16.538.852.794 DMÑQuinolines LH LM  MSA class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation. PM78; was see under DRUG RESISTANCE, MICROBIAL 1975-77 HN78(75); was see under DRUG RESISTANCE, MICROBIAL 1975-77 MHÑR Factors ANbacterial; only /drug eff /genet /rad eff PIDrug Resistance, Microbial (67-74) MNG4.185.515.286.600; G5.225.500.600; G5.386.310.600; G5.706.310.600; G12.392.269.800 XSR Plasmids; Resistance Factors LH LS;  MS13-Ethyl-17-hydroxy-18,19-dinor-17-alpha-prega-4,9,11-trien-20-yn-3-one. A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. Effective if used once a week orally or can also be used in intravaginal devices. HN(79) MHÑR 2323 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN16320-04-0 PIGonanes (68-74); Norgestrienone/AA (75-78) MND4.808.668.651.568.620.700; D7.360.276.210.443.706.855 DMÑNorpregnatrienes LH LM  MSA virus similar to vaccinia and causing epidemics among laboratory rabbits. HN(75); was see under POXVIRUSES 1975-80 MHÑRabbit Pox Virus ANdo not use /blood-csf-urine /cytol MNB4.909.204.783.650 XSRabbit Plague Virus DMÑPoxviridae LH LS LM  MHÑRabbits ANcheck tag: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.521.637 XSBelgian Hare LH LS  MHÑRabies ANhuman & animal MNC2.782.750 XSHYDROPHOBIA LH LS  MHÑRabies Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.899.700 LH  MSAn RNA virus causing rabies in man and other animals. MHÑRabies Virus ANdo not use /blood-csf-urine /cytol MNB4.909.777.750.677 LH  PM68 HN68 MHÑRaccoons ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PICarnivora (66-67) MNB2.649.147.802 LH  MSCultural contacts between people of different races. PM68 HN68 MHÑRace Relations ANonly /hist /legis /trends PIInterpersonal Relations (66-67); Prejudice (66-67) MNI1.880.735.768 FXÑCivil Rights; ÑPsychology, Social LH LX;  OLsearch ISOMERASES 1966-74 HN(75) MHÑRacemases ANGEN only; see Tree D8 under ISOMERASES & choose the most specific; do not use /analogs /defic /physiol RNEC 5.1. MND8.586.399.788 DMÑIsomerases LH LM  MSMajor living subspecies of man differentiated by genetic and physical characteristics; includes four groups: Australoid, Caucasoid, Mongoloid, and Negroid. PM68 HN68 MHÑRacial Stocks ANGEN; only /class /hist; policy: Manual 30.10-30.12 PIAustraloid Race (66-67); Blacks (66-67); Caucasoid Race (66-67); Ethnology (66-67); Mongoloid Race (66-67) MNI1.76.368.763 LH  MSA system using beamed and reflected radio signals to and from an object in such a way that range, bearing, and other characteristics of the object may be determined. MHÑRadar ANnon-ionizing; only /hist /instrum /util (if by MeSH definition) MNL1.178.847.500 FXÑRadio Waves LH LX  MHÑRadial Nerve ANdo not use /innerv MNA8.796.828.169.688 LH  MSThe emission and propagation of electromagnetic energy (rays) or subatomic particles through space or matter; damage results if the rays or particles create ions on passing through living things; discrete bundles or quanta of radiation are called photons; the most common source of radiation is the sun. OLsearch RADIATION IMMUNOLOGY under RADIATION EFFECTS 1966 PMRADIATION IMMUNOLOGY was heading 1964-66 HNRADIATION IMMUNOLOGY was heading 1964-66 MHÑRadiation ANGEN; /adv eff = RADIATION INJURIES but see note there; /diag use = RADIOGRAPHY or RADIOISOTOPE SCANNING; /ther use = RADIOTHERAPY; only /class; Manual 29.12, 29.13; radiation scattering = SCATTERING, RADIATION; TN 158: how to index x-rays, gamma rays & cathode rays; radiation policy: see Manual index under RADIATION & entries following; see all terms below for concepts superior to RADIATION MNH1.671.768 XSElectromagnetic Radiation; Photons FXÑNuclear Warfare; ÑRadioactivity LH LS; LX;  MSAn organism whose body contains cell populations of different genotypes as a result of the injection of foreign cells into it after it has received sufficient ionizing radiation to destroy the mature host cells which would otherwise reject the injected cells. PM70; was see under IMMUNITY /radiation effects 1967-69 HN70(66); was see under IMMUNITY /radiation effects 1967-69 MHÑRadiation Chimera ANno qualif MNG4.610.484.721; G5.148.630.763; G5.800.638 XSCHIMERA, RADIATION FXÑMosaicism LH LS LX  PM72 HN72 MHÑRadiation Dosage ANNIM; no qualif; DOSE-RESPONSE RELATIONSHIP, RADIATION is also available PIRadiometry (66-71) MNE5.799.513; G3.850.810.250; H1.671.768.765.488 FXÑRADIOTHERAPY DOSAGE LH LX  OLuse RADIATION EFFECTS to search RADIATION IMMUNOLOGY 1966 PMRADIATION IMMUNOLOGY was heading 1964-66 HNRADIATION IMMUNOLOGY was heading 1964-66 MHÑRadiation Effects ANGEN only: prefer /rad eff; do not coord with specific term /rad eff; no qualif; TN 158: ionizing vs non-ionizing; indexing policy: Manual 28.13-28.19; radiations causing neopl = NEOPLASMS, RADIATION-INDUCED or LEUKEMIA, RADIATION-INDUCED, causing abnorm = ABNORMALITIES, RADIATION-INDUCED MNG3.850.810.300 LH  MHÑRadiation Genetics ANno qualif MNG3.850.810.300.310; G5.800 XSGENETICS, RADIATION LH LS  MSHarmful effects of non-experimental exposure to ionizing or non-ionizing radiation in chordates. OLuse RADIATION INJURIES to search RADIATION INJURY back thru 1966 PM73; was RADIATION INJURY 1963-72 HN73; was RADIATION INJURY 1963-72 MHÑRadiation Injuries ANonly Cat C qualif; human & vet animals only; exper animals = RADIATION INJURIES, EXPERIMENTAL, but only if B2: see note on RADIATION INJURIES, EXPERIMENTAL; Manual 28.21; radiations causing neopl = NEOPLASMS, RADIATION-INDUCED or LEUKEMIA, RADIATION-INDUCED, causing abnorm = ABNORMALITIES, RADIATION-INDUCED MNC21.866.733; G3.850.810.300.360 XSRADIATION SICKNESS; RADIATION SYNDROME XUÑOsteoradionecrosis LH LS; LU  MSHarmful effects of exposure to ionizing or non-ionizing radiation produced experimentally in chordates. OLuse RADIATION INJURIES, EXPERIMENTAL to search RADIATION INJURY, EXPERIMENTAL back thru 1966 PM73; was RADIATION INJURY, EXPERIMENTAL 1963-72 HN73; was RADIATION INJURY, EXPERIMENTAL 1963-72 MHÑRadiation Injuries, Experimental ANonly Cat C qualif; for B2 animals only; ╥injuries╙ to insects, parasites, bacteria, viruses = RADIATION EFFECTS (general only) or specific organism /rad eff; Manual 28.22, 28.23; radiations causing neopl = NEOPLASMS, RADIATION-INDUCED or LEUKEMIA, RADIATION-INDUCED, causing abnorm = ABNORMALITIES, RADIATION-INDUCED MNC21.866.733.720; G3.850.810.300.360.285 LH  PM64; was see under RADIOMETRY 1963 HN64; was see under RADIOMETRY 1963 MHÑRadiation Monitoring ANonly /econ /instrum /methods /stand /trends MNE5.799.638; G3.850.810.370; H1.671.768.765.588 FXÑHealth Physics LH LX  MHÑRadiation Protection ANincludes ╥shielding╙; only /econ /instrum /methods /stand MNG3.850.810.425 FXÑHealth Physics; ÑNuclear Energy LH LX;  MSThe ability of some cells or tissues to withstand ionizing radiation without serious injury; tolerance depends on the species, cell type and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. PM77 HN77 MHÑRadiation Tolerance ANto ionizing radiations only; no qualif; consider also RADIATION-PROTECTIVE AGENTS & RADIATION-SENSITIZING AGENTS PIRadiation Dosage (72-76); Radiation Effects (66-76); Radiotherapy Dosage (66-76) MNG12.702 XSRadiation Sensitivity; Radiosensitivity LH LS;  MHÑRadiation-Protective Agents AND25-26 qualif; protective against ionizing rad; not for SUNSCREENING AGENTS & not for shields & shielding in diag x-ray ( = RADIATION PROTECTION) MND26.763 LH  PM66 HN66(65) MHÑRadiation-Sensitizing Agents AND25-26 qualif; do not use /ther use when coordinating with disease /radiother but /ther use permitted with specific radiation-sensitizing agents in radiother MND26.776 LH  MSElectromagnetic or corpuscular radiation capable of producing ions, directly or indirectly, in its passage through matter; the wavelengths are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays and high-energy elementary particles. PM76; BACKGROUND RADIATION was see under RADIATION 1975; CATHODE RAYS & GAMMA RAYS were see under RADIATION 1963-75; X-RAYS was see under RADIATION 1965-75 HN76; was NON MESH before 1976 MHÑRadiation, Ionizing ANas NIM: Manual 19.4.52, 28.14; when not to use: Manual 21.16; /adv eff = RADIATION INJURIES but see note there PIRadiation (66-75) MNH1.671.768.513 XSElectromagnetic Radiation, Ionizing XUÑBackground Radiation; ÑGamma Rays; ÑX-Rays LH LS LU; ;  MSElectromagnetic radiation which does not produce ions in matter through which it passes; its wavelengths are generally greater than those of far ultraviolet radiation and range through the longest radio waves. PM76 HN76; was NON MESH before 1976 MHÑRadiation, Non-Ionizing ANas NIM: Manual 19.4.52, 28.14; when not to use: Manual 21.16; /adv eff permitted PIRadiation (66-75) MNH1.671.768.638 XSElectromagnetic Radiation, Non-Ionizing LH LS  PM65 HN65 MHÑRadical Neck Dissection ANdo not use /util except by MeSH definition MNE4.446.638; E4.847.610 LH  MSSlow-growing fluid-filled epithelial sac at the apex of a tooth with a nonvital pulp or defective root canal filling. PM65 HN65 MHÑRadicular Cyst ANnon-neoplastic; /anal /blood supply /secret /ultrastruct permitted; coord IM with organ/dis (IM), not organ/neopl MNC4.182.89.530.690.790.820; C5.500.470.690.790.820; C7.465.690.820 XSPeriapical Cyst; Periodontal Cyst, Apical LH LS;  PM71 HN71 MHÑRadiculitis ANinflamm of a single spinal nerve root; do not confuse with POLYRADICULITIS (inflamm of several spinal nerve roots) nor with POLYRADICULONEURITIS (inflamm of both spinal nerve roots & peripheral nerves) PIPolyradiculitis (66-70) MNC10.772.582.763 LH  MSTherapeutic cult concerned with intangible energies surrounding the living body and based on the detection of these intrinsic radiations by dowsing, or divining, or the use of more elaborate instruments (radionics). PM67,63-65 HN67,63-65 MHÑRadiesthesia ANdo not use /util except by MeSH definition MNE2.924.793 LH  MHÑRadio ANonly /econ /hist /instrum /legis /stand /trends /util (if by MeSH definition) MNL1.178.147.739; L1.178.847.514 LH  MSThat portion of the electromagnetic spectrum beyond the microwaves, with wavelengths as high as 30 KM; used in communications, including television; Short Wave or HF (high frequency), UHF (ultrahigh frequency) and VHF (very high frequency) waves are used in citizen's band communication; Ultrashort waves may also be called MICROWAVES. MHÑRadio Waves ANnon-ionizing; only /adv eff; radiation policy: see Manual index under RADIATION & entries following; short wave, high frequency, ultrahigh frequency & very high frequency waves go here but extremely high frequency waves go under MICROWAVES MNH1.671.768.638.721 XSHertzian Waves FXÑRadar LH LS LX  MHÑRadioactive Fallout ANonly /adv eff /anal /prev MND5.284.638.555; G3.850.810.460 FXÑNuclear Warfare LH LX  MSRadioactive substances which act as pollutants. Use for radioactive pollutants in general or for which there is no specific heading. PM75 HN75 MHÑRadioactive Pollutants ANonly /ad-poi-tox /anal /isol PIEnvironmental Pollution (71-74); Radioactivity (66-74) MND5.284.638 LH  OLsearch RADIOISOTOPES 1974 HN(75) MHÑRadioactive Tracers ANIM for general only; no qualif; Manual 25.97, 25.98 MND1.496.749.731 DMÑRadioisotopes LH LM  MHÑRadioactive Waste ANonly /adv eff /anal /econ /prev MND5.284.638.638; G3.850.810.485; G3.850.460.710.510 FXÑNuclear Energy LH LX  MHÑRadioactivity ANIM GEN only for principle of emission of radiations; NIM as coord for degree of radioactivity of specific radioelements or radioisotopes (IM); do not use as routine coord for amt of radiation or degree of radioactiv of radioisotope tracers; nuclear decay goes here: coord NIM with specific radioactive substance (IM) & do not add RADIOMETRY; no qualif MNH1.671.579.826 FXÑRadiation LH LX  MSAn in vitro allergen radioimmunoassay in which allergens are coupled to an immunosorbent. The coupled allergens bind the IgE in the sera of patients which in turn binds radioisotope-labeled anti-IgE antibodies. HN(77) MHÑRadioallergosorbent Test ANNIM; only /instrum /methods; IMMUNOSORBENTS is also available; DF: RAST PIAllergens (65-76); IgE (71-76); Radioimmunoassay (68-76) MNE1.223.495.567.380.810; E1.223.495.567.639.810; E1.223.495.826.830; E5.478.567.380.810; E5.478.567.639.810 XSRadioimmunosorbent Assay of Allergens DMÑRadioimmunoassay LH LS LM  PM66 HN66 MHÑRadiobiology ANSPEC: SPEC qualif MNG1.273.789 XSRADIATION BIOLOGY FXÑNuclear Medicine LH LS LX  PM66 HN66 MHÑRadiochemistry ANas IM, use SPEC qualif; as NIM no qualif; Manual 25.103: when not to use MNH1.181.529.776 LH  MSA cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation. PM66 HN66(64) MHÑRadiodermatitis ANdo not use /chem ind MNC17.174.826; C21.866.733.804 LH  MSImproving the quality of the photographic image by various technics, including computer processing. PM74 HN74 MHÑRadiographic Image Enhancement ANdo not use /util except by MeSH definition MNE1.818.670; L1.700.568.110.308.380.600 XSDigital Radiography FXÑImage Enhancement XUÑX-Ray Intensifying Screens LH LS LX LU  MSComputer systems or networks designed to provide radiographic interpretive information. HN(87) MHÑRadiographic Image Interpretation, Computer-Assisted ANno qualif; DF: RADIOGR IMAGE INTERP MNE1.158.680; E1.818.677; L1.700.508.100.158.600.680 DMÑImage Interpretation, Computer-Assisted LH LM  PM73 HN73(72) MHÑRadiographic Magnification ANdo not use /util except by MeSH definition PIRadiography (66-71); specific radiography heading; Technology, Radiologic (66-71); specific heading/RA (66-71) MNE1.818.685 LH  MHÑRadiography ANGEN only: prefer /radiogr with organs & diseases: Manual 19.5+; prefer also specific indentions in Categ E1; when GEN & IM, only /adv eff /class /econ /educ /hist /instrum /stand /trends /vet; Manual 26.8-.14; /man = RADIOGRAPHY (IM) + RADIOLOGY /man or TECHNOLOGY, RADIOLOGIC /man (NIM); /methods: consider also TECHNOLOGY, RADIOLOGIC MNE1.818 XSRadiology, Diagnostic X-Ray; Roentgenography; X-Ray, Diagnostic FXÑContrast Media; ÑExtravasation of Diagnostic and Therapeutic Materials LH LS; ; LX;  OLconsider also ABDOMEN /RA or /RA with specific abdom organs MH*Radiography, Abdominal (Non Mesh) MNE1.818.701 LH  MHÑRadiography, Dental ANGEN; prefer /radiogr with dental organ terms; do not use /util except by MeSH definition MNE1.262.556; E1.818.727; E6.342.764 XSDental Radiography LH LS  PM74 HN74 MHÑRadiography, Panoramic ANdo not use /util except by MeSH definition MNE1.262.556.722; E1.818.727.722; E6.342.764.639 XSORTHOPANTOMOGRAPHY; PANORAMIC RADIOGRAPHY LH LS;  PM68 HN68 MHÑRadioimmunoassay ANNIM; do not use /util except by MeSH definition; coord with substance /anal or body fluid qualif but not /immunol PIImmunoassay (66-67) MNE1.223.495.567.639; E1.289.514; E5.478.567.639 XUÑRadioallergosorbent Test; ÑRadioimmunosorbent Test LH LU;  MSRadioimmunoassay of proteins using antibody coupled to an immunosorbent. HN(77) MHÑRadioimmunosorbent Test ANNIM; only /instrum /methods; coord with substance /anal or body fluid qualif but not /immunol; IMMUNOSORBENTS & RADIOALLERGOSORBENT TEST are also available; DF: RIST PIIgE (71-76); Iodine Radioisotopes (74-76); Radioimmunoassay (68-76) MNE1.223.495.567.380.830; E1.223.495.567.639.830; E5.478.567.380.830; E5.478.567.639.830 DMÑRadioimmunoassay LH LM  PM67 HN67(64) MHÑRadioisotope Dilution Technic ANNIM; do not use /methods /util (except by MeSH definition); coord with specific radioisotope /diag use CATALOG: do not use /laboratory manuals MNE1.145.643.722; E1.289.577 FXÑBody Fluids LH LX  MSGraphic tracing over a time period of radioactivity measured externally over the kidneys following intravenous injection of a radionuclide which is taken up and excreted by the kidneys. PM66 HN66(64) MHÑRadioisotope Renography ANa specific kidney function test: read MeSH definition; do not confuse with KIDNEY /radionuclide; coord dis with /radionuclide, not /diag & not /radiogr; do not use /util except by MeSH definition MNE1.289.702.825.805; E1.341.453.764 XSRENOGRAPHY LH LS  MSA type of high energy radiotherapy using a beam of gamma radiation produced by a radioisotope source encapsulated within a teletherapy unit. MHÑRadioisotope Teletherapy ANionizing; do not use /util except by MeSH definition; coord IM with specific radioisotope /ther use (IM) MNE2.810.722.820 XSTELERADIOISOTOPE THERAPY LH LS  MHÑRadioisotopes ANIM for general or unspecified or as coord for a specific radioisotope not in MeSH; when IM, only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but use with caution & not for tracer studies ( = /diag use); policy: Manual 25.86, 25.90-25.93; not with /pharm: Manual 25.99; relation to /rad eff: Manual 28.16; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope; decay: coord RADIOISOTOPES or specific radioisotope (IM) with RADIOACTIVITY (NIM) & do not add RADIOMETRY; radioisotope implants = RADIOISOTOPES or specific /admin or BRACHYTHERAPY (see X refs there) MND1.496.749 XSRadionuclides FXÑIsotope Labeling; ÑNuclear Medicine XUÑRadioactive Tracers LH LS LX; LU  PM73 HN73 MHÑRadioligand Assay ANdo not use /util except by MeSH definition; coord with substance /anal or body fluid qualif but not /immunol PIBinding Sites (68-72); Protein Binding (66-72) MNE1.197.744; E1.223.774; E1.289.764 XSPROTEIN BINDING RADIOASSAY; RADIORECEPTOR ASSAY FXÑLigands; ÑReceptors, Endogenous Substances LH LS; LX;  MH*Radiologic Health (Non Mesh) MNG3.850.810 LH  MSA specialty concerned with the use of x-ray and other forms of radiant energy in the diagnosis and treatment of disease. MHÑRadiology ANSPEC: SPEC qualif; /methods: probably better is TECHNOLOGY, RADIOLOGIC MNG2.403.790.680 LH  MSHospital department which is responsible for the administration and provision of x-ray diagnostic and therapeutic services. HN(Aug 77) MHÑRadiology Department, Hospital ANrestricted to x-ray & radiocobalt diag & ther serv: does not include other radioisotopes ( = NUCLEAR MEDICINE DEPARTMENT, HOSPITAL); only /econ /legis /man /organ /stand /trends /util; DF: RADIOL DEP PIHospital Departments (68-Jul 77); Radiology (66-Jul 77) MNN2.278.354.422.695; N4.452.442.422.695 XSHospital Radiology Department; X-Ray Departments DMÑHospital Departments LH LS; LM  MSAutomated systems used in various functions of the radiology department - includes patient scheduling, film management, diagnostic reporting, and billing. HN(87) MHÑRadiology Information Systems MNL1.700.508.300.780; N4.452.442.452.760 DMÑHospital Information Systems LH LM  MSThe measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Muller tube and SCINTILLATION COUNTING. OLuse RADIOMETRY to search GEIGER-MUELLER COUNTER back thru 1966 PMGEIGER-MUELLER COUNTER was see under RADIOMETRY 1963-77 HNGEIGER-MUELLER COUNTER was see under RADIOMETRY 1963-77 MHÑRadiometry ANIM general only for measurement of radiation & technics & equipment related to it; NIM as coord with specific radiation (IM) for measurement of its radiations; do not use with radioisotope tracers for measurement of amt of radiat emitted by the tracer: this is inherent in the concept of tracing: Manual 25.101, 29.14; for nuclear decay index under RADIOACTIVITY for general articles or specific radioactive substance (IM) + RADIOACTIVITY (NIM) but do not add RADIOMETRY; do not use /util except by MeSH definition; ionization chambers: index under RADIOMETRY /instrum; dosimetry of radiation goes here MNE5.799; H1.671.768.765 XSGeiger-Mueller Counters FXÑHealth Physics LH LS LX  MSThe measurement of visualization by radiation of any organ after a radionuclide has been injected into its blood supply; used to diagnose heart, liver, lung, and other diseases and to measure the function of those organs, except renography, for which RADIOISOTOPE RENOGRAPHY is available. PM87 HN87 MHÑRadionuclide Angiography ANNIM; GEN or unspecified; prefer /radionuclide with specific blood vessels; do not use /util except by MeSH definition PIAngiocardiography (66-86); specific disease/radionuclide imaging (78-86); specific organ/radionuclide imaging (78-86) MNE1.145.77.805; E1.289.702.825 XSAngiography, Radionuclide; Radioisotope Angiography LH LS;  MSSeparation systems containing a relatively long-lived parent radionuclide which produces a short-lived daughter in its decay scheme. The daughter can be periodically extracted (milked) by means of an appropriate eluting agent. PM79 HN79 MHÑRadionuclide Generators ANonly /class /hist /instrum /stand /supply /util (if by MeSH definition) PIRadioisotopes (66-78) MNH1.671.579.835 XSRadioisotope Generators LH LS  MSProcess whereby a radionuclide is injected and a display is obtained from any one of several rectilinear scanner or gamma camera systems. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. OLuse RADIONUCLIDE IMAGING to search RADIOISOTOPE SCANNING back thru 1966 PM77; was RADIOISOTOPE SCANNING 1964-76, was RADIOISOTOPE SCANNING see under RADIOMETRY 1963 HN77; was RADIOISOTOPE SCANNING 1964-76, was RADIOISOTOPE SCANNING see under RADIOMETRY 1963 MHÑRadionuclide Imaging ANIM general or unspecified only: prefer /radionuclide: Manual 19.5+; do not use /util except by MeSH definition; myocardial imaging, myocardial perfusion imaging, myocardial perfusion scintigraphy = HEART /radionuclide only & not also here; EMI scanner or scanning goes under TOMOGRAPHY, X-RAY COMPUTED; DF: do NOT shorten: short form can be confused with RADIONUCLIDES below MNE1.289.702 XSAbsorptiometry, Photon; Gamma Camera Imaging; Radioisotope Scanning; Scanning, Radioisotope; Scintigraphy FXÑScintillation Counting LH LS; ; ; ; LX  MHÑRadiotherapy ANGEN only: prefer /radiother with diseases: Manual 19.5+; when GEN & IM, only /adv eff (consider also RADIATION INJURIES or its specifics) /class /econ /hist /instrum /methods /trends /vet; RADIOISOTOPE TELETHERAPY, PITUITARY IRRADIATION & BRACHYTHERAPY are also available MNE2.810 XUÑX-Ray Therapy LH LU  PM64 HN64 MHÑRadiotherapy Dosage ANNIM; only /stand /vet MNE2.810.639 FXÑDOSE-RESPONSE RELATIONSHIP, RADIATION; ÑRadiation Dosage LH LX;  MSComputer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy. HN(87) MHÑRadiotherapy Planning, Computer-Assisted ANIM; no qualif; differentiate from RADIOTHERAPY, COMPUTER-ASSISTED in that in planning the emphasis is on theoretical principles of radiother rather than on the patient PIComputer Programs (83-86); Computers (66-86); Radiotherapy Dosage (66-86) MNE2.950.825; L1.700.508.100.710.600.608 XSComputer-Assisted Radiotherapy Planning; Dosimetry Calculations, Computer-Assisted DMÑRadiotherapy, Computer-Assisted LH LS; LM  MSComputer systems or programs used in accurate computations for providing radiation dosage treatment to patients. PM87 HN87 MHÑRadiotherapy, Computer-Assisted ANIM; no qualif MNE2.810.540; L1.700.508.100.710.600 XSComputer-Assisted Radiotherapy; Radiation Therapy, Computer-Assisted XUÑRadiotherapy Planning, Computer-Assisted LH LS; LU  MSRadiotherapy using high energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. PM64 HN64 MHÑRadiotherapy, High Energy ANionizing only; only /adv eff /class /econ /hist /instrum /methods /stand /vet MNE2.810.722 XSMEGAVOLT RADIOTHERAPY LH LS  MHÑRadium ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol; /ther use: for curietherapy consider also BRACHYTHERAPY RN7440-14-4 MND1.248.497.300.333.763; D1.287.777; D1.552.539.745 LH  MHÑRadius MNA2.835.232.87.702 LH  MHÑRadius Fractures MNC21.866.88.268.556; C21.866.405.638 XUÑColles' Fracture LH LU  MHÑRadon ANnaturally radioactive; Manual 25.94; IM; do not use /analogs /biosyn /defic /physiol; /ther use: for curietherapy consider also BRACHYTHERAPY RN10043-92-2 MND1.287.798; D1.362.641.745 XSActinon LH LS  MSO-alpha-D-Galactopyranosyl(1,6)-O-alpha-D-glucopyranosyl-(1,2)-beta-D-fructofuranoside. A trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal. HN(75) MHÑRaffinose ANdo not use /defic /physiol; /analogs NIM only RN512-69-6 PIOligosaccharides (70-74) MND9.203.698.629.802.700 XSGossypose; Melitose; Melitriose DMÑOligosaccharides LH LS; ; LM  MS3'-Chloro-4'-(p-chlorophenoxy)-3,5-diiodosalicylanilide. Veterinary anthelmintic for grazing animals; used to treat fluke, hookworm and other infestations. Synonyms: Flukanide; Ranide. HN(75) MHÑRafoxanide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN22662-39-1 PIIodines (72-74); Phenyl Ethers (74); Salicylamides (71-74) MND2.65.199.860.600; D2.65.793.650.600; D21.201.287.743; D21.201.412.539 DMÑSalicylamides LH LM  MSFury; violent, intense anger. OLsearch ANGER 1972-74 HN(75) MHÑRage ANhuman & animal; only /drug eff /physiol /rad eff MNF1.470.93.640 DMÑAnger LH LM  MHÑRailroads ANonly /econ /hist /stand; subways goes here MNJ1.937.690 LH  OLsearch WEATHER 1969-74 HN(75) MHÑRain ANno qualif MNG3.230.300.100.725.450 DMÑWeather LH LM  MSA species of the family Ranidae (true frogs). The only anuran properly referred to by the common name ╥bullfrog╥, and is the largest native anuran in North America. PM72 HN72 MHÑRana Catesbeiana ANbullfrog; usually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.708.180 XSBullfrog LH LS  MSAn edible species of the family Ranidae, occurring in Europe and used extensively in biomedical research. Commonly referred to as ╥edible frog╥. PM72 HN72 MHÑRana Esculenta ANedible frog; usually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.708.240 XSGreen Frog LH LS  MSA highly variable species of the family Ranidae in Canada, the United States and Central America. It is the most widely used Anuran in biomedical research. PM72 HN72 MHÑRana Pipiens ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.708.310 XSFrog, Leopard LH LS  MSA species of the family Ranidae which occurs primarily in Europe and is used widely in biomedical research. HN(81) MHÑRana ridibunda ANlaughing frog; usually NIM; no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-80); Ranidae (72-80) MNB2.90.180.708.360 DMÑRanidae LH LM  MSA species of the family Ranidae occurring in a wide variety of habitats from within the Arctic Circle to South Africa, Australia, etc. PM72 HN72 MHÑRana Temporaria ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.708.420 XSEuropean Common Frog; Frog, Common European LH LS;  MSA process involving chance used in therapeutic trials for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. May also apply to experiments on inanimate objects. HN(78) MHÑRandom Allocation ANno qualif PIResearch Design (73-77) MNH1.770.644.728.805 XSRandomization DMÑResearch Design LH LS LM  MSThe family of true frogs of the order Anura. Occurs worldwide except in Antarctica. OLuse RANIDAE to search RANA back thru 1972 PM81; was RANA 1972-80 HN81; was RANA 1972-80 MHÑRanidae ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.708 XSFrogs, True; Rana XUÑRana ridibunda LH LS; LU  MSN-[2-[[(5-((Dimethylamino)methyl)-2- furanyl)methyl]thio]ethyl]- N'-methyl-2-nitro-1,1-ethenediamine. A non-imidazole blocker of those histamine receptors that mediate gastric secretion; used to treat gastrointestinal ulcers. PM84 HN84 MHÑRanitidine ANdo not use /biosyn /defic /physiol RN66357-35-5 PIFurans (66-83) MND3.383.312.750; D19.316.203.803; D23.654.443.803 LH  PM65 HN65 MHÑRanula ANnon-neoplastic; /anal /blood supply /secret /ultrastruct permitted MNC4.182.766; C7.465.780 FXÑMucocele LH LX  PM73 HN73(65) MHÑRanvier's Nodes ANdo not use /innerv MNA8.663.542.512.560.630; A11.671.514.553.640 LH  MSUnlawful sexual intercourse by a man with a woman without her consent. MHÑRape ANonly /legis /prev MNI1.198.240.748.640 LH  MSCollections of small neurons centrally scattered among many fibers from the level of the trochlear nucleus in the midbrain to the hypoglossal area in the medulla oblongata. PM85; was see under BRAIN STEM 1978-84 HN85(78); was see under BRAIN STEM 1978-84 MHÑRaphe Nuclei ANdo not use /innerv PIBrain Stem (66-77); Mesencephalon (66-77); Reticular Formation (66-77) MNA8.186.211.132.659.632; A8.186.211.132.810.507 LH  MHÑRare Books ANonly /hist MNL1.178.682.192.779 LH  OLuse RAT-BITE FEVER to search RAT-BITE FEVER, SPIRILLARY back thru 1966 PMRAT-BITE FEVER, SPIRILLARY was heading 1963-67 HNRAT-BITE FEVER, SPIRILLARY was heading 1963-67 MHÑRat-Bite Fever ANa disease entity; sodoku goes here MNC1.252.771 LH  MSA method of examining and setting levels of payments. PM80 HN80 MHÑRate Setting and Review ANonly /legis /methods /stand /trends; DF: RATE SETTING CATALOG: /geog /form PIEconomics, Hospital (66-79); Fees and Charges (68-79) MNN3.219.442.800; N3.219.463.60.800 FXÑFees and Charges LH LX  MSA defense mechanism operating unconsciously, in which the individual attempts to justify or make consciously tolerable, by plausible means, feelings, behavior, and motives that would otherwise be intolerable. OLsearch DEFENSE MECHANISMS 1966-74 HN(75) MHÑRationalization ANno qualif MNF1.393.746; F3.407.746 DMÑDefense Mechanisms LH LM  MSThe common name for the species Rattus norvegicus. MHÑRats AN= RATTUS NORVEGICUS only: for other species note RATTUS see MURIDAE; note inverted see ref ╥rat╙ species below (RATS, BANDICOOT; RATS, COTTON; RATS, KANGAROO); ╥sand rat╙ = PSAMMOMYS see CRICETIDAE; check tag: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; rats as a health hazard (e.g., Rattus rattus): index under MURIDAE MNB2.649.865.635.560 XSRats, Laboratory; Rats, Norway; Rattus norvegicus FXÑRODENT CONTROL LH LS; ; LX  MSA mutant strain of Rattus norvegicus used in research on renal function and hypertension and as a disease model for diabetes insipidus. HN(83) MHÑRats, Brattleboro ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (66-82); Rats, Inbred Strains (72-82); Rats, Mutant Strains (82) MNB2.649.865.635.560.610.110 DMÑRats, Mutant Strains LH LM  MSMutant strain of Rattus norvegicus which is used as a disease model of kernicterus. HN(82) MHÑRats, Gunn ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (77-81) MNB2.649.865.635.560.610.308 DMÑRats, Mutant Strains LH LM  HN(72) MHÑRats, Inbred ACI ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (66-71) MNB2.649.865.635.560.500.80 XSRats, Inbred A x C 9935 Irish DMÑRats, Inbred Strains LH LS LM  MSA strain of Rattus norvegicus which is a model for spontaneous diabetes mellitus. HN(86) MHÑRats, Inbred BB ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS; do not confuse with RATS, BRATTLEBORO PIRats, Inbred Strains (72-85) MNB2.649.865.635.560.500.90 XSBB Wistar Rats; Bio-Breeding Inbred Rats DMÑRats, Inbred Strains LH LS; LM  HN(72) MHÑRats, Inbred BN ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (66-71) MNB2.649.865.635.560.500.110 XSRats, Inbred Brown Norway DMÑRats, Inbred Strains LH LS LM  HN(72) MHÑRats, Inbred BUF ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (66-71) MNB2.649.865.635.560.500.130 XSRats, Inbred Buffalo DMÑRats, Inbred Strains LH LS LM  HN(72) MHÑRats, Inbred F344 ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (66-71) MNB2.649.865.635.560.500.200 XSRats, Inbred CDF; Rats, Inbred Fisher 344 DMÑRats, Inbred Strains LH LS; LM  HN(72) MHÑRats, Inbred LEW ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (66-71) MNB2.649.865.635.560.500.280 XSRats, Inbred Lewis DMÑRats, Inbred Strains LH LS LM  MSA strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. HN(85) MHÑRats, Inbred SHR ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIBlood Pressure (66-84); Hypertension (66-84); Rats, Inbred Strains (72-84) MNB2.649.865.635.560.500.300 XSRats, Spontaneously Hypertensive DMÑRats, Inbred Strains LH LS LM  MSGenetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. Also includes animals with a long history of closed colony breeding. PM72 HN72 MHÑRats, Inbred Strains ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS: Manual 18.6.14; TN 109: do not use INBREEDING PIRats (66-71) MNB2.649.865.635.560.500 XSRats, Sprague-Dawley; Rats, Wistar FXÑInbreeding XUÑRats, Inbred ACI; ÑRats, Inbred BB; ÑRats, Inbred BN; ÑRats, Inbred BUF; ÑRats, Inbred F344; ÑRats, Inbred LEW; ÑRats, Inbred SHR; ÑRats, Inbred WF; ÑRats, Inbred WKY LH LS; LX LU; ; ; ; ; ; ; ;  HN(72) MHÑRats, Inbred WF ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (66-71) MNB2.649.865.635.560.500.360 XSRats, Inbred Wistar Furth; Rats, Wistar Furth DMÑRats, Inbred Strains LH LS; LM  MSA strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). HN(85) MHÑRats, Inbred WKY ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats, Inbred Strains (72-84) MNB2.649.865.635.560.500.390 XSRats, Wistar Kyoto DMÑRats, Inbred Strains LH LS LM  MSRats bearing mutant genes which are phenotypically expressed in the animals. PM82; RATS, ZUCKER was see under RATS 1981 HN82 MHÑRats, Mutant Strains ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (77-81) MNB2.649.865.635.560.610 XUÑRats, Brattleboro; ÑRats, Gunn; ÑRats, Nude; ÑRats, Zucker LH LU; ; ;  MSA mutant strain of Rattus norvegicus without a thymus and with depressed or absent T-cell function. This strain of rats may have a small amount of hair at times, but then lose it. HN(87) MHÑRats, Nude ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRat, Mutant Strains (82-86) MNB2.649.865.635.560.610.508 XSAthymic Rats; Nude Rats; Rats, Athymic DMÑRats, Mutant Strains LH LS; ; LM  MSTwo populations of Zucker rats have been cited in research--the ╥fatty╙ or obese and the lean. The ╥fatty╙ rat (Rattus norvegicus) appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene. HN(81); was see under RATS 1981 MHÑRats, Zucker ANusually NIM: no qualif; but when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; do not forget also to check tag RATS PIRats (66-80) MNB2.649.865.635.560.610.700 XSZucker Rats DMÑRats, Mutant Strains LH LS LM  MSAn RNA virus associated with mouse tumors similar to those caused by the Friend virus. PM66 HN66 MHÑRauscher Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM) MNB4.909.574.807.674.632.791; B4.909.777.731.674.632.791; B4.909.777.779.674.632.791 LH  MSA large genus (family Apocynaceae) of tropical Asian trees and shrubs that contain alkaloids used to treat mental illness and hypertension; RESPERINE, RESCINNAMINE, deserpidine and their derivatives are the specific drugs obtained from Rauwolfia. HNwas in Cat B & D 1963-77 MHÑRauwolfia ANplant only; note RAUWOLFIA ALKALOIDS below; do not use /isol /pathogen MNB6.560.755 LH  MSAlkaloids from Rauwolfia serpentina, Benth, and other species; the prototype is reserpine which is a depleter of catecholamines and serotonin from the sympathetic postganglionic fibers and brain areas; it has been used in hypertension and psychoses despite its wide range of potentially adverse effects. PM75; was see under RAUWOLFIA & YOHIMBANS 1969-74 HN75; was see under RAUWOLFIA & YOHIMBANS 1969-74 MHÑRauwolfia Alkaloids ANGEN or unspecified: prefer specific indentions; /biosyn permitted; do not use /analogs /defic /physiol PIRauwolfia (69-74); Yohimbans (69-74) MND3.132.973.641; D3.549.937.641; D16.848.415.804; D18.162.804 LH  MHÑRaynaud's Disease MNC14.907.744 LH  MS4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione. An antimitotic antineoplastic agent with immunosuppressive properties. OLuse RAZOXANE to search ICRF 159 back thru 1975 HN(79); was ICRF 159 see under PIPERAZINES 1975-78 MHÑRazoxane ANdo not use /biosyn /defic /physiol; /analogs NIM only RN21416-87-5 PIPiperazines (66-74); Propane (73-74) MND3.383.606.845; D22.204.802 XSICRF 159 DMÑPiperazines LH LS LM  MSThe time from the onset of a stimulus until the organism responds. OLuse REACTION TIME to search RESPONSE LATENCY back thru 1970 HNRESPONSE LATENCY was see under REACTION TIME 1970-76 MHÑReaction Time ANonly /drug eff /physiol /rad eff MNF2.830.650; F4.669.817; G11.561.656 XSRESPONSE TIME; Response Latency XUÑRefractory Period, Psychological LH LS; LU  MSTendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses. OLsearch INHIBITION (PSYCHOLOGY) 1971-74 HN(75) MHÑReactive Inhibition ANno qualif MNF1.145.544.724; F2.463.425.475.724 DMÑInhibition (Psychology) LH LM  MHÑReading ANno qualif; Braille: coord IM with BLINDNESS (IM) + SENSORY AIDS (IM) MNL1.143.506.423.557 FXÑDyslexia, Acquired LH LX  MSCommercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures; may be for laboratory or personal use. PM78 HN78 MHÑReagent Kits, Diagnostic ANlaboratory or personal use; only /class /econ /hist /stand /supply /util (if by MeSH definition) /vet MND26.550.754; E7.754 XSDiagnostic Reagent Kits; Kits, Diagnostic Reagent FXÑIndicators and Reagents LH LS; LX  PM87; was see under INDICATORS AND REAGENTS 1975-86 HN87(73); was see under INDICATORS AND REAGENTS 1975-86 MHÑReagent Strips AND25-26 qualif with discretion PIIndicators and Reagents (66-72) MND26.550.754.796; E7.754.820 LH  OLsearch REAGINS under IGE 1966-74 (as Prov 1966-71) HN(75)72 only(66-71); was see under IGE 1973-74 MHÑReagins ANonly /admin /anal /biosyn /class /csf /immunol /isol /metab /urine MND24.611.125.890 DMÑAntibodies LH LM  MSThe individual's objective evaluation of the external world and the ability to differentiate adequately between it and the internal world; considered to be a primary ego function. HN(79) MHÑReality Testing ANnote category: not a diag test: ╥ego function that consists of the objective evaluation & judgment of the external world╙; no qualif MNF1.752.747.189.508; F2.739.794.206.508 DMÑEgo LH LM  MSA form of therapy in which the patient learns to fulfill his needs of involvement and responsibility which are basic to facing and accepting reality. PM74 HN74 MHÑReality Therapy ANSPEC qualif MNF4.754.804 LH  MSProtein from E.coli rec gene. Catalyzes the ATP-driven exchange of DNA strands in genetic recombination. The product of the reaction consists of a duplex and a displaced single-stranded loop which has the shape of the letter D and is therefore called a D-loop structure. ATP is hydrolyzed to ADP during the reaction; also has proteolytic activity. PM84 HN84 MHÑRec A Protein ANdo not use /analogs /defic /physiol; synthesized by Escherichia coli so do not coord with it unless particularly discussed PIBacterial Proteins (66-83) MND8.586.277.656.850; D12.776.97.780 XSRecA Protein LH LS  MSThe process whereby a representation of past experience is elicited. OLsearch MEMORY 1966-74 HN(75) MHÑRecall ANonly /drug eff /physiol /rad eff MNF2.463.425.540.641 DMÑMemory LH LM  MSChemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell. PM84 HN84 MHÑReceptor Aggregation ANonly /drug eff /rad eff; DF: RECEPT AGGREGATION PIspecific receptor (68-83) MNG4.335.857 XSAggregation, Receptor; Capping, Receptor LH LS;  MSSpecific sites of molecular structures on cells of smooth muscle, glands and neurons with which specific adrenergic agents (mainly catecholamines) react or to which they bind to elicit the characteristic response of the cell or cell constituent to endogenous sympathomimetics. There are at least three different adrenergic receptors, alpha, beta1 and beta2. Drugs that have adrenergic or adrenolytic actions interfere directly or indirectly with these receptors. PM73 HN73(71) MHÑReceptors, Adrenergic ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of specific adrenergic agents; note specifics below; coord IM with specific adrenergic agent or antag (IM); DF: RECEPT ADREN PIReceptors, Drug (68-70) MNA8.663.906.569.694.678; D12.776.543.750.860.600; G6.184.154.803.645.852.43; G12.803.852.43 XSADRENERGIC RECEPTORS; Adrenoceptors LH LS;  MSSpecific molecular sites or structures on adrenergic effector cell membranes to which alpha adrenergic agonists, their analogs or derivatives, or antagonists bind or with which they interact to initiate or block the specific response of the cell to alpha adrenergic agents. PM84; was see under RECEPTORS, ADRENERGIC 1977-83 HN84(77); was see under RECEPTORS, ADRENERGIC 1977-83 MHÑReceptors, Adrenergic, Alpha ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; /antag = ADREN ALPHA RECEPT BLOCK; coord IM with specific alpha adrenergic agent or antag (IM); DF: ADREN ALPHA RECEPT PIReceptors, Adrenergic (73-76); Receptors, Drug (68-76) MNA8.663.906.569.694.678.72; D12.776.543.750.860.600.500; G6.184.154.803.645.852.43.51; G12.803.852.43.51 XSAdrenergic Alpha Receptors; Alpha Adrenergic Receptors; Receptors, Alpha Adrenergic LH LS; ;  MSSpecific molecular sites or structures on adrenergic effector cell membranes to which beta adrenergic agonists or antagonists bind to initiate or block the specific response of the cell to beta adrenergic substances; the receptor is thought to be a protein and the receptor-agonist complex usually activates adenylate cyclase; beta 1 receptors cause excitation and are found mainly in the heart and beta 2 are in other tissues and tend to be inhibitory. PM84; was see under RECEPTORS, ADRENERGIC 1977-83 HN84(77); was see under RECEPTORS, ADRENERGIC 1977-83 MHÑReceptors, Adrenergic, Beta ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; /antag = ADREN BETA RECEPT BLOCK; coord IM with specific beta adrenergic agent or antag (IM); DF: ADREN BETA RECEPT PIReceptors, Adrenergic (73-76); Receptors, Drug (68-72) MNA8.663.906.569.694.678.112; D12.776.543.750.860.600.550; G6.184.154.803.645.852.43.119; G12.803.852.43.119 XSAdrenergic Beta Receptors; Beta Adrenergic Receptors; Receptors, Beta Adrenergic LH LS; ;  MSSpecific molecular sites or structures on or in cells of androgen target tissues with which molecules of androgens react or to which they bind to elicit the specific response of the cell or its constituents to androgens. PM86; was see under RECEPTORS, STEROID 1977-85 HN86(77); was see under RECEPTORS, STEROID 1977-85 MHÑReceptors, Androgen ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also androgen analogs & antag; coord IM with specific androgen or antag (IM); DF: RECEPT ANDROGEN PIAndrogens (66-76); Receptors, Drug (68-72); Receptors, Endogenous Substances (73-76) MND12.776.543.750.830.600; G6.184.154.803.817.64; G12.803.817.64 XSAndrogen Receptors LH LS  MSSpecific molecular sites or structures on cell membranes with which molecules of angiotensin or its analogs or inhibitors react or to which they bind to elicit the specific response of the cell to angiotensin or to block that response. PM87; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86 HN87(77); was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86 MHÑReceptors, Angiotensin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also angiotensin analogs & antag; coord IM with specific angiotensin or antag (IM); DF: RECEPT ANGIOTENSIN PIAngiotensin II (66-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76) MND12.776.543.750.600; G6.184.154.803.645.61; G12.803.61 XSAngiotensin Binding Sites; Angiotensin Receptors LH LS;  MSMolecules on the surface of B and T lymphocytes which recognize and combine with specific antigens. PM80 HN80 MHÑReceptors, Antigen ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; DF: RECEPT ANTIGEN PIBinding Sites, Antibody (73-79); Lymphocytes (66-79); B Lymphocytes (73-79); T Lymphocytes (73-79) MND24.611.834.816; G4.610.834.816; G6.184.154.834.816 XSAntigen Receptors LH LS  MSImmunoglobulin molecules on the surface of B lymphocytes which recognize and bind antigen. PM80 HN80 MHÑReceptors, Antigen, B-Cell ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; DF: RECEPT ANTIGEN B CELL PIBinding Sites, Antibody (73-79); Immunoglobulin Variable Region (77-79); Immunoglobulins, Fab (73-79); Lymphocytes (66-79); B Lymphocytes (73-79) MND24.611.834.816.821; G4.610.834.816.821; G6.184.154.834.816.821 XSAntigen Receptors, B-Cell LH LS  MSMolecules on the surface of T lymphocytes which recognize and combine with antigens. The nature and specificity of the T-cell receptors is a subject of much controversy; they do not appear to belong to any of the currently recognized classes of immunoglobulins. PM80 HN80 MHÑReceptors, Antigen, T-Cell ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; DF: RECEPT ANTIGEN T CELL PILymphocytes (66-79); T Lymphocytes (73-79) MND24.611.834.816.824; G4.610.834.816.824; G6.184.154.834.816.824 XSAntigen Receptors, T-Cell LH LS  MSProtein complexes on gut, pancreas, gall bladder, and neuron plasma membranes that, upon binding gastrin, cholecystokinin or their analogs, derivatives, antagonists, or antibodies, cause secretion of amylase by pancreatic acinar cells, acid and pepsin by stomach mucosal cells, contraction of the pylorus and gall bladder, and excitation of certain nerve pathways; other functions dependent on the engagement of these receptors have been proposed. PM87 HN87 MHÑReceptors, Cholecystokinin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of cholecystokinin; DF: RECEPT CCK PICholecystokinin (66-86); Receptors, Endogenous Substances (73-86) MND12.776.543.750.615; G6.184.154.803.397.150; G6.184.154.803.645.150; G6.184.154.803.645.852.150; G12.803.150; G12.803.852.150 XSCaerulein Receptors; Cholecystokinin Octapeptide Receptors; Cholecystokinin Receptors; Cholecystokinin-Pancreozymin Receptors; Gastrin Receptors; Pancreozymin Receptors; Proglumide Receptors; Sincalide Receptors; Tetragastrin Receptors LH LS; ; ; ; ; ; ; ;  MSSpecific molecular sites or structures of an effector cell (neuron, gland or muscle) with which molecules of acetylcholine or its analogs or antagonists react or to which they bind in order to elicit or prevent the characteristic response of the cell to parasympathetic stimulation or blockade; there are two major types of cholinergic receptors, the muscarinic and the nicotinic, of which the motor endplate is one. PM74 HN74(71) MHÑReceptors, Cholinergic ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs of specific cholinergic agents & anticholinergic agents; /antag = NEUROMUSCULAR BLOCKING AGENTS or NEUROMUSCULAR DEPOLARIZING AGENTS; coord IM with specific cholinergic agent or antag (IM); DF: RECEPT CHOLINERGIC PIReceptors, Drug (66-70); specific agonist, tissue, or organ affected MNA8.663.906.569.694.701; D12.776.543.750.860.700; G6.184.154.803.645.852.187; G12.803.852.187 XSAcetylcholine Receptors; Cholinergic Receptors; Cholinoceptive Sites; Cholinoceptors; Receptors, Acetylcholine FXÑNeuromuscular Junction LH LS; ; ; ; LX  MSMolecules on the surface of some B lymphocytes and macrophages, which recognize and combine with the C3b, C3d, C1q, and C4b components of complement. PM80 HN80 MHÑReceptors, Complement ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; DF: RECEPT COMPLEMENT PIComplement (66-79); Lymphocytes (66-79); B Lymphocytes (73-79) MND24.611.834.833; G4.610.834.833; G6.184.154.834.833 XSComplement Receptors LH LS  MSGlycoprotein moieties on the surfaces of the cell membranes that bind concanavalin A selectively; the number and location of the sites depends on the type and condition of the cell. PM80; was see under RECEPTORS, DRUG 1977-79 HN80(77); was see under RECEPTORS, DRUG 1977-79 MHÑReceptors, Concanavalin A ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also concanavalin A analogs & antag; coord IM with specific concanavalin or antag (IM); DF: RECEPT CON A PIConcanavalin A (71-76); Lectins (66-70); Receptors, Drug (68-76) MND24.611.834.880.600; G4.610.834.880.600; G6.184.154.834.880.600 XSConcanavalin A Binding Sites; Concanavalin A Receptors LH LS;  MSProteins that specifically bind cAMP and thereby change their conformation in a way that affects other cellular constituents; at least two, possibly related, proteins or cAMP-dependent enzyme fragments are known. Synonyms: cAMP Receptor Protein; Catabolite Activator Protein; CAP; CRP; Regulator Protein. PM77 HN77 MHÑReceptors, Cyclic AMP ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also cyclic AMP analogs & antag; coord IM with specific cyclic AMP cpd or antag (IM); DF: RECEPT CYCL AMP PIAdenine Nucleotides (66-67); Adenosine Cyclic Monophosphate (68-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76) MND12.776.543.750.620; G6.184.154.803.645.787.158; G6.184.154.803.645.852.787.158; G12.803.158 XSCatabolic Gene Activators; Catabolite Activator Protein; Catabolite Gene Activator Protein; Cyclic AMP Receptors LH LS; ; ;  MSSpecific molecular sites or structures on neurons in the central nervous system, autonomic ganglia and on smooth muscle fibers to which dopamine, its analogs or antagonists, bind or with which they react to elicit or block the specific response of the cell to dopamine. PM77 HN77 MHÑReceptors, Dopamine ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also dopamine analogs & antag; coord IM with specific dopamine cpd or antag (IM); DF: RECEPT DOPAMINE PIDopamine (66-76); Receptors, Adrenergic (73-76); Receptors, Drug (68-76) MNA8.663.906.569.694.678.540; D12.776.543.750.860.600.625; G6.184.154.803.645.852.43.293; G12.803.852.43.293 XSDopamine Receptors LH LS  MSSpecific molecular sites or structures of a cell with which molecules of drugs react or to which they bind to modify the functions of the cell. Do not use with endogenous substances for which RECEPTORS, ENDOGENOUS SUBSTANCES are more appropriate. PM68 HN68 MHÑReceptors, Drug ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; do not confuse with CHEMORECEPTORS: TN 160; coord IM with specific drug or chemical (IM); DF: RECEPT DRUG PIPharmacology (66-67) MND12.776.543.700; G6.184.154.763; G12.763 XSDRUG RECEPTORS LH LS  MSSpecific molecular sites or structures on or in cells with which endogenous substances, hormones, neurohumors, etc., react or to which they bind in order to modify the function of the cells. OLuse RECEPTORS, ENDOGENOUS SUBSTANCES to search RECEPTORS, HORMONE back thru 1973 PM83; was RECEPTORS, HORMONE 1973-82 HN83; was RECEPTORS, HORMONE 1973-82 MHÑReceptors, Endogenous Substances ANGEN: prefer specifics; only /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of specific substances; coord IM with specific endogenous substance or antag (IM); DF: RECEPT ENDOGENOUS SUBSTANCES PIReceptors, Drug (68-72) MND12.776.543.750; G6.184.154.803; G12.803 XSCell Receptors; HORMONE RECEPTORS; Receptors, Biological; Receptors, Hormone FXÑLigands; ÑRADIOLIGAND ASSAY LH LS; ; ; LX;  MSSpecific molecular sites or structures on neuron membranes with which molecules of endorphins, narcotics or narcotic antagonists react or to which they bind in order to elicit the characteristic response of the organ or organism to endorphins, narcotics or their antagonists; these receptors seem to be restricted to nerve tissue. OLuse RECEPTORS, ENDORPHIN to search RECEPTORS, NARCOTIC back thru 1977 PM80; was RECEPTORS, NARCOTIC 1977-79 HN80; was RECEPTORS, NARCOTIC 1977-79 MHÑReceptors, Endorphin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for both narcotics & narcotic antag; coord IM with specific narcotic or antag (IM); DF: RECEPT ENDORPHIN PINarcotics (66-76); Receptors, Drug (66-76) MNA8.663.906.569.694.730; D12.776.543.700.650; G6.184.154.803.397.348; G6.184.154.803.645.348; G12.803.320 XSEndorphin Receptors; Enkephalin Receptors; Morphine Receptors; Narcotic Receptors; Receptors, Enkephalin; Receptors, Morphine; Receptors, Narcotic; Receptors, Opiate LH LS; ; ; ; ; ; ;  MSGlycoproteins of about 170 kD that act as protein kinase and span the plasma membranes of growing cells, including tumors. They are activated by the binding of EPIDERMAL GROWTH FACTOR-UROGASTRONE which then initiates DNA and protein synthesis; they are not found on mitotically quiescent cells except in the stomach where they control the synthesis and release of digestive enzymes and gastric acid. PM87 HN87 MHÑReceptors, Epidermal Growth Factor-Urogastrone ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of epidermal growth factor-urogastrone; DF: RECEPT EGF PIEpidermal Growth Factor-Urogastrone (82-86); Epidermal Growth Factors (77-81); Receptors, Endogenous Substances (73-86); Urogastrone (66-81) MND12.776.543.750.625; D24.611.834.880.350; G6.184.154.803.397.350; G6.184.154.803.645.350; G12.803.350 XSEGF-URO Receptors; Epidermal Growth Factor Receptors; Urogastrone Receptors LH LS; ;  MSSpecific proteins on or in cells to which estradiol, its analogs, derivatives, and antagonists bind and thereby trigger or block the characteristic response of that cell to estradiols; there may be several types of receptors for estradiol. HN(85) MHÑReceptors, Estradiol ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also estradiol analogs & antag; DF: RECEPT ESTRADIOL PIEstradiol (66-84); Pharmacology (66-67); Receptors, Drug (68-84); Receptors, Endogenous Substances (73-76); Receptors, Estrogen (77-84) MND12.776.543.750.830.630.340; G6.184.154.803.817.349.340; G12.803.817.349.340 XSEstradiol Receptors DMÑReceptors, Estrogen LH LS LM  MSSpecific proteins on or in cells to which specific estrogens, their analogs, derivatives, antagonists or blockers bind, triggering or blocking a transformation in the receptor protein and the relocation of the estrogen-receptor complex from the cytoplasm into the nucleus to initiate protein synthesis; there are several kinds of estrogen receptors. PM77 HN77 MHÑReceptors, Estrogen ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also estrogen analogs & antag; coord IM with specific estrogen or antag (IM); DF: RECEPT ESTROGEN PIEstrogens (66-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76) MND12.776.543.750.830.630; G6.184.154.803.817.349; G12.803.817.349 XSEstrogen Receptors XUÑReceptors, Estradiol LH LS LU  MSMolecules found on the surface of some, but not all, B lymphocytes, T lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. PM80 HN80 MHÑReceptors, Fc ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; DF: RECEPT FC PIBinding Sites, Antibody (73-79); Immunoglobulins, Fc (73-79); Lymphocytes (66-79); B Lymphocytes (73-79) MND24.611.834.871; G4.610.834.871; G6.184.154.834.871 XSFc Receptors LH LS  MSThose protein or molecular sites on the surfaces of ovarian and testicular cells that bind follitropin (FSH) or its analogs or antagonists and thereby modify their physiology to produce estrogen or testosterone and release it; the follitropin-receptor complex also initiates the proliferation of certain ovarian and testicular cells to produce gametes. PM87 HN87 MHÑReceptors, FSH ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of FSH; DF: RECEPT FSH PIFSH (66-86); Receptors, Endogenous Substances (73-86) MND12.776.543.750.630; G6.184.154.803.740.405.380; G12.803.405.380 XSFSH Receptors; Follicle-Stimulating Hormone Receptors; Follitropin Receptors LH LS; ;  MSGABA receptors are specific molecular sites to which GABA, minor tranquilizers, anticonvulsants, and centrally acting muscle relaxants bind and thereby trigger or block the characteristic response of the cell. PM85 HN85 MHÑReceptors, GABA-Benzodiazepine ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for GABA & benzodiazepine analogs & antag; DF: RECEPT GABA RN0 PIAminobutyric Acids (66-78); GABA (79-84); Pharmacology (66-67); Receptors, Drug (68-84); Receptors, Endogenous Substances (73-84) MND12.776.543.750.640; G6.184.154.803.645.395; G12.803.395 XSGABA Receptors; Receptors, Benzodiazepine; Receptors, Benzodiazepine-GABA; Receptors, Diazepam; Receptors, Gamma-Aminobutyric Acid; Receptors, Muscimol LH LS; ; ; ; ;  MSAny receptor in the body that binds any gastrointestinal, gastric or intestinal hormones, their analogs or antagonists, or any endogenous substance commonly acting in the gastrointestinal tract. PM87 HN87 MHÑReceptors, Gastrointestinal Hormone ANGEN: prefer specifics; only /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of gastrointestinal hormones; coord IM with specific hormone or antag (IM); DF: RECEPT GASTROINTESTINAL HORMONE PIGastrointestinal Hormones (66-86); Receptors, Endogenous Substances (73-86) MNG6.184.154.803.397; D12.776.543.750.642 XSGastrointestinal Hormone Receptors; Intestinal Hormone Receptors LH LS;  MSSpecific proteins on or in cells to which specific glucocorticoids or their analogs, derivatives, antagonists and blockaders bind to elicit or to block the specific response of the cell to glucocorticoids; the receptor-steroid complex moves from the cytosol to the nucleus where it initiates protein synthesis. PM86; was see under RECEPTORS, STEROID 1977-85 HN86(77); was see under RECEPTORS, STEROID 1977-85 MHÑReceptors, Glucocorticoid ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also glucocorticoid analogs & antag; coord IM with specific glucocorticoid or antag (IM); DF: RECEPT GLUCOCORTICOID PIGlucocorticoids (67-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76) MND12.776.543.750.830.650; G6.184.154.803.817.398; G12.803.817.398 XSGlucocorticoid Receptors; Receptors, Corticosteroid LH LS;  MSReceptors with a 6 kD protein on the surfaces of cells that secrete LH or FSH, usually in the adenohypophysis. The gonadoliberin (gonadotropin releasing hormone) binds to these receptors, is endocytosed with the receptor and, in the cell, triggers the release of LH or FSH by the cell. These receptors are also found in rat gonads; INHIBIN prevents the binding of GnRH to its receptors. PM87 HN87 MHÑReceptors, Gonadoliberin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of gonadoliberin; DF: RECEPT GNRH PILH-FSH Releasing Hormone (74-86); Receptors, Endogenous Substances (73-86) MND12.776.543.750.645; G6.184.154.803.645.401; G12.803.401 XSFoliberin Receptors; Gonadoliberin Receptors; Gonadotropin Releasing Hormone Receptors; LHFSHRH Receptors; Luliberin Receptors; Receptors, GnRH LH LS; ; ; ; ;  MSThose protein complexes or molecular sites on the surfaces of gonadal and other sensitive cells that bind gonadotropins and thereby modify the functions of those cells; hCg, LH, and FSH are the major specific gonadotropins. PM87 HN87 MHÑReceptors, Gonadotropin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of gonadotropin; specific precoord gonadotropin receptor terms are available; DF: RECEPT GONADOTROPIN PIGonadotropins, Chorionic (66-86); Gonadotropins, Pituitary (66-86); Receptors, Endogenous Substances (73-86) MND12.776.543.750.648; G6.184.154.803.740.405; G12.803.405 XSChorionic Gonadotropin Receptors; Gonadotropin Receptors; Menotropin Receptors; Pituitary Gonadotropin Receptors LH LS; ; ;  MSSpecific molecular sites or structures on cell membranes with which molecules of HISTAMINE, its analogs or antagonists, react or to which they bind to elicit the specific response of the cell to HISTAMINE or to block that response. There are two types of HISTAMINE receptors, H1 and H2. PM77 HN77 MHÑReceptors, Histamine ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also histamine analogs & antag; coord IM with specific histamine cpd or antag (IM) but note specifics below; DF: RECEPT HISTAMINE PIHistamine (70-76); Receptors, Drug (70-76); Receptors, Endogenous Substances (73-76) MND12.776.543.750.650; G6.184.154.803.453; G6.184.154.803.645.453; G12.803.453 XSHistamine Binding Sites; Histamine Receptors XUÑReceptors, Histamine H1 LH LS; LU  MSSpecific molecular structures on cell membranes of smooth muscle, especially in bronchi, small intestine, blood vessels, heart, etc., that react with HISTAMINE, its analogs or antagonists, to elicit or inhibit the specific response of the cells to histamine; these receptors are blockaded by the classical ANTIHISTAMINICS. HN(77) MHÑReceptors, Histamine H1 ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; receptors for only the classical ╥antihistaminics╙; /antag = RECEPT BLOCK H1; coord IM with specific H1 antag (IM); DF: RECEPT H1 PIHistamine (66-76); Receptors, Drug (70-76) MND12.776.543.750.650.600; G6.184.154.803.453.450; G6.184.154.803.645.453.450; G12.803.453.450 XSHistamine H1 Receptors DMÑRECEPTORS, HISTAMINE LH LS LM  MSSpecific molecular structures on cell membranes that react with histamine, its analogs or antagonists, to elicit or to inhibit the specific response of the cell to histamine; the H2 receptors are more widely distributed and mediate a broader range of functions than the H1 receptors; they cannot be blockaded by the traditional antihistaminics. PM87; was see under RECEPTORS, HISTAMINE 1977-86 HN87(77); was see under RECEPTORS, HISTAMINE 1977-86 MHÑReceptors, Histamine H2 ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; receptors for the non-classical antihistaminics; /antag = RECEPT BLOCK H2; coord IM with specific H2 antag (IM); DF: RECEPT H2 PIHistamine (66-76); Receptors, Drug (70-76) MND12.776.543.750.650.625; G6.184.154.803.397.454; G6.184.154.803.453.454; G6.184.154.803.645.453.454; G12.803.453.454 XSHistamine H2 Receptors LH LS  MSMolecules on the surface of immunologically competent cells which are capable of selectively combining with complementary molecules. PM80 HN80 MHÑReceptors, Immunologic ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; DF: RECEPT IMMUNOL PIBinding Sites, Antibody (73-79); Lymphocytes (66-79); B Lymphocytes (73-79); T Lymphocytes (73-79); Macrophages (66-79) MND24.611.834; G4.610.834; G6.184.154.834 XSImmunologic Receptors LH LS  MSSpecific molecular sites or structures on cell membranes with which molecules of insulin react or to which they bind in order to elicit the specific response of the cell to insulin. PM77 HN77 MHÑReceptors, Insulin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also insulin antag; coord IM with specific insulin or antag (IM); DF: RECEPT INSULIN PIInsulin (66-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76) MND12.776.543.750.770; G6.184.154.803.493; G6.184.154.803.645.493; G12.803.493 XSInsulin Receptors LH LS  MSReceptors on the plasma membrane of nonhepatic cells which specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1) Receptors do not bind to LDL; 2) there is reduced binding of LDL; and 3) there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. PM85 HN85 MHÑReceptors, LDL ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also low-density lipoprotein antag; DF: RECEPT LDL PILipoproteins, LDL (72-84); Receptors, Endogenous Substances (73-84) MND12.776.543.750.780; G6.184.154.803.555; G6.184.154.803.817.555; G12.803.555 XSLDL Receptors; Lipoproteins, LDL Receptors; Receptors, Low Density Lipoproteins LH LS; ;  MSThose protein complexes or molecular sites on the surfaces and cytoplasmae of gonadal cells that bind luteinizing or chorionic gonadotropic hormones and thereby cause the gonadal cells to synthesize and secrete sex steroids. The hormone-receptor complex is internalized from the plasma membrane and initiates steroid synthesis. PM87 HN87 MHÑReceptors, LH ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of LH; DF: RECEPT LH PIGonadotropins, Chorionic (66-86); LH (68-86); Receptors, Endogenous Substances (73-86) MND12.776.543.750.785; G6.184.154.803.740.405.560; G12.803.405.560 XSHCG Receptors; Human Chorionic Gonadotropin Receptors; ICSH Receptors; Interstitial Cell Stimulating Hormone Receptors; LH Receptors; LH-hCG Receptors; Luteinizing Hormone Receptors; Lutropin Receptors; Receptors, Luteinizing Hormone LH LS; ; ; ; ; ; ; ;  MSGlycoprotein molecules on the surface of B and T lymphocytes, which react with molecules of antilymphocyte sera, lectins, and other agents which induce blast transformation of lymphocytes. PM80 HN80 MHÑReceptors, Mitogen ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; DF: RECEPT MITOGEN PILymphocytes (66-79); B Lymphocytes (73-79); T Lymphocytes (73-79); Mitogens (72-79) MND24.611.834.880; G4.610.834.880; G6.184.154.834.880 XSLectin Receptors; Mitogen Receptors; Receptors, Lectin LH LS; ;  MSSpecific molecular sites on neurons in the central nervous system and on smooth muscle or gland effector cells to which muscarinic substances, their derivatives or antagonists, bind or with which they react to elicit or block the specific response of the cell to muscarinic substances (ACETYLCHOLINE); Muscarinic receptors mediate in the parasympathetic autonomic nervous system and are blocked by atropine; there may be different kinds of muscarinic receptors. PM84; was see under RECEPTORS, CHOLINERGIC 1977-83 HN84(77); was see under RECEPTORS, CHOLINERGIC 1977-83 MHÑReceptors, Muscarinic ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of muscarinic substances; coord IM with specific muscarinic substance or antag (IM); DF: RECEPT MUSCARINIC PIAcetylcholine (66-76); Parasympathomimetics (66-76); Receptors, Cholinergic (71-76); Receptors, Drug (68-76) MNA8.663.906.569.694.701.593; D12.776.543.750.860.700.650; G6.184.154.803.397.613; G6.184.154.803.645.852.187.613; G12.803.852.187.613 XSMuscarinic Receptors LH LS  MSAny receptor in the body that binds any neurohumor or neuroregulator, their analogs or antagonists, or any endogenous substance commonly found in the central nervous system. PM87 HN87 MHÑReceptors, Neurohumor ANGEN: prefer specifics; only /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of specific neurohumors; coord IM with specific neurohumor or antag (IM); DF: RECEPT NEUROHUMOR PINeuroregulators (66-86); Receptors, Endogenous Substances (73-86) MNG6.184.154.803.645; D12.776.543.750.790 XSNeurohumor Receptors; Neuromediator Receptors; Neuromodulator Receptors; Neuroregulator Receptors LH LS; ; ;  MSSpecific proteins on the membranes of neurons in the central nervous system and autonomic ganglia, and on skeletal muscle fibers to which nicotinic agents or their analogs or antagonists bind or with which they react to elicit or block the specific response of the cell to nicotinic agents (ACETYLCHOLINE); there are at least two kinds of nicotinic receptors, those that mediate in the autonomic ganglia (GANGLIONIC BLOCKADERS) and those in skeletal muscle; the MOTOR END PLATE is a nicotinic receptor (NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR DEPOLARIZING AGENTS). PM84; was see under RECEPTORS, CHOLINERGIC 1977-83 HN84(77); was see under RECEPTORS, CHOLINERGIC 1977-83 MHÑReceptors, Nicotinic ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of nicotinic agents; coord IM with specific nicotinic agent or antag (IM); DF: RECEPT NICOTINIC PIAcetylcholine (66-76); Nicotine (74-76); Receptors, Cholinergic (71-76); Receptors, Drug (68-76) MNA8.663.906.569.694.701.659; D12.776.543.750.860.700.675; G6.184.154.803.645.852.187.646; G12.803.852.187.646 XSNicotinic Receptors LH LS  MSAny receptor in the body that binds any hormone, its analog or antagonist, or other endogenous substance that is secreted by the pituitary gland or its parts. PM87 HN87 MHÑReceptors, Pituitary Hormone ANGEN: prefer specifics; only /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of specific pituitary hormones; coord IM with specific hormone or antag (IM); DF: RECEPT PITUITARY HORMONE PIPituitary Hormones (72-86); Pituitary Hormones, Anterior (66-86); Pituitary Hormones, Posterior (66-86); Receptors, Endogenous Substances (73-86) MNG6.184.154.803.740; D12.776.543.750.793 XSPituitary Hormone Receptors LH LS  MSSpecific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone; the cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis; there are two kinds of progesterone receptors, A and B; they are induced by estrogen and have short half-lives. PM77 HN77 MHÑReceptors, Progesterone ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also progesterone analogs & antag; coord IM with specific progesterone or antag (IM); DF: RECEPT PROGESTERONE PIProgesterone (66-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76) MND12.776.543.750.830.700; G6.184.154.803.817.777; G12.803.817.777 XSProgesterone Receptors; Progestin Receptors; Receptors, Progestin LH LS; ;  MSLabile proteins on or in prolactin-sensitive cells that bind prolactin which initiates the cells' physiological response to that hormone; mammary casein synthesis is one of the responses; the receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists; this receptor is related to the growth hormone receptor. PM87 HN87 MHÑReceptors, Prolactin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of prolactin; DF: RECEPT PRL PIProlactin (66-86); Receptors, Endogenous Substances (73-86) MND12.776.543.750.795; G6.184.154.803.740.405.750; G12.803.750 XSProlactin Receptors LH LS  MSSpecific sites or molecular structures on cell membranes or in cells of various tissues with which specific prostaglandins react or to which they bind to elicit specific responses of the cell or its constituents to the prostaglandin; the receptors of various cells seem to differ as to specificity for the different prostaglandins. PM87; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86 HN87(77); was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86 MHÑReceptors, Prostaglandin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also prostaglandin antag; coord IM with specific natural or synthetic prostaglandin or antag (IM); DF: RECEPT PG PIReceptors, Drug (68-76); Prostaglandins (66-76) MND12.776.543.750.800; G6.184.154.803.645.774; G6.184.154.803.774; G12.803.774 XSProstaglandin Receptors LH LS  MSProteins or molecular complexes on surfaces of cells that bind various purines, especially ADENOSINE and its analogs, derivatives, and antagonists and thereby modify certain functions of the cells; the binding of these receptors is found to modify the activation of neurons and the functions of certain other cells including cardiac and smooth muscle, the metabolism of fat cells, etc. PM87 HN87 MHÑReceptors, Purinergic ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of purinergic substances; coord IM with specific purine or antag (IM); DF: RECEPT PURINE PIAdenosine (66-86); Purines (66-86); Receptors, Endogenous Substances (73-86) MND12.776.543.750.810; G6.184.154.803.645.787; G6.184.154.803.645.852.787; G12.803.787; G12.803.852.725 XSADP Receptors; ATP Receptors; Adenosine Receptors; Caffeine Receptors; Methyladenine Receptors; Methylxanthine Receptors; Purine Receptors; Purinergic Receptors; Theophylline Receptors LH LS; ; ; ; ; ; ; ;  MSThe part of the nervous system which receives a stimulus. OLuse RECEPTORS, SENSORY to search RECEPTORS, NEURAL back thru 1966 PM77; was RECEPTORS, NEURAL 1963-76 HN77; was RECEPTORS, NEURAL 1963-76 MHÑReceptors, Sensory ANdo not use /innerv; DF: RECEPT SENSORY MNA8.796.511.725 XSNEURORECEPTORS; Nerve Endings, Sensory FXÑSense Organs LH LS; LX  MSSpecific proteolipid sites or structures on membranes of cells sensitive to serotonin in the brain, smooth muscle, platelets, etc, to which serotonin, its analogs or antagonists, bind or with which they interact to elicit or block the specific response of the cell to serotonin; there are different kinds of serotonin receptors. PM77 HN77 MHÑReceptors, Serotonin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also serotonin analogs & antag; coord IM with specific serotonin or antag (IM); DF: RECEPT SEROTONIN PIReceptors, Drug (68-76); Receptors, Endogenous Substances (73-76); Serotonin (66-76) MNA8.663.906.569.694.760; D12.776.543.750.860.800; G6.184.154.803.645.852.832; G12.803.852.832 XSReceptors, Tryptamine; Serotonin Receptors; Tryptamine Receptors LH LS; ;  MSThose proteins or protein complexes on cell membranes that cause the cell to respond to GROWTH HORMONE by releasing somatomedins, or otherwise, when growth hormone (both placental and pituitary), and its analogs, derivatives, and antibodies bind to them; the receptor-hormone complex is internalized for activation; the receptors are complex and may have several components; they vary from organ to organ and by species; and are closely related to PROLACTIN RECEPTORS. PM87 HN87 MHÑReceptors, Somatotropin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of somatotropin; DF: RECEPT GH PIReceptors, Endogenous Substances (73-86); Somatotropin (66-86) MND12.776.543.750.815; G6.184.154.803.645.800; G6.184.154.803.740.800; G6.184.154.803.800; G12.803.800 XSGrowth Hormone Receptors; Somatomammotropin Receptors; Somatotropin Receptors LH LS; ;  MSSpecific molecular sites or structures on or in cells of steroid target tissues with which specific steroid molecules react or to which they bind to elicit the specific response of the target cell or its constituents to the steroid. PM77 HN77 MHÑReceptors, Steroid ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also steroid analogs & antag but not for steroid-binding proteins; coord IM with specific steroid or antag (IM); DF: RECEPT STEROID PIReceptors, Drug (68-72); Receptors, Endogenous Substances (73-76); Steroids (66-76) MND12.776.543.750.830; G6.184.154.803.817; G12.803.817 XSSteroid Receptors LH LS  MSThose proteins, usually on or in nuclei of cells, that bind to thyroid hormones, their analogs, derivatives, or antibodies and thereby initiate microsomal RNA synthesis in somatic cells; they are also involved with energy production in mitochondria and with DNA synthesis. PM87 HN87 MHÑReceptors, Thyroid Hormone ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of thyroid hormones; coord IM with specific thyroid hormone (IM); DF: RECEPT T3 PIReceptors, Endogenous Substances (73-86); Thyroid Hormones (66-86); Thyroxine (66-86); Triiodothyronine (66-86) MND12.776.543.750.840; G6.184.154.803.832; G12.803.832 XSDiiodotyrosine Receptors; LATS Receptors; T3 Receptors; T4 Receptors; Thyroid Hormone Receptors; Thyroxine Receptors; Triiodothyronine Receptors LH LS; ; ; ; ; ;  MSThose glycoproteins or protein complexes on the surfaces of cells in the thyroid gland that bind specifically to thyrotropin and thereupon trigger the uptake of iodine and the synthesis and release of thyroid hormone by the thyroid cells. Autoantibodies to these receptors are implicated in Graves', Hashimoto's, and other thyroid diseases. PM87 HN87 MHÑReceptors, Thyrotropin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of thyrotropin; RECEPT TSH PIReceptors, Endogenous Substances (73-86); Thyrotropin (66-86) MND12.776.543.750.845; G6.184.154.803.740.837; G12.803.837 XSTSH Receptors; Thyroid Stimulating Hormone Receptors; Thyrotropin Receptors LH LS; ;  MSA membrane glycoprotein of 180 kD, found in high concentrations on iron-utilizing cells; it specifically binds iron-bearing transferrrin, is endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released. PM87 HN87 MHÑReceptors, Transferrin ANonly /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; includes receptors for also analogs & antag of transferrin; DF: RECEPT TRANSFERRIN PIReceptors, Endogenous Substances (73-86); Transferrin (66-86) MND12.776.543.750.850; G6.184.154.803.842; G12.803.842 XSTransferrin Receptors FXÑCarrier Proteins LH LS LX  MSSpecific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response. PM79 HN79 MHÑReceptors, Virus ANreceptor on cell binding virus; only /anal /biosyn /drug eff /genet /immunol /isol /metab /physiol /rad eff; DF: RECEPT VIRUS PIBinding Sites (68-78) MND12.776.543.955; G6.184.154.955 XSPhage Receptors; Virus Receptors LH LS;  MSCytoplasmic vesicles formed from coated pits in the cell membrane which internalize macromolecules bound by receptors on the cell surface. PM83 HN83 MHÑReceptosomes ANA 11 qualif except /cytol PIEndocytosis (73-82) MNA11.368.702.801 FXÑEndocytosis XUÑCoated Pits, Cell Membrane LH LX LU  MSThese proteins are the result of genetic engineering. A regulatory part or promoter of one or more genes is combined with a structural gene. The fusion protein is formed after transcription and translation of the fused gene. This type of fusion protein is used in the study of gene regulation or structure-activity relationships. HN(87) MHÑRecombinant Fusion Proteins AN/biosyn /physiol permitted; do not confuse with VIRAL FUSION PROTEINS MND12.776.828.300 XSFusion Proteins, Recombinant DMÑRecombinant Proteins LH LS LM  MSProteins prepared by recombinant DNA technology. PM86 HN86 MHÑRecombinant Proteins AN╥proteins prepared by recombinant DNA technology╙; usually NIM; for synthesis of these proteins, coord IM with /biosyn + specific protein /biosyn (IM) PIDNA, Recombinant (77-85); Proteins or specific protein (66-85) MND12.776.828 XSBiosynthetic Proteins; DNA Recombinant Proteins FXÑBiotechnology XUÑRecombinant Fusion Proteins LH LS; LX LU  MSProduction of new arrangements of genes by various mechanisms such as assortment and segregation, crossing over, gene conversion, transformation, conjugation, transduction, F-duction, or mixed infection of viruses. PM68 HN68 MHÑRecombination, Genetic ANonly /drug eff /rad eff PIGenetics (66-67) MNG5.832 LH  MSUse for general articles concerning health-related records or where there is no specific heading. PM68; HOSPITAL RECORDS was see under MEDICAL RECORDS 1963-78 HN68 MHÑRecords ANonly /stand; vet records go here (IM) + VETERINARY MEDICINE (IM); case reports as a form of writing probably goes under MEDICAL RECORDS or specific records term (IM); note RECORDS CONTROL below PIDental Records (67); Medical Records (66-67); Nursing Records (67) MNN4.452.859 FXÑDocumentation; ÑVital Statistics XUÑHospital Records LH LX; LU  MSHospital unit providing continuous monitoring of the patient following anesthesia. OLsearch INTENSIVE CARE UNITS 1966-74 PM79; was see under INTENSIVE CARE UNITS 1966-78 HN79(75); was see under INTENSIVE CARE UNITS 1966-78 MHÑRecovery Room ANdo not use /educ /methods PIIntensive Care Units (66-74) MNN2.278.388.493.592 XSHospital Recovery Room LH LS  MSActivity engaged in for pleasure. MHÑRecreation ANno qualif MNI3.450.642 LH  HN(72); was see under NEURAL TRANSMISSION 1975-76 MHÑRecruitment (Neurology) ANonly drug eff /rad eff; DF: RECRUITMENT PINeural Transmission (68-71) MNG11.561.537.678 DMÑNeural Conduction LH LM  MSTests for measuring loudness recruitment. PM79 HN79 MHÑRecruitment Detection (Audiology) ANonly /instrum /methods /stand /util (if by MeSH definition); DF: RECRUITMENT DETECTION PIAudiometry (66-78); Auditory Threshold (68-78) MNE1.276.299.375.570 XSAlternate Binaural Loudness Balance Test; Loudness Recruitment Detection; Short Increment Sensitivity Index LH LS; ;  MSAn abnormally disporportionate increase in the sensation of loudness in response to a relatively slight increase in intensity of an acoustic signal. PM79 HN79 MHÑRecruitment, Loudness ANnote categ: use qualif discreetly PIAudiometry (66-78); Auditory Perception (67-78); Auditory Threshold (68-78); Hearing (66-67); Perception (66-67) MNC9.218.458.725; C10.597.257.443.807; C23.888.592.257.443.807 XSLoudness Recruitment LH LS  PM66 HN66 MHÑRectal Diseases ANinflamm dis = PROCTITIS CATALOG: form qualif = COLON AND RECTAL SURGERY (SPECIALTY) /form MNC6.405.469.860 LH  MSAbnormal passage communicating with the rectum. MHÑRectal Fistula ANfistula policy: Manual 23.25+; anal fistula goes here, not under FISSURE IN ANO MNC6.405.469.860.704 FXÑFistula LH LX  MHÑRectal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); /familial: consider also COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS MNC4.588.274.476.411.792; C6.405.469.860.767 LH  MHÑRectal Prolapse MNC6.405.469.860.829 XSANUS PROLAPSE LH LS  MSAbnormal communication between the rectum and the vagina. MHÑRectovaginal Fistula ANfistula policy: Manual 23.25+ MNC6.405.469.860.704.642; C13.371.894.763.558 FXÑFistula LH LX  MHÑRectum AN/surg: do not confuse with the specialty COLON AND RECTAL SURGERY (SPECIALTY); rectal bleeding: RECTUM (NIM) + HEMORRHAGE, GASTROINTESTINAL (IM) for bleeding thru rectum; hemorrhaging rectum is RECTAL DISEASES (IM) + HEMORRHAGE, GASTROINTESTINAL (IM); inflammation = PROCTITIS; consider also terms under PROCT- CATALOG: form qualif = COLON AND RECTAL SURGERY (SPECIALTY) /form MNA3.492.411.495.767 LH  MSThe return of symptoms after a remission. Syn: relapse. HN(71) MHÑRecurrence ANnever IM; no qualif PIappropriate disease heading MNC23.280.734 DMÑDisease LH LM  OLsearch LARYNGEAL NERVES 1966-74 HN(75) MHÑRecurrent Laryngeal Nerve ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.936.508.642 DMÑLaryngeal Nerves LH LM  MSSuppression of erythropoiesis with little or no abnormality of leukocyte or platelet production. PM85 HN85 MHÑRed Cell Aplasia, Pure PIAnemia, Aplastic (66-84) MNC15.378.71.750 XSErythrocyte Aplasia; Pure Red Cell Aplasia LH LS;  MSAn international agency providing various humanitarian services. PM66 HN66 MHÑRed Cross ANonly /hist /organ; specify geog CATALOG: use NAF entry MNN3.540.514.642; N3.540.630.780.608 LH  MHÑRed Nucleus AN= nucleus ruber; do not use /innerv MNA8.186.211.132.659.822.642 LH  MSBooks, e.g., dictionaries, encyclopedias, atlases, intended primarily for consultation. MHÑReference Books ANno qualif MNL1.178.682.192.836 LH  MSBooks in the field of medicine intended primarily for consultation. PM75 HN75 MHÑReference Books, Medical ANno qualif MNL1.178.682.192.836.842 LH  MSA basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, technics, and procedures used in diagnosis and therapy. PM79 HN79 MHÑReference Standards ANNIM with specific subject (IM) with /stand if permitted by category; no qualif; differentiate from REFERENCE VALUES: REFERENCE STANDARDS = basis of value or standard for a measurement, REFERENCE VALUES = range or frequency distribution of a measurement MNH1.939.808 XSStandard Preparations; Standards, Reference FXÑQuality Control LH LS; LX  MSThe range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. OLuse REFERENCE VALUES to search NORMAL VALUES back thru 1977 PM80; was NORMAL VALUES 1977-79 HN80; was NORMAL VALUES 1977-79 MHÑReference Values ANnever IM; no qualif; differentiate from REFERENCE STANDARDS: REFERENCE VALUES = range or frequency distribution of a measurement, REFERENCE STANDARDS = basis of value or standard for a measurement MNH1.939.810 XSNormal Range; Normal Values; Reference Ranges LH LS; ;  MSThe practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide. PM68 HN68 MHÑReferral and Consultation ANonly /econ /legis /trends /util; DF: REFERRAL PIInterprofessional Relations (66-67) MNN4.452.758.849 XSConsultation; Hospital Referral; Second Opinion LH LS; ;  MSAn involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord. MHÑReflex ANonly /drug eff /physiol /rad eff; areflexia, hyporeflexia, hyperreflexia, loss of reflex: index under REFLEX, ABNORMAL MNE1.236.563.642; E1.706.592.642; F2.830.702; G11.561.730 XUÑGagging; ÑPiloerection; ÑReflex, Abdominal; ÑReflex, Oculocardiac LH LU; ; ;  PM65 HN65 MHÑReflex Sympathetic Dystrophy MNC10.120.793 XSALGODYSTROPHIC SYNDROME FXÑShoulder-Hand Syndrome; ÑSudeck's Atrophy LH LS LX;  HN(70) MHÑReflex, Abdominal ANonly /drug eff /rad eff PIAbdominal Wall (66-69); Reflex (66-69) MNE1.236.563.642.475; E1.706.592.642.475; G11.561.730.580 DMÑReflex LH LM  MHÑReflex, Abnormal ANdo not use Cat E qualif; in addition to abnormal, includes hypo-, a- & hyperreflexia MNC10.597.704; C23.888.592.717; E1.236.563.642.558; E1.706.592.642.558 XUÑBabinski Reflex LH LU  MSIntra-aural contraction of tensor tympani and stapedius in response to sound. PM80 HN80 MHÑReflex, Acoustic ANonly /drug eff /rad eff PIAcoustic Stimulation (72-79); Reflex (66-79); Sound (66-71) MNE1.236.563.642.580; E1.706.592.642.580; G11.561.730.594 LH  PM70 HN70(68) MHÑReflex, Monosynaptic ANonly /drug eff /rad eff PIReflex (66-67) MNG11.561.730.643 XUÑH-Reflex LH LU  MSChange of heartbeat induced by pressure on the eyeball, manipulation of extraocular muscles, or pressure upon the tissue remaining in the orbital apex after enucleation. HN(76) MHÑReflex, Oculocardiac ANonly /drug eff /rad eff PIHeart Rate (66-75); Reflex (66-75) MNG11.561.730.685 DMÑReflex LH LM  PM74 HN74(70) MHÑReflex, Pupillary ANonly /drug eff /rad eff PIPupil (66-69); Reflex (66-69) MNE1.236.563.642.642; E1.706.592.642.642; G11.561.730.705 FXÑPupil LH LX  MSReflex contraction of a muscle in response to stretching, which stimulates muscle proprioceptors. OLuse REFLEX, STRETCH to search REFLEX, TENDON back thru 1966 PM82; was REFLEX, TENDON 1965-81 HN82; was REFLEX, TENDON 1965-81 MHÑReflex, Stretch ANonly /drug eff /rad eff MNE1.236.563.642.725; E1.706.592.642.725; G11.561.730.768 XSReflex, Tendon LH LS  MSA reflex wherein impulses are conveyed from the cupulas of the SEMICIRCULAR CANALS and from the OTOLITHIC MEMBRANE of the SACCULE AND UTRICLE via the VESTIBULAR NUCLEI of the BRAIN STEM and the median longitudinal fasciculus to the OCULOMOTOR NERVE nuclei. It functions to maintain a stable retinal image during head rotation by generating appropriate compensatory EYE MOVEMENTS. PM87 HN87 MHÑReflex, Vestibulo-Ocular ANonly /drug eff /rad eff PIEye Movements (66-86); Nystagmus, Physiologic (83-86); Reflex (66-86); Vestibular Apparatus (66-86) MNG11.561.730.795 XSVestibulo-Ocular Reflex LH LS  MHÑReflexotherapy ANdo not use /util except by MeSH definition MNE2.924.843 LH  MSRefraction of light effected by the media of the eye. Determination of the refractive state and refractive correction. MHÑRefraction, Ocular ANnote category; no qualif MNE1.210.935.768 FXÑEye; ÑVisual Acuity LH LX;  MHÑRefractive Errors MNC11.744 XSAMETROPIA; Anisometropia LH LS;  MSMeasurement of the index of refraction (the ratio of the velocity of light or other radiation in the first of two media to its velocity in the second as it passes from one into the other). PM79 HN79 MHÑRefractometry ANonly /instrum /methods /stand; do not use for refractometry in REFRACTION, OCULAR MNH1.181.278.811; H1.671.606.811 XSRefractive Index LH LS  HN(72) MHÑRefractory Period, Neurologic ANonly /drug eff /rad eff PINeural Conduction (66-71) MNG11.561.537.700 DMÑNeural Conduction LH LM  MSA delayed response interval occurring when two stimuli are presented in close succession. OLuse REFRACTORY PERIOD, PSYCHOLOGICAL to search REFRACTORY PERIOD, PSYCHOLOGIC back thru 1972 (as Prov 72-74) HN(79); was REFRACTORY PERIOD, PSYCHOLOGIC see under REACTION TIME 1975-78, was REFRACTORY PERIOD, PSYCHOLOGIC 1972-74 (Prov) MHÑRefractory Period, Psychological ANhuman & animal; only /drug eff /physiol /rad eff PIReaction Time (66-71) MNF2.830.650.400; F4.669.817.559 DMÑReaction Time LH LM  HNwas in Cat E & J 1967-81, was in Cat G only 1963-66 MHÑRefrigeration ANonly /adv eff /econ /hist /instrum /stand MNE5.760.643 FXÑCold; ÑFreezing; ÑHypothermia, Induced LH LX; ;  PM67 HN67(64) MHÑRefsum's Syndrome MNC10.772.708; C18.452.648.556.641.643 XSHeredopathia Atactica Polyneuritiformis LH LS  MHÑRefugees ANonly /psychol; specify geog MNM1.755 LH  MHÑRefuse Disposal ANonly /econ /instrum /methods /stand /trends MNG3.850.860.510.460 XSWASTE DISPOSAL, SOLID XUÑGarbage LH LS LU  MHÑRegeneration ANIM; only /drug eff /rad eff; coord IM with organ /physiol (IM), not /growth; available also are BONE REGENERATION, LIVER REGENERATION, NERVE REGENERATION & WOUND HEALING MNG4.185.753 LH  PM67 HN67(64) MHÑRegional Blood Flow ANalways NIM; only /drug eff /rad eff; coord NIM with organ /blood supply (IM) or specific artery or vein /physiol (IM); specifics available are CEREBROVASCULAR CIRCULATION, CORONARY CIRCULATION, LIVER CIRCULATION, PULMONARY CIRCULATION, RENAL CIRCULATION, SPLANCHNIC CIRCULATION; also available are COLLATERAL CIRCULATION, MICROCIRCULATION & PORTAL SYSTEM; Manual 21.4.2, 21.6; taking of pulse at wrist is not REGIONAL BLOOD FLOW: it is PULSE MNG9.330.612.793 LH  MSPlanning for health resources at a community or regional level. OLto search AREAWIDE PLANNING use REGIONAL HEALTH PLANNING back thru 1975 & HEALTH AND WELFARE PLANNING 1968-74; use REGIONAL HEALTH PLANNING to search COMPREHENSIVE HEALTH PLANNING back thru 1969 (as Prov 1969-71) & APPROPRIATENESS REVIEW (HEALTH CARE) & STATE HEALTH PLANS back thru 1980 & ANNUAL IMPLEMENTATION PLANS back thru 1981 PM77; was AREAWIDE PLANNING see under HEALTH AND WELFARE PLANNING 1968-76; ANNUAL IMPLEMENTATION PLANS was see under REGIONAL HEALTH PLANNING 1981-85, was see under STATE HEALTH PLANS 1980; APPROPRIATENESS REVIEW (HEALTH CARE) was see under REGIONAL HEALTH PLANNING 1980-85; COMPREHENSIVE HEALTH PLANNING was heading 1972-77; HEALTH SYSTEMS PLANS was see under STATE HEALTH PLANS 1980 HN77; was AREAWIDE PLANNING see under HEALTH AND WELFARE PLANNING 1968-76; ANNUAL IMPLEMENTATION PLANS was see under REGIONAL HEALTH PLANNING 1981-85, was see under STATE HEALTH PLANS 1980; APPROPRIATENESS REVIEW (HEALTH CARE) was see under REGIONAL HEALTH PLANNING 1980-85; COMPREHENSIVE HEALTH PLANNING was heading 1969-77 (Prov 1969-71) MHÑRegional Health Planning ANonly /econ /hist /legis /organ /stand /trends CATALOG: /geog /form PIHealth Planning (68-74) MNN3.349.650 XSAnnual Implementation Plans; Appropriateness Review; Areawide Planning; Comprehensive Health Planning XUÑCertificate of Need; ÑHealth Systems Plans LH LS; ; ; LU;  MSCoordination of activities and programs among health care institutions within defined geographic areas for the purpose of improving delivery and quality of medical care to the patients; includes U.S. programs under Public Law 89-239. PM68 HN68(67) MHÑRegional Medical Programs ANonly /class /econ /hist /legis /man /organ /stand /trends; specify geog; TN 163: restricted definition & use PILegislation, Medical (66); Public Health (66); United States Public Health Service (66) MNN3.349.650.400 LH  MSThe systems and processes involved in the establishment, support, management and operation of registers, e.g., disease registers. PM72 HN72(69) MHÑRegistries ANonly /stand PIDrugs/AE (66-68); specific drug group/AE (66-68); Information Systems (66-68); Medical Records (66-68); Records (66-68); Statistics (66-68); specific heading/OC (66-68) MNN4.452.859.819 LH  MSThe partial or symbolic return, under conditions of relaxation or stress, to an earlier stage of functioning. OLuse REGRESSION (PSYCHOLOGY) to search REGRESSION 1966-79 PM80; was REGRESSION 1963-79 HN80; was REGRESSION 1963-79 MHÑRegression (Psychology) ANnote category; no qualif; do not confuse with REMISSION (Cat C); DF: REGRESSION MNF1.393.784; F3.407.784 LH  PM80; was see under STATISTICS 1975-79 HN80(73); was see under STATISTICS 1975-79 MHÑRegression Analysis ANno qualif PIStatistics (66-72) MNH1.548.832.793 LH  MSRestoration to the maximum degree possible of a person or persons suffering from disease or injury. MHÑRehabilitation ANGEN only: prefer /rehabil with diseases: Manual 19.5+; when GEN & IM, use SPEC qualif; /psychol permitted; see note on AFTER CARE MNE2.831; G2.403.790.508.610; N2.421.784 XSHabilitation FXÑCommunity Mental Health Services; ÑDisability Evaluation; ÑHalfway Houses; ÑHandicapped XUÑCommunication Methods, Total LH LS LX; ; ; LU  MSFacilities which provide programs for rehabilitating the mentally or physically disabled individuals. PM68 HN68 MHÑRehabilitation Centers ANdo not use /educ /methods CATALOG: /geog /form PIHospitals (66-67); Rehabilitation (66-67) MNN2.278.808 LH  OLconsider also HEARING DISORDERS /RH or /RH with specific hearing disord terms MH*Rehabilitation of Hearing Impaired (Non Mesh) MNE2.831.671 LH  OLconsider also SPEECH DISORDERS /RH & LANGUAGE DISORDERS /RH or /RH with specific speech & lang disord terms MH*Rehabilitation, Speech and Language (Non Mesh) MNE2.831.727 LH  MSTraining of the mentally or physically disabled in work skills so they may be returned to regular employment utilizing these skills. PM67 HN67(66) MHÑRehabilitation, Vocational ANonly /econ /hist /man /methods /psychol /stand /trends MNE2.831.782; N2.421.784.644 XSVOCATIONAL REHABILITATION FXÑEmployment; ÑSHELTERED WORKSHOPS LH LS LX;  MSProcesses or methods of reimbursement for services rendered or equipment. PM79 HN79 MHÑReimbursement Mechanisms ANdo not use /educ /man /methods /supply /util PIFinancing, Organized (68-78) MNN3.219.521.710.305 XUÑReimbursement, Incentive LH LU  MSA scheme which provides reimbursement for the health services rendered, generally by an institution, and which provides added financial rewards if certain conditions are met. Such a scheme is intended to promote and reward increased efficiency and cost containment, with better care, or at least without adverse effect on the quality of the care rendered. HN(79) MHÑReimbursement, Incentive ANdo not use /educ /man /methods /supply /util MNN3.219.521.710.305.380 XSIncentive Reimbursement DMÑReimbursement Mechanisms LH LS LM  PM68 HN68 MHÑReindeer ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIArtiodactyla (66-67) MNB2.649.77.380.373.644 XUÑCaribou LH LU  MSThe strengthening of a conditioned response. PM65; was REINFORCEMENT LEARNING 1963-64 HN65; was REINFORCEMENT LEARNING 1963-64 MHÑReinforcement (Psychology) ANhuman & animal; no qualif; DF: REINFORCEMENT MNF2.463.425.770 XSNegative Reinforcement; Positive Reinforcement LH LS;  MSA schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent. PM69 HN69(66) MHÑReinforcement Schedule ANhuman & animal; no qualif MNF2.463.425.770.644 LH  MSThe strengthening of a response with a social reward such as a nod of approval, a parent's love or attention. PM69 HN69 MHÑReinforcement, Social ANno qualif PIInterpersonal Relations (66-68); Reinforcement (Psychology) (66-68) MNF2.463.425.770.706 XSSOCIAL REINFORCEMENT LH LS  MSUse of word stimulus to strengthen a response during learning. PM69 HN69(66) MHÑReinforcement, Verbal ANno qualif MNF2.463.425.770.769 LH  MSA triad of nongonococcal urethritis followed by iridocyclitis and arthritis, of unknown etiology. MHÑReiter's Disease MNC1.539.717; C5.550.114.782; C11.187.183.749; C12.777.767.851.644; C20.111.782 FXÑErythema Multiforme LH LX  MSNon-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection. PM75 HN75 MHÑRejection (Psychology) ANno qualif; DF: REJECTION PIAttitude (66-74) MNF1.145.76.850 LH  MHÑRejuvenation ANno qualif MNE2.849 LH  MHÑRelapsing Fever ANa disease entity caused by Borrelia: not for ╥recurrent fever╙ ( = FEVER (IM) + RECURRENCE (NIM) ) MNC1.252.847.193.644 LH  MSThe ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays. PM77 HN77 MHÑRelative Biological Effectiveness ANNIM; no qualif PIDose-Response Relationship, Radiation (73-76) MNG3.850.810.250.275 LH  MSActivity which reduces feelings of tension. MHÑRelaxation ANno qualif; note category; not for muscle relaxation (index MUSCLE RELAXATION) MNI3.450.769 LH  MSThe use of muscular relaxation technics in treatment. PM76 HN76 MHÑRelaxation Technics ANdo not confuse with RELAXATION (I3); not for physiological relaxation of muscles (= MUSCLE RELAXATION); SPEC qualif; transcendental meditation goes here CATALOG: do not use /laboratory manuals PIRelaxation (66-75) MNF4.754.137.750 LH  MHÑRelaxin AN/biosyn /physiol permitted RN9002-69-1 MND6.472.866.362.769 LH  OLsearch DISASTERS 1968-74 & DISASTERS & INDIGENT CARE 1966-67 HN(75); was see under DISASTERS & INDIGENT CARE 1963-67 MHÑRelief Work ANno qualif MNG3.230.100.300 DMÑDisasters LH LM  PMRELIGION AND SOCIOLOGY was heading 1963-65 HNRELIGION AND SOCIOLOGY was heading 1963-65 MHÑReligion ANonly /hist; Saints: TN H MNK1.844 XSReligious Beliefs; Theology LH LS;  MHÑReligion and Medicine ANno qualif; coord IM with medical aspect (IM) MNK1.844.619 LH  MSFor general articles on the interrelationship of psychology and religion. MHÑReligion and Psychology ANno qualif; coord IM with psychol aspect (IM) MNF2.880; K1.844.664 LH  MHÑReligion and Science ANno qualif; usually general; IM MNK1.844.709 FXÑScience LH LX  MHÑReligion and Sex ANno qualif; coord IM with sexual aspect (IM) MNK1.844.754 FXÑSex LH LX  OL╥religious philosophy╙ is indexed RELIGION + possibly PHILOSOPHY MH*Religious Philosophies (Non Mesh) MNK1.844.799 LH  MSSpecialized instruction for students deviating from the expected norm. MHÑRemedial Teaching ANonly /econ /methods /stand /trends MNF2.784.629.709; I2.903.694 LH  MSTherapeutic act or process that initiates a response to a complete or partial remission level. PM87 HN87 MHÑRemission Induction ANNIM; no qualif; coord NIM with disease /ther or specific ther qualif (IM); in translations use ╥induction of remission╙, not ╥remission induction╙ MNE2.860 LH  MSA spontaneous diminution or abatement of the symptoms of a disease. OLuse REMISSION, SPONTANEOUS to search REMISSION 1971-81 (as Prov 1971-74) HN(82); was REMISSION see under DISEASE 1975-81, was REMISSION 1971-74 (Prov) MHÑRemission, Spontaneous ANNIM: never IM; no qualif; do not confuse with REGRESSION, a psychol concept MNC23.280.775 DMÑDisease LH LM  OLconsider also DIURESIS /DE MH*Renal Agents (Non Mesh) MND19.770 LH  MSA branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters. MHÑRenal Artery ANdo not use /blood supply; thrombosis: index under RENAL ARTERY OBSTRUCTION (IM) + THROMBOSIS (IM) MNA7.231.114.745 LH  MSNarrowing or occlusion of the renal arteries; usually due to atherosclerosis, fibromuscular dysplasia, thrombosis, embolism, or external pressure. May result in renovascular hypertension. OLuse RENAL ARTERY OBSTRUCTION to search RENAL ARTERY STENOSIS back thru 1966 HNRENAL ARTERY STENOSIS was see under RENAL ARTERY OBSTRUCTION 1963-83 MHÑRenal Artery Obstruction ANobstruct of external or internal origin; renal artery thrombosis: coord IM with THROMBOSIS (IM); consider also HYPERTENSION, RENOVASCULAR (hypertension caused by renal artery obstruct or compress) MNC12.777.419.775; C14.907.137.727 XSRenal Artery Stenosis LH LS  MSThe circulation of the blood through the vessels of the kidney. PM82 HN82 MHÑRenal Circulation ANconsider also KIDNEY /blood supply; only /drug eff /rad eff PIKidney/BS (66-81); Regional Blood Flow (66-81) MNG9.330.163.812 XSKidney Circulation LH LS  MSDecalcification of bone due to hyperparathyroidism secondary to chronic kidney disease. OLuse RENAL OSTEODYSTROPHY to search RICKETS, RENAL back thru 1966 PM72; was RICKETS, RENAL 1963-71 HN72; was RICKETS, RENAL 1963-71 MHÑRenal Osteodystrophy MNC5.116.198.816.651.770; C12.777.419.795; C18.452.174.845.651.770; C19.642.355.480.645 XSRickets, Renal LH LS  PM65 HN65 MHÑRenal Tubular Transport, Inborn Errors ANdo not use /congen; DF: RENAL TUB TRANSP INBORN ERR MNC12.777.419.815; C18.452.648.851 XSKIDNEY TUBULAR TRANSPORT, INBORN ERRORS XUÑOculocerebrorenal Syndrome LH LS LU  MSShort thick veins which return blood from the kidneys to the vena cava. MHÑRenal Veins ANdo not use /blood supply MNA7.231.908.752 LH  MHÑRenin ANdo not confuse with RENNIN; /biosyn /physiol permitted RNEC 3.4.99.19 MND8.586.277.656.732.695 FXÑJuxtaglomerular Apparatus LH LX  MSSystem consists of renin, angiotensin-converting enzyme, and angiotensin II. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver forming angiotensin I. The converting enzyme contained in the lung acts on angiotensin I in the plasma converting it to angiotensin II, the most powerful directly pressor substance known. It causes contraction of the arteriolar smooth muscle and has other indirect actions mediated through the adrenal cortex. PM82 HN82 MHÑRenin-Angiotensin System ANonly /drug eff /rad eff; note X ref below but do not index under ALDOSTERONE unless particularly discussed; DF: RA SYSTEM PIAngiotensin II (66-81); Renin (66-81) MNG6.535.805; G9.330.612.805 XSRenin-Angiotensin-Aldosterone System LH LS  MHÑRennin ANdo not confuse with RENIN; /biosyn /physiol permitted RNEC 3.4.23.4 MND8.586.277.656.732.720 XSChymosin LH LS  MSRepeat operation for the same condition in the same patient. Includes reoperation for disease progression or recurrence or reoperation following operative failure. HN(82) MHÑReoperation ANNIM; coord with specific type of surg (IM); only /adv eff /instrum /mortal /psychol /rehabil /stand /trends /util (if by MeSH definition) /vet; ╥second look surgery╙ goes here MNE4.690 XSRevision Arthroplasty; Revision, Joint; Revision, Surgical; Surgery, Repeat; Surgical Revision DMÑSurgery, Operative LH LS; ; ; ; LM  MSUnenveloped RNA viruses with cubic symmetry. OLuse REOVIRIDAE to search REOVIRUSES & REOVIRUS back thru 1966 PM81; was REOVIRUSES 1975-80; ROTAVIRUSES was ROTAVIRUS see under RNA VIRUSES 1978-80 HN81; was REOVIRUSES 1975-80, was REOVIRUS 1964-74 (Prov 1964-65) MHÑReoviridae ANfrom Respiratory Enteric Orphan virus; do not use /blood-csf-urine /cytol MNB4.909.777.714 XSChanguinola Virus; Chenuda Virus; Respiratory Enteric Orphan Virus XUÑAfrican Horsesickness Virus; ÑBlue Tongue Virus; ÑColorado Tick Fever Virus; ÑInfectious Bursal Agent; ÑKemerovo Group Viruses; ÑReovirus Type 3 LH LS; ; LU; ; ; ; ;  MSInfections produced by reoviruses, general or unspecified. PM68; COLORADO TICK FEVER was see under ARBOVIRUS INFECTIONS 1975-76 HN68 MHÑReovirus Infections PIReoviridae (66-67); Virus Diseases (66-67) MNC2.782.791 XUÑColorado Tick Fever LH LU  MSA species of the Reovirus genus. HN(75); was see under REOVIRUSES 1975-80 MHÑReovirus Type 3 ANdo not use /blood-csf-urine /cytol MNB4.909.777.714.600 XSAbney Virus DMÑReoviridae LH LS LM  MSNucleotide sequences present in multiple copies in the genome. PM81 HN81 MHÑRepetitive Sequences, Nucleic Acid ANonly /drug eff /rad eff; coord IM with DNA, RNA or specifics (NIM); GENES, REITERATED is also available; DF: REPET SEQ PIBase Sequence (71-80); DNA (68-80) MNG5.331.112.708; G6.184.130.708 XSNucleic Acids Repetitive Sequences FXÑDNA; ÑRNA LH LS LX;  MSRestoration of an organ or other structure to its original site. OLuse REPLANTATION to search REIMPLANTATION back thru 1966 PM82; was REIMPLANTATION 1965-81 HN82; was REIMPLANTATION 1965-81 MHÑReplantation ANdo not use /util except by MeSH definition; differentiate from transpl; coord with organ /surg: Manual 19.4.64 MNE4.936.494 XSReimplantation; Surgical Replantation LH LS;  MSAn autonomous unit of DNA replication, activated by the action of an initiator substance on the site at which replication begins (termed the ╥replicator╙ or ╥origin of replication╙). The bacterial chromosome is a replicon, as are autonomous plasmids, non-integrated viral genomes, mitochondria, and chloroplasts; but lysogeny and plasmid integration repress the prophage or plasmid replicon. Eukaryotic chromosomes contain multiple start points for DNA replication, which are referred to either as replicons or ╥replication units,╙ and the timing of gene replication in eukaryotes is controlled by both nuclear and cytoplasmic factors. PM80 HN80 MHÑReplicon ANonly /drug eff /rad eff PIDNA/BI (66-67); DNA Replication (68-79) MNG5.331.232.710 XSReplication Unit LH LS  MSThe active mental process of keeping out and ejecting, banishing from consciousness, ideas or impulses that are unacceptable to it. MHÑRepression ANno qualif MNF1.393.821; F3.407.821 LH  MSDefense mechanisms involving approach and avoidance responses to threatening stimuli. The sensitizing process involves intellectualization in approaching or controlling the stimulus whereas repression involves unconscious denial in avoiding the stimulus. HN73(71) MHÑRepression-Sensitization ANno qualif PIRepression (66-70) MNF1.393.821.645; F3.407.821.645 XUÑRepression-Sensitization Scales LH LU  MSScales used to identify two polar types of defensive reaction - approach and avoidance responses - to threatening stimuli. OLsearch REPRESSION-SENSITIZATION 1973-74 HN(75) MHÑRepression-Sensitization Scales ANno qualif MNF1.393.821.645.645; F3.407.821.645.645 DMÑRepression-Sensitization LH LM  MSProteins which are normally bound to the operator locus of an operon, thereby preventing transcription of the structural genes. In enzyme induction, the substrate of the inducible enzyme binds to the repressor protein, causing its release from the operator and freeing the structural genes for transcription. In enzyme repression, the end product of the enzyme sequence binds to the free repressor protein, the resulting complex then binds to the operator and prevents transcription of the structural genes. HN(79) MHÑRepressor Proteins AN/biosyn /physiol permitted; do not use /analogs /defic PIBacterial Proteins (66-78); Enzyme Repression (66-78); Genes, Regulator (68-78); Transcription, Genetic (73-78) MND12.776.930.700 XSLac Repressors; Repressor Molecules DMÑTranscription Factors LH LS; LM  MHÑReproduction ANIM for human, other mammals, birds & fish, NIM for vertebrates lower than fish, & for invertebrates, micro-organisms & plants; only /drug eff /rad eff; conception goes under FERTILIZATION MNG8.520 XUÑReproduction, Asexual LH LU  MH*Reproduction Technics (Non Mesh) MNE5.820 LH  MSReproduction without fusion of sex cells. HN(75) MHÑReproduction, Asexual ANonly /drug eff /rad eff MNG8.730 DMÑReproduction LH LM  OLpre-explosion = REPRODUCTION, UROGENITAL PHYSIOLOGY (PX) MH*Reproduction, Urogenital Physiology (Non Mesh) MNG8 LH  OLconsider also REPRODUCTION /DE MH*Reproductive Control Agents (Non Mesh) MND7 LH  MSA proteolytic enzyme obtained from the venom of fer de lance (Bothrops atrox). Used as a plasma clotting agent for fibrinogen and for the detection of fibrinogen degradation products. The presence of heparin does not interfere with the clotting test. HN(75) MHÑReptilase ANdo not use /analogs RNEC 3.4.21.29 PIPeptide Hydrolases (69-74); Snakes (69-74); Venoms (69-74) MND8.586.277.656.732.745; D19.461.427.641; D24.185.965.850.210.641 XSBatroxobin; Defibrase; Defibrol; Hemocoagulase; Reptilase-DEF DMÑPeptide Hydrolases LH LS; ; ; ; LM  MHÑReptiles ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; caymans (caimans): index under ALLIGATORS AND CROCODILES MNB2.833 XUÑAlligators and Crocodiles LH LU  HN(66) MHÑRescinnamine ANdo not use /biosyn /defic /physiol RN24815-24-5 MND3.132.973.641.696.645; D3.549.937.641.646.645; D16.848.415.804.811.809; D18.162.804.811.809 DMÑReserpine LH LM  MHÑResearch ANresearch as a field; avoid since most articles indexed contribute to ╥research╙; IM general only on research as a field; NIM for status or progress of research in a special field or subject (IM); ╥experimental medicine╙ goes here but do not coord with MEDICINE; only /hist /methods (consider also RESEARCH DESIGN) /stand; Manual 29.16, 29.17; CLINICAL TRIALS is also available: see note there CATALOG: /geog /form MNH1.770.644 XSBiomedical Research FXÑInformation Services; ÑOperations Research; ÑSystems Analysis LH LS LX; ;  MSA plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. PM73 HN73 MHÑResearch Design ANonly /stand MNH1.770.644.728 XSExperimental Design XUÑDouble-Blind Method; ÑRandom Allocation LH LS LU;  MSThose individuals engaged in research. PM68 HN68 MHÑResearch Personnel ANdo not use /man /methods CATALOG: /geog /form PIResearch (66-67) MNM1.526.839; M1.770; N2.350.829 XSClinical Investigators LH LS  MSFinancial support of research activities. PM66 HN66(64) MHÑResearch Support ANonly /class /econ /legis /trends /util CATALOG: /geog /form; do not use U. S. MNH1.770.727; N3.219.483.645 XSGrants and Subsidies, Research; Subsidies, Research FXÑEducation LH LS; LX  OLto search RESERPINE DERIVATIVES use RESERPINE /AA back thru 1975 & YOHIMBANS 1969-74 PMRESERPINE DERIVATIVES was see under RESERPINE 1975-77, was see under YOHIMBANS 1969-74; /adverse effects /poisoning /toxicity were RESERPINE TOXICOLOGY 1963-65 HNRESERPINE DERIVATIVES was see under RESERPINE 1975-77, was see under YOHIMBANS 1969-74; /ad-poi-tox was RESERPINE TOXICOLOGY 1963-65 MHÑReserpine ANdo not use /biosyn /defic /physiol; reserpine derivatives = RESERPINE /analogs RN50-55-5 MND3.132.973.641.696; D3.549.937.641.646; D16.848.415.804.811; D18.162.804.811 XUÑRescinnamine LH LU  MSElements of residence that characterize a population and are factors in determining need for and utilization of health services. PM68 HN68 MHÑResidence Characteristics ANno qualif PIEmigration and Immigration (66-67); Transients and Migrants (66-67) MNN1.696 LH  MSLong-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required. PM68 HN68 MHÑResidential Facilities ANonly /class /econ /legis /man /organ /stand /supply /trends /util CATALOG: /geog /form MNN2.278.825 LH  MSFrequent change of residence, either in the same city or town, or between cities, states or communities. PM68 HN68 MHÑResidential Mobility ANno qualif CATALOG: /geog /form PIEmigration and Immigration (66-67); Population (66-67); Transients and Migrants (66-67) MNN1.696.596 LH  MSA specialized program for treating children with behavior disorders who live in residential centers. PM66 HN66(64) MHÑResidential Treatment ANSPEC qualif MNF4.754.864.696 LH  MSThe volume of air remaining in the lungs at the end of a maximal expiration. Common abbreviation is RV. HN(75) MHÑResidual Volume ANNIM; in texts as RV MNE1.302.796.420.820 DMÑLung Volume Measurements LH LM  MHÑResins AND25-26 qualif MND25.786 XUÑPropolis LH LU  MSPolymers of high molecular weight which at some stage are capable of being molded and then harden to form useful components. PM75 HN75 MHÑResins, Synthetic AND25-26 qualif; DF: RESINS SYN PIPlastics (66-74) MND25.720.716.822 LH  OLuse RESORCINOLS to search RESORCINOL back thru 1966 PM75; was RESORCINOL 1963-74 HN75; was RESORCINOL 1963-74 MHÑResorcinols ANdo not use /analogs /biosyn /defic /physiol MND2.755.852; D26.368.627.646 XSm-Dihydroxybenzenes; meta-Dihydroxybenzenes XUÑZearalenone; ÑZeranol LH LS; LU;  MHÑRespiration ANlung only: does not refer to tissue respiration ( = probably OXYGEN CONSUMPTION); only /drug eff /rad eff; array of resp-related terms from other categories: Bull 93 (Jan 77); TN 145: relation to OXYGEN & its qualif; MOUTH BREATHING (Cat C) is available MNG9.772.521 FXÑApnea; ÑBreath Tests; ÑBreathing Exercises; ÑDyspnea; ÑLung XUÑAspiration LH LX; ; ; ; LU  MSUse for general material on diseases of the respiratory system or for specific diseases for which no main heading is provided. PM77; RESPIRATORY DISEASES was a heading 1963-65 superceded by RESPIRATORY TRACT DISEASES in 1966; CHEYNE-STOKES RESPIRATION was see under RESPIRATION 1966-76 HN77; was NON MESH before 1977; RESPIRATORY DISEASES was a heading 1963-65 superceded by RESPIRATORY TRACT DISEASES in 1966 MHÑRespiration Disorders ANCARA (Chronic Aspecific Respiratory Affection) goes under LUNG DISEASES, OBSTRUCTIVE: see note there PIRespiration (66-76); Respiratory Insufficiency (66-76) MNC8.618 XUÑCheyne-Stokes Respiration LH LU  MHÑRespiration, Artificial ANdo not use /util except by MeSH definition; /instrum: consider also RESPIRATORS MNE2.365.647.729; E2.880.820 XSVentilation, Mechanical LH LS  MSMechanical devices used to produce or assist pulmonary ventilation. MHÑRespirators ANdo not use /instrum /methods /util (except by MeSH definition) MNE7.764 XSVentilators, Pulmonary LH LS  PM72 HN72(71) MHÑRespiratory Airflow ANonly /drug eff /rad eff PIRespiration (66-70) MNE1.302.796.624; G9.772.521.646 XUÑMaximal Voluntary Ventilation LH LU  MSThe hospital unit in which patients with respiratory conditions requiring special attention receive intensive medical care and surveillance. PM73 HN73(71) MHÑRespiratory Care Units ANdo not use /educ PIIntensive Care Units (66-70); Respiratory Tract Diseases (66-70) MNN2.278.388.493.696 LH  PM72 HN72(68) MHÑRespiratory Center ANdo not use /innerv PIMedulla Oblongata (66-67); Reticular Formation (66-67) MNA8.186.211.132.772.646 LH  PM72 HN72(69) MHÑRespiratory Dead Space ANNIM; only /drug eff /rad eff PIRespiration (66-68) MNE1.302.796.662; G9.772.521.696 LH  PM65 HN65 MHÑRespiratory Distress Syndrome ANinfants only; for adults see next entry; do not confuse with ╥respiratory distress╙ which may be RESPIRATORY INSUFFICIENCY or a specific; do not use /congen; check tags HUMAN & INFANT, NEWBORN MNC8.381.801; C8.618.801; C16.614.521.563 FXÑHyaline Membrane Disease LH LX  MSA syndrome of life-threatening progressive pulmonary insufficiency in the absence of known pulmonary disease, usually following a systemic insult such as surgery or major trauma. OLto search WET LUNG SYNDROME use RESPIRATORY DISTRESS SYNDROME, ADULT back thru 1977 & PULMONARY EDEMA 1975-76 PM77; WET LUNG was WET LUNG SYNDROME see PULMONARY EDEMA 1975-76 HN77; WET LUNG was WET LUNG SYNDROME see PULMONARY EDEMA 1975-76 MHÑRespiratory Distress Syndrome, Adult ANDanang lung goes here MNC8.381.840; C8.618.840 XSAdult Respiratory Distress Syndrome; Atelectasis, Congestive; Shock Lung; Wet Lung LH LS; ; ;  MHÑRespiratory Function Tests ANNIM; only /instrum /methods /vet MNE1.302.796 LH  MSA form of hypersensitivity affecting the respiratory tract; includes ASTHMA and HAY FEVER. PM66; was RESPIRATORY ALLERGY 1963-65 HN66; was RESPIRATORY ALLERGY 1963-65 MHÑRespiratory Hypersensitivity AN╥respiratory allergy╙ MNC8.674; C20.543.480.680 LH  MHÑRespiratory Insufficiency ANdo not confuse with RESPIRATORY DISTRESS SYNDROME in newborn inf MNC8.618.846 XSRESPIRATORY FAILURE LH LS  PM87 HN87 MHÑRespiratory Muscles PIDiaphragm (66-86); Intercostal Muscles (66-86); Muscles (66-86); Respiration (66-86) MNA2.633.740 XSVentilatory Muscles LH LS  PM73 HN73(68) MHÑRespiratory Paralysis PIParalysis (66-67); Respiratory Insufficiency (66-67) MNC8.618.846.812; C10.597.622.812; C23.888.592.636.812 XSDiaphragmatic Paralysis LH LS  MSRespirators to protect individuals from breathing air contaminated with harmful dusts, fogs, fumes, mists, gases, smokes, sprays, or vapors. OLto search GAS MASKS use RESPIRATORY PROTECTIVE DEVICES back thru 1975 & MASKS 1966-74 HN(75); was in Cat E & J 1975-82; GAS MASKS was see under MASKS 1968-74, was heading 1963-67 MHÑRespiratory Protective Devices ANonly /econ /stand /supply /vet MNE7.712.600 XSGas Masks; Respirators, Air-Purifying; Respirators, Industrial DMÑProtective Devices LH LS; ; LM  MSAny sound emanating from any portion of the respiratory tract, especially those heard on auscultation. Includes breath sounds. PM80; SNORING was see under MOUTH BREATHING 1979 HN80 MHÑRespiratory Sounds ANnormal & abnormal sounds; only /class /diag /etiol /physiopathol /vet MNC23.888.852.779; E1.302.850; G9.772.521.701 XSPleural Rub; Rales; Rhonchi; Stridor; Wheezing LH LS; ; ; ;  MSSpecies of the Pneumovirus genus producing minor respiratory infections in various mammals. OLuse RESPIRATORY SYNCYTIAL VIRUSES to search RESPIRATORY SYNCYTIAL VIRUS back thru 1966 PM77; was RESPIRATORY SYNCYTIAL VIRUS 1966-76 HN77; was RESPIRATORY SYNCYTIAL VIRUS 1964-76 (Prov 1964-65) MHÑRespiratory Syncytial Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with PARAMYXOVIRUS INFECTIONS (IM) MNB4.909.777.569.800 XSChimpanzee Coryza Agent LH LS  MSThe tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. MHÑRespiratory System ANGEN: prefer specifics MNA4 LH  MSCare of patients with deficiencies and abnormalities associated with the cardiopulmonary system. Includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways. OLuse RESPIRATORY THERAPY to search INHALATION THERAPY back thru 1966 PM78; was INHALATION THERAPY 1963-77 HN78; was INHALATION THERAPY 1963-77 MHÑRespiratory Therapy ANdo not use /util except by MeSH definition; do not confuse with ADMINISTRATION, INHALATION MNE2.880 XSInhalation Therapy FXÑAdministration, Inhalation; ÑAerosols; ÑNebulizers and Vaporizers LH LS LX; ;  MSHospital department which is responsible for the administration of diagnostic pulmonary function tests and of procedures to restore optimum pulmonary ventilation. HN(Aug 77) MHÑRespiratory Therapy Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: RESP THER DEP PIHospital Departments (68-Jul 77); Respiratory Therapy (66-Jul 77) MNN2.278.354.422.712; N4.452.442.422.712 XSHospital Respiratory Therapy Department DMÑHospital Departments LH LS LM  PM66; was RESPIRATORY DISEASES 1963-65 HN66; was RESPIRATORY DISEASES 1963-65 MHÑRespiratory Tract Diseases ANGEN: prefer specifics; CARA (Chronic Aspecific Respiratory Affection) goes under LUNG DISEASES, OBSTRUCTIVE: see note there MNC8 LH  MHÑRespiratory Tract Infections ANGEN: prefer specifics; CARA (Chronic Aspecific Respiratory Affection) goes under LUNG DISEASES, OBSTRUCTIVE: see note there MNC1.539.739; C8.730 XSUpper Respiratory Infections LH LS  MHÑRespiratory Tract Neoplasms ANGEN: prefer specific precoord; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.894.797; C8.785 LH  OLconsider also RESPIRATORY SYSTEM /PH or /PH with specific resp organs MH*Respiratory Tract Physiology (Non Mesh) MNG9.772 LH  MSPatient care provided in the home or institution intermittently in order to provide temporary relief to the family home care giver. PM85 HN85 MHÑRespite Care AN╥in the home or institution intermittently in order to provide temporary relief to the family home care giver╙; only /econ /educ /legis /man /stand /trends PIHome Care Services (67-84); Home Nursing (66-84) MNN2.421.143.524.470.610; N2.421.533.320.610; N2.421.589.800 LH  MSThe inability to suppress or screen out intruding associations, in order to make the appropriate response; primarily a schizophrenic trait. HN(75) MHÑResponse Interference ANdo not use /drug eff /physiol /rad eff MNF3.126.185.900 DMÑCognition Disorders LH LM  MSFreedom from activity. MHÑRest ANno qualif; do not confuse with IMMOBILIZATION MNI3.450.769.647 FXÑBed Rest LH LX  MHÑRestaurants ANonly /econ /hist /stand MNJ1.364.772; J1.576.416.730 LH  MSA paresthesia felt deep within the muscles of the leg, which begins when the individual is resting and forces him to keep moving the affected leg to obtain relief. PM73 HN73 MHÑRestless Legs PIParesthesia (66-72) MNC10.597.751.670.647; C23.888.592.763.587.647 XSEKBOM'S SYNDROME LH LS  MSUse of a device for the purpose of preventing the individual from moving all or part of the body. Excludes splints and casts. PM77 HN77 MHÑRestraint, Physical ANNIM with no qualif for restraint of animals in exper stress states; for protective restraint of human & animal; do not confuse with IMMOBILIZATION (see note there): if in doubt use word of text; when IM, only /adv eff /instrum /methods /psychol /vet PIImmobilization (66-76); Protective Devices (70-76); Stress (66-76) MNE5.721 FXÑImmobilization; ÑProtective Devices LH LX;  MSVariations occurring within a species in the length of DNA fragments generated by a specific endonuclease. Such variations are generated by mutations that create or abolish recognition sites for these enzymes. HN(87) MHÑRestriction Fragment Length Polymorphisms ANno qualif PIChromosome Mapping (71-86); DNA (66-71); DNA Restriction Enzymes (79-86); Endonucleases (75-77); Genes, Structural (77-86); Polymorphism (Genetics) (80-86) MNE5.393.183.805; G5.414.615.814 XSRFLP DMÑPolymorphism (Genetics) LH LS LM  MHÑResuscitation ANdo not use /util except by MeSH definition; RESUSCITATION is correct transl for French ╥reanimation╙; ╥cardiopulmonary resuscitation╙ or ╥CPR╙ goes here without organ coords MNE2.365.647 XSCardiopulmonary Resuscitation FXÑDeath, Sudden; ÑDrowning LH LS LX;  MSThe network of canals at the termination of the straight seminiferous tubules in the mediastinum testis. HN(75) MHÑRete Testis MNA5.360.444.849.600 DMÑTestis LH LM  MSThe persistence to perform a learned behavior (facts or experiences) after an interval has elapsed in which there has been no performance or practice of the behavior. OLto search RETENTION use RETENTION (PSYCHOLOGY) 1975-78 & MEMORY 1966-74 HN(79); was RETENTION see under MEMORY 1963-78 MHÑRetention (Psychology) ANonly /drug eff /physiol /rad eff; DF: RETENTION PIMemory (66-74) MNF2.463.425.540.772 DMÑMemory LH LM  MSA region extending from the PONS & MEDULLA OBLONGATA through the MESENCEPHALON, characterized by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fiber network. MHÑReticular Formation ANdo not use /innerv MNA8.186.211.132.772 LH  MHÑReticulin AN/biosyn /physiol permitted RN6835-00-3 MND12.776.860.823 LH  MHÑReticulocytes ANA 11 qualif & /class MNA11.118.413.730; A15.145.229.413.730 LH  MHÑReticuloendothelial System ANRES; reticuloendothelial cells of liver = KUPFFER CELLS MNA15.382.812 FXÑHistiocytes; ÑMacrophages; ÑPhagocytes LH LX; ;  MSHyperplasia of reticuloendothelial tissue, in any organ or tissue. MHÑReticuloendotheliosis ANneoplastic; do not use /anal /blood supply /secret /ultrastruct; coord IM with precoord organ/neopl term (IM); ╥reticulosis╙ goes here MNC4.557.386.802; C15.604.667; C20.683.515.761.802 LH  PM68 HN68 MHÑReticulum ANnote category: animal term PIStomach (66-67) MNA13.869.697 LH  MHÑRetina AN/blood supply = RETINAL VESSELS or RETINAL ARTERY or RETINAL VEIN; do not use /innerv; TN 89: differentiate from FUNDUS OCULI; retinal tears = RETINAL TEARS see RETINAL PERFORATIONS; inflammation = RETINITIS or CHORIORETINITIS; neopl: majority will be RETINOBLASTOMA: see note there; retinal dystrophy: index under RETINAL DEGENERATION or MACULAR DEGENERATION relying on text & refs; ╥dialysis retinae╙ = RETINAL PERFORATIONS MNA9.371.729 FXÑAngioid Streaks; ÑElectroretinography XUÑRetinal Ganglion Cells LH LX; LU  MSCentral retinal artery and its branches; it arises from the ophthalmic artery, pierces the optic nerve and runs through its center, enters the eye through the porus opticus and branches to supply the retina. PM73 HN73 MHÑRetinal Artery ANdo not use /blood supply; retinal artery dis: coord IM with RETINAL DISEASES (NIM), not VASCULAR DISEASES PIRetinal Vessels (66-72) MNA7.231.114.765; A7.231.611.647 XSCENTRAL RETINAL ARTERY LH LS  PM70 HN70(68) MHÑRetinal Degeneration ANretinal dystrophy or macular dystrophy: index under RETINAL DEGENERATION or MACULAR DEGENERATION relying on text & refs PIEye Diseases (66-67); Retina (66-67) MNC11.768.585 LH  MHÑRetinal Detachment AN/surg: consider also SCLERAL BUCKLING; retinal pigment epithelial detachment goes here: do not coord with PIGMENT EPITHELIUM OF EYE unless particularly discussed MNC11.768.648 FXÑScleral Buckling LH LX  PM72 HN72 MHÑRetinal Diseases ANinflamm dis = RETINITIS or CHORIORETINITIS; retinal dystrophy: index under RETINAL DEGENERATION or MACULAR DEGENERATION relying on text & refs PIRetina (66-71) MNC11.768 LH  MSThe cells of the innermost nuclear layer of the retina, the ganglion cell layer. They are quite variable in size with dendrites confined to the inner plexiform layer and axons becoming optic nerve fibers. Histologically they are variously described as parasol, shrub, diffuse, garland and midget. HN(83) MHÑRetinal Ganglion Cells ANA 11 qualif PIRetina (66-82) MNA9.371.729.765; A11.671.829 DMÑRetina LH LM  MHÑRetinal Hemorrhage MNC11.290.807; C11.768.710; C23.542.290.807 XSHEMORRHAGE, RETINAL LH LS  MSPerforations through the whole thickness of the retina including the macula as the result of inflammation, trauma, degeneration, etc. Includes breaks, tears, dialyses, and holes. OLto search RETINAL TEARS use RETINAL PERFORATIONS back thru 1984 & RETINAL DETACHMENT 1977-83 PM84; RETINAL TEARS was see RETINAL DETACHMENT 1977-83 HN84; RETINAL TEARS was see RETINAL DETACHMENT 1977-83 MHÑRetinal Perforations AN╥dialysis retinae╙ goes here PIRetinal Detachment (66-83) MNC11.768.740 XSMacular Holes; Retinal Breaks; Retinal Dialyses; Retinal Holes; Retinal Tears LH LS; ; ; ;  MHÑRetinal Pigments ANsame as ╥visual pigments╙ & ╥visual purple╙; not for deposition of pigments in the retina (= RETINITIS PIGMENTOSA) MND11.557.261.648 FXÑRods and Cones XUÑRhodopsin LH LX LU  MSCentral retinal vein and its tributaries; it runs a short course within the optic nerve and then leaves and empties into the superior ophthalmic vein or cavernous sinus. PM73 HN73 MHÑRetinal Vein ANdo not use /blood supply; retinal vein dis: coord IM with RETINAL DISEASES (NIM), not VASCULAR DISEASES PIRetinal Vessels (66-72) MNA7.231.611.773; A7.231.908.783 XSCENTRAL RETINAL VEIN LH LS  PM87 HN87 MHÑRetinal Vein Occlusion PIRetinal Diseases (72-86); Retinal Vein (73-86) MNC11.768.760; C14.907.760; C14.907.854.830.760 XSThrombosis, Retinal Vein LH LS  MSThe vessels which supply and drain the retina. OLuse RETINAL VESSELS to search PECTEN OCULI back thru 1969 HNPECTEN OCULI was see under RETINAL VESSELS 1969-83 MHÑRetinal Vessels ANGEN & unspecified: prefer RETINAL ARTERY or RETINAL VEIN; do not use /blood supply; dis of retinal vessels: coord IM with RETINAL DISEASES (NIM), not VASCULAR DISEASES MNA7.231.611 XSPecten Oculi FXÑFluorescein Angiography LH LS LX  OLsearch VITAMIN A 1968-74 HN(75); was see under VITAMIN A 1968-83 MHÑRetinaldehyde AN/biosyn /physiol permitted; /analogs NIM only RN116-31-4 MND2.47.850; D2.455.849.291.700.690; D11.557.261.700.690 XSAxerophthal; Retinal; Retinene; Vitamin A Aldehyde DMÑRetinoids LH LS; ; ; LM  MHÑRetinitis MNC11.768.773 LH  MHÑRetinitis Pigmentosa ANdeposition of pigments in retina goes here; do not index under RETINAL PIGMENTS MNC11.768.585.731 LH  MHÑRetinoblastoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with EYE NEOPLASMS (IM); also called retinal glioma, retinal glioblastoma & retinal neuroblastoma MNC4.557.652.642.648 LH  MSDerivatives of vitamin A. Used clinically in the treatment of severe cystic acne, psoriasis, and other disorders of keratinization. Their possible use in the prophylaxis and treatment of cancer is being actively explored. PM84; RETINALDEHYDE was see under VITAMIN A 1968-83 HN84 MHÑRetinoids ANdo not use /analogs /biosyn /physiol PIVitamin A (69-74); Vitamin A/AA (75-83) MND2.455.849.291.700; D11.557.261.700; D26.368.627.666 XUÑRetinaldehyde LH LU  MSProteins which bind with retinol. The retinol binding protein found in plasma has an alpha 1 mobility on electrophoresis and a molecular weight of 21,000-22,000. The protein has one binding site for retinol and is responsible for the transport of Vitamin A. The retinol protein complex (molecular weight 80,000 to 90,000) circulates in plasma in the form of a protein-protein complex with prealbumin. The retinol binding protein found in tissue has a molecular weight of 14,000 and carries retinol as a non-covalently bound ligand. PM76 HN76 MHÑRetinol-Binding Proteins ANdo not use /analogs /blood PIBlood Proteins (72-75); Protein Binding (72-75); Proteins (72-75); Retinol (75); Vitamin A (72-74) MND12.776.124.790.106.750; D12.776.157.700; D12.776.377.715.85.750 LH  OLuse RETINOPATHY OF PREMATURITY to search RETROLENTAL FIBROPLASIA back thru 1966 PM87; was RETROLENTAL FIBROPLASIA 1963-86 HN87; was RETROLENTAL FIBROPLASIA 1963-86 MHÑRetinopathy of Prematurity ANdo not use /congen; caused by oxygen ther of premature inf but for this etiol, do not use /chem ind: use /etiol if this etiol is discussed at all (& then probably NIM): TN 167 MNC11.768.836; C16.614.521.731 XSRetrolental Fibroplasia LH LS  MSThe state of being retired from one's position or occupation. MHÑRetirement ANno qualif MNI3.702 FXÑAged LH LX  PM84 HN84 MHÑRetraction of Publication ANIM; no qualif; for retraction of an article or part of an article previously indexed in INDEX MEDICUS: not for publication retraction as a subject (as an article on ╥Retraction of Fraudulent Data╙) (index under PUBLISHING); do not use for authors' or editors' errata; Manual 33.16 MNL1.737.840 LH  MH*Retrocochlear Diseases (Non Mesh) MNC9.218.807 LH  PM65 HN65 MHÑRetrognathism ANdo not use /congen; consider also MALOCCLUSION, ANGLE CLASS II MNC16.131.621.514.813 FXÑMalocclusion LH LX  OLsearch NERVE DEGENERATION 1967-74 HN(75) MHÑRetrograde Degeneration ANonly /drug eff /rad eff MNG11.561.491.648 DMÑNerve Degeneration LH LM  PM65 HN65 MHÑRetrograde Obturation ANdo not use /util except by MeSH definition MNE6.397.778.778.648 LH  MSA slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space, compressing the ureters, great vessels, bile duct, and other structures. PM66 HN66(64) MHÑRetroperitoneal Fibrosis MNC23.304.787 XSORMOND'S DISEASE LH LS  MHÑRetroperitoneal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.33.731 LH  MSAn area occupying the most posterior aspect of the abdominal cavity. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the diaphragm to the brim of the true pelvis, where it continues as the pelvic extraperitoneal space. MHÑRetroperitoneal Space ANNIM: usually locational so few qualif apply; diagnostic retropneumoperitoneum or pneumoretroperitoneum: index under RETROPERITONEAL SPACE /radiogr (IM) + PNEUMORADIOGRAPHY (NIM): do not confuse with RETROPNEUMOPERITONEUM (Cat C) below MNA1.47.681 LH  MSPathological or accidental introduction of air into the retroperitoneal space. HNwas in Cat E only 1963-85 MHÑRetropneumoperitoneum ANnote category: disease only; for diagnostic retropneumoperitoneum: index under RETROPERITONEAL SPACE /radiogr (IM) + PNEUMORADIOGRAPHY (NIM) MNC21.866.748; C23.888.748 XSPneumoretroperitoneum LH LS  PM67 HN67(65) MHÑRetrospective Studies ANIM for general only; NIM with specific study IM; no qualif MNE5.318.420.820 LH  MSA group of actually or potentially oncogenic RNA viruses infecting birds or mammals. It contains three subfamilies: the Oncoviruses (RNA tumor viruses, leukoviruses), the Lentiviruses (VISNA-MAEDI VIRUSES), and the Spumaviruses (FOAMY VIRUS). OLuse RETROVIRIDAE to search LEUKOVIRUSES & LEUKEMOGENIC VIRUSES back thru 1966 PM81; was LEUKOVIRUSES 1978-80, was LEUKEMOGENIC VIRUSES 1966-77 HN81; was LEUKOVIRUSES 1978-80, was LEUKEMOGENIC VIRUSES 1966-77 MHÑRetroviridae ANcomprises 3 subgroups: Oncoviruses (RNA tumor viruses, leukoviruses), Lentiviruses (visna-maedi viruses), Spumaviruses (foamy viruses); do not use /blood-csf-urine /cytol; infection = RETROVIRUS INFECTIONS if general, TUMOR VIRUS INFECTIONS if by Oncoviruses, MAEDI if by Lentiviruses, RETROVIRUS INFECTIONS if by Spumaviruses MNB4.909.574.807; B4.909.777.731 XSLeukemogenic Viruses; Leukoviruses; Oncornaviruses; Oncoviruses; RNA Tumor Viruses XUÑAvian Reticuloendotheliosis Virus; ÑBovine Leukemia Virus; ÑFeline Fibrosarcoma Virus; ÑFoamy Virus; ÑSimian Sarcoma Viruses LH LS; ; ; ; LU; ; ; ;  MSOncogenic proteins from the family Retroviridae. The most frequently encountered member of this family is the Rous sarcoma virus protein. PM86 HN86 MHÑRetroviridae Proteins ANIM; coord with specific Retrovirus (IM); do not use /analogs PIAntigens, Viral, Tumor (84-85); Viral Proteins (66-85) MND12.776.964.700.750 XSLeukovirus Proteins; Retrovirus Proteins LH LS;  MSVirus diseases caused by the Retroviridae. PM81 HN81 MHÑRetrovirus Infections ANsee note above for infections PIRetroviridae (66-77); Virus Diseases (66-80) MNC2.782.815 LH  MSAny situation where an animal or human is trained to respond differentially to two stimuli (e.g., approach and avoidance) under reward and punishment conditions and subsequently trained under reversed reward values (i.e., the approach which was previously rewarded is punished and vice versa). PM66 HN66(64) MHÑReversal Learning ANhuman & animal; only /drug eff /physiol /rad eff MNF2.463.425.798 LH  PM73 HN73(72) MHÑReverse Transcriptase ANdo not use /analogs /defic RNEC 2.7.7.- PIDNA Nucleotidyltransferases (68-71) MND8.586.913.696.445.308.649 XSRNA-DEPENDENT DNA POLYMERASE LH LS  MHÑReview ANfor review articles or review of the literature: not for review articles as a form of bibliography ( = BIBLIOGRAPHY); Manual section 12; Field 17 on data form for indexers LH  MSAn object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure. PM65; was see under MOTIVATION & REINFORCEMENT LEARNING 1963-64 HN65(64); was see under MOTIVATION & REINFORCEMENT LEARNING 1963-64 MHÑReward ANhuman & animal; no qualif MNF2.463.425.770.836 LH  MSAn acute disease in children characterized by vomiting, hepatic injury with fatty vacuolization, central nervous system damage, and hypoglycemia. PM77 HN77(73) MHÑReye's Syndrome PIBrain Diseases (66-72) MNC6.552.241.649; C10.228.140.869 LH  MSThe process by which fetal RH+ erythrocytes enter the circulation of an RH- mother during delivery, causing her to produce IgG antibodies, which can cross the placenta and destroy the erythrocytes of RH- fetuses in subsequent pregnancies. PM85 HN85 MHÑRH Isoimmunization ANnote categories; use only C qualif PIRH-HR Blood-Group System (66-84) MNC15.378.120.780; C20.188.780; G4.610.143.780 XSIsoimmunization, Rhesus FXÑErythroblastosis, Fetal LH LS LX  MSErythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups, because the genes differ by determining a different number of the over thirty antigens thus far described and do so with remarkably different quality. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. OLuse RH-HR BLOOD-GROUP SYSTEM to search RH FACTORS back thru 1966 PM76; was RH FACTORS 1963-75 HN76; was RH FACTORS 1963-75 MHÑRH-HR Blood-Group System ANonly /genet /immunol; TN 230 MND24.611.216.705.230.775; G4.610.241.775; G9.188.229.775 XSRH Factors; Rhesus Blood-Group System FXÑErythroblastosis, Fetal LH LS; LX  MSA superfamily of intestinal nematode parasites containing one genus, STRONGYLOIDES, and several species. It is transmitted through fecal material on to the skin; occurs in animals and humans. PM86 HN86 MHÑRhabdiasoidea ANa superfamily of nematodes; do not use /blood-csf-urine; infection: coord NIM with STRONGYLOIDIASIS (IM) MNB1.500.294.640 LH  MSNecrosis or disintegration of skeletal muscle often followed by myoglobinuria. PM84; MYOGLOBINURIA was heading 1965-83 HN84 MHÑRhabdomyolysis AN╥necrosis or disintegration of skeletal muscle often followed by myoglobinuria╙: do not index under MYOGLOBINURIA unless this is particularly discussed & then probably NIM PIKidney Failure, Acute (67-83); Muscular Diseases (66-83); Myoglobinuria (66-83) MNC5.651.807 XUÑMyoglobinuria LH LU  MHÑRhabdomyoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.614.774 LH  MHÑRhabdomyosarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.614.836; C4.557.863.724 LH  MSA family of RNA viruses infecting vertebrates, arthropods, protozoa, and plants. OLuse RHABDOVIRIDAE to search RHABDOVIRUSES back thru 1978 PM81; was RHABDOVIRUSES 1978-80; MARBURG VIRUS was see under RNA VIRUSES 1975-77 HN81; was RHABDOVIRUSES 1978-80 MHÑRhabdoviridae ANdo not use /blood-csf-urine /cytol; infection: coord NIM with VIRUS DISEASES (IM) PIRNA Viruses (66-77) MNB4.909.777.750 XUÑEbola Virus; ÑMarburg Virus LH LU;  PM66 HN66(63) MHÑRhamnose RN10485-94-6 MND9.203.254.799; D9.203.546.359.774 XSDEOXYMANNOSE LH LS  MHÑRhenium ANRe-187; do not use /analogs /biosyn /defic /physiol; Re-185 = RHENIUM (IM) + ISOTOPES (NIM); Re-177-184, 186, 188-192 = RHENIUM (IM) + RADIOISOTOPES (IM) RN7440-15-5 MND1.268.735; D1.552.740 LH  PM66 HN66(64) MHÑRheology ANfor non-plethysmographic rheography; no qualif MNH1.671.799 FXÑFlowmeters XUÑPulsatile Flow LH LX LU  MHÑRheumatic Fever ANrheum fever with heart dis, unspecified or specific = RHEUMATIC HEART DISEASE (IM) + the specific heart dis (IM or NIM), but not HEART DISEASES MNC1.252.890.731; C5.550.114.843; C5.799.825 XSBOUILLAUD'S DISEASE LH LS  MHÑRheumatic Heart Disease ANcoord IM with specific heart dis (IM or NIM) MNC1.252.890.731.649; C14.280.874; C20.111.786 LH  OLuse RHEUMATIC NODULE to search ASCHOFF BODIES back thru 1967 PM67 HN67; ASCHOFF BODIES was see under RHEUMATIC NODULE 1967-78 MHÑRheumatic Nodule ANdo not confuse with RHEUMATOID NODULE MNC5.550.114.843.566; C5.799.825.566 XSAschoff Bodies LH LS  MHÑRheumatism AN╥rheumatic disease╙; do not confuse with the specialty RHEUMATOLOGY; /drug ther: consider also ANTI-INFLAMMATORY AGENTS CATALOG: form qualif = RHEUMATOLOGY /form MNC5.799; C23.205.200.732 LH  MHÑRheumatoid Factor ANdo not use /blood RN9009-79-4 MND24.611.125.308.732 LH  PM67 HN67(63) MHÑRheumatoid Nodule ANdo not confuse with RHEUMATIC NODULE PIRHEUMATISM MNC5.550.114.154.683; C5.799.114.683; C23.205.200.732.99.683 LH  MSA subspecialty of internal medicine concerned with the study of inflammatory or degeneraative processes and metabolic derangement of connective tissue structures which pertain to a variety of musculoskeletal disorders, such as arthritis. PM80 HN80 MHÑRheumatology ANSPEC only; SPEC qualif; field covers collagen dis, rheum dis & arthritis CATALOG: use with form qualif instead of ARTHRITIS /form or COLLAGEN DISEASES /form or RHEUMATISM /form PIRheumatism (66-79) MNG2.403.776.409.808 FXÑCollagen Diseases LH LX  MSInflammation of the mucous membrane of the nose. MHÑRhinitis ANGEN or unspecified: note specific types below MNC8.730.674; C9.603.799 LH  MSInflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year. The causes are usually air-borne allergens, particularly dusts, feathers, molds, animal fur, etc. OLsearch RHINITIS, ALLERGIC under HAY FEVER 1966-79 PM80; RHINITIS, ALLERGIC was see HAY FEVER 1963-79 HN80; RHINITIS, ALLERGIC was see HAY FEVER 1963-79 MHÑRhinitis, Allergic, Perennial ANnote X ref: do not confuse with RHINITIS, ALLERGIC, SEASONAL see HAY FEVER PIHay Fever (66-79); Rhinitis (66-79) MNC8.674.810; C9.603.799.631; C20.543.480.680.791 XSRhinitis, Allergic, Nonseasonal LH LS  MHÑRhinitis, Atrophic MNC9.603.799.649 XSOZENA LH LS  MSA form of rhinitis brought about by changes in vascular tone and permeability. The etiology is obscure. OLto search VASOMOTOR RHINITIS use RHINITIS, VASOMOTOR back thru 1980 & HAY FEVER 1973-79 PM80; VASOMOTOR RHINITIS was see HAY FEVER 1973-79 HN80; VASOMOTOR RHINITIS was see HAY FEVER 1973-79 MHÑRhinitis, Vasomotor ANdo not confuse with rhinitis headings above; do not make diagnoses: use word of text PIHay Fever (66-79); Rhinitis (66-79) MNC9.603.799.910 XSVasomotor Rhinitis LH LS  OLsearch ROSACEA 1966-74 HN(75) MHÑRhinophyma MNC17.271.736.649 DMÑRosacea LH LM  MHÑRhinoplasty ANdo not use /util except by MeSH definition MNE4.847.677; E4.860.732 LH  MHÑRhinoscleroma MNC1.252.310.503.650; C8.730.702; C9.603.850; C17.838.764 XSSCLEROMA, NASAL LH LS  MHÑRhinosporidiosis MNC1.703.829 LH  MSAscomycetous fungi of the order Endomycetales which cause rhinosporidiosis. MHÑRhinosporidium ANdo not use /anat /embryol /microbiol /parasitol; infection = RHINOSPORIDIOSIS MNB5.354.107.292.731 LH  MSA genus of RNA viruses inhabiting primarily the respiratory tract of mammalian hosts. Includes the human strains associated with common colds. OLuse RHINOVIRUSES to search COMMON COLD VIRUS & RHINOVIRUS back thru 1966 PM75; was RHINOVIRUS 1964-74; COMMON COLD VIRUS was heading 1963 HN75; was RHINOVIRUS 1964-74; COMMON COLD VIRUS was see under RHINOVIRUSES 1975-78, was see under RHINOVIRUS 1964-74, was heading 1963 MHÑRhinoviruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with PICORNAVIRUS INFECTIONS (IM) but consider also COMMON COLD MNB4.909.777.618.775 XSCommon Cold Virus; Coryza Viruses XUÑEquine Rhinovirus LH LS; LU  MSA family of bacteria (usually Gram-negative) which are saprophytes, symbionts, or plant pathogens. PM75 HN75 MHÑRhizobiaceae ANin soil, water & plants PIBacteria (66-74) MNB3.400.861 LH  MHÑRhizobium ANin soil causing plant dis MNB3.400.861.775 LH  MSA deuteromycetous fungal genus, order Agonomycetales, that is an important plant pathogen affecting potatoes and other plants. HN(75); was see under DEUTEROMYCETES 1975-85 MHÑRhizoctonia ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.740 DMÑHyphomycetes LH LM  MSA genus of zygomycetous fungi of the order Mucorales, a common saprophyte and facultative parasite of mature fruits and vegetables; it may cause cerebral mycoses in diabetes and cutaneous infection in severly burned patients. MHÑRhizopus ANdo not use /anat /embryol /microbiol /parasitol; infection: coord NIM with MUCORMYCOSIS (IM) MNB5.354.730.944.550.800 LH  MSA protein which effects termination of RNA synthesis during the genetic transcription process by dissociating the ternary transcription complex RNA-RNA POLYMERASE DNA at the termination of a gene. HN(77) MHÑRho Factor ANin genetic transcription; do not confuse with blood RH FACTORS; do not use /analogs PIBacterial Proteins (73-76); Proteins (66-76); Transcription, Genetic (73-76) MND12.776.930.750 DMÑTRANSCRIPTION FACTORS LH LM  MSA family of 3,6-di(substituted-amino)-9-benzoate derivatives of xanthene that are used as dyes and as indicators for various metals; also used as fluorescent tracers in histochemistry. Synonyms: rhodamine B; rhodamine G; rhodamine 6G. HN(75) MHÑRhodamines AND25-26 qualif; do not use /analogs PIAmmonium Compounds (69-74); Xanthenes (69-74); Benzoates (74) MND3.494.953.600; D26.408.348.808; D26.550.795 XSTetraethylrhodamine DMÑXanthenes LH LS LM  OLsearch THIAZOLES 1966-74 HN(75) MHÑRhodanine ANdo not use /biosyn /defic /physiol; /analogs NIM only; do not confuse with RHODAMINES or rhodanide RN141-84-4 MND3.383.871.649 DMÑThiazoles LH LM  MHÑRhode Island MNZ1.107.567.875.774 LH  MHÑRhodium ANRh-103; do not use /analogs /biosyn /defic /physiol; Rh-97-102, 104-110 = RHODIUM (IM) + RADIOISOTOPES (IM) RN7440-16-6 MND1.268.742; D1.552.752 LH  MSA genus of true bugs of the family Triatomidae (Reduviidae); a vector of Trypanosoma cruzi. OLsearch TRIATOMIDAE 1973-74 HN(75); was see under TRIATOMINAE 1973-78 MHÑRhodnius ANdo not use /drug eff for insecticides: TN 111; /microbiol /parasitol permitted MNB1.131.617.412.841.650 DMÑTriatomidae LH LM  MSA bacterial genus probably a member of the order Actinomycetales. Rhodococcus equi, the most important species, was previously named Corynebacterium equi and infects horses primarily and humans occasionally. PM87 HN87 MHÑRhodococcus AN╥infects horses primarily & humans occasionally╙; do not use /blood-csf-urine; infection: coord NIM with ACTINOMYCETALES INFECTIONS (IM) PIActinomycetales (67-86); Corynebacterium (66-86); Coryneform Group (76-86); Rhodospirillaceae (76-86) MNB3.100.67.777 XSCorynebacterium equi LH LS  MHÑRhodopseudomonas ANin mud & stagnant water MNB3.650.700.725.566 LH  MSSpherical phototrophic bacteria found in mud and stagnant water exposed to light. PM74 HN74(72) MHÑRhodopseudomonas Spheroides ANin mud & stagnant water PIRhodopseudomonas (66-71) MNB3.650.700.725.566.650 LH  OLsearch RETINAL PIGMENTS 1966-74 HN(75) MHÑRhodopsin AN/biosyn /physiol permitted; /analogs NIM only RN9009-81-8 MND11.557.261.648.650; D12.776.306.750 XSVisual Purple DMÑRetinal Pigments LH LS LM  MSPhototrophic bacteria isolated from stagnant water and mud. OLuse RHODOSPIRILLACEAE to search ATHIORHODACEAE back thru 1975 PM76; was ATHIORHODACEAE 1975 HN76; was ATHIORHODACEAE 1975 MHÑRhodospirillaceae ANin water & mud PIBacteria (66-74) MNB3.650.700.725 XSAthiorhodaceae LH LS  MSAn order of photosynthetic bacteria representing a physiological community of predominantly aquatic bacteria. PM76 HN76 MHÑRhodospirillales ANin water PIBacteria (66-74); Rhodospirillaceae (75) MNB3.650.700 LH  MHÑRhodospirillum ANin mud & stagnant water MNB3.650.700.725.733 LH  MSVibrio- to spiral-shaped phototrophic bacteria found in stagnant water and mud exposed to light. PM74 HN74(72) MHÑRhodospirillum Rubrum ANin mud & stagnant water PIRhodospirillum (66-71) MNB3.650.700.725.733.650 LH  MSRed yeast-like deuteromycetous fungal genus generally regarded as nonpathogenic, cultured from numerous sources in human patients. HN(75); was see under MONILIALES 1975-85 MHÑRhodotorula ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.750; B5.354.930.650 DMÑHyphomycetes LH LM  MSThat part of the brain stem constituting the MEDULLA OBLONGATA (myelencephalon) and PONS (metencephalon). PM87 HN87 MHÑRhombencephalon ANdo not use /innerv; includes the MEDULLA OBLONGATA (myelencephalon) & PONS (metencephalon) PIBrain (66-86); Brain Stem (66-86) MNA8.186.211.132.810 XSHindbrain LH LS  MSRheum officinale (Baill.), r. palmatum (L) and other species of Polygonaceae that contain chrysophanic acid, rhein, emodin and other anthraquinones; the roots were formerly used as purgatives. HN(78)63 MHÑRhubarb ANas plant, food & material medica; do not use /isol /pathogen MNB6.510.806; B6.560.771 XSRheum DMÑPlants, Medicinal LH LS LM  MSA genus of shrubs, vines, or trees that yields a highly allergenic oleoresin which causes a severe contact dermatitis; the most toxic species are Rhus vernix (poison sumac), R. diversiloba (poison oak), and R. radicans (poison ivy); R. vernicifera yields a useful varnish from which certain enzymes (laccases) are obtained. MHÑRhus AN= ivy & sumac; do not use /isol /pathogen (= probably POISON IVY DERMATITIS) MNB6.660.700 XSPoison Ivy; Toxicodendron LH LS;  MSA contraceptive method whereby abstinence is practiced a few days before and after the estimated day of ovulation. PM75 HN75 MHÑRhythm Method ANno qualif PIContraception (66-74) MNE2.197.820 LH  MHÑRib Fractures MNC21.866.405.679; C21.866.891.733 LH  MS1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide. Nucleoside antimetabolite antiviral agent used against both RNA and DNA viruses; blocks nucleic acid synthesis. Synonyms: ICN 1229; Viramid. OLuse RIBAVIRIN to search VIRAZOLE back thru 1975 HN(78); was VIRAZOLE see under RIBONUCLEOSIDES 1975-77 MHÑRibavirin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN36791-04-5 PIAmides (66-74); Nucleosides (66-72); Ribonucleosides (73-74); Triazoles (66-74) MND13.570.800.790; D20.388.809; D26.87.890 XSRibovirin; Virazole DMÑRibonucleosides LH LS; LM  MSA sugar alcohol formed by the reduction of ribose. HN(78) MHÑRibitol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN488-81-3 PISugar Alcohols (72-77) MND2.33.800.780; D9.203.853.780 DMÑSugar Alcohols LH LM  MHÑRiboflavin AN/defic = RIBOFLAVIN DEFICIENCY RN83-88-5 MND11.557.405.650; D11.786.708.806 XSVITAMIN G; Vitamin B 2 LH LS;  MHÑRiboflavin Deficiency MNC18.654.223.133.699.713 LH  MS6,7-Dimethyl-8-(1-D-ribityl)lumazine:6,7-dimethyl-8-(1-D-ribityl)lumazine 2,3-butanediyltransferase. Catalyzes the formation of riboflavin from two molecules of 6,7-dimethyl-8-ribityllumazine, utilizing a four-carbon fragment from one molecule which is transferred to the second molecule. HN(75) MHÑRiboflavin Synthase ANdo not use /analogs RNEC 2.5.1.9 PIPteridines (73-74); Transferases (73-74) MND8.586.913.730 DMÑTransferases LH LM  MSCatalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3'-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2',3'-cyclic phosphate intermediates. PM84 HN84 MHÑRibonuclease, Pancreatic ANdo not use /analogs RNEC 3.1.27.5 PIEndonucleases (79-82); Endoribonucleases (82-83); Ribonucleases (79-82) MND8.586.277.352.630.553.730 XSRNase A; Ribonuclease A LH LS;  OLuse RIBONUCLEASES to search RIBONUCLEASE back thru 1966 PM83; was RIBONUCLEASE 1963-82 HN83; was RIBONUCLEASE 1963-82 MHÑRibonucleases ANdo not use /analogs RNEC 3.1.- MND8.586.277.352.630.553.755 XSNucleases, RNA; RNase LH LS;  MSProteins found in the cell nucleus which are non-covalently bound to RNA or a specific RNA. Many viruses are ribonucleoproteins. PM84; was see under NUCLEOPROTEINS 1976-83 HN84(76); was see under NUCLEOPROTEINS 1976-83 MHÑRibonucleoproteins ANdo not use /analogs PINucleoproteins (66-75); RNA (66-75); specific RNA MND12.776.664.800 LH  OLsearch RIBONUCLEOTIDE REDUCTASES 1974 HN(75) MHÑRibonucleoside Diphosphate Reductase ANdo not use /analogs RNEC 1.17.4.1 MND8.586.682.47.857.567 DMÑRibonucleotide Reductases LH LM  PM73; TOYOCAMYCIN was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-80 HN73(71) MHÑRibonucleosides ANdeoxy or desoxy = DEOXYRIBONUCLEOSIDES; ribonucleoside phosphates = RIBONUCLEOTIDES; do not use /analogs PINucleosides (66-70); specific nucleoside MND13.570.800 XUÑCoformycin; ÑDichlororibofuranosylbenzimidazole; ÑRibavirin; ÑToyocamycin; ÑTubercidin LH LU; ; ; ;  PM74 HN74 MHÑRibonucleotide Reductases ANdo not use /analogs RNEC 1.17.4. MND8.586.682.47.857 XUÑRibonucleoside Diphosphate Reductase LH LU  PM73 HN73(71) MHÑRibonucleotides ANdeoxy or desoxy = DEOXYRIBONUCLEOTIDES; do not use /analogs PINucleotides (66-70); specific nucleotide MND13.695.827 LH  MHÑRibose MND9.203.546.627.651 LH  MSRibose substituted in the 1, 3, or 5 position by a phosphoric acid moiety. HN(75) MHÑRibosemonophosphates ANdo not use /analogs PIPentosephosphates (68-74); Ribose (68-74) MND9.203.894.643.700 DMÑPentosephosphates LH LM  MSATP:ribose-5-phosphate pyrophosphotransferase. Catalyzes the formation of phosphoribosyl pyrophosphate from ATP and ribose-5-phosphate. HN(75) MHÑRibosephosphate Pyrophosphokinase ANdo not use /analogs RNEC 2.7.6.1 PIPentosephosphates (74); Phosphotransferases, ATP (74); Pyrophosphoric Acids (74) MND8.586.913.696.729.820 XSPRPP Synthetase; Phosphoribosyl Pyrophosphate Synthetase DMÑPhosphotransferases, ATP LH LS; LM  MSProteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits. PM75 HN75 MHÑRibosomal Proteins AN/biosyn /physiol permitted; do not use /analogs PIProteins (66-74); Ribosomes (66-74) MND12.776.835 XSProteins, Ribosomal LH LS  PM65 HN65(64) MHÑRibosomes ANA 11 qualif except /cytol; /class permitted MNA11.368.702.248.651 FXÑRNA; ÑRNA, RIBOSOMAL LH LX;  MS0-2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1,4)-0-[beta-D-ribofuranosyl-(1,5)]-2-deoxystreptamine. Broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus. HN(75) MHÑRibostamycin ANdo not use /defic /physiol; /analogs NIM only RN25546-65-0 PIAntibiotics (72-74); Aminoglycosides (74) MND9.203.408.51.820; D20.85.725 DMÑAntibiotics LH LM  MHÑRibs AN/inj permitted: do not coord with THORACIC INJURIES but note RIB FRACTURES is available MNA2.835.232.904.567 LH  MS3-Phospho-D-glycerate carboxy-lyase(dimerizing). A copper-protein. Catalyzes the formation of 2 moles of 3-phosphoglycerate from ribulose 1,5-biphosphate in the presence of carbon dioxide. Utilizes oxygen instead of carbon dioxide to form 2-phosphoglycollate. PM84; was see under CARBOXY-LYASES 1975-83 HN84(75); was see under CARBOXY-LYASES 1975-83 MHÑRibulosebiphosphate Carboxylase ANdo not use /analogs RNEC 4.1.1.39 PICarboxy-Lyases (73-74); Glyceric Acids (73-74); Organophosphorus Compounds (73-74); Pentosephosphates (73-74) MND8.586.520.258.700 XSCarboxydismutase; Ribulose Diphosphate Carboxylase LH LS;  MSRibulose substituted by one or more phosphoric acid moieties. HN(75) MHÑRibulosephosphates ANdo not use /analogs PIKetoses (74); Pentosephosphates (73-74) MND9.203.894.643.720 DMÑPentosephosphates LH LM  MSAnnual cereal grass Oryza sativa used by the majority of the human race as the major source of nutritive carbohydrates. MHÑRice ANas plant & as food; from Cat J only /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply; ╥yusho pois╙: index under RICE /pois (IM) + PLANT OILS /pois (IM) + POLYCHLOROBIPHENYL COMPOUNDS /pois (IM) + FOOD CONTAMINATION (IM) MNB6.510.253.713; J1.341.182.713 XSOryza LH LS  MSA protein phytotoxin from seeds of Ricinus communis (Castor Oil Plant); agglutinates cells, is proteolytic and causes lethal inflammation and hemorrhage if taken internally. PM78; was see under PLANT PROTEINS 1975-77 HN78(64); was see under PLANT PROTEINS 1975-77 MHÑRicin ANdo not use /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS RN9009-86-3 MND12.776.34.756; D12.776.765.685; D24.185.526.545.756; D24.185.926.756; D24.310.545.756; D24.611.125.44.545.756 XSCastor Bean Lectin; Lectin, Castor Bean; Lectin, Ricinus FXÑRicinus LH LS; ; LX  OLsearch FATTY ACIDS 1966-74; to search SODIUM RICINOLEATE use RICINOLEIC ACIDS 1975-80 & SCLEROSING SOLUTIONS 1966-74 HN(75); was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under FATTY ACIDS, UNSATURATED 1975-80, was see under SCLEROSING SOLUTIONS 1963-74 MHÑRicinoleic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.436.776; D10.516.251.355.789 DMÑFatty Acids, Unsaturated LH LM  MSAn euphorbiaceous plant with very toxic seeds, castor beans; CASTOR OIL, RICIN, and other lectins are the most important products. MHÑRicinus ANdo not use /isol /pathogen MNB6.660.751 FXÑCastor Oil; ÑRicin XUÑCastor Bean LH LX; LU  MHÑRickets ANconsider also VITAMIN D DEFICIENCY & note next entry MNC5.116.198.816; C18.452.174.845; C18.654.223.133.770.734 XSRACHITIS LH LS  PM72 HN72 MHÑRickets, Vitamin D Resistant PIRickets (66-71) MNC5.116.198.816.651; C18.452.174.845.651 LH  MHÑRickettsia ANclassified with bacteria; do not use /blood-csf-urine; infection = RICKETTSIAL INFECTIONS or their specifics: see notes below on various species; Rickettsia conorii infection = BOUTONNEUSE FEVER; Rickettsia quintana infection = TRENCH FEVER MNB3.700.651.801.733 LH  MSInfections by the genus Rickettsia. PM87 HN87 MHÑRickettsia Infections ANGEN: prefer specific infection as shown by RICKETTSIA terms below; infection by genus RICKETTSIA: do not confuse with RICKETTSIACEAE INFECTIONS (╥infections with rickettsias of the Family RICKETTSIACEAE╙); Rickettsia conorii infection = BOUTONNEUSE FEVER; Rickettsia quintana infection = TRENCH FEVER PIRickettsial Infections (77-86) MNC1.850.810.800 LH  MHÑRickettsia Prowazekii ANdo not use /blood-csf-urine; infection = TYPHUS MNB3.700.651.801.733.501 LH  MHÑRickettsia Rickettsii ANdo not use /blood-csf-urine; infection = ROCKY MOUNTAIN SPOTTED FEVER MNB3.700.651.801.733.601 LH  MHÑRickettsia Tsutsugamushi ANdo not use /blood-csf-urine; infection = SCRUB TYPHUS MNB3.700.651.801.733.701 LH  MSThe etiologic agent of fleaborne murine typhus. MHÑRickettsia Typhi ANdo not use /blood-csf-urine; infection = TYPHUS, ENDEMIC FLEA-BORNE MNB3.700.651.801.733.801 LH  MSA family of small Gram-negative organisms often parasitic in man and other animals, causing diseases that may be transmitted by invertebrate vectors. OLuse RICKETTSIACEAE to search NEORICKETTSIA back thru 1966 PM75; EHRLICHIA was heading 1963-65; NEORICKETTSIA was heading 1963-81 HN75; NEORICKETTSIA was heading 1963-81 MHÑRickettsiaceae ANdo not use /blood-csf-urine; note genera in X refs below; in addition these genera are also of the Rickettsiaceae Family: Rickettsiella, Rochalimaea & Wolbachia; infections = RICKETTSIACEAE INFECTIONS PIBacteria (66-74) MNB3.700.651.801 XSNeorickettsia XUÑEhrlichia LH LS LU  MSInfections with rickettsias of the Family Rickettsiaceae. OLuse RICKETTSIACEAE INFECTIONS /VE to search NEORICKETTSIOSIS HELMINTHOECA 1971-81; use RICKETTSIACEAE INFECTIONS to search RICKETTSIALPOX back thru 1966 PM77; NEORICKETTSIOSIS HELMINTHOECA was heading 1971-81; RICKETTSIALPOX was heading 1963-81; BOUTONNEUSE FEVER was see under RICKETTSIAL DISEASES 1965-76, was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64 HN77; NEORICKETTSIOSIS HELMINTHOECA was heading 1971-81; RICKETTSIALPOX was heading 1963-81 MHÑRickettsiaceae Infections AN╥infections with rickettsias of the Family RICKETTSIACEAE╙: do not confuse with RICKETTSIAL INFECTIONS (infection by genus RICKETTSIA) PIRickettsial Infections (66-76) MNC1.850.810 XSRickettsialpox LH LS  OL╥rickettsial & chlamydial infections╙ is indexed under indentions here MH*Rickettsial and Chlamydial Infections (Non MeSH) MNC1.850 LH  HN(73) MHÑRickettsial Vaccines ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; coord IM with specific Rickettsia /immunol (IM) MND24.310.894.135.650 DMÑVaccines LH LM  MSAn order of Gram-negative bacteria including many which may cause disease in man or in other vertebrate or invertebrate hosts. OLuse RICKETTSIALES to search MICROTATOBIOTES back thru 1975 PM76; MICROTATOBIOTES was heading 1975 HN76; was NON MESH before 1976; MICROTATOBIOTES was heading 1975 MHÑRickettsiales ANclassified with bacteria; do not use /blood-csf-urine MNB3.700.651 XSMicrotatobiotes LH LS  OLcontains CHLAMYDIALES & RICKETTSIALES MH*Rickettsias and Chlamydias (Non Mesh) MNB3.700 LH  PM73 HN73 MHÑRifampin ANdo not use /defic /physiol RN13292-46-1 PIRifamycins (66-72) MND20.85.89.685; D20.85.739.651; D20.338.135.714; D20.661.733 XSRIFAMPICIN LH LS  OLuse RIFAMYCINS to search RIFOMYCIN back thru 1966 PM73; was RIFOMYCIN 1963-72 HN73; was RIFOMYCIN 1963-72 MHÑRifamycins ANdo not use /analogs /defic /physiol MND20.85.739 XSRIFOMYCINS LH LS  MSA febrile disease resembling dengue; caused by a mosquito-borne arbovirus. MHÑRift Valley Fever ANin man or animal; in animal do not use /vet but check tag ANIMAL MNC2.407.810; C2.782.147.810; C2.782.417.762; C2.81.810; C6.552.380.315.430.812; C22.467.435.812 LH  MSA mosquito-borne species of the Bunyaviridae family found in east, central and southern Africa, producing massive hepatitis, abortion and death in sheep, goats, cattle, and other animals. OLsearch ARBOVIRUSES 1966-74 HN(75); was see under ARBOVIRUSES 1975-80, was see under ARBOVIRUS 1965-74, was see under ARBORVIRUSES 1963-64 MHÑRift Valley Fever Virus ANdo not use /blood-csf-urine /cytol; infection: see heading above MNB4.909.777.147.812 DMÑBunyaviridae LH LM  MSThe right of the patient or the patient's representative to make decisions with regard to dying. OLto search LIVING WILLS use RIGHT TO DIE back thru 1987 & WILLS 1977-86 PM87; LIVING WILLS was see WILLS 1977-86 HN87; LIVING WILLS was see WILLS 1977-86 MHÑRight to Die ANonly /hist /legis PIEuthanasia, Passive (78-86); Patient Advocacy (76-86) MNI1.880.604.473.600.805; N3.706.437.600.805 XSDeath with Dignity; Living Wills LH LS;  MSMuscular rigidity which develops in the cadaver usually from 4 to 10 hours after death and lasts 3 or 4 days. OLsearch DEATH 1966-69 PM70; was see under DEATH 1963-69 HN70; was see under DEATH 1963-69 MHÑRigor Mortis ANonly /physiopathol /pathol PIDeath (66-69) MNC23.240.224.617.839 LH  MSalpha-Methyl-1-adamantanemethylamine. Antiviral agent proposed especially for prophylaxis of influenza A; inhibits viral RNA synthesis. Synonyms: EXP 126; JP 61; Meradan(e); remantadine. HN(80) MHÑRimantadine ANdo not use /biosyn /defic /physiol RN13392-28-4 PIAdamantane/AA (75-79); Bridged Compounds (66-75); Ethylamines (66-75) MND2.219.75.700; D4.615.236.75.700; D20.388.815 XSRemantadine DMÑAdamantane LH LS LM  MSalpha-(3,4-Dihydroxyphenyl)-2-piperidinemethanol hydrobromide. Sympathomimetic bronchodilator; it is predominantly a beta 2 stimulant, therefore affects the cardiovascular system less than isoproterenol, but its action is of shorter duration than that of albuterol. Synonyms: Pulmadil; WG 253. HN(77) MHÑRimiterol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN32953-89-2 PIAlcohol, Methyl (73-75); Catechols (73-76); Piperidines (73-76) MND2.755.166.750; D3.383.621.830; D16.116.806; D16.893.116.348.832 DMÑCatechols LH LM  MHÑRinderpest ANusually animal: do not use /vet but check tag ANIMAL; don't forget also CATTLE (NIM); ╥peste des petits ruminants╙ goes here & should be translated as ╥rinderpest╙ MNC2.782.660.815; C22.780 XSCATTLE PLAGUE LH LS  MSA species of Morbillivirus genus causing cattle plague. PM66 HN66(64) MHÑRinderpest Virus ANdo not use /blood-csf-urine /cytol; infection: see heading above MNB4.909.777.569.830 LH  MSAberrant chromosomes with no ends. HN(85) MHÑRing Chromosomes ANno qualif; do not confuse with chromosome rings ( = CHROMOSOME BANDING) PIChromosome Aberrations (68-84); Chromosome Abnormalities (66-84) MNG5.148.266.751 XSChromosomes, Ring DMÑChromosome Aberrations LH LS LM  MSChemical substances which are employed during a riot in order to control or disperse the rioting parties. Use for chemical riot control agents in general or for which there is no specific heading. PM75 HN75 MHÑRiot Control Agents, Chemical ANdo not use /analogs /biosyn /defic /physiol PIIrritants (66-74); Tear Gases (68-74) MND5.569.734 LH  MSA form of violent crowd behavior which expresses the emotional release of resentments and prejudices, usually relevant to grievances toward the social system. PM70 HN70(69) MHÑRiots ANonly /legis /prev PIEmergency Service, Hospital (66-68); Race Relations (68); Social Conditions (66-68); Social Problems (68) MNI1.880.735.140.652 FXÑMass Behavior; ÑVIOLENCE LH LX;  OLsearch PROBABILITY 1973-74 HN(75) MHÑRisk ANno qualif; risk in dis or surg risk goes here but never IM MNH1.548.832.672.734 DMÑProbability LH LM  MSIdentification, loss evaluation and control of risks, which are usually insurable, in order to minimize financial liability. HN(80) MHÑRisk Management ANonly /class /econ /legis /methods /stand /trends PIInsurance, Liability (66-79); Malpractice (66-79) MNN3.219.463.800 XSHospital Incident Reporting; Incident Reporting, Hospital DMÑFinancial Management LH LS; LM  MSUndertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. OLsearch GAMBLING 1969-74 PM79; was see under GAMBLING 1969-78; GAMBLING was heading 1968-78 HN79(75); was see under GAMBLING 1969-78 MHÑRisk-Taking ANno qualif PIGambling (69-74) MNF1.145.722 XUÑGambling LH LU  MSAn antibiotic mixture of two components, A and B, obtained from Nocardia lurida; no longer used clinically, because of toxicity; causes platelet agglutination and blood coagulation and used to assay those functions in vitro. Synonyms: Riston; Spontin. MHÑRistocetin ANdo not use /defic /physiol RN1404-55-3 MND20.85.753 LH  PM73 HN73(65) MHÑRistomycin ANdo not use /defic /physiol RN11006-74-9 MND20.85.766 LH  MSerythro-p-Hydroxy-alpha-[1-[(p-hydroxyphenethyl)amino]ethyl]benzyl alcohol. Adrenergic beta stimulant used to control premature labor. Synonyms: Premar; Prempar. PM86; was see under PROPANOLAMINES 1975-85 HN86(75); was see under PROPANOLAMINES 1975-85 MHÑRitodrine ANdo not use /biosyn /defic /physiol RN26652-09-5 PIPhenethylamines (71-74); Phenols (71-74); Propanolamines (74) MND2.33.329.624.870; D2.92.63.624.870; D2.92.471.683.870; D16.893.116.348.857 LH  MHÑRNA ANGEN; /drug eff /ultrastruct permitted; do not use /analogs /defic; /immunol: consider also IMMUNE RNA MANIPULATION see IMMUNIZATION, PASSIVE & do not index under RNA unless particularly discussed MND13.444.735 XSRIBONUCLEIC ACID FXÑNissl Bodies; ÑNucleic Acid Denaturation; ÑNucleic Acid Hybridization; ÑRIBOSOMES; ÑRepetitive Sequences, Nucleic Acid LH LS LX; ; ; ;  MSAnalogs of RNA cap compounds which do not have a positive charge. These compounds inhibit the initiation of translation of both capped and uncapped messenger RNA. HN(80) MHÑRNA Cap Analogs ANIM; do not use /analogs /defic PIGuanine Nucleotides (66-79); specific guanine nucleotide; Oligoribonucleotides (76-79); Ribonucleotides (71-75); RNA, Heterogeneous Nuclear (79); RNA, Messenger (66-79) MND13.444.735.544.700.710; D13.695.667.454.700.710; D13.695.827.426.700.710 DMÑRNA Caps LH LM  MSCompounds with the general structure 7-methyl-5'-guanosine triphosphate-5'-X (m(7)G(5')ppp(5')X) which modify the 5' end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear RNAs. These compounds which are positively charged protect the above specified RNAs at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps which lack the positive charge inhibit the initiation of protein synthesis. PM80 HN80 MHÑRNA Caps ANIM; do not use /analogs ( = RNA CAP ANALOGS) /defic PIGuanine Nucleotides (66-71); Guanosine Triphosphate (72-74) /AA (75-79); Oligoribonucleotides (76-79); Ribonucleotides (71-75); RNA, Heterogeneous Nuclear (79); RNA, Messenger (66-79) MND13.444.735.544.700; D13.695.667.454.700; D13.695.827.426.700 XUÑRNA Cap Analogs LH LU  PM68 HN68 MHÑRNA Nucleotidyltransferases ANdo not use /analogs /defic RNEC 2.7.7. PINucleotidyltransferases (66-67) MND8.586.913.696.445.735 XUÑQ beta Replicase; ÑRNA Replicase LH LU;  MSBacteriophages whose genetic material is RNA, which is single-stranded in all except the Pseudomonas phage Phi6. All RNA phages infect their host bacteria via the host's surface pili. Some frequently encountered RNA phages are: QBeta, MS2, BF23, F2, R17, fr, Mu2, PhiCb5, PhiCb12r, PhiCb8r, PhiCb23r, 7s, Phi6, PP7. PM80 HN80 MHÑRNA Phages ANdo not use /cytol; do not confuse X ref PHAGE MU 2 with PHAGE MU 1, a DNA coliphage PIBacteriophages (66-79); Coliphages (66-79) MNB4.123.691 XSBacteriophages, RNA; Phage Mu 2; Phages, RNA LH LS; ;  MSA DNA-dependent RNA polymerase present in bacterial, plant and animal cells. The enzyme functions in the nucleolar structure and transcribes DNA into RNA. It has different requirements for cations and salts than RNA polymerase II and III and is not inhibited by alpha-amanitin. EC 2.7.7.6. PM84; was see under RNA POLYMERASES 1977-83 HN84(77); was see under RNA POLYMERASES 1977-83 MHÑRNA Polymerase I ANdo not use /analogs RNEC 2.7.7.- PIRNA Nucleotidyltransferases (68-72); RNA Polymerases (73-76) MND8.586.913.696.445.735.745 XSDNA-Dependent RNA Polymerase I LH LS  MSA DNA-dependent RNA polymerase present in bacterial, plant and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6. PM84; was see under RNA POLYMERASES 1977-83 HN84(77); was see under RNA POLYMERASES 1977-83 MHÑRNA Polymerase II ANdo not use /analogs RNEC 2.7.7.- PIRNA Nucleotidyltransferases (68-72); RNA Polymerases (73-76) MND8.586.913.696.445.735.750 XSDNA-Dependent RNA Polymerase II LH LS  MSA DNA-dependent RNA polymerase present in bacterial, plant and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II. EC 2.7.7.6. HN(77) MHÑRNA Polymerase III ANdo not use /analogs RNEC 2.7.7.- PIRNA Nucleotidyltransferases (68-72); RNA Polymerases (73-76) MND8.586.913.696.445.735.755 XSDNA-Dependent RNA Polymerase III DMÑRNA Polymerases LH LS LM  OLuse RNA POLYMERASES to search RNA POLYMERASE back thru 1973 PM77; was RNA POLYMERASE 1973-76 HN77; was RNA POLYMERASE 1973-76 MHÑRNA Polymerases ANdo not use /analogs RNEC 2.7.7.6 PIRNA Nucleotidyltransferases (68-72) MND8.586.913.696.445.735.735 XSDNA-Dependent RNA Polymerases; Transcriptases XUÑRNA Polymerase III LH LS; LU  MSPost-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors; includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein. PM83 HN83 MHÑRNA Processing, Post-Transcriptional ANonly /drug eff /rad eff; coord IM with specific RNA /metab (IM); DF: RNA PROC POST TRANS PINucleic Acid Precursors (75-82); RNA, Messenger (66-82); Transcription, Genetic (73-82) MNG5.331.380.812; G5.331.868.601 XSPost-Transcriptional RNA Modification LH LS  MSNucleoside triphosphate:RNA nucleotidyltransferase (RNA-dependent). RNA acts as a template for RNA synthesis. HN(75) MHÑRNA Replicase ANdo not use /analogs RNEC 2.7.7.48 PIRNA Nucleotidyltransferases (69-74) MND8.586.913.696.445.735.780 XSRNA-Dependent RNA Polymerase DMÑRNA Nucleotidyltransferases LH LS LM  MSRNA Viruses which are the etiologic agents of assorted diseases in rats, mice, and other rodents. PM75 HN75 MHÑRNA Rodent Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with VIRUS DISEASES (IM) PIRNA Viruses (66-74) MNB4.909.777.779 LH  MSThe ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm. PM82 HN82 MHÑRNA Splicing ANnote categ: a physiol process taking place within the cell nucleus; do not confuse with DNA, RECOMBINANT; CLONING, MOLECULAR or GENETIC INTERVENTION; only /drug eff /rad eff PIBase Sequence (76-81); Nucleic Acid Precursors (76-81); RNA, Messenger (76-81); Transcription, Genetic (76-81) MNG5.331.380.812.610; G5.331.868.601.610 XSRna, Messenger, Splicing; Splicing, RNA; Split Genes LH LS; ;  OL╥RNA virus infections╙ is indexed RNA VIRUSES + VIRUS DISEASES MH*RNA Virus Infections (Non Mesh) MNC2.782 LH  MSViruses whose genetic material is RNA. PM66; HEMORRHAGIC FEVER VIRUS, EPIDEMIC was see under ARBOVIRUSES 1977, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUS 1965-74, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBORVIRUSES 1963-64 HN66 MHÑRNA Viruses ANavoid: too general; do not use /cytol; infection: coord NIM with VIRUS DISEASES (IM) MNB4.909.777 XUÑInfectious Arteritis Virus, Equine LH LU  MHÑRNA, Bacterial ANIM also when coord with messenger or transfer RNA also IM; coord with specific bacterium (IM); /drug eff /ultrastruct permitted; do not use /analogs /defic RN9010-74-6 MND13.444.735.473 LH  MSRNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms. PM80 HN80 MHÑRNA, Double-Stranded ANIM; /drug eff /ultrastruct permitted; do not use /analogs /defic; DF: DSRNA PIRNA (66-79) MND13.444.735.490 LH  PM80 HN80 MHÑRNA, Fungal ANIM; coord with specific fungus (IM); /drug eff /ultrastruct permitted; do not use /analogs /defic PIRNA (66-79) MND13.444.735.500 LH  MSNuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesized and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnRNA hybridizes with nuclear DNA rather than with mRNA. PM79 HN79 MHÑRNA, Heterogeneous Nuclear ANIM; /drug eff /ultrastruct permitted; do not use /analogs /defic; DF: HNRNA PIRNA (66-78) MND13.444.735.520 XSHeterogeneous Nuclear RNA LH LS  PM65 HN65(64) MHÑRNA, Messenger ANIM; /drug eff /ultrastruct permitted; do not use /analogs /defic MND13.444.735.544 XUÑCodon LH LU  MHÑRNA, Neoplasm ANIM; /drug eff /ultrastruct permitted; do not use /analogs /defic; coord with required neopl term(s) (IM) MND13.444.735.615 FXÑNeoplasms LH LX  PM72 HN72(71) MHÑRNA, Ribosomal ANIM; /drug eff /ultrastruct permitted; do not use /analogs /defic PIRibosomes (66-70); RNA (66-70) MND13.444.735.686 FXÑRibosomes LH LX  MSShort chains of RNA found in the nucleus. Their function is to remove the introns (nontranslated intervening sequences) from mRNA precursors, thereby bringing the two exons (coding segments) together into correct juxtaposition for enzymatic splicing at the correct point. The resulting mRNA is now ready to leave the nucleus. PM86 HN86 MHÑRNA, Small Nuclear ANIM; /drug eff /ultrastruct permitted; do not use /analogs /defic; DF: SNRNA PIRNA (66-85); RNA, Messenger (66-85) MND13.444.735.700 XSLow Molecular Weight Nuclear RNA; Small Nuclear RNA LH LS;  OLuse RNA, TRANSFER to search RNA, SOLUBLE back thru 1966 PM72; was RNA, SOLUBLE 1965-71 HN72; was RNA, SOLUBLE 1965-71 MHÑRNA, Transfer ANIM; /drug eff /ultrastruct permitted; ╥soluble╙ goes here; do not use /analogs /defic RN9014-25-9 MND13.444.735.757 XUÑAnticodon LH LU  PM74 HN74 MHÑRNA, Transfer, Methyltransferases ANdo not use /analogs /defic RNEC 2.1.1.- MND8.586.913.517.702 XSRNA Methylases; T RNA METHYLTRANSFERASES LH LS;  MHÑRNA, Viral ANIM; /drug eff /ultrastruct permitted; coord with specific virus (IM); do not use /analogs /defic MND13.444.735.828 FXÑGenes, Viral LH LX  MS4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. Inhibitor of phosphodiesterases. HN(75) MHÑRO 20-1724 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN29925-17-5 PIBenzyl Compounds (72-74); Ethers (74); Imidazoles (72-74) MND3.383.374.790 DMÑImidazoles LH LM  MS1,3-Bis[(p-chlorobenzylidene)amino]guanidine monohydrochloride. An anticoccidial agent mainly for poultry. Synonyms: Cytostat; Robenz. HN(75) MHÑRobenidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN25875-51-8 PIChlorobenzenes (74); Guanidines (71-74) MND2.78.370.810; D21.370.400.810 XSRobenzidene; Robenzidine DMÑGuanidines LH LS; LM  MSThe application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic (bioelectronic) devices, like automated insulin pumps and other prostheses. OLsearch AUTOMATION 1966-86 PM87; was see AUTOMATION 1963-86 HN87; was see AUTOMATION 1963-86 MHÑRobotics ANonly /class /hist /instrum /util (if by MeSH definition) PIAutomation (66-86); Bionics (66-86) MNH1.288.643; J1.897.104.834; L1.700.568.110.65.630 LH  OLuse ROCKY MOUNTAIN SPOTTED FEVER to search SAO PAULO TYPHUS back thru 1966 HNSAO PAULO TYPHUS was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-76 MHÑRocky Mountain Spotted Fever ANcaused by Rickettsia rickettsii MNC1.850.810.800.830 XSSao Paulo Typhus LH LS  MSThe portion of the retinal rod cell between the inner segment and the pigment epithelium layer of the retina. HN(81) MHÑRod Outer Segments ANdo not use /innerv PIRods and Cones (66-80) MNA8.796.511.725.605.653.750; A9.371.729.778.750; A11.671.838.750 DMÑRods and Cones LH LM  MHÑRodent Control ANspecify rodent (IM); only /econ /hist /instrum /man /methods /stand /trends MNG3.850.180.600.560 FXÑRODENTICIDES; ÑRats LH LX;  MHÑRodent Diseases ANdo not use /compl /vet but check tag ANIMAL; don't forget also RODENTIA (NIM) + check tag ANIMAL or specific rodent (IM) MNC22.795 LH  MSA mammalian order which consists of 35 families and many genera. OLuse RODENTIA to search RODENTS back thru 1966 PM82; was RODENTS 1963-81 HN82; was RODENTS 1963-81 MHÑRodentia ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; capybara, gopher, jerboa go here MNB2.649.865 XSBeavers; Castor; Coendu; Degu; Dormice; Hystrix; Myoxidae; Octodon; Porcupines XUÑDipodomys LH LS; ; ; ; ; ; ; ; LU  MHÑRodenticides ANdo not use /analogs /biosyn /defic /physiol; specify rodent if pertinent but not with /drug eff MND5.723.853 FXÑRodent Control LH LX  PM66 HN66 MHÑRods and Cones ANdo not use /innerv; DF: RODS MNA8.796.511.725.605.653; A9.371.729.778; A11.671.838 FXÑRETINAL PIGMENTS XUÑRod Outer Segments LH LX LU  MSThe expected and characteristic pattern of behavior exhibited by an individual as a member of a particular social group. OLto search ROLE CONCEPT use ROLE back thru 1969 & PSYCHOLOGY, SOCIAL 1966-68 PM69; ROLE CONCEPT was see under PSYCHOLOGY, SOCIAL 1966-68 HN69; ROLE CONCEPT was see under ROLE 1969-78, was see under PSYCHOLOGY, SOCIAL 1966-68 MHÑRole ANno qualif; note category: psychol context only; do not confuse with ╥role╙ for duty or function: ╥Role of physicians: delegation of functions to physicians' assistants╙ is not ROLE nor PHYSICIAN'S ROLE; SEX ROLE, SICK ROLE & PHYSICIAN'S ROLE are also available PIPsychology, Social (66-68) MNF1.829.316.616 XSRole Concept XUÑPhysician's Role LH LS LU  MSThe adopting or performing the role of another significant individual in order to gain insight into the behavior of that person. OLsearch PSYCHODRAMA 1968-74 HN(75) MHÑRole Playing ANno qualif MNF4.754.864.581.679.653 DMÑPsychodrama LH LM  MHÑRolitetracycline ANdo not use /biosyn /defic /physiol RN751-97-3 MND20.85.868.753 XSPYRROLIDINOMETHYLTETRACYCLINE LH LS  OLuse ROMANIA to search RUMANIA back thru 1966 HN79; was RUMANIA 1963-78 MHÑRomania ANdo not spell Roumania; despite current spelling, (RUM) continues to be the language symbol MNZ1.542.248.764 XSRumania LH LS  MHÑRome ANfor ancient & modern Rome: Manual 36.14 MNZ1.542.489.569; Z1.433.850 LH  MS1-Methyl-5-nitroimidazole-2-methanol carbamate ester. Antiprotozoal and antimicrobial agent used mainly in veterinary practice. Synonyms: Dugo; Ridzol(e). HN(75) MHÑRonidazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7681-76-7 PICarbamates (74); Nitroimidazoles (74) MND2.640.672.730; D3.383.374.658.730; D21.370.800 DMÑNitroimidazoles LH LM  MSCare of the newborn infant in a crib near the mother's bed, instead of in a nursery, during the hospital stay. HN(79) MHÑRooming-in Care ANdo not use /educ /supply; check the tag INFANT, NEWBORN MNN2.421.88.120.240 DMÑInfant Care LH LM  PM72 HN72(70) MHÑRoot Canal Filling Materials AND25-26 qualif PIDental Materials (66-69) MND25.339.859 LH  MSChemicals used to disinfect root canals after pulpectomy and before obturation. The major ones are camphorated monochlorophenol, EDTA, formocresol, hydrogen peroxide, metacresylacetate, and sodium hypochlorite. PM84 HN84 MHÑRoot Canal Irrigants AND25-D26 qualif PIIrrigation (66-83); Root Canal Therapy (66-83) MND25.339.888 XSRoot Canal Medicaments LH LS  PM66; was DENTAL PULP OBTURATION 1965 HN66; was DENTAL PULP OBTURATION 1965 MHÑRoot Canal Obturation ANdo not use /util except by MeSH definition MNE6.397.778.778 LH  PM65; was see under ENDODONTICS 1963-64 HN65; was see under ENDODONTICS 1963-64 MHÑRoot Canal Therapy ANdo not use /util except by MeSH definition; the corresponding specialty is ENDODONTICS; reamers & broaches: index ROOT CANAL THERAPY /instrum MNE6.397.778 LH  PM72 HN72(63) MHÑRoot Resorption ANonly Cat C qualif MNC7.793.901.653; G10.549.917.653 FXÑTooth Root LH LX  MSA projective test used to evaluate a broad range of personality variables including pathology of thought and perception. The subject's responses to inkblot prints are scored along with subjective interpretation by the test administrator. MHÑRorschach Test ANno qualif MNF4.711.647.622.341.736 LH  MHÑRosacea MNC17.271.736 XSACNE ROSACEA XUÑRhinophyma LH LS LU  MSAny dye or mixture of dyes made from rosaniline, a red triphenylmethane aniline derivative; used to color fabrics, paper and as biological stain; also used as disinfectant and topical antifungal agent. OLuse ROSANILINE DYES to search FUCHSIN back thru 1966 HNFUCHSINS was FUCHSIN see under ROSANILINE DYES 1963-80 MHÑRosaniline Dyes AND25-26 qualif MND26.408.735 XSFuchsins; Magentas XUÑMethyl Green LH LS; LU  MHÑRose Bengal AND25-26 qualif RN11121-48-5 MND26.408.777 LH  MSA projective test depicting cartoon-like characters in frustrating situations. The scoring of the subject's responses indicates the direction of hostility or aggression; that is, whether he blames himself, the other person or the set of circumstances. OLsearch PROJECTIVE TECHNICS 1968-74; to search PICTURE FRUSTRATION STUDY use ROSENZWEIG PICTURE-FRUSTRATION STUDY back thru 1975 & PROJECTIVE TECHNICS 1966-74 HN(75); PICTURE FRUSTRATION STUDY was see under PROJECTIVE TECHNICS 1963-78 MHÑRosenzweig Picture-Frustration Study ANno qualif MNF4.711.647.622.550 XSPicture Frustration Study DMÑProjective Technics LH LS LM  MSThe in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette forming cell may be an antibody-forming cell, a memory cell, a T cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. PM78 HN78 MHÑRosette Formation ANonly /instrum /methods PIImmune Adherence Reaction (71-77) MNE5.478.810 XSImmunocytoadherence LH LS  MSAn Alphavirus (group A arbovirus) associated with epidemic exanthema and polyarthritis in Australia. HN(75); was see under ARBOVIRUSES 1975-80 MHÑRoss River Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TOGAVIRUS INFECTIONS (IM) MNB4.909.777.923.54.813 DMÑAlphaviruses LH LM  PM68 HN68 MHÑRotation ANonly /adv eff PIAcceleration (66-67); Aerospace Medicine (66-67) MNH1.671.538.703 FXÑCentrifugation LH LX  MSInfection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice. PM83 HN83 MHÑRotavirus Infections PIDiarrhea (66-82); Reovirus Infections (68-82); Rotaviruses (81-82) MNC2.782.791.814 LH  MSA genus of Reoviridae, so named because of the wheel-like appearance under electron microscope. OLuse ROTAVIRUSES to search ROTAVIRUS back thru 1978 PM83; was see under REOVIRIDAE 1981-82, was ROTAVIRUS see under RNA VIRUSES 1978-80 HN83(81); was see under REOVIRIDAE 1981-82, was ROTAVIRUS see under RNA VIRUSES 1978-80 MHÑRotaviruses ANfrom Latin rota, wheel, from its wheel-like form under electron microsc; do not use /blood-csf-urine /cytol PIReoviridae (66-77) MNB4.909.777.714.790 XSNeonatal Calf Diarrhea Virus LH LS  MHÑRotenone ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN83-79-4 MND5.723.491.324.736 LH  MSA Class of minute animals of the Phylum Aschelminthes. PM77 HN77 MHÑRotifera ANan aschelminth; do not use /blood-csf-urine PIAschelminthes (75-76); Invertebrates (66-74) MNB1.500.610 LH  OLsearch ADNEXA UTERI 1966-74 HN(75) MHÑRound Ligament MNA5.360.319.114.803 DMÑAdnexa Uteri LH LM  MSFenestra of the cochlea; an opening in the medial wall of the middle ear leading into the cochlea. HN(79) MHÑRound Window ANdo not confuse with OVAL WINDOW in vestib appar PICochlea (66-78) MNA9.246.631.246.814 DMÑCochlea LH LM  MS4-Hydroxy-3-nitrobenzenearsonic acid. An arsenic derivative which has anticoccidial and promotes growth in animals. Synonym: 3 Nitro. HN(75) MHÑRoxarsone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN121-19-7 PIArsenicals (70-74); Nitrophenols (72-74) MND2.691.88.700; D21.370.400.820 DMÑArsenicals LH LM  MScis-1,4-Polyisoprene. A high molecular weight polymeric elastomer originally obtained from vulcanization of the latex of Hevea brasiliensis and other trees; synthetic elastomers are made from synthetic latices, not necessarily polyisoprene. Synonyms: butyl rubber (or elastomer); Coral; Natsyn; nitrile rubber (or elastomer); polysulfide rubber (or elastomer); Thiocol. OLuse RUBBER to search LATEX RUBBER back thru 1968 HNLATEX RUBBER was see under RUBBER 1968-80 MHÑRubber ANprocessed material from natural or synthetic LATEX; only /adv eff /anal /class /hist /rad eff /stand /supply /tox RN9006-04-6 MND25.720.840; J1.637.767 XSCaoutchouc; Elastica; Elastomers; Latex Rubber LH LS; ; ;  MHÑRubella ANdo not confuse with rubeola ( = MEASLES); French for rubella = rubeole, Ital for rubella = rubeola, Span = roseola; /congen: consider also RUBELLA SYNDROME, CONGENITAL MNC2.782.930.815 XSMEASLES, GERMAN XUÑRubella Syndrome, Congenital LH LS LU  MSIntrauterine rubella infection resulting in severe multiple organ involvement. Also called the expanded rubella syndrome. HN(87) MHÑRubella Syndrome, Congenital ANdo not use /congen; restrict to syndrome: see MeSH definition; otherwise RUBELLA /congen permitted PIRubella/congenital (66-86); Syndrome (72-86) MNC2.782.930.815.819; C16.131.77.790 DMÑRubella LH LM  PM73 HN73(69) MHÑRubella Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox PIRubella Virus (66-68); Viral Vaccines (66-68) MND24.310.894.899.779 LH  PM66 HN66 MHÑRubella Virus ANdo not use /blood-csf-urine /cytol MNB4.909.777.923.891 XSMeasles Virus, German; Rubivirus LH LS;  MHÑRubidium ANRb-85; do not use /analogs /biosyn /defic /physiol; Rb-79-84, 86-95 = RUBIDIUM (IM) + RADIOISOTOPES (IM) RN7440-17-7 MND1.248.497.300.459.764; D1.268.752; D1.552.528.759; D1.937.716 LH  MSAn autosomal recessive disorder usually occurring in males and characterized mainly by motor and mental retardation, broad thumbs, webbing of fingers and toes, facial and skeletal abnormalities. HN(72) MHÑRubinstein-Taybi Syndrome ANdo not use /congen /drug eff /physiol /rad eff PIAbnormalities, Multiple (68-71); Mental Retardation (66-71) MNC5.116.99.370.797; C10.496.830; C16.131.77.804; F3.709.346.854 DMÑAbnormalities, Multiple LH LM  HN(73) MHÑRubredoxins ANdo not use /analogs MND12.776.97.350.650; D12.776.157.435.319.654; D12.776.556.580.302.654 DMÑFerredoxins LH LM  MHÑRumen ANneoplasms: coord IM with NEOPLASMS /vet (IM) (not STOMACH NEOPLASMS /vet) or specific neopl /vet (IM) + precoord animal/dis term (IM) + name of ruminant (NIM) + check tag ANIMAL: Manual 24.33-24.36; rumen ulcer: coord IM with ULCER /vet (IM) (not STOMACH ULCER) MNA13.869.804 LH  MSA suborder of the order ARTIODACTYLA whose members have the distinguishing feature of a four-chambered stomach. Horns or antlers are usually present, at least in males. PM87 HN87 MHÑRuminants ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIArtiodactyla (66-86) MNB2.649.77.380 XSRuminantia LH LS  MSA behavioral response manifested by leaving home in order to escape from threatening situations. Children or adolescents leaving home without permission is usually implied. PM69 HN69 MHÑRunaway Reaction ANno qualif PIChild Behavior Disorders (66-68) MNF3.126.842.688; F3.234.193.560 LH  MSRacing on foot in events ranging in length from 50 yards to 26 miles. PM76; JOGGING was see under SPORTS 1976-79 HN76 MHÑRunning ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); TRACK AND FIELD is also available; animals running in exercise wheel is probably MOTOR ACTIVITY or EXERTION PISports (66-75) MNI3.450.642.845.610 XUÑJogging LH LU  MSForcible or traumatic tear or break of an organ or other soft part of the body. PM68 HN68(66) MHÑRupture ANtraumatic only: differentiate from RUPTURE, SPONTANEOUS; never IM: coord NIM (without qualif) with probably organ /inj (IM) or precoord inj term (IM) MNC21.866.761 LH  MSTear or break of an organ, vessel or other soft part of the body, occurring in the absence of external force. PM68 HN68(65) MHÑRupture, Spontaneous ANincludes spontan rupt unexplained or as a result of dis: differentiate from RUPTURE, traumatic only; never IM: coord NIM (without qualif) with organ/diseases term (IM) MNC23.739.789 LH  MSUse for articles dealing only with the problems of health in rural areas. MHÑRural Health ANonly /hist /stand /trends; specify geog CATALOG: /geog /form MNN1.407.540.750 FXÑAgricultural Workers' Diseases LH LX  MSThe inhabitants of rural areas or of small towns classified as rural. PM68 HN68(65) MHÑRural Population ANno qualif; specify geog CATALOG: /geog /form MNN1.696.704 LH  OLuse RUSSIA (PRE-1917) to search RUSSIA 1966; search RUSSIAN FEDERATION under RUSSIAN S.F.S.R. & SIBERIA 1966 HN67; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66 MHÑRussia (Pre-1917) ANManual 36.12 MNZ1.542.248.950.800; Z1.950.800 LH  OLuse RUSSIAN S.F.S.R. to search RUSSIAN FEDERATION (EUROPE) back thru 1967; use RUSSIAN S.F.S.R. & SIBERIA to search RUSSIAN FEDERATION 1966; search RUSSIA under RUSSIA (PRE-1917) 1966 HN82; was RUSSIAN FEDERATION (EUROPE) 1967-81; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66 MHÑRussian S.F.S.R. ANMOSCOW is also available; Manual 36.12; in texts as RSFSR; DF: RSFSR MNZ1.542.248.950.820; Z1.950.820 LH  MSA macrolide antibiotic of the oligomycin group, obtained from Streptomyces rutgersensis. Used in cytochemistry as a tool to inhibit various ATPases and to uncouple oxidative phosphorylation from electron transport. Used also clinically as an antifungal agent. Synonyms: A 272; RR No 32705. HN(75); was see under ANTIBIOTICS, ANTIFUNGAL 1975-81 MHÑRutamycin ANdo not use /defic /physiol; /analogs NIM only RN1404-59-7 PIAntibiotics, Antifungal (69-74) MND8.373.936.610.700; D20.85.62.840; D20.136.73.840 XSOligomycin D DMÑOligomycins LH LS LM  MHÑRuthenium ANRu-102; do not use /analogs /biosyn /defic /physiol; Ru-96, 98-101, 104 = RUTHENIUM (IM) + ISOTOPES (NIM); Ru-93-95, 97, 103, 105-108 = RUTHENIUM (IM) + RADIOISOTOPES (IM) RN7440-18-8 MND1.268.758; D1.552.767 XUÑRuthenium Red LH LU  MSRuthenium chloride hydroxide heptaammoniate trihydrate. Used in microscopy as reagent for pectin, gum, animal tissues and bacteria. Has also been found to possess beta adrenergic blocking properties. HN(75) MHÑRuthenium Red AND25-26 qualif RN1307-52-4 PIRuthenium (72-74) MND1.552.767.750; D1.620.89.276.750; D26.408.800; D26.550.800 DMÑRuthenium LH LM  MHÑRutin ANdo not use /defic /physiol RN153-18-4 MND9.203.408.134.779; D11.786.170.804 XUÑHydroxyethylrutoside LH LU  MHÑRwanda ANdo not spell Ruanda MNZ1.58.183.590 LH  MSDodecahydro-4,6,7,8A,8B,9A-hexahydroxy-7-isopropyl-3,6A,9-trimethyl-6,9-methanobenzo(1,2)pentaleno(1,6-BC)furan-8-yl ester of pyrrole-2-carboxylic acid. Insecticidal alkaloid isolated from Ryania speciosa; proposed as a myocardial depressant. Synonyms: Ryanex; Ryania. HN(75) MHÑRyanodine ANdo not use /defic /physiol; /analogs NIM only RN15662-33-6 PIAlkaloids (70-74) MND3.132.740 DMÑAlkaloids LH LM  MSA hardy cereal crop, Secale cereale, grown in northern climates; it is the most frequent host to ergot (CLAVICEPS), the toxic fungus; its hybrid with wheat is triticale, another cereal grain. OLsearch CEREALS 1966-84 HN(75); was see under GRAIN 1963-84 MHÑRye ANas plant & food; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply; do not confuse X ref SECALE with Secale cornutum ( = ERGOT FUNGUS see CLAVICEPS) nor RYE GRASS see LOLIUM; Triticale, a rye-wheat hybrid, goes under CEREALS MNB6.510.253.780; J1.341.182.780 XSSecale DMÑCereals LH LS LM  MS5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions. HN(75) MHÑS-Adenosylhomocysteine ANdo not use /defic /physiol RN979-92-0 PIAdenosine (72-74); Homocysteine (72-74) MND12.125.166.498.50; D13.570.583.138.240; D13.570.800.96.240 DMÑHomocysteine LH LM  PM73 HN73(71) MHÑS-Adenosylmethionine RN29908-03-0 PIAdenosine (66-70); Methionine (66-70) MND12.125.166.676.180; D13.570.583.138.264; D13.570.800.96.264 LH  MSS-Adenosyl-L-methionine carboxy-lyase. Catalyzes the decarboxylation of S-adenosyl-L-methionine to yield 5'-deoxylation-(5'-),3-aminopropyl-(1),methylsulfonium salt. One of the enzymes responsible for the synthesis of spermidine from putrescine. HN(75) MHÑS-Adenosylmethionine Decarboxylase ANdo not use /analogs RNEC 4.1.1.50 PIS-Adenosylmethionine (72-74); Carboxy-Lyases (70-74) MND8.586.520.258.60 DMÑCarboxy-Lyases LH LM  MSAn abrupt voluntary shift in ocular fixation from one point to another, as occurs in reading. HN(75) MHÑSaccades ANonly /drug eff /rad eff MNG11.697.384.500 XSPursuit, Saccadic; Saccadic Eye Movements DMÑEye Movements LH LS; LM  OLsearch SWEETENING AGENTS 1966-69 PM71; was see under SWEETENING AGENTS 1963-70 HN71(70); was see under SWEETENING AGENTS 1963-70 MHÑSaccharin AND25-26 qualif RN81-07-2 PISweetening Agents (66-69) MND9.818.738; D26.456.609.738 LH  MSA genus of the family Saccharomycetaceae, order Endomycetales, class Ascomycetes. PM64; was see under YEASTS 1963 HN64; was see under YEASTS 1963 MHÑSaccharomyces ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.292.785; B5.354.930.705 LH  MSA species of the genus Saccharomyces, family Saccharomycetaceae, order Emdomycetales known as ╥baker's╥ or ╥brewer's╥ yeast; the dried form is used as a dietary supplement. PM73 HN73(72) MHÑSaccharomyces Cerevisiae ANwhen brewer's yeast or baker's yeast is the source of matter in enzyme or other metabolic studies use this heading; when given for therapy, use YEAST, DRIED; do not use /anat /embryol /microbiol /parasitol; DF: SACCH CEREV PISaccharomyces (66-71) MNB5.354.107.292.785.800; B5.354.930.705.655 XSBAKER'S YEAST FXÑYeast, Dried LH LS LX  MSYeast-like ascomycetous fungi of the family Saccharomycetaceae, order Endomycetales isolated from the stomach of rabbits. HN(75); was see under ASCOMYCETES 1975-85 MHÑSaccharomycopsis ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.292.815; B5.354.930.710 DMÑEndomycetales LH LM  MSN-5-(1,3-Dicarboxypropyl)-L-lysine:NAD(P)+ oxidoreductase (L-lysine-forming). Catalyzes the oxidative cleavage of saccharopine to lysine plus ketoglutaric acid. EC 1.5.1.7 requires NAD; EC 1.5.1.8 requires NADP. HN(75) MHÑSaccharopine Dehydrogenases ANdo not use /analogs; /defic: consider also LYSINE /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 1.5.1. PIKetoglutaric Acids (72-74); Lysine (70-74); Oxidoreductases (70-74) MND8.586.682.107.750 DMÑAmine Oxidoreductases LH LM  MSTwo membranous sacs within the vestibule of the inner ear. The smaller, the saccule, lies near the opening of the scala vestibuli. The larger, the utricle, is in the superoposterior part of the vestibule. Both receive filaments from the acoustic nerve. OLto search SACCULE & UTRICLE use SACCULE AND UTRICLE back thru 1975 & LABYRINTH back thru 1966 PM83; SACCULE & UTRICLE were see under LABYRINTH 1966-82; MACULAE, ACOUSTIC was see under LABYRINTH 1979-82 HN83; SACCULE & UTRICLE were see under LABYRINTH 1966-82 MHÑSaccule and Utricle ANDF: SACCULE PILabyrinth (66-74); Saccule (75-82); Utricle (75-82) MNA9.246.631.800 XSUtricle XUÑMaculae, Acoustic; ÑOtolithic Membrane LH LS LU;  MHÑSacrococcygeal Region ANnot a substitute for the bones SACRUM & COCCYX; this is merely locational & usually NIM MNA1.176.780 XSCOCCYGEAL REGION; SACRAL REGION LH LS;  MHÑSacroiliac Joint ANany Cat A qualif permitted MNA2.835.583.707 LH  MHÑSacrum ANa bone of the spine; do not confuse with LUMBOSACRAL REGION or SACROCOCCYGEAL REGION, both locational: use term in the text MNA2.835.232.834.717 LH  MSA condition in which there is a derivation of pleasure from inflicting pain, discomfort or humiliation on another person or persons. The sexual significance of sadistic wishes or behavior may be conscious or unconscious. MHÑSadism ANno qualif MNF3.709.597.608.700.660 LH  OLsearch ACCIDENT PREVENTION 1966-74 HN(75) MHÑSafety ANno qualif MNG3.850.110.60.75 DMÑAccident Prevention LH LM  OLsearch FATTY ACIDS, ESSENTIAL 1966-74 HN(75); was see under FATTY ACIDS, ESSENTIAL 1963-74 MHÑSafflower Oil ANdo not use /biosyn /defic /physiol RN8001-23-8 MND10.516.212.302.380.750; D10.516.212.507.750; D10.516.627.700.840; J1.740.250.700; J1.740.700.840 DMÑPlant Oils LH LM  MS4-Allyl-1,2-methylenedioxybenzene. Constituent of several essential oils, notably sassafras; it has been used as a topical antiseptic; it is carcinogenic to the liver and is no longer used as a flavoring agent in foods. HN(75) MHÑSafrole ANdo not use /defic /physiol; /analogs NIM only RN94-59-7 PIDioxoles (69-74); Allyl Compounds (72-74) MND3.383.246.680; D26.191.825; D26.456.599 XSShikimol DMÑDioxoles LH LS LM  MSA genus of Callithricidae consisting of 22 species and occurring in Panama as well as South America. Species seen most frequently in the literature are S. oedipus (cotton-top marmoset), S. nigricollis, and S. fusicollis. HN(81) MHÑSaguinus ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PICallithricidae (75-80) MNB2.649.801.201.280.680 XSMarmoset, Cotton-Top; Marmoset, Long-Tusked DMÑCallithricidae LH LS; LM  MSA genus of the family Cebidae consisting of two species which are S. orstedii (red-backed squirrel monkey) and S. sciureus (common squirrel monkey). They inhabit tropical rain forests in Central and South America. S. sciureus is used extensively in research studies. OLuse Saimiri to search SQUIRREL MONKEYS back thru 1975 HN(81); was SQUIRREL MONKEYS see under MONKEYS 1975-80 MHÑSaimiri ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.801.201.370.610 XSMonkey, Squirrel DMÑCebidae LH LS LM  MSA genus of European newts in the Salamandridae family. The two species of this genus are Salamandra salamandra (European ╥fire╥ salamander) and Salamandra atra (European alpine salamander). PM72 HN72 MHÑSalamandra ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIUrodela (66-71) MNB2.90.608.700.610 LH  MSA family of Urodela consisting of 15 living genera and about 42 species and occurring in North America, Europe, Asia, and North Africa. OLto search NEWTS use SALAMANDRIDAE back thru 1975 & URODELA 1972-74 PM81; was NEWTS see under SALAMANDERS 1972-80 HN81; was NEWTS see under SALAMANDERS 1972-80 MHÑSalamandridae ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.90.608.700 XSNewts; Taricha XUÑNotophthalmus viridescens; ÑPleurodeles LH LS; LU;  MSThe remuneration paid or benefits granted to an employee. PM78 HN78 MHÑSalaries and Fringe Benefits ANonly /legis /trends; DF: SALARIES PIIncome (68-77) MNN1.824.417.700; N4.452.677.800 XSFringe Benefits; Wages LH LS;  MHÑSalicylamides ANdo not use /analogs /biosyn /defic /physiol MND2.65.793; D14.73.278.823; D26.74.75.825 XUÑOxyclozanide; ÑRafoxanide; ÑSalicylanilides LH LU; ;  MS2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes. HN(77) MHÑSalicylanilides ANdo not use /analogs /biosyn /defic /physiol PISalicylamides (66-76) MND2.65.199.860; D2.65.793.650 XSN-Phenylsalicylamides DMÑSalicylamides LH LS LM  MHÑSalicylates ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.106.505.700.710; D2.241.511.390.700.710; D2.755.410.700.710; D14.73.278.861; D26.74.75.832 XUÑBenorilate LH LU  MHÑSalicylazosulfapyridine ANdo not use /biosyn /defic /physiol RN599-79-1 MND2.65.884.700; D2.886.590.700.700; D20.890.431 XSSulfasalazine LH LS  OLuse SALICYLIC ACIDS to search SALICYLIC ACID back thru 1966 PM75; was SALICYLIC ACID 1963-74 HN75; was SALICYLIC ACID 1963-74 MHÑSalicylic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.223.106.505.700; D2.241.511.390.700; D2.755.410.700; D26.368.627.780 XUÑDiflunisal LH LU  MSHypertonic sodium chloride solution. HN(75) MHÑSaline Solution, Hypertonic ANNIM; no qualif; when IM, use D25-26 qualif PIHypertonic Solutions (66-74); Sodium Chloride (66-74) MND1.396.343.260.824.800; D1.552.528.850.524.700; D26.394.225.766.314.890 XSSodium Chloride Solution, Hypertonic DMÑSodium Chloride LH LS LM  MHÑSaliva ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; TN 169: relation to SALIVATION & SALIVARY GLANDS; ╥salivary IGA╙: index SALIVA (IM) + IGA, SECRETORY (IM) MNA12.838.666 LH  MSA solution used for irrigating the mouth in xerostomia and as a substitute for saliva. HN(84) MHÑSaliva, Artificial AND25-D26 qualif PISaliva (66-83) MND25.583.820 DMÑMouthwashes LH LM  OLto search for chem composition of salivary duct calculi, use SALIVARY DUCT CALCULI/anal back thru 1987 & SALIVARY DUCT CALCULI/metab 1966-86 MHÑSalivary Duct Calculi ANchem composition of calculi: use /anal; /ultrastruct permitted; coord IM with specific precoord salivary gland dis term (IM) MNC7.465.815.593 XSSIALOLITHIASIS LH LS  PM65 HN65 MHÑSalivary Gland Diseases ANGEN: prefer specifics; inflamm dis = SIALADENITIS; tuberc sialadenitis or tuberc of salivary glands = SIALADENITIS (IM) + TUBERCULOSIS, ORAL (IM) MNC7.465.815 XUÑSialadenitis; ÑSialometaplasia, Necrotizing; ÑSubmandibular Gland Diseases LH LU; ;  MHÑSalivary Gland Fistula ANfistula policy: Manual 23.25+; coord IM with specific salivary gland (IM) MNC7.465.815.655 FXÑFistula LH LX  MHÑSalivary Gland Neoplasms ANGEN: prefer specific precoord; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.591.824; C7.465.815.718 XUÑSublingual Gland Neoplasms; ÑSubmandibular Gland Neoplasms LH LU;  MHÑSalivary Glands ANGEN: /radiogr = SIALOGRAPHY; /secret: see also SALIVATION; TN 169: relation to SALIVA & SALIVATION; inflammation = SIALADENITIS; tuberc of salivary glands or tuberc sialadenitis = SIALADENITIS (IM) + TUBERCULOSIS, ORAL (IM); consider other terms under SIAL MNA10.336.779; A14.549.760 FXÑExocrine Glands XUÑSalivary Glands, Minor LH LX LU  MSAccessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary. HN(79) MHÑSalivary Glands, Minor PISalivary Glands (66-78) MNA10.336.779.650; A14.549.760.650 DMÑSalivary Glands LH LM  MSProteins found in saliva and the salivary glands. These proteins show some enzymatic activity, but their composition varies in different individuals. PM77 HN77 MHÑSalivary Proteins ANin saliva & salivary glands; /biosyn /physiol permitted; do not use /analogs; do not confuse with SIALOPROTEINS, a type of glycoprotein PIProteins (66-76); Saliva (66-76); Salivary Glands (66-76) MND12.776.850 LH  MHÑSalivation ANTN 169: relation to SALIVA & SALIVARY GLANDS; hypersalivation = SIALORRHEA, hyposalivation or dryness of mouth = XEROSTOMIA MNG10.261.862; G10.549.595 FXÑSialorrhea; ÑXerostomia LH LX;  OLsearch PROTAMINES 1966-74 HN(75) MHÑSalmine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN9014-82-8 MND12.776.664.750.739 DMÑProtamines LH LM  PM72 HN72 MHÑSalmon ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; don't forget SALMONIDAE is also available; salmon for eating: see notes on FISH PRODUCTS; canned salmon = SALMON (IM) + FOOD PRESERVATION (IM) PISalmonidae (68-71) MNB2.493.781.572 XSOncorhynchus; Salmo salmo LH LS;  PMSALMONELLA HIRSCHFELDII and SALMONELLA SCHOTTMUELLERI were indexed under SALMONELLA PARATYPHI 1975, were see under SALMONELLA with SALMONELLA PARATYPHI C (now see SALMONELLA HIRSCHFELDII) & SALMONELLA B (now see under SALMONELLA SCHOTTMUELLERI) see under SALMONELLA PARATYPHI 1974, were see under SALMONELLA PARATYPHI 1966-73 MHÑSalmonella ANGEN; do not use /blood-csf-urine; infection = SALMONELLA INFECTIONS or its specifics: see notes below on various species MNB3.475.300.800 XUÑSalmonella arizonae; ÑSalmonella hirschfeldii; ÑSalmonella schottmuelleri LH LU; ;  MSGram negative rods widely distributed in lizards, snakes, and warm-blooded animals, and implicated in enteric, bone and joint infections in man. HN(78) MHÑSalmonella arizonae ANinfection: coord NIM with SALMONELLA INFECTIONS (IM) PIEnterobacteriaceae (66-77); Salmonella (66-77) MNB3.475.300.800.100 XSArizona Bacteria DMÑSalmonella LH LS LM  MSA bacterium which is an etiologic agent of gastroenteritis in man and other animals. PM74 HN74(72) MHÑSalmonella Enteritidis ANdo not use /blood-csf-urine; infection: coord NIM with SALMONELLA INFECTIONS (IM) PISalmonella (66-71) MNB3.475.300.800.300 LH  MHÑSalmonella Food Poisoning ANdo not use /chem ind MNC1.252.310.821.606; C21.613.415.738 LH  MSAn etiologic agent of paratyphoid fever in Asia, Africa, and southern Europe. OLuse SALMONELLA HIRSCHFELDII to search SALMONELLA PARATYPHI C back thru 1975; search SALMONELLA & SALMONELLA PARATYPHI A 1974 & SALMONELLA PARATYPHI A 1966-73 HN(76); was SALMONELLA PARATYPHI C see under SALMONELLA PARATYPHI 1975, was see under SALMONELLA with SALMONELLA PARATYPHI C see under SALMONELLA PARATYPHI 1974, was see under SALMONELLA PARATYPHI 1966-73 MHÑSalmonella hirschfeldii ANdo not use /blood-csf-urine; infection: coord NIM with PARATYPHOID FEVERS (IM) PISalmonella (74); Salmonella paratyphi A (66-74) MNB3.475.300.800.500 XSSalmonella paratyphi C DMÑSalmonella LH LS LM  MHÑSalmonella Infections ANGEN; see notes on specific species above & below; do not use /vet ( = SALMONELLA INFECTIONS, ANIMAL); note SALMONELLA FOOD POISONING above MNC1.252.310.821 LH  MHÑSalmonella Infections, Animal ANexper or vet but do not use /vet; don't forget to check tag ANIMAL MNC1.252.310.821.706; C22.812 LH  OLuse SALMONELLA PARATYPHI A to search SALMONELLA PARATYPHI back thru 1966 PM76; SALMONELLA PARATYPHI was heading 1963-75 HN76; SALMONELLA PARATYPHI was heading 1963-75 MHÑSalmonella paratyphi A ANdo not use /blood-csf-urine; infection: coord NIM with PARATYPHOID FEVERS (IM) MNB3.475.300.800.600 XSSalmonella paratyphi LH LS  MHÑSalmonella Phages ANdo not use /cytol; specify species of Salmonella if possible MNB4.123.706 LH  MSThe etiologic agent of enteric fever in man. OLuse SALMONELLA SCHOTTMUELLERI to search SALMONELLA PARATYPHI B back thru 1975; search SALMONELLA & SALMONELLA PARATYPHI A 1974 & SALMONELLA PARATYPHI A 1966-73 HN(76); was SALMONELLA PARATYPHI B see under SALMONELLA PARATYPHI 1975, was see under SALMONELLA with SALMONELLA PARATYPHI B see under SALMONELLA PARATYPHI 1974, was see under SALMONELLA PARATYPHI 1966-73 MHÑSalmonella schottmuelleri ANdo not use /blood-csf-urine; infection: coord NIM with PARATYPHOID FEVERS (IM) PISalmonella (74); Salmonella paratyphi A (66-74) MNB3.475.300.800.700 XSSalmonella paratyphi B DMÑSalmonella LH LS LM  MSThe etiologic agent of typhoid fever. OLuse SALMONELLA TYPHI to search SALMONELLA TYPHOSA back thru 1966 PM76; was SALMONELLA TYPHOSA 1963-75 HN76; was SALMONELLA TYPHOSA 1963-75 MHÑSalmonella typhi ANdo not use /blood-csf-urine; infection = TYPHOID MNB3.475.300.800.800 XSSalmonella typhosa LH LS  MHÑSalmonella Typhimurium ANdo not use /blood-csf-urine; infection: consider SALMONELLA FOOD POISONING (IM) or SALMONELLA INFECTIONS (IM) + SALMONELLA TYPHIMURIUM (NIM) MNB3.475.300.800.825 LH  PM68 HN68 MHÑSalmonidae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; don't forget SALMON is available PIFishes (66-67) MNB2.493.781 XSEsox; Graylings; Mudminnows; Pike; Umbra; Whitefish XUÑTrout LH LS; ; ; ; ; LU  MHÑSalpingitis MNC13.371.56.114.781; C13.371.56.390.890 LH  MSTetrahydroisoquinolinol alkaloids in both dextro and levo forms, originally from Salsola richteri; may be hypotensive due to inhibition of certain brain enzymes; may be formed de novo in brain from dopamine during alcoholism. HN(79) MHÑSalsoline Alkaloids AN/biosyn permitted; do not use /analogs /defic /physiol PIAlkaloids (66-78); Isoquinolines (69-78); Quinolines (66-68) MND3.132.750; D3.438.531.750 DMÑIsoquinolines LH LM  PM70 HN70(64) MHÑSalt Gland ANin marine animals & birds only MNA13.811 LH  MHÑSalts ANnote plural: not for ╥salt╙ referring to common salt or table salt ( = SODIUM CHLORIDE); GEN; NIM; do not use /analogs /biosyn /defic /physiol; inorganic salts: Manual 25.15, 25.35, organic salts: Manual 25.36; also Manual Fig. 25.37 MND1.786 LH  MHÑSamarium ANSm-152; do not use /analogs /biosyn /defic /physiol; Sm-144, 150, 154 = SAMARIUM (IM) + ISOTOPES (NIM); Sm-142, 143, 145-149, 151, 153, 155-157 = SAMARIUM (IM) + RADIOISOTOPES (IM) RN7440-19-9 MND1.268.766; D1.552.550.778 LH  PM67 HN67(65) MHÑSampling Studies ANNIM with specific study IM; no qualif; epidemiological only: not for blood samples, soil samples, water samples, air samples, etc. MNE5.318.821 FXÑHealth Surveys LH LX  MHÑSan Marino MNZ1.542.786 LH  MSA variant of Tay-Sachs disease. Deficiency of hexosaminidases A & B inherited as an autosomal recessive trait, leading to accumulation of G(M2) ganglioside and the sphingolipid globoside in neurons. Manifests clinically as psychomotor retardation and deterioration, blindness, cherry red spot in the macula, hepatosplenomegaly and death in 1-3 years. PM79 HN79 MHÑSandhoff Disease ANdo not use /congen; a variant of TAY-SACHS DISEASE PILipoidosis (66-78); Gangliosides (66-78); Gangliosidosis (76-78); G(M2) Ganglioside (75-78); Hexosaminidases (71-78); Sphingolipidosis (74-78) MNC10.228.140.163.300.853; C10.496.253.872; C18.452.648.556.641.803.827; F3.709.346.250.650 XSGangliosidosis, G(M2), Type II LH LS  MSA branch of engineering concerned with the design, construction and maintenance of environmental facilities conducive to public health, such as water supply and waste disposal. MHÑSanitary Engineering ANonly /econ /educ /hist /instrum /methods /stand /trends MNG2.229.656; G3.850.860.510; J1.293.821 XSPlumbing LH LS  MSThe development and establishment of environmental conditions favorable to the health of the public. OLsearch SANITARY SURVEYS under HEALTH SURVEYS 1966 PMSANITARY SURVEYS was heading 1963-66 HNSANITARY SURVEYS was heading 1963-66 MHÑSanitation ANonly /econ /hist /instrum /methods /stand /trends CATALOG: /geog /form MNG2.229.782; G3.850.860 LH  MHÑSantonin ANdo not use /biosyn /defic /physiol RN481-06-1 MND21.201.287.770 LH  MSThe vein which drains the foot and leg. MHÑSaphenous Vein ANdo not use /blood supply MNA7.231.908.819 LH  MSThe aglucon moiety of a saponin molecule. It may be triterpenoid or steroid, usually spirostan, in nature. PM79; OLEANOLIC ACID was see under TRITERPENES 1975-78 HN79 MHÑSapogenins ANdo not use /analogs /defic /physiol PISpirostans (68-78); Terpenes (66-73); Triterpenes (74-78) MND2.455.849.919.650; D4.808.854.700 XUÑDiosgenin; ÑOleanolic Acid LH LU;  MHÑSaponins ANdo not use /analogs /biosyn /defic /physiol MND9.203.408.782 XUÑEscin; ÑHolothurin LH LU;  MSAn octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively; highly specific competitive inhibitor of angiotensin II. Synonym: P 113. OLuse SARALASIN to search 1-SARCOSINE-8-ALANINE ANGIOTENSIN II back thru 1975 PM84; was see under ANGIOTENSIN II 1978-83, was 1-SARCOSINE-8-ALANINE ANGIOTENSIN II see under ANGIOTENSIN II 1975-77 HN84(78); was see under ANGIOTENSIN II 1978-83, was 1-SARCOSINE-8-ALANINE ANGIOTENSIN II see under ANGIOTENSIN II 1975-77 MHÑSaralasin AN/biosyn /physiol permitted RN34273-10-4 PIAlanine (74); Angiotensin II (74); Sarcosine (74) MND12.644.456.73.41.800; D18.162.878; D24.185.798.32.98 XS1-Sar-8-Ala Angiotensin II; 1-Sarcosine-8-Alanine Angiotensin II LH LS;  MHÑSarcina ANin air, water, soil, mud MNB3.525.700.739 LH  MHÑSarcodina ANdo not use /anat /blood-csf-urine /embryol; Naegleria: index under AMOEBA MNB1.841.656 LH  MHÑSarcoidosis ANcoord IM with organ/dis precoord (IM); sarcoidosis of heart: coord IM with MYOCARDIAL DISEASES (IM), not HEART DISEASES MNC15.604.515.827; C23.484.739 XSBESNIER-BOECK DISEASE; BOECK'S SARCOID; PSEUDOTUBERCULOSIS; SCHAUMANN'S DISEASE XUÑUveoparotid Fever LH LS; ; ; LU  PM72 HN72(67) MHÑSarcolemma ANA 11 qualif except /cytol PICell Membrane (66); Muscles (66) MNA11.195.707 FXÑMuscles LH LX  MSA connective tissue neoplasm formed by proliferation of mesodermal cells; usually highly malignant. PMMYOSARCOMA & MYXOSARCOMA were headings 1963-85 MHÑSarcoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.863 FXÑAvian Sarcoma Viruses XUÑMyosarcoma; ÑMyxosarcoma LH LX LU;  OLuse SARCOMA 180 to search SARCOMA 180, CROCKER back thru 1966 PM83; was SARCOMA 180, CROCKER 1963-82 HN83; was SARCOMA 180, CROCKER 1963-82 MHÑSarcoma 180 AN/anal /blood supply /secret /ultrastruct permitted; do not use /vet MNC4.557.863.782.656; C4.619.857.656 XSSarcoma 180, Crocker LH LS  HN(84)63 MHÑSarcoma 37 AN/anal /blood supply /secret /ultrastruct permitted; do not use /vet MNC4.557.863.782.573; C4.619.857.573 DMÑSarcoma, Experimental LH LM  MHÑSarcoma, Ewing's AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.820; C4.557.863.757 XSEwing's Tumor LH LS  OLuse SARCOMA, EXPERIMENTAL to search SARCOMA, JENSEN back thru 1966 PMSARCOMA 37 was heading 1963-83 HNSARCOMA, JENSEN was heading 1963-81 MHÑSarcoma, Experimental AN/anal /blood supply /secret /ultrastruct permitted; do not use /vet; coord IM with precoord organ/neopl term (IM or NIM if relevant) MNC4.557.863.782; C4.619.857 XSEHS Tumor; Sarcoma, Engelbreth-Holm-Swarm; Sarcoma, Jensen XUÑSarcoma 37 LH LS; ; LU  MHÑSarcoma, Kaposi's AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.690.863; C4.557.863.807 XSKaposi's Sarcoma LH LS  PM68 HN68 MHÑSarcoma, Mast Cell AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) PIMast Cells (66-67); Sarcoma (66-67) MNC4.557.863.832 XSMAST CELL SARCOMA; Mastocytoma, Malignant LH LS;  MHÑSarcoma, Osteogenic AN/anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.847; C4.557.863.857 LH  MHÑSarcoma, Yoshida AN/anal /blood supply /secret /ultrastruct permitted; do not use /vet MNC4.557.863.782.822; C4.619.857.822 XSRETICULUM CELL-LIKE SARCOMA, YOSHIDA LH LS  MSThe repeating contractile units of the myofibril, delimited by Z bands along its length. HN(84) MHÑSarcomeres ANA 11 qualif except /cytol PIMuscle Contraction (66-83); Muscles (66-83); Myofibrils (66-83) MNA2.633.585.827; A11.368.702.619.827 DMÑMyofibrils LH LM  PM72 HN72 MHÑSarcoplasmic Reticulum ANA 11 qualif except /cytol PIEndoplasmic Reticulum (66-71) MNA2.633.782; A11.368.702.248.782 FXÑMuscles LH LX  MHÑSarcoptes Scabiei AN/microbiol /parasitol /permitted; infestation = SCABIES MNB1.131.166.132.658 LH  OLsearch GLYCINE 1966-67 PM68; was see under GLYCINE 1963-67 HN68; was see under GLYCINE 1963-67 MHÑSarcosine ANdo not use /defic PIGlycine (66-67) MND12.125.807 LH  MSAn order of Sporozoa whose single genus Sarcocystis infects the striated muscle of mammals. OLuse SARCOSPORIDIA to search SARCOCYSTIS back thru 1966 HNSARCOCYSTIS was see under SARCOSPORIDIA 1963-78 MHÑSarcosporidia ANdo not use /anat /blood-csf-urine /embryol; infection = SARCOSPORIDIOSIS; /drug eff: consider also COCCIDIOSTATS MNB1.841.762.167.600 XSSarcocystis LH LS  MSInfection of the striated muscle of mammals by parasites of the genus Sarcocystis; disease symptoms such as vomiting, diarrhea, muscle weakness and paralysis are produced by a toxin sarcocystin produced by the organism. MHÑSarcosporidiosis MNC3.752.749 LH  HN(72) MHÑSarin ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN107-44-8 PICholinesterase Inhibitors (66-71); Organophosphorus Compounds (71) MND2.705.785 DMÑOrganophosphorus Compounds LH LM  MHÑSaskatchewan MNZ1.107.567.176.858 LH  MSDefective viruses which can multiply only by association with a helper virus which complements the defective gene. OLuse SATELLITE VIRUSES to search ASSOCIATED VIRUSES & ASSOCIATED VIRUS back thru 1967 (as Prov 1967-72) PM79; was see under ASSOCIATED VIRUSES 1975-78, was SATELLITE VIRUS see under ASSOCIATED VIRUS 1974; ASSOCIATED VIRUSES was heading 1975-78, was ASSOCIATED VIRUS 1973-74 HN79(75); was see under ASSOCIATED VIRUSES 1975-78, was SATELLITE VIRUS see under ASSOCIATED VIRUS 1974; ASSOCIATED VIRUSES was heading 1975-78, was ASSOCIATED VIRUS 1967-74 (Prov 1967-72) MHÑSatellite Viruses ANdo not use /cytol PIDefective Viruses (67-74); Viruses (66) MNB4.265.658 XSAssociated Viruses LH LS  MSFull gratification of a need or desire followed by a state of relative insensitivity to that particular need or desire. PM73 HN73 MHÑSatiation ANhuman & animal; only /drug eff /physiol /rad eff MNF2.830.749 XUÑSatiety Response LH LU  MSBehavioral response associated with the achieving of gratification. OLsearch SATIATION 1973-74 HN(75) MHÑSatiety Response ANhuman & animal; only /drug eff /physiol /rad eff MNF2.830.749.658 DMÑSatiation LH LM  HN75 MHÑSaudi Arabia MNZ1.252.245.93.800; Z1.630.100.880 LH  MSPoison found in certain edible mollusks at certain times; elaborated by Gonyaulax species (Dinoflagellate protozoans) and consumed by mollusks, fishes, etc. without ill effects; it is neurotoxic and causes respiratory paralysis and othe effects in mammals, known as paralytic shellfish poisoning. PM74 HN74 MHÑSaxitoxin ANfrom a marine dinoflagellate; do not use /defic /diag use /physiol; /antag permitted but consider also ANTITOXINS RN35523-89-8 MND24.185.926.580.830 XSGonyaulax Toxin FXÑDinoflagellida LH LS LX  MS1-Acetyl-2-(8-chloro-10,11-dihydrodibenz(b,f)(1,4)oxazepine-10-carbonyl hydrazine. Inhibits the activity of prostaglandins. HN(75) MHÑSC 19220 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN19395-87-0 PIDibenzoxazepines (72-74); Hydrazines (72-74) MND3.494.347.750; D24.185.798.575.52.824 DMÑDibenzoxazepines LH LM  OLuse SCABIES to search MANGE, SARCOPTIC back thru 1968 HNMANGE, SARCOPTIC was see under SCABIES 1968-76 MHÑScabies ANcaused by SARCOPTES SCABIEI MNC3.211.394.708 XSMange, Sarcoptic LH LS  MSThe lower tube of the cochlea, extending from the round window to the helicotrema and containing perilymph. HN(79) MHÑScala Tympani PICochlea (66-78) MNA9.246.631.246.848 DMÑCochlea LH LM  HN(72) MHÑScaling, Dental ANdo not use /educ /man /rehabil /supply /util; root scaling goes here + TOOTH ROOT /surg PIDental Prophylaxis (66-71) MNE6.721.189.658; E6.761.227.658 DMÑDental Prophylaxis LH LM  MHÑScalp ANonly skin of head covered with hair: does not include forehead or ears; diseases of skin or hair of scalp = SCALP DERMATOSES; neopl of scalp = SKIN NEOPLASMS (IM) + SCALP (IM) + histol type of neopl (IM) MNA1.835.657 LH  MHÑScalp Dermatoses ANconsider synonym for dermatitis of scalp & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH; does not include neopl of scalp: see note above MNC17.738 LH  MHÑScandinavia ANincludes NORWAY, SWEDEN, DENMARK & FINLAND MNZ1.542.808 LH  MHÑScandium ANSc-45; do not use /analogs /biosyn /defic /physiol; Sc-40-44, 46-50 = SCANDIUM (IM) + RADIOISOTOPES (IM) RN7440-20-2 MND1.268.774; D1.552.782 LH  MSProcess in which the mechanisms of projection or displacement are utilized in focusing feelings of aggression, hostility, frustration, etc., upon another individual or group; the amount of blame being unwarranted. HN(76) MHÑScapegoating ANno qualif PIDisplacement (Psychology) (68-75); Schizophrenia (66-75) MNF1.145.299.500; F1.393.246.500; F1.393.693.500; F3.407.246.500; F3.407.693.500 DMÑDisplacement (Psychology) LH LM  MHÑScapula ANfracture = SCAPULA /inj (IM) + FRACTURES (IM): do not confuse with SHOULDER FRACTURES MNA2.835.232.87.783 XUÑAcromion LH LU  MHÑScarlet Fever ANa streptococcal infect; also called scarlatina MNC1.252.890.823 LH  MSThe process in which energy is removed from a beam of light or other electromagnetic radiation and emitted without appreciable change in wavelength. May be considered as the change in direction of a particle or photon owing to a collision with another particle or system. OLuse SCATTERING, RADIATION to search SCATTERING 1971-73 (as Prov) PM74 HN74; was SCATTERING 1971-73 (Prov) MHÑScattering, Radiation ANNIM; no qualif; includes light scattering (coord with LIGHT (NIM) ) PIRadiation (66-70); specific radiation MNH1.671.768.831 FXÑNephelometry and Turbidimetry LH LX  MSExocrine glands in animals which secrete scents which either repel or attract other animals, e.g. perianal glands of skunks, anal glands of weasels, musk glands of foxes, ventral glands of wood rats, and dorsal glands of peccaries. HN(75) MHÑScent Glands ANanimal only; includes skunk perianal glands, weasel anal glands, fox musk glands, wood rat ventral glands, peccary dorsal glands MNA13.820 DMÑExocrine Glands LH LM  MHÑScheuermann's Disease MNC5.116.791.835; C5.878.534 LH  OLuse SCHIFF BASES to search SCHIFF BASE back thru 1971 (as Prov 1971-72) PM73 HN73; was SCHIFF BASE 1971-72 (Prov) MHÑSchiff Bases ANIM general only; do not use /analogs /biosyn /defic /physiol; an imine: do not confuse with Schiff reagent nor PERIODIC ACID-SCHIFF REACTION PIAmines (66-70) MND2.491.784 LH  PM66 HN66(63) MHÑSchilling Test ANonly /instrum /methods MNE1.223.459.859; E1.289.846 FXÑAnemia, Pernicious LH LX  MSA genus of trematode flukes belonging to the family Schistosomatidae. There are over a dozen species. These parasites are found in man and other mammals. Snails are the intermediate hosts. MHÑSchistosoma ANGEN: do not use /blood-csf-urine; /drug eff: consider also SCHISTOSOMICIDES; infection = SCHISTOSOMIASIS MNB1.500.736.715.770.680 XSBILHARZIA LH LS  MSA species of trematode blood flukes of the family Schistosomatidae which occurs at different stages in development in veins of the pulmonary and hepatic system and finally the bladder lumen. This parasite causes urinary schistosomiasis. PM72 HN72 MHÑSchistosoma haematobium ANdo not use /blood-csf-urine; infection = SCHISTOSOMIASIS HAEMATOBIA PISchistosoma (66-71) MNB1.500.736.715.770.680.510 LH  MSA species of trematode blood flukes belonging to the family Schistosomatidae whose distribution is confined to areas of the Far East. The intermediate host is a snail. It occurs in man and other mammals. PM79 HN79 MHÑSchistosoma japonicum ANdo not use /blood-csf-urine; infection = SCHISTOSOMIASIS JAPONICA PISchistosoma (66-78) MNB1.500.736.715.770.680.570 LH  MSA species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis. PM72 HN72 MHÑSchistosoma mansoni ANdo not use /blood-csf-urine; infection = SCHISTOSOMIASIS MANSONI PISchistosoma (66-71) MNB1.500.736.715.770.680.700 LH  MSA family of blood flukes of the class Trematoda which is found in animals and man. Includes the genera Heterobilharzia, Schistosomatium, Schistosoma, Ornithobilharzia, Bilharziella, Tricholbilharzia, Pseudobilharzia, and Austrobilharzia. PM82 HN82 MHÑSchistosomatidae ANfamily of trematodes; do not use /blood-csf-urine; infection: coord NIM with TREMATODE INFECTIONS (IM) PITrematoda (66-81) MNB1.500.736.715.770 LH  MHÑSchistosomiasis ANprefer specifics below; /drug ther: consider also SCHISTOSOMICIDES MNC3.335.865.859 XSBILHARZIASIS LH LS  MSSchistosomiasis caused by Schistosoma haematobium. It is endemic in Africa and parts of the Middle East, and affects the urinary tract. PM86 HN86 MHÑSchistosomiasis Haematobia ANfor X ref SCHISTOSOMIASIS, URINARY do not coord with URINARY TRACT INFECTIONS PISchistosoma haematobium (72-85); Schistosomiasis (66-85) MNC3.335.865.859.427 XSSchistosomiasis, Urinary LH LS  MSSchistosomiasis caused by Schistosoma japonicum. It is endemic in the Far East and affects the bowel, liver, and spleen, PM86 HN86 MHÑSchistosomiasis Japonica PISchistosoma japonicum (79-85); Schistosomiasis (66-85) MNC3.335.865.859.521 LH  MSSchistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver. PM86 HN86 MHÑSchistosomiasis Mansoni PISchistosoma mansoni (72-85); Schistosomiasis (66-85) MNC3.335.865.859.576 XSSchistosomiasis, Intestinal LH LS  MSAgents that kill the adult schistosomes; most of these are antimonials. PM75 HN75(73) MHÑSchistosomicides AN-cidal or -static; do not use /analogs /biosyn /defic /physiol; consider also SCHISTOSOMA /drug eff & SCHISTOSOMIASIS /drug ther PISchistosomiasis/DT (66-72) MND21.201.412.596 XSAntischistosomal Agents LH LS  MSA personality disorder manifested by a profound defect in the ability to form social relationships, no desire for social involvement, and an indifference to praise or criticism. OLto search SCHIZOID PERSONALITY use SCHIZOID PERSONALITY DISORDER back thru 1972 (as Prov 1972) & PERSONALITY DISORDERS 1969-71 PM81; was SCHIZOID PERSONALITY 1973-80, was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72 HN81; was SCHIZOID PERSONALITY 1972-80 (Prov 1972), was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72 MHÑSchizoid Personality Disorder ANdo not use /drug eff /physiol /rad eff PIPersonality Disorders (68-71) MNF3.709.597.680 XSPersonality Disorder, Schizoid LH LS  MSA class of typically unicellular organisms which includes practically all the known bacteria. HN(76)75 MHÑSchizomycetes ANa class including practically all known bacteria; do not use /blood-csf-urine PIBacteria (66-74) MNB3.775 DMÑBacteria LH LM  MSA severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, hallucations, emotional disharmony, and regressive behavior. MHÑSchizophrenia ANdo not use /drug eff /physiol /psychol ( = SCHIZOPHRENIC PSYCHOLOGY) /rad eff CATALOG: do not use /in inf ( = SCHIZOPHRENIA, CHILDHOOD) MNF3.709.680.786 XSDementia Praecox; Schizophrenic Disorders LH LS;  MSA form of schizophrenia characterized by abnormality of motor behavior which may involve particular forms of stupor, rigidity, excitement or inappropriate posture. PM75 HN75 MHÑSchizophrenia, Catatonic ANdo not use /drug eff /physiol /rad eff; /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if catatonic aspect is less relevant (NIM) PICatatonia (66-74); Schizophrenia (66-74) MNF3.709.680.786.710 XSCatatonic Schizophrenia LH LS  MSSchizophrenia occurring in childhood (after 1 year and up to 11 years). MHÑSchizophrenia, Childhood ANgeneral or unspecified; for specific index only under specific schizophrenia with CHILD tags; don't forget CHILD check tags; do not use /drug eff /physiol /rad eff; /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if juvenile aspect is less relevant (NIM) MNF3.709.680.500.110; F3.709.680.786.730 XSChildhood Schizophrenia LH LS  MSA form of schizophrenia characterized by disorganized thinking, shallow and inappropriate affect, inappropriate giggling, silly and regressive behavior, frequent hypochondriacal complaints, and usually bizarre delusions and hallucinations. OLuse SCHIZOPHRENIA, DISORGANIZED to search SCHIZOPHRENIA, HEBEPHRENIC back thru 1972 (as Prov 1972) PM81; was SCHIZOPHRENIA, HEBEPHRENIC 1973-80 HN81; was SCHIZOPHRENIA, HEBEPHRENIC 1972-80 (Prov 1972) MHÑSchizophrenia, Disorganized ANdo not use /drug eff /physiol /rad eff; /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if hebephrenic aspect is less relevant (NIM) PISchizophrenia (66-71) MNF3.709.680.786.762 XSHebephrenic Schizophrenia; Schizophrenia, Hebephrenic LH LS;  MSA chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination. PM73 HN73 MHÑSchizophrenia, Paranoid ANdo not use /drug eff /physiol /rad eff; /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if paranoid aspect is less relevant (NIM) PIParanoid Disorders (66-72); Schizophrenia (66-72) MNF3.709.680.786.800 XSPARANOID SCHIZOPHRENIA LH LS  MSThe artificial language of schizophrenic patients - neologisms (words of the patient's own making with new meanings). MHÑSchizophrenic Language ANno qualif; any language concept in schizophrenia; coord IM with specific language term (IM) + specific type of schizophrenia if relevant (IM or NIM) MNF3.126.769 LH  MSStudy of mental processes and behavior of schizophrenics. MHÑSchizophrenic Psychology ANno qualif; any mental process in schizophrenia; coord IM with specific psychol term (IM) + specific type of schizophrenia if relevant (IM or NIM) MNF4.824 XSPSYCHOLOGY, SCHIZOPHRENIC LH LS  MSA beta-1,3-glucan obtained from the Aphyllophoral fungus Schizophyllum commune; it is used as immunoadjuvant in the treatment of neoplasms, especially of the stomach. HN(76) MHÑSchizophyllan ANdo not use /defic /physiol; /analogs NIM only RN9050-67-3 PIMucopolysaccharides (73-75) MND9.203.698.582.880; D22.204.837; D24.611.59.837 DMÑMucopolysaccharides LH LM  MSFleshy shelf basidiomycetous fungi, family Schizophyllaceae, order Aphyllophorales, growing on woody substrata. HN(75); was see under AGARICACEAE 1975-85 MHÑSchizophyllum ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.179.824 DMÑBasidiomycetes LH LM  MSA genus of ascomycetous fungi of the family Saccharomycetaceae, order Endomycetales comprising the fission yeasts. HN(75); was see under ASCOMYCETES 1975-85 MHÑSchizosaccharomyces ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.292.820; B5.354.930.720 DMÑEndomycetales LH LM  MSA personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia. OLuse SCHIZOTYPAL PERSONALITY DISORDER to search SCHIZOPHRENIA, LATENT back thru 1972 (as Prov 1972) PM81; was SCHIZOPHRENIA, LATENT 1973-80 HN81; was SCHIZOPHRENIA, LATENT 1972-80 (Prov 1972) MHÑSchizotypal Personality Disorder ANdo not use /drug eff /physiol /rad eff PISchizophrenia (66-71) MNF3.709.597.730 XSIncipient Schizophrenia; Latent Schizophrenia; Personality Disorder, Schizotypal; Pseudoneurotic Schizophrenia; Pseudopsychopathic Schizophrenia; Schizophrenia, Borderline; Schizophrenia, Latent; Schizophrenia, Pseudoneurotic LH LS; ; ; ; ; ; ;  MSRequirements for the selection of students for admission to academic institutions. HN(75) MHÑSchool Admission Criteria ANno qualif MNI2.399.750 XSStudent Selection DMÑEducational Measurement LH LS LM  MSPreventive dental services provided for students in primary and secondary schools. PM74 HN74(72) MHÑSchool Dentistry ANonly /econ /educ /hist /legis /man /organ /stand /trends CATALOG: /geog /form PIDentistry (66-71); School Health Services (66-71) MNG2.163.809; N2.421.143.827.809.576; N2.421.726.809.576 LH  MSPreventive health services provided for students; excludes college or university students. OLuse SCHOOL HEALTH SERVICES to search SCHOOL HEALTH back thru 1966 PM79; was SCHOOL HEALTH 1963-78 HN79; was SCHOOL HEALTH 1963-78 MHÑSchool Health Services ANfor high school & under; do not confuse with STUDENT HEALTH SERVICES for univ; only /class /econ /hist /legis /man /organ /stand /supply /trends /util; specify geog CATALOG: /geog /form MNN2.421.143.827.809; N2.421.726.809 LH  MSHealth and nursing care given to primary and secondary school students by a registered nurse. PM67 HN67 MHÑSchool Nursing ANonly /econ /educ /hist /legis /man /organ /stand /trends CATALOG: /geog /form PINursing (66); Public Health Nursing (66); School Health Services (66) MNG2.478.676.824; N2.421.143.827.809.742; N2.421.726.809.742 LH  MSEducational institutions. MHÑSchools ANonly /class /econ /hist /organ /stand /supply; policy: Manual 30.22; specify geog if pertinent CATALOG: /geog /form MNI2.233.659; I2.783 LH  MSEducational institutions for individuals specializing in the field of dentistry. MHÑSchools, Dental ANonly /class /econ /hist /organ /stand /supply; Manual 30.22; specify geog if pertinent CATALOG: /geog /form MNI2.783.660.481 LH  MSSchools which offer training in the area of health. PM68 HN68 MHÑSchools, Health Occupations ANonly /class /econ /hist /organ /stand /supply; Manual 30.22; specify geog if pertinent CATALOG: /geog /form PIHealth Occupations (66-67); Universities (66-67) MNI2.783.660 XUÑArea Health Education Centers LH LU  MSEducational institutions for individuals specializing in the field of medicine. MHÑSchools, Medical ANincludes Faculte de Medecine, Facultad de Medicina; ╥College of Physicians╙ = SOCIETIES, MEDICAL; Uniformed Services University of the Health Sciences (USUHS), under US Dept of Defense, goes here + UNITED STATES; only /class /econ /hist /organ /stand /supply; Manual 30.22; specify geog if pertinent CATALOG: /geog /form MNI2.783.660.552; N2.278.20.578 LH  MSSchools for children usually under five years of age. MHÑSchools, Nursery ANonly /class /econ /hist /organ /stand /supply; specify geog if pertinent CATALOG: /geog /form MNI2.233.659.660 XSNURSERY SCHOOLS LH LS  MSEducational institutions for individuals specializing in the field of nursing. MHÑSchools, Nursing ANonly /class /econ /hist /organ /stand /supply; Manual 30.22; specify geog if pertinent CATALOG: /geog /form MNI2.783.660.623 LH  MSEducational institutions for individuals specializing in the field of pharmacy. PM68 HN68 MHÑSchools, Pharmacy ANonly /class /econ /hist /organ /stand /supply; Manual 30.22; specify geog if pertinent CATALOG: /geog /form PIEducation, Pharmacy (66-67) MNI2.783.660.694 LH  MSEducational institutions for individuals specializing in the field of public health. MHÑSchools, Public Health ANonly /class /econ /hist /organ /stand /supply; Manual 30.22; specify geog if pertinent CATALOG: /geog /form MNI2.783.660.765 LH  MSEducational institutions for individuals specializing in the field of veterinary medicine. MHÑSchools, Veterinary ANonly /class /econ /hist /organ /stand /supply; Manual 30.22; specify geog if pertinent CATALOG: /geog /form MNI2.783.660.836 LH  PM68 HN68(63) MHÑSchwann Cells ANA 11 qualif MNA8.663.576.660; A11.671.544.660 LH  MHÑSciatic Nerve ANdo not use /innerv MNA8.796.828.569.785 LH  MHÑSciatica ANdo not confuse with BACKACHE or LUMBAGO: use term of text; ╥lombo-sciatique╙ in French texts is indexed here + BACKACHE MNC10.772.770 FXÑIntervertebral Disk Displacement LH LX  MHÑScience ANonly /hist MNH1.770 FXÑRELIGION AND SCIENCE XUÑMethods LH LX LU  MSAnomalous venous drainage of the right lung into the inferior vena cava, with hypoplasia of the right lung. The scimitar-shaped radiographic shadow of the anomalous vein gives the syndrome its name. PM85 HN85 MHÑScimitar Syndrome ANdo not use /congen PILung/AB (66-84); Pulmonary Artery/AB (66-84); Pulmonary Veins/AB (66-84) MNC8.381.844; C14.700; C14.907.780; C16.131.780 LH  MSDetection and counting of scintillations produced in a fluorescent material by ionizing radiation. OLto search SCINTILLATION COUNTERS & SCINTILLATION COUNTER use SCINTILLATION COUNTING back thru 1973 & RADIOMETRY 1966-72 PM79; was SCINTILLATION COUNTERS 1973-78; was SCINTILLATION COUNTER see under RADIOMETRY 1963-72 HN79; was SCINTILLATION COUNTERS 1973-78, was SCINTILLATION COUNTER see under RADIOMETRY 1963-72 MHÑScintillation Counting ANonly /econ /hist /instrum /methods /stand /util (if by MeSH definition); ╥gamma camera╙ goes here PIRadiometry (66-72) MNE5.799.700; H1.671.768.765.710 FXÑRadionuclide Imaging LH LX  MSA family of the order Rodentia which contains 50 genera. Some of the more common genera are Sciurus, which includes the gray squirrel, S. carolinensis; the fox squirrel, S. Niger; Tamias and Eutamias, the eastern and western chipmunk; and Tamiasciurus, the red squirrel. The flying squirrels except the scaly tailed Anomaluridae also belong to this family. OLuse SCIURIDAE to search SQUIRRELS back thru 1968 & CHIPMUNKS & GROUND SQUIRRELS back thru 1975 PM82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was indexed under RODENTS or SQUIRRELS 1975-80; MARMOTA was MARMOTS see under RODENTS 1975-81 HN82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was see under CHIPMUNKS 1975-80 MHÑSciuridae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIRodentia (66-67) MNB2.649.865.750 XSChipmunks; Citellus; Eutamias; Spermophilus; Squirrels; Tamias XUÑMarmota LH LS; ; ; ; ; LU  MHÑSclera ANblue sclera = SCLERA /abnorm; scleritis = SCLERA (IM) + INFLAMMATION (NIM) MNA9.371.784 LH  MSAn operation for retinal detachment which reduces the size of the globe by indenting the sclera so that it approximates the retina. PM75 HN75 MHÑScleral Buckling ANdo not use /util except by MeSH definition PIRetinal Detachment/SU (66-74); Sclera (66-74) MNE4.792.890 FXÑRetinal Detachment LH LX  MHÑScleredema Adultorum MNC17.751; C23.205.200.750 LH  MHÑSclerema Neonatorum ANdo not use /congen MNC16.131.831.812; C16.614.810; C17.762 LH  OLsearch SCLERODERMA under SCLERODERMA, SYSTEMIC 1966-70 PM71; SCLERODERMA was heading 1963-70 HN71; SCLERODERMA was heading 1963-70 MHÑScleroderma, Circumscribed PIScleroderma, Systemic (66-70) MNC17.773 XSDERMATOSCLEROSIS; MORPHEA LH LS;  MSA chronic, progressive dermatosis characterized by boardlike hardening and immobility of the affected skin, with visceral involvement, especially of lungs, esophagus, kidneys and heart. It may be accompanied by calcinosis, Raynaud's phenomenon, and telangiectasis. Includes acrosclerosis and sclerodactyly. Syn: progressive, systemic sclerosis, diffuse scleroderma, progressive scleroderma. OLuse SCLERODERMA, SYSTEMIC to search SCLERODERMA 1966-70 PM71; SCLERODERMA was heading 1963-70 HN71; SCLERODERMA was heading 1963-70 MHÑScleroderma, Systemic AN╥diffuse╙ goes here MNC17.784; C23.205.200.799 XSSCLEROSIS, PROGRESSIVE SYSTEMIC LH LS  OL'scleroproteins' is indexed under PROTEINS for general articles only MH*Scleroproteins (Non Mesh) MND12.776.860 LH  MHÑSclerosing Solutions AND25-26 qualif; coord /ther use with dis /ther, not dis /drug ther MND26.394.225.766.826; D26.585.711 XSINJECTIONS, SCLEROSING FXÑVaricose Veins LH LS LX  MHÑSclerosis ANNIM as pathol process with no qualif: coord with Cat A term /pathol (IM) MNC23.739.823 LH  MHÑScoliosis MNC5.878.616.786 LH  MHÑScopolamine ANdo not use /biosyn /defic /physiol; /analogs = SCOPOLAMINE DERIVATIVES RN51-34-3 MND3.132.760.180.848; D3.132.889.848; D3.605.869.900; D16.653.865.826 XSHYOSCINE LH LS  MSAnalogs or derivatives of scopolamine. OLsearch SCOPOLAMINE 1966-74 & TROPANES 1969-74 PM78; was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74; BUTYLSCOPOLAMMONIUM BROMIDE was see under SCOPOLAMINE 1976-77 HN78(75); was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74 MHÑScopolamine Derivatives ANdo not use /analogs /biosyn /defic /physiol PIScopolamine (66-74); Tropanes (66-74) MND3.132.889.848.661; D3.605.869.900.700 XUÑButylscopolammonium Bromide LH LU  MS7-Hydroxy-6-methoxycoumarin. Plant growth factor. Synonym: 6-methoxy-umbelliferone. HN(75); was see under COUMARINS 1975-76 MHÑScopoletin ANdo not use /defic /physiol; /analogs NIM only RN92-61-5 PICoumarins (69-74); Bioflavonoids (72-74) MND3.438.150.446.912.850 XSChrysotropic Acid; Gelseminic Acid; Methylesculetin DMÑUmbelliferones LH LS; ; LM  MSVenoms from animals of the order Scorpionida of class Arachnida; they contain neuro- and hemotoxins, enzymes and various other factors that may release acetylcholine and catecholamines from nerve endings; several protein toxins have been characterized, most are immunogenic. PM78 HN78 MHÑScorpion Venoms ANdo not use /analogs /chem syn /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS PIScorpions (66-77); Venoms (66-77) MND24.185.965.65.830 LH  MHÑScorpions AN/microbiol /parasitol permitted; scorpion sting: coord NIM with ARACHNIDISM (IM); several genera: Androctonus, Buthus, Centruoides, Leiurus, Nebo, Tityus MNB1.131.166.661 LH  MHÑScotland MNZ1.542.363.766 LH  MHÑScotoma ANpathol, differentiate from physiol blind spot ( = BLIND SPOT) MNC10.597.751.941.811; C11.966.811; C23.888.592.763.941.811 LH  MSA fatal disease of the nervous system in sheep and goats, caused by a small virus, and characterized by pruritis, debility, and locomotor incoordination. PM68 HN68(66) MHÑScrapie ANusually animal: do not use /vet but check tag ANIMAL; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES MNC2.839.766; C10.228.228.861; C10.228.337.799; C22.836.799 XSRIDA LH LS  MSThe agent that causes SCRAPIE in sheep and goats. OLuse SCRAPIE AGENT to search SCRAPIE PRION & SCRAPIE VIRUS back thru 1966 PM87; was SCRAPIE PRION 1986, was SCRAPIE VIRUS 1966-85 HN87; was SCRAPIE PRION 1986, was SCRAPIE VIRUS 1965-85 (Prov 1965) MHÑScrapie Agent ANdo not use /blood-csf-urine /cytol MNB4.909.920.661 XSRida Virus; Scrapie Prion; Scrapie Virus; Scrapie-Associated Fibrils LH LS; ; ;  MSInfection with larvae of the blow fly Cochliomyia hominivorax (Callitroga americanum), a common cause of disease in livestock in the southern and southwestern U.S.A. OLsearch MYIASIS 1968-74 HN(75) MHÑScrew Worm Infection ANcaused by Cochliomyia hominivorax ( = DIPTERA) MNC3.211.503.744 DMÑMyiasis LH LM  MHÑScrotum MNA5.360.444.661 LH  MHÑScrub Typhus ANcaused by Rickettsia tsutsugamushi MNC1.850.810.800.855 XSTSUTSUGAMUSHI; Typhus, Scrub LH LS;  OLsearch ART 1966-74 HN(75) MHÑSculpture ANonly /hist MNK1.93.849 DMÑArt LH LM  MHÑScurvy ANconsider also ASCORBIC ACID DEFICIENCY MNC18.654.223.133.115.661 XSSCORBUTUS LH LS  MSNumerous almost invariably solitary polyps of the order Actiniaria. HN(75) MHÑSea Anemones AN/microbiol /parasitol permitted MNB1.308.700 DMÑCoelenterata LH LM  MSA class of Echinodermata characterized by long, slender bodies. HN(78) MHÑSea Cucumbers AN/microbiol /parasitol permitted PIEchinodermata (66-77) MNB1.408.560 XSHolothuroidea DMÑEchinodermata LH LS LM  MSSomewhat flattened, globular echinoderms of the class Echinoidea, having thin, brittle shells of calcareous plates. PM72 HN72 MHÑSea Urchins ANIM; /microbiol /parasitol permitted; sea urchin eggs = OVUM (IM) + SEA URCHINS (NIM) if merely test organism PIEchinodermata (66-71) MNB1.408.578 XSSand-Dollar LH LS  MSRare disorder consisting of splenomegaly, mild purpura secondary to thrombocytopenia, and occasionally, hepatic cirrhosis associated with the appearance of numerous histiocytes in the spleen and bone marrow which stain a sea-blue color. Sometimes considered a variant of Niemann-Pick disease. PM84 HN84 MHÑSea-Blue Histiocyte Syndrome ANdo not use /congen; also called sea-blue histiocytosis PIHistiocytes (66-83) MNC18.452.648.556.641.803.850 LH  MHÑSealed Cabin Ecology ANIM; no qualif; coord with SPACE FLIGHT (IM) or SUBMARINE MEDICINE (IM) MNG3.230.150.200.450 XSECOLOGY, SEALED CABIN FXÑSpace Flight; ÑSubmarine Medicine XUÑLife Support Systems LH LS LX; LU  OLsearch PINNIPEDIA 1968-74; to search SEA LION use SEALS & PINNIPEDIA 1975-79 & PINNIPEDIA 1968-74 HN(75); SEA LIONS was SEA LION see under PINNIPEDIA 1968-79 MHÑSeals ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.754.578 XSSea Lions DMÑPinnipedia LH LS LM  MHÑSeasons ANno qualif MNG3.230.560; H1.862.645.661 LH  MSRestraining belts fastened to the frame of automobiles or aircraft and strapped around the person occupying the seat in the car or plane, intended to prevent the person from being thrown forward or out of the vehicle in case of sudden deceleration. PM70 HN70; was in Cat J only 1970-82 MHÑSeat Belts ANonly /adv eff /econ /stand PIAccident Prevention (66-69); Accidents, Traffic (66-69); Automobiles (66-69) MNE7.712.831 LH  PM74 HN74(69) MHÑSeawater ANonly /adv eff /anal; consider also THALASSOTHERAPY PIWater (66-68) MNG3.230.700.400 LH  MHÑSeaweed ANdo not use /anat /embryol /microbiol /parasitol MNB5.104.837 FXÑCarrageenan XUÑLaminaria LH LX LU  OL╥sebaceous gland diseases╙ is indexed SEBACEOUS GLANDS (IM) + SKIN APPENDAGE DISEASES (NIM) MH*Sebaceous Gland Diseases (Non Mesh) MNC17.805.711 LH  PM68 HN68 MHÑSebaceous Gland Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PISebaceous Glands (66-67); Skin Neoplasms (66-67) MNC4.588.805.578; C17.805.711.712 LH  MHÑSebaceous Glands ANdiseases: coord IM with SKIN APPENDAGE DISEASES (NIM) MNA1.835.744; A10.336.827 FXÑExocrine Glands LH LX  MHÑSeborrhea MNC17.805.711.812 XSDERMATITIS SEBORRHEICA LH LS  MHÑSebum ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.838.702 LH  MS7-Chloro-3,3a-dihydro-2H,9H-isoxazolo[3,2-b][1.3]benzoxazin-9-one. Proposed anti-inflammatory agent. HN(75) MHÑSeclazone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN29050-11-1 PIOxazines (73-74); Oxazoles (73-74) MND3.383.533.800 DMÑOxazines LH LM  MHÑSecobarbital ANdo not use /biosyn /defic /physiol RN76-73-3 MND3.383.742.698.253.762; D14.166.111.762; D14.591.220.762 XSMeballymal; Quinalbarbitone LH LS;  PM68 HN68 MHÑSecosteroids ANdo not use /analogs /biosyn /defic /physiol MND4.808.812 LH  MHÑSecretin AN/biosyn /physiol permitted RN1393-25-5 MND6.472.317.800; D12.644.820; D12.776.641.650.705; D19.316.629.787 LH  OLconsider also /SE with Cat A & Cat D MH*Secretions (Non Mesh) MNA12.838 LH  MSA A glycoprotein usually associated with secretory immunoglobulins (A and M). Its molecular weight is 60,000 to 75,000, depending on the species; it is linked to the heavy chains of the Ig's by disulfide bonds and probably functions to protect the Ig from proteolysis in the secretions. HN(76) MHÑSecretory Component ANonly /anal /biosyn /class /csf /genet /isol /urine PIColostrum (73-75); IgA (73-75); Immunoglobulin Fragments (73-75) MND12.776.124.486.485.680.800; D12.776.124.790.651.596.800; D12.776.377.715.548.673.800; D24.611.125.600.662.833 XSSecretory Piece; T Chain; Transport Piece DMÑImmunoglobulin Fragments LH LS; ; LM  MSThe amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa. PM68 HN68(66) MHÑSecretory Rate ANNIM; restrict to secret of endogenous substances (see MeSH definition); only /drug eff /rad eff MNG6.535.873 LH  MSRegulations to assure protection of property and equipment. PM78 HN78 MHÑSecurity Measures ANonly /econ /legis /stand /trends MNN4.452.910 LH  MSCompounds with diverse chemical and pharmacological properties that have in common the ability to allay excitement and anxiety and at higher concentrations induce sleep. PM75 HN75 MHÑSedatives, Nonbarbiturate ANdo not use /analogs /biosyn /defic /physiol PIHypnotics and Sedatives (66-74) MND14.591.745 LH  MSThe encapsulated embryos of flowering plants; used for food or animal feed because of the high content of concentrated nutrients like starches, proteins, and fats. Rapeseed, cottonseed, and sunflower seed are produced for the oils (fats) they yield. MHÑSeeds AN= plant embryo, plant zygote; specify plant if in B6 or J; if not, do not use PLANTS; for sunflower seeds, coord IM with HELIANTHUS (IM) MNB6.812 XSEmbryos, Plant FXÑNuts LH LS LX  MSAttacks of cerebral origin consisting of sudden and transitory abnormal phenomena of a motor, sensory, autonomic or psychic nature resulting from transient dysfunction of the brain. PM79 HN79 MHÑSeizures ANunspecified seizures; convulsive seizures = CONVULSIONS; epileptic seizures = EPILEPSY or specifics; audiogenic or acoustic seizures: index under SEIZURES (IM) + ACOUSTIC STIMULATION (probably NIM) PIConvulsions (66-78); Epilepsy (66-78); specific epilepsy heading MNC10.597.742; C23.888.592.742 LH  MSDifferential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population. OLto search NATURAL SELECTION use SELECTION (GENETICS) back thru 1979 & SELECTION (GENETICS) & EVOLUTION 1978 PM68; NATURAL SELECTION was indexed under EVOLUTION 1978 HN68; NATURAL SELECTION was indexed under EVOLUTION 1978 MHÑSelection (Genetics) ANno qualif; DF: SELECTION PIGenetics (66-67); Genetics, Population (66-67) MNG5.414.725 XSNatural Selection LH LS  MSN,alpha-Dimethyl-N-(2-propinyl)phenethylamine. A selective, irreversible inhibitor of Type B monoamine oxidase. Proposed as antiparkinson agent, possible antidepressant. Synonym: E 250. OLuse SELEGILINE to search DEPRENYL back thru 1979 HN(84); was DEPRENYL see under PHENETHYLAMINES 1979-83 MHÑSelegiline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2323-36-6 PIMonoamine Oxidase Inhibitors (66-78); Phenethylamines (66-78) MND2.92.471.683.915; D8.373.616.900; D14.307.835 XSDeprenalin; Deprenil; Deprenyl DMÑPhenethylamines LH LS; ; LM  MHÑSelenium ANSe-80; /defic /physiol permitted; do not use /analogs /biosyn; Se-74, 76-78, 82 = SELENIUM (IM) + ISOTOPES (NIM); Se-70-73, 75, 79, 81, 83-85 = SELENIUM (IM) + RADIOISOTOPES (IM) RN7782-49-2 MND1.268.784; D1.811; D1.937.750 XUÑSelenomethionine LH LU  MS2-Amino-4-(methylselenyl)butyric acid. Diagnostic aid in pancreas function determination. Synonym: Sethotope. HN(75) MHÑSelenomethionine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1464-42-2 PISelenium (69-74); Methionine (71-74) MND1.811.800; D12.125.166.676.900 XSRadioselenomethionine; Selenomethionine Se 75 DMÑSelenium LH LS; LM  MSAdministration of a drug or chemical by the individual under the direction of a physician. Includes clinical or experimental, human, or animal. PM77 HN77 MHÑSelf Administration ANNIM; only /adv eff /econ /instrum /methods /psychol; differentiate from SELF MEDICATION & SELF CARE (see note there) PISelf Medication (66-76); specific heading/AD (66-76) MNE2.319.890; E2.900.890 LH  MSAppraisal of one's own personal qualities or traits. OLto search SELF ASSESSMENT use SELF ASSESSMENT (PSYCHOLOGY) 1975-78 & SELF CONCEPT 1969-74 PM79; was SELF ASSESSMENT see under SELF CONCEPT 1969-78 HN79; was SELF ASSESSMENT see under SELF CONCEPT 1969-78 MHÑSelf Assessment (Psychology) ANno qualif; DF: SELF ASSESSMENT PISelf Concept (69-74) MNF1.752.747.792.537 LH  MSConsumer performance of activities traditionally performed by professional health care providers. Includes care of oneself or one's family and friends. OLsearch ACTIVITIES OF DAILY LIVING 1979-80 PM81; was see ACTIVITIES OF DAILY LIVING 1979-80 HN81; was see ACTIVITIES OF DAILY LIVING 1979-80 MHÑSelf Care ANonly /adv eff /econ /instrum /methods /psychol; = care prescribed by MD or generated by person himself & includes care for self, family or friends; differentiate from SELF MEDICATION (medication not prescribed by MD) and SELF ADMINISTRATION (admin of medication prescribed by MD or self admin of substances by exper animals) PIActivities of Daily Living (78-80); Consumer Participation (74-78); Health Education (66-80); Patient Education (66-80); Patient Participation (78) MNE2.900; N2.421.784.680 LH  MSA person's view of himself. OLuse SELF CONCEPT to search SELF PERCEPTION back thru 1969 PM69 HN69; SELF PERCEPTION was see under SELF CONCEPT 1969-78 MHÑSelf Concept ANno qualif MNF1.752.747.792 XSSelf Esteem; Self Perception FXÑBody Image LH LS; LX  MSA willingness to reveal information about oneself to others. OLsearch SELF CONCEPT 1969-74 PM79; was see under SELF CONCEPT 1969-78 HN79(75); was see under SELF CONCEPT 1969-78 MHÑSelf Disclosure AN╥a willingness to reveal information about oneself to others╙; no qualif PISelf Concept (69-74) MNF1.752.747.792.662 LH  MSThe self administration of medication not prescribed by a physician or in a manner not directed by a physician. PM68 HN68(65) MHÑSelf Medication ANonly /adv eff /econ /instrum /methods /psychol; differentiate from SELF ADMINISTRATION & SELF CARE (see note there) MNE2.319.827; E2.900.880 LH  MSThe act of injuring one's own body. MHÑSelf Mutilation ANdo not use /congen /drug eff /physiol /rad eff MNC21.866.780; F3.126.792 LH  MSCentral stimulation, usually electrical, of the brain, which is administered by the animal's pressing a bar or switch; the stimulation may result in negative or positive reinforcement. PM65 HN65(64) MHÑSelf Stimulation ANhuman & animal; only /drug eff /physiol /rad eff MNF1.145.775; F2.830.784 LH  MSRooms in health care facilities for patients who require a minimal level of care. HN(Aug 77) MHÑSelf-Care Units ANonly /class /econ /legis /man /organ /stand /trends /util MNN2.278.388.740 XSMinimal Care Units DMÑHospital Units LH LS LM  MSEducational programs structured in such a manner that the participating professionals, physicians or students develop an increased awareness of their performance, usually on the basis of self-evaluation questionnaires. HN(79) MHÑSelf-Evaluation Programs ANonly /econ /methods /stand PIEducational Measurement (74-78) MNI2.399.780 DMÑEducational Measurement LH LM  MSDevices, not affixed to the body, designed to help persons having musculoskeletal or neuromuscular disabilities to perform activities involving movement. MHÑSelf-Help Devices ANdo not use /instrum /methods /util (except by MeSH definition) MNE7.796 FXÑHandicapped XUÑCommunication Aids for Handicapped LH LX LU  MSOrganizations which provide an environment encouraging social interactions through group activities or individual relationships especially for the purpose of rehabilitating or supporting patients, individuals with common health problems, or the elderly; includes therapeutic social clubs. OLuse SELF-HELP GROUPS to search SOCIAL CLUBS (now SOCIAL CLUBS, THERAPEUTIC see SELF-HELP GROUPS) 1973-78 (as Prov 1973-74) PM79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78 HN79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78, was SOCIAL CLUBS 1973-74 (Prov) MHÑSelf-Help Groups ANdo not use /educ /man /util PIOrganizations (68-72) MNN3.540.782 XSSocial Clubs, Therapeutic LH LS  MHÑSella Turcica MNA2.835.232.781.802.662 FXÑEmpty Sella Syndrome LH LX  MSAnalysis of word concepts by the association of polar adjectives, e.g., good-bad, with the concept, father. The adjectives are usually scaled in 7 steps. The subject's placement of the concept on the adjectival scale indicates the connotative meaning of the concept. PM68 HN68 MHÑSemantic Differential ANa type of psychol test: do not confuse with SEMANTICS; no qualif PIPsychological Tests (66-67); Semantics (66-67) MNF2.694.663; F4.711.647.745 LH  MSThe relationships between symbols and their meanings. MHÑSemantics ANhist or psychol study of changes in language & meaning; do not confuse with LINGUISTICS (overall study of LANGUAGE & SPEECH) or NOMENCLATURE (names of things & etymology); no qualif MNL1.143.506.598.745 LH  MHÑSemen ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; semen donors: index under INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband); SPERM BANKS is also available; hemospermia: index under SEMEN (IM) + BLOOD (IM) MNA12.838.732 FXÑSPERMATOZOA LH LX  MSMethods of preserving semen. PM78 HN78 MHÑSemen Preservation ANonly /econ /instrum /methods /stand /util (if by MeSH definition) /vet; SPERM BANKS is also available; cryopreservation of semen: coord IM with FREEZING (NIM) PIFreezing (66-77); Semen (66-77) MNE5.760.833.890 XSFrozen Semen LH LS  PM66 HN66 MHÑSemicarbazides ANdo not use /analogs /biosyn /defic /physiol MND2.845 XUÑDiphenylcarbazide LH LU  PM74 HN74(72) MHÑSemicarbazones ANdo not use /analogs /biosyn /defic /physiol PIHemostatics (66-71); Nitrofurazone (66-71); Semicarbazides (66-71); Thiosemicarbazones (66-71) MND2.845.746 LH  MHÑSemicircular Canals MNA9.246.631.909.663 LH  PM73 HN73(67); was in Cat H & J 1967-82 MHÑSemiconductors ANNIM; only /stand PIElectricity (66); Electronics (66) MNH1.288.745 XUÑTransistors LH LU  MHÑSemilunar Bone MNA2.835.232.87.144.663 LH  OLsearch TRIGEMINAL NERVE 1966-74 HN(75) MHÑSemilunar Ganglion ANdo not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.848.813 DMÑTrigeminal Nerve LH LM  MHÑSeminal Vesicles MNA5.360.444.713 LH  MSSpecialized epithelium lining the seminiferous tubules containing developing and mature spermatozoa and Sertoli cells. HN(75) MHÑSeminiferous Epithelium ANdo not use /abnorm /growth /inj /innerv MNA5.360.444.849.700.700; A10.272.700 DMÑTestis LH LM  MSThe canals through which the testicular spermatozoa are conveyed to the rete testis. HN(75) MHÑSeminiferous Tubules MNA5.360.444.849.700 DMÑTestis LH LM  MSAn Alphavirus (group A arbovirus) isolated in central, eastern and southern Africa. Synonym: Kumba virus. PM66 HN66(64) MHÑSemliki Forest Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TOGAVIRUS INFECTIONS (IM) MNB4.909.637.713; B4.909.777.923.54.840 LH  MS1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. 4-Methyl derivative of lomustine (CCNU). An antineoplastic agent which functions as an alkylating agent. Synonyms: NSC-95441; MeCCNU; Me-CCNU. HN(75) MHÑSemustine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13909-09-6 PICyclohexanes (66-74); Nitroso Compounds (66-72); Nitrosourea Compounds (73-74); Urea (66-72) MND2.654.692.440.700; D2.948.594.440.700; D22.204.493.835 XSMethyl-CCNU DMÑNitrosourea Compounds LH LS LM  MSA species of toxic plants of the Compositae; the poisonous compounds are alkaloids which cause cattle diseases, neoplasms, and liver damage and are used to produce cancers in experimental animals. MHÑSenecio ANdo not use /isol /pathogen MNB6.660.826 XSGroundsel; Ragwort FXÑPyrrolizidine Alkaloids LH LS; LX  MHÑSenegal MNZ1.58.432.776 LH  MSPreparations of Cassia senna L. and C. angustifolia of the Leguminosae; they contain sennosides, which are anthraquinone type cathartics and are used in many different preparations as laxatives. Synonyms: Agmalax; Aperens; Casafru; Glysennid; Pursennid; Senokot; Skriptlax. HNwas in Cat B & D 1963-77 MHÑSenna ANdrug only, with CASSIA the plant source; do not use /analogs /defic /physiol; /biosyn permitted if by plant RN8013-11-4 MND19.316.396.875 LH  MSTransduction of physical or chemical changes in the external or internal environment into nerve impulses by specialized receptors, transmission of these impulses by afferent neurons to the effectors, either directly or through the CNS. MHÑSensation ANonly /drug eff /physiol /rad eff; sensation disord: index SENSATION (IM) + NERVOUS SYSTEM DISEASES (NIM); burning, tingling & prickling sensations: index under PARESTHESIA MNF2.830.816; G11.561.796 FXÑNeurophysiology; ÑPerception LH LX;  OL╥sensation disorders╙ is indexed under SENSATION (IM) + NERVOUS SYSTEM DISEASES (NIM) MH*Sensation Disorders (Non Mesh) MNC10.597.751; C23.888.592.763 LH  PM72 HN72 MHÑSense Organs ANGEN: prefer specifics PIReceptors, Sensory (66-71); Sensation (66-71) MNA9 FXÑReceptors, Sensory LH LX  MSSensitivity and specificity refers to the proportion of truly diseased persons in a screened population who are identified as diseased by the screening test (sensitivity) and to the proportion of truly nondiseased persons who are so identified by the screening test (specificity). PM87 HN87 MHÑSensitivity and Specificity (Epidemiology) ANno qualif; see MeSH definition: restrict to epidemiol; not for drug or microbial contexts; DF: SENSITIVITY MNE5.318.848; G3.850.520.820 XSSpecificity LH LS  MSA group of people who meet in an unstructured setting to learn about themselves, interpersonal relationships, group processes and about larger social systems. PM72 HN72(69) MHÑSensitivity Training Groups ANno qualif PIGroup Processes (66-68) MNF1.829.316.697; F4.754.864.581.813 XST-GROUPS XUÑEncounter Groups LH LS LU  PM74 HN74(73) MHÑSensory Aids ANonly /class /econ /hist /stand /supply /trends /util (if by MeSH definition); for deafness consider HEARING AIDS; for Braille coord IM with BLINDNESS (IM) + READING (IM) PIBlindness/RH (66-72); Deafness/RH (66-72); appropriate heading/RH (66-72) MNE7.814 FXÑBlindness LH LX  MSThe absence or restriction of the usual external sensory stimuli to which the individual responds. MHÑSensory Deprivation ANhuman & animal; only /physiol MNF2.463.593.696 FXÑMental Retardation, Psychosocial LH LX  MSThe statistically determined amount of stimulus energy necessary to elicit a sensory response. PM79 HN79; was THRESHOLD (NON MESH) before 1979 MHÑSensory Thresholds ANIM GEN or unspecified; AUDITORY THRESHOLD, DIFFERENTIAL THRESHOLD, SUBLIMINAL STIMULATION & TASTE THRESHOLD are also available; coord NIM with specific sensory concept (e.g., PAIN /physiopathol (IM) + SENSORY THRESHOLDS (NIM) ) MNF2.463.593.710 FXÑPain Measurement LH LX  OLsearch POLYSACCHARIDES 1974 PM84; was see under POLYSACCHARIDES 1975-83 HN84(75); was see under POLYSACCHARIDES 1975-83 MHÑSepharose ANdo not use /biosyn /defic /physiol; /analogs NIM only RN9012-36-6 MND9.203.698.813 XSAgarose LH LS  MSNeural nuclei situated in the septal region of the diencephalon. PM78; was see under SEPTUM PELLUCIDUM 1975-77 HN78(72); was see under SEPTUM PELLUCIDUM 1975-77 MHÑSeptal Nuclei ANdo not use /innerv PICerebral Ventricles (66-71); Hippocampus (66-71); Limbic System (66-71) MNA8.186.211.577.851.664 XUÑNucleus Accumbens LH LU  MHÑSepticemia ANIM; coord with specific bact/infect heading (IM) (but do not use /blood to cover -emia) or specific bacterium (IM) (do not use /blood) if precoord bact/infect heading is not in MeSH; HEMORRHAGIC SEPTICEMIA, a Pasteurella infect, is also available; ╥sepsis╙ is not necessarily SEPTICEMIA: check text for INFECTION or more likely BACTERIAL INFECTIONS (TN 185) MNC1.539.775 XSBACTEREMIA LH LS  PM73 HN73 MHÑSeptum Pellucidum ANdo not use /innerv PICerebral Ventricles (66-72) MNA8.186.211.276.814; A8.186.211.577.851 LH  MSThe sequential correspondence of nucleotide triplets in a nucleic acid molecule which permits nucleic acid hybridization. Sequence homology is important in the study of mechanisms of oncogenesis and also as an indication of the evolutionary relatedness of different organisms. HN(86) MHÑSequence Homology, Nucleic Acid ANonly /drug eff /rad eff; DF: SEQ HOMOL PIBase Sequence (71-85); Nucleic Acid Hybridization (71-85) MNG5.331.112.791; G6.184.130.791 XSBase Sequence Homology; Homologous Sequences, Nucleic Acid DMÑBase Sequence LH LS; LM  PM73 HN73(71) MHÑSerial Extraction ANan orthodontic proced of sequentially extracting selected teeth over a period of years: do not confuse with TOOTH EXTRACTION; do not use /util except by MeSH definition PIOrthodontics, Corrective (66-70); Tooth Extraction (66-70) MNE6.658.641.890; E6.892.834.664 FXÑDentition, Mixed LH LX  MSLearning to make a series of responses in exact order. PM67 HN67(64) MHÑSerial Learning ANonly /drug eff /physiol /rad eff MNF2.463.425.952.747 LH  OLat present includes only NEWSPAPERS & PERIODICALS MH*Serial Publications (Non Mesh) MNL1.178.682.829 LH  MHÑSerine MND12.125.837 XUÑ3,4-Dihydroxyphenylserine; ÑEnterochelin; ÑPhosphoserine LH LU; ;  OLto search SERINE DEAMINASE use SERINE DEHYDRATASE back thru 1972, SERINE DEAMINASE & HYDRO-LYASES 1967-71 & HYDRO-LYASES 1966 PM72; SERINE DEAMINASE was see under HYDRO-LYASES 1963-71 HN72(67); SERINE DEAMINASE was see under HYDRO-LYASES 1963-71 MHÑSerine Dehydratase ANdo not use /analogs RNEC 4.2.1.14 PIHydro-Lyases (66) MND8.586.520.497.747 XSSERINE DEAMINASE LH LS  MS5,10-Methylenetetrahydrofolate:glycine hydroxymethyl-transferase. A pyridoxal phosphate enzyme which catalyzes the reaction of glycine and 5,10-methylene-tetrahydrofolate to form serine. Also catalyzes the reaction of glycine with acetaldehyde to form L-threonine. Synonym: Serine:tetrahydrofolate 5,10-hydroxymethyltransferase. HN(75) MHÑSerine Hydroxymethyltransferase ANdo not use /analogs RNEC 2.1.2.1 PISerine (73-74); Tetrahydrofolates (73-74); Transferases (73-74) MND8.586.913.755 XSSerine Aldolase; Serine Hydroxymethylase; Serine Transhydroxymethylase; Threonine Aldolase DMÑTransferases LH LS; ; ; LM  MSDiagnostic procedures connected with immunology, involving serum reactions. Serologic tests are employed both for 1) identification of microorganisms or 2) demonstration of antibodies in the serum of the host. MHÑSerodiagnosis ANGEN: SPEC qualif; NIM; Manual 26.18, example: 19.4.32; see SEROLOGY below or tree indentions under SERODIAGNOSIS for scope MNE1.223.495.826 FXÑImmunologic Technics LH LX  MSThe study of serum, especially of antigen-antibody reactions in vitro. MHÑSerology ANfield of immunology dealing with in vitro antigen-antibody reactions; SPEC: SPEC qualif; do not confuse with SERODIAGNOSIS MNG2.781 LH  MHÑSerositis MNC23.739.487.746 LH  PMBUFOTENIN was see under HALLUCINOGENS 1963-74 MHÑSerotonin AN/biosyn /physiol permitted; /antag = SEROTONIN ANTAGONISTS RN50-67-9 MND3.438.473.914.814; D16.538.852; D24.185.798.652 XS5-HT; HYDROXYTRYPTAMINE XUÑBufotenin; ÑMethoxydimethyltryptamines LH LS; LU;  MSSubstances that prevent or antagonize the action of serotonin by destroying it, inhibiting its synthesis or release, blocking its receptors or in any other way. OLsearch SEROTONIN /AI 1968-77 & SEROTONIN 1966-67 PM78,64-67 HN78,64-67 MHÑSerotonin Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: SEROTONIN ANTAG PISerotonin (66-67); Serotonin/AI (68-77) MND23.846 XSAntiserotonergic Agents; Serotonin Blockaders LH LS;  PM70 HN70(68) MHÑSerotyping ANrestrict to classification of micro-organisms: do not use for blood typing ( = BLOOD GROUPING AND CROSSMATCHING); NIM; only /instrum /methods /stand /vet; coord with organism /class, not /immunol PIAntigens (66-67); Bacteriological Technics (66-67) MNE5.478.829; E5.909.560.150.890 LH  MHÑSerous Membrane ANGEN: prefer specific membrane; do not use /abnorm /growth /inj /innerv; inflammation = SEROSITIS MNA10.615.789 LH  MHÑSerratia ANin water, soil, food MNB3.475.300.814 LH  MHÑSerratia Marcescens ANin water, soil, dairy products, insects MNB3.475.300.814.664 LH  MHÑSertoli Cell Tumor AN/anal /blood supply /secret /ultrastruct permitted; coord IM with TESTICULAR NEOPLASMS (IM) MNC4.557.576.861 LH  PM68 HN68(64) MHÑSertoli Cells ANA 11 qualif MNA5.360.444.849.789; A11.436.829 LH  MHÑSerum Albumin ANdo not use /analogs /blood MND12.776.34.841; D12.776.124.50.700; D12.776.124.727 LH  MHÑSerum Albumin, Bovine ANdo not use /analogs /blood /defic /physiol MND12.776.34.841.540; D12.776.124.727.540 LH  MHÑSerum Albumin, Radio-Iodinated ANdo not use /analogs /biosyn /blood /defic /physiol; DF: RISA MND1.396.661.530.748; D1.496.448.496.748; D1.496.749.474.748; D12.776.34.841.665; D12.776.124.727.665 FXÑIodoproteins LH LX  OLuse SERUM GLOBULINS to search SERUM GLOBULIN back thru 1966 PM70; was SERUM GLOBULIN 1963-69 HN70; was SERUM GLOBULIN 1963-69 MHÑSerum Globulins ANGEN; do not use /analogs /blood; permeability globulins go here MND12.776.124.790; D12.776.377.715 XSEuglobulins; Pseudoglobulins LH LS;  MHÑSerum Sickness MNC20.543.480.770 LH  MSL-Serine:tRNA-Ser ligase (AMP-forming). Activates serine with its specific transfer RNA. HN(75) MHÑSeryl T RNA Synthetase ANdo not use /analogs; note spacing RNEC 6.1.1.11 PIAmino Acyl T RNA Synthetases (73-74); Serine (73-74) MND8.586.464.136.720 DMÑAmino Acyl T RNA Synthetases LH LM  HN(87)66 MHÑSesame Oil AND25-26 qualif RN8008-74-0 MND10.516.212.302.380.775; D10.516.212.507.775; D10.516.627.700.865; J1.740.250.730; J1.740.700.865 DMÑPlant Oils LH LM  MHÑSesamoid Bones MNA2.835.232.730 LH  PM74 HN74 MHÑSesquiterpenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.849.765 XUÑT-2 Toxin; ÑTrichodermin; ÑTrichothecenes LH LU; ;  MSReadiness to think or respond in a predetermined way when confronted with a problem or stimulus situation. PM65 HN65 MHÑSet (Psychology) ANno qualif; DF: SET MNF2.463.425.838 FXÑAttitude LH LX  MSInfection with nematodes of the genus Setaria. OLsearch FILARIASIS 1968-74 HN(75) MHÑSetariasis ANcaused by Setaria, a filarial nematode; for organism index FILARIOIDEA (IM) + SETARIASIS (NIM) MNC3.335.508.361.852 DMÑFilariasis LH LM  MSLevels of severity of illness within a diagnostic group which are established by various measurement criteria. OLsearch DIAGNOSTIC RELATED GROUPS 1984-85 HN(86); was SEVERITY OF INDEX CLASSIFICATION see CASE MIX 1984-85 MHÑSeverity of Illness Index ANno qualif MNN2.421.589.473.100.608 DMÑDiagnostic Related Groups LH LM  PM74 HN74(71) MHÑSevin ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN63-25-2 PICarbamates (66-70); Insecticides (66-70) MND2.241.81.251.779; D5.723.491.408.830 XSCarbaryl LH LS  MHÑSewage ANonly /adv eff /anal MNG3.850.460.710.600; G3.850.860.510.600 XUÑWaste Disposal, Fluid LH LU  MHÑSex ANIM; no qualif; /educ = SEX EDUCATION; differentiate from SEX FACTORS, largely statist in concept, (NIM); sexology goes here; sex therapy: coord PSYCHOTHERAPY (IM) + SEX DISORDERS /ther or PSYCHOSEXUAL DYSFUNCTIONS /ther or their indentions /ther (IM) MNG8.520.900 FXÑDrive; ÑLibido; ÑPSYCHOSEXUAL DEVELOPMENT; ÑRELIGION AND SEX LH LX; ; ;  MSPheromones that elicit sexual attraction or mating behavior usually in members of the opposite sex in the same species. OLsearch PHEROMONES 1968-74 HN(75) MHÑSex Attractants ANhuman & animal; use only Cat D qualif PIBehavior, Animal (66-67); Pheromones (68-74); Sex Behavior (66-67) MNF1.145.209.103.601.665; D24.185.641.800 XSCopulins; Sex Pheromones DMÑPheromones LH LS; LM  MSNormal sexual activities of humans. PMCELIBACY was heading 1963-67 MHÑSex Behavior ANonly /drug eff /physiol /rad eff; anal and oral sex go here CATALOG: /geog /form MNF1.145.792 XUÑExtramarital Relations; ÑSexual Abstinence LH LU;  MSSexual activities of animals. PM68 HN68 MHÑSex Behavior, Animal ANonly /drug eff /physiol /rad eff PIBehavior, Animal (66-67); Sex Behavior (66-67) MNF1.145.113.252.748 XSMating Behavior, Animal XUÑPair Bond LH LS LU  MSThose characteristics that distinguish one sex from the other. The primary sex characteristics are the ovaries and testes and their related hormones. MHÑSex Characteristics ANno qualif; for phys or physiol differences between male & female; differentiate from SEX DETERMINATION (for genet factors determining male or female), SEX DIFFERENTIATION (for differentiation of male from female during embryogenesis), SEX FACTORS (for physiol, psychol, social, etc., differences between men & women, usually statistical) MNG7.168.825 XSSex Differences; Sex Dimorphism LH LS;  MHÑSex Chromatin ANA 11 qualif except /cytol /pathol MNA11.223.349.748 XSBARR BODIES; CHROMATIN, SEX FXÑChromosome Abnormalities; ÑSex Determination LH LS; LX;  PM68 HN68 MHÑSex Chromosome Abnormalities ANIM for general only; NIM coord with specific dis (IM) + specific sex chromosome (IM): see also note below; do not use /compl /congen /surg /ther PIChromosome Abnormalities (66-67); Sex (66-67) MNC16.131.280.748 XUÑFragile X Syndrome; ÑXYY Karyotype LH LU;  PM68 HN68 MHÑSex Chromosomes AN/abnorm = SEX CHROMOSOME ABNORMALITIES; X chromosome /abnorm = SEX CHROMOSOME ABNORMALITIES (IM) + X CHROMOSOME (IM); Y chromosome /abnorm = SEX CHROMOSOME ABNORMALITIES (IM) + Y CHROMOSOME (IM); A 11 qualif except /cytol PIChromosomes (66-67); Sex Chromatin (66-67) MNA11.223.475.865 XSGONOSOMES LH LS  MSGonadal or genetic determination of sex. MHÑSex Determination ANno qualif; for genetic determ of sex & for diag determ of sex; do not confuse with related sex concepts: see note under SEX CHARACTERISTICS MNE1.223.855; E5.393.830; G5.883 FXÑSEX CHROMATIN LH LX  MSDifferentiation of male and female tissues and organs during embryogenesis. Do not confuse with sex determination. PM75 HN75 MHÑSex Differentiation ANonly /drug eff /rad eff; differentiation during embryogenesis; do not confuse with related sex concepts: see note under SEX CHARACTERISTICS PIGonads/EM (66-74) MNG7.553.800; G8.520.288.520 LH  MHÑSex Differentiation Disorders ANorganic in nature: differentiate from SEX DISORDERS (related to coitus); do not use /congen MNC16.131.939.842 FXÑTRANSSEXUALISM LH LX  MSDisturbances in normal sexual performance. HNwas in Cat C & F 1975-80, was in Cat C only 1963-74 MHÑSex Disorders ANrelated to coitus: differentiate from SEX DIFFERENTIATION DISORDERS (gonadal); do not use /congen /drug eff /physiol /rad eff MNC12.294.644; C13.371.665 LH  MSEducation which increases the knowledge of the functional, structural, and behavioral aspects of human reproduction. MHÑSex Education ANno qualif CATALOG: /geog /form; do not use /pop wks MNI2.233.332.749 LH  MSUse when sex is discussed as a factor in relation to some specific subject or problem. PM68 HN68 MHÑSex Factors ANNIM; no qualif; largely statistical: see note under SEX CHARACTERISTICS; Manual 35.8.2, 35.8.3; relation to MALE, FEMALE: Manual 18.9.5 MNN1.224.816 LH  MSA glycoprotein migrating as a beta globulin, molecular weight 52,000 or 95,000-115,000, which indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, androestenediol and estradiol in the plasma. Changes in its concentration significantly affect the ratio of unbound (biologically active) testosterone to estradiol in plasma. PM77 HN77 MHÑSex Hormone-Binding Globulin AN/biosyn /physiol permitted; do not use /blood; does not refer to all sex hormones: refers to a specific protein in the blood binding only testosterone or estradiol; for other sex hormone-binding globulins consider ANDROGEN-BINDING PROTEINS & PROGESTERONE-BINDING GLOBULIN PIBeta Globulins (74-76); Glycoproteins (74-75); Protein Binding (74-75); Sex Hormones (74-76); specific sex hormone MND12.776.124.790.223.800; D12.776.377.715.182.800 XSEstradiol Binding Globulin; Testosterone Binding Globulin; Testosterone Estradiol Binding Globulin LH LS; ;  MHÑSex Hormones ANGEN; avoid: prefer specifics; do not use /analogs; /biosyn /physiol permitted MND6.472.866 LH  MSBooks used for sex education and procedural instruction. MHÑSex Manuals ANno qualif CATALOG: do not use /pop wks MNL1.178.682.192.609.666 LH  MSAchievement of full sexual capacity. Applies to animals and humans. PM75 HN75 MHÑSex Maturation ANhuman & animal; only /drug eff /rad eff PIPuberty (66-74) MNG7.553.809 LH  MSAny violation of established legal or moral codes in respect to sexual behavior. PM68 HN68 MHÑSex Offenses ANonly /class /hist /legis PICriminology (66-67); Paraphilias (66-67) MNI1.198.240.748 FXÑParaphilias LH LX  MSMethods for control of genetic sex of offspring. HN(75) MHÑSex Preselection ANonly /methods /vet; do not confuse with SEX DETERMINATION: determ is what the gene decides; preselection is the method to control the genetic sex MNE5.393.420.890 XSSex Predetermination DMÑGenetic Intervention LH LS LM  MSThe number of males per 100 females. PM68 HN68 MHÑSex Ratio ANno qualif PISex (66-67) MNG5.414.791; N1.224.935.780 FXÑVital Statistics LH LX  MSChange from one sex to another with regard to gonadal development; may be induced or occurs naturally in some invertebrates. PM73 HN73 MHÑSex Reversal, Gonadal ANno qualif PISex Determination (66-72) MNG8.520.920 FXÑGonads LH LX  MSRefraining from sexual intercourse. OLsearch CELIBACY under SINGLE PERSON 1966-67 HN(75); CELIBACY was heading 1963-67 MHÑSexual Abstinence ANno qualif; ╥celibacy╙ goes here MNF1.145.792.900 DMÑSex Behavior LH LM  MH*Sexual Reproduction Periods (Non MeSH) MNG8.520.940 LH  MSDiseases due to or propagated by sexual contact. OLuse SEXUALLY TRANSMITTED DISEASES to search VENEREAL DISEASES back thru 1966 PM87; was VENEREAL DISEASES 1963-86 HN87; was VENEREAL DISEASES 1963-86 MHÑSexually Transmitted Diseases ANGEN; prefer specific; not all genital diseases are venereal or sexually transm & not all sexually transm diseases are genital; contact tracing: SEXUALLY TRANSMITTED DISEASES /transm; DF: SEX TRANSM DIS CATALOG: form qualif = VENEREOLOGY /form MNC1.539.780 XSVenereal Diseases FXÑVenereology LH LS LX  MHÑSeychelles MNZ1.252.245.419.750 LH  MSA disease characterized by pruritic erythroderma and superficial lymphadenopathy. Atypical mononuclear cells are seen in the circulating blood and in the skin. Splenomegaly is common. PM79 HN79 MHÑSezary Syndrome ANspell in titles & transl with accent: Sezary PIDermatitis Exfoliativa (66-78); Keratosis Palmaris et Plantaris (74-78); Reticuloendotheliosis (66-78) MNC15.604.515.841; C20.683.515.920 LH  MSAn emotional attitude excited by realization of a shortcoming or impropriety. OLsearch GUILT 1966-74 HN(75) MHÑShame ANno qualif MNF1.470.483.666 DMÑGuilt LH LM  MSA condition in which two closely related persons, usually in the same family, share the same delusions. OLuse SHARED PARANOID DISORDER to search FOLIE A DEUX back thru 1968 PM81; was FOLIE A DEUX 1968-80 HN81; was FOLIE A DEUX 1968-80 MHÑShared Paranoid Disorder ANdo not use /drug eff /physiol /rad eff; spell FOLIE A DEUX as folie a deux (with accent) in translations; folie a trois goes here PIPsychotic Disorders (66-67) MNF3.709.680.700.810 XSFolie a Deux; Paranoid Disorder, Shared LH LS;  MHÑSharks ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.853 XUÑDogfish LH LU  MH*Sheathed Bacteria (Non Mesh) MNB3.800 LH  MHÑSheep ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.77.380.791 LH  MHÑSheep Diseases ANdo not use /compl /vet; don't forget also SHEEP (NIM) & check tag ANIMAL MNC22.836 XUÑBorder Disease; ÑSwayback LH LU;  MHÑShellfish ANas food; shellfish as animal = CRUSTACEA or MOLLUSCA; only /ad-poi-tox /anal /class /econ /rad eff /stand /supply MNJ1.341.872 FXÑClams; ÑCrabs; ÑCrayfish; ÑCrustacea; ÑLobsters; ÑMollusca; ÑMussels; ÑOysters; ÑSHRIMP LH LX; ; ; ; ; ; ; ;  MSA protective place of employment for disabled persons which provides training and employment on a temporary or permanent basis. PM67 HN67(65) MHÑSheltered Workshops ANdo not use /educ /methods MNN2.278.808.860 FXÑRehabilitation, Vocational LH LX  MHÑShigella ANGEN; do not use /blood-csf-urine; infection = DYSENTERY, BACILLARY & specify species if pertinent (NIM) MNB3.475.300.850 FXÑDysentery, Bacillary XUÑShigella Boydii LH LX LU  MSOne of the bacteria which produce bacillary dysentery. HN(72) MHÑShigella Boydii ANdo not use /blood-csf-urine; infection: coord NIM with DYSENTERY, BACILLARY (IM) PIShigella (66-71) MNB3.475.300.850.175 DMÑShigella LH LM  MHÑShigella Dysenteriae ANdo not use /blood-csf-urine; infection: coord NIM with DYSENTERY, BACILLARY (IM) MNB3.475.300.850.350 LH  MSA bacterium which is one of the etiologic agents of bacillary dysentery and sometimes of infantile gastroenteritis. PM74 HN74(72) MHÑShigella Flexneri ANdo not use /blood-csf-urine; infection: coord NIM with DYSENTERY, BACILLARY (IM) PIShigella (66-71) MNB3.475.300.850.450 LH  MSA lactose-fermenting bacterium causing dysentery. PM66 HN66(63) MHÑShigella Sonnei ANdo not use /blood-csf-urine; infection: coord NIM with DYSENTERY, BACILLARY (IM) MNB3.475.300.850.800 LH  MHÑShikimic Acid ANdo not use /defic /physiol RN138-59-0 MND2.241.223.268.792; D2.241.511.852 LH  OLsearch PASTEURELLA INFECTIONS 1966-74 HN(75) MHÑShipping Fever ANdo not use /vet but index also PASTEURELLA INFECTIONS /vet for IM; coord with CATTLE DISEASES (IM) + CATTLE (NIM) or SHEEP DISEASES (IM) + SHEEP (NIM); read Dorland on shipping fever (under fever) to explain see ref below MNC1.252.662.749 DMÑPasteurella Infections LH LM  MHÑShips ANsailors goes here if non-med (med = NAVAL MEDICINE); only /stand CATALOG: /geog /form MNJ1.937.817 FXÑNaval Medicine LH LX  PM70 HN70(64) MHÑShivering ANonly /drug eff /rad eff MNG7.315.232.542 FXÑCold LH LX  MHÑShock AN= ╥circulatory collapse╙; therapy of shock = SHOCK /ther, not SHOCK THERAPY (see ELECTROCONVULSIVE THERAPY), a psychother technic; note TOXIC SHOCK SYNDROME see SHOCK, SEPTIC is available MNC23.888.789 XSHypovolemic Shock LH LS  MSShock resulting from diminution of cardiac output in heart disease, as in myocardial infarction. PM71 HN71 MHÑShock, Cardiogenic PIMyocardial Infarction (66-70); Shock (66-70) MNC14.280.211.637.667; C23.888.789.488 LH  MHÑShock, Hemorrhagic ANHYPOVOLEMIC SHOCK does not go here: it is a see ref to SHOCK MNC23.542.857; C23.888.789.630 LH  MSShock due to circulatory insufficiency caused by gram-negative bacteremia. In rare instances caused by gram-positive but with different symptomatology. OLuse SHOCK, SEPTIC to search SHOCK, TOXIC back thru 1966 & SHOCK, ENDOTOXIC back thru 1968 PM77; was SHOCK, TOXIC 1963-76; SHOCK, ENDOTOXIC was heading 1968-76 HN77; was SHOCK, TOXIC 1963-76; SHOCK, ENDOTOXIC was heading 1968-76 MHÑShock, Septic MNC1.539.789; C23.888.789.680 XSShock, Endotoxic; Shock, Toxic; Toxic Shock Syndrome LH LS; ;  MHÑShock, Surgical MNC23.814.767; C23.888.789.701 LH  PMCRUSH SYNDROME was see under KIDNEY FAILURE, ACUTE 1967-78, was see under ACUTE RENAL FAILURE 1963-66 MHÑShock, Traumatic MNC21.866.797; C23.888.789.843 XUÑCrush Syndrome LH LU  MHÑShoes ANonly /adv eff /hist /stand; horseshoes may be indexed here but only as NIM MNJ1.193.750 LH  MSIn rabbits the virus causes subcutaneous localized swellings, usually on the feet. HN(75); was see under POXVIRUSES 1975-80 MHÑShope Fibroma Virus ANdo not use /blood-csf-urine /cytol; do not confuse with SHOPE PAPILLOMA VIRUS; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) MNB4.909.204.783.675; B4.909.574.204.800 XSFibromatosis Virus of Rabbits; Rabbit Fibroma Virus DMÑPoxviridae LH LS; LM  MSA DNA virus which is reported to occur naturally in cottontail rabbits in North America. HN(75); was see under PAPILLOMA VIRUSES 1975-77 MHÑShope Papilloma Virus ANdo not use /blood-csf-urine /cytol; do not confuse with SHOPE FIBROMA VIRUS; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) MNB4.909.204.585.460.700; B4.909.574.204.711.460.800 XSPapilloma Virus, Shope; Rabbit Papilloma Virus DMÑPapillomaviruses LH LS; LM  MSA malabsorption syndrome resulting from extensive operative resection of small bowel. HN(81) MHÑShort Bowel Syndrome PIMalabsorption Syndromes (66-80); Postoperative Complications (66-80); Syndrome (72-80) MNC6.405.469.637.832; C23.814.777 DMÑMalabsorption Syndromes LH LM  MSA syndrome inherited as an autosomal recessive trait and incompatible with life. The main features are narrow thorax, short ribs, scapular and pelvic dysplasia, and polydactyly. HN(85) MHÑShort Rib-Polydactyly Syndrome ANdo not use /congen; do not confuse X ref with NOONAN SYNDROME, the male Turner syndrome PIAbnormalities, Multiple (68-84); Fingers (66-84); Ribs (66-84) MNC5.116.99.708.857; C16.131.77.850; C16.131.621.820 XSMajewski Syndrome; Saldino-Noonan Syndrome DMÑOsteochondrodysplasias LH LS; LM  MSThe use of focused short radio waves to produce local hyperthermia in an injured person or diseased body area. OLsearch DIATHERMY 1966-74 HN(75) MHÑShort-Wave Therapy ANdo not use /util except by MeSH definition MNE2.780.480.280.853 DMÑDiathermy LH LM  MHÑShorthand ANno qualif MNL1.143.506.423.906.539.750 LH  PMSHOULDER ARTHROSES was heading 1963-64 HNSHOULDER ARTHROSES was heading 1963-64 MHÑShoulder ANany Cat A qualif; TN 117: use for human & other vertebrates; TN 238: differentiation from SHOULDER JOINT & indexing instructions MNA1.378.209.749 LH  MHÑShoulder Dislocation ANdisloc of humerus from shoulder joint; acromioclavicular disloc = ACROMIOCLAVICULAR JOINT + DISLOCATIONS MNC21.866.88.666; C21.866.289.750 LH  MSFractures of the proximal humerus, including the head, anatomic and surgical necks, and tuberosities. MHÑShoulder Fractures ANrefers to SHOULDER, not SHOULDER JOINT; restricted to fract of proximal humerus (head, neck, tuberosities): do not confuse with HUMERAL FRACTURES (non-head, etc.) MNC21.866.88.749; C21.866.405.727 LH  PM65; SHOULDER ARTHROSES was heading 1963-64 HN65; SHOULDER ARTHROSES was heading 1963-64 MHÑShoulder Joint ANany Cat A qualif; TN 117: use for human & other vertebrates; TN 238: differentiation from SHOULDER & indexing instructions MNA2.835.583.748 LH  MSA syndrome characterized by pain and stiffness in the shoulder and hand with trophic changes in the latter. It is seen most commonly with myocardial infarction but is also associated with trauma, cervical vertebral disease, arm immobilization,etc. MHÑShoulder-Hand Syndrome MNC5.550.808 FXÑReflex Sympathetic Dystrophy LH LX  MS3-beta-D-Ribofuranosylmaleimide. Antineoplastic antibiotic isolated from Streptomyces showdoensis. Possibly active also as a sulfhydryl reagent. HN(75) MHÑShowdomycin ANdo not use /defic /physiol; /analogs NIM only RN16755-07-0 PIAntibiotics, Antineoplastic (71-74); Maleimides (74); Ribonucleosides (73-74) MND13.570.800.810; D20.85.75.800; D22.204.106.820 DMÑAntibiotics, Antineoplastic LH LM  PM72 HN72 MHÑShrews ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not confuse SHREWS (insectivore) with TREESHREWS (prosimian) PIInsectivora (66-71) MNB2.649.473.751 LH  MSVarious species of mostly marine crustaceans of the order Decapoda with ten legs and long abdomen; includes shrimp as food. PM72 HN72 MHÑShrimp ANas animal & as food; IM; /microbiol /parasitol permitted PICrustacea (66-71) MNB1.131.365.844 FXÑShellfish LH LX  MSA two-stage reaction in which a first encounter with endotoxin produces intravascular fibrin thrombi whose clearance results in reticuloendothelial blockade which prevents the clearance of thrombi caused by a second encounter with endotoxin, resulting in tissue necrosis and/or hemorrhage. In pregnancy gram-negative septicemia during delivery or abortion may serve as the first or provocative encounter. The phenomenon is non-immunologic and is known to occur only in rabbits and man. MHÑShwartzman Phenomenon ANnote spelling: SH-, one -N; note category MNC15.378.463.134.793 LH  MSA progressive degenerative disease of the central and autonomic nervous systems characterized by orthostatic hypotension, urinary and fecal incontinence, anhidrosis, external ophthalmoplegia, generalized weakness, muscle wasting, tremors, and impotence. HN(81) MHÑShy-Drager Syndrome PIHypotension, Orthostatic (66-80); Nervous System Diseases (66-80) MNC10.120.853; C14.907.514.482.853 DMÑAutonomic Nervous System Diseases LH LM  MSDiscomfort and partial inhibition of the usual forms of behavior when in the presence of others. PM87 HN87 MHÑShyness ANno qualif MNF1.145.800 XSTimidity LH LS  OLsearch SALIVARY GLAND DISEASES 1966-74 HN(75) MHÑSialadenitis ANsalivary gland inflammation, also called sialitis; tuberc sialitis: coord IM with TUBERCULOSIS, ORAL (IM) MNC7.465.815.793 DMÑSalivary Gland Diseases LH LM  MSA group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues. OLsearch NEURAMINIC ACIDS 1966-74 PM75; was see under NEURAMINIC ACIDS 1963-74 HN75; was see under NEURAMINIC ACIDS 1963-74 MHÑSialic Acids ANdo not use /analogs PINeuraminic Acids (66-74) MND9.203.67.687.668; D9.203.811.589.668; D2.241.81.844.562.668; D2.241.511.902.562.668 XSN-Acetylneuraminic Acids XUÑCytidine Monophosphate N-Acetylneuraminic Acid LH LS LU  MSGlycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities. PM77 HN77 MHÑSialoglycoproteins AN/biosyn /physiol permitted; do not use /analogs; glycoproteins containing sialic acid: do not confuse with SALIVARY PROTEINS, proteins found in saliva; ASIALOGLYCOPROTEINS is available PIGlycopeptides (73-76); Glycoproteins (66-76); Neuraminic Acids (66-74); Sialic Acids (75-76) MND12.644.233.800; D12.776.395.700 XSSialoglycopeptides; Sialoproteins XUÑGlycophorin LH LS; LU  PM65 HN65 MHÑSialography ANNIM; do not use /util except by MeSH definition MNE1.184.791; E1.262.751; E1.818.782; E6.342.764.793 LH  MSA benign, inflammatory, variably ulcerated, occasionally bilateral, self-healing lesion of the minor salivary glands that is often confused clinically and histologically with carcinoma. HN(83) MHÑSialometaplasia, Necrotizing PIMetaplasia (66-82); Necrosis (66-82); Salivary Gland Diseases (66-82); Salivary Glands (66-82); Salivary Glands, Minor (79-82) MNC7.465.815.802 XSNecrotizing Sialometaplasia DMÑSalivary Gland Diseases LH LS LM  MSIncreased salivary flow. OLsearch SALIVARY GLAND DISEASES 1966-74 PM77; was see under SALIVARY GLAND DISEASES 1965-74 HN77; was see under SALIVARY GLAND DISEASES 1965-74 MHÑSialorrhea AN╥increased salivary flow╙ PISalivary Gland Diseases (66-76); Salivation (66-76) MNC7.465.815.815 XSDrooling; Hypersalivation FXÑSalivation LH LS; LX  MSCMP-N-acetylneuraminate:D-galactosylglycoprotein N-acetylneuraminyl transferase. Catalyzes the transfer of N-acetylneuraminic acid from CMP-N-acetylneuraminic acid to the terminal sugar residue of a ganglioside or glycoprotein releasing free CMP. OLuse SIALYLTRANSFERASES to search SIALYLTRANSFERASE back thru 1975 PM87; was see under TRANSFERASES 1979-86, was SIALYLTRANSFERASE see under TRANSFERASES 1975-78 HN87(79); was see under TRANSFERASES 1979-86, was SIALYLTRANSFERASE see under TRANSFERASES 1975-78 MHÑSialyltransferases ANdo not use /analogs PINeuraminic Acids (72-74); Transferases (72-74) MND8.586.913.770 XSGlycoprotein Sialyltransferases LH LS  OLuse SIBERIA to search RUSSIAN FEDERATION (ASIA) back thru 1967; use SIBERIA & RUSSIAN S.F.S.R. to search RUSSIAN FEDERATION 1966; search RUSSIA under RUSSIA (PRE-1917) 1966 HN82; was RUSSIAN FEDERATION (ASIA) 1967-81; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66 MHÑSiberia ANManual 36.12 MNZ1.252.878.890; Z1.950.820.890 XSRussian S.F.S.R., Asian LH LS  MSInteractions and relationships between sisters and/or brothers. Also applies to animal studies. PM68 HN68 MHÑSibling Relations ANhuman & animal; no qualif PIChild Psychology (66-67); Parent-Child Relations (66-67) MNF1.829.263.370.450 LH  HN70 MHÑSicily PIItaly (66-69) MNZ1.542.489.751 LH  MSBehavior patterns consistent with those expected of an individual functioning in a state of ill health. PM71 HN71 MHÑSick Role ANno qualif PIRole (69-70) MNF1.829.316.616.751 XSILLNESS BEHAVIOR FXÑAttitude to Health LH LS LX  MSDysfunction of the sinoatrial node manifested by persistent sinus bradycardia, sinus arrest, sinoatrial exit block, chronic atrial fibrillation and inability of the heart to resume sinus rhythm following cardioversion for atrial fibrillation. PM80 HN80 MHÑSick Sinus Syndrome ANsinus refers to sinoatrial node PIArrhythmia, Sinus (66-79) MNC14.280.67.829 LH  MSThe condition of being heterozygous for hemoglobin S. OLsearch ANEMIA, SICKLE CELL 1966-74 HN(75) MHÑSickle Cell Trait MNC15.378.71.141.150.150.670; C15.378.420.155.668 DMÑAnemia, Sickle Cell LH LM  MHÑSiderosis ANdo not use /chem ind; do not coord with OCCUPATIONAL DISEASES MNC8.381.655.773; C11.204.855; C21.447.800.773 FXÑHemosiderin; ÑHemosiderosis LH LX;  MHÑSierra Leone MNZ1.58.432.814 LH  MSA protein which is a subunit of RNA polymerase. It effects initiation of specific RNA chains from DNA. HN(77) MHÑSigma Factor AN/biosyn /physiol permitted; do not use /analogs PIBacterial Proteins (73-76); Proteins (66-76); Transcription, Genetic (73-76) MND12.776.930.800 XSSigma Initiation Factor; Sigma Subunit DMÑTRANSCRIPTION FACTORS LH LS; LM  MHÑSigmoid ANsigmoiditis = SIGMOID DISEASES (IM) + COLITIS (NIM) but note PROCTOSIGMOIDITIS see PROCTOCOLITIS & RECTOSIGMOIDITIS see PROCTOCOLITIS; diverticulosis & diverticulitis: see note below MNA3.492.411.495.356.668 LH  PM80 HN80 MHÑSigmoid Diseases ANinflamm dis: coord IM with COLITIS (NIM) but note PROCTOSIGMOIDITIS see PROCTOCOLITIS & RECTOSIGMOIDITIS see PROCTOCOLITIS; diverticula & diverticulosis: coord IM with DIVERTICULOSIS, COLONIC (IM); diverticulitis: coord IM with DIVERTICULITIS, COLONIC (IM) PIColonic Diseases (66-79); specific colonic disease; Sigmoid (66-79); specific intestinal disease MNC6.405.469.158.850 LH  MHÑSigmoid Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.274.476.411.306.668; C6.405.469.158.850.850 LH  MSEndoscopic examination of the sigmoid flexure. MHÑSigmoidoscopy ANNIM; do not use /util except by MeSH definition MNE1.184.200.890; E1.418.213.890 XSPROCTOSIGMOIDOSCOPY LH LS  MSA system of hand gestures used for communication by the deaf or by people speaking different languages. OLsearch MANUAL COMMUNICATION 1974 HN(75)63-65 MHÑSign Language ANno qualif MNE2.831.671.609.668; F1.145.209.530.702.668; L1.143.649.526.668 DMÑManual Communication LH LM  MSAdditional polypeptide sequence of 25 to 30 residues at the amino-terminal end of proteins. They direct the protein to its ultimate destination in the cell. These leaders are recognized by the signal recognition particle and bound by specific receptor sites on the outer surface of the endoplasmic reticulum. They are then transported into the cisterna of the endoplasmic reticulum and from there directed to their ultimate destination in the cell. In prokaryotes, the signal peptides attach to the plasma membrane. These signal sequences are ultimately removed by specific peptidases. PM86 HN86 MHÑSignal Peptides ANdo not use /analogs /defic PIPeptides (66-85) MND12.644.835 XSLeader Signal Peptides; Signal Sequences, Peptides LH LS;  MSComputer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity in physiological studies. PM87 HN87 MHÑSignal Processing, Computer-Assisted ANIM; no qualif MNL1.700.568.110.800 XSDigital Signal Processing; Signal Processing, Digital FXÑFetal Monitoring; ÑMonitoring, Physiologic LH LS; LX;  OLpre-explosion = SIGNS AD SYMPTOMS (PX) MH*Signs and Symptoms (Non Mesh) MNC23.888 LH  OLconsider also specific digestive diseases in C6 MH*Signs and Symptoms, Digestive (Non Mesh) MNC23.888.821 LH  OLconsider also RESPIRATORY TRACT DISEASES & all specifics in C8 MH*Signs and Symptoms, Respiratory (Non Mesh) MNC23.888.852 LH  HN75 MHÑSikkim MNZ1.252.245.393.750 LH  HN(64) MHÑSilage ANonly /ad-poi-tox /anal /econ /rad eff /stand /supply MNJ1.341.52.793 DMÑAnimal Feed LH LM  MSCompounds similar to hydrocarbons in which tetravalent silicon atom replaces the carbon atom. They are very reactive, ignite in air and form useful derivatives. HN(75) MHÑSilanes ANdo not use /analogs /biosyn /defic /physiol PISilicon (66-74) MND1.836.700 XSHydrosilicons; Silicans; Silicohydrides DMÑSilicon LH LS; ; LM  PMQUARTZ was heading 1963-64 MHÑSilica ANdo not confuse with SILICON; includes oxides of silicon; do not use /biosyn /defic /physiol; TN 172: differentiation among silic- terms RN7631-86-9 MND1.578.750; D1.655.498.738; D1.836.751 XUÑKieselguhr; ÑQuartz; ÑSilicic Acid LH LU; ;  PM65 HN65 MHÑSilicate Cement AND25-26 qualif RN1327-39-5 MND25.339.291.618 LH  OLsearch SILICA 1966-74 HN(75) MHÑSilicic Acid ANdo not use /biosyn /defic /physiol RN1343-98-2 MND1.836.751.793 DMÑSilica LH LM  MHÑSilicon ANSi-28; do not confuse with SILICA or SILICONES; TN 172: differentiation among silic- terms; do not use /analogs /biosyn /defic /physiol; Si-29, 30 = SILICON (IM) + ISOTOPES (NIM); Si-26, 27, 31, 32 = SILICON (IM) + RADIOISOTOPES (IM); lung dis from various silicon dusts = SILICOSIS RN7440-21-3 MND1.268.796; D1.836; D1.937.782 FXÑAsbestos XUÑSilanes; ÑTrimethylsilyl Compounds LH LX LU;  PM72 HN72 MHÑSilicone Elastomers AND25-26 qualif; TN 172: differentiation among silic- terms; for prosthetic implants do not use /ther use MND1.836.820.800.750; D25.720.840.849; D25.845.751 XSElastomers, Silicone; RUBBER, SILICONE; Silastics FXÑDental Impression Materials; ÑDenture Liners LH LS; ; LX;  MSOrganic siloxanes which are polymerized to the oily stage. The oils have low surface tension and density less than 1. They are used in industrial applications and in the treatment of retinal detachment, complicated by proliferative vitreoretinopathy. PM87 HN87 MHÑSilicone Oils ANonly /ad-poi-tox /anal /class /rad eff /stand /supply PISilicones (66-86) MNJ1.740.750 LH  MHÑSilicones AND25-26 qualif; TN 172: differentiation among silic- terms; do not confuse with SILICON MND1.836.820; D25.845 XUÑDimethylpolysiloxanes; ÑSiloxanes; ÑSimethicone LH LU; ;  MHÑSilicosis ANdo not use /chem ind for dust causing this dis: use /etiol; note term below but ANTHRACOSILICOSIS is also available; do not coord with OCCUPATIONAL DISEASES MNC8.381.655.845; C21.447.800.834 LH  MHÑSilicotuberculosis ANdo not use /chem ind; do not coord with OCCUPATIONAL DISEASES MNC1.252.40.552.846.899.669; C8.381.655.845.752; C8.381.922.669; C8.730.939.669; C21.447.800.834.752 LH  MHÑSilkworms ANIM; /microbiol /parasitol permitted MNB1.131.617.561.650.669 XSBOMBYX LH LS  MSPneumonia or bronchiolitis caused by inhalation of nitrogen dioxide released by silage. HN(64) MHÑSilo Filler's Disease ANdo not use /chem ind MNC8.381.846; C21.447.80.752 DMÑLung Diseases LH LM  MSSilicon polymers that contain alternate silicon and oxygen atoms in linear or cyclic molecular structures. HN(75) MHÑSiloxanes AND25-26 qualif; do not use /analogs /biosyn /defic /physiol PISilicones (68-74) MND1.836.820.800; D25.845.760 DMÑSilicones LH LM  MHÑSilver ANAg-107; do not use /analogs /biosyn /defic /physiol; /pois = ARGYRIA; Ag-109 = SILVER (IM) + ISOTOPES (NIM); Ag-102-106, 108, 110-117 = SILVER (IM) + RADIOISOTOPES (IM) RN7440-22-4 MND1.248.497.300.459.824; D1.268.803; D1.552.804 LH  MHÑSilver Nitrate ANdo not use /analogs /biosyn /defic /physiol RN7761-88-8 MND1.552.804.669; D1.620.754.399.669; D1.655.498.565.399.669 LH  MHÑSilver Proteins ANdo not use /analogs /biosyn /defic /physiol MND1.552.804.794; D12.776.884; D20.187.776 LH  MSN(1)-2-Pyrimidinylsulfanilanide, monosilver salt. Antibacterial used topically in burn therapy; may also have antiviral and antifungal activity. Synonym: Silvadene. HN(77) MHÑSilver Sulfadiazine ANdo not use /biosyn /defic /physiol RN22199-08-2 PISilver (66-76); Sulfadiazine (66-76) MND2.65.884.725.755.800; D2.886.590.700.725.755.800; D20.890.725.755.855 DMÑSulfadiazine LH LM  MS2-[trans-2-(4-Hydroxy-3-methoxyphenyl)-3-hydroxymethyl-1,4-benzodioxan-6-yl]-3,5,7-trihydroxychroman-4-one. A crystalline flavanolol from Silybum marianum; possibly of use in liver therapy. Synonym: Legalon. HN(75) MHÑSilymarin ANdo not use /defic /physiol; /analogs NIM only RN22888-70-6 PIFlavones (71-74); Alcohols (71-74) MND3.438.150.266.450.700 XSSilybin DMÑFlavones LH LS LM  HN(72) MHÑSimazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN122-34-9 PIHerbicides (66-71); Triazines (66-71) MND3.383.931.819; D5.723.366.477.834 DMÑHerbicides, Triazine LH LM  MSArboviruses of the bunyavirus genus that are found in Asia, Africa, and the Americas. OLsearch BUTTONWILLOW VIRUS under ARBOVIRUSES 1975-76 HN(75); was see under ARBOVIRUSES 1975-80, BUTTONWILLOW VIRUS was see ARBOVIRUSES 1975-76 MHÑSimbu Group Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with BUNYAVIRUS INFECTIONS (IM) MNB4.909.777.147.855 XSSabo Virus; Sango Virus DMÑBunyaviridae LH LS; LM  MSA mixture of dimethyl polysiloxanes and silica gel. Is used as an antiflatulent. Without the addition of silica gel (dimethicone) it is used as an ointment base ingredient and skin protectant. HN(75) MHÑSimethicone AND25-26 qualif; /analogs NIM only RN8050-81-5 PISilicones (72-74) MND1.836.820.800.200.750; D19.316.890; D25.845.760.200.890; D26.368.405.890 XSDimethicone DMÑSilicones LH LS LM  MSRNA viruses with C-type particles, producing tumors in primates. HN(78); was see under LEUKOVIRUSES 1978-80 MHÑSimian Sarcoma Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with SARCOMA, EXPERIMENTAL (IM) PIC-Type Viruses (72-77); Oncogenic Viruses (66-77) MNB4.909.574.807.810; B4.909.777.731.810 XSWoolly Monkey Virus DMÑRetroviridae LH LS LM  MSSeveral species of the genus Simulium (family Simuliidae) are intermediate hosts (vectors) for the parasitic disease, onchocerciasis. PM84 HN84 MHÑSimuliidae AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 PIDiptera (66-83) MNB1.131.617.289.800 XSBlack Flies; Simulium LH LS;  MS1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L- methionine-caerulein. The eight amino acid carbon terminal fragment and physiologically active portion of the cholecystokinin-pancreozymin molecule; it stimulates the GI tract, especially gall bladder and pancreas, and has many, often depressant, effects on the CNS. It is used to diagnose gall bladder disease and also proposed as anorexic. Synonym: L-alpha -asp-O-sulfo-L-tyr-L-met-gly-L-trp-L-met-L- alpha-asp-L-phe amide. PM84 HN84 MHÑSincalide ANdo not use /biosyn /defic /physiol; do not confuse with Sincaline ( = CHOLINE) RN25126-32-3 PICholecystokinin (66-83); Oligopeptides (73-78); Peptide Fragments (79-83); Peptides (66-72) MND6.472.317.152.700; D12.644.120.700; D16.538.198.850; D19.316.325.850; D19.316.629.159.850 XSCCK-8; Cholecystokinin Octapeptide LH LS;  MSAn Alphavirus (group A arbovirus) normally transmitted to birds by Culex mosquitoes in Egypt, South Africa, India, Malaya, the Philippines and Australia; may be associated with fever in man. PM73 HN73(71) MHÑSindbis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TOGAVIRUS INFECTIONS (IM) PIArboviruses (66-70) MNB4.909.777.923.54.860 LH  MHÑSingapore MNZ1.252.145.774 LH  MSThe unmarried man or woman, widow or widower. PM68 HN68 MHÑSingle Person ANonly /psychol; does not include ╥celibacy╙ (index SEXUAL ABSTINENCE); ╥unwed parent╙ = PARENTS (IM) + ILLEGITIMACY (IM); ╥single parent╙ = PARENTS (IM) + SINGLE PERSON (IM) PIIllegitimacy (66-67); Marriage (66-67) MNF1.829.263.315.794; I1.880.225.423.794; M1.785; N1.824.308.794 XSWidow; Widower LH LS;  MSDisturbance of heart conduction in which the atrial response is delayed or ommitted because of partial or complete interference with the propagation of impulses from the sinoatrial node to the atria. HN(75) MHÑSinoatrial Block MNC14.280.67.558.750 DMÑHeart Block LH LM  MSThe small mass of modified cardiac muscle fibers located at the junction of the superior vena cava and right atrium. Contraction impulses probably start in this node, spread over the atrium and are then transmitted by the atrioventricular bundle to the ventricle. OLuse SINOATRIAL NODE to search SINO-ATRIAL NODE back thru 1966 (as Prov 1966-69) PM78; was SINO-ATRIAL NODE 1970-77 HN78; was SINO-ATRIAL NODE 1964-77 (Prov 1964-69) MHÑSinoatrial Node ANdo not use /blood supply /innerv MNA7.541.409.819 LH  MSThe dilatation of the aortic wall behind each of the cusps of the aortic valve. PM79 HN79 MHÑSinus of Valsalva ANaneurysm: coord IM with AORTIC ANEURYSM (IM); ruptured aneurysm of sinus: coord IM with AORTIC RUPTURE (IM) MNA7.231.114.56.847 XSAortic Sinus LH LS  MHÑSinus Thrombosis MNC10.228.140.300.378.669; C14.907.253.378.586; C14.907.854.213.669 XSCRANIAL SINUS THROMBOSIS LH LS  MHÑSinusitis ANIM; coord with specific paranasal sinus (NIM) MNC8.730.749; C9.692.752 LH  MS0-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L- arabinopyranosyl-(1,4)-0-[2,6-diamino-2,3,4,6- tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl- (1,6)]-2-deoxy-L-streptamine. Antibiotic produced by Micromonospora inyoensis. Synonyms: Antibiotic 6640; Extramycin; Pathomycin; Rickamicin; SCH 13475; Siseptin. PM84; was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77 HN84(75); was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77 MHÑSisomicin ANdo not use /defic /physiol RN32385-11-8 PIAminoglycosides (74); Antibiotics (66-74); Glycosides (66-73) MND9.203.408.51.374.785; D20.85.369.785 XSSisomycin; Sissomicin LH LS;  MSAn aberrant crossing over event in which there is an exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. It can be induced by ultraviolet and ionizing radiation or by mutagenic agents and is observed by autoradiography. PM85; was see under CROSSING OVER (GENETICS) 1980-84 HN85(80); was see under CROSSING OVER (GENETICS) 1980-84 MHÑSister Chromatid Exchange ANonly /drug eff /rad eff PIChromatids (68-79); Chromosome Aberrations (68-79); Crossing Over (Genetics) (68-79); Cytogenetics (67); Genetics (66) MNG5.148.301.840; G5.832.260.840 LH  PM74 HN74(72) MHÑSitosterols ANplant sterols; do not use /analogs /defic /physiol PIEstrogens (66-71); Sterols (66-71) MND4.808.247.222.857; D4.808.247.808.756.669 LH  MS4-Acetamido-4'-isothiocyanatostilbene- 2,2'-disulfonic acid. A non-penetrating amino reagent which acts as an inhibitor of anion transport in erythrocytes and other cells. HN(80) MHÑSITS AN = Stilbene IsoThiocyanate diSulfonic acid; do not use /biosyn /defic /physiol; /analogs NIM only RN27816-59-7 PIStilbenes (66-79); Thiocyanates (66-75) MND2.241.866.753.800; D2.455.426.559.389.724.800 XS4-Acetamido-4'-Isothiocyanatostilbene-2,2' -Disulfonic Acid DMÑStilbenes LH LS LM  MHÑSitus Inversus ANdo not use /congen MNC16.131.810 LH  MSThe sensory interpretation of the dimensions of objects. MHÑSize Perception ANonly /drug eff /physiol /rad eff MNF2.463.593.725; F2.463.593.932.869.794 LH  MHÑSjogren's Syndrome ANin translations, use diacrit: Sjogren; do not confuse with SJOGREN-LARSSON SYNDROME above MNC5.550.114.154.774; C5.799.114.774; C7.465.815.929.669; C11.496.719; C20.111.199.774; C23.205.200.732.99.774 LH  MSThe common name for all members of the Rajidae family. Skates and Rays are members of the same order. Skates have weak electric organs. HN(87) MHÑSkates (Fish) ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.378.682 XSRaja DMÑElectric Fish LH LS LM  MSUsing ice skates or roller skates in racing or other competition or for recreation. HN(76) MHÑSkating ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); Manual 30.31+ PISports (66-75) MNI3.450.642.845.700 XSIce Skating; Skateboarding DMÑSports LH LS; LM  HN(64) MHÑSkatole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN83-34-1 MND3.438.473.808 XS3-Methylindole DMÑIndoles LH LS LM  MHÑSkeleton ANthe bony frame as a whole; avoid: use BONE AND BONES; ╥skeletal╙ in titles is probably ╥bone╙, ╥bone tissue╙ or ╥osseous╙ which = BONE AND BONES: TN 173; no qualif MNA2.835 LH  MSUsually destitute, homeless persons who drink excessively and live in low socio-economic areas of the city known as Skid Row. PM76; was see under ALCOHOLISM 1975 HN76(73); was see under ALCOHOLISM 1975; was in Cat F & M 1975-80, was in Cat F, I & M 1973-74 MHÑSkid Row Alcoholics ANonly /psychol PIAlcoholism (66-72) MNM1.325.800 FXÑAlcoholism LH LX  MSA snow sport which utilizes skis to glide over the snow. Does not include water skiing. MHÑSkiing ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); does not include water-skiing (index under SPORTS) MNI3.450.642.845.775 LH  MSExtended care facilities which provide skilled nursing care or rehabilitation services for inpatients on a daily basis. OLuse SKILLED NURSING FACILITIES to search EXTENDED CARE FACILITIES back thru 1968 PM79; was EXTENDED CARE FACILITIES 1968-78 HN79; was EXTENDED CARE FACILITIES 1968-78 MHÑSkilled Nursing Facilities ANdo not use /educ PIHospitals (66-67) MNN2.278.825.610.770 XSExtended Care Facilities LH LS  PM/transplantation was SKIN TRANSPLANTATION 1963-65 HN/transplantation was SKIN TRANSPLANTATION 1963-65 MHÑSkin AN/drug eff: consider also DERMATOLOGIC AGENTS; transpl: consider also SURGICAL FLAPS but see note there; do not coord with TRANSPLANTATION, AUTOLOGOUS unless particularly discussed; for animal tissue in wound ther see note on BIOLOGICAL DRESSINGS; inflammation = DERMATITIS & its specifics; dryness of skin: index under SKIN DISEASES & do not interpret as XERODERMA see ICHTHYOSIS without clues from text; prickly heat: index under MILIARIA; consider also terms under CUTAN- & DERM- or DERMAT- CATALOG: form qualif = DERMATOLOGY /form; do not use /pop wks ( = DERMATOLOGY /pop wks) MNA1.835 LH  OLconsider also SKIN /AB MH*Skin Abnormalities (Non Mesh) MNC16.131.831 LH  PM65 HN65 MHÑSkin Absorption ANonly /drug eff /rad eff MNG10.795.633 XSABSORPTION, SKIN FXÑAdministration, Cutaneous; ÑAdministration, Topical LH LS LX;  PM68 HN68 MHÑSkin Appendage Diseases ANIM: GEN & unspecified only; NIM coord for dis of SEBACEOUS GLANDS (IM) PIspecific skin appendage disease MNC17.805 LH  PM65; was see under DERMATOLOGY 1963-64 HN65; was see under DERMATOLOGY 1963-64 MHÑSkin Diseases ANGEN: prefer specifics; ╥dermatoses╙ = SKIN DISEASES or specific precoord skin dis term but is sometimes used loosely for ╥dermatitis╙, strictly speaking an inflamm dis; /drug ther: consider also DERMATOLOGIC AGENTS; inflamm dis = DERMATITIS & its specifics; dryness of skin goes here: do not interpret as XERODERMA see ICHTHYOSIS without clues from text; also available are FACIAL DERMATOSES, FOOT DERMATOSES, HAND DERMATOSES, LEG DERMATOSES & SCALP DERMATOSES CATALOG: form qualif = DERMATOLOGY /form MNC17 FXÑDermatology XUÑAcantholysis; ÑFavre-Racouchot Syndrome; ÑPoikiloderma Congenitale LH LX LU; ;  MSSkin diseases characterized by bullous eruptions. OLto search ERYTHRODERMA ICHTHYOSIFORME use ICHTHYOSIS & SKIN DISEASES, BULLOUS 1975-78 & ICHTHYOSIS 1966-74 PM76; ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78 HN76; was NON MESH before 1976; ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78 MHÑSkin Diseases, Bullous ANsubcorneal pustular dermatosis goes here PIspecific skin disease MNC17.816 XSBullous Skin Diseases; Erythroderma Ichthyosiforme, Bullous XUÑHerpes Gestationis; ÑPemphigoid, Benign Mucous Membrane; ÑPemphigoid, Bullous LH LS; LU; ;  OLconsider also SKIN DISEASES /FG or /FG with specific skin dis MH*Skin Diseases, Genetic (Non Mesh) MNC17.827 LH  MSSkin diseases caused by bacteria, fungi, or viruses. PM68 HN68 MHÑSkin Diseases, Infectious ANIM; coord with specific infect dis (IM) + site (NIM) but note precoord site terms in note under SKIN DISEASES above; largely bact & viral infectious skin dis: parasitic = SKIN DISEASES, PARASITIC, fungal = DERMATOMYCOSES PIspecific skin disease MNC1.539.800; C17.838 FXÑPOXVIRUS INFECTIONS LH LX  MH*Skin Diseases, Metabolic (Non Mesh) MNC17.849 LH  MSSkin diseases caused by arthropods, helminths, or protozoa. PM68 HN68 MHÑSkin Diseases, Parasitic ANIM; coord with specific parasitic dis (IM) + site (NIM) but note precoord site terms in note under SKIN DISEASES above; note ECTOPARASITIC INFESTATIONS below for parasites on or within the skin PIParasitic Diseases (66-67); Skin Diseases (66-67) MNC3.858; C17.860 FXÑEctoparasitic Infestations LH LX  MSDermatologic disorders attendant upon systemic, non-dermatologic disease. PM65 HN65 MHÑSkin Manifestations ANskin manifest of non-skin diseases; avoid: prefer more specific skin dis terms; no qualif; Manual 23.36+; TN 239: differentiation from SKIN DISEASES & when not to use MNC17.871; C23.888.885 LH  MHÑSkin Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with site (NIM) if merely locational or omitted if irrelevant + histol type of neopl (IM) MNC4.588.805; C17.882 LH  OLconsider also SKIN /PH MH*Skin Physiology (Non Mesh) MNG10.795 LH  MSColoration of the skin. OLsearch PIGMENTATION 1966-74 PM76; was see under PIGMENTATION 1963-75 HN76(75); was see under PIGMENTATION 1963-75 MHÑSkin Pigmentation ANonly /drug eff /genet /rad eff PIPigmentattion (66-74) MNE1.706.760.670; G4.185.672.890; G10.795.704 LH  PM70 HN70 MHÑSkin Temperature ANonly /drug eff /rad eff PIBody Temperature (66-69); Skin (66-69) MNG7.315.753; G10.795.775 LH  MSEpicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. MHÑSkin Tests ANNIM; only /instrum /methods /vet MNE1.223.495.862; E1.862 XUÑIntradermal Tests; ÑKveim Test; ÑPatch Tests LH LU; ;  MHÑSkin Ulcer MNC17.893 FXÑUlcer LH LX  PM70 HN70(67) MHÑSkin Window Technic ANIM; no qualif CATALOG: do not use /laboratory manuals PIInflammation (66) MNE5.478.877 LH  PM73 HN73(68) MHÑSkinfold Thickness ANno qualif PIObesity (66-67); Skin (66-67) MNE1.706.886 FXÑObesity LH LX  MHÑSkull ANbony part of head only: differentiate from HEAD & FACE; /anat: consider also CEPHALOMETRY (living skull) & CRANIOMETRY (dead skull); /inj: TN 96 (relation to HEAD INJURIES), Bull 93 (Jan 77): various types of head & skull inj; ╥cranio-cerebral inj╙ goes under BRAIN INJURIES only & not also here unless particularly discussed; ╥craniofacial dysmorphism╙: index under FACIAL BONES /abnorm + SKULL /abnorm but not also under ABNORMALITIES, MULTIPLE; /surg: consider also CRANIOTOMY & TREPHINING; ╥cranial╙ is SKULL, ╥intracranial╙ is probably BRAIN, not SKULL MNA2.835.232.781 XSCRANIUM FXÑIntracranial Pressure; ÑTREPHINING XUÑCranial Fossa, Posterior; ÑCranial Sutures LH LS LX; LU;  MHÑSkull Fractures ANIM; general or as coord IM for fract of specific bones of skull /inj (IM); Bull 93 (Jan 77) MNC21.866.405.762; C21.866.460.836 XUÑOrbital Fractures LH LU  MHÑSkull Neoplasms ANof bony part of skull only: do not confuse with HEAD AND NECK NEOPLASMS or FACIAL NEOPLASMS; ╥intracranial tumors╙ is probably BRAIN NEOPLASMS, not SKULL NEOPLASMS; GEN: prefer specifics; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.149.721; C5.116.231.754 LH  MSOmnivorous New World mammals showing typical warning coloration of patterned black and white and able to eject a malodorous secretion when the animal is startled or in danger. HN(75) MHÑSkunks ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.147.875 DMÑCarnivora LH LM  MSA readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. MHÑSleep ANonly /drug eff /physiol /rad eff; sleep walking = SOMNAMBULISM MNF2.830.855; G11.561.826 LH  MSDisorders involving apneic episodes during sleep; may be due to cessation of diaphragmatic movement, obstruction of upper airway air flow, or a combination of these; may be associated with hypersomnolence, insomnia, or obesity. PM80 HN80 MHÑSleep Apnea Syndromes AN╥apneic episodes during sleep╙; DF: SLEEP APNEA PIApnea (66-79); Hypoventilation (66-79); Sleep (66-79); Sleep Disorders (66-79) MNC8.618.85.852 XSApnea, Central; Apnea, Obstructive; Apnea, Sleep; Hypersomnia with Periodic Respiration; Hypoventilation, Central Alveolar; Ondine's Curse LH LS; ; ; ; ;  MSThe condition of being deprived of sleep either under experimental or under unusual real life conditions, as distinguished from being unable to sleep. PM67 HN67(64) MHÑSleep Deprivation ANonly /physiol; being deprived of sleep or prevented from sleeping: do not confuse with INSOMNIA, inability to fall asleep or sleep MNF2.830.855.671; G11.561.826.587 LH  MSSleep disturbances due to physical or mental illness. MHÑSleep Disorders ANdo not use /drug eff /physiol /rad eff MNC10.597.785; C23.888.592.796; F3.126.821 XSNight Terrors; Pavor Nocturnus; Sleep Terror Disorder XUÑHypersomnia LH LS; ; LU  MSPeriods of sleep manifested by changes in EEG activity and certain behavioral correlates; includes Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep. PM72 HN72(69) MHÑSleep Stages ANonly /drug eff /physiol /rad eff PISleep (66-68) MNF2.830.855.796; G11.561.826.754 XSDrowsiness; Lethargy LH LS;  MSA stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG; usually associated with dreaming. PM69 HN69 MHÑSleep, REM ANonly /drug eff /physiol /rad eff; fast-wave sleep goes here but slow-wave sleep = SLEEP PISleep (66-68) MNF2.830.855.796.671; G11.561.826.754.671 XSPARADOXICAL SLEEP; RHOMBENCEPHALIC SLEEP; Rapid Eye Movements FXÑEye Movements LH LS; ; LX  MSSlow-moving exclusively arboreal mammals that inhabit the tropical forests of South and Central America. HN(75) MHÑSloths ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.314.800 DMÑEdentata LH LM  MSDiseases of viral origin, characterized by incubation periods of months to years, insidious onset of clinical manifestations, and protracted clinical course. PM72 HN72(68) MHÑSlow Virus Diseases PIVirus Diseases (66-67) MNC2.839 LH  MSA chemically diverse group of substances produced by various tissues in the body that cause slow contraction of smooth muscle; they have other intense, but varied pharmacologic activities. Synonyms: local hormones; autopharmacologic agents. PM74 HN74(67) MHÑSlow-Reacting Substances ANdo not use /analogs /defic PIMuscle, Smooth/PH (66); specific tissue MND24.185.798 XSAutacoids FXÑNeuroregulators LH LS LX  MHÑSmallpox MNC2.256.743.826 XSVariola XUÑAlastrim LH LS LU  MHÑSmallpox Vaccine ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.899.859 LH  MHÑSmallpox Virus ANdo not use /blood-csf-urine /cytol MNB4.909.204.783.705 XSPOXVIRUS VARIOLAE; Variola Virus LH LS;  MHÑSmegma ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.838.769 LH  MSThe sensation or perception of scents or odors; olfaction. MHÑSmell ANonly /drug eff /physiol /rad eff MNF2.830.816.643; G11.561.796.643 FXÑAnosmia; ÑOdors LH LX;  MSA facial expression which may denote feelings of pleasure, affection, amusement, etc. OLsearch FACIAL EXPRESSION 1969-74 HN(75) MHÑSmiling ANno qualif MNF1.145.209.530.385.671 DMÑFacial Expression LH LM  OLsearch AIR POLLUTION 1966-70 PM74; was see under AIR POLLUTION 1969-73 HN74(71); was see under AIR POLLUTION 1969-73 MHÑSmog ANonly /adv eff /anal /prev PIAir Pollution (66-70) MNG3.850.460.100.310 LH  OLsearch AIR POLLUTION 1966-70 PM74; was see under AIR POLLUTION 1963-73 HN74(71); was see under AIR POLLUTION 1963-73 MHÑSmoke ANsmoke in any environment, not restricted to industrial smokes; can refer to smoke-filled rooms, elevators, trains, aircraft, from any source including fires, tobacco, etc.; coord IM or NIM with source of smoke (tobacco smoke = TOBACCO + SMOKE) provided emphasis is on the nature, composition or eff of the smoke; only /adv eff /anal /prev PIAir Pollution (66-70) MNG3.850.460.100.340 LH  MSInhaling and exhaling the smoke of tobacco or something similar to tobacco. MHÑSmoking ANonly /hist /prev; note next entry below; smokers' patches, smokers' tongue = LEUKOPLAKIA, ORAL; almost exclusively tobacco smoking; not for smoking marihuana ( = CANNABIS but not also SMOKING); cancer caused by smoking = organ/neopl term with /etiol (not /chem ind) + SMOKING (not TOBACCO USE DISORDER) MNF1.145.466.753 FXÑTobacco; ÑTobacco Use Disorder LH LX;  MSMarine, freshwater or terrestrial molluscs of the class Gastropoda; most have an enclosing spiral shell, and several genera harbor parasites pathogenic to man. MHÑSnails ANIM; /microbiol /parasitol permitted MNB1.644.776 LH  MHÑSnake Bites ANther with antivenins is /ther, not /drug ther MNC21.613.127.722 LH  MSSolutions or mixtures of toxic and nontoxic substances elaborated by snake (Ophidia) salivary glands for the purpose of killing prey or disabling predators and delivered by grooved or hollow fangs; they usually contain enzymes, toxins and other factors. Taipoxin goes here. PM76; was see under VENOMS 1975 HN76(75); was see under VENOMS 1975 MHÑSnake Venoms ANGEN or unspecified only: prefer the many specifics: common & scientific names of venomous snakes to identify specific SNAKE VENOMS term: TN 241; do not use /analogs /chem syn /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; do not use qualif when coord with ANTIVENINS PIVenoms (68-74) MND24.185.965.850 LH  MHÑSnakes ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; TN 241: common & scientific names of venomous snakes to identify specific SNAKE VENOMS terms MNB2.833.672 LH  MHÑSneezing ANonly /drug eff /rad eff MNG9.772.672 LH  MSRough, noisy breathing during sleep, due to vibration of the uvula and soft palate. PM85; was see under RESPIRATORY SOUNDS 1980-84 & MOUTH BREATHING 1979 HN85(79); was see under RESPIRATORY SOUNDS 1980-84 & MOUTH BREATHING 1979 MHÑSnoring ANnote category MNC23.888.852.779.850 LH  OLsearch WEATHER 1969-74 HN(75) MHÑSnow ANno qualif MNG3.230.300.100.725.480 DMÑWeather LH LM  MSSodium or potassium salts of long chain fatty acids; detergent substances obtained by boiling natural oils or fats with caustic alkali; sodium soaps are harder and used as topical anti-infectives, vehicles in pills and liniments and potassium soaps are soft, used as vehicles for ointments and also as topical antimicrobials. HN63(81) MHÑSoaps AND25-26 qualif MND26.866.265.861; J1.516.872 DMÑSurface-Active Agents LH LM  MSA game in which a round inflated ball is advanced by kicking or propelling with any part of the body except the hands or arms. HN(76) MHÑSoccer ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); Manual 30.31+; does not include rugby (index SPORTS) PISports (66-75) MNI3.450.642.845.800 DMÑSports LH LM  MSThose types of relationships which involve the accommodation of the individual to circumstances in his social environment for the satisfaction of his needs or motives. PM69 HN69 MHÑSocial Adjustment ANno qualif PIAdaptation, Psychological (66-68); Behavior (66-68) MNF1.829.737 XSADJUSTMENT, SOCIAL FXÑAdaptation, Psychological LH LS LX  MSThe state of estrangement individuals feel in cultural settings that they view as foreign, unpredictable, or unacceptable. PM73 HN73 MHÑSocial Alienation ANno qualif PIInterpersonal Relations (66-67); Psychology, Social (66-67); Social Conditions (66-67); Social Isolation (68-72); Sociology (66-67) MNF1.829.56.672; F1.829.850.755; F3.126.842.777; I1.880.683.755 XSALIENATION, SOCIAL LH LS  MSAny behavior caused by or affecting another individual, usually of the same species. PM69 HN69 MHÑSocial Behavior ANhuman & animal; no qualif PIBehavior (66-68); Psychology, Social (66-68) MNF1.145.813; F1.829.759 XUÑSocial Identification LH LU  MSBehaviors which are at variance with the expected social norm and which affect other individuals. PM69 HN69 MHÑSocial Behavior Disorders ANhuman only; do not use /drug eff /physiol /rad eff PIChild Behavior Disorders (66-68) MNF3.126.842 FXÑAnomie; ÑAntisocial Personality Disorder XUÑSocial Breakdown Syndrome LH LX; LU  MSThe deterioration in social relationships of the individual as a result of his or her environment; occurs in prisons, hospitals, etc. HN(73) MHÑSocial Breakdown Syndrome ANhuman only; do not use /drug eff /physiol /rad eff MNF3.126.842.848 DMÑSocial Behavior Disorders LH LM  MSSocial process whereby the values, attitudes or institutions of society, such as education, family, religion and industry becomes modified; includes both the natural process and action programs initiated by members of the community. PM68 HN68 MHÑSocial Change ANno qualif PISocial Conditions (66-67); Sociology (66-67) MNI1.880.526; N1.824.737 FXÑGroup Processes LH LX  MSA stratum of people with similar position and prestige; includes social stratification. Social class is measured by criteria such as education, occupation, and income. PM68 HN68 MHÑSocial Class ANno qualif PISocial Conditions (66-67); Sociology (66-67) MNI1.880.552; I1.880.840.755; N1.824.782 LH  MSUse for articles concerning sociocultural factors in general or for which there is no specific heading. MHÑSocial Conditions ANonly /hist /legis /trends CATALOG: /geog /form MNI1.880.578; N1.824.827 LH  MSBehavioral or attitudinal compliance with recognized social patterns or standards. PM68 HN68 MHÑSocial Conformity ANno qualif PIAttitude (66-67); Behavior (66-67); Interpersonal Relations (66-67) MNF1.145.828; F1.829.782 XSCONFORMITY, SOCIAL FXÑSOCIAL CONTROL, INFORMAL LH LS LX  MSControl which is exerted by the more stable organizations of society, such as established institutions and the law. They are ordinarily embodied in definite codes, usually written. PM68 HN68 MHÑSocial Control, Formal ANonly /class /hist /methods; ╥police╙ goes here PILegislation (66-67); specific control; specific subject controlled MNI1.880.604; N3.706 FXÑQuality of Health Care LH LX  MSThose forms of control which are exerted in less concrete and tangible ways, as through folkways, mores, conventions, and public sentiment. PM68 HN68 MHÑSocial Control, Informal ANonly /class /hist /methods MNI1.880.630 FXÑSocial Conformity LH LX  MSA personality trait rendering the individual acceptable in social or interpersonal relations; related to social acceptance, social approval, popularity, social status, leadership qualities, or any quality making him a socially desirable companion. PM65 HN65 MHÑSocial Desirability ANno qualif MNF1.829.805 LH  MSThe degree of closeness or acceptance an individual or group feels toward another individual or group. PM69 HN69 MHÑSocial Distance ANno qualif PIInterpersonal Relations (66-68); Psychology, Social (66-68) MNF1.829.316.777 LH  MSSuperiority of relationship and rank of an individual in relation to his associates. OLuse SOCIAL DOMINANCE to search DOMINANCE, SOCIAL back thru 1968 PM69; was DOMINANCE, SOCIAL 1968 HN69; was DOMINANCE, SOCIAL 1968 MHÑSocial Dominance ANhuman & animal; no qualif MNF1.145.843; F1.829.316.848 XSDOMINANCE, SOCIAL XUÑDominance-Subordination; ÑHierarchy, Social LH LS LU;  MSThe aggregate of social and cultural institutions, forms, patterns, and processes that influence the life of an individual or community. PM73 HN73(72) MHÑSocial Environment ANhuman & animal; no qualif CATALOG: /geog /form PIAdaptation, Psychological (66-68); Environment (66-71); Social Adjustment (69-71); Social Behavior (69-71); Social Conditions (66-71); Social Isolation (69-71); Social Planning (68-71); Socioeconomic Factors (68-71) MNI1.880.656 FXÑEnvironment; ÑLife Style XUÑSocial Support LH LX; LU  MSAny enhancement of a motivated behavior in which individuals do the same thing with some degree of mutual stimulation and consequent coordination. PM68 HN68 MHÑSocial Facilitation ANhuman & animal; no qualif MNF1.145.857; F1.829.827 LH  MSThe process wherein the individual so strongly feels himself a member of a group that he adopts its ideas, beliefs and habits. HN(78) MHÑSocial Identification ANno qualif PISocial Behavior (69-77) MNF1.145.813.708; F1.829.759.708 XSGroup Identification; Identification, Social DMÑSocial Behavior LH LS; LM  MSThe separation of individuals or groups resulting in the lack of or minimizing of social contact and/or communication. This separation may be accomplished by physical separation, by social barriers and by psychological mechanisms. In the latter, there may be interaction but no real communication. OLuse SOCIAL ISOLATION to search ISOLATION, SOCIAL back thru 1968 PM69; was ISOLATION, SOCIAL 1968 HN69; was ISOLATION, SOCIAL 1968 MHÑSocial Isolation ANhuman & animal; no qualif MNF1.829.850; I1.880.683 XSISOLATION, SOCIAL FXÑPopulation Density XUÑLoneliness LH LS LX LU  MSAn interactive process whereby members of a community are concerned for the equality and rights of all. HN(78) MHÑSocial Justice ANonly /hist /legis /trends MNI1.880.604.473.700; N3.706.437.700 DMÑHuman Rights LH LM  MSA branch of medicine concerned with the role of socio-environmental factors in the occurrence, prevention and treatment of disease. MHÑSocial Medicine ANSPEC: SPEC qualif except /methods MNG2.403.720 FXÑPublic Health LH LX  MSThe movement or shifting of membership between or within social classes by individuals or by groups. PM68 HN68 MHÑSocial Mobility ANno qualif PISociology (66-67) MNI1.880.552.673; I1.880.840.755.673; N1.824.782.673 LH  MSThe perceiving of attributes, characteristics and behaviors of one's associates or social groups. PM69 HN69 MHÑSocial Perception ANno qualif PIPerception (66-68) MNF2.463.593.752 XSPERCEPTION, SOCIAL FXÑStereotyping LH LS LX  MSInteractional process combining investigation, discussion, and agreement by a number of people in the preparation and carrying out of a program to ameliorate conditions of need or social pathology in the community. It usually involves the action of a formal political, legal, or recognized voluntary body. PM68 HN68 MHÑSocial Planning ANno qualif CATALOG: /geog /form PIHousing (66-67); Social Conditions (66-67); Sociology (66-67) MNI1.880.709 FXÑPlanning Technics LH LX  MSSituations affecting a significant number of people, that are believed to be sources of difficulty or threaten the stability of the community, and that require programs of amelioration. PM68 HN68 MHÑSocial Problems ANonly /hist /legis /trends PIAlcoholism (66-67); Antisocial Personality Disorder (66-67); Juvenile Delinquency (66-67); Prostitution (66-67) MNI1.880.735 FXÑAlcoholism; ÑStudent Dropouts; ÑSubstance Dependence LH LX; ;  MSThe obligations and accountability assumed in carrying out actions or ideas in behalf of others. PM78 HN78 MHÑSocial Responsibility ANno qualif MNF1.829.500.680; K1.316.630.680; K1.752.256.547.680 XSObligation, Social; Responsibility, Social; Social Accountability LH LS; ;  MSDisciplines concerned with the interrelationships of individuals in a social environment including social organizations and institutions. Includes Sociology and Anthropology. MHÑSocial Sciences ANSPEC: SPEC qualif CATALOG: /geog /form MNF4.96.879; I1 LH  MSGovernment sponsored social insurance programs. OLto search AID TO THE BLIND & AID TO THE TOTALLY DISABLED use SOCIAL SECURITY back thru 1975 & PUBLIC ASSISTANCE 1968-74 PMAID TO THE BLIND & AID TO THE TOTALLY DISABLED were see under PUBLIC ASSISTANCE 1968-77 HNAID TO THE BLIND & AID TO THE TOTALLY DISABLED were see under PUBLIC ASSISTANCE 1968-77 MHÑSocial Security ANonly /hist /legis /organ; specify country, including U.S. CATALOG: /geog /form MNN3.219.521.346.506.849; N3.219.521.576.823 XSAid to the Blind; Aid to the Totally Disabled; Social Insurance LH LS; ;  MSThere are two kinds of social support, formal and informal. Informal is encouragement and assistance given by friends, relatives, and peers to individuals who are emotionally disturbed or physically ill in order that they may better cope; whereas formal assistance is provided by churches, groups, etc. HN(83) MHÑSocial Support ANhuman only; no qualif PISocial Adjustment (69-82); Social Environment (73-82) MNI1.880.656.600 XSPsychosocial Support Systems DMÑSocial Environment LH LS LM  MSAbstract standards or empirical variables in social life which are believed to be important and/or desirable. PM69 HN69 MHÑSocial Values ANno qualif PIJudgment (66-68); Psychology, Social (66-68) MNF1.829.873 LH  MSOrganized institutions which provide services to ameliorate conditions of need or social pathology in the community. MHÑSocial Welfare ANonly /hist /legis /trends CATALOG: /geog /form MNI1.880.787 FXÑPublic Assistance LH LX  MSThe use of community resources, individual case work or group work to promote the adaptive capacities of individuals in relation to their social and economic environments; includes social service agencies. OLuse SOCIAL WORK to search SOCIAL SERVICE back thru 1966 PM78; was SOCIAL SERVICE 1963-77 HN78; was SOCIAL SERVICE 1963-77 MHÑSocial Work ANSPEC: SPEC qualif CATALOG: /geog /form MNI1.880.792; N2.421.849 XSSocial Service; Social Workers FXÑCommunity Health Services LH LS; LX  MSHospital department responsible for administering and providing social services to patients and their families. HN(84) MHÑSocial Work Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: SOCIAL WORK DEP PIHospital Departments (68-83); Social Work (78-83) MNN2.278.354.422.730; N4.452.442.422.730 XSHospital Social Work Department DMÑHospital Departments LH LS LM  MSUse of all social work processes in the treatment of patients in a psychiatric or mental health setting. OLuse SOCIAL WORK, PSYCHIATRIC to search SOCIAL SERVICE, PSYCHIATRIC back thru 1966 PM78; was SOCIAL SERVICE, PSYCHIATRIC 1963-77 HN78; was SOCIAL SERVICE, PSYCHIATRIC 1963-77 MHÑSocial Work, Psychiatric ANSPEC: SPEC qualif CATALOG: /geog /form MNF4.408.823; I1.880.792.410; N2.421.461.798; N2.421.849.673 XSPSYCHIATRIC SOCIAL WORK; Social Service, Psychiatric LH LS;  MSA system of government in which means of production and distribution of goods are controlled by the state. MHÑSocialism ANonly /hist; specify country; Nazism does not go here: index under POLITICAL SYSTEMS CATALOG: /geog /form MNI1.696.798 LH  MSThe training or molding of an individual through various relationships, educational agencies, and social controls, which enables him to become a member of a particular society. PM68 HN68 MHÑSocialization ANno qualif PIChild Rearing (66-67); Family (66-67); Parent-Child Relations (66-67) MNI1.880.813 FXÑChild Rearing; ÑParent-Child Relations; ÑParent-Child Relations; ÑPersonality Development LH LX; ; ;  MSOrganizations composed of members with common interests and whose professions may be similar. MHÑSocieties ANonly /hist /organ; for societies not covered by specifics below or as defined below under SOCIETIES, MEDICAL & SOCIETIES, SCIENTIFIC; do not confuse with ORGANIZATIONS: see note there; Manual 35.11+; specify geog; Amer Speech & Hear Assoc: index under SOCIETIES (IM) + AUDIOLOGY (IM) + SPEECH PATHOLOGY (IM) + UNITED STATES (NIM); TN 174: scope CATALOG: /geog /form MNN3.540.828 FXÑLibrary Associations XUÑSocieties, Hospital LH LX LU  MSSocieties whose membership is limited to dentists. PM65 HN65 MHÑSocieties, Dental ANonly /hist /organ; specify geog CATALOG: /geog /form MNN3.540.828.506 LH  MSSocieties having institutional membership limited to hospitals and other health care institutions. HN(Aug 77) MHÑSocieties, Hospital ANonly /hist /organ; specify geog CATALOG: /geog /form PIHospitals (66-Jul 77); Societies (66-Jul 77) MNN3.540.828.540 DMÑSocieties LH LM  MSSocieties whose membership is limited to physicians. MHÑSocieties, Medical ANonly /hist /organ; for conventional medical societies & soc of med specialties indented under spec in Cat G2; Manual 35.11, 35.11.1; TN 174: scope; specify geog; ╥College of Physicians╙ goes here CATALOG: /geog /form MNN3.540.828.589 LH  MSSocieties whose membership is limited to nurses. PM66 HN66 MHÑSocieties, Nursing ANonly /hist /organ; specify geog CATALOG: /geog /form MNN3.540.828.672 XUÑInternational Council of Nurses LH LU  MSSocieties whose membership is limited to pharmacists. PM68 HN68 MHÑSocieties, Pharmaceutical ANonly /hist /organ; specify geog CATALOG: /geog /form PIPharmacy (66-67) MNN3.540.828.755 LH  MSSocieties whose membership is limited to scientists. MHÑSocieties, Scientific ANonly /hist /organ; for societies of scientists & professionals in disciplines not covered under SOCIETIES, MEDICAL above; Manual 35.11+; TN 174: scope; specify geog CATALOG: /geog /form MNN3.540.828.838 XSSCIENTIFIC SOCIETIES LH LS  MSSocial and economic factors that characterize the individual or group within the social structure. PM68 HN68 MHÑSocioeconomic Factors ANNIM; no qualif; Manual 35.9; includes both social & economic aspects: purely economic aspect = ECONOMICS PISocial Conditions (66-67); Sociology (66-67) MNI1.880.840; N1.824 FXÑEconomics LH LX  MSTherapy whose primary emphasis is on the physical and social structuring of the environment to promote interpersonal relationships which will be influential in reducing behavioral disturbances of patients. OLuse SOCIOENVIRONMENTAL THERAPY to search SITUATIONAL THERAPY back thru 1973 PM73 HN73; SITUATIONAL THERAPY was see under SOCIOENVIRONMENTAL THERAPY 1973-78 MHÑSocioenvironmental Therapy ANSPEC qualif PIPsychotherapy (66-72) MNF4.754.864 XSSituational Therapy LH LS  MSA social science dealing with group relationships, patterns of collective behavior and social organization. PMRELIGION AND SOCIOLOGY was heading 1963-65 HNRELIGION AND SOCIOLOGY was heading 1963-65 MHÑSociology ANIM: SPEC with SPEC qualif; for ╥sociological aspects of╙, NIM with no qualif; Manual 30.5; /methods: probably SOCIOMETRIC TECHNICS MNF4.96.879.757; I1.880 FXÑGroup Processes LH LX  MSThe study of the social determinants and social effects of health and disease, and of the social structure of medical institutions or professions. PM80; was see under SOCIOLOGY 1978-79 HN80(78); was see under SOCIOLOGY 1978-79 MHÑSociology, Medical ANIM; SPEC: SPEC qualif CATALOG: /geog /form PISociology (66-77) MNF4.96.879.757.400; G2.790 XSMedical Sociology LH LS  MSMethods for quantitatively assessing and measuring interpersonal and group relationships. PM68 HN68 MHÑSociometric Technics ANno qualif CATALOG: do not use /laboratory manuals PIPsychology, Social (66-67); Sociology (66-67) MNI1.880.866 FXÑStatistics LH LX  MHÑSodium ANNa-23; /physiol permitted; do not use /analogs /biosyn; for isotopes & radioisotopes see below; /blood: note also HYPERNATREMIA & HYPONATREMIA; /defic: consider also HYPONATREMIA; /metab: consider also SODIUM CHANNELS see ION CHANNELS & see note there; /urine: consider also NATRIURESIS RN7440-23-5 MND1.248.497.300.459.874; D1.268.814; D1.552.528.850 FXÑHypernatremia; ÑHyponatremia; ÑNatriuresis LH LX; ;  MHÑSodium Chloride ANdo not use /analogs RN7647-14-5 MND1.396.343.260.824; D1.552.528.850.524; J1.341.241.757 XSSaline FXÑDiet, Sodium-Restricted XUÑSaline Solution, Hypertonic LH LS LX LU  MSA highly poisonous compound. It is an inhibitor of many metabolic processes and is used as a test reagent for the function of chemoreceptors. Used in many industrial processes. Synonym: Cyanogran. HN(79) MHÑSodium Cyanide AND25-26 qualif RN143-33-9 PICyanides (66-78); Sodium (66-78) MND1.552.528.850.540; D1.620.305.800 DMÑCyanides LH LM  MSSodium lauryl sulfate. An anionic surfactant, usually a mixture of sodium alkyl sulfates, mainly the lauryl; lowers surface tension of aqueous solutions; used as fat emulsifier, wetting agent, detergent in cosmetics, pharmaceuticals and toothpastes; also as research tool in protein biochemistry. Synonym: Irium. PM74 HN74(72) MHÑSodium Dodecyl Sulfate AND25-26 qualif RN151-21-3 PISurface-Active Agents (66-71) MND2.33.555.700.720; D10.516.289.700.710; D26.866.868 XSSODIUM LAURYL SULFATE LH LS  MSDisodium 1-hydroxyethylidenediphosphonate. A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover. Synonyms: disodium etidronate; ethanehydroxydiphosphonate. PM77 HN77(73) MHÑSodium Etidronate ANdo not use /biosyn /defic /physiol RN7414-83-7 PIOrganophosphorus Compounds (72) MND2.705.206.830 XSDisodium Etidronate; EHDP; Ethanehydroxydiphosphonate; Etidronic Acid LH LS; ; ;  MSInorganic fluoride which has been used orally and topically to prevent dental caries. Also effective as a pesticide and in the therapy of osteoporosis. PM84; was see under FLUORIDES 1977-83; ACIDULATED PHOSPHATE FLUORIDE was see under FLUORIDES 1977-83 HN84(77); was see under FLUORIDES 1977-83 MHÑSodium Fluoride ANdo not use /analogs /biosyn /defic /physiol RN7681-49-4 PIFluorides (66-76); Fluorides, Topical (66-76) MND1.396.514.348.800; D1.552.528.850.574; D25.223.432.866 XUÑAcidulated Phosphate Fluoride LH LU  MSL-Glutamic acid, sodium salt. An additive used to impart meat flavor to foods, and to enhance other natural food flavors. Medically it has been used to reduce blood ammonia levels in ammoniacal azotemia, therapy of hepatic coma, in psychosis and mental retardation. Synonyms: Ajinomoto; Accent; Zest; Glutacyl; Glutavene; Vetsin. HN(75) MHÑSodium Glutamate AND25-26 qualif; /analogs NIM only RN142-47-2 PIGlutamates (66-74) MND12.125.119.511.700; D26.471.700 XSMSG; Monosodium Glutamate DMÑGlutamates LH LS; LM  OLsearch GOLD 1966-74 HN(75) MHÑSodium Gold Thiosulfate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN15283-45-1 MND1.552.322.850 DMÑGold LH LM  PM65 HN65(64) MHÑSodium Hydroxide ANdo not use /analogs /biosyn /defic /physiol RN1310-73-2 MND1.455.824; D1.552.528.850.624 LH  PM65 HN65 MHÑSodium Hypochlorite ANdo not use /analogs /biosyn /defic /physiol RN7681-52-9 MND1.396.343.490.700; D1.552.528.850.724; D1.655.498.400.700; D1.29.260.365.700 LH  MSWhite, odorless deliquescent crystals. Used as iodine supplement, expectorant or in its radioactive (I-131) form as a diagnostic aid, particularly for thyroid function determinants. Synonyms: Anayodin; Ioduril. HN(79) MHÑSodium Iodide AND25-26 qualif RN7681-82-5 PIIodides (66-78); Sodium (66-78) MND1.396.661.388.800; D1.552.528.850.800 DMÑIodides LH LM  MHÑSodium Isotopes ANNIM; no qualif MND1.496.807; D1.552.528.850.824 LH  MSThe sodium salts of the fatty acids in cod liver oil; an irritant and sclerosing agent used to treat varicose veins and arthritic joints. Synonyms: Oleocid; Varicocid; Venotex. OLsearch SCLEROSING SOLUTIONS 1966-74 HN(75); was see under SCLEROSING SOLUTIONS 1963-74 MHÑSodium Morrhuate AND25-26 qualif RN8031-09-2 MND2.241.81.407.800; D10.516.251.860; D26.394.225.766.826.524; D26.585.711.524 XSMorrhuate Sodium DMÑFatty Acids LH LS LM  MSNitrous acid sodium salt. Used in many industrial processes, in meat curing, coloring and preserving and as a reagent in analytical chemistry. The compound is toxic and mutagenic and will react in vivo with secondary or tertiary amines thereby producing highly carcinogenic nitrosamines. HN(79) MHÑSodium Nitrite AND25-26 qualif RN7632-00-0 PINitrites (66-78); Sodium (66-78) MND1.552.528.850.850; D1.620.754.565.567.750; D1.655.498.565.565.567.750; D26.471.385.810 DMÑNitrites LH LM  MSSodium 4-hydroxybutyrate. Anesthetic used for both induction and maintenance; may cause bradycardia and dyskinesias. Synonyms: Somsanit; Wy 3478. HN(75) MHÑSodium Oxybate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN502-85-2 PIHydroxybutyrates (69-74) MND2.241.81.161.627.700; D2.241.511.401.700; D14.166.820 XS4-Hydroxybutyrate Sodium; Gamma-Hydroxybutyrate; Oxybate Sodium; Sodium Oxybutyrate; Sodium gamma-Hydroxybutyrate DMÑHydroxybutyrates LH LS; ; ; ; LM  MSUnstable isotopes of sodium that decay or disintegrate spontaneously emitting radiation. Sodium (Na) 20-22, 24 and 25 are radioactive isotopes of sodium. OLsearch SODIUM ISOTOPES 1966-74 PM75 HN75 MHÑSodium Radioisotopes ANNa-20-22, 24-26; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIRadioisotopes (66-74); Sodium Isotopes (66-74) MND1.496.749.795; D1.496.807.800; D1.552.528.850.900 LH  MHÑSodium Salicylate ANdo not use /biosyn /defic /physiol RN54-21-7 MND2.241.223.106.505.700.750; D2.241.511.390.700.710.750; D2.755.410.700.710.750; D14.73.278.861.757; D26.74.75.832.857 LH  MSSodium 2-methyl-7-ethylundecanol-4-sulfate. An anionic surface-active agent used for its wetting properties in industry and in medicine as irritant and sclerosing agent for hemorrhoids and varicose veins. Synonyms: STS; STD; Sotradecol; Tergitol 4; Trombovar; Trombavar. OLto search SODIUM TETRADECYL SULFATES use SODIUM TETRADECYL SULFATE back thru 1975 & SCLEROSING SOLUTIONS 1966-74 HN(81); was SODIUM TETRADECYL SULFATES see under FATTY ALCOHOLS 1975-80, was SODIUM TETRADECYL SULFATES see under SCLEROSING SOLUTIONS 1963-74 MHÑSodium Tetradecyl Sulfate AND25-26 qualif; /analogs NIM only RN1191-50-0 PISclerosing Solutions (66-74) MND2.33.555.900; D10.516.289.900; D26.394.225.766.826.824; D26.585.711.824; D26.866.875 DMÑFatty Alcohols LH LM  MSNeoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc. PM76 HN76 MHÑSoft Tissue Neoplasms ANneoplasms located in soft (connective) tissue, NOT neoplasms composed of soft tissue; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term or site (IM) MNC4.588.839; C23.205.839 LH  MSSequential operating instructions for a particular problem or function to be run on a digital computer. OLuse SOFTWARE to search COMPUTER PROGRAMS back thru 1983; use COMPUTERS to search PROGRAMS, COMPUTER 1979-82 & PROGRAMMING, COMPUTER 1966-74 PM87; was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMING, COMPUTER see under COMPUTERS 1966-74 HN87(83); was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMIMG, COMPUTER see under COMPUTERS 1966-74 MHÑSoftware ANdo not use /util PIComputers (66-82) MNL1.700.568.810 XSComputer Programs; Computer Software; Software Engineeering; Software Tools XUÑDatabase Management Systems; ÑSoftware Design; ÑSoftware Validation; ÑUser-Computer Interface LH LS; ; ; LU; ; ;  MSSpecifications and instructions applied to the software. HN(87) MHÑSoftware Design ANIM; no qualif MNL1.700.568.810.820 XSFlowcharts (Computer) DMÑSoftware LH LS LM  MSThe act of testing the software for compliance with a standard. HN(87) MHÑSoftware Validation ANIM; no qualif MNL1.700.568.810.868 XSSoftware Verification DMÑSoftware LH LS LM  OLuse SOIL to search PEAT back thru 1966 PMPEAT was heading 1963-81 HNPEAT was heading 1963-81 MHÑSoil ANonly /anal MNG3.230.600 XSPeat LH LS  MHÑSoil Microbiology ANIM; no qualif; coord IM with specific microbe (IM) MNG1.273.540.737; G3.850.425.300 LH  MSSubstances which pollute the soil. Use for soil pollutants in general or for which there is no specific heading. PM75 HN75 MHÑSoil Pollutants ANonly /ad-poi-tox /anal /isol PIEnvironmental Pollution (71-74); Soil (66-74) MND5.284.756 XUÑSoil Pollutants, Radioactive LH LU  MSPollutants, present in soil, which exhibit radioactivity. HN(75) MHÑSoil Pollutants, Radioactive ANonly /ad-poi-tox /anal /isol MND5.284.638.756; D5.284.756.674 DMÑSoil Pollutants LH LM  MSAlkaloids, mainly tropanes, elaborated by plants of the family Solanaceae, including Atropa, Hyoscyamus, Mandragora, Nicotiana, Solanum, etc; they act mainly as cholinergic blockaders; most are very toxic, many are used medicinally. OLuse SOLANACEOUS ALKALOIDS to search SOLANUM ALKALOIDS back thru 1977 PM79; was SOLANUM ALKALOIDS 1977-78 HN79; was SOLANUM ALKALOIDS 1977-78 MHÑSolanaceous Alkaloids ANdo not use /analogs /defic /physiol PIAlkaloids (64-76); Solanum Alkaloids (77-78) MND3.132.760; D16.653.865 XSSolanum Alkaloids LH LS  MHÑSolanine ANdo not use /defic /physiol RN20562-02-1 MND3.132.760.769; D4.808.247.808.874; D9.203.408.782.674 LH  MSEnergy transmitted from the sun in the form of electromagnetic radiation. HN(82) MHÑSolar Energy ANonly /econ /util (if by MeSH definition) PISunlight (66-81) MNG3.230.132.708 DMÑEnergy-Generating Resources LH LM  PM73 HN73 MHÑSoldering, Dental ANincludes soldering & solders; do not use /util except by MeSH definition PIWelding (66-72) MNE6.859 LH  PM65 HN65(64) MHÑSolubility ANNIM; no qualif MNH1.181.529.827 LH  MHÑSolutions ANIM for general only: only /anal (with caution) /stand /supply; NIM when drug in solution is IM; no qualif; /adv eff permitted but be careful: it may be the adv eff of the drug in solution, not the ╥solution╙; rehydration solutions: index under FLUID THERAPY & not under SOLUTIONS MND26.394.225.766 LH  MHÑSolvents AND25-26 qualif MND26.837 LH  MHÑSomalia MNZ1.58.183.612 LH  PM86; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-85 HN86(72); was see under ORGANOPHOSPHORUS COMPOUNDS 1975-85, was Prov 1972-74 MHÑSoman ANdo not use /biosyn /defic /physiol RN96-64-0 PICholinesterase Inhibitors (66-71); Organophosphorus Compounds (71) MND2.705.860 LH  MH*Somatic Therapies, Psychiatric (Non Mesh) MNF4.881 LH  MSDisorders characterized by physical symptoms suggesting a physical disorder for which there are no demonstrable organic findings and for which there is strong or positive evidence that they are linked to psychological factors. Unlike the factitious disorders, the symptom production is not under voluntary control. PM81 HN81 MHÑSomatoform Disorders ANdo not use /drug eff /physiol /rad eff; differentiate from FACTITIOUS DISORDERS: factitious are phys or psychol sympt under voluntary control, somatoform are phys sympt linked to psychol factors but not under voluntary control; differentiate from PSYCHOPHYSIOLOGIC DISORDERS: psychophysiol are organic diseases of psychol origin or psychol exacerbation, somatoform are symptoms of organic dis without actual disease MNF3.709.438.710 XSBriquet Syndrome; Somatization Disorder LH LS;  MSInsulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN; they cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism. OLuse SOMATOMEDINS to search SOMATOMEDIN back thru 1973 & SULFATION FACTOR back thru 1971 (as Prov 1971-72) PM82; was SOMATOMEDIN 1973-81 HN82; was SOMATOMEDIN 1973-81, was SULFATION FACTOR 1971-72 (Prov) MHÑSomatomedins AN/biosyn /physiol permitted; do not use /analogs PIBlood Proteins (66-70); Sulfates/ME (66-70) MND12.776.124.862; D12.776.641.650.710; D24.185.348.862 XSInsulin-Like Growth Factors; SULFATION FACTOR XUÑInsulin-Like Growth Factor I; ÑInsulin-Like Growth Factor II LH LS; LU;  PM71 HN71 MHÑSomatosensory Cortex ANdo not use /innerv PICerebral Cortex (66-70) MNA8.186.211.885.213.670.675 LH  MSA polypeptide hormone produced in the hypothalamus which inhibits the release of somatotropin. OLuse SOMATOSTATIN to search SOMATOTROPIN RELEASE INHIBITING HORMONE back thru 1975 PM85; was SOMATOTROPIN RELEASE INHIBITING HORMONE 1975-84 HN85; was SOMATOTROPIN RELEASE INHIBITING HORMONE 1975-84 MHÑSomatostatin AN/biosyn /physiol permitted; ╥produced in the hypothalamus╙; DF: SRIH PISomatotropin/AI (73-74); Somatotropin Releasing Hormone/AI (74) MND6.347.560.810; D12.644.850; D12.776.641.650.720 XSSomatostatin-14; Somatotropin Release Inhibiting Hormone LH LS;  MSSomatostatin-secreting tumor of pancreatic delta cells associated with diabetes and steatorrhea. HN(82) MHÑSomatostatinoma AN/anal /blood supply /secret /ultrastruct permitted; coord IM with PANCREATIC NEOPLASMS (IM); this is a delta cell tumor PIIslet Cell Tumor (66-81) MNC4.557.576.600.885 DMÑIslet Cell Tumor LH LM  MHÑSomatotropin AN/biosyn /physiol permitted RN9002-72-6 MND6.472.734.525.780; D12.776.641.650.730 XSGrowth Hormone, Pituitary LH LS  PM74 HN74 MHÑSomatotropin Releasing Hormone AN/biosyn /physiol permitted; ╥originates in the hypothalamus╙; DF: SRH RN9034-39-3 MND6.472.709.757; D12.776.641.650.740 XSGROWTH HORMONE RELEASING HORMONE LH LS  MHÑSomatotypes ANno qualif MNG7.265.758 XSBODY TYPES; Body Build; TYPOLOGY FXÑPhenotype LH LS; ; LX  MSA dissociated or fugue-like state in which the person can move about but otherwise seems asleep. Syn: sleep walking. PM69 HN69 MHÑSomnambulism ANdo not use /congen /drug eff /physiol /rad eff PISleep Disorders (66-68) MNC10.597.785.800; C23.888.592.796.800; F3.126.821.700 LH  OLsearch ULTRASONICS 1974 & VIBRATION 1969-73 HN(75); was see under VIBRATION 1969-73 MHÑSonication ANonly /adv eff /diag use /instrum MNH1.671.31.849.675 DMÑUltrasonics LH LM  MS2,4-Hexadienoic acid. Mold and yeast inhibitor. Used as a fungistatic agent for foods, especially cheeses. HN(75) MHÑSorbic Acid AND25-26 qualif; /analogs NIM only; POLYSORBATES is available RN110-44-1 PICaproates (69-74); Fatty Acids, Unsaturated (74) MND2.241.81.436.820; D10.516.251.355.840; D26.471.385.840 XSHexadienoic Acid; Propenylacrylic Acid DMÑFatty Acids, Unsaturated LH LS; LM  MHÑSorbitol ANdo not use /biosyn /defic /physiol RN50-70-4 MND2.33.800.813; D9.203.853.813; D19.770.224.453.758 XSGlucitol XUÑIsosorbide; ÑMeglumine LH LS LU;  MHÑSorbose ANdo not use /biosyn /defic /physiol RN3615-39-2 MND9.203.546.359.862; D9.203.546.465.758 LH  MSAn error-prone mechanism or set of functions for repairing damaged microbial DNA. SOS functions (a concept reputedly derived from the SOS of the international distress signal) are involved in DNA repair and mutagenesis, in cell division inhibition, in recovery of normal physiological conditions after DNA repair, and possibly in cell death when DNA damage is extensive. HN(87) MHÑSOS Response (Genetics) ANonly /drug eff /rad eff; DF: SOS RESPONSE PIDNA, Bacterial (75-86); DNA Repair (75-86); Escherichia coli (75-86) MNG4.185.515.830; G5.331.187.830; G5.386.690 DMÑDNA Repair LH LM  PM73 HN73(72) MHÑSotalol ANdo not use /biosyn /defic /physiol RN3930-20-9 PIAmino Alcohols (66-71); Sympatholytics (66-71) MND2.33.329.291.805; D2.92.63.291.805; D16.848.215.840 LH  MHÑSound ANonly /adv eff /diag use MNH1.671.31.675 FXÑAcoustic Stimulation; ÑNoise LH LX;  MSAbility to determine the specific location of a sound source. HN(80) MHÑSound Localization ANonly /drug eff /physiol /rad eff; do not confuse with ECHOLOCATION (animal only) PIAuditory Perception (67-79); Hearing (66); Perception (66) MNF2.463.593.71.869 XSAuditory Localization DMÑAuditory Perception LH LS LM  MSThe graphic registration of the frequency and intensity of sounds, such as speech, infant crying and animal vocalizations. PM80 HN80 MHÑSound Spectrography ANNIM; only /instrum /methods /stand; includes ╥speech, infant crying & animal vocalizations╙ MNE5.855 XSSonography, Speech LH LS  MHÑSouth Africa ANRepublic of So. Afr., formerly Union of So. Afr.; not same as AFRICA, SOUTHERN MNZ1.58.349.843 LH  MHÑSouth America ANeach So. Amer. country is available as a heading MNZ1.107.757 LH  MHÑSouth Carolina MNZ1.107.567.875.808 LH  MHÑSouth Dakota MNZ1.107.567.875.816 LH  MSOil from soybean or soybean plant. HN(87) MHÑSoybean Oil AND25-26 qualif RN8001-22-7 PIOils (66-86) MND10.516.212.302.380.800; D10.516.212.507.800; D10.516.627.700.880; J1.740.250.750; J1.740.700.880 XSSoya Oil DMÑPlant Oils LH LS LM  MSAn annual legume or the seeds of this plant. OLuse SOYBEANS to search SOY BEANS back thru 1966 PM86; was SOY BEANS 1963-85 HN86; was SOY BEANS 1963-85; was in Cat J only 1963-80 MHÑSoybeans ANas plant & food; from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.570.870; J1.341.956.570.870 XSGlycine Max; Soy Beans LH LS;  MSTravel beyond the earth's atmosphere. MHÑSpace Flight ANonly /econ /hist /instrum /man (if by MeSH definition) MNJ1.95.850 FXÑAerospace Medicine; ÑExtraterrestrial Environment; ÑSEALED CABIN ECOLOGY; ÑWEIGHTLESSNESS LH LX; ; ;  PM72 HN72(65) MHÑSpace Maintenance ANonly /instrum /methods MNE6.658.703.675 LH  MSThe awareness of the spatial properties of objects; includes physical space. MHÑSpace Perception ANonly /drug eff /physiol /rad eff MNF2.463.593.778; F2.463.593.932.869 LH  MSA statistically significant excess of cases of a disease, occurring within a limited space-time continuum. PM78 HN78 MHÑSpace-Time Clustering ANcoord NIM with disease /occur (IM); no qualif PIStatistics (66-77) MNH1.548.832.828 XSClustering FXÑDisease Outbreaks LH LS LX  MHÑSpain MNZ1.542.846 LH  MHÑSparganosis ANsee note under SPARGANUM MNC3.335.190.841 LH  MSThe larval form of the diphyllobothriid tapeworms of the genus DIPHYLLOBOTHRIUM and SPIROMETRA. Fish-eating mammals and man are the final hosts. OLsearch CESTODA 1966-74 PM79; was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64 HN79(75); was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64 MHÑSparganum ANdo not use /blood-csf-urine; both the larval stage of SPIROMETRA (a genus of DIPHYLLOBOTHRIUM) & a genus name; infection = SPARGANOSIS PICestoda (66-74); Diphyllobothrium (66-74) MNB1.500.736.215.228.831; B1.500.736.215.800.810; B1.583.382.831 LH  MS1,2,3,4-Tetrahydro-N-[1-(hydroxymethyl)-2-(((methylthio)methyl)sulfinyl)ethyl]-6-methyl-2,4-dioxo-5-pyrimidineacrylamide. An antitumor antibiotic produced by Streptomyces sparsogenes. Inhibits protein synthesis in 70S and 80S ribosomal systems. HN(75) MHÑSparsomycin ANdo not use /defic /physiol; /analogs NIM only RN1404-64-4 PIAntibiotics (74); Antibiotics, Antineoplastic (74); Ribonucleosides (74) MND20.85.75.825; D22.204.106.840 DMÑAntibiotics, Antineoplastic LH LM  MHÑSparteine ANdo not use /defic /physiol RN90-39-1 MND3.132.786; D18.97.876 LH  MHÑSpasm ANGEN or unspecified only; coord NIM with specific organ/dis (IM); ╥facial spasm╙ = SPASM (IM) + FACIAL MUSCLES (IM) MNC10.597.816; C23.888.592.826 FXÑMuscle Cramp; ÑMuscle Spasticity; ÑMyotonia LH LX; ;  MSA disorder occurring in infants characterized by convulsions and mental retardation. The EEG has a typical hypsarrhythmia pattern. Synonyms for the types of seizures are: Jackknife seizures, Salaam seizures, spasmus mutans, nodding spasm. OLuse SPASMS, INFANTILE to search HYPSARRHYTHMIA back thru 1966 PM77; was HYPSARRHYTHMIA 1963-76 HN77; was HYPSARRHYTHMIA 1963-76 MHÑSpasms, Infantile PIChild, Preschool (66-76); Convulsions (66-76); Epilepsy (66-76); Epilepsy, Petit Mal (66-76); Infant (66-76); Infant, Newborn (66-76); Myoclonus (66-76) MNC10.228.140.490.234.580; F3.709.346.875 XSHypsarrhythmia; Myoclonic Jerking, Massive; West Syndrome LH LS; ;  MSReactions of an individual or groups of individuals with relation to the immediate surrounding area including the animate or inanimate objects within that area. PM68 HN68 MHÑSpatial Behavior ANhuman & animal; no qualif PIAdaptation, Psychological (66-67); Psychotherapy (66-67) MNF1.145.875; I1.880.894 XUÑPersonal Space; ÑProxemics LH LU;  MSUse for general articles on the practice or study of a specialty field for which there is no precoordinated heading. MHÑSpecialism ANconcept of specializing in any field, medical or non-med; for general articles on specialism as a philosophy vis-a-vis ╥generalism╙; for articles on ╥X as a specialty╙ coord IM with field or subject (IM); for medical specialties, use SPECIALTIES, MEDICAL; only /hist /trends MNG2.811 LH  MSUse for general material on dental specialties. PM68 HN68 MHÑSpecialties, Dental ANonly /hist /man /stand /trends; coord IM with field or subject (IM) CATALOG: /geog /form PIDentistry (66-67); Specialism (66-67) MNG2.163.876 LH  MSUse for general material on medical specialties. PM68 HN68 MHÑSpecialties, Medical ANonly /hist /man /stand /trends; coord IM with field or subject (IM); with biog: Manual 17.2.6; policy: Manual 19.4.37, 28.5, 28.7 CATALOG: /geog /form PISpecialism (66-67) MNG2.403.776 LH  MSUse for general material on nursing specialties. PM73 HN73(71) MHÑSpecialties, Nursing ANonly /hist /man /stand /trends; coord IM with type of nursing or subject CATALOG: /geog /form PINursing (66-70) MNG2.478.676 LH  MH*Specialties, Other (Non Mesh) MNG2.403.790 LH  MSUse for general material on the surgical specialties. PM80 HN80 MHÑSpecialties, Surgical ANonly /hist /man /stand /trends; coord IM with field or subject (IM) PICertification (68-77); Specialty Boards (77-79); Surgery (66-79) MNG2.403.810 LH  MSOrganizations which certify physicians and dentists as specialists in various fields of medical and dental practice. HN(Aug 77) MHÑSpecialty Boards ANonly /class /hist /legis /stand /trends; specify specialty (IM) + geog PICertification (68-Jul 77); specific specialty MNN3.706.110.120.580 DMÑCertification LH LM  MSRestriction of a characteristic or response to the members of one species; it usually refers to that property of the immune response which differentiates one species from another on the basis of antigen recognition, but the concept is not limited to immunology and is used loosely at levels higher than the species. PM66 HN66(64) MHÑSpecies Specificity ANNIM; no qualif; may refer to phylum, class, order, family, genus or strain as well as species: TN 176; do not limit to immunol specificity MNG4.610.106.759; G4.875 LH  PM68 HN68 MHÑSpecific Gravity ANNIM; no qualif PIChemistry, Physical (66-67) MNH1.181.529.845 LH  MSAnimals raised in the absence of a particular known disease-causing organism. OLsearch GERM-FREE LIFE 1969-74 HN(75) MHÑSpecific Pathogen Free ANonly /drug eff /rad eff MNG4.185.515.372.676 DMÑGerm-Free Life LH LM  MSProcedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation. MHÑSpecimen Handling ANincludes ╥collection╙; only /econ /instrum /methods /stand /vet MNE1.223.894 LH  MSA high molecular weight (220,000-250,000) water-soluble protein which can be extracted from erythrocyte ghosts in low ionic strength buffers. The protein contains no lipids or carbohydrates, is the predominant species of peripheral erythrocyte membrane proteins and exists as a fibrous coating on the inner, cytoplasmic surface of the membrane. PM84; was see under MEMBRANE PROTEINS 1978-83, was see under BLOOD PROTEINS 1977 HN84(77); was see under MEMBRANE PROTEINS 1978-83, was see under BLOOD PROTEINS 1977 MHÑSpectrin ANfrom erythrocytes; /biosyn /physiol permitted; do not use /analogs /blood RN12634-43-4 PIBlood Proteins (66-76); Cell Membrane (66-75); Erythrocytes (66-75) MND12.776.124.875; D12.776.543.980 LH  OLuse SPECTROMETRY, FLUORESCENCE to search FLUORESCENCE SPECTROPHOTOMETRY back thru 1972 (as Prov 1972-73) PM74 HN74; was FLUORESCENCE SPECTROPHOTOMETRY 1972-73 (Prov) MHÑSpectrometry, Fluorescence ANNIM; only /instrum /methods /stand PIFluorescence (66-71); Spectrum Analysis (66-71) MNE5.196.712.382.676; E5.196.867.726; H1.181.278.862.726 XSFLUORESCENCE SPECTROPHOTOMETRY; SPECTROFLUOROMETRY LH LS;  OLuse SPECTROMETRY, GAMMA to search GAMMA SPECTROMETRY back thru 1969 (as Prov 1969-73) PM74 HN74; was GAMMA SPECTROMETRY 1969-73 (Prov) MHÑSpectrometry, Gamma ANNIM; only /instrum /methods /stand PIRadiometry (66-68); Spectrum Analysis (66-68) MNE5.196.867.776; E5.799.801; H1.181.278.862.776; H1.671.768.765.826 XSGAMMA SPECTROPHOTOMETRY LH LS  MSIdentification and measurement of concentration of elements based on the fact that x-rays emitted by an excited element have a wavelength characteristic of that element and an intensity related to its concentration. Includes fluorescence, or secondary-emission, x-ray spectrometry, in which the specimen is irradiated by x-rays. Primary-emission x-ray spectrometry, in which the specimen is bombarded by electrons, is a specific type of x-ray emission spectrometry known as ELECTRON PROBE MICROANALYSIS. PM78 HN78 MHÑSpectrometry, X-Ray Emission ANNIM; only /instrum /methods /stand; do not confuse with any of numerous X refs under ELECTRON PROBE MICROANALYSIS; PIXE or proton-induced x-ray emission: index under SPECTROMETRY, X-RAY EMISSION (IM) + PROTONS (NIM) PIFluorescence (66-77); Spectrometry, Fluorescence (72-77); Spectrum Analysis (66-77); X-Rays (75-77) MNE5.196.867.800; E5.799.830; H1.181.278.862.800 XSSpectrometry, X-Ray Fluorescence; X-Ray Emission Spectrometry; X-Ray Fluorescence Spectrometry LH LS; ;  MSThe art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum. MHÑSpectrophotometry ANNIM; only /instrum /methods /stand MNE5.196.712.726; E5.196.867.826; H1.181.278.862.826 LH  PM74 HN74(72) MHÑSpectrophotometry, Atomic Absorption ANNIM; only /instrum /methods /stand PISpectrophotometry (66-71) MNE5.196.712.726.551; E5.196.867.826.551; H1.181.278.862.826.551 LH  PM73 HN73 MHÑSpectrophotometry, Infrared ANNIM; only /instrum /methods /stand; 770-1500 millimus PISpectrophotometry (66-72) MNE5.196.712.726.676; E5.196.867.826.676; H1.181.278.862.826.676 LH  PM73 HN73 MHÑSpectrophotometry, Ultraviolet ANNIM; only /instrum /methods /stand; 180-390 millimus PISpectrophotometry (66-72) MNE5.196.712.726.802; E5.196.867.826.802; H1.181.278.862.826.802 LH  MHÑSpectrum Analysis ANNIM; only /instrum /methods /stand; infrared = SPECTROPHOTOMETRY, INFRARED; ultraviolet = SPECTROPHOTOMETRY, ULTRAVIOLET; x-ray absorption spectroscopy goes here + X-RAYS (NIM) MNE5.196.867; H1.181.278.862 XSSPECTROSCOPY XUÑCircular Dichroism; ÑPulse Radiolysis LH LS LU;  OLuse SPECTRUM ANALYSIS, MASS to search MASS SPECTRUM ANALYSIS back thru 1971 (as Prov 1971-73) PM74 HN74; was MASS SPECTRUM ANALYSIS 1971-73 (Prov) MHÑSpectrum Analysis, Mass ANNIM; only /instrum /methods /stand PISpectrum Analysis (66-70) MNE5.196.867.877; H1.181.278.862.877 XSMass Spectrometry; Spectrometry, Mass LH LS;  MSAnalysis of the intensity of Raman scattering of monochromatic light as a function of frequency of the scattered light. PM77 HN77 MHÑSpectrum Analysis, Raman ANNIM; only /instrum /methods /stand PIScattering, Radiation (71-76); Spectrum Analysis (66-76) MNE5.196.867.890; H1.181.278.862.880; H1.671.768.831.860 XSRaman Spectroscopy LH LS  MSCommunication through a system of conventional vocal symbols. MHÑSpeech AN= LANGUAGE as it comes out of the mouth; VERBAL BEHAVIOR is how it comes out; PHONETICS is the sounds making up SPEECH; only /drug eff /physiol /rad eff; Amer Speech & Hear Assoc: index under SPEECH PATHOLOGY (IM) + AUDIOLOGY (IM) + SOCIETIES (IM) + UNITED STATES (NIM) MNF1.145.209.908.677; G11.561.854; L1.143.506.423.676 FXÑLanguage Development; ÑVERBAL BEHAVIOR XUÑSpeech Acoustics LH LX; LU  MSThe acoustic aspects of speech in terms of frequency, intensity and time. HN(80) MHÑSpeech Acoustics ANno qualif PIAcoustics (66-79); Phonetics (66-79); Speech (66-79); Voice (66-79) MNG11.561.854.650 XSAcoustics, Speech DMÑSpeech LH LS LM  MSTests of accuracy in pronouncing speech sounds, e.g., Iowa Pressure Articulation Test, Deep Test of Articulation, Templin-Darley Tests of Articulation, Goldman-Fristoe Test of Articulation, Screening Speech Articulation Test, Arizona Articulation Proficiency Scale. HN(79) MHÑSpeech Articulation Tests ANonly /instrum /methods /stand /util (if by MeSH definition) MNE1.881.929 DMÑSpeech Production Measurement LH LM  MSTests of the ability to hear and understand speech as determined by scoring the number of words in a word list repeated correctly. PM79 HN79 MHÑSpeech Discrimination Tests ANthe examinee hears & understands the examiner's speech; do not confuse with SPEECH INTELLIGIBILITY (the speaker speaks in such a way that the hearer understands him); only /instrum /methods /stand /util (if by MeSH definition) PIAudiometry (66-78); Discrimination (Psychology) (66-78); Speech (66-78) MNE1.276.299.375.297.105.890 XUÑSpeech Reception Threshold Test LH LU  MSAny long term disorder in speaking or in perception of speech (sometimes also of writing or of gestures) so grave as to interfere seriously with communication. MHÑSpeech Disorders ANdo not use /congen /drug eff /physiol /rad eff; /ther: consider also SPEECH THERAPY; do not confuse with LANGUAGE DISORDERS: read differentiation of SPEECH & LANGUAGE above under SPEECH MNC10.597.257.870; C23.888.592.257.870; F3.126.219.870 FXÑVelopharyngeal Insufficiency; ÑVerbal Behavior XUÑDysarthria LH LX; LU  MSAbility to make speech sounds that are recognizable. PM79 HN79 MHÑSpeech Intelligibility ANthe speaker's speech is understood or not understood by the hearer; do not confuse with SPEECH DISCRIMINATION TESTS (the examinee hears & understands the examiner's speech); only /drug eff /physiol /rad eff PIAuditory Perception (67-78); Speech (66-78) MNF1.145.209.908.677.610; G11.561.854.686 FXÑSpeech Production Measurement LH LX  MSThe study of speech disorders and their diagnosis and correction. OLsearch SPEECH THERAPY 1966-79 PM80; was included in SPEECH THERAPY 1966-79 HN80; was included in SPEECH THERAPY 1964-79 (Prov 1964-65) MHÑSpeech Pathology ANSPEC: SPEC qualif; the specialty devoted to study of speech disord, their diag & ther; do not confuse with the patient or dis ( = SPEECH DISORDERS); Amer Speech & Hear Assoc: index under SPEECH PATHOLOGY (IM) + AUDIOLOGY (IM) + SOCIETIES (IM) + UNITED STATES (NIM) PISpeech Therapy (66-79) MNG2.825 LH  MSThe process whereby an utterance is decoded into a representation in terms of linguistic units (sequences of phonetic segments which combine to form lexical and grammatical morphemes). PM79 HN79 MHÑSpeech Perception ANonly /drug eff /physiol /rad eff PIAuditory Perception (67-78); Hearing (66-67); Perception (66-67); Speech (66-78) MNF2.463.593.800 XSSpeech Discrimination LH LS  MSMeasurement of parameters of the speech product such as vocal tone, loudness, pitch, voice quality, articulation, resonance, phonation, phonetic structure and prosody. PM79 HN79 MHÑSpeech Production Measurement ANonly /instrum /methods /stand /util (if by MeSH definition) PISpeech (66-78) MNE1.881 FXÑSpeech Intelligibility XUÑSpeech Articulation Tests LH LX LU  MSA test to determine the lowest sound intensity level at which fifty percent or more of the spondaic test words (words of two syllables having equal stress) are repeated correctly. Syn: SRT. HN(79) MHÑSpeech Reception Threshold Test ANonly /instrum /methods /stand /util (if by MeSH definition); DF: SRT TEST PIAudiometry (66-78); Auditory Threshold (68-78); Hearing (66-67); Speech (66-78) MNE1.276.299.375.297.105.902 DMÑSpeech Discrimination Tests LH LM  PM66 HN66(64); was in Cat E & G 1973-79, was in Cat G only 1968-72, was in Cat E only 1964-67 MHÑSpeech Therapy ANonly /econ /educ /hist /instrum /methods /psychol /trends; do not confuse with LANGUAGE THERAPY: SPEECH THERAPY is for SPEECH DISORDERS, LANGUAGE THERAPY is for LANGUAGE DISORDERS; coord IM with specific speech disord /ther (IM), not /rehabil MNE2.831.727.552 FXÑVOICE TRAINING LH LX  MSMethods of enabling a patient without a larynx or with a non-functional larynx to produce voice or speech; includes electronic devices. OLuse SPEECH, ALARYNGEAL to search VOICE PRODUCTION, ALARYNGEAL back thru 1968 PM80; was VOICE PRODUCTION, ALARYNGEAL 1968-79 HN80; was VOICE PRODUCTION, ALARYNGEAL 1968-79 MHÑSpeech, Alaryngeal ANonly /instrum /methods /psychol MNE2.831.727.541 FXÑLaryngectomy; ÑLarynx, Artificial XUÑSpeech, Esophageal LH LX; LU  OLsearch SPEECH, ALARYNGEAL 1966-74 (as Prov 1966-67) HN(75)(65-67); was see under VOICE PRODUCTION, ALARYNGEAL 1968-79 MHÑSpeech, Esophageal ANonly /instrum /methods /psychol MNE2.831.727.541.677 DMÑSpeech, Alaryngeal LH LM  MSAgglutination of spermatozoa by antibodies or autoantibodies. PM75 HN75 MHÑSperm Agglutination ANonly /drug eff /rad eff PISpermatozoa MNG4.610.143.100.700 LH  MSCenters for acquiring and storing semen. HN(82) MHÑSperm Banks ANdo not use /educ /methods PIInsemination, Artificial (78-81); Semen Preservation (78-81); Spermatozoa (78-81); Tissue Banks (78-81) MNN2.278.920.700 DMÑTissue Banks LH LM  MSThe process by which spermatozoa become capable of fertilizing an ovum after it reaches the ampullary portion of the uterine tube. PM73 HN73(72) MHÑSperm Capacitation ANonly /drug eff /rad eff PISpermatozoa (66-71) MNG8.520.277.760 LH  MSA count of sperm in the ejaculum, expressed as number per milliliter. PM80 HN80 MHÑSperm Count ANonly /drug eff /instrum /methods /rad eff /vet PICell Count (69-79); Oligospermia (75-79); Spermatozoa (66-79) MNE1.223.920; G7.380.870 XSSperm Number FXÑCell Count LH LS LX  MSThe anterior, usually ovoid, nucleus-containing part of spermatozoa. HN(75) MHÑSperm Head ANA 11 qualif except /cytol; /growth permitted MNA5.360.490.890.820; A11.497.760.400 DMÑSpermatozoa LH LM  MSChemical substances with sperm immobilizing activity used as topically administered vaginal contraceptives. PM75 HN75 MHÑSperm Immobilizing Agents ANdo not use /analogs /biosyn /defic /physiol; consider also SPERM MOTILITY /drug eff, etc. PIContraceptive Agents (67-74); Spermatozoa/DE (66-74) MND7.360.276.727 LH  MSPosttesticular ripening of spermatozoa. PM76; was see under SPERMATOZOA 1975 HN76(75); was see under SPERMATOZOA 1975 MHÑSperm Maturation ANonly /drug eff /rad eff; /drug eff: consider also SPERM MATURATION BLOCKING AGENTS PISpermatozoa (66-74) MNG8.520.310.760.700 FXÑSpermatocytes LH LX  MSChemical substances which prevent the maturation of post testicular spermatozoa. PM75 HN75 MHÑSperm Maturation Blocking Agents ANdo not use /analogs /biosyn /defic /physiol; consider also SPERM MATURATION /drug eff PIContraceptive Agents (67-74); Spermatozoa/DE (66-74) MND7.360.443.288.593 LH  MSAbility of the spermatozoon to move by flagellate swimming. PM76; was see under SPERMATOZOA 1975 HN76(75); was see under SPERMATOZOA 1975 MHÑSperm Motility ANonly /drug eff /rad eff; /drug eff: consider also SPERM IMMOBILIZING AGENTS PISpermatozoa (66-74) MNG4.335.283.750; G8.520.277.780 LH  MSThe posterior, filiform part of spermatozoa, which provides sperm motility. HN(75) MHÑSperm Tail ANA 11 qualif except /cytol; /growth permitted MNA5.360.490.890.840; A11.497.760.500 XSSperm Flagellum DMÑSpermatozoa LH LS LM  MSPassive transport or active migration of spermatozoa from the testes through the male genital system as well as within the female genital system. PM76; was see under SPERMATOZOA 1975 HN76(75); was see under SPERMATOZOA 1975 MHÑSperm Transport AN╥passive transport or active migration of spermatozoa from the testes through the male genital system as well as within the female genital system╙; only /drug eff /rad eff PISpermatozoa (66-74) MNG4.335.283.800; G8.520.277.820 LH  MSInteractive processes between the ovum and the spermatozoon. PM85; was see under FERTILIZATION 1975-84 HN85(75); was see under FERTILIZATION 1975-84 MHÑSperm-Ovum Interactions ANonly /drug eff /rad eff MNG8.520.277.800 XSOvum-Sperm Interactions; Sperm Penetration LH LS;  MHÑSpermatic Cord ANdiseases: coord IM with GENITAL DISEASES, MALE (NIM) MNA5.360.444.777 LH  MHÑSpermatic Cord Torsion MNC12.294.693 XSTESTICULAR TORSION LH LS  MSMale germ cells derived from spermatocytes and develop into spermatozoa. PM85; was see under SPERMATOZOA 1975-84 HN85(75); was see under SPERMATOZOA 1975-84 MHÑSpermatids ANA 11 qualif & /growth PISpermatozoa (66-74) MNA5.360.490.890.860; A11.497.760.600 XSSpermatoblasts LH LS  MHÑSpermatocele MNC12.294.731 LH  MSChemical substances with spermatocidal activity used as topically administered vaginal contraceptives. PM75 HN75 MHÑSpermatocidal Agents ANdo not use /analogs /biosyn /defic /physiol; consider also SPERMATOZOA /drug eff PIContraceptive Agents (67-74); Spermatozoa/DE (66-74) MND7.360.276.827 XSSpermicidal Agents LH LS  MSMale germ cells derived from spermatogonia and develop into spermatids. PM85; was see under SPERMATOZOA 1975-84 HN85(75); was see under SPERMATOZOA 1975-84 MHÑSpermatocytes ANA 11 qualif & /class /growth PISpermatozoa (66-74) MNA5.360.490.890.880; A11.497.760.700 XSSpermiocytes FXÑSperm Maturation LH LS LX  MSProcess of formation and development of spermatozoa, including spermatocytogenesis and spermiogenesis. PM73 HN73(71) MHÑSpermatogenesis ANonly /drug eff /rad eff; spermatocytogenesis & spermiogenesis go here; /drug eff: consider also SPERMATOGENESIS BLOCKING AGENTS & ANTISPERMATOGENIC AGENTS PISpermatozoa (66-70) MNG8.520.310.760 LH  MSChemical Substances which prevent the process of spermatogenesis. PM75 HN75 MHÑSpermatogenesis Blocking Agents ANdo not use /analogs /biosyn /defic /physiol; consider also SPERMATOGENESIS /drug eff & ANTISPERMATOGENIC AGENTS PIContraceptive Agents (67-74); Spermatogenesis/DE (71-74) MND7.360.443.288.760 LH  MSThe primitive differentiated male gametes which give rise to spermatocytes. HN(75) MHÑSpermatogonia ANA 11 qualif & /growth MNA5.360.490.890.900; A11.497.760.800 XSSpermatophores DMÑSpermatozoa LH LS LM  MHÑSpermatozoa ANA 11 qualif & /abnorm /class /growth; polyspermia & polyspermy = SPERMATOZOA if excessive sperm or = FERTILIZATION if fertilization of ovum by more than one sperm; azoospermia: index under OLIGOSPERMIA; /drug eff: consider SPERMATOCIDAL AGENTS, ANTISPERMATOGENIC AGENTS & others in D7; sperm donors: index under INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband) but note SPERM BANKS is available; hemospermia: index under BLOOD (IM) + SEMEN (IM) MNA5.360.490.890; A11.497.760 XSSperm FXÑOligospermia; ÑSemen XUÑAcrosome; ÑSperm Head; ÑSperm Tail; ÑSpermatogonia LH LS LX; LU; ; ;  PM73 HN73(71) MHÑSpermidine ANdo not use /defic /physiol RN124-20-9 PIAmines (66-70) MND2.92.782.677 LH  MHÑSpermine ANdo not use /defic /physiol RN71-44-3 MND2.92.782.802 LH  MSCatalyzes the transfer of the propylamine moiety from 5'-deoxy-5'-S-(3-methylthiopropylamine)sulfonium adenosine to spermidine in the biosynthesis of spermine. The enzyme has an acidic isoelectric point at pH 5.0. HN(75) MHÑSpermine Synthase ANdo not confuse with SPERMIDINE SYNTHASE; do not use /analogs RNEC 2.5.1.- PIPropylamines (72-74); Spermine (72-74); Transferases (72-74) MND8.586.913.805 XSSpermine Synthetase DMÑTransferases LH LS LM  MSAn order of ascomycetous fungi which includes many economically important plant parasites as well as saprophytes. OLsearch ASCOMYCETES 1966-74 HN(75) MHÑSphaeriales ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.107.877 DMÑAscomycetes LH LM  MHÑSphaerotilus ANin fresh water MNB3.800.760 LH  MHÑSphenoid Bone ANfractures: coord SPHENOID BONE /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with SKULL NEOPLASMS (IM) MNA2.835.232.781.802 LH  MSOne of the paired paranasal sinuses, located in the body of the sphenoid bone and communicating with the highest meatus of the nasal cavity on the same side. MHÑSphenoid Sinus ANinflammation or sinusitis: coord NIM with SINUSITIS (IM); fractures: coord SPHENOID SINUS /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with PARANASAL SINUS NEOPLASMS (IM) MNA4.621.827 LH  OLsearch ERYTHROCYTES, ABNORMAL 1966-74 (as Prov 1966-67) HN(75)(63-67) MHÑSpherocytes ANA 11 qualif & /class MNA11.118.413.330.802; A15.145.229.413.330.802 DMÑErythrocytes, Abnormal LH LM  MSA familial congenital hemolytic anemia characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions. MHÑSpherocytosis, Hereditary ANdo not use /congen MNC15.378.71.141.150.785 FXÑAnemia, Sideroblastic LH LX  PM74 HN74(72) MHÑSpheroplasts ANA 11 qualif; /class /isol permitted PIL Forms (66-71) MNA11.868; B3.110.761 LH  PM74 HN74 MHÑSphingolipidosis MNC18.452.648.556.641.803 LH  OLsearch LIPIDS 1966-70 PM72; was see under LIPIDS 1963-71 HN72(71); was see under LIPIDS 1963-71 MHÑSphingolipids ANdo not use /analogs PILipids (66-70) MND10.516.695.850; D10.516.808 LH  MSCatalyzes the hydrolysis of sphingomyelin to ceramide (N-acylsphingosine)plus choline phosphate. Defect in this enzyme leads to Niemann-Pick disease. HN(75) MHÑSphingomyelin Phosphodiesterase ANdo not use /analogs; /defic: consider also NIEMANN-PICK DISEASE RNEC 3.1.4.12 PIPhosphodiesterases (73-74); Sphingomyelins (73-74) MND8.586.277.352.630.553.830 XSSphingomyelin Cholinephosphohydrolase; Sphingomyelin Cleaving Enzyme; Sphingomyelinase DMÑPhosphodiesterases LH LS; ; LM  PM66; was see under PHOSPHOLIPIDS 1963-65 HN66(63); was see under PHOSPHOLIPIDS 1963-65 MHÑSphingomyelins ANdo not use /analogs MND10.516.695.850.878; D10.516.808.187.828 LH  PM72 HN72 MHÑSphingosine ANdo not use /biosyn /defic /physiol RN123-78-4 PIAmino Alcohols (66-71); Glycols (66-71) MND2.33.329.291.846; D2.33.618.843; D2.92.63.291.846 XUÑPsychosine LH LU  MSVenoms of arthropods of the order Araneida of the Arachnida; the venoms usually contain several protein fractions, including enzymes, hemolytic, neurolytic and other toxins. Tarantula venoms go here. HN(78) MHÑSpider Venoms ANdo not use /analogs /chem syn /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS PISpiders (66-77); Venoms (66-77) MND24.185.965.65.870 XSAraneid Venoms DMÑArthropod Venoms LH LS LM  MHÑSpiders ANIM; /microbiol /parasitol permitted; spider bites = ARACHNIDISM; several venomous genera: Latrodectus (black widow), Loxosceles (brown recluse), Tarantula MNB1.131.166.803 XUÑBlack Widow Spider LH LU  PM74 HN74 MHÑSpin Labels ANonly /chem syn MND2.389.678 FXÑElectron Spin Resonance LH LX  MSA developmental anomaly characterized by defective closure of the spinal column due to a defect in the development of the vertebrae. MHÑSpina Bifida ANdo not use /congen; open or aperta = SPINA BIFIDA CYSTICA see MENINGOMYELOCELE; occulta goes here MNC16.131.621.824; C16.131.666.680.836.843 LH  MHÑSpinal Canal ANdo not use /innerv; do not use vertebra headings to locate level of spinal canal; ╥narrowing of the spinal canal╙ = SPINAL STENOSIS MNA2.835.232.834.803 XUÑEpidural Space LH LU  MHÑSpinal Cord AN/inj = SPINAL CORD INJURIES; /radiogr permitted but consider MYELOGRAPHY; do not use /innerv; /surg: probably CHORDOTOMY; inflammation = MYELITIS; do not use vertebra headings to locate site on spinal cord; consider also other spinal cord concepts under MYEL- but be careful: some MYEL- words refer to the bone marrow MNA8.186.854 FXÑChordotomy; ÑMyelography XUÑSubstantia Gelatinosa LH LX; LU  MHÑSpinal Cord Compression ANdo not use vertebra headings to locate site on spinal cord; not for ╥cauda equina syndrome╙: use CAUDA EQUINA (IM) + NERVE COMPRESSION SYNDROMES (IM) MNC10.228.854.761; C21.866.819.678 LH  PM66 HN66 MHÑSpinal Cord Diseases ANinflamm dis = MYELITIS MNC10.228.854 LH  MHÑSpinal Cord Injuries ANdo not use vertebra headings to locate site on spinal cord MNC21.866.819 LH  MHÑSpinal Cord Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) but do not use vertebra headings to locate site on spinal cord MNC4.588.614.803; C10.228.854.780 LH  MH*Spinal Curvatures (Non Mesh) MNC5.878.616 LH  MHÑSpinal Diseases ANdo not confuse with SPINAL CORD DISEASES; NIM when specific vertebrae are IM; inflamm dis = SPONDYLITIS; spondylosis is indexed SPINAL OSTEOPHYTOSIS (IM) + specific vertebrae (IM) MNC5.878 LH  MHÑSpinal Fusion ANdo not use /util except by MeSH definition MNE4.557.126.678 FXÑLaminectomy LH LX  MHÑSpinal Injuries ANdo not confuse with SPINAL CORD INJURIES; GEN only, vertebrae unspecified MNC21.866.831 LH  MHÑSpinal Neoplasms ANdo not confuse with SPINAL CORD NEOPLASMS; coord IM with specific vertebrae (IM) + histol type of neopl (IM); /anal /blood supply /secret /ultrastruct permitted MNC4.588.149.828; C5.878.678 LH  PM73 HN73(70) MHÑSpinal Nerve Roots ANdo not use /innerv; DORSAL ROOT GANGLIA is see GANGLIA, SPINAL; inflammation = RADICULITIS (single root) or POLYRADICULITIS (several roots) or POLYRADICULONEURITIS (nerve roots & peripheral nerves); do not use vertebra headings to locate area of spinal nerves; nerve root compression: coord IM with NERVE COMPRESSION SYNDROMES (IM), not SPINAL CORD COMPRESSION PISpinal Nerves (66-69) MNA8.796.728 LH  MHÑSpinal Nerves ANdo not use /innerv; do not use vertebra headings to locate area of spinal nerves MNA8.796.828 XUÑSural Nerve LH LU  PM65 HN65 MHÑSpinal Osteophytosis ANspondylosis: coord SPINAL OSTEOPHYTOSIS (IM) + specific vertebrae (IM) MNC5.550.114.606.761; C5.799.613.678; C5.878.741 XSOSTEOPHYTOSIS, SPINAL; SPONDYLOSIS DEFORMANS XUÑDiffuse Idiopathic Skeletal Hyperostosis LH LS; LU  MSTapping of the subarachnoid space in the lumbar region, usually between the third and fourth lumbar vertebra. MHÑSpinal Puncture ANdo not use /util except by MeSH definition MNE1.223.894.632.804; E1.236.890 XSLumbar Puncture LH LS  MSNarrowing of the spinal canal. PM83 HN83 MHÑSpinal Stenosis AN╥narrowing of the spinal canal╙; do not use vertebra headings to locate level of spinal canal PIConstriction, Pathologic (76-82); Lumbar Vertebrae (66-82); Spinal Canal (66-82); Spinal Diseases (66-82) MNC5.878.772 LH  MHÑSpine AN/inj = SPINAL INJURIES; specific vertebrae are available with /inj; inflammation = SPONDYLITIS; spondylosis is indexed SPINAL OSTEOPHYTOSIS (IM) + specific vertebrae (IM) MNA2.835.232.834 FXÑLaminectomy LH LX  MSDegeneration of the nervous system involving the cerebellum and its afferent and efferent pathways. Ataxia is a principal symptom and most of these conditions are hereditary. PM87 HN87 MHÑSpinocerebellar Degenerations PICerebellar Ataxia (68-86); Cerebellar Diseases (66-86); Spinal Cord Diseases (66-86) MNC10.228.140.252.253.871 XSAtaxias, Hereditary; Machado-Joseph Disease; Marinesco-Sjogren Syndrome; Roussy-Levy Syndrome; Spinocerebellar Ataxias XUÑOlivopontocerebellar Atrophy LH LS; ; ; ; LU  PM71 HN71 MHÑSpinothalamic Tracts ANdo not use /innerv PISpinal Cord (66-70); Thalamus (66-70) MNA8.186.854.761; A8.612.220.735 LH  MS8-[3-(p-Fluorobenzoyl)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one. Spiro butyrophenone analog related to benperidol, droperidol, haloperidol, etc. Synonyms: Spiropitan; R 5147. PM87; was see under BUTYROPHENONES 1975-86 HN87(75); was see under BUTYROPHENONES 1975-86 MHÑSpiperone ANdo not use /biosyn /defic /physiol RN749-02-0 PIBenzoates (66-74); Butyrophenones (66-74); Spiro Compounds (66-74) MND2.522.352.800; D4.615.885.800; D15.236.872.331.241.800 XSSpiroperidol; Spiroperone LH LS;  MH*Spiral and Curved Bacteria (Non Mesh) MNB3.825 LH  MSElongated collection of nerve cells from the cochlear branch of the acoustic nerve which pass from the modiolus to the organ of Corti. HN(79) MHÑSpiral Ganglion ANdo not use /innerv PICochlea (66-78); Cochlear Nerve (66-78); Ganglia (66-78); Organ of Corti (68-78) MNA8.796.214.125.271.817; A9.246.631.246.292.851 XSGanglion of Corti DMÑCochlea LH LS LM  MSThe bony plate which extends outwards from the modiolus. It is part of the structure which divides trhe cochlea into sections. HN(79) MHÑSpiral Lamina PICochlea (66-78) MNA9.246.631.246.930 DMÑCochlea LH LM  MSA family of Gram-negative, curved or spiral bacteria, largely water forms, although some are parasitic on or pathogenic to higher animals and man. PM75 HN75 MHÑSpirillaceae ANlargely water forms PIBacteria (66-74) MNB3.825.850 LH  MHÑSpirillum ANdo not use /blood-csf-urine; one species causes one type of RAT-BITE FEVER MNB3.825.850.679 LH  MSReligious philosophy expressing the fundamental belief that departed spirits may be contacted by the living through a medium. MHÑSpiritualism ANno qualif; do not confuse with SPIRITUAL HEALING see MENTAL HEALING MNK1.844.799.679 LH  MHÑSpiro Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: SPIRO CPDS MND4.615.885 XUÑFenspiride; ÑFluorescamine; ÑFluspirilene; ÑLeucogenenol LH LU; ; ;  MSA genus of flexible spiral rods found in hydrogen sulfide-containing mud, in sewage and in polluted water; none of the species properly referred to the genus Spirochaeta in the American literature are pathogenic. MHÑSpirochaeta ANa genus of the family SPIROCHAETACEAE of the order SPIROCHAETALES; do not confuse with common term ╥spirochete╙ which refers to SPIROCHAETALES; found in mud & slime MNB3.851.595.679 LH  MSA family of spiral bacteria of the order Spirochaetales. PM75 HN75 MHÑSpirochaetaceae ANa family in the order SPIROCHAETALES; in stagnant water & in bivalve mollusks; do not use /blood-csf-urine PIBacteria (66-74) MNB3.851.595 LH  MSAn order of slender, flexuous, helically coiled bacteria, with one or more complete turns in the helix. PM76; was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74 HN76(66); was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74 MHÑSpirochaetales ANloosely referred to as ╥spirochetes╙; pathogenic & non-pathogenic; do not use /blood-csf-urine; Treponemataceae goes here; infection = SPIROCHAETALES INFECTIONS MNB3.851 LH  MSInfections by spirochetes in general or species not identified in Bergey. OLuse SPIROCHAETALES INFECTIONS to search SPIROCHETE INFECTIONS back thru 1972 PM79; was SPIROCHETE INFECTIONS 1972-78 HN79; was SPIROCHETE INFECTIONS 1972-78 MHÑSpirochaetales Infections ANinfection by ╥spirochetes╙; GEN or unspecified only: prefer specific spirochete infection PISpirochaeta (66-71) MNC1.252.847 XSSpirochete Infections LH LS  MSA genus of tapeworms of the family Diphyllobothriidae, which are parasites of fish-eating cats, dogs and birds. Infection in man is caused by eating undercooked fish. The larval form is called SPARGANUM. OLsearch SPARGANUM 1975-78 HN(86)79; was see SPARGANUM 1975-78 MHÑSpirometra ANgenus of tapeworm Diphyllobothriidae; larval form is SPARGANUM; infection: coord NIM with DIPHYLLOBOTHRIASIS (IM) PICestoda (66-78); Sparganum (75-78) MNB1.500.736.215.800 DMÑCestoda LH LM  MSMeasurement of volume of air inhaled or exhaled by the lung. MHÑSpirometry ANNIM; do not use /util except by MeSH definition; BRONCHOSPIROMETRY is also available MNE1.302.796.733 LH  MHÑSpironolactone ANdo not use /biosyn /defic /physiol RN52-01-7 MND2.540.679; D4.808.745.745.855; D6.347.50.735; D19.770.224.862 XSSpirolactone LH LS  MSGram-positive organisms isolated from the leaves of citrus plants affected by ╥Stubborn╙ disease. PM76 HN76 MHÑSpiroplasma ANin citrus plants PIBacteria (66-74); Mycoplasmatales (75) MNB3.600.700 LH  PM68 HN68 MHÑSpirostans ANincludes spirostenes, spirostadienes, spirostatrienes; do not use /analogs /biosyn /defic /physiol MND4.808.854 LH  MSA superfamily of parasitic nematodes which requires one or two intermediate arthropod hosts before finally being eaten by the final host. Occurs rarely in man. OLuse SPIRUROIDEA to search FILARIA LABIALIS, GONGYLONEMA & PHYSALOPTERA back thru 1966 PMGONGYLONEMA & PHYSALOPTERA were see under SPIRUROIDEA 1963-85, FILARIA LABIALIS was see under SPIRUROIDEA 1963-78 HNGONGYLONEMA & PHYSALOPTERA were see under SPIRUROIDEA 1963-85; FILARIA LABIALIS was see under SPIRUROIDEA 1963-78 MHÑSpiruroidea ANa superfamily of nematodes; do not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.680 XSGongylonema; Habronema; Physaloptera; Tetrameres LH LS; ; ;  MSThe circulation of blood through the vessels supplying the abdominal viscera. PM81 HN81 MHÑSplanchnic Circulation ANonly /drug eff /rad eff MNG9.330.163.881 XSMesenteric Circulation LH LS  MHÑSplanchnic Nerves ANdo not use /innerv MNA8.99.893.596 LH  MHÑSpleen ANin addition to SPLENIC DISEASES, note specifics below; /inj: consider also SPLENIC RUPTURE but traumatic spleen perforation is indexed under SPLEEN /inj; splenosis: index under SPLEEN (no qualif) (IM) + HETEROTOPIC TISSUE (IM) + organ/neopl term which is site of splenic tissue (IM) if specified MNA15.382.520.604.713 FXÑLymphoid Tissue LH LX  MSMurine leukemia viruses which are replication-defective and rapidly transforming. The envelope gene plays an essential role in initiating erythroleukemia, manifested by splenic foci, splenomegaly, and polycythemia. At least four types exist: Friend P(polycythemia), Friend A(anemia), Rauscher, and Cas(from wild mice at Lake Casita, CA). HN(86) MHÑSpleen Focus-Forming Viruses ANdo not use /blood-csf-urine /cytol; infection: coord NIM with LEUKEMIA, EXPERIMENTAL (IM); DF: SFFV PIFriend Virus (66-85); Leukemia, Experimental (66-85); Mouse Leukemia Viruses (66-85) MNB4.909.574.807.674.632.869; B4.909.777.731.674.632.869; B4.909.777.779.674.632.869 DMÑMouse Leukemia Viruses LH LM  MHÑSplenectomy ANdo not use /util except by MeSH definition; coord IM with non-splenic dis /ther (IM), not /surg MNE4.726 LH  MSThe largest branch of the celiac trunk with distribution to the spleen, pancreas, stomach and greater omentum. MHÑSplenic Artery ANdo not use /blood supply MNA7.231.114.814 LH  PM66 HN66 MHÑSplenic Diseases MNC15.604.744 LH  MHÑSplenic Infarction ANDF: SPLENIC INFARCT MNC15.604.744.617 FXÑInfarction LH LX  MHÑSplenic Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.842; C15.604.744.680 LH  MHÑSplenic Rupture ANtraumatic or spontaneous; if spontaneous coord IM with RUPTURE, SPONTANEOUS (NIM); differentiate from traumatic spleen perforation ( = SPLEEN /inj) MNC15.604.744.742; C21.866.17.680; C21.866.761.555 LH  MSVein formed by the union (at the hilus of the spleen) of several small veins from the stomach, pancreas, spleen and mesentery. MHÑSplenic Vein ANdo not use /blood supply MNA7.231.908.670.730 LH  MHÑSplenomegaly ANIM only if point of article; do not index at all if the usual symptom of a disease; NIM if merely one of many symptoms in article MNC15.604.744.805 LH  MSAnastomosis of splenic vein to renal vein to relieve portal hypertension. HN(81) MHÑSplenorenal Shunt, Surgical ANdo not use /util except by MeSH definition; DF: SPLENORENAL SHUNT PIEsophageal and Gastric Varices/SU (66-80); Hypertension, Portal/SU (66-80); Renal Veins/SU (66-80); Splenic Vein/SU (66-80) MNE4.752.814.790.870 DMÑPortasystemic Shunt, Surgical LH LM  MHÑSplints ANonly /adv eff /stand /vet MNE7.858.442.660.845 LH  MHÑSpondylitis ANIM; coord with specific vertebra; spondylosis does not go here: index under SPINAL OSTEOPHYTOSIS (IM) + specific vertebra (IM) MNC5.116.165.762; C5.878.805 LH  MHÑSpondylitis, Ankylosing MNC5.550.69.680; C5.550.114.154.856; C5.799.114.856; C5.878.805.680; C20.111.199.856; C23.205.200.732.99.856 XSBECHTEREW'S DISEASE; MARIE-STRUEMPELL DISEASE; SPONDYLARTHRITIS ANKYLOPOIETICA LH LS; ;  MSForward displacement of one vertebra over another. MHÑSpondylolisthesis ANIM; coord with specific vertebra (IM) MNC5.878.822 XUÑSpondylolysis LH LU  MSDissolution of a vertebra, especially the pars interarticularis. OLsearch SPONDYLOLISTHESIS 1968-74 HN(75) MHÑSpondylolysis ANIM; coord with specific vertebra (IM) MNC5.878.822.833 DMÑSpondylolisthesis LH LM  MSThe reproductive elements of lower organisms, such as protozoa, fungi, and cryptogamic plants. PM68 HN68(64) MHÑSpores ANNIM; do not use /anat /blood-csf-urine /embryol /physiol; sporulation: coord organism /physiol (IM) + SPORES (NIM); Manual 22.31 MNB3.867; B5.845 LH  MSHeat and stain resistant, metabolically inactive bodies formed within the vegetative cells of bacteria of the genera Bacillus and Clostridium. PM74 HN74(71) MHÑSpores, Bacterial ANNIM; do not use /blood-csf-urine /embryol; sporulation: coord specific bacterium /physiol (IM) + SPORES, BACTERIAL (NIM); Manual 22.31 PIBacteria (66-70); specific bacterium; Spores (66-70) MNB3.867.680 LH  MSReproductive bodies produced by fungi. PM74 HN74(71) MHÑSpores, Fungal ANNIM; do not use /anat /blood-csf-urine /embryol /microbiol /parasitol /physiol; sporulation: coord specific fungus /physiol (IM) + SPORES, FUNGAL (NIM); Manual 22.31 PIFungi (66-70); specific fungus; Spores (66-70) MNB5.845.680 LH  MSA group of related mycotoxins produced by the pasture fungus Pithomyces chartarum (formerly Sporidesmium bakeri); causes liver damage and facial eczema in cattle and sheep. HN(75) MHÑSporidesmins ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS PIIndoles (66-74); Pyrazines (66-74); Pyrroles (66-74) MND3.438.473.840; D24.185.926.587.800 DMÑIndoles LH LM  MHÑSporotrichosis MNC1.703.892 LH  MHÑSporotrichum ANdo not use /anat /embryol /microbiol /parasitol; infection = SPOROTRICHOSIS MNB5.354.381.546.821 XSSporothrix LH LS  MHÑSporozoa ANdo not use /anat /blood-csf-urine /embryol; infection: coord NIM with PROTOZOAN INFECTIONS (IM) MNB1.841.762 XSBesnoitia XUÑNosema cuniculi LH LS LU  MSAthletic activities or games, usually involving physical effort or skill, whether engaged in competitively or for pleasure. OLuse SPORTS to search ATHLETICS back thru 1966 HNATHLETICS was see under SPORTS 1963-75 MHÑSports ANonly /class /hist; SPORTS is the activity, SPORTS MEDICINE is the speciality; inj = ATHLETIC INJURIES (& see note there; Manual 30.31) CATALOG: do not use /pop wks MNI3.450.642.845 XSAthletics FXÑAthletic Injuries; ÑDoping in Sports; ÑExertion XUÑBaseball; ÑBasketball; ÑBicycling; ÑGolf; ÑHockey; ÑSkating; ÑSoccer; ÑTennis; ÑWeight Lifting; ÑWrestling LH LS LX; ; LU; ; ; ; ; ; ; ; ;  MSThe field of medicine concerned with physical fitness and the diagnosis and treatment of injuries sustained in sports activities. OLuse SPORTS MEDICINE to search SPORT MEDICINE back thru 1966 PM80; was SPORT MEDICINE 1963-79 HN80; was SPORT MEDICINE 1963-79 MHÑSports Medicine ANSPEC: SPEC qualif except /methods; differentiate from SPORTS; sports inj = ATHLETIC INJURIES; policy: Manual 30.31 MNG2.403.830 FXÑAthletic Injuries; ÑPROTECTIVE DEVICES LH LX;  MSDeliberate severe and repeated physical injury to the wife or husband by the other marital partner. PM77 HN77 MHÑSpouse Abuse ANonly /legis /prev MNF3.126.842.89.428; I1.198.240.785 XSWife Abuse LH LS  MHÑSprains and Strains ANDF: SPRAINS MNC21.866.844 LH  PM67 HN67(64) MHÑSpreading Cortical Depression ANonly /drug eff /rad eff MNG11.561.880 XSCORTICAL DEPRESSION, SPREADING FXÑCerebral Cortex LH LS LX  MHÑSprue, Tropical MNC6.405.469.637.850; C18.452.603.850 LH  MHÑSputum ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA12.838.808 LH  MStrans-5-Amino-3-[2-(5-nitro-2-furyl)vinyl]- 1,2,4-oxadiazole. A nitrovinyl furan used as schistosomicidal agent and proposed for trypanosomiasis, especially Chagas disease. HN(75) MHÑSQ 18506 ANdo not use /biosyn /defic /physiol; /analogs NIM only RN28754-68-9 PINitrofurans (72-74); Oxadiazoles (72-74); Vinyl Compounds (72-74) MND2.640.600.900; D3.383.312.649.900; D3.383.548.580.650; D21.201.412.596.660; D21.370.884.660 DMÑNitrofurans LH LM  MHÑSqualene ANdo not use /defic /physiol RN111-02-4 MND2.455.326.271.665.806; D2.455.849.919.681 LH  MSCatalyzes the rearrangement and reduction of the cyclopropane compound, presqualene pyrophosphate to form squalene, with NADPH as the coenzyme. HN(75) MHÑSqualene Synthetase ANdo not use /analogs RNEC 1.3.- PIFarnesol (72-74); Ligases (72-74); Pyrophosphoric Acids (72-74); Squalene (72-74) MND8.586.682.820 DMÑOxidoreductases LH LM  MSA ten-armed cephalopod mollusc of the order Decapoda; includes squid as food. PM73 HN73 MHÑSquid ANas animal & as food; IM; /microbiol /parasitol permitted; giant squid axon: coord NIM with AXONS (IM) PIMollusca (66-72) MNB1.644.857 LH  OLuse SRI LANKA to search CEYLON back thru 1966 HN77; was CEYLON 1963-76 MHÑSri Lanka MNZ1.252.245.840 XSCeylon LH LS  PM73 HN73(67) MHÑSRS-A AN/biosyn /physiol permitted PIAnaphylaxis (66); Muscle, Smooth/PH (66) MND2.241.81.436.835; D10.516.251.355.850; D24.185.798.731 XSLeukotriene C1; Leukotriene C4; Leukotriene D4; Leukotrienes C; Leukotrienes D; SLOW REACTING SUBSTANCE OF ANAPHYLAXIS FXÑAnaphylaxis LH LS; ; ; ; ; LX  MSA species of the Morbillivirus genus, closely related to and possibly a defective variant of measles virus, isolated from the brain tissue of patients with subacute sclerosing panencephalitis. PM78 HN78 MHÑSSPE Virus ANdo not use /blood-csf-urine /cytol; infection = SUBACUTE SCLEROSING PANENCEPHALITIS PISubacute Sclerosing Panencephalitis (71-77) MNB4.909.777.569.890 XSSubacute Sclerosing Panenceph Virus LH LS  MSA deuteromycetous fungal genus including one species which forms a toxin in moldy hay that may cause a serious illness in horses. HN(75); was see under MONILIALES 1975-85 MHÑStachybotrys ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.840 DMÑHyphomycetes LH LM  MSThe process by which the employer promotes staff performance and efficiency consistent with management goals and objectives. HN(86) MHÑStaff Development ANonly /econ /legis /man /methods /stand /trends PIEducation, Nursing, Continuing (66-85); Inservice Training (67-85); Nursing Staff, Hospital/ED (68-85) MNN4.452.677.822 XSHuman Resources Development DMÑPersonnel Management LH LS LM  PM68 HN68(65) MHÑStainless Steel AND25-26 qualif RN12597-68-1 MND1.552.33.847.681; D1.552.412.875; D25.58.807.681 LH  MHÑStains and Staining ANNIM; only /instrum /methods /stand; DF: STAINS MNE5.909.715 FXÑDyes LH LX  MSAn individual intelligence test designed primarily for school children to predict school performance and the ability to adjust to everyday demands. OLto search BINET TESTS use STANFORD-BINET TEST back thru 1975 & INTELLIGENCE TESTS 1966-74 HN(79); was BINET TESTS see under INTELLIGENCE TESTS 1963-78 MHÑStanford-Binet Test ANno qualif PIIntelligence Tests (66-74) MNF4.711.141.493.225 XSBinet Test DMÑIntelligence Tests LH LS LM  MHÑStanolone ANdo not use /biosyn /defic /physiol RN521-18-6 MND4.808.54.40.831; D6.472.79.810 XS5 alpha-Dihydrotestosterone; Androstanolone; Dihydrotestosterone XUÑMesterolone LH LS; ; LU  PM65 HN65(64) MHÑStanozolol ANdo not use /biosyn /defic /physiol RN10418-03-8 MND4.808.54.40.881; D6.597.100.194.893 XSAndrostanazol; Methylstanazol LH LS;  MSThe stapedius muscle arises from the wall of the middle ear and is inserted into the neck of the stapes. Its action is to pull the head of the stapes backward. HN(79) MHÑStapedius PIEar, Middle (66-78); Ear Ossicles (66-78); Stapes (75-78) MNA2.633.802; A9.246.397.727 DMÑMuscles LH LM  OLsearch EAR OSSICLES 1966-74 HN(75) MHÑStapes ANdo not use /surg: = STAPES SURGERY MNA9.246.397.247.806 DMÑEar Ossicles LH LM  MHÑStapes Mobilization ANdo not use /util except by MeSH definition MNE4.847.774.731.681 FXÑOtosclerosis LH LX  PM64 HN64 MHÑStapes Surgery ANdo not use /util except by MeSH definition; note specific above MNE4.847.774.731 FXÑEar Ossicles LH LX  MSPoisoning by staphylococcal toxins present in contaminated food. PM68 HN68(66) MHÑStaphylococcal Food Poisoning ANdo not use /chem ind; DF: STAPH FOOD POIS MNC1.252.868.806; C21.613.415.846 FXÑEnterotoxins LH LX  OLuse STAPHYLOCOCCAL INFECTIONS to search STAPHYLOCOCCCAL INFECTIONS, GASTROINTESTINAL & STAPHYLOCOCCAL INFECTIONS, RESPIRATORY 1966-67 PMSTAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL & STAPHYLOCOCCAL INFECTIONS, RESPIRATORY were headings 1963-67 HNSTAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL & STAPHYLOCOCCAL INFECTIONS, RESPIRATORY were headings 1963-67 MHÑStaphylococcal Infections ANnote STAPHYLOCOCCAL FOOD POISONING above; DF: STAPH INFECTIONS or STAPH INFECT MNC1.252.868 FXÑCross Infection LH LX  MHÑStaphylococcal Phages ANdo not use /cytol; DF: STAPH PHAGES MNB4.123.831 LH  MSA protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IgG. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function. PM78 HN78 MHÑStaphylococcal Protein A ANdo not use /defic /physiol; DF: STAPH PROTEIN A PIAntigens, Bacterial (71-77); Bacterial Proteins (66-77); Staphylococcus (66-75); Staphylococcus aureus (76-77) MND12.776.97.820; D24.611.216.161.821 XSProtein A LH LS  MSA disease of infants due to group 2 phage type 17 staphylococci that produce an epidermolytic exotoxin. Superficial fine vesicles and bullae form and rupture easily, resulting in loss of large sheets of epidermis. OLto search RITTER'S DISEASE use STAPHYLOCOCCAL SCALDED SKIN SYNDROME back thru 1986 & DERMATITIS EXFOLIATIVA 1966-85 HN(86); RITTER'S DISEASE was see DERMATITIS EXFOLIATIVA 1968-85, was heading 1966-67 MHÑStaphylococcal Scalded Skin Syndrome ANDF: SSSS PIEpidermal Necrolysis, Toxic (66-85); Staphylococcal Infections (66-85) MNC1.252.868.820.880; C17.838.820.880 XSRitter Disease DMÑStaphylococcal Skin Infections LH LS LM  PM86; RITTER'S DISEASE (see STAPHYLOCCAL SCALDED SKIN SYNDROME, an XU below) was see DERMATITIS EXFOLIATIVA 1968-85, was heading 1966-67 HN86 MHÑStaphylococcal Skin Infections ANcoord IM with specific STAPHYLOCOCCUS (NIM); DF: STAPH SKIN INFECT PISkin Diseases, Infectious (68-85); Staphylococcal Infections (66-85) MNC1.252.868.820; C17.838.820 XSSkin Diseases, Staphylococcal XUÑStaphylococcal Scalded Skin Syndrome LH LS LU  PM65 HN65 MHÑStaphylococcal Toxoid ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; DF: STAPH TOXOID MND24.310.794.681 LH  PM65 HN65 MHÑStaphylococcal Vaccines ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; DF: STAPH VACCINES MND24.310.894.135.744 LH  MHÑStaphylococcus ANdo not use /blood-csf-urine; infection = STAPH INFECTIONS on data form; staphylococcal clumping factor = COAGULASE; DF: STAPH MNB3.525.645.846 LH  MSPotentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and peritoneum of warm-blooded animals; may cause a wide range of infections and intoxications. OLto search MICROCOCCUS PYOGENES use STAPHYLOCOCCUS AUREUS back thru 1975 & STAPHYLOCOCCUS 1966-74 PM76; was MICROCOCCUS PYOGENES see under STAPHYLOCOCCUS 1963-75 HN76; was MICROCOCCUS PYOGENES see under STAPHYLOCOCCUS 1963-75 MHÑStaphylococcus aureus ANdo not use /blood-csf-urine; infection = STAPH INFECTIONS on data form & do not bother to coord with S. aureus; DF: STAPH AUREUS PIStaphylococcus (66-74) MNB3.525.645.846.100 XSMicrococcus pyogenes LH LS  MSA species of Staphylococcus that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals. A primary pathogen or secondary invader. PM84 HN84 MHÑStaphylococcus epidermidis ANdo not use /blood-csf-urine; infection: coord NIM with STAPHYLOCOCCAL INFECTIONS (IM); DF: STAPH EPIDERMIDIS PIStaphylococcus (66-83) MNB3.525.645.846.343 LH  PMDEXTRINS was see under POLYSACCHARIDES 1963-78 MHÑStarch ANdo not use /defic /physiol RN9005-25-8 MND9.203.698.365.855 XUÑDextrins; ÑHydroxyethyl Starch LH LU;  MSADPglucose:1,4-alpha-D-glucan 4-alpha-glucosyltransferase. Catalyzes the transfer of glucose from ADPglucose to glucose-containing polysaccharides in 1,4-alpha-linkages. Covers starch and glycogen synthases utilizing ADPglucose as donor. HN(75) MHÑStarch (Bacterial Glycogen) Synthase ANdo not use /analogs RNEC 2.4.1.21 PIAdenosine Diphosphate (73-74); Glucosyltransferases (73-74); Nucleoside Diphosphate Sugars (73-74) MND8.586.913.407.323.800 XSADP Glucose Starch Glucosyltransferase DMÑGlucosyltransferases LH LS LM  MSEchinoderms having bodies of usually five radially disposed arms coalescing at the center. PM72 HN72 MHÑStarfish ANIM; /microbiol /parasitol permitted PIEchinodermata (66-71) MNB1.408.765 LH  MSA complex involuntary response to an unexpected strong stimulus usually auditory in nature. PM69 HN69(65) MHÑStartle Reaction ANhuman & animal; only /drug eff /physiol /rad eff MNE1.236.563.642.847; E1.706.592.642.847; F2.830.702.807; G11.561.730.869 LH  MHÑStarvation ANTN 80: definition & relation to FASTING; refeeding after starvation: index refeeding under FOOD if pertinent MNC18.654.832 FXÑFasting; ÑFood Deprivation; ÑHunger LH LX; ;  MSControl, direction and financing of the total dental care of the population by a national government. PM65 HN65 MHÑState Dentistry ANonly /econ /hist /organ /trends; not for dent programs of individual states ( = specific dent program + specific state); specify country CATALOG: /geog /form PISTATE MEDICINE MNN3.787 XSSOCIALIZED DENTISTRY LH LS  MSThe complex of political institutions, laws, and customs through which the function of governing the state is carried out (U.S. only). HN(84) MHÑState Government ANrestricted to the U.S.; no qualif; specify state MNI1.409.700 XSGovernment, State DMÑGovernment LH LS LM  MSAgency established under PL93-641 to coordinate, conduct and implement state health planning activities. Two primary responsibilities are the preparation of an annual State Health Plan and giving assistance to the Statewide Health Coordinating Council. OLto search STATE HEALTH PLANNING AGENCIES, UNITED STATES use STATE HEALTH PLANNING AND DEVELOPMENT AGENCIES back thru 1980 & HEALTH SYSTEMS AGENCIES 1979 HN(80); STATE HEALTH PLANNING AGENCIES, UNITED STATES was see HEALTH SYSTEMS AGENCIES 1979 MHÑState Health Planning and Development Agencies ANU.S. only; only /class /econ /hist /legis /organ /stand /trends /util; Public Law 93-641; specify geog & add UNITED STATES also; DF: SHPDA PIHealth Planning (68-79); Regional Health Planning (77-79) MNN3.540.452.508 DMÑHealth Planning Organizations LH LM  MSState plans prepared by the State Health Planning and Development Agencies which are made up from plans submitted by the Health Systems Agencies and subject to review and revision by the Statewide Health Coordinating Council. PM80 HN80 MHÑState Health Plans ANonly /econ /hist /legis /organ /stand /trends /util; Public Law 93-641; specify geog & add UNITED STATES also CATALOG: /geog /form MNN3.349.650.480 XSComprehensive Health Plans, State LH LS  MSA system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population. MHÑState Medicine ANnot for med programs of individual states; compulsory system of personal med care under control of a natl govt paying physicians out of public funds; compulsory: do not confuse with NATIONAL HEALTH PROGRAMS; specify country, even GREAT BRITAIN despite X ref below; only /econ /hist /organ /trends CATALOG: /geog /form MNN3.858 XSNational Health Service, British; SOCIALIZED MEDICINE LH LS;  MHÑStatistics ANIM for statistical theory or statistical methods; statistics on diseases = /occur; NIM for statist on other concepts; tables in texts are not necessarily STATISTICS; do not confuse with MATHEMATICS; no qualif CATALOG: /geog /form MNH1.548.832 FXÑBiometry; ÑPSYCHOMETRICS; ÑSOCIOMETRIC TECHNICS LH LX; ;  MSA sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts. HN(85) MHÑStatus Asthmaticus PIAsthma (66-84) MNC8.127.108.880 XSAsthmatic Crisis; Asthmatic Shock DMÑAsthma LH LS; LM  PM67 HN67(64) MHÑStatus Dysraphicus ANdo not use /congen MNC16.131.666.680.836 LH  MSA series of rapidly repeated seizures without regaining consciousness between them. PM77 HN77 MHÑStatus Epilepticus AN╥rapidly repeated seizures without regaining consciousness between them╙ PIEpilepsy (66-76) MNC10.228.140.490.690 XSPetit Mal Status LH LS  MHÑSteam ANonly /adv eff /anal MNG3.230.700.435 LH  MSSalts and esters of the 18-carbon saturated, monocarboxylic acid--stearic acid. HN(75) MHÑStearates ANdo not use /analogs /biosyn /defic /physiol PIStearic Acids (66-74) MND2.241.81.407.832.800; D10.516.251.882.800 XSOctadecanoates DMÑStearic Acids LH LS LM  OLuse STEARIC ACIDS to search STEARIC ACID back thru 1966 PM75; was STEARIC ACID 1963-74 HN75; was STEARIC ACID 1963-74 MHÑStearic Acids ANdo not use /analogs /defic /physiol; do not confuse X ref OCTADECANOIC ACIDS with OCTADECENOIC ACIDS see OLEIC ACIDS MND2.241.81.407.832; D10.516.251.882 XSDihydrooleic Acids; Octadecanoic Acids; Tetrahydrolinoleic Acids XUÑStearates LH LS; ; LU  MSA specific substrate for EC 1.14.99.5, fatty acid desaturases; catalyzes the formation of oleyl-CoA from stearyl-CoA. HN(75) MHÑStearyl-CoA Desaturase ANdo not use /analogs RNEC 1.14.99.- PICoenzyme A (73-74); Hydroxylases (73-74); Stearic Acid (73-74) MND8.586.682.420.375.700 DMÑFatty Acid Desaturases LH LM  PM71 HN71 MHÑSteatitis ANanimal only: do not use /vet but check tag ANIMAL PISelenium (66-70); Swine Diseases (66-70); Vitamin E Deficiency/VE (66-70) MNC18.654.223.133.841.682; C22.880 LH  MSA tough, malleable, iron-based alloy containing up to, but no more than two percent carbon and often other metals; used in medicine and dentistry in implants and instrumentation. OLsearch ALLOYS 1968-74 & METALS 1966-67 HN(75); was see under METALS 1963-67 MHÑSteel AND25-26 qualif RN12597-69-2 MND1.552.33.847; D25.58.807 DMÑAlloys LH LM  MHÑStellate Ganglion ANdo not use /innerv MNA8.99.370.411.935; A8.99.893.477.935; A8.340.315.477.935 LH  MSRelatively undifferentiated cells of the same lineage (family type) that retain the ability to divide and cycle throughout postnatal life to provide cells that can become specialized and take the place of those that die or are lost. PM84 HN84 MHÑStem Cells ANA 11 qualif PICell Differentiation (66-83); Cell Line (69-83); Cells, Cultured (72-83); Colony-Forming Units Assay (79-83) MNA11.872 XSColony-Forming Units; Mother Cells; Progenitor Cells LH LS; ;  MSInfection with the swine kidney worm, Stephanurus dentatus. OLsearch NEMATODE INFECTIONS 1968-74 HN(75) MHÑStephanurus Dentatus Infection ANfor organism index NEMATODA (IM) + STEPHANURUS DENTATUS INFECTION (NIM) MNC3.335.508.744 DMÑNematode Infections LH LM  MSPerception of shape and form of objects by touch. PM73 HN73 MHÑStereognosis ANonly /drug eff /physiol /rad eff PIForm Perception (66-72); Touch (66-72) MNF2.463.593.373.765; F2.463.593.885.682; G11.561.796.850.682 LH  PM74 HN74(68) MHÑStereoisomers ANNIM; no qualif; policy: Manual 25.33; stereochemistry: Manual 25.33 PIappropriate chemical heading MNH1.181.404.705.682 LH  PM65 HN65 MHÑStereotaxic Technics ANdo not use /methods /util (except by MeSH definition) CATALOG: do not use /laboratory manuals MNE4.530.832; E5.873 FXÑBrain Mapping LH LX  MSRelatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive. PM81; was see under BEHAVIOR 1975-80 HN81(73); was see under BEHAVIOR 1975-80 MHÑStereotyped Behavior ANhuman & animal; only /drug eff /physiol /rad eff PIBehavior (66-72); Behavior, Animal (66-72) MNF1.145.896; F3.126.892 XSBody Rocking; Head Banging LH LS;  MSAn oversimplified perception or conception especially of persons, social groups, etc. PM81 HN81 MHÑStereotyping ANno qualif; includes both person using stereotype thinking & person or group being stereotyped; do not confuse with STEREOTYPED BEHAVIOR: read MeSH definition PIStereotyped Behavior (73-80) MNF1.829.890 FXÑSocial Perception LH LX  MS3a,12c-Dihydro-8-hydroxy-6-methoxy-7H-furo[3',2':4,5]furo [2,3-c]xanthen-7-one. A carcinogenic mycotoxin produced in high yields by strains of the common molds, Aspergillus versicolor, A. nidulans and an unidentified species of Bipolaris. It causes necrosis of the liver and kidney and has an inhibitory effect on orotic acid incorporation into nuclear RNA. HN(75) MHÑSterigmatocystin ANdo not use /defic /physiol; /analogs NIM only RN10048-13-2 PIFurans (73-74); Xanthenes (69-74) MND3.494.953.650; D24.185.926.587.850; D26.191.869 DMÑXanthenes LH LM  MHÑSterilization ANof the environment, not sexual; only /hist /instrum /methods /stand; differentiate from DISINFECTION: DISINFECTION renders matter free of pathogens, STERILIZATION destroys all microbes; if in doubt, use the word of the text MNG3.850.180.800 XUÑDisinfection LH LU  MSReversal of sexual sterilization. PM75 HN75 MHÑSterilization Reversal ANsexual; do not use /util except by MeSH definition PISterilization, Tubal (73-74); Vasectomy (73-74) MNE4.887.599.500 FXÑSterilization, Tubal; ÑVasectomy LH LX;  MSSexual sterilization without consent of the patient. HN(78) MHÑSterilization, Involuntary AN/psychol /rehabil permitted PISterilization, Sexual (66-77) MNE4.887.599.450 DMÑSterilization, Sexual LH LM  MSProcedures for the purpose of rendering individuals incapable of reproduction. MHÑSterilization, Sexual ANrestrict to humans & Cat B2; for Cat B1 consider PEST CONTROL, BIOLOGICAL; do not use /util except by MeSH definition MNE4.887.599 XSVoluntary Sterilization FXÑPest Control, Biological; ÑPopulation Control XUÑSterilization, Involuntary LH LS LX; LU  PM73 HN73 MHÑSterilization, Tubal ANdo not use /util except by MeSH definition PIFallopian Tubes (66-72); Sterilization, Sexual (66-72) MNE4.819.608.766; E4.887.599.683; E4.887.690.766 XSLigation, Tubal; Tubal Ligation FXÑFallopian Tubes; ÑSterilization Reversal LH LS; LX;  MHÑSternoclavicular Joint ANany Cat A qualif permitted MNA2.835.583.781 LH  OLsearch RIBS 1966-74 HN(75); was see under RIBS 1963-78 MHÑSternocostal Joints MNA2.835.583.790 DMÑJoints LH LM  MHÑSternum MNA2.835.232.904.766 XUÑManubrium; ÑXiphoid Bone LH LU;  PM73 HN73 MHÑSteroid Hydroxylases ANdo not use /analogs RNEC 1.14.- PIHydroxylases (66-72) MND8.586.682.420.783 XSSteroid Monooxygenases XUÑ25-Hydroxycholecalciferol 1-Hydroxylase; ÑCholesterol-7-Hydroxylase; ÑSteroid-11-Hydroxylase; ÑSteroid-12-Hydroxylase; ÑSteroid-17-Hydroxylase; ÑSteroid-21-Hydroxylase LH LS LU; ; ; ; ;  MSCatalyzes the transposition of double bond(s) in a steroid molecule. HN(75) MHÑSteroid Isomerases ANdo not use /analogs RNEC 5.3.3.- PIIsomerases (72-74); Ketosteroids (72-74) MND8.586.399.860 XS3-Ketosteroid Isomerases; 3-Oxosteroid Isomerases DMÑIsomerases LH LS; LM  MSSteroid, reduced-adrenal-ferredoxin:oxygen oxidoreductase (11-beta-hydroxylating). A steroid hydroxylase system found in adrenal tissues. It catalyzes the 11-hydroxylation of steroids in the presence of molecular oxygen and consists of a NADPH specific flavoprotein, a non-heme iron protein and cytochrome P-450. Its deficiency is a cause of congenital adrenal hyperplasia. EC 1.14.15.4. HN(78) MHÑSteroid-11-Hydroxylase ANdo not use /analogs; /defic: consider also ADRENAL HYPERPLASIA, CONGENITAL RNEC 1.14.15.4 PISteroid Hydroxylases (73-77) MND8.586.682.420.783.720 XSSteroid-11-Monooxygenase DMÑSteroid Hydroxylases LH LS LM  MSSteroid, hydrogen-donor:oxygen oxidoreductase (12-alpha-hydroxylating). A steroid hydroxylase found in liver microsomes. It catalyzes the 12-hydroxylation of steroids in the presence of NADPH, cytochrome P-450 and molecular oxygen. It is an important enzyme in the synthesis of cholic acid from cholesterol in the liver. EC 1.14.99.-. HN(78) MHÑSteroid-12-Hydroxylase ANdo not use /analogs RNEC 1.14.99.- PISteroid Hydroxylases (73-77) MND8.586.682.420.783.730 XSSteroid-12-Monooxygenase DMÑSteroid Hydroxylases LH LS LM  MSSteroid, hydrogen-donor:oxygen oxidoreductase (17-alpha-hydroxylating). A steroid hydroxylase system found in the microsomal membrane of the steroid-hormone producing tissues. It catalyzes the 17-hydroxylation of steroids, such as progesterone or pregnenolone in the presence of NADPH and molecular oxygen. This is an important step in the biosynthesis of steroid hormones. EC 1.14.99.9. HN(78) MHÑSteroid-17-Hydroxylase ANdo not use /analogs; /defic: consider also ADRENAL HYPERPLASIA, CONGENITAL RNEC 1.14.99.9 PISteroid Hydroxylases (73-77) MND8.586.682.420.783.745 XSSteroid-17-Monooxygenase DMÑSteroid Hydroxylases LH LS LM  MSSteroid, hydrogen-donor:oxygen oxidoreductase(21-hydroxylating). A steroid hydroxylase system found in adrenal cortex microsomes. It catalyzes the 21-hydroxylation of corticosteroids and shows a requirement for NADPH and molecular oxygen. Its deficiency is a cause of adrenogenital syndrome. EC 1.14.99.10. HN(78) MHÑSteroid-21-Hydroxylase ANdo not use /analogs; /defic: consider also ADRENAL HYPERPLASIA, CONGENITAL RNEC 1.14.99.10 PISteroid Hydroxylases (73-77) MND8.586.682.420.783.760 XSSteroid-21-Monooxygenase DMÑSteroid Hydroxylases LH LS LM  MHÑSteroids ANGEN: avoid: too general; do not use /analogs MND4.808 LH  MSSteroids which are substituted with one or more bromine atoms in any position. PM77; was see under STEROIDS 1975-76 HN77(75); was see under STEROIDS 1975-76 MHÑSteroids, Brominated ANdo not use /analogs /biosyn /defic /physiol PIBromine (66-74); Steroids (66-74) MND4.808.875 XSBrominated Steroids LH LS  PM74 HN74 MHÑSteroids, Chlorinated ANdo not use /analogs /biosyn /defic /physiol MND4.808.883 XSCHLORINATED STEROIDS LH LS  PM74 HN74 MHÑSteroids, Fluorinated ANdo not use /analogs /biosyn /defic /physiol MND4.808.908 XSFLUORINATED STEROIDS LH LS  MSSteroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with non-carbon atoms. PM75 HN75 MHÑSteroids, Heterocyclic ANdo not use /analogs /biosyn /defic /physiol PISteroids (68-74); specific steroid class compound MND4.808.925 XUÑAzasteroids LH LU  MHÑSterols ANdo not use /analogs /defic /physiol MND4.808.247.808; D10.516.851 XUÑAdosterol LH LU  MHÑStevens-Johnson Syndrome MNC7.465.864.558; C11.821; C17.816.475.683 LH  PM73 HN73(66) MHÑStibophen ANdo not use /biosyn /defic /physiol RN15489-16-4 MND1.552.70.683; D21.201.412.596.683 LH  OLsearch HINDLIMB 1968-74 HN(75) MHÑStifle MNA13.473.683 DMÑHindlimb LH LM  HN(72) MHÑStigmasterol ANcalled ╥anti-stiffness factor╙; do not use /defic /physiol; /analogs NIM only RN83-48-7 PISterols (66-71) MND4.808.247.222.222.347.833; D4.808.247.808.756.808 DMÑPhytosterols LH LM  MHÑStilbamidines ANdo not use /analogs /biosyn /defic /physiol MND2.78.766; D21.370.884.720 LH  MHÑStilbenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.426.559.389.724; D2.455.426.559.389.150.700 XUÑSITS LH LU  PM68 HN68 MHÑStimulation, Chemical ANNIM; no qualif; TN 49: definition & use as NIM MNG12.836 FXÑEnzyme Induction LH LX  OLsearch PROBABILITY 1968-74 HN(75) MHÑStochastic Processes ANno qualif MNH1.548.832.672.848 DMÑProbability LH LM  MHÑStomach AN/blood supply: gastric varix or varices = ESOPHAGEAL AND GASTRIC VARICES & see note there; perforation = STOMACH /inj, not STOMACH RUPTURE; gastric secretion = GASTRIC JUICE /secret or GASTRIC MUCOSA /secret, not STOMACH /secret; stomach secretes GASTRIN, HYDROCHLORIC ACID, GASTRIC (see GASTRIC ACID), INTRINSIC FACTOR & PEPSINOGEN; /surg: consider also GASTRECTOMY, GASTROENTEROSTOMY & GASTROSTOMY; inflammation = GASTRITIS; Heidenhain pouch: index STOMACH /physiol; gastric hyperacidity: index under GASTRIC ACID /secret; many parts of STOMACH are available; consider also terms under GASTR- MNA3.492.766 FXÑGastrectomy LH LX  MHÑStomach Dilatation MNC6.405.748.717 LH  PM66 HN66 MHÑStomach Diseases ANGEN; inflamm dis = GASTRITIS; gastric varix or varices = ESOPHAGEAL AND GASTRIC VARICES & see note there MNC6.405.748 LH  MHÑStomach Diverticula ANinflamm divertic or diverticulitis: coord IM with DIVERTICULITIS (NIM) MNC6.405.748.753 XSDiverticulosis, Gastric LH LS  MHÑStomach Neoplasms ANneopl of ruminant stomach do not go here: coord ruminant stomach term (IM) with NEOPLASMS /vet (IM) instead; coord IM with specific site in stomach (IM) + histol type of neopl (IM); /anal /blood supply /secret /ultrastruct permitted MNC4.588.274.476.767; C6.405.748.789 LH  MHÑStomach Rupture ANtraumatic or spontaneous; if spontaneous coord IM with RUPTURE, SPONTANEOUS (NIM); differentiate from traumatic stomach perforation ( = STOMACH /inj) MNC6.405.748.824; C21.866.17.809; C21.866.761.684 LH  MHÑStomach Ulcer ANperforated: coord IM with PEPTIC ULCER PERFORATION (IM); ╥gastroduodenal ulcer╙ = GASTRODUODENAL ULCER see PEPTIC ULCER; hemorrhage: coord IM with PEPTIC ULCER HEMORRHAGE (IM) MNC6.405.613.860; C6.405.748.860 LH  MHÑStomach Volvulus MNC6.405.748.895 XSVOLVULUS, STOMACH LH LS  PM68 HN68 MHÑStomach, Avian PIBirds (66-67); Poultry (66-67); Stomach (66-67) MNA13.853 LH  PM68 HN68 MHÑStomach, Ruminant ANneopl: coord STOMACH, RUMINANT or specific indentions (IM) with NEOPLASMS /vet (IM), not STOMACH NEOPLASMS PIStomach (66-67) MNA13.869 LH  MHÑStomatitis ANmycotic stomatitis = CANDIDIASIS, ORAL; mucositis: coord IM with MOUTH MUCOSA (NIM) MNC7.465.864 XUÑStomatitis, Denture LH LU  MSA disease of the oral mucosa of unknown etiology; characterized by recurrent small white ulcerative lesions. PM65 HN65 MHÑStomatitis, Aphthous AN╥of unknown etiol╙ MNC7.465.864.684 XSAPHTHAE; CANKER SORE; PERIADENITIS; Ulcer, Aphthous LH LS; ; ;  MSInflammation of the mouth due to denture irritation. HN(72) MHÑStomatitis, Denture ANcoord with specific denture /adv eff; unspecified mycotic denture-sore mouth: coord IM with CANDIDIASIS, ORAL (IM) PIDental Prosthesis/AE (66-71); specific dental prosthesis/AE (66-71); Mouth Diseases (66-71); Stomatitis (66-71) MNC7.465.864.809 DMÑStomatitis LH LM  MSStomatitis caused by Herpesvirus hominis. Usually occurs as acute herpetic stomatitis (or gingivostomatitis), an oral manifestation of primary herpes simplex seen primarily in children and adolescents. PM80 HN80 MHÑStomatitis, Herpetic ANHerpes simplex virus infect of the mouth; ╥cold sore╙ & ╥fever blister╙ of the mouth go here but of the lips & nares = HERPES LABIALIS PIHerpes Simplex (66-79); Herpesvirus Hominis (66-79); Herpesvirus Infections (66-79); Mouth Diseases (66-79); Stomatitis (66-79); Stomatitis, Aphthous (66-79) MNC2.256.466.382.834; C7.465.864.840 XSGingivostomatitis, Herpetic; Herpes Simplex, Oral LH LS;  MSThe mouth, teeth, jaws, pharynx, and related structures as they relate to mastication, deglutition, and speech. PM86 HN86; was MOUTH AND TEETH (NON MESH) before 1986 MHÑStomatognathic System MNA14 XSMasticatory System LH LS  MHÑStrabismus MNC11.841 XSPhorias; Squint FXÑOrthoptics XUÑEsotropia; ÑExotropia LH LS; LX LU;  MSOne of the very toxic Solanaceae, Datura stramonium, also called thornapple and jimsonweed; contains the same alkaloids as in Belladonna and causes toxicity to cattle and other grazers. MHÑStramonium ANas plant & drug; do not use /isol /pathogen MNB6.560.868; B6.660.834 XSDATURA; Jimsonweed; Thornapple LH LS; ;  MSDrugs obtained and often manufactured illegally, usually in large cities, for the subjective effects they are said to produce; they tend to be grossly impure and may cause unexpected toxicity. PM87; was see under DRUGS 1977-86 HN87(77); was see under DRUGS 1977-86 MHÑStreet Drugs AND25-26 qualif PIDrug and Narcotic Control (68-76); Substance Abuse (68-76) MND26.394.393.878 XSDrugs of Abuse; Illicit Drugs LH LS;  MHÑStreptobacillus ANdo not use /blood-csf-urine MNB3.475.700 LH  MSGram-positive non-sporing bacteria including many parasitic, pathogenic, and saprophytic forms. OLuse STREPTOCOCCACEAE & MICROCOCCUS to search GAFFKYA (all species) 1966-78 PM76; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75 HN76; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75 MHÑStreptococcaceae ANdo not use /blood-csf-urine; DF: do not abbreviate since it would conflict with DF for STREPTOCOCCUS PIBacteria (66-74); Lactobacillaceae (75); Micrococcaceae (75) MNB3.525.800 XSAerococcus; Gaffkya Homari LH LS;  MHÑStreptococcal Infections ANcoord IM with species (NIM); DF: STREP INFECTIONS or STREP INFECT MNC1.252.890 LH  MHÑStreptococcus ANGEN; hemolytic streptococci = STREPTOCOCCUS unless specified in text as S. pyogenes, S. agalactiae, S. faecalis, etc.; group A = STREPTOCOCCUS PYOGENES; B = STREPTOCOCCUS AGALACTIAE; D = STREPTOCOCCUS FAECALIS, S. faecium, S. bovis, S. equinus & S. suis (these last 4 index under STREPTOCOCCUS); N = STREPTOCOCCUS LACTIS; groups E, L, M, O, R, S go under STREPTOCOCCUS; do not use /blood-csf-urine; infection = STREPTOCOCCAL INFECTIONS; DF: STREP MNB3.525.800.872 LH  MSA bacterium which causes mastitis in cattle and occasionally in man. PM74 HN74(72) MHÑStreptococcus Agalactiae ANdo not use /blood-csf-urine; infection: coord NIM with STREPTOCOCCAL INFECTIONS (IM); DF: STREP AGALACTIAE PIStreptococcus (66-71) MNB3.525.800.872.534 XSStreptococcus Group B LH LS  MHÑStreptococcus Faecalis ANdo not use /blood-csf-urine; although normally found in intestines, can cause infection: coord then NIM with STREPTOCOCCAL INFECTIONS (IM); do not confuse with Streptococcus faecium (index STREPTOCOCCUS); belongs to Streptococcus group D; DF: STREP FAECALIS MNB3.525.800.872.634 LH  MSA non-pathogenic streptococcus found in dairy products and responsible for the souring of milk. PM74 HN74(72) MHÑStreptococcus Lactis ANdo not use /blood-csf-urine; non-pathogenic, causes souring of milk; = Streptococcus group N; DF: STREP LACTIS PIStreptococcus (66-71) MNB3.525.800.872.734 LH  MSA polysaccharide-producing species of Streptococcus isolated from human dental plaque. PM78; was see under STREPTOCOCCUS 1976-77 HN78(76); was see under STREPTOCOCCUS 1976-77 MHÑStreptococcus mutans ANfound in dental plaque; do not use /blood-csf-urine; DF: STREP MUTANS PIStreptococcus (66-75) MNB3.525.800.872.764 LH  MSA Gram-positive organism found in the upper respiratory tract, inflammatory exudates and various body fluids of normal and/or diseased humans and, rarely, domestic animals. OLuse STREPTOCOCCUS PNEUMONIAE to search DIPLOCOCCUS PNEUMONIAE back thru 1966 PM76; was DIPLOCOCCUS PNEUMONIAE 1963-75 HN76; was DIPLOCOCCUS PNEUMONIAE 1963-75 MHÑStreptococcus pneumoniae ANdo not use /blood-csf-urine; infection = PNEUMOCOCCAL INFECTIONS & do not coord with STREPTOCOCCUS PNEUMONIAE; DF: STREP PNEUMONIAE MNB3.525.800.872.804 XSDiplococcus pneumoniae; Pneumococcus FXÑPneumococcal Infections LH LS; LX  MHÑStreptococcus Pyogenes ANdo not use /blood-csf-urine; infection: coord NIM with STREPTOCOCCAL INFECTIONS (IM); DF: STREP PYOGENES MNB3.525.800.872.834 XSStreptococcus Group A LH LS  MSA Gram-positive organism found in dental plaque, in blood and on heart valves in subacute endocarditis, and infrequently in saliva and throat specimens; L-forms are associated with recurrent aphthous stomatitis. PM76 HN76 MHÑStreptococcus sanguis ANdo not use /blood-csf-urine; infection: coord NIM with STREPTOCOCCAL INFECTIONS (IM); DF: STREP SANGUIS PIStreptococcus (66-75) MNB3.525.800.872.904 LH  MHÑStreptodornase and Streptokinase ANa pharm prep as ther agent combining both enzymes in a single dosage form; do not confuse with entry above, STREPTODORNASE see DEOXYRIBONUCLEASES & entry below, STREPTOKINASE; do not use /analogs /biosyn /defic /physiol RNEC 3.- MND8.586.277.352.630.553.860 XSFIBRINOKINASE; PLASMINOKINASE FXÑStreptokinase LH LS; LX  PM66 HN66 MHÑStreptokinase ANan enzyme; see note above; do not use /analogs RNEC 3.4.- MND8.586.277.656.732.775; D19.461.427.684; D24.310.683 FXÑSTREPTODORNASE AND STREPTOKINASE LH LX  MSAntibiotic isolated from culture filtrates of Streptomyces lydicus. Active against gram-positive bacteria except micrococci. Synonym: Portamycin. HN(75) MHÑStreptolydigin ANdo not use /defic /physiol; /analogs NIM only RN7229-50-7 PIAntibiotics (70-74); Pyrans (73-74); Pyrrolidinones (73-74) MND20.85.820 DMÑAntibiotics LH LM  OLuse STREPTOLYSINS to search STREPTOLYSIN back thru 1966 PM78; was STREPTOLYSIN 1963-77 HN78; was STREPTOLYSIN 1963-77 MHÑStreptolysins ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTISTREPTOLYSIN MND24.185.926.123.868; D24.185.926.235.440.868 LH  MHÑStreptomyces ANdo not use /blood-csf-urine; S. africanus = NOCARDIA; S. albidus = ACTINOMYCES MNB3.100.67.810.768 XUÑStreptomyces Antibioticus LH LU  MSAn actinomycete from which the antibiotic actinomycin is obtained. HN(72) MHÑStreptomyces Antibioticus ANdo not use /blood-csf-urine PIStreptomyces (66-71) MNB3.100.67.810.768.560 DMÑStreptomyces LH LM  MSAn actinomycete from which the antibiotic chlortetracycline is obtained. PM74 HN74(72) MHÑStreptomyces Aureofaciens ANdo not use /blood-csf-urine PIStreptomyces (66-71) MNB3.100.67.810.768.685 LH  MSAn actinomycete from which the antibiotics streptomycin, grisein, and candicidin are obtained. PM74 HN74(72) MHÑStreptomyces Griseus ANdo not use /blood-csf-urine PIStreptomyces (66-71) MNB3.100.67.810.768.810 LH  MSA family of soil bacteria; also includes some parasitic forms. PM75 HN75 MHÑStreptomycetaceae ANsoil bacteria PIBacteria (66-74) MNB3.100.67.810 LH  PM/adverse effects /poisoning /toxicity were STREPTOMYCIN TOXICOLOGY 1963-65 HN/ad-poi-tox was STREPTOMYCIN TOXICOLOGY 1963-65 MHÑStreptomycin ANdo not use /defic /physiol RN57-92-1 MND9.203.408.51.885; D20.85.89.790; D20.85.826; D20.338.135.810 LH  MSComplex cytotoxic antibiotic obtained from Streptomyces flocculus or S. rufochronmogenus; used in advanced carcinoma; causes leukopenia. Synonyms: Flomycin; Nigrin; NSC 45383; RP 5278. PM73 HN73(65) MHÑStreptonigrin ANdo not use /defic /physiol RN3930-19-6 MND3.66.707.768; D3.383.725.705.768; D20.85.75.841; D22.204.106.851 XSBruneomycin; Rufocromomycin LH LS;  MSA group of antibiotic substances produced by Streptomyces variants; they are composed of aminoglycosides and different polypeptide chains and may have broad spectrum antimicrobial and some antiviral properties. OLuse STREPTOTHRICINS to search STREPTOTHRICIN back thru 1975 HN(78); was STREPTOTHRICIN see under ANTIBIOTICS 1975-77 MHÑStreptothricins ANdo not use /analogs /defic /physiol PIAntibiotics (72-74); Peptides (72-74); Aminoglycosides (74) MND9.203.408.51.910; D20.85.833 DMÑAntibiotics LH LM  OLuse STREPTOVARICINS to search STREPTOVARICIN back thru 1966 PM73; was STREPTOVARICIN 1963-72 HN73; was STREPTOVARICIN 1963-72 MHÑStreptovaricins ANdo not use /analogs /defic /physiol MND20.85.75.870; D20.85.840; D22.204.106.877 LH  PM73 HN73(72) MHÑStreptozotocin ANdo not use /defic /physiol RN18883-66-4 PIAntibiotics (66-71); Diabetes Mellitus/CI (67-71); Nitroso Compounds (66-71) MND2.654.692.768; D2.948.594.768; D20.85.75.899; D22.204.106.903 XSStreptozocin LH LS  PMGENERAL ADAPTATION SYNDROME was see under STRESS & ADAPTATION, PHYSIOLOGICAL 1963-74 MHÑStress ANincludes ╥aggressology╙ (French: agressologie) & the French ╥agression╙; stress ulcer: index under PEPTIC ULCER or specific (IM) + STRESS or STRESS, PSYCHOLOGICAL (IM or NIM) MNC23.280.853 XUÑGeneral Adaptation Syndrome LH LU  MSAnxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world. OLuse STRESS DISORDERS, POST-TRAUMATIC to search NEUROSES, POST-TRAUMATIC back thru 1966 PM81; was NEUROSES, POST-TRAUMATIC 1963-80; COMBAT DISORDERS was heading NEUROSES, WAR 1963-80 HN81; was NEUROSES, POST-TRAUMATIC 1963-80 MHÑStress Disorders, Post-Traumatic ANdo not use /drug eff /physiol /rad eff; DF: PTSD MNF3.709.438.180.680 XSNeuroses, Post-Traumatic; PTSD; Post-Traumatic Stress Disorders XUÑCombat Disorders LH LS; ; LU  MSA purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area. PM73 HN73(71) MHÑStress, Mechanical ANNIM; no qualif; see MeSH definition: does not refer to stress response to mechanical stimuli such as vibration ( = STRESS + VIBRATION, not STRESS, MECHANICAL) PIBiomechanics (68+70); Physics (66-70) MNH1.671.100.131.685 LH  MSPsychosocial pressures or tension-producing factors in the environment to which the individual attempts to make a homeostatic adjustment. OLuse STRESS, PSYCHOLOGICAL to search STRESS, PSYCHOLOGIC back thru 1969 PM73; was STRESS, PSYCHOLOGIC 1969-72 HN73; was STRESS, PSYCHOLOGIC 1969-72 MHÑStress, Psychological ANCat F3 qualif only; ╥stressful events╙ is indexed under LIFE CHANGE EVENTS; stress ulcer: index under PEPTIC ULCER or specific (IM) + STRESS, PSYCHOLOGICAL or STRESS (IM or NIM) MNF2.830.900; F3.126.903 XSEmotional Stress FXÑCrowding; ÑLife Change Events XUÑBurnout, Professional LH LS LX; LU  MSA layer of highly vascular pigmented granular cells on the outer wall of the cochlear duct. HN(79) MHÑStria Vascularis PICochlea (66-78); Organ of Corti (68-78) MNA9.246.631.246.292.876 DMÑCochlea LH LM  MSWork-related situations in which the employees as a group refuse to work until certain conditions of employment are granted by the employer. PM80 HN80 MHÑStrikes, Employee ANonly /class /econ /hist /legis /methods /organ /trends /util (if by MeSH definition); DF: STRIKES PICollective Bargaining (71-79); Labor Unions (66-70) MNN3.540.571.608; N4.452.677.842 XSEmployee Strikes LH LS  MSThe amount of blood pumped out of the heart per beat not to be confused with cardiac output (volume/time). OLsearch CARDIAC OUTPUT 1974-78 PM86; was indexed under CARDIAC OUTPUT 1974-85 HN86(79); was see under CARDIAC OUTPUT 1979-85, was see CARDIAC OUTPUT 1974-78 MHÑStroke Volume ANonly /drug eff /rad eff PICardiac Output (66-78) MNE1.145.569.205.790; G9.330.612.280.882 XSVentricular Ejection Fraction; Ventricular End-Diastolic Volume LH LS;  MSInfection of horses with parasitic nematodes of the genus Strongylus. PM68 HN68 MHÑStrongyle Infections, Equine ANdo not use /vet; don't forget also HORSES (NIM) & check tag ANIMAL; for organism index STRONGYLOIDEA (IM) + STRONGYLE INFECTIONS, EQUINE (NIM) PINematode Infections (66-67) MNC3.335.508.773; C22.488.861; C22.674.377.840 XSStrongylosis, Equine LH LS  MSA superfamily of strongyles or roundworms which are parasites in the intestinal tract of equines, pigs, rodents, and primates (including man). Includes the genera: Cyasthostomum, Ransomus, Globocephalus, OESOPHAGOSTOMUM, and STRONGYLUS. OLsearch HOOKWORMS 1966 PM73; was see under HOOKWORMS 1963-66 HN73; was see under HOOKWORMS 1963-66 MHÑStrongyloidea ANa superfamily of nematodes; do not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) PIAncylostomatoidea (66); Nematoda (67-72) MNB1.500.294.710 XUÑStrongylus LH LU  MHÑStrongyloides ANa genus of threadworms; do not confuse with STRONGYLOIDEA; do not use /blood-csf-urine; infection = STRONGYLOIDIASIS MNB1.500.294.640.680 LH  MHÑStrongyloidiasis ANcaused by STRONGYLOIDES, not STRONGYLOIDEA MNC3.335.508.799 XSANGUILLULIASIS LH LS  MSA genus of intestinal parasitic nematodes occurring in animals and man. HN(86) MHÑStrongylus ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) PIStrongyloidea (73-85) MNB1.500.294.710.700 DMÑStrongyloidea LH LM  MHÑStrontium ANSr-88; see isotopes & radioisotopes below; do not use /analogs /biosyn /defic /physiol RN7440-24-6 MND1.248.497.300.333.850; D1.268.831; D1.552.539.861; D1.937.825 LH  MHÑStrontium Isotopes ANSr-84,86,87; NIM; no qualif MND1.496.840; D1.552.539.861.602 LH  OLsearch STRONTIUM ISOTOPES 1966-73 PM74 HN74 MHÑStrontium Radioisotopes ANSr-80-83, 85, 89-95; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) MND1.496.749.815; D1.496.840.685; D1.552.539.861.768 LH  MS3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide. The aglycone cardioactive agent isolated from Strophanthus Kombe, S. gratus and other species; it is a very toxic material formerly used as digitalis. Synonyms: Apocymarin; Corchorin; Cynotoxin; Corchorgenin. OLsearch CARDANOLIDES 1968-74 PM77; was see under STROPHANTHINS 1975-76, was see under CARDANOLIDES 1968-74 HN77(75); was see under STROPHANTHINS 1975-76, was see under CARDANOLIDES 1968-74 MHÑStrophanthidin ANdo not use /biosyn /defic /physiol RN66-28-4 PICardanolides (68-74) MND4.808.155.160.861.700 XSConvallatoxigenin; Corchsularin; Cymarigenin LH LS; ;  MSA number of different cardioactive glycosides obtained from Strophanthus species. OUABAIN is from S. gratus and CYMARINE from S. Kombe; they are used like digitalis. OLuse STROPHANTHINS to search STROPHANTHIN back thru 1966 PM75; was STROPHANTHIN 1963-74 HN75; was STROPHANTHIN 1963-74 MHÑStrophanthins ANdo not use /analogs /defic /physiol MND4.808.155.160.861; D9.203.408.180.810; D18.222.175.810 XUÑCymarine LH LU  MSThe relationship between the chemical structure of a compound and its biological or pharmacological activity. PM72 HN72 MHÑStructure-Activity Relationship ANNIM with specific drug IM; no qualif; DF: STRUCT ACTIV RELAT MNG6.184.872; G12.869; H1.181.122.768; H1.181.466.685 LH  MSAn extremely rare type of ovarian teratoma in which the predominant tissue is thyroid. These tumors are usually unilateral and benign. PM67 HN67(63) MHÑStruma Ovarii ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS (IM); struma carcinoid = STRUMA OVARII (IM) + CARCINOID TUMOR (IM) + OVARIAN NEOPLASMS (IM) MNC4.557.537.889.811 FXÑThyroid Gland LH LX  OLuse STRYCHNINE to search NUX VOMICA back thru 1966 PMNUX VOMICA was heading 1963-78 HNNUX VOMICA was heading 1963-78 MHÑStrychnine ANdo not use /defic /physiol RN57-24-9 MND3.132.820; D15.128.224.899 XSNux Vomica XUÑBrucine LH LS LU  MSIndividuals who leave school, secondary or college, prior to completion of specified curriculum requirements. PM67 HN67(64) MHÑStudent Dropouts ANonly /psychol MNF2.784.629.796; I2.233.748.686; M1.848.602 XSSCHOOL DROPOUTS FXÑSocial Problems LH LS LX  MSHealth services for college and university students usually provided by the educational institution. OLuse STUDENT HEALTH SERVICES to search UNIVERSITY HEALTH SERVICES back thru 1966 HNUNIVERSITY HEALTH SERVICES was see under STUDENT HEALTH SERVICES 1963-78 MHÑStudent Health Services ANdo not confuse with SCHOOL HEALTH SERVICES for high school & under; only /class /econ /hist /legis /man /organ /stand /supply /trends /util; specify geog CATALOG: /geog /form MNN2.421.897 XSUniversity Health Services LH LS  MSThose persons who attend school. MHÑStudents ANonly /psychol but consider also PSYCHOLOGY, EDUCATIONAL; as persons: Manual 30.24; as children: Manual 34.22; relation to EDUCATION: Manual 34.22; /educ = EDUCATION MNI2.233.748; I2.851; M1.848 LH  MSIndividuals enrolled in the school of dentistry. PM66 HN66 MHÑStudents, Dental ANonly /psychol; /educ = EDUCATION, DENTAL or its specifics MNI2.851.686.519; M1.848.769.519 LH  MSUse for general articles on students in health occupations. PM68 HN68 MHÑStudents, Health Occupations ANonly /psychol; /educ = HEALTH OCCUPATIONS /educ PIStudents (66-67) MNI2.851.686; M1.848.769 LH  MSIndividuals enrolled in a school of medicine. PM66 HN66 MHÑStudents, Medical ANonly /psychol; /educ = EDUCATION, MEDICAL or its specifics MNI2.851.686.602; M1.848.769.602 LH  MSIndividuals enrolled in a school of nursing. PM66 HN66 MHÑStudents, Nursing ANonly /psychol; /educ = EDUCATION, NURSING or its specifics MNI2.851.686.685; M1.848.769.685 LH  MSIndividuals enrolled in a school of pharmacy. PM68 HN68 MHÑStudents, Pharmacy ANonly /psychol; /educ = EDUCATION, PHARMACY or its specifics PIStudents (66-67) MNI2.851.686.768; M1.848.769.768 LH  MSIndividuals enrolled in a preparatory course for medical school. PM66 HN66 MHÑStudents, Premedical ANonly /psychol; /educ = EDUCATION, PREMEDICAL MNI2.851.686.851; M1.848.769.851 LH  OLsearch ANGIOMATOSIS 1966-74 HN(75) MHÑSturge-Weber Syndrome MNC4.557.690.146.811; C4.700.850 DMÑAngiomatosis LH LM  MSA spasmodic way of speaking in which there are involuntary halts, breaks, and repetitions, usually of psychogenic origin. MHÑStuttering ANdo not use /congen /drug eff /physiol /rad eff MNC10.597.257.870.883; C23.888.592.257.870.883; F3.126.219.870.883 XSSTAMMERING LH LS  PM68 HN68 MHÑStyrenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.426.559.389.150.750 FXÑPOLYSTYRENES LH LX  OLto search VAN BOGAERT'S LEUKOENCEPHALITIS use SUBACUTE SCLEROSING PANENCEPHALITIS back thru 1971 & CEREBRAL SCLEROSIS, DIFFUSE 1966-70 PM71; VAN BOGAERT'S LEUKOENCEPHALITIS was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-70 HN71; VAN BOGAERT'S LEUKOENCEPHALITIS was see under SUBACUTE SCLEROSING PANENCEPHALITIS 1971-78, was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-70 MHÑSubacute Sclerosing Panencephalitis ANalso called subacute inclusion encephalitis, subacute sclerosing leukoencephalitis; caused by SSPE VIRUS PICerebral Sclerosis, Diffuse (66-70) MNC2.782.660.862; C2.839.862; C10.228.140.276.851; C10.228.140.437.851; C10.228.228.245.769 XSVan Bogaert's Leukoencephalitis LH LS  MHÑSubarachnoid Hemorrhage MNC10.228.140.300.420.811; C14.907.253.420.811; C23.542.115.811 XSHEMORRHAGE, SUBARACHNOID LH LS  MHÑSubarachnoid Space ANNIM: usually locational so few qualif apply; do not use /innerv MNA8.186.566.166.686 LH  OLuse SUBCELLULAR FRACTIONS to search HOMOGENATES 1966 PM72 HN72; HOMOGENATES was Prov 1964-66 MHÑSubcellular Fractions ANNIM; A 11 qualif except /cytol; /class permitted PICytology (66-71); Microsomes (66-71) MNA11.904 FXÑCell Fractionation XUÑCell-Free System LH LX LU  MSArtery arising from the innominate artery on the right side and from the arch of the aorta on the left side; it distributes to the neck, thoracic wall, spinal cord, brain, meninges and upper limb. MHÑSubclavian Artery ANdo not use /blood supply MNA7.231.114.839 LH  PM65 HN65(64) MHÑSubclavian Steal Syndrome MNC10.228.140.300.459.832; C14.907.253.459.832 XSBRACHIAL-BASILAR INSUFFICIENCY SYNDROME LH LS  MSThe continuation of the axillary vein which follows the subclavian artery and then joins the internal jugular vein to form the innominate vein. MHÑSubclavian Vein ANdo not use /blood supply MNA7.231.908.877 LH  MSAn ependymal derivative located at the junction of the third ventricle and the cerebral aqueduct, secreting somatostatin. HN(77) MHÑSubcommissural Organ ANdo not use /innerv PINeurosecretory Systems (70-76) MNA8.713.810 DMÑNeurosecretory Systems LH LM  MSPresence of air or gas in the subcutaneous tissues of the body. HN(77) MHÑSubcutaneous Emphysema PIEmphysema (66-76) MNC23.390.880 XSEmphysema, Subcutaneous DMÑEmphysema LH LS LM  HN(72); was in Cat A & C 1972-83 MHÑSubdural Effusion PIMeningitis/CO (66-71); specific meningitis/CO (66-71) MNC10.228.228.507.825 DMÑMeningitis LH LM  MSAn intracranial suppurative process between the dura and the arachnoid. The infection gains entrance to the subdural space from the frontal and ethmoid sinuses, the middle ear, and the mastoid cells. PM84 HN84 MHÑSubdural Empyema PIBrain Abscess (66-83) MNC1.539.307.890; C10.228.228.890 XSAbscess, Subdural; Empyema, Subdural LH LS;  HN(72) MHÑSubdural Space ANNIM: usually locational so few qualif apply; do not use /innerv PIMeninges (66-71) MNA8.186.566.395.687 DMÑMeninges LH LM  MSA structure, situated close to the intraventricular foramen, which induces drinking behavior after stimulation with angiotensin II. HN(77) MHÑSubfornical Organ ANdo not use /innerv PINeurosecretory Systems (70-76) MNA8.713.840 DMÑNeurosecretory Systems LH LM  PM65 HN65 MHÑSubgingival Curettage ANdo not use /util except by MeSH definition MNE6.721.874 FXÑPeriodontitis LH LX  MSTerms or expressions which provide the major means of access by subject to the bibliographic unit. MHÑSubject Headings ANno qualif MNL1.300.890 LH  MSA defense mechanism through which unacceptable impulses and instinctive urges are diverted into personally and socially acceptable channels; e.g., aggression may be diverted through sports activities. PM68 HN68 MHÑSublimation ANno qualif PIPsychoanalytic Theory (66-67) MNF1.393.898; F3.407.898 LH  MSStimulation at an intensity below that where a differentiated response can be elicited. OLuse SUBLIMINAL STIMULATION to search SUBLIMINAL PERCEPTION back thru 1969 PM69 HN69(64); SUBLIMINAL PERCEPTION was see under SUBLIMINAL STIMULATION 1969-78 MHÑSubliminal Stimulation ANno qualif MNF2.463.593.710.750 XSSubliminal Perception LH LS  MHÑSublingual Gland ANdiseases: coord IM with SALIVARY GLAND DISEASES (NIM) MNA10.336.779.687; A14.549.760.687 LH  MSNeoplasms of the sublingual glands. HN(86) MHÑSublingual Gland Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PISalivary Gland Neoplasms (66-85) MNC4.588.443.591.824.882; C7.465.815.718.870 DMÑSalivary Gland Neoplasms LH LM  MHÑSubmandibular Gland MNA10.336.779.812; A14.549.760.812 XSSUBMAXILLARY GLAND LH LS  HN(81) MHÑSubmandibular Gland Diseases PISalivary Gland Diseases (66-80); Submandibular Gland (66-80) MNC7.465.815.882 DMÑSalivary Gland Diseases LH LM  HN(81) MHÑSubmandibular Gland Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PISalivary Gland Neoplasms (66-80); Submandibular Gland (66-80) MNC4.588.443.591.824.885; C7.465.815.718.885 DMÑSalivary Gland Neoplasms LH LM  MSThe field of medicine concerned with conditions affecting the health of people in submarines or sealabs. MHÑSubmarine Medicine ANonly /econ /educ /hist /instrum /man /trends; for med & physiol aspects of activities of submarine personnel; Manual 28.10; DIVING is also available MNG2.403.478.508 FXÑOceanography; ÑSEALED CABIN ECOLOGY LH LX;  MSThe various filaments, granules, tubules or other inclusions within mitochondria. PM85; was see under MITOCHONDRIA 1979-84 HN85(79); was see under MITOCHONDRIA 1979-84 MHÑSubmitochondrial Particles ANA 11 qualif except /cytol; /class permitted PIMitochondria (66-78); specific mitochondria heading MNA11.368.702.564.882; A11.904.626.882 LH  PM65 HN65 MHÑSubmucous Plexus ANdo not use /innerv MNA8.99.842 XSMEISSNER'S PLEXUS LH LS  MHÑSubphrenic Abscess ANalso called ╥subdiaphragmatic╙ MNC1.539.26.812; C6.772.842 XSABSCESS, SUBPHRENIC LH LS  MSDistinguishing features of abuse from nonpathological use are: a pattern of pathological use (intoxication throughout the day, inability to stop or cut down use, and daily need for the substance for adequate functioning) and impairment in social or occupational functioning over a period of time. OLuse SUBSTANCE ABUSE to search DRUG ABUSE back thru 1968 PM81; was DRUG ABUSE 1968-80 HN81; was DRUG ABUSE 1968-80 MHÑSubstance Abuse ANIM + specific drug or substance IM (without qualif); do not use /chem ind /drug eff /educ /instrum /physiol /rad eff; abuse, overuse or misuse of drugs or other substances but not for over-prescription of drugs by physician ( = DRUG UTILIZATION): differentiate from DRUG DEPENDENCE (wherein physical dependence); STREET DRUGS is available; Bull 102 (Oct 77): drugs of abuse PIDrug Therapy (66-67); Substance Dependence (66-67) MNF1.145.905; F3.709.597.780.610; I1.880.735.790 XSDrug Abuse FXÑDRUG AND NARCOTIC CONTROL LH LS LX  MSStrong emotional and/or physiological dependence upon a drug or other substance which has progressed beyond voluntary control. OLuse SUBSTANCE DEPENDENCE to search DRUG DEPENDENCE & DRUG ADDICTION back thru 1966 but in 1968 use SUBSTANCE DEPENDENCE & SUBSTANCE ABUSE PM81; was DRUG DEPENDENCE 1976-80, was DRUG DEPENDENCE see under DRUG ADDICTION 1969-75, was DRUG DEPENDENCE see under DRUG ABUSE 1968; DRUG ADDICTION was heading 1963-75 HN81; was DRUG DEPENDENCE 1976-80, was DRUG DEPENDENCE see under DRUG ADDICTION 1969-75, was DRUG DEPENDENCE see under DRUG ABUSE 1968; DRUG ADDICTION was heading 1963-75 MHÑSubstance Dependence ANIM + specific drug or substance IM (without qualif); do not use /chem ind /drug eff /educ /instrum /physiol /rad eff; differentiate from SUBSTANCE ABUSE (abuse, overuse or misuse of drugs or other substances but no physical dependence); STREET DRUGS is available; Bull 102 (Oct 77): drugs of abuse MNF3.709.597.780.660 XSDrug Addiction; Drug Dependence; Drug Habituation FXÑNarcotics; ÑSocial Problems LH LS; ; LX;  PM73; was see under PEPTIDES 1963-72 HN73(65); was see under PEPTIDES 1963-72 MHÑSubstance P AN/biosyn /physiol permitted RN12769-48-1 MND12.644.866; D12.776.641.650.750; D16.538.871; D24.185.798.837 XSEULER-GADDUM SUBSTANCE P; Hypothalamic Substance P LH LS;  MSDisorders manifested by maladaptive behavior associated with more or less regular use of substances. To be distinguished from substance-induced organic mental disorders in which there are direct effects (acute or chronic) of these substances on the central nervous system. OLuse SUBSTANCE USE DISORDERS to search GLUE SNIFFING back thru 1966 (as Prov 1966-68) PM81; GLUE SNIFFING was heading 1969-80 HN81; GLUE SNIFFING was heading 1964-80 (Prov 1964-68) MHÑSubstance Use Disorders ANIM + specific drug or substance IM (without qualif); do not use /chem ind /drug eff /physiol /rad eff MNF3.709.597.780 XSDrug Use Disorders; Glue Sniffing FXÑImpulse Control Disorders LH LS; LX  MSPhysiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation; includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. OLuse SUBSTANCE WITHDRAWAL SYNDROME to search DRUG WITHDRAWAL SYMPTOMS back thru 1966 (as Prov 1966) PM81; was DRUG WITHDRAWAL SYMPTOMS 1967-80 HN81; was DRUG WITHDRAWAL SYMPTOMS 1964-80 (Prov 1964-66) MHÑSubstance Withdrawal Syndrome ANincludes withdrawal from addictive drugs or other substances, administered drugs, smoking & alcohol (but DELIRIUM TREMENS see ALCOHOL WITHDRAWAL DELIRIUM is also available); do not use /compl for the symptom; coord IM with specific substance /adv eff (IM) + specific dis or symptom following withdrawal /chem ind (IM), e.g., hypertension after propranolol withdrawal = SUBSTANCE WITHDRAWAL SYNDROME (IM) + PROPRANOLOL /adv eff (IM) + HYPERTENSION /chem ind (IM); do not use /drug eff /physiol /rad eff; babies born to addicted mothers & developing withdraw symp = SUBSTANCE WITHDRAWAL SYNDROME /etiol (IM) + specific substance /adv eff (IM) + check tag INFANT, NEWBORN MNF3.709.508.490.310 XSDrug Withdrawal Symptoms; Withdrawal Symptoms LH LS;  OLsearch SPINAL CORD 1966-74 HN(75)(64-67) MHÑSubstantia Gelatinosa ANdo not use /innerv MNA8.186.854.852 DMÑSpinal Cord LH LM  MSTissue in the base of the forebrain inferior to the anterior perforated substance, and anterior to the globus pallidus and ansa lenticularis. It contains the nucleus basalis of Meynert and may be implicated in Alzheimer's disease. HN(84) MHÑSubstantia Innominata ANdo not use /innerv PIBasal Ganglia (82-83); Brain (66-83); Globus Pallidus (66-83); Telencephalon (66-83) MNA8.186.211.885.105.880 XSBasal Nucleus of Meynert; Nucleus Basalis of Meynert DMÑBasal Ganglia LH LS; LM  MHÑSubstantia Nigra ANdo not use /innerv MNA8.186.211.132.659.687 LH  MSA characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme reacts. PM78 HN78 MHÑSubstrate Specificity ANrestricted to enzyme activity; almost never IM; coord NIM with specific enzyme (IM); only /drug eff /rad eff MNG6.184.880 LH  PM74 HN74(73) MHÑSubtilisins AN/biosyn permitted; do not use /analogs /defic /physiol RNEC 3.4.21.14 PIPeptide Peptidohydrolases (66-72) MND8.586.277.656.732.787 LH  MSCombination or superimposition of two images for demonstrating differences between them (e.g., radiograph with contrast vs. one without, radionuclide images using different radionuclides, radiograph vs. radionuclide image) and in the preparation of audio-visual materials (e.g., offsetting identical images, coloring of vessels in angiograms). PM73 HN73(64) MHÑSubtraction Technic ANdo not use /util except by MeSH definition; coord IM with RADIOGRAPHY (NIM) or RADIONUCLIDE IMAGING (NIM) for general articles only: do not use these coords when using /radiogr or /radionuclide CATALOG: do not use /laboratory manuals MNE1.890 FXÑImage Enhancement LH LX  MSThe inhabitants of peripheral or adjacent areas of a city or town. PM80 HN80 MHÑSuburban Population ANno qualif; specify geog CATALOG: /geog /form PIUrban Population (68-79) MNN1.696.810 LH  MSA portion of the electron transport chain, catalyzing the transfer of electron from succinate to cytochrome c via FAD, ubiquinone and cytochrome b. The first step is catalyzed by succinate dehydrogenase (EC 1.3.99.1), the other steps are not well characterized enzymes. HN(75) MHÑSuccinate Cytochrome C Oxidoreductase ANdo not use /analogs RNEC 1.- PICytochome C (73-74); Oxidoreductases (73-74); Succinates (73-74) MND8.586.682.830 DMÑOxidoreductases LH LM  MHÑSuccinate Dehydrogenase ANdo not use /analogs RNEC 1.3.99.1 MND8.586.682.850 XSSUCCINIC OXIDASE LH LS  MHÑSuccinates ANdo not use /analogs /defic /physiol MND2.241.81.337.817 XUÑDioctyl Sulfosuccinates; ÑSuccinic Anhydrides LH LU;  MSDihydro-2,5-furandiones. Succinic acid anhydrides. Can be substituted on any carbon atom. They modify and inhibit proteins and enzymes and are used in the acylation of amino- and hydroxyl groups. HN(79) MHÑSuccinic Anhydrides ANdo not use /analogs /biosyn /defic /physiol PIAnhydrides (66-78); Succinates (66-78) MND2.113.700; D2.241.81.337.817.600 DMÑSuccinates LH LM  OLuse SUCCINIMIDES to search PHENSUXIMIDE 1966-84 (as Prov 1966-72) PM74; PHENSUXIMIDE was heading 1973-84 HN74(72); PHENSUXIMIDE was heading l963-84 (Prov l963-72) MHÑSuccinimides ANdo not use /analogs /biosyn /defic /physiol; = pyrrolidinediones PIPyrrolidines (66-71); Pyrrolidinones (66-71); Succinates (66-71) MND2.241.81.337.817.687; D2.478.770; D3.383.773.812.852; D14.261.770 XUÑBromosuccinimide LH LU  MSSuccinate:CoA ligase (GDP- or ADP-forming). Catalyze the first step leading to the oxidation of succinic acid by the reversible formation of succinyl-CoA from succinate and CoA with the concomitant cleavage of ATP to ADP (EC 6.2.1.5) or GTP to GDP (EC 6.2.1.4) and orthophosphate. Itaconate can act instead of succinate and ITP instead of GTP. HN(76) MHÑSuccinyl Coenzyme A Synthetases ANdo not use /analogs RNEC 6.2.1.- PICoenzyme A Synthetases (73); Succinates (73) MND8.586.464.271.800 XSSuccinic Thiokinases; Succinyl CoA Synthetases DMÑCoenzyme A Synthetases LH LS; LM  MHÑSuccinylcholine ANdo not use /biosyn /defic /physiol RN306-40-1 MND2.92.102.232.780; D2.241.81.337.817.725; D2.675.276.232.780; D17.688.890 XSSuccinyldicholine; Suxamethonium LH LS;  MSAny suction exerted by the mouth; response of the mammalian infant to draw milk from the breast. Includes sucking on inanimate objects. Not to be used for thumb sucking, which is indexed under fingersucking. PM68 HN68(65) MHÑSucking Behavior ANhuman & animal; only /drug eff /physiol /rad eff MNF1.145.916 LH  MSSucrose octakis(hydrogen sulfate)-aluminum complex. Sucralfate is a basic aluminum complex of sulfated sucrose. It is advocated in the therapy of peptic, duodenal, and prepyloric ulcers, gastritis, reflux esophagitis, and other gastrointestinal irritations. It acts primarily at the ulcer site, where it has cytoprotective, pepsinostatic, antacid, and bile acid-binding properties. The drug is only slightly absorbed by the digestive mucosa, which explains the absence of systemic effects and toxicity. PM87 HN87 MHÑSucralfate ANdo not use /biosyn /defic /physiol RN54182-58-0 PIAluminum (66-86); Sucrose/analogs & derivatives (77-81) MND2.691.925; D9.203.698.629.305.770.850; D19.316.203.880 XSAluminum Sucrose Sulfate LH LS  PM72 HN72(63) MHÑSucrase ANdo not use /analogs; /defic: consider also SUCROSE /metab (IM) + CARBOHYDRATE METABOLISM, INBORN ERRORS (IM) RNEC 3.2.1.48 MND8.586.277.450.329.738 LH  MSAn enzyme complex found in the brush border membranes of the small intestine. It is believed to be an enzyme complex with different catalytic sites. Its absence is manifested by an inherited disease called sucrase-isomaltase deficiency. HN(78) MHÑSucrase-Isomaltase Complex ANdo not use /analogs; /defic: consider also SUCROSE /metab (IM) + CARBOHYDRATE METABOLISM, INBORN ERRORS (IM) RNEC 3.2.1.- PIGlycoside Hydrolases (66-77); Multienzyme Complexes (73-77); Sucrase (72-77) MND8.586.277.450.329.738.700; D8.586.277.450.770.800; D8.586.600.850 DMÑMultienzyme Complexes LH LM  MHÑSucrose ANtable sugar goes here; sucrose density gradient is CENTRIFUGATION, DENSITY GRADIENT & ignore sucrose RN57-50-1 MND9.203.698.629.305.770 LH  MSThe removal of secretions, gas or fluid from hollow or tubular organs or cavities by means of a tube and a device that acts on negative pressure. PM77 HN77 MHÑSuction ANNIM; differentiate from DRAINAGE; only /adv eff /instrum /methods /vet; suction lipolysis, suction lipectomy, liposuction, etc. as in obesity is indexed here (NIM) + ADIPOSE TISSUE/surg (IM) MNE4.237.890 XSAspiration, Mechanical; Drainage, Suction LH LS;  MHÑSudan MNZ1.58.183.688 LH  MSSudden death of infants of unknown cause. PM75 HN75 MHÑSudden Infant Death ANonly /blood /class /csf /etiol /occur /pathol /physiopathol /prev PIDeath, Sudden (66-74) MNC23.240.322.500 XSCot Death; Crib Death; SID LH LS; ;  MHÑSudeck's Atrophy MNC5.116.198.579.688 FXÑReflex Sympathetic Dystrophy LH LX  PM73 HN73 MHÑSugar Acids ANdo not use /analogs /defic /physiol PICarbohydrates (66-72) MND2.241.81.844; D2.241.511.902; D9.203.811 XUÑ2,3-Diketogulonic Acid; ÑGlucaric Acid; ÑMuramic Acids LH LU; ;  MSReversibly catalyzes the oxidation of a hydroxyl group of sugar alcohols to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2. and EC 1.1.99. PM78; ALDOSE REDUCTASE was see under ALCOHOL OXIDOREDUCTASES 1976-77; IDITOL DEHYDROGENASE was see under ALCOHOL OXIDOREDUCTASES 1977 HN78 MHÑSugar Alcohol Dehydrogenases ANdo not use / analogs RNEC 1.1. PIAlcohol Oxidoreductases (66-77) MND8.586.682.47.150.700 XSSugar Alcohol Oxidoreductases XUÑAldose Reductase; ÑIditol Dehydrogenase LH LS LU;  PM72 HN72 MHÑSugar Alcohols ANdo not use /analogs /defic /physiol PIAlcohols (66-71) MND2.33.800; D9.203.853 XSALCOHOLS, SUGAR XUÑDianhydrogalactitol; ÑDulcitol; ÑRibitol LH LS LU; ;  PM74 HN74 MHÑSugar Phosphates ANdo not use /analogs /defic /physiol MND9.203.894 FXÑPhosphates XUÑInositol Phosphates; ÑMannitol Phosphates LH LX LU;  MSThe uncritical acceptance of an idea or plan of action. MHÑSuggestion ANno qualif; consider also PERSUASION see PERSUASIVE COMMUNICATION MNF4.754.424.771 FXÑAutogenic Training XUÑAutosuggestion LH LX LU  MSThe act of killing oneself. MHÑSuicide ANonly /hist /legis /occur (for statistics, not causes) /prev /psychol MNC23.240.838; F3.126.918; I1.880.735.856 LH  MSThe unsuccessful attempt to kill oneself. PM75 HN75 MHÑSuicide, Attempted ANonly /legis /occur (for statistics, not causes) /prev /psychol PISuicide (66-74) MNF3.126.918.600; I1.880.735.856.600 LH  MS3,3-Dimethyl-7-oxo-6-(2-phenyl-2-sulfoacetamido)-4-thia-1-azabicyclo(3,2,0)heptane-2-carboxylic acid disodium salt. Semisynthetic penicillin type antibiotic. HN(76) MHÑSulbenicillin ANdo not use /biosyn /defic /physiol RN41744-40-5 PIPenicillin G (73-74) /AA (75); Sulfonic Acids (73-75) MND20.85.99.739.762.875 XSSulfobenzylpenicillin DMÑPenicillin G LH LS LM  MHÑSulfacetamide ANdo not use /biosyn /defic /physiol RN144-80-9 MND2.65.884.725.650; D2.886.590.700.725.650; D20.890.725.650 LH  MSN(1)-(6-Chloro-3-pyridazinyl)sulfanilamide. Sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine. Synonyms: Cosulfa; Sonilyn; Vetisulid. HN(75) MHÑSulfachlorpyridazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN80-32-0 PIPyridazines (74); Sulfanilamides (74) MND2.65.884.725.700; D2.886.590.700.725.700; D20.890.725.700 DMÑSulfanilamides LH LM  MHÑSulfadiazine ANdo not use /biosyn /defic /physiol; note: METHYLSULFADIAZINE see SULFAMERAZINE RN68-35-9 MND2.65.884.725.755; D2.886.590.700.725.755; D20.890.725.755 XUÑSilver Sulfadiazine LH LU  MHÑSulfadimethoxine ANdo not use /biosyn /defic /physiol RN122-11-2 MND2.65.884.725.760; D2.886.590.700.725.760; D20.890.725.760 LH  MSN(1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide. Long acting sulfonamide, plasma bound, used for respiratory and urinary tract infections; may also be effective for malaria and leprosy. Synonyms: Fanasil; Ro 4-4393. HN(75) MHÑSulfadoxine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2447-57-6 PIPyrimidines (71-74); Sulfonamides (71-74) MND2.65.884.725.765; D2.886.590.700.725.765; D20.890.725.765 XSSulformethoxine; Sulforthomidine DMÑSulfanilamides LH LS; LM  HN(63) MHÑSulfaguanidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN57-67-0 MND2.65.884.725.810; D2.78.370.853; D2.886.590.700.725.810; D20.890.725.810 DMÑGuanidines LH LM  MSN-(3-Methoxypyrazinyl)sulfanilamide. Long acting plasma bound sulfonamide used for respiratory and urinary tract infections and also for malaria. HN(75) MHÑSulfalene ANdo not use /biosyn /defic /physiol; /analogs NIM only RN152-47-6 PIPyrazines (71-74); Sulfonamides (71-74) MND2.65.884.725.850; D2.886.590.700.725.850; D20.890.725.850 XSSulfamethoxypyrazine; Sulfapyrazinmethoxine DMÑSulfanilamides LH LS; LM  MHÑSulfamerazine ANdo not use /biosyn /defic /physiol RN127-79-7 MND2.65.884.725.853; D2.886.590.700.725.853; D20.890.725.853 XSMethylsulfadiazine LH LS  MSN(1)-(5-Methoxy-2-pyrimidinyl)sulfanilamide. Long acting sulfonamide used in leprosy, urinary and respiratory tract infections. Synonyms: Bayrena; Dairena; Kinecid; Sulla; Ultrax. HN(75) MHÑSulfameter ANdo not use /biosyn /defic /physiol; /analogs NIM only RN651-06-9 PIPyrimidines (70-74); Sulfanilamides (73-74) MND2.65.884.725.857; D2.886.590.700.725.857; D20.890.725.857 XSSulfamethoxydiazine; Sulfametin; Sulfametorinum DMÑSulfanilamides LH LS; ; LM  MHÑSulfamethazine ANdo not use /biosyn /defic /physiol RN57-68-1 MND2.65.884.725.862; D2.886.590.700.725.862; D20.890.725.862 XSSulfadimidine LH LS  HN(63) MHÑSulfamethizole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN144-82-1 MND2.65.884.725.935.813; D2.886.590.700.725.935.813; D20.890.725.935.813 DMÑSulfathiazoles LH LM  PM68 HN68(63) MHÑSulfamethoxazole ANdo not use /biosyn /defic /physiol RN723-46-6 MND2.65.884.725.867; D2.886.590.700.725.867; D20.890.725.867 XSSulfamethylisoxazole LH LS  MHÑSulfamethoxypyridazine ANdo not use /biosyn /defic /physiol RN80-35-3 MND2.65.884.725.872; D2.886.590.700.725.872; D20.890.725.872 LH  MSN(1)-(-Methoxy-4-pyrimidinyl)sulfanilamide. Long acting sulfonamide. Synonyms: Daimeton; DJ 1550; Ro 4-3476. HN(75) MHÑSulfamonomethoxine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1220-83-3 PIPyrimidines (72-74); Sulfonamides (69-74) MND2.65.884.725.877; D2.886.590.700.725.877; D20.890.725.877 DMÑSulfanilamides LH LM  MHÑSulfamoxole ANdo not use /biosyn /defic /physiol RN729-99-7 MND2.65.884.725.882; D2.886.590.700.725.882; D20.890.725.882 LH  OLuse SULFANILAMIDES to search SULFANILAMIDE back thru 1966 PM75; was SULFANILAMIDE 1963-74 HN75; was SULFANILAMIDE 1963-74 MHÑSulfanilamides ANdo not use /analogs /biosyn /defic /physiol MND2.65.884.725; D2.886.590.700.725; D20.890.725 XUÑSulfachlorpyridazine; ÑSulfadoxine; ÑSulfalene; ÑSulfameter; ÑSulfamonomethoxine; ÑSulfapyridine; ÑSulfaquinoxaline LH LU; ; ; ; ; ;  MSAminobenzenesulfonic acids. Used in the manufacture of dyes and organic chemicals and as a reagent. OLuse SULFANILIC ACIDS to search SULFANILIC ACID back thru 1975 HN(83); was SULFANILIC ACID see under BENZENESULFONATES 1975-82 MHÑSulfanilic Acids ANdo not use /analogs /biosyn /defic /physiol PIAmines (74); Benzenesulfonates (74) MND2.241.866.540.244.222.750; D2.455.426.559.389.97.750; D2.886.610.244.222.750; D26.550.822 XSAminobenzenesulfonic Acids; Anilinesulfonic Acids DMÑBenzenesulfonates LH LS; LM  MHÑSulfaphenazole ANdo not use /biosyn /defic /physiol RN526-08-9 MND2.65.884.725.887; D2.886.590.700.725.887; D20.890.725.887 XSPhenylsulfapyrazole; Sulfaphenylpyrazol LH LS;  MSN'-2-Pyridylsulfanilamide. Antibacterial, potentially toxic, used to treat certain skin diseases. Synonyms: Dagenan; Eubasin: Pyramid. HN(75) MHÑSulfapyridine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN144-83-2 PIPyridines (74); Sulfanilamides (74) MND2.65.884.725.900; D2.886.590.700.725.900; D20.890.725.900 DMÑSulfanilamides LH LM  MSN(1)-(2-Quinoxalinyl)sulfanilamide. An antiprotozoal agent used to combat coccidial infections of swine, cattle, fowl and other veterinary animals. Also used in controlling outbreaks of fowl typhoid and fowl cholera and in treatment of infectious enteritis. Synonyms: Sulfa-Q 20; Sulquin. HN(75) MHÑSulfaquinoxaline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN59-40-5 PIQuinoxalines (74); Sulfanilamides (74) MND2.65.884.725.925; D2.886.590.700.725.925; D20.890.725.925 XSSulfabenzpyrazine; Sulfachinoxalin DMÑSulfanilamides LH LS; LM  MHÑSulfatases ANdo not use /analogs RNEC 3.1.6. MND8.586.277.352.827 XUÑArylsulfatases; ÑChondro-4-Sulfatase; ÑIduronate Sulfatase LH LU; ;  MSATP:Sulfate adenylyltransferase. Catalyzes the activation of sulfate ions by ATP to form adenosine-5'-phosphosulfate and pyrophosphate. This reaction constitutes the first enzymatic step in sulfate utilization following the uptake of sulfate. EC 2.7.7.4. HN(79) MHÑSulfate Adenylyltransferase ANdo not use /analogs RNEC 2.7.7.4 PIAdenosine Triphosphate (66-78); Nucleotidyltransferases (66-78); Sulfates (66-78); Transferases (66-67) MND8.586.913.696.445.800 XSATP Sulfurylase; Sulfurylase DMÑNucleotidyltransferases LH LS; LM  MHÑSulfates ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.845; D1.877.814.539 XSSulfates, Inorganic LH LS  MHÑSulfathiazoles ANdo not use /analogs /biosyn /defic /physiol MND2.65.884.725.935; D2.886.590.700.725.935; D3.383.871.725; D20.890.725.935 XUÑSulfamethizole LH LU  PM73 HN73(71) MHÑSulfatides ANdo not use /analogs /biosyn /defic /physiol PICerebrosides (66-70) MND10.516.390.470.213.772; D10.516.808.530.288.772 LH  PM68 HN68 MHÑSulfenic Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.814; D1.877.481 LH  PM65 HN65(63) MHÑSulfhemoglobin ANdo not use /blood ( = SULFHEMOGLOBINEMIA) /defic /physiol RN9010-20-2 MND12.776.124.400.877; D12.776.422.512.865 LH  PM65 HN65 MHÑSulfhemoglobinemia MNC15.378.896 LH  OLsearch LYASES 1966-74 HN(75) MHÑSulfhydrases ANdo not use /analogs RNEC 4.4. MND8.586.520.844 DMÑLyases LH LM  MHÑSulfhydryl Compounds ANdo not confuse with SULFHYDRYL REAGENTS; do not use /analogs /biosyn /defic /physiol; /antag = SULFHYDRYL REAGENTS; DF: SULFHYDRYL CPDS MND2.886.489 XSMercapto Compounds; Thiols XUÑ3-Mercaptopropionic Acid; ÑDimercaptosuccinic Acid; ÑPantetheine LH LS; LU; ;  PM72 HN72(71) MHÑSulfhydryl Reagents ANdo not confuse with SULFHYDRYL COMPOUNDS; do not use /analogs /biosyn /defic /physiol PISulfhydryl Compounds/AI (68-70) MND8.373.830; D26.550.844 XSSulfhydryl Compounds Antagonists; Sulfhydryl Compounds Inhibitors LH LS;  MSChemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties. Synonym: sulfur ethers. MHÑSulfides ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.874; D1.877.522; D2.886.520 XSThioethers LH LS  PM65 HN65 MHÑSulfinic Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.839; D1.877.564 LH  PM65 HN65(64) MHÑSulfinpyrazone ANdo not use /biosyn /defic /physiol RN57-96-5 MND3.383.694.700.800; D14.73.278.398.946.874; D26.74.75.574.946.874 XSSulfoxyphenylpyrazolidin LH LS  MHÑSulfisomidine ANdo not use /biosyn /defic /physiol RN515-64-0 MND2.65.884.725.940; D2.886.590.700.725.940; D20.890.725.940 LH  MHÑSulfisoxazole ANdo not use /biosyn /defic /physiol RN127-69-5 MND2.65.884.725.945; D2.886.590.700.725.945; D20.890.725.945 XSSulfafurazole LH LS  MSA molybdohemoprotein which catalyzes the terminal reaction in the oxidative degradation of sulfur-containing amino acids with the formation of a sulfate. Cytochrome C, ferricyanide and molecular oxygen can act as acceptors. A deficiency is manifested by brain damage and mental deterioration. EC 1.8.2.1 utilizes ferricytochrome C as acceptor. EC 1.8.3.1 uses molecular oxygen. HN(79) MHÑSulfite Oxidases ANdo not use /analogs RNEC 1.8.3.1 PIOxidoreductases (66-78); Sulfites (66-78) MND8.586.682.864 XSSulfite Dehydrogenases DMÑOxidoreductases LH LS LM  MSHydrogen sulfide:(acceptor) oxidoreductases. Enzymes which reversibly catalyze the oxidation of hydrogen sulfide in the presence of various acceptors to sulfite and a reduced acceptor. EC 1.8.1.2 utilizes NADP+ as the acceptor. EC 1.8.7.1 utilizes oxidized ferredoxin as acceptor and EC 1.8.99.1 will utilize a variety of acceptors. HN(79) MHÑSulfite Reductases ANdo not use /analogs RNEC 1.8.- PIOxidoreductases (66-78); Sulfites (66-78) MND8.586.682.868 XSBisulfite Reductases; Desulfoviridins DMÑOxidoreductases LH LS; LM  MHÑSulfites ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.904; D1.877.855.565 XSSulfites, Inorganic XUÑDithionite LH LS LU  MHÑSulfobromophthalein ANusually /diag use in LIVER FUNCTION TESTS; D25-26 qualif RN71-67-0 MND26.408.646.600.773 XSBROMSULPHALEIN LH LS  OLuse SULFONAMIDES to search SULFONAMIDE MIXTURES 1966-79 PMSULFONAMIDE MIXTURES was heading 1963-79 HNSULFONAMIDE MIXTURES was heading 1963-79 MHÑSulfonamides ANdo not use /analogs /biosyn /defic /physiol MND2.65.884; D2.886.590.700; D20.890 XUÑGlymidine; ÑMafenide LH LU;  MHÑSulfones ANdo not use /analogs /biosyn /defic /physiol MND2.886.590 XUÑPhenylmethylsulfonyl Fluoride LH LU  MHÑSulfonic Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.865; D1.877.606; D2.241.866.540; D2.886.610 XUÑThiosulfonic Acids LH LU  MSSulfur compounds in which the sulfur atom is attached to three organic radicals and an electronegative element or radical. HN(75) MHÑSulfonium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: SULFONIUM CPDS PIOnium Compounds (68-74) MND2.675.800; D2.886.620 XSSulfine Compounds DMÑOnium Compounds LH LS LM  PM72 HN72 MHÑSulfonylurea Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: SULFONYLUREA CPDS PIHypoglycemic Agents (66-71) MND2.886.590.795; D2.948.828 XUÑGlibornuride; ÑGliclazide; ÑGlipizide LH LU; ;  PM66 HN66 MHÑSulfoxides ANdo not use /analogs /biosyn /defic /physiol MND1.655.498.850.830; D2.886.640; D1.877.755.600 LH  MHÑSulfur ANS-32; do not use /analogs /biosyn /defic /physiol; for isotopes & radioisotopes see below RN7704-34-9 MND1.268.842; D1.877 LH  OL╥sulfur acids╙ is indexed under specifics here or under SULFURIC ACIDS (D1) MH*Sulfur Acids (Non Mesh) MND2.241.866 LH  OL╥sulfur compounds╙ is indexed under specifics here or under SULFUR (D1) MH*Sulfur Compounds (Non Mesh) MND2.886 LH  PM66 HN66(64) MHÑSulfur Dioxide ANdo not use /analogs /biosyn /defic /physiol RN7446-09-5 MND1.655.498.850.866; D1.877.755.650 LH  MSAn inert gas used mainly as a test gas in respiratory physiology. Other uses include its injection in vitreoretinal surgery to restore the vitreous chamber and as a tracer in monitoring the dispersion and deposition of air pollutants. HN(80) MHÑSulfur Hexafluoride ANdo not use /analogs /biosyn /defic /physiol RN2551-62-4 PIFluorides (66-79); Gases (66-79); Sulfur (66-79) MND1.396.514.348.825; D1.877.720 DMÑFluorides LH LM  MHÑSulfur Isotopes ANS-33,34,36; NIM; no qualif MND1.496.868; D1.877.731 LH  MSUse for oxides of sulfur in general or for which there is no specific heading. PM75 HN75 MHÑSulfur Oxides ANdo not use /analogs /biosyn /defic /physiol PIOxides (66-74); Sulfur (66-74) MND5.284.101.143.840; D1.877.755; D1.655.498.850 LH  OLsearch SULFUR ISOTOPES 1966-73 PM74 HN74 MHÑSulfur Radioisotopes ANS-29-31, 35, 37, 38; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) MND1.496.749.858; D1.496.868.690; D1.877.772 LH  OLsearch SULFURIC ACIDS 1968-74 HN(75) MHÑSulfuric Acid Esters ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.890.690; D1.877.814.740; D2.886.650; D2.241.866.600 DMÑSulfuric Acids LH LM  OLuse SULFURIC ACIDS to search SULFURIC ACID back thru 1966 PM68; was SULFURIC ACID 1963-67 HN68; was SULFURIC ACID 1963-67 MHÑSulfuric Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.890; D1.877.814 XSSulfates, Organic XUÑSulfuric Acid Esters; ÑThiosulfuric Acid Esters LH LS LU;  PM68 HN68 MHÑSulfurous Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.915; D1.877.855 XSSulfites, Organic LH LS  PM72 HN72 MHÑSulfurtransferases ANdo not use /analogs RNEC 2.8. PITransferases (66-71) MND8.586.913.820 XUÑThiosulfate Sulfurtransferase LH LU  MS(Z)-5-Fluoro-2-methyl-1-(p-(methylsulfinyl) benzylidene)-indene-3-acetic acid. The sulfinyl moiety is converted in vivo to an active anti-inflammatory analgesic which undergoes enterohepatic circulation to maintain constant blood levels without causing gastrointestinal side effecs. Synonyms: Arthrobid; Clinoril; MK 231. HN(79) MHÑSulindac ANdo not use /biosyn /defic /physiol; /analogs NIM only RN38194-50-2 PIBenzene (66-67); Benzene Derivatives (68-74); Benzylidene Compounds (75-78); Indenes (66-78) MND4.615.486.875; D14.73.278.880; D26.74.75.839 DMÑIndenes LH LM  MSerythro-p-(Isopropylthio)alpha(1- (octylamino)ethyl)benzyl alcohol. Smooth muscle relaxant, especially of cerebral blood vessels; also has anticoagulant properties and affects lipid metabolism; proposed for cerebral arteriopathies, especially atherosclerosis. Synonyms: CP 556S; Sulocton. HN(80) MHÑSuloctidil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN54063-56-8 PIAmino Alcohols (66-73); Propanolamines (74-79) MND2.33.329.624.890; D2.92.63.624.890; D18.918.851 DMÑPropanolamines LH LM  PM74 HN74 MHÑSulpiride ANdo not use /biosyn /defic /physiol RN15676-16-1 MND2.65.277.866; D2.241.223.106.162.866; D15.236.122.882 LH  HN(64) MHÑSulthiame ANdo not use /biosyn /defic /physiol; /analogs NIM only RN61-56-3 MND3.383.855.607; D14.261.829 DMÑThiazines LH LM  MHÑSunburn AN/prev: consider also SUNSCREENING AGENTS MNC17.608.840; C21.866.200.855 LH  MHÑSunlight AN/adv eff permitted but consider also SUNBURN & SUNSTROKE; HELIOTHERAPY is also available MNG3.230.300.100.725.525 FXÑLight LH LX  PM72 HN72(66) MHÑSunscreening Agents AND25-26 qualif MND26.313.855; D26.368.878; J1.516.213.690 LH  MHÑSunstroke ANheatstroke = HEAT EXHAUSTION MNC21.866.486.691 LH  MSThe component of the personality associated with ethics, standards, and self-criticism - the ╥conscience╥. It is derived mainly from identification with parents and parent substitutes. PM68 HN68 MHÑSuperego ANno qualif MNF1.752.747.859; F2.739.794.881 LH  MHÑSuperfetation ANonly /drug eff /rad eff MNG8.520.800.608 LH  PM71 HN71 MHÑSuperior Colliculus ANdo not use /innerv PICorpora Quadrigemina (66-70) MNA8.186.211.132.659.237.816 XSCOLLICULUS, SUPERIOR; OPTIC TECTUM LH LS;  MSDuodenal obstruction caused by compression of the third part of the duodenum by the root of the intestinal mesentery which contains the superior mesenteric artery, vein, and nerve. Synonym: cast syndrome. HN(80) MHÑSuperior Mesenteric Artery Syndrome ANduodenal compression by the superior mesenteric artery PIDuodenal Obstruction (66-79); Mesenteric Arteries (66-79) MNC6.405.469.275.395.890 XSDuodenal Compression Syndrome, Mesenteric; Mesenteric Duodenal Compression Syndrome DMÑDuodenal Obstruction LH LS; LM  MSObstruction of the superior vena cava caused by neoplasm, thrombosis, aneurysm, or external compression and causing suffusion and/or cyanosis of the face, neck, and upper arms. PM86 HN86 MHÑSuperior Vena Cava Syndrome PIThrombosis (66-85); Vascular Diseases (66-85); Vena Cava, Superior (66-85) MNC14.907.800 XSSuperior Vena Cava Obstruction; Superior Vena Cava Thrombosis FXÑVena Cava, Superior LH LS; LX  MSOccurrence or induction of release of more ova than are normally released at the same time in a given species. Applies to both animals and humans. HN(75) MHÑSuperovulation ANnote categories; use only G qualif: only /drug eff /rad eff MNE5.820.150.890; G8.520.440.508.768 DMÑOvulation LH LM  MSA highly reactive compound produced when oxygen is reduced by a single electron. In biological systems, it may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to methemoglobin. In living organisms, superoxide dismutase protects the cell from the deleterious effects of superoxide. PM84; was see under OXYGEN 1975-83 HN84(75); was see under OXYGEN 1975-83 MHÑSuperoxide ANdo not use /analogs /biosyn /defic /physiol; /metab permitted RN11062-77-4 PIAnions (74); Oxygen (74) MND1.248.497.158.680.750; D1.655.498.875 LH  PM74 HN74(73) MHÑSuperoxide Dismutase ANdo not use /analogs RNEC 1.15.1.1 PIOxidoreductases (66-72) MND8.586.682.881 XSCu-Zn Superoxide Dismutase; HEMOCUPREIN LH LS;  MSA belief or practice which lacks adequate basis for proof; an embodiment of fear of the unknown, magic, and ignorance. MHÑSuperstitions ANonly /hist; witchcraft = MAGIC MNI1.76.201.450.897 LH  HN81 MHÑSupport, Non-U.S. Gov't ANcheck tag only: NON-US GOVT SUP; for all articles noted as supported by Amer sources (societies, institutes, state govts, universities, private organizations, etc.) & by foreign sources (national, departmental, provincial, academic & private organizations, etc.); for support by both a non-US Govt source & a US Govt source, check NON-US GOVT SUP + NIH/PHS SUP or OTHER US GOVT SUP; Health Care Financing Admin is checked here; Manual 18.15+; DF: SUP NON GOVT CATALOG: do not use: for indexers only LH  OLuse SUPPORT, U.S. GOV'T, NON-P.H.S. to search UNITED STATES GOV'T SUPPORTED (as used for U.S. gov't agencies other than P.H.S.) back thru 1979 & UNITED STATES GOV'T SUPPORTED, NON-N.I.H. & its previous forms 1975-78; search UNITED STATES GOV'T SUPPORTED, N.I.H. & its previous forms under SUPPORT, U.S. GOV'T, P.H.S. back thru 1975 HN81; was UNITED STATES GOV'T SUPPORTED (used for U.S. gov't agencies other than P.H.S.) 1979-80; UNITED STATES GOV'T SUPPORTED, N.I.H. & UNITED STATES GOV'T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-77 (UNITED STATES was U.S. 1977; GOV'T WAS GOVERNMENT 1975-76) MHÑSupport, U.S. Gov't, Non-P.H.S. ANcheck tag only: OTHER US GOVT SUP; for all articles noted as supported by US Govt agencies other than PHS & NIH (see entry below); for support by both a US Govt agency & PHS or NIH, check OTHER US GOVT SUP + NIH/PHS SUP; for support by both a US Govt agency & any non-US Govt source, check OTHER US GOVT SUP + NON-US GOVT SUP; Nat Sci Found is checked here, Nat Acad of Sci & Nat Res Counc are checked NON-US GOVT SUP; Manual 18.15+; DF: SUP NON PHS CATALOG: do not use: for indexers only XSUnited States Gov't Supported, Non-P.H.S. LH LS  OLuse SUPPORT, U.S. GOV'T, P.H.S. to search UNITED STATES GOV'T SUPPORTED, P.H.S. back thru 1979 & UNITED STATES GOV'T SUPPORTED, N.I.H. & its previous forms back thru 1975; search UNITED STATES GOV'T SUPPORTED, NON-N.I.H. & its previous forms under SUPPORT, U.S. GOV'T, NON-P.H.S. 1975-78 HN81; was UNITED STATES GOV'T SUPPORTED, P.H.S. 1979-80; UNITED STATES GOV'T SUPPORTED, N.I.H. & UNITED STATES GOV'T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-77 (UNITED STATES was U.S. 1977; GOV'T was GOVERNMENT 1975-76) MHÑSupport, U.S. Gov't, P.H.S. ANcheck tag only: NIH/PHS SUP; for all articles noted as supported by PHS & its bureaus & serv; includes support by any institute of NIH (note X ref); for support by both PHS or NIH & another US Govt agency, check NIH/PHS SUP + OTHER US GOVT SUP; for support by both PHS or NIH & any non-US Govt source, check NIH/PHS SUP + NON-US GOVT SUP; for support by BRSG (Biomedical Research Support Grants) check NIH/PHS SUP; Manual 18.15+; DF: SUP PHS CATALOG: do not use: for indexers only XSSupport, U.S. Gov't, N.I.H.; United States Gov't Supported, N.I.H.; United States Gov't Supported, P.H.S. LH LS; ;  MHÑSuppositories ANIM for general only: only /anal (with caution) /stand /supply; NIM with specific drug IM: no qualif; /adv eff permitted but be careful: it may be the adv eff of the drug in the suppository, not the ╥suppository╙ MND26.394.225.821 FXÑAdministration, Rectal LH LX  MSThe restoration of the wild-type phenotype in an organism possessing a mutationally altered genotype. The effects of the mutation may be suppressed by a second ╥suppressor╥ mutation on a different gene, by a suppressor mutation on the same gene but located at a distance from the site of the primary mutation, or by the presence of a cytoplasmic suppressor due to a change in non-chromosomal DNA. OLuse SUPPRESSION, GENETIC to search GENES, SUPPRESSOR back thru 1968 (as Prov 1968-69) PM80; was GENES, SUPPRESSOR 1970-79 HN80; was GENES, SUPPRESSOR 1968-79 (Prov 1968-69) MHÑSuppression, Genetic ANonly /drug eff /rad eff PIGenes (66-67); Genes, Suppressor (68-79) MNG5.632.890 XSGenes, Suppressor; Suppressor Mutation LH LS;  MSCells which suppress antibody production by other cells, or inhibit other cellular immune responses. OLsearch T-LYMPHOCYTES 1979 PM80; was see T-LYMPHOCYTES 1979 HN80; was see T-LYMPHOCYTES 1979 MHÑSuppressor Cells ANA 11 qualif; a type of lymphoctye PILymphocytes (66-79); T Lymphocytes (73-79) MNA11.118.637.555.604.800.862; A15.145.229.637.555.604.862; A15.382.490.520.604.800.862; A15.382.520.520.604.800.862 XST Lymphocytes, Suppressor LH LS  MSProteins, protein complexes or glycoproteins secreted by suppressor T cells that inhibit either subsequent T cells, B cells, or other immunologic phenomena; some of these factors have both histocompatibility (I-J) and antigen-specific domains which may be linked by disulfide bridges; they can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory. PM86 HN86 MHÑSuppressor Factors, Immunologic ANdo not use /analogs; /biosyn /physiol permitted; DF: SUPPRESSOR FACTORS IMMUNOL PILymphokines (66-85); Suppressor Cells (79-85) MND24.611.632.700 XSImmunologic Suppressor Factors; Suppressor T Cell Factors; T Cell Suppressive Factors; T Suppressor Factors LH LS; ; ;  MHÑSuppuration ANNIM; TN 178: for suppurative dis & coord MNC1.539.26.878; C23.739.487.856 XSPUS LH LS  MSAn ovoid densely packed collection of small cells of the anterior hypothalamus lying close to the midline in a shallow impression of the optic chiasm. PM83 HN83 MHÑSuprachiasmatic Nucleus ANin the HYPOTHALAMUS, ANTERIOR; do not use /innerv PIHypothalamus (66-82) MNA8.186.211.385.357.342.625 LH  MSA progressive neurological disease usually of the fifth decade characterized by supranuclear ophthalmoplegia especially paralysis of downward gaze, pseudobulbar palsy, gait disturbance, dysathria, truncal dystonia, memory and personality deterioration, and dementia. PM87 HN87 MHÑSupranuclear Palsy, Progressive PIOphthalmoplegia (79-86); Paralysis (66-86); Paralysis, Bulbar (66-86) MNC10.228.140.79.882; F3.709.680.610.392.360.882 XSPalsy, Progressive Supranuclear; Steele-Richardson-Olszewski Syndrome LH LS;  MSHypothalamic nucleus overlying the beginning of the optic tract. PM83; was see under HYPOTHALAMUS 1975-82 HN83(75); was see under HYPOTHALAMUS 1975-82 MHÑSupraoptic Nucleus ANdo not use /innerv MNA8.186.211.385.357.342.650 LH  MSalpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid. Ibuprofen type anti-inflammatory analgesic and antipyretic; inhibits prostaglandin synthesis; proposed as anti-arthritic. Synonym: R 25,061. HN(78) MHÑSuprofen ANdo not use /biosyn /defic /physiol; /analogs NIM only RN40828-46-4 PIBenzene Derivatives (68-73); Phenylpropionates (74-77); Propionates (66-73); Thiophenes (66-77) MND2.241.223.701.700; D14.73.278.886; D26.74.75.841 DMÑPhenylpropionates LH LM  HN(71) MHÑSural Nerve ANdo not use /innerv PILeg/IN (66-70); Spinal Nerves (66-70) MNA8.796.828.569.785.790.691 DMÑSpinal Nerves LH LM  MHÑSuramin ANdo not use /biosyn /defic /physiol RN145-63-1 MND21.201.287.805; D21.370.884.741 XSNAPHURIDE LH LS  PM70 HN70(68) MHÑSurface Properties ANNIM; no qualif PIspecific material; specific surface MNH1.181.529.875 LH  MHÑSurface Tension ANNIM; no qualif MNH1.181.529.875.816 LH  MSAgents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. PMDETERGENTS & SOAPS were headings 1963-80 MHÑSurface-Active Agents AND25-26 qualif MND26.866 XSSurfactants FXÑPulmonary Surfactants XUÑAntifoaming Agents; ÑDetergents; ÑSoaps; ÑWetting Agents LH LS LX LU; ; ;  MSA specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities. MHÑSurgery ANSPEC only: SPEC qualif; prefer /surg with organs & dis: Manual 19.5+; the surgeon & specialty go here: the surgical patient = SURGERY, OPERATIVE: Manual 26.20+; /instrum = SURGICAL INSTRUMENTS or SURGICAL EQUIPMENT; military surgery = MILITARY MEDICINE (IM) + SURGERY (IM) if the specialty MNG2.403.810.762 LH  MSHospital department which administers all departmental functions and the provision of surgical, diagnostic and therapeutic services. HN(Aug 77) MHÑSurgery Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: SURG DEP MNN2.278.354.422.750; N4.452.442.422.750 XSHospital Surgery Department DMÑHospital Departments LH LS LM  OLconsider also CARDIOVASCULAR SYSTEM /SU or /SU with specific parts of the cardiovasc system; also CARDIOVASCULAR DISEASES /SU or /SU with specific cardiovasc dis MH*Surgery, Cardiovascular (Non Mesh) MNE4.752 LH  OLconsider also DIGESTIVE SYSTEM /SU or /SU with specific parts of the digest syst; also /SU with specific digest dis MH*Surgery, Digestive System (Non Mesh) MNE4.765 LH  OLconsider also EAR /SU or /SU with specific ear terms; also EAR DISEASES /SU or /SU with specific ear dis MH*Surgery, Ear (Non Mesh) MNE4.847.774 LH  OLconsider also ENDOCRINE GLANDS /SU or /SU with specific endocrine glands; also ENDOCRINE DISEASES /SU or /SU with specific endocrine dis MH*Surgery, Endocrine (Non Mesh) MNE4.779 LH  OLconsider also EYE /SU or /SU with specific parts of the eye; also EYE DISEASES /SU or /SU with specific eye dis MH*Surgery, Eye (Non Mesh) MNE4.792 LH  OLconsider also GENITALIA, FEMALE /SU or /SU with specific genital terms; also GENITAL DISEASES, FEMALE /SU or /SU with specific gynecol dis MH*Surgery, Gynecologic (Non Mesh) MNE4.819.608; E4.887.690 LH  OLconsider also LUNG /SU & LUNG DISEASES /SU or /SU with specific lung dis MH*Surgery, Lung (Non Mesh) MNE4.920.800 LH  MHÑSurgery, Minor ANSPEC: SPEC qualif; /psychol /rehabil permitted MNE4.806 LH  OLsee notes under SURGERY, GYNECOLOGIC (NON MESH) & SURGERY, OBSTETRICAL (NON MESH) MH*Surgery, Ob-Gyn (Non Mesh) MNE4.819 LH  OLconsider also PREGNANCY COMPLICATIONS /SU & LABOR COMPLICATIONS /SU or /SU with specific pregn & labor compl MH*Surgery, Obstetrical (Non Mesh) MNE4.819.774 LH  MHÑSurgery, Operative ANnot the field nor spec ( = SURGERY); only the surg patient or surg procedures; prefer /surg with organs or dis; when GEN, only /adv eff /class /econ /mortal /psychol /rehabil /stand /trends /vet; /instrum = SURGICAL INSTRUMENTS or SURGICAL EQUIPMENT; surgical inj = INTRAOPERATIVE COMPLICATIONS: see TN 179, substituting INTRAOPERATIVE COMPLICATIONS for SURGERY, OPERATIVE & see also note on INTRAOPERATIVE COMPLICATIONS; do not use /hist ( = SURGERY /hist); differentiation from SURGERY: Manual 26.20+; ╥second look surgery╙ goes under REOPERATION MNE4 FXÑIntraoperative Complications; ÑOperating Rooms; ÑPOSTOPERATIVE COMPLICATIONS XUÑIntraoperative Period; ÑReoperation LH LX; ; LU;  MSA dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region. MHÑSurgery, Oral ANSPEC of surg ther of dis, inj & defects of soft tissue of mouth & jaws; do not confuse with DENTISTRY, OPERATIVE: to restore tooth function; not a substitute for MOUTH /surg or /surg with specific related terms; SPEC qualif; in Cat E do not use /util except by MeSH definition; in Cat G only /econ /educ /trends MNE4.833; E6.892; G2.163.876.886 LH  MSSurgery necessary for a denture to rest on a firm base, free from marked osseous protuberances or undercuts, and devoid of interfering muscle attachments, excess mucoperiosteum, hyperplasias, and fibrous or papillary growths. PM80 HN80 MHÑSurgery, Oral, Preprosthetic ANdo not use /supply /util (except by MeSH definition) PIDental Prosthesis (66-79); specific dental prosthesis; Mouth/SU (66-79); Surgery, Oral (66-79); specific oral surgery heading MNE4.833.800; E6.892.800 XSPreprosthetic Oral Surgery FXÑMouth, Edentulous XUÑAlveolar Ridge Augmentation LH LS LX LU  OLconsider also EAR /SU, NOSE /SU, LARYNX /SU & /SU with specific parts of these organs; also OTORHINOLARYNGOLOGIC DISEASES /SU & /SU with specific ORL dis MH*Surgery, Otorhinolaryngologic (Non Mesh) MNE4.847 LH  MSThe branch of surgery concerned with restoration, reconstruction, or improvement of defective, damaged, or missing structures. MHÑSurgery, Plastic ANin Cat E do not use /util except by MeSH definition; in Cat G, only /econ /educ /trends; /vet permitted; not for -plasty in internal surgery: Manual 26.24, 26.25; ╥cosmetic surgery╙ goes here but do not also add ESTHETICS unless esthetics is especially discussed MNE4.860; G2.403.810.788 LH  OLconsider also UROGENITAL SYSTEM /SU or /SU with specific urogenital syst terms; also UROLOGIC DISEASES /SU or /SU with specific urol dis MH*Surgery, Urogenital (Non Mesh) MNE4.887 LH  MH*Surgery, Urologic (Non Mesh) MNE4.887.774 LH  OLconsider also GENITALIA, MALE /SU or /SU with specific genital terms; also GENITAL DISEASES, MALE /SU or /SU with specific male genital dis MH*Surgery, Urologic, Male (Non Mesh) MNE4.887.774.692 LH  OLsearch VETERINARY MEDICINE 1966-74 HN(75) MHÑSurgery, Veterinary ANsee note on VETERINARY MEDICINE MNG2.956.692 DMÑVeterinary Medicine LH LM  MHÑSurgical Equipment ANonly /econ /hist /stand /supply /vet; differentiate from SURGICAL INSTRUMENTS in that the instrument is for use in the immediate operative field, usually held in the hand MNE7.858 LH  MSTongues of tissue, cut away from the underlying parts but attached at one end. They are used in plastic surgery for filling in a defect in a neighboring region. PM80 HN80 MHÑSurgical Flaps ANonly /vet; includes skin & muscle tissue but do not specify site or tissue unless particularly discussed; do not coord with TRANSPLANTATION, AUTOLOGOUS; pedicled grafts go here PISkin (66-79); Surgery, Plastic (66-79); Transplantation, Autologous (66-79) MNE4.860.887; E4.936.664.890 XSFlaps; Island Flaps LH LS;  PM65 HN65 MHÑSurgical Instruments ANonly /econ /hist /stand /supply /vet; differentiate from SURGICAL EQUIPMENT on basis of size (instruments are holdable in the hand) MNE7.858.670 LH  MHÑSurgical Mesh ANonly /adv eff /econ /hist /stand /vet MNE7.858.708 LH  MSNursing care of the surgical patient before, during and after surgery. PM68 HN68 MHÑSurgical Nursing ANSPEC qualif PINursing Care (66-67); Operating Rooms (66-67); Surgery, Operative (66-67) MNG2.478.676.898; N2.421.533.892 LH  PM66 HN66(64) MHÑSurgical Staplers ANonly /adv eff /econ /hist /stand /supply /vet MNE7.858.746 LH  MSSeparation of the layers of a surgical wound. PM65 HN65(64) MHÑSurgical Wound Dehiscence MNC23.814.842 LH  MHÑSurgical Wound Infection ANIM; do not coord with POSTOPERATIVE COMPLICATIONS; do not coord with BACTERIAL INFECTIONS unless particularly discussed but coord IM with specific bact infect (IM) MNC1.539.947.692; C23.814.892 XSPostoperative Wound Infection LH LS  MSFacilities designed to serve patients who require surgical treatment exceeding the capabilities of usual physician's office yet not of such proportion as to require hospitalization. PM78; was see under HOSPITALS, SPECIAL 1975-77 HN78(72); was see under HOSPITALS, SPECIAL 1975-77 MHÑSurgicenters ANdo not use /educ /methods PIHospitals, Special (68-71); Surgery, Minor (66-71) MNN2.278.35.652; N2.278.421.556.868 FXÑAmbulatory Surgery LH LX  OLuse SURINAME to search SURINAM back thru 1966 HN81; was SURINAM 1963-80 MHÑSuriname ANnote category: do not spell SURAMIN, a drug MNZ1.107.757.833 LH  MSWomen who allow themselves to be impregnated with the understanding that the offspring are to be given over to the parents who have commissioned the surrogate. HN(86) MHÑSurrogate Mothers ANhuman only; only /psychol; check tags HUMAN, FEMALE & PREGNANCY PIEthics, Medical (66-85); Insemination, Artificial (66-85); Insemination, Artificial, Heterologous (75-85) MNF1.829.263.500.320.200.580; I1.880.225.500.340.270.580; M1.620.630.580 XSMothers, Surrogate DMÑMothers LH LS LM  MSContinuance of life or existence especially under adverse conditions; includes methods and philosophy of survival. MHÑSurvival ANsurvival after disasters, plane crashes, shipwrecks, mountain-slides, etc; no qualif; TN 180: definition & use MNI3.784 FXÑMilitary Medicine LH LX  MSColloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas (AEROSOL) and other colloidal systems; water-insoluble drugs may be given as suspensions. MHÑSuspensions ANIM for general only: only /anal (with caution) /stand /supply; NIM with specific drug IM: no qualif; /adv eff permitted but be careful: it may be the adv eff of the drug in suspension, not the ╥suspension╙ MND26.394.225.220.860 LH  MHÑSuture Technics ANonly /hist /instrum /stand /vet CATALOG: do not use /laboratory manuals MNE4.901 LH  MHÑSutures ANonly /hist /stand /util (if by MeSH definition) /vet; /adv eff permitted but do not confuse adv eff of the suture with the adv eff of the material of which suture is made or the adv eff of the suture method; /methods = SUTURE TECHNICS MNE7.858.784 XUÑCatgut LH LU  HN75 MHÑSvalbard MNZ1.542.808.618.650 XSSpitsbergen LH LS  MSA Polyomavirus isolated from Rhesus monkey kidney tissue, which produces malignancy in human and newborn hamster kidney cell cultures and tumors on innoculation into newborn hamsters. PM65 HN65 MHÑSV40 Virus ANfrom Simian Vacuolating virus; do not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) MNB4.909.204.585.615.817; B4.909.574.204.711.615.817 XSSIMIAN VIRUS 40; VACUOLATING AGENT LH LS;  HN(68) MHÑSwayback ANanimal only: disease of sheep; do not use /vet but check tag ANIMAL; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES PIDeficiency Diseases/VE (66-67); Demyelinating Diseases (66-67); Sheep Diseases (66-67) MNC10.228.337.886; C18.654.223.857; C22.836.886 XSEnzootic Ataxia DMÑSheep Diseases LH LS LM  HN75 MHÑSwaziland MNZ1.58.349.869 LH  MHÑSweat ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; TN 181: relation to SWEAT GLANDS & SWEATING MNA12.838.849 LH  MSDiseases of the sweat glands. PM76 HN76; was NON MESH before 1976 MHÑSweat Gland Diseases ANhidradenitis: coord IM with INFLAMMATION (NIM) PISweat Glands (66-75); Sweating (66-75); specific sweat gland disease MNC17.805.843 LH  PM68 HN68 MHÑSweat Gland Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) PISkin Neoplasms (66-67); Sweat Glands (66-67) MNC4.588.805.776; C17.805.843.743 LH  MHÑSweat Glands AN/secret: see also SWEAT or SWEATING: TN 181; hidradenitis = SWEAT GLAND DISEASES (IM) + INFLAMMATION (NIM) MNA1.835.858; A10.336.899 FXÑExocrine Glands XUÑApocrine Glands; ÑEccrine Glands LH LX LU;  MHÑSweating ANonly /drug eff /rad eff; TN 181: relation to SWEAT & SWEAT GLANDS; prickly heat: index under MILIARIA MNG7.315.232.693; G10.795.869 FXÑCystic Fibrosis; ÑHyperhidrosis; ÑHypohidrosis LH LX; ;  OLuse SWEATING, GUSTATORY to search FREY'S SYNDROME back thru 1966 (as Prov 1966-73) PM74 HN74; was FREY'S SYNDROME 1965-73 (Prov) MHÑSweating, Gustatory ANnote category MNC10.772.848; C17.805.843.843 XSAURICULOTEMPORAL SYNDROME; FREY'S SYNDROME LH LS;  MHÑSweden MNZ1.542.808.843 LH  MHÑSweetening Agents AND25-26 qualif MND9.818; D26.456.609; J1.341.390.609 LH  MSA water sport in which the body is propelled through the water by specific movement of limbs, fins, or tail. MHÑSwimming ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); does not include surfing or water-skiing (index under SPORTS); consider also DIVING (G3); index NIM for swimming in animal experiments on EXERTION MNI3.450.642.845.869 LH  MHÑSwimming Pools ANonly /stand MNG3.850.860.410.500 LH  MHÑSwine ANincludes boars & wart hogs; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; check tag MALE for barrow, FEMALE for sow & gilt; consider also terms under PORC- MNB2.649.77.880 XSPigs LH LS  MHÑSwine Diseases ANdo not use /compl /vet; don't forget also SWINE (NIM) & check tag ANIMAL; swine fever & swine plague = HOG CHOLERA MNC22.905 LH  MSAn acute and chronic contagious disease of young pigs caused by Erysipelothrix insidiosa. OLsearch ERYSIPELOTHRIX INFECTIONS 1968-74 & ERYSIPELOID 1966-67 HN(75); was see under ERYSIPELOID 1963-67 MHÑSwine Erysipelas ANdo not use /vet; don't forget also SWINE (NIM) & check tag ANIMAL MNC1.252.334.776; C22.331.693; C22.905.832 DMÑErysipelothrix Infections LH LM  MSAn enterovirus infection of swine clinically indistinguishable from foot-and-mouth disease, vesicular stomatitis, and vesicular exanthema. HN(75) MHÑSwine Vesicular Disease ANdo not use /vet; don't forget also SWINE (NIM) & check tag ANIMAL MNC2.782.687.359.855; C22.905.850 DMÑEnterovirus Infections LH LM  MSGenetically developed small pigs for use in biomedical research. There are several strains - Yucatan miniature, Sinclair miniature, and Minnesota miniature. PM83 HN83 MHÑSwine, Miniature ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; don't forget also SWINE (NIM) & check tag ANIMAL PISwine (66-82) MNB2.649.77.880.800 XSMiniature Swine; Minipigs LH LS;  MHÑSwitzerland MNZ1.542.883 LH  OLsearch OXADIAZOLES 1968-74 HN(75) MHÑSydnones ANdo not use /analogs /biosyn /defic /physiol MND3.383.548.580.693 DMÑOxadiazoles LH LM  MSThe living together of organisms of different species. MHÑSymbiosis ANonly /drug eff /rad eff MNG4.185.848 LH  MHÑSymbiotes ANa genus of the family RICKETTSIACEAE: do not confuse with ╥symbiotes╙, organisms living in a state of symbiosis; found in arthropods MNB3.700.651.801.858 LH  MSThe unconscious associational mental process whereby one object or idea represents another and carries in disguised form emotional feelings vested in the initial object or idea. OLuse SYMBOLISM (PSYCHOLOGY) to search SYMBOLISM 1966-78 PM79; was SYMBOLISM 1963-78 HN79; was SYMBOLISM 1963-78 MHÑSymbolism (Psychology) ANno qualif; symbolism in art, music, literature, etc. probably goes here; graphic symbols go in a variety of places where pertinent (EMBLEMS AND INSIGNIA; LANGUAGE; COMMUNICATION; WRITING; etc.); DF: SYMBOLISM MNF4.628.693 LH  MHÑSympathectomy ANdo not use /class /man /rehabil /supply /util (except by MeSH definition); coord IM with nerve, ganglion or plexus (NIM); lumbar sympathectomy: coord with LUMBOSACRAL REGION (NIM); coord IM with disease /ther (IM) MNE4.530.324.798 LH  MSSympathectomy using chemicals, e.g., 6-hydroxydopamine, guanethidine, which selectively and reversibly destroy adrenergic nerve endings while leaving cholinergic nerve endings intact. PM82 HN82 MHÑSympathectomy, Chemical ANdo not use /class /man /rehabil /supply /util (except by MeSH definition); coord IM with specific chemical (no qualif) (NIM) + disease /ther (IM); do not confuse with SYMPATHETIC NERVE BLOCK see AUTONOMIC NERVE BLOCK PIDopamine (66-72); Guanethidine (66-81); Hydroxydopamines (73-81); Sympathectomy (66-81); Sympathetic Nervous System (66-81); specific sympathetic nervous system term MNE4.530.324.798.890 XSChemosympathectomy; Denervation, Sympathetic, Chemical LH LS;  MHÑSympathetic Nervous System ANdo not use /innerv; /drug eff: consider also SYMPATHOLYTICS & SYMPATHOMIMETICS; /surg: probably SYMPATHECTOMY MNA8.99.893 LH  OLuse SYMPATHOLYTICS to search ADRENERGIC FALSE TRANSMITTERS 1973-81 PMADRENERGIC FALSE TRANSMITTERS was heading 1973-81 HNADRENERGIC FALSE TRANSMITTERS was heading 1973-81 MHÑSympatholytics ANdo not use /analogs /biosyn /defic /physiol; consider also SYMPATHETIC NERVOUS SYSTEM /drug eff MND16.848 XSAdrenergic-Blocking Agents; Adrenolytics; Antiadrenergic Agents; Sympathetic Blocking Agents LH LS; ; ;  MHÑSympathomimetics ANdo not use /analogs /biosyn /defic /physiol; consider also SYMPATHETIC NERVOUS SYSTEM /drug eff MND16.893; D18.222.863 XSAdrenergic Agents; Adrenomimetics; Amines, Sympathomimetic; Sympathetic Transmitter Releasers LH LS; ; ;  MHÑSymphysiotomy ANdo not use /util except by MeSH definition MNE4.887.859 FXÑPubic Symphysis LH LX  MH*Symptoms and General Pathology (Non Mesh) MNC23 LH  MHÑSynapses ANonly /anal /drug eff /enzymol /metab /pathol /physiol /rad eff /secret /ultrastruct MNA8.663.906; A11.671.908 LH  PM73 HN73(70) MHÑSynaptic Membranes ANA 11 qualif except /cytol PICell Membrane (66-69); Synapses (66-69) MNA8.663.906.569; A11.195.844; A11.671.908.569 LH  MSSpecific molecular sites or structures on subsynaptic neurons or other cell membranes with which molecules of neurotransmitters (NEUROHUMORS) react or to which they bind to elicit the characteristic response of the cell; they are not restricted to the central nervous system. PM73 HN73(70) MHÑSynaptic Receptors ANA 11 qualif except /cytol; /class permitted; ignore Cat D & G qualif; presynaptic & postsynaptic receptors or membranes go here PIReceptors, Drug (68-69); Synapses (66-69) MNA8.663.906.569.694; A11.195.844.694; A11.671.908.569.694; D12.776.543.750.860; G6.184.154.803.645.852; G12.803.852 XSReceptors, Neurotransmitter; Receptors, Synaptic LH LS;  PM72 HN72(70) MHÑSynaptic Vesicles ANA 11 qualif except /cytol; /class permitted PICytoplasmic Granules (66-69); Synapses (66-69) MNA8.663.906.694; A11.671.908.694 LH  MSThe three-part structure of ribbon-like proteinaceous material that serves to align and join the paired homologous chromosomes during the pachytene stage of meiotic division. It is a prerequisite for crossing-over. HN(86) MHÑSynaptonemal Complex ANnote category; only /drug eff /rad eff PICell Division (66-67); Meiosis (68-85) MNG4.335.135.220.531.890; G5.148.165.220.531.890; G7.553.135.220.531.890 DMÑMeiosis LH LM  MSPinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates. PM74 HN74(72) MHÑSynaptosomes ANA 11 qualif except /cytol; /class permitted PINerve Endings (66-71); Synaptic Vesicles (70-71) MNA11.904.859 LH  MHÑSyncope MNC10.597.917.777; C23.888.592.925.777 XSFAINTING FXÑUnconsciousness LH LS LX  PM67 HN67 MHÑSyndactylia ANdo not use /congen PIFingers/AB (66) MNC5.116.99.370.885; C16.131.621.906.819; C16.131.831.819 XUÑPoland Syndrome LH LU  MSA symptom complex characteristic of a particular abnormality. HN(72) MHÑSyndrome ANalmost never IM; only /vet permitted; policy: Manual 23.37+ MNC23.280.900 DMÑDisease LH LM  MS4-Hydroxy-alpha-((methylamino)methyl)benzenemethanol. Sympathetic alpha adrenergic with actions like phenylephrine; used as vasopressor, in circulatory failure, asthma, nasal congestion and glaucoma. Synonyms: Actaphen; Analeptin; Corvasymton; Pentedrin; Ethaphene; Simpalon; Sympatol; Vasocordin. OLuse SYNEPHRINE to search OXEDRINE back thru 1966 PM80; was OXEDRINE 1963-79 HN80; was OXEDRINE 1963-79 MHÑSynephrine ANdo not use /biosyn /defic /physiol RN94-07-5 MND2.33.329.291.870; D2.92.63.291.870; D16.893.116.182.882; D18.222.863.882 XSOxedrine; Sympaethamin LH LS;  OLuse SYNGAMIASIS to search SYNGAMOSIS back thru 1967 PM68; was SYNGAMOSIS 1967 HN68; was SYNGAMOSIS 1967 MHÑSyngamiasis ANusually animal: do not use /vet but check tag ANIMAL; don't forget also BIRDS (NIM) but do not index under BIRD DISEASES; coord with specific bird (IM) MNC3.335.508.834; C22.131.849; C22.674.377.894 LH  MHÑSynostosis ANdo not use /congen MNC5.116.99.370.894; C16.131.621.906 FXÑOssification, Pathologic LH LX  MSA nodular, tumorlike lesion in or about a tendon sheath or joint capsule, especially of the hands, wrists, or feet. MHÑSynovial Cyst ANnon-neoplastic; wrist ganglion = WRIST (IM) + SYNOVIAL CYST (IM); /anal /blood supply /secret /ultrastruct permitted MNC4.182.867 XSMyxoid Cyst XUÑPopliteal Cyst LH LS LU  MHÑSynovial Fluid ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret MNA2.835.583.802.694; A12.207.849 LH  MHÑSynovial Membrane ANinflammation = SYNOVITIS MNA2.835.583.802 FXÑMembranes LH LX  MHÑSynovioma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.499.912 LH  MHÑSynovitis ANdo not confuse with TENOSYNOVITIS MNC5.550.870 XUÑSynovitis, Pigmented Villonodular LH LU  MSOutgrowths of synovial membrane composed of villi and fibrous nodules characterized histologically by hemosiderin-and lipid-containing macrophages and multinucleated giant cells. Usually occurs in the knee. HN(78) MHÑSynovitis, Pigmented Villonodular ANusually in the knee PISynovitis (66-77) MNC5.550.870.890 DMÑSynovitis LH LM  MSA contagious venereal disease caused by the spirochaete Treponema pallidum. MHÑSyphilis AN/congen = SYPHILIS, CONGENITAL; /diag will probably be SYPHILIS SERODIAGNOSIS: check for serol method; NEUROSYPHILIS & its indentions are also available MNC1.252.847.840.744; C1.539.780.859 XUÑChancre LH LU  MSSerologic tests for syphilis. MHÑSyphilis Serodiagnosis ANdo not use /util except by MeSH definition MNE1.223.495.826.895 LH  OLuse SYPHILIS, CARDIOVASCULAR to search AORTITIS, SYPHILITIC back thru 1966 (as Prov 1966-74) HNAORTITIS, SYPHILITIC was see under SYPHILIS, CARDIOVASCULAR 1963-83, was Prov 1963-74 MHÑSyphilis, Cardiovascular ANcoord IM with specific cardiovasc organ or dis (IM) but note X ref below MNC1.252.847.840.744.657; C14.728 XSAortitis, Syphilitic LH LS  MHÑSyphilis, Congenital ANdo not use /congen MNC1.252.847.840.744.729; C16.614.868 LH  MHÑSyphilis, Cutaneous MNC1.252.847.840.744.800; C17.838.835 XSSKIN SYPHILIS; SYPHILIDS LH LS;  MHÑSyphilis, Latent MNC1.252.847.840.744.871 LH  MHÑSyria MNZ1.252.245.861; Z1.630.890 LH  MHÑSyringes ANonly /hist /stand /vet MNE7.877 LH  MHÑSyringomyelia MNC10.228.854.833 LH  MHÑSyrosingopine ANdo not use /biosyn /defic /physiol RN84-36-6 MND3.132.973.641.696.820; D3.549.937.641.646.820; D16.848.415.804.811.872; D18.162.804.811.872 XSSyringopine LH LS  MSThe analysis of an activity, procedure, method, technic or business to determine what must be accomplished and how the necessary operations may best be accomplished. PM66; was see under HUMAN ENGINEERING 1963-65 HN66(65); was see under HUMAN ENGINEERING 1963-65 MHÑSystems Analysis ANno qualif MNL1.906 FXÑResearch; ÑSystems Theory; ÑTask Performance and Analysis LH LX; ;  MSPrinciples, models, and laws that apply to complex interrelationships and interdependencies of sets of linked components which form a functioning whole, a system. Any system may be composed of components which are systems in their own right (sub-systems), such as several organs within an individual organism. OLsearch SYSTEMS ANALYSIS 1976-79 PM80; was see SYSTEMS ANALYSIS 1976-79 HN80; was see SYSTEMS ANALYSIS 1976-79 MHÑSystems Theory ANno qualif PISystems Analysis (66-79) MNH1.770.808 XSGeneral Systems Theory; Queuing Theory FXÑModels, Theoretical; ÑSystems Analysis LH LS; LX;  MSPeriod of contraction of the heart, especially of the ventricles. HN(79) MHÑSystole ANonly /drug eff /rad eff; systolic pressure: index under BLOOD PRESSURE & do not add SYSTOLE (NIM) unless particularly discussed PIHeart (66-78); Heart Ventricle (66-78); Myocardial Contraction (75-78) MNG9.330.800.880 XSSystolic Time Interval DMÑMyocardial Contraction LH LS LM  MSA projective test using pictures of several kinds of psychiatric patients, from which the subject selects two pictures he likes most and two he likes least from six sets of pictures. The distribution of selected cards is interpreted in terms of which type of patients the subject identifies with and which traits he rejects. OLsearch PROJECTIVE TECHNICS 1966-74 HN(75) MHÑSzondi Test ANno qualif MNF4.711.647.622.745 DMÑProjective Technics LH LM  PM73 HN73 MHÑT Lymphocytes ANA 11 qualif & /class; also called T-cells; involved in cellular immunity PILymphocytes (66-72) MNA11.118.637.555.604; A15.145.229.637.555.604; A15.382.490.520.604; A15.382.520.520.604 XSTHYMUS-DEPENDENT LYMPHOCYTES FXÑImmunity, Cellular; ÑLymphocyte Cooperation LH LS LX;  MSImmunized T lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These cells are distinct from natural killer cells and from killer cells (K cells) mediating antibody-dependent cell cytotoxicity. PM83 HN83 MHÑT Lymphocytes, Cytotoxic ANA 11 qualif & /class PICytotoxicity, Immunologic (78-82); T Lymphocytes (73-82) MNA11.118.637.555.604.650; A15.145.229.637.555.604.650; A15.382.490.520.604.650; A15.382.520.520.604.650 XSCell-Mediated Lympholytic Cells; Cytotoxic T Lymphocytes FXÑCytotoxicity, Immunologic LH LS; LX  MST lymphocyte subsets which interact with effector T lymphocytes, with B lymphocytes, and with each other both to induce and to suppress immune responses. PM85 HN85 MHÑT Lymphocytes, Regulatory ANA 11 qualif & /class; GEN: prefer specifics PIHelper Cells (83-84); Lymphocyte Cooperation (78-82); Lymphocytes (66-72); T Lymphocytes (73-84); T Lymphocytes, Cytotoxic (83-84); Suppressor Cells (80-84) MNA11.118.637.555.604.800; A15.145.229.637.555.604.660; A15.382.490.520.604.800; A15.382.520.520.604.800 FXÑLymphocyte Cooperation LH LX  MSA series of 7 virulent phages which infect E. coli. The T-even phages T2, T4, and T6, and the phage T5 are called ╥autonomously virulent╙ because they cause cessation of all bacterial metabolism on infection. Phages T1, T3, and T7 are called ╥dependent virulent╙ because they depend on continued bacterial metabolism during the lytic cycle. The T-even phages contain 5-hydroxymethylcytosine in place of ordinary cytosine in their DNA. PM80 HN80 MHÑT-Phages ANdo not use /cytol; do not confuse with T VIRUS below PIColiphages (66-79) MNB4.123.205.891 XSBacteriophages T; Coliphages T; Phages T LH LS; ;  MS3-Hydroxy-4,15-diacetoxy-8-(3-methylbutyryloxy)-12,13-epoxy-delta(9)-trichothecene. A potent mycotoxin produced in feedstuffs by several species of the genus Fusarium. It elicits a severe inflammatory reaction in animals and has teratogenic effects. HN(77) MHÑT-2 Toxin ANa mycotoxin produced by Fusarium; do not use /analogs /defic /physiol RN21259-20-1 PIEthers (75); Sesquiterpenes (74); Trichothecenes (75-76) MND2.455.849.765.850.870; D24.185.926.587.933.870 XSFusaritoxin DMÑSesquiterpenes LH LS LM  MHÑTabes Dorsalis MNC1.252.847.840.744.456.778; C10.228.228.674.778; C10.228.854.889 XSLOCOMOTOR ATAXIA; SPINAL CORD SYPHILIS LH LS;  MHÑTablets ANIM for general only; when IM, only /anal (with caution) /stand /supply; NIM when specific drug IM: no qualif; /adv eff permitted but be careful: it may be the adv eff of the drug in the tablet, not the ╥tablet╙ MND26.394.225.901 LH  MHÑTablets, Enteric-Coated ANIM for general only; when IM, only /anal (with caution) /stand /supply; NIM when specific drug IM: no qualif; /adv eff permitted but be careful: it may be the adv eff of the drug in the tablet, not the ╥tablet╙ MND26.394.225.276.695; D26.394.225.901.695 LH  MSForbidden; the basis for prohibition is generally religious, magical or superstitious. MHÑTaboo ANno qualif MNF1.829.918; I1.76.201.450.897.778 LH  MSExcessive rapidity in the action of the heart; usually a heart rate above 100 per minute. MHÑTachycardia ANGEN or unspecified: prefer specific types below; TN 99: differentiate from HEART RATE; exercise tachycardia = HEART RATE (IM) + EXERTION (NIM) MNC14.280.67.845 XSTorsade de Pointes LH LS  MSA tachycardia characterized by rates between 150 and 250 beats per minute and a QRS complex of supraventricular origin. HN(87) MHÑTachycardia, Atrioventricular Nodal Reentry PIAtrioventricular Node (75-86); Heart Conduction System (66-74); Tachycardia (66-86); Tachycardia, Paroxysmal (66-86) MNC14.280.67.845.880.95 XSAtrioventricular Nodal Reentry Tachycardia; Tachycardia, AV Nodal Reentrant DMÑTachycardia, Supraventricular LH LS; LM  MSA tachycardia originating in the atrial myocardium and characterized by rates between 135 and 175 beats per minute. HN(87) MHÑTachycardia, Ectopic Atrial PIHeart Atrium (66-86); Tachycardia (66-86) MNC14.280.67.845.880.315 XSAtrial Ectopic Tachycardia; Ectopic Atrial Tachycardia DMÑTachycardia, Supraventricular LH LS; LM  MSA tachycardia arising in the conduction tissues surrounding the atrioventricular node, usually occurring during myocardial infarction, after heart surgery, or in digitalis intoxication. The rate may range from 140 to 250 beats per minute. HN(87) MHÑTachycardia, Ectopic Junctional PIAtrioventricular Node (75-86); Heart Conduction System (66-86); Tachycardia (66-86) MNC14.280.67.845.880.320 XSEctopic Junctional Tachycardia; Junctional Ectopic Tachycardia DMÑTachycardia, Supraventricular LH LS; LM  MSCondition marked by attacks of rapid action of the heart having sudden onset and cessation. MHÑTachycardia, Paroxysmal MNC14.280.67.845.695 LH  MSA tachycardia arising from the sinus node region and characterized by rates between 115 and 140 beats per minute; it is paroxysmal rather than constant. HN(87) MHÑTachycardia, Sinoatrial Nodal Reentry PISinoatrial Node (78-86); Tachycardia (66-86) MNC14.280.67.845.880.840 XSSinoatrial Nodal Reentry Tachycardia; Tachycardia, SA Nodal Reentrant DMÑTachycardia, Supraventricular LH LS; LM  MSA simple tachycardia with origin in the sinus node with gradual onset and termination. HN(87) MHÑTachycardia, Sinus PISinoatrial Node (78-86); Tachycardia (66-86) MNC14.280.67.845.880.845 XSSinus Tachycardia DMÑTachycardia, Supraventricular LH LS LM  MSA generic expression for any tachycardia that originates above the bundle of His. PM87 HN87 MHÑTachycardia, Supraventricular ANnote specific types of supraventric tachycardia as XU refs below PITachycardia (66-86); Tachycardia, Paroxysmal (66-86) MNC14.280.67.845.880 XUÑTachycardia, Atrioventricular Nodal Reentry; ÑTachycardia, Ectopic Atrial; ÑTachycardia, Ectopic Junctional; ÑTachycardia, Sinoatrial Nodal Reentry; ÑTachycardia, Sinus LH LU; ; ; ;  PM66 HN66(63) MHÑTachyphylaxis ANonly /rad eff MNG12.910 LH  MS9-Amino-1,2,3,4-tetrahydroacridine. Cholinesterase inhibitor and curare antagonist. Synonyms: Romotal; Tenakrin; T.H.A. HN(75); was see under ACRIDINES 1975-83 MHÑTacrine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN321-64-2 PIAcridines (69-74); Amines (72-74) MND3.494.46.250.900; D15.128.900; D16.698.410.900 XSTetrahydroaminoacrine DMÑAminoacridines LH LS LM  OLuse TADZHIK S.S.R. to search TADZHIKISTAN back thru 1966 HN82; was TADZHIKISTAN 1963-81 MHÑTadzhik S.S.R. ANuse this spelling in translations MNZ1.252.878.100.900; Z1.950.100.900 LH  MSA genus of large tapeworms. OLuse TAENIA to search TAENIARHYNCHUS back thru 1966 HNTAENIARHYNCHUS was see under TAENIA 1966-78 MHÑTaenia ANtapeworm: do not confuse with TINEA (ringworm, a disease); not for taenia coli ( = COLON); do not confuse TAENIARHYNCHUS with Taeniorhyncus, a mosquito; do not use /blood-csf-urine; infection = TAENIASIS but infect by Taenia larvae (cysticerci) = CYSTICERCOSIS & by T. echinococcus & T. granulosus = ECHINOCOCCOSIS MNB1.500.736.215.895 XSTaeniarhynchus XUÑCysticercus LH LS LU  MSInfection with tapeworms of the genus Taenia. PM68 HN68 MHÑTaeniasis AN= infect by Taenia but infect by Taenia larva (cysticerci) = CYSTICERCOSIS & by Taenia echinococcus or T. granulosus = ECHINOCOCCOSIS PICestode Infections (66-67) MNC3.335.190.902 XSTAENIA INFECTIONS FXÑCysticercosis LH LS LX  PM68 HN68 MHÑTail ANavoid such combinations as TAIL /metab or TAIL /anal, etc. where tail is merely test tissue PIspecific animal (66-67) MNA13.895 LH  MHÑTaiwan MNZ1.252.474.872 XSFormosa; Republic of China LH LS;  OLsearch AORTIC ARCH SYNDROMES 1966-74 HN(75); was see under AORTIC DISEASES 1963-64 MHÑTakayasu Syndrome MNC14.907.109.239.696; C23.205.885 XSArteritis, Takayasu; Takayasu Arteritis DMÑAortic Arch Syndromes LH LS; LM  MS1,3-Dihydro-3-oxo-1-isobenzofuranyl-6[(aminophenylacetyl) amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3,2,0)heptane-2-carboxylic acid. A form of ampicillin that has no antibacterial action itself, but is broken in the intestinal mucosa to yield a high level of ampicillin to the blood without affecting intestinal flora. Synonyms: BRL 8988; Talpen. HN(78) MHÑTalampicillin ANdo not use /biosyn /defic /physiol RN47747-56-8 PIAmpicillin (66-77); Benzofurans (66-76) MND20.85.99.739.762.57.897 XSPhthalidyl Ampicillin DMÑAmpicillin LH LS LM  MHÑTalc AND25-26 qualif; talc granuloma = TALC /adv eff + GRANULOMA /etiol (not /chem ind) RN14807-96-6 MND1.578.861; D26.394.225.672.779; J1.516.213.821 LH  MHÑTalus ANone of the TARSAL BONES, the ╥ankle bone╙ MNA2.835.232.484.801.779 XSASTRAGALUS; Os Trigonum FXÑHeel LH LS; LX  MStrans-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-ene. A stilbene derivative with anti-estrogen and antifertility activities. PM78; was see under STILBENES 1975-77 HN78(75); was see under STILBENES 1975-77 MHÑTamoxifen ANdo not use /biosyn /defic /physiol RN10540-29-1 PIDimethylamines (73-74); Phenyl Ethers (74); Stilbenes (66-74) MND2.455.426.559.389.724.850; D6.347.300.760 XSICI 46474 LH LS  MHÑTampons ANonly /adv eff /stand /vet MNE7.858.826 LH  MSA disease in which only a small amount of high density lipoprotein (alpha-lipoprotein) circulates, and this contains an abnormal proportion of the two major HDL apolipoproteins. HN(78); was see under HYPOLIPOPROTEINEMIAS 1978-79 MHÑTangier Disease ANan alpha-lipoprotein defic PIBlood Protein Disorders (66-77); Lipid Metabolism, Inborn Errors (66-77); Lipoproteins (66-77); Lipoproteins, HDL (72-77) MNC18.452.648.556.485.894 DMÑHypolipoproteinemia LH LM  OLsearch TANNINS 1966-74 HN(75) MHÑTannic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only MND9.203.408.846.696 DMÑTannins LH LM  MHÑTanning ANno qualif MNJ1.576.852 LH  MHÑTannins ANdo not use /analogs /biosyn /defic /physiol MND9.203.408.846 XUÑTannic Acid LH LU  MHÑTantalum ANTa-181; do not use /analogs /biosyn /defic /physiol; Ta-180 = TANTALUM (IM) + ISOTOPES (NIM); Ta-172-179, 182-186 = TANTALUM (IM) + RADIOISOTOPES (IM) RN7440-25-7 MND1.268.854; D1.552.842 LH  MHÑTanzania ANTANganyika + ZANzibar MNZ1.58.183.758 LH  MSRecording of information on magnetic or punched paper tape. PM67 HN67(64) MHÑTape Recording ANonly /econ /hist /instrum /legis /methods /stand /trends /util (if by MeSH definition) MNL1.178.147.846; L1.240.940 FXÑElectronics LH LX  MHÑTars AND25-26 qualif MND26.884 LH  PM72 HN72 MHÑTarsal Bones ANthe 7 bones of the ankle of which the TALUS & CALCANEUS are available; the cuboid, navicular (scaphoid) & cuneiform bones go here; do not confuse with ANKLE (the area) or ANKLE JOINT; see note on TARSUS, ANIMAL PIAnkle (66-71); Ankle Joint (66-71) MNA2.835.232.484.801 LH  PM65 HN65 MHÑTarsal Joint ANany Cat A qualif permitted MNA2.835.583.831 XSFOOT JOINT; INTERMETATARSAL JOINT; INTERTARSAL JOINT LH LS; ;  MSCompression of the posterior tibial nerve caused by thickening of the laciniate ligament or by gouty or arthritic deposits around the ankle joint leading to symptoms of pain or paresthesia over the sole of the foot. PM72 HN72(64) MHÑTarsal Tunnel Syndrome MNC10.772.491.821; C23.304.351.821 LH  OLsearch HINDLIMB 1968-74 HN(75) MHÑTarsus, Animal ANTN 102, TN 117 & table: animal extremities MNA13.473.821 DMÑHindlimb LH LM  MHÑTartrates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.337.864; D2.241.81.844.759; D2.241.511.902.759; D9.203.811.779 LH  MS3-Carboxy-5-hydroxy-1-p-sulfophenyl-4-p-sulfophenylazo=pyrazole, trisodium salt. Anionic, hydrophilic azo dye with an orange-yellow color used in fabrics, foods and cosmetics and as a biological stain. Synonyms: C.I. Acid Yellow 23; C.I. 19140; FD&C Yellow No. 5; Hydrazine Yellow; Tartrazol Yellow. HN(77) MHÑTartrazine AND25-26 qualif; /analogs NIM only RN1934-21-0 PIAzo Compounds (69-76); Benzenesulfonates (74-76); Pyrazoles (69-76) MND2.172.950; D26.408.837 DMÑAzo Compounds LH LM  MHÑTartronates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.337.902; D2.241.81.844.821; D2.241.511.902.821; D9.203.811.835 LH  MSThe detailed examination of observable activity or behavior associated with the execution or completion of a required function or unit of work. PM73 HN73(72) MHÑTask Performance and Analysis ANdo not use for anal of performance on individual tasks in learning exper: note XU & XR refs; no qualif; DF: TASK PERFORMANCE MNF2.784.412.846; F2.784.692.746; F2.808.600; J1.293.556.779 FXÑSystems Analysis XUÑTime and Motion Studies LH LX LU  MSThe sensation or perception of certain qualities of substances put in the mouth, primarily sweet, sour, salt and bitter. MHÑTaste ANonly /drug eff /physiol /rad eff MNF2.830.816.724; G11.561.796.724 XUÑTaste Threshold LH LU  MHÑTaste Buds ANdo not use /innerv MNA8.796.511.725.154.823; A9.846; A14.549.885.779 FXÑNerve Endings LH LX  PM73 HN73(71) MHÑTaste Disorders PITaste (66-70) MNC10.597.751.861; C23.888.592.763.861 XUÑAgeusia; ÑDysgeusia LH LU;  MSThe minimum concentration at which taste sensitivity to a particular substance or food can be perceived. HN(76) MHÑTaste Threshold ANonly /drug eff /physiol /rad eff PITaste (66-75) MNF2.463.593.710.790; G11.561.796.724.880 DMÑTaste LH LM  MHÑTattooing ANdo not use /util except by MeSH definition MNE2.218.780; E5.898 LH  MHÑTaurine AN/biosyn /physiol permitted; do not use /defic RN107-35-7 MND2.92.471.891; D2.241.866.540.121.900 LH  MSN-(3-alpha,7-alpha-Dihydroxy-5-beta-cholan-24-oyl)taurine. Bile salts formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt; acts as detergent to solubilize fats in the small intestine and is itself absorbed; used as cholagogue and choleretic. HN(78) MHÑTaurochenodeoxycholic Acid AN/biosyn /physiol permitted RN516-35-8 PIBile Acids and Salts (66-72); Chenodeoxycholic Acid (73-77); Taurine (66-72); Taurocholic Acid (73-77) MND2.241.866.540.121.900.780; D4.808.221.430.342.300.900; D4.808.221.430.342.900.910; D4.808.221.430.873.920.900; D19.316.246.175.895 XSChenodeoxycholyltaurine; Taurine Chenodeoxycholate; Taurochenodeoxycholate DMÑChenodeoxycholic Acid LH LS; ; LM  MSN-Cholyl-taurine. Bile salt, conjugate of cholic acid and taurine, usually as the sodium salt; acts as detergent to solubilize fats for absorption and is itself absorbed; used as cholagogue and choleretic. PM74 HN74(73) MHÑTaurocholic Acid AN/biosyn /physiol permitted RN81-24-3 PIBile Acids and Salts (66-72); Taurine (66-72) MND2.241.866.540.121.900.800; D4.808.221.430.873; D19.316.246.225.905 XSCholyltaurine; Taurine Cholate; Taurocholate LH LS; ;  MSN-(3-alpha,12-alpha-Dihydroxy-5-beta-cholan-24-oyl)taurine. Bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt; used as cholagogue and choleretic, also industrially as fat emulsifier; may be involved in gastrointestinal neoplasms. HN(78) MHÑTaurodeoxycholic Acid AN/biosyn /physiol permitted RN516-50-7 PIBile Acids and Salts (66-72); Deoxycholic Acid (73-77); Taurine (66-72); Taurocholic Acid (73-77) MND2.241.866.540.121.900.830; D4.808.221.430.342.900; D4.808.221.430.873.920; D19.316.246.225.272.925 XSDeoxycholyltaurine; Taurine Deoxycholate; Taurodeoxycholate DMÑDeoxycholic Acid LH LS; ; LM  MSN-(3-alpha-Hydroxy-5-beta-cholan-24-oyl)taurine. A bile salt formed in the liver from lithocholate conjugation with taurine, usually as the sodium salt; it solubilizes fats for absorption and is itself absorbed; it is a cholagogue and choleretic. HN(78) MHÑTaurolithocholic Acid AN/biosyn /physiol permitted RN516-90-5 PIBile Acids and Salts (66-72); Lithocholic Acid (73-77); Taurine (66-72); Taurocholic Acid (73-77) MND2.241.866.540.121.900.850; D4.808.221.430.622.900; D4.808.221.430.873.940; D19.316.246.175.551.935 XSLithocholyltaurine; Taurine Lithocholate; Taurolithocholate DMÑLithocholic Acid LH LS; ; LM  MSTitle I of the Act, PL97-248, specifies ╥provisions relating to savings in health and income security programs.╙ This includes changes in payment for services, benefits and premiums of Medicare; changes in provisions under Medicaid, and other specific programs covered by Social Security. Title II includes various revenue measures. HN(85) MHÑTax Equity and Fiscal Responsibility Act ANonly /econ /hist; specify country or state CATALOG: /geog /form MNN3.219.900.880 XSPL97-248; TEFRA DMÑTaxes LH LS; LM  MSGovernmental levies on property, inheritance, gifts, etc. OLuse TAXES to search INSTITUTIONAL TAXES back thru 1978 PM78 HNINSTITUTIONAL TAX was see under TAXES 1978-82 MHÑTaxes ANonly /class /hist /legis /trends; coord IM with subject of tax (IM); specify geog; INCOME TAX is also available MNN3.219.900 XSInstitutional Tax XUÑTax Equity and Fiscal Responsibility Act LH LS LU  MSDeficiency of hexosaminidase A inherited as an autosomal recessive trait, seen mainly in Ashkenazic Jews, leading to accumulation of G(M2) ganglioside in neurons. Manifests clinically as psychomotor retardation and deterioration, blindness, cherry red spot in the macula and death in 3-4 years. OLsearch LIPOIDOSIS 1966-78 PM79; was see AMAUROTIC FAMILIAL IDIOCY 1963-78 HN79; was see AMAUROTIC FAMILIAL IDIOCY 1963-78 MHÑTay-Sachs Disease ANdo not use /congen PILipoidosis (66-78) MNC10.228.140.163.300.936; C10.496.253.930; C18.452.648.556.641.803.896; F3.709.346.250.720 XSGangliosidosis, G(M2), Type I LH LS  MSCamellia sinensis, formerly Thea sinensis; an evergreen Asiatic shrub of the Theaceae family; the leaves and flowers contain CAFFEINE, THEOPHYLLINE, oils, and tannins; the infusion of leaves of this plant is used as a beverage. MHÑTea ANas plant & beverage; restrict to drink prepared from tea plant, Thea sinensis: ╥teas╙ from other plants go under plant term (IM) + BEVERAGES (IM); from Cat B do not use /isol /pathogen; from Cat J only /ad-poi-tox /econ /hist /rad eff /stand /supply MNB6.510.911; J1.125.873 XSCamellia; Thea FXÑTHEOPHYLLINE LH LS; LX  MSThe educational process of instructing. MHÑTeaching ANonly /econ /hist /man /methods /stand /trends; teacher as the imparter of knowledge goes here, not under FACULTY which is differentiated from student or administrator: Manual 30.25 MNI2.903 LH  MSInstructional materials used in teaching. PM74 HN74 MHÑTeaching Materials ANonly /econ /stand /supply; AUDIO-VISUAL AIDS is also available MNI2.903.847; L1.178.820 LH  PM73 HN73(68) MHÑTear Gases AND25-26 qualif PIspecific chemical; specific effect MND5.569.734.498.697; D26.897 FXÑChemical Warfare Agents LH LX  MHÑTears ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; lacrimation = TEARS /secret unless LACRIMAL APPARATUS /secret or LACRIMAL APPARATUS /physiol is particularly discussed; epiphora: index under LACRIMAL APPARATUS DISEASES; IGA in tears: index TEARS (IM) + IGA, SECRETORY (IM) MNA12.838.882 FXÑLacrimal Apparatus LH LX  MHÑTechnetium ANnaturally radioactive; IM; Manual 25.94; do not use /analogs /biosyn /defic /physiol RN7440-26-8 MND1.287.877; D1.552.850 LH  MSA gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation. PM85 HN85 MHÑTechnetium Tc 99m Aggregated Albumin ANNIM; do not use /analogs /biosyn /defic /physiol; as label, use /diag use; DF: TC HSA PIAlbumins (66-84); Serum Albumin (66-84); Technetium (66-84) MND1.552.850.850; D12.776.34.900 XSTc 99m-Albumin; Tc 99m-Albumin Colloid LH LS;  MSA gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Due to its absorption by a variety of tumors, it is useful for the detection of neoplasms. PM86 HN86 MHÑTechnetium Tc 99m Medronate ANNIM; do not use /analogs /biosyn /defic /physiol; as label, use /diag use; DF: TC MEDRONATE RN63347-66-0 PIDiphosphonates (77-85); Technetium (66-85) MND1.552.850.885; D2.705.206.885 XSTc-99m MDP; Technetium Methylene Diphosphonate LH LS;  MSA gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints. PM85 HN85 MHÑTechnetium Tc 99m Pertechnetate ANNIM; do not use /analogs /biosyn /defic /physiol; as label, use /diag use; DF: TC PERTECHNETATE RN23288-60-0 PITechnetium (66-84) MND1.552.850.900 XSPertechnetate Sodium; Sodium Pertechnetate Tc 99m LH LS;  MSA gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen. PM85 HN85 MHÑTechnetium Tc 99m Sulfur Colloid ANNIM; do not use /analogs /biosyn /defic /physiol; as label, use /diag use; DF: TC SULFUR COLLOID PISulfur (66-84); Technetium (66-84) MND1.552.850.920; D1.877.880 XSTc-99m Sulfur Colloid; Technetium Sulfur Colloid LH LS;  OLsearch INDUSTRIAL ARTS under TECHNOLOGY back thru 1967 & OCCUPATIONS 1966 PMINDUSTRIAL ARTS was see under OCCUPATIONS AND PROFESSIONS 1963-66 HNINDUSTRIAL ARTS was see under TECHNOLOGY 1967-78, was see under OCCUPATIONS AND PROFESSIONS 1963-66 MHÑTechnology ANonly /econ /hist /instrum /man /stand MNJ1.897 XSIndustrial Arts LH LS  MSEvaluation of biomedical technology in relation to cost, efficacy, utilization, etc. and its future impact on social, ethical and legal systems. PM80 HN80 MHÑTechnology Assessment, Biomedical ANonly /econ /legis /methods /stand; restrict to MeSH definition: do not use as routine coord for ╥evaluation╙ of a specific technic or ╥technol╙ MNN3.880 LH  MSThe field of dentistry involved in procedures for designing and constructing dental appliances. MHÑTechnology, Dental ANonly /econ /educ /hist /instrum /man /stand /trends /vet MNE6.912; G2.867; J1.897.724 LH  MSAdvanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialized medical/surgical procedures as well as advanced diagnostic and therapeutic equipment. PM80 HN80 MHÑTechnology, High-Cost ANonly /econ /hist /legis /man /stand /trends MNN3.880.502 XSHigh-Cost Technology LH LS  MH*Technology, Industry, Agriculture (Non Mesh) MNJ1 LH  MSAn allied health specialty concerned with a variety of clinical laboratory procedures used primarily for diagnostic and therapeutic purposes. MHÑTechnology, Medical ANonly /econ /educ /hist /instrum /man /stand /trends /vet MNE5.909; G2.885; J1.897.780 FXÑDiagnosis, Laboratory LH LX  PM68 HN68 MHÑTechnology, Pharmaceutical ANonly /econ /educ /hist /instrum /man /stand /trends /vet PIChemistry, Pharmaceutical (66-67); Pharmacy (66-67) MNE5.916; J1.897.836 FXÑDrug Industry; ÑPharmacy LH LX;  MSAn allied health specialty concerned with x-ray or radioisotope procedures for diagnostic and therapeutic purposes. MHÑTechnology, Radiologic ANonly /econ /educ /hist /instrum /man /stand /trends /vet; do not confuse with RADIOGRAPHY ( = x-ray diag); TECHNOLOGY, RADIOLOGIC is not restricted to radiography & the emphasis is on the technol; IM general only, NIM as the technol coord for a specific radiologic technol MNE5.920; G2.902; J1.897.891 LH  MSA gelatinous membrane, attached to the bony spiral lamina, which overlies the hair cells within the cochlea of the inner ear. HN(79) MHÑTectorial Membrane PICochlea (66-78) MNA9.246.631.246.292.906 DMÑCochlea LH LM  PM74 HN74(71) MHÑTegmentum Mesencephali ANdo not use /innerv; do not confuse with TECTUM MESENCEPHALI PIMesencephalon (66-70) MNA8.186.211.132.659.822 LH  PM74 HN74(71) MHÑTeichoic Acids ANdo not use /analogs /defic /physiol PIGlycosides (66-70); Phosphoric Acids (66-70) MND9.203.408.872; D9.203.894.847 LH  OLto search OSLER-RENDU DISEASE use TELANGIECTASIA, HEREDITARY HEMORRHAGIC back thru 1968 & TELANGIECTASIA, HEREDITARY HEMORRHAGIC & ANGIOMATOSIS 1966-67 PM68; OSLER-RENDU DISEASE was see under ANGIOMATOSIS 1963-67 HN68(66); OSLER-RENDU DISEASE was see under ANGIOMATOSIS 1963-67 MHÑTelangiectasia, Hereditary Hemorrhagic MNC14.907.823.780; C15.378.463.731 XSOSLER-RENDU DISEASE FXÑAngiomatosis LH LS LX  MHÑTelangiectasis MNC14.907.823 LH  MSTransmission of signs, signals, writing, images, sounds, or data of any nature by wire, radio, or other electromagnetic equipment. PM76 HN76; was NON MESH before 1976 MHÑTelecommunications ANonly /class /econ /hist /instrum /man /stand; note TELECOMMUNICATION NETWORKS see COMPUTER COMMUNICATION NETWORKS above PICommunication (66-75); Radio (66-75); Telephone (71-75); Television (66-75) MNL1.178.847 XSSatellite Communications; Teleconference LH LS;  MHÑTelemetry ANdo not use /util except by MeSH definition MNE1.621.697 LH  MHÑTelencephalon ANdo not use /innerv MNA8.186.211.885 LH  MSThe knowledge or communication by one person with the mental processes of another through channels other than known physical or perceptual processes. MHÑTelepathy ANno qualif MNF2.607.847 LH  PM74; DATAPHONE was see under COMPUTERS 1967-74 HN74(71) MHÑTelephone ANonly /econ /hist /instrum /legis /methods /stand /trends /util (if by MeSH definition) PICommunication (66-70) MNL1.178.847.698 XSSwitchboard Service XUÑDataphone LH LS LU  MHÑTelevision ANonly; /econ /hist /instrum /legis /methods /stand /trends /util (if by MeSH definition); do not coord with COLOR unless specifically emphasized & then NIM only MNL1.178.147.898; L1.178.847.823 LH  MHÑTellurium ANTe-130; do not use /analogs /biosyn /defic /physiol; Te-120, 122-126, 128 = TELLURIUM (IM) + ISOTOPES (NIM); Te-115-119, 121, 127, 129, 131-135 = TELLURIUM (IM) + RADIOISOTOPES (IM) RN13494-80-9 MND1.268.862; D1.904 LH  MSThe final phase of cell division, in which two daughter nuclei are formed, the cytoplasm divides, and the chromosomes lose their distinctness and are transformed into chromatin networks. PM81; was see under CELL CYCLE 1978-80 HN81(78); was see under CELL CYCLE 1978-80 MHÑTelophase ANfinal phase of cell div; NIM specific cell when merely test cell; coord with specific cell /cytol; only /drug eff /rad eff; permitted with micro-organisms PICell Division (66-77); Meiosis (68-77); Mitosis (68-77) MNG4.335.135.220.225.900; G5.148.165.220.225.900; G7.553.135.220.225.900 LH  MS7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl- 2H-1,4-benzodiazepin-2-one. A diazepam metabolite or oxazepam precursor; minor tranquilizer also proposed as hypnotic; its dimethylcarbamate is camazepam. Synonyms: Crisoner; Euhypnos; ER 115; hydroxydiazepam; K3917; Levanxen; Levnzol; oxydiazepam; R05-5345; WY 3917. HN(79) MHÑTemazepam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN846-50-4 PIBenzazepines (68-73); Benzodiazepine Tranquilizers (75-78); Benzodiazepinones (74-78) MND3.438.79.80.70.880; D15.236.872.659.191.845 XSHydroxydiazepam; Methyloxazepam DMÑBenzodiazepine Tranquilizers LH LS; LM  MSPredisposition to react to one's environment in a certain way; usually refers to mood changes. OLsearch PERSONALITY 1968-74 HN(75) MHÑTemperament ANonly /drug eff MNF1.752.898 DMÑPersonality LH LM  MSAbstinence from alcohol. MHÑTemperance ANonly /hist CATALOG: do not use /pop wks MNI3.828 LH  MHÑTemperature ANno qualif; prefer to specify HEAT or COLD MNG3.230.150.450; G3.230.300.100.725.710; H1.671.868 FXÑBody Temperature; ÑTHERMOMETERS LH LX;  MSThe sensation of cold, heat, coolness and warmth. MHÑTemperature Sense ANonly /drug eff /physiol /rad eff MNF2.830.816.781; G11.561.796.781 LH  MSMacromolecular moulds for the synthesis of complementary macromolecules, as in DNA replication, transcription of DNA to RNA, and translation of RNA into polypeptides. PM68 HN68 MHÑTemplates ANbiol context only: not for metal templates or patterns or gauges; NIM; no qualif PIDNA (66-67); Genetics (66-67); RNA (66-67) MNG5.331.808 LH  MSArteries arising from the external carotid or the maxillary artery and distributing to the temporal region. MHÑTemporal Arteries ANdo not use /blood supply; inflammation = TEMPORAL ARTERITIS MNA7.231.114.868 LH  MHÑTemporal Arteritis MNC14.907.184.823; C14.907.940.90.905; C23.205.892 XSArteritis, Temporal; Giant Cell Arteritis LH LS;  MHÑTemporal Bone ANfractures: coord TEMPORAL BONE /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with SKULL NEOPLASMS (IM) MNA2.835.232.781.885 FXÑLabyrinth LH LX  MHÑTemporal Lobe ANdo not use /innerv; dis: coord IM with BRAIN DISEASES (NIM); neopl: coord IM with BRAIN NEOPLASMS (IM) MNA8.186.211.885.213.863 XSWernicke Area LH LS  MSA masticatory muscle whose action is closing the jaws; its posterior portion retracts the mandible. HN(80) MHÑTemporal Muscle PIFacial Muscles (66-79); Masticatory Muscles (66-79); Muscles (66-79) MNA2.633.560.940; A14.530.940 DMÑMasticatory Muscles LH LM  MHÑTemporomandibular Joint ANany Cat A qualif permitted; DF: TMJ MNA2.835.583.861; A14.907 FXÑJaw LH LX  PM82 HN82 MHÑTemporomandibular Joint Diseases ANnote term below; DF: TMJ DIS PIJoint Diseases (66-81); Temporomandibular Joint (66-81) MNC5.550.905 LH  MSThe cardinal symptoms are pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. Symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are occlusal dysharmony and psychophysiologic factors. OLuse TEMPOROMANDIBULAR JOINT SYNDROME to search COSTEN'S SYNDROME back thru 1966 PM73; was COSTEN'S SYNDROME 1966-72 HN73; was COSTEN'S SYNDROME 1966-72 MHÑTemporomandibular Joint Syndrome ANnote term above; DF: TMJ SYNDROME MNC5.500.607.781; C5.550.905.905; C5.651.651.905 XSCosten's Syndrome; Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint FXÑFacial Pain LH LS; LX  PM65; was TENDONITIS 1963-64 HN65; was TENDONITIS 1963-64 MHÑTendinitis ANTENDONITIS accepted by computer MNC5.651.854 LH  MSInjuries to the fibrous cords of connective tissue which attach muscles to bones or other structures. OLuse TENDON INJURIES to search TENDON INJURY back thru 1966 PM73; was TENDON INJURY 1963-72 HN73; was TENDON INJURY 1963-72 MHÑTendon Injuries MNC21.866.874 LH  PM73 HN73(69) MHÑTendon Transfer ANdo not use /util except by MeSH definition; do not confuse with TENDONS /transpl PITendons/SU (66-68) MNE4.557.863 LH  PM/transplantation was TENDON TRANSPLANTATION 1963-65 HN/transplantation was TENDON TRANSPLANTATION 1963-65 MHÑTendons ANIM; /inj = TENDON INJURIES; tendon rupt = TENDON INJURIES (IM) + RUPTURE (NIM); /surg: consider TENDON TRANSFER; /transpl permitted: do not confuse with TENDON TRANSFER; for specifically located tendons coord IM with general area of tendon, not a bone term, as metacarpal tendon: TENDONS (IM) + HAND or FINGERS (IM), not METACARPUS; tendon reflex = REFLEX, TENDON see REFLEX, STRETCH MNA2.633.837 LH  PM65 HN65 MHÑTendons, Para-Articular MNA2.633.837.781 LH  MSA genus of beetles which infests grain products; its larva is called 'mealworm.' PM72 HN72 MHÑTenebrio ANa beetle; /microbiol /parasitol permitted PIBeetles (66-71) MNB1.131.617.155.304.615 XSMealworm LH LS  MS4'-Demethyl-9-(4,6-o-2-thenylidine-beta- D-glucopyranosyl) epipodophyllotoxin. Cytotoxic semisynthetic derivative of podophyllotoxin that may be effective in cancer chemotherapy; it prevents cells from entering prophase of mitosis and inhibits DNA synthesis. Synonym: NSC 122819. OLuse TENIPOSIDE to search VM 26 back thru 1976 HN(81); was VM 26 see under PODOPHYLLOTOXIN 1976-80 MHÑTeniposide ANdo not use /defic /physiol; /biosyn permitted if by plant RN29767-20-2 PIGlucosides (75); Glycosides (73-74); Podophyllotoxin (73-74) MND22.204.179.612.696.898 XSDemethyl Epipodophyllotoxin Thenylidine Glucoside; VM 26 DMÑPodophyllotoxin LH LS; LM  MHÑTennessee MNZ1.107.567.875.848 LH  MSA game played by 2 or 4 players with rackets and an elastic ball on a level court divided by a low net. HN(76) MHÑTennis ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); Manual 30.31+ PISports (66-75) MNI3.450.642.845.900 DMÑSports LH LM  MSA condition characterized by pain in or near the lateral humeral epicondyle or in the forearm extensor muscle mass as a result of unusual strain. Occurs in tennis players as well as housewives, artisans, and violinists. OLTN 240 for pre-1982 indexing of TENNIS ELBOW PM82 HN82 MHÑTennis Elbow ANin ╥housewives, artisans & violinists╙ as well as in tennis players; do not coord with TENNIS (NIM) unless the sport is particularly discussed; do not coord with ATHLETIC INJURIES (IM) unless tennis elbow is discussed as an athletic inj PIAthletic Injuries (68-81); Elbow (66-81); Elbow Joint (66-81); Sports (66-75); Sports Medicine (66-67); Tendinitis (66-81); Tennis (76-81) MNC5.906; C21.866.88.890 XSEpicondylitis, Lateral Humeral LH LS  MHÑTenosynovitis ANde Quervain's dis goes here; do not confuse with de Quervain's dis of thyroid or de Quervain's thyroiditis ( = THYROIDITIS, SUBACUTE) MNC5.651.884 LH  MSResistance to rupture under tension. PM77 HN77 MHÑTensile Strength ANNIM; only /drug eff /rad eff PIBiomechanics (68-76); Elasticity (67-76); Stress, Mechanical (73-76) MNG7.900; H1.671.100.131.900 LH  HN(63) MHÑTensor Tympani MNA2.633.893; A9.246.397.749 DMÑTympanic Membrane LH LM  MS3-Acetyl-5-sec-butyl-4-hydroxy-3-pyrrolin-2-one. A metabolite found in a strain of the fungus Alternaria tenuis Auct. which functions as an antibiotic with antiviral and antineoplastic properties, and may also act as a mycotoxin. HN(75) MHÑTenuazonic Acid ANdo not use /defic /physiol; /analogs NIM only RN610-88-8 PIPyrrolidinones (71-74) MND3.383.773.812.900; D20.85.75.930; D22.204.106.920 DMÑAntibiotics, Antineoplastic LH LM  HN(72) MHÑTepa ANdo not use /biosyn /defic /physiol; /analogs NIM only RN545-55-1 PIAzirines (68-71); Chemosterilants (66-71) MND3.383.97.217.864; D5.723.141.749 DMÑAzirines LH LM  MSA synthetic nonapeptide with the sequence Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro which is identical to the peptide from the venom of the snake, Bothrops jararaca. It acts as an inhibitor of kininase II and angiotensin I. Proposed as an antihypertensive agent. Synonyms: BPP-9a; angiotensin I converting enzyme inhibitor; nonapeptide converting enzyme inhibitor. OLuse TEPROTIDE to search SQ 20881 back thru 1975 HN(81); was SQ 20881 see under OLIGOPEPTIDES 1975-80 MHÑTeprotide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN35115-60-7 PIOligopeptides (73-74); Peptides (66-72); Snakes (66-72) MND12.644.456.810; D18.162.885 XSSQ 20881 DMÑOligopeptides LH LS LM  MSAn agent that causes the production of physical defects in the developing embryo. PM75 HN75 MHÑTeratogens AND25-26 qualif except /adv eff /pois: be careful: ╥teratogenic effect╙ of a drug or chem is probably ABNORMALITIES, DRUG-INDUCED + drug or chem named (with required qualif) & not TERATOGENS PIAbnormalities, Drug-Induced (66-74) MND5.569.864; D26.915 XSEmbryotoxins; Fetotoxins FXÑAbnormalities, Drug-Induced LH LS; LX  MSA true neoplasm composed of a number of different types of tissue, foreign to the part in which it arises. OLuse TERATOMA to search TERATOID TUMOR & DYSEMBRYOMA back thru 1966 PM82; was TERATOID TUMOR 1963-81; DYSEMBRYOMA was heading 1963-84 HN82; was TERATOID TUMOR 1963-81; DYSEMBRYOMA was heading 1963-84 MHÑTeratoma ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) MNC4.557.537.889 XSDysembryoma; Teratoid Tumor LH LS;  MHÑTerbium ANTb-159; do not use /analogs /biosyn /defic /physiol; Tb-147-158, 160-164 = TERBIUM (IM) + RADIOISOTOPES (IM) RN7440-27-9 MND1.268.869; D1.552.550.852 LH  PM74 HN74 MHÑTerbutaline ANdo not use /biosyn /defic /physiol RN23031-25-6 MND2.33.329.291.905; D2.92.63.291.905; D16.116.891; D16.893.116.348.915 LH  MSMedical and nursing care of patients in the terminal stage of an illness. PM68 HN68(64) MHÑTerminal Care ANonly /econ /legis /methods /organ /psychol /stand /trends; available also is HOSPICES (╥facilities...to provide palliative & supportive care to the dying patient & his family╙) MNE2.472.905; N2.421.589.886 FXÑDeath; ÑHospices; ÑPalliative Treatment LH LX; ;  MSDNA sequences which signal the termination of transcription. HN(85) MHÑTerminator Regions (Genetics) ANonly /drug eff /rad eff; DF: TERMINATOR REGIONS PIGene Expression Regulation (81-84); Genes (66-67); Genes, Regulator (68-84); Transcription, Genetic (73-84) MNG5.275.470.810; G5.331.380.418.810 DMÑGenes, Regulator LH LM  MHÑTerpenes ANdo not use /analogs /biosyn /defic /physiol; 15 carbon atoms = SESQUITERPENES, 20 carbon atoms = DITERPENES, 30 carbon atoms = TRITERPENES MND2.455.849 XUÑGefarnate LH LU  MSCompounds consisting of benzene rings linked to each other in either ortho, meta or para positions. Permitted are any substitutions, but ring fusion to any of the benzene rings is not allowed. PM75 HN75 MHÑTerphenyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: TERPHENYL CPDS PIBenzene Derivatives (73-74) MND2.455.426.559.389.805 XSTriphenyl Compounds XUÑPolychloroterphenyl Compounds LH LS LU  MSBehavior in defense of an area against another individual or individuals primarily of the same species. PM68 HN68 MHÑTerritoriality ANno qualif PIBehavior, Animal (66-67) MNF1.145.875.864 LH  MSA self-reporting test consisting of items concerning fear and worry about taking tests and physiological activity, such as heart rate, sweating, etc., before during and after tests. OLsearch PERSONALITY INVENTORY 1968-74 HN(75) MHÑTest Anxiety Scale ANno qualif MNF4.711.647.513.886 DMÑPersonality Inventory LH LM  PM66 HN66 MHÑTesticular Diseases ANinflamm dis = ORCHITIS MNC12.294.829 LH  PM70 HN70(68) MHÑTesticular Feminization ANcheck the tag MALE PISex Differentiation Disorders (66-67) MNC16.131.939.842.749; C19.391.301.699 LH  MSHormones produced in the testis. PM75 HN75 MHÑTesticular Hormones AN/biosyn /physiol permitted; do not use /analogs PISex Hormones (66-74) MND6.472.866.900 LH  OLuse TESTICULAR NEOPLASMS to search RETE CELL TUMOR 1966-83 PMRETE CELL TUMOR was heading 1963-83 HNRETE CELL TUMOR was heading 1963-83 MHÑTesticular Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.322.762; C4.588.945.440.915; C12.294.829.782 LH  MSEither of the paired male reproductive glands that produce the male germ cells and the male hormones. MHÑTestis ANtorsion = SPERMATIC CORD TORSION; ╥undescended╙ = CRYPTORCHISM; inflammation = ORCHITIS; /abnorm: agenesis or dysgenesis: coord TESTIS /abnorm (IM) with GONADAL DYSGENESIS (IM); /cytol: consider also LEYDIG CELLS; /surg is probably ORCHIECTOMY; excision = ORCHIECTOMY MNA5.360.444.849; A5.360.576.782; A6.407.312.782 FXÑOrchiectomy XUÑRete Testis; ÑSeminiferous Epithelium; ÑSeminiferous Tubules LH LX LU; ;  PM73 HN73(64) MHÑTestolactone ANdo not use /defic /physiol RN968-93-4 MND4.808.54.79.129.782; D4.808.496.699; D22.204.875 LH  PM/therapeutic use was TESTOSTERONE, THERAPEUTIC 1965 HN/therapeutic use was TESTOSTERONE, THERAPEUTIC 1965 MHÑTestosterone AN/biosyn /physiol permitted RN57-85-2 MND4.808.54.79.429.824; D6.472.79.864; D6.472.866.154.864 XSTestosterone Propionate XUÑEpitestosterone; ÑHydroxytestosterones LH LS LU;  MSCatalyze the oxidation of testosterone at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield 4-androstene-3,17-dione and NADH or NADPH. Includes EC 1.1.1.51; EC 1.1.1.63; EC 1.1.1.64. HN(78) MHÑTestosterone Dehydrogenases ANdo not use /analogs RNEC 1.1.1.- PIHydroxysteroid Dehydrogenases (66-77); Testosterone (66-77) MND8.586.682.47.436.375.900 DMÑ17-Hydroxysteroid Dehydrogenases LH LM  MS3-Oxo-5 alpha-steroid:(acceptor) delta 4-oxidoreductase. NADPH acts as H donor in the reduction of testosterone to dihydrotestosterone. PM86; was see under OXIDOREDUCTASES 1975-85 HN86(75); was see under OXIDOREDUCTASES 1975-85 MHÑTestosterone 5-alpha-Reductase ANdo not use /analogs RNEC 1.3.99.5 PIOxidoreductases (72-74); Testosterone (72-74) MND8.586.682.910 XS3-Keto-5-alpha-Steroid delta-4-Dehydrogenase; 5-Alpha-Reductase, Testosterone; Testosterone delta-4-5-alpha-Reductase LH LS; ;  MHÑTetanus ANdo not confuse with TETANY; do not use for tonic spasm of muscle ( = SPASM) or for tetanic contraction ( = MUSCLE CONTRACTION) MNC1.252.217.864 FXÑTRISMUS LH LX  MHÑTetanus Antitoxin ANfor ther (for prev use TETANUS TOXOID); only /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.121.824; D24.611.125.272.849 LH  MSThe toxin elaborated by Clostridium tetany; it is a protein with a molecular weight of about 150,000, probably consisting of two fragments, tetanolysin being the hemolytic and tetanospasmin the neurotoxic principle; the toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal convulsions. PM65 HN65 MHÑTetanus Toxin ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also TETANUS ANTITOXIN MND24.185.926.123.893 XSClostridial Neurotoxin; Clostridium Tetani Toxin FXÑClostridium Tetani LH LS; LX  MHÑTetanus Toxoid ANfor prev (for ther use TETANUS ANTITOXIN); only /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.794.824 XSTetanus Vaccine LH LS  OLuse TETANY to search SPASMOPHILIA back thru 1966 PMSPASMOPHILIA was heading 1963-76 HNSPASMOPHILIA was heading 1963-76 MHÑTetany ANdo not confuse with TETANUS & do not confuse with tetanic spasm of muscle ( = SPASM) or with tetanic contraction ( = MUSCLE CONTRACTION) MNC10.772.900; C18.452.174.509.700; C19.642.482.700 XSSpasmophilia LH LS  MHÑTetrabenazine ANdo not use /biosyn /defic /physiol RN58-46-8 MND15.236.872.331.838; D16.848.415.876 LH  MHÑTetracaine ANdo not use /biosyn /defic /physiol RN94-24-6 MND2.241.223.106.61.75.900; D14.211.917 XSAmethocaine; Tetrakain LH LS;  MS2,3,7,8-Tetrachlorodibenzo-p-dioxin. A contaminant of 2,4,5-T believed to have teratogenic effects. Synonym: TCDD. HN(75) MHÑTetrachlorodibenzodioxin ANdo not use /biosyn /defic /physiol; /analogs NIM only; DF: TCDD RN1746-01-6 PIChlorobenzenes (74); Dioxins (72-74) MND3.383.231.900 DMÑDioxins LH LM  MSEthylene tetrachloride. Used as grease solvent in industry; defats skin and mucus membranes, causes CNS, liver, and kidney damage on chronic exposure; used as anthelmintic for hookworms. Synonyms: tetrachloroethene; Ankilostin; Didakene; Nema; Perclene; Tetracap; Tetropil. MHÑTetrachloroethylene ANdo not use /biosyn /defic /physiol RN127-18-4 MND2.455.526.439.880; D21.201.287.846 XSPerchloroethylene LH LS  MS2-chloro-1-(2,4,5-trichlorophenyl)-vinyl dimethylphosphate. An organophosphate insecticide. Synonyms: Rabon; Ravap; Shell SD 8447. OLuse TETRACHLORVINPHOS to search GARDONA back thru 1972 (as Prov 1972-73) PM79; was GARDONA 1974-78 HN79; was GARDONA 1972-78 (Prov 1972-73) MHÑTetrachlorvinphos ANdo not use /biosyn /defic /physiol; TN 111 for eff on insects RN22248-79-9 PIOrganophosphorus Compounds (71) MND2.705.890; D5.723.491.574.890 XSGardona LH LS  MHÑTetracycline ANa specific drug: do not confuse with TETRACYCLINES; do not use /analogs ( = TETRACYCLINES) /defic /physiol RN60-54-8 MND20.85.868.850 LH  MSBroad spectrum natural and semisynthetic antibiotics with a naphthacene structure obtained from various Streptomyces species. PM76 HN76; was NON MESH before 1976 MHÑTetracyclines ANdo not confuse with TETRACYCLINE, a specific drug; do not use /analogs /defic /physiol PIspecific tetracycline MND20.85.868 XUÑLymecycline; ÑMinocycline; ÑMorphocycline LH LU; ;  MS1,1a alpha,1b beta,4,4 alpha,7a alpha,7b,8,9,9a-Decahydro-4a beta,7b alpha,9 beta,9a alpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8 alpha-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e] azulen-5-one-9a-acetate-9-myristate. A phorbol ester with very effective tumor promoting activity. Stimulates the synthesis of both DNA and RNA. PM87; was see under PHORBOLS 1975-86 HN87(75); was see under PHORBOLS 1975-86 MHÑTetradecanoylphorbol Acetate AND25-26 qualif RN16561-29-8 PIAlcohols (66-74); Croton Oil (66-74); Diterpenes (74); Fatty Acids (66-74); Terpenes (66-73) MND2.455.849.291.500.510.850; D10.516.627.700.315.500.850; D26.191.208.744.742.903; J1.740.700.315.500.850 XSPhorbol Myristate Acetate LH LS  MSA highly toxic compound used as a gasoline additive; causes acute toxic psychosis or chronic poisoning if inhaled or absorbed through the skin. HN(76) MHÑTetraethyl Lead ANdo not use /analogs /biosyn /defic /physiol RN78-00-2 PILead (69-75); Organometallic Compounds (69-75) MND2.691.950 DMÑOrganometallic Compounds LH LM  MHÑTetraethylammonium Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: TETRAETHYLAMMONIUM CPDS MND2.92.102.787; D2.675.276.787; D16.653.396.800 XSTetramon; Tetrylammonium LH LS;  MSL-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. HN(79) MHÑTetragastrin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1947-37-1 PIGastrins (66-78); Oligopeptides (73-78); Peptides (66-72) MND6.472.317.413.800; D12.644.456.830; D19.316.629.441.900 DMÑGastrins LH LM  MS3-Pentyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,c]pyran-1-ol. The 9-delta isomer is a pharmacologically active constituent of Cannabis sativa L. (marihuana, hashish). PM77; was see under CANNABIS 1975-76 HN77(71); was see under CANNABIS 1975-76 MHÑTetrahydrocannabinol AN/biosyn permitted; do not use /defic /physiol RN33086-25-8 PICannabis (66-70) MND2.455.849.90.810; D15.236.372.211.700 XSDelta(9)-THC; THC LH LS;  HN(73) MHÑTetrahydrocortisol ANdo not use /biosyn /defic /physiol RN53-02-1 PIHydrocortisone (66-72) MND4.808.745.887; D6.472.40.322.478.353.825; D6.472.40.322.478.478.782 DMÑHydrocortisone LH LM  HN(73) MHÑTetrahydrocortisone ANdo not use /biosyn /defic /physiol RN53-05-4 PICortisone (66-72) MND4.808.745.558.783; D6.472.40.322.478.478.865 DMÑCortisone LH LM  PM66 HN66 MHÑTetrahydrofolate Dehydrogenase ANdo not use /analogs RNEC 1.5.1.3 MND8.586.682.107.825 XSDIHYDROFOLATE REDUCTASE; FOLIC ACID REDUCTASE LH LS;  PM74 HN74(72) MHÑTetrahydrofolates ANdo not use /analogs /biosyn /defic /physiol PICoenzymes (66-71); Folic Acid (66-71) MND8.176.840 FXÑCitrovorum Factor XUÑFormyltetrahydrofolates LH LX LU  MS1,2,3,4-Tetrahydronaphthalene compounds. HN(78) MHÑTetrahydronaphthalenes ANdo not use /analogs /biosyn /defic /physiol PINaphthalenes (66-77) MND4.615.638.960 XSTetralins DMÑNaphthalenes LH LS LM  MS1-(3,4-Dihydroxybenzyl)-1,2,3,4-tetrahydro-6,7-isoquinolinediol. A leukomaine (animal alkaloid) formed in brain and liver from dopamine and L-dopa; it has both beta-1 and beta-2 adrenomimetic properties and may be implicated in psychiatric problems. HN(78) MHÑTetrahydropapaveroline AN/biosyn /physiol permitted RN4747-99-3 PIAlcohols (66-73); Benzene Derivatives (68-73); Papaverine (66-77); Quinolines (66-73) MND3.132.610.710.850; D3.438.531.667.850; D16.893.116.348.926 XSNorlaudanosoline; Tetrahydroxypapaveroline DMÑPapaverine LH LS; LM  MS5-Methyltetrahydropteroyl-L-glutamate:L-homocysteine S-methyltransferase. Catalyzes the formation of methionine by transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine. Requires a cobamide coenzyme. Can act on mono- or tri-glutamate derivatives. HN(75) MHÑTetrahydropteroylglutamate Methyltransferase ANdo not use /analogs; /defic: consider also HOMOCYSTINURIA RNEC 2.1.1.13 PIMethionine (73-74); Methyltransferases (73-74); Tetrahydrofolates (73-74) MND8.586.913.517.810 XSMethionine Synthetase; Methyltetrahydrofolate Homocysteine Methyltransferase DMÑMethyltransferases LH LS; LM  MS1-(beta-D-Ribofuranosyl)-4-hydroxy-3,4,5-tetrahydro-pyrimidin-2(1H)-one. An inhibitor of nucleotide metabolism. HN(75) MHÑTetrahydrouridine ANdo not use /biosyn /defic /physiol RN18771-50-1 PIUridine (71-74) MND13.570.685.852.800; D13.570.800.892.800; D26.87.898 DMÑUridine LH LM  MHÑTetrahymena ANdo not use /anat /blood-csf-urine /embryol MNB1.841.184.850 LH  MSA species of ciliate protozoa used extensively in genetic research. PM72 HN72 MHÑTetrahymena Pyriformis ANdo not use /anat /blood-csf-urine /embryol PITetrahymena (66-71) MNB1.841.184.850.700 LH  MSN,N',N'',N'''-Tetraisopropylpyrophosphamide. Cholinesterase inhibitor. HN(75) MHÑTetraisopropylpyrophosphamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN513-00-8 PIAmides (72-74); Organophosphorus Compounds (72-74) MND2.705.900; D16.698.410.910 XSIso-OMPA DMÑOrganophosphorus Compounds LH LS LM  MSA combination of congenital cardiac defects consisting of pulmonary stenosis, interventricular septal defects, dextroposition of the aorta so that it overrides the interventricular septum and receives venous as well as arterial blood, and right ventricular hypertrophy. MHÑTetralogy of Fallot ANdo not use /congen; do not confuse with TRILOGY OF FALLOT MNC14.280.400.849; C16.131.457.850 XSFALLOT'S TETRALOGY LH LS  MSN,N,N',N'-Tetramethyl-p-phenylenediamine. Used in the form of the hydrochloride as a reagent in analytical chemistry. Synonyms: Wurster's blue; Wurster's reagent. HN(75) MHÑTetramethylphenylenediamine AND25-26 qualif; /analogs NIM only RN27215-51-6 PIDimethylamines (74); Phenylenediamines (74) MND2.92.146.651.900; D2.92.782.258.651.900; D26.550.865 DMÑPhenylenediamines LH LM  PM74 HN74 MHÑTetramisole ANdo not use /biosyn /defic /physiol RN5036-02-2 MND3.383.374.884; D3.383.871.782 LH  MSCorrosive oxidant, explosive; additive to diesel and rocket fuels; causes skin and lung irritation; proposed war gas. A useful reagent for studying the modification of specific amino acids, particularly tyrosine residues in proteins. Has also been used for studying carbanion formation and for detecting the presence of double bonds in organic compounds. HN(75) MHÑTetranitromethane AND25-26 qualif RN509-14-8 PIMethane (72-74); Nitro Compounds (72-74) MND2.455.326.146.571.850; D2.455.326.146.672.800; D2.640.720.800; D26.550.875 DMÑMethane LH LM  MSSodium tetraphenylborate. Used as a reagent for determination of potassium, ammonium, rubidium, and cesium ions. Also uncouples oxidative phosphorylation and forms complexes with biological materials; used in biological assays. Synonyms: Dotite-Kalibor; Kalignost. HN(75) MHÑTetraphenylborate AND25-26 qualif; /analogs NIM only RN4358-26-3 PIBenzene Derivatives (73-74); Boron Compounds (73-74) MND2.203.920; D26.550.888 XSSodium Tetraphenylborate; Tetraphenylboron Sodium DMÑBoron Compounds LH LS; LM  MSTetrathionic acid, disodium salt. Has been used to prolong coagulation time. Antidote in cyanide poisoning. HN(75) MHÑTetrathionic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN13760-29-7 PIThiosulfates (70-74) MND1.877.814.539.868.900; D26.550.894 XSSodium Tetrathionate DMÑThiosulfates LH LS LM  OLsearch AZOLES 1966-72 HN(73) MHÑTetrazoles ANdo not use /analogs /biosyn /defic /physiol PIAzoles (66-72) MND3.383.129.617 DMÑAzoles LH LM  MHÑTetrazolium Salts AND25-26 qualif MND3.383.129.617.700; D26.550.900 XUÑNitroblue Tetrazolium LH LU  MSAn aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the Order Tetradontiformes (pufferfish, globefish, toadfish), which are eaten; the toxin causes paresthesia and paralysis due to interference with neuromuscular conduction. PM68 HN68(64) MHÑTetrodotoxin ANdo not use /analogs /defic /diag use /physiol /secret; /antag permitted but consider also ANTITOXINS RN4368-28-9 MND24.185.926.580.910 XSFugu Toxin; TARICHATOXIN FXÑFishes, Poisonous LH LS; LX  MHÑTetroses ANdo not use /analogs /defic /physiol MND9.203.546.805 XUÑErythrose LH LU  MHÑTexas MNZ1.107.567.875.858 LH  MSBooks used in the study of a subject that contain a systematic presentation of the principles and vocabulary of a subject. HN(81) MHÑTextbooks PIBooks (66-80); specific or related book heading; Teaching Materials (74-80) MNI2.903.847.508; L1.178.682.192.900; L1.178.820.900 DMÑBooks LH LM  MHÑTextile Industry ANonly /econ /hist /instrum /stand MNJ1.576.885 LH  MHÑTextiles ANonly /class /hist /rad eff /stand /supply; textile mesh is probably SURGICAL MESH MNJ1.637.879 LH  MHÑThailand AN= Siam MNZ1.252.145.841 LH  PM81 HN81 MHÑThalamic Diseases PIBrain Diseases (66-80); Thalamus (66-80) MNC10.228.140.915 LH  PM71 HN71 MHÑThalamic Nuclei ANdo not use /innerv PIThalamus (66-70) MNA8.186.211.385.826.701 LH  MHÑThalamus ANdo not use /innerv MNA8.186.211.385.826 LH  MSAny of a group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. PM65; was ANEMIA, ERYTHROBLASTIC 1963-64 HN65; was ANEMIA, ERYTHROBLASTIC 1963-64 MHÑThalassemia MNC15.378.71.141.150.875; C15.378.420.826 XSAnemia, Cooley's; Anemia, Erythroblastic; Anemia, Mediterranean; Anemia, Target Cell; Hemoglobin H Disease; Leptocytosis, Hereditary LH LS; ; ; ; ;  MSThe therapeutic use of seaside resorts; includes treatment by sea air, sea voyages, and sea bathing. MHÑThalassotherapy ANdo not use /util except by MeSH definition; includes sea bathing, sea voyages or sea air MNE2.780.910 LH  MS9-[(4,5-Dimethoxy-alpha-[(S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-M-ethyl-1-isoquinolyl]-O-tolyl)oxy]1,2,10-trimethoxy-6a alpha-aporphine. Substance obtained from Thalictrum dasycarpum, proposed as an antineoplastic. HN(76) MHÑThalicarpine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5373-42-2 PIAporphines (73-75); Isoquinolines (73-75) MND3.132.70.900; D3.438.531.860; D3.549.95.900 DMÑAporphines LH LM  MHÑThalidomide ANdo not use /biosyn /defic /physiol RN50-35-1 MND2.241.223.805.810.800; D3.383.621.808.800; D14.591.745.912; D20.661.866 LH  MHÑThallium ANTl-205; do not use /analogs /biosyn /defic /physiol; Tl-203 = THALLIUM (IM) + ISOTOPES (NIM); Tl-198-202, 204, 206-210 = THALLIUM (IM) + RADIOISOTOPES (IM) RN7440-28-0 MND1.268.877; D1.552.858 LH  MSThe study of death. OLsearch DEATH 1974 HN(75) MHÑThanatology ANno qualif MNC23.240.901 DMÑDeath LH LM  MSA severe form of neonatal dwarfism with very short limbs. All cases have died at birth or in the neonatal period. HN(85) MHÑThanatophoric Dysplasia ANdo not use /congen PIDwarfism (66-84); Skull (66-84) MNC5.116.99.343.914; C5.116.99.708.914; C16.131.621.921; C16.614.890; C19.297.914 XSDwarfism, Thanatophoric; Thanatophoric Dwarfism DMÑOsteochondrodysplasias LH LS; LM  OLto search THEBAINE DERIVATIVES use THEBAINE /AA back thru 1975 & MORPHINANS 1969-74 PMTHEBAINE DERIVATIVES was see under THEBAINE 1975-77, was see under MORPHINANS 1969-74 HNTHEBAINE DERIVATIVES was see under THEBAINE 1975-77, was see under MORPHINANS 1969-74 MHÑThebaine ANdo not use /biosyn /defic /physiol; thebaine derivatives = THEBAINE /analogs RN115-37-7 MND3.132.610.422.547.547.856; D3.549.686.575.547.851; D3.605.497.575.547.851; D14.73.153.616.547.437.826; D14.757.638.547.437.826 LH  MHÑTheca Cell Tumor ANbenign or malignant; /anal /blood supply /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS (IM); also called thecoma; lutenoma, luteoma, lutein tumor, luteoblastoma go here MNC4.557.576.921 XSLuteinoma; Luteoma; Thecoma LH LS; ;  MSThe connective tissue cells of the Graafian follicle. OLuse THECA CELLS to search OVARIAN INTERSTITIAL CELLS back thru 1975 PM78; was see under GRAAFIAN FOLLICLE 1975-77; OVARIAN INTERSTITIAL CELLS was see under OVARY 1975-77 HN78(75); was see under GRAAFIAN FOLLICLE 1975-77; OVARIAN INTERSTITIAL CELLS was see under OVARY 1975-77 MHÑTheca Cells ANA 11 qualif MNA5.360.319.114.630.535.400; A6.407.312.497.535.600; A11.329.850 XSOvarian Interstitial Cells LH LS  MSUnlawful act of taking property. PM78 HN78 MHÑTheft ANonly /legis /prev MNI1.198.240.810; I1.880.735.191.410 XSStealing LH LS  MSInfection of bovines with protozoa of the genus Theileria. OLuse THEILERIASIS to search CORRIDOR DISEASE & EAST COAST FEVER back thru 1968 PM68 HN68; CORRIDOR DISEASE was see under THEILERIASIS 1968-78; EAST COAST FEVER was see under THEILERIASIS 1968-81 MHÑTheileriasis ANusually animal: do not use /vet but check tag ANIMAL; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES; for organism index SPOROZOA (IM) + THEILERIASIS (NIM) PIProtozoan Infections (66-67) MNC3.752.823; C22.196.831; C22.674.710.735 XSCorridor Disease; East Coast Fever; Gonderiasis LH LS; ;  MSA superfamily of parasitic nematodes which includes three genera - Thelazia, Spirocerca, and GNATHOSTOMA. Only Thelazia and GNATHOSTOMA occasionally occur in man. OLto search THELASIA use THELAZIOIDEA back thru 1975 & SPIRUROIDEA 1966-74 PM86; GNATHOSTOMA & THELAZIA were see under SPIRUROIDEA 1963-85 HN86; GNATHOSTOMA & THELAZIA were see under SPIRUROIDEA 1963-85 MHÑThelazioidea ANa superfamily of nematodes; do not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.722 XSSpirocerca; Thelazia XUÑGnathostoma LH LS; LU  MSA projective test in which a person is asked to make up stories about a series of pictures suggesting life situations. The themes expressed by the subject are viewed as those important in his own life or expressions of his personality needs. MHÑThematic Apperception Test ANno qualif MNF4.711.647.622.851 LH  MS4,4,4-Trifluoro-1-(2-thienyl)-1,3-butanedione. Chelating agent and inhibitor of cellular respiration. HN(75) MHÑThenoyltrifluoroacetone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN326-91-0 PIButanones (71-74); Hydrocarbons, Fluorinated (74); Thiophenes (71-74) MND2.522.296.900; D3.383.903.820; D26.241.900 DMÑThiophenes LH LM  MS3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacas (the cacao bean) and other plants; it has cardiac stimulant, coronary and bronchial dilating and diuretic actions; used mainly as a cardiac stimulant or in bronchial asthma. MHÑTheobromine ANdo not use /biosyn /defic /physiol RN83-67-0 MND3.132.956.701; D3.438.759.758.824.651; D16.116.905; D18.918.861 XUÑPentoxifylline LH LU  MS1,3-Dimethylxanthine. Alkaloid obtained from Thea sinensis (tea) and others; it stimulates the heart and central nervous system, dilates bronchi and blood vessels and causes diuresis; used mainly in bronchial asthma and for myocardial stimulation. Synonyms: Theocin; Theolix. MHÑTheophylline ANdo not use /biosyn /defic /physiol RN58-55-9 MND3.132.956.826; D3.438.759.758.824.751; D16.116.919; D18.918.882 FXÑTea XUÑ1-Methyl-3-Isobutylxanthine; ÑDyphylline; ÑXanthinol Niacinate LH LX LU; ;  MH*Theoretical Technics (Non Mesh) MNF4.669.880 LH  MSPsychotherapeutic technique which emphasizes socioenvironmental and interpersonal influences in the resocialization and rehabilitation of the patient. The setting is usually a hospital unit or ward in which professional and nonprofessional staff interact with the patients. PM69 HN69(67) MHÑTherapeutic Community ANno qualif PIPsychotherapy (66); Psychotherapy, Group (66) MNF4.754.864.392.701 LH  MHÑTherapeutic Cults ANonly /hist /trends; scientology & dianetics go here MNE2.924 FXÑQUACKERY LH LX  MSThe relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease. PM70 HN70 MHÑTherapeutic Equivalency ANNIM; no qualif PIDrugs (66-69); Pharmacology (66-69) MNG12.91.851 XSBioequivalence; CLINICAL EQUIVALENCY; EQUIVALENCY, THERAPEUTIC; GENERIC EQUIVALENCY LH LS; ; ;  MH*Therapeutic Processes (Non Mesh) MNF4.754.919 LH  MHÑTherapeutics ANavoid: too general: prefer /ther with diseases: Manual 19.5+; when GEN & IM, only /adv eff /hist /stand /trends /vet MNE2 LH  MSComputer systems utilized as adjuncts in the treatment of disease. PM87 HN87 MHÑTherapy, Computer-Assisted ANIM; no qualif; DRUG THERAPY, COMPUTER-ASSISTED & RADIOTHERAPY, COMPUTER-ASSISTED are also available MNE2.950; L1.700.508.100.710 XSComputer-Assisted Therapy; Protocol-Directed Therapy, Computer-Assisted XUÑDrug Therapy, Computer-Assisted LH LS; LU  PM74 HN74(71) MHÑThermal Conductivity ANNIM; no qualif PIHeat (66-70); Physics (66-70) MNH1.671.891 LH  MSMeasurement of blood flow based on induction at one point of the circulation of a known change in the intravascular heat content of flowing blood and detection of the resultant change in temperature at a point downstream. PM77 HN77 MHÑThermodilution ANNIM; only /instrum /methods PICardiac Output (66-76); Indicator Dilution Technics (67-76) MNE1.145.643.940 LH  MHÑThermodynamics ANno qualif MNH1.671.912 LH  PM67 HN67(65) MHÑThermography ANin diag coord IM with disease /diag, not /radiogr; do not use /util except by MeSH definition MNE1.907 FXÑBody Temperature LH LX  MSTechnic whereby the weight of a sample can be followed over a period of time while its temperature is being changed (usually increased at a constant rate). HN(77) MHÑThermogravimetry ANNIM; only /instrum /methods PIHeat (66-76) MNE5.196.904 DMÑChemistry, Analytical LH LM  PM73 HN73(71) MHÑThermoluminescent Dosimetry ANonly /instrum /methods PILuminescence (66-70); Radiation Monitoring (66-70); Radiometry (66-70) MNE5.799.638.785; G3.850.810.370.420; H1.671.768.765.588.852 LH  PM73 HN73(71) MHÑThermolysin ANdo not use /analogs RNEC 3.4.24.- PIPeptide Peptidohydrolases (66-70) MND8.586.277.656.732.827 LH  MHÑThermometers ANonly /hist /stand /supply /vet MNE7.900 FXÑBody Temperature; ÑTemperature LH LX;  MSApparently a true saprophyte which has been isolated from a burning coal refuse pile and from acid hot springs. PM76 HN76 MHÑThermoplasma ANin burning slag & hot springs PIBacteria (66-74); Mycoplasmatales (75) MNB3.600.580.650 LH  OLto search KRAUSE'S END BULBS & RUFFINI'S CORPUSCLES use THERMORECEPTORS back thru 1975 & RECEPTORS, SENSORY 1972-74 & NERVE ENDINGS 1966-71 PM74; KRAUSE'S END BULBS & RUFFINI'S CORPUSCLES were see under RECEPTORS, NEURAL 1972-74, were see under NERVE ENDINGS 1963-71 HN74(71); KRAUSE'S END BULBS & RUFFINI'S CORPUSCLES were see under THERMORECEPTORS 1975-78, were see under RECEPTORS, NEURAL 1972-74, were see under NERVE ENDINGS 1963-71 MHÑThermoreceptors ANdo not use /innerv PIReceptors, Sensory (66-70); Temperature Sense (66-70) MNA8.796.511.725.827 XSKrause's End Bulbs; Ruffini's Corpuscles LH LS;  MSGram-negative aerobic rods found in warm water (40-79 C) such as hot springs, hot water tanks, and thermally polluted rivers. PM78 HN78 MHÑThermus ANin hot springs, hot-water tanks, thermally polluted waters PIBacteria (66-75); Gram-Negative Aerobic Bacteria (76-77) MNB3.400.900 LH  MSA genus of the family Cercopithecidae consisting of only one species, gelada. It inhabits the rocky mountainous areas of Ethiopia. Contrary to baboon troops, the gelada travels in herds containing many family units. OLuse THEROPITHECUS GELADA to search GELADA back thru 1975 HN(81); was GELADA see under MONKEYS 1975-80 MHÑTheropithecus gelada ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; DF: THEROPITHECUS MNB2.649.801.201.468.720 XSBaboon, Gelada; Gelada Baboon DMÑCercopithecidae LH LS; LM  MSWaves in the electroencephalogram which have a frequency of 4-7 cycles per second. HN(75) MHÑTheta Rhythm ANno qualif MNE1.236.257.401.940; E1.399.277.940 XSElectroencephalography, Theta Rhythm DMÑElectroencephalography LH LS LM  PM65 HN65(63) MHÑThiabendazole ANdo not use /biosyn /defic /physiol RN148-79-8 MND3.383.871.840; D3.438.103.850; D21.201.287.881 XSTiabendazol LH LS  PM68 HN68(63) MHÑThiacetazone ANdo not use /biosyn /defic /physiol RN104-06-3 MND2.845.746.703.702; D2.886.803.702; D20.338.903.702 XSAmbathizon; Thioacetazon LH LS;  HN(71) MHÑThiadiazines ANdo not use /analogs /biosyn /defic /physiol PIHeterocyclic Compounds (66-70) MND3.383.855.785 DMÑThiazines LH LM  PM73; METHAZOLAMIDE was see under CARBONIC ANHYDRASE INHIBITORS 1965-74 HN73(71) MHÑThiadiazoles ANincludes thiadiazolines, thiadiazolidines; do not use /analogs /biosyn /defic /physiol PIHeterocyclic Compounds (66-70) MND3.383.871.867 XUÑBenzolamide; ÑMethazolamide LH LU;  MHÑThiamine AN/defic = THIAMINE DEFICIENCY RN59-43-8 MND11.786.708.887 XSANEURIN; Vitamin B 1 XUÑThiamine Monophosphate; ÑThiamine Triphosphate LH LS; LU;  MHÑThiamine Deficiency ANconsider also BERIBERI MNC18.654.223.133.699.827 LH  MSThiamine dihydrogen phosphate ester. The monophosphate ester of thiamine. Synonyms: monophosphothiamine; vitamin B1 monophosphate. HN(79) MHÑThiamine Monophosphate RN532-40-1 PIOrganophosphorus Compounds (71-78); Thiamine (66-78) MND11.786.708.887.600 DMÑThiamine LH LM  MSHydrolyzes thiamine pyrophosphate to thiamine monophosphate plus inorganic phosphate. HN(75) MHÑThiamine Pyrophosphatase ANdo not use /analogs RNEC 3.6.1.- PIPyrophosphatases (73-74); Thiamine Pyrophosphate (73-74) MND8.586.277.352.630.785.900 XSTPPase DMÑPyrophosphatases LH LS LM  MHÑThiamine Pyrophosphate RN154-87-0 MND8.176.878; D11.786.708.887.702 XSCOCARBOXYLASE; Thiamine Diphosphate LH LS;  MSATP:thiamine pyrophosphotransferase. Catalyzes the formation of thiamine pyrophosphate from ATP and thiamine. Synonym: ATP-thiamine transphosphatase. EC 2.7.6.2. HN(79) MHÑThiamine Pyrophosphokinase ANdo not use /analogs; do not confuse with THIAMINE PYROPHOSPHATASE nor with thiamine diphosphate kinase RNEC 2.7.6.2 PIPhosphotransferases (66-73); Phosphotransferases, ATP (74-78); Thiamine (66-78) MND8.586.913.696.729.880 DMÑPhosphotransferases, ATP LH LM  MSAn enzyme present in nerve tissue. It catalyzes reversibly the formation of thiamine pyrophosphate and orthophosphate from thiamine triphosphate. EC 3.6.1..-. HN(79) MHÑThiamine Triphosphatase ANdo not use /analogs; do not confuse with THIAMINE TRIPHOSPHATE RNEC 3.6.1.28 PIPhosphatases (66-78); Phosphoric Acids (68-76); Thiamine (66-76); Thiamine Pyrophosphate (77-78) MND8.586.277.352.630.900 DMÑPhosphatases LH LM  MSThiamine triphosphoric acid ester. The triphosphate ester of thiamine. In Leigh's disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation. HN(79) MHÑThiamine Triphosphate ANdo not confuse with THIAMINE TRIPHOSPHATASE RN3475-65-8 PIOrganophosphorus Compounds (71-78); Thiamine (66-78) MND11.786.708.887.900 DMÑThiamine LH LM  MSThreo-2,2-dichloro-N-[beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl] acetamide. A methylsulfonyl analog of chloramphenicol. It is an antibiotic and immunosuppressive agent. Synonyms: Glitozol; Raceophenidol; Thiamcol; Thiomycetin; Vicemycetin. PM79; was see under ANTIBIOTICS 1975-78 HN79(75); was see under ANTIBIOTICS 1975-78 MHÑThiamphenicol ANdo not use /analogs /biosyn /defic /physiol RN15318-45-3 PIAcetamides (73-74); Phenethylamines (68-74); Sulfones (66-74) MND20.85.215.910; D22.569.910 XSDextrosulfenidol; Thiophenicol LH LS;  PM65 HN65 MHÑThiamylal ANdo not use /biosyn /defic /physiol RN77-27-0 MND3.383.742.698.253.800.750; D14.166.111.852; D14.591.220.852 XSThioquinalbarbitone LH LS  PM74 HN74(73) MHÑThiazepines ANdo not use /analogs /biosyn /defic /physiol PIAzepines (66-72); Benzazepines (68-72); Dibenzazepines (68-72) MND3.383.66.785; D3.383.886.702 LH  MSN,N,N-alpha-Tetramethyl-10H-phenothiazine- 10-ethanaminium methyl sulfate. A quarternary ammonium phenothiazine, usually as the methyl sulfate, that has both histamine 1 and acetylcholine blocking actions. Synonyms: Multergan; Multezin; Padisal; thiazinamon; thiozinamin; Valan. HN(80) MHÑThiazinamium ANdo not use /biosyn /defic /physiol RN58-34-4 PIPromethazine (66-74) /AA (75-79) MND3.494.741.670.900; D16.653.895; D23.654.432.741.895 XSMethylpromethazine DMÑPromethazine LH LS LM  OLuse THIAZINES to search PYRIDOBENZOTHIAZINES 1966-84 PMPYRIDOBENZOTHIAZINES was heading 1963-84 HNPYRIDOBENZOTHIAZINES was heading 1963-84 MHÑThiazines ANdo not use /analogs /biosyn /defic /physiol MND3.383.855 XUÑSulthiame; ÑThiadiazines; ÑXylazine LH LU; ;  PMETHOXZOLAMIDE was see under CARBONIC ANHYDRASE INHIBITORS 1965-74 MHÑThiazoles ANincludes thiazolines, thiazolidines; do not use /analogs /biosyn /defic /physiol MND3.383.871 XUÑEthoxzolamide; ÑFANFT; ÑOxythiamine; ÑRhodanine LH LU; ; ;  MSThose beta-lactam compounds that differ from penicillins in having the thiazolidine sulfur replaced by a carbon, the sulfur then being the first atom in the side chain; it is unstable chemically, but has a very broad antibacterial spectrum; thienamycin and its more stable derivatives are proposed for use in combinations with enzyme blockers. PM83 HN83 MHÑThienamycins ANdo not use /analogs /defic /physiol; /biosyn permitted if by living matter PIAmides (66-73); Antibiotics (66-82); Lactams (74-82) MND20.85.99.915 LH  PM68 HN68 MHÑThiepins ANdo not use /analogs /biosyn /defic /physiol MND3.383.886 LH  PM65 HN65(63) MHÑThiethylperazine ANdo not use /biosyn /defic /physiol RN1420-55-9 MND3.383.606.880; D3.494.741.780; D23.136.852 LH  MHÑThigh ANfor bone use FEMUR; NIM when merely locational as in skin dis (IM); TN 117: use for human & other vertebrates MNA1.378.592.867 LH  MS((o-Carboxyphenyl)thio)ethylmercury sodium salt. Topical antiseptic used on skin and mucous membranes; also used as a preservative in pharmaceuticals. Synonyms: ethylmercurithiosalicylate; Merfamin; Merthiolate; Mertorgan; Merzonin; thiomerosol. HN(75); was see under ETHYL MERCURY COMPOUNDS 1975-79 MHÑThimerosal ANdo not use /biosyn /defic /physiol; /analogs NIM only RN54-64-8 PIBenzoates (74); Ethylmercury Compounds (74); Sulfides (74) MND2.691.750.100.347.850; D20.187.812 XSMercurothiolate; Thiomersal; Thiomersalate DMÑEthylmercury Compounds LH LS; ; LM  MSMental activity, not predominantly perceptual, by which one apprehends some aspect of an object or situation based on past learning and experience. MHÑThinking ANonly /drug eff /physiol /rad eff; transcendental meditation goes under RELAXATION TECHNICS MNF2.463.785 LH  MHÑThinness ANonly Cat C qualif MNC23.888.220.853; G7.553.481.398.828 FXÑEmaciation LH LX  MSTriethylenethiophosphoramide. Very toxic alkylating antineoplastic; causes skin, gastrointestinal, CNS, bone marrow damage. Synonyms: Girostan; NSC 6396; TESPA; Tespamin; Thiotef; Tifosyl; tris(1-aziridinyl) phosphine sulfate. MHÑThio-Tepa ANdo not use /biosyn /defic /physiol RN52-24-4 MND5.723.141.854; D22.204.880 XSThiophosphamide; Thiotepa LH LS;  MSEthanethioamide. Formerly used as a laboratory reagent; it is a potent hepatocarcinogen. Synonyms: Thioacetimidic Acid; Acetothioamide. HN(73) MHÑThioacetamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN62-55-5 MND2.65.64.786; D2.65.900.890; D2.241.81.38.108.786; D2.886.685.800; D26.191.903 XSThiacetamid DMÑAcetamides LH LS LM  MSOrganic compounds containing the radical -CSNH2. HN(75) MHÑThioamides ANdo not use /analogs /biosyn /defic /physiol PIAmides (66-74) MND2.65.900; D2.886.685 DMÑAmides LH LM  MHÑThiobacillus ANin soil, mud, water MNB3.450.828.703 XUÑThiobacillus Thiooxidans LH LU  MSA strictly autotrophic bacterium, oxidizing sulfur and thiosulfate to sulfuric acid. HN(72) MHÑThiobacillus Thiooxidans ANin soil, mud, water PIThiobacillus (66-71) MNB3.450.828.703.703 DMÑThiobacillus LH LM  MSA family of bacteria which oxidize sulfur compounds; found in soil or in water containing such compounds. HN(76)75 MHÑThiobacteriaceae ANin soil & water containing sulfur cpds PIBacteria (66-74) MNB3.450.828 DMÑGram-Negative Chemolithotrophic Bacteria LH LM  MSCompounds in which one or more of the ketone groups on the pyrimidine ring of barbituric acid are replaced by thione groups. PM75 HN75 MHÑThiobarbiturates ANdo not use /analogs /biosyn /defic /physiol PIBarbiturates (66-74) MND3.383.742.698.253.800 LH  PM66 HN66 MHÑThiocarbamates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.251.869; D2.241.866.653; D2.886.703 XUÑDimethyldithiocarbamate; ÑEthylenebis(dithiocarbamates); ÑManeb; ÑThiram; ÑTri-allate; ÑZineb; ÑZiram LH LU; ; ; ; ; ;  MS(2-Mercaptoethyl)trimethylammonium. A reagent for the determination of cholinesterases; acts also as a highly selective nerve stain. HN(75) MHÑThiocholine AND25-26 qualif RN625-00-3 PICholine (66-74); Sulfhydryl Compounds (66-74) MND2.92.102.232.800; D2.675.276.232.800; D26.550.921 DMÑCholine LH LM  MHÑThiocyanates ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.262.703; D1.620.242.703; D1.877.909; D2.241.866.753; D6.347.789.765 XSRhodanates XUÑ1-Naphthylisothiocyanate LH LS LU  MSGalactosides in which the oxygen atom linking the sugar and aglycone is replaced by a sulfur atom. HN(75) MHÑThiogalactosides ANdo not use /analogs PIGalactose (74); Thioglycosides (74) MND9.203.408.320.820; D9.203.408.903.600 XSThiogalactopyranosides DMÑThioglycosides LH LS LM  OLsearch THIOGLYCOSIDES 1974 HN(75) MHÑThioglucosides ANdo not confuse with THIOGLYCOSIDES; do not use /analogs /defic MND9.203.408.348.820; D9.203.408.903.703 XSThioglucopyranosides DMÑThioglycosides LH LS LM  PM70 HN70(64) MHÑThioglycolates ANdo not use /analogs /biosyn /defic /physiol MND2.241.866.853; D2.886.489.828 LH  PM74 HN74 MHÑThioglycosides ANdo not confuse with THIOGLUCOSIDES; do not use /analogs /defic MND9.203.408.903 XUÑGlucosinolates; ÑIsopropyl Thiogalactoside; ÑThiogalactosides; ÑThioglucosides LH LU; ; ;  PM66 HN66(64) MHÑThioguanine ANdo not use /biosyn /defic /physiol RN154-42-7 MND22.204.144.915; D26.87.906 XS6-Thioguanine LH LS  HN(73) MHÑThiohydantoins ANdo not use /analogs /biosyn /defic /physiol MND3.383.374.411.868 DMÑHydantoins LH LM  MS9-beta-D-Ribofuranosyl-9H-purine-6-thiol. Sulfhydryl analog of inosine which inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. HN(75) MHÑThioinosine ANdo not use /biosyn /defic /physiol RN574-25-4 PIInosine (73-74); Mercaptopurine (73-74) MND13.570.583.616.900; D13.570.800.573.900; D13.570.900.800; D26.87.914 XS6-Mercaptopurine Riboside DMÑInosine LH LS LM  PM73 HN73 MHÑThiolester Hydrolases ANdo not use /analogs RNEC 3.1.2. PIEsterases (66-72) MND8.586.277.352.897 XUÑAcetyl CoA Hydrolase; ÑPalmitoyl CoA Hydrolase LH LU;  MHÑThiomalates ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.337.463.703; D2.886.489.891 LH  PM74 HN74 MHÑThiones ANalso ╥thions╙; do not use /analogs /biosyn /defic /physiol MND2.886.753 LH  MSNucleosides in which the base moiety is substituted with one or more sulfur atoms. PM77 HN77 MHÑThionucleosides ANdo not use /analogs PINucleosides (66-76); specific nucleoside MND13.570.900 LH  MSNucleotides in which the base moiety is substituted with one or more sulfur atoms. PM77 HN77 MHÑThionucleotides ANdo not use /analogs PINucleotides (66-76); specific nucleotide MND13.695.900 LH  MHÑThiopental ANdo not use /biosyn /defic /physiol RN76-75-5 MND3.383.742.698.253.800.810; D14.166.111.903; D14.591.220.903 XSPenthiobarbital; Thiomebumal; Thiopentobarbital LH LS; ;  MS4,4'-Phenylenebis(ethyl-3-thioallophanate). Nematocide used in livestock; also has fungicidal properties. Synonyms: Cercobin; Enovit; Nemafax; Topsin. OLuse THIOPHANATE to search THIOPHANATE-METHYL back thru 1975 HN(79); was THIOPHANATE-METHYL see under CARBAMATES 1975-78 MHÑThiophanate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN23564-05-8 PICarbamates (66-74); Phenylthiourea (66-74) MND2.241.81.251.890; D2.886.904.601.900; D2.948.898.601.900; D5.723.288.800 XSDimethylphenylene Bis-Thioallophanate; Thiophanate-Methyl DMÑCarbamates LH LS; LM  MHÑThiophenes ANdo not use /analogs /biosyn /defic /physiol MND3.383.903 XUÑCarticaine; ÑPizotyline; ÑThenoyltrifluoroacetone LH LU; ;  OLsearch ORGANOTHIOPHOSPHORUS COMPOUNDS 1972-74 HN(75) MHÑThiophosphoric Acid Esters ANdo not use /analogs /biosyn /defic /physiol MND2.719.926 DMÑOrganothiophosphorus Compounds LH LM  MHÑThioproperazine ANdo not use /biosyn /defic /physiol RN316-81-4 MND3.494.741.822; D15.236.872.331.628.836 LH  MSA protein composed of about 100 amino acids derived from E. coli which is an important step in the synthesis of deoxyribonucleotides. HN(75) MHÑThioredoxin ANdo not use /analogs /defic /physiol RN52500-60-4 PIBacterial Proteins (68-74) MND12.776.97.900 DMÑBacterial Proteins LH LM  MSNADPH:oxidized thioredoxin oxidoreductase. HN(75) MHÑThioredoxin Reductase (NADPH) ANdo not use /analogs; DF: THIOREDOXIN REDUCTASE RNEC 1.6.4.5 PIBacterial Proteins (72-74); NADH, NADPH Oxidoreductases (74); Oxidoreductases (72-74) MND8.586.682.608.900 DMÑNADH, NADPH Oxidoreductases LH LM  MHÑThioridazine ANdo not use /biosyn /defic /physiol RN50-52-2 MND3.494.741.843; D15.236.872.331.628.858 LH  MHÑThiosemicarbazones ANdo not use /analogs /biosyn /defic /physiol MND2.845.746.703; D2.886.803; D20.338.903 XUÑGloxazone; ÑMethisazone LH LU;  MSPolypeptide-containing antibiotic isolated from a species of Streptomyces in New Mexican soil. Appears to be highly active against gram-positive bacteria. In veterinary medicine, thiostrepton has been used in mastitis caused by gram-negative organisms and in dermatologic disorders. Synonyms: Gargon; Thiactin; Bryamycin. HN(75) MHÑThiostrepton ANdo not use /defic /physiol; /analogs NIM only RN1393-48-2 PIAntibiotics (71-74); Peptides (71-74) MND20.85.882 DMÑAntibiotics LH LM  MSThiosulfate:cyanide sulfurtransferase. Catalyzes the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion. HN(75) MHÑThiosulfate Sulfurtransferase ANdo not use /analogs RNEC 2.8.1.1 PICyanides (73-74); Sulfurtransferases (72-74); Thiosulfates (72-74) MND8.586.913.820.900 XSRhodanese; Thiosulfate Cyanide Transsulphurase DMÑSulfurtransferases LH LS; LM  MHÑThiosulfates ANdo not use /analogs /biosyn /defic /physiol MND1.248.497.158.845.703; D1.877.814.539.868 XUÑTetrathionic Acid LH LU  OLsearch SULFONIC ACIDS 1968-74 HN(75) MHÑThiosulfonic Acids ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.865.704; D1.877.606.704; D2.241.866.540.854; D2.886.610.854 DMÑSulfonic Acids LH LM  OLsearch SULFURIC ACIDS 1968-74 HN(75) MHÑThiosulfuric Acid Esters ANdo not use /analogs /biosyn /defic /physiol MND1.29.260.890.829; D1.877.814.854; D2.886.830; D2.241.866.900 DMÑSulfuric Acids LH LM  PM73 HN73(70) MHÑThiothixene ANdo not use /biosyn /defic /physiol RN5591-45-7 PITranquilizing Agents (66-69); Xanthenes (66-69) MND3.494.953.704.787; D15.236.872.331.898 LH  MS2-Mercapto-4-hydroxypyrimidine. Occurs in seeds of Brassica and Crucifera species; has been used as antithyroid, coronary vasodilator and in congestive heart failure; known to cause blood dyscrasias and suspected of terato- and carcinogenesis. Synonyms: Antagothyroil; Deracil; Noliben. MHÑThiouracil ANdo not use /biosyn /defic /physiol RN141-90-2 MND3.383.742.698.875.842; D6.347.789.829; D26.87.917 LH  MHÑThiourea ANdo not use /biosyn /defic /physiol MND2.886.904; D2.948.898; D6.347.789.891 XUÑBurimamide; ÑGuanylthiourea; ÑIsothiuronium; ÑMethallibure; ÑMetiamide; ÑNoxythiolin LH LU; ; ; ; ;  PM74 HN74(72) MHÑThiouridine ANdo not use /biosyn /defic /physiol RN13957-31-8 PIUridine (66-71) MND13.570.685.852.829; D13.570.800.892.829; D13.570.900.829; D26.87.920 LH  PM74; CLOPENTHIXOL was see under TRANQUILIZING AGENTS 1967-74 HN74 MHÑThioxanthenes ANdo not use /analogs /biosyn /defic /physiol MND3.494.953.704 XUÑClopenthixol; ÑFlupenthixol; ÑHycanthone LH LU; ;  HN(66) MHÑThiram ANdo not use /biosyn /defic /physiol; /analogs NIM only RN137-26-8 MND2.241.81.251.869.210.800; D2.241.866.653.210.800; D2.886.703.210.800; D5.723.288.829; D20.136.720; D20.187.839 DMÑThiocarbamates LH LM  MSA drive stemming from a physiological need for water. MHÑThirst ANonly /drug eff /physiol /rad eff MNF1.658.293.787 FXÑDehydration; ÑWATER DEPRIVATION LH LX;  MSArteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles, mammary gland and the axillary aspect of the chest wall. MHÑThoracic Arteries ANdo not use /blood supply MNA7.231.114.891 XUÑMammary Arteries LH LU  MHÑThoracic Diseases ANGEN: prefer specifics; chest pain: index under THORAX (IM) + PAIN (IM) MNC23.304.898 LH  OLuse THORACIC DUCT to search CISTERNA CHYLI back thru 1966 HNCISTERNA CHYLI was see under THORACIC DUCT 1963-78 MHÑThoracic Duct MNA15.382.520.869 XSCisterna Chyli LH LS  MHÑThoracic Injuries ANGEN or unspecified only: prefer specifics like HEART INJURIES, LUNG /inj, etc.; consider also /inj with specific parts of the chest MNC21.866.891 XUÑFlail Chest LH LU  MHÑThoracic Neoplasms ANGEN or unspecified only; prefer specifics like HEART NEOPLASMS, LUNG NEOPLASMS, etc; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.894 LH  OLuse THORACIC NERVES to search PECTORAL NERVES back thru 1966 HNPECTORAL NERVES was see under THORACIC NERVES 1963-78 MHÑThoracic Nerves ANdo not use /innerv MNA8.796.828.854 XSPectoral Nerves XUÑIntercostal Nerves LH LS LU  MSCompression of the brachial plexus nerve trunks due to a variety of anomalies at the superior thoracic outlet such as cervical rib (CERVICAL RIB SYNDROME), abnormal scalene muscles, first rib abnormalities, and fibrous bands. OLuse THORACIC OUTLET SYNDROME to search SCALENUS ANTICUS SYNDROME back thru 1966 PM83; was SCALENUS ANTICUS SYNDROME 1963-82 HN83; was SCALENUS ANTICUS SYNDROME 1963-82 MHÑThoracic Outlet Syndrome MNC10.772.491.915 XSScalenus Anticus Syndrome XUÑCervical Rib Syndrome LH LS LU  MHÑThoracic Radiography ANGEN only: not a synonym for LUNG /radiogr; only for ╥thoracic╙ when the enclosed organs are not specified or are irrelevant & for THORAX /radiogr; do not use as coord with lung, heart, bronchial, etc. diseases when /radiogr with the specific organ or chest dis is given; do not use /util except by MeSH definition; MASS CHEST X-RAY also exists MNE1.818.870 LH  MSA surgical specialty concerned with diagnosis and treatment of disorders of the heart, lungs and esophagus. Two major types of thoracic surgery are classified as pulmonary and cardiovascular. Use also for technics of thoracic surgery in general. OLto search THORAX /SU use THORACIC SURGERY back thru 1966 (with no qualif 1966-79) PM80; was THORAX /surgery 1966-79 HN80; was THORAX /surgery 1966-79 & SURGERY, THORACIC (NON MESH) before 1980 MHÑThoracic Surgery ANSPEC: SPEC qualif; also for thoracic surg, the procedure, GEN only: do not use for surg of specific thoracic organs ( = LUNG /surg, HEART SURGERY, ESOPHAGUS /surg, etc.) or specific thoracic dis ( = disease /surg) MNE4.920; G2.403.810.803 LH  MHÑThoracic Vertebrae ANdo not use as site to locate intraspinal inject or spinal cord inj: restrict to thorac vert as the bones themselves; inflammation = THORACIC VERTEBRAE (IM) + SPONDYLITIS (IM) MNA2.835.232.834.892 LH  MHÑThoracoplasty ANdo not use /util except by MeSH definition MNE4.920.910 LH  MSEndoscopic examination of the pleural cavity. Syn: pleural endoscopy. MHÑThoracoscopy ANNIM; do not use /util except by MeSH definition MNE1.418.910 LH  OLsearch THORAX /SU under THORACIC SURGERY back thru 1966 PM/surgery ( = THORACIC SURGERY as of 1980) was used for indexing 1966-79 HN/surgery was used for indexing 1966-79 MHÑThorax AN/radiogr = THORACIC RADIOGRAPHY (see note there); /surg = THORACIC SURGERY (see note there); /inj = THORACIC INJURIES; ╥intrathoracic╙ could be THORAX or HEART or LUNG or RIBS: check text; chest pain = CHEST PAIN; stethoscope: index under AUSCULTATION /instrum or HEART AUSCULTATION /instrum MNA1.911; A2.835.232.904 XSCHEST LH LS  MHÑThorium ANnaturally radioactive; IM; Manual 25.94; do not use /analogs /biosyn /defic /physiol RN7440-29-1 MND1.287.906; D1.552.517.889 LH  PM65 HN65 MHÑThorium Dioxide AND25-26 qualif RN1314-20-1 MND1.552.517.889.705; D1.655.498.916; D26.298.916 XSThorium Oxide LH LS  MHÑThreonine AN/biosyn /defic /physiol permitted MND12.125.142.815; D12.125.901 XUÑPhosphothreonine LH LU  MSL-Threonine hydro-lyase(deaminating). A pyridoxal-phosphate protein which catalyzes the deamination of threonine to 2-ketobutyrate and ammonia. The role of this enzyme can be biosynthetic or biodegradative. In the former role it supplies 2-ketobutyrate required for isoleucine biosynthesis, while in the latter it is only involved in the breakdown of threonine to supply energy. PM78; was see under HYDRO-LYASES 1975-77 HN78(75); was see under HYDRO-LYASES 1975-77 MHÑThreonine Dehydratase ANdo not use /analogs RNEC 4.2.1.16 PIHydro-Lyases (66-74); Threonine (66-74) MND8.586.520.497.820 XSThreonine Deaminase; Threonine Dehydrase LH LS;  MSL-Threonine:tRNA-Thr ligase (AMP-forming). Activates threonine with its specific transfer RNA. HN(75) MHÑThreonyl T RNA Synthetase ANdo not use /analogs; note spacing RNEC 6.1.1.3 PIAmino Acyl T RNA Synthetases (73-74); Threonine (73-74) MND8.586.464.136.780 DMÑAmino Acyl T RNA Synthetases LH LM  MSA congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, expecially ADP, and impaired or absent clot retraction. HN(86) MHÑThrombasthenia PIBlood Platelet Disorders (67-85) MNC15.378.463.205.810 XSGlanzmann Thrombasthenia DMÑBlood Platelet Disorders LH LS LM  MSUse of a thrombelastograph, which provides a continuous graphic record of the physical shape of a clot during fibrin formation and subsequent lysis. MHÑThrombelastography ANdo not use /util except by MeSH definition MNE1.223.459.153.830 XSThromboelastography LH LS  MHÑThrombin ANdo not use /analogs /blood; /antag permitted: not same as ANTITHROMBINS; thrombotest goes under PROTHROMBIN TIME RNEC 3.4.21.5 MND8.586.277.656.732.855; D12.776.124.125.885; D19.461.270.463.843 XSTHROMBASE LH LS  MSTest of the conversion of fibrinogen to fibrin by thrombin in which clotting time of plasma mixed with a thrombin solution is measured. Time is prolonged by afibrinogenemia, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, heparin. Reptilase, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin. HN(80) MHÑThrombin Time ANNIM; only /vet; thrombotest goes under PROTHROMBIN TIME PIBlood Coagulation Tests (66-79); Fibrinogen (66-79); Thrombin (66-79) MNE1.223.459.153.870 XSReptilase Time DMÑBlood Coagulation Tests LH LS LM  MHÑThromboangiitis Obliterans ANTN 11: differentiate from other obliterative dis MNC14.907.137.870; C14.907.940.905 XSBUERGER'S DISEASE LH LS  MSA clinical syndrome characterized by repeated spontaneous hemorrhages, and a remarkable increase in the number of circulating platelets. OLuse THROMBOCYTHEMIA, HEMORRHAGIC to search HEMORRHAGIC THROMBOCYTHEMIA back thru 1966 (as Prov 1966) PM86; was HEMORRHAGIC THROMBOCYTHEMIA 1967-85 HN86; was HEMORRHAGIC THROMBOCYTHEMIA 1963-85 (Prov 1963-66) MHÑThrombocythemia, Hemorrhagic MNC15.378.190.636.825; C15.378.463.205.825 XSHemorrhagic Thrombocythemia; LEUKEMIA, MEGAKARYOCYTIC; Thrombocythemia, Essential; Thrombocythemia, Idiopathic; Thrombocythemia, Primary LH LS; ; ; ;  MSDecrease in the number of blood platelets. OLuse THROMBOCYTOPENIA to search THROMBOPENIA back thru 1966 PM85; was THROMBOPENIA 1963-84 HN85; was THROMBOPENIA 1963-84 MHÑThrombocytopenia MNC15.378.463.205.855 XSThrombopenia LH LS  PM67 HN67(63) MHÑThrombocytosis AN= thrombocythemia but hemorrhagic thrombocythemia = THROMBOCYTHEMIA, HEMORRHAGIC MNC15.378.190.636.899 LH  MHÑThromboembolism ANpulmonary thromboembolism = PULMONARY EMBOLISM MNC14.907.854 LH  MSInflammation of a vein associated with thrombus formation. OLuse THROMBOPHLEBITIS to search PHLEGMASIA ALBA DOLENS back thru 1966 HNPHLEGMASIA ALBA DOLENS was see under THROMBOPHLEBITIS 1963-78 MHÑThrombophlebitis ANassume to be of the legs so do not coord with LEG; venous thrombosis unspecified = THROMBOPHLEBITIS but thrombosis of a specific vein = the vein (IM) + THROMBOSIS (IM), like renal vein thrombosis: RENAL VEINS (IM) + THROMBOSIS (IM) MNC14.907.681.788; C14.907.854.830.788; C14.907.940.740.910 XSPhlegmasia Alba Dolens; THROMBOSIS, VENOUS; VENOUS THROMBOSIS LH LS; ;  MHÑThromboplastin ANdo not use /blood RN9035-58-9 MND12.776.124.125.900; D19.461.270.229.901; D19.461.270.463.899 XSFactor III; Tissue Factor LH LS;  HN(66); was see under BLOOD PLATELETS 1975 MHÑThrombopoietin ANonly /anal /genet /immunol /metab /physiol /rad eff RN9014-42-0 MND12.776.395.720; D24.185.861 DMÑGlycoproteins LH LM  MHÑThrombosis AN╥venous thrombosis╙: see note on THROMBOPHLEBITIS; mural thrombus: coord IM with HEART DIS (IM); also available are CEREBRAL EMBOLISM AND THROMBOSIS, CAROTID ARTERY THROMBOSIS, CORONARY THROMBOSIS, SINUS THROMBOSIS, HEPATIC VEIN THROMBOSIS & RETINAL VEIN THROMBOSIS MNC14.907.854.830 LH  MSAn unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). PM86; was see under THROMBOXANES 1978-85 HN86(78); was see under THROMBOXANES 1978-85 MHÑThromboxane A2 AN/biosyn /physiol permitted RN57576-52-0 PIFatty Acids, Unsaturated (73-74); Hydroxy Acids (75-77); Pyrans (66-77) MND2.241.81.436.880.800; D10.516.251.355.880.800; D24.185.798.924.45 XSRabbit Aorta Contracting Substance LH LS  MS8-(1-Hydroxy-3-oxopropyl)-9,12L-dihydroxy-5,10-heptadecadienoic acid, hemiacetal. A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). PM86; was see under THROMBOXANES 1978-85 HN86(78); was see under THROMBOXANES 1978-85 MHÑThromboxane B2 AN/biosyn /physiol permitted RN54397-85-2 PIFatty Acids, Unsaturated (73-74); Hydroxy Acids (75-77); Pyrans (66-77) MND2.241.81.436.880.820; D10.516.251.355.880.820; D24.185.798.924.124 LH  MSAn enzyme found predominately in platelet microsomes. Catalyzes the conversion of PGG(2) and PGH(2) (prostaglandin endoperoxides) to thromboxane A2. EC 1.-. PM86; was see under OXIDOREDUCTASES 1978-85 HN86(78); was see under OXIDOREDUCTASES 1978-85 MHÑThromboxane Synthetase ANfound in platelet microsomes; do not use /analogs RNEC 5.3.99.5 PIHydroxy Acids (75-77); Oxidoreductases (66-77); Pyrans (66-77) MND8.586.399.910 XSThromboxane A Synthase LH LS  MSPhysiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides. PM78 HN78 MHÑThromboxanes AN╥formed in vivo from the prostaglandin endoperoxides╙; /biosyn /physiol permitted; do not use /analogs PIFatty Acids, Unsaturated (73-74); Hydroxy Acids (75-77); Pyrans (66-77) MND2.241.81.436.880; D10.516.251.355.880; D24.185.798.924 LH  MHÑThulium ANTm-169; do not use /analogs /biosyn /defic /physiol; Tm-161-168, 170-176 = THULIUM (IM) + RADIOISOTOPES (IM) RN7440-30-4 MND1.268.887; D1.552.550.889 LH  MHÑThumb ANprimates only; /inj permitted: do not convert to FINGER INJURIES MNA1.378.209.455.430.705 LH  PM65 HN65(64) MHÑThymectomy ANdo not use /util except by MeSH definition MNE4.920.940 LH  MSA thymus-dependent nonapeptide found in normal blood. Stimulates the formation of E rosettes and is believed to be involved in T-cell differentiation. HN(80) MHÑThymic Factor, Circulating AN/biosyn /physiol permitted; do not use /blood; /analogs NIM only RN78922-62-0 PIHormones (66-76); Oligopeptides (73-79); Peptides (66-72); Thymus Gland (66-76); Thymus Hormones (77-79) MND6.472.910.750; D12.644.456.835 XSFacteur Thymique Serique; Serum Thymic Factor DMÑThymus Hormones LH LS; LM  MHÑThymidine AN/biosyn /physiol permitted; ╥tritiated thymidine╙ as a research technic is probably NIM if indexed at all RN50-89-5 MND13.570.230.855; D13.570.685.705 XUÑTrifluorothymidine LH LU  PM65 HN65 MHÑThymidine Kinase ANdo not use /analogs RNEC 2.7.1.21 MND8.586.913.696.729.905 XSDeoxythymidine Kinase LH LS  MS5-Thymidylic acid. A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety. Synonym: DTMP; TMP. OLto search THYMIDYLIC ACIDS use THYMIDINE MONOPHOSPHATE back thru 1975, THYMINE NUCLEOTIDES 1972-74 & NUCLEOTIDES 1966-71 HN(78); was THYMIDYLIC ACIDS see under THYMINE NUCLEOTIDES 1972-77, was THYMIDYLIC ACIDS see under NUCLEOTIDES 1963-71 MHÑThymidine Monophosphate AN/biosyn /physiol permitted; /analogs NIM only RN365-07-1 PINucleotides (66-71); Thymine Nucleotides (72-74) MND13.695.201.789.788; D13.695.740.706.788 XSDTMP; TMP; Thymidylic Acid DMÑThymine Nucleotides LH LS; ; LM  MSThymidine:orthophosphate deoxyribosyltransferase. Catalyzes the transfer of 2-deoxy-D-ribose from thymidine to orthophosphate, liberating thymine. HN(75) MHÑThymidine Phosphorylase ANdo not use /analogs RNEC 2.4.2.4 PIPentosyltransferases (73-74); Phosphates (73-74); Thymidine (73-74) MND8.586.913.647.900 DMÑPentosyltransferases LH LM  PM86; was see under METHYLTRANSFERASES 1975-85 HN86(73); was see under METHYLTRANSFERASES 1975-85, was Prov 1973-74 MHÑThymidylate Synthetase ANdo not use /analogs RNEC 2.1.1.45 PILigases (66-70); Methyltransferases (71-72); Transferases (69-72) MND8.586.913.517.855 LH  MHÑThymine AN/biosyn /physiol permitted; thymine deoxyriboside, thymine deoxyribonucleoside = THYMIDINE RN65-71-4 MND3.383.742.698.875.899 LH  OLto search THYMIDINE PHOSPHATES use THYMINE NUCLEOTIDES back thru 1972, THYMINE NUCLEOTIDES & NUCLEOTIDES 1971 & NUCLEOTIDES 1966-70 PM72; THYMIDINE PHOSPHATES was see under NUCLEOTIDES 1963-71; THYMIDINE MONOPHOSPHATE was THYMIDYLIC ACIDS see under NUCLEOTIDES 1963-71 HN72(71); THYMIDINE PHOSPHATES was see under NUCLEOTIDES 1963-71 MHÑThymine Nucleotides AN/biosyn /physiol permitted; do not use /analogs PINucleotides (66-70); Thymine (66-70) MND13.695.201.789; D13.695.740.706 XSThymidine Phosphates XUÑThymidine Monophosphate LH LS LU  MHÑThymol ANdo not use /biosyn /defic /physiol RN89-83-8 MND2.455.849.856 XUÑBromthymol Blue LH LU  MS5',5''-Diisopropyl-2',2''-dimethylphenolphthalein. Used as a pH indicator and as a reagent for blood after decolorizing the alkaline solution by boiling with zinc dust. HN(75) MHÑThymolphthalein AND25-26 qualif; /analogs NIM only RN125-20-2 PIPhenolphthaleins (69-74) MND26.408.646.600.810; D26.550.620.810 DMÑPhenolphthaleins LH LM  MHÑThymoma ANbenign or malignant; coord IM with THYMUS NEOPLASMS (IM); /anal /blood supply /secret /ultrastruct permitted; also called ╥thymic carcinoma╙ MNC4.557.537.916 LH  MSTwo closely related polypeptides (molecular weight 7,000) isolated from the thymus gland. These hormones induce the differentiation of prothymocytes to thymocytes within the thymus. They also cause a delayed impairment of neuromuscular transmission in vivo and are therefore believed to be the agent responsible for myasthenia gravis. HN(77) MHÑThymopoietins AN/biosyn /physiol permitted; do not use /analogs; do not confuse THYMINS (see X below) with THYMINE PIHormones (66-76); Thymus Extracts (74); Thymus Gland (66-76) MND6.472.910.800 XSThymins DMÑThymus Hormones LH LS LM  MSA carbohydrate and lipid-free protein (molecular weight 12,600) secreted by the thymus gland. Its biological activities include lymphocytopoiesis, restoration of immunological competence and enhancement of expression of T-cell characteristics and function. Has therapeutic potential in patients having primary or secondary immunodeficiency diseases, cancer or diseases related to aging. PM84; was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76 HN84(75); was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76 MHÑThymosin AN/biosyn /physiol permitted RN61512-21-8 PIGlycoproteins (73-74); Thymus Extracts (74); Thymus Gland (73-74); Tissue Extracts (73-74) MND6.472.910.850 LH  PM73 HN73(72) MHÑThymoxamine ANdo not use /biosyn /defic /physiol RN54-32-0 PICarvacrol (66-71); Sympatholytics (66-71) MND2.455.849.182.706; D16.848.115.768 XSMoxisylyte; Thymoxyalcylamine LH LS;  MSExtracts of the thymus that contain specific, but uncharacterized factors or proteins with specific activities; three distinct substances are already known: thymotoxin, thymin and thymosin. PM74 HN74 MHÑThymus Extracts ANextracts of thymus or thymus fractions containing uncharacterized factors; do not confuse with chemical substances ╥extracted╙ from the thymus, as ╥peptides extracted from the mouse thymus╙ ( = PEPTIDES /anal + THYMUS GLAND /anal); do not use /analogs /biosyn /blood-csf-urine /defic /diag use /physiol MND24.185.893.871 LH  MHÑThymus Gland ANdis: coord IM with LYMPHATIC DISEASES (NIM); /surg: probably THYMECTOMY; thymocyte in immunol context is probably T-LYMPHOCYTES; agenesis, aplasia, dysplasia = DIGEORGE SYNDROME; thymic cyst: index under MEDIASTINAL CYST MNA15.382.520.604.811 FXÑBursa of Fabricius; ÑLymphoid Tissue LH LX;  MSHumoral factors secreted by the thymus gland. They participate in the development of the lymphoid system and the maturation of the cellular immune response. PM77 HN77 MHÑThymus Hormones AN/biosyn /physiol permitted; do not use /analogs PIHormones (66-76); Thymus Gland (66-76) MND6.472.910 XSThymic Hormones XUÑThymic Factor, Circulating; ÑThymopoietins LH LS LU;  MHÑThymus Hyperplasia MNC15.604.816 LH  MHÑThymus Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.322.831; C15.604.861 LH  MHÑThyroglobulin AN/biosyn /physiol permitted RN9010-34-8 MND12.776.377.856; D12.776.395.768; D12.776.486.706 FXÑThyroid Hormones LH LX  MHÑThyroglossal Cyst AN/anal /blood supply /secret /ultrastruct permitted; also called ╥thyroglossal duct cyst╙; ╥thyroglossal duct╙ probably goes here MNC4.182.902 LH  OLuse THYROID ANTAGONISTS to search GOITROGENS 1966 PMGOITROGENS was heading 1963-66 HNGOITROGENS was heading 1963-66 MHÑThyroid Antagonists ANdo not use /analogs /antag /biosyn /defic /physiol; DF: THYROID ANTAG MND6.347.789 XSANTITHYROID DRUGS; Goitrogens LH LS;  MSThe largest cartilage of the larynx consisting of two laminae fusing anteriorly at an acute angle in the midline of the neck. The point of fusion forms a subcutaneous projection known as the Adam's apple. HN(79) MHÑThyroid Cartilage ANa laryngeal cartilage: nothing to do with THYROID GLAND; ╥Adam's apple╙ goes here PILaryngeal Cartilages (66-78) MNA2.165.507.870; A4.329.591.870 DMÑLaryngeal Cartilages LH LM  MSSudden and dangerous increase of the symptoms of thyrotoxicosis. MHÑThyroid Crisis AN╥sudden & dangerous increase of the symptoms of thyrotoxicosis╙ MNC19.874.902.905 XSThyroid Storm; Thyrotoxic Crisis; Thyrotoxic Storm LH LS; ;  MHÑThyroid Diseases ANGEN; inflamm dis = THYROIDITIS; thyroid crisis & thyroid storm = THYROID CRISIS; thyroid nodule = THYROID DISEASES unless text says neoplastic ( = THYROID NEOPLASMS); chronic thyroiditis = THYROIDITIS, CHRONIC see THYROIDITIS, AUTOIMMUNE; subacute thyroiditis = THYROIDITIS, SUBACUTE; suppurative or infect thyroiditis = THYROIDITIS, SUPPURATIVE MNC19.874 LH  OLuse THYROID FUNCTION TESTS to search THYROID GLAND FUNCTION TESTS back thru 1966 PM77,63-67; was THYROID GLAND FUNCTION TESTS 1968-76 HN77,63-67; was THYROID GLAND FUNCTION TESTS 1968-76 MHÑThyroid Function Tests ANonly /instrum /methods /vet MNE1.197.882 LH  MSA highly vascular endocrine gland consisting of two lobes, one on either side of the trachea, joined by a narrow isthmus; it produces the thyroid hormones which are concerned in regulating the metabolic rate of the body. MHÑThyroid Gland AN/surg: probably THYROIDECTOMY; inflammation = THYROIDITIS; thyroid nodule: index under THYROID DISEASES unless text says neoplastic ( = THYROID NEOPLASMS) MNA6.407.900 FXÑSTRUMA OVARII; ÑULTIMOBRANCHIAL BODY LH LX;  OLsearch THYROID HORMONES 1968-74 HN(75) MHÑThyroid Gland, Desiccated ANnote category; do not use /analogs /biosyn /defic /physiol MND6.472.931.669 DMÑThyroid Hormones LH LM  MHÑThyroid Hormones ANGEN; do not use /analogs; T3 = TRIIODOTHYRONINE, T4 = THYROXINE; /defic: consider also HYPOTHYROIDISM MND6.472.931 FXÑTHYROGLOBULIN XUÑThyroid Gland, Desiccated LH LX LU  MHÑThyroid Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); neoplastic thyroid nodule goes here, non-neopl goes under THYROID DISEASES MNC4.588.322.894; C4.588.443.915; C19.874.788 LH  MHÑThyroidectomy ANdo not use /util except by MeSH definition MNE4.779.856 LH  MHÑThyroiditis ANGEN or unspecified: prefer specifics MNC19.874.871 XUÑThyroiditis, Suppurative LH LU  MSProgressive enlargement of the thyroid gland, often associated with hypothyroidism. OLuse THYROIDITIS, AUTOIMMUNE to search THYROIDITIS, LYMPHOMATOUS back thru 1966 PM87; was THYROIDITIS, LYMPHOMATOUS 1963-86 HN87; was THYROIDITIS, LYMPHOMATOUS 1963-86 MHÑThyroiditis, Autoimmune MNC19.874.871.102; C20.111.809 XSAutoimmune Thyroiditis; HASHIMOTO'S DISEASE; Thyroiditis, Chronic; Thyroiditis, Lymphocytic; Thyroiditis, Lymphomatous LH LS; ; ; ;  MSSpontaneously remitting inflammatory condition of the thyroid gland characterized by fever, weakness, sore throat, and painful enlargement of the thyroid gland. PM87 HN87 MHÑThyroiditis, Subacute ANdo not confuse X ref DE QUERVAIN THYROIDITIS with de Quervain's dis of tendon sheath of thumb muscles ( = TENOSYNOVITIS) PIThyroiditis (66-86) MNC19.874.871.900 XSDe Quervain Thyroiditis LH LS  MSInflammatory disease of the thyroid gland caused by bacteria, fungi, protozoa, or flatworms. HN(87) MHÑThyroiditis, Suppurative ANcoord IM with specific infect causing this dis (IM) PISuppuration (66-86); Thyroiditis (66-86) MNC1.539.840; C19.874.871.910 XSThyroiditis, Infectious DMÑThyroiditis LH LS LM  OLuse THYRONINES to search THYRONINE back thru 1966 PM79; was THYRONINE 1963-78 HN79; was THYRONINE 1963-78 MHÑThyronines AN/biosyn /physiol permitted; do not use /analogs MND6.472.931.812.741; D12.125.72.734.741 XUÑDiiodothyronines LH LU  MSThe clinical syndrome that reflects the response of the peripheral tissues to an excess of thyroid hormone. OLsearch HYPERTHYROIDISM 1974-86 PM87; was see HYPERTHYROIDISM 1974-86 HN87; was see HYPERTHYROIDISM 1974-86 MHÑThyrotoxicosis PIHyperthyroidism (66-86) MNC19.874.902 LH  MHÑThyrotropin AN/biosyn /physiol permitted RN9002-71-5 MND6.472.734.525.883; D12.776.641.650.810 XSTHYROID STIMULATING HORMONE; TSH LH LS;  OLuse THYROTROPIN RELEASING HORMONE to search THYROTROPIN RELEASING FACTOR back thru 1968 PM74; was THYROTROPIN RELEASING FACTOR 1968-73 HN74; was THYROTROPIN RELEASING FACTOR 1968-73 MHÑThyrotropin Releasing Hormone AN/biosyn /physiol permitted; DF: TRH RN24305-27-9 PIHypothalamo-hypophyseal System/PH (66-67); Thyrotropin/BI (66-67); Thyrotropin/ME (66-67) MND6.472.709.872; D12.644.456.837; D12.776.641.650.820 XSThyroliberin LH LS  PM65; was THYROXIN 1963-64; LEVOTHYROXINE was heading 1963-65 HN65; was THYROXIN 1963-64; LEVOTHYROXINE was heading 1963-65 MHÑThyroxine AN/biosyn /physiol permitted; /blood: consider also HYPERTHYROXINEMIA; note entries below on D-THYROXINE & L-THYROXINE; T4 is THYROXINE RN7488-70-2 MND6.472.931.812; D12.125.72.734 XSL-Thyroxine; Levothyroxine LH LS;  PM66 HN66(65) MHÑThyroxine-Binding Protein ANdo not use /blood; includes thyroxine-binding albumin, globulin, prealbumin, etc.; coord with specific protein (IM) if pertinent but not with SERUM GLOBULINS nor with its indentions MND12.776.34.841.832; D12.776.124.727.832; D12.776.124.790.106.832; D12.776.377.715.85.832; D12.776.395.832 FXÑPROTEIN-BOUND IODINE TEST; ÑProtein Binding LH LX;  MSN-[2-(Diethylamino)ethyl]-5-(methylsulfonyl)- o-anisamide. Benzamide derivative proposed for use in behavior problems of alcoholics, in dyskinesias and other functional abnormalities of the CNS; also as major tranquilizer. Synonyms: FLO 1347; Thiapride; Tiapridal. HN(80) MHÑTiapride ANdo not use /biosyn /defic /physiol; /analogs NIM only RN51012-32-9 PIAmides (66-72); Benzamides (73-79); Benzoates (66-72) MND2.65.277.882; D2.241.223.106.162.882; D15.236.872.331.917 DMÑBenzamides LH LM  MHÑTibia AN/inj: consider also TIBIAL FRACTURES; avoid TIBIA /metab, TIBIA /anal etc. when BONE AND BONES /metab etc. is meant MNA2.835.232.484.883 LH  MHÑTibial Fractures MNC21.866.405.829; C21.866.558.857 LH  PM72 HN72(71) MHÑTibial Nerve ANdo not use /innerv PISpinal Nerves (66-70) MNA8.796.828.569.785.790 LH  MS2-Chloro-5-[(cis-3,5-dimethylpiperidino)sulfonyl]benzoic acid. An antilipemic agent which is especially effective in lowering triglyceride levels in type IV hyperlipoproteinemia. The drug is not very effective in lowering cholesterol levels. Synonyms: CP 18,524; Exirel. HN(79) MHÑTibric Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN37087-94-8 PIBenzoates (66-75); Piperidines (66-78); Sulfones (66-75) MND3.383.621.880; D10.162.900 DMÑPiperidines LH LM  MSAny brief, recurrent, inappropriate, irresistible movement involving a relatively small segment of the body; also known as habit spasm or habit contraction. MHÑTic ANnote TIC DOULOUREUX below MNC10.597.559.860; C23.888.592.574.837; F3.126.720.894 LH  MS6-(2-Carboxy-2-(3-thienyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid disodium salt. An antibiotic derived from penicillin similar to carbenicillin in action. HN(75) MHÑTicarcillin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN34787-01-4 PICarboxylic Acids (73-74); Penicillins (73-74); Thiophenes (73-74) MND20.85.99.739.916 XSBRL 2288 DMÑPenicillins LH LS LM  PM73 HN73 MHÑTick Control ANonly /econ /hist /instrum /methods; chemicals killing or controlling ticks are indexed under INSECTICIDES, not PESTICIDES even though ticks are not insects; mite control can go here as MITES (IM) + TICK CONTROL (IM) PIInsect Control (66-72); Ticks (66-72) MNG3.850.180.600.610 LH  MSInfestations with soft-bodied (Argasidae) or hard-bodied (Ixodidae) ticks. PM68 HN68 MHÑTick Infestations PITicks (66-67) MNC3.211.857 LH  MSParalysis caused by a neurotropic toxin secreted by the salivary glands of ticks. OLsearch TICK TOXICOSES 1968-74 HN(75) MHÑTick Paralysis ANsee note under TICKS MNC21.613.127.857.707 DMÑTick Toxicoses LH LM  MSToxicoses caused by toxic substances secreted by the salivary glands of ticks; include tick paralysis (neurotropic toxin), sweating sickness (dermotropic toxin), and Rhipicephalus appendiculatus toxicosis (leukotropic toxin). PM68 HN68 MHÑTick Toxicoses ANsee note under TICKS PITicks (66-67) MNC21.613.127.857 XUÑTick Paralysis LH LU  MHÑTicks ANtick bites = TICKS + BITES AND STINGS, not TICK TOXICOSES nor TICK PARALYSIS unless toxicoses or paralysis results; tick vectors = ARACHNID VECTORS (IM) + TICKS (IM); /microbiol /parasitol permitted; infection = TICK INFESTATIONS; for chemicals for killing or controlling ticks use INSECTICIDES even though ticks are not insects MNB1.131.166.132.832 XUÑDermacentor LH LU  MS5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c) pyridine. Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis. PM87 HN87 MHÑTiclopidine ANdo not use /biosyn /defic /physiol RN55142-85-3 PIThiophenes (66-86) MND3.383.903.834; D19.461.119.945 LH  MS2,3-Dichloro-4-(2-thienylcarbonyl)phenoxyacetic acid. Novel diuretic with uricosuric action; proposed as an antihypertensive agent. Synonyms: ANP 3624; SKF 62698; thienylic acid. HN(80) MHÑTicrynafen ANdo not use /biosyn /defic /physiol; /analogs NIM only RN40180-04-9 PIPhenoxyacetates (66-79); Thiophenes (66-79) MND2.241.511.316.682.900; D3.383.903.840; D18.162.891; D19.770.224.891 XSTienilic Acid DMÑGlycolates LH LS LM  MSThe volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are TV or V with suscript T. HN(75) MHÑTidal Volume ANNIM; in texts as TV or Vt MNE1.302.796.420.920 DMÑLung Volume Measurements LH LM  MHÑTietze's Syndrome MNC5.182.790; C23.205.182.790 LH  MS2-(Ethylamino)-2-(2-thienyl)cyclohexanone hydrochloride. Proposed anesthetic with possible anticonvulsant and sedative properties. Synonyms: CI 364; CL 399. HN(75) MHÑTiletamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN14176-49-9 PICyclohexanes (72-74); Ethylamines (72-74); Thiophenes (72-74) MND2.455.426.392.368.367.850; D2.522.400.850; D3.383.903.850; D14.166.60.914 DMÑCyclohexanes LH LM  MS2-(Dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester. Proposed analgesic; may depress respiration; used as the hydrochloride. Synonyms: Perdolat; Valoron; GO 1261 C; W 5759 A. HN(75) MHÑTilidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN20380-58-9 PICyclohexanecarboxylic Acids (71-74); Dimethylamines (74) MND2.241.223.268.825; D14.73.935 XSTilidate DMÑCyclohexanecarboxylic Acids LH LS LM  MS2,7-Bis[2-(diethylamino)ethoxy]fluoren-9-one dihydrochloride. Antiviral agent and interferon inducer; also may have anti-neoplastic action. HN(75) MHÑTilorone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN27591-97-5 PIDiethylamines (74); Fluorenes (71-74) MND4.615.389.850; D20.388.643.493.895 XSBis-DEAE-Fluorenone DMÑFluorenes LH LS LM  MHÑTime ANIM as the abstraction; no qualif; do not confuse with TIME FACTORS, the NIM coord aspect of a given subject; ╥diurnal╙ & ╥nocturnal╙: consider preferably CIRCADIAN RHYTHM MNH1.862 XUÑTime Factors LH LU  MSThe observation and analysis of movements in a task with an emphasis on the amount of time required to perform the task. OLsearch TASK PERFORMANCE AND ANALYSIS 1973-74 HN(75) MHÑTime and Motion Studies ANno qualif; DF: TIME STUDIES MNF2.784.412.846.707; F2.784.692.746.707; J1.293.556.779.624 DMÑTask Performance and Analysis LH LM  HN(67) MHÑTime Factors ANNIM coord of a given subject (IM); no qualif; do not confuse with TIME, usually IM, the abstraction; differentiate from AGE FACTORS: Manual 35.7.3, 35.7.4; ╥diurnal╙ & ╥nocturnal╙: see note on TIME above MNH1.862.857 DMÑTime LH LM  MSThe ability to estimate periods of time lapsed or duration of time. MHÑTime Perception ANonly /drug eff /physiol /rad eff MNF2.463.593.857 LH  MS1-(tert-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol maleate (1:1) salt. Beta adrenergic blockader similar in action to propranolol; the levo isomer is the more active; proposed as an antihypertensive. Synonyms: MK 950. PM84; was see under PROPANOLAMINES 1977-83 HN84(77); was see under PROPANOLAMINES 1977-83 MHÑTimolol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26839-75-8 PIAmino Alcohols (72-73); Morpholines (72-75); Propanolamines (74-76); Thiadiazoles (72-76) MND2.33.329.624.915; D2.92.63.624.915; D16.848.215.889; D18.162.889 LH  MHÑTimor MNZ1.252.145.883 LH  MHÑTin ANSn-118; do not use /analogs /biosyn /defic /physiol; Sn-112, 114-117, 119, 122, 124 = TIN (IM) + ISOTOPES (NIM); Sn-108-111, 113, 120, 121, 123, 125-128 = TIN (IM) + RADIOISOTOPES (IM) RN7440-31-5 MND1.268.895; D1.552.875 XSSTANNUM LH LS  MSInorganic fluorides of tin. Include both stannic fluoride (tin tetrafluoride) and stannous fluoride (tin difluoride). The latter is used in the prevention of dental caries. HN(77) MHÑTin Fluorides ANdo not use /analogs /biosyn /defic /physiol PIFluorides (66-76); Fluorides, Topical (66-76); Tin (66-76) MND1.396.514.348.850; D1.552.875.300; D25.223.432.908 XSStannic Fluoride; Stannous Fluoride; Tin Difluoride; Tin Tetrafluoride DMÑFluorides LH LS; ; ; LM  MSPoly or pyrophosphates of tin. In conjunction with radioactive technetium these compounds are used as bone-scanning agents and in scintigraphy to diagnose myocardial and cerebral infarction. HN(77); was see under PHOSPHATES 1977 MHÑTin Polyphosphates ANdo not use /analogs /biosyn /defic /physiol PIPhosphates (66-76); Pyrophosphates (66-76); Tin (66-76) MND1.552.875.700; D1.696.620.603.700.900 XSStannous Polyphosphates; Stannous Pyrophosphates; Tin Pyrophosphates DMÑPolyphosphates LH LS; ; LM  MHÑTinea ANringworm: do not confuse with TAENIA, tapeworm MNC1.703.295.872; C17.838.208.883 XSEPIDERMOPHYTOSIS; RINGWORM; TRICHOPHYTOSIS LH LS; ;  MHÑTinea Capitis ANringworm of the scalp; do not coord with SCALP or SCALP DERMATOSES MNC1.703.295.872.541; C17.738.708; C17.838.208.883.558 LH  MHÑTinea Favosa MNC1.703.295.872.541.500; C17.738.708.708; C17.838.208.883.558.708 XSFAVUS LH LS  MHÑTinea Pedis ANdo not coord with FOOT or FOOT DERMATOSES MNC1.703.295.872.707; C17.305.708; C17.838.208.883.658; C23.304.351.434.708 XSATHLETE'S FOOT LH LS  MHÑTinea Unguium ANdo not coord with NAILS; specify FOOT DERMATOSES (NIM) or HAND DERMATOSES (NIM) MNC1.703.295.872.790; C17.805.506.858; C17.838.208.883.758 XSONYCHOMYCOSIS LH LS  MHÑTinea Versicolor MNC1.703.295.872.873; C17.838.208.883.858 XSPITYRIASIS VERSICOLOR LH LS  MS1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitroimidazole. An antitrichomonal agent for which the single-dose therapy is the treatment of choice. Is also used as an amebicide. Synonym: Fasigyn. HN(75) MHÑTinidazole ANdo not use /biosyn /defic /physiol; /analogs NIM only RN19387-91-8 PINitroimidazoles (71-74); Sulfones (71-74) MND2.640.672.900; D3.383.374.658.900; D21.370.370.900 DMÑNitroimidazoles LH LM  MHÑTinnitus ANnote spelling: -itus, not -itis MNC9.218.458.791; C10.597.257.443.915; C23.888.592.257.443.915 LH  MS4,5-Dihydroxy-m-benzenedisulfonic acid disodium salt. colorimetric reagent for iron, manganese, titanium, molybdenum and complexes of zirconium. HN(75) MHÑTiron AND25-26 qualif; /analogs NIM only RN149-45-1 PIBenzenesulfonates (74); Catechol (74) MND2.241.866.540.244.222.870; D2.455.426.559.389.97.870; D2.886.610.244.222.870; D26.550.950 DMÑBenzenesulfonates LH LM  PM65 HN65(63) MHÑTissue Adhesives AND25-26 qualif MND25.919; D26.16.920; E7.858.876 FXÑBone Cements LH LX  MSCenters for acquiring, characterizing and storing organs or tissue for future use. MHÑTissue Banks ANdo not use /educ /methods MNN2.278.920 XUÑEye Banks; ÑSperm Banks LH LU;  PM72 HN72(68) MHÑTissue Conditioning (Dental) ANdo not use /util except by MeSH definition; DF: TISSUE CONDITIONING PIPeriodontics (66-67); Prosthodontics (66-67) MNE6.780.895 LH  MHÑTissue Culture ANNIM; only /instrum /methods; Manual 18.6.15, 18.7.2-.3, 22.26.1, 26.33+; TN 35, TN 183: as third tier & relation to CELLS, CULTURED, CULTURE MEDIA & CELL LINE MNE5.909.813 FXÑCell Line; ÑCells, Cultured; ÑClone Cells; ÑVirus Cultivation LH LX; ; ;  MSAccumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution are usually expressed as tissue to plasma ratios. PM78 HN78 MHÑTissue Distribution ANdistrib of drugs or chem in organs & tissues; GEN only: not a substitute for organ /metab or organ /anal; never IM; coord NIM with specific Cat D term (IM) PIOrgan Specificity (66-77) MNG6.535.917 LH  PM67 HN67(64) MHÑTissue Donors ANonly /psychol; semen or sperm donors: index under INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband); only /psychol MNM1.898 XSOrgan Donors FXÑOrgan Procurement; ÑTransplantation LH LS LX;  MSPreparations made from animal tissues or organs; they usually contain many components, any one of which may be pharmacologically or physiologically active; extracts may contain specific, but uncharacterized factors or proteins with specific actions. MHÑTissue Extracts ANextracts of organs or tissues or their fractions containing uncharacterized factors; do not confuse with chemical substances ╥extracted╙ from tissues, as ╥peptides extracted from mouse tissue╙ ( = PEPTIDES /anal + organ or tissue /anal); do not use /analogs /biosyn /blood-csf-urine /defic /diag use /physiol /secret MND24.185.893 XUÑActihaemyl; ÑCell Extracts LH LU;  PM67 HN67 MHÑTissue Preservation ANonly /instrum /methods /vet; cryopreservation of tissue: coord IM with FREEZING (NIM) PITissue Banks (66) MNE5.760.833 FXÑTransplantation LH LX  MSThe span of viability of a tissue or an organ. PM76; was see under CYTOLOGY 1975 HN76(71); was see under CYTOLOGY 1975 MHÑTissue Survival ANonly /drug eff /rad eff; viability of organs & tissues goes here PIPreservation, Biological (66-70); Tissue Culture (66-70); Tissue Preservation (66-70); Transplantation (66-70); specific organ or tissue MNG4.185.908 XSOrgan Survival LH LS  MHÑTissue Therapy ANnot restricted to Filatov's therapy; only /adv eff /hist /instrum /methods /nurs /stand; ╥biogenic stimulators╙ go here MNE2.95.884 LH  MH*Tissue Types (Non Mesh) MNA10 LH  MHÑTitanium ANTi-48; do not use /analogs /biosyn /defic /physiol; Ti-46, 47, 49, 50 = TITANIUM (IM) + ISOTOPES (NIM); Ti-43-45, 51 = TITANIUM (IM) + RADIOISOTOPES (IM) RN7440-32-6 MND1.268.902; D1.552.887 LH  MSThe toxic Solanaceous American plant Nicotiana tabacum; it yields NICOTINE and other biologically active chemicals; its dried leaves are used for smoking. MHÑTobacco ANas plant & for smoking (= SMOKING), sniffing ( = SNUFF) & chewing ( = TOBACCO only: no coordinate); do not use /isol /pathogen MNB6.660.920 XSNicotiana FXÑNicotine; ÑSMOKING; ÑTobacco Use Disorder XUÑTobacco, Smokeless LH LS LX; ; LU  MHÑTobacco Mosaic Virus ANdo not use /cytol MNB4.715.464.708 LH  MSContamination of the air by tobacco smoke. PM82 HN82 MHÑTobacco Smoke Pollution ANnote X ref on passive smoking below; only /adv eff /anal /econ /prev PIAir Pollutants (75-81); Air Pollutants, Environmental (75-81); Air Pollution (72-81); Environmental Exposure (72-81); Smoke (72-81); Smoking (72-81); Ventilation (72-81) MNG3.850.460.100.340.680 XSAir Pollution, Tobacco Smoke; Environmental Pollution, Tobacco Smoke; Smoking, Passive LH LS; ;  MSTobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included. PM81 HN81 MHÑTobacco Use Disorder ANincludes cigarettes, cigars, chewing tobacco & snuff; do not use /chem ind /drug eff /physiol /rad eff PISmoking (66-80) MNF3.709.597.780.810 XSTobacco Dependence FXÑSmoking; ÑTobacco LH LS LX;  MSThe powdered leaves of Nicotiana tabacum which are either inhaled through the nose, chewed or stored in cheek pouches; any product of tobacco that is not smoked. OLto search SNUFF use TOBACCO, SMOKELESS 1975-85 & TOBACCO 1966-74 HN(86); was SNUFF see under TOBACCO 1963-85 MHÑTobacco, Smokeless ANonly /anal MNB6.660.920.900 XSChewing Tobacco; Oral Tobacco; Smokeless Tobacco; Snuff DMÑTobacco LH LS; ; ; LM  MS0-3-Amino-3-deoxy-alpha-D-glucopyranosyl (1-4)-0-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-6)]-2-deoxy-L-streptamine. An aminoglycoside, broad spectrum antibiotic produced by Streptomyces tenebrarius. Effective against Gram-negative bacteria, especially the Pseudomonas species. PM84; was see under ANTIBIOTICS 1975-83 HN84(75); was see under ANTIBIOTICS 1975-83 MHÑTobramycin ANdo not use /defic /physiol RN32986-56-4 PIAntibiotics (66-74); Aminoglycosides (74); Glycosides (66-73) MND20.85.533.920 XSNebramycin Factor 6 LH LS  MSN'-(1-Phthalazinyl)-hydrazinecarboxylic acid ethyl ester. An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects. OLuse TODRALAZINE to search BINAZINE back thru 1975 HN(80); was BINAZINE see under HYDRAZINES 1975-79 MHÑTodralazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3778-76-5 PICarboxylic Acids (72-74); Heterocyclic Compounds (71-74); Hydrazines (71-74) MND2.442.925; D3.383.710.605.925; D18.162.893 XSBinazine; Todrazoline DMÑHydrazines LH LS; LM  PM65 HN65 MHÑToe Joint ANany Cat A qualif; TN 117: use for human & other vertebrates; TN 238: differentiation from TOES & indexing instructions MNA2.835.583.899 XUÑMetatarsophalangeal Joint LH LU  MHÑToes ANany Cat A qualif; TN 117: use for human & other vertebrates; TN 238: differentiation from TOE JOINT & indexing instructions; NIM when merely locational as in FOOT DERMATOSES (IM) MNA1.378.592.350.792 LH  MSA family of RNA viruses, mainly arboviruses, consisting of the following genera: ALPHAVIRUSES (group A arboviruses), FLAVIVIRUSES (group B arboviruses), PESTIVIRUSES, and Rubivirus (RUBELLA VIRUS). Virions are spherical, 40-70 nm in diameter, with lipoprotein envelope tightly applied to icosahedral nucleocapsid. OLsearch ARBOVIRUSES 1978-80 PM81; was TOGAVIRUSES see ARBOVIRUSES 1978-80 HN81; was TOGAVIRUSES see ARBOVIRUSES 1978-80 MHÑTogaviridae ANdo not use /blood-csf-urine /cytol; infection = TOGAVIRUS INFECTIONS PIArboviruses (66-80) MNB4.909.777.923 LH  MSVirus diseases caused by the Togaviridae. PM81; WEST NILE FEVER was see under ARBOVIRUS INFECTIONS 1975-80 HN81; WEST NILE FEVER was see under ARBOVIRUS INFECTIONS 1975-80 MHÑTogavirus Infections PIArbovirus Infections (66-80) MNC2.782.930 XUÑWest Nile Fever LH LU  MHÑTogo MNZ1.58.432.888 LH  MSFacilities provided for human excretion, often with accompanying handwashing facilities. OLuse TOILET FACILITIES to search LATRINES back thru 1966 PM77; was LATRINES 1963-76 HN77; was LATRINES 1963-76 MHÑToilet Facilities ANincludes bed pans, urinals, commodes, etc.; only /hist /stand MNG3.850.860.410.560; G3.850.860.510.490 XSLatrines LH LS  MSConditioning to defecate and urinate in culturally acceptable places. PM68 HN68 MHÑToilet Training ANno qualif PIChild Care (66-67) MNF1.318.709 LH  MSTokens representing money, toys, candy, etc., are given as secondary reinforcers contingent upon certain desired behaviors or performances. PM79; was see under REWARD 1975-78 HN79(75); was see under REWARD 1975-78 MHÑToken Economy ANno qualif PIReward (66-74) MNF2.463.425.770.836.500 XSToken Reinforcement LH LS  OLuse JAPAN to search BONIN ISLANDS 1975-83 HNBONIN ISLANDS was see JAPAN 1975-83 MHÑTokyo MNZ1.252.474.463.709; Z1.433.900 XSBonin Islands LH LS  PM73 HN73(64) MHÑTolazamide ANdo not use /biosyn /defic /physiol RN1156-19-0 MND2.886.590.795.834; D2.948.828.834; D9.482.859 LH  MHÑTolazoline ANdo not use /biosyn /defic /physiol RN59-98-3 MND3.383.374.924; D16.848.115.834 XSBenzalolin LH LS  MHÑTolbutamide ANdo not use /biosyn /defic /physiol RN64-77-7 MND2.886.590.795.896; D2.948.828.896; D9.482.909 LH  MS1-Isopropylamino-3-(m-tolyloxy)-2-propanol. Beta adrenergic blockader with some stimulant action; proposed for angina pectoris. Synonyms: ICI 45763; MHIP; Doberol. OLuse TOLIPROLOL to search DOBEROL back thru 1975 HN(81); was DOBEROL see under PROPANOLAMINES 1975-80 MHÑToliprolol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2933-94-0 PIAmino Alcohols (66-73); Ethers (66-73); Phenols (66-73); Phenyl Ethers (74); Propanolamines (74); Propylamines (66-74) MND2.33.329.624.935; D2.92.63.624.935; D16.848.215.933 XSKO 592 DMÑPropanolamines LH LS LM  MS1-Methyl-5-p-toluoylpyrrole-2-acetic acid. Anti-inflammatory antipyretic and analgesic similar to indomethacin; proposed as antirheumatic agent. Synonyms: McN 2559; Tolectin. HN(76) MHÑTolmetin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN26171-23-3 PIBenzoates (73-75); Pyrroles (73-75) MND3.383.757.910; D14.73.278.908; D26.74.75.875 DMÑPyrroles LH LM  PM73 HN73(72) MHÑTolnaftate ANdo not use /biosyn /defic /physiol RN2398-96-1 PIAntifungal Agents (66-71); Thiocarbamates (66-71) MND2.241.81.251.869.791; D2.241.866.653.791; D2.886.703.791; D20.136.763 LH  OLuse TOLONIUM CHLORIDE to search TOLUIDINE BLUE O back thru 1972 (as Prov 1972-73); search HEMOSTATICS 1966-71 PM74; was see under HEMOSTATICS 1963-73 HN74; was see under HEMOSTATICS 1963-73, was TOLUIDINE BLUE O 1972-73 (Prov) MHÑTolonium Chloride AND25-26 qualif RN92-31-9 MND3.494.741.869; D19.461.270.546.709; D26.408.874 XSTOLUIDINE BLUE O LH LS  MS2,4'-Dimethyl-3-piperidinopropiophenone. Proposed central skeletal muscle relaxant that may also dilate some blood vessels. Synonyms: Mideton; Midocalm; Mio-relax; Muscalm; Mydocalm; N 553. HN(79) MHÑTolperisone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN728-88-1 PIPiperidines (66-78); Propiophenones (66-78) MND2.522.818.950; D17.426.890 XSMydeton DMÑPropiophenones LH LS LM  MHÑToluene ANdo not use /biosyn /defic /physiol RN108-88-3 MND2.455.426.559.389.832 LH  MSToluene 2,4-diisocyanate. Used in the manufacture of polyurethane foams and other elastomers. Skin irritant and allergen. HN(75) MHÑToluene Diisocyanate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN584-84-9 PICyanates (70-74); Toluene (73-74) MND1.620.242.800; D2.455.426.559.389.832.500 XSDiisocyanatotoluene; Tolylene Diisocyanate DMÑCyanates LH LS; LM  PM73 HN73(72) MHÑToluidines ANdo not use /analogs /biosyn /defic /physiol PIToluene (66-71) MND2.92.146.859; D2.455.426.559.389.832.559 XUÑTrifluralin LH LU  HN(64) MHÑTomatine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN17406-45-0 MND3.132.760.864; D9.203.408.934; D20.136.801 DMÑAlkaloids LH LM  MSImaging methods that result in sharp images of objects located on a chosen plane and blurred images located above or below the plane. MHÑTomography ANdo not use /util except by MeSH definition; used for non-x-ray & non-radionuclide tomographies; echotomography seen in foreign lit is probably ULTRASONIC DIAGNOSIS & if so use ╥ultrasonics╙ or ╥ultrasonic diagnosis╙ in translations & not ╥echotomography╙ MNE1.927 LH  MSTomography using emissions from radionuclides and a computer algorithm to reconstruct the image. PM80 HN80 MHÑTomography, Emission Computed ANuses radionuclides & computer: do not confuse with TOMOGRAPHY, X-RAY COMPUTED using x-rays & computer; ╥computed tomography╙ unspecified is probably TOMOGRAPHY, X-RAY COMPUTED; do not use /util except by MeSH definition; SPECT (single photon emission computed tomography) goes here; DF: CT EMISS PITomography (66-79); Tomography, X-Ray Computed (77-79) MNE1.289.702.900; E1.927.650 XSCAT Scan, Radionuclide; Computerized Emission Tomography; Radionuclide Tomography, Computed; Scintigraphy, Computed Tomographic; Tomography, Positron Emission; Tomography, Radionuclide Computed LH LS; ; ; ; ;  MSTomography using x-ray transmission. OLuse TOMOGRAPHY, X-RAY to search TOMOGRAPHY, RADIOGRAPHIC back thru 1973 PM80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79 HN80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79 MHÑTomography, X-Ray ANdo not use /util except by MeSH definition PITomography (66-72) MNE1.818.901; E1.927.709 XSLaminagraphy, X-Ray; Planigraphy, X-Ray; Radiography, Body Section; Stratigraphy, X-Ray; Tomography, Transmission; X-Ray Tomography; Zonography LH LS; ; ; ; ; ;  MSTomography using x-ray transmission and a computer algorithm to reconstruct the image. OLuse TOMOGRAPHY, X-RAY COMPUTED to search TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79 PM80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79 HN80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79 MHÑTomography, X-Ray Computed ANuses x-rays & computer: do not confuse with TOMOGRAPHY, EMISSION COMPUTED using radionuclides & computer; ╥computed tomography╙ unspecified probably goes here; CAT, EMI, ACTA & DELTA scanners probably go here: check text; do not use /util except by MeSH definition; DF: CT XRAY PITomography, X-Ray (73-76) MNE1.818.901.901; E1.927.709.940 XSCAT Scan, X-Ray; Computerized Tomography, X-Ray; Tomography, Transmission Computed; X-Ray Tomography, Computed LH LS; ; ;  HN75 MHÑTonga MNZ1.782.815.890 LH  PM/abnormalities was TONGUE ABNORMALITIES 1965 HN/abnormalities was TONGUE ABNORMALITIES 1965 MHÑTongue AN/surg: consider GLOSSECTOMY; /transpl permitted for tongue grafts as in palate surg; inflammation = GLOSSITIS; tongue thrust: index under TONGUE HABITS; painful or sore tongue = GLOSSALGIA; scrotal tongue = TONGUE, FISSURED; consider other terms under GLOSS- & LINGUAL MNA14.549.885 FXÑGlossectomy LH LX  PM65 HN65 MHÑTongue Diseases ANinflamm dis = GLOSSITIS MNC7.465.910 XUÑTongue, Hairy LH LU  MSAcquired responses regularly manifested by tongue movement or positioning. PM65 HN65 MHÑTongue Habits ANno qualif MNF1.145.466.874; F3.234.193.308.680 LH  MHÑTongue Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.591.925; C7.465.910.874 LH  MHÑTongue, Fissured MNC7.465.910.708 XSTONGUE, FURROWED LH LS  OLsearch TONGUE DISEASES 1966-74 HN(75) MHÑTongue, Hairy MNC7.465.910.791 DMÑTongue Diseases LH LM  MHÑTonometry ANrestrict to measurement of intraocular pressure; do not use /util except by MeSH definition MNE1.210.860 FXÑIntraocular Pressure LH LX  MHÑTonsil AN/surg: probably TONSILLECTOMY; inflammation = TONSILLITIS (note -LL-); palatine tonsils = TONSIL: do not add PALATE; pharyngeal tonsil = ADENOIDS MNA14.724.603.925; A15.382.520.604.886 FXÑLymphoid Tissue LH LX  MHÑTonsillar Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.665.710.932; C9.775.549.710 LH  MHÑTonsillectomy ANdo not use /util except by MeSH definition; post-tonsillectomy hemorrh = HEMORRHAGE + POSTOPERATIVE COMPLICATIONS, not HEMORRHAGE, ORAL MNE4.847.848 LH  MHÑTonsillitis MNC8.730.817; C9.775.860 LH  PM65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965 HN65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965 MHÑTooth AN/abnorm = TOOTH ABNORMALITIES; /embryol: consider also TOOTH GERM & ODONTOGENESIS; tooth size & dimension = TOOTH /anat (IM) + ODONTOMETRY (NIM); permanent tooth = TOOTH, deciduous tooth = TOOTH, DECIDUOUS; tooth pain = TOOTHACHE; tooth avulsion = TOOTH LUXATION; tooth socket: index under ALVEOLAR PROCESS; tooth sensitivity = DENTIN SENSITIVITY; consider terms under DENT- & ODONT MNA14.254.860 FXÑDentition; ÑMalocclusion; ÑMastication; ÑOdontogenesis; ÑPaleodontology LH LX; ; ; ;  PM65 HN65 MHÑTooth Abnormalities ANdo not use /congen; duplication of teeth = TOOTH, SUPERNUMERARY; abnorm in congen syphilis = HUTCHINSON'S TEETH; ╥odontome╙ (a form of developmental dental anomaly) goes here MNC16.131.314.904 XUÑDens in Dente; ÑFused Teeth LH LU;  PM65 HN65 MHÑTooth Abrasion ANloss of substance caused by friction: differentiate from TOOTH EROSION (loss of substance by chemical action without bact action); ╥tooth wear╙ goes here MNC7.793.707 XSAttrition, Dental LH LS  PM72 HN72(71) MHÑTooth Bleaching ANno qualif PIMottled Enamel/TH (66-70); Root Canal Therapy (66-70); Tooth Discoloration/TH (66-70) MNE6.940 LH  PM65 HN65 MHÑTooth Calcification ANonly /drug eff /rad eff MNG6.184.227.710; G10.549.688 LH  PM65 HN65 MHÑTooth Discoloration ANexternal staining or staining within pulp; do not confuse with MOTTLED ENAMEL (C16: occurring during tooth calcification) MNC7.793.735 FXÑEndodontics LH LX  PM65 HN65 MHÑTooth Diseases ANGEN: prefer specifics CATALOG: form qualif = DENTISTRY /form; do not use /in inf ( = PEDODONTICS) /in old age ( = GERIATRIC DENTISTRY) MNC7.793 FXÑMouth Rehabilitation XUÑHypercementosis LH LX LU  PM65 HN65 MHÑTooth Erosion ANloss of substance caused by chem action without bact action: differentiate from TOOTH ABRASION (loss of substance caused by friction) MNC7.793.763 LH  PM65 HN65 MHÑTooth Eruption ANonly /drug eff /rad eff; ╥teething╙ goes here MNG10.549.726 LH  PM66 HN66(65) MHÑTooth Eruption, Ectopic ANnote category MNC7.793.790 LH  PM72 HN72(68) MHÑTooth Exfoliation ANonly Cat C qualif PIPeriodontal Diseases (66-67); Tooth, Deciduous (66-67) MNC7.465.714.773; G10.549.764 LH  PM65; was TEETH EXTRACTION 1963-64 HN65; was TEETH EXTRACTION 1963-64 MHÑTooth Extraction ANonly /adv eff /econ /hist /instrum /methods /vet; SERIAL EXTRACTION is available as orthodontic proced for sequential removal of teeth over a period of years MNE4.833.834; E6.892.834 XSEXODONTICS FXÑDry Socket; ÑTooth, Impacted LH LS LX;  MSBreak or rupture of a tooth or tooth root. PM66 HN66(65) MHÑTooth Fractures MNC7.793.818; C21.866.405.863 XUÑCracked Tooth Syndrome LH LU  MHÑTooth Germ AN/embryol: consider also ODONTOGENESIS MNA14.254.860.851 FXÑOdontogenesis XUÑDental Papilla; ÑDental Sac; ÑEnamel Organ LH LX LU; ;  MSPartial or complete displacement of a tooth from its socket. PM70 HN70 MHÑTooth Luxation PIspecific tooth MNC7.793.873; C21.866.909 XSDISLOCATION, TOOTH; Tooth Avulsion LH LS;  PM66 HN66(65) MHÑTooth Migration ANmovement to another position along the line of the dental arch (alveolar process): do not confuse with TOOTH MOBILITY; only Cat C qualif MNC7.465.714.836; G10.549.803 XUÑMesial Movement of Teeth LH LU  PM65 HN65 MHÑTooth Mobility ANphysiol mobility of deciduous teeth or pathol mobility of permanent teeth in periodontal dis or trauma; only Cat C qualif; do not confuse with TOOTH MOVEMENT, MINOR (an orthodontic procedure) MNC7.465.714.898; G10.549.841 LH  PM73 HN73 MHÑTooth Movement, Minor ANnote categ: ╥orthodontic technics used to correct minor degrees of tooth malposition╙; do not confuse with TOOTH MIGRATION or TOOTH MOBILITY above; do not use /util except by MeSH definition PIOrthodontics, Corrective (66-72) MNE6.658.578.836 LH  PM65 HN65 MHÑTooth Permeability ANonly /drug eff /rad eff MNG10.549.879 XSPERMEABILITY, TOOTH XUÑDental Enamel Permeability; ÑDentin Permeability LH LS LU;  MSTherapeutic technic for replacement of minerals in partially decalcified teeth. OLsearch TOOTH CALCIFICATION 1966-84 PM85; was see TOOTH CALCIFICATION 1975-84, was see under TOOTH CALCIFICATION 1969-74 HN85; was see TOOTH CALCIFICATION 1975-84, was see under TOOTH CALCIFICATION 1969-74 MHÑTooth Remineralization ANnote category: replacement of minerals in partially decalcified teeth; only /instrum /methods PITooth Calcification (66-84) MNE6.950 LH  MSReinsertion of a tooth into the alveolus from which it was removed or otherwise lost. OLuse TOOTH REPLANTATION to search TOOTH REIMPLANTATION back thru 1966 PM82; was TOOTH REIMPLANTATION 1965-81 HN82; was TOOTH REIMPLANTATION 1965-81 MHÑTooth Replantation ANdifferentiate from DENTAL IMPLANTATION: see note there; do not use /util except by MeSH definition MNE4.833.876; E4.936.494.711; E6.397.898; E6.892.876 XSReimplantation, Tooth; Replantation, Tooth; Tooth Reimplantation LH LS; ;  PM65 HN65 MHÑTooth Resorption ANonly Cat C qualif MNC7.793.901; G10.549.917 LH  PM65 HN65 MHÑTooth Root ANapex of root goes here; root fract or radicular fract: index under TOOTH ROOT /inj (IM) + TOOTH FRACTURES (IM); /surg: consider also APICOECTOMY; dilaceration of root: index under TOOTH ROOT /abnorm; root planing: index under TOOTH ROOT /surg + SCALING, DENTAL; apical foramen goes here MNA14.254.860.887 XSTOOTH APEX FXÑApicoectomy; ÑROOT RESORPTION LH LS LX;  PM65 HN65 MHÑTooth, Artificial ANonly /stand /vet MNE6.780.377.916 FXÑAcrylic Resins; ÑDental Porcelain LH LX;  PM65; was TEETH, DECIDUOUS 1963-64 HN65; was TEETH, DECIDUOUS 1963-64 MHÑTooth, Deciduous MNA14.254.860.815 FXÑDentition; ÑPedodontics XUÑNatal Teeth LH LX; LU  PM65 HN65 MHÑTooth, Impacted ANdo not confuse with TOOTH, UNERUPTED MNC7.793.846 FXÑTOOTH EXTRACTION; ÑTooth, Unerupted LH LX;  MSAn extra tooth, erupted or unerupted. OLuse TOOTH, SUPERNUMERARY to search MOLAR, FOURTH back thru 1966 PM65 HN65; MOLAR, FOURTH was see under TOOTH, SUPERNUMERARY 1965-78 MHÑTooth, Supernumerary ANdo not use /congen; may refer to erupted or unerupted tooth: if erupted do not use TOOTH ERUPTION; if unerupted coord IM with TOOTH, UNERUPTED (NIM) MNC16.131.314.904.918 XSMolar, Fourth LH LS  PM73 HN73 MHÑTooth, Unerupted ANnote categories: from Cat A only /anal /anat /drug eff /rad eff /transpl /ultrastruct; do not confuse with TOOTH, IMPACTED PITooth Eruption (66-72) MNA14.254.860.923; C7.793.915 FXÑTOOTH, IMPACTED LH LX  MHÑToothache MNC7.793.929; C23.888.592.612.905 LH  OLuse TOOTHBRUSHING to search TOOTHBRUSHES back thru 1966 PM70; was TOOTHBRUSHES 1963-69 HN70; was TOOTHBRUSHES 1963-69 MHÑToothbrushing ANonly /adv eff /instrum (toothbrushes go here) /methods; restrict to brushing with a toothbrush: dental floss & waterpicks, etc. go under DENTAL DEVICES, HOME CARE MNE6.761.726.794 LH  MSA dentifrice in paste form; usually contains binder, humectant, an abrasive, a detergent, flavoring agent and often caries preventives, anti-infective agents or other medicaments. OLsearch DENTIFRICES 1966-74 HN(75) MHÑToothpaste AND25-26 qualif MND25.376.711; D26.313.211.711; J1.516.278.711 DMÑDentifrices LH LM  MSA genus of the Torpedinidae family consisting of several species. This genus as well as all the other genera of this family have powerful electric organs and are commonly called electric rays. PM82 HN82 MHÑTorpedo ANa fish; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (68-81) MNB2.493.378.722 XSElectric Ray; Narcine LH LS;  MSA twisting or rotation of a bodily part or member on its axis. PM68 HN68(63) MHÑTorsion ANnever IM; NIM without qualif; coord with organ/dis precoord (IM) MNC23.739.901 LH  MSA contraction of the cervical muscles producing twisting of the neck and an unnatural position of the head. MHÑTorticollis MNC5.651.925; C10.597.559.895; C23.888.592.574.879 XSWryneck LH LS  MSThe intentional infliction of physical or mental suffering upon an individual or individuals. Includes the torture of animals. PM84; was see under AGGRESSION 1975-83 HN84(75); was see under AGGRESSION 1975-83 MHÑTorture ANof humans or animals; physical or mental torture; no qualif MNF3.126.842.89.700 LH  PM73 HN73(72) MHÑTosyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: TOSYL CPDS PISulfones (66-71); Toluene (66-71) MND2.455.426.559.389.832.661; D2.886.590.887 XSToluenesulfonyl Compounds LH LS  MSN(2)-(p-Tolylsulfonyl)-L-arginine, methyl ester. Arginine derivative which is a substrate for many proteolytic enzymes. As a substrate for the esterase from the first component of complement, it inhibits the action of C(l) on C(4). HN(75) MHÑTosylarginine Methyl Ester ANdo not use /biosyn /defic /physiol RN901-47-3 PIArginine (72-74); Tosyl Compounds (72-74) MND2.455.426.559.389.832.670; D2.886.590.887.570; D12.125.95.104.900 XSTAME DMÑArginine LH LS LM  MSN-[5-amino-1-(chloroacetyl)pentyl]-p-toluenesulfonamide. An inhibitor of serine proteinases. Acts as an alkylating agent and is known to interfere with the translation process. HN(75); was see under LYSINE 1975-76 MHÑTosyllysine Chloromethyl Ketone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2104-86-1 PIChlorine (74); Lysine (74); Tosyl Compounds (74) MND2.455.426.559.389.832.690; D2.886.590.887.600; D8.373.745.75.850; D12.125.65.850 XSChlorotosylamidoaminoheptanone; TLCK; Tosyllysyl Chloromethane DMÑAmino Acid Chloromethyl Ketones LH LS; ; LM  MSN-[alpha-(chloroacetyl)phenethyl]-L-p-toluenesulfonamide. An inhibitor of serine proteinases. Acts as alkylating agent and is known to interfere with the translation process. HN(75); was see under PHENYLALANINE 1975-76 MHÑTosylphenylalanyl Chloromethyl Ketone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN402-71-1 PIChlorine (74); Phenylalanine (72-74); Tosyl Compounds (73-74) MND2.455.426.559.389.832.710; D2.886.590.887.660; D8.373.745.75.930; D12.125.65.930 XSChlorophenyltosylamidobutanone; TPCK; Tosylphenylalanyl Chloromethane DMÑAmino Acid Chloromethyl Ketones LH LS; ; LM  MSThe volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: vital capacity plus residual volume; inspiratory capacity plus functional residual capacity; tidal volume plus inspiratory reserve volume plus functional residual capacity; tidal volume plus inspiratory reserve volume plus expiratory reserve volume plus residual volume. HN(75) MHÑTotal Lung Capacity ANNIM MNE1.302.796.420.960 DMÑLung Volume Measurements LH LM  MSSensation or perception by which contact with objects, animate or inanimate, gives evidence as to certain qualities or characteristics. MHÑTouch ANonly /drug eff /physiol /rad eff MNF2.463.593.885; F2.830.816.850; G11.561.796.850 LH  PM66 HN66(63) MHÑTourniquets ANonly /adv eff /class /hist /stand /vet MNE7.926 LH  HN(72) MHÑToxaphene ANdo not use /biosyn /defic /physiol; /analogs NIM only; TN 111 for eff on insects RN8001-35-2 PIInsecticides (66-72) MND2.455.526.439.913; D2.455.849.618.795; D5.723.491.491.924 DMÑInsecticides, Organochlorine LH LM  MSInfestation of the small intestine roundworms of the genus Toxascaris. OLsearch ASCARIASIS 1968-74 HN(75) MHÑToxascariasis ANdifferentiate from TOXOCARIASIS MNC3.335.508.70.762 DMÑAscariasis LH LM  MSAn ascarid nematode found primarily in the small intestine of the larger Felidae as well as dogs and cats; it differs from Toxocara in that the larvae do not migrate through the lungs. It does occasionally produce visceral larva migrans in man, although more rarely than does Toxocara. PM72 HN72 MHÑToxascaris ANdo not confuse with TOXOCARA; do not use /blood-csf-urine; infection = TOXASCARIASIS PINematoda (66-71) MNB1.500.294.433.700 LH  MSA generalized intoxication produced by toxins and other substances elaborated by an infectious agent. MHÑToxemia ANrelation to ╥toxicosis╙: TN 185; note PREGNANCY TOXEMIAS is available CATALOG: do not use /in pregn ( = PREGNANCY TOXEMIAS) MNC1.539.861 FXÑPREGNANCY TOXEMIAS LH LX  MSThe science concerned with the detection, chemical composition, and pharmacologic action of toxic substances or poisons and the treatment and prevention of toxic manifestations. MHÑToxicology ANSPEC only: SPEC qualif; prefer /ad-poi-tox with specific D terms: Manual 19.5+ CATALOG: use with form qualif instead of POISONS /form or POISONING /form MNG1.703.795; G2.628.795 FXÑPOISONS LH LX  MHÑToxiferine ANdo not use /biosyn /defic /physiol RN302-30-7 MND2.92.102.844; D2.675.276.844; D3.132.267.712; D17.563.367.217.712 XSCALABASH CURARE XUÑAlcuronium LH LS LU  MSSpecific, characterizable, poisonous chemicals, often proteins, with specific biological properties, including immunogenicity, produced by microbes, higher plants or animals. PM66; TOXINS AND ANTITOXINS was heading 1963-65 HN66; TOXINS AND ANTITOXINS was heading 1963-65 MHÑToxins ANdo not use /analogs /antag ( = ANTITOXINS) /defic /diag use /physiol /secret; ANTIBODY-TOXIN CONJUGATES is available as toxin carrier: see note there MND24.185.926 LH  MSA genus of ascarid nematodes commonly parasitic in the intestines of cats and dogs. MHÑToxocara ANdo not confuse with TOXASCARIS; do not use /blood-csf-urine; infection = TOXOCARIASIS MNB1.500.294.433.780 LH  MSInfection by round worms of the genus Toxocara, usually found in wild and domesticated cats and dogs and foxes, except for the larvae, which may produce visceral larva migrans in man. OLsearch ASCARIASIS 1967-74 HN(75) MHÑToxocariasis ANdifferentiate from TOXASCARIASIS; in animals; in man, probably is LARVA MIGRANS, VISCERAL MNC3.335.508.70.862 DMÑAscariasis LH LM  MSPreparations of pathogenic organisms or their derivatives made nontoxic and intended for active immunologic prophylaxis; deactivated toxins. PM66; TOXINS AND ANTITOXINS was heading 1963-65 HN66; TOXINS AND ANTITOXINS was heading 1963-65 MHÑToxoids ANonly /admin /adv eff /anal /csf /class /immunol /isol /rad eff /stand /tox /urine; coord disease with /prev, not /ther (here ANTITOXINS is coord) MND24.310.794 XSAnatoxins LH LS  MSA genus of Sporozoa parasitic to birds and mammals. MHÑToxoplasma ANdo not use /anat /blood-csf-urine /embryol; infection = TOXOPLASMOSIS & its specifics; /drug eff: consider also COCCIDIOSTATS MNB1.841.762.167.650 LH  MSThe acquired form of infection by Toxoplasma gondii in man. MHÑToxoplasmosis AN/congen = TOXOPLASMOSIS, CONGENITAL; /vet = TOXOPLASMOSIS, ANIMAL MNC3.752.865 LH  MSAcquired infection of non-human animals by organisms of the genus Toxoplasma. MHÑToxoplasmosis, Animal ANexper or vet but do not use /vet; /congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL MNC3.752.865.587; C22.674.710.817 LH  MSCongenital infection with Toxoplasma gondii; characterized by lesions of the central nervous system. MHÑToxoplasmosis, Congenital ANdo not use /congen; /vet = TOXOPLASMOSIS, ANIMAL /congen MNC3.752.865.712; C16.614.909 LH  MSChorioretinitis which invariably accompanies the congenital form of toxoplasmosis. MHÑToxoplasmosis, Ocular AN/congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL MNC3.752.865.837; C11.888 LH  MS4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures; an analog of adenosine; blocks RNA synthesis and ribosome function; used mainly as tool in biochemistry. Synonyms: Antibiotic 1037; E 212; Unamycin B; Uramycin B; Vengicide; 7-deaza-7-cyanoadenosine. HN(75); was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-80 MHÑToyocamycin ANdo not use /defic /physiol; /analogs NIM only RN606-58-6 PINitriles (66-74); Nucleosides (66-72); Pyrimidine Nucleosides (74); Pyrroles (66-74); Ribonucleosides (73-74) MND13.570.800.840; D20.85.75.950; D22.204.106.930; D22.204.144.930; D26.87.922 XSDeazacyanoadenosine; Toyokamycin DMÑRibonucleosides LH LS; LM  OLsearch CHROMOMYCINS 1973-74 HN(75) MHÑToyomicin ANdo not use /defic /physiol; /analogs NIM only RN7059-24-7 MND20.85.75.302.837; D22.204.106.307.837 XSChromomycin A3 DMÑChromomycins LH LS LM  MSA porelike structure surrounding the entire circumference of the anterior chamber through which aqueous humor circulates to the canal of Schlemm. PM77 HN77 MHÑTrabecular Meshwork ANin the eye: do not confuse with other trabeculae PIAnterior Chamber (66-76); Ciliary Body (66-76); Uvea (66-76) MNA9.371.60.932 LH  MHÑTrace Elements ANGEN; /physiol permitted; do not use /analogs /biosyn; see dictionary definition: do not coord with METALS for ╥trace metals╙ nor with MINERALS for ╥trace minerals╙; do not confuse with ╥tracers╙ used for detection or with trace amounts of substances in tissue, food, etc. MND1.937 LH  MSThe cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi. MHÑTrachea AN/surg: consider also TRACHEOTOMY; inflammation = TRACHEITIS MNA4.889 FXÑAnesthesia, Intratracheal; ÑIntubation, Intratracheal LH LX;  PM68 HN68 MHÑTracheal Diseases ANinflamm dis = TRACHEITIS PIRespiratory Tract Diseases (66-67); Trachea (66-67) MNC8.907 XUÑTracheobronchomegaly LH LU  MHÑTracheal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.443.925; C4.588.894.797.838; C8.907.563 LH  MHÑTracheal Stenosis MNC8.907.663 LH  MHÑTracheitis MNC8.730.848; C8.907.763 LH  MSA rare and probably congenital condition characterized by great enlargement of the lumen of the trachea and the larger bronchi. HN(87) MHÑTracheobronchomegaly ANdo not use /congen PIBronchi/abnormalities (66-86); Trachea/abnormalities (66-86) MNC8.127.930; C8.907.830; C16.131.930 XSMounier-Kuhn Syndrome DMÑTracheal Diseases LH LS LM  MSAbnormal communication between the esophagus and the tracheobronchial tree. PM65 HN65(63) MHÑTracheoesophageal Fistula ANsame as esophagotracheal fistula; fistula policy: Manual 23.25+ MNC6.306.392.713; C8.907.863 FXÑFistula LH LX  OLuse TRACHEOTOMY to search TRACHEOSTOMY back thru 1966 PMTRACHEOSTOMY was heading 1963-66 HNTRACHEOSTOMY was heading 1963-66 MHÑTracheotomy ANdo not use /util except by MeSH definition MNE4.847.907; E4.920.970 XSTRACHEOSTOMY LH LS  MSA chronic infection of the conjunctiva and cornea caused by Chlamydia trachomatis. MHÑTrachoma ANcaused by Chlamydia trachomatis, a bacterium, not a virus (╥trachoma virus╙) MNC1.850.200.195.920; C11.187.183.220.889 LH  MSSports performed on a track, field, or arena and including running events and other competitions, such as the pole vault, shot put, etc. PM76 HN76 MHÑTrack and Field ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); RUNNING is also available; DF: TRACK PISports (66-75) MNI3.450.642.845.925 LH  MHÑTraction ANonly /adv eff /instrum /methods /vet MNE4.557.919 LH  MSPowdered exudate from Astragalus gummifer and related plants; forms gelatinous mass in water; used as suspending agent, excipient or emulsifier in foods, cosmetics and pharmaceuticals; also as bulk-forming laxative. Synonyms: Gum Dragon; Traganth. HN(78) MHÑTragacanth ANdo not use /analogs /defic /physiol; /biosyn permitted if by plant RN9000-65-1 PIPharmaceutic Aids (68-77); Pharmacy (66-67); Polysaccharides (66-77); Resins (66-77) MND9.203.698.900; D19.316.396.902; D26.698.931.419.902 XSGum Tragacanth DMÑPolysaccharides LH LS LM  MSThe subject's ability to connect 25 numbered and lettered circles in sequence in a specific length of time. A score of 12 or below is suggestive of organic brain damage. HN(71); was see under PSYCHOLOGICAL TESTS 1971-84 MHÑTrail Making Test ANno qualif PIPsychological Tests (66-70) MNF4.711.513.838 DMÑNeuropsychological Tests LH LM  MSFinancial support for training including both student stipends and loans and training grants to institutions. OLuse TRAINING SUPPORT to search STUDENT LOANS back thru 1966 PM66 HN66; STUDENT LOANS was see under TRAINING SUPPORT 1966-78 MHÑTraining Support ANonly /class /econ /hist /legis /trends; specify agency or government & geog if possible CATALOG: /geog /form; do not use U. S. MNH1.770.878; N3.219.483.838 XSGrants and Subsidies, Educational; Student Loans; Subsidies, Educational FXÑEducation LH LS; ; LX  MStrans-2-((Dimethylamino)methyl)-1-(m-methoxyphenyl) cyclohexanol. Analgesic proposed for severe pain; may be habituating. Synonyms: CG 315E; K315; Tramal; U 26,226A. HN(75) MHÑTramadol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN27203-92-5 PIAnisoles (74); Cyclohexanols (74); Dimethylamines (74) MND2.33.460.850; D14.73.947 DMÑCyclohexanols LH LM  MStrans-4-(Aminomethyl)cyclohexanecarboxylic acid. Antifibrinolytic hemostatic used in severe hemorrhage. Synonyms: Cyklokapron; Transamin. HN(75) MHÑTranexamic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1197-18-8 PIAmines (66-73); Cyclohexanecarboxylic Acids (68-74); Methylamines (73-74) MND2.241.223.268.860; D19.461.270.463.91.900 XSAMCHA DMÑCyclohexanecarboxylic Acids LH LS LM  MHÑTranquilizing Agents ANdo not use /analogs /biosyn /defic /physiol; don't forget the precoords below; available also are BENZODIAZEPINE TRANQUILIZERS, BUTYROPHENONE TRANQUILIZERS & PHENOTHIAZINE TRANQUILIZERS MND15.236.872 XSAtaractics FXÑHypnotics And Sedatives LH LS LX  MSAgents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms and exert a quieting effect without clouding consciousness: they are used in schizophrenia, senile dementia, etc., and may be effective against nausea, emesis and pruritus. OLto search NEUROLEPTICS use TRANQUILIZING AGENTS, MAJOR back thru 1979 & TRANQUILIZING AGENTS, MAJOR & TRANQUILIZING AGENTS 1975-78 & TRANQUILIZING AGENTS 1969-74 PM75; NEUROLEPTICS was indexed under TRANQUILIZING AGENTS 1969-78 HN75; NEUROLEPTICS was see TRANQUILIZING AGENTS 1975-78, was see under TRANQUILIZING AGENTS 1969-74 MHÑTranquilizing Agents, Major ANdo not use /analogs /biosyn /defic /physiol PITranquilizing Agents (66-74) MND15.236.872.331 XSAntipsychotic Agents; Neuroleptics LH LS;  MSAgents that alleviate anxiety, tension and neurotic symptoms, promote sedation and have a calming effect without affecting clarity of consciousness or neurologic conditions: some are also effective as anticonvulsants, muscle relaxants or anesthesia adjuvants. PM75 HN75 MHÑTranquilizing Agents, Minor ANdo not use /analogs /biosyn /defic /physiol PITranquilizing Agents (66-74) MND15.236.872.659 XSAntianxiety Agents; Anxiolytic Agents LH LS;  MSA psychoanalytic therapy wherein each social transaction is analyzed to determine the involved ego state (whether parent-like, child-like or adult-like) as a basis for understanding behavior. PM79; was see under PSYCHOANALYTIC THERAPY 1975-78 HN79(73); was see under PSYCHOANALYTIC THERAPY 1975-78 MHÑTransactional Analysis ANSPEC qualif PIPsychoanalytic Therapy (73-78) MNF4.754.709.838 LH  HN(72) MHÑTransaldolase ANdo not use /analogs RNEC 2.2.1.2 PITransferases (66-71) MND8.586.913.881 DMÑTransferases LH LM  MSArea of the USSR that includes Armenian S.S.R., Azerbaijan S.S.R., and Georgian S.S.R. HN82 MHÑTranscaucasia MNZ1.252.878.930; Z1.950.930 LH  MSA group of carrier proteins which bind with vitamin B 12 in the blood and aid in its transport. Transcobalamin I migrates electrophoretically as a beta globulin, while transcobalamins II and III migrate as alpha globulins. PM84; was see under BLOOD PROTEINS 1975-83 HN84(75); was see under BLOOD PROTEINS 1975-83 MHÑTranscobalamins AN/biosyn /physiol permitted; do not use /analogs /blood PIBlood Proteins (73-74); Carrier Proteins (73-74); Vitamin B 12 (73-74) MND11.786.708.950.900; D12.776.124.790.900; D12.776.157.800; D12.776.377.715.900 XSTranscobalamin II; Vitamin B12-Binding Proteins LH LS;  PM65 HN65(64) MHÑTranscortin ANdo not use /blood RN9010-38-2 MND12.776.124.790.106.901; D12.776.157.818; D12.776.377.715.85.901; D12.776.395.901 XSCorticosteroid Binding Globulin LH LS  MSEndogenous substances, usually proteins, which are effective in the initiation, stimulation or termination of the genetic transcription process. PM77 HN77 MHÑTranscription Factors ANin genetic transcription; /biosyn /physiol permitted; do not use /analogs PIBacterial Proteins (73-76); Proteins (66-76); Transcription, Genetic (73-76) MND12.776.930 FXÑGene Expression Regulation; ÑTranscription, Genetic XUÑRepressor Proteins; ÑRho Factor; ÑSigma Factor LH LX; LU; ;  MSThe transfer of genetic information from DNA to messenger RNA by DNA-directed RNA polymerase. PM73 HN73 MHÑTranscription, Genetic ANonly /drug eff /rad eff PIRNA, Messenger (66-72) MNG5.331.868 FXÑTranscription Factors LH LX  OLuse TRANSDUCERS to search TRANSDUCER back thru 1966 (as Prov 1966-67) PM73; was TRANSDUCER 1968-72 HN73; was TRANSDUCER 1966-72 (Prov 1966-67) MHÑTransducers ANNIM; no qualif MNE7.943; H1.288.878 XUÑTransducers, Pressure LH LU  MSTransducers that are activated by pressure changes, e.g. blood pressure. HN(80) MHÑTransducers, Pressure ANNIM; no qualif PIManometry (66-79); Transducers (66-79) MNE7.943.901; H1.288.878.901 DMÑTransducers LH LM  MSTransfer of bacterial DNA by phages from the bacterium in which it originates to another bacterium. PM68 HN68 MHÑTransduction, Genetic ANonly /drug eff /rad eff PIGenetics (66-67) MNG5.386.795; G5.920.795 FXÑCrosses, Genetic LH LX  MSInfection of a competent bacterium with nucleic acid that has been isolated from bacteriophage or animal or plant virus. PM78; was see under TRANSFORMATION, GENETIC 1975-77 HN78(75); was see under TRANSFORMATION, GENETIC 1975-77 MHÑTransfection ANinfection of a bact or other cell with viral DNA; only /drug eff /rad eff; coord IM with specific bact /genet (IM) or other cell (NIM usually for cell line) + specific virus /genet (IM) PITransformation, Genetic (68-74) MNG4.185.515.860; G5.386.860; G5.920.860 LH  MSChange in learning in one situation due to prior learning in another situation; can be positive (with second learning improved by first) or negative (where the reverse holds). PM65 HN65(64) MHÑTransfer (Psychology) ANhuman & animal; only /drug eff /rad eff; ╥transfer of training╙ or ╥transfer of learning╙ goes here; DF: TRANSFER MNF2.463.425.910 LH  MSA written agreement for the transfer of patients and their medical records from one health care institution to another. PM68 HN68 MHÑTransfer Agreement ANonly /econ /legis /trends PIspecific organization MNN4.452.602.713 FXÑPatient Transfer LH LX  MSFactor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients. PM75 HN75 MHÑTransfer Factor ANderived from leukocytes; /biosyn /physiol permitted PIImmunity, Maternally-Acquired (66-74); Immunization, Passive (70-74); Lymphokines (74) MND24.611.632.750 LH  MHÑTransferases ANdo not use /analogs RNEC 2. MND8.586.913 XUÑDihydropteroate Synthase; ÑDimethylallyltransferase; ÑMethionine Adenosyltransferase; ÑPropylamine Transferase; ÑRiboflavin Synthase; ÑSerine Hydroxymethyltransferase; ÑSpermine Synthase; ÑTransaldolase LH LU; ; ; ; ; ; ;  MSThe unconscious transfer to others (including psychotherapists) of feelings and attitudes which were originally associated with important figures (parents, siblings, etc.) in one's early life. PM65 HN65(63) MHÑTransference (Psychology) ANhuman only; no qualif; DF: TRANSFERENCE MNF4.754.919.864 LH  MHÑTransferrin ANdo not use /blood RN11096-37-0 MND12.776.124.50.800; D12.776.124.790.223.839; D12.776.157.890; D12.776.377.715.182.839; D12.776.556.901 XSSiderophilin FXÑIron LH LS LX  MSThe heritable modification of the properties of a competent bacterium by DNA from another bacterial strain. PM78 HN78 MHÑTransformation, Bacterial ANtransform of a bact by DNA from another bact strain; only /drug eff /rad eff; coord IM with specific bact transformed /genet (IM) PIGenetics (66-67); Transformation, Genetic (68-77) MNG5.386.872; G5.920.872 LH  MSGenetic recombination brought about by the introduction of purified chromosome fragments. PM68 HN68 MHÑTransformation, Genetic ANGEN: prefer specifics; only /drug eff /rad eff PIGenetics (66-67) MNG5.920 FXÑCrosses, Genetic; ÑDNA, Recombinant LH LX;  MSMobile, short-term residents who move usually to find work. MHÑTransients and Migrants ANonly /psychol; specify geog if possible; do not index Bedouins here: index under ETHNIC GROUPS + geog; HOMELESS PERSONS is available; DF: TRANSIENTS MNM1.920; N1.696.596.797 XSMigrants LH LS  MHÑTransillumination ANdo not use /util except by MeSH definition MNE1.945 XSDIAPHANOSCOPY LH LS  OLsearch SEMICONDUCTORS 1973-74 HN(75); was in Cat H & J 1975-82 MHÑTransistors ANNIM; only /stand MNH1.288.745.714 DMÑSemiconductors LH LM  PM73 HN73(72) MHÑTransketolase ANdo not use /analogs RNEC 2.2.1.1 PITransferases (66-71) MND8.586.913.920 LH  MSConversion from one language to another language. MHÑTranslating ANa cataloging term; no qualif MNL1.143.506.423.796 LH  MSFormation of peptides on ribosomes, directed by messenger RNA. PM73 HN73 MHÑTranslation, Genetic ANonly /drug eff /rad eff; TRANSLATION, GENETIC is in the realm of biochem genetics: do not confuse with TRANSLOCATION (GENETICS), a chromosome aberration PIRibosomes (66-72) MNG5.331.914 XUÑPolarity of Translation LH LU  MSProducts resulting from the conversion of one language to another. MHÑTranslations ANa cataloging term; no qualif MNL1.178.682.920 LH  MSA type of aberration characterized by fragmentation of a chromosome and transfer of the broken-off portion to another chromosome, often of a different pair. OLsearch CHROMOSOME ABERRATIONS 1968-74 PM78; was see under CHROMOSOME ABERRATIONS 1968-77 HN78(75); was see under CHROMOSOME ABERRATIONS 1968-77 MHÑTranslocation (Genetics) ANdo not confuse with TRANSLATION, GENETIC (RNA-directed formation of peptides); only /drug eff /rad eff; DF: TRANSLOCATION PIChromosome Aberrations (68-74); Chromosome Abnormalities (66-67) MNG5.148.266.764 LH  MSExogenous or endogenous chemicals that block or decrease the uptake of various neurotransmitters after they have been released into the synaptic cleft as a result of a nerve impulse; uptake blockade causes increased nerve activity temporarily and subsequent transmitter depletion and decreased activity. PM85 HN85 MHÑTransmitter Uptake Inhibitors, Neuronal AN/biosyn /physiol permitted only with endogenous chemicals; coord IM with specific neurotransmitters /physiol (IM); DF: TRANSM UPTAKE INHIB NEURONAL PICytoplasmic Granules (66-77); Kinetics (66-84); Nerve Endings (66-73); Synapses (66-71); Synaptic Vesicles (72-73); Synaptosomes (74-84) MND16.893.920 XSInhibitors of Neurotransmitter Uptake; Neurotransmitter Uptake Inhibitors; Uptake Inhibitors, Neurotransmitter FXÑAdrenergic Neurohumor Depleters; ÑBiological Transport, Active LH LS; ; LX;  MSTransference of a tissue or organ, alive or dead, within an individual, between individuals of the same species, or between individuals of different species. MHÑTransplantation ANGEN only: prefer /transpl with organs: Manual 19.5+; when GEN & IM, only /adv eff /econ /hist /instrum /methods /mortal /psychol /rehabil /vet; Manual 26.27; TN 243 MNE4.936 FXÑHistocompatibility Testing; ÑNeoplasm Transplantation; ÑTISSUE DONORS; ÑTISSUE PRESERVATION LH LX; ; ;  MSA general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. PM65 HN65 MHÑTransplantation Immunology ANIM; only /drug eff /rad eff; DF: TRANSPL IMMUNOL MNG4.610.555.714 FXÑHistocompatibility Testing; ÑImmunosuppression LH LX;  PM65 HN65 MHÑTransplantation, Autologous ANNIM if at all: TN 243; no qualif when NIM coord; when IM, only /adv eff /hist /instrum /methods /mortal /psychol /rehabil /vet; Manual 19.4.64; for skin or musc flaps in plastic surg index under SURGICAL FLAPS & not also here; DF: TRANSPL AUTOL MNE4.936.664 XSAutograft; Autotransplant LH LS;  PM65 HN65 MHÑTransplantation, Heterologous ANIM: TN 243: only /adv eff /hist /instrum /methods /mortal /psychol /rehabil /vet; no qualif when NIM coord; do not coord here with BIOPROSTHESIS or BIOLOGICAL DRESSINGS: see notes there; Manual 19.4.64; DF: TRANSPL HETEROL MNE4.936.764 XSHeterograft; Xenograft LH LS;  MSTransplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. OLuse TRANSPLANTATION, HOMOLOGOUS to search TRANSPLANTATION, ALLOGENEIC back thru 1975 PM65 HN65; TRANSPLANTATION, ALLOGENEIC was see under TRANSPLANTATION, HOMOLOGOUS 1975-79 MHÑTransplantation, Homologous ANNIM if at all: TN 243; no qualif when NIM coord; when IM, only /adv eff /hist /instrum /methods /mortal /psychol /rehabil /vet; Manual 19.4.64; DF: TRANSPL HOMOL MNE4.936.864 XSAllograft; Homograft; Transplantation, Allogeneic LH LS; ;  MSTransplantation between genetically identical individuals, i.e. members of the same species with identical histocompatibility antigens, such as monozygotic twins, members of the same inbred strain, or members of a hybrid population produced by crossing certain inbred strains. PM80; was see under TRANSPLANTATION, HOMOLOGOUS 1975-79 HN80(75); was see under TRANSPLANTATION, HOMOLOGOUS 1975-79 MHÑTransplantation, Isogeneic ANNIM: TN 243; no qualif when NIM coord; when IM, only /adv eff /hist /instrum /methods /mortal /psychol /rehabil /vet; Manual 19.4.64; DF: TRANSPL ISOGEN PITransplantation, Homologous (66-74) MNE4.936.864.700 XSHomograft, Isogeneic; Homograft, Syngeneic; Isograft; Transplantation, Syngeneic LH LS; ; ;  MSThe means of moving persons, animals, goods, or materials from one place to another. PM76 HN76; was NON MESH before 1976 MHÑTransportation ANonly /class /econ /hist /man /methods /stand CATALOG: /geog /form MNJ1.937 LH  MSConveying ill or injured individuals from one place to another. OLuse TRANSPORTATION OF PATIENTS to search TRANSPORT OF WOUNDED AND SICK back thru 1966 PM78; was TRANSPORT OF WOUNDED AND SICK 1964-77, was TRANSPORT OF WOUNDED 1963 HN78; was TRANSPORT OF WOUNDED AND SICK 1964-77, was TRANSPORT OF WOUNDED 1963 MHÑTransportation of Patients ANonly /econ /hist /methods /stand; includes transport inside & outside the hosp or elsewhere but do not confuse with PATIENT TRANSFER (interfacility or intrahospital transfer for admin reasons with regard to special care or economics) MNE2.365.839; N2.421.297.879 XSTransport of Wounded and Sick FXÑWounds and Injuries LH LS LX  MSA congenital cardiovascular malformation in which the aorta arises entirely from the right ventricle and the pulmonary artery from the left ventricle, so that the venous return from the peripheral circulation is recirculated by the right ventricle via the aorta to the systemic circulation without being oxygenated in the lungs. PM65 HN65 MHÑTransposition of Great Vessels ANdo not use /congen MNC14.280.400.915; C16.131.457.914 LH  MSOverwhelming desire for conversion of sex. PM68 HN68 MHÑTranssexualism ANnote -ss- ; do not use /drug eff /physiol /rad eff; for check tag use genetic sex PIParaphilias (66-67); Transvestism (66-67) MNF3.709.597.608.810 FXÑSex Differentiation Disorders LH LX  MSSexual pleasure derived from dressing or masquerading in the clothing of the opposite sex; usually seen in men. MHÑTransvestism ANdo not spell as transvestitism; do not use /drug eff /physiol /rad eff MNF3.709.597.608.700.708 LH  MHÑTranylcypromine ANdo not use /biosyn /defic /physiol RN155-09-9 MND8.373.616.914; D15.236.122.627.914 LH  MSN,N-Diethyl-5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7-amine. A coronary vasodilator agent. Synonyms: Rocornal; AR 12008. OLuse TRAPIDIL to search TRAPYMIN back thru 1975 HN(84); was TRAPYMIN see under PYRIMIDINES 1975-83 MHÑTrapidil ANdo not use /biosyn /defic /physiol; /analogs NIM only RN15421-84-8 PIPyrimidines (66-74); Triazoles (66-74) MND3.383.129.799.900; D3.383.742.875; D3.383.946.900; D18.918.900 XSTrapymin DMÑPyrimidines LH LS LM  MSSpecialized hospital facilities which provide diagnostic and therapeutic services for trauma patients. PM75 HN75 MHÑTrauma Centers ANdo not use /educ /methods PIEmergency Service, Hospital (66-74) MNN2.278.354.422.336.500; N2.421.297.388.480; N4.452.442.422.336.400 XSTrauma Units LH LS  MSThe branch of surgery which deals with wounds and disability from injuries. PM87 HN87 MHÑTraumatology ANSPEC; SPEC qualif CATALOG: use with form qualif instead of WOUNDS AND INJURIES /form MNG2.403.850 FXÑWounds and Injuries LH LX  MSAspects of health and disease related to travel; excludes study tours. MHÑTravel ANmed, social, psychol aspects of travel & tourism; for articles on ╥the hazards of travel╙ or ╥the spread of disease by travel╙; not for study tours to various countries: index object of study + geog, as HOSPITALS + GHANA, PEDIATRICS + CHINA; consider also MEDICAL MISSIONS, OFFICIAL or MISSIONS AND MISSIONARIES MNI3.883 LH  MS2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one monohydrochloride. Centrally acting drug which possesses properties as an antidepressive agent, anxiolytic, or anesthesia adjuvant. Synonym: AF-1161. PM86; was see under PIPERAZINES 1975-85 HN86(75); was see under PIPERAZINES 1975-85 MHÑTrazodone ANdo not use /biosyn /defic /physiol RN19794-93-5 PIPiperazines (71-74); Pyridines (71-74); Triazoles (71-74) MND3.383.606.900; D3.383.725.791.900; D15.236.122.932; D15.236.872.659.932 LH  MSWoody, usually tall, perennial higher plants (Angiosperms, Gymnosperms and some Pterophyta) having usually a main stem and numerous branches. OLuse TREES to search JUNIPER back thru 1963 PMACACIA, EUCALYPTUS & JUNIPER were headings 1963-85 HNACACIA, EUCALYPTUS & JUNIPER were headings 1963-85 MHÑTrees ANIM; no qualif; includes foliage, needles, acorns, cones, buds, flowers, but remember FRUIT, POLLEN, RESINS, SEEDS, WOOD are available (coord these IM with TREES (NIM) ); forests go here but coord IM with GEOGRAPHY (IM) or ECOLOGY (IM) or other aspect if pertinent MNB6.915 XSJuniper XUÑAcacia; ÑEucalyptus LH LS LU;  PM73 HN73(71) MHÑTrehalase ANdo not confuse with TREHALOSE; do not use /analogs RNEC 3.2.1.28 PIGlycoside Hydrolases (66-70) MND8.586.277.450.329.865 LH  HN(73) MHÑTrehalose ANcalled ergot sugar & mycose; do not confuse with TREHALASE; do not use /defic /physiol; /analogs NIM only RN99-20-7 MND9.203.698.365.900; D9.203.698.629.305.880 DMÑDisaccharides LH LM  MSClass of parasitic flukes consisting of three subclasses, Monogenea, Aspidogastrea, and Digenea. The digenetic trematodes are the only ones found in man. They are endoparasites and require two hosts to complete their life cycle. MHÑTrematoda ANGEN: prefer specifics; do not use /blood-csf-urine MNB1.500.736.715 XSFlukes LH LS  MSInfections caused by infestation with worms of the class Trematoda. OLuse TREMATODE INFECTIONS to search FASCIOLOPSIASIS & METAGONIMIASIS back thru 1967 HNFASCIOLOPSIASIS & METAGONIMIASIS were see under TREMATODE INFECTIONS 1967-81 MHÑTrematode Infections ANGEN: prefer specific trematode infections in MeSH or coord of specific trematode in MeSH with infection term as directed under name of trematode MNC3.335.865 XSFasciolopsiasis; Metagonimiasis XUÑEchinostomiasis LH LS; LU  MSAn involuntary trembling or quivering. MHÑTremor MNC10.597.559.930; C23.888.592.574.921 LH  PM66 HN66 MHÑTremorine ANdo not use /biosyn /defic /physiol RN51-73-0 MND16.698.628.891 LH  MS17-beta-Hydroxyestra-4,9,11-trien-3-one. An anabolic steroid used mainly as a growth substance in animals. HN(79) MHÑTrenbolone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN10161-33-8 PIAnabolic Steroids (66-78); Estranes (68-74); Estrenes (75-78) MND4.808.365.415.930; D6.597.100.194.930 XSTrienbolone DMÑEstrenes LH LS LM  MSAn intermittent fever characterized by intervals of chills, fever and splenomegaly each of which may last as long as 40 hours; it is caused by Rickettsia quintana and transmitted by the human louse. MHÑTrench Fever ANcaused by Rickettsia quintana; do not confuse with TRENCH FOOT MNC1.850.810.800.920 LH  MSA condition resembling frostbite produced by a prolonged exposure of the feet to water in combination with cold and inactivity, altogether producing insufficient circulation. MHÑTrench Foot ANdo not confuse with TRENCH FEVER, a rickettsial disease MNC21.866.417.840; C23.304.351.902 FXÑCold LH LX  MHÑTrephining ANrestrict to skull: do not use for other tissues; do not use /util except by MeSH definition MNE4.530.915 FXÑSkull LH LX  MSA genus of microorganisms of the order Spirochaetales, many of which are pathogenic and parasitic for man. MHÑTreponema ANdo not use /blood-csf-urine; infection = TREPONEMAL INFECTIONS or its specifics MNB3.851.595.795 LH  MSSyphilis serodiagnosis employing as the antigen T. Pallidum obtained from rabbit syphilis orchitis. Treponemes are kept alive for a few hours in a special medium. When syphilitis serum and complement are added and incubated, the treponemes are immobilized, i.e., stop moving. Syn: Treponema pallidum immobilization; TPI. MHÑTreponema Immobilization Test ANonly /instrum /methods; also called Treponema Pallidum Immobilization & TPI MNE1.223.495.826.895.715 LH  MSThe causative agent of both venereal and non-venereal syphilis in man. MHÑTreponema Pallidum ANdo not use /blood-csf-urine; infection = SYPHILIS MNB3.851.595.795.840 LH  MSInfections by species of Treponema. PMBEJEL was heading 1963-67 MHÑTreponemal Infections ANTreponema pallidum infection = SYPHILIS MNC1.252.847.840 XUÑBejel LH LU  MStrans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoic acid. A topical dermatologic agent which is used in the treatment of psoriasis, acne vulgaris and several other skin diseases; may be teratogenic. PM80; was see under VITAMIN A 1975-79 HN80(75); was see under VITAMIN A 1975-79 MHÑTretinoin AND25-26 qualif RN302-79-4 PICarotenoids (69-74); Vitamin A (66-74) MND2.455.849.291.700.780; D11.557.261.700.780; D26.368.627.666.920 XSRetinoic Acid; Vitamin A Acid LH LS;  MS1,2,3,4-Tetrahydro-1-[(3,4,5-trimethoxyphenyl)methyl]6,7-isoquinolinediol. An adrenergic beta receptor agonist used as a bronchodilator agent in asthma therapy. Synonyms: AQL 208; TMQ. HN(75) MHÑTretoquinol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN18559-59-6 PIBenzyl Compounds (72-74); Isoquinolines (71-74) MND3.438.531.870; D16.116.922; D16.893.116.348.937 XSTrimethoquinol DMÑIsoquinolines LH LS LM  MSS-2,3,3-Trichloroallyl N,N-diisopropylthiocarbamate. A pre-emergence, selective herbicide for the control of wild oats in various crops. Frequently encountered synonyms: Far-Go; Aradex BW. HN(75) MHÑTri-allate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2303-17-5 PIAllyl Compounds (73-74); Thiocarbamates (70-74) MND2.241.81.251.869.820; D2.241.866.653.820; D2.886.703.820; D5.723.366.448.900 DMÑThiocarbamates LH LM  HN(66) MHÑTriacetin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN102-76-1 MND10.516.351.801.632; D20.136.845; D20.187.878 DMÑTriglycerides LH LM  MS2,2,6,6-Tetramethyl-4-piperidone-N-oxyl. Cyclic N-oxide radical functioning as a spin label and radiation-sensitizing agent. HN(75) MHÑTriacetoneamine-N-Oxyl ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2896-70-0 PICyclic N-Oxides (72-74); Piperidones (73-74) MND2.389.678.900; D3.383.621.808.930; D3.661.243.930 XSTAN DMÑCyclic N-Oxides LH LS LM  MHÑTriacetyloleandomycin ANdo not use /biosyn /defic /physiol RN2751-09-9 MND20.85.593.715 XSOleandocetin; Troleandomycin LH LS;  MSThe sorting out and classification of patients or casualties to determine priority of need and proper place of treatment. HN(76); was see under EMERGENCY HEALTH SERVICES 1976-79 MHÑTriage ANonly /man /organ /stand /util PIEmergencies (66-75); Emergency Service, Hospital (66-75) MNN2.421.297.900 DMÑEmergency Medical Services LH LM  MSOrganometallic compounds which contain tin and three alkyl groups. PM75 HN75 MHÑTrialkyltin Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: TRIALKYLTIN CPDS PIOrganometallic Compounds (68-74); Tin (68-74) MND2.691.850.900 XUÑTriethyltin Compounds; ÑTrimethyltin Compounds LH LU;  MHÑTriamcinolone ANdo not use /biosyn /defic /physiol RN124-94-7 MND4.808.745.432.915; D4.808.908.891; D6.597.481.561.353.903; D6.597.481.561.478.909; D26.74.125.447.903; D26.74.125.903; D26.74.148.447.903; D26.368.99.447.903 LH  MHÑTriamcinolone Acetonide ANdo not use /biosyn /defic /physiol RN76-25-5 MND4.808.745.432.915.715; D4.808.908.891.927; D6.597.481.561.353.903.715; D6.597.481.561.478.909.715; D16.116.927; D26.74.125.447.903.927; D26.74.125.903.927; D26.74.148.447.903.927; D26.368.99.447.903.927 LH  PM65 HN65(63) MHÑTriamterene ANdo not use /biosyn /defic /physiol RN396-01-0 MND3.438.733.900; D19.770.224.902 LH  MSA genus of bugs of the family Reduviidae; several species are vectors of Trypanosoma cruzi. OLsearch TRIATOMIDAE 1973-74 HN(75); was see under TRIATOMINAE 1973-78 MHÑTriatoma AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 MNB1.131.617.412.841.841 DMÑTriatomidae LH LM  MSA family of true bugs (Hemiptera) including the genera Triatoma, Rhodnius, and Panstrongylus, which are vectors of Trypanosoma cruzi, the agent of Chagas' Disease. OLuse TRIATOMIDAE to search TRIATOMINAE back thru 1967 (as Prov 1967-72) PM79; was TRIATOMINAE 1973-78 HN79; was TRIATOMINAE 1967-78 (Prov 1967-72) MHÑTriatomidae AN/microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 PIInsect Vectors (66); Insects (66) MNB1.131.617.412.841 XSReduviidae; Triatominae XUÑPanstrongylus; ÑRhodnius; ÑTriatoma LH LS; LU; ;  PM73 HN73(72) MHÑTriazenes ANdo not confuse with TRIAZINES; do not use /analogs /biosyn /defic /physiol PIAzo Compounds (66-71) MND2.925 LH  MHÑTriazines ANdo not confuse with TRIAZENES; do not use /analogs /biosyn /defic /physiol MND3.383.931 XUÑApazone; ÑCycloguanil Pamoate; ÑFerrozine; ÑHexamethylmelamine; ÑOxonic Acid LH LU; ; ; ;  MS2,3,5-tris(1-Aziridinyl)-2,5-cyclohexadiene-1,4-dione. Alkylating antineoplastic agent used mainly for ovarian tumors; toxic to skin, gastrointestinal tract, bone marrow and kidneys. Synonyms: Bayer 3231; NSC 29215; Oncoredox; Riker 601; Trenimon. PM67 HN67(64) MHÑTriaziquone ANdo not use /biosyn /defic /physiol RN68-76-8 MND3.383.97.217.900; D22.204.902 LH  MS8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine. Tranquilizing agent similar in action to flurazepam; used as a hypnotic. Synonym: U 33,030. PM86; was see under BENZODIAZEPINE TRANQUILIZERS 1977-85 HN86(77); was see under BENZODIAZEPINE TRANQUILIZERS 1977-85 MHÑTriazolam ANdo not use /biosyn /defic /physiol RN28911-01-5 PIBenzazepines (74); Benzodiazepines (75-76); Triazoles (74-76) MND3.438.79.80.900; D14.591.745.920; D15.236.872.659.191.896 LH  MHÑTriazoles ANincludes triazolines, triazolidines; do not use /analogs /biosyn /defic /physiol MND3.383.129.799; D3.383.946 XUÑAmitrole; ÑGuanazole LH LU;  MSA genus of small beetles of the family Tenebrionidae; T. confusum is the ╥confused flour beetle╙. PM72 HN72 MHÑTribolium AN╥confused flour beetle╙; /microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111 PIBeetles (66-71) MNB1.131.617.155.304.799 LH  MHÑTribromoethanol ANdo not use /biosyn /defic /physiol RN1329-86-8 MND2.33.57.841; D14.166.872 XSBromethol; Ethobrome LH LS;  OLuse TRICARBOXYLIC ACIDS to search ACIDS, TRICARBOXYLIC back thru 1971 PM72; was ACIDS, TRICARBOXYLIC 1971 HN72; was ACIDS, TRICARBOXYLIC 1971 MHÑTricarboxylic Acids ANdo not use /analogs /physiol; /metab is probably TRICARBOXYLIC ACID CYCLE PIAcids (66-70) MND2.241.81.901 XUÑAconitic Acid LH LU  MSA genus of parasitic nematodes; T. spiralis produces trichinosis. MHÑTrichinella ANdo not use /blood-csf-urine; infection = TRICHINOSIS MNB1.500.294.780.608 XSTRICHINA LH LS  MSA disease due to infection with Trichinella spiralis; it is caused by eating undercooked meat, usually pork. MHÑTrichinosis ANcaused by Trichina or Trichinella: do not confuse with TRICHURIASIS, caused by Trichuris MNC3.335.508.882 XSTRICHINELLIASIS LH LS  PM74 HN74(71) MHÑTrichlorfon ANdo not use /biosyn /defic /physiol RN52-68-6 PIInsecticides (66-71) MND2.705.930; D5.723.491.574.910 XSCHLOROPHOS; Metrifonate LH LS;  MHÑTrichlormethiazide ANdo not use /biosyn /defic /physiol RN133-67-5 MND3.438.174.261.476.716; D18.162.276.237.476.892; D19.770.224.578.237.476.892 LH  MHÑTrichloroacetic Acid ANdo not use /biosyn /defic /physiol RN76-03-9 MND2.241.81.38.866 LH  MS1,1,1-Trichloro-2,3-epoxypropane. A potent epoxide hydrase and aryl hydrocarbon hydroxylase inhibitor. Enhances the tumor-initiating ability of certain carcinogens. HN(80) MHÑTrichloroepoxypropane ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3083-23-6 PIEpoxy Compounds (75-79); Ethers, Cyclic (66-74); Hydrocarbons, Chlorinated (74-79); Hydrocarbons, Halogenated (66-73) MND2.355.291.411.900; D2.455.526.439.920; D8.373.880 XSTrichloropropene Oxide DMÑHydrocarbons, Chlorinated LH LS LM  MSChlorinated ethanes which are used extensively as industrial solvents. They have been utilized in numerous home-use products including spot remover preparations and inhalant decongestant sprays. These compounds cause central nervous system and cardiovascular depression and are hepatotoxic. Include 1,1,1- and 1,1,2-isomers. HN(77) MHÑTrichloroethanes ANdo not use /analogs /biosyn /defic /physiol PIEthane (74-75); Hydrocarbons, Chlorinated (74-76) MND2.455.526.439.927 DMÑHydrocarbons, Chlorinated LH LM  MHÑTrichloroethylene ANdo not use /biosyn /defic /physiol RN79-01-6 MND2.455.526.439.939; D14.166.901 XSEthinyl Trichloride LH LS  MSA deuteromycetous fungal genus of the class Hyphomycetes frequently found in soil and sometimes of use for controlling pathogenic fungi. HN(75); was see under MONILIALES 1975-85 MHÑTrichoderma ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.381.546.910 DMÑHyphomycetes LH LM  MS12,13-Epoxytrichothec-9-en-4-ol acetate. Antifungal metabolite from several fungi, mainly Trichoderma viride; inhibits protein synthesis by binding to ribosomes; proposed as antifungal and antineoplastic; used as tool in cellular biochemistry. Synonym: WG 696. HN(75) MHÑTrichodermin ANdo not use /defic /physiol; /analogs NIM only RN4682-50-2 PISesquiterpenes (74) MND2.455.849.765.850.900; D24.185.926.587.933.900 XSTrichodermol DMÑSesquiterpenes LH LS LM  MSA genus of parasitic flagellate protozoans distinguished by the presence of four anterior flagella, an undulating membrane and a trailing flagellum. MHÑTrichomonas ANdo not use /anat /blood-csf-urine /embryol; trichomonicides = ANTITRICHOMONAL AGENTS; infection = TRICHOMONAS INFECTIONS MNB1.841.443.808 LH  MSInfections in birds and mammals produced by various species of Trichomonas. OLuse TRICHOMONAS INFECTIONS to search TRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS & TRICHOMONAS URETHRITIS back thru 1966 PMTRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS & TRICHOMONAS URETHRITIS were headings 1963-71 HNTRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS & TRICHOMONAS URETHRITIS were headings 1963-71 MHÑTrichomonas Infections AN/drug ther: consider also ANTITRICHOMONAL AGENTS MNC3.752.900 LH  MSA species of Trichomonas which produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males. PM72 HN72 MHÑTrichomonas Vaginalis ANan organism: do not confuse with the disease TRICHOMONAS VAGINITIS; do not use /anat /blood-csf-urine /embryol; infection = probably TRICHOMONAS VAGINITIS PITrichomonas (66-71) MNB1.841.443.808.717 LH  MSInflammation of the vagina, marked by a purulent discharge; caused by Trichomonas vaginalis. MHÑTrichomonas Vaginitis ANdo not confuse with the organism TRICHOMONAS VAGINALIS MNC3.752.900.717; C13.371.894.906.633 LH  HN(86)63 MHÑTrichophytin ANdo not confuse with TRICHOPHYTON; only /admin /adv eff /anal /csf /class /immunol /isol /rad eff /stand /tox /urine RN1404-86-0 MND20.136.885; D24.611.216.202.800 DMÑAntigens, Fungal LH LM  MSA deuteromycetous fungal genus of the class Hyphomycetes; various species attack skin, nails and hair. MHÑTrichophyton ANdo not confuse with TRICHOPHYTIN; do not use /anat /embryol /microbiol /parasitol; infection = TRICHOPHYTOSIS see TINEA MNB5.354.318.842; B5.354.381.546.928 XSENDODERMOPHYTON LH LS  MSA deuteromycetous fungal genus causing opportunistic infections, endocarditis, fungemia, and white piedra (T.beigelii). HN(86) MHÑTrichosporon ANdo not use /embryol /microbiol /parasitol; infection: coord NIM with MYCOSES (IM) PIHyphomycetes (66-85) MNB5.354.381.546.940; B5.354.930.930 DMÑHyphomycetes LH LM  MSA superfamily of nematodes; most are intestinal parasites of ruminants and accidentally in humans. This superfamily includes seven genera: DICTYOCAULUS, HAEMONCHUS, Cooperia, OSTERTAGIA, Nematodirus, Trichostrongylus, and Hyostrongylus. PMDICTYOCAULUS was see under METASTRONGYLOIDEA 1975-85 MHÑTrichostrongyloidea ANa superfamily of nematodes; do not use /blood-csf-urine; infection = TRICHOSTRONGYLOIDIASIS MNB1.500.294.746 XUÑDictyocaulus; ÑHaemonchus LH LU;  MSInfection by roundworms of the superfamily Trichostrongyloidea, including the genera Trichostrongylus, Ostertagia, Cooperia, Haemonchus, Nematodirus, Hyostrongylus. PM68; TRICHOSTRONGYLOSIS was heading 1963-67 HN68 MHÑTrichostrongyloidiasis ANcaused by various genera of Trichostrongyloidea: do not confuse with TRICHOSTRONGYLOSIS (see note below) PINematode Infections (66-67); Trichostrongyloidiasis (66-67) MNC3.335.508.909 XUÑHaemonchiasis; ÑOstertagiasis; ÑTrichostrongylosis LH LU; ;  MSInfestation with nematode worms of the genus Trichostrongylus. OLsearch TRICHOSTRONGYLOIDIASIS 1966-74 HN(75)63-67 MHÑTrichostrongylosis ANcaused by TRICHOSTRONGYLUS; do not confuse with TRICHOSTRONGYLOIDIASIS: see note above MNC3.335.508.909.842 DMÑTrichostrongyloidiasis LH LM  MSA genus of nematodes parasitic in the digestive tract of herbivorous animals; they occur only as incidental infections in humans. The following species have been reported in man: T. colubriformus, T. orientalia, T. axei, and T. probolurus. PM86 HN86 MHÑTrichostrongylus ANdo not use /blood-csf-urine; infection = TRICHOSTRONGYLOSIS PITrichostrongyloidea (66-85) MNB1.500.294.746.610 LH  MSUsually 12,13-epoxytrichothecenes, produced by Fusaria, Stachybotrys, Trichoderma and other fungi, and some higher plants; may contaminate food or feed grains, induce emesis and hemorrhage in lungs and brain, and damage bone marrow due to protein and DNA synthesis inhibition. OLuse TRICHOTHECENES to search EPOXYTRICHOTHECENES back thru 1975 HN(81); was EPOXYTRICHOTHECENES see under SESQUITERPENES 1975-80 MHÑTrichothecenes ANdo not use /analogs /defic /physiol PIBenzoxepins (68-74); Ethers, Cyclic (66-74); Sesquiterpenes (74); Terpenes (66-73) MND2.455.849.765.850; D24.185.926.587.933 XSEpoxytrichothecenes; Trichothecene Epoxides DMÑSesquiterpenes LH LS; LM  MSCompulsion to pull out one's hair. OLsearch OBSESSIVE-COMPULSIVE DISORDER 1966-74 HN(75); was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80, was in Cat F only 1975-79 MHÑTrichotillomania ANdo not use /drug eff /physiol /rad eff MNC17.805.305.940; F3.709.438.180.490.600 DMÑObsessive-Compulsive Disorder LH LM  MSInfection with nematodes of the genus Trichuris. MHÑTrichuriasis ANcaused by Trichuris: do not confuse with TRICHINOSIS, caused by Trichina or Trichinella MNC3.335.508.935 XSTRICHOCEPHALIASIS LH LS  MSA genus of nematode worms comprising the whipworms. OLsearch TRICHUROIDEA 1966-71; to search TRICHOCEPHALUS use TRICHURIS back thru 1974 & TRICHUROIDEA 1966-73 PM72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66 HN72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHURIS 1974-78, was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66 MHÑTrichuris ANdo not use /blood-csf-urine; infection = TRICHURIASIS MNB1.500.294.780.628 XSTrichocephalus LH LS  MSA superfamily of Nematoda. OLuse TRICHUROIDEA to search TRICHINELLOIDEA back thru 1966 PM67; was TRICHINELLOIDEA 1963-66 HN67; was TRICHINELLOIDEA 1963-66 MHÑTrichuroidea ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.780 XSTRICHINELLOIDEA XUÑCapillaria LH LS LU  MS5-Chloro-2-(2,4-dichlorophenoxy)phenol. A diphenyl ether derivative used in cosmetics and toilet soaps as antiseptic; it has some bacteriostatic and fungistatic action. HN(76) MHÑTriclosan ANdo not use /biosyn /defic /physiol; /analogs NIM only RN3380-34-5 PIChlorobenzenes (74-75); Phenyl Ethers (74-75) MND2.355.726.900; D20.187.916 XSIrgasan DP 300 DMÑPhenyl Ethers LH LS LM  MSThe valve consisting of three cusps situated between the right atrium and right ventricle of the heart. MHÑTricuspid Valve ANdo not use /blood supply; atresia: index TRICUSPID VALVE /abnorm; stenosis = TRICUSPID VALVE STENOSIS; regurgitation, incompetence & insufficiency = TRICUSPID VALVE INSUFFICIENCY MNA7.541.510.893 LH  OLuse TRICUSPID VALVE INSUFFICIENCY to search TRICUSPID INSUFFICIENCY back thru 1966 PM67; was TRICUSPID INSUFFICIENCY 1963-66 HN67; was TRICUSPID INSUFFICIENCY 1963-66 MHÑTricuspid Valve Insufficiency ANimperfect closing of valve; incompetence & regurgitation go here; /congen permitted MNC14.280.484.856 LH  MSAbnormal protrusion of one or more of the leaflets of the tricuspid valve into the right atrium during systole. HN(83) MHÑTricuspid Valve Prolapse PIHeart Valve Diseases (67-82); Tricuspid Valve (66-82) MNC14.280.484.870 DMÑHeart Valve Diseases LH LM  OLuse TRICUSPID VALVE STENOSIS to search TRICUSPID STENOSIS back thru 1966 PM67; was TRICUSPID STENOSIS 1963-66 HN67; was TRICUSPID STENOSIS 1963-66 MHÑTricuspid Valve Stenosis AN/congen permitted; atresia = TRICUSPID VALVE /abnorm MNC14.280.484.911 LH  MS2,4,6-tris(1-Aziridinyl)5-triazine. Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers. Synonyms: NSC 9706; Persistol HOE 1/139; SK 1133; TEM; Triamelin; triethanomelamine. OLuse TRIETHYLENEMELAMINE to search TRIETHYLENE MELAMINE back thru 1966 PM81; was TRIETHYLENE MELAMINE 1963-80 HN81; was TRIETHYLENE MELAMINE 1963-80 MHÑTriethylenemelamine ANdo not use /biosyn /defic /physiol RN51-18-3 MND3.383.97.217.924; D22.204.924 XSTretamine LH LS  MSN,N'-Bis(2-aminoethyl)-1,2-ethanediamine. Used as stabilizer for epoxy resins, as ampholyte for isoelectric focusing and as chelating agent for copper in hepatolenticular degeneration; may cause liver damage. Synonyms: Trien; TETA. HN(78) MHÑTriethylenetetramine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN112-24-3 PIAmmonium Compounds (66-74); Ethylenediamines (75-77); Piperidines (66-74) MND2.92.782.258.368.880; D26.241.932 DMÑEthylenediamines LH LM  MSOrganic compounds composed of tin and three ethyl groups. Affect mitochondrial metabolism and inhibit oxidative phosphorylation by acting directly on the energy conserving processes. HN(75) MHÑTriethyltin Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: TRIETHYLTIN CPDS PIOrganometallic Compounds (72-74); Tin (72-74) MND2.691.850.900.910 DMÑTrialkyltin Compounds LH LM  MHÑTrifluoperazine ANdo not use /biosyn /defic /physiol RN117-89-5 MND3.494.741.898; D15.236.872.331.628.895 XSTrifluoroperazine; Triftazin LH LS;  MSTrifluoro substituted acetic acid. HN(75) MHÑTrifluoroacetic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN76-05-1 PIFluoroacetates (72-74) MND2.241.81.38.209.348.900 XSTrifluoroacetate DMÑFluoroacetates LH LS LM  MS2,2,2-Trifluroethanol. HN(75) MHÑTrifluoroethanol ANdo not use /biosyn /defic /physiol RN75-89-8 PIAlcohol, Ethyl (72-74); Fluorine (72-74) MND2.33.57.880 XSTrifluoroethyl Alcohol DMÑAlcohol, Ethyl LH LS LM  MS2'-Deoxy-5-trifluoromethyluridine. An antiviral derivative of thymidine used mainly in treatment of ophthalmic infections. Synonym: F3TDR. HN(75) MHÑTrifluorothymidine ANdo not use /biosyn /defic /physiol RN70-00-8 PIFluorine (72-74); Thymidine (72-74) MND13.570.230.855.900; D13.570.685.705.900; D20.388.902; D26.87.931 DMÑThymidine LH LM  PM72 HN72(65) MHÑTrifluperidol ANdo not use /biosyn /defic /physiol RN749-13-3 MND2.522.352.867; D15.236.872.331.241.867 LH  MHÑTriflupromazine ANdo not use /biosyn /defic /physiol RN146-54-3 MND3.494.741.918; D15.236.872.331.628.917 XSFluopromazine LH LS  HN(72) MHÑTrifluralin ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1582-09-8 PIHerbicides (66-71); Toluene (66-71) MND2.92.146.859.717; D2.455.426.559.389.832.767; D5.723.366.931 DMÑToluidines LH LM  MSThe caudal portion of the nucleus of the spinal trigeminal tract (TRIGEMINAL NUCLEUS, SPINAL), a nucleus involved with pain and temperature sensation. HN(80); was see under TRIGEMINAL NUCLEI 1980-81 MHÑTrigeminal Caudal Nucleus ANdo not use /innerv; do not confuse with CAUDATE NUCLEUS (corpus striatum) PITrigeminal Nerve (66-79) MNA8.186.211.132.931.920.927 XSCaudal Nucleus, Trigeminal DMÑTrigeminal Nucleus, Spinal LH LS LM  MHÑTrigeminal Nerve AN5th cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.848 XUÑSemilunar Ganglion LH LU  MHÑTrigeminal Neuralgia MNC10.772.204.843; C10.772.537.868 XSTic Douloureux FXÑFacial Pain LH LS LX  MSNuclei of the trigeminal nerve situated in the brain stem. They include the nucleus of the spinal trigeminal tract (TRIGEMINAL NUCLEUS, SPINAL), the principal sensory nucleus, the mesencephalic nucleus, and the motor nucleus. PM80 HN80 MHÑTrigeminal Nuclei ANdo not use /innerv PITrigeminal Nerve (66-79) MNA8.186.211.132.931 LH  MSNucleus of the spinal tract of the trigeminal nerve. Divided cytoarchitectonically into three parts: oralis, caudalis (TRIGEMINAL CAUDAL NUCLEUS), and interpolaris. PM82; TRIGEMINAL CAUDAL NUCLEUS was see under TRIGEMINAL NUCLEI 1980-81 HN82 MHÑTrigeminal Nucleus, Spinal ANdo not use /innerv PISpinal Cord (66-81); Trigeminal Nerve (66-79); Trigeminal Nuclei (80-81) MNA8.186.211.132.931.920 XUÑTrigeminal Caudal Nucleus LH LU  PM68 HN68(66) MHÑTriglycerides ANdo not use /analogs /defic; /blood: consider also the hypertriglyceridemias in HYPERLIPOPROTEINEMIA TYPE 1, HYPERLIPOPROTEINEMIA TYPE IV & HYPERLIPOPROTEINEMIA TYPE V MND10.516.351.801 XSTriacylglycerols XUÑTriacetin LH LS LU  MSGlycosphingolipids which contain as their polar head group a trisaccharide (galactose-galactose-glucose) moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in ceramide trihexosidase, is the cause of angiokeratoma corporis diffusum (Fabry's disease). HN(79) MHÑTrihexosylceramides AN/biosyn /physiol permitted; do not use /analogs PICeramides (72-78); Cerebrosides (66-78); Glycosphingolipids (75-78) MND10.516.390.470.820; D10.516.808.530.820 XSCeramide Trihexosides; Trihexosyl Ceramides DMÑGlycosphingolipids LH LS; LM  MHÑTrihexyphenidyl ANdo not use /biosyn /defic /physiol RN144-11-6 MND3.383.621.900; D16.653.926 XSBenzhexol LH LS  OLuse TRIIODOBENZOIC ACIDS to search TRIIODOBENZOIC ACID back thru 1972 (as Prov 1972-74) HN(78); was TRIIODOBENZOIC ACID see under IODOBENZOATES 1975-77, was TRIIODOBENZOIC ACID 1972-74 (Prov) MHÑTriiodobenzoic Acids ANdo not use /analogs /biosyn /defic /physiol PIBenzoates (66-71); Plant Growth Regulators (66-71) MND2.241.223.106.530.718; D11.303.760.894 DMÑIodobenzoates LH LM  OLuse TRIIODOTHYRONINE to search LIOTHYRONINE back thru 1966 PMLIOTHYRONINE was heading 1963-66 HNLIOTHYRONINE was heading 1963-66 MHÑTriiodothyronine AN= T3; /physiol permitted RN6893-02-3 MND6.472.931.812.741.894; D12.125.72.734.741.894 XSLiothyronine LH LS  MS0-(4-Hydroxy-3,5-diiodophenyl)-3-iodo-L-tyrosine. A metabolite of thyroxine formed by the peripheral degradation of thyroxine as a result of the tyrosyl or inner ring 5-deiodination. In systemic disease states or in neonates, levels of triiodothyronine are low and those of reverse triiodothyronine are elevated. Reverse T3 is therefore useful as a diagnostic aid and in the treatment of fetal and infantile hypothyroidism. PM85; was see under TRIIODOTHYRONINE 1979-84 HN85(79); was see under TRIIODOTHYRONINE 1979-84 MHÑTriiodothyronine, Reverse AN/physiol permitted; DF: REVERSE T3 RN5817-39-0 PIIsomerism (71-78); Triiodothyronine (66-78) MND6.472.931.812.741.894.900; D12.125.72.734.741.894.900 XS3,3',5'-Triiodothyronine; Reverse Triiodothyronine LH LS;  MSCombination of pulmonary valve stenosis and atrial septal defect with right ventricular hypertrophy. HN(75) MHÑTrilogy of Fallot ANdo not use /congen; do not confuse with TETRALOGY OF FALLOT MNC14.280.400.560.375.702; C16.131.457.559.376.700 XSFallot's Trilogy DMÑHeart Septal Defects, Atrial LH LS LM  MSbeta-Ethyl-beta-dimethylaminophenylethyl-3,4,5-trimethoxybenzoate. Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders. Synonyms: Debridat; Dromostat; JO 475. HN(77) MHÑTrimebutine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN39133-31-8 PIBenzoates (66-76); Butylamines (66-76) MND2.241.223.106.900; D19.316.929 DMÑBenzoates LH LM  MS2-Diethylamino-2',4',6'-trimethylacetanilide. Acetanilide derivative used as a local anesthetic. Synonyms: Mesidicaine; Mesocaine. HN(75) MHÑTrimecaine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN616-68-2 PIAcetanilides (70-74); Diethylamines (74) MND2.65.199.92.900; D14.211.950 DMÑAcetanilides LH LM  MS1,1'-Trimethylenebis(4-formylpyridiniumdioxime)dibromide. Cholinesterase reactivator used as an antidote in alkyl phosphate poisoning. Synonyms: TMB-4; Dipyroxime. HN(75) MHÑTrimedoxime ANdo not use /biosyn /defic /physiol; /analogs NIM only RN56-97-3 PIOximes (72-74); Pyridinium Compounds (69-74) MND2.92.570.665.850; D3.383.725.762.900; D8.515.347.582.850; D16.653.211.498.900 DMÑOximes LH LM  MS1-(4-Acetoxy-2,3,5-trimethylphenoxy) 3-isopropylamino-2-propanol. Beta adrenergic blocker effective for both beta1 and beta2 receptors; proposed as antiarrhythmic. Synonym: VUFB 6453. HN(79) MHÑTrimepranol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN38202-74-3 PIAmino Alcohols (66-73); Propanolamines (74-78) MND2.33.329.624.945; D2.92.63.624.945; D16.848.215.937 XSMetipranolol DMÑPropanolamines LH LS LM  MHÑTrimeprazine ANdo not use /biosyn /defic /physiol RN84-96-8 MND3.494.741.939; D15.236.872.331.628.940 XSAlimemazine; Isobutrazine; Methylpromazine LH LS; ;  MS1-(2,3,4-Trimethoxybenzyl)piperazine. Vasodilator used in angina of effort or ischemic heart disease. Synonyms: Vasodil; Vastarel. HN(76) MHÑTrimetazidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN5011-34-7 PIBenzyl Compounds (71-75); Methyl Ethers (74-75); Piperazines (69-75) MND3.383.606.920; D18.918.919 DMÑPiperazines LH LM  HN(64); was see under ANTICONVULSANTS 1963-74 MHÑTrimethadione ANdo not use /biosyn /defic /physiol; /analogs NIM only RN127-48-0 MND3.383.548.883; D14.261.912 DMÑOxazoles LH LM  MHÑTrimethaphan ANdo not use /biosyn /defic /physiol RN7187-66-8 MND3.383.374.935; D16.653.396.868; D18.162.895 XSThimethaphan; Trimetaphan LH LS;  PM74 HN74(72) MHÑTrimethoprim ANdo not use /biosyn /defic /physiol RN738-70-5 PIAnti-Infective Agents (66-71); Folic Acid Antagonists (66-71); Pyrimidines (66-71) MND3.383.742.906; D20.237.912; D21.370.286.918; D26.87.393.922 LH  MSSilicon derivatives used to characterize hydroxysteroids, nucleosides and related compounds. Trimethylsilyl esters of amino acids are used in peptide synthesis. HN(75) MHÑTrimethylsilyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: TRIMETHYLSILYL CPDS PIMethane (74); Silicon (74) MND1.836.900; D2.935 DMÑSilicon LH LM  MSOrganic compounds composed of tin and three methyl groups. Affect mitochondrial metabolism and inhibit oxidative phosphorylation by acting directly on the energy conserving processes. HN(75) MHÑTrimethyltin Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: TRIMETHYLTIN CPDS PIOrganometallic Compounds (72-74); Tin (72-74) MND2.691.850.900.950 DMÑTrialkyltin Compounds LH LM  MS10,11-Dihydro-N,N,beta-trimethyl- 5H-dibenz(b,f)azepine-5-propanamine. Tricyclic antidepressant similar to imipramine, but more antihistaminic and sedative. Synonyms: IL6001; methylimipramine; RP 7162; Sapilent; Stangyl; Sulmontil; Surmontil; trimeproprimine. OLsearch DIBENZAZEPINES 1968-74 HN(75) MHÑTrimipramine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN739-71-9 MND3.494.240.918; D15.236.122.140.918 XSTrimeprimine DMÑDibenzazepines LH LS LM  OLuse TRINIDAD AND TOBAGO to search TRINIDAD back thru 1966 HN79; was TRINIDAD 1966-78 MHÑTrinidad and Tobago ANDF: TRINIDAD MNZ1.107.904.912 XSTobago LH LS  MSBenzene derivatives which are substituted with three nitro groups in any position. HN(77) MHÑTrinitrobenzenes ANdo not use /analogs /biosyn /defic /physiol PINitrobenzenes (66-76); Nitrophenols (66-76) MND2.455.426.559.389.565.880; D2.640.529.880 XSTrinitrophenyl Compounds DMÑNitrobenzenes LH LS LM  MS2,4,6-Trinitrobenzenesulfonic acid. HN(75) MHÑTrinitrobenzenesulfonic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2508-19-2 PIBenzenesulfonates (74); Nitrobenzenes (71-74) MND2.241.866.540.244.222.900; D2.455.426.559.389.97.900; D2.455.426.559.389.565.900; D2.640.529.880.900; D2.886.610.244.222.900 XSPicrylsulfonic Acid; Trinitrobenzene Sulfonate DMÑNitrobenzenes LH LS; LM  MHÑTrinitrotoluene ANdo not use /biosyn /defic /physiol RN118-96-7 MND2.455.426.559.389.832.868 XSTNT LH LS  MHÑTriolein ANdo not use /biosyn /blood-csf-urine /defic /physiol RN122-32-7 MND10.516.212.507.850; D10.516.351.801.801 LH  MSCatalyzes reversibly the conversion of D-glyceraldehyde 3-phosphate to dihydroxyacetone phosphate. A deficiency in humans causes nonspherocytic hemolytic disease. HN(75) MHÑTriosephosphate Isomerase ANdo not use /analogs RNEC 5.3.1.1 PICarbohydrate Isomerases (73-74); Organophosphorus Compounds (73-74); Trioses (73-74) MND8.586.399.278.850 XSPhosphotriose Isomerase; Triosephosphate Mutase DMÑCarbohydrate Isomerases LH LS; LM  MHÑTrioses ANdo not use /analogs /defic /physiol MND9.203.546.894 XUÑDihydroxyacetone; ÑDihydroxyacetone Phosphate LH LU;  MS2,5,9-trimethyl-7H-furo(3,2-g)benzopyran-7-one. Pigmenting photoprotective agent obtained from several plants, mainly Psoralea corylifolia; used for vitiligo, either topically or orally, but not with ionizing radiation. Synonyms: NSC 71047; 4,5',8-trimethylpsoralen; Trisoralen. HN(75); was see under COUMARINS 1975-78 MHÑTrioxsalen AND25-26 qualif; /analogs NIM only RN3902-71-4 PICoumarins (66-74); Furans (66-74) MND3.438.150.446.750.480.910; D26.313.855.910; D26.368.878.910 XSTrimethylpsoralen; Trioxisalenum; Trioxysalen DMÑPsoralens LH LS; ; LM  PM64 HN64(63) MHÑTriparanol ANdo not use /biosyn /defic /physiol RN78-41-1 MND10.162.202.906 XSMER 29; METASQUALENE LH LS;  MS2-[Benzyl-(2-dimethylaminoethyl)amino]-pyridine. Histamine H1 blocker with low sedative action but frequent gastrointestinal irritation; used to treat asthma, hay fever, urticaria and rhinitis, also in animals; administered by various routes, including topical. Synonyms: Azaron; Dehistin; Pyribenzamine; Tonaril; Vetibenzamina. MHÑTripelennamine ANdo not use /biosyn /defic /physiol RN91-81-6 MND2.92.782.258.368.900; D3.383.725.50.920; D23.654.432.915 LH  MHÑTriplets ANhuman only: for animals use LITTER SIZE; only /psychol; relation to PREGNANCY: Manual 28.33 MNG8.520.800.680; M1.438.768 LH  MStrans-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine. Histamine H1 blocker used in allergic rhinitis, asthma, and urticaria; may cause drowsiness. Synonyms: Actidil; Actilon; Entra; Pro-Actidil. HN(66) MHÑTriprolidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN486-12-4 MND3.383.725.932; D23.654.432.922 DMÑPyridines LH LM  OLsearch OLIGOSACCHARIDES 1966-74 PM86; was see under OLIGOSACCHARIDES 1966-85 HN86(75); was see under OLIGOSACCHARIDES 1966-85 MHÑTrisaccharides ANdo not use /analogs /defic /physiol MND9.203.698.629.802 LH  MSA spasm of the masticatory muscles producing ╥lockjaw╙ characteristic of tetanus. MHÑTrismus MNC10.597.816.802; C23.888.592.826.802 FXÑTetanus LH LX  MSThe possession of a third chromosome of any one type in an otherwise diploid cell. PM64 HN64(63) MHÑTrisomy ANIM; always coord with specific chromosome number (IM); no qualif; trisomy 21 = DOWN'S SYNDROME MNG5.148.266.869 LH  PM74 HN74 MHÑTriterpenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.849.919 LH  MHÑTritium AN= H3; naturally radioactive; Manual 25.94; do not use /analogs /biosyn /defic /physiol RN10028-17-8 MND1.435.719; D1.496.749.925 LH  MSPhosphoric acid tri(methylphenyl) ester. A mixture of isomeric tritolyl phosphates. Used in the sterilization of certain surgical instruments and in many industrial processes. Synonyms: TCP; Celluflux; Kronitex; Lindol. OLuse TRITOLYL PHOSPHATES to search TRITOLYL PHOSPHATE back thru 1975 HN(79); was TRITOLYL PHOSPHATE see under CRESOLS 1975-78 MHÑTritolyl Phosphates ANdo not use /analogs /biosyn /defic /physiol PICresols (66-74); Organophosphorus Compounds (72-74) MND2.705.960; D2.755.239.900 XSTricresyl Phosphates DMÑCresols LH LS LM  MSA genus of flagellate protozoans of the order Polymastigida; possessing 3 long anterior flagella, it resembles Trichomonas batrachorum, a parasite of amphibia. PM72 HN72 MHÑTritrichomonas ANdo not use /anat /blood-csf-urine /embryol; infection: coord NIM with PROTOZOAN INFECTIONS (IM) PIMastigophora (66-71) MNB1.841.443.849 LH  MSA genus of aquatic newts in the Salamandridae family. During breeding season many Triturus males have a dorsal crest which also serves as an accessory respiratory organ. One of the common Triturus species is Triturus cristatus (crested newt). PM72 HN72 MHÑTriturus ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIUrodela (66-71) MNB2.90.608.700.670 LH  PM74 HN74 MHÑTrityl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: TRITYL CPDS MND2.455.426.559.389.884 XSTriphenylmethyl Compounds LH LS  MHÑTrochlear Nerve AN4th cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.887 LH  OLfamily of trematodes; infection: coord NIM with TREMATODE INFECTIONS (IM) MH*Troglotrematidae (Non Mesh) MNB1.500.736.715.800 LH  MSInfestation with mites of the genus Trombicula, whose larvae carry the rickettsial agent of scrub typhus. OLsearch MITE INFESTATIONS 1968-74 HN(75) MHÑTrombiculiasis MNC3.211.394.869 DMÑMite Infestations LH LM  MSThe larva of mites of the genus Trombicula which attack man and other vertebrates, causing dermatitis and severe allergic reactions; one species is the carrier of scrub typhus or tsutsugamushi disease. HN(75) MHÑTrombiculid Mites AN/microbiol /parasitol permitted; infection = TROMBICULIASIS MNB1.131.166.132.419.875 XSChiggers; Harvest Mites; Red Bugs; Red Mites; Trombicula DMÑMites LH LS; ; ; ; LM  PM65 HN65 MHÑTromethamine AND25-26 qualif RN77-86-1 MND2.33.618.706.900; D26.172.719 XSTris Buffer; Trisamine; Trometamol LH LS; ;  OLsearch NORTROPANES 1966-68 PM69; was see under NORTROPANES 1963-68; HOMATROPINE was see under BELLADONNA 1963-68 HN69; was see under NORTROPANES 1963-68 MHÑTropanes ANdo not use /analogs /biosyn /defic /physiol PIAtropine (66-68); Belladonna (66-68); Cocaine (66-68); Nortropanes (66-68); Scopolamine (66-68) MND3.132.889; D3.605.869 XUÑBenztropine LH LU  MSThe outer layer of cells of the blastocyst which works its way into the endometrium during ovum implantation and grows rapidly, later combining with mesoderm. PM68 HN68(64) MHÑTrophoblast ANdo not use /abnorm /embryol /growth /inj MNA16.759.802; A16.254.85.162 LH  MHÑTrophoblastic Tumor AN= ╥trophoblastic disease╙; coord IM with UTERINE NEOPLASMS (IM); /anal /blood supply /secret /ultrastruct permitted; check the tags FEMALE & PREGNANCY MNC4.557.537.949; C13.703.720.949 LH  MHÑTropical Climate ANonly /adv eff; specify geog if pertinent MNG3.230.300.100.250.600 FXÑHeat LH LX  MSThe branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions. MHÑTropical Medicine ANSPEC: SPEC qualif except /methods; = ╙tropical diseases╥ when very general but avoid: prefer specific diseases MNG2.403.919 LH  MSN-Ethyl-alpha-(hydroxymethyl) N-(4-pyridinylmethyl) benzeneacetamide. Has pharmacologic action similar to atropine, used mainly as ophthalmic parasympatholytic or mydriatic; may cause closed angle glaucoma. Synonyms: Mydracyl; Mydriat; Mydrin; Mydrum; RO 1-7683; Visumidriatic. HN(79) MHÑTropicamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1508-75-4 PIPyridines (66-78) MND3.383.725.942; D16.483.940; D16.653.940 DMÑPyridines LH LM  PM72 HN72 MHÑTropocollagen AN/biosyn /physiol permitted PICollagen (66-71) MND12.776.860.177.719 LH  MSA salt-soluble precursor of elastin. Lysyl oxidase is instrumental in converting it to elastin in connective tissue. HN(77) MHÑTropoelastin AN/biosyn /physiol permitted PIElastin (66-76); Protein Precursors (73-76) MND12.776.811.850; D12.776.860.294.850 DMÑElastin LH LM  MS2-Hydroxy-2,4,6-cycloheptatrien-1-one. HN(75) MHÑTropolone ANdo not use /biosyn /defic /physiol; /analogs NIM only RN533-75-5 PIAlcohols (72-74); Cycloheptanes (70-74) MND2.455.426.392.368.284.900 DMÑCycloheptanes LH LM  PM74 HN74(71) MHÑTropomyosin AN/biosyn /physiol permitted PIMuscle Proteins (66-70) MND12.776.210.500.895; D12.776.220.525.800 XSParamyosin LH LS  MSOne of the minor protein components of skeletal muscle. Its function is to serve as the calcium-binding component in the troponin-tropomyosin B-actin-myosin complex by conferring calcium sensitivity to the cross-linked actin and myosin filaments. PM84; was see under MUSCLE PROTEINS 1975-83 HN84(75); was see under MUSCLE PROTEINS 1975-83 MHÑTroponin AN/biosyn /physiol permitted PIMuscle Proteins (73-74) MND12.776.210.500.910; D12.776.220.525.825 LH  OLsearch SALMONIDAE 1968-74 HN(75) MHÑTrout ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.493.781.802 XSSalmo gairdneri; Salvelinus DMÑSalmonidae LH LS; LM  MSThe embryonic arterial trunk arising from the heart which then divides into the aorta and the main pulmonary artery. PM77 HN77 MHÑTruncus Arteriosus ANnormal; abnormal is probably TRUNCUS ARTERIOSUS, PERSISTENT; do not use /blood supply; pseudotruncus arteriosus = TETRALOGY OF FALLOT PIAorta (66-76); Pulmonary Artery (66-76) MNA7.541.278.930; A16.378.303.930 LH  MSA congenital anomaly resulting from the failure of the aorticopulmonary system to develop and divide the truncus arteriosus into the aorta and the pulmonary trunk. PM77 HN77 MHÑTruncus Arteriosus, Persistent ANabnormal; do not use /congen PIHeart Defects, Congenital (66-76) MNC14.280.400.929; C16.131.457.930 LH  MHÑTrusses ANonly /adv eff /stand MNE7.858.925 FXÑHernia LH LX  MSBoard members of an institution or organization who are entrusted with the administering of funds and the directing of policy. OLsearch GOVERNING BOARD 1968-79 HN(80); was see GOVERNING BOARD 1968-79 MHÑTrustees ANdo not use /man /methods /organ /supply /trends /util (except by MeSH definition) PIGoverning Board (68-79) MNM1.526.70.940; N2.350.45.610; N4.452.394.600 DMÑGoverning Board LH LM  MSOral or written communication of the actual facts. PM78 HN78 MHÑTruth Disclosure ANno qualif MNF1.145.209.800 XSDisclosure, Truth FXÑInformed Consent; ÑPhysician-Patient Relations; ÑProfessional-Patient Relations LH LS LX; ;  MHÑTrypan Blue AND25-26 qualif RN72-57-1 MND26.408.926 LH  PM74 HN74(72) MHÑTrypanocidal Agents ANdo not use /analogs /biosyn /defic /physiol; consider also TRYPANOSOMA /drug eff & TRYPANOSOMIASIS /drug ther or pertinent specifics PIAntiprotozoal Agents (66-71); Trypanosoma (66-71); specific disease MND21.370.884 LH  MSA genus of flagellate protozoans found in the blood and lymph of vertebrates and invertebrates, both hosts being required to complete the life cycle. MHÑTrypanosoma ANGEN; prefer specific; do not use /anat /blood-csf-urine /embryol; /drug eff: consider also TRYPANOCIDAL AGENTS; infection = TRYPANOSOMIASIS but note specific types of trypanosomiasis below MNB1.841.443.868.887 LH  MSA hemoflagellate genus of the Trypanosomatidae which causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina). OLuse TRYPANOSOMA BRUCEI BRUCEI to search TRYPANOSOMA BRUCEI back thru 1972 PM84; was TRYPANOSOMA BRUCEI 1972-83 HN84; was TRYPANOSOMA BRUCEI 1972-83 MHÑTrypanosoma brucei brucei ANcauses NAGANA & also TRYPANOSOMIASIS, BOVINE in African cattle or TRYPANOSOMIASIS, AFRICAN /vet in African game animals; infection: coord NIM with TRYPANOSOMIASIS, AFRICAN (IM) but see note there for NAGANA; do not use /anat /blood-csf-urine /embryol PITrypanosoma (66-71) MNB1.841.443.868.887.80 XSTrypanosoma brucei; Trypanosoma brucei rhodesiense; Trypanosoma rhodesiense LH LS; ;  MSA hemoflagellate genus of the Trypanosomatidae which causes Gambian or West African sleeping sickness in humans. The vector host is usually the tsetse fly (Glossina). OLuse TRYPANOSOMA BRUCEI GAMBIENSE to search TRYPANOSOMA GAMBIENSE back thru 1972 PM84; was TRYPANOSOMA GAMBIENSE 1972-83 HN84; was TRYPANOSOMA GAMBIENSE 1972-83 MHÑTrypanosoma brucei gambiense ANcauses TRYPANOSOMIASIS, AFRICAN in several parts of Africa; infection: coord NIM with TRYPANOSOMIASIS, AFRICAN (IM); do not use /anat /blood-csf-urine /embryol PITrypanosoma (66-71) MNB1.841.443.868.887.110 XSTrypanosoma gambiense LH LS  MSA species of Trypanosome hemoflagellates carried by tsetse flies which causes severe anemia in cattle. These parasites are also found in horses, sheep, goats, and camels. PM84 HN84 MHÑTrypanosoma congolense ANcauses NAGANA & TRYPANOSOMIASIS, BOVINE in African cattle & other animals; infection: coord NIM with TRYPANOSOMIASIS, AFRICAN (IM) but see note there for NAGANA; do not use /anat /blood-csf-urine /embryol PITrypanosoma (66-83) MNB1.841.443.868.887.128 LH  MSThe agent of South American trypanosomiasis (Chagas' Disease). Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. PM72 HN72 MHÑTrypanosoma Cruzi ANcauses TRYPANOSOMIASIS, SOUTH AMERICAN; do not use /anat /blood-csf-urine /embryol PITrypanosoma (66-71) MNB1.841.443.868.887.140 LH  MSA non-pathogenic trypanosome found in the blood of the rat and transmitted by the rat flea. PM72 HN72 MHÑTrypanosoma Lewisi ANfound in rats; infection: coord NIM with TRYPANOSOMIASIS (IM); do not use /anat /blood-csf-urine /embryol PITrypanosoma (66-71) MNB1.841.443.868.887.410 LH  MSA family of monoflagellate parasitic protozoa which live in the blood and tissues of man and animals. There are six genera: CRITHIDIA, LEISHMANIA, Leptomonas, Phytomonas, Herpetomonas, and TRYPANOSOMA. Four of these are also morphologic stages - LEISHMANIA (amastigote stage), Leptomonas (promastigote stage), CRITHIDIA (epimastigote stage), and TRYPANOSOMA (trypomastigote stage). Phytomonas and herpetomonas do not have equivalent stages. Two or more of the stages occur within a specific genus. PM86 HN86 MHÑTrypanosomatidae ANdo not use /anat /blood-csf-urine /embryol; infection: coord NIM with PROTOZOAN INFECTIONS (IM) PITrypanosoma (66-85) MNB1.841.443.868 XSHerpetomonas; Leptomonas LH LS;  MSInfection with protozoa of the genus Trypanosoma. MHÑTrypanosomiasis ANGEN: prefer specific; /drug ther: consider also TRYPANOCIDAL AGENTS; exper trypanosomiasis: TN 187 MNC3.752.935 XUÑDourine LH LU  MSA disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense; its second host is the tse-tse fly. Involvement of the central nervous system produces ╥African sleeping sickness.╙ PMNAGANA was see under TRYPANOSOMIASIS, BOVINE 1968-mid 72 MHÑTrypanosomiasis, African ANfor trypanosomiasis in tropical Africa caused by any species of Trypanosoma: TN 188; coord IM with TRYPANOSOMA GAMBIENSE (NIM) for Gambian trypanosomiasis but do not coord with TRYPANOSOMA BRUCEI BRUCEI for NAGANA; specify geog if pertinent MNC3.752.935.719 XUÑNagana LH LU  MSInfection in cattle caused by various species of trypanosome. PM68 HN68 MHÑTrypanosomiasis, Bovine ANdo not use /vet; don't forget also CATTLE (NIM) & check tag ANIMAL; coord IM with specific type of trypanosomiasis (NIM) PITrypanosomiasis (66-67); Trypanosomiasis, African (66-67) MNC3.752.935.802; C22.196.888; C22.674.710.896 LH  MSA form of trypanosomiasis endemic in Central and South America, caused by Trypanosoma cruzi; it may follow either an acute or chronic course, the former commonly in children. MHÑTrypanosomiasis, South American ANcaused by TRYPANOSOMA CRUZI so do not coord with TRYPANOSOMA CRUZI for trypanosomiasis cruzi; note entry above & see note there for coords MNC3.752.935.885 XSChagas Disease LH LS  MHÑTryparsamide ANdo not use /biosyn /defic /physiol RN554-72-3 MND21.370.884.870 LH  MHÑTrypsin AN/antag = TRYPSIN INHIBITORS; do not use /analogs RNEC 3.4.21.4 MND8.586.277.656.732.895 FXÑPancreatic Juice LH LX  MSA low molecular weight protein (minimum molecular weight 8000) which has the ability to inhibit trypsin as well as chymotrypsin at independent binding sites. It is characterized by a high cystine content and the absence of glycine. HN(75) MHÑTrypsin Inhibitor, Bowman-Birk Soybean ANdo not use /analogs /antag /defic /physiol; DF: TRYPSIN INHIB BOWMAN PIPlant Proteins (72-74); Soy Beans (72-74) MND8.373.745.896.700; D12.776.950.900 XSBowman-Birk Soybean Trypsin Inhibitor DMÑTrypsin Inhibitors LH LS LM  MSA pancreatic trypsin inhibitor common to all mammals. It is secreted with the zymogens into the pancreatic juice. It is a protein composed of 56 amino acid residues and is different in amino acid composition and physiological activity from the Kunitz bovine pancreatic trypsin inhibitor (Kallikrein-Trypsin Inactivator). HN(75) MHÑTrypsin Inhibitor, Kazal Pancreatic ANdo not use /analogs /antag /defic /physiol; DF: TRYPSIN INHIB KAZAL RN50936-63-5 PIPancreatic Juice (72-74); Trypsin Inhibitors (72-74) MND8.373.745.896.780; D12.776.950.910 XSAcidic Pancreatic Trypsin Inhibitor; Kazal Pancreatic Trypsin Inhibitor; Pancreatic Trypsin Secretory Inhibitor, Kazal DMÑTrypsin Inhibitors LH LS; ; LM  MSA high molecular weight protein (approximately 22,500) containing 198 amino acid residues. It is a strong inhibitor of trypsin and human plasmin. HN(75) MHÑTrypsin Inhibitor, Kunitz Soybean ANdo not use /analogs /antag /defic /physiol; DF: TRYPSIN INHIB KUNITZ RN9088-41-9 PIPlant Proteins (72-74); Soybeans (72-74) MND8.373.745.896.850; D12.776.950.920 XSKunitz Soybean Trypsin Inhibitor DMÑTrypsin Inhibitors LH LS LM  PM65 HN65 MHÑTrypsin Inhibitors ANdo not use /analogs /antag; ALPHA 1 ANTITRYPSIN is available; DF: TRYPSIN INHIB MND8.373.745.896; D12.776.950 XUÑTrypsin Inhibitor, Bowman-Birk Soybean; ÑTrypsin Inhibitor, Kazal Pancreatic; ÑTrypsin Inhibitor, Kunitz Soybean LH LU; ;  MHÑTrypsinogen ANdo not use /analogs; /defic: consider also MALABSORPTION SYNDROMES (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RN9002-08-8 MND8.444.885 FXÑPancreatic Juice LH LX  PM66 HN66(64) MHÑTryptamines ANdo not use /analogs /biosyn /defic /physiol MND3.438.473.914 XSIndolylethylamines XUÑDimethyltryptamine; ÑMethoxytryptamine LH LS LU;  MHÑTryptophan AN/biosyn /defic /physiol permitted RN6912-86-3 MND12.125.72.859; D12.125.142.875 LH  MSL-tryptophan, tetrahydropteridine:oxygen oxidoreductase (5-hydroxylating). Catalyzes the hydroxylation of tryptophan to 5-hydroxytryptophan in the presence of NADPH and molecular oxygen. Important in the biosynthesis of serotonin. EC 1.14.16.4 PM78; was see under HYDROXYLASES 1975-77 HN78(73); was see under HYDROXYLASES 1975-77 MHÑTryptophan Hydroxylase ANdo not use /analogs RNEC 1.14.16.4 PIHydroxylases (66-72) MND8.586.682.420.870 XSTryptophan Monooxygenase LH LS  PM68 HN68(65) MHÑTryptophan Oxygenase ANdo not use /analogs RNEC 1.13.11.11 MND8.586.682.690.803 XSTRYPTOPHAN PYRROLASE LH LS  OLuse TRYPTOPHAN SYNTHASE to search TRYPTOPHAN SYNTHETASE back thru 1972 (as Prov 1972-73) PM80; was TRYPTOPHAN SYNTHETASE 1974-79 HN80; was TRYPTOPHAN SYNTHETASE 1972-79 (Prov 1972-73) MHÑTryptophan Synthase ANdo not use /analogs RNEC 4.2.1.20 PIHydro-Lyases (66-71) MND8.586.520.497.859; D8.586.600.896 XSTryptophan Synthetase LH LS  HN(72) MHÑTryptophanase ANdo not use /analogs RNEC 4.1.99.1 PIHydro-Lyases (66-71) MND8.586.520.920 DMÑLyases LH LM  MSL-Tryptophan:tRNA-Trp ligase (AMP-forming). Activates tryptophan with its specific transfer RNA. HN(75) MHÑTryptophanyl T RNA Synthetase ANdo not use /analogs RNEC 6.1.1.2 PIAmino Acyl T RNA Synthetases (74); Tryptophan (74) MND8.586.464.136.790 DMÑAmino Acyl T RNA Synthetases LH LM  MSBloodsucking flies of the genus Glossina, found primarily in equatorial Africa; several species are intermediate hosts of trypanosomes. MHÑTsetse Flies ANdo not use /drug eff with insecticides: TN 111; /microbiol /parasitol permitted MNB1.131.617.289.908 XSGLOSSINA LH LS  OLsearch HYPOTHALAMUS 1969-74 HN(75) MHÑTuber Cinereum ANdo not use /innerv MNA8.186.211.385.357.870 DMÑHypothalamus LH LM  MS4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine. An antibiotic purine ribonucleoside which readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids. HN(75) MHÑTubercidin AN/analogs NIM only RN69-33-0 PIPyrimidines (73-74); Pyrroles (73-74); Ribonucleosides (73-74) MND13.570.583.910; D13.570.800.850; D20.85.75.975; D22.204.144.975; D26.87.939 XS7-Deazaadenosine DMÑRibonucleosides LH LS LM  MHÑTuberculin ANonly /admin /adv eff /anal /csf /class /immunol /isol /rad eff /stand /ther use /tox /urine MND24.611.216.161.845 LH  PM66; was TUBERCULIN REACTION 1963-65 HN66; was TUBERCULIN REACTION 1963-65 MHÑTuberculin Test ANonly /instrum /stand /vet MNE1.223.495.862.870; E1.862.870 LH  MSA tumor-like mass resulting from the enlargement of a tuberculous lesion. MHÑTuberculoma ANnot a neoplasm; coord IM with precoord tuberculosis term below (IM) or organ/dis precoord (IM) if tuberc term is not available MNC1.252.40.552.846.493 FXÑGranuloma LH LX  MSAny of the infectious diseases of man and other animals caused by species of mycobacterium. OLuse TUBERCULOSIS to search TUBERCULOSIS IMMUNITY 1966 PMTUBERCULOSIS IMMUNITY was heading 1963-66 HNTUBERCULOSIS IMMUNITY was heading 1963-66 MHÑTuberculosis ANGEN: prefer specifics; if unspecified as just ╥tuberculosis╙, TUBERCULOSIS, PULMONARY is probably the correct heading but check text carefully; tuberculid: index under TUBERCULOSIS, CUTANEOUS; /drug ther: consider also ANTITUBERCULAR AGENTS; indexing policy: Manual 23.19+ MNC1.252.40.552.846 XUÑTuberculosis, Oral LH LU  MSUnspecified or pulmonary tuberculosis occurring in persons under 13 years. MHÑTuberculosis in Childhood ANfor unspecified or pulm tuberc only; for specific (endocrine, splenic, etc.) index only under specific tuberc with CHILD tags MNC1.252.40.552.846.674 LH  MSVoluntary agencies concerned with prevention and treatment of tuberculosis. OLsearch VOLUNTARY HEALTH AGENCIES 1966-74 HN(75)63-66 MHÑTuberculosis Societies ANonly /econ /hist /man /organ /stand MNN3.540.630.780.850 DMÑVoluntary Health Agencies LH LM  MSA variety of tuberculosis affecting various birds, including chickens and ducks, caused by Mycobacterium avium, and characterized by tubercles consisting principally of epithelioid cells; it may be communicated to other animals including man. MHÑTuberculosis, Avian ANdo not use /vet; don't forget also BIRDS (NIM) & check tag ANIMAL MNC1.252.40.552.846.516; C22.131.921 LH  MSAn infection of cattle caused by Mycobacterium bovis; transmissible to man and other animals. MHÑTuberculosis, Bovine ANdo not use /vet; don't forget also CATTLE (NIM) & check tag ANIMAL MNC1.252.40.552.846.538; C22.196.927 LH  MSTuberculosis of the heart, pericardium or blood vessels. MHÑTuberculosis, Cardiovascular ANIM; coord IM with specific organ or organ /dis (IM) MNC1.252.40.552.846.561; C14.826 XUÑPericarditis, Tuberculous LH LU  MSTuberculosis of the skin; includes scrofuloderma and tuberculid, but not lupus vulgaris, which is LUPUS. MHÑTuberculosis, Cutaneous ANtuberculid goes here MNC1.252.40.552.846.583; C17.838.887 XSSKIN TUBERCULOSIS XUÑErythema Induratum LH LS LU  MSTuberculous infection of the endocrine glands. MHÑTuberculosis, Endocrine ANIM; coord IM with specific organ /dis (IM) MNC1.252.40.552.846.606; C19.927 LH  MSTuberculosis of the genitalia in women. MHÑTuberculosis, Female Genital ANIM; coord IM with specific organ or organ /dis (IM) MNC1.252.40.552.846.944.596; C13.371.803.940 LH  MSGastric and/or enteric tuberculosis; marked by spreading ulcers and diarrhea. MHÑTuberculosis, Gastrointestinal ANIM; coord IM with specific organ or organ /dis (IM) MNC1.252.40.552.846.628; C6.405.831 LH  MSInfection of the liver with tubercle bacilli producing localized granulomata, miliary lesions, or tuberculoma. MHÑTuberculosis, Hepatic MNC1.252.40.552.846.651; C6.552.933 LH  MSTuberculosis involving the larynx, producing ulceration of the vocal cords and laryngeal mucosa; commonly attended by hoarseness, cough, pain on swallowing, and hemoptysis. MHÑTuberculosis, Laryngeal MNC1.252.40.552.846.696; C8.730.884; C9.400.860 LH  MSInfection of the lymph nodes by tuberculosis; tuberculous infection of the cervical lymph nodes is scrofula. MHÑTuberculosis, Lymph Node MNC1.252.40.552.846.719; C15.604.921 XSLYMPHADENITIS, TUBERCULOUS; SCROFULA LH LS;  MSTuberculosis of the genitalia in men. MHÑTuberculosis, Male Genital ANIM; coord IM with specific organ or organ /dis (IM) MNC1.252.40.552.846.944.721; C12.294.889; C12.672.721 LH  MSTuberculous meningitis. MHÑTuberculosis, Meningeal MNC1.252.40.552.846.741; C10.228.228.507.915 XSMENINGITIS, TUBERCULOUS LH LS  MSAn acute form of tuberculosis in which minute tubercles are formed in a number of organs of the body due to dissemination of the bacilli through the blood stream. MHÑTuberculosis, Miliary MNC1.252.40.552.846.764 LH  MSTuberculous infection of the eye, primarily the iris, ciliary body, and choroid. MHÑTuberculosis, Ocular ANIM; coord IM with specific eye heading (IM) or eye dis heading (IM) MNC1.252.40.552.846.786; C11.915 LH  MSTuberculosis of the mouth, tongue, and salivery glands. HN(72) MHÑTuberculosis, Oral AN╥tuberc of the mouth, tongue & salivary glands╙; IM; coord IM with specific mouth, tongue or salivary gland heading (IM) or mouth, tongue or salivary dis heading (IM) PIMouth Diseases (66-71); Tuberculosis (66-71); specific oral disease MNC1.252.40.552.846.809; C7.465.943 DMÑTuberculosis LH LM  MSTuberculosis of the bones or joints. MHÑTuberculosis, Osteoarticular ANIM; may be osteo- or artic; coord IM with specific bone or joint (IM) or bone or joint dis (IM) MNC1.252.40.552.846.831; C5.116.165.886 XSBONE TUBERCULOSIS; JOINT TUBERCULOSIS LH LS;  MSTuberculosis of the serous lining of the abdomen. MHÑTuberculosis, Peritoneal ANtuberculous peritonitis goes here MNC1.252.40.552.846.854; C6.772.922 LH  MSTuberculosis of the serous membrane lining the thoracic cavity and surrounding the lungs. PMEMPYEMA, TUBERCULOUS was heading 1963-83 MHÑTuberculosis, Pleural AN= tuberculous pleurisy MNC1.252.40.552.846.877; C8.528.928; C8.730.912 XUÑEmpyema, Tuberculous LH LU  MSTuberculosis of the lungs. MHÑTuberculosis, Pulmonary ANreferred to as just ╥tuberculosis╙: check text or x-ray plates; atypical Mycobact infect of lung = TUBERCULOSIS, PULMONARY (IM) + MYCOBACTERIUM INFECTIONS, ATYPICAL (NIM) MNC1.252.40.552.846.899; C8.381.922; C8.730.939 FXÑCollapse Therapy; ÑMass Chest X-Ray; ÑPNEUMONECTOMY LH LX; ;  MSInfection of the kidney with species of mycobacterium. MHÑTuberculosis, Renal MNC1.252.40.552.846.944.847; C12.672.847; C12.777.419.912 LH  MSOsteitis or caries of the vertebrae, usually occurring as a complication of tuberculosis of the lungs. MHÑTuberculosis, Spinal ANIM; coord IM with specific vertebra (IM) MNC1.252.40.552.846.831.722; C5.116.165.886.722; C5.878.909 XSPOTT'S DISEASE LH LS  MSInfection of the spleen with species of Mycobacterium. MHÑTuberculosis, Splenic MNC1.252.40.552.846.922; C15.604.744.909 LH  MSA general term for tuberculosis of the urinary and/or genital systems or urinary organs other than the kidney, which is TUBERCULOSIS, RENAL. MHÑTuberculosis, Urogenital ANIM; GEN or as coord IM for organs (IM) or organ/dis (IM) not covered as TUBERCULOSIS, FEMALE GENITAL or TUBERCULOSIS, MALE GENITAL or TUBERCULOSIS, RENAL MNC1.252.40.552.846.944; C12.672; C13.371.803 LH  MSAn autosomal disorder characterized pathologically by multiple nodular tumors throughout the cerebral cortex and clinically manifested by mental retardation and epileptic convulsions. MHÑTuberous Sclerosis ANdo not use /drug eff /physiol /rad eff MNC10.496.933; F3.709.346.944 XSBOURNEVILLE'S DISEASE FXÑFibroma LH LS LX  MHÑTubocurarine ANdo not use /biosyn /defic /physiol RN57-95-4 MND2.92.102.922; D2.675.276.922; D3.132.267.847; D17.563.367.217.847 LH  MSA microtubule subunit protein found in large quantities in mammalian brain. Has also been isolated from sperm flagella, cilia and other sources. It is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to colchicine, vincristine and vinblastine. PM80; was see under GLYCOPROTEINS 1975-79 HN80(75); was see under GLYCOPROTEINS 1975-79 MHÑTubulin AN/biosyn /physiol permitted PIMicrotubules (70-74); Nerve Tissue Proteins (66-74) MND12.776.220.600.800; D12.776.641.920 LH  MSA tetrapeptide with the sequence Thr-Lys-Pro-Arg produced in the spleen by enzymatic cleavage of leukokinin and containing all of the activity of the parent molecule. It stimulates the phagocytic activity of blood polymorphonuclear leukocytes and neutrophils in particular. The peptide is located in the Fd fragment of the leukokinin molecule. OLuse TUFTSIN to search LEUKOKININ back thru 1975 PM84; was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ (with LEUCOKININ a see ref to it) was see under GAMMA GLOBULINS 1975-83 HN84(75); was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ (with LEUCOKININ a see ref to it) was see under GAMMA GLOBULINS 1975-83 MHÑTuftsin AN/anal /class /csf /isol /urine permitted RN9063-57-4 PIImmunoglobulins, Fd (73-74); Oligopeptides (73-74) MND12.644.456.840; D24.611.924 XSLeucokinin; Leukokinin LH LS;  MSA plague-like disease of rodents, transmissible to man. MHÑTularemia ANcaused by FRANCISELLA TULARENSIS (formerly Pasteurella tularensis) MNC1.252.939 LH  MSA cytologic technic for measuring the functional capacity of tumor stem cells by assaying their activity. Used primarily for the in vitro testing of antineoplastic agents. HN(84) MHÑTumor Stem Cell Assay ANno qualif; coord IM with histol type of neopl + precoord organ/neopl term (IM or NIM) if pertinent; DF: TCFU ASSAY PIColony-Forming Units Assay (79-83); specific neoplasm (72-83) MNE5.909.262.383.910 XSClonogenic Cell Assay, Tumor; Colony-Forming Units Assay, Tumor; Drug Sensitivity Assay, Neoplasm; Neoplasm Sensitivity Tests; Neoplasm Stem Cell Assay; Stem Cell Assay, Tumor DMÑColony-Forming Units Assay LH LS; ; ; ; ; LM  MSColony-forming cells which give rise to neoplasms. PM86; was see under STEM CELLS 1984-85 HN86(84); was see under STEM CELLS 1984-85 MHÑTumor Stem Cells AN╥colony-forming cells which give rise to neoplasms╙; A 11 qualif PICell Line (69-85); Clone Cells (75-83); Colony-Forming Units Assay (79-83); Neoplasms, Experimental (75-83); Neoplasms/PA (75-83); Stem Cells (84-85); specific neoplasm/PA (75-83) MNA11.872.910 XSColony-Forming Units, Neoplastic; EC Cells; Embryonal Carcinoma Cells; Stem Cells, Neoplastic LH LS; ; ;  MSInfections produced by oncogenic viruses. OLuse TUMOR VIRUS INFECTIONS to search FIBROMA, SHOPE back thru 1968 & PAPILLOMA, SHOPE back thru 1966 PM72; FIBROMA, SHOPE was heading 1968-81; PAPILLOMA, SHOPE was heading 1963-81 HN72; FIBROMA, SHOPE was heading 1968-81; PAPILLOMA, SHOPE was heading 1963-81 MHÑTumor Virus Infections ANcoord IM with specific oncogenic virus (NIM) PIOncogenic Viruses (66-71); Virus Diseases (66-71) MNC2.928; C4.619.935 XSFibroma, Shope; Papilloma, Shope FXÑNeoplasms, Experimental; ÑOncogenic Viruses LH LS; LX;  MSLarge, vigorous ocean fishes. HN(75) MHÑTuna ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; tuna for eating: see notes on FISH PRODUCTS; canned tuna = TUNA (IM) + FOOD PRESERVATION (IM) MNB2.493.900 DMÑFishes LH LM  MHÑTungsten ANW-184; do not use /analogs /biosyn /defic /physiol; W-180, 182, 183, 186 = TUNGSTEN (IM) + ISOTOPES (NIM); W-176-179, 181, 185, 187-189 = TUNGSTEN (IM) + RADIOISOTOPES (IM) RN7440-33-7 MND1.268.922; D1.552.912; D1.937.888 XSWOLFRAM LH LS  MSGlucosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus; also active against some bacteria and fungi, because it inhibits the glucosylation of proteins; used as tool in the study of microbial biosynthetic mechanisms. PM87; was see under GLUCOSAMINE 1979-86 HN87(79); was see under GLUCOSAMINE 1979-86 MHÑTunicamycin AN/biosyn permitted; do not use /defic /physiol RN11089-65-9 PIAntibiotics (66-78); Glucosamine (66-78) MND9.203.67.342.531.900; D20.85.891; D20.388.913 LH  MHÑTunisia MNZ1.58.266.887 LH  MSA genus of the family Tupaiidae which consists of about 12 species. One of the most frequently encountered species is T. glis. Members of this genus occur in rain forests and secondary growth of southeast Asia. HN(81) MHÑTupaia ANa tree shrew; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg PIPrimates (72-74); Tupaiidae (75-80) MNB2.649.801.700.810.804 DMÑTupaiidae LH LM  MSA family of Primates of the suborder Prosimii consisting of five genera. They are TUPAIA, Ananthana (Indian tree shrew), Dendrogale (small smooth-tailed tree shrew), Urogale (Mindanao tree shrew), and Ptilocercus (pen-tailed tree shrew). The tree shrews occur in forest areas of eastern Asia from India and southwestern China to Borneo and the Philippines. OLto search TREE SHREWS use TUPAIIDAE back thru 1975 & PRIMATES 1972-74 PM81; was TREE SHREWS see under PROSIMIANS 1975-80, was TREE SHREWS see under PRIMATES 1972-74 HN81; was TREE SHREWS see under PROSIMIANS 1975-80, was TREE SHREWS see under PRIMATES 1972-74 MHÑTupaiidae ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg; do not confuse TREESHREWS (prosimian) with SHREWS (insectivore) MNB2.649.801.700.810 XSPtilocercus; Shrews, Tree; Treeshrews; Tupaiinae XUÑTupaia LH LS; ; ; LU  MSA class of free-living freshwater flatworms of North America. PM65 HN65 MHÑTurbellaria ANIM MNB1.500.736.847 XUÑPlanarians LH LU  MSThe scroll-like bony plates with curved margins on the lateral wall of the nasal cavity. MHÑTurbinates ANfractures: coord TURBINATES /inj (IM) + SKULL FRACTURES (IM) MNA2.835.232.781.324.948; A4.531.898 XSCONCHAE NASALES LH LS  MHÑTurkey ANthe country, not TURKEYS MNZ1.252.245.914; Z1.630.940 LH  PM68 HN68 MHÑTurkeys ANdomestic or wild; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol; diseases: coord IM with POULTRY DISEASES (IM) PIPoultry (66-67) MNB2.248.617.872 LH  OLuse TURKMEN S.S.R. to search TURKMENISTAN back thru 1966 HN82; was TURKMENISTAN 1963-81 MHÑTurkmen S.S.R. MNZ1.252.878.100.920; Z1.950.100.920 LH  MHÑTurner's Syndrome ANin females; note TURNER'S SYNDROME, MALE below; do not use /congen MNC16.131.280.748.805; C16.131.939.842.309.872; C19.391.847 XSGonadal Dysgenesis, 45,X; Gonadal Dysgenesis, 45,XO LH LS;  MHÑTurpentine AND25-26 qualif RN8006-64-2 MND26.948 LH  PM68 HN68 MHÑTurtles ANsea turtles, fresh water turtles (terrapin), land turtles (tortoise); IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIReptiles (66-67) MNB2.833.848 LH  MHÑTwins ANIM humans only; if pertinent, NIM for animals not usually giving birth to twins; only /psychol; relation to PREGNANCY: Manual 28.33 MNG8.520.800.708; M1.438.873 FXÑDiseases in Twins XUÑTwins, Dizygotic; ÑTwins, Monozygotic LH LX LU;  PM66 HN66 MHÑTwins, Conjoined ANnote category; only /class /embryol /pathol /physiopathol /psychol /surg; Siamese twins goes here MNC16.131.581.806 LH  MSTwo offspring produced in the same pregnancy from separate ova fertilized at the same time. HN(75) MHÑTwins, Dizygotic ANonly /psychol; two from separate ova MNG8.520.800.708.800; M1.438.873.920 XSTwins, Fraternal DMÑTwins LH LS LM  MSTwo offspring developed from one fertilized ovum. HN(75) MHÑTwins, Monozygotic ANonly /psychol; two from one ovum MNG8.520.800.708.838; M1.438.873.940 XSTwins, Identical DMÑTwins LH LS LM  MSA superfamily of nematodes whose members are free-living saprophytes or parasites of plants. Ova are sometimes found in human feces after ingestion of infected plants. OLsearch NEMATODA 1966-74 HN(75) MHÑTylenchoidea ANdo not use /blood-csf-urine; infection: coord NIM with NEMATODE INFECTIONS (IM) MNB1.500.294.820 XSMeloidogyne; Tylenchida DMÑNematoda LH LS; LM  MHÑTympanic Membrane ANdo not confuse with TYMPANUM; /surg: consider MYRINGOPLASTY MNA9.246.397.873 XUÑTensor Tympani LH LU  PM66 HN66(64) MHÑTympanoplasty ANdo not use /util except by MeSH definition MNE4.847.774.873 LH  MSEstablished behavior pattern characterized by excessive drive and ambition, impatience, competitiveness, sense of time urgency, and poorly contained aggression. PM85 HN85 MHÑType A Personality ANno qualif PICoronary Disease (66-84); Personality (66-84) MNF1.752.747.880 XSCoronary Prone Personality; Personality Type A LH LS;  MSAn acute enteric infection caused by Salmonella typhi. MHÑTyphoid ANcaused by Salmonella typhosa (also called S. typhi); ╥abdominal typhus╙ goes here MNC1.252.310.821.873 XSEnteric Fever LH LS  MHÑTyphoid-Paratyphoid Vaccines ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox MND24.310.894.135.910 XSPARATYPHOID VACCINE LH LS  MSAn infectious disease clinically similar to epidemic louse-borne typhus, but caused by Rickettsia typhi, which is transmitted from rat to man by the rat flea, Xenopsylla cheopis, and by the rat louse, Polyplax spinulosa. OLuse TYPHUS, ENDEMIC FLEA-BORNE to search TYPHUS, MURINE back thru 1966 PM77; was TYPHUS, MURINE 1963-76 HN77; was TYPHUS, MURINE 1963-76 MHÑTyphus, Endemic Flea-Borne ANcaused by Rickettsia typhi MNC1.850.810.800.943 XSTyphus, Murine LH LS  MSThe classic form of typhus, caused by Rickettsia prowazekii, which is transmitted from man to man by the louse Pediculus humanus, var. corporis. OLuse TYPHUS, EPIDEMIC LOUSE-BORNE to search TYPHUS back thru 1966 PM77; was TYPHUS 1963-76 HN77; was TYPHUS 1963-76 MHÑTyphus, Epidemic Louse-Borne ANcaused by Rickettsia prowazekii MNC1.850.810.800.950 XSTyphus XUÑBrill's Disease LH LS LU  MHÑTyramine ANdo not use /biosyn /defic /physiol RN51-67-2 MND16.893.939 LH  MSAntibiotic substance produced by Bacillus brevis which may be separated into three components, tyrocidines A, B, and C. It is the major constituent ((40-60 per cent) of tyrothricin, gramicidin accounting for the remaining 10-20 per cent active material. It is a topical antimicrobial agent, very toxic parenterally. Synonyms: Brevicidin; Rapicidin. HN(75) MHÑTyrocidines ANdo not use /analogs /defic /physiol PIPeptides, Cyclic (74); Tyrothricin (66-74) MND20.85.905.920; D20.187.925.927 DMÑTyrothricin LH LM  MSSodium 3-butyramido-alpha-ethyl-2,4,6-triiodohydro-cinnamate. A diagnostic aid as a radiopaque medium in cholecystography. Synonyms: WIN 8851-2; Bilopaque. HN(75) MHÑTyropanoate AND25-26 qualif; /analogs NIM only RN27293-82-9 PIButyrates (74); Iodobenzoates (74) MND2.455.426.559.389.454.950; D2.455.526.581.496.950; D26.298.950 XSSodium Tyropanoate DMÑIodobenzenes LH LS LM  MSA diphenol oxidase which catalyzes the oxidation of tyrosine to dioxophenylalanine utilizing dopa as a cofactor. EC 1.14.18.-. OLsearch DIPHENOL OXIDASES 1968-76 & TYROSINE DECARBOXYLASE 1966-67 HN(77); was see DIPHENOL OXIDASES 1975-76, was see under DIPHENOL OXIDASES 1968-74, was see TYROSINE DECARBOXYLASE 1963-67 MHÑTyrosinase ANdo not use /analogs; /defic: consider also ALBINISM RNEC 1.14.18.1 PIDiphenol Oxidases (68-76); Tyrosine Decarboxylase (66-67) MND8.586.682.420.238.900 XSPhenoloxidase DMÑDiphenol Oxidases LH LS LM  MHÑTyrosine ANtyrosinemia = TYROSINE /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RN55520-40-6 MND12.125.72.917 LH  PM68 HN68(64) MHÑTyrosine Aminotransferase ANdo not use /analogs; /defic: consider also TYROSINE /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 2.6.1.5 MND8.586.913.140.873 LH  MHÑTyrosine Decarboxylase ANdo not use /analogs RNEC 4.1.1.25 MND8.586.520.258.90.848 LH  PM73 HN73(71) MHÑTyrosine Hydroxylase ANdo not use /analogs RNEC 1.14.16.2 PIHydroxylases (66-70) MND8.586.682.420.923 LH  MSL-Tyrosine phenol-lyase (deaminating). Catalyzes the cleavage of tyrosine to phenol plus pyruvate plus ammonia. A pyridoxal phosphate protein. Also slowly catalyzes pyruvate formation from D-tyrosine, L-cysteine, S-methyl-L-cysteine, L-serine and D-serine. HN(75) MHÑTyrosine Phenol-Lyase ANdo not use /analogs RNEC 4.1.99.2 PILyases (72-74); Phenols (74); Tyrosine (72-74) MND8.586.520.940 XSbeta-Tyrosinase DMÑLyases LH LS LM  MSL-Tyrosine:tRNA-Tyr ligase (AMP-forming). Activates tyrosine with its specific transfer RNA. HN(75) MHÑTyrosyl T RNA Synthetase ANdo not use /analogs; note spacing RNEC 6.1.1.1 PIAmino Acyl T RNA Synthetases (72-74); Tyrosine (72-74) MND8.586.464.136.800 DMÑAmino Acyl T RNA Synthetases LH LM  MSA polypeptide antibiotic mixture obtained from Bacillus brevis; consists of a mixture of three tyrocidines (60%) and several gramicidins (20%); very toxic to blood, liver, kidneys, meninges and the olfactory apparatus; used topically. Synonyms: Bactratycin; Dermotricine; Hydrotricine; Martricin; Soluthricin; Tyroderm. MHÑTyrothricin ANdo not use /defic /physiol RN1404-88-2 MND20.85.905; D20.187.925 XUÑTyrocidines LH LU  MSUbiquinol-ferricytochrome-c oxidoreductase. An 11 subunit enzyme complex which acts as an electron transferring protein in the mitochondrial respiratory chain. The enzyme complex catalyzes the oxidation of ubiquinol to ubiquinone and ferrocytochrome c in the presence of ferricytochrome c. It contains cytochromes b-562, b-566, and c1 as well as an iron ferredoxin. EC 1.10.2.2. PM87 HN87 MHÑUbiquinol-Cytochrome C Reductase ANdo not use /analogs RNEC 1.10.2.2 PICytochrome Reductases (74-79); Multienzyme Complexes (73-86); Oxidoreductases (66-73); Quinone Reductases (75-86) MND8.586.600.925; D8.586.682.925 XSComplex III; Cytochrome bc1 Complex LH LS;  MHÑUbiquinone ANdo not use /defic /physiol RN1339-63-5 MND2.806.900; D8.176.935 XSCOENZYME Q LH LS  MSA non-histone high mobility protein found in chromatin. It is an adenylate cyclase stimulating polypeptide believed to be universal in all living cells. PM87; was see under HIGH MOBILITY GROUP PROTEINS 1985-86 HN87(85); was see under HIGH MOBILITY GROUP PROTEINS 1985-86 MHÑUbiquitin AN/biosyn /physiol permitted RN56574-49-3 PIChromosomal Proteins, Non-Histone (77-84); Nucleoproteins (66-77); Peptides (75-80) MND12.776.664.235.400.850; D12.776.957 XSHMG-20; High Mobility Protein 20 LH LS;  MSUDPglucuronate-phenol transglucuronidase. A drug metabolizing enzyme which catalyzes the conjugation of a variety of endogenous and exogenous compounds with glucuronic acid. EC 2.4.1.17. PM77; was see under HEXOSYLTRANSFERASES 1975-76 HN77(73); was see under HEXOSYLTRANSFERASES 1975-76 MHÑUDP Glucuronosyltransferase ANdo not use /analogs; /defic: consider also CRIGLER-NAJJAR SYNDROME and coord with BILIRUBIN /metab (NIM) RNEC 2.4.1.17 PIHexosyltransferases (72-73); Transferases (66-71) MND8.586.913.407.849 XSGlucuronyltransferase LH LS  MHÑUganda MNZ1.58.183.849 LH  MHÑUkraine MNZ1.542.248.950.950; Z1.950.950 LH  MSA lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue. MHÑUlcer ANNIM; coord with organ/dis precoord (IM); in addition to the see related terms below consider also DECUBITUS ULCER, LEG ULCER, VARICOSE ULCER, STOMACH ULCER & DUODENAL ULCER; stress ulcer: index under PEPTIC ULCER or specific (IM) + STRESS or STRESS, PSYCHOLOGICAL (IM or NIM); foot ulcer: index under FOOT DISEASES (IM) + probably SKIN ULCER (IM) but not LEG ULCER; ulcero-mutilating acropathy: diabetic = DIABETIC NEUROPATHIES, alcoholic = ALCOHOLISM + PERIPHERAL NERVE DISEASES, hereditary = NEUROPATHY, HEREDITARY SENSORY MNC23.739.941 FXÑCorneal Ulcer; ÑPeptic Ulcer; ÑSKIN ULCER LH LX; ;  MHÑUlna ANfracture = ULNA FRACTURES MNA2.835.232.87.911 LH  MSFractures of the larger bone of the forearm. PM73 HN73 MHÑUlna Fractures PIForearm Injuries (66-72); Fractures (66-72); Ulna (66-72) MNC21.866.88.268.807; C21.866.405.908 XUÑMonteggia's Fracture LH LU  MHÑUlnar Nerve ANdo not use /innerv MNA8.796.828.169.874 LH  PM73 HN73 MHÑUltimobranchial Body AN/embryol permitted but consider other qualif PICalcitonin (66-72); Thyroid Gland (66-72) MNA13.939 FXÑCalcitonin; ÑThyroid Gland LH LX;  PM65 HN65 MHÑUltracentrifugation ANNIM; only /instrum /methods MNE5.181.724; E5.196.941; H1.181.278.938 LH  PM73 HN73 MHÑUltrafiltration ANNIM; only /instrum /methods; hemofiltration goes here (IM) + BLOOD (IM) PIFiltration (70-72) MNE5.196.454.807; H1.181.278.469.849; H1.181.529.365.807; H1.671.100.534.807 FXÑMicropore Filters LH LX  OLuse ULTRASONICS /DU to search ULTRASONIC DIAGNOSIS 1968-84 PM85; was DIAGNOSIS, ULTRASONIC (NON MESH) before 1985 HN85; was DIAGNOSIS, ULTRASONIC (NON MESH) before 1985 MHÑUltrasonic Diagnosis ANonly /adv eff /econ /instrum /methods /vet; ultrasonic or sonographic imaging of organs is organ /anat or organ /pathol + ULTRASONIC DIAGNOSIS, not ULTRASONICS; echotomography seen in foreign lit probably goes here & if so use ╥ultrasonics╙ or ╥ultrasonic diagnosis╙╥ in translations & not ╥echotomography╙ MNE1.947 XSEchotomography, Computer; Tomography, Ultrasonic; Ultrasonography LH LS; ;  MSThe use of focused, high-frequency sound waves to produce local hyperthermia in certain diseased or injured parts of the body or to destroy the diseased tissue. MHÑUltrasonic Therapy ANdo not use /util except by MeSH definition; coord with dis /ther, not dis /radiother MNE2.780.480.280.945 LH  PMSONICATION was see under VIBRATION 1969-73 MHÑUltrasonics AN/diag use = ULTRASONIC DIAGNOSIS; /ther use = ULTRASONIC THERAPY; /adv eff permitted but consider also ULTRASONIC DIAGNOSIS /adv eff & ULTRASONIC THERAPY /adv eff; ultrasonic or sonographic imaging of organs is organ /anat or organ /pathol + ULTRASONIC DIAGNOSIS, not ULTRASONICS MNH1.671.31.849 XSDoppler Ultrasound; Shockwaves, Ultrasonic FXÑEchocardiography; ÑEchoencephalography XUÑSonication LH LS; LX; LU  MSThat portion of the electromagnetic spectrum immediately below the visible range and extending into the X-Ray frequencies; the longer wavelengths (Near UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing, wavelengths (Far UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic and carcinogenic and are used as disinfectants. MHÑUltraviolet Rays ANnon-ionizing but short-wave UV is ionizing; /ther use = ULTRAVIOLET THERAPY; only /adv eff /diag use; black light goes here or under INFRARED RAYS depending on text but unspecified, index here MNG3.230.300.100.725.525.600; H1.671.768.638.943 XSActinic Rays LH LS  MSThe use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin; this is part of the sun's spectrum that causes sunburn and tanning; Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing. PM65 HN65 MHÑUltraviolet Therapy ANnon-ionizing but short-wave UV is ionizing; do not use /util except by MeSH definition; coord with dis /radiother, not dis /ther; do not index here for ultraviolet ther in PUVA THERAPY unless particularly discussed MNE2.780.750.945 XSACTINOTHERAPY FXÑPhotochemotherapy LH LS LX  MS7-Hydroxycoumarin. Substance present in many plants, especially umbelliferae; used in sunscreen preparations; may be mutagenic. Its derivatives are used in liver therapy, as reagents, plant growth factors, sunscreens, insecticides, parasiticides, choleretics, spasmolytics, etc. PM77; HYMECROMONE & SCOPOLETIN were see under COUMARINS 1975-76 HN77 MHÑUmbelliferones AN/biosyn permitted if by plant; do not use /analogs /defic /physiol PICoumarins (69-76) MND3.438.150.446.912 XS7-Hydroxycoumarins; Hydrangin; Skimmetin XUÑHymecromone; ÑScopoletin LH LS; ; LU;  MSEither of a pair of arteries originating from the internal iliac artery and passing through the umbilical cord to carry blood from the fetus to the placenta. PM68 HN68(64) MHÑUmbilical Arteries ANdo not use /blood supply PIUmbilical Cord/BS (66-67) MNA7.231.114.929; A16.254.789.641 LH  MSThe flexible structure, giving passage to the umbilical arteries and vein, which connects the embryo or fetus to the placenta. MHÑUmbilical Cord ANcord blood = UMBILICAL CORD BLOOD; do not use /abnorm /embryol /growth /inj MNA16.254.789 LH  MSVeins which carry oxygenated, nutrient-rich blood from the placenta and which are obliterated in the first few days after birth. OLuse UMBILICAL VEINS to search UMBILICAL VEIN back thru 1966 (as Prov 1966-67) PM68 HN68; was UMBILICAL VEIN 1964-67 (Prov) MHÑUmbilical Veins ANdo not use /blood supply MNA7.231.908.670.874; A16.254.789.807 LH  MSThe pit in the center of the abdominal wall marking the point where the umbilical cord entered in the fetus. MHÑUmbilicus MNA1.47.849 LH  MSThose forces and content of the mind which are not ordinarily available to conscious awareness or to immediate recall. OLuse UNCONSCIOUS (PSYCHOLOGY) to search SUBCONSCIOUS back thru 1966 PM69; was SUBCONSCIOUS 1963-68 HN69; was SUBCONSCIOUS 1963-68 MHÑUnconscious (Psychology) ANno qualif; ╥the unconscious╙ or unconscious behavior: do not confuse with UNCONSCIOUSNESS, the physiol loss of consciousness; DF: UNCONSCIOUS MNF1.752.747.930; F2.739.794.942 XSSUBCONSCIOUS LH LS  MSA physiological state in which the patient is incapable of responding to usual environmental stimuli; it is an imprecise term but usually refers to impairment of consciousness less profound than COMA, in which no response can be elicited even at the reflex level. MHÑUnconsciousness ANthe physiol loss of consciousness: do not confuse with UNCONSCIOUS, unconscious behavior or ╥the unconscious╙ in psychol MNC10.597.917; C23.888.592.925 FXÑConsciousness; ÑSYNCOPE LH LX;  PM72; DIO-9 was see under ANTIBIOTICS 1975-81 HN72(69) MHÑUncoupling Agents ANdo not use /analogs /biosyn /defic /physiol PIOxidative Phosphorylation/DE (66-68); Oxidoreductases/AI (68) MND8.373.936 FXÑOxidative Phosphorylation LH LX  OLuse UNDECYLENIC ACIDS to search UNDECYLENIC ACID back thru 1966 PM75; was UNDECYLENIC ACID 1963-74 HN75; was UNDECYLENIC ACID 1963-74 MHÑUndecylenic Acids ANdo not use /analogs /biosyn /defic /physiol MND2.241.81.436.912; D10.516.251.355.919; D20.136.931; D20.187.942 LH  MSPerformance, usually in school work, poorer than that predicted from aptitude and/or intelligence testing. PM68 HN68 MHÑUnderachievement ANno qualif PILearning Disorders (66-67) MNF2.784.629.880 LH  MSThe state of not being engaged in a gainful occupation. MHÑUnemployment ANno qualif MNN1.824.925 LH  OLuse UNITED ARAB EMIRATES to search TRUCIAL STATES back thru 1975 HN81; was TRUCIAL STATES 1975-80 MHÑUnited Arab Emirates ANon south coast of Persian Gulf MNZ1.252.245.93.900; Z1.630.100.960 XSAbu Dhabi; Trucial States LH LS;  MSAn international organization whose members include most of the sovereign nations of the world with headquarters in New York City. The primary objectives of the organization are to maintain peace and security, and to achieve international cooperation in solving international economic, social, cultural or humanitarian problems. PM80 HN80 MHÑUnited Nations ANonly /econ /hist /legis /organ CATALOG: use NAF entry PIInternational Agencies (66-79) MNN3.540.514.718 XSFAO, United Nations; Food and Agricultural Organization, United Nations; UNESCO; UNICEF LH LS; ; ;  OLdo not confuse pre-explosion UNITED STATES (PX) ( = place of publication) with pre-explosion UNITED STATES MC (PX) ( = MeSH geog main heading) MHÑUnited States ANdo not abbreviate; each state is available as a heading; with Amer organizations: Manual 36.16 MNZ1.107.567.875 LH  MSAn agency of the Public Health Service concerned with overall planning, promoting and administering programs pertaining to alcohol, drug abuse and mental health. OLuse UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION to search ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION & UNITED STATES HEALTH SER AND MENTAL HEALTH AD back thru 1973 PM78; was ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77, was UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74 HN78; was ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77, was UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74 MHÑUnited States Alcohol, Drug Abuse, and Mental Health Administration ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: ADAMHA CATALOG: use NAF entry MNN3.540.427.300.425.250 XSAlcohol, Drug Abuse, and Mental Health Administration (U.S.); Health Services and Mental Health Administration (U.S.); United States Health Services and Mental Health Administration XUÑNational Institute of Mental Health (U.S.) LH LS; ; LU  MSA department of the United States government concerned with administering those agencies and offices having programs pertaining to health and human services. OLto search UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES & UNITED STATES DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE use UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES back thru 1976 PM82; was UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES 1981, was UNITED STATES DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 1976-80 HN82; was UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES 1981, was UNITED STATES DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 1976-80 MHÑUnited States Dept. of Health and Human Services ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as OTHER US GOVT SUP; DF: HHS CATALOG: use NAF entry PIGovernment Agencies (68-75); specific agency MNN3.540.427.300 XSDepartment of Health and Human Services (U.S.); United States Department of Health and Human Services; United States Department of Health, Education, and Welfare XUÑUnited States Health Care Financing Administration LH LS; ; LU  MSAn agency in the executive branch which endeavors to abate and control pollution in the areas of air, water, solid waste, noise, radiation, and toxic substances. HN(82) MHÑUnited States Environmental Protection Agency ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as OTHER US GOVT SUP; DF: EPA CATALOG: use NAF entry PIGovernment Agencies (68-81) MNN3.540.427.340 XSEnvironmental Protection Agency (U.S.) DMÑGovernment Agencies LH LS LM  MSAn independent administrative agency concerned with maintaining competitive free enterprise by prohibiting unfair methods of competition and unfair deceptive acts or practices. HN(82) MHÑUnited States Federal Trade Commission ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as OTHER GOVT SUP; DF: FTC CATALOG: use NAF entry PIGovernment Agencies (68-81) MNN3.540.427.380 XSFederal Trade Commission (U.S.) DMÑGovernment Agencies LH LS LM  MSAn agency of the Department of Health, Education and Welfare concerned with overall planning, promoting, and administering programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc. PM66 HN66(64) MHÑUnited States Food and Drug Administration ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: FDA CATALOG: use NAF entry MNN3.540.427.300.425.550 XSFood and Drug Administration (U.S.) LH LS  MSA component of the Department of Health and Human Services to oversee and direct the Medicare and Medicaid programs and related federal medical care quality control staffs. HN(82) MHÑUnited States Health Care Financing Administration ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: HCFA CATALOG: use NAF entry MNN3.540.427.300.310 XSHealth Care Financing Administration (U.S.) DMÑUnited States Dept. of Health and Human Services LH LS LM  MSA component of the United States Public Health Service which provides leadership related to the delivery of health services, and the requirements for and distribution of health resources, including manpower training. OLuse UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION to search UNITED STATES HEALTH RESOURCES ADMINISTRATION back thru 1979 PM84; was UNITED STATES HEALTH RESOURCES ADMINISTRATION 1980-83, was see under UNITED STATES PUBLIC HEALTH SERVICE 1979 HN84; was UNITED STATES HEALTH RESOURCES ADMINISTRATION 1980-83, was see under UNITED STATES PUBLIC HEALTH SERVICE 1979 MHÑUnited States Health Resources and Services Administration ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF: HRA CATALOG: use NAF entry MNN3.540.427.300.425.600 XSHealth Resources Administration (U.S.); United States Health Resources Administration XUÑNational Health Planning Information Center LH LS; LU  MSAn office in the Department of Labor responsible for developing and establishing occupational safety and health standards. PM82 HN82 MHÑUnited States Occupational Safety and Health Administration ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as OTHER US GOVT SUP; DF: OSHA CATALOG: use NAF entry PIGovernment Agencies (68-81) MNN3.540.427.480 XSOccupational Safety and Health Administration (U.S.) LH LS  MSA division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs relative to the provision of opportunities for economic advancement. PM68 HN68 MHÑUnited States Office of Economic Opportunity ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as OTHER US GOVT SUP; DF: OEO CATALOG: use NAF entry PIGovernment (66-67) MNN3.540.427.500 XSOffice of Economic Opportunity (U.S.) LH LS  MSA constituent organization of the Department of Health, Education, and Welfare which is concerned with protecting and improving the health of the nation. PM66 HN66 MHÑUnited States Public Health Service ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as NIH/PHS SUP; DF:PHS CATALOG: use NAF entry MNN3.540.427.300.425 XSPublic Health Service (U.S.) XUÑNational Center for Health Care Technology; ÑNational Center for Health Statistics (U.S.) LH LS LU;  MSA division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs pertaining to veterans. PM66 HN66 MHÑUnited States Veterans Administration ANonly /hist /organ; add UNITED STATES (NIM); research support by this agency is checked as OTHER US GOVT SUP: DF: VA CATALOG: use NAF entry MNN3.540.427.750 XSVeterans Administration (U.S.) LH LS  MS2,3-Dimercapto-1-propanol sodium sulfonate. Chelating agent used as an antidote to heavy metal poisoning. HN(76) MHÑUnithiol AND25-26 qualif RN4076-02-2 PIAlkyl Sulfonates (74-75); Sulfhydryl Compounds (74-75) MND2.886.489.180.900; D26.241.279.945 DMÑDimercaprol LH LM  MSEducational institutions providing facilities for teaching and research and authorized to grant academic degrees. MHÑUniversities ANIM; Manual 30.22, 36.18; specify locale if pertinent; Uniformed Services University of the Health Sciences (USUHS), under US Dept of Defense, goes under SCHOOLS, MEDICAL + UNITED STATES CATALOG: /geog /form MNI2.783.850 LH  MSCyst occurring in a persistent portion of the urachus, presenting as an extraperitoneal mass in the umbilical region; characterized by abdominal pain, and fever, if infected. It may rupture, leading to peritonitis, or it may drain through the umbilicus. OLuse URACHAL CYST to search UMBILICAL CYST back thru 1966 PM81; was UMBILICAL CYST 1963-80 HN81; was UMBILICAL CYST 1963-80 MHÑUrachal Cyst AN/anal /blood supply /secret /ultrastruct permitted MNC4.182.946 XSUmbilical Cyst LH LS  MSThe urinary canal of the fetus; postnatally it is usually a fibrous cord but occasionally persists as a vesicoumbilical fistula. MHÑUrachus ANdo not use /abnorm /embryol /growth /inj MNA16.254.835 LH  MHÑUracil AN/biosyn /physiol permitted; uracil deoxyriboside, uracil deoxyribonucleoside = DEOXYURIDINE; uracil riboside, uracil ribonucleoside = URIDINE RN66-22-8 MND3.383.742.698.875 XUÑHydroxyphenylazouracil; ÑPentoxyl LH LU;  MS5-(Bis(2-chloroethyl)amino)2,4-(1H,3H)pyrimidinedione. Nitrogen mustard derivative of uracil; alkylating antineoplastic agent used in lymphatic malignancies; causes mainly gastrointestinal and bone marrow damage. Synonyms: chlorethaminacil; de(s)methyldopan; Nordopan; NSC 34462; U 8344. PM66 HN66(63) MHÑUracil Mustard ANdo not use /biosyn /defic /physiol RN66-75-1 MND2.455.526.728.650.913; D22.204.585.941 XSUramustine LH LS  MHÑUracil Nucleotides AN/biosyn /physiol permitted; do not use /analogs MND13.695.740.850; D13.695.827.919 XSUridine Phosphates XUÑUridine Diphosphate; ÑUridine Monophosphate; ÑUridine Triphosphate LH LS LU; ;  MHÑUranium ANnaturally radioactive; IM; Manual 25.94; do not use /analogs /biosyn /defic /physiol RN7440-61-1 MND1.287.948; D1.552.517.940 XUÑUranyl Nitrate LH LU  MSA compound used in photography and the porcelain industry. It causes severe renal insufficiency and renal tubular necrosis in mammals and is an effective lymphocyte mitogen. HN(76) MHÑUranyl Nitrate ANdo not use /analogs /biosyn /defic /physiol RN10102-06-4 PINitrates (73-75); Uranium (73-75) MND1.552.517.940.900; D1.620.754.399.900; D1.655.498.565.399.900 DMÑUranium LH LM  PM66 HN66 MHÑUrate Oxidase ANdo not use /analogs RNEC 1.7.3.3 MND8.586.682.943 XSURICASE LH LS  MSUse for articles concerning health problems in an urban population. HN(79) MHÑUrban Health ANonly /hist /stand /trends; specify geog CATALOG: /geog /form PIHealth (66-78) MNN1.407.540.770 DMÑHealth LH LM  MSThe inhabitants of a city or town, including metropolitan and suburban areas. PM68 HN68 MHÑUrban Population ANno qualif; specify geog; note that SUBURBAN POPULATION is also available CATALOG: /geog /form PIPopulation (66-67) MNN1.696.876 LH  MSThe planned upgrading of a deteriorating urban area, involving rebuilding, renovation, or restoration. It frequently refers to programs of major demolition and rebuilding of blighted areas. PM68 HN68 MHÑUrban Renewal ANno qualif; Public Law 89-754; specify locale CATALOG: /geog /form PIHousing (66-67); Social Conditions (66-67) MNI1.880.709.876 XSURBAN DEVELOPMENT FXÑHousing LH LS LX  MSThe process whereby a society changes from a rural to an urban way of life; the gradual increase in the proportion of people living in urban areas. PM68 HN68 MHÑUrbanization ANonly /hist /legis /trends CATALOG: /geog /form PIPopulation (66-67); Sociology (66-67) MNI1.880.526.726 LH  MHÑUrea ANdo not use /defic /physiol RN57-13-6 MND2.948 FXÑBlood Urea Nitrogen XUÑBiuret; ÑBromisovalum LH LX LU;  MSNot well-defined organisms which are common parasitic inhabitants of the urogenital tracts of man, cattle, dogs, and monkeys. PM76 HN76 MHÑUreaplasma ANin mammalian urogenital tract; do not use /blood-csf-urine PIMycoplasma (66-75) MNB3.600.580.553.900 XST-Mycoplasma LH LS  MHÑUrease ANdo not use /analogs RNEC 3.5.1.5 MND8.586.277.87.902 LH  MHÑUremia ANazotemia in foreign lit means often UREMIA & often BLOOD UREA NITROGEN MNC12.777.419.936 XSAZOTEMIA FXÑKidney Failure, Chronic LH LS LX  MHÑUreohydrolases ANdo not use /analogs RNEC 3.5.3. MND8.586.277.913 LH  MHÑUreter ANdo not confuse with URETHRA, espec in Romance lang: uretere (French), ureter (Span), uretere (Ital) = URETER, while uretre (French), uretra (Span), uretra (Ital) = URETHRA; /surg: consider URINARY DIVERSION (TN 189: probably do not index under URETER); ureteral catheterization: coord NIM with URINARY CATHETERIZATION (IM) MNA5.810.776 LH  OLto search for chem composition of ureteral calculi, use URETERAL CALCULI/anal back thru 1987 & URETERAL CALCULI/metab 1966-86 MHÑUreteral Calculi ANchem composition of calculi: use /anal; /ultrastruct permitted MNC12.777.725.576; C12.777.809.851 LH  PM66 HN66 MHÑUreteral Diseases ANdo not confuse with URETHRAL DISEASES, espec in Romance lang: ureteral (French), ureteral (Span), ureterale (Ital) = ╥ureteral╙, while uretral (French), uretral (Span), uretrale (Ital) = ╥urethral╙ MNC12.777.725 LH  MHÑUreteral Neoplasms ANdo not confuse with URETHRAL NEOPLASMS, espec in Romance lang: see note on ╥ureteral╙ & ╥urethral╙ under URETERAL DISEASES above; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945.947.940; C12.777.725.676 LH  MHÑUreteral Obstruction ANdo not confuse with URETHRAL OBSTRUCTION, espec in Romance lang: see note on ╥ureteral╙ & ╥urethral╙ under URETERAL DISEASES MNC12.777.725.776 LH  MSCystic dilatation of the ureter with ballooning of the ureteral orifice into the lumen of the bladder. PM68 HN68(63) MHÑUreterocele MNC12.777.725.876 LH  MHÑUrethane ANdo not use /biosyn /defic /physiol RN51-79-6 MND2.241.81.251.944; D22.204.938 FXÑPOLYURETHANES XUÑNitrosomethylurethane LH LX LU  MHÑUrethra ANdo not confuse with URETER, espec in Romance lang: see note under URETER above; inflammation = URETHRITIS MNA5.360.444.492.726; A5.810.876 LH  PM66 HN66 MHÑUrethral Diseases ANdo not confuse with URETERAL DISEASES, espec in Romance lang: see note on ╥ureteral╙ & ╥urethral╙ under URETERAL DISEASES; inflamm dis = URETHRITIS MNC12.777.767 LH  MHÑUrethral Neoplasms ANdo not confuse with URETERAL NEOPLASMS, espec in Romance lang: see note on ╥ureteral╙ & ╥urethral╙ under URETERAL DISEASES; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945.947.945; C12.777.767.601 LH  MSObstruction anywhere along the urethra. PM79 HN79 MHÑUrethral Obstruction ANdo not confuse with URETERAL OBSTRUCTION, espec in Romance lang: see note on ╥ureteral╙ & ╥urethral╙ under URETERAL DISEASES; note URETHRAL STRICTURE below PIUrethral Diseases (66-78); Urethral Stricture (66-78) MNC12.777.767.700 LH  MHÑUrethral Stricture ANstenosis goes here; do not confuse with URETHRAL OBSTRUCTION MNC12.777.767.700.700 LH  MHÑUrethritis MNC12.777.767.851 LH  MHÑUric Acid ANdo not use /defic /physiol RN69-93-2 MND3.438.759.758.824.877 LH  PM64 HN64 MHÑUricosuric Agents ANdo not use /analogs /biosyn /defic /physiol MND14.73.278.398.946; D26.74.75.574.946 LH  PM66; was see under NUCLEOSIDES 1963-65; ARABINOFURANOSYLURACIL was see under PYRIMIDINE NUCLEOSIDES 1976-77 HN66(64); was see under NUCLEOSIDES 1963-65 MHÑUridine AN/biosyn /physiol permitted RN58-96-8 MND13.570.685.852; D13.570.800.892 XUÑ3-Deazauridine; ÑArabinofuranosyluracil; ÑPseudouridine; ÑTetrahydrouridine LH LU; ; ;  MSUridine 5'-(trihydrogen diphosphate). A uracil nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: uridine pyrophosphate; URPP. HN(78) MHÑUridine Diphosphate AN/biosyn /physiol permitted; /analogs NIM only RN58-98-0 PIUracil Nucleotides (66-77) MND13.695.740.850.600; D13.695.827.919.600 XSUDP DMÑUracil Nucleotides LH LS LM  MSA nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose. HN(75) MHÑUridine Diphosphate Galactose AN/analogs NIM only RN2956-16-3 PIGalactose (73-74); Uridine Diphosphate Sugars (73-74) MND9.203.408.620.569.727.300; D13.695.740.850.600.677.300; D13.695.827.708.727.300; D13.695.827.919.600.677.300 XSUDP Galactose; UDPGal; Uridine Diphosphogalactose; Uridine Pyrophosphogalactose DMÑUridine Diphosphate Sugars LH LS; ; ; LM  MSA key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids. HN(75) MHÑUridine Diphosphate Glucose AN/analogs NIM only RN133-89-1 PIGlucose (73-74); Uridine Diphosphate Sugars (73-74) MND9.203.408.620.569.727.350; D13.695.740.850.600.677.350; D13.695.827.708.727.350; D13.695.827.919.600.677.350 XSUDP Glucose; UDPG; Uridine Diphosphoglucose DMÑUridine Diphosphate Sugars LH LS; ; LM  MSUDPglucose:NAD+ 6-oxidoreductase. Catalyzes the oxidation of UDPglucose to UDPglucuronate in the presence of NAD+. HN(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77 MHÑUridine Diphosphate Glucose Dehydrogenase ANdo not use /analogs RNEC 1.1.1.22 PIAlcohol Oxidoreductases (73-74); Glucose (73-74); Uridine Diphosphate Sugars (73-74) MND8.586.682.47.150.900 XSUDP Glucose Dehydrogenase; UDPG Dehydrogenase DMÑCarbohydrate Dehydrogenases LH LS; LM  MSA necessary enzyme in the metabolism of galactose. It reversibly catalyzes the conversion of UDPglucose to UDPgalactose. NAD+ is an essential component for enzymatic activity. HN(75) MHÑUridine Diphosphate Glucose Epimerase ANdo not use /analogs RNEC 5.1.3.2 PICarbohydrate Isomerases (73-74); Galactose (73-74); Glucose (73-74); Uridine Diphosphate Sugars (73-74 MND8.586.399.278.900; D8.586.399.461.900 XSUDP Galactose Epimerase; UDP Glucose Epimerase DMÑCarbohydrate Isomerases LH LS; LM  MSA nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. Also may be epimerized to UDPiduronic acid, which donates iduronic acid to polysaccharides. In animals it is used for formation of many glucosiduronides with various aglycones. HN(75) MHÑUridine Diphosphate Glucuronic Acid AN/analogs NIM only RN2616-64-0 PIGlucuronates (73-74); Uridine Diphosphate Sugars (73-74) MND9.203.408.620.569.727.375; D13.695.740.850.600.677.375; D13.695.827.708.727.375; D13.695.827.919.600.677.375 XSUDP Glucuronic Acid; UDPGA; Uridine Diphosphoglucuronic Acid DMÑUridine Diphosphate Sugars LH LS; ; LM  MSA nucleoside diphosphate sugar which serves as a source of N-acetylgalactosamine for glycoproteins, sulfatides and cerebrosides. HN(75) MHÑUridine Diphosphate N-Acetylgalactosamine AN/analogs NIM only RN7277-98-7 PIGalactosamine (73-74); Uridine Diphosphate Sugars (73-74) MND9.203.408.620.569.727.100; D13.695.740.850.600.677.100; D13.695.827.708.727.100; D13.695.827.919.600.677.100 XSUDP Acetylgalactosamine DMÑUridine Diphosphate Sugars LH LS LM  MSServes as the biological precursor of insect chitin, of muramic acid in bacterial cell walls, and of sialic acids in mammalian glycoproteins. HN(75) MHÑUridine Diphosphate N-Acetylglucosamine AN/analogs NIM only RN528-04-1 PIUridine Diphosphate Sugars (74); Glucosamine (74) MND9.203.408.620.569.727.120; D13.695.740.850.600.677.120; D13.695.827.708.727.120; D13.695.827.919.600.677.120 XSUDP Acetylglucosamine; UDPGNAc; Uridine Diphospho-N-Acetylglucosamine; Uridine Pyrophosphoacetylglucosamine DMÑUridine Diphosphate Sugars LH LS; ; ; LM  MSA nucleoside diphosphate sugar which is formed from UDP-N-acetylglucosamine and phosphoenolpyruvate. It serves as the building block upon which peptidoglycan is formed. HN(75) MHÑUridine Diphosphate N-Acetylmuramic Acid AN/analogs NIM only PIMuramic Acid (73-74); Uridine Diphosphate Sugars (73-74) MND9.203.408.620.569.727.150; D13.695.740.850.600.677.150; D13.695.827.708.727.150; D13.695.827.919.600.677.150 XSUDP Acetylmuramic Acid DMÑUridine Diphosphate Sugars LH LS LM  PM73 HN73 MHÑUridine Diphosphate Sugars ANdo not use /analogs PIUracil Nucleotides (66-72); specific carbohydrate MND9.203.408.620.569.727; D13.695.740.850.600.677; D13.695.827.708.727; D13.695.827.919.600.677 XSUDP Sugars XUÑUridine Diphosphate Galactose; ÑUridine Diphosphate Glucose; ÑUridine Diphosphate Glucuronic Acid; ÑUridine Diphosphate N-Acetylgalactosamine; ÑUridine Diphosphate N-Acetylglucosamine; ÑUridine Diphosphate N-Acetylmuramic Acid; ÑUridine Diphosphate Xylose LH LS LU; ; ; ; ; ;  MSThe decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans. HN(75) MHÑUridine Diphosphate Xylose AN/analogs NIM only RN3616-06-6 PIUridine Diphosphate Sugars (73-74); Xylose (73-74) MND9.203.408.620.569.727.800; D13.695.740.850.600.677.800; D13.695.827.708.727.800; D13.695.827.919.600.677.800 XSUDP Xylose DMÑUridine Diphosphate Sugars LH LS LM  MSCatalyzes the phosphorylation of uridine and cytidine to uridine 5'-phosphate and cytidine 5'-phosphate, respectively. ATP, dUTP, dGTP and dATP are effective phosphate donors. HN(75) MHÑUridine Kinase ANdo not use /analogs RNEC 2.7.1.48 PIPhosphotransferases, ATP (74); Uridine (74) MND8.586.913.696.729.935 DMÑPhosphotransferases, Atp LH LM  MS5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. Synonym: UMP OLto search URIDYLIC ACIDS use URIDINE MONOPHOSPHATE back thru 1975 & URACIL NUCLEOTIDES 1966-74 HN(78); was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77 MHÑUridine Monophosphate AN/biosyn /physiol permitted; /analogs NIM only RN58-97-9 PIUracil Nucleotides (66-74) MND13.695.740.850.877; D13.695.827.919.877 XSUMP; Uridylic Acid DMÑUracil Nucleotides LH LS; LM  MSUridine:orthophosphate ribosyltransferase. Catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate. HN(75) MHÑUridine Phosphorylase ANdo not use /analogs RNEC 2.4.2.3 PIPentosyltransferases (73-74); Phosphates (73-74); Uridine (73-74) MND8.586.913.647.950 DMÑPentosyltransferases LH LM  MSUridine 5'-(tetrahydrogen triphosphate. A uracil nucleotide containing three phosphate groups esterified to the sugar moiety. Synonym: URPPP. HN(78) MHÑUridine Triphosphate AN/biosyn /physiol permitted; /analogs NIM only RN63-39-8 PIUracil Nucleotides (66-77) MND13.695.740.850.950; D13.695.827.919.950 XSUTP DMÑUracil Nucleotides LH LS LM  OLto search for chem composition of urinary calculi, use URINARY CALCULI/anal back thru 1987 & URINARY CALCULI/metab 1966-86 MHÑUrinary Calculi ANGEN: consider BLADDER CALCULI, KIDNEY CALCULI, URETERAL CALCULI; chem composition of calculi: use /anal; /ultrastruct permitted MNC12.777.809 LH  MSEmployment or passage of a catheter into the bladder (urethral c.) or kidney (ureteral c.). MHÑUrinary Catheterization ANdo not use /util except by MeSH definition; coord IM with specific site (NIM) if pertinent MNE1.223.894.809; E1.341.777 XSCATHETERIZATION, URINARY FXÑBladder LH LS LX  MHÑUrinary Diversion ANdo not use /util except by MeSH definition; coord IM with organ /surg (NIM); TN 189: do not coord with URETER; Manual 26.23; NEPHROSTOMY, PERCUTANEOUS is available MNE4.887.774.852 LH  MHÑUrinary Fistula ANfistula policy: Manual 23.25+; coord IM with pre-coord organ/diseases (IM); BLADDER FISTULA & VESICOVAGINAL FISTULA are available MNC12.777.850 FXÑFistula LH LX  MHÑUrinary Incontinence MNC12.777.934.852 LH  MHÑUrinary Incontinence, Stress MNC12.777.934.852.727 LH  PM72 HN72 MHÑUrinary Tract ANGEN: prefer specific organ; /radiogr = UROGRAPHY but for general only; dis = UROLOGIC DISEASES; neopl = UROLOGIC NEOPLASMS but prefer specifics PIUrogenital System (66-71) MNA5.810 LH  MSInfections affecting those structures of the body which participate in the secretion and elimination of urine, i.e., the kidney, the ureters, the urinary bladder, and the urethra. MHÑUrinary Tract Infections ANGEN; prefer specific organ/diseases coord with infection term; /drug ther: consider also ANTI-INFECTIVE AGENTS, URINARY MNC1.539.895; C12.777.892 LH  OLconsider also URINARY TRACT /PH or /PH with specific parts of the urinary tract MH*Urinary Tract Physiology (Non Mesh) MNG8.852 LH  MHÑUrination ANonly /drug eff /rad eff MNG8.852.877 LH  MHÑUrination Disorders MNC12.777.934 LH  MHÑUrine ANGEN only: prefer /urine with higher animals, substances & diseases: Manual 19.5+; when GEN & IM, only /anal /cytol /microbiol /parasitol; for microbiol, see TN 190; urine volume: index under URINE probably NIM MNA12.207.927 FXÑAlbuminuria; ÑAlkaptonuria; ÑAminoaciduria, Renal; ÑAnuria; ÑBacteriuria; ÑCystinuria; ÑGlycosuria; ÑHematuria; ÑHemoglobinuria; ÑMaple Syrup Urine Disease; ÑPOLYURIA; ÑPROTEINURIA; ÑPYURIA; ÑPhenylketonuria LH LX; ; ; ; ; ; ; ; ; ; ; ; ;  MHÑUrobilin AN/biosyn /physiol permitted RN1856-98-0 MND11.557.193.727 LH  MHÑUrobilinogen AN/biosyn /physiol permitted; do not use /analogs RN14684-37-8 MND11.557.193.852 LH  HN(72) MHÑUrocanase ANdo not use /analogs RNEC 4.2.1.49 PIHydro-Lyases (66-71) MND8.586.520.497.921 DMÑHydro-Lyases LH LM  MS4-Imidazoleacrylic acid. HN(75) MHÑUrocanic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN104-98-3 PIAcrylates (69-74); Imidazoles (69-74) MND2.241.81.69.920; D3.383.374.960 XSGlyoxalinylacrylic Acid DMÑImidazoles LH LS LM  MSA subphylum of chordates intermediate between the invertebrates and the true vertebrates. PM73 HN73 MHÑUrochordata AN/microbiol /parasitol permitted PIChordata (66-72) MNB1.272.727 XSTUNICATA XUÑCiona intestinalis LH LS LU  MSAn order of the Amphibia class which includes salamanders and newts. They are characterized by usually having slim bodies and tails, four limbs of about equal size (except in Sirenidae), and a reduction in skull bones. OLuse URODELA to search SALAMANDERS back thru 1966 PM81; was SALAMANDERS 1963-80 HN81; was SALAMANDERS 1963-80 MHÑUrodela ANincludes SALAMANDERS (note X ref below), mudpuppies ( = NECTURUS & specific) & NEWTS ( = SALAMANDRIDAE & specifics); usually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2.90.608 XSAmphiuma; Caudata; Eel, Congo; Salamanders LH LS; ; ;  MSThe mechanical laws of fluid dynamics as they apply to urine transport. PM78 HN78 MHÑUrodynamics ANsame relation to URINARY TRACT that HEMODYNAMICS is to CARDIOVASCULAR SYSTEM; only /drug eff /rad eff; urine volume: index under URINE probably NIM PIUrinary Tract (72-77); specific urinary tract heading; Urination (66-77); Urologic Diseases (66-77); specific urologic disease MNG8.852.950 LH  OLconsider also UROGENITAL SYSTEM /AB & /AB with specific parts of the uro + genital syst MH*Urogenital Abnormalities (Non Mesh) MNC16.131.939 LH  MHÑUrogenital Neoplasms ANGEN or unspecified but must be both uro + genital: prefer specific precoord; /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945; C12.878; C13.371.830 LH  MHÑUrogenital System ANmust be both uro + genital; GEN; /radiogr = UROGRAPHY MNA5 XSGENITOURINARY SYSTEM LH LS  MHÑUrography ANGEN only: prefer specific organ with /radiogr; NIM; do not use /util except by MeSH definition MNE1.341.878; E1.818.946 XSPyelography LH LS  MSProteolytic enzyme that converts plasminogen to plasmin where the preferential cleavage is between arginine and valine; originally from human urine, but found in most tissues of most vertebrates; used in the therapy of thromboembolic conditions. OLsearch FIBRINOLYTIC AGENTS 1966-74 PM84; was see under PEPTIDE PEPTIDOHYDROLASES 1975-83, was see under FIBRINOLYTIC AGENTS 1966-74, was see under STREPTODORNASE AND STREPTOKINASE 1963-65 HN84(75); was see under PEPTIDE PEPTIDOHYDROLASES 1975-83, was see under FIBRINOLYTIC AGENTS 1966-74, was see under STREPTODORNASE AND STREPTOKINASE 1963-65 MHÑUrokinase ANdo not use /analogs /defic /physiol RNEC 3.4.21.31 MND8.586.277.656.732.635.900; D19.461.427.600.620.928 LH  MH*Urologic and Male Genital Diseases (Non Mesh) MNC12 LH  PM65 HN65 MHÑUrologic Diseases AN= urinary tract diseases; GEN: prefer specifics CATALOG: form qualif = UROLOGY/form MNC12.777 FXÑUrology LH LX  MSNeoplasms of the urinary tract. PM78 HN78 MHÑUrologic Neoplasms ANneopl of urinary tract only; GEN or unspecified: prefer specifics BLADDER NEOPLASMS, KIDNEY NEOPLASMS, URETERAL NEOPLASMS or URETHRAL NEOPLASMS; coord IM with histol type of neopl (IM); /anal /blood supply /secret /ultrastruct permitted PIUrogenital Neoplasms (66-77) MNC4.588.945.947; C12.878.950 LH  MSA surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes and the genital tract in the male. MHÑUrology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of UROLOGIC DISEASES /form MNG2.403.810.860 FXÑUROLOGIC DISEASES LH LX  MSHospital department responsible for the administration and provision of diagnostic and therapeutic services for the urologic patient. HN(Aug 77) MHÑUrology Department, Hospital ANonly /econ /legis /man /organ /stand /trends /util; DF: UROL DEP PIHospital Departments (68-Jul 77); Urology (66-Jul 77) MNN2.278.354.422.790; N4.452.442.422.790 XSHospital Urology Department DMÑHospital Departments LH LS LM  MHÑUronic Acids ANdo not use /analogs /defic /physiol MND2.241.81.844.915; D2.241.152.811; D2.241.511.902.915; D9.203.811.922 XUÑHexuronic Acids; ÑIduronic Acid LH LU;  MHÑUropepsin ANdo not use /analogs RNEC 3.4.- MND8.586.277.656.732.953 LH  MSUroporphyrinogen-III carboxy-lyase. One of the enzymes active in heme biosynthesis. Catalyzes the decarboxylation of uroporphyrinogen III to coproporphyrinogen III by the conversion of four acetic acid groups to four methyl groups. HN(76) MHÑUroporphyrinogen Decarboxylase ANdo not use /analogs RNEC 4.1.1.37 PICarboxy-Lyases (74-75); Porphyrinogens (75); Porphyrins (74) MND8.586.520.258.900 XSUroporphyrinogen Carboxy-Lyase DMÑCarboxy-Lyases LH LS LM  MSCatalyzes the cyclization of hydroxymethylbilane to yield uroporphyrinogen III and water. OLuse UROPORPHYRINOGEN III SYNTHASE to search UROPORPHYRINOGEN ISOMERASE back thru 1975 HN(85); was UROPORPHYRINOGEN ISOMERASE see under ISOMERASES 1975-84 MHÑUroporphyrinogen III Synthase ANdo not use /analogs RNEC 4.2.1.75 PIIsomerases (71-74); Porphobilinogen (73-74) MND8.586.520.497.940 XSCosynthase; Uroporphyrinogen III Cosynthetase; Uroporphyrinogen Isomerase DMÑHydro-Lyases LH LS; ; LM  MSPorphyrinogens which are intermediates in heme biosynthesis. They have four acetic acid and four propionic acid side chains attached to the pyrrole rings. Uroporphyrinogen I and III are formed from polypyrryl methane in the presence of uroporphyrinogen III cosynthetase and uroporphyrin I synthetase, respectively. They can yield uroporphyrins by autooxidation or coproporphyrinogens by decarboxylation. HN(76) MHÑUroporphyrinogens ANdo not use /analogs /defic PIPorphyrinogens (75); Porphyrins (71-74) MND11.557.727.700.900 DMÑPorphyrinogens LH LM  MSPorphyrins with four acetic acid and four propionic acid side chains attached to the pyrrole rings. HN(75) MHÑUroporphyrins ANdo not use /analogs /defic PIPorphyrins (68-74) MND11.557.727.880 DMÑPorphyrins LH LM  MSTeleost hormones; small peptides isolated from urophyses of bony fishes; they have many different physiological effects, including long lasting hypotensive activity; proposed as antihypertensives; there are at least four different compounds: urotensin I; urotensin II; urotensin III; urotensin IV. HN(79) MHÑUrotensins ANfrom urophyses of fish; /biosyn /physiol permitted; do not use /analogs /defic PIFishes (66-78); Peptides (66-78) MND12.644.910; D18.162.943; D24.185.798.354.943 DMÑPeptides LH LM  MS3-alpha,7-beta-Dihydroxy-5-beta-cholan-24-oic acid. Epimer of chenodeoxycholic acid; a mammalian bile acid found first in the bear; it is apparently either a precursor or a product of chenodeoxycholate; administration changes the composition of bile and may dissolve gallstones; used as cholagogue and choleretic. Synonyms: Urosan; Urso; Ursodeoxycholate; Ursodesoxycholic Acid. HN(80) MHÑUrsodeoxycholic Acid ANdo not use /biosyn /defic /physiol; urso- refers to its first isol from bears (Latin ursus) RN128-13-2 PIBile Acids and Salts (66-72); Chenodeoxycholic Acid (73-79); Deoxycholic Acid (73-74) /AA (75-79) MND4.808.221.430.342.925; D19.316.246.175.947 XSDeoxyursocholic Acid DMÑDeoxycholic Acid LH LS LM  MSA vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability; the causative mechanism may be allergy, infection or stress. MHÑUrticaria MNC17.174.948; C20.543.480.904 XSHives LH LS  PM65 HN65(63) MHÑUrticaria Pigmentosa MNC17.508.948; C17.621.893 XSMastocytosis, Bullous; Mastocytosis, Diffuse Cutaneous LH LS;  MHÑUruguay MNZ1.107.757.904 LH  MSThe portion of an interactive computer program that issues messages to and receives commands from a user. HN(87) MHÑUser-Computer Interface ANIM; no qualif MNL1.700.568.810.910 XSInterface, User Computer DMÑSoftware LH LS LM  OLsearch BENZOFURANS 1968-74 HN(75) MHÑUsnic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN125-46-2 MND3.438.127.728 DMÑBenzofurans LH LM  MHÑUSSR ANGEN; some Soviet republics are available as headings; note spelling: no periods MNZ1.252.878; Z1.542.248.950; Z1.950 XSSoviet Union; Union of Soviet Socialist Republics LH LS;  MSAn order of basidiomycetous fungi; some species are parasitic on grasses and maize. OLsearch BASIDIOMYCETES 1966-74 HN(75) MHÑUstilaginales ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.179.853 DMÑBasidiomycetes LH LM  MSA genus of basidiomycetous smut fungi comprising the loose smuts. HN(75) MHÑUstilago ANdo not use /anat /embryol /microbiol /parasitol MNB5.354.179.853.800 DMÑBasidiomycetes LH LM  MHÑUtah MNZ1.107.567.875.895 LH  MSContraction of the uterine muscle. PM75 HN75 MHÑUterine Contraction ANonly /drug eff /rad eff PIUterus (66-74) MNG8.520.769.326.700 LH  PM66 HN66 MHÑUterine Diseases ANinflamm dis = ENDOMETRITIS MNC13.371.852 LH  MHÑUterine Hemorrhage AN╥vaginal bleeding╙ goes here but check text; consider MENORRHAGIA & METRORRHAGIA MNC13.371.852.691; C23.542.946 XSHEMORRHAGE, UTERINE LH LS  MSFailure of the uterus to contract with normal strength and duration and at normal intervals during labor. Synonym: uterine atony. PM67 HN67(64) MHÑUterine Inertia ANincludes ╥atony╙ MNC13.703.420.288.728 LH  MHÑUterine Neoplasms ANfibroma = LEIOMYOMA (IM) + UTERINE NEOPLASMS (IM); /anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); CERVIX NEOPLASMS is available MNC4.588.945.418.948; C13.371.852.762 LH  MSPenetration through the uterine wall. HN(75) MHÑUterine Perforation MNC13.371.852.904.500; C21.866.761.853.500 DMÑUterine Rupture LH LM  MHÑUterine Prolapse MNC13.371.852.833 XSVAGINAL PROLAPSE LH LS  MSA tearing of uterine tissue; it may be traumatic or spontaneous due to multiple pregnancy, large fetus, previous scarring, or obstruction. MHÑUterine Rupture ANspontaneous or traumatic but do not coord with RUPTURE or RUPTURE, SPONTANEOUS MNC13.371.852.904; C13.703.420.904; C21.866.761.853 XUÑUterine Perforation LH LU  MSA protein fraction of pregnant uterine fluid which can induce and regulate blastocystic development. Blastokinin is thought to be similar or identical to uteroglobin. Presence in uterine fluid regulated by progesterone. HN(75) MHÑUteroglobin AN/biosyn /physiol permitted; /analogs NIM only RN9060-09-7 PIGlycoproteins (71-74) MND12.776.395.960 XSBlastokinin DMÑGlycoproteins LH LS LM  MHÑUterus AN/radiogr = HYSTEROSALPINGOGRAPHY; /surg: consider HYSTERECTOMY; inflammation = ENDOMETRITIS MNA5.360.319.679 FXÑHysterectomy; ÑHysterosalpingography LH LX;  MSAn organized procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use. PM68 HN68 MHÑUtilization Review ANonly /legis /methods /stand /trends PIspecific health facility MNN4.761.879 FXÑProfessional Staff Committees XUÑConcurrent Review LH LX LU  MHÑUtopias ANno qualif MNK1.752.884 LH  MHÑUvea ANanterior uvea = IRIS + CILIARY BODY, posterior uvea = CHOROID; uveal neopl = UVEAL NEOPLASMS; anterior uveal neopl = UVEAL NEOPLASMS (IM) + IRIS (IM) + CILIARY BODY (IM), posterior uveal neopl = CHOROID NEOPLASMS; inflammation = UVEITIS (consider also UVEITIS, ANTERIOR) MNA9.371.894 LH  MSDiseases of the uvea. PM76 HN76; was NON MESH before 1976 MHÑUveal Diseases ANinflamm dis = UVEITIS (consider also UVEITIS, ANTERIOR); see note above PIUvea (66-75); specific uveal disease MNC11.941 LH  PM81 HN81 MHÑUveal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); CHOROID NEOPLASMS is also available PICiliary Body (66-80); Eye Neoplasms (66-80); Iris (66-80); Uvea (66-75); Uveal Diseases (76-80) MNC4.588.364.978; C11.319.494; C11.941.855 LH  MHÑUveitis MNC11.941.879 XUÑUveomeningoencephalitic Syndrome LH LU  OLuse UVEITIS, ANTERIOR to search IRIDOCYCLITIS back thru 1966 PM86; was IRIDOCYCLITIS 1963-85 HN86; was IRIDOCYCLITIS 1963-85 MHÑUveitis, Anterior ANinflammation of both the iris & ciliary body; of iris alone = IRITIS, of ciliary body alone = CILIARY BODY (IM) + UVEITIS, ANTERIOR (IM) MNC11.941.500.800; C11.941.879.800 XSIridocyclitis LH LS  HN(65) MHÑUveomeningoencephalitic Syndrome MNC10.228.140.437.615.729; C10.228.228.553.729; C11.941.879.812 XSVogt-Koyanagi-Harada Syndrome DMÑUveitis LH LS LM  MSA manifestation of sarcoidosis marked by chronic inflammation of the parotid gland and the uvea. OLsearch SARCOIDOSIS 1966-74 HN(75) MHÑUveoparotid Fever ANalso called uveoparotitis MNC23.484.739.729 DMÑSarcoidosis LH LM  PM65; was see under PALATE 1963-64 HN65(63); was see under PALATE 1963-64 MHÑUvula MNA14.549.617.780.729 LH  OLuse UZBEK S.S.R. to search UZBEKISTAN back thru 1966 HN82; was UZBEKISTAN 1963-81 MHÑUzbek S.S.R. MNZ1.252.878.100.950; Z1.950.100.950 LH  MSAdministration of vaccines to stimulate the host's immune response. OLsearch BCG VACCINATION under BCG VACCINE back thru 1966 PMBCG VACCINATION was heading 1963-79 HNBCG VACCINATION was heading 1963-79 MHÑVaccination ANdo not use /util except by MeSH definition; Manual 26.29+; for prev only: coord IM with dis /prev (IM); for ther, index under IMMUNOTHERAPY or specific vaccine /ther use MNE2.95.377.854; G3.770.670.310.890; G3.850.180.460.325 LH  MHÑVaccines ANGEN: prefer specifics; only /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /tox; /ther use = IMMUNOTHERAPY MND24.310.894 XUÑRickettsial Vaccines LH LU  PM74 HN74(73) MHÑVaccines, Attenuated ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /tox; coord NIM with specific vaccine (IM); ╥inactivated╙ vaccine goes here but ╥killed╙ does not (index only under the vaccine) PIVaccines (66-72); specific vaccine MND24.310.894.811 LH  MSSmall synthetic peptides that mimic surface antigens of pathogens and are immunogenic or vaccines manufactured with the aid of recombinant DNA technics. The latter vaccines may also be whole viruses whose nucleic acids have been modified. HN(87) MHÑVaccines, Synthetic ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox PIAntigens (66-86) MND12.776.828.868; D24.310.894.865; D24.611.216.865 XSAntigens, Synthetic; Chemical Vaccines; Immunogens, Synthetic; Molecular Vaccines; Semisynthetic Vaccines; Synthetic Vaccines; Vaccines, Recombinant DMÑAntigens LH LS; ; ; ; ; ; LM  MSA viral disease of cattle. MHÑVaccinia MNC2.256.743.929 XSCOWPOX LH LS  MSThe etiologic agent of cowpox; used in vaccination against variola. MHÑVaccinia Virus ANdo not use /blood-csf-urine /cytol; infection = VACCINIA MNB4.909.204.783.834 XSPOXVIRUS OFFICINALE LH LS  MSAny spaces or cavities within a cell. They may function in digestion, storage, secretion, or excretion. OLsearch CELLULAR INCLUSIONS 1974 & CYTOPLASM 1966-73 HN(75); was see under CELLULAR INCLUSIONS 1974-76, was see under CYTOPLASM 1966-73 MHÑVacuoles ANA 11 qualif except /cytol MNA11.368.702.929 DMÑOrganoids LH LM  MSA space in which the pressure is far below atmospheric pressure so that the remaining gases do not affect processes being carried on in the space. HN(78) MHÑVacuum ANalmost never IM; no qualif MNG3.230.300.100.185.902; H1.671.691.902 DMÑAtmospheric Pressure LH LM  MSAspiration of the contents of the uterus with a vacuum curette. HN(75) MHÑVacuum Curettage ANdo not use /util except by MeSH definition MNE4.157.310.970; E4.819.608.310.970 XSSuction Curettage DMÑDilatation and Curettage LH LS LM  OLsearch EXTRACTION, OBSTETRICAL 1966-74 HN(75) MHÑVacuum Extraction, Obstetrical ANdo not use /util except by MeSH definition MNE4.819.774.457.392.729 XSDelivery, Vacuum Extraction DMÑExtraction, Obstetrical LH LS LM  MHÑVagina AN╥vaginal bleeding╙ is probably UTERINE HEMORRHAGE but check text; ╥vaginal discharge╙ = LEUKORRHEA; inflammation = VAGINITIS MNA5.360.319.779 LH  MSA cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent. Use for vaginal creams, foams and jellies in general or for which there is no other specific heading. PM75 HN75 MHÑVaginal Creams, Foams and Jellies ANIM for general only, only D25-26 qualif; NIM when specific drug is IM, no qualif; DF: VAGINAL CREAMS PIDosage Forms (66-74) MND26.394.225.970 FXÑAdministration, Intravaginal; ÑContraceptive Agents, Female LH LX;  PM66 HN66 MHÑVaginal Diseases ANinflamm dis = VAGINITIS MNC13.371.894 LH  MHÑVaginal Fistula ANfistula policy: Manual 23.25+; RECTOVAGINAL FISTULA & VESICOVAGINAL FISTULA are available MNC13.371.894.763 FXÑFistula LH LX  MHÑVaginal Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945.418.955; C13.371.894.834 LH  MSCollection of pooled secretions of the posterior vaginal fornix for cytologic examination. Use for cervical smears. MHÑVaginal Smears ANdo not use /util except by MeSH definition; includes ╥cervical smears╙: do not coord with CERVIX UTERI MNE1.223.230.730; E1.223.894.895; E1.249.917 LH  MHÑVaginitis ANmonilial vaginitis = MONILIASIS, VULVOVAGINAL MNC13.371.894.906 LH  MHÑVagotomy ANdo not use /util except by MeSH definition; ╥truncal vagotomy╙ goes here MNE4.530.324.906; E4.765.936 LH  MSVagal denervation of that part of the stomach lined with acid secreting mucosa. PM86; was see under VAGOTOMY 1981-85 HN86(81); was see under VAGOTOMY 1981-85 MHÑVagotomy, Proximal Gastric ANdo not use /util except by MeSH definition; also called ╥highly selective vagotomy╙, ╥hyperselective╙, ╥superselective╙, ╥supraselective╙, ╥ultraselective╙; ╥truncal vagotomy╙ goes under VAGOTOMY PIDuodenal Ulcer/SU (66-80); Vagotomy (66-80) MNE4.765.936.952 XSVagotomy, Parietal Cell; Vagotomy, Selective Proximal LH LS;  MHÑVagus Nerve AN10th cranial nerve; do not use /innerv; neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM); /surg: probably VAGOTOMY MNA8.99.698.730; A8.796.214.936 XSPNEUMOGASTRIC NERVE XUÑNodose Ganglion LH LS LU  PM66 HN66 MHÑValerates ANdo not use /analogs /biosyn /defic /physiol; 2-propylvalerate, 2-propylvaleric acid = VALPROATE MND2.241.81.465.895; D2.241.81.944; D10.516.251.400.895 XSPentanoates XUÑPentanoic Acids LH LS LU  MSValerian officinale, an ancient, sedative herb of the large family Valerianaceae; the roots were formerly used to treat hysterias and other neurotic states and are presently used to treat sleep disorders. HN(86)63 MHÑValerian ANdo not use /isol /pathogen MNB6.560.956 XSHeliotrope DMÑPlants, Medicinal LH LS LM  MHÑValine AN/biosyn /defic /physiol permitted RN7004-03-7 MND12.125.142.930; D12.125.70.950 LH  PM73 HN73(71) MHÑValinomycin ANdo not use /defic /physiol RN2001-95-8 PIAntibiotics (66-70) MND8.373.936.500.900; D12.644.456.895; D20.85.925 LH  MS2-Propylvaleric acid. A fatty acid with anticonvulsant properties used in the treatment of epilepsy. Dipropyl acetate inhibits competitively GABA transaminase, thereby increasing the brain GABA level. Increased GABA levels may protect the organism against seizure. Frequently encountered synonyms: Depakene; Depakine; Ergenyl. OLuse VALPROATE to search DIPROPYL ACETATE back thru 1975 PM79; was DIPROPYL ACETATE see under VALERATES 1975-78 HN79; was DIPROPYL ACETATE see under VALERATES 1975-78 MHÑValproate ANdo not use /biosyn /defic /physiol RN99-66-1 PIValerates (66-74) MND2.241.81.944.509.900; D14.261.952 XSDipropyl Acetate; Sodium Valproate LH LS;  PM67 HN67(63) MHÑValsalva's Maneuver ANno qualif MNE1.145.569.936; E1.302.796.822 LH  MSL-Valine:tRNA-Val ligase (AMP-forming). Activates valine with its specific transfer RNA. HN(75) MHÑValyl T RNA Synthetase ANdo not use /analogs; note spacing RNEC 6.1.1.9 PIAmino Acyl T RNA Synthetases (72-74); Valine (72-74) MND8.586.464.136.850 DMÑAmino Acyl T RNA Synthetases LH LM  MHÑVanadium ANV-51; do not use /analogs /biosyn /defic /physiol; V-50 = VANADIUM (IM) + ISOTOPES (NIM); V-46-49, 52-54 = VANADIUM (IM) + RADIOISOTOPES (IM) RN7440-62-2 MND1.268.936; D1.552.931; D1.937.922 LH  MSAntibacterial obtained from Streptomyces orientalis; a glycopeptide related to ristocetin; inhibits bacterial cell wall assembly; toxic to kidneys and the inner ear. Synonym: Vancocin. MHÑVancomycin ANdo not use /defic /physiol; do not confuse with trade name Vancomin, a vitamin B12 deriv RN1404-90-6 MND20.85.939 LH  OLsearch BENZOATES 1968-74 HN(75); was see under BENZOATES 1968-74 MHÑVanillic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN121-34-6 MND2.241.223.106.505.850; D2.241.511.390.850; D2.755.410.850 DMÑHydroxybenzoic Acids LH LM  PM72 HN72(68) MHÑVanilmandelic Acid ANdo not use /biosyn /defic /physiol RN55-10-7 PIMandelic Acids (66-67) MND2.241.223.475.730; D2.241.511.536.730 XSMethoxyhydroxymandelic Acid LH LS  MSThe phenotypic differences among individuals in a population. PM68 HN68 MHÑVariation (Genetics) ANonly /drug eff /rad eff; DF: VARIATION PIGenetics (66-67); Genetics, Population (66-67) MNG5.414.918 XSGenetic Diversity LH LS  MSA species of Herpesviridae which causes chickenpox (Varicella) and shingles (Herpes zoster). MHÑVaricella-Zoster Virus ANdo not use /blood-csf-urine /cytol; infection = CHICKENPOX or HERPES ZOSTER; note short entry term MNB4.909.204.382.918 XSChickenpox Virus; Herpes Zoster Virus; Herpesvirus Varicellae; Ocular Herpes Zoster Virus; VZ Virus LH LS; ; ; ;  MHÑVaricocele MNC12.294.936; C14.907.903 LH  MSUlcer due to varicose veins. MHÑVaricose Ulcer ANassume to be of legs & do not coord with LEG ULCER MNC14.907.927.730; C17.893.592.730 XSStasis Ulcer LH LS  MHÑVaricose Veins ANsame as varix, varices; assume to be of legs so do not coord with LEG; other sites: coord VARICOSE VEINS (IM) + organ /blood supply (IM), not organ/dis, as orbit varix = VARICOSE VEINS (IM) + ORBIT /blood supply (IM) (not ORBITAL DISEASES); ESOPHAGEAL AND GASTRIC VARICES is also available MNC14.907.927 FXÑSCLEROSING SOLUTIONS LH LX  MHÑVas Deferens AN/surg: consider also VASECTOMY MNA5.360.444.930 XSDUCTUS DEFERENS LH LS  MSBlood vessels supplying the nerves. HN(64) MHÑVasa Nervorum ANdo not use /innerv MNA7.231.765 DMÑBlood Vessels LH LM  MSNutrient blood vessels which supply the walls of large arteries or veins. PM74 HN74(65) MHÑVasa Vasorum ANdo not use /blood supply MNA7.231.836 LH  MHÑVascular Diseases ANGEN; NIM when specific artery or vein is IM; inflamm dis = VASCULITIS; vascular compression syndromes: coord IM with CONSTRICTION, PATHOLOGIC (NIM) + specific blood vessel if pertinent (IM) MNC14.907 FXÑCardiology LH LX  MSThrobbing headache due to abnormal pulsation of cranial arteries. PM78; was see under HEADACHE 1975-77 HN78(64); was see under HEADACHE 1975-77 MHÑVascular Headache MNC10.228.140.300.937; C14.907.253.937; C23.888.592.612.429.814 XUÑCluster Headache LH LU  MSThe condition of blood vessels not being blocked or obstructed. PM87 HN87 MHÑVascular Patency ANonly /drug eff /rad eff PIGraft Occlusion, Vascular (85-86) MNG9.330.950 XSPatency, Vascular FXÑGraft Occlusion, Vascular LH LS LX  MSAn expression of the resistance offered by the systemic arterioles, and to a lesser extent by the capillaries, to the flow of blood. PM67; CAPILLARY RESISTANCE was heading 1963-85 HN67(64) MHÑVascular Resistance ANonly /drug eff /rad eff MNG9.330.612.931 XSPeripheral Resistance FXÑBlood Vessels; ÑHypertension XUÑCapillary Resistance LH LS LX; LU  MSOperative procedures for the treatment of vascular disorders. HNwas in Cat E & G 1968-79 MHÑVascular Surgery ANGEN only: prefer specific blood vessel /surg; SPEC: SPEC qualif; /psychol /rehabil permitted MNE4.752.814 FXÑBlood Vessels LH LX  MSInflammation of a blood vessel. PM78 HN78 MHÑVasculitis ANblood vessels only; GEN or unspecified only; consider ARTERITIS or PHLEBITIS & their indentions; hemorrhagic vasculitis = PURPURA, SCHOENLEIN-HENOCH PIArteritis (66-77); Periarteritis Nodosa (66-77) MNC14.907.940 XSAngiitis LH LS  MSVasculitis due to allergic reaction, marked by such cutaneous lesions as papules, macules, vesicles, urticarial wheals, purpura, and small ulcers, and accompanied by itching and usually a slight fever and malaise. PM78 HN78 MHÑVasculitis, Allergic Cutaneous PIPurpura (66-77); Skin/BS (66-77); Skin Diseases (66-77); Vascular Diseases (66-77) MNC14.907.940.952; C17.952; C20.543.480.920 XSAllergic Cutaneous Angiitis; Allergic Cutaneous Vasculitis; Angiitis, Allergic Cutaneous LH LS; ;  PM73 HN73 MHÑVasectomy ANdo not use /util except by MeSH definition PIVas Deferens/SU (66-72) MNE4.887.774.692.856; E4.887.599.900 FXÑSterilization Reversal LH LX  MSA highly basic, single-chain polypeptide isolated from the intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal and respiratory systems. PM84; was see under GASTROINTESTINAL HORMONES 1977-83 HN84(77); was see under GASTROINTESTINAL HORMONES 1977-83 MHÑVasoactive Intestinal Peptide AN/biosyn /physiol permitted; do not use /analogs; DF: VIP RN37221-79-7 PIGastrointestinal Hormones (74-76); Peptides (74-76) MND6.472.317.950; D12.644.920; D12.776.641.650.875; D19.316.629.954 LH  MSNarrowing of the blood vessels without anatomic change, for which CONSTRICTION, PATHOLOGIC is used. PM78 HN78 MHÑVasoconstriction ANIM; coord IM with specific vessel or specific organ /blood supply; the physiol process; do not confuse with stenosis of specific blood vessels ( = specific blood vessel (IM) + CONSTRICTION, PATHOLOGIC (NIM)); only /drug eff /rad eff; /drug eff: consider also VASOCONSTRICTOR AGENTS & specifics PIVascular Resistance (66-77); Vasomotor System (66-77); specific blood vessel/PH (66-77) MNG9.330.612.950 LH  PM67 HN67(65) MHÑVasoconstrictor Agents ANdo not use /analogs /biosyn /defic /physiol; consider also VASOMOTOR SYSTEM /drug eff MND18.793 XSVASOPRESSOR AGENTS; Vasoactive Agonists LH LS;  PM67 HN67 MHÑVasoconstrictor Agents, Nasal ANdo not use /analogs /biosyn /defic /physiol PISympathomimetics (66) MND18.793.952 XSNASAL DECONGESTANTS LH LS  MSDilation of the blood vessels without anatomic change, for which DILATATION, PATHOLOGIC or ANEURYSM (or specific aneurysm) is used. PM78 HN78 MHÑVasodilation ANIM; coord IM with specific vessel or specific organ /blood supply; the physiol process: do not confuse with pathol dilat of specific blood vessels ( = specific vessel (IM) + DILATATION, PATHOLOGIC (NIM)); only /drug eff /rad eff; /drug eff: consider also VASODILATOR AGENTS & specifics PIVasomotor System (66-77); tissue or organ/BS (66-77) MNG9.330.612.955 LH  MHÑVasodilator Agents ANdo not use /analogs /biosyn /defic /physiol; consider also VASOMOTOR SYSTEM /drug eff MND18.918 XSVasoactive Antagonists LH LS  MHÑVasomotor System ANdo not use /blood supply /innerv (note category); /drug eff: consider also VASOCONSTRICTOR AGENTS & VASODILATOR AGENTS; VASOCONSTRICTION & VASODILATION are available MNA8.99.893.814 LH  MSThe octapeptide antidiuretic hormone released by the neurohypophysis of all vertebrates (chemical composition varies with species); controls water metabolism and balance by regulating lung, gill, kidney, etc., water loss; also contracts smooth muscle. OLuse VASOPRESSINS to search VASOPRESSIN back thru 1966 PM79; was VASOPRESSIN 1963-78 HN79; was VASOPRESSIN 1963-78 MHÑVasopressins AN/biosyn /physiol permitted; do not use /analogs; /secret: consider also INAPPROPRIATE ADH SYNDROME; pitressin goes here MND6.472.734.692.781; D12.644.456.925; D12.776.641.650.900; D19.770.896 XSAntidiuretic Hormones; beta-Hypophamine FXÑInappropriate ADH Syndrome XUÑOrnipressin LH LS; LX LU  MSCys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly, with a disulfide bond at Cys; the non mammalian hormone that controls water and salt metabolism; the phylogenetic precursor of both antidiuretic hormones and oxytoxins, found to be a possible neuroendocrin mediator in mammals; has oxytocic and vasopressor actions. Synonym: 3-isoleucyl argipressin. PM73 HN73(63) MHÑVasotocin AN/biosyn /physiol permitted RN9034-50-8 MND6.472.734.692.881; D12.644.456.925.940; D12.776.641.650.900.900 XS3-Isoleucyl Vasopressin; Arginine Oxytocin; Arginine Vasotocin; Argiprestocin; Vasopressin, Isoleucyl; Vasopressin, Non-Mammalian LH LS; ; ; ; ;  MHÑVater's Ampulla ANdiseases: coord IM with COMMON BILE DUCT DISEASES (NIM); inflammation: coord IM with CHOLANGITIS (IM); neopl: coord IM with COMMON BILE DUCT NEOPLASMS (IM); note X ref DUODENAL PAPILLA, MAJOR: do not confuse with DUODENAL PAPILLA, MINOR see PANCREATIC DUCTS; ╥duodenal papilla╙ unspecified is probably DUODENAL PAPILLA, MAJOR MNA3.159.183.307.731 XSDuodenal Papilla, Major XUÑOddi's Sphincter LH LS LU  MHÑVatican City MNZ1.542.961 LH  MSRecording of the moment-to-moment electromotive forces of the heart on a plane of the body surface delineated as a vector function of time. Syn: vector electrocardiography. MHÑVectorcardiography ANdo not use /util except by MeSH definition MNE1.145.569.359.731; E1.399.214.731 XUÑPolarcardiography LH LU  MS1-(3 alpha,17 beta-Dihydroxy-2-beta-piperidino- 5-alpha-androstan-16 beta,5 alpha-y1)-1-methylpiperidinium bromide diacetate. Monoquaternary homologue of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, currently available established neuromuscular blocking agents. PM87 HN87 MHÑVecuronium ANdo not use /biosyn /defic /physiol RN50700-72-6 PIAndrostanes (68-71); Pancuronium/analogs & derivatives (72-86) MND4.808.54.40.685.900; D17.563.367.635.955 XSVecuronium Bromide LH LS  MSProteins which are present in or isolated from vegetables or vegetable products. OLsearch PLANT PROTEINS 1966-74 PM75; was see under PLANT PROTEINS 1963-74 HN75; was see under PLANT PROTEINS 1963-74 MHÑVegetable Proteins ANdo not use /analogs /defic /physiol PIPlant Proteins (66-74) MND12.776.256.920; D12.776.765.836 LH  MHÑVegetables ANas plant & food; only /ad-poi-tox /anal /class /hist /rad eff /stand /supply; vegetables as plant tissue: Manual 31.9 MNB6.510.956; J1.341.956 LH  MSDietary practice of consuming only vegetables, grains, and nuts. HNwas in Cat E & I 1963-83 MHÑVegetarianism ANonly /adv eff /econ /hist /psychol CATALOG: do not use /pop wks MNE5.272.731; G6.696.384.731 LH  MHÑVehicles ANpharm & pharmacol, not transportation; NIM; when IM, D25-26 qualif MND26.698.931 LH  MSA genus of gram-negative anaerobic cocci parasitic in the mouth and in the intestinal and respiratory tracts of man and other animals. MHÑVeillonella ANdo not use /blood-csf-urine MNB3.425.800.814 LH  MSA family of Gram-negative bacteria which are parasites of warm-blooded animals such as man, ruminants, rodents and pigs, particularly in the alimentary tract. PM76 HN76 MHÑVeillonellaceae ANdo not use /blood-csf-urine PIBacteria (66-74); Neisseriaceae (75) MNB3.425.800 LH  MSThe vessels carrying blood toward the heart. MHÑVeins ANIM GEN only; NIM as coord to indicate specific vein, as 'pancreatic' vein = PANCREAS /blood supply (IM) + VEINS (NIM); /radiogr = PHLEBOGRAPHY; do not use /blood supply; venous blood: probably not indexed as being the usual sampling method but if significant coord BLOOD (NIM) + VEINS or specific vein (NIM); venous pressure = VENOUS PRESSURE or CENTRAL VENOUS PRESSURE; inflammation = PHLEBITIS MNA7.231.908 XUÑVenules LH LU  MSFailure of the soft palate to reach the posterior pharyngeal wall. It may be caused by cleft palate surgery, palatal or pharyngeal abnormalities or injury, or neuromuscular dysfunction of the velopharyngeal sphincter. It causes hypernasality of speech. PM78 HN78 MHÑVelopharyngeal Insufficiency AN/congen permitted PICleft Palate (66-77); Palate (66-77); Pharynx (66-77) MNC9.775.955; C16.131.314.687.955 XSPalatopharyngeal Incompetence FXÑSpeech Disorders LH LS LX  MSThe venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs. MHÑVena Cava, Inferior ANdo not use /blood supply MNA7.231.908.949.648 LH  MSThe venous trunk which returns blood from the head, neck, upper extremities and chest. MHÑVena Cava, Superior ANdo not use /blood supply; SUPERIOR VENA CAVA SYNDROME is available MNA7.231.908.949.815 FXÑSuperior Vena Cava Syndrome LH LX  MSThe inferior and superior venae cavae. MHÑVenae Cavae ANdo not use /blood supply; try to specify VENA CAVA, INFERIOR or VENA CAVA, SUPERIOR MNA7.231.908.949 LH  MSTumors most commonly seen on or near the genitalia. They are venereal, most likely transmitted through transplantation of cells by contact. Metastases have been reported. Spontaneous regression may occur. PM79 HN79 MHÑVenereal Tumors, Veterinary ANdo not use /vet but check tag ANIMAL; do not coord with GENITALIA or specific genital term unless especially discussed; coord IM with precoord animal/dis term (IM) + animal (NIM); /anal /blood supply /secret /ultrastruct permitted PIDog Diseases (66-78); Neoplasms (66-78); Venereal Diseases (66-78) MNC4.588.945.956; C22.950 XSVenereal Tumors, Transmissible LH LS  MSA branch of medicine which deals with sexually transmitted disease. PM83 HN83 MHÑVenereology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of SEXUALLY TRANSMITTED DISEASES /form PIVenereal Diseases (66-82) MNG2.403.776.680 FXÑSexually Transmitted Diseases LH LX  MHÑVenezuela MNZ1.107.757.943 LH  MSPoisonous animal secretions; fluid mixtures of many different enzymes, toxins and other substances produced in specialized glands and secreted through specialized delivery systems (nematocycts, spines, fangs, etc.) for disabling prey or predator; most animal phyla have venomous members. MHÑVenoms ANincludes poisonous secretions from animal skin, spines, fangs & other specialized glands; GEN or unspecified only: prefer specifics; do not use /analogs /defic /diag use; /antag = probably ANTIVENINS; coord with the animal producing the venom (IM or NIM) but many specific precoord venom terms are available (AMPHIBIAN VENOMS, ARTHROPOD VENOMS, SNAKE VENOMS & its indentions, etc.) MNA12.838.935; D24.185.965 FXÑAntivenins LH LX  MSInadequacy of the venous valves and impairment of venous return (venous stasis) from the legs, often with edema and sometimes with stasis ulcers at the ankle. PM73 HN73 MHÑVenous Insufficiency PIVascular Diseases (66-72) MNC14.907.952 LH  PM70 HN70 MHÑVenous Pressure ANIM GEN only; NIM for pressure within a specific vessel; only /drug eff /rad eff; CENTRAL VENOUS PRESSURE also available; venous hypertension: index under VENOUS PRESSURE (IM) & do not coord with HYPERTENSION PIBlood Pressure (66-69); Veins (66-69) MNG9.330.612.114.732 XSBLOOD PRESSURE, VENOUS LH LS  MHÑVentilation ANenvironment, not lungs; no qualif MNG3.230.150.520 LH  PM70 HN70(68) MHÑVentilation-Perfusion Ratio ANonly /drug eff /rad eff PIRespiratory Function Tests (66-67) MNE1.302.796.568.862; G9.772.521.602.953 FXÑPULMONARY CIRCULATION LH LX  MHÑVentricular Fibrillation ANdoes not include ventric flutter ( = ARRHYTHMIA (IM) + HEART VENTRICLE (NIM)) MNC14.280.67.932 LH  MSRadiography of the ventricular system of the brain after injection of air or other contrast medium directly into the cerebral ventricles. Use also for x-ray computed tomography of the cerebral ventricles. OLuse VENTRICULOGRAPHY, CEREBRAL to search VENTRICULOGRAPHY 1966-76 PM77; was VENTRICULOGRAPHY 1963-76 HN77; was VENTRICULOGRAPHY 1963-76 MHÑVentriculography, Cerebral ANdo not use /util except by MeSH definition MNE1.236.257.897; E1.236.688.882; E1.818.573.882 LH  MSA nucleus of the middle hypothalamus, the largest cell group of the tuberal region with small to medium size cells. PM83 HN83 MHÑVentromedial Hypothalamic Nucleus ANdo not use /innerv PIHypothalamus (66-82); Hypothalamus, Middle (75-82) MNA8.186.211.385.357.352.953 XSHypothalamic Nucleus, Ventromedial LH LS  MSToxic substances isolated from various strains of Streptomyces. They are 20-membered macrolides that inhibit oxidative phosphorylation and mitochondrial ATPases. Venturicidins A and B are glycosides. Used mainly as tools in the study of mitochondrial function. HN(77) MHÑVenturicidins ANfrom Streptomyces; do not use /analogs /defic /physiol PIAntibiotics, Antifungal (73-76); Glycosides (73-74); Lactones (73-76); Rhamnose (73-74) MND2.540.800; D8.373.936.955 DMÑLactones LH LM  MSThe minute vessels that collect blood from the capillary plexuses and join together to form veins. OLsearch VEINS 1966-74 HN(78); was see under VEINS 1964-74 MHÑVenules ANrestrict to blood vessels: not for ╥lymphatic venules╙: index under LYMPHATIC SYSTEM; IM GEN only; NIM as coord with specific organ /blood supply (IM); do not use /blood supply PIVeins (66-77) MNA7.231.432.952; A7.231.908.952 DMÑVeins LH LM  MS5[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)isopropyl-valeronitrile. Blocks the transmembrane carrier of calcium and uncouples excitation from contraction, especially in smooth and cardiac muscle. OLuse VERAPAMIL to search IPROVERATRIL back thru 1966 (as Prov 1966-71) PM84; was IPROVERATRIL 1972-83 HN84; was IPROVERATRIL 1964-83 (Prov 1964-71) MHÑVerapamil ANdo not use /biosyn /defic /physiol RN52-53-9 MND2.92.471.683.953; D18.97.953; D18.192.953; D18.918.925 XSIproveratril LH LS  MS3-Veratroylveracevine. One of the components in the veratrine mixture of alkaloids. Found in the seed of Schoenocaulon officinale and in rhizome of Veratrum album L., Liliaceae. HN(75) MHÑVeratridine ANdo not confuse with VERATRINE; do not use /defic /physiol RN71-62-5 PIVeratrine (73-74) MND3.132.920.256.815.850; D3.549.256.815.850 DMÑVeratrine LH LM  PM73 HN73(63) MHÑVeratrine ANdo not use /defic /physiol; do not confuse with VERATRIDINE RN62-59-9 MND3.132.920.256.815; D3.549.256.815 XUÑVeratridine LH LU  MSA genus of coarse herbs of the Lily family with poisonous roots that contain many alkaloids and are used as emetics, parasiticides, antihypertensives, and other drugs; the specific chemicals isolated from Veratrum viride or V. album are VERATRUM ALKALOIDS. HN(86)63; was in Cat B & D 1963-77 MHÑVeratrum ANplant only with VERATRUM ALKALOIDS or its specifics the probable Cat D term; do not use /isol /pathogen MNB6.560.965; B6.660.932 XSHellebore DMÑPlants, Toxic LH LS LM  MSAlkaloids with powerful hypotensive effects, isolated from American or European Hellebore (Veratrum viride Ait. Liliaceae and Veratrum album L. Liliaceae); they increase cholinergic and decrease adrenergic tone with appropriate sideffects and at higher doses depress respiration and produce cardiac arrhythmias; only the ester alkaloids have been used as hypotensive agents in specific instances. PM75; PROTOVERATRINE A was see under CEVANES 1975-79; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1963-68; CRYPTENAMINE (now see PROTOVERATRINES, an XU below) was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74 HN75 MHÑVeratrum Alkaloids ANdo not use /analogs /defic /physiol PIVeratrum (66-74) MND3.132.920; D18.162.955 XUÑProtoveratrines LH LU  MSIncludes both producing and responding to words, either written or spoken. PM66 HN66(64) MHÑVerbal Behavior ANonly /drug eff /physiol /rad eff MNF1.145.209.908 FXÑLanguage Disorders; ÑSPEECH DISORDERS; ÑSpeech LH LX; ;  MSLearning to respond verbally to a verbal stimulus cue. MHÑVerbal Learning ANonly /drug eff /physiol /rad eff MNF2.463.425.952 FXÑLanguage Disorders LH LX  MHÑVermont MNZ1.107.567.875.907 LH  MSAn unctuous substance composed of sebum and desquamated epithelial cells, which covers the skin of the fetus. MHÑVernix Caseosa ANonly /anal /cytol /drug eff /enzymol /immunol /metab /microbiol /parasitol /physiol /rad eff /secret; check the tag INFANT, NEWBORN MNA12.838.946; A16.378.857 LH  MSA cell line derived from the kidney of the African green (vervet) monkey, Cercopithecus aethiops; used primarily in virus replication studies and plaque assays. PM87 HN87 MHÑVero Cells ANcell line from African green monkey (vervet) kidney; almost never IM; no qualif when NIM, A11 qualif when IM; capitalize Vero in titles PICell Line (69-86); Cercopithecus (75-80); Cercopithecus aethiops (81-86); Kidney (66-86) MNA11.251.210.955 LH  OLto search VERSION use VERSION, FETAL back thru 1975 & DELIVERY 1966-74 HN(81); was VERSION see under DELIVERY 1963-80 MHÑVersion, Fetal ANno qualif MNE4.819.774.457.927 DMÑDelivery LH LM  MSThe first branch of the subclavian artery with distribution to muscles of the neck, vertebrae, spinal cord, cerebellum and interior of the cerebrum. MHÑVertebral Artery ANdo not use /blood supply MNA7.231.114.955 LH  MSViruses infecting vertebrates. PM66; was ANIMAL VIRUSES 1963-65 HN66; was ANIMAL VIRUSES 1963-65 MHÑVertebrate Viruses ANGEN: avoid; do not use /blood-csf-urine /cytol MNB4.909 XSANIMAL VIRUSES; ZOOPHAGINAE LH LS;  MSViruses infecting vertebrates, whose taxonomic relationships have not been established. The most important are the human hepatitis viruses and the agents of spongiform encephalopathies such as scrapie. PM66; BORNA DISEASE VIRUS was see under ENCEPHALITIS VIRUSES 1977-80, was see under ARBOVIRUSES 1975-76 HN66 MHÑVertebrate Viruses, Unclassified ANGEN: avoid; do not use /blood-csf-urine /cytol MNB4.909.920 XUÑAstroviruses; ÑBorna Disease Virus; ÑMink Encephalopathy Virus LH LU; ;  MHÑVertebrates ANavoid: too general; IM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol MNB2 LH  MSObstruction or stenosis of the vertebral-basilar system manifested by disturbances of consciousness, vertigo, headache, hemi- or quadriplegia, dysarthria, and facial paralysis. PM80 HN80 MHÑVertebrobasilar Insufficiency PIBasilar Artery (66-79); Cerebrovascular Disorders (66-79); Vertebral Artery (66-79) MNC10.228.140.300.459.956; C14.907.253.956 XSBasilar Artery Insufficiency; Vertebral Artery Insufficiency LH LS;  PM66 HN66 MHÑVertical Dimension ANno qualif MNE6.276.459.733 XSMANDIBULAR REST POSITION; REST VERTICAL DIMENSION LH LS;  MSAn illusion of movement, either of the external world revolving around the patient or of the patient himself revolving in space. Vertigo is not the same as dizziness, which is a disturbed sense of relation to space. MHÑVertigo ANillusion of revolution in space; differentiate from DIZZINESS, ╥sensation of unsteadiness or lightheadedness╙, but use word of text MNC9.218.568.883; C10.597.951; C23.888.592.958 LH  MHÑVesico-Ureteral Reflux MNC12.777.103.920 LH  MHÑVesicovaginal Fistula ANfistula policy: Manual 23.25+ MNC12.777.103.187.733; C12.777.850.312.733; C13.371.894.763.816 FXÑFistula LH LX  MSA picornavirus infection of swine characterized by hydropic degeneration of the oral and cutaneous epithelia. PM71 HN71 MHÑVesicular Exanthema of Swine ANdo not use /vet; don't forget also SWINE (NIM) & check tag ANIMAL PISwine Diseases (66-70); Virus Diseases/VE (66-70) MNC2.782.957; C22.905.927 LH  MSA genus of Rhabdoviridae causing a disease symptomatically similar to foot-and-mouth disease in cattle and horses; it may be transmitted to other species including man. MHÑVesicular Stomatitis Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with VIRUS DISEASES (IM) + probably STOMATITIS (IM) + precoord animal/dis term (IM), using qualif /vet if pertinent MNB4.909.777.750.918 LH  MHÑVestibular Apparatus ANdiseases: coord IM with LABYRINTH DISEASES (NIM) MNA9.246.631.909 XUÑOval Window; ÑVestibular Aqueduct LH LU;  MSA small bony canal linking the vestibule of the inner ear to the posterior part of the internal surface of the petrous temporal bone. It surrounds the endolymphatic duct. HN(79) MHÑVestibular Aqueduct PIVestibular Apparatus (66-78) MNA9.246.631.909.957 DMÑVestibular Apparatus LH LM  MHÑVestibular Function Tests ANonly /instrum /methods MNE1.276.299.816 XUÑCaloric Tests LH LU  OLuse VESTIBULAR NERVE to search SCARPA'S GANGLION back thru 1966 HNSCARPA'S GANGLION was see under VESTIBULAR NERVE 1963-78 MHÑVestibular Nerve ANdo not use /innerv; dis = VESTIBULAR NERVE (IM) + ACOUSTIC NERVE DISEASES (NIM); neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM) MNA8.796.214.125.816 XSScarpa's Ganglion LH LS  OLuse VESTIBULAR NUCLEI to search SCHWALBE'S NUCLEUS back thru 1967 PM67 HN67(65); SCHWALBE'S NUCLEUS was see under VESTIBULAR NUCLEI 1967-78 MHÑVestibular Nuclei ANdo not use /innerv MNA8.186.211.132.810.616.733 XSSchwalbe's Nucleus XUÑDeiters Nucleus LH LS LU  MSThose procedures designed to widen the zone of attached gingiva and deepen the vestibular depth which will facilitate the clearance of the area for natural food passage, and provide access for toothbrushing and interdental stimulation. PM72 HN72(69) MHÑVestibuloplasty ANdo not use /util except by MeSH definition PISurgery, Oral (66-67) MNE4.833.800.950; E6.892.800.950 LH  MSFormer members of the armed services. OLuse VETERANS to search VETERANS AFFAIRS 1966-80 PM81; was VETERANS AFFAIRS 1963-80 HN81; was VETERANS AFFAIRS 1963-80 MHÑVeterans AN/class /educ /hist /psychol permitted MNM1.930 FXÑMilitary Personnel LH LX  MSDisorders claimed as a result of military service. MHÑVeterans Disability Claims ANonly /class /econ /hist /legis /trends; specify country MNN3.219.521.346.733 FXÑDisability Evaluation LH LX  MSThe medical science concerned with the prevention, diagnosis, and treatment of diseases in animals. MHÑVeterinary Medicine ANSPEC only: SPEC qualif except /methods; prefer /vet with diseases & technics: Manual 19.5+; indexing policy: Manual 23.47-23.52; /educ = EDUCATION, VETERINARY; /legislation & jurisprudence = LEGISLATION, VETERINARY or VETERINARY MEDICINE (IM) + JURISPRUDENCE (IM) CATALOG: use with form qualif instead of ANIMAL DISEASES /form MNG2.956 FXÑAnimal Diseases; ÑAnimal Husbandry; ÑLaboratory Animal Science XUÑSurgery, Veterinary LH LX; ; LU  MHÑVeterinary Service, Military ANSPEC: SPEC qualif; do not use /educ; specify country MNG2.956.858 LH  MHÑVibration ANonly /adv eff /ther use MNH1.671.963 LH  MSA genus of the Pseudomonadales, made up of short, slightly curved, motile, gram-negative rods; various species produce cholera and other gastrointestinal disorders as well as abortion in sheep and cattle. MHÑVibrio ANdo not use /blood-csf-urine; infection = VIBRIO INFECTIONS MNB3.475.900.859 LH  MSThe etiologic agent of cholera. OLuse VIBRIO CHOLERAE to search VIBRIO COMMA back thru 1972 (as Prov 1972-73) PM76; was VIBRIO COMMA 1974-75 HN76; was VIBRIO COMMA 1972-75 (Prov 1972-73) MHÑVibrio cholerae ANdo not use /blood-csf-urine; infection = CHOLERA PIVibrio (66-71) MNB3.475.900.859.650 XSVibrio comma FXÑCholera Toxin LH LS LX  MSInfection with species of the genus Vibrio. PM68 HN68 MHÑVibrio Infections ANV. comma infection = CHOLERA PIVibrio (66-67) MNC1.252.959 LH  MSA species of bacteria found in the marine environment, sea foods, and the feces of patients with acute enteritis. PM76 HN76 MHÑVibrio parahaemolyticus ANin marine environment & human feces; infection: coord NIM with VIBRIO INFECTIONS (IM) PIVibrio (66-75) MNB3.475.900.859.700 LH  MSA family of Gram-negative bacteria usually found in fresh or sea water, occasionally in fish or man. PM76; BENECKEA was heading 1963-65 HN76 MHÑVibrionaceae ANin fresh & sea water PIBacteria (66-74); Pseudomonadaceae (75); Spirillaceae (75) MNB3.475.900 XUÑBeneckea LH LU  MSStiff hairs projecting from the face around the nose of most mammals, acting as touch receptors. PM85 HN85 MHÑVibrissae ANdo not use /blood supply /innerv /physiopathol /secret /surg PIAfferent Pathways (76-84); Hair (66-84); Mechanoreceptors (71-84) MNA8.796.511.725.404.950; A13.950 XSWhiskers LH LS  MS9-beta-D-Arabinofuranosyladenine. A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia virus and varicella zoster virus. OLuse VIDARABINE to search ARABINOFURANOSYLADENINE back thru 1975 PM79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76 HN79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76 MHÑVidarabine ANdo not use /defic /physiol RN5536-17-4 PIAdenine (72-74); Arabinose (72-74); Nucleosides (72-74); Purines (66-73) MND13.570.65.950; D13.570.583.138.900; D20.388.975; D26.87.975 XSAdenine Arabinoside; Ara-A; Arabinofuranosyladenine; Arabinosyladenine LH LS; ; ;  MSThe storing or preserving of video signals for television to be played back later via a transmitter or receiver. Recordings may be made on magnetic tape or discs. PM84 HN84 MHÑVideo Recording ANonly /econ /hist /instrum /legis /methods /stand /trends /util (if by MeSH definition); note heading below PIVideotape Recording (74-83) MNL1.240.960 XUÑVideodisc Recording LH LU  MSThe storing of visual and usually sound signals on discs for later reproduction on a television screen. HN(84) MHÑVideodisc Recording ANonly /econ /hist /instrum /legis /methods /stand /trends /util (if by MeSH definition) PIAudio-Visual Aids (66-83); Videotape Recording (74-83) MNL1.178.147.898.640; L1.240.960.800 DMÑVideo Recording LH LM  MSRecording of visual and sometimes sound signals on magnetic tape. PM74 HN74 MHÑVideotape Recording ANonly /econ /hist /instrum /legis /methods /stand /trends /util (if by MeSH definition) MNL1.178.147.846.734; L1.178.147.898.734; L1.240.960.880 XSTape Recording, Video LH LS  MHÑVietnam MNZ1.252.145.945 LH  MS2-(2-Ethoxyphenoxymethyl)-tetrahydro-1,4-oxazine. Morpholine derivative found to use as an antidepressant; similar in action to imipramine. Synonyms: ICI 58,834; Vivalan. HN(77) MHÑViloxazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN46817-91-8 PIEthers (72-75); Morpholines (76); Oxazines (72-75) MND3.383.468.900; D15.236.122.961 DMÑMorpholines LH LM  MSAn intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000. PM85 HN85 MHÑVimentin AN/biosyn /physiol permitted PIIntermediate Filament Proteins (83-84); Muscle Proteins (66-82) MND12.776.220.475.900 LH  MHÑVinblastine ANdo not use /defic /physiol; /biosyn permitted if by plant RN865-21-4 MND3.132.934.650; D22.204.179.899.650 XSVINCALEUKOBLASTINE LH LS  PM73 HN73 MHÑVinca Alkaloids ANdo not use /analogs /defic /physiol; /biosyn permitted if by plant PIAlkaloids (66-72) MND3.132.934; D22.204.179.899 XUÑVincamine LH LU  MS14,15-Dihydro-14 beta-hydroxy-(3 alpha,16 alpha)eburnamenine-14-carboxylic acid methyl ester. Major alkaloid of Vinca minor L., Apocynaceae. Used therapeutically as a vasodilator and antihypertensive agent; particularly effective in cerebrovascular disorders. Synonyms: Arteriovinca, Perval, Pervincamine, Vincapront. HN(79) MHÑVincamine ANdo not use /defic /physiol; /analogs NIM only; /biosyn permitted if by plant RN1617-90-9 PIAlkaloids (66-72); Vinca Alkaloids (73-78) MND3.132.934.750; D18.918.935 DMÑVinca Alkaloids LH LM  PM66 HN66(63) MHÑVincristine ANdo not use /defic /physiol; /biosyn permitted if by plant RN57-22-7 MND3.132.934.817; D22.204.179.899.817 XSLEUROCRISTINE LH LS  MS3-Carbamoyl-4-deacetyl-3- de(methoxycarbonyl)vincaleukoblastine. Vinblastine derivative with antineoplastic activity against acute leukemia, lung cancer, carcinoma of the breast, squamous cell carcinoma of the esophagus, head and neck, Hodgkin's disease and non-Hodgkin's lymphomas. Major side effects are myelosuppression and neurotoxicity. Used extensively in chemotherapy protocols. PM86 HN86 MHÑVindesine ANdo not use /biosyn /defic /physiol RN53643-48-4 PIVinblastine/AA (80-85); Vinca Alkaloids (73-79) MND3.132.934.830; D22.204.179.899.820 LH  MSA gas which has been used as an aerosol propellant and is the starting material for polyvinyl resins. Toxicity studies have shown various adverse effects, particularly the occurrence of liver neoplasms. HN(75); was in Cat D & J 1975-79 MHÑVinyl Chloride AND25-26 qualif; /analogs NIM only; POLYVINYL CHLORIDE is available RN75-01-4 PIHydrocarbons, Chlorinated (74); Vinyl Compounds (74) MND2.455.326.271.884.750; D2.455.526.439.975; D26.191.962 XSChloroethylene DMÑVinyl Compounds LH LS LM  PM73 HN73(71) MHÑVinyl Compounds ANdo not use /analogs /biosyn /defic /physiol; DF: VINYL CPDS PIspecific component in the molecule; Alkenes (66-70) MND2.455.326.271.884 XUÑVinyl Chloride LH LU  MSIndividual or group aggressive behavior which is socially non-acceptable, turbulent and often destructive; it is precipitated by frustrations, hostility, prejudices, etc. OLsearch ATROCITIES under WAR CRIMES 1966-67 PM70; ATROCITIES was heading 1963-67 HN70(68); ATROCITIES was heading 1963-67 MHÑViolence ANno qualif; hostages go under PRISONERS (IM) (& add VIOLENCE (IM or NIM) only if discussed) PIAggression (66-67); Psychology, Social (66-67) MNF3.126.842.89.734 XSAtrocities; Terrorism FXÑRIOTS XUÑDangerous Behavior LH LS; LX LU  MSA group of dipyridinium chloride derivatives that are used as oxidation-reduction indicators. The general formula is 1,1'-diR-4,4'-bipyridinium chloride, where R=methyl, ethyll, benzyl or betaine. HN(75) MHÑViologens ANdo not use /analogs /biosyn /defic /physiol PIPyridinium Compounds (68-74) MND3.383.725.762.925 DMÑPyridinium Compounds LH LM  MSStrongly basic, complex antibiotics from several strains of Streptomyces; allergenic and toxic to kidneys and the labyrinth; used in tuberculosis as several different salts and in combination with other agents. Synonyms: Celiomycin; Vinactin A; Vinactan(e); Viocin; Viomicin. OLuse VIOMYCINS to search VIOMYCIN back thru 1966 PM81; was VIOMYCIN 1963-80 HN81; was VIOMYCIN 1963-80 MHÑViomycins ANdo not use /analogs /defic /physiol MND20.85.89.910; D20.338.135.922 XSFlorimycin; Tuberactinomycin B XUÑEnviomycin LH LS; LU  MSVenoms from snakes of the Viperid family; they tend to be less toxic than Elapid or Hydrophid venoms and act mainly on the vascular system, interfering with coagulation, capillary membrane integrity and are highly cytotoxic; they contain large amounts of several enzymes, other factors and some toxins. Viperotoxin goes here. PM78 HN78 MHÑViper Venoms ANdo not use /analogs /chem syn /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS; includes adder venoms & viperotoxin; TN 241: common & scientific names of various viperids PISnake Venoms (75-77); Snakes (66-74); Venoms (66-74) MND24.185.965.850.960 LH  MSProteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the capsid. PM86 HN86 MHÑViral Core Proteins ANIM; coord with specific virus (IM); do not use /analogs PICapsid (75-85); Viral Proteins (66-85) MND12.776.964.850 XSCore Proteins, Viral LH LS  MSLayers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins. PM84 HN84 MHÑViral Envelope Proteins ANIM; coord with specific virus (IM); do not use /analogs PIViral Proteins (66-83) MND12.776.964.900 XSEnvelope Proteins, Viral LH LS  MSProteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells. PM87 HN87 MHÑViral Fusion Proteins ANIM; coord with specific virus (IM); do not use /analogs; do not confuse with RECOMBINANT FUSION PROTEINS PIViral Envelope Proteins (84-86); Viral Proteins (66-83) MND12.776.964.900.910 XSFusion Proteins, Viral; Viral Fusion Glycoproteins LH LS;  MSAny vaccine raised against any virus or viral derivative that causes hepatitis. PM85 HN85 MHÑViral Hepatitis Vaccines ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; coord IM with specific hepatitis virus or viral hepatitis (IM or NIM) if pertinent PIViral Vaccines (66-84); Hepatitis, Viral, Animal (77-84); Hepatitis, Viral, Human (77-84) MND24.310.894.899.955 XSHepatitis, Viral, Vaccines LH LS  MSA phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus. PM66 HN66(65) MHÑViral Interference ANonly /drug eff /rad eff MNG4.185.515.875 FXÑInterferons LH LX  MHÑViral Proteins ANIM; coord with specific protein (IM) + specific virus (IM); do not use /analogs MND12.776.964 LH  PM65 HN65 MHÑViral Vaccines ANonly /admin /adv eff /anal /class /hist /immunol /isol /pharm /rad eff /stand /supply /ther use /tox; for specifics not indented here coord IM with specific virus /immunol (IM) MND24.310.894.899 LH  MSThe presence of viruses in the blood. PM80 HN80 MHÑViremia ANIM; coord with specific virus disease (IM) (do not use /blood to cover -emia) or specific virus (IM) (do not use /blood) if precoord virus/dis heading is not in MeSH PIspecific virus; specific virus disease/BL (67-79) MNC2.937 LH  MSAn unincorporated territory of the United States comprising the western Virgin Islands. The three main islands are St. Croix, St. Thomas, and St. John. HN82 MHÑVirgin Islands of the United States ANmajor islands: St. Croix, St. Thomas, St. John; DF: VIRGIN ISLANDS PIWest Indies (66-81) MNZ1.107.904.970 LH  MHÑVirginia MNZ1.107.567.875.918 LH  MSA large group of complex cyclic polypeptide antibiotics from Streptomycis virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus and others; used for infections with Gram positive organisms and as growth promoters in cattle, swine and poultry. Synonyms: Antibiotic 899; Eskalin; Factor M; Factor S; Pyostacine; SK&F 7988; Stafac; Stapyocine. OLuse VIRGINIAMYCINS to search STAPHYLOMYCIN back thru 1966 (as Prov 1966-73); use VIRGINAMYCINS to search MIKAMYCINS back thru 1975 PM74; MIKAMYCINS (with OSTREOGRYCIN & VERNAMYCIN as see refs to it 1978) was see under ANTIBIOTICS 1975-78 HN74; was STAPHYLOMYCIN 1963-73 (Prov); MIKAMYCINS (with OSTREOGRYCIN & VERNAMYCIN as see refs to it 1978-80) was see under VIRGINIAMYCINS 1979-80, was see under ANTIBIOTICS 1975-78 MHÑVirginiamycins ANdo not use /analogs /defic /physiol MND20.85.957 XSMikamycins; Ostreogrycins; Pristinamycins; STAPHYLOMYCIN; Streptogramins; Vernamycins; Virgimycine LH LS; ; ; ; ; ;  MSDevelopment of masculine traits in the female. MHÑVirilism ANcheck the tag FEMALE MNC19.391.922 FXÑAdrenal Hyperplasia, Congenital LH LX  MSThe infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos. Synonym: virus particle. PM78 HN78 MHÑVirion ANalso called ╥virus particle╙; do not use /blood-csf-urine /cytol PIViral Proteins (66-77); specific virus MNB4.950 LH  MSA group of pathogens comprising the smallest known agents of infectious disease. They are unencapsulated and are capable of replicating autonomously in susceptible cells. Positively identified viroids composed of single-stranded RNA have been isolated from higher plants, but the existence of DNA viroids pathogenic to animals is suspected. PM81 HN81 MHÑViroids AN╥smallest known agents of infect dis╙; do not use /blood-csf-urine /cytol PIPlant Viruses (71-80); RNA, Viral (71-80) MNB4.956 LH  PM67 HN67 MHÑVirology ANSPEC: SPEC qualif CATALOG: use with form qualif instead of VIRUSES /form or VIRUS DISEASES /form PIVirus Diseases (66); Viruses (66) MNG1.273.540.859 LH  MSThe degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. PM66 HN66(65) MHÑVirulence ANNIM; only /drug eff /rad eff; coord NIM with micro-organism /pathogen (IM) MNG4.185.515.910 LH  MSThe mechanism by which latent viruses, such as genetically transmitted tumor viruses or prophages of lysogenic bacteria, are induced to replicate and are released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell lipopolysaccharides, glucocorticoid hormones, halogenated pyrimidines, ionizing radiation, ultraviolet light, and superinfecting viruses. PM80 HN80 MHÑVirus Activation ANonly /drug eff /rad eff; coord with specific virus /growth (IM or NIM) PILysogeny (68-79); Virus Replication (68-79); specific virus (66-67) MNG4.185.515.946.940 XSProphage Excision; Prophage Induction; Virus Induction LH LS; ;  MHÑVirus Cultivation ANNIM; only /instrum /methods; relation to TISSUE CULTURE: Manual 26.33.2 MNE5.909.560.970 FXÑTISSUE CULTURE LH LX  MSA general term for diseases produced by viruses. MHÑVirus Diseases ANGEN: prefer specifics; /drug ther: consider also ANTIVIRAL AGENTS CATALOG: form qualif = VIROLOGY /form MNC2 LH  PM70 HN70(65) MHÑVirus Inhibitors ANdo not use /analogs; in normal serum, body fluids & tissues; do not confuse with INTERFERONS or VIRAL INTERFERENCE (factors produced after virus enters cell) or ANTIVIRAL AGENTS (antiviral drugs & chem); blood viricidal activity probably goes here (IM) + BLOOD /physiol (IM); DF: VIRUS INHIB MND24.611.935 LH  MSThe process of intracellular viral multiplication, consisting of the synthesis of proteins, nucleic acids, and sometimes lipids, and their assembly into a new infectious particle. PM68 HN68 MHÑVirus Replication ANonly /drug eff /rad eff; not a substitute for viral growth ( = specific virus /growth) but all right for viral multiplication; coord with specific virus /physiol (IM or NIM); DNA replication in viruses: coord IM with DNA REPLICATION (IM) PIViruses (66-67); specific virus MNG4.185.515.946; G6.184.941 FXÑDNA Replication LH LX  MSMinute infectious agents whose genomes are composed of DNA or RNA, but not both; they are characterized by a lack of independent metabolism and the inability to replicate outside living host cells. MHÑViruses ANGEN: avoid: too general; do not use /cytol; /drug eff: consider also ANTIVIRAL AGENTS; do not confuse ╥slow viruses╙ with ╥latent viruses╙: slow cause dis with very long preclin course & very slow progression, ╥latent╙ are non-infective but activable; presence of viruses in blood = VIREMIA: see note there; see many pre-coord VIR- terms like VIRAL PROTEINS; RNA, VIRAL, etc.; use Permuted MeSH for complete coverage; policy: Manual 22.18, 22.24+ CATALOG: form qualif = VIROLOGY /form MNB4 FXÑInclusion Bodies, Viral; ÑMicrobiology LH LX;  MSAny of the large interior organs in any one of the three great cavities of the body, especially in the abdomen. PM87 HN87 MHÑViscera ANGEN & unspecified only: prefer specific organ term MNA1.960 LH  MHÑVisceroptosis MNC6.405.890 XSSPLANCHNOPTOSIS LH LS  MHÑViscosity ANNIM; no qualif MNH1.181.529.934 FXÑBlood Viscosity LH LX  MSA genus of Old World parasitic plants of the Loranthaceae; Viscum album and Phorandendron flavescens were formerly used as emmenagogues, cardiac stimulants, and vasodilators; contains toxins, lectins, TYRAMINE, PHENETHYLAMINES, and other useful or dangerous compounds. MHÑViscum ANdo not use /isol /pathogen MNB6.560.975 XSMISTLETOE LH LS  MSThe sensation of sight. MHÑVision ANonly /drug eff /physiol /rad eff; differentiate from VISUAL PERCEPTION: vis percept takes place in the brain, vision takes place in the eye; array of vision & eye terms from all categories: Bull 94 (Feb 77); visual stimulation: probably PHOTIC STIMULATION but check text for possible non-light (non-photic) stimul MNF2.830.816.929; G11.561.796.929; G11.697.911 FXÑEye; ÑOphthalmology; ÑOptics; ÑVISUAL PERCEPTION XUÑPhosphenes; ÑVision, Entoptic LH LX; ; ; LU;  PM67 HN67 MHÑVision Disorders ANGEN PIVision (66) MNC10.597.751.941; C11.966; C23.888.592.763.941 LH  MHÑVision Tests ANonly /instrum /methods /stand MNE1.210.935 LH  MSVisual sensation due to shadows or optical effects of structures within the eye or to excitation of the receptor system by stimuli other than light. HN(75) MHÑVision, Entoptic ANonly /drug eff /physiol /rad eff MNF2.830.816.929.800; G11.561.796.929.800; G11.697.911.500 XSEnoptic Vision; Entoptic Vision DMÑVision LH LS; LM  MSPatients' guests and rules for visiting. PM78 HN78 MHÑVisitors to Patients ANonly /psychol MNM1.935 XSPatients' Visitors LH LS  MSThese viruses constitute the Lentiviruses subfamily of the Retroviridae. Visna causes a demyelinating disease of sheep similar to but not the same as Rida (Scrapie). Maedi causes a progressive pneumonia of sheep which is similar to but not the same as Jaagsiekte (Ovine Pulmonary Adenomatosis). PM78; was see under RNA VIRUSES 1975-77 HN78(73); was see under RNA VIRUSES 1975-77 MHÑVisna-Maedi Viruses ANdo not use /blood-csf-urine; lentivirus goes here; infection by visna or maedi virus = MAEDI see PNEUMONIA, PROGRESSIVE INTERSTITIAL, OF SHEEP PIPulmonary Adenomatosis, Ovine (68-72); Scrapie (68-72) MNB4.909.777.731.949 XSMaedi Virus LH LS  MS3,4,5-Trihydroxy-2,2-dimethyl-6-chromanacrylic acid delta-lactone 4-acetate 3-(2-methylbutyrate). Coronary vasodilator agent isolated from seeds of Ammi visnaga L., Umbelliferae. Synonyms: Cardine; Carduben; Provismine; Vibeline; Visgan; Visnacorin; Visnamine. HN(75) MHÑVisnadin ANdo not use /defic /physiol; /analogs NIM only; /biosyn permitted if by plant RN477-32-7 PIBenzopyrans (66-74); Butyrates (66-74); Heterocyclic Compounds (66) MND3.438.150.240.950; D18.918.940 XSVisnagan DMÑBenzopyrans LH LS LM  PM70 HN70(68) MHÑVisual Acuity ANonly /drug eff /rad eff PIVision (66-67) MNG11.697.911.610 FXÑForm Perception; ÑREFRACTION, OCULAR LH LX;  PM70 HN70(68) MHÑVisual Cortex ANdo not use /innerv; do not confuse STRIATE CORTEX with CORPUS STRIATUM (basal ganglia) PICerebral Cortex (66-67); Vision (66-67) MNA8.186.211.885.213.571.735 XSStriate Cortex LH LS  MHÑVisual Fields ANonly /drug eff /rad eff MNG11.697.911.735 FXÑPerimetry LH LX  PM72 HN72(71) MHÑVisual Pathways ANdo not use /innerv PICentral Nervous System (66-70); Vision (66-70) MNA8.612.220.860 LH  MSThe selecting and organizing of visual stimuli based on the individual's past experience. MHÑVisual Perception ANonly /drug eff /physiol /rad eff; differentiate from VISION: vis percept takes place in the brain, vision takes place in the eye MNF2.463.593.932; G11.697.911.860 FXÑVISION LH LX  PM72 HN72(69) MHÑVital Capacity ANonly /drug eff /rad eff; = forced vital capacity; timed vital capacity is FORCED EXPIRATORY VOLUME PISpirometry (66-68) MNE1.302.796.420.970; G9.772.521.885 XSForced Vital Capacity LH LS  MSUse for general articles concerning statistics of births, deaths, marriages, etc. MHÑVital Statistics ANGEN: no qualif; specify geog CATALOG: /geog /form MNN1.224.935 FXÑBiometry; ÑPOPULATION GROWTH; ÑRECORDS; ÑSEX RATIO LH LX; ; ;  MHÑVitalism ANno qualif MNK1.752.935 LH  MSAn alloy of 60% cobalt, 20% chromium, 5% molybdenum and traces of other substances used in dentures, certain surgical appliances, prostheses, implants and instruments. Synonyms: Haynes Stellite; Stellite; Zimaloy. OLsearch CHROMIUM ALLOYS 1966-74 HN(75)63-64; was see under CHROMIUM-COBALT ALLOYS 1965-81 MHÑVitallium AND25-26 qualif RN12629-02-6 MND1.552.33.182.735; D1.552.165.299.900; D25.58.224.735; D25.339.208.224.959 DMÑChromium Alloys LH LM  OLuse VITAMIN A to search RETINOL back thru 1969 HNRETINOL was see under VITAMIN A 1971-76, was see VITAMIN A 1969-70 MHÑVitamin A AN/defic = VITAMIN A DEFICIENCY; /ther use: coord disease with /drug ther, not /diet ther; /pois = HYPERVITAMINOSIS A RN11103-57-4 MND2.455.849.291.700.818; D11.557.261.700.860; D11.786.652 XSRetinol LH LS  MHÑVitamin A Deficiency MNC18.654.223.133.628 FXÑNyctalopia; ÑXEROPHTHALMIA LH LX;  MHÑVitamin B Complex AN/defic = VITAMIN B DEFICIENCY or PELLAGRA; /ther use: coord disease with /drug ther, not /diet ther RN12001-76-2 MND11.786.708 XUÑPangamic Acid LH LU  MHÑVitamin B Deficiency ANconsider also PELLAGRA MNC18.654.223.133.699 LH  MHÑVitamin B 12 ANnote space after B; /defic = VITAMIN B 12 DEFICIENCY; /ther use: coord disease with /drug ther, not /diet ther RN68-19-9 MND11.786.708.950; D19.461.543.901 XSCYANOCOBALAMIN; Cobalamin LH LS;  MHÑVitamin B 12 Deficiency MNC18.654.223.133.699.923 LH  MHÑVitamin D AN/defic = VITAMIN D DEFICIENCY or RICKETS; /ther use: coord disease with /drug ther, not /diet ther RN1406-16-2 MND11.786.763 LH  MHÑVitamin D Deficiency ANconsider also RICKETS MNC18.654.223.133.770 LH  MSAn alpha globulin found in plasma of man and other vertebrates. It is apparently synthesized in the liver and carries vitamin D and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component (Gc). Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine. PM85 HN85 MHÑVitamin D-Binding Protein AN/biosyn /physiol permitted PIAlpha Globulins (66-84); Carrier Proteins (71-84); Proteins (66-71); Vitamin D (66-84) MND12.776.157.920 XSGc Protein; Group Specific Component; Vitamin D Binding Globulin LH LS; ;  MHÑVitamin E AN/defic = VITAMIN E DEFICIENCY; /ther use: coord disease with /drug ther, not /diet ther RN1406-18-4 MND11.786.819 XSTocopherol LH LS  MHÑVitamin E Deficiency MNC18.654.223.133.841 LH  MHÑVitamin K AN/defic = VITAMIN K DEFICIENCY; menadione defic = VITAMIN K DEFICIENCY; /ther use: coord disease with /drug ther, not /diet ther RN12001-79-5 MND11.786.875; D19.461.270.546.861 XSMenadione; Menaquinone LH LS;  MHÑVitamin K Deficiency MNC15.378.463.841; C18.654.223.133.912 LH  MSL-(3-Amino-3-carboxypropyl)dimethylsulfonium chloride. A vitamin found in green vegetables. Used in treatment of peptic ulcers, colitis and gastritis. Has effect on secretory, acid-forming and enzymatic function of intestinal tract. HN(77) MHÑVitamin U ANfound in green vegetables; /analogs NIM only; /ther use: coord disease with /drug ther, not /diet ther RN1115-84-0 PIMethionine (73-76); Vitamins (73-76) MND11.786.950; D12.125.166.676.950; D19.316.203.957 XSMethionine Methylsulfonium Chloride; Methylmethioninesulfonium Chloride DMÑVitamins LH LS; LM  MHÑVitamins ANGEN: prefer specifics; /hist permitted; /defic = AVITAMINOSIS but avitaminosis A (etc.) = VITAMIN A DEFICIENCY (etc.); /ther use: coordinate disease term with /drug ther, not /diet ther MND11.786 XUÑVitamin U LH LU  MSThe narrow tube connecting the yolk sac with the midgut of the embryo; persistence of all or part of it in post-fetal life produces abnormalities, of which the commonest is MECKEL'S DIVERTICULUM. OLuse VITELLINE DUCT to search VITELLINE DUCTS back thru 1966 PM79; was VITELLINE DUCTS 1963-78 HN79; was VITELLINE DUCTS 1963-78 MHÑVitelline Duct ANdo not use /abnorm /embryol /growth /inj MNA16.254.891 XSOmphalomesenteric Duct LH LS  MSThe plasma membrane of the egg. PM73 HN73(63) MHÑVitelline Membrane ANdo not use /abnorm /embryol /growth /inj MNA16.631.886 LH  MSThe production and storage of yolk in the oocyte which is usually initiated after the first meiotic division. PM84 HN84 MHÑVitellogenesis ANonly /drug eff /rad eff MNG8.520.310.500.880 LH  MSA serum and yolk protein which has been characterized as a calcium-binding glycolipophosphoprotein. It is induced by estrogen or juvenile hormone and is essential for yolk formation in various insect species. PM86; was see under LIPOPROTEINS 1975-85 HN86(75); was see under LIPOPROTEINS 1975-85 MHÑVitellogenin AN/biosyn /physiol permitted PIEgg Proteins (73-74); Lipoproteins (72-74); Phosphoproteins (73-74) MND10.516.532.900; D12.776.256.317.925; D12.776.521.925; D12.776.744.925 LH  MHÑVitiligo MNC17.621.943 LH  MSRemoval of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma. PM84 HN84 MHÑVitrectomy ANdo not use /util except by MeSH definition PIVitreous Body/SU (66-83) MNE4.792.960 LH  MHÑVitreous Body ANsame as vitreous humor; /surg: consider also VITRECTOMY; opacities, muscae volitantes & other dis are indexed VITREOUS BODY (IM) + EYE DISEASES (NIM) MNA9.371.943 LH  PM87 HN87 MHÑVitreous Hemorrhage PIHemorrhage (66-86); Vitreous Body (66-86) MNC11.290.960; C23.542.290.960 LH  MHÑVivisection ANonly /hist /instrum /methods /psychol MNE5.969 FXÑAnimal Welfare LH LX  MHÑVocabulary ANa person's stock of words; do not use for nomenclature ( = NOMENCLATURE) or for thesauri ( = SUBJECT HEADINGS); no qualif MNL1.143.506.598.901 LH  MSParalysis of one or both of the vocal cords. MHÑVocal Cord Paralysis MNC9.400.931; C10.597.622.943; C10.772.204.924; C23.888.592.636.943 XSLARYNGEAL PARALYSIS LH LS  MSThe folds of mucous membrane along either wall of the larynx from the angle between the laminae of the thyroid cartilage to the vocal process of the arytenoid cartilage. MHÑVocal Cords ANinflammation = LARYNGITIS MNA4.329.364.737 XSVocal Fold LH LS  MSVocal sounds used in animal communication. PM68 HN68 MHÑVocalization, Animal ANonly /drug eff /physiol /rad eff PICommunication (66-67); Voice (66-67) MNF1.145.209.103.862 XSANIMAL VOCALIZATION LH LS  MSEducation for specific trades or occupations. MHÑVocational Education ANonly /econ /hist /man /methods /stand /trends MNI2.233.862 LH  MSSystematic efforts to assist individuals in selecting an occupation or suitable employment on the basis of aptitude, education, etc. MHÑVocational Guidance ANonly /econ /educ /hist /man /methods /stand /trends; consider also APTITUDE or APTITUDE TESTS MNF2.784.629.937; F2.784.692.887; I2.233.924 FXÑCounseling LH LX  MSThe sounds produced by humans by the passage of air through the larynx and over the vocal cords, and then modified by the resonance organs, the nasopharynx, and the mouth. MHÑVoice ANhuman only: for animal use VOCALIZATION, ANIMAL; only /drug eff /rad eff MNG9.772.862 FXÑCrying XUÑPhonation; ÑVoice Quality LH LX LU;  MSDisorders of voice pitch, loudness and quality. Diseases which present as voice disorders include laryngeal carcinoma, sarcoma and polyps; vocal cord nodules, contact ulcers, polyps and paralysis; and neuromuscular diseases. PM79 HN79 MHÑVoice Disorders ANavailable also is HOARSENESS PIVoice (66-78) MNC9.400.940; C10.597.257.960; C23.888.592.257.960; F3.126.219.960 XSDysphonia; Phonation Disorders LH LS;  MSVoice quality is that component of speech which gives the primary distinction to a given speaker's voice when pitch and loudness are excluded. It involves both phonatory and resonatory characteristics. Some of the descriptions of voice quality are harshness, breathiness and nasality. HN(79) MHÑVoice Quality ANonly /drug eff /rad eff; PHONATION & HOARSENESS are also available PIVoice (66-78) MNG9.772.862.960 DMÑVoice LH LM  MHÑVoice Training ANno qualif MNE2.831.727.862 FXÑSpeech Therapy LH LX  PM74 HN74(71) MHÑVolatilization ANNIM; no qualif PIChemistry, Physical (66-70); Gases (66-70); appropriate chemical heading MNH1.181.529.952 XSVaporization FXÑNebulizers and Vaporizers LH LS LX  MSVoluntary activity without external compulsion. MHÑVolition ANno qualif MNF2.463.902 XSWILL LH LS  MSNon-profit organizations concerned with various aspects of health, e.g., education, promotion, treatment, services, etc. PMTUBERCULOSIS SOCIETIES was heading 1963-66 MHÑVoluntary Health Agencies ANIM; coord with specific pertinent med specialty (IM); only /econ /hist /man /organ /stand; TN 174: definition & use CATALOG: /geog /form; /societies = SPEC /societies (as PSYCHIATRY /societies) MNN3.540.630.780 XUÑAmerican Cancer Society; ÑAmerican Heart Association; ÑMental Health Association; ÑTuberculosis Societies LH LU; ; ;  MSPersons who donate their services. PM68 HN68 MHÑVoluntary Workers ANdo not use /man /methods PIspecific service MNM1.955; N2.350.952 LH  MSThe forcible expulsion of the contents of the stomach through the mouth. MHÑVomiting AN/chem ind: consider also EMETICS; /drug ther: consider also ANTIEMETICS; Jamaican vomiting sickness: index PLANT POISONING + HYPOGLYCINS /pois MNC6.405.937; C23.888.821.937 LH  MSA high molecular weight plasma protein associated with the antihemophilic factor molecule (AHF or Factor VIII). It is a platelet-active factor needed for cellular clotting and hemostatic plug formation. The prolonged bleeding time in von Willebrand's disease is due to the deficiency of this factor. PM86; was see under BLOOD COAGULATION FACTORS 1976-85 HN86(76); was see under BLOOD COAGULATION FACTORS 1976-85 MHÑVon Willebrand Factor ANdo not use /blood; /defic = VON WILLEBRAND'S DISEASE PIBlood Coagulation Factors (66-74); Blood Platelets (66-74); Von Willebrand's Disease (66-75) MND12.776.124.125.920; D19.461.270.229.953 LH  PM68; was see under HEMORRHAGIC DIATHESIS 1967, was see under THROMBOCYTOPATHY 1963-66 HN68(64); was see under HEMORRHAGIC DIATHESIS 1967, was see under THROMBOCYTOPATHY 1963-66 MHÑVon Willebrand's Disease MNC15.378.463.913 XSAngiohemophilia LH LS  MSA paraphilia characterized by repetitive looking at unsuspecting people, usually strangers, who are either naked, in the act of disrobing, or engaging in sexual activity, as the method for achieving sexual excitement. OLsearch PARAPHILIAS 1968-74 HN(75); was see under SEX DEVIATION 1968-80 MHÑVoyeurism ANdo not use /drug eff /physiol /rad eff MNF3.709.597.608.700.800 DMÑParaphilias LH LM  MHÑVulva ANinflammation = VULVITIS MNA5.360.319.887 LH  MSDiseases of the vulva. PM76 HN76; was NON MESH before 1976 MHÑVulvar Diseases ANinflamm dis = VULVITIS PIVulva (66-75); specific vulvar disease MNC13.371.944 LH  MHÑVulvar Neoplasms AN/anal /blood supply /secret /ultrastruct permitted; coord IM with histol type of neopl (IM) MNC4.588.945.418.968; C13.371.944.819 LH  MHÑVulvitis MNC13.371.944.902 LH  MHÑVulvovaginitis MNC13.371.894.906.820; C13.371.944.902.737 LH  HN(64) MHÑWaardenburg's Syndrome ANcheck syndrome book for other Waardenburg skull deform syndromes; do not use /congen MNC16.131.77.938 DMÑAbnormalities, Multiple LH LM  MSProspective patient listings for appointments. OLsearch APPOINTMENTS AND SCHEDULES 1968-74 HN(75) MHÑWaiting Lists ANno qualif MNN4.452.95.738 DMÑAppointments and Schedules LH LM  MSA rhythmically occurring state in which the individual is fully aware of his environment. PM69 HN69(67) MHÑWakefulness ANonly /drug eff /physiol /rad eff PICerebral Cortex/PH (66); Consciousness (66) MNF2.830.104.821; G11.561.65.738 FXÑInsomnia LH LX  MHÑWales MNZ1.542.363.914 LH  MSWalking aids generally having two handgrips and four legs. HN(75) MHÑWalkers ANdo not use /instrum /methods /util (except by MeSH definition) MNE7.858.442.980 DMÑOrthopedic Equipment LH LM  MSSyndrome caused by occlusion of the posterior inferior cerebellar artery, marked by ipsilateral loss of facial pain and temperature sensations, ipsilateral limb ataxia, and contralateral loss of pain and temperature sensations in the trunk and extremities. HN(64) MHÑWallenberg's Syndrome MNC10.228.140.300.378.863; C14.907.253.378.821; C14.907.854.213.863 XSLateral Bulbar Syndrome; Posterior Inferior Cerebellar Artery Syndrome DMÑCerebral Embolism and Thrombosis LH LS; LM  OLsearch NERVE DEGENERATION 1967-74 HN(75) MHÑWallerian Degeneration ANonly /drug eff /rad eff MNG11.561.491.863 DMÑNerve Degeneration LH LM  OLsearch PINNIPEDIA 1968-74 HN(75) MHÑWalrus ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.754.821 DMÑPinnipedia LH LM  MSHostile conflict between organized groups of people. MHÑWar ANonly /hist; war wounds: index under WOUNDS AND INJURIES or specific inj (IM) + WAR (IM or NIM); COMBAT DISORDERS (F3) is also available MNI1.880.735.944 LH  MSCriminal acts committed during, or in connection with, war, e.g., maltreatment of prisoners, willful killing of civilians, etc. MHÑWar Crimes ANonly /hist /legis MNI1.198.240.903; I1.880.735.944.903 LH  MHÑWarfarin ANdo not use /biosyn /defic /physiol RN81-81-2 MND3.438.150.446.520.914; D5.723.853.738; D19.461.119.196.475.971 LH  MSBenign epidermal proliferations or tumors; some are viral in origin. MHÑWarts ANnon-neoplastic; coord IM with organ/dis heading (IM) MNC2.256.925; C2.928.914; C4.619.935.914; C17.838.930 XSVerruca FXÑPapilloma LH LS LX  MHÑWashington ANthe state; for Washington, D. C. use DISTRICT OF COLUMBIA MNZ1.107.567.875.930 LH  MSVenoms produced by the wasp (Vespid) family of stinging insects, including hornets; the venoms contain enzymes, biogenic amines, histamine releasing factors, kinins, toxic polypeptides, etc., and are similar to bee venoms. HN(78) MHÑWasp Venoms ANdo not use /analogs /defic /diag use /physiol; /antag permitted but consider also ANTIVENINS PIBees (66-74); Insect Bites and Stings (66-74); Insects (66-75); Venoms (66-77); Wasps (75-77) MND24.185.965.65.970 XSVespid Venoms DMÑBee Venoms LH LS LM  MSAny of numerous winged hymenopterous insects of social as well as solitary habits and having formidable stings. HN(75) MHÑWasps AN/microbiol /parasitol permitted; wasp stings: coord IM with INSECT BITES AND STINGS (IM) MNB1.131.617.479.900 XSHornets; Yellow Jackets DMÑHymenoptera LH LS; LM  MSA complement fixation test for syphilis. MHÑWassermann Reaction ANno qualif MNE1.223.495.826.208.738; E1.223.495.826.895.863 LH  OLsearch SEWAGE 1969-74 HN(75) MHÑWaste Disposal, Fluid ANno qualif MNG3.850.860.510.460.810; G3.850.860.510.600.780 DMÑSewage LH LM  MSUse for general articles concerning waste products or for which there is no specific heading. PM76 HN76; was NON MESH before 1976 MHÑWaste Products ANonly /adv eff /anal /class /econ; dental wastes such as amalgams, saliva, rinse water, etc. go here, not under MEDICAL WASTE MNG3.850.460.710 XUÑMedical Waste LH LU  MHÑWater ANnote categ: D1 as H2O, G3 as environmental; in body or tissue = BODY WATER; only /anal /diag use /metab /pharm /rad eff; /admin: try INFUSIONS, PARENTERAL; /adv eff: try WATER INTOXICATION; /stand: try WATER SUPPLY; /ther use: try HYDROTHERAPY & related terms; /pois & /tox = WATER INTOXICATION; /blood = BLOOD; /urine = URINE; /metab must refer to metab of exogenous water: for water content of organs & tissue use BODY WATER /metab or BODY WATER /anal; atmospheric water = HUMIDITY; heavy water = DEUTERIUM; water intake = DRINKING; hardness or softness of water: probably WATER /anal & not also HARDNESS but consider also WATER SOFTENING; water consumption = WATER or WATER SUPPLY if on a wide scale: on a personal level = DRINKING; consider also FRESH WATER, SEAWATER RN7732-18-5 MND1.435.863; D1.455.900; G3.230.700 FXÑBody Water; ÑMineral Waters XUÑFresh Water LH LX; LU  MSThe withholding of water in a structured experimental situation. PM69 HN69 MHÑWater Deprivation ANhuman & animal; consider also THIRST; /physiol permitted for physiol & metab eff PIMotivation (66-68); Thirst (66-68) MNF1.658.938 FXÑThirst LH LX  PM65 HN65 MHÑWater Intoxication MNC18.452.950.932 FXÑWATER-ELECTROLYTE BALANCE LH LX  PM74 HN74(72) MHÑWater Loss, Insensible ANonly /drug eff /rad eff PIRespiration (66-71); Sweating (66-71) MNG7.315.232.863; G10.795.869.821 LH  MHÑWater Microbiology ANIM; no qualif; coord with specific microbe (IM) MNG1.273.540.926; G3.850.425.450 LH  PM74 HN74(72) MHÑWater Movements ANno qualif; for waves, currents, tides; floods = NATURAL DISASTERS PIOceanography (66-71); Water (66-71) MNG3.230.700.485 LH  MSSubstances which pollute the water or bodies of water. Use for water pollutants in general or for which there is no specific heading. PM75 HN75 MHÑWater Pollutants ANonly /ad-poi-tox /anal /isol PIWater Pollution (66-74) MND5.284.903 XUÑWater Pollutants, Chemical; ÑWater Pollutants, Radioactive LH LU;  MSChemical compounds which pollute water or bodies of water. Use for chemical water pollutants in general or for which there is no specific heading. HN(75) MHÑWater Pollutants, Chemical ANonly /ad-poi-tox /anal /isol MND5.284.903.655 DMÑWater Pollutants LH LM  MSPollutants, present in water or bodies of water, which exhibit radioactivity. HN(75) MHÑWater Pollutants, Radioactive ANonly /ad-poi-tox /anal /isol MND5.284.638.903; D5.284.903.821 DMÑWater Pollutants LH LM  MHÑWater Pollution ANonly /adv eff /anal /econ /prev CATALOG: /geog /form MNG3.850.460.790 LH  PM73 HN73(71) MHÑWater Pollution, Chemical ANonly /adv eff /anal /econ /prev CATALOG: /geog /form PIspecific chemical; Water Pollution (66-70) MNG3.850.460.790.410 XSChemical Water Pollution FXÑEutrophication LH LS LX  PM66 HN66 MHÑWater Pollution, Radioactive ANonly /adv eff /anal /econ /prev CATALOG: /geog /form MNG3.850.810.530; G3.850.460.790.460 LH  PM73 HN73(71) MHÑWater Pollution, Thermal ANonly /adv eff /anal /econ /prev CATALOG: /geog /form PIHeat (66-70); Water Pollution (66-70) MNG3.850.460.790.510 XSTHERMAL WATER POLLUTION FXÑHeat LH LS LX  MHÑWater Softening ANonly /instrum /methods /stand MNG3.850.860.510.540 LH  MHÑWater Supply ANonly /anal /stand; do not use WATER SUPPLY with regard to FLUORIDATION CATALOG: /geog /form MNG3.850.860.510.565 LH  MHÑWater-Electrolyte Balance ANonly /drug eff /rad eff; consider also WATER-ELECTROLYTE IMBALANCE MNG6.184.963; G7.621.888 XSFluid Balance; OSMOREGULATION FXÑElectrolytes; ÑFluid Therapy; ÑOsmolar Concentration; ÑWATER INTOXICATION LH LS; LX; ; ;  MSDisturbances in the body's water-electrolyte metabolism. PM76 HN76; was NON MESH before 1976 MHÑWater-Electrolyte Imbalance PIWater-Electrolyte Balance (66-75); specific water-electrolyte imbalance MNC18.452.950 LH  MSRapidly fulminating cerebrospinal meningitis, characterized by sudden onset, fever, purpura, adrenal hemorrhage, shock and death. HN(84)63 MHÑWaterhouse-Friderichsen Syndrome MNC1.252.549.822; C19.53.904 DMÑMeningococcal Infections LH LM  MHÑWaxes AND25-26 qualif MND10.516.945 FXÑCerumen; ÑInlay Casting Wax LH LX;  PM66 HN66(63) MHÑWeaning ANhuman & animal; no qualif; NIM when merely an aspect of growth (as ╥in newborn, suckling & weaned╙) MNG6.696.571.822 LH  MHÑWeather ANno qualif; fog & hail go here MNG3.230.300.100.725 XUÑRain; ÑSnow LH LU;  MSTests designed to measure intellectual functioning in children and adults. OLsearch INTELLIGENCE TESTS 1966-74 PM79; was see under INTELLIGENCE TESTS 1963-78 HN79(75); was see under INTELLIGENCE TESTS 1963-78 MHÑWechsler Scales ANno qualif PIIntelligence Tests ( 66-74) MNF4.711.141.493.822 LH  OLuse WEDENSKY INHIBITION to search VVEDENSKII'S INHIBITION back thru 1966 (as Prov 66-74) HN(77); was VVEDENSKII'S INHIBITION see under NEURAL CONDUCTION 1975-76, was VVEDENSKII'S INHIBITION 1965-74 (Prov) MHÑWedensky Inhibition ANonly /drug eff /rad eff MNG11.561.537.910 DMÑNeural Conduction LH LM  MSA syndrome characterized by acute necrotizing giant cell granuloma of the upper respiratory tract. MHÑWegener's Granulomatosis MNC8.381.961; C12.777.419.969; C14.907.184.595.739; C14.907.940.90.720.972; C23.205.720.910; C23.484.904 LH  MSA sport in which barbells are lifted competitively or as an exercise. HN(76) MHÑWeight Lifting ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM); Manual 30.31+ PISports (66-75) MNI3.450.642.845.950 DMÑSports LH LM  MSRecognition and discrimination of the heaviness of a lifted object. PM70 HN70(64) MHÑWeight Perception ANonly /drug eff /physiol /rad eff MNF2.463.593.959 LH  MHÑWeightlessness ANonly /adv eff MNH1.671.323.739 FXÑSpace Flight LH LX  MHÑWeights and Measures ANonly /hist /stand; METRIC SYSTEM is available; TN 192: not for ╥weight╙ of anything; DF: WEIGHTS MNH1.939 XUÑCalibration; ÑInternational System of Units LH LU;  MSA severe form of leptospirosis caused by Leptospira icterohaemorrhagica and transmitted to man by the rat. MHÑWeil's Disease MNC1.252.847.511.739 XSJaundice, Spirochetal; Leptospirosis, Icterohemorrhagic LH LS;  MHÑWelding ANonly /econ /hist /instrum /methods /stand /util (if by MeSH definition) MNJ1.576.953 LH  PM67 HN67(64) MHÑWerner's Syndrome MNC19.753.739 XSProgeria, Adult LH LS  PM70; was see under VITAMIN B DEFICIENCY 1963-69 HN70(64); was see under VITAMIN B DEFICIENCY 1963-69 MHÑWernicke's Encephalopathy MNC10.228.140.163.946; C18.654.223.133.699.827.822 LH  MHÑWest Indies MNZ1.107.904 XSVirgin Islands, British LH LS  MSA mild, febrile, sporadic disease produced by infection with West Nile Virus. It is characterized by drowsiness, headache, rash, abdominal pain, nausea and lymphadenopathy, and sometimes leads to encephalitis. HN(66); was see under ARBOVIRUS INFECTIONS 1966-80 MHÑWest Nile Fever MNC2.782.930.960; C2.81.960 DMÑTogavirus Infections LH LM  MSA Flavivirus (group B arbovirus) which produces encephalitis experimentally when inoculated into some rodents, chicks or monkeys; in man, infection is usually silent, but may produce symptoms. PM73 HN73(65) MHÑWest Nile Virus ANdo not use /blood-csf-urine /cytol; infection = WEST NILE FEVER MNB4.909.637.889; B4.909.777.270.915; B4.909.777.923.377.950 XSEgypt 101 Virus LH LS  MHÑWest Virginia MNZ1.107.567.875.940 LH  HN75 MHÑWestern Samoa MNZ1.782.815.921 XSAmerican Samoa LH LS  MSA surfactant that renders a surface wettable by water or enhances the spreading of water over the surface; used in foods and cosmetics; important in contrast media; also with contact lenses, dentures, and some prostheses. Synonyms: humectants; hydrating agents. OLsearch SURFACE-ACTIVE AGENTS 1966-74 HN(75) MHÑWetting Agents AND25-26 qualif; also called ╥hydrating agents╙ but do not confuse these with intravenous solutions for rehydrating dehydrated subjects MND26.866.974 DMÑSurface-Active Agents LH LM  OLsearch CETACEA 1966-74 HN(75) MHÑWhales ANIM; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol /surg MNB2.649.189.865 DMÑCetacea LH LM  MSThe most nutritious of the cereal grasses, Triticum vulgare, grown mostly in the temperate climates; also includes other triticum species; several lectins, starch, and medium quality proteins are obtained from the seeds; 'triticale' is a hybird between wheat and rye. MHÑWheat ANas plant & as food; from Cat B do not use /isol /pathogen; from Cat J, only /ad-poi-tox /anal /class /econ /hist /rad eff /stand /supply; wheat germ: index under WHEAT, not WHEAT /embryol; do not confuse WHEAT with buckwheat (Phagopyrum, index under CEREALS) nor X ref TRITICUM with Triticale (a wheat-rye hybrid, index under CEREALS) MNB6.510.253.927; J1.341.182.927 XSTriticum LH LS  MSLectins purified from the germinating seeds of common wheat (Triticum vulgare); these bind to certain carbohydrate moieties on cell surface glycoproteins and are used to identify certain cell populations and inhibit or promote some immunological or physiological activities. There are at least two isoforms of this lectin. PM87 HN87 MHÑWheat Germ Agglutinins ANdo not use /analogs /defic /physiol PILectins (66-86) MND12.776.765.850; D24.185.526.545.973; D24.310.545.973; D24.611.125.44.545.973 XSAgglutinins, Wheat Germ; Lectins, Triticum Vulgare; Lectins, Wheat Germ; Triticum Vulgare Lectins; Wheat Germ Lectins LH LS; ; ; ;  MSChairs mounted on wheels and designed to be propelled by the occupant. OLuse WHEELCHAIRS to search WHEEL CHAIRS back thru 1966 PM76; was WHEEL CHAIRS 1963-75 HN76; was WHEEL CHAIRS 1963-75 MHÑWheelchairs ANonly /stand /supply MNE7.796.980 LH  MSInjuries to the spine and spinal cord at the junction of the fourth and fifth cervical vertebrae, occurring as the result of rapid acceleration or deceleration of the body. OLuse WHIPLASH INJURIES to search WHIPLASH INJURY back thru 1966 PM73; was WHIPLASH INJURY 1963-72 HN73; was WHIPLASH INJURY 1963-72 MHÑWhiplash Injuries MNC21.866.831.740 LH  OLsearch MUSCULAR DYSTROPHY, ANIMAL 1970-74 HN(75) MHÑWhite Muscle Disease ANanimal only: do not use /vet but check tag ANIMAL; coord IM with precoord animal/dis term (IM) + animal (NIM) or with animal (IM) in absence of precoord MNC22.595.740 DMÑMuscular Dystrophy, Animal LH LM  MSAn ethnic group of the Caucasoid Race. PM78 HN78 MHÑWhites ANsee note under CAUCASOID RACE; do not index WHITES routinely: only when pertinent as cultural, social, sociol, polit, psychol entity; Manual 30.8-30.10: policy on ethnic groups; differentiate from CAUCASOID RACE, genetic & physiol entity; specify geog; only /class /hist /psychol PICaucasoid Race (66-77); Ethnic Groups (68-77) MNI1.76.201.450.416.650; I1.880.143.522.700; M1.194.980 FXÑCaucasoid Race LH LX  MSMeasurement of the time required by whole blood to produce a visible clot. Factors that could influence the test are all but III, VII, and XIII. Activation may be by contact with the glass tube or exposure to diatomaceous earth. Delay of onset of coagulation may be achieved by use of nonwettable plastic or silicone-coated glass tubes. Used to monitor heparin therapy and as a bedside screening test for deficiencies in the intrinsic coagulation pathway. Synonym: ACT. HN(80) MHÑWhole Blood Coagulation Time ANNIM; only /vet PIBlood Coagulation (66-79); Blood Coagulation Tests (66-79) MNE1.223.459.153.950 XSActivated Coagulation Time, Whole Blood; Blood Coagulation Time, Whole; Coagulation Time, Whole Blood DMÑBlood Coagulation Tests LH LS; ; LM  MSMeasurement of radioactivity in the entire human body. OLuse WHOLE BODY COUNTING to search WHOLE BODY COUNTERS & WHOLE BODY COUNTER back thru 1971 (as Prov 1971-72) PM79; was WHOLE BODY COUNTERS 1973-78 HN79; was WHOLE BODY COUNTERS 1973-78, was WHOLE BODY COUNTER 1971-72 (Prov) MHÑWhole Body Counting ANonly /econ /hist /instrum /methods /stand /util (if by MeSH definition) PIRadiometry (66-70) MNE5.799.950; H1.671.768.765.710.740 LH  MSIrradiation of the whole body with ionizing or non-ionizing radiation. Do not use for microorganisms. PM82 HN82 MHÑWhole Body Irradiation ANonly /adv eff /instrum /methods /mortal /vet; in rad experiments IM when point of article is irrad of entire animal & coord with organ or process /rad eff (IM or NIM); no qualif when NIM; in radiother coord IM with disease /radiother (IM); TN 198: when not to use MNE5.980 XSRadiation, Whole Body; Total Body Irradiation LH LS;  MSA respiratory infection caused by Bordetella pertussis and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath. MHÑWhooping Cough ANcaused by BORDETELLA PERTUSSIS MNC1.252.143.740 XSPERTUSSIS FXÑPertussis Vaccine LH LS LX  MHÑWills ANno qualif MNI1.880.604.583.927 LH  OLsearch AIR MOVEMENTS 1974 & WEATHER 1969-73 HN(75); was see under WEATHER 1969-73 MHÑWind ANno qualif MNG3.230.300.100.150.185.200; G3.230.300.100.725.780 DMÑAir Movements LH LM  MHÑWine ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply MNJ1.125.91.823 LH  PM68 HN68 MHÑWing ANfor bird, insect or bat PIBirds (66-67) MNA13.395.823 LH  MHÑWisconsin MNZ1.107.567.875.949 LH  MSCondition characterized by chronic eczema, chronic suppurative otitis media, anemia, thrombocytopenic purpura, and immune deficiencies. OLuse WISKOTT-ALDRICH SYNDROME to search ALDRICH SYNDROME back thru 1966 PM85; was ALDRICH SYNDROME 1963-84 HN85; was ALDRICH SYNDROME 1963-84 MHÑWiskott-Aldrich Syndrome MNC15.378.463.205.855.972; C15.378.463.597.972; C17.827.926; C20.673.972 XSAldrich Syndrome LH LS  MSA rheumatic syndrome of possibly allergic origin, usually affecting children and adolescents, and characterized by high fever, exanthema, arthralgia, leukocytosis, and increased sedimentation rate. PM65 HN65(64) MHÑWissler's Syndrome MNC5.550.114.843.823; C5.799.825.823; C17.257.823; C20.543.928 XSSubsepsis Allergica; Subsepsis Hyperergica; Wissler-Fanconi Syndrome LH LS; ;  MHÑWit and Humor ANno qualif; DF: WIT MNK1.517.946 XSHUMOR LH LS  MSThe rating of a patient's currently discernible behavior by health personnel in order to ascertain the patient's condition for the planning and evaluation of therapy. There are 52 rating scales and each scale measures one type of pathological manifestation. OLto search WITTENBORN SCALE use WITTENBORN SCALES back thru 1975 & PSYCHIATRIC STATUS RATING SCALES 1969-74 HN(79); was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78 MHÑWittenborn Scales ANno qualif MNF4.586.947 DMÑPsychiatric Status Rating Scales LH LM  MSA form of pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. MHÑWolff-Parkinson-White Syndrome ANshort PR interval & long QRS interval with delta wave; see PRE-EXCITATION SYNDROMES for other ECG notes MNC14.280.67.780.977 LH  MSAn excretory duct of the embryonic kidney. MHÑWolffian Duct ANdo not use /abnorm /embryol /growth /inj MNA16.254.940 XSGartner's Ducts LH LS  MSHereditary association of diabetes mellitus, diabetes insipidus, optic atrophy, and neural deafness. PM86 HN86 MHÑWolfram Syndrome ANX ref = Diabetes Insipidus-Diabetes Mellitus-Optic Atrophy-Deafness PIDeafness (66-85); Diabetes Insipidus (66-85); Diabetes Mellitus, Insulin-Dependent (84-85); Optic Atrophy (66-85) MNC16.131.77.951; C18.452.264.500; C18.452.297.267.500; C19.246.267.500; C19.700.482.215.500 XSDIDMOAD LH LS  MSHuman adult females. As cultural, psychological, sociological, political, and economic entity. MHÑWomen ANfor women only as a cultural, social, sociol, polit, economic force; do not confuse with FEMALE for disease, organs, physiol, genetics, etc.; only /educ /psychol; check tags HUMAN & FEMALE; Manual 18.9.6, 34.18 MNM1.975 XUÑWomen, Working LH LU  MSWomen who are engaged in gainful activities usually outside the home. HN(84) MHÑWomen, Working ANonly /educ /psychol PIWomen (66-83) MNM1.975.825 XSWorking Women DMÑWomen LH LS LM  MSThe rights of women to equal status pertaining to social, economic, and educational opportunities afforded by society. PM77 HN77 MHÑWomen's Rights ANonly /hist /legis /trends PICivil Rights (68-76); Human Rights (73-76) MNI1.880.604.473.850; N3.706.437.850 XSWomen's Liberation LH LS  MHÑWood ANno qualif MNJ1.637.952 LH  MHÑWool ANas animal hair & as textile; use qualif cautiously MNA13.970; J1.637.879.865 LH  MSLists of words to which individuals are asked to respond ascertaining the conceptual meaning held by the individual. PM69 HN69 MHÑWord Association Tests ANno qualif PIAsociation (66-68) MNF4.711.647.905 FXÑAssociation LH LX  MSProductive or purposeful activities. PM66; was see under EXERTION 1963-65 HN66; was see under EXERTION 1963-65 MHÑWork ANpurposeful activity: differentiate from EXERTION (physiol effort), EMPLOYMENT (for pay), ENERGY EXPENDITURE (metab); BURNOUT, PROFESSIONAL is available; no qualif MNI3.946 FXÑEfficiency; ÑExertion XUÑWork Schedule Tolerance LH LX; LU  MSAssessment of physiological capacities in relation to job requirements. Usually done by measuring certain physiological (e.g., circulatory and respiratory) variables during a gradually increasing workload until specific limitations occur with respect to those variables. OLsearch DISABILITY EVALUATION 1966-74 PM86; was see under DISABILITY EVALUATION 1966-85 HN86(75); was see under DISABILITY EVALUATION 1966-85 MHÑWork Capacity Evaluation ANno qualif PIDisability Evaluation (66-74) MNE1.373.741 LH  PM72 HN72(71) MHÑWork of Breathing ANonly /drug eff /rad eff PIRespiration (66-70) MNE1.302.796.947; G9.772.521.941 LH  MSPhysiological or psychological effects of periods of work which may be fixed or flexible such as flexitime, work shifts, and rotating shifts. HN(83) MHÑWork Schedule Tolerance ANno qualif PICircadian Rhythm (66-82); Occupational Medicine (66-82); Work (66-82) MNI3.946.900 DMÑWork LH LM  MSThe construction or arrangement of a task so that it may be done with the greatest possible efficiency. OLsearch EFFICIENCY & TASK PERFORMANCE AND ANALYSIS 1974 & EFFICIENCY 1970-73 PM75; was see under EFFICIENCY 1970-73, was see under EFFICIENCY & TASK PERFORMANCE AND ANALYSIS 1974 HN75; was see under EFFICIENCY 1970-73, was see under EFFICIENCY & TASK PERFORMANCE AND ANALYSIS 1974 MHÑWork Simplification ANno qualif PIEfficiency (66-74); Task Performance and Analysis (72-74) MNJ1.293.556.779.824 LH  MSInsurance coverage providing compensation and medical benefits to individuals because of work-connected injuries or disease. MHÑWorkmen's Compensation ANonly /hist /legis /trends; specify country or state CATALOG: /geog /form MNN3.219.521.346.866 FXÑDisability Evaluation LH LX  MSFor articles pertaining to the health status of inhabitants of the world. PM78 HN78 MHÑWorld Health ANno qualif MNN1.407.540.800 XSInternational Health Problems LH LS  MSA specialized agency of the United Nations designed as a coordinating authority on international health work; its aim is to promote the attainment of the highest possible level of health by all peoples. PM66 HN66(65) MHÑWorld Health Organization ANonly /econ /hist /organ; DF: WHO CATALOG: use NAF entry MNN3.540.514.718.800 LH  MSRestoration of integrity to traumatized tissue. MHÑWound Healing ANonly /drug eff /rad eff; fracture healing goes here (NIM) + FRACTURES (IM) & do not use BONE REGENERATION MNG4.185.753.891 FXÑCicatrix; ÑGranulation Tissue LH LX;  MSInvasion of the site of trauma by pathogenic microorganisms. MHÑWound Infection MNC1.539.947; C21.866.951 LH  MSDamage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity. OLpre-explosion = WOUNDS AD INJURIES (PX) MHÑWounds and Injuries ANGEN only: prefer /inj with organs (Manual 19.5+) or specific organ /inj precoords; note types of wound below; wound suction: coord wd & inj concept with DRAINAGE; DF: WOUNDS CATALOG: form qualif = TRAUMATOLOGY /form MNC21.866 XSINJURIES; TRAUMA FXÑDebridement; ÑFirst Aid; ÑMilitary Medicine; ÑTransportation of Patients; ÑTraumatology LH LS; LX; ; ; ;  MSDisruption of structural continuity of the body as a result of the discharge of firearms. MHÑWounds, Gunshot ANIM; coord with organ /inj or precoord inj term (IM); ballistics in gunshot wds goes here & under FORENSIC MEDICINE if pertinent MNC21.866.986.900 XSBallistics, Wound FXÑFirearms LH LS LX  MSInjuries caused by impact with a blunt object where there is no penetration of the skin. PM76 HN76 MHÑWounds, Nonpenetrating ANIM; coord with organ /inj or precoord inj term (IM) PIAbdominal Injuries (66-75); Head Injuries (66-75); Heart Injuries (66-75); Thoracic Injuries (66-75) MNC21.866.974 XSBlunt Injuries; Injuries, Nonpenetrating LH LS;  MSWounds caused by objects penetrating the skin. PM76 HN76 MHÑWounds, Penetrating ANnote WOUNDS, GUNSHOT & WOUNDS, STAB; IM; coord with organ /inj or precoord inj term (IM) PIspecific heading/IN (66-75) MNC21.866.986 LH  MSPenetrating wounds caused by a pointed object. PM76 HN76 MHÑWounds, Stab ANIM; coord with organ /inj or precoord inj term (IM) PIspecific heading/IN (66-75) MNC21.866.986.950 LH  MSA sport consisting of hand-to-hand combat between 2 unarmed contestants seeking to throw each other. HN(76) MHÑWrestling ANno qualif; for inj, coord IM with ATHLETIC INJURIES (IM) + specific inj (IM): Manual 30.31+; does not include judo or karate (index SPORTS) PISports (66-75) MNI3.450.642.845.975 DMÑSports LH LM  MHÑWrist ANprimates only; any Cat A qualif; /inj = WRIST INJURIES; wrist ganglion is indexed under WRIST (IM) + SYNOVIAL CYST (IM); TN 238: differentiation from WRIST JOINT & indexing instructions; use CARPUS, ANIMAL for non-primate vertebrates: TN 117: other animal joints; wrist bone = CARPAL BONES MNA1.378.209.906 LH  MSInjuries to the wrist or the wrist joint. MHÑWrist Injuries ANconsider also CARPAL BONES /inj MNC21.866.88.906 LH  PM65 HN65 MHÑWrist Joint ANprimates only; any Cat A qualif; /inj = WRIST INJURIES; wrist ganglion is indexed under WRIST (IM) + SYNOVIAL CYST (IM); TN 238: differentiation from WRIST & indexing instructions; use CARPUS, ANIMAL for non-primate vertebrates; TN 117: other animal joints MNA2.835.583.959 LH  MHÑWriting ANno qualif; the act or profession of writing or its product: do not confuse with PUBLISHING (the industry & dissemination of knowledge & research) or LITERATURE (literary production) or AUTHORSHIP (identity as author); no qualif; HANDWRITING also available; includes typewriting; letters & correspondence of biographees & famous persons are indexed as CORRESPONDENCE (NIM only) + required biog terms MNL1.143.506.423.906 XSCorrespondence LH LS  MSA genus of filarial nematodes. MHÑWuchereria ANdo not use /blood-csf-urine; infection: coord NIM with FILARIASIS (IM) MNB1.500.294.530.708 XUÑWuchereria Bancrofti LH LU  MSA white threadlike worm which causes elephantiasis, lymphangitis, and chyluria by interfering with the lymphatic circulation. The microfilaria are found in the circulating blood and are carried by mosquitoes. OLto search FILARIA BANCROFTI & FILARIA SANGUINIS HOMINIS use WUCHERERIA BANCROFTI back thru 1975 & WUCHERERIA 1966-74 HN(79); was FILARIA BANCROFTI see under WUCHERERIA 1963-78; FILARIA SANGUINIS HOMINIS was see under WUCHERERIA 1963-78 MHÑWuchereria Bancrofti ANdo not use /blood-csf-urine; infection: coord NIM with ELEPHANTIASIS, FILARIAL (IM) MNB1.500.294.530.708.700 XSFilaria Bancrofti; Filaria Sanguinis Hominis DMÑWuchereria LH LS; LM  MHÑWyoming MNZ1.107.567.875.959 LH  MSThe female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in man and other male-heterogametic species. OLsearch SEX CHROMOSOMES 1968-77 PM84; was see under SEX CHROMOSOMES 1968-83 HN84(78); was see under SEX CHROMOSOMES 1968-83 MHÑX Chromosome ANA 11 qualif except /cytol; abnorm: coord IM with SEX CHROMOSOME ABNORMALITIES (IM) or specific dis (IM) + SEX CHROMOSOME ABNORMALITIES (NIM); X-linked dis: coord IM or NIM with dis /familial (IM) + LINKAGE (GENETICS) (IM or NIM) PIChromosomes (66-67); Karyotyping (67); Sex Chromosomes (68-77) MNA11.223.475.865.982 LH  PM65 HN65(63) MHÑX-Ray Diffraction ANNIM; only /instrum /methods MNE5.196.309.742; H1.181.278.319.742; H1.181.529.240.742; H1.181.529.972 LH  MSA film base coated with an emulsion designed for use with x-rays. PM82 HN82 MHÑX-Ray Film ANthe film itself: do not confuse with x-ray technic ( = /radiogr or RADIOGRAPHY); only /class /econ /stand /supply /vet; /hist: index under RADIOGRAPHY /hist or TECHNOLOGY, RADIOLOGIC /hist PIRadiography (66-81); specific radiography heading; Technology, Radiologic (66-81) MNE7.960 XSFilm, X-Ray; Radiographic Film LH LS;  MSScreens which absorb the energy in the x-ray beam that has penetrated the patient and convert this energy into a light pattern which has as nearly as possible the same information as the original x-ray beam. The more light a screen produces for a given input of x-radiation, the less x-ray exposure and thus shorter exposure time are needed to expose the film. In most film-screen systems, the film is sandwiched between two screens in a cassette so that the emulsion on each side is exposed to the light from its contiguous screen. HN(82) MHÑX-Ray Intensifying Screens ANonly /class /econ /stand /supply /util (if by MeSH definition) /vet PIAngiography (77-81); Mammography (77-81); Radiographic Image Enhancement (77-81); Radiography (77-81); Technology, Radiologic (77-81) MNE7.970 XSFilm-Screen Systems, X-Ray; Radiographic Intensifying Screens; Screen-Film Systems, X-Ray; X-Ray Film-Screen Systems DMÑRadiographic Image Enhancement LH LS; ; ; LM  OLsearch RADIOTHERAPY 1966-74 HN(75) MHÑX-Ray Therapy ANsee extensive note on RADIOTHERAPY when tempted to use for IM; do not index as IM or NIM coord when using /radiother: assume all /radiother is X-RAY THERAPY unless otherwise specified (as /radiother + RADIUM /ther use or /radiother + ULTRAVIOLET THERAPY, etc.): Manual 19.4.54 MNE2.810.907 XSRoentgenotherapy DMÑRadiotherapy LH LS LM  MSPenetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release energy - in the same energy range as gamma rays (0.010-10 Mev), but of non-nuclear origin, of shorter wavelength than ultraviolet; soft x-rays or Grenz rays are less penetrating and longer in wavelength than hard x-rays. OLsearch RADIATION 1966-74 HN(75); was see under RADIATION 1965-75 MHÑX-Rays ANalmost never IM; /diag use = RADIOGRAPHY (general) or /radiogr with diseases; /ther use = RADIOTHERAPY (general only) or /radiother with diseases (see note on X-RAY THERAPY above); do not index as IM or NIM coord when using /rad eff: assume all /rad eff is X-RAYS unless otherwise specified (as /rad eff + GAMMA RAYS); TN 158: how to index IM or NIM, also Manual 19.4.52, 21.17, 28.17; X-ray or x-ray in translations: follow text MNH1.671.768.513.918 XSGrenz Rays; Roentgen Rays DMÑRadiation, Ionizing LH LS; LM  MHÑXanthenes ANdo not confuse with XANTHINES; includes xanthones; do not use /analogs /biosyn /defic /physiol MND3.494.953 XUÑPyronine; ÑRhodamines; ÑSterigmatocystin LH LU; ;  MSAlkaloids, which contain xanthine as their nitrogenous base. PM75 HN75 MHÑXanthine Alkaloids ANdo not use /analogs /defic /physiol PIAlkaloids (66-74); Xanthines (66-74) MND3.132.956 LH  MSXanthine:NAD+ oxidoreductase. Catalyzes the oxidation of xanthine in the presence of NAD+ to form urate and NADH. Also acts on a variety of other purines and aldehydes. HN(75) MHÑXanthine Dehydrogenase ANdo not use /analogs RNEC 1.2.1.37 PIKetone Oxidoreductases (73-74); Xanthines (73-74) MND8.586.682.472.850 DMÑKetone Oxidoreductases LH LM  PM65 HN65 MHÑXanthine Oxidase ANdo not use /analogs; /defic: consider also XANTHINES /urine (IM) + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS (IM) RNEC 1.1.3.22 MND8.586.682.472.866 LH  MHÑXanthines ANdo not confuse with XANTHENES; do not use /analogs /biosyn /defic /physiol MND3.438.759.758.824 LH  MS7-(2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl)theophylline compounded with nicotinic acid (1:1). Vasodilator used in peripheral vascular disorders and insufficiency; may cause gastric discomfort and hypotension. Synonyms: Complamin; Sadamin; Xavin. HN(75) MHÑXanthinol Niacinate ANdo not use /biosyn /defic /physiol RN437-74-1 PIAmino Alcohols (74); Nicotinic Acid (69-74); Theophylline (69-74) MND3.66.515.950; D3.132.956.826.950; D3.383.725.547.950; D3.438.759.758.824.751.950; D18.918.982 XSMetoxiprofilinnicotinate; Xanthinol Nicotinate DMÑTheophylline LH LS; LM  PM67 HN67(63) MHÑXanthoma, Juvenile ANnon-neoplastic MNC17.849.866 XSNEVOXANTHOENDOTHELIOMA; Xanthogranuloma, Juvenile LH LS;  MHÑXanthomatosis ANnon-neoplastic; coord with organ/disease term (IM); xanthoma goes here but note XANTHOMA, JUVENILE above; xanthogranulomatous pyelonephritis = PYELONEPHRITIS, XANTHOGRANULOMATOUS; xanthogranuloma goes here (IM) + GRANULOMA (IM) but note XANTHOGRANULOMA, JUVENILE above MNC17.849.929 LH  MSA genus of Pseudomonadales whose cells produce a yellow pigment (Gr. Xanthos - yellow); pathogenic to plants. MHÑXanthomonas ANdo not use /blood-csf-urine MNB3.400.750.866 LH  MHÑXanthophyll ANdo not use /defic /physiol RN127-40-2 MND2.455.849.131.824; D11.557.261.206.741 LH  MHÑXanthopterin ANdo not use /defic /physiol RN119-44-8 MND3.438.733.631.825; D11.557.831.742 LH  MHÑXanthurenates ANdo not use /analogs /biosyn /defic /physiol MND3.66.942 LH  MHÑXenon ANXe-132; do not use /analogs /biosyn /defic /physiol; isotopes: see below RN7440-63-3 MND1.268.954; D1.362.641.918 LH  MSStable xenon atoms which have the same atomic number as the element xenon, but differ in atomic weight. Xenon (Xe) 124, 126, 128-131, 134 and 136 are stable xenon isotopes. PM75 HN75 MHÑXenon Isotopes ANXe-124,126,128-131,134,136; NIM, no qualif PIXenon (66-74); Isotopes (66-74) MND1.362.641.918.400; D1.496.920 LH  MSUnstable isotopes of xenon that decay or disintegrate spontaneously emitting radiation. Xenon (Xe) 121-123, 125, 127, 133, 135, 137-145 are radioactive isotopes of xenon. PM75 HN75 MHÑXenon Radioisotopes ANXe-118-123, 125, 127, 133, 135, 137-142; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIXenon (66-74); Radioisotopes (66-74) MND1.362.641.918.700; D1.496.749.945; D1.496.920.700 LH  MSAn aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes. PM72 HN72 MHÑXenopus ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIAnura (66-71) MNB2.90.180.610.500 LH  MSThe commonest and widest ranging species of the clawed ╥frog╙ (Xenopus) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals. PM81 HN81 MHÑXenopus laevis ANusually NIM: no qualif; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIXenopus (72-80) MNB2.90.180.610.500.562 XSPlatanna LH LS  MHÑXeroderma Pigmentosum AN/anal /blood supply /secret /ultrastruct permitted; if non-neopl, coord IM with precoord organ/dis term (IM); if neopl, coord IM with organ/neopl term (IM) MNC4.834.867; C16.131.831.936; C17.608.892; C17.827.936 XSKAPOSI'S DISEASE LH LS  MSXeroradiography of the breast. HN(77) MHÑXeromammography ANdo not use /util except by MeSH definition PIBreast Neoplasms/RA (66-76); Mammography (66-76); Xeroradiography (68-76) MNE1.818.483.990; E1.818.960.960 XSXeroradiography, Breast DMÑMammography LH LS LM  MHÑXerophthalmia ANdryness of the eyes; do not restrict to the xerosis of vit A defic: use for any cause MNC11.496.892 FXÑVitamin A Deficiency LH LX  PM73 HN73(67) MHÑXeroradiography ANonly /instrum /methods /vet PIRadiography (66); specific radiography heading (66); Technology, Radiologic (66); specific heading/RA (66) MNE1.818.960 LH  MSDecreased salivary flow. MHÑXerostomia MNC7.465.815.929 XSAsialia; Hyposalivation; Mouth Dryness FXÑSalivation LH LS; ; LX  MS4-Chloro-5-sulfamoyl-2',6'-salicyloxylidide. Sulfamoyl diuretic and saluretic with antihypertensive activity; it is bound to plasma proteins, thus has a delayed onset and prolonged action. Synonyms: Aquaphor; BE 1293; BEI 1293. HN(77) MHÑXipamide ANdo not use /biosyn /defic /physiol; /analogs NIM only RN14293-44-8 PIDiuretics, Sulfamyl (74-76); Salicylamides (73-76); Xylenes (74-75) MND2.65.884.975; D2.886.590.700.975; D19.770.224.516.982 DMÑDiuretics, Sulfamyl LH LM  OLsearch STERNUM 1966-74 HN(75) MHÑXiphoid Bone MNA2.835.232.904.766.825 DMÑSternum LH LM  MSPolysaccharides consisting of xylose units. OLto search XYLAN use XYLANS back thru 1975 & CELLULOSE 1966-74 HN(75); was XYLAN see under CELLULOSE 1963-74 MHÑXylans ANdo not use /analogs PICarbohydrates (66-74); Cellulose (66-74); Polysaccharides (66-74) MND9.203.698.925 DMÑPolysaccharides LH LM  MS5,6-Dihydro-2-(2,6-xylidino)-4H-1,3-thiazine hydrochloride. Proposed as sedative, analgesic and muscle relaxant in cattle. Synonyms: Rompun; Bay VA 1470. HN(75) MHÑXylazine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7361-61-7 PIAniline Compounds (71-74); Thiazines (69-74); Xylene (71-74) MND3.383.855.985; D14.166.60.985 DMÑThiazines LH LM  OLuse XYLENES to search XYLENE back thru 1966 PM75; was XYLENE 1963-74 HN75; was XYLENE 1963-74 MHÑXylenes ANdo not use /analogs /biosyn /defic /physiol MND2.455.426.559.389.948 LH  PM72 HN72(63) MHÑXylitol ANdo not use /biosyn /defic /physiol RN87-99-0 MND9.203.853.936; D2.33.800.936 LH  MHÑXylose MND9.203.546.627.867 LH  MS1,4- or 1,3-beta-D-Xylan xylohydrolase. Catalyzes the hydrolysis of 1,4- or 1,3-beta-D-xylans so as to remove successive D-xylose residues from the non-reducing termini. The 1,4-isomer is EC 3.2.1.37; the 1,3-isomer is EC 3.2.1.72. HN(78) MHÑXylosidases ANdo not use /analogs RNEC 3.2.1. PIGlycoside Hydrolases (66-77) MND8.586.277.450.950 XSXylobiases DMÑGlycoside Hydrolases LH LS LM  MSDL-threo-Pentulose. A 5-carbon keto sugar. HN(75) MHÑXylulose AN/analogs NIM only PIKetoses (74); Pentoses (72-74); Xylose (74) MND9.203.546.465.920; D9.203.546.627.885 XSLyxulose DMÑPentoses LH LS LM  MSAbnormal genetic constitution in males characterized by an extra Y chromosome. HN(78) MHÑXYY Karyotype ANdo not use /compl /congen /surg /ther; check the tags HUMAN & MALE PIChromosome Abnormalities (66-67); Sex Chromosome Abnormalities (68-77) MNC16.131.280.748.980 DMÑSex Chromosome Abnormalities LH LM  MSThe male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in man and in some other male-heterogametic species in which the homologue of the X chromosome has been retained. OLsearch SEX CHROMOSOMES 1968-77 PM84; was see under SEX CHROMOSOMES 1968-83 HN84(78); was see under SEX CHROMOSOMES 1968-83 MHÑY Chromosome ANA 11 qualif except /cytol; abnorm: coord IM with SEX CHROMOSOME ABNORMALITIES (IM) or specific dis (IM) + SEX CHROMOSOME ABNORMALITIES (NIM) PIChromosomes (66-67); Karyotyping (67); Sex Chromosomes (68-77) MNA11.223.475.865.983 LH  MSA tumor-producing DNA virus discovered in monkeys in Yaba, Nigeria; found to produce histiocytomas in monkeys and man. PM66 HN66(64) MHÑYaba Virus ANdo not use /blood-csf-urine /cytol; infection: coord NIM with TUMOR VIRUS INFECTIONS (IM) + POXVIRUS INFECTIONS (IM) MNB4.909.204.783.918; B4.909.574.204.930 LH  MSAn involuntary deep inspiration with the mouth open, often accompanied by the act of stretching. PM87 HN87 MHÑYawning ANonly /drug eff /rad eff MNG9.772.521.983 LH  MSA systemic non-venereal infection of the tropics caused by Treponema pertenue. MHÑYaws MNC1.252.847.840.892; C17.838.960 XSFRAMBESIA LH LS  MHÑYeast, Dried ANwhen brewer's or baker's yeast is given as therapy, index here; when the yeast is the source of matter in enzyme or other metab studies, index as SACCHAROMYCES CEREVISIAE; do not use /analogs /biosyn /defic /physiol MND11.892 FXÑSACCHAROMYCES CEREVISIAE LH LX  MSA general term for single-celled rounded fungi that reproduce by budding. Brewers' and bakers' yeasts are SACCHAROMYCES CEREVISIAE; therapeutic dried yeast is YEAST, DRIED. MHÑYeasts ANnot for ╥yeast╙ ( = YEAST, DRIED) & see note above; do not use /anat /embryol /microbiol /parasitol MNB5.354.930 LH  MSAn acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genus Aedes and Haemagogus. MHÑYellow Fever MNC2.782.930.980; C2.81.980 LH  MSThe type species of the Flavivirus genus (L. flavus - yellow), the group B arboviruses. MHÑYellow Fever Virus ANdo not use /blood-csf-urine /cytol; infection = YELLOW FEVER MNB4.909.777.923.377.990 LH  MHÑYemen MNZ1.252.245.93.960; Z1.630.100.980 XSAden; South Yemen LH LS;  MSA generic name sometimes currently applied to species of Pasteurella. OLsearch PASTEURELLA 1972-74 PM75; was see under PASTEURELLA 1972-74 HN75; was see under PASTEURELLA 1972-74 MHÑYersinia ANa generic name sometimes applied to species of PASTEURELLA; do not use /blood-csf-urine; infect = YERSINIA INFECTIONS but YERSINIA PESTIS infect = PLAGUE MNB3.475.300.900 LH  MSA species of the genus Yersinia, isolated from both man and animal. It is a frequent cause of bacterial gastroenteritis in children. PM83 HN83 MHÑYersinia enterocolitica ANdo not use /blood-csf-urine; infection: coord NIM with YERSINIA INFECTIONS (IM) PIPasteurella (72-74); Yersinia (75-82) MNB3.475.300.900.300 LH  MSInfections with bacteria of the genus Yersinia. PM77; PSEUDOTUBERCULOSIS, YERSINIA was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA INFECTIONS 1964-76, was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA 1963 HN77 MHÑYersinia Infections PIPasteurella Infections (66-76) MNC1.252.310.980 XUÑYersinia Pseudotuberculosis Infections LH LU  MSThe etiologic agent of plague in man, rats, ground squirrels, and other rodents. OLuse YERSINIA PESTIS to search PASTEURELLA PESTIS back thru 1966 PM76; was PASTEURELLA PESTIS 1963-75 HN76; was PASTEURELLA PESTIS 1963-75 MHÑYersinia pestis ANdo not use /blood-csf-urine; infection = PLAGUE MNB3.475.300.900.600 XSPasteurella pestis LH LS  MSA human and animal pathogen causing mesenteric lymphadenitis, diarrhea, and septicemia. PM87 HN87 MHÑYersinia pseudotuberculosis ANnote category; infect = YERSINIA PSEUDOTUBERCULOSIS INFECTIONS PIYersinia (75-86) MNB3.475.300.900.615 LH  MSInfections with Yersinia pseudotuberculosis. OLuse YERSINIA PSEUDOTUBERCULOSIS INFECTIONS to search PSEUDOTUBERCULOSIS, YERSINIA back thru 1977; to search PSEUDOTUBERCULOSIS, PASTEURELLA use YERSINIA PSEUDOTUBERCULOSIS INFECTIONS back thru 1975 & PASTEURELLA INFECTIONS 1966-74 HN(87); was PSEUDOTUBERCULOSIS, YERSINIA 1977-86, was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA INFECTIONS 1964-76, was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA 1963 MHÑYersinia Pseudotuberculosis Infections PIPasteurella Infections (66-74) MNC1.252.310.980.780 XSPseudotuberculosis Infections, Yersinia; Pseudotuberculosis, Pasteurella DMÑYERSINIA INFECTIONS LH LS; LM  MHÑYoga ANno qualif; transcendental meditation goes under RELAXATION TECHNICS CATALOG: do not use /pop wks MNK1.844.799.867 LH  MSA slightly acid milk food produced by fermentation due to the combined action of Lactobacillus acidophilus and Streptococcus thermophilus. HN(78) MHÑYogurt ANonly /ad-poi-tox /anal /class /hist /rad eff /stand /supply PIDairy Products (66-77) MNJ1.341.273.990 DMÑDairy Products LH LM  PM69 HN69 MHÑYohimbans ANdo not use /analogs /defic /physiol PIRauwolfia (66-68); Yohimbine (66-68) MND3.132.973; D3.549.937 LH  OLto search YOHIMBINE DERIVATIVES use YOHIMBINE /AA back thru 1975 & YOHIMBANS 1969-74 PMCORYNANTHIDINE, RAUWOLSCINE & YOHIMBINE DERIVATIVES were see under YOHIMBINE 1975-77, were see under YOHIMBANS 1969-74 HNYOHIMBINE DERIVATIVES was see under YOHIMBINE 1975-77, was see under YOHIMBANS 1969-74 MHÑYohimbine ANdo not use /defic /physiol RN146-48-5 MND3.132.973.641.893; D3.549.937.641.868; D16.848.115.930 XSRauwolscine LH LS  MSAn embryonic membrane formed from endoderm and mesoderm. In reptiles and birds it incorporates the yolk into the digestive tract for nourishing the embryo. In placental mammals its nutritional function is vestigial; however, it is the source of most of the intestinal mucosa and the site of formation of the germ cells. It is sometimes called the vitelline sac, which should not be confused with the vitelline membrane of the egg. OLsearch VITELLINE MEMBRANE 1973-77 PM78; was see VITELLINE MEMBRANE 1973-77 HN78; was see VITELLINE MEMBRANE 1973-77 MHÑYolk Sac AN╥sometimes called vitelline sac╙: do not confuse with VITELLINE MEMBRANE; mammal (including human) & non-mammal; do not use /abnorm /embryol /growth /inj; YOLK SAC TUMOR (see below): coord IM with OVARIAN NEOPLASMS (IM) PIChick Embryo (66-72); Fetal Membranes (66-72); Vitelline Membrane (66-74) MNA16.254.403.981 LH  MHÑYtterbium ANYb-174; do not use /analogs /biosyn /defic /physiol; Yb-168, 170-173, 176 = YTTERBIUM (IM) + ISOTOPES (NIM); Yb-164-167, 169, 175, 177 = YTTERBIUM (IM) + RADIOISOTOPES (IM) RN7440-64-4 MND1.268.961; D1.552.550.958 LH  MHÑYttrium ANY-89; do not use /analogs /biosyn /defic /physiol RN7440-65-5 MND1.268.965; D1.552.955 LH  MHÑYttrium Isotopes ANNIM; no qualif MND1.496.943; D1.552.955.743 LH  MSUnstable isotopes of yttrium that decay or disintegrate spontaneously emitting radiation. Yttrium (Y) 82-88 and 90-97 are radioactive isotopes of yttrium. OLsearch YTTRIUM ISOTOPES 1966-74 PM75 HN75 MHÑYttrium Radioisotopes ANY-82-88, 90-96; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIYttrium Isotopes (66-74); Radioisotopes (66-74) MND1.496.749.960; D1.496.943.800; D1.552.955.900 LH  MHÑYugoslavia MNZ1.542.248.980 LH  HN74 MHÑZaire ANformerly Republic of the Congo (capital at Leopoldville, now called Kinshasa); do not confuse with Republic of Congo (capital at Brazzaville) ( = CONGO) MNZ1.58.100.949 XSCongo (Kinshasa) LH LS  MHÑZambia MNZ1.58.349.930 LH  MS6-(10-Hydroxy-6-oxo-1-undecenyl)beta- resorcilic acid lactone. Cic, trans, dextro or levo forms of resorcilic acid lactones isolated from the fungus Giberella zeae (formerly Fusarium graminearum); they have estrogenic activity and cause toxicity in livestock, as feed contaminant; used as anabolic or estrogen substitute. Synonym: mycotoxin F2. HN(75) MHÑZearalenone ANdo not use /defic /physiol; /analogs NIM only; do not confuse with zearalanone (index under ZEARALENONE /analogs NIM only) PILactones (66-74); Resorcinols (66-74) MND2.540.950; D2.755.852.900; D6.472.265.950; D6.472.866.540.950; D6.597.350.900; D24.185.926.587.989 XSF-2 Toxin DMÑResorcinols LH LS LM  MS6-(4-Hydroxy-3-methylbut-2-enylamino)purine. Plant growth regulator. HN(75) MHÑZeatin ANdo not use /defic /physiol; /analogs NIM only RN1637-39-4 PIAmino Alcohols (73-74); Purines (73-74) MND3.438.759.950; D11.303.760.265.400.950 DMÑPurines LH LM  MSA genus of North American fishes of the family Cyprinidae. Used in embryological studies and to study effects of certain chemicals on development. HN(87) MHÑZebrafish ANNIM when exper animal; when IM, only /anat /blood-csf-urine /class /embryol /genet /growth /immunol /metab /microbiol /parasitol /physiol PIFishes (66-86) MNB2.493.200.244.828 XSBrachydanio DMÑCyprinidae LH LS LM  MHÑZein ANdo not use /defic /physiol RN9010-66-6 MND12.776.765.919 LH  MS(3S,7X)-3,4,5,6,7,8,9,10,11,12-Decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one. Non-steroid estrogen analog. Synonyms: Ralgro; P-1496; MK-188. HN(75) MHÑZeranol ANdo not use /defic /physiol; /analogs NIM only RN26538-44-3 PILactones (73-74); Resorcinols (73-74) MND2.755.852.970; D6.597.350.950; D6.597.378.950 XSDihydroxyundecyl Resorcylic Acid Lactone; Zearalanol DMÑResorcinols LH LS; LM  OLuse ZIMBABWE RHODESIA to search ZIMBABWE RHODESIA 1980, RHODESIA back thru 1967 & RHODESIA-NYASALAND 1966 HN81; was ZIMBABWE RHODESIA 1980, was RHODESIA 1967-79, was RHODESIA-NYASALAND 1963-66 MHÑZimbabwe MNZ1.58.349.940 XSRhodesia LH LS  MS3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2- propen-1-amine. A para-halophenyl inhibitor of cellular uptake or re-uptake of serotonin; its metabolite, norzimelidine, may be the more effective agent; proposed as antidepressant, especially for the aged, and as anxiolytic. PM84 HN84 MHÑZimelidine ANdo not use /biosyn /defic /physiol RN56775-88-3 PIBrompheniramine (66-83); Pyridines (66-83) MND3.383.725.620.129.960; D15.236.122.987; D23.846.987 LH  MHÑZinc ANZn-64; /defic /physiol permitted; do not use /analogs /biosyn RN7440-66-6 MND1.248.497.300.333.949; D1.268.967; D1.552.966; D1.937.961 XUÑZinc Oxide LH LU  MHÑZinc Isotopes ANZn-66, 67, 68, 70; NIM; no qualif MND1.496.966; D1.552.966.743 LH  MSMild astringent and topical protectant with some antiseptic action; used in bandages, pastes, ointments, dental cements, etc. HN(75) MHÑZinc Oxide AND25-26 qualif RN1314-13-2 PIOxides (66-74); Zinc (66-74) MND1.552.966.860; D1.655.498.960; D26.368.992 DMÑZinc LH LM  PM65 HN65 MHÑZinc Oxide-Eugenol Cement AND25-26 qualif MND25.339.291.793 LH  PM65 HN65 MHÑZinc Phosphate Cement AND25-26 qualif RN7779-90-0 MND25.339.291.893 LH  MSUnstable isotopes of zinc that decay or disintegrate spontaneously emitting radiation. Zinc (Zn) 60-63, 65, 69, 71 and 72 are radioactive isotopes of zinc. OLsearch ZINC ISOTOPES 1966-74 PM75 HN75 MHÑZinc Radioisotopes ANZn-60-63, 65, 69, 71, 72; NIM; only /admin /adv eff /anal /diag use /ther use; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use) PIZinc Isotopes (66-74); Radioisotopes (66-74) MND1.496.749.980; D1.496.966.800; D1.552.966.900 LH  HN(72) MHÑZineb ANdo not use /biosyn /defic /physiol; /analogs NIM only RN12122-67-7 PIAntifungal Agents (66-71); Pesticides (66-71); Thiocarbamates (66-71); Zinc (66-71) MND2.241.81.251.869.265.908; D2.241.866.653.265.908; D2.886.703.265.908; D5.723.288.931 DMÑThiocarbamates LH LM  MSZinc bis(dimethyldithiocarbamate). An industrial fungicidw with low mammalian toxicity. Synonyms: Zerlate; Milbam; Fuklasin. HN(75) MHÑZiram ANdo not use /biosyn /defic /physiol; /analogs NIM only RN137-30-4 PIThiocarbamates (69-74); Zinc (69-74) MND2.241.81.251.869.210.925; D2.241.866.653.210.925; D2.886.703.210.925; D5.723.288.950 DMÑThiocarbamates LH LM  MHÑZirconium ANZr-90; do not use /analogs /biosyn /defic /physiol; Zr-91, 92, 94, 96 = ZIRCONIUM (IM) + ISOTOPES (NIM); Zr-81-89, 93, 95, 97, 98 = ZIRCONIUM (IM) + RADIOISOTOPES (IM) RN7440-67-7 MND1.268.973; D1.552.977 LH  MS4-(o-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-(3,4-e)(1,4)-diazepin-7(1H)-one. A pyrazolodiazepinone with pharmacological actions similar to those of minor tranquilizers; used in combination with tiletamine to obtain immobilization and anesthesia, especially in animals. Synonyms: Flupyrazopon; Zolasepam; Zolazepan. HN(77) MHÑZolazepam ANdo not use /biosyn /defic /physiol; /analogs NIM only RN31352-82-6 PIAzepines (73-76); Fluorobenzenes (74-75); Pyrazoles (74-75) MND3.383.66.985; D15.236.872.659.985 XSCI 716; Flupyrazapon DMÑAzepines LH LS; LM  MS2-(4-(Methylsulfonyl)phenyl)imidazo(1,2-a)pyridine. Compound with analgesic, antipyretic and anti-inflammatory action, used mainly in the treatment of gastrointestinal ulcers due to its considerable mucopoietic action. HN(77) MHÑZolimidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1222-57-7 PIImidazoles (72-75); Pyridines (72-76); Sulfones (72-76) MND3.383.725.960; D19.316.203.987 XSSolimidine DMÑPyridines LH LS LM  MSNon-insulin producing islet cell adenoma of the pancreas with progressive peptic ulceration of the stomach, duodenum, and jejunum. OLto search GASTRINOMA use ZOLLINGER-ELLISON SYNDROME back thru 1982 & ISLET CELL TUMOR 1981 PMGASTRINOMA was see ISLET CELL TUMOR 1981 HNGASTRINOMA was see ISLET CELL TUMOR 1981 MHÑZollinger-Ellison Syndrome MNC4.588.274.761.743; C6.689.667.743; C19.576.983 XSGastrinoma; Islet Cell Tumor, Ulcerogenic FXÑNeoplasms, Multiple Endocrine; ÑPeptic Ulcer LH LS; LX;  MSThe transport non-cellular envelope surrounding the mammalian ovum. HN(75) MHÑZona Pellucida ANA 11 qualif except /cytol MNA5.360.490.690.950; A11.497.497.900; A16.631.900 DMÑOvum LH LM  MSA genus of Pseudomonadales occurring as rod-shaped cells embedded in a gelatinous matrix. It includes two species: Z. filipendula and Z. ramigera. OLuse ZOOGLOEA to search ZOOGLEA 1972-78 PM79,63-65; was ZOOGLEA 1972-78 HN79,63-65; was ZOOGLEA 1972-78 MHÑZoogloea ANdo not use /blood-csf-urine PIBacteria (66-71) MNB3.400.750.931 LH  MHÑZoology ANSPEC: SPEC qualif MNG1.273.943 FXÑAnimals LH LX  MSDiseases of non-human animals that may be transmitted to man. MHÑZoonoses ANavoid qualif: only likely qualif are /class /etiol /hist /microbiol /parasitol /prev /transm; do not use /vet; not a coord for every zoonotic dis: index as ZOONOSES only when discussed: TN 199 MNC1.539.968; C22.969 FXÑDisease Reservoirs; ÑPublic Health LH LX;  MSMinute free-floating animal organisms which live in practically all natural waters. HN(71) MHÑZooplankton ANdo not use /anat /embryol /microbiol /parasitol PIPlankton (66-70) MNB1.766.743 DMÑPlankton LH LM  MHÑZoxazolamine ANdo not use /biosyn /defic /physiol RN61-80-3 MND3.438.221.950; D14.73.278.398.946.987; D17.426.950 LH  MHÑZygoma ANzygomatic arch goes here MNA2.835.232.781.324.995 XSCHEEK BONE; JUGAL BONE; MALAR BONE LH LS; ;  MSFractures of the zygoma. PM72 HN72(71) MHÑZygomatic Fractures PIFractures (66-70) MNC21.866.405.762.959; C21.866.460.589.338.827; C21.866.460.836.827 LH  MSA subdivision of fungi, formerly included in the Phycomycetes, usually saprophytic or parasitic, especially for insects. OLto search ZYGOMYCETES use ZYGOMYCOTINA 1975-85 & PHYCOMYCETES 1971-74 PM86; was ZYGOMYCETES 1979-85, was ZYGOMYCETES see under PHYCOMYCETES 1971-78; ENTOMOPHTHORA was see under ZYGOMYCETES 1979-85, was see under PHYCOMYCETES 1975-78 HN86; was ZYGOMYCETES 1979-85, was ZYGOMYCETES see under PHYCOMYCETES 1971-78 MHÑZygomycotina ANdo not use /anat /embryol /microbiol /parasitol PIPhycomycetes (66-74) MNB5.354.730.944 XUÑEntomophthora LH LU  MSThe fertilized ovum. PM75 HN75 MHÑZygote ANA 11 qualif; plant zygote = SEEDS PIOvum (66-74) MNA5.360.490.690.970; A11.497.497.950; A16.950 XSFertilized Ovum LH LS  HN* * This edition of MeSH was prepared by G. Barnes, E. Calhoun, R. Chivers, S. Davidson, S. Hantsoo, R. Stander , J. van de Kamp. MHÑZymosan ANdo not use /defic /physiol RN9010-72-4 MND9.203.698.964 LH  MS3-Amino-1,1,3-propanetricarboxylic acid. Found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein and in the protein present in various ectopic calcifications. PM87; was see under GLUTAMATES 1979-86 HN87(79); was see under GLUTAMATES 1979-86 MHÑ1-Carboxyglutamic Acid AN/biosyn /physiol permitted; /analogs NIM only RN53445-96-8 PIGlutamates (66-78) MND2.241.81.901.400; D12.125.119.511.300 XSGamma-Carboxyglutamate; Gamma-Carboxyglutamic Acid LH LS;  MS3,7-Dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione. A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates cyclic nucleotide-dependent protein kinases. Synonym: SC-2964. HN(79) MHÑ1-Methyl-3-Isobutylxanthine ANdo not use /biosyn /defic /physiol; DF: MIBX RN28822-58-4 PIPhosphodiesterase Inhibitors (78); Phosphodiesterases/AI (72-77); Xanthines (66-78) MND3.438.759.758.824.751.500; D8.373.735.500 XS3-Isobutyl-1-Methylxanthine; Isobutyltheophylline DMÑTheophylline LH LS; LM  MSalpha-Naphthylamine. Suspected industrial carcinogen; its N-hydroxy metabolite is strongly carcinogenic and mutagenic. HN(76) MHÑ1-Naphthylamine AND25-26 qualif; /analogs NIM only RN134-32-7 PIAmines (69-75); Naphthalenes (69-75) MND2.92.705; D4.615.638.845; D26.191.630 XS1-Aminonaphthalene; alpha-Naphthylamine DMÑNaphthalenes LH LS; LM  MS1-Naphthylisothiocyanate. Tool for the study of liver damage; causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function; may cause skin and kidney damage. OLuse 1-NAPHTHYLISOTHIOCYANATE to search ALPHA-NAPHTHYLISOTHIOCYANATE back thru 1976 HN(77); was ALPHA-NAPHTHYLISOTHIOCYANATE see under THIOCYANATES 1976 MHÑ1-Naphthylisothiocyanate ANdo not use /biosyn /defic /physiol; /analogs NIM only RN551-06-4 PINaphthalenes (72-75); Thiocyanates (72-75) MND1.620.242.703.500; D1.877.909.500; D2.241.866.753.500; D4.615.638.870 XSANIT; alpha-Naphthylisothiocyanate DMÑThiocyanates LH LS; LM  MS1-(N-Methylglycine)-8-L-isoleucine-angiotensin II. An angiotensin II analog which acts as a highly specific inhibitor of angiotensin II. HN(80) MHÑ1-Sarcosine-8-Isoleucine Angiotensin II ANdo not use /biosyn /defic /physiol; DF: SAR ISO ANG RN9088-01-1 PIAngiotensin II (66-74) /AA (75-79); Glycine (66-67); Isoleucine (66-74) /AA (75-79); Sarcosine (68-74) /AA (75-79) MND12.644.456.73.41.815; D24.185.798.32.41.830 XS1-Sar-8-Ile Angiotensin II DMÑAngiotensin II LH LS LM  MSSynthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of PULMONARY SURFACTANTS. OLsearch PULMONARY SURFACTANTS 1977-86 PM87; was DIPALMITOYL PHOSPHATIDYLCHOLINE see PULMONARY SURFACTANT 1977-86 HN87 MHÑ1,2-Dipalmitoylphosphatidylcholine AN/biosyn /physiol permitted; DF: DPPC RN2644-64-6 PIPulmonary Surfactant (71-86); Surface-Active Agents (66-70) MND10.516.695.300.700.710.210; D24.185.701.210 XSDipalmitoyllecithin LH LS  MS1,4-alpha-D-Glucan:1,4-alpha-D-glucan 6-alpha-(1,4-alpha-glucano)-transferase. In glycogen or amylopectin synthesis, the enzyme catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. HN(76) MHÑ1,4-alpha-Glucan Branching Enzyme ANdo not use /analogs; DF: GLUCAN BRANCHING ENZYME RNEC 2.4.1.18 PIGlucosyltransferases (73-75); Polysaccharides (73-75); specific polysaccharide (73-75) MND8.586.913.407.323.320 XSAmylopectin Branching Enzyme; Glycogen Branching Enzyme; Q-Enzyme DMÑGlucosyltransferases LH LS; ; LM  PM73 HN73(72) MHÑ11-Hydroxycorticosteroids ANdo not use /analogs /defic /physiol; /chem syn permitted: do not convert to 11-HYDROXYCORTICOSTEROIDS, SYNTHETIC PIGlucocorticoids (67-71) MND6.472.40.322.478.353; D6.472.40.668.478.561 LH  MSSynthetic chemical steroids which mimic the activity of 11-hydroxycorticosteroids obtained from the adrenal cortex, but differ in structure from the naturally occurring 11-hydroxycorticosteroids. Must have an hydroxy group in the 11 position of the steroid configuration. PM75 HN75 MHÑ11-Hydroxycorticosteroids, Synthetic ANdo not use /analogs /biosyn /defic /physiol; do not confuse with 11-HYDROXYCORTICOSTEROIDS /chem syn; DF: 11 HYDROXYCORTICOSTEROIDS SYN PI11-Hydroxycorticosteroids (72-74) MND6.597.481.561.353 XS11-Hydroxycorticosteroid Analogs LH LS  MS11 alpha-15(R or S)-Dihydroxy-16,16-dimethyl- 9-oxo-prosta-5Z,13E-dien-1-oic acid or methyl ester. This synthetic prostaglandin E analog or its methyl ester protects the gastric mucosa, prevents ulceration and promotes the healing of peptic ulcers. The protective effect is independent of acid inhibition. The compounds are also potent inhibitors of pancreatic function and inhibit the growth of experimental tumors. HN(80) MHÑ16,16-Dimethylprostaglandin E2 ANdo not use /biosyn /defic /physiol; /analogs NIM only; DF: DIMETHYLPGE2 RN39746-25-3 PIProstaglandins (66-74); Prostaglandins E (75-77); Prostaglandins E, Synthetic (78-79); Prostaglandins, Synthetic (77) MND2.241.81.436.687.700.150; D10.516.251.355.708.700.150; D19.316.203.275; D24.185.798.575.750.600.275 XS16,16-Dimethylprostaglandin E2 Methyl Ester; Dimethyldinoprostone DMÑProstaglandins E, Synthetic LH LS; LM  PM65 HN65 MHÑ17-Hydroxycorticosteroids ANdo not use /analogs /defic /physiol; /chem syn permitted: do not convert to 17-HYDROXYCORTICOSTEROIDS, SYNTHETIC MND6.472.40.322.478.478 XUÑCortodoxone LH LU  MSSynthetic chemical steroids which mimic the activity of 17-hydroxycorticosteroids obtained from the adrenal cortex, but differ in structure from the naturally occurring 17-hydroxycorticosteroids. Must have an hydroxy group in the 17 position of the steroid configuration. PM75 HN75 MHÑ17-Hydroxycorticosteroids, Synthetic ANdo not use /analogs /biosyn /defic /physiol; do not confuse with 17-HYDROXYCORTICOSTEROIDS /chem syn; DF: 17 HYDROXYCORTICOSTEROIDS SYN PIHydroxycorticosteroids (72-74) MND6.597.481.561.478 XS17-Hydroxycorticosteroid Analogs LH LS  MSCatalyze the oxidation of 17-hydroxysteroids to 17-ketosteroids. PM78; ESTRADIOL DEHYDROGENASES was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77 HN78 MHÑ17-Hydroxysteroid Dehydrogenases ANdo not use /analogs RNEC 1.1. PIHydroxysteroid Dehydrogenases (66-77) MND8.586.682.47.436.375 XUÑEstradiol Dehydrogenases; ÑTestosterone Dehydrogenases LH LU;  MHÑ17-Ketosteroids ANdo not use /analogs /defic /physiol MND4.808.578.502; D6.472.40.502; D6.597.481.561.627 XS17-Oxosteroids XUÑEquilenin; ÑEquilin LH LS LU;  MS11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione. HN(75) MHÑ18-Hydroxycorticosterone ANdo not use /biosyn /defic /physiol RN561-65-9 PIHydrocortisone (73-74) MND4.808.745.745.654.237.400; D6.472.40.322.478.353.500; D6.472.40.668.478.561.550 XS18-Hydrocorticosterone DMÑCorticosterone LH LS LM  MSAn analog of desoxycorticosterone which is substituted by a hydroxyl group at the C-18 position. HN(75) MHÑ18-Hydroxydesoxycorticosterone ANdo not use /biosyn /defic /physiol PIDesoxycorticosterone (73-74) MND4.808.745.745.654.339.400; D6.472.40.668.478.298.400 DMÑDesoxycorticosterone LH LM  MS19-Iodocholest-5-en-3 beta-ol. A cholesterol derivative usually substituted with radioactive iodine in the 19 position. The compound is an adrenal cortex scanning agent used in the assessment of patients suspected of having Cushing's syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy. HN(79) MHÑ19-Iodocholesterol ANdo not use /biosyn /defic /physiol RN30461-91-7 PICholesterol (68-74) /AA (75-78); Iodine Radioisotopes (66-78) MND4.808.247.222.284.510; D4.808.247.808.197.580 DMÑCholesterol LH LM  MS2-Acetolactate methylmutase. An enzyme involved in the biosynthesis of isoleucine and valine. Converts 2-acetolactate into 3-hydroxy-2-oxo-isovalerate. Also acts on 2-hydroxy-2-acetobutyrate to form 2-hydroxy-2-oxo-3-methylvalerate. HN(75) MHÑ2-Acetolactate Mutase ANdo not use /analogs RNEC 5.4.99.3 PIHydroxybutyrates (73-74); Isomerases (73-74); Lactates (73-74) MND8.586.399.40 XS2-Acetohydroxy-3-Ketoacid Isomeroreductase; Acetohydroxy Acid Reductoisomerase DMÑIsomerases LH LS; LM  MSN-Fluoren-2-yl-acetamide. A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the arylhydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. OLuse 2-ACETYLAMINOFLUORENE to search ACETYLAMINOFLUORENE back thru 1975 PM83; was ACETYLAMINOFLUORENE 1980-82, was ACETYLAMINOFLUORENE see under FLUORENES 1975-79 HN83; was ACETYLAMINOFLUORENE 1980-82, was ACETYLAMINOFLUORENE see under FLUORENES 1975-79 MHÑ2-Acetylaminofluorene AND25-26 qualif; do not use /analogs RN53-96-3 PIAcetamides (71-74); Fluorenes (66-74) MND2.65.64.150; D2.241.81.38.108.80; D4.615.389.50; D26.191.372.16 XS2-Acetamidofluorene; Fluoren-2-ylacetamide XUÑAcetoxyacetylaminofluorene; ÑHydroxyacetylaminofluorene LH LS; LU;  MS2-Aminohexanedioic acid. An amino acid isolated from Vibrio cholera. HN(76) MHÑ2-Aminoadipic Acid AN/biosyn permitted; /analogs NIM only RN542-32-5 PIAdipic Acids (69-75); Amino Acids, Dicarboxylic (74-75) MND2.241.81.337.52.75; D12.125.119.75 XSalpha-Aminoadipic Acid DMÑAmino Acids, Dicarboxylic LH LS LM  MSA purine which is an isomer of adenine. HN(75) MHÑ2-Aminopurine ANdo not use /biosyn /defic /physiol RN452-06-2 PIAmines (72-74); Purines (72-74) MND3.438.759.138.50; D26.87.18 DMÑAdenine LH LM  MS2-Bromo-N,N-diethyl-D-lysergamide. A serotonin antagonist. Synonym: BOL 148. HN(75) MHÑ2-Bromolysergic Acid Diethylamide ANdo not use /biosyn /defic /physiol RN478-84-2 PIBromine (71-74); Lysergic Acid Diethylamide (68-74) MND3.132.327.287.572.522.150; D3.549.439.572.522.150; D23.846.561.146 XSBromo-LSD DMÑLysergic Acid Diethylamide LH LS LM  MS2-(Bromomethyl)-4-nitro-phenol. Reacts with and modifies chemically the tryptophan portion of protein molecules. Used for 'active site' enzyme studies and other protein studies. Sometimes referred to as Koshland's reagent. HN(75) MHÑ2-Hydroxy-5-Nitrobenzyl Bromide AND25-26 qualif; /analogs NIM only RN772-33-8 PIBenzyl Compounds (73-74); Nitrophenols (73-74) MND2.455.426.559.389.140.400; D2.640.743.400; D2.755.566.400; D26.550.405 DMÑNitrophenols LH LM  MSalpha-(Aminomethyl)benzyl alcohol. Simple amine found in brain; may be modulator of sympathetic functions; its derivatives are adrenergic agonists and blockaders; also used in chemical industry. Synonyms: Apophedrine; Beta-Hydroxybenzeneethanamine. HN(78) MHÑ2-Hydroxyphenethylamine AN/biosyn /physiol permitted; /analogs NIM only RN7568-93-6 PIAmino Alcohols (66-72); Ethanolamines (73-77); Phenethylamines (66-73) MND2.33.329.291.410; D2.92.63.291.410; D2.92.471.683.545; D16.538.460 XS2-Phenylethanolamine; Beta-Hydroxyphenethylamine; Beta-Phenylethanolamine; Bisnorephedrine DMÑPhenethylamines LH LS; ; ; LM  MS3-Hydroxy-4-methyl-3-carboxyvalerate 2-oxo-3-methylbutyrate-lyase (CoA-acetylating). Catalyzes the first step in the biosynthetic pathway to leucine, forming isopropyl malate from acetyl-CoA and alpha-ketoisovaleric acid. Synonym: Acetyl CoA:2-Oxoisovalerate C-Acetyltransferase. HN(75) MHÑ2-Isopropylmalate Synthase ANdo not use /analogs RNEC 4.1.3.12 PIKetoacid-Lyases (73-74); Ketoacids (73-74); Malates (73-74) MND8.586.520.567.550 DMÑKetoacid-Lyases LH LM  MS2-Mercaptoethanesulfonic acid. An inhalation expectorant that breaks disulfide bonds in the mucopolysaccharides of mucus; used to treat chronic bronchitis and other respiratory diseases. Synonyms: Mesna; Mistabron; UCB 3983. HN(77) MHÑ2-Mercaptoethanesulfonate ANdo not use /biosyn /defic /physiol PIAlkyl Sulfonates (74-75); Mercaptoethanol (74-76) MND2.241.866.540.121.525; D2.886.489.409.400; D2.886.610.121.525; D23.338.454.602 XSCoenzyme M; Mesna DMÑMercaptoethanol LH LS; LM  MSA naphthalene derivative with carcinogenic action. HN(75) MHÑ2-Naphthylamine AND25-26 qualif; /analogs NIM only RN91-59-8 PIAmines (71-74); Naphthalenes (71-74) MND2.92.710; D4.615.638.850; D26.191.634 XS2-Aminonaphthalene; beta-Naphthylamine DMÑNaphthalenes LH LS; LM  MSalpha,alpha-Dipyridyl. Used as a reagent for the determination of iron. OLuse 2,2'-DIPYRIDYL to search ALPHA,ALPHA-DIPYRIDYL back thru 1975 HN(77); was ALPHA,ALPHA-DIPYRIDYL see under PYRIDINES 1975-76 MHÑ2,2'-Dipyridyl ANdo not use /biosyn /defic /physiol; /analogs NIM only; DF: DIPYRIDYL RN366-18-7 PIPyridines (69-74) MND3.383.725.220; D26.550.269 XS2,2-Bipyridine; Bipyridyl; alpha,alpha-Dipyridyl DMÑPyridines LH LS; ; LM  MSthreo-2,3-Hexodiulosonic acid. Proposed antineoplastic agent. HN(75) MHÑ2,3-Diketogulonic Acid ANdo not use /defic /physiol; /analogs NIM only RN3409-57-2 PIKetoses (74); Sugar Acids (73-74) MND2.241.81.844.200; D2.241.511.902.200; D9.203.811.200 DMÑSugar Acids LH LM  PM73 HN73(71) MHÑ2,4-Dichlorophenoxyacetic Acid ANdo not use /biosyn /defic /physiol RN94-75-7 PIAcetic Acids (66-70); Herbicides (66-70); Phenols (66-70) MND2.241.511.316.300; D5.723.366.279 XS2,4-D LH LS  PM74 HN74(71) MHÑ2,4,5-Trichlorophenoxyacetic Acid ANdo not use /biosyn /defic /physiol RN93-76-5 PIAcetic Acids (66-70); Herbicides (66-70); Phenols (66-70) MND2.241.511.316.881; D5.723.366.901 XS2,4,5-T LH LS  MS2,6-Dichloroindophenol sodium. A dye used as a reagent in the determination of vitamin C. HN(75) MHÑ2,6-Dichloroindophenol AND25-26 qualif RN956-48-9 PIChlorine (72-74); Indophenol (72-74) MND2.755.446.250; D26.550.200 XS2,6-Dichlorophenolindophenol; Sodium 2,6-Dichloroindophenol; Tillmans' Reagent DMÑIndophenol LH LS; ; LM  MSNucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Catalyzes the hydrolysis of the 2' or 3' phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. OLuse 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES to search 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE back thru 1975 PM85; was 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE see under PHOSPHODIESTERASES 1975-84 HN85; was 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE see under PHOSPHODIESTERASES 1975-84 MHÑ2',3'-Cyclic Nucleotide Phosphodiesterases ANdo not use /analogs; DF: CYCL NUCLEOTIDE PHOSPHODIESTERASES RNEC 3.1.4.- PIAdenosine Cyclic Monophosphate (73-74); Phosphodiesterases (73-74) MND8.586.277.352.630.553.170 LH  MSCatalyzes the conversion of ATP into a series of (2'-5') linked oligoadenylates and pyrophosphate in the presence of double-stranded RNA. These oligonucleotides activate an endoribonuclease (RNase L) which cleaves single-stranded RNA. Interferons can act as inducers of these reactions. PM83 HN83 MHÑ2',5'-Oligoadenylate Synthetase ANdo not use /analogs RNEC 2.7.7.- PINucleotidyltransferases (66-82) MND8.586.913.696.445.625 XS2',5'-Oligoadenylate Polymerase; 2-5A Synthetase LH LS;  MSCatalyze the oxidation of 20-hydroxysteroids to 20-ketosteroids. Includes EC 1.1.1.149 and EC 1.1.1.53. PM78 HN78 MHÑ20-Hydroxysteroid Dehydrogenases ANdo not confuse with 20-BETA-HYDROXYSTEROID DEHYDROGENASE (see CORTISONE REDUCTASE); do not use /analogs RNEC 1.1.1.- PIHydroxysteroid Dehydrogenases (66-77) MND8.586.682.47.436.400 XUÑCortisone Reductase LH LU  MSCatalyzes the formation of 1,25-dihydroxycholecalciferol from 25-hydroxycholecalciferol. Requires oxygen, magnesium and NAD(P)H. HN(75) MHÑ25-Hydroxycholecalciferol 1-Hydroxylase ANdo not use /analogs RNEC 1.14.13.13 PIHydroxycholecalciferols (73-74); Steroid Hydroxylases (73-74) MND8.586.682.420.783.400 XS25-Hydroxyvitamin D(3)1-alpha-Hydroxylase
 HYDROXYVITAMIND0301ALPHAHYDROXYLASE DMÑSteroid Hydroxylases LH LS LM  MSAn amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GABA. A rare genetic disorder, hyper-beta-alaninemia, has been reported. HN(79) MHÑ3-Aminopropionic Acid AN/biosyn /physiol permitted RN107-95-9 PIAlanine (66-78); Amino Acids (66-78) MND12.125.42.70 XSBeta-Alanine DMÑAlanine LH LS LM  MS4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. HN(75) MHÑ3-Deazauridine ANdo not use /biosyn /defic /physiol RN23205-42-7 PIPyridones (73-74); Uridine (72-74) MND13.570.685.852.250; D13.570.800.892.250; D22.204.144.400; D26.87.262 DMÑUridine LH LM  MS3-Hydroxy-3-methylpentanedioic acid. An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of hydroxymethylglutaryl CoA reductase which is the rate limiting enzyme in the biosynthesis of cholesterol. HN(80) MHÑ3-Hydroxy-3-Methylglutaric Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN503-49-1 PIAnticholesteremic Agents (66-79); Antilipemic Agents (66-72); Glutarates (66-79); Hydroxy Acids (75-79) MND2.241.81.337.351.400; D10.162.400 DMÑGlutarates LH LM  MSL-3-Hydroxyacyl-CoA:NAD+ oxidoreductases. Reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. Key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. EC 1.1.1.35. PM78 HN78 MHÑ3-Hydroxyacyl CoA Dehydrogenases ANdo not use /analogs RNEC 1.1.1.35 PIAlcohol Oxidoreductases (66-77); Coenzyme A (66-77) MND8.586.682.47.385 XSBeta-Hydroxyacyl Dehydrogenases LH LS  MS3-Hydroxyanthranilic acid. Carcinogen. HN(75) MHÑ3-Hydroxyanthranilic Acid AND25-26 qualif; /analogs NIM only RN548-93-6 PIAnthranilic Acids (70-74); Phenols (72-74) MND2.241.223.106.61.105.460; D26.191.480 DMÑAnthranilic Acids LH LM  MSCatalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. PM78 HN78 MHÑ3-Hydroxysteroid Dehydrogenases ANdo not use /analogs RNEC 1.1. PIHydroxysteroid Dehydrogenases (66-77) MND8.586.682.47.436.350 XS3-Beta-Hydroxysteroid Dehydrogenase XUÑCholesterol Oxidase; ÑProgesterone Reductase LH LS LU;  MS3-Mercaptopropionic acid. Inhibitor of glutamate decarboxylase; it decreases the GABA concentration in the brain, thereby causing convulsions. Synonyms: beta-mercaptopropionic acid; 3-thiohydracrylic acid. HN(78) MHÑ3-Mercaptopropionic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN107-96-0 PIPropionates (66-77); Sulfhydryl Compounds (66-77) MND2.241.81.751.700.550; D2.886.489.520; D8.373.560; D15.128.224.582 XS3-Mercaptopropanoic Acid; Beta-Mercaptopropionate DMÑSulfhydryl Compounds LH LS; LM  MS3-Methoxy-4-hydroxyphenylethanol. Metabolite of serotonin and norepinephrine. HN(75) MHÑ3-Methoxy-4-Hydroxyphenylethanol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN2380-78-1 PIAlcohol, Ethyl (72-74); Catechols (72-74) MND2.755.166.500 XSHydroxymethoxyphenethyl Alcohol; MHPE; MOPET; Methoxyhydroxyphenylethanol DMÑCatechols LH LS; ; ; LM  MSAcyl-(acyl carrier protein):malonyl-(acyl carrier protein) C-acyltransferase (decarboxylating). An enzyme of long-chain fatty acid synthesis, which adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. HN(75) MHÑ3-Oxoacyl (Acyl Carrier Protein) Synthase ANdo not use /analogs; DF: OXOACYL ACP SYNTHASE RNEC 2.3.1.41 PIAcyltransferases (70-74); Malonates (70-74); Carrier Proteins (73-74) MND8.586.913.50.770 DMÑAcyltransferases LH LM  MS3,3',4,4' Biphenyltetramine. HN(75); was see under AMINOBIPHENYL COMPOUNDS 1975-76 MHÑ3,3'-Diaminobenzidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN91-95-2 PIBiphenyl Compounds (70-74); Phenylenediamines (74) MND2.455.426.559.389.185.200 DMÑBenzidines LH LM  MS3,3'-Dichloro-4,4'-diaminodiphenyl. A material used in the manufacture of azo dyes; toxic to skin and carcinogenic in several species. HN(77) MHÑ3,3'-Dichlorobenzidine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN91-94-1 PIAniline Compounds (69-74); Benzidines/AA (75-76); Biphenyl Compounds (69-74) MND2.455.426.559.389.185.226; D26.191.111.267 DMÑBenzidines LH LM  MS3,4-Dihydroxyphenylacetic acid. Metabolite of L-Dopa. Synonyms: DOPAC; Ba 2773. HN(75) MHÑ3,4-Dihydroxyphenylacetic Acid ANdo not use /defic /physiol; /analogs NIM only RN102-32-9 PICatechol (72-74); Phenylacetates (72-74) MND2.241.223.601.220 XSDopacetic Acid; Homoprotocatechuic Acid DMÑPhenylacetates LH LS; LM  MS3-(3,4-Dihydroxyphenyl)serine. HN(75) MHÑ3,4-Dihydroxyphenylserine ANdo not use /biosyn /defic /physiol RN13147-26-7 PICatechol (71-74); Serine (71-74) MND12.125.837.220 XSDops DMÑSerine LH LS LM  MSalpha-Methyl-3,4-(methylenedioxy)-phenethylamine. Sympathomimetic central nervous system stimulant, derivative of amphetamine that is mostly protein-bound, acts as a false transmitter and may inhibit monoamine oxidase; it is used as a hallucinogen. HN(77) MHÑ3,4-Methylenedioxyamphetamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN4764-17-4 PIAmphetamine (73-76); Dioxoles (74-75); Methyl Ether (73) MND2.92.471.683.152.680; D15.236.372.632 XSMDA DMÑAmphetamines LH LS LM  MSCatalyzes the hydrolysis of cyclic AMP to form adenosine 5'-phosphate. The enzyme is widely distributed in animal tissue and controls the level of intracellular cyclic AMP. Also acts on 3',5'-cyclic IMP and 3',5'-cyclic GMP. PM78; was see under PHOSPHODIESTERASES 1975-77 HN78(75); was see under PHOSPHODIESTERASES 1975-77 MHÑ3',5'-Cyclic AMP Phosphodiesterase ANdo not use /analogs; regulation: consider also CALMODULIN; DF: CYCL AMP PHOSPHODIESTERASE RNEC 3.1.4.17 PIAdenosine Cyclic Monophosphate (73-74); Phosphodiesterases (73-74) MND8.586.277.352.630.553.150 XS3',5'-Cyclic AMP 5'-Nucleotidohydrolase LH LS  MS3',5'-Cyclic-GMP 5'-nucleotidohydrolase. Catalyzes the hydrolysis of cyclic GMP to yield guanosine-5'-phosphate. EC 3.1.4.35. PM78 HN78 MHÑ3',5'-Cyclic GMP Phosphodiesterase ANdo not use /analogs; DF: CYCL GMP PHOSPHODIESTERASE RNEC 3.1.4.35 PIGuanosine Cyclic Monophosphate (71-77); Phosphodiesterases (72-77) MND8.586.277.352.630.553.160 XS3',5'-Cyclic GMP 5'-Nucleotidohydrolase LH LS  MSDihydro-2(3H)-furanone. An endogenous neuroregulator made from gamma amino butyrate and the precursor of gamma hydroxybutyrate; causes selective increase of brain dopamine by inhibiting its release from nerve terminals; has sedative properties at low dose and produces surgical anesthesia at high doses; also used as industrial solvent and precursor. OLuse 4-BUTYROLACTONE to search GAMMA BUTYROLACTONE back thru 1976 HN77; was GAMMA BUTYROLACTONE see under FURANS 1976 MHÑ4-Butyrolactone ANdo not use /defic /physiol; /analogs NIM only RN96-48-0 PIFurans (69-75); Lactones (69-75) MND2.540.150; D3.383.312.150; D14.166.150; D14.591.745.105; D16.538.85.395.200 XS1,4-Butanolide; 4-Hydroxybutyric Acid Lactone; gamma-Butyrolactone DMÑFurans LH LS; ; LM  MSA potent mutagen and carcinogen. It is a reduction product of 4-nitroquinoline-1-oxide. It binds with nucleic acids and inactivates both bacteria and bacteriophage. HN(75) MHÑ4-Hydroxyaminoquinoline-1-Oxide AND25-26 qualif; /analogs NIM only RN4637-56-3 PICyclic N-Oxides (72-74); Hydroxylamines (74); Quinolines (72-74) MND2.92.570.450; D3.438.810.50.440; D3.661.243.320; D26.191.474 XS4-Hydroxyaminoquinoline-N-Oxide DMÑAminoquinolines LH LS LM  MS4-Hydroxybenzoate,NADPH:oxygen oxidoreductase (3-hydroxylating). Catalyzes the synthesis of protocatechuic acid from 4-hydroxybenzoate in the presence of molecular oxygen. A flavoprotein. HN(75) MHÑ4-Hydroxybenzoate-3-Monooxygenase ANdo not use /analogs RNEC 1.14.13.2 PIBenzoates (71-74); Hydroxylases (71-74); Phenols (71-74) MND8.586.682.420.425 XSp-Hydroxybenzoate Hydroxylase; para-Hydroxybenzoate Hydroxylase DMÑHydroxylases LH LS; LM  MSSubstances found in many plants, containing the 4-hydroxycoumarin radical; they interfere with vitamin K and the blood clotting mechanism, are tightly protein-bound and inhibit mitochondrial and microsomal enzymes; used as oral anticoagulants. PM77; PHENPROCOUMON was see under COUMARINS 1975-76 HN77 MHÑ4-Hydroxycoumarins AN/biosyn permitted if by plant; do not use /analogs /defic /physiol PICoumarins (72-76) MND3.438.150.446.520; D19.461.119.196.475 XUÑPhenprocoumon LH LU  MS4-Hydroxyphenylpyruvate:oxygen oxidoreductase (hydroxylating, decarboxylating). Catalyzes the conversion of 4-hydroxyphenylpyruvate plus oxygen to homogentisic acid and carbon dioxide. Formerly EC 1.14.2.2. HN(75) MHÑ4-Hydroxyphenylpyruvate Dioxygenase ANdo not use /analogs; /defic: consider also TYROSINE /blood (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) RNEC 1.13.11.27 PIOxygenases (74); Phenylpyruvic Acids (74) MND8.586.682.690.400 XSP-Hydroxyphenylpyruvate Hydroxylase; P-Hydroxyphenylpyruvate Oxidase; para-Hydroxyphenylpyruvate Hydroxylase; para-Hydroxyphenylpyruvate Oxidase DMÑOxygenases LH LS; ; ; LM  MSA potent mutagen and carcinogen. This compound and its metabolite 4-hydroxyaminoquinoline-1-oxide bind to nucleic acids. It inactivates bacteria but not bacteriophage. HN(75) MHÑ4-Nitroquinoline-1-Oxide AND25-26 qualif; /analogs NIM only RN56-57-5 PICyclic N-Oxides (72-74); Nitro Compounds (72-74); Quinolines (70-74) MND2.640.820.600; D3.438.810.470.450; D3.661.243.500; D26.191.641 XS4-Nitroquinoline-N-Oxide DMÑNitroquinolines LH LS LM  MS5 alpha-Androstane-3 beta,17 beta-diol. A naturally occurring steroid with androgenic activity. OLuse 5-ANDROSTANE-3,17-DIOL to search ANDROSTANEDIOL 1975-79 HN(80); was ANDROSTANEDIOL see under ANDROSTANES 1975-79 MHÑ5-Androstane-3,17-diol ANdo not confuse with 5-ANDROSTENE-3,l7-DIOL; /biosyn /physiol permitted; /analogs NIM only RN25126-76-5 PIAndrostanes (73-75); Hydroxysteroids (73-74) MND4.808.54.40.80; D6.472.79.80 DMÑAndrostanols LH LM  MS5-Androstene-3 beta,17 beta-diol. An anabolic steroid. Synonyms: Bisexovis; Stenandiol. HN(76) MHÑ5-Androstene-3,17-diol ANdo not use /biosyn /defic /physiol; /analogs NIM only RN521-17-5 PIAndrostenediols (75) MND4.808.54.79.429.154.50; D6.597.100.194.50 XSAndrostenediol Dipropionate DMÑAndrostenediols LH LS LM  MS3-(2-Aminoethyl)indole-5,6-diol. Tryptamine substituted with two hydroxyl groups in positions 5 and 6; it is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacologic research. PM78; was see under TRYPTAMINES 1975-77 HN78(75); was see under TRYPTAMINES 1975-77 MHÑ5,6-Dihydroxytryptamine ANdo not use /biosyn /defic /physiol RN5090-36-8 PITryptamines (66-74) MND3.438.473.914.201.259; D23.846.282.259 LH  MS3-(2-Aminoethyl)-indole-5,7-diol. Tryptamine substituted with two hydroxyl groups in positions 5 and 7; it is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacology as a tool. HN(78) MHÑ5,7-Dihydroxytryptamine ANdo not use /biosyn /defic /physiol; /analogs NIM only RN31363-74-3 PITryptamines (66-77) MND3.438.473.914.201.263; D23.846.282.263 DMÑDihydroxytryptamines LH LM  MSA 20-carbon unsaturated fatty acid containing 4 alkyne bonds. Inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a). HN(75) MHÑ5,8,11,14-Eicosatetraynoic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN1191-85-1 PIFatty Acids, Unsaturated (73-74) MND2.241.81.436.220; D10.516.251.355.270 XSETYA DMÑFatty Acids, Unsaturated LH LS LM  MSImportant polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. PM86 HN86 MHÑ5,8,11,14,17-Eicosapentaenoic Acid ANdo not use /defic /physiol; DF: EICOSAPENTAENOIC ACID RN1553-41-9 PIFatty Acids (66-72); Fatty Acids, Unsaturated (73-85) MND2.241.81.436.215; D10.516.212.302.380.390; D10.516.251.355.260; D10.516.627.430.390; J1.740.250.300; J1.740.350.375 LH  MS6-Aminohexanoic acid. An antifibrinolytic agent which acts by inhibiting plasminogen activators which have fibrinolytic properties. Synonyms: Amicar; Caprocid; Epsamon; Epsikapron; CY 116. OLsearch AMINOCAPROIC ACIDS 1966-76 HN(77); EPSILON-AMINOCAPROIC ACID was see AMINOCAPROIC ACIDS 1975-76, was see AMINOCAPROIC ACID 1964-74 MHÑ6-Aminocaproic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN60-32-2 PIAminocaproic Acids (66-76) MND2.241.81.193.150.75; D12.125.213.75; D19.461.270.463.91.276 XS6-Aminohexanoic Acid; Epsilon-Aminocaproic Acid DMÑAminocaproic Acids LH LS; LM  MS6-Aminonicotinamide. A vitamin antagonist which has teratogenic effects. HN(76) MHÑ6-Aminonicotinamide ANdo not use /biosyn /defic /physiol RN329-89-5 PIAmines (72-75); Nicotinamide (68-74) /AA (75) MND11.786.708.547.565.50 DMÑNicotinamide LH LM  MS6-Ketoprostaglandin F1 alpha. The physiologically active and stable hydrolysis product of prostacyclin. Found in nearly all mammalian tissue. PM82 HN82 MHÑ6-Ketoprostaglandin F1 alpha AN/biosyn /physiol permitted RN58962-34-8 PIProstaglandins (66-74); Prostaglandins F (75-8l) MND2.241.81.436.687.250.350; D10.516.251.355.708.400.350; D24.185.798.575.400.350 XS6-Keto-PGF1 alpha; 6-Oxo-PGF1 alpha; 6-Oxoprostaglandin F1 alpha LH LS; ;  OLuse 6-MERCAPTOPURINE to search MERCAPTOPURINE back thru 1966 PM85; was MERCAPTOPURINE 1963-84 HN85; was MERCAPTOPURINE 1963-84 MHÑ6-Mercaptopurine ANdo not use /biosyn /defic /physiol; ribosyl, ribofuranosyl mercaptopurine = THIOINOSINE RN50-44-2 MND2.886.489.534; D3.438.759.534; D22.204.144.713; D26.87.582 XUÑArabinosyl-6-mercaptopurine LH LU  MS7,8,8a,9a-Tetrahydrobenzo(10,11) chryseno(3,4-b)oxirene-7,8-diol. Benzopyrene derivative with carcinogenic or mutagenic activity. HN(87) MHÑ7,8-Dihydro-7,8-Dihydroxybenzo(a)pyrene 9,10-Oxide ANdo not use /biosyn /defic /physiol; DF: 7 8 DDBP RN55097-80-8 PIBenzopyrenes (66-86) MND4.615.799.306.400.350; D26.191.262.280 XS7,8-Dihydroxy-9,10-Epoxy-7,8,9,10-Tetrahydrobenzo(a)pyrene; Benzo(a)pyrene 7,8-Dihydrodiol 9,10-Epoxide DMÑDihydroxydihydrobenzopyrenes LH LS; LM  MS8-Bromoadenosine 3',5,-cyclic monophosphate. Long-acting derivative of cyclic AMP. Activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase. PM84 HN84 MHÑ8-Bromo Cyclic Adenosine Monophosphate AN/biosyn /physiol permitted; DF: BR CAMP RN23583-48-4 PIAdenine Nucleotides (66-68); Adenosine Cyclic Monophosphate (68-83) MND13.695.462.180.200; D13.695.667.138.69.200; D13.695.827.68.69.200 XS8-Bromo-cAMP LH LS  MS8-Quinolinol. Antiseptic with mild fungistatic, bacteriostatic, anthelmintic and amebicidal action; also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes; its halogenated derivatives are also used as topical anti-infective agents and as oral antiamebics. HN(75) MHÑ8-Hydroxyquinoline ANdo not use /biosyn /defic /physiol; /analogs NIM only RN148-24-3 PIQuinolines (71-74) MND3.438.810.350.350 XS8-Quinolinol; Oxine; Oxyquinol; Oxyquinoline DMÑHydroxyquinolines LH LS; ; ; LM  MS8,11,14-Eicosatrienoic acid. A 20 carbon chain fatty acid, unsaturated at positions 8,11,14. Differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5. HN(75) MHÑ8,11,14-Eicosatrienoic Acid ANdo not use /biosyn /defic /physiol; /analogs NIM only RN7324-41-6 PIFatty Acids, Unsaturated (73-74) MND2.241.81.436.240; D10.516.251.355.280 XSHomo-Gamma Linolenic Acid DMÑFatty Acids, Unsaturated LH LS LM  MS7,12-Dimethylbenzanthracene. Polycyclic aromatic hydrocarbon found in tobacco smoke; it is a potent carcinogen. PM85; was see under BENZANTHRACENES 1975-84 HN85(75); was see under BENZANTHRACENES 1975-84 MHÑ9,10-Dimethyl-1,2-Benzanthracene ANdo not use /biosyn /defic /physiol RN57-97-6 PIBenzanthracenes (66-74) MND4.615.117.306.301; D26.191.72.122.269 XS7,12-Dimethylbenzanthracene; DMBA LH LS;